id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
94655728|NCT03328897|324198186|FG000|Randomized-treatment Epoch|Adverse Event|4|||
94655729|NCT03328897|324198187|FG001|Randomized-treatment Epoch|Adverse Event|1|||
94655730|NCT03328897|324198188|FG002|Randomized-treatment Epoch|Adverse Event|1|||
94655731|NCT03328897|324198186|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
94655732|NCT03328897|324198187|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
94222243|NCT01537120|322606405|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
94222244|NCT01537120|322606405|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
94222245|NCT00755716|322606406|FG000|Overall Study|Adverse Event|1|||
94222246|NCT00755716|322606407|FG001|Overall Study|Adverse Event|4|||
94655733|NCT03328897|324198188|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
94655734|NCT03328897|324198186|FG000|Randomized-treatment Epoch|Pregnancy|3|||
94655735|NCT03328897|324198187|FG001|Randomized-treatment Epoch|Pregnancy|0|||
94655736|NCT03328897|324198188|FG002|Randomized-treatment Epoch|Pregnancy|0|||
94655737|NCT03328897|324198186|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
94655738|NCT03328897|324198187|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
94655739|NCT03328897|324198188|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
94655740|NCT03328897|324198186|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
94655741|NCT03328897|324198187|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
94655742|NCT03328897|324198188|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
94655743|NCT03328897|324198186|FG000|Follow-up Epoch|Adverse Event|4|||
94655744|NCT03328897|324198187|FG001|Follow-up Epoch|Adverse Event|0|||
94655745|NCT03328897|324198188|FG002|Follow-up Epoch|Adverse Event|1|||
94655746|NCT03328897|324198186|FG000|Follow-up Epoch|Lack of Efficacy|1|||
94655747|NCT03328897|324198187|FG001|Follow-up Epoch|Lack of Efficacy|1|||
94655748|NCT03328897|324198188|FG002|Follow-up Epoch|Lack of Efficacy|1|||
94655749|NCT03328897|324198186|FG000|Follow-up Epoch|Lost to Follow-up|0|||
94655750|NCT03328897|324198187|FG001|Follow-up Epoch|Lost to Follow-up|1|||
94655751|NCT03328897|324198188|FG002|Follow-up Epoch|Lost to Follow-up|0|||
94655752|NCT03328897|324198186|FG000|Follow-up Epoch|Pregnancy|1|||
94655753|NCT03328897|324198187|FG001|Follow-up Epoch|Pregnancy|0|||
94655754|NCT03328897|324198188|FG002|Follow-up Epoch|Pregnancy|0|||
94655755|NCT03328897|324198186|FG000|Follow-up Epoch|Patient/guardian decision|2|||
94655756|NCT03328897|324198187|FG001|Follow-up Epoch|Patient/guardian decision|1|||
94655757|NCT03328897|324198188|FG002|Follow-up Epoch|Patient/guardian decision|0|||
94655758|NCT01607905|324198192|FG000|Overall Study|Withdrawal by participant|7|||
94655759|NCT01607905|324198193|FG001|Overall Study|Withdrawal by participant|2|||
94655760|NCT01607905|324198194|FG002|Overall Study|Withdrawal by participant|4|||
94655761|NCT01607905|324198195|FG003|Overall Study|Withdrawal by participant|6|||
94655762|NCT01607905|324198196|FG004|Overall Study|Withdrawal by participant|0|||
94655763|NCT01607905|324198197|FG005|Overall Study|Withdrawal by participant|4|||
94655764|NCT01607905|324198198|FG006|Overall Study|Withdrawal by participant|12|||
94439376|NCT01290302|323396132|FG000|Overall Study|Adverse Event|2|||
94655765|NCT01607905|324198192|FG000|Overall Study|Incidence or severity of AEs|5|||
94655766|NCT01607905|324198193|FG001|Overall Study|Incidence or severity of AEs|1|||
94655767|NCT01607905|324198194|FG002|Overall Study|Incidence or severity of AEs|1|||
94655768|NCT01607905|324198195|FG003|Overall Study|Incidence or severity of AEs|3|||
94655769|NCT01607905|324198196|FG004|Overall Study|Incidence or severity of AEs|0|||
94655770|NCT01607905|324198197|FG005|Overall Study|Incidence or severity of AEs|2|||
94655771|NCT01607905|324198198|FG006|Overall Study|Incidence or severity of AEs|8|||
94655772|NCT01607905|324198192|FG000|Overall Study|Disease progression|44|||
94655773|NCT01607905|324198193|FG001|Overall Study|Disease progression|16|||
94655774|NCT01607905|324198194|FG002|Overall Study|Disease progression|15|||
94655775|NCT01607905|324198195|FG003|Overall Study|Disease progression|11|||
94439377|NCT01290302|323396133|FG001|Overall Study|Adverse Event|0|||
94439378|NCT01290302|323396132|FG000|Overall Study|Withdrawal by Subject|1|||
94439379|NCT01290302|323396133|FG001|Overall Study|Withdrawal by Subject|0|||
94655776|NCT01607905|324198196|FG004|Overall Study|Disease progression|6|||
94655777|NCT01607905|324198197|FG005|Overall Study|Disease progression|7|||
94655778|NCT01607905|324198198|FG006|Overall Study|Disease progression|21|||
94655779|NCT01607905|324198192|FG000|Overall Study|Non-compliance with study procedures|0|||
94655780|NCT01607905|324198193|FG001|Overall Study|Non-compliance with study procedures|0|||
94655781|NCT01607905|324198194|FG002|Overall Study|Non-compliance with study procedures|0|||
94655782|NCT01607905|324198195|FG003|Overall Study|Non-compliance with study procedures|0|||
94688549|NCT02960763|324315506|FG002|Step 2|Lost to Follow-up|0|||
94222247|NCT00755716|322606408|FG002|Overall Study|Adverse Event|1|||
94222248|NCT00755716|322606406|FG000|Overall Study|Lack of Efficacy|2|||
94222249|NCT00755716|322606407|FG001|Overall Study|Lack of Efficacy|0|||
94222250|NCT00755716|322606408|FG002|Overall Study|Lack of Efficacy|0|||
94222251|NCT00755716|322606406|FG000|Overall Study|Lost to Follow-up|5|||
94222252|NCT00755716|322606407|FG001|Overall Study|Lost to Follow-up|3|||
94222253|NCT00755716|322606408|FG002|Overall Study|Lost to Follow-up|1|||
94222254|NCT00755716|322606406|FG000|Overall Study|work schedule issues|0|||
94222255|NCT00755716|322606407|FG001|Overall Study|work schedule issues|1|||
94439380|NCT01290302|323396132|FG000|Overall Study|Physician Decision|0|||
94439381|NCT01290302|323396133|FG001|Overall Study|Physician Decision|2|||
94222256|NCT00755716|322606408|FG002|Overall Study|work schedule issues|1|||
94222257|NCT02101554|322606409|FG000|Overall Study|Protocol Violation|0|||
94222258|NCT02101554|322606410|FG001|Overall Study|Protocol Violation|1|||
94222259|NCT02101554|322606411|FG002|Overall Study|Protocol Violation|0|||
94222260|NCT02101554|322606409|FG000|Overall Study|Insufficient Clinical Response|0|||
94222261|NCT02101554|322606410|FG001|Overall Study|Insufficient Clinical Response|2|||
94222262|NCT02101554|322606411|FG002|Overall Study|Insufficient Clinical Response|0|||
94222263|NCT02101554|322606409|FG000|Overall Study|Adverse Event|2|||
94222264|NCT02101554|322606410|FG001|Overall Study|Adverse Event|1|||
94222265|NCT02101554|322606411|FG002|Overall Study|Adverse Event|1|||
94222266|NCT02101554|322606409|FG000|Overall Study|Lost to Follow-up|0|||
94222267|NCT02101554|322606410|FG001|Overall Study|Lost to Follow-up|1|||
94222268|NCT02101554|322606411|FG002|Overall Study|Lost to Follow-up|0|||
94222269|NCT02101554|322606409|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
94439382|NCT01290302|323396132|FG000|Overall Study|Expiration of time for screening window|1|||
94222270|NCT02101554|322606410|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
94222271|NCT02101554|322606411|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
94222272|NCT03087851|322606412|FG000|Overall Study|Withdraw on medical grounds|0|||
94222273|NCT03087851|322606413|FG001|Overall Study|Withdraw on medical grounds|1|||
94222274|NCT03087851|322606414|FG002|Overall Study|Withdraw on medical grounds|2|||
94222275|NCT00644332|322606415|FG000|Overall Study|Adverse Event|11|||
94222276|NCT00644332|322606415|FG000|Overall Study|Withdrawal by Subject|6|||
94222277|NCT00644332|322606415|FG000|Overall Study|Completion Status Unknown|2|||
94222278|NCT00644332|322606415|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
94222279|NCT00644332|322606415|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
94222280|NCT02706834|322606419|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
94222281|NCT02706834|322606420|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
94222282|NCT02706834|322606421|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
94439383|NCT01290302|323396133|FG001|Overall Study|Expiration of time for screening window|0|||
94439384|NCT01059786|323396134|FG000|Overall Study|Did not receive 6 cycles.|0|||
94439385|NCT01059786|323396135|FG001|Overall Study|Did not receive 6 cycles.|0|||
94439386|NCT01059786|323396136|FG002|Overall Study|Did not receive 6 cycles.|4|||
94439387|NCT01059786|323396137|FG003|Overall Study|Did not receive 6 cycles.|1|||
94222283|NCT02706834|322606422|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
94439388|NCT01059786|323396138|FG004|Overall Study|Did not receive 6 cycles.|0|||
94439389|NCT03300817|323396139|FG000|Overall Study|Withdrawal by Subject|1|||
94439390|NCT03300817|323396139|FG000|Overall Study|Adverse Event|1|||
94439391|NCT03300817|323396139|FG000|Overall Study|Subject Found to be Ineligible|2|||
94439392|NCT02465398|323396150|FG000|Overall Study|Death|7|||
94439393|NCT02465398|323396150|FG000|Overall Study|Revision|7|||
94439394|NCT02465398|323396150|FG000|Overall Study|did not receive study device|1|||
94439395|NCT02465398|323396150|FG000|Overall Study|Withdrawal by Subject|1|||
94439396|NCT02465398|323396150|FG000|Overall Study|Lost to Follow-up|14|||
94439397|NCT02653625|323396157|FG000|Overall Study|Adverse Event|1|||
94439398|NCT02653625|323396157|FG000|Overall Study|Non-compliance with Study Drug|1|||
94439399|NCT02653625|323396157|FG000|Overall Study|Protocol Violation|1|||
94439400|NCT02653625|323396157|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
94439401|NCT01762800|323396158|FG000|Overall Study|Adverse Event|8|||
94439402|NCT01762800|323396159|FG001|Overall Study|Adverse Event|13|||
94439403|NCT01762800|323396158|FG000|Overall Study|Lack of Efficacy|3|||
94439404|NCT01762800|323396159|FG001|Overall Study|Lack of Efficacy|2|||
94439405|NCT01762800|323396158|FG000|Overall Study|Study Closed/Terminated|0|||
94439406|NCT01762800|323396159|FG001|Overall Study|Study Closed/Terminated|1|||
94439407|NCT01762800|323396158|FG000|Overall Study|Physician Decision|1|||
94439408|NCT01762800|323396159|FG001|Overall Study|Physician Decision|1|||
94439409|NCT01762800|323396158|FG000|Overall Study|Withdrawal by Subject|7|||
94439410|NCT01762800|323396159|FG001|Overall Study|Withdrawal by Subject|4|||
94439411|NCT00064987|323396160|FG000|Overall Study|Physician Decision|3|||
94439412|NCT00064987|323396161|FG001|Overall Study|Physician Decision|0|||
94439413|NCT02969382|323396162|FG000|Overall Study|Adverse Event|8|||
94439414|NCT02969382|323396163|FG001|Overall Study|Adverse Event|10|||
94439415|NCT02969382|323396162|FG000|Overall Study|Lack of Efficacy|4|||
94439416|NCT02969382|323396163|FG001|Overall Study|Lack of Efficacy|5|||
94439417|NCT02969382|323396162|FG000|Overall Study|Death|0|||
94439418|NCT02969382|323396163|FG001|Overall Study|Death|1|||
94222284|NCT02706834|322606423|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
94222285|NCT02706834|322606424|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
94222286|NCT02706834|322606425|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
94222287|NCT02706834|322606426|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
94439419|NCT02969382|323396162|FG000|Overall Study|PROTOCOL DEVIATION|0|||
94439420|NCT02969382|323396163|FG001|Overall Study|PROTOCOL DEVIATION|1|||
94439421|NCT02969382|323396162|FG000|Overall Study|Withdrawal by Subject|14|||
94439422|NCT02969382|323396163|FG001|Overall Study|Withdrawal by Subject|9|||
94439423|NCT02090725|323396164|FG000|Overall Study|Withdrawal by Subject|1|||
94439424|NCT02090725|323396164|FG000|Overall Study|participants moved from area|3|||
94439425|NCT00764881|323396165|FG000|Overall Study|Adverse Event|5|||
94439426|NCT00764881|323396166|FG001|Overall Study|Adverse Event|1|||
94222288|NCT02706834|322606427|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
94222289|NCT02706834|322606428|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
94222290|NCT02706834|322606429|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
94222291|NCT02706834|322606419|FG000|Overall Study|Lost to Follow-up|0|||
94222292|NCT02706834|322606420|FG001|Overall Study|Lost to Follow-up|0|||
94222293|NCT02706834|322606421|FG002|Overall Study|Lost to Follow-up|1|||
94222294|NCT02706834|322606422|FG003|Overall Study|Lost to Follow-up|0|||
94222295|NCT02706834|322606423|FG004|Overall Study|Lost to Follow-up|0|||
94439427|NCT00764881|323396165|FG000|Overall Study|Withdrawal by Subject|1|||
94439428|NCT00764881|323396166|FG001|Overall Study|Withdrawal by Subject|3|||
94439429|NCT00764881|323396165|FG000|Overall Study|Protocol Violation|2|||
94439430|NCT00764881|323396166|FG001|Overall Study|Protocol Violation|2|||
94439431|NCT00764881|323396165|FG000|Overall Study|Lost to Follow-up|2|||
94439432|NCT00764881|323396166|FG001|Overall Study|Lost to Follow-up|0|||
94439433|NCT00764881|323396165|FG000|Overall Study|Noncompliant|1|||
94439434|NCT00764881|323396166|FG001|Overall Study|Noncompliant|0|||
94439435|NCT00764881|323396165|FG000|Overall Study|Accidentally discontinued study drug|1|||
94439436|NCT00764881|323396166|FG001|Overall Study|Accidentally discontinued study drug|0|||
94439437|NCT00764881|323396165|FG000|Overall Study|Wished to become pregnant|1|||
94439438|NCT00764881|323396166|FG001|Overall Study|Wished to become pregnant|0|||
94439439|NCT00764881|323396165|FG000|Overall Study|Carcinoma detected|1|||
94439440|NCT00764881|323396166|FG001|Overall Study|Carcinoma detected|0|||
94439441|NCT00764881|323396165|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
94439442|NCT00764881|323396166|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
94439443|NCT00764881|323396165|FG000|Overall Study|no treatment or no observation|2|||
94439444|NCT00764881|323396166|FG001|Overall Study|no treatment or no observation|2|||
94439445|NCT01499095|323396167|FG000|Overall Study|Randomized But Not Treated|1|||
94222296|NCT02706834|322606424|FG005|Overall Study|Lost to Follow-up|0|||
94222297|NCT02706834|322606425|FG006|Overall Study|Lost to Follow-up|0|||
94439446|NCT01499095|323396168|FG001|Overall Study|Randomized But Not Treated|1|||
94439447|NCT01499095|323396167|FG000|Overall Study|Adverse Event|12|||
94222298|NCT02706834|322606426|FG007|Overall Study|Lost to Follow-up|0|||
94222299|NCT02706834|322606427|FG008|Overall Study|Lost to Follow-up|0|||
94222300|NCT02706834|322606428|FG009|Overall Study|Lost to Follow-up|0|||
94222301|NCT02706834|322606429|FG010|Overall Study|Lost to Follow-up|0|||
94222302|NCT02706834|322606419|FG000|Overall Study|Voluntary Withdrawal|1|||
94222303|NCT02706834|322606420|FG001|Overall Study|Voluntary Withdrawal|0|||
94222304|NCT02706834|322606421|FG002|Overall Study|Voluntary Withdrawal|0|||
94222305|NCT02706834|322606422|FG003|Overall Study|Voluntary Withdrawal|0|||
94222306|NCT02706834|322606423|FG004|Overall Study|Voluntary Withdrawal|0|||
94222307|NCT02706834|322606424|FG005|Overall Study|Voluntary Withdrawal|0|||
94222308|NCT02706834|322606425|FG006|Overall Study|Voluntary Withdrawal|0|||
94222309|NCT02706834|322606426|FG007|Overall Study|Voluntary Withdrawal|0|||
94222310|NCT02706834|322606427|FG008|Overall Study|Voluntary Withdrawal|0|||
94222311|NCT02706834|322606428|FG009|Overall Study|Voluntary Withdrawal|1|||
94222312|NCT02706834|322606429|FG010|Overall Study|Voluntary Withdrawal|0|||
94222313|NCT02706834|322606419|FG000|Overall Study|Other Reason Not Specified|1|||
94222314|NCT02706834|322606420|FG001|Overall Study|Other Reason Not Specified|0|||
94222315|NCT02706834|322606421|FG002|Overall Study|Other Reason Not Specified|0|||
94222316|NCT02706834|322606422|FG003|Overall Study|Other Reason Not Specified|0|||
94222317|NCT02706834|322606423|FG004|Overall Study|Other Reason Not Specified|1|||
94222318|NCT02706834|322606424|FG005|Overall Study|Other Reason Not Specified|0|||
94222319|NCT02706834|322606425|FG006|Overall Study|Other Reason Not Specified|0|||
94439448|NCT01499095|323396168|FG001|Overall Study|Adverse Event|7|||
94439449|NCT01499095|323396167|FG000|Overall Study|Lack of Efficacy|2|||
94439450|NCT01499095|323396168|FG001|Overall Study|Lack of Efficacy|1|||
94222320|NCT02706834|322606426|FG007|Overall Study|Other Reason Not Specified|0|||
94222321|NCT02706834|322606427|FG008|Overall Study|Other Reason Not Specified|0|||
94439451|NCT01499095|323396167|FG000|Overall Study|Protocol Violation|6|||
94439452|NCT01499095|323396168|FG001|Overall Study|Protocol Violation|7|||
94439453|NCT01499095|323396167|FG000|Overall Study|Received Rescue Therapy|32|||
94439454|NCT01499095|323396168|FG001|Overall Study|Received Rescue Therapy|40|||
94439455|NCT01499095|323396167|FG000|Overall Study|Diverse Reasons|22|||
94439456|NCT01499095|323396168|FG001|Overall Study|Diverse Reasons|25|||
94439457|NCT01499095|323396167|FG000|Overall Study|Lost to Follow-up|6|||
94439458|NCT01499095|323396168|FG001|Overall Study|Lost to Follow-up|4|||
94439459|NCT01499095|323396167|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
94439460|NCT01499095|323396168|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
94222322|NCT02706834|322606428|FG009|Overall Study|Other Reason Not Specified|0|||
94222323|NCT02706834|322606429|FG010|Overall Study|Other Reason Not Specified|0|||
94222324|NCT00762723|322606432|FG000|Overall Study|Study Terminated slow enrollement|5|||
94439461|NCT01499095|323396167|FG000|Overall Study|Hypoglycemia|3|||
94439462|NCT01499095|323396168|FG001|Overall Study|Hypoglycemia|1|||
94222325|NCT00762723|322606433|FG001|Overall Study|Study Terminated slow enrollement|5|||
94222326|NCT00762723|322606434|FG002|Overall Study|Study Terminated slow enrollement|3|||
94439463|NCT01499095|323396167|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
94222327|NCT00627523|322606436|FG000|Overall Study|Lack of Efficacy|1|||
94222328|NCT00627523|322606437|FG001|Overall Study|Lack of Efficacy|0|||
94222329|NCT00627523|322606436|FG000|Overall Study|Withdrawal by Subject|0|||
94439464|NCT01499095|323396168|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
94439465|NCT01499095|323396167|FG000|Overall Study|Change in Injection Schedule|2|||
94439466|NCT01499095|323396168|FG001|Overall Study|Change in Injection Schedule|0|||
94439467|NCT01499095|323396167|FG000|Overall Study|Perceived Lack of Efficacy|1|||
94439468|NCT01499095|323396168|FG001|Overall Study|Perceived Lack of Efficacy|1|||
94439469|NCT01214655|323396169|FG000|Part A|Progressive Disease|7|||
94222330|NCT00627523|322606437|FG001|Overall Study|Withdrawal by Subject|2|||
94222331|NCT00627523|322606436|FG000|Overall Study|Other|1|||
94222332|NCT00627523|322606437|FG001|Overall Study|Other|0|||
94222333|NCT04385849|322606438|FG000|Overall Study|Lost to Follow-up|1|||
94222334|NCT04385849|322606439|FG001|Overall Study|Lost to Follow-up|0|||
94222335|NCT01234675|322606444|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
94222336|NCT01234675|322606445|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
94222337|NCT01234675|322606444|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
94222338|NCT01234675|322606445|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
94222339|NCT01882088|322606448|FG000|Overall Study|Intolerance of esophageal manometry|1|||
94439470|NCT01214655|323396170|FG001|Part A|Progressive Disease|0|||
94439471|NCT01214655|323396171|FG002|Part A|Progressive Disease|0|||
94439472|NCT01214655|323396169|FG000|Part A|Physician Decision|1|||
94439473|NCT01214655|323396170|FG001|Part A|Physician Decision|0|||
94439474|NCT01214655|323396171|FG002|Part A|Physician Decision|0|||
94439475|NCT01214655|323396169|FG000|Part B|Progressive disease|0|||
94439476|NCT01214655|323396170|FG001|Part B|Progressive disease|10|||
94439477|NCT01214655|323396171|FG002|Part B|Progressive disease|0|||
94439478|NCT01214655|323396169|FG000|Part B|Death|0|||
94439479|NCT01214655|323396170|FG001|Part B|Death|1|||
94439480|NCT01214655|323396171|FG002|Part B|Death|0|||
94439481|NCT01214655|323396169|FG000|Part B|Withdrawal by Subject|0|||
94439482|NCT01214655|323396170|FG001|Part B|Withdrawal by Subject|2|||
94439483|NCT01214655|323396171|FG002|Part B|Withdrawal by Subject|0|||
94439484|NCT01214655|323396169|FG000|Part C|Progressive Disease|0|||
94439485|NCT01214655|323396170|FG001|Part C|Progressive Disease|0|||
94439486|NCT01214655|323396171|FG002|Part C|Progressive Disease|5|||
94439487|NCT01214655|323396169|FG000|Part C|Death|0|||
94439488|NCT01214655|323396170|FG001|Part C|Death|0|||
94439489|NCT01214655|323396171|FG002|Part C|Death|1|||
94439490|NCT01214655|323396169|FG000|Part C|Physician Decision|0|||
94439491|NCT01214655|323396170|FG001|Part C|Physician Decision|0|||
94439492|NCT01214655|323396171|FG002|Part C|Physician Decision|1|||
94439493|NCT00113763|323396175|FG000|Overall Study|Adverse Event|5|||
94439494|NCT00113763|323396176|FG001|Overall Study|Adverse Event|2|||
94439495|NCT00113763|323396175|FG000|Overall Study|Disease Progression|28|||
94439496|NCT00113763|323396176|FG001|Overall Study|Disease Progression|14|||
94439497|NCT00113763|323396175|FG000|Overall Study|Lost to Follow-up|10|||
94439498|NCT00113763|323396176|FG001|Overall Study|Lost to Follow-up|0|||
94439499|NCT00113763|323396175|FG000|Overall Study|Withdrawal by Subject|1|||
94439500|NCT00113763|323396176|FG001|Overall Study|Withdrawal by Subject|4|||
94439501|NCT00113763|323396175|FG000|Overall Study|Other|27|||
94439502|NCT00113763|323396176|FG001|Overall Study|Other|6|||
94439503|NCT00113763|323396175|FG000|Overall Study|Non-compliance|1|||
94439504|NCT00113763|323396176|FG001|Overall Study|Non-compliance|0|||
94439505|NCT00113763|323396175|FG000|Overall Study|Ongoing|1|||
94222340|NCT01882088|322606448|FG000|Overall Study|no possibility to place the catheter|1|||
94222341|NCT01882088|322606448|FG000|Overall Study|Protocol Violation|1|||
94222342|NCT01882088|322606448|FG000|Overall Study|inadequate pH-impedance tracings|2|||
94222343|NCT01183013|322606451|FG000|Overall Study|Adverse Event|6|||
94222344|NCT01183013|322606452|FG001|Overall Study|Adverse Event|8|||
94222345|NCT01183013|322606453|FG002|Overall Study|Adverse Event|5|||
94222346|NCT01183013|322606454|FG003|Overall Study|Adverse Event|5|||
94222347|NCT01183013|322606455|FG004|Overall Study|Adverse Event|10|||
94222348|NCT01183013|322606456|FG005|Overall Study|Adverse Event|10|||
94439506|NCT00113763|323396176|FG001|Overall Study|Ongoing|0|||
94439507|NCT04358081|323396180|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
94655783|NCT01607905|324198196|FG004|Overall Study|Non-compliance with study procedures|0|||
94439508|NCT04358081|323396181|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
94439509|NCT04358081|323396182|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
94439510|NCT04358081|323396180|FG000|Treatment Phase of Study|Adverse Event|1|||
94439511|NCT04358081|323396181|FG001|Treatment Phase of Study|Adverse Event|0|||
94439512|NCT04358081|323396182|FG002|Treatment Phase of Study|Adverse Event|1|||
94439513|NCT04358081|323396180|FG000|Treatment Phase of Study|Physician Decision|2|||
94439514|NCT04358081|323396181|FG001|Treatment Phase of Study|Physician Decision|0|||
94439515|NCT04358081|323396182|FG002|Treatment Phase of Study|Physician Decision|1|||
94222349|NCT01183013|322606457|FG006|Overall Study|Adverse Event|6|||
94222350|NCT01183013|322606451|FG000|Overall Study|Lack of Efficacy|3|||
94439516|NCT04358081|323396180|FG000|Treatment Phase of Study|Protocol Violation|1|||
94655784|NCT01607905|324198197|FG005|Overall Study|Non-compliance with study procedures|0|||
94439517|NCT04358081|323396181|FG001|Treatment Phase of Study|Protocol Violation|0|||
94655785|NCT01607905|324198198|FG006|Overall Study|Non-compliance with study procedures|1|||
94655786|NCT01607905|324198192|FG000|Overall Study|Death|1|||
94439518|NCT04358081|323396182|FG002|Treatment Phase of Study|Protocol Violation|0|||
94439519|NCT04358081|323396180|FG000|Study Completion Phase|Death|0|||
94439520|NCT04358081|323396181|FG001|Study Completion Phase|Death|0|||
94439521|NCT04358081|323396182|FG002|Study Completion Phase|Death|1|||
94439522|NCT04358081|323396180|FG000|Study Completion Phase|Lost to Follow-up|1|||
94439523|NCT04358081|323396181|FG001|Study Completion Phase|Lost to Follow-up|0|||
94439524|NCT04358081|323396182|FG002|Study Completion Phase|Lost to Follow-up|1|||
94439525|NCT01977417|323396183|FG000|Overall Study|Adverse Event|1|||
94439526|NCT01977417|323396184|FG001|Overall Study|Adverse Event|0|||
94439527|NCT01977417|323396183|FG000|Overall Study|Withdrawal by Subject|2|||
94222351|NCT01183013|322606452|FG001|Overall Study|Lack of Efficacy|2|||
94222352|NCT01183013|322606453|FG002|Overall Study|Lack of Efficacy|1|||
94222353|NCT01183013|322606454|FG003|Overall Study|Lack of Efficacy|2|||
94222354|NCT01183013|322606455|FG004|Overall Study|Lack of Efficacy|1|||
94222355|NCT01183013|322606456|FG005|Overall Study|Lack of Efficacy|2|||
94222356|NCT01183013|322606457|FG006|Overall Study|Lack of Efficacy|0|||
94222357|NCT01183013|322606451|FG000|Overall Study|Protocol Violation|5|||
94222358|NCT01183013|322606452|FG001|Overall Study|Protocol Violation|2|||
94222359|NCT01183013|322606453|FG002|Overall Study|Protocol Violation|4|||
94222360|NCT01183013|322606454|FG003|Overall Study|Protocol Violation|0|||
94222361|NCT01183013|322606455|FG004|Overall Study|Protocol Violation|4|||
94222362|NCT01183013|322606456|FG005|Overall Study|Protocol Violation|3|||
94222363|NCT01183013|322606457|FG006|Overall Study|Protocol Violation|3|||
94222364|NCT01183013|322606451|FG000|Overall Study|Lost to Follow-up|7|||
94222365|NCT01183013|322606452|FG001|Overall Study|Lost to Follow-up|3|||
94222366|NCT01183013|322606453|FG002|Overall Study|Lost to Follow-up|4|||
94222367|NCT01183013|322606454|FG003|Overall Study|Lost to Follow-up|3|||
94439528|NCT01977417|323396184|FG001|Overall Study|Withdrawal by Subject|4|||
94439529|NCT01977417|323396183|FG000|Overall Study|Female enrollment goal met|0|||
94439530|NCT01977417|323396184|FG001|Overall Study|Female enrollment goal met|2|||
94439531|NCT01692626|323396188|FG000|Overall Study|Death|0|||
94439532|NCT01692626|323396189|FG001|Overall Study|Death|1|||
94439533|NCT01692626|323396188|FG000|Overall Study|Adverse Event|2|||
94439534|NCT01692626|323396189|FG001|Overall Study|Adverse Event|3|||
94439535|NCT01692626|323396188|FG000|Overall Study|Protocol Violation|1|||
94439536|NCT01692626|323396189|FG001|Overall Study|Protocol Violation|2|||
94439537|NCT01692626|323396188|FG000|Overall Study|Withdrawal by Subject|1|||
94439538|NCT01692626|323396189|FG001|Overall Study|Withdrawal by Subject|0|||
94439539|NCT02515331|323396194|FG000|Overall Study|Withdrawal by Subject|0|||
94439540|NCT02515331|323396195|FG001|Overall Study|Withdrawal by Subject|0|||
94655787|NCT01607905|324198193|FG001|Overall Study|Death|1|||
94655788|NCT01607905|324198194|FG002|Overall Study|Death|1|||
94655789|NCT01607905|324198195|FG003|Overall Study|Death|1|||
94655790|NCT01607905|324198196|FG004|Overall Study|Death|0|||
94655791|NCT01607905|324198197|FG005|Overall Study|Death|0|||
94655792|NCT01607905|324198198|FG006|Overall Study|Death|3|||
94655793|NCT01607905|324198192|FG000|Overall Study|Other treatments become available|1|||
94655794|NCT01607905|324198193|FG001|Overall Study|Other treatments become available|0|||
94655795|NCT01607905|324198194|FG002|Overall Study|Other treatments become available|0|||
94655796|NCT01607905|324198195|FG003|Overall Study|Other treatments become available|0|||
94655797|NCT01607905|324198196|FG004|Overall Study|Other treatments become available|0|||
94655798|NCT01607905|324198197|FG005|Overall Study|Other treatments become available|0|||
94655799|NCT01607905|324198198|FG006|Overall Study|Other treatments become available|1|||
94655800|NCT01607905|324198192|FG000|Overall Study|Investigator discretion|0|||
94222368|NCT01183013|322606455|FG004|Overall Study|Lost to Follow-up|2|||
94222369|NCT01183013|322606456|FG005|Overall Study|Lost to Follow-up|6|||
94222370|NCT01183013|322606457|FG006|Overall Study|Lost to Follow-up|5|||
94222371|NCT01183013|322606451|FG000|Overall Study|Withdrawal by Subject|9|||
94222372|NCT01183013|322606452|FG001|Overall Study|Withdrawal by Subject|13|||
94222373|NCT01183013|322606453|FG002|Overall Study|Withdrawal by Subject|10|||
94222374|NCT01183013|322606454|FG003|Overall Study|Withdrawal by Subject|8|||
94655801|NCT01607905|324198193|FG001|Overall Study|Investigator discretion|0|||
94222375|NCT01183013|322606455|FG004|Overall Study|Withdrawal by Subject|7|||
94222376|NCT01183013|322606456|FG005|Overall Study|Withdrawal by Subject|9|||
94222377|NCT01183013|322606457|FG006|Overall Study|Withdrawal by Subject|10|||
94222378|NCT01183013|322606451|FG000|Overall Study|Reasons other than stated above|15|||
94222379|NCT01183013|322606452|FG001|Overall Study|Reasons other than stated above|11|||
94222380|NCT01183013|322606453|FG002|Overall Study|Reasons other than stated above|17|||
94222381|NCT01183013|322606454|FG003|Overall Study|Reasons other than stated above|12|||
94439541|NCT02515331|323396196|FG002|Overall Study|Withdrawal by Subject|1|||
94439542|NCT02515331|323396194|FG000|Overall Study|Protocol deviation|0|||
94439543|NCT02515331|323396195|FG001|Overall Study|Protocol deviation|0|||
94439544|NCT02515331|323396196|FG002|Overall Study|Protocol deviation|3|||
94222382|NCT01183013|322606455|FG004|Overall Study|Reasons other than stated above|12|||
94439545|NCT02515331|323396194|FG000|Overall Study|Adverse Event|2|||
94222383|NCT01183013|322606456|FG005|Overall Study|Reasons other than stated above|15|||
94222384|NCT01183013|322606457|FG006|Overall Study|Reasons other than stated above|13|||
94222385|NCT02720198|322606458|FG000|Overall Study|Withdrawal by Subject|0|||
94222386|NCT02720198|322606459|FG001|Overall Study|Withdrawal by Subject|1|||
94222387|NCT04057937|322606462|FG000|Placebo-controlled Phase|Adverse Event|3|||
94222388|NCT04057937|322606463|FG001|Placebo-controlled Phase|Adverse Event|0|||
94222389|NCT04057937|322606462|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
94222390|NCT04057937|322606463|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
94222391|NCT04057937|322606462|FG000|Active-treatment Phase|Pregnancy|0|||
94222392|NCT04057937|322606463|FG001|Active-treatment Phase|Pregnancy|1|||
94222393|NCT04057937|322606462|FG000|Active-treatment Phase|Physician Decision|0|||
94222394|NCT04057937|322606463|FG001|Active-treatment Phase|Physician Decision|1|||
94222395|NCT04748445|322606467|FG000|Overall Study|No longer met eligibility criteria|12|||
94222396|NCT04748445|322606467|FG000|Overall Study|Other|36|||
94222397|NCT04748445|322606467|FG000|Overall Study|Withdrawal by Subject|553|||
94222398|NCT04748445|322606467|FG000|Overall Study|Lost to Follow-up|30|||
94222399|NCT00910871|322606473|FG000|Overall Study|Adverse Event|5|||
94222400|NCT00910871|322606473|FG000|Overall Study|Death|12|||
94222401|NCT00910871|322606473|FG000|Overall Study|Lost to Follow-up|8|||
94222402|NCT00910871|322606473|FG000|Overall Study|Protocol Violation|11|||
94222403|NCT00910871|322606473|FG000|Overall Study|Withdrawal by Subject|12|||
94222404|NCT00910871|322606473|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
94222405|NCT00910871|322606473|FG000|Overall Study|Undefined|1|||
94222406|NCT02359552|322606474|FG000|Overall Study|Lost to Follow-up|3|||
94222407|NCT02359552|322606475|FG001|Overall Study|Lost to Follow-up|4|||
94222408|NCT00274846|322606476|FG000|Overall Study|Did not receive adequate NK cells|1|||
94222409|NCT01190228|322606477|FG000|Overall Study|Protocol Violation|4|||
94222410|NCT01190228|322606478|FG001|Overall Study|Protocol Violation|0|||
94222411|NCT01190228|322606479|FG002|Overall Study|Protocol Violation|0|||
94222412|NCT01190228|322606477|FG000|Overall Study|Withdrawal by Subject|1|||
94222413|NCT01190228|322606478|FG001|Overall Study|Withdrawal by Subject|0|||
94222414|NCT01190228|322606479|FG002|Overall Study|Withdrawal by Subject|0|||
94222415|NCT02267746|322606480|FG000|Overall Study|Adverse Event|0|||
94222416|NCT02267746|322606481|FG001|Overall Study|Adverse Event|2|||
94222417|NCT02267746|322606482|FG002|Overall Study|Adverse Event|1|||
94222418|NCT02267746|322606480|FG000|Overall Study|Protocol Violation|8|||
94222419|NCT02267746|322606481|FG001|Overall Study|Protocol Violation|7|||
94222420|NCT02267746|322606482|FG002|Overall Study|Protocol Violation|3|||
94222421|NCT02267746|322606480|FG000|Overall Study|Lack of Efficacy|11|||
94222422|NCT02267746|322606481|FG001|Overall Study|Lack of Efficacy|11|||
94222423|NCT02267746|322606482|FG002|Overall Study|Lack of Efficacy|15|||
94222424|NCT02267746|322606480|FG000|Overall Study|Protocol Violation|1|||
94222425|NCT02267746|322606481|FG001|Overall Study|Protocol Violation|2|||
94222426|NCT02267746|322606482|FG002|Overall Study|Protocol Violation|1|||
94222427|NCT02267746|322606480|FG000|Overall Study|Miscellaneous|1|||
94222428|NCT02267746|322606481|FG001|Overall Study|Miscellaneous|0|||
94222429|NCT02267746|322606482|FG002|Overall Study|Miscellaneous|1|||
94222430|NCT00348283|322606483|FG000|Induction|Adverse Event|0|||
94222431|NCT00348283|322606484|FG001|Induction|Adverse Event|2|||
94222432|NCT00348283|322606483|FG000|Induction|Protocol Violation|0|||
94222433|NCT00348283|322606484|FG001|Induction|Protocol Violation|4|||
94222434|NCT00348283|322606483|FG000|Double Blind|Adverse Event|2|||
94222435|NCT00348283|322606484|FG001|Double Blind|Adverse Event|5|||
94222436|NCT00348283|322606483|FG000|Double Blind|Withdrawal by Subject|1|||
94222437|NCT00348283|322606484|FG001|Double Blind|Withdrawal by Subject|1|||
94222438|NCT00348283|322606483|FG000|Double Blind|Protocol Violation|0|||
94222439|NCT00348283|322606484|FG001|Double Blind|Protocol Violation|1|||
94222440|NCT00348283|322606483|FG000|Double Blind|Lack of Efficacy|2|||
94222441|NCT00348283|322606484|FG001|Double Blind|Lack of Efficacy|2|||
94222442|NCT00348283|322606483|FG000|Double Blind|Pregnancy|0|||
94222443|NCT00348283|322606484|FG001|Double Blind|Pregnancy|1|||
94222444|NCT00348283|322606483|FG000|Open Label|Adverse Event|0|||
94222445|NCT00348283|322606484|FG001|Open Label|Adverse Event|8|||
94222446|NCT00348283|322606483|FG000|Open Label|Withdrawal by Subject|0|||
94222447|NCT00348283|322606484|FG001|Open Label|Withdrawal by Subject|4|||
94222448|NCT00348283|322606483|FG000|Open Label|Lost to Follow-up|0|||
94222449|NCT00348283|322606484|FG001|Open Label|Lost to Follow-up|1|||
94222450|NCT00348283|322606483|FG000|Open Label|Lack of Efficacy|0|||
94222451|NCT00348283|322606484|FG001|Open Label|Lack of Efficacy|13|||
94222452|NCT00348283|322606483|FG000|Open Label|Administrative reasons|0|||
94222453|NCT00348283|322606484|FG001|Open Label|Administrative reasons|5|||
94222454|NCT00348283|322606483|FG000|Open Label|Subject moved to the United States|0|||
94222455|NCT00348283|322606484|FG001|Open Label|Subject moved to the United States|1|||
94222456|NCT00348283|322606483|FG000|Open Label|Pregnancy|0|||
94222457|NCT00348283|322606484|FG001|Open Label|Pregnancy|1|||
94222458|NCT00348283|322606483|FG000|Open Label|Sponsor decision|0|||
94222459|NCT00348283|322606484|FG001|Open Label|Sponsor decision|1|||
94222460|NCT04372186|322606485|FG000|Overall Study|Death|24|||
94222461|NCT04372186|322606486|FG001|Overall Study|Death|11|||
94331071|NCT01827319|322994113|FG000|Overall Study|Lost to Follow-up|3|||
94222462|NCT04372186|322606485|FG000|Overall Study|Transferred to a different facility for care|0|||
94222463|NCT04372186|322606486|FG001|Overall Study|Transferred to a different facility for care|2|||
94222464|NCT02256488|322606487|FG000|Overall Study|Lost to Follow-up|6|||
94222465|NCT02256488|322606488|FG001|Overall Study|Lost to Follow-up|6|||
94222466|NCT02256488|322606489|FG002|Overall Study|Lost to Follow-up|9|||
94222467|NCT02256488|322606490|FG003|Overall Study|Lost to Follow-up|3|||
94222468|NCT02256488|322606487|FG000|Overall Study|OTHER|1|||
94222469|NCT02256488|322606488|FG001|Overall Study|OTHER|0|||
94222470|NCT02256488|322606489|FG002|Overall Study|OTHER|1|||
94222471|NCT02256488|322606490|FG003|Overall Study|OTHER|1|||
94222472|NCT02256488|322606487|FG000|Overall Study|Withdrawal by Subject|1|||
94222473|NCT02256488|322606488|FG001|Overall Study|Withdrawal by Subject|0|||
94222474|NCT02256488|322606489|FG002|Overall Study|Withdrawal by Subject|0|||
94222475|NCT02256488|322606490|FG003|Overall Study|Withdrawal by Subject|2|||
94222476|NCT02268526|322606491|FG000|Overall Study|Adverse Event|0|||
94222477|NCT02268526|322606492|FG001|Overall Study|Adverse Event|2|||
94222478|NCT02268526|322606493|FG002|Overall Study|Adverse Event|1|||
94222479|NCT02268526|322606491|FG000|Overall Study|Death|1|||
94222480|NCT02268526|322606492|FG001|Overall Study|Death|11|||
94222481|NCT02268526|322606493|FG002|Overall Study|Death|0|||
94222482|NCT02268526|322606491|FG000|Overall Study|protocol deviation|0|||
94222483|NCT02268526|322606492|FG001|Overall Study|protocol deviation|1|||
94222484|NCT02268526|322606493|FG002|Overall Study|protocol deviation|0|||
94222485|NCT02268526|322606491|FG000|Overall Study|Physician Decision|0|||
94222486|NCT02268526|322606492|FG001|Overall Study|Physician Decision|0|||
94222487|NCT02268526|322606493|FG002|Overall Study|Physician Decision|1|||
94222488|NCT02268526|322606491|FG000|Overall Study|Subject/guardian decision|0|||
94222489|NCT02268526|322606492|FG001|Overall Study|Subject/guardian decision|7|||
94222490|NCT02268526|322606493|FG002|Overall Study|Subject/guardian decision|3|||
94222491|NCT01770509|322606494|FG000|Overall Study|Injury|0|||
94222492|NCT01770509|322606495|FG001|Overall Study|Injury|1|||
94222493|NCT01770509|322606494|FG000|Overall Study|Lost to Follow-up|1|||
94222494|NCT01770509|322606495|FG001|Overall Study|Lost to Follow-up|2|||
94222495|NCT03613454|322606499|FG000|Overall Study|Protocol Violation|1|||
94331072|NCT03788967|322994114|FG000|Overall Study|Lost to Follow-up|14|||
94331073|NCT03788967|322994115|FG001|Overall Study|Lost to Follow-up|10|||
94331074|NCT03788967|322994114|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
94331075|NCT03788967|322994115|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
94331076|NCT03788967|322994114|FG000|Overall Study|Participant Withdrawal of Consent|13|||
94331077|NCT03788967|322994115|FG001|Overall Study|Participant Withdrawal of Consent|5|||
94331078|NCT03788967|322994114|FG000|Overall Study|Adverse Event|1|||
94331079|NCT03788967|322994115|FG001|Overall Study|Adverse Event|1|||
94331080|NCT03788967|322994114|FG000|Overall Study|COVID-19|1|||
94331081|NCT03788967|322994115|FG001|Overall Study|COVID-19|2|||
94331082|NCT04432376|322994116|FG000|Double-blind Treatment Period|Adverse Event|2|||
94331083|NCT04432376|322994117|FG001|Double-blind Treatment Period|Adverse Event|6|||
94331084|NCT04432376|322994118|FG002|Double-blind Treatment Period|Adverse Event|0|||
94331085|NCT04432376|322994116|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
94331086|NCT04432376|322994117|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
94331087|NCT04432376|322994118|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
94222496|NCT03613454|322606500|FG001|Overall Study|Protocol Violation|0|||
94222497|NCT03613454|322606499|FG000|Overall Study|Protocol Violation|0|||
94222498|NCT03613454|322606500|FG001|Overall Study|Protocol Violation|1|||
94331088|NCT04432376|322994116|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
94331089|NCT04432376|322994117|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
94331090|NCT04432376|322994118|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
94331091|NCT04432376|322994116|FG000|Double-blind Treatment Period|Protocol Violation|0|||
94331092|NCT04432376|322994117|FG001|Double-blind Treatment Period|Protocol Violation|1|||
94331093|NCT04432376|322994118|FG002|Double-blind Treatment Period|Protocol Violation|0|||
94331094|NCT04432376|322994116|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
94331095|NCT04432376|322994117|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
94331096|NCT04432376|322994118|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
94331097|NCT00656084|322994121|FG000|Overall Study|Adverse Event|4|||
94331098|NCT00656084|322994121|FG000|Overall Study|Withdrawal by Subject|1|||
94331099|NCT00656084|322994121|FG000|Overall Study|Patient Request|1|||
94331100|NCT00656084|322994121|FG000|Overall Study|Investigator Request|1|||
94222499|NCT03356145|322606501|FG000|Overall Study|Withdrawal by Subject|2|||
94222500|NCT03356145|322606502|FG001|Overall Study|Withdrawal by Subject|1|||
94222501|NCT03356145|322606501|FG000|Overall Study|Did not meet inclusion criteria|1|||
94222502|NCT03356145|322606502|FG001|Overall Study|Did not meet inclusion criteria|0|||
94222503|NCT00714688|322606515|FG000|Overall Study|Lack of Efficacy|14|||
94222504|NCT00714688|322606516|FG001|Overall Study|Lack of Efficacy|1|||
94222505|NCT00714688|322606517|FG002|Overall Study|Lack of Efficacy|4|||
94222506|NCT00714688|322606515|FG000|Overall Study|Withdrawal by Subject|4|||
94331101|NCT01293006|322994122|FG000|Period 2|Lost to Follow-up|1|||
94331102|NCT01293006|322994123|FG001|Period 2|Lost to Follow-up|0|||
94222507|NCT00714688|322606516|FG001|Overall Study|Withdrawal by Subject|3|||
94222508|NCT00714688|322606517|FG002|Overall Study|Withdrawal by Subject|3|||
94222509|NCT00714688|322606515|FG000|Overall Study|Lost to Follow-up|5|||
94222510|NCT00714688|322606516|FG001|Overall Study|Lost to Follow-up|2|||
94222511|NCT00714688|322606517|FG002|Overall Study|Lost to Follow-up|0|||
94222512|NCT00714688|322606515|FG000|Overall Study|Adverse Event|2|||
94222513|NCT00714688|322606516|FG001|Overall Study|Adverse Event|15|||
94222514|NCT00714688|322606517|FG002|Overall Study|Adverse Event|19|||
94222515|NCT00714688|322606515|FG000|Overall Study|Subject Non-compliant|3|||
94222516|NCT00714688|322606516|FG001|Overall Study|Subject Non-compliant|5|||
94222517|NCT00714688|322606517|FG002|Overall Study|Subject Non-compliant|5|||
94222518|NCT00714688|322606515|FG000|Overall Study|Ineligible to Continue the Study|0|||
94222519|NCT00714688|322606516|FG001|Overall Study|Ineligible to Continue the Study|1|||
94222520|NCT00714688|322606517|FG002|Overall Study|Ineligible to Continue the Study|1|||
94222521|NCT00714688|322606515|FG000|Overall Study|Sponsor's Decision|0|||
94222522|NCT00714688|322606516|FG001|Overall Study|Sponsor's Decision|2|||
94222523|NCT00714688|322606517|FG002|Overall Study|Sponsor's Decision|0|||
94222524|NCT00714688|322606515|FG000|Overall Study|Other|1|||
94222525|NCT00714688|322606516|FG001|Overall Study|Other|6|||
94222526|NCT00714688|322606517|FG002|Overall Study|Other|5|||
94222527|NCT04150250|322606518|FG000|Overall Study|Lost to Follow-up|0|||
94222528|NCT04150250|322606519|FG001|Overall Study|Lost to Follow-up|2|||
94222529|NCT01808144|322606524|FG000|Overall Study|Death|1|||
94222530|NCT01808144|322606525|FG001|Overall Study|Death|0|||
94222531|NCT01808144|322606524|FG000|Overall Study|Withdrawal by Subject|16|||
94222532|NCT01808144|322606525|FG001|Overall Study|Withdrawal by Subject|23|||
94222533|NCT01808144|322606524|FG000|Overall Study|Lost to Follow-up|6|||
94222534|NCT01808144|322606525|FG001|Overall Study|Lost to Follow-up|3|||
94222535|NCT01808144|322606524|FG000|Overall Study|Protocol Violation|6|||
94222536|NCT01808144|322606525|FG001|Overall Study|Protocol Violation|6|||
94222537|NCT01808144|322606524|FG000|Overall Study|Gout flare|0|||
94222538|NCT01808144|322606525|FG001|Overall Study|Gout flare|1|||
94222539|NCT01808144|322606524|FG000|Overall Study|Adverse Event|11|||
94222540|NCT01808144|322606525|FG001|Overall Study|Adverse Event|15|||
94222541|NCT03302559|322606526|FG000|Overall Study|Adverse Event|2|||
94222542|NCT03302559|322606526|FG000|Overall Study|Lost to Follow-up|1|||
94222543|NCT03302559|322606526|FG000|Overall Study|Withdrew Consent|3|||
94222544|NCT00497198|322606529|FG000|Overall Study|Adverse Event|4|||
94222545|NCT00497198|322606530|FG001|Overall Study|Adverse Event|2|||
94222546|NCT00497198|322606529|FG000|Overall Study|Physician Decision|1|||
94222547|NCT00497198|322606530|FG001|Overall Study|Physician Decision|2|||
94222548|NCT00497198|322606529|FG000|Overall Study|Withdrawal by Subject|0|||
94222549|NCT00497198|322606530|FG001|Overall Study|Withdrawal by Subject|1|||
94222550|NCT02799745|322606531|FG000|Overall Study|Participant moved out of state|1|||
94222551|NCT02799745|322606532|FG001|Overall Study|Participant moved out of state|0|||
94222552|NCT02799745|322606531|FG000|Overall Study|Discontinued due to planned surgery|1|||
94222553|NCT02799745|322606532|FG001|Overall Study|Discontinued due to planned surgery|0|||
94222554|NCT02799745|322606531|FG000|Overall Study|Withdrawal by Subject|16|||
94222555|NCT02799745|322606532|FG001|Overall Study|Withdrawal by Subject|25|||
94222556|NCT02799745|322606531|FG000|Overall Study|Protocol Deviation|4|||
94222557|NCT02799745|322606532|FG001|Overall Study|Protocol Deviation|5|||
94222558|NCT02799745|322606531|FG000|Overall Study|Progressive Disease|28|||
94222559|NCT02799745|322606532|FG001|Overall Study|Progressive Disease|38|||
94222560|NCT02799745|322606531|FG000|Overall Study|Lost to Follow-up|3|||
94222561|NCT02799745|322606532|FG001|Overall Study|Lost to Follow-up|2|||
94222562|NCT02799745|322606531|FG000|Overall Study|Death|3|||
94222563|NCT02799745|322606532|FG001|Overall Study|Death|0|||
94331103|NCT01293006|322994124|FG002|Period 2|Lost to Follow-up|0|||
94331104|NCT01293006|322994125|FG003|Period 2|Lost to Follow-up|0|||
94331105|NCT00436982|322994126|FG000|Overall Study|Withdrawal by Subject|3|||
94331106|NCT00436982|322994127|FG001|Overall Study|Withdrawal by Subject|1|||
94331107|NCT00436982|322994126|FG000|Overall Study|Did not receive allocated intervention|0|||
94331108|NCT00436982|322994127|FG001|Overall Study|Did not receive allocated intervention|1|||
94331109|NCT00436982|322994126|FG000|Overall Study|no RSA data|1|||
94331110|NCT00436982|322994127|FG001|Overall Study|no RSA data|2|||
94331111|NCT00953225|322994128|FG000|Overall Study|Withdrawal by Subject|2|||
94331112|NCT00953225|322994129|FG001|Overall Study|Withdrawal by Subject|0|||
94331113|NCT00640146|322994133|FG000|Overall Study|Adverse Event|2|||
94331114|NCT00640146|322994134|FG001|Overall Study|Adverse Event|0|||
94331115|NCT00640146|322994133|FG000|Overall Study|Lost to Follow-up|0|||
94331116|NCT00640146|322994134|FG001|Overall Study|Lost to Follow-up|1|||
94222564|NCT02799745|322606531|FG000|Overall Study|Adverse Event|0|||
94222565|NCT02799745|322606532|FG001|Overall Study|Adverse Event|1|||
94264095|NCT03684642|322761829|FG001|Overall Study|Other than specified|60|||
94264096|NCT03684642|322761830|FG002|Overall Study|Other than specified|67|||
94264097|NCT03684642|322761828|FG000|Overall Study|Randomized and not treated|0|||
94264098|NCT03684642|322761829|FG001|Overall Study|Randomized and not treated|0|||
94331117|NCT00640146|322994133|FG000|Overall Study|Lack of Efficacy|0|||
94331118|NCT00640146|322994134|FG001|Overall Study|Lack of Efficacy|1|||
94331119|NCT00640146|322994133|FG000|Overall Study|Withdrawal by Subject|1|||
94331120|NCT00640146|322994134|FG001|Overall Study|Withdrawal by Subject|1|||
94331121|NCT00640146|322994133|FG000|Overall Study|Randomized but not treated|1|||
94331122|NCT00640146|322994134|FG001|Overall Study|Randomized but not treated|3|||
94331123|NCT02455388|322994136|FG000|Overall Study|Protocol Violation|1|||
94222566|NCT05878990|322608302|FG000|Overall Study|Lost to Follow-up|7|||
94222567|NCT05878990|322608302|FG000|Overall Study|Withdrawal by Subject|1|||
94222568|NCT02543294|322608304|FG000|Overall Study|Lost to Follow-up|3|||
94222569|NCT02543294|322608304|FG000|Overall Study|Physician Decision|2|||
94222570|NCT02543294|322608304|FG000|Overall Study|Withdrawal by Subject|7|||
94222571|NCT02339506|322608307|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
94222572|NCT02339506|322608308|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
94222573|NCT02339506|322608307|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
94222574|NCT02339506|322608308|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
94222575|NCT00609245|322608309|FG000|Overall Study|Adverse Event|1|||
94222576|NCT01116440|322608310|FG000|Treatment|Withdrawal by Subject|2|||
94222577|NCT01116440|322608311|FG001|Treatment|Withdrawal by Subject|2|||
94222578|NCT01116440|322608310|FG000|Treatment|Lost to Follow-up|1|||
94222579|NCT01116440|322608311|FG001|Treatment|Lost to Follow-up|1|||
94222580|NCT01116440|322608310|FG000|Treatment|Protocol Violation|0|||
94222581|NCT01116440|322608311|FG001|Treatment|Protocol Violation|2|||
94222582|NCT01116440|322608310|FG000|Treatment|Lack of Efficacy|0|||
94222583|NCT01116440|322608311|FG001|Treatment|Lack of Efficacy|1|||
94222584|NCT01116440|322608310|FG000|Treatment|Adverse Event|0|||
94222585|NCT01116440|322608311|FG001|Treatment|Adverse Event|1|||
94222586|NCT01116440|322608310|FG000|Withdrawal|Withdrawal by Subject|0|||
94222587|NCT01116440|322608311|FG001|Withdrawal|Withdrawal by Subject|1|||
94222588|NCT01116440|322608310|FG000|Withdrawal|Lost to Follow-up|0|||
94222589|NCT01116440|322608311|FG001|Withdrawal|Lost to Follow-up|1|||
94222590|NCT01116440|322608310|FG000|Follow-up|Lost to Follow-up|0|||
94222591|NCT01116440|322608311|FG001|Follow-up|Lost to Follow-up|1|||
94222592|NCT01116440|322608310|FG000|Follow-up|Withdrawal by Subject|0|||
94222593|NCT01116440|322608311|FG001|Follow-up|Withdrawal by Subject|1|||
94222594|NCT03568708|322608315|FG000|Overall Study|Withdrawal by Subject|1|||
94222595|NCT03568708|322608316|FG001|Overall Study|Withdrawal by Subject|1|||
94331124|NCT02455388|322994137|FG001|Overall Study|Protocol Violation|0|||
94331125|NCT02455388|322994138|FG002|Overall Study|Protocol Violation|4|||
94331126|NCT02455388|322994136|FG000|Overall Study|Withdrawal by Subject|0|||
94331127|NCT02455388|322994137|FG001|Overall Study|Withdrawal by Subject|0|||
94331128|NCT02455388|322994138|FG002|Overall Study|Withdrawal by Subject|7|||
94331129|NCT05742841|322994139|FG000|Overall Study|Withdrawal by Subject|1|||
94331130|NCT05742841|322994139|FG000|Overall Study|Lost to Follow-up|1|||
94331131|NCT01316939|322994140|FG000|Overall Study|Study closed/terminated|26|||
94331132|NCT01316939|322994141|FG001|Overall Study|Study closed/terminated|25|||
94331133|NCT01316939|322994142|FG002|Overall Study|Study closed/terminated|23|||
94331134|NCT01316939|322994140|FG000|Overall Study|Lack of Efficacy|24|||
94331135|NCT01316939|322994141|FG001|Overall Study|Lack of Efficacy|25|||
94331136|NCT01316939|322994142|FG002|Overall Study|Lack of Efficacy|25|||
94331137|NCT01316939|322994140|FG000|Overall Study|Adverse Event|9|||
94331138|NCT01316939|322994141|FG001|Overall Study|Adverse Event|12|||
94331139|NCT01316939|322994142|FG002|Overall Study|Adverse Event|11|||
94331140|NCT01316939|322994140|FG000|Overall Study|Withdrawal by Subject|1|||
94331141|NCT01316939|322994141|FG001|Overall Study|Withdrawal by Subject|3|||
94331142|NCT01316939|322994142|FG002|Overall Study|Withdrawal by Subject|6|||
94331143|NCT01316939|322994140|FG000|Overall Study|Physician Decision|2|||
94331144|NCT01316939|322994141|FG001|Overall Study|Physician Decision|2|||
94331145|NCT01316939|322994142|FG002|Overall Study|Physician Decision|1|||
94331146|NCT01316939|322994140|FG000|Overall Study|Lost to Follow-up|0|||
94331147|NCT01316939|322994141|FG001|Overall Study|Lost to Follow-up|0|||
94222596|NCT03568708|322608315|FG000|Overall Study|Lost to Follow-up|0|||
94222597|NCT03568708|322608316|FG001|Overall Study|Lost to Follow-up|1|||
94222598|NCT01870999|322608317|FG000|Overall Study|Adverse Event|0|||
94222599|NCT01870999|322608318|FG001|Overall Study|Adverse Event|4|||
94222600|NCT01870999|322608319|FG002|Overall Study|Adverse Event|1|||
94222601|NCT01870999|322608317|FG000|Overall Study|Subject met withdrawal criteria|3|||
94222602|NCT01870999|322608318|FG001|Overall Study|Subject met withdrawal criteria|2|||
94222603|NCT01870999|322608319|FG002|Overall Study|Subject met withdrawal criteria|0|||
94222604|NCT01870999|322608317|FG000|Overall Study|Subject withdrawn by Investigator|1|||
94222605|NCT01870999|322608318|FG001|Overall Study|Subject withdrawn by Investigator|0|||
94222606|NCT01870999|322608319|FG002|Overall Study|Subject withdrawn by Investigator|0|||
94222607|NCT01870999|322608317|FG000|Overall Study|Withdrawal by Subject|0|||
94222608|NCT01870999|322608318|FG001|Overall Study|Withdrawal by Subject|2|||
94222609|NCT01870999|322608319|FG002|Overall Study|Withdrawal by Subject|5|||
94222610|NCT01870999|322608317|FG000|Overall Study|Protocol Violation|0|||
94222611|NCT01870999|322608318|FG001|Overall Study|Protocol Violation|0|||
94222612|NCT01870999|322608319|FG002|Overall Study|Protocol Violation|1|||
94222613|NCT00511147|322608325|FG000|Overall Study|Withdrawal by Subject|1|||
94222614|NCT00511147|322608325|FG000|Overall Study|Disease progression|5|||
94222615|NCT00511147|322608325|FG000|Overall Study|Required platelet transfusion|1|||
94222616|NCT03319719|322608328|FG000|Overall Study|Lost to Follow-up|1|||
94222617|NCT02798861|322608329|FG000|Overall Study|Lost to Follow-up|22|||
94222618|NCT02798861|322608329|FG000|Overall Study|Withdrawal by Subject|1|||
94222619|NCT00907517|322608330|FG000|Overall Study|Progressive Disease|3|||
94222620|NCT00907517|322608331|FG001|Overall Study|Progressive Disease|3|||
94222621|NCT00907517|322608332|FG002|Overall Study|Progressive Disease|4|||
94222622|NCT00907517|322608333|FG003|Overall Study|Progressive Disease|4|||
94222623|NCT00907517|322608334|FG004|Overall Study|Progressive Disease|4|||
94222624|NCT00907517|322608330|FG000|Overall Study|Symptomatic Deterioration|0|||
94222625|NCT00907517|322608331|FG001|Overall Study|Symptomatic Deterioration|0|||
94222626|NCT00907517|322608332|FG002|Overall Study|Symptomatic Deterioration|0|||
94222627|NCT00907517|322608333|FG003|Overall Study|Symptomatic Deterioration|0|||
94222628|NCT00907517|322608334|FG004|Overall Study|Symptomatic Deterioration|1|||
94222629|NCT06247488|322608335|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
94222630|NCT06247488|322608336|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
94222631|NCT06247488|322608337|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
94222632|NCT06247488|322608338|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
94222633|NCT06247488|322608339|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
94222634|NCT06247488|322608340|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
94222635|NCT06247488|322608335|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
94222636|NCT06247488|322608336|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
94222637|NCT06247488|322608337|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
94222638|NCT06247488|322608338|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
94222639|NCT06247488|322608339|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
94222640|NCT06247488|322608340|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
94222641|NCT06247488|322608335|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
94222642|NCT06247488|322608336|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
94222643|NCT06247488|322608337|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
94222644|NCT06247488|322608338|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
94222645|NCT06247488|322608339|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
94222646|NCT06247488|322608340|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
94222647|NCT06247488|322608335|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
94222648|NCT06247488|322608336|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
94222649|NCT06247488|322608337|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
94222650|NCT06247488|322608338|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
94222651|NCT06247488|322608339|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
94222652|NCT06247488|322608340|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
94222653|NCT06247488|322608335|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
94222654|NCT06247488|322608336|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
94222655|NCT06247488|322608337|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
94222656|NCT06247488|322608338|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
94222657|NCT06247488|322608339|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
94222658|NCT06247488|322608340|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
94222659|NCT06247488|322608335|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
94222660|NCT06247488|322608336|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
94222661|NCT06247488|322608337|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
94222662|NCT06247488|322608338|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
94222663|NCT06247488|322608339|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
94222664|NCT06247488|322608340|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
94222665|NCT06247488|322608335|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
94222666|NCT06247488|322608336|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
94222667|NCT06247488|322608337|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
94222668|NCT06247488|322608338|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
94222669|NCT06247488|322608339|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
94222670|NCT06247488|322608340|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
94222671|NCT03772041|322608341|FG000|Overall Study|Adverse Event|8|||
94222672|NCT03772041|322608342|FG001|Overall Study|Adverse Event|3|||
94222673|NCT03772041|322608341|FG000|Overall Study|Withdrawal by Subject|0|||
94222674|NCT03772041|322608342|FG001|Overall Study|Withdrawal by Subject|2|||
94222675|NCT03772041|322608341|FG000|Overall Study|Protocol Violation|4|||
94439546|NCT02515331|323396195|FG001|Overall Study|Adverse Event|0|||
94222676|NCT03772041|322608342|FG001|Overall Study|Protocol Violation|2|||
94222677|NCT03772041|322608341|FG000|Overall Study|Physician Decision|2|||
94222678|NCT03772041|322608342|FG001|Overall Study|Physician Decision|3|||
94222679|NCT02029521|322608343|FG000|Overall Study|Protocol Violation|1|||
94222680|NCT02029521|322608344|FG001|Overall Study|Protocol Violation|0|||
94222681|NCT02029521|322608343|FG000|Overall Study|Withdrawal by Subject|1|||
94222682|NCT02029521|322608344|FG001|Overall Study|Withdrawal by Subject|1|||
94222683|NCT01072396|322608345|FG000|Period One|Adverse Event|1|||
94222684|NCT01072396|322608346|FG001|Period One|Adverse Event|1|||
94222685|NCT01072396|322608345|FG000|Period One|Protocol Violation|2|||
94222686|NCT01072396|322608346|FG001|Period One|Protocol Violation|1|||
94222687|NCT01072396|322608345|FG000|Period One|Withdrawal by Subject|2|||
94222688|NCT01072396|322608346|FG001|Period One|Withdrawal by Subject|0|||
94222689|NCT01072396|322608345|FG000|Washout Period|Missing termination information|0|||
94222690|NCT01072396|322608346|FG001|Washout Period|Missing termination information|1|||
94222691|NCT01072396|322608345|FG000|Period Two|Adverse Event|0|||
94222692|NCT01072396|322608346|FG001|Period Two|Adverse Event|3|||
94222693|NCT01072396|322608345|FG000|Period Two|Lost to Follow-up|1|||
94222694|NCT01072396|322608346|FG001|Period Two|Lost to Follow-up|0|||
94222695|NCT00762502|322608347|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
94222696|NCT00762502|322608348|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
94222697|NCT00762502|322608349|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
94222698|NCT00762502|322608347|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
94222699|NCT00762502|322608348|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
94222700|NCT00762502|322608349|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
94222701|NCT00762502|322608347|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
94222702|NCT00762502|322608348|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
94655802|NCT01607905|324198194|FG002|Overall Study|Investigator discretion|0|||
94655803|NCT01607905|324198195|FG003|Overall Study|Investigator discretion|0|||
94655804|NCT01607905|324198196|FG004|Overall Study|Investigator discretion|0|||
94655805|NCT01607905|324198197|FG005|Overall Study|Investigator discretion|1|||
94655806|NCT01607905|324198198|FG006|Overall Study|Investigator discretion|0|||
94655807|NCT01607905|324198192|FG000|Overall Study|Other|1|||
94655808|NCT01607905|324198193|FG001|Overall Study|Other|0|||
94655809|NCT01607905|324198194|FG002|Overall Study|Other|0|||
94655810|NCT01607905|324198195|FG003|Overall Study|Other|0|||
94655811|NCT01607905|324198196|FG004|Overall Study|Other|0|||
94655812|NCT01607905|324198197|FG005|Overall Study|Other|0|||
94222703|NCT00762502|322608349|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
94222704|NCT02504502|322608350|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
94222705|NCT02504502|322608351|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
94222706|NCT02504502|322608350|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
94222707|NCT02504502|322608351|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
94222708|NCT00105521|322608352|FG000|Overall Study|Other|1|||
94222709|NCT00105521|322608353|FG001|Overall Study|Other|1|||
94222710|NCT00105521|322608354|FG002|Overall Study|Other|2|||
94222711|NCT00105521|322608355|FG003|Overall Study|Other|0|||
94222712|NCT00105521|322608352|FG000|Overall Study|Adverse Event|10|||
94222713|NCT00105521|322608353|FG001|Overall Study|Adverse Event|4|||
94222714|NCT00105521|322608354|FG002|Overall Study|Adverse Event|10|||
94222715|NCT00105521|322608355|FG003|Overall Study|Adverse Event|8|||
94222716|NCT00105521|322608352|FG000|Overall Study|Withdrawal by Subject|1|||
94222717|NCT00105521|322608353|FG001|Overall Study|Withdrawal by Subject|0|||
94222718|NCT00105521|322608354|FG002|Overall Study|Withdrawal by Subject|1|||
94222719|NCT00105521|322608355|FG003|Overall Study|Withdrawal by Subject|4|||
94655813|NCT01607905|324198198|FG006|Overall Study|Other|1|||
94655814|NCT01607905|324198192|FG000|Overall Study|Randomized but not treated|1|||
94655815|NCT01607905|324198193|FG001|Overall Study|Randomized but not treated|0|||
94655816|NCT01607905|324198194|FG002|Overall Study|Randomized but not treated|0|||
94655817|NCT01607905|324198195|FG003|Overall Study|Randomized but not treated|0|||
94222720|NCT00105521|322608352|FG000|Overall Study|Lack of Efficacy|0|||
94222721|NCT00105521|322608353|FG001|Overall Study|Lack of Efficacy|0|||
94222722|NCT00105521|322608354|FG002|Overall Study|Lack of Efficacy|0|||
94222723|NCT00105521|322608355|FG003|Overall Study|Lack of Efficacy|1|||
94222724|NCT00105521|322608352|FG000|Overall Study|Protocol Violation|3|||
94222725|NCT00105521|322608353|FG001|Overall Study|Protocol Violation|5|||
94222726|NCT00105521|322608354|FG002|Overall Study|Protocol Violation|4|||
94222727|NCT00105521|322608355|FG003|Overall Study|Protocol Violation|4|||
94222728|NCT00105521|322608352|FG000|Overall Study|Lost to Follow-up|0|||
94222729|NCT00105521|322608353|FG001|Overall Study|Lost to Follow-up|1|||
94222730|NCT00105521|322608354|FG002|Overall Study|Lost to Follow-up|0|||
94222731|NCT00105521|322608355|FG003|Overall Study|Lost to Follow-up|0|||
94222732|NCT03042559|322608356|FG000|Overall Study|drop out|1|||
94222733|NCT03042559|322608357|FG001|Overall Study|drop out|1|||
94331148|NCT01316939|322994142|FG002|Overall Study|Lost to Follow-up|2|||
94331149|NCT01316939|322994140|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
94439547|NCT02515331|323396196|FG002|Overall Study|Adverse Event|0|||
94222734|NCT00428441|322608362|FG000|Overall Study|Lost to Follow-up|1|||
94222735|NCT00404547|322608365|FG000|Overall Study|Adverse Event|39|||
94222736|NCT00404547|322608366|FG001|Overall Study|Adverse Event|6|||
94222737|NCT00404547|322608365|FG000|Overall Study|Withdrawal by Subject|19|||
94439548|NCT00280735|323396199|FG000|Overall Study|Adverse Event|5|||
94222738|NCT00404547|322608366|FG001|Overall Study|Withdrawal by Subject|2|||
94222739|NCT00404547|322608365|FG000|Overall Study|Protocol Violation|0|||
94222740|NCT00404547|322608366|FG001|Overall Study|Protocol Violation|1|||
94331150|NCT01316939|322994141|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
94331151|NCT01316939|322994142|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
94222741|NCT00404547|322608365|FG000|Overall Study|Lost to Follow-up|20|||
94331152|NCT01316939|322994140|FG000|Overall Study|Protocol Violation|0|||
94331153|NCT01316939|322994141|FG001|Overall Study|Protocol Violation|1|||
94331154|NCT01316939|322994142|FG002|Overall Study|Protocol Violation|0|||
94331155|NCT02254551|322994143|FG000|Dose Escalation|Physician Decision|1|||
94331156|NCT02254551|322994143|FG000|Dose Escalation|Dose-limiting toxicity|2|||
94331157|NCT04847141|322994144|FG000|Overall Study|Adverse Event|1|||
94331158|NCT04847141|322994145|FG001|Overall Study|Adverse Event|0|||
94331159|NCT04847141|322994146|FG002|Overall Study|Adverse Event|1|||
94331160|NCT04847141|322994144|FG000|Overall Study|Withdrawal by Subject|2|||
94331161|NCT04847141|322994145|FG001|Overall Study|Withdrawal by Subject|4|||
94331162|NCT04847141|322994146|FG002|Overall Study|Withdrawal by Subject|3|||
94331163|NCT04847141|322994144|FG000|Overall Study|Lost to Follow-up|7|||
94331164|NCT04847141|322994145|FG001|Overall Study|Lost to Follow-up|5|||
94331165|NCT04847141|322994146|FG002|Overall Study|Lost to Follow-up|7|||
94331166|NCT04847141|322994144|FG000|Overall Study|Reason not Specified|0|||
94331167|NCT04847141|322994145|FG001|Overall Study|Reason not Specified|1|||
94331168|NCT04847141|322994146|FG002|Overall Study|Reason not Specified|0|||
94331169|NCT04058158|322994147|FG000|Period 1|Death|1|||
94331170|NCT04058158|322994148|FG001|Period 1|Death|0|||
94331171|NCT04058158|322994147|FG000|Period 1|Adverse Event|1|||
94331172|NCT04058158|322994148|FG001|Period 1|Adverse Event|1|||
94331173|NCT04058158|322994147|FG000|Period 1|Pregnancy|0|||
94331174|NCT04058158|322994148|FG001|Period 1|Pregnancy|1|||
94331175|NCT00324740|322994149|FG000|Overall Study|Withdrawal by Subject|1|||
94331176|NCT00324740|322994150|FG001|Overall Study|Withdrawal by Subject|0|||
94331177|NCT00324740|322994151|FG002|Overall Study|Withdrawal by Subject|1|||
94331178|NCT03943446|322994152|FG000|Overall Study|Lost to Follow-up|0|||
94331179|NCT03943446|322994153|FG001|Overall Study|Lost to Follow-up|0|||
94331180|NCT03943446|322994154|FG002|Overall Study|Lost to Follow-up|1|||
94439549|NCT00280735|323396199|FG000|Overall Study|Lack of Efficacy|3|||
94439550|NCT00280735|323396199|FG000|Overall Study|Withdrawal by Subject|8|||
94439551|NCT00280735|323396199|FG000|Overall Study|Intercurrent Illness|2|||
94439552|NCT01350271|323396200|FG000|Overall Study|Lost to Follow-up|21|||
94439553|NCT01350271|323396201|FG001|Overall Study|Lost to Follow-up|17|||
94439554|NCT01350271|323396202|FG002|Overall Study|Lost to Follow-up|26|||
94439555|NCT03885661|323396203|FG000|Overall Study|Withdrawal by Subject|0|||
94439556|NCT03885661|323396204|FG001|Overall Study|Withdrawal by Subject|1|||
94439557|NCT03885661|323396203|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
94439558|NCT03885661|323396204|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
94439559|NCT02232984|323396205|FG000|Overall Study|Withdrawal by Subject|5|||
94439560|NCT02232984|323396205|FG000|Overall Study|Death|1|||
94439561|NCT02232984|323396205|FG000|Overall Study|Investigator withdrawal|10|||
94439562|NCT02232984|323396205|FG000|Overall Study|Device implant unsuccessful|53|||
94439563|NCT02232984|323396205|FG000|Overall Study|not disclosed by site|7|||
94439564|NCT02232984|323396205|FG000|Overall Study|Protocol Violation|1|||
94439565|NCT01841593|323396208|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
94439566|NCT01841593|323396209|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
94439567|NCT01841593|323396208|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
94439568|NCT01841593|323396209|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
94439569|NCT03125798|323396210|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
94439570|NCT03125798|323396211|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
94439571|NCT03125798|323396210|FG000|Overall Study|Conversion to thoracotomy|7|||
94439572|NCT03125798|323396211|FG001|Overall Study|Conversion to thoracotomy|7|||
94439573|NCT04728802|323396216|FG000|Overall Study|Withdrawal by Subject|4|||
94439574|NCT04728802|323396217|FG001|Overall Study|Withdrawal by Subject|20|||
94439575|NCT04728802|323396216|FG000|Overall Study|Physician Decision|7|||
94439576|NCT04728802|323396217|FG001|Overall Study|Physician Decision|7|||
94439577|NCT04728802|323396216|FG000|Overall Study|Protocol Violation|10|||
94439578|NCT04728802|323396217|FG001|Overall Study|Protocol Violation|4|||
94439579|NCT04728802|323396216|FG000|Overall Study|Transfer|1|||
94439580|NCT04728802|323396217|FG001|Overall Study|Transfer|0|||
94439581|NCT04728802|323396216|FG000|Overall Study|Death|4|||
94439582|NCT04728802|323396217|FG001|Overall Study|Death|5|||
94439583|NCT04728802|323396216|FG000|Overall Study|Other|3|||
94439584|NCT04728802|323396217|FG001|Overall Study|Other|0|||
94439585|NCT02286843|323396223|FG000|Overall Study|Not Treated|4|||
94439586|NCT02286843|323396223|FG000|Overall Study|Protocol Violation|1|||
94439587|NCT02286843|323396223|FG000|Overall Study|Withdrawal by Subject|1|||
94439588|NCT01526057|323396224|FG000|Overall Study|Withdrawal by Subject|3|||
94439589|NCT01526057|323396225|FG001|Overall Study|Withdrawal by Subject|2|||
94331181|NCT03943446|322994152|FG000|Overall Study|Withdrawal by Subject|1|||
94331182|NCT03943446|322994153|FG001|Overall Study|Withdrawal by Subject|1|||
94331183|NCT03943446|322994154|FG002|Overall Study|Withdrawal by Subject|2|||
94439590|NCT01526057|323396226|FG002|Overall Study|Withdrawal by Subject|2|||
94331184|NCT03943446|322994152|FG000|Overall Study|Study Terminated by Sponsor|1|||
94439591|NCT01526057|323396224|FG000|Overall Study|Adverse Event|3|||
94439592|NCT01526057|323396225|FG001|Overall Study|Adverse Event|1|||
94651288|NCT02460224|324179727|FG012|Overall Study|Physician Decision|0|||
94439593|NCT01526057|323396226|FG002|Overall Study|Adverse Event|1|||
94439594|NCT01526057|323396224|FG000|Overall Study|Death|1|||
94439595|NCT01526057|323396225|FG001|Overall Study|Death|0|||
94439596|NCT01526057|323396226|FG002|Overall Study|Death|0|||
94439597|NCT01526057|323396224|FG000|Overall Study|Lost to Follow-up|1|||
94439598|NCT01526057|323396225|FG001|Overall Study|Lost to Follow-up|0|||
94439599|NCT01526057|323396226|FG002|Overall Study|Lost to Follow-up|1|||
94439600|NCT01526057|323396224|FG000|Overall Study|Other|1|||
94439601|NCT01526057|323396225|FG001|Overall Study|Other|0|||
94439602|NCT01526057|323396226|FG002|Overall Study|Other|1|||
94439603|NCT01526057|323396224|FG000|Overall Study|Protocol Violation|0|||
94439604|NCT01526057|323396225|FG001|Overall Study|Protocol Violation|0|||
94439605|NCT01526057|323396226|FG002|Overall Study|Protocol Violation|1|||
94439606|NCT01320293|323396227|FG000|Overall Study|Lack of Efficacy|1|||
94439607|NCT01320293|323396227|FG000|Overall Study|Adverse Event|1|||
94439608|NCT01042093|323396234|FG000|Overall Study|Protocol Violation|2|||
94439609|NCT01042093|323396235|FG001|Overall Study|Protocol Violation|2|||
94439610|NCT01042093|323396236|FG002|Overall Study|Protocol Violation|2|||
94439611|NCT01042093|323396237|FG003|Overall Study|Protocol Violation|3|||
94439612|NCT01042093|323396234|FG000|Overall Study|Withdrawal by Subject|0|||
94439613|NCT01042093|323396235|FG001|Overall Study|Withdrawal by Subject|0|||
94439614|NCT01042093|323396236|FG002|Overall Study|Withdrawal by Subject|0|||
94439615|NCT01042093|323396237|FG003|Overall Study|Withdrawal by Subject|1|||
94439616|NCT02189837|323396238|FG000|Overall Study|Withdrawal by Subject|2|||
94439617|NCT02189837|323396239|FG001|Overall Study|Withdrawal by Subject|1|||
94439618|NCT02189837|323396240|FG002|Overall Study|Withdrawal by Subject|3|||
94439619|NCT02189837|323396241|FG003|Overall Study|Withdrawal by Subject|1|||
94439620|NCT02189837|323396238|FG000|Overall Study|Sponsor Decision|0|||
94222742|NCT00404547|322608366|FG001|Overall Study|Lost to Follow-up|9|||
94222743|NCT00404547|322608365|FG000|Overall Study|Lack of compliance|5|||
94439621|NCT02189837|323396239|FG001|Overall Study|Sponsor Decision|0|||
94439622|NCT02189837|323396240|FG002|Overall Study|Sponsor Decision|0|||
94439623|NCT02189837|323396241|FG003|Overall Study|Sponsor Decision|1|||
94439624|NCT02198963|323396242|FG000|Overall Study|Adverse Event|1|||
94439625|NCT02198963|323396242|FG000|Overall Study|Withdrawal by Subject|6|||
94439626|NCT00243412|323396243|FG000|Overall Study|Death|0|||
94439627|NCT00243412|323396244|FG001|Overall Study|Death|1|||
94439628|NCT00243412|323396243|FG000|Overall Study|Adverse Event|4|||
94439629|NCT00243412|323396244|FG001|Overall Study|Adverse Event|2|||
94439630|NCT00243412|323396243|FG000|Overall Study|Lost to Follow-up|0|||
94439631|NCT00243412|323396244|FG001|Overall Study|Lost to Follow-up|1|||
94439632|NCT00243412|323396243|FG000|Overall Study|Physician Decision|1|||
94439633|NCT00243412|323396244|FG001|Overall Study|Physician Decision|1|||
94439634|NCT00243412|323396243|FG000|Overall Study|Withdrawal by Subject|4|||
94439635|NCT00243412|323396244|FG001|Overall Study|Withdrawal by Subject|5|||
94439636|NCT00243412|323396243|FG000|Overall Study|Other|1|||
94439637|NCT00243412|323396244|FG001|Overall Study|Other|1|||
94439638|NCT00281957|323396247|FG000|Overall Study|Adverse Event|7|||
94439639|NCT00281957|323396248|FG001|Overall Study|Adverse Event|2|||
94439640|NCT00281957|323396247|FG000|Overall Study|Death|1|||
94439641|NCT00281957|323396248|FG001|Overall Study|Death|0|||
94222744|NCT00404547|322608366|FG001|Overall Study|Lack of compliance|1|||
94222745|NCT00404547|322608365|FG000|Overall Study|Other|4|||
94222746|NCT00404547|322608366|FG001|Overall Study|Other|0|||
94222747|NCT00404547|322608365|FG000|Overall Study|Reason not stated|3|||
94222748|NCT00404547|322608366|FG001|Overall Study|Reason not stated|6|||
94222749|NCT00475735|322608367|FG000|Treatment Period 1|Adverse Event|2|||
94222750|NCT00475735|322608368|FG001|Treatment Period 1|Adverse Event|0|||
94222751|NCT00475735|322608369|FG002|Treatment Period 1|Adverse Event|0|||
94222752|NCT00475735|322608370|FG003|Treatment Period 1|Adverse Event|0|||
94222753|NCT00475735|322608371|FG004|Treatment Period 1|Adverse Event|0|||
94222754|NCT00475735|322608372|FG005|Treatment Period 1|Adverse Event|0|||
94222755|NCT00475735|322608367|FG000|Treatment Period 1|Lack of Efficacy|1|||
94222756|NCT00475735|322608368|FG001|Treatment Period 1|Lack of Efficacy|0|||
94222757|NCT00475735|322608369|FG002|Treatment Period 1|Lack of Efficacy|0|||
94439642|NCT00281957|323396247|FG000|Overall Study|Progression/relapse|47|||
94222758|NCT00475735|322608370|FG003|Treatment Period 1|Lack of Efficacy|0|||
94439643|NCT00281957|323396248|FG001|Overall Study|Progression/relapse|35|||
94439644|NCT00281957|323396247|FG000|Overall Study|Not protocol specified|8|||
94439645|NCT00281957|323396248|FG001|Overall Study|Not protocol specified|1|||
94439646|NCT00281957|323396247|FG000|Overall Study|Not eligible|1|||
94439647|NCT00281957|323396248|FG001|Overall Study|Not eligible|2|||
94439648|NCT00281957|323396247|FG000|Overall Study|Did not start treatment|3|||
94655818|NCT01607905|324198196|FG004|Overall Study|Randomized but not treated|1|||
94222759|NCT00475735|322608371|FG004|Treatment Period 1|Lack of Efficacy|0|||
94222760|NCT00475735|322608372|FG005|Treatment Period 1|Lack of Efficacy|0|||
94222761|NCT00475735|322608367|FG000|Treatment Period 1|Lost to Follow-up|0|||
94439649|NCT00281957|323396248|FG001|Overall Study|Did not start treatment|1|||
94439650|NCT00281957|323396247|FG000|Overall Study|Refusal unrelated to adverse events|0|||
94439651|NCT00281957|323396248|FG001|Overall Study|Refusal unrelated to adverse events|1|||
94439652|NCT02208089|323396251|FG000|Overall Study|Withdrawal by Subject|1|||
94439653|NCT02208089|323396252|FG001|Overall Study|Withdrawal by Subject|0|||
94439654|NCT02208089|323396251|FG000|Overall Study|Lost to Follow-up|6|||
94439655|NCT02208089|323396252|FG001|Overall Study|Lost to Follow-up|0|||
94439656|NCT02443740|323396253|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
94439657|NCT02443740|323396254|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
94439658|NCT02443740|323396255|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
94439659|NCT02443740|323396256|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
94439660|NCT02443740|323396257|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
94439661|NCT02443740|323396258|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
94439662|NCT02443740|323396259|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
94439663|NCT02443740|323396260|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
94439664|NCT02443740|323396261|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
94439665|NCT02443740|323396262|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
94439666|NCT02443740|323396263|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
94439667|NCT02443740|323396253|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
94439668|NCT02443740|323396254|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
94439669|NCT02443740|323396255|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
94439670|NCT02443740|323396256|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
94439671|NCT02443740|323396257|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
94439672|NCT02443740|323396258|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
94439673|NCT02443740|323396259|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
94439674|NCT02443740|323396260|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
94439675|NCT02443740|323396261|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
94439676|NCT02443740|323396262|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
94439677|NCT02443740|323396263|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
94439678|NCT02443740|323396253|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
94439679|NCT02443740|323396254|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
94439680|NCT02443740|323396255|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
94439681|NCT02443740|323396256|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
94439682|NCT02443740|323396257|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
94439683|NCT02443740|323396258|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
94439684|NCT02443740|323396259|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
94439685|NCT02443740|323396260|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
94439686|NCT02443740|323396261|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
94222762|NCT00475735|322608368|FG001|Treatment Period 1|Lost to Follow-up|0|||
94222763|NCT00475735|322608369|FG002|Treatment Period 1|Lost to Follow-up|0|||
94222764|NCT00475735|322608370|FG003|Treatment Period 1|Lost to Follow-up|0|||
94222765|NCT00475735|322608371|FG004|Treatment Period 1|Lost to Follow-up|0|||
94222766|NCT00475735|322608372|FG005|Treatment Period 1|Lost to Follow-up|1|||
94222767|NCT00475735|322608367|FG000|Treatment Period 1|Protocol Violation|0|||
94222768|NCT00475735|322608368|FG001|Treatment Period 1|Protocol Violation|0|||
94222769|NCT00475735|322608369|FG002|Treatment Period 1|Protocol Violation|0|||
94222770|NCT00475735|322608370|FG003|Treatment Period 1|Protocol Violation|1|||
94222771|NCT00475735|322608371|FG004|Treatment Period 1|Protocol Violation|0|||
94222772|NCT00475735|322608372|FG005|Treatment Period 1|Protocol Violation|0|||
94222773|NCT00475735|322608367|FG000|Treatment Period 1|Withdrawal by Subject|1|||
94222774|NCT00475735|322608368|FG001|Treatment Period 1|Withdrawal by Subject|1|||
94222775|NCT00475735|322608369|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94222776|NCT00475735|322608370|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94439687|NCT02443740|323396262|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
94439688|NCT02443740|323396263|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
94439689|NCT01964976|323396264|FG000|Overall Study|Protocol Violation|31|||
94439690|NCT04052620|323396269|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
94439691|NCT04052620|323396270|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
94439692|NCT04052620|323396269|FG000|Overall Study|Withdrawal by Subject|1|||
94439693|NCT04052620|323396270|FG001|Overall Study|Withdrawal by Subject|0|||
94439694|NCT04052620|323396269|FG000|Overall Study|Lost to Follow-up|1|||
94439695|NCT04052620|323396270|FG001|Overall Study|Lost to Follow-up|1|||
94439696|NCT04052620|323396269|FG000|Overall Study|Adverse Event|1|||
94439697|NCT04052620|323396270|FG001|Overall Study|Adverse Event|0|||
94439698|NCT04052620|323396269|FG000|Overall Study|Subject did not meet study Criteria|0|||
94439699|NCT04052620|323396270|FG001|Overall Study|Subject did not meet study Criteria|1|||
94439700|NCT04052620|323396269|FG000|Overall Study|Screened failure, randomized by mistake|0|||
94439701|NCT04052620|323396270|FG001|Overall Study|Screened failure, randomized by mistake|1|||
94439702|NCT04052620|323396269|FG000|Overall Study|Personal reasons|2|||
94439703|NCT04052620|323396270|FG001|Overall Study|Personal reasons|4|||
94222777|NCT00475735|322608371|FG004|Treatment Period 1|Withdrawal by Subject|0|||
94222778|NCT00475735|322608372|FG005|Treatment Period 1|Withdrawal by Subject|0|||
94222779|NCT00475735|322608367|FG000|Treatment Period 1|DC due to AE but continuing|0|||
94439704|NCT04052620|323396269|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
94222780|NCT00475735|322608368|FG001|Treatment Period 1|DC due to AE but continuing|0|||
94222781|NCT00475735|322608369|FG002|Treatment Period 1|DC due to AE but continuing|0|||
94439705|NCT04052620|323396270|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
94439706|NCT00739063|323396272|FG000|Overall Study|Screen failures|8|||
94439707|NCT04779879|323396273|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
94439708|NCT04779879|323396274|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
94439709|NCT04779879|323396275|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
94439710|NCT04779879|323396276|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
94439711|NCT04779879|323396277|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
94439712|NCT04779879|323396278|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
94439713|NCT04779879|323396273|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
94439714|NCT04779879|323396274|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
94439715|NCT04779879|323396275|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
94439716|NCT04779879|323396276|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
94439717|NCT04779879|323396277|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
94439718|NCT04779879|323396278|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
94439719|NCT04779879|323396273|FG000|Part C: Up to Week 36|Death|0|||
94439720|NCT04779879|323396274|FG001|Part C: Up to Week 36|Death|0|||
94222782|NCT00475735|322608370|FG003|Treatment Period 1|DC due to AE but continuing|1|||
94222783|NCT00475735|322608371|FG004|Treatment Period 1|DC due to AE but continuing|2|||
94222784|NCT00475735|322608372|FG005|Treatment Period 1|DC due to AE but continuing|2|||
94222785|NCT00475735|322608367|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
94222786|NCT00475735|322608368|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
94222787|NCT00475735|322608369|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
94222788|NCT00475735|322608370|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
94222789|NCT00475735|322608371|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
94222790|NCT00475735|322608372|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
94222791|NCT00475735|322608367|FG000|Treatment Washout|Lost to Follow-up|0|||
94222792|NCT00475735|322608368|FG001|Treatment Washout|Lost to Follow-up|1|||
94222793|NCT00475735|322608369|FG002|Treatment Washout|Lost to Follow-up|0|||
94222794|NCT00475735|322608370|FG003|Treatment Washout|Lost to Follow-up|0|||
94547125|NCT03172130|323801016|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
94547126|NCT03172130|323801017|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
94547127|NCT01825941|323801018|FG000|Overall Study|Lost to Follow-up|4|||
94547128|NCT01825941|323801019|FG001|Overall Study|Lost to Follow-up|1|||
94222795|NCT00475735|322608371|FG004|Treatment Washout|Lost to Follow-up|0|||
94222796|NCT00475735|322608372|FG005|Treatment Washout|Lost to Follow-up|0|||
94222797|NCT00475735|322608367|FG000|Treatment Washout|Protocol Violation|0|||
94222798|NCT00475735|322608368|FG001|Treatment Washout|Protocol Violation|1|||
94222799|NCT00475735|322608369|FG002|Treatment Washout|Protocol Violation|0|||
94222800|NCT00475735|322608370|FG003|Treatment Washout|Protocol Violation|0|||
94222801|NCT00475735|322608371|FG004|Treatment Washout|Protocol Violation|0|||
94222802|NCT00475735|322608372|FG005|Treatment Washout|Protocol Violation|0|||
94222803|NCT00475735|322608367|FG000|Treatment Period 2|Adverse Event|0|||
94222804|NCT00475735|322608368|FG001|Treatment Period 2|Adverse Event|1|||
94222805|NCT00475735|322608369|FG002|Treatment Period 2|Adverse Event|0|||
94222806|NCT00475735|322608370|FG003|Treatment Period 2|Adverse Event|2|||
94222807|NCT00475735|322608371|FG004|Treatment Period 2|Adverse Event|0|||
94222808|NCT00475735|322608372|FG005|Treatment Period 2|Adverse Event|0|||
94222809|NCT00475735|322608367|FG000|Treatment Period 2|Lack of Efficacy|0|||
94547129|NCT05065190|323801027|FG000|Overall Study|Other than listed|2|||
94547130|NCT05065190|323801028|FG001|Overall Study|Other than listed|12|||
94547131|NCT05065190|323801027|FG000|Overall Study|Lack of Efficacy|4|||
94547132|NCT05065190|323801028|FG001|Overall Study|Lack of Efficacy|0|||
94547133|NCT05065190|323801027|FG000|Overall Study|Adverse Event|1|||
94547134|NCT05065190|323801028|FG001|Overall Study|Adverse Event|10|||
94547135|NCT03647267|323801029|FG000|Overall Study|Lost to Follow-up|1|||
94547136|NCT03647267|323801030|FG001|Overall Study|Lost to Follow-up|0|||
94547137|NCT00471887|323801032|FG000|Overall Study|Adverse Event|9|||
94547138|NCT00701805|323801033|FG000|Overall Study|Withdrawal by Subject|3|||
94547139|NCT00701805|323801034|FG001|Overall Study|Withdrawal by Subject|1|||
94547140|NCT00701805|323801035|FG002|Overall Study|Withdrawal by Subject|4|||
94222810|NCT00475735|322608368|FG001|Treatment Period 2|Lack of Efficacy|0|||
94222811|NCT00475735|322608369|FG002|Treatment Period 2|Lack of Efficacy|0|||
94222812|NCT00475735|322608370|FG003|Treatment Period 2|Lack of Efficacy|0|||
94222813|NCT00475735|322608371|FG004|Treatment Period 2|Lack of Efficacy|0|||
94547141|NCT00701805|323801036|FG003|Overall Study|Withdrawal by Subject|3|||
94547142|NCT00701805|323801033|FG000|Overall Study|Adverse Event|0|||
94222814|NCT00475735|322608372|FG005|Treatment Period 2|Lack of Efficacy|1|||
94222815|NCT00475735|322608367|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94222816|NCT00475735|322608368|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94547143|NCT00701805|323801034|FG001|Overall Study|Adverse Event|1|||
94547144|NCT00701805|323801035|FG002|Overall Study|Adverse Event|1|||
94547145|NCT00701805|323801036|FG003|Overall Study|Adverse Event|0|||
94547146|NCT00701805|323801033|FG000|Overall Study|Missed 7 consecutive doses|0|||
94547147|NCT00701805|323801034|FG001|Overall Study|Missed 7 consecutive doses|1|||
94547148|NCT00701805|323801035|FG002|Overall Study|Missed 7 consecutive doses|0|||
94547149|NCT00701805|323801036|FG003|Overall Study|Missed 7 consecutive doses|0|||
94547150|NCT00701805|323801033|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
94547151|NCT00701805|323801034|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
94547152|NCT00701805|323801035|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
94547153|NCT00701805|323801036|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
94547154|NCT00701805|323801033|FG000|Overall Study|Physician decision, change of therapy|0|||
94547155|NCT00701805|323801034|FG001|Overall Study|Physician decision, change of therapy|0|||
94547156|NCT00701805|323801035|FG002|Overall Study|Physician decision, change of therapy|0|||
94547157|NCT00701805|323801036|FG003|Overall Study|Physician decision, change of therapy|1|||
94547158|NCT00701805|323801033|FG000|Overall Study|Difficult to travel to dialysis site|0|||
94547159|NCT00701805|323801034|FG001|Overall Study|Difficult to travel to dialysis site|0|||
94547160|NCT00701805|323801035|FG002|Overall Study|Difficult to travel to dialysis site|1|||
94547161|NCT00701805|323801036|FG003|Overall Study|Difficult to travel to dialysis site|0|||
94651289|NCT02460224|324179728|FG013|Overall Study|Physician Decision|1|||
94439721|NCT04779879|323396275|FG002|Part C: Up to Week 36|Death|0|||
94439722|NCT04779879|323396276|FG003|Part C: Up to Week 36|Death|0|||
94439723|NCT04779879|323396277|FG004|Part C: Up to Week 36|Death|0|||
94439724|NCT04779879|323396278|FG005|Part C: Up to Week 36|Death|1|||
94222817|NCT00475735|322608369|FG002|Treatment Period 2|Withdrawal by Subject|0|||
94222818|NCT00475735|322608370|FG003|Treatment Period 2|Withdrawal by Subject|0|||
94222819|NCT00475735|322608371|FG004|Treatment Period 2|Withdrawal by Subject|1|||
94222820|NCT00475735|322608372|FG005|Treatment Period 2|Withdrawal by Subject|0|||
94222821|NCT03794609|322608373|FG000|Overall Study|Other|10|||
94222822|NCT03794609|322608373|FG000|Overall Study|Withdrawal by Subject|66|||
94222823|NCT03794609|322608373|FG000|Overall Study|The child is enrolled in an interventional study|70|||
94222824|NCT03794609|322608373|FG000|Overall Study|Inclusion/exclusion criteria|8|||
94222825|NCT03794609|322608373|FG000|Overall Study|At sponsor's request|151|||
94222826|NCT03794609|322608373|FG000|Overall Study|Physician Decision|1|||
94222827|NCT03794609|322608373|FG000|Overall Study|Lost to Follow-up|5|||
94222828|NCT02744898|322608374|FG000|Overall Study|Progressive Disease|2|||
94222829|NCT02744898|322608374|FG000|Overall Study|Physician Decision|1|||
94222830|NCT02744898|322608374|FG000|Overall Study|Toxicity|1|||
94222831|NCT03575572|322608377|FG000|Overall Study|Withdrawal by Subject|2|||
94439725|NCT04779879|323396273|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
94439726|NCT04779879|323396274|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
94222832|NCT03575572|322608377|FG000|Overall Study|Physician Decision|2|||
94222833|NCT01323309|322608380|FG000|Overall Study|Death|9|||
94222834|NCT01323309|322608381|FG001|Overall Study|Death|15|||
94222835|NCT01323309|322608382|FG002|Overall Study|Death|5|||
94222836|NCT01323309|322608380|FG000|Overall Study|Lost to Follow-up|11|||
94439727|NCT04779879|323396275|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
94439728|NCT04779879|323396276|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
94439729|NCT04779879|323396277|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
94439730|NCT04779879|323396278|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
94439731|NCT02072980|323396279|FG000|Period 2, Second Wear|Adverse Event|0|||
94439732|NCT02072980|323396280|FG001|Period 2, Second Wear|Adverse Event|1|||
94439733|NCT01610492|323396281|FG000|Overall Study|Adverse Event|1|||
94439734|NCT01610492|323396281|FG000|Overall Study|Lack of Efficacy|3|||
94439735|NCT01610492|323396281|FG000|Overall Study|Other: Reached stopping criteria|1|||
94439736|NCT01610492|323396281|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
94439737|NCT02633787|323396282|FG000|Overall Study|Withdrawal by Subject|1|||
94439738|NCT02163057|323396283|FG000|Overall Study|Participant Refusal to Continue|2|||
94439739|NCT02163057|323396284|FG001|Overall Study|Participant Refusal to Continue|2|||
94439740|NCT02163057|323396283|FG000|Overall Study|Participant Significant Noncompliance|0|||
94439741|NCT02163057|323396284|FG001|Overall Study|Participant Significant Noncompliance|1|||
94439742|NCT02163057|323396283|FG000|Overall Study|Progression of Disease|1|||
94439743|NCT02163057|323396284|FG001|Overall Study|Progression of Disease|2|||
94439744|NCT01625091|323396285|FG000|Intervention|Death|1|||
94439745|NCT01625091|323396286|FG001|Intervention|Death|1|||
94439746|NCT01625091|323396285|FG000|Intervention|Withdrawal by Subject|4|||
94222837|NCT01323309|322608381|FG001|Overall Study|Lost to Follow-up|14|||
94222838|NCT01323309|322608382|FG002|Overall Study|Lost to Follow-up|24|||
94222839|NCT01323309|322608380|FG000|Overall Study|Withdrawal by Subject|14|||
94222840|NCT01323309|322608381|FG001|Overall Study|Withdrawal by Subject|14|||
94439747|NCT01625091|323396286|FG001|Intervention|Withdrawal by Subject|1|||
94439748|NCT01625091|323396285|FG000|Intervention|Adverse Event|0|||
94439749|NCT01625091|323396286|FG001|Intervention|Adverse Event|2|||
94439750|NCT01625091|323396285|FG000|Intervention|Lost to Follow-up|4|||
94439751|NCT01625091|323396286|FG001|Intervention|Lost to Follow-up|4|||
94439752|NCT01625091|323396285|FG000|Intervention|Study termination|2|||
94222841|NCT01323309|322608382|FG002|Overall Study|Withdrawal by Subject|18|||
94222842|NCT01323309|322608380|FG000|Overall Study|Disease progression|5|||
94222843|NCT01323309|322608381|FG001|Overall Study|Disease progression|11|||
94222844|NCT01323309|322608382|FG002|Overall Study|Disease progression|4|||
94222845|NCT01257698|322608383|FG000|Overall Study|Protocol Violation|4|||
94222846|NCT01257698|322608384|FG001|Overall Study|Protocol Violation|0|||
94222847|NCT00607789|322608386|FG000|Overall Study|Adverse Event|3|||
94439753|NCT01625091|323396286|FG001|Intervention|Study termination|3|||
94439754|NCT01625091|323396285|FG000|Post-intervention|Death|0|||
94439755|NCT01625091|323396286|FG001|Post-intervention|Death|1|||
94439756|NCT01625091|323396285|FG000|Post-intervention|Lost to Follow-up|2|||
94439757|NCT01625091|323396286|FG001|Post-intervention|Lost to Follow-up|0|||
94439758|NCT01625091|323396285|FG000|Post-intervention|Study termination|2|||
94439759|NCT01625091|323396286|FG001|Post-intervention|Study termination|1|||
94439760|NCT02601014|323396287|FG000|Overall Study|Adverse Event|3|||
94439761|NCT02601014|323396288|FG001|Overall Study|Adverse Event|3|||
94439762|NCT02601014|323396287|FG000|Overall Study|Death|3|||
94547162|NCT00701805|323801033|FG000|Overall Study|Resumption criteria were not met|0|||
94547163|NCT00701805|323801034|FG001|Overall Study|Resumption criteria were not met|1|||
94547164|NCT00701805|323801035|FG002|Overall Study|Resumption criteria were not met|0|||
94547165|NCT00701805|323801036|FG003|Overall Study|Resumption criteria were not met|0|||
94547166|NCT03826342|323801039|FG000|Overall Study|Withdrawal by Subject|8|||
94547167|NCT03826342|323801040|FG001|Overall Study|Withdrawal by Subject|1|||
94547168|NCT03826342|323801039|FG000|Overall Study|Lost to Follow-up|7|||
94547169|NCT03826342|323801040|FG001|Overall Study|Lost to Follow-up|7|||
94547170|NCT03826342|323801039|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
94547171|NCT03826342|323801040|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
94547172|NCT01068249|323801043|FG000|Overall Study|Death|1|||
94547173|NCT01068249|323801043|FG000|Overall Study|Withdrawal by Subject|3|||
94547174|NCT04619004|323801044|FG000|Overall Study|Death|114|||
94547175|NCT04619004|323801045|FG001|Overall Study|Death|28|||
94547176|NCT04619004|323801044|FG000|Overall Study|Lost to Follow-up|1|||
94547177|NCT04619004|323801045|FG001|Overall Study|Lost to Follow-up|1|||
94547178|NCT04619004|323801044|FG000|Overall Study|Withdrawal by Subject|24|||
94547179|NCT04619004|323801045|FG001|Overall Study|Withdrawal by Subject|7|||
94547180|NCT04619004|323801044|FG000|Overall Study|Other - Not specified|0|||
94547181|NCT04619004|323801045|FG001|Overall Study|Other - Not specified|1|||
94547182|NCT04030962|323801046|FG000|Stage 2|Adverse Event|0|||
94547183|NCT04030962|323801047|FG001|Stage 2|Adverse Event|0|||
94547184|NCT04030962|323801048|FG002|Stage 2|Adverse Event|0|||
94547185|NCT04030962|323801049|FG003|Stage 2|Adverse Event|0|||
94547186|NCT04030962|323801050|FG004|Stage 2|Adverse Event|0|||
94547187|NCT04030962|323801051|FG005|Stage 2|Adverse Event|0|||
94547188|NCT04030962|323801052|FG006|Stage 2|Adverse Event|0|||
94547189|NCT04030962|323801053|FG007|Stage 2|Adverse Event|0|||
94547190|NCT04030962|323801054|FG008|Stage 2|Adverse Event|1|||
94547191|NCT04030962|323801055|FG009|Stage 2|Adverse Event|0|||
94547192|NCT04030962|323801056|FG010|Stage 2|Adverse Event|1|||
94547193|NCT04030962|323801057|FG011|Stage 2|Adverse Event|1|||
94547194|NCT04030962|323801058|FG012|Stage 2|Adverse Event|1|||
94547195|NCT04030962|323801046|FG000|Stage 2|Withdrawal by Subject|0|||
94547196|NCT04030962|323801047|FG001|Stage 2|Withdrawal by Subject|0|||
94547197|NCT04030962|323801048|FG002|Stage 2|Withdrawal by Subject|0|||
94547198|NCT04030962|323801049|FG003|Stage 2|Withdrawal by Subject|0|||
94547199|NCT04030962|323801050|FG004|Stage 2|Withdrawal by Subject|0|||
94547200|NCT04030962|323801051|FG005|Stage 2|Withdrawal by Subject|0|||
94547201|NCT04030962|323801052|FG006|Stage 2|Withdrawal by Subject|0|||
94547202|NCT04030962|323801053|FG007|Stage 2|Withdrawal by Subject|0|||
94547203|NCT04030962|323801054|FG008|Stage 2|Withdrawal by Subject|1|||
94547204|NCT04030962|323801055|FG009|Stage 2|Withdrawal by Subject|0|||
94547205|NCT04030962|323801056|FG010|Stage 2|Withdrawal by Subject|0|||
94547206|NCT04030962|323801057|FG011|Stage 2|Withdrawal by Subject|2|||
94547207|NCT04030962|323801058|FG012|Stage 2|Withdrawal by Subject|1|||
94547208|NCT04030962|323801046|FG000|Stage 2|Lost to Follow-up|0|||
94222848|NCT00607789|322608387|FG001|Overall Study|Adverse Event|0|||
94547209|NCT04030962|323801047|FG001|Stage 2|Lost to Follow-up|0|||
94547210|NCT04030962|323801048|FG002|Stage 2|Lost to Follow-up|0|||
94547211|NCT04030962|323801049|FG003|Stage 2|Lost to Follow-up|0|||
94547212|NCT04030962|323801050|FG004|Stage 2|Lost to Follow-up|0|||
94547213|NCT04030962|323801051|FG005|Stage 2|Lost to Follow-up|0|||
94547214|NCT04030962|323801052|FG006|Stage 2|Lost to Follow-up|0|||
94547215|NCT04030962|323801053|FG007|Stage 2|Lost to Follow-up|0|||
94547216|NCT04030962|323801054|FG008|Stage 2|Lost to Follow-up|1|||
94547217|NCT04030962|323801055|FG009|Stage 2|Lost to Follow-up|0|||
94222849|NCT00607789|322608386|FG000|Overall Study|Lack of Efficacy|0|||
94547218|NCT04030962|323801056|FG010|Stage 2|Lost to Follow-up|0|||
94547219|NCT04030962|323801057|FG011|Stage 2|Lost to Follow-up|0|||
94547220|NCT04030962|323801058|FG012|Stage 2|Lost to Follow-up|0|||
94547221|NCT04030962|323801046|FG000|Stage 2|Technical Problems|0|||
94222850|NCT00607789|322608387|FG001|Overall Study|Lack of Efficacy|1|||
94439763|NCT02601014|323396288|FG001|Overall Study|Death|1|||
94547222|NCT04030962|323801047|FG001|Stage 2|Technical Problems|0|||
94547223|NCT04030962|323801048|FG002|Stage 2|Technical Problems|0|||
94547224|NCT04030962|323801049|FG003|Stage 2|Technical Problems|0|||
94547225|NCT04030962|323801050|FG004|Stage 2|Technical Problems|0|||
94222851|NCT00607789|322608386|FG000|Overall Study|Inadequate adherence|3|||
94222852|NCT00607789|322608387|FG001|Overall Study|Inadequate adherence|0|||
94222853|NCT00607789|322608386|FG000|Overall Study|Lost to Follow-up|0|||
94222854|NCT00607789|322608387|FG001|Overall Study|Lost to Follow-up|5|||
94222855|NCT00607789|322608386|FG000|Overall Study|Withdrawal by Subject|1|||
94222856|NCT00607789|322608387|FG001|Overall Study|Withdrawal by Subject|0|||
94222857|NCT00050167|322608390|FG000|Overall Study|not eligible not invasive|1|||
94222858|NCT00050167|322608391|FG001|Overall Study|not eligible not invasive|1|||
94222859|NCT04754594|322608392|FG000|Blinded Period|Withdrawal by Subject|4|||
94222860|NCT04754594|322608393|FG001|Blinded Period|Withdrawal by Subject|9|||
94222861|NCT04754594|322608394|FG002|Blinded Period|Withdrawal by Subject|0|||
94222862|NCT04754594|322608395|FG003|Blinded Period|Withdrawal by Subject|0|||
94547226|NCT04030962|323801051|FG005|Stage 2|Technical Problems|0|||
94547227|NCT04030962|323801052|FG006|Stage 2|Technical Problems|0|||
94547228|NCT04030962|323801053|FG007|Stage 2|Technical Problems|0|||
94547229|NCT04030962|323801054|FG008|Stage 2|Technical Problems|0|||
94547230|NCT04030962|323801055|FG009|Stage 2|Technical Problems|0|||
94547231|NCT04030962|323801056|FG010|Stage 2|Technical Problems|0|||
94547232|NCT04030962|323801057|FG011|Stage 2|Technical Problems|1|||
94547233|NCT04030962|323801058|FG012|Stage 2|Technical Problems|0|||
94547234|NCT05601102|323801060|FG000|Overall Study|Death|1|||
94547235|NCT05601102|323801061|FG001|Overall Study|Death|2|||
94222863|NCT04754594|322608392|FG000|Blinded Period|Protocol Violation|2|||
94222864|NCT04754594|322608393|FG001|Blinded Period|Protocol Violation|2|||
94222865|NCT04754594|322608394|FG002|Blinded Period|Protocol Violation|0|||
94222866|NCT04754594|322608395|FG003|Blinded Period|Protocol Violation|0|||
94222867|NCT04754594|322608392|FG000|Blinded Period|Lost to Follow-up|1|||
94222868|NCT04754594|322608393|FG001|Blinded Period|Lost to Follow-up|1|||
94222869|NCT04754594|322608394|FG002|Blinded Period|Lost to Follow-up|0|||
94222870|NCT04754594|322608395|FG003|Blinded Period|Lost to Follow-up|0|||
94547236|NCT05601102|323801060|FG000|Overall Study|Withdrawal by Subject|1|||
94547237|NCT05601102|323801061|FG001|Overall Study|Withdrawal by Subject|1|||
94547238|NCT05601102|323801060|FG000|Overall Study|Lost to Follow-up|0|||
94547239|NCT05601102|323801061|FG001|Overall Study|Lost to Follow-up|2|||
94222871|NCT04754594|322608392|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
94222872|NCT04754594|322608393|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
94222873|NCT04754594|322608394|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
94222874|NCT04754594|322608395|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
94222875|NCT04754594|322608392|FG000|Unblinded Period|Withdrawal by Subject|6|||
94222876|NCT04754594|322608393|FG001|Unblinded Period|Withdrawal by Subject|8|||
94222877|NCT04754594|322608394|FG002|Unblinded Period|Withdrawal by Subject|0|||
94222878|NCT04754594|322608395|FG003|Unblinded Period|Withdrawal by Subject|0|||
94222879|NCT04754594|322608392|FG000|Unblinded Period|Lost to Follow-up|5|||
94222880|NCT04754594|322608393|FG001|Unblinded Period|Lost to Follow-up|3|||
94222881|NCT04754594|322608394|FG002|Unblinded Period|Lost to Follow-up|0|||
94222882|NCT04754594|322608395|FG003|Unblinded Period|Lost to Follow-up|0|||
94222883|NCT04754594|322608392|FG000|Unblinded Period|Protocol Violation|2|||
94222884|NCT04754594|322608393|FG001|Unblinded Period|Protocol Violation|4|||
94655819|NCT01607905|324198197|FG005|Overall Study|Randomized but not treated|1|||
94655820|NCT01607905|324198198|FG006|Overall Study|Randomized but not treated|0|||
94222885|NCT04754594|322608394|FG002|Unblinded Period|Protocol Violation|0|||
94222886|NCT04754594|322608395|FG003|Unblinded Period|Protocol Violation|0|||
94222887|NCT04754594|322608392|FG000|Unblinded Period|Other|3|||
94222888|NCT04754594|322608393|FG001|Unblinded Period|Other|0|||
94222889|NCT04754594|322608394|FG002|Unblinded Period|Other|0|||
94222890|NCT04754594|322608395|FG003|Unblinded Period|Other|0|||
94222891|NCT04754594|322608392|FG000|Infant Participants|Withdrawal by Subject|0|||
94547240|NCT03684304|323801064|FG000|Overall Study|Lost to Follow-up|19|||
94547241|NCT03684304|323801065|FG001|Overall Study|Lost to Follow-up|17|||
94547242|NCT05824936|323801066|FG000|Overall Study|Lost to Follow-up|1|||
94655821|NCT02602288|324198199|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
94222892|NCT04754594|322608393|FG001|Infant Participants|Withdrawal by Subject|0|||
94655822|NCT02602288|324198200|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
94655823|NCT02602288|324198199|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
94222893|NCT04754594|322608394|FG002|Infant Participants|Withdrawal by Subject|9|||
94222894|NCT04754594|322608395|FG003|Infant Participants|Withdrawal by Subject|17|||
94222895|NCT04754594|322608392|FG000|Infant Participants|Lost to Follow-up|0|||
94222896|NCT04754594|322608393|FG001|Infant Participants|Lost to Follow-up|0|||
94222897|NCT04754594|322608394|FG002|Infant Participants|Lost to Follow-up|4|||
94331185|NCT03943446|322994153|FG001|Overall Study|Study Terminated by Sponsor|2|||
94547243|NCT03689712|323801067|FG000|Overall Study|Adverse Event|1|||
94547244|NCT03689712|323801068|FG001|Overall Study|Adverse Event|0|||
94547245|NCT03689712|323801067|FG000|Overall Study|Death|20|||
94547246|NCT03689712|323801068|FG001|Overall Study|Death|10|||
94222898|NCT04754594|322608395|FG003|Infant Participants|Lost to Follow-up|10|||
94547247|NCT03689712|323801067|FG000|Overall Study|Lost to Follow-up|6|||
94547248|NCT03689712|323801068|FG001|Overall Study|Lost to Follow-up|6|||
94547249|NCT03689712|323801067|FG000|Overall Study|Other|1|||
94547250|NCT03689712|323801068|FG001|Overall Study|Other|0|||
94547251|NCT03689712|323801067|FG000|Overall Study|Patient Non-Compliance|0|||
94547252|NCT03689712|323801068|FG001|Overall Study|Patient Non-Compliance|1|||
94547253|NCT03689712|323801067|FG000|Overall Study|Withdrawal by Subject|20|||
94547254|NCT03689712|323801068|FG001|Overall Study|Withdrawal by Subject|4|||
94547255|NCT03689712|323801067|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
94547256|NCT03689712|323801068|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
94547257|NCT03689712|323801067|FG000|Overall Study|Randomized but not Treated|13|||
94547258|NCT03689712|323801068|FG001|Overall Study|Randomized but not Treated|7|||
94547259|NCT03689712|323801067|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
94547260|NCT03689712|323801068|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
94547261|NCT00931801|323801071|FG000|Overall Study|Adverse Event|0|||
94547262|NCT00931801|323801072|FG001|Overall Study|Adverse Event|0|||
94547263|NCT00931801|323801073|FG002|Overall Study|Adverse Event|1|||
94547264|NCT00931801|323801071|FG000|Overall Study|Lost to Follow-up|0|||
94547265|NCT00931801|323801072|FG001|Overall Study|Lost to Follow-up|1|||
94547266|NCT00931801|323801073|FG002|Overall Study|Lost to Follow-up|0|||
94547267|NCT00931801|323801071|FG000|Overall Study|Withdrawal by Subject|1|||
94547268|NCT00931801|323801072|FG001|Overall Study|Withdrawal by Subject|0|||
94547269|NCT00931801|323801073|FG002|Overall Study|Withdrawal by Subject|0|||
94547270|NCT00931801|323801071|FG000|Overall Study|Confirmed Virologic Failure|0|||
94547271|NCT00931801|323801072|FG001|Overall Study|Confirmed Virologic Failure|0|||
94547272|NCT00931801|323801073|FG002|Overall Study|Confirmed Virologic Failure|3|||
94547273|NCT00864851|323801076|FG000|Overall Study|Withdrawal by Subject|0|||
94547274|NCT00864851|323801077|FG001|Overall Study|Withdrawal by Subject|1|||
94547275|NCT00864851|323801078|FG002|Overall Study|Withdrawal by Subject|0|||
94547276|NCT00864851|323801076|FG000|Overall Study|Physician Decision|1|||
94547277|NCT00864851|323801077|FG001|Overall Study|Physician Decision|0|||
94547278|NCT00864851|323801078|FG002|Overall Study|Physician Decision|0|||
94547279|NCT00864851|323801076|FG000|Overall Study|Death|1|||
94547280|NCT00864851|323801077|FG001|Overall Study|Death|0|||
94547281|NCT00864851|323801078|FG002|Overall Study|Death|0|||
94547282|NCT00864851|323801076|FG000|Overall Study|Patient uncooperative|1|||
94547283|NCT00864851|323801077|FG001|Overall Study|Patient uncooperative|0|||
94547284|NCT00864851|323801078|FG002|Overall Study|Patient uncooperative|0|||
94547285|NCT00708734|323801081|FG000|Overall Study|scheduling conflict|2|||
94547286|NCT00708734|323801081|FG000|Overall Study|moved|1|||
94547287|NCT00708734|323801081|FG000|Overall Study|leg injury|1|||
94547288|NCT00708734|323801081|FG000|Overall Study|knee replacement|1|||
94547289|NCT00708734|323801081|FG000|Overall Study|vertigo|1|||
94547290|NCT00708734|323801081|FG000|Overall Study|leg fracture|1|||
94547291|NCT01533922|323801082|FG000|Overall Study|Adverse Event|5|||
94547292|NCT01533922|323801083|FG001|Overall Study|Adverse Event|8|||
94547293|NCT01533922|323801084|FG002|Overall Study|Adverse Event|6|||
94547294|NCT01533922|323801085|FG003|Overall Study|Adverse Event|3|||
94547295|NCT01533922|323801086|FG004|Overall Study|Adverse Event|4|||
94547296|NCT01533922|323801082|FG000|Overall Study|Lack of Efficacy|0|||
94547297|NCT01533922|323801083|FG001|Overall Study|Lack of Efficacy|0|||
94547298|NCT01533922|323801084|FG002|Overall Study|Lack of Efficacy|1|||
94547299|NCT01533922|323801085|FG003|Overall Study|Lack of Efficacy|0|||
94547300|NCT01533922|323801086|FG004|Overall Study|Lack of Efficacy|0|||
94547301|NCT01533922|323801082|FG000|Overall Study|Protocol Violation|0|||
94547302|NCT01533922|323801083|FG001|Overall Study|Protocol Violation|3|||
94547303|NCT01533922|323801084|FG002|Overall Study|Protocol Violation|0|||
94547304|NCT01533922|323801085|FG003|Overall Study|Protocol Violation|0|||
94547305|NCT01533922|323801086|FG004|Overall Study|Protocol Violation|1|||
94547306|NCT01533922|323801082|FG000|Overall Study|Withdrawal by Subject|3|||
94547307|NCT01533922|323801083|FG001|Overall Study|Withdrawal by Subject|1|||
94547308|NCT01533922|323801084|FG002|Overall Study|Withdrawal by Subject|2|||
94547309|NCT01533922|323801085|FG003|Overall Study|Withdrawal by Subject|2|||
94547310|NCT01533922|323801086|FG004|Overall Study|Withdrawal by Subject|1|||
94547311|NCT01533922|323801082|FG000|Overall Study|Other reason not defined above|2|||
94547312|NCT01533922|323801083|FG001|Overall Study|Other reason not defined above|0|||
94547313|NCT01533922|323801084|FG002|Overall Study|Other reason not defined above|1|||
94222899|NCT04754594|322608392|FG000|Infant Participants|Death|0|||
94547314|NCT01533922|323801085|FG003|Overall Study|Other reason not defined above|0|||
94547315|NCT01533922|323801086|FG004|Overall Study|Other reason not defined above|0|||
94547316|NCT03242252|323801089|FG000|Overall Study|At the Participant's own Request|18|||
94547317|NCT03242252|323801090|FG001|Overall Study|At the Participant's own Request|10|||
94547318|NCT03242252|323801091|FG002|Overall Study|At the Participant's own Request|15|||
94547319|NCT03242252|323801089|FG000|Overall Study|Adverse Event|8|||
94547320|NCT03242252|323801090|FG001|Overall Study|Adverse Event|6|||
94547321|NCT03242252|323801091|FG002|Overall Study|Adverse Event|9|||
94547322|NCT03242252|323801089|FG000|Overall Study|Poor Compliance to Protocol|0|||
94547323|NCT03242252|323801090|FG001|Overall Study|Poor Compliance to Protocol|2|||
94651290|NCT02460224|324179729|FG014|Overall Study|Physician Decision|0|||
94547324|NCT03242252|323801091|FG002|Overall Study|Poor Compliance to Protocol|3|||
94547325|NCT03242252|323801089|FG000|Overall Study|Study Terminated by Sponsor|1|||
94547326|NCT03242252|323801090|FG001|Overall Study|Study Terminated by Sponsor|0|||
94547327|NCT03242252|323801091|FG002|Overall Study|Study Terminated by Sponsor|0|||
94547328|NCT03242252|323801089|FG000|Overall Study|Reason not Specified|4|||
94547329|NCT03242252|323801090|FG001|Overall Study|Reason not Specified|4|||
94547330|NCT03242252|323801091|FG002|Overall Study|Reason not Specified|1|||
94547331|NCT03242252|323801089|FG000|Overall Study|Lost to Follow-up|5|||
94547332|NCT03242252|323801090|FG001|Overall Study|Lost to Follow-up|1|||
94547333|NCT03242252|323801091|FG002|Overall Study|Lost to Follow-up|4|||
94547334|NCT01842581|323801094|FG000|Overall Study|Adverse Event|6|||
94547335|NCT01842581|323801095|FG001|Overall Study|Adverse Event|4|||
94547336|NCT01842581|323801094|FG000|Overall Study|HE breakthrough|26|||
94547337|NCT01842581|323801095|FG001|Overall Study|HE breakthrough|13|||
94547338|NCT01842581|323801094|FG000|Overall Study|Liver transplant|2|||
94547339|NCT01842581|323801095|FG001|Overall Study|Liver transplant|0|||
94547340|NCT01842581|323801094|FG000|Overall Study|Lost to Follow-up|2|||
94547341|NCT01842581|323801095|FG001|Overall Study|Lost to Follow-up|5|||
94547342|NCT01842581|323801094|FG000|Overall Study|Withdrawal by Subject|5|||
94547343|NCT01842581|323801095|FG001|Overall Study|Withdrawal by Subject|7|||
94547344|NCT01842581|323801094|FG000|Overall Study|Other than specified|3|||
94547345|NCT01842581|323801095|FG001|Overall Study|Other than specified|1|||
94547346|NCT05432167|323801096|FG000|Overall Study|Adverse Event|0|||
94547347|NCT05432167|323801097|FG001|Overall Study|Adverse Event|2|||
94547348|NCT05432167|323801098|FG002|Overall Study|Adverse Event|1|||
94547349|NCT05432167|323801096|FG000|Overall Study|Lost to Follow-up|3|||
94547350|NCT05432167|323801097|FG001|Overall Study|Lost to Follow-up|3|||
94547351|NCT05432167|323801098|FG002|Overall Study|Lost to Follow-up|2|||
94547352|NCT05432167|323801096|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
94547353|NCT05432167|323801097|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
94547354|NCT05432167|323801098|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
94547355|NCT05432167|323801096|FG000|Overall Study|Physician Decision|1|||
94547356|NCT05432167|323801097|FG001|Overall Study|Physician Decision|0|||
94547357|NCT05432167|323801098|FG002|Overall Study|Physician Decision|0|||
94547358|NCT05432167|323801096|FG000|Overall Study|Withdrawal by Subject|7|||
94547359|NCT05432167|323801097|FG001|Overall Study|Withdrawal by Subject|4|||
94547360|NCT05432167|323801098|FG002|Overall Study|Withdrawal by Subject|11|||
94547361|NCT05432167|323801096|FG000|Overall Study|Other|0|||
94547362|NCT05432167|323801097|FG001|Overall Study|Other|0|||
94547363|NCT05432167|323801098|FG002|Overall Study|Other|1|||
94547364|NCT02006069|323801102|FG000|Overall Study|MPP other programming|239|||
94547365|NCT02006069|323801103|FG001|Overall Study|MPP other programming|0|||
94547366|NCT02006069|323801102|FG000|Overall Study|RV only pacing|0|||
94547367|NCT02006069|323801103|FG001|Overall Study|RV only pacing|3|||
94547368|NCT01116427|323801104|FG000|Core Phase|Adverse Event|0|||
94547369|NCT01116427|323801105|FG001|Core Phase|Adverse Event|1|||
94547370|NCT01116427|323801104|FG000|Core Phase|Lost to Follow-up|1|||
94547371|NCT01116427|323801105|FG001|Core Phase|Lost to Follow-up|0|||
94547372|NCT01116427|323801104|FG000|Core Phase|Withdrawal by Subject|3|||
94655824|NCT02602288|324198200|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
94655825|NCT02602288|324198199|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
94547373|NCT01116427|323801105|FG001|Core Phase|Withdrawal by Subject|0|||
94547374|NCT01116427|323801104|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
94547375|NCT01116427|323801105|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
94547376|NCT01116427|323801104|FG000|Extension Phase|Adverse Event|1|||
94547377|NCT01116427|323801105|FG001|Extension Phase|Adverse Event|1|||
94547378|NCT01116427|323801104|FG000|Extension Phase|Lost to Follow-up|2|||
94547379|NCT01116427|323801105|FG001|Extension Phase|Lost to Follow-up|0|||
94547380|NCT01116427|323801104|FG000|Extension Phase|Withdrawal by Subject|5|||
94547381|NCT01116427|323801105|FG001|Extension Phase|Withdrawal by Subject|1|||
94547382|NCT01116427|323801104|FG000|Extension Phase|Not using appropriate birth control|1|||
94547383|NCT01116427|323801105|FG001|Extension Phase|Not using appropriate birth control|0|||
94547384|NCT02066129|323801108|FG000|Overall Study|Lost to Follow-up|13|||
94547385|NCT02066129|323801109|FG001|Overall Study|Lost to Follow-up|12|||
94547386|NCT02066129|323801108|FG000|Overall Study|Withdrawal by Subject|7|||
94655826|NCT02602288|324198200|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
94547387|NCT02066129|323801109|FG001|Overall Study|Withdrawal by Subject|10|||
94547388|NCT02066129|323801108|FG000|Overall Study|Lack of Efficacy|8|||
94547389|NCT02066129|323801109|FG001|Overall Study|Lack of Efficacy|10|||
94547390|NCT02066129|323801108|FG000|Overall Study|Physician Decision|1|||
94547391|NCT02066129|323801109|FG001|Overall Study|Physician Decision|1|||
94547392|NCT02392403|323801110|FG000|Overall Study|Adverse Event|1|||
94547393|NCT02392403|323801110|FG000|Overall Study|Death|1|||
94547394|NCT02392403|323801110|FG000|Overall Study|Withdrawal by Subject|1|||
94547395|NCT01219933|323801111|FG000|Overall Study|Adverse Event|8|||
94547396|NCT01219933|323801111|FG000|Overall Study|No LDA reached|5|||
94547397|NCT01219933|323801111|FG000|Overall Study|No LDA maintained|7|||
94547398|NCT01219933|323801111|FG000|Overall Study|Lost to Follow-up|3|||
94547399|NCT01219933|323801111|FG000|Overall Study|GC free|1|||
94547400|NCT01219933|323801111|FG000|Overall Study|Withdrawal by Subject|5|||
94547401|NCT01219933|323801111|FG000|Overall Study|Protocol Violation|8|||
94547402|NCT01219933|323801111|FG000|Overall Study|Lack of Efficacy|1|||
94547403|NCT01902888|323801112|FG000|Overall Study|Study Terminated|3|||
94547404|NCT03149003|323801113|FG000|Overall Study|Randomized but not treated|0|||
94547405|NCT03149003|323801114|FG001|Overall Study|Randomized but not treated|1|||
94547406|NCT03149003|323801115|FG002|Overall Study|Randomized but not treated|18|||
94547407|NCT02616393|323801116|FG000|Overall Study|Death|5|||
94547408|NCT02616393|323801117|FG001|Overall Study|Death|12|||
94547409|NCT02616393|323801118|FG002|Overall Study|Death|1|||
94547410|NCT02616393|323801116|FG000|Overall Study|Termination by Sponsor|4|||
94547411|NCT02616393|323801117|FG001|Overall Study|Termination by Sponsor|5|||
94547412|NCT02616393|323801118|FG002|Overall Study|Termination by Sponsor|2|||
94547413|NCT02616393|323801116|FG000|Overall Study|Other|3|||
94547414|NCT02616393|323801117|FG001|Overall Study|Other|0|||
94547415|NCT02616393|323801118|FG002|Overall Study|Other|0|||
94547416|NCT02616393|323801116|FG000|Overall Study|Withdrawal by Subject|1|||
94547417|NCT02616393|323801117|FG001|Overall Study|Withdrawal by Subject|1|||
94655827|NCT02602288|324198199|FG000|12 Month Follow-up|Lost to Follow-up|0|||
94655828|NCT02602288|324198200|FG001|12 Month Follow-up|Lost to Follow-up|4|||
94655829|NCT02602288|324198199|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
94655830|NCT02602288|324198200|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
94655831|NCT02805257|324198201|FG000|Overall Study|Lost to Follow-up|7|||
94655832|NCT02805257|324198202|FG001|Overall Study|Lost to Follow-up|6|||
94655833|NCT02805257|324198201|FG000|Overall Study|Death|0|||
94655834|NCT02805257|324198202|FG001|Overall Study|Death|1|||
94655835|NCT03892889|324198208|FG000|Overall Study|Adverse Event|17|||
94655836|NCT03892889|324198208|FG000|Overall Study|Lack of Efficacy|1|||
94655837|NCT03892889|324198208|FG000|Overall Study|Lost to Follow-up|46|||
94655838|NCT03892889|324198208|FG000|Overall Study|Non-compliance with study drug|22|||
94655839|NCT03892889|324198208|FG000|Overall Study|Pregnancy|1|||
94655840|NCT03892889|324198208|FG000|Overall Study|Protocol Deviation|3|||
94655841|NCT03892889|324198208|FG000|Overall Study|Withdrawal by Subject|50|||
94655842|NCT03892889|324198208|FG000|Overall Study|Withdrawal by Caregiver|1|||
94547418|NCT02616393|323801118|FG002|Overall Study|Withdrawal by Subject|0|||
94547419|NCT02616393|323801116|FG000|Overall Study|Lost to Follow-up|0|||
94655843|NCT03892889|324198208|FG000|Overall Study|Study Terminated by Sponsor|50|||
94655844|NCT03892889|324198208|FG000|Overall Study|Physician Decision|8|||
94655845|NCT03892889|324198208|FG000|Overall Study|Reason not Specified|5|||
94655846|NCT02066298|324198209|FG000|Overall Study|Lost to Follow-up|3|||
94655847|NCT02066298|324198210|FG001|Overall Study|Lost to Follow-up|2|||
94655848|NCT02066298|324198211|FG002|Overall Study|Lost to Follow-up|3|||
94655849|NCT02066298|324198212|FG003|Overall Study|Lost to Follow-up|2|||
94655850|NCT02066298|324198213|FG004|Overall Study|Lost to Follow-up|3|||
94222900|NCT04754594|322608393|FG001|Infant Participants|Death|0|||
94222901|NCT04754594|322608394|FG002|Infant Participants|Death|1|||
94547420|NCT02616393|323801117|FG001|Overall Study|Lost to Follow-up|2|||
94547421|NCT02616393|323801118|FG002|Overall Study|Lost to Follow-up|0|||
94547422|NCT02712424|323801119|FG000|Overall Study|Lost to Follow-up|34|||
94547423|NCT02712424|323801120|FG001|Overall Study|Lost to Follow-up|32|||
94547424|NCT00657371|323801121|FG000|Overall Study|Poor bowel preparation|15|||
94547425|NCT00657371|323801121|FG000|Overall Study|Unable to intubate the cecum|5|||
94547426|NCT00657371|323801121|FG000|Overall Study|Protocol Violation|2|||
94547427|NCT00657371|323801121|FG000|Overall Study|Device- related reasons|13|||
94547428|NCT00657371|323801121|FG000|Overall Study|Pre-existing medical condition|4|||
94547429|NCT00364533|323801122|FG000|Overall Study|Adverse Event|8|||
94547430|NCT00364533|323801123|FG001|Overall Study|Adverse Event|7|||
94547431|NCT00364533|323801124|FG002|Overall Study|Adverse Event|15|||
94547432|NCT00364533|323801125|FG003|Overall Study|Adverse Event|5|||
94547433|NCT00364533|323801126|FG004|Overall Study|Adverse Event|2|||
94547434|NCT00364533|323801122|FG000|Overall Study|Withdrawal by Subject|4|||
94547435|NCT00364533|323801123|FG001|Overall Study|Withdrawal by Subject|8|||
94547436|NCT00364533|323801124|FG002|Overall Study|Withdrawal by Subject|6|||
94222902|NCT04754594|322608395|FG003|Infant Participants|Death|1|||
94222903|NCT04754594|322608392|FG000|Infant Participants|Other|0|||
94222904|NCT04754594|322608393|FG001|Infant Participants|Other|0|||
94331186|NCT03943446|322994154|FG002|Overall Study|Study Terminated by Sponsor|1|||
94331187|NCT03943446|322994152|FG000|Overall Study|Reason not Specified|5|||
94547437|NCT00364533|323801125|FG003|Overall Study|Withdrawal by Subject|6|||
94655851|NCT02066298|324198214|FG005|Overall Study|Lost to Follow-up|4|||
94655852|NCT02066298|324198209|FG000|Overall Study|Withdrawal by Subject|6|||
94222905|NCT04754594|322608394|FG002|Infant Participants|Other|1|||
94222906|NCT04754594|322608395|FG003|Infant Participants|Other|1|||
94222907|NCT00495612|322608398|FG000|Overall Study|Lost to Follow-up|1|||
94547438|NCT00364533|323801126|FG004|Overall Study|Withdrawal by Subject|6|||
94547439|NCT00364533|323801122|FG000|Overall Study|Lack of Efficacy|22|||
94547440|NCT00364533|323801123|FG001|Overall Study|Lack of Efficacy|22|||
94547441|NCT00364533|323801124|FG002|Overall Study|Lack of Efficacy|21|||
94655853|NCT02066298|324198210|FG001|Overall Study|Withdrawal by Subject|6|||
94547442|NCT00364533|323801125|FG003|Overall Study|Lack of Efficacy|17|||
94547443|NCT00364533|323801126|FG004|Overall Study|Lack of Efficacy|42|||
94547444|NCT00364533|323801122|FG000|Overall Study|Subject discharged from hospital|4|||
94547445|NCT00364533|323801123|FG001|Overall Study|Subject discharged from hospital|1|||
94547446|NCT00364533|323801124|FG002|Overall Study|Subject discharged from hospital|2|||
94547447|NCT00364533|323801125|FG003|Overall Study|Subject discharged from hospital|3|||
94547448|NCT00364533|323801126|FG004|Overall Study|Subject discharged from hospital|1|||
94547449|NCT00364533|323801122|FG000|Overall Study|Variations in drug compliance|2|||
94547450|NCT00364533|323801123|FG001|Overall Study|Variations in drug compliance|1|||
94547451|NCT00364533|323801124|FG002|Overall Study|Variations in drug compliance|1|||
94547452|NCT00364533|323801125|FG003|Overall Study|Variations in drug compliance|0|||
94547453|NCT00364533|323801126|FG004|Overall Study|Variations in drug compliance|0|||
94547454|NCT00364533|323801122|FG000|Overall Study|Non-compliance|1|||
94547455|NCT00364533|323801123|FG001|Overall Study|Non-compliance|0|||
94547456|NCT00364533|323801124|FG002|Overall Study|Non-compliance|0|||
94547457|NCT00364533|323801125|FG003|Overall Study|Non-compliance|0|||
94547458|NCT00364533|323801126|FG004|Overall Study|Non-compliance|0|||
94547459|NCT00364533|323801122|FG000|Overall Study|Protocol Violation|1|||
94547460|NCT00364533|323801123|FG001|Overall Study|Protocol Violation|1|||
94547461|NCT00364533|323801124|FG002|Overall Study|Protocol Violation|0|||
94547462|NCT00364533|323801125|FG003|Overall Study|Protocol Violation|0|||
94547463|NCT00364533|323801126|FG004|Overall Study|Protocol Violation|0|||
94547464|NCT00582738|323801127|FG000|Overall Study|Administrative Problems|7|||
94547465|NCT00582738|323801128|FG001|Overall Study|Administrative Problems|8|||
94547466|NCT00582738|323801127|FG000|Overall Study|Adverse Event|0|||
94547467|NCT00582738|323801128|FG001|Overall Study|Adverse Event|5|||
94547468|NCT00582738|323801127|FG000|Overall Study|Graft Lost|0|||
94547469|NCT00582738|323801128|FG001|Overall Study|Graft Lost|1|||
94547470|NCT00582738|323801127|FG000|Overall Study|Other|1|||
94547471|NCT00582738|323801128|FG001|Overall Study|Other|0|||
94547472|NCT00582738|323801127|FG000|Overall Study|Protocol Violation|1|||
94547473|NCT00582738|323801128|FG001|Overall Study|Protocol Violation|1|||
94547474|NCT00582738|323801127|FG000|Overall Study|Withdrawal by Subject|0|||
94547475|NCT00582738|323801128|FG001|Overall Study|Withdrawal by Subject|3|||
94547476|NCT02713867|323801129|FG000|Randomization|Other Reason|2|||
94547477|NCT02713867|323801130|FG001|Randomization|Other Reason|1|||
94547478|NCT02713867|323801129|FG000|Randomization|Participant Withdrew consent|0|||
94547479|NCT02713867|323801130|FG001|Randomization|Participant Withdrew consent|2|||
94547480|NCT02713867|323801129|FG000|Treatment Period|Other Reasons|22|||
94547481|NCT02713867|323801130|FG001|Treatment Period|Other Reasons|28|||
94547482|NCT02713867|323801129|FG000|Treatment Period|Administrative reason by sponsor|21|||
94547483|NCT02713867|323801130|FG001|Treatment Period|Administrative reason by sponsor|16|||
94547484|NCT02713867|323801129|FG000|Treatment Period|No longer meets study criteria|2|||
94547485|NCT02713867|323801130|FG001|Treatment Period|No longer meets study criteria|1|||
94547486|NCT02713867|323801129|FG000|Treatment Period|Poor/Non Compliance|1|||
94222908|NCT00495612|322608399|FG001|Overall Study|Lost to Follow-up|0|||
94222909|NCT00495612|322608398|FG000|Overall Study|Subject's Decision to Withdraw|3|||
94222910|NCT00495612|322608399|FG001|Overall Study|Subject's Decision to Withdraw|0|||
94222911|NCT01247922|322608400|FG000|Overall Study|Disease progression|4|||
94222912|NCT02849509|322608403|FG000|Overall Study|Worsening of disease under study|1|||
94222913|NCT02849509|322608404|FG001|Overall Study|Worsening of disease under study|1|||
94222914|NCT02849509|322608405|FG002|Overall Study|Worsening of disease under study|1|||
94222915|NCT02849509|322608403|FG000|Overall Study|Worsening of other pre-existing disease|0|||
94222916|NCT02849509|322608404|FG001|Overall Study|Worsening of other pre-existing disease|1|||
94222917|NCT02849509|322608405|FG002|Overall Study|Worsening of other pre-existing disease|2|||
94222918|NCT02849509|322608403|FG000|Overall Study|Other adverse event|36|||
94222919|NCT02849509|322608404|FG001|Overall Study|Other adverse event|41|||
94547487|NCT02713867|323801130|FG001|Treatment Period|Poor/Non Compliance|0|||
94547488|NCT02713867|323801129|FG000|Treatment Period|Maximum Clinical Benefit|5|||
94655854|NCT02066298|324198211|FG002|Overall Study|Withdrawal by Subject|6|||
94655855|NCT02066298|324198212|FG003|Overall Study|Withdrawal by Subject|4|||
94655856|NCT02066298|324198213|FG004|Overall Study|Withdrawal by Subject|5|||
94655857|NCT02066298|324198214|FG005|Overall Study|Withdrawal by Subject|8|||
94547489|NCT02713867|323801130|FG001|Treatment Period|Maximum Clinical Benefit|6|||
94547490|NCT02713867|323801129|FG000|Treatment Period|Withdrew consent|3|||
94655858|NCT02066298|324198209|FG000|Overall Study|Physician Decision|0|||
94655859|NCT02066298|324198210|FG001|Overall Study|Physician Decision|0|||
94655860|NCT02066298|324198211|FG002|Overall Study|Physician Decision|1|||
94655861|NCT02066298|324198212|FG003|Overall Study|Physician Decision|0|||
94655862|NCT02066298|324198213|FG004|Overall Study|Physician Decision|1|||
94222920|NCT02849509|322608405|FG002|Overall Study|Other adverse event|8|||
94547491|NCT02713867|323801130|FG001|Treatment Period|Withdrew consent|6|||
94547492|NCT02713867|323801129|FG000|Treatment Period|Requested to Discontinue|8|||
94547493|NCT02713867|323801130|FG001|Treatment Period|Requested to Discontinue|8|||
94547494|NCT02713867|323801129|FG000|Treatment Period|AE unrelated to Study Drug|11|||
94547495|NCT02713867|323801130|FG001|Treatment Period|AE unrelated to Study Drug|10|||
94655863|NCT02066298|324198214|FG005|Overall Study|Physician Decision|0|||
94655864|NCT00630877|324198215|FG000|Overall Study|Adverse Event|11|||
94655865|NCT00630877|324198216|FG001|Overall Study|Adverse Event|8|||
94655866|NCT00630877|324198217|FG002|Overall Study|Adverse Event|7|||
94222921|NCT02849509|322608403|FG000|Overall Study|Withdrawal by Subject|6|||
94655867|NCT00630877|324198215|FG000|Overall Study|Withdrawal by Subject|3|||
94655868|NCT00630877|324198216|FG001|Overall Study|Withdrawal by Subject|4|||
94655869|NCT00630877|324198217|FG002|Overall Study|Withdrawal by Subject|0|||
94655870|NCT00630877|324198215|FG000|Overall Study|Lost to Follow-up|2|||
94655871|NCT00630877|324198216|FG001|Overall Study|Lost to Follow-up|0|||
94655872|NCT00630877|324198217|FG002|Overall Study|Lost to Follow-up|0|||
94655873|NCT00630877|324198215|FG000|Overall Study|Noncompliance|2|||
94655874|NCT00630877|324198216|FG001|Overall Study|Noncompliance|3|||
94655875|NCT00630877|324198217|FG002|Overall Study|Noncompliance|1|||
94655876|NCT00630877|324198215|FG000|Overall Study|Protocol violation|1|||
94655877|NCT00630877|324198216|FG001|Overall Study|Protocol violation|0|||
94655878|NCT00630877|324198217|FG002|Overall Study|Protocol violation|1|||
94222922|NCT02849509|322608404|FG001|Overall Study|Withdrawal by Subject|17|||
94222923|NCT02849509|322608405|FG002|Overall Study|Withdrawal by Subject|12|||
94222924|NCT02849509|322608403|FG000|Overall Study|Lost to Follow-up|27|||
94222925|NCT02849509|322608404|FG001|Overall Study|Lost to Follow-up|67|||
94222926|NCT02849509|322608405|FG002|Overall Study|Lost to Follow-up|36|||
94222927|NCT02849509|322608403|FG000|Overall Study|Other, reason not specified|14|||
94222928|NCT02849509|322608404|FG001|Overall Study|Other, reason not specified|29|||
94222929|NCT02849509|322608405|FG002|Overall Study|Other, reason not specified|25|||
94222930|NCT02849509|322608403|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
94222931|NCT02849509|322608404|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
94222932|NCT02849509|322608405|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
94222933|NCT00975130|322608406|FG000|Study Part 1|Adverse Event|150|||
94222934|NCT00975130|322608407|FG001|Study Part 1|Adverse Event|0|||
94222935|NCT00975130|322608408|FG002|Study Part 1|Adverse Event|0|||
94222936|NCT00975130|322608406|FG000|Study Part 1|Lost to Follow-up|19|||
94222937|NCT00975130|322608407|FG001|Study Part 1|Lost to Follow-up|0|||
94222938|NCT00975130|322608408|FG002|Study Part 1|Lost to Follow-up|0|||
94222939|NCT00975130|322608406|FG000|Study Part 1|Withdrawal by Subject|61|||
94222940|NCT00975130|322608407|FG001|Study Part 1|Withdrawal by Subject|0|||
94222941|NCT00975130|322608408|FG002|Study Part 1|Withdrawal by Subject|0|||
94222942|NCT00975130|322608406|FG000|Study Part 1|Protocol Violation|13|||
94222943|NCT00975130|322608407|FG001|Study Part 1|Protocol Violation|0|||
94222944|NCT00975130|322608408|FG002|Study Part 1|Protocol Violation|0|||
94222945|NCT00975130|322608406|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
94222946|NCT00975130|322608407|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
94222947|NCT00975130|322608408|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
94222948|NCT00975130|322608406|FG000|Study Part 1|Administrative|4|||
94222949|NCT00975130|322608407|FG001|Study Part 1|Administrative|0|||
94222950|NCT00975130|322608408|FG002|Study Part 1|Administrative|0|||
94222951|NCT00975130|322608406|FG000|Study Part 1|Withdrew Consent|24|||
94222952|NCT00975130|322608407|FG001|Study Part 1|Withdrew Consent|0|||
94222953|NCT00975130|322608408|FG002|Study Part 1|Withdrew Consent|0|||
94222954|NCT00975130|322608406|FG000|Study Part 2|Adverse Event|0|||
94222955|NCT00975130|322608407|FG001|Study Part 2|Adverse Event|14|||
94222956|NCT00975130|322608408|FG002|Study Part 2|Adverse Event|7|||
94222957|NCT00975130|322608406|FG000|Study Part 2|Lost to Follow-up|0|||
94222958|NCT00975130|322608407|FG001|Study Part 2|Lost to Follow-up|0|||
94222959|NCT00975130|322608408|FG002|Study Part 2|Lost to Follow-up|1|||
94222960|NCT00975130|322608406|FG000|Study Part 2|Withdrawal by Subject|0|||
94222961|NCT00975130|322608407|FG001|Study Part 2|Withdrawal by Subject|13|||
94222962|NCT00975130|322608408|FG002|Study Part 2|Withdrawal by Subject|5|||
94222963|NCT00975130|322608406|FG000|Study Part 2|Withdrew Consent|0|||
94222964|NCT00975130|322608407|FG001|Study Part 2|Withdrew Consent|6|||
94222965|NCT00975130|322608408|FG002|Study Part 2|Withdrew Consent|2|||
94222966|NCT00975130|322608406|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
94222967|NCT00975130|322608407|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
94222968|NCT00975130|322608408|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
94222969|NCT00975130|322608406|FG000|Study Part 2|Administrative|0|||
94222970|NCT00975130|322608407|FG001|Study Part 2|Administrative|1|||
94222971|NCT00975130|322608408|FG002|Study Part 2|Administrative|0|||
94222972|NCT00975130|322608406|FG000|Study Part 2|Protocol Violation|0|||
94222973|NCT00975130|322608407|FG001|Study Part 2|Protocol Violation|0|||
94222974|NCT00975130|322608408|FG002|Study Part 2|Protocol Violation|1|||
94222975|NCT01196741|322608409|FG000|Overall Study|Disease progression|34|||
94222976|NCT01196741|322608410|FG001|Overall Study|Disease progression|14|||
94222977|NCT01196741|322608409|FG000|Overall Study|Adverse Event|10|||
94222978|NCT01196741|322608410|FG001|Overall Study|Adverse Event|6|||
94222979|NCT01196741|322608409|FG000|Overall Study|Serious Adverse Event|3|||
94655879|NCT00630877|324198215|FG000|Overall Study|Personal reasons|0|||
94655880|NCT00630877|324198216|FG001|Overall Study|Personal reasons|0|||
94222980|NCT01196741|322608410|FG001|Overall Study|Serious Adverse Event|1|||
94222981|NCT01196741|322608409|FG000|Overall Study|Dose limiting Adverse Event|2|||
94222982|NCT01196741|322608410|FG001|Overall Study|Dose limiting Adverse Event|1|||
94222983|NCT01196741|322608409|FG000|Overall Study|Withdrawal by Subject|3|||
94222984|NCT01196741|322608410|FG001|Overall Study|Withdrawal by Subject|0|||
94222985|NCT01196741|322608409|FG000|Overall Study|Other reason|3|||
94222986|NCT01196741|322608410|FG001|Overall Study|Other reason|3|||
94222987|NCT01196741|322608409|FG000|Overall Study|Other|3|||
94222988|NCT01196741|322608410|FG001|Overall Study|Other|2|||
94222989|NCT01196741|322608409|FG000|Overall Study|Protocol Violation|2|||
94222990|NCT01196741|322608410|FG001|Overall Study|Protocol Violation|1|||
94222991|NCT01294358|322608413|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
94222992|NCT01294358|322608414|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
94222993|NCT01294358|322608415|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
94222994|NCT01294358|322608416|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
94222995|NCT01294358|322608417|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
94222996|NCT01294358|322608413|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
94222997|NCT01294358|322608414|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
94222998|NCT01294358|322608415|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
94222999|NCT01294358|322608416|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
94223000|NCT01294358|322608417|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
94223001|NCT01294358|322608413|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
94223002|NCT01294358|322608414|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
94223003|NCT01294358|322608415|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
94223004|NCT01294358|322608416|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
94223005|NCT01294358|322608417|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
94223006|NCT01294358|322608413|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
94223007|NCT01294358|322608414|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
94223008|NCT01294358|322608415|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
94223009|NCT01294358|322608416|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
94223010|NCT01294358|322608417|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
94223011|NCT02963922|322608418|FG000|Overall Study|Adverse Event|15|||
94223012|NCT02963922|322608419|FG001|Overall Study|Adverse Event|6|||
94223013|NCT02963922|322608418|FG000|Overall Study|Protocol deviation|6|||
94223014|NCT02963922|322608419|FG001|Overall Study|Protocol deviation|6|||
94223015|NCT02963922|322608418|FG000|Overall Study|Lack of Efficacy|1|||
94223016|NCT02963922|322608419|FG001|Overall Study|Lack of Efficacy|1|||
94223017|NCT02963922|322608418|FG000|Overall Study|Lost to Follow-up|2|||
94223018|NCT02963922|322608419|FG001|Overall Study|Lost to Follow-up|3|||
94223019|NCT02963922|322608418|FG000|Overall Study|Other|8|||
94223020|NCT02963922|322608419|FG001|Overall Study|Other|14|||
94223021|NCT03740919|322608426|FG000|Lead-in Period|Lost to Follow-up|1|||
94223022|NCT03740919|322608427|FG001|Lead-in Period|Lost to Follow-up|0|||
94223023|NCT03740919|322608428|FG002|Lead-in Period|Lost to Follow-up|0|||
94223024|NCT03740919|322608429|FG003|Lead-in Period|Lost to Follow-up|0|||
94223025|NCT03740919|322608426|FG000|Lead-in Period|Physician Decision|2|||
94223026|NCT03740919|322608427|FG001|Lead-in Period|Physician Decision|0|||
94223027|NCT03740919|322608428|FG002|Lead-in Period|Physician Decision|0|||
94223028|NCT03740919|322608429|FG003|Lead-in Period|Physician Decision|0|||
94223029|NCT03740919|322608426|FG000|Lead-in Period|Protocol Violation|1|||
94223030|NCT03740919|322608427|FG001|Lead-in Period|Protocol Violation|0|||
94223031|NCT03740919|322608428|FG002|Lead-in Period|Protocol Violation|0|||
94223032|NCT03740919|322608429|FG003|Lead-in Period|Protocol Violation|0|||
94223033|NCT03740919|322608426|FG000|Lead-in Period|Withdrawal by Subject|10|||
94223034|NCT03740919|322608427|FG001|Lead-in Period|Withdrawal by Subject|0|||
94223035|NCT03740919|322608428|FG002|Lead-in Period|Withdrawal by Subject|0|||
94223036|NCT03740919|322608429|FG003|Lead-in Period|Withdrawal by Subject|0|||
94223037|NCT03740919|322608426|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
94223038|NCT03740919|322608427|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
94223039|NCT03740919|322608428|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
94223040|NCT03740919|322608429|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
94223041|NCT03740919|322608426|FG000|Lead-in Period|Study Task Too Burdensome|1|||
94223042|NCT03740919|322608427|FG001|Lead-in Period|Study Task Too Burdensome|0|||
94223043|NCT03740919|322608428|FG002|Lead-in Period|Study Task Too Burdensome|0|||
94223044|NCT03740919|322608429|FG003|Lead-in Period|Study Task Too Burdensome|0|||
94223045|NCT03740919|322608426|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
94223046|NCT03740919|322608427|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
94223047|NCT03740919|322608428|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
94223048|NCT03740919|322608429|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
94223049|NCT03740919|322608426|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
94223050|NCT03740919|322608427|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
94223051|NCT03740919|322608428|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
94223052|NCT03740919|322608429|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
94223053|NCT03740919|322608426|FG000|Treatment Period|Adverse Event|0|||
94223054|NCT03740919|322608427|FG001|Treatment Period|Adverse Event|0|||
94223055|NCT03740919|322608428|FG002|Treatment Period|Adverse Event|2|||
94223056|NCT03740919|322608429|FG003|Treatment Period|Adverse Event|0|||
94223057|NCT03740919|322608426|FG000|Treatment Period|Protocol Violation|0|||
94223058|NCT03740919|322608427|FG001|Treatment Period|Protocol Violation|1|||
94223059|NCT03740919|322608428|FG002|Treatment Period|Protocol Violation|0|||
94223060|NCT03740919|322608429|FG003|Treatment Period|Protocol Violation|0|||
94223061|NCT03740919|322608426|FG000|Treatment Period|Withdrawal by Subject|0|||
94223062|NCT03740919|322608427|FG001|Treatment Period|Withdrawal by Subject|7|||
94223063|NCT03740919|322608428|FG002|Treatment Period|Withdrawal by Subject|6|||
94223064|NCT03740919|322608429|FG003|Treatment Period|Withdrawal by Subject|2|||
94223065|NCT03740919|322608426|FG000|Treatment Period|Terminated by Sponsor|0|||
94223066|NCT03740919|322608427|FG001|Treatment Period|Terminated by Sponsor|1|||
94223067|NCT03740919|322608428|FG002|Treatment Period|Terminated by Sponsor|0|||
94223068|NCT03740919|322608429|FG003|Treatment Period|Terminated by Sponsor|0|||
94223069|NCT03740919|322608426|FG000|Treatment Period|Issue with Insulin Pump|0|||
94223070|NCT03740919|322608427|FG001|Treatment Period|Issue with Insulin Pump|1|||
94223071|NCT03740919|322608428|FG002|Treatment Period|Issue with Insulin Pump|0|||
94223072|NCT03740919|322608429|FG003|Treatment Period|Issue with Insulin Pump|0|||
94223073|NCT03740919|322608426|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
94223074|NCT03740919|322608427|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
94223075|NCT03740919|322608428|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
94223076|NCT03740919|322608429|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
94223077|NCT03740919|322608426|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
94223078|NCT03740919|322608427|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
94223079|NCT03740919|322608428|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
94223080|NCT03740919|322608429|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
94223081|NCT03740919|322608426|FG000|Treatment Period|Not Completing Diary|0|||
94223082|NCT03740919|322608427|FG001|Treatment Period|Not Completing Diary|0|||
94223083|NCT03740919|322608428|FG002|Treatment Period|Not Completing Diary|1|||
94223084|NCT03740919|322608429|FG003|Treatment Period|Not Completing Diary|0|||
94223085|NCT03740919|322608426|FG000|Treatment Period|Insulin Painful to Participant|0|||
94223086|NCT03740919|322608427|FG001|Treatment Period|Insulin Painful to Participant|0|||
94223087|NCT03740919|322608428|FG002|Treatment Period|Insulin Painful to Participant|1|||
94223088|NCT03740919|322608429|FG003|Treatment Period|Insulin Painful to Participant|0|||
94223089|NCT01071317|322608435|FG000|Overall Study|Lost to Follow-up|2|||
94223090|NCT01071317|322608436|FG001|Overall Study|Lost to Follow-up|2|||
94223091|NCT01721759|322608440|FG000|Treatment Period|Disease Progression|85|||
94223092|NCT01721759|322608440|FG000|Treatment Period|Study drug toxicity|14|||
94223093|NCT01721759|322608440|FG000|Treatment Period|Death|1|||
94223094|NCT01721759|322608440|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
94223095|NCT01721759|322608440|FG000|Treatment Period|Participant request to withdraw|3|||
94223096|NCT01721759|322608440|FG000|Treatment Period|Other Reasons|3|||
94223097|NCT01721759|322608440|FG000|End of Study Period|Participant Withdrew Consent|5|||
94223098|NCT01721759|322608440|FG000|End of Study Period|Death|101|||
94223099|NCT01721759|322608440|FG000|End of Study Period|Lost to Follow-up|1|||
94223100|NCT01721759|322608440|FG000|End of Study Period|Other Reasons|10|||
94223101|NCT00580047|322608443|FG000|Overall Study|Lost to Follow-up|1|||
94223102|NCT00580047|322608444|FG001|Overall Study|Lost to Follow-up|1|||
94223103|NCT00580047|322608445|FG002|Overall Study|Lost to Follow-up|0|||
94223104|NCT00580047|322608443|FG000|Overall Study|Withdrawal by Subject|1|||
94223105|NCT00580047|322608444|FG001|Overall Study|Withdrawal by Subject|1|||
94223106|NCT00580047|322608445|FG002|Overall Study|Withdrawal by Subject|2|||
94223107|NCT00580047|322608443|FG000|Overall Study|Withdrawal by Subject|1|||
94223108|NCT00580047|322608444|FG001|Overall Study|Withdrawal by Subject|0|||
94223109|NCT00580047|322608445|FG002|Overall Study|Withdrawal by Subject|0|||
94223110|NCT01894256|322608446|FG000|Part A|Adverse Event|0|||
94223111|NCT01894256|322608447|FG001|Part A|Adverse Event|1|||
94223112|NCT01894256|322608448|FG002|Part A|Adverse Event|0|||
94223113|NCT01894256|322608446|FG000|Part B|Death|0|||
94223114|NCT01894256|322608447|FG001|Part B|Death|1|||
94223115|NCT01894256|322608448|FG002|Part B|Death|1|||
94223116|NCT01894256|322608446|FG000|Part B|Withdrawal by Subject|0|||
94223117|NCT01894256|322608447|FG001|Part B|Withdrawal by Subject|1|||
94223118|NCT01894256|322608448|FG002|Part B|Withdrawal by Subject|0|||
94223119|NCT01894256|322608446|FG000|Part B|Lack of Efficacy|15|||
94223120|NCT01894256|322608447|FG001|Part B|Lack of Efficacy|12|||
94223121|NCT01894256|322608448|FG002|Part B|Lack of Efficacy|13|||
94223122|NCT02481934|322608450|FG000|Overall Study|Death|2|||
94223123|NCT01399905|322608451|FG000|Overall Study|Withdrawal by Subject|1|||
94223124|NCT01399905|322608452|FG001|Overall Study|Withdrawal by Subject|1|||
94223125|NCT00942188|322608453|FG000|Overall Study|Adverse Event|0|||
94223126|NCT00942188|322608454|FG001|Overall Study|Adverse Event|3|||
94223127|NCT00942188|322608455|FG002|Overall Study|Adverse Event|2|||
94223128|NCT00942188|322608456|FG003|Overall Study|Adverse Event|0|||
94223129|NCT00942188|322608453|FG000|Overall Study|Lack of Efficacy|0|||
94223130|NCT00942188|322608454|FG001|Overall Study|Lack of Efficacy|0|||
94223131|NCT00942188|322608455|FG002|Overall Study|Lack of Efficacy|0|||
94223132|NCT00942188|322608456|FG003|Overall Study|Lack of Efficacy|1|||
94223133|NCT00942188|322608453|FG000|Overall Study|Protocol Violation|1|||
94223134|NCT00942188|322608454|FG001|Overall Study|Protocol Violation|1|||
94223135|NCT00942188|322608455|FG002|Overall Study|Protocol Violation|0|||
94223136|NCT00942188|322608456|FG003|Overall Study|Protocol Violation|0|||
94223137|NCT00942188|322608453|FG000|Overall Study|Lost to Follow-up|2|||
94223138|NCT00942188|322608454|FG001|Overall Study|Lost to Follow-up|1|||
94223139|NCT00942188|322608455|FG002|Overall Study|Lost to Follow-up|2|||
94223140|NCT00942188|322608456|FG003|Overall Study|Lost to Follow-up|0|||
94223141|NCT00942188|322608453|FG000|Overall Study|Withdrawal by Subject|1|||
94223142|NCT00942188|322608454|FG001|Overall Study|Withdrawal by Subject|3|||
94223143|NCT00942188|322608455|FG002|Overall Study|Withdrawal by Subject|4|||
94223144|NCT00942188|322608456|FG003|Overall Study|Withdrawal by Subject|2|||
94223145|NCT00942188|322608453|FG000|Overall Study|Physician Decision|0|||
94223146|NCT00942188|322608454|FG001|Overall Study|Physician Decision|0|||
94223147|NCT00942188|322608455|FG002|Overall Study|Physician Decision|1|||
94223148|NCT00942188|322608456|FG003|Overall Study|Physician Decision|0|||
94223149|NCT00942188|322608453|FG000|Overall Study|Sponsor Decision|0|||
94223150|NCT00942188|322608454|FG001|Overall Study|Sponsor Decision|2|||
94223151|NCT00942188|322608455|FG002|Overall Study|Sponsor Decision|0|||
94223152|NCT00942188|322608456|FG003|Overall Study|Sponsor Decision|1|||
94223153|NCT01544153|322608457|FG000|Overall Study|Under 18|0|||
94223154|NCT01544153|322608458|FG001|Overall Study|Under 18|1|||
94223155|NCT01544153|322608459|FG002|Overall Study|Under 18|0|||
94223156|NCT01544153|322608460|FG003|Overall Study|Under 18|0|||
94223157|NCT01544153|322608457|FG000|Overall Study|Non-smoker|0|||
94223158|NCT01544153|322608458|FG001|Overall Study|Non-smoker|0|||
94223159|NCT01544153|322608459|FG002|Overall Study|Non-smoker|1|||
94223160|NCT01544153|322608460|FG003|Overall Study|Non-smoker|0|||
94223161|NCT03675308|322610146|FG000|Overall Study|Adverse Event|3|||
94223162|NCT03675308|322610147|FG001|Overall Study|Adverse Event|2|||
94223163|NCT03675308|322610146|FG000|Overall Study|Withdrawal by Subject|6|||
94223164|NCT03675308|322610147|FG001|Overall Study|Withdrawal by Subject|4|||
94223165|NCT03675308|322610146|FG000|Overall Study|Lost to Follow-up|3|||
94223166|NCT03675308|322610147|FG001|Overall Study|Lost to Follow-up|0|||
94223167|NCT03675308|322610146|FG000|Overall Study|Lack of Efficacy|1|||
94223168|NCT03675308|322610147|FG001|Overall Study|Lack of Efficacy|1|||
94223169|NCT03675308|322610146|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
94223170|NCT03675308|322610147|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
94223171|NCT03675308|322610146|FG000|Overall Study|Other|0|||
94223172|NCT03675308|322610147|FG001|Overall Study|Other|1|||
94223173|NCT03681353|322610151|FG000|Overall Study|Lost to Follow-up|2|||
94223174|NCT03681353|322610151|FG000|Overall Study|Withdrawal by Subject|3|||
94223175|NCT03681353|322610151|FG000|Overall Study|withdrawn by PI|2|||
94223176|NCT00726388|322610155|FG000|Overall Study|Withdrawal by Subject|5|||
94223177|NCT00726388|322610155|FG000|Overall Study|Adverse Event|3|||
94223178|NCT00726388|322610155|FG000|Overall Study|Lost to Follow-up|10|||
94223179|NCT00726388|322610155|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
94223180|NCT00726388|322610155|FG000|Overall Study|Other|5|||
94223181|NCT00726388|322610155|FG000|Overall Study|Enrolled, Not Treated|79|||
94223182|NCT00111839|322610156|FG000|Overall Study|Disease Progression|30|||
94223183|NCT00111839|322610157|FG001|Overall Study|Disease Progression|33|||
94223184|NCT00111839|322610158|FG002|Overall Study|Disease Progression|33|||
94223185|NCT00111839|322610156|FG000|Overall Study|Adverse Event|5|||
94223186|NCT00111839|322610157|FG001|Overall Study|Adverse Event|3|||
94223187|NCT00111839|322610158|FG002|Overall Study|Adverse Event|1|||
94223188|NCT00111839|322610156|FG000|Overall Study|Protocol Violation|2|||
94223189|NCT00111839|322610157|FG001|Overall Study|Protocol Violation|4|||
94223190|NCT00111839|322610158|FG002|Overall Study|Protocol Violation|2|||
94223191|NCT00111839|322610156|FG000|Overall Study|Death|1|||
94223192|NCT00111839|322610157|FG001|Overall Study|Death|1|||
94223193|NCT00111839|322610158|FG002|Overall Study|Death|6|||
94223194|NCT00111839|322610156|FG000|Overall Study|Withdrawal by Subject|2|||
94223195|NCT00111839|322610157|FG001|Overall Study|Withdrawal by Subject|2|||
94223196|NCT00111839|322610158|FG002|Overall Study|Withdrawal by Subject|2|||
94223197|NCT00111839|322610156|FG000|Overall Study|Lost to Follow-up|1|||
94223198|NCT00111839|322610157|FG001|Overall Study|Lost to Follow-up|0|||
94547496|NCT02713867|323801129|FG000|Treatment Period|Death|7|||
94223199|NCT00111839|322610158|FG002|Overall Study|Lost to Follow-up|0|||
94223200|NCT00111839|322610156|FG000|Overall Study|Logistical Constraint|1|||
94223201|NCT00111839|322610157|FG001|Overall Study|Logistical Constraint|0|||
94547497|NCT02713867|323801130|FG001|Treatment Period|Death|3|||
94223202|NCT00111839|322610158|FG002|Overall Study|Logistical Constraint|0|||
94547498|NCT02713867|323801129|FG000|Treatment Period|Study Drug Toxicity|16|||
94223203|NCT00111839|322610156|FG000|Overall Study|Other|6|||
94223204|NCT00111839|322610157|FG001|Overall Study|Other|3|||
94223205|NCT00111839|322610158|FG002|Overall Study|Other|3|||
94223206|NCT00111839|322610156|FG000|Overall Study|Randomized but Not Treated|0|||
94223207|NCT00111839|322610157|FG001|Overall Study|Randomized but Not Treated|0|||
94223208|NCT00111839|322610158|FG002|Overall Study|Randomized but Not Treated|2|||
94223209|NCT00377312|322610161|FG000|Overall Study|Adverse Event|1|||
94223210|NCT00377312|322610162|FG001|Overall Study|Adverse Event|1|||
94223211|NCT00352053|322610163|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
94223212|NCT00352053|322610164|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
94223213|NCT00352053|322610163|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
94223214|NCT00352053|322610164|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
94223215|NCT00352053|322610163|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
94223216|NCT00352053|322610164|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
94223217|NCT00352053|322610163|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
94223218|NCT00352053|322610164|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
94223219|NCT00352053|322610163|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
94223220|NCT00352053|322610164|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
94223221|NCT00352053|322610163|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
94223222|NCT00352053|322610164|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
94223223|NCT00352053|322610163|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
94223224|NCT00352053|322610164|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
94223225|NCT00352053|322610163|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
94223226|NCT00352053|322610164|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
94223227|NCT00352053|322610163|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
94223228|NCT00352053|322610164|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
94223229|NCT00352053|322610163|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
94223230|NCT00352053|322610164|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
94223231|NCT00352053|322610163|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
94223232|NCT00352053|322610164|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
94223233|NCT00352053|322610163|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
94223234|NCT00352053|322610164|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
94223235|NCT00352053|322610163|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
94223236|NCT00352053|322610164|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
94223237|NCT03997409|322610165|FG000|Overall Study|Protocol Violation|1|||
94223238|NCT03997409|322610166|FG001|Overall Study|Protocol Violation|1|||
94223239|NCT03997409|322610167|FG002|Overall Study|Protocol Violation|0|||
94547499|NCT02713867|323801130|FG001|Treatment Period|Study Drug Toxicity|19|||
94547500|NCT02713867|323801129|FG000|Treatment Period|Disease Progression|82|||
94223240|NCT03997409|322610165|FG000|Overall Study|Withdrawal by Subject|3|||
94223241|NCT03997409|322610166|FG001|Overall Study|Withdrawal by Subject|0|||
94223242|NCT03997409|322610167|FG002|Overall Study|Withdrawal by Subject|0|||
94223243|NCT03997409|322610165|FG000|Overall Study|Lost to Follow-up|0|||
94223244|NCT03997409|322610166|FG001|Overall Study|Lost to Follow-up|0|||
94223245|NCT03997409|322610167|FG002|Overall Study|Lost to Follow-up|1|||
94223246|NCT01697592|322610173|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
94223247|NCT01697592|322610174|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
94223248|NCT01697592|322610175|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
94223249|NCT01697592|322610176|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
94223250|NCT01697592|322610177|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
94223251|NCT01697592|322610178|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
94223252|NCT01697592|322610179|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
94223253|NCT01697592|322610180|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
94223254|NCT01697592|322610181|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
94223255|NCT01697592|322610182|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
94223256|NCT01697592|322610173|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
94223257|NCT01697592|322610174|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
94223258|NCT01697592|322610175|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
94223259|NCT01697592|322610176|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
94223260|NCT01697592|322610177|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
94223261|NCT01697592|322610178|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
94223262|NCT01697592|322610179|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
94223263|NCT01697592|322610180|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
94223264|NCT01697592|322610181|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
94223265|NCT01697592|322610182|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
94223266|NCT01697592|322610173|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
94223267|NCT01697592|322610174|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
94223268|NCT01697592|322610175|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
94223269|NCT01697592|322610176|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
94223270|NCT01697592|322610177|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
94223271|NCT01697592|322610178|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
94223272|NCT01697592|322610179|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
94439764|NCT02601014|323396287|FG000|Overall Study|Disease progression|4|||
94547501|NCT02713867|323801130|FG001|Treatment Period|Disease Progression|83|||
94223273|NCT01697592|322610180|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
94223274|NCT01697592|322610181|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
94223275|NCT01697592|322610182|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
94223276|NCT01697592|322610173|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
94223277|NCT01697592|322610174|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
94223278|NCT01697592|322610175|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
94223279|NCT01697592|322610176|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
94223280|NCT01697592|322610177|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
94223281|NCT01697592|322610178|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
94223282|NCT01697592|322610179|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
94223283|NCT01697592|322610180|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
94223284|NCT01697592|322610181|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
94223285|NCT01697592|322610182|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
94223286|NCT01697592|322610173|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
94223287|NCT01697592|322610174|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
94223288|NCT01697592|322610175|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
94223289|NCT01697592|322610176|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
94223290|NCT01697592|322610177|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
94223291|NCT01697592|322610178|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
94223292|NCT01697592|322610179|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
94223293|NCT01697592|322610180|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
94223294|NCT01697592|322610181|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
94223295|NCT01697592|322610182|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
94223296|NCT01697592|322610173|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
94223297|NCT01697592|322610174|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
94223298|NCT01697592|322610175|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
94223299|NCT01697592|322610176|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
94223300|NCT01697592|322610177|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
94223301|NCT01697592|322610178|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
94223302|NCT01697592|322610179|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
94223303|NCT01697592|322610180|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
94223304|NCT01697592|322610181|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
94223305|NCT01697592|322610182|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
94223306|NCT01697592|322610173|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
94223307|NCT01697592|322610174|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
94223308|NCT01697592|322610175|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
94223309|NCT01697592|322610176|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
94223310|NCT01697592|322610177|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
94223311|NCT01697592|322610178|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
94223312|NCT01697592|322610179|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
94223313|NCT01697592|322610180|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
94223314|NCT01697592|322610181|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
94223315|NCT01697592|322610182|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
94223316|NCT01697592|322610173|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
94223317|NCT01697592|322610174|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
94331188|NCT03943446|322994153|FG001|Overall Study|Reason not Specified|1|||
94331189|NCT03943446|322994154|FG002|Overall Study|Reason not Specified|3|||
94331190|NCT02905825|322994155|FG000|Overall Study|Protocol Violation|11|||
94331191|NCT02905825|322994155|FG000|Overall Study|Device Malfunction|1|||
94331192|NCT03518034|322994158|FG000|Overall Study|Not Treated|5|||
94331193|NCT03518034|322994159|FG001|Overall Study|Not Treated|1|||
94331194|NCT03518034|322994158|FG000|Overall Study|Withdrawal by Subject|309|||
94547502|NCT01600053|323801131|FG000|Overall Study|Adverse Event|2|||
94547503|NCT01600053|323801131|FG000|Overall Study|trial will not meet the interim endpoint|9|||
94331195|NCT03518034|322994159|FG001|Overall Study|Withdrawal by Subject|351|||
94331196|NCT03518034|322994158|FG000|Overall Study|Lost to Follow-up|446|||
94331197|NCT03518034|322994159|FG001|Overall Study|Lost to Follow-up|458|||
94331198|NCT03518034|322994158|FG000|Overall Study|Adverse Event|138|||
94331199|NCT03518034|322994159|FG001|Overall Study|Adverse Event|130|||
94331200|NCT03518034|322994158|FG000|Overall Study|Lack of Efficacy|11|||
94331201|NCT03518034|322994159|FG001|Overall Study|Lack of Efficacy|23|||
94331202|NCT03518034|322994158|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
94331203|NCT03518034|322994159|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
94331204|NCT03518034|322994158|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
94331205|NCT03518034|322994159|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
94331206|NCT03518034|322994158|FG000|Overall Study|Other, Not Specified|84|||
94331207|NCT03518034|322994159|FG001|Overall Study|Other, Not Specified|53|||
94331208|NCT03518034|322994158|FG000|Overall Study|Reason Missing|2|||
94331209|NCT03518034|322994159|FG001|Overall Study|Reason Missing|3|||
94547504|NCT02715726|323801132|FG000|Overall Study|Adverse Event|2|||
94331210|NCT00093470|322994165|FG000|Overall Study|Disease progression|39|||
94331211|NCT00093470|322994166|FG001|Overall Study|Disease progression|0|||
94331212|NCT00093470|322994165|FG000|Overall Study|Adverse Event|15|||
94331213|NCT00093470|322994166|FG001|Overall Study|Adverse Event|0|||
94223318|NCT01697592|322610175|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
94223319|NCT01697592|322610176|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
94223320|NCT01697592|322610177|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
94223321|NCT01697592|322610178|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
94223322|NCT01697592|322610179|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
94223323|NCT01697592|322610180|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
94223324|NCT01697592|322610181|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
94223325|NCT01697592|322610182|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
94223326|NCT00774306|322610183|FG000|Overall Study|Adverse Event|3|||
94223327|NCT00774306|322610184|FG001|Overall Study|Adverse Event|0|||
94223328|NCT00774306|322610185|FG002|Overall Study|Adverse Event|0|||
94223329|NCT00774306|322610186|FG003|Overall Study|Adverse Event|0|||
94223330|NCT00774306|322610183|FG000|Overall Study|Protocol Violation|2|||
94223331|NCT00774306|322610184|FG001|Overall Study|Protocol Violation|0|||
94223332|NCT00774306|322610185|FG002|Overall Study|Protocol Violation|3|||
94223333|NCT00774306|322610186|FG003|Overall Study|Protocol Violation|0|||
94223334|NCT00774306|322610183|FG000|Overall Study|Withdrawal by Subject|6|||
94223335|NCT00774306|322610184|FG001|Overall Study|Withdrawal by Subject|1|||
94223336|NCT00774306|322610185|FG002|Overall Study|Withdrawal by Subject|1|||
94223337|NCT00774306|322610186|FG003|Overall Study|Withdrawal by Subject|0|||
94223338|NCT00774306|322610183|FG000|Overall Study|Lost to Follow-up|6|||
94223339|NCT00774306|322610184|FG001|Overall Study|Lost to Follow-up|0|||
94223340|NCT00774306|322610185|FG002|Overall Study|Lost to Follow-up|4|||
94223341|NCT00774306|322610186|FG003|Overall Study|Lost to Follow-up|5|||
94223342|NCT00774306|322610183|FG000|Overall Study|Death|1|||
94223343|NCT00774306|322610184|FG001|Overall Study|Death|1|||
94223344|NCT00774306|322610185|FG002|Overall Study|Death|0|||
94223345|NCT00774306|322610186|FG003|Overall Study|Death|0|||
94223346|NCT01126879|322610192|FG000|Overall Study|Progressive Disease|3|||
94223347|NCT01126879|322610193|FG001|Overall Study|Progressive Disease|1|||
94223348|NCT01126879|322610192|FG000|Overall Study|Withdrawal by Subject|1|||
94331214|NCT00093470|322994165|FG000|Overall Study|Death|2|||
94331215|NCT00093470|322994166|FG001|Overall Study|Death|0|||
94331216|NCT00093470|322994165|FG000|Overall Study|Withdrawal by Subject|8|||
94331217|NCT00093470|322994166|FG001|Overall Study|Withdrawal by Subject|0|||
94331218|NCT00093470|322994165|FG000|Overall Study|Alternative therapy|2|||
94331219|NCT00093470|322994166|FG001|Overall Study|Alternative therapy|0|||
94331220|NCT00093470|322994165|FG000|Overall Study|Other complicating disease|3|||
94331221|NCT00093470|322994166|FG001|Overall Study|Other complicating disease|0|||
94331222|NCT00093470|322994165|FG000|Overall Study|Physician Decision|2|||
94331223|NCT00093470|322994166|FG001|Overall Study|Physician Decision|0|||
94331224|NCT00093470|322994165|FG000|Overall Study|Never started treatment|1|||
94331225|NCT00093470|322994166|FG001|Overall Study|Never started treatment|0|||
94331226|NCT00093470|322994165|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
94331227|NCT00093470|322994166|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
94331228|NCT02514772|322994167|FG000|Overall Study|Adverse Event|1|||
94331229|NCT02514772|322994168|FG001|Overall Study|Adverse Event|0|||
94331230|NCT02514772|322994167|FG000|Overall Study|Death|0|||
94331231|NCT02514772|322994168|FG001|Overall Study|Death|1|||
94331232|NCT02514772|322994167|FG000|Overall Study|Withdrawal by Subject|2|||
94331233|NCT02514772|322994168|FG001|Overall Study|Withdrawal by Subject|1|||
94331234|NCT04671342|322994172|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
94331235|NCT04671342|322994172|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
94331236|NCT04671342|322994172|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
94331237|NCT04671342|322994172|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
94331238|NCT04671342|322994172|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
94331239|NCT04671342|322994172|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
94331240|NCT03175562|322994173|FG000|Overall Study|Adverse Event|1|||
94331241|NCT03175562|322994173|FG000|Overall Study|Lost to Follow-up|3|||
94331242|NCT03175562|322994173|FG000|Overall Study|Withdrawal by Subject|7|||
94331243|NCT03175562|322994173|FG000|Overall Study|Other (Not Specified)|5|||
94331244|NCT00688545|322994174|FG000|Overall Study|Lost to Follow-up|1|||
94331245|NCT00688545|322994175|FG001|Overall Study|Lost to Follow-up|4|||
94331246|NCT00688545|322994174|FG000|Overall Study|Insurance/cost of drug|0|||
94547505|NCT02715726|323801133|FG001|Overall Study|Adverse Event|6|||
94223349|NCT01126879|322610193|FG001|Overall Study|Withdrawal by Subject|0|||
94223350|NCT01126879|322610192|FG000|Overall Study|Adverse Event|0|||
94223351|NCT01126879|322610193|FG001|Overall Study|Adverse Event|1|||
94223352|NCT01126879|322610192|FG000|Overall Study|Physician Decision|1|||
94223353|NCT01126879|322610193|FG001|Overall Study|Physician Decision|0|||
94223354|NCT00116584|322610196|FG000|Overall Study|Withdrawal by Subject|1|||
94331247|NCT00688545|322994175|FG001|Overall Study|Insurance/cost of drug|1|||
94331248|NCT00688545|322994174|FG000|Overall Study|Withdrawal by Subject|2|||
94331249|NCT00688545|322994175|FG001|Overall Study|Withdrawal by Subject|3|||
94331250|NCT00688545|322994174|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
94331251|NCT00688545|322994175|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
94331252|NCT01878097|322994176|FG000|Baseline|Surveys not fully completed|2497|||
94331253|NCT01878097|322994177|FG001|Baseline|Surveys not fully completed|1800|||
94331254|NCT01878097|322994176|FG000|Implementation Year 1|Surveys not fully completed|3202|||
94331255|NCT01878097|322994177|FG001|Implementation Year 1|Surveys not fully completed|2549|||
94331256|NCT01878097|322994176|FG000|Implementation Year 2|Surveys not fully completed|3281|||
94331257|NCT01878097|322994177|FG001|Implementation Year 2|Surveys not fully completed|2841|||
94331258|NCT01878097|322994176|FG000|Implementation Year 3|Surveys not fully completed|3494|||
94331259|NCT01878097|322994177|FG001|Implementation Year 3|Surveys not fully completed|2980|||
94331260|NCT01878097|322994176|FG000|Implementation Year 4|Surveys not fully completed|3604|||
94331261|NCT01878097|322994177|FG001|Implementation Year 4|Surveys not fully completed|3007|||
94331262|NCT01373918|322994178|FG000|Overall Study|Physician Decision|0|||
94331263|NCT01373918|322994179|FG001|Overall Study|Physician Decision|1|||
94331264|NCT01590212|322994180|FG000|Overall Study|Withdrawal by Subject|2|||
94331265|NCT01590212|322994181|FG001|Overall Study|Withdrawal by Subject|2|||
94331266|NCT01590212|322994182|FG002|Overall Study|Withdrawal by Subject|2|||
94331267|NCT01590212|322994180|FG000|Overall Study|Lost to Follow-up|1|||
94547506|NCT02715726|323801132|FG000|Overall Study|Protocol Violation|1|||
94547507|NCT02715726|323801133|FG001|Overall Study|Protocol Violation|0|||
94547508|NCT02715726|323801132|FG000|Overall Study|Death|2|||
94547509|NCT02715726|323801133|FG001|Overall Study|Death|1|||
94547510|NCT02715726|323801132|FG000|Overall Study|Participant moved|1|||
94547511|NCT02715726|323801133|FG001|Overall Study|Participant moved|3|||
94547512|NCT02715726|323801132|FG000|Overall Study|Other than specified above|11|||
94547513|NCT02715726|323801133|FG001|Overall Study|Other than specified above|15|||
94547514|NCT02715726|323801132|FG000|Overall Study|Randomized but not treated|1|||
94547515|NCT02715726|323801133|FG001|Overall Study|Randomized but not treated|2|||
94547516|NCT02445573|323801134|FG000|Overall Study|Withdrawal by Subject|1|||
94547517|NCT02445573|323801135|FG001|Overall Study|Withdrawal by Subject|1|||
94547518|NCT02445573|323801134|FG000|Overall Study|Lost to Follow-up|0|||
94547519|NCT02445573|323801135|FG001|Overall Study|Lost to Follow-up|1|||
94655881|NCT00630877|324198217|FG002|Overall Study|Personal reasons|1|||
94655882|NCT01519518|324198218|FG000|Overall Study|Consent not available|7|||
94655883|NCT01519518|324198219|FG001|Overall Study|Consent not available|10|||
94655884|NCT01639001|324198222|FG000|Overall Study|Refused further follow-up|9|||
94655885|NCT01639001|324198223|FG001|Overall Study|Refused further follow-up|12|||
94655886|NCT01639001|324198222|FG000|Overall Study|Lost to Follow-up|3|||
94223355|NCT00116584|322610197|FG001|Overall Study|Withdrawal by Subject|0|||
94331268|NCT01590212|322994181|FG001|Overall Study|Lost to Follow-up|2|||
94547520|NCT03230292|323801136|FG000|Overall Study|Adverse Event|1|||
94547521|NCT03230292|323801136|FG000|Overall Study|Protocol Violation|1|||
94547522|NCT03230292|323801136|FG000|Overall Study|Lost to Follow-up|1|||
94547523|NCT03230292|323801136|FG000|Overall Study|Withdrawal by Subject|3|||
94547524|NCT02855944|323801137|FG000|Period 1: Treatment|Ongoing|14|||
94547525|NCT02855944|323801138|FG001|Period 1: Treatment|Ongoing|0|||
94547526|NCT02855944|323801137|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
94547527|NCT02855944|323801138|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
94547528|NCT02855944|323801137|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
94547529|NCT02855944|323801138|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
94547530|NCT00687609|323801141|FG000|Overall Study|Physician Decision|1|||
94547531|NCT00687609|323801141|FG000|Overall Study|Withdrawal by Subject|2|||
94547532|NCT00635089|323801142|FG000|Overall Study|Adverse Event|7|||
94547533|NCT00635089|323801142|FG000|Overall Study|Lack of Efficacy|28|||
94547534|NCT00635089|323801142|FG000|Overall Study|Protocol Deviation|4|||
94331269|NCT01590212|322994182|FG002|Overall Study|Lost to Follow-up|3|||
94331270|NCT01665768|322994183|FG000|Overall Study|Adverse Event|3|||
94331271|NCT01665768|322994183|FG000|Overall Study|Lack of Efficacy|19|||
94547535|NCT00635089|323801142|FG000|Overall Study|Lost to Follow-up|8|||
94547536|NCT00635089|323801142|FG000|Overall Study|Other|31|||
94547537|NCT00869401|323801147|FG000|Overall Study|Withdrawal by Subject|0|||
94331272|NCT01665768|322994183|FG000|Overall Study|Withdrawal by Subject|1|||
94331273|NCT01989754|322994188|FG000|Overall Study|Withdrawal by Subject|10|||
94331274|NCT01989754|322994189|FG001|Overall Study|Withdrawal by Subject|14|||
94331275|NCT01989754|322994188|FG000|Overall Study|Lost to Follow-up|28|||
94547538|NCT00869401|323801148|FG001|Overall Study|Withdrawal by Subject|0|||
94655887|NCT01639001|324198223|FG001|Overall Study|Lost to Follow-up|0|||
94655888|NCT01639001|324198222|FG000|Overall Study|Death|62|||
94655889|NCT01639001|324198223|FG001|Overall Study|Death|61|||
94655890|NCT01639001|324198222|FG000|Overall Study|Randomized but not treated|0|||
94655891|NCT01639001|324198223|FG001|Overall Study|Randomized but not treated|2|||
94223356|NCT00116584|322610196|FG000|Overall Study|Protocol Violation|1|||
94331276|NCT01989754|322994189|FG001|Overall Study|Lost to Follow-up|20|||
94331277|NCT01989754|322994188|FG000|Overall Study|Closed Site|1|||
94331278|NCT01989754|322994189|FG001|Overall Study|Closed Site|1|||
94547539|NCT00869401|323801149|FG002|Overall Study|Withdrawal by Subject|0|||
94547540|NCT00869401|323801150|FG003|Overall Study|Withdrawal by Subject|5|||
94547541|NCT00869401|323801151|FG004|Overall Study|Withdrawal by Subject|3|||
94331279|NCT02151682|322994190|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
94331280|NCT02151682|322994191|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
94331281|NCT02151682|322994192|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
94331282|NCT02151682|322994193|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
94331283|NCT02151682|322994194|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
94331284|NCT02151682|322994195|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
94331285|NCT02151682|322994190|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
94331286|NCT02151682|322994191|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
94331287|NCT02151682|322994192|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
94331288|NCT02151682|322994193|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
94331289|NCT02151682|322994194|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
94331290|NCT02151682|322994195|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
94331291|NCT02151682|322994190|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
94331292|NCT02151682|322994191|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
94331293|NCT02151682|322994192|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
94331294|NCT02151682|322994193|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
94331295|NCT02151682|322994194|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
94331296|NCT02151682|322994195|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
94331297|NCT02151682|322994190|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
94331298|NCT02151682|322994191|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
94331299|NCT02151682|322994192|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
94331300|NCT02151682|322994193|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
94331301|NCT02151682|322994194|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
94331302|NCT02151682|322994195|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
94331303|NCT02151682|322994190|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
94331304|NCT02151682|322994191|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
94331305|NCT02151682|322994192|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
94331306|NCT02151682|322994193|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
94331307|NCT02151682|322994194|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
94331308|NCT02151682|322994195|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
94331309|NCT02151682|322994190|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
94331310|NCT02151682|322994191|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
94331311|NCT02151682|322994192|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
94331312|NCT02151682|322994193|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
94331313|NCT02151682|322994194|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
94331314|NCT02151682|322994195|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
94331315|NCT02151682|322994190|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
94331316|NCT02151682|322994191|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
94331317|NCT02151682|322994192|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
94331318|NCT02151682|322994193|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
94331319|NCT02151682|322994194|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
94331320|NCT02151682|322994195|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
94331321|NCT02151682|322994190|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
94331322|NCT02151682|322994191|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
94331323|NCT02151682|322994192|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
94331324|NCT02151682|322994193|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
94331325|NCT02151682|322994194|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
94331326|NCT02151682|322994195|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
94331327|NCT02151682|322994190|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
94331328|NCT02151682|322994191|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
94331329|NCT02151682|322994192|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
94331330|NCT02151682|322994193|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
94331331|NCT02151682|322994194|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
94331332|NCT02151682|322994195|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
94331333|NCT02151682|322994190|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
94331334|NCT02151682|322994191|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
94547542|NCT02636946|323801152|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
94547543|NCT02636946|323801153|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
94547544|NCT02636946|323801152|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
94547545|NCT02636946|323801153|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
94547546|NCT02636946|323801152|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
94547547|NCT02636946|323801153|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
94547548|NCT02636946|323801152|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
94547549|NCT02636946|323801153|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
94547550|NCT02636946|323801152|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
94547551|NCT02636946|323801153|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
94547552|NCT02636946|323801152|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
94547553|NCT02636946|323801153|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
94547554|NCT00413374|323801156|FG000|Overall Study|Ineligible due to screening criteria.|3|||
94547555|NCT00413374|323801157|FG001|Overall Study|Ineligible due to screening criteria.|0|||
94547556|NCT00413374|323801156|FG000|Overall Study|Adverse Event|1|||
94547557|NCT00413374|323801157|FG001|Overall Study|Adverse Event|0|||
94547558|NCT00413374|323801156|FG000|Overall Study|Lost to Follow-up|1|||
94223357|NCT00116584|322610197|FG001|Overall Study|Protocol Violation|1|||
94223358|NCT05135156|322610198|FG000|Overall Study|Lost to Follow-up|0|||
94331335|NCT02151682|322994192|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
94331336|NCT02151682|322994193|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
94331337|NCT02151682|322994194|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
94331338|NCT02151682|322994195|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
94331339|NCT02151682|322994190|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
94331340|NCT02151682|322994191|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
94331341|NCT02151682|322994192|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
94331342|NCT02151682|322994193|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
94331343|NCT02151682|322994194|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
94331344|NCT02151682|322994195|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
94331345|NCT02151682|322994190|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
94331346|NCT02151682|322994191|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
94331347|NCT02151682|322994192|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
94331348|NCT02151682|322994193|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
94331349|NCT02151682|322994194|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
94331350|NCT02151682|322994195|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
94331351|NCT02151682|322994190|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
94331352|NCT02151682|322994191|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
94331353|NCT02151682|322994192|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
94331354|NCT02151682|322994193|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
94331355|NCT02151682|322994194|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
94331356|NCT02151682|322994195|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
94331357|NCT02151682|322994190|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
94331358|NCT02151682|322994191|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
94331359|NCT02151682|322994192|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
94331360|NCT02151682|322994193|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
94331361|NCT02151682|322994194|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
94331362|NCT02151682|322994195|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
94331363|NCT02151682|322994190|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
94331364|NCT02151682|322994191|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
94331365|NCT02151682|322994192|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
94331366|NCT02151682|322994193|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
94331367|NCT02151682|322994194|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
94331368|NCT02151682|322994195|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
94331369|NCT02151682|322994190|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
94331370|NCT02151682|322994191|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
94331371|NCT02151682|322994192|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
94331372|NCT02151682|322994193|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
94331373|NCT02151682|322994194|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
94331374|NCT02151682|322994195|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
94331375|NCT02151682|322994190|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
94331376|NCT02151682|322994191|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
94331377|NCT02151682|322994192|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
94331378|NCT02151682|322994193|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
94331379|NCT02151682|322994194|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
94331380|NCT02151682|322994195|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
94331381|NCT02151682|322994190|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
94331382|NCT02151682|322994191|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
94331383|NCT02151682|322994192|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
94331384|NCT02151682|322994193|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
94331385|NCT02151682|322994194|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
94331386|NCT02151682|322994195|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
94331387|NCT01213264|322994196|FG000|Overall Study|Adverse Event|1|||
94331388|NCT01213264|322994197|FG001|Overall Study|Adverse Event|0|||
94547559|NCT00413374|323801157|FG001|Overall Study|Lost to Follow-up|0|||
94223359|NCT05135156|322610199|FG001|Overall Study|Lost to Follow-up|0|||
94223360|NCT05135156|322610200|FG002|Overall Study|Lost to Follow-up|2|||
94331389|NCT01213264|322994198|FG002|Overall Study|Adverse Event|0|||
94331390|NCT01213264|322994196|FG000|Overall Study|Lost to Follow-up|1|||
94331391|NCT01213264|322994197|FG001|Overall Study|Lost to Follow-up|2|||
94331392|NCT01213264|322994198|FG002|Overall Study|Lost to Follow-up|6|||
94331393|NCT00813917|322994199|FG000|Overall Study|Adverse Event|0|||
94331394|NCT00813917|322994200|FG001|Overall Study|Adverse Event|1|||
94331395|NCT00813917|322994199|FG000|Overall Study|Withdrawal by Subject|3|||
94331396|NCT00813917|322994200|FG001|Overall Study|Withdrawal by Subject|4|||
94331397|NCT00813917|322994199|FG000|Overall Study|Lost to Follow-up|3|||
94331398|NCT00813917|322994200|FG001|Overall Study|Lost to Follow-up|1|||
94331399|NCT02980692|322994202|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
94331400|NCT02980692|322994203|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
94547560|NCT00413374|323801156|FG000|Overall Study|Surgery|1|||
94547561|NCT00413374|323801157|FG001|Overall Study|Surgery|0|||
94547562|NCT02440789|323801159|FG000|Overall Study|Withdrawal by Subject|3|||
94547563|NCT02440789|323801159|FG000|Overall Study|Not willing to adhere to reqs|1|||
94547564|NCT03320330|323803271|FG000|Overall Study|Lack of Efficacy|5|||
94547565|NCT03320330|323803272|FG001|Overall Study|Lack of Efficacy|5|||
94547566|NCT03320330|323803273|FG002|Overall Study|Lack of Efficacy|14|||
94547567|NCT03320330|323803271|FG000|Overall Study|Physician Decision|1|||
94547568|NCT03320330|323803272|FG001|Overall Study|Physician Decision|0|||
94547569|NCT03320330|323803273|FG002|Overall Study|Physician Decision|0|||
94547570|NCT04435600|323803278|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
94547571|NCT04435600|323803279|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
94547572|NCT04435600|323803280|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
94547573|NCT04435600|323803281|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
94547574|NCT04435600|323803282|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
94547575|NCT04435600|323803283|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
94547576|NCT04435600|323803284|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
94547577|NCT04435600|323803285|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
94547578|NCT04435600|323803286|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
94655892|NCT01639001|324198222|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
94655893|NCT01639001|324198223|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
94655894|NCT00408993|324198224|FG000|Overall Study|Adverse Event|15|||
94655895|NCT00408993|324198225|FG001|Overall Study|Adverse Event|4|||
94655896|NCT00408993|324198224|FG000|Overall Study|Protocol Violation|1|||
94655897|NCT00408993|324198225|FG001|Overall Study|Protocol Violation|6|||
94223361|NCT02986659|322610201|FG000|First Intervention Period|Adverse Event|3|||
94547579|NCT04435600|323803287|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
94547580|NCT04435600|323803278|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
94547581|NCT04435600|323803279|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
94547582|NCT04435600|323803280|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
94547583|NCT04435600|323803281|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
94547584|NCT04435600|323803282|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
94547585|NCT04435600|323803283|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
94547586|NCT04435600|323803284|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
94547587|NCT04435600|323803285|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
94547588|NCT04435600|323803286|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
94547589|NCT04435600|323803287|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
94547590|NCT04435600|323803278|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
94547591|NCT04435600|323803279|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
94547592|NCT04435600|323803280|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
94547593|NCT04435600|323803281|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
94547594|NCT04435600|323803282|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
94547595|NCT04435600|323803283|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
94547596|NCT04435600|323803284|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
94547597|NCT04435600|323803285|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
94547598|NCT04435600|323803286|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
94547599|NCT04435600|323803287|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
94547600|NCT04435600|323803278|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
94331401|NCT02980692|322994204|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
94331402|NCT02980692|322994205|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
94439765|NCT02601014|323396288|FG001|Overall Study|Disease progression|8|||
94439766|NCT04460885|323397823|FG000|Overall Study|Withdrawal by Subject|6|||
94439767|NCT04460885|323397824|FG001|Overall Study|Withdrawal by Subject|8|||
94439768|NCT04460885|323397823|FG000|Overall Study|Site closure|1|||
94439769|NCT04460885|323397824|FG001|Overall Study|Site closure|0|||
94439770|NCT04460885|323397823|FG000|Overall Study|Death|5|||
94439771|NCT04460885|323397824|FG001|Overall Study|Death|4|||
94439772|NCT04460885|323397823|FG000|Overall Study|Physician Decision|2|||
94439773|NCT04460885|323397824|FG001|Overall Study|Physician Decision|1|||
94547601|NCT04435600|323803279|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
94547602|NCT04435600|323803280|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
94547603|NCT04435600|323803281|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
94547604|NCT04435600|323803282|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
94547605|NCT04435600|323803283|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
94547606|NCT04435600|323803284|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
94547607|NCT04435600|323803285|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
94547608|NCT04435600|323803286|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
94547609|NCT04435600|323803287|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
94547610|NCT02797184|323803288|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
94547611|NCT02797184|323803289|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
94547612|NCT04692077|323803290|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
94547613|NCT05149313|323803291|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
94547614|NCT05149313|323803292|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
94547615|NCT05149313|323803293|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
94547616|NCT05149313|323803294|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
94547617|NCT05149313|323803291|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
94547618|NCT05149313|323803292|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
94547619|NCT05149313|323803293|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
94547620|NCT05149313|323803294|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
94547621|NCT05149313|323803291|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
94547622|NCT05149313|323803292|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
94547623|NCT05149313|323803293|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
94547624|NCT05149313|323803294|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
94547625|NCT05149313|323803291|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
94547626|NCT05149313|323803292|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
94547627|NCT05149313|323803293|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
94547628|NCT05149313|323803294|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
94547629|NCT05149313|323803291|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
94547630|NCT05149313|323803292|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
94547631|NCT05149313|323803293|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
94547632|NCT05149313|323803294|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
94547633|NCT05149313|323803291|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
94547634|NCT05149313|323803292|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
94547635|NCT05149313|323803293|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
94547636|NCT05149313|323803294|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
94547637|NCT05149313|323803291|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
94547638|NCT05149313|323803292|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
94547639|NCT05149313|323803293|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
94547640|NCT05149313|323803294|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
94547641|NCT05149313|323803291|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94547642|NCT05149313|323803292|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94547643|NCT05149313|323803293|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
94547644|NCT05149313|323803294|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
94547645|NCT05149313|323803291|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
94547646|NCT05149313|323803292|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
94547647|NCT05149313|323803293|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
94547648|NCT05149313|323803294|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
94547649|NCT05149313|323803291|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94547650|NCT05149313|323803292|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94547651|NCT05149313|323803293|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
94547652|NCT05149313|323803294|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94547653|NCT05149313|323803291|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
94547654|NCT05149313|323803292|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
94547655|NCT05149313|323803293|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
94547656|NCT05149313|323803294|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
94547657|NCT00940485|323803302|FG000|Overall Study|HBeAb positive at Baseline|3|||
94547658|NCT00940485|323803303|FG001|Overall Study|HBeAb positive at Baseline|2|||
94547659|NCT00940485|323803302|FG000|Overall Study|Lost to Follow-up|2|||
94655898|NCT00408993|324198224|FG000|Overall Study|Lack of Efficacy|1|||
94547660|NCT00940485|323803303|FG001|Overall Study|Lost to Follow-up|3|||
94547661|NCT00940485|323803302|FG000|Overall Study|Adverse Event|8|||
94547662|NCT00940485|323803303|FG001|Overall Study|Adverse Event|0|||
94547663|NCT00940485|323803302|FG000|Overall Study|Withdrawal by Subject|1|||
94655899|NCT00408993|324198225|FG001|Overall Study|Lack of Efficacy|4|||
94547664|NCT00940485|323803303|FG001|Overall Study|Withdrawal by Subject|1|||
94547665|NCT00940485|323803302|FG000|Overall Study|Others|1|||
94547666|NCT00940485|323803303|FG001|Overall Study|Others|1|||
94547667|NCT00385723|323803308|FG000|Overall Study|Lost to Follow-up|1|||
94547668|NCT00385723|323803309|FG001|Overall Study|Lost to Follow-up|1|||
94547669|NCT00385723|323803310|FG002|Overall Study|Lost to Follow-up|0|||
94547670|NCT00385723|323803308|FG000|Overall Study|Withdrawal by Subject|1|||
94547671|NCT00385723|323803309|FG001|Overall Study|Withdrawal by Subject|0|||
94547672|NCT00385723|323803310|FG002|Overall Study|Withdrawal by Subject|2|||
94547673|NCT03455829|323803311|FG000|Overall Study|Death|2|||
94547674|NCT03455829|323803312|FG001|Overall Study|Death|3|||
94547675|NCT03455829|323803313|FG002|Overall Study|Death|2|||
94547676|NCT03455829|323803314|FG003|Overall Study|Death|4|||
94547677|NCT03455829|323803315|FG004|Overall Study|Death|2|||
94547678|NCT03455829|323803311|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
94547679|NCT03455829|323803312|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
94547680|NCT03455829|323803313|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
94547681|NCT03455829|323803314|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
94547682|NCT03455829|323803315|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
94547683|NCT03455829|323803311|FG000|Overall Study|Disease progression|0|||
94547684|NCT03455829|323803312|FG001|Overall Study|Disease progression|0|||
94547685|NCT03455829|323803313|FG002|Overall Study|Disease progression|0|||
94547686|NCT03455829|323803314|FG003|Overall Study|Disease progression|1|||
94547687|NCT03455829|323803315|FG004|Overall Study|Disease progression|1|||
94547688|NCT00286221|323803316|FG000|Overall Study|Protocol Violation|2|||
94547689|NCT00286221|323803317|FG001|Overall Study|Protocol Violation|1|||
94547690|NCT00286221|323803318|FG002|Overall Study|Protocol Violation|6|||
94547691|NCT00286221|323803319|FG003|Overall Study|Protocol Violation|4|||
94547692|NCT00286221|323803316|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
94547693|NCT00286221|323803317|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
94547694|NCT00286221|323803318|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
94547695|NCT00286221|323803319|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
94547696|NCT00286221|323803316|FG000|Overall Study|Inability to trigger PCA|2|||
94547697|NCT00286221|323803317|FG001|Overall Study|Inability to trigger PCA|0|||
94547698|NCT00286221|323803318|FG002|Overall Study|Inability to trigger PCA|0|||
94547699|NCT00286221|323803319|FG003|Overall Study|Inability to trigger PCA|0|||
94547700|NCT00286221|323803316|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
94547701|NCT00286221|323803317|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
94547702|NCT00286221|323803318|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
94547703|NCT00286221|323803319|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
94547704|NCT00121641|323803322|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
94547705|NCT00121641|323803323|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
94547706|NCT00121641|323803324|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
94547707|NCT00121641|323803325|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
94547708|NCT00121641|323803326|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
94547709|NCT00121641|323803322|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
94547710|NCT00121641|323803323|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
94547711|NCT00121641|323803324|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
94547712|NCT00121641|323803325|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
94547713|NCT00121641|323803326|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
94547714|NCT00121641|323803322|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
94547715|NCT00121641|323803323|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
94547716|NCT00121641|323803324|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
94547717|NCT00121641|323803325|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
94547718|NCT00121641|323803326|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
94547719|NCT00121641|323803322|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
94547720|NCT00121641|323803323|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
94547721|NCT00121641|323803324|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
94547722|NCT00121641|323803325|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
94547723|NCT00121641|323803326|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
94547724|NCT00121641|323803322|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
94547725|NCT00121641|323803323|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
94547726|NCT00121641|323803324|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
94547727|NCT00121641|323803325|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
94547728|NCT00121641|323803326|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
94547729|NCT00121641|323803322|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
94547730|NCT00121641|323803323|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
94547731|NCT00121641|323803324|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
94655900|NCT00408993|324198224|FG000|Overall Study|Withdrawal by Subject|2|||
94547732|NCT00121641|323803325|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
94547733|NCT00121641|323803326|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
94547734|NCT00121641|323803322|FG000|24-week Short-term Treatment Period|Other Reason|1|||
94547735|NCT00121641|323803323|FG001|24-week Short-term Treatment Period|Other Reason|0|||
94547736|NCT00121641|323803324|FG002|24-week Short-term Treatment Period|Other Reason|0|||
94547737|NCT00121641|323803325|FG003|24-week Short-term Treatment Period|Other Reason|0|||
94547738|NCT00121641|323803326|FG004|24-week Short-term Treatment Period|Other Reason|0|||
94547739|NCT00121641|323803322|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
94547740|NCT00121641|323803323|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
94547741|NCT00121641|323803324|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
94547742|NCT00121641|323803325|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
94547743|NCT00121641|323803326|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
94547744|NCT00121641|323803322|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
94547745|NCT00121641|323803323|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
94547746|NCT00121641|323803324|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
94547747|NCT00121641|323803325|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
94547748|NCT00121641|323803326|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
94547749|NCT00121641|323803322|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
94547750|NCT00121641|323803323|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
94547751|NCT00121641|323803324|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
94547752|NCT00121641|323803325|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
94547753|NCT00121641|323803326|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
94547754|NCT00121641|323803322|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
94547755|NCT00121641|323803323|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
94547756|NCT00121641|323803324|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
94547757|NCT00121641|323803325|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
94547758|NCT00121641|323803326|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
94547759|NCT00121641|323803322|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
94547760|NCT00121641|323803323|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
94547761|NCT00121641|323803324|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
94547762|NCT00121641|323803325|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
94547763|NCT00121641|323803326|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
94547764|NCT00121641|323803322|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
94547765|NCT00121641|323803323|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
94547766|NCT00121641|323803324|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
94547767|NCT00121641|323803325|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
94547768|NCT00121641|323803326|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
94547769|NCT00121641|323803322|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
94547770|NCT00121641|323803323|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
94547771|NCT00121641|323803324|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
94547772|NCT00121641|323803325|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
94547773|NCT00121641|323803326|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
94547774|NCT00121641|323803322|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
94547775|NCT00121641|323803323|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
94547776|NCT00121641|323803324|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
94547777|NCT00121641|323803325|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
94547778|NCT00121641|323803326|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
94547779|NCT00121641|323803322|FG000|48-month Short Term + Long Term Period|Death|0|||
94547780|NCT00121641|323803323|FG001|48-month Short Term + Long Term Period|Death|0|||
94547781|NCT00121641|323803324|FG002|48-month Short Term + Long Term Period|Death|0|||
94547782|NCT00121641|323803325|FG003|48-month Short Term + Long Term Period|Death|1|||
94547783|NCT00121641|323803326|FG004|48-month Short Term + Long Term Period|Death|0|||
94547784|NCT00121641|323803322|FG000|48-month Short Term + Long Term Period|Missing|0|||
94547785|NCT00121641|323803323|FG001|48-month Short Term + Long Term Period|Missing|0|||
94547786|NCT00121641|323803324|FG002|48-month Short Term + Long Term Period|Missing|1|||
94547787|NCT00121641|323803325|FG003|48-month Short Term + Long Term Period|Missing|0|||
94547788|NCT00121641|323803326|FG004|48-month Short Term + Long Term Period|Missing|0|||
94547789|NCT00121641|323803322|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
94547790|NCT00121641|323803323|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
94547791|NCT00121641|323803324|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
94547792|NCT00121641|323803325|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
94547793|NCT00121641|323803326|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
94547794|NCT01792518|323803327|FG000|Overall Study|Adverse Event|3|||
94547795|NCT01792518|323803328|FG001|Overall Study|Adverse Event|4|||
94547796|NCT01792518|323803327|FG000|Overall Study|Protocol Violation|0|||
94547797|NCT01792518|323803328|FG001|Overall Study|Protocol Violation|1|||
94547798|NCT01792518|323803327|FG000|Overall Study|Lost to Follow-up|3|||
94547799|NCT01792518|323803328|FG001|Overall Study|Lost to Follow-up|1|||
94547800|NCT01792518|323803327|FG000|Overall Study|Withdrawal by Subject|2|||
94547801|NCT01792518|323803328|FG001|Overall Study|Withdrawal by Subject|0|||
94547802|NCT01792518|323803327|FG000|Overall Study|Other Reason|0|||
94547803|NCT01792518|323803328|FG001|Overall Study|Other Reason|1|||
94547804|NCT02428413|323803329|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
94547805|NCT02428413|323803330|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
94547806|NCT02428413|323803329|FG000|Overall Study|Protocol Violation|1|||
94547807|NCT02428413|323803330|FG001|Overall Study|Protocol Violation|2|||
94547808|NCT02428413|323803329|FG000|Overall Study|Case Cancelled|2|||
94547809|NCT02428413|323803330|FG001|Overall Study|Case Cancelled|0|||
94547810|NCT02428413|323803329|FG000|Overall Study|Missed Cases|1|||
94547811|NCT02428413|323803330|FG001|Overall Study|Missed Cases|2|||
94547812|NCT02428413|323803329|FG000|Overall Study|Nurse Refusal|1|||
94547813|NCT02428413|323803330|FG001|Overall Study|Nurse Refusal|0|||
94547814|NCT00661388|323803331|FG000|Overall Study|Adverse Event|14|||
94547815|NCT00661388|323803331|FG000|Overall Study|Protocol Violation|7|||
94547816|NCT00661388|323803331|FG000|Overall Study|Renal transplantation|1|||
94547817|NCT00661388|323803331|FG000|Overall Study|Dialysis initiation|1|||
94547818|NCT00661388|323803331|FG000|Overall Study|Administrative reasons|1|||
94547819|NCT00025155|323803332|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
94547820|NCT00025155|323803332|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
94547821|NCT00094107|323803333|FG000|Overall Study|Lack of Efficacy|23|||
94547822|NCT00094107|323803333|FG000|Overall Study|Death|5|||
94547823|NCT00094107|323803333|FG000|Overall Study|Adverse Event|3|||
94547824|NCT00094107|323803333|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
94547825|NCT02914561|323803337|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
94547826|NCT02914561|323803338|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
94547827|NCT02914561|323803339|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
94547828|NCT02914561|323803340|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
94547829|NCT02914561|323803341|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
94547830|NCT02914561|323803342|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
94547831|NCT02914561|323803343|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
94547832|NCT02914561|323803344|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
94547833|NCT02914561|323803345|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
94547834|NCT02914561|323803346|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
94547835|NCT02914561|323803347|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
94547836|NCT02914561|323803337|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
94547837|NCT02914561|323803338|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
94547838|NCT02914561|323803339|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
94547839|NCT02914561|323803340|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
94547840|NCT02914561|323803341|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
94547841|NCT02914561|323803342|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
94547842|NCT02914561|323803343|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
94547843|NCT02914561|323803344|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
94547844|NCT02914561|323803345|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
94547845|NCT02914561|323803346|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
94547846|NCT02914561|323803347|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
94547847|NCT02914561|323803337|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
94547848|NCT02914561|323803338|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
94547849|NCT02914561|323803339|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
94547850|NCT02914561|323803340|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
94547851|NCT02914561|323803341|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
94547852|NCT02914561|323803342|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
94547853|NCT02914561|323803343|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
94547854|NCT02914561|323803344|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
94547855|NCT02914561|323803345|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
94547856|NCT02914561|323803346|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
94547857|NCT02914561|323803347|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
94547858|NCT02914561|323803337|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
94547859|NCT02914561|323803338|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
94547860|NCT02914561|323803339|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
94547861|NCT02914561|323803340|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
94547862|NCT02914561|323803341|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
94547863|NCT02914561|323803342|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
94547864|NCT02914561|323803343|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
94547865|NCT02914561|323803344|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
94547866|NCT02914561|323803345|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
94651291|NCT02460224|324179730|FG015|Overall Study|Physician Decision|0|||
94547867|NCT02914561|323803346|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
94547868|NCT02914561|323803347|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
94547869|NCT02914561|323803337|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
94547870|NCT02914561|323803338|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
94547871|NCT02914561|323803339|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
94547872|NCT02914561|323803340|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
94547873|NCT02914561|323803341|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
94547874|NCT02914561|323803342|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
94547875|NCT02914561|323803343|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
94547876|NCT02914561|323803344|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
94547877|NCT02914561|323803345|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
94547878|NCT02914561|323803346|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
94547879|NCT02914561|323803347|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
94547880|NCT02914561|323803337|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
94547881|NCT02914561|323803338|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
94547882|NCT02914561|323803339|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
94547883|NCT02914561|323803340|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
94547884|NCT02914561|323803341|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
94547885|NCT02914561|323803342|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
94547886|NCT02914561|323803343|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
94547887|NCT02914561|323803344|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
94547888|NCT02914561|323803345|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
94547889|NCT02914561|323803346|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
94547890|NCT02914561|323803347|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
94547891|NCT02914561|323803337|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
94547892|NCT02914561|323803338|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
94547893|NCT02914561|323803339|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
94547894|NCT02914561|323803340|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
94547895|NCT02914561|323803341|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
94547896|NCT02914561|323803342|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
94547897|NCT02914561|323803343|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
94547898|NCT02914561|323803344|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
94547899|NCT02914561|323803345|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
94547900|NCT02914561|323803346|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
94547901|NCT02914561|323803347|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
94547902|NCT02914561|323803337|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
94547903|NCT02914561|323803338|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
94547904|NCT02914561|323803339|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
94547905|NCT02914561|323803340|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
94547906|NCT02914561|323803341|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
94547907|NCT02914561|323803342|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
94547908|NCT02914561|323803343|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
94547909|NCT02914561|323803344|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
94547910|NCT02914561|323803345|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
94547911|NCT02914561|323803346|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
94547912|NCT02914561|323803347|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
94547913|NCT02914561|323803337|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
94547914|NCT02914561|323803338|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
94547915|NCT02914561|323803339|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
94547916|NCT02914561|323803340|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
94547917|NCT02914561|323803341|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
94547918|NCT02914561|323803342|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
94547919|NCT02914561|323803343|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
94547920|NCT02914561|323803344|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
94547921|NCT02914561|323803345|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
94547922|NCT02914561|323803346|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
94547923|NCT02914561|323803347|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
94547924|NCT02914561|323803337|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
94547925|NCT02914561|323803338|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
94547926|NCT02914561|323803339|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
94547927|NCT02914561|323803340|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
94651292|NCT02460224|324179731|FG016|Overall Study|Physician Decision|2|||
94655901|NCT00408993|324198225|FG001|Overall Study|Withdrawal by Subject|3|||
94439774|NCT04460885|323397823|FG000|Overall Study|Lost to Follow-up|4|||
94547928|NCT02914561|323803341|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
94547929|NCT02914561|323803342|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
94547930|NCT02914561|323803343|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
94547931|NCT02914561|323803344|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
94547932|NCT02914561|323803345|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
94547933|NCT02914561|323803346|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
94547934|NCT02914561|323803347|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
94547935|NCT02914561|323803337|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
94547936|NCT02914561|323803338|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
94547937|NCT02914561|323803339|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
94547938|NCT02914561|323803340|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
94547939|NCT02914561|323803341|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
94547940|NCT02914561|323803342|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
94547941|NCT02914561|323803343|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
94547942|NCT02914561|323803344|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
94547943|NCT02914561|323803345|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
94547944|NCT02914561|323803346|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
94547945|NCT02914561|323803347|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
94547946|NCT02914561|323803337|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
94547947|NCT02914561|323803338|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
94547948|NCT02914561|323803339|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
94547949|NCT02914561|323803340|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
94547950|NCT02914561|323803341|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
94547951|NCT02914561|323803342|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
94547952|NCT02914561|323803343|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
94547953|NCT02914561|323803344|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
94547954|NCT02914561|323803345|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
94547955|NCT02914561|323803346|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
94547956|NCT02914561|323803347|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
94547957|NCT02914561|323803337|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
94547958|NCT02914561|323803338|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
94547959|NCT02914561|323803339|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
94547960|NCT02914561|323803340|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
94547961|NCT02914561|323803341|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
94547962|NCT02914561|323803342|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
94547963|NCT02914561|323803343|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
94547964|NCT02914561|323803344|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
94547965|NCT02914561|323803345|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
94547966|NCT02914561|323803346|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
94547967|NCT02914561|323803347|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
94547968|NCT02914561|323803337|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
94547969|NCT02914561|323803338|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
94547970|NCT02914561|323803339|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
94547971|NCT02914561|323803340|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
94547972|NCT02914561|323803341|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
94547973|NCT02914561|323803342|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
94547974|NCT02914561|323803343|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
94547975|NCT02914561|323803344|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
94547976|NCT02914561|323803345|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
94547977|NCT02914561|323803346|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
94547978|NCT02914561|323803347|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
94547979|NCT02914561|323803337|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
94547980|NCT02914561|323803338|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
94547981|NCT02914561|323803339|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
94547982|NCT02914561|323803340|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
94547983|NCT02914561|323803341|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
94547984|NCT02914561|323803342|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
94547985|NCT02914561|323803343|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
94547986|NCT02914561|323803344|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
94547987|NCT02914561|323803345|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
94547988|NCT02914561|323803346|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
94547989|NCT02914561|323803347|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
94547990|NCT02914561|323803337|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
94547991|NCT02914561|323803338|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
94547992|NCT02914561|323803339|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
94651293|NCT02460224|324179732|FG017|Overall Study|Physician Decision|1|||
94547993|NCT02914561|323803340|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
94547994|NCT02914561|323803341|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
94547995|NCT02914561|323803342|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
94547996|NCT02914561|323803343|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
94547997|NCT02914561|323803344|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
94547998|NCT02914561|323803345|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
94547999|NCT02914561|323803346|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
94548000|NCT02914561|323803347|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
94548001|NCT02914561|323803337|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
94548002|NCT02914561|323803338|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
94548003|NCT02914561|323803339|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
94548004|NCT02914561|323803340|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
94548005|NCT02914561|323803341|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
94548006|NCT02914561|323803342|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
94548007|NCT02914561|323803343|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
94548008|NCT02914561|323803344|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
94548009|NCT02914561|323803345|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
94548010|NCT02914561|323803346|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
94548011|NCT02914561|323803347|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
94548012|NCT01300455|323803348|FG000|Washout|Withdrawal by Subject|1|||
94548013|NCT01300455|323803349|FG001|Washout|Withdrawal by Subject|0|||
94548014|NCT03691779|323803352|FG000|Part B (24 Weeks)|Adverse Event|0|||
94548015|NCT03691779|323803353|FG001|Part B (24 Weeks)|Adverse Event|1|||
94548016|NCT03691779|323803352|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
94548017|NCT03691779|323803353|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
94548018|NCT02528357|323803354|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
94548019|NCT02528357|323803355|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
94548020|NCT02528357|323803356|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
94548021|NCT02528357|323803357|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
94548022|NCT02528357|323803358|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
94548023|NCT02528357|323803359|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
94548024|NCT02528357|323803360|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
94548025|NCT02528357|323803361|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
94548026|NCT02528357|323803362|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
94548027|NCT02528357|323803363|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
94548028|NCT02528357|323803364|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
94548029|NCT02528357|323803365|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
94548030|NCT02528357|323803366|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
94548031|NCT02528357|323803367|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
94548032|NCT02528357|323803368|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
94548033|NCT02528357|323803369|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
94548034|NCT02528357|323803370|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
94548035|NCT02528357|323803371|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
94548036|NCT02528357|323803372|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
94548037|NCT02528357|323803354|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
94548038|NCT02528357|323803355|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
94548039|NCT02528357|323803356|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
94548040|NCT02528357|323803357|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
94548041|NCT02528357|323803358|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
94548042|NCT02528357|323803359|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
94548043|NCT02528357|323803360|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
94548044|NCT02528357|323803361|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
94548045|NCT02528357|323803362|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
94655902|NCT03738865|324198226|FG000|Overall Study|Withdrawal by Subject|3|||
94655903|NCT03738865|324198227|FG001|Overall Study|Withdrawal by Subject|3|||
94548046|NCT02528357|323803363|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
94548047|NCT02528357|323803364|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
94548048|NCT02528357|323803365|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
94548049|NCT02528357|323803366|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
94548050|NCT02528357|323803367|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
94548051|NCT02528357|323803368|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
94548052|NCT02528357|323803369|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
94548053|NCT02528357|323803370|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
94548054|NCT02528357|323803371|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
94548055|NCT02528357|323803372|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
94548056|NCT02528357|323803354|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
94548057|NCT02528357|323803355|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
94548058|NCT02528357|323803356|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
94548059|NCT02528357|323803357|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
94548060|NCT02528357|323803358|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
94548061|NCT02528357|323803359|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
94548062|NCT02528357|323803360|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
94548063|NCT02528357|323803361|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
94548064|NCT02528357|323803362|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
94548065|NCT02528357|323803363|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
94548066|NCT02528357|323803364|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
94655904|NCT03738865|324198226|FG000|Overall Study|Adverse Event|2|||
94655905|NCT03738865|324198227|FG001|Overall Study|Adverse Event|0|||
94548067|NCT02528357|323803365|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
94548068|NCT02528357|323803366|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
94548069|NCT02528357|323803367|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
94548070|NCT02528357|323803368|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
94548071|NCT02528357|323803369|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
94548072|NCT02528357|323803370|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
94548073|NCT02528357|323803371|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
94548074|NCT02528357|323803372|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
94548075|NCT02528357|323803354|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548076|NCT02528357|323803355|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548077|NCT02528357|323803356|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548078|NCT02528357|323803357|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548079|NCT02528357|323803358|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
94548080|NCT02528357|323803359|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548081|NCT02528357|323803360|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548082|NCT02528357|323803361|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548083|NCT02528357|323803362|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548084|NCT02528357|323803363|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548085|NCT02528357|323803364|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548086|NCT02528357|323803365|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548087|NCT02528357|323803366|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548088|NCT02528357|323803367|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548089|NCT02528357|323803368|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548090|NCT02528357|323803369|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548091|NCT02528357|323803370|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548092|NCT02528357|323803371|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548093|NCT02528357|323803372|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548094|NCT02528357|323803354|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
94548095|NCT02528357|323803355|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
94548096|NCT02528357|323803356|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
94548097|NCT02528357|323803357|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
94548098|NCT02528357|323803358|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
94548099|NCT02528357|323803359|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
94548100|NCT02528357|323803360|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
94548101|NCT02528357|323803361|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
94548102|NCT02528357|323803362|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
94548103|NCT02528357|323803363|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
94548104|NCT02528357|323803364|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
94548105|NCT02528357|323803365|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
94548106|NCT02528357|323803366|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
94548107|NCT02528357|323803367|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
94651294|NCT02460224|324179733|FG018|Overall Study|Physician Decision|1|||
94655906|NCT03738865|324198226|FG000|Overall Study|Physician Decision|0|||
94655907|NCT03738865|324198227|FG001|Overall Study|Physician Decision|1|||
94548108|NCT02528357|323803368|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
94548109|NCT02528357|323803369|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
94548110|NCT02528357|323803370|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
94548111|NCT02528357|323803371|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
94548112|NCT02528357|323803372|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
94548113|NCT02528357|323803354|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
94548114|NCT02528357|323803355|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
94548115|NCT02528357|323803356|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
94548116|NCT02528357|323803357|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
94548117|NCT02528357|323803358|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
94548118|NCT02528357|323803359|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
94548119|NCT02528357|323803360|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
94548120|NCT02528357|323803361|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
94548121|NCT02528357|323803362|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
94548122|NCT02528357|323803363|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
94548123|NCT02528357|323803364|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
94548124|NCT02528357|323803365|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
94548125|NCT02528357|323803366|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
94548126|NCT02528357|323803367|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
94548127|NCT02528357|323803368|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
94548128|NCT02528357|323803369|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
94548129|NCT02528357|323803370|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
94548130|NCT02528357|323803371|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
94548131|NCT02528357|323803372|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
94548132|NCT02528357|323803354|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
94548133|NCT02528357|323803355|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
94548134|NCT02528357|323803356|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
94548135|NCT02528357|323803357|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
94548136|NCT02528357|323803358|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
94548137|NCT02528357|323803359|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
94548138|NCT02528357|323803360|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
94548139|NCT02528357|323803361|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
94651295|NCT02460224|324179734|FG019|Overall Study|Physician Decision|2|||
94655908|NCT01602315|324198228|FG000|Overall Study|Protocol Violation|0|||
94655909|NCT01602315|324198229|FG001|Overall Study|Protocol Violation|0|||
94655910|NCT01602315|324198230|FG002|Overall Study|Protocol Violation|0|||
94655911|NCT01602315|324198231|FG003|Overall Study|Protocol Violation|0|||
94655912|NCT01602315|324198232|FG004|Overall Study|Protocol Violation|0|||
94655913|NCT01602315|324198233|FG005|Overall Study|Protocol Violation|1|||
94655914|NCT01602315|324198234|FG006|Overall Study|Protocol Violation|0|||
94655915|NCT01602315|324198228|FG000|Overall Study|Physician Decision|2|||
94655916|NCT01602315|324198229|FG001|Overall Study|Physician Decision|0|||
94655917|NCT01602315|324198230|FG002|Overall Study|Physician Decision|0|||
94655918|NCT01602315|324198231|FG003|Overall Study|Physician Decision|0|||
94655919|NCT01602315|324198232|FG004|Overall Study|Physician Decision|2|||
94655920|NCT01602315|324198233|FG005|Overall Study|Physician Decision|1|||
94655921|NCT01602315|324198234|FG006|Overall Study|Physician Decision|1|||
94655922|NCT01602315|324198228|FG000|Overall Study|Disease progression|6|||
94655923|NCT01602315|324198229|FG001|Overall Study|Disease progression|3|||
94655924|NCT01602315|324198230|FG002|Overall Study|Disease progression|10|||
94655925|NCT01602315|324198231|FG003|Overall Study|Disease progression|1|||
94655926|NCT01602315|324198232|FG004|Overall Study|Disease progression|41|||
94655927|NCT01602315|324198233|FG005|Overall Study|Disease progression|12|||
94655928|NCT01602315|324198234|FG006|Overall Study|Disease progression|15|||
94655929|NCT01602315|324198228|FG000|Overall Study|Death|1|||
94655930|NCT01602315|324198229|FG001|Overall Study|Death|1|||
94655931|NCT01602315|324198230|FG002|Overall Study|Death|1|||
94655932|NCT01602315|324198231|FG003|Overall Study|Death|1|||
94655933|NCT01602315|324198232|FG004|Overall Study|Death|7|||
94655934|NCT01602315|324198233|FG005|Overall Study|Death|2|||
94655935|NCT01602315|324198234|FG006|Overall Study|Death|2|||
94655936|NCT01602315|324198228|FG000|Overall Study|Withdrawal by Subject|2|||
94655937|NCT01602315|324198229|FG001|Overall Study|Withdrawal by Subject|0|||
94655938|NCT01602315|324198230|FG002|Overall Study|Withdrawal by Subject|2|||
94655939|NCT01602315|324198231|FG003|Overall Study|Withdrawal by Subject|0|||
94655940|NCT01602315|324198232|FG004|Overall Study|Withdrawal by Subject|6|||
94655941|NCT01602315|324198233|FG005|Overall Study|Withdrawal by Subject|0|||
94655942|NCT01602315|324198234|FG006|Overall Study|Withdrawal by Subject|1|||
94655943|NCT01602315|324198228|FG000|Overall Study|Adverse Event|5|||
94655944|NCT01602315|324198229|FG001|Overall Study|Adverse Event|1|||
94655945|NCT01602315|324198230|FG002|Overall Study|Adverse Event|5|||
94548140|NCT02528357|323803362|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
94548141|NCT02528357|323803363|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
94548142|NCT02528357|323803364|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
94548143|NCT02528357|323803365|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
94548144|NCT02528357|323803366|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
94548145|NCT02528357|323803367|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
94655946|NCT01602315|324198231|FG003|Overall Study|Adverse Event|4|||
94655947|NCT01602315|324198232|FG004|Overall Study|Adverse Event|15|||
94655948|NCT01602315|324198233|FG005|Overall Study|Adverse Event|3|||
94655949|NCT01602315|324198234|FG006|Overall Study|Adverse Event|9|||
94548146|NCT02528357|323803368|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
94548147|NCT02528357|323803369|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
94548148|NCT02528357|323803370|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
94548149|NCT02528357|323803371|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
94548150|NCT02528357|323803372|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
94548151|NCT02528357|323803354|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548152|NCT02528357|323803355|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548153|NCT02528357|323803356|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548154|NCT02528357|323803357|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548155|NCT02528357|323803358|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548156|NCT02528357|323803359|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548157|NCT02528357|323803360|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548158|NCT02528357|323803361|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548159|NCT02528357|323803362|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
94548160|NCT02528357|323803363|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
94548161|NCT02528357|323803364|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548162|NCT02528357|323803365|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
94548163|NCT02528357|323803366|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
94548164|NCT02528357|323803367|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
94548165|NCT02528357|323803368|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
94548166|NCT02528357|323803369|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548167|NCT02528357|323803370|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548168|NCT02528357|323803371|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548169|NCT02528357|323803372|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548170|NCT02528357|323803354|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
94548171|NCT02528357|323803355|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
94548172|NCT02528357|323803356|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
94548173|NCT02528357|323803357|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
94548174|NCT02528357|323803358|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
94548175|NCT02528357|323803359|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
94548176|NCT02528357|323803360|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
94548177|NCT02528357|323803361|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
94548178|NCT02528357|323803362|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
94548179|NCT02528357|323803363|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
94548180|NCT02528357|323803364|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
94548181|NCT02528357|323803365|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
94548182|NCT02528357|323803366|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
94548183|NCT02528357|323803367|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
94548184|NCT02528357|323803368|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
94548185|NCT02528357|323803369|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
94548186|NCT02528357|323803370|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
94548187|NCT02528357|323803371|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
94548188|NCT02528357|323803372|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
94548189|NCT02528357|323803354|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548190|NCT02528357|323803355|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548191|NCT02528357|323803356|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548192|NCT02528357|323803357|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548193|NCT02528357|323803358|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548194|NCT02528357|323803359|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548195|NCT02528357|323803360|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548196|NCT02528357|323803361|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548197|NCT02528357|323803362|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548198|NCT02528357|323803363|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548199|NCT02528357|323803364|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548200|NCT02528357|323803365|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548201|NCT02528357|323803366|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548202|NCT02528357|323803367|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548203|NCT02528357|323803368|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548204|NCT02528357|323803369|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
94548205|NCT02528357|323803370|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
94548206|NCT02528357|323803371|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
94548207|NCT02528357|323803372|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
94548208|NCT00267150|323803375|FG000|Overall Study|Adverse Event|1|||
94548209|NCT00521222|323803376|FG000|Overall Study|Lost to Follow-up|0|||
94548210|NCT00521222|323803377|FG001|Overall Study|Lost to Follow-up|0|||
94548211|NCT00521222|323803378|FG002|Overall Study|Lost to Follow-up|1|||
94548212|NCT00521222|323803379|FG003|Overall Study|Lost to Follow-up|1|||
94548213|NCT00521222|323803376|FG000|Overall Study|Withdrawal by Subject|0|||
94548214|NCT00521222|323803377|FG001|Overall Study|Withdrawal by Subject|0|||
94548215|NCT00521222|323803378|FG002|Overall Study|Withdrawal by Subject|2|||
94548216|NCT00521222|323803379|FG003|Overall Study|Withdrawal by Subject|0|||
94548217|NCT00521222|323803376|FG000|Overall Study|Physician Decision|0|||
94548218|NCT00521222|323803377|FG001|Overall Study|Physician Decision|1|||
94548219|NCT00521222|323803378|FG002|Overall Study|Physician Decision|0|||
94548220|NCT00521222|323803379|FG003|Overall Study|Physician Decision|1|||
94548221|NCT01561963|323803380|FG000|Overall Study|Adverse Event|1|||
94548222|NCT00351273|323803383|FG000|Overall Study|Lost to Follow-up|1|||
94548223|NCT00351273|323803384|FG001|Overall Study|Lost to Follow-up|2|||
94548224|NCT00351273|323803385|FG002|Overall Study|Lost to Follow-up|5|||
94548225|NCT03869333|323803386|FG000|Overall Study|Lost to Follow-up|1|||
94548226|NCT03869333|323803387|FG001|Overall Study|Lost to Follow-up|0|||
94548227|NCT03869333|323803388|FG002|Overall Study|Lost to Follow-up|0|||
94548228|NCT03869333|323803389|FG003|Overall Study|Lost to Follow-up|0|||
94548229|NCT03869333|323803386|FG000|Overall Study|Pregnancy|1|||
94548230|NCT03869333|323803387|FG001|Overall Study|Pregnancy|0|||
94548231|NCT03869333|323803388|FG002|Overall Study|Pregnancy|0|||
94548232|NCT03869333|323803389|FG003|Overall Study|Pregnancy|0|||
94548233|NCT03869333|323803386|FG000|Overall Study|Physician Decision|0|||
94548234|NCT03869333|323803387|FG001|Overall Study|Physician Decision|1|||
94548235|NCT03869333|323803388|FG002|Overall Study|Physician Decision|0|||
94548236|NCT03869333|323803389|FG003|Overall Study|Physician Decision|0|||
94548237|NCT01672866|323803390|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
94548238|NCT01672866|323803391|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
94548239|NCT01672866|323803392|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
94548240|NCT01672866|323803390|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
94548241|NCT01672866|323803391|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
94548242|NCT01672866|323803392|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
94548243|NCT01672866|323803390|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
94548244|NCT01672866|323803391|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
94548245|NCT01672866|323803392|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
94548246|NCT01672866|323803390|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
94548247|NCT01672866|323803391|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
94548248|NCT01672866|323803392|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
94548249|NCT01672866|323803390|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
94548250|NCT01672866|323803391|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
94548251|NCT01672866|323803392|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
94548252|NCT01672866|323803390|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
94548253|NCT01672866|323803391|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
94548254|NCT01672866|323803392|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
94548255|NCT01672866|323803390|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
94548256|NCT01672866|323803391|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
94548257|NCT01672866|323803392|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
94548258|NCT01672866|323803390|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
94548259|NCT01672866|323803391|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
94548260|NCT01672866|323803392|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
94548261|NCT01672866|323803390|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
94548262|NCT01672866|323803391|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
94548263|NCT01672866|323803392|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
94548264|NCT01672866|323803390|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
94548265|NCT01672866|323803391|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
94548266|NCT01672866|323803392|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
94548267|NCT01672866|323803390|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
94548268|NCT01672866|323803391|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
94548269|NCT01672866|323803392|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
94548270|NCT01672866|323803390|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
94548271|NCT01672866|323803391|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
94548272|NCT01672866|323803392|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
94548273|NCT01672866|323803390|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
94548274|NCT01672866|323803391|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
94548275|NCT01672866|323803392|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
94548276|NCT01064687|323803397|FG000|Overall Study|Adverse Event|9|||
94548277|NCT01064687|323803398|FG001|Overall Study|Adverse Event|4|||
94548278|NCT01064687|323803399|FG002|Overall Study|Adverse Event|10|||
94548279|NCT01064687|323803400|FG003|Overall Study|Adverse Event|3|||
94548280|NCT01064687|323803397|FG000|Overall Study|Death|1|||
94548281|NCT01064687|323803398|FG001|Overall Study|Death|1|||
94548282|NCT01064687|323803399|FG002|Overall Study|Death|0|||
94548283|NCT01064687|323803400|FG003|Overall Study|Death|0|||
94548284|NCT01064687|323803397|FG000|Overall Study|Entry Criteria Not Met|3|||
94548285|NCT01064687|323803398|FG001|Overall Study|Entry Criteria Not Met|0|||
94548286|NCT01064687|323803399|FG002|Overall Study|Entry Criteria Not Met|0|||
94548287|NCT01064687|323803400|FG003|Overall Study|Entry Criteria Not Met|0|||
94548288|NCT01064687|323803397|FG000|Overall Study|Lack of Efficacy|1|||
94548289|NCT01064687|323803398|FG001|Overall Study|Lack of Efficacy|0|||
94548290|NCT01064687|323803399|FG002|Overall Study|Lack of Efficacy|2|||
94548291|NCT01064687|323803400|FG003|Overall Study|Lack of Efficacy|3|||
94548292|NCT01064687|323803397|FG000|Overall Study|Lost to Follow-up|7|||
94548293|NCT01064687|323803398|FG001|Overall Study|Lost to Follow-up|10|||
94548294|NCT01064687|323803399|FG002|Overall Study|Lost to Follow-up|13|||
94548295|NCT01064687|323803400|FG003|Overall Study|Lost to Follow-up|5|||
94548296|NCT01064687|323803397|FG000|Overall Study|Physician Decision|2|||
94548297|NCT01064687|323803398|FG001|Overall Study|Physician Decision|2|||
94548298|NCT01064687|323803399|FG002|Overall Study|Physician Decision|0|||
94548299|NCT01064687|323803400|FG003|Overall Study|Physician Decision|0|||
94548300|NCT01064687|323803397|FG000|Overall Study|Protocol Violation|1|||
94548301|NCT01064687|323803398|FG001|Overall Study|Protocol Violation|1|||
94548302|NCT01064687|323803399|FG002|Overall Study|Protocol Violation|0|||
94548303|NCT01064687|323803400|FG003|Overall Study|Protocol Violation|1|||
94548304|NCT01064687|323803397|FG000|Overall Study|Sponsor Decision|0|||
94548305|NCT01064687|323803398|FG001|Overall Study|Sponsor Decision|0|||
94548306|NCT01064687|323803399|FG002|Overall Study|Sponsor Decision|3|||
94548307|NCT01064687|323803400|FG003|Overall Study|Sponsor Decision|0|||
94548308|NCT01064687|323803397|FG000|Overall Study|Withdrawal by Subject|9|||
94548309|NCT01064687|323803398|FG001|Overall Study|Withdrawal by Subject|7|||
94548310|NCT01064687|323803399|FG002|Overall Study|Withdrawal by Subject|12|||
94548311|NCT01064687|323803400|FG003|Overall Study|Withdrawal by Subject|5|||
94548312|NCT01064687|323803397|FG000|Overall Study|Treatment Noncompliance|1|||
94548313|NCT01064687|323803398|FG001|Overall Study|Treatment Noncompliance|1|||
94655950|NCT01602315|324198228|FG000|Overall Study|Subject/guardian decision|0|||
94655951|NCT01602315|324198229|FG001|Overall Study|Subject/guardian decision|0|||
94655952|NCT01602315|324198230|FG002|Overall Study|Subject/guardian decision|0|||
94655953|NCT01602315|324198231|FG003|Overall Study|Subject/guardian decision|0|||
94655954|NCT01602315|324198232|FG004|Overall Study|Subject/guardian decision|0|||
94655955|NCT01602315|324198233|FG005|Overall Study|Subject/guardian decision|0|||
94655956|NCT01602315|324198234|FG006|Overall Study|Subject/guardian decision|1|||
94655957|NCT01602315|324198228|FG000|Overall Study|Cross-over patients to combo treatment|0|||
94655958|NCT01602315|324198229|FG001|Overall Study|Cross-over patients to combo treatment|0|||
94655959|NCT01602315|324198230|FG002|Overall Study|Cross-over patients to combo treatment|0|||
94655960|NCT01602315|324198231|FG003|Overall Study|Cross-over patients to combo treatment|0|||
94655961|NCT01602315|324198232|FG004|Overall Study|Cross-over patients to combo treatment|0|||
94655962|NCT01602315|324198233|FG005|Overall Study|Cross-over patients to combo treatment|16|||
94655963|NCT01602315|324198234|FG006|Overall Study|Cross-over patients to combo treatment|0|||
94655964|NCT00982319|324198240|FG000|Overall Study|Surgery date change|1|||
94655965|NCT00982319|324198241|FG001|Overall Study|Surgery date change|0|||
94655966|NCT00982319|324198240|FG000|Overall Study|Preop values out of acceptable range|1|||
94655967|NCT00982319|324198241|FG001|Overall Study|Preop values out of acceptable range|1|||
94655968|NCT00982319|324198240|FG000|Overall Study|Pregnancy|0|||
94655969|NCT00982319|324198241|FG001|Overall Study|Pregnancy|1|||
94655970|NCT00975975|324198242|FG000|Overall Study|Death|6|||
94655971|NCT01324024|324198243|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
94655972|NCT01324024|324198244|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
94655973|NCT01923181|324198245|FG000|Overall Study|Protocol Violation|2|||
94655974|NCT01923181|324198246|FG001|Overall Study|Protocol Violation|2|||
94655975|NCT01923181|324198247|FG002|Overall Study|Protocol Violation|0|||
94655976|NCT01923181|324198248|FG003|Overall Study|Protocol Violation|2|||
94655977|NCT01923181|324198249|FG004|Overall Study|Protocol Violation|2|||
94655978|NCT01923181|324198250|FG005|Overall Study|Protocol Violation|1|||
94655979|NCT01923181|324198251|FG006|Overall Study|Protocol Violation|1|||
94655980|NCT01923181|324198252|FG007|Overall Study|Protocol Violation|2|||
94655981|NCT01923181|324198253|FG008|Overall Study|Protocol Violation|1|||
94655982|NCT01923181|324198245|FG000|Overall Study|Withdrawal by Subject|0|||
94655983|NCT01923181|324198246|FG001|Overall Study|Withdrawal by Subject|1|||
94655984|NCT01923181|324198247|FG002|Overall Study|Withdrawal by Subject|0|||
94655985|NCT01923181|324198248|FG003|Overall Study|Withdrawal by Subject|1|||
94655986|NCT01923181|324198249|FG004|Overall Study|Withdrawal by Subject|4|||
94655987|NCT01923181|324198250|FG005|Overall Study|Withdrawal by Subject|2|||
94655988|NCT01923181|324198251|FG006|Overall Study|Withdrawal by Subject|4|||
94655989|NCT01923181|324198252|FG007|Overall Study|Withdrawal by Subject|3|||
94655990|NCT01923181|324198253|FG008|Overall Study|Withdrawal by Subject|1|||
94655991|NCT01923181|324198245|FG000|Overall Study|Other|1|||
94655992|NCT01923181|324198246|FG001|Overall Study|Other|0|||
94655993|NCT01923181|324198247|FG002|Overall Study|Other|0|||
94655994|NCT01923181|324198248|FG003|Overall Study|Other|1|||
94655995|NCT01923181|324198249|FG004|Overall Study|Other|0|||
94655996|NCT01923181|324198250|FG005|Overall Study|Other|0|||
94655997|NCT01923181|324198251|FG006|Overall Study|Other|0|||
94655998|NCT01923181|324198252|FG007|Overall Study|Other|0|||
94655999|NCT01923181|324198253|FG008|Overall Study|Other|0|||
94656000|NCT01923181|324198245|FG000|Overall Study|Lost to Follow-up|0|||
94656001|NCT01923181|324198246|FG001|Overall Study|Lost to Follow-up|3|||
94656002|NCT01923181|324198247|FG002|Overall Study|Lost to Follow-up|2|||
94656003|NCT01923181|324198248|FG003|Overall Study|Lost to Follow-up|1|||
94656004|NCT01923181|324198249|FG004|Overall Study|Lost to Follow-up|2|||
94656005|NCT01923181|324198250|FG005|Overall Study|Lost to Follow-up|1|||
94656006|NCT01923181|324198251|FG006|Overall Study|Lost to Follow-up|3|||
94656007|NCT01923181|324198252|FG007|Overall Study|Lost to Follow-up|3|||
94656008|NCT01923181|324198253|FG008|Overall Study|Lost to Follow-up|1|||
94656009|NCT03586869|324198254|FG000|Overall Study|Progressive Disease|3|||
94656010|NCT01931839|324198267|FG000|Overall Study|Death|0|||
94656011|NCT01931839|324198268|FG001|Overall Study|Death|1|||
94656012|NCT01931839|324198269|FG002|Overall Study|Death|2|||
94656013|NCT01931839|324198270|FG003|Overall Study|Death|0|||
94656014|NCT01931839|324198271|FG004|Overall Study|Death|0|||
94656015|NCT01931839|324198272|FG005|Overall Study|Death|0|||
94656016|NCT01931839|324198273|FG006|Overall Study|Death|0|||
94656017|NCT01931839|324198267|FG000|Overall Study|Physician Decision|1|||
94656018|NCT01931839|324198268|FG001|Overall Study|Physician Decision|0|||
94656019|NCT01931839|324198269|FG002|Overall Study|Physician Decision|1|||
94656020|NCT01931839|324198270|FG003|Overall Study|Physician Decision|0|||
94656021|NCT01931839|324198271|FG004|Overall Study|Physician Decision|0|||
94656022|NCT01931839|324198272|FG005|Overall Study|Physician Decision|0|||
94656023|NCT01931839|324198273|FG006|Overall Study|Physician Decision|1|||
94656024|NCT01931839|324198267|FG000|Overall Study|Withdrawal of consent|0|||
94656025|NCT01931839|324198268|FG001|Overall Study|Withdrawal of consent|0|||
94656026|NCT01931839|324198269|FG002|Overall Study|Withdrawal of consent|0|||
94223362|NCT02986659|322610202|FG001|First Intervention Period|Adverse Event|1|||
94548314|NCT01064687|323803399|FG002|Overall Study|Treatment Noncompliance|1|||
94548315|NCT01064687|323803400|FG003|Overall Study|Treatment Noncompliance|0|||
94548316|NCT00619489|323803401|FG000|Overall Study|Adverse Event|0|||
94548317|NCT00619489|323803402|FG001|Overall Study|Adverse Event|7|||
94548318|NCT00619489|323803401|FG000|Overall Study|Withdrawal by Subject|1|||
94548319|NCT00619489|323803402|FG001|Overall Study|Withdrawal by Subject|1|||
94548320|NCT00619489|323803401|FG000|Overall Study|Lack of Efficacy|0|||
94548321|NCT00619489|323803402|FG001|Overall Study|Lack of Efficacy|11|||
94548322|NCT00619489|323803401|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
94548323|NCT00619489|323803402|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
94548324|NCT02966015|323803403|FG000|Inclusion Visit|did not answer questionnaire|8|||
94548325|NCT02966015|323803404|FG001|Inclusion Visit|did not answer questionnaire|3|||
94548326|NCT01751776|323803407|FG000|Overall Study|Adverse Event|0|||
94223363|NCT02986659|322610201|FG000|First Intervention Period|Lost to Follow-up|1|||
94656027|NCT01931839|324198270|FG003|Overall Study|Withdrawal of consent|0|||
94656028|NCT01931839|324198271|FG004|Overall Study|Withdrawal of consent|1|||
94656029|NCT01931839|324198272|FG005|Overall Study|Withdrawal of consent|0|||
94656030|NCT01931839|324198273|FG006|Overall Study|Withdrawal of consent|0|||
94656031|NCT01931839|324198267|FG000|Overall Study|Adverse Event|9|||
94656032|NCT01931839|324198268|FG001|Overall Study|Adverse Event|4|||
94656033|NCT01931839|324198269|FG002|Overall Study|Adverse Event|1|||
94548327|NCT01751776|323803408|FG001|Overall Study|Adverse Event|0|||
94548328|NCT01751776|323803409|FG002|Overall Study|Adverse Event|0|||
94548329|NCT01751776|323803410|FG003|Overall Study|Adverse Event|0|||
94548330|NCT01751776|323803411|FG004|Overall Study|Adverse Event|0|||
94548331|NCT01751776|323803412|FG005|Overall Study|Adverse Event|0|||
94548332|NCT01751776|323803413|FG006|Overall Study|Adverse Event|4|||
94548333|NCT01751776|323803414|FG007|Overall Study|Adverse Event|2|||
94548334|NCT01751776|323803407|FG000|Overall Study|Consent withdrawn|0|||
94548335|NCT01751776|323803408|FG001|Overall Study|Consent withdrawn|0|||
94548336|NCT01751776|323803409|FG002|Overall Study|Consent withdrawn|0|||
94548337|NCT01751776|323803410|FG003|Overall Study|Consent withdrawn|0|||
94548338|NCT01751776|323803411|FG004|Overall Study|Consent withdrawn|0|||
94548339|NCT01751776|323803412|FG005|Overall Study|Consent withdrawn|0|||
94548340|NCT01751776|323803413|FG006|Overall Study|Consent withdrawn|0|||
94548341|NCT01751776|323803414|FG007|Overall Study|Consent withdrawn|1|||
94548342|NCT01751776|323803407|FG000|Overall Study|Other reason not specified above|0|||
94548343|NCT01751776|323803408|FG001|Overall Study|Other reason not specified above|0|||
94548344|NCT01751776|323803409|FG002|Overall Study|Other reason not specified above|0|||
94548345|NCT01751776|323803410|FG003|Overall Study|Other reason not specified above|0|||
94548346|NCT01751776|323803411|FG004|Overall Study|Other reason not specified above|0|||
94548347|NCT01751776|323803412|FG005|Overall Study|Other reason not specified above|0|||
94548348|NCT01751776|323803413|FG006|Overall Study|Other reason not specified above|0|||
94548349|NCT01751776|323803414|FG007|Overall Study|Other reason not specified above|1|||
94548350|NCT00160654|323803415|FG000|Overall Study|Adverse Event|14|||
94548351|NCT00160654|323803415|FG000|Overall Study|Lack of Efficacy|4|||
94548352|NCT00160654|323803415|FG000|Overall Study|Lost to Follow-up|2|||
94548353|NCT00160654|323803415|FG000|Overall Study|Intake of expired drug|7|||
94548354|NCT00160654|323803415|FG000|Overall Study|Psychological trauma|1|||
94548355|NCT00160654|323803415|FG000|Overall Study|Sponsor decision|1|||
94548356|NCT00160654|323803415|FG000|Overall Study|Patient met exclusion criteria|1|||
94548357|NCT00160654|323803415|FG000|Overall Study|Patient decision|1|||
94548358|NCT00160654|323803415|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
94548359|NCT00160654|323803415|FG000|Overall Study|Met exclusion criteria|1|||
94548360|NCT03134183|323803416|FG000|Overall Study|Withdrawal by Subject|1|||
94548361|NCT03134183|323803417|FG001|Overall Study|Withdrawal by Subject|1|||
94548362|NCT00162266|323803418|FG000|Double-Blind Period|Adverse Event|5|||
94548363|NCT00162266|323803419|FG001|Double-Blind Period|Adverse Event|9|||
94548364|NCT00162266|323803420|FG002|Double-Blind Period|Adverse Event|11|||
94548365|NCT00162266|323803421|FG003|Double-Blind Period|Adverse Event|0|||
94548366|NCT00162266|323803418|FG000|Double-Blind Period|Death|0|||
94548367|NCT00162266|323803419|FG001|Double-Blind Period|Death|1|||
94548368|NCT00162266|323803420|FG002|Double-Blind Period|Death|0|||
94548369|NCT00162266|323803421|FG003|Double-Blind Period|Death|0|||
94548370|NCT00162266|323803418|FG000|Double-Blind Period|Lost to Follow-up|1|||
94548371|NCT00162266|323803419|FG001|Double-Blind Period|Lost to Follow-up|2|||
94548372|NCT00162266|323803420|FG002|Double-Blind Period|Lost to Follow-up|0|||
94548373|NCT00162266|323803421|FG003|Double-Blind Period|Lost to Follow-up|0|||
94548374|NCT00162266|323803418|FG000|Double-Blind Period|Other Reason|1|||
94548375|NCT00162266|323803419|FG001|Double-Blind Period|Other Reason|0|||
94548376|NCT00162266|323803420|FG002|Double-Blind Period|Other Reason|1|||
94548377|NCT00162266|323803421|FG003|Double-Blind Period|Other Reason|0|||
94548378|NCT00162266|323803418|FG000|Double-Blind Period|Lack of Efficacy|13|||
94548379|NCT00162266|323803419|FG001|Double-Blind Period|Lack of Efficacy|17|||
94548380|NCT00162266|323803420|FG002|Double-Blind Period|Lack of Efficacy|30|||
94223364|NCT02986659|322610202|FG001|First Intervention Period|Lost to Follow-up|0|||
94548381|NCT00162266|323803421|FG003|Double-Blind Period|Lack of Efficacy|0|||
94548382|NCT00162266|323803418|FG000|Double-Blind Period|Withdrawal by Subject|5|||
94548383|NCT00162266|323803419|FG001|Double-Blind Period|Withdrawal by Subject|2|||
94548384|NCT00162266|323803420|FG002|Double-Blind Period|Withdrawal by Subject|6|||
94548385|NCT00162266|323803421|FG003|Double-Blind Period|Withdrawal by Subject|0|||
94548386|NCT00162266|323803418|FG000|Open-Label Period|Death|0|||
94548387|NCT00162266|323803419|FG001|Open-Label Period|Death|0|||
94548388|NCT00162266|323803420|FG002|Open-Label Period|Death|0|||
94548389|NCT00162266|323803421|FG003|Open-Label Period|Death|7|||
94548390|NCT00162266|323803418|FG000|Open-Label Period|Adverse Event|0|||
94548391|NCT00162266|323803419|FG001|Open-Label Period|Adverse Event|0|||
94548392|NCT00162266|323803420|FG002|Open-Label Period|Adverse Event|0|||
94548393|NCT00162266|323803421|FG003|Open-Label Period|Adverse Event|46|||
94548394|NCT00162266|323803418|FG000|Open-Label Period|Lack of Efficacy|0|||
94548395|NCT00162266|323803419|FG001|Open-Label Period|Lack of Efficacy|0|||
94548396|NCT00162266|323803420|FG002|Open-Label Period|Lack of Efficacy|0|||
94548397|NCT00162266|323803421|FG003|Open-Label Period|Lack of Efficacy|26|||
94548398|NCT00162266|323803418|FG000|Open-Label Period|Lost to Follow-up|0|||
94548399|NCT00162266|323803419|FG001|Open-Label Period|Lost to Follow-up|0|||
94548400|NCT00162266|323803420|FG002|Open-Label Period|Lost to Follow-up|0|||
94331403|NCT02980692|322994206|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
94548401|NCT00162266|323803421|FG003|Open-Label Period|Lost to Follow-up|3|||
94548402|NCT00162266|323803418|FG000|Open-Label Period|Withdrawal by Subject|0|||
94548403|NCT00162266|323803419|FG001|Open-Label Period|Withdrawal by Subject|0|||
94548404|NCT00162266|323803420|FG002|Open-Label Period|Withdrawal by Subject|0|||
94548405|NCT00162266|323803421|FG003|Open-Label Period|Withdrawal by Subject|31|||
94548406|NCT00162266|323803418|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
94548407|NCT00162266|323803419|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
94548408|NCT00162266|323803420|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
94548409|NCT00162266|323803421|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
94656034|NCT01931839|324198270|FG003|Overall Study|Adverse Event|3|||
94656035|NCT01931839|324198271|FG004|Overall Study|Adverse Event|0|||
94656036|NCT01931839|324198272|FG005|Overall Study|Adverse Event|0|||
94656037|NCT01931839|324198273|FG006|Overall Study|Adverse Event|1|||
94656038|NCT01931839|324198267|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
94656039|NCT01931839|324198268|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
94656040|NCT01931839|324198269|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
94656041|NCT01931839|324198270|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
94656042|NCT01931839|324198271|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
94656043|NCT01931839|324198272|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
94656044|NCT01931839|324198273|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
94656045|NCT01931839|324198267|FG000|Overall Study|Other non-compliance|15|||
94656046|NCT01931839|324198268|FG001|Overall Study|Other non-compliance|9|||
94656047|NCT01931839|324198269|FG002|Overall Study|Other non-compliance|12|||
94656048|NCT01931839|324198270|FG003|Overall Study|Other non-compliance|3|||
94656049|NCT01931839|324198271|FG004|Overall Study|Other non-compliance|0|||
94656050|NCT01931839|324198272|FG005|Overall Study|Other non-compliance|3|||
94656051|NCT01931839|324198273|FG006|Overall Study|Other non-compliance|0|||
94656052|NCT01931839|324198267|FG000|Overall Study|Lost to Follow-up|1|||
94656053|NCT01931839|324198268|FG001|Overall Study|Lost to Follow-up|2|||
94656054|NCT01931839|324198269|FG002|Overall Study|Lost to Follow-up|4|||
94656055|NCT01931839|324198270|FG003|Overall Study|Lost to Follow-up|5|||
94656056|NCT01931839|324198271|FG004|Overall Study|Lost to Follow-up|0|||
94656057|NCT01931839|324198272|FG005|Overall Study|Lost to Follow-up|0|||
94656058|NCT01931839|324198273|FG006|Overall Study|Lost to Follow-up|0|||
94656059|NCT01931839|324198267|FG000|Overall Study|Other|4|||
94656060|NCT01931839|324198268|FG001|Overall Study|Other|2|||
94656061|NCT01931839|324198269|FG002|Overall Study|Other|6|||
94656062|NCT01931839|324198270|FG003|Overall Study|Other|0|||
94656063|NCT01931839|324198271|FG004|Overall Study|Other|0|||
94656064|NCT01931839|324198272|FG005|Overall Study|Other|0|||
94656065|NCT01931839|324198273|FG006|Overall Study|Other|0|||
94656066|NCT04382326|324198274|FG000|Overall Study|Adverse Event, not serious|1|||
94656067|NCT04382326|324198275|FG001|Overall Study|Adverse Event, not serious|2|||
94656068|NCT04382326|324198274|FG000|Overall Study|Other|1|||
94656069|NCT04382326|324198275|FG001|Overall Study|Other|0|||
94656070|NCT04382326|324198274|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
94656071|NCT04382326|324198275|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
94656072|NCT04382326|324198274|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
94656073|NCT04382326|324198275|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
94656074|NCT04382326|324198274|FG000|Overall Study|Protocol Violation|29|||
94656075|NCT04382326|324198275|FG001|Overall Study|Protocol Violation|23|||
94656076|NCT04382326|324198274|FG000|Overall Study|Physician Decision|0|||
94656077|NCT04382326|324198275|FG001|Overall Study|Physician Decision|1|||
94656078|NCT04382326|324198274|FG000|Overall Study|Lost to Follow-up|48|||
94656079|NCT04382326|324198275|FG001|Overall Study|Lost to Follow-up|63|||
94656080|NCT04382326|324198274|FG000|Overall Study|Adverse Event, non-fatal|1|||
94656081|NCT04382326|324198275|FG001|Overall Study|Adverse Event, non-fatal|1|||
94656082|NCT02317575|324198278|FG000|Period 1|Difficulty with venous cannulation|0|||
94656083|NCT02317575|324198279|FG001|Period 1|Difficulty with venous cannulation|1|||
94656084|NCT02317575|324198280|FG002|Period 1|Difficulty with venous cannulation|0|||
94656085|NCT02317575|324198281|FG003|Period 1|Difficulty with venous cannulation|0|||
94656086|NCT02317575|324198282|FG004|Period 1|Difficulty with venous cannulation|0|||
94656087|NCT02317575|324198278|FG000|Period 1|Withdrawal by Subject|1|||
94656088|NCT02317575|324198279|FG001|Period 1|Withdrawal by Subject|0|||
94656089|NCT02317575|324198280|FG002|Period 1|Withdrawal by Subject|0|||
94656090|NCT02317575|324198281|FG003|Period 1|Withdrawal by Subject|0|||
94656091|NCT02317575|324198282|FG004|Period 1|Withdrawal by Subject|0|||
94656092|NCT01958918|324198284|FG000|Overall Study|Death|1|||
94656093|NCT01958918|324198285|FG001|Overall Study|Death|3|||
94656094|NCT01958918|324198284|FG000|Overall Study|Lost to Follow-up|4|||
94656095|NCT01958918|324198285|FG001|Overall Study|Lost to Follow-up|7|||
94656096|NCT01958918|324198284|FG000|Overall Study|Withdrawal by Subject|13|||
94656097|NCT01958918|324198285|FG001|Overall Study|Withdrawal by Subject|8|||
94656098|NCT01958918|324198284|FG000|Overall Study|Lack of Efficacy|13|||
94656099|NCT01958918|324198285|FG001|Overall Study|Lack of Efficacy|10|||
94656100|NCT01958918|324198284|FG000|Overall Study|Adverse Event|12|||
94548410|NCT00162266|323803418|FG000|Open-Label Period|Other Reasons|0|||
94656101|NCT01958918|324198285|FG001|Overall Study|Adverse Event|12|||
94688550|NCT02960763|324315507|FG003|Step 2|Lost to Follow-up|4|||
94656102|NCT01958918|324198284|FG000|Overall Study|administrative problems|0|||
94656103|NCT01958918|324198285|FG001|Overall Study|administrative problems|2|||
94656104|NCT02013765|324198288|FG000|Overall Study|Trial was terminated by sponsor|1|||
94656105|NCT01877421|324198289|FG000|Phase 2|Lost to Follow-up|0|||
94656106|NCT01877421|324198290|FG001|Phase 2|Lost to Follow-up|0|||
94656107|NCT01877421|324198291|FG002|Phase 2|Lost to Follow-up|0|||
94656108|NCT01877421|324198292|FG003|Phase 2|Lost to Follow-up|0|||
94656109|NCT01877421|324198293|FG004|Phase 2|Lost to Follow-up|0|||
94656110|NCT01877421|324198294|FG005|Phase 2|Lost to Follow-up|0|||
94656111|NCT01877421|324198295|FG006|Phase 2|Lost to Follow-up|1|||
94656112|NCT01877421|324198296|FG007|Phase 2|Lost to Follow-up|0|||
94656113|NCT01877421|324198297|FG008|Phase 2|Lost to Follow-up|0|||
94656114|NCT01877421|324198298|FG009|Phase 2|Lost to Follow-up|0|||
94656115|NCT01877421|324198299|FG010|Phase 2|Lost to Follow-up|0|||
94331404|NCT02980692|322994202|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
94656116|NCT01877421|324198300|FG011|Phase 2|Lost to Follow-up|0|||
94656117|NCT01877421|324198301|FG012|Phase 2|Lost to Follow-up|0|||
94656118|NCT01877421|324198302|FG013|Phase 2|Lost to Follow-up|0|||
94656119|NCT01877421|324198303|FG014|Phase 2|Lost to Follow-up|0|||
94656120|NCT01877421|324198304|FG015|Phase 2|Lost to Follow-up|0|||
94656121|NCT01877421|324198305|FG016|Phase 2|Lost to Follow-up|0|||
94656122|NCT01877421|324198306|FG017|Phase 2|Lost to Follow-up|0|||
94656123|NCT01877421|324198289|FG000|Phase 2|Withdrawal by Subject|0|||
94656124|NCT01877421|324198290|FG001|Phase 2|Withdrawal by Subject|0|||
94656125|NCT01877421|324198291|FG002|Phase 2|Withdrawal by Subject|0|||
94656126|NCT01877421|324198292|FG003|Phase 2|Withdrawal by Subject|0|||
94656127|NCT01877421|324198293|FG004|Phase 2|Withdrawal by Subject|0|||
94656128|NCT01877421|324198294|FG005|Phase 2|Withdrawal by Subject|0|||
94656129|NCT01877421|324198295|FG006|Phase 2|Withdrawal by Subject|0|||
94656130|NCT01877421|324198296|FG007|Phase 2|Withdrawal by Subject|0|||
94656131|NCT01877421|324198297|FG008|Phase 2|Withdrawal by Subject|1|||
94656132|NCT01877421|324198298|FG009|Phase 2|Withdrawal by Subject|0|||
94656133|NCT01877421|324198299|FG010|Phase 2|Withdrawal by Subject|1|||
94656134|NCT01877421|324198300|FG011|Phase 2|Withdrawal by Subject|0|||
94656135|NCT01877421|324198301|FG012|Phase 2|Withdrawal by Subject|1|||
94656136|NCT01877421|324198302|FG013|Phase 2|Withdrawal by Subject|0|||
94656137|NCT01877421|324198303|FG014|Phase 2|Withdrawal by Subject|0|||
94656138|NCT01877421|324198304|FG015|Phase 2|Withdrawal by Subject|1|||
94656139|NCT01877421|324198305|FG016|Phase 2|Withdrawal by Subject|0|||
94656140|NCT01877421|324198306|FG017|Phase 2|Withdrawal by Subject|0|||
94656141|NCT01877421|324198289|FG000|Phase 2|Protocol Violation|0|||
94656142|NCT01877421|324198290|FG001|Phase 2|Protocol Violation|0|||
94656143|NCT01877421|324198291|FG002|Phase 2|Protocol Violation|0|||
94656144|NCT01877421|324198292|FG003|Phase 2|Protocol Violation|0|||
94656145|NCT01877421|324198293|FG004|Phase 2|Protocol Violation|0|||
94656146|NCT01877421|324198294|FG005|Phase 2|Protocol Violation|0|||
94656147|NCT01877421|324198295|FG006|Phase 2|Protocol Violation|0|||
94656148|NCT01877421|324198296|FG007|Phase 2|Protocol Violation|0|||
94656149|NCT01877421|324198297|FG008|Phase 2|Protocol Violation|0|||
94656150|NCT01877421|324198298|FG009|Phase 2|Protocol Violation|0|||
94656151|NCT01877421|324198299|FG010|Phase 2|Protocol Violation|1|||
94656152|NCT01877421|324198300|FG011|Phase 2|Protocol Violation|0|||
94656153|NCT01877421|324198301|FG012|Phase 2|Protocol Violation|0|||
94656154|NCT01877421|324198302|FG013|Phase 2|Protocol Violation|0|||
94656155|NCT01877421|324198303|FG014|Phase 2|Protocol Violation|0|||
94656156|NCT01877421|324198304|FG015|Phase 2|Protocol Violation|0|||
94656157|NCT01877421|324198305|FG016|Phase 2|Protocol Violation|0|||
94656158|NCT01877421|324198306|FG017|Phase 2|Protocol Violation|0|||
94656159|NCT01047683|324198307|FG000|Overall Study|Adverse Event|3|||
94656160|NCT01047683|324198308|FG001|Overall Study|Adverse Event|1|||
94656161|NCT01047683|324198309|FG002|Overall Study|Adverse Event|0|||
94656162|NCT01047683|324198307|FG000|Overall Study|Withdrew Consent|1|||
94656163|NCT01047683|324198308|FG001|Overall Study|Withdrew Consent|4|||
94656164|NCT01047683|324198309|FG002|Overall Study|Withdrew Consent|2|||
94656165|NCT01047683|324198307|FG000|Overall Study|Lost to Follow-up|0|||
94656166|NCT01047683|324198308|FG001|Overall Study|Lost to Follow-up|1|||
94656167|NCT01047683|324198309|FG002|Overall Study|Lost to Follow-up|0|||
94656168|NCT01047683|324198307|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
94656169|NCT01047683|324198308|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
94656170|NCT01047683|324198309|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
94656171|NCT01485861|324198315|FG000|Phase Ib|Death|1|||
94656172|NCT01485861|324198316|FG001|Phase Ib|Death|0|||
94656173|NCT01485861|324198317|FG002|Phase Ib|Death|0|||
94656174|NCT01485861|324198318|FG003|Phase Ib|Death|0|||
94656175|NCT01485861|324198319|FG004|Phase Ib|Death|0|||
94656176|NCT01485861|324198320|FG005|Phase Ib|Death|0|||
94656177|NCT01485861|324198315|FG000|Phase Ib|Physician Decision|1|||
94656178|NCT01485861|324198316|FG001|Phase Ib|Physician Decision|1|||
94656179|NCT01485861|324198317|FG002|Phase Ib|Physician Decision|0|||
94656180|NCT01485861|324198318|FG003|Phase Ib|Physician Decision|0|||
94656181|NCT01485861|324198319|FG004|Phase Ib|Physician Decision|0|||
94656182|NCT01485861|324198320|FG005|Phase Ib|Physician Decision|0|||
94656183|NCT01485861|324198315|FG000|Phase Ib|Adverse Event|0|||
94656184|NCT01485861|324198316|FG001|Phase Ib|Adverse Event|4|||
94656185|NCT01485861|324198317|FG002|Phase Ib|Adverse Event|0|||
94656186|NCT01485861|324198318|FG003|Phase Ib|Adverse Event|0|||
94656187|NCT01485861|324198319|FG004|Phase Ib|Adverse Event|0|||
94656188|NCT01485861|324198320|FG005|Phase Ib|Adverse Event|0|||
94656189|NCT01485861|324198315|FG000|Phase Ib|Progression of disease|5|||
94656190|NCT01485861|324198316|FG001|Phase Ib|Progression of disease|0|||
94656191|NCT01485861|324198317|FG002|Phase Ib|Progression of disease|0|||
94656192|NCT01485861|324198318|FG003|Phase Ib|Progression of disease|0|||
94656193|NCT01485861|324198319|FG004|Phase Ib|Progression of disease|0|||
94656194|NCT01485861|324198320|FG005|Phase Ib|Progression of disease|0|||
94656195|NCT01485861|324198315|FG000|Phase Ib|Other|3|||
94656196|NCT01485861|324198316|FG001|Phase Ib|Other|0|||
94656197|NCT01485861|324198317|FG002|Phase Ib|Other|0|||
94656198|NCT01485861|324198318|FG003|Phase Ib|Other|0|||
94656199|NCT01485861|324198319|FG004|Phase Ib|Other|0|||
94656200|NCT01485861|324198320|FG005|Phase Ib|Other|0|||
94656201|NCT01485861|324198315|FG000|Phase Ib|Withdrawal by Subject|4|||
94656202|NCT01485861|324198316|FG001|Phase Ib|Withdrawal by Subject|1|||
94656203|NCT01485861|324198317|FG002|Phase Ib|Withdrawal by Subject|0|||
94656204|NCT01485861|324198318|FG003|Phase Ib|Withdrawal by Subject|0|||
94656205|NCT01485861|324198319|FG004|Phase Ib|Withdrawal by Subject|0|||
94656206|NCT01485861|324198320|FG005|Phase Ib|Withdrawal by Subject|0|||
94656207|NCT01485861|324198315|FG000|Phase II|Death|0|||
94656208|NCT01485861|324198316|FG001|Phase II|Death|0|||
94656209|NCT01485861|324198317|FG002|Phase II|Death|67|||
94656210|NCT01485861|324198318|FG003|Phase II|Death|71|||
94656211|NCT01485861|324198319|FG004|Phase II|Death|68|||
94656212|NCT01485861|324198320|FG005|Phase II|Death|0|||
94656213|NCT01485861|324198315|FG000|Phase II|Progression of Disease|0|||
94656214|NCT01485861|324198316|FG001|Phase II|Progression of Disease|0|||
94656215|NCT01485861|324198317|FG002|Phase II|Progression of Disease|1|||
94656216|NCT01485861|324198318|FG003|Phase II|Progression of Disease|0|||
94656217|NCT01485861|324198319|FG004|Phase II|Progression of Disease|0|||
94656218|NCT01485861|324198320|FG005|Phase II|Progression of Disease|0|||
94656219|NCT01485861|324198315|FG000|Phase II|Other|0|||
94656220|NCT01485861|324198316|FG001|Phase II|Other|0|||
94656221|NCT01485861|324198317|FG002|Phase II|Other|0|||
94656222|NCT01485861|324198318|FG003|Phase II|Other|1|||
94656223|NCT01485861|324198319|FG004|Phase II|Other|0|||
94656224|NCT01485861|324198320|FG005|Phase II|Other|0|||
94656225|NCT01485861|324198315|FG000|Phase II|Withdrawal by Subject|0|||
94656226|NCT01485861|324198316|FG001|Phase II|Withdrawal by Subject|0|||
94656227|NCT01485861|324198317|FG002|Phase II|Withdrawal by Subject|6|||
94656228|NCT01485861|324198318|FG003|Phase II|Withdrawal by Subject|3|||
94656229|NCT01485861|324198319|FG004|Phase II|Withdrawal by Subject|4|||
94656230|NCT01485861|324198320|FG005|Phase II|Withdrawal by Subject|0|||
94656231|NCT01485861|324198315|FG000|Phase II|Lost to Follow-up|0|||
94656232|NCT01485861|324198316|FG001|Phase II|Lost to Follow-up|0|||
94656233|NCT01485861|324198317|FG002|Phase II|Lost to Follow-up|2|||
94656234|NCT01485861|324198318|FG003|Phase II|Lost to Follow-up|3|||
94656235|NCT01485861|324198319|FG004|Phase II|Lost to Follow-up|5|||
94656236|NCT01485861|324198320|FG005|Phase II|Lost to Follow-up|0|||
94656237|NCT01485861|324198315|FG000|Phase II|Study Ended|0|||
94656238|NCT01485861|324198316|FG001|Phase II|Study Ended|0|||
94656239|NCT01485861|324198317|FG002|Phase II|Study Ended|7|||
94656240|NCT01485861|324198318|FG003|Phase II|Study Ended|8|||
94656241|NCT01485861|324198319|FG004|Phase II|Study Ended|6|||
94656242|NCT01485861|324198320|FG005|Phase II|Study Ended|0|||
94656243|NCT01485861|324198315|FG000|Safety Phase|Death|0|||
94656244|NCT01485861|324198316|FG001|Safety Phase|Death|0|||
94656245|NCT01485861|324198317|FG002|Safety Phase|Death|0|||
94656246|NCT01485861|324198318|FG003|Safety Phase|Death|0|||
94656247|NCT01485861|324198319|FG004|Safety Phase|Death|0|||
94656248|NCT01485861|324198320|FG005|Safety Phase|Death|2|||
94656249|NCT01485861|324198315|FG000|Safety Phase|Adverse Event|0|||
94656250|NCT01485861|324198316|FG001|Safety Phase|Adverse Event|0|||
94656251|NCT01485861|324198317|FG002|Safety Phase|Adverse Event|0|||
94656252|NCT01485861|324198318|FG003|Safety Phase|Adverse Event|0|||
94656253|NCT01485861|324198319|FG004|Safety Phase|Adverse Event|0|||
94656254|NCT01485861|324198320|FG005|Safety Phase|Adverse Event|1|||
94656255|NCT01485861|324198315|FG000|Safety Phase|Other|0|||
94656256|NCT01485861|324198316|FG001|Safety Phase|Other|0|||
94656257|NCT01485861|324198317|FG002|Safety Phase|Other|0|||
94656258|NCT01485861|324198318|FG003|Safety Phase|Other|0|||
94656259|NCT01485861|324198319|FG004|Safety Phase|Other|0|||
94656260|NCT01485861|324198320|FG005|Safety Phase|Other|5|||
94656261|NCT01485861|324198315|FG000|Safety Phase|Progression of Disease|0|||
94656262|NCT01485861|324198316|FG001|Safety Phase|Progression of Disease|0|||
94656263|NCT01485861|324198317|FG002|Safety Phase|Progression of Disease|0|||
94656264|NCT01485861|324198318|FG003|Safety Phase|Progression of Disease|0|||
94656265|NCT01485861|324198319|FG004|Safety Phase|Progression of Disease|0|||
94656266|NCT01485861|324198320|FG005|Safety Phase|Progression of Disease|9|||
94656267|NCT01485861|324198315|FG000|Safety Phase|Withdrawal by Subject|0|||
94656268|NCT01485861|324198316|FG001|Safety Phase|Withdrawal by Subject|0|||
94656269|NCT01485861|324198317|FG002|Safety Phase|Withdrawal by Subject|0|||
94656270|NCT01485861|324198318|FG003|Safety Phase|Withdrawal by Subject|0|||
94656271|NCT01485861|324198319|FG004|Safety Phase|Withdrawal by Subject|0|||
94656272|NCT01485861|324198320|FG005|Safety Phase|Withdrawal by Subject|6|||
94656273|NCT01485861|324198315|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
94656274|NCT01485861|324198316|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
94656275|NCT01485861|324198317|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
94656276|NCT01485861|324198318|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
94656277|NCT01485861|324198319|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
94656278|NCT01485861|324198320|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
94656279|NCT02059148|324198321|FG000|Treatment 1|Protocol Violation|0|||
94656280|NCT02059148|324198322|FG001|Treatment 1|Protocol Violation|0|||
94656281|NCT02059148|324198323|FG002|Treatment 1|Protocol Violation|0|||
94656282|NCT02059148|324198324|FG003|Treatment 1|Protocol Violation|0|||
94656283|NCT02059148|324198325|FG004|Treatment 1|Protocol Violation|0|||
94656284|NCT02059148|324198326|FG005|Treatment 1|Protocol Violation|1|||
94656285|NCT01410110|324198327|FG000|Overall Study|Withdrawal by Subject|4|||
94656286|NCT01410110|324198328|FG001|Overall Study|Withdrawal by Subject|2|||
94656287|NCT02802345|324198332|FG000|Overall Study|Not Treated|0|||
94656288|NCT02802345|324198333|FG001|Overall Study|Not Treated|1|||
94656289|NCT02802345|324198332|FG000|Overall Study|Adverse Event|28|||
94656290|NCT02802345|324198333|FG001|Overall Study|Adverse Event|20|||
94656291|NCT02802345|324198332|FG000|Overall Study|Withdrawal by Subject|3|||
94656292|NCT02802345|324198333|FG001|Overall Study|Withdrawal by Subject|3|||
94656293|NCT02802345|324198332|FG000|Overall Study|Protocol Violation|0|||
94656294|NCT02802345|324198333|FG001|Overall Study|Protocol Violation|1|||
94656295|NCT02802345|324198332|FG000|Overall Study|Other than listed|1|||
94656296|NCT02802345|324198333|FG001|Overall Study|Other than listed|5|||
94656297|NCT01525082|324198334|FG000|Overall Study|Death|1|||
94656298|NCT01767116|324198337|FG000|Overall Study|Lost to Follow-up|2|||
94656299|NCT01767116|324198338|FG001|Overall Study|Lost to Follow-up|2|||
94656300|NCT03099382|324198341|FG000|Overall Study|Protocol Violation|2|||
94656301|NCT03099382|324198342|FG001|Overall Study|Protocol Violation|3|||
94656302|NCT01940705|324198343|FG000|Overall Study|Lost to Follow-up|1|||
94656303|NCT01940705|324198344|FG001|Overall Study|Lost to Follow-up|3|||
94656304|NCT01940705|324198345|FG002|Overall Study|Lost to Follow-up|2|||
94656305|NCT01940705|324198346|FG003|Overall Study|Lost to Follow-up|2|||
94656306|NCT01940705|324198343|FG000|Overall Study|Withdrawal by Subject|2|||
94656307|NCT01940705|324198344|FG001|Overall Study|Withdrawal by Subject|2|||
94656308|NCT01940705|324198345|FG002|Overall Study|Withdrawal by Subject|3|||
94656309|NCT01940705|324198346|FG003|Overall Study|Withdrawal by Subject|2|||
94656310|NCT01940705|324198343|FG000|Overall Study|Intervention not given|0|||
94656311|NCT01940705|324198344|FG001|Overall Study|Intervention not given|3|||
94656312|NCT01940705|324198345|FG002|Overall Study|Intervention not given|3|||
94656313|NCT01940705|324198346|FG003|Overall Study|Intervention not given|0|||
94656314|NCT01940705|324198343|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
94656315|NCT01940705|324198344|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
94656316|NCT01940705|324198345|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
94656317|NCT01940705|324198346|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
94656318|NCT02091167|324198363|FG000|Overall Study|Lost to Follow-up|0|||
94656319|NCT02091167|324198364|FG001|Overall Study|Lost to Follow-up|2|||
94656320|NCT02199691|324198367|FG000|Overall Study|Protocol Violation|3|||
94656321|NCT02199691|324198368|FG001|Overall Study|Protocol Violation|3|||
94656322|NCT02199691|324198369|FG002|Overall Study|Protocol Violation|6|||
94656323|NCT02199691|324198370|FG003|Overall Study|Protocol Violation|7|||
94656324|NCT02199691|324198367|FG000|Overall Study|Withdrawal by Subject|5|||
94656325|NCT02199691|324198368|FG001|Overall Study|Withdrawal by Subject|3|||
94656326|NCT02199691|324198369|FG002|Overall Study|Withdrawal by Subject|12|||
94656327|NCT02199691|324198370|FG003|Overall Study|Withdrawal by Subject|13|||
94656328|NCT02199691|324198367|FG000|Overall Study|Lost to Follow-up|2|||
94656329|NCT02199691|324198368|FG001|Overall Study|Lost to Follow-up|1|||
94656330|NCT02199691|324198369|FG002|Overall Study|Lost to Follow-up|9|||
94223365|NCT02986659|322610201|FG000|First Intervention Period|Withdrawal by Subject|0|||
94223366|NCT02986659|322610202|FG001|First Intervention Period|Withdrawal by Subject|1|||
94656331|NCT02199691|324198370|FG003|Overall Study|Lost to Follow-up|10|||
94656332|NCT00836875|324198382|FG000|Overall Study|Death|3|||
94656333|NCT00836875|324198383|FG001|Overall Study|Death|2|||
94656334|NCT00836875|324198382|FG000|Overall Study|Withdrawal by Subject|0|||
94656335|NCT00836875|324198383|FG001|Overall Study|Withdrawal by Subject|1|||
94656336|NCT03246529|324198386|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
94656337|NCT03246529|324198387|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
94656338|NCT03246529|324198388|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
94656339|NCT03246529|324198386|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
94656340|NCT03246529|324198387|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
94656341|NCT03246529|324198388|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
94656342|NCT03246529|324198386|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
94656343|NCT03246529|324198387|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
94656344|NCT03246529|324198388|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
94656345|NCT03246529|324198386|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
94656346|NCT03246529|324198387|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
94656347|NCT03246529|324198388|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
94656348|NCT03246529|324198386|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
94656349|NCT03246529|324198387|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
94656350|NCT03246529|324198388|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
94656351|NCT03246529|324198386|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
94656352|NCT03246529|324198387|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
94656353|NCT03246529|324198388|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
94656354|NCT03246529|324198386|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
94656355|NCT03246529|324198387|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
94656356|NCT03246529|324198388|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
94656357|NCT03246529|324198386|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
94656358|NCT03246529|324198387|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
94656359|NCT03246529|324198388|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
94656360|NCT03246529|324198386|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
94656361|NCT03246529|324198387|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
94656362|NCT03246529|324198388|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
94656363|NCT03952039|324198394|FG000|Overall Study|Adverse Event|22|||
94656364|NCT03952039|324198395|FG001|Overall Study|Adverse Event|8|||
94656365|NCT03952039|324198394|FG000|Overall Study|Withdrawal by Participant|17|||
94656366|NCT03952039|324198395|FG001|Overall Study|Withdrawal by Participant|12|||
94656367|NCT03952039|324198394|FG000|Overall Study|Death|13|||
94656368|NCT03952039|324198395|FG001|Overall Study|Death|6|||
94656369|NCT03952039|324198394|FG000|Overall Study|Lack of Efficacy|12|||
94656370|NCT03952039|324198395|FG001|Overall Study|Lack of Efficacy|2|||
94656371|NCT03952039|324198394|FG000|Overall Study|Physician Decision|9|||
94656372|NCT03952039|324198395|FG001|Overall Study|Physician Decision|3|||
94656373|NCT03952039|324198394|FG000|Overall Study|Progressive Disease|6|||
94656374|NCT03952039|324198395|FG001|Overall Study|Progressive Disease|4|||
94656375|NCT03952039|324198394|FG000|Overall Study|Other Reasons|12|||
94656376|NCT03952039|324198395|FG001|Overall Study|Other Reasons|4|||
94656377|NCT02080091|324199844|FG000|Overall Study|Study Terminated|22|||
94656378|NCT02080091|324199844|FG000|Overall Study|Death|1|||
94656379|NCT02080091|324199844|FG000|Overall Study|Withdrawal by Subject|1|||
94656380|NCT02080091|324199844|FG000|Overall Study|Other|1|||
94656381|NCT01913041|324199845|FG000|Overall Study|Protocol Violation|35|||
94656382|NCT01913041|324199845|FG000|Overall Study|Withdrawal by Subject|3|||
94656383|NCT01913041|324199845|FG000|Overall Study|Physician Decision|1|||
94656384|NCT01265953|324199846|FG000|Overall Study|Non compliance|5|||
94656385|NCT01265953|324199847|FG001|Overall Study|Non compliance|3|||
94656386|NCT01610700|324199848|FG000|Overall Study|Adverse Event|3|||
94656387|NCT01610700|324199849|FG001|Overall Study|Adverse Event|1|||
94656388|NCT01610700|324199848|FG000|Overall Study|Withdrawal by Subject|0|||
94656389|NCT01610700|324199849|FG001|Overall Study|Withdrawal by Subject|1|||
94656390|NCT01610700|324199848|FG000|Overall Study|subject took one dose of street cannabis|0|||
94656391|NCT01610700|324199849|FG001|Overall Study|subject took one dose of street cannabis|1|||
94656392|NCT01640301|324199850|FG000|Overall Study|Death|0|||
94656393|NCT01640301|324199851|FG001|Overall Study|Death|8|||
94656394|NCT02348489|324199852|FG000|Overall Study|Death|336|||
94656395|NCT02348489|324199853|FG001|Overall Study|Death|335|||
94656396|NCT02348489|324199852|FG000|Overall Study|Withdrawal by Subject|14|||
94656397|NCT02348489|324199853|FG001|Overall Study|Withdrawal by Subject|27|||
94656398|NCT02348489|324199852|FG000|Overall Study|Lost to Follow-up|3|||
94656399|NCT02348489|324199853|FG001|Overall Study|Lost to Follow-up|5|||
94656400|NCT01175824|324199854|FG000|Overall Study|Adverse Event|2|||
94656401|NCT01175824|324199855|FG001|Overall Study|Adverse Event|1|||
94656402|NCT01175824|324199854|FG000|Overall Study|Lack of Efficacy|2|||
94656403|NCT01175824|324199855|FG001|Overall Study|Lack of Efficacy|0|||
94656404|NCT01175824|324199854|FG000|Overall Study|Lost to Follow-up|0|||
94656405|NCT01175824|324199855|FG001|Overall Study|Lost to Follow-up|1|||
94656406|NCT01175824|324199854|FG000|Overall Study|Physician Decision|0|||
94656407|NCT01175824|324199855|FG001|Overall Study|Physician Decision|4|||
94656408|NCT01175824|324199854|FG000|Overall Study|Protocol Violation|2|||
94656409|NCT01175824|324199855|FG001|Overall Study|Protocol Violation|5|||
94656410|NCT01175824|324199854|FG000|Overall Study|Withdrawal by Subject|3|||
94656411|NCT01175824|324199855|FG001|Overall Study|Withdrawal by Subject|7|||
94223367|NCT02986659|322610201|FG000|Second Intervention Period|Adverse Event|0|||
94656412|NCT01175824|324199854|FG000|Overall Study|Sponsor Decision|1|||
94656413|NCT01175824|324199855|FG001|Overall Study|Sponsor Decision|0|||
94656414|NCT01175824|324199854|FG000|Overall Study|Entry Criteria Not Met|6|||
94656415|NCT01175824|324199855|FG001|Overall Study|Entry Criteria Not Met|4|||
94656416|NCT04820673|324199858|FG000|Overall Study|Adverse Event|6|||
94656417|NCT04820673|324199858|FG000|Overall Study|Due to Lack of Effectiveness|1|||
94656418|NCT04820673|324199858|FG000|Overall Study|Pregnancy|1|||
94656419|NCT04820673|324199858|FG000|Overall Study|Voluntary Withdrawal|20|||
94656420|NCT04820673|324199858|FG000|Overall Study|Lost to Follow-up|10|||
94656421|NCT03003676|324199864|FG000|Overall Study|Lack of Efficacy|5|||
94656422|NCT03003676|324199865|FG001|Overall Study|Lack of Efficacy|7|||
94656423|NCT03003676|324199864|FG000|Overall Study|Withdrawal by Subject|0|||
94656424|NCT03003676|324199865|FG001|Overall Study|Withdrawal by Subject|1|||
94656425|NCT03003676|324199864|FG000|Overall Study|Hepatitis B infection|1|||
94656426|NCT03003676|324199865|FG001|Overall Study|Hepatitis B infection|0|||
94656427|NCT00389324|324199871|FG000|Run-In Phase|Adverse Event|1|||
94656428|NCT00389324|324199871|FG000|Run-In Phase|Lost to Follow-up|1|||
94656429|NCT00389324|324199871|FG000|Run-In Phase|Withdrawal by Subject|1|||
94656430|NCT00389324|324199871|FG000|Subcutaneous Phase|Adverse Event|2|||
94656431|NCT00389324|324199871|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
94656432|NCT00389324|324199871|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
94656433|NCT00389324|324199871|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
94656434|NCT00795600|324199872|FG000|Overall Study|Adverse Event|1|||
94656435|NCT00795600|324199873|FG001|Overall Study|Adverse Event|1|||
94656436|NCT00795600|324199872|FG000|Overall Study|Protocol Violation|1|||
94656437|NCT00795600|324199873|FG001|Overall Study|Protocol Violation|2|||
94656438|NCT00795600|324199872|FG000|Overall Study|Withdrawal by Subject|1|||
94656439|NCT00795600|324199873|FG001|Overall Study|Withdrawal by Subject|0|||
94656440|NCT00795600|324199872|FG000|Overall Study|Unclassified|1|||
94656441|NCT00795600|324199873|FG001|Overall Study|Unclassified|1|||
94656442|NCT01925183|324199874|FG000|Overall Study|Adverse Event|1|||
94656443|NCT01925183|324199875|FG001|Overall Study|Adverse Event|0|||
94656444|NCT01046110|324199876|FG000|Overall Study|Adverse Event|9|||
94656445|NCT01046110|324199877|FG001|Overall Study|Adverse Event|2|||
94656446|NCT01046110|324199876|FG000|Overall Study|Lack of Efficacy|0|||
94656447|NCT01046110|324199877|FG001|Overall Study|Lack of Efficacy|1|||
94656448|NCT01046110|324199876|FG000|Overall Study|Protocol Violation|7|||
94656449|NCT01046110|324199877|FG001|Overall Study|Protocol Violation|12|||
94656450|NCT01046110|324199876|FG000|Overall Study|Withdrawal Criteria|3|||
94656451|NCT01046110|324199877|FG001|Overall Study|Withdrawal Criteria|5|||
94656452|NCT01046110|324199876|FG000|Overall Study|Unclassified|36|||
94656453|NCT01046110|324199877|FG001|Overall Study|Unclassified|35|||
94656454|NCT02114892|324199880|FG000|Overall Study|Lost to Follow-up|1|||
94656455|NCT02114892|324199881|FG001|Overall Study|Lost to Follow-up|2|||
94656456|NCT04360824|324199888|FG000|Overall Study|Withdrawal by Subject|2|||
94656457|NCT04360824|324199889|FG001|Overall Study|Withdrawal by Subject|1|||
94656458|NCT04360824|324199888|FG000|Overall Study|Did not receive assigned treatment|1|||
94656459|NCT04360824|324199889|FG001|Overall Study|Did not receive assigned treatment|3|||
94656460|NCT00718042|324199890|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
94656461|NCT00718042|324199891|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
94656462|NCT00718042|324199892|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
94656463|NCT00718042|324199893|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
94656464|NCT00718042|324199894|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
94656465|NCT00718042|324199895|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
94656466|NCT00718042|324199890|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
94656467|NCT00718042|324199891|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
94656468|NCT00718042|324199892|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
94656469|NCT00718042|324199893|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
94656470|NCT00718042|324199894|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
94656471|NCT00718042|324199895|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
94656472|NCT00718042|324199890|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
94656473|NCT00718042|324199891|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
94656474|NCT00718042|324199892|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
94656475|NCT00718042|324199893|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
94656476|NCT00718042|324199894|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
94656477|NCT00718042|324199895|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
94656478|NCT00718042|324199890|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
94656479|NCT00718042|324199891|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
94656480|NCT00718042|324199892|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
94656481|NCT00718042|324199893|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
94656482|NCT00718042|324199894|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
94656483|NCT00718042|324199895|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
94656484|NCT00718042|324199890|FG000|Donor Follow-up|Lost to Follow-up|13|||
94656485|NCT00718042|324199891|FG001|Donor Follow-up|Lost to Follow-up|0|||
94656486|NCT00718042|324199892|FG002|Donor Follow-up|Lost to Follow-up|0|||
94656487|NCT00718042|324199893|FG003|Donor Follow-up|Lost to Follow-up|0|||
94656488|NCT00718042|324199894|FG004|Donor Follow-up|Lost to Follow-up|19|||
94656489|NCT00718042|324199895|FG005|Donor Follow-up|Lost to Follow-up|0|||
94656490|NCT00304070|324199896|FG000|Overall Study|Death|0|||
94656491|NCT00304070|324199897|FG001|Overall Study|Death|0|||
94656492|NCT00304070|324199898|FG002|Overall Study|Death|3|||
94656493|NCT00304070|324199896|FG000|Overall Study|Lost to Follow-up|0|||
94656494|NCT00304070|324199897|FG001|Overall Study|Lost to Follow-up|0|||
94656495|NCT00304070|324199898|FG002|Overall Study|Lost to Follow-up|1|||
94656496|NCT00304070|324199896|FG000|Overall Study|Physician Decision|0|||
94656497|NCT00304070|324199897|FG001|Overall Study|Physician Decision|0|||
94656498|NCT00304070|324199898|FG002|Overall Study|Physician Decision|3|||
94656499|NCT00304070|324199896|FG000|Overall Study|Withdrawal by Subject|0|||
94656500|NCT00304070|324199897|FG001|Overall Study|Withdrawal by Subject|0|||
94656501|NCT00304070|324199898|FG002|Overall Study|Withdrawal by Subject|1|||
94656502|NCT00304070|324199896|FG000|Overall Study|Progressive Disease|3|||
94656503|NCT00304070|324199897|FG001|Overall Study|Progressive Disease|7|||
94656504|NCT00304070|324199898|FG002|Overall Study|Progressive Disease|4|||
94656505|NCT04327934|324199899|FG000|Overall Study|Did not qualify|7|||
94656506|NCT04327934|324199900|FG001|Overall Study|Did not qualify|4|||
94656507|NCT04327934|324199899|FG000|Overall Study|Physician Decision|0|||
94656508|NCT04327934|324199900|FG001|Overall Study|Physician Decision|1|||
94656509|NCT00575588|324199901|FG000|Overall Study|Adverse Event|11|||
94656510|NCT00575588|324199902|FG001|Overall Study|Adverse Event|13|||
94656511|NCT00575588|324199901|FG000|Overall Study|Withdrawal by Subject|27|||
94656512|NCT00575588|324199902|FG001|Overall Study|Withdrawal by Subject|31|||
94656513|NCT00575588|324199901|FG000|Overall Study|Lost to Follow-up|1|||
94656514|NCT00575588|324199902|FG001|Overall Study|Lost to Follow-up|3|||
94656515|NCT00575588|324199901|FG000|Overall Study|Death|4|||
94656516|NCT00575588|324199902|FG001|Overall Study|Death|2|||
94656517|NCT00575588|324199901|FG000|Overall Study|Incorrect enrollment|8|||
94656518|NCT00575588|324199902|FG001|Overall Study|Incorrect enrollment|4|||
94656519|NCT00575588|324199901|FG000|Overall Study|Study specific discontinuation criteria|203|||
94656520|NCT00575588|324199902|FG001|Overall Study|Study specific discontinuation criteria|218|||
94656521|NCT00575588|324199901|FG000|Overall Study|Severe non-compliance to protocol|5|||
94656522|NCT00575588|324199902|FG001|Overall Study|Severe non-compliance to protocol|7|||
94656523|NCT00575588|324199901|FG000|Overall Study|Safety reasons|2|||
94656524|NCT00575588|324199902|FG001|Overall Study|Safety reasons|1|||
94656525|NCT00575588|324199901|FG000|Overall Study|Elevated triglyceride|1|||
94656526|NCT00575588|324199902|FG001|Overall Study|Elevated triglyceride|0|||
94656527|NCT00575588|324199901|FG000|Overall Study|Patient moved|1|||
94656528|NCT00575588|324199902|FG001|Overall Study|Patient moved|3|||
94656529|NCT00575588|324199901|FG000|Overall Study|Impossible to determine HbA1c|0|||
94656530|NCT00575588|324199902|FG001|Overall Study|Impossible to determine HbA1c|1|||
94656531|NCT01430130|324199903|FG000|Overall Study|Lost to Follow-up|1|||
94656532|NCT01430130|324199903|FG000|Overall Study|Infection on Control Side of Incision|1|||
94656533|NCT00377676|324199906|FG000|Overall Study|Adverse Event|498|||
94656534|NCT00377676|324199907|FG001|Overall Study|Adverse Event|107|||
94656535|NCT00377676|324199906|FG000|Overall Study|Protocol Violation|33|||
94656536|NCT00377676|324199907|FG001|Overall Study|Protocol Violation|27|||
94656537|NCT00377676|324199906|FG000|Overall Study|Death|5|||
94656538|NCT00377676|324199907|FG001|Overall Study|Death|2|||
94656539|NCT00377676|324199906|FG000|Overall Study|Withdrawal by Subject|187|||
94656540|NCT00377676|324199907|FG001|Overall Study|Withdrawal by Subject|72|||
94656541|NCT00377676|324199906|FG000|Overall Study|Lost to Follow-up|120|||
94656542|NCT00377676|324199907|FG001|Overall Study|Lost to Follow-up|56|||
94656543|NCT00377676|324199906|FG000|Overall Study|Other|118|||
94656544|NCT00377676|324199907|FG001|Overall Study|Other|58|||
94656545|NCT00614939|324199913|FG000|Overall Study|Withdrawal by Subject|10|||
94656546|NCT00614939|324199914|FG001|Overall Study|Withdrawal by Subject|17|||
94656547|NCT00614939|324199913|FG000|Overall Study|Study specific discontinuation criteris|13|||
94656548|NCT00614939|324199914|FG001|Overall Study|Study specific discontinuation criteris|16|||
94656549|NCT00614939|324199913|FG000|Overall Study|Adverse Event|2|||
94656550|NCT00614939|324199914|FG001|Overall Study|Adverse Event|5|||
94656551|NCT00614939|324199913|FG000|Overall Study|Incorrect enrollment|1|||
94656552|NCT00614939|324199914|FG001|Overall Study|Incorrect enrollment|2|||
94656553|NCT00614939|324199913|FG000|Overall Study|Death|4|||
94656554|NCT00614939|324199914|FG001|Overall Study|Death|3|||
94656555|NCT00614939|324199913|FG000|Overall Study|Poor/non-compliance|4|||
94656556|NCT00614939|324199914|FG001|Overall Study|Poor/non-compliance|0|||
94656557|NCT00614939|324199913|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
94656558|NCT00614939|324199914|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
94656559|NCT00504829|324199915|FG000|Overall Study|Protocol Violation|6|||
94656560|NCT00504829|324199916|FG001|Overall Study|Protocol Violation|4|||
94656561|NCT00504829|324199917|FG002|Overall Study|Protocol Violation|10|||
94656562|NCT03095417|324199918|FG000|Overall Study|missed|1|||
94656563|NCT03095417|324199919|FG001|Overall Study|missed|2|||
94656564|NCT03095417|324199920|FG002|Overall Study|missed|0|||
94656565|NCT03095417|324199921|FG003|Overall Study|missed|1|||
94656566|NCT03095417|324199918|FG000|Overall Study|Lost to Follow-up|2|||
94656567|NCT03095417|324199919|FG001|Overall Study|Lost to Follow-up|2|||
94656568|NCT03095417|324199920|FG002|Overall Study|Lost to Follow-up|1|||
94656569|NCT03095417|324199921|FG003|Overall Study|Lost to Follow-up|0|||
94656570|NCT03095417|324199918|FG000|Overall Study|refusal|0|||
94656571|NCT03095417|324199919|FG001|Overall Study|refusal|1|||
94656572|NCT03095417|324199920|FG002|Overall Study|refusal|0|||
94656573|NCT03095417|324199921|FG003|Overall Study|refusal|1|||
94656574|NCT03095417|324199918|FG000|Overall Study|Withdrawal by Subject|8|||
94656575|NCT03095417|324199919|FG001|Overall Study|Withdrawal by Subject|2|||
94656576|NCT03095417|324199920|FG002|Overall Study|Withdrawal by Subject|5|||
94656577|NCT03095417|324199921|FG003|Overall Study|Withdrawal by Subject|4|||
94656578|NCT03095417|324199918|FG000|Overall Study|Physician Decision|1|||
94656579|NCT03095417|324199919|FG001|Overall Study|Physician Decision|2|||
94656580|NCT03095417|324199920|FG002|Overall Study|Physician Decision|2|||
94656581|NCT03095417|324199921|FG003|Overall Study|Physician Decision|2|||
94656582|NCT03095417|324199918|FG000|Overall Study|Death|1|||
94656583|NCT03095417|324199919|FG001|Overall Study|Death|2|||
94656584|NCT03095417|324199920|FG002|Overall Study|Death|1|||
94656585|NCT03095417|324199921|FG003|Overall Study|Death|3|||
94656586|NCT00383435|324199922|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
94656587|NCT00383435|324199923|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
94656588|NCT00383435|324199924|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
94656589|NCT00383435|324199925|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
94656590|NCT00383435|324199926|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
94656591|NCT00383435|324199922|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
94656592|NCT00383435|324199923|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
94656593|NCT00383435|324199924|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
94656594|NCT00383435|324199925|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
94656595|NCT00383435|324199926|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
94656596|NCT00383435|324199922|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
94656597|NCT00383435|324199923|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
94656598|NCT00383435|324199924|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
94656599|NCT00383435|324199925|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
94656600|NCT00383435|324199926|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
94656601|NCT00383435|324199922|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
94656602|NCT00383435|324199923|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
94656603|NCT00383435|324199924|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
94656604|NCT00383435|324199925|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
94656605|NCT00383435|324199926|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
94656606|NCT00383435|324199922|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
94656607|NCT00383435|324199923|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
94656608|NCT00383435|324199924|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
94656609|NCT00383435|324199925|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
94656610|NCT00383435|324199926|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
94656611|NCT00383435|324199922|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
94656612|NCT00383435|324199923|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
94656613|NCT00383435|324199924|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
94656614|NCT00383435|324199925|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
94656615|NCT00383435|324199926|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
94656616|NCT00383435|324199922|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
94656617|NCT00383435|324199923|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
94656618|NCT00383435|324199924|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
94656619|NCT00383435|324199925|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
94656620|NCT00383435|324199926|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
94656621|NCT00383435|324199922|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
94656622|NCT00383435|324199923|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
94656623|NCT00383435|324199924|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
94656624|NCT00383435|324199925|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
94656625|NCT00383435|324199926|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
94656626|NCT00383435|324199922|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
94656627|NCT00383435|324199923|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
94656628|NCT00383435|324199924|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
94656629|NCT00383435|324199925|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
94656630|NCT00383435|324199926|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
94656631|NCT00383435|324199922|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
94656632|NCT00383435|324199923|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
94656633|NCT00383435|324199924|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
94656634|NCT00383435|324199925|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
94656635|NCT00383435|324199926|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
94656636|NCT00383435|324199922|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
94656637|NCT00383435|324199923|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
94656638|NCT00383435|324199924|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
94656639|NCT00383435|324199925|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
94656640|NCT00383435|324199926|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
94656641|NCT00383435|324199922|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
94656642|NCT00383435|324199923|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
94656643|NCT00383435|324199924|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
94656644|NCT00383435|324199925|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
94656645|NCT00383435|324199926|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
94656646|NCT00383435|324199922|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
94656647|NCT00383435|324199923|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
94656648|NCT00383435|324199924|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
94656649|NCT00383435|324199925|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
94656650|NCT00383435|324199926|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
94656651|NCT00383435|324199922|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
94656652|NCT00383435|324199923|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
94656653|NCT00383435|324199924|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
94656654|NCT00383435|324199925|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
94656655|NCT00383435|324199926|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
94656656|NCT00383435|324199922|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
94656657|NCT00383435|324199923|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
94656658|NCT00383435|324199924|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
94656659|NCT00383435|324199925|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
94656660|NCT00383435|324199926|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
94656661|NCT00383435|324199922|FG000|26-Week Treatment Safety Extension|Administrative|1|||
94656662|NCT00383435|324199923|FG001|26-Week Treatment Safety Extension|Administrative|1|||
94656663|NCT00383435|324199924|FG002|26-Week Treatment Safety Extension|Administrative|0|||
94656664|NCT00383435|324199925|FG003|26-Week Treatment Safety Extension|Administrative|1|||
94656665|NCT00383435|324199926|FG004|26-Week Treatment Safety Extension|Administrative|0|||
94656666|NCT02660944|324199927|FG000|Overall Study|Adverse Event|3|||
94656667|NCT02660944|324199928|FG001|Overall Study|Adverse Event|4|||
94656668|NCT02660944|324199927|FG000|Overall Study|Physician Decision|3|||
94656669|NCT02660944|324199928|FG001|Overall Study|Physician Decision|1|||
94656670|NCT02660944|324199927|FG000|Overall Study|Withdrawal by Subject|5|||
94656671|NCT02660944|324199928|FG001|Overall Study|Withdrawal by Subject|3|||
94656672|NCT02660944|324199927|FG000|Overall Study|Lost to Follow-up|4|||
94656673|NCT02660944|324199928|FG001|Overall Study|Lost to Follow-up|1|||
94656674|NCT02660944|324199927|FG000|Overall Study|Subject schedule|0|||
94656675|NCT02660944|324199928|FG001|Overall Study|Subject schedule|1|||
94656676|NCT02660944|324199927|FG000|Overall Study|Exclusion criteria met|2|||
94656677|NCT02660944|324199928|FG001|Overall Study|Exclusion criteria met|0|||
94656678|NCT04776148|324199929|FG000|Overall Study|Death|172|||
94656679|NCT04776148|324199930|FG001|Overall Study|Death|188|||
94656680|NCT04776148|324199929|FG000|Overall Study|Lost to Follow-up|0|||
94656681|NCT04776148|324199930|FG001|Overall Study|Lost to Follow-up|1|||
94656682|NCT04776148|324199929|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94656683|NCT04776148|324199930|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
94439775|NCT04460885|323397824|FG001|Overall Study|Lost to Follow-up|4|||
94656684|NCT04776148|324199929|FG000|Overall Study|Withdrawal by Subject|2|||
94656685|NCT04776148|324199930|FG001|Overall Study|Withdrawal by Subject|4|||
94656686|NCT04776148|324199929|FG000|Overall Study|Ongoing in Study|67|||
94656687|NCT04776148|324199930|FG001|Overall Study|Ongoing in Study|45|||
94656688|NCT03586999|324199931|FG000|Overall Study|Lack of Efficacy|2|||
94656689|NCT01986829|324199943|FG000|Overall Study|Death|1|||
94656690|NCT04177108|324199950|FG000|Overall Study|Withdrawal by Subject|4|||
94656691|NCT04177108|324199951|FG001|Overall Study|Withdrawal by Subject|8|||
94656692|NCT04177108|324199952|FG002|Overall Study|Withdrawal by Subject|9|||
94656693|NCT04177108|324199953|FG003|Overall Study|Withdrawal by Subject|11|||
94656694|NCT04177108|324199954|FG004|Overall Study|Withdrawal by Subject|13|||
94656695|NCT04177108|324199950|FG000|Overall Study|Physician Decision|23|||
94656696|NCT04177108|324199951|FG001|Overall Study|Physician Decision|15|||
94656697|NCT04177108|324199952|FG002|Overall Study|Physician Decision|18|||
94656698|NCT04177108|324199953|FG003|Overall Study|Physician Decision|29|||
94656699|NCT04177108|324199954|FG004|Overall Study|Physician Decision|23|||
94656700|NCT04177108|324199950|FG000|Overall Study|Reason Not Specified|0|||
94656701|NCT04177108|324199951|FG001|Overall Study|Reason Not Specified|1|||
94656702|NCT04177108|324199952|FG002|Overall Study|Reason Not Specified|0|||
94656703|NCT04177108|324199953|FG003|Overall Study|Reason Not Specified|0|||
94656704|NCT04177108|324199954|FG004|Overall Study|Reason Not Specified|2|||
94656705|NCT04177108|324199950|FG000|Overall Study|Lost to Follow-up|0|||
94656706|NCT04177108|324199951|FG001|Overall Study|Lost to Follow-up|0|||
94656707|NCT04177108|324199952|FG002|Overall Study|Lost to Follow-up|1|||
94656708|NCT04177108|324199953|FG003|Overall Study|Lost to Follow-up|1|||
94656709|NCT04177108|324199954|FG004|Overall Study|Lost to Follow-up|1|||
94656710|NCT04177108|324199950|FG000|Overall Study|Death|16|||
94656711|NCT04177108|324199951|FG001|Overall Study|Death|19|||
94656712|NCT04177108|324199952|FG002|Overall Study|Death|13|||
94656713|NCT04177108|324199953|FG003|Overall Study|Death|17|||
94656714|NCT04177108|324199954|FG004|Overall Study|Death|18|||
94656715|NCT04433767|324199955|FG000|Overall Study|Adverse Event|1|||
94656716|NCT03864900|324199956|FG000|Overall Study|Withdrawal by Subject|1|||
94656717|NCT03864900|324199957|FG001|Overall Study|Withdrawal by Subject|1|||
94656718|NCT03864900|324199956|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
94656719|NCT03864900|324199957|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
94656720|NCT01827904|324199958|FG000|Main Study|Withdrawal by Subject|1|||
94656721|NCT01827904|324199959|FG001|Main Study|Withdrawal by Subject|0|||
94656722|NCT01827904|324199960|FG002|Main Study|Withdrawal by Subject|0|||
94656723|NCT01827904|324199958|FG000|Main Study|Adverse Event|1|||
94656724|NCT01827904|324199959|FG001|Main Study|Adverse Event|0|||
94656725|NCT01827904|324199960|FG002|Main Study|Adverse Event|0|||
94656726|NCT01827904|324199958|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
94656727|NCT01827904|324199959|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
94656728|NCT01827904|324199960|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
94656729|NCT01827904|324199958|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
94656730|NCT01827904|324199959|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
94656731|NCT01827904|324199960|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
94656732|NCT01827904|324199958|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
94656733|NCT01827904|324199959|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
94656734|NCT01827904|324199960|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
94656735|NCT01827904|324199958|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
94656736|NCT01827904|324199959|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
94656737|NCT01827904|324199960|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
94656738|NCT01827904|324199958|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
94656739|NCT01827904|324199959|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
94656740|NCT01827904|324199960|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
94656741|NCT01827904|324199958|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
94656742|NCT01827904|324199959|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
94656743|NCT01827904|324199960|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
94656744|NCT01827904|324199958|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
94656745|NCT01827904|324199959|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
94656746|NCT01827904|324199960|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
94656747|NCT01827904|324199958|FG000|Long-term Annual Follow-up|Physician Decision|1|||
94656748|NCT01827904|324199959|FG001|Long-term Annual Follow-up|Physician Decision|0|||
94656749|NCT01827904|324199960|FG002|Long-term Annual Follow-up|Physician Decision|0|||
94656750|NCT01827904|324199958|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
94656751|NCT01827904|324199959|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
94656752|NCT01827904|324199960|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
94656753|NCT01827904|324199958|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
94656754|NCT01827904|324199959|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
94656755|NCT01827904|324199960|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
94656756|NCT04382612|324199965|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
94656757|NCT01181895|324199966|FG000|Overall Study|Adverse Event|3|||
94656758|NCT01181895|324199967|FG001|Overall Study|Adverse Event|1|||
94656759|NCT01181895|324199968|FG002|Overall Study|Adverse Event|1|||
94656760|NCT01181895|324199966|FG000|Overall Study|Lack of Efficacy|8|||
94656761|NCT01181895|324199967|FG001|Overall Study|Lack of Efficacy|9|||
94656762|NCT01181895|324199968|FG002|Overall Study|Lack of Efficacy|9|||
94656763|NCT01181895|324199966|FG000|Overall Study|Protocol Violation|2|||
94656764|NCT01181895|324199967|FG001|Overall Study|Protocol Violation|1|||
94656765|NCT01181895|324199968|FG002|Overall Study|Protocol Violation|0|||
94656766|NCT01181895|324199966|FG000|Overall Study|Lost to Follow-up|0|||
94656767|NCT01181895|324199967|FG001|Overall Study|Lost to Follow-up|1|||
94656768|NCT01181895|324199968|FG002|Overall Study|Lost to Follow-up|2|||
94656769|NCT01181895|324199966|FG000|Overall Study|Investigator Discretion|1|||
94656770|NCT01181895|324199967|FG001|Overall Study|Investigator Discretion|2|||
94656771|NCT01181895|324199968|FG002|Overall Study|Investigator Discretion|1|||
94656772|NCT01181895|324199966|FG000|Overall Study|Withdrawal by Subject|3|||
94656773|NCT01181895|324199967|FG001|Overall Study|Withdrawal by Subject|0|||
94656774|NCT01181895|324199968|FG002|Overall Study|Withdrawal by Subject|5|||
94656775|NCT00499369|324199969|FG000|Overall Study|Adverse Event|2|||
94656776|NCT00499369|324199970|FG001|Overall Study|Adverse Event|2|||
94656777|NCT00499369|324199971|FG002|Overall Study|Adverse Event|3|||
94656778|NCT00499369|324199972|FG003|Overall Study|Adverse Event|1|||
94656779|NCT00499369|324199973|FG004|Overall Study|Adverse Event|2|||
94656780|NCT00499369|324199969|FG000|Overall Study|Withdrawal by Subject|0|||
94656781|NCT00499369|324199970|FG001|Overall Study|Withdrawal by Subject|1|||
94656782|NCT00499369|324199971|FG002|Overall Study|Withdrawal by Subject|1|||
94656783|NCT00499369|324199972|FG003|Overall Study|Withdrawal by Subject|0|||
94656784|NCT00499369|324199973|FG004|Overall Study|Withdrawal by Subject|0|||
94656785|NCT00499369|324199969|FG000|Overall Study|Progression|10|||
94656786|NCT00499369|324199970|FG001|Overall Study|Progression|12|||
94656787|NCT00499369|324199971|FG002|Overall Study|Progression|9|||
94656788|NCT00499369|324199972|FG003|Overall Study|Progression|6|||
94656789|NCT00499369|324199973|FG004|Overall Study|Progression|10|||
94656790|NCT00499369|324199969|FG000|Overall Study|Death|0|||
94656791|NCT00499369|324199970|FG001|Overall Study|Death|1|||
94656792|NCT00499369|324199971|FG002|Overall Study|Death|0|||
94656793|NCT00499369|324199972|FG003|Overall Study|Death|0|||
94656794|NCT00499369|324199973|FG004|Overall Study|Death|0|||
94656795|NCT00499369|324199969|FG000|Overall Study|Not protocol specified|2|||
94656796|NCT00499369|324199970|FG001|Overall Study|Not protocol specified|0|||
94656797|NCT00499369|324199971|FG002|Overall Study|Not protocol specified|3|||
94656798|NCT00499369|324199972|FG003|Overall Study|Not protocol specified|1|||
94656799|NCT00499369|324199973|FG004|Overall Study|Not protocol specified|0|||
94656800|NCT00499369|324199969|FG000|Overall Study|Ineligible|2|||
94656801|NCT00499369|324199970|FG001|Overall Study|Ineligible|2|||
94656802|NCT00499369|324199971|FG002|Overall Study|Ineligible|1|||
94656803|NCT00499369|324199972|FG003|Overall Study|Ineligible|1|||
94656804|NCT00499369|324199973|FG004|Overall Study|Ineligible|0|||
94656805|NCT01802411|324199977|FG000|Overall Study|Death|2|||
94656806|NCT01802411|324199978|FG001|Overall Study|Death|1|||
94656807|NCT01802411|324199977|FG000|Overall Study|Adverse Event|2|||
94656808|NCT01802411|324199978|FG001|Overall Study|Adverse Event|7|||
94656809|NCT01802411|324199977|FG000|Overall Study|Lack of Efficacy|8|||
94656810|NCT01802411|324199978|FG001|Overall Study|Lack of Efficacy|10|||
94656811|NCT01802411|324199977|FG000|Overall Study|Withdrawal by Subject|0|||
94656812|NCT01802411|324199978|FG001|Overall Study|Withdrawal by Subject|2|||
94656813|NCT01802411|324199977|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
94656814|NCT01802411|324199978|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
94656815|NCT01802411|324199977|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
94656816|NCT01802411|324199978|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
94656817|NCT01802411|324199977|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
94656818|NCT01802411|324199978|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
94656819|NCT02120924|324199979|FG000|Overall Study|Lack of Efficacy|1|||
94656820|NCT02120924|324199980|FG001|Overall Study|Lack of Efficacy|2|||
94656821|NCT02120924|324199981|FG002|Overall Study|Lack of Efficacy|3|||
94656822|NCT02120924|324199979|FG000|Overall Study|Adverse Event|0|||
94656823|NCT02120924|324199980|FG001|Overall Study|Adverse Event|1|||
94656824|NCT02120924|324199981|FG002|Overall Study|Adverse Event|3|||
94656825|NCT02120924|324199979|FG000|Overall Study|Withdrawal by Subject|16|||
94656826|NCT02120924|324199980|FG001|Overall Study|Withdrawal by Subject|20|||
94656827|NCT02120924|324199981|FG002|Overall Study|Withdrawal by Subject|8|||
94656828|NCT02120924|324199979|FG000|Overall Study|Lost to Follow-up|14|||
94656829|NCT02120924|324199980|FG001|Overall Study|Lost to Follow-up|14|||
94656830|NCT02120924|324199981|FG002|Overall Study|Lost to Follow-up|11|||
94656831|NCT02120924|324199979|FG000|Overall Study|Pregnancy|2|||
94656832|NCT02120924|324199980|FG001|Overall Study|Pregnancy|0|||
94656833|NCT02120924|324199981|FG002|Overall Study|Pregnancy|0|||
94656834|NCT02120924|324199979|FG000|Overall Study|Protocol Violation|3|||
94656835|NCT02120924|324199980|FG001|Overall Study|Protocol Violation|7|||
94656836|NCT02120924|324199981|FG002|Overall Study|Protocol Violation|2|||
94223368|NCT02986659|322610202|FG001|Second Intervention Period|Adverse Event|6|||
94223369|NCT01533181|322610203|FG000|Overall Study|Disease progression pre-active treatment|0|||
94223370|NCT01533181|322610204|FG001|Overall Study|Disease progression pre-active treatment|1|||
94223371|NCT01533181|322610203|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
94223372|NCT01533181|322610204|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
94223373|NCT03785210|322610205|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
94223374|NCT03785210|322610206|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
94656837|NCT02120924|324199979|FG000|Overall Study|Physician Decision|0|||
94656838|NCT02120924|324199980|FG001|Overall Study|Physician Decision|1|||
94656839|NCT02120924|324199981|FG002|Overall Study|Physician Decision|1|||
94656840|NCT02120924|324199979|FG000|Overall Study|Death|1|||
94656841|NCT02120924|324199980|FG001|Overall Study|Death|0|||
94656842|NCT02120924|324199981|FG002|Overall Study|Death|0|||
94656843|NCT02120924|324199979|FG000|Overall Study|Compliance with IP|5|||
94656844|NCT02120924|324199980|FG001|Overall Study|Compliance with IP|1|||
94656845|NCT02120924|324199981|FG002|Overall Study|Compliance with IP|1|||
94656846|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
94656847|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
94656848|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
94656849|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
94656850|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
94656851|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
94656852|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
94656853|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
94656854|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
94656855|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
94656856|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
94656857|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
94656858|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
94656859|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
94656860|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
94656861|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
94656862|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
94656863|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
94656864|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
94656865|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
94656866|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
94656867|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
94656868|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
94656869|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
94656870|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
94656871|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
94656872|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
94656873|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
94656874|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
94656875|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
94656876|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
94656877|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
94656878|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
94656879|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
94656880|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
94656881|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
94656882|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
94656883|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
94656884|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
94656885|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
94656886|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
94656887|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
94656888|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
94656889|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
94656890|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
94656891|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
94656892|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
94656893|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
94656894|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
94656895|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
94656896|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
94656897|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
94656898|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
94656899|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
94656900|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
94656901|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
94656902|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
94656903|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
94656904|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
94223375|NCT02720081|322610210|FG000|Overall Study|Adverse Event|0|||
94223376|NCT02720081|322610211|FG001|Overall Study|Adverse Event|3|||
94223377|NCT02720081|322610210|FG000|Overall Study|Protocol Violation|4|||
94223378|NCT02720081|322610211|FG001|Overall Study|Protocol Violation|1|||
94223379|NCT01732588|322610212|FG000|First Intervention (7 Days)|Adverse Event|0|||
94223380|NCT01732588|322610213|FG001|First Intervention (7 Days)|Adverse Event|1|||
94223381|NCT01732588|322610214|FG002|First Intervention (7 Days)|Adverse Event|0|||
94223382|NCT02005029|322610215|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
94223383|NCT02005029|322610216|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
94223384|NCT01370018|322610217|FG000|Overall Study|Did not meet criteria for analysis|1|||
94223385|NCT01675050|322610222|FG000|Period One Treatment|Withdrawal by Subject|1|||
94223386|NCT01675050|322610223|FG001|Period One Treatment|Withdrawal by Subject|0|||
94223387|NCT00084747|322610224|FG000|Overall Study|Relapsed|8|||
94223388|NCT00084747|322610224|FG000|Overall Study|Death|3|||
94223389|NCT00084747|322610224|FG000|Overall Study|Withdrawal by Subject|2|||
94223390|NCT04043806|322610229|FG000|Overall Study|Commercial drug is available for participants|13|||
94223391|NCT04043806|322610229|FG000|Overall Study|Physician Decision|2|||
94223392|NCT04043806|322610229|FG000|Overall Study|Other|12|||
94223393|NCT04043806|322610229|FG000|Overall Study|Adverse Event|2|||
94223394|NCT04043806|322610229|FG000|Overall Study|Lost to Follow-up|6|||
94223395|NCT04043806|322610229|FG000|Overall Study|Other non-compliance|2|||
94223396|NCT04043806|322610229|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
94223397|NCT04043806|322610229|FG000|Overall Study|Never Dosed|1|||
94223398|NCT00776984|322610236|FG000|Overall Study|Adverse Event|8|||
94223399|NCT00776984|322610237|FG001|Overall Study|Adverse Event|2|||
94223400|NCT00776984|322610236|FG000|Overall Study|Protocol Violation|4|||
94223401|NCT00776984|322610237|FG001|Overall Study|Protocol Violation|2|||
94223402|NCT00776984|322610236|FG000|Overall Study|Lost to Follow-up|2|||
94223403|NCT00776984|322610237|FG001|Overall Study|Lost to Follow-up|0|||
94223404|NCT00776984|322610236|FG000|Overall Study|Withdrawal by Subject|12|||
94223405|NCT00776984|322610237|FG001|Overall Study|Withdrawal by Subject|7|||
94223406|NCT00776984|322610236|FG000|Overall Study|Lack of Efficacy|0|||
94223407|NCT00776984|322610237|FG001|Overall Study|Lack of Efficacy|1|||
94223408|NCT00776984|322610236|FG000|Overall Study|Other|5|||
94223409|NCT00776984|322610237|FG001|Overall Study|Other|9|||
94223410|NCT02391116|322610242|FG000|Treatment|Withdrawal by Subject|1|||
94223411|NCT02391116|322610242|FG000|Treatment|Protocol Violation|1|||
94223412|NCT02391116|322610242|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
94223413|NCT02391116|322610242|FG000|Treatment|AE with Clinical PD|3|||
94223414|NCT02391116|322610242|FG000|Safety Follow-up|Adverse Event|1|||
94223415|NCT02391116|322610242|FG000|Safety Follow-up|Withdrawal by Subject|4|||
94223416|NCT02391116|322610242|FG000|Safety Follow-up|Switching to Other Therapy|4|||
94223417|NCT02391116|322610242|FG000|Safety Follow-up|No Follow Up|1|||
94223418|NCT02391116|322610242|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
94223419|NCT02391116|322610242|FG000|Active Follow-up|Withdrawal by Subject|1|||
94223420|NCT02391116|322610242|FG000|Active Follow-up|Switching to Other Therapy|2|||
94223421|NCT02391116|322610242|FG000|Survival Follow-up|Withdrawal by Subject|3|||
94223422|NCT02391116|322610242|FG000|Survival Follow-up|Switching to Other Therapy|1|||
94223423|NCT02282917|322610246|FG000|Overall Study|Withdrawal by Subject|1|||
94223424|NCT02282917|322610246|FG000|Overall Study|Screen Failure/Not Eligible|1|||
94223425|NCT03045302|322610247|FG000|Overall Study|Pre-treatment adverse event|1|||
94223426|NCT04414397|322610251|FG000|Control Period|Withdrawal by Subject|2|||
94223427|NCT04414397|322610252|FG001|Control Period|Withdrawal by Subject|2|||
94223428|NCT04414397|322610251|FG000|Control Period|Lost to Follow-up|0|||
94223429|NCT04414397|322610252|FG001|Control Period|Lost to Follow-up|4|||
94223430|NCT04414397|322610251|FG000|Control Period|Protocol deviation|0|||
94223431|NCT04414397|322610252|FG001|Control Period|Protocol deviation|1|||
94223432|NCT04414397|322610251|FG000|Post-Control Period|Withdrawal by Subject|3|||
94223433|NCT04414397|322610252|FG001|Post-Control Period|Withdrawal by Subject|6|||
94223434|NCT04414397|322610251|FG000|Post-Control Period|Lost to Follow-up|4|||
94223435|NCT04414397|322610252|FG001|Post-Control Period|Lost to Follow-up|9|||
94223436|NCT04414397|322610251|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
94223437|NCT04414397|322610252|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
94223438|NCT04414397|322610251|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
94223439|NCT04414397|322610252|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
94223440|NCT01313299|322610253|FG000|Overall Study|Adverse Event|3|||
94223441|NCT01313299|322610254|FG001|Overall Study|Adverse Event|1|||
94223442|NCT01313299|322610255|FG002|Overall Study|Adverse Event|1|||
94223443|NCT01313299|322610253|FG000|Overall Study|Lost to Follow-up|1|||
94223444|NCT01313299|322610254|FG001|Overall Study|Lost to Follow-up|0|||
94223445|NCT01313299|322610255|FG002|Overall Study|Lost to Follow-up|0|||
94223446|NCT01313299|322610253|FG000|Overall Study|Protocol Violation|2|||
94223447|NCT01313299|322610254|FG001|Overall Study|Protocol Violation|0|||
94223448|NCT01313299|322610255|FG002|Overall Study|Protocol Violation|0|||
94223449|NCT01313299|322610253|FG000|Overall Study|Withdrawal by Subject|1|||
94223450|NCT01313299|322610254|FG001|Overall Study|Withdrawal by Subject|0|||
94223451|NCT01313299|322610255|FG002|Overall Study|Withdrawal by Subject|2|||
94223452|NCT01313299|322610253|FG000|Overall Study|Family reason and moved out of state|0|||
94223453|NCT01313299|322610254|FG001|Overall Study|Family reason and moved out of state|2|||
94223454|NCT01313299|322610255|FG002|Overall Study|Family reason and moved out of state|0|||
94223455|NCT01313299|322610253|FG000|Overall Study|Lack of subject compliance|0|||
94223456|NCT01313299|322610254|FG001|Overall Study|Lack of subject compliance|0|||
94223457|NCT01313299|322610255|FG002|Overall Study|Lack of subject compliance|1|||
94223458|NCT02391545|322610257|FG000|Overall Study|Death|0|||
94223459|NCT02391545|322610258|FG001|Overall Study|Death|2|||
94223460|NCT02391545|322610257|FG000|Overall Study|Lost to Follow-up|0|||
94223461|NCT02391545|322610258|FG001|Overall Study|Lost to Follow-up|1|||
94223462|NCT02391545|322610257|FG000|Overall Study|Termination of study by sponsor|20|||
94223463|NCT02391545|322610258|FG001|Overall Study|Termination of study by sponsor|20|||
94223464|NCT02391545|322610257|FG000|Overall Study|Withdrawal by Subject|0|||
94223465|NCT02391545|322610258|FG001|Overall Study|Withdrawal by Subject|1|||
94223466|NCT02391545|322610257|FG000|Overall Study|Other Reasons|6|||
94223467|NCT02391545|322610258|FG001|Overall Study|Other Reasons|4|||
94223468|NCT04089332|322610260|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
94223469|NCT04089332|322610260|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
94223470|NCT04089332|322610260|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
94223471|NCT06016127|322610264|FG000|Overall Study|Withdrawal by Subject|4|||
94223472|NCT06016127|322610265|FG001|Overall Study|Withdrawal by Subject|3|||
94223473|NCT02418819|322610266|FG000|Overall Study|Adverse Event|0|||
94223474|NCT02418819|322610267|FG001|Overall Study|Adverse Event|0|||
94223475|NCT02418819|322610268|FG002|Overall Study|Adverse Event|1|||
94223476|NCT02418819|322610269|FG003|Overall Study|Adverse Event|0|||
94223477|NCT02418819|322610266|FG000|Overall Study|Lost to Follow-up|1|||
94223478|NCT02418819|322610267|FG001|Overall Study|Lost to Follow-up|0|||
94223479|NCT02418819|322610268|FG002|Overall Study|Lost to Follow-up|0|||
94223480|NCT02418819|322610269|FG003|Overall Study|Lost to Follow-up|0|||
94439776|NCT04324073|323397825|FG000|Overall Study|withdrew consent|0|||
94223481|NCT02418819|322610266|FG000|Overall Study|No longer meets eligibility criteria|0|||
94223482|NCT02418819|322610267|FG001|Overall Study|No longer meets eligibility criteria|0|||
94223483|NCT02418819|322610268|FG002|Overall Study|No longer meets eligibility criteria|1|||
94223484|NCT02418819|322610269|FG003|Overall Study|No longer meets eligibility criteria|0|||
94223485|NCT02418819|322610266|FG000|Overall Study|No longer willing to participate|0|||
94223486|NCT02418819|322610267|FG001|Overall Study|No longer willing to participate|0|||
94223487|NCT02418819|322610268|FG002|Overall Study|No longer willing to participate|2|||
94223488|NCT02418819|322610269|FG003|Overall Study|No longer willing to participate|1|||
94223489|NCT04743999|322610270|FG000|3-month Questionnaire|Death|1|||
94223490|NCT04743999|322610270|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
94223491|NCT04743999|322610270|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
94223492|NCT04743999|322610270|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
94223493|NCT02820298|322610271|FG000|Overall Study|Withdrawal by Subject|0|||
94223494|NCT02820298|322610272|FG001|Overall Study|Withdrawal by Subject|1|||
94223495|NCT02820298|322610271|FG000|Overall Study|Physician Decision|1|||
94223496|NCT02820298|322610272|FG001|Overall Study|Physician Decision|0|||
94223497|NCT02820298|322610271|FG000|Overall Study|Protocol Violation|0|||
94223498|NCT02820298|322610272|FG001|Overall Study|Protocol Violation|1|||
94223499|NCT00562484|322610273|FG000|Overall Study|Adverse Event|6|||
94223500|NCT00562484|322610274|FG001|Overall Study|Adverse Event|1|||
94223501|NCT00562484|322610273|FG000|Overall Study|Protocol Violation|11|||
94223502|NCT00562484|322610274|FG001|Overall Study|Protocol Violation|2|||
94223503|NCT00562484|322610273|FG000|Overall Study|Withdrawal by Subject|12|||
94223504|NCT00562484|322610274|FG001|Overall Study|Withdrawal by Subject|9|||
94223505|NCT00562484|322610273|FG000|Overall Study|Moved away from the study area|20|||
94223506|NCT00562484|322610274|FG001|Overall Study|Moved away from the study area|9|||
94223507|NCT00562484|322610273|FG000|Overall Study|Lost to Follow-up|132|||
94223508|NCT00562484|322610274|FG001|Overall Study|Lost to Follow-up|71|||
94223509|NCT00562484|322610273|FG000|Overall Study|Reason not provided or not specified|25|||
94223510|NCT00562484|322610274|FG001|Overall Study|Reason not provided or not specified|12|||
94223511|NCT00702520|322610275|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
94223512|NCT00702520|322610276|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
94223513|NCT00702520|322610277|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
94223514|NCT00702520|322610278|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
94223515|NCT00702520|322610275|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
94223516|NCT00702520|322610276|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
94223517|NCT00702520|322610277|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
94223518|NCT00702520|322610278|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
94223519|NCT00702520|322610275|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
94223520|NCT00702520|322610276|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
94439777|NCT04324073|323397826|FG001|Overall Study|withdrew consent|4|||
94223521|NCT00702520|322610277|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
94223522|NCT00702520|322610278|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
94223523|NCT01204775|322610281|FG000|Overall Study|Poor/non-compliance|0|||
94223524|NCT01204775|322610282|FG001|Overall Study|Poor/non-compliance|1|||
94223525|NCT01204775|322610281|FG000|Overall Study|Withdrawal by Subject|1|||
94223526|NCT01204775|322610282|FG001|Overall Study|Withdrawal by Subject|0|||
94223527|NCT00884793|322610287|FG000|Overall Study|Withdrawal by Subject|1|||
94223528|NCT01032200|322610288|FG000|Overall Study|Death|1|||
94223529|NCT01032200|322610289|FG001|Overall Study|Death|1|||
94223530|NCT01032200|322610288|FG000|Overall Study|Withdrawal by Subject|1|||
94223531|NCT01032200|322610289|FG001|Overall Study|Withdrawal by Subject|3|||
94223532|NCT01032200|322610288|FG000|Overall Study|Toxicity|0|||
94223533|NCT01032200|322610289|FG001|Overall Study|Toxicity|2|||
94223534|NCT01032200|322610288|FG000|Overall Study|Progression|1|||
94223535|NCT01032200|322610289|FG001|Overall Study|Progression|0|||
94223536|NCT01032200|322610288|FG000|Overall Study|Multiple|1|||
94223537|NCT01032200|322610289|FG001|Overall Study|Multiple|1|||
94223538|NCT04295499|322610290|FG000|Overall Study|moving out of state|1|||
94223539|NCT04295499|322610291|FG001|Overall Study|moving out of state|0|||
94223540|NCT04295499|322610290|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
94223541|NCT04295499|322610291|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
94223542|NCT01786551|322610292|FG000|Overall Study|Participant withdrew consent|2|||
94223543|NCT02154516|322610293|FG000|Overall Study|Withdrawal by Subject|0|||
94223544|NCT02154516|322610294|FG001|Overall Study|Withdrawal by Subject|1|||
94223545|NCT02154516|322610293|FG000|Overall Study|Lost to Follow-up|1|||
94223546|NCT02154516|322610294|FG001|Overall Study|Lost to Follow-up|0|||
94223547|NCT02154516|322610293|FG000|Overall Study|Removal/revision of device|1|||
94223548|NCT02154516|322610294|FG001|Overall Study|Removal/revision of device|0|||
94223549|NCT02154516|322610293|FG000|Overall Study|Death|2|||
94223550|NCT02154516|322610294|FG001|Overall Study|Death|1|||
94223551|NCT03406507|322610295|FG000|Extension Period|Lack of Efficacy|0|||
94223552|NCT03406507|322610296|FG001|Extension Period|Lack of Efficacy|1|||
94223553|NCT00663923|322610297|FG000|Overall Study|Lost to Follow-up|2|||
94223554|NCT02965599|322610298|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
94223555|NCT02965599|322610299|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
94223556|NCT03993054|322610300|FG000|Overall Study|PI Decision|1|||
94223557|NCT03749616|322610301|FG000|Overall Study|Lost to Follow-up|4|||
94223558|NCT03749616|322610302|FG001|Overall Study|Lost to Follow-up|7|||
94223559|NCT03749616|322610301|FG000|Overall Study|Screen Failure|1|||
94223560|NCT03749616|322610302|FG001|Overall Study|Screen Failure|1|||
94223561|NCT03749616|322610301|FG000|Overall Study|Withdrawal by Subject|2|||
94223562|NCT03749616|322610302|FG001|Overall Study|Withdrawal by Subject|0|||
94223563|NCT00919061|322610303|FG000|Overall Study|Adverse Event|1|||
94223564|NCT00919061|322610303|FG000|Overall Study|Withdrawal by Subject|1|||
94223565|NCT04944784|322610304|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
94223566|NCT04944784|322610305|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
94223567|NCT04944784|322610306|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
94223568|NCT04944784|322610307|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
94223569|NCT04944784|322610304|FG000|Double-blind Period|Adverse Event|20|||
94223570|NCT04944784|322610305|FG001|Double-blind Period|Adverse Event|4|||
94223571|NCT04944784|322610306|FG002|Double-blind Period|Adverse Event|0|||
94223572|NCT04944784|322610307|FG003|Double-blind Period|Adverse Event|0|||
94223573|NCT04944784|322610304|FG000|Double-blind Period|Withdrawal by Subject|15|||
94223574|NCT04944784|322610305|FG001|Double-blind Period|Withdrawal by Subject|4|||
94223575|NCT04944784|322610306|FG002|Double-blind Period|Withdrawal by Subject|0|||
94223576|NCT04944784|322610307|FG003|Double-blind Period|Withdrawal by Subject|0|||
94223577|NCT04944784|322610304|FG000|Double-blind Period|Death|7|||
94223578|NCT04944784|322610305|FG001|Double-blind Period|Death|2|||
94223579|NCT04944784|322610306|FG002|Double-blind Period|Death|0|||
94223580|NCT04944784|322610307|FG003|Double-blind Period|Death|0|||
94223581|NCT04944784|322610304|FG000|Double-blind Period|Physician Decision|2|||
94223582|NCT04944784|322610305|FG001|Double-blind Period|Physician Decision|1|||
94223583|NCT04944784|322610306|FG002|Double-blind Period|Physician Decision|0|||
94223584|NCT04944784|322610307|FG003|Double-blind Period|Physician Decision|0|||
94223585|NCT04944784|322610304|FG000|Double-blind Period|Lack of Efficacy|0|||
94223586|NCT04944784|322610305|FG001|Double-blind Period|Lack of Efficacy|1|||
94223587|NCT04944784|322610306|FG002|Double-blind Period|Lack of Efficacy|0|||
94223588|NCT04944784|322610307|FG003|Double-blind Period|Lack of Efficacy|0|||
94223589|NCT04944784|322610304|FG000|Double-blind Period|Sponsor Request|2|||
94223590|NCT04944784|322610305|FG001|Double-blind Period|Sponsor Request|1|||
94223591|NCT04944784|322610306|FG002|Double-blind Period|Sponsor Request|0|||
94223592|NCT04944784|322610307|FG003|Double-blind Period|Sponsor Request|0|||
94223593|NCT04944784|322610304|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
94223594|NCT04944784|322610305|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
94223595|NCT04944784|322610306|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
94223596|NCT04944784|322610307|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
94223597|NCT04944784|322610304|FG000|Double-blind Period|Participant Choice|1|||
94223598|NCT04944784|322610305|FG001|Double-blind Period|Participant Choice|1|||
94223599|NCT04944784|322610306|FG002|Double-blind Period|Participant Choice|0|||
94223600|NCT04944784|322610307|FG003|Double-blind Period|Participant Choice|0|||
94223601|NCT04944784|322610304|FG000|Double-blind Period|Progressive Disease|2|||
94223602|NCT04944784|322610305|FG001|Double-blind Period|Progressive Disease|2|||
94223603|NCT04944784|322610306|FG002|Double-blind Period|Progressive Disease|0|||
94223604|NCT04944784|322610307|FG003|Double-blind Period|Progressive Disease|0|||
94223605|NCT04944784|322610304|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
94223606|NCT04944784|322610305|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
94223607|NCT04944784|322610306|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
94223608|NCT04944784|322610307|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
94223609|NCT04944784|322610304|FG000|Active Drug Period|Adverse Event|0|||
94223610|NCT04944784|322610305|FG001|Active Drug Period|Adverse Event|0|||
94223611|NCT04944784|322610306|FG002|Active Drug Period|Adverse Event|3|||
94223612|NCT04944784|322610307|FG003|Active Drug Period|Adverse Event|6|||
94223613|NCT04944784|322610304|FG000|Active Drug Period|Withdrawal by Subject|0|||
94223614|NCT04944784|322610305|FG001|Active Drug Period|Withdrawal by Subject|0|||
94223615|NCT04944784|322610306|FG002|Active Drug Period|Withdrawal by Subject|4|||
94223616|NCT04944784|322610307|FG003|Active Drug Period|Withdrawal by Subject|7|||
94223617|NCT04944784|322610304|FG000|Active Drug Period|Death|0|||
94223618|NCT04944784|322610305|FG001|Active Drug Period|Death|0|||
94223619|NCT04944784|322610306|FG002|Active Drug Period|Death|3|||
94223620|NCT04944784|322610307|FG003|Active Drug Period|Death|4|||
94223621|NCT04944784|322610304|FG000|Active Drug Period|Lack of Efficacy|0|||
94223622|NCT04944784|322610305|FG001|Active Drug Period|Lack of Efficacy|0|||
94223623|NCT04944784|322610306|FG002|Active Drug Period|Lack of Efficacy|2|||
94223624|NCT04944784|322610307|FG003|Active Drug Period|Lack of Efficacy|2|||
94223625|NCT04944784|322610304|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
94223626|NCT04944784|322610305|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
94223627|NCT04944784|322610306|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
94223628|NCT04944784|322610307|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
94223629|NCT04944784|322610304|FG000|Active Drug Period|Participant Choice|0|||
94223630|NCT04944784|322610305|FG001|Active Drug Period|Participant Choice|0|||
94223631|NCT04944784|322610306|FG002|Active Drug Period|Participant Choice|0|||
94223632|NCT04944784|322610307|FG003|Active Drug Period|Participant Choice|1|||
94223633|NCT04944784|322610304|FG000|Active Drug Period|Progressive Disease|0|||
94223634|NCT04944784|322610305|FG001|Active Drug Period|Progressive Disease|0|||
94223635|NCT04944784|322610306|FG002|Active Drug Period|Progressive Disease|4|||
94223636|NCT04944784|322610307|FG003|Active Drug Period|Progressive Disease|4|||
94223637|NCT04944784|322610304|FG000|Active Drug Period|Lost to Follow-up|0|||
94223638|NCT04944784|322610305|FG001|Active Drug Period|Lost to Follow-up|0|||
94223639|NCT04944784|322610306|FG002|Active Drug Period|Lost to Follow-up|0|||
94223640|NCT04944784|322610307|FG003|Active Drug Period|Lost to Follow-up|1|||
94223641|NCT02056873|322610312|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
94223642|NCT04853238|322610313|FG000|Overall Study|Death|4|||
94223643|NCT04853238|322610314|FG001|Overall Study|Death|0|||
94223644|NCT04853238|322610315|FG002|Overall Study|Death|2|||
94223645|NCT04853238|322610313|FG000|Overall Study|Lost to Follow-up|16|||
94223646|NCT04853238|322610314|FG001|Overall Study|Lost to Follow-up|2|||
94223647|NCT04853238|322610315|FG002|Overall Study|Lost to Follow-up|37|||
94223648|NCT04853238|322610313|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
94223649|NCT04853238|322610314|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
94223650|NCT04853238|322610315|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
94223651|NCT04853238|322610313|FG000|Overall Study|Withdrawal by Subject|6|||
94223652|NCT04853238|322610314|FG001|Overall Study|Withdrawal by Subject|0|||
94223653|NCT04853238|322610315|FG002|Overall Study|Withdrawal by Subject|21|||
94223654|NCT04853238|322610313|FG000|Overall Study|Physician Decision|0|||
94223655|NCT04853238|322610314|FG001|Overall Study|Physician Decision|0|||
94223656|NCT04853238|322610315|FG002|Overall Study|Physician Decision|2|||
94223657|NCT04853238|322610313|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
94223658|NCT04853238|322610314|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
94223659|NCT04853238|322610315|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
94223660|NCT02294461|322610316|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
94223661|NCT02294461|322610317|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
94656905|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
94656906|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
94656907|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
94223662|NCT02294461|322610316|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
94656908|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
94656909|NCT01884350|324199982|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
94656910|NCT01884350|324199983|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
94656911|NCT01884350|324199984|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
94656912|NCT00852397|324199985|FG000|Overall Study|Adverse Event|4|||
94656913|NCT00852397|324199986|FG001|Overall Study|Adverse Event|6|||
94656914|NCT00852397|324199987|FG002|Overall Study|Adverse Event|4|||
94656915|NCT00852397|324199985|FG000|Overall Study|Death|0|||
94656916|NCT00852397|324199986|FG001|Overall Study|Death|0|||
94656917|NCT00852397|324199987|FG002|Overall Study|Death|1|||
94656918|NCT00852397|324199985|FG000|Overall Study|Withdrawal by Subject|4|||
94656919|NCT00852397|324199986|FG001|Overall Study|Withdrawal by Subject|1|||
94439778|NCT04324073|323397827|FG002|Overall Study|withdrew consent|2|||
94223663|NCT02294461|322610317|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
94223664|NCT02294461|322610316|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
94223665|NCT02294461|322610317|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
94223666|NCT02294461|322610316|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
94223667|NCT02294461|322610317|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
94223668|NCT02294461|322610316|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
94223669|NCT02294461|322610317|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
94223670|NCT02294461|322610316|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
94223671|NCT02294461|322610317|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
94223672|NCT02294461|322610316|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
94223673|NCT02294461|322610317|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
94223674|NCT02294461|322610316|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
94223675|NCT02294461|322610317|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
94223676|NCT02294461|322610316|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
94223677|NCT02294461|322610317|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
94223678|NCT02294461|322610316|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
94223679|NCT02294461|322610317|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
94223680|NCT02294461|322610316|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
94223681|NCT02294461|322610317|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
94223682|NCT02294461|322610316|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
94223683|NCT02294461|322610317|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
94223684|NCT02294461|322610316|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
94223685|NCT02294461|322610317|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
94223686|NCT02294461|322610316|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
94223687|NCT02294461|322610317|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
94223688|NCT02294461|322610316|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
94223689|NCT02294461|322610317|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
94223690|NCT00676195|322611674|FG000|Overall Study|Lost to Follow-up|1|||
94223691|NCT00676195|322611674|FG000|Overall Study|Adverse Event|1|||
94223692|NCT00676195|322611674|FG000|Overall Study|Physician Decision|1|||
94223693|NCT02661490|322611675|FG000|Overall Study|Lost to Follow-up|0|||
94223694|NCT02661490|322611676|FG001|Overall Study|Lost to Follow-up|1|||
94223695|NCT02661490|322611677|FG002|Overall Study|Lost to Follow-up|0|||
94223696|NCT02661490|322611678|FG003|Overall Study|Lost to Follow-up|0|||
94223697|NCT02661490|322611679|FG004|Overall Study|Lost to Follow-up|2|||
94223698|NCT02661490|322611675|FG000|Overall Study|Withdrawal by Subject|2|||
94223699|NCT02661490|322611676|FG001|Overall Study|Withdrawal by Subject|0|||
94223700|NCT02661490|322611677|FG002|Overall Study|Withdrawal by Subject|2|||
94223701|NCT02661490|322611678|FG003|Overall Study|Withdrawal by Subject|0|||
94223702|NCT02661490|322611679|FG004|Overall Study|Withdrawal by Subject|0|||
94223703|NCT02661490|322611675|FG000|Overall Study|Death|1|||
94223704|NCT02661490|322611676|FG001|Overall Study|Death|1|||
94223705|NCT02661490|322611677|FG002|Overall Study|Death|0|||
94223706|NCT02661490|322611678|FG003|Overall Study|Death|1|||
94223707|NCT02661490|322611679|FG004|Overall Study|Death|0|||
94223708|NCT02661490|322611675|FG000|Overall Study|Reason not Specified|0|||
94223709|NCT02661490|322611676|FG001|Overall Study|Reason not Specified|0|||
94223710|NCT02661490|322611677|FG002|Overall Study|Reason not Specified|0|||
94223711|NCT02661490|322611678|FG003|Overall Study|Reason not Specified|0|||
94223712|NCT02661490|322611679|FG004|Overall Study|Reason not Specified|1|||
94223713|NCT02093897|322611680|FG000|Overall Study|Physician Decision|1|||
94223714|NCT02093897|322611680|FG000|Overall Study|Planned age group closure - no's reached|17|||
94223715|NCT02093897|322611680|FG000|Overall Study|Adverse event, non-fatal|1|||
94223716|NCT04044352|322611683|FG000|Overall Study|Lost to Follow-up|9|||
94223717|NCT04044352|322611683|FG000|Overall Study|Withdrawal by Subject|2|||
94223718|NCT00733226|322611691|FG000|Overall Study|Withdrawal by Subject|1|||
94223719|NCT00733226|322611692|FG001|Overall Study|Withdrawal by Subject|0|||
94223720|NCT00733226|322611691|FG000|Overall Study|Lost to Follow-up|2|||
94223721|NCT00733226|322611692|FG001|Overall Study|Lost to Follow-up|0|||
94223722|NCT00733226|322611691|FG000|Overall Study|moved to another place|2|||
94223723|NCT00733226|322611692|FG001|Overall Study|moved to another place|0|||
94223724|NCT05335005|322611694|FG000|Overall Study|Lost to Follow-up|1|||
94223725|NCT01145417|322611696|FG000|Overall Study|Death|1|||
94223726|NCT01145417|322611697|FG001|Overall Study|Death|0|||
94223727|NCT01145417|322611696|FG000|Overall Study|Lost to Follow-up|2|||
94223728|NCT01145417|322611697|FG001|Overall Study|Lost to Follow-up|1|||
94223729|NCT01145417|322611696|FG000|Overall Study|Withdrawal by Subject|1|||
94223730|NCT01145417|322611697|FG001|Overall Study|Withdrawal by Subject|2|||
94223731|NCT01145417|322611696|FG000|Overall Study|Pregnancy|1|||
94223732|NCT01145417|322611697|FG001|Overall Study|Pregnancy|0|||
94223733|NCT01145417|322611696|FG000|Overall Study|Adverse Event|0|||
94223734|NCT01145417|322611697|FG001|Overall Study|Adverse Event|1|||
94223735|NCT01145417|322611696|FG000|Overall Study|Study terminated by sponsor|35|||
94223736|NCT01145417|322611697|FG001|Overall Study|Study terminated by sponsor|43|||
94223737|NCT01145417|322611696|FG000|Overall Study|Other|1|||
94223738|NCT01145417|322611697|FG001|Overall Study|Other|0|||
94223739|NCT01812707|322611700|FG000|Overall Study|Adverse Event|0|||
94223740|NCT01812707|322611701|FG001|Overall Study|Adverse Event|0|||
94223741|NCT01812707|322611702|FG002|Overall Study|Adverse Event|0|||
94223742|NCT01812707|322611703|FG003|Overall Study|Adverse Event|2|||
94223743|NCT01812707|322611700|FG000|Overall Study|Poor compliance to protocol|1|||
94223744|NCT01812707|322611701|FG001|Overall Study|Poor compliance to protocol|0|||
94223745|NCT01812707|322611702|FG002|Overall Study|Poor compliance to protocol|0|||
94223746|NCT01812707|322611703|FG003|Overall Study|Poor compliance to protocol|0|||
94223747|NCT01812707|322611700|FG000|Overall Study|Consent withdrawn by participant|1|||
94223748|NCT01812707|322611701|FG001|Overall Study|Consent withdrawn by participant|0|||
94223749|NCT01812707|322611702|FG002|Overall Study|Consent withdrawn by participant|0|||
94223750|NCT01812707|322611703|FG003|Overall Study|Consent withdrawn by participant|0|||
94223751|NCT01572493|322611704|FG000|Overall Study|Physician Decision|1|||
94223752|NCT01572493|322611705|FG001|Overall Study|Physician Decision|0|||
94223753|NCT01572493|322611706|FG002|Overall Study|Physician Decision|0|||
94223754|NCT01572493|322611707|FG003|Overall Study|Physician Decision|0|||
94223755|NCT01572493|322611708|FG004|Overall Study|Physician Decision|0|||
94223756|NCT01572493|322611709|FG005|Overall Study|Physician Decision|0|||
94223757|NCT01572493|322611710|FG006|Overall Study|Physician Decision|0|||
94223758|NCT01572493|322611711|FG007|Overall Study|Physician Decision|0|||
94223759|NCT01572493|322611712|FG008|Overall Study|Physician Decision|0|||
94223760|NCT01572493|322611704|FG000|Overall Study|Switched to alternative treatment|0|||
94223761|NCT01572493|322611705|FG001|Overall Study|Switched to alternative treatment|1|||
94223762|NCT01572493|322611706|FG002|Overall Study|Switched to alternative treatment|2|||
94223763|NCT01572493|322611707|FG003|Overall Study|Switched to alternative treatment|1|||
94223764|NCT01572493|322611708|FG004|Overall Study|Switched to alternative treatment|2|||
94223765|NCT01572493|322611709|FG005|Overall Study|Switched to alternative treatment|0|||
94223766|NCT01572493|322611710|FG006|Overall Study|Switched to alternative treatment|2|||
94223767|NCT01572493|322611711|FG007|Overall Study|Switched to alternative treatment|0|||
94223768|NCT01572493|322611712|FG008|Overall Study|Switched to alternative treatment|2|||
94223769|NCT01572493|322611704|FG000|Overall Study|Death|0|||
94223770|NCT01572493|322611705|FG001|Overall Study|Death|0|||
94223771|NCT01572493|322611706|FG002|Overall Study|Death|0|||
94223772|NCT01572493|322611707|FG003|Overall Study|Death|1|||
94223773|NCT01572493|322611708|FG004|Overall Study|Death|0|||
94223774|NCT01572493|322611709|FG005|Overall Study|Death|1|||
94223775|NCT01572493|322611710|FG006|Overall Study|Death|0|||
94223776|NCT01572493|322611711|FG007|Overall Study|Death|0|||
94223777|NCT01572493|322611712|FG008|Overall Study|Death|0|||
94223778|NCT01572493|322611704|FG000|Overall Study|Adverse Event|0|||
94223779|NCT01572493|322611705|FG001|Overall Study|Adverse Event|0|||
94223780|NCT01572493|322611706|FG002|Overall Study|Adverse Event|0|||
94223781|NCT01572493|322611707|FG003|Overall Study|Adverse Event|0|||
94223782|NCT01572493|322611708|FG004|Overall Study|Adverse Event|0|||
94223783|NCT01572493|322611709|FG005|Overall Study|Adverse Event|0|||
94223784|NCT01572493|322611710|FG006|Overall Study|Adverse Event|1|||
94223785|NCT01572493|322611711|FG007|Overall Study|Adverse Event|0|||
94223786|NCT01572493|322611712|FG008|Overall Study|Adverse Event|0|||
94223787|NCT02889809|322611713|FG000|Overall Study|Withdrawal by Subject|30|||
94223788|NCT02889809|322611714|FG001|Overall Study|Withdrawal by Subject|21|||
94223789|NCT02889809|322611713|FG000|Overall Study|Lost to Follow-up|1|||
94223790|NCT02889809|322611714|FG001|Overall Study|Lost to Follow-up|1|||
94223791|NCT02889809|322611713|FG000|Overall Study|Site Closed|12|||
94223792|NCT02889809|322611714|FG001|Overall Study|Site Closed|11|||
94223793|NCT02186015|322611721|FG000|Overall Study|Physician Decision|1|||
94223794|NCT02186015|322611722|FG001|Overall Study|Physician Decision|0|||
94223795|NCT01193283|322611723|FG000|Overall Study|Death|1|||
94223796|NCT00168805|322611731|FG000|Overall Study|Adverse Event|7|||
94223797|NCT00168805|322611732|FG001|Overall Study|Adverse Event|11|||
94223798|NCT00168805|322611733|FG002|Overall Study|Adverse Event|16|||
94223799|NCT00168805|322611731|FG000|Overall Study|Protocol Violation|12|||
94223800|NCT00168805|322611732|FG001|Overall Study|Protocol Violation|11|||
94223801|NCT00168805|322611733|FG002|Overall Study|Protocol Violation|8|||
94223802|NCT00168805|322611731|FG000|Overall Study|Lost to Follow-up|12|||
94223803|NCT00168805|322611732|FG001|Overall Study|Lost to Follow-up|17|||
94223804|NCT00168805|322611733|FG002|Overall Study|Lost to Follow-up|11|||
94223805|NCT00168805|322611731|FG000|Overall Study|Withdrawal by Subject|16|||
94223806|NCT00168805|322611732|FG001|Overall Study|Withdrawal by Subject|18|||
94223807|NCT00168805|322611733|FG002|Overall Study|Withdrawal by Subject|21|||
94223808|NCT00168805|322611731|FG000|Overall Study|Other|24|||
94223809|NCT00168805|322611732|FG001|Overall Study|Other|21|||
94223810|NCT00168805|322611733|FG002|Overall Study|Other|22|||
94223811|NCT00168805|322611731|FG000|Treatment|Adverse Event|25|||
94223812|NCT00168805|322611732|FG001|Treatment|Adverse Event|26|||
94223813|NCT00168805|322611733|FG002|Treatment|Adverse Event|32|||
94223814|NCT00168805|322611731|FG000|Treatment|Protocol Violation|3|||
94223815|NCT00168805|322611732|FG001|Treatment|Protocol Violation|5|||
94223816|NCT00168805|322611733|FG002|Treatment|Protocol Violation|5|||
94223817|NCT00168805|322611731|FG000|Treatment|Withdrawal by Subject|3|||
94223818|NCT00168805|322611732|FG001|Treatment|Withdrawal by Subject|7|||
94223819|NCT00168805|322611733|FG002|Treatment|Withdrawal by Subject|8|||
94223820|NCT00168805|322611731|FG000|Treatment|Other|18|||
94223821|NCT00168805|322611732|FG001|Treatment|Other|18|||
94223822|NCT00168805|322611733|FG002|Treatment|Other|17|||
94223823|NCT01837719|322611734|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
94223824|NCT01837719|322611734|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
94223825|NCT02995733|322611735|FG000|Overall Study|Study site closed|9|||
94223826|NCT02995733|322611736|FG001|Overall Study|Study site closed|10|||
94223827|NCT02995733|322611735|FG000|Overall Study|Death|3|||
94223828|NCT02995733|322611736|FG001|Overall Study|Death|4|||
94223829|NCT02995733|322611735|FG000|Overall Study|Withdrawal by Subject|6|||
94223830|NCT02995733|322611736|FG001|Overall Study|Withdrawal by Subject|2|||
94223831|NCT02995733|322611735|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
94223832|NCT02995733|322611736|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
94223833|NCT02995733|322611735|FG000|Overall Study|Lost to Follow-up|48|||
94223834|NCT02995733|322611736|FG001|Overall Study|Lost to Follow-up|37|||
94223835|NCT02995733|322611735|FG000|Overall Study|Other|0|||
94223836|NCT02995733|322611736|FG001|Overall Study|Other|1|||
94223837|NCT02402465|322611737|FG000|Overall Study|Withdrawal by Subject|0|||
94223838|NCT02402465|322611738|FG001|Overall Study|Withdrawal by Subject|0|||
94223839|NCT02402465|322611739|FG002|Overall Study|Withdrawal by Subject|0|||
94223840|NCT02402465|322611740|FG003|Overall Study|Withdrawal by Subject|0|||
94223841|NCT02402465|322611741|FG004|Overall Study|Withdrawal by Subject|0|||
94223842|NCT02402465|322611742|FG005|Overall Study|Withdrawal by Subject|1|||
94223843|NCT02402465|322611737|FG000|Overall Study|Lost to Follow-up|0|||
94223844|NCT02402465|322611738|FG001|Overall Study|Lost to Follow-up|1|||
94223845|NCT02402465|322611739|FG002|Overall Study|Lost to Follow-up|0|||
94223846|NCT02402465|322611740|FG003|Overall Study|Lost to Follow-up|0|||
94223847|NCT02402465|322611741|FG004|Overall Study|Lost to Follow-up|1|||
94223848|NCT02402465|322611742|FG005|Overall Study|Lost to Follow-up|0|||
94223849|NCT01284634|322611743|FG000|Overall Study|Adverse Event|1|||
94223850|NCT01284634|322611744|FG001|Overall Study|Adverse Event|0|||
94223851|NCT01284634|322611745|FG002|Overall Study|Adverse Event|2|||
94223852|NCT01284634|322611746|FG003|Overall Study|Adverse Event|1|||
94223853|NCT02845375|322611747|FG000|Overall Study|upper airway obstruction|1|||
94223854|NCT02845375|322611748|FG001|Overall Study|upper airway obstruction|2|||
94223855|NCT02845375|322611749|FG002|Overall Study|upper airway obstruction|1|||
94223856|NCT01061775|322611752|FG000|Overall Study|Physician Decision|2|||
94223857|NCT01061775|322611752|FG000|Overall Study|Lost to Follow-up|1|||
94223858|NCT00730925|322611753|FG000|Overall Study|Progressive Disease|21|||
94223859|NCT00730925|322611753|FG000|Overall Study|Dose reducing Event|2|||
94223860|NCT00730925|322611753|FG000|Overall Study|Other Averse Event|7|||
94223861|NCT00730925|322611753|FG000|Overall Study|Protocol Violation|1|||
94223862|NCT00730925|322611753|FG000|Overall Study|Withdrawal by Subject|1|||
94223863|NCT00730925|322611753|FG000|Overall Study|Switch to combination therapy|8|||
94223864|NCT00730925|322611753|FG000|Overall Study|Other|1|||
94223865|NCT02131155|322611762|FG000|Overall Study|Adverse Event|1|||
94223866|NCT02131155|322611763|FG001|Overall Study|Adverse Event|0|||
94223867|NCT02131155|322611762|FG000|Overall Study|Treatment completed|1|||
94223868|NCT02131155|322611763|FG001|Overall Study|Treatment completed|0|||
94223869|NCT02131155|322611762|FG000|Overall Study|Primary tumour recurrence|2|||
94223870|NCT02131155|322611763|FG001|Overall Study|Primary tumour recurrence|1|||
94223871|NCT02131155|322611762|FG000|Overall Study|Refused to continue study medication|1|||
94223872|NCT02131155|322611763|FG001|Overall Study|Refused to continue study medication|0|||
94223873|NCT02131155|322611762|FG000|Overall Study|Study early termination|20|||
94223874|NCT02131155|322611763|FG001|Overall Study|Study early termination|10|||
94223875|NCT04543942|322611766|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
94223876|NCT04543942|322611767|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
94223877|NCT04543942|322611766|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
94223878|NCT04543942|322611767|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
94223879|NCT02515097|322611770|FG000|Overall Study|Lost to Follow-up|4|||
94223880|NCT02515097|322611771|FG001|Overall Study|Lost to Follow-up|2|||
94223881|NCT02515097|322611770|FG000|Overall Study|Withdrawal by Subject|1|||
94223882|NCT02515097|322611771|FG001|Overall Study|Withdrawal by Subject|3|||
94223883|NCT02515097|322611770|FG000|Overall Study|Adverse Event|2|||
94223884|NCT02515097|322611771|FG001|Overall Study|Adverse Event|1|||
94223885|NCT04783519|322611775|FG000|Overall Study|Withdrawal by Subject|2|||
94223886|NCT04783519|322611776|FG001|Overall Study|Withdrawal by Subject|7|||
94223887|NCT04783519|322611777|FG002|Overall Study|Withdrawal by Subject|3|||
94223888|NCT04783519|322611775|FG000|Overall Study|Lost to Follow-up|9|||
94223889|NCT04783519|322611776|FG001|Overall Study|Lost to Follow-up|7|||
94223890|NCT04783519|322611777|FG002|Overall Study|Lost to Follow-up|6|||
94223891|NCT05041439|322611778|FG000|Overall Study|Withdrawal by Subject|1|||
94223892|NCT05041439|322611779|FG001|Overall Study|Withdrawal by Subject|1|||
94223893|NCT05041439|322611778|FG000|Overall Study|Death|1|||
94223894|NCT05041439|322611779|FG001|Overall Study|Death|0|||
94223895|NCT00727259|322611780|FG000|Overall Study|Not all questionnaires completed|1055|||
94223896|NCT01021683|322611781|FG000|Overall Study|Lack of Efficacy|12|||
94223897|NCT01021683|322611781|FG000|Overall Study|Recovery of neutrophil count|51|||
94223898|NCT01021683|322611781|FG000|Overall Study|Other|8|||
94223899|NCT00509925|322611782|FG000|Overall Study|Personal reasons|0|||
94223900|NCT00509925|322611783|FG001|Overall Study|Personal reasons|1|||
94223901|NCT00645099|322611784|FG000|Overall Study|Lack of Efficacy|15|||
94223902|NCT00645099|322611785|FG001|Overall Study|Lack of Efficacy|6|||
94223903|NCT00645099|322611784|FG000|Overall Study|Withdrawal by Subject|30|||
94223904|NCT00645099|322611785|FG001|Overall Study|Withdrawal by Subject|22|||
94223905|NCT00645099|322611784|FG000|Overall Study|Lost to Follow-up|6|||
94223906|NCT00645099|322611785|FG001|Overall Study|Lost to Follow-up|4|||
94223907|NCT00645099|322611784|FG000|Overall Study|Adverse Event|11|||
94223908|NCT00645099|322611785|FG001|Overall Study|Adverse Event|5|||
94223909|NCT00645099|322611784|FG000|Overall Study|Other|9|||
94223910|NCT00645099|322611785|FG001|Overall Study|Other|5|||
94223911|NCT01201915|322611786|FG000|Overall Study|Adverse Event|2|||
94223912|NCT01201915|322611787|FG001|Overall Study|Adverse Event|1|||
94223913|NCT01201915|322611788|FG002|Overall Study|Adverse Event|1|||
94223914|NCT01201915|322611786|FG000|Overall Study|Lost to Follow-up|0|||
94223915|NCT01201915|322611787|FG001|Overall Study|Lost to Follow-up|4|||
94223916|NCT01201915|322611788|FG002|Overall Study|Lost to Follow-up|0|||
94223917|NCT01201915|322611786|FG000|Overall Study|Physician Decision|3|||
94223918|NCT01201915|322611787|FG001|Overall Study|Physician Decision|0|||
94223919|NCT01201915|322611788|FG002|Overall Study|Physician Decision|0|||
94223920|NCT01201915|322611786|FG000|Overall Study|Subject Decision|3|||
94223921|NCT01201915|322611787|FG001|Overall Study|Subject Decision|3|||
94223922|NCT01201915|322611788|FG002|Overall Study|Subject Decision|5|||
94223923|NCT01201915|322611786|FG000|Overall Study|Target Lesion Progression|0|||
94223924|NCT01201915|322611787|FG001|Overall Study|Target Lesion Progression|3|||
94223925|NCT01201915|322611788|FG002|Overall Study|Target Lesion Progression|0|||
94223926|NCT00705614|322613380|FG000|Initial Intervention|Adverse Event|40|||
94223927|NCT00705614|322613381|FG001|Initial Intervention|Adverse Event|21|||
94223928|NCT00705614|322613380|FG000|Initial Intervention|Lost to Follow-up|310|||
94223929|NCT00705614|322613381|FG001|Initial Intervention|Lost to Follow-up|191|||
94223930|NCT00705614|322613380|FG000|Initial Intervention|Withdrawal by Subject|114|||
94223931|NCT00705614|322613381|FG001|Initial Intervention|Withdrawal by Subject|71|||
94223932|NCT00705614|322613380|FG000|Initial Intervention|Administrative Reason|51|||
94223933|NCT00705614|322613381|FG001|Initial Intervention|Administrative Reason|38|||
94223934|NCT00705614|322613380|FG000|Initial Intervention|Status completion unknown|3|||
94223935|NCT00705614|322613381|FG001|Initial Intervention|Status completion unknown|0|||
94223936|NCT00705614|322613380|FG000|Switch to Remicade|Adverse Event|0|||
94223937|NCT00705614|322613381|FG001|Switch to Remicade|Adverse Event|5|||
94223938|NCT00705614|322613380|FG000|Switch to Remicade|Lost to Follow-up|0|||
94223939|NCT00705614|322613381|FG001|Switch to Remicade|Lost to Follow-up|23|||
94223940|NCT00705614|322613380|FG000|Switch to Remicade|Withdrawal by Subject|0|||
94223941|NCT00705614|322613381|FG001|Switch to Remicade|Withdrawal by Subject|12|||
94223942|NCT00705614|322613380|FG000|Switch to Remicade|Administrative Reason|0|||
94223943|NCT00705614|322613381|FG001|Switch to Remicade|Administrative Reason|9|||
94223944|NCT02859558|322613382|FG000|Step 1|Not Eligible|0|||
94223945|NCT02859558|322613383|FG001|Step 1|Not Eligible|0|||
94223946|NCT02859558|322613384|FG002|Step 1|Not Eligible|0|||
94223947|NCT02859558|322613385|FG003|Step 1|Not Eligible|0|||
94223948|NCT02859558|322613386|FG004|Step 1|Not Eligible|3|||
94223949|NCT02859558|322613382|FG000|Step 1|Lost to Follow-up|1|||
94223950|NCT02859558|322613383|FG001|Step 1|Lost to Follow-up|3|||
94223951|NCT02859558|322613384|FG002|Step 1|Lost to Follow-up|3|||
94223952|NCT02859558|322613385|FG003|Step 1|Lost to Follow-up|0|||
94223953|NCT02859558|322613386|FG004|Step 1|Lost to Follow-up|0|||
94223954|NCT02859558|322613382|FG000|Step 1|Did Not Return to Clinic|2|||
94223955|NCT02859558|322613383|FG001|Step 1|Did Not Return to Clinic|3|||
94223956|NCT02859558|322613384|FG002|Step 1|Did Not Return to Clinic|4|||
94223957|NCT02859558|322613385|FG003|Step 1|Did Not Return to Clinic|0|||
94223958|NCT02859558|322613386|FG004|Step 1|Did Not Return to Clinic|0|||
94223959|NCT02859558|322613382|FG000|Step 1|Moved|0|||
94223960|NCT02859558|322613383|FG001|Step 1|Moved|1|||
94223961|NCT02859558|322613384|FG002|Step 1|Moved|1|||
94223962|NCT02859558|322613385|FG003|Step 1|Moved|0|||
94223963|NCT02859558|322613386|FG004|Step 1|Moved|0|||
94223964|NCT02859558|322613382|FG000|Step 1|Withdrawal By Participant|1|||
94223965|NCT02859558|322613383|FG001|Step 1|Withdrawal By Participant|2|||
94223966|NCT02859558|322613384|FG002|Step 1|Withdrawal By Participant|1|||
94223967|NCT02859558|322613385|FG003|Step 1|Withdrawal By Participant|0|||
94223968|NCT02859558|322613386|FG004|Step 1|Withdrawal By Participant|0|||
94223969|NCT02859558|322613382|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
94223970|NCT02859558|322613383|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
94223971|NCT02859558|322613384|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
94223972|NCT02859558|322613385|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
94223973|NCT02859558|322613386|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
94223974|NCT02859558|322613382|FG000|Step 1|Incarceration|0|||
94223975|NCT02859558|322613383|FG001|Step 1|Incarceration|1|||
94223976|NCT02859558|322613384|FG002|Step 1|Incarceration|0|||
94223977|NCT02859558|322613385|FG003|Step 1|Incarceration|0|||
94223978|NCT02859558|322613386|FG004|Step 1|Incarceration|0|||
94223979|NCT02859558|322613382|FG000|Step 1|Non-Adherence to Study Drug|2|||
94223980|NCT02859558|322613383|FG001|Step 1|Non-Adherence to Study Drug|0|||
94223981|NCT02859558|322613384|FG002|Step 1|Non-Adherence to Study Drug|1|||
94223982|NCT02859558|322613385|FG003|Step 1|Non-Adherence to Study Drug|0|||
94223983|NCT02859558|322613386|FG004|Step 1|Non-Adherence to Study Drug|0|||
94223984|NCT02859558|322613382|FG000|Step 1|Non-Adherence to Study Requirements|3|||
94223985|NCT02859558|322613383|FG001|Step 1|Non-Adherence to Study Requirements|1|||
94223986|NCT02859558|322613384|FG002|Step 1|Non-Adherence to Study Requirements|0|||
94223987|NCT02859558|322613385|FG003|Step 1|Non-Adherence to Study Requirements|0|||
94223988|NCT02859558|322613386|FG004|Step 1|Non-Adherence to Study Requirements|0|||
94223989|NCT02859558|322613382|FG000|Step 1|Virologic Failure|2|||
94223990|NCT02859558|322613383|FG001|Step 1|Virologic Failure|1|||
94223991|NCT02859558|322613384|FG002|Step 1|Virologic Failure|1|||
94223992|NCT02859558|322613385|FG003|Step 1|Virologic Failure|0|||
94223993|NCT02859558|322613386|FG004|Step 1|Virologic Failure|0|||
94223994|NCT02859558|322613382|FG000|Step 2|Active On Study|23|||
94223995|NCT02859558|322613383|FG001|Step 2|Active On Study|38|||
94223996|NCT02859558|322613384|FG002|Step 2|Active On Study|20|||
94223997|NCT02859558|322613385|FG003|Step 2|Active On Study|0|||
94223998|NCT02859558|322613386|FG004|Step 2|Active On Study|0|||
94223999|NCT02859558|322613382|FG000|Step 2|Did Not Return to Clinic|2|||
94224000|NCT02859558|322613383|FG001|Step 2|Did Not Return to Clinic|0|||
94224001|NCT02859558|322613384|FG002|Step 2|Did Not Return to Clinic|0|||
94224002|NCT02859558|322613385|FG003|Step 2|Did Not Return to Clinic|0|||
94224003|NCT02859558|322613386|FG004|Step 2|Did Not Return to Clinic|0|||
94224004|NCT02859558|322613382|FG000|Step 2|Unexpected Closure of Site|0|||
94224005|NCT02859558|322613383|FG001|Step 2|Unexpected Closure of Site|1|||
94224006|NCT02859558|322613384|FG002|Step 2|Unexpected Closure of Site|1|||
94224007|NCT02859558|322613385|FG003|Step 2|Unexpected Closure of Site|0|||
94224008|NCT02859558|322613386|FG004|Step 2|Unexpected Closure of Site|0|||
94224009|NCT00925288|322613389|FG000|Overall Study|Lost to Follow-up|9|||
94224010|NCT00925288|322613390|FG001|Overall Study|Lost to Follow-up|7|||
94224011|NCT00088452|322613391|FG000|Overall Study|Did not receive intervention|1|||
94224012|NCT00088452|322613392|FG001|Overall Study|Did not receive intervention|0|||
94224013|NCT00088452|322613393|FG002|Overall Study|Did not receive intervention|1|||
94224014|NCT01232569|322613395|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
94224015|NCT01232569|322613396|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
94224016|NCT01232569|322613397|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
94224017|NCT01232569|322613398|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
94224018|NCT01232569|322613395|FG000|Double-blind Treatment Period|Escape|2|||
94224019|NCT01232569|322613396|FG001|Double-blind Treatment Period|Escape|2|||
94224020|NCT01232569|322613397|FG002|Double-blind Treatment Period|Escape|0|||
94224021|NCT01232569|322613398|FG003|Double-blind Treatment Period|Escape|0|||
94224022|NCT01232569|322613395|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
94224023|NCT01232569|322613396|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
94224024|NCT01232569|322613397|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
94224025|NCT01232569|322613398|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
94224026|NCT01232569|322613395|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
94224027|NCT01232569|322613396|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
94224028|NCT01232569|322613397|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
94224029|NCT01232569|322613398|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
94224030|NCT01232569|322613395|FG000|Double-blind Treatment Period|Physician Decision|1|||
94224031|NCT01232569|322613396|FG001|Double-blind Treatment Period|Physician Decision|0|||
94224032|NCT01232569|322613397|FG002|Double-blind Treatment Period|Physician Decision|0|||
94224033|NCT01232569|322613398|FG003|Double-blind Treatment Period|Physician Decision|0|||
94224034|NCT01232569|322613395|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
94224035|NCT01232569|322613396|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
94224036|NCT01232569|322613397|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
94224037|NCT01232569|322613398|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
94224038|NCT01232569|322613395|FG000|Double-blind Treatment Period|Death|2|||
94224039|NCT01232569|322613396|FG001|Double-blind Treatment Period|Death|0|||
94224040|NCT01232569|322613397|FG002|Double-blind Treatment Period|Death|0|||
94224041|NCT01232569|322613398|FG003|Double-blind Treatment Period|Death|0|||
94224042|NCT00814632|322613399|FG000|Overall Study|Lack of Efficacy|2|||
94224043|NCT00506922|322613406|FG000|Overall Study|Physician Decision|0|||
94224044|NCT00506922|322613407|FG001|Overall Study|Physician Decision|0|||
94224045|NCT00506922|322613408|FG002|Overall Study|Physician Decision|0|||
94224046|NCT00506922|322613409|FG003|Overall Study|Physician Decision|2|||
94224047|NCT00506922|322613410|FG004|Overall Study|Physician Decision|0|||
94224048|NCT00506922|322613406|FG000|Overall Study|Withdrawal by Subject|0|||
94224049|NCT00506922|322613407|FG001|Overall Study|Withdrawal by Subject|0|||
94224050|NCT00506922|322613408|FG002|Overall Study|Withdrawal by Subject|0|||
94224051|NCT00506922|322613409|FG003|Overall Study|Withdrawal by Subject|0|||
94224052|NCT00506922|322613410|FG004|Overall Study|Withdrawal by Subject|1|||
94224053|NCT03721978|322613411|FG000|Overall Study|Withdrawal by Subject|6|||
94224054|NCT03721978|322613412|FG001|Overall Study|Withdrawal by Subject|1|||
94224055|NCT03721978|322613411|FG000|Overall Study|Adverse Event|1|||
94224056|NCT03721978|322613412|FG001|Overall Study|Adverse Event|1|||
94224057|NCT03721978|322613411|FG000|Overall Study|Progressive Disease|1|||
94224058|NCT03721978|322613412|FG001|Overall Study|Progressive Disease|0|||
94224059|NCT03721978|322613411|FG000|Overall Study|Lost to Follow-up|5|||
94224060|NCT03721978|322613412|FG001|Overall Study|Lost to Follow-up|1|||
94224061|NCT03721978|322613411|FG000|Overall Study|Reason not Specified|0|||
94224062|NCT03721978|322613412|FG001|Overall Study|Reason not Specified|2|||
94224063|NCT05244226|322613413|FG000|Overall Study|Adverse Event|1|||
94224064|NCT05244226|322613414|FG001|Overall Study|Adverse Event|0|||
94224065|NCT05244226|322613415|FG002|Overall Study|Adverse Event|0|||
94224066|NCT05244226|322613413|FG000|Overall Study|Lost to Follow-up|0|||
94224067|NCT05244226|322613414|FG001|Overall Study|Lost to Follow-up|0|||
94224068|NCT05244226|322613415|FG002|Overall Study|Lost to Follow-up|1|||
94224069|NCT05244226|322613413|FG000|Overall Study|Protocol Violation|0|||
94224070|NCT05244226|322613414|FG001|Overall Study|Protocol Violation|2|||
94224071|NCT05244226|322613415|FG002|Overall Study|Protocol Violation|2|||
94224072|NCT04816708|322613418|FG000|Overall Study|Lost to Follow-up|10|||
94224073|NCT04816708|322613419|FG001|Overall Study|Lost to Follow-up|4|||
94224074|NCT01066897|322613427|FG000|Overall Study|Withdrawal by Subject|1|||
94224075|NCT01066897|322613428|FG001|Overall Study|Withdrawal by Subject|0|||
94224076|NCT01066897|322613427|FG000|Overall Study|stopped study after developing the flu.|1|||
94224077|NCT01066897|322613428|FG001|Overall Study|stopped study after developing the flu.|0|||
94224078|NCT05109117|322613429|FG000|Overall Study|Lost to Follow-up|1|||
94224079|NCT05109117|322613429|FG000|Overall Study|Discontinued for non-compliance|1|||
94224080|NCT03972137|322613430|FG000|Overall Study|Lost to Follow-up|2|||
94224081|NCT03972137|322613430|FG000|Overall Study|Withdrawal by Subject|4|||
94224082|NCT03029234|322613431|FG000|Overall Study|Sponsor Decision|1|||
94224083|NCT03029234|322613431|FG000|Overall Study|Withdrawal by Subject|5|||
94224084|NCT03029234|322613431|FG000|Overall Study|Death|91|||
94224085|NCT03029234|322613431|FG000|Overall Study|Lost to Follow-up|2|||
94224086|NCT02581189|322613432|FG000|Overall Study|Failure to return|36|||
94224087|NCT02581189|322613432|FG000|Overall Study|Withdrew consent|5|||
94224088|NCT02581189|322613432|FG000|Overall Study|Death|3|||
94224089|NCT02581189|322613432|FG000|Overall Study|Insufficient virological response|2|||
94224090|NCT02581189|322613432|FG000|Overall Study|Other, not specified|7|||
94224091|NCT03193216|322613433|FG000|Overall Study|Lost to Follow-up|1|||
94224092|NCT03193216|322613434|FG001|Overall Study|Lost to Follow-up|0|||
94224093|NCT03193216|322613433|FG000|Overall Study|Withdrawal by Subject|5|||
94224094|NCT03193216|322613434|FG001|Overall Study|Withdrawal by Subject|0|||
94224095|NCT03193216|322613433|FG000|Overall Study|Physician Decision|4|||
94224096|NCT03193216|322613434|FG001|Overall Study|Physician Decision|0|||
94224097|NCT00922441|322613436|FG000|Overall Study|Protocol Violation|0|||
94224098|NCT00922441|322613437|FG001|Overall Study|Protocol Violation|0|||
94224099|NCT00922441|322613438|FG002|Overall Study|Protocol Violation|2|||
94331405|NCT02980692|322994203|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
94224100|NCT00922441|322613436|FG000|Overall Study|Withdrawal by Subject|0|||
94224101|NCT00922441|322613437|FG001|Overall Study|Withdrawal by Subject|0|||
94224102|NCT00922441|322613438|FG002|Overall Study|Withdrawal by Subject|1|||
94224103|NCT00396097|322613439|FG000|Overall Study|Withdrawal by Subject|17|||
94224104|NCT00396097|322613440|FG001|Overall Study|Withdrawal by Subject|17|||
94224105|NCT00396097|322613439|FG000|Overall Study|Lost to Follow-up|4|||
94224106|NCT00396097|322613440|FG001|Overall Study|Lost to Follow-up|9|||
94224107|NCT00396097|322613439|FG000|Overall Study|Other|3|||
94224108|NCT00396097|322613440|FG001|Overall Study|Other|5|||
94224109|NCT00396097|322613439|FG000|Overall Study|Protocol Violation|0|||
94224110|NCT00396097|322613440|FG001|Overall Study|Protocol Violation|6|||
94224111|NCT00396097|322613439|FG000|Overall Study|Adverse Event|1|||
94224112|NCT00396097|322613440|FG001|Overall Study|Adverse Event|5|||
94224113|NCT00396097|322613439|FG000|Overall Study|Insufficient Clinical Response|1|||
94224114|NCT00396097|322613440|FG001|Overall Study|Insufficient Clinical Response|4|||
94224115|NCT02236598|322613453|FG000|Overall Study|Adverse Event|0|||
94224116|NCT02236598|322613454|FG001|Overall Study|Adverse Event|1|||
94224117|NCT02236598|322613453|FG000|Overall Study|Withdrawal by Subject|0|||
94224118|NCT02236598|322613454|FG001|Overall Study|Withdrawal by Subject|1|||
94224119|NCT05012397|322613457|FG000|Overall Study|Death|10|||
94224120|NCT05012397|322613457|FG000|Overall Study|Physician Decision|9|||
94224121|NCT05012397|322613457|FG000|Overall Study|Withdrawal by Subject|5|||
94224122|NCT05012397|322613457|FG000|Overall Study|Lost to Follow-up|2|||
94224123|NCT03334747|322613458|FG000|Treatment Phase|Technical problems|0|||
94224124|NCT03334747|322613459|FG001|Treatment Phase|Technical problems|0|||
94224125|NCT03334747|322613460|FG002|Treatment Phase|Technical problems|0|||
94224126|NCT03334747|322613461|FG003|Treatment Phase|Technical problems|0|||
94224127|NCT03334747|322613462|FG004|Treatment Phase|Technical problems|1|||
94224128|NCT03334747|322613463|FG005|Treatment Phase|Technical problems|0|||
94224129|NCT03334747|322613464|FG006|Treatment Phase|Technical problems|0|||
94224130|NCT03334747|322613465|FG007|Treatment Phase|Technical problems|0|||
94224131|NCT03334747|322613466|FG008|Treatment Phase|Technical problems|0|||
94224132|NCT03334747|322613458|FG000|Treatment Phase|Subject/guardian decision|1|||
94224133|NCT03334747|322613459|FG001|Treatment Phase|Subject/guardian decision|0|||
94224134|NCT03334747|322613460|FG002|Treatment Phase|Subject/guardian decision|0|||
94224135|NCT03334747|322613461|FG003|Treatment Phase|Subject/guardian decision|0|||
94224136|NCT03334747|322613462|FG004|Treatment Phase|Subject/guardian decision|0|||
94224137|NCT03334747|322613463|FG005|Treatment Phase|Subject/guardian decision|1|||
94224138|NCT03334747|322613464|FG006|Treatment Phase|Subject/guardian decision|0|||
94224139|NCT03334747|322613465|FG007|Treatment Phase|Subject/guardian decision|0|||
94224140|NCT03334747|322613466|FG008|Treatment Phase|Subject/guardian decision|0|||
94224141|NCT03334747|322613458|FG000|Follow-Up Phase|Subject/guardian decision|0|||
94224142|NCT03334747|322613459|FG001|Follow-Up Phase|Subject/guardian decision|0|||
94224143|NCT03334747|322613460|FG002|Follow-Up Phase|Subject/guardian decision|0|||
94224144|NCT03334747|322613461|FG003|Follow-Up Phase|Subject/guardian decision|0|||
94224145|NCT03334747|322613462|FG004|Follow-Up Phase|Subject/guardian decision|0|||
94224146|NCT03334747|322613463|FG005|Follow-Up Phase|Subject/guardian decision|0|||
94224147|NCT03334747|322613464|FG006|Follow-Up Phase|Subject/guardian decision|1|||
94224148|NCT03334747|322613465|FG007|Follow-Up Phase|Subject/guardian decision|0|||
94224149|NCT03334747|322613466|FG008|Follow-Up Phase|Subject/guardian decision|1|||
94224150|NCT00191984|322613467|FG000|Overall Study|Disease Progression|21|||
94224151|NCT00191984|322613467|FG000|Overall Study|Adverse Event|4|||
94224152|NCT00191984|322613467|FG000|Overall Study|Death|2|||
94224153|NCT00191984|322613467|FG000|Overall Study|Entry Criteria Exclusion|1|||
94224154|NCT00191984|322613467|FG000|Overall Study|Withdrawal by Subject|7|||
94224155|NCT00191984|322613467|FG000|Overall Study|Physician Decision|4|||
94224156|NCT03303521|322613468|FG000|Overall Study|Withdrawal by Subject|2|||
94224157|NCT03303521|322613469|FG001|Overall Study|Withdrawal by Subject|0|||
94224158|NCT03303521|322613468|FG000|Overall Study|Death|1|||
94224159|NCT03303521|322613469|FG001|Overall Study|Death|0|||
94224160|NCT03303521|322613468|FG000|Overall Study|Kidney transplantation|0|||
94224161|NCT03303521|322613469|FG001|Overall Study|Kidney transplantation|1|||
94224162|NCT03303521|322613468|FG000|Overall Study|Investigational product discontinuation|0|||
94224163|NCT03303521|322613469|FG001|Overall Study|Investigational product discontinuation|1|||
94224164|NCT03303521|322613468|FG000|Overall Study|Transferred to non-study dialysis center|1|||
94224165|NCT03303521|322613469|FG001|Overall Study|Transferred to non-study dialysis center|0|||
94224166|NCT03303521|322613468|FG000|Overall Study|Non-comliance to study protocol|0|||
94224167|NCT03303521|322613469|FG001|Overall Study|Non-comliance to study protocol|1|||
94224168|NCT03303521|322613468|FG000|Overall Study|Adverse Event|1|||
94224169|NCT03303521|322613469|FG001|Overall Study|Adverse Event|0|||
94224170|NCT04194541|322613470|FG000|Day 1 Through 13|Lost to Follow-up|3|||
94224171|NCT04194541|322613470|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
94224172|NCT04194541|322613470|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
94224173|NCT01485991|322613473|FG000|Overall Study|Adverse Event|0|||
94224174|NCT01485991|322613474|FG001|Overall Study|Adverse Event|4|||
94224175|NCT01485991|322613473|FG000|Overall Study|Lost to Follow-up|13|||
94224176|NCT01485991|322613474|FG001|Overall Study|Lost to Follow-up|10|||
94224177|NCT01485991|322613473|FG000|Overall Study|Withdrawal by Subject|13|||
94224178|NCT01485991|322613474|FG001|Overall Study|Withdrawal by Subject|20|||
94224179|NCT01485991|322613473|FG000|Overall Study|randomized but not treated|6|||
94224180|NCT01485991|322613474|FG001|Overall Study|randomized but not treated|2|||
94224181|NCT01475370|322613475|FG000|Overall Study|Exacerbation of primary disease|2|||
94224182|NCT01475370|322613476|FG001|Overall Study|Exacerbation of primary disease|2|||
94224183|NCT01475370|322613477|FG002|Overall Study|Exacerbation of primary disease|2|||
94224184|NCT01475370|322613475|FG000|Overall Study|Study drug administration difficult|0|||
94224185|NCT01475370|322613476|FG001|Overall Study|Study drug administration difficult|1|||
94224186|NCT01475370|322613477|FG002|Overall Study|Study drug administration difficult|1|||
94224187|NCT01475370|322613475|FG000|Overall Study|Other than specified|1|||
94224188|NCT01475370|322613476|FG001|Overall Study|Other than specified|0|||
94224189|NCT01475370|322613477|FG002|Overall Study|Other than specified|0|||
94224190|NCT02538471|322613478|FG000|Overall Study|Progression of disease|2|||
94224191|NCT01887418|322613479|FG000|Overall Study|Travelling difficulties|0|||
94224192|NCT01887418|322613480|FG001|Overall Study|Travelling difficulties|0|||
94224193|NCT01887418|322613481|FG002|Overall Study|Travelling difficulties|1|||
94224194|NCT03132753|322613482|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
94224195|NCT03132753|322613483|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
94224196|NCT03132753|322613482|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
94224197|NCT03132753|322613483|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
94224198|NCT04688086|322613489|FG000|Overall Study|Lost to Follow-up|164|||
94224199|NCT04688086|322613489|FG000|Overall Study|Imaging error;|64|||
94224200|NCT03120949|322613490|FG000|Overall Study|randomized in error|1|||
94224201|NCT03120949|322613491|FG001|Overall Study|randomized in error|0|||
94224202|NCT03120949|322613490|FG000|Overall Study|Death|13|||
94224203|NCT03120949|322613491|FG001|Overall Study|Death|13|||
94224204|NCT03120949|322613490|FG000|Overall Study|Lost to Follow-up|23|||
94224205|NCT03120949|322613491|FG001|Overall Study|Lost to Follow-up|13|||
94224206|NCT03120949|322613490|FG000|Overall Study|Withdrawal by Subject|139|||
94224207|NCT03120949|322613491|FG001|Overall Study|Withdrawal by Subject|124|||
94224208|NCT03120949|322613490|FG000|Overall Study|Covid-19|43|||
94224209|NCT03120949|322613491|FG001|Overall Study|Covid-19|34|||
94224210|NCT03120949|322613490|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
94224211|NCT03120949|322613491|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
94224212|NCT03120949|322613490|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
94224213|NCT03120949|322613491|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
94224214|NCT03120949|322613490|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
94224215|NCT03120949|322613491|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
94224216|NCT03120949|322613490|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
94224217|NCT03120949|322613491|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
94224218|NCT03120949|322613490|FG000|Overall Study|Site was closed|2|||
94224219|NCT03120949|322613491|FG001|Overall Study|Site was closed|3|||
94224220|NCT03120949|322613490|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
94224221|NCT03120949|322613491|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
94224222|NCT03120949|322613490|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
94224223|NCT03120949|322613491|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
94224224|NCT03120949|322613490|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
94224225|NCT03120949|322613491|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
94224226|NCT03120949|322613490|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
94224227|NCT03120949|322613491|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
94224228|NCT03120949|322613490|FG000|Overall Study|Other: Adverse Event|0|||
94224229|NCT03120949|322613491|FG001|Overall Study|Other: Adverse Event|1|||
94224230|NCT03120949|322613490|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
94224231|NCT03120949|322613491|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
94224232|NCT03120949|322613490|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
94224233|NCT03120949|322613491|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
94224234|NCT03120949|322613490|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
94224235|NCT03120949|322613491|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
94224236|NCT03120949|322613490|FG000|Overall Study|Personal Reasons|0|||
94224237|NCT03120949|322613491|FG001|Overall Study|Personal Reasons|1|||
94224238|NCT03120949|322613490|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
94331406|NCT02980692|322994204|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
94224239|NCT03120949|322613491|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
94224240|NCT03120949|322613490|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
94224241|NCT03120949|322613491|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
94224242|NCT03120949|322613490|FG000|Overall Study|Compliance With Medication|0|||
94224243|NCT03120949|322613491|FG001|Overall Study|Compliance With Medication|1|||
94224244|NCT03120949|322613490|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
94224245|NCT03120949|322613491|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
94224246|NCT03120949|322613490|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
94224247|NCT03120949|322613491|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
94224248|NCT03120949|322613490|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
94224249|NCT03120949|322613491|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
94224250|NCT03915951|322613498|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
94224251|NCT03915951|322613499|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
94224252|NCT03915951|322613498|FG000|Overall Study|Adverse Event|12|||
94224253|NCT03915951|322613499|FG001|Overall Study|Adverse Event|6|||
94224254|NCT03915951|322613498|FG000|Overall Study|Disease progression (radiological)|17|||
94224255|NCT03915951|322613499|FG001|Overall Study|Disease progression (radiological)|15|||
94224256|NCT03915951|322613498|FG000|Overall Study|Disease progression (clinical)|4|||
94224257|NCT03915951|322613499|FG001|Overall Study|Disease progression (clinical)|1|||
94224258|NCT03915951|322613498|FG000|Overall Study|Patient decision|0|||
94224259|NCT03915951|322613499|FG001|Overall Study|Patient decision|4|||
94224260|NCT03915951|322613498|FG000|Overall Study|Investigator decision|0|||
94224261|NCT03915951|322613499|FG001|Overall Study|Investigator decision|1|||
94224262|NCT03915951|322613498|FG000|Overall Study|Consent withdrawn|1|||
94224263|NCT03915951|322613499|FG001|Overall Study|Consent withdrawn|1|||
94224264|NCT03915951|322613498|FG000|Overall Study|Death|0|||
94224265|NCT03915951|322613499|FG001|Overall Study|Death|3|||
94224266|NCT03340766|322613502|FG000|Overall Study|Withdrawal by Subject|2|||
94224267|NCT03340766|322613503|FG001|Overall Study|Withdrawal by Subject|1|||
94224268|NCT03340766|322613504|FG002|Overall Study|Withdrawal by Subject|3|||
94224269|NCT03340766|322613502|FG000|Overall Study|Lost to Follow-up|0|||
94224270|NCT03340766|322613503|FG001|Overall Study|Lost to Follow-up|0|||
94224271|NCT03340766|322613504|FG002|Overall Study|Lost to Follow-up|1|||
94224272|NCT03340766|322613502|FG000|Overall Study|Death|6|||
94224273|NCT03340766|322613503|FG001|Overall Study|Death|7|||
94224274|NCT03340766|322613504|FG002|Overall Study|Death|4|||
94224275|NCT01876823|322613505|FG000|Overall Study|Withdrawal by Subject|5|||
94224276|NCT01876823|322613505|FG000|Overall Study|Physician Decision|2|||
94224277|NCT01876823|322613505|FG000|Overall Study|Patients moved|2|||
94224278|NCT02864147|322613508|FG000|Overall Study|Withdrawal by Subject|3|||
94224279|NCT02864147|322613509|FG001|Overall Study|Withdrawal by Subject|2|||
94224280|NCT02864147|322613510|FG002|Overall Study|Withdrawal by Subject|1|||
94224281|NCT02864147|322613508|FG000|Overall Study|Lost to Follow-up|0|||
94224282|NCT02864147|322613509|FG001|Overall Study|Lost to Follow-up|4|||
94224283|NCT02864147|322613510|FG002|Overall Study|Lost to Follow-up|0|||
94224284|NCT02864147|322613508|FG000|Overall Study|Adverse Event|0|||
94224285|NCT02864147|322613509|FG001|Overall Study|Adverse Event|1|||
94224286|NCT02864147|322613510|FG002|Overall Study|Adverse Event|0|||
94224287|NCT02864147|322613508|FG000|Overall Study|Pregnancy|4|||
94224288|NCT02864147|322613509|FG001|Overall Study|Pregnancy|0|||
94224289|NCT02864147|322613510|FG002|Overall Study|Pregnancy|0|||
94224290|NCT02864147|322613508|FG000|Overall Study|Physician Decision|0|||
94224291|NCT02864147|322613509|FG001|Overall Study|Physician Decision|0|||
94224292|NCT02864147|322613510|FG002|Overall Study|Physician Decision|1|||
94224293|NCT02864147|322613508|FG000|Overall Study|Opted for excisional procedures|0|||
94224294|NCT02864147|322613509|FG001|Overall Study|Opted for excisional procedures|0|||
94224295|NCT02864147|322613510|FG002|Overall Study|Opted for excisional procedures|3|||
94224296|NCT01078584|322613511|FG000|Overall Study|Final Status Unknown|1073|||
94224297|NCT01078584|322613511|FG000|Overall Study|Lost to Follow-up|670|||
94224298|NCT01078584|322613511|FG000|Overall Study|Non-serious Adverse Event|577|||
94224299|NCT01078584|322613511|FG000|Overall Study|Withdrawal of Consent|244|||
94224300|NCT01078584|322613511|FG000|Overall Study|Physician Withdrew from Study|90|||
94224301|NCT01078584|322613511|FG000|Overall Study|Non-compliance|67|||
94224302|NCT01078584|322613511|FG000|Overall Study|Blood Pressure Controlled|49|||
94224303|NCT01078584|322613511|FG000|Overall Study|Physician Switched Medication|26|||
94224304|NCT01078584|322613511|FG000|Overall Study|Physician Discontinued Patient|12|||
94224305|NCT01078584|322613511|FG000|Overall Study|Lack of Efficacy|98|||
94224306|NCT01078584|322613511|FG000|Overall Study|Protocol Violation|75|||
94224307|NCT01078584|322613511|FG000|Overall Study|Serious Adverse Event|27|||
94224308|NCT01078584|322613511|FG000|Overall Study|Multiple Reasons|2|||
94224309|NCT00655668|322613517|FG000|Overall Study|Adverse Event|6|||
94224310|NCT00655668|322613517|FG000|Overall Study|Death|5|||
94224311|NCT00655668|322613517|FG000|Overall Study|Disease Progression|27|||
94224312|NCT00655668|322613517|FG000|Overall Study|Study Terminated|9|||
94224313|NCT00655668|322613517|FG000|Overall Study|Other|1|||
94224314|NCT00655668|322613517|FG000|Overall Study|New Lymphoma Treatment Started|4|||
94224315|NCT00655668|322613517|FG000|Overall Study|Withdrawal by Subject|2|||
94224316|NCT02335242|322613518|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
94224317|NCT02335242|322613519|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
94224318|NCT02335242|322613518|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
94224319|NCT02335242|322613519|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
94224320|NCT02335242|322613518|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
94224321|NCT02335242|322613519|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
94224322|NCT04582864|322613520|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
94224323|NCT04582864|322613520|FG000|Overall Study|Death|1|||
94224324|NCT01332318|322613522|FG000|Overall Study|Adverse Event|0|||
94224325|NCT01332318|322613523|FG001|Overall Study|Adverse Event|3|||
94224326|NCT01332318|322613524|FG002|Overall Study|Adverse Event|0|||
94224327|NCT01332318|322613525|FG003|Overall Study|Adverse Event|0|||
94224328|NCT01332318|322613522|FG000|Overall Study|Withdrawal by Subject|1|||
94224329|NCT01332318|322613523|FG001|Overall Study|Withdrawal by Subject|1|||
94224330|NCT01332318|322613524|FG002|Overall Study|Withdrawal by Subject|0|||
94224331|NCT01332318|322613525|FG003|Overall Study|Withdrawal by Subject|1|||
94224332|NCT01332318|322613522|FG000|Overall Study|Protocol Violation|1|||
94224333|NCT01332318|322613523|FG001|Overall Study|Protocol Violation|0|||
94224334|NCT01332318|322613524|FG002|Overall Study|Protocol Violation|1|||
94224335|NCT01332318|322613525|FG003|Overall Study|Protocol Violation|1|||
94224336|NCT01780584|322613532|FG000|Overall Study|Death|1|||
94224337|NCT01780584|322613533|FG001|Overall Study|Death|0|||
94224338|NCT01780584|322613534|FG002|Overall Study|Death|1|||
94224339|NCT01780584|322613532|FG000|Overall Study|Adverse Event|0|||
94224340|NCT01780584|322613533|FG001|Overall Study|Adverse Event|1|||
94224341|NCT01780584|322613534|FG002|Overall Study|Adverse Event|0|||
94224342|NCT01780584|322613532|FG000|Overall Study|Protocol Violation|0|||
94224343|NCT01780584|322613533|FG001|Overall Study|Protocol Violation|0|||
94224344|NCT01780584|322613534|FG002|Overall Study|Protocol Violation|1|||
94224345|NCT04130061|322613539|FG000|Overall Study|OR team forgot to request membrane|1|||
94224346|NCT04130061|322613540|FG001|Overall Study|OR team forgot to request membrane|0|||
94224347|NCT02329223|322615044|FG000|Overall Study|Withdrawal by Subject|1|||
94224348|NCT02329223|322615045|FG001|Overall Study|Withdrawal by Subject|2|||
94224349|NCT02329223|322615046|FG002|Overall Study|Withdrawal by Subject|5|||
94224350|NCT02329223|322615044|FG000|Overall Study|Physician Decision|0|||
94224351|NCT02329223|322615045|FG001|Overall Study|Physician Decision|0|||
94224352|NCT02329223|322615046|FG002|Overall Study|Physician Decision|1|||
94224353|NCT02329223|322615044|FG000|Overall Study|Adverse Event|0|||
94224354|NCT02329223|322615045|FG001|Overall Study|Adverse Event|1|||
94224355|NCT02329223|322615046|FG002|Overall Study|Adverse Event|0|||
94224356|NCT00651937|322615047|FG000|Overall Study|Withdrawal by Subject|4|||
94224357|NCT00651937|322615048|FG001|Overall Study|Withdrawal by Subject|1|||
94224358|NCT04357964|322615049|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
94224359|NCT04357964|322615050|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
94224360|NCT04357964|322615049|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
94224361|NCT04357964|322615050|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
94224362|NCT04357964|322615049|FG000|Overall Study|Adipose sample was insufficient quality|0|||
94224363|NCT04357964|322615050|FG001|Overall Study|Adipose sample was insufficient quality|1|||
94224364|NCT01902381|322615051|FG000|Overall Study|Withdrawal by Subject|1|||
94224365|NCT02229396|322615054|FG000|Overall Study|Adverse Event|6|||
94224366|NCT02229396|322615055|FG001|Overall Study|Adverse Event|12|||
94224367|NCT02229396|322615056|FG002|Overall Study|Adverse Event|12|||
94224368|NCT02229396|322615054|FG000|Overall Study|Death|2|||
94224369|NCT02229396|322615055|FG001|Overall Study|Death|3|||
94224370|NCT02229396|322615056|FG002|Overall Study|Death|1|||
94224371|NCT02229396|322615054|FG000|Overall Study|Lost to Follow-up|14|||
94224372|NCT02229396|322615055|FG001|Overall Study|Lost to Follow-up|14|||
94224373|NCT02229396|322615056|FG002|Overall Study|Lost to Follow-up|21|||
94224374|NCT02229396|322615054|FG000|Overall Study|Protocol Violation|2|||
94224375|NCT02229396|322615055|FG001|Overall Study|Protocol Violation|1|||
94224376|NCT02229396|322615056|FG002|Overall Study|Protocol Violation|0|||
94224377|NCT02229396|322615054|FG000|Overall Study|Patient Incorrectly Randomized|0|||
94224378|NCT02229396|322615055|FG001|Overall Study|Patient Incorrectly Randomized|0|||
94224379|NCT02229396|322615056|FG002|Overall Study|Patient Incorrectly Randomized|1|||
94224380|NCT02229396|322615054|FG000|Overall Study|Other|10|||
94224381|NCT02229396|322615055|FG001|Overall Study|Other|18|||
94224382|NCT02229396|322615056|FG002|Overall Study|Other|15|||
94224383|NCT02229396|322615054|FG000|Overall Study|Withdrawal by Subject|42|||
94224384|NCT02229396|322615055|FG001|Overall Study|Withdrawal by Subject|28|||
94548411|NCT00162266|323803419|FG001|Open-Label Period|Other Reasons|0|||
94548412|NCT00162266|323803420|FG002|Open-Label Period|Other Reasons|0|||
94548413|NCT00162266|323803421|FG003|Open-Label Period|Other Reasons|15|||
94224385|NCT02229396|322615056|FG002|Overall Study|Withdrawal by Subject|41|||
94224386|NCT02229396|322615054|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
94224387|NCT02229396|322615055|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
94224388|NCT02229396|322615056|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
94224389|NCT02229396|322615054|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
94224390|NCT02229396|322615055|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
94224391|NCT02229396|322615056|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
94224392|NCT02396953|322615057|FG000|Overall Study|Withdrawal by Subject|0|||
94224393|NCT02396953|322615058|FG001|Overall Study|Withdrawal by Subject|0|||
94224394|NCT02396953|322615059|FG002|Overall Study|Withdrawal by Subject|1|||
94224395|NCT02396953|322615057|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
94224396|NCT02396953|322615058|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
94224397|NCT02396953|322615059|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
94224398|NCT02396953|322615057|FG000|Overall Study|Personal Reasons|1|||
94224399|NCT02396953|322615058|FG001|Overall Study|Personal Reasons|1|||
94224400|NCT02396953|322615059|FG002|Overall Study|Personal Reasons|0|||
94224401|NCT02679079|322615064|FG000|Overall Study|Adverse Event|2|||
94224402|NCT02679079|322615065|FG001|Overall Study|Adverse Event|0|||
94224403|NCT02679079|322615066|FG002|Overall Study|Adverse Event|2|||
94224404|NCT02679079|322615064|FG000|Overall Study|Protocol Violation|0|||
94224405|NCT02679079|322615065|FG001|Overall Study|Protocol Violation|1|||
94224406|NCT02679079|322615066|FG002|Overall Study|Protocol Violation|0|||
94224407|NCT02679079|322615064|FG000|Overall Study|Withdrawal by Subject|2|||
94224408|NCT02679079|322615065|FG001|Overall Study|Withdrawal by Subject|1|||
94224409|NCT02679079|322615066|FG002|Overall Study|Withdrawal by Subject|0|||
94224410|NCT02123797|322615069|FG000|Baseline Intervention|Death|9|||
94224411|NCT02123797|322615070|FG001|Baseline Intervention|Death|16|||
94224412|NCT02123797|322615071|FG002|Baseline Intervention|Death|0|||
94224413|NCT02123797|322615072|FG003|Baseline Intervention|Death|0|||
94224414|NCT02123797|322615073|FG004|Baseline Intervention|Death|0|||
94224415|NCT02123797|322615069|FG000|Baseline Intervention|Withdrawal by Subject|2|||
94224416|NCT02123797|322615070|FG001|Baseline Intervention|Withdrawal by Subject|8|||
94224417|NCT02123797|322615071|FG002|Baseline Intervention|Withdrawal by Subject|0|||
94224418|NCT02123797|322615072|FG003|Baseline Intervention|Withdrawal by Subject|0|||
94224419|NCT02123797|322615073|FG004|Baseline Intervention|Withdrawal by Subject|0|||
94224420|NCT02123797|322615069|FG000|Baseline Intervention|Relocation|2|||
94224421|NCT02123797|322615070|FG001|Baseline Intervention|Relocation|0|||
94224422|NCT02123797|322615071|FG002|Baseline Intervention|Relocation|0|||
94224423|NCT02123797|322615072|FG003|Baseline Intervention|Relocation|0|||
94224424|NCT02123797|322615073|FG004|Baseline Intervention|Relocation|0|||
94224425|NCT02123797|322615069|FG000|Baseline Intervention|Out of window for initial survey|6|||
94224426|NCT02123797|322615070|FG001|Baseline Intervention|Out of window for initial survey|13|||
94224427|NCT02123797|322615071|FG002|Baseline Intervention|Out of window for initial survey|0|||
94224428|NCT02123797|322615072|FG003|Baseline Intervention|Out of window for initial survey|0|||
94224429|NCT02123797|322615073|FG004|Baseline Intervention|Out of window for initial survey|0|||
94224430|NCT02123797|322615069|FG000|Baseline Intervention|Lost to Follow-up|0|||
94224431|NCT02123797|322615070|FG001|Baseline Intervention|Lost to Follow-up|5|||
94224432|NCT02123797|322615071|FG002|Baseline Intervention|Lost to Follow-up|0|||
94224433|NCT02123797|322615072|FG003|Baseline Intervention|Lost to Follow-up|0|||
94224434|NCT02123797|322615073|FG004|Baseline Intervention|Lost to Follow-up|0|||
94224435|NCT02123797|322615069|FG000|Baseline Intervention|Other Disease|3|||
94224436|NCT02123797|322615070|FG001|Baseline Intervention|Other Disease|0|||
94224437|NCT02123797|322615071|FG002|Baseline Intervention|Other Disease|0|||
94224438|NCT02123797|322615072|FG003|Baseline Intervention|Other Disease|0|||
94224439|NCT02123797|322615073|FG004|Baseline Intervention|Other Disease|0|||
94224440|NCT02123797|322615069|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
94224441|NCT02123797|322615070|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
94224442|NCT02123797|322615071|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
94224443|NCT02123797|322615072|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
94224444|NCT02123797|322615073|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
94224445|NCT02123797|322615069|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
94224446|NCT02123797|322615070|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
94224447|NCT02123797|322615071|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
94224448|NCT02123797|322615072|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
94224449|NCT02123797|322615073|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
94224450|NCT02123797|322615069|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
94224451|NCT02123797|322615070|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
94224452|NCT02123797|322615071|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
94224453|NCT02123797|322615072|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
94224454|NCT02123797|322615073|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
94224455|NCT02123797|322615069|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
94224456|NCT02123797|322615070|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
94224457|NCT02123797|322615071|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
94224458|NCT02123797|322615072|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
94224459|NCT02123797|322615073|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
94224460|NCT02123797|322615069|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
94224461|NCT02123797|322615070|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
94224462|NCT02123797|322615071|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
94224463|NCT02123797|322615072|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
94224464|NCT02123797|322615073|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
94331407|NCT02980692|322994205|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
94331408|NCT02980692|322994206|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
94331409|NCT02980692|322994202|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
94331410|NCT02980692|322994203|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
94331411|NCT02980692|322994204|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
94331412|NCT02980692|322994205|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
94331413|NCT02980692|322994206|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
94331414|NCT02980692|322994202|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
94331415|NCT02980692|322994203|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
94331416|NCT02980692|322994204|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
94331417|NCT02980692|322994205|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
94331418|NCT02980692|322994206|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
94331419|NCT02980692|322994202|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
94331420|NCT02980692|322994203|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
94331421|NCT02980692|322994204|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
94331422|NCT02980692|322994205|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
94331423|NCT02980692|322994206|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
94331424|NCT02980692|322994202|FG000|Double Blind Placebo Controlled Period|Other|1|||
94331425|NCT02980692|322994203|FG001|Double Blind Placebo Controlled Period|Other|0|||
94331426|NCT02980692|322994204|FG002|Double Blind Placebo Controlled Period|Other|0|||
94331427|NCT02980692|322994205|FG003|Double Blind Placebo Controlled Period|Other|0|||
94331428|NCT02980692|322994206|FG004|Double Blind Placebo Controlled Period|Other|1|||
94331429|NCT02980692|322994202|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
94331430|NCT02980692|322994203|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
94331431|NCT02980692|322994204|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
94331432|NCT02980692|322994205|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
94331433|NCT02980692|322994206|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
94331434|NCT02980692|322994202|FG000|Double-blind Follow-up Period|Adverse Event|0|||
94331435|NCT02980692|322994203|FG001|Double-blind Follow-up Period|Adverse Event|0|||
94331436|NCT02980692|322994204|FG002|Double-blind Follow-up Period|Adverse Event|0|||
94331437|NCT02980692|322994205|FG003|Double-blind Follow-up Period|Adverse Event|1|||
94331438|NCT02980692|322994206|FG004|Double-blind Follow-up Period|Adverse Event|1|||
94331439|NCT02980692|322994202|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
94331440|NCT02980692|322994203|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
94331441|NCT02980692|322994204|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
94331442|NCT02980692|322994205|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
94331443|NCT02980692|322994206|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
94331444|NCT02980692|322994202|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
94331445|NCT02980692|322994203|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
94331446|NCT02980692|322994204|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
94331447|NCT02980692|322994205|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
94331448|NCT02980692|322994206|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
94331449|NCT02980692|322994202|FG000|Double-blind Follow-up Period|Pregnancy|0|||
94331450|NCT02980692|322994203|FG001|Double-blind Follow-up Period|Pregnancy|0|||
94331451|NCT02980692|322994204|FG002|Double-blind Follow-up Period|Pregnancy|1|||
94331452|NCT02980692|322994205|FG003|Double-blind Follow-up Period|Pregnancy|1|||
94331453|NCT02980692|322994206|FG004|Double-blind Follow-up Period|Pregnancy|0|||
94331454|NCT02980692|322994202|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
94331455|NCT02980692|322994203|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
94331456|NCT02980692|322994204|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
94331457|NCT02980692|322994205|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
94331458|NCT02980692|322994206|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
94331459|NCT02980692|322994202|FG000|Double-blind Follow-up Period|Other|0|||
94331460|NCT02980692|322994203|FG001|Double-blind Follow-up Period|Other|0|||
94331461|NCT02980692|322994204|FG002|Double-blind Follow-up Period|Other|1|||
94331462|NCT02980692|322994205|FG003|Double-blind Follow-up Period|Other|1|||
94331463|NCT02980692|322994206|FG004|Double-blind Follow-up Period|Other|3|||
94331464|NCT00555568|322994208|FG000|Overall Study|Lost to Follow-up|26|||
94331465|NCT00555568|322994209|FG001|Overall Study|Lost to Follow-up|16|||
94331466|NCT00555568|322994210|FG002|Overall Study|Lost to Follow-up|16|||
94331467|NCT04702984|322994211|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
94331468|NCT03332303|322994214|FG000|Overall Study|Participant did not dose|1|||
94331469|NCT03332303|322994215|FG001|Overall Study|Participant did not dose|2|||
94331470|NCT03332303|322994216|FG002|Overall Study|Participant did not dose|0|||
94331471|NCT03332303|322994214|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
94331472|NCT03332303|322994215|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
94331473|NCT03332303|322994216|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
94331474|NCT03332303|322994214|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
94331475|NCT03332303|322994215|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
94331476|NCT03332303|322994216|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
94331477|NCT03332303|322994214|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
94331478|NCT03332303|322994215|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
94331479|NCT03332303|322994216|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
94331480|NCT03332303|322994214|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
94331481|NCT03332303|322994215|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
94331482|NCT03332303|322994216|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
94331483|NCT03332303|322994214|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
94331484|NCT03332303|322994215|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
94331485|NCT03332303|322994216|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
94331486|NCT03332303|322994214|FG000|Overall Study|Participant had a significant protocol deviation|0|||
94331487|NCT03332303|322994215|FG001|Overall Study|Participant had a significant protocol deviation|1|||
94331488|NCT03332303|322994216|FG002|Overall Study|Participant had a significant protocol deviation|0|||
94331489|NCT00729326|322994221|FG000|Overall Study|Lost to Follow-up|2|||
94331490|NCT00729326|322994222|FG001|Overall Study|Lost to Follow-up|0|||
94331491|NCT00729326|322994221|FG000|Overall Study|Physician Decision|0|||
94331492|NCT00729326|322994222|FG001|Overall Study|Physician Decision|1|||
94331493|NCT00729326|322994221|FG000|Overall Study|Protocol Violation|3|||
94331494|NCT00729326|322994222|FG001|Overall Study|Protocol Violation|2|||
94331495|NCT00729326|322994221|FG000|Overall Study|Subject Decision|4|||
94331496|NCT00729326|322994222|FG001|Overall Study|Subject Decision|4|||
94331497|NCT00729326|322994221|FG000|Overall Study|Sponsor Decision|1|||
94331498|NCT00729326|322994222|FG001|Overall Study|Sponsor Decision|2|||
94331499|NCT01235728|322994223|FG000|Overall Study|Protocol Violation|0|||
94331500|NCT01235728|322994224|FG001|Overall Study|Protocol Violation|0|||
94331501|NCT01235728|322994225|FG002|Overall Study|Protocol Violation|0|||
94331502|NCT01235728|322994226|FG003|Overall Study|Protocol Violation|1|||
94331503|NCT01235728|322994227|FG004|Overall Study|Protocol Violation|0|||
94331504|NCT01235728|322994228|FG005|Overall Study|Protocol Violation|0|||
94331505|NCT01235728|322994229|FG006|Overall Study|Protocol Violation|0|||
94331506|NCT01235728|322994230|FG007|Overall Study|Protocol Violation|0|||
94331507|NCT04169061|322994235|FG000|Overall Study|Adverse Event|2|||
94331508|NCT04169061|322994235|FG000|Overall Study|Death|1|||
94331509|NCT04169061|322994235|FG000|Overall Study|Withdrawal by Subject|1|||
94331510|NCT04169061|322994235|FG000|Overall Study|Protocol Violation|1|||
94331511|NCT05425719|322994236|FG000|Overall Study|Lost to Follow-up|4|||
94331512|NCT05425719|322994237|FG001|Overall Study|Lost to Follow-up|0|||
94331513|NCT05425719|322994236|FG000|Overall Study|Withdrew consent|1|||
94331514|NCT05425719|322994237|FG001|Overall Study|Withdrew consent|1|||
94331515|NCT01230749|322994240|FG000|Overall Study|Adverse Event|0|||
94331516|NCT01230749|322994241|FG001|Overall Study|Adverse Event|0|||
94331517|NCT01230749|322994242|FG002|Overall Study|Adverse Event|0|||
94331518|NCT01230749|322994243|FG003|Overall Study|Adverse Event|1|||
94331519|NCT01230749|322994240|FG000|Overall Study|Physician Decision|0|||
94331520|NCT01230749|322994241|FG001|Overall Study|Physician Decision|0|||
94331521|NCT01230749|322994242|FG002|Overall Study|Physician Decision|1|||
94331522|NCT01230749|322994243|FG003|Overall Study|Physician Decision|0|||
94331523|NCT01230749|322994240|FG000|Overall Study|Withdrawal by Subject|0|||
94331524|NCT01230749|322994241|FG001|Overall Study|Withdrawal by Subject|1|||
94331525|NCT01230749|322994242|FG002|Overall Study|Withdrawal by Subject|0|||
94331526|NCT01230749|322994243|FG003|Overall Study|Withdrawal by Subject|0|||
94331527|NCT01230749|322994240|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
94331528|NCT01230749|322994241|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
94331529|NCT01230749|322994242|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
94331530|NCT01230749|322994243|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
94331531|NCT02193828|322994246|FG000|Overall Study|Withdrawal by Subject|0|||
94331532|NCT02193828|322994247|FG001|Overall Study|Withdrawal by Subject|0|||
94331533|NCT02193828|322994248|FG002|Overall Study|Withdrawal by Subject|1|||
94331534|NCT02193828|322994249|FG003|Overall Study|Withdrawal by Subject|1|||
94331535|NCT01769469|322994250|FG000|Overall Study|Consent Withdrawn|5|||
94331536|NCT01769469|322994250|FG000|Overall Study|Moved Out Of Area|3|||
94331537|NCT01769469|322994250|FG000|Overall Study|Lost to Follow-up|17|||
94331538|NCT01769469|322994250|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
94331539|NCT01769469|322994250|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
94331540|NCT02394795|322994251|FG000|Overall Study|Adverse Event|92|||
94331541|NCT02394795|322994252|FG001|Overall Study|Adverse Event|70|||
94331542|NCT02394795|322994251|FG000|Overall Study|Lost to Follow-up|0|||
94331543|NCT02394795|322994252|FG001|Overall Study|Lost to Follow-up|1|||
94331544|NCT02394795|322994251|FG000|Overall Study|Withdrawal by Subject|17|||
94331545|NCT02394795|322994252|FG001|Overall Study|Withdrawal by Subject|26|||
94331546|NCT02394795|322994251|FG000|Overall Study|Lack of Efficacy|181|||
94331547|NCT02394795|322994252|FG001|Overall Study|Lack of Efficacy|211|||
94331548|NCT02394795|322994251|FG000|Overall Study|Death|4|||
94331549|NCT02394795|322994252|FG001|Overall Study|Death|5|||
94331550|NCT02394795|322994251|FG000|Overall Study|Physician Decision|109|||
94331551|NCT02394795|322994252|FG001|Overall Study|Physician Decision|93|||
94331552|NCT02849626|322994253|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
94331553|NCT02849626|322994254|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
94331554|NCT02849626|322994255|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
94331555|NCT02849626|322994256|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
94331556|NCT02849626|322994253|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
94331557|NCT02849626|322994254|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
94331558|NCT02849626|322994255|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
94331559|NCT02849626|322994256|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
94331560|NCT02849626|322994253|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
94331561|NCT02849626|322994254|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
94331562|NCT02849626|322994255|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
94331563|NCT02849626|322994256|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
94331564|NCT02849626|322994253|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
94331565|NCT02849626|322994254|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
94331566|NCT02849626|322994255|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
94331567|NCT02849626|322994256|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
94331568|NCT02849626|322994253|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
94331569|NCT02849626|322994254|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
94331570|NCT02849626|322994255|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
94331571|NCT02849626|322994256|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
94331572|NCT02849626|322994253|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
94331573|NCT02849626|322994254|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
94331574|NCT02849626|322994255|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
94331575|NCT02849626|322994256|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
94331576|NCT02849626|322994253|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
94331577|NCT02849626|322994254|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
94331578|NCT02849626|322994255|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
94331579|NCT02849626|322994256|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
94331580|NCT02849626|322994253|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
94331581|NCT02849626|322994254|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
94331582|NCT02849626|322994255|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
94331583|NCT02849626|322994256|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
94331584|NCT02849626|322994253|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
94331585|NCT02849626|322994254|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
94331586|NCT02849626|322994255|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
94331587|NCT02849626|322994256|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
94331588|NCT02849626|322994253|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
94331589|NCT02849626|322994254|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
94331590|NCT02849626|322994255|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
94331591|NCT02849626|322994256|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
94331592|NCT02849626|322994253|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
94331593|NCT02849626|322994254|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
94331594|NCT02849626|322994255|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
94331595|NCT02849626|322994256|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
94331596|NCT01185704|322994257|FG000|Overall Study|Randomized but not treated|3|||
94331597|NCT01185704|322994258|FG001|Overall Study|Randomized but not treated|3|||
94331598|NCT01185704|322994257|FG000|Overall Study|Lack of ovarian response|5|||
94331599|NCT01185704|322994258|FG001|Overall Study|Lack of ovarian response|1|||
94331600|NCT01185704|322994257|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
94331601|NCT01185704|322994258|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
94331602|NCT01185704|322994257|FG000|Overall Study|Ectopic pregnancy|0|||
94331603|NCT01185704|322994258|FG001|Overall Study|Ectopic pregnancy|1|||
94331604|NCT01654523|322994259|FG000|Overall Study|Withdrawal by Subject|1|||
94331605|NCT03954444|322994266|FG000|Overall Study|Withdrawal by Subject|5|||
94331606|NCT03954444|322994267|FG001|Overall Study|Withdrawal by Subject|5|||
94331607|NCT03954444|322994268|FG002|Overall Study|Withdrawal by Subject|5|||
94331608|NCT03954444|322994266|FG000|Overall Study|Adverse Event|1|||
94331609|NCT03954444|322994267|FG001|Overall Study|Adverse Event|3|||
94331610|NCT03954444|322994268|FG002|Overall Study|Adverse Event|2|||
94331611|NCT03954444|322994266|FG000|Overall Study|Protocol Violation|0|||
94331612|NCT03954444|322994267|FG001|Overall Study|Protocol Violation|3|||
94331613|NCT03954444|322994268|FG002|Overall Study|Protocol Violation|5|||
94331614|NCT03954444|322994266|FG000|Overall Study|Use of prohibited therapy|1|||
94331615|NCT03954444|322994267|FG001|Overall Study|Use of prohibited therapy|1|||
94331616|NCT03954444|322994268|FG002|Overall Study|Use of prohibited therapy|2|||
94331617|NCT03954444|322994266|FG000|Overall Study|Lost to Follow-up|1|||
94331618|NCT03954444|322994267|FG001|Overall Study|Lost to Follow-up|0|||
94331619|NCT03954444|322994268|FG002|Overall Study|Lost to Follow-up|1|||
94331620|NCT03954444|322994266|FG000|Overall Study|Non-compliant with study drug application|2|||
94331621|NCT03954444|322994267|FG001|Overall Study|Non-compliant with study drug application|2|||
94331622|NCT03954444|322994268|FG002|Overall Study|Non-compliant with study drug application|0|||
94331623|NCT03954444|322994266|FG000|Overall Study|Administrative reasons|0|||
94331624|NCT03954444|322994267|FG001|Overall Study|Administrative reasons|0|||
94331625|NCT03954444|322994268|FG002|Overall Study|Administrative reasons|1|||
94331626|NCT03954444|322994266|FG000|Overall Study|Miscellaneous|3|||
94331627|NCT03954444|322994267|FG001|Overall Study|Miscellaneous|2|||
94331628|NCT03954444|322994268|FG002|Overall Study|Miscellaneous|1|||
94331629|NCT02447458|322994269|FG000|Overall Study|Other|0|||
94331630|NCT02447458|322994270|FG001|Overall Study|Other|0|||
94331631|NCT02447458|322994271|FG002|Overall Study|Other|1|||
94331632|NCT02447458|322994272|FG003|Overall Study|Other|0|||
94331633|NCT02447458|322994273|FG004|Overall Study|Other|0|||
94331634|NCT02447458|322994274|FG005|Overall Study|Other|0|||
94331635|NCT00435994|322994278|FG000|Overall Study|Lost to Follow-up|7|||
94331636|NCT00435994|322994279|FG001|Overall Study|Lost to Follow-up|0|||
94331637|NCT00435994|322994280|FG002|Overall Study|Lost to Follow-up|0|||
94331638|NCT01151540|322994281|FG000|Overall Study|Other|2|||
94331639|NCT01151540|322994281|FG000|Overall Study|Adverse event, non-fatal|4|||
94331640|NCT01151540|322994281|FG000|Overall Study|Withdrawal by Subject|7|||
94331641|NCT02248857|322994286|FG000|3 Month|Withdrawal by Subject|9|||
94331642|NCT02248857|322994287|FG001|3 Month|Withdrawal by Subject|3|||
94331643|NCT02248857|322994288|FG002|3 Month|Withdrawal by Subject|4|||
94331644|NCT02248857|322994286|FG000|3 Month|Unable to reach for 3 month|35|||
94331645|NCT02248857|322994287|FG001|3 Month|Unable to reach for 3 month|29|||
94331646|NCT02248857|322994288|FG002|3 Month|Unable to reach for 3 month|26|||
94331647|NCT02248857|322994286|FG000|3 Month|Partially completed, unable to finish|2|||
94331648|NCT02248857|322994287|FG001|3 Month|Partially completed, unable to finish|2|||
94331649|NCT02248857|322994288|FG002|3 Month|Partially completed, unable to finish|1|||
94331650|NCT02248857|322994286|FG000|6 Month|Lost to Follow-up|27|||
94331651|NCT02248857|322994287|FG001|6 Month|Lost to Follow-up|26|||
94331652|NCT02248857|322994288|FG002|6 Month|Lost to Follow-up|15|||
94331653|NCT02248857|322994286|FG000|6 Month|Partially completed, unable to finish|0|||
94331654|NCT02248857|322994287|FG001|6 Month|Partially completed, unable to finish|1|||
94331655|NCT02248857|322994288|FG002|6 Month|Partially completed, unable to finish|0|||
94331656|NCT02248857|322994286|FG000|6 Month|Withdrawal by Subject|0|||
94331657|NCT02248857|322994287|FG001|6 Month|Withdrawal by Subject|2|||
94331658|NCT02248857|322994288|FG002|6 Month|Withdrawal by Subject|2|||
94331659|NCT02248857|322994286|FG000|6 Month|Death|1|||
94331660|NCT02248857|322994287|FG001|6 Month|Death|0|||
94331661|NCT02248857|322994288|FG002|6 Month|Death|0|||
94331662|NCT04126031|322994291|FG000|Part A|Withdrawal by Subject|0|||
94331663|NCT04126031|322994292|FG001|Part A|Withdrawal by Subject|0|||
94331664|NCT04126031|322994293|FG002|Part A|Withdrawal by Subject|1|||
94331665|NCT04126031|322994294|FG003|Part A|Withdrawal by Subject|0|||
94331666|NCT04126031|322994295|FG004|Part A|Withdrawal by Subject|0|||
94331667|NCT04126031|322994296|FG005|Part A|Withdrawal by Subject|0|||
94331668|NCT04126031|322994291|FG000|Part A|Other|1|||
94331669|NCT04126031|322994292|FG001|Part A|Other|0|||
94331670|NCT04126031|322994293|FG002|Part A|Other|0|||
94331671|NCT04126031|322994294|FG003|Part A|Other|0|||
94331672|NCT04126031|322994295|FG004|Part A|Other|0|||
94651296|NCT02460224|324179735|FG020|Overall Study|Physician Decision|1|||
94331673|NCT04126031|322994296|FG005|Part A|Other|0|||
94331674|NCT04126031|322994291|FG000|Part B|Adverse Event|0|||
94331675|NCT04126031|322994292|FG001|Part B|Adverse Event|0|||
94331676|NCT04126031|322994293|FG002|Part B|Adverse Event|0|||
94331677|NCT04126031|322994294|FG003|Part B|Adverse Event|0|||
94331678|NCT04126031|322994295|FG004|Part B|Adverse Event|0|||
94331679|NCT04126031|322994296|FG005|Part B|Adverse Event|2|||
94331680|NCT04126031|322994291|FG000|Part B|Pre-existing hypertransaminasemia|0|||
94331681|NCT04126031|322994292|FG001|Part B|Pre-existing hypertransaminasemia|0|||
94331682|NCT04126031|322994293|FG002|Part B|Pre-existing hypertransaminasemia|0|||
94331683|NCT04126031|322994294|FG003|Part B|Pre-existing hypertransaminasemia|0|||
94331684|NCT04126031|322994295|FG004|Part B|Pre-existing hypertransaminasemia|1|||
94331685|NCT04126031|322994296|FG005|Part B|Pre-existing hypertransaminasemia|0|||
94331686|NCT01602549|322994297|FG000|Overall Study|Protocol Violation|0|||
94331687|NCT01602549|322994298|FG001|Overall Study|Protocol Violation|1|||
94331688|NCT01602549|322994297|FG000|Overall Study|Withdrawal by Subject|1|||
94331689|NCT01602549|322994298|FG001|Overall Study|Withdrawal by Subject|0|||
94331690|NCT00719862|322994299|FG000|Overall Study|Adverse Event|1|||
94331691|NCT00719862|322994300|FG001|Overall Study|Adverse Event|2|||
94331692|NCT00719862|322994299|FG000|Overall Study|Lack of Efficacy|3|||
94331693|NCT00719862|322994300|FG001|Overall Study|Lack of Efficacy|0|||
94331694|NCT00719862|322994299|FG000|Overall Study|Non-Compliance|1|||
94331695|NCT00719862|322994300|FG001|Overall Study|Non-Compliance|0|||
94331696|NCT00719862|322994299|FG000|Overall Study|Withdrawal by Subject|1|||
94331697|NCT00719862|322994300|FG001|Overall Study|Withdrawal by Subject|0|||
94331698|NCT00719862|322994299|FG000|Overall Study|Lost to Follow-up|0|||
94331699|NCT00719862|322994300|FG001|Overall Study|Lost to Follow-up|1|||
94331700|NCT00719862|322994299|FG000|Overall Study|Other|2|||
94331701|NCT00719862|322994300|FG001|Overall Study|Other|3|||
94331702|NCT01576406|322994301|FG000|Overall Study|Lost to Follow-up|1|||
94331703|NCT01576406|322994302|FG001|Overall Study|Lost to Follow-up|2|||
94331704|NCT01576406|322994303|FG002|Overall Study|Lost to Follow-up|0|||
94331705|NCT01576406|322994304|FG003|Overall Study|Lost to Follow-up|0|||
94331706|NCT01576406|322994305|FG004|Overall Study|Lost to Follow-up|0|||
94331707|NCT01576406|322994306|FG005|Overall Study|Lost to Follow-up|0|||
94331708|NCT01576406|322994301|FG000|Overall Study|Death|3|||
94331709|NCT01576406|322994302|FG001|Overall Study|Death|4|||
94331710|NCT01576406|322994303|FG002|Overall Study|Death|8|||
94331711|NCT01576406|322994304|FG003|Overall Study|Death|5|||
94331712|NCT01576406|322994305|FG004|Overall Study|Death|7|||
94331713|NCT01576406|322994306|FG005|Overall Study|Death|9|||
94331714|NCT01576406|322994301|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
94331715|NCT01576406|322994302|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
94331716|NCT01576406|322994303|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
94331717|NCT01576406|322994304|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
94331718|NCT01576406|322994305|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
94331719|NCT01576406|322994306|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
94331720|NCT01576406|322994301|FG000|Overall Study|Withdrawal the consent|2|||
94331721|NCT01576406|322994302|FG001|Overall Study|Withdrawal the consent|2|||
94331722|NCT01576406|322994303|FG002|Overall Study|Withdrawal the consent|5|||
94331723|NCT01576406|322994304|FG003|Overall Study|Withdrawal the consent|1|||
94331724|NCT01576406|322994305|FG004|Overall Study|Withdrawal the consent|1|||
94331725|NCT01576406|322994306|FG005|Overall Study|Withdrawal the consent|3|||
94331726|NCT01576406|322994301|FG000|Overall Study|Other|0|||
94331727|NCT01576406|322994302|FG001|Overall Study|Other|0|||
94331728|NCT01576406|322994303|FG002|Overall Study|Other|2|||
94331729|NCT01576406|322994304|FG003|Overall Study|Other|2|||
94331730|NCT01576406|322994305|FG004|Overall Study|Other|0|||
94331731|NCT01576406|322994306|FG005|Overall Study|Other|0|||
94331732|NCT01770145|322996375|FG000|Baseline|Adverse Event|20|||
94331733|NCT01770145|322996375|FG000|Baseline|Withdrawal by Subject|1|||
94331734|NCT01770145|322996375|FG000|Baseline|Lost to Follow-up|1|||
94331735|NCT01770145|322996375|FG000|Baseline|Unable to define optimal dose|4|||
94331736|NCT01770145|322996375|FG000|Treatment|Adverse Event|3|||
94331737|NCT01770145|322996375|FG000|Treatment|Withdrawal by Subject|1|||
94331738|NCT03326869|322996376|FG000|Overall Study|Study data has been lost to natural disa|1|||
94331739|NCT03326869|322996377|FG001|Overall Study|Study data has been lost to natural disa|1|||
94331740|NCT01824693|322996379|FG000|Overall Study|Death|0|||
94331741|NCT01824693|322996380|FG001|Overall Study|Death|1|||
94331742|NCT01824693|322996381|FG002|Overall Study|Death|0|||
94331743|NCT01824693|322996379|FG000|Overall Study|Physician Decision|1|||
94331744|NCT01824693|322996380|FG001|Overall Study|Physician Decision|1|||
94331745|NCT01824693|322996381|FG002|Overall Study|Physician Decision|1|||
94331746|NCT01824693|322996379|FG000|Overall Study|Withdrawal by Subject|0|||
94331747|NCT01824693|322996380|FG001|Overall Study|Withdrawal by Subject|0|||
94331748|NCT01824693|322996381|FG002|Overall Study|Withdrawal by Subject|1|||
94331749|NCT01824693|322996379|FG000|Overall Study|Progressive Disease|0|||
94331750|NCT01824693|322996380|FG001|Overall Study|Progressive Disease|5|||
94331751|NCT01824693|322996381|FG002|Overall Study|Progressive Disease|0|||
94331752|NCT01824693|322996379|FG000|Overall Study|Ineligible|0|||
94331753|NCT01824693|322996380|FG001|Overall Study|Ineligible|0|||
94331754|NCT01824693|322996381|FG002|Overall Study|Ineligible|3|||
94331755|NCT01824693|322996379|FG000|Overall Study|No Transplant Planned|0|||
94331756|NCT01824693|322996380|FG001|Overall Study|No Transplant Planned|0|||
94331757|NCT01824693|322996381|FG002|Overall Study|No Transplant Planned|10|||
94331758|NCT01634113|322996382|FG000|Overall Study|Not treated|0|||
94331759|NCT01634113|322996383|FG001|Overall Study|Not treated|0|||
94331760|NCT01634113|322996384|FG002|Overall Study|Not treated|1|||
94331761|NCT01544478|322996387|FG000|Overall Study|Adverse Event|1|||
94331762|NCT01544478|322996387|FG000|Overall Study|Death|1|||
94331763|NCT01544478|322996387|FG000|Overall Study|Lost to Follow-up|48|||
94331764|NCT01544478|322996387|FG000|Overall Study|Physician Decision|15|||
94331765|NCT01544478|322996387|FG000|Overall Study|Pregnancy|1|||
94331766|NCT01544478|322996387|FG000|Overall Study|Withdrawal by Subject|52|||
94331767|NCT01352845|322996388|FG000|Overall Study|Lost to Follow-up|313|||
94331768|NCT01352845|322996389|FG001|Overall Study|Lost to Follow-up|92|||
94331769|NCT01352845|322996388|FG000|Overall Study|No Longer Willing to Participate|205|||
94331770|NCT01352845|322996389|FG001|Overall Study|No Longer Willing to Participate|58|||
94331771|NCT01352845|322996388|FG000|Overall Study|Withdrawal by Subject|48|||
94331772|NCT01352845|322996389|FG001|Overall Study|Withdrawal by Subject|16|||
94331773|NCT01352845|322996388|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
94331774|NCT01352845|322996389|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
94331775|NCT01352845|322996388|FG000|Overall Study|Pregnancy|27|||
94331776|NCT01352845|322996389|FG001|Overall Study|Pregnancy|7|||
94331777|NCT01352845|322996388|FG000|Overall Study|Adverse Event|22|||
94331778|NCT01352845|322996389|FG001|Overall Study|Adverse Event|6|||
94331779|NCT01352845|322996388|FG000|Overall Study|Other|17|||
94331780|NCT01352845|322996389|FG001|Overall Study|Other|7|||
94331781|NCT01352845|322996388|FG000|Overall Study|Protocol Violation|12|||
94331782|NCT01352845|322996389|FG001|Overall Study|Protocol Violation|6|||
94331783|NCT01352845|322996388|FG000|Overall Study|Death|3|||
94331784|NCT01352845|322996389|FG001|Overall Study|Death|0|||
94331785|NCT01563107|322996390|FG000|Overall Study|Physician Decision|0|||
94331786|NCT01563107|322996391|FG001|Overall Study|Physician Decision|1|||
94331787|NCT01563107|322996392|FG002|Overall Study|Physician Decision|1|||
94331788|NCT01563107|322996393|FG003|Overall Study|Physician Decision|3|||
94331789|NCT01563107|322996390|FG000|Overall Study|Withdrawal by Subject|1|||
94331790|NCT01563107|322996391|FG001|Overall Study|Withdrawal by Subject|2|||
94331791|NCT01563107|322996392|FG002|Overall Study|Withdrawal by Subject|1|||
94331792|NCT01563107|322996393|FG003|Overall Study|Withdrawal by Subject|2|||
94331793|NCT02959970|322996394|FG000|Overall Study|Adverse Event|1|||
94331794|NCT02959970|322996395|FG001|Overall Study|Adverse Event|0|||
94331795|NCT02959970|322996394|FG000|Overall Study|Withdrawal by Subject|0|||
94331796|NCT02959970|322996395|FG001|Overall Study|Withdrawal by Subject|2|||
94331797|NCT02959970|322996394|FG000|Overall Study|Lost to Follow-up|1|||
94331798|NCT02959970|322996395|FG001|Overall Study|Lost to Follow-up|5|||
94331799|NCT01175590|322996396|FG000|Overall Study|Lost to Follow-up|1|||
94331800|NCT01175590|322996397|FG001|Overall Study|Lost to Follow-up|0|||
94331801|NCT01175590|322996396|FG000|Overall Study|Withdrawal by Subject|0|||
94331802|NCT01175590|322996397|FG001|Overall Study|Withdrawal by Subject|2|||
94331803|NCT01175590|322996396|FG000|Overall Study|Adverse Event|4|||
94331804|NCT01175590|322996397|FG001|Overall Study|Adverse Event|0|||
94331805|NCT01175590|322996396|FG000|Overall Study|Physician Decision|1|||
94331806|NCT01175590|322996397|FG001|Overall Study|Physician Decision|4|||
94331807|NCT01175590|322996396|FG000|Overall Study|Lack of Efficacy|1|||
94331808|NCT01175590|322996397|FG001|Overall Study|Lack of Efficacy|1|||
94331809|NCT01175590|322996396|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
94331810|NCT01175590|322996397|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
94331811|NCT01175590|322996396|FG000|Overall Study|Treated not as randomized|3|||
94331812|NCT01175590|322996397|FG001|Overall Study|Treated not as randomized|2|||
94331813|NCT01175590|322996396|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
94331814|NCT01175590|322996397|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
94331815|NCT01175590|322996396|FG000|Overall Study|Protocol Violation|0|||
94331816|NCT01175590|322996397|FG001|Overall Study|Protocol Violation|1|||
94331817|NCT00010803|322996398|FG000|Overall Study|Withdrawal by Subject|97|||
94331818|NCT00010803|322996399|FG001|Overall Study|Withdrawal by Subject|98|||
94331819|NCT01415908|322996400|FG000|Overall Study|Withdrawal by Subject|1|||
94331820|NCT01415908|322996401|FG001|Overall Study|Withdrawal by Subject|0|||
94331821|NCT00469209|322996404|FG000|Overall Study|Adverse Event|1|||
94331822|NCT00469209|322996405|FG001|Overall Study|Adverse Event|0|||
94331823|NCT00469209|322996406|FG002|Overall Study|Adverse Event|1|||
94331824|NCT01143714|322996408|FG000|Overall Study|Adverse Event|4|||
94331825|NCT01143714|322996409|FG001|Overall Study|Adverse Event|2|||
94331826|NCT01143714|322996408|FG000|Overall Study|Withdrawal by Subject|1|||
94331827|NCT01143714|322996409|FG001|Overall Study|Withdrawal by Subject|0|||
94331828|NCT01143714|322996408|FG000|Overall Study|Subject non-compliance|0|||
94331829|NCT01143714|322996409|FG001|Overall Study|Subject non-compliance|1|||
94331830|NCT01143714|322996408|FG000|Overall Study|wound closed = deemed healed|1|||
94331831|NCT01143714|322996409|FG001|Overall Study|wound closed = deemed healed|0|||
94331832|NCT01143714|322996408|FG000|Overall Study|wound size increased|1|||
94331833|NCT01143714|322996409|FG001|Overall Study|wound size increased|0|||
94331834|NCT01106391|322996410|FG000|Overall Study|Death|12|||
94331835|NCT01106391|322996410|FG000|Overall Study|Withdrawal by Subject|7|||
94331836|NCT01387074|322996411|FG000|Overall Study|Lost to Follow-up|7|||
94331837|NCT01387074|322996411|FG000|Overall Study|Lack of Efficacy|1|||
94331838|NCT01532570|322996412|FG000|Overall Study|Lack of Efficacy|1|||
94331839|NCT01532570|322996413|FG001|Overall Study|Lack of Efficacy|0|||
94331840|NCT01532570|322996414|FG002|Overall Study|Lack of Efficacy|0|||
94331841|NCT01532570|322996415|FG003|Overall Study|Lack of Efficacy|0|||
94331842|NCT01532570|322996412|FG000|Overall Study|Withdrawal by Subject|0|||
94331843|NCT01532570|322996413|FG001|Overall Study|Withdrawal by Subject|1|||
94331844|NCT01532570|322996414|FG002|Overall Study|Withdrawal by Subject|0|||
94331845|NCT01532570|322996415|FG003|Overall Study|Withdrawal by Subject|0|||
94331846|NCT04325906|322996418|FG000|Overall Study|Withdrawal by Subject|2|||
94331847|NCT04325906|322996419|FG001|Overall Study|Withdrawal by Subject|0|||
94331848|NCT02141217|322996420|FG000|Overall Study|Adverse Event|1|||
94331849|NCT02141217|322996421|FG001|Overall Study|Adverse Event|2|||
94331850|NCT02141217|322996420|FG000|Overall Study|Protocol Violation|1|||
94331851|NCT02141217|322996421|FG001|Overall Study|Protocol Violation|4|||
94331852|NCT02141217|322996420|FG000|Overall Study|Withdrawal by Subject|6|||
94331853|NCT02141217|322996421|FG001|Overall Study|Withdrawal by Subject|0|||
94331854|NCT02141217|322996420|FG000|Overall Study|Lost to Follow-up|1|||
94331855|NCT02141217|322996421|FG001|Overall Study|Lost to Follow-up|1|||
94331856|NCT02141217|322996420|FG000|Overall Study|Physician Decision|1|||
94331857|NCT02141217|322996421|FG001|Overall Study|Physician Decision|0|||
94331858|NCT02141217|322996420|FG000|Overall Study|Surgical Intervention|1|||
94331859|NCT02141217|322996421|FG001|Overall Study|Surgical Intervention|1|||
94331860|NCT01457924|322996422|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
94331861|NCT01457924|322996423|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
94331862|NCT01457924|322996424|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
94331863|NCT01457924|322996425|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
94331864|NCT01457924|322996426|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
94331865|NCT01457924|322996422|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
94331866|NCT01457924|322996423|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
94331867|NCT01457924|322996424|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
94331868|NCT01457924|322996425|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
94331869|NCT01457924|322996426|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
94331870|NCT01457924|322996422|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
94331871|NCT01457924|322996423|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
94331872|NCT01457924|322996424|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
94331873|NCT01457924|322996425|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
94331874|NCT01457924|322996426|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
94331875|NCT01457924|322996422|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
94331876|NCT01457924|322996423|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
94331877|NCT01457924|322996424|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
94331878|NCT01457924|322996425|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
94331879|NCT01457924|322996426|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
94331880|NCT01457924|322996422|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
94331881|NCT01457924|322996423|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
94331882|NCT01457924|322996424|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
94331883|NCT01457924|322996425|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
94331884|NCT01457924|322996426|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
94331885|NCT01457924|322996422|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
94331886|NCT01457924|322996423|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
94331887|NCT01457924|322996424|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
94331888|NCT01457924|322996425|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
94331889|NCT01457924|322996426|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
94331890|NCT01457924|322996422|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
94331891|NCT01457924|322996423|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
94331892|NCT01457924|322996424|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
94331893|NCT01457924|322996425|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
94331894|NCT01457924|322996426|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
94331895|NCT01457924|322996422|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
94331896|NCT01457924|322996423|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
94331897|NCT01457924|322996424|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
94331898|NCT01457924|322996425|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
94331899|NCT01457924|322996426|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
94331900|NCT01457924|322996422|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
94331901|NCT01457924|322996423|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
94331902|NCT01457924|322996424|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
94331903|NCT01457924|322996425|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
94331904|NCT01457924|322996426|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
94331905|NCT01457924|322996422|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
94331906|NCT01457924|322996423|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
94331907|NCT01457924|322996424|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
94331908|NCT01457924|322996425|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
94331909|NCT01457924|322996426|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
94224465|NCT02123797|322615069|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
94331910|NCT01457924|322996422|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
94331911|NCT01457924|322996423|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
94331912|NCT01457924|322996424|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
94331913|NCT01457924|322996425|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
94331914|NCT01457924|322996426|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
94331915|NCT01457924|322996422|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
94331916|NCT01457924|322996423|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
94331917|NCT01457924|322996424|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
94331918|NCT01457924|322996425|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
94331919|NCT01457924|322996426|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
94331920|NCT01457924|322996422|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
94331921|NCT01457924|322996423|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
94331922|NCT01457924|322996424|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
94331923|NCT01457924|322996425|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
94331924|NCT01457924|322996426|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
94331925|NCT01181141|322996430|FG000|Overall Study|Adverse Event|2|||
94331926|NCT01181141|322996431|FG001|Overall Study|Adverse Event|1|||
94331927|NCT01181141|322996430|FG000|Overall Study|Lack of Efficacy|1|||
94331928|NCT01181141|322996431|FG001|Overall Study|Lack of Efficacy|0|||
94331929|NCT01181141|322996430|FG000|Overall Study|Lost to Follow-up|1|||
94331930|NCT01181141|322996431|FG001|Overall Study|Lost to Follow-up|1|||
94331931|NCT01181141|322996430|FG000|Overall Study|Physician Decision|2|||
94331932|NCT01181141|322996431|FG001|Overall Study|Physician Decision|0|||
94331933|NCT01181141|322996430|FG000|Overall Study|Protocol Violation|3|||
94331934|NCT01181141|322996431|FG001|Overall Study|Protocol Violation|1|||
94331935|NCT01181141|322996430|FG000|Overall Study|Withdrawal by Subject|3|||
94331936|NCT01181141|322996431|FG001|Overall Study|Withdrawal by Subject|1|||
94331937|NCT02001688|322996432|FG000|Overall Study|Withdrawal by Subject|0|||
94331938|NCT02001688|322996433|FG001|Overall Study|Withdrawal by Subject|0|||
94331939|NCT02001688|322996434|FG002|Overall Study|Withdrawal by Subject|1|||
94331940|NCT02001688|322996432|FG000|Overall Study|Adverse Event|0|||
94331941|NCT02001688|322996433|FG001|Overall Study|Adverse Event|1|||
94331942|NCT02001688|322996434|FG002|Overall Study|Adverse Event|0|||
94331943|NCT01329341|322996435|FG000|Overall Study|Withdrawal by Subject|44|||
94331944|NCT01369225|322996443|FG000|Overall Study|Withdrawal by Subject|1|||
94331945|NCT01369225|322996444|FG001|Overall Study|Withdrawal by Subject|0|||
94331946|NCT01369225|322996445|FG002|Overall Study|Withdrawal by Subject|2|||
94331947|NCT01369225|322996446|FG003|Overall Study|Withdrawal by Subject|1|||
94331948|NCT01369225|322996447|FG004|Overall Study|Withdrawal by Subject|0|||
94331949|NCT01369225|322996448|FG005|Overall Study|Withdrawal by Subject|0|||
94331950|NCT01369225|322996443|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
94331951|NCT01369225|322996444|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
94331952|NCT01369225|322996445|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
94331953|NCT01369225|322996446|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
94331954|NCT01369225|322996447|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
94331955|NCT01369225|322996448|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
94331956|NCT01369225|322996443|FG000|Overall Study|Other|1|||
94331957|NCT01369225|322996444|FG001|Overall Study|Other|0|||
94331958|NCT01369225|322996445|FG002|Overall Study|Other|0|||
94331959|NCT01369225|322996446|FG003|Overall Study|Other|0|||
94331960|NCT01369225|322996447|FG004|Overall Study|Other|1|||
94331961|NCT01369225|322996448|FG005|Overall Study|Other|0|||
94331962|NCT01369225|322996443|FG000|Overall Study|Adverse Event|0|||
94331963|NCT01369225|322996444|FG001|Overall Study|Adverse Event|0|||
94331964|NCT01369225|322996445|FG002|Overall Study|Adverse Event|0|||
94331965|NCT01369225|322996446|FG003|Overall Study|Adverse Event|1|||
94331966|NCT01369225|322996447|FG004|Overall Study|Adverse Event|1|||
94331967|NCT01369225|322996448|FG005|Overall Study|Adverse Event|0|||
94331968|NCT00168064|322996449|FG000|Overall Study|Adverse Event|26|||
94331969|NCT00168064|322996450|FG001|Overall Study|Adverse Event|22|||
94331970|NCT00168064|322996449|FG000|Overall Study|Withdrawal by Subject|3|||
94331971|NCT00168064|322996450|FG001|Overall Study|Withdrawal by Subject|4|||
94331972|NCT00168064|322996449|FG000|Overall Study|Lack of Efficacy|4|||
94331973|NCT00168064|322996450|FG001|Overall Study|Lack of Efficacy|4|||
94331974|NCT00168064|322996449|FG000|Overall Study|Lost to Follow-up|4|||
94331975|NCT00168064|322996450|FG001|Overall Study|Lost to Follow-up|3|||
94331976|NCT00168064|322996449|FG000|Overall Study|Non-compliance|2|||
94331977|NCT00168064|322996450|FG001|Overall Study|Non-compliance|3|||
94331978|NCT00168064|322996449|FG000|Overall Study|Concurrent Illness|4|||
94331979|NCT00168064|322996450|FG001|Overall Study|Concurrent Illness|3|||
94331980|NCT00168064|322996449|FG000|Overall Study|Subject's Best interest|2|||
94331981|NCT00168064|322996450|FG001|Overall Study|Subject's Best interest|2|||
94331982|NCT00168064|322996449|FG000|Overall Study|Various|4|||
94331983|NCT00168064|322996450|FG001|Overall Study|Various|3|||
94331984|NCT00792701|322996451|FG000|Overall Study|Adverse Event|0|||
94331985|NCT00792701|322996452|FG001|Overall Study|Adverse Event|22|||
94331986|NCT00792701|322996451|FG000|Overall Study|Ineligible|1|||
94331987|NCT00792701|322996452|FG001|Overall Study|Ineligible|3|||
94331988|NCT00792701|322996451|FG000|Overall Study|Withdrawal by Subject|1|||
94331989|NCT00792701|322996452|FG001|Overall Study|Withdrawal by Subject|19|||
94331990|NCT00792701|322996451|FG000|Overall Study|Not protocol specified|17|||
94331991|NCT00792701|322996452|FG001|Overall Study|Not protocol specified|0|||
94331992|NCT03862495|322996453|FG000|Overall Study|Lost to Follow-up|37|||
94331993|NCT03862495|322996454|FG001|Overall Study|Lost to Follow-up|35|||
94331994|NCT01467661|322996455|FG000|Overall Study|Adverse Event|16|||
94331995|NCT01467661|322996455|FG000|Overall Study|Withdrawal by Subject|1|||
94331996|NCT01467661|322996455|FG000|Overall Study|Lack of Efficacy|3|||
94331997|NCT01467661|322996455|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
94331998|NCT00493467|322996456|FG000|Overall Study|Death|1|||
94331999|NCT01074658|322996457|FG000|Overall Study|No implant attempted|19|||
94332000|NCT00294684|322996462|FG000|Overall Study|Lost to Follow-up|5|||
94332001|NCT00294684|322996463|FG001|Overall Study|Lost to Follow-up|8|||
94332002|NCT02247401|322996464|FG000|Overall Study|Adverse Event|1|||
94332003|NCT02247401|322996465|FG001|Overall Study|Adverse Event|0|||
94332004|NCT02247401|322996466|FG002|Overall Study|Adverse Event|0|||
94332005|NCT02247401|322996464|FG000|Overall Study|Withdrawal by Subject|4|||
94332006|NCT02247401|322996465|FG001|Overall Study|Withdrawal by Subject|1|||
94332007|NCT02247401|322996466|FG002|Overall Study|Withdrawal by Subject|1|||
94332008|NCT02247401|322996464|FG000|Overall Study|Lost to Follow-up|1|||
94332009|NCT02247401|322996465|FG001|Overall Study|Lost to Follow-up|1|||
94332010|NCT02247401|322996466|FG002|Overall Study|Lost to Follow-up|1|||
94332011|NCT01313208|322996471|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
94332012|NCT01313208|322996472|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
94332013|NCT01313208|322996471|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
94332014|NCT01313208|322996472|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
94332015|NCT01313208|322996471|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
94332016|NCT01313208|322996472|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
94332017|NCT01313208|322996471|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
94332018|NCT01313208|322996472|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
94332019|NCT01313208|322996471|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
94332020|NCT01313208|322996472|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
94332021|NCT01313208|322996471|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
94332022|NCT01313208|322996472|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
94332023|NCT01313208|322996471|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
94332024|NCT01313208|322996472|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
94332025|NCT01313208|322996471|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
94332026|NCT01313208|322996472|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
94332027|NCT01313208|322996471|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
94332028|NCT01313208|322996472|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
94332029|NCT04354155|322996475|FG000|Overall Study|Withdrawal by Subject|1|||
94332030|NCT04354155|322996475|FG000|Overall Study|Did not meet criteria for study intervention|1|||
94332031|NCT00187889|322996476|FG000|Overall Study|Withdrawal by Subject|6|||
94332032|NCT00187889|322996477|FG001|Overall Study|Withdrawal by Subject|4|||
94332033|NCT02133742|322996482|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
94332034|NCT02133742|322996482|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
94332035|NCT02133742|322996482|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
94332036|NCT02133742|322996482|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
94332037|NCT02133742|322996482|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
94332038|NCT05109702|322996485|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
94332039|NCT05109702|322996486|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
94332040|NCT05109702|322996487|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
94332041|NCT05109702|322996485|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
94332042|NCT05109702|322996486|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
94332043|NCT05109702|322996487|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
94332044|NCT05109702|322996485|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
94332045|NCT05109702|322996486|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
94332046|NCT05109702|322996487|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
94332047|NCT05109702|322996485|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
94332048|NCT05109702|322996486|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
94332049|NCT05109702|322996487|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
94332050|NCT05109702|322996485|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
94332051|NCT05109702|322996486|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
94332052|NCT05109702|322996487|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
94332053|NCT03094832|322996488|FG000|Overall Study|Lost to Follow-up|0|||
94332054|NCT03094832|322996489|FG001|Overall Study|Lost to Follow-up|0|||
94332055|NCT03094832|322996490|FG002|Overall Study|Lost to Follow-up|0|||
94332056|NCT03094832|322996491|FG003|Overall Study|Lost to Follow-up|1|||
94332057|NCT03094832|322996492|FG004|Overall Study|Lost to Follow-up|1|||
94332058|NCT03094832|322996488|FG000|Overall Study|Death|1|||
94548414|NCT01977690|323803430|FG000|Overall Study|Withdrawal by Subject|0|||
94332059|NCT03094832|322996489|FG001|Overall Study|Death|0|||
94332060|NCT03094832|322996490|FG002|Overall Study|Death|0|||
94332061|NCT03094832|322996491|FG003|Overall Study|Death|0|||
94332062|NCT03094832|322996492|FG004|Overall Study|Death|0|||
94332063|NCT03094832|322996488|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
94332064|NCT03094832|322996489|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94332065|NCT03094832|322996490|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
94332066|NCT03094832|322996491|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
94332067|NCT03094832|322996492|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
94332068|NCT03094832|322996488|FG000|Overall Study|Other|13|||
94332069|NCT03094832|322996489|FG001|Overall Study|Other|20|||
94332070|NCT03094832|322996490|FG002|Overall Study|Other|1|||
94332071|NCT03094832|322996491|FG003|Overall Study|Other|7|||
94224466|NCT02123797|322615070|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
94224467|NCT02123797|322615071|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
94224468|NCT02123797|322615072|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
94224469|NCT02123797|322615073|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
94224470|NCT02123797|322615069|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
94224471|NCT02123797|322615070|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
94224472|NCT02123797|322615071|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
94224473|NCT02123797|322615072|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
94224474|NCT02123797|322615073|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
94224475|NCT02123797|322615069|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
94224476|NCT02123797|322615070|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
94224477|NCT02123797|322615071|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
94224478|NCT02123797|322615072|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
94224479|NCT02123797|322615073|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
94224480|NCT02123797|322615069|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
94224481|NCT02123797|322615070|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
94224482|NCT02123797|322615071|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
94224483|NCT02123797|322615072|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
94224484|NCT02123797|322615073|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
94224485|NCT02775214|322615074|FG000|Overall Study|Withdrawal by Subject|2|||
94224486|NCT02775214|322615075|FG001|Overall Study|Withdrawal by Subject|0|||
94224487|NCT03730662|322615076|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
94224488|NCT03730662|322615077|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
94224489|NCT03730662|322615078|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
94224490|NCT03730662|322615079|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
94224491|NCT03730662|322615076|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
94224492|NCT03730662|322615077|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
94224493|NCT03730662|322615078|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
94224494|NCT03730662|322615079|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
94224495|NCT03730662|322615076|FG000|Treatment Period (52 Weeks)|Death|6|||
94224496|NCT03730662|322615077|FG001|Treatment Period (52 Weeks)|Death|2|||
94224497|NCT03730662|322615078|FG002|Treatment Period (52 Weeks)|Death|2|||
94224498|NCT03730662|322615079|FG003|Treatment Period (52 Weeks)|Death|9|||
94224499|NCT03730662|322615076|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
94224500|NCT03730662|322615077|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
94224501|NCT03730662|322615078|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
94224502|NCT03730662|322615079|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
94224503|NCT03730662|322615076|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
94224504|NCT03730662|322615077|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
94224505|NCT03730662|322615078|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
94224506|NCT03730662|322615079|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
94224507|NCT03730662|322615076|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
94224508|NCT03730662|322615077|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
94224509|NCT03730662|322615078|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
94224510|NCT03730662|322615079|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
94224511|NCT03730662|322615076|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
94224512|NCT03730662|322615077|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
94224513|NCT03730662|322615078|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
94224514|NCT03730662|322615079|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
94224515|NCT03730662|322615076|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
94224516|NCT03730662|322615077|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
94224517|NCT03730662|322615078|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
94224518|NCT03730662|322615079|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
94224519|NCT03730662|322615076|FG000|Variable Treatment Period|Adverse Event|1|||
94224520|NCT03730662|322615077|FG001|Variable Treatment Period|Adverse Event|2|||
94332072|NCT03094832|322996492|FG004|Overall Study|Other|1|||
94332073|NCT02565615|322996493|FG000|Overall Study|Death|0|||
94332074|NCT02565615|322996494|FG001|Overall Study|Death|1|||
94332075|NCT02565615|322996495|FG002|Overall Study|Death|0|||
94332076|NCT02565615|322996496|FG003|Overall Study|Death|0|||
94332077|NCT02565615|322996497|FG004|Overall Study|Death|4|||
94332078|NCT02565615|322996493|FG000|Overall Study|Not willing to participate in study|2|||
94332079|NCT02565615|322996494|FG001|Overall Study|Not willing to participate in study|21|||
94332080|NCT02565615|322996495|FG002|Overall Study|Not willing to participate in study|0|||
94332081|NCT02565615|322996496|FG003|Overall Study|Not willing to participate in study|1|||
94332082|NCT02565615|322996497|FG004|Overall Study|Not willing to participate in study|169|||
94332083|NCT02565615|322996493|FG000|Overall Study|Lost to Follow-up|0|||
94332084|NCT02565615|322996494|FG001|Overall Study|Lost to Follow-up|4|||
94332085|NCT02565615|322996495|FG002|Overall Study|Lost to Follow-up|0|||
94332086|NCT02565615|322996496|FG003|Overall Study|Lost to Follow-up|1|||
94332087|NCT02565615|322996497|FG004|Overall Study|Lost to Follow-up|765|||
94332088|NCT02565615|322996493|FG000|Overall Study|Not meeting eligibility criteria|0|||
94332089|NCT02565615|322996494|FG001|Overall Study|Not meeting eligibility criteria|7|||
94332090|NCT02565615|322996495|FG002|Overall Study|Not meeting eligibility criteria|0|||
94332091|NCT02565615|322996496|FG003|Overall Study|Not meeting eligibility criteria|0|||
94332092|NCT02565615|322996497|FG004|Overall Study|Not meeting eligibility criteria|25|||
94332093|NCT02565615|322996493|FG000|Overall Study|Reason not defined|0|||
94332094|NCT02565615|322996494|FG001|Overall Study|Reason not defined|2|||
94332095|NCT02565615|322996495|FG002|Overall Study|Reason not defined|0|||
94332096|NCT02565615|322996496|FG003|Overall Study|Reason not defined|1|||
94332097|NCT02565615|322996497|FG004|Overall Study|Reason not defined|62|||
94332098|NCT02565615|322996493|FG000|Overall Study|Adverse Event|1|||
94332099|NCT02565615|322996494|FG001|Overall Study|Adverse Event|1|||
94332100|NCT02565615|322996495|FG002|Overall Study|Adverse Event|0|||
94332101|NCT02565615|322996496|FG003|Overall Study|Adverse Event|0|||
94332102|NCT02565615|322996497|FG004|Overall Study|Adverse Event|9|||
94332103|NCT02565615|322996493|FG000|Overall Study|Untreated|0|||
94332104|NCT02565615|322996494|FG001|Overall Study|Untreated|0|||
94332105|NCT02565615|322996495|FG002|Overall Study|Untreated|0|||
94332106|NCT02565615|322996496|FG003|Overall Study|Untreated|0|||
94332107|NCT02565615|322996497|FG004|Overall Study|Untreated|567|||
94332108|NCT01392378|322996500|FG000|Infant Series|Adverse Event|0|||
94332109|NCT01392378|322996501|FG001|Infant Series|Adverse Event|0|||
94332110|NCT01392378|322996502|FG002|Infant Series|Adverse Event|0|||
94332111|NCT01392378|322996503|FG003|Infant Series|Adverse Event|1|||
94332112|NCT01392378|322996504|FG004|Infant Series|Adverse Event|0|||
94332113|NCT01392378|322996500|FG000|Infant Series|Lost to Follow-up|0|||
94332114|NCT01392378|322996501|FG001|Infant Series|Lost to Follow-up|0|||
94332115|NCT01392378|322996502|FG002|Infant Series|Lost to Follow-up|0|||
94332116|NCT01392378|322996503|FG003|Infant Series|Lost to Follow-up|1|||
94332117|NCT01392378|322996504|FG004|Infant Series|Lost to Follow-up|0|||
94332118|NCT01392378|322996500|FG000|Infant Series|Protocol Violation|0|||
94332119|NCT01392378|322996501|FG001|Infant Series|Protocol Violation|1|||
94332120|NCT01392378|322996502|FG002|Infant Series|Protocol Violation|0|||
94332121|NCT01392378|322996503|FG003|Infant Series|Protocol Violation|0|||
94332122|NCT01392378|322996504|FG004|Infant Series|Protocol Violation|0|||
94332123|NCT01392378|322996500|FG000|Infant Series|Withdrawal by Parent|4|||
94332124|NCT01392378|322996501|FG001|Infant Series|Withdrawal by Parent|1|||
94332125|NCT01392378|322996502|FG002|Infant Series|Withdrawal by Parent|0|||
94332126|NCT01392378|322996503|FG003|Infant Series|Withdrawal by Parent|0|||
94332127|NCT01392378|322996504|FG004|Infant Series|Withdrawal by Parent|0|||
94332128|NCT01392378|322996500|FG000|After Infant Series|Lost to Follow-up|0|||
94332129|NCT01392378|322996501|FG001|After Infant Series|Lost to Follow-up|0|||
94332130|NCT01392378|322996502|FG002|After Infant Series|Lost to Follow-up|1|||
94332131|NCT01392378|322996503|FG003|After Infant Series|Lost to Follow-up|0|||
94332132|NCT01392378|322996504|FG004|After Infant Series|Lost to Follow-up|0|||
94332133|NCT01392378|322996500|FG000|After Infant Series|Withdrawal by Parent|0|||
94332134|NCT01392378|322996501|FG001|After Infant Series|Withdrawal by Parent|1|||
94332135|NCT01392378|322996502|FG002|After Infant Series|Withdrawal by Parent|1|||
94332136|NCT01392378|322996503|FG003|After Infant Series|Withdrawal by Parent|0|||
94332137|NCT01392378|322996504|FG004|After Infant Series|Withdrawal by Parent|1|||
94332138|NCT01392378|322996500|FG000|Toddler Dose|Lost to Follow-up|0|||
94332139|NCT01392378|322996501|FG001|Toddler Dose|Lost to Follow-up|0|||
94332140|NCT01392378|322996502|FG002|Toddler Dose|Lost to Follow-up|0|||
94332141|NCT01392378|322996503|FG003|Toddler Dose|Lost to Follow-up|1|||
94332142|NCT01392378|322996504|FG004|Toddler Dose|Lost to Follow-up|0|||
94332143|NCT01392378|322996500|FG000|Toddler Dose|Withdrawal by Parent|0|||
94332144|NCT01392378|322996501|FG001|Toddler Dose|Withdrawal by Parent|1|||
94332145|NCT01392378|322996502|FG002|Toddler Dose|Withdrawal by Parent|0|||
94332146|NCT01392378|322996503|FG003|Toddler Dose|Withdrawal by Parent|1|||
94332147|NCT01392378|322996504|FG004|Toddler Dose|Withdrawal by Parent|1|||
94332148|NCT01998880|322996511|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
94332149|NCT01998880|322996512|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
94332150|NCT01998880|322996511|FG000|Overall Study|Disease Progression|1|||
94332151|NCT01998880|322996512|FG001|Overall Study|Disease Progression|8|||
94332152|NCT01998880|322996511|FG000|Overall Study|Withdrew Consent|2|||
94332153|NCT01998880|322996512|FG001|Overall Study|Withdrew Consent|1|||
94332154|NCT01998880|322996511|FG000|Overall Study|Death|3|||
94332155|NCT01998880|322996512|FG001|Overall Study|Death|6|||
94332156|NCT01998880|322996511|FG000|Overall Study|Insufficient Therapeutic Response|1|||
94332157|NCT01998880|322996512|FG001|Overall Study|Insufficient Therapeutic Response|5|||
94332158|NCT01998880|322996511|FG000|Overall Study|Administrative/Other|1|||
94332159|NCT01998880|322996512|FG001|Overall Study|Administrative/Other|1|||
94332160|NCT01998880|322996511|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
94332161|NCT01998880|322996512|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
94332162|NCT01998880|322996511|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
94332163|NCT01998880|322996512|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
94332164|NCT01998880|322996511|FG000|Overall Study|Did Not Receive Treatment|3|||
94332165|NCT01998880|322996512|FG001|Overall Study|Did Not Receive Treatment|2|||
94332166|NCT01419080|322996513|FG000|Overall Study|Withdrawal by Subject|75|||
94332167|NCT01419080|322996513|FG000|Overall Study|Death|30|||
94332168|NCT01419080|322996513|FG000|Overall Study|Lost to Follow-up|23|||
94332169|NCT01419080|322996513|FG000|Overall Study|Too Ill|3|||
94332170|NCT03199638|322996514|FG000|Overall Study|inability to drink glutamine during regularly|0|||
94332171|NCT03199638|322996515|FG001|Overall Study|inability to drink glutamine during regularly|2|||
94332172|NCT01575899|322996518|FG000|Overall Study|Lost to Follow-up|3|||
94332173|NCT01575899|322996519|FG001|Overall Study|Lost to Follow-up|4|||
94332174|NCT01575899|322996520|FG002|Overall Study|Lost to Follow-up|2|||
94332175|NCT01575899|322996518|FG000|Overall Study|Protocol Violation|2|||
94332176|NCT01575899|322996519|FG001|Overall Study|Protocol Violation|1|||
94332177|NCT01575899|322996520|FG002|Overall Study|Protocol Violation|0|||
94332178|NCT02261883|322996521|FG000|Overall Study|Death|3|||
94332179|NCT02261883|322996522|FG001|Overall Study|Death|2|||
94332180|NCT02261883|322996521|FG000|Overall Study|Physician Decision|1|||
94332181|NCT02261883|322996522|FG001|Overall Study|Physician Decision|0|||
94332182|NCT02261883|322996521|FG000|Overall Study|Protocol Violation|1|||
94332183|NCT02261883|322996522|FG001|Overall Study|Protocol Violation|0|||
94332184|NCT02261883|322996521|FG000|Overall Study|Withdrawal by Subject|0|||
94332185|NCT02261883|322996522|FG001|Overall Study|Withdrawal by Subject|1|||
94332186|NCT02261883|322996521|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
94332187|NCT02261883|322996522|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
94332188|NCT00709124|322996523|FG000|Overall Study|Death|3|||
94332189|NCT00709124|322996524|FG001|Overall Study|Death|1|||
94332190|NCT00709124|322996523|FG000|Overall Study|encephalopathy; can't do assessment|1|||
94332191|NCT00709124|322996524|FG001|Overall Study|encephalopathy; can't do assessment|0|||
94332192|NCT03726333|322996529|FG000|Overall Study|Progressive Disease|0|||
94332193|NCT03726333|322996530|FG001|Overall Study|Progressive Disease|0|||
94332194|NCT03726333|322996531|FG002|Overall Study|Progressive Disease|1|||
94332195|NCT03726333|322996532|FG003|Overall Study|Progressive Disease|0|||
94332196|NCT03726333|322996533|FG004|Overall Study|Progressive Disease|0|||
94332197|NCT01410799|322996534|FG000|Overall Study|PI decision|13|||
94332198|NCT03627494|322996535|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
94332199|NCT03627494|322996536|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
94332200|NCT03627494|322996537|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
94332201|NCT03627494|322996538|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
94332202|NCT03627494|322996539|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
94332203|NCT03627494|322996540|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
94332204|NCT03627494|322996541|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
94439779|NCT04324073|323397828|FG003|Overall Study|withdrew consent|8|||
94332205|NCT03627494|322996542|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
94332206|NCT03627494|322996543|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
94332207|NCT03627494|322996544|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
94332208|NCT03627494|322996545|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
94332209|NCT03627494|322996546|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
94332210|NCT03627494|322996535|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
94332211|NCT03627494|322996536|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
94332212|NCT03627494|322996537|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
94332213|NCT03627494|322996538|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
94332214|NCT03627494|322996539|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
94332215|NCT03627494|322996540|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
94332216|NCT03627494|322996541|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
94332217|NCT03627494|322996542|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
94332218|NCT03627494|322996543|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
94332219|NCT03627494|322996544|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
94332220|NCT03627494|322996545|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
94332221|NCT03627494|322996546|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
94332222|NCT03627494|322996535|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
94332223|NCT03627494|322996536|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
94332224|NCT03627494|322996537|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
94332225|NCT03627494|322996538|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
94332226|NCT03627494|322996539|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
94332227|NCT03627494|322996540|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
94332228|NCT03627494|322996541|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
94332229|NCT03627494|322996542|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
94332230|NCT03627494|322996543|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
94332231|NCT03627494|322996544|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
94332232|NCT03627494|322996545|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
94332233|NCT03627494|322996546|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
94332234|NCT00355134|322998713|FG000|Core Phase|Withdrawal by Subject|35|||
94332235|NCT00355134|322998714|FG001|Core Phase|Withdrawal by Subject|24|||
94332236|NCT00355134|322998715|FG002|Core Phase|Withdrawal by Subject|35|||
94439780|NCT04147234|323397829|FG000|Overall Study|Clinical deterioration|0|||
94439781|NCT04147234|323397830|FG001|Overall Study|Clinical deterioration|0|||
94548415|NCT01977690|323803431|FG001|Overall Study|Withdrawal by Subject|4|||
94548416|NCT02644356|323803434|FG000|Overall Study|Withdrawal by Subject|2|||
94548417|NCT00324233|323803435|FG000|First Period|unable to insert catheter|1|||
94548418|NCT00324233|323803436|FG001|First Period|unable to insert catheter|0|||
94548419|NCT00324233|323803435|FG000|Second Period|unable to insert catheter|1|||
94548420|NCT00324233|323803436|FG001|Second Period|unable to insert catheter|1|||
94548421|NCT00324233|323803435|FG000|Second Period|Protocol Violation|4|||
94548422|NCT00324233|323803436|FG001|Second Period|Protocol Violation|6|||
94548423|NCT02540291|323803440|FG000|Overall Study|Death|7|||
94548424|NCT02540291|323803441|FG001|Overall Study|Death|7|||
94548425|NCT02540291|323803442|FG002|Overall Study|Death|5|||
94548426|NCT02540291|323803443|FG003|Overall Study|Death|7|||
94548427|NCT02540291|323803440|FG000|Overall Study|Lost to Follow-up|0|||
94548428|NCT02540291|323803441|FG001|Overall Study|Lost to Follow-up|0|||
94548429|NCT02540291|323803442|FG002|Overall Study|Lost to Follow-up|1|||
94548430|NCT02540291|323803443|FG003|Overall Study|Lost to Follow-up|0|||
94548431|NCT02540291|323803440|FG000|Overall Study|Withdrawal Of Consent|0|||
94548432|NCT02540291|323803441|FG001|Overall Study|Withdrawal Of Consent|1|||
94439782|NCT04147234|323397831|FG002|Overall Study|Clinical deterioration|1|||
94439783|NCT04147234|323397832|FG003|Overall Study|Clinical deterioration|0|||
94332237|NCT00355134|322998716|FG003|Core Phase|Withdrawal by Subject|0|||
94332238|NCT00355134|322998717|FG004|Core Phase|Withdrawal by Subject|0|||
94332239|NCT00355134|322998713|FG000|Core Phase|Adverse Event|28|||
94332240|NCT00355134|322998714|FG001|Core Phase|Adverse Event|22|||
94332241|NCT00355134|322998715|FG002|Core Phase|Adverse Event|16|||
94332242|NCT00355134|322998716|FG003|Core Phase|Adverse Event|0|||
94548433|NCT02540291|323803442|FG002|Overall Study|Withdrawal Of Consent|0|||
94548434|NCT02540291|323803443|FG003|Overall Study|Withdrawal Of Consent|0|||
94548435|NCT02540291|323803440|FG000|Overall Study|Study Terminated By Sponsor|1|||
94548436|NCT02540291|323803441|FG001|Overall Study|Study Terminated By Sponsor|0|||
94548437|NCT02540291|323803442|FG002|Overall Study|Study Terminated By Sponsor|0|||
94548438|NCT02540291|323803443|FG003|Overall Study|Study Terminated By Sponsor|0|||
94548439|NCT02540291|323803440|FG000|Overall Study|Other|0|||
94548440|NCT02540291|323803441|FG001|Overall Study|Other|0|||
94548441|NCT02540291|323803442|FG002|Overall Study|Other|1|||
94548442|NCT02540291|323803443|FG003|Overall Study|Other|0|||
94548443|NCT00279812|323803453|FG000|Overall Study|Protocol Violation|1|||
94548444|NCT00279812|323803454|FG001|Overall Study|Protocol Violation|1|||
94548445|NCT00279812|323803455|FG002|Overall Study|Protocol Violation|0|||
94548446|NCT00279812|323803456|FG003|Overall Study|Protocol Violation|0|||
94548447|NCT00279812|323803457|FG004|Overall Study|Protocol Violation|1|||
94548448|NCT00279812|323803458|FG005|Overall Study|Protocol Violation|0|||
94548449|NCT00279812|323803453|FG000|Overall Study|Withdrawal by Subject|0|||
94548450|NCT00279812|323803454|FG001|Overall Study|Withdrawal by Subject|4|||
94548451|NCT00279812|323803455|FG002|Overall Study|Withdrawal by Subject|2|||
94548452|NCT00279812|323803456|FG003|Overall Study|Withdrawal by Subject|0|||
94332243|NCT00355134|322998717|FG004|Core Phase|Adverse Event|0|||
94332244|NCT00355134|322998713|FG000|Core Phase|Lost to Follow-up|17|||
94332245|NCT00355134|322998714|FG001|Core Phase|Lost to Follow-up|13|||
94332246|NCT00355134|322998715|FG002|Core Phase|Lost to Follow-up|21|||
94332247|NCT00355134|322998716|FG003|Core Phase|Lost to Follow-up|0|||
94332248|NCT00355134|322998717|FG004|Core Phase|Lost to Follow-up|0|||
94332249|NCT00355134|322998713|FG000|Core Phase|Abnormal laboratory value(s)|19|||
94332250|NCT00355134|322998714|FG001|Core Phase|Abnormal laboratory value(s)|14|||
94332251|NCT00355134|322998715|FG002|Core Phase|Abnormal laboratory value(s)|2|||
94332252|NCT00355134|322998716|FG003|Core Phase|Abnormal laboratory value(s)|0|||
94332253|NCT00355134|322998717|FG004|Core Phase|Abnormal laboratory value(s)|0|||
94332254|NCT00355134|322998713|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
94548453|NCT00279812|323803457|FG004|Overall Study|Withdrawal by Subject|0|||
94548454|NCT00279812|323803458|FG005|Overall Study|Withdrawal by Subject|0|||
94548455|NCT00279812|323803453|FG000|Overall Study|Adverse Event|0|||
94548456|NCT00279812|323803454|FG001|Overall Study|Adverse Event|1|||
94548457|NCT00279812|323803455|FG002|Overall Study|Adverse Event|1|||
94548458|NCT00279812|323803456|FG003|Overall Study|Adverse Event|0|||
94332255|NCT00355134|322998714|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
94548459|NCT00279812|323803457|FG004|Overall Study|Adverse Event|2|||
94548460|NCT00279812|323803458|FG005|Overall Study|Adverse Event|1|||
94332256|NCT00355134|322998715|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
94332257|NCT00355134|322998716|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
94332258|NCT00355134|322998717|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
94332259|NCT00355134|322998713|FG000|Core Phase|Administrative problems|5|||
94332260|NCT00355134|322998714|FG001|Core Phase|Administrative problems|3|||
94332261|NCT00355134|322998715|FG002|Core Phase|Administrative problems|5|||
94332262|NCT00355134|322998716|FG003|Core Phase|Administrative problems|0|||
94332263|NCT00355134|322998717|FG004|Core Phase|Administrative problems|0|||
94332264|NCT00355134|322998713|FG000|Core Phase|Protocol Violation|3|||
94332265|NCT00355134|322998714|FG001|Core Phase|Protocol Violation|2|||
94332266|NCT00355134|322998715|FG002|Core Phase|Protocol Violation|2|||
94332267|NCT00355134|322998716|FG003|Core Phase|Protocol Violation|0|||
94548461|NCT00528996|323805582|FG000|Overall Study|Other reasons than listing|6|||
94548462|NCT00528996|323805583|FG001|Overall Study|Other reasons than listing|7|||
94548463|NCT00528996|323805584|FG002|Overall Study|Other reasons than listing|14|||
94548464|NCT00528996|323805585|FG003|Overall Study|Other reasons than listing|11|||
94332268|NCT00355134|322998717|FG004|Core Phase|Protocol Violation|0|||
94332269|NCT00355134|322998713|FG000|Core Phase|Abnormal test procedure result(s)|1|||
94332270|NCT00355134|322998714|FG001|Core Phase|Abnormal test procedure result(s)|2|||
94332271|NCT00355134|322998715|FG002|Core Phase|Abnormal test procedure result(s)|1|||
94332272|NCT00355134|322998716|FG003|Core Phase|Abnormal test procedure result(s)|0|||
94332273|NCT00355134|322998717|FG004|Core Phase|Abnormal test procedure result(s)|0|||
94332274|NCT00355134|322998713|FG000|Core Phase|Condition no longer requires study drug|1|||
94332275|NCT00355134|322998714|FG001|Core Phase|Condition no longer requires study drug|0|||
94332276|NCT00355134|322998715|FG002|Core Phase|Condition no longer requires study drug|1|||
94548465|NCT00528996|323805586|FG004|Overall Study|Other reasons than listing|5|||
94548466|NCT00528996|323805582|FG000|Overall Study|Refused continue medication|16|||
94548467|NCT00528996|323805583|FG001|Overall Study|Refused continue medication|0|||
94548468|NCT00528996|323805584|FG002|Overall Study|Refused continue medication|3|||
94548469|NCT00528996|323805585|FG003|Overall Study|Refused continue medication|3|||
94548470|NCT00528996|323805586|FG004|Overall Study|Refused continue medication|6|||
94548471|NCT00528996|323805582|FG000|Overall Study|Lost to Follow-up|2|||
94548472|NCT00528996|323805583|FG001|Overall Study|Lost to Follow-up|0|||
94548473|NCT00528996|323805584|FG002|Overall Study|Lost to Follow-up|4|||
94548474|NCT00528996|323805585|FG003|Overall Study|Lost to Follow-up|1|||
94548475|NCT00528996|323805586|FG004|Overall Study|Lost to Follow-up|3|||
94548476|NCT00528996|323805582|FG000|Overall Study|Protocol Violation|1|||
94548477|NCT00528996|323805583|FG001|Overall Study|Protocol Violation|2|||
94548478|NCT00528996|323805584|FG002|Overall Study|Protocol Violation|3|||
94548479|NCT00528996|323805585|FG003|Overall Study|Protocol Violation|3|||
94548480|NCT00528996|323805586|FG004|Overall Study|Protocol Violation|2|||
94548481|NCT00528996|323805582|FG000|Overall Study|Lack of Efficacy|7|||
94548482|NCT00528996|323805583|FG001|Overall Study|Lack of Efficacy|2|||
94332277|NCT00355134|322998716|FG003|Core Phase|Condition no longer requires study drug|0|||
94332278|NCT00355134|322998717|FG004|Core Phase|Condition no longer requires study drug|0|||
94332279|NCT00355134|322998713|FG000|Extension Phase|Withdrawal by Subject|7|||
94332280|NCT00355134|322998714|FG001|Extension Phase|Withdrawal by Subject|11|||
94548483|NCT00528996|323805584|FG002|Overall Study|Lack of Efficacy|1|||
94548484|NCT00528996|323805585|FG003|Overall Study|Lack of Efficacy|3|||
94548485|NCT00528996|323805586|FG004|Overall Study|Lack of Efficacy|3|||
94548486|NCT00528996|323805582|FG000|Overall Study|Adverse Event|32|||
94548487|NCT00528996|323805583|FG001|Overall Study|Adverse Event|13|||
94548488|NCT00528996|323805584|FG002|Overall Study|Adverse Event|18|||
94548489|NCT00528996|323805585|FG003|Overall Study|Adverse Event|29|||
94548490|NCT00528996|323805586|FG004|Overall Study|Adverse Event|18|||
94548491|NCT00837759|323805595|FG000|Overall Study|Protocol Violation|3|||
94548492|NCT00837759|323805595|FG000|Overall Study|Lost to Follow-up|1|||
94548493|NCT05565937|323805596|FG000|Overall Study|Adverse Event|0|||
94548494|NCT05565937|323805597|FG001|Overall Study|Adverse Event|1|||
94548495|NCT05565937|323805596|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
94332281|NCT00355134|322998715|FG002|Extension Phase|Withdrawal by Subject|0|||
94332282|NCT00355134|322998716|FG003|Extension Phase|Withdrawal by Subject|7|||
94332283|NCT00355134|322998717|FG004|Extension Phase|Withdrawal by Subject|5|||
94548496|NCT05565937|323805597|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
94548497|NCT05565937|323805596|FG000|Overall Study|Lost to Follow-up|2|||
94548498|NCT05565937|323805597|FG001|Overall Study|Lost to Follow-up|0|||
94548499|NCT05565937|323805596|FG000|Overall Study|Pregnancy|0|||
94548500|NCT05565937|323805597|FG001|Overall Study|Pregnancy|2|||
94548501|NCT05565937|323805596|FG000|Overall Study|Anisometropia|0|||
94548502|NCT05565937|323805597|FG001|Overall Study|Anisometropia|1|||
94548503|NCT01022424|323805599|FG000|Overall Study|Adverse Event|1|||
94548504|NCT01022424|323805599|FG000|Overall Study|Physician Decision|1|||
94548505|NCT01022424|323805599|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
94548506|NCT00151372|323805600|FG000|Overall Study|Death|12|||
94548507|NCT00151372|323805601|FG001|Overall Study|Death|11|||
94548508|NCT00151372|323805600|FG000|Overall Study|Lost to Follow-up|5|||
94548509|NCT00151372|323805601|FG001|Overall Study|Lost to Follow-up|5|||
94548510|NCT00151372|323805600|FG000|Overall Study|Too sick medically to continue|5|||
94548511|NCT00151372|323805601|FG001|Overall Study|Too sick medically to continue|6|||
94548512|NCT00151372|323805600|FG000|Overall Study|Withdrawal by Subject|7|||
94548513|NCT00151372|323805601|FG001|Overall Study|Withdrawal by Subject|7|||
94548514|NCT00203021|323805610|FG000|Overall Study|Death|4|||
94548515|NCT00203021|323805611|FG001|Overall Study|Death|1|||
94548516|NCT00203021|323805610|FG000|Overall Study|Adverse Event|10|||
94548517|NCT00203021|323805611|FG001|Overall Study|Adverse Event|5|||
94548518|NCT00203021|323805610|FG000|Overall Study|Withdrawal by Subject|45|||
94548519|NCT00203021|323805611|FG001|Overall Study|Withdrawal by Subject|48|||
94548520|NCT00203021|323805610|FG000|Overall Study|Lost to Follow-up|9|||
94548521|NCT00203021|323805611|FG001|Overall Study|Lost to Follow-up|7|||
94548522|NCT00203021|323805610|FG000|Overall Study|Other than specified|11|||
94548523|NCT00203021|323805611|FG001|Overall Study|Other than specified|16|||
94548524|NCT02198794|323805612|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
94548525|NCT02198794|323805613|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
94548526|NCT02198794|323805614|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
94548527|NCT02198794|323805615|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
94548528|NCT02198794|323805612|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
94548529|NCT02198794|323805613|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
94548530|NCT02198794|323805614|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
94548531|NCT02198794|323805615|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
94548532|NCT02198794|323805612|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
94548533|NCT02198794|323805613|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
94548534|NCT02198794|323805614|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
94548535|NCT02198794|323805615|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
94548536|NCT02198794|323805612|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
94332284|NCT00355134|322998713|FG000|Extension Phase|Adverse Event|13|||
94332285|NCT00355134|322998714|FG001|Extension Phase|Adverse Event|9|||
94332286|NCT00355134|322998715|FG002|Extension Phase|Adverse Event|0|||
94332287|NCT00355134|322998716|FG003|Extension Phase|Adverse Event|3|||
94332288|NCT00355134|322998717|FG004|Extension Phase|Adverse Event|5|||
94332289|NCT00355134|322998713|FG000|Extension Phase|Lost to Follow-up|2|||
94332290|NCT00355134|322998714|FG001|Extension Phase|Lost to Follow-up|6|||
94332291|NCT00355134|322998715|FG002|Extension Phase|Lost to Follow-up|0|||
94332292|NCT00355134|322998716|FG003|Extension Phase|Lost to Follow-up|2|||
94332293|NCT00355134|322998717|FG004|Extension Phase|Lost to Follow-up|4|||
94332294|NCT00355134|322998713|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
94332295|NCT00355134|322998714|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
94548537|NCT02198794|323805613|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
94548538|NCT02198794|323805614|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
94548539|NCT02198794|323805615|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
94548540|NCT02198794|323805612|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
94548541|NCT02198794|323805613|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
94548542|NCT02198794|323805614|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
94548543|NCT02198794|323805615|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
94548544|NCT02198794|323805612|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
94548545|NCT02198794|323805613|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
94548546|NCT02198794|323805614|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
94548547|NCT02198794|323805615|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
94548548|NCT02198794|323805612|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
94548549|NCT02198794|323805613|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
94548550|NCT02198794|323805614|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
94548551|NCT02198794|323805615|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
94548552|NCT02198794|323805612|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
94548553|NCT02198794|323805613|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
94548554|NCT02198794|323805614|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
94548555|NCT02198794|323805615|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
94548556|NCT02198794|323805612|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
94548557|NCT02198794|323805613|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
94548558|NCT02198794|323805614|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
94548559|NCT02198794|323805615|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
94332296|NCT00355134|322998715|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
94548560|NCT02198794|323805612|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
94548561|NCT02198794|323805613|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
94548562|NCT02198794|323805614|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
94548563|NCT02198794|323805615|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
94548564|NCT02198794|323805612|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
94548565|NCT02198794|323805613|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
94548566|NCT02198794|323805614|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
94548567|NCT02198794|323805615|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
94548568|NCT02198794|323805612|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
94548569|NCT02198794|323805613|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
94548570|NCT02198794|323805614|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
94548571|NCT02198794|323805615|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
94548572|NCT02198794|323805612|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
94548573|NCT02198794|323805613|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
94548574|NCT02198794|323805614|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
94548575|NCT02198794|323805615|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
94651297|NCT02460224|324179736|FG021|Overall Study|Physician Decision|1|||
94651298|NCT02460224|324179737|FG022|Overall Study|Physician Decision|0|||
94651299|NCT02460224|324179738|FG023|Overall Study|Physician Decision|0|||
94651300|NCT02460224|324179739|FG024|Overall Study|Physician Decision|1|||
94656920|NCT00852397|324199987|FG002|Overall Study|Withdrawal by Subject|2|||
94656921|NCT00852397|324199985|FG000|Overall Study|Study terminated by sponsor|2|||
94332297|NCT00355134|322998716|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
94332298|NCT00355134|322998717|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
94332299|NCT00355134|322998713|FG000|Extension Phase|Administrative problems|2|||
94332300|NCT00355134|322998714|FG001|Extension Phase|Administrative problems|4|||
94332301|NCT00355134|322998715|FG002|Extension Phase|Administrative problems|0|||
94332302|NCT00355134|322998716|FG003|Extension Phase|Administrative problems|1|||
94332303|NCT00355134|322998717|FG004|Extension Phase|Administrative problems|1|||
94332304|NCT00355134|322998713|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
94332305|NCT00355134|322998714|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
94332306|NCT00355134|322998715|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
94656922|NCT00852397|324199986|FG001|Overall Study|Study terminated by sponsor|1|||
94656923|NCT00852397|324199987|FG002|Overall Study|Study terminated by sponsor|6|||
94656924|NCT00852397|324199985|FG000|Overall Study|Difficulty in study site visit|1|||
94688551|NCT02960763|324315508|FG004|Step 2|Lost to Follow-up|1|||
94332307|NCT00355134|322998716|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
94332308|NCT00355134|322998717|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
94332309|NCT00355134|322998713|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
94332310|NCT00355134|322998714|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
94332311|NCT00355134|322998715|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
94332312|NCT00355134|322998716|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
94332313|NCT00355134|322998717|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
94332314|NCT00355134|322998713|FG000|Extension Phase|Protocol Violation|0|||
94332315|NCT00355134|322998714|FG001|Extension Phase|Protocol Violation|0|||
94332316|NCT00355134|322998715|FG002|Extension Phase|Protocol Violation|0|||
94332317|NCT00355134|322998716|FG003|Extension Phase|Protocol Violation|1|||
94332318|NCT00355134|322998717|FG004|Extension Phase|Protocol Violation|0|||
94332319|NCT02848313|322998718|FG000|Overall Study|Adverse Event|1|||
94332320|NCT02848313|322998719|FG001|Overall Study|Adverse Event|2|||
94332321|NCT02848313|322998718|FG000|Overall Study|Lack of Efficacy|0|||
94332322|NCT02848313|322998719|FG001|Overall Study|Lack of Efficacy|1|||
94332323|NCT02848313|322998718|FG000|Overall Study|Withdrawal by Subject|1|||
94332324|NCT02848313|322998719|FG001|Overall Study|Withdrawal by Subject|1|||
94332325|NCT02848313|322998718|FG000|Overall Study|Lost to follow up|1|||
94332326|NCT02848313|322998719|FG001|Overall Study|Lost to follow up|0|||
94332327|NCT03805971|322998722|FG000|Overall Study|Withdrawal by Subject|1|||
94332328|NCT03805971|322998722|FG000|Overall Study|Protocol Violation|2|||
94332329|NCT03276572|322998725|FG000|Overall Study|In follow-up|0|||
94332330|NCT03276572|322998726|FG001|Overall Study|In follow-up|0|||
94332331|NCT03276572|322998727|FG002|Overall Study|In follow-up|0|||
94332332|NCT03276572|322998728|FG003|Overall Study|In follow-up|0|||
94332333|NCT03276572|322998729|FG004|Overall Study|In follow-up|0|||
94332334|NCT03276572|322998730|FG005|Overall Study|In follow-up|1|||
94332335|NCT03276572|322998731|FG006|Overall Study|In follow-up|1|||
94651301|NCT02460224|324179740|FG025|Overall Study|Physician Decision|0|||
94651302|NCT02460224|324179741|FG026|Overall Study|Physician Decision|14|||
94651303|NCT02460224|324179742|FG027|Overall Study|Physician Decision|1|||
94651304|NCT02460224|324179743|FG028|Overall Study|Physician Decision|6|||
94651305|NCT02460224|324179715|FG000|Overall Study|Progressive disease|15|||
94651306|NCT02460224|324179716|FG001|Overall Study|Progressive disease|11|||
94651307|NCT02460224|324179717|FG002|Overall Study|Progressive disease|5|||
94651308|NCT02460224|324179718|FG003|Overall Study|Progressive disease|6|||
94651309|NCT02460224|324179719|FG004|Overall Study|Progressive disease|3|||
94651310|NCT02460224|324179720|FG005|Overall Study|Progressive disease|26|||
94651311|NCT02460224|324179721|FG006|Overall Study|Progressive disease|28|||
94656925|NCT00852397|324199986|FG001|Overall Study|Difficulty in study site visit|0|||
94656926|NCT00852397|324199987|FG002|Overall Study|Difficulty in study site visit|0|||
94656927|NCT00852397|324199985|FG000|Overall Study|Protocol Violation|0|||
94656928|NCT00852397|324199986|FG001|Overall Study|Protocol Violation|0|||
94656929|NCT00852397|324199987|FG002|Overall Study|Protocol Violation|1|||
94656930|NCT01438541|324199988|FG000|Overall Study|Physician Decision|1|||
94656931|NCT01438541|324199988|FG000|Overall Study|Withdrawal by Subject|1|||
94656932|NCT01438541|324199988|FG000|Overall Study|discharge from the hospital|5|||
94656933|NCT01968434|324199989|FG000|Overall Study|Lost to Follow-up|3|||
94656934|NCT01968434|324199990|FG001|Overall Study|Lost to Follow-up|6|||
94656935|NCT02766608|324202105|FG000|Overall Study|Adverse Event|27|||
94656936|NCT02766608|324202106|FG001|Overall Study|Adverse Event|22|||
94656937|NCT02766608|324202107|FG002|Overall Study|Adverse Event|17|||
94656938|NCT02766608|324202108|FG003|Overall Study|Adverse Event|13|||
94332336|NCT03276572|322998725|FG000|Overall Study|Lost to Follow-up|0|||
94332337|NCT03276572|322998726|FG001|Overall Study|Lost to Follow-up|0|||
94332338|NCT03276572|322998727|FG002|Overall Study|Lost to Follow-up|0|||
94332339|NCT03276572|322998728|FG003|Overall Study|Lost to Follow-up|0|||
94332340|NCT03276572|322998729|FG004|Overall Study|Lost to Follow-up|0|||
94332341|NCT03276572|322998730|FG005|Overall Study|Lost to Follow-up|0|||
94332342|NCT03276572|322998731|FG006|Overall Study|Lost to Follow-up|1|||
94332343|NCT02580240|322998749|FG000|Overall Study|Physician Decision|2|||
94332344|NCT02580240|322998750|FG001|Overall Study|Physician Decision|0|||
94332345|NCT00607919|322998751|FG000|Acute Phase|Adverse Event|9|||
94332346|NCT00607919|322998752|FG001|Acute Phase|Adverse Event|2|||
94332347|NCT00607919|322998751|FG000|Acute Phase|Entry Criteria Not Met|1|||
94332348|NCT00607919|322998752|FG001|Acute Phase|Entry Criteria Not Met|1|||
94332349|NCT00607919|322998751|FG000|Acute Phase|Lack of Efficacy|1|||
94656939|NCT02766608|324202109|FG004|Overall Study|Adverse Event|12|||
94656940|NCT02766608|324202105|FG000|Overall Study|Withdrawal by Subject|21|||
94656941|NCT02766608|324202106|FG001|Overall Study|Withdrawal by Subject|20|||
94656942|NCT02766608|324202107|FG002|Overall Study|Withdrawal by Subject|24|||
94656943|NCT02766608|324202108|FG003|Overall Study|Withdrawal by Subject|13|||
94656944|NCT02766608|324202109|FG004|Overall Study|Withdrawal by Subject|10|||
94656945|NCT02766608|324202105|FG000|Overall Study|Lack of Efficacy|16|||
94656946|NCT02766608|324202106|FG001|Overall Study|Lack of Efficacy|15|||
94656947|NCT02766608|324202107|FG002|Overall Study|Lack of Efficacy|32|||
94656948|NCT02766608|324202108|FG003|Overall Study|Lack of Efficacy|8|||
94656949|NCT02766608|324202109|FG004|Overall Study|Lack of Efficacy|2|||
94656950|NCT02766608|324202105|FG000|Overall Study|Lost to Follow-up|6|||
94656951|NCT02766608|324202106|FG001|Overall Study|Lost to Follow-up|3|||
94656952|NCT02766608|324202107|FG002|Overall Study|Lost to Follow-up|5|||
94656953|NCT02766608|324202108|FG003|Overall Study|Lost to Follow-up|2|||
94656954|NCT02766608|324202109|FG004|Overall Study|Lost to Follow-up|2|||
94656955|NCT02766608|324202105|FG000|Overall Study|Physician Decision|3|||
94656956|NCT02766608|324202106|FG001|Overall Study|Physician Decision|2|||
94656957|NCT02766608|324202107|FG002|Overall Study|Physician Decision|3|||
94656958|NCT02766608|324202108|FG003|Overall Study|Physician Decision|1|||
94656959|NCT02766608|324202109|FG004|Overall Study|Physician Decision|2|||
94656960|NCT02766608|324202105|FG000|Overall Study|Protocol disc criteria|3|||
94656961|NCT02766608|324202106|FG001|Overall Study|Protocol disc criteria|3|||
94656962|NCT02766608|324202107|FG002|Overall Study|Protocol disc criteria|4|||
94656963|NCT02766608|324202108|FG003|Overall Study|Protocol disc criteria|0|||
94656964|NCT02766608|324202109|FG004|Overall Study|Protocol disc criteria|0|||
94656965|NCT02766608|324202105|FG000|Overall Study|Protocol Violation|0|||
94656966|NCT02766608|324202106|FG001|Overall Study|Protocol Violation|4|||
94656967|NCT02766608|324202107|FG002|Overall Study|Protocol Violation|4|||
94656968|NCT02766608|324202108|FG003|Overall Study|Protocol Violation|0|||
94656969|NCT02766608|324202109|FG004|Overall Study|Protocol Violation|1|||
94656970|NCT02766608|324202105|FG000|Overall Study|Administrative Reasons|3|||
94656971|NCT02766608|324202106|FG001|Overall Study|Administrative Reasons|1|||
94656972|NCT02766608|324202107|FG002|Overall Study|Administrative Reasons|1|||
94656973|NCT02766608|324202108|FG003|Overall Study|Administrative Reasons|0|||
94656974|NCT02766608|324202109|FG004|Overall Study|Administrative Reasons|0|||
94332350|NCT00607919|322998752|FG001|Acute Phase|Lack of Efficacy|2|||
94332351|NCT00607919|322998751|FG000|Acute Phase|Lost to Follow-up|9|||
94332352|NCT00607919|322998752|FG001|Acute Phase|Lost to Follow-up|3|||
94332353|NCT00607919|322998751|FG000|Acute Phase|Parent/Caregiver Decision|6|||
94332354|NCT00607919|322998752|FG001|Acute Phase|Parent/Caregiver Decision|4|||
94656975|NCT02033889|324202111|FG000|Overall Study|Adverse Event|3|||
94656976|NCT02033889|324202112|FG001|Overall Study|Adverse Event|1|||
94656977|NCT02033889|324202113|FG002|Overall Study|Adverse Event|3|||
94656978|NCT02033889|324202111|FG000|Overall Study|Death|3|||
94656979|NCT02033889|324202112|FG001|Overall Study|Death|1|||
94656980|NCT02033889|324202113|FG002|Overall Study|Death|2|||
94656981|NCT02033889|324202111|FG000|Overall Study|Excluded Medication|1|||
94656982|NCT02033889|324202112|FG001|Overall Study|Excluded Medication|1|||
94332355|NCT00607919|322998751|FG000|Acute Phase|Protocol Violation|5|||
94332356|NCT00607919|322998752|FG001|Acute Phase|Protocol Violation|1|||
94332357|NCT00607919|322998751|FG000|Acute Phase|Withdrawal by Subject|3|||
94332358|NCT00607919|322998752|FG001|Acute Phase|Withdrawal by Subject|3|||
94332359|NCT00607919|322998751|FG000|Open-Label Phase|Adverse Event|1|||
94332360|NCT00607919|322998752|FG001|Open-Label Phase|Adverse Event|5|||
94332361|NCT00607919|322998751|FG000|Open-Label Phase|Lost to Follow-up|4|||
94332362|NCT00607919|322998752|FG001|Open-Label Phase|Lost to Follow-up|1|||
94332363|NCT00607919|322998751|FG000|Open-Label Phase|Protocol Violation|2|||
94332364|NCT00607919|322998752|FG001|Open-Label Phase|Protocol Violation|2|||
94332365|NCT00607919|322998751|FG000|Open-Label Phase|Withdrawal by Subject|2|||
94332366|NCT00607919|322998752|FG001|Open-Label Phase|Withdrawal by Subject|2|||
94332367|NCT00607919|322998751|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
94332368|NCT00607919|322998752|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
94332369|NCT01527110|322998755|FG000|Overall Study|Adverse Event|1|||
94332370|NCT02007252|322998756|FG000|Overall Study|Administrative problems|3|||
94332371|NCT02007252|322998757|FG001|Overall Study|Administrative problems|7|||
94332372|NCT02007252|322998756|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94332373|NCT02007252|322998757|FG001|Overall Study|Abnormal laboratory value(s)|0|||
94332374|NCT02007252|322998756|FG000|Overall Study|Adverse Event|7|||
94332375|NCT02007252|322998757|FG001|Overall Study|Adverse Event|4|||
94332376|NCT02533401|322998758|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
94332377|NCT02533401|322998758|FG000|Overall Study|Death|5|||
94332378|NCT02533401|322998758|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
94332379|NCT02533401|322998758|FG000|Overall Study|Lost to Follow-up|1|||
94332380|NCT02533401|322998758|FG000|Overall Study|Violation of Selection Criteria|1|||
94332381|NCT00150345|322998761|FG000|Overall Study|Death|5|||
94332382|NCT00150345|322998762|FG001|Overall Study|Death|2|||
94332383|NCT00150345|322998761|FG000|Overall Study|Adverse Event|8|||
94332384|NCT00150345|322998762|FG001|Overall Study|Adverse Event|6|||
94332385|NCT00150345|322998761|FG000|Overall Study|Lack of Efficacy|5|||
94332386|NCT00150345|322998762|FG001|Overall Study|Lack of Efficacy|4|||
94332387|NCT00150345|322998761|FG000|Overall Study|Withdrawal by Subject|3|||
94332388|NCT00150345|322998762|FG001|Overall Study|Withdrawal by Subject|4|||
94332389|NCT00150345|322998761|FG000|Overall Study|Laboratory abnormality|1|||
94332390|NCT00150345|322998762|FG001|Overall Study|Laboratory abnormality|2|||
94332391|NCT00150345|322998761|FG000|Overall Study|Other|12|||
94332392|NCT00150345|322998762|FG001|Overall Study|Other|14|||
94332393|NCT05441540|322998771|FG000|Overall Study|Withdrawal by Subject|2|||
94439784|NCT04147234|323397833|FG004|Overall Study|Clinical deterioration|0|||
94439785|NCT04147234|323397834|FG005|Overall Study|Clinical deterioration|0|||
94439786|NCT04147234|323397835|FG006|Overall Study|Clinical deterioration|0|||
94439787|NCT04147234|323397829|FG000|Overall Study|Withdrawal by Subject|0|||
94439788|NCT04147234|323397830|FG001|Overall Study|Withdrawal by Subject|1|||
94439789|NCT04147234|323397831|FG002|Overall Study|Withdrawal by Subject|1|||
94439790|NCT04147234|323397832|FG003|Overall Study|Withdrawal by Subject|0|||
94439791|NCT04147234|323397833|FG004|Overall Study|Withdrawal by Subject|0|||
94439792|NCT04147234|323397834|FG005|Overall Study|Withdrawal by Subject|0|||
94439793|NCT04147234|323397835|FG006|Overall Study|Withdrawal by Subject|0|||
94439794|NCT04147234|323397829|FG000|Overall Study|Clinical disease progression|1|||
94439795|NCT04147234|323397830|FG001|Overall Study|Clinical disease progression|3|||
94332394|NCT03934541|322998772|FG000|Overall Study|Study Terminated by Sponsor|0|||
94332395|NCT03934541|322998773|FG001|Overall Study|Study Terminated by Sponsor|1|||
94332396|NCT03934541|322998774|FG002|Overall Study|Study Terminated by Sponsor|0|||
94332397|NCT03934541|322998775|FG003|Overall Study|Study Terminated by Sponsor|0|||
94332398|NCT00105183|322998777|FG000|Overall Study|Death|19|||
94332399|NCT00105183|322998778|FG001|Overall Study|Death|13|||
94332400|NCT00105183|322998779|FG002|Overall Study|Death|15|||
94332401|NCT00105183|322998777|FG000|Overall Study|Withdrawal by Subject|1|||
94332402|NCT00105183|322998778|FG001|Overall Study|Withdrawal by Subject|1|||
94332403|NCT00105183|322998779|FG002|Overall Study|Withdrawal by Subject|4|||
94332404|NCT00105183|322998777|FG000|Overall Study|Physician Decision|1|||
94332405|NCT00105183|322998778|FG001|Overall Study|Physician Decision|2|||
94439796|NCT04147234|323397831|FG002|Overall Study|Clinical disease progression|1|||
94439797|NCT04147234|323397832|FG003|Overall Study|Clinical disease progression|1|||
94439798|NCT04147234|323397833|FG004|Overall Study|Clinical disease progression|0|||
94439799|NCT04147234|323397834|FG005|Overall Study|Clinical disease progression|1|||
94439800|NCT04147234|323397835|FG006|Overall Study|Clinical disease progression|0|||
94439801|NCT04147234|323397829|FG000|Overall Study|Objective disease progression|6|||
94439802|NCT04147234|323397830|FG001|Overall Study|Objective disease progression|4|||
94439803|NCT04147234|323397831|FG002|Overall Study|Objective disease progression|3|||
94439804|NCT04147234|323397832|FG003|Overall Study|Objective disease progression|3|||
94332406|NCT00105183|322998779|FG002|Overall Study|Physician Decision|3|||
94332407|NCT00105183|322998777|FG000|Overall Study|Lost to Follow-up|0|||
94332408|NCT00105183|322998778|FG001|Overall Study|Lost to Follow-up|1|||
94332409|NCT00105183|322998779|FG002|Overall Study|Lost to Follow-up|1|||
94224521|NCT03730662|322615078|FG002|Variable Treatment Period|Adverse Event|0|||
94224522|NCT03730662|322615079|FG003|Variable Treatment Period|Adverse Event|7|||
94224523|NCT03730662|322615076|FG000|Variable Treatment Period|Death|9|||
94224524|NCT03730662|322615077|FG001|Variable Treatment Period|Death|0|||
94224525|NCT03730662|322615078|FG002|Variable Treatment Period|Death|6|||
94224526|NCT03730662|322615079|FG003|Variable Treatment Period|Death|26|||
94224527|NCT03730662|322615076|FG000|Variable Treatment Period|Lost to Follow-up|2|||
94224528|NCT03730662|322615077|FG001|Variable Treatment Period|Lost to Follow-up|1|||
94224529|NCT03730662|322615078|FG002|Variable Treatment Period|Lost to Follow-up|4|||
94224530|NCT03730662|322615079|FG003|Variable Treatment Period|Lost to Follow-up|11|||
94548576|NCT02198794|323805612|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
94548577|NCT02198794|323805613|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
94548578|NCT02198794|323805614|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
94548579|NCT02198794|323805615|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
94548580|NCT02198794|323805612|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
94224531|NCT03730662|322615076|FG000|Variable Treatment Period|Personal Reason|0|||
94548581|NCT02198794|323805613|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
94548582|NCT02198794|323805614|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
94548583|NCT02198794|323805615|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
94548584|NCT05160766|323805616|FG000|Overall Study|Adverse Event|0|||
94548585|NCT05160766|323805617|FG001|Overall Study|Adverse Event|1|||
94548586|NCT05160766|323805618|FG002|Overall Study|Adverse Event|0|||
94548587|NCT05160766|323805619|FG003|Overall Study|Adverse Event|0|||
94548588|NCT05160766|323805616|FG000|Overall Study|COVID-19 infection|0|||
94548589|NCT05160766|323805617|FG001|Overall Study|COVID-19 infection|1|||
94548590|NCT05160766|323805618|FG002|Overall Study|COVID-19 infection|0|||
94548591|NCT05160766|323805619|FG003|Overall Study|COVID-19 infection|0|||
94548592|NCT05160766|323805616|FG000|Overall Study|travel time|1|||
94548593|NCT05160766|323805617|FG001|Overall Study|travel time|0|||
94548594|NCT05160766|323805618|FG002|Overall Study|travel time|0|||
94548595|NCT05160766|323805619|FG003|Overall Study|travel time|1|||
94548596|NCT05160766|323805616|FG000|Overall Study|Withdrawal by Subject|3|||
94548597|NCT05160766|323805617|FG001|Overall Study|Withdrawal by Subject|5|||
94548598|NCT05160766|323805618|FG002|Overall Study|Withdrawal by Subject|4|||
94548599|NCT05160766|323805619|FG003|Overall Study|Withdrawal by Subject|2|||
94548600|NCT05160766|323805616|FG000|Overall Study|Death|0|||
94548601|NCT05160766|323805617|FG001|Overall Study|Death|0|||
94548602|NCT05160766|323805618|FG002|Overall Study|Death|2|||
94548603|NCT05160766|323805619|FG003|Overall Study|Death|5|||
94548604|NCT05160766|323805616|FG000|Overall Study|Lost to Follow-up|0|||
94548605|NCT05160766|323805617|FG001|Overall Study|Lost to Follow-up|0|||
94548606|NCT05160766|323805618|FG002|Overall Study|Lost to Follow-up|1|||
94548607|NCT05160766|323805619|FG003|Overall Study|Lost to Follow-up|2|||
94548608|NCT05160766|323805616|FG000|Overall Study|No show|0|||
94548609|NCT05160766|323805617|FG001|Overall Study|No show|0|||
94548610|NCT05160766|323805618|FG002|Overall Study|No show|1|||
94548611|NCT05160766|323805619|FG003|Overall Study|No show|1|||
94548612|NCT05160766|323805616|FG000|Overall Study|Physician Decision|0|||
94548613|NCT05160766|323805617|FG001|Overall Study|Physician Decision|0|||
94548614|NCT05160766|323805618|FG002|Overall Study|Physician Decision|0|||
94548615|NCT05160766|323805619|FG003|Overall Study|Physician Decision|1|||
94548616|NCT05160766|323805616|FG000|Overall Study|Protocol Violation|0|||
94548617|NCT05160766|323805617|FG001|Overall Study|Protocol Violation|0|||
94548618|NCT05160766|323805618|FG002|Overall Study|Protocol Violation|1|||
94548619|NCT05160766|323805619|FG003|Overall Study|Protocol Violation|0|||
94548620|NCT01282294|323805620|FG000|Overall Study|Lost to Follow-up|14|||
94548621|NCT01282294|323805620|FG000|Overall Study|Screening failure|1|||
94548622|NCT01282294|323805620|FG000|Overall Study|Adverse Event|1|||
94548623|NCT01282294|323805620|FG000|Overall Study|Patient non-compliance|2|||
94548624|NCT01282294|323805620|FG000|Overall Study|Physician Decision|1|||
94548625|NCT02408523|323805621|FG000|Overall Study|Adverse Event|4|||
94548626|NCT02408523|323805622|FG001|Overall Study|Adverse Event|10|||
94548627|NCT02408523|323805621|FG000|Overall Study|Lack of Efficacy|0|||
94548628|NCT02408523|323805622|FG001|Overall Study|Lack of Efficacy|1|||
94548629|NCT02408523|323805621|FG000|Overall Study|Protocol Violation|1|||
94548630|NCT02408523|323805622|FG001|Overall Study|Protocol Violation|2|||
94548631|NCT02408523|323805621|FG000|Overall Study|Lost to Follow-up|2|||
94548632|NCT02408523|323805622|FG001|Overall Study|Lost to Follow-up|3|||
94548633|NCT02408523|323805621|FG000|Overall Study|Withdrawal by Subject|3|||
94548634|NCT02408523|323805622|FG001|Overall Study|Withdrawal by Subject|1|||
94548635|NCT02408523|323805621|FG000|Overall Study|Sponsor request|1|||
94548636|NCT02408523|323805622|FG001|Overall Study|Sponsor request|0|||
94548637|NCT02408523|323805621|FG000|Overall Study|Did not satisfy extension conditions|0|||
94548638|NCT02408523|323805622|FG001|Overall Study|Did not satisfy extension conditions|1|||
94548639|NCT01549873|323805623|FG000|Overall Study|Physician Decision|0|||
94548640|NCT01549873|323805624|FG001|Overall Study|Physician Decision|1|||
94548641|NCT02252965|323805625|FG000|Overall Study|Adverse Event|9|||
94548642|NCT02252965|323805626|FG001|Overall Study|Adverse Event|14|||
94548643|NCT02252965|323805625|FG000|Overall Study|Lost to Follow-up|16|||
94548644|NCT02252965|323805626|FG001|Overall Study|Lost to Follow-up|8|||
94548645|NCT02252965|323805625|FG000|Overall Study|Protocol Violation|4|||
94548646|NCT02252965|323805626|FG001|Overall Study|Protocol Violation|5|||
94548647|NCT02252965|323805625|FG000|Overall Study|Lack of Efficacy|0|||
94548648|NCT02252965|323805626|FG001|Overall Study|Lack of Efficacy|2|||
94548649|NCT02252965|323805625|FG000|Overall Study|Withdrawal by Subject|7|||
94548650|NCT02252965|323805626|FG001|Overall Study|Withdrawal by Subject|9|||
94548651|NCT02252965|323805625|FG000|Overall Study|Other|4|||
94548652|NCT02252965|323805626|FG001|Overall Study|Other|5|||
94548653|NCT03458910|323805627|FG000|Overall Study|Withdrawal by Subject|7|||
94548654|NCT03458910|323805628|FG001|Overall Study|Withdrawal by Subject|8|||
94548655|NCT03458910|323805629|FG002|Overall Study|Withdrawal by Subject|6|||
94548656|NCT03458910|323805630|FG003|Overall Study|Withdrawal by Subject|4|||
94548657|NCT03458910|323805627|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
94548658|NCT03458910|323805628|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
94548659|NCT03458910|323805629|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
94548660|NCT03458910|323805630|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
94548661|NCT02853435|323805631|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
94548662|NCT02853435|323805632|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
94548663|NCT02853435|323805633|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
94548664|NCT02853435|323805634|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
94548665|NCT02853435|323805635|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
94548666|NCT02853435|323805636|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
94548667|NCT01266317|323805642|FG000|Overall Study|Withdrawal by Subject|2|||
94548668|NCT03199391|323805643|FG000|Overall Study|Death|1|||
94548669|NCT03199391|323805643|FG000|Overall Study|Lost to Follow-up|3|||
94548670|NCT03199391|323805643|FG000|Overall Study|Adverse Event|2|||
94548671|NCT03199391|323805643|FG000|Overall Study|Withdrawal by Subject|10|||
94548672|NCT00490776|323805644|FG000|Overall Study|Withdrawal by Subject|1|||
94548673|NCT00490776|323805644|FG000|Overall Study|Administrative Problems|1|||
94548674|NCT00490776|323805644|FG000|Overall Study|Death|1|||
94548675|NCT00490776|323805644|FG000|Overall Study|New Cancer Therapy|1|||
94548676|NCT00490776|323805644|FG000|Overall Study|Disease Progression|5|||
94548677|NCT04736628|323805653|FG000|Overall Study|Not treated|0|||
94548678|NCT04736628|323805654|FG001|Overall Study|Not treated|0|||
94548679|NCT04736628|323805655|FG002|Overall Study|Not treated|0|||
94548680|NCT04736628|323805656|FG003|Overall Study|Not treated|2|||
94548681|NCT04736628|323805653|FG000|Overall Study|Other reason than listed|1|||
94548682|NCT04736628|323805654|FG001|Overall Study|Other reason than listed|2|||
94548683|NCT04736628|323805655|FG002|Overall Study|Other reason than listed|2|||
94548684|NCT04736628|323805656|FG003|Overall Study|Other reason than listed|3|||
94548685|NCT04736628|323805653|FG000|Overall Study|Protocol deviation|0|||
94548686|NCT04736628|323805654|FG001|Overall Study|Protocol deviation|0|||
94548687|NCT04736628|323805655|FG002|Overall Study|Protocol deviation|0|||
94548688|NCT04736628|323805656|FG003|Overall Study|Protocol deviation|1|||
94548689|NCT04736628|323805653|FG000|Overall Study|Burden of study procedures|1|||
94548690|NCT04736628|323805654|FG001|Overall Study|Burden of study procedures|0|||
94651312|NCT02460224|324179722|FG007|Overall Study|Progressive disease|4|||
94651313|NCT02460224|324179723|FG008|Overall Study|Progressive disease|5|||
94651314|NCT02460224|324179724|FG009|Overall Study|Progressive disease|9|||
94651315|NCT02460224|324179725|FG010|Overall Study|Progressive disease|5|||
94332410|NCT00105183|322998777|FG000|Overall Study|Other reason|1|||
94651316|NCT02460224|324179726|FG011|Overall Study|Progressive disease|4|||
94651317|NCT02460224|324179727|FG012|Overall Study|Progressive disease|5|||
94651318|NCT02460224|324179728|FG013|Overall Study|Progressive disease|4|||
94651319|NCT02460224|324179729|FG014|Overall Study|Progressive disease|5|||
94651320|NCT02460224|324179730|FG015|Overall Study|Progressive disease|5|||
94651321|NCT02460224|324179731|FG016|Overall Study|Progressive disease|15|||
94651322|NCT02460224|324179732|FG017|Overall Study|Progressive disease|3|||
94656983|NCT02033889|324202113|FG002|Overall Study|Excluded Medication|0|||
94656984|NCT02033889|324202111|FG000|Overall Study|Lost to Follow-up|8|||
94656985|NCT02033889|324202112|FG001|Overall Study|Lost to Follow-up|5|||
94656986|NCT02033889|324202113|FG002|Overall Study|Lost to Follow-up|6|||
94656987|NCT02033889|324202111|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94656988|NCT02033889|324202112|FG001|Overall Study|Non-Compliance With Study Drug|0|||
94656989|NCT02033889|324202113|FG002|Overall Study|Non-Compliance With Study Drug|0|||
94656990|NCT02033889|324202111|FG000|Overall Study|Physician Decision|0|||
94656991|NCT02033889|324202112|FG001|Overall Study|Physician Decision|1|||
94656992|NCT02033889|324202113|FG002|Overall Study|Physician Decision|1|||
94548691|NCT04736628|323805655|FG002|Overall Study|Burden of study procedures|0|||
94548692|NCT04736628|323805656|FG003|Overall Study|Burden of study procedures|1|||
94548693|NCT04736628|323805653|FG000|Overall Study|Change of residence|0|||
94548694|NCT04736628|323805654|FG001|Overall Study|Change of residence|1|||
94548695|NCT04736628|323805655|FG002|Overall Study|Change of residence|0|||
94548696|NCT04736628|323805656|FG003|Overall Study|Change of residence|0|||
94548697|NCT04736628|323805653|FG000|Overall Study|Perceived lack of efficacy|1|||
94548698|NCT04736628|323805654|FG001|Overall Study|Perceived lack of efficacy|0|||
94548699|NCT04736628|323805655|FG002|Overall Study|Perceived lack of efficacy|0|||
94548700|NCT04736628|323805656|FG003|Overall Study|Perceived lack of efficacy|1|||
94548701|NCT04736628|323805653|FG000|Overall Study|Adverse Event|3|||
94548702|NCT04736628|323805654|FG001|Overall Study|Adverse Event|2|||
94548703|NCT04736628|323805655|FG002|Overall Study|Adverse Event|4|||
94548704|NCT04736628|323805656|FG003|Overall Study|Adverse Event|3|||
94548705|NCT04279613|323805657|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
94548706|NCT04279613|323805658|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
94548707|NCT04279613|323805659|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
94548708|NCT04279613|323805660|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
94548709|NCT04279613|323805661|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
94548710|NCT04279613|323805657|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
94548711|NCT04279613|323805658|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
94548712|NCT04279613|323805659|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
94548713|NCT04279613|323805660|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
94548714|NCT04279613|323805661|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
94548715|NCT04279613|323805657|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
94548716|NCT04279613|323805658|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
94548717|NCT04279613|323805659|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
94548718|NCT04279613|323805660|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
94548719|NCT04279613|323805661|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
94548720|NCT04279613|323805657|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
94548721|NCT04279613|323805658|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
94548722|NCT04279613|323805659|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
94548723|NCT04279613|323805660|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
94548724|NCT04279613|323805661|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
94548725|NCT04279613|323805657|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
94548726|NCT04279613|323805658|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
94656993|NCT02033889|324202111|FG000|Overall Study|Participant moved|0|||
94656994|NCT02033889|324202112|FG001|Overall Study|Participant moved|1|||
94656995|NCT02033889|324202113|FG002|Overall Study|Participant moved|0|||
94656996|NCT02033889|324202111|FG000|Overall Study|Withdrawal by Subject|18|||
94656997|NCT02033889|324202112|FG001|Overall Study|Withdrawal by Subject|10|||
94656998|NCT02033889|324202113|FG002|Overall Study|Withdrawal by Subject|13|||
94656999|NCT01043874|324202116|FG000|Overall Study|Adverse Event|3|||
94657000|NCT01043874|324202116|FG000|Overall Study|Withdrawal by Subject|1|||
94657001|NCT01043874|324202116|FG000|Overall Study|Lack of Efficacy|1|||
94657002|NCT01043874|324202116|FG000|Overall Study|Administrative Problems|1|||
94657003|NCT00182689|324202122|FG000|Overall Study|Adverse Event|8|||
94657004|NCT00182689|324202123|FG001|Overall Study|Adverse Event|11|||
94657005|NCT00182689|324202122|FG000|Overall Study|Withdrawal by Subject|2|||
94657006|NCT00182689|324202123|FG001|Overall Study|Withdrawal by Subject|2|||
94657007|NCT00182689|324202122|FG000|Overall Study|Progression|27|||
94657008|NCT00182689|324202123|FG001|Overall Study|Progression|29|||
94657009|NCT00182689|324202122|FG000|Overall Study|Death|1|||
94657010|NCT00182689|324202123|FG001|Overall Study|Death|0|||
94657011|NCT00182689|324202122|FG000|Overall Study|not protocol specified|0|||
94657012|NCT00182689|324202123|FG001|Overall Study|not protocol specified|3|||
94657013|NCT00182689|324202122|FG000|Overall Study|Ineligible|1|||
94657014|NCT00182689|324202123|FG001|Overall Study|Ineligible|4|||
94657015|NCT00182689|324202122|FG000|Overall Study|Never received treatment|1|||
94657016|NCT00182689|324202123|FG001|Overall Study|Never received treatment|0|||
94657017|NCT03422003|324202124|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
94657018|NCT03422003|324202125|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
94657019|NCT03422003|324202124|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
94657020|NCT03422003|324202125|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
94657021|NCT01337089|324202126|FG000|Overall Study|Adverse Event|237|||
94657022|NCT01337089|324202126|FG000|Overall Study|Withdrawal by Subject|129|||
94657023|NCT01337089|324202126|FG000|Overall Study|Withdrawal by Investigator|33|||
94657024|NCT01337089|324202126|FG000|Overall Study|Met Withdrawal Criteria|3|||
94657025|NCT01337089|324202126|FG000|Overall Study|Lost to Follow-up|2|||
94657026|NCT02866682|324202129|FG000|Overall Study|Death|0|||
94657027|NCT02866682|324202130|FG001|Overall Study|Death|1|||
94657028|NCT02866682|324202129|FG000|Overall Study|Lost to Follow-up|0|||
94657029|NCT02866682|324202130|FG001|Overall Study|Lost to Follow-up|4|||
94657030|NCT02866682|324202129|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
94657031|NCT02866682|324202130|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
94657032|NCT02866682|324202129|FG000|Overall Study|Other|0|||
94657033|NCT02866682|324202130|FG001|Overall Study|Other|1|||
94657034|NCT01750268|324202131|FG000|Overall Study|Lost to Follow-up|0|||
94657035|NCT01750268|324202132|FG001|Overall Study|Lost to Follow-up|2|||
94657036|NCT01750268|324202131|FG000|Overall Study|Physician Decision|0|||
94657037|NCT01750268|324202132|FG001|Overall Study|Physician Decision|3|||
94657038|NCT01750268|324202131|FG000|Overall Study|Withdrawal by Subject|2|||
94657039|NCT01750268|324202132|FG001|Overall Study|Withdrawal by Subject|0|||
94657040|NCT01040871|324202133|FG000|Overall Study|Adverse Event|6|||
94657041|NCT01040871|324202134|FG001|Overall Study|Adverse Event|2|||
94657042|NCT01040871|324202133|FG000|Overall Study|Withdrawal by Subject|2|||
94657043|NCT01040871|324202134|FG001|Overall Study|Withdrawal by Subject|0|||
94657044|NCT01040871|324202133|FG000|Overall Study|Death|1|||
94657045|NCT01040871|324202134|FG001|Overall Study|Death|3|||
94657046|NCT01040871|324202133|FG000|Overall Study|Lack of Efficacy|1|||
94657047|NCT01040871|324202134|FG001|Overall Study|Lack of Efficacy|1|||
94657048|NCT01040871|324202133|FG000|Overall Study|drug supply issue|1|||
94657049|NCT01040871|324202134|FG001|Overall Study|drug supply issue|0|||
94657050|NCT01040871|324202133|FG000|Overall Study|Randomized and Not Treated|2|||
94657051|NCT01040871|324202134|FG001|Overall Study|Randomized and Not Treated|1|||
94657052|NCT02886572|324202135|FG000|Overall Study|Death|8|||
94657053|NCT01969838|324202136|FG000|Double-blind Phase|Adverse Event|10|||
94657054|NCT01969838|324202137|FG001|Double-blind Phase|Adverse Event|4|||
94657055|NCT01969838|324202138|FG002|Double-blind Phase|Adverse Event|0|||
94657056|NCT01969838|324202139|FG003|Double-blind Phase|Adverse Event|0|||
94657057|NCT01969838|324202136|FG000|Double-blind Phase|Death|5|||
94657058|NCT01969838|324202137|FG001|Double-blind Phase|Death|2|||
94657059|NCT01969838|324202138|FG002|Double-blind Phase|Death|0|||
94657060|NCT01969838|324202139|FG003|Double-blind Phase|Death|0|||
94657061|NCT01969838|324202136|FG000|Double-blind Phase|Physician Decision|5|||
94657062|NCT01969838|324202137|FG001|Double-blind Phase|Physician Decision|1|||
94657063|NCT01969838|324202138|FG002|Double-blind Phase|Physician Decision|0|||
94657064|NCT01969838|324202139|FG003|Double-blind Phase|Physician Decision|0|||
94657065|NCT01969838|324202136|FG000|Double-blind Phase|Subject Decision|4|||
94657066|NCT01969838|324202137|FG001|Double-blind Phase|Subject Decision|2|||
94657067|NCT01969838|324202138|FG002|Double-blind Phase|Subject Decision|0|||
94657068|NCT01969838|324202139|FG003|Double-blind Phase|Subject Decision|0|||
94657069|NCT01969838|324202136|FG000|Double-blind Phase|Disease Progression|2|||
94657070|NCT01969838|324202137|FG001|Double-blind Phase|Disease Progression|0|||
94657071|NCT01969838|324202138|FG002|Double-blind Phase|Disease Progression|0|||
94657072|NCT01969838|324202139|FG003|Double-blind Phase|Disease Progression|0|||
94657073|NCT01969838|324202136|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
94657074|NCT01969838|324202137|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
94657075|NCT01969838|324202138|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
94657076|NCT01969838|324202139|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
94657077|NCT01969838|324202136|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
94657078|NCT01969838|324202137|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
94657079|NCT01969838|324202138|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
94657080|NCT01969838|324202139|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
94657081|NCT01969838|324202136|FG000|Open-label Phase|Adverse Event|0|||
94657082|NCT01969838|324202137|FG001|Open-label Phase|Adverse Event|0|||
94657083|NCT01969838|324202138|FG002|Open-label Phase|Adverse Event|37|||
94657084|NCT01969838|324202139|FG003|Open-label Phase|Adverse Event|49|||
94657085|NCT01969838|324202136|FG000|Open-label Phase|Disease Progression|0|||
94657086|NCT01969838|324202137|FG001|Open-label Phase|Disease Progression|0|||
94657087|NCT01969838|324202138|FG002|Open-label Phase|Disease Progression|26|||
94657088|NCT01969838|324202139|FG003|Open-label Phase|Disease Progression|27|||
94657089|NCT01969838|324202136|FG000|Open-label Phase|Lack of Efficacy|0|||
94657090|NCT01969838|324202137|FG001|Open-label Phase|Lack of Efficacy|0|||
94657091|NCT01969838|324202138|FG002|Open-label Phase|Lack of Efficacy|17|||
94657092|NCT01969838|324202139|FG003|Open-label Phase|Lack of Efficacy|19|||
94657093|NCT01969838|324202136|FG000|Open-label Phase|Subject Decision|0|||
94657094|NCT01969838|324202137|FG001|Open-label Phase|Subject Decision|0|||
94657095|NCT01969838|324202138|FG002|Open-label Phase|Subject Decision|14|||
94657096|NCT01969838|324202139|FG003|Open-label Phase|Subject Decision|15|||
94657097|NCT01969838|324202136|FG000|Open-label Phase|Death|0|||
94657098|NCT01969838|324202137|FG001|Open-label Phase|Death|0|||
94657099|NCT01969838|324202138|FG002|Open-label Phase|Death|13|||
94657100|NCT01969838|324202139|FG003|Open-label Phase|Death|11|||
94657101|NCT01969838|324202136|FG000|Open-label Phase|Physician Decision|0|||
94657102|NCT01969838|324202137|FG001|Open-label Phase|Physician Decision|0|||
94657103|NCT01969838|324202138|FG002|Open-label Phase|Physician Decision|9|||
94657104|NCT01969838|324202139|FG003|Open-label Phase|Physician Decision|14|||
94657105|NCT01969838|324202136|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
94657106|NCT01969838|324202137|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
94657107|NCT01969838|324202138|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
94657108|NCT01969838|324202139|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
94657109|NCT03087591|324202143|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
94657110|NCT03087591|324202143|FG000|Overall Study|Withdrawal by Subject|1|||
94657111|NCT02621606|324202146|FG000|Overall Study|Withdrawal by Subject|0|||
94657112|NCT02621606|324202147|FG001|Overall Study|Withdrawal by Subject|1|||
94657113|NCT02621606|324202148|FG002|Overall Study|Withdrawal by Subject|0|||
94657114|NCT04193202|324202149|FG000|Overall Study|Adverse Event|2|||
94657115|NCT04193202|324202150|FG001|Overall Study|Adverse Event|1|||
94657116|NCT04193202|324202149|FG000|Overall Study|Death|0|||
94657117|NCT04193202|324202150|FG001|Overall Study|Death|1|||
94657118|NCT04193202|324202149|FG000|Overall Study|Physician Decision|1|||
94657119|NCT04193202|324202150|FG001|Overall Study|Physician Decision|1|||
94657120|NCT04193202|324202149|FG000|Overall Study|Protocol Violation|2|||
94657121|NCT04193202|324202150|FG001|Overall Study|Protocol Violation|2|||
94657122|NCT04193202|324202149|FG000|Overall Study|Withdrawal by Subject|11|||
94657123|NCT04193202|324202150|FG001|Overall Study|Withdrawal by Subject|5|||
94657124|NCT01933334|324202151|FG000|Overall Study|Adverse Event|5|||
94657125|NCT01933334|324202152|FG001|Overall Study|Adverse Event|1|||
94657126|NCT01933334|324202151|FG000|Overall Study|Withdrawal by Subject|0|||
94657127|NCT01933334|324202152|FG001|Overall Study|Withdrawal by Subject|1|||
94657128|NCT01252251|324202153|FG000|Overall Study|Withdrawal by Subject|1|||
94657129|NCT00466193|324202154|FG000|Overall Study|Adverse Event|0|||
94657130|NCT00466193|324202155|FG001|Overall Study|Adverse Event|1|||
94657131|NCT00466193|324202154|FG000|Overall Study|Lost to Follow-up|2|||
94657132|NCT00466193|324202155|FG001|Overall Study|Lost to Follow-up|4|||
94657133|NCT00466193|324202154|FG000|Overall Study|Physician Decision|1|||
94657134|NCT00466193|324202155|FG001|Overall Study|Physician Decision|0|||
94657135|NCT00466193|324202154|FG000|Overall Study|Protocol Violation|1|||
94657136|NCT00466193|324202155|FG001|Overall Study|Protocol Violation|1|||
94657137|NCT00466193|324202154|FG000|Overall Study|Withdrawal by Subject|7|||
94657138|NCT00466193|324202155|FG001|Overall Study|Withdrawal by Subject|2|||
94657139|NCT00466193|324202154|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
94657140|NCT00466193|324202155|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
94657141|NCT01575561|324202156|FG000|Overall Study|Adverse Event|9|||
94657142|NCT01575561|324202156|FG000|Overall Study|Lack of Efficacy|8|||
94657143|NCT01575561|324202156|FG000|Overall Study|Lost to Follow-up|6|||
94657144|NCT01575561|324202156|FG000|Overall Study|Protocol Violation|4|||
94657145|NCT01575561|324202156|FG000|Overall Study|Withdrawal by Subject|11|||
94657146|NCT01575561|324202156|FG000|Overall Study|administration|1|||
94657147|NCT01175382|324202157|FG000|Overall Study|Lost to Follow-up|4|||
94657148|NCT01175382|324202158|FG001|Overall Study|Lost to Follow-up|3|||
94657149|NCT01175382|324202159|FG002|Overall Study|Lost to Follow-up|1|||
94657150|NCT01175382|324202157|FG000|Overall Study|Physician Decision|0|||
94657151|NCT01175382|324202158|FG001|Overall Study|Physician Decision|1|||
94657152|NCT01175382|324202159|FG002|Overall Study|Physician Decision|0|||
94657153|NCT01175382|324202157|FG000|Overall Study|Withdrawal by Subject|0|||
94657154|NCT01175382|324202158|FG001|Overall Study|Withdrawal by Subject|0|||
94657155|NCT01175382|324202159|FG002|Overall Study|Withdrawal by Subject|1|||
94657156|NCT01175382|324202157|FG000|Overall Study|No longer having problem|1|||
94657157|NCT01175382|324202158|FG001|Overall Study|No longer having problem|0|||
94657158|NCT01175382|324202159|FG002|Overall Study|No longer having problem|1|||
94657159|NCT01175382|324202157|FG000|Overall Study|Unable/unwilling to attend visits|3|||
94657160|NCT01175382|324202158|FG001|Overall Study|Unable/unwilling to attend visits|1|||
94657161|NCT01175382|324202159|FG002|Overall Study|Unable/unwilling to attend visits|2|||
94657162|NCT01175382|324202157|FG000|Overall Study|Unwilling to follow protocol|0|||
94657163|NCT01175382|324202158|FG001|Overall Study|Unwilling to follow protocol|1|||
94657164|NCT01175382|324202159|FG002|Overall Study|Unwilling to follow protocol|0|||
94657165|NCT01175382|324202157|FG000|Overall Study|Unable to tolerate study meds|0|||
94657166|NCT01175382|324202158|FG001|Overall Study|Unable to tolerate study meds|1|||
94657167|NCT01175382|324202159|FG002|Overall Study|Unable to tolerate study meds|1|||
94332411|NCT00105183|322998778|FG001|Overall Study|Other reason|2|||
94657168|NCT04535037|324202160|FG000|Overall Study|Protocol Violation|1|||
94657169|NCT04535037|324202161|FG001|Overall Study|Protocol Violation|0|||
94657170|NCT04535037|324202160|FG000|Overall Study|Withdrawal by Subject|8|||
94657171|NCT04535037|324202161|FG001|Overall Study|Withdrawal by Subject|9|||
94657172|NCT04535037|324202160|FG000|Overall Study|Migrated / moved from the study area|1|||
94688552|NCT02960763|324315504|FG000|Step 2|Investigator discretion|0|||
94657173|NCT04535037|324202161|FG001|Overall Study|Migrated / moved from the study area|4|||
94657174|NCT04535037|324202160|FG000|Overall Study|Other|2|||
94657175|NCT04535037|324202161|FG001|Overall Study|Other|5|||
94657176|NCT03766646|324202162|FG000|Overall Study|Withdrawal by Subject|1|||
94657177|NCT03766646|324202163|FG001|Overall Study|Withdrawal by Subject|0|||
94657178|NCT03766646|324202162|FG000|Overall Study|Protocol Violation|0|||
94657179|NCT03766646|324202163|FG001|Overall Study|Protocol Violation|3|||
94657180|NCT01542528|324202169|FG000|Overall Study|Lost to Follow-up|2|||
94657181|NCT01542528|324202170|FG001|Overall Study|Lost to Follow-up|1|||
94657182|NCT01542528|324202169|FG000|Overall Study|Physician Decision|1|||
94657183|NCT01542528|324202170|FG001|Overall Study|Physician Decision|0|||
94657184|NCT01542528|324202169|FG000|Overall Study|Withdrawal by Subject|9|||
94657185|NCT01542528|324202170|FG001|Overall Study|Withdrawal by Subject|6|||
94657186|NCT01992536|324202172|FG000|Overall Study|Administrative Reason|0|||
94657187|NCT01992536|324202173|FG001|Overall Study|Administrative Reason|0|||
94657188|NCT01992536|324202174|FG002|Overall Study|Administrative Reason|0|||
94657189|NCT01992536|324202175|FG003|Overall Study|Administrative Reason|0|||
94657190|NCT01992536|324202176|FG004|Overall Study|Administrative Reason|0|||
94657191|NCT01992536|324202177|FG005|Overall Study|Administrative Reason|0|||
94657192|NCT01992536|324202178|FG006|Overall Study|Administrative Reason|7|||
94657193|NCT01992536|324202179|FG007|Overall Study|Administrative Reason|0|||
94657194|NCT01992536|324202180|FG008|Overall Study|Administrative Reason|0|||
94657195|NCT01992536|324202181|FG009|Overall Study|Administrative Reason|0|||
94657196|NCT01992536|324202172|FG000|Overall Study|Lost to Follow-up|4|||
94657197|NCT01992536|324202173|FG001|Overall Study|Lost to Follow-up|2|||
94657198|NCT01992536|324202174|FG002|Overall Study|Lost to Follow-up|1|||
94657199|NCT01992536|324202175|FG003|Overall Study|Lost to Follow-up|0|||
94657200|NCT01992536|324202176|FG004|Overall Study|Lost to Follow-up|0|||
94657201|NCT01992536|324202177|FG005|Overall Study|Lost to Follow-up|1|||
94657202|NCT01992536|324202178|FG006|Overall Study|Lost to Follow-up|0|||
94657203|NCT01992536|324202179|FG007|Overall Study|Lost to Follow-up|0|||
94657204|NCT01992536|324202180|FG008|Overall Study|Lost to Follow-up|1|||
94657205|NCT01992536|324202181|FG009|Overall Study|Lost to Follow-up|1|||
94657206|NCT01992536|324202172|FG000|Overall Study|Withdrawal by Subject|0|||
94657207|NCT01992536|324202173|FG001|Overall Study|Withdrawal by Subject|1|||
94657208|NCT01992536|324202174|FG002|Overall Study|Withdrawal by Subject|0|||
94657209|NCT01992536|324202175|FG003|Overall Study|Withdrawal by Subject|2|||
94657210|NCT01992536|324202176|FG004|Overall Study|Withdrawal by Subject|0|||
94657211|NCT01992536|324202177|FG005|Overall Study|Withdrawal by Subject|0|||
94657212|NCT01992536|324202178|FG006|Overall Study|Withdrawal by Subject|0|||
94657213|NCT01992536|324202179|FG007|Overall Study|Withdrawal by Subject|0|||
94657214|NCT01992536|324202180|FG008|Overall Study|Withdrawal by Subject|0|||
94657215|NCT01992536|324202181|FG009|Overall Study|Withdrawal by Subject|0|||
94657216|NCT01762761|324202186|FG000|Overall Study|Adverse Event|15|||
94657217|NCT01762761|324202187|FG001|Overall Study|Adverse Event|17|||
94657218|NCT01762761|324202186|FG000|Overall Study|Lack of Efficacy|9|||
94657219|NCT01762761|324202187|FG001|Overall Study|Lack of Efficacy|25|||
94657220|NCT01762761|324202186|FG000|Overall Study|Protocol Violation|1|||
94657221|NCT01762761|324202187|FG001|Overall Study|Protocol Violation|1|||
94657222|NCT01762761|324202186|FG000|Overall Study|Study closed/terminated|0|||
94657223|NCT01762761|324202187|FG001|Overall Study|Study closed/terminated|2|||
94657224|NCT01762761|324202186|FG000|Overall Study|Lost to Follow-up|3|||
94657225|NCT01762761|324202187|FG001|Overall Study|Lost to Follow-up|6|||
94657226|NCT01762761|324202186|FG000|Overall Study|Physician Decision|4|||
94657227|NCT01762761|324202187|FG001|Overall Study|Physician Decision|6|||
94657228|NCT01762761|324202186|FG000|Overall Study|Withdrawal by Subject|7|||
94657229|NCT01762761|324202187|FG001|Overall Study|Withdrawal by Subject|8|||
94657230|NCT03224468|324202188|FG000|Overall Study|Did not obtain MM card|53|||
94657231|NCT03224468|324202189|FG001|Overall Study|Did not obtain MM card|0|||
94657232|NCT03224468|324202188|FG000|Overall Study|Lost to Follow-up|4|||
94657233|NCT03224468|324202189|FG001|Overall Study|Lost to Follow-up|11|||
94657234|NCT03224468|324202188|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
94657235|NCT03224468|324202189|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
94657236|NCT02265705|324202199|FG000|Treatment Period Week 0-24|Adverse Event|3|||
94657237|NCT02265705|324202200|FG001|Treatment Period Week 0-24|Adverse Event|2|||
94657238|NCT02265705|324202201|FG002|Treatment Period Week 0-24|Adverse Event|0|||
94657239|NCT02265705|324202202|FG003|Treatment Period Week 0-24|Adverse Event|0|||
94657240|NCT02265705|324202203|FG004|Treatment Period Week 0-24|Adverse Event|0|||
94657241|NCT02265705|324202204|FG005|Treatment Period Week 0-24|Adverse Event|0|||
94657242|NCT02265705|324202205|FG006|Treatment Period Week 0-24|Adverse Event|0|||
94657243|NCT02265705|324202199|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
94657244|NCT02265705|324202200|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
94657245|NCT02265705|324202201|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
94657246|NCT02265705|324202202|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
94657247|NCT02265705|324202203|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
94657248|NCT02265705|324202204|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
94657249|NCT02265705|324202205|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
94657250|NCT02265705|324202199|FG000|Treatment Period Week 0-24|Physician Decision|1|||
94657251|NCT02265705|324202200|FG001|Treatment Period Week 0-24|Physician Decision|0|||
94657252|NCT02265705|324202201|FG002|Treatment Period Week 0-24|Physician Decision|0|||
94657253|NCT02265705|324202202|FG003|Treatment Period Week 0-24|Physician Decision|0|||
94657254|NCT02265705|324202203|FG004|Treatment Period Week 0-24|Physician Decision|0|||
94657255|NCT02265705|324202204|FG005|Treatment Period Week 0-24|Physician Decision|0|||
94657256|NCT02265705|324202205|FG006|Treatment Period Week 0-24|Physician Decision|0|||
94657257|NCT02265705|324202199|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
94657258|NCT02265705|324202200|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
94657259|NCT02265705|324202201|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
94657260|NCT02265705|324202202|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
94657261|NCT02265705|324202203|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
94657262|NCT02265705|324202204|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
94657263|NCT02265705|324202205|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
94657264|NCT02265705|324202199|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
94657265|NCT02265705|324202200|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
94657266|NCT02265705|324202201|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
94657267|NCT02265705|324202202|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
94657268|NCT02265705|324202203|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
94657269|NCT02265705|324202204|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
94657270|NCT02265705|324202205|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
94657271|NCT02265705|324202199|FG000|Rescue Period|Withdrawal by Subject|0|||
94657272|NCT02265705|324202200|FG001|Rescue Period|Withdrawal by Subject|0|||
94657273|NCT02265705|324202201|FG002|Rescue Period|Withdrawal by Subject|1|||
94657274|NCT02265705|324202202|FG003|Rescue Period|Withdrawal by Subject|0|||
94657275|NCT02265705|324202203|FG004|Rescue Period|Withdrawal by Subject|0|||
94657276|NCT02265705|324202204|FG005|Rescue Period|Withdrawal by Subject|0|||
94657277|NCT02265705|324202205|FG006|Rescue Period|Withdrawal by Subject|0|||
94657278|NCT02265705|324202199|FG000|Rescue Period|Death|0|||
94657279|NCT02265705|324202200|FG001|Rescue Period|Death|0|||
94657280|NCT02265705|324202201|FG002|Rescue Period|Death|1|||
94657281|NCT02265705|324202202|FG003|Rescue Period|Death|0|||
94657282|NCT02265705|324202203|FG004|Rescue Period|Death|0|||
94657283|NCT02265705|324202204|FG005|Rescue Period|Death|0|||
94657284|NCT02265705|324202205|FG006|Rescue Period|Death|0|||
94657285|NCT02265705|324202199|FG000|Rescue Period|Lack of Efficacy|0|||
94657286|NCT02265705|324202200|FG001|Rescue Period|Lack of Efficacy|0|||
94657287|NCT02265705|324202201|FG002|Rescue Period|Lack of Efficacy|1|||
94657288|NCT02265705|324202202|FG003|Rescue Period|Lack of Efficacy|0|||
94657289|NCT02265705|324202203|FG004|Rescue Period|Lack of Efficacy|0|||
94657290|NCT02265705|324202204|FG005|Rescue Period|Lack of Efficacy|0|||
94657291|NCT02265705|324202205|FG006|Rescue Period|Lack of Efficacy|0|||
94657292|NCT02265705|324202199|FG000|Open Label Period|Adverse Event|0|||
94657293|NCT02265705|324202200|FG001|Open Label Period|Adverse Event|0|||
94657294|NCT02265705|324202201|FG002|Open Label Period|Adverse Event|0|||
94657295|NCT02265705|324202202|FG003|Open Label Period|Adverse Event|2|||
94657296|NCT02265705|324202203|FG004|Open Label Period|Adverse Event|2|||
94657297|NCT02265705|324202204|FG005|Open Label Period|Adverse Event|0|||
94657298|NCT02265705|324202205|FG006|Open Label Period|Adverse Event|0|||
94657299|NCT02265705|324202199|FG000|Open Label Period|Physician Decision|0|||
94657300|NCT02265705|324202200|FG001|Open Label Period|Physician Decision|0|||
94657301|NCT02265705|324202201|FG002|Open Label Period|Physician Decision|0|||
94657302|NCT02265705|324202202|FG003|Open Label Period|Physician Decision|0|||
94657303|NCT02265705|324202203|FG004|Open Label Period|Physician Decision|1|||
94657304|NCT02265705|324202204|FG005|Open Label Period|Physician Decision|0|||
94657305|NCT02265705|324202205|FG006|Open Label Period|Physician Decision|0|||
94657306|NCT02265705|324202199|FG000|Open Label Period|Withdrawal by Subject|0|||
94657307|NCT02265705|324202200|FG001|Open Label Period|Withdrawal by Subject|0|||
94657308|NCT02265705|324202201|FG002|Open Label Period|Withdrawal by Subject|0|||
94657309|NCT02265705|324202202|FG003|Open Label Period|Withdrawal by Subject|0|||
94657310|NCT02265705|324202203|FG004|Open Label Period|Withdrawal by Subject|2|||
94657311|NCT02265705|324202204|FG005|Open Label Period|Withdrawal by Subject|0|||
94657312|NCT02265705|324202205|FG006|Open Label Period|Withdrawal by Subject|0|||
94657313|NCT02265705|324202199|FG000|Follow-up Period|Sponsor Decision|0|||
94657314|NCT02265705|324202200|FG001|Follow-up Period|Sponsor Decision|0|||
94657315|NCT02265705|324202201|FG002|Follow-up Period|Sponsor Decision|0|||
94657316|NCT02265705|324202202|FG003|Follow-up Period|Sponsor Decision|0|||
94657317|NCT02265705|324202203|FG004|Follow-up Period|Sponsor Decision|0|||
94657318|NCT02265705|324202204|FG005|Follow-up Period|Sponsor Decision|1|||
94657319|NCT02265705|324202205|FG006|Follow-up Period|Sponsor Decision|6|||
94657320|NCT02265705|324202199|FG000|Follow-up Period|Adverse Event|0|||
94657321|NCT02265705|324202200|FG001|Follow-up Period|Adverse Event|0|||
94657322|NCT02265705|324202201|FG002|Follow-up Period|Adverse Event|0|||
94657323|NCT02265705|324202202|FG003|Follow-up Period|Adverse Event|0|||
94657324|NCT02265705|324202203|FG004|Follow-up Period|Adverse Event|0|||
94657325|NCT02265705|324202204|FG005|Follow-up Period|Adverse Event|0|||
94657326|NCT02265705|324202205|FG006|Follow-up Period|Adverse Event|3|||
94657327|NCT02265705|324202199|FG000|Follow-up Period|Physician Decision|0|||
94657328|NCT02265705|324202200|FG001|Follow-up Period|Physician Decision|0|||
94657329|NCT02265705|324202201|FG002|Follow-up Period|Physician Decision|0|||
94657330|NCT02265705|324202202|FG003|Follow-up Period|Physician Decision|0|||
94657331|NCT02265705|324202203|FG004|Follow-up Period|Physician Decision|0|||
94657332|NCT02265705|324202204|FG005|Follow-up Period|Physician Decision|0|||
94657333|NCT02265705|324202205|FG006|Follow-up Period|Physician Decision|1|||
94657334|NCT02265705|324202199|FG000|Follow-up Period|Withdrawal by Subject|0|||
94657335|NCT02265705|324202200|FG001|Follow-up Period|Withdrawal by Subject|0|||
94657336|NCT02265705|324202201|FG002|Follow-up Period|Withdrawal by Subject|0|||
94657337|NCT02265705|324202202|FG003|Follow-up Period|Withdrawal by Subject|0|||
94657338|NCT02265705|324202203|FG004|Follow-up Period|Withdrawal by Subject|0|||
94657339|NCT02265705|324202204|FG005|Follow-up Period|Withdrawal by Subject|0|||
94657340|NCT02265705|324202205|FG006|Follow-up Period|Withdrawal by Subject|1|||
94657341|NCT00534352|324202206|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
94657342|NCT00534352|324202206|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
94657343|NCT00534352|324202206|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
94657344|NCT00534352|324202206|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
94657345|NCT00534352|324202206|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
94657346|NCT00534352|324202206|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
94657347|NCT04788147|324202211|FG000|Overall Study|Screen Failure|3|||
94657348|NCT04788147|324202212|FG001|Overall Study|Screen Failure|10|||
94657349|NCT04788147|324202211|FG000|Overall Study|Incomplete RMRS image session|2|||
94657350|NCT04788147|324202212|FG001|Overall Study|Incomplete RMRS image session|0|||
94657351|NCT02401672|324202217|FG000|Overall Study|Withdrawal by Subject|1|||
94657352|NCT02401672|324202218|FG001|Overall Study|Withdrawal by Subject|3|||
94657353|NCT00701051|324202219|FG000|Screening|Failed Screening|40|||
94657354|NCT00701051|324202220|FG001|Screening|Failed Screening|0|||
94657355|NCT00701051|324202221|FG002|Screening|Failed Screening|0|||
94657356|NCT00701051|324202219|FG000|Screening|Time conflicts|19|||
94657357|NCT00701051|324202220|FG001|Screening|Time conflicts|0|||
94657358|NCT00701051|324202221|FG002|Screening|Time conflicts|0|||
94657359|NCT00701051|324202219|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
94657360|NCT00701051|324202220|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
94657361|NCT00701051|324202221|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
94657362|NCT03653429|324202226|FG000|Overall Study|Physician Decision|4|||
94657363|NCT03653429|324202227|FG001|Overall Study|Physician Decision|10|||
94657364|NCT02604589|324202228|FG000|Overall Study|catheter dislodgement|0|||
94657365|NCT02604589|324202229|FG001|Overall Study|catheter dislodgement|0|||
94657366|NCT02604589|324202230|FG002|Overall Study|catheter dislodgement|1|||
94657367|NCT03880578|324202231|FG000|Overall Study|Withdrawal by Subject|0|||
94657368|NCT03880578|324202232|FG001|Overall Study|Withdrawal by Subject|3|||
94657369|NCT03880578|324202233|FG002|Overall Study|Withdrawal by Subject|1|||
94657370|NCT03880578|324202231|FG000|Overall Study|Death|0|||
94657371|NCT03880578|324202232|FG001|Overall Study|Death|1|||
94657372|NCT03880578|324202233|FG002|Overall Study|Death|0|||
94657373|NCT04934670|324202234|FG000|Overall Study|Death|4|||
94657374|NCT04934670|324202235|FG001|Overall Study|Death|0|||
94657375|NCT04934670|324202234|FG000|Overall Study|Lost to Follow-up|1|||
94657376|NCT04934670|324202235|FG001|Overall Study|Lost to Follow-up|4|||
94657377|NCT03067441|324202236|FG000|Overall Study|Withdrawal by Subject|16|||
94657378|NCT03067441|324202237|FG001|Overall Study|Withdrawal by Subject|34|||
94657379|NCT03067441|324202236|FG000|Overall Study|Lost to Follow-up|7|||
94657380|NCT03067441|324202237|FG001|Overall Study|Lost to Follow-up|5|||
94657381|NCT03067441|324202236|FG000|Overall Study|Adverse Event|7|||
94657382|NCT03067441|324202237|FG001|Overall Study|Adverse Event|14|||
94657383|NCT03067441|324202236|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
94657384|NCT03067441|324202237|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
94657385|NCT03067441|324202236|FG000|Overall Study|Physician Decision|1|||
94657386|NCT03067441|324202237|FG001|Overall Study|Physician Decision|3|||
94657387|NCT03067441|324202236|FG000|Overall Study|Other|1|||
94657388|NCT03067441|324202237|FG001|Overall Study|Other|1|||
94657389|NCT00439777|324202238|FG000|Treatment Period|Death|29|||
94657390|NCT00439777|324202239|FG001|Treatment Period|Death|21|||
94657391|NCT00439777|324202238|FG000|Treatment Period|Study terminated by sponsor|125|||
94657392|NCT00439777|324202239|FG001|Treatment Period|Study terminated by sponsor|132|||
94657393|NCT00439777|324202238|FG000|Treatment Period|Site closed by investigator|0|||
94657394|NCT00439777|324202239|FG001|Treatment Period|Site closed by investigator|1|||
94657395|NCT00439777|324202238|FG000|Treatment Period|Did not take study treatment|7|||
94657396|NCT00439777|324202239|FG001|Treatment Period|Did not take study treatment|8|||
94657397|NCT00439777|324202238|FG000|Treatment Period|Adverse Event|111|||
94657398|NCT00439777|324202239|FG001|Treatment Period|Adverse Event|92|||
94657399|NCT00439777|324202238|FG000|Treatment Period|Protocol Violation|23|||
94657400|NCT00439777|324202239|FG001|Treatment Period|Protocol Violation|30|||
94657401|NCT00439777|324202238|FG000|Treatment Period|Withdrawal by Subject|66|||
94657402|NCT00439777|324202239|FG001|Treatment Period|Withdrawal by Subject|118|||
94657403|NCT00439777|324202238|FG000|Treatment Period|Lack of Efficacy|1|||
94657404|NCT00439777|324202239|FG001|Treatment Period|Lack of Efficacy|4|||
94657405|NCT00439777|324202238|FG000|Treatment Period|Lost to Follow-up|8|||
94657406|NCT00439777|324202239|FG001|Treatment Period|Lost to Follow-up|10|||
94657407|NCT00439777|324202238|FG000|Treatment Period|Protocol driven decision point|1|||
94657408|NCT00439777|324202239|FG001|Treatment Period|Protocol driven decision point|3|||
94657409|NCT00439777|324202238|FG000|Treatment Period|Physician Decision|7|||
94657410|NCT00439777|324202239|FG001|Treatment Period|Physician Decision|18|||
94657411|NCT00439777|324202238|FG000|Treatment Period|Clinical endpoint reached|26|||
94657412|NCT00439777|324202239|FG001|Treatment Period|Clinical endpoint reached|13|||
94657413|NCT00439777|324202238|FG000|Treatment Period|Technical problems|3|||
94657414|NCT00439777|324202239|FG001|Treatment Period|Technical problems|1|||
94657415|NCT00439777|324202238|FG000|Treatment Period|Participant convenience|12|||
94657416|NCT00439777|324202239|FG001|Treatment Period|Participant convenience|8|||
94657417|NCT00439777|324202238|FG000|Observational Period|Protocol Violation|0|||
94657418|NCT00439777|324202239|FG001|Observational Period|Protocol Violation|2|||
94657419|NCT00439777|324202238|FG000|Observational Period|Withdrawal by Subject|9|||
94657420|NCT00439777|324202239|FG001|Observational Period|Withdrawal by Subject|5|||
94657421|NCT00439777|324202238|FG000|Observational Period|Lost to Follow-up|1|||
94657422|NCT00439777|324202239|FG001|Observational Period|Lost to Follow-up|11|||
94657423|NCT00439777|324202238|FG000|Observational Period|Death|27|||
94657424|NCT00439777|324202239|FG001|Observational Period|Death|20|||
94657425|NCT00439777|324202238|FG000|Observational Period|Study terminated by sponsor|3|||
94657426|NCT00439777|324202239|FG001|Observational Period|Study terminated by sponsor|1|||
94657427|NCT00439777|324202238|FG000|Observational Period|Protocol driven decision point|0|||
94657428|NCT00439777|324202239|FG001|Observational Period|Protocol driven decision point|1|||
94657429|NCT00439777|324202238|FG000|Observational Period|Lack of Efficacy|1|||
94657430|NCT00439777|324202239|FG001|Observational Period|Lack of Efficacy|0|||
94657431|NCT00439777|324202238|FG000|Observational Period|Technical problems|0|||
94657432|NCT00439777|324202239|FG001|Observational Period|Technical problems|1|||
94657433|NCT03855189|324202240|FG000|Overall Study|Adverse Event|5|||
94657434|NCT03855189|324202241|FG001|Overall Study|Adverse Event|2|||
94657435|NCT03855189|324202242|FG002|Overall Study|Adverse Event|4|||
94657436|NCT03855189|324202240|FG000|Overall Study|Treatment Failure|1|||
94657437|NCT03855189|324202241|FG001|Overall Study|Treatment Failure|1|||
94657438|NCT03855189|324202242|FG002|Overall Study|Treatment Failure|2|||
94657439|NCT03855189|324202240|FG000|Overall Study|Noncompliance with Protocol|0|||
94657440|NCT03855189|324202241|FG001|Overall Study|Noncompliance with Protocol|1|||
94657441|NCT03855189|324202242|FG002|Overall Study|Noncompliance with Protocol|0|||
94657442|NCT03855189|324202240|FG000|Overall Study|Did Not Return|4|||
94657443|NCT03855189|324202241|FG001|Overall Study|Did Not Return|3|||
94657444|NCT03855189|324202242|FG002|Overall Study|Did Not Return|0|||
94657445|NCT01143259|324202243|FG000|Overall Study|Withdrawal by Subject|3|||
94657446|NCT01143259|324202244|FG001|Overall Study|Withdrawal by Subject|2|||
94657447|NCT01143259|324202243|FG000|Overall Study|Protocol Violation|13|||
94657448|NCT01143259|324202244|FG001|Overall Study|Protocol Violation|9|||
94657449|NCT01143259|324202243|FG000|Overall Study|Screen Failure|7|||
94657450|NCT01143259|324202244|FG001|Overall Study|Screen Failure|9|||
94657451|NCT03238001|324202246|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
94657452|NCT03238001|324202246|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
94657453|NCT03238001|324202246|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
94657454|NCT03238001|324202246|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
94657455|NCT03238001|324202246|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
94657456|NCT03238001|324202246|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
94657457|NCT03238001|324202246|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
94657458|NCT03238001|324202246|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
94657459|NCT00142909|324202252|FG000|Randomization|Various Reasons|7|||
94657460|NCT00142909|324202253|FG001|Randomization|Various Reasons|10|||
94657461|NCT00142909|324202252|FG000|Medications Begin|Protocol Violation|2|||
94657462|NCT00142909|324202253|FG001|Medications Begin|Protocol Violation|0|||
94657463|NCT00142909|324202252|FG000|Medications Begin|Withdrawal by Subject|5|||
94657464|NCT00142909|324202253|FG001|Medications Begin|Withdrawal by Subject|3|||
94657465|NCT00142909|324202252|FG000|Medications Begin|Withdrawal by Subject|2|||
94657466|NCT00142909|324202253|FG001|Medications Begin|Withdrawal by Subject|0|||
94657467|NCT04028388|324202261|FG000|Overall Study|Evaluations missing|3|||
94657468|NCT04028388|324202262|FG001|Overall Study|Evaluations missing|6|||
94657469|NCT04028388|324202261|FG000|Overall Study|Not started|2|||
94657470|NCT04028388|324202262|FG001|Overall Study|Not started|0|||
94657471|NCT05204134|324202263|FG000|Overall Study|Withdrawal by Subject|3|||
94657472|NCT05204134|324202263|FG000|Overall Study|Physician Decision|1|||
94657473|NCT00459134|324202267|FG000|Overall Study|Physician Decision|1|||
94657474|NCT00459134|324202268|FG001|Overall Study|Physician Decision|1|||
94657475|NCT00459134|324202267|FG000|Overall Study|Withdrawal by Subject|8|||
94657476|NCT00459134|324202268|FG001|Overall Study|Withdrawal by Subject|7|||
94657477|NCT00459134|324202267|FG000|Overall Study|Lost to Follow-up|6|||
94657478|NCT00459134|324202268|FG001|Overall Study|Lost to Follow-up|7|||
94657479|NCT00459134|324202267|FG000|Overall Study|Surgery|1|||
94657480|NCT00459134|324202268|FG001|Overall Study|Surgery|2|||
94657481|NCT00459134|324202267|FG000|Overall Study|Toxicity|4|||
94657482|NCT00459134|324202268|FG001|Overall Study|Toxicity|5|||
94657483|NCT00459134|324202267|FG000|Overall Study|Progression|1|||
94657484|NCT00459134|324202268|FG001|Overall Study|Progression|0|||
94657485|NCT00459134|324202267|FG000|Overall Study|Multiple Reasons|2|||
94657486|NCT00459134|324202268|FG001|Overall Study|Multiple Reasons|3|||
94657487|NCT03285477|324202269|FG000|Treatment and Response Assessment Period|Death|1|||
94657488|NCT03285477|324202270|FG001|Treatment and Response Assessment Period|Death|0|||
94657489|NCT03285477|324202269|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
94657490|NCT03285477|324202270|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
94657491|NCT03285477|324202269|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
94657492|NCT03285477|324202270|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
94657493|NCT03285477|324202269|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
94657494|NCT03285477|324202270|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
94657495|NCT03285477|324202269|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
94657496|NCT03285477|324202270|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
94688553|NCT02960763|324315505|FG001|Step 2|Investigator discretion|0|||
94688554|NCT02960763|324315506|FG002|Step 2|Investigator discretion|0|||
94688555|NCT02960763|324315507|FG003|Step 2|Investigator discretion|0|||
94688556|NCT02960763|324315508|FG004|Step 2|Investigator discretion|1|||
94688557|NCT00636792|324315509|FG000|Overall Study|Adverse Event|16|||
94688558|NCT00636792|324315509|FG000|Overall Study|Physician Decision|7|||
94688559|NCT00636792|324315509|FG000|Overall Study|Progressive Disease|4|||
94688560|NCT00636792|324315509|FG000|Overall Study|Withdrawal by Subject|3|||
94688561|NCT00636792|324315509|FG000|Overall Study|Other|3|||
94688562|NCT00451217|324315512|FG000|Overall Study|Lost to Follow-up|0|||
94688563|NCT00451217|324315513|FG001|Overall Study|Lost to Follow-up|1|||
94688564|NCT00451217|324315514|FG002|Overall Study|Lost to Follow-up|1|||
94688565|NCT00451217|324315515|FG003|Overall Study|Lost to Follow-up|1|||
94688566|NCT00451217|324315512|FG000|Overall Study|Withdrawal by Subject|1|||
94688567|NCT00451217|324315513|FG001|Overall Study|Withdrawal by Subject|0|||
94688568|NCT00451217|324315514|FG002|Overall Study|Withdrawal by Subject|0|||
94688569|NCT00451217|324315515|FG003|Overall Study|Withdrawal by Subject|0|||
94688570|NCT00451217|324315512|FG000|Overall Study|Not Treated|1|||
94688571|NCT00451217|324315513|FG001|Overall Study|Not Treated|1|||
94688572|NCT00451217|324315514|FG002|Overall Study|Not Treated|3|||
94688573|NCT00451217|324315515|FG003|Overall Study|Not Treated|4|||
94688574|NCT03154359|324315516|FG000|Overall Study|Adverse Event|1|||
94688575|NCT03154359|324315516|FG000|Overall Study|Lack of Efficacy|2|||
94688576|NCT03154359|324315516|FG000|Overall Study|Lost to Follow-up|3|||
94688577|NCT03154359|324315516|FG000|Overall Study|Physician Decision|3|||
94688578|NCT03154359|324315516|FG000|Overall Study|Protocol Violation|4|||
94688579|NCT03154359|324315516|FG000|Overall Study|Withdrawal by Subject|5|||
94688580|NCT03154359|324315516|FG000|Overall Study|Disruption of study due to COVID-19|4|||
94688581|NCT00358150|324315520|FG000|Overall Study|Adverse Event|3|||
94688582|NCT00358150|324315520|FG000|Overall Study|Withdrawal by Subject|1|||
94688583|NCT00358150|324315520|FG000|Overall Study|Undefined|3|||
94688584|NCT01622348|324315521|FG000|Overall Study|Withdrawal by Subject|1|||
94688585|NCT01622348|324315522|FG001|Overall Study|Withdrawal by Subject|0|||
94688586|NCT01622348|324315523|FG002|Overall Study|Withdrawal by Subject|1|||
94688587|NCT03249376|324315524|FG000|Overall Study|Adverse Event|11|||
94688588|NCT03249376|324315525|FG001|Overall Study|Adverse Event|5|||
94688589|NCT03249376|324315524|FG000|Overall Study|Lack of Efficacy|2|||
94688590|NCT03249376|324315525|FG001|Overall Study|Lack of Efficacy|4|||
94688591|NCT03249376|324315524|FG000|Overall Study|Protocol Violation|3|||
94688592|NCT03249376|324315525|FG001|Overall Study|Protocol Violation|2|||
94688593|NCT03249376|324315524|FG000|Overall Study|Physician Decision|0|||
94688594|NCT03249376|324315525|FG001|Overall Study|Physician Decision|2|||
94688595|NCT03249376|324315524|FG000|Overall Study|Withdrawal by Subject|3|||
94688596|NCT03249376|324315525|FG001|Overall Study|Withdrawal by Subject|9|||
94688597|NCT03249376|324315524|FG000|Overall Study|LTFU|2|||
94688598|NCT03249376|324315525|FG001|Overall Study|LTFU|1|||
94224532|NCT03730662|322615077|FG001|Variable Treatment Period|Personal Reason|2|||
94224533|NCT03730662|322615078|FG002|Variable Treatment Period|Personal Reason|1|||
94224534|NCT03730662|322615079|FG003|Variable Treatment Period|Personal Reason|6|||
94224535|NCT03730662|322615076|FG000|Variable Treatment Period|Physician Decision|0|||
94224536|NCT03730662|322615077|FG001|Variable Treatment Period|Physician Decision|0|||
94224537|NCT03730662|322615078|FG002|Variable Treatment Period|Physician Decision|0|||
94224538|NCT03730662|322615079|FG003|Variable Treatment Period|Physician Decision|3|||
94224539|NCT03730662|322615076|FG000|Variable Treatment Period|Protocol Violation|0|||
94224540|NCT03730662|322615077|FG001|Variable Treatment Period|Protocol Violation|1|||
94224541|NCT03730662|322615078|FG002|Variable Treatment Period|Protocol Violation|1|||
94224542|NCT03730662|322615079|FG003|Variable Treatment Period|Protocol Violation|1|||
94224543|NCT03730662|322615076|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
94224544|NCT03730662|322615077|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
94224545|NCT03730662|322615078|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
94224546|NCT03730662|322615079|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
94224547|NCT01797562|322615080|FG000|Overall Study|Protocol Violation|5|||
94224548|NCT03341312|322615081|FG000|Period 1|Withdrawal by Subject|0|||
94224549|NCT03341312|322615082|FG001|Period 1|Withdrawal by Subject|1|||
94224550|NCT03341312|322615083|FG002|Period 1|Withdrawal by Subject|0|||
94224551|NCT03341312|322615084|FG003|Period 1|Withdrawal by Subject|0|||
94224552|NCT01631825|322615085|FG000|Overall Study|Adverse Event|42|||
94332412|NCT00105183|322998779|FG002|Overall Study|Other reason|0|||
94332413|NCT01438307|322998781|FG000|Overall Study|Death|1|||
94224553|NCT01631825|322615085|FG000|Overall Study|Lack of Efficacy|7|||
94657497|NCT00201006|324204313|FG000|Overall Study|Withdrawal by Subject|7|||
94657498|NCT00201006|324204314|FG001|Overall Study|Withdrawal by Subject|2|||
94657499|NCT00201006|324204315|FG002|Overall Study|Withdrawal by Subject|3|||
94657500|NCT00201006|324204313|FG000|Overall Study|Adverse Event|1|||
94657501|NCT00201006|324204314|FG001|Overall Study|Adverse Event|0|||
94657502|NCT00201006|324204315|FG002|Overall Study|Adverse Event|1|||
94657503|NCT00966940|324204316|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
94657504|NCT00966940|324204317|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
94657505|NCT00966940|324204316|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
94657506|NCT00966940|324204317|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
94657507|NCT00274716|324204320|FG000|Phase A|Other non-reported reason|4|||
94657508|NCT00274716|324204321|FG001|Phase A|Other non-reported reason|2|||
94651323|NCT02460224|324179733|FG018|Overall Study|Progressive disease|8|||
94548727|NCT04279613|323805659|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
94224554|NCT01631825|322615085|FG000|Overall Study|Withdrawal by Subject|9|||
94224555|NCT01631825|322615085|FG000|Overall Study|Protocol Violation|4|||
94651324|NCT02460224|324179734|FG019|Overall Study|Progressive disease|3|||
94224556|NCT01631825|322615085|FG000|Overall Study|Discontinuation criteria|1|||
94224557|NCT01631825|322615085|FG000|Overall Study|Physician Decision|2|||
94224558|NCT02110225|322615086|FG000|Overall Study|Lost to Follow-up|0|||
94224559|NCT02110225|322615087|FG001|Overall Study|Lost to Follow-up|1|||
94657509|NCT00274716|324204322|FG002|Phase A|Other non-reported reason|1|||
94657510|NCT00274716|324204323|FG003|Phase A|Other non-reported reason|2|||
94657511|NCT00274716|324204324|FG004|Phase A|Other non-reported reason|0|||
94657512|NCT00274716|324204325|FG005|Phase A|Other non-reported reason|1|||
94657513|NCT00274716|324204320|FG000|Phase A|Participant moved|0|||
94657514|NCT00274716|324204321|FG001|Phase A|Participant moved|0|||
94657515|NCT00274716|324204322|FG002|Phase A|Participant moved|1|||
94657516|NCT00274716|324204323|FG003|Phase A|Participant moved|0|||
94657517|NCT00274716|324204324|FG004|Phase A|Participant moved|0|||
94657518|NCT00274716|324204325|FG005|Phase A|Participant moved|1|||
94657519|NCT00274716|324204320|FG000|Phase A|Site Terminated|0|||
94657520|NCT00274716|324204321|FG001|Phase A|Site Terminated|0|||
94657521|NCT00274716|324204322|FG002|Phase A|Site Terminated|0|||
94657522|NCT00274716|324204323|FG003|Phase A|Site Terminated|1|||
94657523|NCT00274716|324204324|FG004|Phase A|Site Terminated|0|||
94657524|NCT00274716|324204325|FG005|Phase A|Site Terminated|0|||
94657525|NCT00274716|324204320|FG000|Phase A|Protocol Violation|1|||
94657526|NCT00274716|324204321|FG001|Phase A|Protocol Violation|0|||
94657527|NCT00274716|324204322|FG002|Phase A|Protocol Violation|0|||
94657528|NCT00274716|324204323|FG003|Phase A|Protocol Violation|1|||
94657529|NCT00274716|324204324|FG004|Phase A|Protocol Violation|0|||
94657530|NCT00274716|324204325|FG005|Phase A|Protocol Violation|0|||
94657531|NCT00274716|324204320|FG000|Phase A|Met criteria for discontinuation|1|||
94657532|NCT00274716|324204321|FG001|Phase A|Met criteria for discontinuation|1|||
94657533|NCT00274716|324204322|FG002|Phase A|Met criteria for discontinuation|0|||
94657534|NCT00274716|324204323|FG003|Phase A|Met criteria for discontinuation|0|||
94224560|NCT02110225|322615088|FG002|Overall Study|Lost to Follow-up|0|||
94224561|NCT05153499|322615089|FG000|Overall Study|Withdrawal by Subject|1|||
94224562|NCT05153499|322615090|FG001|Overall Study|Withdrawal by Subject|0|||
94224563|NCT05153499|322615089|FG000|Overall Study|Clinical Hold|1|||
94224564|NCT05153499|322615090|FG001|Overall Study|Clinical Hold|0|||
94224565|NCT05153499|322615089|FG000|Overall Study|Study Termination|6|||
94224566|NCT05153499|322615090|FG001|Overall Study|Study Termination|5|||
94224567|NCT00666835|322615091|FG000|Overall Study|Withdrawal by Subject|5|||
94224568|NCT00666835|322615092|FG001|Overall Study|Withdrawal by Subject|2|||
94224569|NCT00666835|322615091|FG000|Overall Study|Lack of Efficacy|0|||
94224570|NCT00666835|322615092|FG001|Overall Study|Lack of Efficacy|1|||
94224571|NCT00666835|322615091|FG000|Overall Study|Incl./excl. not fulfilled|7|||
94224572|NCT00666835|322615092|FG001|Overall Study|Incl./excl. not fulfilled|2|||
94224573|NCT00666835|322615091|FG000|Overall Study|Adverse Event|7|||
94224574|NCT00666835|322615092|FG001|Overall Study|Adverse Event|6|||
94224575|NCT00666835|322615091|FG000|Overall Study|Protocol Violation|2|||
94224576|NCT00666835|322615092|FG001|Overall Study|Protocol Violation|0|||
94224577|NCT00666835|322615091|FG000|Overall Study|Death|15|||
94224578|NCT00666835|322615092|FG001|Overall Study|Death|4|||
94224579|NCT00666835|322615091|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
94224580|NCT00666835|322615092|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
94224581|NCT00666835|322615091|FG000|Overall Study|Hemoglobulin concentration|4|||
94224582|NCT00666835|322615092|FG001|Overall Study|Hemoglobulin concentration|3|||
94224583|NCT00666835|322615091|FG000|Overall Study|Planned operation|2|||
94224584|NCT00666835|322615092|FG001|Overall Study|Planned operation|0|||
94224585|NCT00666835|322615091|FG000|Overall Study|Physician Decision|1|||
94224586|NCT00666835|322615092|FG001|Overall Study|Physician Decision|2|||
94224587|NCT02499835|322615093|FG000|Overall Study|Withdrawal by Subject|1|||
94224588|NCT02499835|322615094|FG001|Overall Study|Withdrawal by Subject|0|||
94224589|NCT02499835|322615095|FG002|Overall Study|Withdrawal by Subject|0|||
94224590|NCT02499835|322615096|FG003|Overall Study|Withdrawal by Subject|1|||
94224591|NCT02499835|322615093|FG000|Overall Study|Physician Decision|0|||
94224592|NCT02499835|322615094|FG001|Overall Study|Physician Decision|3|||
94224593|NCT02499835|322615095|FG002|Overall Study|Physician Decision|18|||
94224594|NCT02499835|322615096|FG003|Overall Study|Physician Decision|7|||
94224595|NCT02499835|322615093|FG000|Overall Study|Adverse Event|0|||
94224596|NCT02499835|322615094|FG001|Overall Study|Adverse Event|0|||
94224597|NCT02499835|322615095|FG002|Overall Study|Adverse Event|0|||
94224598|NCT02499835|322615096|FG003|Overall Study|Adverse Event|1|||
94224599|NCT02499835|322615093|FG000|Overall Study|Disease progression|2|||
94224600|NCT02499835|322615094|FG001|Overall Study|Disease progression|1|||
94224601|NCT02499835|322615095|FG002|Overall Study|Disease progression|0|||
94224602|NCT02499835|322615096|FG003|Overall Study|Disease progression|7|||
94224603|NCT01797705|322615101|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
94224604|NCT01797705|322615101|FG000|Overall Study|Withdrawal by Subject|1|||
94224605|NCT02262364|322615105|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
94224606|NCT02469077|322615110|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
94224607|NCT02469077|322615111|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
94224608|NCT02469077|322615110|FG000|Post Randomization/Intervention Period|Relocated|1|||
94224609|NCT02469077|322615111|FG001|Post Randomization/Intervention Period|Relocated|1|||
94224610|NCT02469077|322615110|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
94224611|NCT02469077|322615111|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
94224612|NCT02469077|322615110|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
94224613|NCT02469077|322615111|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
94224614|NCT03461211|322615112|FG000|Overall Study|Adverse Event|1|||
94224615|NCT03461211|322615113|FG001|Overall Study|Adverse Event|1|||
94224616|NCT03461211|322615112|FG000|Overall Study|Lack of Efficacy|0|||
94224617|NCT03461211|322615113|FG001|Overall Study|Lack of Efficacy|1|||
94224618|NCT01177137|322615114|FG000|Overall Study|Withdrawal by Subject|10|||
94224619|NCT01177137|322615115|FG001|Overall Study|Withdrawal by Subject|10|||
94224620|NCT01177137|322615116|FG002|Overall Study|Withdrawal by Subject|2|||
94224621|NCT01654289|322615117|FG000|Overall Study|Withdrawal by Subject|10|||
94224622|NCT01654289|322615118|FG001|Overall Study|Withdrawal by Subject|8|||
94224623|NCT01654289|322615119|FG002|Overall Study|Withdrawal by Subject|5|||
94224624|NCT01654289|322615117|FG000|Overall Study|Withdrew from intervention only|17|||
94224625|NCT01654289|322615118|FG001|Overall Study|Withdrew from intervention only|20|||
94224626|NCT01654289|322615119|FG002|Overall Study|Withdrew from intervention only|0|||
94224627|NCT00187135|322615120|FG000|Visit One|Withdrawal by Subject|1|||
94224628|NCT00187135|322615121|FG001|Visit One|Withdrawal by Subject|0|||
94224629|NCT00187135|322615122|FG002|Visit One|Withdrawal by Subject|0|||
94224630|NCT00187135|322615123|FG003|Visit One|Withdrawal by Subject|0|||
94224631|NCT00187135|322615124|FG004|Visit One|Withdrawal by Subject|0|||
94224632|NCT00187135|322615125|FG005|Visit One|Withdrawal by Subject|1|||
94224633|NCT00187135|322615120|FG000|Visit One|Physician Decision|3|||
94224634|NCT00187135|322615121|FG001|Visit One|Physician Decision|1|||
94224635|NCT00187135|322615122|FG002|Visit One|Physician Decision|0|||
94224636|NCT00187135|322615123|FG003|Visit One|Physician Decision|0|||
94224637|NCT00187135|322615124|FG004|Visit One|Physician Decision|0|||
94224638|NCT00187135|322615125|FG005|Visit One|Physician Decision|1|||
94224639|NCT00187135|322615120|FG000|Visit Two|Death|0|||
94224640|NCT00187135|322615121|FG001|Visit Two|Death|0|||
94224641|NCT00187135|322615122|FG002|Visit Two|Death|0|||
94224642|NCT00187135|322615123|FG003|Visit Two|Death|1|||
94224643|NCT00187135|322615124|FG004|Visit Two|Death|0|||
94224644|NCT00187135|322615125|FG005|Visit Two|Death|1|||
94224645|NCT00187135|322615120|FG000|Visit Two|Physician Decision|1|||
94224646|NCT00187135|322615121|FG001|Visit Two|Physician Decision|0|||
94224647|NCT00187135|322615122|FG002|Visit Two|Physician Decision|0|||
94224648|NCT00187135|322615123|FG003|Visit Two|Physician Decision|0|||
94224649|NCT00187135|322615124|FG004|Visit Two|Physician Decision|0|||
94224650|NCT00187135|322615125|FG005|Visit Two|Physician Decision|0|||
94224651|NCT00187135|322615120|FG000|Visit Two|Withdrawal by Subject|1|||
94224652|NCT00187135|322615121|FG001|Visit Two|Withdrawal by Subject|1|||
94224653|NCT00187135|322615122|FG002|Visit Two|Withdrawal by Subject|1|||
94224654|NCT00187135|322615123|FG003|Visit Two|Withdrawal by Subject|0|||
94224655|NCT00187135|322615124|FG004|Visit Two|Withdrawal by Subject|1|||
94224656|NCT00187135|322615125|FG005|Visit Two|Withdrawal by Subject|1|||
94224657|NCT00187135|322615120|FG000|Visit Two|Study Discontinued|3|||
94224658|NCT00187135|322615121|FG001|Visit Two|Study Discontinued|2|||
94224659|NCT00187135|322615122|FG002|Visit Two|Study Discontinued|1|||
94224660|NCT00187135|322615123|FG003|Visit Two|Study Discontinued|7|||
94224661|NCT00187135|322615124|FG004|Visit Two|Study Discontinued|5|||
94224662|NCT00187135|322615125|FG005|Visit Two|Study Discontinued|6|||
94224663|NCT00187135|322615120|FG000|Visit Three|Death|0|||
94224664|NCT00187135|322615121|FG001|Visit Three|Death|0|||
94224665|NCT00187135|322615122|FG002|Visit Three|Death|1|||
94224666|NCT00187135|322615123|FG003|Visit Three|Death|0|||
94224667|NCT00187135|322615124|FG004|Visit Three|Death|1|||
94224668|NCT00187135|322615125|FG005|Visit Three|Death|0|||
94224669|NCT00187135|322615120|FG000|Visit Three|Withdrawal by Subject|0|||
94224670|NCT00187135|322615121|FG001|Visit Three|Withdrawal by Subject|1|||
94224671|NCT00187135|322615122|FG002|Visit Three|Withdrawal by Subject|1|||
94224672|NCT00187135|322615123|FG003|Visit Three|Withdrawal by Subject|2|||
94224673|NCT00187135|322615124|FG004|Visit Three|Withdrawal by Subject|0|||
94224674|NCT00187135|322615125|FG005|Visit Three|Withdrawal by Subject|0|||
94224675|NCT00187135|322615120|FG000|Visit Three|Study Discontinued|7|||
94224676|NCT00187135|322615121|FG001|Visit Three|Study Discontinued|6|||
94224677|NCT00187135|322615122|FG002|Visit Three|Study Discontinued|7|||
94224678|NCT00187135|322615123|FG003|Visit Three|Study Discontinued|7|||
94224679|NCT00187135|322615124|FG004|Visit Three|Study Discontinued|7|||
94224680|NCT00187135|322615125|FG005|Visit Three|Study Discontinued|6|||
94224681|NCT03635775|322615127|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
94224682|NCT03635775|322615128|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
94224683|NCT03635775|322615129|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
94224684|NCT03635775|322615130|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
94224685|NCT01536535|322615131|FG000|Overall Study|Withdrawal by Subject|10|||
94224686|NCT01536535|322615132|FG001|Overall Study|Withdrawal by Subject|5|||
94224687|NCT01536535|322615131|FG000|Overall Study|Lost to Follow-up|4|||
94224688|NCT01536535|322615132|FG001|Overall Study|Lost to Follow-up|6|||
94224689|NCT01536535|322615131|FG000|Overall Study|Physician Decision|1|||
94224690|NCT01536535|322615132|FG001|Overall Study|Physician Decision|1|||
94224691|NCT01536535|322615131|FG000|Overall Study|Participant moved|0|||
94224692|NCT01536535|322615132|FG001|Overall Study|Participant moved|1|||
94224693|NCT02025985|322615133|FG000|Overall Study|Consent withdrawn|0|||
94224694|NCT02025985|322615134|FG001|Overall Study|Consent withdrawn|0|||
94224695|NCT02025985|322615135|FG002|Overall Study|Consent withdrawn|1|||
94224696|NCT02025985|322615136|FG003|Overall Study|Consent withdrawn|0|||
94224697|NCT02025985|322615137|FG004|Overall Study|Consent withdrawn|0|||
94224698|NCT02025985|322615133|FG000|Overall Study|Termination of study by Sponsor|4|||
94224699|NCT02025985|322615134|FG001|Overall Study|Termination of study by Sponsor|3|||
94224700|NCT02025985|322615135|FG002|Overall Study|Termination of study by Sponsor|1|||
94224701|NCT02025985|322615136|FG003|Overall Study|Termination of study by Sponsor|1|||
94224702|NCT02025985|322615137|FG004|Overall Study|Termination of study by Sponsor|3|||
94224703|NCT02025985|322615133|FG000|Overall Study|Death|21|||
94224704|NCT02025985|322615134|FG001|Overall Study|Death|20|||
94224705|NCT02025985|322615135|FG002|Overall Study|Death|23|||
94224706|NCT02025985|322615136|FG003|Overall Study|Death|20|||
94224707|NCT02025985|322615137|FG004|Overall Study|Death|17|||
94224708|NCT01678898|322615140|FG000|PB-102-F01|Adverse Event|0|||
94224709|NCT01678898|322615141|FG001|PB-102-F01|Adverse Event|1|||
94224710|NCT01678898|322615142|FG002|PB-102-F01|Adverse Event|0|||
94224711|NCT01678898|322615140|FG000|PB-102-F01|Physician Decision|0|||
94224712|NCT01678898|322615141|FG001|PB-102-F01|Physician Decision|1|||
94224713|NCT01678898|322615142|FG002|PB-102-F01|Physician Decision|0|||
94224714|NCT00139659|322615143|FG000|Overall Study|Adverse Event|12|||
94224715|NCT00139659|322615144|FG001|Overall Study|Adverse Event|1|||
94224716|NCT00139659|322615143|FG000|Overall Study|Lack of Efficacy|1|||
94224717|NCT00139659|322615144|FG001|Overall Study|Lack of Efficacy|1|||
94224718|NCT00139659|322615143|FG000|Overall Study|Lost to Follow-up|7|||
94224719|NCT00139659|322615144|FG001|Overall Study|Lost to Follow-up|3|||
94224720|NCT00139659|322615143|FG000|Overall Study|Reason not Specified|6|||
94224721|NCT00139659|322615144|FG001|Overall Study|Reason not Specified|3|||
94224722|NCT00139659|322615143|FG000|Overall Study|Withdrawal by Subject|14|||
94224723|NCT00139659|322615144|FG001|Overall Study|Withdrawal by Subject|10|||
94224724|NCT02162771|322615145|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
94224725|NCT02162771|322615146|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
94224726|NCT02162771|322615145|FG000|Core Study Period (Part 2)|Adverse Event|4|||
94224727|NCT02162771|322615146|FG001|Core Study Period (Part 2)|Adverse Event|1|||
94224728|NCT02162771|322615145|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
94224729|NCT02162771|322615146|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
94224730|NCT02162771|322615145|FG000|Core Study Period (Part 2)|Physician Decision|0|||
94224731|NCT02162771|322615146|FG001|Core Study Period (Part 2)|Physician Decision|2|||
94224732|NCT02162771|322615145|FG000|Core Study Period (Part 2)|Death|1|||
94224733|NCT02162771|322615146|FG001|Core Study Period (Part 2)|Death|0|||
94224734|NCT02162771|322615145|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
94224735|NCT02162771|322615146|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
94224736|NCT02162771|322615145|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
94224737|NCT02162771|322615146|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
94224738|NCT02162771|322615145|FG000|Maintenance Study Period (Part 2)|Death|2|||
94224739|NCT02162771|322615146|FG001|Maintenance Study Period (Part 2)|Death|1|||
94224740|NCT02162771|322615145|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
94224741|NCT02162771|322615146|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
94224742|NCT02162771|322615145|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
94224743|NCT02162771|322615146|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
94224744|NCT02162771|322615145|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
94224745|NCT02162771|322615146|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
94224746|NCT01527500|322615147|FG000|Part A|Administrative|11|||
94224747|NCT01527500|322615148|FG001|Part A|Administrative|7|||
94224748|NCT01527500|322615147|FG000|Part A|Adverse Event|4|||
94224749|NCT01527500|322615148|FG001|Part A|Adverse Event|2|||
94224750|NCT01527500|322615147|FG000|Part A|Death|4|||
94224751|NCT01527500|322615148|FG001|Part A|Death|1|||
94224752|NCT01527500|322615147|FG000|Part A|Lost to Follow-up|0|||
94224753|NCT01527500|322615148|FG001|Part A|Lost to Follow-up|1|||
94224754|NCT01527500|322615147|FG000|Part A|Protocol Deviation|9|||
94224755|NCT01527500|322615148|FG001|Part A|Protocol Deviation|2|||
94224756|NCT01527500|322615147|FG000|Part A|Withdrawal by Subject|2|||
94224757|NCT01527500|322615148|FG001|Part A|Withdrawal by Subject|0|||
94224758|NCT01527500|322615147|FG000|Part B|Adverse Event|1|||
94224759|NCT01527500|322615148|FG001|Part B|Adverse Event|0|||
94224760|NCT01747629|322615149|FG000|Overall Study|Adverse Event|1|||
94224761|NCT01747629|322615150|FG001|Overall Study|Adverse Event|2|||
94224762|NCT01747629|322615149|FG000|Overall Study|Withdrawal by Subject|2|||
94224763|NCT01747629|322615150|FG001|Overall Study|Withdrawal by Subject|2|||
94224764|NCT01747629|322615149|FG000|Overall Study|Noncompliance|1|||
94224765|NCT01747629|322615150|FG001|Overall Study|Noncompliance|1|||
94224766|NCT01747629|322615149|FG000|Overall Study|Inclusion criteria not met|1|||
94224767|NCT01747629|322615150|FG001|Overall Study|Inclusion criteria not met|0|||
94224768|NCT01747629|322615149|FG000|Overall Study|Not treated|1|||
94224769|NCT01747629|322615150|FG001|Overall Study|Not treated|0|||
94224770|NCT01747629|322615149|FG000|Overall Study|Other|2|||
94224771|NCT01747629|322615150|FG001|Overall Study|Other|1|||
94224772|NCT01395914|322615151|FG000|Overall Study|Unrelated to study drug AE|6|||
94224773|NCT01395914|322615152|FG001|Overall Study|Unrelated to study drug AE|1|||
94224774|NCT01395914|322615151|FG000|Overall Study|Death|23|||
94224775|NCT01395914|322615152|FG001|Overall Study|Death|17|||
94224776|NCT01395914|322615151|FG000|Overall Study|Other|9|||
94224777|NCT01395914|322615152|FG001|Overall Study|Other|3|||
94224778|NCT01395914|322615151|FG000|Overall Study|Withdrawal by patient|27|||
94224779|NCT01395914|322615152|FG001|Overall Study|Withdrawal by patient|14|||
94224780|NCT01395914|322615151|FG000|Overall Study|Study drug-related AE|1|||
94224781|NCT01395914|322615152|FG001|Overall Study|Study drug-related AE|0|||
94224782|NCT01395914|322615151|FG000|Overall Study|Lost to Follow-up|6|||
94224783|NCT01395914|322615152|FG001|Overall Study|Lost to Follow-up|2|||
94224784|NCT00981578|322615153|FG000|Overall Study|Death|1|||
94224785|NCT00981578|322615153|FG000|Overall Study|Withdrawal by Subject|2|||
94224786|NCT02865135|322615154|FG000|Overall Study|Death|0|||
94224787|NCT02865135|322615155|FG001|Overall Study|Death|1|||
94224788|NCT02865135|322615156|FG002|Overall Study|Death|0|||
94224789|NCT02865135|322615154|FG000|Overall Study|Progression|6|||
94224790|NCT02865135|322615155|FG001|Overall Study|Progression|2|||
94224791|NCT02865135|322615156|FG002|Overall Study|Progression|2|||
94224792|NCT02040532|322615158|FG000|Overall Study|Lost to Follow-up|1|||
94224793|NCT02040532|322615158|FG000|Overall Study|Physician Decision|4|||
94224794|NCT02040532|322615158|FG000|Overall Study|Adverse Event|4|||
94224795|NCT02040532|322615158|FG000|Overall Study|Withdrawal by Subject|3|||
94224796|NCT01064856|322615161|FG000|Double-blind (DB) Period|Adverse Event|1|||
94224797|NCT01064856|322615162|FG001|Double-blind (DB) Period|Adverse Event|0|||
94224798|NCT01064856|322615163|FG002|Double-blind (DB) Period|Adverse Event|0|||
94224799|NCT01064856|322615164|FG003|Double-blind (DB) Period|Adverse Event|0|||
94224800|NCT01064856|322615161|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
94224801|NCT01064856|322615162|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
94224802|NCT01064856|322615163|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
94224803|NCT01064856|322615164|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
94224804|NCT01064856|322615161|FG000|Open-label (OL) Period|Adverse Event|0|||
94224805|NCT01064856|322615162|FG001|Open-label (OL) Period|Adverse Event|0|||
94224806|NCT01064856|322615163|FG002|Open-label (OL) Period|Adverse Event|12|||
94224807|NCT01064856|322615164|FG003|Open-label (OL) Period|Adverse Event|6|||
94224808|NCT01064856|322615161|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
94224809|NCT01064856|322615162|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
94224810|NCT01064856|322615163|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
94224811|NCT01064856|322615164|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
94224812|NCT01064856|322615161|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
94224813|NCT01064856|322615162|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
94224814|NCT01064856|322615163|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
94224815|NCT01064856|322615164|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
94224816|NCT01064856|322615161|FG000|Open-label (OL) Period|Other|0|||
94224817|NCT01064856|322615162|FG001|Open-label (OL) Period|Other|0|||
94224818|NCT01064856|322615163|FG002|Open-label (OL) Period|Other|7|||
94224819|NCT01064856|322615164|FG003|Open-label (OL) Period|Other|7|||
94224820|NCT01374971|322615168|FG000|Overall Study|Withdrawal by Subject|1|||
94224821|NCT02979613|322615170|FG000|Double-Blind Phase|Withdrew Consent|2|||
94224822|NCT02979613|322615171|FG001|Double-Blind Phase|Withdrew Consent|4|||
94224823|NCT02979613|322615170|FG000|Double-Blind Phase|Pregnancy|2|||
94224824|NCT02979613|322615171|FG001|Double-Blind Phase|Pregnancy|2|||
94224825|NCT02979613|322615170|FG000|Double-Blind Phase|Adverse Event|2|||
94224826|NCT02979613|322615171|FG001|Double-Blind Phase|Adverse Event|0|||
94224827|NCT02979613|322615170|FG000|Double-Blind Phase|Lost to Follow-up|1|||
94224828|NCT02979613|322615171|FG001|Double-Blind Phase|Lost to Follow-up|1|||
94224829|NCT02979613|322615170|FG000|Double-Blind Phase|Protocol Violation|1|||
94224830|NCT02979613|322615171|FG001|Double-Blind Phase|Protocol Violation|1|||
94224831|NCT02979613|322615170|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
94224832|NCT02979613|322615171|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
94224833|NCT02979613|322615170|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
94224834|NCT02979613|322615171|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
94224835|NCT02979613|322615170|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
94224836|NCT02979613|322615171|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
94224837|NCT02979613|322615170|FG000|Open-Label Extension (OLE) Phase|Death|0|||
94224838|NCT02979613|322615171|FG001|Open-Label Extension (OLE) Phase|Death|1|||
94224839|NCT02979613|322615170|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
94224840|NCT02979613|322615171|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
94224841|NCT01568112|322615174|FG000|Overall Study|Randomized But Not Treated|0|||
94224842|NCT01568112|322615175|FG001|Overall Study|Randomized But Not Treated|1|||
94224843|NCT01568112|322615176|FG002|Overall Study|Randomized But Not Treated|0|||
94224844|NCT01568112|322615177|FG003|Overall Study|Randomized But Not Treated|0|||
94224845|NCT01568112|322615174|FG000|Overall Study|Withdrew due to Adverse Event|2|||
94224846|NCT01568112|322615175|FG001|Overall Study|Withdrew due to Adverse Event|4|||
94224847|NCT01568112|322615176|FG002|Overall Study|Withdrew due to Adverse Event|6|||
94224848|NCT01568112|322615177|FG003|Overall Study|Withdrew due to Adverse Event|3|||
94224849|NCT01568112|322615174|FG000|Overall Study|Lost to Follow-up|0|||
94224850|NCT01568112|322615175|FG001|Overall Study|Lost to Follow-up|0|||
94224851|NCT01568112|322615176|FG002|Overall Study|Lost to Follow-up|0|||
94224852|NCT01568112|322615177|FG003|Overall Study|Lost to Follow-up|1|||
94224853|NCT01568112|322615174|FG000|Overall Study|Withdrawal by Subject|2|||
94224854|NCT01568112|322615175|FG001|Overall Study|Withdrawal by Subject|3|||
94224855|NCT01568112|322615176|FG002|Overall Study|Withdrawal by Subject|0|||
94224856|NCT01568112|322615177|FG003|Overall Study|Withdrawal by Subject|7|||
94224857|NCT01568112|322615174|FG000|Overall Study|Withdrawal by Physician|1|||
94224858|NCT01568112|322615175|FG001|Overall Study|Withdrawal by Physician|0|||
94224859|NCT01568112|322615176|FG002|Overall Study|Withdrawal by Physician|1|||
94224860|NCT01568112|322615177|FG003|Overall Study|Withdrawal by Physician|1|||
94224861|NCT02176356|322616476|FG000|Overall Study|Screen Failure|14|||
94224862|NCT02176356|322616476|FG000|Overall Study|Lost to Follow-up|4|||
94224863|NCT02176356|322616476|FG000|Overall Study|Personal Reasons|3|||
94224864|NCT02176356|322616476|FG000|Overall Study|Other Miscellaneous Reasons|2|||
94224865|NCT00837096|322616486|FG000|Overall Study|Physician Decision|1|||
94224866|NCT00837096|322616487|FG001|Overall Study|Physician Decision|1|||
94224867|NCT00837096|322616486|FG000|Overall Study|Not reported|9|||
94224868|NCT00837096|322616487|FG001|Overall Study|Not reported|8|||
94224869|NCT00550771|322616490|FG000|Overall Study|Adverse Event|11|||
94224870|NCT00550771|322616491|FG001|Overall Study|Adverse Event|3|||
94224871|NCT00550771|322616490|FG000|Overall Study|Discontinued for study-related reasons|0|||
94224872|NCT00550771|322616491|FG001|Overall Study|Discontinued for study-related reasons|1|||
94224873|NCT00550771|322616490|FG000|Overall Study|Physician Decision|2|||
94224874|NCT00550771|322616491|FG001|Overall Study|Physician Decision|0|||
94224875|NCT00550771|322616490|FG000|Overall Study|Withdrawal by Subject|0|||
94224876|NCT00550771|322616491|FG001|Overall Study|Withdrawal by Subject|1|||
94224877|NCT00550771|322616490|FG000|Overall Study|Protocol Violation|4|||
94224878|NCT00550771|322616491|FG001|Overall Study|Protocol Violation|5|||
94224879|NCT00405912|322616496|FG000|Overall Study|Withdrawal by Subject|12|||
94224880|NCT00405912|322616497|FG001|Overall Study|Withdrawal by Subject|11|||
94224881|NCT00405912|322616498|FG002|Overall Study|Withdrawal by Subject|12|||
94224882|NCT00405912|322616496|FG000|Overall Study|Lost to Follow-up|4|||
94224883|NCT00405912|322616497|FG001|Overall Study|Lost to Follow-up|8|||
94224884|NCT00405912|322616498|FG002|Overall Study|Lost to Follow-up|4|||
94224885|NCT05060237|322616499|FG000|Overall Study|Withdrawal by Subject|4|||
94224886|NCT05060237|322616499|FG000|Overall Study|Screening failure|8|||
94224887|NCT02176018|322616500|FG000|Overall Study|Adverse Event|0|||
94224888|NCT02176018|322616501|FG001|Overall Study|Adverse Event|2|||
94224889|NCT02176018|322616500|FG000|Overall Study|Lost to Follow-up|3|||
94224890|NCT02176018|322616501|FG001|Overall Study|Lost to Follow-up|1|||
94224891|NCT02176018|322616500|FG000|Overall Study|Protocol Violation|1|||
94224892|NCT02176018|322616501|FG001|Overall Study|Protocol Violation|1|||
94224893|NCT02176018|322616500|FG000|Overall Study|Withdrawal by Subject|1|||
94224894|NCT02176018|322616501|FG001|Overall Study|Withdrawal by Subject|2|||
94224895|NCT03022045|322616503|FG000|Overall Study|Adverse Event|0|||
94224896|NCT03022045|322616504|FG001|Overall Study|Adverse Event|1|||
94224897|NCT03022045|322616503|FG000|Overall Study|Withdrawal by Subject|1|||
94224898|NCT03022045|322616504|FG001|Overall Study|Withdrawal by Subject|1|||
94224899|NCT03220776|322616505|FG000|Overall Study|Claustrophobia|0|||
94224900|NCT03220776|322616506|FG001|Overall Study|Claustrophobia|1|||
94224901|NCT03220776|322616507|FG002|Overall Study|Claustrophobia|1|||
94224902|NCT03220776|322616508|FG003|Overall Study|Claustrophobia|0|||
94224903|NCT03220776|322616509|FG004|Overall Study|Claustrophobia|1|||
94224904|NCT03220776|322616510|FG005|Overall Study|Claustrophobia|0|||
94224905|NCT03220776|322616505|FG000|Overall Study|MRI Equipment Failure|1|||
94224906|NCT03220776|322616506|FG001|Overall Study|MRI Equipment Failure|0|||
94224907|NCT03220776|322616507|FG002|Overall Study|MRI Equipment Failure|0|||
94224908|NCT03220776|322616508|FG003|Overall Study|MRI Equipment Failure|0|||
94224909|NCT03220776|322616509|FG004|Overall Study|MRI Equipment Failure|0|||
94224910|NCT03220776|322616510|FG005|Overall Study|MRI Equipment Failure|0|||
94224911|NCT03220776|322616505|FG000|Overall Study|Inclimate Weather|0|||
94224912|NCT03220776|322616506|FG001|Overall Study|Inclimate Weather|0|||
94224913|NCT03220776|322616507|FG002|Overall Study|Inclimate Weather|0|||
94224914|NCT03220776|322616508|FG003|Overall Study|Inclimate Weather|0|||
94224915|NCT03220776|322616509|FG004|Overall Study|Inclimate Weather|0|||
94224916|NCT03220776|322616510|FG005|Overall Study|Inclimate Weather|1|||
94224917|NCT03220776|322616505|FG000|Overall Study|Physician Decision|0|||
94224918|NCT03220776|322616506|FG001|Overall Study|Physician Decision|0|||
94224919|NCT03220776|322616507|FG002|Overall Study|Physician Decision|0|||
94224920|NCT03220776|322616508|FG003|Overall Study|Physician Decision|1|||
94224921|NCT03220776|322616509|FG004|Overall Study|Physician Decision|0|||
94224922|NCT03220776|322616510|FG005|Overall Study|Physician Decision|0|||
94224923|NCT03220776|322616505|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
94224924|NCT03220776|322616506|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
94224925|NCT03220776|322616507|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
94224926|NCT03220776|322616508|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
94224927|NCT03220776|322616509|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
94224928|NCT03220776|322616510|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
94224929|NCT03220776|322616505|FG000|Overall Study|Protocol Violation|0|||
94224930|NCT03220776|322616506|FG001|Overall Study|Protocol Violation|0|||
94224931|NCT03220776|322616507|FG002|Overall Study|Protocol Violation|0|||
94224932|NCT03220776|322616508|FG003|Overall Study|Protocol Violation|2|||
94224933|NCT03220776|322616509|FG004|Overall Study|Protocol Violation|0|||
94224934|NCT03220776|322616510|FG005|Overall Study|Protocol Violation|1|||
94224935|NCT03220776|322616505|FG000|Overall Study|Withdrawal by Subject|1|||
94224936|NCT03220776|322616506|FG001|Overall Study|Withdrawal by Subject|0|||
94224937|NCT03220776|322616507|FG002|Overall Study|Withdrawal by Subject|0|||
94224938|NCT03220776|322616508|FG003|Overall Study|Withdrawal by Subject|0|||
94224939|NCT03220776|322616509|FG004|Overall Study|Withdrawal by Subject|0|||
94224940|NCT03220776|322616510|FG005|Overall Study|Withdrawal by Subject|0|||
94224941|NCT03226353|322616514|FG000|Overall Study|Withdrawal by Subject|1|||
94224942|NCT03226353|322616514|FG000|Overall Study|Screen Failure|5|||
94224943|NCT03441789|322616516|FG000|Overall Study|Withdrawal by Subject|1|||
94224944|NCT03441789|322616517|FG001|Overall Study|Withdrawal by Subject|1|||
94224945|NCT03441789|322616516|FG000|Overall Study|Adverse Event|0|||
94224946|NCT03441789|322616517|FG001|Overall Study|Adverse Event|1|||
94224947|NCT03441789|322616516|FG000|Overall Study|Protocol Violation|0|||
94224948|NCT03441789|322616517|FG001|Overall Study|Protocol Violation|1|||
94224949|NCT03441789|322616516|FG000|Overall Study|Lost to Follow-up|0|||
94224950|NCT03441789|322616517|FG001|Overall Study|Lost to Follow-up|1|||
94224951|NCT01780545|322616518|FG000|Overall Study|Withdrawal by Subject|3|||
94224952|NCT01780545|322616519|FG001|Overall Study|Withdrawal by Subject|1|||
94224953|NCT01780545|322616518|FG000|Overall Study|Lost to Follow-up|1|||
94224954|NCT01780545|322616519|FG001|Overall Study|Lost to Follow-up|1|||
94224955|NCT03168425|322616520|FG000|Overall Study|Lost to Follow-up|5|||
94224956|NCT03168425|322616521|FG001|Overall Study|Lost to Follow-up|8|||
94224957|NCT03168425|322616520|FG000|Overall Study|unable to confirm post op opioids|2|||
94224958|NCT03168425|322616521|FG001|Overall Study|unable to confirm post op opioids|3|||
94224959|NCT05372913|322616529|FG000|Overall Study|Withdrawal by Subject|0|||
94224960|NCT05372913|322616530|FG001|Overall Study|Withdrawal by Subject|2|||
94224961|NCT05372913|322616529|FG000|Overall Study|Protocol Violation|2|||
94224962|NCT05372913|322616530|FG001|Overall Study|Protocol Violation|2|||
94224963|NCT05372913|322616529|FG000|Overall Study|Adverse Event|0|||
94224964|NCT05372913|322616530|FG001|Overall Study|Adverse Event|1|||
94224965|NCT03275402|322616531|FG000|Overall Study|Death|17|||
94224966|NCT03275402|322616531|FG000|Overall Study|Study terminated by sponsor|21|||
94224967|NCT03275402|322616531|FG000|Overall Study|Withdrawal by Subject|1|||
94224968|NCT01960114|322616532|FG000|Overall Study|Adverse Event|1|||
94224969|NCT01960114|322616533|FG001|Overall Study|Adverse Event|0|||
94224970|NCT01960114|322616532|FG000|Overall Study|Could not swallow study medication|0|||
94224971|NCT01960114|322616533|FG001|Overall Study|Could not swallow study medication|1|||
94224972|NCT02253147|322616538|FG000|Overall Study|Protocol Violation|30|||
94224973|NCT02253147|322616538|FG000|Overall Study|Did not consent to study extension|9|||
94224974|NCT02253147|322616538|FG000|Overall Study|Conditional re-treatment at W52|5|||
94224975|NCT02253147|322616538|FG000|Overall Study|Lost to Follow-up|2|||
94224976|NCT02253147|322616538|FG000|Overall Study|Withdrawal by Subject|1|||
94224977|NCT01732926|322616539|FG000|Overall Study|Study Terminated by Sponsor|168|||
94224978|NCT01732926|322616540|FG001|Overall Study|Study Terminated by Sponsor|80|||
94224979|NCT01732926|322616539|FG000|Overall Study|Withdrawal by Subject|46|||
94224980|NCT01732926|322616540|FG001|Overall Study|Withdrawal by Subject|8|||
94224981|NCT01732926|322616539|FG000|Overall Study|Physician Decision|24|||
94224982|NCT01732926|322616540|FG001|Overall Study|Physician Decision|11|||
94224983|NCT01732926|322616539|FG000|Overall Study|Other Reason|21|||
94224984|NCT01732926|322616540|FG001|Overall Study|Other Reason|4|||
94224985|NCT01732926|322616539|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
94224986|NCT01732926|322616540|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
94224987|NCT01732926|322616539|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
94224988|NCT01732926|322616540|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
94224989|NCT01040403|322616541|FG000|Overall Study|Adverse Event|10|||
94224990|NCT01040403|322616541|FG000|Overall Study|Protocol Violation|2|||
94224991|NCT01040403|322616541|FG000|Overall Study|Lost to Follow-up|1|||
94224992|NCT01040403|322616541|FG000|Overall Study|Not treated|1|||
94224993|NCT01040403|322616541|FG000|Overall Study|Other reason not defined above|6|||
94224994|NCT03807700|322616543|FG000|Overall Study|Withdrawal by Subject|2|||
94224995|NCT03807700|322616544|FG001|Overall Study|Withdrawal by Subject|1|||
94224996|NCT01059526|322616545|FG000|Overall Study|Patient enrolled but not treated|20|||
94224997|NCT01059526|322616546|FG001|Overall Study|Patient enrolled but not treated|17|||
94224998|NCT01059526|322616545|FG000|Overall Study|Adverse Event|2|||
94224999|NCT01059526|322616546|FG001|Overall Study|Adverse Event|2|||
94225000|NCT01059526|322616545|FG000|Overall Study|Protocol Violation|0|||
94225001|NCT01059526|322616546|FG001|Overall Study|Protocol Violation|1|||
94225002|NCT01059526|322616545|FG000|Overall Study|Withdrawal by Subject|3|||
94225003|NCT01059526|322616546|FG001|Overall Study|Withdrawal by Subject|1|||
94225004|NCT01059526|322616545|FG000|Overall Study|Lost to Follow-up|4|||
94225005|NCT01059526|322616546|FG001|Overall Study|Lost to Follow-up|1|||
94225006|NCT01059526|322616545|FG000|Overall Study|Patient found to be dermatographic|1|||
94225007|NCT01059526|322616546|FG001|Overall Study|Patient found to be dermatographic|0|||
94225008|NCT00053352|322616547|FG000|Overall Study|Lost to Follow-up|0|||
94225009|NCT00053352|322616548|FG001|Overall Study|Lost to Follow-up|1|||
94225010|NCT00053352|322616547|FG000|Overall Study|Physician Decision|11|||
94225011|NCT00053352|322616548|FG001|Overall Study|Physician Decision|1|||
94225012|NCT00053352|322616547|FG000|Overall Study|Withdrawal by Subject|1|||
94225013|NCT00053352|322616548|FG001|Overall Study|Withdrawal by Subject|0|||
94225014|NCT00053352|322616547|FG000|Overall Study|Ineligible|8|||
94225015|NCT00053352|322616548|FG001|Overall Study|Ineligible|8|||
94225016|NCT00053352|322616547|FG000|Overall Study|Disease at new site|1|||
94225017|NCT00053352|322616548|FG001|Overall Study|Disease at new site|0|||
94225018|NCT02316847|322616549|FG000|Overall Study|Adverse Event|0|||
94225019|NCT02316847|322616550|FG001|Overall Study|Adverse Event|3|||
94225020|NCT02316847|322616549|FG000|Overall Study|Lost to Follow-up|0|||
94225021|NCT02316847|322616550|FG001|Overall Study|Lost to Follow-up|2|||
94225022|NCT02316847|322616549|FG000|Overall Study|Physician Decision|0|||
94225023|NCT02316847|322616550|FG001|Overall Study|Physician Decision|1|||
94225024|NCT02316847|322616549|FG000|Overall Study|Pregnancy|0|||
94225025|NCT02316847|322616550|FG001|Overall Study|Pregnancy|1|||
94225026|NCT02316847|322616549|FG000|Overall Study|Withdrawal by Subject|2|||
94225027|NCT02316847|322616550|FG001|Overall Study|Withdrawal by Subject|9|||
94225028|NCT02316847|322616549|FG000|Overall Study|Noncompliance with study drug|0|||
94225029|NCT02316847|322616550|FG001|Overall Study|Noncompliance with study drug|3|||
94225030|NCT02316847|322616549|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
94225031|NCT02316847|322616550|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
94225032|NCT01525641|322616551|FG000|Overall Study|Case report form not collected|25|||
94225033|NCT01525641|322616551|FG000|Overall Study|No visit since the first visit|16|||
94225034|NCT01525641|322616551|FG000|Overall Study|Adverse Event|73|||
94225035|NCT01525641|322616551|FG000|Overall Study|Lack of Efficacy|24|||
94225036|NCT01525641|322616551|FG000|Overall Study|Improvement|5|||
94225037|NCT01525641|322616551|FG000|Overall Study|Lost to follow-up (relocation)|1|||
94225038|NCT01525641|322616551|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
94225039|NCT01525641|322616551|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
94225040|NCT01525641|322616551|FG000|Overall Study|Other than stated above|7|||
94225041|NCT02381652|322616553|FG000|Overall Study|Withdrawal by Subject|0|||
94225042|NCT02381652|322616554|FG001|Overall Study|Withdrawal by Subject|0|||
94225043|NCT02381652|322616555|FG002|Overall Study|Withdrawal by Subject|1|||
94225044|NCT00588341|322616556|FG000|Overall Study|Withdrawal by Subject|3|||
94225045|NCT00588341|322616556|FG000|Overall Study|Not treated due to metastatic disease|1|||
94225046|NCT00588341|322616556|FG000|Overall Study|Patient ineligible|1|||
94225047|NCT01732627|322616557|FG000|Overall Study|Withdrawal by Subject|1|||
94225048|NCT01732627|322616558|FG001|Overall Study|Withdrawal by Subject|0|||
94225049|NCT03746483|322616559|FG000|Overall Study|Adverse Event|0|||
94225050|NCT03746483|322616560|FG001|Overall Study|Adverse Event|1|||
94225051|NCT03746483|322616559|FG000|Overall Study|Lack of Efficacy|3|||
94225052|NCT03746483|322616560|FG001|Overall Study|Lack of Efficacy|2|||
94225053|NCT03746483|322616559|FG000|Overall Study|Lost to Follow-up|1|||
94225054|NCT03746483|322616560|FG001|Overall Study|Lost to Follow-up|0|||
94225055|NCT03746483|322616559|FG000|Overall Study|Protocol Violation|2|||
94225056|NCT03746483|322616560|FG001|Overall Study|Protocol Violation|0|||
94225057|NCT00745121|322616563|FG000|Overall Study|Death|3|||
94225058|NCT00745121|322616564|FG001|Overall Study|Death|0|||
94225059|NCT00745121|322616563|FG000|Overall Study|Adverse Event|1|||
94225060|NCT00745121|322616564|FG001|Overall Study|Adverse Event|0|||
94225061|NCT00745121|322616563|FG000|Overall Study|Lost to Follow-up|1|||
94225062|NCT00745121|322616564|FG001|Overall Study|Lost to Follow-up|0|||
94225063|NCT00745121|322616563|FG000|Overall Study|Withdrawal by Subject|4|||
94225064|NCT00745121|322616564|FG001|Overall Study|Withdrawal by Subject|2|||
94225065|NCT00679549|322616571|FG000|Overall Study|dropout|2|||
94225066|NCT00679549|322616572|FG001|Overall Study|dropout|4|||
94225067|NCT00679549|322616571|FG000|Overall Study|missing outcome echocardiograms|4|||
94225068|NCT00679549|322616572|FG001|Overall Study|missing outcome echocardiograms|5|||
94225069|NCT03280108|322616573|FG000|Overall Study|Lost to Follow-up|2|||
94225070|NCT03280108|322616574|FG001|Overall Study|Lost to Follow-up|0|||
94225071|NCT02201771|322616575|FG000|Overall Study|Death|3|||
94225072|NCT02201771|322616576|FG001|Overall Study|Death|2|||
94225073|NCT02201771|322616577|FG002|Overall Study|Death|0|||
94225074|NCT02201771|322616575|FG000|Overall Study|Protocol Violation|10|||
94225075|NCT02201771|322616576|FG001|Overall Study|Protocol Violation|8|||
94225076|NCT02201771|322616577|FG002|Overall Study|Protocol Violation|10|||
94225077|NCT00583115|322616580|FG000|Overall Study|Death|1|||
94225078|NCT00264498|322616581|FG000|Randomized Treatment|Death|0|||
94225079|NCT00264498|322616582|FG001|Randomized Treatment|Death|3|||
94225080|NCT00264498|322616581|FG000|Randomized Treatment|Withdrawal by Subject|0|||
94225081|NCT00264498|322616582|FG001|Randomized Treatment|Withdrawal by Subject|1|||
94225082|NCT00264498|322616581|FG000|Randomized Treatment|Objective disease Progression|13|||
94225083|NCT00264498|322616582|FG001|Randomized Treatment|Objective disease Progression|14|||
94225084|NCT00264498|322616581|FG000|Randomized Treatment|Physician Decision|1|||
94225085|NCT00264498|322616582|FG001|Randomized Treatment|Physician Decision|0|||
94225086|NCT00264498|322616581|FG000|Randomized Treatment|Incorrectly randomized|1|||
94225087|NCT00264498|322616582|FG001|Randomized Treatment|Incorrectly randomized|0|||
94225088|NCT00264498|322616581|FG000|Randomized Treatment|Study Closure|1|||
94225089|NCT00264498|322616582|FG001|Randomized Treatment|Study Closure|0|||
94225090|NCT00264498|322616581|FG000|Randomized Treatment|Protocol Violation|1|||
94225091|NCT00264498|322616582|FG001|Randomized Treatment|Protocol Violation|0|||
94225092|NCT00264498|322616581|FG000|Crossover Treatment|Death|1|||
94225093|NCT00264498|322616582|FG001|Crossover Treatment|Death|3|||
94332414|NCT01438307|322998782|FG001|Overall Study|Death|1|||
94225094|NCT00264498|322616581|FG000|Crossover Treatment|Objective disease progression|4|||
94225095|NCT00264498|322616582|FG001|Crossover Treatment|Objective disease progression|5|||
94225096|NCT00264498|322616581|FG000|Crossover Treatment|Study closure|0|||
94225097|NCT00264498|322616582|FG001|Crossover Treatment|Study closure|1|||
94225098|NCT00264498|322616581|FG000|Crossover Treatment|Withdrawal by Subject|1|||
94225099|NCT00264498|322616582|FG001|Crossover Treatment|Withdrawal by Subject|0|||
94225100|NCT02382406|322616583|FG000|Study Treatment|Disease Progression|8|||
94225101|NCT02382406|322616584|FG001|Study Treatment|Disease Progression|0|||
94225102|NCT02382406|322616585|FG002|Study Treatment|Disease Progression|20|||
94225103|NCT02382406|322616583|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
94225104|NCT02382406|322616584|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
94225105|NCT02382406|322616585|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
94225106|NCT02382406|322616583|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
94225107|NCT02382406|322616584|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
94225108|NCT02382406|322616585|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
94225109|NCT02382406|322616583|FG000|Study Treatment|symptomatic deterioration|1|||
94225110|NCT02382406|322616584|FG001|Study Treatment|symptomatic deterioration|0|||
94225111|NCT02382406|322616585|FG002|Study Treatment|symptomatic deterioration|1|||
94225112|NCT02382406|322616583|FG000|Study Treatment|Death|0|||
94225113|NCT02382406|322616584|FG001|Study Treatment|Death|0|||
94225114|NCT02382406|322616585|FG002|Study Treatment|Death|2|||
94225115|NCT02382406|322616583|FG000|Follow up|Death|11|||
94225116|NCT02382406|322616584|FG001|Follow up|Death|0|||
94225117|NCT02382406|322616585|FG002|Follow up|Death|19|||
94225118|NCT02382406|322616583|FG000|Follow up|Symptomatic deterioration|1|||
94225119|NCT02382406|322616584|FG001|Follow up|Symptomatic deterioration|0|||
94225120|NCT02382406|322616585|FG002|Follow up|Symptomatic deterioration|1|||
94225121|NCT02382406|322616583|FG000|Follow up|Patient Refused Follow-up|1|||
94225122|NCT02382406|322616584|FG001|Follow up|Patient Refused Follow-up|0|||
94225123|NCT02382406|322616585|FG002|Follow up|Patient Refused Follow-up|0|||
94225124|NCT02382406|322616583|FG000|Follow up|Study Terminated|1|||
94225125|NCT02382406|322616584|FG001|Follow up|Study Terminated|0|||
94225126|NCT02382406|322616585|FG002|Follow up|Study Terminated|8|||
94225127|NCT02382406|322616583|FG000|Follow up|Withdrawal by Subject|0|||
94225128|NCT02382406|322616584|FG001|Follow up|Withdrawal by Subject|0|||
94225129|NCT02382406|322616585|FG002|Follow up|Withdrawal by Subject|2|||
94225130|NCT01713998|322616586|FG000|Overall Study|Lost to Follow-up|2|||
94225131|NCT01713998|322616587|FG001|Overall Study|Lost to Follow-up|0|||
94225132|NCT01713998|322616588|FG002|Overall Study|Lost to Follow-up|2|||
94225133|NCT01713998|322616586|FG000|Overall Study|Withdrawal by Subject|1|||
94225134|NCT01713998|322616587|FG001|Overall Study|Withdrawal by Subject|0|||
94225135|NCT01713998|322616588|FG002|Overall Study|Withdrawal by Subject|0|||
94225136|NCT00125853|322616589|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
94225137|NCT00125853|322616590|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
94225138|NCT01287416|322616594|FG000|Pre-post Training|Withdrawal by Subject|17|||
94225139|NCT01287416|322616595|FG001|Pre-post Training|Withdrawal by Subject|24|||
94225140|NCT01287416|322616594|FG000|Pre-post Training|Lost to Follow-up|5|||
94225141|NCT01287416|322616595|FG001|Pre-post Training|Lost to Follow-up|1|||
94225142|NCT01287416|322616594|FG000|6 Month Follow-up|Lost to Follow-up|3|||
94225143|NCT01287416|322616595|FG001|6 Month Follow-up|Lost to Follow-up|2|||
94225144|NCT01544309|322616601|FG000|Overall Study|Withdrawal by Subject|12|||
94225145|NCT01544309|322616602|FG001|Overall Study|Withdrawal by Subject|7|||
94225146|NCT01544309|322616601|FG000|Overall Study|Protocol Violation|2|||
94225147|NCT01544309|322616602|FG001|Overall Study|Protocol Violation|1|||
94225148|NCT01544309|322616601|FG000|Overall Study|Physician Decision|4|||
94225149|NCT01544309|322616602|FG001|Overall Study|Physician Decision|1|||
94225150|NCT01544309|322616601|FG000|Overall Study|Not performed pre-dose examination|1|||
94225151|NCT01544309|322616602|FG001|Overall Study|Not performed pre-dose examination|2|||
94225152|NCT01544309|322616601|FG000|Overall Study|Administered prohibit prior medication|1|||
94225153|NCT01544309|322616602|FG001|Overall Study|Administered prohibit prior medication|0|||
94225154|NCT01920178|322616603|FG000|Overall Study|Lost to Follow-up|2|||
94225155|NCT01920178|322616604|FG001|Overall Study|Lost to Follow-up|1|||
94225156|NCT02016690|322616605|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
94225157|NCT02016690|322616605|FG000|Overall Study|Excluded from SAS: Duplication|2|||
94225158|NCT02016690|322616605|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
94225159|NCT02016690|322616605|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
94225160|NCT02016690|322616605|FG000|Overall Study|Did not meet inclusion criteria|13|||
94225161|NCT02016690|322616605|FG000|Overall Study|Hospitalized for RSV at study start|3|||
94225162|NCT00240097|322616611|FG000|Part I|Adverse Event|1|||
94225163|NCT00240097|322616611|FG000|Part I|Death|1|||
94225164|NCT00240097|322616611|FG000|Part I|histology|1|||
94225165|NCT00240097|322616611|FG000|Part I|unevaluable|1|||
94225166|NCT00240097|322616611|FG000|Part II|did not continue from Part I|23|||
94225167|NCT01121185|322616612|FG000|Overall Study|Not infused|0|||
94225168|NCT01121185|322616613|FG001|Overall Study|Not infused|1|||
94225169|NCT01121185|322616612|FG000|Overall Study|Not transplanted|1|||
94225170|NCT01121185|322616613|FG001|Overall Study|Not transplanted|0|||
94225171|NCT02188784|322616614|FG000|Overall Study|Death|3|||
94225172|NCT02188784|322616615|FG001|Overall Study|Death|1|||
94225173|NCT02188784|322616614|FG000|Overall Study|Lost to Follow-up|1|||
94225174|NCT02188784|322616615|FG001|Overall Study|Lost to Follow-up|0|||
94225175|NCT02188784|322616614|FG000|Overall Study|Withdrawal by Subject|3|||
94225176|NCT02188784|322616615|FG001|Overall Study|Withdrawal by Subject|9|||
94225177|NCT02188784|322616614|FG000|Overall Study|Physician Decision|2|||
94225178|NCT02188784|322616615|FG001|Overall Study|Physician Decision|3|||
94225179|NCT01679613|322616616|FG000|Overall Study|other than stated above|0|||
94225180|NCT01679613|322616617|FG001|Overall Study|other than stated above|1|||
94225181|NCT01679613|322616618|FG002|Overall Study|other than stated above|2|||
94225182|NCT01679613|322616619|FG003|Overall Study|other than stated above|2|||
94225183|NCT02473913|322616620|FG000|Overall Study|Lost to Follow-up|3|||
94225184|NCT02473913|322616621|FG001|Overall Study|Lost to Follow-up|3|||
94225185|NCT01190449|322616628|FG000|Overall Study|Ineligible|0|||
94225186|NCT01190449|322616629|FG001|Overall Study|Ineligible|4|||
94225187|NCT05294328|322616634|FG000|Overall Study|Adverse Event|1|||
94225188|NCT05294328|322616635|FG001|Overall Study|Adverse Event|0|||
94225189|NCT05294328|322616636|FG002|Overall Study|Adverse Event|0|||
94225190|NCT05294328|322616634|FG000|Overall Study|Physician Decision|1|||
94225191|NCT05294328|322616635|FG001|Overall Study|Physician Decision|1|||
94225192|NCT05294328|322616636|FG002|Overall Study|Physician Decision|0|||
94225193|NCT05294328|322616634|FG000|Overall Study|Withdrawal by Subject|0|||
94225194|NCT05294328|322616635|FG001|Overall Study|Withdrawal by Subject|2|||
94225195|NCT05294328|322616636|FG002|Overall Study|Withdrawal by Subject|1|||
94225196|NCT05294328|322616634|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
94225197|NCT05294328|322616635|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
94225198|NCT05294328|322616636|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
94225199|NCT01002547|322617847|FG000|Overall Study|Withdrawal by Subject|4|||
94225200|NCT01002547|322617848|FG001|Overall Study|Withdrawal by Subject|0|||
94225201|NCT01002547|322617849|FG002|Overall Study|Withdrawal by Subject|5|||
94225202|NCT01002547|322617847|FG000|Overall Study|Lost to Follow-up|2|||
94225203|NCT01002547|322617848|FG001|Overall Study|Lost to Follow-up|1|||
94225204|NCT01002547|322617849|FG002|Overall Study|Lost to Follow-up|1|||
94225205|NCT01002547|322617847|FG000|Overall Study|Physician Decision|1|||
94225206|NCT01002547|322617848|FG001|Overall Study|Physician Decision|0|||
94225207|NCT01002547|322617849|FG002|Overall Study|Physician Decision|0|||
94225208|NCT01002547|322617847|FG000|Overall Study|Death|0|||
94225209|NCT01002547|322617848|FG001|Overall Study|Death|2|||
94225210|NCT01002547|322617849|FG002|Overall Study|Death|2|||
94225211|NCT01002547|322617847|FG000|Overall Study|Adverse Event|1|||
94225212|NCT01002547|322617848|FG001|Overall Study|Adverse Event|0|||
94225213|NCT01002547|322617849|FG002|Overall Study|Adverse Event|0|||
94225214|NCT01123642|322617850|FG000|Overall Study|Lost to Follow-up|23|||
94225215|NCT01123642|322617850|FG000|Overall Study|Withdrawal by Subject|9|||
94225216|NCT01123642|322617850|FG000|Overall Study|ineligible at baseline assessment|36|||
94225217|NCT01184859|322617851|FG000|Period 1: Single Dose|Insufficient urine production|0|||
94225218|NCT01184859|322617852|FG001|Period 1: Single Dose|Insufficient urine production|1|||
94225219|NCT01184859|322617853|FG002|Period 1: Single Dose|Insufficient urine production|0|||
94225220|NCT01184859|322617854|FG003|Period 1: Single Dose|Insufficient urine production|0|||
94225221|NCT01184859|322617855|FG004|Period 1: Single Dose|Insufficient urine production|0|||
94225222|NCT01184859|322617851|FG000|Period 1: Single Dose|Protocol Violation|0|||
94225223|NCT01184859|322617852|FG001|Period 1: Single Dose|Protocol Violation|1|||
94225224|NCT01184859|322617853|FG002|Period 1: Single Dose|Protocol Violation|0|||
94225225|NCT01184859|322617854|FG003|Period 1: Single Dose|Protocol Violation|0|||
94225226|NCT01184859|322617855|FG004|Period 1: Single Dose|Protocol Violation|0|||
94225227|NCT01184859|322617851|FG000|Period 1: Single Dose|Adverse Event|0|||
94225228|NCT01184859|322617852|FG001|Period 1: Single Dose|Adverse Event|0|||
94225229|NCT01184859|322617853|FG002|Period 1: Single Dose|Adverse Event|0|||
94225230|NCT01184859|322617854|FG003|Period 1: Single Dose|Adverse Event|0|||
94225231|NCT01184859|322617855|FG004|Period 1: Single Dose|Adverse Event|1|||
94225232|NCT01184859|322617851|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
94225233|NCT01184859|322617852|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
94225234|NCT01184859|322617853|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
94225235|NCT01184859|322617854|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
94225236|NCT01184859|322617855|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
94225237|NCT01184859|322617851|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
94225238|NCT01184859|322617852|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
94225239|NCT01184859|322617853|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
94225240|NCT01184859|322617854|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
94225241|NCT01184859|322617855|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
94225242|NCT03098797|322617856|FG000|Part 2 Open Label Extension|Adverse Event|2|||
94225243|NCT03098797|322617857|FG001|Part 2 Open Label Extension|Adverse Event|0|||
94225244|NCT00635570|322617861|FG000|Overall Study|Lost to Follow-up|8|||
94225245|NCT00635570|322617862|FG001|Overall Study|Lost to Follow-up|8|||
94225246|NCT00635570|322617861|FG000|Overall Study|Withdrawal by Subject|1|||
94225247|NCT00635570|322617862|FG001|Overall Study|Withdrawal by Subject|1|||
94225248|NCT00635570|322617861|FG000|Overall Study|Adverse Event|2|||
94225249|NCT00635570|322617862|FG001|Overall Study|Adverse Event|0|||
94225250|NCT00635570|322617861|FG000|Overall Study|Physician Decision|1|||
94225251|NCT00635570|322617862|FG001|Overall Study|Physician Decision|0|||
94225252|NCT00635570|322617861|FG000|Overall Study|Did not complete survey|2|||
94225253|NCT00635570|322617862|FG001|Overall Study|Did not complete survey|1|||
94225254|NCT00635570|322617861|FG000|Overall Study|Early termination(No sexual activity)|1|||
94225255|NCT00635570|322617862|FG001|Overall Study|Early termination(No sexual activity)|1|||
94225256|NCT00951171|322617868|FG000|Overall Study|Adverse Event|2|||
94225257|NCT00951171|322617869|FG001|Overall Study|Adverse Event|0|||
94225258|NCT00792259|322617870|FG000|Overall Study|Poor Quality Scans|1|||
94225259|NCT00792259|322617871|FG001|Overall Study|Poor Quality Scans|0|||
94225260|NCT00792259|322617872|FG002|Overall Study|Poor Quality Scans|0|||
94225261|NCT00332488|322617873|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
94225262|NCT00332488|322617874|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
94225263|NCT00332488|322617875|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
94225264|NCT00332488|322617873|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
94225265|NCT00332488|322617874|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
94225266|NCT00332488|322617875|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
94225267|NCT00332488|322617873|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
94225268|NCT00332488|322617874|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
94225269|NCT00332488|322617875|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
94225270|NCT00332488|322617873|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
94225271|NCT00332488|322617874|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
94225272|NCT00332488|322617875|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
94225273|NCT00332488|322617873|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
94225274|NCT00332488|322617874|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
94225275|NCT00332488|322617875|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
94225276|NCT00332488|322617873|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
94225277|NCT00332488|322617874|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
94225278|NCT00332488|322617875|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
94225279|NCT00332488|322617873|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
94225280|NCT00332488|322617874|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
94225281|NCT00332488|322617875|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
94225282|NCT00332488|322617873|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
94225283|NCT00332488|322617874|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
94225284|NCT00332488|322617875|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
94225285|NCT00332488|322617873|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
94225286|NCT00332488|322617874|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
94225287|NCT00332488|322617875|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
94225288|NCT00332488|322617873|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
94225289|NCT00332488|322617874|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
94225290|NCT00332488|322617875|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
94225291|NCT00332488|322617873|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
94225292|NCT00332488|322617874|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
94225293|NCT00332488|322617875|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
94225294|NCT00332488|322617873|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
94225295|NCT00332488|322617874|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
94225296|NCT00332488|322617875|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
94225297|NCT00275301|322617876|FG000|Overall Study|Adverse Event|5|||
94225298|NCT00443898|322617879|FG000|Overall Study|Adverse Event|0|||
94225299|NCT00443898|322617880|FG001|Overall Study|Adverse Event|0|||
94225300|NCT00443898|322617881|FG002|Overall Study|Adverse Event|1|||
94225301|NCT00443898|322617882|FG003|Overall Study|Adverse Event|1|||
94225302|NCT00443898|322617879|FG000|Overall Study|Lack of Efficacy|2|||
94225303|NCT00443898|322617880|FG001|Overall Study|Lack of Efficacy|3|||
94225304|NCT00443898|322617881|FG002|Overall Study|Lack of Efficacy|3|||
94225305|NCT00443898|322617882|FG003|Overall Study|Lack of Efficacy|1|||
94225306|NCT00443898|322617879|FG000|Overall Study|Protocol Violation|1|||
94225307|NCT00443898|322617880|FG001|Overall Study|Protocol Violation|1|||
94225308|NCT00443898|322617881|FG002|Overall Study|Protocol Violation|1|||
94332415|NCT00615914|322998787|FG000|Overall Study|Adverse Event|274|||
94225309|NCT00443898|322617882|FG003|Overall Study|Protocol Violation|0|||
94225310|NCT00443898|322617879|FG000|Overall Study|Withdrawal by Subject|11|||
94225311|NCT00443898|322617880|FG001|Overall Study|Withdrawal by Subject|10|||
94225312|NCT00443898|322617881|FG002|Overall Study|Withdrawal by Subject|10|||
94225313|NCT00443898|322617882|FG003|Overall Study|Withdrawal by Subject|6|||
94225314|NCT00443898|322617879|FG000|Overall Study|Lost to Follow-up|10|||
94225315|NCT00443898|322617880|FG001|Overall Study|Lost to Follow-up|10|||
94225316|NCT00443898|322617881|FG002|Overall Study|Lost to Follow-up|14|||
94225317|NCT00443898|322617882|FG003|Overall Study|Lost to Follow-up|10|||
94225318|NCT00443898|322617879|FG000|Overall Study|Death|0|||
94225319|NCT00443898|322617880|FG001|Overall Study|Death|1|||
94225320|NCT00443898|322617881|FG002|Overall Study|Death|0|||
94225321|NCT00443898|322617882|FG003|Overall Study|Death|0|||
94225322|NCT03722485|322617883|FG000|Overall Study|Withdrawal by Subject|1|||
94225323|NCT03722485|322617884|FG001|Overall Study|Withdrawal by Subject|0|||
94225324|NCT03722485|322617883|FG000|Overall Study|Adverse Event|0|||
94225325|NCT03722485|322617884|FG001|Overall Study|Adverse Event|2|||
94225326|NCT03722485|322617883|FG000|Overall Study|subject discharged prior to study completion|1|||
94225327|NCT03722485|322617884|FG001|Overall Study|subject discharged prior to study completion|5|||
94225328|NCT03722485|322617883|FG000|Overall Study|eligibility criteria not met|2|||
94225329|NCT03722485|322617884|FG001|Overall Study|eligibility criteria not met|0|||
94225330|NCT02388932|322617885|FG000|Overall Study|Death|1|||
94225331|NCT00508274|322617886|FG000|Overall Study|Adverse Event|5|||
94225332|NCT00508274|322617886|FG000|Overall Study|Death|7|||
94225333|NCT00508274|322617886|FG000|Overall Study|Disease progression|32|||
94225334|NCT00508274|322617886|FG000|Overall Study|Withdrawal by Subject|1|||
94225335|NCT00508274|322617886|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
94225336|NCT00508274|322617886|FG000|Overall Study|Missing|3|||
94225337|NCT02815735|322617896|FG000|First Intervention (4 Weeks)|Discomfort|1|||
94225338|NCT02815735|322617897|FG001|First Intervention (4 Weeks)|Discomfort|0|||
94225339|NCT02815735|322617896|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
94225340|NCT02815735|322617897|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
94225341|NCT02815735|322617896|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
94225342|NCT02815735|322617897|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
94225343|NCT02815735|322617896|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
94225344|NCT02815735|322617897|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
94225345|NCT00382408|322617898|FG000|Overall Study|Did not meet protocol requirement|3|||
94225346|NCT00382408|322617899|FG001|Overall Study|Did not meet protocol requirement|3|||
94225347|NCT00382408|322617898|FG000|Overall Study|Protocol Violation|2|||
94225348|NCT00382408|322617899|FG001|Overall Study|Protocol Violation|2|||
94225349|NCT00382408|322617898|FG000|Overall Study|Physician Decision|1|||
94225350|NCT00382408|322617899|FG001|Overall Study|Physician Decision|0|||
94225351|NCT00382408|322617898|FG000|Overall Study|Withdrawal by Subject|17|||
94225352|NCT00382408|322617899|FG001|Overall Study|Withdrawal by Subject|6|||
94225353|NCT00382408|322617898|FG000|Overall Study|Pregnancy|2|||
94225354|NCT00382408|322617899|FG001|Overall Study|Pregnancy|0|||
94225355|NCT00382408|322617898|FG000|Overall Study|Lost to Follow-up|19|||
94225356|NCT00382408|322617899|FG001|Overall Study|Lost to Follow-up|8|||
94225357|NCT00382408|322617898|FG000|Overall Study|Other|100|||
94225358|NCT00382408|322617899|FG001|Overall Study|Other|35|||
94225359|NCT00520403|322617903|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
94225360|NCT00520403|322617903|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
94225361|NCT00520403|322617903|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
94225362|NCT00520403|322617903|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
94225363|NCT00520403|322617903|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
94225364|NCT00520403|322617903|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
94225365|NCT00520403|322617903|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
94225366|NCT00520403|322617903|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
94225367|NCT02435381|322617904|FG000|Overall Study|Lost to Follow-up|2|||
94225368|NCT02435381|322617905|FG001|Overall Study|Lost to Follow-up|1|||
94225369|NCT01309243|322617908|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
94225370|NCT01309243|322617909|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
94225371|NCT01309243|322617908|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
94225372|NCT01309243|322617909|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
94225373|NCT01309243|322617908|FG000|Randomized Phase Through Week 96|Death|0|||
94225374|NCT01309243|322617909|FG001|Randomized Phase Through Week 96|Death|1|||
94225375|NCT01309243|322617908|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
94225376|NCT01309243|322617909|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
94225377|NCT01309243|322617908|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
94225378|NCT01309243|322617909|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
94225379|NCT01309243|322617908|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
94225380|NCT01309243|322617909|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
94225381|NCT01309243|322617908|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
94225382|NCT01309243|322617909|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
94225383|NCT01309243|322617908|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
94225384|NCT01309243|322617909|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
94225385|NCT01309243|322617908|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
94225386|NCT01309243|322617909|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
94225387|NCT01309243|322617908|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
94225388|NCT01309243|322617909|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
94225389|NCT01309243|322617908|FG000|Extension Phase|Lost to Follow-up|6|||
94225390|NCT01309243|322617909|FG001|Extension Phase|Lost to Follow-up|0|||
94225391|NCT00632931|322617910|FG000|Part 1, Period 1|Protocol Violation|1|||
94225392|NCT00632931|322617911|FG001|Part 1, Period 1|Protocol Violation|0|||
94225393|NCT00632931|322617912|FG002|Part 1, Period 1|Protocol Violation|0|||
94225394|NCT00632931|322617910|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
94225395|NCT00632931|322617911|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
94225396|NCT00632931|322617912|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
94225397|NCT00632931|322617910|FG000|Part 2|Adverse Event|0|||
94225398|NCT00632931|322617911|FG001|Part 2|Adverse Event|0|||
94225399|NCT00632931|322617912|FG002|Part 2|Adverse Event|3|||
94225400|NCT00632931|322617910|FG000|Part 2|Death|0|||
94225401|NCT00632931|322617911|FG001|Part 2|Death|0|||
94225402|NCT00632931|322617912|FG002|Part 2|Death|1|||
94225403|NCT00632931|322617910|FG000|Part 2|Lack of Efficacy|0|||
94225404|NCT00632931|322617911|FG001|Part 2|Lack of Efficacy|0|||
94225405|NCT00632931|322617912|FG002|Part 2|Lack of Efficacy|17|||
94225406|NCT00632931|322617910|FG000|Part 2|Withdrawal by Subject|0|||
94225407|NCT00632931|322617911|FG001|Part 2|Withdrawal by Subject|0|||
94225408|NCT00632931|322617912|FG002|Part 2|Withdrawal by Subject|3|||
94225409|NCT00833898|322617913|FG000|Overall Study|Withdrawal by Subject|33|||
94225410|NCT00833898|322617914|FG001|Overall Study|Withdrawal by Subject|27|||
94225411|NCT00833898|322617913|FG000|Overall Study|Lost to Follow-up|7|||
94225412|NCT00833898|322617914|FG001|Overall Study|Lost to Follow-up|7|||
94225413|NCT00833898|322617913|FG000|Overall Study|Patient did not receive transplant|0|||
94225414|NCT00833898|322617914|FG001|Overall Study|Patient did not receive transplant|2|||
94225415|NCT00917462|322617915|FG000|Overall Study|Clinical Deterioration|1|||
94225416|NCT04491006|322617916|FG000|Overall Study|Adverse Event|0|||
94225417|NCT04491006|322617917|FG001|Overall Study|Adverse Event|3|||
94225418|NCT04491006|322617918|FG002|Overall Study|Adverse Event|5|||
94225419|NCT04491006|322617916|FG000|Overall Study|Withdrawal by Subject|1|||
94225420|NCT04491006|322617917|FG001|Overall Study|Withdrawal by Subject|0|||
94225421|NCT04491006|322617918|FG002|Overall Study|Withdrawal by Subject|2|||
94225422|NCT00744796|322617919|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
94225423|NCT01514864|322617920|FG000|Overall Study|Disease progression|7|||
94225424|NCT01514864|322617921|FG001|Overall Study|Disease progression|5|||
94225425|NCT01514864|322617920|FG000|Overall Study|Study drug toxicity|2|||
94225426|NCT01514864|322617921|FG001|Overall Study|Study drug toxicity|0|||
94225427|NCT02254681|322617926|FG000|Overall Study|Lack of Efficacy|6|||
94225428|NCT00797511|322617927|FG000|Overall Study|Withdrawal by Subject|1|||
94225429|NCT00931918|322617928|FG000|Overall Study|Adverse Event|4|||
94225430|NCT00931918|322617929|FG001|Overall Study|Adverse Event|6|||
94225431|NCT00931918|322617928|FG000|Overall Study|Progressive Disease|2|||
94225432|NCT00931918|322617929|FG001|Overall Study|Progressive Disease|1|||
94225433|NCT00931918|322617928|FG000|Overall Study|Symptomatic Deterioration|1|||
94225434|NCT00931918|322617929|FG001|Overall Study|Symptomatic Deterioration|0|||
94332416|NCT00615914|322998787|FG000|Overall Study|Death|20|||
94225435|NCT00931918|322617928|FG000|Overall Study|Withdrawal by Patient|3|||
94225436|NCT00931918|322617929|FG001|Overall Study|Withdrawal by Patient|4|||
94225437|NCT00931918|322617928|FG000|Overall Study|Other Reason not Specified|4|||
94225438|NCT00931918|322617929|FG001|Overall Study|Other Reason not Specified|4|||
94225439|NCT00931918|322617928|FG000|Overall Study|Did not receive study drug|3|||
94225440|NCT00931918|322617929|FG001|Overall Study|Did not receive study drug|2|||
94225441|NCT01264887|322617931|FG000|Overall Study|Adverse Event|5|||
94225442|NCT01264887|322617931|FG000|Overall Study|Death|7|||
94225443|NCT01264887|322617931|FG000|Overall Study|Lack of Efficacy|5|||
94225444|NCT01264887|322617931|FG000|Overall Study|Physician Decision|4|||
94225445|NCT01264887|322617931|FG000|Overall Study|Withdrawal by Subject|6|||
94225446|NCT01264887|322617931|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
94225447|NCT01264887|322617931|FG000|Overall Study|Other|2|||
94225448|NCT02642159|322617933|FG000|Overall Study|Randomized but not treated|1|||
94225449|NCT02642159|322617934|FG001|Overall Study|Randomized but not treated|0|||
94225450|NCT02642159|322617933|FG000|Overall Study|Adverse Event|10|||
94225451|NCT02642159|322617934|FG001|Overall Study|Adverse Event|4|||
94225452|NCT02642159|322617933|FG000|Overall Study|Withdrawal by Subject|9|||
94225453|NCT02642159|322617934|FG001|Overall Study|Withdrawal by Subject|1|||
94225454|NCT02642159|322617933|FG000|Overall Study|Poor compliance to study protocol|1|||
94225455|NCT02642159|322617934|FG001|Overall Study|Poor compliance to study protocol|0|||
94225456|NCT02642159|322617933|FG000|Overall Study|Other than specified above|10|||
94225457|NCT02642159|322617934|FG001|Overall Study|Other than specified above|3|||
94225458|NCT01670188|322617935|FG000|Overall Study|Death|0|||
94225459|NCT01670188|322617936|FG001|Overall Study|Death|1|||
94225460|NCT01954771|322617937|FG000|Overall Study|Missing HbA1c of end-point|1|||
94225461|NCT01954771|322617938|FG001|Overall Study|Missing HbA1c of end-point|1|||
94225462|NCT01954771|322617939|FG002|Overall Study|Missing HbA1c of end-point|0|||
94225463|NCT01954771|322617937|FG000|Overall Study|Missing CGMS of end-point|1|||
94225464|NCT01954771|322617938|FG001|Overall Study|Missing CGMS of end-point|1|||
94225465|NCT01954771|322617939|FG002|Overall Study|Missing CGMS of end-point|0|||
94225466|NCT01954771|322617937|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
94225467|NCT01954771|322617938|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
94225468|NCT01954771|322617939|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
94225469|NCT03569475|322617942|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
94225470|NCT03569475|322617943|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
94225471|NCT03569475|322617944|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
94225472|NCT03569475|322617942|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
94225473|NCT03569475|322617943|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
94225474|NCT03569475|322617944|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
94225475|NCT03569475|322617942|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
94225476|NCT03569475|322617943|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
94225477|NCT03569475|322617944|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
94225478|NCT03569475|322617942|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
94225479|NCT03569475|322617943|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
94225480|NCT03569475|322617944|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
94225481|NCT03569475|322617942|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
94225482|NCT03569475|322617943|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
94225483|NCT03569475|322617944|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
94225484|NCT03569475|322617942|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
94225485|NCT03569475|322617943|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
94225486|NCT03569475|322617944|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
94225487|NCT03569475|322617942|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
94225488|NCT03569475|322617943|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
94225489|NCT03569475|322617944|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
94225490|NCT03569475|322617942|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
94225491|NCT03569475|322617943|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
94225492|NCT03569475|322617944|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
94225493|NCT03569475|322617942|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
94225494|NCT03569475|322617943|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
94225495|NCT03569475|322617944|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
94225496|NCT02132117|322617945|FG000|Overall Study|Adverse Event|6|||
94225497|NCT02132117|322617946|FG001|Overall Study|Adverse Event|1|||
94225498|NCT02132117|322617945|FG000|Overall Study|Lost to Follow-up|2|||
94225499|NCT02132117|322617946|FG001|Overall Study|Lost to Follow-up|2|||
94225500|NCT02132117|322617945|FG000|Overall Study|Personal Reasons|1|||
94225501|NCT02132117|322617946|FG001|Overall Study|Personal Reasons|2|||
94225502|NCT02132117|322617945|FG000|Overall Study|Other Miscellaneous Reasons|2|||
94225503|NCT02132117|322617946|FG001|Overall Study|Other Miscellaneous Reasons|0|||
94225504|NCT03638258|322617947|FG000|Overall Study|Adverse Event|1|||
94225505|NCT03638258|322617948|FG001|Overall Study|Adverse Event|0|||
94332417|NCT00615914|322998787|FG000|Overall Study|Lack of Efficacy|59|||
94225506|NCT03638258|322617949|FG002|Overall Study|Adverse Event|2|||
94225507|NCT03638258|322617947|FG000|Overall Study|Lost to Follow-up|2|||
94225508|NCT03638258|322617948|FG001|Overall Study|Lost to Follow-up|4|||
94225509|NCT03638258|322617949|FG002|Overall Study|Lost to Follow-up|5|||
94225510|NCT03638258|322617947|FG000|Overall Study|Pregnancy|0|||
94225511|NCT03638258|322617948|FG001|Overall Study|Pregnancy|0|||
94225512|NCT03638258|322617949|FG002|Overall Study|Pregnancy|1|||
94225513|NCT03638258|322617947|FG000|Overall Study|Protocol Violation|0|||
94225514|NCT03638258|322617948|FG001|Overall Study|Protocol Violation|0|||
94225515|NCT03638258|322617949|FG002|Overall Study|Protocol Violation|1|||
94225516|NCT03638258|322617947|FG000|Overall Study|Withdrawal by Subject|4|||
94225517|NCT03638258|322617948|FG001|Overall Study|Withdrawal by Subject|5|||
94225518|NCT03638258|322617949|FG002|Overall Study|Withdrawal by Subject|12|||
94225519|NCT03638258|322617947|FG000|Overall Study|Lack of Efficacy|0|||
94225520|NCT03638258|322617948|FG001|Overall Study|Lack of Efficacy|0|||
94225521|NCT03638258|322617949|FG002|Overall Study|Lack of Efficacy|2|||
94225522|NCT02350127|322617951|FG000|4-Month Assessment|Withdrawal by Subject|10|||
94225523|NCT02350127|322617952|FG001|4-Month Assessment|Withdrawal by Subject|9|||
94225524|NCT02350127|322617951|FG000|4-Month Assessment|Death|1|||
94225525|NCT02350127|322617952|FG001|4-Month Assessment|Death|0|||
94225526|NCT02350127|322617951|FG000|8-Month Assessment|Death|1|||
94225527|NCT02350127|322617952|FG001|8-Month Assessment|Death|1|||
94225528|NCT02350127|322617951|FG000|8-Month Assessment|Withdrawal by Subject|5|||
94225529|NCT02350127|322617952|FG001|8-Month Assessment|Withdrawal by Subject|8|||
94225530|NCT03048058|322617953|FG000|Overall Study|Lost to Follow-up|4|||
94225531|NCT03048058|322617954|FG001|Overall Study|Lost to Follow-up|0|||
94225532|NCT03048058|322617953|FG000|Overall Study|Withdrawal by Subject|0|||
94225533|NCT03048058|322617954|FG001|Overall Study|Withdrawal by Subject|4|||
94225534|NCT01919398|322617958|FG000|Overall Study|Progressive Disease|0|||
94225535|NCT01919398|322617959|FG001|Overall Study|Progressive Disease|0|||
94225536|NCT01919398|322617960|FG002|Overall Study|Progressive Disease|4|||
94225537|NCT02383927|322617964|FG000|Overall Study|Disease Progression|8|||
94225538|NCT02383927|322617965|FG001|Overall Study|Disease Progression|8|||
94225539|NCT02383927|322617966|FG002|Overall Study|Disease Progression|15|||
94225540|NCT02383927|322617967|FG003|Overall Study|Disease Progression|4|||
94225541|NCT02383927|322617964|FG000|Overall Study|Physician Decision|0|||
94225542|NCT02383927|322617965|FG001|Overall Study|Physician Decision|0|||
94225543|NCT02383927|322617966|FG002|Overall Study|Physician Decision|2|||
94225544|NCT02383927|322617967|FG003|Overall Study|Physician Decision|0|||
94225545|NCT02383927|322617964|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
94225546|NCT02383927|322617965|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
94225547|NCT02383927|322617966|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
94225548|NCT02383927|322617967|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
94225549|NCT02383927|322617964|FG000|Overall Study|Adverse Event|4|||
94225550|NCT02383927|322617965|FG001|Overall Study|Adverse Event|1|||
94225551|NCT02383927|322617966|FG002|Overall Study|Adverse Event|3|||
94225552|NCT02383927|322617967|FG003|Overall Study|Adverse Event|5|||
94225553|NCT02383927|322617964|FG000|Overall Study|Miscellaneous|1|||
94225554|NCT02383927|322617965|FG001|Overall Study|Miscellaneous|0|||
94225555|NCT02383927|322617966|FG002|Overall Study|Miscellaneous|0|||
94225556|NCT02383927|322617967|FG003|Overall Study|Miscellaneous|1|||
94225557|NCT02383927|322617964|FG000|Overall Study|Withdrawal by Subject|0|||
94225558|NCT02383927|322617965|FG001|Overall Study|Withdrawal by Subject|1|||
94225559|NCT02383927|322617966|FG002|Overall Study|Withdrawal by Subject|4|||
94225560|NCT02383927|322617967|FG003|Overall Study|Withdrawal by Subject|0|||
94225561|NCT00276016|322617971|FG000|Intervention 1|Withdrawal by Subject|0|||
94225562|NCT00276016|322617972|FG001|Intervention 1|Withdrawal by Subject|1|||
94225563|NCT00276016|322617973|FG002|Intervention 1|Withdrawal by Subject|0|||
94225564|NCT00276016|322617974|FG003|Intervention 1|Withdrawal by Subject|0|||
94225565|NCT00276016|322617975|FG004|Intervention 1|Withdrawal by Subject|0|||
94225566|NCT00276016|322617976|FG005|Intervention 1|Withdrawal by Subject|0|||
94225567|NCT01772147|322619625|FG000|Overall Study|Adverse Event|13|||
94225568|NCT01772147|322619626|FG001|Overall Study|Adverse Event|10|||
94225569|NCT01772147|322619627|FG002|Overall Study|Adverse Event|6|||
94225570|NCT01772147|322619625|FG000|Overall Study|Withdrew Consent|7|||
94225571|NCT01772147|322619626|FG001|Overall Study|Withdrew Consent|8|||
94225572|NCT01772147|322619627|FG002|Overall Study|Withdrew Consent|4|||
94225573|NCT01772147|322619625|FG000|Overall Study|Lost to Follow-up|1|||
94225574|NCT01772147|322619626|FG001|Overall Study|Lost to Follow-up|0|||
94225575|NCT01772147|322619627|FG002|Overall Study|Lost to Follow-up|1|||
94225576|NCT01772147|322619625|FG000|Overall Study|Protocol Deviation|2|||
94225577|NCT01772147|322619626|FG001|Overall Study|Protocol Deviation|1|||
94225578|NCT01772147|322619627|FG002|Overall Study|Protocol Deviation|1|||
94225579|NCT01772147|322619625|FG000|Overall Study|Lack of Efficacy|8|||
94225580|NCT01772147|322619626|FG001|Overall Study|Lack of Efficacy|6|||
94225581|NCT01772147|322619627|FG002|Overall Study|Lack of Efficacy|6|||
94225582|NCT02675998|322619629|FG000|8-Week Treatment Period|Adverse Event|6|||
94225583|NCT02675998|322619630|FG001|8-Week Treatment Period|Adverse Event|5|||
94225584|NCT02675998|322619631|FG002|8-Week Treatment Period|Adverse Event|6|||
94225585|NCT02675998|322619632|FG003|8-Week Treatment Period|Adverse Event|0|||
94225586|NCT02675998|322619629|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
94225587|NCT02675998|322619630|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
94225588|NCT02675998|322619631|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
94225589|NCT02675998|322619632|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
94225590|NCT02675998|322619629|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
94225591|NCT02675998|322619630|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
94225592|NCT02675998|322619631|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
94225593|NCT02675998|322619632|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
94225594|NCT02675998|322619629|FG000|8-Week Treatment Period|Physician Decision|1|||
94225595|NCT02675998|322619630|FG001|8-Week Treatment Period|Physician Decision|0|||
94225596|NCT02675998|322619631|FG002|8-Week Treatment Period|Physician Decision|2|||
94225597|NCT02675998|322619632|FG003|8-Week Treatment Period|Physician Decision|0|||
94225598|NCT02675998|322619629|FG000|8-Week Treatment Period|GI side Effects|1|||
94225599|NCT02675998|322619630|FG001|8-Week Treatment Period|GI side Effects|4|||
94225600|NCT02675998|322619631|FG002|8-Week Treatment Period|GI side Effects|2|||
94225601|NCT02675998|322619632|FG003|8-Week Treatment Period|GI side Effects|0|||
94225602|NCT02675998|322619629|FG000|8-Week Treatment Period|Protocol Violation|1|||
94225603|NCT02675998|322619630|FG001|8-Week Treatment Period|Protocol Violation|1|||
94225604|NCT02675998|322619631|FG002|8-Week Treatment Period|Protocol Violation|1|||
94225605|NCT02675998|322619632|FG003|8-Week Treatment Period|Protocol Violation|0|||
94225606|NCT02675998|322619629|FG000|8-Week Treatment Period|Other|3|||
94225607|NCT02675998|322619630|FG001|8-Week Treatment Period|Other|1|||
94225608|NCT02675998|322619631|FG002|8-Week Treatment Period|Other|2|||
94225609|NCT02675998|322619632|FG003|8-Week Treatment Period|Other|0|||
94225610|NCT02675998|322619629|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
94225611|NCT02675998|322619630|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
94225612|NCT02675998|322619631|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
94225613|NCT02675998|322619632|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
94225614|NCT02675998|322619629|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
94225615|NCT02675998|322619630|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
94225616|NCT02675998|322619631|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
94225617|NCT02675998|322619632|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
94225618|NCT02675998|322619629|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
94225619|NCT02675998|322619630|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
94225620|NCT02675998|322619631|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
94225621|NCT02675998|322619632|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
94225622|NCT02675998|322619629|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
94225623|NCT02675998|322619630|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
94225624|NCT02675998|322619631|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
94225625|NCT02675998|322619632|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
94225626|NCT02675998|322619629|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
94225627|NCT02675998|322619630|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
94225628|NCT02675998|322619631|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
94225629|NCT02675998|322619632|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
94225630|NCT01011049|322619635|FG000|Overall Study|Protocol Violation|0|||
94225631|NCT01011049|322619636|FG001|Overall Study|Protocol Violation|0|||
94225632|NCT01011049|322619637|FG002|Overall Study|Protocol Violation|2|||
94225633|NCT01011049|322619638|FG003|Overall Study|Protocol Violation|0|||
94225634|NCT01011049|322619635|FG000|Overall Study|Lost to Follow-up|1|||
94225635|NCT01011049|322619636|FG001|Overall Study|Lost to Follow-up|2|||
94225636|NCT01011049|322619637|FG002|Overall Study|Lost to Follow-up|1|||
94225637|NCT01011049|322619638|FG003|Overall Study|Lost to Follow-up|0|||
94225638|NCT01011049|322619635|FG000|Overall Study|Withdrawal by Subject|0|||
94225639|NCT01011049|322619636|FG001|Overall Study|Withdrawal by Subject|0|||
94225640|NCT01011049|322619637|FG002|Overall Study|Withdrawal by Subject|1|||
94225641|NCT01011049|322619638|FG003|Overall Study|Withdrawal by Subject|0|||
94225642|NCT01191697|322619639|FG000|Overall Study|Death|1|||
94225643|NCT01191697|322619639|FG000|Overall Study|Physician Decision|2|||
94225644|NCT01191697|322619639|FG000|Overall Study|Pursue chemoradiation|2|||
94225645|NCT01191697|322619639|FG000|Overall Study|Break from chemotherapy|2|||
94225646|NCT01191697|322619639|FG000|Overall Study|Withdrawal by Subject|1|||
94225647|NCT01191697|322619639|FG000|Overall Study|Surveillance|1|||
94225648|NCT01191697|322619639|FG000|Overall Study|Adverse Event|2|||
94225649|NCT01191697|322619639|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
94225650|NCT01191697|322619639|FG000|Overall Study|Not completed but analyzed|25|||
94225651|NCT02396758|322619641|FG000|Overall Study|Withdrawal by Subject|2|||
94225652|NCT02396758|322619642|FG001|Overall Study|Withdrawal by Subject|0|||
94225653|NCT02396758|322619643|FG002|Overall Study|Withdrawal by Subject|0|||
94225654|NCT02396758|322619644|FG003|Overall Study|Withdrawal by Subject|1|||
94225655|NCT02396758|322619641|FG000|Overall Study|Lost to Follow-up|8|||
94225656|NCT02396758|322619642|FG001|Overall Study|Lost to Follow-up|5|||
94225657|NCT02396758|322619643|FG002|Overall Study|Lost to Follow-up|3|||
94225658|NCT02396758|322619644|FG003|Overall Study|Lost to Follow-up|3|||
94225659|NCT02396758|322619641|FG000|Overall Study|Death|1|||
94225660|NCT02396758|322619642|FG001|Overall Study|Death|1|||
94225661|NCT02396758|322619643|FG002|Overall Study|Death|0|||
94225662|NCT02396758|322619644|FG003|Overall Study|Death|1|||
94225663|NCT02396758|322619641|FG000|Overall Study|Randomized but not treated|1|||
94225664|NCT02396758|322619642|FG001|Overall Study|Randomized but not treated|0|||
94225665|NCT02396758|322619643|FG002|Overall Study|Randomized but not treated|1|||
94225666|NCT02396758|322619644|FG003|Overall Study|Randomized but not treated|0|||
94225667|NCT00498433|322619645|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
94225668|NCT00498433|322619646|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
94225669|NCT00498433|322619647|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
94225670|NCT00498433|322619645|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
94225671|NCT00498433|322619646|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
94225672|NCT00498433|322619647|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
94225673|NCT00498433|322619645|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
94225674|NCT00498433|322619646|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
94225675|NCT00498433|322619647|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
94225676|NCT00498433|322619645|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
94225677|NCT00498433|322619646|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
94225678|NCT00498433|322619647|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
94225679|NCT02490878|322619650|FG000|Overall Study|deemed ineligible|0|||
94225680|NCT02490878|322619651|FG001|Overall Study|deemed ineligible|1|||
94225681|NCT02490878|322619650|FG000|Overall Study|progression prior to treatment|0|||
94225682|NCT02490878|322619651|FG001|Overall Study|progression prior to treatment|1|||
94225683|NCT02490878|322619650|FG000|Overall Study|only submitted baseline QOL|0|||
94225684|NCT02490878|322619651|FG001|Overall Study|only submitted baseline QOL|1|||
94225685|NCT02847637|322619652|FG000|Overall Study|Withdrawal by Subject|0|||
94225686|NCT02847637|322619653|FG001|Overall Study|Withdrawal by Subject|1|||
94225687|NCT02847637|322619654|FG002|Overall Study|Withdrawal by Subject|1|||
94225688|NCT02847637|322619655|FG003|Overall Study|Withdrawal by Subject|0|||
94225689|NCT02847637|322619652|FG000|Overall Study|Lost to Follow-up|1|||
94225690|NCT02847637|322619653|FG001|Overall Study|Lost to Follow-up|1|||
94225691|NCT02847637|322619654|FG002|Overall Study|Lost to Follow-up|0|||
94225692|NCT02847637|322619655|FG003|Overall Study|Lost to Follow-up|0|||
94225693|NCT00439647|322619657|FG000|Overall Study|Withdrawal by Subject|25|||
94225694|NCT00439647|322619658|FG001|Overall Study|Withdrawal by Subject|22|||
94225695|NCT00439647|322619657|FG000|Overall Study|Death|15|||
94225696|NCT00439647|322619658|FG001|Overall Study|Death|18|||
94225697|NCT00439647|322619657|FG000|Overall Study|Adverse Event|11|||
94225698|NCT00439647|322619658|FG001|Overall Study|Adverse Event|11|||
94225699|NCT00439647|322619657|FG000|Overall Study|Lost to Follow-up|4|||
94225700|NCT00439647|322619658|FG001|Overall Study|Lost to Follow-up|12|||
94225701|NCT00439647|322619657|FG000|Overall Study|Protocol Violation|3|||
94225702|NCT00439647|322619658|FG001|Overall Study|Protocol Violation|4|||
94225703|NCT00439647|322619657|FG000|Overall Study|Lack of Efficacy|0|||
94225704|NCT00439647|322619658|FG001|Overall Study|Lack of Efficacy|4|||
94225705|NCT04531813|322619662|FG000|Overall Study|Protocol Violation|1|||
94225706|NCT04531813|322619662|FG000|Overall Study|Withdrawal by Subject|1|||
94225707|NCT00578318|322619663|FG000|Overall Study|Lost to Follow-up|2|||
94225708|NCT00578318|322619664|FG001|Overall Study|Lost to Follow-up|0|||
94225709|NCT00578318|322619663|FG000|Overall Study|Physician Decision|1|||
94225710|NCT00578318|322619664|FG001|Overall Study|Physician Decision|0|||
94225711|NCT00527514|322619665|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
94225712|NCT00527514|322619665|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
94225713|NCT00527514|322619665|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
94225714|NCT00527514|322619665|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
94225715|NCT00527514|322619665|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
94225716|NCT00527514|322619665|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
94225717|NCT00527514|322619665|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
94225718|NCT03041701|322619666|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
94225719|NCT03041701|322619667|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
94225720|NCT03041701|322619668|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
94225721|NCT03041701|322619666|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
94225722|NCT03041701|322619667|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
94225723|NCT03041701|322619668|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
94225724|NCT00920699|322619672|FG000|Overall Study|Withdrawal by Subject|2|||
94225725|NCT00920699|322619673|FG001|Overall Study|Withdrawal by Subject|0|||
94225726|NCT00920699|322619674|FG002|Overall Study|Withdrawal by Subject|2|||
94225727|NCT00920699|322619672|FG000|Overall Study|no longer met eligibility|0|||
94225728|NCT00920699|322619673|FG001|Overall Study|no longer met eligibility|1|||
94225729|NCT00920699|322619674|FG002|Overall Study|no longer met eligibility|0|||
94225730|NCT00920699|322619672|FG000|Overall Study|Lost to Follow-up|0|||
94225731|NCT00920699|322619673|FG001|Overall Study|Lost to Follow-up|0|||
94225732|NCT00920699|322619674|FG002|Overall Study|Lost to Follow-up|2|||
94225733|NCT00297778|322619687|FG000|Overall Study|Adverse Event|16|||
94225734|NCT00297778|322619688|FG001|Overall Study|Adverse Event|10|||
94225735|NCT00297778|322619687|FG000|Overall Study|Withdrawal by Subject|1|||
94225736|NCT00297778|322619688|FG001|Overall Study|Withdrawal by Subject|5|||
94225737|NCT00297778|322619687|FG000|Overall Study|Lack of Efficacy|2|||
94225738|NCT00297778|322619688|FG001|Overall Study|Lack of Efficacy|1|||
94225739|NCT00297778|322619687|FG000|Overall Study|Non-compliant with trial protocol|0|||
94225740|NCT00297778|322619688|FG001|Overall Study|Non-compliant with trial protocol|3|||
94225741|NCT00297778|322619687|FG000|Overall Study|Other|0|||
94225742|NCT00297778|322619688|FG001|Overall Study|Other|1|||
94225743|NCT03410108|322619689|FG000|Overall Study|Ongoing|41|||
94225744|NCT03410108|322619689|FG000|Overall Study|Adverse Event|4|||
94225745|NCT03410108|322619689|FG000|Overall Study|Progressive Disease|58|||
94225746|NCT03410108|322619689|FG000|Overall Study|Withdrawal by Subject|1|||
94225747|NCT02996097|322619693|FG000|Overall Study|Lost to Follow-up|11|||
94225748|NCT02996097|322619694|FG001|Overall Study|Lost to Follow-up|11|||
94225749|NCT01978236|322619695|FG000|Overall Study|Discontinued due to study close|2|||
94225750|NCT01820637|322619696|FG000|Overall Study|Death|2|||
94225751|NCT01820637|322619696|FG000|Overall Study|Withdrawal by Subject|1|||
94225752|NCT00819013|322619699|FG000|Overall Study|Not meeting continuing study eligibility|2|||
94225753|NCT00819013|322619700|FG001|Overall Study|Not meeting continuing study eligibility|1|||
94225754|NCT00819013|322619701|FG002|Overall Study|Not meeting continuing study eligibility|2|||
94225755|NCT00819013|322619702|FG003|Overall Study|Not meeting continuing study eligibility|1|||
94225756|NCT00819013|322619699|FG000|Overall Study|Adverse Event|0|||
94225757|NCT00819013|322619700|FG001|Overall Study|Adverse Event|0|||
94225758|NCT00819013|322619701|FG002|Overall Study|Adverse Event|1|||
94225759|NCT00819013|322619702|FG003|Overall Study|Adverse Event|0|||
94225760|NCT00819013|322619699|FG000|Overall Study|Withdrawal by Subject|1|||
94225761|NCT00819013|322619700|FG001|Overall Study|Withdrawal by Subject|0|||
94225762|NCT00819013|322619701|FG002|Overall Study|Withdrawal by Subject|1|||
94225763|NCT00819013|322619702|FG003|Overall Study|Withdrawal by Subject|0|||
94225764|NCT00819013|322619699|FG000|Overall Study|Lost to Follow-up|0|||
94225765|NCT00819013|322619700|FG001|Overall Study|Lost to Follow-up|0|||
94225766|NCT00819013|322619701|FG002|Overall Study|Lost to Follow-up|1|||
94225767|NCT00819013|322619702|FG003|Overall Study|Lost to Follow-up|2|||
94225768|NCT00819013|322619699|FG000|Overall Study|Death|0|||
94225769|NCT00819013|322619700|FG001|Overall Study|Death|0|||
94225770|NCT00819013|322619701|FG002|Overall Study|Death|0|||
94225771|NCT00819013|322619702|FG003|Overall Study|Death|1|||
94225772|NCT00576823|322619703|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
94225773|NCT00576823|322619704|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
94225774|NCT00576823|322619705|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
94225775|NCT00576823|322619703|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
94225776|NCT00576823|322619704|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
94225777|NCT00576823|322619705|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
94225778|NCT01200485|322619706|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
94225779|NCT01200485|322619707|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
94225780|NCT01200485|322619708|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
94225781|NCT01200485|322619706|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
94225782|NCT01200485|322619707|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
94225783|NCT01200485|322619708|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
94225784|NCT06080438|322619709|FG000|Overall Study|Lost to Follow-up|2|||
94225785|NCT00312845|322619721|FG000|Overall Study|Adverse Event|19|||
94225786|NCT00312845|322619722|FG001|Overall Study|Adverse Event|5|||
94225787|NCT00312845|322619721|FG000|Overall Study|Death|2|||
94225788|NCT00312845|322619722|FG001|Overall Study|Death|2|||
94225789|NCT00312845|322619721|FG000|Overall Study|Withdrawal by Subject|14|||
94225790|NCT00312845|322619722|FG001|Overall Study|Withdrawal by Subject|6|||
94225791|NCT00312845|322619721|FG000|Overall Study|Disease Progression|56|||
94225792|NCT00312845|322619722|FG001|Overall Study|Disease Progression|77|||
94225793|NCT00312845|322619721|FG000|Overall Study|Lost to Follow-up|2|||
94225794|NCT00312845|322619722|FG001|Overall Study|Lost to Follow-up|0|||
94225795|NCT00312845|322619721|FG000|Overall Study|Other|6|||
94225796|NCT00312845|322619722|FG001|Overall Study|Other|5|||
94225797|NCT04206384|322619725|FG000|Overall Study|Withdrawal by Subject|8|||
94225798|NCT04206384|322619725|FG000|Overall Study|Adverse Event|2|||
94225799|NCT03015181|322619728|FG000|Overall Study|Enrolled, but product never administered|1|||
94225800|NCT03015181|322619729|FG001|Overall Study|Enrolled, but product never administered|0|||
94225801|NCT03015181|322619730|FG002|Overall Study|Enrolled, but product never administered|0|||
94225802|NCT03015181|322619731|FG003|Overall Study|Enrolled, but product never administered|0|||
94225803|NCT03015181|322619732|FG004|Overall Study|Enrolled, but product never administered|0|||
94225804|NCT03015181|322619733|FG005|Overall Study|Enrolled, but product never administered|0|||
94225805|NCT03015181|322619734|FG006|Overall Study|Enrolled, but product never administered|0|||
94225806|NCT03015181|322619728|FG000|Overall Study|Withdrawal by Subject|0|||
94225807|NCT03015181|322619729|FG001|Overall Study|Withdrawal by Subject|0|||
94225808|NCT03015181|322619730|FG002|Overall Study|Withdrawal by Subject|0|||
94225809|NCT03015181|322619731|FG003|Overall Study|Withdrawal by Subject|0|||
94225810|NCT03015181|322619732|FG004|Overall Study|Withdrawal by Subject|0|||
94225811|NCT03015181|322619733|FG005|Overall Study|Withdrawal by Subject|1|||
94225812|NCT03015181|322619734|FG006|Overall Study|Withdrawal by Subject|0|||
94225813|NCT03015181|322619728|FG000|Overall Study|Physician Decision|0|||
94225814|NCT03015181|322619729|FG001|Overall Study|Physician Decision|0|||
94225815|NCT03015181|322619730|FG002|Overall Study|Physician Decision|0|||
94225816|NCT03015181|322619731|FG003|Overall Study|Physician Decision|0|||
94225817|NCT03015181|322619732|FG004|Overall Study|Physician Decision|0|||
94225818|NCT03015181|322619733|FG005|Overall Study|Physician Decision|0|||
94225819|NCT03015181|322619734|FG006|Overall Study|Physician Decision|1|||
94225820|NCT01077622|322619735|FG000|Overall Study|Physician Decision|2|||
94225821|NCT01077622|322619735|FG000|Overall Study|Withdrawal by Subject|1|||
94225822|NCT00424177|322619736|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
94225823|NCT00424177|322619736|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
94225824|NCT00424177|322619736|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
94225825|NCT00424177|322619736|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
94225826|NCT00424177|322619736|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
94225827|NCT00424177|322619736|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
94225828|NCT00424177|322619736|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
94225829|NCT00424177|322619736|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
94225830|NCT00424177|322619736|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
94225831|NCT00424177|322619736|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
94225832|NCT02551692|322619737|FG000|Overall Study|Lost to Follow-up|0|||
94225833|NCT02551692|322619738|FG001|Overall Study|Lost to Follow-up|1|||
94225834|NCT02551692|322619739|FG002|Overall Study|Lost to Follow-up|4|||
94225835|NCT02551692|322619737|FG000|Overall Study|Withdrawal by Subject|1|||
94225836|NCT02551692|322619738|FG001|Overall Study|Withdrawal by Subject|0|||
94225837|NCT02551692|322619739|FG002|Overall Study|Withdrawal by Subject|1|||
94225838|NCT04088136|322619742|FG000|Overall Study|Withdrawal by Subject|5|||
94225839|NCT04088136|322619743|FG001|Overall Study|Withdrawal by Subject|0|||
94225840|NCT04088136|322619742|FG000|Overall Study|Lack of Efficacy|0|||
94225841|NCT04088136|322619743|FG001|Overall Study|Lack of Efficacy|1|||
94225842|NCT01177228|322619744|FG000|Overall Study|Positive tuberculosis test|0|||
94225843|NCT01177228|322619745|FG001|Overall Study|Positive tuberculosis test|1|||
94225844|NCT01177228|322619746|FG002|Overall Study|Positive tuberculosis test|0|||
94225845|NCT01177228|322619747|FG003|Overall Study|Positive tuberculosis test|0|||
94225846|NCT01177228|322619744|FG000|Overall Study|Worsening disease activity|1|||
94225847|NCT01177228|322619745|FG001|Overall Study|Worsening disease activity|0|||
94225848|NCT01177228|322619746|FG002|Overall Study|Worsening disease activity|0|||
94225849|NCT01177228|322619747|FG003|Overall Study|Worsening disease activity|0|||
94225850|NCT01177228|322619744|FG000|Overall Study|Withdrawal by Subject|0|||
94225851|NCT01177228|322619745|FG001|Overall Study|Withdrawal by Subject|1|||
94225852|NCT01177228|322619746|FG002|Overall Study|Withdrawal by Subject|0|||
94225853|NCT01177228|322619747|FG003|Overall Study|Withdrawal by Subject|0|||
94225854|NCT01592383|322619748|FG000|Overall Study|Adverse Event|1|||
94225855|NCT01494298|322619749|FG000|Overall Study|Protocol Violation|2|||
94225856|NCT01494298|322619750|FG001|Overall Study|Protocol Violation|8|||
94225857|NCT01180790|322619751|FG000|Overall Study|Adverse Event|1|||
94225858|NCT01180790|322619752|FG001|Overall Study|Adverse Event|1|||
94225859|NCT01180790|322619753|FG002|Overall Study|Adverse Event|2|||
94225860|NCT01180790|322619754|FG003|Overall Study|Adverse Event|0|||
94225861|NCT01180790|322619755|FG004|Overall Study|Adverse Event|1|||
94225862|NCT01180790|322619756|FG005|Overall Study|Adverse Event|3|||
94225863|NCT01180790|322619757|FG006|Overall Study|Adverse Event|0|||
94225864|NCT01180790|322619751|FG000|Overall Study|Withdrawal by Subject|3|||
94225865|NCT01180790|322619752|FG001|Overall Study|Withdrawal by Subject|0|||
94225866|NCT01180790|322619753|FG002|Overall Study|Withdrawal by Subject|5|||
94225867|NCT01180790|322619754|FG003|Overall Study|Withdrawal by Subject|0|||
94225868|NCT01180790|322619755|FG004|Overall Study|Withdrawal by Subject|2|||
94225869|NCT01180790|322619756|FG005|Overall Study|Withdrawal by Subject|1|||
94225870|NCT01180790|322619757|FG006|Overall Study|Withdrawal by Subject|0|||
94225871|NCT01180790|322619751|FG000|Overall Study|Lost to Follow-up|3|||
94225872|NCT01180790|322619752|FG001|Overall Study|Lost to Follow-up|1|||
94225873|NCT01180790|322619753|FG002|Overall Study|Lost to Follow-up|0|||
94225874|NCT01180790|322619754|FG003|Overall Study|Lost to Follow-up|2|||
94225875|NCT01180790|322619755|FG004|Overall Study|Lost to Follow-up|1|||
94225876|NCT01180790|322619756|FG005|Overall Study|Lost to Follow-up|0|||
94225877|NCT01180790|322619757|FG006|Overall Study|Lost to Follow-up|1|||
94225878|NCT01180790|322619751|FG000|Overall Study|Physician Decision|1|||
94225879|NCT01180790|322619752|FG001|Overall Study|Physician Decision|0|||
94225880|NCT01180790|322619753|FG002|Overall Study|Physician Decision|0|||
94225881|NCT01180790|322619754|FG003|Overall Study|Physician Decision|1|||
94225882|NCT01180790|322619755|FG004|Overall Study|Physician Decision|0|||
94225883|NCT01180790|322619756|FG005|Overall Study|Physician Decision|0|||
94225884|NCT01180790|322619757|FG006|Overall Study|Physician Decision|0|||
94225885|NCT01180790|322619751|FG000|Overall Study|Lack of Efficacy|1|||
94225886|NCT01180790|322619752|FG001|Overall Study|Lack of Efficacy|2|||
94225887|NCT01180790|322619753|FG002|Overall Study|Lack of Efficacy|5|||
94225888|NCT01180790|322619754|FG003|Overall Study|Lack of Efficacy|6|||
94225889|NCT01180790|322619755|FG004|Overall Study|Lack of Efficacy|1|||
94225890|NCT01180790|322619756|FG005|Overall Study|Lack of Efficacy|3|||
94225891|NCT01180790|322619757|FG006|Overall Study|Lack of Efficacy|0|||
94225892|NCT01180790|322619751|FG000|Overall Study|compliance|0|||
94225893|NCT01180790|322619752|FG001|Overall Study|compliance|1|||
94225894|NCT01180790|322619753|FG002|Overall Study|compliance|0|||
94225895|NCT01180790|322619754|FG003|Overall Study|compliance|0|||
94225896|NCT01180790|322619755|FG004|Overall Study|compliance|0|||
94225897|NCT01180790|322619756|FG005|Overall Study|compliance|0|||
94332418|NCT00615914|322998787|FG000|Overall Study|Lost to Follow-up|187|||
94225898|NCT01180790|322619757|FG006|Overall Study|compliance|0|||
94225899|NCT01180790|322619751|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
94225900|NCT01180790|322619752|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
94225901|NCT01180790|322619753|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
94225902|NCT01180790|322619754|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
94225903|NCT01180790|322619755|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
94225904|NCT01180790|322619756|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
94225905|NCT01180790|322619757|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
94225906|NCT04167085|322619758|FG000|Baseline|Withdrawal by Subject|2|||
94225907|NCT04167085|322619759|FG001|Baseline|Withdrawal by Subject|1|||
94225908|NCT04167085|322619758|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
94225909|NCT04167085|322619759|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
94225910|NCT01283971|322619762|FG000|Overall Study|Adverse Event|3|||
94225911|NCT01283971|322619763|FG001|Overall Study|Adverse Event|5|||
94225912|NCT01283971|322619762|FG000|Overall Study|Insufficient therapeutic responses|3|||
94225913|NCT01283971|322619763|FG001|Overall Study|Insufficient therapeutic responses|3|||
94225914|NCT01283971|322619762|FG000|Overall Study|Protocol Violation|5|||
94225915|NCT01283971|322619763|FG001|Overall Study|Protocol Violation|1|||
94225916|NCT01283971|322619762|FG000|Overall Study|Refused treatment|3|||
94225917|NCT01283971|322619763|FG001|Overall Study|Refused treatment|1|||
94225918|NCT01283971|322619762|FG000|Overall Study|Failure to return|0|||
94225919|NCT01283971|322619763|FG001|Overall Study|Failure to return|1|||
94225920|NCT01283971|322619762|FG000|Overall Study|Administrative reasons|1|||
94225921|NCT01283971|322619763|FG001|Overall Study|Administrative reasons|1|||
94225922|NCT03325608|322619767|FG000|Overall Study|Lost to Follow-up|23|||
94225923|NCT03325608|322619768|FG001|Overall Study|Lost to Follow-up|23|||
94225924|NCT03325608|322619769|FG002|Overall Study|Lost to Follow-up|30|||
94225925|NCT03325608|322619770|FG003|Overall Study|Lost to Follow-up|30|||
94225926|NCT03325608|322619767|FG000|Overall Study|Death of Caregiver|0|||
94225927|NCT03325608|322619768|FG001|Overall Study|Death of Caregiver|0|||
94225928|NCT03325608|322619769|FG002|Overall Study|Death of Caregiver|2|||
94225929|NCT03325608|322619770|FG003|Overall Study|Death of Caregiver|2|||
94225930|NCT03325608|322619767|FG000|Overall Study|Death of Care Recipient|34|||
94225931|NCT03325608|322619768|FG001|Overall Study|Death of Care Recipient|34|||
94225932|NCT03325608|322619769|FG002|Overall Study|Death of Care Recipient|28|||
94225933|NCT03325608|322619770|FG003|Overall Study|Death of Care Recipient|28|||
94225934|NCT03325608|322619767|FG000|Overall Study|Withdrawal by Subject|49|||
94225935|NCT03325608|322619768|FG001|Overall Study|Withdrawal by Subject|49|||
94225936|NCT03325608|322619769|FG002|Overall Study|Withdrawal by Subject|35|||
94225937|NCT03325608|322619770|FG003|Overall Study|Withdrawal by Subject|35|||
94225938|NCT03325608|322619767|FG000|Overall Study|Ineligible|7|||
94225939|NCT03325608|322619768|FG001|Overall Study|Ineligible|7|||
94225940|NCT03325608|322619769|FG002|Overall Study|Ineligible|5|||
94225941|NCT03325608|322619770|FG003|Overall Study|Ineligible|5|||
94225942|NCT03151551|322619771|FG000|Open-Label Treatment Period|Adverse Event|0|||
94225943|NCT03151551|322619772|FG001|Open-Label Treatment Period|Adverse Event|2|||
94225944|NCT03151551|322619771|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
94225945|NCT03151551|322619772|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
94225946|NCT03151551|322619771|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
94225947|NCT03151551|322619772|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
94225948|NCT03151551|322619771|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
94225949|NCT03151551|322619772|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
94225950|NCT03151551|322619771|FG000|Open-Label Treatment Period|Physician Decision|3|||
94225951|NCT03151551|322619772|FG001|Open-Label Treatment Period|Physician Decision|0|||
94225952|NCT03151551|322619771|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
94225953|NCT03151551|322619772|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
94225954|NCT03151551|322619771|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
94225955|NCT03151551|322619772|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
94225956|NCT03151551|322619771|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
94225957|NCT03151551|322619772|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
94225958|NCT03151551|322619771|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
94225959|NCT03151551|322619772|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
94225960|NCT03151551|322619771|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
94225961|NCT03151551|322619772|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
94225962|NCT01075100|322619777|FG000|Overall Study|Adverse Event|15|||
94225963|NCT01075100|322619778|FG001|Overall Study|Adverse Event|18|||
94225964|NCT01075100|322619777|FG000|Overall Study|Patient Request|4|||
94225965|NCT01075100|322619778|FG001|Overall Study|Patient Request|4|||
94225966|NCT01075100|322619777|FG000|Overall Study|Investigator Request|2|||
94225967|NCT01075100|322619778|FG001|Overall Study|Investigator Request|1|||
94225968|NCT01075100|322619777|FG000|Overall Study|Disease Progression|25|||
94225969|NCT01075100|322619778|FG001|Overall Study|Disease Progression|29|||
94225970|NCT01075100|322619777|FG000|Overall Study|Other|3|||
94225971|NCT01075100|322619778|FG001|Overall Study|Other|1|||
94225972|NCT03282799|322619779|FG000|Overall Study|Pregnancy|1|||
94225973|NCT03282799|322619780|FG001|Overall Study|Pregnancy|0|||
94225974|NCT03282799|322619779|FG000|Overall Study|Physician Decision|1|||
94225975|NCT03282799|322619780|FG001|Overall Study|Physician Decision|0|||
94225976|NCT01231464|322621770|FG000|Overall Study|Adverse Event|0|||
94225977|NCT01231464|322621771|FG001|Overall Study|Adverse Event|1|||
94225978|NCT01231464|322621770|FG000|Overall Study|Protocol Violation|1|||
94225979|NCT01231464|322621771|FG001|Overall Study|Protocol Violation|2|||
94225980|NCT01231464|322621770|FG000|Overall Study|Lost to Follow-up|1|||
94225981|NCT01231464|322621771|FG001|Overall Study|Lost to Follow-up|2|||
94225982|NCT01231464|322621770|FG000|Overall Study|Withdrawal by Subject|3|||
94225983|NCT01231464|322621771|FG001|Overall Study|Withdrawal by Subject|2|||
94225984|NCT01589523|322621773|FG000|Overall Study|Withdrawal by Subject|1|||
94225985|NCT00961896|322621774|FG000|Overall Study|Abnormal laboratory value|0|||
94225986|NCT00961896|322621775|FG001|Overall Study|Abnormal laboratory value|0|||
94225987|NCT00961896|322621776|FG002|Overall Study|Abnormal laboratory value|1|||
94225988|NCT00371462|322621777|FG000|Overall Study|Withdrawal by Subject|1|||
94225989|NCT00371462|322621778|FG001|Overall Study|Withdrawal by Subject|0|||
94225990|NCT00371462|322621777|FG000|Overall Study|Other|7|||
94225991|NCT00371462|322621778|FG001|Overall Study|Other|8|||
94225992|NCT02514577|322621779|FG000|Overall Study|Lost to Follow-up|6|||
94225993|NCT02514577|322621780|FG001|Overall Study|Lost to Follow-up|6|||
94225994|NCT02514577|322621779|FG000|Overall Study|Protocol Violation|1|||
94225995|NCT02514577|322621780|FG001|Overall Study|Protocol Violation|0|||
94225996|NCT02514577|322621779|FG000|Overall Study|Withdrawal by Subject|6|||
94225997|NCT02514577|322621780|FG001|Overall Study|Withdrawal by Subject|6|||
94225998|NCT02514577|322621779|FG000|Overall Study|Adverse Event|1|||
94225999|NCT02514577|322621780|FG001|Overall Study|Adverse Event|1|||
94226000|NCT02916706|322621781|FG000|Overall Study|Adverse Event|0|||
94226001|NCT02916706|322621782|FG001|Overall Study|Adverse Event|1|||
94226002|NCT02916706|322621781|FG000|Overall Study|Lost to Follow-up|0|||
94226003|NCT02916706|322621782|FG001|Overall Study|Lost to Follow-up|1|||
94226004|NCT02916706|322621781|FG000|Overall Study|Physician Decision|1|||
94226005|NCT02916706|322621782|FG001|Overall Study|Physician Decision|0|||
94226006|NCT02916706|322621781|FG000|Overall Study|Protocol Violation|3|||
94226007|NCT02916706|322621782|FG001|Overall Study|Protocol Violation|1|||
94226008|NCT02916706|322621781|FG000|Overall Study|Withdrawal by Subject|6|||
94226009|NCT02916706|322621782|FG001|Overall Study|Withdrawal by Subject|9|||
94226010|NCT02916706|322621781|FG000|Overall Study|Other|5|||
94226011|NCT02916706|322621782|FG001|Overall Study|Other|19|||
94226012|NCT02561078|322621787|FG000|Overall Study|Adverse Event|5|||
94226013|NCT02561078|322621788|FG001|Overall Study|Adverse Event|2|||
94226014|NCT02561078|322621787|FG000|Overall Study|Death|2|||
94226015|NCT02561078|322621788|FG001|Overall Study|Death|1|||
94226016|NCT02561078|322621787|FG000|Overall Study|Lost to Follow-up|2|||
94226017|NCT02561078|322621788|FG001|Overall Study|Lost to Follow-up|6|||
94226018|NCT02561078|322621787|FG000|Overall Study|Non-Compliance with Study Drug|6|||
94226019|NCT02561078|322621788|FG001|Overall Study|Non-Compliance with Study Drug|3|||
94226020|NCT02561078|322621787|FG000|Overall Study|Physician Decision|2|||
94226021|NCT02561078|322621788|FG001|Overall Study|Physician Decision|3|||
94226022|NCT02561078|322621787|FG000|Overall Study|Withdrawal by Subject|13|||
94226023|NCT02561078|322621788|FG001|Overall Study|Withdrawal by Subject|10|||
94226024|NCT01194271|322621789|FG000|Overall Study|Withdrawal by Subject|1|||
94226025|NCT01194271|322621789|FG000|Overall Study|Ineligible, Screen Failure|1|||
94226026|NCT01194271|322621789|FG000|Overall Study|Death|1|||
94226027|NCT00043186|322621792|FG000|Overall Study|Physician Decision|0|||
94226028|NCT00043186|322621793|FG001|Overall Study|Physician Decision|0|||
94226029|NCT00043186|322621794|FG002|Overall Study|Physician Decision|3|||
94226030|NCT00043186|322621795|FG003|Overall Study|Physician Decision|0|||
94226031|NCT00043186|322621796|FG004|Overall Study|Physician Decision|1|||
94226032|NCT00043186|322621797|FG005|Overall Study|Physician Decision|0|||
94226033|NCT00043186|322621798|FG006|Overall Study|Physician Decision|0|||
94226034|NCT00043186|322621799|FG007|Overall Study|Physician Decision|1|||
94226035|NCT00043186|322621800|FG008|Overall Study|Physician Decision|1|||
94226036|NCT00043186|322621792|FG000|Overall Study|Adverse Event|2|||
94226037|NCT00043186|322621793|FG001|Overall Study|Adverse Event|2|||
94226038|NCT00043186|322621794|FG002|Overall Study|Adverse Event|2|||
94226039|NCT00043186|322621795|FG003|Overall Study|Adverse Event|3|||
94226040|NCT00043186|322621796|FG004|Overall Study|Adverse Event|2|||
94226041|NCT00043186|322621797|FG005|Overall Study|Adverse Event|1|||
94226042|NCT00043186|322621798|FG006|Overall Study|Adverse Event|2|||
94226043|NCT00043186|322621799|FG007|Overall Study|Adverse Event|1|||
94226044|NCT00043186|322621800|FG008|Overall Study|Adverse Event|3|||
94226045|NCT00043186|322621792|FG000|Overall Study|Withdrawal by Subject|11|||
94226046|NCT00043186|322621793|FG001|Overall Study|Withdrawal by Subject|8|||
94226047|NCT00043186|322621794|FG002|Overall Study|Withdrawal by Subject|11|||
94226048|NCT00043186|322621795|FG003|Overall Study|Withdrawal by Subject|13|||
94226049|NCT00043186|322621796|FG004|Overall Study|Withdrawal by Subject|14|||
94226050|NCT00043186|322621797|FG005|Overall Study|Withdrawal by Subject|6|||
94226051|NCT00043186|322621798|FG006|Overall Study|Withdrawal by Subject|12|||
94226052|NCT00043186|322621799|FG007|Overall Study|Withdrawal by Subject|9|||
94226053|NCT00043186|322621800|FG008|Overall Study|Withdrawal by Subject|10|||
94226054|NCT00043186|322621792|FG000|Overall Study|Death|0|||
94226055|NCT00043186|322621793|FG001|Overall Study|Death|0|||
94226056|NCT00043186|322621794|FG002|Overall Study|Death|1|||
94226057|NCT00043186|322621795|FG003|Overall Study|Death|0|||
94226058|NCT00043186|322621796|FG004|Overall Study|Death|0|||
94226059|NCT00043186|322621797|FG005|Overall Study|Death|0|||
94226060|NCT00043186|322621798|FG006|Overall Study|Death|2|||
94226061|NCT00043186|322621799|FG007|Overall Study|Death|0|||
94226062|NCT00043186|322621800|FG008|Overall Study|Death|0|||
94226063|NCT00043186|322621792|FG000|Overall Study|Disease progression|1|||
94226064|NCT00043186|322621793|FG001|Overall Study|Disease progression|0|||
94226065|NCT00043186|322621794|FG002|Overall Study|Disease progression|0|||
94226066|NCT00043186|322621795|FG003|Overall Study|Disease progression|3|||
94226067|NCT00043186|322621796|FG004|Overall Study|Disease progression|0|||
94226068|NCT00043186|322621797|FG005|Overall Study|Disease progression|0|||
94226069|NCT00043186|322621798|FG006|Overall Study|Disease progression|0|||
94226070|NCT00043186|322621799|FG007|Overall Study|Disease progression|4|||
94226071|NCT00043186|322621800|FG008|Overall Study|Disease progression|0|||
94226072|NCT00043186|322621792|FG000|Overall Study|Ineligibility determined|0|||
94226073|NCT00043186|322621793|FG001|Overall Study|Ineligibility determined|0|||
94226074|NCT00043186|322621794|FG002|Overall Study|Ineligibility determined|0|||
94226075|NCT00043186|322621795|FG003|Overall Study|Ineligibility determined|0|||
94226076|NCT00043186|322621796|FG004|Overall Study|Ineligibility determined|0|||
94226077|NCT00043186|322621797|FG005|Overall Study|Ineligibility determined|0|||
94226078|NCT00043186|322621798|FG006|Overall Study|Ineligibility determined|0|||
94226079|NCT00043186|322621799|FG007|Overall Study|Ineligibility determined|0|||
94226080|NCT00043186|322621800|FG008|Overall Study|Ineligibility determined|1|||
94226081|NCT00043186|322621792|FG000|Overall Study|Lost to Follow-up|3|||
94226082|NCT00043186|322621793|FG001|Overall Study|Lost to Follow-up|5|||
94226083|NCT00043186|322621794|FG002|Overall Study|Lost to Follow-up|1|||
94226084|NCT00043186|322621795|FG003|Overall Study|Lost to Follow-up|1|||
94226085|NCT00043186|322621796|FG004|Overall Study|Lost to Follow-up|1|||
94226086|NCT00043186|322621797|FG005|Overall Study|Lost to Follow-up|1|||
94226087|NCT00043186|322621798|FG006|Overall Study|Lost to Follow-up|1|||
94226088|NCT00043186|322621799|FG007|Overall Study|Lost to Follow-up|1|||
94226089|NCT00043186|322621800|FG008|Overall Study|Lost to Follow-up|2|||
94226090|NCT00043186|322621792|FG000|Overall Study|Noncompliance|0|||
94226091|NCT00043186|322621793|FG001|Overall Study|Noncompliance|0|||
94226092|NCT00043186|322621794|FG002|Overall Study|Noncompliance|1|||
94226093|NCT00043186|322621795|FG003|Overall Study|Noncompliance|1|||
94226094|NCT00043186|322621796|FG004|Overall Study|Noncompliance|0|||
94226095|NCT00043186|322621797|FG005|Overall Study|Noncompliance|0|||
94226096|NCT00043186|322621798|FG006|Overall Study|Noncompliance|0|||
94332419|NCT00615914|322998787|FG000|Overall Study|Withdrawal by Subject|16|||
94332420|NCT00615914|322998787|FG000|Overall Study|Physician Decision|4|||
94332421|NCT00615914|322998787|FG000|Overall Study|No data was collected.|65|||
94332422|NCT00615914|322998787|FG000|Overall Study|No treatment|2|||
94332423|NCT00615914|322998787|FG000|Overall Study|Irregularly enrolled patients|10|||
94332424|NCT00064077|322998788|FG000|Overall Study|Improper prior treatment|1|||
94332425|NCT00064077|322998789|FG001|Overall Study|Improper prior treatment|0|||
94332426|NCT00064077|322998790|FG002|Overall Study|Improper prior treatment|0|||
94332427|NCT00064077|322998791|FG003|Overall Study|Improper prior treatment|0|||
94332428|NCT00064077|322998788|FG000|Overall Study|Poor risk|2|||
94332429|NCT00064077|322998789|FG001|Overall Study|Poor risk|0|||
94332430|NCT00064077|322998790|FG002|Overall Study|Poor risk|1|||
94332431|NCT00064077|322998791|FG003|Overall Study|Poor risk|1|||
94332432|NCT00064077|322998788|FG000|Overall Study|Pathology|10|||
94332433|NCT00064077|322998789|FG001|Overall Study|Pathology|7|||
94332434|NCT00064077|322998790|FG002|Overall Study|Pathology|3|||
94332435|NCT00064077|322998791|FG003|Overall Study|Pathology|4|||
94332436|NCT00064077|322998788|FG000|Overall Study|No surgery|0|||
94332437|NCT00064077|322998789|FG001|Overall Study|No surgery|0|||
94332438|NCT00064077|322998790|FG002|Overall Study|No surgery|1|||
94332439|NCT00064077|322998791|FG003|Overall Study|No surgery|0|||
94332440|NCT00064077|322998788|FG000|Overall Study|No tumor|0|||
94332441|NCT00064077|322998789|FG001|Overall Study|No tumor|0|||
94332442|NCT00064077|322998790|FG002|Overall Study|No tumor|1|||
94332443|NCT00064077|322998791|FG003|Overall Study|No tumor|0|||
94332444|NCT00064077|322998788|FG000|Overall Study|Other reasons|2|||
94332445|NCT00064077|322998789|FG001|Overall Study|Other reasons|2|||
94332446|NCT00064077|322998790|FG002|Overall Study|Other reasons|1|||
94226097|NCT00043186|322621799|FG007|Overall Study|Noncompliance|0|||
94226098|NCT00043186|322621800|FG008|Overall Study|Noncompliance|0|||
94226099|NCT00043186|322621792|FG000|Overall Study|Other|0|||
94226100|NCT00043186|322621793|FG001|Overall Study|Other|0|||
94226101|NCT00043186|322621794|FG002|Overall Study|Other|1|||
94226102|NCT00043186|322621795|FG003|Overall Study|Other|1|||
94226103|NCT00043186|322621796|FG004|Overall Study|Other|0|||
94226104|NCT00043186|322621797|FG005|Overall Study|Other|0|||
94332447|NCT00064077|322998791|FG003|Overall Study|Other reasons|2|||
94332448|NCT04397796|322998792|FG000|Overall Study|Death|3|||
94226105|NCT00043186|322621798|FG006|Overall Study|Other|0|||
94226106|NCT00043186|322621799|FG007|Overall Study|Other|0|||
94226107|NCT00043186|322621800|FG008|Overall Study|Other|0|||
94226108|NCT03296566|322621801|FG000|Overall Study|Lost to Follow-up|19|||
94226109|NCT03296566|322621802|FG001|Overall Study|Lost to Follow-up|46|||
94226110|NCT03296566|322621801|FG000|Overall Study|Withdrawal by Subject|0|||
94226111|NCT03296566|322621802|FG001|Overall Study|Withdrawal by Subject|3|||
94226112|NCT03226106|322621803|FG000|Overall Study|Withdrawal by Subject|2|||
94226113|NCT03226106|322621804|FG001|Overall Study|Withdrawal by Subject|0|||
94226114|NCT03226106|322621803|FG000|Overall Study|Adverse Event|1|||
94226115|NCT03226106|322621804|FG001|Overall Study|Adverse Event|0|||
94226116|NCT03226106|322621803|FG000|Overall Study|Lost to Follow-up|2|||
94226117|NCT03226106|322621804|FG001|Overall Study|Lost to Follow-up|0|||
94226118|NCT01084239|322621805|FG000|28-Day Follow-up|Lost to Follow-up|4|||
94226119|NCT01084239|322621806|FG001|28-Day Follow-up|Lost to Follow-up|9|||
94226120|NCT00510198|322621808|FG000|Overall Study|Withdrawal by Subject|5|||
94226121|NCT00510198|322621809|FG001|Overall Study|Withdrawal by Subject|4|||
94226122|NCT02158247|322621811|FG000|Overall Study|Invisible vocal cords|5|||
94226123|NCT02166047|322621812|FG000|Overall Study|Withdrawal by Participant|0|||
94226124|NCT02166047|322621813|FG001|Overall Study|Withdrawal by Participant|1|||
94226125|NCT02166047|322621814|FG002|Overall Study|Withdrawal by Participant|2|||
94226126|NCT02166047|322621815|FG003|Overall Study|Withdrawal by Participant|0|||
94226127|NCT02166047|322621816|FG004|Overall Study|Withdrawal by Participant|0|||
94226128|NCT02166047|322621817|FG005|Overall Study|Withdrawal by Participant|0|||
94226129|NCT02166047|322621818|FG006|Overall Study|Withdrawal by Participant|1|||
94226130|NCT02166047|322621819|FG007|Overall Study|Withdrawal by Participant|0|||
94226131|NCT02166047|322621820|FG008|Overall Study|Withdrawal by Participant|0|||
94226132|NCT02166047|322621821|FG009|Overall Study|Withdrawal by Participant|0|||
94226133|NCT02166047|322621822|FG010|Overall Study|Withdrawal by Participant|0|||
94226134|NCT02166047|322621823|FG011|Overall Study|Withdrawal by Participant|0|||
94226135|NCT02166047|322621812|FG000|Overall Study|Adverse Event|0|||
94226136|NCT02166047|322621813|FG001|Overall Study|Adverse Event|0|||
94226137|NCT02166047|322621814|FG002|Overall Study|Adverse Event|0|||
94226138|NCT02166047|322621815|FG003|Overall Study|Adverse Event|0|||
94226139|NCT02166047|322621816|FG004|Overall Study|Adverse Event|1|||
94226140|NCT02166047|322621817|FG005|Overall Study|Adverse Event|0|||
94226141|NCT02166047|322621818|FG006|Overall Study|Adverse Event|1|||
94226142|NCT02166047|322621819|FG007|Overall Study|Adverse Event|0|||
94226143|NCT02166047|322621820|FG008|Overall Study|Adverse Event|0|||
94226144|NCT02166047|322621821|FG009|Overall Study|Adverse Event|0|||
94226145|NCT02166047|322621822|FG010|Overall Study|Adverse Event|2|||
94226146|NCT02166047|322621823|FG011|Overall Study|Adverse Event|0|||
94226147|NCT02544113|322621824|FG000|Overall Study|Death|3|||
94226148|NCT02544113|322621825|FG001|Overall Study|Death|4|||
94226149|NCT00843115|322621830|FG000|Overall Study|Death|4|||
94226150|NCT00843115|322621830|FG000|Overall Study|Adverse Event|30|||
94226151|NCT00843115|322621830|FG000|Overall Study|Lost to Follow-up|4|||
94226152|NCT00843115|322621830|FG000|Overall Study|Withdrawal by Subject|17|||
94226153|NCT00843115|322621830|FG000|Overall Study|Family wanted meds stopped|1|||
94226154|NCT00843115|322621830|FG000|Overall Study|Family does not want continuation|1|||
94226155|NCT00843115|322621830|FG000|Overall Study|Patient forgot to take meds|1|||
94226156|NCT00843115|322621830|FG000|Overall Study|Does not meet entrance criteria|1|||
94226157|NCT00843115|322621830|FG000|Overall Study|Physician Decision|1|||
94226158|NCT00843115|322621830|FG000|Overall Study|Family discontinued meds|1|||
94226159|NCT00843115|322621830|FG000|Overall Study|patient took for 2 days then stopped|1|||
94226160|NCT00843115|322621830|FG000|Overall Study|patient never took the medication|1|||
94226161|NCT00843115|322621830|FG000|Overall Study|hospitalized due to deterioration|1|||
94226162|NCT00843115|322621830|FG000|Overall Study|week 12 not done|1|||
94226163|NCT00843115|322621830|FG000|Overall Study|Syndrome De Glissement|1|||
94226164|NCT01388478|322621831|FG000|Overall Study|Adverse Event|4|||
94226165|NCT01388478|322621831|FG000|Overall Study|Withdrawal by Subject|1|||
94226166|NCT02621047|322621832|FG000|Overall Study|Adverse Event|0|||
94226167|NCT02621047|322621833|FG001|Overall Study|Adverse Event|0|||
94226168|NCT02621047|322621834|FG002|Overall Study|Adverse Event|1|||
94226169|NCT01990664|322621837|FG000|Overall Study|Lost to Follow-up|2|||
94226170|NCT01990664|322621838|FG001|Overall Study|Lost to Follow-up|6|||
94226171|NCT01990664|322621837|FG000|Overall Study|Withdrawal by Subject|2|||
94226172|NCT01990664|322621838|FG001|Overall Study|Withdrawal by Subject|3|||
94226173|NCT01990664|322621837|FG000|Overall Study|Protocol Violation|1|||
94226174|NCT01990664|322621838|FG001|Overall Study|Protocol Violation|0|||
94226175|NCT01990664|322621837|FG000|Overall Study|Lens Discomfort|1|||
94226176|NCT01990664|322621838|FG001|Overall Study|Lens Discomfort|1|||
94226177|NCT01990664|322621837|FG000|Overall Study|Lens Handling Difficulties|1|||
94226178|NCT01990664|322621838|FG001|Overall Study|Lens Handling Difficulties|0|||
94226179|NCT01990664|322621837|FG000|Overall Study|Unsatisfactory Visual Response|0|||
94226180|NCT01990664|322621838|FG001|Overall Study|Unsatisfactory Visual Response|1|||
94226181|NCT03371485|322621841|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
94226182|NCT03371485|322621841|FG000|2-year Follow-up|Death|5|||
94226183|NCT02204319|322621842|FG000|Overall Study|Pregnancy|1|||
94226184|NCT02204319|322621842|FG000|Overall Study|Withdrawal by Subject|2|||
94226185|NCT02959177|322621843|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
94226186|NCT02959177|322621844|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
94226187|NCT02959177|322621845|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
94226188|NCT02959177|322621843|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
94226189|NCT02959177|322621844|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
94226190|NCT02959177|322621845|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
94226191|NCT02959177|322621843|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
94226192|NCT02959177|322621844|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
94226193|NCT02959177|322621845|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
94226194|NCT02959177|322621843|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
94226195|NCT02959177|322621844|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
94226196|NCT02959177|322621845|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
94226197|NCT02959177|322621843|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
94226198|NCT02959177|322621844|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
94226199|NCT02959177|322621845|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
94226200|NCT02959177|322621843|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
94226201|NCT02959177|322621844|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
94226202|NCT02959177|322621845|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
94226203|NCT02959177|322621843|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
94226204|NCT02959177|322621844|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
94226205|NCT02959177|322621845|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
94226206|NCT02853305|322621847|FG000|Overall Study|Death|287|||
94226207|NCT02853305|322621848|FG001|Overall Study|Death|249|||
94226208|NCT02853305|322621849|FG002|Overall Study|Death|300|||
94226209|NCT02853305|322621847|FG000|Overall Study|Withdrawal by Subject|2|||
94226210|NCT02853305|322621848|FG001|Overall Study|Withdrawal by Subject|8|||
94226211|NCT02853305|322621849|FG002|Overall Study|Withdrawal by Subject|3|||
94226212|NCT02853305|322621847|FG000|Overall Study|Transferred to Extension Study|46|||
94226213|NCT02853305|322621848|FG001|Overall Study|Transferred to Extension Study|30|||
94226214|NCT02853305|322621849|FG002|Overall Study|Transferred to Extension Study|25|||
94226215|NCT02853305|322621847|FG000|Overall Study|Did Not Continue on Extension Study|16|||
94226216|NCT02853305|322621848|FG001|Overall Study|Did Not Continue on Extension Study|20|||
94226217|NCT02853305|322621849|FG002|Overall Study|Did Not Continue on Extension Study|24|||
94226218|NCT01340300|322621854|FG000|Overall Study|Lost to Follow-up|3|||
94226219|NCT01340300|322621855|FG001|Overall Study|Lost to Follow-up|0|||
94226220|NCT01340300|322621856|FG002|Overall Study|Lost to Follow-up|5|||
94226221|NCT01340300|322621857|FG003|Overall Study|Lost to Follow-up|10|||
94226222|NCT01340300|322621854|FG000|Overall Study|Withdrawal by Subject|5|||
94226223|NCT01340300|322621855|FG001|Overall Study|Withdrawal by Subject|6|||
94226224|NCT01340300|322621856|FG002|Overall Study|Withdrawal by Subject|6|||
94226225|NCT01340300|322621857|FG003|Overall Study|Withdrawal by Subject|3|||
94226226|NCT01340300|322621854|FG000|Overall Study|Adverse Event|1|||
94226227|NCT01340300|322621855|FG001|Overall Study|Adverse Event|0|||
94226228|NCT01340300|322621856|FG002|Overall Study|Adverse Event|4|||
94226229|NCT01340300|322621857|FG003|Overall Study|Adverse Event|0|||
94226230|NCT01340300|322621854|FG000|Overall Study|Physician Decision|0|||
94226231|NCT01340300|322621855|FG001|Overall Study|Physician Decision|1|||
94226232|NCT01340300|322621856|FG002|Overall Study|Physician Decision|0|||
94226233|NCT01340300|322621857|FG003|Overall Study|Physician Decision|0|||
94226234|NCT01340300|322621854|FG000|Overall Study|Unrelated sickness|0|||
94226235|NCT01340300|322621855|FG001|Overall Study|Unrelated sickness|2|||
94226236|NCT01340300|322621856|FG002|Overall Study|Unrelated sickness|0|||
94226237|NCT01340300|322621857|FG003|Overall Study|Unrelated sickness|1|||
94226238|NCT02215954|322621859|FG000|Overall Study|Adverse Event|0|||
94226239|NCT02215954|322621860|FG001|Overall Study|Adverse Event|0|||
94226240|NCT02215954|322621861|FG002|Overall Study|Adverse Event|1|||
94226241|NCT02215954|322621859|FG000|Overall Study|Withdrawal by Subject|0|||
94226242|NCT02215954|322621860|FG001|Overall Study|Withdrawal by Subject|0|||
94226243|NCT02215954|322621861|FG002|Overall Study|Withdrawal by Subject|2|||
94226244|NCT02215954|322621859|FG000|Overall Study|Not exposed|1|||
94226245|NCT02215954|322621860|FG001|Overall Study|Not exposed|1|||
94226246|NCT02215954|322621861|FG002|Overall Study|Not exposed|3|||
94226247|NCT03503162|322621862|FG000|Overall Study|did not meet eligibility|1|||
94226248|NCT00784277|322621863|FG000|IR Treatment|Adverse Event|4|||
94226249|NCT00784277|322621864|FG001|IR Treatment|Adverse Event|8|||
94226250|NCT00784277|322621865|FG002|IR Treatment|Adverse Event|19|||
94226251|NCT00784277|322621866|FG003|IR Treatment|Adverse Event|35|||
94226252|NCT00784277|322621867|FG004|IR Treatment|Adverse Event|0|||
94226253|NCT00784277|322621868|FG005|IR Treatment|Adverse Event|0|||
94226254|NCT00784277|322621869|FG006|IR Treatment|Adverse Event|0|||
94226255|NCT00784277|322621863|FG000|IR Treatment|Lack of Efficacy|4|||
94226256|NCT00784277|322621864|FG001|IR Treatment|Lack of Efficacy|4|||
94226257|NCT00784277|322621865|FG002|IR Treatment|Lack of Efficacy|1|||
94226258|NCT00784277|322621866|FG003|IR Treatment|Lack of Efficacy|0|||
94226259|NCT00784277|322621867|FG004|IR Treatment|Lack of Efficacy|0|||
94226260|NCT00784277|322621868|FG005|IR Treatment|Lack of Efficacy|0|||
94226261|NCT00784277|322621869|FG006|IR Treatment|Lack of Efficacy|0|||
94226262|NCT00784277|322621863|FG000|IR Treatment|Lost to Follow-up|1|||
94226263|NCT00784277|322621864|FG001|IR Treatment|Lost to Follow-up|0|||
94226264|NCT00784277|322621865|FG002|IR Treatment|Lost to Follow-up|1|||
94226265|NCT00784277|322621866|FG003|IR Treatment|Lost to Follow-up|0|||
94226266|NCT00784277|322621867|FG004|IR Treatment|Lost to Follow-up|0|||
94226267|NCT00784277|322621868|FG005|IR Treatment|Lost to Follow-up|0|||
94226268|NCT00784277|322621869|FG006|IR Treatment|Lost to Follow-up|0|||
94226269|NCT00784277|322621863|FG000|IR Treatment|Withdrawal by Subject|5|||
94226270|NCT00784277|322621864|FG001|IR Treatment|Withdrawal by Subject|1|||
94226271|NCT00784277|322621865|FG002|IR Treatment|Withdrawal by Subject|4|||
94226272|NCT00784277|322621866|FG003|IR Treatment|Withdrawal by Subject|6|||
94226273|NCT00784277|322621867|FG004|IR Treatment|Withdrawal by Subject|0|||
94226274|NCT00784277|322621868|FG005|IR Treatment|Withdrawal by Subject|0|||
94226275|NCT00784277|322621869|FG006|IR Treatment|Withdrawal by Subject|0|||
94226276|NCT00784277|322621863|FG000|IR Treatment|Resolution Of Pain|0|||
94226277|NCT00784277|322621864|FG001|IR Treatment|Resolution Of Pain|1|||
94226278|NCT00784277|322621865|FG002|IR Treatment|Resolution Of Pain|0|||
94226279|NCT00784277|322621866|FG003|IR Treatment|Resolution Of Pain|0|||
94226280|NCT00784277|322621867|FG004|IR Treatment|Resolution Of Pain|0|||
94226281|NCT00784277|322621868|FG005|IR Treatment|Resolution Of Pain|0|||
94226282|NCT00784277|322621869|FG006|IR Treatment|Resolution Of Pain|0|||
94226283|NCT00784277|322621863|FG000|IR Treatment|Other|2|||
94226284|NCT00784277|322621864|FG001|IR Treatment|Other|3|||
94226285|NCT00784277|322621865|FG002|IR Treatment|Other|3|||
94226286|NCT00784277|322621866|FG003|IR Treatment|Other|2|||
94226287|NCT00784277|322621867|FG004|IR Treatment|Other|0|||
94226288|NCT00784277|322621868|FG005|IR Treatment|Other|0|||
94226289|NCT00784277|322621869|FG006|IR Treatment|Other|0|||
94226290|NCT00784277|322621863|FG000|ER Treatment|Adverse Event|0|||
94226291|NCT00784277|322621864|FG001|ER Treatment|Adverse Event|0|||
94226292|NCT00784277|322621865|FG002|ER Treatment|Adverse Event|0|||
94226293|NCT00784277|322621866|FG003|ER Treatment|Adverse Event|0|||
94226294|NCT00784277|322621867|FG004|ER Treatment|Adverse Event|1|||
94226295|NCT00784277|322621868|FG005|ER Treatment|Adverse Event|7|||
94226296|NCT00784277|322621869|FG006|ER Treatment|Adverse Event|7|||
94226297|NCT00784277|322621863|FG000|ER Treatment|Lack of Efficacy|0|||
94226298|NCT00784277|322621864|FG001|ER Treatment|Lack of Efficacy|0|||
94226299|NCT00784277|322621865|FG002|ER Treatment|Lack of Efficacy|0|||
94226300|NCT00784277|322621866|FG003|ER Treatment|Lack of Efficacy|0|||
94226301|NCT00784277|322621867|FG004|ER Treatment|Lack of Efficacy|3|||
94226302|NCT00784277|322621868|FG005|ER Treatment|Lack of Efficacy|4|||
94226303|NCT00784277|322621869|FG006|ER Treatment|Lack of Efficacy|0|||
94226304|NCT00784277|322621863|FG000|ER Treatment|Lost to Follow-up|0|||
94226305|NCT00784277|322621864|FG001|ER Treatment|Lost to Follow-up|0|||
94226306|NCT00784277|322621865|FG002|ER Treatment|Lost to Follow-up|0|||
94226307|NCT00784277|322621866|FG003|ER Treatment|Lost to Follow-up|0|||
94226308|NCT00784277|322621867|FG004|ER Treatment|Lost to Follow-up|0|||
94226309|NCT00784277|322621868|FG005|ER Treatment|Lost to Follow-up|2|||
94226310|NCT00784277|322621869|FG006|ER Treatment|Lost to Follow-up|0|||
94226311|NCT00784277|322621863|FG000|ER Treatment|Withdrawal by Subject|0|||
94226312|NCT00784277|322621864|FG001|ER Treatment|Withdrawal by Subject|0|||
94226313|NCT00784277|322621865|FG002|ER Treatment|Withdrawal by Subject|0|||
94226314|NCT00784277|322621866|FG003|ER Treatment|Withdrawal by Subject|0|||
94226315|NCT00784277|322621867|FG004|ER Treatment|Withdrawal by Subject|2|||
94226316|NCT00784277|322621868|FG005|ER Treatment|Withdrawal by Subject|5|||
94226317|NCT00784277|322621869|FG006|ER Treatment|Withdrawal by Subject|3|||
94226318|NCT00784277|322621863|FG000|ER Treatment|Study Medication Non-Compliant|0|||
94226319|NCT00784277|322621864|FG001|ER Treatment|Study Medication Non-Compliant|0|||
94226320|NCT00784277|322621865|FG002|ER Treatment|Study Medication Non-Compliant|0|||
94226321|NCT00784277|322621866|FG003|ER Treatment|Study Medication Non-Compliant|0|||
94226322|NCT00784277|322621867|FG004|ER Treatment|Study Medication Non-Compliant|2|||
94226323|NCT00784277|322621868|FG005|ER Treatment|Study Medication Non-Compliant|3|||
94226324|NCT00784277|322621869|FG006|ER Treatment|Study Medication Non-Compliant|3|||
94226325|NCT00784277|322621863|FG000|ER Treatment|Other|0|||
94226326|NCT00784277|322621864|FG001|ER Treatment|Other|0|||
94226327|NCT00784277|322621865|FG002|ER Treatment|Other|0|||
94226328|NCT00784277|322621866|FG003|ER Treatment|Other|0|||
94226329|NCT00784277|322621867|FG004|ER Treatment|Other|1|||
94226330|NCT00784277|322621868|FG005|ER Treatment|Other|3|||
94226331|NCT00784277|322621869|FG006|ER Treatment|Other|2|||
94226332|NCT00385697|322621880|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
94226333|NCT00385697|322621881|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
94226334|NCT00385697|322621882|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
94226335|NCT00385697|322621883|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
94226336|NCT00385697|322621884|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
94226337|NCT00385697|322621880|FG000|Open-label Segment 1|Lost to Follow-up|1|||
94226338|NCT00385697|322621881|FG001|Open-label Segment 1|Lost to Follow-up|0|||
94226339|NCT00385697|322621882|FG002|Open-label Segment 1|Lost to Follow-up|0|||
94226340|NCT00385697|322621883|FG003|Open-label Segment 1|Lost to Follow-up|0|||
94226341|NCT00385697|322621884|FG004|Open-label Segment 1|Lost to Follow-up|0|||
94226342|NCT00385697|322621880|FG000|Double-blind Segment 2|Adverse Event|0|||
94226343|NCT00385697|322621881|FG001|Double-blind Segment 2|Adverse Event|3|||
94226344|NCT00385697|322621882|FG002|Double-blind Segment 2|Adverse Event|1|||
94226345|NCT00385697|322621883|FG003|Double-blind Segment 2|Adverse Event|0|||
94226346|NCT00385697|322621884|FG004|Double-blind Segment 2|Adverse Event|0|||
94226347|NCT00385697|322621880|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
94226348|NCT00385697|322621881|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
94226349|NCT00385697|322621882|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
94226350|NCT00385697|322621883|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
94226351|NCT00385697|322621884|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
94226352|NCT00385697|322621880|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
94226353|NCT00385697|322621881|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
94226354|NCT00385697|322621882|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
94226355|NCT00385697|322621883|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
94226356|NCT00385697|322621884|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
94226357|NCT00385697|322621880|FG000|Double-blind Segment 2|Other|0|||
94226358|NCT00385697|322621881|FG001|Double-blind Segment 2|Other|2|||
94226359|NCT00385697|322621882|FG002|Double-blind Segment 2|Other|0|||
94226360|NCT00385697|322621883|FG003|Double-blind Segment 2|Other|0|||
94226361|NCT00385697|322621884|FG004|Double-blind Segment 2|Other|0|||
94226362|NCT03175198|322621890|FG000|Overall Study|Adverse Event|480|||
94226363|NCT03175198|322621890|FG000|Overall Study|No actual visit|120|||
94226364|NCT03175198|322621890|FG000|Overall Study|Registration rule not followed|4|||
94226365|NCT03175198|322621890|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
94226366|NCT03175198|322621890|FG000|Overall Study|Other personal reason|509|||
94226367|NCT03175198|322621890|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
94226368|NCT03175198|322621890|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
94226369|NCT03175198|322621890|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
94226370|NCT03175198|322621890|FG000|Overall Study|To conduct invasive treatment of operation|53|||
94226371|NCT03175198|322621890|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
94226372|NCT02161185|322621891|FG000|Treatment Phase|Administrative/Other|7|||
94226373|NCT00640042|322621892|FG000|Enrollment|Did not receive study drug|83|||
94226374|NCT03796208|322621893|FG000|Overall Study|Withdrawal by Subject|3|||
94226375|NCT03796208|322621894|FG001|Overall Study|Withdrawal by Subject|0|||
94226376|NCT03796208|322621893|FG000|Overall Study|Loss of pregnancy|1|||
94226377|NCT03796208|322621894|FG001|Overall Study|Loss of pregnancy|1|||
94226378|NCT03796208|322621893|FG000|Overall Study|Changed prenatal clinics|0|||
94226379|NCT03796208|322621894|FG001|Overall Study|Changed prenatal clinics|5|||
94226380|NCT03796208|322621893|FG000|Overall Study|Lost to Follow-up|20|||
94226381|NCT03796208|322621894|FG001|Overall Study|Lost to Follow-up|16|||
94226382|NCT02506881|322621895|FG000|First Intervention (Day 1)|Protocol Violation|0|||
94226383|NCT02506881|322621896|FG001|First Intervention (Day 1)|Protocol Violation|0|||
94226384|NCT02506881|322621897|FG002|First Intervention (Day 1)|Protocol Violation|1|||
94226385|NCT02506881|322621898|FG003|First Intervention (Day 1)|Protocol Violation|0|||
94226386|NCT02506881|322621895|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
94226387|NCT02506881|322621896|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
94226388|NCT02506881|322621897|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
94226389|NCT02506881|322621898|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
94226390|NCT02506881|322621895|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
94226391|NCT02506881|322621896|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
94226392|NCT02506881|322621897|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
94226393|NCT02506881|322621898|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
94226394|NCT01363297|322621903|FG000|Overall Study|Other|0|||
94226395|NCT01363297|322621904|FG001|Overall Study|Other|0|||
94226396|NCT01363297|322621905|FG002|Overall Study|Other|0|||
94226397|NCT01363297|322621906|FG003|Overall Study|Other|0|||
94226398|NCT01363297|322621907|FG004|Overall Study|Other|1|||
94226399|NCT01363297|322621903|FG000|Overall Study|Death|3|||
94226400|NCT01363297|322621904|FG001|Overall Study|Death|6|||
94226401|NCT01363297|322621905|FG002|Overall Study|Death|6|||
94226402|NCT01363297|322621906|FG003|Overall Study|Death|10|||
94226403|NCT01363297|322621907|FG004|Overall Study|Death|30|||
94226404|NCT02269917|322621909|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
94226405|NCT02269917|322621910|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
94226406|NCT02269917|322621911|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
94226407|NCT02269917|322621909|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
94226408|NCT02269917|322621910|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
94226409|NCT02269917|322621911|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
94226410|NCT02269917|322621909|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
94226411|NCT02269917|322621910|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
94226412|NCT02269917|322621911|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
94226413|NCT02269917|322621909|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
94226414|NCT02269917|322621910|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
94226415|NCT02269917|322621911|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
94226416|NCT02269917|322621909|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
94226417|NCT02269917|322621910|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
94226418|NCT02269917|322621911|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
94226419|NCT02269917|322621909|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
94226420|NCT02269917|322621910|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
94226421|NCT02269917|322621911|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
94226422|NCT02269917|322621909|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
94226423|NCT02269917|322621910|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
94226424|NCT02269917|322621911|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
94226425|NCT02269917|322621909|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
94226426|NCT02269917|322621910|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
94226427|NCT02269917|322621911|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
94226428|NCT02269917|322621909|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
94226429|NCT02269917|322621910|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
94226430|NCT02269917|322621911|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
94226431|NCT02269917|322621909|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
94226432|NCT02269917|322621910|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
94226433|NCT02269917|322621911|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
94226434|NCT02269917|322621909|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
94226435|NCT02269917|322621910|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
94226436|NCT02269917|322621911|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
94226437|NCT02269917|322621909|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
94226438|NCT02269917|322621910|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
94226439|NCT02269917|322621911|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
94226440|NCT02269917|322621909|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
94226441|NCT02269917|322621910|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
94226442|NCT02269917|322621911|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
94226443|NCT02269917|322621909|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
94226444|NCT02269917|322621910|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
94226445|NCT02269917|322621911|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
94226446|NCT02269917|322621909|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
94226447|NCT02269917|322621910|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
94226448|NCT02269917|322621911|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
94226449|NCT02269917|322621909|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
94226450|NCT02269917|322621910|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
94226451|NCT02269917|322621911|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
94226452|NCT04159805|322621914|FG000|Overall Study|Withdrawal by Subject|0|||
94226453|NCT04159805|322621915|FG001|Overall Study|Withdrawal by Subject|2|||
94226454|NCT04159805|322621916|FG002|Overall Study|Withdrawal by Subject|2|||
94226455|NCT00006436|322621922|FG000|Overall Study|Refused further treatment|2|||
94226456|NCT00006436|322621922|FG000|Overall Study|Declined to participate (before treatment started)|1|||
94226457|NCT00316589|322621923|FG000|Overall Study|Withdrawal by Subject|0|||
94226458|NCT00316589|322621924|FG001|Overall Study|Withdrawal by Subject|5|||
94226459|NCT00316589|322621925|FG002|Overall Study|Withdrawal by Subject|0|||
94226460|NCT00316589|322621926|FG003|Overall Study|Withdrawal by Subject|1|||
94226461|NCT00316589|322621923|FG000|Overall Study|Subject unwilling/unable to comply|0|||
94226462|NCT00316589|322621924|FG001|Overall Study|Subject unwilling/unable to comply|6|||
94226463|NCT00316589|322621925|FG002|Overall Study|Subject unwilling/unable to comply|0|||
94226464|NCT00316589|322621926|FG003|Overall Study|Subject unwilling/unable to comply|2|||
94226465|NCT00316589|322621923|FG000|Overall Study|Adverse Event|1|||
94226466|NCT00316589|322621924|FG001|Overall Study|Adverse Event|0|||
94226467|NCT00316589|322621925|FG002|Overall Study|Adverse Event|0|||
94226468|NCT00316589|322621926|FG003|Overall Study|Adverse Event|1|||
94226469|NCT00316589|322621923|FG000|Overall Study|Physician Decision|0|||
94226470|NCT00316589|322621924|FG001|Overall Study|Physician Decision|1|||
94226471|NCT00316589|322621925|FG002|Overall Study|Physician Decision|0|||
94226472|NCT00316589|322621926|FG003|Overall Study|Physician Decision|0|||
94226473|NCT00316589|322621923|FG000|Overall Study|Other reason|0|||
94226474|NCT00316589|322621924|FG001|Overall Study|Other reason|12|||
94226475|NCT00316589|322621925|FG002|Overall Study|Other reason|1|||
94226476|NCT00316589|322621926|FG003|Overall Study|Other reason|1|||
94226477|NCT01482819|322621927|FG000|Overall Study|Lost to Follow-up|2|||
94226478|NCT01502371|322621928|FG000|Overall Study|Withdrawal by Subject|1|||
94226479|NCT01502371|322621929|FG001|Overall Study|Withdrawal by Subject|2|||
94226480|NCT01502371|322621930|FG002|Overall Study|Withdrawal by Subject|1|||
94226481|NCT01502371|322621931|FG003|Overall Study|Withdrawal by Subject|1|||
94226482|NCT01502371|322621932|FG004|Overall Study|Withdrawal by Subject|1|||
94226483|NCT01502371|322621928|FG000|Overall Study|Adverse Event|2|||
94226484|NCT01502371|322621929|FG001|Overall Study|Adverse Event|1|||
94226485|NCT01502371|322621930|FG002|Overall Study|Adverse Event|0|||
94226486|NCT01502371|322621931|FG003|Overall Study|Adverse Event|4|||
94226487|NCT01502371|322621932|FG004|Overall Study|Adverse Event|3|||
94226488|NCT01502371|322621928|FG000|Overall Study|Treatment Failure|22|||
94226489|NCT01502371|322621929|FG001|Overall Study|Treatment Failure|20|||
94226490|NCT01502371|322621930|FG002|Overall Study|Treatment Failure|12|||
94226491|NCT01502371|322621931|FG003|Overall Study|Treatment Failure|19|||
94226492|NCT01502371|322621932|FG004|Overall Study|Treatment Failure|30|||
94226493|NCT01502371|322621928|FG000|Overall Study|Lack of Efficacy|3|||
94226494|NCT01502371|322621929|FG001|Overall Study|Lack of Efficacy|3|||
94226495|NCT01502371|322621930|FG002|Overall Study|Lack of Efficacy|2|||
94226496|NCT01502371|322621931|FG003|Overall Study|Lack of Efficacy|2|||
94226497|NCT01502371|322621932|FG004|Overall Study|Lack of Efficacy|4|||
94226498|NCT01502371|322621928|FG000|Overall Study|Physician Decision|3|||
94226499|NCT01502371|322621929|FG001|Overall Study|Physician Decision|0|||
94226500|NCT01502371|322621930|FG002|Overall Study|Physician Decision|0|||
94226501|NCT01502371|322621931|FG003|Overall Study|Physician Decision|0|||
94226502|NCT01502371|322621932|FG004|Overall Study|Physician Decision|1|||
94226503|NCT01502371|322621928|FG000|Overall Study|Noncompliance with Study Drug|0|||
94226504|NCT01502371|322621929|FG001|Overall Study|Noncompliance with Study Drug|0|||
94226505|NCT01502371|322621930|FG002|Overall Study|Noncompliance with Study Drug|1|||
94226506|NCT01502371|322621931|FG003|Overall Study|Noncompliance with Study Drug|2|||
94226507|NCT01502371|322621932|FG004|Overall Study|Noncompliance with Study Drug|1|||
94226508|NCT01502371|322621928|FG000|Overall Study|Technical Problems|1|||
94226509|NCT01502371|322621929|FG001|Overall Study|Technical Problems|0|||
94226510|NCT01502371|322621930|FG002|Overall Study|Technical Problems|2|||
94226511|NCT01502371|322621931|FG003|Overall Study|Technical Problems|4|||
94226512|NCT01502371|322621932|FG004|Overall Study|Technical Problems|1|||
94226513|NCT01502371|322621928|FG000|Overall Study|Protocol Violation|9|||
94226514|NCT01502371|322621929|FG001|Overall Study|Protocol Violation|5|||
94226515|NCT01502371|322621930|FG002|Overall Study|Protocol Violation|6|||
94226516|NCT01502371|322621931|FG003|Overall Study|Protocol Violation|5|||
94226517|NCT01502371|322621932|FG004|Overall Study|Protocol Violation|10|||
94226518|NCT01502371|322621928|FG000|Overall Study|Excluded Medication|0|||
94226519|NCT01502371|322621929|FG001|Overall Study|Excluded Medication|1|||
94226520|NCT01502371|322621930|FG002|Overall Study|Excluded Medication|1|||
94226521|NCT01502371|322621931|FG003|Overall Study|Excluded Medication|0|||
94226522|NCT01502371|322621932|FG004|Overall Study|Excluded Medication|1|||
94226523|NCT04435522|322621935|FG000|Overall Study|Withdrawal by Subject|2|||
94226524|NCT02956278|322623582|FG000|Overall Study|Withdrawal by Subject|6|||
94226525|NCT02956278|322623583|FG001|Overall Study|Withdrawal by Subject|2|||
94226526|NCT02956278|322623584|FG002|Overall Study|Withdrawal by Subject|0|||
94226527|NCT00434577|322623585|FG000|Months 0-3|Serious Adverse Event|0|||
94226528|NCT00434577|322623586|FG001|Months 0-3|Serious Adverse Event|0|||
94226529|NCT00434577|322623587|FG002|Months 0-3|Serious Adverse Event|1|||
94226530|NCT00434577|322623588|FG003|Months 0-3|Serious Adverse Event|0|||
94226531|NCT00434577|322623589|FG004|Months 0-3|Serious Adverse Event|0|||
94226532|NCT00434577|322623585|FG000|Months 0-3|Adverse Event|0|||
94226533|NCT00434577|322623586|FG001|Months 0-3|Adverse Event|1|||
94226534|NCT00434577|322623587|FG002|Months 0-3|Adverse Event|1|||
94226535|NCT00434577|322623588|FG003|Months 0-3|Adverse Event|0|||
94226536|NCT00434577|322623589|FG004|Months 0-3|Adverse Event|0|||
94226537|NCT00434577|322623585|FG000|Months 0-3|Lost to Follow-up|0|||
94226538|NCT00434577|322623586|FG001|Months 0-3|Lost to Follow-up|0|||
94226539|NCT00434577|322623587|FG002|Months 0-3|Lost to Follow-up|0|||
94226540|NCT00434577|322623588|FG003|Months 0-3|Lost to Follow-up|0|||
94226541|NCT00434577|322623589|FG004|Months 0-3|Lost to Follow-up|2|||
94226542|NCT00434577|322623585|FG000|Months 0-3|Protocol Violation|1|||
94226543|NCT00434577|322623586|FG001|Months 0-3|Protocol Violation|0|||
94226544|NCT00434577|322623587|FG002|Months 0-3|Protocol Violation|1|||
94226545|NCT00434577|322623588|FG003|Months 0-3|Protocol Violation|0|||
94226546|NCT00434577|322623589|FG004|Months 0-3|Protocol Violation|0|||
94226547|NCT00434577|322623585|FG000|Months 0-3|Withdrawal by Subject|2|||
94226548|NCT00434577|322623586|FG001|Months 0-3|Withdrawal by Subject|1|||
94226549|NCT00434577|322623587|FG002|Months 0-3|Withdrawal by Subject|1|||
94226550|NCT00434577|322623588|FG003|Months 0-3|Withdrawal by Subject|1|||
94226551|NCT00434577|322623589|FG004|Months 0-3|Withdrawal by Subject|1|||
94226552|NCT02720185|322623594|FG000|Overall Study|Lost to Follow-up|1|||
94226553|NCT00560313|322623595|FG000|Overall Study|Adverse Events or Death|2|||
94226554|NCT00560313|322623595|FG000|Overall Study|Withdrawal by Subject|2|||
94226555|NCT00560313|322623595|FG000|Overall Study|Lost to Follow-up|1|||
94226556|NCT00560313|322623595|FG000|Overall Study|Protocol Violation|1|||
94226557|NCT03449134|322623596|FG000|52-Week Treatment Period|Death|2|||
94226558|NCT03449134|322623597|FG001|52-Week Treatment Period|Death|1|||
94226559|NCT03449134|322623598|FG002|52-Week Treatment Period|Death|0|||
94226560|NCT03449134|322623596|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
94226561|NCT03449134|322623597|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
94226562|NCT03449134|322623598|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
94226563|NCT03449134|322623596|FG000|52-Week Treatment Period|Physician Decision|2|||
94226564|NCT03449134|322623597|FG001|52-Week Treatment Period|Physician Decision|3|||
94226565|NCT03449134|322623598|FG002|52-Week Treatment Period|Physician Decision|3|||
94226566|NCT03449134|322623596|FG000|52-Week Treatment Period|Screen Failure|1|||
94226567|NCT03449134|322623597|FG001|52-Week Treatment Period|Screen Failure|0|||
94226568|NCT03449134|322623598|FG002|52-Week Treatment Period|Screen Failure|1|||
94226569|NCT03449134|322623596|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
94226570|NCT03449134|322623597|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
94226571|NCT03449134|322623598|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
94226572|NCT03449134|322623596|FG000|52-Week Treatment Period|Site Closure|1|||
94226573|NCT03449134|322623597|FG001|52-Week Treatment Period|Site Closure|0|||
94226574|NCT03449134|322623598|FG002|52-Week Treatment Period|Site Closure|0|||
94226575|NCT00957996|322623604|FG000|Overall Study|Death|4|||
94226576|NCT00957996|322623605|FG001|Overall Study|Death|10|||
94226577|NCT00957996|322623604|FG000|Overall Study|Lost to Follow-up|4|||
94226578|NCT00957996|322623605|FG001|Overall Study|Lost to Follow-up|7|||
94226579|NCT00957996|322623604|FG000|Overall Study|Withdrawal by Subject|9|||
94226580|NCT00957996|322623605|FG001|Overall Study|Withdrawal by Subject|2|||
94226581|NCT00957996|322623604|FG000|Overall Study|Adverse Event|2|||
94226582|NCT00957996|322623605|FG001|Overall Study|Adverse Event|1|||
94226583|NCT00957996|322623604|FG000|Overall Study|Physician Decision|1|||
94226584|NCT00957996|322623605|FG001|Overall Study|Physician Decision|1|||
94226585|NCT00957996|322623604|FG000|Overall Study|Influenza-related complication|0|||
94226586|NCT00957996|322623605|FG001|Overall Study|Influenza-related complication|1|||
94226587|NCT00957996|322623604|FG000|Overall Study|Missing|1|||
94226588|NCT00957996|322623605|FG001|Overall Study|Missing|0|||
94226589|NCT00957996|322623604|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
94226590|NCT00957996|322623605|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
94226591|NCT00113269|322623607|FG000|Overall Study|Not transplanted, donor issues|4|||
94226592|NCT00113269|322623608|FG001|Overall Study|Not transplanted, donor issues|0|||
94226593|NCT00113269|322623609|FG002|Overall Study|Not transplanted, donor issues|2|||
94226594|NCT00113269|322623610|FG003|Overall Study|Not transplanted, donor issues|2|||
94226595|NCT00113269|322623607|FG000|Overall Study|Not transplanted, recipient issues|2|||
94226596|NCT00113269|322623608|FG001|Overall Study|Not transplanted, recipient issues|1|||
94226597|NCT00113269|322623609|FG002|Overall Study|Not transplanted, recipient issues|7|||
94226598|NCT00113269|322623610|FG003|Overall Study|Not transplanted, recipient issues|4|||
94226599|NCT00113269|322623607|FG000|Overall Study|Early graft loss, technical|0|||
94226600|NCT00113269|322623608|FG001|Overall Study|Early graft loss, technical|0|||
94226601|NCT00113269|322623609|FG002|Overall Study|Early graft loss, technical|2|||
94226602|NCT00113269|322623610|FG003|Overall Study|Early graft loss, technical|0|||
94226603|NCT00113269|322623607|FG000|Overall Study|Death in operating room|0|||
94226604|NCT00113269|322623608|FG001|Overall Study|Death in operating room|0|||
94226605|NCT00113269|322623609|FG002|Overall Study|Death in operating room|0|||
94226606|NCT00113269|322623610|FG003|Overall Study|Death in operating room|1|||
94226607|NCT00113269|322623607|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
94226608|NCT00113269|322623608|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
94226609|NCT00113269|322623609|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
94226610|NCT00113269|322623610|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
94226611|NCT00113269|322623607|FG000|Overall Study|Adverse Event|2|||
94226612|NCT00113269|322623608|FG001|Overall Study|Adverse Event|7|||
94226613|NCT00113269|322623609|FG002|Overall Study|Adverse Event|11|||
94226614|NCT00113269|322623610|FG003|Overall Study|Adverse Event|7|||
94226615|NCT00113269|322623607|FG000|Overall Study|Withdrawal by Subject|4|||
94226616|NCT00113269|322623608|FG001|Overall Study|Withdrawal by Subject|3|||
94226617|NCT00113269|322623609|FG002|Overall Study|Withdrawal by Subject|4|||
94226618|NCT00113269|322623610|FG003|Overall Study|Withdrawal by Subject|2|||
94226619|NCT00113269|322623607|FG000|Overall Study|Graft loss|6|||
94226620|NCT00113269|322623608|FG001|Overall Study|Graft loss|6|||
94226621|NCT00113269|322623609|FG002|Overall Study|Graft loss|4|||
94226622|NCT00113269|322623610|FG003|Overall Study|Graft loss|9|||
94226623|NCT00113269|322623607|FG000|Overall Study|Protocol Violation|1|||
94226624|NCT00113269|322623608|FG001|Overall Study|Protocol Violation|0|||
94226625|NCT00113269|322623609|FG002|Overall Study|Protocol Violation|4|||
94226626|NCT00113269|322623610|FG003|Overall Study|Protocol Violation|2|||
94226627|NCT00113269|322623607|FG000|Overall Study|Lost to Follow-up|2|||
94226628|NCT00113269|322623608|FG001|Overall Study|Lost to Follow-up|3|||
94226629|NCT00113269|322623609|FG002|Overall Study|Lost to Follow-up|6|||
94226630|NCT00113269|322623610|FG003|Overall Study|Lost to Follow-up|3|||
94226631|NCT00113269|322623607|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
94226632|NCT00113269|322623608|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
94226633|NCT00113269|322623609|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
94226634|NCT00113269|322623610|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
94226635|NCT00113269|322623607|FG000|Overall Study|Discontinued due to rejection|0|||
94226636|NCT00113269|322623608|FG001|Overall Study|Discontinued due to rejection|0|||
94226637|NCT00113269|322623609|FG002|Overall Study|Discontinued due to rejection|1|||
94226638|NCT00113269|322623610|FG003|Overall Study|Discontinued due to rejection|0|||
94226639|NCT00113269|322623607|FG000|Overall Study|Moved|0|||
94226640|NCT00113269|322623608|FG001|Overall Study|Moved|1|||
94226641|NCT00113269|322623609|FG002|Overall Study|Moved|0|||
94226642|NCT00113269|322623610|FG003|Overall Study|Moved|3|||
94226643|NCT00113269|322623607|FG000|Overall Study|Received pancreas transplant|0|||
94226644|NCT00113269|322623608|FG001|Overall Study|Received pancreas transplant|0|||
94226645|NCT00113269|322623609|FG002|Overall Study|Received pancreas transplant|0|||
94226646|NCT00113269|322623610|FG003|Overall Study|Received pancreas transplant|2|||
94226647|NCT00113269|322623607|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
94226648|NCT00113269|322623608|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
94226649|NCT00113269|322623609|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
94226650|NCT00113269|322623610|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
94226651|NCT00113269|322623607|FG000|Overall Study|Did not meet eligibility criteria|1|||
94226652|NCT00113269|322623608|FG001|Overall Study|Did not meet eligibility criteria|0|||
94226653|NCT00113269|322623609|FG002|Overall Study|Did not meet eligibility criteria|0|||
94226654|NCT00113269|322623610|FG003|Overall Study|Did not meet eligibility criteria|1|||
94226655|NCT00113269|322623607|FG000|Overall Study|Unable to return for follow up|2|||
94226656|NCT00113269|322623608|FG001|Overall Study|Unable to return for follow up|1|||
94226657|NCT00113269|322623609|FG002|Overall Study|Unable to return for follow up|0|||
94226658|NCT00113269|322623610|FG003|Overall Study|Unable to return for follow up|0|||
94226659|NCT00848393|322623617|FG000|Overall Study|Protocol Violation|0|||
94226660|NCT00848393|322623618|FG001|Overall Study|Protocol Violation|0|||
94226661|NCT00848393|322623619|FG002|Overall Study|Protocol Violation|1|||
94226662|NCT00848393|322623617|FG000|Overall Study|surgical complications unrelated to stud|0|||
94226663|NCT00848393|322623618|FG001|Overall Study|surgical complications unrelated to stud|0|||
94226664|NCT00848393|322623619|FG002|Overall Study|surgical complications unrelated to stud|2|||
94226665|NCT00381797|322623620|FG000|Overall Study|Withdrawal by Subject|1|||
94226666|NCT00381797|322623621|FG001|Overall Study|Withdrawal by Subject|1|||
94226667|NCT00381797|322623622|FG002|Overall Study|Withdrawal by Subject|0|||
94226668|NCT00381797|322623623|FG003|Overall Study|Withdrawal by Subject|0|||
94226669|NCT00381797|322623624|FG004|Overall Study|Withdrawal by Subject|2|||
94226670|NCT00381797|322623620|FG000|Overall Study|Ineligible|0|||
94226671|NCT00381797|322623621|FG001|Overall Study|Ineligible|0|||
94226672|NCT00381797|322623622|FG002|Overall Study|Ineligible|0|||
94226673|NCT00381797|322623623|FG003|Overall Study|Ineligible|1|||
94226674|NCT00381797|322623624|FG004|Overall Study|Ineligible|0|||
94226675|NCT00958711|322623625|FG000|Overall Study|Withdrawal by Subject|0|||
94226676|NCT00958711|322623626|FG001|Overall Study|Withdrawal by Subject|4|||
94226677|NCT00958711|322623625|FG000|Overall Study|Physician Decision|5|||
94226678|NCT00958711|322623626|FG001|Overall Study|Physician Decision|7|||
94226679|NCT00958711|322623625|FG000|Overall Study|Lost to Follow-up|4|||
94226680|NCT00958711|322623626|FG001|Overall Study|Lost to Follow-up|1|||
94226681|NCT00958711|322623625|FG000|Overall Study|Other|2|||
94226682|NCT00958711|322623626|FG001|Overall Study|Other|5|||
94226683|NCT00958711|322623625|FG000|Overall Study|Death|1|||
94226684|NCT00958711|322623626|FG001|Overall Study|Death|2|||
94226685|NCT00958711|322623625|FG000|Overall Study|Adverse Event|1|||
94226686|NCT00958711|322623626|FG001|Overall Study|Adverse Event|2|||
94226687|NCT00349622|322623627|FG000|Overall Study|Death|168|||
94226688|NCT00349622|322623628|FG001|Overall Study|Death|86|||
94226689|NCT00349622|322623627|FG000|Overall Study|Lost to Follow-up|5|||
94226690|NCT00349622|322623628|FG001|Overall Study|Lost to Follow-up|1|||
94226691|NCT00349622|322623627|FG000|Overall Study|Withdrawal by Subject|5|||
94226692|NCT00349622|322623628|FG001|Overall Study|Withdrawal by Subject|9|||
94226693|NCT02151643|322623629|FG000|Overall Study|Adverse Event|2|||
94226694|NCT02151643|322623630|FG001|Overall Study|Adverse Event|0|||
94226695|NCT02151643|322623631|FG002|Overall Study|Adverse Event|1|||
94332449|NCT04397796|322998793|FG001|Overall Study|Death|1|||
94332450|NCT01831804|322998794|FG000|Overall Study|Adverse Event|0|||
94332451|NCT01831804|322998795|FG001|Overall Study|Adverse Event|0|||
94332452|NCT01831804|322998796|FG002|Overall Study|Adverse Event|0|||
94332453|NCT01831804|322998797|FG003|Overall Study|Adverse Event|0|||
94332454|NCT01831804|322998798|FG004|Overall Study|Adverse Event|0|||
94332455|NCT01831804|322998799|FG005|Overall Study|Adverse Event|0|||
94332456|NCT01831804|322998800|FG006|Overall Study|Adverse Event|1|||
94332457|NCT01831804|322998801|FG007|Overall Study|Adverse Event|0|||
94332458|NCT01831804|322998802|FG008|Overall Study|Adverse Event|1|||
94332459|NCT01831804|322998794|FG000|Overall Study|Protocol Violation|0|||
94226696|NCT02151643|322623632|FG003|Overall Study|Adverse Event|4|||
94226697|NCT02151643|322623633|FG004|Overall Study|Adverse Event|0|||
94226698|NCT02151643|322623629|FG000|Overall Study|Withdrawal by Subject|0|||
94226699|NCT02151643|322623630|FG001|Overall Study|Withdrawal by Subject|1|||
94226700|NCT02151643|322623631|FG002|Overall Study|Withdrawal by Subject|1|||
94226701|NCT02151643|322623632|FG003|Overall Study|Withdrawal by Subject|1|||
94226702|NCT02151643|322623633|FG004|Overall Study|Withdrawal by Subject|1|||
94226703|NCT02151643|322623629|FG000|Overall Study|Hyperphosphataemia|1|||
94226704|NCT02151643|322623630|FG001|Overall Study|Hyperphosphataemia|0|||
94332460|NCT01831804|322998795|FG001|Overall Study|Protocol Violation|0|||
94332461|NCT01831804|322998796|FG002|Overall Study|Protocol Violation|2|||
94226705|NCT02151643|322623631|FG002|Overall Study|Hyperphosphataemia|0|||
94226706|NCT02151643|322623632|FG003|Overall Study|Hyperphosphataemia|0|||
94226707|NCT02151643|322623633|FG004|Overall Study|Hyperphosphataemia|1|||
94226708|NCT02151643|322623629|FG000|Overall Study|High Ferritin levels|3|||
94226709|NCT02151643|322623630|FG001|Overall Study|High Ferritin levels|3|||
94226710|NCT02151643|322623631|FG002|Overall Study|High Ferritin levels|2|||
94226711|NCT02151643|322623632|FG003|Overall Study|High Ferritin levels|2|||
94226712|NCT02151643|322623633|FG004|Overall Study|High Ferritin levels|1|||
94226713|NCT03022578|322623636|FG000|Overall Study|Adverse Event|1|||
94226714|NCT03022578|322623636|FG000|Overall Study|Lack of Efficacy|2|||
94226715|NCT03022578|322623636|FG000|Overall Study|Withdrawal by Subject|1|||
94226716|NCT00265096|322623637|FG000|Overall Study|Adverse Event|14|||
94226717|NCT00265096|322623638|FG001|Overall Study|Adverse Event|18|||
94226718|NCT00265096|322623639|FG002|Overall Study|Adverse Event|18|||
94226719|NCT00265096|322623637|FG000|Overall Study|Lost to Follow-up|2|||
94226720|NCT00265096|322623638|FG001|Overall Study|Lost to Follow-up|5|||
94226721|NCT00265096|322623639|FG002|Overall Study|Lost to Follow-up|3|||
94226722|NCT00265096|322623637|FG000|Overall Study|Death|0|||
94226723|NCT00265096|322623638|FG001|Overall Study|Death|1|||
94226724|NCT00265096|322623639|FG002|Overall Study|Death|2|||
94226725|NCT00265096|322623637|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
94226726|NCT00265096|322623638|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
94226727|NCT00265096|322623639|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
94226728|NCT00265096|322623637|FG000|Overall Study|Other|11|||
94226729|NCT00265096|322623638|FG001|Overall Study|Other|19|||
94226730|NCT00265096|322623639|FG002|Overall Study|Other|10|||
94226731|NCT01649297|322623640|FG000|Overall Study|Adverse Event|5|||
94226732|NCT01649297|322623641|FG001|Overall Study|Adverse Event|5|||
94226733|NCT01649297|322623642|FG002|Overall Study|Adverse Event|4|||
94226734|NCT01649297|322623643|FG003|Overall Study|Adverse Event|13|||
94226735|NCT01649297|322623644|FG004|Overall Study|Adverse Event|1|||
94226736|NCT01649297|322623640|FG000|Overall Study|Lack of Efficacy|0|||
94226737|NCT01649297|322623641|FG001|Overall Study|Lack of Efficacy|0|||
94226738|NCT01649297|322623642|FG002|Overall Study|Lack of Efficacy|0|||
94226739|NCT01649297|322623643|FG003|Overall Study|Lack of Efficacy|0|||
94226740|NCT01649297|322623644|FG004|Overall Study|Lack of Efficacy|1|||
94226741|NCT01649297|322623640|FG000|Overall Study|Non compliant with Protocol|1|||
94226742|NCT01649297|322623641|FG001|Overall Study|Non compliant with Protocol|0|||
94226743|NCT01649297|322623642|FG002|Overall Study|Non compliant with Protocol|3|||
94226744|NCT01649297|322623643|FG003|Overall Study|Non compliant with Protocol|2|||
94226745|NCT01649297|322623644|FG004|Overall Study|Non compliant with Protocol|1|||
94226746|NCT01649297|322623640|FG000|Overall Study|Lost to Follow-up|1|||
94226747|NCT01649297|322623641|FG001|Overall Study|Lost to Follow-up|1|||
94226748|NCT01649297|322623642|FG002|Overall Study|Lost to Follow-up|4|||
94226749|NCT01649297|322623643|FG003|Overall Study|Lost to Follow-up|3|||
94226750|NCT01649297|322623644|FG004|Overall Study|Lost to Follow-up|0|||
94226751|NCT01649297|322623640|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
94226752|NCT01649297|322623641|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
94226753|NCT01649297|322623642|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
94226754|NCT01649297|322623643|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
94226755|NCT01649297|322623644|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
94226756|NCT01649297|322623640|FG000|Overall Study|For other reason|4|||
94226757|NCT01649297|322623641|FG001|Overall Study|For other reason|1|||
94226758|NCT01649297|322623642|FG002|Overall Study|For other reason|2|||
94226759|NCT01649297|322623643|FG003|Overall Study|For other reason|0|||
94226760|NCT01649297|322623644|FG004|Overall Study|For other reason|0|||
94226761|NCT01685047|322623645|FG000|Overall Study|Withdrawal by Subject|20|||
94226762|NCT01685047|322623645|FG000|Overall Study|Death|26|||
94226763|NCT01685047|322623645|FG000|Overall Study|Lost to Follow-up|8|||
94226764|NCT01685047|322623645|FG000|Overall Study|Physician Decision|25|||
94226765|NCT01685047|322623645|FG000|Overall Study|Adverse Event|5|||
94226766|NCT01685047|322623645|FG000|Overall Study|patient withdrawn by sponsor|1|||
94226767|NCT00463580|322623646|FG000|Overall Study|Lost to Follow-up|1|||
94226768|NCT00463580|322623647|FG001|Overall Study|Lost to Follow-up|0|||
94226769|NCT00463580|322623646|FG000|Overall Study|Schedule conflict|2|||
94226770|NCT00463580|322623647|FG001|Overall Study|Schedule conflict|0|||
94332462|NCT01831804|322998797|FG003|Overall Study|Protocol Violation|0|||
94332463|NCT01831804|322998798|FG004|Overall Study|Protocol Violation|0|||
94332464|NCT01831804|322998799|FG005|Overall Study|Protocol Violation|0|||
94332465|NCT01831804|322998800|FG006|Overall Study|Protocol Violation|0|||
94332466|NCT01831804|322998801|FG007|Overall Study|Protocol Violation|0|||
94332467|NCT01831804|322998802|FG008|Overall Study|Protocol Violation|0|||
94332468|NCT01831804|322998794|FG000|Overall Study|Protocol defined stopping criteria|1|||
94332469|NCT01831804|322998795|FG001|Overall Study|Protocol defined stopping criteria|1|||
94332470|NCT01831804|322998796|FG002|Overall Study|Protocol defined stopping criteria|3|||
94332471|NCT01831804|322998797|FG003|Overall Study|Protocol defined stopping criteria|0|||
94332472|NCT01831804|322998798|FG004|Overall Study|Protocol defined stopping criteria|1|||
94332473|NCT01831804|322998799|FG005|Overall Study|Protocol defined stopping criteria|0|||
94332474|NCT01831804|322998800|FG006|Overall Study|Protocol defined stopping criteria|0|||
94332475|NCT01831804|322998801|FG007|Overall Study|Protocol defined stopping criteria|0|||
94332476|NCT01831804|322998802|FG008|Overall Study|Protocol defined stopping criteria|0|||
94332477|NCT01831804|322998794|FG000|Overall Study|Lost to Follow-up|0|||
94332478|NCT01831804|322998795|FG001|Overall Study|Lost to Follow-up|0|||
94332479|NCT01831804|322998796|FG002|Overall Study|Lost to Follow-up|1|||
94332480|NCT01831804|322998797|FG003|Overall Study|Lost to Follow-up|0|||
94332481|NCT01831804|322998798|FG004|Overall Study|Lost to Follow-up|0|||
94226771|NCT00463580|322623646|FG000|Overall Study|Medical/psychiatric complications|0|||
94226772|NCT00463580|322623647|FG001|Overall Study|Medical/psychiatric complications|2|||
94226773|NCT00451555|322623652|FG000|Overall Study|Protocol Violation|2|||
94226774|NCT00451555|322623653|FG001|Overall Study|Protocol Violation|2|||
94226775|NCT00451555|322623652|FG000|Overall Study|Adverse Event|3|||
94226776|NCT00451555|322623653|FG001|Overall Study|Adverse Event|1|||
94226777|NCT00451555|322623652|FG000|Overall Study|Withdrawal by Subject|6|||
94226778|NCT00451555|322623653|FG001|Overall Study|Withdrawal by Subject|0|||
94332482|NCT01831804|322998799|FG005|Overall Study|Lost to Follow-up|0|||
94332483|NCT01831804|322998800|FG006|Overall Study|Lost to Follow-up|0|||
94332484|NCT01831804|322998801|FG007|Overall Study|Lost to Follow-up|0|||
94332485|NCT01831804|322998802|FG008|Overall Study|Lost to Follow-up|1|||
94332486|NCT01831804|322998794|FG000|Overall Study|Investigator discretion|0|||
94332487|NCT01831804|322998795|FG001|Overall Study|Investigator discretion|0|||
94332488|NCT01831804|322998796|FG002|Overall Study|Investigator discretion|0|||
94332489|NCT01831804|322998797|FG003|Overall Study|Investigator discretion|0|||
94332490|NCT01831804|322998798|FG004|Overall Study|Investigator discretion|1|||
94332491|NCT01831804|322998799|FG005|Overall Study|Investigator discretion|0|||
94332492|NCT01831804|322998800|FG006|Overall Study|Investigator discretion|0|||
94332493|NCT01831804|322998801|FG007|Overall Study|Investigator discretion|1|||
94226779|NCT00451555|322623652|FG000|Overall Study|Physician Decision|2|||
94226780|NCT00451555|322623653|FG001|Overall Study|Physician Decision|1|||
94226781|NCT01049984|322623654|FG000|Overall Study|Withdrawal by Subject|1|||
94226782|NCT01049984|322623655|FG001|Overall Study|Withdrawal by Subject|5|||
94226783|NCT01049984|322623654|FG000|Overall Study|Protocol Violation|3|||
94226784|NCT01049984|322623655|FG001|Overall Study|Protocol Violation|4|||
94226785|NCT01049984|322623654|FG000|Overall Study|Lost to Follow-up|2|||
94226786|NCT01049984|322623655|FG001|Overall Study|Lost to Follow-up|1|||
94226787|NCT01049984|322623654|FG000|Overall Study|Adverse Event|13|||
94226788|NCT01049984|322623655|FG001|Overall Study|Adverse Event|7|||
94226789|NCT01049984|322623654|FG000|Overall Study|Treatment failure|0|||
94226790|NCT01049984|322623655|FG001|Overall Study|Treatment failure|2|||
94226791|NCT02973477|322623658|FG000|First Intervention|Lost to Follow-up|0|||
94226792|NCT02973477|322623659|FG001|First Intervention|Lost to Follow-up|2|||
94226793|NCT02973477|322623658|FG000|Washout|Withdrawal by Subject|1|||
94226794|NCT02973477|322623659|FG001|Washout|Withdrawal by Subject|0|||
94226795|NCT02973477|322623658|FG000|Second Intervention|Lost to Follow-up|1|||
94226796|NCT02973477|322623659|FG001|Second Intervention|Lost to Follow-up|0|||
94226797|NCT03036150|322623660|FG000|Overall Study|Withdrawal by Subject|8|||
94226798|NCT03036150|322623661|FG001|Overall Study|Withdrawal by Subject|3|||
94226799|NCT03036150|322623660|FG000|Overall Study|Lost to Follow-up|2|||
94226800|NCT03036150|322623661|FG001|Overall Study|Lost to Follow-up|2|||
94226801|NCT00523549|322623667|FG000|Overall Study|Adverse Event|6|||
94226802|NCT00523549|322623668|FG001|Overall Study|Adverse Event|3|||
94226803|NCT00523549|322623667|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94226804|NCT00523549|322623668|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
94226805|NCT00523549|322623667|FG000|Overall Study|Protocol Deviation|3|||
94226806|NCT00523549|322623668|FG001|Overall Study|Protocol Deviation|1|||
94226807|NCT00523549|322623667|FG000|Overall Study|Patient withdrew consent|7|||
94226808|NCT00523549|322623668|FG001|Overall Study|Patient withdrew consent|6|||
94226809|NCT00523549|322623667|FG000|Overall Study|Lost to Follow-up|3|||
94226810|NCT00523549|322623668|FG001|Overall Study|Lost to Follow-up|5|||
94226811|NCT01037413|322623669|FG000|Part A: Skin Testing|Adverse Event|1|||
94226812|NCT01037413|322623670|FG001|Part A: Skin Testing|Adverse Event|0|||
94226813|NCT01037413|322623669|FG000|Part A: Skin Testing|Protocol Violation|1|||
94226814|NCT01037413|322623670|FG001|Part A: Skin Testing|Protocol Violation|0|||
94226815|NCT01037413|322623669|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
94332494|NCT01831804|322998802|FG008|Overall Study|Investigator discretion|0|||
94332495|NCT01831804|322998794|FG000|Overall Study|Withdrew Consent|0|||
94226816|NCT01037413|322623670|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
94226817|NCT01037413|322623669|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
94226818|NCT01037413|322623670|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
94226819|NCT02172950|322623671|FG000|Overall Study|Physician Decision|3|||
94226820|NCT02172950|322623672|FG001|Overall Study|Physician Decision|3|||
94226821|NCT02172950|322623671|FG000|Overall Study|Lack of Efficacy|1|||
94226822|NCT02172950|322623672|FG001|Overall Study|Lack of Efficacy|0|||
94226823|NCT02172950|322623671|FG000|Overall Study|Adverse Event|4|||
94226824|NCT02172950|322623672|FG001|Overall Study|Adverse Event|1|||
94226825|NCT02172950|322623671|FG000|Overall Study|Withdrawal by Subject|10|||
94226826|NCT02172950|322623672|FG001|Overall Study|Withdrawal by Subject|0|||
94226827|NCT02172950|322623671|FG000|Overall Study|Protocol Violation|1|||
94226828|NCT02172950|322623672|FG001|Overall Study|Protocol Violation|0|||
94226829|NCT02172950|322623671|FG000|Overall Study|Lost to Follow-up|1|||
94226830|NCT02172950|322623672|FG001|Overall Study|Lost to Follow-up|0|||
94226831|NCT02172950|322623671|FG000|Overall Study|Death|1|||
94226832|NCT02172950|322623672|FG001|Overall Study|Death|0|||
94226833|NCT02172950|322623671|FG000|Overall Study|Patient traveling|1|||
94226834|NCT02172950|322623672|FG001|Overall Study|Patient traveling|0|||
94226835|NCT02172950|322623671|FG000|Overall Study|Patient went to other country|1|||
94226836|NCT02172950|322623672|FG001|Overall Study|Patient went to other country|0|||
94226837|NCT02172950|322623671|FG000|Overall Study|Patient relocated overseas|1|||
94226838|NCT02172950|322623672|FG001|Overall Study|Patient relocated overseas|1|||
94226839|NCT02172950|322623671|FG000|Overall Study|Patient moving|1|||
94226840|NCT02172950|322623672|FG001|Overall Study|Patient moving|0|||
94226841|NCT00496626|322623673|FG000|Overall Study|Lost to Follow-up|0|||
94226842|NCT00496626|322623674|FG001|Overall Study|Lost to Follow-up|1|||
94226843|NCT00496626|322623673|FG000|Overall Study|Protocol Violation|1|||
94226844|NCT00496626|322623674|FG001|Overall Study|Protocol Violation|0|||
94226845|NCT00496626|322623673|FG000|Overall Study|Withdrawal by Subject|5|||
94226846|NCT00496626|322623674|FG001|Overall Study|Withdrawal by Subject|4|||
94226847|NCT00496626|322623673|FG000|Overall Study|Relocated|0|||
94226848|NCT00496626|322623674|FG001|Overall Study|Relocated|1|||
94226849|NCT00570921|322623676|FG000|Overall Study|Protocol Violation|1|||
94226850|NCT00570921|322623676|FG000|Overall Study|Physician Decision|1|||
94226851|NCT04582669|322623683|FG000|Overall Study|Subject missed appointment(s).|1|||
94226852|NCT04582669|322623684|FG001|Overall Study|Subject missed appointment(s).|0|||
94226853|NCT04582669|322623685|FG002|Overall Study|Subject missed appointment(s).|1|||
94226854|NCT04582669|322623686|FG003|Overall Study|Subject missed appointment(s).|2|||
94226855|NCT04582669|322623683|FG000|Overall Study|Protocol Violation|0|||
94226856|NCT04582669|322623684|FG001|Overall Study|Protocol Violation|1|||
94226857|NCT04582669|322623685|FG002|Overall Study|Protocol Violation|1|||
94332496|NCT01831804|322998795|FG001|Overall Study|Withdrew Consent|1|||
94332497|NCT01831804|322998796|FG002|Overall Study|Withdrew Consent|0|||
94332498|NCT01831804|322998797|FG003|Overall Study|Withdrew Consent|0|||
94332499|NCT01831804|322998798|FG004|Overall Study|Withdrew Consent|0|||
94332500|NCT01831804|322998799|FG005|Overall Study|Withdrew Consent|0|||
94332501|NCT01831804|322998800|FG006|Overall Study|Withdrew Consent|0|||
94332502|NCT01831804|322998801|FG007|Overall Study|Withdrew Consent|2|||
94332503|NCT01831804|322998802|FG008|Overall Study|Withdrew Consent|0|||
94332504|NCT01192204|322998804|FG000|Overall Study|could not keep recall appointments|1|||
94332505|NCT01192204|322998805|FG001|Overall Study|could not keep recall appointments|0|||
94332506|NCT02853032|322998806|FG000|Overall Study|Adverse Event|4|||
94332507|NCT02853032|322998807|FG001|Overall Study|Adverse Event|0|||
94332508|NCT02853032|322998806|FG000|Overall Study|Withdrawal by Subject|3|||
94332509|NCT02853032|322998807|FG001|Overall Study|Withdrawal by Subject|1|||
94332510|NCT02853032|322998806|FG000|Overall Study|Requested to withdraw from all treatment|2|||
94465650|NCT00772005|323494894|FG003|Overall Study|Lack of Efficacy|0|||
94332511|NCT02853032|322998807|FG001|Overall Study|Requested to withdraw from all treatment|2|||
94332512|NCT03505749|322998808|FG000|Overall Study|Lost to Follow-up|7|||
94332513|NCT03505749|322998809|FG001|Overall Study|Lost to Follow-up|11|||
94332514|NCT03505749|322998808|FG000|Overall Study|Withdrawal by Subject|6|||
94332515|NCT03505749|322998809|FG001|Overall Study|Withdrawal by Subject|0|||
94332516|NCT03505749|322998808|FG000|Overall Study|Discharged from treatment|3|||
94332517|NCT03505749|322998809|FG001|Overall Study|Discharged from treatment|6|||
94332518|NCT02472795|322998811|FG000|Overall Study|Adverse Event|0|||
94332519|NCT02472795|322998812|FG001|Overall Study|Adverse Event|1|||
94332520|NCT02472795|322998813|FG002|Overall Study|Adverse Event|0|||
94332521|NCT02472795|322998814|FG003|Overall Study|Adverse Event|0|||
94332522|NCT02472795|322998815|FG004|Overall Study|Adverse Event|2|||
94332523|NCT02472795|322998811|FG000|Overall Study|Withdrawal by Subject|0|||
94332524|NCT02472795|322998812|FG001|Overall Study|Withdrawal by Subject|0|||
94332525|NCT02472795|322998813|FG002|Overall Study|Withdrawal by Subject|0|||
94332526|NCT02472795|322998814|FG003|Overall Study|Withdrawal by Subject|0|||
94332527|NCT02472795|322998815|FG004|Overall Study|Withdrawal by Subject|1|||
94332528|NCT02322411|322998816|FG000|Overall Study|Lost to Follow-up|4|||
94332529|NCT02322411|322998817|FG001|Overall Study|Lost to Follow-up|7|||
94332530|NCT02322411|322998816|FG000|Overall Study|Withdrawal by Subject|1|||
94332531|NCT02322411|322998817|FG001|Overall Study|Withdrawal by Subject|0|||
94332532|NCT00788697|322998818|FG000|Overall Study|No study drug administered|12|||
94332533|NCT00788697|322998818|FG000|Overall Study|Training Patients|74|||
94332534|NCT00788697|322998818|FG000|Overall Study|no truth standard procedure available|5|||
94332535|NCT00788697|322998818|FG000|Overall Study|Technically inadequate truth standard|1|||
94332536|NCT00788697|322998818|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
94332537|NCT01626989|322998819|FG000|Screening Period|Screen Failure|15|||
94332538|NCT01626989|322998820|FG001|Screening Period|Screen Failure|0|||
94332539|NCT01626989|322998821|FG002|Screening Period|Screen Failure|0|||
94332540|NCT01626989|322998819|FG000|Screening Period|Withdrawal by Subject|2|||
94332541|NCT01626989|322998820|FG001|Screening Period|Withdrawal by Subject|0|||
94332542|NCT01626989|322998821|FG002|Screening Period|Withdrawal by Subject|0|||
94332543|NCT02674685|322998824|FG000|Overall Study|Withdrawal by Subject|4|||
94332544|NCT02713789|322998825|FG000|Overall Study|Lost to Follow-up|0|||
94332545|NCT02713789|322998826|FG001|Overall Study|Lost to Follow-up|1|||
94332546|NCT02713789|322998827|FG002|Overall Study|Lost to Follow-up|1|||
94332547|NCT02999100|322998828|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
94332548|NCT02999100|322998829|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
94332549|NCT02999100|322998830|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
94332550|NCT02999100|322998831|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
94332551|NCT02999100|322998832|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
94332552|NCT02999100|322998833|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
94332553|NCT02999100|322998828|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
94332554|NCT02999100|322998829|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
94332555|NCT02999100|322998830|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
94332556|NCT02999100|322998831|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
94332557|NCT02999100|322998832|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
94332558|NCT02999100|322998833|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
94332559|NCT02999100|322998828|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
94332560|NCT02999100|322998829|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
94332561|NCT02999100|322998830|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
94332562|NCT02999100|322998831|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
94332563|NCT02999100|322998832|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
94332564|NCT02999100|322998833|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
94332565|NCT01928082|322998834|FG000|Overall Study|Study terminated.|1|||
94332566|NCT03549117|322998835|FG000|Overall Study|Withdrawal by Subject|1|||
94332567|NCT03549117|322998836|FG001|Overall Study|Withdrawal by Subject|0|||
94332568|NCT03595384|322998837|FG000|Overall Study|Other time commitments|8|||
94332569|NCT03595384|322998837|FG000|Overall Study|Changes to session time|7|||
94332570|NCT03595384|322998837|FG000|Overall Study|Relocation out of country|1|||
94332571|NCT00293241|322998838|FG000|Overall Study|Lost to Follow-up|9|||
94332572|NCT00293241|322998839|FG001|Overall Study|Lost to Follow-up|16|||
94332573|NCT00293241|322998838|FG000|Overall Study|Physician Decision|23|||
94332574|NCT00293241|322998839|FG001|Overall Study|Physician Decision|17|||
94332575|NCT00293241|322998838|FG000|Overall Study|Withdrawal by Subject|4|||
94332576|NCT00293241|322998839|FG001|Overall Study|Withdrawal by Subject|8|||
94332577|NCT05567393|322998842|FG000|Overall Study|Voluntary Withdrawal|0|||
94332578|NCT05567393|322998843|FG001|Overall Study|Voluntary Withdrawal|0|||
94332579|NCT05567393|322998844|FG002|Overall Study|Voluntary Withdrawal|0|||
94332580|NCT05567393|322998845|FG003|Overall Study|Voluntary Withdrawal|0|||
94332581|NCT05567393|322998846|FG004|Overall Study|Voluntary Withdrawal|0|||
94332582|NCT05567393|322998847|FG005|Overall Study|Voluntary Withdrawal|0|||
94332583|NCT05567393|322998848|FG006|Overall Study|Voluntary Withdrawal|0|||
94332584|NCT05567393|322998849|FG007|Overall Study|Voluntary Withdrawal|0|||
94332585|NCT05567393|322998850|FG008|Overall Study|Voluntary Withdrawal|0|||
94332586|NCT05567393|322998851|FG009|Overall Study|Voluntary Withdrawal|0|||
94332587|NCT05567393|322998852|FG010|Overall Study|Voluntary Withdrawal|0|||
94332588|NCT05567393|322998853|FG011|Overall Study|Voluntary Withdrawal|0|||
94332589|NCT05567393|322998854|FG012|Overall Study|Voluntary Withdrawal|0|||
94332590|NCT05567393|322998855|FG013|Overall Study|Voluntary Withdrawal|1|||
94332591|NCT05567393|322998856|FG014|Overall Study|Voluntary Withdrawal|0|||
94332592|NCT05567393|322998857|FG015|Overall Study|Voluntary Withdrawal|0|||
94332593|NCT05567393|322998858|FG016|Overall Study|Voluntary Withdrawal|0|||
94332594|NCT05567393|322998859|FG017|Overall Study|Voluntary Withdrawal|0|||
94332595|NCT01270958|322998862|FG000|Overall Study|Lost to Follow-up|2|||
94332596|NCT01270958|322998862|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
94332597|NCT01815580|322998867|FG000|Overall Study|Lost to Follow-up|4|||
94332598|NCT01815580|322998868|FG001|Overall Study|Lost to Follow-up|7|||
94332599|NCT01815580|322998867|FG000|Overall Study|Withdrawal by Subject|3|||
94332600|NCT01815580|322998868|FG001|Overall Study|Withdrawal by Subject|4|||
94332601|NCT01815580|322998867|FG000|Overall Study|Excluded from analysis|5|||
94332602|NCT01815580|322998868|FG001|Overall Study|Excluded from analysis|4|||
94332603|NCT00888615|322998869|FG000|Overall Study|No treatment|2|||
94332604|NCT00659126|322998870|FG000|Overall Study|Adverse Event|2|||
94332605|NCT00659126|322998871|FG001|Overall Study|Adverse Event|2|||
94332606|NCT00659126|322998870|FG000|Overall Study|Screen failure|1|||
94332607|NCT00659126|322998871|FG001|Overall Study|Screen failure|1|||
94332608|NCT00659126|322998870|FG000|Overall Study|Technical problems with MRI|0|||
94332609|NCT00659126|322998871|FG001|Overall Study|Technical problems with MRI|1|||
94332610|NCT03310580|322998872|FG000|Overall Study|Adverse Event|0|||
94332611|NCT03310580|322998873|FG001|Overall Study|Adverse Event|1|||
94332612|NCT03310580|322998874|FG002|Overall Study|Adverse Event|0|||
94332613|NCT00795509|322998877|FG000|Overall Study|Protocol Violation|31|||
94332614|NCT02079519|322998878|FG000|Overall Study|Disease Progression|9|||
94332615|NCT02079519|322998878|FG000|Overall Study|Adverse Event|1|||
94332616|NCT04186663|322998881|FG000|Overall Study|Lost to Follow-up|1|||
94332617|NCT04186663|322998881|FG000|Overall Study|Unable to complete blood draw|3|||
94332618|NCT01184846|322998883|FG000|Overall Study|Adverse Event|2|||
94332619|NCT01184846|322998883|FG000|Overall Study|Insufficient response|1|||
94332620|NCT02091921|322998884|FG000|Overall Study|Adverse Event|3|||
94332621|NCT03077243|323000688|FG000|Overall Study|Death|1|||
94332622|NCT03077243|323000689|FG001|Overall Study|Death|2|||
94332623|NCT03077243|323000690|FG002|Overall Study|Death|0|||
94332624|NCT03077243|323000691|FG003|Overall Study|Death|0|||
94332625|NCT03077243|323000688|FG000|Overall Study|Withdrawal by Subject|1|||
94332626|NCT03077243|323000689|FG001|Overall Study|Withdrawal by Subject|3|||
94332627|NCT03077243|323000690|FG002|Overall Study|Withdrawal by Subject|0|||
94332628|NCT03077243|323000691|FG003|Overall Study|Withdrawal by Subject|0|||
94332629|NCT03077243|323000688|FG000|Overall Study|Physician Decision|1|||
94332630|NCT03077243|323000689|FG001|Overall Study|Physician Decision|0|||
94332631|NCT03077243|323000690|FG002|Overall Study|Physician Decision|0|||
94332632|NCT03077243|323000691|FG003|Overall Study|Physician Decision|0|||
94332633|NCT03077243|323000688|FG000|Overall Study|Research at two study sites terminated early|0|||
94332634|NCT03077243|323000689|FG001|Overall Study|Research at two study sites terminated early|0|||
94332635|NCT03077243|323000690|FG002|Overall Study|Research at two study sites terminated early|0|||
94332636|NCT03077243|323000691|FG003|Overall Study|Research at two study sites terminated early|69|||
94332637|NCT00212758|323000692|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
94332638|NCT00212758|323000693|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
94332639|NCT00212758|323000692|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
94332640|NCT00212758|323000693|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
94332641|NCT00094835|323000696|FG000|Overall Study|Physician Decision|1|||
94332642|NCT00094835|323000697|FG001|Overall Study|Physician Decision|0|||
94332643|NCT00094835|323000698|FG002|Overall Study|Physician Decision|0|||
94332644|NCT00094835|323000699|FG003|Overall Study|Physician Decision|0|||
94332645|NCT00094835|323000700|FG004|Overall Study|Physician Decision|0|||
94332646|NCT00094835|323000701|FG005|Overall Study|Physician Decision|1|||
94332647|NCT00094835|323000702|FG006|Overall Study|Physician Decision|0|||
94332648|NCT00094835|323000696|FG000|Overall Study|Withdrawal by Subject|0|||
94332649|NCT00094835|323000697|FG001|Overall Study|Withdrawal by Subject|0|||
94332650|NCT00094835|323000698|FG002|Overall Study|Withdrawal by Subject|0|||
94332651|NCT00094835|323000699|FG003|Overall Study|Withdrawal by Subject|0|||
94332652|NCT00094835|323000700|FG004|Overall Study|Withdrawal by Subject|0|||
94332653|NCT00094835|323000701|FG005|Overall Study|Withdrawal by Subject|0|||
94332654|NCT00094835|323000702|FG006|Overall Study|Withdrawal by Subject|1|||
94226858|NCT04582669|322623686|FG003|Overall Study|Protocol Violation|0|||
94226859|NCT02137239|322623690|FG000|Overall Study|Discontinued Study Treatment|0|||
94226860|NCT02137239|322623691|FG001|Overall Study|Discontinued Study Treatment|3|||
94226861|NCT02137239|322623690|FG000|Overall Study|Withdrew Consent|1|||
94226862|NCT02137239|322623691|FG001|Overall Study|Withdrew Consent|1|||
94226863|NCT02137239|322623690|FG000|Overall Study|Adverse Event|2|||
94226864|NCT02137239|322623691|FG001|Overall Study|Adverse Event|2|||
94226865|NCT01951261|322623692|FG000|Overall Study|Death|1|||
94226866|NCT01951261|322623693|FG001|Overall Study|Death|0|||
94226867|NCT01951261|322623692|FG000|Overall Study|Lost to Follow-up|4|||
94226868|NCT01951261|322623693|FG001|Overall Study|Lost to Follow-up|3|||
94226869|NCT01951261|322623692|FG000|Overall Study|Protocol Violation|4|||
94226870|NCT01951261|322623693|FG001|Overall Study|Protocol Violation|3|||
94226871|NCT01924806|322623694|FG000|Overall Study|Physician Decision|2|||
94226872|NCT01924806|322623695|FG001|Overall Study|Physician Decision|1|||
94226873|NCT02212301|322623696|FG000|Period 1|Lost to Follow-up|0|||
94226874|NCT02212301|322623697|FG001|Period 1|Lost to Follow-up|1|||
94226875|NCT02109107|322623704|FG000|Overall Study|Lost to Follow-up|2|||
94226876|NCT02573883|322623708|FG000|Six Month Follow Up|Lost to Follow-up|1|||
94226877|NCT02573883|322623709|FG001|Six Month Follow Up|Lost to Follow-up|0|||
94226878|NCT02573883|322623710|FG002|Six Month Follow Up|Lost to Follow-up|0|||
94226879|NCT02573883|322623711|FG003|Six Month Follow Up|Lost to Follow-up|0|||
94226880|NCT02573883|322623708|FG000|One Year Follow Up|Lost to Follow-up|2|||
94226881|NCT02573883|322623709|FG001|One Year Follow Up|Lost to Follow-up|1|||
94226882|NCT02573883|322623710|FG002|One Year Follow Up|Lost to Follow-up|0|||
94226883|NCT02573883|322623711|FG003|One Year Follow Up|Lost to Follow-up|0|||
94226884|NCT03078751|322623712|FG000|Overall Study|Adverse Event|4|||
94226885|NCT03078751|322623713|FG001|Overall Study|Adverse Event|0|||
94226886|NCT03078751|322623712|FG000|Overall Study|Physician Decision|1|||
94226887|NCT03078751|322623713|FG001|Overall Study|Physician Decision|0|||
94226888|NCT03078751|322623712|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
94226889|NCT03078751|322623713|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
94226890|NCT03078751|322623712|FG000|Overall Study|Subject/guardian decision|8|||
94226891|NCT03078751|322623713|FG001|Overall Study|Subject/guardian decision|1|||
94226892|NCT03078751|322623712|FG000|Overall Study|Untreated|0|||
94226893|NCT03078751|322623713|FG001|Overall Study|Untreated|4|||
94226894|NCT00118703|322623714|FG000|Overall Study|Protocol Violation|1|||
94226895|NCT00118703|322623715|FG001|Overall Study|Protocol Violation|0|||
94226896|NCT00118703|322623714|FG000|Overall Study|Adverse Event|1|||
94226897|NCT00118703|322623715|FG001|Overall Study|Adverse Event|1|||
94226898|NCT00118703|322623714|FG000|Overall Study|Participant took two different treatment|0|||
94226899|NCT00118703|322623715|FG001|Overall Study|Participant took two different treatment|1|||
94226900|NCT00118703|322623714|FG000|Overall Study|Withdrawal by Subject|2|||
94226901|NCT00118703|322623715|FG001|Overall Study|Withdrawal by Subject|5|||
94226902|NCT00118703|322623714|FG000|Overall Study|Lost to Follow-up|1|||
94226903|NCT00118703|322623715|FG001|Overall Study|Lost to Follow-up|2|||
94226904|NCT00130728|322623716|FG000|Overall Study|Death|258|||
94226905|NCT00130728|322623717|FG001|Overall Study|Death|258|||
94226906|NCT00130728|322623716|FG000|Overall Study|Lost to Follow-up|4|||
94226907|NCT00130728|322623717|FG001|Overall Study|Lost to Follow-up|0|||
94226908|NCT00130728|322623716|FG000|Overall Study|Withdrawal by Subject|0|||
94226909|NCT00130728|322623717|FG001|Overall Study|Withdrawal by Subject|2|||
94226910|NCT02175745|322623719|FG000|Overall Study|Not Eligible|1|||
94226911|NCT01726517|322623722|FG000|Overall Study|Withdrawal by Subject|0|||
94226912|NCT01726517|322623723|FG001|Overall Study|Withdrawal by Subject|0|||
94226913|NCT01726517|322623724|FG002|Overall Study|Withdrawal by Subject|1|||
94226914|NCT01726517|322623725|FG003|Overall Study|Withdrawal by Subject|0|||
94226915|NCT01726517|322623726|FG004|Overall Study|Withdrawal by Subject|0|||
94226916|NCT01705145|322623727|FG000|Part B|Adverse Event|1|||
94332655|NCT00094835|323000696|FG000|Overall Study|Lost to Follow-up|0|||
94226917|NCT03512288|322623730|FG000|Overall Study|Adverse Event|1|||
94226918|NCT03512288|322623731|FG001|Overall Study|Adverse Event|0|||
94226919|NCT03512288|322623730|FG000|Overall Study|Lost to Follow-up|12|||
94226920|NCT03512288|322623731|FG001|Overall Study|Lost to Follow-up|15|||
94226921|NCT03512288|322623730|FG000|Overall Study|Physician Decision|0|||
94226922|NCT03512288|322623731|FG001|Overall Study|Physician Decision|2|||
94226923|NCT03512288|322623730|FG000|Overall Study|Protocol Violation|6|||
94226924|NCT03512288|322623731|FG001|Overall Study|Protocol Violation|4|||
94226925|NCT03512288|322623730|FG000|Overall Study|Medication error without associated adverse event|1|||
94226926|NCT03512288|322623731|FG001|Overall Study|Medication error without associated adverse event|0|||
94226927|NCT03512288|322623730|FG000|Overall Study|No longer met eligibility criteria|5|||
94226928|NCT03512288|322623731|FG001|Overall Study|No longer met eligibility criteria|2|||
94226929|NCT03512288|322623730|FG000|Overall Study|Withdrawal by parent/guardian|14|||
94226930|NCT03512288|322623731|FG001|Overall Study|Withdrawal by parent/guardian|18|||
94226931|NCT03512288|322623730|FG000|Overall Study|Other|1|||
94226932|NCT03512288|322623731|FG001|Overall Study|Other|1|||
94226933|NCT03512288|322623730|FG000|Overall Study|Randomized but not treated|1|||
94226934|NCT03512288|322623731|FG001|Overall Study|Randomized but not treated|1|||
94226935|NCT04088500|322623732|FG000|Overall Study|Reason unknown|1|||
94226936|NCT04088500|322623732|FG000|Overall Study|Participant withdrew consent|1|||
94226937|NCT04088500|322623732|FG000|Overall Study|Disease progression|3|||
94226938|NCT01208870|322623733|FG000|Overall Study|Lost to Follow-up|2|||
94226939|NCT01208870|322623734|FG001|Overall Study|Lost to Follow-up|8|||
94226940|NCT00496834|322623737|FG000|Overall Study|Withdrawal by Subject|4|||
94226941|NCT00496834|322623738|FG001|Overall Study|Withdrawal by Subject|6|||
94226942|NCT00496834|322623737|FG000|Overall Study|Contraindicated medication administered|0|||
94226943|NCT00496834|322623738|FG001|Overall Study|Contraindicated medication administered|1|||
94226944|NCT00496834|322623737|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
94226945|NCT00496834|322623738|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
94332656|NCT00094835|323000697|FG001|Overall Study|Lost to Follow-up|0|||
94332657|NCT00094835|323000698|FG002|Overall Study|Lost to Follow-up|0|||
94332658|NCT00094835|323000699|FG003|Overall Study|Lost to Follow-up|0|||
94226946|NCT00496834|322623737|FG000|Overall Study|Adverse Event|5|||
94226947|NCT00496834|322623738|FG001|Overall Study|Adverse Event|3|||
94226948|NCT00496834|322623737|FG000|Overall Study|IP administration violation|2|||
94226949|NCT00496834|322623738|FG001|Overall Study|IP administration violation|0|||
94226950|NCT00496834|322623737|FG000|Overall Study|Lost to Follow-up|2|||
94332659|NCT00094835|323000700|FG004|Overall Study|Lost to Follow-up|1|||
94332660|NCT00094835|323000701|FG005|Overall Study|Lost to Follow-up|0|||
94332661|NCT00094835|323000702|FG006|Overall Study|Lost to Follow-up|0|||
94332662|NCT00094835|323000696|FG000|Overall Study|Death|1|||
94332663|NCT00094835|323000697|FG001|Overall Study|Death|0|||
94332664|NCT00094835|323000698|FG002|Overall Study|Death|0|||
94332665|NCT00094835|323000699|FG003|Overall Study|Death|0|||
94332666|NCT00094835|323000700|FG004|Overall Study|Death|1|||
94332667|NCT00094835|323000701|FG005|Overall Study|Death|0|||
94332668|NCT00094835|323000702|FG006|Overall Study|Death|0|||
94332669|NCT00094835|323000696|FG000|Overall Study|Non-compliance|1|||
94226951|NCT00496834|322623738|FG001|Overall Study|Lost to Follow-up|0|||
94332670|NCT00094835|323000697|FG001|Overall Study|Non-compliance|2|||
94226952|NCT00496834|322623737|FG000|Overall Study|Blood Pressure control failure|2|||
94226953|NCT00496834|322623738|FG001|Overall Study|Blood Pressure control failure|1|||
94226954|NCT03049306|322623746|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
94226955|NCT03049306|322623747|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
94226956|NCT02154347|322623748|FG000|Double-blind Period|Adverse Event|1|||
94226957|NCT02154347|322623749|FG001|Double-blind Period|Adverse Event|2|||
94226958|NCT02154347|322623748|FG000|Double-blind Period|Lack of Efficacy|1|||
94226959|NCT02154347|322623749|FG001|Double-blind Period|Lack of Efficacy|0|||
94226960|NCT02154347|322623748|FG000|Double-blind Period|Physician Decision|0|||
94226961|NCT02154347|322623749|FG001|Double-blind Period|Physician Decision|1|||
94226962|NCT02154347|322623748|FG000|Double-blind Period|Withdrawal by Subject|1|||
94226963|NCT02154347|322623749|FG001|Double-blind Period|Withdrawal by Subject|1|||
94226964|NCT02154347|322623748|FG000|Open-label Period|Adverse Event|3|||
94226965|NCT02154347|322623749|FG001|Open-label Period|Adverse Event|4|||
94226966|NCT02154347|322623748|FG000|Open-label Period|Lack of Efficacy|4|||
94226967|NCT02154347|322623749|FG001|Open-label Period|Lack of Efficacy|19|||
94226968|NCT02154347|322623748|FG000|Open-label Period|Protocol Violation|0|||
94226969|NCT02154347|322623749|FG001|Open-label Period|Protocol Violation|1|||
94226970|NCT02154347|322623748|FG000|Open-label Period|Withdrawal by Subject|0|||
94226971|NCT02154347|322623749|FG001|Open-label Period|Withdrawal by Subject|1|||
94226972|NCT00514813|322623752|FG000|Overall Study|Study terminated|14|||
94226973|NCT00514813|322623753|FG001|Overall Study|Study terminated|74|||
94226974|NCT00514813|322623754|FG002|Overall Study|Study terminated|40|||
94226975|NCT00514813|322623755|FG003|Overall Study|Study terminated|2|||
94226976|NCT00514813|322623752|FG000|Overall Study|Adverse Event|0|||
94226977|NCT00514813|322623753|FG001|Overall Study|Adverse Event|2|||
94226978|NCT00514813|322623754|FG002|Overall Study|Adverse Event|2|||
94226979|NCT00514813|322623755|FG003|Overall Study|Adverse Event|0|||
94226980|NCT00514813|322623752|FG000|Overall Study|Protocol Violation|1|||
94226981|NCT00514813|322623753|FG001|Overall Study|Protocol Violation|0|||
94226982|NCT00514813|322623754|FG002|Overall Study|Protocol Violation|0|||
94226983|NCT00514813|322623755|FG003|Overall Study|Protocol Violation|0|||
94226984|NCT00514813|322623752|FG000|Overall Study|Withdrawal by Subject|0|||
94226985|NCT00514813|322623753|FG001|Overall Study|Withdrawal by Subject|1|||
94226986|NCT00514813|322623754|FG002|Overall Study|Withdrawal by Subject|0|||
94226987|NCT00514813|322623755|FG003|Overall Study|Withdrawal by Subject|0|||
94226988|NCT00514813|322623752|FG000|Overall Study|Lack of Efficacy|0|||
94226989|NCT00514813|322623753|FG001|Overall Study|Lack of Efficacy|1|||
94226990|NCT00514813|322623754|FG002|Overall Study|Lack of Efficacy|0|||
94226991|NCT00514813|322623755|FG003|Overall Study|Lack of Efficacy|0|||
94226992|NCT00514813|322623752|FG000|Overall Study|Kidney transplant|0|||
94226993|NCT00514813|322623753|FG001|Overall Study|Kidney transplant|6|||
94226994|NCT00514813|322623754|FG002|Overall Study|Kidney transplant|2|||
94226995|NCT00514813|322623755|FG003|Overall Study|Kidney transplant|0|||
94226996|NCT00514813|322623752|FG000|Overall Study|Death|0|||
94226997|NCT00514813|322623753|FG001|Overall Study|Death|2|||
94226998|NCT00514813|322623754|FG002|Overall Study|Death|3|||
94226999|NCT00514813|322623755|FG003|Overall Study|Death|2|||
94227000|NCT02250183|322623756|FG000|Overall Study|Withdrawal by Subject|2|||
94227001|NCT02250183|322623756|FG000|Overall Study|Adverse Event|5|||
94227002|NCT02250183|322623756|FG000|Overall Study|Lost to Follow-up|1|||
94227003|NCT01967719|322625677|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
94227004|NCT01967719|322625678|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
94227005|NCT01967719|322625679|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
94227006|NCT01967719|322625680|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
94227007|NCT01967719|322625677|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
94227008|NCT01967719|322625678|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
94332671|NCT00094835|323000698|FG002|Overall Study|Non-compliance|2|||
94332672|NCT00094835|323000699|FG003|Overall Study|Non-compliance|0|||
94332673|NCT00094835|323000700|FG004|Overall Study|Non-compliance|2|||
94332674|NCT00094835|323000701|FG005|Overall Study|Non-compliance|2|||
94332675|NCT00094835|323000702|FG006|Overall Study|Non-compliance|1|||
94332676|NCT00094835|323000696|FG000|Overall Study|Other|1|||
94332677|NCT00094835|323000697|FG001|Overall Study|Other|1|||
94332678|NCT00094835|323000698|FG002|Overall Study|Other|1|||
94332679|NCT00094835|323000699|FG003|Overall Study|Other|1|||
94332680|NCT00094835|323000700|FG004|Overall Study|Other|0|||
94332681|NCT00094835|323000701|FG005|Overall Study|Other|0|||
94332682|NCT00094835|323000702|FG006|Overall Study|Other|0|||
94332683|NCT03628599|323000703|FG000|Overall Study|Adverse Event|0|||
94332684|NCT03628599|323000704|FG001|Overall Study|Adverse Event|1|||
94332685|NCT03170258|323000710|FG000|Overall Study|Physician Decision|4|||
94332686|NCT03170258|323000711|FG001|Overall Study|Physician Decision|0|||
94332687|NCT03170258|323000710|FG000|Overall Study|Equipment issues|1|||
94332688|NCT03170258|323000711|FG001|Overall Study|Equipment issues|0|||
94332689|NCT03170258|323000710|FG000|Overall Study|Medication|1|||
94332690|NCT03170258|323000711|FG001|Overall Study|Medication|0|||
94332691|NCT03170258|323000710|FG000|Overall Study|Sleep issues|1|||
94332692|NCT03170258|323000711|FG001|Overall Study|Sleep issues|0|||
94332693|NCT00666536|323000720|FG000|Overall Study|Adverse Event|9|||
94332694|NCT00666536|323000721|FG001|Overall Study|Adverse Event|19|||
94332695|NCT00666536|323000720|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
94332696|NCT00666536|323000721|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94332697|NCT00666536|323000720|FG000|Overall Study|Protocol deviation(s)|8|||
94332698|NCT00666536|323000721|FG001|Overall Study|Protocol deviation(s)|6|||
94332699|NCT00666536|323000720|FG000|Overall Study|Withdrawal by Subject|10|||
94332700|NCT00666536|323000721|FG001|Overall Study|Withdrawal by Subject|9|||
94332701|NCT00666536|323000720|FG000|Overall Study|Lost to Follow-up|4|||
94332702|NCT00666536|323000721|FG001|Overall Study|Lost to Follow-up|3|||
94332703|NCT00948428|323000727|FG000|Overall Study|Withdrawal by Subject|6|||
94332704|NCT00948428|323000728|FG001|Overall Study|Withdrawal by Subject|12|||
94332705|NCT00948428|323000729|FG002|Overall Study|Withdrawal by Subject|7|||
94332706|NCT00948428|323000727|FG000|Overall Study|Adverse Event|6|||
94332707|NCT00948428|323000728|FG001|Overall Study|Adverse Event|3|||
94332708|NCT00948428|323000729|FG002|Overall Study|Adverse Event|0|||
94332709|NCT00948428|323000727|FG000|Overall Study|Lost to Follow-up|2|||
94332710|NCT00948428|323000728|FG001|Overall Study|Lost to Follow-up|1|||
94332711|NCT00948428|323000729|FG002|Overall Study|Lost to Follow-up|1|||
94332712|NCT00948428|323000727|FG000|Overall Study|Death|2|||
94332713|NCT00948428|323000728|FG001|Overall Study|Death|0|||
94332714|NCT00948428|323000729|FG002|Overall Study|Death|0|||
94332715|NCT00948428|323000727|FG000|Overall Study|Intercurrent Illness|1|||
94332716|NCT00948428|323000728|FG001|Overall Study|Intercurrent Illness|0|||
94332717|NCT00948428|323000729|FG002|Overall Study|Intercurrent Illness|0|||
94332718|NCT00948428|323000727|FG000|Overall Study|Non-compliance|1|||
94332719|NCT00948428|323000728|FG001|Overall Study|Non-compliance|2|||
94332720|NCT00948428|323000729|FG002|Overall Study|Non-compliance|0|||
94332721|NCT00247273|323000732|FG000|Overall Study|Adverse Event|85|||
94332722|NCT00247273|323000733|FG001|Overall Study|Adverse Event|80|||
94332723|NCT00247273|323000732|FG000|Overall Study|Physician Decision|6|||
94332724|NCT00247273|323000733|FG001|Overall Study|Physician Decision|3|||
94332725|NCT00247273|323000732|FG000|Overall Study|Lost to Follow-up|7|||
94332726|NCT00247273|323000733|FG001|Overall Study|Lost to Follow-up|7|||
94332727|NCT00247273|323000732|FG000|Overall Study|Withdrawal by Subject|46|||
94332728|NCT00247273|323000733|FG001|Overall Study|Withdrawal by Subject|47|||
94332729|NCT00247273|323000732|FG000|Overall Study|Did not take any study drug|2|||
94332730|NCT00247273|323000733|FG001|Overall Study|Did not take any study drug|0|||
94332731|NCT04839393|323000735|FG000|Overall Study|Adverse Event|0|||
94332732|NCT04839393|323000736|FG001|Overall Study|Adverse Event|0|||
94332733|NCT04839393|323000737|FG002|Overall Study|Adverse Event|2|||
94332734|NCT04839393|323000735|FG000|Overall Study|Withdrawal by participant|0|||
94332735|NCT04839393|323000736|FG001|Overall Study|Withdrawal by participant|0|||
94332736|NCT04839393|323000737|FG002|Overall Study|Withdrawal by participant|1|||
94332737|NCT00762268|323000738|FG000|Overall Study|Withdrawal by Subject|3|||
94332738|NCT00762268|323000739|FG001|Overall Study|Withdrawal by Subject|3|||
94332739|NCT01392742|323000745|FG000|Overall Study|Premature study termination|42|||
94332740|NCT01392742|323000745|FG000|Overall Study|Failure to return|35|||
94332741|NCT01392742|323000745|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
94332742|NCT01392742|323000745|FG000|Overall Study|Lost to Follow-up|34|||
94332743|NCT01392742|323000745|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
94332744|NCT01392742|323000745|FG000|Overall Study|ITR and Protocol deviation|1|||
94332745|NCT01392742|323000745|FG000|Overall Study|Adverse event/intercurrent illness|17|||
94332746|NCT01392742|323000745|FG000|Overall Study|Protocol Violation|14|||
94332747|NCT01392742|323000745|FG000|Overall Study|Other|3|||
94332748|NCT01392742|323000745|FG000|Overall Study|Missing information|13|||
94332749|NCT03210220|323000746|FG000|Overall Study|Physician Decision|1|||
94332750|NCT03210220|323000747|FG001|Overall Study|Physician Decision|0|||
94227009|NCT01967719|322625679|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
94227010|NCT01967719|322625680|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
94227011|NCT00796614|322625686|FG000|Overall Study|Adverse Event|1|||
94227012|NCT00796614|322625687|FG001|Overall Study|Adverse Event|2|||
94332751|NCT05552859|323000748|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
94332752|NCT05552859|323000749|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
94332753|NCT01807949|323000750|FG000|Overall Study|Adverse Event|1|||
94332754|NCT01807949|323000751|FG001|Overall Study|Adverse Event|2|||
94332755|NCT01807949|323000752|FG002|Overall Study|Adverse Event|2|||
94332756|NCT01807949|323000750|FG000|Overall Study|Withdrawal by Subject|1|||
94332757|NCT01807949|323000751|FG001|Overall Study|Withdrawal by Subject|2|||
94332758|NCT01807949|323000752|FG002|Overall Study|Withdrawal by Subject|2|||
94332759|NCT01807949|323000750|FG000|Overall Study|Non-Compliance|0|||
94332760|NCT01807949|323000751|FG001|Overall Study|Non-Compliance|0|||
94332761|NCT01807949|323000752|FG002|Overall Study|Non-Compliance|1|||
94332762|NCT01807949|323000750|FG000|Overall Study|Undefined|0|||
94332763|NCT01807949|323000751|FG001|Overall Study|Undefined|1|||
94332764|NCT01807949|323000752|FG002|Overall Study|Undefined|2|||
94332765|NCT01807949|323000750|FG000|Overall Study|Randomized But Not Treated|0|||
94332766|NCT01807949|323000751|FG001|Overall Study|Randomized But Not Treated|2|||
94332767|NCT01807949|323000752|FG002|Overall Study|Randomized But Not Treated|2|||
94332768|NCT02137837|323000753|FG000|Overall Study|Adverse Event|0|||
94332769|NCT02137837|323000754|FG001|Overall Study|Adverse Event|2|||
94332770|NCT02137837|323000755|FG002|Overall Study|Adverse Event|1|||
94332771|NCT02137837|323000753|FG000|Overall Study|Refusal unrelated to adverse event|2|||
94332772|NCT02137837|323000754|FG001|Overall Study|Refusal unrelated to adverse event|2|||
94332773|NCT02137837|323000755|FG002|Overall Study|Refusal unrelated to adverse event|1|||
94332774|NCT02137837|323000753|FG000|Overall Study|Progression/relapse|9|||
94332775|NCT02137837|323000754|FG001|Overall Study|Progression/relapse|7|||
94332776|NCT02137837|323000755|FG002|Overall Study|Progression/relapse|7|||
94332777|NCT02137837|323000753|FG000|Overall Study|Not protocol specified|2|||
94332778|NCT02137837|323000754|FG001|Overall Study|Not protocol specified|1|||
94332779|NCT02137837|323000755|FG002|Overall Study|Not protocol specified|3|||
94332780|NCT00724815|323000756|FG000|Overall Study|Randomized, not treated|31|||
94332781|NCT00724815|323000757|FG001|Overall Study|Randomized, not treated|30|||
94332782|NCT00724815|323000756|FG000|Overall Study|Adverse Event|5|||
94332783|NCT00724815|323000757|FG001|Overall Study|Adverse Event|3|||
94332784|NCT00724815|323000756|FG000|Overall Study|Lost to Follow-up|4|||
94332785|NCT00724815|323000757|FG001|Overall Study|Lost to Follow-up|1|||
94332786|NCT00724815|323000756|FG000|Overall Study|Other Various|3|||
94332787|NCT00724815|323000757|FG001|Overall Study|Other Various|5|||
94332788|NCT01599806|323000764|FG000|Overall Study|Lost to Follow-up|20|||
94332789|NCT01599806|323000765|FG001|Overall Study|Lost to Follow-up|20|||
94332790|NCT01599806|323000764|FG000|Overall Study|Withdrawal by Subject|12|||
94332791|NCT01599806|323000765|FG001|Overall Study|Withdrawal by Subject|12|||
94332792|NCT01599806|323000764|FG000|Overall Study|Other Eligibility criteria|11|||
94332793|NCT01599806|323000765|FG001|Overall Study|Other Eligibility criteria|9|||
94332794|NCT00391807|323000766|FG000|Overall Study|Did not receive study medication|23|||
94332795|NCT00391807|323000766|FG000|Overall Study|Adverse Event|177|||
94332796|NCT00391807|323000766|FG000|Overall Study|Pregnancy|25|||
94332797|NCT00391807|323000766|FG000|Overall Study|Lost to Follow-up|227|||
94332798|NCT00391807|323000766|FG000|Overall Study|Withdrawal by Subject|147|||
94332799|NCT00391807|323000766|FG000|Overall Study|Protocol Violation|20|||
94332800|NCT00391807|323000766|FG000|Overall Study|Various|96|||
94332801|NCT01359046|323000767|FG000|Overall Study|Did not receive allocated intervention|6|||
94332802|NCT01359046|323000768|FG001|Overall Study|Did not receive allocated intervention|6|||
94332803|NCT01359046|323000767|FG000|Overall Study|Physician Decision|1|||
94332804|NCT01359046|323000768|FG001|Overall Study|Physician Decision|11|||
94332805|NCT00802867|323000771|FG000|Overall Study|Lost to Follow-up|6|||
94332806|NCT00802867|323000771|FG000|Overall Study|Protocol Violation|6|||
94332807|NCT00802867|323000771|FG000|Overall Study|Withdrawal by Subject|1|||
94332808|NCT00563368|323000774|FG000|Overall Study|Lost to Follow-up|14|||
94332809|NCT00563368|323000775|FG001|Overall Study|Lost to Follow-up|14|||
94332810|NCT00563368|323000776|FG002|Overall Study|Lost to Follow-up|12|||
94332811|NCT00563368|323000777|FG003|Overall Study|Lost to Follow-up|6|||
94332812|NCT00563368|323000778|FG004|Overall Study|Lost to Follow-up|9|||
94332813|NCT00563368|323000779|FG005|Overall Study|Lost to Follow-up|8|||
94332814|NCT00563368|323000780|FG006|Overall Study|Lost to Follow-up|9|||
94332815|NCT00563368|323000774|FG000|Overall Study|Adverse Event|3|||
94332816|NCT00563368|323000775|FG001|Overall Study|Adverse Event|4|||
94332817|NCT00563368|323000776|FG002|Overall Study|Adverse Event|5|||
94332818|NCT00563368|323000777|FG003|Overall Study|Adverse Event|9|||
94332819|NCT00563368|323000778|FG004|Overall Study|Adverse Event|6|||
94332820|NCT00563368|323000779|FG005|Overall Study|Adverse Event|10|||
94332821|NCT00563368|323000780|FG006|Overall Study|Adverse Event|17|||
94332822|NCT00563368|323000774|FG000|Overall Study|Withdrawal by Subject|11|||
94332823|NCT00563368|323000775|FG001|Overall Study|Withdrawal by Subject|6|||
94332824|NCT00563368|323000776|FG002|Overall Study|Withdrawal by Subject|5|||
94332825|NCT00563368|323000777|FG003|Overall Study|Withdrawal by Subject|7|||
94332826|NCT00563368|323000778|FG004|Overall Study|Withdrawal by Subject|8|||
94332827|NCT00563368|323000779|FG005|Overall Study|Withdrawal by Subject|5|||
94227013|NCT00796614|322625688|FG002|Overall Study|Adverse Event|0|||
94227014|NCT00796614|322625689|FG003|Overall Study|Adverse Event|0|||
94227015|NCT00796614|322625686|FG000|Overall Study|Protocol Violation|0|||
94227016|NCT00796614|322625687|FG001|Overall Study|Protocol Violation|0|||
94227017|NCT00796614|322625688|FG002|Overall Study|Protocol Violation|2|||
94227018|NCT00796614|322625689|FG003|Overall Study|Protocol Violation|0|||
94227019|NCT00796614|322625686|FG000|Overall Study|Lost to Follow-up|2|||
94227020|NCT00796614|322625687|FG001|Overall Study|Lost to Follow-up|2|||
94227021|NCT00796614|322625688|FG002|Overall Study|Lost to Follow-up|1|||
94227022|NCT00796614|322625689|FG003|Overall Study|Lost to Follow-up|0|||
94227023|NCT00796614|322625686|FG000|Overall Study|Withdrawal by Subject|1|||
94227024|NCT00796614|322625687|FG001|Overall Study|Withdrawal by Subject|0|||
94227025|NCT00796614|322625688|FG002|Overall Study|Withdrawal by Subject|0|||
94227026|NCT00796614|322625689|FG003|Overall Study|Withdrawal by Subject|1|||
94227027|NCT00796614|322625686|FG000|Overall Study|Other than stated|1|||
94227028|NCT00796614|322625687|FG001|Overall Study|Other than stated|0|||
94227029|NCT00796614|322625688|FG002|Overall Study|Other than stated|0|||
94227030|NCT00796614|322625689|FG003|Overall Study|Other than stated|0|||
94227031|NCT00509821|322625690|FG000|Study Period 1 (Induction)|Death|0|||
94227032|NCT00509821|322625691|FG001|Study Period 1 (Induction)|Death|1|||
94227033|NCT00509821|322625690|FG000|Study Period 1 (Induction)|Adverse Event|0|||
94227034|NCT00509821|322625691|FG001|Study Period 1 (Induction)|Adverse Event|2|||
94227035|NCT00509821|322625690|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
94227036|NCT00509821|322625691|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
94227037|NCT00740597|322625692|FG000|Overall Study|insurance would not cover treatment|1|||
94227038|NCT00552513|322625694|FG000|Overall Study|Lost to Follow-up|5|||
94227039|NCT00552513|322625695|FG001|Overall Study|Lost to Follow-up|1|||
94227040|NCT01960348|322625696|FG000|Overall Study|Adverse event, not serious|2|||
94227041|NCT01960348|322625697|FG001|Overall Study|Adverse event, not serious|2|||
94227042|NCT01960348|322625696|FG000|Overall Study|Adverse event, serious fatal|6|||
94227043|NCT01960348|322625697|FG001|Overall Study|Adverse event, serious fatal|5|||
94227044|NCT01960348|322625696|FG000|Overall Study|Adverse event, serious non-fatal|0|||
94227045|NCT01960348|322625697|FG001|Overall Study|Adverse event, serious non-fatal|3|||
94227046|NCT01960348|322625696|FG000|Overall Study|Withdrawal by Subject|1|||
94227047|NCT01960348|322625697|FG001|Overall Study|Withdrawal by Subject|11|||
94227048|NCT01960348|322625696|FG000|Overall Study|Physician Decision|0|||
94227049|NCT01960348|322625697|FG001|Overall Study|Physician Decision|1|||
94227050|NCT01960348|322625696|FG000|Overall Study|Protocol Violation|1|||
94227051|NCT01960348|322625697|FG001|Overall Study|Protocol Violation|0|||
94227052|NCT01580995|322625698|FG000|Overall Study|Lost to Follow-up|2|||
94227053|NCT01580995|322625699|FG001|Overall Study|Lost to Follow-up|2|||
94227054|NCT04140266|322625705|FG000|Overall Study|Physician Decision|2|||
94227055|NCT04140266|322625706|FG001|Overall Study|Physician Decision|0|||
94227056|NCT04140266|322625705|FG000|Overall Study|Withdrawal by Subject|4|||
94227057|NCT04140266|322625706|FG001|Overall Study|Withdrawal by Subject|2|||
94227058|NCT01990313|322625707|FG000|Overall Study|Lost to Follow-up|1|||
94227059|NCT00329550|322625708|FG000|Overall Study|Adverse Event|3|||
94227060|NCT00329550|322625709|FG001|Overall Study|Adverse Event|4|||
94227061|NCT00329550|322625710|FG002|Overall Study|Adverse Event|2|||
94227062|NCT00329550|322625708|FG000|Overall Study|Withdrawal of Consent|1|||
94227063|NCT00329550|322625709|FG001|Overall Study|Withdrawal of Consent|0|||
94227064|NCT00329550|322625710|FG002|Overall Study|Withdrawal of Consent|1|||
94227065|NCT00329550|322625708|FG000|Overall Study|Due to Relocation|0|||
94227066|NCT00329550|322625709|FG001|Overall Study|Due to Relocation|0|||
94227067|NCT00329550|322625710|FG002|Overall Study|Due to Relocation|1|||
94227068|NCT02466243|322625711|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
94227069|NCT02466243|322625712|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
94227070|NCT02466243|322625711|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
94227071|NCT02466243|322625712|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
94227072|NCT02466243|322625711|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
94227073|NCT02466243|322625712|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
94227074|NCT02466243|322625711|FG000|Part B Open-label Treatment Period|Missing|2|||
94227075|NCT02466243|322625712|FG001|Part B Open-label Treatment Period|Missing|2|||
94227076|NCT00477464|322625713|FG000|Overall Study|Lost to Follow-up|1|||
94227077|NCT00477464|322625713|FG000|Overall Study|Death|36|||
94227078|NCT00477464|322625713|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
94227079|NCT00488319|322625714|FG000|Overall Study|Adverse Event|1|||
94227080|NCT00488319|322625715|FG001|Overall Study|Adverse Event|2|||
94227081|NCT00488319|322625716|FG002|Overall Study|Adverse Event|23|||
94227082|NCT00488319|322625714|FG000|Overall Study|Lack of Efficacy|6|||
94227083|NCT00488319|322625715|FG001|Overall Study|Lack of Efficacy|12|||
94227084|NCT00488319|322625716|FG002|Overall Study|Lack of Efficacy|27|||
94227085|NCT00488319|322625714|FG000|Overall Study|Lost to Follow-up|3|||
94227086|NCT00488319|322625715|FG001|Overall Study|Lost to Follow-up|5|||
94227087|NCT00488319|322625716|FG002|Overall Study|Lost to Follow-up|16|||
94227088|NCT00488319|322625714|FG000|Overall Study|Withdrawal by Subject|5|||
94227089|NCT00488319|322625715|FG001|Overall Study|Withdrawal by Subject|20|||
94332828|NCT00563368|323000780|FG006|Overall Study|Withdrawal by Subject|4|||
94332829|NCT00563368|323000774|FG000|Overall Study|protocol non-compliance|1|||
94332830|NCT00563368|323000775|FG001|Overall Study|protocol non-compliance|1|||
94332831|NCT00563368|323000776|FG002|Overall Study|protocol non-compliance|2|||
94332832|NCT00563368|323000777|FG003|Overall Study|protocol non-compliance|1|||
94332833|NCT00563368|323000778|FG004|Overall Study|protocol non-compliance|0|||
94332834|NCT00563368|323000779|FG005|Overall Study|protocol non-compliance|1|||
94332835|NCT00563368|323000780|FG006|Overall Study|protocol non-compliance|3|||
94332836|NCT00563368|323000774|FG000|Overall Study|Pregnancy|1|||
94332837|NCT00563368|323000775|FG001|Overall Study|Pregnancy|0|||
94332838|NCT00563368|323000776|FG002|Overall Study|Pregnancy|1|||
94332839|NCT00563368|323000777|FG003|Overall Study|Pregnancy|2|||
94332840|NCT00563368|323000778|FG004|Overall Study|Pregnancy|1|||
94332841|NCT00563368|323000779|FG005|Overall Study|Pregnancy|2|||
94332842|NCT00563368|323000780|FG006|Overall Study|Pregnancy|0|||
94332843|NCT00563368|323000774|FG000|Overall Study|requirement for restricted medication|0|||
94332844|NCT00563368|323000775|FG001|Overall Study|requirement for restricted medication|0|||
94332845|NCT00563368|323000776|FG002|Overall Study|requirement for restricted medication|2|||
94332846|NCT00563368|323000777|FG003|Overall Study|requirement for restricted medication|0|||
94332847|NCT00563368|323000778|FG004|Overall Study|requirement for restricted medication|0|||
94332848|NCT00563368|323000779|FG005|Overall Study|requirement for restricted medication|0|||
94332849|NCT00563368|323000780|FG006|Overall Study|requirement for restricted medication|0|||
94332850|NCT00563368|323000774|FG000|Overall Study|Other|5|||
94332851|NCT00563368|323000775|FG001|Overall Study|Other|5|||
94332852|NCT00563368|323000776|FG002|Overall Study|Other|3|||
94332853|NCT00563368|323000777|FG003|Overall Study|Other|4|||
94332854|NCT00563368|323000778|FG004|Overall Study|Other|4|||
94332855|NCT00563368|323000779|FG005|Overall Study|Other|4|||
94332856|NCT00563368|323000780|FG006|Overall Study|Other|0|||
94332857|NCT01156532|323000787|FG000|Overall Study|Family Reasons|1|||
94332858|NCT01156532|323000787|FG000|Overall Study|Lost to Follow-up|1|||
94332859|NCT01855945|323000790|FG000|Overall Study|Adverse Event|0|||
94332860|NCT01855945|323000791|FG001|Overall Study|Adverse Event|0|||
94332861|NCT01855945|323000792|FG002|Overall Study|Adverse Event|0|||
94332862|NCT01855945|323000793|FG003|Overall Study|Adverse Event|0|||
94332863|NCT01855945|323000794|FG004|Overall Study|Adverse Event|0|||
94332864|NCT01855945|323000795|FG005|Overall Study|Adverse Event|0|||
94332865|NCT01855945|323000796|FG006|Overall Study|Adverse Event|1|||
94332866|NCT01855945|323000797|FG007|Overall Study|Adverse Event|0|||
94332867|NCT01855945|323000798|FG008|Overall Study|Adverse Event|0|||
94332868|NCT01855945|323000799|FG009|Overall Study|Adverse Event|0|||
94332869|NCT01855945|323000800|FG010|Overall Study|Adverse Event|0|||
94332870|NCT01855945|323000801|FG011|Overall Study|Adverse Event|0|||
94332871|NCT01855945|323000790|FG000|Overall Study|Death|0|||
94332872|NCT01855945|323000791|FG001|Overall Study|Death|0|||
94332873|NCT01855945|323000792|FG002|Overall Study|Death|0|||
94332874|NCT01855945|323000793|FG003|Overall Study|Death|0|||
94332875|NCT01855945|323000794|FG004|Overall Study|Death|0|||
94332876|NCT01855945|323000795|FG005|Overall Study|Death|0|||
94332877|NCT01855945|323000796|FG006|Overall Study|Death|2|||
94332878|NCT01855945|323000797|FG007|Overall Study|Death|0|||
94332879|NCT01855945|323000798|FG008|Overall Study|Death|0|||
94332880|NCT01855945|323000799|FG009|Overall Study|Death|0|||
94332881|NCT01855945|323000800|FG010|Overall Study|Death|0|||
94332882|NCT01855945|323000801|FG011|Overall Study|Death|0|||
94332883|NCT01855945|323000790|FG000|Overall Study|Lost to Follow-up|11|||
94332884|NCT01855945|323000791|FG001|Overall Study|Lost to Follow-up|10|||
94332885|NCT01855945|323000792|FG002|Overall Study|Lost to Follow-up|7|||
94332886|NCT01855945|323000793|FG003|Overall Study|Lost to Follow-up|3|||
94332887|NCT01855945|323000794|FG004|Overall Study|Lost to Follow-up|0|||
94332888|NCT01855945|323000795|FG005|Overall Study|Lost to Follow-up|3|||
94332889|NCT01855945|323000796|FG006|Overall Study|Lost to Follow-up|4|||
94332890|NCT01855945|323000797|FG007|Overall Study|Lost to Follow-up|7|||
94332891|NCT01855945|323000798|FG008|Overall Study|Lost to Follow-up|2|||
94332892|NCT01855945|323000799|FG009|Overall Study|Lost to Follow-up|0|||
94332893|NCT01855945|323000800|FG010|Overall Study|Lost to Follow-up|0|||
94332894|NCT01855945|323000801|FG011|Overall Study|Lost to Follow-up|2|||
94332895|NCT01855945|323000790|FG000|Overall Study|Other - Unclassified|1|||
94332896|NCT01855945|323000791|FG001|Overall Study|Other - Unclassified|1|||
94332897|NCT01855945|323000792|FG002|Overall Study|Other - Unclassified|1|||
94332898|NCT01855945|323000793|FG003|Overall Study|Other - Unclassified|0|||
94332899|NCT01855945|323000794|FG004|Overall Study|Other - Unclassified|0|||
94332900|NCT01855945|323000795|FG005|Overall Study|Other - Unclassified|0|||
94332901|NCT01855945|323000796|FG006|Overall Study|Other - Unclassified|2|||
94332902|NCT01855945|323000797|FG007|Overall Study|Other - Unclassified|1|||
94332903|NCT01855945|323000798|FG008|Overall Study|Other - Unclassified|0|||
94332904|NCT01855945|323000799|FG009|Overall Study|Other - Unclassified|0|||
94332905|NCT01855945|323000800|FG010|Overall Study|Other - Unclassified|1|||
94332906|NCT01855945|323000801|FG011|Overall Study|Other - Unclassified|0|||
94332907|NCT01855945|323000790|FG000|Overall Study|Withdrawal by Subject|4|||
94332908|NCT01855945|323000791|FG001|Overall Study|Withdrawal by Subject|0|||
94332909|NCT01855945|323000792|FG002|Overall Study|Withdrawal by Subject|4|||
94332910|NCT01855945|323000793|FG003|Overall Study|Withdrawal by Subject|1|||
94332911|NCT01855945|323000794|FG004|Overall Study|Withdrawal by Subject|1|||
94332912|NCT01855945|323000795|FG005|Overall Study|Withdrawal by Subject|0|||
94332913|NCT01855945|323000796|FG006|Overall Study|Withdrawal by Subject|1|||
94332914|NCT01855945|323000797|FG007|Overall Study|Withdrawal by Subject|0|||
94332915|NCT01855945|323000798|FG008|Overall Study|Withdrawal by Subject|0|||
94332916|NCT01855945|323000799|FG009|Overall Study|Withdrawal by Subject|2|||
94332917|NCT01855945|323000800|FG010|Overall Study|Withdrawal by Subject|4|||
94332918|NCT01855945|323000801|FG011|Overall Study|Withdrawal by Subject|1|||
94332919|NCT01135017|323000802|FG000|Overall Study|Adverse Event|3|||
94332920|NCT01135017|323000803|FG001|Overall Study|Adverse Event|8|||
94332921|NCT01135017|323000802|FG000|Overall Study|Other than above|3|||
94332922|NCT01135017|323000803|FG001|Overall Study|Other than above|4|||
94332923|NCT00050622|323000804|FG000|Overall Study|Adverse Event|1|||
94332924|NCT01342952|323000805|FG000|Overall Study|Adverse Event|0|||
94332925|NCT01342952|323000806|FG001|Overall Study|Adverse Event|5|||
94332926|NCT01342952|323000807|FG002|Overall Study|Adverse Event|1|||
94332927|NCT01342952|323000808|FG003|Overall Study|Adverse Event|0|||
94332928|NCT01342952|323000805|FG000|Overall Study|Lost to Follow-up|0|||
94332929|NCT01342952|323000806|FG001|Overall Study|Lost to Follow-up|2|||
94332930|NCT01342952|323000807|FG002|Overall Study|Lost to Follow-up|0|||
94332931|NCT01342952|323000808|FG003|Overall Study|Lost to Follow-up|0|||
94332932|NCT01342952|323000805|FG000|Overall Study|Withdrawal by Subject|1|||
94332933|NCT01342952|323000806|FG001|Overall Study|Withdrawal by Subject|1|||
94332934|NCT01342952|323000807|FG002|Overall Study|Withdrawal by Subject|0|||
94332935|NCT01342952|323000808|FG003|Overall Study|Withdrawal by Subject|0|||
94332936|NCT01342952|323000805|FG000|Overall Study|Physician Decision|3|||
94332937|NCT01342952|323000806|FG001|Overall Study|Physician Decision|3|||
94332938|NCT01342952|323000807|FG002|Overall Study|Physician Decision|1|||
94332939|NCT01342952|323000808|FG003|Overall Study|Physician Decision|0|||
94332940|NCT02156804|323000809|FG000|Overall Study|Withdrawal by Subject|1|||
94332941|NCT04581863|323000810|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
94332942|NCT04581863|323000811|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
94332943|NCT02920450|323000812|FG000|Overall Study|Death|1|||
94332944|NCT02920450|323000813|FG001|Overall Study|Death|0|||
94332945|NCT02920450|323000814|FG002|Overall Study|Death|0|||
94332946|NCT02920450|323000815|FG003|Overall Study|Death|0|||
94332947|NCT02920450|323000812|FG000|Overall Study|Withdrawal by Subject|1|||
94332948|NCT02920450|323000813|FG001|Overall Study|Withdrawal by Subject|0|||
94332949|NCT02920450|323000814|FG002|Overall Study|Withdrawal by Subject|0|||
94332950|NCT02920450|323000815|FG003|Overall Study|Withdrawal by Subject|0|||
94332951|NCT00225212|323000816|FG000|Overall Study|Disease progression|2|||
94332952|NCT00225212|323000816|FG000|Overall Study|Death|1|||
94332953|NCT00225212|323000816|FG000|Overall Study|Adverse Event|2|||
94332954|NCT00225212|323000816|FG000|Overall Study|Intercurrent illness|1|||
94332955|NCT01125293|323000817|FG000|Overall Study|Disease Progression|1|||
94332956|NCT01125293|323000818|FG001|Overall Study|Disease Progression|3|||
94332957|NCT01125293|323000819|FG002|Overall Study|Disease Progression|4|||
94332958|NCT01125293|323000820|FG003|Overall Study|Disease Progression|3|||
94332959|NCT01125293|323000821|FG004|Overall Study|Disease Progression|5|||
94332960|NCT01125293|323000822|FG005|Overall Study|Disease Progression|12|||
94332961|NCT01125293|323000817|FG000|Overall Study|Adverse Event|1|||
94332962|NCT01125293|323000818|FG001|Overall Study|Adverse Event|0|||
94332963|NCT01125293|323000819|FG002|Overall Study|Adverse Event|0|||
94332964|NCT01125293|323000820|FG003|Overall Study|Adverse Event|0|||
94332965|NCT01125293|323000821|FG004|Overall Study|Adverse Event|2|||
94332966|NCT01125293|323000822|FG005|Overall Study|Adverse Event|8|||
94332967|NCT01125293|323000817|FG000|Overall Study|Symptomatic Deterioration|1|||
94332968|NCT01125293|323000818|FG001|Overall Study|Symptomatic Deterioration|0|||
94332969|NCT01125293|323000819|FG002|Overall Study|Symptomatic Deterioration|0|||
94332970|NCT01125293|323000820|FG003|Overall Study|Symptomatic Deterioration|0|||
94332971|NCT01125293|323000821|FG004|Overall Study|Symptomatic Deterioration|0|||
94332972|NCT01125293|323000822|FG005|Overall Study|Symptomatic Deterioration|0|||
94332973|NCT01125293|323000817|FG000|Overall Study|Death|0|||
94332974|NCT01125293|323000818|FG001|Overall Study|Death|0|||
94332975|NCT01125293|323000819|FG002|Overall Study|Death|0|||
94332976|NCT01125293|323000820|FG003|Overall Study|Death|0|||
94332977|NCT01125293|323000821|FG004|Overall Study|Death|1|||
94332978|NCT01125293|323000822|FG005|Overall Study|Death|0|||
94332979|NCT01125293|323000817|FG000|Overall Study|Withdrawal by Subject|0|||
94332980|NCT01125293|323000818|FG001|Overall Study|Withdrawal by Subject|0|||
94332981|NCT01125293|323000819|FG002|Overall Study|Withdrawal by Subject|0|||
94332982|NCT01125293|323000820|FG003|Overall Study|Withdrawal by Subject|0|||
94332983|NCT01125293|323000821|FG004|Overall Study|Withdrawal by Subject|2|||
94332984|NCT01125293|323000822|FG005|Overall Study|Withdrawal by Subject|1|||
94332985|NCT01125293|323000817|FG000|Overall Study|Physician Decision|0|||
94332986|NCT01125293|323000818|FG001|Overall Study|Physician Decision|0|||
94332987|NCT01125293|323000819|FG002|Overall Study|Physician Decision|0|||
94332988|NCT01125293|323000820|FG003|Overall Study|Physician Decision|0|||
94332989|NCT01125293|323000821|FG004|Overall Study|Physician Decision|0|||
94332990|NCT01125293|323000822|FG005|Overall Study|Physician Decision|2|||
94332991|NCT03820726|323000825|FG000|Overall Study|Other than listed|23|||
94332992|NCT03820726|323000825|FG000|Overall Study|Withdrawal by Subject|37|||
94332993|NCT03820726|323000825|FG000|Overall Study|Lost to Follow-up|3|||
94332994|NCT03820726|323000825|FG000|Overall Study|Protocol deviation|1|||
94332995|NCT03820726|323000825|FG000|Overall Study|Adverse Event|146|||
94332996|NCT03820726|323000825|FG000|Overall Study|Not treated|1|||
94332997|NCT01406652|323000826|FG000|Overall Study|Lost-to-follow-up|3|||
94332998|NCT01406652|323000827|FG001|Overall Study|Lost-to-follow-up|4|||
94332999|NCT01406652|323000826|FG000|Overall Study|Withdrawal by Subject|2|||
94333000|NCT01406652|323000827|FG001|Overall Study|Withdrawal by Subject|2|||
94333001|NCT01406652|323000826|FG000|Overall Study|Insufficient follow-up|5|||
94333002|NCT01406652|323000827|FG001|Overall Study|Insufficient follow-up|4|||
94333003|NCT01406652|323000826|FG000|Overall Study|Infection not sure|10|||
94333004|NCT01406652|323000827|FG001|Overall Study|Infection not sure|10|||
94333005|NCT04179786|323000829|FG000|Overall Study|Withdrawal by Subject|8|||
94333006|NCT02228564|323000830|FG000|Overall Study|Withdrawal by Subject|10|||
94333007|NCT02228564|323000830|FG000|Overall Study|Death|11|||
94333008|NCT02228564|323000830|FG000|Overall Study|Physician Decision|5|||
94333009|NCT02228564|323000830|FG000|Overall Study|Lost to Follow-up|17|||
94333010|NCT02228564|323000830|FG000|Overall Study|Other|6|||
94333011|NCT01455415|323000833|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
94227090|NCT00488319|322625716|FG002|Overall Study|Withdrawal by Subject|44|||
94227091|NCT00488319|322625714|FG000|Overall Study|Other reasons for withdrawal|0|||
94227092|NCT00488319|322625715|FG001|Overall Study|Other reasons for withdrawal|4|||
94227093|NCT00488319|322625716|FG002|Overall Study|Other reasons for withdrawal|12|||
94227094|NCT01649557|322625723|FG000|Overall Study|Lost to Follow-up|5|||
94227095|NCT01649557|322625724|FG001|Overall Study|Lost to Follow-up|0|||
94227096|NCT01649557|322625725|FG002|Overall Study|Lost to Follow-up|3|||
94227097|NCT01649557|322625723|FG000|Overall Study|Adverse Event|7|||
94227098|NCT01649557|322625724|FG001|Overall Study|Adverse Event|5|||
94227099|NCT01649557|322625725|FG002|Overall Study|Adverse Event|1|||
94227100|NCT01649557|322625723|FG000|Overall Study|Met withdrawal criteria|4|||
94227101|NCT01649557|322625724|FG001|Overall Study|Met withdrawal criteria|0|||
94227102|NCT01649557|322625725|FG002|Overall Study|Met withdrawal criteria|0|||
94227103|NCT01649557|322625723|FG000|Overall Study|Physician Decision|8|||
94227104|NCT01649557|322625724|FG001|Overall Study|Physician Decision|2|||
94227105|NCT01649557|322625725|FG002|Overall Study|Physician Decision|1|||
94227106|NCT01649557|322625723|FG000|Overall Study|Withdrawal by Subject|15|||
94227107|NCT01649557|322625724|FG001|Overall Study|Withdrawal by Subject|5|||
94227108|NCT01649557|322625725|FG002|Overall Study|Withdrawal by Subject|4|||
94227109|NCT01649557|322625723|FG000|Overall Study|Protocol deviation|0|||
94227110|NCT01649557|322625724|FG001|Overall Study|Protocol deviation|2|||
94227111|NCT01649557|322625725|FG002|Overall Study|Protocol deviation|0|||
94227112|NCT01649557|322625723|FG000|Overall Study|Lack of Efficacy|5|||
94227113|NCT01649557|322625724|FG001|Overall Study|Lack of Efficacy|0|||
94227114|NCT01649557|322625725|FG002|Overall Study|Lack of Efficacy|0|||
94227115|NCT04544865|322625726|FG000|Overall Study|Death|0|||
94227116|NCT04544865|322625727|FG001|Overall Study|Death|2|||
94227117|NCT04544865|322625726|FG000|Overall Study|Lost to Follow-up|11|||
94227118|NCT04544865|322625727|FG001|Overall Study|Lost to Follow-up|7|||
94227119|NCT04544865|322625726|FG000|Overall Study|Withdrawal by Subject|0|||
94227120|NCT04544865|322625727|FG001|Overall Study|Withdrawal by Subject|1|||
94227121|NCT04544865|322625726|FG000|Overall Study|Other|0|||
94227122|NCT04544865|322625727|FG001|Overall Study|Other|1|||
94227123|NCT00706914|322625728|FG000|Overall Study|Lack of Efficacy|0|||
94227124|NCT00706914|322625729|FG001|Overall Study|Lack of Efficacy|1|||
94227125|NCT00706914|322625730|FG002|Overall Study|Lack of Efficacy|0|||
94227126|NCT00706914|322625728|FG000|Overall Study|Lost to Follow-up|1|||
94227127|NCT00706914|322625729|FG001|Overall Study|Lost to Follow-up|0|||
94227128|NCT00706914|322625730|FG002|Overall Study|Lost to Follow-up|0|||
94227129|NCT00706914|322625728|FG000|Overall Study|Adverse Event|2|||
94227130|NCT00706914|322625729|FG001|Overall Study|Adverse Event|2|||
94227131|NCT00706914|322625730|FG002|Overall Study|Adverse Event|0|||
94227132|NCT00706914|322625728|FG000|Overall Study|Protocol Violation|3|||
94333012|NCT01455415|323000834|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
94333013|NCT01455415|323000833|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
94333014|NCT01455415|323000834|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
94333015|NCT01455415|323000833|FG000|Period 1|Drug Error not Associated to AE|0|||
94333016|NCT01455415|323000834|FG001|Period 1|Drug Error not Associated to AE|1|||
94333017|NCT01455415|323000833|FG000|Period 1|AE Not Related to Study Drug|2|||
94333018|NCT01455415|323000834|FG001|Period 1|AE Not Related to Study Drug|6|||
94227133|NCT00706914|322625729|FG001|Overall Study|Protocol Violation|1|||
94227134|NCT00706914|322625730|FG002|Overall Study|Protocol Violation|1|||
94227135|NCT03924947|322625732|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
94333019|NCT01455415|323000833|FG000|Period 1|Withdrawal by Subject|4|||
94333020|NCT01455415|323000834|FG001|Period 1|Withdrawal by Subject|5|||
94333021|NCT01455415|323000833|FG000|Period 1|Unspecified Reason|1|||
94333022|NCT01455415|323000834|FG001|Period 1|Unspecified Reason|1|||
94333023|NCT01455415|323000833|FG000|Period 1|Protocol Violation|0|||
94333024|NCT01455415|323000834|FG001|Period 1|Protocol Violation|2|||
94333025|NCT01455415|323000833|FG000|Washout|AE Related to Study Drug|2|||
94333026|NCT01455415|323000834|FG001|Washout|AE Related to Study Drug|0|||
94333027|NCT01455415|323000833|FG000|Washout|Lost to Follow-up|1|||
94333028|NCT01455415|323000834|FG001|Washout|Lost to Follow-up|0|||
94333029|NCT01455415|323000833|FG000|Washout|Drug Error not Associated to AE|2|||
94333030|NCT01455415|323000834|FG001|Washout|Drug Error not Associated to AE|1|||
94333031|NCT01455415|323000833|FG000|Washout|AE Not Related to Study Drug|2|||
94333032|NCT01455415|323000834|FG001|Washout|AE Not Related to Study Drug|3|||
94333033|NCT01455415|323000833|FG000|Washout|Unspecified Reason|1|||
94333034|NCT01455415|323000834|FG001|Washout|Unspecified Reason|2|||
94333035|NCT01455415|323000833|FG000|Washout|Protocol Violation|0|||
94333036|NCT01455415|323000834|FG001|Washout|Protocol Violation|1|||
94333037|NCT01455415|323000833|FG000|Period 2|AE Related to Study Drug|1|||
94333038|NCT01455415|323000834|FG001|Period 2|AE Related to Study Drug|2|||
94333039|NCT01455415|323000833|FG000|Period 2|Lost to Follow-up|2|||
94333040|NCT01455415|323000834|FG001|Period 2|Lost to Follow-up|1|||
94333041|NCT01455415|323000833|FG000|Period 2|AE Not Related to Study Drug|2|||
94333042|NCT01455415|323000834|FG001|Period 2|AE Not Related to Study Drug|1|||
94333043|NCT01455415|323000833|FG000|Period 2|Lack of Efficacy|2|||
94333044|NCT01455415|323000834|FG001|Period 2|Lack of Efficacy|0|||
94333045|NCT01455415|323000833|FG000|Period 2|Withdrawal by Subject|2|||
94333046|NCT01455415|323000834|FG001|Period 2|Withdrawal by Subject|3|||
94333047|NCT01455415|323000833|FG000|Period 2|Unspecified Reason|2|||
94333048|NCT01455415|323000834|FG001|Period 2|Unspecified Reason|3|||
94333049|NCT01455415|323000833|FG000|Period 2|Protocol Violation|2|||
94333050|NCT01455415|323000834|FG001|Period 2|Protocol Violation|0|||
94333051|NCT01455415|323000833|FG000|Follow-up|AE Related to Study Drug|0|||
94333052|NCT01455415|323000834|FG001|Follow-up|AE Related to Study Drug|1|||
94333053|NCT01455415|323000833|FG000|Follow-up|Lack of Efficacy|0|||
94333054|NCT01455415|323000834|FG001|Follow-up|Lack of Efficacy|1|||
94333055|NCT01455415|323000833|FG000|Follow-up|Withdrawal by Subject|2|||
94333056|NCT01455415|323000834|FG001|Follow-up|Withdrawal by Subject|0|||
94333057|NCT01455415|323000833|FG000|Follow-up|Unspecified Reason|1|||
94333058|NCT01455415|323000834|FG001|Follow-up|Unspecified Reason|0|||
94333059|NCT03205982|323000835|FG000|Overall Study|Lost to Follow-up|20|||
94333060|NCT03205982|323000836|FG001|Overall Study|Lost to Follow-up|19|||
94333061|NCT03205982|323000835|FG000|Overall Study|Withdrawal by Subject|4|||
94333062|NCT03205982|323000836|FG001|Overall Study|Withdrawal by Subject|3|||
94333063|NCT03205982|323000835|FG000|Overall Study|Withdrawal by PI|0|||
94333064|NCT03205982|323000836|FG001|Overall Study|Withdrawal by PI|1|||
94333065|NCT00196196|323000840|FG000|Overall Study|Withdrawal by Subject|2|||
94333066|NCT00196196|323000840|FG000|Overall Study|Did not have required condition (hydroce|5|||
94333067|NCT01468701|323000842|FG000|Overall Study|Not eligible|91|||
94333068|NCT01468701|323000843|FG001|Overall Study|Not eligible|140|||
94333069|NCT01468701|323000844|FG002|Overall Study|Not eligible|29|||
94333070|NCT01468701|323000845|FG003|Overall Study|Not eligible|12|||
94333071|NCT01468701|323000846|FG004|Overall Study|Not eligible|22|||
94333072|NCT01468701|323000847|FG005|Overall Study|Not eligible|2|||
94333073|NCT01468701|323000848|FG006|Overall Study|Not eligible|39|||
94333074|NCT01468701|323000849|FG007|Overall Study|Not eligible|1|||
94333075|NCT01468701|323000850|FG008|Overall Study|Not eligible|40|||
94333076|NCT01468701|323000851|FG009|Overall Study|Not eligible|126|||
94333077|NCT01468701|323000852|FG010|Overall Study|Not eligible|39|||
94333078|NCT01468701|323000853|FG011|Overall Study|Not eligible|33|||
94333079|NCT01468701|323000854|FG012|Overall Study|Not eligible|1|||
94333080|NCT01468701|323000855|FG013|Overall Study|Not eligible|19|||
94333081|NCT01468701|323000856|FG014|Overall Study|Not eligible|1|||
94333082|NCT01468701|323000857|FG015|Overall Study|Not eligible|32|||
94333083|NCT01468701|323000858|FG016|Overall Study|Not eligible|0|||
94333084|NCT01468701|323000842|FG000|Overall Study|Lost to Follow-up|306|||
94333085|NCT01468701|323000843|FG001|Overall Study|Lost to Follow-up|0|||
94333086|NCT01468701|323000844|FG002|Overall Study|Lost to Follow-up|0|||
94333087|NCT01468701|323000845|FG003|Overall Study|Lost to Follow-up|0|||
94333088|NCT01468701|323000846|FG004|Overall Study|Lost to Follow-up|0|||
94333089|NCT01468701|323000847|FG005|Overall Study|Lost to Follow-up|0|||
94333090|NCT01468701|323000848|FG006|Overall Study|Lost to Follow-up|0|||
94333091|NCT01468701|323000849|FG007|Overall Study|Lost to Follow-up|0|||
94333092|NCT01468701|323000850|FG008|Overall Study|Lost to Follow-up|215|||
94333093|NCT01468701|323000851|FG009|Overall Study|Lost to Follow-up|309|||
94333094|NCT01468701|323000852|FG010|Overall Study|Lost to Follow-up|224|||
94333095|NCT01468701|323000853|FG011|Overall Study|Lost to Follow-up|212|||
94333096|NCT01468701|323000854|FG012|Overall Study|Lost to Follow-up|11|||
94333097|NCT01468701|323000855|FG013|Overall Study|Lost to Follow-up|164|||
94333098|NCT01468701|323000856|FG014|Overall Study|Lost to Follow-up|17|||
94333099|NCT01468701|323000857|FG015|Overall Study|Lost to Follow-up|127|||
94333100|NCT01468701|323000858|FG016|Overall Study|Lost to Follow-up|1|||
94333101|NCT01468701|323000842|FG000|Overall Study|Withdrawal by Subject|165|||
94333102|NCT01468701|323000843|FG001|Overall Study|Withdrawal by Subject|0|||
94333103|NCT01468701|323000844|FG002|Overall Study|Withdrawal by Subject|0|||
94333104|NCT01468701|323000845|FG003|Overall Study|Withdrawal by Subject|0|||
94333105|NCT01468701|323000846|FG004|Overall Study|Withdrawal by Subject|0|||
94333106|NCT01468701|323000847|FG005|Overall Study|Withdrawal by Subject|0|||
94333107|NCT01468701|323000848|FG006|Overall Study|Withdrawal by Subject|0|||
94333108|NCT01468701|323000849|FG007|Overall Study|Withdrawal by Subject|0|||
94333109|NCT01468701|323000850|FG008|Overall Study|Withdrawal by Subject|83|||
94333110|NCT01468701|323000851|FG009|Overall Study|Withdrawal by Subject|88|||
94333111|NCT01468701|323000852|FG010|Overall Study|Withdrawal by Subject|100|||
94333112|NCT01468701|323000853|FG011|Overall Study|Withdrawal by Subject|114|||
94333113|NCT01468701|323000854|FG012|Overall Study|Withdrawal by Subject|9|||
94333114|NCT01468701|323000855|FG013|Overall Study|Withdrawal by Subject|47|||
94333115|NCT01468701|323000856|FG014|Overall Study|Withdrawal by Subject|6|||
94333116|NCT01468701|323000857|FG015|Overall Study|Withdrawal by Subject|31|||
94333117|NCT01468701|323000858|FG016|Overall Study|Withdrawal by Subject|0|||
94333118|NCT01468701|323000842|FG000|Overall Study|Other reasons than listed|437|||
94333119|NCT01468701|323000843|FG001|Overall Study|Other reasons than listed|0|||
94333120|NCT01468701|323000844|FG002|Overall Study|Other reasons than listed|0|||
94333121|NCT01468701|323000845|FG003|Overall Study|Other reasons than listed|0|||
94333122|NCT01468701|323000846|FG004|Overall Study|Other reasons than listed|0|||
94333123|NCT01468701|323000847|FG005|Overall Study|Other reasons than listed|0|||
94333124|NCT01468701|323000848|FG006|Overall Study|Other reasons than listed|0|||
94333125|NCT01468701|323000849|FG007|Overall Study|Other reasons than listed|0|||
94333126|NCT01468701|323000850|FG008|Overall Study|Other reasons than listed|318|||
94333127|NCT01468701|323000851|FG009|Overall Study|Other reasons than listed|658|||
94333128|NCT01468701|323000852|FG010|Overall Study|Other reasons than listed|433|||
94333129|NCT01468701|323000853|FG011|Overall Study|Other reasons than listed|504|||
94333130|NCT01468701|323000854|FG012|Overall Study|Other reasons than listed|28|||
94333131|NCT01468701|323000855|FG013|Overall Study|Other reasons than listed|239|||
94333132|NCT01468701|323000856|FG014|Overall Study|Other reasons than listed|39|||
94333133|NCT01468701|323000857|FG015|Overall Study|Other reasons than listed|172|||
94333134|NCT01468701|323000858|FG016|Overall Study|Other reasons than listed|0|||
94333135|NCT01468701|323000842|FG000|Overall Study|No end of study case report form|0|||
94333136|NCT01468701|323000843|FG001|Overall Study|No end of study case report form|0|||
94333137|NCT01468701|323000844|FG002|Overall Study|No end of study case report form|0|||
94333138|NCT01468701|323000845|FG003|Overall Study|No end of study case report form|0|||
94333139|NCT01468701|323000846|FG004|Overall Study|No end of study case report form|0|||
94333140|NCT01468701|323000847|FG005|Overall Study|No end of study case report form|0|||
94333141|NCT01468701|323000848|FG006|Overall Study|No end of study case report form|0|||
94333142|NCT01468701|323000849|FG007|Overall Study|No end of study case report form|0|||
94333143|NCT01468701|323000850|FG008|Overall Study|No end of study case report form|4|||
94333144|NCT01468701|323000851|FG009|Overall Study|No end of study case report form|1|||
94333145|NCT01468701|323000852|FG010|Overall Study|No end of study case report form|2|||
94333146|NCT01468701|323000853|FG011|Overall Study|No end of study case report form|3|||
94333147|NCT01468701|323000854|FG012|Overall Study|No end of study case report form|0|||
94333148|NCT01468701|323000855|FG013|Overall Study|No end of study case report form|1|||
94333149|NCT01468701|323000856|FG014|Overall Study|No end of study case report form|0|||
94333150|NCT01468701|323000857|FG015|Overall Study|No end of study case report form|0|||
94333151|NCT01468701|323000858|FG016|Overall Study|No end of study case report form|0|||
94333152|NCT01468701|323000842|FG000|Overall Study|Not being followed up|0|||
94333153|NCT01468701|323000843|FG001|Overall Study|Not being followed up|4963|||
94333154|NCT01468701|323000844|FG002|Overall Study|Not being followed up|1755|||
94333155|NCT01468701|323000845|FG003|Overall Study|Not being followed up|703|||
94333156|NCT01468701|323000846|FG004|Overall Study|Not being followed up|1714|||
94333157|NCT01468701|323000847|FG005|Overall Study|Not being followed up|126|||
94333158|NCT01468701|323000848|FG006|Overall Study|Not being followed up|1170|||
94333159|NCT01468701|323000849|FG007|Overall Study|Not being followed up|4|||
94333160|NCT01468701|323000850|FG008|Overall Study|Not being followed up|0|||
94333161|NCT01468701|323000851|FG009|Overall Study|Not being followed up|0|||
94333162|NCT01468701|323000852|FG010|Overall Study|Not being followed up|0|||
94333163|NCT01468701|323000853|FG011|Overall Study|Not being followed up|0|||
94333164|NCT01468701|323000854|FG012|Overall Study|Not being followed up|0|||
94333165|NCT01468701|323000855|FG013|Overall Study|Not being followed up|0|||
94333166|NCT01468701|323000856|FG014|Overall Study|Not being followed up|0|||
94333167|NCT01468701|323000857|FG015|Overall Study|Not being followed up|0|||
94333168|NCT01468701|323000858|FG016|Overall Study|Not being followed up|0|||
94333169|NCT02332798|323002900|FG000|Overall Study|Unwilling to Participate in Study|0|||
94333170|NCT02332798|323002901|FG001|Overall Study|Unwilling to Participate in Study|1|||
94333171|NCT02332798|323002902|FG002|Overall Study|Unwilling to Participate in Study|1|||
94333172|NCT02332798|323002900|FG000|Overall Study|Positive Urine Drug Test|0|||
94333173|NCT02332798|323002901|FG001|Overall Study|Positive Urine Drug Test|1|||
94333174|NCT02332798|323002902|FG002|Overall Study|Positive Urine Drug Test|0|||
94333175|NCT02332798|323002900|FG000|Overall Study|Abnormal Laboratory Findings|1|||
94333176|NCT02332798|323002901|FG001|Overall Study|Abnormal Laboratory Findings|0|||
94333177|NCT02332798|323002902|FG002|Overall Study|Abnormal Laboratory Findings|0|||
94333178|NCT00595868|323002903|FG000|Overall Study|Lost to Follow-up|45|||
94333179|NCT00595868|323002904|FG001|Overall Study|Lost to Follow-up|50|||
94333180|NCT05406440|323002905|FG000|Overall Study|Lost to Follow-up|0|||
94333181|NCT05406440|323002906|FG001|Overall Study|Lost to Follow-up|0|||
94333182|NCT05406440|323002907|FG002|Overall Study|Lost to Follow-up|0|||
94333183|NCT05406440|323002908|FG003|Overall Study|Lost to Follow-up|0|||
94333184|NCT05406440|323002909|FG004|Overall Study|Lost to Follow-up|2|||
94333185|NCT05406440|323002910|FG005|Overall Study|Lost to Follow-up|0|||
94333186|NCT05406440|323002911|FG006|Overall Study|Lost to Follow-up|0|||
94333187|NCT05406440|323002905|FG000|Overall Study|Physician Decision|0|||
94333188|NCT05406440|323002906|FG001|Overall Study|Physician Decision|0|||
94333189|NCT05406440|323002907|FG002|Overall Study|Physician Decision|0|||
94333190|NCT05406440|323002908|FG003|Overall Study|Physician Decision|0|||
94333191|NCT05406440|323002909|FG004|Overall Study|Physician Decision|1|||
94333192|NCT05406440|323002910|FG005|Overall Study|Physician Decision|0|||
94333193|NCT05406440|323002911|FG006|Overall Study|Physician Decision|0|||
94333194|NCT05406440|323002905|FG000|Overall Study|Withdrawal by Subject|0|||
94333195|NCT05406440|323002906|FG001|Overall Study|Withdrawal by Subject|0|||
94333196|NCT05406440|323002907|FG002|Overall Study|Withdrawal by Subject|0|||
94333197|NCT05406440|323002908|FG003|Overall Study|Withdrawal by Subject|0|||
94333198|NCT05406440|323002909|FG004|Overall Study|Withdrawal by Subject|0|||
94333199|NCT05406440|323002910|FG005|Overall Study|Withdrawal by Subject|2|||
94333200|NCT05406440|323002911|FG006|Overall Study|Withdrawal by Subject|0|||
94333201|NCT01412151|323002912|FG000|Week 0 - 306 - Treatment Period|Death|1|||
94333202|NCT01412151|323002912|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
94333203|NCT01412151|323002912|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
94333204|NCT01412151|323002912|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
94333205|NCT03127852|323002913|FG000|Overall Study|Withdrawal by Subject|4|||
94333206|NCT03127852|323002914|FG001|Overall Study|Withdrawal by Subject|1|||
94333207|NCT03127852|323002913|FG000|Overall Study|Death|1|||
94333208|NCT03127852|323002914|FG001|Overall Study|Death|1|||
94333209|NCT02687711|323002915|FG000|Overall Study|Adverse Event|89|||
94333210|NCT02687711|323002915|FG000|Overall Study|Lack of Efficacy|70|||
94333211|NCT02687711|323002915|FG000|Overall Study|Lost to Follow-up|20|||
94333212|NCT02687711|323002915|FG000|Overall Study|Consent withdrawn|15|||
94333213|NCT02687711|323002915|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
94333214|NCT02687711|323002915|FG000|Overall Study|Too expensive|4|||
94333215|NCT02687711|323002915|FG000|Overall Study|Participant moved abroad|1|||
94333216|NCT02687711|323002915|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
94333217|NCT02687711|323002915|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
94333218|NCT02687711|323002915|FG000|Overall Study|Disliked taste|1|||
94333219|NCT02687711|323002915|FG000|Overall Study|Low mood|1|||
94333220|NCT02687711|323002915|FG000|Overall Study|Side effects|1|||
94333221|NCT02687711|323002915|FG000|Overall Study|Change of Hospital|1|||
94333222|NCT02687711|323002915|FG000|Overall Study|Liver Encephalopathy|1|||
94333223|NCT02687711|323002915|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
94333224|NCT02687711|323002915|FG000|Overall Study|Withdrawn due to intake interruption|1|||
94333225|NCT02687711|323002915|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
94333226|NCT02687711|323002915|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
94333227|NCT02687711|323002915|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
94333228|NCT03750240|323002918|FG000|Overall Study|Technical Difficulties|2|||
94333229|NCT00439725|323002920|FG000|Treatment Period|Withdrawal by Subject|22|||
94333230|NCT00439725|323002921|FG001|Treatment Period|Withdrawal by Subject|19|||
94333231|NCT00439725|323002920|FG000|Treatment Period|Study terminated by sponsor|156|||
94333232|NCT00439725|323002921|FG001|Treatment Period|Study terminated by sponsor|148|||
94333233|NCT00439725|323002920|FG000|Treatment Period|Site closed by investigator|1|||
94333234|NCT00439725|323002921|FG001|Treatment Period|Site closed by investigator|2|||
94333235|NCT00439725|323002920|FG000|Treatment Period|Adverse Event|39|||
94333236|NCT00439725|323002921|FG001|Treatment Period|Adverse Event|18|||
94333237|NCT00439725|323002920|FG000|Treatment Period|Physician Decision|1|||
94333238|NCT00439725|323002921|FG001|Treatment Period|Physician Decision|1|||
94333239|NCT00439725|323002920|FG000|Treatment Period|Protocol Violation|2|||
94333240|NCT00439725|323002921|FG001|Treatment Period|Protocol Violation|1|||
94333241|NCT00439725|323002920|FG000|Treatment Period|Clinical endpoint reached|6|||
94333242|NCT00439725|323002921|FG001|Treatment Period|Clinical endpoint reached|50|||
94333243|NCT00439725|323002920|FG000|Treatment Period|Technical problems|1|||
94333244|NCT00439725|323002921|FG001|Treatment Period|Technical problems|0|||
94333245|NCT00439725|323002920|FG000|Treatment Period|Lost to Follow-up|1|||
94333246|NCT00439725|323002921|FG001|Treatment Period|Lost to Follow-up|1|||
94333247|NCT00439725|323002920|FG000|Treatment Period|Participant convenience|1|||
94333248|NCT00439725|323002921|FG001|Treatment Period|Participant convenience|0|||
94333249|NCT00439725|323002920|FG000|Treatment Period|Protocol driven decision point|1|||
94333250|NCT00439725|323002921|FG001|Treatment Period|Protocol driven decision point|1|||
94333251|NCT00439725|323002920|FG000|Treatment Period|Death|1|||
94333252|NCT00439725|323002921|FG001|Treatment Period|Death|1|||
94333253|NCT00439725|323002920|FG000|Treatment Period|Participant did not receive treatment|4|||
94333254|NCT00439725|323002921|FG001|Treatment Period|Participant did not receive treatment|4|||
94333255|NCT00439725|323002920|FG000|Observational Period|Withdrawal by Subject|2|||
94333256|NCT00439725|323002921|FG001|Observational Period|Withdrawal by Subject|2|||
94333257|NCT00439725|323002920|FG000|Observational Period|Lost to Follow-up|0|||
94333258|NCT00439725|323002921|FG001|Observational Period|Lost to Follow-up|1|||
94333259|NCT00439725|323002920|FG000|Observational Period|Death|0|||
94333260|NCT00439725|323002921|FG001|Observational Period|Death|2|||
94333261|NCT00439725|323002920|FG000|Observational Period|Study termination by sponsor|1|||
94333262|NCT00439725|323002921|FG001|Observational Period|Study termination by sponsor|1|||
94333263|NCT00439725|323002920|FG000|Observational Period|Clinical endpoint reached|3|||
94333264|NCT00439725|323002921|FG001|Observational Period|Clinical endpoint reached|1|||
94333265|NCT00439725|323002920|FG000|Observational Period|Technical problems|1|||
94333266|NCT00439725|323002921|FG001|Observational Period|Technical problems|0|||
94333267|NCT00439725|323002920|FG000|Observational Period|Participant convenience|1|||
94333268|NCT00439725|323002921|FG001|Observational Period|Participant convenience|0|||
94333269|NCT01432457|323002922|FG000|Overall Study|Adverse Event|7|||
94333270|NCT01432457|323002923|FG001|Overall Study|Adverse Event|10|||
94333271|NCT01432457|323002924|FG002|Overall Study|Adverse Event|16|||
94333272|NCT01432457|323002922|FG000|Overall Study|Lack of Efficacy|2|||
94333273|NCT01432457|323002923|FG001|Overall Study|Lack of Efficacy|1|||
94333274|NCT01432457|323002924|FG002|Overall Study|Lack of Efficacy|1|||
94333275|NCT01432457|323002922|FG000|Overall Study|Lost to Follow-up|11|||
94333276|NCT01432457|323002923|FG001|Overall Study|Lost to Follow-up|15|||
94333277|NCT01432457|323002924|FG002|Overall Study|Lost to Follow-up|20|||
94333278|NCT01432457|323002922|FG000|Overall Study|Protocol Violation|3|||
94333279|NCT01432457|323002923|FG001|Overall Study|Protocol Violation|2|||
94333280|NCT01432457|323002924|FG002|Overall Study|Protocol Violation|6|||
94333281|NCT01432457|323002922|FG000|Overall Study|Withdrawal by Subject|6|||
94333282|NCT01432457|323002923|FG001|Overall Study|Withdrawal by Subject|11|||
94333283|NCT01432457|323002924|FG002|Overall Study|Withdrawal by Subject|9|||
94333284|NCT01432457|323002922|FG000|Overall Study|Reasons not defined|2|||
94333285|NCT01432457|323002923|FG001|Overall Study|Reasons not defined|3|||
94333286|NCT01432457|323002924|FG002|Overall Study|Reasons not defined|4|||
94333287|NCT01432457|323002922|FG000|Overall Study|Did not take study drug|6|||
94333288|NCT01432457|323002923|FG001|Overall Study|Did not take study drug|6|||
94333289|NCT01432457|323002924|FG002|Overall Study|Did not take study drug|3|||
94333290|NCT02574481|323002927|FG000|Overall Study|Withdrawal by Subject|29|||
94333291|NCT02574481|323002928|FG001|Overall Study|Withdrawal by Subject|15|||
94333292|NCT02574481|323002929|FG002|Overall Study|Withdrawal by Subject|4|||
94333293|NCT02574481|323002930|FG003|Overall Study|Withdrawal by Subject|1|||
94333294|NCT02574481|323002927|FG000|Overall Study|Adverse Event|5|||
94333295|NCT02574481|323002928|FG001|Overall Study|Adverse Event|1|||
94333296|NCT02574481|323002929|FG002|Overall Study|Adverse Event|1|||
94333297|NCT02574481|323002930|FG003|Overall Study|Adverse Event|0|||
94333298|NCT02574481|323002927|FG000|Overall Study|Visit Missed|15|||
94333299|NCT02574481|323002928|FG001|Overall Study|Visit Missed|7|||
94333300|NCT02574481|323002929|FG002|Overall Study|Visit Missed|5|||
94333301|NCT02574481|323002930|FG003|Overall Study|Visit Missed|0|||
94333302|NCT02574481|323002927|FG000|Overall Study|Other|7|||
94333303|NCT02574481|323002928|FG001|Overall Study|Other|2|||
94333304|NCT02574481|323002929|FG002|Overall Study|Other|0|||
94333305|NCT02574481|323002930|FG003|Overall Study|Other|0|||
94333306|NCT02574481|323002927|FG000|Overall Study|Death|48|||
94333307|NCT02574481|323002928|FG001|Overall Study|Death|26|||
94333308|NCT02574481|323002929|FG002|Overall Study|Death|12|||
94333309|NCT02574481|323002930|FG003|Overall Study|Death|4|||
94333310|NCT02574481|323002927|FG000|Overall Study|Physician Decision|5|||
94333311|NCT02574481|323002928|FG001|Overall Study|Physician Decision|2|||
94333312|NCT02574481|323002929|FG002|Overall Study|Physician Decision|0|||
94333313|NCT02574481|323002930|FG003|Overall Study|Physician Decision|0|||
94333314|NCT02574481|323002927|FG000|Overall Study|Lost to Follow-up|5|||
94333315|NCT02574481|323002928|FG001|Overall Study|Lost to Follow-up|1|||
94333316|NCT02574481|323002929|FG002|Overall Study|Lost to Follow-up|3|||
94333317|NCT02574481|323002930|FG003|Overall Study|Lost to Follow-up|0|||
94333318|NCT03510910|323002931|FG000|Overall Study|Incomplete Survey|2|||
94333319|NCT03510910|323002932|FG001|Overall Study|Incomplete Survey|3|||
94333320|NCT01105936|323002936|FG000|Period 1|Adverse Event|0|||
94333321|NCT01105936|323002937|FG001|Period 1|Adverse Event|0|||
94333322|NCT01105936|323002938|FG002|Period 1|Adverse Event|0|||
94333323|NCT01105936|323002939|FG003|Period 1|Adverse Event|1|||
94333324|NCT01105936|323002936|FG000|Period 2|Adverse Event|1|||
94333325|NCT01105936|323002937|FG001|Period 2|Adverse Event|0|||
94333326|NCT01105936|323002938|FG002|Period 2|Adverse Event|0|||
94333327|NCT01105936|323002939|FG003|Period 2|Adverse Event|0|||
94333328|NCT01105936|323002936|FG000|Period 3|Protocol Violation|0|||
94333329|NCT01105936|323002937|FG001|Period 3|Protocol Violation|2|||
94333330|NCT01105936|323002938|FG002|Period 3|Protocol Violation|0|||
94333331|NCT01105936|323002939|FG003|Period 3|Protocol Violation|0|||
94333332|NCT01673490|323002940|FG000|Overall Study|Lost to Follow-up|1|||
94333333|NCT01673490|323002940|FG000|Overall Study|Adverse Event|3|||
94333334|NCT01673490|323002940|FG000|Overall Study|Withdrawal by Subject|3|||
94333335|NCT00379236|323002941|FG000|Double-blind|Adverse Event|11|||
94333336|NCT00379236|323002942|FG001|Double-blind|Adverse Event|6|||
94333337|NCT00379236|323002943|FG002|Double-blind|Adverse Event|0|||
94333338|NCT00379236|323002941|FG000|Double-blind|Protocol Violation|3|||
94333339|NCT00379236|323002942|FG001|Double-blind|Protocol Violation|3|||
94333340|NCT00379236|323002943|FG002|Double-blind|Protocol Violation|0|||
94333341|NCT00379236|323002941|FG000|Double-blind|Withdrawal by Subject|12|||
94333342|NCT00379236|323002942|FG001|Double-blind|Withdrawal by Subject|13|||
94333343|NCT00379236|323002943|FG002|Double-blind|Withdrawal by Subject|0|||
94333344|NCT00379236|323002941|FG000|Double-blind|Lost to Follow-up|4|||
94333345|NCT00379236|323002942|FG001|Double-blind|Lost to Follow-up|3|||
94333346|NCT00379236|323002943|FG002|Double-blind|Lost to Follow-up|0|||
94333347|NCT00379236|323002941|FG000|Double-blind|Use of exclusionary medication|1|||
94333348|NCT00379236|323002942|FG001|Double-blind|Use of exclusionary medication|2|||
94333349|NCT00379236|323002943|FG002|Double-blind|Use of exclusionary medication|0|||
94333350|NCT00379236|323002941|FG000|Double-blind|Other|3|||
94333351|NCT00379236|323002942|FG001|Double-blind|Other|7|||
94333352|NCT00379236|323002943|FG002|Double-blind|Other|0|||
94333353|NCT00379236|323002941|FG000|Double-blind|Data could not be retrieved|2|||
94333354|NCT00379236|323002942|FG001|Double-blind|Data could not be retrieved|2|||
94333355|NCT00379236|323002943|FG002|Double-blind|Data could not be retrieved|0|||
94333356|NCT00379236|323002941|FG000|Open-label Extension|Adverse Event|0|||
94333357|NCT00379236|323002942|FG001|Open-label Extension|Adverse Event|0|||
94333358|NCT00379236|323002943|FG002|Open-label Extension|Adverse Event|13|||
94333359|NCT00379236|323002941|FG000|Open-label Extension|Protocol Violation|0|||
94333360|NCT00379236|323002942|FG001|Open-label Extension|Protocol Violation|0|||
94333361|NCT00379236|323002943|FG002|Open-label Extension|Protocol Violation|7|||
94333362|NCT00379236|323002941|FG000|Open-label Extension|Withdrawal by Subject|0|||
94333363|NCT00379236|323002942|FG001|Open-label Extension|Withdrawal by Subject|0|||
94333364|NCT00379236|323002943|FG002|Open-label Extension|Withdrawal by Subject|13|||
94333365|NCT00379236|323002941|FG000|Open-label Extension|Lost to Follow-up|0|||
94333366|NCT00379236|323002942|FG001|Open-label Extension|Lost to Follow-up|0|||
94333367|NCT00379236|323002943|FG002|Open-label Extension|Lost to Follow-up|12|||
94333368|NCT00379236|323002941|FG000|Open-label Extension|Use of exclusionary medication|0|||
94333369|NCT00379236|323002942|FG001|Open-label Extension|Use of exclusionary medication|0|||
94333370|NCT00379236|323002943|FG002|Open-label Extension|Use of exclusionary medication|3|||
94333371|NCT00379236|323002941|FG000|Open-label Extension|Other|0|||
94333372|NCT00379236|323002942|FG001|Open-label Extension|Other|0|||
94333373|NCT00379236|323002943|FG002|Open-label Extension|Other|7|||
94333374|NCT02911519|323002944|FG000|Overall Study|Lost to Follow-up|2|||
94333375|NCT02911519|323002945|FG001|Overall Study|Lost to Follow-up|2|||
94333376|NCT02911519|323002944|FG000|Overall Study|Death|0|||
94333377|NCT02911519|323002945|FG001|Overall Study|Death|2|||
94333378|NCT00653328|323002946|FG000|Overall Study|Withdrawal by Subject|1|||
94333379|NCT00653328|323002946|FG000|Overall Study|Adverse Event|2|||
94333380|NCT00653328|323002946|FG000|Overall Study|Disease progression|10|||
94333381|NCT00653328|323002946|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
94333382|NCT00407550|323002947|FG000|Overall Study|Adverse Event|0|||
94333383|NCT00407550|323002948|FG001|Overall Study|Adverse Event|1|||
94333384|NCT00407550|323002947|FG000|Overall Study|Withdrawal by Subject|0|||
94333385|NCT00407550|323002948|FG001|Overall Study|Withdrawal by Subject|2|||
94333386|NCT00407550|323002947|FG000|Overall Study|Death|1|||
94333387|NCT00407550|323002948|FG001|Overall Study|Death|0|||
94333388|NCT00407550|323002947|FG000|Overall Study|Insurance or Other medical condition|2|||
94333389|NCT00407550|323002948|FG001|Overall Study|Insurance or Other medical condition|1|||
94333390|NCT01444898|323002949|FG000|Overall Study|Withdrawal by Subject|1|||
94333391|NCT03235726|323002950|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
94333392|NCT03235726|323002951|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
94333393|NCT03235726|323002952|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
94333394|NCT03235726|323002953|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
94333395|NCT03235726|323002954|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
94333396|NCT03235726|323002955|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
94333397|NCT03235726|323002956|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
94333398|NCT03235726|323002957|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
94333399|NCT03235726|323002958|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
94333400|NCT03235726|323002959|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
94333401|NCT03235726|323002950|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
94333402|NCT03235726|323002951|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
94333403|NCT03235726|323002952|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
94333404|NCT03235726|323002953|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
94333405|NCT03235726|323002954|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
94333406|NCT03235726|323002955|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
94333407|NCT03235726|323002956|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
94333408|NCT03235726|323002957|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
94333409|NCT03235726|323002958|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
94333410|NCT03235726|323002959|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
94333411|NCT01628393|323002960|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
94333412|NCT01628393|323002961|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
94333413|NCT01628393|323002962|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
94333414|NCT01628393|323002963|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
94333415|NCT01628393|323002964|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
94333416|NCT01628393|323002960|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
94333417|NCT01628393|323002961|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
94333418|NCT01628393|323002962|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
94333419|NCT01628393|323002963|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
94333420|NCT01628393|323002964|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
94333421|NCT01628393|323002960|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
94333422|NCT01628393|323002961|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
94333423|NCT01628393|323002962|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
94333424|NCT01628393|323002963|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
94333425|NCT01628393|323002964|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
94333426|NCT01628393|323002960|FG000|Blinded Active Extension Period|Adverse Event|0|||
94333427|NCT01628393|323002961|FG001|Blinded Active Extension Period|Adverse Event|1|||
94333428|NCT01628393|323002962|FG002|Blinded Active Extension Period|Adverse Event|0|||
94333429|NCT01628393|323002963|FG003|Blinded Active Extension Period|Adverse Event|2|||
94333430|NCT01628393|323002964|FG004|Blinded Active Extension Period|Adverse Event|2|||
94333431|NCT01628393|323002960|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
94333432|NCT01628393|323002961|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
94333433|NCT01628393|323002962|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
94333434|NCT01628393|323002963|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
94333435|NCT01628393|323002964|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
94333436|NCT01628393|323002960|FG000|Blinded Active Extension Period|Physician Decision|0|||
94333437|NCT01628393|323002961|FG001|Blinded Active Extension Period|Physician Decision|3|||
94333438|NCT01628393|323002962|FG002|Blinded Active Extension Period|Physician Decision|0|||
94333439|NCT01628393|323002963|FG003|Blinded Active Extension Period|Physician Decision|1|||
94333440|NCT01628393|323002964|FG004|Blinded Active Extension Period|Physician Decision|0|||
94333441|NCT01628393|323002960|FG000|Blinded Active Extension Period|Protocol Violation|0|||
94333442|NCT01628393|323002961|FG001|Blinded Active Extension Period|Protocol Violation|0|||
94333443|NCT01628393|323002962|FG002|Blinded Active Extension Period|Protocol Violation|2|||
94333444|NCT01628393|323002963|FG003|Blinded Active Extension Period|Protocol Violation|1|||
94333445|NCT01628393|323002964|FG004|Blinded Active Extension Period|Protocol Violation|0|||
94333446|NCT01628393|323002960|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
94333447|NCT01628393|323002961|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
94333448|NCT01628393|323002962|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
94333449|NCT01628393|323002963|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
94333450|NCT01628393|323002964|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
94333451|NCT00561340|323002965|FG000|Overall Study|refused to drink pediasure|6|||
94333452|NCT00561340|323002966|FG001|Overall Study|refused to drink pediasure|0|||
94333453|NCT04539262|323002976|FG000|Overall Study|Adverse Event|0|||
94333454|NCT04539262|323002977|FG001|Overall Study|Adverse Event|0|||
94333455|NCT04539262|323002978|FG002|Overall Study|Adverse Event|1|||
94333456|NCT04539262|323002979|FG003|Overall Study|Adverse Event|0|||
94333457|NCT04539262|323002980|FG004|Overall Study|Adverse Event|0|||
94333458|NCT04539262|323002981|FG005|Overall Study|Adverse Event|0|||
94333459|NCT04539262|323002982|FG006|Overall Study|Adverse Event|0|||
94333460|NCT04539262|323002983|FG007|Overall Study|Adverse Event|0|||
94333461|NCT04539262|323002976|FG000|Overall Study|Withdrew Consent|0|||
94333462|NCT04539262|323002977|FG001|Overall Study|Withdrew Consent|0|||
94333463|NCT04539262|323002978|FG002|Overall Study|Withdrew Consent|0|||
94333464|NCT04539262|323002979|FG003|Overall Study|Withdrew Consent|1|||
94333465|NCT04539262|323002980|FG004|Overall Study|Withdrew Consent|0|||
94333466|NCT04539262|323002981|FG005|Overall Study|Withdrew Consent|0|||
94333467|NCT04539262|323002982|FG006|Overall Study|Withdrew Consent|0|||
94227136|NCT03924947|322625733|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
94227137|NCT03924947|322625734|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
94227138|NCT03924947|322625735|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
94227139|NCT03924947|322625736|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
94227140|NCT03924947|322625737|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
94227141|NCT04150341|322625738|FG000|Overall Study|Physician Decision|0|||
94227142|NCT04150341|322625739|FG001|Overall Study|Physician Decision|0|||
94227143|NCT04150341|322625740|FG002|Overall Study|Physician Decision|1|||
94227144|NCT04150341|322625741|FG003|Overall Study|Physician Decision|0|||
94227145|NCT04150341|322625742|FG004|Overall Study|Physician Decision|0|||
94227146|NCT04150341|322625743|FG005|Overall Study|Physician Decision|0|||
94227147|NCT04150341|322625738|FG000|Overall Study|Adverse Event|0|||
94227148|NCT04150341|322625739|FG001|Overall Study|Adverse Event|0|||
94227149|NCT04150341|322625740|FG002|Overall Study|Adverse Event|0|||
94227150|NCT04150341|322625741|FG003|Overall Study|Adverse Event|0|||
94227151|NCT04150341|322625742|FG004|Overall Study|Adverse Event|1|||
94227152|NCT04150341|322625743|FG005|Overall Study|Adverse Event|0|||
94227153|NCT00702650|322625744|FG000|Overall Study|Withdrawal by Subject|9|||
94227154|NCT00702650|322625744|FG000|Overall Study|Non-Compliance of Study Drug|3|||
94227155|NCT00702650|322625744|FG000|Overall Study|Lost to Follow-up|2|||
94227156|NCT00702650|322625744|FG000|Overall Study|Non-Compliance with Site Directives|1|||
94227157|NCT00702650|322625744|FG000|Overall Study|Sponsor Request|1|||
94227158|NCT00702650|322625744|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
94227159|NCT00702650|322625744|FG000|Overall Study|Adverse Event|3|||
94227160|NCT00899379|322625757|FG000|Overall Study|Adverse Event|2|||
94227161|NCT00899379|322625758|FG001|Overall Study|Adverse Event|2|||
94227162|NCT00899379|322625759|FG002|Overall Study|Adverse Event|1|||
94227163|NCT00899379|322625760|FG003|Overall Study|Adverse Event|1|||
94227164|NCT00899379|322625761|FG004|Overall Study|Adverse Event|2|||
94227165|NCT00899379|322625757|FG000|Overall Study|Lack of Efficacy|0|||
94227166|NCT00899379|322625758|FG001|Overall Study|Lack of Efficacy|4|||
94227167|NCT00899379|322625759|FG002|Overall Study|Lack of Efficacy|3|||
94227168|NCT00899379|322625760|FG003|Overall Study|Lack of Efficacy|0|||
94227169|NCT00899379|322625761|FG004|Overall Study|Lack of Efficacy|1|||
94227170|NCT00899379|322625757|FG000|Overall Study|Lost to Follow-up|9|||
94227171|NCT00899379|322625758|FG001|Overall Study|Lost to Follow-up|3|||
94227172|NCT00899379|322625759|FG002|Overall Study|Lost to Follow-up|0|||
94227173|NCT00899379|322625760|FG003|Overall Study|Lost to Follow-up|6|||
94227174|NCT00899379|322625761|FG004|Overall Study|Lost to Follow-up|2|||
94227175|NCT00899379|322625757|FG000|Overall Study|Protocol Violation|0|||
94227176|NCT00899379|322625758|FG001|Overall Study|Protocol Violation|0|||
94227177|NCT00899379|322625759|FG002|Overall Study|Protocol Violation|1|||
94227178|NCT00899379|322625760|FG003|Overall Study|Protocol Violation|1|||
94227179|NCT00899379|322625761|FG004|Overall Study|Protocol Violation|0|||
94227180|NCT00899379|322625757|FG000|Overall Study|Withdrawal by Subject|2|||
94227181|NCT00899379|322625758|FG001|Overall Study|Withdrawal by Subject|4|||
94227182|NCT00899379|322625759|FG002|Overall Study|Withdrawal by Subject|2|||
94227183|NCT00899379|322625760|FG003|Overall Study|Withdrawal by Subject|3|||
94227184|NCT00899379|322625761|FG004|Overall Study|Withdrawal by Subject|6|||
94227185|NCT00899379|322625757|FG000|Overall Study|Pregnancy|0|||
94227186|NCT00899379|322625758|FG001|Overall Study|Pregnancy|0|||
94227187|NCT00899379|322625759|FG002|Overall Study|Pregnancy|1|||
94227188|NCT00899379|322625760|FG003|Overall Study|Pregnancy|0|||
94227189|NCT00899379|322625761|FG004|Overall Study|Pregnancy|1|||
94227190|NCT00899379|322625757|FG000|Overall Study|Patient Uncooperative|0|||
94227191|NCT00899379|322625758|FG001|Overall Study|Patient Uncooperative|1|||
94227192|NCT00899379|322625759|FG002|Overall Study|Patient Uncooperative|0|||
94227193|NCT00899379|322625760|FG003|Overall Study|Patient Uncooperative|1|||
94227194|NCT00899379|322625761|FG004|Overall Study|Patient Uncooperative|2|||
94227195|NCT00899379|322625757|FG000|Overall Study|Abnormal Baseline ECG|0|||
94227196|NCT00899379|322625758|FG001|Overall Study|Abnormal Baseline ECG|0|||
94227197|NCT00899379|322625759|FG002|Overall Study|Abnormal Baseline ECG|0|||
94227198|NCT00899379|322625760|FG003|Overall Study|Abnormal Baseline ECG|1|||
94227199|NCT00899379|322625761|FG004|Overall Study|Abnormal Baseline ECG|0|||
94227200|NCT00899379|322625757|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
94227201|NCT00899379|322625758|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
94227202|NCT00899379|322625759|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
94227203|NCT00899379|322625760|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
94227204|NCT00899379|322625761|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
94227205|NCT00899379|322625757|FG000|Overall Study|Not Completed/Entered Extn|5|||
94227206|NCT00899379|322625758|FG001|Overall Study|Not Completed/Entered Extn|1|||
94227207|NCT00899379|322625759|FG002|Overall Study|Not Completed/Entered Extn|6|||
94227208|NCT00899379|322625760|FG003|Overall Study|Not Completed/Entered Extn|4|||
94227209|NCT00899379|322625761|FG004|Overall Study|Not Completed/Entered Extn|3|||
94227210|NCT00899379|322625757|FG000|Overall Study|Study Terminated|3|||
94227211|NCT00899379|322625758|FG001|Overall Study|Study Terminated|0|||
94227212|NCT00899379|322625759|FG002|Overall Study|Study Terminated|3|||
94333468|NCT04539262|323002983|FG007|Overall Study|Withdrew Consent|0|||
94227213|NCT00899379|322625760|FG003|Overall Study|Study Terminated|3|||
94227214|NCT00899379|322625761|FG004|Overall Study|Study Terminated|1|||
94227215|NCT00899379|322625757|FG000|Overall Study|Lost to Follow-up|3|||
94227216|NCT00899379|322625758|FG001|Overall Study|Lost to Follow-up|1|||
94227217|NCT00899379|322625759|FG002|Overall Study|Lost to Follow-up|0|||
94227218|NCT00899379|322625760|FG003|Overall Study|Lost to Follow-up|2|||
94227219|NCT00899379|322625761|FG004|Overall Study|Lost to Follow-up|5|||
94227220|NCT00899379|322625757|FG000|Overall Study|Withdrawal by Subject|4|||
94227221|NCT00899379|322625758|FG001|Overall Study|Withdrawal by Subject|7|||
94227222|NCT00899379|322625759|FG002|Overall Study|Withdrawal by Subject|4|||
94227223|NCT00899379|322625760|FG003|Overall Study|Withdrawal by Subject|7|||
94227224|NCT00899379|322625761|FG004|Overall Study|Withdrawal by Subject|2|||
94227225|NCT00899379|322625757|FG000|Overall Study|Pregnancy|1|||
94227226|NCT00899379|322625758|FG001|Overall Study|Pregnancy|0|||
94227227|NCT00899379|322625759|FG002|Overall Study|Pregnancy|0|||
94227228|NCT00899379|322625760|FG003|Overall Study|Pregnancy|0|||
94227229|NCT00899379|322625761|FG004|Overall Study|Pregnancy|0|||
94227230|NCT00899379|322625757|FG000|Overall Study|Patient Uncooperative|0|||
94227231|NCT00899379|322625758|FG001|Overall Study|Patient Uncooperative|0|||
94227232|NCT00899379|322625759|FG002|Overall Study|Patient Uncooperative|0|||
94227233|NCT00899379|322625760|FG003|Overall Study|Patient Uncooperative|1|||
94227234|NCT00899379|322625761|FG004|Overall Study|Patient Uncooperative|0|||
94227235|NCT00899379|322625757|FG000|Overall Study|Abnormal Prestudy Labs|0|||
94227236|NCT00899379|322625758|FG001|Overall Study|Abnormal Prestudy Labs|0|||
94227237|NCT00899379|322625759|FG002|Overall Study|Abnormal Prestudy Labs|0|||
94227238|NCT00899379|322625760|FG003|Overall Study|Abnormal Prestudy Labs|0|||
94227239|NCT00899379|322625761|FG004|Overall Study|Abnormal Prestudy Labs|2|||
94227240|NCT00899379|322625757|FG000|Overall Study|Abnormal Baseline ECG|0|||
94227241|NCT00899379|322625758|FG001|Overall Study|Abnormal Baseline ECG|0|||
94227242|NCT00899379|322625759|FG002|Overall Study|Abnormal Baseline ECG|1|||
94227243|NCT00899379|322625760|FG003|Overall Study|Abnormal Baseline ECG|1|||
94227244|NCT00899379|322625761|FG004|Overall Study|Abnormal Baseline ECG|0|||
94227245|NCT00899379|322625757|FG000|Overall Study|No Attack Pretreatment|3|||
94227246|NCT00899379|322625758|FG001|Overall Study|No Attack Pretreatment|5|||
94227247|NCT00899379|322625759|FG002|Overall Study|No Attack Pretreatment|5|||
94227248|NCT00899379|322625760|FG003|Overall Study|No Attack Pretreatment|6|||
94227249|NCT00899379|322625761|FG004|Overall Study|No Attack Pretreatment|4|||
94227250|NCT00899379|322625757|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
94227251|NCT00899379|322625758|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
94227252|NCT00899379|322625759|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
94227253|NCT00899379|322625760|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
94227254|NCT00899379|322625761|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
94227255|NCT00899379|322625757|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
94227256|NCT00899379|322625758|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
94227257|NCT00899379|322625759|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
94227258|NCT00899379|322625760|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
94227259|NCT00899379|322625761|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
94227260|NCT03214250|322625762|FG000|Overall Study|Death|5|||
94227261|NCT03214250|322625763|FG001|Overall Study|Death|5|||
94227262|NCT03214250|322625764|FG002|Overall Study|Death|7|||
94227263|NCT03214250|322625765|FG003|Overall Study|Death|4|||
94227264|NCT03214250|322625766|FG004|Overall Study|Death|23|||
94227265|NCT03214250|322625767|FG005|Overall Study|Death|23|||
94227266|NCT03214250|322625768|FG006|Overall Study|Death|24|||
94227267|NCT03214250|322625762|FG000|Overall Study|Lost to Follow-up|0|||
94227268|NCT03214250|322625763|FG001|Overall Study|Lost to Follow-up|0|||
94227269|NCT03214250|322625764|FG002|Overall Study|Lost to Follow-up|0|||
94227270|NCT03214250|322625765|FG003|Overall Study|Lost to Follow-up|1|||
94227271|NCT03214250|322625766|FG004|Overall Study|Lost to Follow-up|1|||
94227272|NCT03214250|322625767|FG005|Overall Study|Lost to Follow-up|2|||
94227273|NCT03214250|322625768|FG006|Overall Study|Lost to Follow-up|0|||
94227274|NCT03214250|322625762|FG000|Overall Study|Other|0|||
94227275|NCT03214250|322625763|FG001|Overall Study|Other|0|||
94227276|NCT03214250|322625764|FG002|Overall Study|Other|0|||
94227277|NCT03214250|322625765|FG003|Overall Study|Other|0|||
94227278|NCT03214250|322625766|FG004|Overall Study|Other|1|||
94227279|NCT03214250|322625767|FG005|Overall Study|Other|1|||
94227280|NCT03214250|322625768|FG006|Overall Study|Other|2|||
94227281|NCT03214250|322625762|FG000|Overall Study|Remains on Study|2|||
94227282|NCT03214250|322625763|FG001|Overall Study|Remains on Study|2|||
94227283|NCT03214250|322625764|FG002|Overall Study|Remains on Study|0|||
94227284|NCT03214250|322625765|FG003|Overall Study|Remains on Study|1|||
94227285|NCT03214250|322625766|FG004|Overall Study|Remains on Study|7|||
94227286|NCT03214250|322625767|FG005|Overall Study|Remains on Study|5|||
94227287|NCT03214250|322625768|FG006|Overall Study|Remains on Study|3|||
94227288|NCT03214250|322625762|FG000|Overall Study|Withdrawal by Subject|0|||
94333469|NCT04539262|323002976|FG000|Overall Study|Randomized, Not treated|0|||
94333470|NCT04539262|323002977|FG001|Overall Study|Randomized, Not treated|1|||
94333471|NCT04539262|323002978|FG002|Overall Study|Randomized, Not treated|0|||
94333472|NCT04539262|323002979|FG003|Overall Study|Randomized, Not treated|0|||
94333473|NCT04539262|323002980|FG004|Overall Study|Randomized, Not treated|0|||
94333474|NCT04539262|323002981|FG005|Overall Study|Randomized, Not treated|0|||
94333475|NCT04539262|323002982|FG006|Overall Study|Randomized, Not treated|1|||
94333476|NCT04539262|323002983|FG007|Overall Study|Randomized, Not treated|0|||
94333477|NCT03725293|323002984|FG000|Overall Study|Physician Decision|9|||
94333478|NCT03725293|323002985|FG001|Overall Study|Physician Decision|6|||
94333479|NCT03725293|323002984|FG000|Overall Study|alternative vascular access needs|1|||
94333480|NCT03725293|323002985|FG001|Overall Study|alternative vascular access needs|2|||
94333481|NCT03725293|323002984|FG000|Overall Study|venous anatomy screen failures|2|||
94333482|NCT03725293|323002985|FG001|Overall Study|venous anatomy screen failures|1|||
94333483|NCT02143141|323002986|FG000|Overall Study|pain scores at 24 hours not collected|1|||
94333484|NCT02143141|323002987|FG001|Overall Study|pain scores at 24 hours not collected|0|||
94333485|NCT03673956|323002988|FG000|Overall Study|Lost to Follow-up|1|||
94333486|NCT03673956|323002989|FG001|Overall Study|Lost to Follow-up|0|||
94333487|NCT03673956|323002990|FG002|Overall Study|Lost to Follow-up|0|||
94333488|NCT03673956|323002991|FG003|Overall Study|Lost to Follow-up|0|||
94333489|NCT03673956|323002988|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
94333490|NCT03673956|323002989|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
94333491|NCT03673956|323002990|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
94333492|NCT03673956|323002991|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
94333493|NCT00268463|323002992|FG000|Overall Study|study terminated due to low accrual|10|||
94333494|NCT00268463|323002993|FG001|Overall Study|study terminated due to low accrual|12|||
94333495|NCT00432562|323003002|FG000|Overall Study|Death|3|||
94333496|NCT00432562|323003003|FG001|Overall Study|Death|0|||
94333497|NCT03168555|323003006|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
94333498|NCT03168555|323003006|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
94333499|NCT03168555|323003006|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
94333500|NCT03168555|323003006|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
94333501|NCT04362813|323003007|FG000|Overall Study|Death|12|||
94333502|NCT04362813|323003008|FG001|Overall Study|Death|16|||
94333503|NCT04362813|323003007|FG000|Overall Study|Withdrawal by Subject|3|||
94333504|NCT04362813|323003008|FG001|Overall Study|Withdrawal by Subject|1|||
94333505|NCT04362813|323003007|FG000|Overall Study|Protocol Violation|0|||
94333506|NCT04362813|323003008|FG001|Overall Study|Protocol Violation|3|||
94333507|NCT04362813|323003007|FG000|Overall Study|Lost to Follow-up|1|||
94333508|NCT04362813|323003008|FG001|Overall Study|Lost to Follow-up|1|||
94333509|NCT04362813|323003007|FG000|Overall Study|Enrolled but did not receive treatment|2|||
94333510|NCT04362813|323003008|FG001|Overall Study|Enrolled but did not receive treatment|4|||
94333511|NCT00961116|323003009|FG000|Washout Period of 7 Days|Adverse Event|1|||
94333512|NCT00961116|323003010|FG001|Washout Period of 7 Days|Adverse Event|1|||
94333513|NCT00961116|323003009|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
94333514|NCT00961116|323003010|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
94333515|NCT00961116|323003009|FG000|Washout Period of 7 Days|Protocol Violation|0|||
94333516|NCT00961116|323003010|FG001|Washout Period of 7 Days|Protocol Violation|1|||
94333517|NCT00389441|323003011|FG000|Overall Study|Adverse Event|7|||
94333518|NCT00389441|323003011|FG000|Overall Study|Death|4|||
94333519|NCT00389441|323003011|FG000|Overall Study|Lost to Follow-up|2|||
94333520|NCT00389441|323003011|FG000|Overall Study|Withdrawal by Subject|4|||
94333521|NCT00389441|323003011|FG000|Overall Study|Physician Decision|1|||
94333522|NCT00389441|323003011|FG000|Overall Study|Protocol Violation|1|||
94333523|NCT00389441|323003011|FG000|Overall Study|Global deterioration of health status|4|||
94333524|NCT00389441|323003011|FG000|Overall Study|Objective progression or relapse|26|||
94333525|NCT00389441|323003011|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
94333526|NCT00389441|323003011|FG000|Overall Study|Clinical progression|1|||
94333527|NCT01001234|323003017|FG000|Overall Study|Withdrawal by Subject|2|||
94333528|NCT01001234|323003018|FG001|Overall Study|Withdrawal by Subject|0|||
94333529|NCT01001234|323003019|FG002|Overall Study|Withdrawal by Subject|3|||
94333530|NCT01001234|323003020|FG003|Overall Study|Withdrawal by Subject|0|||
94333531|NCT01001234|323003021|FG004|Overall Study|Withdrawal by Subject|0|||
94333532|NCT01001234|323003017|FG000|Overall Study|Protocol Violation|34|||
94333533|NCT01001234|323003018|FG001|Overall Study|Protocol Violation|3|||
94333534|NCT01001234|323003019|FG002|Overall Study|Protocol Violation|19|||
94333535|NCT01001234|323003020|FG003|Overall Study|Protocol Violation|18|||
94333536|NCT01001234|323003021|FG004|Overall Study|Protocol Violation|0|||
94333537|NCT01001234|323003017|FG000|Overall Study|Lost to Follow-up|0|||
94333538|NCT01001234|323003018|FG001|Overall Study|Lost to Follow-up|0|||
94333539|NCT01001234|323003019|FG002|Overall Study|Lost to Follow-up|1|||
94333540|NCT01001234|323003020|FG003|Overall Study|Lost to Follow-up|2|||
94333541|NCT01001234|323003021|FG004|Overall Study|Lost to Follow-up|0|||
94333542|NCT01001234|323003017|FG000|Overall Study|Physician Decision|1|||
94333543|NCT01001234|323003018|FG001|Overall Study|Physician Decision|0|||
94333544|NCT01001234|323003019|FG002|Overall Study|Physician Decision|0|||
94333545|NCT01001234|323003020|FG003|Overall Study|Physician Decision|0|||
94333546|NCT01001234|323003021|FG004|Overall Study|Physician Decision|0|||
94333547|NCT01001234|323003017|FG000|Overall Study|Not Treated: Adverse Event|1|||
94333548|NCT01001234|323003018|FG001|Overall Study|Not Treated: Adverse Event|0|||
94333549|NCT01001234|323003019|FG002|Overall Study|Not Treated: Adverse Event|0|||
94333550|NCT01001234|323003020|FG003|Overall Study|Not Treated: Adverse Event|0|||
94333551|NCT01001234|323003021|FG004|Overall Study|Not Treated: Adverse Event|0|||
94333552|NCT01001234|323003017|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
94333553|NCT01001234|323003018|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
94333554|NCT01001234|323003019|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
94333555|NCT01001234|323003020|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
94333556|NCT01001234|323003021|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
94333557|NCT01001234|323003017|FG000|Overall Study|Not Treated: Protocol Violation|3|||
94333558|NCT01001234|323003018|FG001|Overall Study|Not Treated: Protocol Violation|0|||
94333559|NCT01001234|323003019|FG002|Overall Study|Not Treated: Protocol Violation|0|||
94333560|NCT01001234|323003020|FG003|Overall Study|Not Treated: Protocol Violation|0|||
94333561|NCT01001234|323003021|FG004|Overall Study|Not Treated: Protocol Violation|0|||
94333562|NCT01001234|323003017|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
94333563|NCT01001234|323003018|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
94333564|NCT01001234|323003019|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
94333565|NCT01001234|323003020|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
94333566|NCT01001234|323003021|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
94333567|NCT01001234|323003017|FG000|Overall Study|Not Treated: Pregnancy|3|||
94333568|NCT01001234|323003018|FG001|Overall Study|Not Treated: Pregnancy|0|||
94333569|NCT01001234|323003019|FG002|Overall Study|Not Treated: Pregnancy|0|||
94333570|NCT01001234|323003020|FG003|Overall Study|Not Treated: Pregnancy|0|||
94333571|NCT01001234|323003021|FG004|Overall Study|Not Treated: Pregnancy|0|||
94333572|NCT01001234|323003017|FG000|Overall Study|Not Treated: Physician Decision|37|||
94333573|NCT01001234|323003018|FG001|Overall Study|Not Treated: Physician Decision|4|||
94333574|NCT01001234|323003019|FG002|Overall Study|Not Treated: Physician Decision|0|||
94333575|NCT01001234|323003020|FG003|Overall Study|Not Treated: Physician Decision|0|||
94333576|NCT01001234|323003021|FG004|Overall Study|Not Treated: Physician Decision|0|||
94333577|NCT01001234|323003017|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
94333578|NCT01001234|323003018|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
94333579|NCT01001234|323003019|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
94333580|NCT01001234|323003020|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
94333581|NCT01001234|323003021|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
94333582|NCT01162304|323003022|FG000|Overall Study|Beck scale to high|11|||
94333583|NCT01851863|323003023|FG000|Overall Study|Did not receive study medication|2|||
94333584|NCT01851863|323003024|FG001|Overall Study|Did not receive study medication|5|||
94333585|NCT01851863|323003025|FG002|Overall Study|Did not receive study medication|3|||
94333586|NCT01851863|323003026|FG003|Overall Study|Did not receive study medication|0|||
94333587|NCT01851863|323003023|FG000|Overall Study|Lost to Follow-up|3|||
94333588|NCT01851863|323003024|FG001|Overall Study|Lost to Follow-up|4|||
94333589|NCT01851863|323003025|FG002|Overall Study|Lost to Follow-up|2|||
94333590|NCT01851863|323003026|FG003|Overall Study|Lost to Follow-up|3|||
94333591|NCT03379376|323003027|FG000|Overall Study|Lost to Follow-up|2|||
94333592|NCT03379376|323003027|FG000|Overall Study|Did not wish to complete follow up|1|||
94333593|NCT03379376|323003027|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
94333594|NCT03379376|323003027|FG000|Overall Study|Death|1|||
94333595|NCT01296698|323003030|FG000|Overall Study|Adverse Event|1|||
94333596|NCT01296698|323003031|FG001|Overall Study|Adverse Event|0|||
94333597|NCT01296698|323003030|FG000|Overall Study|Death|1|||
94333598|NCT01296698|323003031|FG001|Overall Study|Death|0|||
94333599|NCT01296698|323003030|FG000|Overall Study|Lost to Follow-up|19|||
94333600|NCT01296698|323003031|FG001|Overall Study|Lost to Follow-up|1|||
94333601|NCT01296698|323003030|FG000|Overall Study|Withdrawal by Subject|12|||
94333602|NCT01296698|323003031|FG001|Overall Study|Withdrawal by Subject|0|||
94333603|NCT01296698|323003030|FG000|Overall Study|Difficulty Contacting Subject|2|||
94333604|NCT01296698|323003031|FG001|Overall Study|Difficulty Contacting Subject|0|||
94333605|NCT01296698|323003030|FG000|Overall Study|Study Terminated by Sponsor|209|||
94333606|NCT01296698|323003031|FG001|Overall Study|Study Terminated by Sponsor|12|||
94333607|NCT03639987|323003034|FG000|Overall Study|Study terminated by sponsor|26|||
94333608|NCT03639987|323003035|FG001|Overall Study|Study terminated by sponsor|25|||
94333609|NCT03639987|323003034|FG000|Overall Study|Lost to Follow-up|0|||
94333610|NCT03639987|323003035|FG001|Overall Study|Lost to Follow-up|1|||
94333611|NCT00425100|323003037|FG000|Overall Study|Adverse Event|36|||
94333612|NCT00425100|323003037|FG000|Overall Study|Lack of Efficacy|4|||
94333613|NCT00425100|323003037|FG000|Overall Study|Lost to Follow-up|2|||
94333614|NCT00425100|323003037|FG000|Overall Study|Protocol Violation|4|||
94333615|NCT00425100|323003037|FG000|Overall Study|Withdrawal by Subject|7|||
94333616|NCT02810951|323003040|FG000|Overall Study|Adverse Event|1|||
94333617|NCT01250756|323003044|FG000|Infant Series|Withdrawal by Subject|4|||
94333618|NCT01250756|323003045|FG001|Infant Series|Withdrawal by Subject|5|||
94333619|NCT01250756|323003044|FG000|Infant Series|Randomized, Not Vaccinated|2|||
94333620|NCT01250756|323003045|FG001|Infant Series|Randomized, Not Vaccinated|2|||
94333621|NCT01250756|323003044|FG000|Infant Series|Other|22|||
94333622|NCT01250756|323003045|FG001|Infant Series|Other|0|||
94333623|NCT01250756|323003044|FG000|After Infant Series|Adverse Event|5|||
94333624|NCT01250756|323003045|FG001|After Infant Series|Adverse Event|2|||
94333625|NCT01250756|323003044|FG000|After Infant Series|Withdrawal by Subject|4|||
94333626|NCT01250756|323003045|FG001|After Infant Series|Withdrawal by Subject|1|||
94333627|NCT01250756|323003044|FG000|After Infant Series|Other|2|||
94333628|NCT01250756|323003045|FG001|After Infant Series|Other|1|||
94333629|NCT01250756|323003044|FG000|Toddler Dose|Adverse Event|0|||
94333630|NCT01250756|323003045|FG001|Toddler Dose|Adverse Event|1|||
94333631|NCT01250756|323003044|FG000|After Toddler Dose|Adverse Event|0|||
94333632|NCT01250756|323003045|FG001|After Toddler Dose|Adverse Event|1|||
94333633|NCT03803202|323003049|FG000|Overall Study|Other|0|||
94333634|NCT03803202|323003050|FG001|Overall Study|Other|1|||
94333635|NCT03803202|323003051|FG002|Overall Study|Other|0|||
94333636|NCT03803202|323003052|FG003|Overall Study|Other|0|||
94333637|NCT03803202|323003053|FG004|Overall Study|Other|0|||
94333638|NCT03803202|323003054|FG005|Overall Study|Other|0|||
94333639|NCT03803202|323003055|FG006|Overall Study|Other|0|||
94333640|NCT03803202|323003056|FG007|Overall Study|Other|0|||
94333641|NCT03803202|323003057|FG008|Overall Study|Other|0|||
94333642|NCT03803202|323003049|FG000|Overall Study|Death|0|||
94333643|NCT03803202|323003050|FG001|Overall Study|Death|0|||
94333644|NCT03803202|323003051|FG002|Overall Study|Death|0|||
94333645|NCT03803202|323003052|FG003|Overall Study|Death|0|||
94333646|NCT03803202|323003053|FG004|Overall Study|Death|0|||
94333647|NCT03803202|323003054|FG005|Overall Study|Death|1|||
94333648|NCT03803202|323003055|FG006|Overall Study|Death|0|||
94333649|NCT03803202|323003056|FG007|Overall Study|Death|0|||
94333650|NCT03803202|323003057|FG008|Overall Study|Death|0|||
94333651|NCT03803202|323003049|FG000|Overall Study|Withdrawal by Subject|0|||
94333652|NCT03803202|323003050|FG001|Overall Study|Withdrawal by Subject|0|||
94333653|NCT03803202|323003051|FG002|Overall Study|Withdrawal by Subject|1|||
94333654|NCT03803202|323003052|FG003|Overall Study|Withdrawal by Subject|0|||
94333655|NCT03803202|323003053|FG004|Overall Study|Withdrawal by Subject|0|||
94333656|NCT03803202|323003054|FG005|Overall Study|Withdrawal by Subject|0|||
94333657|NCT03803202|323003055|FG006|Overall Study|Withdrawal by Subject|0|||
94333658|NCT03803202|323003056|FG007|Overall Study|Withdrawal by Subject|1|||
94333659|NCT03803202|323003057|FG008|Overall Study|Withdrawal by Subject|0|||
94333660|NCT03803202|323003049|FG000|Overall Study|Lost to Follow-up|0|||
94333661|NCT03803202|323003050|FG001|Overall Study|Lost to Follow-up|0|||
94333662|NCT03803202|323003051|FG002|Overall Study|Lost to Follow-up|0|||
94333663|NCT03803202|323003052|FG003|Overall Study|Lost to Follow-up|1|||
94333664|NCT03803202|323003053|FG004|Overall Study|Lost to Follow-up|1|||
94333665|NCT03803202|323003054|FG005|Overall Study|Lost to Follow-up|0|||
94333666|NCT03803202|323003055|FG006|Overall Study|Lost to Follow-up|1|||
94333667|NCT03803202|323003056|FG007|Overall Study|Lost to Follow-up|0|||
94333668|NCT03803202|323003057|FG008|Overall Study|Lost to Follow-up|0|||
94333669|NCT01946412|323003058|FG000|Overall Study|Adverse Event|1|||
94333670|NCT01946412|323003058|FG000|Overall Study|Non-Compliance|1|||
94333671|NCT01946412|323003058|FG000|Overall Study|Continued with commercial Kalydeco|2|||
94333672|NCT01946412|323003058|FG000|Overall Study|Difficulty in swallowing|1|||
94333673|NCT04199793|323003065|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
94333674|NCT04199793|323003066|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
94333675|NCT04199793|323003065|FG000|Overall Study|Withdrawal by Subject|1|||
94333676|NCT04199793|323003066|FG001|Overall Study|Withdrawal by Subject|1|||
94333677|NCT00260429|323003067|FG000|Overall Study|failure to follow appointments|1|||
94333678|NCT00260429|323003068|FG001|Overall Study|failure to follow appointments|0|||
94333679|NCT00260429|323003067|FG000|Overall Study|scheduled hand surgery|1|||
94333680|NCT00260429|323003068|FG001|Overall Study|scheduled hand surgery|0|||
94333681|NCT01601470|323003080|FG000|Period 2 - LCZ696|Physician Decision|1|||
94333682|NCT03032510|323003081|FG000|Overall Study|Adverse Event|5|||
94333683|NCT03032510|323003082|FG001|Overall Study|Adverse Event|2|||
94333684|NCT03032510|323003081|FG000|Overall Study|Lost to Follow-up|8|||
94333685|NCT03032510|323003082|FG001|Overall Study|Lost to Follow-up|7|||
94333686|NCT03032510|323003081|FG000|Overall Study|Withdrawal by Subject|8|||
94333687|NCT03032510|323003082|FG001|Overall Study|Withdrawal by Subject|7|||
94333688|NCT03032510|323003081|FG000|Overall Study|Subject noncompliance|4|||
94333689|NCT03032510|323003082|FG001|Overall Study|Subject noncompliance|2|||
94333690|NCT03032510|323003081|FG000|Overall Study|Physician Decision|2|||
94333691|NCT03032510|323003082|FG001|Overall Study|Physician Decision|0|||
94333692|NCT03404518|323003083|FG000|Overall Study|Lost to Follow-up|28|||
94333693|NCT03404518|323003084|FG001|Overall Study|Lost to Follow-up|30|||
94333694|NCT03404518|323003083|FG000|Overall Study|Protocol Violation|13|||
94333695|NCT03404518|323003084|FG001|Overall Study|Protocol Violation|6|||
94333696|NCT02999191|323003085|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
94333697|NCT02999191|323003086|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
94333698|NCT02999191|323003087|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
94333699|NCT01993667|323003088|FG000|Overall Study|Insufficient data to analyze|16|||
94333700|NCT01993667|323003089|FG001|Overall Study|Insufficient data to analyze|16|||
94333701|NCT01993667|323003088|FG000|Overall Study|Insufficient altitude reached|3|||
94333702|NCT01993667|323003089|FG001|Overall Study|Insufficient altitude reached|1|||
94333703|NCT01993667|323003088|FG000|Overall Study|Lost to Follow-up|2|||
94333704|NCT01993667|323003089|FG001|Overall Study|Lost to Follow-up|2|||
94333705|NCT00445341|323004306|FG000|Overall Study|refused further treatment|1|||
94333706|NCT00445341|323004306|FG000|Overall Study|taken off treatment too early|1|||
94333707|NCT00109772|323004307|FG000|Double-blind Treatment|Adverse Event|14|||
94333708|NCT00109772|323004308|FG001|Double-blind Treatment|Adverse Event|5|||
94333709|NCT00109772|323004307|FG000|Double-blind Treatment|Lack of Efficacy|1|||
94333710|NCT00109772|323004308|FG001|Double-blind Treatment|Lack of Efficacy|0|||
94333711|NCT00109772|323004307|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
94333712|NCT00109772|323004308|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
94333713|NCT00109772|323004307|FG000|Double-blind Treatment|Lost to Follow-up|2|||
94333714|NCT00109772|323004308|FG001|Double-blind Treatment|Lost to Follow-up|3|||
94333715|NCT00109772|323004307|FG000|Double-blind Treatment|Protocol Violation|0|||
94333716|NCT00109772|323004308|FG001|Double-blind Treatment|Protocol Violation|1|||
94333717|NCT00109772|323004307|FG000|Double-blind Treatment|Other|0|||
94333718|NCT00109772|323004308|FG001|Double-blind Treatment|Other|4|||
94333719|NCT00109772|323004307|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
94333720|NCT00109772|323004308|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
94333721|NCT00109772|323004307|FG000|Open-label Extension|Adverse Event|10|||
94333722|NCT00109772|323004308|FG001|Open-label Extension|Adverse Event|19|||
94333723|NCT00109772|323004307|FG000|Open-label Extension|Lack of Efficacy|19|||
94333724|NCT00109772|323004308|FG001|Open-label Extension|Lack of Efficacy|11|||
94333725|NCT00109772|323004307|FG000|Open-label Extension|Withdrawal by Subject|9|||
94333726|NCT00109772|323004308|FG001|Open-label Extension|Withdrawal by Subject|6|||
94333727|NCT00109772|323004307|FG000|Open-label Extension|Lost to Follow-up|1|||
94333728|NCT00109772|323004308|FG001|Open-label Extension|Lost to Follow-up|0|||
94333729|NCT00109772|323004307|FG000|Open-label Extension|Death|0|||
94333730|NCT00109772|323004308|FG001|Open-label Extension|Death|1|||
94333731|NCT00109772|323004307|FG000|Open-label Extension|Protocol Violation|2|||
94333732|NCT00109772|323004308|FG001|Open-label Extension|Protocol Violation|2|||
94333733|NCT00109772|323004307|FG000|Open-label Extension|Other|4|||
94333734|NCT00109772|323004308|FG001|Open-label Extension|Other|10|||
94333735|NCT01548417|323004313|FG000|Overall Study|Withdrawal by Subject|0|||
94333736|NCT01548417|323004314|FG001|Overall Study|Withdrawal by Subject|2|||
94333737|NCT03841526|323004317|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
94333738|NCT03841526|323004318|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
94333739|NCT03841526|323004319|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
94333740|NCT03841526|323004320|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
94333741|NCT03841526|323004321|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
94333742|NCT03841526|323004322|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
94333743|NCT03841526|323004317|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
94333744|NCT03841526|323004318|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
94333745|NCT03841526|323004319|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
94333746|NCT03841526|323004320|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
94333747|NCT03841526|323004321|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
94333748|NCT03841526|323004322|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
94333749|NCT03841526|323004317|FG000|Outpatient Phase Treatment|Physician Decision|0|||
94333750|NCT03841526|323004318|FG001|Outpatient Phase Treatment|Physician Decision|1|||
94333751|NCT03841526|323004319|FG002|Outpatient Phase Treatment|Physician Decision|0|||
94333752|NCT03841526|323004320|FG003|Outpatient Phase Treatment|Physician Decision|0|||
94333753|NCT03841526|323004321|FG004|Outpatient Phase Treatment|Physician Decision|0|||
94333754|NCT03841526|323004322|FG005|Outpatient Phase Treatment|Physician Decision|0|||
94333755|NCT03841526|323004317|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
94333756|NCT03841526|323004318|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
94333757|NCT03841526|323004319|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
94333758|NCT03841526|323004320|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
94333759|NCT03841526|323004321|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
94333760|NCT03841526|323004322|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
94333761|NCT01732107|323004323|FG000|Overall Study|Adverse Event|2|||
94333762|NCT01732107|323004323|FG000|Overall Study|Disease Progression|8|||
94333763|NCT01732107|323004323|FG000|Overall Study|Physician Decision|1|||
94333764|NCT01732107|323004323|FG000|Overall Study|Withdrawal by Subject|2|||
94333765|NCT01981109|323004325|FG000|Overall Study|Death|36|||
94333766|NCT01981109|323004325|FG000|Overall Study|Withdrawal by Subject|40|||
94333767|NCT01981109|323004325|FG000|Overall Study|Lost to Follow-up|9|||
94333768|NCT01981109|323004325|FG000|Overall Study|No Discontinuation Documentation|37|||
94333769|NCT01981109|323004325|FG000|Overall Study|Study Termination|100|||
94333770|NCT01981109|323004325|FG000|Overall Study|No data available|2|||
94333771|NCT03407170|323004326|FG000|Overall Study|Adverse Event|1|||
94333772|NCT00636441|323004328|FG000|Overall Study|Adverse Event|0|||
94333773|NCT00636441|323004329|FG001|Overall Study|Adverse Event|1|||
94333774|NCT00636441|323004330|FG002|Overall Study|Adverse Event|1|||
94333775|NCT00636441|323004331|FG003|Overall Study|Adverse Event|0|||
94333776|NCT00636441|323004332|FG004|Overall Study|Adverse Event|0|||
94333777|NCT00636441|323004333|FG005|Overall Study|Adverse Event|1|||
94333778|NCT00636441|323004334|FG006|Overall Study|Adverse Event|0|||
94333779|NCT00636441|323004328|FG000|Overall Study|Late, ineligible|0|||
94333780|NCT00636441|323004329|FG001|Overall Study|Late, ineligible|0|||
94333781|NCT00636441|323004330|FG002|Overall Study|Late, ineligible|0|||
94333782|NCT00636441|323004331|FG003|Overall Study|Late, ineligible|0|||
94333783|NCT00636441|323004332|FG004|Overall Study|Late, ineligible|0|||
94333784|NCT00636441|323004333|FG005|Overall Study|Late, ineligible|0|||
94333785|NCT00636441|323004334|FG006|Overall Study|Late, ineligible|1|||
94333786|NCT00636441|323004328|FG000|Overall Study|Screen Failure|0|||
94333787|NCT00636441|323004329|FG001|Overall Study|Screen Failure|0|||
94333788|NCT00636441|323004330|FG002|Overall Study|Screen Failure|0|||
94333789|NCT00636441|323004331|FG003|Overall Study|Screen Failure|0|||
94333790|NCT00636441|323004332|FG004|Overall Study|Screen Failure|0|||
94333791|NCT00636441|323004333|FG005|Overall Study|Screen Failure|0|||
94333792|NCT00636441|323004334|FG006|Overall Study|Screen Failure|17|||
94333793|NCT02709109|323004346|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
94333794|NCT02709109|323004347|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
94333795|NCT02709109|323004348|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
94333796|NCT02709109|323004349|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
94333797|NCT02709109|323004346|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
94333798|NCT02709109|323004347|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
94333799|NCT02709109|323004348|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
94333800|NCT02709109|323004349|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
94333801|NCT02709109|323004346|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
94333802|NCT02709109|323004347|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
94333803|NCT02709109|323004348|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
94333804|NCT02709109|323004349|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
94333805|NCT02709109|323004346|FG000|Washout Period (28 Days)|Other|2|||
94333806|NCT02709109|323004347|FG001|Washout Period (28 Days)|Other|2|||
94333807|NCT02709109|323004348|FG002|Washout Period (28 Days)|Other|3|||
94333808|NCT02709109|323004349|FG003|Washout Period (28 Days)|Other|0|||
94333809|NCT02709109|323004346|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
94333810|NCT02709109|323004347|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
94333811|NCT02709109|323004348|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
94333812|NCT02709109|323004349|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
94333813|NCT02709109|323004346|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
94333814|NCT02709109|323004347|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
94333815|NCT02709109|323004348|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
94333816|NCT02709109|323004349|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
94333817|NCT02709109|323004346|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
94333818|NCT02709109|323004347|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
94333819|NCT02709109|323004348|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
94333820|NCT02709109|323004349|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
94333821|NCT02709109|323004346|FG000|Treatment Period 2 (28 Days)|Other|0|||
94333822|NCT02709109|323004347|FG001|Treatment Period 2 (28 Days)|Other|0|||
94333823|NCT02709109|323004348|FG002|Treatment Period 2 (28 Days)|Other|1|||
94333824|NCT02709109|323004349|FG003|Treatment Period 2 (28 Days)|Other|0|||
94333825|NCT00345540|323004350|FG000|Overall Study|Withdrawal by Subject|1|||
94333826|NCT00141037|323004351|FG000|Overall Study|Physician Decision|1|||
94333827|NCT00141037|323004352|FG001|Overall Study|Physician Decision|2|||
94333828|NCT00141037|323004351|FG000|Overall Study|Lost to Follow-up|3|||
94333829|NCT00141037|323004352|FG001|Overall Study|Lost to Follow-up|1|||
94333830|NCT00141037|323004351|FG000|Overall Study|Protocol Violation|0|||
94333831|NCT00141037|323004352|FG001|Overall Study|Protocol Violation|2|||
94333832|NCT00141037|323004351|FG000|Overall Study|Withdrawal by Subject|2|||
94333833|NCT00141037|323004352|FG001|Overall Study|Withdrawal by Subject|1|||
94333834|NCT00141037|323004351|FG000|Overall Study|Other|0|||
94333835|NCT00141037|323004352|FG001|Overall Study|Other|1|||
94333836|NCT00141037|323004351|FG000|Overall Study|Moved from area|1|||
94333837|NCT00141037|323004352|FG001|Overall Study|Moved from area|7|||
94333838|NCT00141037|323004351|FG000|Overall Study|Graft Failure|3|||
94333839|NCT00141037|323004352|FG001|Overall Study|Graft Failure|4|||
94333840|NCT00861380|323004353|FG000|Overall Study|Withdrawal Information not recorded|8427|||
94333841|NCT00861380|323004354|FG001|Overall Study|Withdrawal Information not recorded|9112|||
94333842|NCT00861380|323004355|FG002|Overall Study|Withdrawal Information not recorded|8872|||
94333843|NCT00861380|323004356|FG003|Overall Study|Withdrawal Information not recorded|3689|||
94333844|NCT00861380|323004357|FG004|Overall Study|Withdrawal Information not recorded|1812|||
94333845|NCT00861380|323004358|FG005|Overall Study|Withdrawal Information not recorded|6249|||
94333846|NCT00861380|323004359|FG006|Overall Study|Withdrawal Information not recorded|3020|||
94333847|NCT00637377|323004365|FG000|Overall Study|Adverse Event|2|||
94333848|NCT00637377|323004366|FG001|Overall Study|Adverse Event|6|||
94333849|NCT00637377|323004367|FG002|Overall Study|Adverse Event|8|||
94333850|NCT00637377|323004368|FG003|Overall Study|Adverse Event|9|||
94333851|NCT00637377|323004365|FG000|Overall Study|Death|1|||
94333852|NCT00637377|323004366|FG001|Overall Study|Death|3|||
94333853|NCT00637377|323004367|FG002|Overall Study|Death|2|||
94333854|NCT00637377|323004368|FG003|Overall Study|Death|1|||
94333855|NCT00637377|323004365|FG000|Overall Study|Lack of Efficacy|0|||
94333856|NCT00637377|323004366|FG001|Overall Study|Lack of Efficacy|0|||
94333857|NCT00637377|323004367|FG002|Overall Study|Lack of Efficacy|1|||
94333858|NCT00637377|323004368|FG003|Overall Study|Lack of Efficacy|1|||
94333859|NCT00637377|323004365|FG000|Overall Study|Lost to Follow-up|4|||
94333860|NCT00637377|323004366|FG001|Overall Study|Lost to Follow-up|1|||
94333861|NCT00637377|323004367|FG002|Overall Study|Lost to Follow-up|2|||
94333862|NCT00637377|323004368|FG003|Overall Study|Lost to Follow-up|2|||
94333863|NCT00637377|323004365|FG000|Overall Study|Protocol Violation|2|||
94333864|NCT00637377|323004366|FG001|Overall Study|Protocol Violation|1|||
94333865|NCT00637377|323004367|FG002|Overall Study|Protocol Violation|1|||
94333866|NCT00637377|323004368|FG003|Overall Study|Protocol Violation|0|||
94333867|NCT00637377|323004365|FG000|Overall Study|Withdrawal by Subject|11|||
94333868|NCT00637377|323004366|FG001|Overall Study|Withdrawal by Subject|15|||
94333869|NCT00637377|323004367|FG002|Overall Study|Withdrawal by Subject|13|||
94333870|NCT00637377|323004368|FG003|Overall Study|Withdrawal by Subject|11|||
94333871|NCT00637377|323004365|FG000|Overall Study|Other (no further information available)|7|||
94333872|NCT00637377|323004366|FG001|Overall Study|Other (no further information available)|6|||
94333873|NCT00637377|323004367|FG002|Overall Study|Other (no further information available)|10|||
94333874|NCT00637377|323004368|FG003|Overall Study|Other (no further information available)|5|||
94333875|NCT02925312|323004369|FG000|Overall Study|Lost to Follow-up|25|||
94333876|NCT02925312|323004370|FG001|Overall Study|Lost to Follow-up|0|||
94333877|NCT02925312|323004369|FG000|Overall Study|Adverse Event|2|||
94333878|NCT02925312|323004370|FG001|Overall Study|Adverse Event|0|||
94333879|NCT02427100|323004371|FG000|Overall Study|Lost to Follow-up|0|||
94333880|NCT02427100|323004372|FG001|Overall Study|Lost to Follow-up|2|||
94333881|NCT00617591|323004373|FG000|Overall Study|Withdrew consent during Induction|4|||
94333882|NCT00617591|323004373|FG000|Overall Study|Withdrew consent during Maintenance|6|||
94333883|NCT00376246|323004375|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
94333884|NCT00376246|323004376|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
94333885|NCT00376246|323004375|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
94333886|NCT00376246|323004376|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
94333887|NCT00376246|323004375|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
94333888|NCT00376246|323004376|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
94333889|NCT00166517|323004382|FG000|Overall Study|Lost to Follow-up|1|||
94333890|NCT00166517|323004383|FG001|Overall Study|Lost to Follow-up|0|||
94333891|NCT00166517|323004382|FG000|Overall Study|Protocol Violation|4|||
94333892|NCT00166517|323004383|FG001|Overall Study|Protocol Violation|1|||
94333893|NCT00166517|323004382|FG000|Overall Study|Withdrawal by Subject|0|||
94333894|NCT00166517|323004383|FG001|Overall Study|Withdrawal by Subject|1|||
94333895|NCT01496274|323004384|FG000|Overall Study|Protocol Violation|0|||
94333896|NCT01496274|323004385|FG001|Overall Study|Protocol Violation|1|||
94333897|NCT01496274|323004384|FG000|Overall Study|Adverse Event|1|||
94333898|NCT01496274|323004385|FG001|Overall Study|Adverse Event|1|||
94333899|NCT01496274|323004384|FG000|Overall Study|Withdrawal by Subject|2|||
94333900|NCT01496274|323004385|FG001|Overall Study|Withdrawal by Subject|0|||
94333901|NCT01496274|323004384|FG000|Overall Study|Lost to Follow-up|0|||
94333902|NCT01496274|323004385|FG001|Overall Study|Lost to Follow-up|3|||
94333903|NCT02758613|323004386|FG000|Treatment|Physician and Sponsor Decision|1|||
94333904|NCT02758613|323004387|FG001|Treatment|Physician and Sponsor Decision|0|||
94333905|NCT02758613|323004388|FG002|Treatment|Physician and Sponsor Decision|0|||
94333906|NCT02758613|323004389|FG003|Treatment|Physician and Sponsor Decision|0|||
94333907|NCT02758613|323004386|FG000|Treatment|Withdrawal by Subject|1|||
94333908|NCT02758613|323004387|FG001|Treatment|Withdrawal by Subject|0|||
94333909|NCT02758613|323004388|FG002|Treatment|Withdrawal by Subject|1|||
94333910|NCT02758613|323004389|FG003|Treatment|Withdrawal by Subject|0|||
94333911|NCT01459068|323004392|FG000|Overall Study|Withdrawal by Subject|8|||
94333912|NCT01459068|323004393|FG001|Overall Study|Withdrawal by Subject|18|||
94333913|NCT01459068|323004392|FG000|Overall Study|Lost to Follow-up|31|||
94333914|NCT01459068|323004393|FG001|Overall Study|Lost to Follow-up|15|||
94333915|NCT01459068|323004392|FG000|Overall Study|Death|0|||
94333916|NCT01459068|323004393|FG001|Overall Study|Death|1|||
94333917|NCT02910219|323004394|FG000|Overall Study|Withdrawal by Subject|1|||
94333918|NCT02910219|323004395|FG001|Overall Study|Withdrawal by Subject|1|||
94333919|NCT00669032|323004402|FG000|Overall Study|Lost to Follow-up|6|||
94333920|NCT00669032|323004403|FG001|Overall Study|Lost to Follow-up|5|||
94333921|NCT00669032|323004402|FG000|Overall Study|Lack of Efficacy|8|||
94333922|NCT00669032|323004403|FG001|Overall Study|Lack of Efficacy|19|||
94333923|NCT00669032|323004402|FG000|Overall Study|Withdrawal by Subject|12|||
94333924|NCT00669032|323004403|FG001|Overall Study|Withdrawal by Subject|13|||
94333925|NCT00669032|323004402|FG000|Overall Study|Adverse Event|12|||
94333926|NCT00669032|323004403|FG001|Overall Study|Adverse Event|16|||
94333927|NCT00669032|323004402|FG000|Overall Study|Physician Decision|1|||
94333928|NCT00669032|323004403|FG001|Overall Study|Physician Decision|1|||
94333929|NCT00669032|323004402|FG000|Overall Study|No fulfilment of the selection criteria|5|||
94333930|NCT00669032|323004403|FG001|Overall Study|No fulfilment of the selection criteria|5|||
94333931|NCT01068717|323004408|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
94333932|NCT01068717|323004409|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
94333933|NCT01068717|323004410|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
94333934|NCT01068717|323004411|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
94333935|NCT01203787|323004414|FG000|Overall Study|Death|12|||
94333936|NCT01203787|323004415|FG001|Overall Study|Death|10|||
94333937|NCT01203787|323004414|FG000|Overall Study|Withdrawal by Subject|6|||
94333938|NCT01203787|323004415|FG001|Overall Study|Withdrawal by Subject|2|||
94333939|NCT01203787|323004414|FG000|Overall Study|Lost to Follow-up|2|||
94333940|NCT01203787|323004415|FG001|Overall Study|Lost to Follow-up|0|||
94333941|NCT01203787|323004414|FG000|Overall Study|Adverse Event|11|||
94333942|NCT01203787|323004415|FG001|Overall Study|Adverse Event|15|||
94333943|NCT01915095|323004416|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
94333944|NCT01915095|323004417|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
94333945|NCT01915095|323004418|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
94333946|NCT01915095|323004419|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
94333947|NCT01915095|323004420|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
94333948|NCT04018612|323004421|FG000|Overall Study|Withdrawal by Subject|1|||
94333949|NCT04018612|323004422|FG001|Overall Study|Withdrawal by Subject|0|||
94333950|NCT04018612|323004423|FG002|Overall Study|Withdrawal by Subject|1|||
94333951|NCT02671760|323004424|FG000|Overall Study|Lost to Follow-up|0|||
94333952|NCT02671760|323004425|FG001|Overall Study|Lost to Follow-up|1|||
94333953|NCT02671760|323004426|FG002|Overall Study|Lost to Follow-up|0|||
94333954|NCT03693404|323004429|FG000|Overall Study|Withdrawal by Subject|1|||
94333955|NCT03693404|323004430|FG001|Overall Study|Withdrawal by Subject|0|||
94333956|NCT03693404|323004429|FG000|Overall Study|Lost to Follow-up|0|||
94333957|NCT03693404|323004430|FG001|Overall Study|Lost to Follow-up|5|||
94333958|NCT03693404|323004429|FG000|Overall Study|Excluded from Analysis|0|||
94333959|NCT03693404|323004430|FG001|Overall Study|Excluded from Analysis|1|||
94333960|NCT01802515|323004431|FG000|Overall Study|Withdrawal by Subject|3|||
94333961|NCT01802515|323004432|FG001|Overall Study|Withdrawal by Subject|0|||
94333962|NCT01802515|323004433|FG002|Overall Study|Withdrawal by Subject|0|||
94333963|NCT00651313|323004434|FG000|Overall Study|Adverse Event|0|||
94333964|NCT00651313|323004435|FG001|Overall Study|Adverse Event|1|||
94333965|NCT00651313|323004434|FG000|Overall Study|Withdrawal by Subject|3|||
94333966|NCT00651313|323004435|FG001|Overall Study|Withdrawal by Subject|1|||
94333967|NCT00651313|323004434|FG000|Overall Study|Lost to Follow-up|1|||
94333968|NCT00651313|323004435|FG001|Overall Study|Lost to Follow-up|1|||
94333969|NCT00651313|323004434|FG000|Overall Study|Adminstrative Discontinuation|2|||
94333970|NCT00651313|323004435|FG001|Overall Study|Adminstrative Discontinuation|3|||
94333971|NCT02290340|323004436|FG000|Overall Study|Lost to Follow-up|0|||
94333972|NCT02290340|323004437|FG001|Overall Study|Lost to Follow-up|0|||
94333973|NCT02290340|323004438|FG002|Overall Study|Lost to Follow-up|0|||
94333974|NCT02290340|323004439|FG003|Overall Study|Lost to Follow-up|1|||
94333975|NCT02290340|323004436|FG000|Overall Study|Withdrawal by Subject|1|||
94333976|NCT02290340|323004437|FG001|Overall Study|Withdrawal by Subject|0|||
94333977|NCT02290340|323004438|FG002|Overall Study|Withdrawal by Subject|0|||
94333978|NCT02290340|323004439|FG003|Overall Study|Withdrawal by Subject|0|||
94333979|NCT02290340|323004436|FG000|Overall Study|Other|1|||
94333980|NCT02290340|323004437|FG001|Overall Study|Other|0|||
94333981|NCT02290340|323004438|FG002|Overall Study|Other|0|||
94333982|NCT02290340|323004439|FG003|Overall Study|Other|1|||
94333983|NCT02571972|323004447|FG000|Overall Study|Protocol Violation|2|||
94333984|NCT02571972|323004447|FG000|Overall Study|Withdrawal by Subject|2|||
94333985|NCT04021706|323006038|FG000|Overall Study|Adverse Event|2|||
94333986|NCT04021706|323006039|FG001|Overall Study|Adverse Event|0|||
94333987|NCT04021706|323006038|FG000|Overall Study|Withdrawal by Subject|1|||
94333988|NCT04021706|323006039|FG001|Overall Study|Withdrawal by Subject|2|||
94333989|NCT04021706|323006038|FG000|Overall Study|Physician Decision|1|||
94333990|NCT04021706|323006039|FG001|Overall Study|Physician Decision|0|||
94333991|NCT02688153|323006047|FG000|Overall Study|Death|7|||
94333992|NCT02688153|323006048|FG001|Overall Study|Death|5|||
94333993|NCT02688153|323006047|FG000|Overall Study|Withdrawal by Subject|4|||
94333994|NCT02688153|323006048|FG001|Overall Study|Withdrawal by Subject|2|||
94333995|NCT02688153|323006047|FG000|Overall Study|Valve Explant|1|||
94333996|NCT02688153|323006048|FG001|Overall Study|Valve Explant|0|||
94333997|NCT02688153|323006047|FG000|Overall Study|Conversion to Commercial Valve|3|||
94333998|NCT02688153|323006048|FG001|Overall Study|Conversion to Commercial Valve|0|||
94333999|NCT00107172|323006049|FG000|Overall Study|Withdrawal by Subject|1|||
94334000|NCT00107172|323006050|FG001|Overall Study|Withdrawal by Subject|0|||
94334001|NCT00107172|323006049|FG000|Overall Study|Death|0|||
94334002|NCT00107172|323006050|FG001|Overall Study|Death|2|||
94334003|NCT00107172|323006049|FG000|Overall Study|Other Reason|4|||
94334004|NCT00107172|323006050|FG001|Overall Study|Other Reason|3|||
94334005|NCT01102140|323006051|FG000|Overall Study|Lost to Follow-up|1|||
94334006|NCT01102140|323006052|FG001|Overall Study|Lost to Follow-up|0|||
94334007|NCT01102140|323006051|FG000|Overall Study|Investigator terminated study|2|||
94334008|NCT01102140|323006052|FG001|Overall Study|Investigator terminated study|2|||
94334009|NCT00191386|323006053|FG000|Overall Study|Adverse Event|16|||
94334010|NCT00191386|323006053|FG000|Overall Study|Lost to Follow-up|1|||
94334011|NCT00191386|323006053|FG000|Overall Study|Entry Criteria Exclusion|3|||
94334012|NCT00191386|323006053|FG000|Overall Study|Protocol Violation|18|||
94334013|NCT00191386|323006053|FG000|Overall Study|Withdrawal by Subject|96|||
94334014|NCT00191386|323006053|FG000|Overall Study|Physician Decision|11|||
94334015|NCT00191386|323006053|FG000|Overall Study|Lack of Efficacy|15|||
94334016|NCT02088541|323006054|FG000|Overall Study|Adverse Event|3|||
94334017|NCT02088541|323006055|FG001|Overall Study|Adverse Event|0|||
94334018|NCT02088541|323006056|FG002|Overall Study|Adverse Event|3|||
94334019|NCT02088541|323006057|FG003|Overall Study|Adverse Event|3|||
94334020|NCT02088541|323006058|FG004|Overall Study|Adverse Event|0|||
94334021|NCT02088541|323006054|FG000|Overall Study|Death|51|||
94334022|NCT02088541|323006055|FG001|Overall Study|Death|21|||
94334023|NCT02088541|323006056|FG002|Overall Study|Death|85|||
94334024|NCT02088541|323006057|FG003|Overall Study|Death|28|||
94334025|NCT02088541|323006058|FG004|Overall Study|Death|38|||
94334026|NCT02088541|323006054|FG000|Overall Study|Lost to Follow-up|2|||
94334027|NCT02088541|323006055|FG001|Overall Study|Lost to Follow-up|0|||
94334028|NCT02088541|323006056|FG002|Overall Study|Lost to Follow-up|1|||
94334029|NCT02088541|323006057|FG003|Overall Study|Lost to Follow-up|0|||
94334030|NCT02088541|323006058|FG004|Overall Study|Lost to Follow-up|0|||
94334031|NCT02088541|323006054|FG000|Overall Study|Physician Decision|2|||
94334032|NCT02088541|323006055|FG001|Overall Study|Physician Decision|1|||
94334033|NCT02088541|323006056|FG002|Overall Study|Physician Decision|2|||
94334034|NCT02088541|323006057|FG003|Overall Study|Physician Decision|0|||
94334035|NCT02088541|323006058|FG004|Overall Study|Physician Decision|2|||
94334036|NCT02088541|323006054|FG000|Overall Study|Disease progression|7|||
94334037|NCT02088541|323006055|FG001|Overall Study|Disease progression|1|||
94334038|NCT02088541|323006056|FG002|Overall Study|Disease progression|2|||
94334039|NCT02088541|323006057|FG003|Overall Study|Disease progression|3|||
94334040|NCT02088541|323006058|FG004|Overall Study|Disease progression|1|||
94334041|NCT02088541|323006054|FG000|Overall Study|Study terminated by sponsor|1|||
94334042|NCT02088541|323006055|FG001|Overall Study|Study terminated by sponsor|1|||
94334043|NCT02088541|323006056|FG002|Overall Study|Study terminated by sponsor|12|||
94334044|NCT02088541|323006057|FG003|Overall Study|Study terminated by sponsor|2|||
94334045|NCT02088541|323006058|FG004|Overall Study|Study terminated by sponsor|6|||
94334046|NCT02088541|323006054|FG000|Overall Study|Withdrawal by Subject|3|||
94334047|NCT02088541|323006055|FG001|Overall Study|Withdrawal by Subject|2|||
94334048|NCT02088541|323006056|FG002|Overall Study|Withdrawal by Subject|9|||
94334049|NCT02088541|323006057|FG003|Overall Study|Withdrawal by Subject|7|||
94334050|NCT02088541|323006058|FG004|Overall Study|Withdrawal by Subject|10|||
94334051|NCT02088541|323006054|FG000|Overall Study|Other|2|||
94334052|NCT02088541|323006055|FG001|Overall Study|Other|1|||
94334053|NCT02088541|323006056|FG002|Overall Study|Other|3|||
94334054|NCT02088541|323006057|FG003|Overall Study|Other|1|||
94334055|NCT02088541|323006058|FG004|Overall Study|Other|1|||
94334056|NCT04038385|323006060|FG000|Overall Study|Completed baseline assessment only|7|||
94334057|NCT04038385|323006061|FG001|Overall Study|Completed baseline assessment only|4|||
94334058|NCT04038385|323006060|FG000|Overall Study|Moved out of area|4|||
94334059|NCT04038385|323006061|FG001|Overall Study|Moved out of area|2|||
94334060|NCT04038385|323006060|FG000|Overall Study|Discontinued study involvement|6|||
94334061|NCT04038385|323006061|FG001|Overall Study|Discontinued study involvement|1|||
94334062|NCT02009930|323006063|FG000|Overall Study|withdrawn|5|||
94334063|NCT03250624|323006064|FG000|Overall Study|Lack of Efficacy|1|||
94334064|NCT03250624|323006065|FG001|Overall Study|Lack of Efficacy|4|||
94334065|NCT03250624|323006064|FG000|Overall Study|Adverse Event|0|||
94334066|NCT03250624|323006065|FG001|Overall Study|Adverse Event|1|||
94334067|NCT03250624|323006064|FG000|Overall Study|Other|1|||
94334068|NCT03250624|323006065|FG001|Overall Study|Other|2|||
94334069|NCT02657434|323006066|FG000|Overall Study|Study Terminated By Sponsor|64|||
94334070|NCT02657434|323006067|FG001|Overall Study|Study Terminated By Sponsor|82|||
94334071|NCT02657434|323006066|FG000|Overall Study|Death|189|||
94334072|NCT02657434|323006067|FG001|Overall Study|Death|190|||
94334073|NCT02657434|323006066|FG000|Overall Study|Lost to Follow-up|2|||
94334074|NCT02657434|323006067|FG001|Overall Study|Lost to Follow-up|2|||
94334075|NCT02657434|323006066|FG000|Overall Study|Randomization by Error|2|||
94334076|NCT02657434|323006067|FG001|Overall Study|Randomization by Error|0|||
94334077|NCT02657434|323006066|FG000|Overall Study|Withdrawal by Subject|28|||
94334078|NCT02657434|323006067|FG001|Overall Study|Withdrawal by Subject|17|||
94334079|NCT02657434|323006066|FG000|Overall Study|Protocol Violation|1|||
94334080|NCT02657434|323006067|FG001|Overall Study|Protocol Violation|0|||
94334081|NCT02657434|323006066|FG000|Overall Study|Physician Decision|0|||
94334082|NCT02657434|323006067|FG001|Overall Study|Physician Decision|1|||
94334083|NCT04897594|323006068|FG000|Overall Study|Lost to Follow-up|0|||
94334084|NCT04897594|323006069|FG001|Overall Study|Lost to Follow-up|1|||
94334085|NCT04897594|323006070|FG002|Overall Study|Lost to Follow-up|1|||
94334086|NCT04897594|323006068|FG000|Overall Study|Sponsor Decision|0|||
94334087|NCT04897594|323006069|FG001|Overall Study|Sponsor Decision|0|||
94334088|NCT04897594|323006070|FG002|Overall Study|Sponsor Decision|1|||
94334089|NCT04897594|323006068|FG000|Overall Study|Withdrawal by Subject|1|||
94334090|NCT04897594|323006069|FG001|Overall Study|Withdrawal by Subject|0|||
94334091|NCT04897594|323006070|FG002|Overall Study|Withdrawal by Subject|1|||
94334092|NCT00810043|323006073|FG000|Overall Study|Withdrawal by Subject|1|||
94334093|NCT00810043|323006074|FG001|Overall Study|Withdrawal by Subject|0|||
94334094|NCT00810043|323006075|FG002|Overall Study|Withdrawal by Subject|2|||
94334095|NCT00810043|323006073|FG000|Overall Study|Lost to Follow-up|1|||
94334096|NCT00810043|323006074|FG001|Overall Study|Lost to Follow-up|0|||
94334097|NCT00810043|323006075|FG002|Overall Study|Lost to Follow-up|0|||
94334098|NCT00810043|323006073|FG000|Overall Study|Physician Decision|0|||
94334099|NCT00810043|323006074|FG001|Overall Study|Physician Decision|0|||
94334100|NCT00810043|323006075|FG002|Overall Study|Physician Decision|2|||
94334101|NCT00810043|323006073|FG000|Overall Study|Death|2|||
94334102|NCT00810043|323006074|FG001|Overall Study|Death|0|||
94334103|NCT00810043|323006075|FG002|Overall Study|Death|0|||
94334104|NCT00810043|323006073|FG000|Overall Study|Unrelated medical problem|0|||
94334105|NCT00810043|323006074|FG001|Overall Study|Unrelated medical problem|1|||
94334106|NCT00810043|323006075|FG002|Overall Study|Unrelated medical problem|0|||
94334107|NCT00810043|323006073|FG000|Overall Study|Non-medical problem|0|||
94334108|NCT00810043|323006074|FG001|Overall Study|Non-medical problem|0|||
94334109|NCT00810043|323006075|FG002|Overall Study|Non-medical problem|1|||
94334110|NCT00810043|323006073|FG000|Overall Study|No longer met enrollment criteria|0|||
94334111|NCT00810043|323006074|FG001|Overall Study|No longer met enrollment criteria|0|||
94334112|NCT00810043|323006075|FG002|Overall Study|No longer met enrollment criteria|3|||
94334113|NCT00443846|323006076|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
94334114|NCT00443846|323006077|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
94334115|NCT00443846|323006076|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
94334116|NCT00443846|323006077|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
94334117|NCT00443846|323006076|FG000|Overall Study|Adverse Event|0|||
94334118|NCT00443846|323006077|FG001|Overall Study|Adverse Event|1|||
94334119|NCT00443846|323006076|FG000|Overall Study|Personal reason|8|||
94334120|NCT00443846|323006077|FG001|Overall Study|Personal reason|3|||
94334121|NCT00443846|323006076|FG000|Overall Study|Lost to Follow-up|1|||
94334122|NCT00443846|323006077|FG001|Overall Study|Lost to Follow-up|2|||
94334123|NCT00282568|323006085|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
94334124|NCT00282568|323006085|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
94334125|NCT00282568|323006085|FG000|Extended Treatment Period|Adverse Event|17|||
94334126|NCT00282568|323006085|FG000|Extended Treatment Period|Non-compliance|4|||
94334127|NCT00282568|323006085|FG000|Extended Treatment Period|Physician Decision|1|||
94334128|NCT00282568|323006085|FG000|Extended Treatment Period|Lost to Follow-up|2|||
94334129|NCT03689972|323006086|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
94334130|NCT03689972|323006087|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
94334131|NCT03689972|323006088|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
94334132|NCT03689972|323006089|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
94334133|NCT03689972|323006090|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
94334134|NCT03689972|323006086|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
94334135|NCT03689972|323006087|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
94334136|NCT03689972|323006088|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
94334137|NCT03689972|323006089|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
94334138|NCT03689972|323006090|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
94334139|NCT03689972|323006086|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
94334140|NCT03689972|323006087|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
94334141|NCT03689972|323006088|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
94334142|NCT03689972|323006089|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
94334143|NCT03689972|323006090|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
94334144|NCT03689972|323006086|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
94334145|NCT03689972|323006087|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
94334146|NCT03689972|323006088|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
94334147|NCT03689972|323006089|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
94334148|NCT03689972|323006090|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
94334149|NCT03689972|323006086|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
94334150|NCT03689972|323006087|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
94334151|NCT03689972|323006088|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
94334152|NCT03689972|323006089|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
94334153|NCT03689972|323006090|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
94334154|NCT03689972|323006086|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
94334155|NCT03689972|323006087|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
94334156|NCT03689972|323006088|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
94334157|NCT03689972|323006089|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
94334158|NCT03689972|323006090|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
94334159|NCT03689972|323006086|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
94334160|NCT03689972|323006087|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
94334161|NCT03689972|323006088|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
94334162|NCT03689972|323006089|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
94334163|NCT03689972|323006090|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
94334164|NCT03689972|323006086|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
94334165|NCT03689972|323006087|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
94334166|NCT03689972|323006088|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
94334167|NCT03689972|323006089|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
94334168|NCT03689972|323006090|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
94334169|NCT03689972|323006086|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
94334170|NCT03689972|323006087|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
94334171|NCT03689972|323006088|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
94334172|NCT03689972|323006089|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
94334173|NCT03689972|323006090|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
94334174|NCT03689972|323006086|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
94334175|NCT03689972|323006087|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
94334176|NCT03689972|323006088|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
94334177|NCT03689972|323006089|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
94334178|NCT03689972|323006090|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
94334179|NCT03689972|323006086|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
94334180|NCT03689972|323006087|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
94334181|NCT03689972|323006088|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
94334182|NCT03689972|323006089|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
94334183|NCT03689972|323006090|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
94334184|NCT03689972|323006086|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
94334185|NCT03689972|323006087|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
94334186|NCT03689972|323006088|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
94334187|NCT03689972|323006089|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
94334188|NCT03689972|323006090|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
94334189|NCT03689972|323006086|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
94334190|NCT03689972|323006087|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
94334191|NCT03689972|323006088|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
94334192|NCT03689972|323006089|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
94334193|NCT03689972|323006090|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
94334194|NCT03689972|323006086|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
94334195|NCT03689972|323006087|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
94334196|NCT03689972|323006088|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
94334197|NCT03689972|323006089|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
94334198|NCT03689972|323006090|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
94334199|NCT03689972|323006086|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
94334200|NCT03689972|323006087|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
94334201|NCT03689972|323006088|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
94334202|NCT03689972|323006089|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
94334203|NCT03689972|323006090|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
94334204|NCT03689972|323006086|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
94334205|NCT03689972|323006087|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
94334206|NCT03689972|323006088|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
94334207|NCT03689972|323006089|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
94334208|NCT03689972|323006090|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
94334209|NCT03689972|323006086|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
94334210|NCT03689972|323006087|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
94334211|NCT03689972|323006088|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
94334212|NCT03689972|323006089|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
94334213|NCT03689972|323006090|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
94334214|NCT03689972|323006086|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
94334215|NCT03689972|323006087|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
94334216|NCT03689972|323006088|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
94334217|NCT03689972|323006089|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
94334218|NCT03689972|323006090|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
94334219|NCT03689972|323006086|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
94334220|NCT03689972|323006087|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
94334221|NCT03689972|323006088|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
94334222|NCT03689972|323006089|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
94334223|NCT03689972|323006090|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
94334224|NCT00990249|323006093|FG000|Overall Study|Disease Progression|8|||
94334225|NCT00990249|323006093|FG000|Overall Study|Non-Compliance|1|||
94334226|NCT00990249|323006093|FG000|Overall Study|Death|2|||
94334227|NCT00990249|323006093|FG000|Overall Study|Not treated|2|||
94334228|NCT00973622|323006094|FG000|Overall Study|did not attend MRI|14|||
94334229|NCT00973622|323006095|FG001|Overall Study|did not attend MRI|3|||
94334230|NCT00973622|323006094|FG000|Overall Study|did not pass MRI screen|6|||
94334231|NCT00973622|323006095|FG001|Overall Study|did not pass MRI screen|0|||
94334232|NCT00973622|323006094|FG000|Overall Study|did not complete rTMS sessions|11|||
94334233|NCT00973622|323006095|FG001|Overall Study|did not complete rTMS sessions|2|||
94334234|NCT01061567|323006098|FG000|Overall Study|Adverse Event|32|||
94334235|NCT01061567|323006098|FG000|Overall Study|Death|2|||
94334236|NCT01061567|323006098|FG000|Overall Study|Lack of Efficacy|3|||
94334237|NCT01061567|323006098|FG000|Overall Study|Lost to Follow-up|24|||
94334238|NCT01061567|323006098|FG000|Overall Study|Protocol Violation|1|||
94334239|NCT01061567|323006098|FG000|Overall Study|Withdrawal by Subject|11|||
94334240|NCT01061567|323006098|FG000|Overall Study|Other reason than stated above|3|||
94334241|NCT00114218|323006102|FG000|Overall Study|Wrong Cell Type|2|||
94334242|NCT00114218|323006102|FG000|Overall Study|Wrong Primary|1|||
94334243|NCT00114218|323006102|FG000|Overall Study|Never Treated|1|||
94334244|NCT00291187|323006103|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
94334245|NCT00291187|323006104|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
94334246|NCT00291187|323006105|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
94334247|NCT00291187|323006106|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
94334248|NCT01040845|323006108|FG000|Overall Study|Withdrawal by Subject|1|||
94334249|NCT01040845|323006109|FG001|Overall Study|Withdrawal by Subject|1|||
94334250|NCT01040845|323006108|FG000|Overall Study|Physician Decision|1|||
94334251|NCT01040845|323006109|FG001|Overall Study|Physician Decision|0|||
94334252|NCT00968708|323006110|FG000|Overall Study|Adverse Event|169|||
94334253|NCT00968708|323006111|FG001|Overall Study|Adverse Event|150|||
94334254|NCT00968708|323006110|FG000|Overall Study|Major Protocol Deviation|0|||
94334255|NCT00968708|323006111|FG001|Overall Study|Major Protocol Deviation|1|||
94334256|NCT00968708|323006110|FG000|Overall Study|Lost to Follow-up|19|||
94334257|NCT00968708|323006111|FG001|Overall Study|Lost to Follow-up|11|||
94334258|NCT00968708|323006110|FG000|Overall Study|Voluntary Withdrawal|104|||
94334259|NCT00968708|323006111|FG001|Overall Study|Voluntary Withdrawal|101|||
94334260|NCT00968708|323006110|FG000|Overall Study|Investigator Discretion|0|||
94334261|NCT00968708|323006111|FG001|Overall Study|Investigator Discretion|1|||
94334262|NCT00968708|323006110|FG000|Overall Study|Other|26|||
94334263|NCT00968708|323006111|FG001|Overall Study|Other|34|||
94334264|NCT00928512|323006120|FG000|Overall Study|Adverse Event|4|||
94334265|NCT00928512|323006121|FG001|Overall Study|Adverse Event|3|||
94334266|NCT00928512|323006122|FG002|Overall Study|Adverse Event|2|||
94334267|NCT00928512|323006123|FG003|Overall Study|Adverse Event|8|||
94334268|NCT00928512|323006124|FG004|Overall Study|Adverse Event|6|||
94334269|NCT00928512|323006120|FG000|Overall Study|Lack of Efficacy|2|||
94334270|NCT00928512|323006121|FG001|Overall Study|Lack of Efficacy|0|||
94334271|NCT00928512|323006122|FG002|Overall Study|Lack of Efficacy|4|||
94334272|NCT00928512|323006123|FG003|Overall Study|Lack of Efficacy|7|||
94334273|NCT00928512|323006124|FG004|Overall Study|Lack of Efficacy|3|||
94334274|NCT00928512|323006120|FG000|Overall Study|Protocol Violation|0|||
94334275|NCT00928512|323006121|FG001|Overall Study|Protocol Violation|1|||
94334276|NCT00928512|323006122|FG002|Overall Study|Protocol Violation|0|||
94334277|NCT00928512|323006123|FG003|Overall Study|Protocol Violation|1|||
94334278|NCT00928512|323006124|FG004|Overall Study|Protocol Violation|3|||
94334279|NCT00928512|323006120|FG000|Overall Study|Withdrawal by Subject|3|||
94334280|NCT00928512|323006121|FG001|Overall Study|Withdrawal by Subject|0|||
94334281|NCT00928512|323006122|FG002|Overall Study|Withdrawal by Subject|3|||
94334282|NCT00928512|323006123|FG003|Overall Study|Withdrawal by Subject|4|||
94334283|NCT00928512|323006124|FG004|Overall Study|Withdrawal by Subject|0|||
94334284|NCT00928512|323006120|FG000|Overall Study|Lost to Follow-up|1|||
94334285|NCT00928512|323006121|FG001|Overall Study|Lost to Follow-up|1|||
94334286|NCT00928512|323006122|FG002|Overall Study|Lost to Follow-up|2|||
94334287|NCT00928512|323006123|FG003|Overall Study|Lost to Follow-up|1|||
94334288|NCT00928512|323006124|FG004|Overall Study|Lost to Follow-up|3|||
94334289|NCT00928512|323006120|FG000|Overall Study|Administrative Problems|0|||
94334290|NCT00928512|323006121|FG001|Overall Study|Administrative Problems|1|||
94334291|NCT00928512|323006122|FG002|Overall Study|Administrative Problems|0|||
94334292|NCT00928512|323006123|FG003|Overall Study|Administrative Problems|0|||
94334293|NCT00928512|323006124|FG004|Overall Study|Administrative Problems|0|||
94334294|NCT03383614|323006125|FG000|Overall Study|Withdrawal by Subject|0|||
94334295|NCT03383614|323006126|FG001|Overall Study|Withdrawal by Subject|1|||
94334296|NCT03383614|323006127|FG002|Overall Study|Withdrawal by Subject|0|||
94334297|NCT03383614|323006128|FG003|Overall Study|Withdrawal by Subject|0|||
94334298|NCT01975675|323006129|FG000|Overall Study|Death|0|||
94334299|NCT01975675|323006130|FG001|Overall Study|Death|1|||
94334300|NCT01975675|323006131|FG002|Overall Study|Death|0|||
94334301|NCT01975675|323006132|FG003|Overall Study|Death|0|||
94334302|NCT02224638|323006138|FG000|Overall Study|Adverse Event|1|||
94334303|NCT02224638|323006139|FG001|Overall Study|Adverse Event|1|||
94334304|NCT05563714|323006142|FG000|Overall Study|Death|2|||
94334305|NCT05563714|323006143|FG001|Overall Study|Death|2|||
94334306|NCT05563714|323006144|FG002|Overall Study|Death|0|||
94334307|NCT05563714|323006145|FG003|Overall Study|Death|0|||
94334308|NCT05563714|323006142|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
94334309|NCT05563714|323006143|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
94334310|NCT05563714|323006144|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
94334311|NCT05563714|323006145|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
94334312|NCT05563714|323006142|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
94334313|NCT05563714|323006143|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
94334314|NCT05563714|323006144|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
94334315|NCT05563714|323006145|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
94334316|NCT05563714|323006142|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
94334317|NCT05563714|323006143|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
94334318|NCT05563714|323006144|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
94334319|NCT05563714|323006145|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
94334320|NCT05563714|323006142|FG000|Overall Study|Lost to Follow-up|22|||
94334321|NCT05563714|323006143|FG001|Overall Study|Lost to Follow-up|19|||
94334322|NCT05563714|323006144|FG002|Overall Study|Lost to Follow-up|0|||
94334323|NCT05563714|323006145|FG003|Overall Study|Lost to Follow-up|0|||
94334324|NCT02142504|323006151|FG000|Overall Study|Protocol Violation|2|||
94334325|NCT02142504|323006152|FG001|Overall Study|Protocol Violation|1|||
94334326|NCT02142504|323006153|FG002|Overall Study|Protocol Violation|2|||
94334327|NCT02142504|323006151|FG000|Overall Study|Adverse Event|2|||
94334328|NCT02142504|323006152|FG001|Overall Study|Adverse Event|3|||
94334329|NCT02142504|323006153|FG002|Overall Study|Adverse Event|4|||
94334330|NCT02142504|323006151|FG000|Overall Study|Lost to Follow-up|12|||
94334331|NCT02142504|323006152|FG001|Overall Study|Lost to Follow-up|19|||
94334332|NCT02142504|323006153|FG002|Overall Study|Lost to Follow-up|17|||
94334333|NCT02142504|323006151|FG000|Overall Study|Withdrawal by Subject|7|||
94334334|NCT02142504|323006152|FG001|Overall Study|Withdrawal by Subject|9|||
94334335|NCT02142504|323006153|FG002|Overall Study|Withdrawal by Subject|11|||
94334336|NCT02142504|323006151|FG000|Overall Study|Pregnancy|4|||
94334337|NCT02142504|323006152|FG001|Overall Study|Pregnancy|4|||
94334338|NCT02142504|323006153|FG002|Overall Study|Pregnancy|2|||
94334339|NCT02142504|323006151|FG000|Overall Study|Physician Decision|0|||
94334340|NCT02142504|323006152|FG001|Overall Study|Physician Decision|1|||
94334341|NCT02142504|323006153|FG002|Overall Study|Physician Decision|3|||
94334342|NCT02142504|323006151|FG000|Overall Study|Reason Not Specified|4|||
94334343|NCT02142504|323006152|FG001|Overall Study|Reason Not Specified|5|||
94334344|NCT02142504|323006153|FG002|Overall Study|Reason Not Specified|4|||
94334345|NCT04114539|323006159|FG000|Overall Study|Adverse Event|14|||
94334346|NCT04114539|323006159|FG000|Overall Study|Lost to Follow-up|2|||
94334347|NCT04114539|323006159|FG000|Overall Study|Non-compliance with Protocol|2|||
94334348|NCT04114539|323006159|FG000|Overall Study|Non-compliance with Study Drug|1|||
94334349|NCT04114539|323006159|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
94334350|NCT04114539|323006159|FG000|Overall Study|Withdrew consent|10|||
94334351|NCT04114539|323006159|FG000|Overall Study|Others not specified|5|||
94334352|NCT04114539|323006159|FG000|Overall Study|Investigator Decision|2|||
94334353|NCT00351819|323006164|FG000|Overall Study|Lost to Follow-up|4|||
94334354|NCT00351819|323006165|FG001|Overall Study|Lost to Follow-up|4|||
94334355|NCT00351819|323006164|FG000|Overall Study|Withdrawal by Subject|0|||
94334356|NCT00351819|323006165|FG001|Overall Study|Withdrawal by Subject|4|||
94334357|NCT00351819|323006164|FG000|Overall Study|Elevated PSA|1|||
94334358|NCT00351819|323006165|FG001|Overall Study|Elevated PSA|1|||
94334359|NCT00351819|323006164|FG000|Overall Study|Traumatic ankle fracture|1|||
94334360|NCT00351819|323006165|FG001|Overall Study|Traumatic ankle fracture|0|||
94334361|NCT00351819|323006164|FG000|Overall Study|Unprofessional behavior|1|||
94334362|NCT00351819|323006165|FG001|Overall Study|Unprofessional behavior|0|||
94334363|NCT00351819|323006164|FG000|Overall Study|Non-compliance|0|||
94334364|NCT00351819|323006165|FG001|Overall Study|Non-compliance|1|||
94334365|NCT00351819|323006164|FG000|Overall Study|Incarcerated|0|||
94334366|NCT00351819|323006165|FG001|Overall Study|Incarcerated|1|||
94334367|NCT00351819|323006164|FG000|Overall Study|Enrolled in another trial|0|||
94334368|NCT00351819|323006165|FG001|Overall Study|Enrolled in another trial|1|||
94334369|NCT01400139|323006166|FG000|HYD Core Study|Adverse Event|210|||
94334370|NCT01400139|323006166|FG000|HYD Core Study|Lack of Efficacy|59|||
94334371|NCT01400139|323006166|FG000|HYD Core Study|Withdrawal by Subject|114|||
94334372|NCT01400139|323006166|FG000|HYD Core Study|Lost to Follow-up|39|||
94334373|NCT01400139|323006166|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
94334374|NCT01400139|323006166|FG000|HYD Core Study|Administrative|56|||
94334375|NCT01400139|323006166|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
94334376|NCT01400139|323006166|FG000|HYD Extension Period|Adverse Event|8|||
94334377|NCT01400139|323006166|FG000|HYD Extension Period|Withdrawal by Subject|5|||
94334378|NCT01400139|323006166|FG000|HYD Extension Period|Administrative|10|||
94334379|NCT01142193|323006167|FG000|Overall Study|Adverse Event|12|||
94334380|NCT01142193|323006168|FG001|Overall Study|Adverse Event|4|||
94334381|NCT01142193|323006167|FG000|Overall Study|Lack of Efficacy|2|||
94334382|NCT01142193|323006168|FG001|Overall Study|Lack of Efficacy|1|||
94334383|NCT01142193|323006167|FG000|Overall Study|Physician Decision|1|||
94334384|NCT01142193|323006168|FG001|Overall Study|Physician Decision|1|||
94334385|NCT01142193|323006167|FG000|Overall Study|Withdrawal by Subject|4|||
94334386|NCT01142193|323006168|FG001|Overall Study|Withdrawal by Subject|3|||
94334387|NCT01142193|323006167|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
94334388|NCT01142193|323006168|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
94334389|NCT01142193|323006167|FG000|Overall Study|Other|1|||
94334390|NCT01142193|323006168|FG001|Overall Study|Other|2|||
94334391|NCT01015820|323006170|FG000|Overall Study|Suboptimal measurements|1|||
94334392|NCT01015820|323006171|FG001|Overall Study|Suboptimal measurements|0|||
94334393|NCT00701441|323006172|FG000|Overall Study|failure in cpap compliance|0|||
94334394|NCT00701441|323006173|FG001|Overall Study|failure in cpap compliance|4|||
94334395|NCT02679781|323006177|FG000|Overall Study|Lost to Follow-up|1|||
94334396|NCT02679781|323006178|FG001|Overall Study|Lost to Follow-up|2|||
94334397|NCT02679781|323006177|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
94334398|NCT02679781|323006178|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
94334399|NCT00643448|323006183|FG000|Overall Study|Lack of Efficacy|2|||
94334400|NCT00643448|323006184|FG001|Overall Study|Lack of Efficacy|0|||
94334401|NCT00643448|323006185|FG002|Overall Study|Lack of Efficacy|4|||
94334402|NCT00643448|323006183|FG000|Overall Study|Adverse Event|2|||
94334403|NCT00643448|323006184|FG001|Overall Study|Adverse Event|2|||
94334404|NCT00643448|323006185|FG002|Overall Study|Adverse Event|2|||
94334405|NCT00643448|323006183|FG000|Overall Study|QTcF>550 ms|0|||
94334406|NCT00643448|323006184|FG001|Overall Study|QTcF>550 ms|3|||
94334407|NCT00643448|323006185|FG002|Overall Study|QTcF>550 ms|0|||
94334408|NCT04268303|323008239|FG000|Overall Study|Lost to Follow-up|1|||
94334409|NCT04268303|323008240|FG001|Overall Study|Lost to Follow-up|1|||
94334410|NCT04268303|323008241|FG002|Overall Study|Lost to Follow-up|2|||
94334411|NCT04268303|323008239|FG000|Overall Study|Withdrawal by Subject|0|||
94334412|NCT04268303|323008240|FG001|Overall Study|Withdrawal by Subject|1|||
94334413|NCT04268303|323008241|FG002|Overall Study|Withdrawal by Subject|1|||
94334414|NCT04268303|323008239|FG000|Overall Study|Adverse Event|2|||
94334415|NCT04268303|323008240|FG001|Overall Study|Adverse Event|0|||
94334416|NCT04268303|323008241|FG002|Overall Study|Adverse Event|0|||
94334417|NCT03682055|323008242|FG000|Overall Study|Lack of Efficacy|1|||
94334418|NCT03682055|323008243|FG001|Overall Study|Lack of Efficacy|2|||
94334419|NCT03682055|323008244|FG002|Overall Study|Lack of Efficacy|1|||
94334420|NCT03682055|323008245|FG003|Overall Study|Lack of Efficacy|2|||
94334421|NCT03682055|323008246|FG004|Overall Study|Lack of Efficacy|1|||
94334422|NCT03682055|323008247|FG005|Overall Study|Lack of Efficacy|3|||
94334423|NCT03682055|323008242|FG000|Overall Study|Withdrawal by Subject|0|||
94334424|NCT03682055|323008243|FG001|Overall Study|Withdrawal by Subject|0|||
94334425|NCT03682055|323008244|FG002|Overall Study|Withdrawal by Subject|0|||
94334426|NCT03682055|323008245|FG003|Overall Study|Withdrawal by Subject|0|||
94334427|NCT03682055|323008246|FG004|Overall Study|Withdrawal by Subject|0|||
94334428|NCT03682055|323008247|FG005|Overall Study|Withdrawal by Subject|1|||
94334429|NCT03682055|323008242|FG000|Overall Study|Termination of Study by Sponsor|0|||
94334430|NCT03682055|323008243|FG001|Overall Study|Termination of Study by Sponsor|0|||
94334431|NCT03682055|323008244|FG002|Overall Study|Termination of Study by Sponsor|0|||
94334432|NCT03682055|323008245|FG003|Overall Study|Termination of Study by Sponsor|0|||
94334433|NCT03682055|323008246|FG004|Overall Study|Termination of Study by Sponsor|0|||
94334434|NCT03682055|323008247|FG005|Overall Study|Termination of Study by Sponsor|3|||
94334435|NCT00859573|323008249|FG000|Overall Study|Withdrawal by Subject|4|||
94334436|NCT00859573|323008250|FG001|Overall Study|Withdrawal by Subject|1|||
94334437|NCT00859573|323008249|FG000|Overall Study|Physician Decision|1|||
94334438|NCT00859573|323008250|FG001|Overall Study|Physician Decision|1|||
94334439|NCT03621189|323008251|FG000|Overall Study|Withdrawal by Subject|0|||
94334440|NCT03621189|323008252|FG001|Overall Study|Withdrawal by Subject|3|||
94334441|NCT03621189|323008251|FG000|Overall Study|Physician Decision|0|||
94334442|NCT03621189|323008252|FG001|Overall Study|Physician Decision|2|||
94334443|NCT01135394|323008253|FG000|Screening|Lost to Follow-up|2|||
94334444|NCT01135394|323008253|FG000|Screening|Withdrawal by Subject|10|||
94334445|NCT01135394|323008253|FG000|Screening|Screening failure|16|||
94334446|NCT01135394|323008253|FG000|Screening|Physician Decision|5|||
94334447|NCT01135394|323008253|FG000|Baseline Assessment|Withdrawal by Subject|9|||
94334448|NCT01135394|323008253|FG000|Baseline Assessment|Physician Decision|3|||
94334449|NCT01135394|323008253|FG000|Baseline Assessment|Lost to Follow-up|2|||
94334450|NCT01135394|323008253|FG000|Baseline Assessment|Adverse Event|1|||
94334451|NCT01135394|323008253|FG000|Study Treatment|Withdrawal by Subject|1|||
94334452|NCT01135394|323008253|FG000|Study Treatment|Physician Decision|1|||
94334453|NCT01135394|323008253|FG000|Study Treatment|Adverse Event|2|||
94334454|NCT04134728|323008254|FG000|Overall Study|Adverse Event|3|||
94334455|NCT04134728|323008255|FG001|Overall Study|Adverse Event|2|||
94334456|NCT04134728|323008256|FG002|Overall Study|Adverse Event|9|||
94334457|NCT04134728|323008257|FG003|Overall Study|Adverse Event|0|||
94334458|NCT04134728|323008258|FG004|Overall Study|Adverse Event|0|||
94334459|NCT04134728|323008259|FG005|Overall Study|Adverse Event|0|||
94334460|NCT04134728|323008254|FG000|Overall Study|Lack of Efficacy|3|||
94334461|NCT04134728|323008255|FG001|Overall Study|Lack of Efficacy|3|||
94334462|NCT04134728|323008256|FG002|Overall Study|Lack of Efficacy|1|||
94334463|NCT04134728|323008257|FG003|Overall Study|Lack of Efficacy|2|||
94334464|NCT04134728|323008258|FG004|Overall Study|Lack of Efficacy|0|||
94334465|NCT04134728|323008259|FG005|Overall Study|Lack of Efficacy|0|||
94334466|NCT04134728|323008254|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
94334467|NCT04134728|323008255|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
94334468|NCT04134728|323008256|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
94334469|NCT04134728|323008257|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
94334470|NCT04134728|323008258|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
94334471|NCT04134728|323008259|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
94334472|NCT04134728|323008254|FG000|Overall Study|Protocol Deviation|0|||
94334473|NCT04134728|323008255|FG001|Overall Study|Protocol Deviation|0|||
94334474|NCT04134728|323008256|FG002|Overall Study|Protocol Deviation|1|||
94334475|NCT04134728|323008257|FG003|Overall Study|Protocol Deviation|0|||
94334476|NCT04134728|323008258|FG004|Overall Study|Protocol Deviation|0|||
94334477|NCT04134728|323008259|FG005|Overall Study|Protocol Deviation|0|||
94334478|NCT04134728|323008254|FG000|Overall Study|Informed Consent Withdrawn|3|||
94334479|NCT04134728|323008255|FG001|Overall Study|Informed Consent Withdrawn|6|||
94334480|NCT04134728|323008256|FG002|Overall Study|Informed Consent Withdrawn|8|||
94334481|NCT04134728|323008257|FG003|Overall Study|Informed Consent Withdrawn|1|||
94334482|NCT04134728|323008258|FG004|Overall Study|Informed Consent Withdrawn|1|||
94334483|NCT04134728|323008259|FG005|Overall Study|Informed Consent Withdrawn|0|||
94334484|NCT04134728|323008254|FG000|Overall Study|Physician Decision|2|||
94334485|NCT04134728|323008255|FG001|Overall Study|Physician Decision|0|||
94334486|NCT04134728|323008256|FG002|Overall Study|Physician Decision|0|||
94334487|NCT04134728|323008257|FG003|Overall Study|Physician Decision|0|||
94334488|NCT04134728|323008258|FG004|Overall Study|Physician Decision|0|||
94334489|NCT04134728|323008259|FG005|Overall Study|Physician Decision|0|||
94334490|NCT04134728|323008254|FG000|Overall Study|Lost to Follow-up|1|||
94334491|NCT04134728|323008255|FG001|Overall Study|Lost to Follow-up|2|||
94334492|NCT04134728|323008256|FG002|Overall Study|Lost to Follow-up|1|||
94334493|NCT04134728|323008257|FG003|Overall Study|Lost to Follow-up|0|||
94334494|NCT04134728|323008258|FG004|Overall Study|Lost to Follow-up|0|||
94334495|NCT04134728|323008259|FG005|Overall Study|Lost to Follow-up|1|||
94334496|NCT04134728|323008254|FG000|Overall Study|Investigator Site Closed|0|||
94334497|NCT04134728|323008255|FG001|Overall Study|Investigator Site Closed|1|||
94334498|NCT04134728|323008256|FG002|Overall Study|Investigator Site Closed|1|||
94334499|NCT04134728|323008257|FG003|Overall Study|Investigator Site Closed|0|||
94334500|NCT04134728|323008258|FG004|Overall Study|Investigator Site Closed|0|||
94334501|NCT04134728|323008259|FG005|Overall Study|Investigator Site Closed|0|||
94334502|NCT02715804|323008260|FG000|Overall Study|Death|222|||
94334503|NCT02715804|323008261|FG001|Overall Study|Death|106|||
94334504|NCT02715804|323008260|FG000|Overall Study|Withdrawal by Subject|5|||
94334505|NCT02715804|323008261|FG001|Overall Study|Withdrawal by Subject|4|||
94334506|NCT02715804|323008260|FG000|Overall Study|Other than specified|2|||
94334507|NCT02715804|323008261|FG001|Overall Study|Other than specified|3|||
94334508|NCT02971007|323008263|FG000|Overall Study|Adverse Event|1|||
94334509|NCT02971007|323008264|FG001|Overall Study|Adverse Event|0|||
94334510|NCT02971007|323008265|FG002|Overall Study|Adverse Event|0|||
94334511|NCT02971007|323008263|FG000|Overall Study|Lost to Follow-up|0|||
94334512|NCT02971007|323008264|FG001|Overall Study|Lost to Follow-up|1|||
94334513|NCT02971007|323008265|FG002|Overall Study|Lost to Follow-up|1|||
94334514|NCT02971007|323008263|FG000|Overall Study|Withdrawal by Subject|0|||
94334515|NCT02971007|323008264|FG001|Overall Study|Withdrawal by Subject|1|||
94334516|NCT02971007|323008265|FG002|Overall Study|Withdrawal by Subject|0|||
94334517|NCT02971007|323008263|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
94334518|NCT02971007|323008264|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
94334519|NCT02971007|323008265|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
94334520|NCT02971007|323008263|FG000|Overall Study|Patient discontinued study drug|0|||
94334521|NCT02971007|323008264|FG001|Overall Study|Patient discontinued study drug|1|||
94334522|NCT02971007|323008265|FG002|Overall Study|Patient discontinued study drug|0|||
94334523|NCT02707601|323008268|FG000|Overall Study|Death|0|||
94334524|NCT02707601|323008269|FG001|Overall Study|Death|1|||
94334525|NCT02707601|323008268|FG000|Overall Study|Lack of Efficacy|0|||
94334526|NCT02707601|323008269|FG001|Overall Study|Lack of Efficacy|1|||
94334527|NCT02707601|323008268|FG000|Overall Study|Investigator's Discretion|1|||
94334528|NCT02707601|323008269|FG001|Overall Study|Investigator's Discretion|0|||
94334529|NCT02707601|323008268|FG000|Overall Study|Withdrew Consent|0|||
94334530|NCT02707601|323008269|FG001|Overall Study|Withdrew Consent|1|||
94334531|NCT02707601|323008268|FG000|Overall Study|Lost to Follow-up|1|||
94334532|NCT02707601|323008269|FG001|Overall Study|Lost to Follow-up|1|||
94334533|NCT02707601|323008268|FG000|Overall Study|Participants Randomized but Not Treated|2|||
94334534|NCT02707601|323008269|FG001|Overall Study|Participants Randomized but Not Treated|0|||
94334535|NCT03907969|323008270|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
94334536|NCT03907969|323008271|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
94334537|NCT03907969|323008272|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
94334538|NCT03907969|323008273|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
94334539|NCT03907969|323008274|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
94334540|NCT03907969|323008275|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
94334541|NCT03907969|323008276|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
94334542|NCT03907969|323008277|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
94334543|NCT03907969|323008278|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
94334544|NCT03907969|323008279|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
94334545|NCT03907969|323008280|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
94334546|NCT03907969|323008270|FG000|Monotherapy Part A|Progressive Disease|0|||
94334547|NCT03907969|323008271|FG001|Monotherapy Part A|Progressive Disease|1|||
94334548|NCT03907969|323008272|FG002|Monotherapy Part A|Progressive Disease|0|||
94334549|NCT03907969|323008273|FG003|Monotherapy Part A|Progressive Disease|0|||
94334550|NCT03907969|323008274|FG004|Monotherapy Part A|Progressive Disease|0|||
94334551|NCT03907969|323008275|FG005|Monotherapy Part A|Progressive Disease|1|||
94334552|NCT03907969|323008276|FG006|Monotherapy Part A|Progressive Disease|2|||
94334553|NCT03907969|323008277|FG007|Monotherapy Part A|Progressive Disease|0|||
94334554|NCT03907969|323008278|FG008|Monotherapy Part A|Progressive Disease|0|||
94334555|NCT03907969|323008279|FG009|Monotherapy Part A|Progressive Disease|0|||
94334556|NCT03907969|323008280|FG010|Monotherapy Part A|Progressive Disease|0|||
94334557|NCT03907969|323008270|FG000|Monotherapy Part A|Death|0|||
94334558|NCT03907969|323008271|FG001|Monotherapy Part A|Death|0|||
94334559|NCT03907969|323008272|FG002|Monotherapy Part A|Death|1|||
94334560|NCT03907969|323008273|FG003|Monotherapy Part A|Death|1|||
94334561|NCT03907969|323008274|FG004|Monotherapy Part A|Death|0|||
94334562|NCT03907969|323008275|FG005|Monotherapy Part A|Death|1|||
94334563|NCT03907969|323008276|FG006|Monotherapy Part A|Death|0|||
94334564|NCT03907969|323008277|FG007|Monotherapy Part A|Death|0|||
94334565|NCT03907969|323008278|FG008|Monotherapy Part A|Death|0|||
94334566|NCT03907969|323008279|FG009|Monotherapy Part A|Death|0|||
94334567|NCT03907969|323008280|FG010|Monotherapy Part A|Death|0|||
94334568|NCT03907969|323008270|FG000|Combination Therapy Part A|Adverse Event|0|||
94334569|NCT03907969|323008271|FG001|Combination Therapy Part A|Adverse Event|0|||
94334570|NCT03907969|323008272|FG002|Combination Therapy Part A|Adverse Event|0|||
94334571|NCT03907969|323008273|FG003|Combination Therapy Part A|Adverse Event|0|||
94334572|NCT03907969|323008274|FG004|Combination Therapy Part A|Adverse Event|0|||
94334573|NCT03907969|323008275|FG005|Combination Therapy Part A|Adverse Event|0|||
94334574|NCT03907969|323008276|FG006|Combination Therapy Part A|Adverse Event|0|||
94334575|NCT03907969|323008277|FG007|Combination Therapy Part A|Adverse Event|0|||
94334576|NCT03907969|323008278|FG008|Combination Therapy Part A|Adverse Event|0|||
94334577|NCT03907969|323008279|FG009|Combination Therapy Part A|Adverse Event|1|||
94334578|NCT03907969|323008280|FG010|Combination Therapy Part A|Adverse Event|1|||
94334579|NCT03907969|323008270|FG000|Combination Therapy Part A|Progressive disease|0|||
94334580|NCT03907969|323008271|FG001|Combination Therapy Part A|Progressive disease|0|||
94334581|NCT03907969|323008272|FG002|Combination Therapy Part A|Progressive disease|0|||
94334582|NCT03907969|323008273|FG003|Combination Therapy Part A|Progressive disease|0|||
94334583|NCT03907969|323008274|FG004|Combination Therapy Part A|Progressive disease|0|||
94334584|NCT03907969|323008275|FG005|Combination Therapy Part A|Progressive disease|0|||
94334585|NCT03907969|323008276|FG006|Combination Therapy Part A|Progressive disease|0|||
94334586|NCT03907969|323008277|FG007|Combination Therapy Part A|Progressive disease|1|||
94334587|NCT03907969|323008278|FG008|Combination Therapy Part A|Progressive disease|0|||
94334588|NCT03907969|323008279|FG009|Combination Therapy Part A|Progressive disease|2|||
94334589|NCT03907969|323008280|FG010|Combination Therapy Part A|Progressive disease|3|||
94334590|NCT03907969|323008270|FG000|Combination Therapy Part A|Death|0|||
94334591|NCT03907969|323008271|FG001|Combination Therapy Part A|Death|0|||
94334592|NCT03907969|323008272|FG002|Combination Therapy Part A|Death|0|||
94334593|NCT03907969|323008273|FG003|Combination Therapy Part A|Death|0|||
94334594|NCT03907969|323008274|FG004|Combination Therapy Part A|Death|0|||
94334595|NCT03907969|323008275|FG005|Combination Therapy Part A|Death|0|||
94334596|NCT03907969|323008276|FG006|Combination Therapy Part A|Death|0|||
94334597|NCT03907969|323008277|FG007|Combination Therapy Part A|Death|0|||
94334598|NCT03907969|323008278|FG008|Combination Therapy Part A|Death|1|||
94334599|NCT03907969|323008279|FG009|Combination Therapy Part A|Death|0|||
94334600|NCT03907969|323008280|FG010|Combination Therapy Part A|Death|1|||
94334601|NCT03907969|323008270|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
94334602|NCT03907969|323008271|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
94334603|NCT03907969|323008272|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
94334604|NCT03907969|323008273|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
94334605|NCT03907969|323008274|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
94334606|NCT03907969|323008275|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
94334607|NCT03907969|323008276|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
94334608|NCT03907969|323008277|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
94334609|NCT03907969|323008278|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
94334610|NCT03907969|323008279|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
94334611|NCT03907969|323008280|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
94334612|NCT03907969|323008270|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
94334613|NCT03907969|323008271|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
94334614|NCT03907969|323008272|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
94334615|NCT03907969|323008273|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
94334616|NCT03907969|323008274|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
94334617|NCT03907969|323008275|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
94334618|NCT03907969|323008276|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
94334619|NCT03907969|323008277|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
94334620|NCT03907969|323008278|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
94334621|NCT03907969|323008279|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
94334622|NCT03907969|323008280|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
94334623|NCT03907969|323008270|FG000|Combination Therapy Part A|Physician Decision|0|||
94334624|NCT03907969|323008271|FG001|Combination Therapy Part A|Physician Decision|0|||
94334625|NCT03907969|323008272|FG002|Combination Therapy Part A|Physician Decision|0|||
94334626|NCT03907969|323008273|FG003|Combination Therapy Part A|Physician Decision|0|||
94334627|NCT03907969|323008274|FG004|Combination Therapy Part A|Physician Decision|0|||
94334628|NCT03907969|323008275|FG005|Combination Therapy Part A|Physician Decision|0|||
94334629|NCT03907969|323008276|FG006|Combination Therapy Part A|Physician Decision|0|||
94334630|NCT03907969|323008277|FG007|Combination Therapy Part A|Physician Decision|1|||
94334631|NCT03907969|323008278|FG008|Combination Therapy Part A|Physician Decision|0|||
94334632|NCT03907969|323008279|FG009|Combination Therapy Part A|Physician Decision|0|||
94334633|NCT03907969|323008280|FG010|Combination Therapy Part A|Physician Decision|1|||
94334634|NCT02327078|323008281|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
94334635|NCT02327078|323008282|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
94334636|NCT02327078|323008283|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
94334637|NCT02327078|323008284|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
94334638|NCT02327078|323008285|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
94334639|NCT02327078|323008286|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
94334640|NCT02327078|323008287|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
94334641|NCT02327078|323008288|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
94334642|NCT02327078|323008289|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
94334643|NCT02327078|323008281|FG000|Overall Study|Death|2|||
94334644|NCT02327078|323008282|FG001|Overall Study|Death|4|||
94334645|NCT02327078|323008283|FG002|Overall Study|Death|10|||
94334646|NCT02327078|323008284|FG003|Overall Study|Death|6|||
94334647|NCT02327078|323008285|FG004|Overall Study|Death|4|||
94334648|NCT02327078|323008286|FG005|Overall Study|Death|3|||
94334649|NCT02327078|323008287|FG006|Overall Study|Death|2|||
94334650|NCT02327078|323008288|FG007|Overall Study|Death|51|||
94334651|NCT02327078|323008289|FG008|Overall Study|Death|97|||
94334652|NCT02327078|323008281|FG000|Overall Study|Lost to Follow-up|0|||
94334653|NCT02327078|323008282|FG001|Overall Study|Lost to Follow-up|1|||
94334654|NCT02327078|323008283|FG002|Overall Study|Lost to Follow-up|1|||
94334655|NCT02327078|323008284|FG003|Overall Study|Lost to Follow-up|0|||
94334656|NCT02327078|323008285|FG004|Overall Study|Lost to Follow-up|0|||
94334657|NCT02327078|323008286|FG005|Overall Study|Lost to Follow-up|0|||
94334658|NCT02327078|323008287|FG006|Overall Study|Lost to Follow-up|0|||
94334659|NCT02327078|323008288|FG007|Overall Study|Lost to Follow-up|2|||
94334660|NCT02327078|323008289|FG008|Overall Study|Lost to Follow-up|5|||
94651325|NCT02460224|324179735|FG020|Overall Study|Progressive disease|4|||
94334661|NCT02327078|323008281|FG000|Overall Study|Site Terminated by Sponsor|1|||
94334662|NCT02327078|323008282|FG001|Overall Study|Site Terminated by Sponsor|0|||
94334663|NCT02327078|323008283|FG002|Overall Study|Site Terminated by Sponsor|1|||
94334664|NCT02327078|323008284|FG003|Overall Study|Site Terminated by Sponsor|4|||
94334665|NCT02327078|323008285|FG004|Overall Study|Site Terminated by Sponsor|0|||
94334666|NCT02327078|323008286|FG005|Overall Study|Site Terminated by Sponsor|0|||
94334667|NCT02327078|323008287|FG006|Overall Study|Site Terminated by Sponsor|0|||
94334668|NCT02327078|323008288|FG007|Overall Study|Site Terminated by Sponsor|11|||
94334669|NCT02327078|323008289|FG008|Overall Study|Site Terminated by Sponsor|25|||
94334670|NCT02327078|323008281|FG000|Overall Study|Physician Decision|0|||
94334671|NCT02327078|323008282|FG001|Overall Study|Physician Decision|0|||
94334672|NCT02327078|323008283|FG002|Overall Study|Physician Decision|0|||
94334673|NCT02327078|323008284|FG003|Overall Study|Physician Decision|1|||
94334674|NCT02327078|323008285|FG004|Overall Study|Physician Decision|0|||
94334675|NCT02327078|323008286|FG005|Overall Study|Physician Decision|0|||
94334676|NCT02327078|323008287|FG006|Overall Study|Physician Decision|0|||
94334677|NCT02327078|323008288|FG007|Overall Study|Physician Decision|0|||
94334678|NCT02327078|323008289|FG008|Overall Study|Physician Decision|1|||
94334679|NCT02327078|323008281|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
94334680|NCT02327078|323008282|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
94334681|NCT02327078|323008283|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
94334682|NCT02327078|323008284|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
94334683|NCT02327078|323008285|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
94334684|NCT02327078|323008286|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
94334685|NCT02327078|323008287|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
94334686|NCT02327078|323008288|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
94334687|NCT02327078|323008289|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
94334688|NCT02327078|323008281|FG000|Overall Study|Reason not Specified|0|||
94334689|NCT02327078|323008282|FG001|Overall Study|Reason not Specified|0|||
94334690|NCT02327078|323008283|FG002|Overall Study|Reason not Specified|0|||
94334691|NCT02327078|323008284|FG003|Overall Study|Reason not Specified|0|||
94334692|NCT02327078|323008285|FG004|Overall Study|Reason not Specified|0|||
94334693|NCT02327078|323008286|FG005|Overall Study|Reason not Specified|0|||
94334694|NCT02327078|323008287|FG006|Overall Study|Reason not Specified|0|||
94334695|NCT02327078|323008288|FG007|Overall Study|Reason not Specified|5|||
94334696|NCT02327078|323008289|FG008|Overall Study|Reason not Specified|12|||
94334697|NCT03228394|323008294|FG000|Overall Study|Lost to Follow-up|0|||
94334698|NCT03228394|323008295|FG001|Overall Study|Lost to Follow-up|0|||
94334699|NCT03228394|323008296|FG002|Overall Study|Lost to Follow-up|1|||
94334700|NCT03228394|323008297|FG003|Overall Study|Lost to Follow-up|1|||
94334701|NCT03228394|323008298|FG004|Overall Study|Lost to Follow-up|0|||
94334702|NCT03228394|323008299|FG005|Overall Study|Lost to Follow-up|0|||
94334703|NCT03228394|323008300|FG006|Overall Study|Lost to Follow-up|2|||
94334704|NCT03228394|323008301|FG007|Overall Study|Lost to Follow-up|0|||
94334705|NCT03228394|323008294|FG000|Overall Study|Withdrawal by Subject|0|||
94334706|NCT03228394|323008295|FG001|Overall Study|Withdrawal by Subject|0|||
94334707|NCT03228394|323008296|FG002|Overall Study|Withdrawal by Subject|1|||
94334708|NCT03228394|323008297|FG003|Overall Study|Withdrawal by Subject|0|||
94334709|NCT03228394|323008298|FG004|Overall Study|Withdrawal by Subject|0|||
94334710|NCT03228394|323008299|FG005|Overall Study|Withdrawal by Subject|0|||
94334711|NCT03228394|323008300|FG006|Overall Study|Withdrawal by Subject|1|||
94334712|NCT03228394|323008301|FG007|Overall Study|Withdrawal by Subject|3|||
94334713|NCT03228394|323008294|FG000|Overall Study|Protocol Violation|0|||
94334714|NCT03228394|323008295|FG001|Overall Study|Protocol Violation|0|||
94334715|NCT03228394|323008296|FG002|Overall Study|Protocol Violation|0|||
94334716|NCT03228394|323008297|FG003|Overall Study|Protocol Violation|1|||
94334717|NCT03228394|323008298|FG004|Overall Study|Protocol Violation|0|||
94334718|NCT03228394|323008299|FG005|Overall Study|Protocol Violation|0|||
94334719|NCT03228394|323008300|FG006|Overall Study|Protocol Violation|0|||
94334720|NCT03228394|323008301|FG007|Overall Study|Protocol Violation|0|||
94334721|NCT03228394|323008294|FG000|Overall Study|Physician Decision|0|||
94334722|NCT03228394|323008295|FG001|Overall Study|Physician Decision|0|||
94334723|NCT03228394|323008296|FG002|Overall Study|Physician Decision|0|||
94334724|NCT03228394|323008297|FG003|Overall Study|Physician Decision|0|||
94334725|NCT03228394|323008298|FG004|Overall Study|Physician Decision|0|||
94334726|NCT03228394|323008299|FG005|Overall Study|Physician Decision|0|||
94334727|NCT03228394|323008300|FG006|Overall Study|Physician Decision|1|||
94334728|NCT03228394|323008301|FG007|Overall Study|Physician Decision|0|||
94334729|NCT03228394|323008294|FG000|Overall Study|Noncompliance|0|||
94334730|NCT03228394|323008295|FG001|Overall Study|Noncompliance|0|||
94334731|NCT03228394|323008296|FG002|Overall Study|Noncompliance|0|||
94334732|NCT03228394|323008297|FG003|Overall Study|Noncompliance|0|||
94334733|NCT03228394|323008298|FG004|Overall Study|Noncompliance|0|||
94334734|NCT03228394|323008299|FG005|Overall Study|Noncompliance|0|||
94334735|NCT03228394|323008300|FG006|Overall Study|Noncompliance|1|||
94334736|NCT03228394|323008301|FG007|Overall Study|Noncompliance|0|||
94334737|NCT02633046|323008307|FG000|Overall Study|Adverse Event|8|||
94334738|NCT02633046|323008307|FG000|Overall Study|Physician Decision|7|||
94334739|NCT02633046|323008307|FG000|Overall Study|Withdrawal by Subject|8|||
94334740|NCT02633046|323008307|FG000|Overall Study|Increased proteinuria|2|||
94334741|NCT02633046|323008307|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
94334742|NCT02633046|323008307|FG000|Overall Study|Mutual decision patient and physician|1|||
94334743|NCT02120352|323008308|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
94334744|NCT02120352|323008309|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
94334745|NCT02120352|323008310|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
94334746|NCT02120352|323008311|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
94334747|NCT02120352|323008312|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
94334748|NCT02120352|323008313|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
94334749|NCT02120352|323008314|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
94334750|NCT02120352|323008308|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
94334751|NCT02120352|323008309|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
94334752|NCT02120352|323008310|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
94334753|NCT02120352|323008311|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
94334754|NCT02120352|323008312|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
94334755|NCT02120352|323008313|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
94334756|NCT02120352|323008314|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
94334757|NCT02120352|323008308|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
94334758|NCT02120352|323008309|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
94334759|NCT02120352|323008310|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
94334760|NCT02120352|323008311|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
94334761|NCT02120352|323008312|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
94334762|NCT02120352|323008313|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
94334763|NCT02120352|323008314|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
94334764|NCT02120352|323008308|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
94334765|NCT02120352|323008309|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
94334766|NCT02120352|323008310|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
94334767|NCT02120352|323008311|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
94334768|NCT02120352|323008312|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
94334769|NCT02120352|323008313|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
94334770|NCT02120352|323008314|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
94334771|NCT02120352|323008308|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
94334772|NCT02120352|323008309|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
94334773|NCT02120352|323008310|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
94334774|NCT02120352|323008311|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
94334775|NCT02120352|323008312|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
94334776|NCT02120352|323008313|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
94334777|NCT02120352|323008314|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
94334778|NCT02120352|323008308|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
94334779|NCT02120352|323008309|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
94334780|NCT02120352|323008310|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
94334781|NCT02120352|323008311|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
94334782|NCT02120352|323008312|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
94334783|NCT02120352|323008313|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
94334784|NCT02120352|323008314|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
94334785|NCT02120352|323008308|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
94334786|NCT02120352|323008309|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
94334787|NCT02120352|323008310|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
94334788|NCT02120352|323008311|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
94334789|NCT02120352|323008312|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
94334790|NCT02120352|323008313|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
94334791|NCT02120352|323008314|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
94334792|NCT02120352|323008308|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
94334793|NCT02120352|323008309|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
94334794|NCT02120352|323008310|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
94334795|NCT02120352|323008311|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
94334796|NCT02120352|323008312|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
94334797|NCT02120352|323008313|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
94334798|NCT02120352|323008314|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
94334799|NCT02120352|323008308|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
94334800|NCT02120352|323008309|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
94334801|NCT02120352|323008310|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
94334802|NCT02120352|323008311|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
94334803|NCT02120352|323008312|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
94334804|NCT02120352|323008313|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
94334805|NCT02120352|323008314|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
94651326|NCT02460224|324179736|FG021|Overall Study|Progressive disease|9|||
94334806|NCT02120352|323008308|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
94334807|NCT02120352|323008309|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
94334808|NCT02120352|323008310|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
94334809|NCT02120352|323008311|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
94334810|NCT02120352|323008312|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
94334811|NCT02120352|323008313|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
94334812|NCT02120352|323008314|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
94334813|NCT02120352|323008308|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
94334814|NCT02120352|323008309|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
94334815|NCT02120352|323008310|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
94334816|NCT02120352|323008311|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
94334817|NCT02120352|323008312|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
94334818|NCT02120352|323008313|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
94334819|NCT02120352|323008314|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
94334820|NCT02120352|323008308|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
94334821|NCT02120352|323008309|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
94334822|NCT02120352|323008310|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
94334823|NCT02120352|323008311|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
94334824|NCT02120352|323008312|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
94334825|NCT02120352|323008313|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
94334826|NCT02120352|323008314|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
94334827|NCT02120352|323008308|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
94334828|NCT02120352|323008309|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
94334829|NCT02120352|323008310|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
94334830|NCT02120352|323008311|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
94334831|NCT02120352|323008312|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
94334832|NCT02120352|323008313|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
94334833|NCT02120352|323008314|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
94334834|NCT02120352|323008308|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
94334835|NCT02120352|323008309|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
94334836|NCT02120352|323008310|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
94334837|NCT02120352|323008311|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
94334838|NCT02120352|323008312|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
94334839|NCT02120352|323008313|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
94334840|NCT02120352|323008314|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
94334841|NCT02120352|323008308|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
94334842|NCT02120352|323008309|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
94334843|NCT02120352|323008310|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
94334844|NCT02120352|323008311|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
94334845|NCT02120352|323008312|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
94334846|NCT02120352|323008313|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
94334847|NCT02120352|323008314|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
94334848|NCT02120352|323008308|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
94334849|NCT02120352|323008309|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
94334850|NCT02120352|323008310|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
94334851|NCT02120352|323008311|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
94334852|NCT02120352|323008312|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
94334853|NCT02120352|323008313|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
94334854|NCT02120352|323008314|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
94334855|NCT02120352|323008308|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
94334856|NCT02120352|323008309|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
94334857|NCT02120352|323008310|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
94334858|NCT02120352|323008311|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
94334859|NCT02120352|323008312|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
94334860|NCT02120352|323008313|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
94334861|NCT02120352|323008314|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
94334862|NCT02120352|323008308|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
94334863|NCT02120352|323008309|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
94334864|NCT02120352|323008310|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
94334865|NCT02120352|323008311|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
94334866|NCT02120352|323008312|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
94334867|NCT02120352|323008313|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
94334868|NCT02120352|323008314|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
94334869|NCT02120352|323008308|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
94334870|NCT02120352|323008309|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
94334871|NCT02120352|323008310|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
94334872|NCT02120352|323008311|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
94334873|NCT02120352|323008312|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
94334874|NCT02120352|323008313|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
94334875|NCT02120352|323008314|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
94334876|NCT02120352|323008308|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
94334877|NCT02120352|323008309|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
94334878|NCT02120352|323008310|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
94334879|NCT02120352|323008311|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
94334880|NCT02120352|323008312|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
94334881|NCT02120352|323008313|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
94334882|NCT02120352|323008314|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
94334883|NCT02120352|323008308|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
94334884|NCT02120352|323008309|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
94334885|NCT02120352|323008310|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
94334886|NCT02120352|323008311|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
94334887|NCT02120352|323008312|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
94334888|NCT02120352|323008313|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
94334889|NCT02120352|323008314|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
94334890|NCT02120352|323008308|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
94334891|NCT02120352|323008309|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
94334892|NCT02120352|323008310|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
94334893|NCT02120352|323008311|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
94334894|NCT02120352|323008312|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
94334895|NCT02120352|323008313|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
94334896|NCT02120352|323008314|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
94334897|NCT01998399|323008319|FG000|Overall Study|Lost to Follow-up|1|||
94334898|NCT01998399|323008320|FG001|Overall Study|Lost to Follow-up|3|||
94334899|NCT01998399|323008319|FG000|Overall Study|Death|4|||
94334900|NCT01998399|323008320|FG001|Overall Study|Death|2|||
94334901|NCT01998399|323008319|FG000|Overall Study|Study stopped before dosing completed|3|||
94334902|NCT01998399|323008320|FG001|Overall Study|Study stopped before dosing completed|3|||
94334903|NCT01998399|323008319|FG000|Overall Study|Withdrawal by Subject|0|||
94334904|NCT01998399|323008320|FG001|Overall Study|Withdrawal by Subject|1|||
94334905|NCT01610206|323008321|FG000|Overall Study|Adverse Event|10|||
94334906|NCT01610206|323008322|FG001|Overall Study|Adverse Event|30|||
94334907|NCT00587301|323008329|FG000|Overall Study|Screen Failure|9|||
94334908|NCT00587301|323008329|FG000|Overall Study|Lost to Follow-up|22|||
94334909|NCT00587301|323008329|FG000|Overall Study|Withdrawal by Subject|7|||
94334910|NCT00587301|323008329|FG000|Overall Study|Protocol Violation|7|||
94334911|NCT00418717|323008331|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
94334912|NCT00418717|323008331|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
94334913|NCT00249795|323008332|FG000|Overall Study|Not treated|16|||
94334914|NCT00249795|323008333|FG001|Overall Study|Not treated|14|||
94334915|NCT00249795|323008332|FG000|Overall Study|Symptomatic hypotension|127|||
94334916|NCT00249795|323008333|FG001|Overall Study|Symptomatic hypotension|64|||
94334917|NCT00249795|323008332|FG000|Overall Study|Other Serious Adverse Event|84|||
94334918|NCT00249795|323008333|FG001|Overall Study|Other Serious Adverse Event|93|||
94334919|NCT00249795|323008332|FG000|Overall Study|Qualifying condition not present|26|||
94334920|NCT00249795|323008333|FG001|Overall Study|Qualifying condition not present|29|||
94334921|NCT00249795|323008332|FG000|Overall Study|Withdrawal by Subject|678|||
94334922|NCT00249795|323008333|FG001|Overall Study|Withdrawal by Subject|742|||
94334923|NCT00249795|323008332|FG000|Overall Study|Thromboembolic / outcome event|39|||
94334924|NCT00249795|323008333|FG001|Overall Study|Thromboembolic / outcome event|45|||
94334925|NCT00249795|323008332|FG000|Overall Study|Oral anticoagulant required|2|||
94334926|NCT00249795|323008333|FG001|Overall Study|Oral anticoagulant required|0|||
94334927|NCT00249795|323008332|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
94334928|NCT00249795|323008333|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
94334929|NCT00249795|323008332|FG000|Overall Study|Non-compliance|71|||
94334930|NCT00249795|323008333|FG001|Overall Study|Non-compliance|69|||
94334931|NCT00249795|323008332|FG000|Overall Study|Study drug intolerance|3|||
94334932|NCT00249795|323008333|FG001|Overall Study|Study drug intolerance|3|||
94334933|NCT00249795|323008332|FG000|Overall Study|Other adverse events (non-serious)|188|||
94334934|NCT00249795|323008333|FG001|Overall Study|Other adverse events (non-serious)|159|||
94334935|NCT00249795|323008332|FG000|Overall Study|Physician withdrew consent|71|||
94334936|NCT00249795|323008333|FG001|Overall Study|Physician withdrew consent|63|||
94334937|NCT00249795|323008332|FG000|Overall Study|Surgery / procedure|4|||
94334938|NCT00249795|323008333|FG001|Overall Study|Surgery / procedure|5|||
94334939|NCT00249795|323008332|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
94334940|NCT00249795|323008333|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
94334941|NCT00249795|323008332|FG000|Overall Study|Lightheadedness / dizziness|15|||
94334942|NCT00249795|323008333|FG001|Overall Study|Lightheadedness / dizziness|11|||
94334943|NCT00249795|323008332|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
94334944|NCT00249795|323008333|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
94334945|NCT00249795|323008332|FG000|Overall Study|Other contraindicated medication|1|||
94334946|NCT00249795|323008333|FG001|Overall Study|Other contraindicated medication|1|||
94334947|NCT00249795|323008332|FG000|Overall Study|Event related to cardiac condition|17|||
94334948|NCT00249795|323008333|FG001|Overall Study|Event related to cardiac condition|16|||
94334949|NCT00249795|323008332|FG000|Overall Study|Patient not wish to continue after May08|4|||
94334950|NCT00249795|323008333|FG001|Overall Study|Patient not wish to continue after May08|6|||
94334951|NCT00249795|323008332|FG000|Overall Study|Site not agree to continue after May08|1|||
94334952|NCT00249795|323008333|FG001|Overall Study|Site not agree to continue after May08|1|||
94334953|NCT00249795|323008332|FG000|Overall Study|Lost to Follow-up|0|||
94334954|NCT00249795|323008333|FG001|Overall Study|Lost to Follow-up|2|||
94334955|NCT00249795|323008332|FG000|Overall Study|Missing|0|||
94334956|NCT00249795|323008333|FG001|Overall Study|Missing|1|||
94334957|NCT00719537|323008336|FG000|Overall Study|Withdrawal by Subject|1|||
94334958|NCT00719537|323008337|FG001|Overall Study|Withdrawal by Subject|0|||
94334959|NCT00719537|323008336|FG000|Overall Study|Lost to Follow-up|0|||
94334960|NCT00719537|323008337|FG001|Overall Study|Lost to Follow-up|1|||
94334961|NCT00045630|323008338|FG000|Overall Study|Adverse Event|1|||
94334962|NCT00045630|323008338|FG000|Overall Study|Refusal unrelated to adverse event|1|||
94334963|NCT00045630|323008338|FG000|Overall Study|Progression/relapse|1|||
94334964|NCT00045630|323008338|FG000|Overall Study|Death|1|||
94334965|NCT00045630|323008338|FG000|Overall Study|Ineligible|2|||
94334966|NCT02023112|323008342|FG000|Overall Study|Withdrawal by Subject|2|||
94334967|NCT02023112|323008343|FG001|Overall Study|Withdrawal by Subject|1|||
94334968|NCT01425749|323008344|FG000|Overall Study|progression of melanoma|0|||
94334969|NCT01425749|323008345|FG001|Overall Study|progression of melanoma|1|||
94334970|NCT02983799|323008348|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
94334971|NCT02983799|323008349|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
94334972|NCT02983799|323008350|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
94334973|NCT02983799|323008351|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
94334974|NCT02983799|323008352|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
94334975|NCT02983799|323008348|FG000|Overall Study|Death|20|||
94334976|NCT02983799|323008349|FG001|Overall Study|Death|5|||
94334977|NCT02983799|323008350|FG002|Overall Study|Death|23|||
94334978|NCT02983799|323008351|FG003|Overall Study|Death|47|||
94334979|NCT02983799|323008352|FG004|Overall Study|Death|7|||
94334980|NCT02983799|323008348|FG000|Overall Study|Withdrawal by Subject|1|||
94334981|NCT02983799|323008349|FG001|Overall Study|Withdrawal by Subject|0|||
94334982|NCT02983799|323008350|FG002|Overall Study|Withdrawal by Subject|3|||
94334983|NCT02983799|323008351|FG003|Overall Study|Withdrawal by Subject|4|||
94334984|NCT02983799|323008352|FG004|Overall Study|Withdrawal by Subject|1|||
94334985|NCT02983799|323008348|FG000|Overall Study|Protocol Violation|0|||
94334986|NCT02983799|323008349|FG001|Overall Study|Protocol Violation|1|||
94334987|NCT02983799|323008350|FG002|Overall Study|Protocol Violation|0|||
94334988|NCT02983799|323008351|FG003|Overall Study|Protocol Violation|0|||
94334989|NCT02983799|323008352|FG004|Overall Study|Protocol Violation|1|||
94334990|NCT02983799|323008348|FG000|Overall Study|Lost to Follow-up|1|||
94334991|NCT02983799|323008349|FG001|Overall Study|Lost to Follow-up|0|||
94334992|NCT02983799|323008350|FG002|Overall Study|Lost to Follow-up|1|||
94334993|NCT02983799|323008351|FG003|Overall Study|Lost to Follow-up|0|||
94334994|NCT02983799|323008352|FG004|Overall Study|Lost to Follow-up|0|||
94334995|NCT00981747|323008353|FG000|Losartan|Withdrawal by Subject|1|||
94334996|NCT00981747|323008353|FG000|Losartan|Death|1|||
94334997|NCT00981747|323008353|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
94334998|NCT00718523|323008354|FG000|Overall Study|Withdrawal by Subject|5|||
94334999|NCT00718523|323008355|FG001|Overall Study|Withdrawal by Subject|7|||
94335000|NCT00718523|323008354|FG000|Overall Study|Death|13|||
94335001|NCT00718523|323008355|FG001|Overall Study|Death|17|||
94335002|NCT02762708|323008356|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
94335003|NCT02762708|323008357|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
94335004|NCT02762708|323008358|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
94335005|NCT02762708|323008359|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
94335006|NCT01313078|323008360|FG000|Overall Study|Death|1|||
94335007|NCT01313078|323008360|FG000|Overall Study|Discontinued study drug|1|||
94335008|NCT01313078|323008360|FG000|Overall Study|Withdrawal by Subject|1|||
94335009|NCT03365947|323008361|FG000|Overall Study|Lost to Follow-up|0|||
94335010|NCT03365947|323008362|FG001|Overall Study|Lost to Follow-up|0|||
94335011|NCT03365947|323008363|FG002|Overall Study|Lost to Follow-up|0|||
94335012|NCT03365947|323008364|FG003|Overall Study|Lost to Follow-up|0|||
94335013|NCT03365947|323008365|FG004|Overall Study|Lost to Follow-up|0|||
94335014|NCT03365947|323008366|FG005|Overall Study|Lost to Follow-up|1|||
94335015|NCT03365947|323008367|FG006|Overall Study|Lost to Follow-up|0|||
94335016|NCT03365947|323008368|FG007|Overall Study|Lost to Follow-up|0|||
94335017|NCT03365947|323008369|FG008|Overall Study|Lost to Follow-up|0|||
94335018|NCT03365947|323008370|FG009|Overall Study|Lost to Follow-up|0|||
94335019|NCT03365947|323008371|FG010|Overall Study|Lost to Follow-up|0|||
94335020|NCT03365947|323008372|FG011|Overall Study|Lost to Follow-up|0|||
94335021|NCT03365947|323008373|FG012|Overall Study|Lost to Follow-up|0|||
94335022|NCT03365947|323008374|FG013|Overall Study|Lost to Follow-up|0|||
94335023|NCT03365947|323008375|FG014|Overall Study|Lost to Follow-up|0|||
94335024|NCT03365947|323008376|FG015|Overall Study|Lost to Follow-up|0|||
94335025|NCT03365947|323008377|FG016|Overall Study|Lost to Follow-up|0|||
94335026|NCT03365947|323008378|FG017|Overall Study|Lost to Follow-up|0|||
94335027|NCT03365947|323008379|FG018|Overall Study|Lost to Follow-up|0|||
94335028|NCT01822223|323008383|FG000|Overall Study|Death|0|||
94335029|NCT01822223|323008384|FG001|Overall Study|Death|1|||
94335030|NCT01042938|323008385|FG000|Overall Study|Withdrawal by Subject|1|||
94335031|NCT01042938|323008386|FG001|Overall Study|Withdrawal by Subject|1|||
94335032|NCT01042938|323008385|FG000|Overall Study|Protocol Violation|1|||
94335033|NCT01042938|323008386|FG001|Overall Study|Protocol Violation|1|||
94335034|NCT01042938|323008385|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
94335035|NCT01042938|323008386|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
94335036|NCT03136484|323008387|FG000|Overall Study|Withdrawal by Subject|19|||
94335037|NCT03136484|323008388|FG001|Overall Study|Withdrawal by Subject|14|||
94335038|NCT03136484|323008387|FG000|Overall Study|Lost to Follow-up|7|||
94335039|NCT03136484|323008388|FG001|Overall Study|Lost to Follow-up|8|||
94335040|NCT03136484|323008387|FG000|Overall Study|Death|1|||
94335041|NCT03136484|323008388|FG001|Overall Study|Death|0|||
94335042|NCT01449955|323008394|FG000|Overall Study|Withdrawal by Subject|1|||
94335043|NCT01449955|323008395|FG001|Overall Study|Withdrawal by Subject|2|||
94335044|NCT00970268|323008396|FG000|Overall Study|Withdrawal by Subject|12|||
94335045|NCT00970268|323008397|FG001|Overall Study|Withdrawal by Subject|19|||
94335046|NCT00970268|323008396|FG000|Overall Study|Adverse Event|15|||
94335047|NCT00970268|323008397|FG001|Overall Study|Adverse Event|12|||
94335048|NCT00970268|323008396|FG000|Overall Study|Lack of Efficacy|3|||
94335049|NCT00970268|323008397|FG001|Overall Study|Lack of Efficacy|6|||
94335050|NCT00970268|323008396|FG000|Overall Study|Protocol Violation|4|||
94335051|NCT00970268|323008397|FG001|Overall Study|Protocol Violation|7|||
94335052|NCT00970268|323008396|FG000|Overall Study|Other Reason|3|||
94335053|NCT00970268|323008397|FG001|Overall Study|Other Reason|1|||
94335054|NCT00970268|323008396|FG000|Overall Study|COPD Exacerbation|4|||
94335055|NCT00970268|323008397|FG001|Overall Study|COPD Exacerbation|2|||
94335056|NCT00970268|323008396|FG000|Overall Study|Lost to Follow-up|1|||
94335057|NCT00970268|323008397|FG001|Overall Study|Lost to Follow-up|2|||
94335058|NCT00970268|323008396|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
94335059|NCT00970268|323008397|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
94335060|NCT01079195|323008398|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
94335061|NCT01079195|323008398|FG000|Overall Study|No Documentation Available|437|||
94335062|NCT01079195|323008398|FG000|Overall Study|Adverse Event|157|||
94335063|NCT01079195|323008398|FG000|Overall Study|Reason Unknown|39|||
94335064|NCT01079195|323008398|FG000|Overall Study|Withdrawal by Subject|18|||
94335065|NCT01079195|323008398|FG000|Overall Study|Financial Reasons|15|||
94335066|NCT01079195|323008398|FG000|Overall Study|Lack of Effectiveness|12|||
94335067|NCT01079195|323008398|FG000|Overall Study|Physician Decision|4|||
94335068|NCT01079195|323008398|FG000|Overall Study|Improved Status of Participant|4|||
94335069|NCT01079195|323008398|FG000|Overall Study|No Follow-up Documentation Available|4|||
94335070|NCT01079195|323008398|FG000|Overall Study|Non-compliance|2|||
94335071|NCT02650895|323008399|FG000|Overall Study|Withdrawal by Subject|0|||
94335072|NCT02650895|323008400|FG001|Overall Study|Withdrawal by Subject|1|||
94335073|NCT02650895|323008401|FG002|Overall Study|Withdrawal by Subject|0|||
94335074|NCT02650895|323008402|FG003|Overall Study|Withdrawal by Subject|0|||
94335075|NCT02650895|323008403|FG004|Overall Study|Withdrawal by Subject|0|||
94335076|NCT02650895|323008404|FG005|Overall Study|Withdrawal by Subject|0|||
94335077|NCT01906476|323008410|FG000|Overall Study|Lost to Follow-up|17|||
94335078|NCT01906476|323008411|FG001|Overall Study|Lost to Follow-up|16|||
94335079|NCT02896192|323008415|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
94335080|NCT02896192|323008415|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
94335081|NCT02896192|323008415|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
94335082|NCT00383708|323008416|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
94335083|NCT00383708|323008416|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
94335084|NCT00383708|323008416|FG000|Run-in Period|Protocol Violation|4|||
94335085|NCT00383708|323008416|FG000|Run-in Period|Adverse Event|2|||
94335086|NCT00383708|323008416|FG000|Run-in Period|Claustrophobia|1|||
94335087|NCT00383708|323008416|FG000|Co-administration Period|Adverse Event|5|||
94335088|NCT00318370|323008417|FG000|Period 1|Lack of Efficacy|5|||
94335089|NCT00318370|323008418|FG001|Period 1|Lack of Efficacy|0|||
94335090|NCT00318370|323008419|FG002|Period 1|Lack of Efficacy|0|||
94335091|NCT00318370|323008417|FG000|Period 1|Physician Decision|1|||
94335092|NCT00318370|323008418|FG001|Period 1|Physician Decision|0|||
94335093|NCT00318370|323008419|FG002|Period 1|Physician Decision|0|||
94335094|NCT00318370|323008417|FG000|Period 1|Withdrawal by Subject|1|||
94335095|NCT00318370|323008418|FG001|Period 1|Withdrawal by Subject|0|||
94335096|NCT00318370|323008419|FG002|Period 1|Withdrawal by Subject|0|||
94335097|NCT00318370|323008417|FG000|Period 2|Adverse Event|0|||
94335098|NCT00318370|323008418|FG001|Period 2|Adverse Event|3|||
94335099|NCT00318370|323008419|FG002|Period 2|Adverse Event|0|||
94335100|NCT00318370|323008417|FG000|Period 2|Lack of Efficacy|0|||
94335101|NCT00318370|323008418|FG001|Period 2|Lack of Efficacy|5|||
94335102|NCT00318370|323008419|FG002|Period 2|Lack of Efficacy|0|||
94335103|NCT00318370|323008417|FG000|Period 2|Physician Decision|0|||
94335104|NCT00318370|323008418|FG001|Period 2|Physician Decision|1|||
94335105|NCT00318370|323008419|FG002|Period 2|Physician Decision|0|||
94335106|NCT00318370|323008417|FG000|Period 2|Withdrawal by Subject|0|||
94335107|NCT00318370|323008418|FG001|Period 2|Withdrawal by Subject|1|||
94335108|NCT00318370|323008419|FG002|Period 2|Withdrawal by Subject|0|||
94335109|NCT00318370|323008417|FG000|Period 2|Other|0|||
94335110|NCT00318370|323008418|FG001|Period 2|Other|1|||
94335111|NCT00318370|323008419|FG002|Period 2|Other|0|||
94335112|NCT00318370|323008417|FG000|Period 3|Adverse Event|0|||
94335113|NCT00318370|323008418|FG001|Period 3|Adverse Event|0|||
94335114|NCT00318370|323008419|FG002|Period 3|Adverse Event|1|||
94335115|NCT00318370|323008417|FG000|Period 3|Lack of Efficacy|0|||
94335116|NCT00318370|323008418|FG001|Period 3|Lack of Efficacy|0|||
94335117|NCT00318370|323008419|FG002|Period 3|Lack of Efficacy|24|||
94335118|NCT00318370|323008417|FG000|Period 3|Death|0|||
94335119|NCT00318370|323008418|FG001|Period 3|Death|0|||
94335120|NCT00318370|323008419|FG002|Period 3|Death|1|||
94335121|NCT00318370|323008417|FG000|Period 3|Physician Decision|0|||
94335122|NCT00318370|323008418|FG001|Period 3|Physician Decision|0|||
94335123|NCT00318370|323008419|FG002|Period 3|Physician Decision|1|||
94335124|NCT00318370|323008417|FG000|Period 3|Withdrawal by Subject|0|||
94335125|NCT00318370|323008418|FG001|Period 3|Withdrawal by Subject|0|||
94335126|NCT00318370|323008419|FG002|Period 3|Withdrawal by Subject|3|||
94335127|NCT00318370|323008417|FG000|Period 3|Other|0|||
94335128|NCT00318370|323008418|FG001|Period 3|Other|0|||
94335129|NCT00318370|323008419|FG002|Period 3|Other|3|||
94335130|NCT01750840|323008423|FG000|Overall Study|Lost to Follow-up|4|||
94335131|NCT00479167|323008424|FG000|Overall Study|Withdrawal by Subject|1|||
94335132|NCT01997281|323008427|FG000|Overall Study|Withdrawal by Subject|1|||
94335133|NCT01997281|323008428|FG001|Overall Study|Withdrawal by Subject|0|||
94335134|NCT01570309|323008430|FG000|Overall Study|Withdrawal by Subject|3|||
94335135|NCT01570309|323008431|FG001|Overall Study|Withdrawal by Subject|3|||
94335136|NCT00560794|323008432|FG000|Overall Study|Adverse Event|2|||
94335137|NCT00560794|323008432|FG000|Overall Study|Patient was not Compliant|1|||
94335138|NCT00560794|323008432|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
94335139|NCT00560794|323008432|FG000|Overall Study|Hematological Relapse|1|||
94335140|NCT00560794|323008432|FG000|Overall Study|Received Bone Marrow Transplant|6|||
94335141|NCT03619837|323008439|FG000|Screening|received organs from HCV-negative donors|47|||
94335142|NCT03619837|323008439|FG000|Screening|died on the wait-list|2|||
94335143|NCT03619837|323008439|FG000|Screening|remained on the wait list|40|||
94335144|NCT03619837|323008439|FG000|Screening|didn't meet eligibility criteria|3|||
94335145|NCT03619837|323008439|FG000|Screening|withdrew consent|2|||
94335146|NCT03619837|323008439|FG000|Screening|never listed for HCV-viremic donor|1|||
94335147|NCT03619837|323008439|FG000|Screening|developed exclusion criteria|2|||
94335148|NCT03619837|323008439|FG000|Screening|excluded by the investigator due to non-compliance|1|||
94335149|NCT02384993|323008440|FG000|Overall Study|Adverse Event|0|||
94335150|NCT02384993|323008441|FG001|Overall Study|Adverse Event|1|||
94335151|NCT04095793|323008442|FG000|Overall Study|Adverse Event|3|||
94335152|NCT04095793|323008442|FG000|Overall Study|Study Terminated by Sponsor|103|||
94335153|NCT04095793|323008442|FG000|Overall Study|Withdrawal by Subject|4|||
94335154|NCT00089999|323008444|FG000|Overall Study|Adverse Event|4|||
94335155|NCT00089999|323008445|FG001|Overall Study|Adverse Event|7|||
94335156|NCT00089999|323008444|FG000|Overall Study|Withdrawal by Subject|0|||
94335157|NCT00089999|323008445|FG001|Overall Study|Withdrawal by Subject|4|||
94335158|NCT00089999|323008444|FG000|Overall Study|Lost to Follow-up|2|||
94335159|NCT00089999|323008445|FG001|Overall Study|Lost to Follow-up|1|||
94335160|NCT00089999|323008444|FG000|Overall Study|Radiological Progression of Cancer|52|||
94335161|NCT00089999|323008445|FG001|Overall Study|Radiological Progression of Cancer|44|||
94335162|NCT00089999|323008444|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
94335163|NCT00089999|323008445|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
94335164|NCT00089999|323008444|FG000|Overall Study|Death|3|||
94335165|NCT00089999|323008445|FG001|Overall Study|Death|3|||
94335166|NCT00089999|323008444|FG000|Overall Study|Poor General Condition|1|||
94335167|NCT00089999|323008445|FG001|Overall Study|Poor General Condition|0|||
94335168|NCT00089999|323008444|FG000|Overall Study|Clinical Progression|1|||
94335169|NCT00089999|323008445|FG001|Overall Study|Clinical Progression|2|||
94335170|NCT00089999|323008444|FG000|Overall Study|Physician Decision|2|||
94335171|NCT00089999|323008445|FG001|Overall Study|Physician Decision|2|||
94335172|NCT00089999|323008444|FG000|Overall Study|Patient Underwent Surgery|2|||
94335173|NCT00089999|323008445|FG001|Overall Study|Patient Underwent Surgery|0|||
94335174|NCT00089999|323008444|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
94335175|NCT00089999|323008445|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
94335176|NCT03565991|323010701|FG000|Overall Study|Other|11|||
94335177|NCT03565991|323010702|FG001|Overall Study|Other|0|||
94335178|NCT03565991|323010701|FG000|Overall Study|Global deterioration of health status|14|||
94335179|NCT03565991|323010702|FG001|Overall Study|Global deterioration of health status|4|||
94335180|NCT03565991|323010701|FG000|Overall Study|Withdrawal by Subject|2|||
94335181|NCT03565991|323010702|FG001|Overall Study|Withdrawal by Subject|6|||
94335182|NCT03565991|323010701|FG000|Overall Study|Progressive disease|121|||
94335183|NCT03565991|323010702|FG001|Overall Study|Progressive disease|29|||
94335184|NCT03565991|323010701|FG000|Overall Study|Death|3|||
94335185|NCT03565991|323010702|FG001|Overall Study|Death|0|||
94335186|NCT03565991|323010701|FG000|Overall Study|Adverse Event|7|||
94335187|NCT03565991|323010702|FG001|Overall Study|Adverse Event|2|||
94335188|NCT01826448|323010708|FG000|Overall Study|Adverse Event|1|||
94335189|NCT01826448|323010709|FG001|Overall Study|Adverse Event|3|||
94335190|NCT01826448|323010708|FG000|Overall Study|Disease progression|2|||
94335191|NCT01826448|323010709|FG001|Overall Study|Disease progression|4|||
94335192|NCT01826448|323010708|FG000|Overall Study|Withdrawal by Subject|1|||
94335193|NCT01826448|323010709|FG001|Overall Study|Withdrawal by Subject|0|||
94335194|NCT01826448|323010708|FG000|Overall Study|Physician Decision|0|||
94335195|NCT01826448|323010709|FG001|Overall Study|Physician Decision|1|||
94335196|NCT01826448|323010708|FG000|Overall Study|2 active cancers|0|||
94335197|NCT01826448|323010709|FG001|Overall Study|2 active cancers|1|||
94335198|NCT04914819|323010710|FG000|Overall Study|Pregnancy|3|||
94335199|NCT04914819|323010711|FG001|Overall Study|Pregnancy|1|||
94335200|NCT04914819|323010710|FG000|Overall Study|Discontinued study|4|||
94335201|NCT04914819|323010711|FG001|Overall Study|Discontinued study|1|||
94335202|NCT04914819|323010710|FG000|Overall Study|Lost to Follow-up|7|||
94335203|NCT04914819|323010711|FG001|Overall Study|Lost to Follow-up|0|||
94335204|NCT00608881|323010717|FG000|Overall Study|Death|22|||
94335205|NCT00608881|323010718|FG001|Overall Study|Death|13|||
94335206|NCT00608881|323010717|FG000|Overall Study|Adverse Event|5|||
94335207|NCT00608881|323010718|FG001|Overall Study|Adverse Event|3|||
94335208|NCT00608881|323010717|FG000|Overall Study|Lost to Follow-up|28|||
94335209|NCT00608881|323010718|FG001|Overall Study|Lost to Follow-up|14|||
94335210|NCT00608881|323010717|FG000|Overall Study|Withdrawal by Subject|18|||
94335211|NCT00608881|323010718|FG001|Overall Study|Withdrawal by Subject|29|||
94335212|NCT00608881|323010717|FG000|Overall Study|Physician Decision|5|||
94335213|NCT00608881|323010718|FG001|Overall Study|Physician Decision|5|||
94335214|NCT00608881|323010717|FG000|Overall Study|Institutionalized|1|||
94335215|NCT00608881|323010718|FG001|Overall Study|Institutionalized|2|||
94335216|NCT03006926|323010724|FG000|Overall Study|Adverse Event|0|||
94335217|NCT03006926|323010725|FG001|Overall Study|Adverse Event|27|||
94335218|NCT03006926|323010724|FG000|Overall Study|Withdrawal by Subject|0|||
94335219|NCT03006926|323010725|FG001|Overall Study|Withdrawal by Subject|1|||
94335220|NCT03006926|323010724|FG000|Overall Study|Radiological Disease Progression|0|||
94335221|NCT03006926|323010725|FG001|Overall Study|Radiological Disease Progression|52|||
94335222|NCT03006926|323010724|FG000|Overall Study|Clinical Disease Progression|0|||
94335223|NCT03006926|323010725|FG001|Overall Study|Clinical Disease Progression|10|||
94335224|NCT03006926|323010724|FG000|Overall Study|Other|0|||
94335225|NCT03006926|323010725|FG001|Overall Study|Other|8|||
94335226|NCT05166603|323010726|FG000|Overall Study|Withdrawal by Subject|68|||
94335227|NCT05166603|323010727|FG001|Overall Study|Withdrawal by Subject|0|||
94335228|NCT02918318|323010732|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
94335229|NCT02918318|323010733|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
94335230|NCT02918318|323010734|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
94335231|NCT02918318|323010735|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
94335232|NCT02918318|323010736|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
94335233|NCT02918318|323010732|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
94335234|NCT02918318|323010733|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
94335235|NCT02918318|323010734|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
94335236|NCT02918318|323010735|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
94335237|NCT02918318|323010736|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
94335238|NCT02918318|323010732|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
94335239|NCT02918318|323010733|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
94335240|NCT02918318|323010734|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
94335241|NCT02918318|323010735|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
94335242|NCT02918318|323010736|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
94335243|NCT02918318|323010732|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
94335244|NCT02918318|323010733|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
94335245|NCT02918318|323010734|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
94335246|NCT02918318|323010735|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
94335247|NCT02918318|323010736|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
94335248|NCT02918318|323010732|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
94335249|NCT02918318|323010733|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
94335250|NCT02918318|323010734|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
94335251|NCT02918318|323010735|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
94335252|NCT02918318|323010736|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
94335253|NCT02918318|323010732|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
94335254|NCT02918318|323010733|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
94335255|NCT02918318|323010734|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
94335256|NCT02918318|323010735|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
94335257|NCT02918318|323010736|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
94335258|NCT02918318|323010732|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
94335259|NCT02918318|323010733|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
94335260|NCT02918318|323010734|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
94335261|NCT02918318|323010735|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
94335262|NCT02918318|323010736|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
94335263|NCT02918318|323010732|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
94335264|NCT02918318|323010733|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
94335265|NCT02918318|323010734|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
94335266|NCT02918318|323010735|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
94335267|NCT02918318|323010736|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
94335268|NCT02918318|323010732|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
94335269|NCT02918318|323010733|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
94335270|NCT02918318|323010734|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
94335271|NCT02918318|323010735|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
94335272|NCT02918318|323010736|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
94335273|NCT02918318|323010732|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
94335274|NCT02918318|323010733|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
94335275|NCT02918318|323010734|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
94335276|NCT02918318|323010735|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
94335277|NCT02918318|323010736|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
94335278|NCT02918318|323010732|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
94335279|NCT02918318|323010733|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
94335280|NCT02918318|323010734|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
94335281|NCT02918318|323010735|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
94335282|NCT02918318|323010736|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
94335283|NCT02918318|323010732|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
94335284|NCT02918318|323010733|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
94335285|NCT02918318|323010734|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
94335286|NCT02918318|323010735|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
94335287|NCT02918318|323010736|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
94335288|NCT01194414|323010737|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
94335289|NCT01194414|323010738|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
94335290|NCT01194414|323010739|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
94335291|NCT01194414|323010740|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
94335292|NCT01194414|323010737|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
94335293|NCT01194414|323010738|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
94335294|NCT01194414|323010739|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
94335295|NCT01194414|323010740|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
94335296|NCT01194414|323010737|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
94335297|NCT01194414|323010738|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
94335298|NCT01194414|323010739|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
94335299|NCT01194414|323010740|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
94335300|NCT01194414|323010737|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
94335301|NCT01194414|323010738|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
94335302|NCT01194414|323010739|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
94335303|NCT01194414|323010740|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
94335304|NCT01194414|323010737|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
94335305|NCT01194414|323010738|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
94335306|NCT01194414|323010739|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
94335307|NCT01194414|323010740|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
94335308|NCT01194414|323010737|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
94335309|NCT01194414|323010738|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
94335310|NCT01194414|323010739|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
94335311|NCT01194414|323010740|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
94335312|NCT01194414|323010737|FG000|24 Weeks Double Blind Period|Other|0|||
94335313|NCT01194414|323010738|FG001|24 Weeks Double Blind Period|Other|1|||
94335314|NCT01194414|323010739|FG002|24 Weeks Double Blind Period|Other|0|||
94335315|NCT01194414|323010740|FG003|24 Weeks Double Blind Period|Other|0|||
94335316|NCT01194414|323010737|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
94335317|NCT01194414|323010738|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
94335318|NCT01194414|323010739|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
94335319|NCT01194414|323010740|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
94335320|NCT01194414|323010737|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
94335321|NCT01194414|323010738|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
94335322|NCT01194414|323010739|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
94335323|NCT01194414|323010740|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
94335324|NCT01194414|323010737|FG000|24 Weeks Double Blind Period|Death|0|||
94335325|NCT01194414|323010738|FG001|24 Weeks Double Blind Period|Death|1|||
94335326|NCT01194414|323010739|FG002|24 Weeks Double Blind Period|Death|0|||
94335327|NCT01194414|323010740|FG003|24 Weeks Double Blind Period|Death|0|||
94335328|NCT01194414|323010737|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
94335329|NCT01194414|323010738|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
94335330|NCT01194414|323010739|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
94335331|NCT01194414|323010740|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
94335332|NCT01194414|323010737|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
94335333|NCT01194414|323010738|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
94335334|NCT01194414|323010739|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
94335335|NCT01194414|323010740|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
94335336|NCT01194414|323010737|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
94335337|NCT01194414|323010738|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
94335338|NCT01194414|323010739|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
94335339|NCT01194414|323010740|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
94335340|NCT01194414|323010737|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
94335341|NCT01194414|323010738|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
94335342|NCT01194414|323010739|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
94335343|NCT01194414|323010740|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
94335344|NCT01194414|323010737|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
94335345|NCT01194414|323010738|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
94335346|NCT01194414|323010739|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
94335347|NCT01194414|323010740|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
94335348|NCT01194414|323010737|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
94335349|NCT01194414|323010738|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
94335350|NCT01194414|323010739|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
94335351|NCT01194414|323010740|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
94335352|NCT01194414|323010737|FG000|72 Weeks Open Label Extension|Other|2|||
94335353|NCT01194414|323010738|FG001|72 Weeks Open Label Extension|Other|1|||
94335354|NCT01194414|323010739|FG002|72 Weeks Open Label Extension|Other|0|||
94335355|NCT01194414|323010740|FG003|72 Weeks Open Label Extension|Other|0|||
94335356|NCT01194414|323010737|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
94335357|NCT01194414|323010738|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
94335358|NCT01194414|323010739|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
94335359|NCT01194414|323010740|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
94335360|NCT01194414|323010737|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
94335361|NCT01194414|323010738|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
94335362|NCT01194414|323010739|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
94335363|NCT01194414|323010740|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
94335364|NCT01194414|323010737|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
94335365|NCT01194414|323010738|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
94335366|NCT01194414|323010739|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
94335367|NCT01194414|323010740|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
94335368|NCT01194414|323010737|FG000|72 Weeks Open Label Extension|Death|1|||
94335369|NCT01194414|323010738|FG001|72 Weeks Open Label Extension|Death|2|||
94335370|NCT01194414|323010739|FG002|72 Weeks Open Label Extension|Death|0|||
94335371|NCT01194414|323010740|FG003|72 Weeks Open Label Extension|Death|2|||
94335372|NCT03000686|323010742|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
94335373|NCT03000686|323010743|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
94335374|NCT03000686|323010744|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
94335375|NCT03000686|323010745|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
94335376|NCT04685538|323010746|FG000|Overall Study|Adverse Event|0|||
94335377|NCT04685538|323010747|FG001|Overall Study|Adverse Event|1|||
94335378|NCT04685538|323010746|FG000|Overall Study|Lost to Follow-up|0|||
94335379|NCT04685538|323010747|FG001|Overall Study|Lost to Follow-up|2|||
94335380|NCT00770224|323010755|FG000|Step 1: Induction|Adverse Event|3|||
94335381|NCT00770224|323010756|FG001|Step 1: Induction|Adverse Event|0|||
94335382|NCT00770224|323010755|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
94335383|NCT00770224|323010756|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
94335384|NCT00770224|323010755|FG000|Step 1: Induction|Other reason not protocol specified|2|||
94335385|NCT00770224|323010756|FG001|Step 1: Induction|Other reason not protocol specified|0|||
94335386|NCT00770224|323010755|FG000|Step 1: Induction|Ineligible|2|||
94335387|NCT00770224|323010756|FG001|Step 1: Induction|Ineligible|0|||
94335388|NCT00770224|323010755|FG000|Step 1: Induction|No protocol treatment given|1|||
94335389|NCT00770224|323010756|FG001|Step 1: Induction|No protocol treatment given|0|||
94335390|NCT00770224|323010755|FG000|Step 2: Maintenance|Adverse Event|0|||
94335391|NCT00770224|323010756|FG001|Step 2: Maintenance|Adverse Event|10|||
94335392|NCT00770224|323010755|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
94335393|NCT00770224|323010756|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
94335394|NCT00770224|323010755|FG000|Step 2: Maintenance|Progression/relapse|0|||
94335395|NCT00770224|323010756|FG001|Step 2: Maintenance|Progression/relapse|1|||
94335396|NCT00770224|323010755|FG000|Step 2: Maintenance|Death|0|||
94335397|NCT00770224|323010756|FG001|Step 2: Maintenance|Death|2|||
94335398|NCT00770224|323010755|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
94335399|NCT00770224|323010756|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
94335400|NCT00770224|323010755|FG000|Step 2: Maintenance|Ineligible|0|||
94335401|NCT00770224|323010756|FG001|Step 2: Maintenance|Ineligible|2|||
94335402|NCT01484561|323010757|FG000|Overall Study|Lack of Efficacy|3|||
94335403|NCT01484561|323010758|FG001|Overall Study|Lack of Efficacy|1|||
94335404|NCT01484561|323010757|FG000|Overall Study|Lost to Follow-up|1|||
94335405|NCT01484561|323010758|FG001|Overall Study|Lost to Follow-up|0|||
94335406|NCT01484561|323010757|FG000|Overall Study|Withdrawal by Subject|3|||
94335407|NCT01484561|323010758|FG001|Overall Study|Withdrawal by Subject|0|||
94335408|NCT01484561|323010757|FG000|Overall Study|Other|1|||
94335409|NCT01484561|323010758|FG001|Overall Study|Other|1|||
94335410|NCT01484561|323010757|FG000|Overall Study|Adverse Event|1|||
94335411|NCT01484561|323010758|FG001|Overall Study|Adverse Event|4|||
94335412|NCT01112982|323010759|FG000|Overall Study|Withdrawal by Subject|1|||
94335413|NCT01112982|323010759|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
94335414|NCT03371251|323010760|FG000|Overall Study|Withdrawal by Subject|1|||
94335415|NCT03371251|323010761|FG001|Overall Study|Withdrawal by Subject|0|||
94335416|NCT03371251|323010762|FG002|Overall Study|Withdrawal by Subject|1|||
94335417|NCT03371251|323010763|FG003|Overall Study|Withdrawal by Subject|0|||
94335418|NCT03371251|323010764|FG004|Overall Study|Withdrawal by Subject|2|||
94335419|NCT03371251|323010765|FG005|Overall Study|Withdrawal by Subject|2|||
94335420|NCT03371251|323010760|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
94335421|NCT03371251|323010761|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
94335422|NCT03371251|323010762|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
94335423|NCT03371251|323010763|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
94335424|NCT03371251|323010764|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
94335425|NCT03371251|323010765|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
94335426|NCT03371251|323010760|FG000|Overall Study|Adverse Event|0|||
94335427|NCT03371251|323010761|FG001|Overall Study|Adverse Event|0|||
94335428|NCT03371251|323010762|FG002|Overall Study|Adverse Event|0|||
94335429|NCT03371251|323010763|FG003|Overall Study|Adverse Event|0|||
94335430|NCT03371251|323010764|FG004|Overall Study|Adverse Event|1|||
94335431|NCT03371251|323010765|FG005|Overall Study|Adverse Event|0|||
94335432|NCT03371251|323010760|FG000|Overall Study|Decision by Sponsor|0|||
94335433|NCT03371251|323010761|FG001|Overall Study|Decision by Sponsor|0|||
94335434|NCT03371251|323010762|FG002|Overall Study|Decision by Sponsor|0|||
94335435|NCT03371251|323010763|FG003|Overall Study|Decision by Sponsor|0|||
94335436|NCT03371251|323010764|FG004|Overall Study|Decision by Sponsor|2|||
94335437|NCT03371251|323010765|FG005|Overall Study|Decision by Sponsor|0|||
94335438|NCT02443805|323010768|FG000|Overall Study|Adverse Event|100|||
94335439|NCT02443805|323010769|FG001|Overall Study|Adverse Event|18|||
94335440|NCT02443805|323010768|FG000|Overall Study|Withdrawal by Subject|73|||
94335441|NCT02443805|323010769|FG001|Overall Study|Withdrawal by Subject|74|||
94335442|NCT02443805|323010768|FG000|Overall Study|Lost to Follow-up|19|||
94335443|NCT02443805|323010769|FG001|Overall Study|Lost to Follow-up|14|||
94335444|NCT02443805|323010768|FG000|Overall Study|Pregnancy|6|||
94335445|NCT02443805|323010769|FG001|Overall Study|Pregnancy|5|||
94335446|NCT02443805|323010768|FG000|Overall Study|Protocol Violation|2|||
94335447|NCT02443805|323010769|FG001|Overall Study|Protocol Violation|4|||
94335448|NCT02443805|323010768|FG000|Overall Study|Lack of Efficacy|1|||
94335449|NCT02443805|323010769|FG001|Overall Study|Lack of Efficacy|1|||
94335450|NCT02443805|323010768|FG000|Overall Study|Non-compliance with study drug|6|||
94335451|NCT02443805|323010769|FG001|Overall Study|Non-compliance with study drug|4|||
94335452|NCT02443805|323010768|FG000|Overall Study|Withdrawal by parent/guardian|3|||
94335453|NCT02443805|323010769|FG001|Overall Study|Withdrawal by parent/guardian|5|||
94335454|NCT02443805|323010768|FG000|Overall Study|Any other reason not above-mentioned|3|||
94335455|NCT02443805|323010769|FG001|Overall Study|Any other reason not above-mentioned|2|||
94335456|NCT02708966|323010770|FG000|Overall Study|Lost to Follow-up|2|||
94335457|NCT02708966|323010771|FG001|Overall Study|Lost to Follow-up|2|||
94335458|NCT02260388|323010774|FG000|Overall Study|Lost to Follow-up|2|||
94335459|NCT02260388|323010775|FG001|Overall Study|Lost to Follow-up|8|||
94335460|NCT02260388|323010776|FG002|Overall Study|Lost to Follow-up|3|||
94335461|NCT02260388|323010777|FG003|Overall Study|Lost to Follow-up|4|||
94335462|NCT02959190|323010779|FG000|Open Label|Adverse Event|5|||
94335463|NCT02959190|323010780|FG001|Open Label|Adverse Event|7|||
94335464|NCT02959190|323010781|FG002|Open Label|Adverse Event|3|||
94335465|NCT02959190|323010782|FG003|Open Label|Adverse Event|4|||
94335466|NCT02959190|323010779|FG000|Open Label|Pregnancy|0|||
94335467|NCT02959190|323010780|FG001|Open Label|Pregnancy|1|||
94335468|NCT02959190|323010781|FG002|Open Label|Pregnancy|0|||
94335469|NCT02959190|323010782|FG003|Open Label|Pregnancy|0|||
94335470|NCT02959190|323010779|FG000|Open Label|Withdrawal by Subject|2|||
94335471|NCT02959190|323010780|FG001|Open Label|Withdrawal by Subject|8|||
94335472|NCT02959190|323010781|FG002|Open Label|Withdrawal by Subject|0|||
94335473|NCT02959190|323010782|FG003|Open Label|Withdrawal by Subject|0|||
94335474|NCT02959190|323010779|FG000|Open Label|Physician Decision|0|||
94335475|NCT02959190|323010780|FG001|Open Label|Physician Decision|0|||
94335476|NCT02959190|323010781|FG002|Open Label|Physician Decision|1|||
94335477|NCT02959190|323010782|FG003|Open Label|Physician Decision|0|||
94335478|NCT02959190|323010779|FG000|Open Label|Protocol Violation|0|||
94335479|NCT02959190|323010780|FG001|Open Label|Protocol Violation|0|||
94335480|NCT02959190|323010781|FG002|Open Label|Protocol Violation|0|||
94335481|NCT02959190|323010782|FG003|Open Label|Protocol Violation|2|||
94335482|NCT02959190|323010779|FG000|Post Treatment Follow Up|Adverse Event|1|||
94335483|NCT02959190|323010780|FG001|Post Treatment Follow Up|Adverse Event|1|||
94335484|NCT02959190|323010781|FG002|Post Treatment Follow Up|Adverse Event|0|||
94335485|NCT02959190|323010782|FG003|Post Treatment Follow Up|Adverse Event|0|||
94335486|NCT02959190|323010779|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
94335487|NCT02959190|323010780|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
94335488|NCT02959190|323010781|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
94335489|NCT02959190|323010782|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
94335490|NCT02023268|323010783|FG000|Overall Study|Lack of Efficacy|0|||
94335491|NCT02023268|323010784|FG001|Overall Study|Lack of Efficacy|1|||
94335492|NCT02023268|323010783|FG000|Overall Study|Adverse Event|0|||
94335493|NCT02023268|323010784|FG001|Overall Study|Adverse Event|2|||
94335494|NCT02023268|323010783|FG000|Overall Study|Withdrawal by Subject|0|||
94335495|NCT02023268|323010784|FG001|Overall Study|Withdrawal by Subject|1|||
94335496|NCT04445688|323010785|FG000|Washout (One Week)|Adverse Event|2|||
94335497|NCT04445688|323010785|FG000|Washout (One Week)|Withdrawal by Subject|1|||
94335498|NCT00615459|323010789|FG000|Period I|Adverse Event|2|||
94335499|NCT00615459|323010790|FG001|Period I|Adverse Event|0|||
94335500|NCT00615459|323010791|FG002|Period I|Adverse Event|1|||
94335501|NCT00615459|323010792|FG003|Period I|Adverse Event|0|||
94335502|NCT00615459|323010789|FG000|Period I|Subject withdrew consent|1|||
94335503|NCT00615459|323010790|FG001|Period I|Subject withdrew consent|0|||
94335504|NCT00615459|323010791|FG002|Period I|Subject withdrew consent|0|||
94335505|NCT00615459|323010792|FG003|Period I|Subject withdrew consent|1|||
94335506|NCT00615459|323010789|FG000|Period I|Abnormal test procedure results|1|||
94335507|NCT00615459|323010790|FG001|Period I|Abnormal test procedure results|1|||
94335508|NCT00615459|323010791|FG002|Period I|Abnormal test procedure results|1|||
94335509|NCT00615459|323010792|FG003|Period I|Abnormal test procedure results|0|||
94335510|NCT00615459|323010789|FG000|Period II|Adverse Event|1|||
94335511|NCT00615459|323010790|FG001|Period II|Adverse Event|0|||
94335512|NCT00615459|323010791|FG002|Period II|Adverse Event|0|||
94335513|NCT00615459|323010792|FG003|Period II|Adverse Event|0|||
94335514|NCT00615459|323010789|FG000|Period II|Lost to Follow-up|0|||
94335515|NCT00615459|323010790|FG001|Period II|Lost to Follow-up|0|||
94335516|NCT00615459|323010791|FG002|Period II|Lost to Follow-up|0|||
94335517|NCT00615459|323010792|FG003|Period II|Lost to Follow-up|1|||
94335518|NCT00615459|323010789|FG000|Period III|Adverse Event|0|||
94335519|NCT00615459|323010790|FG001|Period III|Adverse Event|1|||
94335520|NCT00615459|323010791|FG002|Period III|Adverse Event|0|||
94335521|NCT00615459|323010792|FG003|Period III|Adverse Event|0|||
94335522|NCT00615459|323010789|FG000|Period III|Administrative problems|0|||
94335523|NCT00615459|323010790|FG001|Period III|Administrative problems|1|||
94335524|NCT00615459|323010791|FG002|Period III|Administrative problems|1|||
94335525|NCT00615459|323010792|FG003|Period III|Administrative problems|0|||
94335526|NCT00615459|323010789|FG000|Period III|Unsatisfactory therapeutic effect|0|||
94335527|NCT00615459|323010790|FG001|Period III|Unsatisfactory therapeutic effect|1|||
94335528|NCT00615459|323010791|FG002|Period III|Unsatisfactory therapeutic effect|0|||
94335529|NCT00615459|323010792|FG003|Period III|Unsatisfactory therapeutic effect|0|||
94335530|NCT02076334|323010793|FG000|Overall Study|Protocol Violation|1|||
94335531|NCT02076334|323010794|FG001|Overall Study|Protocol Violation|0|||
94335532|NCT02076334|323010795|FG002|Overall Study|Protocol Violation|0|||
94335533|NCT02076334|323010796|FG003|Overall Study|Protocol Violation|0|||
94335534|NCT02076334|323010793|FG000|Overall Study|Lost to Follow-up|0|||
94335535|NCT02076334|323010794|FG001|Overall Study|Lost to Follow-up|1|||
94335536|NCT02076334|323010795|FG002|Overall Study|Lost to Follow-up|1|||
94335537|NCT02076334|323010796|FG003|Overall Study|Lost to Follow-up|0|||
94335538|NCT02076334|323010793|FG000|Overall Study|muscle soreness|0|||
94335539|NCT02076334|323010794|FG001|Overall Study|muscle soreness|0|||
94335540|NCT02076334|323010795|FG002|Overall Study|muscle soreness|0|||
94335541|NCT02076334|323010796|FG003|Overall Study|muscle soreness|1|||
94335542|NCT02475629|323010797|FG000|Overall Study|Adverse Event|1|||
94335543|NCT02475629|323010797|FG000|Overall Study|Death|4|||
94335544|NCT02475629|323010797|FG000|Overall Study|Physician Decision|1|||
94335545|NCT02475629|323010797|FG000|Overall Study|Withdrawal by Subject|1|||
94335546|NCT02475629|323010797|FG000|Overall Study|Lost to Follow-up|1|||
94335547|NCT02475629|323010797|FG000|Overall Study|Subject non-compliance|1|||
94335548|NCT01611298|323010798|FG000|Overall Study|Relapsed|2|||
94335549|NCT01641081|323010799|FG000|Period 1|Sponsor request (potential unblinding)|0|||
94335550|NCT01641081|323010800|FG001|Period 1|Sponsor request (potential unblinding)|0|||
94335551|NCT01641081|323010801|FG002|Period 1|Sponsor request (potential unblinding)|0|||
94335552|NCT01641081|323010802|FG003|Period 1|Sponsor request (potential unblinding)|0|||
94335553|NCT01641081|323010803|FG004|Period 1|Sponsor request (potential unblinding)|0|||
94335554|NCT01641081|323010804|FG005|Period 1|Sponsor request (potential unblinding)|0|||
94335555|NCT01641081|323010805|FG006|Period 1|Sponsor request (potential unblinding)|1|||
94335556|NCT01641081|323010806|FG007|Period 1|Sponsor request (potential unblinding)|0|||
94335557|NCT01641081|323010807|FG008|Period 1|Sponsor request (potential unblinding)|0|||
94335558|NCT01641081|323010808|FG009|Period 1|Sponsor request (potential unblinding)|0|||
94335559|NCT01641081|323010799|FG000|Period 1|Protocol Violation|0|||
94335560|NCT01641081|323010800|FG001|Period 1|Protocol Violation|0|||
94335561|NCT01641081|323010801|FG002|Period 1|Protocol Violation|0|||
94335562|NCT01641081|323010802|FG003|Period 1|Protocol Violation|0|||
94335563|NCT01641081|323010803|FG004|Period 1|Protocol Violation|1|||
94335564|NCT01641081|323010804|FG005|Period 1|Protocol Violation|0|||
94335565|NCT01641081|323010805|FG006|Period 1|Protocol Violation|0|||
94335566|NCT01641081|323010806|FG007|Period 1|Protocol Violation|1|||
94335567|NCT01641081|323010807|FG008|Period 1|Protocol Violation|0|||
94335568|NCT01641081|323010808|FG009|Period 1|Protocol Violation|0|||
94335569|NCT01641081|323010799|FG000|Period 1|Adverse Event|1|||
94335570|NCT01641081|323010800|FG001|Period 1|Adverse Event|0|||
94335571|NCT01641081|323010801|FG002|Period 1|Adverse Event|0|||
94335572|NCT01641081|323010802|FG003|Period 1|Adverse Event|0|||
94335573|NCT01641081|323010803|FG004|Period 1|Adverse Event|0|||
94335574|NCT01641081|323010804|FG005|Period 1|Adverse Event|0|||
94335575|NCT01641081|323010805|FG006|Period 1|Adverse Event|0|||
94335576|NCT01641081|323010806|FG007|Period 1|Adverse Event|2|||
94335577|NCT01641081|323010807|FG008|Period 1|Adverse Event|0|||
94335578|NCT01641081|323010808|FG009|Period 1|Adverse Event|0|||
94335579|NCT01641081|323010799|FG000|Period 2|Adverse Event|0|||
94335580|NCT01641081|323010800|FG001|Period 2|Adverse Event|0|||
94335581|NCT01641081|323010801|FG002|Period 2|Adverse Event|0|||
94335582|NCT01641081|323010802|FG003|Period 2|Adverse Event|0|||
94335583|NCT01641081|323010803|FG004|Period 2|Adverse Event|0|||
94335584|NCT01641081|323010804|FG005|Period 2|Adverse Event|1|||
94335585|NCT01641081|323010805|FG006|Period 2|Adverse Event|0|||
94335586|NCT01641081|323010806|FG007|Period 2|Adverse Event|0|||
94335587|NCT01641081|323010807|FG008|Period 2|Adverse Event|0|||
94335588|NCT01641081|323010808|FG009|Period 2|Adverse Event|0|||
94335589|NCT01641081|323010799|FG000|Period 2|Withdrawal by Subject|0|||
94335590|NCT01641081|323010800|FG001|Period 2|Withdrawal by Subject|0|||
94335591|NCT01641081|323010801|FG002|Period 2|Withdrawal by Subject|0|||
94335592|NCT01641081|323010802|FG003|Period 2|Withdrawal by Subject|1|||
94335593|NCT01641081|323010803|FG004|Period 2|Withdrawal by Subject|0|||
94335594|NCT01641081|323010804|FG005|Period 2|Withdrawal by Subject|0|||
94335595|NCT01641081|323010805|FG006|Period 2|Withdrawal by Subject|2|||
94335596|NCT01641081|323010806|FG007|Period 2|Withdrawal by Subject|0|||
94335597|NCT01641081|323010807|FG008|Period 2|Withdrawal by Subject|0|||
94335598|NCT01641081|323010808|FG009|Period 2|Withdrawal by Subject|0|||
94335599|NCT01641081|323010799|FG000|Period 2|Protocol Violation|1|||
94335600|NCT01641081|323010800|FG001|Period 2|Protocol Violation|0|||
94335601|NCT01641081|323010801|FG002|Period 2|Protocol Violation|0|||
94335602|NCT01641081|323010802|FG003|Period 2|Protocol Violation|0|||
94335603|NCT01641081|323010803|FG004|Period 2|Protocol Violation|0|||
94335604|NCT01641081|323010804|FG005|Period 2|Protocol Violation|0|||
94335605|NCT01641081|323010805|FG006|Period 2|Protocol Violation|0|||
94335606|NCT01641081|323010806|FG007|Period 2|Protocol Violation|0|||
94335607|NCT01641081|323010807|FG008|Period 2|Protocol Violation|0|||
94335608|NCT01641081|323010808|FG009|Period 2|Protocol Violation|0|||
94335609|NCT01641081|323010799|FG000|Period 3|Adverse Event|0|||
94335610|NCT01641081|323010800|FG001|Period 3|Adverse Event|0|||
94335611|NCT01641081|323010801|FG002|Period 3|Adverse Event|1|||
94335612|NCT01641081|323010802|FG003|Period 3|Adverse Event|0|||
94335613|NCT01641081|323010803|FG004|Period 3|Adverse Event|0|||
94335614|NCT01641081|323010804|FG005|Period 3|Adverse Event|0|||
94335615|NCT01641081|323010805|FG006|Period 3|Adverse Event|0|||
94335616|NCT01641081|323010806|FG007|Period 3|Adverse Event|0|||
94335617|NCT01641081|323010807|FG008|Period 3|Adverse Event|0|||
94335618|NCT01641081|323010808|FG009|Period 3|Adverse Event|0|||
94335619|NCT01641081|323010799|FG000|Period 3|Withdrawal by Subject|0|||
94335620|NCT01641081|323010800|FG001|Period 3|Withdrawal by Subject|0|||
94335621|NCT01641081|323010801|FG002|Period 3|Withdrawal by Subject|0|||
94335622|NCT01641081|323010802|FG003|Period 3|Withdrawal by Subject|0|||
94335623|NCT01641081|323010803|FG004|Period 3|Withdrawal by Subject|0|||
94335624|NCT01641081|323010804|FG005|Period 3|Withdrawal by Subject|0|||
94335625|NCT01641081|323010805|FG006|Period 3|Withdrawal by Subject|0|||
94335626|NCT01641081|323010806|FG007|Period 3|Withdrawal by Subject|0|||
94335627|NCT01641081|323010807|FG008|Period 3|Withdrawal by Subject|1|||
94335628|NCT01641081|323010808|FG009|Period 3|Withdrawal by Subject|0|||
94335629|NCT01641081|323010799|FG000|Period 4|Adverse Event|0|||
94335630|NCT01641081|323010800|FG001|Period 4|Adverse Event|1|||
94335631|NCT01641081|323010801|FG002|Period 4|Adverse Event|0|||
94335632|NCT01641081|323010802|FG003|Period 4|Adverse Event|1|||
94335633|NCT01641081|323010803|FG004|Period 4|Adverse Event|0|||
94335634|NCT01641081|323010804|FG005|Period 4|Adverse Event|0|||
94335635|NCT01641081|323010805|FG006|Period 4|Adverse Event|0|||
94335636|NCT01641081|323010806|FG007|Period 4|Adverse Event|0|||
94335637|NCT01641081|323010807|FG008|Period 4|Adverse Event|0|||
94335638|NCT01641081|323010808|FG009|Period 4|Adverse Event|0|||
94335639|NCT01641081|323010799|FG000|Period 5|Adverse Event|0|||
94335640|NCT01641081|323010800|FG001|Period 5|Adverse Event|0|||
94335641|NCT01641081|323010801|FG002|Period 5|Adverse Event|2|||
94335642|NCT01641081|323010802|FG003|Period 5|Adverse Event|0|||
94335643|NCT01641081|323010803|FG004|Period 5|Adverse Event|0|||
94335644|NCT01641081|323010804|FG005|Period 5|Adverse Event|0|||
94335645|NCT01641081|323010805|FG006|Period 5|Adverse Event|0|||
94335646|NCT01641081|323010806|FG007|Period 5|Adverse Event|0|||
94335647|NCT01641081|323010807|FG008|Period 5|Adverse Event|0|||
94335648|NCT01641081|323010808|FG009|Period 5|Adverse Event|0|||
94335649|NCT01095666|323010812|FG000|Overall Study|Lack of Efficacy|0|||
94335650|NCT01095666|323010813|FG001|Overall Study|Lack of Efficacy|0|||
94335651|NCT01095666|323010814|FG002|Overall Study|Lack of Efficacy|1|||
94335652|NCT01095666|323010812|FG000|Overall Study|Adverse Event|2|||
94335653|NCT01095666|323010813|FG001|Overall Study|Adverse Event|1|||
94335654|NCT01095666|323010814|FG002|Overall Study|Adverse Event|3|||
94335655|NCT01095666|323010812|FG000|Overall Study|Lost to Follow-up|2|||
94335656|NCT01095666|323010813|FG001|Overall Study|Lost to Follow-up|2|||
94335657|NCT01095666|323010814|FG002|Overall Study|Lost to Follow-up|0|||
94335658|NCT01095666|323010812|FG000|Overall Study|Withdrawal by Subject|6|||
94335659|NCT01095666|323010813|FG001|Overall Study|Withdrawal by Subject|6|||
94335660|NCT01095666|323010814|FG002|Overall Study|Withdrawal by Subject|1|||
94335661|NCT01095666|323010812|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
94335662|NCT01095666|323010813|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
94335663|NCT01095666|323010814|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
94335664|NCT01963780|323010815|FG000|Overall Study|Death|7|||
94335665|NCT04153929|323010816|FG000|Overall Study|Other than listed|2|||
94335666|NCT04153929|323010817|FG001|Overall Study|Other than listed|2|||
94335667|NCT04153929|323010818|FG002|Overall Study|Other than listed|0|||
94335668|NCT04153929|323010819|FG003|Overall Study|Other than listed|1|||
94335669|NCT04153929|323010820|FG004|Overall Study|Other than listed|0|||
94335670|NCT04153929|323010821|FG005|Overall Study|Other than listed|2|||
94335671|NCT04153929|323010822|FG006|Overall Study|Other than listed|2|||
94335672|NCT04153929|323010823|FG007|Overall Study|Other than listed|1|||
94335673|NCT04153929|323010816|FG000|Overall Study|Lost to Follow-up|2|||
94335674|NCT04153929|323010817|FG001|Overall Study|Lost to Follow-up|1|||
94335675|NCT04153929|323010818|FG002|Overall Study|Lost to Follow-up|0|||
94335676|NCT04153929|323010819|FG003|Overall Study|Lost to Follow-up|1|||
94335677|NCT04153929|323010820|FG004|Overall Study|Lost to Follow-up|1|||
94335678|NCT04153929|323010821|FG005|Overall Study|Lost to Follow-up|0|||
94335679|NCT04153929|323010822|FG006|Overall Study|Lost to Follow-up|0|||
94335680|NCT04153929|323010823|FG007|Overall Study|Lost to Follow-up|0|||
94335681|NCT04153929|323010816|FG000|Overall Study|Withdrawal by Subject|3|||
94335682|NCT04153929|323010817|FG001|Overall Study|Withdrawal by Subject|1|||
94335683|NCT04153929|323010818|FG002|Overall Study|Withdrawal by Subject|0|||
94335684|NCT04153929|323010819|FG003|Overall Study|Withdrawal by Subject|3|||
94335685|NCT04153929|323010820|FG004|Overall Study|Withdrawal by Subject|1|||
94335686|NCT04153929|323010821|FG005|Overall Study|Withdrawal by Subject|0|||
94335687|NCT04153929|323010822|FG006|Overall Study|Withdrawal by Subject|1|||
94335688|NCT04153929|323010823|FG007|Overall Study|Withdrawal by Subject|0|||
94335689|NCT04153929|323010816|FG000|Overall Study|Protocol Violation|0|||
94335690|NCT04153929|323010817|FG001|Overall Study|Protocol Violation|0|||
94335691|NCT04153929|323010818|FG002|Overall Study|Protocol Violation|0|||
94335692|NCT04153929|323010819|FG003|Overall Study|Protocol Violation|0|||
94335693|NCT04153929|323010820|FG004|Overall Study|Protocol Violation|0|||
94335694|NCT04153929|323010821|FG005|Overall Study|Protocol Violation|0|||
94335695|NCT04153929|323010822|FG006|Overall Study|Protocol Violation|1|||
94335696|NCT04153929|323010823|FG007|Overall Study|Protocol Violation|2|||
94335697|NCT04153929|323010816|FG000|Overall Study|Adverse Event|3|||
94335698|NCT04153929|323010817|FG001|Overall Study|Adverse Event|5|||
94335699|NCT04153929|323010818|FG002|Overall Study|Adverse Event|5|||
94335700|NCT04153929|323010819|FG003|Overall Study|Adverse Event|11|||
94335701|NCT04153929|323010820|FG004|Overall Study|Adverse Event|15|||
94335702|NCT04153929|323010821|FG005|Overall Study|Adverse Event|4|||
94335703|NCT04153929|323010822|FG006|Overall Study|Adverse Event|8|||
94335704|NCT04153929|323010823|FG007|Overall Study|Adverse Event|2|||
94335705|NCT04153929|323010816|FG000|Overall Study|Not treated|1|||
94335706|NCT04153929|323010817|FG001|Overall Study|Not treated|0|||
94335707|NCT04153929|323010818|FG002|Overall Study|Not treated|0|||
94335708|NCT04153929|323010819|FG003|Overall Study|Not treated|0|||
94335709|NCT04153929|323010820|FG004|Overall Study|Not treated|0|||
94335710|NCT04153929|323010821|FG005|Overall Study|Not treated|0|||
94335711|NCT04153929|323010822|FG006|Overall Study|Not treated|1|||
94335712|NCT04153929|323010823|FG007|Overall Study|Not treated|0|||
94335713|NCT00753623|323010824|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
94335714|NCT00753623|323010825|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
94335715|NCT00753623|323010824|FG000|Phase I (14 Days)|Physician Decision|1|||
94335716|NCT00753623|323010825|FG001|Phase I (14 Days)|Physician Decision|2|||
94335717|NCT00753623|323010824|FG000|Phase I (14 Days)|Adverse Event|0|||
94335718|NCT00753623|323010825|FG001|Phase I (14 Days)|Adverse Event|1|||
94335719|NCT00753623|323010824|FG000|Washout (7 Days)|Physician Decision|1|||
94335720|NCT00753623|323010825|FG001|Washout (7 Days)|Physician Decision|0|||
94335721|NCT00753623|323010824|FG000|Phase II (14 Days)|Physician Decision|0|||
94335722|NCT00753623|323010825|FG001|Phase II (14 Days)|Physician Decision|1|||
94335723|NCT04083794|323010826|FG000|Overall Study|Lost to Follow-up|9|||
94335724|NCT01749800|323010827|FG000|Overall Study|not meeting inclusion criteria|3|||
94335725|NCT01749800|323010828|FG001|Overall Study|not meeting inclusion criteria|0|||
94335726|NCT01749800|323010829|FG002|Overall Study|not meeting inclusion criteria|0|||
94335727|NCT01749800|323010827|FG000|Overall Study|Withdrawal by Subject|0|||
94335728|NCT01749800|323010828|FG001|Overall Study|Withdrawal by Subject|1|||
94335729|NCT01749800|323010829|FG002|Overall Study|Withdrawal by Subject|0|||
94335730|NCT00224003|323010830|FG000|Overall Study|Adverse Event|1|||
94335731|NCT00224003|323010830|FG000|Overall Study|Protocol Violation|2|||
94335732|NCT00224003|323010830|FG000|Overall Study|Withdrawal by Subject|1|||
94335733|NCT00224003|323010830|FG000|Overall Study|unk|3|||
94335734|NCT01451398|323010831|FG000|Overall Study|Adverse Event|7|||
94335735|NCT01451398|323010832|FG001|Overall Study|Adverse Event|9|||
94335736|NCT01451398|323010831|FG000|Overall Study|Protocol Violation|1|||
94335737|NCT01451398|323010832|FG001|Overall Study|Protocol Violation|2|||
94335738|NCT01451398|323010831|FG000|Overall Study|Physician Decision|1|||
94335739|NCT01451398|323010832|FG001|Overall Study|Physician Decision|1|||
94335740|NCT01451398|323010831|FG000|Overall Study|Withdrawal by Subject|10|||
94335741|NCT01451398|323010832|FG001|Overall Study|Withdrawal by Subject|14|||
94335742|NCT01451398|323010831|FG000|Overall Study|Lost to Follow-up|6|||
94335743|NCT01451398|323010832|FG001|Overall Study|Lost to Follow-up|4|||
94335744|NCT01451398|323010831|FG000|Overall Study|Non-compliance with study drug|1|||
94335745|NCT01451398|323010832|FG001|Overall Study|Non-compliance with study drug|3|||
94335746|NCT01451398|323010831|FG000|Overall Study|Non-compliance with protocol|1|||
94335747|NCT01451398|323010832|FG001|Overall Study|Non-compliance with protocol|1|||
94335748|NCT01451398|323010831|FG000|Overall Study|Moved out of country|0|||
94335749|NCT01451398|323010832|FG001|Overall Study|Moved out of country|1|||
94335750|NCT01451398|323010831|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
94335751|NCT01451398|323010832|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
94335752|NCT01451398|323010831|FG000|Overall Study|Lack of Efficacy|0|||
94335753|NCT01451398|323010832|FG001|Overall Study|Lack of Efficacy|1|||
94335754|NCT01000025|323010836|FG000|Overall Study|Adverse Event|43|||
94335755|NCT01000025|323010837|FG001|Overall Study|Adverse Event|2|||
94335756|NCT01000025|323010836|FG000|Overall Study|Withdrawal by Subject|13|||
94335757|NCT01000025|323010837|FG001|Overall Study|Withdrawal by Subject|8|||
94335758|NCT01000025|323010836|FG000|Overall Study|Death|23|||
94335759|NCT01000025|323010837|FG001|Overall Study|Death|13|||
94335760|NCT01000025|323010836|FG000|Overall Study|Lack of Efficacy|363|||
94335761|NCT01000025|323010837|FG001|Overall Study|Lack of Efficacy|208|||
94335762|NCT01000025|323010836|FG000|Overall Study|Intercurrent Illness|26|||
94335763|NCT01000025|323010837|FG001|Overall Study|Intercurrent Illness|7|||
94335764|NCT04423757|323010838|FG000|Overall Study|Adverse Event|2|||
94335765|NCT04423757|323010839|FG001|Overall Study|Adverse Event|0|||
94335766|NCT04423757|323010838|FG000|Overall Study|Not treated|1|||
94335767|NCT04423757|323010839|FG001|Overall Study|Not treated|1|||
94335768|NCT00422669|323010840|FG000|Overall Study|The study was terminated early.|98|||
94335769|NCT00422669|323010841|FG001|Overall Study|The study was terminated early.|100|||
94335770|NCT00422669|323010842|FG002|Overall Study|The study was terminated early.|7|||
94335771|NCT01202760|323010849|FG000|Overall Study|Entry Criteria Not Met|0|||
94335772|NCT01202760|323010850|FG001|Overall Study|Entry Criteria Not Met|3|||
94335773|NCT01202760|323010851|FG002|Overall Study|Entry Criteria Not Met|1|||
94335774|NCT01202760|323010849|FG000|Overall Study|Adverse Event|11|||
94335775|NCT01202760|323010850|FG001|Overall Study|Adverse Event|9|||
94335776|NCT01202760|323010851|FG002|Overall Study|Adverse Event|10|||
94335777|NCT01202760|323010849|FG000|Overall Study|Death|2|||
94335778|NCT01202760|323010850|FG001|Overall Study|Death|1|||
94335779|NCT01202760|323010851|FG002|Overall Study|Death|0|||
94335780|NCT01202760|323010849|FG000|Overall Study|Lack of Efficacy|6|||
94335781|NCT01202760|323010850|FG001|Overall Study|Lack of Efficacy|8|||
94335782|NCT01202760|323010851|FG002|Overall Study|Lack of Efficacy|7|||
94335783|NCT01202760|323010849|FG000|Overall Study|Lost to Follow-up|0|||
94335784|NCT01202760|323010850|FG001|Overall Study|Lost to Follow-up|2|||
94335785|NCT01202760|323010851|FG002|Overall Study|Lost to Follow-up|1|||
94335786|NCT01202760|323010849|FG000|Overall Study|Parent / Caregiver Decision|0|||
94335787|NCT01202760|323010850|FG001|Overall Study|Parent / Caregiver Decision|1|||
94335788|NCT01202760|323010851|FG002|Overall Study|Parent / Caregiver Decision|0|||
94335789|NCT01202760|323010849|FG000|Overall Study|Withdrawal by Subject|17|||
94335790|NCT01202760|323010850|FG001|Overall Study|Withdrawal by Subject|18|||
94335791|NCT01202760|323010851|FG002|Overall Study|Withdrawal by Subject|14|||
94335792|NCT01202760|323010849|FG000|Overall Study|Physician Decision|0|||
94335793|NCT01202760|323010850|FG001|Overall Study|Physician Decision|1|||
94335794|NCT01202760|323010851|FG002|Overall Study|Physician Decision|0|||
94335795|NCT01202760|323010849|FG000|Overall Study|Protocol Violation|7|||
94335796|NCT01202760|323010850|FG001|Overall Study|Protocol Violation|5|||
94335797|NCT01202760|323010851|FG002|Overall Study|Protocol Violation|2|||
94335798|NCT01202760|323010849|FG000|Overall Study|Sponsor Decision|4|||
94335799|NCT01202760|323010850|FG001|Overall Study|Sponsor Decision|4|||
94335800|NCT01202760|323010851|FG002|Overall Study|Sponsor Decision|0|||
94335801|NCT03148756|323010852|FG000|Overall Study|Study Terminated|0|||
94335802|NCT03148756|323010853|FG001|Overall Study|Study Terminated|1|||
94335803|NCT02186561|323010859|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
94335804|NCT02186561|323010859|FG000|Enrollment|Enrollment Cap Reached|5|||
94335805|NCT02186561|323010859|FG000|Enrollment|Insurance Denial|2|||
94335806|NCT02186561|323010859|FG000|Enrollment|Withdrawal by Subject|2|||
94335807|NCT02186561|323010859|FG000|Enrollment|Investigator Withdrew Consent|1|||
94335808|NCT02186561|323010859|FG000|30-Day Post Index Procedure Visit|Death|1|||
94335809|NCT02186561|323010859|FG000|1- Year Post Index Procedure Visit|Death|1|||
94335810|NCT02186561|323010859|FG000|1- Year Post Index Procedure Visit|Missed|1|||
94335811|NCT01072448|323010860|FG000|Overall Study|Adverse Event|9|||
94335812|NCT01072448|323010861|FG001|Overall Study|Adverse Event|10|||
94335813|NCT01072448|323010860|FG000|Overall Study|Subject withdrew consent|4|||
94335814|NCT01072448|323010861|FG001|Overall Study|Subject withdrew consent|9|||
94335815|NCT01072448|323010860|FG000|Overall Study|Protocol deviation|3|||
94335816|NCT01072448|323010861|FG001|Overall Study|Protocol deviation|4|||
94335817|NCT01072448|323010860|FG000|Overall Study|Abnormal test procedure result(s)|1|||
94335818|NCT01072448|323010861|FG001|Overall Study|Abnormal test procedure result(s)|0|||
94335819|NCT01072448|323010860|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94335820|NCT01072448|323010861|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
94335821|NCT01072448|323010860|FG000|Overall Study|Lost to Follow-up|1|||
94335822|NCT01072448|323010861|FG001|Overall Study|Lost to Follow-up|1|||
94335823|NCT01072448|323010860|FG000|Overall Study|Abnormal laboratory value(s)|0|||
94335824|NCT01072448|323010861|FG001|Overall Study|Abnormal laboratory value(s)|1|||
94335825|NCT01072448|323010860|FG000|Overall Study|Death|0|||
94335826|NCT01072448|323010861|FG001|Overall Study|Death|2|||
94335827|NCT03549429|323010865|FG000|Overall Study|Protocol Violation|5|||
94335828|NCT03549429|323010866|FG001|Overall Study|Protocol Violation|3|||
94335829|NCT01614795|323010867|FG000|Overall Study|Adverse Event|0|||
94335830|NCT01614795|323010868|FG001|Overall Study|Adverse Event|0|||
94335831|NCT01614795|323010869|FG002|Overall Study|Adverse Event|1|||
94335832|NCT01614795|323010870|FG003|Overall Study|Adverse Event|1|||
94335833|NCT01614795|323010867|FG000|Overall Study|Lack of Efficacy|10|||
94335834|NCT01614795|323010868|FG001|Overall Study|Lack of Efficacy|10|||
94335835|NCT01614795|323010869|FG002|Overall Study|Lack of Efficacy|9|||
94335836|NCT01614795|323010870|FG003|Overall Study|Lack of Efficacy|8|||
94335837|NCT01614795|323010867|FG000|Overall Study|Physician Decision|1|||
94335838|NCT01614795|323010868|FG001|Overall Study|Physician Decision|0|||
94335839|NCT01614795|323010869|FG002|Overall Study|Physician Decision|1|||
94335840|NCT01614795|323010870|FG003|Overall Study|Physician Decision|1|||
94335841|NCT01614795|323010867|FG000|Overall Study|Withdrawal by Subject|0|||
94335842|NCT01614795|323010868|FG001|Overall Study|Withdrawal by Subject|1|||
94335843|NCT01614795|323010869|FG002|Overall Study|Withdrawal by Subject|0|||
94335844|NCT01614795|323010870|FG003|Overall Study|Withdrawal by Subject|2|||
94335845|NCT01614795|323010867|FG000|Overall Study|Ineligible|0|||
94335846|NCT01614795|323010868|FG001|Overall Study|Ineligible|1|||
94335847|NCT01614795|323010869|FG002|Overall Study|Ineligible|0|||
94335848|NCT01614795|323010870|FG003|Overall Study|Ineligible|0|||
94335849|NCT01293084|323010871|FG000|Overall Study|Physician Decision|3|||
94335850|NCT01293084|323010871|FG000|Overall Study|Withdrawal by Subject|2|||
94335851|NCT02096042|323010872|FG000|Overall Study|Disease Progression|1|||
94335852|NCT02096042|323010873|FG001|Overall Study|Disease Progression|0|||
94335853|NCT02096042|323010874|FG002|Overall Study|Disease Progression|0|||
94335854|NCT03034057|323010875|FG000|Overall Study|Withdrawal by Subject|10|||
94335855|NCT03034057|323010875|FG000|Overall Study|Protocol Violation|1|||
94335856|NCT03034057|323010875|FG000|Overall Study|Not defined|2|||
94335857|NCT03034057|323010875|FG000|Overall Study|Lost to Follow-up|19|||
94335858|NCT03034057|323010875|FG000|Overall Study|Adverse Event|22|||
94335859|NCT03034057|323010875|FG000|Overall Study|Medication error without associated AE|1|||
94335860|NCT01814826|323010876|FG000|Overall Study|Other|3|||
94335861|NCT01814826|323010877|FG001|Overall Study|Other|5|||
94335862|NCT01814826|323010878|FG002|Overall Study|Other|0|||
94335863|NCT01814826|323010876|FG000|Overall Study|Death|29|||
94335864|NCT01814826|323010877|FG001|Overall Study|Death|24|||
94335865|NCT01814826|323010878|FG002|Overall Study|Death|3|||
94335866|NCT02917629|323010882|FG000|Overall Study|Withdrawal by Subject|0|||
94335867|NCT02917629|323010883|FG001|Overall Study|Withdrawal by Subject|1|||
94335868|NCT04209400|323010888|FG000|Overall Study|Withdrawal by Subject|0|||
94335869|NCT04209400|323010889|FG001|Overall Study|Withdrawal by Subject|1|||
94335870|NCT00856986|323010896|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
94335871|NCT00856986|323010897|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
94335872|NCT00856986|323010898|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
94335873|NCT00856986|323010899|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
94335874|NCT00856986|323010900|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
94335875|NCT00856986|323010896|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
94335876|NCT00856986|323010897|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
94335877|NCT00856986|323010898|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
94335878|NCT00856986|323010899|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
94335879|NCT00856986|323010900|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
94335880|NCT00856986|323010896|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
94335881|NCT00856986|323010897|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
94335882|NCT00856986|323010898|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
94335883|NCT00856986|323010899|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
94335884|NCT00856986|323010900|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
94335885|NCT00856986|323010896|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
94335886|NCT00856986|323010897|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
94335887|NCT00856986|323010898|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
94335888|NCT00856986|323010899|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
94335889|NCT00856986|323010900|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
94335890|NCT00856986|323010896|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
94335891|NCT00856986|323010897|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
94335892|NCT00856986|323010898|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
94335893|NCT00856986|323010899|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
94335894|NCT00856986|323010900|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
94335895|NCT00856986|323010896|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
94335896|NCT00856986|323010897|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
94335897|NCT00856986|323010898|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
94335898|NCT00856986|323010899|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
94335899|NCT00856986|323010900|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
94335900|NCT00856986|323010896|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
94335901|NCT00856986|323010897|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
94335902|NCT00856986|323010898|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
94335903|NCT00856986|323010899|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
94335904|NCT00856986|323010900|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
94335905|NCT00856986|323010896|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
94335906|NCT00856986|323010897|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
94335907|NCT00856986|323010898|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
94335908|NCT00856986|323010899|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
94335909|NCT00856986|323010900|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
94335910|NCT00856986|323010896|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
94335911|NCT00856986|323010897|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
94335912|NCT00856986|323010898|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
94335913|NCT00856986|323010899|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
94335914|NCT00856986|323010900|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
94335915|NCT00856986|323010896|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
94335916|NCT00856986|323010897|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
94335917|NCT00856986|323010898|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
94335918|NCT00856986|323010899|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
94335919|NCT00856986|323010900|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
94335920|NCT00856986|323010896|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
94335921|NCT00856986|323010897|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
94335922|NCT00856986|323010898|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
94335923|NCT00856986|323010899|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
94335924|NCT00856986|323010900|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
94335925|NCT00856986|323010896|FG000|Main Period, Weeks 0-26|Unclassified|7|||
94335926|NCT00856986|323010897|FG001|Main Period, Weeks 0-26|Unclassified|6|||
94335927|NCT00856986|323010898|FG002|Main Period, Weeks 0-26|Unclassified|7|||
94335928|NCT00856986|323010899|FG003|Main Period, Weeks 0-26|Unclassified|0|||
94335929|NCT00856986|323010900|FG004|Main Period, Weeks 0-26|Unclassified|0|||
94335930|NCT00856986|323010896|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
94335931|NCT00856986|323010897|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
94651327|NCT02460224|324179737|FG022|Overall Study|Progressive disease|4|||
94335932|NCT00856986|323010898|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
94335933|NCT00856986|323010899|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
94335934|NCT00856986|323010900|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
94335935|NCT00856986|323010896|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
94335936|NCT00856986|323010897|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
94335937|NCT00856986|323010898|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
94335938|NCT00856986|323010899|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
94335939|NCT00856986|323010900|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
94335940|NCT00856986|323010896|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
94335941|NCT00856986|323010897|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
94335942|NCT00856986|323010898|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
94335943|NCT00856986|323010899|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
94335944|NCT00856986|323010900|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
94335945|NCT00856986|323010896|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
94335946|NCT00856986|323010897|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
94335947|NCT00856986|323010898|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
94335948|NCT00856986|323010899|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
94335949|NCT00856986|323010900|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
94335950|NCT00856986|323010896|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
94335951|NCT00856986|323010897|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
94335952|NCT00856986|323010898|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
94335953|NCT00856986|323010899|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
94335954|NCT00856986|323010900|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
94335955|NCT00856986|323010896|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
94335956|NCT00856986|323010897|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
94335957|NCT00856986|323010898|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
94335958|NCT00856986|323010899|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
94335959|NCT00856986|323010900|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
94335960|NCT05041062|323010903|FG000|Overall Study|Adverse Event|2|||
94335961|NCT01041404|323010914|FG000|Overall Study|Adverse Event|45|||
94335962|NCT01041404|323010915|FG001|Overall Study|Adverse Event|35|||
94335963|NCT01041404|323010914|FG000|Overall Study|Lack of Efficacy|200|||
94335964|NCT01041404|323010915|FG001|Overall Study|Lack of Efficacy|210|||
94335965|NCT01041404|323010914|FG000|Overall Study|Violation of Selection Criteria|0|||
94335966|NCT01041404|323010915|FG001|Overall Study|Violation of Selection Criteria|1|||
94335967|NCT01041404|323010914|FG000|Overall Study|Protocol Violation|4|||
94335968|NCT01041404|323010915|FG001|Overall Study|Protocol Violation|0|||
94335969|NCT01041404|323010914|FG000|Overall Study|Withdrawal by Subject|29|||
94335970|NCT01041404|323010915|FG001|Overall Study|Withdrawal by Subject|23|||
94335971|NCT01041404|323010914|FG000|Overall Study|Failure to Return|1|||
94335972|NCT01041404|323010915|FG001|Overall Study|Failure to Return|2|||
94335973|NCT01041404|323010914|FG000|Overall Study|Other|11|||
94335974|NCT01041404|323010915|FG001|Overall Study|Other|23|||
94335975|NCT03906136|323013312|FG000|Overall Study|Adverse Event|1|||
94335976|NCT03906136|323013313|FG001|Overall Study|Adverse Event|0|||
94335977|NCT03906136|323013312|FG000|Overall Study|Lost to Follow-up|7|||
94335978|NCT03906136|323013313|FG001|Overall Study|Lost to Follow-up|4|||
94335979|NCT03906136|323013312|FG000|Overall Study|Physician Decision|1|||
94335980|NCT03906136|323013313|FG001|Overall Study|Physician Decision|0|||
94335981|NCT03906136|323013312|FG000|Overall Study|Withdrawal by Subject|3|||
94335982|NCT03906136|323013313|FG001|Overall Study|Withdrawal by Subject|7|||
94335983|NCT02967692|323013314|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|3|||
94335984|NCT02967692|323013315|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|1|||
94335985|NCT02967692|323013316|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|86|||
94335986|NCT02967692|323013317|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|82|||
94335987|NCT02967692|323013314|FG000|Overall Study|Progressive disease|3|||
94335988|NCT02967692|323013315|FG001|Overall Study|Progressive disease|15|||
94335989|NCT02967692|323013316|FG002|Overall Study|Progressive disease|99|||
94335990|NCT02967692|323013317|FG003|Overall Study|Progressive disease|128|||
94335991|NCT02967692|323013314|FG000|Overall Study|Subject/guardian decision|1|||
94335992|NCT02967692|323013315|FG001|Overall Study|Subject/guardian decision|1|||
94335993|NCT02967692|323013316|FG002|Overall Study|Subject/guardian decision|6|||
94335994|NCT02967692|323013317|FG003|Overall Study|Subject/guardian decision|13|||
94335995|NCT02967692|323013314|FG000|Overall Study|Death|0|||
94335996|NCT02967692|323013315|FG001|Overall Study|Death|1|||
94335997|NCT02967692|323013316|FG002|Overall Study|Death|10|||
94335998|NCT02967692|323013317|FG003|Overall Study|Death|9|||
94335999|NCT02967692|323013314|FG000|Overall Study|Protocol deviation|1|||
94336000|NCT02967692|323013315|FG001|Overall Study|Protocol deviation|0|||
94336001|NCT02967692|323013316|FG002|Overall Study|Protocol deviation|1|||
94336002|NCT02967692|323013317|FG003|Overall Study|Protocol deviation|1|||
94336003|NCT02967692|323013314|FG000|Overall Study|Lost to Follow-up|0|||
94336004|NCT02967692|323013315|FG001|Overall Study|Lost to Follow-up|0|||
94336005|NCT02967692|323013316|FG002|Overall Study|Lost to Follow-up|1|||
94336006|NCT02967692|323013317|FG003|Overall Study|Lost to Follow-up|0|||
94336007|NCT02967692|323013314|FG000|Overall Study|Physician Decision|0|||
94336008|NCT02967692|323013315|FG001|Overall Study|Physician Decision|0|||
94336009|NCT02967692|323013316|FG002|Overall Study|Physician Decision|13|||
94336010|NCT02967692|323013317|FG003|Overall Study|Physician Decision|9|||
94336011|NCT02967692|323013314|FG000|Overall Study|Adverse Event|1|||
94336012|NCT02967692|323013315|FG001|Overall Study|Adverse Event|9|||
94336013|NCT02967692|323013316|FG002|Overall Study|Adverse Event|51|||
94336014|NCT02967692|323013317|FG003|Overall Study|Adverse Event|23|||
94336015|NCT00922974|323013320|FG000|Phase II Component|Protocol Violation|2|||
94336016|NCT00922974|323013321|FG001|Phase II Component|Protocol Violation|0|||
94336017|NCT00922974|323013320|FG000|Phase II Component|Not evaluable for treatment review|5|||
94336018|NCT00922974|323013321|FG001|Phase II Component|Not evaluable for treatment review|0|||
94336019|NCT00922974|323013320|FG000|Phase III Component|Protocol Violation|8|||
94336020|NCT00922974|323013321|FG001|Phase III Component|Protocol Violation|6|||
94336021|NCT00462488|323013322|FG000|Overall Study|Protocol Violation|1|||
94336022|NCT00462488|323013323|FG001|Overall Study|Protocol Violation|0|||
94336023|NCT00462488|323013322|FG000|Overall Study|Lack of Efficacy|19|||
94336024|NCT00462488|323013323|FG001|Overall Study|Lack of Efficacy|17|||
94336025|NCT01742091|323013326|FG000|Overall Study|Adverse Event|0|||
94336026|NCT01742091|323013327|FG001|Overall Study|Adverse Event|0|||
94336027|NCT01742091|323013328|FG002|Overall Study|Adverse Event|0|||
94336028|NCT01742091|323013329|FG003|Overall Study|Adverse Event|0|||
94336029|NCT01742091|323013330|FG004|Overall Study|Adverse Event|1|||
94336030|NCT01742091|323013331|FG005|Overall Study|Adverse Event|0|||
94336031|NCT01742091|323013326|FG000|Overall Study|Physician Decision|0|||
94336032|NCT01742091|323013327|FG001|Overall Study|Physician Decision|0|||
94336033|NCT01742091|323013328|FG002|Overall Study|Physician Decision|0|||
94336034|NCT01742091|323013329|FG003|Overall Study|Physician Decision|0|||
94336035|NCT01742091|323013330|FG004|Overall Study|Physician Decision|0|||
94336036|NCT01742091|323013331|FG005|Overall Study|Physician Decision|1|||
94336037|NCT01742091|323013326|FG000|Overall Study|Withdrawal by Subject|0|||
94336038|NCT01742091|323013327|FG001|Overall Study|Withdrawal by Subject|0|||
94336039|NCT01742091|323013328|FG002|Overall Study|Withdrawal by Subject|0|||
94336040|NCT01742091|323013329|FG003|Overall Study|Withdrawal by Subject|1|||
94336041|NCT01742091|323013330|FG004|Overall Study|Withdrawal by Subject|0|||
94336042|NCT01742091|323013331|FG005|Overall Study|Withdrawal by Subject|0|||
94336043|NCT01742091|323013326|FG000|Overall Study|Lost to Follow-up|0|||
94336044|NCT01742091|323013327|FG001|Overall Study|Lost to Follow-up|0|||
94336045|NCT01742091|323013328|FG002|Overall Study|Lost to Follow-up|0|||
94336046|NCT01742091|323013329|FG003|Overall Study|Lost to Follow-up|0|||
94336047|NCT01742091|323013330|FG004|Overall Study|Lost to Follow-up|0|||
94336048|NCT01742091|323013331|FG005|Overall Study|Lost to Follow-up|1|||
94336049|NCT03706040|323013332|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
94336050|NCT03706040|323013333|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
94336051|NCT03706040|323013334|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
94336052|NCT03706040|323013335|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
94336053|NCT03706040|323013336|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
94336054|NCT03706040|323013337|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
94336055|NCT03706040|323013338|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
94336056|NCT03706040|323013332|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
94336057|NCT03706040|323013333|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
94336058|NCT03706040|323013334|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
94336059|NCT03706040|323013335|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
94336060|NCT03706040|323013336|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
94336061|NCT03706040|323013337|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
94336062|NCT03706040|323013338|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
94336063|NCT03706040|323013332|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
94336064|NCT03706040|323013333|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
94336065|NCT03706040|323013334|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
94336066|NCT03706040|323013335|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
94336067|NCT03706040|323013336|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
94336068|NCT03706040|323013337|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
94336069|NCT03706040|323013338|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
94336070|NCT03706040|323013332|FG000|Period A (Week 0 to Week 16)|Other|2|||
94336071|NCT03706040|323013333|FG001|Period A (Week 0 to Week 16)|Other|0|||
94336072|NCT03706040|323013334|FG002|Period A (Week 0 to Week 16)|Other|2|||
94336073|NCT03706040|323013335|FG003|Period A (Week 0 to Week 16)|Other|0|||
94336074|NCT03706040|323013336|FG004|Period A (Week 0 to Week 16)|Other|0|||
94336075|NCT03706040|323013337|FG005|Period A (Week 0 to Week 16)|Other|0|||
94336076|NCT03706040|323013338|FG006|Period A (Week 0 to Week 16)|Other|0|||
94336077|NCT03706040|323013332|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
94336078|NCT03706040|323013333|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
94336079|NCT03706040|323013334|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
94336080|NCT03706040|323013335|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
94336081|NCT03706040|323013336|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
94336082|NCT03706040|323013337|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
94336083|NCT03706040|323013338|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
94336084|NCT03706040|323013332|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
94336085|NCT03706040|323013333|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
94336086|NCT03706040|323013334|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
94336087|NCT03706040|323013335|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
94336088|NCT03706040|323013336|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
94336089|NCT03706040|323013337|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
94336090|NCT03706040|323013338|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
94336091|NCT03706040|323013332|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
94336092|NCT03706040|323013333|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
94336093|NCT03706040|323013334|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
94336094|NCT03706040|323013335|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
94336095|NCT03706040|323013336|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
94336096|NCT03706040|323013337|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
94336097|NCT03706040|323013338|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
94336098|NCT03706040|323013332|FG000|Period B (Week 16 to Week 52)|Other|0|||
94336099|NCT03706040|323013333|FG001|Period B (Week 16 to Week 52)|Other|0|||
94336100|NCT03706040|323013334|FG002|Period B (Week 16 to Week 52)|Other|0|||
94336101|NCT03706040|323013335|FG003|Period B (Week 16 to Week 52)|Other|4|||
94336102|NCT03706040|323013336|FG004|Period B (Week 16 to Week 52)|Other|5|||
94336103|NCT03706040|323013337|FG005|Period B (Week 16 to Week 52)|Other|23|||
94336104|NCT03706040|323013338|FG006|Period B (Week 16 to Week 52)|Other|17|||
94336105|NCT00927758|323013339|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
94336106|NCT00927758|323013340|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
94336107|NCT00927758|323013341|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
94336108|NCT00927758|323013342|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
94336109|NCT00927758|323013343|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
94336110|NCT00927758|323013344|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
94336111|NCT00927758|323013339|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
94336112|NCT00927758|323013340|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
94336113|NCT00927758|323013341|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
94336114|NCT00927758|323013342|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
94336115|NCT00927758|323013343|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
94336116|NCT00927758|323013344|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
94336117|NCT03984812|323013346|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
94336118|NCT03984812|323013347|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
94336119|NCT03984812|323013348|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
94336120|NCT03984812|323013349|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
94336121|NCT03984812|323013350|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
94336122|NCT03984812|323013351|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
94336123|NCT03984812|323013352|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
94336124|NCT03984812|323013353|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
94336125|NCT03984812|323013354|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
94336126|NCT03984812|323013355|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
94336127|NCT03984812|323013356|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
94336128|NCT00446641|323013357|FG000|Overall Study|Withdrawal by Subject|8|||
94336129|NCT00446641|323013358|FG001|Overall Study|Withdrawal by Subject|3|||
94336130|NCT00446641|323013357|FG000|Overall Study|poor compliance|8|||
94336131|NCT00446641|323013358|FG001|Overall Study|poor compliance|6|||
94336132|NCT00446641|323013357|FG000|Overall Study|Lost to Follow-up|1|||
94336133|NCT00446641|323013358|FG001|Overall Study|Lost to Follow-up|1|||
94336134|NCT03417505|323013365|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
94336135|NCT03417505|323013366|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
94336136|NCT02580591|323013367|FG000|Overall Study|Adverse Event|0|||
94336137|NCT02580591|323013368|FG001|Overall Study|Adverse Event|1|||
94336138|NCT02580591|323013369|FG002|Overall Study|Adverse Event|2|||
94336139|NCT02580591|323013370|FG003|Overall Study|Adverse Event|5|||
94336140|NCT02580591|323013367|FG000|Overall Study|Protocol Violation|3|||
94336141|NCT02580591|323013368|FG001|Overall Study|Protocol Violation|2|||
94336142|NCT02580591|323013369|FG002|Overall Study|Protocol Violation|1|||
94336143|NCT02580591|323013370|FG003|Overall Study|Protocol Violation|1|||
94336144|NCT02580591|323013367|FG000|Overall Study|Lost to Follow-up|5|||
94336145|NCT02580591|323013368|FG001|Overall Study|Lost to Follow-up|3|||
94336146|NCT02580591|323013369|FG002|Overall Study|Lost to Follow-up|3|||
94336147|NCT02580591|323013370|FG003|Overall Study|Lost to Follow-up|1|||
94336148|NCT02580591|323013367|FG000|Overall Study|Withdrawal by Subject|6|||
94336149|NCT02580591|323013368|FG001|Overall Study|Withdrawal by Subject|1|||
94336150|NCT02580591|323013369|FG002|Overall Study|Withdrawal by Subject|2|||
94336151|NCT02580591|323013370|FG003|Overall Study|Withdrawal by Subject|3|||
94336152|NCT02580591|323013367|FG000|Overall Study|Not treated|1|||
94336153|NCT02580591|323013368|FG001|Overall Study|Not treated|1|||
94336154|NCT02580591|323013369|FG002|Overall Study|Not treated|0|||
94336155|NCT02580591|323013370|FG003|Overall Study|Not treated|0|||
94336156|NCT02580591|323013367|FG000|Overall Study|Other than specified|3|||
94336157|NCT02580591|323013368|FG001|Overall Study|Other than specified|2|||
94336158|NCT02580591|323013369|FG002|Overall Study|Other than specified|5|||
94336159|NCT02580591|323013370|FG003|Overall Study|Other than specified|2|||
94336160|NCT03051217|323013371|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
94336161|NCT03051217|323013372|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94336162|NCT03051217|323013373|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
94336163|NCT03051217|323013374|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94336164|NCT03051217|323013375|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94336165|NCT03051217|323013376|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94336166|NCT03051217|323013377|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94336167|NCT03051217|323013371|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
94336168|NCT03051217|323013372|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
94336169|NCT03051217|323013373|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
94336170|NCT03051217|323013374|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
94336171|NCT03051217|323013375|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
94336172|NCT03051217|323013376|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
94336173|NCT03051217|323013377|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
94336174|NCT03051217|323013371|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
94336175|NCT03051217|323013372|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
94336176|NCT03051217|323013373|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
94336177|NCT03051217|323013374|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94336178|NCT03051217|323013375|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94336179|NCT03051217|323013376|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94336180|NCT03051217|323013377|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94336181|NCT03051217|323013371|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
94336182|NCT03051217|323013372|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
94336183|NCT03051217|323013373|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
94336184|NCT03051217|323013374|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
94336185|NCT03051217|323013375|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
94336186|NCT03051217|323013376|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
94336187|NCT03051217|323013377|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
94336188|NCT03051217|323013371|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
94336189|NCT03051217|323013372|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
94336190|NCT03051217|323013373|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
94336191|NCT03051217|323013374|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
94336192|NCT03051217|323013375|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
94336193|NCT03051217|323013376|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
94336194|NCT03051217|323013377|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
94336195|NCT03051217|323013371|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
94336196|NCT03051217|323013372|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
94336197|NCT03051217|323013373|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
94336198|NCT03051217|323013374|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
94336199|NCT03051217|323013375|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
94336200|NCT03051217|323013376|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
94336201|NCT03051217|323013377|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
94336202|NCT03051217|323013371|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
94336203|NCT03051217|323013372|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
94336204|NCT03051217|323013373|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
94336205|NCT03051217|323013374|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
94336206|NCT03051217|323013375|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
94336207|NCT03051217|323013376|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
94336208|NCT03051217|323013377|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
94336209|NCT03051217|323013371|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
94336210|NCT03051217|323013372|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
94336211|NCT03051217|323013373|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
94336212|NCT03051217|323013374|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
94336213|NCT03051217|323013375|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
94336214|NCT03051217|323013376|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
94336215|NCT03051217|323013377|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
94336216|NCT00641706|323013378|FG000|Overall Study|Adverse Event|2|||
94336217|NCT00641706|323013379|FG001|Overall Study|Adverse Event|1|||
94336218|NCT00641706|323013378|FG000|Overall Study|Withdrawal by Subject|6|||
94336219|NCT00641706|323013379|FG001|Overall Study|Withdrawal by Subject|1|||
94336220|NCT00641706|323013378|FG000|Overall Study|Clinical Decline|1|||
94336221|NCT00641706|323013379|FG001|Overall Study|Clinical Decline|0|||
94336222|NCT00641706|323013378|FG000|Overall Study|Lead Investigator Decision|0|||
94336223|NCT00641706|323013379|FG001|Overall Study|Lead Investigator Decision|1|||
94336224|NCT01266070|323013380|FG000|Overall Study|Adverse Event|3|||
94336225|NCT01266070|323013380|FG000|Overall Study|Protocol Violation|1|||
94336226|NCT01838213|323013381|FG000|Overall Study|Ineligible|166|||
94336227|NCT01838213|323013382|FG001|Overall Study|Ineligible|191|||
94336228|NCT03185819|323013383|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
94336229|NCT03185819|323013384|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
94336230|NCT03185819|323013385|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
94336231|NCT03185819|323013386|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
94336232|NCT03185819|323013383|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
94336233|NCT03185819|323013384|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
94336234|NCT03185819|323013385|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
94336235|NCT03185819|323013386|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
94336236|NCT03185819|323013383|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
94336237|NCT03185819|323013384|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
94336238|NCT03185819|323013385|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
94336239|NCT03185819|323013386|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
94336240|NCT03185819|323013383|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
94336241|NCT03185819|323013384|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
94336242|NCT03185819|323013385|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
94336243|NCT03185819|323013386|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
94336244|NCT03185819|323013383|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
94336245|NCT03185819|323013384|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
94336246|NCT03185819|323013385|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
94336247|NCT03185819|323013386|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
94336248|NCT03185819|323013383|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
94336249|NCT03185819|323013384|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
94336250|NCT03185819|323013385|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
94336251|NCT03185819|323013386|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
94336252|NCT03185819|323013383|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
94336253|NCT03185819|323013384|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
94336254|NCT03185819|323013385|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
94336255|NCT03185819|323013386|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
94336256|NCT03185819|323013383|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
94336257|NCT03185819|323013384|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
94336258|NCT03185819|323013385|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
94336259|NCT03185819|323013386|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
94336260|NCT03185819|323013383|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
94336261|NCT03185819|323013384|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
94336262|NCT03185819|323013385|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
94336263|NCT03185819|323013386|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
94336264|NCT03185819|323013383|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
94336265|NCT03185819|323013384|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
94336266|NCT03185819|323013385|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
94336267|NCT03185819|323013386|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
94336268|NCT03185819|323013383|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
94336269|NCT03185819|323013384|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
94336270|NCT03185819|323013385|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
94336271|NCT03185819|323013386|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
94336272|NCT03185819|323013383|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
94336273|NCT03185819|323013384|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
94336274|NCT03185819|323013385|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
94336275|NCT03185819|323013386|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
94336276|NCT03185819|323013383|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
94336277|NCT03185819|323013384|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
94336278|NCT03185819|323013385|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
94336279|NCT03185819|323013386|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
94336280|NCT03375203|323013387|FG000|Overall Study|Protocol Violation|0|||
94336281|NCT03375203|323013388|FG001|Overall Study|Protocol Violation|0|||
94336282|NCT03375203|323013389|FG002|Overall Study|Protocol Violation|1|||
94336283|NCT03375203|323013390|FG003|Overall Study|Protocol Violation|0|||
94336284|NCT03375203|323013391|FG004|Overall Study|Protocol Violation|0|||
94336285|NCT03375203|323013387|FG000|Overall Study|Adverse Event|2|||
94336286|NCT03375203|323013388|FG001|Overall Study|Adverse Event|3|||
94336287|NCT03375203|323013389|FG002|Overall Study|Adverse Event|0|||
94336288|NCT03375203|323013390|FG003|Overall Study|Adverse Event|2|||
94336289|NCT03375203|323013391|FG004|Overall Study|Adverse Event|2|||
94336290|NCT03375203|323013387|FG000|Overall Study|Withdrawal by Subject|3|||
94336291|NCT03375203|323013388|FG001|Overall Study|Withdrawal by Subject|0|||
94336292|NCT03375203|323013389|FG002|Overall Study|Withdrawal by Subject|1|||
94336293|NCT03375203|323013390|FG003|Overall Study|Withdrawal by Subject|0|||
94336294|NCT03375203|323013391|FG004|Overall Study|Withdrawal by Subject|2|||
94336295|NCT03375203|323013387|FG000|Overall Study|Non-compliance with study drug|1|||
94336296|NCT03375203|323013388|FG001|Overall Study|Non-compliance with study drug|0|||
94336297|NCT03375203|323013389|FG002|Overall Study|Non-compliance with study drug|0|||
94336298|NCT03375203|323013390|FG003|Overall Study|Non-compliance with study drug|0|||
94336299|NCT03375203|323013391|FG004|Overall Study|Non-compliance with study drug|0|||
94336300|NCT03375203|323013387|FG000|Overall Study|Randomized, not treated.|0|||
94336301|NCT03375203|323013388|FG001|Overall Study|Randomized, not treated.|1|||
94336302|NCT03375203|323013389|FG002|Overall Study|Randomized, not treated.|0|||
94336303|NCT03375203|323013390|FG003|Overall Study|Randomized, not treated.|0|||
94336304|NCT03375203|323013391|FG004|Overall Study|Randomized, not treated.|0|||
94336305|NCT03321526|323013392|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
94336306|NCT03321526|323013393|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
94336307|NCT03321526|323013392|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
94336308|NCT03321526|323013393|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
94336309|NCT03321526|323013392|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
94336310|NCT03321526|323013393|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
94336311|NCT03321526|323013392|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
94336312|NCT03321526|323013393|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
94336313|NCT03321526|323013392|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
94336314|NCT03321526|323013393|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
94336315|NCT03321526|323013392|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
94336316|NCT03321526|323013393|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
94336317|NCT03321526|323013392|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
94336318|NCT03321526|323013393|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
94336319|NCT03321526|323013392|FG000|Follow-up Phase (2 Weeks)|Other|24|||
94336320|NCT03321526|323013393|FG001|Follow-up Phase (2 Weeks)|Other|24|||
94336321|NCT02873208|323013398|FG000|Overall Study|Withdrawal by Subject|36|||
94336322|NCT02873208|323013398|FG000|Overall Study|Lost to Follow-up|22|||
94336323|NCT02873208|323013398|FG000|Overall Study|Adverse Event|15|||
94336324|NCT02873208|323013398|FG000|Overall Study|Non-compliance with study drug|12|||
94336325|NCT02873208|323013398|FG000|Overall Study|Protocol Violation|8|||
94336326|NCT02873208|323013398|FG000|Overall Study|Pregnancy|2|||
94336327|NCT02873208|323013398|FG000|Overall Study|Incarceration|1|||
94336328|NCT02873208|323013398|FG000|Overall Study|Lack of Efficacy|1|||
94336329|NCT02873208|323013398|FG000|Overall Study|Physician Decision|1|||
94336330|NCT03434041|323013399|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
94336331|NCT03434041|323013400|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
94336332|NCT03434041|323013399|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
94336333|NCT03434041|323013400|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
94336334|NCT03434041|323013399|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
94336335|NCT03434041|323013400|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
94336336|NCT03434041|323013399|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
94336337|NCT03434041|323013400|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
94336338|NCT03434041|323013399|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
94336339|NCT03434041|323013400|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
94336340|NCT03434041|323013399|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
94336341|NCT03434041|323013400|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
94336342|NCT03434041|323013399|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
94336343|NCT03434041|323013400|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
94336344|NCT03434041|323013399|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
94336345|NCT03434041|323013400|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
94336346|NCT03434041|323013399|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
94336347|NCT03434041|323013400|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
94336348|NCT03434041|323013399|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
94336349|NCT03434041|323013400|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
94336350|NCT03434041|323013399|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
94365553|NCT01345058|323122418|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
94336351|NCT03434041|323013400|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
94336352|NCT01585168|323013401|FG000|Overall Study|Lost to Follow-up|3|||
94336353|NCT01585168|323013402|FG001|Overall Study|Lost to Follow-up|1|||
94336354|NCT01585168|323013403|FG002|Overall Study|Lost to Follow-up|1|||
94336355|NCT01585168|323013404|FG003|Overall Study|Lost to Follow-up|1|||
94336356|NCT01809197|323013405|FG000|Overall Study|Lost to Follow-up|4|||
94336357|NCT01809197|323013406|FG001|Overall Study|Lost to Follow-up|2|||
94336358|NCT01809197|323013405|FG000|Overall Study|Adverse Event|2|||
94336359|NCT01809197|323013406|FG001|Overall Study|Adverse Event|3|||
94336360|NCT01809197|323013405|FG000|Overall Study|Failed slit lamp exam|1|||
94336361|NCT01809197|323013406|FG001|Overall Study|Failed slit lamp exam|0|||
94336362|NCT01809197|323013405|FG000|Overall Study|Non-Compliance|1|||
94336363|NCT01809197|323013406|FG001|Overall Study|Non-Compliance|1|||
94336364|NCT01809197|323013405|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
94336365|NCT01809197|323013406|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
94336366|NCT01809197|323013405|FG000|Overall Study|Withdrawal by Subject|1|||
94336367|NCT01809197|323013406|FG001|Overall Study|Withdrawal by Subject|1|||
94336368|NCT01809197|323013405|FG000|Overall Study|Product not available|0|||
94336369|NCT01809197|323013406|FG001|Overall Study|Product not available|1|||
94336370|NCT00126672|323013408|FG000|Overall Study|Adverse Event|4|||
94336371|NCT00126672|323013408|FG000|Overall Study|Lost to Follow-up|4|||
94336372|NCT02017704|323013411|FG000|Overall Study|Withdrawal by Subject|2|||
94336373|NCT02017704|323013412|FG001|Overall Study|Withdrawal by Subject|0|||
94336374|NCT01587274|323013413|FG000|Overall Study|Lost to Follow-up|4|||
94336375|NCT01587274|323013414|FG001|Overall Study|Lost to Follow-up|5|||
94336376|NCT01587274|323013415|FG002|Overall Study|Lost to Follow-up|3|||
94336377|NCT01421069|323013416|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
94336378|NCT01421069|323013416|FG000|Parent Study|Failed to return|3|||
94336379|NCT01421069|323013416|FG000|Parent Study|Withdrawal by Subject|1|||
94336380|NCT01421069|323013416|FG000|Parent Study|Lost to Follow-up|2|||
94336381|NCT01421069|323013416|FG000|Parent Study|Lack of Efficacy|1|||
94336382|NCT01421069|323013416|FG000|Overall Period for Extension Study|Other|2|||
94336383|NCT01421069|323013416|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
94336384|NCT01421069|323013416|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
94336385|NCT01421069|323013416|FG000|Overall Period for Extension Study|Pregnancy|1|||
94336386|NCT01421069|323013416|FG000|Overall Period for Extension Study|Adverse Event|1|||
94336387|NCT01421069|323013416|FG000|Overall Period for Extension Study|Protocol Violation|1|||
94336388|NCT01421069|323013416|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
94336389|NCT01421069|323013416|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
94336390|NCT01421069|323013416|FG000|Active Treatment Period|Other|1|||
94336391|NCT01421069|323013416|FG000|Active Treatment Period|No longer willing to participate in study|8|||
94336392|NCT01421069|323013416|FG000|Active Treatment Period|Insufficient clinical response|1|||
94336393|NCT01421069|323013416|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
94336394|NCT01421069|323013416|FG000|Active Treatment Period|Pregnancy|1|||
94336395|NCT01421069|323013416|FG000|Active Treatment Period|Adverse Event|1|||
94336396|NCT01421069|323013416|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
94336397|NCT01421069|323013416|FG000|Active Treatment Period|Enrolled in observational period|29|||
94336398|NCT01421069|323013416|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
94336399|NCT01421069|323013416|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
94336400|NCT01421069|323013416|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
94336401|NCT01421069|323013416|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
94336402|NCT01421069|323013416|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
94336403|NCT01421069|323013416|FG000|2b. Retreatment Period|Protocol Violation|1|||
94336404|NCT01421069|323013416|FG000|Observational Period|Other|1|||
94336405|NCT01421069|323013416|FG000|Observational Period|No longer willing to participate in study|4|||
94336406|NCT01421069|323013416|FG000|Observational Period|Lost to Follow-up|3|||
94336407|NCT00842361|323013422|FG000|Overall Study|Protocol Violation|1|||
94336408|NCT00842361|323013423|FG001|Overall Study|Protocol Violation|0|||
94336409|NCT00842361|323013422|FG000|Overall Study|Unclassified|0|||
94336410|NCT00842361|323013423|FG001|Overall Study|Unclassified|2|||
94336411|NCT04285853|323013426|FG000|Overall Study|Withdrawal by Subject|1|||
94336412|NCT04285853|323013427|FG001|Overall Study|Withdrawal by Subject|0|||
94336413|NCT04285853|323013426|FG000|Overall Study|Lost to Follow-up|9|||
94336414|NCT04285853|323013427|FG001|Overall Study|Lost to Follow-up|5|||
94336415|NCT02460978|323013432|FG000|Overall Study|Adverse Event|17|||
94336416|NCT02460978|323013433|FG001|Overall Study|Adverse Event|11|||
94336417|NCT02460978|323013434|FG002|Overall Study|Adverse Event|11|||
94336418|NCT02460978|323013432|FG000|Overall Study|Withdrawal by Subject|5|||
94336419|NCT02460978|323013433|FG001|Overall Study|Withdrawal by Subject|5|||
94336420|NCT02460978|323013434|FG002|Overall Study|Withdrawal by Subject|14|||
94336421|NCT02460978|323013432|FG000|Overall Study|Lost to Follow-up|2|||
94336422|NCT02460978|323013433|FG001|Overall Study|Lost to Follow-up|3|||
94336423|NCT02460978|323013434|FG002|Overall Study|Lost to Follow-up|1|||
94336424|NCT02460978|323013432|FG000|Overall Study|Protocol Violation|1|||
94336425|NCT02460978|323013433|FG001|Overall Study|Protocol Violation|1|||
94336426|NCT02460978|323013434|FG002|Overall Study|Protocol Violation|1|||
94336427|NCT02460978|323013432|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
94336428|NCT02460978|323013433|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
94336429|NCT02460978|323013434|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
94336430|NCT02460978|323013432|FG000|Overall Study|Pregnancy|0|||
94336431|NCT02460978|323013433|FG001|Overall Study|Pregnancy|0|||
94336432|NCT02460978|323013434|FG002|Overall Study|Pregnancy|2|||
94336433|NCT00994162|323013435|FG000|Overall Study|Withdrawal by Subject|1|||
94336434|NCT00994162|323013435|FG000|Overall Study|Lost to Follow-up|2|||
94336435|NCT00994162|323013435|FG000|Overall Study|Product Complaint|1|||
94336436|NCT00994162|323013435|FG000|Overall Study|Poor Compliance|5|||
94336437|NCT00994162|323013435|FG000|Overall Study|Lack of Response|3|||
94336438|NCT00994162|323013435|FG000|Overall Study|Discharged from Hospital|4|||
94336439|NCT00994162|323013435|FG000|Overall Study|Death|2|||
94336440|NCT00994162|323013435|FG000|Overall Study|Care Transferred to Another Physician|2|||
94336441|NCT00994162|323013435|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
94336442|NCT00994162|323013435|FG000|Overall Study|Physician Decision|2|||
94336443|NCT00994162|323013435|FG000|Overall Study|Surrounding Wound Erythematous|1|||
94336444|NCT00994162|323013435|FG000|Overall Study|Machine Losing Vaccum|1|||
94336445|NCT00994162|323013435|FG000|Overall Study|Patient Lived Too Far Away|1|||
94336446|NCT00994162|323013435|FG000|Overall Study|Above Knee Amputation|1|||
94336447|NCT00994162|323013435|FG000|Overall Study|Reason Not Reported By Site|1|||
94336448|NCT00924729|323013436|FG000|Overall Study|insufficient volume for analysis|1|||
94336449|NCT00924729|323013437|FG001|Overall Study|insufficient volume for analysis|0|||
94336450|NCT00924729|323013436|FG000|Overall Study|Protocol Violation|1|||
94336451|NCT00924729|323013437|FG001|Overall Study|Protocol Violation|0|||
94336452|NCT04449276|323013438|FG000|Overall Study|Adverse Event|1|||
94336453|NCT04449276|323013439|FG001|Overall Study|Adverse Event|2|||
94336454|NCT04449276|323013440|FG002|Overall Study|Adverse Event|0|||
94336455|NCT04449276|323013441|FG003|Overall Study|Adverse Event|0|||
94336456|NCT04449276|323013442|FG004|Overall Study|Adverse Event|2|||
94336457|NCT04449276|323013443|FG005|Overall Study|Adverse Event|0|||
94336458|NCT04449276|323013444|FG006|Overall Study|Adverse Event|0|||
94336459|NCT04449276|323013445|FG007|Overall Study|Adverse Event|1|||
94336460|NCT04449276|323013438|FG000|Overall Study|Withdrawal by Subject|2|||
94336461|NCT04449276|323013439|FG001|Overall Study|Withdrawal by Subject|0|||
94336462|NCT04449276|323013440|FG002|Overall Study|Withdrawal by Subject|0|||
94336463|NCT04449276|323013441|FG003|Overall Study|Withdrawal by Subject|1|||
94336464|NCT04449276|323013442|FG004|Overall Study|Withdrawal by Subject|0|||
94336465|NCT04449276|323013443|FG005|Overall Study|Withdrawal by Subject|0|||
94336466|NCT04449276|323013444|FG006|Overall Study|Withdrawal by Subject|0|||
94336467|NCT04449276|323013445|FG007|Overall Study|Withdrawal by Subject|0|||
94336468|NCT04449276|323013438|FG000|Overall Study|Other|0|||
94336469|NCT04449276|323013439|FG001|Overall Study|Other|2|||
94336470|NCT04449276|323013440|FG002|Overall Study|Other|3|||
94336471|NCT04449276|323013441|FG003|Overall Study|Other|2|||
94336472|NCT04449276|323013442|FG004|Overall Study|Other|0|||
94336473|NCT04449276|323013443|FG005|Overall Study|Other|0|||
94336474|NCT04449276|323013444|FG006|Overall Study|Other|0|||
94336475|NCT04449276|323013445|FG007|Overall Study|Other|1|||
94336476|NCT03339401|323013453|FG000|Overall Study|Death|2|||
94336477|NCT03339401|323013454|FG001|Overall Study|Death|1|||
94336478|NCT03339401|323013453|FG000|Overall Study|Withdrawal by Subject|2|||
94336479|NCT03339401|323013454|FG001|Overall Study|Withdrawal by Subject|0|||
94336480|NCT03339401|323013453|FG000|Overall Study|Study terminated|4|||
94336481|NCT03339401|323013454|FG001|Overall Study|Study terminated|3|||
94336482|NCT03339401|323013453|FG000|Overall Study|Investigator Decision|1|||
94336483|NCT03339401|323013454|FG001|Overall Study|Investigator Decision|0|||
94336484|NCT03271307|323013455|FG000|Overall Study|Lost to Follow-up|0|||
94336485|NCT03271307|323013456|FG001|Overall Study|Lost to Follow-up|0|||
94336486|NCT03271307|323013457|FG002|Overall Study|Lost to Follow-up|0|||
94336487|NCT03271307|323013458|FG003|Overall Study|Lost to Follow-up|28|||
94336488|NCT03271307|323013459|FG004|Overall Study|Lost to Follow-up|91|||
94336489|NCT00179517|323013460|FG000|Overall Study|Withdrawal by Subject|2|||
94336490|NCT00179517|323013461|FG001|Overall Study|Withdrawal by Subject|1|||
94336491|NCT00437203|323013462|FG000|Overall Study|Death|0|||
94336492|NCT00437203|323013463|FG001|Overall Study|Death|0|||
94336493|NCT00437203|323013464|FG002|Overall Study|Death|1|||
94336494|NCT00437203|323013465|FG003|Overall Study|Death|0|||
94336495|NCT00437203|323013466|FG004|Overall Study|Death|0|||
94336496|NCT00437203|323013467|FG005|Overall Study|Death|0|||
94336497|NCT00437203|323013468|FG006|Overall Study|Death|0|||
94336498|NCT00437203|323013469|FG007|Overall Study|Death|1|||
94336499|NCT00437203|323013470|FG008|Overall Study|Death|0|||
94336500|NCT00437203|323013471|FG009|Overall Study|Death|1|||
94336501|NCT00437203|323013462|FG000|Overall Study|Adverse Event|1|||
94336502|NCT00437203|323013463|FG001|Overall Study|Adverse Event|1|||
94336503|NCT00437203|323013464|FG002|Overall Study|Adverse Event|0|||
94336504|NCT00437203|323013465|FG003|Overall Study|Adverse Event|0|||
94336505|NCT00437203|323013466|FG004|Overall Study|Adverse Event|0|||
94336506|NCT00437203|323013467|FG005|Overall Study|Adverse Event|0|||
94336507|NCT00437203|323013468|FG006|Overall Study|Adverse Event|0|||
94336508|NCT00437203|323013469|FG007|Overall Study|Adverse Event|1|||
94336509|NCT00437203|323013470|FG008|Overall Study|Adverse Event|0|||
94336510|NCT00437203|323013471|FG009|Overall Study|Adverse Event|1|||
94336511|NCT00437203|323013462|FG000|Overall Study|Study terminated by sponsor|0|||
94336512|NCT00437203|323013463|FG001|Overall Study|Study terminated by sponsor|0|||
94336513|NCT00437203|323013464|FG002|Overall Study|Study terminated by sponsor|0|||
94336514|NCT00437203|323013465|FG003|Overall Study|Study terminated by sponsor|0|||
94336515|NCT00437203|323013466|FG004|Overall Study|Study terminated by sponsor|0|||
94336516|NCT00437203|323013467|FG005|Overall Study|Study terminated by sponsor|0|||
94336517|NCT00437203|323013468|FG006|Overall Study|Study terminated by sponsor|0|||
94336518|NCT00437203|323013469|FG007|Overall Study|Study terminated by sponsor|0|||
94336519|NCT00437203|323013470|FG008|Overall Study|Study terminated by sponsor|1|||
94336520|NCT00437203|323013471|FG009|Overall Study|Study terminated by sponsor|0|||
94336521|NCT00437203|323013462|FG000|Overall Study|Objective progression or relapse|5|||
94336522|NCT00437203|323013463|FG001|Overall Study|Objective progression or relapse|6|||
94336523|NCT00437203|323013464|FG002|Overall Study|Objective progression or relapse|2|||
94336524|NCT00437203|323013465|FG003|Overall Study|Objective progression or relapse|3|||
94336525|NCT00437203|323013466|FG004|Overall Study|Objective progression or relapse|3|||
94336526|NCT00437203|323013467|FG005|Overall Study|Objective progression or relapse|3|||
94336527|NCT00437203|323013468|FG006|Overall Study|Objective progression or relapse|6|||
94336528|NCT00437203|323013469|FG007|Overall Study|Objective progression or relapse|1|||
94336529|NCT00437203|323013470|FG008|Overall Study|Objective progression or relapse|2|||
94336530|NCT00437203|323013471|FG009|Overall Study|Objective progression or relapse|2|||
94336531|NCT00437203|323013462|FG000|Overall Study|Other|0|||
94336532|NCT00437203|323013463|FG001|Overall Study|Other|1|||
94336533|NCT00437203|323013464|FG002|Overall Study|Other|0|||
94336534|NCT00437203|323013465|FG003|Overall Study|Other|0|||
94336535|NCT00437203|323013466|FG004|Overall Study|Other|0|||
94336536|NCT00437203|323013467|FG005|Overall Study|Other|0|||
94336537|NCT00437203|323013468|FG006|Overall Study|Other|1|||
94336538|NCT00437203|323013469|FG007|Overall Study|Other|0|||
94336539|NCT00437203|323013470|FG008|Overall Study|Other|0|||
94336540|NCT00437203|323013471|FG009|Overall Study|Other|0|||
94336541|NCT01685203|323013476|FG000|Overall Study|Lost to Follow-up|3|||
94336542|NCT01685203|323013477|FG001|Overall Study|Lost to Follow-up|3|||
94336543|NCT01685203|323013478|FG002|Overall Study|Lost to Follow-up|0|||
94336544|NCT01685203|323013479|FG003|Overall Study|Lost to Follow-up|1|||
94336545|NCT01685203|323013480|FG004|Overall Study|Lost to Follow-up|0|||
94336546|NCT01685203|323013481|FG005|Overall Study|Lost to Follow-up|0|||
94336547|NCT01685203|323013482|FG006|Overall Study|Lost to Follow-up|0|||
94336548|NCT01685203|323013476|FG000|Overall Study|Adverse Event|0|||
94336549|NCT01685203|323013477|FG001|Overall Study|Adverse Event|0|||
94336550|NCT01685203|323013478|FG002|Overall Study|Adverse Event|0|||
94336551|NCT01685203|323013479|FG003|Overall Study|Adverse Event|0|||
94336552|NCT01685203|323013480|FG004|Overall Study|Adverse Event|0|||
94336553|NCT01685203|323013481|FG005|Overall Study|Adverse Event|2|||
94336554|NCT01685203|323013482|FG006|Overall Study|Adverse Event|0|||
94336555|NCT01685203|323013476|FG000|Overall Study|Adverse event and withdrew consent|1|||
94336556|NCT01685203|323013477|FG001|Overall Study|Adverse event and withdrew consent|0|||
94336557|NCT01685203|323013478|FG002|Overall Study|Adverse event and withdrew consent|0|||
94336558|NCT01685203|323013479|FG003|Overall Study|Adverse event and withdrew consent|0|||
94336559|NCT01685203|323013480|FG004|Overall Study|Adverse event and withdrew consent|0|||
94336560|NCT01685203|323013481|FG005|Overall Study|Adverse event and withdrew consent|0|||
94336561|NCT01685203|323013482|FG006|Overall Study|Adverse event and withdrew consent|0|||
94336562|NCT01685203|323013476|FG000|Overall Study|Patient's decision|0|||
94336563|NCT01685203|323013477|FG001|Overall Study|Patient's decision|0|||
94336564|NCT01685203|323013478|FG002|Overall Study|Patient's decision|0|||
94336565|NCT01685203|323013479|FG003|Overall Study|Patient's decision|0|||
94336566|NCT01685203|323013480|FG004|Overall Study|Patient's decision|0|||
94336567|NCT01685203|323013481|FG005|Overall Study|Patient's decision|1|||
94336568|NCT01685203|323013482|FG006|Overall Study|Patient's decision|0|||
94336569|NCT02177812|323013485|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
94336570|NCT02177812|323013486|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
94336571|NCT02177812|323013487|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
94336572|NCT02177812|323013488|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
94336573|NCT02177812|323013489|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
94336574|NCT02177812|323013490|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
94336575|NCT02177812|323013491|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
94336576|NCT02177812|323013492|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
94336577|NCT02177812|323013493|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
94336578|NCT02177812|323013485|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
94336579|NCT02177812|323013486|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
94336580|NCT02177812|323013487|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
94336581|NCT02177812|323013488|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
94336582|NCT02177812|323013489|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
94336583|NCT02177812|323013490|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
94336584|NCT02177812|323013491|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
94336585|NCT02177812|323013492|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
94336586|NCT02177812|323013493|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
94336587|NCT02177812|323013485|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
94336588|NCT02177812|323013486|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
94336589|NCT02177812|323013487|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
94336590|NCT02177812|323013488|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
94336591|NCT02177812|323013489|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
94336592|NCT02177812|323013490|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
94336593|NCT02177812|323013491|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
94336594|NCT02177812|323013492|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
94336595|NCT02177812|323013493|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
94336596|NCT01607073|323013494|FG000|Overall Study|Adverse Event|1|||
94336597|NCT01731990|323015070|FG000|Overall Study|Adverse Event|1|||
94336598|NCT01731990|323015071|FG001|Overall Study|Adverse Event|5|||
94336599|NCT01731990|323015070|FG000|Overall Study|Withdrawal by Subject|1|||
94336600|NCT01731990|323015071|FG001|Overall Study|Withdrawal by Subject|1|||
94336601|NCT01731990|323015070|FG000|Overall Study|Protocol deviation|1|||
94336602|NCT01731990|323015071|FG001|Overall Study|Protocol deviation|2|||
94336603|NCT01731990|323015070|FG000|Overall Study|Death|1|||
94336604|NCT01731990|323015071|FG001|Overall Study|Death|0|||
94336605|NCT01280812|323015072|FG000|Overall Study|Withdrawal by Subject|2|||
94336606|NCT01280812|323015073|FG001|Overall Study|Withdrawal by Subject|1|||
94336607|NCT01280812|323015074|FG002|Overall Study|Withdrawal by Subject|0|||
94336608|NCT01280812|323015072|FG000|Overall Study|Lost to Follow-up|1|||
94336609|NCT01280812|323015073|FG001|Overall Study|Lost to Follow-up|1|||
94336610|NCT01280812|323015074|FG002|Overall Study|Lost to Follow-up|1|||
94336611|NCT01375647|323015075|FG000|Overall Study|Lost to Follow-up|3|||
94336612|NCT01375647|323015076|FG001|Overall Study|Lost to Follow-up|3|||
94336613|NCT01375647|323015077|FG002|Overall Study|Lost to Follow-up|7|||
94336614|NCT01375647|323015078|FG003|Overall Study|Lost to Follow-up|10|||
94336615|NCT01375647|323015075|FG000|Overall Study|Death|1|||
94336616|NCT01375647|323015076|FG001|Overall Study|Death|2|||
94336617|NCT01375647|323015077|FG002|Overall Study|Death|1|||
94336618|NCT01375647|323015078|FG003|Overall Study|Death|0|||
94336619|NCT01375647|323015075|FG000|Overall Study|Withdrawal by Subject|17|||
94336620|NCT01375647|323015076|FG001|Overall Study|Withdrawal by Subject|20|||
94336621|NCT01375647|323015077|FG002|Overall Study|Withdrawal by Subject|26|||
94336622|NCT01375647|323015078|FG003|Overall Study|Withdrawal by Subject|14|||
94336623|NCT01375647|323015075|FG000|Overall Study|Physician Decision|1|||
94336624|NCT01375647|323015076|FG001|Overall Study|Physician Decision|0|||
94336625|NCT01375647|323015077|FG002|Overall Study|Physician Decision|0|||
94336626|NCT01375647|323015078|FG003|Overall Study|Physician Decision|0|||
94336627|NCT04483544|323015079|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
94336628|NCT04483544|323015079|FG000|Post-Treatment|Admitted to hospice|2|||
94336629|NCT04483544|323015079|FG000|Post-Treatment|Study terminated|3|||
94336630|NCT03366844|323015082|FG000|Overall Study|Physician Decision|1|||
94336631|NCT03366844|323015082|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
94336632|NCT03382262|323015083|FG000|Overall Study|Physician Decision|0|||
94336633|NCT03382262|323015084|FG001|Overall Study|Physician Decision|0|||
94336634|NCT03382262|323015085|FG002|Overall Study|Physician Decision|1|||
94336635|NCT03382262|323015086|FG003|Overall Study|Physician Decision|0|||
94336636|NCT03382262|323015083|FG000|Overall Study|Withdrawal by Subject|0|||
94336637|NCT03382262|323015084|FG001|Overall Study|Withdrawal by Subject|0|||
94336638|NCT03382262|323015085|FG002|Overall Study|Withdrawal by Subject|0|||
94336639|NCT03382262|323015086|FG003|Overall Study|Withdrawal by Subject|1|||
94336640|NCT02940860|323015087|FG000|Overall Study|Non-serious AE|1|||
94336641|NCT02940860|323015088|FG001|Overall Study|Non-serious AE|2|||
94336642|NCT02940860|323015087|FG000|Overall Study|Serious AE|7|||
94336643|NCT02940860|323015088|FG001|Overall Study|Serious AE|3|||
94336644|NCT02940860|323015087|FG000|Overall Study|Withdrawal by Subject|19|||
94336645|NCT02940860|323015088|FG001|Overall Study|Withdrawal by Subject|9|||
94336646|NCT02940860|323015087|FG000|Overall Study|Lost to Follow-up|13|||
94336647|NCT02940860|323015088|FG001|Overall Study|Lost to Follow-up|7|||
94336648|NCT02940860|323015087|FG000|Overall Study|Physician Decision|5|||
94336649|NCT02940860|323015088|FG001|Overall Study|Physician Decision|3|||
94336650|NCT02940860|323015087|FG000|Overall Study|Sponsor Decision|0|||
94336651|NCT02940860|323015088|FG001|Overall Study|Sponsor Decision|1|||
94336652|NCT02940860|323015087|FG000|Overall Study|Protocol Violation|0|||
94336653|NCT02940860|323015088|FG001|Overall Study|Protocol Violation|2|||
94336654|NCT02940860|323015087|FG000|Overall Study|Death|3|||
94336655|NCT02940860|323015088|FG001|Overall Study|Death|2|||
94336656|NCT02940860|323015087|FG000|Overall Study|Moved, poor venous access, transport|6|||
94336657|NCT02940860|323015088|FG001|Overall Study|Moved, poor venous access, transport|4|||
94336658|NCT02940860|323015087|FG000|Overall Study|Not treated|2|||
94336659|NCT02940860|323015088|FG001|Overall Study|Not treated|2|||
94336660|NCT03424044|323015090|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
94336661|NCT03424044|323015091|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
94336662|NCT03424044|323015092|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
94336663|NCT03424044|323015093|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
94336664|NCT03424044|323015094|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
94336665|NCT03424044|323015095|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
94336666|NCT03424044|323015096|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
94336667|NCT03424044|323015097|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
94336668|NCT03424044|323015098|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
94336669|NCT03424044|323015090|FG000|First Intervention (76 Hours)|Adverse Event|0|||
94336670|NCT03424044|323015091|FG001|First Intervention (76 Hours)|Adverse Event|0|||
94336671|NCT03424044|323015092|FG002|First Intervention (76 Hours)|Adverse Event|0|||
94336672|NCT03424044|323015093|FG003|First Intervention (76 Hours)|Adverse Event|0|||
94336673|NCT03424044|323015094|FG004|First Intervention (76 Hours)|Adverse Event|1|||
94336674|NCT03424044|323015095|FG005|First Intervention (76 Hours)|Adverse Event|0|||
94336675|NCT03424044|323015096|FG006|First Intervention (76 Hours)|Adverse Event|0|||
94336676|NCT03424044|323015097|FG007|First Intervention (76 Hours)|Adverse Event|0|||
94336677|NCT03424044|323015098|FG008|First Intervention (76 Hours)|Adverse Event|0|||
94336678|NCT03424044|323015090|FG000|First Intervention (76 Hours)|device issues|0|||
94336679|NCT03424044|323015091|FG001|First Intervention (76 Hours)|device issues|0|||
94336680|NCT03424044|323015092|FG002|First Intervention (76 Hours)|device issues|0|||
94336681|NCT03424044|323015093|FG003|First Intervention (76 Hours)|device issues|0|||
94336682|NCT03424044|323015094|FG004|First Intervention (76 Hours)|device issues|0|||
94336683|NCT03424044|323015095|FG005|First Intervention (76 Hours)|device issues|0|||
94336684|NCT03424044|323015096|FG006|First Intervention (76 Hours)|device issues|1|||
94336685|NCT03424044|323015097|FG007|First Intervention (76 Hours)|device issues|1|||
94336686|NCT03424044|323015098|FG008|First Intervention (76 Hours)|device issues|1|||
94336687|NCT03424044|323015090|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
94336688|NCT03424044|323015091|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
94336689|NCT03424044|323015092|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
94336690|NCT03424044|323015093|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
94336691|NCT03424044|323015094|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
94336692|NCT03424044|323015095|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
94336693|NCT03424044|323015096|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
94336694|NCT03424044|323015097|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
94336695|NCT03424044|323015098|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
94336696|NCT03424044|323015090|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
94336697|NCT03424044|323015091|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
94336698|NCT03424044|323015092|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
94336699|NCT03424044|323015093|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
94336700|NCT03424044|323015094|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
94336701|NCT03424044|323015095|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
94336702|NCT03424044|323015096|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
94336703|NCT03424044|323015097|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
94336704|NCT03424044|323015098|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
94336705|NCT00402285|323015103|FG000|Overall Study|insufficient RNA quality|7|||
94336706|NCT00402285|323015104|FG001|Overall Study|insufficient RNA quality|6|||
94336707|NCT00402285|323015105|FG002|Overall Study|insufficient RNA quality|2|||
94336708|NCT02431793|323015106|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
94336709|NCT02431793|323015107|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
94336710|NCT02431793|323015108|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
94336711|NCT02431793|323015106|FG000|Overall Study|Withdrawal by Subject|7|||
94336712|NCT02431793|323015107|FG001|Overall Study|Withdrawal by Subject|5|||
94336713|NCT02431793|323015108|FG002|Overall Study|Withdrawal by Subject|5|||
94336714|NCT02431793|323015106|FG000|Overall Study|Lost to Follow-up|101|||
94336715|NCT02431793|323015107|FG001|Overall Study|Lost to Follow-up|122|||
94336716|NCT02431793|323015108|FG002|Overall Study|Lost to Follow-up|104|||
94336717|NCT00233324|323015109|FG000|Main Study|Death|68|||
94336718|NCT00233324|323015110|FG001|Main Study|Death|60|||
94336719|NCT00233324|323015111|FG002|Main Study|Death|62|||
94336720|NCT00233324|323015112|FG003|Main Study|Death|47|||
94336721|NCT00233324|323015109|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
94336722|NCT00233324|323015110|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
94336723|NCT00233324|323015111|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
94336724|NCT00233324|323015112|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
94336725|NCT00233324|323015109|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
94365554|NCT01345058|323122419|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
94336726|NCT00233324|323015110|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
94336727|NCT00233324|323015111|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
94336728|NCT00233324|323015112|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
94336729|NCT05282121|323015115|FG000|Overall Study|Adverse Event|1|||
94336730|NCT05282121|323015116|FG001|Overall Study|Adverse Event|1|||
94336731|NCT05282121|323015117|FG002|Overall Study|Adverse Event|4|||
94336732|NCT05282121|323015118|FG003|Overall Study|Adverse Event|1|||
94336733|NCT05282121|323015115|FG000|Overall Study|Study Terminated by Sponsor|1|||
94336734|NCT05282121|323015116|FG001|Overall Study|Study Terminated by Sponsor|2|||
94336735|NCT05282121|323015117|FG002|Overall Study|Study Terminated by Sponsor|2|||
94336736|NCT05282121|323015118|FG003|Overall Study|Study Terminated by Sponsor|2|||
94336737|NCT05282121|323015115|FG000|Overall Study|Other than listed|0|||
94336738|NCT05282121|323015116|FG001|Overall Study|Other than listed|0|||
94336739|NCT05282121|323015117|FG002|Overall Study|Other than listed|1|||
94336740|NCT05282121|323015118|FG003|Overall Study|Other than listed|0|||
94336741|NCT05282121|323015115|FG000|Overall Study|No reason available|0|||
94336742|NCT05282121|323015116|FG001|Overall Study|No reason available|0|||
94336743|NCT05282121|323015117|FG002|Overall Study|No reason available|1|||
94336744|NCT05282121|323015118|FG003|Overall Study|No reason available|0|||
94336745|NCT00693420|323015125|FG000|Overall Study|Adverse Event|4|||
94336746|NCT00693420|323015126|FG001|Overall Study|Adverse Event|4|||
94336747|NCT00693420|323015125|FG000|Overall Study|Lost to Follow-up|0|||
94336748|NCT00693420|323015126|FG001|Overall Study|Lost to Follow-up|3|||
94336749|NCT00693420|323015125|FG000|Overall Study|Withdrawal by Subject|1|||
94336750|NCT00693420|323015126|FG001|Overall Study|Withdrawal by Subject|0|||
94336751|NCT00693420|323015125|FG000|Overall Study|Protocol Violation|0|||
94336752|NCT00693420|323015126|FG001|Overall Study|Protocol Violation|2|||
94336753|NCT00693420|323015125|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
94336754|NCT00693420|323015126|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
94336755|NCT00693420|323015125|FG000|Overall Study|Personal Reasons|1|||
94336756|NCT00693420|323015126|FG001|Overall Study|Personal Reasons|4|||
94336757|NCT00063986|323015134|FG000|Overall Study|Withdrawal by Subject|1|||
94336758|NCT00063986|323015134|FG000|Overall Study|Ineligible|1|||
94336759|NCT00063986|323015134|FG000|Overall Study|Intra-operatively ineligible|4|||
94336760|NCT00509028|323015135|FG000|Overall Study|Adverse Event|2|||
94336761|NCT00509028|323015136|FG001|Overall Study|Adverse Event|0|||
94336762|NCT00509028|323015135|FG000|Overall Study|Withdrawal by Subject|4|||
94336763|NCT00509028|323015136|FG001|Overall Study|Withdrawal by Subject|3|||
94336764|NCT00509028|323015135|FG000|Overall Study|Lost to Follow-up|0|||
94336765|NCT00509028|323015136|FG001|Overall Study|Lost to Follow-up|1|||
94336766|NCT00509028|323015135|FG000|Overall Study|Protocol Violation|4|||
94336767|NCT00509028|323015136|FG001|Overall Study|Protocol Violation|2|||
94336768|NCT00509028|323015135|FG000|Overall Study|Non-compliance|2|||
94336769|NCT00509028|323015136|FG001|Overall Study|Non-compliance|1|||
94336770|NCT02408484|323015139|FG000|Overall Study|Withdrawal by Subject|3|||
94336771|NCT02408484|323015139|FG000|Overall Study|Not treated during study period|1|||
94336772|NCT01709708|323015150|FG000|Overall Study|Protocol Violation|1|||
94336773|NCT01709708|323015151|FG001|Overall Study|Protocol Violation|2|||
94336774|NCT00254163|323015152|FG000|Overall Study|Adverse Event|29|||
94336775|NCT00254163|323015153|FG001|Overall Study|Adverse Event|26|||
94336776|NCT00254163|323015152|FG000|Overall Study|Patient request/withdrew consent|6|||
94336777|NCT00254163|323015153|FG001|Overall Study|Patient request/withdrew consent|4|||
94336778|NCT00254163|323015152|FG000|Overall Study|Investigator request|1|||
94336779|NCT00254163|323015153|FG001|Overall Study|Investigator request|3|||
94336780|NCT00254163|323015152|FG000|Overall Study|Failed entry|1|||
94336781|NCT00254163|323015153|FG001|Overall Study|Failed entry|3|||
94336782|NCT00254163|323015152|FG000|Overall Study|Progressive disease|0|||
94336783|NCT00254163|323015153|FG001|Overall Study|Progressive disease|1|||
94336784|NCT00254163|323015152|FG000|Overall Study|Death|0|||
94336785|NCT00254163|323015153|FG001|Overall Study|Death|1|||
94336786|NCT00254163|323015152|FG000|Overall Study|Other|8|||
94336787|NCT00254163|323015153|FG001|Overall Study|Other|8|||
94336788|NCT01843205|323015157|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
94336789|NCT01843205|323015158|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
94336790|NCT03938636|323015159|FG000|Overall Study|Protocol Violation|0|||
94336791|NCT03938636|323015160|FG001|Overall Study|Protocol Violation|1|||
94336792|NCT03938636|323015161|FG002|Overall Study|Protocol Violation|1|||
94336793|NCT03938636|323015159|FG000|Overall Study|Subject withdrew due to death in family|0|||
94336794|NCT03938636|323015160|FG001|Overall Study|Subject withdrew due to death in family|1|||
94336795|NCT03938636|323015161|FG002|Overall Study|Subject withdrew due to death in family|0|||
94336796|NCT03938636|323015159|FG000|Overall Study|Missed visit|0|||
94336797|NCT03938636|323015160|FG001|Overall Study|Missed visit|1|||
94336798|NCT03938636|323015161|FG002|Overall Study|Missed visit|0|||
94336799|NCT03938636|323015159|FG000|Overall Study|Adverse Event|0|||
94336800|NCT03938636|323015160|FG001|Overall Study|Adverse Event|0|||
94336801|NCT03938636|323015161|FG002|Overall Study|Adverse Event|1|||
94336802|NCT03938636|323015159|FG000|Overall Study|Lost to Follow-up|0|||
94336803|NCT03938636|323015160|FG001|Overall Study|Lost to Follow-up|0|||
94336804|NCT03938636|323015161|FG002|Overall Study|Lost to Follow-up|1|||
94336805|NCT01355497|323015164|FG000|Overall Study|Death|19|||
94336806|NCT01355497|323015165|FG001|Overall Study|Death|18|||
94336807|NCT01355497|323015164|FG000|Overall Study|Lost to Follow-up|3|||
94336808|NCT01355497|323015165|FG001|Overall Study|Lost to Follow-up|0|||
94336809|NCT01355497|323015164|FG000|Overall Study|Protocol Violation|0|||
94336810|NCT01355497|323015165|FG001|Overall Study|Protocol Violation|1|||
94336811|NCT01355497|323015164|FG000|Overall Study|other-not provided|9|||
94336812|NCT01355497|323015165|FG001|Overall Study|other-not provided|4|||
94336813|NCT01355497|323015164|FG000|Overall Study|Withdrawal by Subject|12|||
94336814|NCT01355497|323015165|FG001|Overall Study|Withdrawal by Subject|20|||
94336815|NCT01355497|323015164|FG000|Overall Study|noncompliance|1|||
94336816|NCT01355497|323015165|FG001|Overall Study|noncompliance|2|||
94336817|NCT01355497|323015164|FG000|Overall Study|progressive disease|11|||
94336818|NCT01355497|323015165|FG001|Overall Study|progressive disease|8|||
94336819|NCT01355497|323015164|FG000|Overall Study|Adverse Event|11|||
94336820|NCT01355497|323015165|FG001|Overall Study|Adverse Event|10|||
94336821|NCT02741310|323015166|FG000|Overall Study|Sponsor Decision|2|||
94336822|NCT02741310|323015167|FG001|Overall Study|Sponsor Decision|2|||
94336823|NCT01094808|323015169|FG000|Overall Study|Withdrawal by Subject|1|||
94336824|NCT01094808|323015170|FG001|Overall Study|Withdrawal by Subject|1|||
94336825|NCT01094808|323015171|FG002|Overall Study|Withdrawal by Subject|0|||
94336826|NCT02910089|323015172|FG000|Overall Study|Lost insurance eligibility|22|||
94336827|NCT02910089|323015173|FG001|Overall Study|Lost insurance eligibility|16|||
94336828|NCT01057862|323015174|FG000|Overall Study|Withdrawal by Subject|1|||
94336829|NCT01057862|323015175|FG001|Overall Study|Withdrawal by Subject|2|||
94336830|NCT00918346|323015180|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
94336831|NCT00918346|323015181|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
94336832|NCT03238352|323015182|FG000|Overall Study|Lost to Follow-up|0|||
94336833|NCT03238352|323015183|FG001|Overall Study|Lost to Follow-up|2|||
94336834|NCT03238352|323015184|FG002|Overall Study|Lost to Follow-up|1|||
94336835|NCT03238352|323015182|FG000|Overall Study|Withdrawal by Subject|0|||
94336836|NCT03238352|323015183|FG001|Overall Study|Withdrawal by Subject|1|||
94336837|NCT03238352|323015184|FG002|Overall Study|Withdrawal by Subject|0|||
94336838|NCT00701103|323015185|FG000|Overall Study|Adverse Event|0|||
94336839|NCT00701103|323015186|FG001|Overall Study|Adverse Event|0|||
94336840|NCT00701103|323015187|FG002|Overall Study|Adverse Event|1|||
94336841|NCT00701103|323015188|FG003|Overall Study|Adverse Event|1|||
94336842|NCT00701103|323015189|FG004|Overall Study|Adverse Event|0|||
94336843|NCT00701103|323015190|FG005|Overall Study|Adverse Event|1|||
94336844|NCT00701103|323015191|FG006|Overall Study|Adverse Event|1|||
94336845|NCT00701103|323015192|FG007|Overall Study|Adverse Event|0|||
94336846|NCT00701103|323015193|FG008|Overall Study|Adverse Event|0|||
94336847|NCT00701103|323015194|FG009|Overall Study|Adverse Event|2|||
94336848|NCT00701103|323015195|FG010|Overall Study|Adverse Event|0|||
94336849|NCT00701103|323015185|FG000|Overall Study|Progressive Disease|5|||
94336850|NCT00701103|323015186|FG001|Overall Study|Progressive Disease|2|||
94336851|NCT00701103|323015187|FG002|Overall Study|Progressive Disease|6|||
94336852|NCT00701103|323015188|FG003|Overall Study|Progressive Disease|5|||
94336853|NCT00701103|323015189|FG004|Overall Study|Progressive Disease|6|||
94336854|NCT00701103|323015190|FG005|Overall Study|Progressive Disease|5|||
94336855|NCT00701103|323015191|FG006|Overall Study|Progressive Disease|7|||
94336856|NCT00701103|323015192|FG007|Overall Study|Progressive Disease|7|||
94336857|NCT00701103|323015193|FG008|Overall Study|Progressive Disease|8|||
94336858|NCT00701103|323015194|FG009|Overall Study|Progressive Disease|8|||
94336859|NCT00701103|323015195|FG010|Overall Study|Progressive Disease|11|||
94336860|NCT00701103|323015185|FG000|Overall Study|Withdrawal by Subject|0|||
94336861|NCT00701103|323015186|FG001|Overall Study|Withdrawal by Subject|1|||
94336862|NCT00701103|323015187|FG002|Overall Study|Withdrawal by Subject|1|||
94336863|NCT00701103|323015188|FG003|Overall Study|Withdrawal by Subject|0|||
94336864|NCT00701103|323015189|FG004|Overall Study|Withdrawal by Subject|0|||
94336865|NCT00701103|323015190|FG005|Overall Study|Withdrawal by Subject|0|||
94336866|NCT00701103|323015191|FG006|Overall Study|Withdrawal by Subject|0|||
94336867|NCT00701103|323015192|FG007|Overall Study|Withdrawal by Subject|0|||
94336868|NCT00701103|323015193|FG008|Overall Study|Withdrawal by Subject|0|||
94336869|NCT00701103|323015194|FG009|Overall Study|Withdrawal by Subject|0|||
94336870|NCT00701103|323015195|FG010|Overall Study|Withdrawal by Subject|0|||
94336871|NCT00701103|323015185|FG000|Overall Study|Other|0|||
94336872|NCT00701103|323015186|FG001|Overall Study|Other|0|||
94336873|NCT00701103|323015187|FG002|Overall Study|Other|0|||
94336874|NCT00701103|323015188|FG003|Overall Study|Other|0|||
94336875|NCT00701103|323015189|FG004|Overall Study|Other|0|||
94336876|NCT00701103|323015190|FG005|Overall Study|Other|0|||
94336877|NCT00701103|323015191|FG006|Overall Study|Other|0|||
94336878|NCT00701103|323015192|FG007|Overall Study|Other|0|||
94336879|NCT00701103|323015193|FG008|Overall Study|Other|1|||
94336880|NCT00701103|323015194|FG009|Overall Study|Other|1|||
94336881|NCT00701103|323015195|FG010|Overall Study|Other|0|||
94336882|NCT02067533|323015197|FG000|Overall Study|Lost to Follow-up|4|||
94336883|NCT02067533|323015198|FG001|Overall Study|Lost to Follow-up|2|||
94336884|NCT00565812|323015201|FG000|Overall Study|Death|2|||
94336885|NCT00565812|323015202|FG001|Overall Study|Death|1|||
94336886|NCT00565812|323015203|FG002|Overall Study|Death|3|||
94336887|NCT00565812|323015201|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
94336888|NCT00565812|323015202|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
94336889|NCT00565812|323015203|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
94336890|NCT00565812|323015201|FG000|Overall Study|Lost to Follow-up|10|||
94336891|NCT00565812|323015202|FG001|Overall Study|Lost to Follow-up|8|||
94336892|NCT00565812|323015203|FG002|Overall Study|Lost to Follow-up|8|||
94336893|NCT00565812|323015201|FG000|Overall Study|Withdrawal by Subject|58|||
94336894|NCT00565812|323015202|FG001|Overall Study|Withdrawal by Subject|47|||
94336895|NCT00565812|323015203|FG002|Overall Study|Withdrawal by Subject|48|||
94336896|NCT00565812|323015201|FG000|Overall Study|Work Schedule|5|||
94336897|NCT00565812|323015202|FG001|Overall Study|Work Schedule|3|||
94336898|NCT00565812|323015203|FG002|Overall Study|Work Schedule|1|||
94336899|NCT00565812|323015201|FG000|Overall Study|Protocol Violation|2|||
94336900|NCT00565812|323015202|FG001|Overall Study|Protocol Violation|6|||
94336901|NCT00565812|323015203|FG002|Overall Study|Protocol Violation|4|||
94336902|NCT00565812|323015201|FG000|Overall Study|Adverse Event|41|||
94336903|NCT00565812|323015202|FG001|Overall Study|Adverse Event|54|||
94336904|NCT00565812|323015203|FG002|Overall Study|Adverse Event|40|||
94336905|NCT00565812|323015201|FG000|Overall Study|Jury Duty|1|||
94336906|NCT00565812|323015202|FG001|Overall Study|Jury Duty|0|||
94336907|NCT00565812|323015203|FG002|Overall Study|Jury Duty|0|||
94336908|NCT00565812|323015201|FG000|Overall Study|Relocated Out of Area|5|||
94336909|NCT00565812|323015202|FG001|Overall Study|Relocated Out of Area|8|||
94336910|NCT00565812|323015203|FG002|Overall Study|Relocated Out of Area|9|||
94336911|NCT00565812|323015201|FG000|Overall Study|Sponsor Decision|1|||
94336912|NCT00565812|323015202|FG001|Overall Study|Sponsor Decision|5|||
94336913|NCT00565812|323015203|FG002|Overall Study|Sponsor Decision|1|||
94336914|NCT00565812|323015201|FG000|Overall Study|Domestic Reasons|7|||
94336915|NCT00565812|323015202|FG001|Overall Study|Domestic Reasons|1|||
94336916|NCT00565812|323015203|FG002|Overall Study|Domestic Reasons|3|||
94336917|NCT00565812|323015201|FG000|Overall Study|Research Site Closure|6|||
94336918|NCT00565812|323015202|FG001|Overall Study|Research Site Closure|1|||
94336919|NCT00565812|323015203|FG002|Overall Study|Research Site Closure|8|||
94336920|NCT00565812|323015201|FG000|Overall Study|Surgical Intervention|0|||
94336921|NCT00565812|323015202|FG001|Overall Study|Surgical Intervention|1|||
94336922|NCT00565812|323015203|FG002|Overall Study|Surgical Intervention|2|||
94336923|NCT00565812|323015201|FG000|Overall Study|Low Compliance|1|||
94336924|NCT00565812|323015202|FG001|Overall Study|Low Compliance|0|||
94336925|NCT00565812|323015203|FG002|Overall Study|Low Compliance|1|||
94336926|NCT00565812|323015201|FG000|Overall Study|Follow-up Visit Not Completed|2|||
94336927|NCT00565812|323015202|FG001|Overall Study|Follow-up Visit Not Completed|0|||
94336928|NCT00565812|323015203|FG002|Overall Study|Follow-up Visit Not Completed|1|||
94336929|NCT00565812|323015201|FG000|Overall Study|Physician Decision|2|||
94336930|NCT00565812|323015202|FG001|Overall Study|Physician Decision|0|||
94336931|NCT00565812|323015203|FG002|Overall Study|Physician Decision|0|||
94336932|NCT02566109|323015204|FG000|Overall Study|Withdrawal by Subject|1|||
94336933|NCT01176240|323015205|FG000|Study 306A|Lack of Efficacy|2|||
94336934|NCT01176240|323015206|FG001|Study 306A|Lack of Efficacy|1|||
94336935|NCT01176240|323015205|FG000|Study 306A|Protocol Violation|0|||
94336936|NCT01176240|323015206|FG001|Study 306A|Protocol Violation|1|||
94336937|NCT01176240|323015205|FG000|Study 306A|Withdrawal by Subject|0|||
94336938|NCT01176240|323015206|FG001|Study 306A|Withdrawal by Subject|1|||
94336939|NCT01176240|323015205|FG000|Study 306A|Stop due to diverse problems|1|||
94336940|NCT01176240|323015206|FG001|Study 306A|Stop due to diverse problems|0|||
94336941|NCT01176240|323015205|FG000|Study 306B|Lack of Efficacy|5|||
94336942|NCT01176240|323015206|FG001|Study 306B|Lack of Efficacy|3|||
94439805|NCT04147234|323397833|FG004|Overall Study|Objective disease progression|5|||
94439806|NCT04147234|323397834|FG005|Overall Study|Objective disease progression|2|||
94439807|NCT04147234|323397835|FG006|Overall Study|Objective disease progression|3|||
94439808|NCT04147234|323397829|FG000|Overall Study|Adverse Event|0|||
94439809|NCT04147234|323397830|FG001|Overall Study|Adverse Event|0|||
94439810|NCT04147234|323397831|FG002|Overall Study|Adverse Event|0|||
94439811|NCT04147234|323397832|FG003|Overall Study|Adverse Event|0|||
94439812|NCT04147234|323397833|FG004|Overall Study|Adverse Event|1|||
94336943|NCT01176240|323015205|FG000|Study 306B|Adverse Event|10|||
94336944|NCT01176240|323015206|FG001|Study 306B|Adverse Event|5|||
94336945|NCT01176240|323015205|FG000|Study 306B|Protocol Violation|2|||
94336946|NCT01176240|323015206|FG001|Study 306B|Protocol Violation|3|||
94336947|NCT01176240|323015205|FG000|Study 306B|Withdrawal by Subject|4|||
94336948|NCT01176240|323015206|FG001|Study 306B|Withdrawal by Subject|1|||
94336949|NCT01176240|323015205|FG000|Study 306B|Physician Decision|2|||
94336950|NCT01176240|323015206|FG001|Study 306B|Physician Decision|1|||
94336951|NCT01176240|323015205|FG000|Study 306B|Supine Hypertension|1|||
94336952|NCT01176240|323015206|FG001|Study 306B|Supine Hypertension|2|||
94336953|NCT01176240|323015205|FG000|Study 306B|Lost to Follow-up|0|||
94336954|NCT01176240|323015206|FG001|Study 306B|Lost to Follow-up|1|||
94336955|NCT01176240|323015205|FG000|Study 306B|withdrew prior to dosing|2|||
94336956|NCT01176240|323015206|FG001|Study 306B|withdrew prior to dosing|1|||
94336957|NCT01931150|323015209|FG000|Overall Study|Withdrawal by Subject|1|||
94336958|NCT01931150|323015210|FG001|Overall Study|Withdrawal by Subject|2|||
94336959|NCT01390038|323015222|FG000|Overall Study|Death|1|||
94336960|NCT01390038|323015222|FG000|Overall Study|Lost to Follow-up|1|||
94336961|NCT01390038|323015222|FG000|Overall Study|Withdrawal by Subject|4|||
94336962|NCT01390038|323015222|FG000|Overall Study|Simpliciti System Removal|2|||
94336963|NCT00790218|323017533|FG000|Overall Study|Death|1|||
94336964|NCT00790218|323017534|FG001|Overall Study|Death|0|||
94336965|NCT00790218|323017535|FG002|Overall Study|Death|0|||
94336966|NCT00784459|323017538|FG000|Overall Study|Adverse Event|0|||
94336967|NCT00784459|323017539|FG001|Overall Study|Adverse Event|2|||
94336968|NCT02431702|323017540|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
94336969|NCT02431702|323017541|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
94336970|NCT02431702|323017542|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
94336971|NCT02431702|323017543|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
94336972|NCT02431702|323017544|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
94336973|NCT02431702|323017545|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
94336974|NCT02431702|323017546|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
94336975|NCT02431702|323017540|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
94336976|NCT02431702|323017541|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
94336977|NCT02431702|323017542|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
94336978|NCT02431702|323017543|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
94336979|NCT02431702|323017544|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
94336980|NCT02431702|323017545|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
94336981|NCT02431702|323017546|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
94336982|NCT02431702|323017540|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
94336983|NCT02431702|323017541|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
94336984|NCT02431702|323017542|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
94336985|NCT02431702|323017543|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
94336986|NCT02431702|323017544|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
94336987|NCT02431702|323017545|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
94336988|NCT02431702|323017546|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
94336989|NCT02431702|323017540|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
94336990|NCT02431702|323017541|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
94336991|NCT02431702|323017542|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
94336992|NCT02431702|323017543|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
94336993|NCT02431702|323017544|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
94336994|NCT02431702|323017545|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
94336995|NCT02431702|323017546|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
94336996|NCT02431702|323017540|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
94336997|NCT02431702|323017541|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
94336998|NCT02431702|323017542|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
94336999|NCT02431702|323017543|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
94337000|NCT02431702|323017544|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
94337001|NCT02431702|323017545|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
94337002|NCT02431702|323017546|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
94337003|NCT02431702|323017540|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
94337004|NCT02431702|323017541|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
94337005|NCT02431702|323017542|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
94337006|NCT02431702|323017543|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
94337007|NCT02431702|323017544|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
94337008|NCT02431702|323017545|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
94337009|NCT02431702|323017546|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
94337010|NCT02431702|323017540|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
94337011|NCT02431702|323017541|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
94337012|NCT02431702|323017542|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
94337013|NCT02431702|323017543|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
94337014|NCT02431702|323017544|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
94337015|NCT02431702|323017545|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
94337016|NCT02431702|323017546|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
94337017|NCT02431702|323017540|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
94337018|NCT02431702|323017541|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
94337019|NCT02431702|323017542|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
94337020|NCT02431702|323017543|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
94337021|NCT02431702|323017544|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
94337022|NCT02431702|323017545|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
94337023|NCT02431702|323017546|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
94337024|NCT02431702|323017540|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
94337025|NCT02431702|323017541|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
94337026|NCT02431702|323017542|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
94337027|NCT02431702|323017543|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
94337028|NCT02431702|323017544|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
94337029|NCT02431702|323017545|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
94337030|NCT02431702|323017546|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
94337031|NCT02431702|323017540|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
94337032|NCT02431702|323017541|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
94337033|NCT02431702|323017542|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
94337034|NCT02431702|323017543|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
94337035|NCT02431702|323017544|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
94337036|NCT02431702|323017545|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
94337037|NCT02431702|323017546|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
94337038|NCT02431702|323017540|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
94337039|NCT02431702|323017541|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
94337040|NCT02431702|323017542|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
94337041|NCT02431702|323017543|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
94337042|NCT02431702|323017544|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
94337043|NCT02431702|323017545|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
94337044|NCT02431702|323017546|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
94337045|NCT02431702|323017540|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
94337046|NCT02431702|323017541|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
94337047|NCT02431702|323017542|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
94337048|NCT02431702|323017543|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
94337049|NCT02431702|323017544|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
94337050|NCT02431702|323017545|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
94337051|NCT02431702|323017546|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
94337052|NCT02431702|323017540|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
94337053|NCT02431702|323017541|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
94337054|NCT02431702|323017542|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
94337055|NCT02431702|323017543|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
94337056|NCT02431702|323017544|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
94337057|NCT02431702|323017545|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
94337058|NCT02431702|323017546|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
94337059|NCT02431702|323017540|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
94337060|NCT02431702|323017541|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
94337061|NCT02431702|323017542|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
94337062|NCT02431702|323017543|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
94337063|NCT02431702|323017544|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
94337064|NCT02431702|323017545|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
94337065|NCT02431702|323017546|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
94337066|NCT02431702|323017540|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
94337067|NCT02431702|323017541|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
94337068|NCT02431702|323017542|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
94337069|NCT02431702|323017543|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
94337070|NCT02431702|323017544|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
94337071|NCT02431702|323017545|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
94337072|NCT02431702|323017546|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
94337073|NCT00608894|323017547|FG000|Overall Study|Withdrawal by Subject|0|||
94337074|NCT00608894|323017548|FG001|Overall Study|Withdrawal by Subject|2|||
94337075|NCT00606177|323017549|FG000|Overall Study|Adverse Event|9|||
94337076|NCT00606177|323017550|FG001|Overall Study|Adverse Event|5|||
94337077|NCT00606177|323017549|FG000|Overall Study|Lack of Efficacy|3|||
94337078|NCT00606177|323017550|FG001|Overall Study|Lack of Efficacy|7|||
94337079|NCT00606177|323017549|FG000|Overall Study|Physician Decision|1|||
94337080|NCT00606177|323017550|FG001|Overall Study|Physician Decision|0|||
94337081|NCT00606177|323017549|FG000|Overall Study|Protocol Violation|1|||
94337082|NCT00606177|323017550|FG001|Overall Study|Protocol Violation|4|||
94337083|NCT00606177|323017549|FG000|Overall Study|Withdrawal by Subject|5|||
94337084|NCT00606177|323017550|FG001|Overall Study|Withdrawal by Subject|6|||
94337085|NCT00606177|323017549|FG000|Overall Study|Progression to depressive phase|6|||
94337086|NCT00606177|323017550|FG001|Overall Study|Progression to depressive phase|1|||
94337087|NCT00606177|323017549|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
94337088|NCT00606177|323017550|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
94337089|NCT00606177|323017549|FG000|Overall Study|Change of residence or other commitments|1|||
94337090|NCT00606177|323017550|FG001|Overall Study|Change of residence or other commitments|1|||
94337091|NCT00136357|323017551|FG000|Overall Study|Withdrawal by Subject|3|||
94337092|NCT00136357|323017552|FG001|Overall Study|Withdrawal by Subject|2|||
94337093|NCT00239356|323017557|FG000|Overall Study|Lack of Efficacy|1|||
94337094|NCT00239356|323017558|FG001|Overall Study|Lack of Efficacy|0|||
94337095|NCT00239356|323017557|FG000|Overall Study|Adverse Event|6|||
94337096|NCT00239356|323017558|FG001|Overall Study|Adverse Event|0|||
94337097|NCT00239356|323017557|FG000|Overall Study|Withdrawal by Subject|15|||
94337098|NCT00239356|323017558|FG001|Overall Study|Withdrawal by Subject|6|||
94337099|NCT00239356|323017557|FG000|Overall Study|Lost to Follow-up|3|||
94337100|NCT00239356|323017558|FG001|Overall Study|Lost to Follow-up|0|||
94337101|NCT00239356|323017557|FG000|Overall Study|poor/non-compliance|2|||
94337102|NCT00239356|323017558|FG001|Overall Study|poor/non-compliance|0|||
94337103|NCT00239356|323017557|FG000|Overall Study|Pregnancy|1|||
94337104|NCT00239356|323017558|FG001|Overall Study|Pregnancy|0|||
94337105|NCT00239356|323017557|FG000|Overall Study|Administrative reason|0|||
94337106|NCT00239356|323017558|FG001|Overall Study|Administrative reason|1|||
94337107|NCT00239356|323017557|FG000|Overall Study|Drug available on market|11|||
94337108|NCT00239356|323017558|FG001|Overall Study|Drug available on market|2|||
94337109|NCT01001572|323017559|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
94337110|NCT01001572|323017560|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
94337111|NCT01001572|323017561|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
94337112|NCT01001572|323017559|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
94337113|NCT01001572|323017560|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
94337114|NCT01001572|323017561|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
94337115|NCT01001572|323017559|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
94337116|NCT01001572|323017560|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
94337117|NCT01001572|323017561|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
94337118|NCT01001572|323017559|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
94337119|NCT01001572|323017560|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
94337120|NCT01001572|323017561|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
94337121|NCT01001572|323017559|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
94337122|NCT01001572|323017560|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
94337123|NCT01001572|323017561|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
94337124|NCT01001572|323017559|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
94337125|NCT01001572|323017560|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
94337126|NCT01001572|323017561|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
94337127|NCT01001572|323017559|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
94337128|NCT01001572|323017560|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
94337129|NCT01001572|323017561|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
94337130|NCT01001572|323017559|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
94337131|NCT01001572|323017560|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
94337132|NCT01001572|323017561|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
94337133|NCT01001572|323017559|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
94337134|NCT01001572|323017560|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
94337135|NCT01001572|323017561|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
94337136|NCT01001572|323017559|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
94337137|NCT01001572|323017560|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
94337138|NCT01001572|323017561|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
94337139|NCT01001572|323017559|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
94337140|NCT01001572|323017560|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
94337141|NCT01001572|323017561|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
94337142|NCT01001572|323017559|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
94337143|NCT01001572|323017560|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
94337144|NCT01001572|323017561|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
94337145|NCT01001572|323017559|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
94337146|NCT01001572|323017560|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
94337147|NCT01001572|323017561|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
94337148|NCT01001572|323017559|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
94337149|NCT01001572|323017560|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
94337150|NCT01001572|323017561|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
94337151|NCT00369278|323017562|FG000|Overall Study|Adverse Event|14|||
94337152|NCT00369278|323017563|FG001|Overall Study|Adverse Event|11|||
94337153|NCT00369278|323017562|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
94337154|NCT00369278|323017563|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
94337155|NCT00369278|323017562|FG000|Overall Study|Protocol Violation|2|||
94337156|NCT00369278|323017563|FG001|Overall Study|Protocol Violation|1|||
94337157|NCT00369278|323017562|FG000|Overall Study|Withdrawal by Subject|2|||
94337158|NCT00369278|323017563|FG001|Overall Study|Withdrawal by Subject|2|||
94337159|NCT00369278|323017562|FG000|Overall Study|Lost to Follow-up|1|||
94337160|NCT00369278|323017563|FG001|Overall Study|Lost to Follow-up|0|||
94337161|NCT00369278|323017562|FG000|Overall Study|Graft loss|1|||
94337162|NCT00369278|323017563|FG001|Overall Study|Graft loss|2|||
94337163|NCT01224106|323017564|FG000|Double-Blind Treatment Phase|Death|3|||
94337164|NCT01224106|323017565|FG001|Double-Blind Treatment Phase|Death|0|||
94337165|NCT01224106|323017566|FG002|Double-Blind Treatment Phase|Death|0|||
94337166|NCT01224106|323017567|FG003|Double-Blind Treatment Phase|Death|0|||
94337167|NCT01224106|323017568|FG004|Double-Blind Treatment Phase|Death|0|||
94337168|NCT01224106|323017564|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
94337169|NCT01224106|323017565|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
94337170|NCT01224106|323017566|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
94337171|NCT01224106|323017567|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
94337172|NCT01224106|323017568|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
94337173|NCT01224106|323017564|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
94337174|NCT01224106|323017565|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
94337175|NCT01224106|323017566|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
94337176|NCT01224106|323017567|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
94337177|NCT01224106|323017568|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
94337178|NCT01224106|323017564|FG000|Double-Blind Treatment Phase|Other|0|||
94337179|NCT01224106|323017565|FG001|Double-Blind Treatment Phase|Other|0|||
94337180|NCT01224106|323017566|FG002|Double-Blind Treatment Phase|Other|1|||
94337181|NCT01224106|323017567|FG003|Double-Blind Treatment Phase|Other|0|||
94337182|NCT01224106|323017568|FG004|Double-Blind Treatment Phase|Other|0|||
94337183|NCT01224106|323017564|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
94337184|NCT01224106|323017565|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
94337185|NCT01224106|323017566|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
94337186|NCT01224106|323017567|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
94337187|NCT01224106|323017568|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
94337188|NCT01224106|323017564|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
94337189|NCT01224106|323017565|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
94337190|NCT01224106|323017566|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
94337191|NCT01224106|323017567|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
94337192|NCT01224106|323017568|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
94337193|NCT01224106|323017564|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
94337194|NCT01224106|323017565|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
94337195|NCT01224106|323017566|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
94337196|NCT01224106|323017567|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
94337197|NCT01224106|323017568|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
94337198|NCT01224106|323017564|FG000|Open-Label Extension (OLE) Phase|Death|0|||
94337199|NCT01224106|323017565|FG001|Open-Label Extension (OLE) Phase|Death|0|||
94337200|NCT01224106|323017566|FG002|Open-Label Extension (OLE) Phase|Death|0|||
94337201|NCT01224106|323017567|FG003|Open-Label Extension (OLE) Phase|Death|1|||
94337202|NCT01224106|323017568|FG004|Open-Label Extension (OLE) Phase|Death|3|||
94337203|NCT01224106|323017564|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
94337204|NCT01224106|323017565|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
94337205|NCT01224106|323017566|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
94337206|NCT01224106|323017567|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
94337207|NCT01224106|323017568|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
94337208|NCT01224106|323017564|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
94337209|NCT01224106|323017565|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
94337210|NCT01224106|323017566|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
94337211|NCT01224106|323017567|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
94337212|NCT01224106|323017568|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
94337213|NCT01224106|323017564|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
94337214|NCT01224106|323017565|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
94337215|NCT01224106|323017566|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
94337216|NCT01224106|323017567|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
94337217|NCT01224106|323017568|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
94337218|NCT01224106|323017564|FG000|Open-Label Extension (OLE) Phase|Other|0|||
94337219|NCT01224106|323017565|FG001|Open-Label Extension (OLE) Phase|Other|0|||
94337220|NCT01224106|323017566|FG002|Open-Label Extension (OLE) Phase|Other|0|||
94337221|NCT01224106|323017567|FG003|Open-Label Extension (OLE) Phase|Other|5|||
94337222|NCT01224106|323017568|FG004|Open-Label Extension (OLE) Phase|Other|3|||
94337223|NCT00441727|323017571|FG000|Overall Study|Protocol Violation|19|||
94337224|NCT00441727|323017572|FG001|Overall Study|Protocol Violation|28|||
94337225|NCT00441727|323017573|FG002|Overall Study|Protocol Violation|32|||
94337226|NCT00441727|323017571|FG000|Overall Study|Adverse Event|26|||
94337227|NCT00441727|323017572|FG001|Overall Study|Adverse Event|33|||
94337228|NCT00441727|323017573|FG002|Overall Study|Adverse Event|28|||
94337229|NCT00441727|323017571|FG000|Overall Study|Lack of Efficacy|7|||
94337230|NCT00441727|323017572|FG001|Overall Study|Lack of Efficacy|8|||
94337231|NCT00441727|323017573|FG002|Overall Study|Lack of Efficacy|48|||
94337232|NCT00441727|323017571|FG000|Overall Study|Withdrawal by Subject|40|||
94337233|NCT00441727|323017572|FG001|Overall Study|Withdrawal by Subject|34|||
94337234|NCT00441727|323017573|FG002|Overall Study|Withdrawal by Subject|47|||
94337235|NCT00441727|323017571|FG000|Overall Study|Lost to Follow-up|5|||
94337236|NCT00441727|323017572|FG001|Overall Study|Lost to Follow-up|6|||
94337237|NCT00441727|323017573|FG002|Overall Study|Lost to Follow-up|5|||
94337238|NCT00441727|323017571|FG000|Overall Study|Safety Reasons|3|||
94337239|NCT00441727|323017572|FG001|Overall Study|Safety Reasons|1|||
94337240|NCT00441727|323017573|FG002|Overall Study|Safety Reasons|3|||
94337241|NCT00441727|323017571|FG000|Overall Study|Various reason specified|6|||
94337242|NCT00441727|323017572|FG001|Overall Study|Various reason specified|8|||
94337243|NCT00441727|323017573|FG002|Overall Study|Various reason specified|5|||
94337244|NCT02025530|323017574|FG000|Overall Study|No longer met elligibility criteria|5|||
94337245|NCT02025530|323017575|FG001|Overall Study|No longer met elligibility criteria|1|||
94337246|NCT00711412|323017576|FG000|Induction Treatment|Death|2|||
94337247|NCT00711412|323017576|FG000|Induction Treatment|Adverse Event|1|||
94337248|NCT00711412|323017576|FG000|Induction Treatment|Other|1|||
94337249|NCT00711412|323017576|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
94337250|NCT00711412|323017576|FG000|Evaluated for Combination Treatment|Death|1|||
94337251|NCT00711412|323017576|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
94337252|NCT00711412|323017576|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
94337253|NCT00711412|323017576|FG000|Combination Treatment|Progressive Disease|1|||
94337254|NCT00711412|323017576|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
94337255|NCT00711412|323017576|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
94337256|NCT00711412|323017576|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
94337257|NCT00711412|323017576|FG000|Evaluation for Response and Surgery|Death|1|||
94337258|NCT00711412|323017576|FG000|Survival Follow up Until Death|Other|12|||
94337259|NCT03551626|323017581|FG000|Overall Study|Adverse Event|88|||
94337260|NCT03551626|323017581|FG000|Overall Study|Disease relapse|18|||
94337261|NCT03551626|323017581|FG000|Overall Study|Withdrawal of informed consent|6|||
94337262|NCT03551626|323017581|FG000|Overall Study|Patient decision|5|||
94337263|NCT03551626|323017581|FG000|Overall Study|Physician Decision|4|||
94337264|NCT03551626|323017581|FG000|Overall Study|Lost to Follow-up|3|||
94337265|NCT03551626|323017581|FG000|Overall Study|Pregnancy|1|||
94337266|NCT03551626|323017581|FG000|Overall Study|Protocol deviation|1|||
94337267|NCT03551626|323017581|FG000|Overall Study|Technical problems|1|||
94337268|NCT02133001|323017582|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
94337269|NCT02133001|323017583|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
94337270|NCT02133001|323017582|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
94337271|NCT02133001|323017583|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
94337272|NCT02133001|323017582|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
94337273|NCT02133001|323017583|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
94337274|NCT02133001|323017582|FG000|Double Blind (Day 1-25)|Other|2|||
94337275|NCT02133001|323017583|FG001|Double Blind (Day 1-25)|Other|2|||
94337276|NCT02133001|323017582|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
94337277|NCT02133001|323017583|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
94337278|NCT02133001|323017582|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
94337279|NCT02133001|323017583|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
94337280|NCT02133001|323017582|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
94337281|NCT02133001|323017583|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
94337282|NCT02133001|323017582|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
94337283|NCT02133001|323017583|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
94337284|NCT02498392|323017584|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
94337285|NCT02498392|323017585|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
94337286|NCT02498392|323017584|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
94337287|NCT02498392|323017585|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
94337288|NCT02498392|323017584|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
94337289|NCT02498392|323017585|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
94337290|NCT02498392|323017584|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
94337291|NCT02498392|323017585|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
94337292|NCT02498392|323017584|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
94337293|NCT02498392|323017585|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
94337294|NCT02498392|323017584|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
94337295|NCT02498392|323017585|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
94337296|NCT05784129|323017586|FG000|Overall Study|Study terminated by sponsor|2|||
94337297|NCT05784129|323017587|FG001|Overall Study|Study terminated by sponsor|2|||
94337298|NCT00429572|323017591|FG000|Overall Study|Disease progression|1|||
94337299|NCT03277105|323017592|FG000|Overall Study|Death|129|||
94337300|NCT03277105|323017593|FG001|Overall Study|Death|124|||
94337301|NCT03277105|323017592|FG000|Overall Study|Lost to Follow-up|2|||
94337302|NCT03277105|323017593|FG001|Overall Study|Lost to Follow-up|4|||
94337303|NCT03277105|323017592|FG000|Overall Study|Withdrawal by Subject|10|||
94337304|NCT03277105|323017593|FG001|Overall Study|Withdrawal by Subject|10|||
94337305|NCT03277105|323017592|FG000|Overall Study|Other|118|||
94337306|NCT03277105|323017593|FG001|Overall Study|Other|125|||
94337307|NCT04583969|323017594|FG000|Overall Study|Death|31|||
94337308|NCT04583969|323017595|FG001|Overall Study|Death|38|||
94337309|NCT04583969|323017594|FG000|Overall Study|Lost to Follow-up|16|||
94337310|NCT04583969|323017595|FG001|Overall Study|Lost to Follow-up|13|||
94337311|NCT04583969|323017594|FG000|Overall Study|Protocol Violation|1|||
94337312|NCT04583969|323017595|FG001|Overall Study|Protocol Violation|0|||
94337313|NCT04583969|323017594|FG000|Overall Study|Withdrawal by Subject|3|||
94337314|NCT04583969|323017595|FG001|Overall Study|Withdrawal by Subject|3|||
94337315|NCT04583969|323017594|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
94337316|NCT04583969|323017595|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
94337317|NCT04583969|323017594|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
94337318|NCT04583969|323017595|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
94337319|NCT04583969|323017594|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
94337320|NCT04583969|323017595|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
94337321|NCT04583969|323017594|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
94337322|NCT04583969|323017595|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
94337323|NCT04583969|323017594|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
94337324|NCT04583969|323017595|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
94337325|NCT00246376|323017596|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
94337326|NCT00246376|323017597|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
94337327|NCT00246376|323017598|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
94337328|NCT00246376|323017599|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
94337329|NCT00246376|323017600|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
94337330|NCT00246376|323017596|FG000|Overall Study|Adverse Event|2|||
94337331|NCT00246376|323017597|FG001|Overall Study|Adverse Event|3|||
94337332|NCT00246376|323017598|FG002|Overall Study|Adverse Event|1|||
94337333|NCT00246376|323017599|FG003|Overall Study|Adverse Event|3|||
94337334|NCT00246376|323017600|FG004|Overall Study|Adverse Event|1|||
94337335|NCT00246376|323017596|FG000|Overall Study|Lost to Follow-up|2|||
94337336|NCT00246376|323017597|FG001|Overall Study|Lost to Follow-up|11|||
94337337|NCT00246376|323017598|FG002|Overall Study|Lost to Follow-up|11|||
94337338|NCT00246376|323017599|FG003|Overall Study|Lost to Follow-up|16|||
94337339|NCT00246376|323017600|FG004|Overall Study|Lost to Follow-up|13|||
94337340|NCT02640755|323017601|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
94337341|NCT02640755|323017602|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
94337342|NCT02640755|323017601|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
94337343|NCT02640755|323017602|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
94337344|NCT02640755|323017601|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
94337345|NCT02640755|323017602|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
94337346|NCT04080752|323017603|FG000|Overall Study|Adverse Event|2|||
94337347|NCT04080752|323017604|FG001|Overall Study|Adverse Event|3|||
94337348|NCT04080752|323017603|FG000|Overall Study|Lack of Efficacy|1|||
94337349|NCT04080752|323017604|FG001|Overall Study|Lack of Efficacy|0|||
94337350|NCT04080752|323017603|FG000|Overall Study|Lost to Follow-up|1|||
94337351|NCT04080752|323017604|FG001|Overall Study|Lost to Follow-up|0|||
94337352|NCT04080752|323017603|FG000|Overall Study|Pregnancy|0|||
94337353|NCT04080752|323017604|FG001|Overall Study|Pregnancy|1|||
94337354|NCT04080752|323017603|FG000|Overall Study|Withdrawal by Subject|7|||
94337355|NCT04080752|323017604|FG001|Overall Study|Withdrawal by Subject|0|||
94337356|NCT04080752|323017603|FG000|Overall Study|Non-Compliance with Study Drug|0|||
94337357|NCT04080752|323017604|FG001|Overall Study|Non-Compliance with Study Drug|1|||
94337358|NCT04080752|323017603|FG000|Overall Study|Other|2|||
94337359|NCT04080752|323017604|FG001|Overall Study|Other|1|||
94337360|NCT03363165|323017605|FG000|3-month Follow-up|Death|0|||
94337361|NCT03363165|323017606|FG001|3-month Follow-up|Death|1|||
94337362|NCT03363165|323017605|FG000|6-month Follow-up|Death|0|||
94337363|NCT03363165|323017606|FG001|6-month Follow-up|Death|1|||
94337364|NCT03363165|323017605|FG000|6-month Follow-up|Withdrawal by Subject|1|||
94337365|NCT03363165|323017606|FG001|6-month Follow-up|Withdrawal by Subject|1|||
94337366|NCT03363165|323017605|FG000|12-month Follow-up|Death|1|||
94337367|NCT03363165|323017606|FG001|12-month Follow-up|Death|1|||
94337368|NCT03363165|323017605|FG000|12-month Follow-up|Withdrawal by Subject|1|||
94337369|NCT03363165|323017606|FG001|12-month Follow-up|Withdrawal by Subject|1|||
94337370|NCT02255760|323017607|FG000|Overall Study|Lost to Follow-up|0|||
94337371|NCT02255760|323017608|FG001|Overall Study|Lost to Follow-up|1|||
94337372|NCT02255760|323017609|FG002|Overall Study|Lost to Follow-up|0|||
94337373|NCT02255760|323017610|FG003|Overall Study|Lost to Follow-up|0|||
94337374|NCT02255760|323017611|FG004|Overall Study|Lost to Follow-up|0|||
94337375|NCT00618813|323017612|FG000|Overall Study|Lack of Efficacy|1|||
94337376|NCT00618813|323017612|FG000|Overall Study|Physician Decision|2|||
94337377|NCT00618813|323017612|FG000|Overall Study|Withdrawal by Subject|1|||
94337378|NCT00003838|323017613|FG000|Overall Study|Death|0|||
94337379|NCT00003838|323017614|FG001|Overall Study|Death|12|||
94337380|NCT00003838|323017615|FG002|Overall Study|Death|7|||
94337381|NCT00003838|323017613|FG000|Overall Study|Lost to Follow-up|0|||
94337382|NCT00003838|323017614|FG001|Overall Study|Lost to Follow-up|1|||
94337383|NCT00003838|323017615|FG002|Overall Study|Lost to Follow-up|1|||
94337384|NCT00003838|323017613|FG000|Overall Study|Disease Progression|0|||
94337385|NCT00003838|323017614|FG001|Overall Study|Disease Progression|12|||
94337386|NCT00003838|323017615|FG002|Overall Study|Disease Progression|0|||
94337387|NCT01192100|323017616|FG000|Overall Study|Withdrawal by Subject|0|||
94337388|NCT01192100|323017617|FG001|Overall Study|Withdrawal by Subject|0|||
94337389|NCT01192100|323017618|FG002|Overall Study|Withdrawal by Subject|0|||
94337390|NCT01192100|323017619|FG003|Overall Study|Withdrawal by Subject|0|||
94337391|NCT01192100|323017620|FG004|Overall Study|Withdrawal by Subject|1|||
94337392|NCT01192100|323017621|FG005|Overall Study|Withdrawal by Subject|0|||
94337393|NCT01192100|323017616|FG000|Overall Study|Protocol Violation|0|||
94337394|NCT01192100|323017617|FG001|Overall Study|Protocol Violation|0|||
94337395|NCT01192100|323017618|FG002|Overall Study|Protocol Violation|0|||
94337396|NCT01192100|323017619|FG003|Overall Study|Protocol Violation|1|||
94337397|NCT01192100|323017620|FG004|Overall Study|Protocol Violation|0|||
94337398|NCT01192100|323017621|FG005|Overall Study|Protocol Violation|0|||
94337399|NCT02057068|323017622|FG000|Overall Study|Withdrawal by Subject|2|||
94337400|NCT02057068|323017623|FG001|Overall Study|Withdrawal by Subject|2|||
94337401|NCT02057068|323017622|FG000|Overall Study|Caregiver (CG) Health|0|||
94337402|NCT02057068|323017623|FG001|Overall Study|Caregiver (CG) Health|2|||
94337403|NCT02057068|323017622|FG000|Overall Study|Carepartner (CP) Health|4|||
94337404|NCT02057068|323017623|FG001|Overall Study|Carepartner (CP) Health|2|||
94337405|NCT02057068|323017622|FG000|Overall Study|Lost to Follow-up|2|||
94337406|NCT02057068|323017623|FG001|Overall Study|Lost to Follow-up|2|||
94337407|NCT01782885|323017629|FG000|Overall Study|Lost to Follow-up|4|||
94337408|NCT01782885|323017630|FG001|Overall Study|Lost to Follow-up|6|||
94337409|NCT04737759|323017631|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
94337410|NCT04737759|323017632|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
94337411|NCT04737759|323017631|FG000|Overall Study|Death|2|||
94337412|NCT04737759|323017632|FG001|Overall Study|Death|0|||
94337413|NCT04737759|323017631|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
94337414|NCT04737759|323017632|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
94337415|NCT04737759|323017631|FG000|Overall Study|Lost to Follow-up|4|||
94337416|NCT04737759|323017632|FG001|Overall Study|Lost to Follow-up|12|||
94337417|NCT00633360|323017633|FG000|Overall Study|Lost to Follow-up|1|||
94337418|NCT00633360|323017634|FG001|Overall Study|Lost to Follow-up|1|||
94337419|NCT00633360|323017633|FG000|Overall Study|Adverse Event|3|||
94337420|NCT00633360|323017634|FG001|Overall Study|Adverse Event|1|||
94337421|NCT00633360|323017633|FG000|Overall Study|Protocol Violation|0|||
94337422|NCT00633360|323017634|FG001|Overall Study|Protocol Violation|1|||
94337423|NCT01235507|323017636|FG000|Overall Study|Adverse Event|1|||
94337424|NCT01235507|323017636|FG000|Overall Study|Withdrawal by Subject|1|||
94337425|NCT02738580|323017639|FG000|Overall Study|Adverse Event|1|||
94337426|NCT02738580|323017640|FG001|Overall Study|Adverse Event|0|||
94337427|NCT02738580|323017639|FG000|Overall Study|Lack of Efficacy|3|||
94337428|NCT02738580|323017640|FG001|Overall Study|Lack of Efficacy|2|||
94337429|NCT02738580|323017639|FG000|Overall Study|Withdrawal by Subject|0|||
94337430|NCT02738580|323017640|FG001|Overall Study|Withdrawal by Subject|1|||
94337431|NCT02738580|323017639|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
94337432|NCT02738580|323017640|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
94337433|NCT00996593|323017641|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
94337434|NCT00996593|323017641|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
94337435|NCT00996593|323017641|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
94337436|NCT00996593|323017641|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
94337437|NCT00996593|323017641|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
94337438|NCT00996593|323017641|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
94337439|NCT00996593|323017641|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
94337440|NCT00996593|323017641|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
94337441|NCT00996593|323017641|FG000|Long-Term Follow-Up|Site Closed|1|||
94337442|NCT03094611|323017645|FG000|Overall Study|Lack of Efficacy|1|||
94337443|NCT03094611|323017645|FG000|Overall Study|Stem Cell Transplant|1|||
94337444|NCT00588523|323017648|FG000|Overall Study|Not treated|3|||
94337445|NCT04968353|323017651|FG000|Overall Study|Non-compliance|1|||
94337446|NCT04968353|323017652|FG001|Overall Study|Non-compliance|0|||
94337447|NCT04968353|323017653|FG002|Overall Study|Non-compliance|2|||
94337448|NCT04968353|323017654|FG003|Overall Study|Non-compliance|0|||
94337449|NCT00845845|323017655|FG000|Overall Study|Lost to Follow-up|0|||
94337450|NCT00845845|323017656|FG001|Overall Study|Lost to Follow-up|4|||
94337451|NCT02820038|323017660|FG000|Overall Study|Lost to Follow-up|7|||
94337452|NCT02820038|323017661|FG001|Overall Study|Lost to Follow-up|11|||
94337453|NCT02820038|323017662|FG002|Overall Study|Lost to Follow-up|2|||
94337454|NCT02820038|323017663|FG003|Overall Study|Lost to Follow-up|9|||
94337455|NCT02820038|323017660|FG000|Overall Study|Withdrawal by Subject|3|||
94337456|NCT02820038|323017661|FG001|Overall Study|Withdrawal by Subject|14|||
94337457|NCT02820038|323017662|FG002|Overall Study|Withdrawal by Subject|3|||
94337458|NCT02820038|323017663|FG003|Overall Study|Withdrawal by Subject|13|||
94337459|NCT03215667|323017664|FG000|Overall Study|Physician Decision|4|||
94337460|NCT04857892|323017667|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
94337461|NCT04857892|323017668|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
94337462|NCT04857892|323017669|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
94337463|NCT04857892|323017670|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
94337464|NCT04857892|323017671|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
94337465|NCT04857892|323017667|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
94337466|NCT04857892|323017668|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
94337467|NCT04857892|323017669|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
94337468|NCT04857892|323017670|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
94337469|NCT04857892|323017671|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
94337470|NCT04857892|323017667|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
94337471|NCT04857892|323017668|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
94337472|NCT04857892|323017669|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
94337473|NCT04857892|323017670|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
94337474|NCT04857892|323017671|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
94337475|NCT02623699|323017672|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
94337476|NCT02623699|323017673|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
94337477|NCT02623699|323017674|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
94337478|NCT02623699|323017675|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
94337479|NCT02623699|323017676|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
94337480|NCT02623699|323017677|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
94337481|NCT02623699|323017678|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
94337482|NCT02623699|323017679|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
94337483|NCT02623699|323017680|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
94337484|NCT02623699|323017681|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
94337485|NCT02623699|323017682|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
94337486|NCT02623699|323017683|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
94337487|NCT02623699|323017672|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
94337488|NCT02623699|323017673|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
94337489|NCT02623699|323017674|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
94337490|NCT02623699|323017675|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
94337491|NCT02623699|323017676|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
94337492|NCT02623699|323017677|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
94337493|NCT02623699|323017678|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
94337494|NCT02623699|323017679|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
94337495|NCT02623699|323017680|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
94337496|NCT02623699|323017681|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
94337497|NCT02623699|323017682|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
94337498|NCT02623699|323017683|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
94337499|NCT02623699|323017672|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
94337500|NCT02623699|323017673|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
94337501|NCT02623699|323017674|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
94337502|NCT02623699|323017675|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
94337503|NCT02623699|323017676|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
94337504|NCT02623699|323017677|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
94337505|NCT02623699|323017678|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
94337506|NCT02623699|323017679|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
94337507|NCT02623699|323017680|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
94337508|NCT02623699|323017681|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
94337509|NCT02623699|323017682|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
94337510|NCT02623699|323017683|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
94337511|NCT02623699|323017672|FG000|Part B (Up to 289 Days)|Death|0|||
94337512|NCT02623699|323017673|FG001|Part B (Up to 289 Days)|Death|0|||
94337513|NCT02623699|323017674|FG002|Part B (Up to 289 Days)|Death|0|||
94337514|NCT02623699|323017675|FG003|Part B (Up to 289 Days)|Death|0|||
94337515|NCT02623699|323017676|FG004|Part B (Up to 289 Days)|Death|0|||
94337516|NCT02623699|323017677|FG005|Part B (Up to 289 Days)|Death|1|||
94337517|NCT02623699|323017678|FG006|Part B (Up to 289 Days)|Death|1|||
94337518|NCT02623699|323017679|FG007|Part B (Up to 289 Days)|Death|0|||
94337519|NCT02623699|323017680|FG008|Part B (Up to 289 Days)|Death|1|||
94337520|NCT02623699|323017681|FG009|Part B (Up to 289 Days)|Death|0|||
94337521|NCT02623699|323017682|FG010|Part B (Up to 289 Days)|Death|0|||
94337522|NCT02623699|323017683|FG011|Part B (Up to 289 Days)|Death|0|||
94337523|NCT02623699|323017672|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
94337524|NCT02623699|323017673|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
94337525|NCT02623699|323017674|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
94337526|NCT02623699|323017675|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
94337527|NCT02623699|323017676|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
94337528|NCT02623699|323017677|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
94337529|NCT02623699|323017678|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
94337530|NCT02623699|323017679|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
94337531|NCT02623699|323017680|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
94337532|NCT02623699|323017681|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
94337533|NCT02623699|323017682|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
94337534|NCT02623699|323017683|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
94337535|NCT02623699|323017672|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
94337536|NCT02623699|323017673|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
94337537|NCT02623699|323017674|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
94337538|NCT02623699|323017675|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
94337539|NCT02623699|323017676|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
94337540|NCT02623699|323017677|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
94337541|NCT02623699|323017678|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
94337542|NCT02623699|323017679|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
94337543|NCT02623699|323017680|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
94337544|NCT02623699|323017681|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
94337545|NCT02623699|323017682|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
94337546|NCT02623699|323017683|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
94337547|NCT02623699|323017672|FG000|Part C (Up to 236 Days)|Death|0|||
94337548|NCT02623699|323017673|FG001|Part C (Up to 236 Days)|Death|0|||
94337549|NCT02623699|323017674|FG002|Part C (Up to 236 Days)|Death|0|||
94337550|NCT02623699|323017675|FG003|Part C (Up to 236 Days)|Death|0|||
94337551|NCT02623699|323017676|FG004|Part C (Up to 236 Days)|Death|0|||
94337552|NCT02623699|323017677|FG005|Part C (Up to 236 Days)|Death|0|||
94337553|NCT02623699|323017678|FG006|Part C (Up to 236 Days)|Death|0|||
94337554|NCT02623699|323017679|FG007|Part C (Up to 236 Days)|Death|0|||
94337555|NCT02623699|323017680|FG008|Part C (Up to 236 Days)|Death|0|||
94337556|NCT02623699|323017681|FG009|Part C (Up to 236 Days)|Death|0|||
94337557|NCT02623699|323017682|FG010|Part C (Up to 236 Days)|Death|0|||
94337558|NCT02623699|323017683|FG011|Part C (Up to 236 Days)|Death|1|||
94337559|NCT02623699|323017672|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
94337560|NCT02623699|323017673|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
94337561|NCT02623699|323017674|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
94337562|NCT02623699|323017675|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
94337563|NCT02623699|323017676|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
94337564|NCT02623699|323017677|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
94337565|NCT02623699|323017678|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
94337566|NCT02623699|323017679|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
94337567|NCT02623699|323017680|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
94337568|NCT02623699|323017681|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
94337569|NCT02623699|323017682|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
94337570|NCT02623699|323017683|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
94337571|NCT00899678|323017684|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
94337572|NCT00899678|323017685|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
94337573|NCT00899678|323017686|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
94337574|NCT00899678|323017684|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
94337575|NCT00899678|323017685|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
94337576|NCT00899678|323017686|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
94337577|NCT00899678|323017684|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
94337578|NCT00899678|323017685|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
94337579|NCT00899678|323017686|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
94337580|NCT00899678|323017684|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
94337581|NCT00899678|323017685|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
94337582|NCT00899678|323017686|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
94337583|NCT00899678|323017684|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
94337584|NCT00899678|323017685|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
94337585|NCT00899678|323017686|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
94337586|NCT00899678|323017684|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
94337587|NCT00899678|323017685|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
94337588|NCT00899678|323017686|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
94337589|NCT00899678|323017684|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
94337590|NCT00899678|323017685|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
94337591|NCT00899678|323017686|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
94337592|NCT00899678|323017684|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
94337593|NCT00899678|323017685|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
94337594|NCT00899678|323017686|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
94337595|NCT00899678|323017684|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
94337596|NCT00899678|323017685|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
94337597|NCT00899678|323017686|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
94337598|NCT02699125|323017687|FG000|Placebo|Lost to Follow-up|2|||
94337599|NCT02699125|323017688|FG001|Placebo|Lost to Follow-up|0|||
94337600|NCT02699125|323017687|FG000|Placebo|Protocol Violation|1|||
94337601|NCT02699125|323017688|FG001|Placebo|Protocol Violation|0|||
94337602|NCT02699125|323017687|FG000|Placebo|Withdrawal by Subject|0|||
94337603|NCT02699125|323017688|FG001|Placebo|Withdrawal by Subject|4|||
94337604|NCT02699125|323017687|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
94337605|NCT02699125|323017688|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
94337606|NCT00368472|323017689|FG000|Overall Study|Adverse Event|22|||
94337607|NCT00368472|323017689|FG000|Overall Study|Medication non-compliance|4|||
94337608|NCT00368472|323017689|FG000|Overall Study|Protocol Violation|2|||
94337609|NCT00368472|323017689|FG000|Overall Study|Request of Investigator or Sponsor|3|||
94337610|NCT00368472|323017689|FG000|Overall Study|Withdrawal by Subject|40|||
94337611|NCT00368472|323017689|FG000|Overall Study|Diary non-compliance|1|||
94337612|NCT00368472|323017689|FG000|Overall Study|Other|32|||
94337613|NCT00368472|323017689|FG000|Overall Study|Missing Final Disposition Date|1|||
94337614|NCT02224274|323017693|FG000|Overall Study|Death|1|||
94337615|NCT02224274|323017694|FG001|Overall Study|Death|0|||
94337616|NCT00412113|323017699|FG000|Overall Study|Adverse Event|11|||
94337617|NCT00412113|323017700|FG001|Overall Study|Adverse Event|15|||
94337618|NCT00412113|323017699|FG000|Overall Study|did not receive treatment|1|||
94337619|NCT00412113|323017700|FG001|Overall Study|did not receive treatment|0|||
94337620|NCT00251589|323017703|FG000|Overall Study|Adverse Event|5|||
94337621|NCT00251589|323017704|FG001|Overall Study|Adverse Event|1|||
94337622|NCT00251589|323017705|FG002|Overall Study|Adverse Event|2|||
94337623|NCT00251589|323017706|FG003|Overall Study|Adverse Event|1|||
94337624|NCT00251589|323017703|FG000|Overall Study|Withdrawal by Subject|1|||
94337625|NCT00251589|323017704|FG001|Overall Study|Withdrawal by Subject|1|||
94337626|NCT00251589|323017705|FG002|Overall Study|Withdrawal by Subject|0|||
94337627|NCT00251589|323017706|FG003|Overall Study|Withdrawal by Subject|0|||
94337628|NCT00251589|323017703|FG000|Overall Study|Discontinued due to progressive disease|9|||
94337629|NCT00251589|323017704|FG001|Overall Study|Discontinued due to progressive disease|1|||
94337630|NCT00251589|323017705|FG002|Overall Study|Discontinued due to progressive disease|0|||
94337631|NCT00251589|323017706|FG003|Overall Study|Discontinued due to progressive disease|1|||
94337632|NCT03039192|323017707|FG000|Overall Study|Lost to Follow-up|4|||
94337633|NCT03039192|323017708|FG001|Overall Study|Lost to Follow-up|4|||
94337634|NCT03039192|323017707|FG000|Overall Study|Adverse event, serious fatal|0|||
94337635|NCT03039192|323017708|FG001|Overall Study|Adverse event, serious fatal|1|||
94337636|NCT03039192|323017707|FG000|Overall Study|Adverse event, non-fatal|0|||
94337637|NCT03039192|323017708|FG001|Overall Study|Adverse event, non-fatal|2|||
94337638|NCT03039192|323017707|FG000|Overall Study|Withdrawal by Subject|6|||
94337639|NCT03039192|323017708|FG001|Overall Study|Withdrawal by Subject|9|||
94337640|NCT03039192|323017707|FG000|Overall Study|Discontinued from treatment phase|19|||
94337641|NCT03039192|323017708|FG001|Overall Study|Discontinued from treatment phase|12|||
94337642|NCT03039192|323017707|FG000|Overall Study|Other|3|||
94337643|NCT03039192|323017708|FG001|Overall Study|Other|2|||
94337644|NCT02407236|323017709|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
94337645|NCT02407236|323017710|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
94337646|NCT02407236|323017711|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
94337647|NCT02407236|323017712|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
94337648|NCT02407236|323017713|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
94337649|NCT02407236|323017714|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
94337650|NCT02407236|323017715|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
94337651|NCT02407236|323017716|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
94337652|NCT02407236|323017717|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
94337653|NCT02407236|323017718|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
94337654|NCT02407236|323017719|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
94337655|NCT02407236|323017720|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
94337656|NCT02407236|323017721|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
94337657|NCT02407236|323017709|FG000|Induction Study (8 Weeks)|Death|0|||
94439813|NCT04147234|323397834|FG005|Overall Study|Adverse Event|0|||
94439814|NCT04147234|323397835|FG006|Overall Study|Adverse Event|0|||
94439815|NCT02586688|323397837|FG000|Overall Study|Lost to Follow-up|2|||
94439816|NCT02586688|323397838|FG001|Overall Study|Lost to Follow-up|1|||
94439817|NCT02586688|323397837|FG000|Overall Study|Withdrawal by Subject|1|||
94439818|NCT02586688|323397838|FG001|Overall Study|Withdrawal by Subject|1|||
94439819|NCT02586688|323397837|FG000|Overall Study|Adverse Event|3|||
94439820|NCT02586688|323397838|FG001|Overall Study|Adverse Event|1|||
94439821|NCT03620708|323397839|FG000|Overall Study|Lost to Follow-up|1|||
94439822|NCT03620708|323397840|FG001|Overall Study|Lost to Follow-up|1|||
94439823|NCT03620708|323397841|FG002|Overall Study|Lost to Follow-up|2|||
94439824|NCT03620708|323397839|FG000|Overall Study|Withdrawal by Subject|0|||
94439825|NCT03620708|323397840|FG001|Overall Study|Withdrawal by Subject|0|||
94439826|NCT03620708|323397841|FG002|Overall Study|Withdrawal by Subject|1|||
94439827|NCT02243605|323397842|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
94439828|NCT02243605|323397843|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
94439829|NCT02243605|323397842|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
94439830|NCT02243605|323397843|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
94439831|NCT02243605|323397842|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
94439832|NCT02243605|323397843|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
94439833|NCT02243605|323397842|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
94439834|NCT02243605|323397843|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
94439835|NCT02243605|323397842|FG000|Stage 2 - Final Analysis Population|Progression|0|||
94439836|NCT02243605|323397843|FG001|Stage 2 - Final Analysis Population|Progression|1|||
94439837|NCT04848480|323397844|FG000|Main Phase (26 Weeks)|Death|1|||
94439838|NCT04848480|323397845|FG001|Main Phase (26 Weeks)|Death|0|||
94439839|NCT04848480|323397844|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
94439840|NCT04848480|323397845|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
94439841|NCT04848480|323397844|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
94439842|NCT04848480|323397845|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
94439843|NCT04848480|323397844|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
94439844|NCT04848480|323397845|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
94439845|NCT04848480|323397844|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
94439846|NCT04848480|323397845|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
94439847|NCT04848480|323397844|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
94439848|NCT04848480|323397845|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
94439849|NCT00678210|323397848|FG000|Overall Study|Adverse Event|1|||
94439850|NCT00678210|323397849|FG001|Overall Study|Adverse Event|2|||
94439851|NCT00678210|323397850|FG002|Overall Study|Adverse Event|3|||
94439852|NCT00678210|323397851|FG003|Overall Study|Adverse Event|3|||
94439853|NCT00678210|323397848|FG000|Overall Study|Lack of Efficacy|2|||
94439854|NCT00678210|323397849|FG001|Overall Study|Lack of Efficacy|3|||
94439855|NCT00678210|323397850|FG002|Overall Study|Lack of Efficacy|1|||
94439856|NCT00678210|323397851|FG003|Overall Study|Lack of Efficacy|9|||
94439857|NCT00678210|323397848|FG000|Overall Study|Lost to Follow-up|4|||
94337658|NCT02407236|323017710|FG001|Induction Study (8 Weeks)|Death|0|||
94337659|NCT02407236|323017711|FG002|Induction Study (8 Weeks)|Death|1|||
94337660|NCT02407236|323017712|FG003|Induction Study (8 Weeks)|Death|0|||
94337661|NCT02407236|323017713|FG004|Induction Study (8 Weeks)|Death|0|||
94337662|NCT02407236|323017714|FG005|Induction Study (8 Weeks)|Death|0|||
94337663|NCT02407236|323017715|FG006|Induction Study (8 Weeks)|Death|0|||
94337664|NCT02407236|323017716|FG007|Induction Study (8 Weeks)|Death|0|||
94337665|NCT02407236|323017717|FG008|Induction Study (8 Weeks)|Death|0|||
94337666|NCT02407236|323017718|FG009|Induction Study (8 Weeks)|Death|0|||
94337667|NCT02407236|323017719|FG010|Induction Study (8 Weeks)|Death|0|||
94337668|NCT02407236|323017720|FG011|Induction Study (8 Weeks)|Death|0|||
94337669|NCT02407236|323017721|FG012|Induction Study (8 Weeks)|Death|0|||
94337670|NCT02407236|323017709|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
94337671|NCT02407236|323017710|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
94337672|NCT02407236|323017711|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
94337673|NCT02407236|323017712|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
94337674|NCT02407236|323017713|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
94337675|NCT02407236|323017714|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
94337676|NCT02407236|323017715|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
94337677|NCT02407236|323017716|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
94337678|NCT02407236|323017717|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
94337679|NCT02407236|323017718|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
94337680|NCT02407236|323017719|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
94337681|NCT02407236|323017720|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
94337682|NCT02407236|323017721|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
94337683|NCT02407236|323017709|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
94337684|NCT02407236|323017710|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
94337685|NCT02407236|323017711|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
94337686|NCT02407236|323017712|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
94337687|NCT02407236|323017713|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
94337688|NCT02407236|323017714|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
94439858|NCT00678210|323397849|FG001|Overall Study|Lost to Follow-up|2|||
94337689|NCT02407236|323017715|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
94337690|NCT02407236|323017716|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
94337691|NCT02407236|323017717|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
94337692|NCT02407236|323017718|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
94337693|NCT02407236|323017719|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
94439859|NCT00678210|323397850|FG002|Overall Study|Lost to Follow-up|0|||
94439860|NCT00678210|323397851|FG003|Overall Study|Lost to Follow-up|1|||
94439861|NCT00678210|323397848|FG000|Overall Study|Withdrawal by Subject|3|||
94439862|NCT00678210|323397849|FG001|Overall Study|Withdrawal by Subject|4|||
94439863|NCT00678210|323397850|FG002|Overall Study|Withdrawal by Subject|1|||
94439864|NCT00678210|323397851|FG003|Overall Study|Withdrawal by Subject|7|||
94439865|NCT00678210|323397848|FG000|Overall Study|Other|1|||
94439866|NCT00678210|323397849|FG001|Overall Study|Other|0|||
94439867|NCT00678210|323397850|FG002|Overall Study|Other|1|||
94439868|NCT00678210|323397851|FG003|Overall Study|Other|0|||
94439869|NCT03779334|323397852|FG000|Overall Study|Withdrawal by Subject|3|||
94439870|NCT03779334|323397853|FG001|Overall Study|Withdrawal by Subject|0|||
94439871|NCT03779334|323397854|FG002|Overall Study|Withdrawal by Subject|0|||
94439872|NCT03779334|323397852|FG000|Overall Study|Ongoing in Study|5|||
94439873|NCT03779334|323397853|FG001|Overall Study|Ongoing in Study|13|||
94439874|NCT03779334|323397854|FG002|Overall Study|Ongoing in Study|5|||
94439875|NCT03657797|323397859|FG000|Overall Study|Lost to Follow-up|0|||
94439876|NCT03657797|323397860|FG001|Overall Study|Lost to Follow-up|1|||
94439877|NCT03657797|323397861|FG002|Overall Study|Lost to Follow-up|1|||
94439878|NCT03657797|323397862|FG003|Overall Study|Lost to Follow-up|0|||
94439879|NCT03657797|323397859|FG000|Overall Study|Physician Decision|0|||
94439880|NCT03657797|323397860|FG001|Overall Study|Physician Decision|1|||
94439881|NCT03657797|323397861|FG002|Overall Study|Physician Decision|0|||
94439882|NCT03657797|323397862|FG003|Overall Study|Physician Decision|0|||
94439883|NCT03657797|323397859|FG000|Overall Study|Withdrawal by Subject|0|||
94439884|NCT03657797|323397860|FG001|Overall Study|Withdrawal by Subject|1|||
94439885|NCT03657797|323397861|FG002|Overall Study|Withdrawal by Subject|2|||
94439886|NCT03657797|323397862|FG003|Overall Study|Withdrawal by Subject|0|||
94439887|NCT03657797|323397859|FG000|Overall Study|Adverse Event|0|||
94439888|NCT03657797|323397860|FG001|Overall Study|Adverse Event|0|||
94439889|NCT03657797|323397861|FG002|Overall Study|Adverse Event|2|||
94439890|NCT03657797|323397862|FG003|Overall Study|Adverse Event|0|||
94439891|NCT00725283|323397865|FG000|Overall Study|Missing Code|3|||
94439892|NCT00725283|323397865|FG000|Overall Study|Death|5|||
94439893|NCT00725283|323397865|FG000|Overall Study|Other|6|||
94439894|NCT00725283|323397865|FG000|Overall Study|Withdrawal by Subject|10|||
94439895|NCT05256134|323397866|FG000|Overall Study|Study Terminated by Sponsor|11|||
94439896|NCT05256134|323397867|FG001|Overall Study|Study Terminated by Sponsor|10|||
94439897|NCT05256134|323397866|FG000|Overall Study|Withdrawal by Subject|1|||
94439898|NCT05256134|323397867|FG001|Overall Study|Withdrawal by Subject|3|||
94439899|NCT01130532|323397868|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
94439900|NCT01130532|323397869|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
94439901|NCT01130532|323397870|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
94439902|NCT01130532|323397871|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
94439903|NCT01130532|323397868|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
94337694|NCT02407236|323017720|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
94337695|NCT02407236|323017721|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
94337696|NCT02407236|323017709|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
94337697|NCT02407236|323017710|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
94439904|NCT01130532|323397869|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
94439905|NCT01130532|323397870|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
94439906|NCT01130532|323397871|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
94337698|NCT02407236|323017711|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
94337699|NCT02407236|323017712|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
94337700|NCT02407236|323017713|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
94337701|NCT02407236|323017714|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
94337702|NCT02407236|323017715|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
94337703|NCT02407236|323017716|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
94337704|NCT02407236|323017717|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
94337705|NCT02407236|323017718|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
94337706|NCT02407236|323017719|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
94337707|NCT02407236|323017720|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
94337708|NCT02407236|323017721|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
94337709|NCT02407236|323017709|FG000|Induction Study (8 Weeks)|Other|2|||
94337710|NCT02407236|323017710|FG001|Induction Study (8 Weeks)|Other|1|||
94337711|NCT02407236|323017711|FG002|Induction Study (8 Weeks)|Other|5|||
94337712|NCT02407236|323017712|FG003|Induction Study (8 Weeks)|Other|0|||
94337713|NCT02407236|323017713|FG004|Induction Study (8 Weeks)|Other|0|||
94337714|NCT02407236|323017714|FG005|Induction Study (8 Weeks)|Other|0|||
94337715|NCT02407236|323017715|FG006|Induction Study (8 Weeks)|Other|0|||
94337716|NCT02407236|323017716|FG007|Induction Study (8 Weeks)|Other|0|||
94337717|NCT02407236|323017717|FG008|Induction Study (8 Weeks)|Other|0|||
94439907|NCT01130532|323397868|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
94439908|NCT01130532|323397869|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
94439909|NCT01130532|323397870|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
94439910|NCT01130532|323397871|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
94439911|NCT01130532|323397868|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
94337718|NCT02407236|323017718|FG009|Induction Study (8 Weeks)|Other|0|||
94337719|NCT02407236|323017719|FG010|Induction Study (8 Weeks)|Other|0|||
94439912|NCT01130532|323397869|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
94439913|NCT01130532|323397870|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
94439914|NCT01130532|323397871|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
94439915|NCT01130532|323397868|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
94439916|NCT01130532|323397869|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
94337720|NCT02407236|323017720|FG011|Induction Study (8 Weeks)|Other|0|||
94337721|NCT02407236|323017721|FG012|Induction Study (8 Weeks)|Other|0|||
94337722|NCT02407236|323017709|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
94337723|NCT02407236|323017710|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
94337724|NCT02407236|323017711|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
94337725|NCT02407236|323017712|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
94337726|NCT02407236|323017713|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
94337727|NCT02407236|323017714|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
94337728|NCT02407236|323017715|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
94337729|NCT02407236|323017716|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
94337730|NCT02407236|323017717|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
94337731|NCT02407236|323017718|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
94337732|NCT02407236|323017719|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
94337733|NCT02407236|323017720|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
94337734|NCT02407236|323017721|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
94337735|NCT02407236|323017709|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
94337736|NCT02407236|323017710|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
94337737|NCT02407236|323017711|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
94337738|NCT02407236|323017712|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
94337739|NCT02407236|323017713|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
94337740|NCT02407236|323017714|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
94337741|NCT02407236|323017715|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
94337742|NCT02407236|323017716|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
94337743|NCT02407236|323017717|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
94337744|NCT02407236|323017718|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
94337745|NCT02407236|323017719|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
94337746|NCT02407236|323017720|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
94337747|NCT02407236|323017721|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
94337748|NCT02407236|323017709|FG000|Maintenance Study (44 Weeks)|Other|0|||
94337749|NCT02407236|323017710|FG001|Maintenance Study (44 Weeks)|Other|0|||
94337750|NCT02407236|323017711|FG002|Maintenance Study (44 Weeks)|Other|0|||
94337751|NCT02407236|323017712|FG003|Maintenance Study (44 Weeks)|Other|5|||
94337752|NCT02407236|323017713|FG004|Maintenance Study (44 Weeks)|Other|7|||
94337753|NCT02407236|323017714|FG005|Maintenance Study (44 Weeks)|Other|8|||
94337754|NCT02407236|323017715|FG006|Maintenance Study (44 Weeks)|Other|4|||
94337755|NCT02407236|323017716|FG007|Maintenance Study (44 Weeks)|Other|6|||
94337756|NCT02407236|323017717|FG008|Maintenance Study (44 Weeks)|Other|0|||
94337757|NCT02407236|323017718|FG009|Maintenance Study (44 Weeks)|Other|0|||
94337758|NCT02407236|323017719|FG010|Maintenance Study (44 Weeks)|Other|0|||
94337759|NCT02407236|323017720|FG011|Maintenance Study (44 Weeks)|Other|0|||
94337760|NCT02407236|323017721|FG012|Maintenance Study (44 Weeks)|Other|0|||
94337761|NCT02407236|323017709|FG000|Maintenance Study (44 Weeks)|Death|0|||
94337762|NCT02407236|323017710|FG001|Maintenance Study (44 Weeks)|Death|0|||
94337763|NCT02407236|323017711|FG002|Maintenance Study (44 Weeks)|Death|0|||
94337764|NCT02407236|323017712|FG003|Maintenance Study (44 Weeks)|Death|0|||
94337765|NCT02407236|323017713|FG004|Maintenance Study (44 Weeks)|Death|0|||
94337766|NCT02407236|323017714|FG005|Maintenance Study (44 Weeks)|Death|0|||
94337767|NCT02407236|323017715|FG006|Maintenance Study (44 Weeks)|Death|0|||
94337768|NCT02407236|323017716|FG007|Maintenance Study (44 Weeks)|Death|1|||
94337769|NCT02407236|323017717|FG008|Maintenance Study (44 Weeks)|Death|0|||
94337770|NCT02407236|323017718|FG009|Maintenance Study (44 Weeks)|Death|0|||
94337771|NCT02407236|323017719|FG010|Maintenance Study (44 Weeks)|Death|0|||
94337772|NCT02407236|323017720|FG011|Maintenance Study (44 Weeks)|Death|0|||
94337773|NCT02407236|323017721|FG012|Maintenance Study (44 Weeks)|Death|0|||
94337774|NCT02407236|323017709|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
94337775|NCT02407236|323017710|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
94337776|NCT02407236|323017711|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
94337777|NCT02407236|323017712|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
94337778|NCT02407236|323017713|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
94337779|NCT02407236|323017714|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
94337780|NCT02407236|323017715|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
94337781|NCT02407236|323017716|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
94337782|NCT02407236|323017717|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
94337783|NCT02407236|323017718|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
94337784|NCT02407236|323017719|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
94337785|NCT02407236|323017720|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
94337786|NCT02407236|323017721|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
94337787|NCT02407236|323017709|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
94337788|NCT02407236|323017710|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
94337789|NCT02407236|323017711|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
94439917|NCT01130532|323397870|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
94337790|NCT02407236|323017712|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
94337791|NCT02407236|323017713|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
94337792|NCT02407236|323017714|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
94337793|NCT02407236|323017715|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
94337794|NCT02407236|323017716|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
94337795|NCT02407236|323017717|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
94337796|NCT02407236|323017718|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
94337797|NCT02407236|323017719|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
94337798|NCT02407236|323017720|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
94337799|NCT02407236|323017721|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
94337800|NCT02407236|323017709|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
94337801|NCT02407236|323017710|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
94337802|NCT02407236|323017711|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
94337803|NCT02407236|323017712|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
94337804|NCT02407236|323017713|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
94337805|NCT02407236|323017714|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
94337806|NCT02407236|323017715|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
94337807|NCT02407236|323017716|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
94337808|NCT02407236|323017717|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
94337809|NCT02407236|323017718|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
94337810|NCT02407236|323017719|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
94337811|NCT02407236|323017720|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
94337812|NCT02407236|323017721|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
94337813|NCT02407236|323017709|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
94337814|NCT02407236|323017710|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
94337815|NCT02407236|323017711|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
94337816|NCT02407236|323017712|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
94337817|NCT02407236|323017713|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
94337818|NCT02407236|323017714|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
94337819|NCT02407236|323017715|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
94337820|NCT02407236|323017716|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
94337821|NCT02407236|323017717|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
94337822|NCT02407236|323017718|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
94337823|NCT02407236|323017719|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
94337824|NCT02407236|323017720|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
94337825|NCT02407236|323017721|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
94337826|NCT01167153|323017722|FG000|Overall Study|Non-effective therapy|1|||
94337827|NCT01167153|323017723|FG001|Overall Study|Non-effective therapy|4|||
94337828|NCT01167153|323017722|FG000|Overall Study|AE including clinical laboratory AE|2|||
94337829|NCT01167153|323017723|FG001|Overall Study|AE including clinical laboratory AE|8|||
94337830|NCT01167153|323017722|FG000|Overall Study|Hypotension|1|||
94337831|NCT01167153|323017723|FG001|Overall Study|Hypotension|0|||
94337832|NCT01167153|323017722|FG000|Overall Study|Lost to Follow-up|7|||
94337833|NCT01167153|323017723|FG001|Overall Study|Lost to Follow-up|9|||
94337834|NCT01167153|323017722|FG000|Overall Study|Non-compliance to concomitant medication|0|||
94337835|NCT01167153|323017723|FG001|Overall Study|Non-compliance to concomitant medication|2|||
94337836|NCT01167153|323017722|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
94337837|NCT01167153|323017723|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
94337838|NCT01167153|323017722|FG000|Overall Study|Withdrawal consent|1|||
94337839|NCT01167153|323017723|FG001|Overall Study|Withdrawal consent|1|||
94337840|NCT01167153|323017722|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
94337841|NCT01167153|323017723|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
94337842|NCT00653068|323019697|FG000|Overall Study|Death|9|||
94337843|NCT00653068|323019697|FG000|Overall Study|Lack of Efficacy|34|||
94337844|NCT00653068|323019697|FG000|Overall Study|Physician Decision|4|||
94337845|NCT00653068|323019697|FG000|Overall Study|Withdrawal by Subject|1|||
94337846|NCT00653068|323019697|FG000|Overall Study|Ineligible|2|||
94337847|NCT02043509|323019698|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
94337848|NCT02043509|323019699|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
94337849|NCT02043509|323019698|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
94337850|NCT02043509|323019699|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
94337851|NCT02043509|323019698|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
94337852|NCT02043509|323019699|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
94337853|NCT02043509|323019698|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
94337854|NCT02043509|323019699|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
94337855|NCT00430027|323019700|FG000|Overall Study|Study terminated|8|||
94337856|NCT01685060|323019704|FG000|Overall Study|Rollover patients|16|||
94337857|NCT01685060|323019704|FG000|Overall Study|Adverse Event|12|||
94337858|NCT01685060|323019704|FG000|Overall Study|Progressive disease|69|||
94337859|NCT01685060|323019704|FG000|Overall Study|Physician Decision|14|||
94337860|NCT01685060|323019704|FG000|Overall Study|Subject/guardian decision|20|||
94337861|NCT01685060|323019704|FG000|Overall Study|Lost to Follow-up|1|||
94337862|NCT01685060|323019704|FG000|Overall Study|Death|8|||
94337863|NCT05569421|323019707|FG000|Overall Study|Withdrawal by Subject|1|||
94337864|NCT05569421|323019708|FG001|Overall Study|Withdrawal by Subject|0|||
94337865|NCT05569421|323019709|FG002|Overall Study|Withdrawal by Subject|0|||
94337866|NCT01495689|323019710|FG000|Overall Study|Death|0|||
94337867|NCT01495689|323019711|FG001|Overall Study|Death|1|||
94337868|NCT01495689|323019710|FG000|Overall Study|Withdrawal by Subject|3|||
94337869|NCT01495689|323019711|FG001|Overall Study|Withdrawal by Subject|0|||
94337870|NCT01495689|323019710|FG000|Overall Study|Lost to Follow-up|7|||
94337871|NCT01495689|323019711|FG001|Overall Study|Lost to Follow-up|6|||
94337872|NCT00633893|323019712|FG000|Overall Study|Death|1|||
94337873|NCT00633893|323019713|FG001|Overall Study|Death|3|||
94337874|NCT00633893|323019714|FG002|Overall Study|Death|9|||
94337875|NCT00633893|323019712|FG000|Overall Study|Adverse Event|65|||
94337876|NCT00633893|323019713|FG001|Overall Study|Adverse Event|58|||
94337877|NCT00633893|323019714|FG002|Overall Study|Adverse Event|126|||
94337878|NCT00633893|323019712|FG000|Overall Study|Withdrawal by Subject|7|||
94337879|NCT00633893|323019713|FG001|Overall Study|Withdrawal by Subject|12|||
94337880|NCT00633893|323019714|FG002|Overall Study|Withdrawal by Subject|6|||
94337881|NCT00633893|323019712|FG000|Overall Study|Lost to Follow-up|2|||
94337882|NCT00633893|323019713|FG001|Overall Study|Lost to Follow-up|4|||
94337883|NCT00633893|323019714|FG002|Overall Study|Lost to Follow-up|8|||
94337884|NCT00633893|323019712|FG000|Overall Study|Poor/non-compliance|5|||
94337885|NCT00633893|323019713|FG001|Overall Study|Poor/non-compliance|12|||
94337886|NCT00633893|323019714|FG002|Overall Study|Poor/non-compliance|3|||
94337887|NCT00633893|323019712|FG000|Overall Study|Pregnancy|2|||
94337888|NCT00633893|323019713|FG001|Overall Study|Pregnancy|1|||
94337889|NCT00633893|323019714|FG002|Overall Study|Pregnancy|1|||
94337890|NCT00633893|323019712|FG000|Overall Study|Not meet/no longer meets criteria|4|||
94337891|NCT00633893|323019713|FG001|Overall Study|Not meet/no longer meets criteria|6|||
94337892|NCT00633893|323019714|FG002|Overall Study|Not meet/no longer meets criteria|4|||
94337893|NCT00633893|323019712|FG000|Overall Study|Other|28|||
94337894|NCT00633893|323019713|FG001|Overall Study|Other|33|||
94337895|NCT00633893|323019714|FG002|Overall Study|Other|31|||
94337896|NCT00216086|323019719|FG000|Overall Study|Protocol Violation|1|||
94337897|NCT00216086|323019719|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
94337898|NCT00216086|323019719|FG000|Overall Study|Social Reasons|2|||
94337899|NCT00446797|323019720|FG000|Overall Study|Lack of Efficacy|0|||
94337900|NCT00446797|323019721|FG001|Overall Study|Lack of Efficacy|2|||
94337901|NCT00446797|323019720|FG000|Overall Study|Lost to Follow-up|5|||
94337902|NCT00446797|323019721|FG001|Overall Study|Lost to Follow-up|3|||
94337903|NCT00446797|323019720|FG000|Overall Study|Withdrawal by Subject|2|||
94337904|NCT00446797|323019721|FG001|Overall Study|Withdrawal by Subject|2|||
94337905|NCT00446797|323019720|FG000|Overall Study|Protocol Violation|1|||
94337906|NCT00446797|323019721|FG001|Overall Study|Protocol Violation|3|||
94337907|NCT00446797|323019720|FG000|Overall Study|subject entered at another site|0|||
94337908|NCT00446797|323019721|FG001|Overall Study|subject entered at another site|1|||
94337909|NCT00446797|323019720|FG000|Overall Study|did not meet entrance criteria|0|||
94337910|NCT00446797|323019721|FG001|Overall Study|did not meet entrance criteria|1|||
94337911|NCT00511108|323019722|FG000|Overall Study|Adverse Event|2|||
94337912|NCT00511108|323019723|FG001|Overall Study|Adverse Event|0|||
94337913|NCT00511108|323019724|FG002|Overall Study|Adverse Event|1|||
94337914|NCT00511108|323019725|FG003|Overall Study|Adverse Event|2|||
94337915|NCT00511108|323019722|FG000|Overall Study|Lost to Follow-up|0|||
94337916|NCT00511108|323019723|FG001|Overall Study|Lost to Follow-up|2|||
94337917|NCT00511108|323019724|FG002|Overall Study|Lost to Follow-up|1|||
94337918|NCT00511108|323019725|FG003|Overall Study|Lost to Follow-up|0|||
94337919|NCT00511108|323019722|FG000|Overall Study|Physician Decision|0|||
94337920|NCT00511108|323019723|FG001|Overall Study|Physician Decision|0|||
94337921|NCT00511108|323019724|FG002|Overall Study|Physician Decision|0|||
94337922|NCT00511108|323019725|FG003|Overall Study|Physician Decision|1|||
94337923|NCT00511108|323019722|FG000|Overall Study|Withdrawal by Subject|4|||
94337924|NCT00511108|323019723|FG001|Overall Study|Withdrawal by Subject|0|||
94337925|NCT00511108|323019724|FG002|Overall Study|Withdrawal by Subject|3|||
94337926|NCT00511108|323019725|FG003|Overall Study|Withdrawal by Subject|2|||
94337927|NCT02147691|323019728|FG000|Overall Study|Withdrawal by Subject|2|||
94337928|NCT02147691|323019729|FG001|Overall Study|Withdrawal by Subject|0|||
94337929|NCT02147691|323019728|FG000|Overall Study|Adverse Event|2|||
94337930|NCT02147691|323019729|FG001|Overall Study|Adverse Event|0|||
94337931|NCT02147691|323019728|FG000|Overall Study|Lost to Follow-up|0|||
94337932|NCT02147691|323019729|FG001|Overall Study|Lost to Follow-up|1|||
94337933|NCT01998958|323019732|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337934|NCT01998958|323019733|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
94337935|NCT01998958|323019734|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337936|NCT01998958|323019735|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337937|NCT01998958|323019736|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337938|NCT01998958|323019737|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94651328|NCT02460224|324179738|FG023|Overall Study|Progressive disease|11|||
94337939|NCT01998958|323019738|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337940|NCT01998958|323019739|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337941|NCT01998958|323019740|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337942|NCT01998958|323019741|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337943|NCT01998958|323019742|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337944|NCT01998958|323019743|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337945|NCT01998958|323019744|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337946|NCT01998958|323019745|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337947|NCT01998958|323019746|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337948|NCT01998958|323019747|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337949|NCT01998958|323019748|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337950|NCT01998958|323019749|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337951|NCT01998958|323019750|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337952|NCT01998958|323019751|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337953|NCT01998958|323019752|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337954|NCT01998958|323019753|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337955|NCT01998958|323019754|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337956|NCT01998958|323019755|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337957|NCT01998958|323019756|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337958|NCT01998958|323019757|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337959|NCT01998958|323019758|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337960|NCT01998958|323019759|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337961|NCT01998958|323019760|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337962|NCT01998958|323019761|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337963|NCT01998958|323019762|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337964|NCT01998958|323019763|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
94337965|NCT01998958|323019732|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337966|NCT01998958|323019733|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
94337967|NCT01998958|323019734|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337968|NCT01998958|323019735|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337969|NCT01998958|323019736|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337970|NCT01998958|323019737|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337971|NCT01998958|323019738|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337972|NCT01998958|323019739|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337973|NCT01998958|323019740|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337974|NCT01998958|323019741|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337975|NCT01998958|323019742|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337976|NCT01998958|323019743|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337977|NCT01998958|323019744|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337978|NCT01998958|323019745|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337979|NCT01998958|323019746|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337980|NCT01998958|323019747|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337981|NCT01998958|323019748|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337982|NCT01998958|323019749|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337983|NCT01998958|323019750|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337984|NCT01998958|323019751|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337985|NCT01998958|323019752|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337986|NCT01998958|323019753|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337987|NCT01998958|323019754|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337988|NCT01998958|323019755|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337989|NCT01998958|323019756|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337990|NCT01998958|323019757|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337991|NCT01998958|323019758|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337992|NCT01998958|323019759|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337993|NCT01998958|323019760|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337994|NCT01998958|323019761|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337995|NCT01998958|323019762|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337996|NCT01998958|323019763|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
94337997|NCT01998958|323019732|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
94337998|NCT01998958|323019733|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
94337999|NCT01998958|323019734|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
94338000|NCT01998958|323019735|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
94338001|NCT01998958|323019736|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
94338002|NCT01998958|323019737|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
94338003|NCT01998958|323019738|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
94338004|NCT01998958|323019739|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
94338005|NCT01998958|323019740|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
94338006|NCT01998958|323019741|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
94338007|NCT01998958|323019742|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
94338008|NCT01998958|323019743|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
94338009|NCT01998958|323019744|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
94338010|NCT01998958|323019745|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
94338011|NCT01998958|323019746|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
94338012|NCT01998958|323019747|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
94338013|NCT01998958|323019748|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
94338014|NCT01998958|323019749|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
94338015|NCT01998958|323019750|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
94338016|NCT01998958|323019751|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
94338017|NCT01998958|323019752|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
94338018|NCT01998958|323019753|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
94338019|NCT01998958|323019754|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
94338020|NCT01998958|323019755|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
94338021|NCT01998958|323019756|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
94338022|NCT01998958|323019757|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
94338023|NCT01998958|323019758|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
94338024|NCT01998958|323019759|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
94338025|NCT01998958|323019760|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
94338026|NCT01998958|323019761|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
94338027|NCT01998958|323019762|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
94338028|NCT01998958|323019763|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
94338029|NCT01998958|323019732|FG000|Period 1 (Panel A and B)|Other|1|||
94338030|NCT01998958|323019733|FG001|Period 1 (Panel A and B)|Other|0|||
94338031|NCT01998958|323019734|FG002|Period 1 (Panel A and B)|Other|0|||
94338032|NCT01998958|323019735|FG003|Period 1 (Panel A and B)|Other|0|||
94338033|NCT01998958|323019736|FG004|Period 1 (Panel A and B)|Other|0|||
94338034|NCT01998958|323019737|FG005|Period 1 (Panel A and B)|Other|0|||
94338035|NCT01998958|323019738|FG006|Period 1 (Panel A and B)|Other|0|||
94338036|NCT01998958|323019739|FG007|Period 1 (Panel A and B)|Other|0|||
94338037|NCT01998958|323019740|FG008|Period 1 (Panel A and B)|Other|0|||
94338038|NCT01998958|323019741|FG009|Period 1 (Panel A and B)|Other|0|||
94338039|NCT01998958|323019742|FG010|Period 1 (Panel A and B)|Other|0|||
94338040|NCT01998958|323019743|FG011|Period 1 (Panel A and B)|Other|0|||
94338041|NCT01998958|323019744|FG012|Period 1 (Panel A and B)|Other|0|||
94338042|NCT01998958|323019745|FG013|Period 1 (Panel A and B)|Other|0|||
94338043|NCT01998958|323019746|FG014|Period 1 (Panel A and B)|Other|0|||
94338044|NCT01998958|323019747|FG015|Period 1 (Panel A and B)|Other|0|||
94338045|NCT01998958|323019748|FG016|Period 1 (Panel A and B)|Other|0|||
94338046|NCT01998958|323019749|FG017|Period 1 (Panel A and B)|Other|0|||
94338047|NCT01998958|323019750|FG018|Period 1 (Panel A and B)|Other|0|||
94338048|NCT01998958|323019751|FG019|Period 1 (Panel A and B)|Other|0|||
94338049|NCT01998958|323019752|FG020|Period 1 (Panel A and B)|Other|0|||
94338050|NCT01998958|323019753|FG021|Period 1 (Panel A and B)|Other|0|||
94338051|NCT01998958|323019754|FG022|Period 1 (Panel A and B)|Other|0|||
94338052|NCT01998958|323019755|FG023|Period 1 (Panel A and B)|Other|0|||
94338053|NCT01998958|323019756|FG024|Period 1 (Panel A and B)|Other|0|||
94338054|NCT01998958|323019757|FG025|Period 1 (Panel A and B)|Other|0|||
94338055|NCT01998958|323019758|FG026|Period 1 (Panel A and B)|Other|0|||
94338056|NCT01998958|323019759|FG027|Period 1 (Panel A and B)|Other|0|||
94338057|NCT01998958|323019760|FG028|Period 1 (Panel A and B)|Other|0|||
94338058|NCT01998958|323019761|FG029|Period 1 (Panel A and B)|Other|0|||
94338059|NCT01998958|323019762|FG030|Period 1 (Panel A and B)|Other|0|||
94338060|NCT01998958|323019763|FG031|Period 1 (Panel A and B)|Other|0|||
94338061|NCT01998958|323019732|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
94338062|NCT01998958|323019733|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
94338063|NCT01998958|323019734|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
94338064|NCT01998958|323019735|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
94338065|NCT01998958|323019736|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
94338066|NCT01998958|323019737|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
94338067|NCT01998958|323019738|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
94338068|NCT01998958|323019739|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
94338069|NCT01998958|323019740|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
94338070|NCT01998958|323019741|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
94338071|NCT01998958|323019742|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
94338072|NCT01998958|323019743|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
94338073|NCT01998958|323019744|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
94338074|NCT01998958|323019745|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
94338075|NCT01998958|323019746|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
94338076|NCT01998958|323019747|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
94338077|NCT01998958|323019748|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
94338078|NCT01998958|323019749|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
94338079|NCT01998958|323019750|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
94338080|NCT01998958|323019751|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
94338081|NCT01998958|323019752|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
94338082|NCT01998958|323019753|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
94338083|NCT01998958|323019754|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
94338084|NCT01998958|323019755|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
94338085|NCT01998958|323019756|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
94338086|NCT01998958|323019757|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
94338087|NCT01998958|323019758|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
94338088|NCT01998958|323019759|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
94338089|NCT01998958|323019760|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
94338090|NCT01998958|323019761|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
94338091|NCT01998958|323019762|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
94338092|NCT01998958|323019763|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
94338093|NCT01998958|323019732|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338094|NCT01998958|323019733|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338095|NCT01998958|323019734|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338096|NCT01998958|323019735|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338097|NCT01998958|323019736|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338098|NCT01998958|323019737|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338099|NCT01998958|323019738|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338100|NCT01998958|323019739|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338101|NCT01998958|323019740|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338102|NCT01998958|323019741|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338103|NCT01998958|323019742|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338104|NCT01998958|323019743|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338105|NCT01998958|323019744|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338106|NCT01998958|323019745|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338107|NCT01998958|323019746|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
94338108|NCT01998958|323019747|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338109|NCT01998958|323019748|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338110|NCT01998958|323019749|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338111|NCT01998958|323019750|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
94338112|NCT01998958|323019751|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338113|NCT01998958|323019752|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338114|NCT01998958|323019753|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338115|NCT01998958|323019754|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338116|NCT01998958|323019755|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338117|NCT01998958|323019756|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338118|NCT01998958|323019757|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338119|NCT01998958|323019758|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338120|NCT01998958|323019759|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338121|NCT01998958|323019760|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338122|NCT01998958|323019761|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338123|NCT01998958|323019762|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338124|NCT01998958|323019763|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
94338125|NCT01998958|323019732|FG000|Open Label Phase (Optional)|Adverse Event|0|||
94338126|NCT01998958|323019733|FG001|Open Label Phase (Optional)|Adverse Event|0|||
94338127|NCT01998958|323019734|FG002|Open Label Phase (Optional)|Adverse Event|0|||
94338128|NCT01998958|323019735|FG003|Open Label Phase (Optional)|Adverse Event|0|||
94338129|NCT01998958|323019736|FG004|Open Label Phase (Optional)|Adverse Event|0|||
94338130|NCT01998958|323019737|FG005|Open Label Phase (Optional)|Adverse Event|0|||
94338131|NCT01998958|323019738|FG006|Open Label Phase (Optional)|Adverse Event|0|||
94338132|NCT01998958|323019739|FG007|Open Label Phase (Optional)|Adverse Event|0|||
94338133|NCT01998958|323019740|FG008|Open Label Phase (Optional)|Adverse Event|0|||
94338134|NCT01998958|323019741|FG009|Open Label Phase (Optional)|Adverse Event|0|||
94338135|NCT01998958|323019742|FG010|Open Label Phase (Optional)|Adverse Event|0|||
94338136|NCT01998958|323019743|FG011|Open Label Phase (Optional)|Adverse Event|0|||
94338137|NCT01998958|323019744|FG012|Open Label Phase (Optional)|Adverse Event|0|||
94338138|NCT01998958|323019745|FG013|Open Label Phase (Optional)|Adverse Event|0|||
94338139|NCT01998958|323019746|FG014|Open Label Phase (Optional)|Adverse Event|0|||
94338140|NCT01998958|323019747|FG015|Open Label Phase (Optional)|Adverse Event|0|||
94338141|NCT01998958|323019748|FG016|Open Label Phase (Optional)|Adverse Event|0|||
94338142|NCT01998958|323019749|FG017|Open Label Phase (Optional)|Adverse Event|0|||
94338143|NCT01998958|323019750|FG018|Open Label Phase (Optional)|Adverse Event|0|||
94338144|NCT01998958|323019751|FG019|Open Label Phase (Optional)|Adverse Event|0|||
94338145|NCT01998958|323019752|FG020|Open Label Phase (Optional)|Adverse Event|0|||
94338146|NCT01998958|323019753|FG021|Open Label Phase (Optional)|Adverse Event|0|||
94338147|NCT01998958|323019754|FG022|Open Label Phase (Optional)|Adverse Event|0|||
94338148|NCT01998958|323019755|FG023|Open Label Phase (Optional)|Adverse Event|1|||
94338149|NCT01998958|323019756|FG024|Open Label Phase (Optional)|Adverse Event|0|||
94338150|NCT01998958|323019757|FG025|Open Label Phase (Optional)|Adverse Event|0|||
94338151|NCT01998958|323019758|FG026|Open Label Phase (Optional)|Adverse Event|0|||
94338152|NCT01998958|323019759|FG027|Open Label Phase (Optional)|Adverse Event|0|||
94338153|NCT01998958|323019760|FG028|Open Label Phase (Optional)|Adverse Event|0|||
94338154|NCT01998958|323019761|FG029|Open Label Phase (Optional)|Adverse Event|0|||
94338155|NCT01998958|323019762|FG030|Open Label Phase (Optional)|Adverse Event|0|||
94338156|NCT01998958|323019763|FG031|Open Label Phase (Optional)|Adverse Event|0|||
94338157|NCT01998958|323019732|FG000|Open Label Phase (Optional)|Other|0|||
94338158|NCT01998958|323019733|FG001|Open Label Phase (Optional)|Other|0|||
94338159|NCT01998958|323019734|FG002|Open Label Phase (Optional)|Other|0|||
94338160|NCT01998958|323019735|FG003|Open Label Phase (Optional)|Other|0|||
94338161|NCT01998958|323019736|FG004|Open Label Phase (Optional)|Other|0|||
94439918|NCT01130532|323397871|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
94338162|NCT01998958|323019737|FG005|Open Label Phase (Optional)|Other|0|||
94338163|NCT01998958|323019738|FG006|Open Label Phase (Optional)|Other|0|||
94338164|NCT01998958|323019739|FG007|Open Label Phase (Optional)|Other|0|||
94338165|NCT01998958|323019740|FG008|Open Label Phase (Optional)|Other|0|||
94338166|NCT01998958|323019741|FG009|Open Label Phase (Optional)|Other|0|||
94338167|NCT01998958|323019742|FG010|Open Label Phase (Optional)|Other|0|||
94338168|NCT01998958|323019743|FG011|Open Label Phase (Optional)|Other|0|||
94338169|NCT01998958|323019744|FG012|Open Label Phase (Optional)|Other|0|||
94338170|NCT01998958|323019745|FG013|Open Label Phase (Optional)|Other|0|||
94338171|NCT01998958|323019746|FG014|Open Label Phase (Optional)|Other|0|||
94338172|NCT01998958|323019747|FG015|Open Label Phase (Optional)|Other|0|||
94338173|NCT01998958|323019748|FG016|Open Label Phase (Optional)|Other|0|||
94338174|NCT01998958|323019749|FG017|Open Label Phase (Optional)|Other|0|||
94338175|NCT01998958|323019750|FG018|Open Label Phase (Optional)|Other|0|||
94338176|NCT01998958|323019751|FG019|Open Label Phase (Optional)|Other|0|||
94338177|NCT01998958|323019752|FG020|Open Label Phase (Optional)|Other|0|||
94338178|NCT01998958|323019753|FG021|Open Label Phase (Optional)|Other|0|||
94338179|NCT01998958|323019754|FG022|Open Label Phase (Optional)|Other|5|||
94338180|NCT01998958|323019755|FG023|Open Label Phase (Optional)|Other|1|||
94338181|NCT01998958|323019756|FG024|Open Label Phase (Optional)|Other|0|||
94338182|NCT01998958|323019757|FG025|Open Label Phase (Optional)|Other|0|||
94338183|NCT01998958|323019758|FG026|Open Label Phase (Optional)|Other|0|||
94338184|NCT01998958|323019759|FG027|Open Label Phase (Optional)|Other|0|||
94338185|NCT01998958|323019760|FG028|Open Label Phase (Optional)|Other|0|||
94338186|NCT01998958|323019761|FG029|Open Label Phase (Optional)|Other|0|||
94338187|NCT01998958|323019762|FG030|Open Label Phase (Optional)|Other|0|||
94338188|NCT01998958|323019763|FG031|Open Label Phase (Optional)|Other|0|||
94338189|NCT01998958|323019732|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338190|NCT01998958|323019733|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338191|NCT01998958|323019734|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338192|NCT01998958|323019735|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338193|NCT01998958|323019736|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338194|NCT01998958|323019737|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338195|NCT01998958|323019738|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338196|NCT01998958|323019739|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338197|NCT01998958|323019740|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338198|NCT01998958|323019741|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338199|NCT01998958|323019742|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338200|NCT01998958|323019743|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338201|NCT01998958|323019744|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338202|NCT01998958|323019745|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338203|NCT01998958|323019746|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338204|NCT01998958|323019747|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338205|NCT01998958|323019748|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338206|NCT01998958|323019749|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338207|NCT01998958|323019750|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338208|NCT01998958|323019751|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338209|NCT01998958|323019752|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338210|NCT01998958|323019753|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338211|NCT01998958|323019754|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
94338212|NCT01998958|323019755|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338213|NCT01998958|323019756|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338214|NCT01998958|323019757|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338215|NCT01998958|323019758|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338216|NCT01998958|323019759|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338217|NCT01998958|323019760|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338218|NCT01998958|323019761|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338219|NCT01998958|323019762|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338220|NCT01998958|323019763|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
94338221|NCT01998958|323019732|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338222|NCT01998958|323019733|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338223|NCT01998958|323019734|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338224|NCT01998958|323019735|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338225|NCT01998958|323019736|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338226|NCT01998958|323019737|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338227|NCT01998958|323019738|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338228|NCT01998958|323019739|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338229|NCT01998958|323019740|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338230|NCT01998958|323019741|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338231|NCT01998958|323019742|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338232|NCT01998958|323019743|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338233|NCT01998958|323019744|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338234|NCT01998958|323019745|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338235|NCT01998958|323019746|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338236|NCT01998958|323019747|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338237|NCT01998958|323019748|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338238|NCT01998958|323019749|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338239|NCT01998958|323019750|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338240|NCT01998958|323019751|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338241|NCT01998958|323019752|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338242|NCT01998958|323019753|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
94338243|NCT01998958|323019754|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
94338244|NCT01998958|323019755|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338245|NCT01998958|323019756|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338246|NCT01998958|323019757|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338247|NCT01998958|323019758|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338248|NCT01998958|323019759|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338249|NCT01998958|323019760|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338250|NCT01998958|323019761|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338251|NCT01998958|323019762|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338252|NCT01998958|323019763|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
94338253|NCT01998958|323019732|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338254|NCT01998958|323019733|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338255|NCT01998958|323019734|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338256|NCT01998958|323019735|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338257|NCT01998958|323019736|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338258|NCT01998958|323019737|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338259|NCT01998958|323019738|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338260|NCT01998958|323019739|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338261|NCT01998958|323019740|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338262|NCT01998958|323019741|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338263|NCT01998958|323019742|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338264|NCT01998958|323019743|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338265|NCT01998958|323019744|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338266|NCT01998958|323019745|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338267|NCT01998958|323019746|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338268|NCT01998958|323019747|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338269|NCT01998958|323019748|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338270|NCT01998958|323019749|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338271|NCT01998958|323019750|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338272|NCT01998958|323019751|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338273|NCT01998958|323019752|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338274|NCT01998958|323019753|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
94338275|NCT01998958|323019754|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
94338276|NCT01998958|323019755|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
94338277|NCT01998958|323019756|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338278|NCT01998958|323019757|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338279|NCT01998958|323019758|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338280|NCT01998958|323019759|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338281|NCT01998958|323019760|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338282|NCT01998958|323019761|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338283|NCT01998958|323019762|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338284|NCT01998958|323019763|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
94338285|NCT02062827|323019766|FG000|Overall Study|Death|1|||
94338286|NCT02062827|323019767|FG001|Overall Study|Death|0|||
94338287|NCT02062827|323019768|FG002|Overall Study|Death|0|||
94338288|NCT02062827|323019769|FG003|Overall Study|Death|0|||
94338289|NCT02062827|323019770|FG004|Overall Study|Death|0|||
94338290|NCT02062827|323019771|FG005|Overall Study|Death|0|||
94338291|NCT02062827|323019772|FG006|Overall Study|Death|0|||
94338292|NCT02062827|323019773|FG007|Overall Study|Death|0|||
94338293|NCT02062827|323019766|FG000|Overall Study|Withdrawal by Subject|3|||
94338294|NCT02062827|323019767|FG001|Overall Study|Withdrawal by Subject|1|||
94338295|NCT02062827|323019768|FG002|Overall Study|Withdrawal by Subject|1|||
94338296|NCT02062827|323019769|FG003|Overall Study|Withdrawal by Subject|2|||
94338297|NCT02062827|323019770|FG004|Overall Study|Withdrawal by Subject|6|||
94338298|NCT02062827|323019771|FG005|Overall Study|Withdrawal by Subject|0|||
94338299|NCT02062827|323019772|FG006|Overall Study|Withdrawal by Subject|5|||
94338300|NCT02062827|323019773|FG007|Overall Study|Withdrawal by Subject|0|||
94338301|NCT02062827|323019766|FG000|Overall Study|Screen Fail|0|||
94338302|NCT02062827|323019767|FG001|Overall Study|Screen Fail|0|||
94338303|NCT02062827|323019768|FG002|Overall Study|Screen Fail|0|||
94338304|NCT02062827|323019769|FG003|Overall Study|Screen Fail|0|||
94338305|NCT02062827|323019770|FG004|Overall Study|Screen Fail|0|||
94338306|NCT02062827|323019771|FG005|Overall Study|Screen Fail|0|||
94338307|NCT02062827|323019772|FG006|Overall Study|Screen Fail|0|||
94338308|NCT02062827|323019773|FG007|Overall Study|Screen Fail|8|||
94338309|NCT00420342|323019774|FG000|Overall Study|Lost to Follow-up|1|||
94338310|NCT00420342|323019775|FG001|Overall Study|Lost to Follow-up|0|||
94338311|NCT00420342|323019776|FG002|Overall Study|Lost to Follow-up|1|||
94338312|NCT00420342|323019774|FG000|Overall Study|Withdrawal by Subject|0|||
94338313|NCT00420342|323019775|FG001|Overall Study|Withdrawal by Subject|2|||
94338314|NCT00420342|323019776|FG002|Overall Study|Withdrawal by Subject|0|||
94338315|NCT04097028|323019785|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
94338316|NCT04097028|323019785|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
94338317|NCT04097028|323019785|FG000|Overall Study|Disease Progression prior to Surgery|2|||
94338318|NCT04097028|323019785|FG000|Overall Study|Adverse Event prior to Surgery|1|||
94338319|NCT02473289|323019786|FG000|Overall Study|Adverse Event|2|||
94338320|NCT02473289|323019787|FG001|Overall Study|Adverse Event|3|||
94338321|NCT02473289|323019786|FG000|Overall Study|Lost to Follow-up|1|||
94338322|NCT02473289|323019787|FG001|Overall Study|Lost to Follow-up|1|||
94338323|NCT02473289|323019786|FG000|Overall Study|Protocol Violation|0|||
94338324|NCT02473289|323019787|FG001|Overall Study|Protocol Violation|1|||
94338325|NCT02473289|323019786|FG000|Overall Study|Withdrawal of consent|6|||
94338326|NCT02473289|323019787|FG001|Overall Study|Withdrawal of consent|7|||
94338327|NCT02473289|323019786|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
94338328|NCT02473289|323019787|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
94338329|NCT02473289|323019786|FG000|Overall Study|Other|2|||
94338330|NCT02473289|323019787|FG001|Overall Study|Other|0|||
94338331|NCT02939976|323019792|FG000|Overall Study|Lost to Follow-up|7|||
94338332|NCT02939976|323019793|FG001|Overall Study|Lost to Follow-up|1|||
94338333|NCT02939976|323019794|FG002|Overall Study|Lost to Follow-up|1|||
94338334|NCT02939976|323019795|FG003|Overall Study|Lost to Follow-up|2|||
94338335|NCT02939976|323019792|FG000|Overall Study|Withdrawal by Subject|4|||
94338336|NCT02939976|323019793|FG001|Overall Study|Withdrawal by Subject|0|||
94338337|NCT02939976|323019794|FG002|Overall Study|Withdrawal by Subject|2|||
94338338|NCT02939976|323019795|FG003|Overall Study|Withdrawal by Subject|4|||
94338339|NCT02939976|323019792|FG000|Overall Study|Due to early study closure|4|||
94338340|NCT02939976|323019793|FG001|Overall Study|Due to early study closure|3|||
94338341|NCT02939976|323019794|FG002|Overall Study|Due to early study closure|2|||
94338342|NCT02939976|323019795|FG003|Overall Study|Due to early study closure|3|||
94338343|NCT00415584|323019796|FG000|Overall Study|Withdrawal by Subject|1|||
94338344|NCT00693693|323019797|FG000|Overall Study|Lost to Follow-up|1|||
94338345|NCT00693693|323019798|FG001|Overall Study|Lost to Follow-up|1|||
94338346|NCT00693693|323019799|FG002|Overall Study|Lost to Follow-up|2|||
94338347|NCT00841672|323019800|FG000|Overall Study|Adverse Event|7|||
94338348|NCT00841672|323019801|FG001|Overall Study|Adverse Event|16|||
94338349|NCT00841672|323019800|FG000|Overall Study|Abnormal test procedure result(s)|0|||
94338350|NCT00841672|323019801|FG001|Overall Study|Abnormal test procedure result(s)|1|||
94338351|NCT00841672|323019800|FG000|Overall Study|Subject withdrew consent|2|||
94338352|NCT00841672|323019801|FG001|Overall Study|Subject withdrew consent|4|||
94338353|NCT00841672|323019800|FG000|Overall Study|Lost to Follow-up|1|||
94338354|NCT00841672|323019801|FG001|Overall Study|Lost to Follow-up|1|||
94338355|NCT00841672|323019800|FG000|Overall Study|Administrative problems|9|||
94338356|NCT00841672|323019801|FG001|Overall Study|Administrative problems|9|||
94338357|NCT00841672|323019800|FG000|Overall Study|Misrandomized|1|||
94338358|NCT00841672|323019801|FG001|Overall Study|Misrandomized|0|||
94338359|NCT00841672|323019800|FG000|Overall Study|Protocol Deviation|0|||
94338360|NCT00841672|323019801|FG001|Overall Study|Protocol Deviation|1|||
94338361|NCT04731922|323019802|FG000|Overall Study|Adverse Event|0|||
94338362|NCT04731922|323019803|FG001|Overall Study|Adverse Event|0|||
94338363|NCT04731922|323019804|FG002|Overall Study|Adverse Event|0|||
94338364|NCT04731922|323019805|FG003|Overall Study|Adverse Event|0|||
94338365|NCT04731922|323019806|FG004|Overall Study|Adverse Event|0|||
94338366|NCT04731922|323019807|FG005|Overall Study|Adverse Event|0|||
94338367|NCT04731922|323019808|FG006|Overall Study|Adverse Event|0|||
94338368|NCT04731922|323019809|FG007|Overall Study|Adverse Event|0|||
94338369|NCT04731922|323019810|FG008|Overall Study|Adverse Event|0|||
94338370|NCT04731922|323019811|FG009|Overall Study|Adverse Event|0|||
94338371|NCT04731922|323019812|FG010|Overall Study|Adverse Event|1|||
94338372|NCT04731922|323019813|FG011|Overall Study|Adverse Event|0|||
94338373|NCT04731922|323019814|FG012|Overall Study|Adverse Event|0|||
94338374|NCT04731922|323019815|FG013|Overall Study|Adverse Event|0|||
94338375|NCT04731922|323019816|FG014|Overall Study|Adverse Event|0|||
94338376|NCT04731922|323019817|FG015|Overall Study|Adverse Event|0|||
94338377|NCT04731922|323019818|FG016|Overall Study|Adverse Event|0|||
94338378|NCT04731922|323019802|FG000|Overall Study|Lost to Follow-up|0|||
94338379|NCT04731922|323019803|FG001|Overall Study|Lost to Follow-up|0|||
94338380|NCT04731922|323019804|FG002|Overall Study|Lost to Follow-up|0|||
94338381|NCT04731922|323019805|FG003|Overall Study|Lost to Follow-up|1|||
94338382|NCT04731922|323019806|FG004|Overall Study|Lost to Follow-up|0|||
94338383|NCT04731922|323019807|FG005|Overall Study|Lost to Follow-up|1|||
94338384|NCT04731922|323019808|FG006|Overall Study|Lost to Follow-up|0|||
94338385|NCT04731922|323019809|FG007|Overall Study|Lost to Follow-up|0|||
94338386|NCT04731922|323019810|FG008|Overall Study|Lost to Follow-up|0|||
94338387|NCT04731922|323019811|FG009|Overall Study|Lost to Follow-up|0|||
94338388|NCT04731922|323019812|FG010|Overall Study|Lost to Follow-up|0|||
94338389|NCT04731922|323019813|FG011|Overall Study|Lost to Follow-up|0|||
94338390|NCT04731922|323019814|FG012|Overall Study|Lost to Follow-up|0|||
94338391|NCT04731922|323019815|FG013|Overall Study|Lost to Follow-up|0|||
94338392|NCT04731922|323019816|FG014|Overall Study|Lost to Follow-up|0|||
94338393|NCT04731922|323019817|FG015|Overall Study|Lost to Follow-up|0|||
94338394|NCT04731922|323019818|FG016|Overall Study|Lost to Follow-up|0|||
94338395|NCT04731922|323019802|FG000|Overall Study|Withdrawal by Subject|1|||
94338396|NCT04731922|323019803|FG001|Overall Study|Withdrawal by Subject|0|||
94338397|NCT04731922|323019804|FG002|Overall Study|Withdrawal by Subject|0|||
94338398|NCT04731922|323019805|FG003|Overall Study|Withdrawal by Subject|0|||
94338399|NCT04731922|323019806|FG004|Overall Study|Withdrawal by Subject|1|||
94338400|NCT04731922|323019807|FG005|Overall Study|Withdrawal by Subject|0|||
94338401|NCT04731922|323019808|FG006|Overall Study|Withdrawal by Subject|1|||
94338402|NCT04731922|323019809|FG007|Overall Study|Withdrawal by Subject|0|||
94338403|NCT04731922|323019810|FG008|Overall Study|Withdrawal by Subject|0|||
94338404|NCT04731922|323019811|FG009|Overall Study|Withdrawal by Subject|0|||
94338405|NCT04731922|323019812|FG010|Overall Study|Withdrawal by Subject|0|||
94338406|NCT04731922|323019813|FG011|Overall Study|Withdrawal by Subject|0|||
94338407|NCT04731922|323019814|FG012|Overall Study|Withdrawal by Subject|0|||
94338408|NCT04731922|323019815|FG013|Overall Study|Withdrawal by Subject|1|||
94338409|NCT04731922|323019816|FG014|Overall Study|Withdrawal by Subject|0|||
94338410|NCT04731922|323019817|FG015|Overall Study|Withdrawal by Subject|0|||
94338411|NCT04731922|323019818|FG016|Overall Study|Withdrawal by Subject|0|||
94338412|NCT04731922|323019802|FG000|Overall Study|Other|0|||
94338413|NCT04731922|323019803|FG001|Overall Study|Other|0|||
94338414|NCT04731922|323019804|FG002|Overall Study|Other|0|||
94338415|NCT04731922|323019805|FG003|Overall Study|Other|0|||
94338416|NCT04731922|323019806|FG004|Overall Study|Other|0|||
94338417|NCT04731922|323019807|FG005|Overall Study|Other|0|||
94338418|NCT04731922|323019808|FG006|Overall Study|Other|1|||
94338419|NCT04731922|323019809|FG007|Overall Study|Other|0|||
94338420|NCT04731922|323019810|FG008|Overall Study|Other|0|||
94338421|NCT04731922|323019811|FG009|Overall Study|Other|0|||
94338422|NCT04731922|323019812|FG010|Overall Study|Other|0|||
94338423|NCT04731922|323019813|FG011|Overall Study|Other|0|||
94338424|NCT04731922|323019814|FG012|Overall Study|Other|0|||
94338425|NCT04731922|323019815|FG013|Overall Study|Other|0|||
94338426|NCT04731922|323019816|FG014|Overall Study|Other|0|||
94338427|NCT04731922|323019817|FG015|Overall Study|Other|0|||
94338428|NCT04731922|323019818|FG016|Overall Study|Other|0|||
94338429|NCT03074318|323019819|FG000|Overall Study|Adverse Event|0|||
94338430|NCT03074318|323019820|FG001|Overall Study|Adverse Event|1|||
94338431|NCT03074318|323019821|FG002|Overall Study|Adverse Event|1|||
94338432|NCT03074318|323019822|FG003|Overall Study|Adverse Event|1|||
94338433|NCT03074318|323019819|FG000|Overall Study|Death|1|||
94338434|NCT03074318|323019820|FG001|Overall Study|Death|0|||
94338435|NCT03074318|323019821|FG002|Overall Study|Death|0|||
94338436|NCT03074318|323019822|FG003|Overall Study|Death|0|||
94338437|NCT03074318|323019819|FG000|Overall Study|Withdrawal by Subject|1|||
94338438|NCT03074318|323019820|FG001|Overall Study|Withdrawal by Subject|2|||
94338439|NCT03074318|323019821|FG002|Overall Study|Withdrawal by Subject|2|||
94338440|NCT03074318|323019822|FG003|Overall Study|Withdrawal by Subject|4|||
94338441|NCT03074318|323019819|FG000|Overall Study|Trial Closure|2|||
94338442|NCT03074318|323019820|FG001|Overall Study|Trial Closure|2|||
94338443|NCT03074318|323019821|FG002|Overall Study|Trial Closure|3|||
94338444|NCT03074318|323019822|FG003|Overall Study|Trial Closure|11|||
94338445|NCT00741260|323019825|FG000|Overall Study|Disease Progression|3|||
94338446|NCT00741260|323019826|FG001|Overall Study|Disease Progression|5|||
94338447|NCT00741260|323019827|FG002|Overall Study|Disease Progression|3|||
94338448|NCT00741260|323019828|FG003|Overall Study|Disease Progression|3|||
94338449|NCT00741260|323019829|FG004|Overall Study|Disease Progression|5|||
94338450|NCT00741260|323019830|FG005|Overall Study|Disease Progression|37|||
94338451|NCT00741260|323019831|FG006|Overall Study|Disease Progression|4|||
94338452|NCT00741260|323019825|FG000|Overall Study|Death|0|||
94338453|NCT00741260|323019826|FG001|Overall Study|Death|1|||
94338454|NCT00741260|323019827|FG002|Overall Study|Death|0|||
94338455|NCT00741260|323019828|FG003|Overall Study|Death|1|||
94338456|NCT00741260|323019829|FG004|Overall Study|Death|2|||
94338457|NCT00741260|323019830|FG005|Overall Study|Death|2|||
94338458|NCT00741260|323019831|FG006|Overall Study|Death|1|||
94338459|NCT00741260|323019825|FG000|Overall Study|Withdrawal by Subject|0|||
94338460|NCT00741260|323019826|FG001|Overall Study|Withdrawal by Subject|0|||
94338461|NCT00741260|323019827|FG002|Overall Study|Withdrawal by Subject|0|||
94338462|NCT00741260|323019828|FG003|Overall Study|Withdrawal by Subject|0|||
94338463|NCT00741260|323019829|FG004|Overall Study|Withdrawal by Subject|1|||
94338464|NCT00741260|323019830|FG005|Overall Study|Withdrawal by Subject|3|||
94338465|NCT00741260|323019831|FG006|Overall Study|Withdrawal by Subject|1|||
94338466|NCT00741260|323019825|FG000|Overall Study|Physician Decision|1|||
94338467|NCT00741260|323019826|FG001|Overall Study|Physician Decision|1|||
94338468|NCT00741260|323019827|FG002|Overall Study|Physician Decision|0|||
94338469|NCT00741260|323019828|FG003|Overall Study|Physician Decision|0|||
94338470|NCT00741260|323019829|FG004|Overall Study|Physician Decision|0|||
94338471|NCT00741260|323019830|FG005|Overall Study|Physician Decision|0|||
94338472|NCT00741260|323019831|FG006|Overall Study|Physician Decision|0|||
94338473|NCT00741260|323019825|FG000|Overall Study|Other|2|||
94338474|NCT00741260|323019826|FG001|Overall Study|Other|1|||
94338475|NCT00741260|323019827|FG002|Overall Study|Other|1|||
94338476|NCT00741260|323019828|FG003|Overall Study|Other|2|||
94338477|NCT00741260|323019829|FG004|Overall Study|Other|1|||
94338478|NCT00741260|323019830|FG005|Overall Study|Other|3|||
94338479|NCT00741260|323019831|FG006|Overall Study|Other|1|||
94338480|NCT03997760|323019832|FG000|Overall Study|Protocol Deviation|0|||
94338481|NCT03997760|323019833|FG001|Overall Study|Protocol Deviation|1|||
94338482|NCT03997760|323019834|FG002|Overall Study|Protocol Deviation|0|||
94338483|NCT03997760|323019835|FG003|Overall Study|Protocol Deviation|0|||
94338484|NCT00423592|323019836|FG000|Overall Study|Adverse Event (through Week 12)|2|||
94338485|NCT00423592|323019836|FG000|Overall Study|Adverse Event (post Week 12)|5|||
94338486|NCT03446612|323019837|FG000|Overall Study|Protocol defined stopping criteria|0|||
94338487|NCT03446612|323019838|FG001|Overall Study|Protocol defined stopping criteria|1|||
94338488|NCT01448707|323019839|FG000|Overall Study|Adverse Event|3|||
94338489|NCT01448707|323019840|FG001|Overall Study|Adverse Event|1|||
94338490|NCT01448707|323019839|FG000|Overall Study|Lost to Follow-up|2|||
94338491|NCT01448707|323019840|FG001|Overall Study|Lost to Follow-up|6|||
94338492|NCT01448707|323019839|FG000|Overall Study|Withdrawal by Subject|6|||
94338493|NCT01448707|323019840|FG001|Overall Study|Withdrawal by Subject|7|||
94338494|NCT01448707|323019839|FG000|Overall Study|Other|7|||
94338495|NCT01448707|323019840|FG001|Overall Study|Other|4|||
94338496|NCT02033850|323019841|FG000|Overall Study|Death|1|||
94338497|NCT02033850|323019842|FG001|Overall Study|Death|0|||
94338498|NCT02033850|323019841|FG000|Overall Study|unrelated medical reason|1|||
94338499|NCT02033850|323019842|FG001|Overall Study|unrelated medical reason|1|||
94338500|NCT00608842|323019843|FG000|Overall Study|Participant's Request|0|||
94338501|NCT00608842|323019844|FG001|Overall Study|Participant's Request|1|||
94338502|NCT00608842|323019845|FG002|Overall Study|Participant's Request|2|||
94338503|NCT00608842|323019846|FG003|Overall Study|Participant's Request|1|||
94338504|NCT00608842|323019843|FG000|Overall Study|Lost to Follow-up|1|||
94338505|NCT00608842|323019844|FG001|Overall Study|Lost to Follow-up|0|||
94338506|NCT00608842|323019845|FG002|Overall Study|Lost to Follow-up|0|||
94338507|NCT00608842|323019846|FG003|Overall Study|Lost to Follow-up|0|||
94338508|NCT00033371|323019847|FG000|Overall Study|Adverse Event|1|||
94338509|NCT00033371|323019848|FG001|Overall Study|Adverse Event|5|||
94338510|NCT00033371|323019847|FG000|Overall Study|Lost to Follow-up|2|||
94338511|NCT00033371|323019848|FG001|Overall Study|Lost to Follow-up|1|||
94338512|NCT00033371|323019847|FG000|Overall Study|Withdrawal by Subject|3|||
94338513|NCT00033371|323019848|FG001|Overall Study|Withdrawal by Subject|3|||
94338514|NCT00033371|323019847|FG000|Overall Study|Disease Progression|0|||
94338515|NCT00033371|323019848|FG001|Overall Study|Disease Progression|1|||
94338516|NCT03796195|323019851|FG000|Overall Study|Study closed early|1|||
94338517|NCT00062647|323019852|FG000|Overall Study|Death|2|||
94338518|NCT00062647|323019853|FG001|Overall Study|Death|2|||
94338519|NCT00062647|323019852|FG000|Overall Study|Adverse Event|1|||
94338520|NCT00062647|323019853|FG001|Overall Study|Adverse Event|1|||
94338521|NCT00062647|323019852|FG000|Overall Study|Withdrawal by Subject|2|||
94338522|NCT00062647|323019853|FG001|Overall Study|Withdrawal by Subject|1|||
94338523|NCT00062647|323019852|FG000|Overall Study|Protocol Violation|1|||
94338524|NCT00062647|323019853|FG001|Overall Study|Protocol Violation|0|||
94338525|NCT00062647|323019852|FG000|Overall Study|Lost to Follow-up|1|||
94338526|NCT00062647|323019853|FG001|Overall Study|Lost to Follow-up|2|||
94338527|NCT00062647|323019852|FG000|Overall Study|Failed continuation criteria|4|||
94338528|NCT00062647|323019853|FG001|Overall Study|Failed continuation criteria|2|||
94338529|NCT00062647|323019852|FG000|Overall Study|Other|4|||
94338530|NCT00062647|323019853|FG001|Overall Study|Other|4|||
94338531|NCT00062647|323019852|FG000|Overall Study|Never received study treatment|1|||
94338532|NCT00062647|323019853|FG001|Overall Study|Never received study treatment|1|||
94338533|NCT02392468|323019858|FG000|Overall Study|Adverse Event|0|||
94338534|NCT02392468|323019859|FG001|Overall Study|Adverse Event|1|||
94338535|NCT02392468|323019860|FG002|Overall Study|Adverse Event|0|||
94338536|NCT02392468|323019861|FG003|Overall Study|Adverse Event|0|||
94338537|NCT02392468|323019862|FG004|Overall Study|Adverse Event|0|||
94338538|NCT02392468|323019863|FG005|Overall Study|Adverse Event|1|||
94338539|NCT02092324|323019864|FG000|Overall Study|Adverse Event|1|||
94338540|NCT02092324|323019864|FG000|Overall Study|Lack of Efficacy|6|||
94338541|NCT02092324|323019864|FG000|Overall Study|Proceed to Transplant|3|||
94338542|NCT02092324|323019864|FG000|Overall Study|Physician Decision|7|||
94338543|NCT02092324|323019864|FG000|Overall Study|Misdiagnosis|2|||
94338544|NCT03148795|323019867|FG000|Overall Study|Progressive Disease|1|||
94338545|NCT01927068|323019868|FG000|Overall Study|Death|37|||
94338546|NCT01927068|323019869|FG001|Overall Study|Death|3|||
94338547|NCT01927068|323019868|FG000|Overall Study|Withdrawal by Subject|50|||
94338548|NCT01927068|323019869|FG001|Overall Study|Withdrawal by Subject|3|||
94338549|NCT01927068|323019868|FG000|Overall Study|Lost to Follow-up|10|||
94338550|NCT01927068|323019869|FG001|Overall Study|Lost to Follow-up|2|||
94338551|NCT01927068|323019868|FG000|Overall Study|Physician Decision|9|||
94338552|NCT01927068|323019869|FG001|Overall Study|Physician Decision|0|||
94338553|NCT01927068|323019868|FG000|Overall Study|Missed last follow-up visit|2|||
94338554|NCT01927068|323019869|FG001|Overall Study|Missed last follow-up visit|0|||
94338555|NCT00499460|323019870|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
94338556|NCT00499460|323019871|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
94338557|NCT00499460|323019870|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
94338558|NCT00499460|323019871|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
94338559|NCT00499460|323019870|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
94338560|NCT00499460|323019871|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
94338561|NCT03418376|323019872|FG000|Overall Study|Musculoskeletal injury|1|||
94338562|NCT03418376|323019873|FG001|Overall Study|Musculoskeletal injury|2|||
94338563|NCT03418376|323019874|FG002|Overall Study|Musculoskeletal injury|1|||
94338564|NCT03418376|323019875|FG003|Overall Study|Musculoskeletal injury|0|||
94338565|NCT03418376|323019872|FG000|Overall Study|Personal reasons|0|||
94338566|NCT03418376|323019873|FG001|Overall Study|Personal reasons|2|||
94338567|NCT03418376|323019874|FG002|Overall Study|Personal reasons|2|||
94338568|NCT03418376|323019875|FG003|Overall Study|Personal reasons|1|||
94338569|NCT03418376|323019872|FG000|Overall Study|Exacerbation|0|||
94338570|NCT03418376|323019873|FG001|Overall Study|Exacerbation|1|||
94338571|NCT03418376|323019874|FG002|Overall Study|Exacerbation|0|||
94338572|NCT03418376|323019875|FG003|Overall Study|Exacerbation|0|||
94338573|NCT00814307|323019876|FG000|Overall Study|Randomized but not treated|1|||
94338574|NCT00814307|323019877|FG001|Overall Study|Randomized but not treated|0|||
94338575|NCT00814307|323019878|FG002|Overall Study|Randomized but not treated|0|||
94338576|NCT00814307|323019879|FG003|Overall Study|Randomized but not treated|0|||
94338577|NCT00814307|323019876|FG000|Overall Study|Adverse Event|3|||
94338578|NCT00814307|323019877|FG001|Overall Study|Adverse Event|9|||
94338579|NCT00814307|323019878|FG002|Overall Study|Adverse Event|3|||
94338580|NCT00814307|323019879|FG003|Overall Study|Adverse Event|2|||
94338581|NCT00814307|323019876|FG000|Overall Study|Lack of Efficacy|1|||
94338582|NCT00814307|323019877|FG001|Overall Study|Lack of Efficacy|1|||
94338583|NCT00814307|323019878|FG002|Overall Study|Lack of Efficacy|3|||
94338584|NCT00814307|323019879|FG003|Overall Study|Lack of Efficacy|4|||
94338585|NCT00814307|323019876|FG000|Overall Study|Other|1|||
94338586|NCT00814307|323019877|FG001|Overall Study|Other|2|||
94338587|NCT00814307|323019878|FG002|Overall Study|Other|0|||
94338588|NCT00814307|323019879|FG003|Overall Study|Other|1|||
94338589|NCT00814307|323019876|FG000|Overall Study|Protocol Violation|2|||
94338590|NCT00814307|323019877|FG001|Overall Study|Protocol Violation|8|||
94338591|NCT00814307|323019878|FG002|Overall Study|Protocol Violation|1|||
94338592|NCT00814307|323019879|FG003|Overall Study|Protocol Violation|1|||
94338593|NCT00814307|323019876|FG000|Overall Study|Withdrawal by Subject|4|||
94338594|NCT00814307|323019877|FG001|Overall Study|Withdrawal by Subject|6|||
94338595|NCT00814307|323019878|FG002|Overall Study|Withdrawal by Subject|0|||
94338596|NCT00814307|323019879|FG003|Overall Study|Withdrawal by Subject|2|||
94338597|NCT00814307|323019876|FG000|Overall Study|Death|0|||
94338598|NCT00814307|323019877|FG001|Overall Study|Death|1|||
94338599|NCT00814307|323019878|FG002|Overall Study|Death|0|||
94338600|NCT00814307|323019879|FG003|Overall Study|Death|0|||
94338601|NCT00807014|323019880|FG000|Overall Study|Participant Considered Disease Cured|13|||
94338602|NCT00807014|323019881|FG001|Overall Study|Participant Considered Disease Cured|2|||
94338603|NCT00807014|323019880|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
94338604|NCT00807014|323019881|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
94338605|NCT00807014|323019880|FG000|Overall Study|Protocol Violation|2|||
94338606|NCT00807014|323019881|FG001|Overall Study|Protocol Violation|8|||
94338607|NCT00807014|323019880|FG000|Overall Study|Adverse Event|0|||
94338608|NCT00807014|323019881|FG001|Overall Study|Adverse Event|2|||
94338609|NCT00807014|323019880|FG000|Overall Study|Lost to Follow-up|9|||
94338610|NCT00807014|323019881|FG001|Overall Study|Lost to Follow-up|7|||
94338611|NCT00807014|323019880|FG000|Overall Study|Recovery|1|||
94338612|NCT00807014|323019881|FG001|Overall Study|Recovery|0|||
94338613|NCT00807014|323019880|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
94338614|NCT00807014|323019881|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
94338615|NCT03209362|323019890|FG000|Overall Study|Adverse Event|0|||
94439919|NCT01130532|323397868|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
94439920|NCT01130532|323397869|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
94439921|NCT01130532|323397870|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
94439922|NCT01130532|323397871|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
94338616|NCT03209362|323019891|FG001|Overall Study|Adverse Event|1|||
94338617|NCT03209362|323019890|FG000|Overall Study|Lost to Follow-up|0|||
94338618|NCT03209362|323019891|FG001|Overall Study|Lost to Follow-up|1|||
94338619|NCT03209362|323019890|FG000|Overall Study|Withdrawal by Subject|2|||
94338620|NCT03209362|323019891|FG001|Overall Study|Withdrawal by Subject|0|||
94338621|NCT03209362|323019890|FG000|Overall Study|Other|0|||
94338622|NCT03209362|323019891|FG001|Overall Study|Other|1|||
94338623|NCT01190020|323019892|FG000|Overall Study|Adverse Event|2|||
94338624|NCT01190020|323019893|FG001|Overall Study|Adverse Event|0|||
94338625|NCT01190020|323019892|FG000|Overall Study|Lost to Follow-up|2|||
94338626|NCT01190020|323019893|FG001|Overall Study|Lost to Follow-up|0|||
94338627|NCT01190020|323019892|FG000|Overall Study|Withdrawal by Subject|3|||
94338628|NCT01190020|323019893|FG001|Overall Study|Withdrawal by Subject|0|||
94338629|NCT00796224|323019894|FG000|Overall Study|Adverse Event|1|||
94338630|NCT00796224|323019895|FG001|Overall Study|Adverse Event|0|||
94338631|NCT00796224|323019894|FG000|Overall Study|Protocol Violation|0|||
94338632|NCT00796224|323019895|FG001|Overall Study|Protocol Violation|1|||
94338633|NCT02569398|323019896|FG000|Overall Study|Adverse Event|0|||
94338634|NCT02569398|323019897|FG001|Overall Study|Adverse Event|1|||
94338635|NCT02569398|323019898|FG002|Overall Study|Adverse Event|6|||
94338636|NCT02569398|323019896|FG000|Overall Study|Withdrawal by Subject|43|||
94338637|NCT02569398|323019897|FG001|Overall Study|Withdrawal by Subject|43|||
94338638|NCT02569398|323019898|FG002|Overall Study|Withdrawal by Subject|30|||
94338639|NCT02569398|323019896|FG000|Overall Study|Study terminated by sponsor|130|||
94338640|NCT02569398|323019897|FG001|Overall Study|Study terminated by sponsor|131|||
94338641|NCT02569398|323019898|FG002|Overall Study|Study terminated by sponsor|134|||
94338642|NCT02569398|323019896|FG000|Overall Study|Other|12|||
94338643|NCT02569398|323019897|FG001|Overall Study|Other|14|||
94338644|NCT02569398|323019898|FG002|Overall Study|Other|13|||
94338645|NCT02493868|323019899|FG000|Induction Phase: DE Participants|Adverse Event|22|||
94338646|NCT02493868|323019900|FG001|Induction Phase: DE Participants|Adverse Event|0|||
94338647|NCT02493868|323019899|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
94338648|NCT02493868|323019900|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
94338649|NCT02493868|323019899|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
94338650|NCT02493868|323019900|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
94338651|NCT02493868|323019899|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
94338652|NCT02493868|323019900|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
94338653|NCT02493868|323019899|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
94338654|NCT02493868|323019900|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
94338655|NCT02493868|323019899|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
94338656|NCT02493868|323019900|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
94338657|NCT02493868|323019899|FG000|Induction Phase: DE Participants|Other|8|||
94338658|NCT02493868|323019900|FG001|Induction Phase: DE Participants|Other|0|||
94338659|NCT02493868|323019899|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
94338660|NCT02493868|323019900|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
94338661|NCT02493868|323019899|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
94338662|NCT02493868|323019900|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
94338663|NCT02493868|323019899|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
94338664|NCT02493868|323019900|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
94338665|NCT02493868|323019899|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
94338666|NCT02493868|323019900|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
94338667|NCT02493868|323019899|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
94338668|NCT02493868|323019900|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
94338669|NCT02493868|323019899|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
94338670|NCT02493868|323019900|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
94338671|NCT02493868|323019899|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
94338672|NCT02493868|323019900|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
94338673|NCT02493868|323019899|FG000|Optimization Phase: DE+TE Participants|Other|10|||
94338674|NCT02493868|323019900|FG001|Optimization Phase: DE+TE Participants|Other|2|||
94338675|NCT02493868|323019899|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
94338676|NCT02493868|323019900|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
94338677|NCT02493868|323019899|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
94338678|NCT02493868|323019900|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
94338679|NCT02493868|323019899|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
94338680|NCT02493868|323019900|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
94338681|NCT02493868|323019899|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
94338682|NCT02493868|323019900|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
94338683|NCT02493868|323019899|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
94338684|NCT02493868|323019900|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
94338685|NCT02493868|323019899|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
94338686|NCT02493868|323019900|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
94338687|NCT02493868|323019899|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
94338688|NCT02493868|323019900|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
94338689|NCT02493868|323019899|FG000|Follow-up Phase|Lost to Follow-up|1|||
94338690|NCT02493868|323019900|FG001|Follow-up Phase|Lost to Follow-up|0|||
94338691|NCT02493868|323019899|FG000|Follow-up Phase|Withdrawal by Subject|3|||
94338692|NCT02493868|323019900|FG001|Follow-up Phase|Withdrawal by Subject|0|||
94338693|NCT02493868|323019899|FG000|Follow-up Phase|Investigator Decision|5|||
94338694|NCT02493868|323019900|FG001|Follow-up Phase|Investigator Decision|1|||
94338695|NCT02493868|323019899|FG000|Follow-up Phase|Other|2|||
94338696|NCT02493868|323019900|FG001|Follow-up Phase|Other|1|||
94338697|NCT03517722|323019901|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
94338698|NCT03517722|323019902|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
94338699|NCT03517722|323019901|FG000|Double Blind Period: Week 0-52|Death|0|||
94338700|NCT03517722|323019902|FG001|Double Blind Period: Week 0-52|Death|4|||
94338701|NCT03517722|323019901|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
94338702|NCT03517722|323019902|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
94338703|NCT03517722|323019901|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
94338704|NCT03517722|323019902|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
94338705|NCT03517722|323019901|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
94338706|NCT03517722|323019902|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
94338707|NCT03517722|323019901|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
94338708|NCT03517722|323019902|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
94338709|NCT03517722|323019901|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
94338710|NCT03517722|323019902|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
94338711|NCT03517722|323019901|FG000|Double Blind Period: Week 0-52|Other|4|||
94338712|NCT03517722|323019902|FG001|Double Blind Period: Week 0-52|Other|3|||
94338713|NCT03517722|323019901|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
94338714|NCT03517722|323019902|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
94338715|NCT03517722|323019901|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
94338716|NCT03517722|323019902|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
94338717|NCT03517722|323019901|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
94338718|NCT03517722|323019902|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
94338719|NCT03517722|323019901|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
94338720|NCT03517722|323019902|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
94338721|NCT03517722|323019901|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
94338722|NCT03517722|323019902|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
94338723|NCT01627782|323019905|FG000|Overall Study|Adverse Event|1|||
94338724|NCT01627782|323019906|FG001|Overall Study|Adverse Event|2|||
94338725|NCT01627782|323019907|FG002|Overall Study|Adverse Event|0|||
94338726|NCT01627782|323019908|FG003|Overall Study|Adverse Event|1|||
94338727|NCT01627782|323019905|FG000|Overall Study|Lack of Efficacy|11|||
94338728|NCT01627782|323019906|FG001|Overall Study|Lack of Efficacy|1|||
94338729|NCT01627782|323019907|FG002|Overall Study|Lack of Efficacy|15|||
94338730|NCT01627782|323019908|FG003|Overall Study|Lack of Efficacy|2|||
94338731|NCT01627782|323019905|FG000|Overall Study|Protocol Violation|1|||
94338732|NCT01627782|323019906|FG001|Overall Study|Protocol Violation|0|||
94338733|NCT01627782|323019907|FG002|Overall Study|Protocol Violation|0|||
94338734|NCT01627782|323019908|FG003|Overall Study|Protocol Violation|0|||
94338735|NCT01627782|323019905|FG000|Overall Study|Withdrawal by Subject|2|||
94338736|NCT01627782|323019906|FG001|Overall Study|Withdrawal by Subject|1|||
94338737|NCT01627782|323019907|FG002|Overall Study|Withdrawal by Subject|0|||
94338738|NCT01627782|323019908|FG003|Overall Study|Withdrawal by Subject|0|||
94338739|NCT01627782|323019905|FG000|Overall Study|Other|0|||
94338740|NCT01627782|323019906|FG001|Overall Study|Other|2|||
94338741|NCT01627782|323019907|FG002|Overall Study|Other|0|||
94338742|NCT01627782|323019908|FG003|Overall Study|Other|3|||
94338743|NCT01627782|323019905|FG000|Overall Study|Randomized But Not Treated|1|||
94338744|NCT01627782|323019906|FG001|Overall Study|Randomized But Not Treated|0|||
94338745|NCT01627782|323019907|FG002|Overall Study|Randomized But Not Treated|0|||
94338746|NCT01627782|323019908|FG003|Overall Study|Randomized But Not Treated|0|||
94338747|NCT03038672|323022384|FG000|Initial Treatment|Unacceptable chemistry|0|||
94338748|NCT03038672|323022385|FG001|Initial Treatment|Unacceptable chemistry|1|||
94338749|NCT03038672|323022384|FG000|Initial Treatment|Progression prior to treatment|1|||
94338750|NCT03038672|323022385|FG001|Initial Treatment|Progression prior to treatment|0|||
94338751|NCT03038672|323022384|FG000|Initial Treatment|No treatment per protocol|1|||
94338752|NCT03038672|323022385|FG001|Initial Treatment|No treatment per protocol|0|||
94338753|NCT01131078|323022390|FG000|Overall Study|Adverse Event|22|||
94338754|NCT01131078|323022391|FG001|Overall Study|Adverse Event|12|||
94338755|NCT01131078|323022392|FG002|Overall Study|Adverse Event|17|||
94338756|NCT01131078|323022390|FG000|Overall Study|Progressive Disease|58|||
94338757|NCT01131078|323022391|FG001|Overall Study|Progressive Disease|77|||
94338758|NCT01131078|323022392|FG002|Overall Study|Progressive Disease|71|||
94338759|NCT01131078|323022390|FG000|Overall Study|Protocol Violation|1|||
94338760|NCT01131078|323022391|FG001|Overall Study|Protocol Violation|0|||
94338761|NCT01131078|323022392|FG002|Overall Study|Protocol Violation|0|||
94338762|NCT01131078|323022390|FG000|Overall Study|Lost to Follow-up|1|||
94439923|NCT01130532|323397868|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
94439924|NCT01130532|323397869|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
94439925|NCT01130532|323397870|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
94439926|NCT01130532|323397871|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
94439927|NCT01130532|323397868|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
94439928|NCT01130532|323397869|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
94439929|NCT01130532|323397870|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
94439930|NCT01130532|323397871|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
94439931|NCT01130532|323397868|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
94439932|NCT01130532|323397869|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
94439933|NCT01130532|323397870|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
94439934|NCT01130532|323397871|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
94439935|NCT01130532|323397868|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
94439936|NCT01130532|323397869|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
94439937|NCT01130532|323397870|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
94439938|NCT01130532|323397871|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
94439939|NCT01130532|323397868|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
94439940|NCT01130532|323397869|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
94439941|NCT01130532|323397870|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
94439942|NCT01130532|323397871|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
94439943|NCT02847260|323397872|FG000|Overall Study|Adverse Event|3|||
94439944|NCT02847260|323397872|FG000|Overall Study|Withdrawal by Subject|2|||
94439945|NCT02847260|323397872|FG000|Overall Study|Clinical Deterioration|1|||
94439946|NCT02847260|323397872|FG000|Overall Study|Physician Decision|1|||
94439947|NCT00886015|323397881|FG000|Overall Study|Death|0|||
94439948|NCT00886015|323397882|FG001|Overall Study|Death|2|||
94439949|NCT04909853|323397883|FG000|Part 1|Assigned but not treated|0|||
94439950|NCT04909853|323397884|FG001|Part 1|Assigned but not treated|0|||
94439951|NCT04909853|323397885|FG002|Part 1|Assigned but not treated|1|||
94439952|NCT04909853|323397886|FG003|Part 1|Assigned but not treated|0|||
94439953|NCT04909853|323397883|FG000|Part 2|Adverse Event|0|||
94439954|NCT04909853|323397884|FG001|Part 2|Adverse Event|0|||
94439955|NCT04909853|323397885|FG002|Part 2|Adverse Event|0|||
94439956|NCT04909853|323397886|FG003|Part 2|Adverse Event|1|||
94439957|NCT03642262|323397887|FG000|Period 1|Withdrawal by Subject|1|||
94439958|NCT03642262|323397888|FG001|Period 1|Withdrawal by Subject|1|||
94439959|NCT03642262|323397887|FG000|Period 1|Adverse Event|0|||
94439960|NCT03642262|323397888|FG001|Period 1|Adverse Event|1|||
94338763|NCT01131078|323022391|FG001|Overall Study|Lost to Follow-up|1|||
94338764|NCT01131078|323022392|FG002|Overall Study|Lost to Follow-up|1|||
94338765|NCT01131078|323022390|FG000|Overall Study|Withdrawal by Subject|2|||
94338766|NCT01131078|323022391|FG001|Overall Study|Withdrawal by Subject|4|||
94338767|NCT01131078|323022392|FG002|Overall Study|Withdrawal by Subject|3|||
94338768|NCT01131078|323022390|FG000|Overall Study|Non-compliance|3|||
94338769|NCT01131078|323022391|FG001|Overall Study|Non-compliance|0|||
94338770|NCT01131078|323022392|FG002|Overall Study|Non-compliance|0|||
94338771|NCT01131078|323022390|FG000|Overall Study|Physician Decision|10|||
94338772|NCT01131078|323022391|FG001|Overall Study|Physician Decision|6|||
94338773|NCT01131078|323022392|FG002|Overall Study|Physician Decision|8|||
94338774|NCT01131078|323022390|FG000|Overall Study|Death|4|||
94338775|NCT01131078|323022391|FG001|Overall Study|Death|0|||
94338776|NCT01131078|323022392|FG002|Overall Study|Death|2|||
94338777|NCT01131078|323022390|FG000|Overall Study|Other|0|||
94338778|NCT01131078|323022391|FG001|Overall Study|Other|1|||
94338779|NCT01131078|323022392|FG002|Overall Study|Other|0|||
94338780|NCT00959894|323022393|FG000|Overall Study|Lost to Follow-up|10|||
94338781|NCT00959894|323022393|FG000|Overall Study|Adverse Event|3|||
94338782|NCT00959894|323022393|FG000|Overall Study|Withdrawal by Subject|1|||
94338783|NCT00959894|323022393|FG000|Overall Study|Need for contraindicated medication|1|||
94338784|NCT00959894|323022393|FG000|Overall Study|Subject moved out of town|1|||
94338785|NCT03597503|323022394|FG000|Overall Study|Withdrawal by Subject|0|||
94338786|NCT03597503|323022395|FG001|Overall Study|Withdrawal by Subject|2|||
94338787|NCT03597503|323022394|FG000|Overall Study|Lost to Follow-up|1|||
94338788|NCT03597503|323022395|FG001|Overall Study|Lost to Follow-up|2|||
94338789|NCT03597503|323022394|FG000|Overall Study|Protocol Violation|1|||
94338790|NCT03597503|323022395|FG001|Overall Study|Protocol Violation|0|||
94338791|NCT00937326|323022397|FG000|Overall Study|Adverse Event|0|||
94338792|NCT00937326|323022398|FG001|Overall Study|Adverse Event|3|||
94338793|NCT00937326|323022399|FG002|Overall Study|Adverse Event|1|||
94338794|NCT00937326|323022400|FG003|Overall Study|Adverse Event|1|||
94338795|NCT00937326|323022401|FG004|Overall Study|Adverse Event|2|||
94338796|NCT00937326|323022397|FG000|Overall Study|Death|0|||
94338797|NCT00937326|323022398|FG001|Overall Study|Death|0|||
94338798|NCT00937326|323022399|FG002|Overall Study|Death|1|||
94338799|NCT00937326|323022400|FG003|Overall Study|Death|0|||
94338800|NCT00937326|323022401|FG004|Overall Study|Death|0|||
94338801|NCT00937326|323022397|FG000|Overall Study|Withdrawal by Subject|3|||
94338802|NCT00937326|323022398|FG001|Overall Study|Withdrawal by Subject|4|||
94439961|NCT04982575|323397889|FG000|Overall Study|Withdrawal by Subject|2|||
94439962|NCT04982575|323397890|FG001|Overall Study|Withdrawal by Subject|0|||
94439963|NCT04982575|323397891|FG002|Overall Study|Withdrawal by Subject|2|||
94439964|NCT03718832|323397892|FG000|Analysis Sample|Withdrawal by Subject|18|||
94439965|NCT03718832|323397893|FG001|Analysis Sample|Withdrawal by Subject|15|||
94439966|NCT03718832|323397892|FG000|Analysis Sample|Legal hold on data|1|||
94439967|NCT03718832|323397893|FG001|Analysis Sample|Legal hold on data|0|||
94439968|NCT03718832|323397892|FG000|Analysis Sample|Participant from treated household|0|||
94439969|NCT03718832|323397893|FG001|Analysis Sample|Participant from treated household|1|||
94439970|NCT03718832|323397892|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
94439971|NCT03718832|323397893|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
94439972|NCT03375320|323397894|FG000|Overall Study|Adverse Event|34|||
94439973|NCT03375320|323397895|FG001|Overall Study|Adverse Event|9|||
94439974|NCT03375320|323397896|FG002|Overall Study|Adverse Event|10|||
94439975|NCT03375320|323397897|FG003|Overall Study|Adverse Event|0|||
94439976|NCT03375320|323397894|FG000|Overall Study|Death|6|||
94439977|NCT03375320|323397895|FG001|Overall Study|Death|3|||
94439978|NCT03375320|323397896|FG002|Overall Study|Death|0|||
94439979|NCT03375320|323397897|FG003|Overall Study|Death|0|||
94439980|NCT03375320|323397894|FG000|Overall Study|Withdrawal by Subject|7|||
94439981|NCT03375320|323397895|FG001|Overall Study|Withdrawal by Subject|4|||
94439982|NCT03375320|323397896|FG002|Overall Study|Withdrawal by Subject|5|||
94439983|NCT03375320|323397897|FG003|Overall Study|Withdrawal by Subject|4|||
94439984|NCT03375320|323397894|FG000|Overall Study|Progressive disease|55|||
94439985|NCT03375320|323397895|FG001|Overall Study|Progressive disease|41|||
94439986|NCT03375320|323397896|FG002|Overall Study|Progressive disease|29|||
94439987|NCT03375320|323397897|FG003|Overall Study|Progressive disease|24|||
94439988|NCT03375320|323397894|FG000|Overall Study|Alternative treatment|6|||
94439989|NCT03375320|323397895|FG001|Overall Study|Alternative treatment|1|||
94439990|NCT03375320|323397896|FG002|Overall Study|Alternative treatment|1|||
94439991|NCT03375320|323397897|FG003|Overall Study|Alternative treatment|0|||
94439992|NCT03375320|323397894|FG000|Overall Study|Other disease|1|||
94439993|NCT03375320|323397895|FG001|Overall Study|Other disease|1|||
94439994|NCT03375320|323397896|FG002|Overall Study|Other disease|3|||
94439995|NCT03375320|323397897|FG003|Overall Study|Other disease|0|||
94439996|NCT03375320|323397894|FG000|Overall Study|Withdrawal prior to initiation|2|||
94439997|NCT03375320|323397895|FG001|Overall Study|Withdrawal prior to initiation|2|||
94439998|NCT03375320|323397896|FG002|Overall Study|Withdrawal prior to initiation|1|||
94439999|NCT03375320|323397897|FG003|Overall Study|Withdrawal prior to initiation|0|||
94440000|NCT03375320|323397894|FG000|Overall Study|Physician Decision|1|||
94440001|NCT03375320|323397895|FG001|Overall Study|Physician Decision|1|||
94440002|NCT03375320|323397896|FG002|Overall Study|Physician Decision|1|||
94440003|NCT03375320|323397897|FG003|Overall Study|Physician Decision|1|||
94440004|NCT03375320|323397894|FG000|Overall Study|Non-compliance|1|||
94440005|NCT03375320|323397895|FG001|Overall Study|Non-compliance|0|||
94440006|NCT03375320|323397896|FG002|Overall Study|Non-compliance|0|||
94440007|NCT03375320|323397897|FG003|Overall Study|Non-compliance|0|||
94440008|NCT00970593|323397898|FG000|Overall Study|Adverse Event|1|||
94440009|NCT00970593|323397899|FG001|Overall Study|Adverse Event|1|||
94440010|NCT00970593|323397900|FG002|Overall Study|Adverse Event|0|||
94440011|NCT00970593|323397901|FG003|Overall Study|Adverse Event|0|||
94440012|NCT00970593|323397902|FG004|Overall Study|Adverse Event|0|||
94440013|NCT00970593|323397903|FG005|Overall Study|Adverse Event|0|||
94440014|NCT00970593|323397904|FG006|Overall Study|Adverse Event|0|||
94440015|NCT00970593|323397898|FG000|Overall Study|Discontinuation of study by sponsor|0|||
94440016|NCT00970593|323397899|FG001|Overall Study|Discontinuation of study by sponsor|0|||
94440017|NCT00970593|323397900|FG002|Overall Study|Discontinuation of study by sponsor|5|||
94440018|NCT00970593|323397901|FG003|Overall Study|Discontinuation of study by sponsor|0|||
94440019|NCT00970593|323397902|FG004|Overall Study|Discontinuation of study by sponsor|0|||
94440020|NCT00970593|323397903|FG005|Overall Study|Discontinuation of study by sponsor|0|||
94440021|NCT00970593|323397904|FG006|Overall Study|Discontinuation of study by sponsor|2|||
94440022|NCT00970593|323397898|FG000|Overall Study|Withdrawal by Subject|0|||
94440023|NCT00970593|323397899|FG001|Overall Study|Withdrawal by Subject|0|||
94440024|NCT00970593|323397900|FG002|Overall Study|Withdrawal by Subject|1|||
94440025|NCT00970593|323397901|FG003|Overall Study|Withdrawal by Subject|0|||
94440026|NCT00970593|323397902|FG004|Overall Study|Withdrawal by Subject|0|||
94440027|NCT00970593|323397903|FG005|Overall Study|Withdrawal by Subject|0|||
94440028|NCT00970593|323397904|FG006|Overall Study|Withdrawal by Subject|0|||
94440029|NCT02094300|323397913|FG000|Overall Study|Death|7|||
94440030|NCT02094300|323397913|FG000|Overall Study|Lost to Follow-up|10|||
94440031|NCT02094300|323397913|FG000|Overall Study|Still be eligible for follow-up|3|||
94440032|NCT01276041|323397914|FG000|Overall Study|Adverse Event|2|||
94440033|NCT01276041|323397914|FG000|Overall Study|Protocol Violation|1|||
94440034|NCT00485264|323397916|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
94440035|NCT00485264|323397917|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
94440036|NCT00485264|323397918|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
94440037|NCT00485264|323397919|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
94440038|NCT00485264|323397920|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
94440039|NCT00485264|323397921|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
94440040|NCT00485264|323397916|FG000|Overall Study|Death|1|||
94440041|NCT00485264|323397917|FG001|Overall Study|Death|0|||
94440042|NCT00485264|323397918|FG002|Overall Study|Death|0|||
94440043|NCT00485264|323397919|FG003|Overall Study|Death|0|||
94440044|NCT00485264|323397920|FG004|Overall Study|Death|1|||
94440045|NCT00485264|323397921|FG005|Overall Study|Death|0|||
94440046|NCT00485264|323397916|FG000|Overall Study|Adverse Event|1|||
94440047|NCT00485264|323397917|FG001|Overall Study|Adverse Event|0|||
94440048|NCT00485264|323397918|FG002|Overall Study|Adverse Event|2|||
94440049|NCT00485264|323397919|FG003|Overall Study|Adverse Event|3|||
94440050|NCT00485264|323397920|FG004|Overall Study|Adverse Event|1|||
94440051|NCT00485264|323397921|FG005|Overall Study|Adverse Event|3|||
94440052|NCT00485264|323397916|FG000|Overall Study|Pregnancy|4|||
94440053|NCT00485264|323397917|FG001|Overall Study|Pregnancy|0|||
94440054|NCT00485264|323397918|FG002|Overall Study|Pregnancy|0|||
94440055|NCT00485264|323397919|FG003|Overall Study|Pregnancy|0|||
94440056|NCT00485264|323397920|FG004|Overall Study|Pregnancy|0|||
94440057|NCT00485264|323397921|FG005|Overall Study|Pregnancy|0|||
94440058|NCT00485264|323397916|FG000|Overall Study|Disallowed Medication|0|||
94440059|NCT00485264|323397917|FG001|Overall Study|Disallowed Medication|0|||
94440060|NCT00485264|323397918|FG002|Overall Study|Disallowed Medication|0|||
94440061|NCT00485264|323397919|FG003|Overall Study|Disallowed Medication|0|||
94440062|NCT00485264|323397920|FG004|Overall Study|Disallowed Medication|0|||
94440063|NCT00485264|323397921|FG005|Overall Study|Disallowed Medication|1|||
94440064|NCT00485264|323397916|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
94440065|NCT00485264|323397917|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
94440066|NCT00485264|323397918|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
94440067|NCT00485264|323397919|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
94440068|NCT00485264|323397920|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
94440069|NCT00485264|323397921|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
94338803|NCT00937326|323022399|FG002|Overall Study|Withdrawal by Subject|1|||
94338804|NCT00937326|323022400|FG003|Overall Study|Withdrawal by Subject|4|||
94338805|NCT00937326|323022401|FG004|Overall Study|Withdrawal by Subject|3|||
94338806|NCT00937326|323022397|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
94338807|NCT00937326|323022398|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
94338808|NCT00937326|323022399|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
94338809|NCT00937326|323022400|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
94338810|NCT00937326|323022401|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
94338811|NCT01431521|323022406|FG000|Overall Study|Withdrawal by Subject|0|||
94338812|NCT01431521|323022407|FG001|Overall Study|Withdrawal by Subject|0|||
94338813|NCT01431521|323022408|FG002|Overall Study|Withdrawal by Subject|1|||
94338814|NCT01431521|323022409|FG003|Overall Study|Withdrawal by Subject|0|||
94338815|NCT02443155|323022412|FG000|Overall Study|Adverse Event|3|||
94338816|NCT02443155|323022413|FG001|Overall Study|Adverse Event|4|||
94338817|NCT02443155|323022414|FG002|Overall Study|Adverse Event|1|||
94338818|NCT02443155|323022415|FG003|Overall Study|Adverse Event|2|||
94338819|NCT02443155|323022412|FG000|Overall Study|Unclassified|0|||
94338820|NCT02443155|323022413|FG001|Overall Study|Unclassified|0|||
94338821|NCT02443155|323022414|FG002|Overall Study|Unclassified|2|||
94338822|NCT02443155|323022415|FG003|Overall Study|Unclassified|1|||
94338823|NCT02443155|323022412|FG000|Overall Study|Withdrawal by Subject|4|||
94338824|NCT02443155|323022413|FG001|Overall Study|Withdrawal by Subject|7|||
94440070|NCT00485264|323397916|FG000|Overall Study|Lack of Efficacy|0|||
94440071|NCT00485264|323397917|FG001|Overall Study|Lack of Efficacy|1|||
94440072|NCT00485264|323397918|FG002|Overall Study|Lack of Efficacy|0|||
94440073|NCT00485264|323397919|FG003|Overall Study|Lack of Efficacy|0|||
94440074|NCT00485264|323397920|FG004|Overall Study|Lack of Efficacy|0|||
94440075|NCT00485264|323397921|FG005|Overall Study|Lack of Efficacy|0|||
94440076|NCT00485264|323397916|FG000|Overall Study|Guardian Consent Withdrawn|1|||
94440077|NCT00485264|323397917|FG001|Overall Study|Guardian Consent Withdrawn|0|||
94440078|NCT00485264|323397918|FG002|Overall Study|Guardian Consent Withdrawn|0|||
94440079|NCT00485264|323397919|FG003|Overall Study|Guardian Consent Withdrawn|0|||
94440080|NCT00485264|323397920|FG004|Overall Study|Guardian Consent Withdrawn|1|||
94338825|NCT02443155|323022414|FG002|Overall Study|Withdrawal by Subject|3|||
94338826|NCT02443155|323022415|FG003|Overall Study|Withdrawal by Subject|9|||
94338827|NCT02443155|323022412|FG000|Overall Study|Pregnancy|3|||
94338828|NCT02443155|323022413|FG001|Overall Study|Pregnancy|1|||
94440081|NCT00485264|323397921|FG005|Overall Study|Guardian Consent Withdrawn|0|||
94440082|NCT00485264|323397916|FG000|Overall Study|Physician Decision|0|||
94440083|NCT00485264|323397917|FG001|Overall Study|Physician Decision|2|||
94440084|NCT00485264|323397918|FG002|Overall Study|Physician Decision|0|||
94440085|NCT00485264|323397919|FG003|Overall Study|Physician Decision|0|||
94440086|NCT00485264|323397920|FG004|Overall Study|Physician Decision|0|||
94440087|NCT00485264|323397921|FG005|Overall Study|Physician Decision|0|||
94440088|NCT00485264|323397916|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
94440089|NCT00485264|323397917|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
94338829|NCT02443155|323022414|FG002|Overall Study|Pregnancy|1|||
94338830|NCT02443155|323022415|FG003|Overall Study|Pregnancy|2|||
94338831|NCT02443155|323022412|FG000|Overall Study|Lost to Follow-up|1|||
94338832|NCT02443155|323022413|FG001|Overall Study|Lost to Follow-up|2|||
94338833|NCT02443155|323022414|FG002|Overall Study|Lost to Follow-up|0|||
94338834|NCT02443155|323022415|FG003|Overall Study|Lost to Follow-up|1|||
94338835|NCT02443155|323022412|FG000|Overall Study|Protocol Violation|1|||
94338836|NCT02443155|323022413|FG001|Overall Study|Protocol Violation|0|||
94338837|NCT02443155|323022414|FG002|Overall Study|Protocol Violation|1|||
94338838|NCT02443155|323022415|FG003|Overall Study|Protocol Violation|1|||
94338839|NCT02443155|323022412|FG000|Overall Study|Death|0|||
94338840|NCT02443155|323022413|FG001|Overall Study|Death|0|||
94338841|NCT02443155|323022414|FG002|Overall Study|Death|1|||
94338842|NCT02443155|323022415|FG003|Overall Study|Death|0|||
94338843|NCT02000219|323022417|FG000|14-Week Study Period|Physician Decision|1|||
94338844|NCT02000219|323022417|FG000|14-Week Study Period|Adverse Event|1|||
94338845|NCT02000219|323022417|FG000|14-Week Study Period|Underwent transplantation|1|||
94338846|NCT02000219|323022417|FG000|Continuation Period|Withdrawal by Subject|1|||
94338847|NCT02000219|323022417|FG000|Continuation Period|Had liver transplant|2|||
94338848|NCT02000219|323022417|FG000|Continuation Period|Non-compliance with study drug|2|||
94338849|NCT00948194|323022418|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
94338850|NCT00948194|323022419|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
94338851|NCT00634751|323022422|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
94338852|NCT00634751|323022423|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
94338853|NCT00634751|323022424|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
94338854|NCT00634751|323022425|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
94338855|NCT00634751|323022422|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
94338856|NCT00634751|323022423|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
94338857|NCT00634751|323022424|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
94338858|NCT00634751|323022425|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
94338859|NCT00634751|323022422|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
94338860|NCT00634751|323022423|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
94338861|NCT00634751|323022424|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
94338862|NCT00634751|323022425|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
94338863|NCT00405275|323022428|FG000|Overall Study|Death|1|||
94338864|NCT00405275|323022429|FG001|Overall Study|Death|0|||
94338865|NCT00405275|323022428|FG000|Overall Study|Lost to Follow-up|5|||
94338866|NCT00405275|323022429|FG001|Overall Study|Lost to Follow-up|1|||
94338867|NCT00405275|323022428|FG000|Overall Study|Withdrawal by Subject|7|||
94338868|NCT00405275|323022429|FG001|Overall Study|Withdrawal by Subject|9|||
94338869|NCT00405275|323022428|FG000|Overall Study|Unwilling to continue|10|||
94338870|NCT00405275|323022429|FG001|Overall Study|Unwilling to continue|9|||
94338871|NCT00731666|323022430|FG000|Overall Study|Adverse Event|2|||
94338872|NCT00731666|323022430|FG000|Overall Study|Lost to Follow-up|8|||
94338873|NCT00731666|323022430|FG000|Overall Study|Withdrawal by Subject|2|||
94338874|NCT01308853|323022434|FG000|Overall Study|Adverse Event|1|||
94338875|NCT01308853|323022434|FG000|Overall Study|Lost to Follow-up|2|||
94338876|NCT01308853|323022434|FG000|Overall Study|Insertion of permanent implants|1|||
94338877|NCT03654560|323022446|FG000|Overall Study|Death|3|||
94338878|NCT03654560|323022447|FG001|Overall Study|Death|1|||
94338879|NCT03654560|323022446|FG000|Overall Study|Lost to Follow-up|1|||
94338880|NCT03654560|323022447|FG001|Overall Study|Lost to Follow-up|0|||
94338881|NCT02853123|323022452|FG000|Treatment Period 1|Adverse Event|0|||
94338882|NCT02853123|323022453|FG001|Treatment Period 1|Adverse Event|3|||
94338883|NCT02853123|323022452|FG000|Washout Period|Worsening of COPD|0|||
94338884|NCT02853123|323022453|FG001|Washout Period|Worsening of COPD|3|||
94338885|NCT02853123|323022452|FG000|Washout Period|Adverse Event|1|||
94338886|NCT02853123|323022453|FG001|Washout Period|Adverse Event|0|||
94338887|NCT02809118|323022456|FG000|Overall Study|Withdrawal by Subject|0|||
94338888|NCT02809118|323022457|FG001|Overall Study|Withdrawal by Subject|1|||
94338889|NCT02809118|323022458|FG002|Overall Study|Withdrawal by Subject|1|||
94338890|NCT01235338|323022463|FG000|Overall Study|Adverse Event|3|||
94338891|NCT01235338|323022464|FG001|Overall Study|Adverse Event|2|||
94338892|NCT01235338|323022463|FG000|Overall Study|Protocol Violation|1|||
94338893|NCT01235338|323022464|FG001|Overall Study|Protocol Violation|1|||
94338894|NCT01235338|323022463|FG000|Overall Study|Withdrawal by Subject|5|||
94338895|NCT01235338|323022464|FG001|Overall Study|Withdrawal by Subject|0|||
94338896|NCT01235338|323022463|FG000|Overall Study|Exclusion criteria violations|1|||
94338897|NCT01235338|323022464|FG001|Overall Study|Exclusion criteria violations|1|||
94338898|NCT01235338|323022463|FG000|Overall Study|Positive drug screen|0|||
94338899|NCT01235338|323022464|FG001|Overall Study|Positive drug screen|1|||
94338900|NCT01235338|323022463|FG000|Overall Study|Prohibited meds|1|||
94338901|NCT01235338|323022464|FG001|Overall Study|Prohibited meds|0|||
94338902|NCT01462045|323022465|FG000|Overall Study|Family matter|0|||
94338903|NCT01462045|323022466|FG001|Overall Study|Family matter|1|||
94338904|NCT01462045|323022467|FG002|Overall Study|Family matter|0|||
94338905|NCT02152982|323022469|FG000|Overall Study|Ineligible|4|||
94338906|NCT02152982|323022470|FG001|Overall Study|Ineligible|4|||
94338907|NCT02152982|323022469|FG000|Overall Study|Did not start treatment|12|||
94338908|NCT02152982|323022470|FG001|Overall Study|Did not start treatment|6|||
94338909|NCT01784211|323022472|FG000|Part A (Days 1-15)|Adverse Event|1|||
94338910|NCT01784211|323022473|FG001|Part A (Days 1-15)|Adverse Event|1|||
94338911|NCT01784211|323022474|FG002|Part A (Days 1-15)|Adverse Event|0|||
94338912|NCT01784211|323022475|FG003|Part A (Days 1-15)|Adverse Event|0|||
94338913|NCT01784211|323022476|FG004|Part A (Days 1-15)|Adverse Event|0|||
94338914|NCT01784211|323022477|FG005|Part A (Days 1-15)|Adverse Event|0|||
94338915|NCT01784211|323022472|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
94338916|NCT01784211|323022473|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
94338917|NCT01784211|323022474|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
94338918|NCT01784211|323022475|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
94338919|NCT01784211|323022476|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
94338920|NCT01784211|323022477|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
94338921|NCT00364832|323022478|FG000|Core Period|Early Withdrawals|2|||
94338922|NCT00364832|323022479|FG001|Core Period|Early Withdrawals|2|||
94338923|NCT00364832|323022480|FG002|Core Period|Early Withdrawals|1|||
94338924|NCT00364832|323022481|FG003|Core Period|Early Withdrawals|1|||
94338925|NCT00364832|323022482|FG004|Core Period|Early Withdrawals|0|||
94338926|NCT00364832|323022483|FG005|Core Period|Early Withdrawals|0|||
94338927|NCT00364832|323022484|FG006|Core Period|Early Withdrawals|4|||
94338928|NCT00364832|323022485|FG007|Core Period|Early Withdrawals|1|||
94338929|NCT00364832|323022486|FG008|Core Period|Early Withdrawals|0|||
94338930|NCT00364832|323022487|FG009|Core Period|Early Withdrawals|0|||
94338931|NCT00364832|323022488|FG010|Core Period|Early Withdrawals|0|||
94338932|NCT00364832|323022489|FG011|Core Period|Early Withdrawals|0|||
94338933|NCT00364832|323022478|FG000|Extension Year 1|Early Withdrawals|0|||
94338934|NCT00364832|323022479|FG001|Extension Year 1|Early Withdrawals|0|||
94338935|NCT00364832|323022480|FG002|Extension Year 1|Early Withdrawals|0|||
94338936|NCT00364832|323022481|FG003|Extension Year 1|Early Withdrawals|0|||
94338937|NCT00364832|323022482|FG004|Extension Year 1|Early Withdrawals|0|||
94338938|NCT00364832|323022483|FG005|Extension Year 1|Early Withdrawals|0|||
94338939|NCT00364832|323022484|FG006|Extension Year 1|Early Withdrawals|0|||
94338940|NCT00364832|323022485|FG007|Extension Year 1|Early Withdrawals|0|||
94338941|NCT00364832|323022486|FG008|Extension Year 1|Early Withdrawals|0|||
94338942|NCT00364832|323022487|FG009|Extension Year 1|Early Withdrawals|4|||
94338943|NCT00364832|323022488|FG010|Extension Year 1|Early Withdrawals|2|||
94338944|NCT00364832|323022489|FG011|Extension Year 1|Early Withdrawals|10|||
94338945|NCT00364832|323022478|FG000|Extension Year 2|Early Withdrawals|0|||
94338946|NCT00364832|323022479|FG001|Extension Year 2|Early Withdrawals|0|||
94338947|NCT00364832|323022480|FG002|Extension Year 2|Early Withdrawals|0|||
94338948|NCT00364832|323022481|FG003|Extension Year 2|Early Withdrawals|0|||
94338949|NCT00364832|323022482|FG004|Extension Year 2|Early Withdrawals|0|||
94338950|NCT00364832|323022483|FG005|Extension Year 2|Early Withdrawals|0|||
94338951|NCT00364832|323022484|FG006|Extension Year 2|Early Withdrawals|0|||
94338952|NCT00364832|323022485|FG007|Extension Year 2|Early Withdrawals|0|||
94338953|NCT00364832|323022486|FG008|Extension Year 2|Early Withdrawals|0|||
94338954|NCT00364832|323022487|FG009|Extension Year 2|Early Withdrawals|5|||
94338955|NCT00364832|323022488|FG010|Extension Year 2|Early Withdrawals|5|||
94338956|NCT00364832|323022489|FG011|Extension Year 2|Early Withdrawals|3|||
94338957|NCT02044822|323022490|FG000|Overall Study|Study Terminated by Sponsor|77|||
94338958|NCT02044822|323022490|FG000|Overall Study|Investigator's Discretion|10|||
94338959|NCT02044822|323022490|FG000|Overall Study|Withdrew Consent|3|||
94338960|NCT02044822|323022490|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
94338961|NCT02044822|323022490|FG000|Overall Study|Lost to Follow-up|1|||
94338962|NCT01237223|323022493|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
94338963|NCT01237223|323022494|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
94338964|NCT01237223|323022495|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
94338965|NCT01237223|323022496|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
94338966|NCT01237223|323022497|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
94338967|NCT01237223|323022498|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
94338968|NCT01237223|323022493|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
94338969|NCT01237223|323022494|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
94338970|NCT01237223|323022495|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
94338971|NCT01237223|323022496|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
94338972|NCT01237223|323022497|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
94338973|NCT01237223|323022498|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
94338974|NCT01237223|323022493|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
94338975|NCT01237223|323022494|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
94338976|NCT01237223|323022495|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
94338977|NCT01237223|323022496|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
94440090|NCT00485264|323397918|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
94440091|NCT00485264|323397919|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
94440092|NCT00485264|323397920|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
94440093|NCT00485264|323397921|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
94440094|NCT00485264|323397916|FG000|Overall Study|Not Able to Attend Clinic|5|||
94440095|NCT00485264|323397917|FG001|Overall Study|Not Able to Attend Clinic|0|||
94440096|NCT00485264|323397918|FG002|Overall Study|Not Able to Attend Clinic|0|||
94338978|NCT01237223|323022497|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
94338979|NCT01237223|323022498|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
94338980|NCT01237223|323022493|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
94338981|NCT01237223|323022494|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
94338982|NCT01237223|323022495|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
94338983|NCT01237223|323022496|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
94338984|NCT01237223|323022497|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
94338985|NCT01237223|323022498|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
94338986|NCT01237223|323022493|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
94440097|NCT00485264|323397919|FG003|Overall Study|Not Able to Attend Clinic|1|||
94440098|NCT00485264|323397920|FG004|Overall Study|Not Able to Attend Clinic|1|||
94440099|NCT00485264|323397921|FG005|Overall Study|Not Able to Attend Clinic|2|||
94440100|NCT00485264|323397916|FG000|Overall Study|Non-Compliant|17|||
94440101|NCT00485264|323397917|FG001|Overall Study|Non-Compliant|2|||
94440102|NCT00485264|323397918|FG002|Overall Study|Non-Compliant|1|||
94440103|NCT00485264|323397919|FG003|Overall Study|Non-Compliant|0|||
94440104|NCT00485264|323397920|FG004|Overall Study|Non-Compliant|1|||
94440105|NCT00485264|323397921|FG005|Overall Study|Non-Compliant|0|||
94440106|NCT00485264|323397916|FG000|Overall Study|Lost to Follow-up|2|||
94440107|NCT00485264|323397917|FG001|Overall Study|Lost to Follow-up|1|||
94440108|NCT00485264|323397918|FG002|Overall Study|Lost to Follow-up|1|||
94440109|NCT00485264|323397919|FG003|Overall Study|Lost to Follow-up|0|||
94440110|NCT00485264|323397920|FG004|Overall Study|Lost to Follow-up|0|||
94338987|NCT01237223|323022494|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
94440111|NCT00485264|323397921|FG005|Overall Study|Lost to Follow-up|1|||
94440112|NCT00485264|323397916|FG000|Overall Study|Other Reason|3|||
94440113|NCT00485264|323397917|FG001|Overall Study|Other Reason|0|||
94440114|NCT00485264|323397918|FG002|Overall Study|Other Reason|0|||
94440115|NCT00485264|323397919|FG003|Overall Study|Other Reason|0|||
94440116|NCT00485264|323397920|FG004|Overall Study|Other Reason|0|||
94440117|NCT00485264|323397921|FG005|Overall Study|Other Reason|0|||
94548728|NCT04279613|323805660|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
94548729|NCT04279613|323805661|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
94548730|NCT03446456|323805662|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
94548731|NCT03446456|323805663|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
94548732|NCT03446456|323805662|FG000|Overall Study|Lost to Follow-up|1|||
94548733|NCT03446456|323805663|FG001|Overall Study|Lost to Follow-up|3|||
94548734|NCT03446456|323805662|FG000|Overall Study|Participant failed the toxicology test|1|||
94548735|NCT03446456|323805663|FG001|Overall Study|Participant failed the toxicology test|0|||
94548736|NCT03446456|323805662|FG000|Overall Study|Break down of the experimental equipment|1|||
94548737|NCT03446456|323805663|FG001|Overall Study|Break down of the experimental equipment|0|||
94548738|NCT01657760|323805666|FG000|Overall Study|Withdrawal by Subject|0|||
94548739|NCT01657760|323805667|FG001|Overall Study|Withdrawal by Subject|0|||
94548740|NCT01657760|323805668|FG002|Overall Study|Withdrawal by Subject|0|||
94548741|NCT01657760|323805669|FG003|Overall Study|Withdrawal by Subject|1|||
94548742|NCT01657760|323805666|FG000|Overall Study|Physician Decision|1|||
94548743|NCT01657760|323805667|FG001|Overall Study|Physician Decision|1|||
94548744|NCT01657760|323805668|FG002|Overall Study|Physician Decision|1|||
94338988|NCT01237223|323022495|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
94440118|NCT00124748|323397922|FG000|Overall Study|Adverse Event|8|||
94548745|NCT01657760|323805669|FG003|Overall Study|Physician Decision|2|||
94548746|NCT00308074|323805670|FG000|Overall Study|Withdrawal by Subject|1|||
94548747|NCT01113580|323805671|FG000|Overall Study|Protocol Violation|1|||
94548748|NCT01113580|323805672|FG001|Overall Study|Protocol Violation|0|||
94548749|NCT04181827|323805675|FG000|Overall Study|Ongoing|124|||
94548750|NCT04181827|323805676|FG001|Overall Study|Ongoing|157|||
94548751|NCT04181827|323805675|FG000|Overall Study|Death|82|||
94548752|NCT04181827|323805676|FG001|Overall Study|Death|50|||
94548753|NCT04181827|323805675|FG000|Overall Study|Lost to Follow-up|0|||
94548754|NCT04181827|323805676|FG001|Overall Study|Lost to Follow-up|1|||
94440119|NCT00124748|323397923|FG001|Overall Study|Adverse Event|39|||
94440120|NCT00124748|323397922|FG000|Overall Study|Abnormal laboratory Value|2|||
94440121|NCT00124748|323397923|FG001|Overall Study|Abnormal laboratory Value|2|||
94440122|NCT00124748|323397922|FG000|Overall Study|Abnormal Procedure|0|||
94440123|NCT00124748|323397923|FG001|Overall Study|Abnormal Procedure|1|||
94440124|NCT00124748|323397922|FG000|Overall Study|Lack of Efficacy|20|||
94440125|NCT00124748|323397923|FG001|Overall Study|Lack of Efficacy|41|||
94440126|NCT00124748|323397922|FG000|Overall Study|No longer requires study drug|1|||
94440127|NCT00124748|323397923|FG001|Overall Study|No longer requires study drug|1|||
94440128|NCT00124748|323397922|FG000|Overall Study|Protocol Violation|3|||
94440129|NCT00124748|323397923|FG001|Overall Study|Protocol Violation|1|||
94440130|NCT00124748|323397922|FG000|Overall Study|Withdrawal by Subject|5|||
94440131|NCT00124748|323397923|FG001|Overall Study|Withdrawal by Subject|15|||
94440132|NCT00124748|323397922|FG000|Overall Study|Lost to Follow-up|2|||
94440133|NCT00124748|323397923|FG001|Overall Study|Lost to Follow-up|7|||
94440134|NCT00124748|323397922|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
94440135|NCT00124748|323397923|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
94440136|NCT00124748|323397922|FG000|Overall Study|Death|1|||
94440137|NCT00124748|323397923|FG001|Overall Study|Death|3|||
94440138|NCT00322712|323397924|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
94440139|NCT02071225|323397925|FG000|Overall Study|Withdrawal of Consent|2|||
94440140|NCT02071225|323397925|FG000|Overall Study|Protocol Deviation|1|||
94440141|NCT02071225|323397925|FG000|Overall Study|Lost to Follow-up|2|||
94440142|NCT02071225|323397925|FG000|Overall Study|Death|25|||
94440143|NCT01514461|323397926|FG000|Overall Study|Adverse Event|2|||
94440144|NCT01514461|323397927|FG001|Overall Study|Adverse Event|1|||
94440145|NCT01514461|323397928|FG002|Overall Study|Adverse Event|3|||
94440146|NCT01514461|323397926|FG000|Overall Study|Physician Decision|1|||
94440147|NCT01514461|323397927|FG001|Overall Study|Physician Decision|1|||
94440148|NCT01514461|323397928|FG002|Overall Study|Physician Decision|0|||
94440149|NCT01514461|323397926|FG000|Overall Study|Patient/guardian decision|1|||
94440150|NCT01514461|323397927|FG001|Overall Study|Patient/guardian decision|1|||
94440151|NCT01514461|323397928|FG002|Overall Study|Patient/guardian decision|1|||
94440152|NCT01514461|323397926|FG000|Overall Study|Death|1|||
94440153|NCT01514461|323397927|FG001|Overall Study|Death|0|||
94338989|NCT01237223|323022496|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
94338990|NCT01237223|323022497|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
94338991|NCT01237223|323022498|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
94338992|NCT01237223|323022493|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
94338993|NCT01237223|323022494|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
94338994|NCT01237223|323022495|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
94440154|NCT01514461|323397928|FG002|Overall Study|Death|0|||
94440155|NCT00276484|323397932|FG000|Overall Study|Adverse Event|4|||
94440156|NCT00276484|323397933|FG001|Overall Study|Adverse Event|7|||
94440157|NCT00276484|323397932|FG000|Overall Study|Lost to Follow-up|1|||
94440158|NCT00276484|323397933|FG001|Overall Study|Lost to Follow-up|1|||
94440159|NCT00276484|323397932|FG000|Overall Study|Protocol Violation|0|||
94440160|NCT00276484|323397933|FG001|Overall Study|Protocol Violation|1|||
94338995|NCT01237223|323022496|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
94338996|NCT01237223|323022497|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
94338997|NCT01237223|323022498|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
94338998|NCT01237223|323022493|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
94338999|NCT01237223|323022494|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
94339000|NCT01237223|323022495|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
94339001|NCT01237223|323022496|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
94339002|NCT01237223|323022497|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
94339003|NCT01237223|323022498|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
94339004|NCT01237223|323022493|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
94339005|NCT01237223|323022494|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
94339006|NCT01237223|323022495|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
94339007|NCT01237223|323022496|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
94339008|NCT01237223|323022497|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
94339009|NCT01237223|323022498|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
94339010|NCT01237223|323022493|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
94339011|NCT01237223|323022494|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
94339012|NCT01237223|323022495|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
94339013|NCT01237223|323022496|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
94339014|NCT01237223|323022497|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
94339015|NCT01237223|323022498|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
94339016|NCT01237223|323022493|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
94339017|NCT01237223|323022494|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
94440161|NCT00276484|323397932|FG000|Overall Study|Withdrawal by Subject|4|||
94440162|NCT00276484|323397933|FG001|Overall Study|Withdrawal by Subject|3|||
94440163|NCT00276484|323397932|FG000|Overall Study|Could not take time off work|0|||
94440164|NCT00276484|323397933|FG001|Overall Study|Could not take time off work|1|||
94440165|NCT01431079|323397942|FG000|Overall Study|Lost to Follow-up|35|||
94440166|NCT01431079|323397943|FG001|Overall Study|Lost to Follow-up|39|||
94440167|NCT03345420|323397944|FG000|Overall Study|Withdrawal by Subject|1|||
94440168|NCT01942993|323397953|FG000|Overall Study|Lost to Follow-up|1|||
94440169|NCT01942993|323397953|FG000|Overall Study|Physician Decision|1|||
94440170|NCT01349192|323397954|FG000|Overall Study|Protocol Violation|0|||
94440171|NCT01349192|323397955|FG001|Overall Study|Protocol Violation|1|||
94339018|NCT01237223|323022495|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
94339019|NCT01237223|323022496|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
94339020|NCT01237223|323022497|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
94440172|NCT01349192|323397954|FG000|Overall Study|Withdrawal by Subject|0|||
94339021|NCT01237223|323022498|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
94339022|NCT03933215|323022501|FG000|Overall Study|Other|6|||
94339023|NCT03933215|323022501|FG000|Overall Study|Sponsor decision|5|||
94339024|NCT03933215|323022501|FG000|Overall Study|Protocol Violation|5|||
94339025|NCT03933215|323022501|FG000|Overall Study|Withdrawal by Subject|6|||
94339026|NCT03933215|323022501|FG000|Overall Study|Lost to Follow-up|6|||
94339027|NCT03933215|323022501|FG000|Overall Study|Enrolled but not treated|38|||
94339028|NCT03135262|323022503|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
94339029|NCT03135262|323022504|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
94339030|NCT03135262|323022505|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
94339031|NCT03135262|323022506|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
94339032|NCT03135262|323022507|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
94339033|NCT03135262|323022503|FG000|Overall Study|Progression of disease|0|||
94339034|NCT03135262|323022504|FG001|Overall Study|Progression of disease|0|||
94339035|NCT03135262|323022505|FG002|Overall Study|Progression of disease|0|||
94339036|NCT03135262|323022506|FG003|Overall Study|Progression of disease|1|||
94339037|NCT03135262|323022507|FG004|Overall Study|Progression of disease|0|||
94339038|NCT03135262|323022503|FG000|Overall Study|Death|6|||
94339039|NCT03135262|323022504|FG001|Overall Study|Death|2|||
94339040|NCT03135262|323022505|FG002|Overall Study|Death|2|||
94339041|NCT03135262|323022506|FG003|Overall Study|Death|2|||
94339042|NCT03135262|323022507|FG004|Overall Study|Death|0|||
94339043|NCT03135262|323022503|FG000|Overall Study|Withdrawal by Subject|0|||
94339044|NCT03135262|323022504|FG001|Overall Study|Withdrawal by Subject|0|||
94339045|NCT03135262|323022505|FG002|Overall Study|Withdrawal by Subject|1|||
94339046|NCT03135262|323022506|FG003|Overall Study|Withdrawal by Subject|0|||
94339047|NCT03135262|323022507|FG004|Overall Study|Withdrawal by Subject|1|||
94339048|NCT03135262|323022503|FG000|Overall Study|Study terminated by sponsor|2|||
94339049|NCT03135262|323022504|FG001|Overall Study|Study terminated by sponsor|4|||
94339050|NCT03135262|323022505|FG002|Overall Study|Study terminated by sponsor|4|||
94339051|NCT03135262|323022506|FG003|Overall Study|Study terminated by sponsor|3|||
94339052|NCT03135262|323022507|FG004|Overall Study|Study terminated by sponsor|0|||
94339053|NCT00047008|323022509|FG000|Overall Study|Withdrawn consent|2|||
94339054|NCT00047008|323022510|FG001|Overall Study|Withdrawn consent|3|||
94339055|NCT00047008|323022509|FG000|Overall Study|Ineligible|9|||
94339056|NCT00047008|323022510|FG001|Overall Study|Ineligible|8|||
94339057|NCT01929018|323022514|FG000|Overall Study|Lost to Follow-up|1|||
94339058|NCT01929018|323022515|FG001|Overall Study|Lost to Follow-up|0|||
94339059|NCT01929018|323022514|FG000|Overall Study|Hospitalization|0|||
94339060|NCT01929018|323022515|FG001|Overall Study|Hospitalization|1|||
94339061|NCT01366534|323022516|FG000|Overall Study|Lost to Follow-up|1|||
94339062|NCT01366534|323022517|FG001|Overall Study|Lost to Follow-up|0|||
94339063|NCT01366534|323022518|FG002|Overall Study|Lost to Follow-up|0|||
94339064|NCT01366534|323022516|FG000|Overall Study|Migrated|1|||
94339065|NCT01366534|323022517|FG001|Overall Study|Migrated|1|||
94339066|NCT01366534|323022518|FG002|Overall Study|Migrated|0|||
94339067|NCT01366534|323022516|FG000|Overall Study|Declined challenged|0|||
94339068|NCT01366534|323022517|FG001|Overall Study|Declined challenged|1|||
94339069|NCT01366534|323022518|FG002|Overall Study|Declined challenged|0|||
94339070|NCT01047436|323022520|FG000|Overall Study|Protocol Violation|1|||
94339071|NCT01047436|323022521|FG001|Overall Study|Protocol Violation|0|||
94339072|NCT01678313|323022524|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
94339073|NCT01678313|323022525|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
94339074|NCT01678313|323022524|FG000|Completed the 3-month Therapy|Physician Decision|3|||
94339075|NCT01678313|323022525|FG001|Completed the 3-month Therapy|Physician Decision|4|||
94339076|NCT01678313|323022524|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
94339077|NCT01678313|323022525|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
94339078|NCT01678313|323022524|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
94339079|NCT01678313|323022525|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
94339080|NCT02635867|323022528|FG000|Overall Study|Lost to Follow-up|4|||
94339081|NCT02635867|323022529|FG001|Overall Study|Lost to Follow-up|3|||
94339082|NCT02635867|323022530|FG002|Overall Study|Lost to Follow-up|3|||
94339083|NCT02635867|323022531|FG003|Overall Study|Lost to Follow-up|4|||
94339084|NCT02635867|323022532|FG004|Overall Study|Lost to Follow-up|1|||
94440173|NCT01349192|323397955|FG001|Overall Study|Withdrawal by Subject|2|||
94440174|NCT01349192|323397954|FG000|Overall Study|Lost to Follow-up|1|||
94440175|NCT01349192|323397955|FG001|Overall Study|Lost to Follow-up|3|||
94339085|NCT00796003|323022533|FG000|Overall Study|Disease Progression|2|||
94339086|NCT00796003|323022534|FG001|Overall Study|Disease Progression|13|||
94339087|NCT00796003|323022533|FG000|Overall Study|Adverse Event|1|||
94339088|NCT00796003|323022534|FG001|Overall Study|Adverse Event|7|||
94339089|NCT00796003|323022533|FG000|Overall Study|Specified organ function not met|0|||
94339090|NCT00796003|323022534|FG001|Overall Study|Specified organ function not met|1|||
94339091|NCT00796003|323022533|FG000|Overall Study|Physician Decision|0|||
94339092|NCT00796003|323022534|FG001|Overall Study|Physician Decision|4|||
94339093|NCT00796003|323022533|FG000|Overall Study|Withdrawal by Subject|0|||
94339094|NCT00796003|323022534|FG001|Overall Study|Withdrawal by Subject|1|||
94339095|NCT00796003|323022533|FG000|Overall Study|Other|0|||
94339096|NCT00796003|323022534|FG001|Overall Study|Other|1|||
94339097|NCT00796003|323022533|FG000|Overall Study|Participants Not treated|0|||
94339098|NCT00796003|323022534|FG001|Overall Study|Participants Not treated|2|||
94339099|NCT03981744|323022535|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
94339100|NCT03981744|323022536|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
94339101|NCT03981744|323022537|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
94339102|NCT03981744|323022538|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
94339103|NCT03981744|323022535|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
94339104|NCT03981744|323022536|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
94339105|NCT03981744|323022537|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
94339106|NCT03981744|323022538|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
94339107|NCT03981744|323022535|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
94339108|NCT03981744|323022536|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
94339109|NCT03981744|323022537|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
94339110|NCT03981744|323022538|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
94339111|NCT02782104|323022539|FG000|Overall Study|Other|215|||
94339112|NCT02782104|323022539|FG000|Overall Study|Induction Day 28 Non Responder|9|||
94339113|NCT02782104|323022539|FG000|Overall Study|Non-Compliance with Study Drug|2|||
94339114|NCT02782104|323022539|FG000|Overall Study|Death|8|||
94339115|NCT02782104|323022539|FG000|Overall Study|Pregnancy|6|||
94339116|NCT02782104|323022539|FG000|Overall Study|Withdrawal by Subject|63|||
94339117|NCT02782104|323022539|FG000|Overall Study|Protocol Violation|7|||
94339118|NCT02782104|323022539|FG000|Overall Study|Lack of Efficacy|61|||
94339119|NCT02782104|323022539|FG000|Overall Study|Lost to Follow-up|23|||
94339120|NCT02782104|323022539|FG000|Overall Study|Adverse Event|74|||
94339121|NCT03464136|323022540|FG000|Overall Study|Lost to Follow-up|5|||
94339122|NCT03464136|323022541|FG001|Overall Study|Lost to Follow-up|8|||
94339123|NCT03464136|323022540|FG000|Overall Study|Withdrawal by Subject|16|||
94339124|NCT03464136|323022541|FG001|Overall Study|Withdrawal by Subject|13|||
94339125|NCT03464136|323022540|FG000|Overall Study|Death|1|||
94339126|NCT03464136|323022541|FG001|Overall Study|Death|0|||
94339127|NCT03464136|323022540|FG000|Overall Study|Other|8|||
94339128|NCT03464136|323022541|FG001|Overall Study|Other|4|||
94339129|NCT00732641|323022545|FG000|Overall Study|Relapse or Progressive Disease|65|||
94339130|NCT00732641|323022546|FG001|Overall Study|Relapse or Progressive Disease|101|||
94339131|NCT00732641|323022545|FG000|Overall Study|Serious Adverse Events|12|||
94339132|NCT00732641|323022546|FG001|Overall Study|Serious Adverse Events|3|||
94339133|NCT00732641|323022545|FG000|Overall Study|Physician Decision|6|||
94339134|NCT00732641|323022546|FG001|Overall Study|Physician Decision|0|||
94339135|NCT00732641|323022545|FG000|Overall Study|Withdrawal by Subject|4|||
94339136|NCT00732641|323022546|FG001|Overall Study|Withdrawal by Subject|2|||
94339137|NCT00732641|323022545|FG000|Overall Study|Unable to Complete|1|||
94339138|NCT00732641|323022546|FG001|Overall Study|Unable to Complete|1|||
94339139|NCT00732641|323022545|FG000|Overall Study|Other|18|||
94339140|NCT00732641|323022546|FG001|Overall Study|Other|5|||
94339141|NCT02418585|323022547|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
94339142|NCT02418585|323022548|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
94339143|NCT02418585|323022547|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
94339144|NCT02418585|323022548|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
94339145|NCT02418585|323022547|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
94339146|NCT02418585|323022548|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
94339147|NCT02418585|323022547|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
94339148|NCT02418585|323022548|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
94339149|NCT02418585|323022547|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
94339150|NCT02418585|323022548|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
94339151|NCT02418585|323022547|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
94339152|NCT02418585|323022548|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
94339153|NCT02418585|323022547|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
94339154|NCT02418585|323022548|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
94339155|NCT02418585|323022547|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
94339156|NCT02418585|323022548|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
94339157|NCT02418585|323022547|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
94651329|NCT02460224|324179739|FG024|Overall Study|Progressive disease|4|||
94339158|NCT02418585|323022548|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
94339159|NCT02418585|323022547|FG000|Follow-up Phase (24 Weeks)|Other|3|||
94339160|NCT02418585|323022548|FG001|Follow-up Phase (24 Weeks)|Other|2|||
94339161|NCT02040857|323022549|FG000|Overall Study|Adverse Event|14|||
94339162|NCT02040857|323022549|FG000|Overall Study|Physician Decision|5|||
94339163|NCT02040857|323022549|FG000|Overall Study|Withdrawal by Subject|31|||
94339164|NCT02040857|323022549|FG000|Overall Study|patient non-compliance|3|||
94339165|NCT02040857|323022549|FG000|Overall Study|Lost to Follow-up|2|||
94339166|NCT02040857|323022549|FG000|Overall Study|recurrence|4|||
94339167|NCT02040857|323022549|FG000|Overall Study|ineligible|1|||
94339168|NCT01116648|323022550|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
94339169|NCT01116648|323022551|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
94339170|NCT01116648|323022552|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
94339171|NCT01116648|323022553|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
94339172|NCT01116648|323022554|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
94339173|NCT01116648|323022555|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
94339174|NCT01116648|323022556|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
94339175|NCT01116648|323022557|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
94440176|NCT01349192|323397954|FG000|Overall Study|Failure to adhere to Protocol|2|||
94440177|NCT01349192|323397955|FG001|Overall Study|Failure to adhere to Protocol|0|||
94440178|NCT03908125|323397956|FG000|Overall Study|Withdrawal by Subject|92|||
94440179|NCT03908125|323397956|FG000|Overall Study|Lost to Follow-up|8|||
94440180|NCT03571828|323397957|FG000|Overall Study|Withdrawal by Subject|1|||
94440181|NCT03571828|323397958|FG001|Overall Study|Withdrawal by Subject|0|||
94440182|NCT03571828|323397957|FG000|Overall Study|Decision by sponsor|5|||
94440183|NCT03571828|323397958|FG001|Overall Study|Decision by sponsor|1|||
94440184|NCT03571828|323397957|FG000|Overall Study|Death|2|||
94440185|NCT03571828|323397958|FG001|Overall Study|Death|0|||
94440186|NCT00245466|323397959|FG000|Overall Study|Adverse Event|2|||
94440187|NCT00245466|323397960|FG001|Overall Study|Adverse Event|8|||
94440188|NCT00245466|323397961|FG002|Overall Study|Adverse Event|4|||
94440189|NCT00245466|323397959|FG000|Overall Study|Low prostate specific antigen suppr|16|||
94440190|NCT00245466|323397960|FG001|Overall Study|Low prostate specific antigen suppr|14|||
94440191|NCT00245466|323397961|FG002|Overall Study|Low prostate specific antigen suppr|5|||
94440192|NCT00245466|323397959|FG000|Overall Study|Insufficient testosterone suppr|12|||
94440193|NCT00245466|323397960|FG001|Overall Study|Insufficient testosterone suppr|12|||
94440194|NCT00245466|323397961|FG002|Overall Study|Insufficient testosterone suppr|21|||
94440195|NCT00245466|323397959|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
94440196|NCT00245466|323397960|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
94440197|NCT00245466|323397961|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
94440198|NCT00245466|323397959|FG000|Overall Study|Withdrawal by Subject|2|||
94440199|NCT00245466|323397960|FG001|Overall Study|Withdrawal by Subject|2|||
94440200|NCT00245466|323397961|FG002|Overall Study|Withdrawal by Subject|1|||
94440201|NCT00245466|323397959|FG000|Overall Study|Lost to Follow-up|3|||
94440202|NCT00245466|323397960|FG001|Overall Study|Lost to Follow-up|0|||
94440203|NCT00245466|323397961|FG002|Overall Study|Lost to Follow-up|0|||
94440204|NCT00245466|323397959|FG000|Overall Study|Disease progression|0|||
94440205|NCT00245466|323397960|FG001|Overall Study|Disease progression|3|||
94440206|NCT00245466|323397961|FG002|Overall Study|Disease progression|1|||
94440207|NCT00245466|323397959|FG000|Overall Study|Protocol Violation|1|||
94440208|NCT00245466|323397960|FG001|Overall Study|Protocol Violation|2|||
94440209|NCT00245466|323397961|FG002|Overall Study|Protocol Violation|2|||
94440210|NCT00245466|323397959|FG000|Overall Study|Death|0|||
94440211|NCT00245466|323397960|FG001|Overall Study|Death|2|||
94440212|NCT00245466|323397961|FG002|Overall Study|Death|0|||
94440213|NCT00245466|323397959|FG000|Overall Study|Administrative reasons|0|||
94440214|NCT00245466|323397960|FG001|Overall Study|Administrative reasons|1|||
94440215|NCT00245466|323397961|FG002|Overall Study|Administrative reasons|0|||
94440216|NCT00948155|323397964|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
94440217|NCT00948155|323397965|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
94440218|NCT00948155|323397964|FG000|Washout 14 Days|Lost to Follow-up|1|||
94440219|NCT00948155|323397965|FG001|Washout 14 Days|Lost to Follow-up|2|||
94440220|NCT03452943|323397966|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
94440221|NCT03452943|323397967|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
94440222|NCT03452943|323397966|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
94440223|NCT03452943|323397967|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
94440224|NCT03452943|323397966|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
94440225|NCT03452943|323397967|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
94440226|NCT03452943|323397966|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
94440227|NCT03452943|323397967|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
94440228|NCT03452943|323397966|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
94440229|NCT03452943|323397967|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
94440230|NCT03452943|323397966|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
94440231|NCT03452943|323397967|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
94440232|NCT01870778|323397971|FG000|Overall Study|Withdrawal by Subject|8|||
94651330|NCT02460224|324179740|FG025|Overall Study|Progressive disease|5|||
94440233|NCT01870778|323397972|FG001|Overall Study|Withdrawal by Subject|7|||
94440234|NCT01870778|323397971|FG000|Overall Study|Lost to Follow-up|0|||
94440235|NCT01870778|323397972|FG001|Overall Study|Lost to Follow-up|2|||
94440236|NCT02348112|323397973|FG000|Overall Study|Withdrawal by Subject|32|||
94440237|NCT02348112|323397974|FG001|Overall Study|Withdrawal by Subject|29|||
94440238|NCT02348112|323397973|FG000|Overall Study|Lost to Follow-up|24|||
94440239|NCT02348112|323397974|FG001|Overall Study|Lost to Follow-up|20|||
94440240|NCT02348112|323397973|FG000|Overall Study|Physician Decision|17|||
94440241|NCT02348112|323397974|FG001|Overall Study|Physician Decision|15|||
94440242|NCT02348112|323397973|FG000|Overall Study|Site closed due to PI leaving|0|||
94440243|NCT02348112|323397974|FG001|Overall Study|Site closed due to PI leaving|30|||
94440244|NCT02348112|323397973|FG000|Overall Study|Sponsor withdrawal|0|||
94440245|NCT02348112|323397974|FG001|Overall Study|Sponsor withdrawal|7|||
94440246|NCT02348112|323397973|FG000|Overall Study|Death|0|||
94440247|NCT02348112|323397974|FG001|Overall Study|Death|1|||
94440248|NCT04559347|323399265|FG000|Overall Study|Death|1|||
94440249|NCT04559347|323399266|FG001|Overall Study|Death|0|||
94440250|NCT04559347|323399265|FG000|Overall Study|Thoracotomy conversion|1|||
94440251|NCT04559347|323399266|FG001|Overall Study|Thoracotomy conversion|1|||
94440252|NCT04559347|323399265|FG000|Overall Study|Provider unavailable|2|||
94440253|NCT04559347|323399266|FG001|Overall Study|Provider unavailable|1|||
94440254|NCT04559347|323399265|FG000|Overall Study|Other|2|||
94440255|NCT04559347|323399266|FG001|Overall Study|Other|1|||
94440256|NCT00001521|323399268|FG000|Overall Study|Withdrawal by Subject|3|||
94440257|NCT00001521|323399269|FG001|Overall Study|Withdrawal by Subject|3|||
94440258|NCT00001521|323399268|FG000|Overall Study|Physician Decision|1|||
94440259|NCT00001521|323399269|FG001|Overall Study|Physician Decision|1|||
94440260|NCT00001521|323399268|FG000|Overall Study|Noncompliant|6|||
94440261|NCT00001521|323399269|FG001|Overall Study|Noncompliant|3|||
94440262|NCT04100018|323399270|FG000|Pre-Treatment Period|Not Reported|0|||
94440263|NCT04100018|323399271|FG001|Pre-Treatment Period|Not Reported|4|||
94339176|NCT01116648|323022558|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
94339177|NCT01116648|323022559|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
94339178|NCT01116648|323022560|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
94339179|NCT01116648|323022561|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
94339180|NCT01116648|323022562|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
94339181|NCT01116648|323022563|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
94339182|NCT01116648|323022564|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
94339183|NCT04159701|323022565|FG000|Period 1: Treatment Period|Pregnancy|1|||
94339184|NCT04159701|323022566|FG001|Period 1: Treatment Period|Pregnancy|0|||
94339185|NCT04159701|323022565|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
94339186|NCT04159701|323022566|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
94339187|NCT04159701|323022565|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
94339188|NCT04159701|323022566|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
94339189|NCT04159701|323022565|FG000|Washout Period|site terminated by sponsor|0|||
94339190|NCT04159701|323022566|FG001|Washout Period|site terminated by sponsor|1|||
94339191|NCT04159701|323022565|FG000|Washout Period|study terminated by sponsor|10|||
94339192|NCT04159701|323022566|FG001|Washout Period|study terminated by sponsor|3|||
94339193|NCT04159701|323022565|FG000|Washout Period|Withdrawal by Subject|1|||
94339194|NCT04159701|323022566|FG001|Washout Period|Withdrawal by Subject|0|||
94339195|NCT04159701|323022565|FG000|Washout Period|Inadvertent Enrollment|1|||
94339196|NCT04159701|323022566|FG001|Washout Period|Inadvertent Enrollment|0|||
94339197|NCT04159701|323022565|FG000|Washout Period|Miscellaneous|1|||
94339198|NCT04159701|323022566|FG001|Washout Period|Miscellaneous|0|||
94339199|NCT04159701|323022565|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
94339200|NCT04159701|323022566|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
94339201|NCT04159701|323022565|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
94339202|NCT04159701|323022566|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
94339203|NCT04159701|323022565|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
94339204|NCT04159701|323022566|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
94339205|NCT04159701|323022565|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
94440264|NCT04100018|323399270|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
94440265|NCT04100018|323399271|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
94440266|NCT04100018|323399270|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
94440267|NCT04100018|323399271|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
94440268|NCT04100018|323399270|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
94440269|NCT04100018|323399271|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
94440270|NCT04100018|323399270|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
94440271|NCT04100018|323399271|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
94440272|NCT04100018|323399270|FG000|Treatment Period|Ongoing Treatment|1|||
94440273|NCT04100018|323399271|FG001|Treatment Period|Ongoing Treatment|0|||
94440274|NCT04100018|323399270|FG000|Treatment Period|Other Reason|26|||
94440275|NCT04100018|323399271|FG001|Treatment Period|Other Reason|37|||
94440276|NCT04100018|323399270|FG000|Treatment Period|Completed treatment as per protocol|1|||
94339206|NCT04159701|323022566|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
94339207|NCT04159701|323022565|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
94339208|NCT04159701|323022566|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
94339209|NCT00865046|323022567|FG000|Overall Study|Lost to Follow-up|1|||
94339210|NCT00865046|323022568|FG001|Overall Study|Lost to Follow-up|4|||
94339211|NCT00865046|323022569|FG002|Overall Study|Lost to Follow-up|0|||
94339212|NCT00865046|323022567|FG000|Overall Study|Death|0|||
94339213|NCT00865046|323022568|FG001|Overall Study|Death|1|||
94339214|NCT00865046|323022569|FG002|Overall Study|Death|1|||
94339215|NCT00865046|323022567|FG000|Overall Study|Withdrawal by Subject|5|||
94339216|NCT00865046|323022568|FG001|Overall Study|Withdrawal by Subject|0|||
94339217|NCT00865046|323022569|FG002|Overall Study|Withdrawal by Subject|0|||
94339218|NCT03146403|323022570|FG000|Overall Study|Withdrawal by Subject|0|||
94339219|NCT03146403|323022571|FG001|Overall Study|Withdrawal by Subject|3|||
94339220|NCT03146403|323022570|FG000|Overall Study|Lost to Follow-up|2|||
94339221|NCT03146403|323022571|FG001|Overall Study|Lost to Follow-up|0|||
94339222|NCT01929707|323022578|FG000|Intervention Period 1|Lost to Follow-up|0|||
94339223|NCT01929707|323022579|FG001|Intervention Period 1|Lost to Follow-up|0|||
94339224|NCT01929707|323022580|FG002|Intervention Period 1|Lost to Follow-up|0|||
94339225|NCT01929707|323022581|FG003|Intervention Period 1|Lost to Follow-up|1|||
94339226|NCT01929707|323022582|FG004|Intervention Period 1|Lost to Follow-up|0|||
94339227|NCT01929707|323022583|FG005|Intervention Period 1|Lost to Follow-up|0|||
94339228|NCT01929707|323022584|FG006|Intervention Period 1|Lost to Follow-up|0|||
94339229|NCT01929707|323022585|FG007|Intervention Period 1|Lost to Follow-up|0|||
94339230|NCT01929707|323022578|FG000|Intervention Period 1|Withdrawal by Subject|0|||
94339231|NCT01929707|323022579|FG001|Intervention Period 1|Withdrawal by Subject|0|||
94339232|NCT01929707|323022580|FG002|Intervention Period 1|Withdrawal by Subject|0|||
94339233|NCT01929707|323022581|FG003|Intervention Period 1|Withdrawal by Subject|2|||
94339234|NCT01929707|323022582|FG004|Intervention Period 1|Withdrawal by Subject|0|||
94339235|NCT01929707|323022583|FG005|Intervention Period 1|Withdrawal by Subject|0|||
94339236|NCT01929707|323022584|FG006|Intervention Period 1|Withdrawal by Subject|0|||
94339237|NCT01929707|323022585|FG007|Intervention Period 1|Withdrawal by Subject|0|||
94339238|NCT01929707|323022578|FG000|Intervention Period 2|Withdrawal by Subject|0|||
94339239|NCT01929707|323022579|FG001|Intervention Period 2|Withdrawal by Subject|0|||
94339240|NCT01929707|323022580|FG002|Intervention Period 2|Withdrawal by Subject|0|||
94339241|NCT01929707|323022581|FG003|Intervention Period 2|Withdrawal by Subject|0|||
94339242|NCT01929707|323022582|FG004|Intervention Period 2|Withdrawal by Subject|0|||
94339243|NCT01929707|323022583|FG005|Intervention Period 2|Withdrawal by Subject|2|||
94339244|NCT01929707|323022584|FG006|Intervention Period 2|Withdrawal by Subject|0|||
94339245|NCT01929707|323022585|FG007|Intervention Period 2|Withdrawal by Subject|0|||
94339246|NCT00910728|323022586|FG000|Overall Study|Lack of Efficacy|2|||
94339247|NCT00910728|323022587|FG001|Overall Study|Lack of Efficacy|3|||
94339248|NCT00910728|323022588|FG002|Overall Study|Lack of Efficacy|1|||
94339249|NCT00910728|323022589|FG003|Overall Study|Lack of Efficacy|2|||
94339250|NCT00910728|323022590|FG004|Overall Study|Lack of Efficacy|1|||
94339251|NCT00910728|323022591|FG005|Overall Study|Lack of Efficacy|0|||
94339252|NCT00910728|323022592|FG006|Overall Study|Lack of Efficacy|2|||
94339253|NCT00910728|323022593|FG007|Overall Study|Lack of Efficacy|2|||
94339254|NCT00910728|323022594|FG008|Overall Study|Lack of Efficacy|2|||
94339255|NCT00910728|323022586|FG000|Overall Study|Withdrawal by Subject|0|||
94339256|NCT00910728|323022587|FG001|Overall Study|Withdrawal by Subject|0|||
94339257|NCT00910728|323022588|FG002|Overall Study|Withdrawal by Subject|0|||
94339258|NCT00910728|323022589|FG003|Overall Study|Withdrawal by Subject|0|||
94339259|NCT00910728|323022590|FG004|Overall Study|Withdrawal by Subject|3|||
94339260|NCT00910728|323022591|FG005|Overall Study|Withdrawal by Subject|1|||
94339261|NCT00910728|323022592|FG006|Overall Study|Withdrawal by Subject|2|||
94339262|NCT00910728|323022593|FG007|Overall Study|Withdrawal by Subject|0|||
94339263|NCT00910728|323022594|FG008|Overall Study|Withdrawal by Subject|0|||
94339264|NCT00910728|323022586|FG000|Overall Study|(not specified)|2|||
94339265|NCT00910728|323022587|FG001|Overall Study|(not specified)|0|||
94339266|NCT00910728|323022588|FG002|Overall Study|(not specified)|1|||
94339267|NCT00910728|323022589|FG003|Overall Study|(not specified)|0|||
94339268|NCT00910728|323022590|FG004|Overall Study|(not specified)|1|||
94339269|NCT00910728|323022591|FG005|Overall Study|(not specified)|0|||
94339270|NCT00910728|323022592|FG006|Overall Study|(not specified)|0|||
94339271|NCT00910728|323022593|FG007|Overall Study|(not specified)|0|||
94339272|NCT00910728|323022594|FG008|Overall Study|(not specified)|0|||
94339273|NCT00910728|323022586|FG000|Overall Study|Adverse Event|2|||
94339274|NCT00910728|323022587|FG001|Overall Study|Adverse Event|0|||
94339275|NCT00910728|323022588|FG002|Overall Study|Adverse Event|1|||
94339276|NCT00910728|323022589|FG003|Overall Study|Adverse Event|1|||
94339277|NCT00910728|323022590|FG004|Overall Study|Adverse Event|0|||
94339278|NCT00910728|323022591|FG005|Overall Study|Adverse Event|0|||
94339279|NCT00910728|323022592|FG006|Overall Study|Adverse Event|2|||
94339280|NCT00910728|323022593|FG007|Overall Study|Adverse Event|1|||
94339281|NCT00910728|323022594|FG008|Overall Study|Adverse Event|1|||
94339282|NCT01225172|323022595|FG000|Overall Study|Subject decision to stop|1|||
94339283|NCT01225172|323022596|FG001|Overall Study|Subject decision to stop|0|||
94339284|NCT01225172|323022595|FG000|Overall Study|Subject request to discontinue treatment|3|||
94339285|NCT01225172|323022596|FG001|Overall Study|Subject request to discontinue treatment|1|||
94339286|NCT01225172|323022595|FG000|Overall Study|Subject no longer meets study criteria|1|||
94339287|NCT01225172|323022596|FG001|Overall Study|Subject no longer meets study criteria|0|||
94339288|NCT01225172|323022595|FG000|Overall Study|Withdrawal by Subject|1|||
94339289|NCT01225172|323022596|FG001|Overall Study|Withdrawal by Subject|0|||
94339290|NCT00422903|323022597|FG000|Overall Study|Disease Progression|3|||
94339291|NCT00422903|323022598|FG001|Overall Study|Disease Progression|1|||
94339292|NCT00422903|323022597|FG000|Overall Study|Adverse Event|0|||
94339293|NCT00422903|323022598|FG001|Overall Study|Adverse Event|2|||
94339294|NCT00422903|323022597|FG000|Overall Study|Informed Consent Withdrawn|1|||
94339295|NCT00422903|323022598|FG001|Overall Study|Informed Consent Withdrawn|2|||
94339296|NCT00431496|323022599|FG000|Overall Study|Adverse Event|3|||
94339297|NCT00431496|323022599|FG000|Overall Study|Lost to Follow-up|1|||
94339298|NCT00431496|323022599|FG000|Overall Study|Withdrawal by Subject|2|||
94339299|NCT00431496|323022599|FG000|Overall Study|Protocol-specified criteria|5|||
94339300|NCT00361218|323022600|FG000|Overall Study|Lost to Follow-up|11|||
94339301|NCT00361218|323022600|FG000|Overall Study|Personal Reasons|7|||
94339302|NCT00361218|323022600|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
94339303|NCT01947894|323022601|FG000|Overall Study|Other|3|||
94339304|NCT01947894|323022602|FG001|Overall Study|Other|4|||
94339305|NCT01947894|323022603|FG002|Overall Study|Other|3|||
94339306|NCT01947894|323022601|FG000|Overall Study|Withdrawal by Subject|12|||
94339307|NCT01947894|323022602|FG001|Overall Study|Withdrawal by Subject|4|||
94339308|NCT01947894|323022603|FG002|Overall Study|Withdrawal by Subject|1|||
94339309|NCT01947894|323022601|FG000|Overall Study|Death|12|||
94339310|NCT01947894|323022602|FG001|Overall Study|Death|1|||
94339311|NCT01947894|323022603|FG002|Overall Study|Death|0|||
94339312|NCT01947894|323022601|FG000|Overall Study|Physician Decision|2|||
94339313|NCT01947894|323022602|FG001|Overall Study|Physician Decision|0|||
94339314|NCT01947894|323022603|FG002|Overall Study|Physician Decision|0|||
94339315|NCT01947894|323022601|FG000|Overall Study|Adverse Event|5|||
94339316|NCT01947894|323022602|FG001|Overall Study|Adverse Event|1|||
94339317|NCT01947894|323022603|FG002|Overall Study|Adverse Event|0|||
94339318|NCT01947894|323022601|FG000|Overall Study|Switched to other growth hormone brand|53|||
94339319|NCT01947894|323022602|FG001|Overall Study|Switched to other growth hormone brand|8|||
94339320|NCT01947894|323022603|FG002|Overall Study|Switched to other growth hormone brand|23|||
94339321|NCT03559192|323022606|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
94339322|NCT03559192|323022607|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
94339323|NCT03559192|323022608|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
94339324|NCT03559192|323022606|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
94339325|NCT03559192|323022607|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
94339326|NCT03559192|323022608|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
94339327|NCT03559192|323022606|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
94339328|NCT03559192|323022607|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
94339329|NCT03559192|323022608|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
94339330|NCT03559192|323022606|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
94339331|NCT03559192|323022607|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
94339332|NCT03559192|323022608|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
94339333|NCT03559192|323022606|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
94339334|NCT03559192|323022607|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
94339335|NCT03559192|323022608|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
94339336|NCT03559192|323022606|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
94339337|NCT03559192|323022607|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
94339338|NCT03559192|323022608|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
94339339|NCT03559192|323022606|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
94339340|NCT03559192|323022607|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
94339341|NCT03559192|323022608|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
94339342|NCT03559192|323022606|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
94339343|NCT03559192|323022607|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
94339344|NCT03559192|323022608|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
94339345|NCT03559192|323022606|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
94339346|NCT03559192|323022607|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
94339347|NCT03559192|323022608|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
94339348|NCT03950440|323024623|FG000|Overall Study|Death|8|||
94339349|NCT03950440|323024624|FG001|Overall Study|Death|2|||
94339350|NCT03950440|323024625|FG002|Overall Study|Death|1|||
94339351|NCT00608244|323024629|FG000|Overall Study|Adverse Event|1|||
94339352|NCT00608244|323024629|FG000|Overall Study|Low trough levels|1|||
94339353|NCT01957215|323024634|FG000|Overall Study|Adverse Event|2|||
94339354|NCT01957215|323024635|FG001|Overall Study|Adverse Event|2|||
94339355|NCT01957215|323024634|FG000|Overall Study|Lost to Follow-up|3|||
94440277|NCT04100018|323399271|FG001|Treatment Period|Completed treatment as per protocol|2|||
94440278|NCT04100018|323399270|FG000|Treatment Period|Maximum clinical benefit|3|||
94440279|NCT04100018|323399271|FG001|Treatment Period|Maximum clinical benefit|0|||
94440280|NCT04100018|323399270|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
94440281|NCT04100018|323399271|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
94440282|NCT04100018|323399270|FG000|Treatment Period|Study drug toxicity|67|||
94440283|NCT04100018|323399271|FG001|Treatment Period|Study drug toxicity|28|||
94440284|NCT04100018|323399270|FG000|Treatment Period|Disease Progression|284|||
94440285|NCT04100018|323399271|FG001|Treatment Period|Disease Progression|327|||
94440286|NCT04100018|323399270|FG000|Treatment Period|Administrative reasons by sponsor|16|||
94440287|NCT04100018|323399271|FG001|Treatment Period|Administrative reasons by sponsor|30|||
94440288|NCT04100018|323399270|FG000|Treatment Period|Poor/Non-Compliance|1|||
94440289|NCT04100018|323399271|FG001|Treatment Period|Poor/Non-Compliance|0|||
94440290|NCT04100018|323399270|FG000|Treatment Period|Lost to Follow-up|2|||
94440291|NCT04100018|323399271|FG001|Treatment Period|Lost to Follow-up|2|||
94440292|NCT04100018|323399270|FG000|Treatment Period|Death|16|||
94440293|NCT04100018|323399271|FG001|Treatment Period|Death|11|||
94339356|NCT01957215|323024635|FG001|Overall Study|Lost to Follow-up|3|||
94339357|NCT01957215|323024634|FG000|Overall Study|Protocol Violation|1|||
94339358|NCT01957215|323024635|FG001|Overall Study|Protocol Violation|2|||
94339359|NCT01957215|323024634|FG000|Overall Study|Withdrawal by Subject|7|||
94339360|NCT01957215|323024635|FG001|Overall Study|Withdrawal by Subject|5|||
94339361|NCT00323310|323024640|FG000|Overall Study|Withdrawal by Subject|1|||
94339362|NCT00323310|323024640|FG000|Overall Study|a parent refused blood draw|1|||
94339363|NCT00323310|323024640|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
94339364|NCT02944513|323024641|FG000|Overall Study|Withdrawal by Subject|4|||
94339365|NCT02944513|323024642|FG001|Overall Study|Withdrawal by Subject|1|||
94339366|NCT02578992|323024643|FG000|Overall Study|equipment not available or malfunction|3|||
94339367|NCT02578992|323024644|FG001|Overall Study|equipment not available or malfunction|3|||
94339368|NCT00086385|323024645|FG000|Overall Study|Death|2|||
94339369|NCT00086385|323024646|FG001|Overall Study|Death|2|||
94339370|NCT00086385|323024647|FG002|Overall Study|Death|1|||
94339371|NCT00086385|323024648|FG003|Overall Study|Death|1|||
94339372|NCT00880100|323024649|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
94339373|NCT00880100|323024649|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
94339374|NCT00880100|323024649|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
94339375|NCT01625611|323024650|FG000|Overall Study|No adlib drinks Lab 1|3|||
94339376|NCT01625611|323024651|FG001|Overall Study|No adlib drinks Lab 1|0|||
94339377|NCT01625611|323024650|FG000|Overall Study|Technical issues with PET|1|||
94339378|NCT01625611|323024651|FG001|Overall Study|Technical issues with PET|0|||
94339379|NCT01625611|323024650|FG000|Overall Study|Unable to complete study procedures|1|||
94339380|NCT01625611|323024651|FG001|Overall Study|Unable to complete study procedures|0|||
94339381|NCT01625611|323024650|FG000|Overall Study|Withdrawal by Subject|3|||
94339382|NCT01625611|323024651|FG001|Overall Study|Withdrawal by Subject|0|||
94339383|NCT02038790|323024652|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
94339384|NCT02038790|323024653|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
94339385|NCT00209092|323024656|FG000|Overall Study|Progression of disease|7|||
94339386|NCT00209092|323024657|FG001|Overall Study|Progression of disease|1|||
94339387|NCT00209092|323024656|FG000|Overall Study|Adverse Event|0|||
94339388|NCT00209092|323024657|FG001|Overall Study|Adverse Event|1|||
94339389|NCT00209092|323024656|FG000|Overall Study|Withdrawal by Subject|1|||
94339390|NCT00209092|323024657|FG001|Overall Study|Withdrawal by Subject|0|||
94339391|NCT01473355|323024658|FG000|Overall Study|Protocol Violation|2|||
94339392|NCT01473355|323024658|FG000|Overall Study|Adverse Event|2|||
94339393|NCT01473355|323024658|FG000|Overall Study|Lost to Follow-up|2|||
94339394|NCT00106249|323024659|FG000|Overall Study|Lost to Follow-up|3|||
94339395|NCT00106249|323024660|FG001|Overall Study|Lost to Follow-up|2|||
94339396|NCT05516134|323024661|FG000|Overall Study|Lost to Follow-up|1|||
94339397|NCT05516134|323024662|FG001|Overall Study|Lost to Follow-up|0|||
94339398|NCT05516134|323024663|FG002|Overall Study|Lost to Follow-up|0|||
94339399|NCT01119963|323024664|FG000|Overall Study|Lost to Follow-up|1|||
94440294|NCT04100018|323399270|FG000|Treatment Period|Participant withdrew consent|10|||
94339400|NCT01119963|323024665|FG001|Overall Study|Lost to Follow-up|1|||
94339401|NCT05091918|323024670|FG000|Overall Study|Adverse Event|1|||
94339402|NCT05091918|323024670|FG000|Overall Study|Withdrawal by Subject|81|||
94339403|NCT04179032|323024671|FG000|Part B (Up to Week 52)|Adverse Event|1|||
94339404|NCT04179032|323024671|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
94339405|NCT04179032|323024671|FG000|Access Extension Phase|Ongoing|11|||
94339406|NCT02432703|323024672|FG000|Overall Study|Adverse Event|1|||
94339407|NCT02432703|323024673|FG001|Overall Study|Adverse Event|4|||
94339408|NCT02432703|323024672|FG000|Overall Study|Lack of Efficacy|1|||
94339409|NCT02432703|323024673|FG001|Overall Study|Lack of Efficacy|0|||
94339410|NCT02432703|323024672|FG000|Overall Study|Lost to Follow-up|5|||
94339411|NCT02432703|323024673|FG001|Overall Study|Lost to Follow-up|3|||
94440295|NCT04100018|323399271|FG001|Treatment Period|Participant withdrew consent|10|||
94651331|NCT02460224|324179741|FG026|Overall Study|Progressive disease|85|||
94440296|NCT04100018|323399270|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
94440297|NCT04100018|323399271|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
94440298|NCT04100018|323399270|FG000|Treatment Period|Adverse Event|14|||
94440299|NCT04100018|323399271|FG001|Treatment Period|Adverse Event|6|||
94440300|NCT04100018|323399270|FG000|Treatment Period|Lack of Efficacy|4|||
94440301|NCT04100018|323399271|FG001|Treatment Period|Lack of Efficacy|2|||
94440302|NCT00855894|323399274|FG000|Overall Study|Death|31|||
94440303|NCT00855894|323399274|FG000|Overall Study|Patient's decision|1|||
94440304|NCT00855894|323399274|FG000|Overall Study|Disease progression|1|||
94440305|NCT02070965|323399275|FG000|Overall Study|Lost to Follow-up|0|||
94440306|NCT02070965|323399276|FG001|Overall Study|Lost to Follow-up|1|||
94440307|NCT02070965|323399277|FG002|Overall Study|Lost to Follow-up|0|||
94440308|NCT02070965|323399275|FG000|Overall Study|Withdrawal by Subject|1|||
94440309|NCT02070965|323399276|FG001|Overall Study|Withdrawal by Subject|1|||
94440310|NCT02070965|323399277|FG002|Overall Study|Withdrawal by Subject|1|||
94440311|NCT02070965|323399275|FG000|Overall Study|Subject moved|1|||
94440312|NCT02070965|323399276|FG001|Overall Study|Subject moved|0|||
94440313|NCT02070965|323399277|FG002|Overall Study|Subject moved|0|||
94440314|NCT01071915|323399278|FG000|Overall Study|Adverse Event|3|||
94440315|NCT01071915|323399278|FG000|Overall Study|Physician Decision|2|||
94440316|NCT01071915|323399278|FG000|Overall Study|Withdrawal by Subject|2|||
94440317|NCT01071915|323399278|FG000|Overall Study|Miscellaneous Reasons|2|||
94440318|NCT01125189|323399279|FG000|Treatment Period|Lack of Efficacy|15|||
94440319|NCT01125189|323399280|FG001|Treatment Period|Lack of Efficacy|18|||
94440320|NCT01125189|323399281|FG002|Treatment Period|Lack of Efficacy|25|||
94440321|NCT01125189|323399279|FG000|Treatment Period|Adverse Event|7|||
94440322|NCT01125189|323399280|FG001|Treatment Period|Adverse Event|8|||
94440323|NCT01125189|323399281|FG002|Treatment Period|Adverse Event|8|||
94440324|NCT01125189|323399279|FG000|Treatment Period|Withdrawal by Subject|3|||
94440325|NCT01125189|323399280|FG001|Treatment Period|Withdrawal by Subject|1|||
94440326|NCT01125189|323399281|FG002|Treatment Period|Withdrawal by Subject|1|||
94440327|NCT01125189|323399279|FG000|Treatment Period|Death|1|||
94440328|NCT01125189|323399280|FG001|Treatment Period|Death|0|||
94440329|NCT01125189|323399281|FG002|Treatment Period|Death|0|||
94440330|NCT01125189|323399279|FG000|Treatment Period|Lost to Follow-up|1|||
94440331|NCT01125189|323399280|FG001|Treatment Period|Lost to Follow-up|2|||
94339412|NCT02432703|323024672|FG000|Overall Study|Withdrawal by Subject|9|||
94339413|NCT02432703|323024673|FG001|Overall Study|Withdrawal by Subject|6|||
94339414|NCT02432703|323024672|FG000|Overall Study|Other|6|||
94339415|NCT02432703|323024673|FG001|Overall Study|Other|5|||
94339416|NCT04211961|323024674|FG000|Overall Study|Death|0|||
94339417|NCT04211961|323024675|FG001|Overall Study|Death|1|||
94339418|NCT04211961|323024674|FG000|Overall Study|Lost to Follow-up|0|||
94339419|NCT04211961|323024675|FG001|Overall Study|Lost to Follow-up|1|||
94339420|NCT04211961|323024674|FG000|Overall Study|Withdrawal by Subject|0|||
94339421|NCT04211961|323024675|FG001|Overall Study|Withdrawal by Subject|1|||
94339422|NCT04222673|323024681|FG000|Overall Study|Lost to Follow-up|5|||
94339423|NCT01856192|323024682|FG000|Overall Study|Adverse Event|12|||
94339424|NCT01856192|323024683|FG001|Overall Study|Adverse Event|4|||
94339425|NCT01856192|323024682|FG000|Overall Study|Alternative therapy|0|||
94339426|NCT01856192|323024683|FG001|Overall Study|Alternative therapy|3|||
94339427|NCT01856192|323024682|FG000|Overall Study|Death|3|||
94339428|NCT01856192|323024683|FG001|Overall Study|Death|5|||
94339429|NCT01856192|323024682|FG000|Overall Study|Lack of Efficacy|0|||
94339430|NCT01856192|323024683|FG001|Overall Study|Lack of Efficacy|5|||
94339431|NCT01856192|323024682|FG000|Overall Study|Withdrawal by Subject|1|||
94339432|NCT01856192|323024683|FG001|Overall Study|Withdrawal by Subject|1|||
94339433|NCT01856192|323024682|FG000|Overall Study|Other diseases|1|||
94339434|NCT01856192|323024683|FG001|Overall Study|Other diseases|0|||
94339435|NCT01856192|323024682|FG000|Overall Study|Never started treatment|7|||
94339436|NCT01856192|323024683|FG001|Overall Study|Never started treatment|5|||
94339437|NCT01856192|323024682|FG000|Overall Study|Path ineligible|20|||
94339438|NCT01856192|323024683|FG001|Overall Study|Path ineligible|34|||
94339439|NCT01856192|323024682|FG000|Overall Study|Non-path ineligible|2|||
94339440|NCT01856192|323024683|FG001|Overall Study|Non-path ineligible|2|||
94339441|NCT01856192|323024682|FG000|Overall Study|Physician Decision|1|||
94339442|NCT01856192|323024683|FG001|Overall Study|Physician Decision|1|||
94339443|NCT01856192|323024682|FG000|Overall Study|Suspicion of progressive disease|1|||
94339444|NCT01856192|323024683|FG001|Overall Study|Suspicion of progressive disease|0|||
94339445|NCT01856192|323024682|FG000|Overall Study|Non-compliance|1|||
94339446|NCT01856192|323024683|FG001|Overall Study|Non-compliance|0|||
94339447|NCT04072575|323024684|FG000|Overall Study|Physician Decision|1|||
94339448|NCT04072575|323024684|FG000|Overall Study|Adverse Event|7|||
94339449|NCT04072575|323024684|FG000|Overall Study|Withdrawal by Subject|14|||
94339450|NCT04072575|323024684|FG000|Overall Study|Other|2|||
94339451|NCT02244619|323024685|FG000|Overall Study|Did not receive study intervention|8|||
94339452|NCT02244619|323024686|FG001|Overall Study|Did not receive study intervention|21|||
94339453|NCT01156363|323024687|FG000|Overall Study|Adverse Event|6|||
94339454|NCT01156363|323024687|FG000|Overall Study|Insufficient Therapeutic Response|5|||
94339455|NCT01156363|323024687|FG000|Overall Study|Failure to Return|1|||
94339456|NCT01156363|323024687|FG000|Overall Study|Refused Treatment|4|||
94339457|NCT01156363|323024687|FG000|Overall Study|Other|6|||
94339458|NCT03285490|323024688|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
94339459|NCT03285490|323024689|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
94339460|NCT03285490|323024688|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
94339461|NCT03285490|323024689|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
94339462|NCT03745989|323024690|FG000|Overall Study|Death|3|||
94339463|NCT03745989|323024691|FG001|Overall Study|Death|7|||
94339464|NCT03745989|323024692|FG002|Overall Study|Death|4|||
94339465|NCT03745989|323024690|FG000|Overall Study|Lost to Follow-up|0|||
94339466|NCT03745989|323024691|FG001|Overall Study|Lost to Follow-up|2|||
94339467|NCT03745989|323024692|FG002|Overall Study|Lost to Follow-up|0|||
94339468|NCT03745989|323024690|FG000|Overall Study|Sponsor Decision|0|||
94339469|NCT03745989|323024691|FG001|Overall Study|Sponsor Decision|2|||
94339470|NCT03745989|323024692|FG002|Overall Study|Sponsor Decision|8|||
94339471|NCT03745989|323024690|FG000|Overall Study|Withdrawal by Subject|0|||
94339472|NCT03745989|323024691|FG001|Overall Study|Withdrawal by Subject|1|||
94339473|NCT03745989|323024692|FG002|Overall Study|Withdrawal by Subject|3|||
94339474|NCT02728206|323024693|FG000|Overall Study|Death|1|||
94339475|NCT01675141|323024697|FG000|Overall Study|Lenalidomide outside NIH|3|||
94339476|NCT01675141|323024697|FG000|Overall Study|Withdrawal by Subject|3|||
94339477|NCT01675141|323024697|FG000|Overall Study|Physician Decision|4|||
94339478|NCT01675141|323024697|FG000|Overall Study|No treatment, per protocol|1|||
94339479|NCT02773368|323024703|FG000|Overall Study|Lost to Follow-up|4|||
94339480|NCT02773368|323024704|FG001|Overall Study|Lost to Follow-up|1|||
94339481|NCT02773368|323024703|FG000|Overall Study|Withdrawal by Subject|5|||
94339482|NCT02773368|323024704|FG001|Overall Study|Withdrawal by Subject|1|||
94339483|NCT02773368|323024703|FG000|Overall Study|Unclassified|1|||
94339484|NCT02773368|323024704|FG001|Overall Study|Unclassified|1|||
94339485|NCT02773368|323024703|FG000|Overall Study|Missing|0|||
94339486|NCT02773368|323024704|FG001|Overall Study|Missing|1|||
94339487|NCT05179057|323024705|FG000|Overall Study|Adverse Event|3|||
94339488|NCT05179057|323024706|FG001|Overall Study|Adverse Event|2|||
94339489|NCT05179057|323024705|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
94339490|NCT05179057|323024706|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
94339491|NCT05179057|323024705|FG000|Overall Study|Study terminated|13|||
94339492|NCT05179057|323024706|FG001|Overall Study|Study terminated|7|||
94339493|NCT05179057|323024705|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
94339494|NCT05179057|323024706|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
94339495|NCT05179057|323024705|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
94339496|NCT05179057|323024706|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
94339497|NCT02417064|323024707|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
94339498|NCT02417064|323024708|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
94339499|NCT02417064|323024709|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
94339500|NCT02417064|323024707|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
94339501|NCT02417064|323024708|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
94339502|NCT02417064|323024709|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
94339503|NCT02417064|323024707|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
94339504|NCT02417064|323024708|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
94339505|NCT02417064|323024709|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
94339506|NCT02417064|323024707|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
94339507|NCT02417064|323024708|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
94339508|NCT02417064|323024709|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
94339509|NCT02417064|323024707|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
94339510|NCT02417064|323024708|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
94339511|NCT02417064|323024709|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
94339512|NCT02417064|323024707|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
94339513|NCT02417064|323024708|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
94339514|NCT02417064|323024709|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
94339515|NCT02417064|323024707|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
94339516|NCT02417064|323024708|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
94339517|NCT02417064|323024709|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
94339518|NCT02417064|323024707|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
94339519|NCT02417064|323024708|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
94339520|NCT02417064|323024709|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
94339521|NCT02417064|323024707|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
94339522|NCT02417064|323024708|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
94339523|NCT02417064|323024709|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
94548755|NCT04181827|323805675|FG000|Overall Study|Withdrawal by Subject|5|||
94440332|NCT01125189|323399281|FG002|Treatment Period|Lost to Follow-up|1|||
94440333|NCT01125189|323399279|FG000|Treatment Period|Poor compliance/noncompliance|0|||
94440334|NCT01125189|323399280|FG001|Treatment Period|Poor compliance/noncompliance|1|||
94440335|NCT01125189|323399281|FG002|Treatment Period|Poor compliance/noncompliance|0|||
94440336|NCT01125189|323399279|FG000|Treatment Period|Participants requested to discontinue|1|||
94440337|NCT01125189|323399280|FG001|Treatment Period|Participants requested to discontinue|3|||
94440338|NCT01125189|323399281|FG002|Treatment Period|Participants requested to discontinue|4|||
94440339|NCT01125189|323399279|FG000|Treatment Period|Other reasons|1|||
94440340|NCT01125189|323399280|FG001|Treatment Period|Other reasons|1|||
94440341|NCT01125189|323399281|FG002|Treatment Period|Other reasons|0|||
94440342|NCT01125189|323399279|FG000|Treatment Period|Completed 24 week treatment period only|2|||
94440343|NCT01125189|323399280|FG001|Treatment Period|Completed 24 week treatment period only|1|||
94440344|NCT01125189|323399281|FG002|Treatment Period|Completed 24 week treatment period only|2|||
94440345|NCT01125189|323399279|FG000|Follow up Period|Withdrawal by Subject|3|||
94440346|NCT01125189|323399280|FG001|Follow up Period|Withdrawal by Subject|2|||
94440347|NCT01125189|323399281|FG002|Follow up Period|Withdrawal by Subject|5|||
94440348|NCT01125189|323399279|FG000|Follow up Period|Death|1|||
94440349|NCT01125189|323399280|FG001|Follow up Period|Death|0|||
94440350|NCT01125189|323399281|FG002|Follow up Period|Death|0|||
94440351|NCT01125189|323399279|FG000|Follow up Period|Lost to Follow-up|12|||
94440352|NCT01125189|323399280|FG001|Follow up Period|Lost to Follow-up|9|||
94440353|NCT01125189|323399281|FG002|Follow up Period|Lost to Follow-up|6|||
94440354|NCT01125189|323399279|FG000|Follow up Period|Other reasons|4|||
94440355|NCT01125189|323399280|FG001|Follow up Period|Other reasons|4|||
94440356|NCT01125189|323399281|FG002|Follow up Period|Other reasons|5|||
94440357|NCT00114140|323399282|FG000|Overall Study|Protocol Violation|7|||
94440358|NCT02942017|323399283|FG000|Overall Study|Adverse Event|0|||
94440359|NCT02942017|323399284|FG001|Overall Study|Adverse Event|1|||
94440360|NCT02942017|323399283|FG000|Overall Study|Withdrawal by Subject|0|||
94440361|NCT02942017|323399284|FG001|Overall Study|Withdrawal by Subject|1|||
94440362|NCT02942017|323399283|FG000|Overall Study|Lost to Follow-up|1|||
94440363|NCT02942017|323399284|FG001|Overall Study|Lost to Follow-up|1|||
94440364|NCT02942017|323399283|FG000|Overall Study|Randomized but not dosed|1|||
94440365|NCT02942017|323399284|FG001|Overall Study|Randomized but not dosed|3|||
94440366|NCT02088177|323399285|FG000|Overall Study|Lost to Follow-up|3|||
94440367|NCT00666328|323399290|FG000|Overall Study|Death|2|||
94440368|NCT00666328|323399290|FG000|Overall Study|Lost to Follow-up|2|||
94440369|NCT00666328|323399290|FG000|Overall Study|No longer met eligibility criteria|1|||
94440370|NCT02288325|323399291|FG000|Run-in Period|Adverse Event|48|||
94440371|NCT02288325|323399292|FG001|Run-in Period|Adverse Event|0|||
94440372|NCT02288325|323399293|FG002|Run-in Period|Adverse Event|0|||
94440373|NCT02288325|323399291|FG000|Run-in Period|Lack of Efficacy|16|||
94440374|NCT02288325|323399292|FG001|Run-in Period|Lack of Efficacy|0|||
94440375|NCT02288325|323399293|FG002|Run-in Period|Lack of Efficacy|0|||
94440376|NCT02288325|323399291|FG000|Run-in Period|Withdrawal of Consent|28|||
94440377|NCT02288325|323399292|FG001|Run-in Period|Withdrawal of Consent|0|||
94440378|NCT02288325|323399293|FG002|Run-in Period|Withdrawal of Consent|0|||
94440379|NCT02288325|323399291|FG000|Run-in Period|Lost to Follow-up|25|||
94440380|NCT02288325|323399292|FG001|Run-in Period|Lost to Follow-up|0|||
94440381|NCT02288325|323399293|FG002|Run-in Period|Lost to Follow-up|0|||
94440382|NCT02288325|323399291|FG000|Run-in Period|Protocol Violation|17|||
94440383|NCT02288325|323399292|FG001|Run-in Period|Protocol Violation|0|||
94440384|NCT02288325|323399293|FG002|Run-in Period|Protocol Violation|0|||
94440385|NCT02288325|323399291|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
94440386|NCT02288325|323399292|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
94440387|NCT02288325|323399293|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
94440388|NCT02288325|323399291|FG000|Run-in Period|Reason not Specified|8|||
94440389|NCT02288325|323399292|FG001|Run-in Period|Reason not Specified|0|||
94440390|NCT02288325|323399293|FG002|Run-in Period|Reason not Specified|0|||
94440391|NCT02288325|323399291|FG000|Stabilization Period|Adverse Event|13|||
94440392|NCT02288325|323399292|FG001|Stabilization Period|Adverse Event|0|||
94440393|NCT02288325|323399293|FG002|Stabilization Period|Adverse Event|0|||
94440394|NCT02288325|323399291|FG000|Stabilization Period|Lack of Efficacy|22|||
94440395|NCT02288325|323399292|FG001|Stabilization Period|Lack of Efficacy|0|||
94440396|NCT02288325|323399293|FG002|Stabilization Period|Lack of Efficacy|0|||
94440397|NCT02288325|323399291|FG000|Stabilization Period|Withdrawal of Consent|23|||
94440398|NCT02288325|323399292|FG001|Stabilization Period|Withdrawal of Consent|0|||
94440399|NCT02288325|323399293|FG002|Stabilization Period|Withdrawal of Consent|0|||
94440400|NCT02288325|323399291|FG000|Stabilization Period|Lost to Follow-up|12|||
94440401|NCT02288325|323399292|FG001|Stabilization Period|Lost to Follow-up|0|||
94440402|NCT02288325|323399293|FG002|Stabilization Period|Lost to Follow-up|0|||
94440403|NCT02288325|323399291|FG000|Stabilization Period|Protocol Violation|8|||
94440404|NCT02288325|323399292|FG001|Stabilization Period|Protocol Violation|0|||
94440405|NCT02288325|323399293|FG002|Stabilization Period|Protocol Violation|0|||
94440406|NCT02288325|323399291|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
94440407|NCT02288325|323399292|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
94440408|NCT02288325|323399293|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
94440409|NCT02288325|323399291|FG000|Stabilization Period|Reason not Specified|15|||
94440410|NCT02288325|323399292|FG001|Stabilization Period|Reason not Specified|0|||
94440411|NCT02288325|323399293|FG002|Stabilization Period|Reason not Specified|0|||
94440412|NCT02288325|323399291|FG000|Double-blind Treatment Period|Adverse Event|0|||
94440413|NCT02288325|323399292|FG001|Double-blind Treatment Period|Adverse Event|2|||
94440414|NCT02288325|323399293|FG002|Double-blind Treatment Period|Adverse Event|5|||
94440415|NCT02288325|323399291|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
94440416|NCT02288325|323399292|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
94440417|NCT02288325|323399293|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
94440418|NCT02288325|323399291|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
94440419|NCT02288325|323399292|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
94440420|NCT02288325|323399293|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
94440421|NCT02288325|323399291|FG000|Double-blind Treatment Period|Protocol Violation|0|||
94440422|NCT02288325|323399292|FG001|Double-blind Treatment Period|Protocol Violation|1|||
94440423|NCT02288325|323399293|FG002|Double-blind Treatment Period|Protocol Violation|2|||
94440424|NCT02288325|323399291|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
94440425|NCT02288325|323399292|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
94440426|NCT02288325|323399293|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
94440427|NCT02288325|323399291|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
94440428|NCT02288325|323399292|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
94440429|NCT02288325|323399293|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
94440430|NCT05064397|323399294|FG000|Overall Study|Adverse Event|4|||
94440431|NCT05064397|323399294|FG000|Overall Study|Lack of Efficacy|12|||
94440432|NCT05064397|323399294|FG000|Overall Study|Withdrawal by Subject|3|||
94440433|NCT05064397|323399294|FG000|Overall Study|Lost to Follow-up|1|||
94440434|NCT05064397|323399294|FG000|Overall Study|Other reasons|3|||
94440435|NCT00769379|323399299|FG000|Overall Study|No follow up data mapped to Other.|3|||
94440436|NCT00769379|323399300|FG001|Overall Study|No follow up data mapped to Other.|13|||
94440437|NCT03735121|323399301|FG000|Overall Study|Death|3|||
94440438|NCT03735121|323399302|FG001|Overall Study|Death|6|||
94440439|NCT03735121|323399303|FG002|Overall Study|Death|8|||
94440440|NCT03735121|323399304|FG003|Overall Study|Death|37|||
94440441|NCT03735121|323399305|FG004|Overall Study|Death|86|||
94440442|NCT03735121|323399301|FG000|Overall Study|Withdrawal by Subject|1|||
94440443|NCT03735121|323399302|FG001|Overall Study|Withdrawal by Subject|1|||
94440444|NCT03735121|323399303|FG002|Overall Study|Withdrawal by Subject|3|||
94440445|NCT03735121|323399304|FG003|Overall Study|Withdrawal by Subject|4|||
94440446|NCT03735121|323399305|FG004|Overall Study|Withdrawal by Subject|2|||
94440447|NCT03735121|323399301|FG000|Overall Study|Progressive Disease|0|||
94440448|NCT03735121|323399302|FG001|Overall Study|Progressive Disease|0|||
94440449|NCT03735121|323399303|FG002|Overall Study|Progressive Disease|1|||
94440450|NCT03735121|323399304|FG003|Overall Study|Progressive Disease|0|||
94440451|NCT03735121|323399305|FG004|Overall Study|Progressive Disease|0|||
94440452|NCT03735121|323399301|FG000|Overall Study|Lost to Follow-up|0|||
94440453|NCT03735121|323399302|FG001|Overall Study|Lost to Follow-up|0|||
94440454|NCT03735121|323399303|FG002|Overall Study|Lost to Follow-up|0|||
94440455|NCT03735121|323399304|FG003|Overall Study|Lost to Follow-up|0|||
94440456|NCT03735121|323399305|FG004|Overall Study|Lost to Follow-up|1|||
94440457|NCT03735121|323399301|FG000|Overall Study|Ongoing|3|||
94440458|NCT03735121|323399302|FG001|Overall Study|Ongoing|3|||
94440459|NCT03735121|323399303|FG002|Overall Study|Ongoing|26|||
94440460|NCT03735121|323399304|FG003|Overall Study|Ongoing|83|||
94440461|NCT03735121|323399305|FG004|Overall Study|Ongoing|158|||
94440462|NCT06481709|323399306|FG000|Overall Study|Withdrawal by Subject|0|||
94440463|NCT06481709|323399307|FG001|Overall Study|Withdrawal by Subject|0|||
94440464|NCT06481709|323399308|FG002|Overall Study|Withdrawal by Subject|2|||
94440465|NCT06481709|323399309|FG003|Overall Study|Withdrawal by Subject|0|||
94440466|NCT05211726|323399310|FG000|Overall Study|Withdrawal by Subject|2|||
94440467|NCT05211726|323399311|FG001|Overall Study|Withdrawal by Subject|3|||
94440468|NCT05211726|323399310|FG000|Overall Study|Protocol Violation|0|||
94440469|NCT05211726|323399311|FG001|Overall Study|Protocol Violation|1|||
94440470|NCT05767905|323399312|FG000|Overall Study|Adverse Event|0|||
94440471|NCT05767905|323399313|FG001|Overall Study|Adverse Event|0|||
94440472|NCT05767905|323399314|FG002|Overall Study|Adverse Event|1|||
94440473|NCT03762239|323399315|FG000|Overall Study|Appointment to the doctor|1|||
94440474|NCT03762239|323399316|FG001|Overall Study|Appointment to the doctor|1|||
94440475|NCT04471428|323399318|FG000|Overall Study|Withdrawal by Subject|29|||
94440476|NCT04471428|323399319|FG001|Overall Study|Withdrawal by Subject|1|||
94440477|NCT04471428|323399318|FG000|Overall Study|Physician Decision|0|||
94440478|NCT04471428|323399319|FG001|Overall Study|Physician Decision|1|||
94440479|NCT04471428|323399318|FG000|Overall Study|Reason Not Specified|0|||
94440480|NCT04471428|323399319|FG001|Overall Study|Reason Not Specified|2|||
94440481|NCT04471428|323399318|FG000|Overall Study|Death|106|||
94440482|NCT04471428|323399319|FG001|Overall Study|Death|114|||
94440483|NCT04471428|323399318|FG000|Overall Study|Ongoing in the study|45|||
94339524|NCT02417064|323024707|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
94339525|NCT02417064|323024708|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
94339526|NCT02417064|323024709|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
94339527|NCT02417064|323024707|FG000|Follow-up Phase (24 Weeks)|Other|2|||
94339528|NCT02417064|323024708|FG001|Follow-up Phase (24 Weeks)|Other|2|||
94339529|NCT02417064|323024709|FG002|Follow-up Phase (24 Weeks)|Other|3|||
94339530|NCT02136134|323024710|FG000|Overall Study|Death|170|||
94339531|NCT02136134|323024711|FG001|Overall Study|Death|148|||
94339532|NCT02136134|323024710|FG000|Overall Study|Withdrawal by Subject|19|||
94339533|NCT02136134|323024711|FG001|Overall Study|Withdrawal by Subject|10|||
94339534|NCT02136134|323024710|FG000|Overall Study|Lost to Follow-up|3|||
94339535|NCT02136134|323024711|FG001|Overall Study|Lost to Follow-up|3|||
94339536|NCT02136134|323024710|FG000|Overall Study|Uspecified|55|||
94339537|NCT02136134|323024711|FG001|Overall Study|Uspecified|90|||
94339538|NCT04882072|323024712|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
94339539|NCT04882072|323024713|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
94339540|NCT04882072|323024712|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
94339541|NCT04882072|323024713|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
94339542|NCT04882072|323024712|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
94339543|NCT04882072|323024713|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
94339544|NCT03345342|323024714|FG000|Open-Label Phase|Adverse Event|30|||
94339545|NCT03345342|323024715|FG001|Open-Label Phase|Adverse Event|0|||
94339546|NCT03345342|323024716|FG002|Open-Label Phase|Adverse Event|0|||
94339547|NCT03345342|323024717|FG003|Open-Label Phase|Adverse Event|0|||
94339548|NCT03345342|323024718|FG004|Open-Label Phase|Adverse Event|0|||
94339549|NCT03345342|323024714|FG000|Open-Label Phase|Death|1|||
94339550|NCT03345342|323024715|FG001|Open-Label Phase|Death|0|||
94339551|NCT03345342|323024716|FG002|Open-Label Phase|Death|0|||
94339552|NCT03345342|323024717|FG003|Open-Label Phase|Death|0|||
94339553|NCT03345342|323024718|FG004|Open-Label Phase|Death|0|||
94339554|NCT03345342|323024714|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
94339555|NCT03345342|323024715|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
94339556|NCT03345342|323024716|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
94339557|NCT03345342|323024717|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
94339558|NCT03345342|323024718|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
94339559|NCT03345342|323024714|FG000|Open-Label Phase|Lack of Efficacy|6|||
94339560|NCT03345342|323024715|FG001|Open-Label Phase|Lack of Efficacy|0|||
94339561|NCT03345342|323024716|FG002|Open-Label Phase|Lack of Efficacy|0|||
94339562|NCT03345342|323024717|FG003|Open-Label Phase|Lack of Efficacy|0|||
94339563|NCT03345342|323024718|FG004|Open-Label Phase|Lack of Efficacy|0|||
94339564|NCT03345342|323024714|FG000|Open-Label Phase|Lost to Follow-up|9|||
94339565|NCT03345342|323024715|FG001|Open-Label Phase|Lost to Follow-up|0|||
94339566|NCT03345342|323024716|FG002|Open-Label Phase|Lost to Follow-up|0|||
94339567|NCT03345342|323024717|FG003|Open-Label Phase|Lost to Follow-up|0|||
94339568|NCT03345342|323024718|FG004|Open-Label Phase|Lost to Follow-up|0|||
94339569|NCT03345342|323024714|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
94339570|NCT03345342|323024715|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
94339571|NCT03345342|323024716|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
94339572|NCT03345342|323024717|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
94339573|NCT03345342|323024718|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
94339574|NCT03345342|323024714|FG000|Open-Label Phase|Physician Decision|4|||
94339575|NCT03345342|323024715|FG001|Open-Label Phase|Physician Decision|0|||
94339576|NCT03345342|323024716|FG002|Open-Label Phase|Physician Decision|0|||
94339577|NCT03345342|323024717|FG003|Open-Label Phase|Physician Decision|0|||
94339578|NCT03345342|323024718|FG004|Open-Label Phase|Physician Decision|0|||
94339579|NCT03345342|323024714|FG000|Open-Label Phase|Protocol Violation|8|||
94339580|NCT03345342|323024715|FG001|Open-Label Phase|Protocol Violation|0|||
94339581|NCT03345342|323024716|FG002|Open-Label Phase|Protocol Violation|0|||
94339582|NCT03345342|323024717|FG003|Open-Label Phase|Protocol Violation|0|||
94339583|NCT03345342|323024718|FG004|Open-Label Phase|Protocol Violation|0|||
94339584|NCT03345342|323024714|FG000|Open-Label Phase|Withdrawal by Subject|57|||
94339585|NCT03345342|323024715|FG001|Open-Label Phase|Withdrawal by Subject|0|||
94339586|NCT03345342|323024716|FG002|Open-Label Phase|Withdrawal by Subject|0|||
94339587|NCT03345342|323024717|FG003|Open-Label Phase|Withdrawal by Subject|0|||
94339588|NCT03345342|323024718|FG004|Open-Label Phase|Withdrawal by Subject|0|||
94339589|NCT03345342|323024714|FG000|Open-Label Phase|Other|15|||
94339590|NCT03345342|323024715|FG001|Open-Label Phase|Other|0|||
94339591|NCT03345342|323024716|FG002|Open-Label Phase|Other|0|||
94339592|NCT03345342|323024717|FG003|Open-Label Phase|Other|0|||
94339593|NCT03345342|323024718|FG004|Open-Label Phase|Other|0|||
94339594|NCT03345342|323024714|FG000|Double-Blind Phase|Adverse Event|0|||
94339595|NCT03345342|323024715|FG001|Double-Blind Phase|Adverse Event|1|||
94339596|NCT03345342|323024716|FG002|Double-Blind Phase|Adverse Event|6|||
94339597|NCT03345342|323024717|FG003|Double-Blind Phase|Adverse Event|0|||
94339598|NCT03345342|323024718|FG004|Double-Blind Phase|Adverse Event|0|||
94339599|NCT03345342|323024714|FG000|Double-Blind Phase|Death|0|||
94339600|NCT03345342|323024715|FG001|Double-Blind Phase|Death|2|||
94339601|NCT03345342|323024716|FG002|Double-Blind Phase|Death|1|||
94339602|NCT03345342|323024717|FG003|Double-Blind Phase|Death|0|||
94339603|NCT03345342|323024718|FG004|Double-Blind Phase|Death|0|||
94339604|NCT03345342|323024714|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
94339605|NCT03345342|323024715|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
94339606|NCT03345342|323024716|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
94339607|NCT03345342|323024717|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
94339608|NCT03345342|323024718|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
94339609|NCT03345342|323024714|FG000|Double-Blind Phase|Lost to Follow-up|0|||
94339610|NCT03345342|323024715|FG001|Double-Blind Phase|Lost to Follow-up|1|||
94339611|NCT03345342|323024716|FG002|Double-Blind Phase|Lost to Follow-up|7|||
94339612|NCT03345342|323024717|FG003|Double-Blind Phase|Lost to Follow-up|0|||
94339613|NCT03345342|323024718|FG004|Double-Blind Phase|Lost to Follow-up|0|||
94339614|NCT03345342|323024714|FG000|Double-Blind Phase|Physician Decision|0|||
94339615|NCT03345342|323024715|FG001|Double-Blind Phase|Physician Decision|1|||
94339616|NCT03345342|323024716|FG002|Double-Blind Phase|Physician Decision|4|||
94339617|NCT03345342|323024717|FG003|Double-Blind Phase|Physician Decision|0|||
94339618|NCT03345342|323024718|FG004|Double-Blind Phase|Physician Decision|0|||
94339619|NCT03345342|323024714|FG000|Double-Blind Phase|Protocol Violation|0|||
94339620|NCT03345342|323024715|FG001|Double-Blind Phase|Protocol Violation|0|||
94339621|NCT03345342|323024716|FG002|Double-Blind Phase|Protocol Violation|1|||
94339622|NCT03345342|323024717|FG003|Double-Blind Phase|Protocol Violation|0|||
94339623|NCT03345342|323024718|FG004|Double-Blind Phase|Protocol Violation|0|||
94339624|NCT03345342|323024714|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
94339625|NCT03345342|323024715|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
94339626|NCT03345342|323024716|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
94339627|NCT03345342|323024717|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
94339628|NCT03345342|323024718|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
94339629|NCT03345342|323024714|FG000|Double-Blind Phase|Other|0|||
94339630|NCT03345342|323024715|FG001|Double-Blind Phase|Other|1|||
94339631|NCT03345342|323024716|FG002|Double-Blind Phase|Other|3|||
94339632|NCT03345342|323024717|FG003|Double-Blind Phase|Other|0|||
94339633|NCT03345342|323024718|FG004|Double-Blind Phase|Other|0|||
94339634|NCT03345342|323024714|FG000|Follow-Up Phase|Adverse Event|0|||
94339635|NCT03345342|323024715|FG001|Follow-Up Phase|Adverse Event|0|||
94339636|NCT03345342|323024716|FG002|Follow-Up Phase|Adverse Event|0|||
94339637|NCT03345342|323024717|FG003|Follow-Up Phase|Adverse Event|0|||
94339638|NCT03345342|323024718|FG004|Follow-Up Phase|Adverse Event|4|||
94339639|NCT03345342|323024714|FG000|Follow-Up Phase|Lost to Follow-up|0|||
94339640|NCT03345342|323024715|FG001|Follow-Up Phase|Lost to Follow-up|0|||
94339641|NCT03345342|323024716|FG002|Follow-Up Phase|Lost to Follow-up|0|||
94339642|NCT03345342|323024717|FG003|Follow-Up Phase|Lost to Follow-up|0|||
94339643|NCT03345342|323024718|FG004|Follow-Up Phase|Lost to Follow-up|6|||
94339644|NCT03345342|323024714|FG000|Follow-Up Phase|Physician Decision|0|||
94339645|NCT03345342|323024715|FG001|Follow-Up Phase|Physician Decision|0|||
94339646|NCT03345342|323024716|FG002|Follow-Up Phase|Physician Decision|0|||
94339647|NCT03345342|323024717|FG003|Follow-Up Phase|Physician Decision|0|||
94339648|NCT03345342|323024718|FG004|Follow-Up Phase|Physician Decision|5|||
94339649|NCT03345342|323024714|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
94339650|NCT03345342|323024715|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
94339651|NCT03345342|323024716|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
94339652|NCT03345342|323024717|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
94339653|NCT03345342|323024718|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
94339654|NCT03345342|323024714|FG000|Follow-Up Phase|Other|0|||
94339655|NCT03345342|323024715|FG001|Follow-Up Phase|Other|0|||
94339656|NCT03345342|323024716|FG002|Follow-Up Phase|Other|0|||
94339657|NCT03345342|323024717|FG003|Follow-Up Phase|Other|3|||
94339658|NCT03345342|323024718|FG004|Follow-Up Phase|Other|1|||
94339659|NCT02437162|323024719|FG000|Overall Study|Protocol Violation|0|||
94339660|NCT02437162|323024720|FG001|Overall Study|Protocol Violation|1|||
94339661|NCT02437162|323024721|FG002|Overall Study|Protocol Violation|0|||
94339662|NCT02437162|323024719|FG000|Overall Study|Randomized but not treated|0|||
94339663|NCT02437162|323024720|FG001|Overall Study|Randomized but not treated|0|||
94339664|NCT02437162|323024721|FG002|Overall Study|Randomized but not treated|1|||
94339665|NCT02437162|323024719|FG000|Overall Study|Study discontinued by Sponsor|93|||
94339666|NCT02437162|323024720|FG001|Overall Study|Study discontinued by Sponsor|98|||
94339667|NCT02437162|323024721|FG002|Overall Study|Study discontinued by Sponsor|97|||
94339668|NCT02437162|323024719|FG000|Overall Study|Withdrawal by Subject|13|||
94339669|NCT02437162|323024720|FG001|Overall Study|Withdrawal by Subject|7|||
94339670|NCT02437162|323024721|FG002|Overall Study|Withdrawal by Subject|9|||
94339671|NCT02437162|323024719|FG000|Overall Study|Adverse Event|0|||
94339672|NCT02437162|323024720|FG001|Overall Study|Adverse Event|1|||
94339673|NCT02437162|323024721|FG002|Overall Study|Adverse Event|0|||
94339674|NCT02437162|323024719|FG000|Overall Study|Lost to Follow-up|1|||
94339675|NCT02437162|323024720|FG001|Overall Study|Lost to Follow-up|0|||
94339676|NCT02437162|323024721|FG002|Overall Study|Lost to Follow-up|1|||
94339677|NCT02437162|323024719|FG000|Overall Study|Death|0|||
94339678|NCT02437162|323024720|FG001|Overall Study|Death|1|||
94339679|NCT02437162|323024721|FG002|Overall Study|Death|0|||
94339680|NCT02437162|323024719|FG000|Overall Study|Other|0|||
94339681|NCT02437162|323024720|FG001|Overall Study|Other|0|||
94339682|NCT02437162|323024721|FG002|Overall Study|Other|1|||
94339683|NCT04338321|323024722|FG000|Overall Study|Adverse Event|4|||
94339684|NCT04338321|323024723|FG001|Overall Study|Adverse Event|10|||
94339685|NCT04338321|323024722|FG000|Overall Study|Death|1|||
94339686|NCT04338321|323024723|FG001|Overall Study|Death|1|||
94339687|NCT04338321|323024722|FG000|Overall Study|Lost to Follow-up|4|||
94339688|NCT04338321|323024723|FG001|Overall Study|Lost to Follow-up|9|||
94339689|NCT04338321|323024722|FG000|Overall Study|Withdrawal by Subject|45|||
94339690|NCT04338321|323024723|FG001|Overall Study|Withdrawal by Subject|69|||
94339691|NCT04338321|323024722|FG000|Overall Study|Physician Decision|5|||
94339692|NCT04338321|323024723|FG001|Overall Study|Physician Decision|9|||
94339693|NCT04338321|323024722|FG000|Overall Study|Other|3|||
94339694|NCT04338321|323024723|FG001|Overall Study|Other|10|||
94440484|NCT04471428|323399319|FG001|Overall Study|Ongoing in the study|68|||
94440485|NCT05198518|323399322|FG000|Screening Visit|Deemed unable to participate|58|||
94440486|NCT05198518|323399323|FG001|Screening Visit|Deemed unable to participate|0|||
94440487|NCT05198518|323399324|FG002|Screening Visit|Deemed unable to participate|0|||
94440488|NCT03624192|323399331|FG000|Overall Study|Lost to Follow-up|1|||
94440489|NCT03624192|323399332|FG001|Overall Study|Lost to Follow-up|1|||
94440490|NCT00312338|323399333|FG000|Overall Study|Adverse Event|7|||
94440491|NCT00312338|323399334|FG001|Overall Study|Adverse Event|2|||
94440492|NCT00312338|323399333|FG000|Overall Study|Lost to Follow-up|9|||
94440493|NCT00312338|323399334|FG001|Overall Study|Lost to Follow-up|1|||
94440494|NCT00312338|323399333|FG000|Overall Study|Withdrawal by Subject|4|||
94440495|NCT00312338|323399334|FG001|Overall Study|Withdrawal by Subject|0|||
94440496|NCT00312338|323399333|FG000|Overall Study|Subsequent infection|2|||
94440497|NCT00312338|323399334|FG001|Overall Study|Subsequent infection|0|||
94440498|NCT01176513|323399335|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
94440499|NCT00613171|323399336|FG000|Overall Study|Adverse Event|7|||
94440500|NCT00613171|323399336|FG000|Overall Study|Withdrawal by Subject|3|||
94440501|NCT00613171|323399336|FG000|Overall Study|Reason not Specified|4|||
94548756|NCT04181827|323805676|FG001|Overall Study|Withdrawal by Subject|0|||
94548757|NCT01818284|323805681|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
94548758|NCT01818284|323805682|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
94548759|NCT01818284|323805681|FG000|Overall Study|Death|0|||
94548760|NCT01818284|323805682|FG001|Overall Study|Death|2|||
94548761|NCT03007745|323805685|FG000|Overall Study|Sleep test negative for OSA|53|||
94440502|NCT01169350|323399345|FG000|Overall Study|Physician Decision|3|||
94440503|NCT01169350|323399345|FG000|Overall Study|Lost to Follow-up|2|||
94440504|NCT04870710|323399346|FG000|Overall Study|Lost to Follow-up|3|||
94440505|NCT00476190|323399347|FG000|Overall Study|Ineligible|1|||
94440506|NCT00476190|323399348|FG001|Overall Study|Ineligible|1|||
94440507|NCT00476190|323399347|FG000|Overall Study|Induction Death|2|||
94440508|NCT00476190|323399348|FG001|Overall Study|Induction Death|0|||
94440509|NCT00476190|323399347|FG000|Overall Study|Induction Failure|2|||
94440510|NCT00476190|323399348|FG001|Overall Study|Induction Failure|4|||
94440511|NCT00476190|323399347|FG000|Overall Study|Lost to Follow-up|1|||
94440512|NCT00476190|323399348|FG001|Overall Study|Lost to Follow-up|0|||
94440513|NCT00476190|323399347|FG000|Overall Study|Relapse/Progression|5|||
94440514|NCT00476190|323399348|FG001|Overall Study|Relapse/Progression|2|||
94440515|NCT00476190|323399347|FG000|Overall Study|Remission Death|0|||
94440516|NCT00476190|323399348|FG001|Overall Study|Remission Death|1|||
94440517|NCT00476190|323399347|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
94440518|NCT00476190|323399348|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
94440519|NCT00476190|323399347|FG000|Overall Study|Withdrawal by Subject|6|||
94440520|NCT00476190|323399348|FG001|Overall Study|Withdrawal by Subject|2|||
94440521|NCT00476190|323399347|FG000|Overall Study|Other|9|||
94440522|NCT00476190|323399348|FG001|Overall Study|Other|10|||
94440523|NCT04338022|323399349|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
94440524|NCT04338022|323399350|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
94440525|NCT04338022|323399349|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
94440526|NCT04338022|323399350|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
94440527|NCT04338022|323399349|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
94440528|NCT04338022|323399350|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
94440529|NCT04338022|323399349|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
94440530|NCT04338022|323399350|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
94440531|NCT04338022|323399349|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
94440532|NCT04338022|323399350|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
94339695|NCT02438787|323024724|FG000|Overall Study|Adverse Event|1|||
94440533|NCT04338022|323399349|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
94440534|NCT04338022|323399350|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
94339696|NCT02438787|323024725|FG001|Overall Study|Adverse Event|0|||
94339697|NCT02438787|323024726|FG002|Overall Study|Adverse Event|2|||
94339698|NCT02438787|323024724|FG000|Overall Study|Lack of Efficacy|1|||
94339699|NCT02438787|323024725|FG001|Overall Study|Lack of Efficacy|2|||
94339700|NCT02438787|323024726|FG002|Overall Study|Lack of Efficacy|0|||
94339701|NCT02438787|323024724|FG000|Overall Study|Lost to Follow-up|0|||
94339702|NCT02438787|323024725|FG001|Overall Study|Lost to Follow-up|1|||
94339703|NCT02438787|323024726|FG002|Overall Study|Lost to Follow-up|0|||
94339704|NCT02438787|323024724|FG000|Overall Study|Protocol Violation|0|||
94339705|NCT02438787|323024725|FG001|Overall Study|Protocol Violation|0|||
94339706|NCT02438787|323024726|FG002|Overall Study|Protocol Violation|1|||
94339707|NCT02438787|323024724|FG000|Overall Study|Withdrawal by Subject|15|||
94339708|NCT02438787|323024725|FG001|Overall Study|Withdrawal by Subject|7|||
94339709|NCT02438787|323024726|FG002|Overall Study|Withdrawal by Subject|10|||
94339710|NCT02438787|323024724|FG000|Overall Study|Study discontinued by sponsor|64|||
94339711|NCT02438787|323024725|FG001|Overall Study|Study discontinued by sponsor|72|||
94339712|NCT02438787|323024726|FG002|Overall Study|Study discontinued by sponsor|69|||
94339713|NCT02438787|323024724|FG000|Overall Study|Other|0|||
94339714|NCT02438787|323024725|FG001|Overall Study|Other|1|||
94339715|NCT02438787|323024726|FG002|Overall Study|Other|0|||
94339716|NCT02438787|323024724|FG000|Overall Study|Site terminated by sponsor|0|||
94339717|NCT02438787|323024725|FG001|Overall Study|Site terminated by sponsor|0|||
94339718|NCT02438787|323024726|FG002|Overall Study|Site terminated by sponsor|1|||
94339719|NCT03412565|323024727|FG000|Overall Study|Lost to Follow-up|0|||
94339720|NCT03412565|323024728|FG001|Overall Study|Lost to Follow-up|0|||
94339721|NCT03412565|323024729|FG002|Overall Study|Lost to Follow-up|1|||
94339722|NCT03412565|323024730|FG003|Overall Study|Lost to Follow-up|0|||
94339723|NCT03412565|323024727|FG000|Overall Study|Physician Decision|0|||
94339724|NCT03412565|323024728|FG001|Overall Study|Physician Decision|0|||
94339725|NCT03412565|323024729|FG002|Overall Study|Physician Decision|0|||
94339726|NCT03412565|323024730|FG003|Overall Study|Physician Decision|1|||
94339727|NCT03412565|323024727|FG000|Overall Study|Withdrawal by Subject|0|||
94339728|NCT03412565|323024728|FG001|Overall Study|Withdrawal by Subject|4|||
94339729|NCT03412565|323024729|FG002|Overall Study|Withdrawal by Subject|5|||
94339730|NCT03412565|323024730|FG003|Overall Study|Withdrawal by Subject|5|||
94339731|NCT03412565|323024727|FG000|Overall Study|Death|1|||
94339732|NCT03412565|323024728|FG001|Overall Study|Death|3|||
94339733|NCT03412565|323024729|FG002|Overall Study|Death|4|||
94339734|NCT03412565|323024730|FG003|Overall Study|Death|5|||
94339735|NCT03412565|323024727|FG000|Overall Study|Data collection ended|0|||
94339736|NCT03412565|323024728|FG001|Overall Study|Data collection ended|41|||
94339737|NCT03412565|323024729|FG002|Overall Study|Data collection ended|41|||
94339738|NCT03412565|323024730|FG003|Overall Study|Data collection ended|40|||
94339739|NCT03107793|323024731|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
94339740|NCT03107793|323024732|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
94339741|NCT03107793|323024733|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
94339742|NCT03107793|323024734|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
94339743|NCT03107793|323024735|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
94339744|NCT03107793|323024731|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
94339745|NCT03107793|323024732|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
94339746|NCT03107793|323024733|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
94339747|NCT03107793|323024734|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
94339748|NCT03107793|323024735|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
94339749|NCT03107793|323024731|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
94339750|NCT03107793|323024732|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
94339751|NCT03107793|323024733|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
94339752|NCT03107793|323024734|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
94339753|NCT03107793|323024735|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
94339754|NCT03107793|323024731|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
94339755|NCT03107793|323024732|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94339756|NCT03107793|323024733|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94339757|NCT03107793|323024734|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94339758|NCT03107793|323024735|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94440535|NCT04338022|323399349|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
94339759|NCT03107793|323024731|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
94339760|NCT03107793|323024732|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
94339761|NCT03107793|323024733|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
94339762|NCT03107793|323024734|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
94339763|NCT03107793|323024735|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
94339764|NCT03107793|323024731|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
94339765|NCT03107793|323024732|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
94339766|NCT03107793|323024733|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
94339767|NCT03107793|323024734|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
94339768|NCT03107793|323024735|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
94339769|NCT03107793|323024731|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
94339770|NCT03107793|323024732|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
94440536|NCT04338022|323399350|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
94440537|NCT04338022|323399349|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
94440538|NCT04338022|323399350|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
94440539|NCT04338022|323399349|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
94440540|NCT04338022|323399350|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
94440541|NCT04338022|323399349|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
94440542|NCT04338022|323399350|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
94440543|NCT04338022|323399349|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
94440544|NCT04338022|323399350|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
94440545|NCT04338022|323399349|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
94440546|NCT04338022|323399350|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
94440547|NCT04338022|323399349|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
94440548|NCT04338022|323399350|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
94440549|NCT04338022|323399349|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
94440550|NCT04338022|323399350|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
94440551|NCT06071754|323399351|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
94440552|NCT00683657|323399353|FG000|Overall Study|Adverse Event|0|||
94440553|NCT00683657|323399354|FG001|Overall Study|Adverse Event|1|||
94440554|NCT00683657|323399353|FG000|Overall Study|Subject Withdrew Consent|1|||
94440555|NCT00683657|323399354|FG001|Overall Study|Subject Withdrew Consent|0|||
94440556|NCT00972595|323399355|FG000|Period 1|Adverse Event|1|||
94440557|NCT00972595|323399356|FG001|Period 1|Adverse Event|0|||
94440558|NCT01461538|323399357|FG000|Overall Study|Death|15|||
94440559|NCT01461538|323399358|FG001|Overall Study|Death|6|||
94440560|NCT01461538|323399359|FG002|Overall Study|Death|2|||
94440561|NCT01461538|323399357|FG000|Overall Study|Study Stopped by Sponsor|2|||
94440562|NCT01461538|323399358|FG001|Overall Study|Study Stopped by Sponsor|1|||
94440563|NCT01461538|323399359|FG002|Overall Study|Study Stopped by Sponsor|0|||
94440564|NCT01461538|323399357|FG000|Overall Study|Withdrawal by Subject|1|||
94440565|NCT01461538|323399358|FG001|Overall Study|Withdrawal by Subject|1|||
94440566|NCT01461538|323399359|FG002|Overall Study|Withdrawal by Subject|0|||
94440567|NCT00768248|323399360|FG000|Overall Study|Research coordinator didn't collect data|1|||
94440568|NCT00768248|323399361|FG001|Overall Study|Research coordinator didn't collect data|1|||
94440569|NCT01459783|323399362|FG000|Baseline to 6 Months|Death|1|||
94440570|NCT01459783|323399363|FG001|Baseline to 6 Months|Death|0|||
94440571|NCT01459783|323399362|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
94440572|NCT01459783|323399363|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
94440573|NCT01459783|323399362|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
94440574|NCT01459783|323399363|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
94440575|NCT01459783|323399362|FG000|6 Months to 12 Months|Death|0|||
94440576|NCT01459783|323399363|FG001|6 Months to 12 Months|Death|1|||
94440577|NCT01459783|323399362|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
94440578|NCT01459783|323399363|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
94440579|NCT01459783|323399362|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
94440580|NCT01459783|323399363|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
94548762|NCT03007745|323805686|FG001|Overall Study|Sleep test negative for OSA|49|||
94548763|NCT03007745|323805685|FG000|Overall Study|Physician Decision|6|||
94548764|NCT03007745|323805686|FG001|Overall Study|Physician Decision|9|||
94548765|NCT03007745|323805685|FG000|Overall Study|Withdrawal by Subject|38|||
94548766|NCT03007745|323805686|FG001|Overall Study|Withdrawal by Subject|16|||
94548767|NCT03007745|323805685|FG000|Overall Study|Lost to Follow-up|19|||
94548768|NCT03007745|323805686|FG001|Overall Study|Lost to Follow-up|25|||
94548769|NCT03007745|323805685|FG000|Overall Study|Unable to login to website|17|||
94548770|NCT03007745|323805686|FG001|Overall Study|Unable to login to website|4|||
94548771|NCT00413010|323805691|FG000|Overall Study|Adverse Event|8|||
94548772|NCT00413010|323805692|FG001|Overall Study|Adverse Event|4|||
94548773|NCT00413010|323805691|FG000|Overall Study|Laboratory abnormality|0|||
94548774|NCT00413010|323805692|FG001|Overall Study|Laboratory abnormality|2|||
94548775|NCT00413010|323805691|FG000|Overall Study|Lack of Efficacy|0|||
94548776|NCT00413010|323805692|FG001|Overall Study|Lack of Efficacy|3|||
94548777|NCT00413010|323805691|FG000|Overall Study|Lost to Follow-up|3|||
94548778|NCT00413010|323805692|FG001|Overall Study|Lost to Follow-up|0|||
94548779|NCT00413010|323805691|FG000|Overall Study|Withdrawal by Subject|7|||
94548780|NCT00413010|323805692|FG001|Overall Study|Withdrawal by Subject|2|||
94548781|NCT00413010|323805691|FG000|Overall Study|Due to termination of the study|54|||
94548782|NCT00413010|323805692|FG001|Overall Study|Due to termination of the study|52|||
94548783|NCT00430937|323805693|FG000|Overall Study|Adverse Event|3|||
94440581|NCT01459783|323399362|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
94440582|NCT01459783|323399363|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
94440583|NCT00752128|323399366|FG000|Overall Study|Withdrawal by Subject|4|||
94440584|NCT02166333|323399367|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
94440585|NCT02166333|323399368|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
94440586|NCT02166333|323399369|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
94440587|NCT02166333|323399370|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
94440588|NCT02166333|323399371|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
94440589|NCT02166333|323399372|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
94440590|NCT02166333|323399367|FG000|Stage 1|Death|4|||
94440591|NCT02166333|323399368|FG001|Stage 1|Death|0|||
94440592|NCT02166333|323399369|FG002|Stage 1|Death|2|||
94440593|NCT02166333|323399370|FG003|Stage 1|Death|0|||
94440594|NCT02166333|323399371|FG004|Stage 1|Death|3|||
94440595|NCT02166333|323399372|FG005|Stage 1|Death|2|||
94440596|NCT02166333|323399367|FG000|Stage 1|Lost to Follow-up|12|||
94440597|NCT02166333|323399368|FG001|Stage 1|Lost to Follow-up|0|||
94440598|NCT02166333|323399369|FG002|Stage 1|Lost to Follow-up|6|||
94440599|NCT02166333|323399370|FG003|Stage 1|Lost to Follow-up|0|||
94440600|NCT02166333|323399371|FG004|Stage 1|Lost to Follow-up|3|||
94440601|NCT02166333|323399372|FG005|Stage 1|Lost to Follow-up|3|||
94440602|NCT02166333|323399367|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
94440603|NCT02166333|323399368|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
94440604|NCT02166333|323399369|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
94440605|NCT02166333|323399370|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
94440606|NCT02166333|323399371|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
94440607|NCT02166333|323399372|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
94440608|NCT02166333|323399367|FG000|Stage 2|Death|4|||
94440609|NCT02166333|323399368|FG001|Stage 2|Death|2|||
94440610|NCT02166333|323399369|FG002|Stage 2|Death|1|||
94440611|NCT02166333|323399370|FG003|Stage 2|Death|0|||
94440612|NCT02166333|323399371|FG004|Stage 2|Death|0|||
94440613|NCT02166333|323399372|FG005|Stage 2|Death|1|||
94440614|NCT02166333|323399367|FG000|Stage 2|Lost to Follow-up|23|||
94440615|NCT02166333|323399368|FG001|Stage 2|Lost to Follow-up|4|||
94440616|NCT02166333|323399369|FG002|Stage 2|Lost to Follow-up|11|||
94440617|NCT02166333|323399370|FG003|Stage 2|Lost to Follow-up|9|||
94440618|NCT02166333|323399371|FG004|Stage 2|Lost to Follow-up|3|||
94440619|NCT02166333|323399372|FG005|Stage 2|Lost to Follow-up|6|||
94440620|NCT04314037|323399374|FG000|Treatment Period 2|Adverse Event|1|||
94440621|NCT04314037|323399375|FG001|Treatment Period 2|Adverse Event|0|||
94440622|NCT04314037|323399374|FG000|Treatment Period 3|Protocol Violation|1|||
94440623|NCT04314037|323399375|FG001|Treatment Period 3|Protocol Violation|0|||
94440624|NCT04314037|323399374|FG000|Treatment Period 3|Adverse Event|0|||
94440625|NCT04314037|323399375|FG001|Treatment Period 3|Adverse Event|1|||
94440626|NCT00955617|323399379|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
94440627|NCT00955617|323399380|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
94440628|NCT00955617|323399379|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
94440629|NCT00955617|323399380|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
94440630|NCT00955617|323399379|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
94440631|NCT00955617|323399380|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
94440632|NCT00955617|323399379|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
94440633|NCT00955617|323399380|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
94465651|NCT00772005|323494891|FG000|Overall Study|Withdrawal by Subject|3|||
94465652|NCT00772005|323494892|FG001|Overall Study|Withdrawal by Subject|7|||
94465653|NCT00772005|323494893|FG002|Overall Study|Withdrawal by Subject|10|||
94465654|NCT00772005|323494894|FG003|Overall Study|Withdrawal by Subject|2|||
94465655|NCT00772005|323494891|FG000|Overall Study|Protocol Violation|2|||
94465656|NCT00772005|323494892|FG001|Overall Study|Protocol Violation|4|||
94465657|NCT00772005|323494893|FG002|Overall Study|Protocol Violation|1|||
94465658|NCT00772005|323494894|FG003|Overall Study|Protocol Violation|6|||
94465659|NCT00772005|323494891|FG000|Overall Study|Lost to Follow-up|7|||
94465660|NCT00772005|323494892|FG001|Overall Study|Lost to Follow-up|3|||
94465661|NCT00772005|323494893|FG002|Overall Study|Lost to Follow-up|6|||
94465662|NCT00772005|323494894|FG003|Overall Study|Lost to Follow-up|3|||
94465663|NCT00772005|323494891|FG000|Overall Study|Non-compliance with study procedures|1|||
94465664|NCT00772005|323494892|FG001|Overall Study|Non-compliance with study procedures|1|||
94465665|NCT00772005|323494893|FG002|Overall Study|Non-compliance with study procedures|0|||
94465666|NCT00772005|323494894|FG003|Overall Study|Non-compliance with study procedures|1|||
94465667|NCT00772005|323494891|FG000|Overall Study|Non-compliance with drug administration|3|||
94465668|NCT00772005|323494892|FG001|Overall Study|Non-compliance with drug administration|0|||
94465669|NCT00772005|323494893|FG002|Overall Study|Non-compliance with drug administration|1|||
94465670|NCT00772005|323494894|FG003|Overall Study|Non-compliance with drug administration|1|||
94465671|NCT01440569|323494896|FG000|Main Study|Enrolled but not treated|1|||
94465672|NCT01440569|323494897|FG001|Main Study|Enrolled but not treated|0|||
94465673|NCT01440569|323494896|FG000|Main Study|Adverse Event|9|||
94465674|NCT01440569|323494897|FG001|Main Study|Adverse Event|0|||
94465675|NCT01440569|323494896|FG000|Main Study|Pregnancy|1|||
94465676|NCT01440569|323494897|FG001|Main Study|Pregnancy|0|||
94339771|NCT03107793|323024733|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
94339772|NCT03107793|323024734|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
94339773|NCT03107793|323024735|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
94339774|NCT03107793|323024731|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
94339775|NCT03107793|323024732|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
94339776|NCT03107793|323024733|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
94339777|NCT03107793|323024734|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
94339778|NCT03107793|323024735|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
94339779|NCT03107793|323024731|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
94339780|NCT03107793|323024732|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
94339781|NCT03107793|323024733|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
94339782|NCT03107793|323024734|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
94339783|NCT03107793|323024735|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
94339784|NCT03107793|323024731|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
94339785|NCT03107793|323024732|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
94339786|NCT03107793|323024733|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
94339787|NCT03107793|323024734|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
94339788|NCT03107793|323024735|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
94339789|NCT03107793|323024731|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
94339790|NCT03107793|323024732|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
94339791|NCT03107793|323024733|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
94339792|NCT03107793|323024734|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
94339793|NCT03107793|323024735|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
94339794|NCT03107793|323024731|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
94339795|NCT03107793|323024732|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
94339796|NCT03107793|323024733|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
94339797|NCT03107793|323024734|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
94339798|NCT03107793|323024735|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
94339799|NCT03107793|323024731|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
94339800|NCT03107793|323024732|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
94339801|NCT03107793|323024733|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
94339802|NCT03107793|323024734|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
94339803|NCT03107793|323024735|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
94339804|NCT03107793|323024731|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
94339805|NCT03107793|323024732|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
94339806|NCT03107793|323024733|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
94339807|NCT03107793|323024734|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
94339808|NCT03107793|323024735|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
94339809|NCT03107793|323024731|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
94339810|NCT03107793|323024732|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
94339811|NCT03107793|323024733|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
94339812|NCT03107793|323024734|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
94339813|NCT03107793|323024735|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
94339814|NCT03107793|323024731|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
94339815|NCT03107793|323024732|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
94339816|NCT03107793|323024733|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
94339817|NCT03107793|323024734|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
94339818|NCT03107793|323024735|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
94339819|NCT03107793|323024731|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
94339820|NCT03107793|323024732|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
94339821|NCT03107793|323024733|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
94339822|NCT03107793|323024734|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
94339823|NCT03107793|323024735|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
94339824|NCT03107793|323024731|FG000|Extension Period (Week 48- Week 104)|Death|0|||
94339825|NCT03107793|323024732|FG001|Extension Period (Week 48- Week 104)|Death|0|||
94339826|NCT03107793|323024733|FG002|Extension Period (Week 48- Week 104)|Death|0|||
94339827|NCT03107793|323024734|FG003|Extension Period (Week 48- Week 104)|Death|0|||
94339828|NCT03107793|323024735|FG004|Extension Period (Week 48- Week 104)|Death|1|||
94339829|NCT03107793|323024731|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
94339830|NCT03107793|323024732|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
94339831|NCT03107793|323024733|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
94339832|NCT03107793|323024734|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
94339833|NCT03107793|323024735|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
94339834|NCT03107793|323024731|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
94339835|NCT03107793|323024732|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
94548784|NCT00430937|323805694|FG001|Overall Study|Adverse Event|8|||
94548785|NCT00430937|323805693|FG000|Overall Study|Death|0|||
94548786|NCT00430937|323805694|FG001|Overall Study|Death|1|||
94548787|NCT00430937|323805693|FG000|Overall Study|Lost to Follow-up|6|||
94548788|NCT00430937|323805694|FG001|Overall Study|Lost to Follow-up|6|||
94548789|NCT00430937|323805693|FG000|Overall Study|Withdrawal by Subject|5|||
94548790|NCT00430937|323805694|FG001|Overall Study|Withdrawal by Subject|2|||
94548791|NCT00430937|323805693|FG000|Overall Study|Protocol Violation|3|||
94548792|NCT00430937|323805694|FG001|Overall Study|Protocol Violation|2|||
94548793|NCT00430937|323805693|FG000|Overall Study|Lack of Efficacy|6|||
94548794|NCT00430937|323805694|FG001|Overall Study|Lack of Efficacy|5|||
94548795|NCT00430937|323805693|FG000|Overall Study|Inappropriate enrollment|2|||
94548796|NCT00430937|323805694|FG001|Overall Study|Inappropriate enrollment|1|||
94548797|NCT00430937|323805693|FG000|Overall Study|Administrative reasons|1|||
94548798|NCT00430937|323805694|FG001|Overall Study|Administrative reasons|0|||
94548799|NCT00430937|323805693|FG000|Overall Study|Protocol discontinuation criteria met|1|||
94548800|NCT00430937|323805694|FG001|Overall Study|Protocol discontinuation criteria met|2|||
94548801|NCT00430937|323805693|FG000|Overall Study|Unable to classify|0|||
94548802|NCT00430937|323805694|FG001|Overall Study|Unable to classify|1|||
94548803|NCT02771626|323805698|FG000|Overall Study|Adverse Event|1|||
94548804|NCT02771626|323805699|FG001|Overall Study|Adverse Event|5|||
94548805|NCT02771626|323805700|FG002|Overall Study|Adverse Event|3|||
94548806|NCT02771626|323805701|FG003|Overall Study|Adverse Event|0|||
94548807|NCT02771626|323805702|FG004|Overall Study|Adverse Event|1|||
94548808|NCT02771626|323805703|FG005|Overall Study|Adverse Event|1|||
94548809|NCT02771626|323805698|FG000|Overall Study|Radiologic Disease Progression|6|||
94548810|NCT02771626|323805699|FG001|Overall Study|Radiologic Disease Progression|13|||
94548811|NCT02771626|323805700|FG002|Overall Study|Radiologic Disease Progression|10|||
94548812|NCT02771626|323805701|FG003|Overall Study|Radiologic Disease Progression|7|||
94548813|NCT02771626|323805702|FG004|Overall Study|Radiologic Disease Progression|28|||
94548814|NCT02771626|323805703|FG005|Overall Study|Radiologic Disease Progression|15|||
94548815|NCT02771626|323805698|FG000|Overall Study|Symptomatic Deterioration|0|||
94548816|NCT02771626|323805699|FG001|Overall Study|Symptomatic Deterioration|4|||
94548817|NCT02771626|323805700|FG002|Overall Study|Symptomatic Deterioration|2|||
94548818|NCT02771626|323805701|FG003|Overall Study|Symptomatic Deterioration|0|||
94548819|NCT02771626|323805702|FG004|Overall Study|Symptomatic Deterioration|5|||
94548820|NCT02771626|323805703|FG005|Overall Study|Symptomatic Deterioration|2|||
94548821|NCT02771626|323805698|FG000|Overall Study|Participant Request|0|||
94548822|NCT02771626|323805699|FG001|Overall Study|Participant Request|1|||
94548823|NCT02771626|323805700|FG002|Overall Study|Participant Request|0|||
94548824|NCT02771626|323805701|FG003|Overall Study|Participant Request|2|||
94548825|NCT02771626|323805702|FG004|Overall Study|Participant Request|0|||
94548826|NCT02771626|323805703|FG005|Overall Study|Participant Request|1|||
94548827|NCT02771626|323805698|FG000|Overall Study|Investigator Decision|0|||
94548828|NCT02771626|323805699|FG001|Overall Study|Investigator Decision|1|||
94548829|NCT02771626|323805700|FG002|Overall Study|Investigator Decision|0|||
94548830|NCT02771626|323805701|FG003|Overall Study|Investigator Decision|0|||
94548831|NCT02771626|323805702|FG004|Overall Study|Investigator Decision|1|||
94548832|NCT02771626|323805703|FG005|Overall Study|Investigator Decision|0|||
94548833|NCT02771626|323805698|FG000|Overall Study|Study Termination by Sponsor|0|||
94548834|NCT02771626|323805699|FG001|Overall Study|Study Termination by Sponsor|2|||
94548835|NCT02771626|323805700|FG002|Overall Study|Study Termination by Sponsor|1|||
94548836|NCT02771626|323805701|FG003|Overall Study|Study Termination by Sponsor|0|||
94548837|NCT02771626|323805702|FG004|Overall Study|Study Termination by Sponsor|1|||
94548838|NCT02771626|323805703|FG005|Overall Study|Study Termination by Sponsor|0|||
94548839|NCT02771626|323805698|FG000|Overall Study|Informed Consent Withdrawn|0|||
94548840|NCT02771626|323805699|FG001|Overall Study|Informed Consent Withdrawn|0|||
94548841|NCT02771626|323805700|FG002|Overall Study|Informed Consent Withdrawn|1|||
94548842|NCT02771626|323805701|FG003|Overall Study|Informed Consent Withdrawn|0|||
94548843|NCT02771626|323805702|FG004|Overall Study|Informed Consent Withdrawn|1|||
94548844|NCT02771626|323805703|FG005|Overall Study|Informed Consent Withdrawn|1|||
94548845|NCT02771626|323805698|FG000|Overall Study|Other, Not Specified|1|||
94548846|NCT02771626|323805699|FG001|Overall Study|Other, Not Specified|0|||
94548847|NCT02771626|323805700|FG002|Overall Study|Other, Not Specified|0|||
94548848|NCT02771626|323805701|FG003|Overall Study|Other, Not Specified|0|||
94548849|NCT02771626|323805702|FG004|Overall Study|Other, Not Specified|0|||
94548850|NCT02771626|323805703|FG005|Overall Study|Other, Not Specified|1|||
94548851|NCT02690649|323805706|FG000|Overall Study|Withdrawal by Subject|1|||
94548852|NCT02690649|323805707|FG001|Overall Study|Withdrawal by Subject|1|||
94548853|NCT02690649|323805706|FG000|Overall Study|Protocol Violation|0|||
94548854|NCT02690649|323805707|FG001|Overall Study|Protocol Violation|3|||
94548855|NCT02276547|323805708|FG000|Overall Study|Death|2|||
94548856|NCT02276547|323805708|FG000|Overall Study|Explant|2|||
94548857|NCT02776033|323805712|FG000|Overall Study|Withdrawal by Subject|0|||
94548858|NCT02776033|323805713|FG001|Overall Study|Withdrawal by Subject|0|||
94548859|NCT02776033|323805714|FG002|Overall Study|Withdrawal by Subject|2|||
94548860|NCT02776033|323805712|FG000|Overall Study|Physician Decision|2|||
94548861|NCT02776033|323805713|FG001|Overall Study|Physician Decision|0|||
94548862|NCT02776033|323805714|FG002|Overall Study|Physician Decision|0|||
94548863|NCT02776033|323805712|FG000|Overall Study|Lost to Follow-up|1|||
94548864|NCT02776033|323805713|FG001|Overall Study|Lost to Follow-up|0|||
94548865|NCT02776033|323805714|FG002|Overall Study|Lost to Follow-up|0|||
94548866|NCT02776033|323805712|FG000|Overall Study|Adverse Event|1|||
94548867|NCT02776033|323805713|FG001|Overall Study|Adverse Event|2|||
94339836|NCT03107793|323024733|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
94339837|NCT03107793|323024734|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
94339838|NCT03107793|323024735|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
94339839|NCT03107793|323024731|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
94339840|NCT03107793|323024732|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
94339841|NCT03107793|323024733|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
94339842|NCT03107793|323024734|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
94339843|NCT03107793|323024735|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
94339844|NCT03107793|323024731|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
94339845|NCT03107793|323024732|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
94339846|NCT03107793|323024733|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
94339847|NCT03107793|323024734|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
94339848|NCT03107793|323024735|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
94339849|NCT03107793|323024731|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
94339850|NCT03107793|323024732|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
94339851|NCT03107793|323024733|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
94339852|NCT03107793|323024734|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
94339853|NCT03107793|323024735|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
94339854|NCT03107793|323024731|FG000|Extension Period (Week 48- Week 104)|Other|0|||
94339855|NCT03107793|323024732|FG001|Extension Period (Week 48- Week 104)|Other|0|||
94339856|NCT03107793|323024733|FG002|Extension Period (Week 48- Week 104)|Other|0|||
94339857|NCT03107793|323024734|FG003|Extension Period (Week 48- Week 104)|Other|1|||
94339858|NCT03107793|323024735|FG004|Extension Period (Week 48- Week 104)|Other|3|||
94339859|NCT03107793|323024731|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
94339860|NCT03107793|323024732|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
94339861|NCT03107793|323024733|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
94339862|NCT03107793|323024734|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
94339863|NCT03107793|323024735|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
94339864|NCT03097133|323024736|FG000|Overall Study|Lost to Follow-up|3|||
94339865|NCT03097133|323024737|FG001|Overall Study|Lost to Follow-up|2|||
94339866|NCT03097133|323024736|FG000|Overall Study|Withdrawal by Subject|2|||
94339867|NCT03097133|323024737|FG001|Overall Study|Withdrawal by Subject|5|||
94339868|NCT03097133|323024736|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
94339869|NCT03097133|323024737|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
94339870|NCT03097133|323024736|FG000|Overall Study|Other|3|||
94339871|NCT03097133|323024737|FG001|Overall Study|Other|2|||
94339872|NCT03097133|323024736|FG000|Overall Study|Adverse Event|1|||
94339873|NCT03097133|323024737|FG001|Overall Study|Adverse Event|0|||
94339874|NCT01989572|323024738|FG000|Overall Study|Lack of Efficacy|35|||
94339875|NCT01989572|323024739|FG001|Overall Study|Lack of Efficacy|48|||
94339876|NCT01989572|323024740|FG002|Overall Study|Lack of Efficacy|48|||
94339877|NCT01989572|323024741|FG003|Overall Study|Lack of Efficacy|43|||
94339878|NCT01989572|323024742|FG004|Overall Study|Lack of Efficacy|71|||
94339879|NCT01989572|323024743|FG005|Overall Study|Lack of Efficacy|79|||
94339880|NCT01989572|323024738|FG000|Overall Study|Adverse Event|2|||
94339881|NCT01989572|323024739|FG001|Overall Study|Adverse Event|1|||
94339882|NCT01989572|323024740|FG002|Overall Study|Adverse Event|3|||
94339883|NCT01989572|323024741|FG003|Overall Study|Adverse Event|0|||
94339884|NCT01989572|323024742|FG004|Overall Study|Adverse Event|3|||
94339885|NCT01989572|323024743|FG005|Overall Study|Adverse Event|0|||
94339886|NCT01989572|323024738|FG000|Overall Study|Death|0|||
94339887|NCT01989572|323024739|FG001|Overall Study|Death|0|||
94339888|NCT01989572|323024740|FG002|Overall Study|Death|0|||
94339889|NCT01989572|323024741|FG003|Overall Study|Death|0|||
94339890|NCT01989572|323024742|FG004|Overall Study|Death|1|||
94339891|NCT01989572|323024743|FG005|Overall Study|Death|0|||
94339892|NCT01989572|323024738|FG000|Overall Study|Withdrawal by Subject|4|||
94339893|NCT01989572|323024739|FG001|Overall Study|Withdrawal by Subject|1|||
94339894|NCT01989572|323024740|FG002|Overall Study|Withdrawal by Subject|5|||
94339895|NCT01989572|323024741|FG003|Overall Study|Withdrawal by Subject|1|||
94339896|NCT01989572|323024742|FG004|Overall Study|Withdrawal by Subject|12|||
94339897|NCT01989572|323024743|FG005|Overall Study|Withdrawal by Subject|4|||
94339898|NCT01989572|323024738|FG000|Overall Study|complicating disease|1|||
94548868|NCT02776033|323805714|FG002|Overall Study|Adverse Event|0|||
94548869|NCT01302054|323805715|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
94548870|NCT01302054|323805716|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
94548871|NCT01302054|323805717|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
94548872|NCT01302054|323805715|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
94548873|NCT01302054|323805716|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
94548874|NCT01302054|323805717|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
94548875|NCT01302054|323805715|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
94548876|NCT01302054|323805716|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
94548877|NCT01302054|323805717|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
94548878|NCT01302054|323805715|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
94548879|NCT01302054|323805716|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
94548880|NCT01302054|323805717|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
94548881|NCT01302054|323805715|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
94548882|NCT01302054|323805716|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
94548883|NCT01302054|323805717|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
94548884|NCT01302054|323805715|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
94548885|NCT01302054|323805716|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
94339899|NCT01989572|323024739|FG001|Overall Study|complicating disease|1|||
94339900|NCT01989572|323024740|FG002|Overall Study|complicating disease|2|||
94339901|NCT01989572|323024741|FG003|Overall Study|complicating disease|0|||
94339902|NCT01989572|323024742|FG004|Overall Study|complicating disease|1|||
94339903|NCT01989572|323024743|FG005|Overall Study|complicating disease|0|||
94339904|NCT01989572|323024738|FG000|Overall Study|error|2|||
94339905|NCT01989572|323024739|FG001|Overall Study|error|1|||
94339906|NCT01989572|323024740|FG002|Overall Study|error|1|||
94339907|NCT01989572|323024741|FG003|Overall Study|error|1|||
94339908|NCT01989572|323024742|FG004|Overall Study|error|1|||
94339909|NCT01989572|323024743|FG005|Overall Study|error|1|||
94339910|NCT01989572|323024738|FG000|Overall Study|maximum dose reached|0|||
94339911|NCT01989572|323024739|FG001|Overall Study|maximum dose reached|1|||
94339912|NCT01989572|323024740|FG002|Overall Study|maximum dose reached|0|||
94339913|NCT01989572|323024741|FG003|Overall Study|maximum dose reached|0|||
94339914|NCT01989572|323024742|FG004|Overall Study|maximum dose reached|1|||
94339915|NCT01989572|323024743|FG005|Overall Study|maximum dose reached|0|||
94339916|NCT01989572|323024738|FG000|Overall Study|unknown/not specify|3|||
94339917|NCT01989572|323024739|FG001|Overall Study|unknown/not specify|4|||
94339918|NCT01989572|323024740|FG002|Overall Study|unknown/not specify|1|||
94339919|NCT01989572|323024741|FG003|Overall Study|unknown/not specify|3|||
94339920|NCT01989572|323024742|FG004|Overall Study|unknown/not specify|3|||
94339921|NCT01989572|323024743|FG005|Overall Study|unknown/not specify|5|||
94339922|NCT01989572|323024738|FG000|Overall Study|not start protocol therapy|5|||
94339923|NCT01989572|323024739|FG001|Overall Study|not start protocol therapy|1|||
94339924|NCT01989572|323024740|FG002|Overall Study|not start protocol therapy|2|||
94339925|NCT01989572|323024741|FG003|Overall Study|not start protocol therapy|3|||
94339926|NCT01989572|323024742|FG004|Overall Study|not start protocol therapy|4|||
94339927|NCT01989572|323024743|FG005|Overall Study|not start protocol therapy|18|||
94339928|NCT01989572|323024738|FG000|Overall Study|alternative therapy|3|||
94339929|NCT01989572|323024739|FG001|Overall Study|alternative therapy|0|||
94339930|NCT01989572|323024740|FG002|Overall Study|alternative therapy|0|||
94339931|NCT01989572|323024741|FG003|Overall Study|alternative therapy|0|||
94339932|NCT01989572|323024742|FG004|Overall Study|alternative therapy|1|||
94339933|NCT01989572|323024743|FG005|Overall Study|alternative therapy|3|||
94339934|NCT00732238|323024748|FG000|Overall Study|Bacteremia|4|||
94339935|NCT00732238|323024749|FG001|Overall Study|Bacteremia|1|||
94339936|NCT00732238|323024748|FG000|Overall Study|Asymptomatic bacteriuria|1|||
94339937|NCT00732238|323024749|FG001|Overall Study|Asymptomatic bacteriuria|0|||
94339938|NCT02280096|323024750|FG000|Overall Study|Pregnancy|1|||
94339939|NCT02280096|323024751|FG001|Overall Study|Pregnancy|0|||
94339940|NCT02280096|323024750|FG000|Overall Study|Functional neurological disorder|1|||
94339941|NCT02280096|323024751|FG001|Overall Study|Functional neurological disorder|0|||
94339942|NCT02280096|323024750|FG000|Overall Study|Lack of attachment|0|||
94339943|NCT02280096|323024751|FG001|Overall Study|Lack of attachment|1|||
94339944|NCT04661150|323024752|FG000|Overall Study|Ongoing in study|19|||
94339945|NCT04661150|323024753|FG001|Overall Study|Ongoing in study|20|||
94339946|NCT04661150|323024752|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
94339947|NCT04661150|323024753|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
94339948|NCT04661150|323024752|FG000|Overall Study|Death|2|||
94339949|NCT04661150|323024753|FG001|Overall Study|Death|0|||
94339950|NCT01872897|323024756|FG000|Overall Study|Withdrawal by Subject|1|||
94339951|NCT01872897|323024757|FG001|Overall Study|Withdrawal by Subject|0|||
94339952|NCT04075396|323024758|FG000|Overall Study|Death|11|||
94339953|NCT04075396|323024759|FG001|Overall Study|Death|9|||
94339954|NCT04075396|323024758|FG000|Overall Study|Withdrawal by Subject|1|||
94339955|NCT04075396|323024759|FG001|Overall Study|Withdrawal by Subject|2|||
94339956|NCT04075396|323024758|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
94339957|NCT04075396|323024759|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
94339958|NCT04075396|323024758|FG000|Overall Study|Enrolled but not-treated|0|||
94339959|NCT04075396|323024759|FG001|Overall Study|Enrolled but not-treated|1|||
94339960|NCT03605836|323024760|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
94339961|NCT03605836|323024761|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
94339962|NCT03605836|323024762|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
94339963|NCT03605836|323024763|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
94339964|NCT03605836|323024760|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
94339965|NCT03605836|323024761|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
94339966|NCT03605836|323024762|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
94339967|NCT03605836|323024763|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
94339968|NCT03605836|323024760|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
94339969|NCT03605836|323024761|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
94339970|NCT03605836|323024762|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
94339971|NCT03605836|323024763|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
94339972|NCT03605836|323024760|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
94339973|NCT03605836|323024761|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
94440634|NCT02603146|323401468|FG000|Overall Study|Lost to Follow-up|5|||
94440635|NCT02603146|323401469|FG001|Overall Study|Lost to Follow-up|6|||
94440636|NCT02603146|323401468|FG000|Overall Study|Withdrawal by Subject|8|||
94548886|NCT01302054|323805717|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
94548887|NCT01302054|323805715|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
94548888|NCT01302054|323805716|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
94548889|NCT01302054|323805717|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
94548890|NCT01302054|323805715|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
94548891|NCT01302054|323805716|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
94548892|NCT01302054|323805717|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
94548893|NCT01302054|323805715|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
94548894|NCT01302054|323805716|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
94548895|NCT01302054|323805717|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
94548896|NCT01302054|323805715|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
94548897|NCT01302054|323805716|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
94548898|NCT01302054|323805717|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
94548899|NCT01302054|323805715|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
94548900|NCT01302054|323805716|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
94548901|NCT01302054|323805717|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
94548902|NCT01302054|323805715|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
94548903|NCT01302054|323805716|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
94548904|NCT01302054|323805717|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
94548905|NCT01302054|323805715|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
94548906|NCT01302054|323805716|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
94548907|NCT01302054|323805717|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
94548908|NCT01302054|323805715|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
94548909|NCT01302054|323805716|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
94440637|NCT02603146|323401469|FG001|Overall Study|Withdrawal by Subject|10|||
94440638|NCT02603146|323401468|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
94440639|NCT02603146|323401469|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
94440640|NCT02603146|323401468|FG000|Overall Study|Participant moved|2|||
94440641|NCT02603146|323401469|FG001|Overall Study|Participant moved|0|||
94440642|NCT02603146|323401468|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
94440643|NCT02603146|323401469|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
94440644|NCT03493685|323401470|FG000|Overall Study|Death|4|||
94440645|NCT03493685|323401471|FG001|Overall Study|Death|3|||
94440646|NCT03493685|323401470|FG000|Overall Study|Lost to Follow-up|3|||
94440647|NCT03493685|323401471|FG001|Overall Study|Lost to Follow-up|2|||
94440648|NCT03493685|323401470|FG000|Overall Study|Physician Decision|2|||
94440649|NCT03493685|323401471|FG001|Overall Study|Physician Decision|0|||
94440650|NCT03493685|323401470|FG000|Overall Study|Withdrawal by Subject|7|||
94440651|NCT03493685|323401471|FG001|Overall Study|Withdrawal by Subject|11|||
94440652|NCT03999996|323401475|FG000|Prior to Booster|Adverse Event|2|||
94440653|NCT03999996|323401476|FG001|Prior to Booster|Adverse Event|0|||
94440654|NCT03999996|323401477|FG002|Prior to Booster|Adverse Event|0|||
94440655|NCT03999996|323401478|FG003|Prior to Booster|Adverse Event|0|||
94440656|NCT03999996|323401475|FG000|Prior to Booster|Lost to Follow-up|17|||
94440657|NCT03999996|323401476|FG001|Prior to Booster|Lost to Follow-up|22|||
94440658|NCT03999996|323401477|FG002|Prior to Booster|Lost to Follow-up|0|||
94440659|NCT03999996|323401478|FG003|Prior to Booster|Lost to Follow-up|0|||
94440660|NCT03999996|323401475|FG000|Prior to Booster|Withdrawal of Consent|51|||
94440661|NCT03999996|323401476|FG001|Prior to Booster|Withdrawal of Consent|8|||
94440662|NCT03999996|323401477|FG002|Prior to Booster|Withdrawal of Consent|0|||
94440663|NCT03999996|323401478|FG003|Prior to Booster|Withdrawal of Consent|0|||
94440664|NCT03999996|323401475|FG000|Prior to Booster|Death|0|||
94440665|NCT03999996|323401476|FG001|Prior to Booster|Death|1|||
94440666|NCT03999996|323401477|FG002|Prior to Booster|Death|0|||
94440667|NCT03999996|323401478|FG003|Prior to Booster|Death|0|||
94440668|NCT03999996|323401475|FG000|Prior to Booster|Reason Not Specified|27|||
94440669|NCT03999996|323401476|FG001|Prior to Booster|Reason Not Specified|4|||
94440670|NCT03999996|323401477|FG002|Prior to Booster|Reason Not Specified|0|||
94440671|NCT03999996|323401478|FG003|Prior to Booster|Reason Not Specified|0|||
94440672|NCT03999996|323401475|FG000|Booster Phase|Lost to Follow-up|0|||
94440673|NCT03999996|323401476|FG001|Booster Phase|Lost to Follow-up|0|||
94440674|NCT03999996|323401477|FG002|Booster Phase|Lost to Follow-up|3|||
94440675|NCT03999996|323401478|FG003|Booster Phase|Lost to Follow-up|3|||
94440676|NCT03999996|323401475|FG000|Booster Phase|Withdrawal of Consent|0|||
94440677|NCT03999996|323401476|FG001|Booster Phase|Withdrawal of Consent|0|||
94440678|NCT03999996|323401477|FG002|Booster Phase|Withdrawal of Consent|0|||
94440679|NCT03999996|323401478|FG003|Booster Phase|Withdrawal of Consent|1|||
94440680|NCT03999996|323401475|FG000|Booster Phase|Reason Not Specified|0|||
94440681|NCT03999996|323401476|FG001|Booster Phase|Reason Not Specified|0|||
94440682|NCT03999996|323401477|FG002|Booster Phase|Reason Not Specified|0|||
94440683|NCT03999996|323401478|FG003|Booster Phase|Reason Not Specified|1|||
94440684|NCT02848001|323401479|FG000|Overall Study|other reasons|0|||
94440685|NCT02848001|323401480|FG001|Overall Study|other reasons|0|||
94440686|NCT02848001|323401481|FG002|Overall Study|other reasons|1|||
94440687|NCT02848001|323401482|FG003|Overall Study|other reasons|0|||
94440688|NCT02848001|323401483|FG004|Overall Study|other reasons|4|||
94440689|NCT02848001|323401484|FG005|Overall Study|other reasons|1|||
94440690|NCT02848001|323401485|FG006|Overall Study|other reasons|0|||
94440691|NCT02848001|323401486|FG007|Overall Study|other reasons|2|||
94440692|NCT02848001|323401487|FG008|Overall Study|other reasons|2|||
94440693|NCT02848001|323401488|FG009|Overall Study|other reasons|3|||
94548910|NCT01302054|323805717|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
94548911|NCT01302054|323805715|FG000|Double-Blind Treatment Phase|Other|0|||
94548912|NCT01302054|323805716|FG001|Double-Blind Treatment Phase|Other|4|||
94548913|NCT01302054|323805717|FG002|Double-Blind Treatment Phase|Other|9|||
94548914|NCT05059977|323805720|FG000|Overall Study|Withdrawal by Subject|0|||
94548915|NCT05059977|323805721|FG001|Overall Study|Withdrawal by Subject|0|||
94548916|NCT05059977|323805722|FG002|Overall Study|Withdrawal by Subject|1|||
94548917|NCT00576472|323805724|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
94548918|NCT00576472|323805725|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
94548919|NCT00576472|323805726|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
94548920|NCT00576472|323805727|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
94548921|NCT00576472|323805728|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
94548922|NCT00576472|323805729|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
94548923|NCT00576472|323805730|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
94548924|NCT00576472|323805731|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
94548925|NCT00576472|323805732|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
94548926|NCT00576472|323805733|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
94548927|NCT00576472|323805734|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
94548928|NCT00576472|323805735|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
94548929|NCT00576472|323805736|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
94548930|NCT00576472|323805737|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
94548931|NCT00576472|323805738|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
94548932|NCT00576472|323805724|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
94548933|NCT00576472|323805725|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
94548934|NCT00576472|323805726|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
94440694|NCT02848001|323401489|FG010|Overall Study|other reasons|0|||
94440695|NCT02848001|323401490|FG011|Overall Study|other reasons|1|||
94440696|NCT02848001|323401491|FG012|Overall Study|other reasons|1|||
94440697|NCT02848001|323401492|FG013|Overall Study|other reasons|0|||
94440698|NCT02848001|323401493|FG014|Overall Study|other reasons|0|||
94440699|NCT02848001|323401494|FG015|Overall Study|other reasons|2|||
94440700|NCT02848001|323401495|FG016|Overall Study|other reasons|1|||
94440701|NCT02848001|323401479|FG000|Overall Study|Lack of Efficacy|0|||
94440702|NCT02848001|323401480|FG001|Overall Study|Lack of Efficacy|1|||
94440703|NCT02848001|323401481|FG002|Overall Study|Lack of Efficacy|1|||
94548935|NCT00576472|323805727|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
94548936|NCT00576472|323805728|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
94548937|NCT00576472|323805729|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
94548938|NCT00576472|323805730|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
94440704|NCT02848001|323401482|FG003|Overall Study|Lack of Efficacy|2|||
94440705|NCT02848001|323401483|FG004|Overall Study|Lack of Efficacy|3|||
94440706|NCT02848001|323401484|FG005|Overall Study|Lack of Efficacy|0|||
94440707|NCT02848001|323401485|FG006|Overall Study|Lack of Efficacy|1|||
94440708|NCT02848001|323401486|FG007|Overall Study|Lack of Efficacy|0|||
94440709|NCT02848001|323401487|FG008|Overall Study|Lack of Efficacy|0|||
94440710|NCT02848001|323401488|FG009|Overall Study|Lack of Efficacy|1|||
94440711|NCT02848001|323401489|FG010|Overall Study|Lack of Efficacy|0|||
94440712|NCT02848001|323401490|FG011|Overall Study|Lack of Efficacy|2|||
94440713|NCT02848001|323401491|FG012|Overall Study|Lack of Efficacy|0|||
94440714|NCT02848001|323401492|FG013|Overall Study|Lack of Efficacy|2|||
94440715|NCT02848001|323401493|FG014|Overall Study|Lack of Efficacy|2|||
94440716|NCT02848001|323401494|FG015|Overall Study|Lack of Efficacy|0|||
94440717|NCT02848001|323401495|FG016|Overall Study|Lack of Efficacy|0|||
94440718|NCT02848001|323401479|FG000|Overall Study|Progressive Disease|2|||
94440719|NCT02848001|323401480|FG001|Overall Study|Progressive Disease|1|||
94440720|NCT02848001|323401481|FG002|Overall Study|Progressive Disease|0|||
94440721|NCT02848001|323401482|FG003|Overall Study|Progressive Disease|4|||
94440722|NCT02848001|323401483|FG004|Overall Study|Progressive Disease|3|||
94440723|NCT02848001|323401484|FG005|Overall Study|Progressive Disease|0|||
94440724|NCT02848001|323401485|FG006|Overall Study|Progressive Disease|4|||
94440725|NCT02848001|323401486|FG007|Overall Study|Progressive Disease|1|||
94440726|NCT02848001|323401487|FG008|Overall Study|Progressive Disease|0|||
94440727|NCT02848001|323401488|FG009|Overall Study|Progressive Disease|2|||
94440728|NCT02848001|323401489|FG010|Overall Study|Progressive Disease|3|||
94440729|NCT02848001|323401490|FG011|Overall Study|Progressive Disease|2|||
94440730|NCT02848001|323401491|FG012|Overall Study|Progressive Disease|1|||
94440731|NCT02848001|323401492|FG013|Overall Study|Progressive Disease|0|||
94440732|NCT02848001|323401493|FG014|Overall Study|Progressive Disease|2|||
94440733|NCT02848001|323401494|FG015|Overall Study|Progressive Disease|4|||
94440734|NCT02848001|323401495|FG016|Overall Study|Progressive Disease|0|||
94440735|NCT02848001|323401479|FG000|Overall Study|Adverse Event|0|||
94440736|NCT02848001|323401480|FG001|Overall Study|Adverse Event|0|||
94440737|NCT02848001|323401481|FG002|Overall Study|Adverse Event|0|||
94440738|NCT02848001|323401482|FG003|Overall Study|Adverse Event|0|||
94440739|NCT02848001|323401483|FG004|Overall Study|Adverse Event|2|||
94440740|NCT02848001|323401484|FG005|Overall Study|Adverse Event|0|||
94440741|NCT02848001|323401485|FG006|Overall Study|Adverse Event|0|||
94440742|NCT02848001|323401486|FG007|Overall Study|Adverse Event|0|||
94440743|NCT02848001|323401487|FG008|Overall Study|Adverse Event|0|||
94440744|NCT02848001|323401488|FG009|Overall Study|Adverse Event|1|||
94440745|NCT02848001|323401489|FG010|Overall Study|Adverse Event|0|||
94440746|NCT02848001|323401490|FG011|Overall Study|Adverse Event|1|||
94440747|NCT02848001|323401491|FG012|Overall Study|Adverse Event|1|||
94440748|NCT02848001|323401492|FG013|Overall Study|Adverse Event|0|||
94440749|NCT02848001|323401493|FG014|Overall Study|Adverse Event|2|||
94440750|NCT02848001|323401494|FG015|Overall Study|Adverse Event|0|||
94440751|NCT02848001|323401495|FG016|Overall Study|Adverse Event|0|||
94440752|NCT02848001|323401479|FG000|Overall Study|Death|0|||
94440753|NCT02848001|323401480|FG001|Overall Study|Death|0|||
94440754|NCT02848001|323401481|FG002|Overall Study|Death|0|||
94440755|NCT02848001|323401482|FG003|Overall Study|Death|1|||
94440756|NCT02848001|323401483|FG004|Overall Study|Death|3|||
94440757|NCT02848001|323401484|FG005|Overall Study|Death|1|||
94440758|NCT02848001|323401485|FG006|Overall Study|Death|2|||
94440759|NCT02848001|323401486|FG007|Overall Study|Death|3|||
94440760|NCT02848001|323401487|FG008|Overall Study|Death|4|||
94440761|NCT02848001|323401488|FG009|Overall Study|Death|1|||
94440762|NCT02848001|323401489|FG010|Overall Study|Death|0|||
94440763|NCT02848001|323401490|FG011|Overall Study|Death|1|||
94440764|NCT02848001|323401491|FG012|Overall Study|Death|3|||
94440765|NCT02848001|323401492|FG013|Overall Study|Death|0|||
94440766|NCT02848001|323401493|FG014|Overall Study|Death|2|||
94440767|NCT02848001|323401494|FG015|Overall Study|Death|3|||
94440768|NCT02848001|323401495|FG016|Overall Study|Death|0|||
94440769|NCT02848001|323401479|FG000|Overall Study|Physician Decision|0|||
94440770|NCT02848001|323401480|FG001|Overall Study|Physician Decision|0|||
94440771|NCT02848001|323401481|FG002|Overall Study|Physician Decision|0|||
94440772|NCT02848001|323401482|FG003|Overall Study|Physician Decision|0|||
94440773|NCT02848001|323401483|FG004|Overall Study|Physician Decision|0|||
94440774|NCT02848001|323401484|FG005|Overall Study|Physician Decision|0|||
94440775|NCT02848001|323401485|FG006|Overall Study|Physician Decision|0|||
94440776|NCT02848001|323401486|FG007|Overall Study|Physician Decision|0|||
94440777|NCT02848001|323401487|FG008|Overall Study|Physician Decision|1|||
94440778|NCT02848001|323401488|FG009|Overall Study|Physician Decision|1|||
94440779|NCT02848001|323401489|FG010|Overall Study|Physician Decision|0|||
94440780|NCT02848001|323401490|FG011|Overall Study|Physician Decision|0|||
94440781|NCT02848001|323401491|FG012|Overall Study|Physician Decision|2|||
94440782|NCT02848001|323401492|FG013|Overall Study|Physician Decision|0|||
94440783|NCT02848001|323401493|FG014|Overall Study|Physician Decision|0|||
94440784|NCT02848001|323401494|FG015|Overall Study|Physician Decision|0|||
94440785|NCT02848001|323401495|FG016|Overall Study|Physician Decision|0|||
94440786|NCT02848001|323401479|FG000|Overall Study|Withdrawal by Subject|0|||
94440787|NCT02848001|323401480|FG001|Overall Study|Withdrawal by Subject|0|||
94440788|NCT02848001|323401481|FG002|Overall Study|Withdrawal by Subject|0|||
94440789|NCT02848001|323401482|FG003|Overall Study|Withdrawal by Subject|0|||
94440790|NCT02848001|323401483|FG004|Overall Study|Withdrawal by Subject|0|||
94440791|NCT02848001|323401484|FG005|Overall Study|Withdrawal by Subject|1|||
94440792|NCT02848001|323401485|FG006|Overall Study|Withdrawal by Subject|1|||
94440793|NCT02848001|323401486|FG007|Overall Study|Withdrawal by Subject|1|||
94440794|NCT02848001|323401487|FG008|Overall Study|Withdrawal by Subject|0|||
94440795|NCT02848001|323401488|FG009|Overall Study|Withdrawal by Subject|0|||
94440796|NCT02848001|323401489|FG010|Overall Study|Withdrawal by Subject|0|||
94440797|NCT02848001|323401490|FG011|Overall Study|Withdrawal by Subject|0|||
94440798|NCT02848001|323401491|FG012|Overall Study|Withdrawal by Subject|0|||
94440799|NCT02848001|323401492|FG013|Overall Study|Withdrawal by Subject|0|||
94440800|NCT02848001|323401493|FG014|Overall Study|Withdrawal by Subject|0|||
94440801|NCT02848001|323401494|FG015|Overall Study|Withdrawal by Subject|0|||
94440802|NCT02848001|323401495|FG016|Overall Study|Withdrawal by Subject|0|||
94440803|NCT01368497|323401499|FG000|Overall Study|Lost to Follow-up|2|||
94440804|NCT01567462|323401500|FG000|Overall Study|Withdrawal by Subject|4|||
94440805|NCT01567462|323401501|FG001|Overall Study|Withdrawal by Subject|7|||
94440806|NCT01842438|323401503|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
94440807|NCT01842438|323401504|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
94440808|NCT01842438|323401503|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
94440809|NCT01842438|323401504|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
94440810|NCT01842438|323401503|FG000|T2: 6month Follow-up|Death|0|||
94440811|NCT01842438|323401504|FG001|T2: 6month Follow-up|Death|1|||
94440812|NCT00782626|323401505|FG000|Overall Study|Adverse Event|1|||
94440813|NCT00782626|323401505|FG000|Overall Study|Progressive Disease|5|||
94440814|NCT00782626|323401505|FG000|Overall Study|Other Complicating Disease|1|||
94440815|NCT04882241|323401507|FG000|Overall Study|Ongoing in study|46|||
94440816|NCT04882241|323401508|FG001|Overall Study|Ongoing in study|48|||
94440817|NCT04882241|323401509|FG002|Overall Study|Ongoing in study|0|||
94440818|NCT04882241|323401510|FG003|Overall Study|Ongoing in study|0|||
94440819|NCT04882241|323401507|FG000|Overall Study|Death|13|||
94548939|NCT00576472|323805731|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
94548940|NCT00576472|323805732|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
94548941|NCT00576472|323805733|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
94548942|NCT00576472|323805734|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
94548943|NCT00576472|323805735|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
94548944|NCT00576472|323805736|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
94548945|NCT00576472|323805737|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
94548946|NCT00576472|323805738|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
94548947|NCT00576472|323805724|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
94548948|NCT00576472|323805725|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
94548949|NCT00576472|323805726|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
94548950|NCT00576472|323805727|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
94548951|NCT00576472|323805728|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
94548952|NCT00576472|323805729|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
94548953|NCT00576472|323805730|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
94548954|NCT00576472|323805731|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
94548955|NCT00576472|323805732|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
94548956|NCT00576472|323805733|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
94548957|NCT00576472|323805734|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
94548958|NCT00576472|323805735|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
94548959|NCT00576472|323805736|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
94548960|NCT00576472|323805737|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
94548961|NCT00576472|323805738|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
94548962|NCT00576472|323805724|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
94548963|NCT00576472|323805725|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
94548964|NCT00576472|323805726|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
94548965|NCT00576472|323805727|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
94548966|NCT00576472|323805728|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
94548967|NCT00576472|323805729|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
94548968|NCT00576472|323805730|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
94548969|NCT00576472|323805731|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
94548970|NCT00576472|323805732|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
94548971|NCT00576472|323805733|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
94548972|NCT00576472|323805734|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
94548973|NCT00576472|323805735|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
94548974|NCT00576472|323805736|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
94548975|NCT00576472|323805737|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
94440820|NCT04882241|323401508|FG001|Overall Study|Death|13|||
94440821|NCT04882241|323401509|FG002|Overall Study|Death|0|||
94440822|NCT04882241|323401510|FG003|Overall Study|Death|0|||
94440823|NCT01050530|323401515|FG000|Overall Study|Adverse Event|6|||
94440824|NCT01050530|323401516|FG001|Overall Study|Adverse Event|3|||
94548976|NCT00576472|323805738|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
94548977|NCT00576472|323805724|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
94548978|NCT00576472|323805725|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
94548979|NCT00576472|323805726|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
94548980|NCT00576472|323805727|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
94548981|NCT00576472|323805728|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
94548982|NCT00576472|323805729|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
94548983|NCT00576472|323805730|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
94548984|NCT00576472|323805731|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
94548985|NCT00576472|323805732|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
94548986|NCT00576472|323805733|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
94548987|NCT00576472|323805734|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
94548988|NCT00576472|323805735|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
94548989|NCT00576472|323805736|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
94548990|NCT00576472|323805737|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
94548991|NCT00576472|323805738|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
94548992|NCT00576472|323805724|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
94548993|NCT00576472|323805725|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
94548994|NCT00576472|323805726|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
94548995|NCT00576472|323805727|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
94548996|NCT00576472|323805728|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
94548997|NCT00576472|323805729|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
94548998|NCT00576472|323805730|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
94548999|NCT00576472|323805731|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
94549000|NCT00576472|323805732|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
94549001|NCT00576472|323805733|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
94549002|NCT00576472|323805734|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
94549003|NCT00576472|323805735|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
94549004|NCT00576472|323805736|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
94549005|NCT00576472|323805737|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
94549006|NCT00576472|323805738|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
94549007|NCT00576472|323805724|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
94549008|NCT00576472|323805725|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
94549009|NCT00576472|323805726|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
94549010|NCT00576472|323805727|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
94549011|NCT00576472|323805728|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
94549012|NCT00576472|323805729|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
94549013|NCT00576472|323805730|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
94549014|NCT00576472|323805731|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
94549015|NCT00576472|323805732|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
94549016|NCT00576472|323805733|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
94549017|NCT00576472|323805734|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
94549018|NCT00576472|323805735|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
94549019|NCT00576472|323805736|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
94549020|NCT00576472|323805737|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
94549021|NCT00576472|323805738|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
94549022|NCT00576472|323805724|FG000|MPH Cross Over Phase|Physician Decision|0|||
94549023|NCT00576472|323805725|FG001|MPH Cross Over Phase|Physician Decision|0|||
94549024|NCT00576472|323805726|FG002|MPH Cross Over Phase|Physician Decision|0|||
94549025|NCT00576472|323805727|FG003|MPH Cross Over Phase|Physician Decision|0|||
94549026|NCT00576472|323805728|FG004|MPH Cross Over Phase|Physician Decision|0|||
94549027|NCT00576472|323805729|FG005|MPH Cross Over Phase|Physician Decision|0|||
94549028|NCT00576472|323805730|FG006|MPH Cross Over Phase|Physician Decision|4|||
94549029|NCT00576472|323805731|FG007|MPH Cross Over Phase|Physician Decision|0|||
94549030|NCT00576472|323805732|FG008|MPH Cross Over Phase|Physician Decision|0|||
94549031|NCT00576472|323805733|FG009|MPH Cross Over Phase|Physician Decision|0|||
94549032|NCT00576472|323805734|FG010|MPH Cross Over Phase|Physician Decision|0|||
94549033|NCT00576472|323805735|FG011|MPH Cross Over Phase|Physician Decision|0|||
94549034|NCT00576472|323805736|FG012|MPH Cross Over Phase|Physician Decision|0|||
94549035|NCT00576472|323805737|FG013|MPH Cross Over Phase|Physician Decision|0|||
94549036|NCT00576472|323805738|FG014|MPH Cross Over Phase|Physician Decision|0|||
94549037|NCT00576472|323805724|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
94549038|NCT00576472|323805725|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
94549039|NCT00576472|323805726|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
94549040|NCT00576472|323805727|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
94549041|NCT00576472|323805728|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
94549042|NCT00576472|323805729|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
94549043|NCT00576472|323805730|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
94549044|NCT00576472|323805731|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
94549045|NCT00576472|323805732|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
94549046|NCT00576472|323805733|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
94440825|NCT01050530|323401515|FG000|Overall Study|Lack of Efficacy|1|||
94440826|NCT01050530|323401516|FG001|Overall Study|Lack of Efficacy|4|||
94440827|NCT01050530|323401515|FG000|Overall Study|Withdrawal by Subject|0|||
94440828|NCT01050530|323401516|FG001|Overall Study|Withdrawal by Subject|3|||
94440829|NCT01050530|323401515|FG000|Overall Study|Protocol Violation|1|||
94440830|NCT01050530|323401516|FG001|Overall Study|Protocol Violation|0|||
94440831|NCT02968576|323401527|FG000|Overall Study|Pregnancy|0|||
94440832|NCT02968576|323401528|FG001|Overall Study|Pregnancy|1|||
94440833|NCT03359850|323401534|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
94440834|NCT03359850|323401535|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
94440835|NCT03359850|323401534|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
94440836|NCT03359850|323401535|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
94440837|NCT03359850|323401534|FG000|Extension Phase (Up to 28 Months)|Death|2|||
94440838|NCT03359850|323401535|FG001|Extension Phase (Up to 28 Months)|Death|4|||
94440839|NCT03359850|323401534|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
94440840|NCT03359850|323401535|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
94440841|NCT03359850|323401534|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
94440842|NCT03359850|323401535|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
94440843|NCT04720053|323401537|FG000|Overall Study|Lost to Follow-up|12|||
94440844|NCT02906670|323401540|FG000|Cohort 1, QW|Radiological Progression|1|||
94440845|NCT02906670|323401541|FG001|Cohort 1, QW|Radiological Progression|0|||
94440846|NCT02906670|323401542|FG002|Cohort 1, QW|Radiological Progression|0|||
94440847|NCT02906670|323401543|FG003|Cohort 1, QW|Radiological Progression|0|||
94440848|NCT02906670|323401544|FG004|Cohort 1, QW|Radiological Progression|0|||
94440849|NCT02906670|323401545|FG005|Cohort 1, QW|Radiological Progression|0|||
94440850|NCT02906670|323401546|FG006|Cohort 1, QW|Radiological Progression|0|||
94440851|NCT02906670|323401547|FG007|Cohort 1, QW|Radiological Progression|0|||
94440852|NCT02906670|323401548|FG008|Cohort 1, QW|Radiological Progression|0|||
94440853|NCT02906670|323401549|FG009|Cohort 1, QW|Radiological Progression|0|||
94440854|NCT02906670|323401540|FG000|Cohort 2, QW|Radiological Progression|0|||
94440855|NCT02906670|323401541|FG001|Cohort 2, QW|Radiological Progression|1|||
94440856|NCT02906670|323401542|FG002|Cohort 2, QW|Radiological Progression|0|||
94440857|NCT02906670|323401543|FG003|Cohort 2, QW|Radiological Progression|0|||
94440858|NCT02906670|323401544|FG004|Cohort 2, QW|Radiological Progression|0|||
94440859|NCT02906670|323401545|FG005|Cohort 2, QW|Radiological Progression|0|||
94440860|NCT02906670|323401546|FG006|Cohort 2, QW|Radiological Progression|0|||
94440861|NCT02906670|323401547|FG007|Cohort 2, QW|Radiological Progression|0|||
94440862|NCT02906670|323401548|FG008|Cohort 2, QW|Radiological Progression|0|||
94440863|NCT02906670|323401549|FG009|Cohort 2, QW|Radiological Progression|0|||
94440864|NCT02906670|323401540|FG000|Cohort 3, QW|Radiological Progression|0|||
94440865|NCT02906670|323401541|FG001|Cohort 3, QW|Radiological Progression|0|||
94440866|NCT02906670|323401542|FG002|Cohort 3, QW|Radiological Progression|2|||
94440867|NCT02906670|323401543|FG003|Cohort 3, QW|Radiological Progression|0|||
94440868|NCT02906670|323401544|FG004|Cohort 3, QW|Radiological Progression|0|||
94440869|NCT02906670|323401545|FG005|Cohort 3, QW|Radiological Progression|0|||
94440870|NCT02906670|323401546|FG006|Cohort 3, QW|Radiological Progression|0|||
94440871|NCT02906670|323401547|FG007|Cohort 3, QW|Radiological Progression|0|||
94440872|NCT02906670|323401548|FG008|Cohort 3, QW|Radiological Progression|0|||
94440873|NCT02906670|323401549|FG009|Cohort 3, QW|Radiological Progression|0|||
94440874|NCT02906670|323401540|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
94440875|NCT02906670|323401541|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
94440876|NCT02906670|323401542|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
94440877|NCT02906670|323401543|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
94440878|NCT02906670|323401544|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
94440879|NCT02906670|323401545|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
94440880|NCT02906670|323401546|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
94440881|NCT02906670|323401547|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
94440882|NCT02906670|323401548|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
94440883|NCT02906670|323401549|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
94440884|NCT02906670|323401540|FG000|Cohort 4, Q2W|Radiological Progression|0|||
94440885|NCT02906670|323401541|FG001|Cohort 4, Q2W|Radiological Progression|0|||
94440886|NCT02906670|323401542|FG002|Cohort 4, Q2W|Radiological Progression|0|||
94440887|NCT02906670|323401543|FG003|Cohort 4, Q2W|Radiological Progression|0|||
94440888|NCT02906670|323401544|FG004|Cohort 4, Q2W|Radiological Progression|0|||
94440889|NCT02906670|323401545|FG005|Cohort 4, Q2W|Radiological Progression|1|||
94440890|NCT02906670|323401546|FG006|Cohort 4, Q2W|Radiological Progression|0|||
94440891|NCT02906670|323401547|FG007|Cohort 4, Q2W|Radiological Progression|0|||
94440892|NCT02906670|323401548|FG008|Cohort 4, Q2W|Radiological Progression|0|||
94440893|NCT02906670|323401549|FG009|Cohort 4, Q2W|Radiological Progression|0|||
94440894|NCT02906670|323401540|FG000|Cohort 4, Q2W|Clinical Progression|0|||
94440895|NCT02906670|323401541|FG001|Cohort 4, Q2W|Clinical Progression|0|||
94440896|NCT02906670|323401542|FG002|Cohort 4, Q2W|Clinical Progression|0|||
94440897|NCT02906670|323401543|FG003|Cohort 4, Q2W|Clinical Progression|0|||
94440898|NCT02906670|323401544|FG004|Cohort 4, Q2W|Clinical Progression|0|||
94440899|NCT02906670|323401545|FG005|Cohort 4, Q2W|Clinical Progression|2|||
94549047|NCT00576472|323805734|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
94549048|NCT00576472|323805735|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
94549049|NCT00576472|323805736|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
94339974|NCT03605836|323024762|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
94339975|NCT03605836|323024763|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
94549050|NCT00576472|323805737|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
94549051|NCT00576472|323805738|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
94549052|NCT00576472|323805724|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
94549053|NCT00576472|323805725|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
94549054|NCT00576472|323805726|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
94549055|NCT00576472|323805727|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
94549056|NCT00576472|323805728|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
94549057|NCT00576472|323805729|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
94549058|NCT00576472|323805730|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
94549059|NCT00576472|323805731|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
94549060|NCT00576472|323805732|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
94549061|NCT00576472|323805733|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
94549062|NCT00576472|323805734|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
94339976|NCT03605836|323024760|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
94339977|NCT03605836|323024761|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
94339978|NCT03605836|323024762|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
94549063|NCT00576472|323805735|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
94549064|NCT00576472|323805736|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
94549065|NCT00576472|323805737|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
94549066|NCT00576472|323805738|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
94549067|NCT00576472|323805724|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
94549068|NCT00576472|323805725|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
94549069|NCT00576472|323805726|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
94549070|NCT00576472|323805727|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
94549071|NCT00576472|323805728|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
94549072|NCT00576472|323805729|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
94549073|NCT00576472|323805730|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
94549074|NCT00576472|323805731|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
94549075|NCT00576472|323805732|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
94549076|NCT00576472|323805733|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
94549077|NCT00576472|323805734|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
94549078|NCT00576472|323805735|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
94549079|NCT00576472|323805736|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
94549080|NCT00576472|323805737|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
94549081|NCT00576472|323805738|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
94549082|NCT00576472|323805724|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
94549083|NCT00576472|323805725|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
94549084|NCT00576472|323805726|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
94549085|NCT00576472|323805727|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
94549086|NCT00576472|323805728|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
94549087|NCT00576472|323805729|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
94549088|NCT00576472|323805730|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
94549089|NCT00576472|323805731|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
94549090|NCT00576472|323805732|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
94549091|NCT00576472|323805733|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
94549092|NCT00576472|323805734|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
94549093|NCT00576472|323805735|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
94549094|NCT00576472|323805736|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
94549095|NCT00576472|323805737|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
94549096|NCT00576472|323805738|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
94549097|NCT00576472|323805724|FG000|MPH Home Maintenance Phase|Side effects|0|||
94549098|NCT00576472|323805725|FG001|MPH Home Maintenance Phase|Side effects|0|||
94549099|NCT00576472|323805726|FG002|MPH Home Maintenance Phase|Side effects|0|||
94549100|NCT00576472|323805727|FG003|MPH Home Maintenance Phase|Side effects|0|||
94549101|NCT00576472|323805728|FG004|MPH Home Maintenance Phase|Side effects|0|||
94549102|NCT00576472|323805729|FG005|MPH Home Maintenance Phase|Side effects|0|||
94549103|NCT00576472|323805730|FG006|MPH Home Maintenance Phase|Side effects|0|||
94549104|NCT00576472|323805731|FG007|MPH Home Maintenance Phase|Side effects|0|||
94549105|NCT00576472|323805732|FG008|MPH Home Maintenance Phase|Side effects|0|||
94549106|NCT00576472|323805733|FG009|MPH Home Maintenance Phase|Side effects|0|||
94549107|NCT00576472|323805734|FG010|MPH Home Maintenance Phase|Side effects|0|||
94549108|NCT00576472|323805735|FG011|MPH Home Maintenance Phase|Side effects|0|||
94549109|NCT00576472|323805736|FG012|MPH Home Maintenance Phase|Side effects|0|||
94549110|NCT00576472|323805737|FG013|MPH Home Maintenance Phase|Side effects|0|||
94549111|NCT00576472|323805738|FG014|MPH Home Maintenance Phase|Side effects|8|||
94549112|NCT00576472|323805724|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
94549113|NCT00576472|323805725|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
94549114|NCT00576472|323805726|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
94549115|NCT00576472|323805727|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
94549116|NCT00576472|323805728|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
94549117|NCT00576472|323805729|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
94549118|NCT00576472|323805730|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
94549119|NCT00576472|323805731|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
94549120|NCT00576472|323805732|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
94549121|NCT00576472|323805733|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
94549122|NCT00576472|323805734|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
94549123|NCT00576472|323805735|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
94549124|NCT00576472|323805736|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
94549125|NCT00576472|323805737|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
94549126|NCT00576472|323805738|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
94549127|NCT00576472|323805724|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
94549128|NCT00576472|323805725|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
94549129|NCT00576472|323805726|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
94549130|NCT00576472|323805727|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
94549131|NCT00576472|323805728|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
94549132|NCT00576472|323805729|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
94549133|NCT00576472|323805730|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
94549134|NCT00576472|323805731|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
94549135|NCT00576472|323805732|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
94549136|NCT00576472|323805733|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
94549137|NCT00576472|323805734|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
94549138|NCT00576472|323805735|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
94549139|NCT00576472|323805736|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
94549140|NCT00576472|323805737|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
94549141|NCT00576472|323805738|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
94549142|NCT00576472|323805724|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
94549143|NCT00576472|323805725|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
94549144|NCT00576472|323805726|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
94549145|NCT00576472|323805727|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
94549146|NCT00576472|323805728|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
94549147|NCT00576472|323805729|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
94549148|NCT00576472|323805730|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
94549149|NCT00576472|323805731|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
94549150|NCT00576472|323805732|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
94549151|NCT00576472|323805733|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
94549152|NCT00576472|323805734|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
94549153|NCT00576472|323805735|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
94549154|NCT00576472|323805736|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
94549155|NCT00576472|323805737|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
94549156|NCT00576472|323805738|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
94549157|NCT03443427|323805739|FG000|Overall Study|Adverse Event|2|||
94549158|NCT03443427|323805740|FG001|Overall Study|Adverse Event|3|||
94549159|NCT03443427|323805739|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
94549160|NCT03443427|323805740|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
94549161|NCT03443427|323805739|FG000|Overall Study|Other|4|||
94549162|NCT03443427|323805740|FG001|Overall Study|Other|6|||
94549163|NCT02391961|323805743|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
94549164|NCT02391961|323805744|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
94549165|NCT02391961|323805743|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
94549166|NCT02391961|323805744|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
94549167|NCT02391961|323805743|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
94549168|NCT02391961|323805744|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
94549169|NCT00903331|323805749|FG000|Overall Study|Death|4|||
94549170|NCT00903331|323805750|FG001|Overall Study|Death|8|||
94549171|NCT00903331|323805749|FG000|Overall Study|Withdrawal of consent|1|||
94549172|NCT00903331|323805750|FG001|Overall Study|Withdrawal of consent|8|||
94549173|NCT00903331|323805749|FG000|Overall Study|Lung transplant|0|||
94549174|NCT00903331|323805750|FG001|Overall Study|Lung transplant|2|||
94549175|NCT01459913|323805751|FG000|Overall Study|Adverse Event|0|||
94549176|NCT01459913|323805752|FG001|Overall Study|Adverse Event|0|||
94549177|NCT01459913|323805753|FG002|Overall Study|Adverse Event|0|||
94549178|NCT01459913|323805754|FG003|Overall Study|Adverse Event|3|||
94549179|NCT01459913|323805751|FG000|Overall Study|Withdrawal by Subject|4|||
94549180|NCT01459913|323805752|FG001|Overall Study|Withdrawal by Subject|0|||
94549181|NCT01459913|323805753|FG002|Overall Study|Withdrawal by Subject|0|||
94549182|NCT01459913|323805754|FG003|Overall Study|Withdrawal by Subject|5|||
94549183|NCT01459913|323805751|FG000|Overall Study|Lost to Follow-up|7|||
94549184|NCT01459913|323805752|FG001|Overall Study|Lost to Follow-up|4|||
94549185|NCT01459913|323805753|FG002|Overall Study|Lost to Follow-up|1|||
94549186|NCT01459913|323805754|FG003|Overall Study|Lost to Follow-up|8|||
94549187|NCT01459913|323805751|FG000|Overall Study|Death|0|||
94549188|NCT01459913|323805752|FG001|Overall Study|Death|0|||
94549189|NCT01459913|323805753|FG002|Overall Study|Death|0|||
94549190|NCT01459913|323805754|FG003|Overall Study|Death|1|||
94549191|NCT01459913|323805751|FG000|Overall Study|Non- Compliance|0|||
94549192|NCT01459913|323805752|FG001|Overall Study|Non- Compliance|0|||
94549193|NCT01459913|323805753|FG002|Overall Study|Non- Compliance|0|||
94549194|NCT01459913|323805754|FG003|Overall Study|Non- Compliance|3|||
94549195|NCT01459913|323805751|FG000|Overall Study|Physician Decision|0|||
94440900|NCT02906670|323401546|FG006|Cohort 4, Q2W|Clinical Progression|0|||
94440901|NCT02906670|323401547|FG007|Cohort 4, Q2W|Clinical Progression|0|||
94440902|NCT02906670|323401548|FG008|Cohort 4, Q2W|Clinical Progression|0|||
94440903|NCT02906670|323401549|FG009|Cohort 4, Q2W|Clinical Progression|0|||
94440904|NCT02906670|323401540|FG000|Cohort 5, Q2W|Radiological Progression|0|||
94440905|NCT02906670|323401541|FG001|Cohort 5, Q2W|Radiological Progression|0|||
94440906|NCT02906670|323401542|FG002|Cohort 5, Q2W|Radiological Progression|0|||
94440907|NCT02906670|323401543|FG003|Cohort 5, Q2W|Radiological Progression|0|||
94440908|NCT02906670|323401544|FG004|Cohort 5, Q2W|Radiological Progression|0|||
94440909|NCT02906670|323401545|FG005|Cohort 5, Q2W|Radiological Progression|0|||
94440910|NCT02906670|323401546|FG006|Cohort 5, Q2W|Radiological Progression|4|||
94440911|NCT02906670|323401547|FG007|Cohort 5, Q2W|Radiological Progression|0|||
94440912|NCT02906670|323401548|FG008|Cohort 5, Q2W|Radiological Progression|0|||
94440913|NCT02906670|323401549|FG009|Cohort 5, Q2W|Radiological Progression|0|||
94440914|NCT02906670|323401540|FG000|Cohort 5, Q2W|Clinical Progression|0|||
94440915|NCT02906670|323401541|FG001|Cohort 5, Q2W|Clinical Progression|0|||
94440916|NCT02906670|323401542|FG002|Cohort 5, Q2W|Clinical Progression|0|||
94440917|NCT02906670|323401543|FG003|Cohort 5, Q2W|Clinical Progression|0|||
94440918|NCT02906670|323401544|FG004|Cohort 5, Q2W|Clinical Progression|0|||
94440919|NCT02906670|323401545|FG005|Cohort 5, Q2W|Clinical Progression|0|||
94440920|NCT02906670|323401546|FG006|Cohort 5, Q2W|Clinical Progression|1|||
94440921|NCT02906670|323401547|FG007|Cohort 5, Q2W|Clinical Progression|0|||
94440922|NCT02906670|323401548|FG008|Cohort 5, Q2W|Clinical Progression|0|||
94440923|NCT02906670|323401549|FG009|Cohort 5, Q2W|Clinical Progression|0|||
94440924|NCT02906670|323401540|FG000|Cohort 5, Q2W|Adverse Event|0|||
94440925|NCT02906670|323401541|FG001|Cohort 5, Q2W|Adverse Event|0|||
94440926|NCT02906670|323401542|FG002|Cohort 5, Q2W|Adverse Event|0|||
94440927|NCT02906670|323401543|FG003|Cohort 5, Q2W|Adverse Event|0|||
94440928|NCT02906670|323401544|FG004|Cohort 5, Q2W|Adverse Event|0|||
94440929|NCT02906670|323401545|FG005|Cohort 5, Q2W|Adverse Event|0|||
94440930|NCT02906670|323401546|FG006|Cohort 5, Q2W|Adverse Event|1|||
94440931|NCT02906670|323401547|FG007|Cohort 5, Q2W|Adverse Event|0|||
94440932|NCT02906670|323401548|FG008|Cohort 5, Q2W|Adverse Event|0|||
94440933|NCT02906670|323401549|FG009|Cohort 5, Q2W|Adverse Event|0|||
94440934|NCT02906670|323401540|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
94440935|NCT02906670|323401541|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
94440936|NCT02906670|323401542|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
94440937|NCT02906670|323401543|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
94440938|NCT02906670|323401544|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
94440939|NCT02906670|323401545|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
94440940|NCT02906670|323401546|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
94440941|NCT02906670|323401547|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
94440942|NCT02906670|323401548|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
94440943|NCT02906670|323401549|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
94440944|NCT02906670|323401540|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
94440945|NCT02906670|323401541|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
94440946|NCT02906670|323401542|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
94440947|NCT02906670|323401543|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
94440948|NCT02906670|323401544|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
94440949|NCT02906670|323401545|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
94440950|NCT02906670|323401546|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
94440951|NCT02906670|323401547|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
94440952|NCT02906670|323401548|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
94440953|NCT02906670|323401549|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
94440954|NCT02906670|323401540|FG000|Cohort 5P, Q2W|Adverse Event|0|||
94440955|NCT02906670|323401541|FG001|Cohort 5P, Q2W|Adverse Event|0|||
94440956|NCT02906670|323401542|FG002|Cohort 5P, Q2W|Adverse Event|0|||
94440957|NCT02906670|323401543|FG003|Cohort 5P, Q2W|Adverse Event|0|||
94440958|NCT02906670|323401544|FG004|Cohort 5P, Q2W|Adverse Event|0|||
94440959|NCT02906670|323401545|FG005|Cohort 5P, Q2W|Adverse Event|0|||
94440960|NCT02906670|323401546|FG006|Cohort 5P, Q2W|Adverse Event|0|||
94549196|NCT01459913|323805752|FG001|Overall Study|Physician Decision|1|||
94549197|NCT01459913|323805753|FG002|Overall Study|Physician Decision|0|||
94549198|NCT01459913|323805754|FG003|Overall Study|Physician Decision|0|||
94440961|NCT02906670|323401547|FG007|Cohort 5P, Q2W|Adverse Event|1|||
94440962|NCT02906670|323401548|FG008|Cohort 5P, Q2W|Adverse Event|0|||
94440963|NCT02906670|323401549|FG009|Cohort 5P, Q2W|Adverse Event|0|||
94440964|NCT02906670|323401540|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
94440965|NCT02906670|323401541|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
94440966|NCT02906670|323401542|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
94440967|NCT02906670|323401543|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
94440968|NCT02906670|323401544|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
94440969|NCT02906670|323401545|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
94440970|NCT02906670|323401546|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
94440971|NCT02906670|323401547|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
94440972|NCT02906670|323401548|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
94440973|NCT02906670|323401549|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
94440974|NCT02906670|323401540|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
94440975|NCT02906670|323401541|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
94440976|NCT02906670|323401542|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
94440977|NCT02906670|323401543|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
94440978|NCT02906670|323401544|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
94440979|NCT02906670|323401545|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
94440980|NCT02906670|323401546|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
94440981|NCT02906670|323401547|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
94440982|NCT02906670|323401548|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
94440983|NCT02906670|323401549|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
94440984|NCT02906670|323401540|FG000|Cohort 4P, QW|Radiological Progression|0|||
94440985|NCT02906670|323401541|FG001|Cohort 4P, QW|Radiological Progression|0|||
94440986|NCT02906670|323401542|FG002|Cohort 4P, QW|Radiological Progression|0|||
94440987|NCT02906670|323401543|FG003|Cohort 4P, QW|Radiological Progression|3|||
94440988|NCT02906670|323401544|FG004|Cohort 4P, QW|Radiological Progression|0|||
94440989|NCT02906670|323401545|FG005|Cohort 4P, QW|Radiological Progression|0|||
94440990|NCT02906670|323401546|FG006|Cohort 4P, QW|Radiological Progression|0|||
94440991|NCT02906670|323401547|FG007|Cohort 4P, QW|Radiological Progression|0|||
94440992|NCT02906670|323401548|FG008|Cohort 4P, QW|Radiological Progression|0|||
94440993|NCT02906670|323401549|FG009|Cohort 4P, QW|Radiological Progression|0|||
94440994|NCT02906670|323401540|FG000|Cohort 7P, Q2W|Adverse Event|0|||
94440995|NCT02906670|323401541|FG001|Cohort 7P, Q2W|Adverse Event|0|||
94440996|NCT02906670|323401542|FG002|Cohort 7P, Q2W|Adverse Event|0|||
94440997|NCT02906670|323401543|FG003|Cohort 7P, Q2W|Adverse Event|0|||
94440998|NCT02906670|323401544|FG004|Cohort 7P, Q2W|Adverse Event|0|||
94440999|NCT02906670|323401545|FG005|Cohort 7P, Q2W|Adverse Event|0|||
94441000|NCT02906670|323401546|FG006|Cohort 7P, Q2W|Adverse Event|0|||
94441001|NCT02906670|323401547|FG007|Cohort 7P, Q2W|Adverse Event|0|||
94441002|NCT02906670|323401548|FG008|Cohort 7P, Q2W|Adverse Event|0|||
94441003|NCT02906670|323401549|FG009|Cohort 7P, Q2W|Adverse Event|1|||
94441004|NCT02906670|323401540|FG000|Cohort 7P, Q2W|Physician Decision|0|||
94441005|NCT02906670|323401541|FG001|Cohort 7P, Q2W|Physician Decision|0|||
94441006|NCT02906670|323401542|FG002|Cohort 7P, Q2W|Physician Decision|0|||
94441007|NCT02906670|323401543|FG003|Cohort 7P, Q2W|Physician Decision|0|||
94441008|NCT02906670|323401544|FG004|Cohort 7P, Q2W|Physician Decision|0|||
94441009|NCT02906670|323401545|FG005|Cohort 7P, Q2W|Physician Decision|0|||
94441010|NCT02906670|323401546|FG006|Cohort 7P, Q2W|Physician Decision|0|||
94441011|NCT02906670|323401547|FG007|Cohort 7P, Q2W|Physician Decision|0|||
94441012|NCT02906670|323401548|FG008|Cohort 7P, Q2W|Physician Decision|0|||
94441013|NCT02906670|323401549|FG009|Cohort 7P, Q2W|Physician Decision|1|||
94441014|NCT02906670|323401540|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
94441015|NCT02906670|323401541|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
94441016|NCT02906670|323401542|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
94441017|NCT02906670|323401543|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
94441018|NCT02906670|323401544|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
94441019|NCT02906670|323401545|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
94441020|NCT02906670|323401546|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
94441021|NCT02906670|323401547|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
94441022|NCT02906670|323401548|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
94441023|NCT02906670|323401549|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
94441024|NCT02906670|323401540|FG000|Cohort 5P, QW|Radiological Progression|0|||
94441025|NCT02906670|323401541|FG001|Cohort 5P, QW|Radiological Progression|0|||
94441026|NCT02906670|323401542|FG002|Cohort 5P, QW|Radiological Progression|0|||
94441027|NCT02906670|323401543|FG003|Cohort 5P, QW|Radiological Progression|0|||
94441028|NCT02906670|323401544|FG004|Cohort 5P, QW|Radiological Progression|3|||
94441029|NCT02906670|323401545|FG005|Cohort 5P, QW|Radiological Progression|0|||
94441030|NCT02906670|323401546|FG006|Cohort 5P, QW|Radiological Progression|0|||
94441031|NCT02906670|323401547|FG007|Cohort 5P, QW|Radiological Progression|0|||
94441032|NCT02906670|323401548|FG008|Cohort 5P, QW|Radiological Progression|0|||
94441033|NCT02906670|323401549|FG009|Cohort 5P, QW|Radiological Progression|0|||
94441034|NCT02038010|323401553|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
94441035|NCT02038010|323401554|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
94441036|NCT02038010|323401555|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
94441037|NCT02038010|323401556|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
94441038|NCT02038010|323401553|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
94441039|NCT02038010|323401554|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
94441040|NCT02038010|323401555|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
94441041|NCT02038010|323401556|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
94441042|NCT02038010|323401553|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
94441043|NCT02038010|323401554|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
94441044|NCT02038010|323401555|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
94441045|NCT02038010|323401556|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
94441046|NCT02038010|323401553|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
94441047|NCT02038010|323401554|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
94441048|NCT02038010|323401555|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
94441049|NCT02038010|323401556|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
94441050|NCT02038010|323401553|FG000|Follow Up|Death|4|||
94441051|NCT02038010|323401554|FG001|Follow Up|Death|3|||
94441052|NCT02038010|323401555|FG002|Follow Up|Death|0|||
94441053|NCT02038010|323401556|FG003|Follow Up|Death|0|||
94441054|NCT02038010|323401553|FG000|Follow Up|Other|3|||
94441055|NCT02038010|323401554|FG001|Follow Up|Other|0|||
94441056|NCT02038010|323401555|FG002|Follow Up|Other|0|||
94441057|NCT02038010|323401556|FG003|Follow Up|Other|0|||
94441058|NCT01998919|323401559|FG000|Overall Study|Death|2|||
94441059|NCT01998919|323401560|FG001|Overall Study|Death|2|||
94441060|NCT01998919|323401559|FG000|Overall Study|Adverse Event|0|||
94441061|NCT01998919|323401560|FG001|Overall Study|Adverse Event|5|||
94441062|NCT01998919|323401559|FG000|Overall Study|Disease progression|31|||
94441063|NCT01998919|323401560|FG001|Overall Study|Disease progression|22|||
94441064|NCT01998919|323401559|FG000|Overall Study|Withdrawal by Subject|2|||
94441065|NCT01998919|323401560|FG001|Overall Study|Withdrawal by Subject|4|||
94441066|NCT01998919|323401559|FG000|Overall Study|Lost to Follow-up|2|||
94441067|NCT01998919|323401560|FG001|Overall Study|Lost to Follow-up|0|||
94441068|NCT01998919|323401559|FG000|Overall Study|Other|5|||
94441069|NCT01998919|323401560|FG001|Overall Study|Other|2|||
94441070|NCT02105467|323401563|FG000|Period 1|Lost to Follow-up|1|||
94441071|NCT02105467|323401564|FG001|Period 1|Lost to Follow-up|0|||
94441072|NCT02105467|323401563|FG000|Period 1|Death|1|||
94441073|NCT02105467|323401564|FG001|Period 1|Death|0|||
94441074|NCT02105467|323401563|FG000|Period 2|Lost to Follow-up|1|||
94441075|NCT02105467|323401564|FG001|Period 2|Lost to Follow-up|0|||
94441076|NCT02105467|323401563|FG000|Period 2|Death|1|||
94441077|NCT02105467|323401564|FG001|Period 2|Death|0|||
94441078|NCT02105467|323401563|FG000|Period 2|Withdrawal by Subject|0|||
94441079|NCT02105467|323401564|FG001|Period 2|Withdrawal by Subject|2|||
94441080|NCT02105467|323401563|FG000|Period 3|Lost to Follow-up|0|||
94441081|NCT02105467|323401564|FG001|Period 3|Lost to Follow-up|1|||
94441082|NCT02262325|323401565|FG000|Overall Study|Death|16|||
94441083|NCT02262325|323401565|FG000|Overall Study|Lost to Follow-up|1|||
94441084|NCT02815995|323401566|FG000|Overall Study|Disease Progression|3|||
94441085|NCT02815995|323401567|FG001|Overall Study|Disease Progression|7|||
94441086|NCT02815995|323401568|FG002|Overall Study|Disease Progression|2|||
94441087|NCT02815995|323401569|FG003|Overall Study|Disease Progression|4|||
94441088|NCT02815995|323401570|FG004|Overall Study|Disease Progression|3|||
94441089|NCT02815995|323401571|FG005|Overall Study|Disease Progression|9|||
94441090|NCT02815995|323401572|FG006|Overall Study|Disease Progression|3|||
94441091|NCT02815995|323401573|FG007|Overall Study|Disease Progression|1|||
94441092|NCT02815995|323401566|FG000|Overall Study|Adverse Event|1|||
94441093|NCT02815995|323401567|FG001|Overall Study|Adverse Event|2|||
94441094|NCT02815995|323401568|FG002|Overall Study|Adverse Event|2|||
94441095|NCT02815995|323401569|FG003|Overall Study|Adverse Event|0|||
94441096|NCT02815995|323401570|FG004|Overall Study|Adverse Event|0|||
94441097|NCT02815995|323401571|FG005|Overall Study|Adverse Event|1|||
94441098|NCT02815995|323401572|FG006|Overall Study|Adverse Event|0|||
94441099|NCT02815995|323401573|FG007|Overall Study|Adverse Event|0|||
94441100|NCT02815995|323401566|FG000|Overall Study|Pregnancy|0|||
94441101|NCT02815995|323401567|FG001|Overall Study|Pregnancy|0|||
94441102|NCT02815995|323401568|FG002|Overall Study|Pregnancy|0|||
94441103|NCT02815995|323401569|FG003|Overall Study|Pregnancy|0|||
94441104|NCT02815995|323401570|FG004|Overall Study|Pregnancy|0|||
94441105|NCT02815995|323401571|FG005|Overall Study|Pregnancy|0|||
94441106|NCT02815995|323401572|FG006|Overall Study|Pregnancy|1|||
94441107|NCT02815995|323401573|FG007|Overall Study|Pregnancy|0|||
94441108|NCT02115282|323401576|FG000|Overall Study|Disease progression during treatment|216|||
94441109|NCT02115282|323401577|FG001|Overall Study|Disease progression during treatment|229|||
94441110|NCT02115282|323401576|FG000|Overall Study|Adverse Event|49|||
94441111|NCT02115282|323401577|FG001|Overall Study|Adverse Event|23|||
94441112|NCT02115282|323401576|FG000|Overall Study|Death|1|||
94441113|NCT02115282|323401577|FG001|Overall Study|Death|3|||
94441114|NCT02115282|323401576|FG000|Overall Study|Alternative therapy|1|||
94441115|NCT02115282|323401577|FG001|Overall Study|Alternative therapy|1|||
94441116|NCT02115282|323401576|FG000|Overall Study|Complicating disease|0|||
94441117|NCT02115282|323401577|FG001|Overall Study|Complicating disease|3|||
94441118|NCT02115282|323401576|FG000|Overall Study|Withdrawal by Subject|12|||
94441119|NCT02115282|323401577|FG001|Overall Study|Withdrawal by Subject|10|||
94441120|NCT02115282|323401576|FG000|Overall Study|Symptomatic progression/deterioration|7|||
94441121|NCT02115282|323401577|FG001|Overall Study|Symptomatic progression/deterioration|18|||
94441122|NCT02115282|323401576|FG000|Overall Study|Non-compliance|5|||
94441123|NCT02115282|323401577|FG001|Overall Study|Non-compliance|1|||
94441124|NCT02115282|323401576|FG000|Overall Study|Protocol Violation|2|||
94441125|NCT02115282|323401577|FG001|Overall Study|Protocol Violation|2|||
94441126|NCT02115282|323401576|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
94441127|NCT02115282|323401577|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
94441128|NCT02115282|323401576|FG000|Overall Study|Not start protocol therapy|9|||
94441129|NCT02115282|323401577|FG001|Overall Study|Not start protocol therapy|10|||
94441130|NCT02756611|323401583|FG000|Overall Study|Death|70|||
94441131|NCT02756611|323401583|FG000|Overall Study|Withdrawal by Subject|2|||
94441132|NCT02756611|323401583|FG000|Overall Study|Lost to Follow-up|3|||
94441133|NCT02756611|323401583|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
94441134|NCT02756611|323401583|FG000|Overall Study|Other|10|||
94441135|NCT01522456|323401592|FG000|Overall Study|Adverse Event|2|||
94441136|NCT01522456|323401592|FG000|Overall Study|Lost to Follow-up|2|||
94441137|NCT01522456|323401592|FG000|Overall Study|Withdrawal by Subject|2|||
94441138|NCT01522456|323401592|FG000|Overall Study|Pregnancy|1|||
94441139|NCT01522456|323401592|FG000|Overall Study|Tolerability Assessment|1|||
94441140|NCT03483012|323401599|FG000|Overall Study|Lack of Efficacy|6|||
94441141|NCT02466321|323401604|FG000|Overall Study|Death|26|||
94441142|NCT02466321|323401604|FG000|Overall Study|Revision|6|||
94441143|NCT02466321|323401604|FG000|Overall Study|Lost to Follow-up|60|||
94441144|NCT02466321|323401604|FG000|Overall Study|Did not receive study device|1|||
94441145|NCT04331808|323401605|FG000|Overall Study|Withdrew consent|1|||
94441146|NCT04331808|323401606|FG001|Overall Study|Withdrew consent|0|||
94441147|NCT04331808|323401607|FG002|Overall Study|Withdrew consent|2|||
94441148|NCT04331808|323401608|FG003|Overall Study|Withdrew consent|3|||
94441149|NCT02586155|323401611|FG000|Overall Study|Adverse Event|2|||
94441150|NCT02586155|323401612|FG001|Overall Study|Adverse Event|3|||
94441151|NCT02586155|323401611|FG000|Overall Study|Withdrawal by Subject|31|||
94441152|NCT02586155|323401612|FG001|Overall Study|Withdrawal by Subject|24|||
94441153|NCT02586155|323401611|FG000|Overall Study|Lost to Follow-up|7|||
94441154|NCT02586155|323401612|FG001|Overall Study|Lost to Follow-up|13|||
94441155|NCT02586155|323401611|FG000|Overall Study|Death|61|||
94441156|NCT02586155|323401612|FG001|Overall Study|Death|72|||
94441157|NCT02586155|323401611|FG000|Overall Study|Other reasons|26|||
94441158|NCT02586155|323401612|FG001|Overall Study|Other reasons|15|||
94441159|NCT02201784|323401614|FG000|Overall Study|Failure to achieve adequate block|2|||
94549199|NCT01459913|323805751|FG000|Overall Study|Study Terminated by Sponsor|30|||
94549200|NCT01459913|323805752|FG001|Overall Study|Study Terminated by Sponsor|15|||
94549201|NCT01459913|323805753|FG002|Overall Study|Study Terminated by Sponsor|9|||
94549202|NCT01459913|323805754|FG003|Overall Study|Study Terminated by Sponsor|11|||
94549203|NCT01459913|323805751|FG000|Overall Study|Other|0|||
94549204|NCT01459913|323805752|FG001|Overall Study|Other|0|||
94549205|NCT01459913|323805753|FG002|Overall Study|Other|3|||
94549206|NCT01459913|323805754|FG003|Overall Study|Other|1|||
94549207|NCT01459913|323805751|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
94549208|NCT01459913|323805752|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
94549209|NCT01459913|323805753|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
94549210|NCT01459913|323805754|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
94549211|NCT04208087|323805755|FG000|Overall Study|Adverse Event|1|||
94549212|NCT04208087|323805756|FG001|Overall Study|Adverse Event|0|||
94549213|NCT04208087|323805757|FG002|Overall Study|Adverse Event|0|||
94549214|NCT04208087|323805758|FG003|Overall Study|Adverse Event|0|||
94549215|NCT04208087|323805759|FG004|Overall Study|Adverse Event|0|||
94549216|NCT04208087|323805755|FG000|Overall Study|Withdrawal by Subject|0|||
94549217|NCT04208087|323805756|FG001|Overall Study|Withdrawal by Subject|0|||
94549218|NCT04208087|323805757|FG002|Overall Study|Withdrawal by Subject|1|||
94549219|NCT04208087|323805758|FG003|Overall Study|Withdrawal by Subject|0|||
94549220|NCT04208087|323805759|FG004|Overall Study|Withdrawal by Subject|0|||
94549221|NCT04208087|323805755|FG000|Overall Study|Other|0|||
94549222|NCT04208087|323805756|FG001|Overall Study|Other|0|||
94549223|NCT04208087|323805757|FG002|Overall Study|Other|0|||
94441160|NCT02201784|323401615|FG001|Overall Study|Failure to achieve adequate block|0|||
94441161|NCT05101343|323401616|FG000|Overall Study|Withdrawal by Subject|2|||
94441162|NCT05101343|323401617|FG001|Overall Study|Withdrawal by Subject|1|||
94549224|NCT04208087|323805758|FG003|Overall Study|Other|0|||
94549225|NCT04208087|323805759|FG004|Overall Study|Other|1|||
94549226|NCT00952614|323805760|FG000|Overall Study|Death|3|||
94549227|NCT00952614|323805760|FG000|Overall Study|Lost to Follow-up|3|||
94549228|NCT00952614|323805760|FG000|Overall Study|other reason|1|||
94549229|NCT01345682|323805761|FG000|Overall Study|Progressive disease per RECIST|226|||
94549230|NCT01345682|323805762|FG001|Overall Study|Progressive disease per RECIST|93|||
94549231|NCT01345682|323805761|FG000|Overall Study|Worsening of underlying cancer disease|23|||
94549232|NCT01345682|323805762|FG001|Overall Study|Worsening of underlying cancer disease|12|||
94549233|NCT01345682|323805761|FG000|Overall Study|Adverse Event|51|||
94549234|NCT01345682|323805762|FG001|Overall Study|Adverse Event|41|||
94549235|NCT01345682|323805761|FG000|Overall Study|Non-compliance with protocol|0|||
94549236|NCT01345682|323805762|FG001|Overall Study|Non-compliance with protocol|1|||
94549237|NCT01345682|323805761|FG000|Overall Study|Lost to Follow-up|0|||
94339979|NCT03605836|323024763|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
94339980|NCT03605836|323024760|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
94339981|NCT03605836|323024761|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
94339982|NCT03605836|323024762|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
94339983|NCT03605836|323024763|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
94339984|NCT03605836|323024760|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
94339985|NCT03605836|323024761|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
94339986|NCT03605836|323024762|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
94339987|NCT03605836|323024763|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
94339988|NCT03605836|323024760|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
94339989|NCT03605836|323024761|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
94339990|NCT03605836|323024762|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
94339991|NCT03605836|323024763|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
94339992|NCT03605836|323024760|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
94339993|NCT03605836|323024761|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
94339994|NCT03605836|323024762|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
94339995|NCT03605836|323024763|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
94339996|NCT03605836|323024760|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
94339997|NCT03605836|323024761|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
94339998|NCT03605836|323024762|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
94339999|NCT03605836|323024763|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
94340000|NCT03605836|323024760|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
94340001|NCT03605836|323024761|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
94340002|NCT03605836|323024762|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
94340003|NCT03605836|323024763|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
94340004|NCT03605836|323024760|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
94340005|NCT03605836|323024761|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
94340006|NCT03605836|323024762|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
94340007|NCT03605836|323024763|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
94340008|NCT03605836|323024760|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
94340009|NCT03605836|323024761|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
94340010|NCT03605836|323024762|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
94340011|NCT03605836|323024763|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
94340012|NCT03605836|323024760|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
94340013|NCT03605836|323024761|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
94340014|NCT03605836|323024762|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
94340015|NCT03605836|323024763|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
94340016|NCT03605836|323024760|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
94340017|NCT03605836|323024761|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
94340018|NCT03605836|323024762|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
94340019|NCT03605836|323024763|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
94340020|NCT03605836|323024760|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
94340021|NCT03605836|323024761|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
94340022|NCT03605836|323024762|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
94340023|NCT03605836|323024763|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
94340024|NCT03605836|323024760|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
94340025|NCT03605836|323024761|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
94340026|NCT03605836|323024762|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
94340027|NCT03605836|323024763|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
94340028|NCT03605836|323024760|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
94340029|NCT03605836|323024761|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
94340030|NCT03605836|323024762|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
94340031|NCT03605836|323024763|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
94549238|NCT01345682|323805762|FG001|Overall Study|Lost to Follow-up|1|||
94651332|NCT02460224|324179742|FG027|Overall Study|Progressive disease|17|||
94441163|NCT03447743|323401618|FG000|Overall Study|Withdrawal by Subject|2|||
94441164|NCT03447743|323401618|FG000|Overall Study|Lost to Follow-up|3|||
94441165|NCT03447743|323401618|FG000|Overall Study|Adverse Event|1|||
94441166|NCT03447743|323401618|FG000|Overall Study|Did not meet criteria to continue|1|||
94441167|NCT02431364|323401619|FG000|Overall Study|Adverse Event|0|||
94441168|NCT02431364|323401620|FG001|Overall Study|Adverse Event|1|||
94441169|NCT02431364|323401621|FG002|Overall Study|Adverse Event|0|||
94441170|NCT02431364|323401622|FG003|Overall Study|Adverse Event|0|||
94441171|NCT02431364|323401623|FG004|Overall Study|Adverse Event|0|||
94441172|NCT02431364|323401619|FG000|Overall Study|Randomized but never treated|0|||
94441173|NCT02431364|323401620|FG001|Overall Study|Randomized but never treated|0|||
94441174|NCT02431364|323401621|FG002|Overall Study|Randomized but never treated|0|||
94441175|NCT02431364|323401622|FG003|Overall Study|Randomized but never treated|1|||
94441176|NCT02431364|323401623|FG004|Overall Study|Randomized but never treated|0|||
94441177|NCT00866359|323401624|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
94441178|NCT00866359|323401625|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
94441179|NCT00866359|323401626|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
94441180|NCT00866359|323401627|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
94441181|NCT00866359|323401624|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
94441182|NCT00866359|323401625|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
94441183|NCT00866359|323401626|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
94340032|NCT03605836|323024760|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
94340033|NCT03605836|323024761|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
94340034|NCT03605836|323024762|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
94340035|NCT03605836|323024763|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
94340036|NCT03605836|323024760|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
94340037|NCT03605836|323024761|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
94340038|NCT03605836|323024762|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
94340039|NCT03605836|323024763|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
94340040|NCT03605836|323024760|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
94441184|NCT00866359|323401627|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
94441185|NCT00866359|323401624|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
94441186|NCT00866359|323401625|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
94441187|NCT00866359|323401626|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
94340041|NCT03605836|323024761|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
94340042|NCT03605836|323024762|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
94340043|NCT03605836|323024763|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
94340044|NCT03605836|323024760|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
94340045|NCT03605836|323024761|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
94340046|NCT03605836|323024762|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
94340047|NCT03605836|323024763|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
94340048|NCT03447821|323024764|FG000|Overall Study|Withdrawal by Subject|1|||
94340049|NCT03447821|323024765|FG001|Overall Study|Withdrawal by Subject|1|||
94340050|NCT03447821|323024766|FG002|Overall Study|Withdrawal by Subject|0|||
94340051|NCT03447821|323024764|FG000|Overall Study|Lost to Follow-up|0|||
94340052|NCT03447821|323024765|FG001|Overall Study|Lost to Follow-up|0|||
94340053|NCT03447821|323024766|FG002|Overall Study|Lost to Follow-up|1|||
94340054|NCT02465489|323024774|FG000|Overall Study|Adverse Event|5|||
94340055|NCT04599972|323024777|FG000|Overall Study|Withdrawal by Subject|6|||
94340056|NCT04599972|323024778|FG001|Overall Study|Withdrawal by Subject|1|||
94340057|NCT04599972|323024777|FG000|Overall Study|Adverse Event|1|||
94340058|NCT04599972|323024778|FG001|Overall Study|Adverse Event|1|||
94340059|NCT04599972|323024777|FG000|Overall Study|Lost to Follow-up|1|||
94340060|NCT04599972|323024778|FG001|Overall Study|Lost to Follow-up|6|||
94340061|NCT04599972|323024777|FG000|Overall Study|Protocol Violation|1|||
94441188|NCT00866359|323401627|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
94441189|NCT00866359|323401624|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
94441190|NCT00866359|323401625|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
94441191|NCT00866359|323401626|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
94441192|NCT00866359|323401627|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
94441193|NCT00866359|323401624|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
94441194|NCT00866359|323401625|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
94441195|NCT00866359|323401626|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
94441196|NCT00866359|323401627|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
94441197|NCT00866359|323401624|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
94441198|NCT00866359|323401625|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
94441199|NCT00866359|323401626|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
94441200|NCT00866359|323401627|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
94441201|NCT01326845|323401628|FG000|Overall Study|Administrative Problems|5|||
94441202|NCT01326845|323401629|FG001|Overall Study|Administrative Problems|2|||
94549239|NCT01345682|323805761|FG000|Overall Study|Refused to continue trial medication|16|||
94441203|NCT01326845|323401628|FG000|Overall Study|Adverse Event|1|||
94441204|NCT01326845|323401629|FG001|Overall Study|Adverse Event|0|||
94441205|NCT01326845|323401628|FG000|Overall Study|Misisng|1|||
94441206|NCT01326845|323401629|FG001|Overall Study|Misisng|3|||
94340062|NCT04599972|323024778|FG001|Overall Study|Protocol Violation|0|||
94340063|NCT04599972|323024777|FG000|Overall Study|Other reason|1|||
94340064|NCT04599972|323024778|FG001|Overall Study|Other reason|0|||
94340065|NCT01855425|323024783|FG000|Overall Study|Physician Decision|20|||
94340066|NCT00023712|323024787|FG000|Overall Study|Not platinum sensitive|1|||
94340067|NCT00023712|323024788|FG001|Overall Study|Not platinum sensitive|0|||
94340068|NCT00023712|323024787|FG000|Overall Study|Never treated|1|||
94340069|NCT00023712|323024788|FG001|Overall Study|Never treated|1|||
94340070|NCT01437267|323024795|FG000|Overall Study|Withdrawal by Subject|0|||
94340071|NCT01437267|323024796|FG001|Overall Study|Withdrawal by Subject|0|||
94340072|NCT01437267|323024797|FG002|Overall Study|Withdrawal by Subject|0|||
94340073|NCT01437267|323024798|FG003|Overall Study|Withdrawal by Subject|1|||
94340074|NCT01437267|323024799|FG004|Overall Study|Withdrawal by Subject|0|||
94340075|NCT01437267|323024800|FG005|Overall Study|Withdrawal by Subject|0|||
94340076|NCT01437267|323024795|FG000|Overall Study|Protocol Violation|0|||
94340077|NCT01437267|323024796|FG001|Overall Study|Protocol Violation|1|||
94340078|NCT01437267|323024797|FG002|Overall Study|Protocol Violation|0|||
94340079|NCT01437267|323024798|FG003|Overall Study|Protocol Violation|0|||
94340080|NCT01437267|323024799|FG004|Overall Study|Protocol Violation|0|||
94340081|NCT01437267|323024800|FG005|Overall Study|Protocol Violation|0|||
94340082|NCT01976624|323024805|FG000|Overall Study|Participants contraindicated|2|||
94340083|NCT01976624|323024805|FG000|Overall Study|Participants age less than 19 years|12|||
94340084|NCT04350372|323024806|FG000|Overall Study|Death|1|||
94340085|NCT01696396|323026593|FG000|Overall Study|Withdrawal by Subject|19|||
94340086|NCT01696396|323026594|FG001|Overall Study|Withdrawal by Subject|5|||
94340087|NCT01696396|323026595|FG002|Overall Study|Withdrawal by Subject|19|||
94340088|NCT01696396|323026596|FG003|Overall Study|Withdrawal by Subject|11|||
94340089|NCT01696396|323026593|FG000|Overall Study|Decision by Sponsor|3|||
94340090|NCT01696396|323026594|FG001|Overall Study|Decision by Sponsor|1|||
94340091|NCT01696396|323026595|FG002|Overall Study|Decision by Sponsor|2|||
94340092|NCT01696396|323026596|FG003|Overall Study|Decision by Sponsor|2|||
94340093|NCT01696396|323026593|FG000|Overall Study|Lost to Follow-up|9|||
94340094|NCT01696396|323026594|FG001|Overall Study|Lost to Follow-up|1|||
94340095|NCT01696396|323026595|FG002|Overall Study|Lost to Follow-up|4|||
94340096|NCT01696396|323026596|FG003|Overall Study|Lost to Follow-up|1|||
94340097|NCT01696396|323026593|FG000|Overall Study|Death|0|||
94340098|NCT01696396|323026594|FG001|Overall Study|Death|0|||
94340099|NCT01696396|323026595|FG002|Overall Study|Death|1|||
94340100|NCT01696396|323026596|FG003|Overall Study|Death|0|||
94340101|NCT02712008|323026599|FG000|Baseline (Day 1) up to Week 12|Death|3|||
94340102|NCT02712008|323026600|FG001|Baseline (Day 1) up to Week 12|Death|0|||
94340103|NCT02712008|323026601|FG002|Baseline (Day 1) up to Week 12|Death|0|||
94340104|NCT02712008|323026602|FG003|Baseline (Day 1) up to Week 12|Death|0|||
94340105|NCT02712008|323026603|FG004|Baseline (Day 1) up to Week 12|Death|0|||
94340106|NCT02712008|323026604|FG005|Baseline (Day 1) up to Week 12|Death|0|||
94340107|NCT02712008|323026605|FG006|Baseline (Day 1) up to Week 12|Death|0|||
94340108|NCT02712008|323026606|FG007|Baseline (Day 1) up to Week 12|Death|0|||
94340109|NCT02712008|323026599|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
94340110|NCT02712008|323026600|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
94340111|NCT02712008|323026601|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
94340112|NCT02712008|323026602|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
94340113|NCT02712008|323026603|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
94340114|NCT02712008|323026604|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
94340115|NCT02712008|323026605|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
94340116|NCT02712008|323026606|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
94340117|NCT02712008|323026599|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
94340118|NCT02712008|323026600|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
94340119|NCT02712008|323026601|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
94441207|NCT02524847|323401630|FG000|Overall Study|Adverse Event|4|||
94441208|NCT02524847|323401630|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
94441209|NCT02524847|323401630|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
94441210|NCT02524847|323401630|FG000|Overall Study|Death|1|||
94441211|NCT02524847|323401630|FG000|Overall Study|Reason not Specified|1|||
94441212|NCT02623725|323401631|FG000|Overall Study|Non compliance with protocol|9|||
94441213|NCT02623725|323401632|FG001|Overall Study|Non compliance with protocol|3|||
94441214|NCT02623725|323401631|FG000|Overall Study|Serious adverse event|0|||
94441215|NCT02623725|323401632|FG001|Overall Study|Serious adverse event|2|||
94441216|NCT02623725|323401631|FG000|Overall Study|Withdrawal by Subject|7|||
94441217|NCT02623725|323401632|FG001|Overall Study|Withdrawal by Subject|1|||
94340120|NCT02712008|323026602|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
94340121|NCT02712008|323026603|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
94340122|NCT02712008|323026604|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
94340123|NCT02712008|323026605|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
94340124|NCT02712008|323026606|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
94340125|NCT02712008|323026599|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
94340126|NCT02712008|323026600|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
94340127|NCT02712008|323026601|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
94340128|NCT02712008|323026602|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
94340129|NCT02712008|323026603|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
94340130|NCT02712008|323026604|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
94340131|NCT02712008|323026605|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
94340132|NCT02712008|323026606|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
94340133|NCT02712008|323026599|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
94340134|NCT02712008|323026600|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
94340135|NCT02712008|323026601|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
94340136|NCT02712008|323026602|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
94340137|NCT02712008|323026603|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
94340138|NCT02712008|323026604|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
94340139|NCT02712008|323026605|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
94340140|NCT02712008|323026606|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
94340141|NCT02712008|323026599|FG000|From Week 12 up to Week 36|Adverse Event|0|||
94340142|NCT02712008|323026600|FG001|From Week 12 up to Week 36|Adverse Event|0|||
94340143|NCT02712008|323026601|FG002|From Week 12 up to Week 36|Adverse Event|0|||
94340144|NCT02712008|323026602|FG003|From Week 12 up to Week 36|Adverse Event|0|||
94340145|NCT02712008|323026603|FG004|From Week 12 up to Week 36|Adverse Event|1|||
94340146|NCT02712008|323026604|FG005|From Week 12 up to Week 36|Adverse Event|0|||
94340147|NCT02712008|323026605|FG006|From Week 12 up to Week 36|Adverse Event|0|||
94340148|NCT02712008|323026606|FG007|From Week 12 up to Week 36|Adverse Event|2|||
94340149|NCT02712008|323026599|FG000|From Week 12 up to Week 36|Death|1|||
94340150|NCT02712008|323026600|FG001|From Week 12 up to Week 36|Death|0|||
94340151|NCT02712008|323026601|FG002|From Week 12 up to Week 36|Death|0|||
94340152|NCT02712008|323026602|FG003|From Week 12 up to Week 36|Death|0|||
94340153|NCT02712008|323026603|FG004|From Week 12 up to Week 36|Death|0|||
94340154|NCT02712008|323026604|FG005|From Week 12 up to Week 36|Death|0|||
94340155|NCT02712008|323026605|FG006|From Week 12 up to Week 36|Death|1|||
94340156|NCT02712008|323026606|FG007|From Week 12 up to Week 36|Death|0|||
94340157|NCT02712008|323026599|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
94340158|NCT02712008|323026600|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
94340159|NCT02712008|323026601|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
94340160|NCT02712008|323026602|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
94340161|NCT02712008|323026603|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
94340162|NCT02712008|323026604|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
94340163|NCT02712008|323026605|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
94340164|NCT02712008|323026606|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
94340165|NCT02712008|323026599|FG000|From Week 12 up to Week 36|Physician Decision|0|||
94340166|NCT02712008|323026600|FG001|From Week 12 up to Week 36|Physician Decision|0|||
94340167|NCT02712008|323026601|FG002|From Week 12 up to Week 36|Physician Decision|0|||
94340168|NCT02712008|323026602|FG003|From Week 12 up to Week 36|Physician Decision|1|||
94340169|NCT02712008|323026603|FG004|From Week 12 up to Week 36|Physician Decision|1|||
94340170|NCT02712008|323026604|FG005|From Week 12 up to Week 36|Physician Decision|0|||
94340171|NCT02712008|323026605|FG006|From Week 12 up to Week 36|Physician Decision|0|||
94340172|NCT02712008|323026606|FG007|From Week 12 up to Week 36|Physician Decision|0|||
94340173|NCT02712008|323026599|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
94340174|NCT02712008|323026600|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
94340175|NCT02712008|323026601|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
94340176|NCT02712008|323026602|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
94340177|NCT02712008|323026603|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
94340178|NCT02712008|323026604|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
94340179|NCT02712008|323026605|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
94340180|NCT02712008|323026606|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
94340181|NCT04984876|323026614|FG000|Overall Study|Subject decision|2|||
94340182|NCT04984876|323026615|FG001|Overall Study|Subject decision|10|||
94340183|NCT04984876|323026616|FG002|Overall Study|Subject decision|3|||
94340184|NCT04984876|323026617|FG003|Overall Study|Subject decision|3|||
94340185|NCT04984876|323026618|FG004|Overall Study|Subject decision|3|||
94340186|NCT04984876|323026619|FG005|Overall Study|Subject decision|0|||
94340187|NCT04984876|323026614|FG000|Overall Study|Guardian decision|0|||
94340188|NCT04984876|323026615|FG001|Overall Study|Guardian decision|1|||
94340189|NCT04984876|323026616|FG002|Overall Study|Guardian decision|0|||
94340190|NCT04984876|323026617|FG003|Overall Study|Guardian decision|2|||
94340191|NCT04984876|323026618|FG004|Overall Study|Guardian decision|0|||
94340192|NCT04984876|323026619|FG005|Overall Study|Guardian decision|1|||
94340193|NCT04984876|323026614|FG000|Overall Study|Lost to Follow-up|0|||
94340194|NCT04984876|323026615|FG001|Overall Study|Lost to Follow-up|0|||
94340195|NCT04984876|323026616|FG002|Overall Study|Lost to Follow-up|1|||
94340196|NCT04984876|323026617|FG003|Overall Study|Lost to Follow-up|1|||
94340197|NCT04984876|323026618|FG004|Overall Study|Lost to Follow-up|0|||
94340198|NCT04984876|323026619|FG005|Overall Study|Lost to Follow-up|0|||
94340199|NCT04984876|323026614|FG000|Overall Study|Physician Decision|1|||
94340200|NCT04984876|323026615|FG001|Overall Study|Physician Decision|0|||
94340201|NCT04984876|323026616|FG002|Overall Study|Physician Decision|0|||
94340202|NCT04984876|323026617|FG003|Overall Study|Physician Decision|1|||
94340203|NCT04984876|323026618|FG004|Overall Study|Physician Decision|0|||
94340204|NCT04984876|323026619|FG005|Overall Study|Physician Decision|0|||
94340205|NCT04984876|323026614|FG000|Overall Study|Adverse Event|0|||
94340206|NCT04984876|323026615|FG001|Overall Study|Adverse Event|0|||
94340207|NCT04984876|323026616|FG002|Overall Study|Adverse Event|1|||
94340208|NCT04984876|323026617|FG003|Overall Study|Adverse Event|0|||
94340209|NCT04984876|323026618|FG004|Overall Study|Adverse Event|0|||
94340210|NCT04984876|323026619|FG005|Overall Study|Adverse Event|0|||
94340211|NCT02204410|323026620|FG000|Overall Study|Lost to Follow-up|5|||
94340212|NCT02204410|323026620|FG000|Overall Study|Physician Decision|2|||
94340213|NCT02204410|323026620|FG000|Overall Study|Protocol Violation|1|||
94340214|NCT02204410|323026620|FG000|Overall Study|Withdrawal by Subject|3|||
94340215|NCT01376388|323026621|FG000|Overall Study|Adverse Event|13|||
94340216|NCT01376388|323026621|FG000|Overall Study|Lack of Efficacy|2|||
94340217|NCT01376388|323026621|FG000|Overall Study|Withdrawal by Subject|3|||
94340218|NCT00524043|323026625|FG000|Overall Study|Lack of Efficacy|15|||
94340219|NCT00524043|323026626|FG001|Overall Study|Lack of Efficacy|13|||
94340220|NCT00524043|323026627|FG002|Overall Study|Lack of Efficacy|14|||
94340221|NCT00524043|323026625|FG000|Overall Study|Withdrawal by Subject|5|||
94340222|NCT00524043|323026626|FG001|Overall Study|Withdrawal by Subject|7|||
94340223|NCT00524043|323026627|FG002|Overall Study|Withdrawal by Subject|7|||
94340224|NCT00524043|323026625|FG000|Overall Study|Adverse Event|5|||
94340225|NCT00524043|323026626|FG001|Overall Study|Adverse Event|2|||
94340226|NCT00524043|323026627|FG002|Overall Study|Adverse Event|7|||
94340227|NCT00524043|323026625|FG000|Overall Study|Lost to Follow-up|3|||
94340228|NCT00524043|323026626|FG001|Overall Study|Lost to Follow-up|5|||
94340229|NCT00524043|323026627|FG002|Overall Study|Lost to Follow-up|3|||
94340230|NCT00524043|323026625|FG000|Overall Study|Various (eg, incarceration)|2|||
94340231|NCT00524043|323026626|FG001|Overall Study|Various (eg, incarceration)|1|||
94340232|NCT00524043|323026627|FG002|Overall Study|Various (eg, incarceration)|0|||
94340233|NCT00517413|323026630|FG000|Overall Study|Adverse Event|7|||
94441218|NCT02456740|323401633|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
94441219|NCT02456740|323401634|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
94441220|NCT02456740|323401635|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
94441221|NCT02456740|323401636|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
94441222|NCT02456740|323401637|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
94441223|NCT02456740|323401638|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
94549240|NCT01345682|323805762|FG001|Overall Study|Refused to continue trial medication|9|||
94549241|NCT01345682|323805761|FG000|Overall Study|Not treated|2|||
94549242|NCT01345682|323805762|FG001|Overall Study|Not treated|1|||
94549243|NCT01345682|323805761|FG000|Overall Study|Reason other than those specified above|4|||
94549244|NCT01345682|323805762|FG001|Overall Study|Reason other than those specified above|3|||
94549245|NCT00637572|323805763|FG000|Overall Study|Adverse Event|1|||
94549246|NCT00637572|323805764|FG001|Overall Study|Adverse Event|2|||
94549247|NCT00637572|323805763|FG000|Overall Study|Death|0|||
94549248|NCT00637572|323805764|FG001|Overall Study|Death|1|||
94549249|NCT00637572|323805763|FG000|Overall Study|Lost to Follow-up|0|||
94549250|NCT00637572|323805764|FG001|Overall Study|Lost to Follow-up|1|||
94549251|NCT00637572|323805763|FG000|Overall Study|Physician Decision|1|||
94549252|NCT00637572|323805764|FG001|Overall Study|Physician Decision|1|||
94549253|NCT00637572|323805763|FG000|Overall Study|Withdrawal by Subject|0|||
94549254|NCT00637572|323805764|FG001|Overall Study|Withdrawal by Subject|2|||
94441224|NCT02456740|323401639|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
94441225|NCT02456740|323401640|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
94441226|NCT02456740|323401641|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
94549255|NCT00637572|323805763|FG000|Overall Study|Illicit Drug Use|1|||
94549256|NCT00637572|323805764|FG001|Overall Study|Illicit Drug Use|0|||
94549257|NCT04033068|323805765|FG000|Overall Study|Withdrawal by Subject|0|||
94549258|NCT04033068|323805766|FG001|Overall Study|Withdrawal by Subject|0|||
94441227|NCT02456740|323401633|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
94441228|NCT02456740|323401634|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
94441229|NCT02456740|323401635|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
94441230|NCT02456740|323401636|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
94441231|NCT02456740|323401637|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
94441232|NCT02456740|323401638|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
94549259|NCT04033068|323805767|FG002|Overall Study|Withdrawal by Subject|1|||
94549260|NCT04033068|323805768|FG003|Overall Study|Withdrawal by Subject|0|||
94340234|NCT00517413|323026630|FG000|Overall Study|Death|13|||
94340235|NCT00517413|323026630|FG000|Overall Study|Protocol Violation|15|||
94549261|NCT04033068|323805765|FG000|Overall Study|Lost to Follow-up|0|||
94549262|NCT04033068|323805766|FG001|Overall Study|Lost to Follow-up|1|||
94549263|NCT04033068|323805767|FG002|Overall Study|Lost to Follow-up|0|||
94340236|NCT00517413|323026630|FG000|Overall Study|Withdrawal by Subject|2|||
94340237|NCT00517413|323026630|FG000|Overall Study|Failure to return|1|||
94340238|NCT00517413|323026630|FG000|Overall Study|Other-Reasons|23|||
94340239|NCT01510028|323026631|FG000|Overall Study|Lack of Efficacy|1|||
94340240|NCT01510028|323026632|FG001|Overall Study|Lack of Efficacy|0|||
94340241|NCT01510028|323026633|FG002|Overall Study|Lack of Efficacy|0|||
94340242|NCT01510028|323026634|FG003|Overall Study|Lack of Efficacy|0|||
94340243|NCT02954952|323026640|FG000|Overall Study|Withdrawal by Subject|1|||
94340244|NCT02954952|323026641|FG001|Overall Study|Withdrawal by Subject|0|||
94340245|NCT02954952|323026642|FG002|Overall Study|Withdrawal by Subject|0|||
94340246|NCT02954952|323026640|FG000|Overall Study|No data collected|0|||
94340247|NCT02954952|323026641|FG001|Overall Study|No data collected|1|||
94340248|NCT02954952|323026642|FG002|Overall Study|No data collected|0|||
94340249|NCT00839436|323026643|FG000|Overall Study|Developed exclusionary condition|1|||
94340250|NCT00839436|323026644|FG001|Overall Study|Developed exclusionary condition|0|||
94340251|NCT00839436|323026645|FG002|Overall Study|Developed exclusionary condition|0|||
94340252|NCT00839436|323026643|FG000|Overall Study|Withdrawal by Subject|0|||
94340253|NCT00839436|323026644|FG001|Overall Study|Withdrawal by Subject|1|||
94340254|NCT00839436|323026645|FG002|Overall Study|Withdrawal by Subject|0|||
94340255|NCT00839436|323026643|FG000|Overall Study|Study drug no longer available|0|||
94340256|NCT00839436|323026644|FG001|Overall Study|Study drug no longer available|0|||
94340257|NCT00839436|323026645|FG002|Overall Study|Study drug no longer available|1|||
94340258|NCT02565576|323026646|FG000|Overall Study|abnormal lab value|2|||
94340259|NCT02565576|323026647|FG001|Overall Study|abnormal lab value|0|||
94340260|NCT02565576|323026646|FG000|Overall Study|subject / guardian decision|1|||
94340261|NCT02565576|323026647|FG001|Overall Study|subject / guardian decision|3|||
94340262|NCT02565576|323026646|FG000|Overall Study|Lost to Follow-up|1|||
94340263|NCT02565576|323026647|FG001|Overall Study|Lost to Follow-up|0|||
94340264|NCT02565576|323026646|FG000|Overall Study|Death|0|||
94340265|NCT02565576|323026647|FG001|Overall Study|Death|2|||
94340266|NCT02565576|323026646|FG000|Overall Study|Adverse Event|1|||
94340267|NCT02565576|323026647|FG001|Overall Study|Adverse Event|0|||
94340268|NCT04157348|323026648|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
94340269|NCT04157348|323026649|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
94340270|NCT04157348|323026648|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
94340271|NCT04157348|323026649|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
94340272|NCT04157348|323026648|FG000|Double-blind Treatment Period|Adverse Event|0|||
94340273|NCT04157348|323026649|FG001|Double-blind Treatment Period|Adverse Event|1|||
94340274|NCT04157348|323026648|FG000|Open-label Extension Period|Adverse Event|1|||
94340275|NCT04157348|323026649|FG001|Open-label Extension Period|Adverse Event|1|||
94340276|NCT04157348|323026648|FG000|Open-label Extension Period|Death|0|||
94340277|NCT04157348|323026649|FG001|Open-label Extension Period|Death|1|||
94340278|NCT04157348|323026648|FG000|Open-label Extension Period|Lack of Efficacy|2|||
94340279|NCT04157348|323026649|FG001|Open-label Extension Period|Lack of Efficacy|2|||
94340280|NCT04157348|323026648|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
94340281|NCT04157348|323026649|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
94340282|NCT04157348|323026648|FG000|Open-label Extension Period|Ongoing|60|||
94340283|NCT04157348|323026649|FG001|Open-label Extension Period|Ongoing|57|||
94340284|NCT04157348|323026648|FG000|Open-label Extension Period|other reasons|1|||
94340285|NCT04157348|323026649|FG001|Open-label Extension Period|other reasons|1|||
94340286|NCT01024920|323026652|FG000|Overall Study|Progressive disease|47|||
94340287|NCT01024920|323026653|FG001|Overall Study|Progressive disease|25|||
94340288|NCT01024920|323026652|FG000|Overall Study|Adverse Event|8|||
94340289|NCT01024920|323026653|FG001|Overall Study|Adverse Event|4|||
94340290|NCT01024920|323026652|FG000|Overall Study|Lost to Follow-up|0|||
94340291|NCT01024920|323026653|FG001|Overall Study|Lost to Follow-up|1|||
94340292|NCT01024920|323026652|FG000|Overall Study|Patient refusal to continue|4|||
94340293|NCT01024920|323026653|FG001|Overall Study|Patient refusal to continue|0|||
94340294|NCT01024920|323026652|FG000|Overall Study|Other than listed|5|||
94340295|NCT01024920|323026653|FG001|Overall Study|Other than listed|1|||
94340296|NCT01024920|323026652|FG000|Overall Study|Not treated|3|||
94340297|NCT01024920|323026653|FG001|Overall Study|Not treated|0|||
94340298|NCT01024920|323026652|FG000|Overall Study|Protocol Violation|0|||
94340299|NCT01024920|323026653|FG001|Overall Study|Protocol Violation|1|||
94340300|NCT02977507|323026654|FG000|Overall Study|Protocol Deviation|1|||
94340301|NCT02977507|323026655|FG001|Overall Study|Protocol Deviation|0|||
94340302|NCT02977507|323026654|FG000|Overall Study|Lost to Follow-up|1|||
94340303|NCT02977507|323026655|FG001|Overall Study|Lost to Follow-up|0|||
94549264|NCT04033068|323805768|FG003|Overall Study|Lost to Follow-up|0|||
94549265|NCT04033068|323805765|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
94340304|NCT02252588|323026657|FG000|Overall Study|Withdrawal by Subject|4|||
94340305|NCT02252588|323026658|FG001|Overall Study|Withdrawal by Subject|0|||
94340306|NCT04362189|323026659|FG000|Overall Study|Lost to Follow-up|0|||
94340307|NCT04362189|323026660|FG001|Overall Study|Lost to Follow-up|1|||
94549266|NCT04033068|323805766|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
94549267|NCT04033068|323805767|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
94549268|NCT04033068|323805768|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
94549269|NCT01105377|323805771|FG000|Overall Study|Withdrawal by Subject|0|||
94549270|NCT01105377|323805772|FG001|Overall Study|Withdrawal by Subject|1|||
94549271|NCT03834220|323805774|FG000|Overall Study|Adverse Event|1|||
94549272|NCT03834220|323805775|FG001|Overall Study|Adverse Event|0|||
94549273|NCT03834220|323805776|FG002|Overall Study|Adverse Event|0|||
94549274|NCT03834220|323805774|FG000|Overall Study|Death|8|||
94549275|NCT03834220|323805775|FG001|Overall Study|Death|1|||
94549276|NCT03834220|323805776|FG002|Overall Study|Death|17|||
94340308|NCT04362189|323026659|FG000|Overall Study|Withdrawal by Subject|1|||
94340309|NCT04362189|323026660|FG001|Overall Study|Withdrawal by Subject|0|||
94340310|NCT04362189|323026659|FG000|Overall Study|FDA Clinical Hold|7|||
94340311|NCT04362189|323026660|FG001|Overall Study|FDA Clinical Hold|2|||
94340312|NCT04362189|323026659|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
94340313|NCT04362189|323026660|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
94340314|NCT04362189|323026659|FG000|Overall Study|Adverse Event|0|||
94340315|NCT04362189|323026660|FG001|Overall Study|Adverse Event|2|||
94340316|NCT04362189|323026659|FG000|Overall Study|Death|4|||
94340317|NCT04362189|323026660|FG001|Overall Study|Death|1|||
94340318|NCT03342404|323026661|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
94340319|NCT03342404|323026662|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
94340320|NCT03342404|323026661|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
94340321|NCT03342404|323026662|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
94340322|NCT03342404|323026661|FG000|Blinded Treatment Phase|Adverse Event|5|||
94340323|NCT03342404|323026662|FG001|Blinded Treatment Phase|Adverse Event|4|||
94340324|NCT03342404|323026661|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
94340325|NCT03342404|323026662|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
94340326|NCT03342404|323026661|FG000|Blinded Treatment Phase|Other reasons|1|||
94340327|NCT03342404|323026662|FG001|Blinded Treatment Phase|Other reasons|0|||
94340328|NCT03342404|323026661|FG000|Blinded Treatment Phase|Physician Decision|1|||
94340329|NCT03342404|323026662|FG001|Blinded Treatment Phase|Physician Decision|0|||
94340330|NCT03342404|323026661|FG000|Blinded Treatment Phase|Death|1|||
94340331|NCT03342404|323026662|FG001|Blinded Treatment Phase|Death|0|||
94340332|NCT03342404|323026661|FG000|Open-Label Phase|Lost to Follow-up|0|||
94340333|NCT03342404|323026662|FG001|Open-Label Phase|Lost to Follow-up|1|||
94340334|NCT03342404|323026661|FG000|Open-Label Phase|Other reasons|0|||
94340335|NCT03342404|323026662|FG001|Open-Label Phase|Other reasons|1|||
94340336|NCT03342404|323026661|FG000|Open-Label Phase|Adverse Event|0|||
94340337|NCT03342404|323026662|FG001|Open-Label Phase|Adverse Event|3|||
94340338|NCT03342404|323026661|FG000|Open-Label Phase|Withdrawal by Subject|0|||
94340339|NCT03342404|323026662|FG001|Open-Label Phase|Withdrawal by Subject|6|||
94340340|NCT01263444|323026663|FG000|Overall Study|Adverse Event|8|||
94340341|NCT01263444|323026663|FG000|Overall Study|Withdrawal by Subject|1|||
94340342|NCT01263444|323026663|FG000|Overall Study|Protocol Violation|1|||
94340343|NCT04007367|323026664|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
94340344|NCT04007367|323026665|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
94340345|NCT04007367|323026666|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
94340346|NCT04007367|323026664|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
94340347|NCT04007367|323026665|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
94340348|NCT04007367|323026666|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
94340349|NCT04007367|323026664|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
94340350|NCT04007367|323026665|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
94340351|NCT04007367|323026666|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
94340352|NCT04007367|323026664|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
94340353|NCT04007367|323026665|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
94340354|NCT04007367|323026666|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
94340355|NCT04007367|323026664|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
94340356|NCT04007367|323026665|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
94340357|NCT04007367|323026666|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
94340358|NCT01302691|323026671|FG000|Overall Study|Adverse Event|2|||
94340359|NCT01302691|323026672|FG001|Overall Study|Adverse Event|0|||
94340360|NCT01302691|323026671|FG000|Overall Study|Death|0|||
94340361|NCT01302691|323026672|FG001|Overall Study|Death|1|||
94549277|NCT03834220|323805774|FG000|Overall Study|Reason not Specified|9|||
94340362|NCT01302691|323026671|FG000|Overall Study|Lost to Follow-up|1|||
94340363|NCT01302691|323026672|FG001|Overall Study|Lost to Follow-up|0|||
94340364|NCT01302691|323026671|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
94340365|NCT01302691|323026672|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
94340366|NCT01302691|323026671|FG000|Overall Study|Physician Decision|0|||
94340367|NCT01302691|323026672|FG001|Overall Study|Physician Decision|1|||
94340368|NCT01302691|323026671|FG000|Overall Study|Protocol Violation|1|||
94441233|NCT02456740|323401639|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
94441234|NCT02456740|323401640|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
94441235|NCT02456740|323401641|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
94441236|NCT02456740|323401633|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
94441237|NCT02456740|323401634|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
94441238|NCT02456740|323401635|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
94441239|NCT02456740|323401636|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
94441240|NCT02456740|323401637|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
94441241|NCT02456740|323401638|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
94441242|NCT02456740|323401639|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
94441243|NCT02456740|323401640|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
94441244|NCT02456740|323401641|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
94441245|NCT02456740|323401633|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
94441246|NCT02456740|323401634|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
94441247|NCT02456740|323401635|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
94441248|NCT02456740|323401636|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
94441249|NCT02456740|323401637|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
94441250|NCT02456740|323401638|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
94441251|NCT02456740|323401639|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
94441252|NCT02456740|323401640|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
94441253|NCT02456740|323401641|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
94441254|NCT02456740|323401633|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
94441255|NCT02456740|323401634|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
94441256|NCT02456740|323401635|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
94441257|NCT02456740|323401636|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
94441258|NCT02456740|323401637|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
94441259|NCT02456740|323401638|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
94441260|NCT02456740|323401639|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
94441261|NCT02456740|323401640|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
94441262|NCT02456740|323401641|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
94441263|NCT02456740|323401633|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
94441264|NCT02456740|323401634|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
94441265|NCT02456740|323401635|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
94441266|NCT02456740|323401636|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
94441267|NCT02456740|323401637|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
94441268|NCT02456740|323401638|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
94441269|NCT02456740|323401639|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
94441270|NCT02456740|323401640|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
94441271|NCT02456740|323401641|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
94441272|NCT02456740|323401633|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
94441273|NCT02456740|323401634|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
94441274|NCT02456740|323401635|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
94441275|NCT02456740|323401636|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
94441276|NCT02456740|323401637|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
94441277|NCT02456740|323401638|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
94441278|NCT02456740|323401639|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
94441279|NCT02456740|323401640|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
94441280|NCT02456740|323401641|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
94441281|NCT03759392|323401642|FG000|Overall Study|Adverse Event|12|||
94441282|NCT03759392|323401643|FG001|Overall Study|Adverse Event|4|||
94441283|NCT03759392|323401642|FG000|Overall Study|Death|2|||
94441284|NCT03759392|323401643|FG001|Overall Study|Death|1|||
94441285|NCT03759392|323401642|FG000|Overall Study|Withdrawal by Subject|2|||
94441286|NCT03759392|323401643|FG001|Overall Study|Withdrawal by Subject|0|||
94441287|NCT03759392|323401642|FG000|Overall Study|Protocol Violation|2|||
94441288|NCT03759392|323401643|FG001|Overall Study|Protocol Violation|0|||
94441289|NCT03759392|323401642|FG000|Overall Study|Physician Decision|0|||
94441290|NCT03759392|323401643|FG001|Overall Study|Physician Decision|1|||
94441291|NCT03759392|323401642|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
94441292|NCT03759392|323401643|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
94441293|NCT03759392|323401642|FG000|Overall Study|No longer able to take medicines|1|||
94441294|NCT03759392|323401643|FG001|Overall Study|No longer able to take medicines|0|||
94441295|NCT03759392|323401642|FG000|Overall Study|Stopped taking study drug|1|||
94441296|NCT03759392|323401643|FG001|Overall Study|Stopped taking study drug|0|||
94441297|NCT01891864|323401644|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
94441298|NCT01891864|323401645|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
94441299|NCT01891864|323401646|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
94441300|NCT01891864|323401647|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
94441301|NCT01891864|323401648|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
94441302|NCT01891864|323401649|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
94441303|NCT01891864|323401644|FG000|Treatment Period 1|Physician Decision|0|||
94441304|NCT01891864|323401645|FG001|Treatment Period 1|Physician Decision|1|||
94441305|NCT01891864|323401646|FG002|Treatment Period 1|Physician Decision|0|||
94441306|NCT01891864|323401647|FG003|Treatment Period 1|Physician Decision|0|||
94441307|NCT01891864|323401648|FG004|Treatment Period 1|Physician Decision|0|||
94441308|NCT01891864|323401649|FG005|Treatment Period 1|Physician Decision|0|||
94441309|NCT01891864|323401644|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
94441310|NCT01891864|323401645|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
94441311|NCT01891864|323401646|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
94441312|NCT01891864|323401647|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
94441313|NCT01891864|323401648|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
94441314|NCT01891864|323401649|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
94441315|NCT01891864|323401644|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
94441316|NCT01891864|323401645|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
94441317|NCT01891864|323401646|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
94441318|NCT01891864|323401647|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
94441319|NCT01891864|323401648|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
94441320|NCT01891864|323401649|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
94441321|NCT01891864|323401644|FG000|Treatment Period 1|Withdrawal by Subject|2|||
94441322|NCT01891864|323401645|FG001|Treatment Period 1|Withdrawal by Subject|5|||
94441323|NCT01891864|323401646|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94441324|NCT01891864|323401647|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94441325|NCT01891864|323401648|FG004|Treatment Period 1|Withdrawal by Subject|0|||
94441326|NCT01891864|323401649|FG005|Treatment Period 1|Withdrawal by Subject|0|||
94441327|NCT01891864|323401644|FG000|Treatment Period 1|Lost to Follow-up|1|||
94441328|NCT01891864|323401645|FG001|Treatment Period 1|Lost to Follow-up|0|||
94441329|NCT01891864|323401646|FG002|Treatment Period 1|Lost to Follow-up|0|||
94441330|NCT01891864|323401647|FG003|Treatment Period 1|Lost to Follow-up|0|||
94441331|NCT01891864|323401648|FG004|Treatment Period 1|Lost to Follow-up|0|||
94441332|NCT01891864|323401649|FG005|Treatment Period 1|Lost to Follow-up|0|||
94441333|NCT01891864|323401644|FG000|Treatment Period 2|Protocol Violation|0|||
94441334|NCT01891864|323401645|FG001|Treatment Period 2|Protocol Violation|0|||
94441335|NCT01891864|323401646|FG002|Treatment Period 2|Protocol Violation|0|||
94441336|NCT01891864|323401647|FG003|Treatment Period 2|Protocol Violation|1|||
94441337|NCT01891864|323401648|FG004|Treatment Period 2|Protocol Violation|0|||
94441338|NCT01891864|323401649|FG005|Treatment Period 2|Protocol Violation|0|||
94441339|NCT01891864|323401644|FG000|Treatment Period 2|Physician Decision|0|||
94441340|NCT01891864|323401645|FG001|Treatment Period 2|Physician Decision|0|||
94441341|NCT01891864|323401646|FG002|Treatment Period 2|Physician Decision|1|||
94441342|NCT01891864|323401647|FG003|Treatment Period 2|Physician Decision|0|||
94441343|NCT01891864|323401648|FG004|Treatment Period 2|Physician Decision|0|||
94441344|NCT01891864|323401649|FG005|Treatment Period 2|Physician Decision|0|||
94441345|NCT01891864|323401644|FG000|Treatment Period 2|Site Termination|0|||
94441346|NCT01891864|323401645|FG001|Treatment Period 2|Site Termination|0|||
94441347|NCT01891864|323401646|FG002|Treatment Period 2|Site Termination|1|||
94441348|NCT01891864|323401647|FG003|Treatment Period 2|Site Termination|2|||
94441349|NCT01891864|323401648|FG004|Treatment Period 2|Site Termination|0|||
94441350|NCT01891864|323401649|FG005|Treatment Period 2|Site Termination|0|||
94441351|NCT01891864|323401644|FG000|Treatment Period 2|Lack of Efficacy|0|||
94441352|NCT01891864|323401645|FG001|Treatment Period 2|Lack of Efficacy|0|||
94441353|NCT01891864|323401646|FG002|Treatment Period 2|Lack of Efficacy|1|||
94441354|NCT01891864|323401647|FG003|Treatment Period 2|Lack of Efficacy|0|||
94441355|NCT01891864|323401648|FG004|Treatment Period 2|Lack of Efficacy|1|||
94441356|NCT01891864|323401649|FG005|Treatment Period 2|Lack of Efficacy|0|||
94441357|NCT01891864|323401644|FG000|Treatment Period 2|Adverse Event|0|||
94441358|NCT01891864|323401645|FG001|Treatment Period 2|Adverse Event|0|||
94441359|NCT01891864|323401646|FG002|Treatment Period 2|Adverse Event|1|||
94441360|NCT01891864|323401647|FG003|Treatment Period 2|Adverse Event|2|||
94441361|NCT01891864|323401648|FG004|Treatment Period 2|Adverse Event|0|||
94441362|NCT01891864|323401649|FG005|Treatment Period 2|Adverse Event|4|||
94441363|NCT01891864|323401644|FG000|Treatment Period 2|Termination of Site|0|||
94441364|NCT01891864|323401645|FG001|Treatment Period 2|Termination of Site|0|||
94441365|NCT01891864|323401646|FG002|Treatment Period 2|Termination of Site|0|||
94549278|NCT03834220|323805775|FG001|Overall Study|Reason not Specified|0|||
94441366|NCT01891864|323401647|FG003|Treatment Period 2|Termination of Site|0|||
94441367|NCT01891864|323401648|FG004|Treatment Period 2|Termination of Site|2|||
94549279|NCT03834220|323805776|FG002|Overall Study|Reason not Specified|6|||
94441368|NCT01891864|323401649|FG005|Treatment Period 2|Termination of Site|0|||
94549280|NCT03834220|323805774|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
94441369|NCT01891864|323401644|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94441370|NCT01891864|323401645|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94441371|NCT01891864|323401646|FG002|Treatment Period 2|Withdrawal by Subject|3|||
94441372|NCT01891864|323401647|FG003|Treatment Period 2|Withdrawal by Subject|4|||
94441373|NCT01891864|323401648|FG004|Treatment Period 2|Withdrawal by Subject|1|||
94441374|NCT01891864|323401649|FG005|Treatment Period 2|Withdrawal by Subject|1|||
94441375|NCT01891864|323401644|FG000|Extension Period|Lack of Efficacy|0|||
94441376|NCT01891864|323401645|FG001|Extension Period|Lack of Efficacy|0|||
94441377|NCT01891864|323401646|FG002|Extension Period|Lack of Efficacy|0|||
94441378|NCT01891864|323401647|FG003|Extension Period|Lack of Efficacy|1|||
94441379|NCT01891864|323401648|FG004|Extension Period|Lack of Efficacy|1|||
94441380|NCT01891864|323401649|FG005|Extension Period|Lack of Efficacy|0|||
94441381|NCT01891864|323401644|FG000|Extension Period|Pregnancy|0|||
94441382|NCT01891864|323401645|FG001|Extension Period|Pregnancy|0|||
94441383|NCT01891864|323401646|FG002|Extension Period|Pregnancy|1|||
94340369|NCT01302691|323026672|FG001|Overall Study|Protocol Violation|0|||
94340370|NCT00441480|323026674|FG000|Overall Study|Protocol Violation|1|||
94340371|NCT00441480|323026675|FG001|Overall Study|Protocol Violation|1|||
94340372|NCT00441480|323026674|FG000|Overall Study|Withdrawal by Subject|2|||
94340373|NCT00441480|323026675|FG001|Overall Study|Withdrawal by Subject|3|||
94340374|NCT00422240|323026679|FG000|Overall Study|Lack of Efficacy|1|||
94340375|NCT00422240|323026680|FG001|Overall Study|Lack of Efficacy|2|||
94340376|NCT00422240|323026681|FG002|Overall Study|Lack of Efficacy|0|||
94340377|NCT00422240|323026682|FG003|Overall Study|Lack of Efficacy|1|||
94340378|NCT00422240|323026679|FG000|Overall Study|Adverse Event|11|||
94340379|NCT00422240|323026680|FG001|Overall Study|Adverse Event|4|||
94340380|NCT00422240|323026681|FG002|Overall Study|Adverse Event|5|||
94340381|NCT00422240|323026682|FG003|Overall Study|Adverse Event|2|||
94340382|NCT00422240|323026679|FG000|Overall Study|Subject request|21|||
94340383|NCT00422240|323026680|FG001|Overall Study|Subject request|17|||
94340384|NCT00422240|323026681|FG002|Overall Study|Subject request|18|||
94340385|NCT00422240|323026682|FG003|Overall Study|Subject request|30|||
94340386|NCT00422240|323026679|FG000|Overall Study|Protocol Violation|0|||
94340387|NCT00422240|323026680|FG001|Overall Study|Protocol Violation|1|||
94340388|NCT00422240|323026681|FG002|Overall Study|Protocol Violation|0|||
94340389|NCT00422240|323026682|FG003|Overall Study|Protocol Violation|1|||
94340390|NCT00422240|323026679|FG000|Overall Study|Lost to Follow-up|31|||
94340391|NCT00422240|323026680|FG001|Overall Study|Lost to Follow-up|32|||
94340392|NCT00422240|323026681|FG002|Overall Study|Lost to Follow-up|19|||
94340393|NCT00422240|323026682|FG003|Overall Study|Lost to Follow-up|34|||
94340394|NCT00422240|323026679|FG000|Overall Study|Other|1|||
94340395|NCT00422240|323026680|FG001|Overall Study|Other|0|||
94340396|NCT00422240|323026681|FG002|Overall Study|Other|0|||
94340397|NCT00422240|323026682|FG003|Overall Study|Other|1|||
94340398|NCT00422240|323026679|FG000|Overall Study|Pregnancy|3|||
94340399|NCT00422240|323026680|FG001|Overall Study|Pregnancy|1|||
94340400|NCT00422240|323026681|FG002|Overall Study|Pregnancy|1|||
94340401|NCT00422240|323026682|FG003|Overall Study|Pregnancy|2|||
94340402|NCT00441012|323026683|FG000|Overall Study|Adverse Event|0|||
94340403|NCT00441012|323026684|FG001|Overall Study|Adverse Event|1|||
94340404|NCT00441012|323026683|FG000|Overall Study|Lost to Follow-up|3|||
94340405|NCT00441012|323026684|FG001|Overall Study|Lost to Follow-up|3|||
94340406|NCT00441012|323026683|FG000|Overall Study|Protocol Violation|10|||
94340407|NCT00441012|323026684|FG001|Overall Study|Protocol Violation|9|||
94340408|NCT00441012|323026683|FG000|Overall Study|Withdrawal by Subject|4|||
94340409|NCT00441012|323026684|FG001|Overall Study|Withdrawal by Subject|0|||
94340410|NCT00441012|323026683|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
94340411|NCT00441012|323026684|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
94340412|NCT00880607|323026685|FG000|Overall Study|Physician Decision|2|||
94340413|NCT00880607|323026686|FG001|Overall Study|Physician Decision|2|||
94340414|NCT00880607|323026685|FG000|Overall Study|Protocol Violation|2|||
94340415|NCT00880607|323026686|FG001|Overall Study|Protocol Violation|1|||
94340416|NCT00880607|323026685|FG000|Overall Study|surgery did not extend past L1 level|3|||
94340417|NCT00880607|323026686|FG001|Overall Study|surgery did not extend past L1 level|0|||
94340418|NCT02725268|323026687|FG000|Overall Study|Death|58|||
94441384|NCT01891864|323401647|FG003|Extension Period|Pregnancy|0|||
94441385|NCT01891864|323401648|FG004|Extension Period|Pregnancy|0|||
94441386|NCT01891864|323401649|FG005|Extension Period|Pregnancy|0|||
94340419|NCT02725268|323026688|FG001|Overall Study|Death|59|||
94340420|NCT02725268|323026689|FG002|Overall Study|Death|30|||
94441387|NCT01891864|323401644|FG000|Extension Period|Adverse Event|0|||
94340421|NCT02725268|323026690|FG003|Overall Study|Death|16|||
94340422|NCT02725268|323026687|FG000|Overall Study|Lost to Follow-up|4|||
94340423|NCT02725268|323026688|FG001|Overall Study|Lost to Follow-up|3|||
94340424|NCT02725268|323026689|FG002|Overall Study|Lost to Follow-up|0|||
94340425|NCT02725268|323026690|FG003|Overall Study|Lost to Follow-up|1|||
94441388|NCT01891864|323401645|FG001|Extension Period|Adverse Event|0|||
94340426|NCT02725268|323026687|FG000|Overall Study|Site Terminated by Sponsor|0|||
94340427|NCT02725268|323026688|FG001|Overall Study|Site Terminated by Sponsor|1|||
94340428|NCT02725268|323026689|FG002|Overall Study|Site Terminated by Sponsor|0|||
94441389|NCT01891864|323401646|FG002|Extension Period|Adverse Event|4|||
94441390|NCT01891864|323401647|FG003|Extension Period|Adverse Event|2|||
94441391|NCT01891864|323401648|FG004|Extension Period|Adverse Event|2|||
94441392|NCT01891864|323401649|FG005|Extension Period|Adverse Event|0|||
94441393|NCT01891864|323401644|FG000|Extension Period|Withdrawal by Subject|0|||
94441394|NCT01891864|323401645|FG001|Extension Period|Withdrawal by Subject|0|||
94441395|NCT01891864|323401646|FG002|Extension Period|Withdrawal by Subject|1|||
94441396|NCT01891864|323401647|FG003|Extension Period|Withdrawal by Subject|2|||
94441397|NCT01891864|323401648|FG004|Extension Period|Withdrawal by Subject|4|||
94441398|NCT01891864|323401649|FG005|Extension Period|Withdrawal by Subject|0|||
94441399|NCT01891864|323401644|FG000|Extension Period|Lost to Follow-up|0|||
94441400|NCT01891864|323401645|FG001|Extension Period|Lost to Follow-up|0|||
94441401|NCT01891864|323401646|FG002|Extension Period|Lost to Follow-up|2|||
94441402|NCT01891864|323401647|FG003|Extension Period|Lost to Follow-up|0|||
94441403|NCT01891864|323401648|FG004|Extension Period|Lost to Follow-up|0|||
94441404|NCT01891864|323401649|FG005|Extension Period|Lost to Follow-up|0|||
94441405|NCT05373108|323401650|FG000|Overall Study|Withdrawal by Subject|2|||
94441406|NCT06082843|323403568|FG000|Overall Study|Withdrawal by Subject|0|||
94441407|NCT06082843|323403569|FG001|Overall Study|Withdrawal by Subject|2|||
94441408|NCT06082843|323403568|FG000|Overall Study|Study terminated by sponsor|12|||
94441409|NCT06082843|323403569|FG001|Overall Study|Study terminated by sponsor|8|||
94441410|NCT05085834|323403570|FG000|Overall Study|Lost to Follow-up|9|||
94441411|NCT05085834|323403571|FG001|Overall Study|Lost to Follow-up|2|||
94441412|NCT05085834|323403570|FG000|Overall Study|Adverse Event|6|||
94441413|NCT05085834|323403571|FG001|Overall Study|Adverse Event|0|||
94441414|NCT05085834|323403570|FG000|Overall Study|Death|1|||
94441415|NCT05085834|323403571|FG001|Overall Study|Death|0|||
94441416|NCT05085834|323403570|FG000|Overall Study|Inability to swallow the pill|0|||
94441417|NCT05085834|323403571|FG001|Overall Study|Inability to swallow the pill|1|||
94441418|NCT02762929|323403574|FG000|Overall Study|Adverse Event|0|||
94441419|NCT02762929|323403575|FG001|Overall Study|Adverse Event|0|||
94441420|NCT02762929|323403576|FG002|Overall Study|Adverse Event|0|||
94441421|NCT02762929|323403577|FG003|Overall Study|Adverse Event|1|||
94441422|NCT02762929|323403578|FG004|Overall Study|Adverse Event|0|||
94441423|NCT02762929|323403579|FG005|Overall Study|Adverse Event|0|||
94441424|NCT02762929|323403574|FG000|Overall Study|Lost to Follow-up|1|||
94441425|NCT02762929|323403575|FG001|Overall Study|Lost to Follow-up|2|||
94441426|NCT02762929|323403576|FG002|Overall Study|Lost to Follow-up|0|||
94441427|NCT02762929|323403577|FG003|Overall Study|Lost to Follow-up|1|||
94441428|NCT02762929|323403578|FG004|Overall Study|Lost to Follow-up|0|||
94441429|NCT02762929|323403579|FG005|Overall Study|Lost to Follow-up|0|||
94441430|NCT02762929|323403574|FG000|Overall Study|Withdrawal by Subject|0|||
94441431|NCT02762929|323403575|FG001|Overall Study|Withdrawal by Subject|1|||
94441432|NCT02762929|323403576|FG002|Overall Study|Withdrawal by Subject|0|||
94441433|NCT02762929|323403577|FG003|Overall Study|Withdrawal by Subject|0|||
94441434|NCT02762929|323403578|FG004|Overall Study|Withdrawal by Subject|0|||
94441435|NCT02762929|323403579|FG005|Overall Study|Withdrawal by Subject|0|||
94441436|NCT02762929|323403574|FG000|Overall Study|exclusionary medication disclosed late|0|||
94441437|NCT02762929|323403575|FG001|Overall Study|exclusionary medication disclosed late|0|||
94441438|NCT02762929|323403576|FG002|Overall Study|exclusionary medication disclosed late|0|||
94441439|NCT02762929|323403577|FG003|Overall Study|exclusionary medication disclosed late|1|||
94441440|NCT02762929|323403578|FG004|Overall Study|exclusionary medication disclosed late|0|||
94441441|NCT02762929|323403579|FG005|Overall Study|exclusionary medication disclosed late|0|||
94441442|NCT00118157|323403580|FG000|Overall Study|Adverse Event|2|||
94441443|NCT00118157|323403580|FG000|Overall Study|Death|8|||
94441444|NCT00118157|323403580|FG000|Overall Study|Withdrawal by Subject|2|||
94441445|NCT05989672|323403584|FG000|Overall Study|Adverse Event|3|||
94441446|NCT05989672|323403585|FG001|Overall Study|Adverse Event|0|||
94441447|NCT05989672|323403586|FG002|Overall Study|Adverse Event|0|||
94441448|NCT03989102|323403588|FG000|Year 1|Withdrawal by Subject|6|||
94441449|NCT03989102|323403589|FG001|Year 1|Withdrawal by Subject|2|||
94441450|NCT03989102|323403590|FG002|Year 1|Withdrawal by Subject|7|||
94441451|NCT03989102|323403588|FG000|Year 1|Lost to Follow-up|5|||
94441452|NCT03989102|323403589|FG001|Year 1|Lost to Follow-up|2|||
94441453|NCT03989102|323403590|FG002|Year 1|Lost to Follow-up|5|||
94441454|NCT03989102|323403588|FG000|Year 1|Subject met withdrawal criteria|1|||
94441455|NCT03989102|323403589|FG001|Year 1|Subject met withdrawal criteria|0|||
94441456|NCT03989102|323403590|FG002|Year 1|Subject met withdrawal criteria|1|||
94441457|NCT03989102|323403588|FG000|Year 2|Lost to Follow-up|7|||
94441458|NCT03989102|323403589|FG001|Year 2|Lost to Follow-up|3|||
94441459|NCT03989102|323403590|FG002|Year 2|Lost to Follow-up|4|||
94441460|NCT03989102|323403588|FG000|Year 2|Withdrawal by Subject|3|||
94441461|NCT03989102|323403589|FG001|Year 2|Withdrawal by Subject|1|||
94441462|NCT03989102|323403590|FG002|Year 2|Withdrawal by Subject|2|||
94441463|NCT03989102|323403588|FG000|Year 2|Subject non-compliant|3|||
94441464|NCT03989102|323403589|FG001|Year 2|Subject non-compliant|2|||
94441465|NCT03989102|323403590|FG002|Year 2|Subject non-compliant|0|||
94441466|NCT03989102|323403588|FG000|Year 2|Travel|1|||
94441467|NCT03989102|323403589|FG001|Year 2|Travel|0|||
94441468|NCT03989102|323403590|FG002|Year 2|Travel|1|||
94441469|NCT03989102|323403588|FG000|Year 2|P16 missing|4|||
94441470|NCT03989102|323403589|FG001|Year 2|P16 missing|2|||
94441471|NCT03989102|323403590|FG002|Year 2|P16 missing|1|||
94441472|NCT03989102|323403588|FG000|Year 2|P11 missing|1|||
94441473|NCT03989102|323403589|FG001|Year 2|P11 missing|3|||
94441474|NCT03989102|323403590|FG002|Year 2|P11 missing|7|||
94441475|NCT03989102|323403588|FG000|Year 2|Definitive displacement outside the study site|0|||
94441476|NCT03989102|323403589|FG001|Year 2|Definitive displacement outside the study site|1|||
94441477|NCT03989102|323403590|FG002|Year 2|Definitive displacement outside the study site|0|||
94441478|NCT03989102|323403588|FG000|Year 2|Subject missed last study visit|0|||
94441479|NCT03989102|323403589|FG001|Year 2|Subject missed last study visit|1|||
94441480|NCT03989102|323403590|FG002|Year 2|Subject missed last study visit|0|||
94441481|NCT03989102|323403588|FG000|Year 2|Death|0|||
94441482|NCT03989102|323403589|FG001|Year 2|Death|1|||
94441483|NCT03989102|323403590|FG002|Year 2|Death|0|||
94441484|NCT03989102|323403588|FG000|Year 2|Subject not reachable|0|||
94441485|NCT03989102|323403589|FG001|Year 2|Subject not reachable|0|||
94441486|NCT03989102|323403590|FG002|Year 2|Subject not reachable|1|||
94441487|NCT03989102|323403588|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
94441488|NCT03989102|323403589|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
94441489|NCT03989102|323403590|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
94441490|NCT03989102|323403588|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
94441491|NCT03989102|323403589|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
94441492|NCT03989102|323403590|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
94441493|NCT03989102|323403588|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
94441494|NCT03989102|323403589|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
94441495|NCT03989102|323403590|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
94441496|NCT03989102|323403588|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
94441497|NCT03989102|323403589|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
94441498|NCT03989102|323403590|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
94441499|NCT03989102|323403588|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
94441500|NCT03989102|323403589|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
94441501|NCT03989102|323403590|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
94441502|NCT03989102|323403588|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
94441503|NCT03989102|323403589|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
94441504|NCT03989102|323403590|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
94441505|NCT01557504|323403593|FG000|Overall Study|Physician Decision|1|||
94441506|NCT01557504|323403594|FG001|Overall Study|Physician Decision|0|||
94441507|NCT01962103|323403597|FG000|Phase 1|Adverse Event|4|||
94441508|NCT01962103|323403598|FG001|Phase 1|Adverse Event|0|||
94441509|NCT01962103|323403599|FG002|Phase 1|Adverse Event|2|||
94441510|NCT01962103|323403600|FG003|Phase 1|Adverse Event|1|||
94441511|NCT01962103|323403601|FG004|Phase 1|Adverse Event|2|||
94441512|NCT01962103|323403602|FG005|Phase 1|Adverse Event|2|||
94441513|NCT01962103|323403603|FG006|Phase 1|Adverse Event|0|||
94441514|NCT01962103|323403604|FG007|Phase 1|Adverse Event|0|||
94441515|NCT01962103|323403605|FG008|Phase 1|Adverse Event|0|||
94441516|NCT01962103|323403597|FG000|Phase 1|Progressive Disease|8|||
94441517|NCT01962103|323403598|FG001|Phase 1|Progressive Disease|6|||
94549281|NCT03834220|323805775|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
94549282|NCT03834220|323805776|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
94549283|NCT03834220|323805774|FG000|Overall Study|Withdrawal of Consent|2|||
94549284|NCT03834220|323805775|FG001|Overall Study|Withdrawal of Consent|2|||
94549285|NCT03834220|323805776|FG002|Overall Study|Withdrawal of Consent|2|||
94549286|NCT01174173|323805777|FG000|Overall Study|drug-drug interaction|1|||
94441518|NCT01962103|323403599|FG002|Phase 1|Progressive Disease|8|||
94441519|NCT01962103|323403600|FG003|Phase 1|Progressive Disease|4|||
94441520|NCT01962103|323403601|FG004|Phase 1|Progressive Disease|5|||
94441521|NCT01962103|323403602|FG005|Phase 1|Progressive Disease|4|||
94441522|NCT01962103|323403603|FG006|Phase 1|Progressive Disease|0|||
94441523|NCT01962103|323403604|FG007|Phase 1|Progressive Disease|0|||
94549287|NCT00720343|323807320|FG000|Overall Study|Lost to Follow-up|1|||
94549288|NCT00720343|323807321|FG001|Overall Study|Lost to Follow-up|0|||
94441524|NCT01962103|323403605|FG008|Phase 1|Progressive Disease|0|||
94441525|NCT01962103|323403597|FG000|Phase 1|Withdrawal by Subject|0|||
94441526|NCT01962103|323403598|FG001|Phase 1|Withdrawal by Subject|0|||
94441527|NCT01962103|323403599|FG002|Phase 1|Withdrawal by Subject|0|||
94441528|NCT01962103|323403600|FG003|Phase 1|Withdrawal by Subject|2|||
94441529|NCT01962103|323403601|FG004|Phase 1|Withdrawal by Subject|0|||
94441530|NCT01962103|323403602|FG005|Phase 1|Withdrawal by Subject|0|||
94441531|NCT01962103|323403603|FG006|Phase 1|Withdrawal by Subject|0|||
94441532|NCT01962103|323403604|FG007|Phase 1|Withdrawal by Subject|0|||
94441533|NCT01962103|323403605|FG008|Phase 1|Withdrawal by Subject|0|||
94441534|NCT01962103|323403597|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
94549289|NCT00720343|323807320|FG000|Overall Study|Protocol Violation|0|||
94549290|NCT00720343|323807321|FG001|Overall Study|Protocol Violation|2|||
94227289|NCT03214250|322625763|FG001|Overall Study|Withdrawal by Subject|0|||
94441535|NCT01962103|323403598|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
94441536|NCT01962103|323403599|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
94441537|NCT01962103|323403600|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
94441538|NCT01962103|323403601|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
94441539|NCT01962103|323403602|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
94441540|NCT01962103|323403603|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
94441541|NCT01962103|323403604|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
94441542|NCT01962103|323403605|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
94441543|NCT01962103|323403597|FG000|Phase 1|Physician Decision|0|||
94441544|NCT01962103|323403598|FG001|Phase 1|Physician Decision|0|||
94441545|NCT01962103|323403599|FG002|Phase 1|Physician Decision|0|||
94441546|NCT01962103|323403600|FG003|Phase 1|Physician Decision|1|||
94441547|NCT01962103|323403601|FG004|Phase 1|Physician Decision|0|||
94441548|NCT01962103|323403602|FG005|Phase 1|Physician Decision|0|||
94441549|NCT01962103|323403603|FG006|Phase 1|Physician Decision|0|||
94441550|NCT01962103|323403604|FG007|Phase 1|Physician Decision|0|||
94441551|NCT01962103|323403605|FG008|Phase 1|Physician Decision|0|||
94441552|NCT01962103|323403597|FG000|Phase 1|Symptomatic Deterioration|3|||
94441553|NCT01962103|323403598|FG001|Phase 1|Symptomatic Deterioration|2|||
94441554|NCT01962103|323403599|FG002|Phase 1|Symptomatic Deterioration|2|||
94441555|NCT01962103|323403600|FG003|Phase 1|Symptomatic Deterioration|2|||
94441556|NCT01962103|323403601|FG004|Phase 1|Symptomatic Deterioration|1|||
94441557|NCT01962103|323403602|FG005|Phase 1|Symptomatic Deterioration|1|||
94441558|NCT01962103|323403603|FG006|Phase 1|Symptomatic Deterioration|0|||
94441559|NCT01962103|323403604|FG007|Phase 1|Symptomatic Deterioration|0|||
94441560|NCT01962103|323403605|FG008|Phase 1|Symptomatic Deterioration|0|||
94441561|NCT01962103|323403597|FG000|Phase 1|Miscellaneous|1|||
94441562|NCT01962103|323403598|FG001|Phase 1|Miscellaneous|0|||
94441563|NCT01962103|323403599|FG002|Phase 1|Miscellaneous|0|||
94441564|NCT01962103|323403600|FG003|Phase 1|Miscellaneous|0|||
94441565|NCT01962103|323403601|FG004|Phase 1|Miscellaneous|0|||
94441566|NCT01962103|323403602|FG005|Phase 1|Miscellaneous|0|||
94441567|NCT01962103|323403603|FG006|Phase 1|Miscellaneous|0|||
94441568|NCT01962103|323403604|FG007|Phase 1|Miscellaneous|0|||
94441569|NCT01962103|323403605|FG008|Phase 1|Miscellaneous|0|||
94441570|NCT01962103|323403597|FG000|Phase 2|Adverse Event|0|||
94441571|NCT01962103|323403598|FG001|Phase 2|Adverse Event|0|||
94441572|NCT01962103|323403599|FG002|Phase 2|Adverse Event|0|||
94441573|NCT01962103|323403600|FG003|Phase 2|Adverse Event|0|||
94441574|NCT01962103|323403601|FG004|Phase 2|Adverse Event|0|||
94441575|NCT01962103|323403602|FG005|Phase 2|Adverse Event|0|||
94441576|NCT01962103|323403603|FG006|Phase 2|Adverse Event|1|||
94441577|NCT01962103|323403604|FG007|Phase 2|Adverse Event|0|||
94441578|NCT01962103|323403605|FG008|Phase 2|Adverse Event|3|||
94441579|NCT01962103|323403597|FG000|Phase 2|Progressive Disease|0|||
94441580|NCT01962103|323403598|FG001|Phase 2|Progressive Disease|0|||
94441581|NCT01962103|323403599|FG002|Phase 2|Progressive Disease|0|||
94441582|NCT01962103|323403600|FG003|Phase 2|Progressive Disease|0|||
94441583|NCT01962103|323403601|FG004|Phase 2|Progressive Disease|0|||
94441584|NCT01962103|323403602|FG005|Phase 2|Progressive Disease|0|||
94441585|NCT01962103|323403603|FG006|Phase 2|Progressive Disease|11|||
94441586|NCT01962103|323403604|FG007|Phase 2|Progressive Disease|12|||
94441587|NCT01962103|323403605|FG008|Phase 2|Progressive Disease|11|||
94441588|NCT01962103|323403597|FG000|Phase 2|Symptomatic Deterioration|0|||
94441589|NCT01962103|323403598|FG001|Phase 2|Symptomatic Deterioration|0|||
94441590|NCT01962103|323403599|FG002|Phase 2|Symptomatic Deterioration|0|||
94441591|NCT01962103|323403600|FG003|Phase 2|Symptomatic Deterioration|0|||
94441592|NCT01962103|323403601|FG004|Phase 2|Symptomatic Deterioration|0|||
94441593|NCT01962103|323403602|FG005|Phase 2|Symptomatic Deterioration|0|||
94441594|NCT01962103|323403603|FG006|Phase 2|Symptomatic Deterioration|2|||
94441595|NCT01962103|323403604|FG007|Phase 2|Symptomatic Deterioration|2|||
94441596|NCT01962103|323403605|FG008|Phase 2|Symptomatic Deterioration|0|||
94441597|NCT01321749|323403606|FG000|Overall Study|Lost to Follow-up|4|||
94441598|NCT01321749|323403607|FG001|Overall Study|Lost to Follow-up|11|||
94441599|NCT01321749|323403606|FG000|Overall Study|Protocol Violation|4|||
94441600|NCT01321749|323403607|FG001|Overall Study|Protocol Violation|7|||
94441601|NCT01321749|323403606|FG000|Overall Study|Withdrawal by Subject|5|||
94441602|NCT01321749|323403607|FG001|Overall Study|Withdrawal by Subject|4|||
94441603|NCT00077207|323403608|FG000|Overall Study|Adverse Event|5|||
94441604|NCT00077207|323403608|FG000|Overall Study|Lack of Efficacy|12|||
94441605|NCT00077207|323403608|FG000|Overall Study|Physician Decision|6|||
94441606|NCT00077207|323403608|FG000|Overall Study|Withdrawal by Subject|6|||
94441607|NCT00077207|323403608|FG000|Overall Study|Ineligible|1|||
94441608|NCT02750618|323403614|FG000|Overall Study|Withdrawal by Subject|1|||
94441609|NCT04179838|323403615|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
94441610|NCT04179838|323403616|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
94227290|NCT03214250|322625764|FG002|Overall Study|Withdrawal by Subject|1|||
94441611|NCT04179838|323403615|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
94441612|NCT04179838|323403616|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
94441613|NCT02439216|323403621|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
94441614|NCT02439216|323403622|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
94441615|NCT02439216|323403623|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
94441616|NCT02439216|323403624|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
94441617|NCT02439216|323403625|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
94441618|NCT02439216|323403626|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
94441619|NCT02439216|323403627|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
94441620|NCT02439216|323403628|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
94441621|NCT02439216|323403629|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
94441622|NCT02439216|323403621|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
94441623|NCT02439216|323403622|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
94441624|NCT02439216|323403623|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
94441625|NCT02439216|323403624|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
94441626|NCT02439216|323403625|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
94441627|NCT02439216|323403626|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
94549291|NCT03459365|323807322|FG000|Overall Study|Withdrawal by Subject|6|||
94549292|NCT03459365|323807322|FG000|Overall Study|Protocol Violation|8|||
94549293|NCT01939366|323807324|FG000|Overall Study|Adverse Event|8|||
94549294|NCT01939366|323807325|FG001|Overall Study|Adverse Event|17|||
94549295|NCT01939366|323807326|FG002|Overall Study|Adverse Event|30|||
94549296|NCT01939366|323807327|FG003|Overall Study|Adverse Event|8|||
94549297|NCT01939366|323807328|FG004|Overall Study|Adverse Event|5|||
94549298|NCT01939366|323807324|FG000|Overall Study|Lack of Efficacy|2|||
94549299|NCT01939366|323807325|FG001|Overall Study|Lack of Efficacy|1|||
94549300|NCT01939366|323807326|FG002|Overall Study|Lack of Efficacy|1|||
94549301|NCT01939366|323807327|FG003|Overall Study|Lack of Efficacy|1|||
94549302|NCT01939366|323807328|FG004|Overall Study|Lack of Efficacy|3|||
94549303|NCT01939366|323807324|FG000|Overall Study|Lost to Follow-up|1|||
94549304|NCT01939366|323807325|FG001|Overall Study|Lost to Follow-up|1|||
94549305|NCT01939366|323807326|FG002|Overall Study|Lost to Follow-up|0|||
94549306|NCT01939366|323807327|FG003|Overall Study|Lost to Follow-up|0|||
94549307|NCT01939366|323807328|FG004|Overall Study|Lost to Follow-up|0|||
94549308|NCT01939366|323807324|FG000|Overall Study|Withdrawal by Subject|1|||
94549309|NCT01939366|323807325|FG001|Overall Study|Withdrawal by Subject|0|||
94549310|NCT01939366|323807326|FG002|Overall Study|Withdrawal by Subject|2|||
94549311|NCT01939366|323807327|FG003|Overall Study|Withdrawal by Subject|2|||
94549312|NCT01939366|323807328|FG004|Overall Study|Withdrawal by Subject|3|||
94549313|NCT01939366|323807324|FG000|Overall Study|Inclusion criteria not met|0|||
94549314|NCT01939366|323807325|FG001|Overall Study|Inclusion criteria not met|1|||
94549315|NCT01939366|323807326|FG002|Overall Study|Inclusion criteria not met|1|||
94549316|NCT01939366|323807327|FG003|Overall Study|Inclusion criteria not met|0|||
94549317|NCT01939366|323807328|FG004|Overall Study|Inclusion criteria not met|1|||
94549318|NCT01939366|323807324|FG000|Overall Study|Other|0|||
94549319|NCT01939366|323807325|FG001|Overall Study|Other|0|||
94549320|NCT01939366|323807326|FG002|Overall Study|Other|2|||
94549321|NCT01939366|323807327|FG003|Overall Study|Other|2|||
94549322|NCT01939366|323807328|FG004|Overall Study|Other|1|||
94549323|NCT01939366|323807324|FG000|Overall Study|Protocol Violation|0|||
94549324|NCT01939366|323807325|FG001|Overall Study|Protocol Violation|0|||
94549325|NCT01939366|323807326|FG002|Overall Study|Protocol Violation|0|||
94549326|NCT01939366|323807327|FG003|Overall Study|Protocol Violation|1|||
94549327|NCT01939366|323807328|FG004|Overall Study|Protocol Violation|0|||
94441628|NCT02439216|323403627|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
94441629|NCT02439216|323403628|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
94441630|NCT02439216|323403629|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
94441631|NCT02439216|323403621|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
94441632|NCT02439216|323403622|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
94441633|NCT02439216|323403623|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
94549328|NCT01939366|323807324|FG000|Overall Study|Sponsor decision|0|||
94549329|NCT01939366|323807325|FG001|Overall Study|Sponsor decision|0|||
94549330|NCT01939366|323807326|FG002|Overall Study|Sponsor decision|0|||
94441634|NCT02439216|323403624|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
94441635|NCT02439216|323403625|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
94549331|NCT01939366|323807327|FG003|Overall Study|Sponsor decision|0|||
94549332|NCT01939366|323807328|FG004|Overall Study|Sponsor decision|2|||
94549333|NCT01939366|323807324|FG000|Overall Study|GCP non-compliance at site|2|||
94549334|NCT01939366|323807325|FG001|Overall Study|GCP non-compliance at site|3|||
94549335|NCT01939366|323807326|FG002|Overall Study|GCP non-compliance at site|2|||
94549336|NCT01939366|323807327|FG003|Overall Study|GCP non-compliance at site|3|||
94549337|NCT01939366|323807328|FG004|Overall Study|GCP non-compliance at site|3|||
94549338|NCT01276223|323807329|FG000|Overall Study|Adverse Event|7|||
94549339|NCT01276223|323807330|FG001|Overall Study|Adverse Event|4|||
94549340|NCT01276223|323807331|FG002|Overall Study|Adverse Event|1|||
94549341|NCT01276223|323807329|FG000|Overall Study|Lost to Follow-up|0|||
94441636|NCT02439216|323403626|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
94441637|NCT02439216|323403627|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
94441638|NCT02439216|323403628|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
94441639|NCT02439216|323403629|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
94441640|NCT02439216|323403621|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
94441641|NCT02439216|323403622|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
94441642|NCT02439216|323403623|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
94441643|NCT02439216|323403624|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
94441644|NCT02439216|323403625|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
94441645|NCT02439216|323403626|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
94441646|NCT02439216|323403627|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
94441647|NCT02439216|323403628|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
94441648|NCT02439216|323403629|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
94441649|NCT02439216|323403621|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
94441650|NCT02439216|323403622|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
94441651|NCT02439216|323403623|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
94441652|NCT02439216|323403624|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
94441653|NCT02439216|323403625|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
94441654|NCT02439216|323403626|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
94441655|NCT02439216|323403627|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
94441656|NCT02439216|323403628|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
94441657|NCT02439216|323403629|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
94441658|NCT02288312|323403630|FG000|Overall Study|Pregnancy|1|||
94441659|NCT02288312|323403631|FG001|Overall Study|Pregnancy|0|||
94441660|NCT02288312|323403632|FG002|Overall Study|Pregnancy|0|||
94441661|NCT00742209|323403633|FG000|Overall Study|Adverse Event|11|||
94441662|NCT00742209|323403634|FG001|Overall Study|Adverse Event|4|||
94441663|NCT00742209|323403635|FG002|Overall Study|Adverse Event|17|||
94549342|NCT01276223|323807330|FG001|Overall Study|Lost to Follow-up|0|||
94549343|NCT01276223|323807331|FG002|Overall Study|Lost to Follow-up|1|||
94549344|NCT01276223|323807329|FG000|Overall Study|Other|0|||
94340429|NCT02725268|323026690|FG003|Overall Study|Site Terminated by Sponsor|0|||
94340430|NCT02725268|323026687|FG000|Overall Study|Withdrawal by Subject|8|||
94340431|NCT02725268|323026688|FG001|Overall Study|Withdrawal by Subject|6|||
94340432|NCT02725268|323026689|FG002|Overall Study|Withdrawal by Subject|8|||
94340433|NCT02725268|323026690|FG003|Overall Study|Withdrawal by Subject|1|||
94340434|NCT02725268|323026687|FG000|Overall Study|Reason not Specified|2|||
94340435|NCT02725268|323026688|FG001|Overall Study|Reason not Specified|1|||
94340436|NCT02725268|323026689|FG002|Overall Study|Reason not Specified|0|||
94340437|NCT02725268|323026690|FG003|Overall Study|Reason not Specified|0|||
94340438|NCT04498468|323026691|FG000|Overall Study|Lost to Follow-up|3|||
94340439|NCT03399786|323026694|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
94340440|NCT03399786|323026695|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
94340441|NCT03399786|323026696|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
94340442|NCT03399786|323026697|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
94340443|NCT03399786|323026694|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
94340444|NCT03399786|323026695|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
94340445|NCT03399786|323026696|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
94340446|NCT03399786|323026697|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
94340447|NCT03399786|323026694|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
94340448|NCT03399786|323026695|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
94340449|NCT03399786|323026696|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
94340450|NCT03399786|323026697|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
94340451|NCT02963766|323026702|FG000|Double-Blind Period|Adverse Event|1|||
94441664|NCT00742209|323403636|FG003|Overall Study|Adverse Event|16|||
94441665|NCT00742209|323403637|FG004|Overall Study|Adverse Event|13|||
94549345|NCT01276223|323807330|FG001|Overall Study|Other|0|||
94549346|NCT01276223|323807331|FG002|Overall Study|Other|1|||
94549347|NCT01276223|323807329|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
94549348|NCT01276223|323807330|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
94549349|NCT01276223|323807331|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
94549350|NCT01276223|323807329|FG000|Overall Study|Protocol Violation|1|||
94549351|NCT01276223|323807330|FG001|Overall Study|Protocol Violation|0|||
94549352|NCT01276223|323807331|FG002|Overall Study|Protocol Violation|0|||
94549353|NCT01751139|323807332|FG000|Overall Study|Other|135|||
94549354|NCT01751139|323807332|FG000|Overall Study|Sponsor study termination|1609|||
94549355|NCT01751139|323807332|FG000|Overall Study|Lost to Follow-up|240|||
94549356|NCT01751139|323807332|FG000|Overall Study|Withdrawal by Subject|251|||
94340452|NCT02963766|323026703|FG001|Double-Blind Period|Adverse Event|0|||
94340453|NCT02963766|323026704|FG002|Double-Blind Period|Adverse Event|1|||
94340454|NCT02963766|323026702|FG000|Double-Blind Period|Physician Decision|1|||
94340455|NCT02963766|323026703|FG001|Double-Blind Period|Physician Decision|0|||
94340456|NCT02963766|323026704|FG002|Double-Blind Period|Physician Decision|0|||
94340457|NCT02963766|323026702|FG000|Double-Blind Period|Withdrawal by Subject|1|||
94340458|NCT02963766|323026703|FG001|Double-Blind Period|Withdrawal by Subject|1|||
94340459|NCT02963766|323026704|FG002|Double-Blind Period|Withdrawal by Subject|0|||
94340460|NCT02963766|323026702|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
94340461|NCT02963766|323026703|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
94340462|NCT02963766|323026704|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
94340463|NCT02963766|323026702|FG000|Double-Blind Period|Protocol Violation|1|||
94340464|NCT02963766|323026703|FG001|Double-Blind Period|Protocol Violation|0|||
94340465|NCT02963766|323026704|FG002|Double-Blind Period|Protocol Violation|0|||
94340466|NCT02963766|323026702|FG000|Double-Blind Period|Lost to Follow-up|0|||
94340467|NCT02963766|323026703|FG001|Double-Blind Period|Lost to Follow-up|1|||
94340468|NCT02963766|323026704|FG002|Double-Blind Period|Lost to Follow-up|0|||
94340469|NCT02963766|323026702|FG000|Open Label Extension (OLE)|Physician Decision|1|||
94340470|NCT02963766|323026703|FG001|Open Label Extension (OLE)|Physician Decision|2|||
94340471|NCT02963766|323026704|FG002|Open Label Extension (OLE)|Physician Decision|2|||
94340472|NCT02963766|323026702|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
94340473|NCT02963766|323026703|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
94340474|NCT02963766|323026704|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
94340475|NCT00398138|323026705|FG000|Overall Study|Adverse Event|2|||
94340476|NCT00322387|323026706|FG000|Treatment Period|Adverse Event|0|||
94340477|NCT00322387|323026707|FG001|Treatment Period|Adverse Event|1|||
94340478|NCT00322387|323026706|FG000|Follow-up Period|Final assessment not done|1|||
94340479|NCT00322387|323026707|FG001|Follow-up Period|Final assessment not done|3|||
94340480|NCT00322387|323026706|FG000|Follow-up Period|Death|1|||
94340481|NCT00322387|323026707|FG001|Follow-up Period|Death|0|||
94340482|NCT04228445|323026708|FG000|Overall Study|Lost to Follow-up|1|||
94340483|NCT04228445|323026709|FG001|Overall Study|Lost to Follow-up|1|||
94340484|NCT04228445|323026708|FG000|Overall Study|Physician Decision|1|||
94340485|NCT04228445|323026709|FG001|Overall Study|Physician Decision|2|||
94340486|NCT04228445|323026708|FG000|Overall Study|Withdrawal by Subject|0|||
94340487|NCT04228445|323026709|FG001|Overall Study|Withdrawal by Subject|1|||
94340488|NCT04228445|323026708|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
94340489|NCT04228445|323026709|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
94340490|NCT05116683|323026710|FG000|Overall Study|Physician Decision|4|||
94340491|NCT02116361|323026715|FG000|Overall Study|Pregnancy|0|||
94340492|NCT02116361|323026716|FG001|Overall Study|Pregnancy|0|||
94340493|NCT02116361|323026717|FG002|Overall Study|Pregnancy|0|||
94340494|NCT02116361|323026718|FG003|Overall Study|Pregnancy|1|||
94340495|NCT02116361|323026715|FG000|Overall Study|Protocol Violation|1|||
94340496|NCT02116361|323026716|FG001|Overall Study|Protocol Violation|0|||
94340497|NCT02116361|323026717|FG002|Overall Study|Protocol Violation|0|||
94340498|NCT02116361|323026718|FG003|Overall Study|Protocol Violation|2|||
94340499|NCT02116361|323026715|FG000|Overall Study|Physician Decision|2|||
94340500|NCT02116361|323026716|FG001|Overall Study|Physician Decision|3|||
94340501|NCT02116361|323026717|FG002|Overall Study|Physician Decision|0|||
94340502|NCT02116361|323026718|FG003|Overall Study|Physician Decision|0|||
94340503|NCT02116361|323026715|FG000|Overall Study|Adverse Event|1|||
94340504|NCT02116361|323026716|FG001|Overall Study|Adverse Event|0|||
94340505|NCT02116361|323026717|FG002|Overall Study|Adverse Event|0|||
94340506|NCT02116361|323026718|FG003|Overall Study|Adverse Event|3|||
94340507|NCT02116361|323026715|FG000|Overall Study|Other Reasons|3|||
94340508|NCT02116361|323026716|FG001|Overall Study|Other Reasons|3|||
94340509|NCT02116361|323026717|FG002|Overall Study|Other Reasons|3|||
94340510|NCT02116361|323026718|FG003|Overall Study|Other Reasons|3|||
94340511|NCT02116361|323026715|FG000|Overall Study|Lack of Efficacy|5|||
94340512|NCT02116361|323026716|FG001|Overall Study|Lack of Efficacy|7|||
94340513|NCT02116361|323026717|FG002|Overall Study|Lack of Efficacy|4|||
94340514|NCT02116361|323026718|FG003|Overall Study|Lack of Efficacy|3|||
94340515|NCT02116361|323026715|FG000|Overall Study|Lost to Follow-up|4|||
94340516|NCT02116361|323026716|FG001|Overall Study|Lost to Follow-up|5|||
94340517|NCT02116361|323026717|FG002|Overall Study|Lost to Follow-up|7|||
94340518|NCT02116361|323026718|FG003|Overall Study|Lost to Follow-up|5|||
94340519|NCT02116361|323026715|FG000|Overall Study|Personal Reasons|6|||
94340520|NCT02116361|323026716|FG001|Overall Study|Personal Reasons|6|||
94340521|NCT02116361|323026717|FG002|Overall Study|Personal Reasons|4|||
94340522|NCT02116361|323026718|FG003|Overall Study|Personal Reasons|9|||
94340523|NCT02116361|323026715|FG000|Overall Study|Investigator Decision - Relapse|9|||
94340524|NCT02116361|323026716|FG001|Overall Study|Investigator Decision - Relapse|7|||
94340525|NCT02116361|323026717|FG002|Overall Study|Investigator Decision - Relapse|8|||
94441666|NCT00742209|323403633|FG000|Overall Study|Participant Withdrew Consent|8|||
94340526|NCT02116361|323026718|FG003|Overall Study|Investigator Decision - Relapse|5|||
94340527|NCT03227224|323026719|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
94340528|NCT03227224|323026720|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
94340529|NCT03227224|323026721|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
94340530|NCT03227224|323026722|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
94340531|NCT03227224|323026719|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
94340532|NCT03227224|323026720|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
94340533|NCT03227224|323026721|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
94340534|NCT03227224|323026722|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
94340535|NCT03227224|323026719|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
94340536|NCT03227224|323026720|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
94340537|NCT03227224|323026721|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
94340538|NCT03227224|323026722|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
94340539|NCT03227224|323026719|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
94340540|NCT03227224|323026720|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
94340541|NCT03227224|323026721|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
94340542|NCT03227224|323026722|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
94340543|NCT03227224|323026719|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
94340544|NCT03227224|323026720|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
94340545|NCT03227224|323026721|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
94340546|NCT03227224|323026722|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
94340547|NCT03227224|323026719|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
94340548|NCT03227224|323026720|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
94340549|NCT03227224|323026721|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
94340550|NCT03227224|323026722|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
94340551|NCT03227224|323026719|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
94340552|NCT03227224|323026720|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
94340553|NCT03227224|323026721|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
94340554|NCT03227224|323026722|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
94340555|NCT03227224|323026719|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
94340556|NCT03227224|323026720|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
94340557|NCT03227224|323026721|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
94340558|NCT03227224|323026722|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
94340559|NCT03227224|323026719|FG000|Follow-up Phase (2 Weeks)|Other|4|||
94340560|NCT03227224|323026720|FG001|Follow-up Phase (2 Weeks)|Other|4|||
94340561|NCT03227224|323026721|FG002|Follow-up Phase (2 Weeks)|Other|6|||
94340562|NCT03227224|323026722|FG003|Follow-up Phase (2 Weeks)|Other|3|||
94340563|NCT04195750|323026723|FG000|Overall Study|Death|245|||
94340564|NCT04195750|323026724|FG001|Overall Study|Death|253|||
94340565|NCT04195750|323026725|FG002|Overall Study|Death|5|||
94340566|NCT04195750|323026723|FG000|Overall Study|Physician Decision|0|||
94340567|NCT04195750|323026724|FG001|Overall Study|Physician Decision|1|||
94340568|NCT04195750|323026725|FG002|Overall Study|Physician Decision|0|||
94340569|NCT04195750|323026723|FG000|Overall Study|Withdrawal by Subject|9|||
94340570|NCT04195750|323026724|FG001|Overall Study|Withdrawal by Subject|8|||
94340571|NCT04195750|323026725|FG002|Overall Study|Withdrawal by Subject|0|||
94340572|NCT04195750|323026723|FG000|Overall Study|Ongoing|120|||
94340573|NCT04195750|323026724|FG001|Overall Study|Ongoing|110|||
94340574|NCT04195750|323026725|FG002|Overall Study|Ongoing|4|||
94340575|NCT02406027|323026726|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
94340576|NCT02406027|323026727|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
94340577|NCT02406027|323026728|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
94340578|NCT02406027|323026729|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
94340579|NCT02406027|323026730|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
94340580|NCT02406027|323026731|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
94340581|NCT02406027|323026732|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
94340582|NCT02406027|323026726|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
94340583|NCT02406027|323026727|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
94340584|NCT02406027|323026728|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
94340585|NCT02406027|323026729|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
94340586|NCT02406027|323026730|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
94340587|NCT02406027|323026731|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
94441667|NCT00742209|323403634|FG001|Overall Study|Participant Withdrew Consent|4|||
94441668|NCT00742209|323403635|FG002|Overall Study|Participant Withdrew Consent|14|||
94441669|NCT00742209|323403636|FG003|Overall Study|Participant Withdrew Consent|7|||
94441670|NCT00742209|323403637|FG004|Overall Study|Participant Withdrew Consent|4|||
94441671|NCT00742209|323403633|FG000|Overall Study|Protocol Violation|6|||
94441672|NCT00742209|323403634|FG001|Overall Study|Protocol Violation|5|||
94441673|NCT00742209|323403635|FG002|Overall Study|Protocol Violation|4|||
94441674|NCT00742209|323403636|FG003|Overall Study|Protocol Violation|5|||
94441675|NCT00742209|323403637|FG004|Overall Study|Protocol Violation|3|||
94441676|NCT00742209|323403633|FG000|Overall Study|Lost to Follow-up|3|||
94441677|NCT00742209|323403634|FG001|Overall Study|Lost to Follow-up|4|||
94441678|NCT00742209|323403635|FG002|Overall Study|Lost to Follow-up|5|||
94441679|NCT00742209|323403636|FG003|Overall Study|Lost to Follow-up|5|||
94441680|NCT00742209|323403637|FG004|Overall Study|Lost to Follow-up|3|||
94441681|NCT00742209|323403633|FG000|Overall Study|Lack of Efficacy|6|||
94441682|NCT00742209|323403634|FG001|Overall Study|Lack of Efficacy|1|||
94441683|NCT00742209|323403635|FG002|Overall Study|Lack of Efficacy|1|||
94441684|NCT00742209|323403636|FG003|Overall Study|Lack of Efficacy|3|||
94441685|NCT00742209|323403637|FG004|Overall Study|Lack of Efficacy|1|||
94441686|NCT00742209|323403633|FG000|Overall Study|Investigator Discretion|0|||
94441687|NCT00742209|323403634|FG001|Overall Study|Investigator Discretion|0|||
94441688|NCT00742209|323403635|FG002|Overall Study|Investigator Discretion|5|||
94441689|NCT00742209|323403636|FG003|Overall Study|Investigator Discretion|1|||
94441690|NCT00742209|323403637|FG004|Overall Study|Investigator Discretion|1|||
94441691|NCT01495000|323403638|FG000|Overall Study|Lost to Follow-up|2|||
94441692|NCT01495000|323403639|FG001|Overall Study|Lost to Follow-up|2|||
94441693|NCT01495000|323403638|FG000|Overall Study|Protocol Violation|1|||
94441694|NCT01495000|323403639|FG001|Overall Study|Protocol Violation|0|||
94441695|NCT01495000|323403638|FG000|Overall Study|Withdrawal by Subject|10|||
94441696|NCT01495000|323403639|FG001|Overall Study|Withdrawal by Subject|10|||
94441697|NCT02440464|323403644|FG000|Overall Study|Withdrawal by Subject|3|||
94441698|NCT02440464|323403645|FG001|Overall Study|Withdrawal by Subject|2|||
94441699|NCT01342081|323403648|FG000|Overall Study|Did not receive allocated intervention|0|||
94441700|NCT01342081|323403649|FG001|Overall Study|Did not receive allocated intervention|0|||
94441701|NCT01342081|323403650|FG002|Overall Study|Did not receive allocated intervention|1|||
94441702|NCT01342081|323403648|FG000|Overall Study|Adverse Event|1|||
94441703|NCT01342081|323403649|FG001|Overall Study|Adverse Event|0|||
94441704|NCT01342081|323403650|FG002|Overall Study|Adverse Event|0|||
94441705|NCT01342081|323403648|FG000|Overall Study|Physician Decision|0|||
94441706|NCT01342081|323403649|FG001|Overall Study|Physician Decision|1|||
94441707|NCT01342081|323403650|FG002|Overall Study|Physician Decision|0|||
94441708|NCT01342081|323403648|FG000|Overall Study|Withdrawal by Subject|1|||
94441709|NCT01342081|323403649|FG001|Overall Study|Withdrawal by Subject|1|||
94441710|NCT01342081|323403650|FG002|Overall Study|Withdrawal by Subject|0|||
94441711|NCT04688671|323403653|FG000|Overall Study|Adverse Event|3|||
94441712|NCT04688671|323403654|FG001|Overall Study|Adverse Event|1|||
94441713|NCT04688671|323403653|FG000|Overall Study|Withdrawal by Subject|3|||
94441714|NCT04688671|323403654|FG001|Overall Study|Withdrawal by Subject|1|||
94441715|NCT04688671|323403653|FG000|Overall Study|Lack of Efficacy|1|||
94441716|NCT04688671|323403654|FG001|Overall Study|Lack of Efficacy|1|||
94441717|NCT04688671|323403653|FG000|Overall Study|Protocol Violation|1|||
94441718|NCT04688671|323403654|FG001|Overall Study|Protocol Violation|0|||
94441719|NCT04688671|323403653|FG000|Overall Study|Lost to Follow-up|0|||
94441720|NCT04688671|323403654|FG001|Overall Study|Lost to Follow-up|1|||
94441721|NCT00942357|323403668|FG000|Overall Study|Ineligible|37|||
94441722|NCT00942357|323403669|FG001|Overall Study|Ineligible|40|||
94441723|NCT03749330|323403675|FG000|Overall Study|Clinicians left work in the CICU|0|||
94441724|NCT03749330|323403676|FG001|Overall Study|Clinicians left work in the CICU|2|||
94441725|NCT03749330|323403677|FG002|Overall Study|Clinicians left work in the CICU|0|||
94441726|NCT03749330|323403678|FG003|Overall Study|Clinicians left work in the CICU|0|||
94441727|NCT03749330|323403679|FG004|Overall Study|Clinicians left work in the CICU|0|||
94441728|NCT03749330|323403680|FG005|Overall Study|Clinicians left work in the CICU|0|||
94441729|NCT01973439|323403681|FG000|Overall Study|Lost samples from one PK Day|2|||
94441730|NCT01973439|323403681|FG000|Overall Study|Vomiting after commencing once daily|1|||
94441731|NCT01973439|323403681|FG000|Overall Study|PK curve incomplete|2|||
94441732|NCT03305848|323403682|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
94441733|NCT03305848|323403682|FG000|Overall Study|Physician Decision|2|||
94441734|NCT02224157|323403685|FG000|Overall Study|Severe non-compliance to protocol|2|||
94441735|NCT02224157|323403686|FG001|Overall Study|Severe non-compliance to protocol|2|||
94441736|NCT02224157|323403685|FG000|Overall Study|Other|13|||
94441737|NCT02224157|323403686|FG001|Overall Study|Other|10|||
94441738|NCT02224157|323403685|FG000|Overall Study|Subject decision|58|||
94441739|NCT02224157|323403686|FG001|Overall Study|Subject decision|50|||
94441740|NCT02224157|323403685|FG000|Overall Study|Prematurely closed site|4|||
94441741|NCT02224157|323403686|FG001|Overall Study|Prematurely closed site|2|||
94441742|NCT02224157|323403685|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
94441743|NCT02224157|323403686|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
94441744|NCT02224157|323403685|FG000|Overall Study|Lost to Follow-up|27|||
94441745|NCT02224157|323403686|FG001|Overall Study|Lost to Follow-up|35|||
94441746|NCT02224157|323403685|FG000|Overall Study|Death|1|||
94441747|NCT02224157|323403686|FG001|Overall Study|Death|1|||
94441748|NCT02224157|323403685|FG000|Overall Study|Adverse Event|1|||
94441749|NCT02224157|323403686|FG001|Overall Study|Adverse Event|3|||
94441750|NCT02766335|323403689|FG000|Initial Registration|Adverse Event|6|||
94441751|NCT02766335|323403690|FG001|Initial Registration|Adverse Event|3|||
94441752|NCT02766335|323403691|FG002|Initial Registration|Adverse Event|0|||
94441753|NCT02766335|323403689|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
94441754|NCT02766335|323403690|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
94441755|NCT02766335|323403691|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
94441756|NCT02766335|323403689|FG000|Initial Registration|Progression/relapse|49|||
94441757|NCT02766335|323403690|FG001|Initial Registration|Progression/relapse|15|||
94441758|NCT02766335|323403691|FG002|Initial Registration|Progression/relapse|0|||
94441759|NCT02766335|323403689|FG000|Initial Registration|Death|1|||
94441760|NCT02766335|323403690|FG001|Initial Registration|Death|3|||
94441761|NCT02766335|323403691|FG002|Initial Registration|Death|0|||
94441762|NCT02766335|323403689|FG000|Initial Registration|not protocol specified|1|||
94441763|NCT02766335|323403690|FG001|Initial Registration|not protocol specified|9|||
94441764|NCT02766335|323403691|FG002|Initial Registration|not protocol specified|0|||
94441765|NCT02766335|323403689|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
94441766|NCT02766335|323403690|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
94441767|NCT02766335|323403691|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
94441768|NCT02766335|323403689|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
94441769|NCT02766335|323403690|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
94441770|NCT02766335|323403691|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
94441771|NCT02635984|323403692|FG000|Overall Study|Lost to Follow-up|2|||
94441772|NCT02635984|323403693|FG001|Overall Study|Lost to Follow-up|4|||
94441773|NCT02635984|323403692|FG000|Overall Study|Study Arm Closed|1|||
94441774|NCT02635984|323403693|FG001|Overall Study|Study Arm Closed|0|||
94441775|NCT01640249|323403694|FG000|Period 1|Withdrawal by Subject|1|||
94441776|NCT01640249|323403695|FG001|Period 1|Withdrawal by Subject|0|||
94441777|NCT01640249|323403696|FG002|Period 1|Withdrawal by Subject|0|||
94441778|NCT01640249|323403697|FG003|Period 1|Withdrawal by Subject|0|||
94441779|NCT01640249|323403698|FG004|Period 1|Withdrawal by Subject|0|||
94441780|NCT01640249|323403699|FG005|Period 1|Withdrawal by Subject|1|||
94441781|NCT01640249|323403700|FG006|Period 1|Withdrawal by Subject|0|||
94441782|NCT00065156|323403706|FG000|Overall Study|Adverse Event|37|||
94441783|NCT00065156|323403706|FG000|Overall Study|Lack of Efficacy|52|||
94441784|NCT00065156|323403706|FG000|Overall Study|Withdrawal by Subject|8|||
94441785|NCT00065156|323403706|FG000|Overall Study|Lost to Follow-up|1|||
94441786|NCT00065156|323403706|FG000|Overall Study|Death|11|||
94441787|NCT00065156|323403706|FG000|Overall Study|Study Closed by Sponsor|2|||
94441788|NCT00065156|323403706|FG000|Overall Study|Disease Progression|7|||
94441789|NCT00065156|323403706|FG000|Overall Study|Investigator Decision|2|||
94441790|NCT00065156|323403706|FG000|Overall Study|Non-Compliance|2|||
94441791|NCT00065156|323403706|FG000|Overall Study|Loss of Response|1|||
94441792|NCT00065156|323403706|FG000|Overall Study|Secondary Malign Disease|1|||
94441793|NCT05317312|323403707|FG000|Overall Study|Withdrawal by Subject|0|||
94441794|NCT05317312|323403708|FG001|Overall Study|Withdrawal by Subject|1|||
94441795|NCT05317312|323403709|FG002|Overall Study|Withdrawal by Subject|0|||
94441796|NCT05317312|323403710|FG003|Overall Study|Withdrawal by Subject|0|||
94441797|NCT05317312|323403707|FG000|Overall Study|Lost to Follow-up|0|||
94441798|NCT05317312|323403708|FG001|Overall Study|Lost to Follow-up|0|||
94441799|NCT05317312|323403709|FG002|Overall Study|Lost to Follow-up|0|||
94441800|NCT05317312|323403710|FG003|Overall Study|Lost to Follow-up|1|||
94441801|NCT05317312|323403707|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
94441802|NCT05317312|323403708|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
94441803|NCT05317312|323403709|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
94441804|NCT05317312|323403710|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
94441805|NCT00100828|323403711|FG000|Overall Study|Physician Decision|6|||
94441806|NCT00124917|323403712|FG000|Overall Study|Physician Decision|3|||
94441807|NCT00837148|323403713|FG000|Overall Study|Adverse Event|1|||
94441808|NCT00837148|323403713|FG000|Overall Study|Death|1|||
94441809|NCT03518008|323403714|FG000|Period 2, Second Week of Wear|Family emergency|0|||
94441810|NCT03518008|323403715|FG001|Period 2, Second Week of Wear|Family emergency|1|||
94441811|NCT00235755|323403716|FG000|4-Week Titration Phase|Adverse Event|6|||
94441812|NCT00235755|323403717|FG001|4-Week Titration Phase|Adverse Event|14|||
94441813|NCT00235755|323403718|FG002|4-Week Titration Phase|Adverse Event|20|||
94441814|NCT00235755|323403716|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
94441815|NCT00235755|323403717|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
94441816|NCT00235755|323403718|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
94441817|NCT00235755|323403716|FG000|4-Week Titration Phase|Protocol Violation|2|||
94441818|NCT00235755|323403717|FG001|4-Week Titration Phase|Protocol Violation|2|||
94441819|NCT00235755|323403718|FG002|4-Week Titration Phase|Protocol Violation|1|||
94441820|NCT00235755|323403716|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
94441821|NCT00235755|323403717|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
94441822|NCT00235755|323403718|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
94441823|NCT00235755|323403716|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
94441824|NCT00235755|323403717|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
94441825|NCT00235755|323403718|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
94549357|NCT01751139|323807332|FG000|Overall Study|Adverse Event|1|||
94549358|NCT01751139|323807332|FG000|Overall Study|Death|31|||
94549359|NCT02704689|323807333|FG000|Overall Study|Physician Decision|1|||
94549360|NCT02704689|323807333|FG000|Overall Study|Study device not implanted|2|||
94549361|NCT04676867|323807340|FG000|Overall Study|Screen failure|0|||
94549362|NCT04676867|323807341|FG001|Overall Study|Screen failure|0|||
94549363|NCT04676867|323807342|FG002|Overall Study|Screen failure|6|||
94549364|NCT04676867|323807343|FG003|Overall Study|Screen failure|2|||
94549365|NCT04676867|323807340|FG000|Overall Study|Death|0|||
94549366|NCT04676867|323807341|FG001|Overall Study|Death|0|||
94549367|NCT04676867|323807342|FG002|Overall Study|Death|1|||
94549368|NCT04676867|323807343|FG003|Overall Study|Death|0|||
94549369|NCT04676867|323807340|FG000|Overall Study|Withdrawal by Subject|2|||
94549370|NCT04676867|323807341|FG001|Overall Study|Withdrawal by Subject|2|||
94549371|NCT04676867|323807342|FG002|Overall Study|Withdrawal by Subject|4|||
94549372|NCT04676867|323807343|FG003|Overall Study|Withdrawal by Subject|4|||
94549373|NCT04676867|323807340|FG000|Overall Study|Lost to Follow-up|1|||
94549374|NCT04676867|323807341|FG001|Overall Study|Lost to Follow-up|0|||
94549375|NCT04676867|323807342|FG002|Overall Study|Lost to Follow-up|0|||
94549376|NCT04676867|323807343|FG003|Overall Study|Lost to Follow-up|0|||
94549377|NCT02981524|323807344|FG000|Overall Study|Progressive Disease|14|||
94549378|NCT02981524|323807344|FG000|Overall Study|Death (unrelated)|1|||
94549379|NCT02981524|323807344|FG000|Overall Study|Treatment Related Toxicity|1|||
94549380|NCT02981524|323807344|FG000|Overall Study|Withdrawal by Subject|1|||
94549381|NCT02634606|323807348|FG000|Overall Study|unable to obtain the drug at start|13|||
94549382|NCT01659255|323807349|FG000|Overall Study|Adverse Event|0|||
94549383|NCT01659255|323807350|FG001|Overall Study|Adverse Event|0|||
94549384|NCT01659255|323807351|FG002|Overall Study|Adverse Event|0|||
94549385|NCT01659255|323807352|FG003|Overall Study|Adverse Event|0|||
94549386|NCT01659255|323807353|FG004|Overall Study|Adverse Event|0|||
94549387|NCT01659255|323807354|FG005|Overall Study|Adverse Event|1|||
94549388|NCT01659255|323807355|FG006|Overall Study|Adverse Event|1|||
94549389|NCT01659255|323807356|FG007|Overall Study|Adverse Event|0|||
94549390|NCT01659255|323807357|FG008|Overall Study|Adverse Event|0|||
94549391|NCT01659255|323807358|FG009|Overall Study|Adverse Event|1|||
94549392|NCT01659255|323807359|FG010|Overall Study|Adverse Event|0|||
94549393|NCT01659255|323807360|FG011|Overall Study|Adverse Event|1|||
94549394|NCT01659255|323807361|FG012|Overall Study|Adverse Event|0|||
94549395|NCT01659255|323807362|FG013|Overall Study|Adverse Event|2|||
94549396|NCT01659255|323807363|FG014|Overall Study|Adverse Event|0|||
94549397|NCT01659255|323807364|FG015|Overall Study|Adverse Event|1|||
94549398|NCT01659255|323807365|FG016|Overall Study|Adverse Event|0|||
94549399|NCT01659255|323807349|FG000|Overall Study|Death|0|||
94549400|NCT01659255|323807350|FG001|Overall Study|Death|1|||
94549401|NCT01659255|323807351|FG002|Overall Study|Death|0|||
94549402|NCT01659255|323807352|FG003|Overall Study|Death|0|||
94549403|NCT01659255|323807353|FG004|Overall Study|Death|0|||
94549404|NCT01659255|323807354|FG005|Overall Study|Death|0|||
94549405|NCT01659255|323807355|FG006|Overall Study|Death|0|||
94549406|NCT01659255|323807356|FG007|Overall Study|Death|1|||
94549407|NCT01659255|323807357|FG008|Overall Study|Death|1|||
94549408|NCT01659255|323807358|FG009|Overall Study|Death|0|||
94549409|NCT01659255|323807359|FG010|Overall Study|Death|0|||
94549410|NCT01659255|323807360|FG011|Overall Study|Death|0|||
94549411|NCT01659255|323807361|FG012|Overall Study|Death|1|||
94549412|NCT01659255|323807362|FG013|Overall Study|Death|1|||
94549413|NCT01659255|323807363|FG014|Overall Study|Death|2|||
94549414|NCT01659255|323807364|FG015|Overall Study|Death|1|||
94549415|NCT01659255|323807365|FG016|Overall Study|Death|0|||
94549416|NCT01659255|323807349|FG000|Overall Study|Progressive Disease|2|||
94549417|NCT01659255|323807350|FG001|Overall Study|Progressive Disease|0|||
94340588|NCT02406027|323026732|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
94340589|NCT02406027|323026726|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
94340590|NCT02406027|323026727|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
94549418|NCT01659255|323807351|FG002|Overall Study|Progressive Disease|0|||
94549419|NCT01659255|323807352|FG003|Overall Study|Progressive Disease|0|||
94549420|NCT01659255|323807353|FG004|Overall Study|Progressive Disease|0|||
94549421|NCT01659255|323807354|FG005|Overall Study|Progressive Disease|0|||
94549422|NCT01659255|323807355|FG006|Overall Study|Progressive Disease|0|||
94549423|NCT01659255|323807356|FG007|Overall Study|Progressive Disease|1|||
94549424|NCT01659255|323807357|FG008|Overall Study|Progressive Disease|0|||
94549425|NCT01659255|323807358|FG009|Overall Study|Progressive Disease|2|||
94549426|NCT01659255|323807359|FG010|Overall Study|Progressive Disease|2|||
94549427|NCT01659255|323807360|FG011|Overall Study|Progressive Disease|3|||
94549428|NCT01659255|323807361|FG012|Overall Study|Progressive Disease|5|||
94549429|NCT01659255|323807362|FG013|Overall Study|Progressive Disease|13|||
94549430|NCT01659255|323807363|FG014|Overall Study|Progressive Disease|6|||
94549431|NCT01659255|323807364|FG015|Overall Study|Progressive Disease|2|||
94549432|NCT01659255|323807365|FG016|Overall Study|Progressive Disease|3|||
94549433|NCT01659255|323807349|FG000|Overall Study|Withdrew Consent|0|||
94549434|NCT01659255|323807350|FG001|Overall Study|Withdrew Consent|0|||
94549435|NCT01659255|323807351|FG002|Overall Study|Withdrew Consent|0|||
94441826|NCT00235755|323403716|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
94441827|NCT00235755|323403717|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
94441828|NCT00235755|323403718|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
94441829|NCT00235755|323403716|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
94441830|NCT00235755|323403717|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
94441831|NCT00235755|323403718|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
94441832|NCT00235755|323403716|FG000|12-Week Maintenance Phase|Adverse Event|8|||
94441833|NCT00235755|323403717|FG001|12-Week Maintenance Phase|Adverse Event|12|||
94441834|NCT00235755|323403718|FG002|12-Week Maintenance Phase|Adverse Event|26|||
94441835|NCT00235755|323403716|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
94441836|NCT00235755|323403717|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
94441837|NCT00235755|323403718|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
94441838|NCT00235755|323403716|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
94441839|NCT00235755|323403717|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
94441840|NCT00235755|323403718|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
94441841|NCT00235755|323403716|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
94441842|NCT00235755|323403717|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
94441843|NCT00235755|323403718|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
94441844|NCT00235755|323403716|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
94441845|NCT00235755|323403717|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
94441846|NCT00235755|323403718|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
94441847|NCT00235755|323403716|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
94441848|NCT00235755|323403717|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
94441849|NCT00235755|323403718|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
94441850|NCT02301169|323403719|FG000|Overall Study|Adverse Event|1|||
94441851|NCT02301169|323403720|FG001|Overall Study|Adverse Event|0|||
94441852|NCT03839628|323403721|FG000|Overall Study|Withdrawal by Subject|1|||
94441853|NCT01215136|323403722|FG000|Overall Study|Adverse Event|2|||
94441854|NCT01215136|323403723|FG001|Overall Study|Adverse Event|9|||
94441855|NCT01215136|323403722|FG000|Overall Study|Disease Progression|3|||
94441856|NCT01215136|323403723|FG001|Overall Study|Disease Progression|14|||
94441857|NCT01215136|323403722|FG000|Overall Study|Symptomatic Deterioration|1|||
94441858|NCT01215136|323403723|FG001|Overall Study|Symptomatic Deterioration|1|||
94441859|NCT01215136|323403722|FG000|Overall Study|Death|0|||
94441860|NCT01215136|323403723|FG001|Overall Study|Death|2|||
94441861|NCT01215136|323403722|FG000|Overall Study|Withdrawal by Subject|0|||
94441862|NCT01215136|323403723|FG001|Overall Study|Withdrawal by Subject|1|||
94441863|NCT01197911|323403724|FG000|Overall Study|Adverse Event|0|||
94441864|NCT01197911|323403725|FG001|Overall Study|Adverse Event|0|||
94441865|NCT01197911|323403726|FG002|Overall Study|Adverse Event|1|||
94441866|NCT01112059|323403739|FG000|Overall Study|Withdrawal by Subject|1|||
94441867|NCT01112059|323403740|FG001|Overall Study|Withdrawal by Subject|0|||
94441868|NCT04352101|323403746|FG000|Overall Study|Physician Decision|2|||
94441869|NCT04352101|323403747|FG001|Overall Study|Physician Decision|1|||
94441870|NCT00982657|323403748|FG000|Overall Study|Death|1|||
94441871|NCT00982657|323403749|FG001|Overall Study|Death|0|||
94441872|NCT00982657|323403750|FG002|Overall Study|Death|1|||
94441873|NCT00982657|323403751|FG003|Overall Study|Death|1|||
94441874|NCT00982657|323403748|FG000|Overall Study|Withdrawal by Subject|0|||
94441875|NCT00982657|323403749|FG001|Overall Study|Withdrawal by Subject|0|||
94441876|NCT00982657|323403750|FG002|Overall Study|Withdrawal by Subject|1|||
94441877|NCT00982657|323403751|FG003|Overall Study|Withdrawal by Subject|3|||
94441878|NCT00982657|323403748|FG000|Overall Study|Other|0|||
94441879|NCT00982657|323403749|FG001|Overall Study|Other|0|||
94441880|NCT00982657|323403750|FG002|Overall Study|Other|0|||
94441881|NCT00982657|323403751|FG003|Overall Study|Other|4|||
94441882|NCT00982657|323403748|FG000|Overall Study|On going at date of cut-off|0|||
94441883|NCT00982657|323403749|FG001|Overall Study|On going at date of cut-off|0|||
94441884|NCT00982657|323403750|FG002|Overall Study|On going at date of cut-off|0|||
94441885|NCT00982657|323403751|FG003|Overall Study|On going at date of cut-off|1|||
94441886|NCT00625820|323403752|FG000|Overall Study|Withdrawal by Subject|1|||
94441887|NCT01133067|323403753|FG000|Overall Study|Death|136|||
94441888|NCT01133067|323403753|FG000|Overall Study|Lost to Follow-up|3|||
94441889|NCT04447027|323403757|FG000|Dose Escalation|Withdrawal by Subject|1|||
94441890|NCT04447027|323403758|FG001|Dose Escalation|Withdrawal by Subject|4|||
94441891|NCT04447027|323403759|FG002|Dose Escalation|Withdrawal by Subject|3|||
94441892|NCT04447027|323403760|FG003|Dose Escalation|Withdrawal by Subject|3|||
94441893|NCT04447027|323403761|FG004|Dose Escalation|Withdrawal by Subject|1|||
94441894|NCT04447027|323403762|FG005|Dose Escalation|Withdrawal by Subject|0|||
94441895|NCT04447027|323403763|FG006|Dose Escalation|Withdrawal by Subject|0|||
94441896|NCT04447027|323403764|FG007|Dose Escalation|Withdrawal by Subject|0|||
94441897|NCT04447027|323403765|FG008|Dose Escalation|Withdrawal by Subject|0|||
94441898|NCT04447027|323403757|FG000|Dose Escalation|Refused further treatment|0|||
94441899|NCT04447027|323403758|FG001|Dose Escalation|Refused further treatment|1|||
94441900|NCT04447027|323403759|FG002|Dose Escalation|Refused further treatment|1|||
94441901|NCT04447027|323403760|FG003|Dose Escalation|Refused further treatment|0|||
94441902|NCT04447027|323403761|FG004|Dose Escalation|Refused further treatment|0|||
94441903|NCT04447027|323403762|FG005|Dose Escalation|Refused further treatment|0|||
94441904|NCT04447027|323403763|FG006|Dose Escalation|Refused further treatment|0|||
94441905|NCT04447027|323403764|FG007|Dose Escalation|Refused further treatment|0|||
94441906|NCT04447027|323403765|FG008|Dose Escalation|Refused further treatment|0|||
94441907|NCT04447027|323403757|FG000|Dose Expansion|Withdrawal by Subject|0|||
94441908|NCT04447027|323403758|FG001|Dose Expansion|Withdrawal by Subject|0|||
94441909|NCT04447027|323403759|FG002|Dose Expansion|Withdrawal by Subject|0|||
94441910|NCT04447027|323403760|FG003|Dose Expansion|Withdrawal by Subject|0|||
94441911|NCT04447027|323403761|FG004|Dose Expansion|Withdrawal by Subject|0|||
94441912|NCT04447027|323403762|FG005|Dose Expansion|Withdrawal by Subject|2|||
94441913|NCT04447027|323403763|FG006|Dose Expansion|Withdrawal by Subject|0|||
94441914|NCT04447027|323403764|FG007|Dose Expansion|Withdrawal by Subject|2|||
94441915|NCT04447027|323403765|FG008|Dose Expansion|Withdrawal by Subject|0|||
94441916|NCT01546025|323403766|FG000|Overall Study|Lost to Follow-up|0|||
94441917|NCT01546025|323403767|FG001|Overall Study|Lost to Follow-up|1|||
94441918|NCT03641469|323403768|FG000|Overall Study|Ineligible|2|||
94441919|NCT03641469|323403768|FG000|Overall Study|Withdrawal by Subject|5|||
94441920|NCT03641469|323403768|FG000|Overall Study|Physician Decision|1|||
94441921|NCT03641469|323403768|FG000|Overall Study|Protocol Violation|1|||
94441922|NCT03641469|323403768|FG000|Overall Study|Lost to Follow-up|2|||
94441923|NCT05479435|323403769|FG000|Overall Study|Withdrawal by Subject|1|||
94441924|NCT05479435|323403770|FG001|Overall Study|Withdrawal by Subject|0|||
94441925|NCT05479435|323403771|FG002|Overall Study|Withdrawal by Subject|0|||
94441926|NCT05479435|323403769|FG000|Overall Study|Covid 19|0|||
94441927|NCT05479435|323403770|FG001|Overall Study|Covid 19|0|||
94441928|NCT05479435|323403771|FG002|Overall Study|Covid 19|2|||
94441929|NCT05620082|323403772|FG000|Overall Study|Discharged before study end|1|||
94441930|NCT05620082|323403773|FG001|Overall Study|Discharged before study end|4|||
94441931|NCT05620082|323403774|FG002|Overall Study|Discharged before study end|0|||
94441932|NCT05620082|323403772|FG000|Overall Study|Moved to a different ward|1|||
94441933|NCT05620082|323403773|FG001|Overall Study|Moved to a different ward|0|||
94441934|NCT05620082|323403774|FG002|Overall Study|Moved to a different ward|0|||
94441935|NCT05620082|323403772|FG000|Overall Study|Feeling too unwell|1|||
94441936|NCT05620082|323403773|FG001|Overall Study|Feeling too unwell|0|||
94441937|NCT05620082|323403774|FG002|Overall Study|Feeling too unwell|0|||
94441938|NCT00868530|323403775|FG000|Overall Study|Adverse Event|3|||
94441939|NCT00868530|323403775|FG000|Overall Study|Lost to Follow-up|1|||
94441940|NCT02656303|323405562|FG000|Overall Study|Adverse Event|3|||
94441941|NCT02656303|323405563|FG001|Overall Study|Adverse Event|2|||
94441942|NCT02656303|323405564|FG002|Overall Study|Adverse Event|0|||
94549436|NCT01659255|323807352|FG003|Overall Study|Withdrew Consent|0|||
94340591|NCT02406027|323026728|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
94340592|NCT02406027|323026729|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
94549437|NCT01659255|323807353|FG004|Overall Study|Withdrew Consent|0|||
94549438|NCT01659255|323807354|FG005|Overall Study|Withdrew Consent|0|||
94549439|NCT01659255|323807355|FG006|Overall Study|Withdrew Consent|0|||
94549440|NCT01659255|323807356|FG007|Overall Study|Withdrew Consent|0|||
94549441|NCT01659255|323807357|FG008|Overall Study|Withdrew Consent|0|||
94549442|NCT01659255|323807358|FG009|Overall Study|Withdrew Consent|0|||
94340593|NCT02406027|323026730|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
94340594|NCT02406027|323026731|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
94340595|NCT02406027|323026732|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
94340596|NCT02406027|323026726|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
94340597|NCT02406027|323026727|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
94340598|NCT02406027|323026728|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
94340599|NCT02406027|323026729|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
94549443|NCT01659255|323807359|FG010|Overall Study|Withdrew Consent|1|||
94340600|NCT02406027|323026730|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
94441943|NCT02656303|323405562|FG000|Overall Study|Death|12|||
94441944|NCT02656303|323405563|FG001|Overall Study|Death|4|||
94549444|NCT01659255|323807360|FG011|Overall Study|Withdrew Consent|0|||
94441945|NCT02656303|323405564|FG002|Overall Study|Death|1|||
94549445|NCT01659255|323807361|FG012|Overall Study|Withdrew Consent|0|||
94549446|NCT01659255|323807362|FG013|Overall Study|Withdrew Consent|1|||
94441946|NCT02656303|323405562|FG000|Overall Study|Lack of Efficacy|1|||
94441947|NCT02656303|323405563|FG001|Overall Study|Lack of Efficacy|0|||
94441948|NCT02656303|323405564|FG002|Overall Study|Lack of Efficacy|0|||
94441949|NCT02656303|323405562|FG000|Overall Study|Non-Compliance with Study|1|||
94441950|NCT02656303|323405563|FG001|Overall Study|Non-Compliance with Study|1|||
94441951|NCT02656303|323405564|FG002|Overall Study|Non-Compliance with Study|0|||
94441952|NCT02656303|323405562|FG000|Overall Study|Investigator Decision|2|||
94441953|NCT02656303|323405563|FG001|Overall Study|Investigator Decision|1|||
94549447|NCT01659255|323807363|FG014|Overall Study|Withdrew Consent|0|||
94441954|NCT02656303|323405564|FG002|Overall Study|Investigator Decision|0|||
94441955|NCT02656303|323405562|FG000|Overall Study|Progressive Disease|25|||
94441956|NCT02656303|323405563|FG001|Overall Study|Progressive Disease|14|||
94441957|NCT02656303|323405564|FG002|Overall Study|Progressive Disease|10|||
94441958|NCT02656303|323405562|FG000|Overall Study|Study Terminated by Sponsor|20|||
94441959|NCT02656303|323405563|FG001|Overall Study|Study Terminated by Sponsor|7|||
94441960|NCT02656303|323405564|FG002|Overall Study|Study Terminated by Sponsor|5|||
94441961|NCT02656303|323405562|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
94441962|NCT02656303|323405563|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
94441963|NCT02656303|323405564|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
94441964|NCT02656303|323405562|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
94441965|NCT02656303|323405563|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
94441966|NCT02656303|323405564|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
94441967|NCT02656303|323405562|FG000|Overall Study|Reason not Specified|1|||
94441968|NCT02656303|323405563|FG001|Overall Study|Reason not Specified|1|||
94441969|NCT02656303|323405564|FG002|Overall Study|Reason not Specified|2|||
94441970|NCT00413699|323405565|FG000|Initial Period|Death|25|||
94441971|NCT00413699|323405566|FG001|Initial Period|Death|30|||
94441972|NCT00413699|323405567|FG002|Initial Period|Death|0|||
94441973|NCT00413699|323405565|FG000|Initial Period|Lack of Efficacy|59|||
94441974|NCT00413699|323405566|FG001|Initial Period|Lack of Efficacy|115|||
94441975|NCT00413699|323405567|FG002|Initial Period|Lack of Efficacy|0|||
94441976|NCT00413699|323405565|FG000|Initial Period|Lost to Follow-up|31|||
94441977|NCT00413699|323405566|FG001|Initial Period|Lost to Follow-up|101|||
94441978|NCT00413699|323405567|FG002|Initial Period|Lost to Follow-up|0|||
94441979|NCT00413699|323405565|FG000|Initial Period|Protocol Violation|38|||
94441980|NCT00413699|323405566|FG001|Initial Period|Protocol Violation|89|||
94441981|NCT00413699|323405567|FG002|Initial Period|Protocol Violation|0|||
94441982|NCT00413699|323405565|FG000|Initial Period|Pregnancy|10|||
94441983|NCT00413699|323405566|FG001|Initial Period|Pregnancy|8|||
94441984|NCT00413699|323405567|FG002|Initial Period|Pregnancy|0|||
94441985|NCT00413699|323405565|FG000|Initial Period|Did not meet entrance criteria|2|||
94441986|NCT00413699|323405566|FG001|Initial Period|Did not meet entrance criteria|2|||
94441987|NCT00413699|323405567|FG002|Initial Period|Did not meet entrance criteria|0|||
94441988|NCT00413699|323405565|FG000|Initial Period|Medication error without adverse event|0|||
94441989|NCT00413699|323405566|FG001|Initial Period|Medication error without adverse event|1|||
94441990|NCT00413699|323405567|FG002|Initial Period|Medication error without adverse event|0|||
94441991|NCT00413699|323405565|FG000|Initial Period|Study terminated by Sponsor|0|||
94441992|NCT00413699|323405566|FG001|Initial Period|Study terminated by Sponsor|1|||
94441993|NCT00413699|323405567|FG002|Initial Period|Study terminated by Sponsor|0|||
94441994|NCT00413699|323405565|FG000|Initial Period|Other|67|||
94441995|NCT00413699|323405566|FG001|Initial Period|Other|211|||
94441996|NCT00413699|323405567|FG002|Initial Period|Other|0|||
94441997|NCT00413699|323405565|FG000|Initial Period|Adverse event related to study drug|178|||
94441998|NCT00413699|323405566|FG001|Initial Period|Adverse event related to study drug|527|||
94441999|NCT00413699|323405567|FG002|Initial Period|Adverse event related to study drug|0|||
94442000|NCT00413699|323405565|FG000|Initial Period|Adverse event not related to study drug|113|||
94442001|NCT00413699|323405566|FG001|Initial Period|Adverse event not related to study drug|248|||
94442002|NCT00413699|323405567|FG002|Initial Period|Adverse event not related to study drug|0|||
94442003|NCT00413699|323405565|FG000|Initial Period|Missing end of study page|0|||
94442004|NCT00413699|323405566|FG001|Initial Period|Missing end of study page|4|||
94442005|NCT00413699|323405567|FG002|Initial Period|Missing end of study page|0|||
94442006|NCT00413699|323405565|FG000|Initial Period|No longer willing to participate|116|||
94442007|NCT00413699|323405566|FG001|Initial Period|No longer willing to participate|368|||
94442008|NCT00413699|323405567|FG002|Initial Period|No longer willing to participate|0|||
94549448|NCT01659255|323807364|FG015|Overall Study|Withdrew Consent|0|||
94549449|NCT01659255|323807365|FG016|Overall Study|Withdrew Consent|0|||
94549450|NCT01659255|323807349|FG000|Overall Study|Investigator Decision|0|||
94549451|NCT01659255|323807350|FG001|Overall Study|Investigator Decision|0|||
94549452|NCT01659255|323807351|FG002|Overall Study|Investigator Decision|0|||
94549453|NCT01659255|323807352|FG003|Overall Study|Investigator Decision|0|||
94549454|NCT01659255|323807353|FG004|Overall Study|Investigator Decision|0|||
94442009|NCT00413699|323405565|FG000|Extension Period|No Longer Willing to Participate|0|||
94442010|NCT00413699|323405566|FG001|Extension Period|No Longer Willing to Participate|0|||
94442011|NCT00413699|323405567|FG002|Extension Period|No Longer Willing to Participate|2|||
94442012|NCT00413699|323405565|FG000|Extension Period|Protocol Violation|0|||
94442013|NCT00413699|323405566|FG001|Extension Period|Protocol Violation|0|||
94442014|NCT00413699|323405567|FG002|Extension Period|Protocol Violation|1|||
94442015|NCT00413699|323405565|FG000|Extension Period|Adverse Event|0|||
94549455|NCT01659255|323807354|FG005|Overall Study|Investigator Decision|0|||
94442016|NCT00413699|323405566|FG001|Extension Period|Adverse Event|0|||
94442017|NCT00413699|323405567|FG002|Extension Period|Adverse Event|2|||
94442018|NCT00696423|323405568|FG000|Overall Study|Lost to Follow-up|0|||
94442019|NCT00696423|323405569|FG001|Overall Study|Lost to Follow-up|5|||
94549456|NCT01659255|323807355|FG006|Overall Study|Investigator Decision|0|||
94442020|NCT02366689|323405578|FG000|Overall Study|Withdrawal by Subject|1|||
94442021|NCT02366689|323405579|FG001|Overall Study|Withdrawal by Subject|0|||
94442022|NCT02366689|323405580|FG002|Overall Study|Withdrawal by Subject|1|||
94442023|NCT02366689|323405578|FG000|Overall Study|Lost to Follow-up|3|||
94442024|NCT02366689|323405579|FG001|Overall Study|Lost to Follow-up|2|||
94442025|NCT02366689|323405580|FG002|Overall Study|Lost to Follow-up|0|||
94442026|NCT02366689|323405578|FG000|Overall Study|Pregnancy|0|||
94442027|NCT02366689|323405579|FG001|Overall Study|Pregnancy|1|||
94442028|NCT02366689|323405580|FG002|Overall Study|Pregnancy|1|||
94549457|NCT01659255|323807356|FG007|Overall Study|Investigator Decision|0|||
94549458|NCT01659255|323807357|FG008|Overall Study|Investigator Decision|0|||
94549459|NCT01659255|323807358|FG009|Overall Study|Investigator Decision|0|||
94549460|NCT01659255|323807359|FG010|Overall Study|Investigator Decision|0|||
94549461|NCT01659255|323807360|FG011|Overall Study|Investigator Decision|0|||
94549462|NCT01659255|323807361|FG012|Overall Study|Investigator Decision|1|||
94549463|NCT01659255|323807362|FG013|Overall Study|Investigator Decision|1|||
94549464|NCT01659255|323807363|FG014|Overall Study|Investigator Decision|0|||
94549465|NCT01659255|323807364|FG015|Overall Study|Investigator Decision|0|||
94549466|NCT01659255|323807365|FG016|Overall Study|Investigator Decision|0|||
94549467|NCT01659255|323807349|FG000|Overall Study|Sponsor's Decision|0|||
94549468|NCT01659255|323807350|FG001|Overall Study|Sponsor's Decision|0|||
94549469|NCT01659255|323807351|FG002|Overall Study|Sponsor's Decision|0|||
94340601|NCT02406027|323026731|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
94340602|NCT02406027|323026732|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
94340603|NCT02406027|323026726|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
94340604|NCT02406027|323026727|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
94340605|NCT02406027|323026728|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
94340606|NCT02406027|323026729|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
94340607|NCT02406027|323026730|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
94340608|NCT02406027|323026731|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
94340609|NCT02406027|323026732|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
94340610|NCT02406027|323026726|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
94340611|NCT02406027|323026727|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
94340612|NCT02406027|323026728|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
94340613|NCT02406027|323026729|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
94340614|NCT02406027|323026730|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
94340615|NCT02406027|323026731|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
94340616|NCT02406027|323026732|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
94340617|NCT02406027|323026726|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
94340618|NCT02406027|323026727|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
94340619|NCT02406027|323026728|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
94340620|NCT02406027|323026729|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
94340621|NCT02406027|323026730|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
94340622|NCT02406027|323026731|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
94340623|NCT02406027|323026732|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
94340624|NCT02406027|323026726|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
94340625|NCT02406027|323026727|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
94340626|NCT02406027|323026728|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
94340627|NCT02406027|323026729|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
94340628|NCT02406027|323026730|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
94340629|NCT02406027|323026731|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
94340630|NCT02406027|323026732|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
94340631|NCT02406027|323026726|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
94340632|NCT02406027|323026727|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
94340633|NCT02406027|323026728|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
94340634|NCT02406027|323026729|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
94340635|NCT02406027|323026730|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
94340636|NCT02406027|323026731|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
94340637|NCT02406027|323026732|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
94340638|NCT02406027|323026726|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
94340639|NCT02406027|323026727|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
94340640|NCT02406027|323026728|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
94340641|NCT02406027|323026729|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
94340642|NCT02406027|323026730|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
94340643|NCT02406027|323026731|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
94340644|NCT02406027|323026732|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
94340645|NCT03782376|323026733|FG000|Overall Study|Lost to Follow-up|2|||
94442029|NCT01290068|323405581|FG000|Overall Study|Adverse Event|1|||
94549470|NCT01659255|323807352|FG003|Overall Study|Sponsor's Decision|0|||
94442030|NCT01290068|323405582|FG001|Overall Study|Adverse Event|3|||
94442031|NCT01290068|323405581|FG000|Overall Study|Lost to Follow-up|3|||
94549471|NCT01659255|323807353|FG004|Overall Study|Sponsor's Decision|0|||
94442032|NCT01290068|323405582|FG001|Overall Study|Lost to Follow-up|0|||
94442033|NCT01290068|323405581|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
94442034|NCT01290068|323405582|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
94442035|NCT01290068|323405581|FG000|Overall Study|Other|3|||
94442036|NCT01290068|323405582|FG001|Overall Study|Other|1|||
94442037|NCT00513695|323405583|FG000|Overall Study|Discontinued therapy|2|||
94442038|NCT00513695|323405583|FG000|Overall Study|Progression prior to surgery|3|||
94442039|NCT02157935|323405586|FG000|Overall Study|Withdrawal by Subject|25|||
94442040|NCT02157935|323405587|FG001|Overall Study|Withdrawal by Subject|39|||
94442041|NCT02157935|323405586|FG000|Overall Study|Screen failure|1|||
94442042|NCT02157935|323405587|FG001|Overall Study|Screen failure|2|||
94442043|NCT02157935|323405586|FG000|Overall Study|Protocol Violation|1|||
94442044|NCT02157935|323405587|FG001|Overall Study|Protocol Violation|0|||
94442045|NCT02157935|323405586|FG000|Overall Study|Progressive disease|0|||
94442046|NCT02157935|323405587|FG001|Overall Study|Progressive disease|2|||
94442047|NCT02157935|323405586|FG000|Overall Study|Other|5|||
94442048|NCT02157935|323405587|FG001|Overall Study|Other|12|||
94442049|NCT02157935|323405586|FG000|Overall Study|Lack of Efficacy|0|||
94442050|NCT02157935|323405587|FG001|Overall Study|Lack of Efficacy|1|||
94442051|NCT02157935|323405586|FG000|Overall Study|Death|4|||
94442052|NCT02157935|323405587|FG001|Overall Study|Death|4|||
94442053|NCT02157935|323405586|FG000|Overall Study|Adverse Event|3|||
94442054|NCT02157935|323405587|FG001|Overall Study|Adverse Event|5|||
94442055|NCT01417156|323405588|FG000|Overall Study|Adverse Event|12|||
94442056|NCT01417156|323405588|FG000|Overall Study|Protocol Violation|2|||
94442057|NCT00818766|323405589|FG000|Overall Study|Could not be Contacted on Day 28|11|||
94442058|NCT00818766|323405590|FG001|Overall Study|Could not be Contacted on Day 28|10|||
94442059|NCT00818766|323405589|FG000|Overall Study|Death|1|||
94442060|NCT00818766|323405590|FG001|Overall Study|Death|0|||
94442061|NCT00818766|323405589|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
94442062|NCT00818766|323405590|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
94442063|NCT04570670|323405591|FG000|Overall Study|Withdrawal by Subject|1|||
94442064|NCT04570670|323405592|FG001|Overall Study|Withdrawal by Subject|0|||
94442065|NCT00086684|323405593|FG000|Overall Study|Adverse Event|12|||
94442066|NCT00086684|323405594|FG001|Overall Study|Adverse Event|17|||
94442067|NCT00086684|323405595|FG002|Overall Study|Adverse Event|14|||
94442068|NCT00086684|323405593|FG000|Overall Study|Lack of Efficacy|6|||
94442069|NCT00086684|323405594|FG001|Overall Study|Lack of Efficacy|6|||
94442070|NCT00086684|323405595|FG002|Overall Study|Lack of Efficacy|5|||
94442071|NCT00086684|323405593|FG000|Overall Study|Lost to Follow-up|15|||
94442072|NCT00086684|323405594|FG001|Overall Study|Lost to Follow-up|8|||
94442073|NCT00086684|323405595|FG002|Overall Study|Lost to Follow-up|10|||
94442074|NCT00086684|323405593|FG000|Overall Study|Protocol Violation|8|||
94442075|NCT00086684|323405594|FG001|Overall Study|Protocol Violation|3|||
94442076|NCT00086684|323405595|FG002|Overall Study|Protocol Violation|0|||
94442077|NCT00086684|323405593|FG000|Overall Study|Withdrawal by Subject|0|||
94442078|NCT00086684|323405594|FG001|Overall Study|Withdrawal by Subject|4|||
94442079|NCT00086684|323405595|FG002|Overall Study|Withdrawal by Subject|10|||
94442080|NCT00086684|323405593|FG000|Overall Study|NONCOMPLIANCE|5|||
94442081|NCT00086684|323405594|FG001|Overall Study|NONCOMPLIANCE|7|||
94442082|NCT00086684|323405595|FG002|Overall Study|NONCOMPLIANCE|6|||
94442083|NCT00086684|323405593|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
94442084|NCT00086684|323405594|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
94442085|NCT00086684|323405595|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
94442086|NCT00086684|323405593|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
94442087|NCT00086684|323405594|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
94549472|NCT01659255|323807354|FG005|Overall Study|Sponsor's Decision|0|||
94549473|NCT01659255|323807355|FG006|Overall Study|Sponsor's Decision|1|||
94549474|NCT01659255|323807356|FG007|Overall Study|Sponsor's Decision|0|||
94549475|NCT01659255|323807357|FG008|Overall Study|Sponsor's Decision|0|||
94549476|NCT01659255|323807358|FG009|Overall Study|Sponsor's Decision|0|||
94549477|NCT01659255|323807359|FG010|Overall Study|Sponsor's Decision|0|||
94549478|NCT01659255|323807360|FG011|Overall Study|Sponsor's Decision|0|||
94442088|NCT00086684|323405595|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
94442089|NCT00086684|323405593|FG000|Overall Study|Other|4|||
94442090|NCT00086684|323405594|FG001|Overall Study|Other|2|||
94442091|NCT00086684|323405595|FG002|Overall Study|Other|3|||
94442092|NCT02719184|323405596|FG000|Overall Study|Other than listed|1|||
94549479|NCT01659255|323807361|FG012|Overall Study|Sponsor's Decision|0|||
94549480|NCT01659255|323807362|FG013|Overall Study|Sponsor's Decision|0|||
94549481|NCT01659255|323807363|FG014|Overall Study|Sponsor's Decision|0|||
94442093|NCT02719184|323405597|FG001|Overall Study|Other than listed|12|||
94442094|NCT02719184|323405598|FG002|Overall Study|Other than listed|13|||
94442095|NCT02719184|323405599|FG003|Overall Study|Other than listed|22|||
94442096|NCT02719184|323405600|FG004|Overall Study|Other than listed|9|||
94442097|NCT02719184|323405596|FG000|Overall Study|Withdrawal by Subject|5|||
94442098|NCT02719184|323405597|FG001|Overall Study|Withdrawal by Subject|3|||
94549482|NCT01659255|323807364|FG015|Overall Study|Sponsor's Decision|0|||
94340646|NCT03782376|323026734|FG001|Overall Study|Lost to Follow-up|2|||
94340647|NCT03782376|323026733|FG000|Overall Study|Withdrawal by Subject|7|||
94340648|NCT03782376|323026734|FG001|Overall Study|Withdrawal by Subject|11|||
94340649|NCT03782376|323026733|FG000|Overall Study|Death|1|||
94340650|NCT03782376|323026734|FG001|Overall Study|Death|0|||
94340651|NCT03782376|323026733|FG000|Overall Study|Other|16|||
94340652|NCT03782376|323026734|FG001|Overall Study|Other|17|||
94340653|NCT02422186|323026735|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
94340654|NCT02422186|323026736|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
94340655|NCT02422186|323026735|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
94340656|NCT02422186|323026736|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
94340657|NCT02422186|323026735|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
94340658|NCT02422186|323026736|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
94340659|NCT02422186|323026735|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
94340660|NCT02422186|323026736|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
94340661|NCT02422186|323026735|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
94340662|NCT02422186|323026736|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
94340663|NCT02422186|323026735|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
94340664|NCT02422186|323026736|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
94340665|NCT02422186|323026735|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
94340666|NCT02422186|323026736|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
94340667|NCT02422186|323026735|FG000|Follow-up Phase (2 Weeks)|Other|3|||
94340668|NCT02422186|323026736|FG001|Follow-up Phase (2 Weeks)|Other|0|||
94340669|NCT03573401|323026737|FG000|Overall Study|Withdrawal by Subject|2|||
94340670|NCT03573401|323026738|FG001|Overall Study|Withdrawal by Subject|0|||
94340671|NCT03573401|323026737|FG000|Overall Study|Subject non-compliance with study schedule|1|||
94340672|NCT03573401|323026738|FG001|Overall Study|Subject non-compliance with study schedule|0|||
94340673|NCT03573401|323026737|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
94340674|NCT03573401|323026738|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
94340675|NCT03573401|323026737|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
94340676|NCT03573401|323026738|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
94340677|NCT03128307|323026739|FG000|Overall Study|Lost to Follow-up|29|||
94340678|NCT03128307|323026739|FG000|Overall Study|Withdrawal by Subject|5|||
94340679|NCT02371980|323028850|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
94340680|NCT02371980|323028851|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
94340681|NCT02371980|323028852|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
94340682|NCT02371980|323028853|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
94340683|NCT02371980|323028854|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
94340684|NCT02371980|323028850|FG000|Open-label Period|Significant Protocol Deviation|19|||
94340685|NCT02371980|323028851|FG001|Open-label Period|Significant Protocol Deviation|0|||
94340686|NCT02371980|323028852|FG002|Open-label Period|Significant Protocol Deviation|0|||
94340687|NCT02371980|323028853|FG003|Open-label Period|Significant Protocol Deviation|0|||
94340688|NCT02371980|323028854|FG004|Open-label Period|Significant Protocol Deviation|0|||
94340689|NCT02371980|323028850|FG000|Open-label Period|Noncompliance with Study Drug|10|||
94340690|NCT02371980|323028851|FG001|Open-label Period|Noncompliance with Study Drug|0|||
94340691|NCT02371980|323028852|FG002|Open-label Period|Noncompliance with Study Drug|0|||
94340692|NCT02371980|323028853|FG003|Open-label Period|Noncompliance with Study Drug|0|||
94340693|NCT02371980|323028854|FG004|Open-label Period|Noncompliance with Study Drug|0|||
94340694|NCT02371980|323028850|FG000|Open-label Period|Lost to Follow-up|55|||
94340695|NCT02371980|323028851|FG001|Open-label Period|Lost to Follow-up|0|||
94340696|NCT02371980|323028852|FG002|Open-label Period|Lost to Follow-up|0|||
94340697|NCT02371980|323028853|FG003|Open-label Period|Lost to Follow-up|0|||
94340698|NCT02371980|323028854|FG004|Open-label Period|Lost to Follow-up|0|||
94340699|NCT02371980|323028850|FG000|Open-label Period|Voluntary Withdrawal|91|||
94340700|NCT02371980|323028851|FG001|Open-label Period|Voluntary Withdrawal|0|||
94340701|NCT02371980|323028852|FG002|Open-label Period|Voluntary Withdrawal|0|||
94340702|NCT02371980|323028853|FG003|Open-label Period|Voluntary Withdrawal|0|||
94340703|NCT02371980|323028854|FG004|Open-label Period|Voluntary Withdrawal|0|||
94340704|NCT02371980|323028850|FG000|Open-label Period|Pregnancy|1|||
94340705|NCT02371980|323028851|FG001|Open-label Period|Pregnancy|0|||
94340706|NCT02371980|323028852|FG002|Open-label Period|Pregnancy|0|||
94340707|NCT02371980|323028853|FG003|Open-label Period|Pregnancy|0|||
94340708|NCT02371980|323028854|FG004|Open-label Period|Pregnancy|0|||
94340709|NCT02371980|323028850|FG000|Open-label Period|Lack of Efficacy|116|||
94340710|NCT02371980|323028851|FG001|Open-label Period|Lack of Efficacy|0|||
94340711|NCT02371980|323028852|FG002|Open-label Period|Lack of Efficacy|0|||
94340712|NCT02371980|323028853|FG003|Open-label Period|Lack of Efficacy|0|||
94340713|NCT02371980|323028854|FG004|Open-label Period|Lack of Efficacy|0|||
94442099|NCT02719184|323405598|FG002|Overall Study|Withdrawal by Subject|6|||
94442100|NCT02719184|323405599|FG003|Overall Study|Withdrawal by Subject|6|||
94442101|NCT02719184|323405600|FG004|Overall Study|Withdrawal by Subject|0|||
94442102|NCT02719184|323405596|FG000|Overall Study|Lost to Follow-up|0|||
94442103|NCT02719184|323405597|FG001|Overall Study|Lost to Follow-up|4|||
94442104|NCT02719184|323405598|FG002|Overall Study|Lost to Follow-up|1|||
94442105|NCT02719184|323405599|FG003|Overall Study|Lost to Follow-up|3|||
94442106|NCT02719184|323405600|FG004|Overall Study|Lost to Follow-up|0|||
94442107|NCT02719184|323405596|FG000|Overall Study|Protocol Violation|0|||
94442108|NCT02719184|323405597|FG001|Overall Study|Protocol Violation|3|||
94442109|NCT02719184|323405598|FG002|Overall Study|Protocol Violation|0|||
94442110|NCT02719184|323405599|FG003|Overall Study|Protocol Violation|2|||
94442111|NCT02719184|323405600|FG004|Overall Study|Protocol Violation|0|||
94442112|NCT02719184|323405596|FG000|Overall Study|Adverse Event|0|||
94442113|NCT02719184|323405597|FG001|Overall Study|Adverse Event|0|||
94442114|NCT02719184|323405598|FG002|Overall Study|Adverse Event|0|||
94442115|NCT02719184|323405599|FG003|Overall Study|Adverse Event|3|||
94442116|NCT02719184|323405600|FG004|Overall Study|Adverse Event|0|||
94442117|NCT01439802|323405601|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
94442118|NCT01439802|323405601|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
94442119|NCT01866826|323405602|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
94442120|NCT01866826|323405603|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
94442121|NCT01866826|323405602|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
94442122|NCT01866826|323405603|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
94442123|NCT01866826|323405602|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
94442124|NCT01866826|323405603|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
94442125|NCT00725491|323405608|FG000|Overall Study|Adverse Event|3|||
94442126|NCT00725491|323405609|FG001|Overall Study|Adverse Event|2|||
94442127|NCT00725491|323405608|FG000|Overall Study|Pregnancy|0|||
94442128|NCT00725491|323405609|FG001|Overall Study|Pregnancy|3|||
94442129|NCT00725491|323405608|FG000|Overall Study|Risk for hyperstimulation|2|||
94442130|NCT00725491|323405609|FG001|Overall Study|Risk for hyperstimulation|9|||
94442131|NCT00725491|323405608|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
94442132|NCT00725491|323405609|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
94340714|NCT02371980|323028850|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
94442133|NCT00725491|323405608|FG000|Overall Study|Fertilization failure|0|||
94442134|NCT00725491|323405609|FG001|Overall Study|Fertilization failure|1|||
94442135|NCT00725491|323405608|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
94442136|NCT00725491|323405609|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
94442137|NCT00654095|323405610|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
94442138|NCT00654095|323405610|FG000|Overall Study|Elevated triglyceride level (2)|1|||
94442139|NCT00654095|323405610|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
94442140|NCT00654095|323405610|FG000|Overall Study|Adverse Event|11|||
94442141|NCT00654095|323405610|FG000|Overall Study|Withdrawal by Subject|5|||
94442142|NCT00654095|323405610|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
94442143|NCT00654095|323405610|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
94442144|NCT00654095|323405610|FG000|Overall Study|Did not meet inclusion criteria|1|||
94340715|NCT02371980|323028851|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
94442145|NCT00758524|323405611|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
94442146|NCT00758524|323405612|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
94442147|NCT00758524|323405613|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
94442148|NCT00758524|323405614|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
94442149|NCT00758524|323405615|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
94442150|NCT00758524|323405616|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
94442151|NCT00758524|323405617|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
94442152|NCT00758524|323405618|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
94340716|NCT02371980|323028852|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
94340717|NCT02371980|323028853|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
94340718|NCT02371980|323028854|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
94340719|NCT02371980|323028850|FG000|Open-label Period|Reason not Specified|9|||
94340720|NCT02371980|323028851|FG001|Open-label Period|Reason not Specified|0|||
94340721|NCT02371980|323028852|FG002|Open-label Period|Reason not Specified|0|||
94340722|NCT02371980|323028853|FG003|Open-label Period|Reason not Specified|0|||
94340723|NCT02371980|323028854|FG004|Open-label Period|Reason not Specified|0|||
94340724|NCT02371980|323028850|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
94442153|NCT00758524|323405619|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
94442154|NCT00758524|323405620|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
94442155|NCT00758524|323405621|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
94442156|NCT00758524|323405622|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
94442157|NCT00758524|323405623|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
94442158|NCT00758524|323405624|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
94340725|NCT02371980|323028851|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
94340726|NCT02371980|323028852|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
94340727|NCT02371980|323028853|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
94340728|NCT02371980|323028854|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
94340729|NCT02371980|323028850|FG000|Double-blind Period|Significant Protocol Deviation|0|||
94340730|NCT02371980|323028851|FG001|Double-blind Period|Significant Protocol Deviation|2|||
94340731|NCT02371980|323028852|FG002|Double-blind Period|Significant Protocol Deviation|7|||
94340732|NCT02371980|323028853|FG003|Double-blind Period|Significant Protocol Deviation|3|||
94340733|NCT02371980|323028854|FG004|Double-blind Period|Significant Protocol Deviation|3|||
94340734|NCT02371980|323028850|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
94340735|NCT02371980|323028851|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
94340736|NCT02371980|323028852|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
94340737|NCT02371980|323028853|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
94340738|NCT02371980|323028854|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
94340739|NCT02371980|323028850|FG000|Double-blind Period|Lost to Follow-up|0|||
94340740|NCT02371980|323028851|FG001|Double-blind Period|Lost to Follow-up|8|||
94340741|NCT02371980|323028852|FG002|Double-blind Period|Lost to Follow-up|8|||
94340742|NCT02371980|323028853|FG003|Double-blind Period|Lost to Follow-up|6|||
94340743|NCT02371980|323028854|FG004|Double-blind Period|Lost to Follow-up|5|||
94340744|NCT02371980|323028850|FG000|Double-blind Period|Voluntary Withdrawal|0|||
94340745|NCT02371980|323028851|FG001|Double-blind Period|Voluntary Withdrawal|12|||
94340746|NCT02371980|323028852|FG002|Double-blind Period|Voluntary Withdrawal|8|||
94340747|NCT02371980|323028853|FG003|Double-blind Period|Voluntary Withdrawal|9|||
94340748|NCT02371980|323028854|FG004|Double-blind Period|Voluntary Withdrawal|11|||
94340749|NCT02371980|323028850|FG000|Double-blind Period|Relapse|0|||
94340750|NCT02371980|323028851|FG001|Double-blind Period|Relapse|50|||
94340751|NCT02371980|323028852|FG002|Double-blind Period|Relapse|25|||
94340752|NCT02371980|323028853|FG003|Double-blind Period|Relapse|25|||
94340753|NCT02371980|323028854|FG004|Double-blind Period|Relapse|26|||
94340754|NCT02371980|323028850|FG000|Double-blind Period|Reason not Specified|0|||
94340755|NCT02371980|323028851|FG001|Double-blind Period|Reason not Specified|3|||
94340756|NCT02371980|323028852|FG002|Double-blind Period|Reason not Specified|3|||
94340757|NCT02371980|323028853|FG003|Double-blind Period|Reason not Specified|2|||
94340758|NCT02371980|323028854|FG004|Double-blind Period|Reason not Specified|1|||
94340759|NCT02371980|323028850|FG000|Double-blind Period|Missing|0|||
94340760|NCT02371980|323028851|FG001|Double-blind Period|Missing|1|||
94340761|NCT02371980|323028852|FG002|Double-blind Period|Missing|0|||
94340762|NCT02371980|323028853|FG003|Double-blind Period|Missing|0|||
94340763|NCT02371980|323028854|FG004|Double-blind Period|Missing|0|||
94340764|NCT00777257|323028855|FG000|Overall Study|Adverse Event|3|||
94340765|NCT00777257|323028856|FG001|Overall Study|Adverse Event|1|||
94340766|NCT00777257|323028857|FG002|Overall Study|Adverse Event|0|||
94340767|NCT00777257|323028855|FG000|Overall Study|Lost to Follow-up|3|||
94340768|NCT00777257|323028856|FG001|Overall Study|Lost to Follow-up|3|||
94340769|NCT00777257|323028857|FG002|Overall Study|Lost to Follow-up|2|||
94340770|NCT00777257|323028855|FG000|Overall Study|Protocol Violation|2|||
94340771|NCT00777257|323028856|FG001|Overall Study|Protocol Violation|2|||
94340772|NCT00777257|323028857|FG002|Overall Study|Protocol Violation|2|||
94340773|NCT00777257|323028855|FG000|Overall Study|Withdrawal by Subject|3|||
94340774|NCT00777257|323028856|FG001|Overall Study|Withdrawal by Subject|6|||
94340775|NCT00777257|323028857|FG002|Overall Study|Withdrawal by Subject|5|||
94340776|NCT01199198|323028858|FG000|Overall Study|Adverse Event|3|||
94340777|NCT01199198|323028859|FG001|Overall Study|Adverse Event|0|||
94340778|NCT01199198|323028858|FG000|Overall Study|Lost to Follow-up|1|||
94340779|NCT01199198|323028859|FG001|Overall Study|Lost to Follow-up|5|||
94340780|NCT01199198|323028858|FG000|Overall Study|Withdrawal by Subject|1|||
94340781|NCT01199198|323028859|FG001|Overall Study|Withdrawal by Subject|2|||
94340782|NCT01199198|323028858|FG000|Overall Study|ICU Transfer|1|||
94340783|NCT01199198|323028859|FG001|Overall Study|ICU Transfer|2|||
94340784|NCT01199198|323028858|FG000|Overall Study|Hospice-care transfer|1|||
94340785|NCT01199198|323028859|FG001|Overall Study|Hospice-care transfer|2|||
94340786|NCT04315298|323028860|FG000|Overall Study|Withdrawal by Subject|0|||
94340787|NCT04315298|323028861|FG001|Overall Study|Withdrawal by Subject|0|||
94549483|NCT01659255|323807365|FG016|Overall Study|Sponsor's Decision|0|||
94549484|NCT01659255|323807349|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
94549485|NCT01659255|323807350|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
94340788|NCT04315298|323028862|FG002|Overall Study|Withdrawal by Subject|0|||
94340789|NCT04315298|323028863|FG003|Overall Study|Withdrawal by Subject|2|||
94340790|NCT04315298|323028864|FG004|Overall Study|Withdrawal by Subject|2|||
94340791|NCT04315298|323028865|FG005|Overall Study|Withdrawal by Subject|2|||
94340792|NCT04315298|323028866|FG006|Overall Study|Withdrawal by Subject|0|||
94340793|NCT04315298|323028867|FG007|Overall Study|Withdrawal by Subject|1|||
94340794|NCT04315298|323028868|FG008|Overall Study|Withdrawal by Subject|1|||
94340795|NCT04315298|323028869|FG009|Overall Study|Withdrawal by Subject|1|||
94340796|NCT04315298|323028870|FG010|Overall Study|Withdrawal by Subject|0|||
94340797|NCT04315298|323028871|FG011|Overall Study|Withdrawal by Subject|0|||
94442159|NCT00758524|323405625|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
94442160|NCT00758524|323405626|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
94442161|NCT00758524|323405627|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
94442162|NCT00758524|323405611|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
94442163|NCT00758524|323405612|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
94442164|NCT00758524|323405613|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
94442165|NCT00758524|323405614|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
94442166|NCT00758524|323405615|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
94442167|NCT00758524|323405616|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
94442168|NCT00758524|323405617|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
94442169|NCT00758524|323405618|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
94442170|NCT00758524|323405619|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
94442171|NCT00758524|323405620|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
94442172|NCT00758524|323405621|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
94442173|NCT00758524|323405622|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
94442174|NCT00758524|323405623|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
94442175|NCT00758524|323405624|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
94442176|NCT00758524|323405625|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
94442177|NCT00758524|323405626|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
94442178|NCT00758524|323405627|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
94442179|NCT00758524|323405611|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
94442180|NCT00758524|323405612|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
94442181|NCT00758524|323405613|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
94442182|NCT00758524|323405614|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
94442183|NCT00758524|323405615|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
94442184|NCT00758524|323405616|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
94442185|NCT00758524|323405617|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
94442186|NCT00758524|323405618|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
94442187|NCT00758524|323405619|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
94442188|NCT00758524|323405620|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
94442189|NCT00758524|323405621|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
94442190|NCT00758524|323405622|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
94442191|NCT00758524|323405623|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
94442192|NCT00758524|323405624|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
94442193|NCT00758524|323405625|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
94442194|NCT00758524|323405626|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
94442195|NCT00758524|323405627|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
94442196|NCT00758524|323405611|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
94340798|NCT04315298|323028872|FG012|Overall Study|Withdrawal by Subject|0|||
94340799|NCT04315298|323028873|FG013|Overall Study|Withdrawal by Subject|0|||
94340800|NCT04315298|323028874|FG014|Overall Study|Withdrawal by Subject|0|||
94340801|NCT04315298|323028875|FG015|Overall Study|Withdrawal by Subject|0|||
94340802|NCT04315298|323028876|FG016|Overall Study|Withdrawal by Subject|0|||
94340803|NCT04315298|323028877|FG017|Overall Study|Withdrawal by Subject|0|||
94340804|NCT04315298|323028878|FG018|Overall Study|Withdrawal by Subject|0|||
94340805|NCT04315298|323028860|FG000|Overall Study|Physician Decision|0|||
94340806|NCT04315298|323028861|FG001|Overall Study|Physician Decision|0|||
94340807|NCT04315298|323028862|FG002|Overall Study|Physician Decision|0|||
94340808|NCT04315298|323028863|FG003|Overall Study|Physician Decision|0|||
94340809|NCT04315298|323028864|FG004|Overall Study|Physician Decision|1|||
94442197|NCT00758524|323405612|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
94442198|NCT00758524|323405613|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
94442199|NCT00758524|323405614|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
94442200|NCT00758524|323405615|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
94442201|NCT00758524|323405616|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
94442202|NCT00758524|323405617|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
94442203|NCT00758524|323405618|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
94442204|NCT00758524|323405619|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
94442205|NCT00758524|323405620|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
94442206|NCT00758524|323405621|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
94442207|NCT00758524|323405622|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
94442208|NCT00758524|323405623|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
94442209|NCT00758524|323405624|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
94442210|NCT00758524|323405625|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
94442211|NCT00758524|323405626|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
94442212|NCT00758524|323405627|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
94442213|NCT00758524|323405611|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
94442214|NCT00758524|323405612|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
94340810|NCT04315298|323028865|FG005|Overall Study|Physician Decision|0|||
94340811|NCT04315298|323028866|FG006|Overall Study|Physician Decision|0|||
94442215|NCT00758524|323405613|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
94442216|NCT00758524|323405614|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
94442217|NCT00758524|323405615|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
94442218|NCT00758524|323405616|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
94442219|NCT00758524|323405617|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
94442220|NCT00758524|323405618|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
94442221|NCT00758524|323405619|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
94442222|NCT00758524|323405620|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
94442223|NCT00758524|323405621|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
94442224|NCT00758524|323405622|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
94442225|NCT00758524|323405623|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
94442226|NCT00758524|323405624|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
94442227|NCT00758524|323405625|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
94442228|NCT00758524|323405626|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
94442229|NCT00758524|323405627|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
94442230|NCT00758524|323405611|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
94442231|NCT00758524|323405612|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
94442232|NCT00758524|323405613|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
94442233|NCT00758524|323405614|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
94442234|NCT00758524|323405615|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
94442235|NCT00758524|323405616|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
94442236|NCT00758524|323405617|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
94442237|NCT00758524|323405618|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
94442238|NCT00758524|323405619|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
94442239|NCT00758524|323405620|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
94442240|NCT00758524|323405621|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
94442241|NCT00758524|323405622|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
94442242|NCT00758524|323405623|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
94442243|NCT00758524|323405624|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
94442244|NCT00758524|323405625|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
94442245|NCT00758524|323405626|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
94442246|NCT00758524|323405627|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
94442247|NCT00758524|323405611|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
94442248|NCT00758524|323405612|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
94442249|NCT00758524|323405613|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
94442250|NCT00758524|323405614|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
94442251|NCT00758524|323405615|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
94442252|NCT00758524|323405616|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
94442253|NCT00758524|323405617|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
94442254|NCT00758524|323405618|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
94442255|NCT00758524|323405619|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
94442256|NCT00758524|323405620|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
94442257|NCT00758524|323405621|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
94442258|NCT00758524|323405622|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
94442259|NCT00758524|323405623|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
94442260|NCT00758524|323405624|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
94442261|NCT00758524|323405625|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
94442262|NCT00758524|323405626|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
94442263|NCT00758524|323405627|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
94442264|NCT00758524|323405611|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
94549486|NCT01659255|323807351|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
94549487|NCT01659255|323807352|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
94549488|NCT01659255|323807353|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
94549489|NCT01659255|323807354|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
94549490|NCT01659255|323807355|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
94549491|NCT01659255|323807356|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
94549492|NCT01659255|323807357|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
94549493|NCT01659255|323807358|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
94549494|NCT01659255|323807359|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
94549495|NCT01659255|323807360|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
94549496|NCT01659255|323807361|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
94549497|NCT01659255|323807362|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
94549498|NCT01659255|323807363|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
94651333|NCT02460224|324179743|FG028|Overall Study|Progressive disease|77|||
94442265|NCT00758524|323405612|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
94442266|NCT00758524|323405613|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
94442267|NCT00758524|323405614|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
94442268|NCT00758524|323405615|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
94442269|NCT00758524|323405616|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
94442270|NCT00758524|323405617|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
94442271|NCT00758524|323405618|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
94442272|NCT00758524|323405619|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
94442273|NCT00758524|323405620|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
94442274|NCT00758524|323405621|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
94442275|NCT00758524|323405622|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
94442276|NCT00758524|323405623|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
94442277|NCT00758524|323405624|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
94442278|NCT00758524|323405625|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
94442279|NCT00758524|323405626|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
94442280|NCT00758524|323405627|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
94442281|NCT00758524|323405611|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
94442282|NCT00758524|323405612|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
94442283|NCT00758524|323405613|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
94442284|NCT00758524|323405614|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
94442285|NCT00758524|323405615|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
94442286|NCT00758524|323405616|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
94442287|NCT00758524|323405617|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
94442288|NCT00758524|323405618|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
94442289|NCT00758524|323405619|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
94442290|NCT00758524|323405620|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
94442291|NCT00758524|323405621|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
94442292|NCT00758524|323405622|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
94442293|NCT00758524|323405623|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
94442294|NCT00758524|323405624|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
94442295|NCT00758524|323405625|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
94442296|NCT00758524|323405626|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
94442297|NCT00758524|323405627|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
94442298|NCT00758524|323405611|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
94442299|NCT00758524|323405612|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
94442300|NCT00758524|323405613|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
94442301|NCT00758524|323405614|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
94442302|NCT00758524|323405615|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
94442303|NCT00758524|323405616|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
94442304|NCT00758524|323405617|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
94442305|NCT00758524|323405618|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
94442306|NCT00758524|323405619|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
94442307|NCT00758524|323405620|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
94442308|NCT00758524|323405621|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
94442309|NCT00758524|323405622|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
94442310|NCT00758524|323405623|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
94442311|NCT00758524|323405624|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
94442312|NCT00758524|323405625|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
94442313|NCT00758524|323405626|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
94442314|NCT00758524|323405627|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
94442315|NCT02502149|323405628|FG000|Intermediate|Discontinued prematurely|1|||
94442316|NCT02502149|323405629|FG001|Intermediate|Discontinued prematurely|0|||
94442317|NCT02502149|323405630|FG002|Intermediate|Discontinued prematurely|0|||
94442318|NCT02502149|323405631|FG003|Intermediate|Discontinued prematurely|0|||
94442319|NCT02502149|323405632|FG004|Intermediate|Discontinued prematurely|0|||
94442320|NCT02548832|323405633|FG000|Overall Study|Lost to Follow-up|2|||
94442321|NCT02548832|323405634|FG001|Overall Study|Lost to Follow-up|2|||
94442322|NCT02548832|323405635|FG002|Overall Study|Lost to Follow-up|2|||
94442323|NCT04747470|323405636|FG000|Overall Study|Death|0|||
94442324|NCT04747470|323405637|FG001|Overall Study|Death|3|||
94442325|NCT04747470|323405638|FG002|Overall Study|Death|2|||
94442326|NCT04747470|323405639|FG003|Overall Study|Death|2|||
94549499|NCT01659255|323807364|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
94549500|NCT01659255|323807365|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
94442327|NCT04747470|323405640|FG004|Overall Study|Death|2|||
94442328|NCT04747470|323405641|FG005|Overall Study|Death|0|||
94442329|NCT04747470|323405642|FG006|Overall Study|Death|0|||
94442330|NCT04747470|323405643|FG007|Overall Study|Death|0|||
94442331|NCT04747470|323405644|FG008|Overall Study|Death|0|||
94442332|NCT04747470|323405645|FG009|Overall Study|Death|0|||
94442333|NCT04747470|323405646|FG010|Overall Study|Death|0|||
94442334|NCT04747470|323405636|FG000|Overall Study|Withdrew Consent|0|||
94442335|NCT04747470|323405637|FG001|Overall Study|Withdrew Consent|0|||
94442336|NCT04747470|323405638|FG002|Overall Study|Withdrew Consent|0|||
94442337|NCT04747470|323405639|FG003|Overall Study|Withdrew Consent|1|||
94442338|NCT04747470|323405640|FG004|Overall Study|Withdrew Consent|0|||
94442339|NCT04747470|323405641|FG005|Overall Study|Withdrew Consent|0|||
94442340|NCT04747470|323405642|FG006|Overall Study|Withdrew Consent|0|||
94442341|NCT04747470|323405643|FG007|Overall Study|Withdrew Consent|0|||
94442342|NCT04747470|323405644|FG008|Overall Study|Withdrew Consent|0|||
94442343|NCT04747470|323405645|FG009|Overall Study|Withdrew Consent|0|||
94442344|NCT04747470|323405646|FG010|Overall Study|Withdrew Consent|0|||
94442345|NCT04747470|323405636|FG000|Overall Study|Study Terminated by Sponsor|0|||
94442346|NCT04747470|323405637|FG001|Overall Study|Study Terminated by Sponsor|0|||
94442347|NCT04747470|323405638|FG002|Overall Study|Study Terminated by Sponsor|1|||
94442348|NCT04747470|323405639|FG003|Overall Study|Study Terminated by Sponsor|0|||
94442349|NCT04747470|323405640|FG004|Overall Study|Study Terminated by Sponsor|2|||
94442350|NCT04747470|323405641|FG005|Overall Study|Study Terminated by Sponsor|0|||
94442351|NCT04747470|323405642|FG006|Overall Study|Study Terminated by Sponsor|0|||
94442352|NCT04747470|323405643|FG007|Overall Study|Study Terminated by Sponsor|0|||
94442353|NCT04747470|323405644|FG008|Overall Study|Study Terminated by Sponsor|0|||
94442354|NCT04747470|323405645|FG009|Overall Study|Study Terminated by Sponsor|0|||
94442355|NCT04747470|323405646|FG010|Overall Study|Study Terminated by Sponsor|0|||
94442356|NCT03565900|323405647|FG000|Overall Study|Disposition Unknown|4|||
94442357|NCT03565900|323405648|FG001|Overall Study|Disposition Unknown|1|||
94442358|NCT03565900|323405647|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
94442359|NCT03565900|323405648|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
94442360|NCT03565900|323405647|FG000|Overall Study|Withdrawal by Subject|4|||
94442361|NCT03565900|323405648|FG001|Overall Study|Withdrawal by Subject|5|||
94442362|NCT03565900|323405647|FG000|Overall Study|Randomized By Mistake|0|||
94442363|NCT03565900|323405648|FG001|Overall Study|Randomized By Mistake|2|||
94442364|NCT03565900|323405647|FG000|Overall Study|Physician Decision|7|||
94442365|NCT03565900|323405648|FG001|Overall Study|Physician Decision|11|||
94442366|NCT03565900|323405647|FG000|Overall Study|Death|9|||
94442367|NCT03565900|323405648|FG001|Overall Study|Death|7|||
94442368|NCT02058069|323405649|FG000|Overall Study|Exclusion due to implant size|5|||
94442369|NCT02058069|323405649|FG000|Overall Study|Withdrawal by Subject|6|||
94442370|NCT02002221|323405653|FG000|Overall Study|Adverse Event|2|||
94442371|NCT02002221|323405654|FG001|Overall Study|Adverse Event|1|||
94442372|NCT02002221|323405653|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94442373|NCT02002221|323405654|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
94442374|NCT02002221|323405653|FG000|Overall Study|Patient withdrew consent|0|||
94442375|NCT02002221|323405654|FG001|Overall Study|Patient withdrew consent|1|||
94549501|NCT01659255|323807349|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
94549502|NCT01659255|323807350|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
94549503|NCT01659255|323807351|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
94549504|NCT01659255|323807352|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
94549505|NCT01659255|323807353|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
94549506|NCT01659255|323807354|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
94549507|NCT01659255|323807355|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
94549508|NCT01659255|323807356|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
94549509|NCT01659255|323807357|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
94549510|NCT01659255|323807358|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
94549511|NCT01659255|323807359|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
94549512|NCT01659255|323807360|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
94549513|NCT01659255|323807361|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
94549514|NCT01659255|323807362|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
94442376|NCT02676882|323405655|FG000|Overall Study|Adverse Event|1|||
94442377|NCT02676882|323405656|FG001|Overall Study|Adverse Event|0|||
94442378|NCT02676882|323405655|FG000|Overall Study|Lost to Follow-up|1|||
94549515|NCT01659255|323807363|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
94442379|NCT02676882|323405656|FG001|Overall Study|Lost to Follow-up|0|||
94442380|NCT02676882|323405655|FG000|Overall Study|Withdrawal by Subject|1|||
94442381|NCT02676882|323405656|FG001|Overall Study|Withdrawal by Subject|2|||
94442382|NCT02568072|323405660|FG000|Overall Study|Unavailable for appointment|23|||
94442383|NCT02568072|323405660|FG000|Overall Study|Unable to contact|3|||
94442384|NCT02568072|323405660|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
94549516|NCT01659255|323807364|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
94442385|NCT02568072|323405660|FG000|Overall Study|Withdrawal by Subject|1|||
94442386|NCT02568072|323405660|FG000|Overall Study|Sustained injury, marathon not run|24|||
94442387|NCT00958828|323405662|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
94442388|NCT00958828|323405663|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
94442389|NCT00958828|323405662|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
94442390|NCT00958828|323405663|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
94442391|NCT01958437|323405664|FG000|Overall Study|Incidental MRI findings|0|||
94442392|NCT01958437|323405665|FG001|Overall Study|Incidental MRI findings|0|||
94442393|NCT01958437|323405666|FG002|Overall Study|Incidental MRI findings|1|||
94442394|NCT01958437|323405667|FG003|Overall Study|Incidental MRI findings|1|||
94442395|NCT02394600|323405670|FG000|Overall Study|Adverse Event|3|||
94442396|NCT02394600|323405671|FG001|Overall Study|Adverse Event|0|||
94442397|NCT02394600|323405670|FG000|Overall Study|Lost to Follow-up|0|||
94442398|NCT02394600|323405671|FG001|Overall Study|Lost to Follow-up|1|||
94442399|NCT02394600|323405670|FG000|Overall Study|Withdrawal by Subject|0|||
94442400|NCT02394600|323405671|FG001|Overall Study|Withdrawal by Subject|1|||
94442401|NCT02394600|323405670|FG000|Overall Study|Protocol Violation|1|||
94442402|NCT02394600|323405671|FG001|Overall Study|Protocol Violation|0|||
94442403|NCT03534687|323405672|FG000|Overall Study|Lost to Follow-up|7|||
94442404|NCT03534687|323405673|FG001|Overall Study|Lost to Follow-up|2|||
94442405|NCT01836471|323405680|FG000|Overall Study|Pregnancy|1|||
94442406|NCT01836471|323405681|FG001|Overall Study|Pregnancy|0|||
94442407|NCT01836471|323405682|FG002|Overall Study|Pregnancy|0|||
94442408|NCT01836471|323405683|FG003|Overall Study|Pregnancy|0|||
94442409|NCT01836471|323405684|FG004|Overall Study|Pregnancy|0|||
94442410|NCT01836471|323405680|FG000|Overall Study|Withdrawal by Subject|3|||
94442411|NCT01836471|323405681|FG001|Overall Study|Withdrawal by Subject|4|||
94442412|NCT01836471|323405682|FG002|Overall Study|Withdrawal by Subject|1|||
94442413|NCT01836471|323405683|FG003|Overall Study|Withdrawal by Subject|0|||
94442414|NCT01836471|323405684|FG004|Overall Study|Withdrawal by Subject|2|||
94442415|NCT01836471|323405680|FG000|Overall Study|Physician Decision|0|||
94549517|NCT01659255|323807365|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
94549518|NCT01287195|323807368|FG000|Overall Study|Withdrawal by Subject|2|||
94549519|NCT01267175|323807369|FG000|Overall Study|Withdrawal by Subject|1|||
94549520|NCT01267175|323807369|FG000|Overall Study|Lost to Follow-up|1|||
94549521|NCT00548717|323807373|FG000|Overall Study|Death|5|||
94549522|NCT00548717|323807374|FG001|Overall Study|Death|2|||
94549523|NCT00548717|323807373|FG000|Overall Study|Relapse|3|||
94549524|NCT00548717|323807374|FG001|Overall Study|Relapse|0|||
94549525|NCT00548717|323807373|FG000|Overall Study|Alternative treatment for GVHD|1|||
94549526|NCT00548717|323807374|FG001|Overall Study|Alternative treatment for GVHD|0|||
94549527|NCT00847015|323807383|FG000|Overall Study|Withdrawal by Subject|1|||
94549528|NCT00847015|323807383|FG000|Overall Study|declined any surgery|1|||
94549529|NCT00847015|323807383|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
94549530|NCT02049138|323807388|FG000|Overall Study|Adverse Event|46|||
94549531|NCT02049138|323807389|FG001|Overall Study|Adverse Event|25|||
94549532|NCT02049138|323807390|FG002|Overall Study|Adverse Event|1|||
94549533|NCT02049138|323807388|FG000|Overall Study|Withdrawal by Subject|57|||
94549534|NCT02049138|323807389|FG001|Overall Study|Withdrawal by Subject|21|||
94549535|NCT02049138|323807390|FG002|Overall Study|Withdrawal by Subject|5|||
94549536|NCT02049138|323807388|FG000|Overall Study|Lost to Follow-up|18|||
94549537|NCT02049138|323807389|FG001|Overall Study|Lost to Follow-up|5|||
94549538|NCT02049138|323807390|FG002|Overall Study|Lost to Follow-up|1|||
94549539|NCT02049138|323807388|FG000|Overall Study|Lack of Efficacy|10|||
94549540|NCT02049138|323807389|FG001|Overall Study|Lack of Efficacy|26|||
94549541|NCT02049138|323807390|FG002|Overall Study|Lack of Efficacy|1|||
94549542|NCT02049138|323807388|FG000|Overall Study|Non-Compliance|15|||
94549543|NCT02049138|323807389|FG001|Overall Study|Non-Compliance|6|||
94549544|NCT02049138|323807390|FG002|Overall Study|Non-Compliance|0|||
94549545|NCT02049138|323807388|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
94549546|NCT02049138|323807389|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
94549547|NCT02049138|323807390|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
94549548|NCT02049138|323807388|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
94549549|NCT02049138|323807389|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
94549550|NCT02049138|323807390|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
94549551|NCT02049138|323807388|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
94549552|NCT02049138|323807389|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
94549553|NCT02049138|323807390|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
94442416|NCT01836471|323405681|FG001|Overall Study|Physician Decision|1|||
94442417|NCT01836471|323405682|FG002|Overall Study|Physician Decision|0|||
94442418|NCT01836471|323405683|FG003|Overall Study|Physician Decision|0|||
94442419|NCT01836471|323405684|FG004|Overall Study|Physician Decision|0|||
94442420|NCT01836471|323405680|FG000|Overall Study|Lost to Follow-up|0|||
94549554|NCT02049138|323807388|FG000|Overall Study|Other|15|||
94549555|NCT02049138|323807389|FG001|Overall Study|Other|13|||
94549556|NCT02049138|323807390|FG002|Overall Study|Other|0|||
94549557|NCT02049138|323807388|FG000|Overall Study|Missing|0|||
94549558|NCT02049138|323807389|FG001|Overall Study|Missing|1|||
94549559|NCT02049138|323807390|FG002|Overall Study|Missing|0|||
94442421|NCT01836471|323405681|FG001|Overall Study|Lost to Follow-up|0|||
94549560|NCT00552760|323807391|FG000|Overall Study|Adverse Event|3|||
94549561|NCT00552760|323807392|FG001|Overall Study|Adverse Event|5|||
94549562|NCT00552760|323807391|FG000|Overall Study|Relapsed- Depressed Event|10|||
94549563|NCT00552760|323807392|FG001|Overall Study|Relapsed- Depressed Event|16|||
94549564|NCT00552760|323807391|FG000|Overall Study|Relapse- Manic Event|3|||
94549565|NCT00552760|323807392|FG001|Overall Study|Relapse- Manic Event|3|||
94549566|NCT00552760|323807391|FG000|Overall Study|Relapsed- Mixed Event|3|||
94549567|NCT00552760|323807392|FG001|Overall Study|Relapsed- Mixed Event|5|||
94549568|NCT00552760|323807391|FG000|Overall Study|Protocol Violation|0|||
94549569|NCT00552760|323807392|FG001|Overall Study|Protocol Violation|1|||
94549570|NCT00552760|323807391|FG000|Overall Study|Lost to Follow-up|1|||
94549571|NCT00552760|323807392|FG001|Overall Study|Lost to Follow-up|1|||
94549572|NCT00552760|323807391|FG000|Overall Study|Non-compliance|1|||
94549573|NCT00552760|323807392|FG001|Overall Study|Non-compliance|1|||
94549574|NCT00552760|323807391|FG000|Overall Study|Medical Condition|1|||
94549575|NCT00552760|323807392|FG001|Overall Study|Medical Condition|1|||
94549576|NCT00552760|323807391|FG000|Overall Study|Withdrawal by Subject|3|||
94549577|NCT00552760|323807392|FG001|Overall Study|Withdrawal by Subject|0|||
94549578|NCT00552760|323807391|FG000|Overall Study|Medication Change|1|||
94549579|NCT00552760|323807392|FG001|Overall Study|Medication Change|0|||
94549580|NCT00444067|323807395|FG000|Overall Study|Lost to Follow-up|0|||
94549581|NCT00444067|323807396|FG001|Overall Study|Lost to Follow-up|1|||
94549582|NCT00710385|323807397|FG000|Overall Study|Did not qualify|1|||
94549583|NCT00710385|323807397|FG000|Overall Study|Withdrawal by Subject|1|||
94549584|NCT00710385|323807397|FG000|Overall Study|Undisclosed back pain|1|||
94549585|NCT00710385|323807397|FG000|Overall Study|Physician Decision|1|||
94549586|NCT00710385|323807397|FG000|Overall Study|Undisclosed excessive methadone use|1|||
94549587|NCT01985360|323807398|FG000|Overall Study|Withdrawal by Subject|4|||
94549588|NCT01985360|323807399|FG001|Overall Study|Withdrawal by Subject|0|||
94340812|NCT04315298|323028867|FG007|Overall Study|Physician Decision|0|||
94340813|NCT04315298|323028868|FG008|Overall Study|Physician Decision|0|||
94340814|NCT04315298|323028869|FG009|Overall Study|Physician Decision|0|||
94340815|NCT04315298|323028870|FG010|Overall Study|Physician Decision|0|||
94340816|NCT04315298|323028871|FG011|Overall Study|Physician Decision|0|||
94340817|NCT04315298|323028872|FG012|Overall Study|Physician Decision|0|||
94340818|NCT04315298|323028873|FG013|Overall Study|Physician Decision|0|||
94340819|NCT04315298|323028874|FG014|Overall Study|Physician Decision|0|||
94340820|NCT04315298|323028875|FG015|Overall Study|Physician Decision|0|||
94340821|NCT04315298|323028876|FG016|Overall Study|Physician Decision|0|||
94340822|NCT04315298|323028877|FG017|Overall Study|Physician Decision|0|||
94340823|NCT04315298|323028878|FG018|Overall Study|Physician Decision|0|||
94340824|NCT04315298|323028860|FG000|Overall Study|Lost to Follow-up|5|||
94340825|NCT04315298|323028861|FG001|Overall Study|Lost to Follow-up|10|||
94340826|NCT04315298|323028862|FG002|Overall Study|Lost to Follow-up|6|||
94340827|NCT04315298|323028863|FG003|Overall Study|Lost to Follow-up|8|||
94340828|NCT04315298|323028864|FG004|Overall Study|Lost to Follow-up|12|||
94340829|NCT04315298|323028865|FG005|Overall Study|Lost to Follow-up|13|||
94340830|NCT04315298|323028866|FG006|Overall Study|Lost to Follow-up|9|||
94340831|NCT04315298|323028867|FG007|Overall Study|Lost to Follow-up|16|||
94340832|NCT04315298|323028868|FG008|Overall Study|Lost to Follow-up|14|||
94340833|NCT04315298|323028869|FG009|Overall Study|Lost to Follow-up|0|||
94340834|NCT04315298|323028870|FG010|Overall Study|Lost to Follow-up|2|||
94340835|NCT04315298|323028871|FG011|Overall Study|Lost to Follow-up|1|||
94340836|NCT04315298|323028872|FG012|Overall Study|Lost to Follow-up|0|||
94340837|NCT04315298|323028873|FG013|Overall Study|Lost to Follow-up|0|||
94340838|NCT04315298|323028874|FG014|Overall Study|Lost to Follow-up|0|||
94340839|NCT04315298|323028875|FG015|Overall Study|Lost to Follow-up|2|||
94340840|NCT04315298|323028876|FG016|Overall Study|Lost to Follow-up|0|||
94340841|NCT04315298|323028877|FG017|Overall Study|Lost to Follow-up|0|||
94340842|NCT04315298|323028878|FG018|Overall Study|Lost to Follow-up|0|||
94340843|NCT04315298|323028860|FG000|Overall Study|Death|24|||
94340844|NCT04315298|323028861|FG001|Overall Study|Death|60|||
94340845|NCT04315298|323028862|FG002|Overall Study|Death|49|||
94340846|NCT04315298|323028863|FG003|Overall Study|Death|59|||
94340847|NCT04315298|323028864|FG004|Overall Study|Death|70|||
94549589|NCT01985360|323807398|FG000|Overall Study|Lost to Follow-up|5|||
94549590|NCT01985360|323807399|FG001|Overall Study|Lost to Follow-up|3|||
94549591|NCT02976103|323807400|FG000|Overall Study|Withdrawal by Subject|1|||
94549592|NCT02976103|323807401|FG001|Overall Study|Withdrawal by Subject|0|||
94549593|NCT02976103|323807400|FG000|Overall Study|Lost to Follow-up|12|||
94549594|NCT02976103|323807401|FG001|Overall Study|Lost to Follow-up|8|||
94549595|NCT02438813|323807404|FG000|Overall Study|Patient Decision|59|||
94340848|NCT04315298|323028865|FG005|Overall Study|Death|114|||
94340849|NCT04315298|323028866|FG006|Overall Study|Death|9|||
94340850|NCT04315298|323028867|FG007|Overall Study|Death|12|||
94549596|NCT02438813|323807404|FG000|Overall Study|Patient Lost to Follow-Up|137|||
94340851|NCT04315298|323028868|FG008|Overall Study|Death|21|||
94340852|NCT04315298|323028869|FG009|Overall Study|Death|16|||
94340853|NCT04315298|323028870|FG010|Overall Study|Death|40|||
94340854|NCT04315298|323028871|FG011|Overall Study|Death|40|||
94340855|NCT04315298|323028872|FG012|Overall Study|Death|3|||
94340856|NCT04315298|323028873|FG013|Overall Study|Death|4|||
94549597|NCT02438813|323807404|FG000|Overall Study|Study Ended by Sponsor|80|||
94549598|NCT02438813|323807404|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
94549599|NCT04881747|323807405|FG000|Period 2 Washout|Adverse Event|1|||
94549600|NCT04881747|323807406|FG001|Period 2 Washout|Adverse Event|0|||
94549601|NCT04881747|323807407|FG002|Period 2 Washout|Adverse Event|0|||
94549602|NCT04881747|323807408|FG003|Period 2 Washout|Adverse Event|0|||
94549603|NCT04881747|323807409|FG004|Period 2 Washout|Adverse Event|1|||
94549604|NCT04881747|323807410|FG005|Period 2 Washout|Adverse Event|0|||
94549605|NCT04881747|323807405|FG000|Period 2 Washout|Withdrawal by Subject|1|||
94549606|NCT04881747|323807406|FG001|Period 2 Washout|Withdrawal by Subject|0|||
94549607|NCT04881747|323807407|FG002|Period 2 Washout|Withdrawal by Subject|0|||
94549608|NCT04881747|323807408|FG003|Period 2 Washout|Withdrawal by Subject|1|||
94549609|NCT04881747|323807409|FG004|Period 2 Washout|Withdrawal by Subject|0|||
94549610|NCT04881747|323807410|FG005|Period 2 Washout|Withdrawal by Subject|0|||
94549611|NCT00424190|323807413|FG000|Overall Study|Withdrew consent|3|||
94549612|NCT00424190|323807414|FG001|Overall Study|Withdrew consent|4|||
94549613|NCT00424190|323807413|FG000|Overall Study|Death|3|||
94549614|NCT00424190|323807414|FG001|Overall Study|Death|0|||
94549615|NCT00424190|323807413|FG000|Overall Study|Noncompliance|1|||
94549616|NCT00424190|323807414|FG001|Overall Study|Noncompliance|2|||
94549617|NCT00424190|323807413|FG000|Overall Study|Request of sponsor or investigator|0|||
94549618|NCT00424190|323807414|FG001|Overall Study|Request of sponsor or investigator|2|||
94549619|NCT00424190|323807413|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
94549620|NCT00424190|323807414|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
94549621|NCT00424190|323807413|FG000|Overall Study|Other|15|||
94340857|NCT04315298|323028874|FG014|Overall Study|Death|6|||
94340858|NCT04315298|323028875|FG015|Overall Study|Death|4|||
94340859|NCT04315298|323028876|FG016|Overall Study|Death|3|||
94340860|NCT04315298|323028877|FG017|Overall Study|Death|1|||
94340861|NCT04315298|323028878|FG018|Overall Study|Death|0|||
94340862|NCT03050307|323028880|FG000|Overall Study|Adverse Event|4|||
94340863|NCT03050307|323028881|FG001|Overall Study|Adverse Event|2|||
94340864|NCT03050307|323028880|FG000|Overall Study|Significant Protocol Deviation|0|||
94340865|NCT03050307|323028881|FG001|Overall Study|Significant Protocol Deviation|1|||
94340866|NCT03050307|323028880|FG000|Overall Study|Lost to Follow-up|0|||
94340867|NCT03050307|323028881|FG001|Overall Study|Lost to Follow-up|1|||
94340868|NCT03050307|323028880|FG000|Overall Study|Voluntary Withdrawal|3|||
94340869|NCT03050307|323028881|FG001|Overall Study|Voluntary Withdrawal|4|||
94340870|NCT03050307|323028880|FG000|Overall Study|Reason not Specified|1|||
94340871|NCT03050307|323028881|FG001|Overall Study|Reason not Specified|1|||
94340872|NCT01305941|323028882|FG000|Overall Study|Adverse Event|6|||
94340873|NCT01305941|323028882|FG000|Overall Study|Clinical decline|2|||
94340874|NCT01305941|323028882|FG000|Overall Study|Withdrawal by Subject|1|||
94340875|NCT01305941|323028882|FG000|Overall Study|Death|1|||
94340876|NCT02892734|323028883|FG000|Treatment on Study|Progressive Disease|2|||
94340877|NCT02892734|323028883|FG000|Follow up for 2 Years|Death|2|||
94340878|NCT02892734|323028883|FG000|Follow up for 2 Years|Study closed early|1|||
94340879|NCT00688623|323028884|FG000|Overall Study|Adverse Event|22|||
94340880|NCT00688623|323028884|FG000|Overall Study|abnormal lab value|1|||
94340881|NCT00688623|323028884|FG000|Overall Study|Withdrawal by Subject|4|||
94340882|NCT00688623|323028884|FG000|Overall Study|Death|3|||
94340883|NCT00688623|323028884|FG000|Overall Study|disease progression|23|||
94340884|NCT00688623|323028884|FG000|Overall Study|Protocol Violation|2|||
94340885|NCT00088595|323028888|FG000|Overall Study|Adverse Event|11|||
94340886|NCT00088595|323028888|FG000|Overall Study|Withdrawal by Subject|8|||
94340887|NCT00088595|323028888|FG000|Overall Study|Ongoing (After Core)|7|||
94340888|NCT00088595|323028888|FG000|Overall Study|New Cancer Therapy|2|||
94340889|NCT05283499|323028893|FG000|Overall Study|Did not receive intervention|1|||
94340890|NCT05283499|323028894|FG001|Overall Study|Did not receive intervention|2|||
94340891|NCT02471586|323028897|FG000|Overall Study|Lost to Follow-up|3|||
94340892|NCT02471586|323028898|FG001|Overall Study|Lost to Follow-up|8|||
94340893|NCT02471586|323028899|FG002|Overall Study|Lost to Follow-up|4|||
94549622|NCT00424190|323807414|FG001|Overall Study|Other|21|||
94549623|NCT01378429|323807415|FG000|Overall Study|Noncompliance with study drug|1|||
94549624|NCT01378429|323807416|FG001|Overall Study|Noncompliance with study drug|0|||
94340894|NCT02471586|323028897|FG000|Overall Study|Death|2|||
94340895|NCT02471586|323028898|FG001|Overall Study|Death|2|||
94340896|NCT02471586|323028899|FG002|Overall Study|Death|0|||
94340897|NCT02436915|323028900|FG000|Overall Study|Withdrawal by Subject|0|||
94340898|NCT02436915|323028901|FG001|Overall Study|Withdrawal by Subject|1|||
94549625|NCT00845065|323807418|FG000|Overall Study|Adverse Event|3|||
94549626|NCT00845065|323807419|FG001|Overall Study|Adverse Event|23|||
94549627|NCT00845065|323807418|FG000|Overall Study|Lack of Efficacy|43|||
94549628|NCT00845065|323807419|FG001|Overall Study|Lack of Efficacy|21|||
94549629|NCT00845065|323807418|FG000|Overall Study|Non-Medical Reasons|1|||
94340899|NCT01117181|323028902|FG000|Overall Study|Lost to Follow-up|1|||
94340900|NCT01117181|323028903|FG001|Overall Study|Lost to Follow-up|0|||
94340901|NCT01117181|323028902|FG000|Overall Study|Withdrawal by Subject|0|||
94340902|NCT01117181|323028903|FG001|Overall Study|Withdrawal by Subject|2|||
94340903|NCT02158728|323028904|FG000|Overall Study|no procedure according to CIP done|3|||
94340904|NCT02158728|323028904|FG000|Overall Study|no qualified dataset|24|||
94340905|NCT01100658|323028908|FG000|Overall Study|Withdrawal by Subject|1|||
94340906|NCT01536418|323028930|FG000|Overall Study|Protocol Violation|2|||
94340907|NCT01536418|323028931|FG001|Overall Study|Protocol Violation|3|||
94340908|NCT01536418|323028930|FG000|Overall Study|Physician Decision|1|||
94340909|NCT01536418|323028931|FG001|Overall Study|Physician Decision|3|||
94340910|NCT01536418|323028930|FG000|Overall Study|Study closed/terminated|41|||
94340911|NCT01536418|323028931|FG001|Overall Study|Study closed/terminated|37|||
94340912|NCT01536418|323028930|FG000|Overall Study|Lack of Efficacy|10|||
94340913|NCT01536418|323028931|FG001|Overall Study|Lack of Efficacy|16|||
94340914|NCT01536418|323028930|FG000|Overall Study|Adverse Event|9|||
94340915|NCT01536418|323028931|FG001|Overall Study|Adverse Event|4|||
94340916|NCT01536418|323028930|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
94340917|NCT01536418|323028931|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
94340918|NCT01536418|323028930|FG000|Overall Study|Withdrawal by Subject|5|||
94340919|NCT01536418|323028931|FG001|Overall Study|Withdrawal by Subject|3|||
94340920|NCT00329784|323028944|FG000|Overall Study|Lost to Follow-up|0|||
94340921|NCT00329784|323028945|FG001|Overall Study|Lost to Follow-up|1|||
94340922|NCT00329784|323028946|FG002|Overall Study|Lost to Follow-up|0|||
94340923|NCT00329784|323028947|FG003|Overall Study|Lost to Follow-up|0|||
94340924|NCT00329784|323028944|FG000|Overall Study|Withdrawal by Subject|4|||
94340925|NCT00329784|323028945|FG001|Overall Study|Withdrawal by Subject|2|||
94340926|NCT00329784|323028946|FG002|Overall Study|Withdrawal by Subject|0|||
94340927|NCT00329784|323028947|FG003|Overall Study|Withdrawal by Subject|0|||
94340928|NCT00329784|323028944|FG000|Overall Study|Other|1|||
94340929|NCT00329784|323028945|FG001|Overall Study|Other|2|||
94340930|NCT00329784|323028946|FG002|Overall Study|Other|0|||
94340931|NCT00329784|323028947|FG003|Overall Study|Other|0|||
94340932|NCT01098032|323028948|FG000|Overall Study|Withdrawal by Subject|1|||
94340933|NCT01098032|323028949|FG001|Overall Study|Withdrawal by Subject|1|||
94340934|NCT02768103|323028950|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
94340935|NCT03039790|323028955|FG000|Overall Study|Lost to Follow-up|2|||
94340936|NCT03039790|323028956|FG001|Overall Study|Lost to Follow-up|0|||
94340937|NCT03039790|323028957|FG002|Overall Study|Lost to Follow-up|1|||
94340938|NCT03039790|323028958|FG003|Overall Study|Lost to Follow-up|1|||
94340939|NCT03039790|323028959|FG004|Overall Study|Lost to Follow-up|0|||
94340940|NCT03039790|323028960|FG005|Overall Study|Lost to Follow-up|1|||
94340941|NCT03039790|323028961|FG006|Overall Study|Lost to Follow-up|1|||
94340942|NCT03039790|323028962|FG007|Overall Study|Lost to Follow-up|1|||
94340943|NCT03039790|323028963|FG008|Overall Study|Lost to Follow-up|0|||
94340944|NCT03039790|323028964|FG009|Overall Study|Lost to Follow-up|1|||
94340945|NCT03039790|323028965|FG010|Overall Study|Lost to Follow-up|1|||
94340946|NCT03039790|323028966|FG011|Overall Study|Lost to Follow-up|0|||
94340947|NCT03039790|323028967|FG012|Overall Study|Lost to Follow-up|1|||
94340948|NCT03039790|323028968|FG013|Overall Study|Lost to Follow-up|0|||
94340949|NCT03039790|323028969|FG014|Overall Study|Lost to Follow-up|3|||
94340950|NCT03039790|323028970|FG015|Overall Study|Lost to Follow-up|1|||
94340951|NCT03039790|323028971|FG016|Overall Study|Lost to Follow-up|2|||
94340952|NCT03039790|323028972|FG017|Overall Study|Lost to Follow-up|2|||
94340953|NCT03039790|323028973|FG018|Overall Study|Lost to Follow-up|1|||
94340954|NCT03039790|323028974|FG019|Overall Study|Lost to Follow-up|3|||
94340955|NCT03039790|323028955|FG000|Overall Study|Withdrawal of Consent|1|||
94340956|NCT03039790|323028956|FG001|Overall Study|Withdrawal of Consent|0|||
94340957|NCT03039790|323028957|FG002|Overall Study|Withdrawal of Consent|0|||
94340958|NCT03039790|323028958|FG003|Overall Study|Withdrawal of Consent|1|||
94340959|NCT03039790|323028959|FG004|Overall Study|Withdrawal of Consent|0|||
94340960|NCT03039790|323028960|FG005|Overall Study|Withdrawal of Consent|0|||
94340961|NCT03039790|323028961|FG006|Overall Study|Withdrawal of Consent|0|||
94340962|NCT03039790|323028962|FG007|Overall Study|Withdrawal of Consent|0|||
94340963|NCT03039790|323028963|FG008|Overall Study|Withdrawal of Consent|0|||
94340964|NCT03039790|323028964|FG009|Overall Study|Withdrawal of Consent|1|||
94340965|NCT03039790|323028965|FG010|Overall Study|Withdrawal of Consent|0|||
94340966|NCT03039790|323028966|FG011|Overall Study|Withdrawal of Consent|0|||
94340967|NCT03039790|323028967|FG012|Overall Study|Withdrawal of Consent|2|||
94340968|NCT03039790|323028968|FG013|Overall Study|Withdrawal of Consent|0|||
94340969|NCT03039790|323028969|FG014|Overall Study|Withdrawal of Consent|1|||
94340970|NCT03039790|323028970|FG015|Overall Study|Withdrawal of Consent|5|||
94340971|NCT03039790|323028971|FG016|Overall Study|Withdrawal of Consent|3|||
94340972|NCT03039790|323028972|FG017|Overall Study|Withdrawal of Consent|0|||
94340973|NCT03039790|323028973|FG018|Overall Study|Withdrawal of Consent|2|||
94340974|NCT03039790|323028974|FG019|Overall Study|Withdrawal of Consent|5|||
94340975|NCT03039790|323028955|FG000|Overall Study|Death|0|||
94340976|NCT03039790|323028956|FG001|Overall Study|Death|0|||
94340977|NCT03039790|323028957|FG002|Overall Study|Death|0|||
94340978|NCT03039790|323028958|FG003|Overall Study|Death|0|||
94340979|NCT03039790|323028959|FG004|Overall Study|Death|0|||
94340980|NCT03039790|323028960|FG005|Overall Study|Death|0|||
94340981|NCT03039790|323028961|FG006|Overall Study|Death|0|||
94442422|NCT01836471|323405682|FG002|Overall Study|Lost to Follow-up|0|||
94442423|NCT01836471|323405683|FG003|Overall Study|Lost to Follow-up|1|||
94442424|NCT01836471|323405684|FG004|Overall Study|Lost to Follow-up|1|||
94442425|NCT01836471|323405680|FG000|Overall Study|Adverse Event|6|||
94442426|NCT01836471|323405681|FG001|Overall Study|Adverse Event|3|||
94442427|NCT01836471|323405682|FG002|Overall Study|Adverse Event|1|||
94442428|NCT01836471|323405683|FG003|Overall Study|Adverse Event|1|||
94442429|NCT01836471|323405684|FG004|Overall Study|Adverse Event|2|||
94442430|NCT01836471|323405680|FG000|Overall Study|Non compliance with tx|1|||
94442431|NCT01836471|323405681|FG001|Overall Study|Non compliance with tx|1|||
94442432|NCT01836471|323405682|FG002|Overall Study|Non compliance with tx|0|||
94442433|NCT01836471|323405683|FG003|Overall Study|Non compliance with tx|0|||
94442434|NCT01836471|323405684|FG004|Overall Study|Non compliance with tx|0|||
94442435|NCT03411863|323405687|FG000|Overall Study|Withdrawal by Subject|3|||
94442436|NCT03411863|323405688|FG001|Overall Study|Withdrawal by Subject|1|||
94442437|NCT03411863|323405687|FG000|Overall Study|Physician Decision|0|||
94442438|NCT03411863|323405688|FG001|Overall Study|Physician Decision|1|||
94442439|NCT02105987|323405691|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
94442440|NCT02105987|323405692|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
94442441|NCT02105987|323405693|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
94442442|NCT02105987|323405694|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
94442443|NCT02105987|323405695|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
94442444|NCT02105987|323405696|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
94442445|NCT02105987|323405691|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
94442446|NCT02105987|323405692|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
94442447|NCT02105987|323405693|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
94442448|NCT02105987|323405694|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
94442449|NCT02105987|323405695|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
94442450|NCT02105987|323405696|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
94442451|NCT02105987|323405691|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
94442452|NCT02105987|323405692|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
94442453|NCT02105987|323405693|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
94442454|NCT02105987|323405694|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
94442455|NCT02105987|323405695|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
94442456|NCT02105987|323405696|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
94442457|NCT02105987|323405691|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
94442458|NCT02105987|323405692|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
94442459|NCT02105987|323405693|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
94442460|NCT02105987|323405694|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
94442461|NCT02105987|323405695|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
94442462|NCT02105987|323405696|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
94442463|NCT02105987|323405691|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
94442464|NCT02105987|323405692|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
94442465|NCT02105987|323405693|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
94442466|NCT02105987|323405694|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
94442467|NCT02105987|323405695|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
94442468|NCT02105987|323405696|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
94442469|NCT02105987|323405691|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
94442470|NCT02105987|323405692|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
94442471|NCT02105987|323405693|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
94442472|NCT02105987|323405694|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
94442473|NCT02105987|323405695|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
94442474|NCT02105987|323405696|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
94442475|NCT02105987|323405691|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
94442476|NCT02105987|323405692|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
94442477|NCT02105987|323405693|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
94442478|NCT02105987|323405694|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
94442479|NCT02105987|323405695|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
94442480|NCT02105987|323405696|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
94442481|NCT02105987|323405691|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
94442482|NCT02105987|323405692|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
94442483|NCT02105987|323405693|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
94442484|NCT02105987|323405694|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
94442485|NCT02105987|323405695|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
94442486|NCT02105987|323405696|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
94442487|NCT02105987|323405691|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
94442488|NCT02105987|323405692|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
94442489|NCT02105987|323405693|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
94442490|NCT02105987|323405694|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
94442491|NCT02105987|323405695|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
94442492|NCT02105987|323405696|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
94442493|NCT02105987|323405691|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
94442494|NCT02105987|323405692|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
94442495|NCT02105987|323405693|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
94442496|NCT02105987|323405694|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
94442497|NCT02105987|323405695|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
94442498|NCT02105987|323405696|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
94442499|NCT02105987|323405691|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
94442500|NCT02105987|323405692|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
94442501|NCT02105987|323405693|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
94442502|NCT02105987|323405694|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
94442503|NCT02105987|323405695|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
94442504|NCT02105987|323405696|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
94442505|NCT02105987|323405691|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
94442506|NCT02105987|323405692|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
94442507|NCT02105987|323405693|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
94442508|NCT02105987|323405694|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
94442509|NCT02105987|323405695|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
94442510|NCT02105987|323405696|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
94442511|NCT02105987|323405691|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
94442512|NCT02105987|323405692|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
94442513|NCT02105987|323405693|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
94442514|NCT02105987|323405694|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
94442515|NCT02105987|323405695|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
94442516|NCT02105987|323405696|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
94442517|NCT02105987|323405691|FG000|Continuation Phase|Protocol Violation|0|||
94442518|NCT02105987|323405692|FG001|Continuation Phase|Protocol Violation|0|||
94442519|NCT02105987|323405693|FG002|Continuation Phase|Protocol Violation|0|||
94442520|NCT02105987|323405694|FG003|Continuation Phase|Protocol Violation|0|||
94442521|NCT02105987|323405695|FG004|Continuation Phase|Protocol Violation|1|||
94442522|NCT02105987|323405696|FG005|Continuation Phase|Protocol Violation|0|||
94442523|NCT00380874|323405697|FG000|Overall Study|Adverse Event|7|||
94442524|NCT00380874|323405698|FG001|Overall Study|Adverse Event|7|||
94442525|NCT00380874|323405697|FG000|Overall Study|Death|1|||
94442526|NCT00380874|323405698|FG001|Overall Study|Death|0|||
94442527|NCT00380874|323405697|FG000|Overall Study|Withdrawal by Subject|2|||
94340982|NCT03039790|323028962|FG007|Overall Study|Death|0|||
94340983|NCT03039790|323028963|FG008|Overall Study|Death|0|||
94340984|NCT03039790|323028964|FG009|Overall Study|Death|0|||
94340985|NCT03039790|323028965|FG010|Overall Study|Death|0|||
94340986|NCT03039790|323028966|FG011|Overall Study|Death|0|||
94340987|NCT03039790|323028967|FG012|Overall Study|Death|0|||
94340988|NCT03039790|323028968|FG013|Overall Study|Death|0|||
94340989|NCT03039790|323028969|FG014|Overall Study|Death|0|||
94340990|NCT03039790|323028970|FG015|Overall Study|Death|1|||
94340991|NCT03039790|323028971|FG016|Overall Study|Death|3|||
94340992|NCT03039790|323028972|FG017|Overall Study|Death|0|||
94340993|NCT03039790|323028973|FG018|Overall Study|Death|2|||
94340994|NCT03039790|323028974|FG019|Overall Study|Death|0|||
94340995|NCT03039790|323028955|FG000|Overall Study|Reason, not Specified|1|||
94340996|NCT03039790|323028956|FG001|Overall Study|Reason, not Specified|0|||
94340997|NCT03039790|323028957|FG002|Overall Study|Reason, not Specified|0|||
94340998|NCT03039790|323028958|FG003|Overall Study|Reason, not Specified|0|||
94340999|NCT03039790|323028959|FG004|Overall Study|Reason, not Specified|0|||
94341000|NCT03039790|323028960|FG005|Overall Study|Reason, not Specified|0|||
94341001|NCT03039790|323028961|FG006|Overall Study|Reason, not Specified|0|||
94341002|NCT03039790|323028962|FG007|Overall Study|Reason, not Specified|0|||
94341003|NCT03039790|323028963|FG008|Overall Study|Reason, not Specified|0|||
94341004|NCT03039790|323028964|FG009|Overall Study|Reason, not Specified|0|||
94341005|NCT03039790|323028965|FG010|Overall Study|Reason, not Specified|0|||
94341006|NCT03039790|323028966|FG011|Overall Study|Reason, not Specified|0|||
94341007|NCT03039790|323028967|FG012|Overall Study|Reason, not Specified|0|||
94341008|NCT03039790|323028968|FG013|Overall Study|Reason, not Specified|0|||
94341009|NCT03039790|323028969|FG014|Overall Study|Reason, not Specified|0|||
94341010|NCT03039790|323028970|FG015|Overall Study|Reason, not Specified|0|||
94341011|NCT03039790|323028971|FG016|Overall Study|Reason, not Specified|2|||
94442528|NCT00380874|323405698|FG001|Overall Study|Withdrawal by Subject|1|||
94442529|NCT00380874|323405697|FG000|Overall Study|Not related to study drug|3|||
94442530|NCT00380874|323405698|FG001|Overall Study|Not related to study drug|2|||
94442531|NCT03164551|323405699|FG000|Overall Study|Imaging discontinued prior completion|8|||
94442532|NCT03164551|323405700|FG001|Overall Study|Imaging discontinued prior completion|0|||
94341012|NCT03039790|323028972|FG017|Overall Study|Reason, not Specified|0|||
94341013|NCT03039790|323028973|FG018|Overall Study|Reason, not Specified|1|||
94341014|NCT03039790|323028974|FG019|Overall Study|Reason, not Specified|0|||
94341015|NCT00537771|323028975|FG000|Overall Study|Withdrawal by Subject|6|||
94549630|NCT00845065|323807419|FG001|Overall Study|Non-Medical Reasons|11|||
94549631|NCT02273960|323807420|FG000|Short Term Period|Lost to Follow-up|1|||
94549632|NCT02273960|323807421|FG001|Short Term Period|Lost to Follow-up|0|||
94549633|NCT02273960|323807422|FG002|Short Term Period|Lost to Follow-up|0|||
94549634|NCT02273960|323807423|FG003|Short Term Period|Lost to Follow-up|0|||
94549635|NCT02273960|323807420|FG000|Short Term Period|Lack of Efficacy|0|||
94549636|NCT02273960|323807421|FG001|Short Term Period|Lack of Efficacy|0|||
94549637|NCT02273960|323807422|FG002|Short Term Period|Lack of Efficacy|0|||
94341016|NCT00537771|323028976|FG001|Overall Study|Withdrawal by Subject|23|||
94341017|NCT00537771|323028975|FG000|Overall Study|Adverse Event|8|||
94341018|NCT00537771|323028976|FG001|Overall Study|Adverse Event|15|||
94341019|NCT00537771|323028975|FG000|Overall Study|Lost to Follow-up|9|||
94341020|NCT00537771|323028976|FG001|Overall Study|Lost to Follow-up|15|||
94341021|NCT00537771|323028975|FG000|Overall Study|Protocol Violation|2|||
94341022|NCT00537771|323028976|FG001|Overall Study|Protocol Violation|6|||
94341023|NCT00537771|323028975|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
94341024|NCT00537771|323028976|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
94341025|NCT00610207|323028977|FG000|Overall Study|Lost to Follow-up|3|||
94341026|NCT00638690|323028978|FG000|Overall Study|Death|655|||
94341027|NCT00638690|323028979|FG001|Overall Study|Death|335|||
94341028|NCT00638690|323028978|FG000|Overall Study|Withdrawal by Subject|22|||
94341029|NCT00638690|323028979|FG001|Overall Study|Withdrawal by Subject|5|||
94341030|NCT00638690|323028978|FG000|Overall Study|Lost to Follow-up|4|||
94341031|NCT00638690|323028979|FG001|Overall Study|Lost to Follow-up|2|||
94341032|NCT01690988|323028980|FG000|Overall Study|Withdrawal by Subject|2|||
94341033|NCT01690988|323028981|FG001|Overall Study|Withdrawal by Subject|2|||
94341034|NCT01690988|323028982|FG002|Overall Study|Withdrawal by Subject|3|||
94341035|NCT01690988|323028980|FG000|Overall Study|Physician Decision|0|||
94341036|NCT01690988|323028981|FG001|Overall Study|Physician Decision|0|||
94341037|NCT01690988|323028982|FG002|Overall Study|Physician Decision|1|||
94341038|NCT01690988|323028980|FG000|Overall Study|Operation Cancelled|1|||
94341039|NCT01690988|323028981|FG001|Overall Study|Operation Cancelled|1|||
94341040|NCT01690988|323028982|FG002|Overall Study|Operation Cancelled|0|||
94341041|NCT01690988|323028980|FG000|Overall Study|Determined ineligible|1|||
94341042|NCT01690988|323028981|FG001|Overall Study|Determined ineligible|0|||
94341043|NCT01690988|323028982|FG002|Overall Study|Determined ineligible|0|||
94341044|NCT01690988|323028980|FG000|Overall Study|Death|1|||
94341045|NCT01690988|323028981|FG001|Overall Study|Death|1|||
94341046|NCT01690988|323028982|FG002|Overall Study|Death|1|||
94341047|NCT01690988|323028980|FG000|Overall Study|Sedated|1|||
94341048|NCT01690988|323028981|FG001|Overall Study|Sedated|1|||
94341049|NCT01690988|323028982|FG002|Overall Study|Sedated|2|||
94341050|NCT00552344|323028984|FG000|Overall Study|Lack of Efficacy|55|||
94341051|NCT00552344|323028984|FG000|Overall Study|Loss of efficacy|75|||
94341052|NCT00552344|323028984|FG000|Overall Study|Lost to Follow-up|8|||
94341053|NCT00552344|323028984|FG000|Overall Study|Withdrawal by Subject|48|||
94341054|NCT00552344|323028984|FG000|Overall Study|SAE, non-fatal|6|||
94341055|NCT00552344|323028984|FG000|Overall Study|AE, non-serious non-fatal|38|||
94341056|NCT00552344|323028984|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
94341057|NCT00552344|323028984|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
94341058|NCT00552344|323028984|FG000|Overall Study|Other Reason|22|||
94341059|NCT00471276|323028985|FG000|Overall Study|Death|2|||
94341060|NCT00471276|323028985|FG000|Overall Study|Adverse Event|16|||
94341061|NCT00471276|323028985|FG000|Overall Study|Protocol Violation|1|||
94341062|NCT00471276|323028985|FG000|Overall Study|Objective progression or relapse|54|||
94341063|NCT00471276|323028985|FG000|Overall Study|Global deterioration of health status|1|||
94341064|NCT00471276|323028985|FG000|Overall Study|Other|3|||
94341065|NCT00471276|323028985|FG000|Overall Study|Refused treatment|6|||
94341066|NCT00744991|323028986|FG000|Overall Study|Progressive Disease|11|||
94341067|NCT00744991|323028986|FG000|Overall Study|Withdrawal by Subject|8|||
94341068|NCT00744991|323028986|FG000|Overall Study|Physician Decision|3|||
94341069|NCT00744991|323028986|FG000|Overall Study|Adverse Event|2|||
94341070|NCT00744991|323028986|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
94341071|NCT01594411|323028987|FG000|Overall Study|Lost to Follow-up|2|||
94341072|NCT03797144|323028988|FG000|Enrollment|Protocol Violation|4|||
94341073|NCT03797144|323028989|FG001|Enrollment|Protocol Violation|1|||
94341074|NCT03797144|323028988|FG000|Surgery|Protocol Violation|1|||
94341075|NCT03797144|323028989|FG001|Surgery|Protocol Violation|0|||
94341076|NCT03797144|323028988|FG000|3 Month|Early termination cut-off date|2|||
94341077|NCT03797144|323028989|FG001|3 Month|Early termination cut-off date|0|||
94341078|NCT03797144|323028988|FG000|12 Month|Early termination cut-off date|8|||
94341079|NCT03797144|323028989|FG001|12 Month|Early termination cut-off date|9|||
94341080|NCT03797144|323028988|FG000|24 Month|Early termination cut-off date|1|||
94341081|NCT03797144|323028989|FG001|24 Month|Early termination cut-off date|1|||
94341082|NCT01512693|323028990|FG000|Overall Study|Withdrawal by Subject|0|||
94341083|NCT01512693|323028991|FG001|Overall Study|Withdrawal by Subject|1|||
94341084|NCT01975376|323028992|FG000|Overall Study|Adverse Event|5|||
94341085|NCT01975376|323028993|FG001|Overall Study|Adverse Event|5|||
94341086|NCT01975376|323028992|FG000|Overall Study|Death|65|||
94341087|NCT01975376|323028993|FG001|Overall Study|Death|72|||
94341088|NCT01975376|323028992|FG000|Overall Study|Lost to Follow-up|70|||
94341089|NCT01975376|323028993|FG001|Overall Study|Lost to Follow-up|66|||
94341090|NCT01975376|323028992|FG000|Overall Study|Withdrew consent|68|||
94341091|NCT01975376|323028993|FG001|Overall Study|Withdrew consent|62|||
94341092|NCT01975376|323028992|FG000|Overall Study|Other|2|||
94341093|NCT01975376|323028993|FG001|Overall Study|Other|4|||
94341094|NCT01975376|323028992|FG000|Overall Study|Randomized, Not Treated|16|||
94341095|NCT01975376|323028993|FG001|Overall Study|Randomized, Not Treated|8|||
94341096|NCT02201251|323028995|FG000|Overall Study|Adverse Event|1|||
94341097|NCT02201251|323028996|FG001|Overall Study|Adverse Event|1|||
94341098|NCT02201251|323028995|FG000|Overall Study|Protocol Violation|1|||
94341099|NCT02201251|323028996|FG001|Overall Study|Protocol Violation|0|||
94341100|NCT02201251|323028995|FG000|Overall Study|Noncompliance with Study Drug|0|||
94341101|NCT02201251|323028996|FG001|Overall Study|Noncompliance with Study Drug|1|||
94341102|NCT02201251|323028995|FG000|Overall Study|Withdrawal by Subject|2|||
94341103|NCT02201251|323028996|FG001|Overall Study|Withdrawal by Subject|1|||
94341104|NCT01819194|323028999|FG000|Overall Study|Loss of study articles|2|||
94341105|NCT00614991|323029003|FG000|Overall Study|Adverse Event|3|||
94341106|NCT00614991|323029004|FG001|Overall Study|Adverse Event|3|||
94341107|NCT00614991|323029005|FG002|Overall Study|Adverse Event|0|||
94341108|NCT00614991|323029006|FG003|Overall Study|Adverse Event|0|||
94341109|NCT00614991|323029007|FG004|Overall Study|Adverse Event|1|||
94341110|NCT00614991|323029008|FG005|Overall Study|Adverse Event|0|||
94341111|NCT03799627|323029009|FG000|Overall Study|Adverse Event|1|||
94341112|NCT03799627|323029010|FG001|Overall Study|Adverse Event|2|||
94341113|NCT03799627|323029011|FG002|Overall Study|Adverse Event|0|||
94341114|NCT03799627|323029012|FG003|Overall Study|Adverse Event|0|||
94341115|NCT03799627|323029013|FG004|Overall Study|Adverse Event|2|||
94341116|NCT03799627|323029014|FG005|Overall Study|Adverse Event|5|||
94341117|NCT03799627|323029015|FG006|Overall Study|Adverse Event|0|||
94341118|NCT03799627|323029016|FG007|Overall Study|Adverse Event|2|||
94341119|NCT03799627|323029017|FG008|Overall Study|Adverse Event|0|||
94341120|NCT03799627|323029009|FG000|Overall Study|Physician Decision|2|||
94341121|NCT03799627|323029010|FG001|Overall Study|Physician Decision|2|||
94341122|NCT03799627|323029011|FG002|Overall Study|Physician Decision|0|||
94341123|NCT03799627|323029012|FG003|Overall Study|Physician Decision|0|||
94341124|NCT03799627|323029013|FG004|Overall Study|Physician Decision|2|||
94341125|NCT03799627|323029014|FG005|Overall Study|Physician Decision|2|||
94341126|NCT03799627|323029015|FG006|Overall Study|Physician Decision|0|||
94341127|NCT03799627|323029016|FG007|Overall Study|Physician Decision|0|||
94341128|NCT03799627|323029017|FG008|Overall Study|Physician Decision|0|||
94341129|NCT03799627|323029009|FG000|Overall Study|Withdrawal by Subject|1|||
94341130|NCT03799627|323029010|FG001|Overall Study|Withdrawal by Subject|1|||
94341131|NCT03799627|323029011|FG002|Overall Study|Withdrawal by Subject|0|||
94341132|NCT03799627|323029012|FG003|Overall Study|Withdrawal by Subject|2|||
94341133|NCT03799627|323029013|FG004|Overall Study|Withdrawal by Subject|0|||
94341134|NCT03799627|323029014|FG005|Overall Study|Withdrawal by Subject|3|||
94341135|NCT03799627|323029015|FG006|Overall Study|Withdrawal by Subject|0|||
94442533|NCT03164551|323405699|FG000|Overall Study|Participant was non-compliant|1|||
94442534|NCT03164551|323405700|FG001|Overall Study|Participant was non-compliant|0|||
94442535|NCT03164551|323405699|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
94442536|NCT03164551|323405700|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
94442537|NCT03164551|323405699|FG000|Overall Study|Other|8|||
94442538|NCT03164551|323405700|FG001|Overall Study|Other|2|||
94442539|NCT02314026|323405705|FG000|Overall Study|Protocol Violation|28|||
94442540|NCT02949973|323405708|FG000|Overall Study|Physician Decision|1|||
94442541|NCT00699998|323405709|FG000|Overall Study|Withdrawal by Subject|194|||
94442542|NCT00699998|323405710|FG001|Overall Study|Withdrawal by Subject|83|||
94341136|NCT03799627|323029016|FG007|Overall Study|Withdrawal by Subject|0|||
94341137|NCT03799627|323029017|FG008|Overall Study|Withdrawal by Subject|0|||
94341138|NCT03799627|323029009|FG000|Overall Study|Lack of Efficacy|0|||
94341139|NCT03799627|323029010|FG001|Overall Study|Lack of Efficacy|0|||
94341140|NCT03799627|323029011|FG002|Overall Study|Lack of Efficacy|0|||
94341141|NCT03799627|323029012|FG003|Overall Study|Lack of Efficacy|1|||
94341142|NCT03799627|323029013|FG004|Overall Study|Lack of Efficacy|0|||
94341143|NCT03799627|323029014|FG005|Overall Study|Lack of Efficacy|0|||
94341144|NCT03799627|323029015|FG006|Overall Study|Lack of Efficacy|0|||
94341145|NCT03799627|323029016|FG007|Overall Study|Lack of Efficacy|0|||
94341146|NCT03799627|323029017|FG008|Overall Study|Lack of Efficacy|0|||
94341147|NCT03799627|323029009|FG000|Overall Study|Lost to Follow-up|0|||
94341148|NCT03799627|323029010|FG001|Overall Study|Lost to Follow-up|0|||
94341149|NCT03799627|323029011|FG002|Overall Study|Lost to Follow-up|0|||
94341150|NCT03799627|323029012|FG003|Overall Study|Lost to Follow-up|0|||
94341151|NCT03799627|323029013|FG004|Overall Study|Lost to Follow-up|0|||
94442543|NCT00699998|323405711|FG002|Overall Study|Withdrawal by Subject|202|||
94442544|NCT00699998|323405712|FG003|Overall Study|Withdrawal by Subject|80|||
94442545|NCT00699998|323405709|FG000|Overall Study|Physician Decision|3|||
94442546|NCT00699998|323405710|FG001|Overall Study|Physician Decision|2|||
94442547|NCT00699998|323405711|FG002|Overall Study|Physician Decision|1|||
94442548|NCT00699998|323405712|FG003|Overall Study|Physician Decision|1|||
94442549|NCT00699998|323405709|FG000|Overall Study|Lost to Follow-up|2|||
94442550|NCT00699998|323405710|FG001|Overall Study|Lost to Follow-up|1|||
94442551|NCT00699998|323405711|FG002|Overall Study|Lost to Follow-up|3|||
94442552|NCT00699998|323405712|FG003|Overall Study|Lost to Follow-up|1|||
94442553|NCT03552380|323405713|FG000|Study Treatment|Disease Progression|3|||
94442554|NCT03552380|323405714|FG001|Study Treatment|Disease Progression|4|||
94442555|NCT03552380|323405713|FG000|Study Treatment|Adverse Event|2|||
94442556|NCT03552380|323405714|FG001|Study Treatment|Adverse Event|2|||
94442557|NCT03552380|323405713|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
94442558|NCT03552380|323405714|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
94442559|NCT03552380|323405713|FG000|Follow up|Death|3|||
94442560|NCT03552380|323405714|FG001|Follow up|Death|4|||
94442561|NCT03552380|323405713|FG000|Follow up|Site IRB terminated|0|||
94442562|NCT03552380|323405714|FG001|Follow up|Site IRB terminated|1|||
94442563|NCT02430480|323405715|FG000|Overall Study|Death|1|||
94442564|NCT02430480|323405715|FG000|Overall Study|Anesthesia concerns|1|||
94442565|NCT02430480|323405715|FG000|Overall Study|Progressed on treatment|1|||
94442566|NCT00916383|323405716|FG000|Overall Study|Adverse Event|1|||
94442567|NCT00916383|323405716|FG000|Overall Study|Death|1|||
94442568|NCT00916383|323405716|FG000|Overall Study|Protocol Violation|1|||
94442569|NCT00473590|323405717|FG000|Overall Study|Adverse Event|3|||
94442570|NCT00473590|323405718|FG001|Overall Study|Adverse Event|3|||
94442571|NCT00473590|323405717|FG000|Overall Study|Death|4|||
94442572|NCT00473590|323405718|FG001|Overall Study|Death|2|||
94442573|NCT00473590|323405717|FG000|Overall Study|Progression not resulting in death|24|||
94442574|NCT00473590|323405718|FG001|Overall Study|Progression not resulting in death|20|||
94442575|NCT00473590|323405717|FG000|Overall Study|Non-protocol-specified therapy|7|||
94442576|NCT00473590|323405718|FG001|Overall Study|Non-protocol-specified therapy|5|||
94442577|NCT00473590|323405717|FG000|Overall Study|Physician Decision|2|||
94442578|NCT00473590|323405718|FG001|Overall Study|Physician Decision|4|||
94442579|NCT00473590|323405717|FG000|Overall Study|Withdrawal by Subject|5|||
94442580|NCT00473590|323405718|FG001|Overall Study|Withdrawal by Subject|3|||
94442581|NCT00473590|323405717|FG000|Overall Study|Other|0|||
94442582|NCT00473590|323405718|FG001|Overall Study|Other|1|||
94442583|NCT00858273|323405719|FG000|Overall Study|Protocol Violation|3|||
94442584|NCT00858273|323405720|FG001|Overall Study|Protocol Violation|5|||
94442585|NCT02964247|323405722|FG000|Overall Study|Lost to Follow-up|2|||
94442586|NCT02964247|323405723|FG001|Overall Study|Lost to Follow-up|0|||
94442587|NCT02964247|323405722|FG000|Overall Study|Withdrawal by Subject|1|||
94442588|NCT02964247|323405723|FG001|Overall Study|Withdrawal by Subject|2|||
94442589|NCT02892331|323405727|FG000|Overall Study|Withdrawal by Subject|0|||
94442590|NCT02892331|323405728|FG001|Overall Study|Withdrawal by Subject|1|||
94442591|NCT02892331|323405729|FG002|Overall Study|Withdrawal by Subject|1|||
94442592|NCT02892331|323405727|FG000|Overall Study|Sick family member|0|||
94442593|NCT02892331|323405728|FG001|Overall Study|Sick family member|0|||
94442594|NCT02892331|323405729|FG002|Overall Study|Sick family member|1|||
94442595|NCT02892331|323405727|FG000|Overall Study|Corona virus pandemic|1|||
94442596|NCT02892331|323405728|FG001|Overall Study|Corona virus pandemic|0|||
94442597|NCT02892331|323405729|FG002|Overall Study|Corona virus pandemic|1|||
94442598|NCT02892331|323405727|FG000|Overall Study|Lost to Follow-up|1|||
94442599|NCT02892331|323405728|FG001|Overall Study|Lost to Follow-up|0|||
94442600|NCT02892331|323405729|FG002|Overall Study|Lost to Follow-up|1|||
94442601|NCT02892331|323405727|FG000|Overall Study|Blood pressure was too elevated|0|||
94442602|NCT02892331|323405728|FG001|Overall Study|Blood pressure was too elevated|1|||
94442603|NCT02892331|323405729|FG002|Overall Study|Blood pressure was too elevated|0|||
94442604|NCT02892331|323405727|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
94442605|NCT02892331|323405728|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
94442606|NCT02892331|323405729|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
94442607|NCT00071110|323405730|FG000|Overall Study|Protocol Violation|0|||
94442608|NCT00071110|323405731|FG001|Overall Study|Protocol Violation|4|||
94442609|NCT02286713|323405732|FG000|One Week Follow-Up|Death|1|||
94549638|NCT02273960|323807423|FG003|Short Term Period|Lack of Efficacy|1|||
94442610|NCT02286713|323405733|FG001|One Week Follow-Up|Death|0|||
94442611|NCT02286713|323405732|FG000|One Week Follow-Up|Lost to Follow-up|17|||
94442612|NCT02286713|323405733|FG001|One Week Follow-Up|Lost to Follow-up|21|||
94442613|NCT02286713|323405732|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
94442614|NCT02286713|323405733|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
94442615|NCT02286713|323405732|FG000|Three Month Follow-Up|Death|1|||
94442616|NCT02286713|323405733|FG001|Three Month Follow-Up|Death|1|||
94442617|NCT02286713|323405732|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
94442618|NCT02286713|323405733|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
94442619|NCT02286713|323405732|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
94442620|NCT02286713|323405733|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
94442621|NCT02286713|323405732|FG000|Six Month Follow-Up|Death|2|||
94442622|NCT02286713|323405733|FG001|Six Month Follow-Up|Death|0|||
94442623|NCT02286713|323405732|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
94442624|NCT02286713|323405733|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
94442625|NCT02548143|323405734|FG000|Overall Study|Adverse Event|1|||
94442626|NCT02548143|323405735|FG001|Overall Study|Adverse Event|0|||
94442627|NCT02548143|323405734|FG000|Overall Study|Withdrawal by Subject|0|||
94442628|NCT02548143|323405735|FG001|Overall Study|Withdrawal by Subject|1|||
94442629|NCT02654054|323405736|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
94442630|NCT02654054|323405737|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
94442631|NCT02654054|323405738|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
94442632|NCT02654054|323405736|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
94442633|NCT02654054|323405737|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94442634|NCT02654054|323405738|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
94442635|NCT02654054|323405736|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
94442636|NCT02654054|323405737|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
94442637|NCT02654054|323405738|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
94442638|NCT02654054|323405736|FG000|Post-Treatment Follow-Up Period|Other|1|||
94442639|NCT02654054|323405737|FG001|Post-Treatment Follow-Up Period|Other|0|||
94442640|NCT02654054|323405738|FG002|Post-Treatment Follow-Up Period|Other|4|||
94442641|NCT02654054|323405736|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
94442642|NCT02654054|323405737|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
94442643|NCT02654054|323405738|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
94442644|NCT04871776|323405739|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
94442645|NCT04871776|323405740|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
94442646|NCT04871776|323405741|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
94442647|NCT04871776|323405739|FG000|Overall Study|Did not meet eligibility criteria|1|||
94442648|NCT04871776|323405740|FG001|Overall Study|Did not meet eligibility criteria|1|||
94442649|NCT04871776|323405741|FG002|Overall Study|Did not meet eligibility criteria|1|||
94442650|NCT00420420|323405743|FG000|Overall Study|Adverse Event|5|||
94442651|NCT00420420|323405744|FG001|Overall Study|Adverse Event|3|||
94442652|NCT00420420|323405743|FG000|Overall Study|Protocol Violation|1|||
94442653|NCT00420420|323405744|FG001|Overall Study|Protocol Violation|1|||
94442654|NCT00420420|323405743|FG000|Overall Study|Withdrawal by Subject|1|||
94442655|NCT00420420|323405744|FG001|Overall Study|Withdrawal by Subject|0|||
94442656|NCT00420420|323405743|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
94442657|NCT00420420|323405744|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
94442658|NCT00856492|323405749|FG000|Overall Study|Ineligible or withdrew consent|1|||
94442659|NCT00856492|323405750|FG001|Overall Study|Ineligible or withdrew consent|1|||
94442660|NCT00856492|323405751|FG002|Overall Study|Ineligible or withdrew consent|2|||
94442661|NCT03832686|323405752|FG000|Overall Study|Lost to Follow-up|6|||
94442662|NCT03832686|323405753|FG001|Overall Study|Lost to Follow-up|9|||
94442663|NCT03832686|323405752|FG000|Overall Study|Discontinued Intervention|5|||
94442664|NCT03832686|323405753|FG001|Overall Study|Discontinued Intervention|4|||
94442665|NCT02235454|323405754|FG000|Overall Study|Withdrawal by Subject|2|||
94442666|NCT05966584|323405756|FG000|Overall Study|Lost to Follow-up|1|||
94442667|NCT00265759|323406949|FG000|Overall Study|Withdrawal by Subject|0|||
94442668|NCT00265759|323406950|FG001|Overall Study|Withdrawal by Subject|1|||
94442669|NCT00265759|323406951|FG002|Overall Study|Withdrawal by Subject|2|||
94442670|NCT00265759|323406952|FG003|Overall Study|Withdrawal by Subject|2|||
94549639|NCT02273960|323807420|FG000|Short Term Period|ST complete, not entering LTE|4|||
94549640|NCT02273960|323807421|FG001|Short Term Period|ST complete, not entering LTE|6|||
94549641|NCT02273960|323807422|FG002|Short Term Period|ST complete, not entering LTE|4|||
94549642|NCT02273960|323807423|FG003|Short Term Period|ST complete, not entering LTE|5|||
94549643|NCT02273960|323807420|FG000|Long Term Extension|Death|0|||
94549644|NCT02273960|323807421|FG001|Long Term Extension|Death|0|||
94442671|NCT00265759|323406949|FG000|Overall Study|Cancel|0|||
94442672|NCT00265759|323406950|FG001|Overall Study|Cancel|0|||
94442673|NCT00265759|323406951|FG002|Overall Study|Cancel|0|||
94442674|NCT00265759|323406952|FG003|Overall Study|Cancel|3|||
94442675|NCT00265759|323406949|FG000|Overall Study|Ineligible|0|||
94442676|NCT00265759|323406950|FG001|Overall Study|Ineligible|0|||
94442677|NCT00265759|323406951|FG002|Overall Study|Ineligible|0|||
94442678|NCT00265759|323406952|FG003|Overall Study|Ineligible|1|||
94442679|NCT00265759|323406949|FG000|Overall Study|Bilateral disease|0|||
94442680|NCT00265759|323406950|FG001|Overall Study|Bilateral disease|0|||
94442681|NCT00265759|323406951|FG002|Overall Study|Bilateral disease|0|||
94442682|NCT00265759|323406952|FG003|Overall Study|Bilateral disease|2|||
94549645|NCT02273960|323807422|FG002|Long Term Extension|Death|0|||
94549646|NCT02273960|323807423|FG003|Long Term Extension|Death|1|||
94549647|NCT02265796|323807424|FG000|Overall Study|Death|1|||
94549648|NCT02265796|323807425|FG001|Overall Study|Death|0|||
94549649|NCT02265796|323807424|FG000|Overall Study|started on excluded medication|1|||
94549650|NCT02265796|323807425|FG001|Overall Study|started on excluded medication|0|||
94442683|NCT00265759|323406949|FG000|Overall Study|Discontinued due to intolerability|0|||
94442684|NCT00265759|323406950|FG001|Overall Study|Discontinued due to intolerability|0|||
94442685|NCT00265759|323406951|FG002|Overall Study|Discontinued due to intolerability|0|||
94442686|NCT00265759|323406952|FG003|Overall Study|Discontinued due to intolerability|1|||
94442687|NCT00931528|323406953|FG000|Overall Study|Protocol Violation|9|||
94442688|NCT00931528|323406954|FG001|Overall Study|Protocol Violation|12|||
94442689|NCT00931528|323406953|FG000|Overall Study|Withdrawal by Subject|4|||
94442690|NCT00931528|323406954|FG001|Overall Study|Withdrawal by Subject|12|||
94442691|NCT00931528|323406953|FG000|Overall Study|Lost to Follow-up|6|||
94442692|NCT00931528|323406954|FG001|Overall Study|Lost to Follow-up|13|||
94442693|NCT00931528|323406953|FG000|Overall Study|Assessment outside of Time Frame|22|||
94442694|NCT00931528|323406954|FG001|Overall Study|Assessment outside of Time Frame|23|||
94442695|NCT02810457|323406955|FG000|Overall Study|Randomised but no treatment received|2|||
94442696|NCT02810457|323406956|FG001|Overall Study|Randomised but no treatment received|1|||
94442697|NCT02810457|323406955|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
94442698|NCT02810457|323406956|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
94442699|NCT02810457|323406955|FG000|Overall Study|Adverse Event|37|||
94442700|NCT02810457|323406956|FG001|Overall Study|Adverse Event|43|||
94442701|NCT02810457|323406955|FG000|Overall Study|Patient decision|31|||
94442702|NCT02810457|323406956|FG001|Overall Study|Patient decision|35|||
94442703|NCT02810457|323406955|FG000|Overall Study|Patient lost to follow-up|2|||
94442704|NCT02810457|323406956|FG001|Overall Study|Patient lost to follow-up|2|||
94442705|NCT02810457|323406955|FG000|Overall Study|Death|39|||
94442706|NCT02810457|323406956|FG001|Overall Study|Death|28|||
94442707|NCT02810457|323406955|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
94442708|NCT02810457|323406956|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
94442709|NCT02810457|323406955|FG000|Overall Study|Clinical progression|15|||
94442710|NCT02810457|323406956|FG001|Overall Study|Clinical progression|16|||
94442711|NCT02810457|323406955|FG000|Overall Study|Investigator decision|3|||
94442712|NCT02810457|323406956|FG001|Overall Study|Investigator decision|2|||
94442713|NCT02810457|323406955|FG000|Overall Study|Patient ineligibility|3|||
94442714|NCT02810457|323406956|FG001|Overall Study|Patient ineligibility|0|||
94442715|NCT02810457|323406955|FG000|Overall Study|Miscalculated PD|1|||
94442716|NCT02810457|323406956|FG001|Overall Study|Miscalculated PD|0|||
94442717|NCT02810457|323406955|FG000|Overall Study|Physician Decision|0|||
94549651|NCT02265796|323807424|FG000|Overall Study|Withdrawal by Subject|1|||
94549652|NCT02265796|323807425|FG001|Overall Study|Withdrawal by Subject|1|||
94549653|NCT02745535|323807427|FG000|Overall Study|Death|1|||
94549654|NCT02745535|323807427|FG000|Overall Study|Adverse Event|3|||
94549655|NCT02745535|323807427|FG000|Overall Study|Lost to Follow-up|2|||
94549656|NCT00849108|323807428|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
94549657|NCT00849108|323807429|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
94549658|NCT00849108|323807428|FG000|Cohort 2 Efficacy|Adverse Event|0|||
94442718|NCT02810457|323406956|FG001|Overall Study|Physician Decision|1|||
94442719|NCT04173507|323406957|FG000|Overall Study|On Treatment|3|||
94442720|NCT04173507|323406957|FG000|Overall Study|Adverse Event|3|||
94442721|NCT04173507|323406957|FG000|Overall Study|Progression/Relapse|34|||
94442722|NCT04173507|323406957|FG000|Overall Study|Death|2|||
94442723|NCT01823328|323406958|FG000|Overall Study|Withdrawal by Subject|8|||
94442724|NCT01823328|323406959|FG001|Overall Study|Withdrawal by Subject|6|||
94442725|NCT01402570|323406960|FG000|Overall Study|Adverse Event|1|||
94442726|NCT02764762|323406963|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
94442727|NCT02764762|323406963|FG000|Overall Study|Lost to Follow-up|4|||
94442728|NCT02764762|323406963|FG000|Overall Study|Voluntary Withdrawal|8|||
94549659|NCT00849108|323807429|FG001|Cohort 2 Efficacy|Adverse Event|1|||
94442729|NCT02764762|323406963|FG000|Overall Study|Site Termination|1|||
94442730|NCT02764762|323406963|FG000|Overall Study|Lack of Efficacy|16|||
94442731|NCT02764762|323406963|FG000|Overall Study|Reason not Specified|1|||
94442732|NCT04515147|323406965|FG000|Overall Study|Withdrawal by Subject|1|||
94442733|NCT04515147|323406966|FG001|Overall Study|Withdrawal by Subject|0|||
94442734|NCT04515147|323406967|FG002|Overall Study|Withdrawal by Subject|10|||
94442735|NCT04515147|323406968|FG003|Overall Study|Withdrawal by Subject|18|||
94442736|NCT04515147|323406969|FG004|Overall Study|Withdrawal by Subject|1|||
94442737|NCT04515147|323406970|FG005|Overall Study|Withdrawal by Subject|8|||
94442738|NCT04515147|323406965|FG000|Overall Study|Lost to Follow-up|0|||
94442739|NCT04515147|323406966|FG001|Overall Study|Lost to Follow-up|1|||
94442740|NCT04515147|323406967|FG002|Overall Study|Lost to Follow-up|5|||
94442741|NCT04515147|323406968|FG003|Overall Study|Lost to Follow-up|6|||
94442742|NCT04515147|323406969|FG004|Overall Study|Lost to Follow-up|2|||
94549660|NCT00849108|323807428|FG000|Cohort 2 Efficacy|Other|0|||
94549661|NCT00849108|323807429|FG001|Cohort 2 Efficacy|Other|9|||
94549662|NCT02963701|323807433|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
94442743|NCT04515147|323406970|FG005|Overall Study|Lost to Follow-up|1|||
94442744|NCT04515147|323406965|FG000|Overall Study|Adverse Event|0|||
94442745|NCT04515147|323406966|FG001|Overall Study|Adverse Event|0|||
94442746|NCT04515147|323406967|FG002|Overall Study|Adverse Event|0|||
94549663|NCT02963701|323807434|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
94341152|NCT03799627|323029014|FG005|Overall Study|Lost to Follow-up|0|||
94341153|NCT03799627|323029015|FG006|Overall Study|Lost to Follow-up|1|||
94341154|NCT03799627|323029016|FG007|Overall Study|Lost to Follow-up|0|||
94341155|NCT03799627|323029017|FG008|Overall Study|Lost to Follow-up|1|||
94341156|NCT03799627|323029009|FG000|Overall Study|Death|0|||
94341157|NCT03799627|323029010|FG001|Overall Study|Death|0|||
94341158|NCT03799627|323029011|FG002|Overall Study|Death|0|||
94341159|NCT03799627|323029012|FG003|Overall Study|Death|1|||
94341160|NCT03799627|323029013|FG004|Overall Study|Death|0|||
94341161|NCT03799627|323029014|FG005|Overall Study|Death|0|||
94341162|NCT03799627|323029015|FG006|Overall Study|Death|0|||
94341163|NCT03799627|323029016|FG007|Overall Study|Death|0|||
94341164|NCT03799627|323029017|FG008|Overall Study|Death|0|||
94341165|NCT03799627|323029009|FG000|Overall Study|Study Drug Put on Hold|1|||
94341166|NCT03799627|323029010|FG001|Overall Study|Study Drug Put on Hold|0|||
94341167|NCT03799627|323029011|FG002|Overall Study|Study Drug Put on Hold|0|||
94341168|NCT03799627|323029012|FG003|Overall Study|Study Drug Put on Hold|0|||
94341169|NCT03799627|323029013|FG004|Overall Study|Study Drug Put on Hold|0|||
94341170|NCT03799627|323029014|FG005|Overall Study|Study Drug Put on Hold|0|||
94341171|NCT03799627|323029015|FG006|Overall Study|Study Drug Put on Hold|0|||
94341172|NCT03799627|323029016|FG007|Overall Study|Study Drug Put on Hold|0|||
94341173|NCT03799627|323029017|FG008|Overall Study|Study Drug Put on Hold|0|||
94341174|NCT03799627|323029009|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
94341175|NCT03799627|323029010|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
94341176|NCT03799627|323029011|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
94341177|NCT03799627|323029012|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
94341178|NCT03799627|323029013|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
94341179|NCT03799627|323029014|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
94341180|NCT03799627|323029015|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
94341181|NCT03799627|323029016|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
94341182|NCT03799627|323029017|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
94341183|NCT03799627|323029009|FG000|Overall Study|Kidney Transplantation|1|||
94341184|NCT03799627|323029010|FG001|Overall Study|Kidney Transplantation|0|||
94341185|NCT03799627|323029011|FG002|Overall Study|Kidney Transplantation|0|||
94341186|NCT03799627|323029012|FG003|Overall Study|Kidney Transplantation|1|||
94341187|NCT03799627|323029013|FG004|Overall Study|Kidney Transplantation|1|||
94341188|NCT03799627|323029014|FG005|Overall Study|Kidney Transplantation|0|||
94341189|NCT03799627|323029015|FG006|Overall Study|Kidney Transplantation|0|||
94341190|NCT03799627|323029016|FG007|Overall Study|Kidney Transplantation|0|||
94341191|NCT03799627|323029017|FG008|Overall Study|Kidney Transplantation|0|||
94341192|NCT03799627|323029009|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
94341193|NCT03799627|323029010|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
94341194|NCT03799627|323029011|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
94341195|NCT03799627|323029012|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
94341196|NCT03799627|323029013|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
94341197|NCT03799627|323029014|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
94341198|NCT03799627|323029015|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
94341199|NCT03799627|323029016|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
94341200|NCT03799627|323029017|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
94341201|NCT03799627|323029009|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
94341202|NCT03799627|323029010|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
94341203|NCT03799627|323029011|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
94341204|NCT03799627|323029012|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
94341205|NCT03799627|323029013|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
94341206|NCT03799627|323029014|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
94341207|NCT03799627|323029015|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
94341208|NCT03799627|323029016|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
94341209|NCT03799627|323029017|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
94341210|NCT03799627|323029009|FG000|Overall Study|Met Exclusion Criteria|0|||
94341211|NCT03799627|323029010|FG001|Overall Study|Met Exclusion Criteria|0|||
94341212|NCT03799627|323029011|FG002|Overall Study|Met Exclusion Criteria|0|||
94341213|NCT03799627|323029012|FG003|Overall Study|Met Exclusion Criteria|1|||
94341214|NCT03799627|323029013|FG004|Overall Study|Met Exclusion Criteria|0|||
94341215|NCT03799627|323029014|FG005|Overall Study|Met Exclusion Criteria|0|||
94341216|NCT03799627|323029015|FG006|Overall Study|Met Exclusion Criteria|0|||
94341217|NCT03799627|323029016|FG007|Overall Study|Met Exclusion Criteria|0|||
94341218|NCT03799627|323029017|FG008|Overall Study|Met Exclusion Criteria|0|||
94341219|NCT03799627|323029009|FG000|Overall Study|Investigational Product Noncompliance|0|||
94341220|NCT03799627|323029010|FG001|Overall Study|Investigational Product Noncompliance|0|||
94341221|NCT03799627|323029011|FG002|Overall Study|Investigational Product Noncompliance|0|||
94341222|NCT03799627|323029012|FG003|Overall Study|Investigational Product Noncompliance|1|||
94549664|NCT05098509|323807437|FG000|Overall Study|Withdrawal by Subject|0|||
94442747|NCT04515147|323406968|FG003|Overall Study|Adverse Event|2|||
94442748|NCT04515147|323406969|FG004|Overall Study|Adverse Event|0|||
94442749|NCT04515147|323406970|FG005|Overall Study|Adverse Event|0|||
94442750|NCT04515147|323406965|FG000|Overall Study|Miscellaneous|0|||
94442751|NCT04515147|323406966|FG001|Overall Study|Miscellaneous|0|||
94442752|NCT04515147|323406967|FG002|Overall Study|Miscellaneous|0|||
94442753|NCT04515147|323406968|FG003|Overall Study|Miscellaneous|1|||
94442754|NCT04515147|323406969|FG004|Overall Study|Miscellaneous|0|||
94442755|NCT04515147|323406970|FG005|Overall Study|Miscellaneous|1|||
94442756|NCT01067105|323406973|FG000|Overall Study|Adverse Event|14|||
94442757|NCT01067105|323406973|FG000|Overall Study|Protocol Violation|48|||
94442758|NCT01067105|323406973|FG000|Overall Study|Withdrawal by Subject|36|||
94442759|NCT01067105|323406973|FG000|Overall Study|Lost to Follow-up|6|||
94442760|NCT01067105|323406973|FG000|Overall Study|Physician Decision|6|||
94442761|NCT01067105|323406973|FG000|Overall Study|Other|31|||
94442762|NCT02760004|323406975|FG000|Overall Study|Lost to Follow-up|13|||
94442763|NCT02760004|323406976|FG001|Overall Study|Lost to Follow-up|22|||
94549665|NCT05098509|323807438|FG001|Overall Study|Withdrawal by Subject|0|||
94549666|NCT05098509|323807439|FG002|Overall Study|Withdrawal by Subject|1|||
94549667|NCT05098509|323807440|FG003|Overall Study|Withdrawal by Subject|0|||
94549668|NCT05098509|323807437|FG000|Overall Study|Early study termination|1|||
94549669|NCT05098509|323807438|FG001|Overall Study|Early study termination|1|||
94549670|NCT05098509|323807439|FG002|Overall Study|Early study termination|1|||
94549671|NCT05098509|323807440|FG003|Overall Study|Early study termination|0|||
94549672|NCT00896649|323807441|FG000|Overall Study|Physician Decision|1|||
94549673|NCT00896649|323807441|FG000|Overall Study|Pregnancy|1|||
94549674|NCT00896649|323807441|FG000|Overall Study|missing documentation|1|||
94549675|NCT00896649|323807441|FG000|Overall Study|technical difficulties|2|||
94549676|NCT03652675|323807442|FG000|Overall Study|Lost to Follow-up|4|||
94442764|NCT00638508|323406987|FG000|Overall Study|Physician Decision|5|||
94442765|NCT00638508|323406988|FG001|Overall Study|Physician Decision|2|||
94442766|NCT03499067|323406989|FG000|First Intervention|Physician Decision|2|||
94442767|NCT03499067|323406990|FG001|First Intervention|Physician Decision|1|||
94442768|NCT03499067|323406989|FG000|First Intervention|Withdrawal by Subject|3|||
94442769|NCT03499067|323406990|FG001|First Intervention|Withdrawal by Subject|6|||
94442770|NCT01254643|323406991|FG000|Overall Study|Withdrawal by Subject|1|||
94442771|NCT00897715|323406995|FG000|Overall Study|Lost to Follow-up|0|||
94442772|NCT00897715|323406996|FG001|Overall Study|Lost to Follow-up|1|||
94442773|NCT00897715|323406995|FG000|Overall Study|Physician Decision|1|||
94442774|NCT00897715|323406996|FG001|Overall Study|Physician Decision|0|||
94442775|NCT00897715|323406995|FG000|Overall Study|increased risk of infection|1|||
94442776|NCT00897715|323406996|FG001|Overall Study|increased risk of infection|0|||
94442777|NCT01518322|323407005|FG000|Overall Study|FeNO measurement was missing|13|||
94442778|NCT00707239|323407006|FG000|Overall Study|Adverse Event|5|||
94442779|NCT00707239|323407007|FG001|Overall Study|Adverse Event|3|||
94549677|NCT03652675|323807443|FG001|Overall Study|Lost to Follow-up|4|||
94549678|NCT00483002|323807444|FG000|Overall Study|Adverse Event|68|||
94549679|NCT00483002|323807444|FG000|Overall Study|Lack of Efficacy|555|||
94549680|NCT00483002|323807444|FG000|Overall Study|Lost to Follow-up|962|||
94549681|NCT00483002|323807444|FG000|Overall Study|Other|2|||
94549682|NCT00483002|323807444|FG000|Overall Study|Other|967|||
94549683|NCT03442296|323807445|FG000|3 Month Follow-up|Death|3|||
94549684|NCT03442296|323807446|FG001|3 Month Follow-up|Death|1|||
94549685|NCT03442296|323807445|FG000|3 Month Follow-up|Lost to Follow-up|1|||
94442780|NCT00707239|323407008|FG002|Overall Study|Adverse Event|2|||
94549686|NCT03442296|323807446|FG001|3 Month Follow-up|Lost to Follow-up|1|||
94549687|NCT03442296|323807445|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
94549688|NCT03442296|323807446|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
94549689|NCT03442296|323807445|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
94549690|NCT03442296|323807446|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
94442781|NCT00707239|323407006|FG000|Overall Study|Death|3|||
94442782|NCT00707239|323407007|FG001|Overall Study|Death|1|||
94442783|NCT00707239|323407008|FG002|Overall Study|Death|3|||
94442784|NCT00707239|323407006|FG000|Overall Study|Physician Decision|1|||
94442785|NCT00707239|323407007|FG001|Overall Study|Physician Decision|1|||
94442786|NCT00707239|323407008|FG002|Overall Study|Physician Decision|2|||
94442787|NCT00707239|323407006|FG000|Overall Study|Protocol Violation|0|||
94442788|NCT00707239|323407007|FG001|Overall Study|Protocol Violation|0|||
94442789|NCT00707239|323407008|FG002|Overall Study|Protocol Violation|1|||
94442790|NCT00707239|323407006|FG000|Overall Study|Lack of Efficacy|1|||
94442791|NCT00707239|323407007|FG001|Overall Study|Lack of Efficacy|2|||
94549691|NCT03442296|323807445|FG000|12 Month Follow-up|Incomplete measurement|1|||
94549692|NCT03442296|323807446|FG001|12 Month Follow-up|Incomplete measurement|1|||
94549693|NCT03596450|323807447|FG000|Overall Study|Death|9|||
94549694|NCT03596450|323807448|FG001|Overall Study|Death|9|||
94549695|NCT03596450|323807447|FG000|Overall Study|Protocol Violation|18|||
94549696|NCT03596450|323807448|FG001|Overall Study|Protocol Violation|26|||
94442792|NCT00707239|323407008|FG002|Overall Study|Lack of Efficacy|0|||
94549697|NCT03596450|323807447|FG000|Overall Study|Lost to Follow-up|50|||
94549698|NCT03596450|323807448|FG001|Overall Study|Lost to Follow-up|56|||
94442793|NCT00707239|323407006|FG000|Overall Study|Randomized, but not treated|1|||
94442794|NCT00707239|323407007|FG001|Overall Study|Randomized, but not treated|1|||
94442795|NCT00707239|323407008|FG002|Overall Study|Randomized, but not treated|1|||
94442796|NCT00707239|323407006|FG000|Overall Study|Other|8|||
94442797|NCT00707239|323407007|FG001|Overall Study|Other|3|||
94442798|NCT00707239|323407008|FG002|Overall Study|Other|5|||
94442799|NCT02792517|323407009|FG000|Overall Study|Withdrawal by Subject|10|||
94442800|NCT02792517|323407009|FG000|Overall Study|Decision by Sponsor|7|||
94442801|NCT02792517|323407009|FG000|Overall Study|Lost to Follow-up|3|||
94442802|NCT00110396|323407010|FG000|Overall Study|Adverse Event|15|||
94442803|NCT00110396|323407010|FG000|Overall Study|Lost to Follow-up|1|||
94442804|NCT00110396|323407010|FG000|Overall Study|Administration of plasmapheresis|1|||
94442805|NCT00110396|323407010|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
94442806|NCT00110396|323407010|FG000|Overall Study|Lack of Efficacy|1|||
94442807|NCT00110396|323407010|FG000|Overall Study|Decided not to continue treatment|1|||
94442808|NCT00110396|323407010|FG000|Overall Study|Patient non-compliance|1|||
94442809|NCT00110396|323407010|FG000|Overall Study|Patient refused to continue|1|||
94442810|NCT00110396|323407010|FG000|Overall Study|Patient refused to participate|1|||
94442811|NCT00110396|323407010|FG000|Overall Study|Patient will|1|||
94442812|NCT00110396|323407010|FG000|Overall Study|Patient's decision|1|||
94442813|NCT00110396|323407010|FG000|Overall Study|Participation in MS vaccine study|1|||
94442814|NCT00110396|323407010|FG000|Overall Study|Pregnancy|1|||
94442815|NCT00110396|323407010|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
94442816|NCT00110396|323407010|FG000|Overall Study|Protocol Violation|2|||
94442817|NCT00110396|323407010|FG000|Overall Study|Patient refused to come back|1|||
94442818|NCT00110396|323407010|FG000|Overall Study|The patient has refused|2|||
94442819|NCT00110396|323407010|FG000|Overall Study|The patient has refused to visit site|1|||
94442820|NCT00110396|323407010|FG000|Overall Study|Patient is to be administered copaxone|1|||
94442821|NCT00882518|323407011|FG000|Overall Study|Adverse Event|9|||
94442822|NCT00882518|323407012|FG001|Overall Study|Adverse Event|18|||
94442823|NCT00882518|323407011|FG000|Overall Study|Withdrawal by Subject|9|||
94442824|NCT00882518|323407012|FG001|Overall Study|Withdrawal by Subject|13|||
94442825|NCT00882518|323407011|FG000|Overall Study|Lack of Efficacy|12|||
94442826|NCT00882518|323407012|FG001|Overall Study|Lack of Efficacy|9|||
94442827|NCT00882518|323407011|FG000|Overall Study|Severe non-compliance to protocol|3|||
94442828|NCT00882518|323407012|FG001|Overall Study|Severe non-compliance to protocol|1|||
94442829|NCT00882518|323407011|FG000|Overall Study|Incorrect enrolment|4|||
94442830|NCT00882518|323407012|FG001|Overall Study|Incorrect enrolment|2|||
94442831|NCT00882518|323407011|FG000|Overall Study|Central lab closure for National day|1|||
94442832|NCT00882518|323407012|FG001|Overall Study|Central lab closure for National day|0|||
94442833|NCT00882518|323407011|FG000|Overall Study|Allocating random number by mistake|0|||
94442834|NCT00882518|323407012|FG001|Overall Study|Allocating random number by mistake|1|||
94442835|NCT03743051|323407013|FG000|Overall Study|Adverse Event|5|||
94442836|NCT03743051|323407014|FG001|Overall Study|Adverse Event|9|||
94442837|NCT03743051|323407013|FG000|Overall Study|Death|27|||
94442838|NCT03743051|323407014|FG001|Overall Study|Death|26|||
94442839|NCT03743051|323407013|FG000|Overall Study|Lost to Follow-up|4|||
94442840|NCT03743051|323407014|FG001|Overall Study|Lost to Follow-up|8|||
94442841|NCT03743051|323407013|FG000|Overall Study|Withdrawal by Subject|32|||
94442842|NCT03743051|323407014|FG001|Overall Study|Withdrawal by Subject|19|||
94442843|NCT03743051|323407013|FG000|Overall Study|Physician Decision|10|||
94442844|NCT03743051|323407014|FG001|Overall Study|Physician Decision|15|||
94442845|NCT03743051|323407013|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
94549699|NCT03596450|323807447|FG000|Overall Study|Adverse Event|14|||
94442846|NCT03743051|323407014|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
94442847|NCT00711087|323407015|FG000|Overall Study|Lost to Follow-up|1|||
94442848|NCT00711087|323407016|FG001|Overall Study|Lost to Follow-up|0|||
94442849|NCT03776357|323407018|FG000|Overall Study|Lost to Follow-up|3|||
94442850|NCT01928472|323407019|FG000|Overall Study|Death|0|||
94442851|NCT01928472|323407020|FG001|Overall Study|Death|0|||
94442852|NCT01928472|323407021|FG002|Overall Study|Death|1|||
94442853|NCT01928472|323407022|FG003|Overall Study|Death|0|||
94442854|NCT01928472|323407019|FG000|Overall Study|Withdrawal by Subject|4|||
94442855|NCT01928472|323407020|FG001|Overall Study|Withdrawal by Subject|4|||
94442856|NCT01928472|323407021|FG002|Overall Study|Withdrawal by Subject|1|||
94442857|NCT01928472|323407022|FG003|Overall Study|Withdrawal by Subject|2|||
94442858|NCT01928472|323407019|FG000|Overall Study|Lost to Follow-up|2|||
94442859|NCT01928472|323407020|FG001|Overall Study|Lost to Follow-up|3|||
94442860|NCT01928472|323407021|FG002|Overall Study|Lost to Follow-up|4|||
94442861|NCT01928472|323407022|FG003|Overall Study|Lost to Follow-up|0|||
94442862|NCT01928472|323407019|FG000|Overall Study|Administrative Reason|2|||
94442863|NCT01928472|323407020|FG001|Overall Study|Administrative Reason|1|||
94442864|NCT01928472|323407021|FG002|Overall Study|Administrative Reason|0|||
94442865|NCT01928472|323407022|FG003|Overall Study|Administrative Reason|0|||
94442866|NCT01928472|323407019|FG000|Overall Study|Unclassified|0|||
94442867|NCT01928472|323407020|FG001|Overall Study|Unclassified|0|||
94442868|NCT01928472|323407021|FG002|Overall Study|Unclassified|1|||
94442869|NCT01928472|323407022|FG003|Overall Study|Unclassified|0|||
94442870|NCT04620746|323407027|FG000|Overall Study|Adverse Event|2|||
94442871|NCT04620746|323407028|FG001|Overall Study|Adverse Event|0|||
94442872|NCT04620746|323407027|FG000|Overall Study|Uniterpretable skin test|1|||
94442873|NCT04620746|323407028|FG001|Overall Study|Uniterpretable skin test|0|||
94442874|NCT04620746|323407027|FG000|Overall Study|Withdrawal by Subject|0|||
94442875|NCT04620746|323407028|FG001|Overall Study|Withdrawal by Subject|1|||
94442876|NCT01108718|323407031|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
94442877|NCT01108718|323407032|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
94442878|NCT01707290|323407035|FG000|Overall Study|Adverse event (AE)|1|||
94442879|NCT01707290|323407036|FG001|Overall Study|Adverse event (AE)|0|||
94442880|NCT01707290|323407035|FG000|Overall Study|Physician Decision|1|||
94442881|NCT01707290|323407036|FG001|Overall Study|Physician Decision|0|||
94442882|NCT01707290|323407035|FG000|Overall Study|Lost to Follow-up|3|||
94442883|NCT01707290|323407036|FG001|Overall Study|Lost to Follow-up|0|||
94442884|NCT01707290|323407035|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
94442885|NCT01707290|323407036|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
94442886|NCT01707290|323407035|FG000|Overall Study|Commercial drug available|60|||
94442887|NCT01707290|323407036|FG001|Overall Study|Commercial drug available|1|||
94442888|NCT01707290|323407035|FG000|Overall Study|Other unspecified|17|||
94442889|NCT01707290|323407036|FG001|Overall Study|Other unspecified|0|||
94442890|NCT01125917|323407037|FG000|Overall Study|Adverse Event|43|||
94442891|NCT01125917|323407037|FG000|Overall Study|Lost to Follow-up|23|||
94442892|NCT01125917|323407037|FG000|Overall Study|Withdrawal by Subject|31|||
94442893|NCT01125917|323407037|FG000|Overall Study|Administrative|223|||
94442894|NCT01125917|323407037|FG000|Overall Study|Lack of Efficacy|19|||
94442895|NCT00838526|323407043|FG000|Overall Study|Adverse Event|3|||
94442896|NCT00838526|323407044|FG001|Overall Study|Adverse Event|12|||
94442897|NCT00838526|323407043|FG000|Overall Study|Lost to Follow-up|4|||
94442898|NCT00838526|323407044|FG001|Overall Study|Lost to Follow-up|12|||
94442899|NCT00838526|323407043|FG000|Overall Study|Withdrawal by Subject|4|||
94442900|NCT00838526|323407044|FG001|Overall Study|Withdrawal by Subject|5|||
94442901|NCT00838526|323407043|FG000|Overall Study|Lack of Efficacy|2|||
94442902|NCT00838526|323407044|FG001|Overall Study|Lack of Efficacy|3|||
94442903|NCT00838526|323407043|FG000|Overall Study|Other|11|||
94442904|NCT00838526|323407044|FG001|Overall Study|Other|7|||
94442905|NCT01532934|323407045|FG000|Overall Study|Lost to Follow-up|11|||
94442906|NCT01532934|323407046|FG001|Overall Study|Lost to Follow-up|11|||
94442907|NCT01532934|323407045|FG000|Overall Study|In controlled environment|3|||
94442908|NCT01532934|323407046|FG001|Overall Study|In controlled environment|2|||
94442909|NCT01147068|323407048|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
94442910|NCT01147068|323407049|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
94442911|NCT01147068|323407050|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
94549700|NCT03596450|323807448|FG001|Overall Study|Adverse Event|7|||
94549701|NCT03596450|323807447|FG000|Overall Study|Withdrawal by Subject|38|||
94549702|NCT03596450|323807448|FG001|Overall Study|Withdrawal by Subject|36|||
94549703|NCT03596450|323807447|FG000|Overall Study|Accidentally Randomized|2|||
94549704|NCT03596450|323807448|FG001|Overall Study|Accidentally Randomized|0|||
94549705|NCT03596450|323807447|FG000|Overall Study|Other reasons|48|||
94549706|NCT03596450|323807448|FG001|Overall Study|Other reasons|53|||
94549707|NCT03596450|323807447|FG000|Overall Study|Pregnancy|2|||
94549708|NCT03596450|323807448|FG001|Overall Study|Pregnancy|0|||
94549709|NCT00042666|323807449|FG000|Overall Study|Adverse Event|2|||
94549710|NCT00042666|323807449|FG000|Overall Study|Death|4|||
94549711|NCT00042666|323807449|FG000|Overall Study|Protocol Violation|1|||
94549712|NCT00042666|323807449|FG000|Overall Study|Participant/Physician Perception|1|||
94442912|NCT01147068|323407051|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
94442913|NCT01147068|323407052|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
94442914|NCT01147068|323407053|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
94442915|NCT01147068|323407054|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
94442916|NCT01147068|323407048|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
94442917|NCT01147068|323407049|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
94549713|NCT00042666|323807449|FG000|Overall Study|Progressive Disease|41|||
94442918|NCT01147068|323407050|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
94442919|NCT01147068|323407051|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
94442920|NCT01147068|323407052|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
94442921|NCT01147068|323407053|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
94442922|NCT01147068|323407054|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
94442923|NCT01147068|323407048|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
94442924|NCT01147068|323407049|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
94442925|NCT01147068|323407050|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
94442926|NCT01147068|323407051|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
94549714|NCT00042666|323807449|FG000|Overall Study|Other|1|||
94549715|NCT00042666|323807449|FG000|Overall Study|Other|4|||
94549716|NCT04268745|323807450|FG000|Overall Study|Lost to Follow-up|2|||
94549717|NCT04268745|323807451|FG001|Overall Study|Lost to Follow-up|3|||
94442927|NCT01147068|323407052|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
94442928|NCT01147068|323407053|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
94442929|NCT01147068|323407054|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
94442930|NCT01147068|323407048|FG000|Subjects That Received 2nd Dose|Other|0|||
94442931|NCT01147068|323407049|FG001|Subjects That Received 2nd Dose|Other|3|||
94442932|NCT01147068|323407050|FG002|Subjects That Received 2nd Dose|Other|3|||
94442933|NCT01147068|323407051|FG003|Subjects That Received 2nd Dose|Other|0|||
94442934|NCT01147068|323407052|FG004|Subjects That Received 2nd Dose|Other|1|||
94442935|NCT01147068|323407053|FG005|Subjects That Received 2nd Dose|Other|0|||
94442936|NCT01147068|323407054|FG006|Subjects That Received 2nd Dose|Other|0|||
94442937|NCT01147068|323407048|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
94442938|NCT01147068|323407049|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
94442939|NCT01147068|323407050|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
94442940|NCT01147068|323407051|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
94442941|NCT01147068|323407052|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
94442942|NCT01147068|323407053|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
94442943|NCT01147068|323407054|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
94442944|NCT01147068|323407048|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
94442945|NCT01147068|323407049|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
94442946|NCT01147068|323407050|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
94442947|NCT01147068|323407051|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
94442948|NCT01147068|323407052|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
94442949|NCT01147068|323407053|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
94442950|NCT01147068|323407054|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
94442951|NCT01147068|323407048|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
94442952|NCT01147068|323407049|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
94442953|NCT01147068|323407050|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
94442954|NCT01147068|323407051|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
94442955|NCT01147068|323407052|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
94442956|NCT01147068|323407053|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
94442957|NCT01147068|323407054|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
94442958|NCT00991887|323407059|FG000|Overall Study|Lost to Follow-up|2|||
94442959|NCT00991887|323407060|FG001|Overall Study|Lost to Follow-up|1|||
94442960|NCT01149863|323407061|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
94442961|NCT01306305|323407062|FG000|Overall Study|Lost to Follow-up|1|||
94442962|NCT01306305|323407063|FG001|Overall Study|Lost to Follow-up|0|||
94442963|NCT01306305|323407062|FG000|Overall Study|Withdrew consent|1|||
94442964|NCT01306305|323407063|FG001|Overall Study|Withdrew consent|0|||
94442965|NCT01406574|323407064|FG000|Overall Study|Adverse Event|0|||
94442966|NCT01406574|323407065|FG001|Overall Study|Adverse Event|0|||
94442967|NCT01406574|323407066|FG002|Overall Study|Adverse Event|1|||
94442968|NCT01406574|323407067|FG003|Overall Study|Adverse Event|3|||
94442969|NCT01406574|323407064|FG000|Overall Study|Physician Decision|0|||
94442970|NCT01406574|323407065|FG001|Overall Study|Physician Decision|0|||
94442971|NCT01406574|323407066|FG002|Overall Study|Physician Decision|0|||
94442972|NCT01406574|323407067|FG003|Overall Study|Physician Decision|1|||
94442973|NCT01406574|323407064|FG000|Overall Study|Withdrawal by Subject|0|||
94442974|NCT01406574|323407065|FG001|Overall Study|Withdrawal by Subject|1|||
94442975|NCT01406574|323407066|FG002|Overall Study|Withdrawal by Subject|0|||
94442976|NCT01406574|323407067|FG003|Overall Study|Withdrawal by Subject|0|||
94442977|NCT01406574|323407064|FG000|Overall Study|Definite progression of primary disease|1|||
94442978|NCT01406574|323407065|FG001|Overall Study|Definite progression of primary disease|0|||
94442979|NCT01406574|323407066|FG002|Overall Study|Definite progression of primary disease|0|||
94442980|NCT01406574|323407067|FG003|Overall Study|Definite progression of primary disease|0|||
94442981|NCT01757275|323407068|FG000|Overall Study|Lost to Follow-up|1|||
94442982|NCT01757275|323407069|FG001|Overall Study|Lost to Follow-up|2|||
94442983|NCT01757275|323407068|FG000|Overall Study|Adverse Event|3|||
94442984|NCT01757275|323407069|FG001|Overall Study|Adverse Event|3|||
94442985|NCT01757275|323407068|FG000|Overall Study|Withdrawal by Subject|2|||
94442986|NCT01757275|323407069|FG001|Overall Study|Withdrawal by Subject|4|||
94442987|NCT01757275|323407068|FG000|Overall Study|Not treated|3|||
94442988|NCT01757275|323407069|FG001|Overall Study|Not treated|4|||
94442989|NCT03367819|323407070|FG000|Overall Study|Adverse Event|4|||
94442990|NCT03367819|323407071|FG001|Overall Study|Adverse Event|4|||
94442991|NCT03367819|323407070|FG000|Overall Study|Progressive Disease|15|||
94442992|NCT03367819|323407071|FG001|Overall Study|Progressive Disease|13|||
94442993|NCT03367819|323407070|FG000|Overall Study|Withdrawal by Subject|1|||
94442994|NCT03367819|323407071|FG001|Overall Study|Withdrawal by Subject|0|||
94442995|NCT03367819|323407070|FG000|Overall Study|Other|4|||
94442996|NCT03367819|323407071|FG001|Overall Study|Other|2|||
94442997|NCT04720105|323407073|FG000|Overall Study|Lack of Efficacy|1|||
94442998|NCT04720105|323407073|FG000|Overall Study|Lost to Follow-up|1|||
94341223|NCT03799627|323029013|FG004|Overall Study|Investigational Product Noncompliance|0|||
94341224|NCT03799627|323029014|FG005|Overall Study|Investigational Product Noncompliance|0|||
94341225|NCT03799627|323029015|FG006|Overall Study|Investigational Product Noncompliance|0|||
94341226|NCT03799627|323029016|FG007|Overall Study|Investigational Product Noncompliance|0|||
94341227|NCT03799627|323029017|FG008|Overall Study|Investigational Product Noncompliance|0|||
94341228|NCT03799627|323029009|FG000|Overall Study|Participant Relocation|0|||
94341229|NCT03799627|323029010|FG001|Overall Study|Participant Relocation|0|||
94341230|NCT03799627|323029011|FG002|Overall Study|Participant Relocation|0|||
94341231|NCT03799627|323029012|FG003|Overall Study|Participant Relocation|1|||
94341232|NCT03799627|323029013|FG004|Overall Study|Participant Relocation|0|||
94341233|NCT03799627|323029014|FG005|Overall Study|Participant Relocation|1|||
94341234|NCT03799627|323029015|FG006|Overall Study|Participant Relocation|0|||
94341235|NCT03799627|323029016|FG007|Overall Study|Participant Relocation|0|||
94341236|NCT03799627|323029017|FG008|Overall Study|Participant Relocation|0|||
94341237|NCT03799627|323029009|FG000|Overall Study|Eurofin Issue|0|||
94341238|NCT03799627|323029010|FG001|Overall Study|Eurofin Issue|0|||
94341239|NCT03799627|323029011|FG002|Overall Study|Eurofin Issue|0|||
94341240|NCT03799627|323029012|FG003|Overall Study|Eurofin Issue|0|||
94341241|NCT03799627|323029013|FG004|Overall Study|Eurofin Issue|1|||
94341242|NCT03799627|323029014|FG005|Overall Study|Eurofin Issue|0|||
94341243|NCT03799627|323029015|FG006|Overall Study|Eurofin Issue|0|||
94341244|NCT03799627|323029016|FG007|Overall Study|Eurofin Issue|0|||
94341245|NCT03799627|323029017|FG008|Overall Study|Eurofin Issue|0|||
94341246|NCT03799627|323029009|FG000|Overall Study|Noncompliance with Site Instructions|0|||
94341247|NCT03799627|323029010|FG001|Overall Study|Noncompliance with Site Instructions|0|||
94341248|NCT03799627|323029011|FG002|Overall Study|Noncompliance with Site Instructions|0|||
94341249|NCT03799627|323029012|FG003|Overall Study|Noncompliance with Site Instructions|0|||
94341250|NCT03799627|323029013|FG004|Overall Study|Noncompliance with Site Instructions|1|||
94341251|NCT03799627|323029014|FG005|Overall Study|Noncompliance with Site Instructions|0|||
94341252|NCT03799627|323029015|FG006|Overall Study|Noncompliance with Site Instructions|0|||
94341253|NCT03799627|323029016|FG007|Overall Study|Noncompliance with Site Instructions|0|||
94341254|NCT03799627|323029017|FG008|Overall Study|Noncompliance with Site Instructions|0|||
94341255|NCT03799627|323029009|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
94341256|NCT03799627|323029010|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
94341257|NCT03799627|323029011|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
94341258|NCT03799627|323029012|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
94341259|NCT03799627|323029013|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
94341260|NCT03799627|323029014|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
94341261|NCT03799627|323029015|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
94341262|NCT03799627|323029016|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
94341263|NCT03799627|323029017|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
94341264|NCT03799627|323029009|FG000|Overall Study|Changes In Hemoglobin Values|1|||
94341265|NCT03799627|323029010|FG001|Overall Study|Changes In Hemoglobin Values|2|||
94341266|NCT03799627|323029011|FG002|Overall Study|Changes In Hemoglobin Values|1|||
94341267|NCT03799627|323029012|FG003|Overall Study|Changes In Hemoglobin Values|0|||
94341268|NCT03799627|323029013|FG004|Overall Study|Changes In Hemoglobin Values|0|||
94341269|NCT03799627|323029014|FG005|Overall Study|Changes In Hemoglobin Values|2|||
94341270|NCT03799627|323029015|FG006|Overall Study|Changes In Hemoglobin Values|1|||
94341271|NCT03799627|323029016|FG007|Overall Study|Changes In Hemoglobin Values|0|||
94341272|NCT03799627|323029017|FG008|Overall Study|Changes In Hemoglobin Values|1|||
94341273|NCT00044213|323029034|FG000|Overall Study|Withdrawal by Subject|50|||
94341274|NCT00044213|323029035|FG001|Overall Study|Withdrawal by Subject|65|||
94341275|NCT00044213|323029036|FG002|Overall Study|Withdrawal by Subject|91|||
94341276|NCT00044213|323029037|FG003|Overall Study|Withdrawal by Subject|83|||
94341277|NCT00044213|323029034|FG000|Overall Study|Death|42|||
94341278|NCT00044213|323029035|FG001|Overall Study|Death|42|||
94341279|NCT00044213|323029036|FG002|Overall Study|Death|42|||
94341280|NCT00044213|323029037|FG003|Overall Study|Death|49|||
94341281|NCT00044213|323029034|FG000|Overall Study|Lost to Follow-up|8|||
94341282|NCT00044213|323029035|FG001|Overall Study|Lost to Follow-up|5|||
94341283|NCT00044213|323029036|FG002|Overall Study|Lost to Follow-up|5|||
94341284|NCT00044213|323029037|FG003|Overall Study|Lost to Follow-up|4|||
94341285|NCT01624467|323029040|FG000|Overall Study|Withdrawal by Subject|2|||
94341286|NCT01624467|323029040|FG000|Overall Study|Lost to Follow-up|1|||
94341287|NCT01624467|323029040|FG000|Overall Study|Adverse Event|7|||
94341288|NCT01624467|323029040|FG000|Overall Study|Progressive Disease|19|||
94341289|NCT01624467|323029040|FG000|Overall Study|Per Sponsor Requirement|1|||
94341290|NCT01624467|323029040|FG000|Overall Study|Subject Withdrew from Treatment|1|||
94341291|NCT02828644|323030351|FG000|Overall Study|Lost to Follow-up|23|||
94341292|NCT02828644|323030352|FG001|Overall Study|Lost to Follow-up|22|||
94341293|NCT02658149|323030357|FG000|Overall Study|Physician Decision|1|||
94341294|NCT02658149|323030358|FG001|Overall Study|Physician Decision|0|||
94341295|NCT01804842|323030365|FG000|Overall Study|Adverse Event|1|||
94341296|NCT01804842|323030366|FG001|Overall Study|Adverse Event|1|||
94341297|NCT01804842|323030367|FG002|Overall Study|Adverse Event|0|||
94341298|NCT01804842|323030365|FG000|Overall Study|Lost to Follow-up|1|||
94341299|NCT01804842|323030366|FG001|Overall Study|Lost to Follow-up|0|||
94341300|NCT01804842|323030367|FG002|Overall Study|Lost to Follow-up|0|||
94341301|NCT01804842|323030365|FG000|Overall Study|Non-Compliance|1|||
94341302|NCT01804842|323030366|FG001|Overall Study|Non-Compliance|1|||
94341303|NCT01804842|323030367|FG002|Overall Study|Non-Compliance|0|||
94341304|NCT01804842|323030365|FG000|Overall Study|Personal Reason|0|||
94341305|NCT01804842|323030366|FG001|Overall Study|Personal Reason|0|||
94341306|NCT01804842|323030367|FG002|Overall Study|Personal Reason|1|||
94341307|NCT03369704|323030396|FG000|Treatment Epoch|technical problems|1|||
94341308|NCT03369704|323030397|FG001|Treatment Epoch|technical problems|0|||
94341309|NCT03369704|323030396|FG000|Treatment Epoch|Protocol Violation|1|||
94341310|NCT03369704|323030397|FG001|Treatment Epoch|Protocol Violation|0|||
94341311|NCT03369704|323030396|FG000|Treatment Epoch|Lost to Follow-up|0|||
94341312|NCT03369704|323030397|FG001|Treatment Epoch|Lost to Follow-up|1|||
94341313|NCT03369704|323030396|FG000|Treatment Epoch|Lack of Efficacy|0|||
94341314|NCT03369704|323030397|FG001|Treatment Epoch|Lack of Efficacy|2|||
94341315|NCT03369704|323030396|FG000|Treatment Epoch|Adverse Event|2|||
94341316|NCT03369704|323030397|FG001|Treatment Epoch|Adverse Event|0|||
94341317|NCT03369704|323030396|FG000|Follow-up Epoch|Lost to Follow-up|1|||
94341318|NCT03369704|323030397|FG001|Follow-up Epoch|Lost to Follow-up|0|||
94341319|NCT02348840|323030401|FG000|Overall Study|Withdrawal by Subject|2|||
94341320|NCT02348840|323030402|FG001|Overall Study|Withdrawal by Subject|1|||
94341321|NCT02348840|323030403|FG002|Overall Study|Withdrawal by Subject|0|||
94341322|NCT02348840|323030404|FG003|Overall Study|Withdrawal by Subject|0|||
94341323|NCT01025232|323030405|FG000|Overall Study|Study drug no longer available|3|||
94341324|NCT01025232|323030406|FG001|Overall Study|Study drug no longer available|6|||
94341325|NCT03748420|323030407|FG000|Overall Study|No 12 month medication adherence data available|0|||
94341326|NCT03748420|323030408|FG001|Overall Study|No 12 month medication adherence data available|1|||
94341327|NCT03748420|323030407|FG000|Overall Study|Death|24|||
94341328|NCT03748420|323030408|FG001|Overall Study|Death|28|||
94341329|NCT03748420|323030407|FG000|Overall Study|Lost to Follow-up|231|||
94341330|NCT03748420|323030408|FG001|Overall Study|Lost to Follow-up|230|||
94341331|NCT00373880|323030409|FG000|Overall Study|Physician Decision|3|||
94341332|NCT00373880|323030409|FG000|Overall Study|Arrested|1|||
94341333|NCT00373880|323030409|FG000|Overall Study|Protocol Violation|14|||
94341334|NCT01764022|323030411|FG000|Overall Study|Death|3|||
94341335|NCT01764022|323030412|FG001|Overall Study|Death|5|||
94341336|NCT01764022|323030411|FG000|Overall Study|Withdrawal by Subject|2|||
94341337|NCT01764022|323030412|FG001|Overall Study|Withdrawal by Subject|6|||
94341338|NCT01764022|323030411|FG000|Overall Study|Lack of Efficacy|0|||
94341339|NCT01764022|323030412|FG001|Overall Study|Lack of Efficacy|1|||
94341340|NCT01764022|323030411|FG000|Overall Study|Physician Decision|0|||
94341341|NCT01764022|323030412|FG001|Overall Study|Physician Decision|2|||
94341342|NCT01764022|323030411|FG000|Overall Study|Lost to Follow-up|2|||
94341343|NCT01764022|323030412|FG001|Overall Study|Lost to Follow-up|0|||
94341344|NCT01764022|323030411|FG000|Overall Study|Protocol Violation|1|||
94341345|NCT01764022|323030412|FG001|Overall Study|Protocol Violation|0|||
94341346|NCT01899768|323030414|FG000|Part A|Adverse Event|2|||
94341347|NCT01899768|323030414|FG000|Part A|Withdrawal by Subject|1|||
94341348|NCT01899768|323030414|FG000|Part B|Adverse Event|1|||
94341349|NCT01899768|323030414|FG000|Part B|Withdrawal by Subject|1|||
94341350|NCT01925014|323030415|FG000|Overall Study|Inappropriate enrollment|4|||
94341351|NCT01925014|323030416|FG001|Overall Study|Inappropriate enrollment|6|||
94341352|NCT01925014|323030415|FG000|Overall Study|Withdrawal by Subject|5|||
94341353|NCT01925014|323030416|FG001|Overall Study|Withdrawal by Subject|13|||
94341354|NCT00372489|323030424|FG000|Overall Study|Adverse Event|18|||
94341355|NCT00372489|323030424|FG000|Overall Study|Lack of Efficacy|1|||
94341356|NCT00372489|323030424|FG000|Overall Study|Lost to Follow-up|3|||
94341357|NCT00372489|323030424|FG000|Overall Study|Physician Decision|3|||
94341358|NCT00372489|323030424|FG000|Overall Study|Withdrawal by Subject|5|||
94341359|NCT00372489|323030424|FG000|Overall Study|Patient Relocation|2|||
94341360|NCT00372489|323030424|FG000|Overall Study|Renal transplant|6|||
94341361|NCT00372489|323030424|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
94341362|NCT01662986|323030429|FG000|Overall Study|Adverse Event|5|||
94341363|NCT01662986|323030430|FG001|Overall Study|Adverse Event|4|||
94341364|NCT01662986|323030429|FG000|Overall Study|Protocol Violation|2|||
94341365|NCT01662986|323030430|FG001|Overall Study|Protocol Violation|3|||
94341366|NCT01662986|323030429|FG000|Overall Study|Lost to Follow-up|5|||
94341367|NCT01662986|323030430|FG001|Overall Study|Lost to Follow-up|4|||
94341368|NCT01662986|323030429|FG000|Overall Study|Withdrawal by Subject|2|||
94341369|NCT01662986|323030430|FG001|Overall Study|Withdrawal by Subject|2|||
94341370|NCT01662986|323030429|FG000|Overall Study|Not Treated|1|||
94341371|NCT01662986|323030430|FG001|Overall Study|Not Treated|0|||
94341372|NCT01662986|323030429|FG000|Overall Study|Other than stated above|3|||
94341373|NCT01662986|323030430|FG001|Overall Study|Other than stated above|0|||
94341374|NCT01487863|323030434|FG000|Overall Study|Death|19|||
94341375|NCT01487863|323030435|FG001|Overall Study|Death|19|||
94341376|NCT02343952|323030438|FG000|Study Treatment|Disease Progression|23|||
94341377|NCT02343952|323030438|FG000|Study Treatment|Death|3|||
94341378|NCT02343952|323030438|FG000|Study Treatment|Adverse Event|19|||
94341379|NCT02343952|323030438|FG000|Study Treatment|Withdrawal by Subject|7|||
94341380|NCT02343952|323030438|FG000|Study Treatment|other complicating Diseases|1|||
94341381|NCT02343952|323030438|FG000|Follow up|Withdrawal by Subject|3|||
94341382|NCT02343952|323030438|FG000|Follow up|Death|33|||
94341383|NCT02343952|323030438|FG000|Follow up|Patient does not meet eligibility for study.|1|||
94341384|NCT02343952|323030438|FG000|Follow up|Research department closed by the practice.|5|||
94341385|NCT02343952|323030438|FG000|Follow up|Patient went home to Russia|1|||
94341386|NCT02343952|323030438|FG000|Follow up|Disease Progression|1|||
94341387|NCT02343952|323030438|FG000|Follow up|study terminated|1|||
94341388|NCT03934203|323030442|FG000|Overall Study|Adverse Event|0|||
94341389|NCT03934203|323030443|FG001|Overall Study|Adverse Event|0|||
94341390|NCT03934203|323030444|FG002|Overall Study|Adverse Event|1|||
94341391|NCT03934203|323030445|FG003|Overall Study|Adverse Event|0|||
94341392|NCT03934203|323030446|FG004|Overall Study|Adverse Event|1|||
94341393|NCT03934203|323030447|FG005|Overall Study|Adverse Event|0|||
94341394|NCT03934203|323030448|FG006|Overall Study|Adverse Event|2|||
94341395|NCT03934203|323030449|FG007|Overall Study|Adverse Event|0|||
94341396|NCT03934203|323030450|FG008|Overall Study|Adverse Event|0|||
94341397|NCT03934203|323030451|FG009|Overall Study|Adverse Event|0|||
94341398|NCT03934203|323030452|FG010|Overall Study|Adverse Event|0|||
94341399|NCT03934203|323030453|FG011|Overall Study|Adverse Event|0|||
94341400|NCT03934203|323030454|FG012|Overall Study|Adverse Event|0|||
94341401|NCT03934203|323030455|FG013|Overall Study|Adverse Event|1|||
94341402|NCT03934203|323030456|FG014|Overall Study|Adverse Event|0|||
94341403|NCT00333970|323030457|FG000|Overall Study|Withdrawal by Subject|13|||
94341404|NCT00333970|323030458|FG001|Overall Study|Withdrawal by Subject|7|||
94341405|NCT01810380|323030460|FG000|Overall Study|Randomised not treated|2|||
94341406|NCT01810380|323030461|FG001|Overall Study|Randomised not treated|1|||
94341407|NCT01810380|323030462|FG002|Overall Study|Randomised not treated|1|||
94341408|NCT01810380|323030460|FG000|Overall Study|Adverse Event|11|||
94341409|NCT01810380|323030461|FG001|Overall Study|Adverse Event|14|||
94341410|NCT01810380|323030462|FG002|Overall Study|Adverse Event|4|||
94341411|NCT01810380|323030460|FG000|Overall Study|Lack of Efficacy|24|||
94341412|NCT01810380|323030461|FG001|Overall Study|Lack of Efficacy|10|||
94341413|NCT01810380|323030462|FG002|Overall Study|Lack of Efficacy|11|||
94341414|NCT01810380|323030460|FG000|Overall Study|Protocol Violation|1|||
94341415|NCT01810380|323030461|FG001|Overall Study|Protocol Violation|0|||
94341416|NCT01810380|323030462|FG002|Overall Study|Protocol Violation|1|||
94341417|NCT01810380|323030460|FG000|Overall Study|Withdrawal by Subject|6|||
94341418|NCT01810380|323030461|FG001|Overall Study|Withdrawal by Subject|0|||
94341419|NCT01810380|323030462|FG002|Overall Study|Withdrawal by Subject|6|||
94341420|NCT01810380|323030460|FG000|Overall Study|Administrative or other reasons|11|||
94341421|NCT01810380|323030461|FG001|Overall Study|Administrative or other reasons|13|||
94341422|NCT01810380|323030462|FG002|Overall Study|Administrative or other reasons|9|||
94341423|NCT02829775|323030463|FG000|Overall Study|Death|1|||
94341424|NCT02829775|323030463|FG000|Overall Study|Withdrawal by Subject|3|||
94341425|NCT02829775|323030463|FG000|Overall Study|Disease remission|1|||
94341426|NCT03457636|323030470|FG000|Overall Study|Lost to Follow-up|2|||
94341427|NCT05083949|323030471|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
94341428|NCT05083949|323030472|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
94341429|NCT05083949|323030471|FG000|Period 1|Adverse Event|1|||
94341430|NCT05083949|323030472|FG001|Period 1|Adverse Event|1|||
94341431|NCT05083949|323030471|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
94341432|NCT05083949|323030472|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
94341433|NCT05083949|323030471|FG000|Period 2|Adverse Event|0|||
94341434|NCT05083949|323030472|FG001|Period 2|Adverse Event|2|||
94341435|NCT00981682|323030473|FG000|Overall Study|Adverse Event|48|||
94549718|NCT04268745|323807450|FG000|Overall Study|Withdrawal by Subject|4|||
94549719|NCT04268745|323807451|FG001|Overall Study|Withdrawal by Subject|2|||
94341436|NCT00981682|323030473|FG000|Overall Study|Withdrawal by Subject|52|||
94341437|NCT00981682|323030473|FG000|Overall Study|Lost to Follow-up|14|||
94341438|NCT00981682|323030473|FG000|Overall Study|Lack of Efficacy|13|||
94341439|NCT00981682|323030473|FG000|Overall Study|Protocol Violation|6|||
94341440|NCT00981682|323030473|FG000|Overall Study|administrative|9|||
94341441|NCT01922739|323030474|FG000|Titration/Adjustment Period|Adverse Event|3|||
94341442|NCT01922739|323030474|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
94341443|NCT01922739|323030474|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
94341444|NCT01922739|323030474|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
94341445|NCT01922739|323030474|FG000|Open-label Treatment Period|Adverse Event|6|||
94341446|NCT01922739|323030474|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
94341447|NCT01922739|323030474|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
94341448|NCT01922739|323030474|FG000|Open-label Treatment Period|Protocol Violation|5|||
94549720|NCT04268745|323807450|FG000|Overall Study|Death in the family|1|||
94549721|NCT04268745|323807451|FG001|Overall Study|Death in the family|0|||
94549722|NCT03281304|323807458|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
94549723|NCT03281304|323807459|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
94549724|NCT03281304|323807458|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
94549725|NCT03281304|323807459|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
94549726|NCT03281304|323807458|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
94549727|NCT03281304|323807459|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
94549728|NCT03281304|323807458|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
94549729|NCT03281304|323807459|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
94549730|NCT03281304|323807458|FG000|Treatment Phase (up to 42 Months)|Death|0|||
94549731|NCT03281304|323807459|FG001|Treatment Phase (up to 42 Months)|Death|1|||
94549732|NCT03281304|323807458|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
94549733|NCT03281304|323807459|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
94549734|NCT03281304|323807458|FG000|Treatment Phase (up to 42 Months)|Other|0|||
94549735|NCT03281304|323807459|FG001|Treatment Phase (up to 42 Months)|Other|2|||
94549736|NCT03281304|323807458|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
94549737|NCT03281304|323807459|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
94549738|NCT04046250|323807462|FG000|Overall Study|Death|0|||
94549739|NCT04046250|323807463|FG001|Overall Study|Death|1|||
94549740|NCT04046250|323807462|FG000|Overall Study|Withdrawal by Subject|3|||
94549741|NCT04046250|323807463|FG001|Overall Study|Withdrawal by Subject|3|||
94651334|NCT02460224|324179715|FG000|Overall Study|Subject/guardian decision|2|||
94651335|NCT02460224|324179716|FG001|Overall Study|Subject/guardian decision|0|||
94341449|NCT01922739|323030474|FG000|Open-label Treatment Period|Pregnancy|1|||
94341450|NCT01922739|323030474|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
94341451|NCT01922739|323030474|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
94341452|NCT01922739|323030474|FG000|Open-label Treatment Period|Physician Decision|1|||
94341453|NCT01922739|323030474|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
94341454|NCT02201472|323030475|FG000|Overall Study|Lack of Efficacy|2|||
94341455|NCT00262314|323030476|FG000|Overall Study|Changing physicians|38|||
94341456|NCT00262314|323030476|FG000|Overall Study|Death|12|||
94341457|NCT00262314|323030476|FG000|Overall Study|Patient's decision|92|||
94341458|NCT00262314|323030476|FG000|Overall Study|Other|95|||
94341459|NCT00262314|323030476|FG000|Overall Study|Lost to Follow-up|70|||
94341460|NCT00262314|323030476|FG000|Overall Study|Administrative withdrawal|30|||
94341461|NCT05104749|323030477|FG000|Overall Study|Lost to Follow-up|2|||
94341462|NCT05104749|323030478|FG001|Overall Study|Lost to Follow-up|3|||
94341463|NCT02470429|323030479|FG000|Overall Study|Adverse Event|1|||
94341464|NCT02470429|323030480|FG001|Overall Study|Adverse Event|0|||
94341465|NCT02470429|323030479|FG000|Overall Study|Withdrawal by Subject|1|||
94341466|NCT02470429|323030480|FG001|Overall Study|Withdrawal by Subject|0|||
94341467|NCT04973085|323030482|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
94341468|NCT04973085|323030483|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
94341469|NCT00090766|323030484|FG000|Overall Study|Nephrectomy Planned|0|||
94341470|NCT00090766|323030485|FG001|Overall Study|Nephrectomy Planned|0|||
94341471|NCT00090766|323030486|FG002|Overall Study|Nephrectomy Planned|1|||
94341472|NCT00090766|323030484|FG000|Overall Study|Death|1|||
94341473|NCT00090766|323030485|FG001|Overall Study|Death|0|||
94341474|NCT00090766|323030486|FG002|Overall Study|Death|0|||
94341475|NCT00090766|323030484|FG000|Overall Study|Admin|0|||
94341476|NCT00090766|323030485|FG001|Overall Study|Admin|2|||
94341477|NCT00090766|323030486|FG002|Overall Study|Admin|0|||
94341478|NCT00090766|323030484|FG000|Overall Study|Lost to Follow-up|2|||
94341479|NCT00090766|323030485|FG001|Overall Study|Lost to Follow-up|0|||
94341480|NCT00090766|323030486|FG002|Overall Study|Lost to Follow-up|2|||
94341481|NCT00707486|323030487|FG000|Overall Study|Withdrawal by Subject|1|||
94341482|NCT02254304|323030488|FG000|Overall Study|Adverse Event|2|||
94341483|NCT02254304|323030489|FG001|Overall Study|Adverse Event|1|||
94341484|NCT02254304|323030488|FG000|Overall Study|Lost to Follow-up|2|||
94341485|NCT02254304|323030489|FG001|Overall Study|Lost to Follow-up|2|||
94651336|NCT02460224|324179717|FG002|Overall Study|Subject/guardian decision|1|||
94651337|NCT02460224|324179718|FG003|Overall Study|Subject/guardian decision|0|||
94651338|NCT02460224|324179719|FG004|Overall Study|Subject/guardian decision|2|||
94651339|NCT02460224|324179720|FG005|Overall Study|Subject/guardian decision|2|||
94651340|NCT02460224|324179721|FG006|Overall Study|Subject/guardian decision|0|||
94651341|NCT02460224|324179722|FG007|Overall Study|Subject/guardian decision|0|||
94651342|NCT02460224|324179723|FG008|Overall Study|Subject/guardian decision|1|||
94651343|NCT02460224|324179724|FG009|Overall Study|Subject/guardian decision|1|||
94651344|NCT02460224|324179725|FG010|Overall Study|Subject/guardian decision|0|||
94341486|NCT02254304|323030488|FG000|Overall Study|Protocol Violation|1|||
94341487|NCT02254304|323030489|FG001|Overall Study|Protocol Violation|0|||
94341488|NCT02254304|323030488|FG000|Overall Study|Withdrawal by Subject|3|||
94341489|NCT02254304|323030489|FG001|Overall Study|Withdrawal by Subject|0|||
94341490|NCT02254304|323030488|FG000|Overall Study|Injection site pain and Injection fear|1|||
94341491|NCT02254304|323030489|FG001|Overall Study|Injection site pain and Injection fear|0|||
94549742|NCT02943915|323809105|FG000|Overall Study|Withdrawal by Subject|2|||
94549743|NCT02943915|323809106|FG001|Overall Study|Withdrawal by Subject|1|||
94341492|NCT02254304|323030488|FG000|Overall Study|Personal causes|4|||
94549744|NCT02943915|323809107|FG002|Overall Study|Withdrawal by Subject|0|||
94549745|NCT02943915|323809108|FG003|Overall Study|Withdrawal by Subject|0|||
94549746|NCT02943915|323809105|FG000|Overall Study|Lost to Follow-up|3|||
94549747|NCT02943915|323809106|FG001|Overall Study|Lost to Follow-up|1|||
94549748|NCT02943915|323809107|FG002|Overall Study|Lost to Follow-up|0|||
94549749|NCT02943915|323809108|FG003|Overall Study|Lost to Follow-up|0|||
94549750|NCT02943915|323809105|FG000|Overall Study|excluded|0|||
94549751|NCT02943915|323809106|FG001|Overall Study|excluded|1|||
94549752|NCT02943915|323809107|FG002|Overall Study|excluded|0|||
94549753|NCT02943915|323809108|FG003|Overall Study|excluded|0|||
94549754|NCT03769311|323809109|FG000|Overall Study|Withdrawal by Subject|1|||
94549755|NCT02017522|323809110|FG000|Overall Study|Withdrawal by Subject|1|||
94549756|NCT02271945|323809111|FG000|Overall Study|Death|3|||
94549757|NCT02271945|323809112|FG001|Overall Study|Death|3|||
94549758|NCT02271945|323809111|FG000|Overall Study|Withdrawal by Subject|1|||
94549759|NCT02271945|323809112|FG001|Overall Study|Withdrawal by Subject|1|||
94549760|NCT02271945|323809111|FG000|Overall Study|Other|1|||
94549761|NCT02271945|323809112|FG001|Overall Study|Other|1|||
94549762|NCT00151476|323809113|FG000|FAP Identified Subjects|Protocol Violation|0|||
94341493|NCT02254304|323030489|FG001|Overall Study|Personal causes|1|||
94341494|NCT02254304|323030488|FG000|Overall Study|Personal decision|1|||
94341495|NCT02254304|323030489|FG001|Overall Study|Personal decision|0|||
94341496|NCT03573804|323030492|FG000|Overall Study|claustrophobia or MRI table problems|10|||
94341497|NCT02177786|323032111|FG000|Overall Study|Withdrew Consent|2|||
94341498|NCT02177786|323032112|FG001|Overall Study|Withdrew Consent|6|||
94341499|NCT02177786|323032113|FG002|Overall Study|Withdrew Consent|9|||
94341500|NCT02177786|323032114|FG003|Overall Study|Withdrew Consent|5|||
94341501|NCT02177786|323032111|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
94341502|NCT02177786|323032112|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
94341503|NCT02177786|323032113|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
94341504|NCT02177786|323032114|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
94341505|NCT02177786|323032111|FG000|Overall Study|Adverse Event|1|||
94341506|NCT02177786|323032112|FG001|Overall Study|Adverse Event|1|||
94341507|NCT02177786|323032113|FG002|Overall Study|Adverse Event|2|||
94341508|NCT02177786|323032114|FG003|Overall Study|Adverse Event|3|||
94341509|NCT02177786|323032111|FG000|Overall Study|Death|1|||
94341510|NCT02177786|323032112|FG001|Overall Study|Death|1|||
94341511|NCT02177786|323032113|FG002|Overall Study|Death|1|||
94341512|NCT02177786|323032114|FG003|Overall Study|Death|1|||
94341513|NCT02177786|323032111|FG000|Overall Study|Lost to Follow-up|0|||
94341514|NCT02177786|323032112|FG001|Overall Study|Lost to Follow-up|0|||
94442999|NCT04720105|323407073|FG000|Overall Study|Withdrawal by Subject|3|||
94443000|NCT00273182|323407074|FG000|Overall Study|Death|450|||
94443001|NCT00273182|323407074|FG000|Overall Study|Lost to Follow-up|88|||
94443002|NCT00273182|323407074|FG000|Overall Study|Withdrawal by Subject|257|||
94443003|NCT00273182|323407074|FG000|Overall Study|Device/System Explant|154|||
94443004|NCT00273182|323407074|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
94443005|NCT04284774|323407077|FG000|Overall Study|Progressive disease|5|||
94443006|NCT02115269|323409603|FG000|Overall Study|Lost to Follow-up|43|||
94443007|NCT02115269|323409603|FG000|Overall Study|Did not complete patient diary|3|||
94443008|NCT02115269|323409603|FG000|Overall Study|Moved to another city|7|||
94443009|NCT02115269|323409603|FG000|Overall Study|Withdrawal by Subject|2|||
94443010|NCT02115269|323409603|FG000|Overall Study|Didn't take study drug|2|||
94443011|NCT00711243|323409604|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
94443012|NCT00711243|323409605|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
94443013|NCT00711243|323409606|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
94443014|NCT00711243|323409607|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
94443015|NCT00711243|323409608|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
94443016|NCT00711243|323409609|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
94443017|NCT00711243|323409604|FG000|Reached First Response/4 Cycles|Death|0|||
94443018|NCT00711243|323409605|FG001|Reached First Response/4 Cycles|Death|0|||
94443019|NCT00711243|323409606|FG002|Reached First Response/4 Cycles|Death|0|||
94443020|NCT00711243|323409607|FG003|Reached First Response/4 Cycles|Death|0|||
94443021|NCT00711243|323409608|FG004|Reached First Response/4 Cycles|Death|0|||
94549763|NCT00151476|323809114|FG001|FAP Identified Subjects|Protocol Violation|1|||
94549764|NCT00151476|323809113|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
94549765|NCT00151476|323809114|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
94341515|NCT02177786|323032113|FG002|Overall Study|Lost to Follow-up|2|||
94341516|NCT02177786|323032114|FG003|Overall Study|Lost to Follow-up|2|||
94341517|NCT02177786|323032111|FG000|Overall Study|Non-Compliance with Study Drug|0|||
94341518|NCT02177786|323032112|FG001|Overall Study|Non-Compliance with Study Drug|1|||
94341519|NCT02177786|323032113|FG002|Overall Study|Non-Compliance with Study Drug|0|||
94341520|NCT02177786|323032114|FG003|Overall Study|Non-Compliance with Study Drug|1|||
94688599|NCT00390455|324315526|FG000|Overall Study|Adverse Event|17|||
94443022|NCT00711243|323409609|FG005|Reached First Response/4 Cycles|Death|2|||
94443023|NCT00711243|323409604|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
94443024|NCT00711243|323409605|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
94443025|NCT00711243|323409606|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
94443026|NCT00711243|323409607|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
94443027|NCT00711243|323409608|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
94443028|NCT00711243|323409609|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
94443029|NCT00711243|323409604|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
94443030|NCT00711243|323409605|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
94341521|NCT02177786|323032111|FG000|Overall Study|Protocol Violation|0|||
94341522|NCT02177786|323032112|FG001|Overall Study|Protocol Violation|0|||
94341523|NCT02177786|323032113|FG002|Overall Study|Protocol Violation|2|||
94341524|NCT02177786|323032114|FG003|Overall Study|Protocol Violation|0|||
94341525|NCT02177786|323032111|FG000|Overall Study|Progressive Disease|0|||
94341526|NCT02177786|323032112|FG001|Overall Study|Progressive Disease|1|||
94341527|NCT02177786|323032113|FG002|Overall Study|Progressive Disease|0|||
94341528|NCT02177786|323032114|FG003|Overall Study|Progressive Disease|0|||
94341529|NCT02177786|323032111|FG000|Overall Study|Missing study completion status|0|||
94341530|NCT02177786|323032112|FG001|Overall Study|Missing study completion status|1|||
94341531|NCT02177786|323032113|FG002|Overall Study|Missing study completion status|0|||
94341532|NCT02177786|323032114|FG003|Overall Study|Missing study completion status|0|||
94341533|NCT00439309|323032115|FG000|Follow-Up|Death|1|||
94341534|NCT00439309|323032116|FG001|Follow-Up|Death|0|||
94341535|NCT00439309|323032115|FG000|Follow-Up|Lost to Follow-up|2|||
94341536|NCT00439309|323032116|FG001|Follow-Up|Lost to Follow-up|0|||
94341537|NCT00439309|323032115|FG000|Follow-Up|Withdrawal by Subject|0|||
94341538|NCT00439309|323032116|FG001|Follow-Up|Withdrawal by Subject|1|||
94341539|NCT00439309|323032115|FG000|Follow-Up|Late response by subject|0|||
94341540|NCT00439309|323032116|FG001|Follow-Up|Late response by subject|1|||
94341541|NCT00464620|323032120|FG000|Overall Study|Physician Decision|1|||
94341542|NCT00464620|323032121|FG001|Overall Study|Physician Decision|0|||
94341543|NCT00464620|323032122|FG002|Overall Study|Physician Decision|0|||
94549766|NCT00151476|323809113|FG000|FAP Analyzed Subjects|Other study participation|0|||
94549767|NCT00151476|323809114|FG001|FAP Analyzed Subjects|Other study participation|1|||
94549768|NCT03002311|323809119|FG000|Overall Study|Lost to Follow-up|13|||
94549769|NCT03002311|323809120|FG001|Overall Study|Lost to Follow-up|26|||
94549770|NCT03002311|323809119|FG000|Overall Study|Referral provider called to schedule app|3|||
94549771|NCT03002311|323809120|FG001|Overall Study|Referral provider called to schedule app|3|||
94549772|NCT03002311|323809119|FG000|Overall Study|Physician Decision|3|||
94549773|NCT03002311|323809120|FG001|Overall Study|Physician Decision|1|||
94549774|NCT03779503|323809125|FG000|First Intervention|Adverse Event|0|||
94549775|NCT03779503|323809126|FG001|First Intervention|Adverse Event|1|||
94549776|NCT03779503|323809125|FG000|First Intervention|Withdrawal by Subject|1|||
94549777|NCT03779503|323809126|FG001|First Intervention|Withdrawal by Subject|0|||
94549778|NCT00443781|323809127|FG000|Overall Study|Lost to Follow-up|10|||
94443031|NCT00711243|323409606|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
94443032|NCT00711243|323409607|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
94549779|NCT00443781|323809127|FG000|Overall Study|Physician Decision|2|||
94549780|NCT00443781|323809127|FG000|Overall Study|Protocol Violation|1|||
94549781|NCT00443781|323809127|FG000|Overall Study|Withdrawal by Subject|6|||
94549782|NCT00443781|323809127|FG000|Overall Study|Unable to comply with study follow up|2|||
94549783|NCT00443781|323809127|FG000|Overall Study|Investigator terminated participation|1|||
94549784|NCT00443781|323809127|FG000|Overall Study|Insurance not covered|2|||
94549785|NCT00443781|323809127|FG000|Overall Study|PD/FAD not done|1|||
94549786|NCT02066415|323809128|FG000|Overall Study|Decision by Sponsor|5|||
94549787|NCT02066415|323809129|FG001|Overall Study|Decision by Sponsor|4|||
94549788|NCT02066415|323809130|FG002|Overall Study|Decision by Sponsor|2|||
94549789|NCT02066415|323809128|FG000|Overall Study|Withdrawal by Subject|9|||
94549790|NCT02066415|323809129|FG001|Overall Study|Withdrawal by Subject|1|||
94549791|NCT02066415|323809130|FG002|Overall Study|Withdrawal by Subject|4|||
94549792|NCT02066415|323809128|FG000|Overall Study|Lost to Follow-up|7|||
94549793|NCT02066415|323809129|FG001|Overall Study|Lost to Follow-up|2|||
94549794|NCT02066415|323809130|FG002|Overall Study|Lost to Follow-up|2|||
94443033|NCT00711243|323409608|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
94549795|NCT00895661|323809131|FG000|Overall Study|Death|1|||
94549796|NCT00895661|323809131|FG000|Overall Study|reason unknown|2|||
94549797|NCT02211313|323809136|FG000|Overall Study|Treatment Failure|5|||
94341544|NCT00464620|323032120|FG000|Overall Study|Withdrawal by Subject|1|||
94549798|NCT02211313|323809137|FG001|Overall Study|Treatment Failure|2|||
94341545|NCT00464620|323032121|FG001|Overall Study|Withdrawal by Subject|0|||
94341546|NCT00464620|323032122|FG002|Overall Study|Withdrawal by Subject|3|||
94341547|NCT00464620|323032120|FG000|Overall Study|Ineligible sarcoma subtype|0|||
94549799|NCT02211313|323809136|FG000|Overall Study|No Follow up Questionnaires|1|||
94688600|NCT00390455|324315527|FG001|Overall Study|Adverse Event|3|||
94341548|NCT00464620|323032121|FG001|Overall Study|Ineligible sarcoma subtype|2|||
94341549|NCT00464620|323032122|FG002|Overall Study|Ineligible sarcoma subtype|2|||
94341550|NCT00464620|323032120|FG000|Overall Study|Use of prohibited concomitant medication|0|||
94341551|NCT00464620|323032121|FG001|Overall Study|Use of prohibited concomitant medication|0|||
94341552|NCT00464620|323032122|FG002|Overall Study|Use of prohibited concomitant medication|2|||
94341553|NCT04402385|323032123|FG000|Overall Study|Withdrawal by Subject|4|||
94341554|NCT04402385|323032124|FG001|Overall Study|Withdrawal by Subject|4|||
94341555|NCT04402385|323032123|FG000|Overall Study|Lost to Follow-up|1|||
94341556|NCT04402385|323032124|FG001|Overall Study|Lost to Follow-up|1|||
94341557|NCT04402385|323032123|FG000|Overall Study|Physician Decision|0|||
94341558|NCT04402385|323032124|FG001|Overall Study|Physician Decision|1|||
94341559|NCT02996110|323032125|FG000|Pre-Treatment|Other Reasons|0|||
94341560|NCT02996110|323032126|FG001|Pre-Treatment|Other Reasons|1|||
94341561|NCT02996110|323032127|FG002|Pre-Treatment|Other Reasons|0|||
94341562|NCT02996110|323032128|FG003|Pre-Treatment|Other Reasons|0|||
94341563|NCT02996110|323032129|FG004|Pre-Treatment|Other Reasons|1|||
94341564|NCT02996110|323032125|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
94341565|NCT02996110|323032126|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
94341566|NCT02996110|323032127|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
94341567|NCT02996110|323032128|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
94341568|NCT02996110|323032129|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
94341569|NCT02996110|323032125|FG000|Track 1|Disease Progression|15|||
94341570|NCT02996110|323032126|FG001|Track 1|Disease Progression|17|||
94341571|NCT02996110|323032127|FG002|Track 1|Disease Progression|0|||
94341572|NCT02996110|323032128|FG003|Track 1|Disease Progression|0|||
94341573|NCT02996110|323032129|FG004|Track 1|Disease Progression|0|||
94341574|NCT02996110|323032125|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
94341575|NCT02996110|323032126|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
94341576|NCT02996110|323032127|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
94341577|NCT02996110|323032128|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
94341578|NCT02996110|323032129|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
94341579|NCT02996110|323032125|FG000|Track 1|Study Drug Toxicity|5|||
94341580|NCT02996110|323032126|FG001|Track 1|Study Drug Toxicity|3|||
94341581|NCT02996110|323032127|FG002|Track 1|Study Drug Toxicity|0|||
94341582|NCT02996110|323032128|FG003|Track 1|Study Drug Toxicity|0|||
94341583|NCT02996110|323032129|FG004|Track 1|Study Drug Toxicity|0|||
94341584|NCT02996110|323032125|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
94341585|NCT02996110|323032126|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
94341586|NCT02996110|323032127|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
94549800|NCT02211313|323809137|FG001|Overall Study|No Follow up Questionnaires|1|||
94549801|NCT03743064|323809138|FG000|Overall Study|Adverse Event|7|||
94549802|NCT03743064|323809139|FG001|Overall Study|Adverse Event|9|||
94549803|NCT03743064|323809138|FG000|Overall Study|Death|25|||
94549804|NCT03743064|323809139|FG001|Overall Study|Death|28|||
94549805|NCT03743064|323809138|FG000|Overall Study|Lost to Follow-up|3|||
94549806|NCT03743064|323809139|FG001|Overall Study|Lost to Follow-up|6|||
94549807|NCT03743064|323809138|FG000|Overall Study|Withdrawal by Subject|28|||
94549808|NCT03743064|323809139|FG001|Overall Study|Withdrawal by Subject|25|||
94549809|NCT03743064|323809138|FG000|Overall Study|Physician Decision|2|||
94549810|NCT03743064|323809139|FG001|Overall Study|Physician Decision|4|||
94549811|NCT03743064|323809138|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
94549812|NCT03743064|323809139|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
94549813|NCT02553538|323809142|FG000|Overall Study|Could Not Reach by Telephone|133|||
94549814|NCT02553538|323809143|FG001|Overall Study|Could Not Reach by Telephone|0|||
94549815|NCT02553538|323809142|FG000|Overall Study|Died or Left Network|54|||
94549816|NCT02553538|323809143|FG001|Overall Study|Died or Left Network|56|||
94549817|NCT02648217|323809144|FG000|Overall Study|Adverse Event|0|||
94549818|NCT02648217|323809145|FG001|Overall Study|Adverse Event|1|||
94549819|NCT02648217|323809144|FG000|Overall Study|Lost to Follow-up|1|||
94549820|NCT02648217|323809145|FG001|Overall Study|Lost to Follow-up|1|||
94549821|NCT02648217|323809144|FG000|Overall Study|Withdrawal by Subject|4|||
94549822|NCT02648217|323809145|FG001|Overall Study|Withdrawal by Subject|3|||
94341587|NCT02996110|323032128|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
94549823|NCT02648217|323809144|FG000|Overall Study|Unclassified|5|||
94549824|NCT02648217|323809145|FG001|Overall Study|Unclassified|0|||
94549825|NCT03316950|323809146|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
94549826|NCT03316950|323809147|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
94549827|NCT03316950|323809148|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
94341588|NCT02996110|323032129|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
94341589|NCT02996110|323032125|FG000|Track 1|Administrative Reason by Sponsor|0|||
94341590|NCT02996110|323032126|FG001|Track 1|Administrative Reason by Sponsor|1|||
94341591|NCT02996110|323032127|FG002|Track 1|Administrative Reason by Sponsor|0|||
94341592|NCT02996110|323032128|FG003|Track 1|Administrative Reason by Sponsor|0|||
94549828|NCT03316950|323809149|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
94549829|NCT03316950|323809146|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
94549830|NCT03316950|323809147|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
94341593|NCT02996110|323032129|FG004|Track 1|Administrative Reason by Sponsor|0|||
94341594|NCT02996110|323032125|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
94341595|NCT02996110|323032126|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
94341596|NCT02996110|323032127|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
94341597|NCT02996110|323032128|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
94341598|NCT02996110|323032129|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
94341599|NCT02996110|323032125|FG000|Track 2|Disease Progression|33|||
94341600|NCT02996110|323032126|FG001|Track 2|Disease Progression|26|||
94341601|NCT02996110|323032127|FG002|Track 2|Disease Progression|19|||
94341602|NCT02996110|323032128|FG003|Track 2|Disease Progression|16|||
94341603|NCT02996110|323032129|FG004|Track 2|Disease Progression|15|||
94341604|NCT02996110|323032125|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
94341605|NCT02996110|323032126|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
94341606|NCT02996110|323032127|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
94341607|NCT02996110|323032128|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
94341608|NCT02996110|323032129|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
94341609|NCT02996110|323032125|FG000|Track 2|Death|0|||
94341610|NCT02996110|323032126|FG001|Track 2|Death|0|||
94341611|NCT02996110|323032127|FG002|Track 2|Death|1|||
94341612|NCT02996110|323032128|FG003|Track 2|Death|0|||
94341613|NCT02996110|323032129|FG004|Track 2|Death|1|||
94341614|NCT02996110|323032125|FG000|Track 2|Study Drug Toxicity|4|||
94341615|NCT02996110|323032126|FG001|Track 2|Study Drug Toxicity|1|||
94341616|NCT02996110|323032127|FG002|Track 2|Study Drug Toxicity|4|||
94341617|NCT02996110|323032128|FG003|Track 2|Study Drug Toxicity|1|||
94341618|NCT02996110|323032129|FG004|Track 2|Study Drug Toxicity|0|||
94341619|NCT02996110|323032125|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
94341620|NCT02996110|323032126|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
94341621|NCT02996110|323032127|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
94341622|NCT02996110|323032128|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
94341623|NCT02996110|323032129|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
94341624|NCT02996110|323032125|FG000|Track 2|Participant Withdrew Consent|1|||
94341625|NCT02996110|323032126|FG001|Track 2|Participant Withdrew Consent|2|||
94341626|NCT02996110|323032127|FG002|Track 2|Participant Withdrew Consent|3|||
94341627|NCT02996110|323032128|FG003|Track 2|Participant Withdrew Consent|1|||
94341628|NCT02996110|323032129|FG004|Track 2|Participant Withdrew Consent|1|||
94341629|NCT02996110|323032125|FG000|Track 2|Other Reasons|0|||
94341630|NCT02996110|323032126|FG001|Track 2|Other Reasons|0|||
94341631|NCT02996110|323032127|FG002|Track 2|Other Reasons|1|||
94341632|NCT02996110|323032128|FG003|Track 2|Other Reasons|0|||
94341633|NCT02996110|323032129|FG004|Track 2|Other Reasons|1|||
94341634|NCT01518309|323032133|FG000|Overall Study|Adverse Event|6|||
94341635|NCT01518309|323032133|FG000|Overall Study|Death|6|||
94341636|NCT01518309|323032133|FG000|Overall Study|Lack of Efficacy|7|||
94341637|NCT01518309|323032133|FG000|Overall Study|Withdrawal by Subject|6|||
94341638|NCT01518309|323032133|FG000|Overall Study|Physician Decision|3|||
94341639|NCT01518309|323032133|FG000|Overall Study|Sponsor Decision|2|||
94341640|NCT01518309|323032133|FG000|Overall Study|Not in Predefined Categories|9|||
94341641|NCT02603172|323032134|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
94341642|NCT02603172|323032135|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
94341643|NCT02603172|323032136|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
94341644|NCT02603172|323032137|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
94341645|NCT02603172|323032138|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
94341646|NCT02603172|323032139|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
94341647|NCT02603172|323032140|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
94341648|NCT02603172|323032141|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
94341649|NCT00863317|323032142|FG000|Overall Study|Lost to Follow-up|8|||
94341650|NCT00863317|323032143|FG001|Overall Study|Lost to Follow-up|9|||
94341651|NCT02579863|323032144|FG000|Overall Study|Final Disposition Unknown|2|||
94341652|NCT02579863|323032145|FG001|Overall Study|Final Disposition Unknown|1|||
94341653|NCT02579863|323032144|FG000|Overall Study|Adverse Event|18|||
94549831|NCT03316950|323809148|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
94549832|NCT03316950|323809149|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
94341654|NCT02579863|323032145|FG001|Overall Study|Adverse Event|11|||
94341655|NCT02579863|323032144|FG000|Overall Study|Death|31|||
94341656|NCT02579863|323032145|FG001|Overall Study|Death|29|||
94341657|NCT02579863|323032144|FG000|Overall Study|Lost to Follow-up|2|||
94341658|NCT02579863|323032145|FG001|Overall Study|Lost to Follow-up|1|||
94341659|NCT02579863|323032144|FG000|Overall Study|Physician Decision|1|||
94341660|NCT02579863|323032145|FG001|Overall Study|Physician Decision|2|||
94549833|NCT03316950|323809146|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
94341661|NCT02579863|323032144|FG000|Overall Study|Screen Failure|0|||
94341662|NCT02579863|323032145|FG001|Overall Study|Screen Failure|2|||
94341663|NCT02579863|323032144|FG000|Overall Study|Study Terminated at Selected Sites|82|||
94341664|NCT02579863|323032145|FG001|Overall Study|Study Terminated at Selected Sites|88|||
94341665|NCT02579863|323032144|FG000|Overall Study|Withdrawal by Subject|20|||
94443034|NCT00711243|323409609|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
94443035|NCT00711243|323409604|FG000|Treated Cycle 5 After First Response|Death|0|||
94443036|NCT00711243|323409605|FG001|Treated Cycle 5 After First Response|Death|0|||
94443037|NCT00711243|323409606|FG002|Treated Cycle 5 After First Response|Death|0|||
94443038|NCT00711243|323409607|FG003|Treated Cycle 5 After First Response|Death|0|||
94443039|NCT00711243|323409608|FG004|Treated Cycle 5 After First Response|Death|0|||
94443040|NCT00711243|323409609|FG005|Treated Cycle 5 After First Response|Death|2|||
94443041|NCT00711243|323409604|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
94443042|NCT00711243|323409605|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
94443043|NCT00711243|323409606|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
94443044|NCT00711243|323409607|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
94341666|NCT02579863|323032145|FG001|Overall Study|Withdrawal by Subject|20|||
94341667|NCT03878160|323032149|FG000|Overall Study|Lost to Follow-up|1|||
94341668|NCT03878160|323032150|FG001|Overall Study|Lost to Follow-up|1|||
94341669|NCT03878160|323032151|FG002|Overall Study|Lost to Follow-up|1|||
94341670|NCT03878160|323032149|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
94341671|NCT03878160|323032150|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
94341672|NCT03878160|323032151|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
94341673|NCT01505114|323032154|FG000|Overall Study|Withdrawal by Subject|5|||
94341674|NCT01505114|323032155|FG001|Overall Study|Withdrawal by Subject|4|||
94341675|NCT01505114|323032156|FG002|Overall Study|Withdrawal by Subject|4|||
94341676|NCT01505114|323032157|FG003|Overall Study|Withdrawal by Subject|7|||
94549834|NCT03316950|323809147|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
94549835|NCT03316950|323809148|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
94549836|NCT03316950|323809149|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
94549837|NCT00300365|323809152|FG000|Overall Study|Lost to Follow-up|1|||
94549838|NCT00300365|323809153|FG001|Overall Study|Lost to Follow-up|0|||
94549839|NCT00300365|323809152|FG000|Overall Study|Physician Decision|2|||
94549840|NCT00300365|323809153|FG001|Overall Study|Physician Decision|0|||
94549841|NCT00300365|323809152|FG000|Overall Study|Withdrawal by Subject|1|||
94549842|NCT00300365|323809153|FG001|Overall Study|Withdrawal by Subject|0|||
94549843|NCT00300365|323809152|FG000|Overall Study|Adverse Event|0|||
94549844|NCT00300365|323809153|FG001|Overall Study|Adverse Event|2|||
94549845|NCT00549770|323809154|FG000|Overall Study|Protocol deviation|1|||
94549846|NCT00549770|323809155|FG001|Overall Study|Protocol deviation|1|||
94549847|NCT00549770|323809156|FG002|Overall Study|Protocol deviation|1|||
94549848|NCT00549770|323809157|FG003|Overall Study|Protocol deviation|2|||
94549849|NCT00549770|323809158|FG004|Overall Study|Protocol deviation|2|||
94549850|NCT00549770|323809159|FG005|Overall Study|Protocol deviation|2|||
94549851|NCT00549770|323809160|FG006|Overall Study|Protocol deviation|1|||
94549852|NCT00549770|323809161|FG007|Overall Study|Protocol deviation|2|||
94549853|NCT00549770|323809154|FG000|Overall Study|Administrative problems|0|||
94549854|NCT00549770|323809155|FG001|Overall Study|Administrative problems|1|||
94549855|NCT00549770|323809156|FG002|Overall Study|Administrative problems|0|||
94549856|NCT00549770|323809157|FG003|Overall Study|Administrative problems|0|||
94341677|NCT01505114|323032154|FG000|Overall Study|Death|1|||
94443045|NCT00711243|323409608|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
94443046|NCT00711243|323409609|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
94443047|NCT00711243|323409604|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
94443048|NCT00711243|323409605|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
94443049|NCT00711243|323409606|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
94443050|NCT00711243|323409607|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
94549857|NCT00549770|323809158|FG004|Overall Study|Administrative problems|0|||
94549858|NCT00549770|323809159|FG005|Overall Study|Administrative problems|0|||
94549859|NCT00549770|323809160|FG006|Overall Study|Administrative problems|0|||
94549860|NCT00549770|323809161|FG007|Overall Study|Administrative problems|1|||
94549861|NCT00549770|323809154|FG000|Overall Study|Lost to Follow-up|0|||
94549862|NCT00549770|323809155|FG001|Overall Study|Lost to Follow-up|0|||
94549863|NCT00549770|323809156|FG002|Overall Study|Lost to Follow-up|2|||
94549864|NCT00549770|323809157|FG003|Overall Study|Lost to Follow-up|2|||
94549865|NCT00549770|323809158|FG004|Overall Study|Lost to Follow-up|3|||
94549866|NCT00549770|323809159|FG005|Overall Study|Lost to Follow-up|2|||
94549867|NCT00549770|323809160|FG006|Overall Study|Lost to Follow-up|0|||
94549868|NCT00549770|323809161|FG007|Overall Study|Lost to Follow-up|0|||
94549869|NCT00549770|323809154|FG000|Overall Study|Withdrawal by Subject|4|||
94549870|NCT00549770|323809155|FG001|Overall Study|Withdrawal by Subject|6|||
94549871|NCT00549770|323809156|FG002|Overall Study|Withdrawal by Subject|4|||
94549872|NCT00549770|323809157|FG003|Overall Study|Withdrawal by Subject|5|||
94549873|NCT00549770|323809158|FG004|Overall Study|Withdrawal by Subject|6|||
94549874|NCT00549770|323809159|FG005|Overall Study|Withdrawal by Subject|6|||
94549875|NCT00549770|323809160|FG006|Overall Study|Withdrawal by Subject|4|||
94549876|NCT00549770|323809161|FG007|Overall Study|Withdrawal by Subject|9|||
94341678|NCT01505114|323032155|FG001|Overall Study|Death|0|||
94549877|NCT00549770|323809154|FG000|Overall Study|Lack of Efficacy|1|||
94549878|NCT00549770|323809155|FG001|Overall Study|Lack of Efficacy|0|||
94549879|NCT00549770|323809156|FG002|Overall Study|Lack of Efficacy|2|||
94549880|NCT00549770|323809157|FG003|Overall Study|Lack of Efficacy|3|||
94549881|NCT00549770|323809158|FG004|Overall Study|Lack of Efficacy|5|||
94549882|NCT00549770|323809159|FG005|Overall Study|Lack of Efficacy|1|||
94549883|NCT00549770|323809160|FG006|Overall Study|Lack of Efficacy|3|||
94549884|NCT00549770|323809161|FG007|Overall Study|Lack of Efficacy|8|||
94549885|NCT00549770|323809154|FG000|Overall Study|Abnormal test procedure results|0|||
94549886|NCT00549770|323809155|FG001|Overall Study|Abnormal test procedure results|0|||
94549887|NCT00549770|323809156|FG002|Overall Study|Abnormal test procedure results|0|||
94549888|NCT00549770|323809157|FG003|Overall Study|Abnormal test procedure results|2|||
94549889|NCT00549770|323809158|FG004|Overall Study|Abnormal test procedure results|0|||
94549890|NCT00549770|323809159|FG005|Overall Study|Abnormal test procedure results|1|||
94341679|NCT01505114|323032156|FG002|Overall Study|Death|0|||
94341680|NCT01505114|323032157|FG003|Overall Study|Death|1|||
94341681|NCT01505114|323032154|FG000|Overall Study|unable to adhere to visit schedule|3|||
94341682|NCT01505114|323032155|FG001|Overall Study|unable to adhere to visit schedule|2|||
94341683|NCT01505114|323032156|FG002|Overall Study|unable to adhere to visit schedule|3|||
94341684|NCT01505114|323032157|FG003|Overall Study|unable to adhere to visit schedule|3|||
94341685|NCT01505114|323032154|FG000|Overall Study|Lost to Follow-up|11|||
94341686|NCT01505114|323032155|FG001|Overall Study|Lost to Follow-up|5|||
94549891|NCT00549770|323809160|FG006|Overall Study|Abnormal test procedure results|1|||
94549892|NCT00549770|323809161|FG007|Overall Study|Abnormal test procedure results|1|||
94549893|NCT00549770|323809154|FG000|Overall Study|Abnormal laboratory values|0|||
94549894|NCT00549770|323809155|FG001|Overall Study|Abnormal laboratory values|0|||
94549895|NCT00549770|323809156|FG002|Overall Study|Abnormal laboratory values|0|||
94549896|NCT00549770|323809157|FG003|Overall Study|Abnormal laboratory values|0|||
94549897|NCT00549770|323809158|FG004|Overall Study|Abnormal laboratory values|0|||
94549898|NCT00549770|323809159|FG005|Overall Study|Abnormal laboratory values|1|||
94549899|NCT00549770|323809160|FG006|Overall Study|Abnormal laboratory values|0|||
94549900|NCT00549770|323809161|FG007|Overall Study|Abnormal laboratory values|0|||
94549901|NCT00549770|323809154|FG000|Overall Study|Adverse Event|1|||
94549902|NCT00549770|323809155|FG001|Overall Study|Adverse Event|3|||
94341687|NCT01505114|323032156|FG002|Overall Study|Lost to Follow-up|8|||
94341688|NCT01505114|323032157|FG003|Overall Study|Lost to Follow-up|7|||
94549903|NCT00549770|323809156|FG002|Overall Study|Adverse Event|1|||
94549904|NCT00549770|323809157|FG003|Overall Study|Adverse Event|2|||
94341689|NCT01505114|323032154|FG000|Overall Study|relocated|4|||
94341690|NCT01505114|323032155|FG001|Overall Study|relocated|2|||
94341691|NCT01505114|323032156|FG002|Overall Study|relocated|2|||
94341692|NCT01505114|323032157|FG003|Overall Study|relocated|3|||
94341693|NCT01505114|323032154|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
94549905|NCT00549770|323809158|FG004|Overall Study|Adverse Event|1|||
94549906|NCT00549770|323809159|FG005|Overall Study|Adverse Event|0|||
94549907|NCT00549770|323809160|FG006|Overall Study|Adverse Event|5|||
94549908|NCT00549770|323809161|FG007|Overall Study|Adverse Event|4|||
94549909|NCT02294734|323809164|FG000|Overall Study|Adverse Event|5|||
94549910|NCT02294734|323809165|FG001|Overall Study|Adverse Event|5|||
94549911|NCT02294734|323809164|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
94549912|NCT02294734|323809165|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
94549913|NCT02294734|323809164|FG000|Overall Study|Lost to Follow-up|2|||
94549914|NCT02294734|323809165|FG001|Overall Study|Lost to Follow-up|0|||
94341694|NCT01505114|323032155|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
94341695|NCT01505114|323032156|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
94341696|NCT01505114|323032157|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
94341697|NCT01505114|323032154|FG000|Overall Study|staff safety concerns|0|||
94341698|NCT01505114|323032155|FG001|Overall Study|staff safety concerns|0|||
94341699|NCT01505114|323032156|FG002|Overall Study|staff safety concerns|0|||
94341700|NCT01505114|323032157|FG003|Overall Study|staff safety concerns|1|||
94341701|NCT01505114|323032154|FG000|Overall Study|investigator decision|1|||
94341702|NCT01505114|323032155|FG001|Overall Study|investigator decision|0|||
94341703|NCT01505114|323032156|FG002|Overall Study|investigator decision|1|||
94341704|NCT01505114|323032157|FG003|Overall Study|investigator decision|0|||
94341705|NCT01688999|323032158|FG000|Overall Study|Withdrawal by Subject|5|||
94341706|NCT01688999|323032159|FG001|Overall Study|Withdrawal by Subject|1|||
94341707|NCT01688999|323032160|FG002|Overall Study|Withdrawal by Subject|1|||
94341708|NCT01688999|323032158|FG000|Overall Study|Adverse Event|2|||
94341709|NCT01688999|323032159|FG001|Overall Study|Adverse Event|0|||
94341710|NCT01688999|323032160|FG002|Overall Study|Adverse Event|2|||
94549915|NCT02294734|323809164|FG000|Overall Study|Physician Decision|2|||
94549916|NCT02294734|323809165|FG001|Overall Study|Physician Decision|1|||
94549917|NCT02294734|323809164|FG000|Overall Study|Withdrawal by Subject|4|||
94549918|NCT02294734|323809165|FG001|Overall Study|Withdrawal by Subject|2|||
94549919|NCT02335424|323809166|FG000|Overall Study|Withdrawal by Subject|19|||
94549920|NCT02335424|323809166|FG000|Overall Study|Adverse Event|25|||
94549921|NCT02335424|323809166|FG000|Overall Study|Death|273|||
94549922|NCT02335424|323809166|FG000|Overall Study|Lost to Follow-up|3|||
94549923|NCT02335424|323809166|FG000|Overall Study|Physician Decision|13|||
94549924|NCT02335424|323809166|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
94549925|NCT02335424|323809166|FG000|Overall Study|Protocol Violation|1|||
94549926|NCT02335424|323809166|FG000|Overall Study|Screen failure|1|||
94549927|NCT01177969|323809170|FG000|Overall Study|Protocol Violation|2|||
94549928|NCT01177969|323809171|FG001|Overall Study|Protocol Violation|1|||
94549929|NCT01177969|323809170|FG000|Overall Study|Withdrawal by Subject|1|||
94549930|NCT01177969|323809171|FG001|Overall Study|Withdrawal by Subject|2|||
94549931|NCT01639755|323809172|FG000|Overall Study|Study Ongoing|15|||
94549932|NCT01639755|323809172|FG000|Overall Study|Patient had device explantation|4|||
94549933|NCT03629912|323809174|FG000|Overall Study|Lost to Follow-up|19|||
94341711|NCT01688999|323032158|FG000|Overall Study|Ineligible/Not treated|1|||
94341712|NCT01688999|323032159|FG001|Overall Study|Ineligible/Not treated|0|||
94341713|NCT01688999|323032160|FG002|Overall Study|Ineligible/Not treated|0|||
94341714|NCT00481988|323032161|FG000|Overall Study|Withdrawal by Subject|1|||
94341715|NCT00481988|323032162|FG001|Overall Study|Withdrawal by Subject|1|||
94341716|NCT00654420|323032163|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
94341717|NCT00654420|323032164|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
94341718|NCT00654420|323032165|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
94341719|NCT00654420|323032166|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
94341720|NCT00654420|323032163|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
94341721|NCT00654420|323032164|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
94341722|NCT00654420|323032165|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
94443051|NCT00711243|323409608|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
94443052|NCT00711243|323409609|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
94443053|NCT00443729|323409610|FG000|Overall Study|Never Treated|0|||
94443054|NCT00443729|323409611|FG001|Overall Study|Never Treated|1|||
94443055|NCT00443729|323409610|FG000|Overall Study|Lack of Efficacy|4|||
94443056|NCT00443729|323409611|FG001|Overall Study|Lack of Efficacy|2|||
94443057|NCT00443729|323409610|FG000|Overall Study|Lost to Follow-up|0|||
94443058|NCT00443729|323409611|FG001|Overall Study|Lost to Follow-up|1|||
94443059|NCT00443729|323409610|FG000|Overall Study|Physician Decision|2|||
94443060|NCT00443729|323409611|FG001|Overall Study|Physician Decision|1|||
94443061|NCT00443729|323409610|FG000|Overall Study|Protocol Violation|1|||
94443062|NCT00443729|323409611|FG001|Overall Study|Protocol Violation|1|||
94443063|NCT00443729|323409610|FG000|Overall Study|Withdrawal by Subject|3|||
94443064|NCT00443729|323409611|FG001|Overall Study|Withdrawal by Subject|1|||
94443065|NCT02572570|323409612|FG000|Overall Study|Study Terminated|27|||
94443066|NCT03283566|323409615|FG000|Overall Study|Lost to Follow-up|1|||
94443067|NCT03283566|323409616|FG001|Overall Study|Lost to Follow-up|2|||
94443068|NCT02547428|323409617|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
94443069|NCT02547428|323409618|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
94443070|NCT02547428|323409617|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
94443071|NCT02547428|323409618|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
94443072|NCT02547428|323409617|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
94443073|NCT02547428|323409618|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
94443074|NCT02547428|323409617|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
94443075|NCT02547428|323409618|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
94443076|NCT02547428|323409617|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
94443077|NCT02547428|323409618|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
94443078|NCT02547428|323409617|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
94443079|NCT02547428|323409618|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
94443080|NCT02547428|323409617|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
94443081|NCT02547428|323409618|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
94443082|NCT02547428|323409617|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
94443083|NCT02547428|323409618|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
94443084|NCT03052751|323409619|FG000|Dosing Period 1|Adverse Event|0|||
94443085|NCT03052751|323409620|FG001|Dosing Period 1|Adverse Event|1|||
94443086|NCT03052751|323409621|FG002|Dosing Period 1|Adverse Event|0|||
94443087|NCT03052751|323409622|FG003|Dosing Period 1|Adverse Event|0|||
94443088|NCT03052751|323409623|FG004|Dosing Period 1|Adverse Event|0|||
94443089|NCT03052751|323409624|FG005|Dosing Period 1|Adverse Event|0|||
94443090|NCT03052751|323409619|FG000|Dosing Period 2|Adverse Event|0|||
94443091|NCT03052751|323409620|FG001|Dosing Period 2|Adverse Event|0|||
94443092|NCT03052751|323409621|FG002|Dosing Period 2|Adverse Event|3|||
94443093|NCT03052751|323409622|FG003|Dosing Period 2|Adverse Event|0|||
94443094|NCT03052751|323409623|FG004|Dosing Period 2|Adverse Event|0|||
94549934|NCT03629912|323809175|FG001|Overall Study|Lost to Follow-up|7|||
94549935|NCT03629912|323809176|FG002|Overall Study|Lost to Follow-up|5|||
94443095|NCT03052751|323409624|FG005|Dosing Period 2|Adverse Event|0|||
94443096|NCT03052751|323409619|FG000|Observation Period|Adverse Event|0|||
94443097|NCT03052751|323409620|FG001|Observation Period|Adverse Event|0|||
94443098|NCT03052751|323409621|FG002|Observation Period|Adverse Event|0|||
94341723|NCT00654420|323032166|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
94341724|NCT00654420|323032163|FG000|Phase II|Adverse Event|0|||
94341725|NCT00654420|323032164|FG001|Phase II|Adverse Event|0|||
94341726|NCT00654420|323032165|FG002|Phase II|Adverse Event|3|||
94341727|NCT00654420|323032166|FG003|Phase II|Adverse Event|3|||
94341728|NCT00654420|323032163|FG000|Phase II|Lost to Follow-up|0|||
94341729|NCT00654420|323032164|FG001|Phase II|Lost to Follow-up|0|||
94341730|NCT00654420|323032165|FG002|Phase II|Lost to Follow-up|0|||
94341731|NCT00654420|323032166|FG003|Phase II|Lost to Follow-up|1|||
94341732|NCT00654420|323032163|FG000|Phase II|Physician Decision|0|||
94341733|NCT00654420|323032164|FG001|Phase II|Physician Decision|0|||
94341734|NCT00654420|323032165|FG002|Phase II|Physician Decision|0|||
94341735|NCT00654420|323032166|FG003|Phase II|Physician Decision|4|||
94341736|NCT00654420|323032163|FG000|Phase II|Progressive Disease|0|||
94341737|NCT00654420|323032164|FG001|Phase II|Progressive Disease|0|||
94341738|NCT00654420|323032165|FG002|Phase II|Progressive Disease|29|||
94341739|NCT00654420|323032166|FG003|Phase II|Progressive Disease|29|||
94341740|NCT00654420|323032163|FG000|Phase II|Withdrawal by Subject|0|||
94341741|NCT00654420|323032164|FG001|Phase II|Withdrawal by Subject|0|||
94341742|NCT00654420|323032165|FG002|Phase II|Withdrawal by Subject|4|||
94341743|NCT00654420|323032166|FG003|Phase II|Withdrawal by Subject|1|||
94341744|NCT00654420|323032163|FG000|Phase II|Missing Disposition Record|0|||
94341745|NCT00654420|323032164|FG001|Phase II|Missing Disposition Record|0|||
94341746|NCT00654420|323032165|FG002|Phase II|Missing Disposition Record|1|||
94341747|NCT00654420|323032166|FG003|Phase II|Missing Disposition Record|0|||
94341748|NCT02182999|323032168|FG000|Overall Study|Adverse Event|4|||
94341749|NCT02182999|323032169|FG001|Overall Study|Adverse Event|3|||
94341750|NCT02182999|323032168|FG000|Overall Study|Physician Decision|1|||
94341751|NCT02182999|323032169|FG001|Overall Study|Physician Decision|0|||
94341752|NCT00557323|323032171|FG000|Overall Study|Death|3|||
94341753|NCT00557323|323032171|FG000|Overall Study|Withdrawal by Subject|2|||
94341754|NCT00557323|323032171|FG000|Overall Study|Administrative change|2|||
94341755|NCT00498368|323032181|FG000|Overall Study|Withdrawal by Subject|3|||
94341756|NCT00498368|323032182|FG001|Overall Study|Withdrawal by Subject|2|||
94341757|NCT02266004|323032183|FG000|Overall Study|unrelated adverse event|1|||
94341758|NCT02266004|323032183|FG000|Overall Study|Physician Decision|1|||
94341759|NCT02736929|323032189|FG000|Main Study|Lost to Follow-up|7|||
94341760|NCT02736929|323032190|FG001|Main Study|Lost to Follow-up|1|||
94341761|NCT02736929|323032191|FG002|Main Study|Lost to Follow-up|0|||
94341762|NCT02736929|323032189|FG000|Main Study|Withdrawal by Subject|1|||
94341763|NCT02736929|323032190|FG001|Main Study|Withdrawal by Subject|1|||
94341764|NCT02736929|323032191|FG002|Main Study|Withdrawal by Subject|0|||
94341765|NCT02736929|323032189|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
94341766|NCT02736929|323032190|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
94341767|NCT02736929|323032191|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
94341768|NCT00285649|323032192|FG000|Overall Study|Lost to Follow-up|6|||
94341769|NCT00285649|323032193|FG001|Overall Study|Lost to Follow-up|4|||
94443099|NCT03052751|323409622|FG003|Observation Period|Adverse Event|0|||
94443100|NCT03052751|323409623|FG004|Observation Period|Adverse Event|1|||
94443101|NCT03052751|323409624|FG005|Observation Period|Adverse Event|0|||
94443102|NCT02493660|323409627|FG000|Overall Study|Physician Decision|0|||
94443103|NCT02493660|323409628|FG001|Overall Study|Physician Decision|1|||
94443104|NCT02493660|323409627|FG000|Overall Study|Adverse Event|4|||
94443105|NCT02493660|323409628|FG001|Overall Study|Adverse Event|2|||
94443106|NCT02493660|323409627|FG000|Overall Study|Withdrawal by Subject|2|||
94443107|NCT02493660|323409628|FG001|Overall Study|Withdrawal by Subject|3|||
94443108|NCT02493660|323409627|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
94443109|NCT02493660|323409628|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
94443110|NCT02493660|323409627|FG000|Overall Study|Protocol Violation|0|||
94443111|NCT02493660|323409628|FG001|Overall Study|Protocol Violation|1|||
94443112|NCT02493660|323409627|FG000|Overall Study|Death|0|||
94443113|NCT02493660|323409628|FG001|Overall Study|Death|1|||
94443114|NCT02493660|323409627|FG000|Overall Study|Lost to Follow-up|2|||
94443115|NCT02493660|323409628|FG001|Overall Study|Lost to Follow-up|4|||
94443116|NCT00709995|323409629|FG000|Overall Study|Adverse Event|4|||
94443117|NCT00709995|323409630|FG001|Overall Study|Adverse Event|2|||
94443118|NCT00709995|323409629|FG000|Overall Study|Withdrawal by Subject|1|||
94443119|NCT00709995|323409630|FG001|Overall Study|Withdrawal by Subject|3|||
94443120|NCT02222922|323409631|FG000|Overall Study|Death|0|||
94443121|NCT02222922|323409632|FG001|Overall Study|Death|0|||
94443122|NCT02222922|323409633|FG002|Overall Study|Death|0|||
94443123|NCT02222922|323409634|FG003|Overall Study|Death|0|||
94341770|NCT00285649|323032194|FG002|Overall Study|Lost to Follow-up|4|||
94443124|NCT02222922|323409635|FG004|Overall Study|Death|13|||
94549936|NCT03629912|323809177|FG003|Overall Study|Lost to Follow-up|1|||
94341771|NCT00285649|323032192|FG000|Overall Study|Withdrawal by Subject|3|||
94341772|NCT00285649|323032193|FG001|Overall Study|Withdrawal by Subject|2|||
94443125|NCT02222922|323409636|FG005|Overall Study|Death|0|||
94443126|NCT02222922|323409637|FG006|Overall Study|Death|0|||
94443127|NCT02222922|323409638|FG007|Overall Study|Death|0|||
94341773|NCT00285649|323032194|FG002|Overall Study|Withdrawal by Subject|2|||
94341774|NCT02877134|323032208|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
94341775|NCT02877134|323032209|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
94341776|NCT02877134|323032210|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
94341777|NCT02877134|323032211|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
94341778|NCT02877134|323032212|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
94341779|NCT02877134|323032213|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
94341780|NCT02877134|323032214|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
94341781|NCT02877134|323032215|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
94341782|NCT02877134|323032216|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
94341783|NCT02877134|323032217|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
94341784|NCT02877134|323032218|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
94341785|NCT02877134|323032219|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
94341786|NCT02877134|323032208|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
94341787|NCT02877134|323032209|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
94341788|NCT02877134|323032210|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
94341789|NCT02877134|323032211|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
94341790|NCT02877134|323032212|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
94341791|NCT02877134|323032213|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
94341792|NCT02877134|323032214|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
94341793|NCT02877134|323032215|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
94341794|NCT02877134|323032216|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
94341795|NCT02877134|323032217|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
94341796|NCT02877134|323032218|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
94341797|NCT02877134|323032219|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
94341798|NCT02877134|323032208|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
94341799|NCT02877134|323032209|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
94341800|NCT02877134|323032210|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
94341801|NCT02877134|323032211|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
94341802|NCT02877134|323032212|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
94341803|NCT02877134|323032213|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
94341804|NCT02877134|323032214|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
94443128|NCT02222922|323409639|FG008|Overall Study|Death|2|||
94443129|NCT02222922|323409631|FG000|Overall Study|Lost to Follow-up|0|||
94443130|NCT02222922|323409632|FG001|Overall Study|Lost to Follow-up|0|||
94443131|NCT02222922|323409633|FG002|Overall Study|Lost to Follow-up|1|||
94443132|NCT02222922|323409634|FG003|Overall Study|Lost to Follow-up|0|||
94443133|NCT02222922|323409635|FG004|Overall Study|Lost to Follow-up|9|||
94443134|NCT02222922|323409636|FG005|Overall Study|Lost to Follow-up|1|||
94443135|NCT02222922|323409637|FG006|Overall Study|Lost to Follow-up|0|||
94443136|NCT02222922|323409638|FG007|Overall Study|Lost to Follow-up|0|||
94443137|NCT02222922|323409639|FG008|Overall Study|Lost to Follow-up|0|||
94443138|NCT02222922|323409631|FG000|Overall Study|Other|0|||
94443139|NCT02222922|323409632|FG001|Overall Study|Other|0|||
94443140|NCT02222922|323409633|FG002|Overall Study|Other|0|||
94443141|NCT02222922|323409634|FG003|Overall Study|Other|2|||
94443142|NCT02222922|323409635|FG004|Overall Study|Other|10|||
94443143|NCT02222922|323409636|FG005|Overall Study|Other|2|||
94443144|NCT02222922|323409637|FG006|Overall Study|Other|2|||
94443145|NCT02222922|323409638|FG007|Overall Study|Other|4|||
94443146|NCT02222922|323409639|FG008|Overall Study|Other|1|||
94443147|NCT02222922|323409631|FG000|Overall Study|Participant refused further follow-up|1|||
94443148|NCT02222922|323409632|FG001|Overall Study|Participant refused further follow-up|0|||
94443149|NCT02222922|323409633|FG002|Overall Study|Participant refused further follow-up|0|||
94443150|NCT02222922|323409634|FG003|Overall Study|Participant refused further follow-up|1|||
94443151|NCT02222922|323409635|FG004|Overall Study|Participant refused further follow-up|6|||
94443152|NCT02222922|323409636|FG005|Overall Study|Participant refused further follow-up|0|||
94443153|NCT02222922|323409637|FG006|Overall Study|Participant refused further follow-up|0|||
94443154|NCT02222922|323409638|FG007|Overall Study|Participant refused further follow-up|0|||
94443155|NCT02222922|323409639|FG008|Overall Study|Participant refused further follow-up|3|||
94443156|NCT03347110|323409644|FG000|Overall Study|Other (Participant is incarcerated)|1|||
94443157|NCT03347110|323409644|FG000|Overall Study|Withdrawal by Subject|9|||
94443158|NCT03347110|323409644|FG000|Overall Study|Lost to Follow-up|1|||
94443159|NCT03347110|323409644|FG000|Overall Study|Lack of Efficacy|2|||
94443160|NCT03347110|323409644|FG000|Overall Study|Adverse Event, non-fatal|9|||
94443161|NCT00116779|323409645|FG000|Overall Study|Adverse Event|4|||
94443162|NCT00116779|323409646|FG001|Overall Study|Adverse Event|2|||
94443163|NCT00116779|323409645|FG000|Overall Study|Protocol Violation|1|||
94443164|NCT00116779|323409646|FG001|Overall Study|Protocol Violation|4|||
94443165|NCT00116779|323409645|FG000|Overall Study|Withdrawal by Subject|4|||
94443166|NCT00116779|323409646|FG001|Overall Study|Withdrawal by Subject|1|||
94443167|NCT00116779|323409645|FG000|Overall Study|Inadequate testosterone suppression|7|||
94443168|NCT00116779|323409646|FG001|Overall Study|Inadequate testosterone suppression|9|||
94443169|NCT00116779|323409645|FG000|Overall Study|Physician Decision|3|||
94443170|NCT00116779|323409646|FG001|Overall Study|Physician Decision|1|||
94443171|NCT00116779|323409645|FG000|Overall Study|Elevated PSA levels|2|||
94443172|NCT00116779|323409646|FG001|Overall Study|Elevated PSA levels|2|||
94443173|NCT02342678|323409647|FG000|Overall Study|Lost to Follow-up|0|||
94443174|NCT02342678|323409648|FG001|Overall Study|Lost to Follow-up|1|||
94443175|NCT02342678|323409647|FG000|Overall Study|Too busy to complete study|0|||
94443176|NCT02342678|323409648|FG001|Overall Study|Too busy to complete study|2|||
94443177|NCT02342678|323409647|FG000|Overall Study|Family illness/emergency|0|||
94443178|NCT02342678|323409648|FG001|Overall Study|Family illness/emergency|1|||
94443179|NCT02342678|323409647|FG000|Overall Study|Illness/medical reason|1|||
94443180|NCT02342678|323409648|FG001|Overall Study|Illness/medical reason|1|||
94443181|NCT03270657|323409649|FG000|Overall Study|Withdrawal by Subject|1|||
94443182|NCT02383017|323409650|FG000|Overall Study|Injury Sustained Outside Study|1|||
94443183|NCT02383017|323409651|FG001|Overall Study|Injury Sustained Outside Study|0|||
94443184|NCT02383017|323409650|FG000|Overall Study|Compliance|3|||
94443185|NCT02383017|323409651|FG001|Overall Study|Compliance|2|||
94443186|NCT02383017|323409650|FG000|Overall Study|Found to be Hypogonadal|1|||
94443187|NCT02383017|323409651|FG001|Overall Study|Found to be Hypogonadal|0|||
94443188|NCT01037218|323409654|FG000|Overall Study|Adverse Event|4|||
94443189|NCT01037218|323409655|FG001|Overall Study|Adverse Event|2|||
94443190|NCT01037218|323409656|FG002|Overall Study|Adverse Event|2|||
94443191|NCT01037218|323409657|FG003|Overall Study|Adverse Event|1|||
94443192|NCT01037218|323409654|FG000|Overall Study|Lack of Efficacy|0|||
94443193|NCT01037218|323409655|FG001|Overall Study|Lack of Efficacy|2|||
94443194|NCT01037218|323409656|FG002|Overall Study|Lack of Efficacy|1|||
94443195|NCT01037218|323409657|FG003|Overall Study|Lack of Efficacy|5|||
94443196|NCT01037218|323409654|FG000|Overall Study|Lost to Follow-up|3|||
94443197|NCT01037218|323409655|FG001|Overall Study|Lost to Follow-up|5|||
94443198|NCT01037218|323409656|FG002|Overall Study|Lost to Follow-up|4|||
94443199|NCT01037218|323409657|FG003|Overall Study|Lost to Follow-up|2|||
94443200|NCT01037218|323409654|FG000|Overall Study|Withdrawal by Subject|6|||
94443201|NCT01037218|323409655|FG001|Overall Study|Withdrawal by Subject|7|||
94443202|NCT01037218|323409656|FG002|Overall Study|Withdrawal by Subject|7|||
94443203|NCT01037218|323409657|FG003|Overall Study|Withdrawal by Subject|4|||
94443204|NCT01037218|323409654|FG000|Overall Study|Partner Withdrew Consent|0|||
94443205|NCT01037218|323409655|FG001|Overall Study|Partner Withdrew Consent|3|||
94443206|NCT01037218|323409656|FG002|Overall Study|Partner Withdrew Consent|2|||
94443207|NCT01037218|323409657|FG003|Overall Study|Partner Withdrew Consent|1|||
94443208|NCT01037218|323409654|FG000|Overall Study|Protocol Violation|0|||
94443209|NCT01037218|323409655|FG001|Overall Study|Protocol Violation|0|||
94443210|NCT01037218|323409656|FG002|Overall Study|Protocol Violation|2|||
94443211|NCT01037218|323409657|FG003|Overall Study|Protocol Violation|2|||
94443212|NCT01037218|323409654|FG000|Overall Study|Various|3|||
94443213|NCT01037218|323409655|FG001|Overall Study|Various|2|||
94443214|NCT01037218|323409656|FG002|Overall Study|Various|3|||
94443215|NCT01037218|323409657|FG003|Overall Study|Various|1|||
94443216|NCT01068860|323409658|FG000|Overall Study|Withdrawal by Subject|0|||
94443217|NCT01068860|323409659|FG001|Overall Study|Withdrawal by Subject|0|||
94443218|NCT01068860|323409660|FG002|Overall Study|Withdrawal by Subject|0|||
94443219|NCT01068860|323409661|FG003|Overall Study|Withdrawal by Subject|0|||
94443220|NCT01068860|323409662|FG004|Overall Study|Withdrawal by Subject|0|||
94443221|NCT01068860|323409663|FG005|Overall Study|Withdrawal by Subject|2|||
94443222|NCT01068860|323409664|FG006|Overall Study|Withdrawal by Subject|0|||
94443223|NCT01068860|323409665|FG007|Overall Study|Withdrawal by Subject|0|||
94443224|NCT01068860|323409666|FG008|Overall Study|Withdrawal by Subject|0|||
94443225|NCT01068860|323409667|FG009|Overall Study|Withdrawal by Subject|3|||
94443226|NCT01068860|323409658|FG000|Overall Study|Administrative problems; misrandomized|0|||
94443227|NCT01068860|323409659|FG001|Overall Study|Administrative problems; misrandomized|0|||
94443228|NCT01068860|323409660|FG002|Overall Study|Administrative problems; misrandomized|0|||
94443229|NCT01068860|323409661|FG003|Overall Study|Administrative problems; misrandomized|1|||
94443230|NCT01068860|323409662|FG004|Overall Study|Administrative problems; misrandomized|0|||
94443231|NCT01068860|323409663|FG005|Overall Study|Administrative problems; misrandomized|0|||
94443232|NCT01068860|323409664|FG006|Overall Study|Administrative problems; misrandomized|0|||
94443233|NCT01068860|323409665|FG007|Overall Study|Administrative problems; misrandomized|0|||
94443234|NCT01068860|323409666|FG008|Overall Study|Administrative problems; misrandomized|0|||
94443235|NCT01068860|323409667|FG009|Overall Study|Administrative problems; misrandomized|1|||
94443236|NCT01068860|323409658|FG000|Overall Study|Lost to Follow-up|0|||
94443237|NCT01068860|323409659|FG001|Overall Study|Lost to Follow-up|1|||
94443238|NCT01068860|323409660|FG002|Overall Study|Lost to Follow-up|0|||
94443239|NCT01068860|323409661|FG003|Overall Study|Lost to Follow-up|0|||
94443240|NCT01068860|323409662|FG004|Overall Study|Lost to Follow-up|0|||
94443241|NCT01068860|323409663|FG005|Overall Study|Lost to Follow-up|0|||
94443242|NCT01068860|323409664|FG006|Overall Study|Lost to Follow-up|0|||
94443243|NCT01068860|323409665|FG007|Overall Study|Lost to Follow-up|0|||
94443244|NCT01068860|323409666|FG008|Overall Study|Lost to Follow-up|0|||
94549937|NCT03629912|323809174|FG000|Overall Study|Withdrawal by Subject|6|||
94549938|NCT03629912|323809175|FG001|Overall Study|Withdrawal by Subject|0|||
94549939|NCT03629912|323809176|FG002|Overall Study|Withdrawal by Subject|1|||
94549940|NCT03629912|323809177|FG003|Overall Study|Withdrawal by Subject|2|||
94549941|NCT03629912|323809174|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
94549942|NCT03629912|323809175|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
94549943|NCT03629912|323809176|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
94549944|NCT03629912|323809177|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
94549945|NCT03629912|323809174|FG000|Overall Study|Death|1|||
94549946|NCT03629912|323809175|FG001|Overall Study|Death|0|||
94549947|NCT03629912|323809176|FG002|Overall Study|Death|0|||
94549948|NCT03629912|323809177|FG003|Overall Study|Death|0|||
94341805|NCT02877134|323032215|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
94341806|NCT02877134|323032216|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
94341807|NCT02877134|323032217|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
94341808|NCT02877134|323032218|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
94341809|NCT02877134|323032219|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
94341810|NCT02877134|323032208|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
94341811|NCT02877134|323032209|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
94341812|NCT02877134|323032210|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
94341813|NCT02877134|323032211|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
94341814|NCT02877134|323032212|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
94341815|NCT02877134|323032213|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
94341816|NCT02877134|323032214|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
94341817|NCT02877134|323032215|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
94341818|NCT02877134|323032216|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
94341819|NCT02877134|323032217|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
94341820|NCT02877134|323032218|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
94341821|NCT02877134|323032219|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
94341822|NCT02877134|323032208|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
94341823|NCT02877134|323032209|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
94341824|NCT02877134|323032210|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
94341825|NCT02877134|323032211|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
94341826|NCT02877134|323032212|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
94341827|NCT02877134|323032213|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
94341828|NCT02877134|323032214|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
94341829|NCT02877134|323032215|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
94341830|NCT02877134|323032216|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
94341831|NCT02877134|323032217|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
94341832|NCT02877134|323032218|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
94341833|NCT02877134|323032219|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
94341834|NCT02877134|323032208|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
94341835|NCT02877134|323032209|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
94341836|NCT02877134|323032210|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
94341837|NCT02877134|323032211|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
94341838|NCT02877134|323032212|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
94341839|NCT02877134|323032213|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
94341840|NCT02877134|323032214|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
94341841|NCT02877134|323032215|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
94341842|NCT02877134|323032216|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
94341843|NCT02877134|323032217|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
94341844|NCT02877134|323032218|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
94341845|NCT02877134|323032219|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
94341846|NCT02877134|323032208|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
94341847|NCT02877134|323032209|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
94341848|NCT02877134|323032210|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
94443245|NCT01068860|323409667|FG009|Overall Study|Lost to Follow-up|0|||
94443246|NCT00460603|323409668|FG000|Phase 1|Death|1|||
94443247|NCT00460603|323409669|FG001|Phase 1|Death|0|||
94443248|NCT00460603|323409670|FG002|Phase 1|Death|0|||
94443249|NCT00460603|323409671|FG003|Phase 1|Death|2|||
94443250|NCT00460603|323409672|FG004|Phase 1|Death|0|||
94443251|NCT00460603|323409673|FG005|Phase 1|Death|0|||
94443252|NCT00460603|323409674|FG006|Phase 1|Death|0|||
94443253|NCT00460603|323409675|FG007|Phase 1|Death|0|||
94443254|NCT00460603|323409676|FG008|Phase 1|Death|1|||
94443255|NCT00460603|323409677|FG009|Phase 1|Death|0|||
94443256|NCT00460603|323409678|FG010|Phase 1|Death|0|||
94443257|NCT00460603|323409679|FG011|Phase 1|Death|0|||
94443258|NCT00460603|323409668|FG000|Phase 1|Adverse Event|3|||
94443259|NCT00460603|323409669|FG001|Phase 1|Adverse Event|1|||
94443260|NCT00460603|323409670|FG002|Phase 1|Adverse Event|1|||
94443261|NCT00460603|323409671|FG003|Phase 1|Adverse Event|2|||
94443262|NCT00460603|323409672|FG004|Phase 1|Adverse Event|0|||
94443263|NCT00460603|323409673|FG005|Phase 1|Adverse Event|0|||
94443264|NCT00460603|323409674|FG006|Phase 1|Adverse Event|3|||
94443265|NCT00460603|323409675|FG007|Phase 1|Adverse Event|0|||
94443266|NCT00460603|323409676|FG008|Phase 1|Adverse Event|4|||
94443267|NCT00460603|323409677|FG009|Phase 1|Adverse Event|0|||
94443268|NCT00460603|323409678|FG010|Phase 1|Adverse Event|0|||
94443269|NCT00460603|323409679|FG011|Phase 1|Adverse Event|0|||
94443270|NCT00460603|323409668|FG000|Phase 1|Lack of Efficacy|1|||
94443271|NCT00460603|323409669|FG001|Phase 1|Lack of Efficacy|0|||
94443272|NCT00460603|323409670|FG002|Phase 1|Lack of Efficacy|1|||
94443273|NCT00460603|323409671|FG003|Phase 1|Lack of Efficacy|2|||
94443274|NCT00460603|323409672|FG004|Phase 1|Lack of Efficacy|2|||
94341849|NCT02877134|323032211|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
94341850|NCT02877134|323032212|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
94341851|NCT02877134|323032213|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
94341852|NCT02877134|323032214|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
94341853|NCT02877134|323032215|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
94341854|NCT02877134|323032216|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
94341855|NCT02877134|323032217|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
94341856|NCT02877134|323032218|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
94341857|NCT02877134|323032219|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
94341858|NCT02877134|323032208|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
94341859|NCT02877134|323032209|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
94341860|NCT02877134|323032210|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
94341861|NCT02877134|323032211|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
94341862|NCT02877134|323032212|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
94341863|NCT02877134|323032213|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
94443275|NCT00460603|323409673|FG005|Phase 1|Lack of Efficacy|2|||
94443276|NCT00460603|323409674|FG006|Phase 1|Lack of Efficacy|2|||
94341864|NCT02877134|323032214|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
94341865|NCT02877134|323032215|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
94341866|NCT02877134|323032216|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
94341867|NCT02877134|323032217|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
94341868|NCT02877134|323032218|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
94341869|NCT02877134|323032219|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
94341870|NCT01039428|323032220|FG000|Overall Study|Protocol Violation|1|||
94341871|NCT01039428|323032221|FG001|Overall Study|Protocol Violation|0|||
94341872|NCT01039428|323032220|FG000|Overall Study|Withdrawal by Subject|1|||
94341873|NCT01039428|323032221|FG001|Overall Study|Withdrawal by Subject|0|||
94341874|NCT01313039|323032222|FG000|Overall Study|Physician Decision|1|||
94341875|NCT01313039|323032222|FG000|Overall Study|Adverse Event|1|||
94341876|NCT03630016|323032223|FG000|Overall Study|Poor Sensor Placement|1|||
94341877|NCT00002981|323032224|FG000|Overall Study|Inevaluable|6|||
94341878|NCT01833806|323032225|FG000|Overall Study|Alternative treatment|2|||
94341879|NCT01833806|323032225|FG000|Overall Study|Death|5|||
94341880|NCT01833806|323032225|FG000|Overall Study|Physician Decision|1|||
94341881|NCT01833806|323032225|FG000|Overall Study|Lost to Follow-up|1|||
94341882|NCT01678560|323032226|FG000|Overall Study|Physician Decision|4|||
94341883|NCT01678560|323032227|FG001|Overall Study|Physician Decision|4|||
94341884|NCT01678560|323032226|FG000|Overall Study|Death|0|||
94341885|NCT01678560|323032227|FG001|Overall Study|Death|1|||
94341886|NCT01678560|323032226|FG000|Overall Study|Withdrawal by Subject|0|||
94341887|NCT01678560|323032227|FG001|Overall Study|Withdrawal by Subject|1|||
94341888|NCT03964493|323032228|FG000|Overall Study|Withdrawal by Subject|4|||
94341889|NCT03964493|323032229|FG001|Overall Study|Withdrawal by Subject|1|||
94341890|NCT03964493|323032228|FG000|Overall Study|Lost to Follow-up|13|||
94341891|NCT03964493|323032229|FG001|Overall Study|Lost to Follow-up|4|||
94341892|NCT00117572|323032232|FG000|Overall Study|Site withdrew before starting treatment|2|||
94341893|NCT00117572|323032233|FG001|Overall Study|Site withdrew before starting treatment|3|||
94341894|NCT00117572|323032232|FG000|Overall Study|Withdrawal by Subject|3|||
94341895|NCT00117572|323032233|FG001|Overall Study|Withdrawal by Subject|3|||
94341896|NCT00117572|323032232|FG000|Overall Study|Protocol Violation|1|||
94341897|NCT00117572|323032233|FG001|Overall Study|Protocol Violation|0|||
94341898|NCT00887068|323032234|FG000|Overall Study|Withdrawal by Subject|2|||
94341899|NCT00887068|323032235|FG001|Overall Study|Withdrawal by Subject|0|||
94341900|NCT00887068|323032234|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
94341901|NCT00887068|323032235|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
94341902|NCT01828567|323032241|FG000|Overall Study|Lost to Follow-up|27|||
94341903|NCT01828567|323032242|FG001|Overall Study|Lost to Follow-up|9|||
94341904|NCT01828567|323032241|FG000|Overall Study|Excluded - did not meet criteria|4|||
94341905|NCT01828567|323032242|FG001|Overall Study|Excluded - did not meet criteria|1|||
94341906|NCT01188811|323032247|FG000|Overall Study|Withdrawal by Subject|0|||
94341907|NCT01188811|323032248|FG001|Overall Study|Withdrawal by Subject|2|||
94341908|NCT01188811|323032247|FG000|Overall Study|Adverse Event|6|||
94341909|NCT01188811|323032248|FG001|Overall Study|Adverse Event|0|||
94341910|NCT00804986|323032255|FG000|Overall Study|Adverse Event|0|||
94549949|NCT01475162|323809180|FG000|Overall Study|Physician Decision|1|||
94341911|NCT00804986|323032256|FG001|Overall Study|Adverse Event|1|||
94341912|NCT00804986|323032257|FG002|Overall Study|Adverse Event|2|||
94341913|NCT00804986|323032258|FG003|Overall Study|Adverse Event|1|||
94341914|NCT00804986|323032259|FG004|Overall Study|Adverse Event|3|||
94341915|NCT00804986|323032260|FG005|Overall Study|Adverse Event|0|||
94341916|NCT00804986|323032255|FG000|Overall Study|Lack of Efficacy|0|||
94341917|NCT00804986|323032256|FG001|Overall Study|Lack of Efficacy|0|||
94341918|NCT00804986|323032257|FG002|Overall Study|Lack of Efficacy|0|||
94549950|NCT01475162|323809180|FG000|Overall Study|Death|10|||
94341919|NCT00804986|323032258|FG003|Overall Study|Lack of Efficacy|1|||
94341920|NCT00804986|323032259|FG004|Overall Study|Lack of Efficacy|0|||
94341921|NCT00804986|323032260|FG005|Overall Study|Lack of Efficacy|3|||
94341922|NCT00804986|323032255|FG000|Overall Study|Lost to Follow-up|0|||
94341923|NCT00804986|323032256|FG001|Overall Study|Lost to Follow-up|0|||
94341924|NCT00804986|323032257|FG002|Overall Study|Lost to Follow-up|0|||
94341925|NCT00804986|323032258|FG003|Overall Study|Lost to Follow-up|1|||
94341926|NCT00804986|323032259|FG004|Overall Study|Lost to Follow-up|1|||
94341927|NCT00804986|323032260|FG005|Overall Study|Lost to Follow-up|3|||
94341928|NCT00804986|323032255|FG000|Overall Study|Protocol Violation|0|||
94341929|NCT00804986|323032256|FG001|Overall Study|Protocol Violation|1|||
94341930|NCT00804986|323032257|FG002|Overall Study|Protocol Violation|0|||
94341931|NCT00804986|323032258|FG003|Overall Study|Protocol Violation|1|||
94341932|NCT00804986|323032259|FG004|Overall Study|Protocol Violation|0|||
94341933|NCT00804986|323032260|FG005|Overall Study|Protocol Violation|0|||
94341934|NCT00804986|323032255|FG000|Overall Study|Withdrawal by Subject|0|||
94341935|NCT00804986|323032256|FG001|Overall Study|Withdrawal by Subject|3|||
94341936|NCT00804986|323032257|FG002|Overall Study|Withdrawal by Subject|0|||
94341937|NCT00804986|323032258|FG003|Overall Study|Withdrawal by Subject|3|||
94341938|NCT00804986|323032259|FG004|Overall Study|Withdrawal by Subject|5|||
94549951|NCT01475162|323809180|FG000|Overall Study|Study closed for safety|3|||
94341939|NCT00804986|323032260|FG005|Overall Study|Withdrawal by Subject|3|||
94341940|NCT00804986|323032255|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
94341941|NCT00804986|323032256|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
94341942|NCT00804986|323032257|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
94341943|NCT00804986|323032258|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
94341944|NCT00804986|323032259|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
94341945|NCT00804986|323032260|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
94341946|NCT00804986|323032255|FG000|Overall Study|Sponsor Decision|0|||
94341947|NCT00804986|323032256|FG001|Overall Study|Sponsor Decision|1|||
94341948|NCT00804986|323032257|FG002|Overall Study|Sponsor Decision|0|||
94341949|NCT00804986|323032258|FG003|Overall Study|Sponsor Decision|0|||
94341950|NCT00804986|323032259|FG004|Overall Study|Sponsor Decision|0|||
94341951|NCT00804986|323032260|FG005|Overall Study|Sponsor Decision|0|||
94341952|NCT00804986|323032255|FG000|Overall Study|Physician Decision|1|||
94341953|NCT00804986|323032256|FG001|Overall Study|Physician Decision|0|||
94341954|NCT00804986|323032257|FG002|Overall Study|Physician Decision|0|||
94341955|NCT00804986|323032258|FG003|Overall Study|Physician Decision|0|||
94341956|NCT00804986|323032259|FG004|Overall Study|Physician Decision|0|||
94341957|NCT00804986|323032260|FG005|Overall Study|Physician Decision|0|||
94341958|NCT01432938|323032261|FG000|First Intervention|Protocol Violation|1|||
94341959|NCT01432938|323032262|FG001|First Intervention|Protocol Violation|0|||
94341960|NCT01432938|323032261|FG000|First Intervention|Physician Decision|1|||
94341961|NCT01432938|323032262|FG001|First Intervention|Physician Decision|0|||
94341962|NCT01432938|323032261|FG000|Second Intervention|Adverse Event|1|||
94341963|NCT01432938|323032262|FG001|Second Intervention|Adverse Event|0|||
94341964|NCT00374127|323032263|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
94341965|NCT00374127|323032263|FG000|Overall Study|Blood could not be drawn.|2|||
94341966|NCT00374127|323032263|FG000|Overall Study|Protocol Violation|5|||
94341967|NCT00374127|323032263|FG000|Overall Study|Pregnancy|1|||
94341968|NCT03864627|323032264|FG000|Overall Study|Adverse Event|0|||
94341969|NCT03864627|323032265|FG001|Overall Study|Adverse Event|1|||
94341970|NCT03864627|323032264|FG000|Overall Study|Lack of Efficacy|0|||
94549952|NCT00908037|323809181|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
94549953|NCT00908037|323809182|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
94549954|NCT00908037|323809183|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
94549955|NCT00908037|323809184|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
94549956|NCT00908037|323809185|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
94549957|NCT00908037|323809186|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
94549958|NCT00908037|323809187|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
94549959|NCT00908037|323809188|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
94549960|NCT00908037|323809189|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
94549961|NCT00908037|323809190|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
94549962|NCT00908037|323809191|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
94549963|NCT00908037|323809192|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
94549964|NCT00908037|323809181|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
94549965|NCT00908037|323809182|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
94549966|NCT00908037|323809183|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
94549967|NCT00908037|323809184|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
94549968|NCT00908037|323809185|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
94549969|NCT00908037|323809186|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
94549970|NCT00908037|323809187|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
94549971|NCT00908037|323809188|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
94341971|NCT03864627|323032265|FG001|Overall Study|Lack of Efficacy|1|||
94341972|NCT03864627|323032264|FG000|Overall Study|Lost to Follow-up|0|||
94341973|NCT03864627|323032265|FG001|Overall Study|Lost to Follow-up|1|||
94341974|NCT03864627|323032264|FG000|Overall Study|Withdrawal by Subject|4|||
94341975|NCT03864627|323032265|FG001|Overall Study|Withdrawal by Subject|8|||
94341976|NCT03864627|323032264|FG000|Overall Study|Study terminated by sponsor|0|||
94341977|NCT03864627|323032265|FG001|Overall Study|Study terminated by sponsor|1|||
94341978|NCT01388491|323032267|FG000|Overall Study|Adverse Event|10|||
94341979|NCT01388491|323032268|FG001|Overall Study|Adverse Event|9|||
94549972|NCT00908037|323809189|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
94549973|NCT00908037|323809190|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
94549974|NCT00908037|323809191|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
94549975|NCT00908037|323809192|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
94549976|NCT00908037|323809181|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
94549977|NCT00908037|323809182|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
94341980|NCT01388491|323032267|FG000|Overall Study|Sponsor Request|9|||
94341981|NCT01388491|323032268|FG001|Overall Study|Sponsor Request|7|||
94341982|NCT01388491|323032267|FG000|Overall Study|Withdrawal by Subject|6|||
94549978|NCT00908037|323809183|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
94341983|NCT01388491|323032268|FG001|Overall Study|Withdrawal by Subject|10|||
94341984|NCT01388491|323032267|FG000|Overall Study|Lost to Follow-up|4|||
94341985|NCT01388491|323032268|FG001|Overall Study|Lost to Follow-up|3|||
94341986|NCT01388491|323032267|FG000|Overall Study|Protocol Violation|2|||
94341987|NCT01388491|323032268|FG001|Overall Study|Protocol Violation|0|||
94341988|NCT01388491|323032267|FG000|Overall Study|Noncompliance|2|||
94341989|NCT01388491|323032268|FG001|Overall Study|Noncompliance|0|||
94341990|NCT01388491|323032267|FG000|Overall Study|Pregnancy|1|||
94341991|NCT01388491|323032268|FG001|Overall Study|Pregnancy|0|||
94341992|NCT04035473|323032273|FG000|Screening/Baseline|Death|0|||
94341993|NCT04035473|323032274|FG001|Screening/Baseline|Death|1|||
94341994|NCT04035473|323032273|FG000|Screening/Baseline|Adverse Event|0|||
94341995|NCT04035473|323032274|FG001|Screening/Baseline|Adverse Event|1|||
94341996|NCT04035473|323032273|FG000|Follow-up Period|Adverse Event|2|||
94341997|NCT04035473|323032274|FG001|Follow-up Period|Adverse Event|0|||
94341998|NCT02875366|323032275|FG000|Overall Study|Adverse Event|0|||
94341999|NCT02875366|323032276|FG001|Overall Study|Adverse Event|2|||
94342000|NCT02875366|323032275|FG000|Overall Study|Noncompliance|0|||
94342001|NCT02875366|323032276|FG001|Overall Study|Noncompliance|1|||
94342002|NCT01222416|323032277|FG000|Overall Study|ineligible;metastasis|3|||
94342003|NCT01222416|323032278|FG001|Overall Study|ineligible;metastasis|0|||
94342004|NCT01222416|323032277|FG000|Overall Study|Adverse Event|4|||
94342005|NCT01222416|323032278|FG001|Overall Study|Adverse Event|0|||
94342006|NCT01222416|323032277|FG000|Overall Study|Withdrawal by Subject|5|||
94342007|NCT01222416|323032278|FG001|Overall Study|Withdrawal by Subject|0|||
94342008|NCT01222416|323032277|FG000|Overall Study|scheduling|6|||
94342009|NCT01222416|323032278|FG001|Overall Study|scheduling|0|||
94342010|NCT01222416|323032277|FG000|Overall Study|missed view/scan|1|||
94342011|NCT01222416|323032278|FG001|Overall Study|missed view/scan|0|||
94342012|NCT01222416|323032277|FG000|Overall Study|Death|1|||
94342013|NCT01222416|323032278|FG001|Overall Study|Death|0|||
94342014|NCT03595176|323032279|FG000|Overall Study|Death|0|||
94342015|NCT03595176|323032280|FG001|Overall Study|Death|2|||
94342016|NCT03595176|323032279|FG000|Overall Study|Lost to Follow-up|0|||
94342017|NCT03595176|323032280|FG001|Overall Study|Lost to Follow-up|1|||
94342018|NCT01201967|323032288|FG000|Overall Study|Lost to Follow-up|6|||
94342019|NCT01201967|323032289|FG001|Overall Study|Lost to Follow-up|5|||
94342020|NCT02497287|323032290|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
94342021|NCT02497287|323032290|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
94342022|NCT02497287|323032290|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
94342023|NCT02497287|323032290|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
94342024|NCT02497287|323032290|FG000|Induction Phase (4 Weeks)|Other|13|||
94342025|NCT02497287|323032290|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
94342026|NCT02497287|323032290|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
94342027|NCT02497287|323032290|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
94342028|NCT02497287|323032290|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
94342029|NCT02497287|323032290|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
94342030|NCT02497287|323032290|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
94342031|NCT02497287|323032290|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
94342032|NCT02497287|323032290|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
94342033|NCT02497287|323032290|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
94342034|NCT02497287|323032290|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
94342035|NCT02497287|323032290|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
94342036|NCT02497287|323032290|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
94342037|NCT02497287|323032290|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
94342038|NCT02497287|323032290|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
94342039|NCT02497287|323032290|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
94342040|NCT02497287|323032290|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
94342041|NCT02497287|323032290|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
94342042|NCT02497287|323032290|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
94342043|NCT02497287|323032290|FG000|Follow-up Phase (4 Week)|Other|1|||
94342044|NCT02659098|323032291|FG000|Overall Study|Withdrawal by Subject|7|||
94342045|NCT03277794|323032292|FG000|Overall Study|Lost to Follow-up|2|||
94342046|NCT03277794|323032293|FG001|Overall Study|Lost to Follow-up|4|||
94342047|NCT03277794|323032292|FG000|Overall Study|Withdrew due to high acuity|1|||
94342048|NCT03277794|323032293|FG001|Overall Study|Withdrew due to high acuity|0|||
94342049|NCT03039569|323032299|FG000|Overall Study|Lost to Follow-up|5|||
94342050|NCT03039569|323032300|FG001|Overall Study|Lost to Follow-up|4|||
94342051|NCT01226472|323032301|FG000|Overall Study|Progressive Disease|1|||
94342052|NCT00444951|323033628|FG000|Overall Study|Lost to Follow-up|1|||
94342053|NCT00444951|323033629|FG001|Overall Study|Lost to Follow-up|1|||
94342054|NCT00444951|323033630|FG002|Overall Study|Lost to Follow-up|0|||
94342055|NCT00444951|323033628|FG000|Overall Study|Withdrawal by Subject|4|||
94342056|NCT00444951|323033629|FG001|Overall Study|Withdrawal by Subject|5|||
94342057|NCT00444951|323033630|FG002|Overall Study|Withdrawal by Subject|3|||
94342058|NCT01405027|323033633|FG000|Overall Study|Withdrawn consent|3|||
94342059|NCT01405027|323033634|FG001|Overall Study|Withdrawn consent|0|||
94342060|NCT01405027|323033633|FG000|Overall Study|Lost to Follow-up|16|||
94342061|NCT01405027|323033634|FG001|Overall Study|Lost to Follow-up|24|||
94342062|NCT01405027|323033633|FG000|Overall Study|Investigator judgement|0|||
94342063|NCT01405027|323033634|FG001|Overall Study|Investigator judgement|2|||
94342064|NCT01405027|323033633|FG000|Overall Study|Death|1|||
94342065|NCT01405027|323033634|FG001|Overall Study|Death|0|||
94342066|NCT01405027|323033633|FG000|Overall Study|Other or Unknown|12|||
94342067|NCT01405027|323033634|FG001|Overall Study|Other or Unknown|25|||
94342068|NCT00038142|323033638|FG000|Overall Study|Ineligible|1|||
94342069|NCT00038142|323033639|FG001|Overall Study|Ineligible|0|||
94342070|NCT00038142|323033638|FG000|Overall Study|Progressive Disease|11|||
94342071|NCT00038142|323033639|FG001|Overall Study|Progressive Disease|7|||
94342072|NCT00038142|323033638|FG000|Overall Study|Death|1|||
94342073|NCT00038142|323033639|FG001|Overall Study|Death|0|||
94342074|NCT00038142|323033638|FG000|Overall Study|Adverse Event|1|||
94342075|NCT00038142|323033639|FG001|Overall Study|Adverse Event|0|||
94342076|NCT00038142|323033638|FG000|Overall Study|Unknown Reason|8|||
94342077|NCT00038142|323033639|FG001|Overall Study|Unknown Reason|0|||
94342078|NCT00809614|323033640|FG000|Overall Study|Lack of Efficacy|2|||
94342079|NCT00809614|323033641|FG001|Overall Study|Lack of Efficacy|3|||
94342080|NCT00809614|323033640|FG000|Overall Study|Withdrawal by Subject|1|||
94342081|NCT00809614|323033641|FG001|Overall Study|Withdrawal by Subject|1|||
94342082|NCT01017549|323033643|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
94342083|NCT01017549|323033643|FG000|One-year Follow-up|Lost to Follow-up|2|||
94342084|NCT01017549|323033643|FG000|One-year Follow-up|Withdrawal by Subject|5|||
94342085|NCT01017549|323033643|FG000|5 Year Follow-up|Lost to Follow-up|9|||
94342086|NCT01017549|323033643|FG000|5 Year Follow-up|Mastectomy|3|||
94342087|NCT01291511|323033644|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
94342088|NCT01291511|323033645|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
94342089|NCT01291511|323033644|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
94342090|NCT01291511|323033645|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
94342091|NCT01291511|323033644|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
94342092|NCT01291511|323033645|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
94342093|NCT01291511|323033644|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
94342094|NCT01291511|323033645|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
94342095|NCT01291511|323033644|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
94342096|NCT01291511|323033645|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
94342097|NCT01291511|323033644|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
94342098|NCT01291511|323033645|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
94342099|NCT01291511|323033644|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
94443277|NCT00460603|323409675|FG007|Phase 1|Lack of Efficacy|2|||
94443278|NCT00460603|323409676|FG008|Phase 1|Lack of Efficacy|11|||
94443279|NCT00460603|323409677|FG009|Phase 1|Lack of Efficacy|0|||
94443280|NCT00460603|323409678|FG010|Phase 1|Lack of Efficacy|0|||
94443281|NCT00460603|323409679|FG011|Phase 1|Lack of Efficacy|0|||
94443282|NCT00460603|323409668|FG000|Phase 1|Withdrawal by Subject|1|||
94443283|NCT00460603|323409669|FG001|Phase 1|Withdrawal by Subject|2|||
94443284|NCT00460603|323409670|FG002|Phase 1|Withdrawal by Subject|1|||
94443285|NCT00460603|323409671|FG003|Phase 1|Withdrawal by Subject|1|||
94443286|NCT00460603|323409672|FG004|Phase 1|Withdrawal by Subject|3|||
94443287|NCT00460603|323409673|FG005|Phase 1|Withdrawal by Subject|0|||
94443288|NCT00460603|323409674|FG006|Phase 1|Withdrawal by Subject|1|||
94443289|NCT00460603|323409675|FG007|Phase 1|Withdrawal by Subject|0|||
94443290|NCT00460603|323409676|FG008|Phase 1|Withdrawal by Subject|2|||
94443291|NCT00460603|323409677|FG009|Phase 1|Withdrawal by Subject|0|||
94443292|NCT00460603|323409678|FG010|Phase 1|Withdrawal by Subject|0|||
94342100|NCT01291511|323033645|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
94342101|NCT01291511|323033644|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
94342102|NCT01291511|323033645|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
94342103|NCT01291511|323033644|FG000|Cross-Titration and Stabilization Phase|Death|1|||
94342104|NCT01291511|323033645|FG001|Cross-Titration and Stabilization Phase|Death|0|||
94342105|NCT01291511|323033644|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
94342106|NCT01291511|323033645|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
94342107|NCT01291511|323033644|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
94342108|NCT01291511|323033645|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
94342109|NCT01291511|323033644|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
94443293|NCT00460603|323409679|FG011|Phase 1|Withdrawal by Subject|0|||
94443294|NCT00460603|323409668|FG000|Phase 1|Other|0|||
94549979|NCT00908037|323809184|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
94549980|NCT00908037|323809185|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
94549981|NCT00908037|323809186|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
94549982|NCT00908037|323809187|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
94549983|NCT00908037|323809188|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
94549984|NCT00908037|323809189|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
94549985|NCT00908037|323809190|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
94549986|NCT00908037|323809191|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
94549987|NCT00908037|323809192|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
94342110|NCT01291511|323033645|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
94342111|NCT01291511|323033644|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
94342112|NCT01291511|323033645|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
94549988|NCT00908037|323809181|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
94549989|NCT00908037|323809182|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
94549990|NCT00908037|323809183|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
94549991|NCT00908037|323809184|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
94549992|NCT00908037|323809185|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
94549993|NCT00908037|323809186|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
94549994|NCT00908037|323809187|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
94549995|NCT00908037|323809188|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
94549996|NCT00908037|323809189|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
94549997|NCT00908037|323809190|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
94549998|NCT00908037|323809191|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
94342113|NCT01291511|323033644|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
94342114|NCT01291511|323033645|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
94342115|NCT01291511|323033644|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
94549999|NCT00908037|323809192|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
94550000|NCT00908037|323809181|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
94443295|NCT00460603|323409669|FG001|Phase 1|Other|3|||
94443296|NCT00460603|323409670|FG002|Phase 1|Other|1|||
94443297|NCT00460603|323409671|FG003|Phase 1|Other|1|||
94443298|NCT00460603|323409672|FG004|Phase 1|Other|1|||
94443299|NCT00460603|323409673|FG005|Phase 1|Other|2|||
94443300|NCT00460603|323409674|FG006|Phase 1|Other|0|||
94443301|NCT00460603|323409675|FG007|Phase 1|Other|1|||
94443302|NCT00460603|323409676|FG008|Phase 1|Other|0|||
94443303|NCT00460603|323409677|FG009|Phase 1|Other|0|||
94443304|NCT00460603|323409678|FG010|Phase 1|Other|0|||
94443305|NCT00460603|323409679|FG011|Phase 1|Other|0|||
94443306|NCT00460603|323409668|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
94443307|NCT00460603|323409669|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
94443308|NCT00460603|323409670|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
94443309|NCT00460603|323409671|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
94443310|NCT00460603|323409672|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
94443311|NCT00460603|323409673|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
94443312|NCT00460603|323409674|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
94443313|NCT00460603|323409675|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
94443314|NCT00460603|323409676|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
94443315|NCT00460603|323409677|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
94443316|NCT00460603|323409678|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
94443317|NCT00460603|323409679|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
94443318|NCT00460603|323409668|FG000|Phase 2|Adverse Event|0|||
94443319|NCT00460603|323409669|FG001|Phase 2|Adverse Event|0|||
94443320|NCT00460603|323409670|FG002|Phase 2|Adverse Event|0|||
94443321|NCT00460603|323409671|FG003|Phase 2|Adverse Event|0|||
94550001|NCT00908037|323809182|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
94342116|NCT01291511|323033645|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
94342117|NCT01291511|323033644|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
94550002|NCT00908037|323809183|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
94550003|NCT00908037|323809184|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
94550004|NCT00908037|323809185|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
94550005|NCT00908037|323809186|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
94342118|NCT01291511|323033645|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
94550006|NCT00908037|323809187|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
94550007|NCT00908037|323809188|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
94550008|NCT00908037|323809189|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
94550009|NCT00908037|323809190|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
94550010|NCT00908037|323809191|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
94550011|NCT00908037|323809192|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
94550012|NCT00908037|323809181|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
94550013|NCT00908037|323809182|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
94550014|NCT00908037|323809183|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
94550015|NCT00908037|323809184|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
94550016|NCT00908037|323809185|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
94550017|NCT00908037|323809186|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
94550018|NCT00908037|323809187|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
94550019|NCT00908037|323809188|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
94550020|NCT00908037|323809189|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
94550021|NCT00908037|323809190|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
94550022|NCT00908037|323809191|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
94550023|NCT00908037|323809192|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
94550024|NCT00908037|323809181|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
94550025|NCT00908037|323809182|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
94550026|NCT00908037|323809183|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
94550027|NCT00908037|323809184|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
94550028|NCT00908037|323809185|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
94550029|NCT00908037|323809186|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
94550030|NCT00908037|323809187|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
94550031|NCT00908037|323809188|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
94550032|NCT00908037|323809189|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
94550033|NCT00908037|323809190|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
94550034|NCT00908037|323809191|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
94550035|NCT00908037|323809192|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
94550036|NCT00908037|323809181|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
94550037|NCT00908037|323809182|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
94550038|NCT00908037|323809183|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
94550039|NCT00908037|323809184|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
94550040|NCT00908037|323809185|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
94550041|NCT00908037|323809186|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
94550042|NCT00908037|323809187|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
94550043|NCT00908037|323809188|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
94550044|NCT00908037|323809189|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
94550045|NCT00908037|323809190|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
94550046|NCT00908037|323809191|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
94550047|NCT00908037|323809192|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
94342119|NCT01291511|323033644|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
94342120|NCT01291511|323033645|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
94342121|NCT01291511|323033644|FG000|Double-blind Relapse Prevention Phase|Death|1|||
94342122|NCT01291511|323033645|FG001|Double-blind Relapse Prevention Phase|Death|0|||
94342123|NCT00981292|323033648|FG000|Day 1|Protocol Violation|1|||
94342124|NCT00981292|323033649|FG001|Day 1|Protocol Violation|0|||
94342125|NCT00981292|323033650|FG002|Day 1|Protocol Violation|0|||
94342126|NCT00981292|323033651|FG003|Day 1|Protocol Violation|0|||
94550048|NCT00908037|323809181|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
94550049|NCT00908037|323809182|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
94550050|NCT00908037|323809183|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
94550051|NCT00908037|323809184|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
94342127|NCT00981292|323033652|FG004|Day 1|Protocol Violation|0|||
94342128|NCT00981292|323033653|FG005|Day 1|Protocol Violation|2|||
94342129|NCT00981292|323033648|FG000|Day 2|Protocol Violation|2|||
94342130|NCT00981292|323033649|FG001|Day 2|Protocol Violation|0|||
94342131|NCT00981292|323033650|FG002|Day 2|Protocol Violation|0|||
94443322|NCT00460603|323409672|FG004|Phase 2|Adverse Event|0|||
94443323|NCT00460603|323409673|FG005|Phase 2|Adverse Event|0|||
94443324|NCT00460603|323409674|FG006|Phase 2|Adverse Event|0|||
94443325|NCT00460603|323409675|FG007|Phase 2|Adverse Event|0|||
94443326|NCT00460603|323409676|FG008|Phase 2|Adverse Event|0|||
94443327|NCT00460603|323409677|FG009|Phase 2|Adverse Event|12|||
94443328|NCT00460603|323409678|FG010|Phase 2|Adverse Event|9|||
94443329|NCT00460603|323409679|FG011|Phase 2|Adverse Event|10|||
94443330|NCT00460603|323409668|FG000|Phase 2|Death|0|||
94443331|NCT00460603|323409669|FG001|Phase 2|Death|0|||
94443332|NCT00460603|323409670|FG002|Phase 2|Death|0|||
94443333|NCT00460603|323409671|FG003|Phase 2|Death|0|||
94443334|NCT00460603|323409672|FG004|Phase 2|Death|0|||
94443335|NCT00460603|323409673|FG005|Phase 2|Death|0|||
94443336|NCT00460603|323409674|FG006|Phase 2|Death|0|||
94443337|NCT00460603|323409675|FG007|Phase 2|Death|0|||
94443338|NCT00460603|323409676|FG008|Phase 2|Death|0|||
94443339|NCT00460603|323409677|FG009|Phase 2|Death|4|||
94443340|NCT00460603|323409678|FG010|Phase 2|Death|2|||
94443341|NCT00460603|323409679|FG011|Phase 2|Death|2|||
94443342|NCT00460603|323409668|FG000|Phase 2|Protocol Violation|0|||
94443343|NCT00460603|323409669|FG001|Phase 2|Protocol Violation|0|||
94443344|NCT00460603|323409670|FG002|Phase 2|Protocol Violation|0|||
94443345|NCT00460603|323409671|FG003|Phase 2|Protocol Violation|0|||
94443346|NCT00460603|323409672|FG004|Phase 2|Protocol Violation|0|||
94443347|NCT00460603|323409673|FG005|Phase 2|Protocol Violation|0|||
94443348|NCT00460603|323409674|FG006|Phase 2|Protocol Violation|0|||
94443349|NCT00460603|323409675|FG007|Phase 2|Protocol Violation|0|||
94443350|NCT00460603|323409676|FG008|Phase 2|Protocol Violation|0|||
94443351|NCT00460603|323409677|FG009|Phase 2|Protocol Violation|1|||
94443352|NCT00460603|323409678|FG010|Phase 2|Protocol Violation|1|||
94443353|NCT00460603|323409679|FG011|Phase 2|Protocol Violation|0|||
94443354|NCT00460603|323409668|FG000|Phase 2|Lost to Follow-up|0|||
94443355|NCT00460603|323409669|FG001|Phase 2|Lost to Follow-up|0|||
94443356|NCT00460603|323409670|FG002|Phase 2|Lost to Follow-up|0|||
94443357|NCT00460603|323409671|FG003|Phase 2|Lost to Follow-up|0|||
94443358|NCT00460603|323409672|FG004|Phase 2|Lost to Follow-up|0|||
94443359|NCT00460603|323409673|FG005|Phase 2|Lost to Follow-up|0|||
94443360|NCT00460603|323409674|FG006|Phase 2|Lost to Follow-up|0|||
94443361|NCT00460603|323409675|FG007|Phase 2|Lost to Follow-up|0|||
94443362|NCT00460603|323409676|FG008|Phase 2|Lost to Follow-up|0|||
94443363|NCT00460603|323409677|FG009|Phase 2|Lost to Follow-up|1|||
94443364|NCT00460603|323409678|FG010|Phase 2|Lost to Follow-up|0|||
94443365|NCT00460603|323409679|FG011|Phase 2|Lost to Follow-up|0|||
94443366|NCT00460603|323409668|FG000|Phase 2|Other|0|||
94443367|NCT00460603|323409669|FG001|Phase 2|Other|0|||
94443368|NCT00460603|323409670|FG002|Phase 2|Other|0|||
94443369|NCT00460603|323409671|FG003|Phase 2|Other|0|||
94443370|NCT00460603|323409672|FG004|Phase 2|Other|0|||
94443371|NCT00460603|323409673|FG005|Phase 2|Other|0|||
94443372|NCT00460603|323409674|FG006|Phase 2|Other|0|||
94443373|NCT00460603|323409675|FG007|Phase 2|Other|0|||
94443374|NCT00460603|323409676|FG008|Phase 2|Other|0|||
94443375|NCT00460603|323409677|FG009|Phase 2|Other|6|||
94443376|NCT00460603|323409678|FG010|Phase 2|Other|16|||
94443377|NCT00460603|323409679|FG011|Phase 2|Other|7|||
94443378|NCT00460603|323409668|FG000|Phase 2|Objective Progression or Relapse|0|||
94443379|NCT00460603|323409669|FG001|Phase 2|Objective Progression or Relapse|0|||
94443380|NCT00460603|323409670|FG002|Phase 2|Objective Progression or Relapse|0|||
94443381|NCT00460603|323409671|FG003|Phase 2|Objective Progression or Relapse|0|||
94443382|NCT00460603|323409672|FG004|Phase 2|Objective Progression or Relapse|0|||
94443383|NCT00460603|323409673|FG005|Phase 2|Objective Progression or Relapse|0|||
94443384|NCT00460603|323409674|FG006|Phase 2|Objective Progression or Relapse|0|||
94443385|NCT00460603|323409675|FG007|Phase 2|Objective Progression or Relapse|0|||
94443386|NCT00460603|323409676|FG008|Phase 2|Objective Progression or Relapse|0|||
94443387|NCT00460603|323409677|FG009|Phase 2|Objective Progression or Relapse|9|||
94443388|NCT00460603|323409678|FG010|Phase 2|Objective Progression or Relapse|10|||
94443389|NCT00460603|323409679|FG011|Phase 2|Objective Progression or Relapse|17|||
94443390|NCT00460603|323409668|FG000|Phase 2|Global Deterioration of Health Status|0|||
94443391|NCT00460603|323409669|FG001|Phase 2|Global Deterioration of Health Status|0|||
94443392|NCT00460603|323409670|FG002|Phase 2|Global Deterioration of Health Status|0|||
94443393|NCT00460603|323409671|FG003|Phase 2|Global Deterioration of Health Status|0|||
94443394|NCT00460603|323409672|FG004|Phase 2|Global Deterioration of Health Status|0|||
94443395|NCT00460603|323409673|FG005|Phase 2|Global Deterioration of Health Status|0|||
94443396|NCT00460603|323409674|FG006|Phase 2|Global Deterioration of Health Status|0|||
94443397|NCT00460603|323409675|FG007|Phase 2|Global Deterioration of Health Status|0|||
94443398|NCT00460603|323409676|FG008|Phase 2|Global Deterioration of Health Status|0|||
94443399|NCT00460603|323409677|FG009|Phase 2|Global Deterioration of Health Status|0|||
94443400|NCT00460603|323409678|FG010|Phase 2|Global Deterioration of Health Status|1|||
94443401|NCT00460603|323409679|FG011|Phase 2|Global Deterioration of Health Status|0|||
94443402|NCT00460603|323409668|FG000|Phase 2|Withdrawal by Subject|0|||
94443403|NCT00460603|323409669|FG001|Phase 2|Withdrawal by Subject|0|||
94443404|NCT00460603|323409670|FG002|Phase 2|Withdrawal by Subject|0|||
94443405|NCT00460603|323409671|FG003|Phase 2|Withdrawal by Subject|0|||
94342132|NCT00981292|323033651|FG003|Day 2|Protocol Violation|0|||
94342133|NCT00981292|323033652|FG004|Day 2|Protocol Violation|0|||
94342134|NCT00981292|323033653|FG005|Day 2|Protocol Violation|0|||
94342135|NCT00981292|323033648|FG000|Day 3|Protocol Violation|0|||
94342136|NCT00981292|323033649|FG001|Day 3|Protocol Violation|0|||
94342137|NCT00981292|323033650|FG002|Day 3|Protocol Violation|0|||
94342138|NCT00981292|323033651|FG003|Day 3|Protocol Violation|0|||
94342139|NCT00981292|323033652|FG004|Day 3|Protocol Violation|0|||
94342140|NCT00981292|323033653|FG005|Day 3|Protocol Violation|1|||
94342141|NCT00939341|323033654|FG000|Overall Study|Adverse Event|15|||
94342142|NCT00939341|323033654|FG000|Overall Study|Pregnancy|1|||
94342143|NCT00939341|323033654|FG000|Overall Study|Lost to Follow-up|23|||
94342144|NCT00939341|323033654|FG000|Overall Study|Withdrawal by Subject|13|||
94342145|NCT00939341|323033654|FG000|Overall Study|Protocol Violation|6|||
94342146|NCT00939341|323033654|FG000|Overall Study|Incorrect enrolment|8|||
94342147|NCT00424099|323033655|FG000|Overall Study|Adverse Event|0|||
94342148|NCT00424099|323033656|FG001|Overall Study|Adverse Event|1|||
94342149|NCT00424099|323033657|FG002|Overall Study|Adverse Event|1|||
94342150|NCT00424099|323033658|FG003|Overall Study|Adverse Event|0|||
94342151|NCT00424099|323033655|FG000|Overall Study|Death|0|||
94342152|NCT00424099|323033656|FG001|Overall Study|Death|1|||
94342153|NCT00424099|323033657|FG002|Overall Study|Death|0|||
94342154|NCT00424099|323033658|FG003|Overall Study|Death|0|||
94443406|NCT00460603|323409672|FG004|Phase 2|Withdrawal by Subject|0|||
94443407|NCT00460603|323409673|FG005|Phase 2|Withdrawal by Subject|0|||
94443408|NCT00460603|323409674|FG006|Phase 2|Withdrawal by Subject|0|||
94443409|NCT00460603|323409675|FG007|Phase 2|Withdrawal by Subject|0|||
94443410|NCT00460603|323409676|FG008|Phase 2|Withdrawal by Subject|0|||
94443411|NCT00460603|323409677|FG009|Phase 2|Withdrawal by Subject|5|||
94443412|NCT00460603|323409678|FG010|Phase 2|Withdrawal by Subject|4|||
94443413|NCT00460603|323409679|FG011|Phase 2|Withdrawal by Subject|5|||
94443414|NCT00460603|323409668|FG000|Phase 2|Randomized, but not treated|0|||
94443415|NCT00460603|323409669|FG001|Phase 2|Randomized, but not treated|0|||
94443416|NCT00460603|323409670|FG002|Phase 2|Randomized, but not treated|0|||
94443417|NCT00460603|323409671|FG003|Phase 2|Randomized, but not treated|0|||
94443418|NCT00460603|323409672|FG004|Phase 2|Randomized, but not treated|0|||
94443419|NCT00460603|323409673|FG005|Phase 2|Randomized, but not treated|0|||
94443420|NCT00460603|323409674|FG006|Phase 2|Randomized, but not treated|0|||
94443421|NCT00460603|323409675|FG007|Phase 2|Randomized, but not treated|0|||
94443422|NCT00460603|323409676|FG008|Phase 2|Randomized, but not treated|0|||
94443423|NCT00460603|323409677|FG009|Phase 2|Randomized, but not treated|3|||
94443424|NCT00460603|323409678|FG010|Phase 2|Randomized, but not treated|0|||
94443425|NCT00460603|323409679|FG011|Phase 2|Randomized, but not treated|0|||
94443426|NCT01321879|323409683|FG000|Overall Study|Lack of Efficacy|5|||
94443427|NCT01321879|323409683|FG000|Overall Study|Adverse Event|5|||
94443428|NCT01321879|323409683|FG000|Overall Study|Death|3|||
94443429|NCT01321879|323409683|FG000|Overall Study|Withdrawal by Subject|1|||
94443430|NCT02687451|323409684|FG000|Overall Study|Withdrawal by Subject|1|||
94443431|NCT02687451|323409685|FG001|Overall Study|Withdrawal by Subject|0|||
94443432|NCT02687451|323409686|FG002|Overall Study|Withdrawal by Subject|0|||
94443433|NCT02687451|323409687|FG003|Overall Study|Withdrawal by Subject|0|||
94443434|NCT02687451|323409688|FG004|Overall Study|Withdrawal by Subject|0|||
94443435|NCT02687451|323409689|FG005|Overall Study|Withdrawal by Subject|1|||
94443436|NCT00927589|323409690|FG000|Overall Study|Death|1|||
94443437|NCT00927589|323409690|FG000|Overall Study|Physician Decision|1|||
94443438|NCT00927589|323409690|FG000|Overall Study|Withdrawal by Subject|3|||
94443439|NCT00927589|323409690|FG000|Overall Study|Adverse Event|2|||
94443440|NCT00927589|323409690|FG000|Overall Study|Disease Progression|8|||
94443441|NCT00927589|323409690|FG000|Overall Study|Non-compliance|1|||
94443442|NCT00513240|323409691|FG000|Overall Study|Did not have intended surgery|3|||
94443443|NCT00513240|323409692|FG001|Overall Study|Did not have intended surgery|0|||
94443444|NCT00513240|323409691|FG000|Overall Study|Death|3|||
94342155|NCT00424099|323033655|FG000|Overall Study|Illness|2|||
94342156|NCT00424099|323033656|FG001|Overall Study|Illness|0|||
94443445|NCT00513240|323409692|FG001|Overall Study|Death|3|||
94443446|NCT00513240|323409691|FG000|Overall Study|Withdrawal by Subject|7|||
94342157|NCT00424099|323033657|FG002|Overall Study|Illness|1|||
94342158|NCT00424099|323033658|FG003|Overall Study|Illness|4|||
94342159|NCT00424099|323033655|FG000|Overall Study|Lost to Follow-up|0|||
94443447|NCT00513240|323409692|FG001|Overall Study|Withdrawal by Subject|4|||
94443448|NCT01651117|323409697|FG000|Overall Study|Death|2|||
94443449|NCT01651117|323409698|FG001|Overall Study|Death|3|||
94443450|NCT01651117|323409699|FG002|Overall Study|Death|2|||
94443451|NCT01651117|323409700|FG003|Overall Study|Death|2|||
94342160|NCT00424099|323033656|FG001|Overall Study|Lost to Follow-up|0|||
94342161|NCT00424099|323033657|FG002|Overall Study|Lost to Follow-up|3|||
94342162|NCT00424099|323033658|FG003|Overall Study|Lost to Follow-up|0|||
94342163|NCT00424099|323033655|FG000|Overall Study|Hospitalized|1|||
94342164|NCT00424099|323033656|FG001|Overall Study|Hospitalized|2|||
94342165|NCT00424099|323033657|FG002|Overall Study|Hospitalized|1|||
94342166|NCT00424099|323033658|FG003|Overall Study|Hospitalized|3|||
94342167|NCT00424099|323033655|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
94342168|NCT00424099|323033656|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
94342169|NCT00424099|323033657|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
94342170|NCT00424099|323033658|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
94342171|NCT00424099|323033655|FG000|Overall Study|Withdrawal by Subject|1|||
94342172|NCT00424099|323033656|FG001|Overall Study|Withdrawal by Subject|9|||
94342173|NCT00424099|323033657|FG002|Overall Study|Withdrawal by Subject|4|||
94342174|NCT00424099|323033658|FG003|Overall Study|Withdrawal by Subject|6|||
94342175|NCT00424099|323033655|FG000|Overall Study|Physician Decision|0|||
94342176|NCT00424099|323033656|FG001|Overall Study|Physician Decision|0|||
94342177|NCT00424099|323033657|FG002|Overall Study|Physician Decision|1|||
94342178|NCT00424099|323033658|FG003|Overall Study|Physician Decision|0|||
94342179|NCT00424099|323033655|FG000|Overall Study|Missing|0|||
94342180|NCT00424099|323033656|FG001|Overall Study|Missing|0|||
94342181|NCT00424099|323033657|FG002|Overall Study|Missing|1|||
94342182|NCT00424099|323033658|FG003|Overall Study|Missing|0|||
94342183|NCT03377452|323033659|FG000|Overall Study|Refused assessment|0|||
94342184|NCT03377452|323033660|FG001|Overall Study|Refused assessment|2|||
94342185|NCT03377452|323033659|FG000|Overall Study|Lost to Follow-up|5|||
94342186|NCT03377452|323033660|FG001|Overall Study|Lost to Follow-up|4|||
94342187|NCT02015104|323033665|FG000|Overall Study|Withdrew consent after first dose drug|1|||
94342188|NCT02015104|323033666|FG001|Overall Study|Withdrew consent after first dose drug|0|||
94342189|NCT02015104|323033665|FG000|Overall Study|Withdrew consent prior to treatment|0|||
94342190|NCT02015104|323033666|FG001|Overall Study|Withdrew consent prior to treatment|1|||
94342191|NCT01600105|323033669|FG000|Total Participants|Withdrawal by Subject|1|||
94342192|NCT01600105|323033670|FG001|Total Participants|Withdrawal by Subject|0|||
94342193|NCT01600105|323033669|FG000|Total Participants|No images in PACS|10|||
94342194|NCT01600105|323033670|FG001|Total Participants|No images in PACS|0|||
94342195|NCT01600105|323033669|FG000|Total Participants|Insufficient image quality|30|||
94342196|NCT01600105|323033670|FG001|Total Participants|Insufficient image quality|10|||
94342197|NCT01600105|323033669|FG000|Sub Study I|Insufficient image quality|0|||
94342198|NCT01600105|323033670|FG001|Sub Study I|Insufficient image quality|10|||
94342199|NCT01600105|323033669|FG000|Sub Study II|Withdrawal by Subject|1|||
94342200|NCT01600105|323033670|FG001|Sub Study II|Withdrawal by Subject|0|||
94342201|NCT01600105|323033669|FG000|Sub Study II|No images in PACS|1|||
94342202|NCT01600105|323033670|FG001|Sub Study II|No images in PACS|0|||
94342203|NCT01600105|323033669|FG000|Sub Study II|Insufficient image quality|3|||
94342204|NCT01600105|323033670|FG001|Sub Study II|Insufficient image quality|0|||
94342205|NCT01600105|323033669|FG000|Sub Study III|Insufficient image quality|5|||
94342206|NCT01600105|323033670|FG001|Sub Study III|Insufficient image quality|0|||
94342207|NCT01600105|323033669|FG000|Sub Study V|Poor Image Quality|2|||
94342208|NCT01600105|323033670|FG001|Sub Study V|Poor Image Quality|0|||
94342209|NCT01347073|323033672|FG000|Overall Study|Adverse Event|1|||
94342210|NCT01347073|323033672|FG000|Overall Study|Liver Transplant|1|||
94342211|NCT04043416|323033674|FG000|Washout|Change in health condition|0|||
94342212|NCT04043416|323033675|FG001|Washout|Change in health condition|1|||
94342213|NCT02203916|323033677|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
94342214|NCT02203916|323033678|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
94342215|NCT02203916|323033679|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
94342216|NCT02203916|323033677|FG000|Overall Study|Major Protocol Deviation|1|||
94342217|NCT02203916|323033678|FG001|Overall Study|Major Protocol Deviation|1|||
94443452|NCT02714218|323409701|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94443453|NCT02714218|323409702|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
94443454|NCT02714218|323409703|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94443455|NCT02714218|323409701|FG000|Pre-Treatment Period|Other reasons|0|||
94443456|NCT02714218|323409702|FG001|Pre-Treatment Period|Other reasons|1|||
94443457|NCT02714218|323409703|FG002|Pre-Treatment Period|Other reasons|0|||
94443458|NCT02714218|323409701|FG000|Treatment Period|Disease Progression|55|||
94443459|NCT02714218|323409702|FG001|Treatment Period|Disease Progression|52|||
94443460|NCT02714218|323409703|FG002|Treatment Period|Disease Progression|14|||
94443461|NCT02714218|323409701|FG000|Treatment Period|Study drug toxicity|46|||
94443462|NCT02714218|323409702|FG001|Treatment Period|Study drug toxicity|70|||
94443463|NCT02714218|323409703|FG002|Treatment Period|Study drug toxicity|6|||
94443464|NCT02714218|323409701|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
94443465|NCT02714218|323409702|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
94443466|NCT02714218|323409703|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
94443467|NCT02714218|323409701|FG000|Treatment Period|Request to discontinue treatment|1|||
94443468|NCT02714218|323409702|FG001|Treatment Period|Request to discontinue treatment|4|||
94443469|NCT02714218|323409703|FG002|Treatment Period|Request to discontinue treatment|1|||
94443470|NCT02714218|323409701|FG000|Treatment Period|Participant withdrew consent|2|||
94443471|NCT02714218|323409702|FG001|Treatment Period|Participant withdrew consent|2|||
94443472|NCT02714218|323409703|FG002|Treatment Period|Participant withdrew consent|0|||
94443473|NCT02714218|323409701|FG000|Treatment Period|Maximum clinical benefit|4|||
94443474|NCT02714218|323409702|FG001|Treatment Period|Maximum clinical benefit|2|||
94443475|NCT02714218|323409703|FG002|Treatment Period|Maximum clinical benefit|0|||
94342218|NCT02203916|323033679|FG002|Overall Study|Major Protocol Deviation|0|||
94342219|NCT02203916|323033677|FG000|Overall Study|Lost to Follow-up|0|||
94342220|NCT02203916|323033678|FG001|Overall Study|Lost to Follow-up|1|||
94342221|NCT02203916|323033679|FG002|Overall Study|Lost to Follow-up|0|||
94342222|NCT02203916|323033677|FG000|Overall Study|Voluntary Withdrawal|3|||
94342223|NCT02203916|323033678|FG001|Overall Study|Voluntary Withdrawal|3|||
94342224|NCT02203916|323033679|FG002|Overall Study|Voluntary Withdrawal|8|||
94342225|NCT02203916|323033677|FG000|Overall Study|Lack of Efficacy|3|||
94342226|NCT02203916|323033678|FG001|Overall Study|Lack of Efficacy|0|||
94342227|NCT02203916|323033679|FG002|Overall Study|Lack of Efficacy|0|||
94342228|NCT02203916|323033677|FG000|Overall Study|Reason Not Specified|0|||
94342229|NCT02203916|323033678|FG001|Overall Study|Reason Not Specified|2|||
94342230|NCT02203916|323033679|FG002|Overall Study|Reason Not Specified|1|||
94342231|NCT03236506|323033680|FG000|Overall Study|Death|1|||
94342232|NCT03236506|323033681|FG001|Overall Study|Death|1|||
94342233|NCT03236506|323033682|FG002|Overall Study|Death|1|||
94342234|NCT03236506|323033680|FG000|Overall Study|Withdrawal by Subject|3|||
94342235|NCT03236506|323033681|FG001|Overall Study|Withdrawal by Subject|3|||
94342236|NCT03236506|323033682|FG002|Overall Study|Withdrawal by Subject|4|||
94550052|NCT00908037|323809185|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
94550053|NCT00908037|323809186|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
94550054|NCT00908037|323809187|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
94550055|NCT00908037|323809188|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
94550056|NCT00908037|323809189|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
94550057|NCT00908037|323809190|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
94550058|NCT00908037|323809191|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
94550059|NCT00908037|323809192|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
94550060|NCT00117793|323809193|FG000|Overall Study|Withdrawal by Subject|12|||
94550061|NCT00975143|323809194|FG000|Overall Study|Adverse Event|19|||
94550062|NCT00975143|323809195|FG001|Overall Study|Adverse Event|15|||
94550063|NCT00975143|323809194|FG000|Overall Study|Withdrawal by Subject|15|||
94550064|NCT00975143|323809195|FG001|Overall Study|Withdrawal by Subject|15|||
94550065|NCT00975143|323809194|FG000|Overall Study|Lost to Follow-up|20|||
94550066|NCT00975143|323809195|FG001|Overall Study|Lost to Follow-up|16|||
94550067|NCT00975143|323809194|FG000|Overall Study|Non-compliance|5|||
94550068|NCT00975143|323809195|FG001|Overall Study|Non-compliance|8|||
94550069|NCT00975143|323809194|FG000|Overall Study|Physician Decision|1|||
94550070|NCT00975143|323809195|FG001|Overall Study|Physician Decision|2|||
94550071|NCT00975143|323809194|FG000|Overall Study|Details not available|10|||
94550072|NCT00975143|323809195|FG001|Overall Study|Details not available|4|||
94550073|NCT01147900|323809196|FG000|At Year 10|Lost to Follow-up|0|||
94550074|NCT01147900|323809197|FG001|At Year 10|Lost to Follow-up|1|||
94550075|NCT01147900|323809198|FG002|At Year 10|Lost to Follow-up|0|||
94550076|NCT00491608|323809207|FG000|Overall Study|Death|2|||
94550077|NCT00491608|323809207|FG000|Overall Study|Withdrawal by Subject|1|||
94550078|NCT02925741|323809208|FG000|Overall Study|Withdrawal by Subject|11|||
94550079|NCT02925741|323809209|FG001|Overall Study|Withdrawal by Subject|0|||
94550080|NCT05086510|323809212|FG000|Overall Study|Lost to Follow-up|0|||
94550081|NCT05086510|323809213|FG001|Overall Study|Lost to Follow-up|2|||
94550082|NCT05086510|323809212|FG000|Overall Study|Death|0|||
94550083|NCT05086510|323809213|FG001|Overall Study|Death|2|||
94550084|NCT02613169|323809218|FG000|Overall Study|Withdrawal by Subject|4|||
94550085|NCT02613169|323809219|FG001|Overall Study|Withdrawal by Subject|1|||
94550086|NCT02613169|323809218|FG000|Overall Study|Lost to Follow-up|0|||
94550087|NCT02613169|323809219|FG001|Overall Study|Lost to Follow-up|5|||
94550088|NCT02613169|323809218|FG000|Overall Study|HIV|0|||
94550089|NCT02613169|323809219|FG001|Overall Study|HIV|2|||
94550090|NCT02613169|323809218|FG000|Overall Study|No TB infection endpoint|14|||
94550091|NCT02613169|323809219|FG001|Overall Study|No TB infection endpoint|9|||
94550092|NCT03322423|323809221|FG000|Period 1|Subject no longer eligible|0|||
94550093|NCT03322423|323809222|FG001|Period 1|Subject no longer eligible|1|||
94550094|NCT03322423|323809221|FG000|Period 1|Withdrawal by Subject|0|||
94550095|NCT03322423|323809222|FG001|Period 1|Withdrawal by Subject|1|||
94550096|NCT03322423|323809221|FG000|Period 1|Incorrect Lens Dispensed|1|||
94550097|NCT03322423|323809222|FG001|Period 1|Incorrect Lens Dispensed|0|||
94550098|NCT03322423|323809221|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
94550099|NCT03322423|323809222|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
94550100|NCT03322423|323809221|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
94550101|NCT03322423|323809222|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
94550102|NCT03322423|323809221|FG000|Period 2|Protocol Violation|1|||
94550103|NCT03322423|323809222|FG001|Period 2|Protocol Violation|0|||
94550104|NCT03322423|323809221|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
94550105|NCT03322423|323809222|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
94550106|NCT01571453|323809223|FG000|Overall Study|Adverse Event|14|||
94550107|NCT01571453|323809224|FG001|Overall Study|Adverse Event|32|||
94550108|NCT01571453|323809223|FG000|Overall Study|Lack of Efficacy|8|||
94550109|NCT01571453|323809224|FG001|Overall Study|Lack of Efficacy|3|||
94550110|NCT01571453|323809223|FG000|Overall Study|Non-compliance|2|||
94550111|NCT01571453|323809224|FG001|Overall Study|Non-compliance|4|||
94550112|NCT01571453|323809223|FG000|Overall Study|Protocol Violation|1|||
94550113|NCT01571453|323809224|FG001|Overall Study|Protocol Violation|5|||
94550114|NCT01571453|323809223|FG000|Overall Study|Withdrawal of consent|5|||
94550115|NCT01571453|323809224|FG001|Overall Study|Withdrawal of consent|13|||
94550116|NCT01571453|323809223|FG000|Overall Study|Lost to Follow-up|4|||
94550117|NCT01571453|323809224|FG001|Overall Study|Lost to Follow-up|2|||
94550118|NCT01571453|323809223|FG000|Overall Study|Administrative or other reason(s)|4|||
94550119|NCT01571453|323809224|FG001|Overall Study|Administrative or other reason(s)|3|||
94550120|NCT02453555|323809225|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
94550121|NCT02453555|323809226|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
94550122|NCT02453555|323809227|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
94550123|NCT02453555|323809228|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
94550124|NCT02453555|323809229|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
94550125|NCT02453555|323809230|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
94443476|NCT02714218|323409701|FG000|Treatment Period|Administrative reason by sponsor|2|||
94443477|NCT02714218|323409702|FG001|Treatment Period|Administrative reason by sponsor|1|||
94443478|NCT02714218|323409703|FG002|Treatment Period|Administrative reason by sponsor|0|||
94443479|NCT02714218|323409701|FG000|Treatment Period|Other reasons|6|||
94443480|NCT02714218|323409702|FG001|Treatment Period|Other reasons|6|||
94443481|NCT02714218|323409703|FG002|Treatment Period|Other reasons|0|||
94443482|NCT02714218|323409701|FG000|Treatment Period|Completed treatment as per protocol|36|||
94443483|NCT02714218|323409702|FG001|Treatment Period|Completed treatment as per protocol|27|||
94443484|NCT02714218|323409703|FG002|Treatment Period|Completed treatment as per protocol|3|||
94443485|NCT02714218|323409701|FG000|Treatment Period|Not reported|9|||
94443486|NCT02714218|323409702|FG001|Treatment Period|Not reported|6|||
94443487|NCT02714218|323409703|FG002|Treatment Period|Not reported|0|||
94443488|NCT01641640|323409706|FG000|Overall Study|Enrolled but not treated|1|||
94443489|NCT01641640|323409706|FG000|Overall Study|Efficacy failure|29|||
94443490|NCT01641640|323409706|FG000|Overall Study|Lost to Follow-up|3|||
94443491|NCT01641640|323409706|FG000|Overall Study|Withdrawal by Subject|2|||
94443492|NCT01641640|323409706|FG000|Overall Study|Adverse Event|1|||
94443493|NCT00289848|323409711|FG000|Overall Study|Adverse Event|6|||
94443494|NCT00289848|323409712|FG001|Overall Study|Adverse Event|4|||
94443495|NCT00289848|323409711|FG000|Overall Study|Death|1|||
94443496|NCT00289848|323409712|FG001|Overall Study|Death|0|||
94443497|NCT00289848|323409711|FG000|Overall Study|Lack of Efficacy|20|||
94443498|NCT00289848|323409712|FG001|Overall Study|Lack of Efficacy|24|||
94443499|NCT00289848|323409711|FG000|Overall Study|Lost to Follow-up|3|||
94443500|NCT00289848|323409712|FG001|Overall Study|Lost to Follow-up|1|||
94443501|NCT00289848|323409711|FG000|Overall Study|Protocol Violation|5|||
94443502|NCT00289848|323409712|FG001|Overall Study|Protocol Violation|2|||
94443503|NCT00289848|323409711|FG000|Overall Study|Withdrawal by Subject|5|||
94443504|NCT00289848|323409712|FG001|Overall Study|Withdrawal by Subject|11|||
94443505|NCT00289848|323409711|FG000|Overall Study|Patient Moved|6|||
94443506|NCT00289848|323409712|FG001|Overall Study|Patient Moved|2|||
94443507|NCT00289848|323409711|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
94443508|NCT00289848|323409712|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
94443509|NCT00428246|323409715|FG000|Overall Study|Withdrawal by Subject|0|||
94443510|NCT00428246|323409716|FG001|Overall Study|Withdrawal by Subject|0|||
94443511|NCT00428246|323409717|FG002|Overall Study|Withdrawal by Subject|1|||
94443512|NCT00428246|323409715|FG000|Overall Study|Adverse Event|1|||
94443513|NCT00428246|323409716|FG001|Overall Study|Adverse Event|0|||
94443514|NCT00428246|323409717|FG002|Overall Study|Adverse Event|0|||
94443515|NCT02059135|323409719|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
94443516|NCT02059135|323409720|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
94443517|NCT02059135|323409719|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
94443518|NCT02059135|323409720|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
94443519|NCT02059135|323409719|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
94443520|NCT02059135|323409720|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
94443521|NCT02059135|323409719|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
94443522|NCT02059135|323409720|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
94443523|NCT02059135|323409719|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
94443524|NCT02059135|323409720|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
94443525|NCT02059135|323409719|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
94443526|NCT02059135|323409720|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
94443527|NCT02059135|323409719|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
94443528|NCT02059135|323409720|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
94443529|NCT02059135|323409719|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
94443530|NCT02059135|323409720|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
94443531|NCT03335475|323409722|FG000|Overall Study|Did not wear accelerometer|4|||
94443532|NCT03335475|323409723|FG001|Overall Study|Did not wear accelerometer|0|||
94443533|NCT03335475|323409722|FG000|Overall Study|Withdrawal by Subject|0|||
94443534|NCT03335475|323409723|FG001|Overall Study|Withdrawal by Subject|1|||
94443535|NCT00789854|323409724|FG000|Overall Study|Adverse Event|28|||
94443536|NCT00789854|323409725|FG001|Overall Study|Adverse Event|23|||
94443537|NCT00789854|323409726|FG002|Overall Study|Adverse Event|18|||
94443538|NCT00789854|323409724|FG000|Overall Study|Lost to Follow-up|1|||
94443539|NCT00789854|323409725|FG001|Overall Study|Lost to Follow-up|1|||
94443540|NCT00789854|323409726|FG002|Overall Study|Lost to Follow-up|4|||
94443541|NCT00789854|323409724|FG000|Overall Study|Withdrawal by Subject|9|||
94443542|NCT00789854|323409725|FG001|Overall Study|Withdrawal by Subject|6|||
94443543|NCT00789854|323409726|FG002|Overall Study|Withdrawal by Subject|17|||
94443544|NCT00789854|323409724|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
94443545|NCT00789854|323409725|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
94443546|NCT00789854|323409726|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
94443547|NCT00789854|323409724|FG000|Overall Study|Severe non-compliance to the protocol|3|||
94443548|NCT00789854|323409725|FG001|Overall Study|Severe non-compliance to the protocol|0|||
94443549|NCT00789854|323409726|FG002|Overall Study|Severe non-compliance to the protocol|0|||
94443550|NCT00789854|323409724|FG000|Overall Study|Safety reasons|0|||
94443551|NCT00789854|323409725|FG001|Overall Study|Safety reasons|0|||
94443552|NCT00789854|323409726|FG002|Overall Study|Safety reasons|2|||
94443553|NCT00789854|323409724|FG000|Overall Study|Other|6|||
94443554|NCT00789854|323409725|FG001|Overall Study|Other|0|||
94443555|NCT00789854|323409726|FG002|Overall Study|Other|5|||
94443556|NCT03473925|323409727|FG000|Overall Study|Death|48|||
94443557|NCT03473925|323409728|FG001|Overall Study|Death|44|||
94443558|NCT03473925|323409727|FG000|Overall Study|Sponsor Decision|2|||
94443559|NCT03473925|323409728|FG001|Overall Study|Sponsor Decision|7|||
94443560|NCT03473925|323409727|FG000|Overall Study|Withdrawal by Subject|1|||
94443561|NCT03473925|323409728|FG001|Overall Study|Withdrawal by Subject|3|||
94443562|NCT03473925|323409727|FG000|Overall Study|Not Treated|1|||
94443563|NCT03473925|323409728|FG001|Overall Study|Not Treated|1|||
94443564|NCT04578535|323409729|FG000|Overall Study|Lost to Follow-up|1|||
94443565|NCT04578535|323409730|FG001|Overall Study|Lost to Follow-up|0|||
94443566|NCT04578535|323409731|FG002|Overall Study|Lost to Follow-up|0|||
94443567|NCT04578535|323409732|FG003|Overall Study|Lost to Follow-up|1|||
94443568|NCT04578535|323409733|FG004|Overall Study|Lost to Follow-up|0|||
94443569|NCT04578535|323409734|FG005|Overall Study|Lost to Follow-up|2|||
94443570|NCT04578535|323409729|FG000|Overall Study|Pregnancy|1|||
94443571|NCT04578535|323409730|FG001|Overall Study|Pregnancy|0|||
94443572|NCT04578535|323409731|FG002|Overall Study|Pregnancy|0|||
94443573|NCT04578535|323409732|FG003|Overall Study|Pregnancy|0|||
94443574|NCT04578535|323409733|FG004|Overall Study|Pregnancy|0|||
94443575|NCT04578535|323409734|FG005|Overall Study|Pregnancy|0|||
94443576|NCT04578535|323409729|FG000|Overall Study|Withdrawal by Subject|0|||
94443577|NCT04578535|323409730|FG001|Overall Study|Withdrawal by Subject|0|||
94443578|NCT04578535|323409731|FG002|Overall Study|Withdrawal by Subject|0|||
94443579|NCT04578535|323409732|FG003|Overall Study|Withdrawal by Subject|1|||
94443580|NCT04578535|323409733|FG004|Overall Study|Withdrawal by Subject|1|||
94443581|NCT04578535|323409734|FG005|Overall Study|Withdrawal by Subject|5|||
94443582|NCT04578535|323409729|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
94443583|NCT04578535|323409730|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
94443584|NCT04578535|323409731|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
94443585|NCT04578535|323409732|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
94443586|NCT04578535|323409733|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
94443587|NCT04578535|323409734|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
94443588|NCT04583735|323409735|FG000|Double-masked Treatment Period|Adverse Event|0|||
94443589|NCT04583735|323409736|FG001|Double-masked Treatment Period|Adverse Event|1|||
94443590|NCT04583735|323409735|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
94443591|NCT04583735|323409736|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
94443592|NCT04583735|323409735|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
94443593|NCT04583735|323409736|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
94443594|NCT04583735|323409735|FG000|Open-label Treatment Period|Adverse Event|1|||
94443595|NCT04583735|323409736|FG001|Open-label Treatment Period|Adverse Event|1|||
94443596|NCT04583735|323409735|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
94443597|NCT04583735|323409736|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
94443598|NCT04583735|323409735|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
94443599|NCT04583735|323409736|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
94443600|NCT01060072|323409737|FG000|Overall Study|Adverse Event|1|||
94443601|NCT01060072|323409738|FG001|Overall Study|Adverse Event|1|||
94443602|NCT01060072|323409737|FG000|Overall Study|Physician Decision|0|||
94443603|NCT01060072|323409738|FG001|Overall Study|Physician Decision|2|||
94443604|NCT01060072|323409737|FG000|Overall Study|Protocol Violation|0|||
94443605|NCT01060072|323409738|FG001|Overall Study|Protocol Violation|1|||
94443606|NCT01060072|323409737|FG000|Overall Study|Acute cholecystitis|1|||
94443607|NCT01060072|323409738|FG001|Overall Study|Acute cholecystitis|0|||
94443608|NCT01060072|323409737|FG000|Overall Study|Excluded Medications|0|||
94342237|NCT03236506|323033680|FG000|Overall Study|Did not initiate treatment|2|||
94342238|NCT03236506|323033681|FG001|Overall Study|Did not initiate treatment|1|||
94342239|NCT03236506|323033682|FG002|Overall Study|Did not initiate treatment|2|||
94342240|NCT01466062|323033683|FG000|Overall Study|Adverse Event|1|||
94342241|NCT01466062|323033683|FG000|Overall Study|Withdrawal by Subject|1|||
94342242|NCT02865928|323033684|FG000|Overall Study|Withdrawal by Subject|1|||
94342243|NCT02865928|323033685|FG001|Overall Study|Withdrawal by Subject|0|||
94342244|NCT02865928|323033684|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
94342245|NCT02865928|323033685|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
94342246|NCT02865928|323033684|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
94342247|NCT02865928|323033685|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
94342248|NCT00118040|323033686|FG000|Overall Study|Adverse Event|0|||
94342249|NCT00118040|323033687|FG001|Overall Study|Adverse Event|1|||
94443609|NCT01060072|323409738|FG001|Overall Study|Excluded Medications|1|||
94443610|NCT01515423|323409743|FG000|Open Label Phase|Adverse Event|57|||
94443611|NCT01515423|323409744|FG001|Open Label Phase|Adverse Event|0|||
94443612|NCT01515423|323409745|FG002|Open Label Phase|Adverse Event|0|||
94443613|NCT01515423|323409743|FG000|Open Label Phase|Death|2|||
94443614|NCT01515423|323409744|FG001|Open Label Phase|Death|0|||
94443615|NCT01515423|323409745|FG002|Open Label Phase|Death|0|||
94443616|NCT01515423|323409743|FG000|Open Label Phase|Lack of Efficacy|117|||
94443617|NCT01515423|323409744|FG001|Open Label Phase|Lack of Efficacy|0|||
94443618|NCT01515423|323409745|FG002|Open Label Phase|Lack of Efficacy|0|||
94443619|NCT01515423|323409743|FG000|Open Label Phase|Lost to Follow-up|21|||
94443620|NCT01515423|323409744|FG001|Open Label Phase|Lost to Follow-up|0|||
94443621|NCT01515423|323409745|FG002|Open Label Phase|Lost to Follow-up|0|||
94443622|NCT01515423|323409743|FG000|Open Label Phase|Withdrawal by Subject|118|||
94443623|NCT01515423|323409744|FG001|Open Label Phase|Withdrawal by Subject|0|||
94443624|NCT01515423|323409745|FG002|Open Label Phase|Withdrawal by Subject|0|||
94443625|NCT01515423|323409743|FG000|Open Label Phase|excluded from DB Phase|70|||
94443626|NCT01515423|323409744|FG001|Open Label Phase|excluded from DB Phase|0|||
94443627|NCT01515423|323409745|FG002|Open Label Phase|excluded from DB Phase|0|||
94443628|NCT01515423|323409743|FG000|Open Label Phase|Other|28|||
94443629|NCT01515423|323409744|FG001|Open Label Phase|Other|0|||
94443630|NCT01515423|323409745|FG002|Open Label Phase|Other|0|||
94443631|NCT01515423|323409743|FG000|DOUBLE BLIND|Adverse Event|0|||
94443632|NCT01515423|323409744|FG001|DOUBLE BLIND|Adverse Event|15|||
94443633|NCT01515423|323409745|FG002|DOUBLE BLIND|Adverse Event|13|||
94443634|NCT01515423|323409743|FG000|DOUBLE BLIND|Death|0|||
94443635|NCT01515423|323409744|FG001|DOUBLE BLIND|Death|1|||
94443636|NCT01515423|323409745|FG002|DOUBLE BLIND|Death|2|||
94443637|NCT01515423|323409743|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
94443638|NCT01515423|323409744|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
94443639|NCT01515423|323409745|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
94443640|NCT01515423|323409743|FG000|DOUBLE BLIND|Pregnancy|0|||
94443641|NCT01515423|323409744|FG001|DOUBLE BLIND|Pregnancy|2|||
94443642|NCT01515423|323409745|FG002|DOUBLE BLIND|Pregnancy|0|||
94443643|NCT01515423|323409743|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
94443644|NCT01515423|323409744|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
94443645|NCT01515423|323409745|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
94443646|NCT01515423|323409743|FG000|DOUBLE BLIND|Other|0|||
94443647|NCT01515423|323409744|FG001|DOUBLE BLIND|Other|6|||
94443648|NCT01515423|323409745|FG002|DOUBLE BLIND|Other|12|||
94443649|NCT01515423|323409743|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
94443650|NCT01515423|323409744|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
94443651|NCT01515423|323409745|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
94443652|NCT00931411|323409746|FG000|First Intervention - 42 Days|Adverse Event|2|||
94443653|NCT00931411|323409747|FG001|First Intervention - 42 Days|Adverse Event|3|||
94443654|NCT00931411|323409746|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
94443655|NCT00931411|323409747|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
94443656|NCT00931411|323409746|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
94443657|NCT00931411|323409747|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
94443658|NCT04782076|323409750|FG000|Overall Study|Family Emergency|1|||
94443659|NCT02860546|323409751|FG000|Overall Study|Clinical Progression|6|||
94443660|NCT02860546|323409751|FG000|Overall Study|Radiological Progression|12|||
94443661|NCT02291237|323409759|FG000|Overall Study|Study Terminated by Sponsor|72|||
94443662|NCT02291237|323409760|FG001|Overall Study|Study Terminated by Sponsor|67|||
94443663|NCT02291237|323409759|FG000|Overall Study|Adverse Event|1|||
94443664|NCT02291237|323409760|FG001|Overall Study|Adverse Event|3|||
94443665|NCT02291237|323409759|FG000|Overall Study|Investigator's Discretion|0|||
94443666|NCT02291237|323409760|FG001|Overall Study|Investigator's Discretion|3|||
94342250|NCT00118040|323033688|FG002|Overall Study|Adverse Event|0|||
94443667|NCT02291237|323409759|FG000|Overall Study|Withdrew Consent|11|||
94443668|NCT02291237|323409760|FG001|Overall Study|Withdrew Consent|11|||
94443669|NCT02291237|323409759|FG000|Overall Study|Lost to Follow-up|0|||
94443670|NCT02291237|323409760|FG001|Overall Study|Lost to Follow-up|2|||
94443671|NCT02291237|323409759|FG000|Overall Study|Subject Required Prohibited Medication|2|||
94443672|NCT02291237|323409760|FG001|Overall Study|Subject Required Prohibited Medication|0|||
94443673|NCT05271175|323409761|FG000|One Week Follow up|Lost to Follow-up|10|||
94443674|NCT05271175|323409762|FG001|One Week Follow up|Lost to Follow-up|7|||
94443675|NCT05271175|323409763|FG002|One Week Follow up|Lost to Follow-up|5|||
94443676|NCT05271175|323409761|FG000|One Month Follow up|Lost to Follow-up|12|||
94443677|NCT05271175|323409762|FG001|One Month Follow up|Lost to Follow-up|7|||
94443678|NCT05271175|323409763|FG002|One Month Follow up|Lost to Follow-up|9|||
94443679|NCT05271175|323409761|FG000|Six Months Follow up|Lost to Follow-up|8|||
94443680|NCT05271175|323409762|FG001|Six Months Follow up|Lost to Follow-up|2|||
94443681|NCT05271175|323409763|FG002|Six Months Follow up|Lost to Follow-up|2|||
94443682|NCT00729937|323409764|FG000|Overall Study|Lost to Follow-up|49|||
94443683|NCT00729937|323409765|FG001|Overall Study|Lost to Follow-up|58|||
94443684|NCT00729937|323409766|FG002|Overall Study|Lost to Follow-up|18|||
94443685|NCT00729937|323409767|FG003|Overall Study|Lost to Follow-up|33|||
94443686|NCT00729937|323409768|FG004|Overall Study|Lost to Follow-up|18|||
94443687|NCT00729937|323409769|FG005|Overall Study|Lost to Follow-up|23|||
94443688|NCT00729937|323409764|FG000|Overall Study|Physician Decision|7|||
94443689|NCT00729937|323409765|FG001|Overall Study|Physician Decision|16|||
94443690|NCT00729937|323409766|FG002|Overall Study|Physician Decision|2|||
94443691|NCT00729937|323409767|FG003|Overall Study|Physician Decision|0|||
94443692|NCT00729937|323409768|FG004|Overall Study|Physician Decision|5|||
94443693|NCT00729937|323409769|FG005|Overall Study|Physician Decision|8|||
94443694|NCT00729937|323409764|FG000|Overall Study|Death|1|||
94443695|NCT00729937|323409765|FG001|Overall Study|Death|0|||
94443696|NCT00729937|323409766|FG002|Overall Study|Death|1|||
94443697|NCT00729937|323409767|FG003|Overall Study|Death|0|||
94443698|NCT00729937|323409768|FG004|Overall Study|Death|0|||
94443699|NCT00729937|323409769|FG005|Overall Study|Death|1|||
94443700|NCT00729937|323409764|FG000|Overall Study|Withdrawal by Subject|3|||
94443701|NCT00729937|323409765|FG001|Overall Study|Withdrawal by Subject|5|||
94443702|NCT00729937|323409766|FG002|Overall Study|Withdrawal by Subject|6|||
94443703|NCT00729937|323409767|FG003|Overall Study|Withdrawal by Subject|0|||
94443704|NCT00729937|323409768|FG004|Overall Study|Withdrawal by Subject|4|||
94443705|NCT00729937|323409769|FG005|Overall Study|Withdrawal by Subject|2|||
94443706|NCT00729937|323409764|FG000|Overall Study|Randomized but not treated|12|||
94443707|NCT00729937|323409765|FG001|Overall Study|Randomized but not treated|6|||
94443708|NCT00729937|323409766|FG002|Overall Study|Randomized but not treated|1|||
94443709|NCT00729937|323409767|FG003|Overall Study|Randomized but not treated|0|||
94443710|NCT00729937|323409768|FG004|Overall Study|Randomized but not treated|1|||
94443711|NCT00729937|323409769|FG005|Overall Study|Randomized but not treated|3|||
94443712|NCT00729937|323409764|FG000|Overall Study|Did not meet eligibility criteria|2|||
94443713|NCT00729937|323409765|FG001|Overall Study|Did not meet eligibility criteria|1|||
94443714|NCT00729937|323409766|FG002|Overall Study|Did not meet eligibility criteria|0|||
94443715|NCT00729937|323409767|FG003|Overall Study|Did not meet eligibility criteria|0|||
94443716|NCT00729937|323409768|FG004|Overall Study|Did not meet eligibility criteria|0|||
94443717|NCT00729937|323409769|FG005|Overall Study|Did not meet eligibility criteria|0|||
94443718|NCT00729937|323409764|FG000|Overall Study|Incarcerated|0|||
94443719|NCT00729937|323409765|FG001|Overall Study|Incarcerated|2|||
94443720|NCT00729937|323409766|FG002|Overall Study|Incarcerated|1|||
94443721|NCT00729937|323409767|FG003|Overall Study|Incarcerated|1|||
94443722|NCT00729937|323409768|FG004|Overall Study|Incarcerated|0|||
94443723|NCT00729937|323409769|FG005|Overall Study|Incarcerated|0|||
94443724|NCT00946920|323409770|FG000|Overall Study|Withdrawal by Subject|28|||
94443725|NCT00946920|323409771|FG001|Overall Study|Withdrawal by Subject|15|||
94443726|NCT00946920|323409770|FG000|Overall Study|Lost to Follow-up|2|||
94443727|NCT00946920|323409771|FG001|Overall Study|Lost to Follow-up|2|||
94443728|NCT00946920|323409770|FG000|Overall Study|Physician Decision|5|||
94443729|NCT00946920|323409771|FG001|Overall Study|Physician Decision|2|||
94443730|NCT00946920|323409770|FG000|Overall Study|Adverse Event|41|||
94443731|NCT00946920|323409771|FG001|Overall Study|Adverse Event|14|||
94443732|NCT00946920|323409770|FG000|Overall Study|Protocol Violation|16|||
94443733|NCT00946920|323409771|FG001|Overall Study|Protocol Violation|8|||
94443734|NCT00946920|323409770|FG000|Overall Study|Miscellaneous reasons|18|||
94443735|NCT00946920|323409771|FG001|Overall Study|Miscellaneous reasons|3|||
94443736|NCT01821807|323409772|FG000|Overall Study|Lost to Follow-up|3|||
94443737|NCT01821807|323409773|FG001|Overall Study|Lost to Follow-up|1|||
94443738|NCT01401452|323409776|FG000|Overall Study|Adverse reaction|9|||
94443739|NCT01401452|323409776|FG000|Overall Study|Lost to Follow-up|12|||
94443740|NCT01401452|323409776|FG000|Overall Study|Lack of Efficacy|30|||
94443741|NCT01401452|323409776|FG000|Overall Study|Participant developed breast cancer|1|||
94443742|NCT01401452|323409776|FG000|Overall Study|Tx stopped due to financial reasons|1|||
94443743|NCT01401452|323409776|FG000|Overall Study|Tx stopped by psychiatrist|1|||
94443744|NCT01401452|323409776|FG000|Overall Study|No more visits within the 36 wk followup|4|||
94443745|NCT01401452|323409776|FG000|Overall Study|Subject did not come to follow up visits|2|||
94443746|NCT01401452|323409776|FG000|Overall Study|Subject didn't return for routine visits|1|||
94443747|NCT01401452|323409776|FG000|Overall Study|Subject moved to another city|1|||
94550126|NCT02453555|323809225|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
94550127|NCT02453555|323809226|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
94550128|NCT02453555|323809227|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
94550129|NCT02453555|323809228|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
94550130|NCT02453555|323809229|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
94550131|NCT02453555|323809230|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
94550132|NCT02453555|323809225|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
94550133|NCT02453555|323809226|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
94550134|NCT02453555|323809227|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
94550135|NCT02453555|323809228|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
94550136|NCT02453555|323809229|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
94550137|NCT02453555|323809230|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
94550138|NCT02453555|323809225|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
94550139|NCT02453555|323809226|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
94550140|NCT02453555|323809227|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
94550141|NCT02453555|323809228|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
94550142|NCT02453555|323809229|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
94550143|NCT02453555|323809230|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
94550144|NCT02453555|323809225|FG000|Extension Period|Adverse Event|0|||
94550145|NCT02453555|323809226|FG001|Extension Period|Adverse Event|0|||
94550146|NCT02453555|323809227|FG002|Extension Period|Adverse Event|1|||
94550147|NCT02453555|323809228|FG003|Extension Period|Adverse Event|2|||
94550148|NCT02453555|323809229|FG004|Extension Period|Adverse Event|1|||
94550149|NCT02453555|323809230|FG005|Extension Period|Adverse Event|1|||
94550150|NCT02453555|323809225|FG000|Extension Period|Protocol Violation|0|||
94550151|NCT02453555|323809226|FG001|Extension Period|Protocol Violation|0|||
94550152|NCT02453555|323809227|FG002|Extension Period|Protocol Violation|1|||
94550153|NCT02453555|323809228|FG003|Extension Period|Protocol Violation|0|||
94550154|NCT02453555|323809229|FG004|Extension Period|Protocol Violation|0|||
94550155|NCT02453555|323809230|FG005|Extension Period|Protocol Violation|0|||
94550156|NCT02453555|323809225|FG000|Extension Period|Withdrawal by Subject|0|||
94550157|NCT02453555|323809226|FG001|Extension Period|Withdrawal by Subject|0|||
94550158|NCT02453555|323809227|FG002|Extension Period|Withdrawal by Subject|1|||
94550159|NCT02453555|323809228|FG003|Extension Period|Withdrawal by Subject|0|||
94550160|NCT02453555|323809229|FG004|Extension Period|Withdrawal by Subject|0|||
94550161|NCT02453555|323809230|FG005|Extension Period|Withdrawal by Subject|0|||
94550162|NCT02177838|323809245|FG000|Overall Study|Withdrawal by Subject|1|||
94550163|NCT02177838|323809245|FG000|Overall Study|Physician Decision|1|||
94550164|NCT02177838|323809245|FG000|Overall Study|Death|1|||
94550165|NCT02117349|323809248|FG000|Overall Study|Withdrawal by Subject|1|||
94550166|NCT02117349|323809249|FG001|Overall Study|Withdrawal by Subject|0|||
94550167|NCT02117349|323809248|FG000|Overall Study|Lost to Follow-up|1|||
94550168|NCT02117349|323809249|FG001|Overall Study|Lost to Follow-up|1|||
94550169|NCT02117349|323809248|FG000|Overall Study|Death|1|||
94550170|NCT02117349|323809249|FG001|Overall Study|Death|0|||
94550171|NCT00558272|323809251|FG000|Overall Study|Adverse Event|10|||
94550172|NCT00558272|323809252|FG001|Overall Study|Adverse Event|0|||
94550173|NCT00558272|323809251|FG000|Overall Study|Death|1|||
94550174|NCT00558272|323809252|FG001|Overall Study|Death|0|||
94550175|NCT00558272|323809251|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
94550176|NCT00558272|323809252|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
94550177|NCT00558272|323809251|FG000|Overall Study|AZ study team decision|0|||
94550178|NCT00558272|323809252|FG001|Overall Study|AZ study team decision|1|||
94550179|NCT00558272|323809251|FG000|Overall Study|Incorrectly enrolled|1|||
94550180|NCT00558272|323809252|FG001|Overall Study|Incorrectly enrolled|0|||
94550181|NCT00558272|323809251|FG000|Overall Study|Withdrawal by Subject|0|||
94550182|NCT00558272|323809252|FG001|Overall Study|Withdrawal by Subject|1|||
94550183|NCT00454649|323809255|FG000|Overall Study|Lack of Efficacy|2|||
94550184|NCT00454649|323809256|FG001|Overall Study|Lack of Efficacy|2|||
94550185|NCT00454649|323809257|FG002|Overall Study|Lack of Efficacy|10|||
94550186|NCT00454649|323809258|FG003|Overall Study|Lack of Efficacy|3|||
94550187|NCT00454649|323809259|FG004|Overall Study|Lack of Efficacy|0|||
94550188|NCT00454649|323809260|FG005|Overall Study|Lack of Efficacy|4|||
94550189|NCT00454649|323809261|FG006|Overall Study|Lack of Efficacy|5|||
94550190|NCT00454649|323809262|FG007|Overall Study|Lack of Efficacy|13|||
94550191|NCT00454649|323809263|FG008|Overall Study|Lack of Efficacy|10|||
94550192|NCT00454649|323809264|FG009|Overall Study|Lack of Efficacy|2|||
94550193|NCT00454649|323809255|FG000|Overall Study|Adverse Event|0|||
94550194|NCT00454649|323809256|FG001|Overall Study|Adverse Event|1|||
94550195|NCT00454649|323809257|FG002|Overall Study|Adverse Event|3|||
94550196|NCT00454649|323809258|FG003|Overall Study|Adverse Event|0|||
94550197|NCT00454649|323809259|FG004|Overall Study|Adverse Event|1|||
94550198|NCT00454649|323809260|FG005|Overall Study|Adverse Event|2|||
94550199|NCT00454649|323809261|FG006|Overall Study|Adverse Event|3|||
94342251|NCT00118040|323033686|FG000|Overall Study|Withdrawal by Subject|0|||
94342252|NCT00118040|323033687|FG001|Overall Study|Withdrawal by Subject|0|||
94342253|NCT00118040|323033688|FG002|Overall Study|Withdrawal by Subject|2|||
94342254|NCT00118040|323033686|FG000|Overall Study|Medical Contraindication|0|||
94342255|NCT00118040|323033687|FG001|Overall Study|Medical Contraindication|0|||
94342256|NCT00118040|323033688|FG002|Overall Study|Medical Contraindication|1|||
94342257|NCT00118040|323033686|FG000|Overall Study|Non-Compliant Participant|1|||
94342258|NCT00118040|323033687|FG001|Overall Study|Non-Compliant Participant|1|||
94342259|NCT00118040|323033688|FG002|Overall Study|Non-Compliant Participant|2|||
94342260|NCT00118040|323033686|FG000|Overall Study|Other|0|||
94342261|NCT00118040|323033687|FG001|Overall Study|Other|0|||
94342262|NCT00118040|323033688|FG002|Overall Study|Other|1|||
94342263|NCT04476108|323033691|FG000|Overall Study|Adverse Event|4|||
94342264|NCT04476108|323033692|FG001|Overall Study|Adverse Event|1|||
94342265|NCT04476108|323033691|FG000|Overall Study|Lost to Follow-up|1|||
94342266|NCT04476108|323033692|FG001|Overall Study|Lost to Follow-up|0|||
94342267|NCT04476108|323033691|FG000|Overall Study|Inadvertent Enrollment|1|||
94342268|NCT04476108|323033692|FG001|Overall Study|Inadvertent Enrollment|0|||
94342269|NCT04476108|323033691|FG000|Overall Study|Protocol Violation|1|||
94342270|NCT04476108|323033692|FG001|Overall Study|Protocol Violation|1|||
94342271|NCT04476108|323033691|FG000|Overall Study|Withdrawal by Subject|1|||
94342272|NCT04476108|323033692|FG001|Overall Study|Withdrawal by Subject|1|||
94342273|NCT00312728|323033693|FG000|Overall Study|Progressive disease|53|||
94342274|NCT00312728|323033693|FG000|Overall Study|Adverse Event|32|||
94342275|NCT00312728|323033693|FG000|Overall Study|Withdrawal by Subject|10|||
94342276|NCT00312728|323033693|FG000|Overall Study|Required non-protocol cancer treatment|2|||
94342277|NCT00312728|323033693|FG000|Overall Study|Protocol Violation|2|||
94342278|NCT00312728|323033693|FG000|Overall Study|Other|10|||
94342279|NCT00312728|323033693|FG000|Overall Study|Other|1|||
94342280|NCT00623766|323033694|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
94342281|NCT00623766|323033695|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
94342282|NCT00623766|323033694|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
94342283|NCT00623766|323033695|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
94342284|NCT00623766|323033694|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
94342285|NCT00623766|323033695|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
94342286|NCT00623766|323033694|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
94342287|NCT00623766|323033695|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
94342288|NCT00623766|323033694|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
94342289|NCT00623766|323033695|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
94342290|NCT00486889|323033699|FG000|Overall Study|Death|3|||
94342291|NCT00486889|323033699|FG000|Overall Study|Non-compliant|2|||
94342292|NCT00486889|323033699|FG000|Overall Study|Withdrawal by Subject|6|||
94342293|NCT03198728|323033700|FG000|Overall Study|Adverse Event|10|||
94342294|NCT03198728|323033701|FG001|Overall Study|Adverse Event|5|||
94342295|NCT03198728|323033700|FG000|Overall Study|Lost to Follow-up|21|||
94342296|NCT03198728|323033701|FG001|Overall Study|Lost to Follow-up|7|||
94342297|NCT03198728|323033700|FG000|Overall Study|Physician Decision|7|||
94342298|NCT03198728|323033701|FG001|Overall Study|Physician Decision|2|||
94342299|NCT03198728|323033700|FG000|Overall Study|Withdrawal by Subject|14|||
94342300|NCT03198728|323033701|FG001|Overall Study|Withdrawal by Subject|10|||
94342301|NCT01878175|323033703|FG000|Overall Study|Developed contraindicated health problem|2|||
94342302|NCT04157751|323033704|FG000|Overall Study|Withdrawal by Subject|12|||
94342303|NCT04157751|323033705|FG001|Overall Study|Withdrawal by Subject|17|||
94342304|NCT04157751|323033704|FG000|Overall Study|Lost to Follow-up|6|||
94342305|NCT04157751|323033705|FG001|Overall Study|Lost to Follow-up|2|||
94342306|NCT04157751|323033704|FG000|Overall Study|Adverse Event|34|||
94342307|NCT04157751|323033705|FG001|Overall Study|Adverse Event|23|||
94342308|NCT04157751|323033704|FG000|Overall Study|Not treated|1|||
94342309|NCT04157751|323033705|FG001|Overall Study|Not treated|5|||
94342310|NCT04157751|323033704|FG000|Overall Study|Other reason not stated above|10|||
94342311|NCT04157751|323033705|FG001|Overall Study|Other reason not stated above|10|||
94342312|NCT04489940|323033713|FG000|Overall Study|Other|2|||
94342313|NCT04489940|323033713|FG000|Overall Study|Withdrawal by Subject|2|||
94342314|NCT04489940|323033713|FG000|Overall Study|Death|5|||
94342315|NCT04489940|323033713|FG000|Overall Study|Lost to Follow-up|1|||
94342316|NCT00959699|323033717|FG000|Treatment Period|Adverse Event|3|||
94443748|NCT01401452|323409776|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
94342317|NCT00959699|323033718|FG001|Treatment Period|Adverse Event|13|||
94342318|NCT00959699|323033717|FG000|Treatment Period|Lack of Efficacy|15|||
94342319|NCT00959699|323033718|FG001|Treatment Period|Lack of Efficacy|6|||
94342320|NCT00959699|323033717|FG000|Treatment Period|Lost to Follow-up|0|||
94443749|NCT01401452|323409776|FG000|Overall Study|Psoriatic arthritis|1|||
94342321|NCT00959699|323033718|FG001|Treatment Period|Lost to Follow-up|1|||
94342322|NCT00959699|323033717|FG000|Treatment Period|Withdrawal by Subject|1|||
94342323|NCT00959699|323033718|FG001|Treatment Period|Withdrawal by Subject|3|||
94342324|NCT00959699|323033717|FG000|Treatment Period|Non-Compliance with Protocol|0|||
94342325|NCT00959699|323033718|FG001|Treatment Period|Non-Compliance with Protocol|1|||
94342326|NCT00959699|323033717|FG000|Treatment Period|Did not receive treatment|0|||
94342327|NCT00959699|323033718|FG001|Treatment Period|Did not receive treatment|1|||
94342328|NCT00959699|323033717|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
94342329|NCT00959699|323033718|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
94342330|NCT00959699|323033717|FG000|Follow-up Period|Lost to Follow-up|3|||
94342331|NCT00959699|323033718|FG001|Follow-up Period|Lost to Follow-up|2|||
94342332|NCT00959699|323033717|FG000|Follow-up Period|Withdrawal by Subject|3|||
94342333|NCT00959699|323033718|FG001|Follow-up Period|Withdrawal by Subject|4|||
94342334|NCT01316380|323033719|FG000|Overall Study|Adverse Event|0|||
94342335|NCT01316380|323033720|FG001|Overall Study|Adverse Event|2|||
94342336|NCT01316380|323033721|FG002|Overall Study|Adverse Event|1|||
94342337|NCT01316380|323033719|FG000|Overall Study|Protocol Violation|0|||
94342338|NCT01316380|323033720|FG001|Overall Study|Protocol Violation|0|||
94342339|NCT01316380|323033721|FG002|Overall Study|Protocol Violation|1|||
94342340|NCT01316380|323033719|FG000|Overall Study|Withdrawal by Subject|1|||
94342341|NCT01316380|323033720|FG001|Overall Study|Withdrawal by Subject|2|||
94342342|NCT01316380|323033721|FG002|Overall Study|Withdrawal by Subject|0|||
94342343|NCT01316380|323033719|FG000|Overall Study|Other|0|||
94342344|NCT01316380|323033720|FG001|Overall Study|Other|1|||
94342345|NCT01316380|323033721|FG002|Overall Study|Other|1|||
94342346|NCT01316380|323033719|FG000|Overall Study|Not treated|1|||
94342347|NCT01316380|323033720|FG001|Overall Study|Not treated|0|||
94342348|NCT01316380|323033721|FG002|Overall Study|Not treated|0|||
94342349|NCT03325010|323033725|FG000|Overall Study|Adverse Event|3|||
94342350|NCT03325010|323033726|FG001|Overall Study|Adverse Event|8|||
94342351|NCT03325010|323033725|FG000|Overall Study|Protocol Violation|1|||
94342352|NCT03325010|323033726|FG001|Overall Study|Protocol Violation|8|||
94342353|NCT03325010|323033725|FG000|Overall Study|Withdrawal by Subject|1|||
94342354|NCT03325010|323033726|FG001|Overall Study|Withdrawal by Subject|3|||
94342355|NCT03325010|323033725|FG000|Overall Study|Lost to Follow-up|1|||
94342356|NCT03325010|323033726|FG001|Overall Study|Lost to Follow-up|0|||
94342357|NCT03325010|323033725|FG000|Overall Study|Physician Decision|1|||
94342358|NCT03325010|323033726|FG001|Overall Study|Physician Decision|1|||
94342359|NCT03325010|323033725|FG000|Overall Study|Lack of Efficacy|2|||
94342360|NCT03325010|323033726|FG001|Overall Study|Lack of Efficacy|0|||
94342361|NCT03860844|323033728|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
94342362|NCT03860844|323033729|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
94342363|NCT03860844|323033730|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
94342364|NCT03860844|323033728|FG000|Overall Study|Progressive disease|5|||
94342365|NCT03860844|323033729|FG001|Overall Study|Progressive disease|3|||
94342366|NCT03860844|323033730|FG002|Overall Study|Progressive disease|4|||
94342367|NCT03860844|323033728|FG000|Overall Study|Other, Not related to COVID-19|0|||
94342368|NCT03860844|323033729|FG001|Overall Study|Other, Not related to COVID-19|1|||
94342369|NCT03860844|323033730|FG002|Overall Study|Other, Not related to COVID-19|0|||
94342370|NCT03898323|323033731|FG000|Overall Study|Physician Decision|1|||
94342371|NCT00320190|323033733|FG000|First 12 Months|Completed but did not enter extension|5|||
94342372|NCT00320190|323033734|FG001|First 12 Months|Completed but did not enter extension|3|||
94342373|NCT00320190|323033733|FG000|First 12 Months|Sponsor terminated study|2|||
94342374|NCT00320190|323033734|FG001|First 12 Months|Sponsor terminated study|2|||
94342375|NCT00320190|323033733|FG000|First 12 Months|Lost to Follow-up|0|||
94342376|NCT00320190|323033734|FG001|First 12 Months|Lost to Follow-up|1|||
94342377|NCT00320190|323033733|FG000|First 12 Months|Enrollment failure|0|||
94342378|NCT00320190|323033734|FG001|First 12 Months|Enrollment failure|1|||
94342379|NCT00320190|323033733|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
94342380|NCT00320190|323033734|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
94342381|NCT00320190|323033733|FG000|First 12 Months|Investigator request|0|||
94342382|NCT00320190|323033734|FG001|First 12 Months|Investigator request|1|||
94342383|NCT00320190|323033733|FG000|First 12 Months|Study drug toxicity|0|||
94443750|NCT01401452|323409776|FG000|Overall Study|Participant stopped Tx|2|||
94443751|NCT01401452|323409776|FG000|Overall Study|Discontinuation for personal reasons|1|||
94342384|NCT00320190|323033734|FG001|First 12 Months|Study drug toxicity|1|||
94342385|NCT00320190|323033733|FG000|First 12 Months|Withdrawal by Subject|0|||
94342386|NCT00320190|323033734|FG001|First 12 Months|Withdrawal by Subject|1|||
94342387|NCT00320190|323033733|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
94342388|NCT00320190|323033734|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
94342389|NCT00320190|323033733|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
94342390|NCT00320190|323033734|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
94342391|NCT00320190|323033733|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
94342392|NCT00320190|323033734|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
94550200|NCT00454649|323809262|FG007|Overall Study|Adverse Event|4|||
94550201|NCT00454649|323809263|FG008|Overall Study|Adverse Event|6|||
94550202|NCT00454649|323809264|FG009|Overall Study|Adverse Event|2|||
94550203|NCT00454649|323809255|FG000|Overall Study|Lost to Follow-up|0|||
94550204|NCT00454649|323809256|FG001|Overall Study|Lost to Follow-up|0|||
94550205|NCT00454649|323809257|FG002|Overall Study|Lost to Follow-up|1|||
94550206|NCT00454649|323809258|FG003|Overall Study|Lost to Follow-up|0|||
94550207|NCT00454649|323809259|FG004|Overall Study|Lost to Follow-up|0|||
94550208|NCT00454649|323809260|FG005|Overall Study|Lost to Follow-up|0|||
94550209|NCT00454649|323809261|FG006|Overall Study|Lost to Follow-up|1|||
94550210|NCT00454649|323809262|FG007|Overall Study|Lost to Follow-up|0|||
94550211|NCT00454649|323809263|FG008|Overall Study|Lost to Follow-up|0|||
94550212|NCT00454649|323809264|FG009|Overall Study|Lost to Follow-up|0|||
94550213|NCT00454649|323809255|FG000|Overall Study|Other|1|||
94550214|NCT00454649|323809256|FG001|Overall Study|Other|1|||
94550215|NCT00454649|323809257|FG002|Overall Study|Other|5|||
94550216|NCT00454649|323809258|FG003|Overall Study|Other|3|||
94550217|NCT00454649|323809259|FG004|Overall Study|Other|0|||
94550218|NCT00454649|323809260|FG005|Overall Study|Other|0|||
94550219|NCT00454649|323809261|FG006|Overall Study|Other|0|||
94550220|NCT00454649|323809262|FG007|Overall Study|Other|0|||
94550221|NCT00454649|323809263|FG008|Overall Study|Other|3|||
94550222|NCT00454649|323809264|FG009|Overall Study|Other|1|||
94550223|NCT00454649|323809255|FG000|Overall Study|Withdrawal by Subject|0|||
94550224|NCT00454649|323809256|FG001|Overall Study|Withdrawal by Subject|0|||
94550225|NCT00454649|323809257|FG002|Overall Study|Withdrawal by Subject|0|||
94550226|NCT00454649|323809258|FG003|Overall Study|Withdrawal by Subject|0|||
94550227|NCT00454649|323809259|FG004|Overall Study|Withdrawal by Subject|0|||
94550228|NCT00454649|323809260|FG005|Overall Study|Withdrawal by Subject|1|||
94550229|NCT00454649|323809261|FG006|Overall Study|Withdrawal by Subject|0|||
94550230|NCT00454649|323809262|FG007|Overall Study|Withdrawal by Subject|2|||
94550231|NCT00454649|323809263|FG008|Overall Study|Withdrawal by Subject|1|||
94550232|NCT00454649|323809264|FG009|Overall Study|Withdrawal by Subject|0|||
94550233|NCT02262754|323809265|FG000|Overall Study|Adverse Event|3|||
94550234|NCT02262754|323809266|FG001|Overall Study|Adverse Event|4|||
94550235|NCT02262754|323809267|FG002|Overall Study|Adverse Event|0|||
94550236|NCT02262754|323809265|FG000|Overall Study|Lack of Efficacy|2|||
94550237|NCT02262754|323809266|FG001|Overall Study|Lack of Efficacy|0|||
94550238|NCT02262754|323809267|FG002|Overall Study|Lack of Efficacy|1|||
94550239|NCT02262754|323809265|FG000|Overall Study|Lost to Follow-up|0|||
94550240|NCT02262754|323809266|FG001|Overall Study|Lost to Follow-up|0|||
94550241|NCT02262754|323809267|FG002|Overall Study|Lost to Follow-up|1|||
94550242|NCT02262754|323809265|FG000|Overall Study|No longer meets eligibility criteria|0|||
94550243|NCT02262754|323809266|FG001|Overall Study|No longer meets eligibility criteria|1|||
94550244|NCT02262754|323809267|FG002|Overall Study|No longer meets eligibility criteria|0|||
94550245|NCT02262754|323809265|FG000|Overall Study|Study terminated by sponsor|5|||
94550246|NCT02262754|323809266|FG001|Overall Study|Study terminated by sponsor|4|||
94550247|NCT02262754|323809267|FG002|Overall Study|Study terminated by sponsor|4|||
94550248|NCT02262754|323809265|FG000|Overall Study|Protocol Violation|1|||
94550249|NCT02262754|323809266|FG001|Overall Study|Protocol Violation|0|||
94550250|NCT02262754|323809267|FG002|Overall Study|Protocol Violation|0|||
94550251|NCT02262754|323809265|FG000|Overall Study|Withdrawal by Subject|1|||
94550252|NCT02262754|323809266|FG001|Overall Study|Withdrawal by Subject|0|||
94550253|NCT02262754|323809267|FG002|Overall Study|Withdrawal by Subject|1|||
94550254|NCT02262754|323809265|FG000|Overall Study|Other|4|||
94550255|NCT02262754|323809266|FG001|Overall Study|Other|0|||
94550256|NCT02262754|323809267|FG002|Overall Study|Other|2|||
94550257|NCT05327361|323809269|FG000|Overall Study|Lost to Follow-up|4|||
94550258|NCT01141478|323810685|FG000|Overall Study|Withdrawal by Subject|1|||
94550259|NCT01141478|323810686|FG001|Overall Study|Withdrawal by Subject|1|||
94550260|NCT02809053|323810687|FG000|Overall Study|Death|0|||
94550261|NCT02809053|323810688|FG001|Overall Study|Death|1|||
94550262|NCT02809053|323810687|FG000|Overall Study|Lost to Follow-up|3|||
94550263|NCT02809053|323810688|FG001|Overall Study|Lost to Follow-up|1|||
94550264|NCT02809053|323810687|FG000|Overall Study|Withdrawal by Subject|2|||
94550265|NCT02809053|323810688|FG001|Overall Study|Withdrawal by Subject|3|||
94342393|NCT01365091|323033741|FG000|Period 1|Adverse Event|1|||
94550266|NCT02809053|323810687|FG000|Overall Study|Disease Progression|2|||
94550267|NCT02809053|323810688|FG001|Overall Study|Disease Progression|1|||
94550268|NCT00551291|323810691|FG000|Overall Study|Physician Decision|1|||
94550269|NCT01641822|323810695|FG000|Run-in Phase|Noncompliance with study drug|1|||
94550270|NCT01641822|323810696|FG001|Run-in Phase|Noncompliance with study drug|0|||
94550271|NCT01641822|323810697|FG002|Run-in Phase|Noncompliance with study drug|0|||
94550272|NCT01641822|323810695|FG000|Run-in Phase|Adverse Event|3|||
94550273|NCT01641822|323810696|FG001|Run-in Phase|Adverse Event|0|||
94550274|NCT01641822|323810697|FG002|Run-in Phase|Adverse Event|0|||
94550275|NCT01641822|323810695|FG000|Run-in Phase|Withdrew consent|1|||
94550276|NCT01641822|323810696|FG001|Run-in Phase|Withdrew consent|0|||
94550277|NCT01641822|323810697|FG002|Run-in Phase|Withdrew consent|0|||
94550278|NCT01641822|323810695|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
94550279|NCT01641822|323810696|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
94550280|NCT01641822|323810697|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
94550281|NCT01641822|323810695|FG000|Comparative Phase|Noncompliance with study drug|0|||
94550282|NCT01641822|323810696|FG001|Comparative Phase|Noncompliance with study drug|1|||
94550283|NCT01641822|323810697|FG002|Comparative Phase|Noncompliance with study drug|0|||
94550284|NCT01641822|323810695|FG000|Comparative Phase|Investigator's discretion|0|||
94550285|NCT01641822|323810696|FG001|Comparative Phase|Investigator's discretion|0|||
94550286|NCT01641822|323810697|FG002|Comparative Phase|Investigator's discretion|1|||
94550287|NCT01641822|323810695|FG000|Comparative Phase|Pregnancy|0|||
94550288|NCT01641822|323810696|FG001|Comparative Phase|Pregnancy|0|||
94550289|NCT01641822|323810697|FG002|Comparative Phase|Pregnancy|1|||
94550290|NCT01641822|323810695|FG000|Comparative Phase|Adverse event, serious fatal|0|||
94550291|NCT01641822|323810696|FG001|Comparative Phase|Adverse event, serious fatal|1|||
94550292|NCT01641822|323810697|FG002|Comparative Phase|Adverse event, serious fatal|0|||
94550293|NCT01641822|323810695|FG000|Comparative Phase|Withdrew consent|0|||
94550294|NCT01641822|323810696|FG001|Comparative Phase|Withdrew consent|3|||
94550295|NCT01641822|323810697|FG002|Comparative Phase|Withdrew consent|7|||
94443752|NCT01401452|323409776|FG000|Overall Study|Treatment failure|1|||
94443753|NCT01401452|323409776|FG000|Overall Study|Unsatisfactory output|1|||
94443754|NCT01401452|323409776|FG000|Overall Study|Subject withdrew because of Tx success|1|||
94443755|NCT01401452|323409776|FG000|Overall Study|Subject chose to discontinue treatment|1|||
94443756|NCT01401452|323409776|FG000|Overall Study|Participant withdrew consent|1|||
94443757|NCT00584454|323409777|FG000|Overall Study|Adverse Event|1|||
94443758|NCT00584454|323409777|FG000|Overall Study|Relocation|1|||
94443759|NCT00584454|323409777|FG000|Overall Study|Clinical Hold|2|||
94443760|NCT01154231|323409778|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
94443761|NCT01154231|323409778|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
94443762|NCT01597973|323409779|FG000|Overall Study|Found ineligible before study medication started|4|||
94443763|NCT01597973|323409780|FG001|Overall Study|Found ineligible before study medication started|2|||
94443764|NCT01597973|323409779|FG000|Overall Study|Eligible pathogen not confirmed|14|||
94443765|NCT01597973|323409780|FG001|Overall Study|Eligible pathogen not confirmed|15|||
94443766|NCT01597973|323409779|FG000|Overall Study|LAR not authorized to consent|0|||
94443767|NCT01597973|323409780|FG001|Overall Study|LAR not authorized to consent|1|||
94443768|NCT01597973|323409779|FG000|Overall Study|Ineligible due to early seizures|1|||
94443769|NCT01597973|323409780|FG001|Overall Study|Ineligible due to early seizures|0|||
94443770|NCT01597973|323409779|FG000|Overall Study|Ineligible due to non-target infection|1|||
94443771|NCT01597973|323409780|FG001|Overall Study|Ineligible due to non-target infection|1|||
94443772|NCT01565889|323409781|FG000|Part A|Withdrawal by Subject|1|||
94443773|NCT01565889|323409782|FG001|Part A|Withdrawal by Subject|0|||
94550296|NCT01641822|323810695|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
94550297|NCT01641822|323810696|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
94550298|NCT01641822|323810697|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
94550299|NCT01375608|323810701|FG000|Overall Study|Withdrawal by Subject|2|||
94550300|NCT01283542|323810702|FG000|Main Phase|Acute or progressive vision loss|1|||
94550301|NCT01283542|323810702|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
94550302|NCT01283542|323810702|FG000|Main Phase|abnormal laboratory values|5|||
94550303|NCT01283542|323810702|FG000|Extension Phase|Physician Decision|1|||
94550304|NCT01283542|323810702|FG000|Extension Phase|Adverse Event|1|||
94550305|NCT01283542|323810702|FG000|Extension Phase|Administrative problems|1|||
94550306|NCT00581360|323810703|FG000|Overall Study|Withdrawal by Subject|1|||
94550307|NCT04405245|323810704|FG000|Overall Study|Adverse Event|0|||
94550308|NCT04405245|323810705|FG001|Overall Study|Adverse Event|1|||
94550309|NCT04405245|323810706|FG002|Overall Study|Adverse Event|0|||
94550310|NCT03006887|323810707|FG000|Overall Study|Adverse Event|1|||
94550311|NCT01732913|323810708|FG000|Overall Study|Study Terminated by Sponsor|105|||
94550312|NCT01732913|323810709|FG001|Overall Study|Study Terminated by Sponsor|55|||
94550313|NCT01732913|323810708|FG000|Overall Study|Withdrawal by Subject|27|||
94550314|NCT01732913|323810709|FG001|Overall Study|Withdrawal by Subject|4|||
94550315|NCT01732913|323810708|FG000|Overall Study|Physician Decision|14|||
94550316|NCT01732913|323810709|FG001|Overall Study|Physician Decision|7|||
94550317|NCT01732913|323810708|FG000|Overall Study|Other|7|||
94550318|NCT01732913|323810709|FG001|Overall Study|Other|1|||
94550319|NCT01732913|323810708|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
94550320|NCT01732913|323810709|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
94550321|NCT02723175|323810710|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
94550322|NCT02723175|323810711|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
94550323|NCT02723175|323810710|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
94550324|NCT02723175|323810711|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
94550325|NCT00257660|323810712|FG000|Overall Study|Lack of Efficacy|5|||
94550326|NCT00257660|323810713|FG001|Overall Study|Lack of Efficacy|23|||
94550327|NCT00257660|323810712|FG000|Overall Study|Withdrawal by Subject|2|||
94550328|NCT00257660|323810713|FG001|Overall Study|Withdrawal by Subject|0|||
94550329|NCT00257660|323810712|FG000|Overall Study|Lost to Follow-up|1|||
94550330|NCT00257660|323810713|FG001|Overall Study|Lost to Follow-up|0|||
94550331|NCT00257660|323810712|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
94550332|NCT00257660|323810713|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
94550333|NCT00257660|323810712|FG000|Overall Study|No longer wanted to do blood draws|1|||
94550334|NCT00257660|323810713|FG001|Overall Study|No longer wanted to do blood draws|0|||
94550335|NCT00249613|323810714|FG000|12 Month Follow-up|Death|1|||
94550336|NCT00249613|323810715|FG001|12 Month Follow-up|Death|1|||
94550337|NCT00249613|323810714|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
94550338|NCT00249613|323810715|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
94550339|NCT00249613|323810714|FG000|12 Month Follow-up|Lost to Follow-up|10|||
94550340|NCT00249613|323810715|FG001|12 Month Follow-up|Lost to Follow-up|8|||
94550341|NCT00343382|323810716|FG000|Overall Study|Adverse Event|2|||
94550342|NCT00343382|323810717|FG001|Overall Study|Adverse Event|10|||
94550343|NCT00343382|323810718|FG002|Overall Study|Adverse Event|7|||
94550344|NCT00343382|323810716|FG000|Overall Study|Withdrawal by Subject|1|||
94550345|NCT00343382|323810717|FG001|Overall Study|Withdrawal by Subject|2|||
94550346|NCT00343382|323810718|FG002|Overall Study|Withdrawal by Subject|6|||
94550347|NCT00343382|323810716|FG000|Overall Study|Other Reason Not Specified|1|||
94550348|NCT00343382|323810717|FG001|Overall Study|Other Reason Not Specified|2|||
94550349|NCT00343382|323810718|FG002|Overall Study|Other Reason Not Specified|4|||
94550350|NCT00884832|323810719|FG000|Overall Study|Withdrawal by Subject|0|||
94550351|NCT00884832|323810720|FG001|Overall Study|Withdrawal by Subject|1|||
94550352|NCT02096263|323810721|FG000|Overall Study|Adverse Event|1|||
94550353|NCT02096263|323810722|FG001|Overall Study|Adverse Event|0|||
94550354|NCT02096263|323810723|FG002|Overall Study|Adverse Event|1|||
94550355|NCT02096263|323810721|FG000|Overall Study|Lost to Follow-up|14|||
94550356|NCT02096263|323810722|FG001|Overall Study|Lost to Follow-up|18|||
94550357|NCT02096263|323810723|FG002|Overall Study|Lost to Follow-up|15|||
94550358|NCT02096263|323810721|FG000|Overall Study|Other|7|||
94550359|NCT02096263|323810722|FG001|Overall Study|Other|9|||
94550360|NCT02096263|323810723|FG002|Overall Study|Other|6|||
94550361|NCT02096263|323810721|FG000|Overall Study|Sponsor study termination|0|||
94550362|NCT02096263|323810722|FG001|Overall Study|Sponsor study termination|0|||
94550363|NCT02096263|323810723|FG002|Overall Study|Sponsor study termination|1|||
94550364|NCT02096263|323810721|FG000|Overall Study|Protocol Violation|7|||
94550365|NCT02096263|323810722|FG001|Overall Study|Protocol Violation|2|||
94550366|NCT02096263|323810723|FG002|Overall Study|Protocol Violation|8|||
94550367|NCT02096263|323810721|FG000|Overall Study|Withdrawal by Subject|5|||
94550368|NCT02096263|323810722|FG001|Overall Study|Withdrawal by Subject|7|||
94550369|NCT02096263|323810723|FG002|Overall Study|Withdrawal by Subject|8|||
94550370|NCT04891107|323810724|FG000|Overall Study|Physician Decision|1|||
94550371|NCT04891107|323810724|FG000|Overall Study|Withdrawal by Subject|1|||
94550372|NCT04891107|323810724|FG000|Overall Study|Screen failure after consent|1|||
94550373|NCT00500760|323810725|FG000|Overall Study|Death|32|||
94550374|NCT00500760|323810726|FG001|Overall Study|Death|15|||
94550375|NCT00500760|323810725|FG000|Overall Study|Withdrawal by Subject|5|||
94550376|NCT00500760|323810726|FG001|Overall Study|Withdrawal by Subject|7|||
94550377|NCT00500760|323810725|FG000|Overall Study|Administrative decision|2|||
94550378|NCT00500760|323810726|FG001|Overall Study|Administrative decision|0|||
94550379|NCT00500760|323810725|FG000|Overall Study|Lost to Follow-up|3|||
94550380|NCT00500760|323810726|FG001|Overall Study|Lost to Follow-up|0|||
94550381|NCT00500760|323810725|FG000|Overall Study|Other|1|||
94550382|NCT00500760|323810726|FG001|Overall Study|Other|2|||
94550383|NCT04598269|323810727|FG000|Overall Study|Adverse Event|0|||
94550384|NCT04598269|323810728|FG001|Overall Study|Adverse Event|3|||
94550385|NCT04598269|323810727|FG000|Overall Study|Withdrawal by Subject|1|||
94550386|NCT04598269|323810728|FG001|Overall Study|Withdrawal by Subject|4|||
94550387|NCT04598269|323810727|FG000|Overall Study|Lost to Follow-up|1|||
94550388|NCT04598269|323810728|FG001|Overall Study|Lost to Follow-up|0|||
94550389|NCT04598269|323810727|FG000|Overall Study|Not Treated|2|||
94550390|NCT04598269|323810728|FG001|Overall Study|Not Treated|0|||
94550391|NCT03040986|323810732|FG000|Overall Study|Hospice|1|||
94550392|NCT03040986|323810733|FG001|Overall Study|Hospice|0|||
94550393|NCT03040986|323810732|FG000|Overall Study|Adverse Event|2|||
94550394|NCT03040986|323810733|FG001|Overall Study|Adverse Event|1|||
94550395|NCT03040986|323810732|FG000|Overall Study|Disease progression on study|3|||
94550396|NCT03040986|323810733|FG001|Overall Study|Disease progression on study|1|||
94550397|NCT02879578|323810734|FG000|Overall Study|Adverse Event|1|||
94550398|NCT02879578|323810735|FG001|Overall Study|Adverse Event|2|||
94550399|NCT02879578|323810736|FG002|Overall Study|Adverse Event|14|||
94550400|NCT02879578|323810734|FG000|Overall Study|Protocol Violation|0|||
94550401|NCT02879578|323810735|FG001|Overall Study|Protocol Violation|1|||
94550402|NCT02879578|323810736|FG002|Overall Study|Protocol Violation|1|||
94550403|NCT02879578|323810734|FG000|Overall Study|Withdrawal by Subject|8|||
94550404|NCT02879578|323810735|FG001|Overall Study|Withdrawal by Subject|6|||
94550405|NCT02879578|323810736|FG002|Overall Study|Withdrawal by Subject|9|||
94550406|NCT02879578|323810734|FG000|Overall Study|Lost to Follow-up|1|||
94550407|NCT02879578|323810735|FG001|Overall Study|Lost to Follow-up|0|||
94550408|NCT02879578|323810736|FG002|Overall Study|Lost to Follow-up|4|||
94550409|NCT02879578|323810734|FG000|Overall Study|Physician Decision|0|||
94550410|NCT02879578|323810735|FG001|Overall Study|Physician Decision|0|||
94550411|NCT02879578|323810736|FG002|Overall Study|Physician Decision|4|||
94550412|NCT01198509|323810737|FG000|Overall Study|Withdrawal by Subject|1|||
94550413|NCT01198509|323810738|FG001|Overall Study|Withdrawal by Subject|0|||
94550414|NCT01198509|323810739|FG002|Overall Study|Withdrawal by Subject|0|||
94550415|NCT01198509|323810740|FG003|Overall Study|Withdrawal by Subject|0|||
94550416|NCT01198509|323810741|FG004|Overall Study|Withdrawal by Subject|0|||
94550417|NCT01198509|323810742|FG005|Overall Study|Withdrawal by Subject|0|||
94550418|NCT00499746|323810743|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
94550419|NCT00499746|323810743|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
94550420|NCT00499746|323810743|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
94550421|NCT00499746|323810743|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
94550422|NCT02228096|323810744|FG000|Overall Study|Study terminated by Sponsor|24|||
94550423|NCT02228096|323810744|FG000|Overall Study|Lack of Efficacy|18|||
94550424|NCT02228096|323810744|FG000|Overall Study|Death|12|||
94550425|NCT02228096|323810744|FG000|Overall Study|Physician Decision|3|||
94550426|NCT02228096|323810744|FG000|Overall Study|Subject/guardian decision|2|||
94550427|NCT02228096|323810744|FG000|Overall Study|New therapy for study indication|1|||
94550428|NCT02228096|323810744|FG000|Overall Study|Enrolled, not infused|11|||
94550429|NCT01969721|323810745|FG000|Overall Study|Adverse Event|3|||
94550430|NCT01969721|323810746|FG001|Overall Study|Adverse Event|8|||
94550431|NCT01969721|323810747|FG002|Overall Study|Adverse Event|3|||
94550432|NCT01969721|323810748|FG003|Overall Study|Adverse Event|2|||
94550433|NCT01969721|323810745|FG000|Overall Study|Lack of Efficacy|0|||
94550434|NCT01969721|323810746|FG001|Overall Study|Lack of Efficacy|0|||
94550435|NCT01969721|323810747|FG002|Overall Study|Lack of Efficacy|1|||
94550436|NCT01969721|323810748|FG003|Overall Study|Lack of Efficacy|0|||
94550437|NCT01969721|323810745|FG000|Overall Study|Non compliant with protocol|1|||
94550438|NCT01969721|323810746|FG001|Overall Study|Non compliant with protocol|1|||
94550439|NCT01969721|323810747|FG002|Overall Study|Non compliant with protocol|0|||
94550440|NCT01969721|323810748|FG003|Overall Study|Non compliant with protocol|2|||
94550441|NCT01969721|323810745|FG000|Overall Study|Other not defined above|0|||
94550442|NCT01969721|323810746|FG001|Overall Study|Other not defined above|2|||
94550443|NCT01969721|323810747|FG002|Overall Study|Other not defined above|0|||
94550444|NCT01969721|323810748|FG003|Overall Study|Other not defined above|0|||
94550445|NCT01969721|323810745|FG000|Overall Study|Discontinued during washout periods.|0|||
94550446|NCT01969721|323810746|FG001|Overall Study|Discontinued during washout periods.|1|||
94550447|NCT01969721|323810747|FG002|Overall Study|Discontinued during washout periods.|1|||
94550448|NCT01969721|323810748|FG003|Overall Study|Discontinued during washout periods.|2|||
94550449|NCT01012323|323810750|FG000|Overall Study|Investigator Judgment|1|||
94550450|NCT00495755|323810751|FG000|Overall Study|Adverse Event|3|||
94550451|NCT01440881|323810754|FG000|Overall Study|Death|0|||
94550452|NCT01440881|323810755|FG001|Overall Study|Death|1|||
94550453|NCT02477553|323810756|FG000|Overall Study|Screening up-to-date|12|||
94550454|NCT02477553|323810757|FG001|Overall Study|Screening up-to-date|13|||
94550455|NCT02477553|323810756|FG000|Overall Study|No MD visit|1|||
94550456|NCT02477553|323810757|FG001|Overall Study|No MD visit|1|||
94443774|NCT01565889|323409783|FG002|Part A|Withdrawal by Subject|0|||
94443775|NCT01565889|323409784|FG003|Part A|Withdrawal by Subject|0|||
94443776|NCT01565889|323409785|FG004|Part A|Withdrawal by Subject|0|||
94443777|NCT01565889|323409786|FG005|Part A|Withdrawal by Subject|0|||
94443778|NCT01565889|323409781|FG000|Part B|Withdrawal by Subject|0|||
94443779|NCT01565889|323409782|FG001|Part B|Withdrawal by Subject|0|||
94443780|NCT01565889|323409783|FG002|Part B|Withdrawal by Subject|0|||
94443781|NCT01565889|323409784|FG003|Part B|Withdrawal by Subject|0|||
94443782|NCT01565889|323409785|FG004|Part B|Withdrawal by Subject|0|||
94443783|NCT01565889|323409786|FG005|Part B|Withdrawal by Subject|1|||
94443784|NCT01565889|323409781|FG000|Part B|Lack of Efficacy|0|||
94443785|NCT01565889|323409782|FG001|Part B|Lack of Efficacy|0|||
94443786|NCT01565889|323409783|FG002|Part B|Lack of Efficacy|0|||
94443787|NCT01565889|323409784|FG003|Part B|Lack of Efficacy|0|||
94443788|NCT01565889|323409785|FG004|Part B|Lack of Efficacy|0|||
94443789|NCT01565889|323409786|FG005|Part B|Lack of Efficacy|2|||
94443790|NCT01565889|323409781|FG000|Part B|Lost to Follow-up|0|||
94443791|NCT01565889|323409782|FG001|Part B|Lost to Follow-up|0|||
94443792|NCT01565889|323409783|FG002|Part B|Lost to Follow-up|0|||
94443793|NCT01565889|323409784|FG003|Part B|Lost to Follow-up|0|||
94443794|NCT01565889|323409785|FG004|Part B|Lost to Follow-up|0|||
94443795|NCT01565889|323409786|FG005|Part B|Lost to Follow-up|1|||
94443796|NCT02723344|323409787|FG000|Overall Study|Lost to Follow-up|0|||
94443797|NCT02723344|323409788|FG001|Overall Study|Lost to Follow-up|4|||
94443798|NCT00725920|323409789|FG000|Overall Study|Lack of Efficacy|3|||
94443799|NCT00725920|323409790|FG001|Overall Study|Lack of Efficacy|6|||
94443800|NCT03918629|323409791|FG000|Overall Study|Adverse Event|19|||
94443801|NCT03918629|323409792|FG001|Overall Study|Adverse Event|20|||
94443802|NCT03918629|323409791|FG000|Overall Study|Death|14|||
94443803|NCT03918629|323409792|FG001|Overall Study|Death|7|||
94342394|NCT01365091|323033742|FG001|Period 1|Adverse Event|0|||
94342395|NCT01365091|323033743|FG002|Period 1|Adverse Event|2|||
94342396|NCT01365091|323033744|FG003|Period 1|Adverse Event|3|||
94342397|NCT01365091|323033741|FG000|Period 1|Positive test result for drugs of abuse|1|||
94342398|NCT01365091|323033742|FG001|Period 1|Positive test result for drugs of abuse|0|||
94342399|NCT01365091|323033743|FG002|Period 1|Positive test result for drugs of abuse|0|||
94342400|NCT01365091|323033744|FG003|Period 1|Positive test result for drugs of abuse|0|||
94342401|NCT01365091|323033741|FG000|Period 1|No longer met study criteria|0|||
94342402|NCT01365091|323033742|FG001|Period 1|No longer met study criteria|1|||
94342403|NCT01365091|323033743|FG002|Period 1|No longer met study criteria|0|||
94342404|NCT01365091|323033744|FG003|Period 1|No longer met study criteria|0|||
94342405|NCT01365091|323033741|FG000|Period 1|Withdrawal by Subject|0|||
94342406|NCT01365091|323033742|FG001|Period 1|Withdrawal by Subject|1|||
94342407|NCT01365091|323033743|FG002|Period 1|Withdrawal by Subject|0|||
94342408|NCT01365091|323033744|FG003|Period 1|Withdrawal by Subject|0|||
94342409|NCT01365091|323033741|FG000|Period 1|Personal reasons|0|||
94342410|NCT01365091|323033742|FG001|Period 1|Personal reasons|0|||
94342411|NCT01365091|323033743|FG002|Period 1|Personal reasons|1|||
94342412|NCT01365091|323033744|FG003|Period 1|Personal reasons|0|||
94342413|NCT01365091|323033741|FG000|Period 2|Withdrawal by Subject|1|||
94342414|NCT01365091|323033742|FG001|Period 2|Withdrawal by Subject|0|||
94342415|NCT01365091|323033743|FG002|Period 2|Withdrawal by Subject|0|||
94342416|NCT01365091|323033744|FG003|Period 2|Withdrawal by Subject|0|||
94342417|NCT01365091|323033741|FG000|Period 2|Adverse Event|0|||
94342418|NCT01365091|323033742|FG001|Period 2|Adverse Event|0|||
94342419|NCT01365091|323033743|FG002|Period 2|Adverse Event|1|||
94342420|NCT01365091|323033744|FG003|Period 2|Adverse Event|0|||
94342421|NCT04412668|323033745|FG000|Overall Study|Death - multiple comorbidities|2|||
94342422|NCT04412668|323033746|FG001|Overall Study|Death - multiple comorbidities|0|||
94342423|NCT04412668|323033747|FG002|Overall Study|Death - multiple comorbidities|0|||
94342424|NCT04412668|323033745|FG000|Overall Study|Withdrawal by Subject|3|||
94342425|NCT04412668|323033746|FG001|Overall Study|Withdrawal by Subject|0|||
94342426|NCT04412668|323033747|FG002|Overall Study|Withdrawal by Subject|0|||
94342427|NCT04412668|323033745|FG000|Overall Study|Other than Specified|2|||
94342428|NCT04412668|323033746|FG001|Overall Study|Other than Specified|0|||
94342429|NCT04412668|323033747|FG002|Overall Study|Other than Specified|0|||
94342430|NCT00542425|323033748|FG000|Initial 24 Weeks|Administrative reasons|0|||
94342431|NCT00542425|323033749|FG001|Initial 24 Weeks|Administrative reasons|0|||
94342432|NCT00542425|323033750|FG002|Initial 24 Weeks|Administrative reasons|1|||
94342433|NCT00542425|323033751|FG003|Initial 24 Weeks|Administrative reasons|1|||
94342434|NCT00542425|323033752|FG004|Initial 24 Weeks|Administrative reasons|0|||
94342435|NCT00542425|323033748|FG000|Initial 24 Weeks|Adverse Event|0|||
94342436|NCT00542425|323033749|FG001|Initial 24 Weeks|Adverse Event|1|||
94342437|NCT00542425|323033750|FG002|Initial 24 Weeks|Adverse Event|1|||
94342438|NCT00542425|323033751|FG003|Initial 24 Weeks|Adverse Event|3|||
94342439|NCT00542425|323033752|FG004|Initial 24 Weeks|Adverse Event|2|||
94342440|NCT00542425|323033748|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
94342441|NCT00542425|323033749|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
94342442|NCT00542425|323033750|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
94550457|NCT02477553|323810756|FG000|Overall Study|Workup consistent w/CRC|1|||
94550458|NCT02477553|323810757|FG001|Overall Study|Workup consistent w/CRC|1|||
94443804|NCT03918629|323409791|FG000|Overall Study|Lost to Follow-up|36|||
94443805|NCT03918629|323409792|FG001|Overall Study|Lost to Follow-up|28|||
94443806|NCT03918629|323409791|FG000|Overall Study|Physician Decision|1|||
94443807|NCT03918629|323409792|FG001|Overall Study|Physician Decision|0|||
94443808|NCT03918629|323409791|FG000|Overall Study|Protocol Violation|7|||
94443809|NCT03918629|323409792|FG001|Overall Study|Protocol Violation|4|||
94443810|NCT03918629|323409791|FG000|Overall Study|Withdrawal by Subject|47|||
94443811|NCT03918629|323409792|FG001|Overall Study|Withdrawal by Subject|47|||
94443812|NCT03918629|323409791|FG000|Overall Study|Other|7|||
94443813|NCT03918629|323409792|FG001|Overall Study|Other|11|||
94443814|NCT03918629|323409791|FG000|Overall Study|Randomized but not vaccinated|2|||
94443815|NCT03918629|323409792|FG001|Overall Study|Randomized but not vaccinated|1|||
94443816|NCT01530464|323409795|FG000|Washout (24h)|Withdrawal by Subject|1|||
94443817|NCT01530464|323409796|FG001|Washout (24h)|Withdrawal by Subject|0|||
94443818|NCT01530464|323409795|FG000|Washout (24h)|Withdrawal by Subject|0|||
94443819|NCT01530464|323409796|FG001|Washout (24h)|Withdrawal by Subject|1|||
94443820|NCT02698163|323409797|FG000|Overall Study|Lost to Follow-up|0|||
94443821|NCT02698163|323409798|FG001|Overall Study|Lost to Follow-up|1|||
94443822|NCT04564092|323409810|FG000|Overall Study|Withdrawal by Subject|1|||
94443823|NCT02747108|323409814|FG000|Overall Study|Death|2|||
94443824|NCT02747108|323409815|FG001|Overall Study|Death|2|||
94443825|NCT02747108|323409814|FG000|Overall Study|Withdrawal by Subject|1|||
94443826|NCT02747108|323409815|FG001|Overall Study|Withdrawal by Subject|0|||
94443827|NCT02747108|323409814|FG000|Overall Study|Protocol Violation|2|||
94443828|NCT02747108|323409815|FG001|Overall Study|Protocol Violation|0|||
94443829|NCT02763046|323411686|FG000|Overall Study|Adverse Event|5|||
94443830|NCT02763046|323411687|FG001|Overall Study|Adverse Event|4|||
94443831|NCT02763046|323411688|FG002|Overall Study|Adverse Event|0|||
94443832|NCT02763046|323411686|FG000|Overall Study|Lack of Efficacy|1|||
94443833|NCT02763046|323411687|FG001|Overall Study|Lack of Efficacy|1|||
94443834|NCT02763046|323411688|FG002|Overall Study|Lack of Efficacy|3|||
94443835|NCT02763046|323411686|FG000|Overall Study|Physician Decision|1|||
94443836|NCT02763046|323411687|FG001|Overall Study|Physician Decision|0|||
94443837|NCT02763046|323411688|FG002|Overall Study|Physician Decision|1|||
94443838|NCT02763046|323411686|FG000|Overall Study|Subject/guardian decision|2|||
94443839|NCT02763046|323411687|FG001|Overall Study|Subject/guardian decision|0|||
94443840|NCT02763046|323411688|FG002|Overall Study|Subject/guardian decision|4|||
94443841|NCT01103180|323411692|FG000|Overall Study|Withdrawal by Subject|8|||
94443842|NCT01103180|323411693|FG001|Overall Study|Withdrawal by Subject|13|||
94443843|NCT01103180|323411692|FG000|Overall Study|Lost to Follow-up|13|||
94443844|NCT01103180|323411693|FG001|Overall Study|Lost to Follow-up|7|||
94443845|NCT01103180|323411692|FG000|Overall Study|Physician Decision|1|||
94443846|NCT01103180|323411693|FG001|Overall Study|Physician Decision|0|||
94443847|NCT01103180|323411692|FG000|Overall Study|Protocol Violation|0|||
94443848|NCT01103180|323411693|FG001|Overall Study|Protocol Violation|1|||
94443849|NCT01173523|323411694|FG000|Overall Study|Clinical Progression|1|||
94443850|NCT01173523|323411695|FG001|Overall Study|Clinical Progression|1|||
94443851|NCT01173523|323411694|FG000|Overall Study|Progressive Disease|10|||
94443852|NCT01173523|323411695|FG001|Overall Study|Progressive Disease|8|||
94443853|NCT01173523|323411694|FG000|Overall Study|Other|2|||
94443854|NCT01173523|323411695|FG001|Overall Study|Other|3|||
94443855|NCT02717507|323411696|FG000|Overall Study|Lost to Follow-up|5|||
94443856|NCT02717507|323411697|FG001|Overall Study|Lost to Follow-up|8|||
94443857|NCT02717507|323411696|FG000|Overall Study|Pregnancy|1|||
94443858|NCT02717507|323411697|FG001|Overall Study|Pregnancy|1|||
94443859|NCT02717507|323411696|FG000|Overall Study|Protocol Violation|2|||
94443860|NCT02717507|323411697|FG001|Overall Study|Protocol Violation|2|||
94443861|NCT02717507|323411696|FG000|Overall Study|Withdrawal by Subject|20|||
94443862|NCT02717507|323411697|FG001|Overall Study|Withdrawal by Subject|20|||
94443863|NCT02717507|323411696|FG000|Overall Study|Relapse|1|||
94443864|NCT02717507|323411697|FG001|Overall Study|Relapse|1|||
94443865|NCT02717507|323411696|FG000|Overall Study|Cardiac Event|2|||
94443866|NCT02717507|323411697|FG001|Overall Study|Cardiac Event|6|||
94443867|NCT00370552|323411700|FG000|Overall Study|Adverse Event|2|||
94443868|NCT00370552|323411701|FG001|Overall Study|Adverse Event|2|||
94443869|NCT00370552|323411702|FG002|Overall Study|Adverse Event|2|||
94443870|NCT00370552|323411700|FG000|Overall Study|Disease progression|23|||
94443871|NCT00370552|323411701|FG001|Overall Study|Disease progression|23|||
94443872|NCT00370552|323411702|FG002|Overall Study|Disease progression|15|||
94443873|NCT00370552|323411700|FG000|Overall Study|Maximum clinical benefit|3|||
94443874|NCT00370552|323411701|FG001|Overall Study|Maximum clinical benefit|5|||
94443875|NCT00370552|323411702|FG002|Overall Study|Maximum clinical benefit|5|||
94342443|NCT00542425|323033751|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
94443876|NCT00370552|323411700|FG000|Overall Study|Poor or noncompliance|0|||
94342444|NCT00542425|323033752|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
94342445|NCT00542425|323033748|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
94342446|NCT00542425|323033749|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
94342447|NCT00542425|323033750|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
94342448|NCT00542425|323033751|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
94342449|NCT00542425|323033752|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
94342450|NCT00542425|323033748|FG000|Initial 24 Weeks|Non-compliance|0|||
94342451|NCT00542425|323033749|FG001|Initial 24 Weeks|Non-compliance|0|||
94342452|NCT00542425|323033750|FG002|Initial 24 Weeks|Non-compliance|0|||
94342453|NCT00542425|323033751|FG003|Initial 24 Weeks|Non-compliance|1|||
94342454|NCT00542425|323033752|FG004|Initial 24 Weeks|Non-compliance|1|||
94342455|NCT00542425|323033748|FG000|Initial 24 Weeks|Protocol Violation|0|||
94342456|NCT00542425|323033749|FG001|Initial 24 Weeks|Protocol Violation|0|||
94550459|NCT02477553|323810756|FG000|Overall Study|Technical issues with intervention|2|||
94550460|NCT02477553|323810757|FG001|Overall Study|Technical issues with intervention|0|||
94550461|NCT02477553|323810756|FG000|Overall Study|Elevated risk for CRC|2|||
94550462|NCT02477553|323810757|FG001|Overall Study|Elevated risk for CRC|2|||
94550463|NCT02477553|323810756|FG000|Overall Study|MD advised against screening|1|||
94550464|NCT02477553|323810757|FG001|Overall Study|MD advised against screening|3|||
94550465|NCT02477553|323810756|FG000|Overall Study|patient deceased|1|||
94550466|NCT02477553|323810757|FG001|Overall Study|patient deceased|0|||
94550467|NCT00377364|323810758|FG000|Overall Study|Lost to Follow-up|1|||
94550468|NCT00377364|323810759|FG001|Overall Study|Lost to Follow-up|0|||
94550469|NCT00377364|323810758|FG000|Overall Study|Withdrawal by Subject|1|||
94550470|NCT00377364|323810759|FG001|Overall Study|Withdrawal by Subject|0|||
94550471|NCT02986854|323810760|FG000|Overall Study|Withdrawal by Subject|0|||
94550472|NCT02986854|323810761|FG001|Overall Study|Withdrawal by Subject|1|||
94550473|NCT02986854|323810762|FG002|Overall Study|Withdrawal by Subject|1|||
94550474|NCT02986854|323810760|FG000|Overall Study|Lost to Follow-up|3|||
94550475|NCT02986854|323810761|FG001|Overall Study|Lost to Follow-up|11|||
94550476|NCT02986854|323810762|FG002|Overall Study|Lost to Follow-up|2|||
94550477|NCT01704456|323810763|FG000|Overall Study|Lost to Follow-up|8|||
94550478|NCT01704456|323810764|FG001|Overall Study|Lost to Follow-up|14|||
94550479|NCT00772109|323810765|FG000|Overall Study|Serious adverse event|1|||
94550480|NCT00772109|323810766|FG001|Overall Study|Serious adverse event|0|||
94550481|NCT00772109|323810767|FG002|Overall Study|Serious adverse event|1|||
94550482|NCT00772109|323810768|FG003|Overall Study|Serious adverse event|0|||
94550483|NCT00772109|323810765|FG000|Overall Study|Protocol Violation|5|||
94550484|NCT00772109|323810766|FG001|Overall Study|Protocol Violation|8|||
94550485|NCT00772109|323810767|FG002|Overall Study|Protocol Violation|7|||
94550486|NCT00772109|323810768|FG003|Overall Study|Protocol Violation|6|||
94550487|NCT00772109|323810765|FG000|Overall Study|Lost to Follow-up|7|||
94550488|NCT00772109|323810766|FG001|Overall Study|Lost to Follow-up|3|||
94550489|NCT00772109|323810767|FG002|Overall Study|Lost to Follow-up|5|||
94550490|NCT00772109|323810768|FG003|Overall Study|Lost to Follow-up|9|||
94550491|NCT00772109|323810765|FG000|Overall Study|Withdrawal by Subject|8|||
94550492|NCT00772109|323810766|FG001|Overall Study|Withdrawal by Subject|8|||
94550493|NCT00772109|323810767|FG002|Overall Study|Withdrawal by Subject|6|||
94550494|NCT00772109|323810768|FG003|Overall Study|Withdrawal by Subject|16|||
94550495|NCT00752726|323810769|FG000|Overall Study|Lost to Follow-up|2|||
94550496|NCT00752726|323810770|FG001|Overall Study|Lost to Follow-up|1|||
94550497|NCT00752726|323810769|FG000|Overall Study|Adverse Event|3|||
94550498|NCT00752726|323810770|FG001|Overall Study|Adverse Event|0|||
94550499|NCT00752726|323810769|FG000|Overall Study|Withdrawal by Subject|5|||
94550500|NCT00752726|323810770|FG001|Overall Study|Withdrawal by Subject|10|||
94550501|NCT00752726|323810769|FG000|Overall Study|Other Reason|1|||
94550502|NCT00752726|323810770|FG001|Overall Study|Other Reason|2|||
94550503|NCT02039856|323810771|FG000|Overall Study|Death|5|||
94550504|NCT02039856|323810772|FG001|Overall Study|Death|3|||
94550505|NCT02039856|323810771|FG000|Overall Study|Partial survey completion|61|||
94550506|NCT02039856|323810772|FG001|Overall Study|Partial survey completion|26|||
94550507|NCT02039856|323810771|FG000|Overall Study|Lost to Follow-up|388|||
94550508|NCT02039856|323810772|FG001|Overall Study|Lost to Follow-up|206|||
94550509|NCT02039856|323810771|FG000|Overall Study|Withdrawal by Subject|1573|||
94550510|NCT02039856|323810772|FG001|Overall Study|Withdrawal by Subject|618|||
94550511|NCT02999633|323810773|FG000|Overall Study|Adverse Event|2|||
94550512|NCT02999633|323810773|FG000|Overall Study|Progressive disease|12|||
94550513|NCT03238924|323810775|FG000|Overall Study|Withdrawal by Subject|2|||
94550514|NCT03238924|323810776|FG001|Overall Study|Withdrawal by Subject|2|||
94550515|NCT02516228|323810777|FG000|Overall Study|Lost to Follow-up|1|||
94550516|NCT02516228|323810777|FG000|Overall Study|Withdrawal by Subject|1|||
94550517|NCT02516228|323810777|FG000|Overall Study|Physician Decision|1|||
94550518|NCT01983774|323810781|FG000|Overall Study|Lung Transplant|0|||
94550519|NCT01983774|323810782|FG001|Overall Study|Lung Transplant|1|||
94550520|NCT01983774|323810781|FG000|Overall Study|Lost to Follow-up|1|||
94550521|NCT01983774|323810782|FG001|Overall Study|Lost to Follow-up|0|||
94550522|NCT01879072|323810784|FG000|Overall Study|Withdrawal by Subject|121|||
94550523|NCT01879072|323810784|FG000|Overall Study|Not Transplanted|30|||
94550524|NCT01439373|323810794|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
94550525|NCT01439373|323810795|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
94550526|NCT01439373|323810794|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
94550527|NCT01439373|323810795|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
94550528|NCT00527332|323810797|FG000|Overall Study|Protocol Violation|4|||
94550529|NCT00527332|323810798|FG001|Overall Study|Protocol Violation|8|||
94550530|NCT00527332|323810797|FG000|Overall Study|Withdrew consent|5|||
94550531|NCT00527332|323810798|FG001|Overall Study|Withdrew consent|1|||
94550532|NCT02666105|323810799|FG000|Overall Study|Death|1|||
94550533|NCT01078168|323810800|FG000|Overall Study|Physician Decision|0|||
94550534|NCT01078168|323810801|FG001|Overall Study|Physician Decision|1|||
94550535|NCT01264419|323810803|FG000|Overall Study|Lost to Follow-up|3|||
94550536|NCT03667690|323812446|FG000|Overall Study|Adverse Event|0|||
94550537|NCT03667690|323812447|FG001|Overall Study|Adverse Event|3|||
94550538|NCT03667690|323812446|FG000|Overall Study|Death|22|||
94550539|NCT03667690|323812447|FG001|Overall Study|Death|21|||
94550540|NCT03667690|323812446|FG000|Overall Study|Lost to Follow-up|4|||
94550541|NCT03667690|323812447|FG001|Overall Study|Lost to Follow-up|5|||
94550542|NCT03667690|323812446|FG000|Overall Study|Withdrawal by Subject|7|||
94550543|NCT03667690|323812447|FG001|Overall Study|Withdrawal by Subject|8|||
94550544|NCT03667690|323812446|FG000|Overall Study|Subject could not return for additional investigational product|1|||
94550545|NCT03667690|323812447|FG001|Overall Study|Subject could not return for additional investigational product|0|||
94550546|NCT03667690|323812446|FG000|Overall Study|Subject discharged to hospice care|2|||
94550547|NCT03667690|323812447|FG001|Overall Study|Subject discharged to hospice care|0|||
94550548|NCT03667690|323812446|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
94550549|NCT03667690|323812447|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
94550550|NCT03667690|323812446|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
94550551|NCT03667690|323812447|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
94550552|NCT03667690|323812446|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
94550553|NCT03667690|323812447|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
94550554|NCT03667690|323812446|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
94550555|NCT03667690|323812447|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
94550556|NCT03667690|323812446|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
94550557|NCT03667690|323812447|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
94550558|NCT01041287|323812451|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
94550559|NCT01041287|323812452|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
94550560|NCT01041287|323812451|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
94550561|NCT01041287|323812452|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
94550562|NCT04544683|323812453|FG000|Overall Study|Lost to Follow-up|2|||
94550563|NCT04544683|323812453|FG000|Overall Study|Underwent cervical spine surgery|6|||
94550564|NCT01073930|323812454|FG000|Overall Study|Withdrawal by Subject|3|||
94550565|NCT01073930|323812455|FG001|Overall Study|Withdrawal by Subject|2|||
94550566|NCT01073930|323812454|FG000|Overall Study|Lost to Follow-up|0|||
94550567|NCT01073930|323812455|FG001|Overall Study|Lost to Follow-up|1|||
94550568|NCT01073930|323812454|FG000|Overall Study|Adverse Event|0|||
94550569|NCT01073930|323812455|FG001|Overall Study|Adverse Event|1|||
94550570|NCT01073930|323812454|FG000|Overall Study|Noncompliance with study drug|0|||
94550571|NCT01073930|323812455|FG001|Overall Study|Noncompliance with study drug|1|||
94550572|NCT01073930|323812454|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
94550573|NCT01073930|323812455|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
94550574|NCT01192568|323812456|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
94550575|NCT01192568|323812457|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
94550576|NCT01192568|323812458|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
94550577|NCT01192568|323812459|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
94550578|NCT01192568|323812456|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
94550579|NCT01192568|323812457|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
94550580|NCT01192568|323812458|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
94550581|NCT01192568|323812459|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
94550582|NCT02593825|323812460|FG000|Intervention|Lost to Follow-up|10|||
94550583|NCT02593825|323812461|FG001|Intervention|Lost to Follow-up|12|||
94550584|NCT02522325|323812462|FG000|Overall Study|Adverse Event|0|||
94550585|NCT02522325|323812463|FG001|Overall Study|Adverse Event|1|||
94550586|NCT01209078|323812464|FG000|Overall Study|Adverse Event|5|||
94550587|NCT01209078|323812465|FG001|Overall Study|Adverse Event|0|||
94550588|NCT01209078|323812464|FG000|Overall Study|Lost to Follow-up|4|||
94550589|NCT01209078|323812465|FG001|Overall Study|Lost to Follow-up|0|||
94550590|NCT01209078|323812464|FG000|Overall Study|Physician Decision|5|||
94550591|NCT01209078|323812465|FG001|Overall Study|Physician Decision|2|||
94550592|NCT01209078|323812464|FG000|Overall Study|Withdrawal by Subject|2|||
94550593|NCT01209078|323812465|FG001|Overall Study|Withdrawal by Subject|1|||
94550594|NCT00924508|323812468|FG000|Overall Study|Withdrawal by Subject|3|||
94342457|NCT00542425|323033750|FG002|Initial 24 Weeks|Protocol Violation|0|||
94550595|NCT02100969|323812469|FG000|Overall Study|Did not pass screening phase|1|||
94550596|NCT02081599|323812470|FG000|Period 1：Double-blind Period|Adverse Event|3|||
94550597|NCT02081599|323812471|FG001|Period 1：Double-blind Period|Adverse Event|0|||
94550598|NCT02081599|323812470|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
94550599|NCT02081599|323812471|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
94550600|NCT02081599|323812470|FG000|Period 1：Double-blind Period|Physician Decision|1|||
94550601|NCT02081599|323812471|FG001|Period 1：Double-blind Period|Physician Decision|0|||
94550602|NCT02081599|323812470|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
94550603|NCT02081599|323812471|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
94550604|NCT02081599|323812470|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
94550605|NCT02081599|323812471|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
94550606|NCT02081599|323812470|FG000|Period 1：Double-blind Period|stopping criteria|1|||
94550607|NCT02081599|323812471|FG001|Period 1：Double-blind Period|stopping criteria|0|||
94550608|NCT02081599|323812470|FG000|Period 2：Open-label Period|Adverse Event|1|||
94550609|NCT02081599|323812471|FG001|Period 2：Open-label Period|Adverse Event|0|||
94550610|NCT02081599|323812470|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
94550611|NCT02081599|323812471|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
94550612|NCT02081599|323812470|FG000|Period 2：Open-label Period|Physician Decision|1|||
94550613|NCT02081599|323812471|FG001|Period 2：Open-label Period|Physician Decision|0|||
94550614|NCT02081599|323812470|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
94550615|NCT02081599|323812471|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
94550616|NCT01629953|323812472|FG000|Overall Study|Death|3|||
94550617|NCT01629953|323812473|FG001|Overall Study|Death|1|||
94550618|NCT01629953|323812472|FG000|Overall Study|Lost to Follow-up|10|||
94550619|NCT01629953|323812473|FG001|Overall Study|Lost to Follow-up|14|||
94550620|NCT01266590|323812474|FG000|Overall Study|Adverse Event|3|||
94550621|NCT01266590|323812474|FG000|Overall Study|Lost to Follow-up|1|||
94550622|NCT01266590|323812474|FG000|Overall Study|Withdrawal by Subject|1|||
94550623|NCT01266590|323812474|FG000|Overall Study|Physician Decision|1|||
94550624|NCT01912339|323812475|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
94550625|NCT01912339|323812476|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
94550626|NCT01912339|323812477|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
94550627|NCT01912339|323812475|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
94550628|NCT01912339|323812476|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
94550629|NCT01912339|323812477|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
94550630|NCT01912339|323812475|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
94550631|NCT01912339|323812476|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
94550632|NCT01912339|323812477|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
94550633|NCT01912339|323812475|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
94550634|NCT01912339|323812476|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
94550635|NCT01912339|323812477|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
94550636|NCT01912339|323812475|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
94550637|NCT01912339|323812476|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
94550638|NCT01912339|323812477|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
94550639|NCT01912339|323812475|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
94550640|NCT01912339|323812476|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
94550641|NCT01912339|323812477|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
94550642|NCT01912339|323812475|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
94550643|NCT01912339|323812476|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
94550644|NCT01912339|323812477|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
94550645|NCT01912339|323812475|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
94550646|NCT01912339|323812476|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
94550647|NCT01912339|323812477|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
94550648|NCT01912339|323812475|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
94550649|NCT01912339|323812476|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
94550650|NCT01912339|323812477|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
94550651|NCT01912339|323812475|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
94550652|NCT01912339|323812476|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
94550653|NCT01912339|323812477|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
94550654|NCT01912339|323812475|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
94550655|NCT01912339|323812476|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
94550656|NCT01912339|323812477|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
94550657|NCT01912339|323812475|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
94550658|NCT01912339|323812476|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
94550659|NCT01912339|323812477|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
94550660|NCT01912339|323812475|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
94550661|NCT01912339|323812476|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
94550662|NCT01912339|323812477|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
94550663|NCT01272869|323812483|FG000|Period 2 (14 Days)|Adverse Event|1|||
94550664|NCT01272869|323812484|FG001|Period 2 (14 Days)|Adverse Event|0|||
94550665|NCT01571232|323812485|FG000|Overall Study|Lost to Follow-up|0|||
94550666|NCT01571232|323812486|FG001|Overall Study|Lost to Follow-up|1|||
94550667|NCT01571232|323812485|FG000|Overall Study|Withdrawal by Subject|1|||
94550668|NCT01571232|323812486|FG001|Overall Study|Withdrawal by Subject|0|||
94550669|NCT00771615|323812487|FG000|Overall Study|Withdrawal by Subject|0|||
94550670|NCT00771615|323812488|FG001|Overall Study|Withdrawal by Subject|1|||
94550671|NCT00771615|323812489|FG002|Overall Study|Withdrawal by Subject|0|||
94550672|NCT00771615|323812490|FG003|Overall Study|Withdrawal by Subject|0|||
94550673|NCT00771615|323812491|FG004|Overall Study|Withdrawal by Subject|0|||
94550674|NCT00771615|323812492|FG005|Overall Study|Withdrawal by Subject|0|||
94550675|NCT00771615|323812493|FG006|Overall Study|Withdrawal by Subject|0|||
94550676|NCT00771615|323812494|FG007|Overall Study|Withdrawal by Subject|1|||
94550677|NCT00771615|323812495|FG008|Overall Study|Withdrawal by Subject|0|||
94550678|NCT00771615|323812487|FG000|Overall Study|Lost to Follow-up|1|||
94550679|NCT00771615|323812488|FG001|Overall Study|Lost to Follow-up|1|||
94550680|NCT00771615|323812489|FG002|Overall Study|Lost to Follow-up|1|||
94550681|NCT00771615|323812490|FG003|Overall Study|Lost to Follow-up|1|||
94550682|NCT00771615|323812491|FG004|Overall Study|Lost to Follow-up|0|||
94550683|NCT00771615|323812492|FG005|Overall Study|Lost to Follow-up|1|||
94550684|NCT00771615|323812493|FG006|Overall Study|Lost to Follow-up|1|||
94550685|NCT00771615|323812494|FG007|Overall Study|Lost to Follow-up|0|||
94550686|NCT00771615|323812495|FG008|Overall Study|Lost to Follow-up|0|||
94550687|NCT02455076|323812496|FG000|Inpatient|Withdrawal by Subject|1|||
94550688|NCT02455076|323812497|FG001|Inpatient|Withdrawal by Subject|0|||
94550689|NCT02455076|323812498|FG002|Inpatient|Withdrawal by Subject|0|||
94550690|NCT02455076|323812499|FG003|Inpatient|Withdrawal by Subject|0|||
94550691|NCT02455076|323812500|FG004|Inpatient|Withdrawal by Subject|0|||
94550692|NCT02455076|323812496|FG000|Inpatient|Discharged <24 h after admission|0|||
94550693|NCT02455076|323812497|FG001|Inpatient|Discharged <24 h after admission|1|||
94550694|NCT02455076|323812498|FG002|Inpatient|Discharged <24 h after admission|0|||
94550695|NCT02455076|323812499|FG003|Inpatient|Discharged <24 h after admission|0|||
94550696|NCT02455076|323812500|FG004|Inpatient|Discharged <24 h after admission|0|||
94550697|NCT02455076|323812496|FG000|Inpatient|Adverse Event|3|||
94550698|NCT02455076|323812497|FG001|Inpatient|Adverse Event|0|||
94550699|NCT02455076|323812498|FG002|Inpatient|Adverse Event|0|||
94550700|NCT02455076|323812499|FG003|Inpatient|Adverse Event|0|||
94550701|NCT02455076|323812500|FG004|Inpatient|Adverse Event|0|||
94550702|NCT02455076|323812496|FG000|Outpatient|Adverse Event|0|||
94550703|NCT02455076|323812497|FG001|Outpatient|Adverse Event|0|||
94550704|NCT02455076|323812498|FG002|Outpatient|Adverse Event|0|||
94550705|NCT02455076|323812499|FG003|Outpatient|Adverse Event|5|||
94550706|NCT02455076|323812500|FG004|Outpatient|Adverse Event|0|||
94550707|NCT02455076|323812496|FG000|Outpatient|Lost to Follow-up|0|||
94550708|NCT02455076|323812497|FG001|Outpatient|Lost to Follow-up|0|||
94550709|NCT02455076|323812498|FG002|Outpatient|Lost to Follow-up|0|||
94550710|NCT02455076|323812499|FG003|Outpatient|Lost to Follow-up|1|||
94550711|NCT02455076|323812500|FG004|Outpatient|Lost to Follow-up|12|||
94550712|NCT01867086|323812502|FG000|Overall Study|Disease Progression|1|||
94550713|NCT00859937|323812503|FG000|Overall Study|Protocol Violation|1|||
94550714|NCT00859937|323812504|FG001|Overall Study|Protocol Violation|0|||
94550715|NCT03149029|323812505|FG000|Overall Study|Adverse Event|2|||
94550716|NCT03149029|323812506|FG001|Overall Study|Adverse Event|0|||
94550717|NCT03908476|323812507|FG000|Overall Study|Death|3|||
94550718|NCT03908476|323812508|FG001|Overall Study|Death|0|||
94550719|NCT03908476|323812507|FG000|Overall Study|Lost to Follow-up|3|||
94550720|NCT03908476|323812508|FG001|Overall Study|Lost to Follow-up|1|||
94550721|NCT03908476|323812507|FG000|Overall Study|Withdrawal by Subject|7|||
94550722|NCT03908476|323812508|FG001|Overall Study|Withdrawal by Subject|1|||
94550723|NCT03908476|323812507|FG000|Overall Study|Physician Decision|2|||
94550724|NCT03908476|323812508|FG001|Overall Study|Physician Decision|0|||
94550725|NCT03908476|323812507|FG000|Overall Study|System Explanted and not Replaced|4|||
94550726|NCT03908476|323812508|FG001|Overall Study|System Explanted and not Replaced|0|||
94550727|NCT03908476|323812507|FG000|Overall Study|Intrathecal Pump|1|||
94550728|NCT03908476|323812508|FG001|Overall Study|Intrathecal Pump|0|||
94550729|NCT03908476|323812507|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
94550730|NCT03908476|323812508|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
94550731|NCT01424566|323812512|FG000|Single-blind Treatment|Adverse Event|71|||
94550732|NCT01424566|323812513|FG001|Single-blind Treatment|Adverse Event|0|||
94550733|NCT01424566|323812514|FG002|Single-blind Treatment|Adverse Event|0|||
94550734|NCT01424566|323812512|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
94550735|NCT01424566|323812513|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
94550736|NCT01424566|323812514|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
94550737|NCT01424566|323812512|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
94550738|NCT01424566|323812513|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
94550739|NCT01424566|323812514|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
94550740|NCT01424566|323812512|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
94550741|NCT01424566|323812513|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
94550742|NCT01424566|323812514|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
94550743|NCT01424566|323812512|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
94550744|NCT01424566|323812513|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
94550745|NCT01424566|323812514|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
94550746|NCT01424566|323812512|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
94550747|NCT01424566|323812513|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
94550748|NCT01424566|323812514|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
94550749|NCT01424566|323812512|FG000|Double-blind Treatment|Adverse Event|0|||
94342458|NCT00542425|323033751|FG003|Initial 24 Weeks|Protocol Violation|1|||
94342459|NCT00542425|323033752|FG004|Initial 24 Weeks|Protocol Violation|0|||
94342460|NCT00542425|323033748|FG000|Initial 24 Weeks|Refusal of treatment|2|||
94342461|NCT00542425|323033749|FG001|Initial 24 Weeks|Refusal of treatment|2|||
94342462|NCT00542425|323033750|FG002|Initial 24 Weeks|Refusal of treatment|1|||
94342463|NCT00542425|323033751|FG003|Initial 24 Weeks|Refusal of treatment|4|||
94342464|NCT00542425|323033752|FG004|Initial 24 Weeks|Refusal of treatment|1|||
94342465|NCT00542425|323033748|FG000|Initial 24 Weeks|Other|0|||
94342466|NCT00542425|323033749|FG001|Initial 24 Weeks|Other|2|||
94342467|NCT00542425|323033750|FG002|Initial 24 Weeks|Other|1|||
94342468|NCT00542425|323033751|FG003|Initial 24 Weeks|Other|0|||
94342469|NCT00542425|323033752|FG004|Initial 24 Weeks|Other|0|||
94342470|NCT00542425|323033748|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
94342471|NCT00542425|323033749|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
94342472|NCT00542425|323033750|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
94342473|NCT00542425|323033751|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
94342474|NCT00542425|323033752|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
94342475|NCT00542425|323033748|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
94342476|NCT00542425|323033749|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
94342477|NCT00542425|323033750|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
94342478|NCT00542425|323033751|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
94342479|NCT00542425|323033752|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
94342480|NCT00542425|323033748|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
94342481|NCT00542425|323033749|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
94342482|NCT00542425|323033750|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
94342483|NCT00542425|323033751|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
94342484|NCT00542425|323033752|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
94342485|NCT00542425|323033748|FG000|Extended 24 Weeks of Treatment|Other|1|||
94342486|NCT00542425|323033749|FG001|Extended 24 Weeks of Treatment|Other|1|||
94342487|NCT00542425|323033750|FG002|Extended 24 Weeks of Treatment|Other|0|||
94342488|NCT00542425|323033751|FG003|Extended 24 Weeks of Treatment|Other|0|||
94342489|NCT00542425|323033752|FG004|Extended 24 Weeks of Treatment|Other|1|||
94342490|NCT00952419|323033754|FG000|Overall Study|Adverse Event|2|||
94342491|NCT00952419|323033755|FG001|Overall Study|Adverse Event|0|||
94342492|NCT00952419|323033756|FG002|Overall Study|Adverse Event|0|||
94342493|NCT00952419|323033754|FG000|Overall Study|Protocol Violation|3|||
94342494|NCT00952419|323033755|FG001|Overall Study|Protocol Violation|7|||
94342495|NCT00952419|323033756|FG002|Overall Study|Protocol Violation|0|||
94342496|NCT00952419|323033754|FG000|Overall Study|Withdrawal by Subject|1|||
94342497|NCT00952419|323033755|FG001|Overall Study|Withdrawal by Subject|3|||
94342498|NCT00952419|323033756|FG002|Overall Study|Withdrawal by Subject|0|||
94342499|NCT02667236|323035861|FG000|Overall Study|Adverse Event|1|||
94342500|NCT02667236|323035862|FG001|Overall Study|Adverse Event|1|||
94342501|NCT02667236|323035861|FG000|Overall Study|Withdrawal by Subject|2|||
94342502|NCT02667236|323035862|FG001|Overall Study|Withdrawal by Subject|0|||
94342503|NCT00425945|323035863|FG000|Overall Study|Concern about Supplement|2|||
94342504|NCT00425945|323035864|FG001|Overall Study|Concern about Supplement|0|||
94342505|NCT00425945|323035863|FG000|Overall Study|Inconvenience|0|||
94342506|NCT00425945|323035864|FG001|Overall Study|Inconvenience|2|||
94342507|NCT00425945|323035863|FG000|Overall Study|Lost to Follow-up|0|||
94342508|NCT00425945|323035864|FG001|Overall Study|Lost to Follow-up|2|||
94342509|NCT00425945|323035863|FG000|Overall Study|Began hypertension medication|1|||
94342510|NCT00425945|323035864|FG001|Overall Study|Began hypertension medication|0|||
94342511|NCT00425945|323035863|FG000|Overall Study|Began cancer treatments|1|||
94342512|NCT00425945|323035864|FG001|Overall Study|Began cancer treatments|0|||
94342513|NCT00425945|323035863|FG000|Overall Study|Moved from area|0|||
94342514|NCT00425945|323035864|FG001|Overall Study|Moved from area|1|||
94342515|NCT03991936|323035867|FG000|Overall Study|Lost to Follow-up|1|||
94342516|NCT03991936|323035868|FG001|Overall Study|Lost to Follow-up|1|||
94342517|NCT03991936|323035869|FG002|Overall Study|Lost to Follow-up|1|||
94342518|NCT03991936|323035870|FG003|Overall Study|Lost to Follow-up|1|||
94342519|NCT03991936|323035871|FG004|Overall Study|Lost to Follow-up|1|||
94342520|NCT00673816|323035872|FG000|Overall Study|Adverse Event|1|||
94342521|NCT00673816|323035872|FG000|Overall Study|Withdrawal by Subject|1|||
94342522|NCT00584987|323035875|FG000|Overall Study|Protocol Violation|1|||
94342523|NCT00584987|323035876|FG001|Overall Study|Protocol Violation|1|||
94342524|NCT00584987|323035877|FG002|Overall Study|Protocol Violation|1|||
94342525|NCT00584987|323035878|FG003|Overall Study|Protocol Violation|0|||
94342526|NCT00584987|323035875|FG000|Overall Study|Adverse Event|0|||
94342527|NCT00584987|323035876|FG001|Overall Study|Adverse Event|0|||
94342528|NCT00584987|323035877|FG002|Overall Study|Adverse Event|0|||
94342529|NCT00584987|323035878|FG003|Overall Study|Adverse Event|1|||
94342530|NCT01080625|323035879|FG000|Overall Study|Physician Decision|0|||
94342531|NCT01080625|323035880|FG001|Overall Study|Physician Decision|2|||
94342532|NCT01080625|323035881|FG002|Overall Study|Physician Decision|1|||
94342533|NCT00589602|323035885|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
94342534|NCT03887052|323035889|FG000|Overall Study|Adverse Event|2|||
94550750|NCT01424566|323812513|FG001|Double-blind Treatment|Adverse Event|21|||
94550751|NCT01424566|323812514|FG002|Double-blind Treatment|Adverse Event|13|||
94550752|NCT01424566|323812512|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
94550753|NCT01424566|323812513|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
94550754|NCT01424566|323812514|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
94550755|NCT01424566|323812512|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
94550756|NCT01424566|323812513|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
94550757|NCT01424566|323812514|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
94550758|NCT01424566|323812512|FG000|Double-blind Treatment|Lack of Efficacy|0|||
94550759|NCT01424566|323812513|FG001|Double-blind Treatment|Lack of Efficacy|1|||
94550760|NCT01424566|323812514|FG002|Double-blind Treatment|Lack of Efficacy|1|||
94550761|NCT00527319|323812515|FG000|Overall Study|Withdrawal by Subject|5|||
94550762|NCT00527319|323812516|FG001|Overall Study|Withdrawal by Subject|0|||
94550763|NCT00527319|323812517|FG002|Overall Study|Withdrawal by Subject|1|||
94550764|NCT00527319|323812515|FG000|Overall Study|Lost to Follow-up|1|||
94550765|NCT00527319|323812516|FG001|Overall Study|Lost to Follow-up|0|||
94550766|NCT00527319|323812517|FG002|Overall Study|Lost to Follow-up|0|||
94550767|NCT00527319|323812515|FG000|Overall Study|Death|0|||
94550768|NCT00527319|323812516|FG001|Overall Study|Death|3|||
94550769|NCT00527319|323812517|FG002|Overall Study|Death|1|||
94550770|NCT00527319|323812515|FG000|Overall Study|Intercurrent Medical Illness|0|||
94550771|NCT00527319|323812516|FG001|Overall Study|Intercurrent Medical Illness|1|||
94550772|NCT00527319|323812517|FG002|Overall Study|Intercurrent Medical Illness|3|||
94550773|NCT00527319|323812515|FG000|Overall Study|Adverse Event|0|||
94550774|NCT00527319|323812516|FG001|Overall Study|Adverse Event|0|||
94550775|NCT00527319|323812517|FG002|Overall Study|Adverse Event|1|||
94550776|NCT03194438|323812520|FG000|Overall Study|Withdrawal by Subject|2|||
94550777|NCT03344172|323812521|FG000|Overall Study|Received <1 dose of treatment|1|||
94550778|NCT03344172|323812522|FG001|Overall Study|Received <1 dose of treatment|0|||
94550779|NCT01146288|323812524|FG000|First Intervention(1 Day)|Adverse Event|0|||
94550780|NCT01146288|323812525|FG001|First Intervention(1 Day)|Adverse Event|1|||
94550781|NCT01110382|323812529|FG000|Overall Study|Withdrawal by Subject|0|||
94550782|NCT01110382|323812530|FG001|Overall Study|Withdrawal by Subject|1|||
94550783|NCT01110382|323812529|FG000|Overall Study|Protocol Violation|0|||
94550784|NCT01110382|323812530|FG001|Overall Study|Protocol Violation|1|||
94550785|NCT00902174|323812533|FG000|Overall Study|Adverse Event|27|||
94550786|NCT00902174|323812534|FG001|Overall Study|Adverse Event|7|||
94550787|NCT00902174|323812533|FG000|Overall Study|Lack of Efficacy|1|||
94550788|NCT00902174|323812534|FG001|Overall Study|Lack of Efficacy|5|||
94550789|NCT00902174|323812533|FG000|Overall Study|Death|2|||
94550790|NCT00902174|323812534|FG001|Overall Study|Death|2|||
94550791|NCT00902174|323812533|FG000|Overall Study|Withdrawal by Subject|2|||
94550792|NCT00902174|323812534|FG001|Overall Study|Withdrawal by Subject|1|||
94550793|NCT00902174|323812533|FG000|Overall Study|Abnormal labs|1|||
94550794|NCT00902174|323812534|FG001|Overall Study|Abnormal labs|1|||
94550795|NCT00902174|323812533|FG000|Overall Study|Protocol Violation|1|||
94550796|NCT00902174|323812534|FG001|Overall Study|Protocol Violation|1|||
94550797|NCT00902174|323812533|FG000|Overall Study|Administration problem|0|||
94550798|NCT00902174|323812534|FG001|Overall Study|Administration problem|1|||
94550799|NCT00290498|323812535|FG000|Overall Study|Death|2|||
94550800|NCT00290498|323812536|FG001|Overall Study|Death|0|||
94550801|NCT00290498|323812535|FG000|Overall Study|Physician Decision|1|||
94550802|NCT00290498|323812536|FG001|Overall Study|Physician Decision|0|||
94550803|NCT00290498|323812535|FG000|Overall Study|Withdrawal by Subject|1|||
94550804|NCT00290498|323812536|FG001|Overall Study|Withdrawal by Subject|0|||
94550805|NCT00290498|323812535|FG000|Overall Study|Ineligible|3|||
94550806|NCT00290498|323812536|FG001|Overall Study|Ineligible|0|||
94550807|NCT00290498|323812535|FG000|Overall Study|Non-Compliance|1|||
94550808|NCT00290498|323812536|FG001|Overall Study|Non-Compliance|0|||
94550809|NCT01818492|323812543|FG000|Overall Study|Adverse Event|2|||
94550810|NCT01818492|323812543|FG000|Overall Study|Death|3|||
94550811|NCT01818492|323812543|FG000|Overall Study|Withdrawal by Subject|1|||
94550812|NCT01818492|323812543|FG000|Overall Study|Additional therapy when not allowed PP|4|||
94550813|NCT03022981|323812544|FG000|Overall Study|Adverse Event|0|||
94550814|NCT03022981|323812545|FG001|Overall Study|Adverse Event|1|||
94550815|NCT03022981|323812546|FG002|Overall Study|Adverse Event|0|||
94550816|NCT03022981|323812544|FG000|Overall Study|Investigator's Discretion|0|||
94550817|NCT03022981|323812545|FG001|Overall Study|Investigator's Discretion|1|||
94550818|NCT03022981|323812546|FG002|Overall Study|Investigator's Discretion|2|||
94550819|NCT03022981|323812544|FG000|Overall Study|Lost to Follow-up|6|||
94550820|NCT03022981|323812545|FG001|Overall Study|Lost to Follow-up|2|||
94550821|NCT03022981|323812546|FG002|Overall Study|Lost to Follow-up|1|||
94550822|NCT03022981|323812544|FG000|Overall Study|Non-Compliance With Study Drug|0|||
94550823|NCT03022981|323812545|FG001|Overall Study|Non-Compliance With Study Drug|0|||
94550824|NCT03022981|323812546|FG002|Overall Study|Non-Compliance With Study Drug|2|||
94550825|NCT03022981|323812544|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
94550826|NCT03022981|323812545|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
94443877|NCT00370552|323411701|FG001|Overall Study|Poor or noncompliance|0|||
94443878|NCT00370552|323411702|FG002|Overall Study|Poor or noncompliance|1|||
94443879|NCT00370552|323411700|FG000|Overall Study|Study drug toxicity|11|||
94443880|NCT00370552|323411701|FG001|Overall Study|Study drug toxicity|8|||
94443881|NCT00370552|323411702|FG002|Overall Study|Study drug toxicity|6|||
94443882|NCT00370552|323411700|FG000|Overall Study|Withdrawal by Subject|2|||
94443883|NCT00370552|323411701|FG001|Overall Study|Withdrawal by Subject|0|||
94443884|NCT00370552|323411702|FG002|Overall Study|Withdrawal by Subject|1|||
94443885|NCT00370552|323411700|FG000|Overall Study|Still on treatment|1|||
94443886|NCT00370552|323411701|FG001|Overall Study|Still on treatment|3|||
94443887|NCT00370552|323411702|FG002|Overall Study|Still on treatment|2|||
94443888|NCT00370552|323411700|FG000|Overall Study|Never treated|1|||
94443889|NCT00370552|323411701|FG001|Overall Study|Never treated|0|||
94443890|NCT00370552|323411702|FG002|Overall Study|Never treated|0|||
94443891|NCT00370552|323411700|FG000|Overall Study|Physician Decision|1|||
94443892|NCT00370552|323411701|FG001|Overall Study|Physician Decision|1|||
94443893|NCT00370552|323411702|FG002|Overall Study|Physician Decision|0|||
94443894|NCT00370552|323411700|FG000|Overall Study|Investigator decision|2|||
94443895|NCT00370552|323411701|FG001|Overall Study|Investigator decision|1|||
94443896|NCT00370552|323411702|FG002|Overall Study|Investigator decision|0|||
94443897|NCT00370552|323411700|FG000|Overall Study|High risk of allergic reaction|0|||
94443898|NCT00370552|323411701|FG001|Overall Study|High risk of allergic reaction|1|||
94443899|NCT00370552|323411702|FG002|Overall Study|High risk of allergic reaction|0|||
94443900|NCT00370552|323411700|FG000|Overall Study|Planned radiation for palliation|0|||
94443901|NCT00370552|323411701|FG001|Overall Study|Planned radiation for palliation|1|||
94443902|NCT00370552|323411702|FG002|Overall Study|Planned radiation for palliation|0|||
94443903|NCT00324987|323411708|FG000|Overall Study|Adverse Event|2|||
94443904|NCT00324987|323411709|FG001|Overall Study|Adverse Event|1|||
94443905|NCT00324987|323411708|FG000|Overall Study|Withdrawal by Subject|1|||
94443906|NCT00324987|323411709|FG001|Overall Study|Withdrawal by Subject|1|||
94443907|NCT00324987|323411708|FG000|Overall Study|Progression|1|||
94443908|NCT00324987|323411709|FG001|Overall Study|Progression|1|||
94443909|NCT00324987|323411708|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
94443910|NCT00324987|323411709|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
94443911|NCT01062425|323411710|FG000|Overall Study|Protocol Violation|3|||
94443912|NCT01062425|323411711|FG001|Overall Study|Protocol Violation|6|||
94443913|NCT01234350|323411712|FG000|Overall Study|Adverse Event|277|||
94443914|NCT01234350|323411713|FG001|Overall Study|Adverse Event|92|||
94443915|NCT01234350|323411712|FG000|Overall Study|Withdrawal by Subject|61|||
94443916|NCT01234350|323411713|FG001|Overall Study|Withdrawal by Subject|36|||
94443917|NCT01234350|323411712|FG000|Overall Study|Lost to Follow-up|115|||
94443918|NCT01234350|323411713|FG001|Overall Study|Lost to Follow-up|47|||
94443919|NCT01234350|323411712|FG000|Overall Study|Covers a diverse set of reasons|234|||
94443920|NCT01234350|323411713|FG001|Overall Study|Covers a diverse set of reasons|92|||
94443921|NCT00162981|323411715|FG000|Overall Study|Adverse Event|2|||
94443922|NCT00162981|323411716|FG001|Overall Study|Adverse Event|5|||
94443923|NCT00162981|323411715|FG000|Overall Study|Withdrawal by Subject|1|||
94443924|NCT00162981|323411716|FG001|Overall Study|Withdrawal by Subject|1|||
94443925|NCT00162981|323411715|FG000|Overall Study|Physician Decision|1|||
94443926|NCT00162981|323411716|FG001|Overall Study|Physician Decision|0|||
94443927|NCT01778530|323411719|FG000|Overall Study|Progression on study|1|||
94443928|NCT01778530|323411719|FG000|Overall Study|Adverse event/side effect|1|||
94443929|NCT01199939|323411720|FG000|Overall Study|Adverse Event|4|||
94443930|NCT01199939|323411720|FG000|Overall Study|Protocol Violation|3|||
94443931|NCT01199939|323411720|FG000|Overall Study|Lost to Follow-up|2|||
94443932|NCT01199939|323411720|FG000|Overall Study|Reached a virologic endpoint|4|||
94443933|NCT03472014|323411721|FG000|Overall Study|Lost to Follow-up|4|||
94443934|NCT01894919|323411734|FG000|Overall Study|Withdrawal by Subject|1|||
94443935|NCT01894919|323411735|FG001|Overall Study|Withdrawal by Subject|0|||
94443936|NCT01894919|323411736|FG002|Overall Study|Withdrawal by Subject|0|||
94443937|NCT01894919|323411737|FG003|Overall Study|Withdrawal by Subject|0|||
94443938|NCT01894919|323411738|FG004|Overall Study|Withdrawal by Subject|1|||
94443939|NCT01894919|323411739|FG005|Overall Study|Withdrawal by Subject|0|||
94443940|NCT01894919|323411740|FG006|Overall Study|Withdrawal by Subject|0|||
94443941|NCT01894919|323411741|FG007|Overall Study|Withdrawal by Subject|0|||
94443942|NCT01894919|323411742|FG008|Overall Study|Withdrawal by Subject|0|||
94443943|NCT01894919|323411743|FG009|Overall Study|Withdrawal by Subject|1|||
94443944|NCT01894919|323411744|FG010|Overall Study|Withdrawal by Subject|1|||
94443945|NCT01894919|323411745|FG011|Overall Study|Withdrawal by Subject|0|||
94443946|NCT01894919|323411746|FG012|Overall Study|Withdrawal by Subject|0|||
94443947|NCT01894919|323411734|FG000|Overall Study|Adverse Event|0|||
94443948|NCT01894919|323411735|FG001|Overall Study|Adverse Event|0|||
94443949|NCT01894919|323411736|FG002|Overall Study|Adverse Event|0|||
94443950|NCT01894919|323411737|FG003|Overall Study|Adverse Event|0|||
94443951|NCT01894919|323411738|FG004|Overall Study|Adverse Event|0|||
94443952|NCT01894919|323411739|FG005|Overall Study|Adverse Event|0|||
94443953|NCT01894919|323411740|FG006|Overall Study|Adverse Event|0|||
94550827|NCT03022981|323812546|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
94550828|NCT00231413|323812550|FG000|Overall Study|Non-serious AE|0|||
94550829|NCT00231413|323812551|FG001|Overall Study|Non-serious AE|0|||
94550830|NCT00231413|323812552|FG002|Overall Study|Non-serious AE|1|||
94550831|NCT00231413|323812553|FG003|Overall Study|Non-serious AE|0|||
94550832|NCT00231413|323812554|FG004|Overall Study|Non-serious AE|0|||
94550833|NCT00231413|323812555|FG005|Overall Study|Non-serious AE|0|||
94550834|NCT00231413|323812556|FG006|Overall Study|Non-serious AE|1|||
94550835|NCT00231413|323812550|FG000|Overall Study|Withdrawal by Subject|3|||
94550836|NCT00231413|323812551|FG001|Overall Study|Withdrawal by Subject|1|||
94550837|NCT00231413|323812552|FG002|Overall Study|Withdrawal by Subject|4|||
94550838|NCT00231413|323812553|FG003|Overall Study|Withdrawal by Subject|2|||
94550839|NCT00231413|323812554|FG004|Overall Study|Withdrawal by Subject|2|||
94550840|NCT00231413|323812555|FG005|Overall Study|Withdrawal by Subject|0|||
94550841|NCT00231413|323812556|FG006|Overall Study|Withdrawal by Subject|3|||
94550842|NCT00231413|323812550|FG000|Overall Study|Migrated/moved from study area|0|||
94550843|NCT00231413|323812551|FG001|Overall Study|Migrated/moved from study area|0|||
94550844|NCT00231413|323812552|FG002|Overall Study|Migrated/moved from study area|1|||
94550845|NCT00231413|323812553|FG003|Overall Study|Migrated/moved from study area|0|||
94550846|NCT00231413|323812554|FG004|Overall Study|Migrated/moved from study area|0|||
94550847|NCT00231413|323812555|FG005|Overall Study|Migrated/moved from study area|1|||
94550848|NCT00231413|323812556|FG006|Overall Study|Migrated/moved from study area|0|||
94550849|NCT00231413|323812550|FG000|Overall Study|Lost to Follow-up|4|||
94550850|NCT00231413|323812551|FG001|Overall Study|Lost to Follow-up|4|||
94550851|NCT00231413|323812552|FG002|Overall Study|Lost to Follow-up|1|||
94550852|NCT00231413|323812553|FG003|Overall Study|Lost to Follow-up|1|||
94550853|NCT00231413|323812554|FG004|Overall Study|Lost to Follow-up|1|||
94550854|NCT00231413|323812555|FG005|Overall Study|Lost to Follow-up|4|||
94550855|NCT00231413|323812556|FG006|Overall Study|Lost to Follow-up|0|||
94550856|NCT00231413|323812550|FG000|Overall Study|Pregnancy|1|||
94550857|NCT00231413|323812551|FG001|Overall Study|Pregnancy|0|||
94550858|NCT00231413|323812552|FG002|Overall Study|Pregnancy|0|||
94550859|NCT00231413|323812553|FG003|Overall Study|Pregnancy|0|||
94550860|NCT00231413|323812554|FG004|Overall Study|Pregnancy|0|||
94550861|NCT00231413|323812555|FG005|Overall Study|Pregnancy|0|||
94550862|NCT00231413|323812556|FG006|Overall Study|Pregnancy|0|||
94550863|NCT00129961|323812557|FG000|Overall Study|Adverse Event|1|||
94550864|NCT00129961|323812558|FG001|Overall Study|Adverse Event|0|||
94550865|NCT00129961|323812557|FG000|Overall Study|Death|1|||
94550866|NCT00129961|323812558|FG001|Overall Study|Death|1|||
94550867|NCT00129961|323812557|FG000|Overall Study|Withdrawal by Sponsor|14|||
94550868|NCT00129961|323812558|FG001|Overall Study|Withdrawal by Sponsor|20|||
94550869|NCT00129961|323812557|FG000|Overall Study|Physician Decision|1|||
94550870|NCT00129961|323812558|FG001|Overall Study|Physician Decision|0|||
94550871|NCT00129961|323812557|FG000|Overall Study|Withdrawal by Subject|2|||
94550872|NCT00129961|323812558|FG001|Overall Study|Withdrawal by Subject|1|||
94550873|NCT00129961|323812557|FG000|Overall Study|Missing Record|0|||
94550874|NCT00129961|323812558|FG001|Overall Study|Missing Record|1|||
94550875|NCT00079677|323812559|FG000|Overall Study|Adverse Event|5|||
94550876|NCT00079677|323812560|FG001|Overall Study|Adverse Event|6|||
94550877|NCT00079677|323812559|FG000|Overall Study|Lack of Efficacy|1|||
94550878|NCT00079677|323812560|FG001|Overall Study|Lack of Efficacy|0|||
94550879|NCT00079677|323812559|FG000|Overall Study|Lost to Follow-up|2|||
94550880|NCT00079677|323812560|FG001|Overall Study|Lost to Follow-up|2|||
94550881|NCT00079677|323812559|FG000|Overall Study|Physician Decision|3|||
94550882|NCT00079677|323812560|FG001|Overall Study|Physician Decision|0|||
94550883|NCT00079677|323812559|FG000|Overall Study|Protocol Violation|2|||
94550884|NCT00079677|323812560|FG001|Overall Study|Protocol Violation|3|||
94550885|NCT00079677|323812559|FG000|Overall Study|Withdrawal by Subject|5|||
94550886|NCT00079677|323812560|FG001|Overall Study|Withdrawal by Subject|3|||
94550887|NCT00079677|323812559|FG000|Overall Study|Miscellaneous|2|||
94550888|NCT00079677|323812560|FG001|Overall Study|Miscellaneous|0|||
94550889|NCT00409344|323812563|FG000|Overall Study|no enrollment|0|||
94550890|NCT00409344|323812564|FG001|Overall Study|no enrollment|0|||
94342535|NCT03887052|323035889|FG000|Overall Study|Physician Decision|2|||
94550891|NCT03550404|323812565|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
94550892|NCT03550404|323812566|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
94550893|NCT03550404|323812567|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
94550894|NCT03550404|323812565|FG000|Phase 2|Vacated position|1|||
94550895|NCT03550404|323812566|FG001|Phase 2|Vacated position|0|||
94550896|NCT03550404|323812567|FG002|Phase 2|Vacated position|0|||
94550897|NCT01183468|323812581|FG000|Overall Study|Lost to Follow-up|2|||
94550898|NCT01183468|323812582|FG001|Overall Study|Lost to Follow-up|1|||
94550899|NCT01183468|323812583|FG002|Overall Study|Lost to Follow-up|0|||
94550900|NCT01183468|323812584|FG003|Overall Study|Lost to Follow-up|0|||
94550901|NCT01183468|323812581|FG000|Overall Study|Physician Decision|1|||
94550902|NCT01183468|323812582|FG001|Overall Study|Physician Decision|0|||
94550903|NCT01183468|323812583|FG002|Overall Study|Physician Decision|0|||
94550904|NCT01183468|323812584|FG003|Overall Study|Physician Decision|0|||
94550905|NCT01183468|323812581|FG000|Overall Study|Withdrawal by Subject|0|||
94550906|NCT01183468|323812582|FG001|Overall Study|Withdrawal by Subject|1|||
94550907|NCT01183468|323812583|FG002|Overall Study|Withdrawal by Subject|0|||
94550908|NCT01183468|323812584|FG003|Overall Study|Withdrawal by Subject|0|||
94550909|NCT01789606|323812588|FG000|Overall Study|Participant not Purchased the Product|0|||
94550910|NCT01789606|323812589|FG001|Overall Study|Participant not Purchased the Product|20|||
94550911|NCT01789606|323812588|FG000|Overall Study|Withdrawal by Subject|0|||
94550912|NCT01789606|323812589|FG001|Overall Study|Withdrawal by Subject|1|||
94550913|NCT01789606|323812588|FG000|Overall Study|Ineligible|6|||
94550914|NCT01789606|323812589|FG001|Overall Study|Ineligible|2|||
94550915|NCT01789606|323812588|FG000|Overall Study|Administrative Reasons|17|||
94550916|NCT01789606|323812589|FG001|Overall Study|Administrative Reasons|6|||
94550917|NCT01789606|323812588|FG000|Overall Study|No Study Medication Taken|0|||
94550918|NCT01789606|323812589|FG001|Overall Study|No Study Medication Taken|1|||
94550919|NCT01789606|323812588|FG000|Overall Study|Protocol Violation|0|||
94550920|NCT01789606|323812589|FG001|Overall Study|Protocol Violation|55|||
94550921|NCT01789606|323812588|FG000|Overall Study|Adverse Event|0|||
94550922|NCT01789606|323812589|FG001|Overall Study|Adverse Event|3|||
94550923|NCT01789606|323812588|FG000|Overall Study|Lost to Follow-up|0|||
94550924|NCT01789606|323812589|FG001|Overall Study|Lost to Follow-up|14|||
94550925|NCT01789606|323812588|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
94550926|NCT01789606|323812589|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
94550927|NCT02925728|323812590|FG000|Overall Study|Death|3|||
94550928|NCT02925728|323812591|FG001|Overall Study|Death|5|||
94550929|NCT02925728|323812590|FG000|Overall Study|Physician Decision|1|||
94550930|NCT02925728|323812591|FG001|Overall Study|Physician Decision|0|||
94550931|NCT02925728|323812590|FG000|Overall Study|Withdrawal by Subject|1|||
94550932|NCT02925728|323812591|FG001|Overall Study|Withdrawal by Subject|0|||
94550933|NCT03480009|323812592|FG000|Overall Study|Lost to Follow-up|4|||
94550934|NCT03480009|323812593|FG001|Overall Study|Lost to Follow-up|5|||
94550935|NCT03480009|323812594|FG002|Overall Study|Lost to Follow-up|4|||
94550936|NCT03480009|323812595|FG003|Overall Study|Lost to Follow-up|0|||
94550937|NCT01563172|323812598|FG000|Overall Study|Adverse Event|5|||
94550938|NCT01563172|323812598|FG000|Overall Study|Lost to Follow-up|2|||
94550939|NCT01563172|323812598|FG000|Overall Study|Other (Protocol deviation)|5|||
94550940|NCT01563172|323812598|FG000|Overall Study|Other (Not specified)|1|||
94550941|NCT04349033|323812600|FG000|Overall Study|Lost to Follow-up|3|||
94550942|NCT04349033|323812601|FG001|Overall Study|Lost to Follow-up|1|||
94550943|NCT04349033|323812602|FG002|Overall Study|Lost to Follow-up|1|||
94550944|NCT01972789|323812610|FG000|Overall Study|Adverse Event|11|||
94550945|NCT01972789|323812611|FG001|Overall Study|Adverse Event|4|||
94550946|NCT01972789|323812610|FG000|Overall Study|Subject withdrew consent|14|||
94550947|NCT01972789|323812611|FG001|Overall Study|Subject withdrew consent|12|||
94550948|NCT01972789|323812610|FG000|Overall Study|Lost to Follow-up|4|||
94550949|NCT01972789|323812611|FG001|Overall Study|Lost to Follow-up|7|||
94550950|NCT01972789|323812610|FG000|Overall Study|Death|7|||
94550951|NCT01972789|323812611|FG001|Overall Study|Death|5|||
94550952|NCT01972789|323812610|FG000|Overall Study|Protocol deviation|1|||
94550953|NCT01972789|323812611|FG001|Overall Study|Protocol deviation|0|||
94550954|NCT01972789|323812610|FG000|Overall Study|Physician Decision|3|||
94550955|NCT01972789|323812611|FG001|Overall Study|Physician Decision|2|||
94550956|NCT00086411|323812614|FG000|Overall Study|Lost to Follow-up|11|||
94550957|NCT00086411|323812615|FG001|Overall Study|Lost to Follow-up|11|||
94550958|NCT00086411|323812616|FG002|Overall Study|Lost to Follow-up|13|||
94550959|NCT00086411|323812617|FG003|Overall Study|Lost to Follow-up|12|||
94550960|NCT00718770|323812618|FG000|Overall Study|Adverse Event|1|||
94550961|NCT00718770|323812618|FG000|Overall Study|Lack of Efficacy|1|||
94550962|NCT00718770|323812618|FG000|Overall Study|Lack of Efficacy|1|||
94550963|NCT00718770|323812618|FG000|Overall Study|Adverse Event|1|||
94550964|NCT00718770|323812618|FG000|Overall Study|Lack of Efficacy|1|||
94550965|NCT00718770|323812618|FG000|Overall Study|Adverse Event|1|||
94550966|NCT00718770|323812618|FG000|Overall Study|Lack of Efficacy|1|||
94550967|NCT00718770|323812618|FG000|Overall Study|Adverse Event|1|||
94550968|NCT01624090|323812619|FG000|Overall Study|DLT, taken off therapy|0|||
94550969|NCT01624090|323812620|FG001|Overall Study|DLT, taken off therapy|1|||
94550970|NCT01624090|323812621|FG002|Overall Study|DLT, taken off therapy|0|||
94550971|NCT01624090|323812622|FG003|Overall Study|DLT, taken off therapy|0|||
94550972|NCT01624090|323812619|FG000|Overall Study|Withdrew prior to treatment|0|||
94550973|NCT01624090|323812620|FG001|Overall Study|Withdrew prior to treatment|1|||
94550974|NCT01624090|323812621|FG002|Overall Study|Withdrew prior to treatment|0|||
94550975|NCT01624090|323812622|FG003|Overall Study|Withdrew prior to treatment|0|||
94550976|NCT01624090|323812619|FG000|Overall Study|Died on study|0|||
94550977|NCT01624090|323812620|FG001|Overall Study|Died on study|0|||
94550978|NCT01624090|323812621|FG002|Overall Study|Died on study|2|||
94550979|NCT01624090|323812622|FG003|Overall Study|Died on study|0|||
94550980|NCT01624090|323812619|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
94550981|NCT01624090|323812620|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
94550982|NCT01624090|323812621|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
94550983|NCT01624090|323812622|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
94550984|NCT01624090|323812619|FG000|Overall Study|Dose escalated|0|||
94550985|NCT01624090|323812620|FG001|Overall Study|Dose escalated|0|||
94550986|NCT01624090|323812621|FG002|Overall Study|Dose escalated|3|||
94550987|NCT01624090|323812622|FG003|Overall Study|Dose escalated|0|||
94550988|NCT01403116|323812623|FG000|Overall Study|Adverse Event|7|||
94550989|NCT01403116|323812624|FG001|Overall Study|Adverse Event|4|||
94550990|NCT01403116|323812623|FG000|Overall Study|Lost to Follow-up|7|||
94550991|NCT01403116|323812624|FG001|Overall Study|Lost to Follow-up|5|||
94550992|NCT01403116|323812623|FG000|Overall Study|Withdrawal by Subject|12|||
94550993|NCT01403116|323812624|FG001|Overall Study|Withdrawal by Subject|15|||
94550994|NCT01403116|323812623|FG000|Overall Study|Non-compliance of study drug|3|||
94550995|NCT01403116|323812624|FG001|Overall Study|Non-compliance of study drug|0|||
94550996|NCT01403116|323812623|FG000|Overall Study|Protocol Violation|0|||
94550997|NCT01403116|323812624|FG001|Overall Study|Protocol Violation|1|||
94550998|NCT01403116|323812623|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
94550999|NCT01403116|323812624|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
94551000|NCT01403116|323812623|FG000|Overall Study|Hct >54%|2|||
94551001|NCT01403116|323812624|FG001|Overall Study|Hct >54%|0|||
94551002|NCT01403116|323812623|FG000|Overall Study|unable to keep appointments|0|||
94551003|NCT01403116|323812624|FG001|Overall Study|unable to keep appointments|2|||
94551004|NCT02831933|323814798|FG000|Overall Study|Physician Decision|11|||
94551005|NCT01161537|323814799|FG000|Part B|Withdrawal by Subject|2|||
94551006|NCT01673620|323814800|FG000|Overall Study|Adverse Event|1|||
94551007|NCT01673620|323814801|FG001|Overall Study|Adverse Event|0|||
94551008|NCT01206582|323814802|FG000|Overall Study|Withdrew prior to study|1|||
94551009|NCT01206582|323814803|FG001|Overall Study|Withdrew prior to study|0|||
94551010|NCT01206582|323814802|FG000|Overall Study|Discontinued intervention before week 8|1|||
94551011|NCT01206582|323814803|FG001|Overall Study|Discontinued intervention before week 8|2|||
94443954|NCT01894919|323411741|FG007|Overall Study|Adverse Event|0|||
94443955|NCT01894919|323411742|FG008|Overall Study|Adverse Event|0|||
94443956|NCT01894919|323411743|FG009|Overall Study|Adverse Event|0|||
94443957|NCT01894919|323411744|FG010|Overall Study|Adverse Event|1|||
94443958|NCT01894919|323411745|FG011|Overall Study|Adverse Event|0|||
94443959|NCT01894919|323411746|FG012|Overall Study|Adverse Event|0|||
94443960|NCT01894919|323411734|FG000|Overall Study|Other-Unspecified|1|||
94443961|NCT01894919|323411735|FG001|Overall Study|Other-Unspecified|0|||
94443962|NCT01894919|323411736|FG002|Overall Study|Other-Unspecified|0|||
94443963|NCT01894919|323411737|FG003|Overall Study|Other-Unspecified|0|||
94443964|NCT01894919|323411738|FG004|Overall Study|Other-Unspecified|0|||
94443965|NCT01894919|323411739|FG005|Overall Study|Other-Unspecified|0|||
94443966|NCT01894919|323411740|FG006|Overall Study|Other-Unspecified|0|||
94443967|NCT01894919|323411741|FG007|Overall Study|Other-Unspecified|0|||
94443968|NCT01894919|323411742|FG008|Overall Study|Other-Unspecified|0|||
94443969|NCT01894919|323411743|FG009|Overall Study|Other-Unspecified|0|||
94443970|NCT01894919|323411744|FG010|Overall Study|Other-Unspecified|0|||
94551012|NCT01971008|323814804|FG000|Overall Study|Protocol Violation|2|||
94551013|NCT01971008|323814805|FG001|Overall Study|Protocol Violation|1|||
94551014|NCT06359080|323814806|FG000|Overall Study|Withdrawal by Subject|3|||
94551015|NCT00306527|323814809|FG000|Overall Study|Lost to Follow-up|3|||
94551016|NCT00306527|323814810|FG001|Overall Study|Lost to Follow-up|4|||
94551017|NCT00306527|323814811|FG002|Overall Study|Lost to Follow-up|3|||
94551018|NCT00306527|323814812|FG003|Overall Study|Lost to Follow-up|0|||
94443971|NCT01894919|323411745|FG011|Overall Study|Other-Unspecified|0|||
94443972|NCT01894919|323411746|FG012|Overall Study|Other-Unspecified|0|||
94443973|NCT01894919|323411734|FG000|Overall Study|Lost to Follow-up|0|||
94443974|NCT01894919|323411735|FG001|Overall Study|Lost to Follow-up|0|||
94551019|NCT00306527|323814809|FG000|Overall Study|Withdrawal by Subject|2|||
94551020|NCT00306527|323814810|FG001|Overall Study|Withdrawal by Subject|3|||
94551021|NCT00306527|323814811|FG002|Overall Study|Withdrawal by Subject|0|||
94551022|NCT00306527|323814812|FG003|Overall Study|Withdrawal by Subject|3|||
94551023|NCT00306527|323814809|FG000|Overall Study|Adverse Event|0|||
94551024|NCT00306527|323814810|FG001|Overall Study|Adverse Event|0|||
94551025|NCT00306527|323814811|FG002|Overall Study|Adverse Event|1|||
94551026|NCT00306527|323814812|FG003|Overall Study|Adverse Event|1|||
94551027|NCT00306527|323814809|FG000|Overall Study|Death|1|||
94551028|NCT00306527|323814810|FG001|Overall Study|Death|0|||
94551029|NCT00306527|323814811|FG002|Overall Study|Death|1|||
94551030|NCT00306527|323814812|FG003|Overall Study|Death|2|||
94551031|NCT00528801|323814813|FG000|Overall Study|Withdrawal by Subject|1|||
94551032|NCT00528801|323814814|FG001|Overall Study|Withdrawal by Subject|1|||
94551033|NCT00528801|323814813|FG000|Overall Study|Protocol Violation|11|||
94551034|NCT00528801|323814814|FG001|Overall Study|Protocol Violation|5|||
94551035|NCT00528801|323814813|FG000|Overall Study|Lost to Follow-up|15|||
94551036|NCT00528801|323814814|FG001|Overall Study|Lost to Follow-up|4|||
94551037|NCT00528801|323814813|FG000|Overall Study|Administrative Reasons|0|||
94551038|NCT00528801|323814814|FG001|Overall Study|Administrative Reasons|1|||
94551039|NCT01306656|323814815|FG000|Overall Study|Lost to Follow-up|1|||
94551040|NCT01306656|323814816|FG001|Overall Study|Lost to Follow-up|0|||
94551041|NCT00679172|323814819|FG000|Overall Study|Non-compliance|1|||
94551042|NCT00679172|323814820|FG001|Overall Study|Non-compliance|1|||
94551043|NCT00679172|323814821|FG002|Overall Study|Non-compliance|0|||
94342536|NCT03887052|323035889|FG000|Overall Study|Withdrawal by Subject|3|||
94342537|NCT03887052|323035889|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
94342538|NCT03887052|323035889|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
94342539|NCT02365506|323035891|FG000|Overall Study|Investigator's Discretion|0|||
94342540|NCT02365506|323035892|FG001|Overall Study|Investigator's Discretion|0|||
94342541|NCT02365506|323035893|FG002|Overall Study|Investigator's Discretion|1|||
94342542|NCT01440972|323035896|FG000|Overall Study|Withdrawal by Subject|3|||
94342543|NCT01440972|323035897|FG001|Overall Study|Withdrawal by Subject|2|||
94342544|NCT01680991|323035898|FG000|Overall Study|Adverse Event|1|||
94342545|NCT01680991|323035899|FG001|Overall Study|Adverse Event|0|||
94342546|NCT01680991|323035900|FG002|Overall Study|Adverse Event|0|||
94342547|NCT01680991|323035898|FG000|Overall Study|Death|1|||
94342548|NCT01680991|323035899|FG001|Overall Study|Death|0|||
94342549|NCT01680991|323035900|FG002|Overall Study|Death|1|||
94342550|NCT01680991|323035898|FG000|Overall Study|Protocol Violation|0|||
94342551|NCT01680991|323035899|FG001|Overall Study|Protocol Violation|1|||
94342552|NCT01680991|323035900|FG002|Overall Study|Protocol Violation|0|||
94342553|NCT01680991|323035898|FG000|Overall Study|Withdrawal by Subject|5|||
94342554|NCT01680991|323035899|FG001|Overall Study|Withdrawal by Subject|1|||
94342555|NCT01680991|323035900|FG002|Overall Study|Withdrawal by Subject|0|||
94342556|NCT01680991|323035898|FG000|Overall Study|Progressive disease (PD)|0|||
94342557|NCT01680991|323035899|FG001|Overall Study|Progressive disease (PD)|10|||
94342558|NCT01680991|323035900|FG002|Overall Study|Progressive disease (PD)|0|||
94342559|NCT01680991|323035898|FG000|Overall Study|Physician Decision|0|||
94342560|NCT01680991|323035899|FG001|Overall Study|Physician Decision|7|||
94342561|NCT01680991|323035900|FG002|Overall Study|Physician Decision|2|||
94342562|NCT01680991|323035898|FG000|Overall Study|Bad physical condition|0|||
94342563|NCT01680991|323035899|FG001|Overall Study|Bad physical condition|0|||
94342564|NCT01680991|323035900|FG002|Overall Study|Bad physical condition|1|||
94342565|NCT01680991|323035898|FG000|Overall Study|PD confirmed in other hospital|1|||
94342566|NCT01680991|323035899|FG001|Overall Study|PD confirmed in other hospital|0|||
94342567|NCT01680991|323035900|FG002|Overall Study|PD confirmed in other hospital|0|||
94342568|NCT05049122|323035901|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
94342569|NCT05049122|323035901|FG000|Overall Study|Participant moved|1|||
94342570|NCT05049122|323035901|FG000|Overall Study|At the direction of the doctor|1|||
94342571|NCT02352090|323035902|FG000|Overall Study|general malaise|1|||
94342572|NCT02352090|323035903|FG001|Overall Study|general malaise|0|||
94342573|NCT02352090|323035904|FG002|Overall Study|general malaise|0|||
94342574|NCT02352090|323035902|FG000|Overall Study|non-specified mild side-effects|0|||
94342575|NCT02352090|323035903|FG001|Overall Study|non-specified mild side-effects|0|||
94342576|NCT02352090|323035904|FG002|Overall Study|non-specified mild side-effects|2|||
94342577|NCT03687827|323035905|FG000|Treatment Period 1|Death|0|||
94342578|NCT03687827|323035906|FG001|Treatment Period 1|Death|1|||
94342579|NCT03687827|323035905|FG000|Treatment Period 1|Lost to Follow-up|2|||
94342580|NCT03687827|323035906|FG001|Treatment Period 1|Lost to Follow-up|2|||
94342581|NCT03687827|323035905|FG000|Treatment Period 1|Physician Decision|5|||
94342582|NCT03687827|323035906|FG001|Treatment Period 1|Physician Decision|2|||
94342583|NCT03687827|323035905|FG000|Treatment Period 1|Withdrawal by Subject|7|||
94342584|NCT03687827|323035906|FG001|Treatment Period 1|Withdrawal by Subject|3|||
94342585|NCT03687827|323035905|FG000|Treatment Period 2|Physician Decision|4|||
94342586|NCT03687827|323035906|FG001|Treatment Period 2|Physician Decision|1|||
94342587|NCT03687827|323035905|FG000|Treatment Period 2|Withdrawal by Subject|1|||
94342588|NCT03687827|323035906|FG001|Treatment Period 2|Withdrawal by Subject|2|||
94342589|NCT00068822|323035907|FG000|First Randomized Intervention|Lost to Follow-up|1|||
94551044|NCT00679172|323814822|FG003|Overall Study|Non-compliance|1|||
94551045|NCT00679172|323814823|FG004|Overall Study|Non-compliance|0|||
94342590|NCT00068822|323035908|FG001|First Randomized Intervention|Lost to Follow-up|2|||
94342591|NCT00610714|323035911|FG000|Overall Study|Adverse Event|3|||
94551046|NCT00679172|323814819|FG000|Overall Study|Other not specified|0|||
94551047|NCT00679172|323814820|FG001|Overall Study|Other not specified|0|||
94551048|NCT00679172|323814821|FG002|Overall Study|Other not specified|1|||
94551049|NCT00679172|323814822|FG003|Overall Study|Other not specified|0|||
94551050|NCT00679172|323814823|FG004|Overall Study|Other not specified|0|||
94551051|NCT00387725|323814826|FG000|Overall Study|Adverse Event|0|||
94551052|NCT00387725|323814827|FG001|Overall Study|Adverse Event|0|||
94551053|NCT00387725|323814828|FG002|Overall Study|Adverse Event|0|||
94551054|NCT00387725|323814829|FG003|Overall Study|Adverse Event|1|||
94551055|NCT00387725|323814826|FG000|Overall Study|Protocol Violation|0|||
94551056|NCT00387725|323814827|FG001|Overall Study|Protocol Violation|1|||
94551057|NCT00387725|323814828|FG002|Overall Study|Protocol Violation|0|||
94551058|NCT00387725|323814829|FG003|Overall Study|Protocol Violation|0|||
94551059|NCT00387725|323814826|FG000|Overall Study|Withdrawal by Subject|1|||
94551060|NCT00387725|323814827|FG001|Overall Study|Withdrawal by Subject|0|||
94551061|NCT00387725|323814828|FG002|Overall Study|Withdrawal by Subject|1|||
94551062|NCT00387725|323814829|FG003|Overall Study|Withdrawal by Subject|0|||
94551063|NCT00387725|323814826|FG000|Overall Study|Parent/legal guardian request|0|||
94551064|NCT00387725|323814827|FG001|Overall Study|Parent/legal guardian request|0|||
94551065|NCT00387725|323814828|FG002|Overall Study|Parent/legal guardian request|1|||
94551066|NCT00387725|323814829|FG003|Overall Study|Parent/legal guardian request|1|||
94551067|NCT01918332|323814830|FG000|Overall Study|Adverse Event|0|||
94551068|NCT01918332|323814831|FG001|Overall Study|Adverse Event|0|||
94551069|NCT01918332|323814832|FG002|Overall Study|Adverse Event|0|||
94551070|NCT01918332|323814833|FG003|Overall Study|Adverse Event|1|||
94551071|NCT01918332|323814830|FG000|Overall Study|Withdrawal by Subject|2|||
94551072|NCT01918332|323814831|FG001|Overall Study|Withdrawal by Subject|3|||
94551073|NCT01918332|323814832|FG002|Overall Study|Withdrawal by Subject|2|||
94551074|NCT01918332|323814833|FG003|Overall Study|Withdrawal by Subject|3|||
94551075|NCT01918332|323814830|FG000|Overall Study|Protocol Violation|6|||
94551076|NCT01918332|323814831|FG001|Overall Study|Protocol Violation|2|||
94551077|NCT01918332|323814832|FG002|Overall Study|Protocol Violation|6|||
94551078|NCT01918332|323814833|FG003|Overall Study|Protocol Violation|3|||
94551079|NCT01918332|323814830|FG000|Overall Study|lipid result by central lab did not meet|0|||
94551080|NCT01918332|323814831|FG001|Overall Study|lipid result by central lab did not meet|0|||
94551081|NCT01918332|323814832|FG002|Overall Study|lipid result by central lab did not meet|1|||
94551082|NCT01918332|323814833|FG003|Overall Study|lipid result by central lab did not meet|0|||
94551083|NCT02905006|323814834|FG000|Overall Study|Adverse Event|1|||
94551084|NCT02905006|323814835|FG001|Overall Study|Adverse Event|1|||
94551085|NCT02905006|323814836|FG002|Overall Study|Adverse Event|1|||
94551086|NCT02905006|323814837|FG003|Overall Study|Adverse Event|1|||
94551087|NCT02905006|323814838|FG004|Overall Study|Adverse Event|0|||
94551088|NCT02905006|323814839|FG005|Overall Study|Adverse Event|1|||
94551089|NCT02905006|323814834|FG000|Overall Study|Lack of Efficacy|1|||
94551090|NCT02905006|323814835|FG001|Overall Study|Lack of Efficacy|0|||
94551091|NCT02905006|323814836|FG002|Overall Study|Lack of Efficacy|0|||
94551092|NCT02905006|323814837|FG003|Overall Study|Lack of Efficacy|0|||
94551093|NCT02905006|323814838|FG004|Overall Study|Lack of Efficacy|0|||
94551094|NCT02905006|323814839|FG005|Overall Study|Lack of Efficacy|0|||
94551095|NCT02905006|323814834|FG000|Overall Study|Protocol Violation|2|||
94551096|NCT02905006|323814835|FG001|Overall Study|Protocol Violation|0|||
94551097|NCT02905006|323814836|FG002|Overall Study|Protocol Violation|0|||
94551098|NCT02905006|323814837|FG003|Overall Study|Protocol Violation|0|||
94551099|NCT02905006|323814838|FG004|Overall Study|Protocol Violation|0|||
94551100|NCT02905006|323814839|FG005|Overall Study|Protocol Violation|0|||
94551101|NCT02905006|323814834|FG000|Overall Study|Lost to Follow-up|0|||
94551102|NCT02905006|323814835|FG001|Overall Study|Lost to Follow-up|0|||
94551103|NCT02905006|323814836|FG002|Overall Study|Lost to Follow-up|0|||
94551104|NCT02905006|323814837|FG003|Overall Study|Lost to Follow-up|1|||
94551105|NCT02905006|323814838|FG004|Overall Study|Lost to Follow-up|1|||
94551106|NCT02905006|323814839|FG005|Overall Study|Lost to Follow-up|0|||
94551107|NCT02905006|323814834|FG000|Overall Study|Withdrawal by Subject|0|||
94551108|NCT02905006|323814835|FG001|Overall Study|Withdrawal by Subject|0|||
94551109|NCT02905006|323814836|FG002|Overall Study|Withdrawal by Subject|1|||
94551110|NCT02905006|323814837|FG003|Overall Study|Withdrawal by Subject|1|||
94551111|NCT02905006|323814838|FG004|Overall Study|Withdrawal by Subject|0|||
94551112|NCT02905006|323814839|FG005|Overall Study|Withdrawal by Subject|1|||
94551113|NCT02905006|323814834|FG000|Overall Study|Screening exclusion criteria met|1|||
94551114|NCT02905006|323814835|FG001|Overall Study|Screening exclusion criteria met|0|||
94551115|NCT02905006|323814836|FG002|Overall Study|Screening exclusion criteria met|0|||
94551116|NCT02905006|323814837|FG003|Overall Study|Screening exclusion criteria met|0|||
94551117|NCT02905006|323814838|FG004|Overall Study|Screening exclusion criteria met|0|||
94551118|NCT02905006|323814839|FG005|Overall Study|Screening exclusion criteria met|0|||
94551119|NCT02905006|323814834|FG000|Overall Study|Lab withdrawal criterion met|0|||
94551120|NCT02905006|323814835|FG001|Overall Study|Lab withdrawal criterion met|1|||
94551121|NCT02905006|323814836|FG002|Overall Study|Lab withdrawal criterion met|2|||
94551122|NCT02905006|323814837|FG003|Overall Study|Lab withdrawal criterion met|2|||
94551123|NCT02905006|323814838|FG004|Overall Study|Lab withdrawal criterion met|2|||
94551124|NCT02905006|323814839|FG005|Overall Study|Lab withdrawal criterion met|1|||
94551125|NCT02905006|323814834|FG000|Overall Study|Positive for Tuberculosis|0|||
94551126|NCT02905006|323814835|FG001|Overall Study|Positive for Tuberculosis|1|||
94551127|NCT02905006|323814836|FG002|Overall Study|Positive for Tuberculosis|0|||
94551128|NCT02905006|323814837|FG003|Overall Study|Positive for Tuberculosis|0|||
94551129|NCT02905006|323814838|FG004|Overall Study|Positive for Tuberculosis|0|||
94551130|NCT02905006|323814839|FG005|Overall Study|Positive for Tuberculosis|0|||
94551131|NCT02905006|323814834|FG000|Overall Study|Subject positive for Hep B|0|||
94342592|NCT00610714|323035912|FG001|Overall Study|Adverse Event|1|||
94342593|NCT00610714|323035911|FG000|Overall Study|Death|12|||
94342594|NCT00610714|323035912|FG001|Overall Study|Death|18|||
94342595|NCT00610714|323035911|FG000|Overall Study|Withdrawal by Subject|9|||
94342596|NCT00610714|323035912|FG001|Overall Study|Withdrawal by Subject|3|||
94342597|NCT00610714|323035911|FG000|Overall Study|Study completion at 120 PFS events|2|||
94342598|NCT00610714|323035912|FG001|Overall Study|Study completion at 120 PFS events|2|||
94342599|NCT00735072|323035913|FG000|Overall Study|interrupted study med during ARV change|1|||
94342600|NCT00735072|323035914|FG001|Overall Study|interrupted study med during ARV change|0|||
94342601|NCT00735072|323035913|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
94342602|NCT00735072|323035914|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
94342603|NCT00413777|323035916|FG000|Fixed-dose Period|Lost to Follow-up|1|||
94342604|NCT00413777|323035917|FG001|Fixed-dose Period|Lost to Follow-up|1|||
94342605|NCT00413777|323035916|FG000|Fixed-dose Period|Adverse Event|2|||
94342606|NCT00413777|323035917|FG001|Fixed-dose Period|Adverse Event|1|||
94342607|NCT00413777|323035916|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
94342608|NCT00413777|323035917|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
94342609|NCT00413777|323035916|FG000|Fixed-dose Period|Withdrew Consent|0|||
94342610|NCT00413777|323035917|FG001|Fixed-dose Period|Withdrew Consent|1|||
94342611|NCT03287830|323035922|FG000|Overall Study|Withdrawal by Subject|1|||
94342612|NCT03287830|323035923|FG001|Overall Study|Withdrawal by Subject|1|||
94342613|NCT03287830|323035922|FG000|Overall Study|not meeting inclusion criteria|5|||
94342614|NCT03287830|323035923|FG001|Overall Study|not meeting inclusion criteria|12|||
94342615|NCT01131130|323035924|FG000|Period 1 - Baseline|Pregnancy|1|||
94342616|NCT01131130|323035924|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
94342617|NCT00621244|323035926|FG000|Overall Study|Withdrawal by Subject|7|||
94342618|NCT00621244|323035927|FG001|Overall Study|Withdrawal by Subject|3|||
94342619|NCT00621244|323035928|FG002|Overall Study|Withdrawal by Subject|3|||
94342620|NCT00621244|323035929|FG003|Overall Study|Withdrawal by Subject|3|||
94342621|NCT00621244|323035926|FG000|Overall Study|Disease progression|44|||
94342622|NCT00621244|323035927|FG001|Overall Study|Disease progression|20|||
94342623|NCT00621244|323035928|FG002|Overall Study|Disease progression|20|||
94342624|NCT00621244|323035929|FG003|Overall Study|Disease progression|15|||
94342625|NCT00621244|323035926|FG000|Overall Study|Death|3|||
94342626|NCT00621244|323035927|FG001|Overall Study|Death|3|||
94342627|NCT00621244|323035928|FG002|Overall Study|Death|1|||
94342628|NCT00621244|323035929|FG003|Overall Study|Death|1|||
94342629|NCT00621244|323035926|FG000|Overall Study|Adverse Event|27|||
94342630|NCT00621244|323035927|FG001|Overall Study|Adverse Event|7|||
94342631|NCT00621244|323035928|FG002|Overall Study|Adverse Event|9|||
94342632|NCT00621244|323035929|FG003|Overall Study|Adverse Event|2|||
94342633|NCT00621244|323035926|FG000|Overall Study|Administrative problems|5|||
94342634|NCT00621244|323035927|FG001|Overall Study|Administrative problems|1|||
94443975|NCT01894919|323411736|FG002|Overall Study|Lost to Follow-up|0|||
94443976|NCT01894919|323411737|FG003|Overall Study|Lost to Follow-up|0|||
94443977|NCT01894919|323411738|FG004|Overall Study|Lost to Follow-up|2|||
94443978|NCT01894919|323411739|FG005|Overall Study|Lost to Follow-up|0|||
94443979|NCT01894919|323411740|FG006|Overall Study|Lost to Follow-up|0|||
94443980|NCT01894919|323411741|FG007|Overall Study|Lost to Follow-up|0|||
94443981|NCT01894919|323411742|FG008|Overall Study|Lost to Follow-up|0|||
94443982|NCT01894919|323411743|FG009|Overall Study|Lost to Follow-up|0|||
94443983|NCT01894919|323411744|FG010|Overall Study|Lost to Follow-up|0|||
94443984|NCT01894919|323411745|FG011|Overall Study|Lost to Follow-up|0|||
94443985|NCT01894919|323411746|FG012|Overall Study|Lost to Follow-up|0|||
94443986|NCT02075203|323411747|FG000|Overall Study|Withdrawal by Subject|1|||
94443987|NCT02075203|323411748|FG001|Overall Study|Withdrawal by Subject|0|||
94443988|NCT02075203|323411749|FG002|Overall Study|Withdrawal by Subject|1|||
94443989|NCT02075203|323411747|FG000|Overall Study|Adverse Event|1|||
94443990|NCT02075203|323411748|FG001|Overall Study|Adverse Event|0|||
94443991|NCT02075203|323411749|FG002|Overall Study|Adverse Event|0|||
94443992|NCT02075203|323411747|FG000|Overall Study|participant refused to use contraception|1|||
94443993|NCT02075203|323411748|FG001|Overall Study|participant refused to use contraception|0|||
94443994|NCT02075203|323411749|FG002|Overall Study|participant refused to use contraception|0|||
94443995|NCT01433471|323411750|FG000|Overall Study|Withdrawal by Subject|0|||
94342635|NCT00621244|323035928|FG002|Overall Study|Administrative problems|0|||
94342636|NCT00621244|323035929|FG003|Overall Study|Administrative problems|2|||
94342637|NCT03152110|323035936|FG000|Overall Study|Withdrawal by Subject|3|||
94342638|NCT02447952|323035937|FG000|Overall Study|Adverse Event|2|||
94342639|NCT02447952|323035937|FG000|Overall Study|Physician Decision|1|||
94551132|NCT02905006|323814835|FG001|Overall Study|Subject positive for Hep B|0|||
94551133|NCT02905006|323814836|FG002|Overall Study|Subject positive for Hep B|1|||
94551134|NCT02905006|323814837|FG003|Overall Study|Subject positive for Hep B|0|||
94551135|NCT02905006|323814838|FG004|Overall Study|Subject positive for Hep B|0|||
94551136|NCT02905006|323814839|FG005|Overall Study|Subject positive for Hep B|0|||
94551137|NCT02905006|323814834|FG000|Overall Study|Patient moved abroad|0|||
94551138|NCT02905006|323814835|FG001|Overall Study|Patient moved abroad|0|||
94551139|NCT02905006|323814836|FG002|Overall Study|Patient moved abroad|0|||
94551140|NCT02905006|323814837|FG003|Overall Study|Patient moved abroad|1|||
94551141|NCT02905006|323814838|FG004|Overall Study|Patient moved abroad|0|||
94551142|NCT02905006|323814839|FG005|Overall Study|Patient moved abroad|0|||
94551143|NCT02905006|323814834|FG000|Overall Study|Patient randomized by mistake|0|||
94551144|NCT02905006|323814835|FG001|Overall Study|Patient randomized by mistake|0|||
94551145|NCT02905006|323814836|FG002|Overall Study|Patient randomized by mistake|0|||
94551146|NCT02905006|323814837|FG003|Overall Study|Patient randomized by mistake|0|||
94551147|NCT02905006|323814838|FG004|Overall Study|Patient randomized by mistake|0|||
94551148|NCT02905006|323814839|FG005|Overall Study|Patient randomized by mistake|1|||
94551149|NCT02429791|323814842|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
94342640|NCT02447952|323035937|FG000|Overall Study|Withdrawal by Subject|4|||
94342641|NCT02253992|323035947|FG000|Overall Study|Study drug toxicity|1|||
94342642|NCT02253992|323035948|FG001|Overall Study|Study drug toxicity|0|||
94342643|NCT02253992|323035949|FG002|Overall Study|Study drug toxicity|10|||
94551150|NCT02429791|323814843|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
94551151|NCT02429791|323814842|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
94551152|NCT02429791|323814843|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
94551153|NCT02429791|323814842|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
94551154|NCT02429791|323814843|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
94551155|NCT02429791|323814842|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
94342644|NCT02253992|323035947|FG000|Overall Study|Disease progression|4|||
94342645|NCT02253992|323035948|FG001|Overall Study|Disease progression|3|||
94342646|NCT02253992|323035949|FG002|Overall Study|Disease progression|98|||
94342647|NCT02253992|323035947|FG000|Overall Study|Withdrawal by Subject|0|||
94342648|NCT02253992|323035948|FG001|Overall Study|Withdrawal by Subject|0|||
94342649|NCT02253992|323035949|FG002|Overall Study|Withdrawal by Subject|3|||
94342650|NCT02253992|323035947|FG000|Overall Study|Adverse Event|0|||
94342651|NCT02253992|323035948|FG001|Overall Study|Adverse Event|0|||
94342652|NCT02253992|323035949|FG002|Overall Study|Adverse Event|8|||
94342653|NCT02253992|323035947|FG000|Overall Study|Death|0|||
94342654|NCT02253992|323035948|FG001|Overall Study|Death|0|||
94342655|NCT02253992|323035949|FG002|Overall Study|Death|1|||
94342656|NCT02253992|323035947|FG000|Overall Study|Subject discontinued study drug|1|||
94342657|NCT02253992|323035948|FG001|Overall Study|Subject discontinued study drug|0|||
94342658|NCT02253992|323035949|FG002|Overall Study|Subject discontinued study drug|1|||
94342659|NCT02253992|323035947|FG000|Overall Study|Completed treatment as per protocol|0|||
94342660|NCT02253992|323035948|FG001|Overall Study|Completed treatment as per protocol|1|||
94342661|NCT02253992|323035949|FG002|Overall Study|Completed treatment as per protocol|22|||
94342662|NCT02253992|323035947|FG000|Overall Study|Other|0|||
94342663|NCT02253992|323035948|FG001|Overall Study|Other|0|||
94342664|NCT02253992|323035949|FG002|Overall Study|Other|1|||
94342665|NCT01634100|323035950|FG000|Overall Study|Withdrawal by Subject|1|||
94342666|NCT01634100|323035951|FG001|Overall Study|Withdrawal by Subject|0|||
94342667|NCT01634100|323035952|FG002|Overall Study|Withdrawal by Subject|1|||
94342668|NCT01634100|323035953|FG003|Overall Study|Withdrawal by Subject|0|||
94342669|NCT01634100|323035954|FG004|Overall Study|Withdrawal by Subject|0|||
94342670|NCT01634100|323035955|FG005|Overall Study|Withdrawal by Subject|0|||
94342671|NCT00338806|323035956|FG000|Acute Phase|Withdrawal by Subject|0|||
94342672|NCT00338806|323035957|FG001|Acute Phase|Withdrawal by Subject|1|||
94342673|NCT00338806|323035956|FG000|Follow-up|Lost to Follow-up|1|||
94342674|NCT00338806|323035957|FG001|Follow-up|Lost to Follow-up|3|||
94342675|NCT00772889|323035958|FG000|Overall Study|Adverse Event|7|||
94342676|NCT00772889|323035959|FG001|Overall Study|Adverse Event|4|||
94342677|NCT00772889|323035960|FG002|Overall Study|Adverse Event|0|||
94342678|NCT00772889|323035958|FG000|Overall Study|Withdrawal by Subject|9|||
94342679|NCT00772889|323035959|FG001|Overall Study|Withdrawal by Subject|8|||
94342680|NCT00772889|323035960|FG002|Overall Study|Withdrawal by Subject|9|||
94551156|NCT02429791|323814843|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
94551157|NCT02429791|323814842|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
94551158|NCT02429791|323814843|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
94342681|NCT00772889|323035958|FG000|Overall Study|Lost to Follow-up|6|||
94342682|NCT00772889|323035959|FG001|Overall Study|Lost to Follow-up|6|||
94342683|NCT00772889|323035960|FG002|Overall Study|Lost to Follow-up|7|||
94342684|NCT03323086|323035961|FG000|Overall Study|Lost to Follow-up|3|||
94342685|NCT03323086|323035962|FG001|Overall Study|Lost to Follow-up|2|||
94443996|NCT01433471|323411751|FG001|Overall Study|Withdrawal by Subject|1|||
94443997|NCT03711188|323411752|FG000|Overall Study|Disease progression|11|||
94443998|NCT03711188|323411752|FG000|Overall Study|Adverse Event|1|||
94443999|NCT03214224|323411753|FG000|Overall Study|Protocol Violation|1|||
94444000|NCT03214224|323411753|FG000|Overall Study|Withdrawal by Subject|2|||
94444001|NCT03214224|323411753|FG000|Overall Study|Practice controls or therapists|6|||
94444002|NCT01269918|323411754|FG000|Overall Study|Did not receive study drug|0|||
94444003|NCT01269918|323411755|FG001|Overall Study|Did not receive study drug|3|||
94444004|NCT00856193|323411759|FG000|Period 2|Abnormal test procedure results|0|||
94444005|NCT00856193|323411760|FG001|Period 2|Abnormal test procedure results|1|||
94444006|NCT00856193|323411759|FG000|Period 2|Lost to Follow-up|0|||
94444007|NCT00856193|323411760|FG001|Period 2|Lost to Follow-up|1|||
94444008|NCT04341363|323411762|FG000|Overall Study|Adverse Event|1|||
94444009|NCT04341363|323411762|FG000|Overall Study|Withdrawal by Subject|1|||
94444010|NCT03652051|323411763|FG000|Stage 1|Adverse Event|0|||
94444011|NCT03652051|323411764|FG001|Stage 1|Adverse Event|5|||
94444012|NCT03652051|323411765|FG002|Stage 1|Adverse Event|7|||
94444013|NCT03652051|323411766|FG003|Stage 1|Adverse Event|1|||
94444014|NCT03652051|323411763|FG000|Stage 1|Withdrawal by Subject|0|||
94444015|NCT03652051|323411764|FG001|Stage 1|Withdrawal by Subject|0|||
94444016|NCT03652051|323411765|FG002|Stage 1|Withdrawal by Subject|1|||
94444017|NCT03652051|323411766|FG003|Stage 1|Withdrawal by Subject|0|||
94444018|NCT03652051|323411763|FG000|Stage 2|Adverse Event|0|||
94444019|NCT03652051|323411764|FG001|Stage 2|Adverse Event|2|||
94444020|NCT03652051|323411765|FG002|Stage 2|Adverse Event|1|||
94551159|NCT02429791|323814842|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
94551160|NCT02429791|323814843|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
94551161|NCT02429791|323814842|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
94551162|NCT02429791|323814843|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
94551163|NCT02429791|323814842|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
94551164|NCT02429791|323814843|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
94551165|NCT02429791|323814842|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
94444021|NCT03652051|323411766|FG003|Stage 2|Adverse Event|0|||
94444022|NCT03652051|323411763|FG000|Stage 2|Protocol Violation|0|||
94444023|NCT03652051|323411764|FG001|Stage 2|Protocol Violation|1|||
94444024|NCT03652051|323411765|FG002|Stage 2|Protocol Violation|6|||
94551166|NCT02429791|323814843|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
94551167|NCT02429791|323814842|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
94551168|NCT02429791|323814843|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
94551169|NCT02429791|323814842|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
94551170|NCT02429791|323814843|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
94551171|NCT02429791|323814842|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
94551172|NCT02429791|323814843|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
94551173|NCT02429791|323814842|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
94551174|NCT02429791|323814843|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
94551175|NCT02429791|323814842|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
94551176|NCT02429791|323814843|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
94551177|NCT02429791|323814842|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
94551178|NCT02429791|323814843|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
94551179|NCT02429791|323814842|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
94551180|NCT02429791|323814843|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
94551181|NCT02429791|323814842|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
94551182|NCT02429791|323814843|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
94551183|NCT02429791|323814842|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
94551184|NCT02429791|323814843|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
94551185|NCT00881504|323814844|FG000|Overall Study|Withdrawal by Subject|1|||
94551186|NCT00007020|323814845|FG000|Overall Study|Death|16|||
94551187|NCT00007020|323814845|FG000|Overall Study|Lost to Follow-up|13|||
94551188|NCT00007020|323814845|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
94551189|NCT00007020|323814845|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
94551190|NCT00007020|323814845|FG000|Overall Study|Pt cared for by outside physician|4|||
94551191|NCT00007020|323814845|FG000|Overall Study|No evidence of treatment|6|||
94342686|NCT04259346|323035965|FG000|Overall Study|Lost to Follow-up|1|||
94342687|NCT04259346|323035966|FG001|Overall Study|Lost to Follow-up|3|||
94342688|NCT04259346|323035965|FG000|Overall Study|Protocol Violation|1|||
94342689|NCT04259346|323035966|FG001|Overall Study|Protocol Violation|0|||
94342690|NCT04259346|323035965|FG000|Overall Study|Withdrawal by Subject|1|||
94342691|NCT04259346|323035966|FG001|Overall Study|Withdrawal by Subject|0|||
94342692|NCT04259346|323035965|FG000|Overall Study|Adverse Event|1|||
94342693|NCT04259346|323035966|FG001|Overall Study|Adverse Event|1|||
94342694|NCT00085644|323035974|FG000|Double-Blind Period|Adverse Event|5|||
94342695|NCT00085644|323035975|FG001|Double-Blind Period|Adverse Event|2|||
94342696|NCT00085644|323035976|FG002|Double-Blind Period|Adverse Event|0|||
94342697|NCT00085644|323035974|FG000|Double-Blind Period|Withdrawal by Subject|3|||
94342698|NCT00085644|323035975|FG001|Double-Blind Period|Withdrawal by Subject|0|||
94342699|NCT00085644|323035976|FG002|Double-Blind Period|Withdrawal by Subject|0|||
94342700|NCT00085644|323035974|FG000|Double-Blind Period|Lost to Follow-up|2|||
94342701|NCT00085644|323035975|FG001|Double-Blind Period|Lost to Follow-up|1|||
94342702|NCT00085644|323035976|FG002|Double-Blind Period|Lost to Follow-up|0|||
94342703|NCT00085644|323035974|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
94342704|NCT00085644|323035975|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
94342705|NCT00085644|323035976|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
94342706|NCT00085644|323035974|FG000|Double-Blind Period|Contemplating pregnancy|1|||
94342707|NCT00085644|323035975|FG001|Double-Blind Period|Contemplating pregnancy|0|||
94342708|NCT00085644|323035976|FG002|Double-Blind Period|Contemplating pregnancy|0|||
94342709|NCT00085644|323035974|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
94342710|NCT00085644|323035975|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
94342711|NCT00085644|323035976|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
94342712|NCT00085644|323035974|FG000|Open-Label Period|Adverse Event|0|||
94342713|NCT00085644|323035975|FG001|Open-Label Period|Adverse Event|0|||
94342714|NCT00085644|323035976|FG002|Open-Label Period|Adverse Event|38|||
94342715|NCT00085644|323035974|FG000|Open-Label Period|Withdrawal by Subject|0|||
94342716|NCT00085644|323035975|FG001|Open-Label Period|Withdrawal by Subject|0|||
94342717|NCT00085644|323035976|FG002|Open-Label Period|Withdrawal by Subject|29|||
94342718|NCT00085644|323035974|FG000|Open-Label Period|Lost to Follow-up|0|||
94342719|NCT00085644|323035975|FG001|Open-Label Period|Lost to Follow-up|0|||
94342720|NCT00085644|323035976|FG002|Open-Label Period|Lost to Follow-up|13|||
94342721|NCT00085644|323035974|FG000|Open-Label Period|Lack of Efficacy|0|||
94342722|NCT00085644|323035975|FG001|Open-Label Period|Lack of Efficacy|0|||
94342723|NCT00085644|323035976|FG002|Open-Label Period|Lack of Efficacy|15|||
94342724|NCT00085644|323035974|FG000|Open-Label Period|Pregnancy|0|||
94342725|NCT00085644|323035975|FG001|Open-Label Period|Pregnancy|0|||
94342726|NCT00085644|323035976|FG002|Open-Label Period|Pregnancy|3|||
94342727|NCT00085644|323035974|FG000|Open-Label Period|Contemplating pregnancy|0|||
94342728|NCT00085644|323035975|FG001|Open-Label Period|Contemplating pregnancy|0|||
94342729|NCT00085644|323035976|FG002|Open-Label Period|Contemplating pregnancy|3|||
94342730|NCT00085644|323035974|FG000|Open-Label Period|Protocol Violation|0|||
94551192|NCT00802893|323814846|FG000|Overall Study|study terminated|3|||
94551193|NCT02868229|323814847|FG000|Overall Study|Adverse Event|1|||
94551194|NCT02868229|323814848|FG001|Overall Study|Adverse Event|0|||
94551195|NCT02868229|323814849|FG002|Overall Study|Adverse Event|0|||
94551196|NCT02868229|323814850|FG003|Overall Study|Adverse Event|1|||
94551197|NCT02868229|323814847|FG000|Overall Study|Death|0|||
94551198|NCT02868229|323814848|FG001|Overall Study|Death|0|||
94551199|NCT02868229|323814849|FG002|Overall Study|Death|1|||
94551200|NCT02868229|323814850|FG003|Overall Study|Death|1|||
94551201|NCT02868229|323814847|FG000|Overall Study|Missed dose|0|||
94551202|NCT02868229|323814848|FG001|Overall Study|Missed dose|0|||
94551203|NCT02868229|323814849|FG002|Overall Study|Missed dose|0|||
94551204|NCT02868229|323814850|FG003|Overall Study|Missed dose|3|||
94551205|NCT00680368|323814854|FG000|Overall Study|not supervised, not eligible|15|||
94551206|NCT00483041|323814855|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
94551207|NCT00483041|323814856|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
94551208|NCT01716104|323814860|FG000|Overall Study|Do not meet inclusion criteria|6|||
94551209|NCT01716104|323814861|FG001|Overall Study|Do not meet inclusion criteria|7|||
94551210|NCT02565810|323814862|FG000|Overall Study|Withdrawal by Subject|1|||
94551211|NCT00545103|323814865|FG000|Overall Study|Lack of Efficacy|48|||
94551212|NCT00545103|323814866|FG001|Overall Study|Lack of Efficacy|45|||
94551213|NCT00545103|323814867|FG002|Overall Study|Lack of Efficacy|31|||
94551214|NCT00545103|323814868|FG003|Overall Study|Lack of Efficacy|27|||
94551215|NCT00545103|323814865|FG000|Overall Study|Withdrawal by Subject|6|||
94551216|NCT00545103|323814866|FG001|Overall Study|Withdrawal by Subject|10|||
94444025|NCT03652051|323411766|FG003|Stage 2|Protocol Violation|0|||
94444026|NCT03652051|323411763|FG000|Stage 2|Lost to Follow-up|0|||
94444027|NCT03652051|323411764|FG001|Stage 2|Lost to Follow-up|2|||
94444028|NCT03652051|323411765|FG002|Stage 2|Lost to Follow-up|0|||
94444029|NCT03652051|323411766|FG003|Stage 2|Lost to Follow-up|3|||
94444030|NCT03652051|323411763|FG000|Stage 2|Withdrawal by Subject|0|||
94444031|NCT03652051|323411764|FG001|Stage 2|Withdrawal by Subject|11|||
94444032|NCT03652051|323411765|FG002|Stage 2|Withdrawal by Subject|9|||
94444033|NCT03652051|323411766|FG003|Stage 2|Withdrawal by Subject|3|||
94444034|NCT00840749|323411770|FG000|Overall Study|Death|1|||
94444035|NCT00840749|323411771|FG001|Overall Study|Death|2|||
94444036|NCT00840749|323411770|FG000|Overall Study|not treated on study arm|11|||
94444037|NCT00840749|323411771|FG001|Overall Study|not treated on study arm|11|||
94444038|NCT00840749|323411770|FG000|Overall Study|study closed|19|||
94444039|NCT00840749|323411771|FG001|Overall Study|study closed|14|||
94444040|NCT02550561|323411772|FG000|Overall Study|Lost to Follow-up|5|||
94444041|NCT02550561|323411772|FG000|Overall Study|Withdrawal by Subject|1|||
94444042|NCT01113892|323411777|FG000|Overall Study|Lost to Follow-up|2|||
94444043|NCT01113892|323411778|FG001|Overall Study|Lost to Follow-up|2|||
94444044|NCT01113892|323411777|FG000|Overall Study|Withdrawal by Subject|1|||
94444045|NCT01113892|323411778|FG001|Overall Study|Withdrawal by Subject|1|||
94444046|NCT01113892|323411777|FG000|Overall Study|Death|2|||
94444047|NCT01113892|323411778|FG001|Overall Study|Death|4|||
94444048|NCT01113892|323411777|FG000|Overall Study|Graft no longer evaluable|9|||
94444049|NCT01113892|323411778|FG001|Overall Study|Graft no longer evaluable|9|||
94444050|NCT01051960|323411779|FG000|Overall Study|Adverse Event|1|||
94444051|NCT00395629|323411780|FG000|Core Study|Adverse Event|0|||
94444052|NCT00395629|323411781|FG001|Core Study|Adverse Event|3|||
94444053|NCT00395629|323411782|FG002|Core Study|Adverse Event|4|||
94444054|NCT00395629|323411780|FG000|Core Study|Abnormal laboratory value(s)|0|||
94444055|NCT00395629|323411781|FG001|Core Study|Abnormal laboratory value(s)|0|||
94444056|NCT00395629|323411782|FG002|Core Study|Abnormal laboratory value(s)|1|||
94444057|NCT00395629|323411780|FG000|Core Study|Protocol Violation|1|||
94444058|NCT00395629|323411781|FG001|Core Study|Protocol Violation|0|||
94444059|NCT00395629|323411782|FG002|Core Study|Protocol Violation|0|||
94444060|NCT00395629|323411780|FG000|Core Study|Withdrawal by Subject|0|||
94444061|NCT00395629|323411781|FG001|Core Study|Withdrawal by Subject|1|||
94444062|NCT00395629|323411782|FG002|Core Study|Withdrawal by Subject|1|||
94444063|NCT00395629|323411780|FG000|Core Study|Lost to Follow-up|0|||
94444064|NCT00395629|323411781|FG001|Core Study|Lost to Follow-up|0|||
94444065|NCT00395629|323411782|FG002|Core Study|Lost to Follow-up|1|||
94444066|NCT00395629|323411780|FG000|Extension Study|Adverse Event|0|||
94444067|NCT00395629|323411781|FG001|Extension Study|Adverse Event|0|||
94444068|NCT00395629|323411782|FG002|Extension Study|Adverse Event|2|||
94444069|NCT00395629|323411780|FG000|Extension Study|Administrative problems|0|||
94444070|NCT00395629|323411781|FG001|Extension Study|Administrative problems|0|||
94551217|NCT00545103|323814867|FG002|Overall Study|Withdrawal by Subject|18|||
94551218|NCT00545103|323814868|FG003|Overall Study|Withdrawal by Subject|22|||
94551219|NCT00545103|323814865|FG000|Overall Study|Adverse Event|11|||
94551220|NCT00545103|323814866|FG001|Overall Study|Adverse Event|12|||
94551221|NCT00545103|323814867|FG002|Overall Study|Adverse Event|17|||
94551222|NCT00545103|323814868|FG003|Overall Study|Adverse Event|10|||
94551223|NCT00545103|323814865|FG000|Overall Study|Lost to Follow-up|4|||
94551224|NCT00545103|323814866|FG001|Overall Study|Lost to Follow-up|6|||
94551225|NCT00545103|323814867|FG002|Overall Study|Lost to Follow-up|3|||
94551226|NCT00545103|323814868|FG003|Overall Study|Lost to Follow-up|4|||
94551227|NCT00545103|323814865|FG000|Overall Study|Protocol Violation|1|||
94551228|NCT00545103|323814866|FG001|Overall Study|Protocol Violation|2|||
94551229|NCT00545103|323814867|FG002|Overall Study|Protocol Violation|3|||
94551230|NCT00545103|323814868|FG003|Overall Study|Protocol Violation|0|||
94551231|NCT00545103|323814865|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
94551232|NCT00545103|323814866|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
94551233|NCT00545103|323814867|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
94551234|NCT00545103|323814868|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
94551235|NCT00545103|323814865|FG000|Overall Study|Difficult to open package|0|||
94551236|NCT00545103|323814866|FG001|Overall Study|Difficult to open package|0|||
94551237|NCT00545103|323814867|FG002|Overall Study|Difficult to open package|0|||
94551238|NCT00545103|323814868|FG003|Overall Study|Difficult to open package|1|||
94551239|NCT00545103|323814865|FG000|Overall Study|Investigational product not taken|1|||
94551240|NCT00545103|323814866|FG001|Overall Study|Investigational product not taken|0|||
94551241|NCT00545103|323814867|FG002|Overall Study|Investigational product not taken|0|||
94551242|NCT00545103|323814868|FG003|Overall Study|Investigational product not taken|1|||
94551243|NCT00545103|323814865|FG000|Overall Study|Wish to start a family|0|||
94551244|NCT00545103|323814866|FG001|Overall Study|Wish to start a family|0|||
94551245|NCT00545103|323814867|FG002|Overall Study|Wish to start a family|0|||
94551246|NCT00545103|323814868|FG003|Overall Study|Wish to start a family|1|||
94551247|NCT00545103|323814865|FG000|Overall Study|Diverticulitis crisis|0|||
94551248|NCT00545103|323814866|FG001|Overall Study|Diverticulitis crisis|0|||
94551249|NCT00545103|323814867|FG002|Overall Study|Diverticulitis crisis|0|||
94551250|NCT00545103|323814868|FG003|Overall Study|Diverticulitis crisis|1|||
94551251|NCT00545103|323814865|FG000|Overall Study|Personal reasons|1|||
94551252|NCT00545103|323814866|FG001|Overall Study|Personal reasons|0|||
94551253|NCT00545103|323814867|FG002|Overall Study|Personal reasons|0|||
94551254|NCT00545103|323814868|FG003|Overall Study|Personal reasons|0|||
94551255|NCT00545103|323814865|FG000|Overall Study|Subject's decision|1|||
94551256|NCT00545103|323814866|FG001|Overall Study|Subject's decision|0|||
94551257|NCT00545103|323814867|FG002|Overall Study|Subject's decision|0|||
94551258|NCT00545103|323814868|FG003|Overall Study|Subject's decision|0|||
94551259|NCT00545103|323814865|FG000|Overall Study|Noncompliance|0|||
94551260|NCT00545103|323814866|FG001|Overall Study|Noncompliance|1|||
94551261|NCT00545103|323814867|FG002|Overall Study|Noncompliance|0|||
94551262|NCT00545103|323814868|FG003|Overall Study|Noncompliance|0|||
94551263|NCT00545103|323814865|FG000|Overall Study|Investigator decision|0|||
94551264|NCT00545103|323814866|FG001|Overall Study|Investigator decision|0|||
94551265|NCT00545103|323814867|FG002|Overall Study|Investigator decision|1|||
94551266|NCT00545103|323814868|FG003|Overall Study|Investigator decision|0|||
94551267|NCT00545103|323814865|FG000|Overall Study|Subject moved|0|||
94551268|NCT00545103|323814866|FG001|Overall Study|Subject moved|1|||
94551269|NCT00545103|323814867|FG002|Overall Study|Subject moved|0|||
94551270|NCT00545103|323814868|FG003|Overall Study|Subject moved|0|||
94551271|NCT00545103|323814865|FG000|Overall Study|Use of prohibited medication|0|||
94551272|NCT00545103|323814866|FG001|Overall Study|Use of prohibited medication|0|||
94551273|NCT00545103|323814867|FG002|Overall Study|Use of prohibited medication|1|||
94551274|NCT00545103|323814868|FG003|Overall Study|Use of prohibited medication|0|||
94551275|NCT00545103|323814865|FG000|Overall Study|Does not want to take study drug anymore|1|||
94551276|NCT00545103|323814866|FG001|Overall Study|Does not want to take study drug anymore|0|||
94551277|NCT00545103|323814867|FG002|Overall Study|Does not want to take study drug anymore|1|||
94551278|NCT00545103|323814868|FG003|Overall Study|Does not want to take study drug anymore|0|||
94551279|NCT00545103|323814865|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
94551280|NCT00545103|323814866|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
94551281|NCT00545103|323814867|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
94551282|NCT00545103|323814868|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
94551283|NCT00545103|323814865|FG000|Overall Study|Death|0|||
94551284|NCT00545103|323814866|FG001|Overall Study|Death|1|||
94551285|NCT00545103|323814867|FG002|Overall Study|Death|0|||
94551286|NCT00545103|323814868|FG003|Overall Study|Death|0|||
94551287|NCT01953913|323814869|FG000|Overall Study|Disease Progression|349|||
94551288|NCT01953913|323814869|FG000|Overall Study|Worsening of underlying cancer|22|||
94551289|NCT01953913|323814869|FG000|Overall Study|Adverse Event|20|||
94551290|NCT01953913|323814869|FG000|Overall Study|Protocol Violation|6|||
94551291|NCT01953913|323814869|FG000|Overall Study|Lost to Follow-up|4|||
94551292|NCT01953913|323814869|FG000|Overall Study|Withdrawal by Subject|32|||
94551293|NCT01953913|323814869|FG000|Overall Study|Other than listed|108|||
94551294|NCT01953913|323814869|FG000|Overall Study|Not Treated|1|||
94551295|NCT03995355|323814871|FG000|Overall Study|Adverse Event|1|||
94551296|NCT03995355|323814872|FG001|Overall Study|Adverse Event|0|||
94342731|NCT00085644|323035975|FG001|Open-Label Period|Protocol Violation|0|||
94342732|NCT00085644|323035976|FG002|Open-Label Period|Protocol Violation|4|||
94342733|NCT00085644|323035974|FG000|Open-Label Period|Personal reason|0|||
94342734|NCT00085644|323035975|FG001|Open-Label Period|Personal reason|0|||
94342735|NCT00085644|323035976|FG002|Open-Label Period|Personal reason|4|||
94342736|NCT00832091|323035977|FG000|Overall Study|Adverse Event|1|||
94342737|NCT00832091|323035978|FG001|Overall Study|Adverse Event|1|||
94342738|NCT00832091|323035977|FG000|Overall Study|Protocol Violation|1|||
94342739|NCT00832091|323035978|FG001|Overall Study|Protocol Violation|0|||
94342740|NCT00832091|323035977|FG000|Overall Study|Withdrawal by Subject|2|||
94342741|NCT00832091|323035978|FG001|Overall Study|Withdrawal by Subject|1|||
94342742|NCT00832091|323035977|FG000|Overall Study|Prohibited Medication|1|||
94444071|NCT00395629|323411782|FG002|Extension Study|Administrative problems|1|||
94444072|NCT02569801|323411783|FG000|Overall Study|Withdrawal by Subject|9|||
94444073|NCT02569801|323411784|FG001|Overall Study|Withdrawal by Subject|9|||
94444074|NCT02569801|323411783|FG000|Overall Study|Sponsor Decision|13|||
94444075|NCT02569801|323411784|FG001|Overall Study|Sponsor Decision|14|||
94444076|NCT02569801|323411783|FG000|Overall Study|Progressive Disease|2|||
94444077|NCT02569801|323411784|FG001|Overall Study|Progressive Disease|7|||
94444078|NCT02569801|323411783|FG000|Overall Study|Lost to Follow-up|0|||
94444079|NCT02569801|323411784|FG001|Overall Study|Lost to Follow-up|1|||
94444080|NCT02569801|323411783|FG000|Overall Study|Death|12|||
94444081|NCT02569801|323411784|FG001|Overall Study|Death|4|||
94444082|NCT01960413|323411787|FG000|Overall Study|Withdrawal by Subject|1|||
94444083|NCT01960413|323411788|FG001|Overall Study|Withdrawal by Subject|1|||
94444084|NCT01960413|323411787|FG000|Overall Study|Physician Decision|1|||
94444085|NCT01960413|323411788|FG001|Overall Study|Physician Decision|0|||
94444086|NCT01960413|323411787|FG000|Overall Study|Lost to Follow-up|2|||
94444087|NCT01960413|323411788|FG001|Overall Study|Lost to Follow-up|0|||
94444088|NCT00031590|323411790|FG000|Overall Study|Adverse Event|1|||
94444089|NCT00031590|323411790|FG000|Overall Study|Withdrawal by parents|2|||
94444090|NCT05506046|323411791|FG000|Overall Study|Lost to Follow-up|89|||
94444091|NCT05506046|323411792|FG001|Overall Study|Lost to Follow-up|101|||
94444092|NCT05506046|323411793|FG002|Overall Study|Lost to Follow-up|102|||
94444093|NCT05506046|323411794|FG003|Overall Study|Lost to Follow-up|99|||
94444094|NCT01283464|323411797|FG000|Overall Study|Lost to Follow-up|0|||
94444095|NCT01283464|323411798|FG001|Overall Study|Lost to Follow-up|1|||
94444096|NCT01283464|323411797|FG000|Overall Study|Withdrawal by Subject|1|||
94444097|NCT01283464|323411798|FG001|Overall Study|Withdrawal by Subject|0|||
94444098|NCT01283464|323411797|FG000|Overall Study|Physician Decision|1|||
94444099|NCT01283464|323411798|FG001|Overall Study|Physician Decision|0|||
94444100|NCT03051100|323411800|FG000|Overall Study|Withdrawal by Subject|1|||
94444101|NCT03051100|323411801|FG001|Overall Study|Withdrawal by Subject|0|||
94444102|NCT03442751|323411802|FG000|Overall Study|Withdrawal by Subject|3|||
94444103|NCT03442751|323411803|FG001|Overall Study|Withdrawal by Subject|1|||
94444104|NCT03442751|323411802|FG000|Overall Study|Lost to Follow-up|3|||
94444105|NCT03442751|323411803|FG001|Overall Study|Lost to Follow-up|0|||
94444106|NCT00191477|323411804|FG000|Overall Study|Tumor Recurrence|49|||
94444107|NCT00191477|323411805|FG001|Overall Study|Tumor Recurrence|48|||
94444108|NCT00191477|323411804|FG000|Overall Study|Death, Study Disease|1|||
94444109|NCT00191477|323411805|FG001|Overall Study|Death, Study Disease|1|||
94444110|NCT00191477|323411804|FG000|Overall Study|Death, Other Cause|3|||
94444111|NCT00191477|323411805|FG001|Overall Study|Death, Other Cause|6|||
94444112|NCT00191477|323411804|FG000|Overall Study|Lost to Follow-up|23|||
94444113|NCT00191477|323411805|FG001|Overall Study|Lost to Follow-up|21|||
94444114|NCT00191477|323411804|FG000|Overall Study|Protocol Violation|1|||
94444115|NCT00191477|323411805|FG001|Overall Study|Protocol Violation|1|||
94444116|NCT00191477|323411804|FG000|Overall Study|Treatment Change|2|||
94444117|NCT00191477|323411805|FG001|Overall Study|Treatment Change|0|||
94444118|NCT00191477|323411804|FG000|Overall Study|Withdrawal by Subject|2|||
94444119|NCT00191477|323411805|FG001|Overall Study|Withdrawal by Subject|0|||
94444120|NCT00191477|323411804|FG000|Overall Study|Other|2|||
94444121|NCT00191477|323411805|FG001|Overall Study|Other|0|||
94444122|NCT00191477|323411804|FG000|Overall Study|Not Eligible|41|||
94444123|NCT00191477|323411805|FG001|Overall Study|Not Eligible|38|||
94444124|NCT00191477|323411804|FG000|Overall Study|Pathological Specimen Lost|1|||
94444125|NCT00191477|323411805|FG001|Overall Study|Pathological Specimen Lost|0|||
94551297|NCT03995355|323814871|FG000|Overall Study|Withdrawal by Subject|1|||
94342743|NCT00832091|323035978|FG001|Overall Study|Prohibited Medication|0|||
94342744|NCT00606229|323035981|FG000|Overall Study|Adverse Event|11|||
94444126|NCT00191477|323411804|FG000|Overall Study|Discontinued Prior to Instillation|13|||
94444127|NCT00191477|323411805|FG001|Overall Study|Discontinued Prior to Instillation|14|||
94444128|NCT03922308|323411810|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
94444129|NCT03922308|323411811|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
94444130|NCT03922308|323411812|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
94444131|NCT03922308|323411810|FG000|Overall Study|Lost to Follow-up|1|||
94444132|NCT03922308|323411811|FG001|Overall Study|Lost to Follow-up|0|||
94444133|NCT03922308|323411812|FG002|Overall Study|Lost to Follow-up|0|||
94444134|NCT03922308|323411810|FG000|Overall Study|Reason not Specified|0|||
94444135|NCT03922308|323411811|FG001|Overall Study|Reason not Specified|2|||
94444136|NCT03922308|323411812|FG002|Overall Study|Reason not Specified|1|||
94444137|NCT01286467|323411813|FG000|Overall Study|Death|1|||
94444138|NCT01286467|323411814|FG001|Overall Study|Death|1|||
94444139|NCT01286467|323411815|FG002|Overall Study|Death|1|||
94444140|NCT01286467|323411816|FG003|Overall Study|Death|0|||
94444141|NCT01286467|323411813|FG000|Overall Study|Lost to Follow-up|0|||
94444142|NCT01286467|323411814|FG001|Overall Study|Lost to Follow-up|0|||
94444143|NCT01286467|323411815|FG002|Overall Study|Lost to Follow-up|0|||
94444144|NCT01286467|323411816|FG003|Overall Study|Lost to Follow-up|1|||
94444145|NCT01286467|323411813|FG000|Overall Study|Withdrawal by Subject|0|||
94551298|NCT03995355|323814872|FG001|Overall Study|Withdrawal by Subject|0|||
94551299|NCT03995355|323814871|FG000|Overall Study|Scheduling Issues|0|||
94551300|NCT03995355|323814872|FG001|Overall Study|Scheduling Issues|1|||
94551301|NCT03688100|323814873|FG000|Overall Study|Lost to Follow-up|21|||
94551302|NCT03688100|323814874|FG001|Overall Study|Lost to Follow-up|15|||
94551303|NCT03688100|323814875|FG002|Overall Study|Lost to Follow-up|15|||
94551304|NCT03688100|323814876|FG003|Overall Study|Lost to Follow-up|18|||
94551305|NCT03688100|323814873|FG000|Overall Study|Withdrawal by Subject|19|||
94551306|NCT03688100|323814874|FG001|Overall Study|Withdrawal by Subject|16|||
94551307|NCT03688100|323814875|FG002|Overall Study|Withdrawal by Subject|0|||
94551308|NCT03688100|323814876|FG003|Overall Study|Withdrawal by Subject|0|||
94551309|NCT03688100|323814873|FG000|Overall Study|Death|36|||
94551310|NCT03688100|323814874|FG001|Overall Study|Death|27|||
94551311|NCT03688100|323814875|FG002|Overall Study|Death|0|||
94551312|NCT03688100|323814876|FG003|Overall Study|Death|0|||
94551313|NCT00494507|323814879|FG000|Double-Blind Phase|Adverse Event|2|||
94551314|NCT00494507|323814880|FG001|Double-Blind Phase|Adverse Event|0|||
94551315|NCT00494507|323814881|FG002|Double-Blind Phase|Adverse Event|1|||
94551316|NCT00494507|323814882|FG003|Double-Blind Phase|Adverse Event|0|||
94551317|NCT00494507|323814879|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
94551318|NCT00494507|323814880|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
94551319|NCT00494507|323814881|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
94551320|NCT00494507|323814882|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
94551321|NCT00494507|323814879|FG000|Double-Blind Phase|Subject Non-compliance|0|||
94551322|NCT00494507|323814880|FG001|Double-Blind Phase|Subject Non-compliance|0|||
94551323|NCT00494507|323814881|FG002|Double-Blind Phase|Subject Non-compliance|1|||
94551324|NCT00494507|323814882|FG003|Double-Blind Phase|Subject Non-compliance|0|||
94551325|NCT00494507|323814879|FG000|Double-Blind Phase|Negative DNA test|0|||
94551326|NCT00494507|323814880|FG001|Double-Blind Phase|Negative DNA test|0|||
94551327|NCT00494507|323814881|FG002|Double-Blind Phase|Negative DNA test|0|||
94551328|NCT00494507|323814882|FG003|Double-Blind Phase|Negative DNA test|1|||
94551329|NCT00494507|323814879|FG000|Open-Label Phase|Adverse Event|0|||
94551330|NCT00494507|323814880|FG001|Open-Label Phase|Adverse Event|1|||
94551331|NCT00494507|323814881|FG002|Open-Label Phase|Adverse Event|5|||
94551332|NCT00494507|323814882|FG003|Open-Label Phase|Adverse Event|3|||
94551333|NCT00494507|323814879|FG000|Open-Label Phase|Worsening Disease|0|||
94551334|NCT00494507|323814880|FG001|Open-Label Phase|Worsening Disease|0|||
94551335|NCT00494507|323814881|FG002|Open-Label Phase|Worsening Disease|0|||
94551336|NCT00494507|323814882|FG003|Open-Label Phase|Worsening Disease|2|||
94551337|NCT00924404|323814883|FG000|Overall Study|Lost to Follow-up|6|||
94551338|NCT00924404|323814884|FG001|Overall Study|Lost to Follow-up|4|||
94551339|NCT00295932|323814885|FG000|Overall Study|Not Treated|0|||
94551340|NCT00295932|323814886|FG001|Overall Study|Not Treated|0|||
94551341|NCT00295932|323814887|FG002|Overall Study|Not Treated|0|||
94551342|NCT00295932|323814888|FG003|Overall Study|Not Treated|0|||
94551343|NCT00295932|323814889|FG004|Overall Study|Not Treated|0|||
94551344|NCT00295932|323814890|FG005|Overall Study|Not Treated|0|||
94551345|NCT00295932|323814891|FG006|Overall Study|Not Treated|0|||
94551346|NCT00295932|323814892|FG007|Overall Study|Not Treated|0|||
94551347|NCT00295932|323814893|FG008|Overall Study|Not Treated|0|||
94551348|NCT00295932|323814894|FG009|Overall Study|Not Treated|0|||
94551349|NCT00295932|323814895|FG010|Overall Study|Not Treated|1|||
94551350|NCT00587847|323814896|FG000|Overall Study|Lack of Efficacy|5|||
94551351|NCT00587847|323814896|FG000|Overall Study|Adverse Event|2|||
94551352|NCT02337725|323814897|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
94551353|NCT02337725|323814898|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
94551354|NCT02337725|323814897|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
94551355|NCT02337725|323814898|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
94551356|NCT02337725|323814897|FG000|Overall Study|Major Protocol Deviation|0|||
94551357|NCT02337725|323814898|FG001|Overall Study|Major Protocol Deviation|1|||
94551358|NCT02337725|323814897|FG000|Overall Study|Voluntary Withdrawal|14|||
94551359|NCT02337725|323814898|FG001|Overall Study|Voluntary Withdrawal|3|||
94551360|NCT02337725|323814897|FG000|Overall Study|Lack of Efficacy|4|||
94551361|NCT02337725|323814898|FG001|Overall Study|Lack of Efficacy|0|||
94551362|NCT01438177|323814900|FG000|Overall Study|Withdrawal by Subject|1|||
94551363|NCT01438177|323814900|FG000|Overall Study|Initiation of new therapy|1|||
94551364|NCT00084487|323814904|FG000|Overall Study|Death|1|||
94551365|NCT02772978|323814905|FG000|Overall Study|Withdrawal by Subject|1|||
94551366|NCT02772978|323814906|FG001|Overall Study|Withdrawal by Subject|1|||
94551367|NCT00989781|323814907|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
94551368|NCT00989781|323814908|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
94551369|NCT00129467|323814909|FG000|Received Intervention|Death|1|||
94551370|NCT00129467|323814910|FG001|Received Intervention|Death|1|||
94551371|NCT00129467|323814909|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
94551372|NCT00129467|323814910|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
94551373|NCT00129467|323814909|FG000|Received Intervention|Delirium|2|||
94551374|NCT00129467|323814910|FG001|Received Intervention|Delirium|0|||
94551375|NCT00129467|323814909|FG000|Received Intervention|Withdrawal by Subject|1|||
94551376|NCT00129467|323814910|FG001|Received Intervention|Withdrawal by Subject|0|||
94444146|NCT01286467|323411814|FG001|Overall Study|Withdrawal by Subject|0|||
94444147|NCT01286467|323411815|FG002|Overall Study|Withdrawal by Subject|1|||
94444148|NCT01286467|323411816|FG003|Overall Study|Withdrawal by Subject|0|||
94444149|NCT01286467|323411813|FG000|Overall Study|Physician Decision|0|||
94444150|NCT01286467|323411814|FG001|Overall Study|Physician Decision|0|||
94444151|NCT01286467|323411815|FG002|Overall Study|Physician Decision|0|||
94444152|NCT01286467|323411816|FG003|Overall Study|Physician Decision|1|||
94444153|NCT01286467|323411813|FG000|Overall Study|Disease progression|3|||
94444154|NCT01286467|323411814|FG001|Overall Study|Disease progression|2|||
94444155|NCT01286467|323411815|FG002|Overall Study|Disease progression|2|||
94444156|NCT01286467|323411816|FG003|Overall Study|Disease progression|3|||
94444157|NCT01286467|323411813|FG000|Overall Study|Adverse Event|0|||
94444158|NCT01286467|323411814|FG001|Overall Study|Adverse Event|1|||
94444159|NCT01286467|323411815|FG002|Overall Study|Adverse Event|2|||
94444160|NCT01286467|323411816|FG003|Overall Study|Adverse Event|3|||
94444161|NCT01286467|323411813|FG000|Overall Study|Study drug stop longer than 14 days|0|||
94444162|NCT01286467|323411814|FG001|Overall Study|Study drug stop longer than 14 days|0|||
94444163|NCT01286467|323411815|FG002|Overall Study|Study drug stop longer than 14 days|1|||
94444164|NCT01286467|323411816|FG003|Overall Study|Study drug stop longer than 14 days|0|||
94444165|NCT04421131|323411823|FG000|Overall Study|Lost to Follow-up|1|||
94444166|NCT04421131|323411823|FG000|Overall Study|Protocol Violation|2|||
94444167|NCT04421131|323411823|FG000|Overall Study|App crashed|5|||
94444168|NCT02501928|323411824|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
94444169|NCT02501928|323411825|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
94444170|NCT02501928|323411826|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
94444171|NCT02501928|323411827|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
94444172|NCT02501928|323411828|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
94444173|NCT02501928|323411829|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
94444174|NCT00258960|323411831|FG000|Overall Study|Death|2|||
94444175|NCT00258960|323411831|FG000|Overall Study|Disease Progression|7|||
94444176|NCT00258960|323411831|FG000|Overall Study|Adverse Event|4|||
94444177|NCT00258960|323411831|FG000|Overall Study|Physician Decision|1|||
94444178|NCT00258960|323411831|FG000|Overall Study|Withdrawal by Subject|1|||
94444179|NCT00258960|323411831|FG000|Overall Study|Mistake|2|||
94444180|NCT02492867|323411832|FG000|Overall Study|Alternate therapy|1|||
94444181|NCT02492867|323411832|FG000|Overall Study|Withdrawal by Subject|2|||
94444182|NCT02492867|323411832|FG000|Overall Study|Disease progression after treatment started|1|||
94444183|NCT02492867|323411832|FG000|Overall Study|Death|1|||
94444184|NCT03296527|323411835|FG000|Overall Study|Adverse Event|15|||
94444185|NCT03296527|323411836|FG001|Overall Study|Adverse Event|33|||
94444186|NCT03296527|323411835|FG000|Overall Study|Protocol Deviation|4|||
94444187|NCT03296527|323411836|FG001|Overall Study|Protocol Deviation|0|||
94444188|NCT03296527|323411835|FG000|Overall Study|Participant withdrew consent|3|||
94444189|NCT03296527|323411836|FG001|Overall Study|Participant withdrew consent|1|||
94444190|NCT03296527|323411835|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
94444191|NCT03296527|323411836|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
94444192|NCT03296527|323411835|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
94444193|NCT03296527|323411836|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
94444194|NCT03296527|323411835|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
94444195|NCT03296527|323411836|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
94444196|NCT03296527|323411835|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
94444197|NCT03296527|323411836|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
94444198|NCT03296527|323411835|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
94444199|NCT03296527|323411836|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
94444200|NCT03817190|323411838|FG000|Overall Study|Early Termination|13|||
94444201|NCT03817190|323411839|FG001|Overall Study|Early Termination|20|||
94444202|NCT03817190|323411838|FG000|Overall Study|Adverse Event|10|||
94444203|NCT03817190|323411839|FG001|Overall Study|Adverse Event|17|||
94444204|NCT03817190|323411838|FG000|Overall Study|Withdrawal by Subject|12|||
94444205|NCT03817190|323411839|FG001|Overall Study|Withdrawal by Subject|8|||
94444206|NCT03817190|323411838|FG000|Overall Study|Lost to Follow-up|11|||
94444207|NCT03817190|323411839|FG001|Overall Study|Lost to Follow-up|7|||
94444208|NCT03817190|323411838|FG000|Overall Study|Lack of Efficacy|7|||
94444209|NCT03817190|323411839|FG001|Overall Study|Lack of Efficacy|5|||
94444210|NCT03817190|323411838|FG000|Overall Study|Investigator Decision|5|||
94444211|NCT03817190|323411839|FG001|Overall Study|Investigator Decision|1|||
94444212|NCT03817190|323411838|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
94444213|NCT03817190|323411839|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
94444214|NCT03817190|323411838|FG000|Overall Study|Lack of Contact|1|||
94444215|NCT03817190|323411839|FG001|Overall Study|Lack of Contact|0|||
94444216|NCT03817190|323411838|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
94444217|NCT03817190|323411839|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
94551377|NCT00129467|323814909|FG000|Received Intervention|Nausea|1|||
94551378|NCT00129467|323814910|FG001|Received Intervention|Nausea|0|||
94551379|NCT00129467|323814909|FG000|Received Intervention|Intolerance to citalopram|0|||
94551380|NCT00129467|323814910|FG001|Received Intervention|Intolerance to citalopram|1|||
94551381|NCT00129467|323814909|FG000|Received Intervention|Dizzyness, fatigue|0|||
94551382|NCT00129467|323814910|FG001|Received Intervention|Dizzyness, fatigue|1|||
94551383|NCT00129467|323814909|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
94551384|NCT00129467|323814910|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
94551385|NCT00129467|323814909|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
94551386|NCT00129467|323814910|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
94551387|NCT01455220|323814911|FG000|Overall Study|screen fail|30|||
94551388|NCT01532869|323814912|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
94551389|NCT01532869|323814913|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
94551390|NCT01532869|323814912|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
94551391|NCT01532869|323814913|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
94551392|NCT01532869|323814912|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
94551393|NCT01532869|323814913|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
94551394|NCT01532869|323814912|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
94551395|NCT01532869|323814913|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
94551396|NCT01532869|323814912|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
94551397|NCT01532869|323814913|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
94551398|NCT01532869|323814912|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
94551399|NCT01532869|323814913|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
94551400|NCT01532869|323814912|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
94551401|NCT01532869|323814913|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
94551402|NCT01532869|323814912|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
94551403|NCT01532869|323814913|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
94551404|NCT01532869|323814912|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
94551405|NCT01532869|323814913|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
94551406|NCT01532869|323814912|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
94551407|NCT01532869|323814913|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
94551408|NCT01532869|323814912|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
94551409|NCT01532869|323814913|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
94551410|NCT01532869|323814912|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
94551411|NCT01532869|323814913|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
94551412|NCT01532869|323814912|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
94551413|NCT01532869|323814913|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
94551414|NCT01532869|323814912|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
94551415|NCT01532869|323814913|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
94551416|NCT01532869|323814912|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
94551417|NCT01532869|323814913|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
94551418|NCT01532869|323814912|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
94551419|NCT01532869|323814913|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
94551420|NCT01532869|323814912|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
94551421|NCT01532869|323814913|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
94551422|NCT01331291|323814914|FG000|Overall Study|Lack of Efficacy|2|||
94551423|NCT01331291|323814915|FG001|Overall Study|Lack of Efficacy|8|||
94551424|NCT01331291|323814914|FG000|Overall Study|Death|0|||
94551425|NCT01331291|323814915|FG001|Overall Study|Death|1|||
94551426|NCT00694304|323814916|FG000|Overall Study|Adverse Event|42|||
94551427|NCT00694304|323814916|FG000|Overall Study|Lack of Efficacy|35|||
94551428|NCT00694304|323814916|FG000|Overall Study|Non-compliance With Study Product|16|||
94551429|NCT00694304|323814916|FG000|Overall Study|Protocol Violation|6|||
94551430|NCT00694304|323814916|FG000|Overall Study|Withdrawal of Consent|61|||
94551431|NCT00694304|323814916|FG000|Overall Study|Lost to Follow-up|15|||
94551432|NCT00694304|323814916|FG000|Overall Study|Administrative or Other Reasons|32|||
94551433|NCT01026220|323814917|FG000|Induction|Death|1|||
94551434|NCT01026220|323814918|FG001|Induction|Death|0|||
94551435|NCT01026220|323814919|FG002|Induction|Death|0|||
94551436|NCT01026220|323814917|FG000|Induction|Lack of Efficacy|2|||
94551437|NCT01026220|323814918|FG001|Induction|Lack of Efficacy|0|||
94551438|NCT01026220|323814919|FG002|Induction|Lack of Efficacy|0|||
94551439|NCT01026220|323814917|FG000|Induction|Physician Decision|12|||
94551440|NCT01026220|323814918|FG001|Induction|Physician Decision|0|||
94342745|NCT00606229|323035981|FG000|Overall Study|Lack of Efficacy|1|||
94342746|NCT00606229|323035981|FG000|Overall Study|Withdrawal by Subject|4|||
94342747|NCT00606229|323035981|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
94342748|NCT00606229|323035981|FG000|Overall Study|change of residence or other commitments|2|||
94342749|NCT00376675|323035988|FG000|Overall Study|Withdrawal by Subject|9|||
94342750|NCT00376675|323035989|FG001|Overall Study|Withdrawal by Subject|2|||
94342751|NCT00376675|323035988|FG000|Overall Study|Adverse Event|10|||
94342752|NCT00376675|323035989|FG001|Overall Study|Adverse Event|5|||
94342753|NCT00376675|323035988|FG000|Overall Study|Other Reason|1|||
94342754|NCT00376675|323035989|FG001|Overall Study|Other Reason|7|||
94342755|NCT00736450|323035992|FG000|Overall Study|Not ABC gene eligible|19|||
94342756|NCT00736450|323035992|FG000|Overall Study|Withdrawal by Subject|5|||
94342757|NCT00736450|323035992|FG000|Overall Study|Physician Decision|1|||
94342758|NCT02943668|323035993|FG000|Overall Study|Disease Progression|1|||
94342759|NCT01332851|323035994|FG000|Overall Study|Withdrawal by Subject|4|||
94342760|NCT01332851|323035995|FG001|Overall Study|Withdrawal by Subject|2|||
94342761|NCT01332851|323035994|FG000|Overall Study|Lost to Follow-up|7|||
94342762|NCT01332851|323035995|FG001|Overall Study|Lost to Follow-up|11|||
94342763|NCT04048876|323035996|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
94342764|NCT04048876|323035997|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
94342765|NCT04048876|323035998|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
94342766|NCT04048876|323035999|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
94342767|NCT04048876|323035996|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
94342768|NCT04048876|323035997|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
94342769|NCT04048876|323035998|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
94342770|NCT04048876|323035999|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
94342771|NCT04048876|323035996|FG000|Placebo Controlled Phase|Adverse Event|0|||
94342772|NCT04048876|323035997|FG001|Placebo Controlled Phase|Adverse Event|1|||
94342773|NCT04048876|323035998|FG002|Placebo Controlled Phase|Adverse Event|0|||
94342774|NCT04048876|323035999|FG003|Placebo Controlled Phase|Adverse Event|0|||
94342775|NCT04048876|323035996|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
94342776|NCT04048876|323035997|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
94342777|NCT04048876|323035998|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
94342778|NCT04048876|323035999|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
94342779|NCT01249157|323036000|FG000|Overall Study|Withdrawal by Subject|1|||
94342780|NCT01197794|323036001|FG000|Overall Study|Adverse Event|3|||
94342781|NCT01197794|323036002|FG001|Overall Study|Adverse Event|2|||
94342782|NCT01197794|323036003|FG002|Overall Study|Adverse Event|4|||
94342783|NCT01197794|323036004|FG003|Overall Study|Adverse Event|4|||
94342784|NCT01197794|323036005|FG004|Overall Study|Adverse Event|4|||
94342785|NCT01197794|323036006|FG005|Overall Study|Adverse Event|2|||
94342786|NCT01197794|323036007|FG006|Overall Study|Adverse Event|3|||
94342787|NCT01197794|323036001|FG000|Overall Study|Protocol Violation|0|||
94342788|NCT01197794|323036002|FG001|Overall Study|Protocol Violation|0|||
94342789|NCT01197794|323036003|FG002|Overall Study|Protocol Violation|0|||
94342790|NCT01197794|323036004|FG003|Overall Study|Protocol Violation|0|||
94342791|NCT01197794|323036005|FG004|Overall Study|Protocol Violation|2|||
94342792|NCT01197794|323036006|FG005|Overall Study|Protocol Violation|0|||
94342793|NCT01197794|323036007|FG006|Overall Study|Protocol Violation|1|||
94342794|NCT01197794|323036001|FG000|Overall Study|Development of study withdrawal criteria|3|||
94342795|NCT01197794|323036002|FG001|Overall Study|Development of study withdrawal criteria|0|||
94342796|NCT01197794|323036003|FG002|Overall Study|Development of study withdrawal criteria|0|||
94342797|NCT01197794|323036004|FG003|Overall Study|Development of study withdrawal criteria|1|||
94342798|NCT01197794|323036005|FG004|Overall Study|Development of study withdrawal criteria|0|||
94342799|NCT01197794|323036006|FG005|Overall Study|Development of study withdrawal criteria|0|||
94342800|NCT01197794|323036007|FG006|Overall Study|Development of study withdrawal criteria|1|||
94342801|NCT01197794|323036001|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
94342802|NCT01197794|323036002|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
94342803|NCT01197794|323036003|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
94342804|NCT01197794|323036004|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
94342805|NCT01197794|323036005|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
94342806|NCT01197794|323036006|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
94342807|NCT01197794|323036007|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
94342808|NCT01197794|323036001|FG000|Overall Study|Withdrawal by Subject|3|||
94342809|NCT01197794|323036002|FG001|Overall Study|Withdrawal by Subject|3|||
94342810|NCT01197794|323036003|FG002|Overall Study|Withdrawal by Subject|4|||
94342811|NCT01197794|323036004|FG003|Overall Study|Withdrawal by Subject|1|||
94342812|NCT01197794|323036005|FG004|Overall Study|Withdrawal by Subject|1|||
94342813|NCT01197794|323036006|FG005|Overall Study|Withdrawal by Subject|5|||
94342814|NCT01197794|323036007|FG006|Overall Study|Withdrawal by Subject|6|||
94342815|NCT01197794|323036001|FG000|Overall Study|Lost to Follow-up|1|||
94342816|NCT01197794|323036002|FG001|Overall Study|Lost to Follow-up|1|||
94342817|NCT01197794|323036003|FG002|Overall Study|Lost to Follow-up|0|||
94444218|NCT04146012|323411840|FG000|Overall Study|Study Terminated|30|||
94551441|NCT01026220|323814919|FG002|Induction|Physician Decision|0|||
94551442|NCT01026220|323814917|FG000|Induction|Withdrawal by Subject|9|||
94551443|NCT01026220|323814918|FG001|Induction|Withdrawal by Subject|0|||
94551444|NCT01026220|323814919|FG002|Induction|Withdrawal by Subject|0|||
94551445|NCT01026220|323814917|FG000|Induction|Ineligible|1|||
94551446|NCT01026220|323814918|FG001|Induction|Ineligible|0|||
94551447|NCT01026220|323814919|FG002|Induction|Ineligible|0|||
94551448|NCT01026220|323814917|FG000|Consolidation Maintenance|Death|0|||
94551449|NCT01026220|323814918|FG001|Consolidation Maintenance|Death|1|||
94551450|NCT01026220|323814919|FG002|Consolidation Maintenance|Death|0|||
94551451|NCT01026220|323814917|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
94551452|NCT01026220|323814918|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
94551453|NCT01026220|323814919|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
94551454|NCT01026220|323814917|FG000|Consolidation Maintenance|Physician Decision|0|||
94551455|NCT01026220|323814918|FG001|Consolidation Maintenance|Physician Decision|2|||
94551456|NCT01026220|323814919|FG002|Consolidation Maintenance|Physician Decision|7|||
94551457|NCT01026220|323814917|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
94551458|NCT01026220|323814918|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
94551459|NCT01026220|323814919|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
94551460|NCT01927055|323814926|FG000|Open-label|Adverse Event|6|||
94551461|NCT01927055|323814927|FG001|Open-label|Adverse Event|0|||
94551462|NCT01927055|323814928|FG002|Open-label|Adverse Event|0|||
94551463|NCT01927055|323814926|FG000|Open-label|Withdrawal by Subject|1|||
94551464|NCT01927055|323814927|FG001|Open-label|Withdrawal by Subject|0|||
94551465|NCT01927055|323814928|FG002|Open-label|Withdrawal by Subject|0|||
94551466|NCT01927055|323814926|FG000|Open-label|Study Stopped|4|||
94551467|NCT01927055|323814927|FG001|Open-label|Study Stopped|0|||
94551468|NCT01927055|323814928|FG002|Open-label|Study Stopped|0|||
94551469|NCT01927055|323814926|FG000|Open-label|Supine Hypertension|4|||
94551470|NCT01927055|323814927|FG001|Open-label|Supine Hypertension|0|||
94551471|NCT01927055|323814928|FG002|Open-label|Supine Hypertension|0|||
94551472|NCT01927055|323814926|FG000|Open-label|Difficulty attending study visits|1|||
94551473|NCT01927055|323814927|FG001|Open-label|Difficulty attending study visits|0|||
94551474|NCT01927055|323814928|FG002|Open-label|Difficulty attending study visits|0|||
94551475|NCT01927055|323814926|FG000|Double-Blind|Adverse Event|0|||
94551476|NCT01927055|323814927|FG001|Double-Blind|Adverse Event|1|||
94551477|NCT01927055|323814928|FG002|Double-Blind|Adverse Event|1|||
94551478|NCT01927055|323814926|FG000|Double-Blind|Protocol Violation|0|||
94551479|NCT01927055|323814927|FG001|Double-Blind|Protocol Violation|0|||
94551480|NCT01927055|323814928|FG002|Double-Blind|Protocol Violation|1|||
94551481|NCT01927055|323814926|FG000|Double-Blind|Withdrawal by Subject|0|||
94551482|NCT01927055|323814927|FG001|Double-Blind|Withdrawal by Subject|2|||
94551483|NCT01927055|323814928|FG002|Double-Blind|Withdrawal by Subject|3|||
94551484|NCT01927055|323814926|FG000|Double-Blind|Study Stopped|0|||
94551485|NCT01927055|323814927|FG001|Double-Blind|Study Stopped|7|||
94551486|NCT01927055|323814928|FG002|Double-Blind|Study Stopped|7|||
94551487|NCT01927055|323814926|FG000|Double-Blind|Supine Hypertension|0|||
94551488|NCT01927055|323814927|FG001|Double-Blind|Supine Hypertension|0|||
94551489|NCT01927055|323814928|FG002|Double-Blind|Supine Hypertension|1|||
94551490|NCT01927055|323814926|FG000|Double-Blind|Extended Vacation|0|||
94551491|NCT01927055|323814927|FG001|Double-Blind|Extended Vacation|1|||
94551492|NCT01927055|323814928|FG002|Double-Blind|Extended Vacation|0|||
94551493|NCT02540265|323814930|FG000|Overall Study|Lost to Follow-up|0|||
94551494|NCT02540265|323814931|FG001|Overall Study|Lost to Follow-up|0|||
94551495|NCT02540265|323814932|FG002|Overall Study|Lost to Follow-up|1|||
94551496|NCT02102399|323814933|FG000|Overall Study|Withdrawal by Subject|6|||
94551497|NCT02102399|323814934|FG001|Overall Study|Withdrawal by Subject|4|||
94551498|NCT02014584|323814936|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
94551499|NCT02014584|323814937|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
94551500|NCT02014584|323814938|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
94551501|NCT02014584|323814939|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
94551502|NCT02014584|323814940|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
94551503|NCT02014584|323814941|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
94551504|NCT02014584|323814936|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
94551505|NCT02014584|323814937|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
94551506|NCT02014584|323814938|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
94551507|NCT02014584|323814939|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
94551508|NCT02014584|323814940|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
94551509|NCT02014584|323814941|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
94551510|NCT02014584|323814936|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
94551511|NCT02014584|323814937|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
94551512|NCT02014584|323814938|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
94551513|NCT02014584|323814939|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
94551514|NCT02014584|323814940|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
94551515|NCT02014584|323814941|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
94551516|NCT02014584|323814936|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
94342818|NCT01197794|323036004|FG003|Overall Study|Lost to Follow-up|1|||
94342819|NCT01197794|323036005|FG004|Overall Study|Lost to Follow-up|0|||
94342820|NCT01197794|323036006|FG005|Overall Study|Lost to Follow-up|1|||
94342821|NCT01197794|323036007|FG006|Overall Study|Lost to Follow-up|0|||
94342822|NCT01197794|323036001|FG000|Overall Study|Other|1|||
94342823|NCT01197794|323036002|FG001|Overall Study|Other|1|||
94342824|NCT01197794|323036003|FG002|Overall Study|Other|3|||
94342825|NCT01197794|323036004|FG003|Overall Study|Other|0|||
94342826|NCT01197794|323036005|FG004|Overall Study|Other|2|||
94342827|NCT01197794|323036006|FG005|Overall Study|Other|2|||
94342828|NCT01197794|323036007|FG006|Overall Study|Other|4|||
94342829|NCT01055457|323036013|FG000|Overall Study|Lost to Follow-up|0|||
94342830|NCT01055457|323036014|FG001|Overall Study|Lost to Follow-up|1|||
94342831|NCT01055457|323036015|FG002|Overall Study|Lost to Follow-up|0|||
94342832|NCT01055457|323036016|FG003|Overall Study|Lost to Follow-up|0|||
94342833|NCT01055457|323036017|FG004|Overall Study|Lost to Follow-up|0|||
94342834|NCT01055457|323036018|FG005|Overall Study|Lost to Follow-up|1|||
94342835|NCT01055457|323036019|FG006|Overall Study|Lost to Follow-up|0|||
94342836|NCT01055457|323036020|FG007|Overall Study|Lost to Follow-up|0|||
94342837|NCT01055457|323036021|FG008|Overall Study|Lost to Follow-up|0|||
94342838|NCT01055457|323036022|FG009|Overall Study|Lost to Follow-up|0|||
94342839|NCT01055457|323036013|FG000|Overall Study|Protocol Violation|0|||
94342840|NCT01055457|323036014|FG001|Overall Study|Protocol Violation|0|||
94444219|NCT04146012|323411841|FG001|Overall Study|Study Terminated|15|||
94444220|NCT03323398|323411842|FG000|Overall Study|Other than Specified|0|||
94444221|NCT03323398|323411843|FG001|Overall Study|Other than Specified|1|||
94444222|NCT03323398|323411844|FG002|Overall Study|Other than Specified|2|||
94444223|NCT03323398|323411845|FG003|Overall Study|Other than Specified|0|||
94444224|NCT03323398|323411846|FG004|Overall Study|Other than Specified|0|||
94444225|NCT03323398|323411847|FG005|Overall Study|Other than Specified|0|||
94444226|NCT03323398|323411848|FG006|Overall Study|Other than Specified|1|||
94551517|NCT02014584|323814937|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
94551518|NCT02014584|323814938|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
94551519|NCT02014584|323814939|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
94551520|NCT02014584|323814940|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
94551521|NCT02014584|323814941|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
94551522|NCT02014584|323814936|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
94551523|NCT02014584|323814937|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
94551524|NCT02014584|323814938|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
94551525|NCT02014584|323814939|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
94551526|NCT02014584|323814940|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
94551527|NCT02014584|323814941|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
94551528|NCT01895309|323814945|FG000|Overall Study|Adverse Event|13|||
94551529|NCT01895309|323814946|FG001|Overall Study|Adverse Event|17|||
94551530|NCT01895309|323814945|FG000|Overall Study|Protocol Violation|1|||
94551531|NCT01895309|323814946|FG001|Overall Study|Protocol Violation|0|||
94551532|NCT01895309|323814945|FG000|Overall Study|Lack of Efficacy|1|||
94551533|NCT01895309|323814946|FG001|Overall Study|Lack of Efficacy|3|||
94551534|NCT01895309|323814945|FG000|Overall Study|Lost to Follow-up|1|||
94551535|NCT01895309|323814946|FG001|Overall Study|Lost to Follow-up|3|||
94551536|NCT01895309|323814945|FG000|Overall Study|Physician Decision|15|||
94551537|NCT01895309|323814946|FG001|Overall Study|Physician Decision|10|||
94551538|NCT01895309|323814945|FG000|Overall Study|Withdrawal by Subject|9|||
94551539|NCT01895309|323814946|FG001|Overall Study|Withdrawal by Subject|18|||
94551540|NCT04496453|323814947|FG000|Overall Study|Lost to Follow-up|6|||
94551541|NCT01555125|323814948|FG000|Induction Period|Lost to Follow-up|0|||
94551542|NCT01555125|323814949|FG001|Induction Period|Lost to Follow-up|2|||
94551543|NCT01555125|323814950|FG002|Induction Period|Lost to Follow-up|0|||
94551544|NCT01555125|323814951|FG003|Induction Period|Lost to Follow-up|0|||
94551545|NCT01555125|323814952|FG004|Induction Period|Lost to Follow-up|0|||
94551546|NCT01555125|323814948|FG000|Induction Period|Adverse Event|0|||
94551547|NCT01555125|323814949|FG001|Induction Period|Adverse Event|1|||
94551548|NCT01555125|323814950|FG002|Induction Period|Adverse Event|0|||
94551549|NCT01555125|323814951|FG003|Induction Period|Adverse Event|0|||
94551550|NCT01555125|323814952|FG004|Induction Period|Adverse Event|1|||
94551551|NCT01555125|323814948|FG000|Induction Period|Subject / guardian decision|0|||
94551552|NCT01555125|323814949|FG001|Induction Period|Subject / guardian decision|0|||
94551553|NCT01555125|323814950|FG002|Induction Period|Subject / guardian decision|0|||
94551554|NCT01555125|323814951|FG003|Induction Period|Subject / guardian decision|0|||
94551555|NCT01555125|323814952|FG004|Induction Period|Subject / guardian decision|2|||
94551556|NCT01555125|323814948|FG000|Induction Period|Death|1|||
94551557|NCT01555125|323814949|FG001|Induction Period|Death|0|||
94551558|NCT01555125|323814950|FG002|Induction Period|Death|0|||
94551559|NCT01555125|323814951|FG003|Induction Period|Death|0|||
94551560|NCT01555125|323814952|FG004|Induction Period|Death|0|||
94551561|NCT01555125|323814948|FG000|Maintenance Period|Adverse Event|1|||
94551562|NCT01555125|323814949|FG001|Maintenance Period|Adverse Event|1|||
94551563|NCT01555125|323814950|FG002|Maintenance Period|Adverse Event|0|||
94551564|NCT01555125|323814951|FG003|Maintenance Period|Adverse Event|0|||
94551565|NCT01555125|323814952|FG004|Maintenance Period|Adverse Event|0|||
94551566|NCT01555125|323814948|FG000|Maintenance Period|Subject / guardian decision|1|||
94551567|NCT01555125|323814949|FG001|Maintenance Period|Subject / guardian decision|2|||
94551568|NCT01555125|323814950|FG002|Maintenance Period|Subject / guardian decision|0|||
94551569|NCT01555125|323814951|FG003|Maintenance Period|Subject / guardian decision|0|||
94551570|NCT01555125|323814952|FG004|Maintenance Period|Subject / guardian decision|0|||
94551571|NCT01555125|323814948|FG000|Maintenance Period|Lost to Follow-up|2|||
94551572|NCT01555125|323814949|FG001|Maintenance Period|Lost to Follow-up|0|||
94551573|NCT01555125|323814950|FG002|Maintenance Period|Lost to Follow-up|0|||
94551574|NCT01555125|323814951|FG003|Maintenance Period|Lost to Follow-up|1|||
94551575|NCT01555125|323814952|FG004|Maintenance Period|Lost to Follow-up|0|||
94551576|NCT01555125|323814948|FG000|Maintenance Period|Lack of Efficacy|6|||
94551577|NCT01555125|323814949|FG001|Maintenance Period|Lack of Efficacy|1|||
94551578|NCT01555125|323814950|FG002|Maintenance Period|Lack of Efficacy|3|||
94551579|NCT01555125|323814951|FG003|Maintenance Period|Lack of Efficacy|0|||
94551580|NCT01555125|323814952|FG004|Maintenance Period|Lack of Efficacy|0|||
94444227|NCT03323398|323411849|FG007|Overall Study|Other than Specified|0|||
94444228|NCT03323398|323411850|FG008|Overall Study|Other than Specified|2|||
94551581|NCT01555125|323814948|FG000|Maintenance Period|Physician Decision|0|||
94551582|NCT01555125|323814949|FG001|Maintenance Period|Physician Decision|0|||
94551583|NCT01555125|323814950|FG002|Maintenance Period|Physician Decision|1|||
94551584|NCT01555125|323814951|FG003|Maintenance Period|Physician Decision|0|||
94551585|NCT01555125|323814952|FG004|Maintenance Period|Physician Decision|0|||
94551586|NCT01555125|323814948|FG000|Maintenance Period|Death|0|||
94551587|NCT01555125|323814949|FG001|Maintenance Period|Death|0|||
94551588|NCT01555125|323814950|FG002|Maintenance Period|Death|0|||
94551589|NCT01555125|323814951|FG003|Maintenance Period|Death|1|||
94551590|NCT01555125|323814952|FG004|Maintenance Period|Death|0|||
94551591|NCT01555125|323814948|FG000|Extension|Adverse Event|1|||
94551592|NCT01555125|323814949|FG001|Extension|Adverse Event|2|||
94551593|NCT01555125|323814950|FG002|Extension|Adverse Event|1|||
94551594|NCT01555125|323814951|FG003|Extension|Adverse Event|1|||
94551595|NCT01555125|323814952|FG004|Extension|Adverse Event|0|||
94551596|NCT01555125|323814948|FG000|Extension|Protocol deviation|1|||
94551597|NCT01555125|323814949|FG001|Extension|Protocol deviation|0|||
94551598|NCT01555125|323814950|FG002|Extension|Protocol deviation|0|||
94551599|NCT01555125|323814951|FG003|Extension|Protocol deviation|0|||
94551600|NCT01555125|323814952|FG004|Extension|Protocol deviation|0|||
94551601|NCT01555125|323814948|FG000|Extension|Lack of Efficacy|7|||
94551602|NCT01555125|323814949|FG001|Extension|Lack of Efficacy|6|||
94551603|NCT01555125|323814950|FG002|Extension|Lack of Efficacy|3|||
94551604|NCT01555125|323814951|FG003|Extension|Lack of Efficacy|0|||
94551605|NCT01555125|323814952|FG004|Extension|Lack of Efficacy|0|||
94551606|NCT01555125|323814948|FG000|Extension|Lost to Follow-up|2|||
94551607|NCT01555125|323814949|FG001|Extension|Lost to Follow-up|1|||
94551608|NCT01555125|323814950|FG002|Extension|Lost to Follow-up|2|||
94551609|NCT01555125|323814951|FG003|Extension|Lost to Follow-up|0|||
94551610|NCT01555125|323814952|FG004|Extension|Lost to Follow-up|0|||
94551611|NCT01555125|323814948|FG000|Extension|Study terminated by sponsor|32|||
94551612|NCT01555125|323814949|FG001|Extension|Study terminated by sponsor|33|||
94551613|NCT01555125|323814950|FG002|Extension|Study terminated by sponsor|16|||
94551614|NCT01555125|323814951|FG003|Extension|Study terminated by sponsor|20|||
94551615|NCT01555125|323814952|FG004|Extension|Study terminated by sponsor|0|||
94551616|NCT01555125|323814948|FG000|Extension|Subject/guardian decision|1|||
94551617|NCT01555125|323814949|FG001|Extension|Subject/guardian decision|9|||
94551618|NCT01555125|323814950|FG002|Extension|Subject/guardian decision|1|||
94551619|NCT01555125|323814951|FG003|Extension|Subject/guardian decision|0|||
94551620|NCT01555125|323814952|FG004|Extension|Subject/guardian decision|0|||
94551621|NCT01555125|323814948|FG000|Extension|Technical Problems|1|||
94551622|NCT01555125|323814949|FG001|Extension|Technical Problems|0|||
94551623|NCT01555125|323814950|FG002|Extension|Technical Problems|0|||
94551624|NCT01555125|323814951|FG003|Extension|Technical Problems|1|||
94551625|NCT01555125|323814952|FG004|Extension|Technical Problems|0|||
94551626|NCT01555125|323814948|FG000|Follow-Up Period|Lost to Follow-up|1|||
94551627|NCT01555125|323814949|FG001|Follow-Up Period|Lost to Follow-up|0|||
94551628|NCT01555125|323814950|FG002|Follow-Up Period|Lost to Follow-up|0|||
94551629|NCT01555125|323814951|FG003|Follow-Up Period|Lost to Follow-up|0|||
94551630|NCT01555125|323814952|FG004|Follow-Up Period|Lost to Follow-up|0|||
94551631|NCT01555125|323814948|FG000|Follow-Up Period|Subject / guardian decision|3|||
94551632|NCT01555125|323814949|FG001|Follow-Up Period|Subject / guardian decision|1|||
94551633|NCT01555125|323814950|FG002|Follow-Up Period|Subject / guardian decision|1|||
94551634|NCT01555125|323814951|FG003|Follow-Up Period|Subject / guardian decision|1|||
94551635|NCT01555125|323814952|FG004|Follow-Up Period|Subject / guardian decision|0|||
94551636|NCT04407234|323814955|FG000|Overall Study|Adverse Event|3|||
94551637|NCT04407234|323814956|FG001|Overall Study|Adverse Event|3|||
94551638|NCT03908970|323814957|FG000|Overall Study|Adverse Event|7|||
94551639|NCT03908970|323814958|FG001|Overall Study|Adverse Event|21|||
94551640|NCT03908970|323814957|FG000|Overall Study|Physician Decision|1|||
94551641|NCT03908970|323814958|FG001|Overall Study|Physician Decision|4|||
94551642|NCT03908970|323814957|FG000|Overall Study|Withdrawal by Subject|9|||
94551643|NCT03908970|323814958|FG001|Overall Study|Withdrawal by Subject|22|||
94551644|NCT01597635|323816971|FG000|Part A|Adverse Event|3|||
94551645|NCT01597635|323816972|FG001|Part A|Adverse Event|0|||
94551646|NCT01597635|323816973|FG002|Part A|Adverse Event|0|||
94551647|NCT01597635|323816971|FG000|Part B|Adverse Event|0|||
94551648|NCT01597635|323816972|FG001|Part B|Adverse Event|0|||
94551649|NCT01597635|323816973|FG002|Part B|Adverse Event|1|||
94551650|NCT01597635|323816971|FG000|Part B|Protocol Violation|0|||
94551651|NCT01597635|323816972|FG001|Part B|Protocol Violation|1|||
94551652|NCT01597635|323816973|FG002|Part B|Protocol Violation|0|||
94551653|NCT01597635|323816971|FG000|Part B|Protocol-defined stopping criteria|0|||
94551654|NCT01597635|323816972|FG001|Part B|Protocol-defined stopping criteria|4|||
94551655|NCT01597635|323816973|FG002|Part B|Protocol-defined stopping criteria|3|||
94551656|NCT01597635|323816971|FG000|Part B|Withdrawal by Subject|0|||
94551657|NCT01597635|323816972|FG001|Part B|Withdrawal by Subject|1|||
94551658|NCT01597635|323816973|FG002|Part B|Withdrawal by Subject|0|||
94551659|NCT02008773|323816974|FG000|Overall Study|Adverse Event|3|||
94551660|NCT02008773|323816975|FG001|Overall Study|Adverse Event|3|||
94551661|NCT02008773|323816976|FG002|Overall Study|Adverse Event|1|||
94551662|NCT02008773|323816977|FG003|Overall Study|Adverse Event|2|||
94551663|NCT02008773|323816974|FG000|Overall Study|Medication Non-compliance|2|||
94551664|NCT02008773|323816975|FG001|Overall Study|Medication Non-compliance|1|||
94551665|NCT02008773|323816976|FG002|Overall Study|Medication Non-compliance|3|||
94551666|NCT02008773|323816977|FG003|Overall Study|Medication Non-compliance|2|||
94551667|NCT02008773|323816974|FG000|Overall Study|Withdrawal by Subject|8|||
94551668|NCT02008773|323816975|FG001|Overall Study|Withdrawal by Subject|4|||
94551669|NCT02008773|323816976|FG002|Overall Study|Withdrawal by Subject|7|||
94551670|NCT02008773|323816977|FG003|Overall Study|Withdrawal by Subject|6|||
94551671|NCT02008773|323816974|FG000|Overall Study|Lost to Follow-up|0|||
94551672|NCT02008773|323816975|FG001|Overall Study|Lost to Follow-up|1|||
94551673|NCT02008773|323816976|FG002|Overall Study|Lost to Follow-up|3|||
94551674|NCT02008773|323816977|FG003|Overall Study|Lost to Follow-up|2|||
94551675|NCT01543776|323816978|FG000|Overall Study|Withdrawal by Subject|2|||
94551676|NCT01543776|323816979|FG001|Overall Study|Withdrawal by Subject|2|||
94551677|NCT03626545|323816980|FG000|Overall Study|Progressive disease|3|||
94551678|NCT03626545|323816981|FG001|Overall Study|Progressive disease|82|||
94551679|NCT03626545|323816982|FG002|Overall Study|Progressive disease|85|||
94551680|NCT03626545|323816980|FG000|Overall Study|Adverse Event|3|||
94551681|NCT03626545|323816981|FG001|Overall Study|Adverse Event|13|||
94551682|NCT03626545|323816982|FG002|Overall Study|Adverse Event|10|||
94551683|NCT03626545|323816980|FG000|Overall Study|Physician Decision|1|||
94551684|NCT03626545|323816981|FG001|Overall Study|Physician Decision|18|||
94551685|NCT03626545|323816982|FG002|Overall Study|Physician Decision|14|||
94551686|NCT03626545|323816980|FG000|Overall Study|Subject Decision|0|||
94551687|NCT03626545|323816981|FG001|Overall Study|Subject Decision|5|||
94551688|NCT03626545|323816982|FG002|Overall Study|Subject Decision|5|||
94551689|NCT03626545|323816980|FG000|Overall Study|Death|1|||
94551690|NCT03626545|323816981|FG001|Overall Study|Death|1|||
94551691|NCT03626545|323816982|FG002|Overall Study|Death|1|||
94551692|NCT03626545|323816980|FG000|Overall Study|Protocol Deviation|0|||
94551693|NCT03626545|323816981|FG001|Overall Study|Protocol Deviation|1|||
94551694|NCT03626545|323816982|FG002|Overall Study|Protocol Deviation|1|||
94551695|NCT03626545|323816980|FG000|Overall Study|Guardian Decision|0|||
94551696|NCT03626545|323816981|FG001|Overall Study|Guardian Decision|0|||
94551697|NCT03626545|323816982|FG002|Overall Study|Guardian Decision|1|||
94551698|NCT00417963|323816983|FG000|Overall Study|Lost to Follow-up|3|||
94551699|NCT00417963|323816983|FG000|Overall Study|Withdrawal by Subject|18|||
94551700|NCT00417963|323816983|FG000|Overall Study|Death|17|||
94551701|NCT00417963|323816983|FG000|Overall Study|Study device could not be deployed|3|||
94551702|NCT00477152|323816984|FG000|Overall Study|Parent withdrew consent|2|||
94551703|NCT00477152|323816984|FG000|Overall Study|Adverse Event|1|||
94551704|NCT02478164|323816987|FG000|Overall Study|Lack of Efficacy|13|||
94551705|NCT02478164|323816987|FG000|Overall Study|Adverse Event|1|||
94551706|NCT02478164|323816987|FG000|Overall Study|Withdrawal by Subject|1|||
94551707|NCT02337634|323816988|FG000|Overall Study|Protocol Violation|3|||
94551708|NCT02337634|323816989|FG001|Overall Study|Protocol Violation|1|||
94551709|NCT02337634|323816988|FG000|Overall Study|Lost to Follow-up|1|||
94551710|NCT02337634|323816989|FG001|Overall Study|Lost to Follow-up|0|||
94551711|NCT03266172|323816990|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
94551712|NCT03266172|323816991|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
94551713|NCT03266172|323816992|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
94551714|NCT03266172|323816990|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
94551715|NCT03266172|323816991|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
94551716|NCT03266172|323816992|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
94551717|NCT03266172|323816990|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
94551718|NCT03266172|323816991|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
94551719|NCT03266172|323816992|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
94551720|NCT03266172|323816990|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
94551721|NCT03266172|323816991|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
94551722|NCT03266172|323816992|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
94551723|NCT03266172|323816990|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
94551724|NCT03266172|323816991|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
94551725|NCT03266172|323816992|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
94551726|NCT03266172|323816990|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
94551727|NCT03266172|323816991|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
94551728|NCT03266172|323816992|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
94551729|NCT01422824|323816997|FG000|Overall Study|Case record form not evaluated|1|||
94551730|NCT01422824|323816997|FG000|Overall Study|Lost to Follow-up|37|||
94444229|NCT03323398|323411842|FG000|Overall Study|Lost to Follow-up|1|||
94444230|NCT03323398|323411843|FG001|Overall Study|Lost to Follow-up|2|||
94444231|NCT03323398|323411844|FG002|Overall Study|Lost to Follow-up|1|||
94444232|NCT03323398|323411845|FG003|Overall Study|Lost to Follow-up|0|||
94444233|NCT03323398|323411846|FG004|Overall Study|Lost to Follow-up|0|||
94444234|NCT03323398|323411847|FG005|Overall Study|Lost to Follow-up|0|||
94444235|NCT03323398|323411848|FG006|Overall Study|Lost to Follow-up|0|||
94444236|NCT03323398|323411849|FG007|Overall Study|Lost to Follow-up|0|||
94444237|NCT03323398|323411850|FG008|Overall Study|Lost to Follow-up|0|||
94444238|NCT03323398|323411842|FG000|Overall Study|Death|4|||
94444239|NCT03323398|323411843|FG001|Overall Study|Death|6|||
94444240|NCT03323398|323411844|FG002|Overall Study|Death|2|||
94444241|NCT03323398|323411845|FG003|Overall Study|Death|2|||
94444242|NCT03323398|323411846|FG004|Overall Study|Death|1|||
94444243|NCT03323398|323411847|FG005|Overall Study|Death|2|||
94444244|NCT03323398|323411848|FG006|Overall Study|Death|0|||
94444245|NCT03323398|323411849|FG007|Overall Study|Death|0|||
94444246|NCT03323398|323411850|FG008|Overall Study|Death|6|||
94444247|NCT03323398|323411842|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
94444248|NCT03323398|323411843|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
94444249|NCT03323398|323411844|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
94444250|NCT03323398|323411845|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
94444251|NCT03323398|323411846|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
94444252|NCT03323398|323411847|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
94444253|NCT03323398|323411848|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
94444254|NCT03323398|323411849|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
94444255|NCT03323398|323411850|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
94444256|NCT03323398|323411842|FG000|Overall Study|Withdrawal by Subject|2|||
94444257|NCT03323398|323411843|FG001|Overall Study|Withdrawal by Subject|1|||
94444258|NCT03323398|323411844|FG002|Overall Study|Withdrawal by Subject|3|||
94444259|NCT03323398|323411845|FG003|Overall Study|Withdrawal by Subject|0|||
94444260|NCT03323398|323411846|FG004|Overall Study|Withdrawal by Subject|0|||
94444261|NCT03323398|323411847|FG005|Overall Study|Withdrawal by Subject|1|||
94444262|NCT03323398|323411848|FG006|Overall Study|Withdrawal by Subject|0|||
94444263|NCT03323398|323411849|FG007|Overall Study|Withdrawal by Subject|0|||
94444264|NCT03323398|323411850|FG008|Overall Study|Withdrawal by Subject|0|||
94444265|NCT03323398|323411842|FG000|Overall Study|Participant was Put on Hospice|0|||
94444266|NCT03323398|323411843|FG001|Overall Study|Participant was Put on Hospice|0|||
94444267|NCT03323398|323411844|FG002|Overall Study|Participant was Put on Hospice|0|||
94444268|NCT03323398|323411845|FG003|Overall Study|Participant was Put on Hospice|0|||
94444269|NCT03323398|323411846|FG004|Overall Study|Participant was Put on Hospice|0|||
94444270|NCT03323398|323411847|FG005|Overall Study|Participant was Put on Hospice|0|||
94444271|NCT03323398|323411848|FG006|Overall Study|Participant was Put on Hospice|1|||
94444272|NCT03323398|323411849|FG007|Overall Study|Participant was Put on Hospice|0|||
94444273|NCT03323398|323411850|FG008|Overall Study|Participant was Put on Hospice|0|||
94444274|NCT03323398|323411842|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
94444275|NCT03323398|323411843|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
94444276|NCT03323398|323411844|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
94444277|NCT03323398|323411845|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
94444278|NCT03323398|323411846|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
94444279|NCT03323398|323411847|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
94444280|NCT03323398|323411848|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
94444281|NCT03323398|323411849|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
94444282|NCT03323398|323411850|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
94444283|NCT00739882|323413332|FG000|Double-blind Period|Adverse Event|1|||
94444284|NCT00739882|323413333|FG001|Double-blind Period|Adverse Event|2|||
94444285|NCT00739882|323413332|FG000|Double-blind Period|Protocol Violation|1|||
94444286|NCT00739882|323413333|FG001|Double-blind Period|Protocol Violation|0|||
94444287|NCT00739882|323413332|FG000|Double-blind Period|Lack of Efficacy|1|||
94444288|NCT00739882|323413333|FG001|Double-blind Period|Lack of Efficacy|1|||
94444289|NCT00739882|323413332|FG000|Double-blind Period|Other|16|||
94444290|NCT00739882|323413333|FG001|Double-blind Period|Other|8|||
94444291|NCT00739882|323413332|FG000|Open-label Period|Adverse Event|1|||
94444292|NCT00739882|323413333|FG001|Open-label Period|Adverse Event|0|||
94444293|NCT00739882|323413332|FG000|Open-label Period|Other|9|||
94444294|NCT00739882|323413333|FG001|Open-label Period|Other|5|||
94444295|NCT01168232|323413334|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
94444296|NCT01168232|323413334|FG000|Overall Study|Ineligible- Wrong cell type|6|||
94444297|NCT01168232|323413334|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
94444298|NCT03096314|323413339|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
94444299|NCT03096314|323413340|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
94444300|NCT01002989|323413346|FG000|Overall Study|exclusion criteria, no consent|5|||
94444301|NCT01996241|323413347|FG000|Overall Study|Lost to Follow-up|252|||
94444302|NCT01996241|323413348|FG001|Overall Study|Lost to Follow-up|235|||
94551731|NCT00454584|323816998|FG000|Controlled Period|Adverse Event|5|||
94551732|NCT00454584|323816999|FG001|Controlled Period|Adverse Event|2|||
94551733|NCT00454584|323817000|FG002|Controlled Period|Adverse Event|1|||
94551734|NCT00454584|323817001|FG003|Controlled Period|Adverse Event|0|||
94551735|NCT00454584|323817002|FG004|Controlled Period|Adverse Event|0|||
94551736|NCT00454584|323817003|FG005|Controlled Period|Adverse Event|0|||
94551737|NCT00454584|323816998|FG000|Controlled Period|Lost to Follow-up|1|||
94551738|NCT00454584|323816999|FG001|Controlled Period|Lost to Follow-up|2|||
94551739|NCT00454584|323817000|FG002|Controlled Period|Lost to Follow-up|2|||
94551740|NCT00454584|323817001|FG003|Controlled Period|Lost to Follow-up|0|||
94551741|NCT00454584|323817002|FG004|Controlled Period|Lost to Follow-up|0|||
94551742|NCT00454584|323817003|FG005|Controlled Period|Lost to Follow-up|0|||
94551743|NCT00454584|323816998|FG000|Controlled Period|Other|5|||
94551744|NCT00454584|323816999|FG001|Controlled Period|Other|4|||
94551745|NCT00454584|323817000|FG002|Controlled Period|Other|2|||
94551746|NCT00454584|323817001|FG003|Controlled Period|Other|0|||
94444303|NCT01479465|323413355|FG000|Overall Study|Disease Progression|9|||
94444304|NCT01479465|323413356|FG001|Overall Study|Disease Progression|61|||
94444305|NCT01479465|323413357|FG002|Overall Study|Disease Progression|65|||
94444306|NCT01479465|323413358|FG003|Overall Study|Disease Progression|70|||
94444307|NCT01479465|323413355|FG000|Overall Study|Study Discontinued by Sponsor|0|||
94444308|NCT01479465|323413356|FG001|Overall Study|Study Discontinued by Sponsor|7|||
94444309|NCT01479465|323413357|FG002|Overall Study|Study Discontinued by Sponsor|5|||
94444310|NCT01479465|323413358|FG003|Overall Study|Study Discontinued by Sponsor|3|||
94444311|NCT01479465|323413355|FG000|Overall Study|Adverse Event|0|||
94444312|NCT01479465|323413356|FG001|Overall Study|Adverse Event|3|||
94444313|NCT01479465|323413357|FG002|Overall Study|Adverse Event|6|||
94444314|NCT01479465|323413358|FG003|Overall Study|Adverse Event|4|||
94444315|NCT01479465|323413355|FG000|Overall Study|Investigator Discretion|1|||
94444316|NCT01479465|323413356|FG001|Overall Study|Investigator Discretion|4|||
94444317|NCT01479465|323413357|FG002|Overall Study|Investigator Discretion|2|||
94444318|NCT01479465|323413358|FG003|Overall Study|Investigator Discretion|4|||
94444319|NCT01479465|323413355|FG000|Overall Study|Subject Request|1|||
94444320|NCT01479465|323413356|FG001|Overall Study|Subject Request|3|||
94444321|NCT01479465|323413357|FG002|Overall Study|Subject Request|4|||
94444322|NCT01479465|323413358|FG003|Overall Study|Subject Request|2|||
94444323|NCT01479465|323413355|FG000|Overall Study|Subject Withdrew Consent|0|||
94444324|NCT01479465|323413356|FG001|Overall Study|Subject Withdrew Consent|5|||
94444325|NCT01479465|323413357|FG002|Overall Study|Subject Withdrew Consent|2|||
94444326|NCT01479465|323413358|FG003|Overall Study|Subject Withdrew Consent|1|||
94444327|NCT01479465|323413355|FG000|Overall Study|Protocol Violation|0|||
94444328|NCT01479465|323413356|FG001|Overall Study|Protocol Violation|1|||
94444329|NCT01479465|323413357|FG002|Overall Study|Protocol Violation|1|||
94444330|NCT01479465|323413358|FG003|Overall Study|Protocol Violation|0|||
94444331|NCT01479465|323413355|FG000|Overall Study|Death|0|||
94444332|NCT01479465|323413356|FG001|Overall Study|Death|0|||
94444333|NCT01479465|323413357|FG002|Overall Study|Death|0|||
94444334|NCT01479465|323413358|FG003|Overall Study|Death|1|||
94444335|NCT01479465|323413355|FG000|Overall Study|Lost to Follow-up|0|||
94444336|NCT01479465|323413356|FG001|Overall Study|Lost to Follow-up|0|||
94444337|NCT01479465|323413357|FG002|Overall Study|Lost to Follow-up|1|||
94444338|NCT01479465|323413358|FG003|Overall Study|Lost to Follow-up|0|||
94444339|NCT00595621|323413369|FG000|Open Label Run in|Adverse Event|1|||
94444340|NCT00595621|323413370|FG001|Open Label Run in|Adverse Event|0|||
94444341|NCT00595621|323413369|FG000|Open Label Run in|Physician Decision|1|||
94444342|NCT00595621|323413370|FG001|Open Label Run in|Physician Decision|0|||
94444343|NCT00595621|323413369|FG000|Open Label Run in|Withdrawal by Subject|1|||
94444344|NCT00595621|323413370|FG001|Open Label Run in|Withdrawal by Subject|0|||
94444345|NCT00595621|323413369|FG000|Randomization and Study|Adverse Event|2|||
94444346|NCT00595621|323413370|FG001|Randomization and Study|Adverse Event|0|||
94444347|NCT00595621|323413369|FG000|Randomization and Study|Withdrawal by Subject|0|||
94551747|NCT00454584|323817002|FG004|Controlled Period|Other|0|||
94551748|NCT00454584|323817003|FG005|Controlled Period|Other|0|||
94444348|NCT00595621|323413370|FG001|Randomization and Study|Withdrawal by Subject|1|||
94444349|NCT02392481|323413371|FG000|Overall Study|Adverse Event|0|||
94444350|NCT02392481|323413372|FG001|Overall Study|Adverse Event|0|||
94444351|NCT02392481|323413373|FG002|Overall Study|Adverse Event|1|||
94444352|NCT02392481|323413374|FG003|Overall Study|Adverse Event|2|||
94444353|NCT02392481|323413371|FG000|Overall Study|Withdrawal by Subject|0|||
94444354|NCT02392481|323413372|FG001|Overall Study|Withdrawal by Subject|0|||
94444355|NCT02392481|323413373|FG002|Overall Study|Withdrawal by Subject|1|||
94444356|NCT02392481|323413374|FG003|Overall Study|Withdrawal by Subject|0|||
94444357|NCT03597295|323413383|FG000|Overall Study|Death|70|||
94444358|NCT03597295|323413383|FG000|Overall Study|Lost to Follow-up|7|||
94444359|NCT03871543|323413392|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
94551749|NCT00454584|323816998|FG000|After Controlled Period|Adverse Event|0|||
94551750|NCT00454584|323816999|FG001|After Controlled Period|Adverse Event|0|||
94551751|NCT00454584|323817000|FG002|After Controlled Period|Adverse Event|0|||
94551752|NCT00454584|323817001|FG003|After Controlled Period|Adverse Event|9|||
94551753|NCT00454584|323817002|FG004|After Controlled Period|Adverse Event|3|||
94551754|NCT00454584|323817003|FG005|After Controlled Period|Adverse Event|9|||
94551755|NCT00454584|323816998|FG000|After Controlled Period|Lack of Efficacy|0|||
94551756|NCT00454584|323816999|FG001|After Controlled Period|Lack of Efficacy|0|||
94551757|NCT00454584|323817000|FG002|After Controlled Period|Lack of Efficacy|0|||
94551758|NCT00454584|323817001|FG003|After Controlled Period|Lack of Efficacy|1|||
94444360|NCT03871543|323413392|FG000|Period 1|Investigator Error|1|||
94444361|NCT03871543|323413392|FG000|Period 1|Protocol Violation|2|||
94444362|NCT03871543|323413392|FG000|Period 1|COVID-19 Related|1|||
94444363|NCT03871543|323413392|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
94444364|NCT03871543|323413392|FG000|Period 1|Withdrawal by Subject|10|||
94444365|NCT03871543|323413392|FG000|Period 2|Adverse Event|1|||
94444366|NCT03871543|323413392|FG000|Period 2|Withdrawal by Subject|1|||
94444367|NCT02414958|323413394|FG000|Overall Study|Adverse Event|6|||
94444368|NCT02414958|323413395|FG001|Overall Study|Adverse Event|6|||
94444369|NCT02414958|323413396|FG002|Overall Study|Adverse Event|3|||
94444370|NCT02414958|323413394|FG000|Overall Study|Protocol Violation|10|||
94444371|NCT02414958|323413395|FG001|Overall Study|Protocol Violation|3|||
94444372|NCT02414958|323413396|FG002|Overall Study|Protocol Violation|1|||
94444373|NCT02414958|323413394|FG000|Overall Study|Lost to Follow-up|7|||
94444374|NCT02414958|323413395|FG001|Overall Study|Lost to Follow-up|4|||
94444375|NCT02414958|323413396|FG002|Overall Study|Lost to Follow-up|0|||
94444376|NCT02414958|323413394|FG000|Overall Study|Withdrawal by Subject|5|||
94444377|NCT02414958|323413395|FG001|Overall Study|Withdrawal by Subject|3|||
94444378|NCT02414958|323413396|FG002|Overall Study|Withdrawal by Subject|5|||
94444379|NCT02414958|323413394|FG000|Overall Study|Other than specified|4|||
94444380|NCT02414958|323413395|FG001|Overall Study|Other than specified|4|||
94444381|NCT02414958|323413396|FG002|Overall Study|Other than specified|5|||
94444382|NCT00350207|323413399|FG000|Overall Study|Adverse Event|5|||
94444383|NCT00350207|323413400|FG001|Overall Study|Adverse Event|2|||
94444384|NCT00350207|323413401|FG002|Overall Study|Adverse Event|2|||
94444385|NCT00350207|323413399|FG000|Overall Study|Lack of Efficacy|1|||
94444386|NCT00350207|323413400|FG001|Overall Study|Lack of Efficacy|0|||
94444387|NCT00350207|323413401|FG002|Overall Study|Lack of Efficacy|2|||
94444388|NCT00350207|323413399|FG000|Overall Study|Lost to Follow-up|1|||
94444389|NCT00350207|323413400|FG001|Overall Study|Lost to Follow-up|0|||
94444390|NCT00350207|323413401|FG002|Overall Study|Lost to Follow-up|1|||
94444391|NCT00350207|323413399|FG000|Overall Study|Withdrawal by Subject|0|||
94444392|NCT00350207|323413400|FG001|Overall Study|Withdrawal by Subject|1|||
94444393|NCT00350207|323413401|FG002|Overall Study|Withdrawal by Subject|1|||
94444394|NCT00350207|323413399|FG000|Overall Study|Other|1|||
94444395|NCT00350207|323413400|FG001|Overall Study|Other|3|||
94444396|NCT00350207|323413401|FG002|Overall Study|Other|1|||
94444397|NCT03238651|323413404|FG000|Overall Study|Other|0|||
94444398|NCT03238651|323413405|FG001|Overall Study|Other|0|||
94444399|NCT03238651|323413406|FG002|Overall Study|Other|0|||
94444400|NCT03238651|323413407|FG003|Overall Study|Other|0|||
94444401|NCT03238651|323413408|FG004|Overall Study|Other|1|||
94551759|NCT00454584|323817002|FG004|After Controlled Period|Lack of Efficacy|0|||
94551760|NCT00454584|323817003|FG005|After Controlled Period|Lack of Efficacy|0|||
94551761|NCT00454584|323816998|FG000|After Controlled Period|Lost to Follow-up|0|||
94551762|NCT00454584|323816999|FG001|After Controlled Period|Lost to Follow-up|0|||
94551763|NCT00454584|323817000|FG002|After Controlled Period|Lost to Follow-up|0|||
94551764|NCT00454584|323817001|FG003|After Controlled Period|Lost to Follow-up|2|||
94551765|NCT00454584|323817002|FG004|After Controlled Period|Lost to Follow-up|4|||
94551766|NCT00454584|323817003|FG005|After Controlled Period|Lost to Follow-up|6|||
94551767|NCT00454584|323816998|FG000|After Controlled Period|Other|0|||
94551768|NCT00454584|323816999|FG001|After Controlled Period|Other|0|||
94551769|NCT00454584|323817000|FG002|After Controlled Period|Other|0|||
94551770|NCT00454584|323817001|FG003|After Controlled Period|Other|1|||
94444402|NCT03238651|323413404|FG000|Overall Study|Progressive Disease|2|||
94444403|NCT03238651|323413405|FG001|Overall Study|Progressive Disease|2|||
94551771|NCT00454584|323817002|FG004|After Controlled Period|Other|0|||
94551772|NCT00454584|323817003|FG005|After Controlled Period|Other|0|||
94444404|NCT03238651|323413406|FG002|Overall Study|Progressive Disease|2|||
94444405|NCT03238651|323413407|FG003|Overall Study|Progressive Disease|2|||
94444406|NCT03238651|323413408|FG004|Overall Study|Progressive Disease|0|||
94444407|NCT03238651|323413404|FG000|Overall Study|Withdrawal by Subject|0|||
94444408|NCT03238651|323413405|FG001|Overall Study|Withdrawal by Subject|1|||
94444409|NCT03238651|323413406|FG002|Overall Study|Withdrawal by Subject|0|||
94444410|NCT03238651|323413407|FG003|Overall Study|Withdrawal by Subject|1|||
94444411|NCT03238651|323413408|FG004|Overall Study|Withdrawal by Subject|0|||
94551773|NCT00454584|323816998|FG000|After Controlled Period|Other|0|||
94551774|NCT00454584|323816999|FG001|After Controlled Period|Other|0|||
94551775|NCT00454584|323817000|FG002|After Controlled Period|Other|0|||
94551776|NCT00454584|323817001|FG003|After Controlled Period|Other|13|||
94551777|NCT00454584|323817002|FG004|After Controlled Period|Other|5|||
94551778|NCT00454584|323817003|FG005|After Controlled Period|Other|17|||
94551779|NCT02421601|323817004|FG000|Overall Study|Adverse Event|4|||
94551780|NCT02421601|323817004|FG000|Overall Study|Lack of Efficacy|5|||
94551781|NCT02421601|323817004|FG000|Overall Study|Physician Decision|1|||
94551782|NCT02421601|323817004|FG000|Overall Study|Withdrawal by Subject|31|||
94551783|NCT02421601|323817004|FG000|Overall Study|Others|41|||
94551784|NCT01581619|323817005|FG000|Overall Study|Withdrawal by Subject|1|||
94551785|NCT01581619|323817005|FG000|Overall Study|Lost to Follow-up|1|||
94551786|NCT02250664|323817008|FG000|Overall Study|Lost to Follow-up|18|||
94551787|NCT02250664|323817009|FG001|Overall Study|Lost to Follow-up|28|||
94551788|NCT02250664|323817010|FG002|Overall Study|Lost to Follow-up|33|||
94551789|NCT02250664|323817008|FG000|Overall Study|Personal Reasons|7|||
94551790|NCT02250664|323817009|FG001|Overall Study|Personal Reasons|8|||
94551791|NCT02250664|323817010|FG002|Overall Study|Personal Reasons|14|||
94551792|NCT02250664|323817008|FG000|Overall Study|Adverse Event|6|||
94551793|NCT02250664|323817009|FG001|Overall Study|Adverse Event|3|||
94551794|NCT02250664|323817010|FG002|Overall Study|Adverse Event|8|||
94551795|NCT02250664|323817008|FG000|Overall Study|Incarcerated|2|||
94551796|NCT02250664|323817009|FG001|Overall Study|Incarcerated|1|||
94551797|NCT02250664|323817010|FG002|Overall Study|Incarcerated|2|||
94551798|NCT02250664|323817008|FG000|Overall Study|Withdrawal by Subject|0|||
94551799|NCT02250664|323817009|FG001|Overall Study|Withdrawal by Subject|1|||
94551800|NCT02250664|323817010|FG002|Overall Study|Withdrawal by Subject|2|||
94551801|NCT02250664|323817008|FG000|Overall Study|Death|0|||
94551802|NCT02250664|323817009|FG001|Overall Study|Death|1|||
94551803|NCT02250664|323817010|FG002|Overall Study|Death|1|||
94551804|NCT02250664|323817008|FG000|Overall Study|Physician Decision|1|||
94551805|NCT02250664|323817009|FG001|Overall Study|Physician Decision|3|||
94551806|NCT02250664|323817010|FG002|Overall Study|Physician Decision|1|||
94551807|NCT02250664|323817008|FG000|Overall Study|Protocol Violation|1|||
94551808|NCT02250664|323817009|FG001|Overall Study|Protocol Violation|0|||
94551809|NCT02250664|323817010|FG002|Overall Study|Protocol Violation|1|||
94551810|NCT02250664|323817008|FG000|Overall Study|Reason unknown|1|||
94551811|NCT02250664|323817009|FG001|Overall Study|Reason unknown|0|||
94551812|NCT02250664|323817010|FG002|Overall Study|Reason unknown|0|||
94551813|NCT04268173|323817011|FG000|Overall Study|Lost to Follow-up|75|||
94551814|NCT04268173|323817012|FG001|Overall Study|Lost to Follow-up|108|||
94551815|NCT05026853|323817013|FG000|Overall Study|Cancelled appointment|1|||
94551816|NCT05026853|323817014|FG001|Overall Study|Cancelled appointment|0|||
94551817|NCT05026853|323817013|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
94551818|NCT05026853|323817014|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
94551819|NCT05026853|323817013|FG000|Overall Study|Did not complete 12-week survey|16|||
94551820|NCT05026853|323817014|FG001|Overall Study|Did not complete 12-week survey|16|||
94551821|NCT03836677|323817015|FG000|Period 1|Adverse Event|0|||
94551822|NCT03836677|323817016|FG001|Period 1|Adverse Event|1|||
94551823|NCT03836677|323817015|FG000|Period 2|Severe non-compliance to protocol|1|||
94551824|NCT03836677|323817016|FG001|Period 2|Severe non-compliance to protocol|0|||
94551825|NCT01353911|323817017|FG000|Overall Study|Lost to Follow-up|2|||
94551826|NCT01353911|323817018|FG001|Overall Study|Lost to Follow-up|6|||
94551827|NCT01353911|323817019|FG002|Overall Study|Lost to Follow-up|4|||
94551828|NCT01353911|323817020|FG003|Overall Study|Lost to Follow-up|0|||
94551829|NCT01353911|323817021|FG004|Overall Study|Lost to Follow-up|4|||
94551830|NCT01353911|323817022|FG005|Overall Study|Lost to Follow-up|4|||
94551831|NCT01353911|323817023|FG006|Overall Study|Lost to Follow-up|3|||
94551832|NCT01353911|323817024|FG007|Overall Study|Lost to Follow-up|6|||
94551833|NCT01353911|323817017|FG000|Overall Study|Withdrawal by Subject|2|||
94551834|NCT01353911|323817018|FG001|Overall Study|Withdrawal by Subject|3|||
94551835|NCT01353911|323817019|FG002|Overall Study|Withdrawal by Subject|4|||
94551836|NCT01353911|323817020|FG003|Overall Study|Withdrawal by Subject|2|||
94551837|NCT01353911|323817021|FG004|Overall Study|Withdrawal by Subject|2|||
94551838|NCT01353911|323817022|FG005|Overall Study|Withdrawal by Subject|3|||
94551839|NCT01353911|323817023|FG006|Overall Study|Withdrawal by Subject|3|||
94551840|NCT01353911|323817024|FG007|Overall Study|Withdrawal by Subject|9|||
94551841|NCT01353911|323817017|FG000|Overall Study|Status Not Recorded|4|||
94551842|NCT01353911|323817018|FG001|Overall Study|Status Not Recorded|0|||
94551843|NCT01353911|323817019|FG002|Overall Study|Status Not Recorded|1|||
94551844|NCT01353911|323817020|FG003|Overall Study|Status Not Recorded|0|||
94551845|NCT01353911|323817021|FG004|Overall Study|Status Not Recorded|0|||
94551846|NCT01353911|323817022|FG005|Overall Study|Status Not Recorded|0|||
94551847|NCT01353911|323817023|FG006|Overall Study|Status Not Recorded|0|||
94551848|NCT01353911|323817024|FG007|Overall Study|Status Not Recorded|0|||
94551849|NCT01504204|323817027|FG000|Overall Study|Lost to Follow-up|1|||
94551850|NCT01504204|323817028|FG001|Overall Study|Lost to Follow-up|1|||
94551851|NCT03233438|323817031|FG000|Overall Study|Lost to Follow-up|4|||
94551852|NCT03233438|323817032|FG001|Overall Study|Lost to Follow-up|9|||
94551853|NCT03233438|323817031|FG000|Overall Study|Withdrawal by Subject|2|||
94551854|NCT03233438|323817032|FG001|Overall Study|Withdrawal by Subject|1|||
94551855|NCT03233438|323817031|FG000|Overall Study|No recording of dalbavancin|0|||
94551856|NCT03233438|323817032|FG001|Overall Study|No recording of dalbavancin|1|||
94551857|NCT03429543|323817033|FG000|Overall Study|Adverse Event|1|||
94551858|NCT03429543|323817034|FG001|Overall Study|Adverse Event|1|||
94551859|NCT03429543|323817035|FG002|Overall Study|Adverse Event|0|||
94551860|NCT03429543|323817036|FG003|Overall Study|Adverse Event|0|||
94551861|NCT03429543|323817037|FG004|Overall Study|Adverse Event|0|||
94551862|NCT03429543|323817038|FG005|Overall Study|Adverse Event|2|||
94551863|NCT03429543|323817039|FG006|Overall Study|Adverse Event|0|||
94551864|NCT03429543|323817033|FG000|Overall Study|Lost to Follow-up|1|||
94551865|NCT03429543|323817034|FG001|Overall Study|Lost to Follow-up|0|||
94551866|NCT03429543|323817035|FG002|Overall Study|Lost to Follow-up|0|||
94551867|NCT03429543|323817036|FG003|Overall Study|Lost to Follow-up|0|||
94551868|NCT03429543|323817037|FG004|Overall Study|Lost to Follow-up|1|||
94551869|NCT03429543|323817038|FG005|Overall Study|Lost to Follow-up|0|||
94551870|NCT03429543|323817039|FG006|Overall Study|Lost to Follow-up|0|||
94551871|NCT03429543|323817033|FG000|Overall Study|Withdrawal by Subject|5|||
94551872|NCT03429543|323817034|FG001|Overall Study|Withdrawal by Subject|0|||
94551873|NCT03429543|323817035|FG002|Overall Study|Withdrawal by Subject|1|||
94551874|NCT03429543|323817036|FG003|Overall Study|Withdrawal by Subject|2|||
94551875|NCT03429543|323817037|FG004|Overall Study|Withdrawal by Subject|6|||
94551876|NCT03429543|323817038|FG005|Overall Study|Withdrawal by Subject|3|||
94551877|NCT03429543|323817039|FG006|Overall Study|Withdrawal by Subject|1|||
94551878|NCT03429543|323817033|FG000|Overall Study|Other reason than listed|0|||
94551879|NCT03429543|323817034|FG001|Overall Study|Other reason than listed|1|||
94551880|NCT03429543|323817035|FG002|Overall Study|Other reason than listed|0|||
94551881|NCT03429543|323817036|FG003|Overall Study|Other reason than listed|0|||
94551882|NCT03429543|323817037|FG004|Overall Study|Other reason than listed|4|||
94551883|NCT03429543|323817038|FG005|Overall Study|Other reason than listed|4|||
94551884|NCT03429543|323817039|FG006|Overall Study|Other reason than listed|0|||
94551885|NCT03429543|323817033|FG000|Overall Study|Not treated|0|||
94551886|NCT03429543|323817034|FG001|Overall Study|Not treated|0|||
94551887|NCT03429543|323817035|FG002|Overall Study|Not treated|0|||
94551888|NCT03429543|323817036|FG003|Overall Study|Not treated|0|||
94551889|NCT03429543|323817037|FG004|Overall Study|Not treated|1|||
94551890|NCT03429543|323817038|FG005|Overall Study|Not treated|0|||
94551891|NCT03429543|323817039|FG006|Overall Study|Not treated|0|||
94551892|NCT01729208|323817040|FG000|Baseline|Physician Decision|5|||
94551893|NCT01729208|323817041|FG001|Baseline|Physician Decision|4|||
94551894|NCT01729208|323817040|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
94551895|NCT01729208|323817041|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
94551896|NCT01729208|323817040|FG000|12 Months Follow-up|Lost to Follow-up|3|||
94551897|NCT01729208|323817041|FG001|12 Months Follow-up|Lost to Follow-up|3|||
94551898|NCT01729208|323817040|FG000|24 Months Follow-up|Lost to Follow-up|3|||
94551899|NCT01729208|323817041|FG001|24 Months Follow-up|Lost to Follow-up|0|||
94551900|NCT01729208|323817040|FG000|36 Months Follow-up|Physician Decision|1|||
94551901|NCT01729208|323817041|FG001|36 Months Follow-up|Physician Decision|0|||
94551902|NCT01729208|323817040|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
94551903|NCT01729208|323817041|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
94551904|NCT00082381|323817042|FG000|Overall Study|Adverse Event|27|||
94551905|NCT00082381|323817043|FG001|Overall Study|Adverse Event|2|||
94551906|NCT00082381|323817042|FG000|Overall Study|Lost to Follow-up|5|||
94551907|NCT00082381|323817043|FG001|Overall Study|Lost to Follow-up|7|||
94551908|NCT00082381|323817042|FG000|Overall Study|Patient Decision|8|||
94551909|NCT00082381|323817043|FG001|Overall Study|Patient Decision|4|||
94551910|NCT00082381|323817042|FG000|Overall Study|Physician Decision|1|||
94551911|NCT00082381|323817043|FG001|Overall Study|Physician Decision|2|||
94551912|NCT00082381|323817042|FG000|Overall Study|Protocol Violation|10|||
94551913|NCT00082381|323817043|FG001|Overall Study|Protocol Violation|11|||
94551914|NCT00082381|323817042|FG000|Overall Study|Loss of Glucose Control|4|||
94551915|NCT00082381|323817043|FG001|Overall Study|Loss of Glucose Control|0|||
94551916|NCT04109976|323817045|FG000|Overall Study|Withdrawal by Subject|1|||
94551917|NCT04109976|323817046|FG001|Overall Study|Withdrawal by Subject|0|||
94551918|NCT03689855|323817051|FG000|Overall Study|Adverse Event|3|||
94551919|NCT03689855|323817051|FG000|Overall Study|Withdrawal by Subject|1|||
94551920|NCT00764673|323817059|FG000|Overall Study|Death|1|||
94551921|NCT00764673|323817059|FG000|Overall Study|Lost to Follow-up|3|||
94551922|NCT00764673|323817059|FG000|Overall Study|Withdrawal by Subject|6|||
94551923|NCT00764673|323817059|FG000|Overall Study|Revision of Device|2|||
94551924|NCT01389323|323817060|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
94551925|NCT01389323|323817060|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
94551926|NCT01389323|323817060|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
94551927|NCT01389323|323817060|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
94444412|NCT03238651|323413404|FG000|Overall Study|Adverse Event|1|||
94551928|NCT01389323|323817060|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
94551929|NCT01389323|323817060|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
94551930|NCT01389323|323817060|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
94551931|NCT01389323|323817060|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
94551932|NCT01389323|323817060|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
94551933|NCT01389323|323817060|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
94551934|NCT01389323|323817060|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
94551935|NCT02683668|323817061|FG000|Period 2|Withdrawal by Subject|0|||
94551936|NCT02683668|323817062|FG001|Period 2|Withdrawal by Subject|1|||
94551937|NCT02683668|323817063|FG002|Period 2|Withdrawal by Subject|0|||
94551938|NCT01270256|323817064|FG000|Overall Study|Withdrawal by Subject|1|||
94551939|NCT01270256|323817065|FG001|Overall Study|Withdrawal by Subject|0|||
94551940|NCT04566692|323817071|FG000|Overall Study|Adverse Event|2|||
94551941|NCT04566692|323817072|FG001|Overall Study|Adverse Event|0|||
94551942|NCT04566692|323817071|FG000|Overall Study|Withdrawal by Subject|1|||
94551943|NCT04566692|323817072|FG001|Overall Study|Withdrawal by Subject|1|||
94551944|NCT00590577|323817073|FG000|Overall Study|Lack of Efficacy|31|||
94551945|NCT00590577|323817074|FG001|Overall Study|Lack of Efficacy|28|||
94551946|NCT00590577|323817075|FG002|Overall Study|Lack of Efficacy|23|||
94551947|NCT00590577|323817076|FG003|Overall Study|Lack of Efficacy|45|||
94551948|NCT00590577|323817073|FG000|Overall Study|Withdrawal by Subject|23|||
94551949|NCT00590577|323817074|FG001|Overall Study|Withdrawal by Subject|28|||
94551950|NCT00590577|323817075|FG002|Overall Study|Withdrawal by Subject|30|||
94551951|NCT00590577|323817076|FG003|Overall Study|Withdrawal by Subject|26|||
94551952|NCT00590577|323817073|FG000|Overall Study|Adverse Event|10|||
94551953|NCT00590577|323817074|FG001|Overall Study|Adverse Event|10|||
94551954|NCT00590577|323817075|FG002|Overall Study|Adverse Event|13|||
94551955|NCT00590577|323817076|FG003|Overall Study|Adverse Event|11|||
94551956|NCT00590577|323817073|FG000|Overall Study|Lost to Follow-up|12|||
94444413|NCT03238651|323413405|FG001|Overall Study|Adverse Event|3|||
94444414|NCT03238651|323413406|FG002|Overall Study|Adverse Event|2|||
94444415|NCT03238651|323413407|FG003|Overall Study|Adverse Event|0|||
94444416|NCT03238651|323413408|FG004|Overall Study|Adverse Event|0|||
94444417|NCT04030299|323413411|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
94444418|NCT04030299|323413411|FG000|Overall Study|Withdrawal by Subject|3|||
94444419|NCT02137252|323413412|FG000|Overall Study|trial terminated early|2|||
94444420|NCT02137252|323413413|FG001|Overall Study|trial terminated early|1|||
94444421|NCT00811733|323413414|FG000|Overall Study|Investigator Discretion|10|||
94444422|NCT00811733|323413415|FG001|Overall Study|Investigator Discretion|8|||
94444423|NCT00811733|323413414|FG000|Overall Study|Withdrawal by Subject|1|||
94444424|NCT00811733|323413415|FG001|Overall Study|Withdrawal by Subject|2|||
94444425|NCT00793871|323413416|FG000|Overall Study|Death|50|||
94444426|NCT00793871|323413416|FG000|Overall Study|Lost to Follow-up|3|||
94444427|NCT00793871|323413416|FG000|Overall Study|Study terminated by the Sponsor|7|||
94444428|NCT02500589|323413417|FG000|Overall Study|Withdrawal by Subject|11|||
94444429|NCT02500589|323413418|FG001|Overall Study|Withdrawal by Subject|14|||
94444430|NCT02500589|323413417|FG000|Overall Study|Lost to Follow-up|10|||
94444431|NCT02500589|323413418|FG001|Overall Study|Lost to Follow-up|12|||
94444432|NCT02500589|323413417|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
94444433|NCT02500589|323413418|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
94444434|NCT02500589|323413417|FG000|Overall Study|Death|7|||
94444435|NCT02500589|323413418|FG001|Overall Study|Death|5|||
94444436|NCT05005507|323413424|FG000|Overall Study|Premature termination of study|1|||
94444437|NCT01753570|323413426|FG000|Overall Study|Adverse Event|1|||
94444438|NCT01753570|323413427|FG001|Overall Study|Adverse Event|0|||
94444439|NCT01753570|323413428|FG002|Overall Study|Adverse Event|1|||
94444440|NCT01753570|323413426|FG000|Overall Study|Physician Decision|0|||
94444441|NCT01753570|323413427|FG001|Overall Study|Physician Decision|1|||
94444442|NCT01753570|323413428|FG002|Overall Study|Physician Decision|0|||
94444443|NCT01753570|323413426|FG000|Overall Study|Withdrawal by Subject|1|||
94444444|NCT01753570|323413427|FG001|Overall Study|Withdrawal by Subject|4|||
94444445|NCT01753570|323413428|FG002|Overall Study|Withdrawal by Subject|0|||
94444446|NCT04616612|323413429|FG000|Overall Study|Lost to Follow-up|6|||
94444447|NCT04616612|323413430|FG001|Overall Study|Lost to Follow-up|3|||
94444448|NCT01288079|323413433|FG000|Overall Study|Withdrawal by Subject|2|||
94444449|NCT01288079|323413434|FG001|Overall Study|Withdrawal by Subject|4|||
94551957|NCT00590577|323817074|FG001|Overall Study|Lost to Follow-up|6|||
94444450|NCT01288079|323413435|FG002|Overall Study|Withdrawal by Subject|1|||
94444451|NCT01288079|323413436|FG003|Overall Study|Withdrawal by Subject|0|||
94444452|NCT01288079|323413433|FG000|Overall Study|Adverse Event|2|||
94444453|NCT01288079|323413434|FG001|Overall Study|Adverse Event|1|||
94444454|NCT01288079|323413435|FG002|Overall Study|Adverse Event|2|||
94444455|NCT01288079|323413436|FG003|Overall Study|Adverse Event|3|||
94444456|NCT01288079|323413433|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
94444457|NCT01288079|323413434|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
94342841|NCT01055457|323036015|FG002|Overall Study|Protocol Violation|1|||
94342842|NCT01055457|323036016|FG003|Overall Study|Protocol Violation|1|||
94342843|NCT01055457|323036017|FG004|Overall Study|Protocol Violation|1|||
94342844|NCT01055457|323036018|FG005|Overall Study|Protocol Violation|2|||
94342845|NCT01055457|323036019|FG006|Overall Study|Protocol Violation|1|||
94342846|NCT01055457|323036020|FG007|Overall Study|Protocol Violation|0|||
94342847|NCT01055457|323036021|FG008|Overall Study|Protocol Violation|0|||
94342848|NCT01055457|323036022|FG009|Overall Study|Protocol Violation|1|||
94342849|NCT01055457|323036013|FG000|Overall Study|Subject Disinterest|0|||
94342850|NCT01055457|323036014|FG001|Overall Study|Subject Disinterest|0|||
94342851|NCT01055457|323036015|FG002|Overall Study|Subject Disinterest|0|||
94342852|NCT01055457|323036016|FG003|Overall Study|Subject Disinterest|0|||
94342853|NCT01055457|323036017|FG004|Overall Study|Subject Disinterest|0|||
94342854|NCT01055457|323036018|FG005|Overall Study|Subject Disinterest|0|||
94342855|NCT01055457|323036019|FG006|Overall Study|Subject Disinterest|0|||
94342856|NCT01055457|323036020|FG007|Overall Study|Subject Disinterest|1|||
94342857|NCT01055457|323036021|FG008|Overall Study|Subject Disinterest|0|||
94342858|NCT01055457|323036022|FG009|Overall Study|Subject Disinterest|0|||
94342859|NCT01055457|323036013|FG000|Overall Study|Subject Ineligible|1|||
94342860|NCT01055457|323036014|FG001|Overall Study|Subject Ineligible|0|||
94342861|NCT01055457|323036015|FG002|Overall Study|Subject Ineligible|1|||
94342862|NCT01055457|323036016|FG003|Overall Study|Subject Ineligible|0|||
94342863|NCT01055457|323036017|FG004|Overall Study|Subject Ineligible|1|||
94342864|NCT01055457|323036018|FG005|Overall Study|Subject Ineligible|0|||
94342865|NCT01055457|323036019|FG006|Overall Study|Subject Ineligible|0|||
94342866|NCT01055457|323036020|FG007|Overall Study|Subject Ineligible|0|||
94342867|NCT01055457|323036021|FG008|Overall Study|Subject Ineligible|0|||
94342868|NCT01055457|323036022|FG009|Overall Study|Subject Ineligible|0|||
94342869|NCT01055457|323036013|FG000|Overall Study|Discomfort|0|||
94342870|NCT01055457|323036014|FG001|Overall Study|Discomfort|0|||
94342871|NCT01055457|323036015|FG002|Overall Study|Discomfort|0|||
94342872|NCT01055457|323036016|FG003|Overall Study|Discomfort|0|||
94342873|NCT01055457|323036017|FG004|Overall Study|Discomfort|1|||
94342874|NCT01055457|323036018|FG005|Overall Study|Discomfort|0|||
94342875|NCT01055457|323036019|FG006|Overall Study|Discomfort|0|||
94342876|NCT01055457|323036020|FG007|Overall Study|Discomfort|0|||
94342877|NCT01055457|323036021|FG008|Overall Study|Discomfort|0|||
94342878|NCT01055457|323036022|FG009|Overall Study|Discomfort|0|||
94342879|NCT01055457|323036013|FG000|Overall Study|Pregnancy|0|||
94342880|NCT01055457|323036014|FG001|Overall Study|Pregnancy|0|||
94342881|NCT01055457|323036015|FG002|Overall Study|Pregnancy|0|||
94342882|NCT01055457|323036016|FG003|Overall Study|Pregnancy|1|||
94342883|NCT01055457|323036017|FG004|Overall Study|Pregnancy|0|||
94342884|NCT01055457|323036018|FG005|Overall Study|Pregnancy|0|||
94342885|NCT01055457|323036019|FG006|Overall Study|Pregnancy|0|||
94342886|NCT01055457|323036020|FG007|Overall Study|Pregnancy|0|||
94342887|NCT01055457|323036021|FG008|Overall Study|Pregnancy|0|||
94342888|NCT01055457|323036022|FG009|Overall Study|Pregnancy|0|||
94342889|NCT01055457|323036013|FG000|Overall Study|Adverse Event|0|||
94342890|NCT01055457|323036014|FG001|Overall Study|Adverse Event|0|||
94342891|NCT01055457|323036015|FG002|Overall Study|Adverse Event|0|||
94342892|NCT01055457|323036016|FG003|Overall Study|Adverse Event|1|||
94342893|NCT01055457|323036017|FG004|Overall Study|Adverse Event|0|||
94342894|NCT01055457|323036018|FG005|Overall Study|Adverse Event|0|||
94342895|NCT01055457|323036019|FG006|Overall Study|Adverse Event|0|||
94342896|NCT01055457|323036020|FG007|Overall Study|Adverse Event|0|||
94342897|NCT01055457|323036021|FG008|Overall Study|Adverse Event|0|||
94342898|NCT01055457|323036022|FG009|Overall Study|Adverse Event|0|||
94342899|NCT04055844|323036023|FG000|Overall Study|Adverse Event|12|||
94342900|NCT04055844|323036023|FG000|Overall Study|Poor Performance|1|||
94444458|NCT01288079|323413435|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
94444459|NCT01288079|323413436|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
94551958|NCT00590577|323817075|FG002|Overall Study|Lost to Follow-up|6|||
94342901|NCT04055844|323036023|FG000|Overall Study|Death|1|||
94342902|NCT00255008|323036026|FG000|Overall Study|Adverse Event|1|||
94342903|NCT00255008|323036027|FG001|Overall Study|Adverse Event|1|||
94342904|NCT00255008|323036028|FG002|Overall Study|Adverse Event|2|||
94342905|NCT00255008|323036029|FG003|Overall Study|Adverse Event|0|||
94342906|NCT00255008|323036026|FG000|Overall Study|Lost to Follow-up|1|||
94342907|NCT00255008|323036027|FG001|Overall Study|Lost to Follow-up|0|||
94342908|NCT00255008|323036028|FG002|Overall Study|Lost to Follow-up|1|||
94342909|NCT00255008|323036029|FG003|Overall Study|Lost to Follow-up|2|||
94342910|NCT00255008|323036026|FG000|Overall Study|Did not meet viral reduction criteria|4|||
94342911|NCT00255008|323036027|FG001|Overall Study|Did not meet viral reduction criteria|5|||
94342912|NCT00255008|323036028|FG002|Overall Study|Did not meet viral reduction criteria|0|||
94342913|NCT00255008|323036029|FG003|Overall Study|Did not meet viral reduction criteria|1|||
94342914|NCT00255008|323036026|FG000|Overall Study|Withdrew consent|0|||
94444460|NCT01288079|323413433|FG000|Overall Study|Condition under Investigation Worsened|0|||
94444461|NCT01288079|323413434|FG001|Overall Study|Condition under Investigation Worsened|0|||
94444462|NCT01288079|323413435|FG002|Overall Study|Condition under Investigation Worsened|0|||
94444463|NCT01288079|323413436|FG003|Overall Study|Condition under Investigation Worsened|1|||
94444464|NCT01288079|323413433|FG000|Overall Study|Lack of Efficacy|2|||
94444465|NCT01288079|323413434|FG001|Overall Study|Lack of Efficacy|2|||
94444466|NCT01288079|323413435|FG002|Overall Study|Lack of Efficacy|0|||
94444467|NCT01288079|323413436|FG003|Overall Study|Lack of Efficacy|2|||
94444468|NCT01288079|323413433|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
94444469|NCT01288079|323413434|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
94444470|NCT01288079|323413435|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
94444471|NCT01288079|323413436|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
94444472|NCT01288079|323413433|FG000|Overall Study|Lost to Follow-up|1|||
94444473|NCT01288079|323413434|FG001|Overall Study|Lost to Follow-up|1|||
94444474|NCT01288079|323413435|FG002|Overall Study|Lost to Follow-up|1|||
94444475|NCT01288079|323413436|FG003|Overall Study|Lost to Follow-up|0|||
94444476|NCT01288079|323413433|FG000|Overall Study|Other or Study Termination|11|||
94444477|NCT01288079|323413434|FG001|Overall Study|Other or Study Termination|15|||
94444478|NCT01288079|323413435|FG002|Overall Study|Other or Study Termination|14|||
94444479|NCT01288079|323413436|FG003|Overall Study|Other or Study Termination|8|||
94444480|NCT01709500|323413437|FG000|Overall Study|Randomized but not treated|0|||
94444481|NCT01709500|323413438|FG001|Overall Study|Randomized but not treated|1|||
94444482|NCT01709500|323413437|FG000|Overall Study|Adverse Event|5|||
94444483|NCT01709500|323413438|FG001|Overall Study|Adverse Event|1|||
94444484|NCT01709500|323413437|FG000|Overall Study|Poor compliance to protocol|2|||
94444485|NCT01709500|323413438|FG001|Overall Study|Poor compliance to protocol|1|||
94444486|NCT01709500|323413437|FG000|Overall Study|Other|3|||
94444487|NCT01709500|323413438|FG001|Overall Study|Other|1|||
94444488|NCT01709500|323413437|FG000|Overall Study|Related to IMP administration|1|||
94444489|NCT01709500|323413438|FG001|Overall Study|Related to IMP administration|0|||
94444490|NCT01709500|323413437|FG000|Overall Study|Treatment ongoing|156|||
94444491|NCT01709500|323413438|FG001|Overall Study|Treatment ongoing|78|||
94444492|NCT02387840|323413440|FG000|Overall Study|Death|0|||
94444493|NCT02387840|323413441|FG001|Overall Study|Death|0|||
94444494|NCT02387840|323413442|FG002|Overall Study|Death|0|||
94444495|NCT02387840|323413443|FG003|Overall Study|Death|0|||
94444496|NCT02387840|323413444|FG004|Overall Study|Death|0|||
94444497|NCT02387840|323413445|FG005|Overall Study|Death|1|||
94444498|NCT00908544|323413446|FG000|Overall Study|Withdrawal by Subject|2|||
94444499|NCT00908544|323413447|FG001|Overall Study|Withdrawal by Subject|4|||
94444500|NCT00908544|323413446|FG000|Overall Study|Lack of Efficacy|0|||
94444501|NCT00908544|323413447|FG001|Overall Study|Lack of Efficacy|1|||
94444502|NCT00908544|323413446|FG000|Overall Study|Pregnancy|1|||
94444503|NCT00908544|323413447|FG001|Overall Study|Pregnancy|0|||
94444504|NCT00908544|323413446|FG000|Overall Study|Relocation abroad|1|||
94444505|NCT00908544|323413447|FG001|Overall Study|Relocation abroad|1|||
94444506|NCT00908544|323413446|FG000|Overall Study|Unable to visit sutdy center|1|||
94444507|NCT00908544|323413447|FG001|Overall Study|Unable to visit sutdy center|0|||
94444508|NCT04135937|323413448|FG000|Overall Study|Lost to Follow-up|2|||
94444509|NCT04135937|323413448|FG000|Overall Study|Withdrawal by Subject|1|||
94444510|NCT02269098|323413450|FG000|Overall Study|Lost to Follow-up|14|||
94444511|NCT02269098|323413451|FG001|Overall Study|Lost to Follow-up|9|||
94444512|NCT01831635|323413457|FG000|Overall Study|Withdrawal by Subject|0|||
94444513|NCT01831635|323413458|FG001|Overall Study|Withdrawal by Subject|2|||
94444514|NCT01831635|323413459|FG002|Overall Study|Withdrawal by Subject|0|||
94444515|NCT02389829|323413460|FG000|Overall Study|Lost to Follow-up|0|||
94444516|NCT02389829|323413461|FG001|Overall Study|Lost to Follow-up|1|||
94444517|NCT01622673|323413462|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94444518|NCT01622673|323413463|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94444519|NCT01622673|323413464|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94444520|NCT01622673|323413465|FG003|Treatment Period 1|Withdrawal by Subject|1|||
94444521|NCT01622673|323413466|FG004|Treatment Period 1|Withdrawal by Subject|0|||
94444522|NCT01622673|323413467|FG005|Treatment Period 1|Withdrawal by Subject|0|||
94444523|NCT01622673|323413462|FG000|Treatment Period 1|Protocol Violation|0|||
94444524|NCT01622673|323413463|FG001|Treatment Period 1|Protocol Violation|1|||
94444525|NCT01622673|323413464|FG002|Treatment Period 1|Protocol Violation|0|||
94551959|NCT00590577|323817076|FG003|Overall Study|Lost to Follow-up|9|||
94444526|NCT01622673|323413465|FG003|Treatment Period 1|Protocol Violation|0|||
94551960|NCT00590577|323817073|FG000|Overall Study|Pregnancy|0|||
94444527|NCT01622673|323413466|FG004|Treatment Period 1|Protocol Violation|0|||
94444528|NCT01622673|323413467|FG005|Treatment Period 1|Protocol Violation|0|||
94444529|NCT01622673|323413462|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94444530|NCT01622673|323413463|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94444531|NCT01622673|323413464|FG002|Treatment Period 2|Withdrawal by Subject|0|||
94551961|NCT00590577|323817074|FG001|Overall Study|Pregnancy|1|||
94444532|NCT01622673|323413465|FG003|Treatment Period 2|Withdrawal by Subject|1|||
94444533|NCT01622673|323413466|FG004|Treatment Period 2|Withdrawal by Subject|0|||
94551962|NCT00590577|323817075|FG002|Overall Study|Pregnancy|0|||
94342915|NCT00255008|323036027|FG001|Overall Study|Withdrew consent|0|||
94342916|NCT00255008|323036028|FG002|Overall Study|Withdrew consent|2|||
94342917|NCT00255008|323036029|FG003|Overall Study|Withdrew consent|0|||
94551963|NCT00590577|323817076|FG003|Overall Study|Pregnancy|0|||
94551964|NCT00590577|323817073|FG000|Overall Study|Various reasons|1|||
94551965|NCT00590577|323817074|FG001|Overall Study|Various reasons|3|||
94551966|NCT00590577|323817075|FG002|Overall Study|Various reasons|1|||
94342918|NCT00255008|323036026|FG000|Overall Study|Sponsor request|18|||
94342919|NCT00255008|323036027|FG001|Overall Study|Sponsor request|3|||
94342920|NCT00255008|323036028|FG002|Overall Study|Sponsor request|8|||
94342921|NCT00255008|323036029|FG003|Overall Study|Sponsor request|17|||
94342922|NCT00255008|323036026|FG000|Overall Study|Adverse lab experience|1|||
94342923|NCT00255008|323036027|FG001|Overall Study|Adverse lab experience|0|||
94342924|NCT00255008|323036028|FG002|Overall Study|Adverse lab experience|0|||
94342925|NCT00255008|323036029|FG003|Overall Study|Adverse lab experience|0|||
94342926|NCT00255008|323036026|FG000|Overall Study|Other|7|||
94342927|NCT00255008|323036027|FG001|Overall Study|Other|0|||
94342928|NCT00255008|323036028|FG002|Overall Study|Other|3|||
94342929|NCT00255008|323036029|FG003|Overall Study|Other|2|||
94342930|NCT02724111|323036030|FG000|Overall Study|Protocol Violation|2|||
94342931|NCT02724111|323036031|FG001|Overall Study|Protocol Violation|5|||
94342932|NCT02996500|323036032|FG000|Overall Study|Adverse Event|1|||
94342933|NCT02996500|323036033|FG001|Overall Study|Adverse Event|1|||
94342934|NCT02996500|323036034|FG002|Overall Study|Adverse Event|4|||
94342935|NCT02996500|323036035|FG003|Overall Study|Adverse Event|3|||
94342936|NCT02996500|323036036|FG004|Overall Study|Adverse Event|1|||
94342937|NCT02996500|323036037|FG005|Overall Study|Adverse Event|2|||
94342938|NCT02996500|323036032|FG000|Overall Study|Lack of Efficacy|0|||
94342939|NCT02996500|323036033|FG001|Overall Study|Lack of Efficacy|0|||
94342940|NCT02996500|323036034|FG002|Overall Study|Lack of Efficacy|0|||
94342941|NCT02996500|323036035|FG003|Overall Study|Lack of Efficacy|0|||
94342942|NCT02996500|323036036|FG004|Overall Study|Lack of Efficacy|2|||
94342943|NCT02996500|323036037|FG005|Overall Study|Lack of Efficacy|0|||
94342944|NCT02996500|323036032|FG000|Overall Study|Lost to Follow-up|1|||
94342945|NCT02996500|323036033|FG001|Overall Study|Lost to Follow-up|0|||
94342946|NCT02996500|323036034|FG002|Overall Study|Lost to Follow-up|0|||
94342947|NCT02996500|323036035|FG003|Overall Study|Lost to Follow-up|0|||
94342948|NCT02996500|323036036|FG004|Overall Study|Lost to Follow-up|0|||
94342949|NCT02996500|323036037|FG005|Overall Study|Lost to Follow-up|1|||
94342950|NCT02996500|323036032|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
94342951|NCT02996500|323036033|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
94342952|NCT02996500|323036034|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
94342953|NCT02996500|323036035|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
94342954|NCT02996500|323036036|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
94342955|NCT02996500|323036037|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
94342956|NCT02996500|323036032|FG000|Overall Study|Non-Compliance With Study Drug|0|||
94342957|NCT02996500|323036033|FG001|Overall Study|Non-Compliance With Study Drug|0|||
94342958|NCT02996500|323036034|FG002|Overall Study|Non-Compliance With Study Drug|0|||
94342959|NCT02996500|323036035|FG003|Overall Study|Non-Compliance With Study Drug|0|||
94342960|NCT02996500|323036036|FG004|Overall Study|Non-Compliance With Study Drug|0|||
94342961|NCT02996500|323036037|FG005|Overall Study|Non-Compliance With Study Drug|1|||
94342962|NCT02996500|323036032|FG000|Overall Study|Progressive Disease|1|||
94342963|NCT02996500|323036033|FG001|Overall Study|Progressive Disease|0|||
94342964|NCT02996500|323036034|FG002|Overall Study|Progressive Disease|0|||
94342965|NCT02996500|323036035|FG003|Overall Study|Progressive Disease|0|||
94342966|NCT02996500|323036036|FG004|Overall Study|Progressive Disease|0|||
94342967|NCT02996500|323036037|FG005|Overall Study|Progressive Disease|0|||
94342968|NCT02996500|323036032|FG000|Overall Study|Other|2|||
94342969|NCT02996500|323036033|FG001|Overall Study|Other|0|||
94342970|NCT02996500|323036034|FG002|Overall Study|Other|2|||
94342971|NCT02996500|323036035|FG003|Overall Study|Other|0|||
94342972|NCT02996500|323036036|FG004|Overall Study|Other|0|||
94342973|NCT02996500|323036037|FG005|Overall Study|Other|0|||
94342974|NCT02996500|323036032|FG000|Overall Study|Protocol Violation|0|||
94342975|NCT02996500|323036033|FG001|Overall Study|Protocol Violation|0|||
94551967|NCT00590577|323817076|FG003|Overall Study|Various reasons|2|||
94551968|NCT00844558|323817077|FG000|Overall Study|Withdrawal by Subject|9|||
94342976|NCT02996500|323036034|FG002|Overall Study|Protocol Violation|0|||
94342977|NCT02996500|323036035|FG003|Overall Study|Protocol Violation|1|||
94342978|NCT02996500|323036036|FG004|Overall Study|Protocol Violation|0|||
94342979|NCT02996500|323036037|FG005|Overall Study|Protocol Violation|0|||
94444534|NCT01622673|323413467|FG005|Treatment Period 2|Withdrawal by Subject|0|||
94444535|NCT01622673|323413462|FG000|Treatment Period 3|Protocol Violation|0|||
94444536|NCT01622673|323413463|FG001|Treatment Period 3|Protocol Violation|1|||
94444537|NCT01622673|323413464|FG002|Treatment Period 3|Protocol Violation|0|||
94444538|NCT01622673|323413465|FG003|Treatment Period 3|Protocol Violation|0|||
94444539|NCT01622673|323413466|FG004|Treatment Period 3|Protocol Violation|0|||
94444540|NCT01622673|323413467|FG005|Treatment Period 3|Protocol Violation|0|||
94444541|NCT02729025|323413468|FG000|Overall Study|Sponsor Decision|0|||
94444542|NCT02729025|323413469|FG001|Overall Study|Sponsor Decision|1|||
94444543|NCT05016960|323414874|FG000|Overall Study|Withdrawal by Subject|1|||
94444544|NCT05016960|323414875|FG001|Overall Study|Withdrawal by Subject|9|||
94444545|NCT04565145|323414876|FG000|Overall Study|Withdrawal by Subject|1|||
94444546|NCT04565145|323414877|FG001|Overall Study|Withdrawal by Subject|1|||
94444547|NCT00471822|323414878|FG000|Overall Study|Protocol Violation|2|||
94444548|NCT03500198|323414879|FG000|Overall Study|Lost to Follow-up|0|||
94444549|NCT03500198|323414880|FG001|Overall Study|Lost to Follow-up|1|||
94444550|NCT03334435|323414881|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
94444551|NCT03334435|323414882|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
94444552|NCT03334435|323414883|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
94444553|NCT03334435|323414884|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
94444554|NCT03334435|323414885|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
94444555|NCT03334435|323414886|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
94444556|NCT03334435|323414887|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
94444557|NCT03334435|323414888|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
94444558|NCT03334435|323414889|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
94444559|NCT03334435|323414890|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
94444560|NCT03334435|323414891|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
94444561|NCT03334435|323414892|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
94444562|NCT03334435|323414893|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
94444563|NCT03334435|323414894|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
94444564|NCT03334435|323414895|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
94444565|NCT03334435|323414881|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
94444566|NCT03334435|323414882|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
94444567|NCT03334435|323414883|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
94444568|NCT03334435|323414884|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
94444569|NCT03334435|323414885|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
94444570|NCT03334435|323414886|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
94444571|NCT03334435|323414887|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
94444572|NCT03334435|323414888|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
94444573|NCT03334435|323414889|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
94444574|NCT03334435|323414890|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
94444575|NCT03334435|323414891|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
94444576|NCT03334435|323414892|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
94444577|NCT03334435|323414893|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
94444578|NCT03334435|323414894|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
94444579|NCT03334435|323414895|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
94444580|NCT03334435|323414881|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
94444581|NCT03334435|323414882|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
94444582|NCT03334435|323414883|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
94444583|NCT03334435|323414884|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
94444584|NCT03334435|323414885|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
94444585|NCT03334435|323414886|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
94444586|NCT03334435|323414887|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
94444587|NCT03334435|323414888|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
94444588|NCT03334435|323414889|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
94444589|NCT03334435|323414890|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
94444590|NCT03334435|323414891|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
94551969|NCT00844558|323817078|FG001|Overall Study|Withdrawal by Subject|2|||
94342980|NCT02996500|323036032|FG000|Overall Study|Withdrawal by Subject|3|||
94444591|NCT03334435|323414892|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
94444592|NCT03334435|323414893|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
94444593|NCT03334435|323414894|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
94444594|NCT03334435|323414895|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
94444595|NCT03334435|323414881|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
94444596|NCT03334435|323414882|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
94444597|NCT03334435|323414883|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
94444598|NCT03334435|323414884|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
94444599|NCT03334435|323414885|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
94444600|NCT03334435|323414886|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
94444601|NCT03334435|323414887|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
94444602|NCT03334435|323414888|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
94444603|NCT03334435|323414889|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
94444604|NCT03334435|323414890|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
94444605|NCT03334435|323414891|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
94444606|NCT03334435|323414892|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
94444607|NCT03334435|323414893|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
94444608|NCT03334435|323414894|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
94444609|NCT03334435|323414895|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
94444610|NCT03334435|323414881|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
94444611|NCT03334435|323414882|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
94444612|NCT03334435|323414883|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
94444613|NCT03334435|323414884|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
94444614|NCT03334435|323414885|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
94444615|NCT03334435|323414886|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
94444616|NCT03334435|323414887|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
94444617|NCT03334435|323414888|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
94444618|NCT03334435|323414889|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
94444619|NCT03334435|323414890|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
94444620|NCT03334435|323414891|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
94444621|NCT03334435|323414892|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
94444622|NCT03334435|323414893|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
94444623|NCT03334435|323414894|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
94444624|NCT03334435|323414895|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
94444625|NCT03334435|323414881|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
94444626|NCT03334435|323414882|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
94444627|NCT03334435|323414883|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
94444628|NCT03334435|323414884|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
94444629|NCT03334435|323414885|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
94444630|NCT03334435|323414886|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
94444631|NCT03334435|323414887|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
94444632|NCT03334435|323414888|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
94444633|NCT03334435|323414889|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
94444634|NCT03334435|323414890|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
94444635|NCT03334435|323414891|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
94444636|NCT03334435|323414892|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
94444637|NCT03334435|323414893|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
94444638|NCT03334435|323414894|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
94444639|NCT03334435|323414895|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
94444640|NCT03334435|323414881|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
94444641|NCT03334435|323414882|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
94444642|NCT03334435|323414883|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
94444643|NCT03334435|323414884|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
94551970|NCT00844558|323817077|FG000|Overall Study|Death|1|||
94342981|NCT02996500|323036033|FG001|Overall Study|Withdrawal by Subject|0|||
94342982|NCT02996500|323036034|FG002|Overall Study|Withdrawal by Subject|3|||
94342983|NCT02996500|323036035|FG003|Overall Study|Withdrawal by Subject|0|||
94342984|NCT02996500|323036036|FG004|Overall Study|Withdrawal by Subject|2|||
94342985|NCT02996500|323036037|FG005|Overall Study|Withdrawal by Subject|0|||
94342986|NCT01300767|323036038|FG000|Overall Study|Discomfort|2|||
94342987|NCT01300767|323036038|FG000|Overall Study|Biomicroscopy|1|||
94342988|NCT01300767|323036038|FG000|Overall Study|Unacceptable fit|1|||
94342989|NCT00606294|323036039|FG000|Overall Study|Withdrawal by Subject|36|||
94342990|NCT00606294|323036040|FG001|Overall Study|Withdrawal by Subject|0|||
94342991|NCT03073200|323036041|FG000|Double Blind Treatment Period|Protocol Violation|1|||
94342992|NCT03073200|323036042|FG001|Double Blind Treatment Period|Protocol Violation|0|||
94342993|NCT03073200|323036043|FG002|Double Blind Treatment Period|Protocol Violation|0|||
94444644|NCT03334435|323414885|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
94444645|NCT03334435|323414886|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
94444646|NCT03334435|323414887|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
94444647|NCT03334435|323414888|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
94444648|NCT03334435|323414889|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
94444649|NCT03334435|323414890|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
94444650|NCT03334435|323414891|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
94444651|NCT03334435|323414892|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
94444652|NCT03334435|323414893|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
94444653|NCT03334435|323414894|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
94444654|NCT03334435|323414895|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
94444655|NCT03334435|323414881|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
94444656|NCT03334435|323414882|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
94444657|NCT03334435|323414883|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
94444658|NCT03334435|323414884|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
94444659|NCT03334435|323414885|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
94444660|NCT03334435|323414886|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
94444661|NCT03334435|323414887|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
94444662|NCT03334435|323414888|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
94444663|NCT03334435|323414889|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
94444664|NCT03334435|323414890|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
94444665|NCT03334435|323414891|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
94444666|NCT03334435|323414892|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
94444667|NCT03334435|323414893|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
94444668|NCT03334435|323414894|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
94444669|NCT03334435|323414895|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
94444670|NCT03334435|323414881|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
94444671|NCT03334435|323414882|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
94444672|NCT03334435|323414883|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
94444673|NCT03334435|323414884|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
94444674|NCT03334435|323414885|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
94444675|NCT03334435|323414886|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
94444676|NCT03334435|323414887|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
94444677|NCT03334435|323414888|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
94444678|NCT03334435|323414889|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
94444679|NCT03334435|323414890|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
94444680|NCT03334435|323414891|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
94444681|NCT03334435|323414892|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
94444682|NCT03334435|323414893|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
94444683|NCT03334435|323414894|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
94444684|NCT03334435|323414895|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
94444685|NCT03334435|323414881|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
94444686|NCT03334435|323414882|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
94444687|NCT03334435|323414883|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
94444688|NCT03334435|323414884|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
94444689|NCT03334435|323414885|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
94444690|NCT03334435|323414886|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
94444691|NCT03334435|323414887|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
94444692|NCT03334435|323414888|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
94444693|NCT03334435|323414889|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
94444694|NCT03334435|323414890|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
94444695|NCT03334435|323414891|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
94444696|NCT03334435|323414892|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
94444697|NCT03334435|323414893|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
94444698|NCT03334435|323414894|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
94444699|NCT03334435|323414895|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
94444700|NCT03334435|323414881|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
94444701|NCT03334435|323414882|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
94444702|NCT03334435|323414883|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
94444703|NCT03334435|323414884|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
94444704|NCT03334435|323414885|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
94551971|NCT00844558|323817078|FG001|Overall Study|Death|0|||
94551972|NCT00844558|323817077|FG000|Overall Study|Protocol Violation|1|||
94551973|NCT00844558|323817078|FG001|Overall Study|Protocol Violation|1|||
94551974|NCT00844558|323817077|FG000|Overall Study|Lost to Follow-up|0|||
94551975|NCT00844558|323817078|FG001|Overall Study|Lost to Follow-up|1|||
94551976|NCT00844558|323817077|FG000|Overall Study|Physician Decision|1|||
94551977|NCT00844558|323817078|FG001|Overall Study|Physician Decision|0|||
94551978|NCT03203291|323817079|FG000|Overall Study|Withdrawal by Subject|1|||
94551979|NCT00737633|323817080|FG000|Overall Study|Study terminated by sponsor|44|||
94551980|NCT00737633|323817081|FG001|Overall Study|Study terminated by sponsor|55|||
94551981|NCT00737633|323817080|FG000|Overall Study|Lost to Follow-up|0|||
94551982|NCT00737633|323817081|FG001|Overall Study|Lost to Follow-up|1|||
94551983|NCT00737633|323817080|FG000|Overall Study|protocol non-compliance|0|||
94551984|NCT00737633|323817081|FG001|Overall Study|protocol non-compliance|1|||
94551985|NCT01300260|323817086|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
94551986|NCT01300260|323817087|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
94551987|NCT01300260|323817086|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
94551988|NCT01300260|323817087|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
94551989|NCT01300260|323817086|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
94551990|NCT01300260|323817087|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
94551991|NCT03157037|323817089|FG000|Overall Study|Death|1|||
94551992|NCT01457846|323817093|FG000|Overall Study|Death before treatment|1|||
94551993|NCT01457846|323817094|FG001|Overall Study|Death before treatment|2|||
94551994|NCT01457846|323817093|FG000|Overall Study|Did not receive treatment|0|||
94551995|NCT01457846|323817094|FG001|Overall Study|Did not receive treatment|1|||
94551996|NCT01457846|323817093|FG000|Overall Study|Death|27|||
94551997|NCT01457846|323817094|FG001|Overall Study|Death|16|||
94551998|NCT01457846|323817093|FG000|Overall Study|Unclassified reason for not completed|11|||
94551999|NCT01457846|323817094|FG001|Overall Study|Unclassified reason for not completed|10|||
94552000|NCT01457846|323817093|FG000|Overall Study|Withdrawal by Subject|1|||
94552001|NCT01457846|323817094|FG001|Overall Study|Withdrawal by Subject|1|||
94552002|NCT01457846|323817093|FG000|Overall Study|Lost to Follow-up|1|||
94552003|NCT01457846|323817094|FG001|Overall Study|Lost to Follow-up|0|||
94552004|NCT02161757|323817095|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
94552005|NCT02161757|323817096|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
94552006|NCT02161757|323817097|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
94552007|NCT02161757|323817095|FG000|Treatment Through Study Completion|Adverse Event|1|||
94552008|NCT02161757|323817096|FG001|Treatment Through Study Completion|Adverse Event|1|||
94552009|NCT02161757|323817097|FG002|Treatment Through Study Completion|Adverse Event|0|||
94552010|NCT02161757|323817095|FG000|Treatment Through Study Completion|Protocol Violation|0|||
94552011|NCT02161757|323817096|FG001|Treatment Through Study Completion|Protocol Violation|1|||
94552012|NCT02161757|323817097|FG002|Treatment Through Study Completion|Protocol Violation|2|||
94552013|NCT02161757|323817095|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
94552014|NCT02161757|323817096|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
94552015|NCT02161757|323817097|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
94552016|NCT02161757|323817095|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
94552017|NCT02161757|323817096|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
94552018|NCT02161757|323817097|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
94552019|NCT02161757|323817095|FG000|Treatment Through Study Completion|Other|20|||
94552020|NCT02161757|323817096|FG001|Treatment Through Study Completion|Other|19|||
94552021|NCT02161757|323817097|FG002|Treatment Through Study Completion|Other|12|||
94552022|NCT02161757|323817095|FG000|Treatment Through Study Completion|Death|2|||
94552023|NCT02161757|323817096|FG001|Treatment Through Study Completion|Death|1|||
94552024|NCT02161757|323817097|FG002|Treatment Through Study Completion|Death|1|||
94552025|NCT00788710|323817100|FG000|Overall Study|Adverse Event|1|||
94552026|NCT00788710|323817101|FG001|Overall Study|Adverse Event|3|||
94552027|NCT00788710|323817102|FG002|Overall Study|Adverse Event|4|||
94552028|NCT00788710|323817100|FG000|Overall Study|Lack of Efficacy|0|||
94552029|NCT00788710|323817101|FG001|Overall Study|Lack of Efficacy|0|||
94552030|NCT00788710|323817102|FG002|Overall Study|Lack of Efficacy|1|||
94552031|NCT00788710|323817100|FG000|Overall Study|Lost to Follow-up|0|||
94552032|NCT00788710|323817101|FG001|Overall Study|Lost to Follow-up|1|||
94552033|NCT00788710|323817102|FG002|Overall Study|Lost to Follow-up|0|||
94552034|NCT00788710|323817100|FG000|Overall Study|Physician Decision|2|||
94552035|NCT00788710|323817101|FG001|Overall Study|Physician Decision|1|||
94552036|NCT00788710|323817102|FG002|Overall Study|Physician Decision|0|||
94552037|NCT00788710|323817100|FG000|Overall Study|Protocol Violation|0|||
94444705|NCT03334435|323414886|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
94444706|NCT03334435|323414887|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
94444707|NCT03334435|323414888|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
94444708|NCT03334435|323414889|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
94444709|NCT03334435|323414890|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
94444710|NCT03334435|323414891|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
94444711|NCT03334435|323414892|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
94444712|NCT03334435|323414893|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
94444713|NCT03334435|323414894|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
94444714|NCT03334435|323414895|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
94444715|NCT03334435|323414881|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
94444716|NCT03334435|323414882|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
94444717|NCT03334435|323414883|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
94444718|NCT03334435|323414884|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
94444719|NCT03334435|323414885|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
94444720|NCT03334435|323414886|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
94444721|NCT03334435|323414887|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
94444722|NCT03334435|323414888|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
94444723|NCT03334435|323414889|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
94444724|NCT03334435|323414890|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
94444725|NCT03334435|323414891|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
94444726|NCT03334435|323414892|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
94444727|NCT03334435|323414893|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
94444728|NCT03334435|323414894|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
94444729|NCT03334435|323414895|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
94444730|NCT03334435|323414881|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
94444731|NCT03334435|323414882|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
94444732|NCT03334435|323414883|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
94444733|NCT03334435|323414884|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
94444734|NCT03334435|323414885|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
94444735|NCT03334435|323414886|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
94444736|NCT03334435|323414887|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
94444737|NCT03334435|323414888|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
94444738|NCT03334435|323414889|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
94444739|NCT03334435|323414890|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
94444740|NCT03334435|323414891|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
94444741|NCT03334435|323414892|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
94444742|NCT03334435|323414893|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
94444743|NCT03334435|323414894|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
94444744|NCT03334435|323414895|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
94444745|NCT03334435|323414881|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
94444746|NCT03334435|323414882|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
94444747|NCT03334435|323414883|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
94444748|NCT03334435|323414884|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
94444749|NCT03334435|323414885|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
94444750|NCT03334435|323414886|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
94444751|NCT03334435|323414887|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
94444752|NCT03334435|323414888|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
94444753|NCT03334435|323414889|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
94444754|NCT03334435|323414890|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
94444755|NCT03334435|323414891|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
94444756|NCT03334435|323414892|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
94444757|NCT03334435|323414893|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
94444758|NCT03334435|323414894|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
94444759|NCT03334435|323414895|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
94444760|NCT03334435|323414881|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
94444761|NCT03334435|323414882|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
94444762|NCT03334435|323414883|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
94444763|NCT03334435|323414884|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
94444764|NCT03334435|323414885|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
94444765|NCT03334435|323414886|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
94444766|NCT03334435|323414887|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
94444767|NCT03334435|323414888|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
94444768|NCT03334435|323414889|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
94444769|NCT03334435|323414890|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
94444770|NCT03334435|323414891|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
94444771|NCT03334435|323414892|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
94444772|NCT03334435|323414893|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
94444773|NCT03334435|323414894|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
94444774|NCT03334435|323414895|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
94444775|NCT03334435|323414881|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
94444776|NCT03334435|323414882|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
94444777|NCT03334435|323414883|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
94444778|NCT03334435|323414884|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
94444779|NCT03334435|323414885|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
94444780|NCT03334435|323414886|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
94444781|NCT03334435|323414887|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
94444782|NCT03334435|323414888|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
94444783|NCT03334435|323414889|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
94444784|NCT03334435|323414890|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
94444785|NCT03334435|323414891|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
94444786|NCT03334435|323414892|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
94444787|NCT03334435|323414893|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
94444788|NCT03334435|323414894|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
94444789|NCT03334435|323414895|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
94552038|NCT00788710|323817101|FG001|Overall Study|Protocol Violation|1|||
94444790|NCT03334435|323414881|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
94444791|NCT03334435|323414882|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
94444792|NCT03334435|323414883|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
94552039|NCT00788710|323817102|FG002|Overall Study|Protocol Violation|1|||
94444793|NCT03334435|323414884|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
94444794|NCT03334435|323414885|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
94444795|NCT03334435|323414886|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
94444796|NCT03334435|323414887|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
94444797|NCT03334435|323414888|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
94444798|NCT03334435|323414889|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
94444799|NCT03334435|323414890|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
94444800|NCT03334435|323414891|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
94444801|NCT03334435|323414892|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
94444802|NCT03334435|323414893|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
94444803|NCT03334435|323414894|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
94444804|NCT03334435|323414895|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
94444805|NCT03334435|323414881|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
94444806|NCT03334435|323414882|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
94444807|NCT03334435|323414883|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
94444808|NCT03334435|323414884|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
94444809|NCT03334435|323414885|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
94444810|NCT03334435|323414886|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
94444811|NCT03334435|323414887|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
94444812|NCT03334435|323414888|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
94444813|NCT03334435|323414889|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
94444814|NCT03334435|323414890|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
94444815|NCT03334435|323414891|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
94444816|NCT03334435|323414892|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
94444817|NCT03334435|323414893|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
94444818|NCT03334435|323414894|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
94444819|NCT03334435|323414895|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
94444820|NCT03334435|323414881|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
94444821|NCT03334435|323414882|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
94444822|NCT03334435|323414883|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
94444823|NCT03334435|323414884|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
94444824|NCT03334435|323414885|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
94444825|NCT03334435|323414886|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
94444826|NCT03334435|323414887|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
94444827|NCT03334435|323414888|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
94444828|NCT03334435|323414889|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
94444829|NCT03334435|323414890|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
94444830|NCT03334435|323414891|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
94444831|NCT03334435|323414892|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
94444832|NCT03334435|323414893|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
94444833|NCT03334435|323414894|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
94444834|NCT03334435|323414895|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
94444835|NCT03922321|323414896|FG000|Overall Study|Participant Moved|1|||
94444836|NCT03922321|323414896|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
94444837|NCT04067050|323414897|FG000|One Month|Lost to Follow-up|4|||
94444838|NCT04067050|323414898|FG001|One Month|Lost to Follow-up|0|||
94444839|NCT04067050|323414897|FG000|Two Month|Lost to Follow-up|1|||
94444840|NCT04067050|323414898|FG001|Two Month|Lost to Follow-up|0|||
94444841|NCT04067050|323414897|FG000|Two Month|Adverse Event|1|||
94444842|NCT04067050|323414898|FG001|Two Month|Adverse Event|0|||
94444843|NCT03817125|323414899|FG000|Overall Study|Adverse Event|1|||
94444844|NCT03817125|323414900|FG001|Overall Study|Adverse Event|0|||
94444845|NCT03817125|323414899|FG000|Overall Study|Physician Decision|0|||
94444846|NCT03817125|323414900|FG001|Overall Study|Physician Decision|1|||
94444847|NCT03817125|323414899|FG000|Overall Study|Lack of Efficacy|1|||
94444848|NCT03817125|323414900|FG001|Overall Study|Lack of Efficacy|5|||
94444849|NCT00942084|323414901|FG000|Overall Study|Death|2|||
94552040|NCT00788710|323817100|FG000|Overall Study|Withdrawal by Subject|2|||
94552041|NCT00788710|323817101|FG001|Overall Study|Withdrawal by Subject|2|||
94552042|NCT00788710|323817102|FG002|Overall Study|Withdrawal by Subject|0|||
94444850|NCT02712320|323414902|FG000|Overall Study|Lost to Follow-up|1|||
94444851|NCT02712320|323414902|FG000|Overall Study|Withdrawal by Subject|1|||
94444852|NCT02712320|323414902|FG000|Overall Study|Transferred to another facility|1|||
94444853|NCT02712320|323414902|FG000|Overall Study|Treating with the prohibited medications|2|||
94444854|NCT01686373|323414903|FG000|Overall Study|Lost to Follow-up|3|||
94444855|NCT01686373|323414904|FG001|Overall Study|Lost to Follow-up|0|||
94444856|NCT01686373|323414903|FG000|Overall Study|Withdrawal by Subject|0|||
94444857|NCT01686373|323414904|FG001|Overall Study|Withdrawal by Subject|1|||
94444858|NCT01686373|323414903|FG000|Overall Study|Adverse Event|0|||
94444859|NCT01686373|323414904|FG001|Overall Study|Adverse Event|1|||
94444860|NCT00360282|323414905|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
94444861|NCT00360282|323414906|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
94444862|NCT00360282|323414907|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
94444863|NCT00360282|323414908|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
94444864|NCT00360282|323414905|FG000|Second Intervention|Adverse Event|0|||
94444865|NCT00360282|323414906|FG001|Second Intervention|Adverse Event|1|||
94444866|NCT00360282|323414907|FG002|Second Intervention|Adverse Event|0|||
94552043|NCT01183065|323817103|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
94552044|NCT00727558|323817104|FG000|Overall Study|Lens issue|0|||
94444867|NCT00360282|323414908|FG003|Second Intervention|Adverse Event|0|||
94444868|NCT02285361|323414919|FG000|Overall Study|Protocol Violation|43|||
94444869|NCT02285361|323414919|FG000|Overall Study|Lost to Follow-up|5|||
94444870|NCT02285361|323414919|FG000|Overall Study|Not taken GIOTRIF|2|||
94444871|NCT02285361|323414919|FG000|Overall Study|Consented prior to the contract date|1|||
94444872|NCT01697748|323414924|FG000|Overall Study|ineligible skin incision|1|||
94444873|NCT01697748|323414925|FG001|Overall Study|ineligible skin incision|2|||
94444874|NCT01697748|323414924|FG000|Overall Study|ineligible uterine incision|4|||
94444875|NCT01697748|323414925|FG001|Overall Study|ineligible uterine incision|1|||
94444876|NCT01697748|323414924|FG000|Overall Study|Lost to Follow-up|53|||
94444877|NCT01697748|323414925|FG001|Overall Study|Lost to Follow-up|65|||
94444878|NCT01058642|323414929|FG000|Treatment Period 1|Adverse Event|0|||
94444879|NCT01058642|323414930|FG001|Treatment Period 1|Adverse Event|1|||
94444880|NCT01058642|323414931|FG002|Treatment Period 1|Adverse Event|1|||
94444881|NCT01058642|323414932|FG003|Treatment Period 1|Adverse Event|0|||
94444882|NCT01058642|323414929|FG000|Treatment Period 1|Physician Decision|0|||
94444883|NCT01058642|323414930|FG001|Treatment Period 1|Physician Decision|0|||
94444884|NCT01058642|323414931|FG002|Treatment Period 1|Physician Decision|1|||
94444885|NCT01058642|323414932|FG003|Treatment Period 1|Physician Decision|0|||
94444886|NCT01058642|323414929|FG000|Treatment Period 1|Withdrawal by Subject|1|||
94444887|NCT01058642|323414930|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94444888|NCT01058642|323414931|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94444889|NCT01058642|323414932|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94444890|NCT01058642|323414929|FG000|Treatment Period 1|Lack of Efficacy|0|||
94444891|NCT01058642|323414930|FG001|Treatment Period 1|Lack of Efficacy|0|||
94444892|NCT01058642|323414931|FG002|Treatment Period 1|Lack of Efficacy|0|||
94444893|NCT01058642|323414932|FG003|Treatment Period 1|Lack of Efficacy|1|||
94444894|NCT01058642|323414929|FG000|Treatment Period 1|Protocol Violation|0|||
94444895|NCT01058642|323414930|FG001|Treatment Period 1|Protocol Violation|0|||
94444896|NCT01058642|323414931|FG002|Treatment Period 1|Protocol Violation|0|||
94444897|NCT01058642|323414932|FG003|Treatment Period 1|Protocol Violation|1|||
94444898|NCT01058642|323414929|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
94444899|NCT01058642|323414930|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
94444900|NCT01058642|323414931|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
94444901|NCT01058642|323414932|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
94444902|NCT01256450|323414933|FG000|Open-label Titration|Adverse Event|39|||
94444903|NCT01256450|323414934|FG001|Open-label Titration|Adverse Event|0|||
94444904|NCT01256450|323414935|FG002|Open-label Titration|Adverse Event|0|||
94444905|NCT01256450|323414933|FG000|Open-label Titration|Lost to Follow-up|7|||
94444906|NCT01256450|323414934|FG001|Open-label Titration|Lost to Follow-up|0|||
94444907|NCT01256450|323414935|FG002|Open-label Titration|Lost to Follow-up|0|||
94444908|NCT01256450|323414933|FG000|Open-label Titration|Lack of analgesic effect|30|||
94444909|NCT01256450|323414934|FG001|Open-label Titration|Lack of analgesic effect|0|||
94444910|NCT01256450|323414935|FG002|Open-label Titration|Lack of analgesic effect|0|||
94444911|NCT01256450|323414933|FG000|Open-label Titration|Non-compliance|9|||
94444912|NCT01256450|323414934|FG001|Open-label Titration|Non-compliance|0|||
94444913|NCT01256450|323414935|FG002|Open-label Titration|Non-compliance|0|||
94444914|NCT01256450|323414933|FG000|Open-label Titration|Screen failure|1|||
94444915|NCT01256450|323414934|FG001|Open-label Titration|Screen failure|0|||
94444916|NCT01256450|323414935|FG002|Open-label Titration|Screen failure|0|||
94444917|NCT01256450|323414933|FG000|Open-label Titration|Other|13|||
94444918|NCT01256450|323414934|FG001|Open-label Titration|Other|0|||
94444919|NCT01256450|323414935|FG002|Open-label Titration|Other|0|||
94444920|NCT01256450|323414933|FG000|Double-blind Treatment|Adverse Event|0|||
94444921|NCT01256450|323414934|FG001|Double-blind Treatment|Adverse Event|8|||
94444922|NCT01256450|323414935|FG002|Double-blind Treatment|Adverse Event|6|||
94444923|NCT01256450|323414933|FG000|Double-blind Treatment|Lost to Follow-up|0|||
94444924|NCT01256450|323414934|FG001|Double-blind Treatment|Lost to Follow-up|1|||
94444925|NCT01256450|323414935|FG002|Double-blind Treatment|Lost to Follow-up|7|||
94444926|NCT01256450|323414933|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
94444927|NCT01256450|323414934|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
94552045|NCT00727558|323817105|FG001|Overall Study|Lens issue|1|||
94444928|NCT01256450|323414935|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
94444929|NCT01256450|323414933|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
94444930|NCT01256450|323414934|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
94444931|NCT01256450|323414935|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
94444932|NCT01256450|323414933|FG000|Double-blind Treatment|Non-compliance|0|||
94444933|NCT01256450|323414934|FG001|Double-blind Treatment|Non-compliance|5|||
94444934|NCT01256450|323414935|FG002|Double-blind Treatment|Non-compliance|4|||
94444935|NCT01256450|323414933|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
94444936|NCT01256450|323414934|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
94444937|NCT01256450|323414935|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
94444938|NCT01256450|323414933|FG000|Double-blind Treatment|Other|0|||
94444939|NCT01256450|323414934|FG001|Double-blind Treatment|Other|9|||
94444940|NCT01256450|323414935|FG002|Double-blind Treatment|Other|12|||
94444941|NCT02275819|323414936|FG000|Overall Study|Adverse Event|0|||
94444942|NCT02275819|323414937|FG001|Overall Study|Adverse Event|1|||
94444943|NCT03380429|323414942|FG000|Overall Study|Physician Decision|0|||
94444944|NCT03380429|323414943|FG001|Overall Study|Physician Decision|1|||
94444945|NCT03380429|323414944|FG002|Overall Study|Physician Decision|0|||
94444946|NCT03380429|323414945|FG003|Overall Study|Physician Decision|1|||
94444947|NCT03380429|323414946|FG004|Overall Study|Physician Decision|1|||
94444948|NCT03380429|323414942|FG000|Overall Study|Withdrawal by Subject|3|||
94444949|NCT03380429|323414943|FG001|Overall Study|Withdrawal by Subject|3|||
94444950|NCT03380429|323414944|FG002|Overall Study|Withdrawal by Subject|5|||
94444951|NCT03380429|323414945|FG003|Overall Study|Withdrawal by Subject|2|||
94444952|NCT03380429|323414946|FG004|Overall Study|Withdrawal by Subject|1|||
94444953|NCT03380429|323414942|FG000|Overall Study|Lost to Follow-up|0|||
94444954|NCT03380429|323414943|FG001|Overall Study|Lost to Follow-up|2|||
94444955|NCT03380429|323414944|FG002|Overall Study|Lost to Follow-up|4|||
94444956|NCT03380429|323414945|FG003|Overall Study|Lost to Follow-up|3|||
94444957|NCT03380429|323414946|FG004|Overall Study|Lost to Follow-up|1|||
94444958|NCT03380429|323414942|FG000|Overall Study|Protocol Violation|1|||
94444959|NCT03380429|323414943|FG001|Overall Study|Protocol Violation|0|||
94444960|NCT03380429|323414944|FG002|Overall Study|Protocol Violation|1|||
94444961|NCT03380429|323414945|FG003|Overall Study|Protocol Violation|0|||
94444962|NCT03380429|323414946|FG004|Overall Study|Protocol Violation|1|||
94444963|NCT03380429|323414942|FG000|Overall Study|Lack of Efficacy|0|||
94444964|NCT03380429|323414943|FG001|Overall Study|Lack of Efficacy|0|||
94444965|NCT03380429|323414944|FG002|Overall Study|Lack of Efficacy|0|||
94444966|NCT03380429|323414945|FG003|Overall Study|Lack of Efficacy|2|||
94444967|NCT03380429|323414946|FG004|Overall Study|Lack of Efficacy|1|||
94444968|NCT03380429|323414942|FG000|Overall Study|Adverse Event|1|||
94444969|NCT03380429|323414943|FG001|Overall Study|Adverse Event|1|||
94444970|NCT03380429|323414944|FG002|Overall Study|Adverse Event|1|||
94444971|NCT03380429|323414945|FG003|Overall Study|Adverse Event|2|||
94444972|NCT03380429|323414946|FG004|Overall Study|Adverse Event|0|||
94444973|NCT01198470|323414949|FG000|Overall Study|Adverse Event|2|||
94444974|NCT00720213|323414950|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
94444975|NCT00720213|323414951|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
94444976|NCT00720213|323414952|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
94444977|NCT01808066|323414956|FG000|Overall Study|Withdrawal by Subject|15|||
94444978|NCT00586703|323414957|FG000|Overall Study|Death|12|||
94444979|NCT01422213|323414958|FG000|Overall Study|Adverse Event|8|||
94444980|NCT01422213|323414959|FG001|Overall Study|Adverse Event|7|||
94444981|NCT01422213|323414960|FG002|Overall Study|Adverse Event|11|||
94552046|NCT00727558|323817104|FG000|Overall Study|Adverse Event|0|||
94552047|NCT00727558|323817105|FG001|Overall Study|Adverse Event|1|||
94552048|NCT00727558|323817104|FG000|Overall Study|Subject unable to return for follow-up|1|||
94444982|NCT01422213|323414958|FG000|Overall Study|Lack of Efficacy|10|||
94444983|NCT01422213|323414959|FG001|Overall Study|Lack of Efficacy|2|||
94444984|NCT01422213|323414960|FG002|Overall Study|Lack of Efficacy|2|||
94444985|NCT01422213|323414958|FG000|Overall Study|Non-compliance with study drug|0|||
94444986|NCT01422213|323414959|FG001|Overall Study|Non-compliance with study drug|1|||
94444987|NCT01422213|323414960|FG002|Overall Study|Non-compliance with study drug|0|||
94444988|NCT01422213|323414958|FG000|Overall Study|Protocol Violation|0|||
94444989|NCT01422213|323414959|FG001|Overall Study|Protocol Violation|2|||
94552049|NCT00727558|323817105|FG001|Overall Study|Subject unable to return for follow-up|1|||
94444990|NCT01422213|323414960|FG002|Overall Study|Protocol Violation|4|||
94444991|NCT01422213|323414958|FG000|Overall Study|Withdrawal of Consent|7|||
94444992|NCT01422213|323414959|FG001|Overall Study|Withdrawal of Consent|3|||
94444993|NCT01422213|323414960|FG002|Overall Study|Withdrawal of Consent|5|||
94444994|NCT01422213|323414958|FG000|Overall Study|Lost to Follow-up|3|||
94444995|NCT01422213|323414959|FG001|Overall Study|Lost to Follow-up|3|||
94444996|NCT01422213|323414960|FG002|Overall Study|Lost to Follow-up|5|||
94444997|NCT01422213|323414958|FG000|Overall Study|Administrative or Other Reason(s)|5|||
94444998|NCT01422213|323414959|FG001|Overall Study|Administrative or Other Reason(s)|4|||
94444999|NCT01422213|323414960|FG002|Overall Study|Administrative or Other Reason(s)|2|||
94552050|NCT00727558|323817104|FG000|Overall Study|Lost to Follow-up|1|||
94445000|NCT03762265|323414961|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
94445001|NCT03762265|323414962|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
94445002|NCT03762265|323414961|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
94445003|NCT03762265|323414962|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
94445004|NCT03762265|323414961|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
94445005|NCT03762265|323414962|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
94445006|NCT03762265|323414961|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
94445007|NCT03762265|323414962|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
94445008|NCT03762265|323414961|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
94445009|NCT03762265|323414962|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
94445010|NCT03762265|323414961|FG000|BT Period: Weeks 1 to 37|Other|0|||
94445011|NCT03762265|323414962|FG001|BT Period: Weeks 1 to 37|Other|1|||
94445012|NCT03762265|323414961|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
94445013|NCT03762265|323414962|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
94445014|NCT03762265|323414961|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
94445015|NCT03762265|323414962|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
94445016|NCT03762265|323414961|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
94445017|NCT03762265|323414962|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
94445018|NCT03762265|323414961|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
94445019|NCT03762265|323414962|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
94445020|NCT03762265|323414961|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
94445021|NCT03762265|323414962|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
94445022|NCT03762265|323414961|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
94445023|NCT03762265|323414962|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
94445024|NCT03762265|323414961|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
94445025|NCT03762265|323414962|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
94445026|NCT03762265|323414961|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
94445027|NCT03762265|323414962|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
94445028|NCT03762265|323414961|FG000|LTE Period: Weeks 61 to 109|Other|1|||
94445029|NCT03762265|323414962|FG001|LTE Period: Weeks 61 to 109|Other|0|||
94445030|NCT01956773|323414965|FG000|Overall Study|Lost to Follow-up|628|||
94445031|NCT01956773|323414966|FG001|Overall Study|Lost to Follow-up|1|||
94445032|NCT01383174|323414967|FG000|3 Month Assessment|Death|0|||
94445033|NCT01383174|323414968|FG001|3 Month Assessment|Death|1|||
94445034|NCT01383174|323414967|FG000|3 Month Assessment|Lost to Follow-up|2|||
94445035|NCT01383174|323414968|FG001|3 Month Assessment|Lost to Follow-up|0|||
94445036|NCT01383174|323414967|FG000|3 Month Assessment|Refused to complete|4|||
94445037|NCT01383174|323414968|FG001|3 Month Assessment|Refused to complete|0|||
94445038|NCT01383174|323414967|FG000|6 Month Assessment|Lost to Follow-up|1|||
94445039|NCT01383174|323414968|FG001|6 Month Assessment|Lost to Follow-up|1|||
94445040|NCT01383174|323414967|FG000|6 Month Assessment|Refused to complete|4|||
94445041|NCT01383174|323414968|FG001|6 Month Assessment|Refused to complete|0|||
94445042|NCT00470470|323414969|FG000|Overall Study|Adverse Event|2|||
94445043|NCT00470470|323414969|FG000|Overall Study|Death|2|||
94445044|NCT00470470|323414969|FG000|Overall Study|Not treated|1|||
94445045|NCT01787292|323414970|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
94445046|NCT01787292|323414971|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
94445047|NCT01787292|323414970|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
94445048|NCT01787292|323414971|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
94445049|NCT03181633|323414972|FG000|Overall Study|Withdrawal by Subject|1|||
94445050|NCT03181633|323414972|FG000|Overall Study|Missing follow-up visit|1|||
94445051|NCT02962648|323414973|FG000|Overall Study|Withdrawal by Subject|3|||
94445052|NCT02962648|323414973|FG000|Overall Study|Lost to Follow-up|3|||
94445053|NCT02962648|323414973|FG000|Overall Study|Physician Decision|1|||
94445054|NCT02962648|323414973|FG000|Overall Study|Subject had problems with transportation|2|||
94552051|NCT00727558|323817105|FG001|Overall Study|Lost to Follow-up|0|||
94552052|NCT01274429|323817111|FG000|Overall Study|Study closed do to lack of funding|5|||
94445055|NCT01924689|323414974|FG000|Overall Study|Death|0|||
94445056|NCT01924689|323414975|FG001|Overall Study|Death|1|||
94445057|NCT01924689|323414976|FG002|Overall Study|Death|0|||
94445058|NCT01924689|323414977|FG003|Overall Study|Death|1|||
94445059|NCT01924689|323414978|FG004|Overall Study|Death|0|||
94445060|NCT01924689|323414979|FG005|Overall Study|Death|0|||
94445061|NCT01924689|323414974|FG000|Overall Study|Disease progression|0|||
94445062|NCT01924689|323414975|FG001|Overall Study|Disease progression|0|||
94445063|NCT01924689|323414976|FG002|Overall Study|Disease progression|2|||
94445064|NCT01924689|323414977|FG003|Overall Study|Disease progression|0|||
94445065|NCT01924689|323414978|FG004|Overall Study|Disease progression|3|||
94445066|NCT01924689|323414979|FG005|Overall Study|Disease progression|2|||
94445067|NCT01924689|323414974|FG000|Overall Study|New therapy or study|3|||
94445068|NCT01924689|323414975|FG001|Overall Study|New therapy or study|2|||
94445069|NCT01924689|323414976|FG002|Overall Study|New therapy or study|1|||
94445070|NCT01924689|323414977|FG003|Overall Study|New therapy or study|4|||
94445071|NCT01924689|323414978|FG004|Overall Study|New therapy or study|2|||
94445072|NCT01924689|323414979|FG005|Overall Study|New therapy or study|0|||
94445073|NCT01924689|323414974|FG000|Overall Study|Withdrawal of consent|0|||
94445074|NCT01924689|323414975|FG001|Overall Study|Withdrawal of consent|0|||
94445075|NCT01924689|323414976|FG002|Overall Study|Withdrawal of consent|1|||
94445076|NCT01924689|323414977|FG003|Overall Study|Withdrawal of consent|1|||
94445077|NCT01924689|323414978|FG004|Overall Study|Withdrawal of consent|0|||
94445078|NCT01924689|323414979|FG005|Overall Study|Withdrawal of consent|0|||
94445079|NCT01924689|323414974|FG000|Overall Study|Other|0|||
94445080|NCT01924689|323414975|FG001|Overall Study|Other|0|||
94445081|NCT01924689|323414976|FG002|Overall Study|Other|0|||
94445082|NCT01924689|323414977|FG003|Overall Study|Other|0|||
94445083|NCT01924689|323414978|FG004|Overall Study|Other|1|||
94445084|NCT01924689|323414979|FG005|Overall Study|Other|0|||
94445085|NCT01597778|323414981|FG000|Overall Study|Death|7|||
94445086|NCT01597778|323414982|FG001|Overall Study|Death|10|||
94445087|NCT01597778|323414981|FG000|Overall Study|Withdrawal by Subject|3|||
94445088|NCT01597778|323414982|FG001|Overall Study|Withdrawal by Subject|4|||
94445089|NCT01597778|323414981|FG000|Overall Study|Adverse Event|1|||
94445090|NCT01597778|323414982|FG001|Overall Study|Adverse Event|1|||
94445091|NCT01597778|323414981|FG000|Overall Study|Protocol Violation|1|||
94445092|NCT01597778|323414982|FG001|Overall Study|Protocol Violation|11|||
94445093|NCT01597778|323414981|FG000|Overall Study|Transplanted off protocol|2|||
94445094|NCT01597778|323414982|FG001|Overall Study|Transplanted off protocol|3|||
94445095|NCT03267212|323414983|FG000|First Intervention|Lost to Follow-up|0|||
94445096|NCT03267212|323414984|FG001|First Intervention|Lost to Follow-up|2|||
94445097|NCT03267212|323414983|FG000|First Intervention|Withdrawal by Subject|1|||
94445098|NCT03267212|323414984|FG001|First Intervention|Withdrawal by Subject|1|||
94445099|NCT03267212|323414983|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
94445100|NCT03267212|323414984|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
94445101|NCT02907177|323414986|FG000|Overall Study|Death|0|||
94445102|NCT02907177|323414987|FG001|Overall Study|Death|1|||
94445103|NCT02907177|323414986|FG000|Overall Study|Physician Decision|3|||
94445104|NCT02907177|323414987|FG001|Overall Study|Physician Decision|3|||
94445105|NCT02907177|323414986|FG000|Overall Study|Withdrawal by Subject|15|||
94445106|NCT02907177|323414987|FG001|Overall Study|Withdrawal by Subject|7|||
94445107|NCT02907177|323414986|FG000|Overall Study|Sponsor's Decision|50|||
94445108|NCT02907177|323414987|FG001|Overall Study|Sponsor's Decision|57|||
94445109|NCT02505217|323414988|FG000|Overall Study|Withdrawal by Subject|1|||
94445110|NCT02505217|323414989|FG001|Overall Study|Withdrawal by Subject|2|||
94445111|NCT01289678|323414990|FG000|Overall Study|Physician Decision|6|||
94445112|NCT02040805|323414991|FG000|Overall Study|Lost to Follow-up|14|||
94445113|NCT02040805|323414992|FG001|Overall Study|Lost to Follow-up|9|||
94445114|NCT02040805|323414991|FG000|Overall Study|Withdrawal by Subject|28|||
94445115|NCT02040805|323414992|FG001|Overall Study|Withdrawal by Subject|41|||
94445116|NCT01213966|323414994|FG000|Overall Study|Protocol Violation|1|||
94445117|NCT01213966|323414995|FG001|Overall Study|Protocol Violation|0|||
94445118|NCT01213966|323414996|FG002|Overall Study|Protocol Violation|3|||
94445119|NCT01213966|323414997|FG003|Overall Study|Protocol Violation|1|||
94552053|NCT01717326|323817112|FG000|Overall Study|Death|0|||
94552054|NCT01717326|323817113|FG001|Overall Study|Death|0|||
94552055|NCT01717326|323817114|FG002|Overall Study|Death|0|||
94552056|NCT01717326|323817115|FG003|Overall Study|Death|0|||
94552057|NCT01717326|323817116|FG004|Overall Study|Death|0|||
94552058|NCT01717326|323817117|FG005|Overall Study|Death|0|||
94552059|NCT01717326|323817118|FG006|Overall Study|Death|0|||
94552060|NCT01717326|323817119|FG007|Overall Study|Death|0|||
94552061|NCT01717326|323817120|FG008|Overall Study|Death|0|||
94552062|NCT01717326|323817121|FG009|Overall Study|Death|0|||
94552063|NCT01717326|323817122|FG010|Overall Study|Death|1|||
94552064|NCT01717326|323817123|FG011|Overall Study|Death|0|||
94552065|NCT01717326|323817124|FG012|Overall Study|Death|0|||
94552066|NCT01717326|323817125|FG013|Overall Study|Death|0|||
94552067|NCT01717326|323817126|FG014|Overall Study|Death|0|||
94552068|NCT01717326|323817127|FG015|Overall Study|Death|0|||
94445120|NCT00740636|323415000|FG000|Overall Study|Adverse Event|0|||
94445121|NCT00740636|323415001|FG001|Overall Study|Adverse Event|2|||
94445122|NCT00740636|323415000|FG000|Overall Study|Patient Ineligible|0|||
94445123|NCT00740636|323415001|FG001|Overall Study|Patient Ineligible|1|||
94445124|NCT00740636|323415000|FG000|Overall Study|Patient Not Treated|0|||
94445125|NCT00740636|323415001|FG001|Overall Study|Patient Not Treated|1|||
94445126|NCT00740636|323415000|FG000|Overall Study|Progressive Disease|1|||
94445127|NCT00740636|323415001|FG001|Overall Study|Progressive Disease|0|||
94445128|NCT00740636|323415000|FG000|Overall Study|Death|1|||
94445129|NCT00740636|323415001|FG001|Overall Study|Death|0|||
94445130|NCT03539302|323415004|FG000|Overall Study|Spontaneous cardio version|0|||
94552069|NCT01717326|323817128|FG016|Overall Study|Death|0|||
94552070|NCT01717326|323817129|FG017|Overall Study|Death|0|||
94552071|NCT01717326|323817130|FG018|Overall Study|Death|0|||
94552072|NCT01717326|323817131|FG019|Overall Study|Death|0|||
94445131|NCT03539302|323415005|FG001|Overall Study|Spontaneous cardio version|0|||
94445132|NCT03539302|323415006|FG002|Overall Study|Spontaneous cardio version|0|||
94552073|NCT01717326|323817112|FG000|Overall Study|Lost to Follow-up|3|||
94342994|NCT03073200|323036044|FG003|Double Blind Treatment Period|Protocol Violation|0|||
94342995|NCT03073200|323036045|FG004|Double Blind Treatment Period|Protocol Violation|0|||
94552074|NCT01717326|323817113|FG001|Overall Study|Lost to Follow-up|0|||
94552075|NCT01717326|323817114|FG002|Overall Study|Lost to Follow-up|0|||
94552076|NCT01717326|323817115|FG003|Overall Study|Lost to Follow-up|2|||
94552077|NCT01717326|323817116|FG004|Overall Study|Lost to Follow-up|1|||
94552078|NCT01717326|323817117|FG005|Overall Study|Lost to Follow-up|0|||
94552079|NCT01717326|323817118|FG006|Overall Study|Lost to Follow-up|1|||
94552080|NCT01717326|323817119|FG007|Overall Study|Lost to Follow-up|0|||
94552081|NCT01717326|323817120|FG008|Overall Study|Lost to Follow-up|0|||
94552082|NCT01717326|323817121|FG009|Overall Study|Lost to Follow-up|0|||
94552083|NCT01717326|323817122|FG010|Overall Study|Lost to Follow-up|1|||
94552084|NCT01717326|323817123|FG011|Overall Study|Lost to Follow-up|0|||
94552085|NCT01717326|323817124|FG012|Overall Study|Lost to Follow-up|0|||
94552086|NCT01717326|323817125|FG013|Overall Study|Lost to Follow-up|0|||
94552087|NCT01717326|323817126|FG014|Overall Study|Lost to Follow-up|0|||
94552088|NCT01717326|323817127|FG015|Overall Study|Lost to Follow-up|2|||
94342996|NCT03073200|323036046|FG005|Double Blind Treatment Period|Protocol Violation|0|||
94342997|NCT03073200|323036047|FG006|Double Blind Treatment Period|Protocol Violation|0|||
94342998|NCT03073200|323036048|FG007|Double Blind Treatment Period|Protocol Violation|0|||
94342999|NCT03073200|323036049|FG008|Double Blind Treatment Period|Protocol Violation|0|||
94343000|NCT03073200|323036050|FG009|Double Blind Treatment Period|Protocol Violation|0|||
94343001|NCT03073200|323036051|FG010|Double Blind Treatment Period|Protocol Violation|0|||
94343002|NCT03073200|323036052|FG011|Double Blind Treatment Period|Protocol Violation|0|||
94343003|NCT03073200|323036053|FG012|Double Blind Treatment Period|Protocol Violation|0|||
94343004|NCT03073200|323036054|FG013|Double Blind Treatment Period|Protocol Violation|0|||
94343005|NCT03073200|323036055|FG014|Double Blind Treatment Period|Protocol Violation|0|||
94343006|NCT03073200|323036041|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
94343007|NCT03073200|323036042|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
94343008|NCT03073200|323036043|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
94343009|NCT03073200|323036044|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
94343010|NCT03073200|323036045|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
94343011|NCT03073200|323036046|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
94343012|NCT03073200|323036047|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
94343013|NCT03073200|323036048|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
94343014|NCT03073200|323036049|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
94343015|NCT03073200|323036050|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
94343016|NCT03073200|323036051|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
94343017|NCT03073200|323036052|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
94343018|NCT03073200|323036053|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
94343019|NCT03073200|323036054|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
94343020|NCT03073200|323036055|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
94343021|NCT03073200|323036041|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
94343022|NCT03073200|323036042|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
94343023|NCT03073200|323036043|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
94343024|NCT03073200|323036044|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
94343025|NCT03073200|323036045|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
94343026|NCT03073200|323036046|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
94343027|NCT03073200|323036047|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
94343028|NCT03073200|323036048|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
94343029|NCT03073200|323036049|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
94343030|NCT03073200|323036050|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
94343031|NCT03073200|323036051|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
94343032|NCT03073200|323036052|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
94343033|NCT03073200|323036053|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
94552089|NCT01717326|323817128|FG016|Overall Study|Lost to Follow-up|1|||
94552090|NCT01717326|323817129|FG017|Overall Study|Lost to Follow-up|0|||
94552091|NCT01717326|323817130|FG018|Overall Study|Lost to Follow-up|2|||
94552092|NCT01717326|323817131|FG019|Overall Study|Lost to Follow-up|3|||
94552093|NCT01717326|323817112|FG000|Overall Study|Physician Decision|0|||
94552094|NCT01717326|323817113|FG001|Overall Study|Physician Decision|0|||
94552095|NCT01717326|323817114|FG002|Overall Study|Physician Decision|0|||
94552096|NCT01717326|323817115|FG003|Overall Study|Physician Decision|0|||
94552097|NCT01717326|323817116|FG004|Overall Study|Physician Decision|0|||
94552098|NCT01717326|323817117|FG005|Overall Study|Physician Decision|0|||
94552099|NCT01717326|323817118|FG006|Overall Study|Physician Decision|0|||
94552100|NCT01717326|323817119|FG007|Overall Study|Physician Decision|0|||
94552101|NCT01717326|323817120|FG008|Overall Study|Physician Decision|0|||
94552102|NCT01717326|323817121|FG009|Overall Study|Physician Decision|1|||
94552103|NCT01717326|323817122|FG010|Overall Study|Physician Decision|0|||
94552104|NCT01717326|323817123|FG011|Overall Study|Physician Decision|0|||
94552105|NCT01717326|323817124|FG012|Overall Study|Physician Decision|0|||
94552106|NCT01717326|323817125|FG013|Overall Study|Physician Decision|0|||
94445133|NCT03539302|323415007|FG003|Overall Study|Spontaneous cardio version|0|||
94445134|NCT03539302|323415008|FG004|Overall Study|Spontaneous cardio version|0|||
94445135|NCT03539302|323415009|FG005|Overall Study|Spontaneous cardio version|1|||
94445136|NCT03539302|323415010|FG006|Overall Study|Spontaneous cardio version|1|||
94445137|NCT00349973|323415011|FG000|Overall Study|Adverse Event|3|||
94445138|NCT00349973|323415012|FG001|Overall Study|Adverse Event|3|||
94445139|NCT00349973|323415011|FG000|Overall Study|Withdrawal by Subject|1|||
94445140|NCT00349973|323415012|FG001|Overall Study|Withdrawal by Subject|0|||
94445141|NCT03591874|323415013|FG000|Overall Study|Adverse Event|4|||
94445142|NCT03591874|323415014|FG001|Overall Study|Adverse Event|0|||
94445143|NCT03591874|323415013|FG000|Overall Study|Withdrawal by Subject|2|||
94445144|NCT03591874|323415014|FG001|Overall Study|Withdrawal by Subject|1|||
94445145|NCT03591874|323415013|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
94445146|NCT03591874|323415014|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
94445147|NCT03591874|323415013|FG000|Overall Study|On Study at Time of Study Termination|12|||
94445148|NCT03591874|323415014|FG001|Overall Study|On Study at Time of Study Termination|6|||
94445149|NCT00153179|323415015|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
94445150|NCT00153179|323415016|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
94445151|NCT00153179|323415017|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
94552107|NCT01717326|323817126|FG014|Overall Study|Physician Decision|0|||
94552108|NCT01717326|323817127|FG015|Overall Study|Physician Decision|0|||
94552109|NCT01717326|323817128|FG016|Overall Study|Physician Decision|0|||
94552110|NCT01717326|323817129|FG017|Overall Study|Physician Decision|0|||
94445152|NCT00153179|323415018|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
94445153|NCT00503698|323415019|FG000|Overall Study|Protocol Violation|5|||
94552111|NCT01717326|323817130|FG018|Overall Study|Physician Decision|0|||
94552112|NCT01717326|323817131|FG019|Overall Study|Physician Decision|0|||
94445154|NCT00503698|323415020|FG001|Overall Study|Protocol Violation|6|||
94445155|NCT00503698|323415019|FG000|Overall Study|Adverse Event|52|||
94445156|NCT00503698|323415020|FG001|Overall Study|Adverse Event|41|||
94445157|NCT00503698|323415019|FG000|Overall Study|Death|1|||
94445158|NCT00503698|323415020|FG001|Overall Study|Death|0|||
94445159|NCT00503698|323415019|FG000|Overall Study|Lack of Efficacy|3|||
94445160|NCT00503698|323415020|FG001|Overall Study|Lack of Efficacy|4|||
94445161|NCT00503698|323415019|FG000|Overall Study|Trial terminated|216|||
94445162|NCT00503698|323415020|FG001|Overall Study|Trial terminated|253|||
94445163|NCT00503698|323415019|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
94445164|NCT00503698|323415020|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
94445165|NCT00503698|323415019|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
94445166|NCT00503698|323415020|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
94445167|NCT00503698|323415019|FG000|Overall Study|Any condition in exclusion criteria|4|||
94445168|NCT00503698|323415020|FG001|Overall Study|Any condition in exclusion criteria|6|||
94445169|NCT00503698|323415019|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
94445170|NCT00503698|323415020|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
94445171|NCT00503698|323415019|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
94445172|NCT00503698|323415020|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
94445173|NCT00503698|323415019|FG000|Overall Study|Critically ill|2|||
94445174|NCT00503698|323415020|FG001|Overall Study|Critically ill|0|||
94445175|NCT00503698|323415019|FG000|Overall Study|Unclassified|48|||
94445176|NCT00503698|323415020|FG001|Overall Study|Unclassified|32|||
94445177|NCT00503698|323415019|FG000|Overall Study|Not exposed to trial drug|11|||
94445178|NCT00503698|323415020|FG001|Overall Study|Not exposed to trial drug|6|||
94445179|NCT01662492|323415023|FG000|Overall Study|Other miscellaneous reasons.|1|||
94445180|NCT01662492|323415024|FG001|Overall Study|Other miscellaneous reasons.|0|||
94445181|NCT01662492|323415025|FG002|Overall Study|Other miscellaneous reasons.|1|||
94445182|NCT01662492|323415023|FG000|Overall Study|Withdrawal by Subject|0|||
94445183|NCT01662492|323415024|FG001|Overall Study|Withdrawal by Subject|0|||
94445184|NCT01662492|323415025|FG002|Overall Study|Withdrawal by Subject|1|||
94445185|NCT01662492|323415023|FG000|Overall Study|Protocol Violation|1|||
94445186|NCT01662492|323415024|FG001|Overall Study|Protocol Violation|0|||
94445187|NCT01662492|323415025|FG002|Overall Study|Protocol Violation|0|||
94445188|NCT01662492|323415023|FG000|Overall Study|Lost to Follow-up|0|||
94445189|NCT01662492|323415024|FG001|Overall Study|Lost to Follow-up|0|||
94445190|NCT01662492|323415025|FG002|Overall Study|Lost to Follow-up|2|||
94445191|NCT01662492|323415023|FG000|Overall Study|Lack of Efficacy|1|||
94445192|NCT01662492|323415024|FG001|Overall Study|Lack of Efficacy|1|||
94445193|NCT01662492|323415025|FG002|Overall Study|Lack of Efficacy|2|||
94445194|NCT01591096|323415026|FG000|Overall Study|Adverse Event|1|||
94445195|NCT01609790|323415030|FG000|Overall Study|Protocol Violation|1|||
94445196|NCT01609790|323415031|FG001|Overall Study|Protocol Violation|7|||
94445197|NCT01609790|323415032|FG002|Overall Study|Protocol Violation|8|||
94445198|NCT02832687|323417209|FG000|Overall Study|Adverse Event|0|||
94445199|NCT02832687|323417210|FG001|Overall Study|Adverse Event|2|||
94445200|NCT02512302|323417211|FG000|Period 1|Adverse Event|0|||
94445201|NCT02512302|323417212|FG001|Period 1|Adverse Event|1|||
94445202|NCT02512302|323417213|FG002|Period 1|Adverse Event|0|||
94445203|NCT02512302|323417214|FG003|Period 1|Adverse Event|0|||
94445204|NCT02512302|323417215|FG004|Period 1|Adverse Event|0|||
94445205|NCT02512302|323417216|FG005|Period 1|Adverse Event|0|||
94445206|NCT02512302|323417217|FG006|Period 1|Adverse Event|0|||
94445207|NCT02512302|323417218|FG007|Period 1|Adverse Event|0|||
94445208|NCT02512302|323417219|FG008|Period 1|Adverse Event|0|||
94445209|NCT02512302|323417220|FG009|Period 1|Adverse Event|0|||
94445210|NCT02512302|323417211|FG000|Period 2|Adverse Event|0|||
94445211|NCT02512302|323417212|FG001|Period 2|Adverse Event|0|||
94445212|NCT02512302|323417213|FG002|Period 2|Adverse Event|0|||
94552113|NCT01717326|323817112|FG000|Overall Study|Protocol Violation|0|||
94552114|NCT01717326|323817113|FG001|Overall Study|Protocol Violation|0|||
94552115|NCT01717326|323817114|FG002|Overall Study|Protocol Violation|0|||
94552116|NCT01717326|323817115|FG003|Overall Study|Protocol Violation|0|||
94552117|NCT01717326|323817116|FG004|Overall Study|Protocol Violation|1|||
94552118|NCT01717326|323817117|FG005|Overall Study|Protocol Violation|0|||
94552119|NCT01717326|323817118|FG006|Overall Study|Protocol Violation|0|||
94552120|NCT01717326|323817119|FG007|Overall Study|Protocol Violation|0|||
94445213|NCT02512302|323417214|FG003|Period 2|Adverse Event|0|||
94445214|NCT02512302|323417215|FG004|Period 2|Adverse Event|0|||
94445215|NCT02512302|323417216|FG005|Period 2|Adverse Event|0|||
94552121|NCT01717326|323817120|FG008|Overall Study|Protocol Violation|0|||
94445216|NCT02512302|323417217|FG006|Period 2|Adverse Event|0|||
94445217|NCT02512302|323417218|FG007|Period 2|Adverse Event|0|||
94445218|NCT02512302|323417219|FG008|Period 2|Adverse Event|0|||
94445219|NCT02512302|323417220|FG009|Period 2|Adverse Event|1|||
94445220|NCT02512302|323417211|FG000|Period 3|Lost to Follow-up|0|||
94552122|NCT01717326|323817121|FG009|Overall Study|Protocol Violation|0|||
94552123|NCT01717326|323817122|FG010|Overall Study|Protocol Violation|0|||
94445221|NCT02512302|323417212|FG001|Period 3|Lost to Follow-up|0|||
94445222|NCT02512302|323417213|FG002|Period 3|Lost to Follow-up|1|||
94445223|NCT02512302|323417214|FG003|Period 3|Lost to Follow-up|0|||
94445224|NCT02512302|323417215|FG004|Period 3|Lost to Follow-up|0|||
94445225|NCT02512302|323417216|FG005|Period 3|Lost to Follow-up|0|||
94445226|NCT02512302|323417217|FG006|Period 3|Lost to Follow-up|0|||
94445227|NCT02512302|323417218|FG007|Period 3|Lost to Follow-up|0|||
94445228|NCT02512302|323417219|FG008|Period 3|Lost to Follow-up|0|||
94445229|NCT02512302|323417220|FG009|Period 3|Lost to Follow-up|0|||
94445230|NCT02512302|323417211|FG000|Period 4|Adverse Event|0|||
94445231|NCT02512302|323417212|FG001|Period 4|Adverse Event|0|||
94445232|NCT02512302|323417213|FG002|Period 4|Adverse Event|0|||
94445233|NCT02512302|323417214|FG003|Period 4|Adverse Event|0|||
94445234|NCT02512302|323417215|FG004|Period 4|Adverse Event|0|||
94445235|NCT02512302|323417216|FG005|Period 4|Adverse Event|0|||
94445236|NCT02512302|323417217|FG006|Period 4|Adverse Event|1|||
94445237|NCT02512302|323417218|FG007|Period 4|Adverse Event|0|||
94445238|NCT02512302|323417219|FG008|Period 4|Adverse Event|0|||
94445239|NCT02512302|323417220|FG009|Period 4|Adverse Event|0|||
94445240|NCT00568451|323417223|FG000|Overall Study|Disease Progression|0|||
94445241|NCT00568451|323417224|FG001|Overall Study|Disease Progression|0|||
94445242|NCT00568451|323417225|FG002|Overall Study|Disease Progression|2|||
94445243|NCT00568451|323417226|FG003|Overall Study|Disease Progression|7|||
94445244|NCT01343043|323417230|FG000|Overall Study|Disease progression before treatment|1|||
94445245|NCT01343043|323417231|FG001|Overall Study|Disease progression before treatment|0|||
94445246|NCT01343043|323417232|FG002|Overall Study|Disease progression before treatment|0|||
94445247|NCT01343043|323417233|FG003|Overall Study|Disease progression before treatment|0|||
94445248|NCT01343043|323417230|FG000|Overall Study|Withdrawal by Subject|1|||
94445249|NCT01343043|323417231|FG001|Overall Study|Withdrawal by Subject|0|||
94445250|NCT01343043|323417232|FG002|Overall Study|Withdrawal by Subject|0|||
94445251|NCT01343043|323417233|FG003|Overall Study|Withdrawal by Subject|0|||
94445252|NCT01343043|323417230|FG000|Overall Study|Death|1|||
94445253|NCT01343043|323417231|FG001|Overall Study|Death|1|||
94445254|NCT01343043|323417232|FG002|Overall Study|Death|0|||
94445255|NCT01343043|323417233|FG003|Overall Study|Death|1|||
94445256|NCT01017874|323417234|FG000|Overall Study|Withdrawal by Subject|23|||
94445257|NCT01017874|323417235|FG001|Overall Study|Withdrawal by Subject|20|||
94445258|NCT01017874|323417234|FG000|Overall Study|Sponsor decision|3|||
94445259|NCT01017874|323417235|FG001|Overall Study|Sponsor decision|1|||
94445260|NCT01017874|323417234|FG000|Overall Study|Lost to Follow-up|3|||
94445261|NCT01017874|323417235|FG001|Overall Study|Lost to Follow-up|2|||
94445262|NCT01017874|323417234|FG000|Overall Study|Physician Decision|1|||
94445263|NCT01017874|323417235|FG001|Overall Study|Physician Decision|3|||
94445264|NCT02996968|323417236|FG000|Overall Study|Withdrawal by Subject|1|||
94445265|NCT02996968|323417237|FG001|Overall Study|Withdrawal by Subject|0|||
94445266|NCT00502242|323417242|FG000|Overall Study|Lack of Efficacy|1|||
94445267|NCT00502242|323417243|FG001|Overall Study|Lack of Efficacy|11|||
94445268|NCT00502242|323417242|FG000|Overall Study|Adverse Event|31|||
94445269|NCT00502242|323417243|FG001|Overall Study|Adverse Event|20|||
94445270|NCT00502242|323417242|FG000|Overall Study|Physician Decision|2|||
94445271|NCT00502242|323417243|FG001|Overall Study|Physician Decision|3|||
94445272|NCT00502242|323417242|FG000|Overall Study|Other - Unspecified|8|||
94445273|NCT00502242|323417243|FG001|Overall Study|Other - Unspecified|14|||
94445274|NCT00502242|323417242|FG000|Overall Study|Protocol Violation|3|||
94445275|NCT00502242|323417243|FG001|Overall Study|Protocol Violation|1|||
94445276|NCT00502242|323417242|FG000|Overall Study|Withdrawal by Subject|6|||
94445277|NCT00502242|323417243|FG001|Overall Study|Withdrawal by Subject|7|||
94445278|NCT03207815|323417244|FG000|Overall Study|Protocol Violation|3|||
94445279|NCT03207815|323417245|FG001|Overall Study|Protocol Violation|1|||
94445280|NCT03207815|323417244|FG000|Overall Study|Adverse Event|1|||
94445281|NCT03207815|323417245|FG001|Overall Study|Adverse Event|2|||
94445282|NCT03207815|323417244|FG000|Overall Study|Lost to Follow-up|1|||
94445283|NCT03207815|323417245|FG001|Overall Study|Lost to Follow-up|2|||
94445284|NCT03207815|323417244|FG000|Overall Study|Investigator's Discretion|1|||
94445285|NCT03207815|323417245|FG001|Overall Study|Investigator's Discretion|1|||
94445286|NCT03207815|323417244|FG000|Overall Study|Lack of Efficacy|0|||
94445287|NCT03207815|323417245|FG001|Overall Study|Lack of Efficacy|1|||
94445288|NCT03207815|323417244|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
94445289|NCT03207815|323417245|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
94445290|NCT03207815|323417244|FG000|Overall Study|Withdrew Consent|1|||
94445291|NCT03207815|323417245|FG001|Overall Study|Withdrew Consent|0|||
94445292|NCT04537078|323417246|FG000|Overall Study|Protocol Violation|3|||
94445293|NCT04537078|323417247|FG001|Overall Study|Protocol Violation|2|||
94445294|NCT04537078|323417246|FG000|Overall Study|Lost to Follow-up|1|||
94445295|NCT04537078|323417247|FG001|Overall Study|Lost to Follow-up|0|||
94445296|NCT04537078|323417246|FG000|Overall Study|Withdrawal by Subject|0|||
94445297|NCT04537078|323417247|FG001|Overall Study|Withdrawal by Subject|1|||
94445298|NCT01671007|323417248|FG000|Overall Study|Other reasons than listed|166|||
94445299|NCT01671007|323417249|FG001|Overall Study|Other reasons than listed|373|||
94445300|NCT01671007|323417250|FG002|Overall Study|Other reasons than listed|197|||
94445301|NCT01671007|323417251|FG003|Overall Study|Other reasons than listed|228|||
94445302|NCT01671007|323417252|FG004|Overall Study|Other reasons than listed|14|||
94343034|NCT03073200|323036054|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
94343035|NCT03073200|323036055|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
94343036|NCT03073200|323036041|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
94343037|NCT03073200|323036042|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
94343038|NCT03073200|323036043|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
94343039|NCT03073200|323036044|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
94343040|NCT03073200|323036045|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
94343041|NCT03073200|323036046|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
94343042|NCT03073200|323036047|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
94343043|NCT03073200|323036048|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
94343044|NCT03073200|323036049|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
94343045|NCT03073200|323036050|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
94343046|NCT03073200|323036051|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
94343047|NCT03073200|323036052|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
94343048|NCT03073200|323036053|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
94343049|NCT03073200|323036054|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
94343050|NCT03073200|323036055|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
94343051|NCT03073200|323036041|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
94343052|NCT03073200|323036042|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
94343053|NCT03073200|323036043|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
94343054|NCT03073200|323036044|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
94343055|NCT03073200|323036045|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
94343056|NCT03073200|323036046|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
94343057|NCT03073200|323036047|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
94343058|NCT03073200|323036048|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
94343059|NCT03073200|323036049|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
94343060|NCT03073200|323036050|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
94343061|NCT03073200|323036051|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
94343062|NCT03073200|323036052|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
94343063|NCT03073200|323036053|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
94343064|NCT03073200|323036054|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
94343065|NCT03073200|323036055|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
94343066|NCT03073200|323036041|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
94343067|NCT03073200|323036042|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
94343068|NCT03073200|323036043|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
94343069|NCT03073200|323036044|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
94343070|NCT03073200|323036045|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
94343071|NCT03073200|323036046|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
94343072|NCT03073200|323036047|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
94343073|NCT03073200|323036048|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
94343074|NCT03073200|323036049|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
94343075|NCT03073200|323036050|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
94343076|NCT03073200|323036051|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
94343077|NCT03073200|323036052|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
94343078|NCT03073200|323036053|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
94343079|NCT03073200|323036054|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
94343080|NCT03073200|323036055|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
94343081|NCT03073200|323036041|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
94343082|NCT03073200|323036042|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
94343083|NCT03073200|323036043|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
94343084|NCT03073200|323036044|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
94343085|NCT03073200|323036045|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
94343086|NCT03073200|323036046|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
94343087|NCT03073200|323036047|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
94343088|NCT03073200|323036048|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
94343089|NCT03073200|323036049|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
94343090|NCT03073200|323036050|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
94445303|NCT01671007|323417253|FG005|Overall Study|Other reasons than listed|71|||
94445304|NCT01671007|323417254|FG006|Overall Study|Other reasons than listed|17|||
94445305|NCT01671007|323417255|FG007|Overall Study|Other reasons than listed|66|||
94445306|NCT01671007|323417256|FG008|Overall Study|Other reasons than listed|0|||
94445307|NCT01671007|323417248|FG000|Overall Study|Withdrawal by Subject|36|||
94445308|NCT01671007|323417249|FG001|Overall Study|Withdrawal by Subject|59|||
94445309|NCT01671007|323417250|FG002|Overall Study|Withdrawal by Subject|53|||
94445310|NCT01671007|323417251|FG003|Overall Study|Withdrawal by Subject|58|||
94445311|NCT01671007|323417252|FG004|Overall Study|Withdrawal by Subject|4|||
94445312|NCT01671007|323417253|FG005|Overall Study|Withdrawal by Subject|15|||
94445313|NCT01671007|323417254|FG006|Overall Study|Withdrawal by Subject|1|||
94445314|NCT01671007|323417255|FG007|Overall Study|Withdrawal by Subject|19|||
94445315|NCT01671007|323417256|FG008|Overall Study|Withdrawal by Subject|0|||
94445316|NCT01671007|323417248|FG000|Overall Study|Lost to Follow-up|93|||
94445317|NCT01671007|323417249|FG001|Overall Study|Lost to Follow-up|142|||
94445318|NCT01671007|323417250|FG002|Overall Study|Lost to Follow-up|91|||
94445319|NCT01671007|323417251|FG003|Overall Study|Lost to Follow-up|63|||
94445320|NCT01671007|323417252|FG004|Overall Study|Lost to Follow-up|7|||
94445321|NCT01671007|323417253|FG005|Overall Study|Lost to Follow-up|20|||
94445322|NCT01671007|323417254|FG006|Overall Study|Lost to Follow-up|2|||
94445323|NCT01671007|323417255|FG007|Overall Study|Lost to Follow-up|28|||
94445324|NCT01671007|323417256|FG008|Overall Study|Lost to Follow-up|0|||
94445325|NCT01671007|323417248|FG000|Overall Study|No end of study case report form|3|||
94445326|NCT01671007|323417249|FG001|Overall Study|No end of study case report form|1|||
94445327|NCT01671007|323417250|FG002|Overall Study|No end of study case report form|0|||
94445328|NCT01671007|323417251|FG003|Overall Study|No end of study case report form|2|||
94445329|NCT01671007|323417252|FG004|Overall Study|No end of study case report form|0|||
94445330|NCT01671007|323417253|FG005|Overall Study|No end of study case report form|0|||
94445331|NCT01671007|323417254|FG006|Overall Study|No end of study case report form|0|||
94445332|NCT01671007|323417255|FG007|Overall Study|No end of study case report form|0|||
94445333|NCT01671007|323417256|FG008|Overall Study|No end of study case report form|0|||
94445334|NCT01671007|323417248|FG000|Overall Study|Not eligible|23|||
94445335|NCT01671007|323417249|FG001|Overall Study|Not eligible|76|||
94445336|NCT01671007|323417250|FG002|Overall Study|Not eligible|25|||
94445337|NCT01671007|323417251|FG003|Overall Study|Not eligible|17|||
94445338|NCT01671007|323417252|FG004|Overall Study|Not eligible|0|||
94445339|NCT01671007|323417253|FG005|Overall Study|Not eligible|6|||
94445340|NCT01671007|323417254|FG006|Overall Study|Not eligible|1|||
94445341|NCT01671007|323417255|FG007|Overall Study|Not eligible|19|||
94445342|NCT01671007|323417256|FG008|Overall Study|Not eligible|0|||
94445343|NCT03817853|323417257|FG000|Induction Phase|Adverse Event|5|||
94445344|NCT03817853|323417258|FG001|Induction Phase|Adverse Event|0|||
94445345|NCT03817853|323417259|FG002|Induction Phase|Adverse Event|0|||
94445346|NCT03817853|323417257|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
94445347|NCT03817853|323417258|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
94445348|NCT03817853|323417259|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
94445349|NCT03817853|323417257|FG000|Induction Phase|Physician Decision|2|||
94445350|NCT03817853|323417258|FG001|Induction Phase|Physician Decision|0|||
94445351|NCT03817853|323417259|FG002|Induction Phase|Physician Decision|0|||
94445352|NCT03817853|323417257|FG000|Induction Phase|Progressive Disease|6|||
94445353|NCT03817853|323417258|FG001|Induction Phase|Progressive Disease|0|||
94445354|NCT03817853|323417259|FG002|Induction Phase|Progressive Disease|0|||
94445355|NCT03817853|323417257|FG000|Induction Phase|Withdrawal by Subject|4|||
94445356|NCT03817853|323417258|FG001|Induction Phase|Withdrawal by Subject|0|||
94445357|NCT03817853|323417259|FG002|Induction Phase|Withdrawal by Subject|0|||
94445358|NCT03817853|323417257|FG000|Maintenance Phase|Adverse Event|0|||
94445359|NCT03817853|323417258|FG001|Maintenance Phase|Adverse Event|8|||
94445360|NCT03817853|323417259|FG002|Maintenance Phase|Adverse Event|0|||
94445361|NCT03817853|323417257|FG000|Maintenance Phase|Death|0|||
94445362|NCT03817853|323417258|FG001|Maintenance Phase|Death|5|||
94445363|NCT03817853|323417259|FG002|Maintenance Phase|Death|0|||
94445364|NCT03817853|323417257|FG000|Maintenance Phase|Progressive Disease|0|||
94445365|NCT03817853|323417258|FG001|Maintenance Phase|Progressive Disease|7|||
94445366|NCT03817853|323417259|FG002|Maintenance Phase|Progressive Disease|0|||
94445367|NCT03817853|323417257|FG000|Maintenance Phase|Withdrawal by Subject|0|||
94445368|NCT03817853|323417258|FG001|Maintenance Phase|Withdrawal by Subject|2|||
94445369|NCT03817853|323417259|FG002|Maintenance Phase|Withdrawal by Subject|0|||
94445370|NCT03817853|323417257|FG000|Maintenance Phase|Physician Decision|0|||
94445371|NCT03817853|323417258|FG001|Maintenance Phase|Physician Decision|1|||
94445372|NCT03817853|323417259|FG002|Maintenance Phase|Physician Decision|0|||
94445373|NCT03817853|323417257|FG000|Maintenance Phase|Various reasons|0|||
94445374|NCT03817853|323417258|FG001|Maintenance Phase|Various reasons|4|||
94445375|NCT03817853|323417259|FG002|Maintenance Phase|Various reasons|0|||
94445376|NCT03817853|323417257|FG000|Maintenance Phase|Protocol Deviation|0|||
94445377|NCT03817853|323417258|FG001|Maintenance Phase|Protocol Deviation|1|||
94445378|NCT03817853|323417259|FG002|Maintenance Phase|Protocol Deviation|0|||
94445379|NCT03817853|323417257|FG000|Follow-up Phase|Adverse Event|0|||
94445380|NCT03817853|323417258|FG001|Follow-up Phase|Adverse Event|0|||
94445381|NCT03817853|323417259|FG002|Follow-up Phase|Adverse Event|2|||
94445382|NCT03817853|323417257|FG000|Follow-up Phase|Death|0|||
94445383|NCT03817853|323417258|FG001|Follow-up Phase|Death|0|||
94445384|NCT03817853|323417259|FG002|Follow-up Phase|Death|1|||
94445385|NCT03817853|323417257|FG000|Follow-up Phase|Progressive Disease|0|||
94445386|NCT03817853|323417258|FG001|Follow-up Phase|Progressive Disease|0|||
94445387|NCT03817853|323417259|FG002|Follow-up Phase|Progressive Disease|3|||
94445388|NCT03817853|323417257|FG000|Follow-up Phase|Withdrawal by Subject|0|||
94445389|NCT03817853|323417258|FG001|Follow-up Phase|Withdrawal by Subject|0|||
94445390|NCT03817853|323417259|FG002|Follow-up Phase|Withdrawal by Subject|1|||
94445391|NCT00791778|323417260|FG000|Double-blind Treatment|Adverse Event|49|||
94445392|NCT00791778|323417261|FG001|Double-blind Treatment|Adverse Event|9|||
94445393|NCT00791778|323417260|FG000|Double-blind Treatment|Physician Decision|6|||
94445394|NCT00791778|323417261|FG001|Double-blind Treatment|Physician Decision|26|||
94445395|NCT00791778|323417260|FG000|Double-blind Treatment|Protocol Violation|0|||
94445396|NCT00791778|323417261|FG001|Double-blind Treatment|Protocol Violation|4|||
94445397|NCT00791778|323417260|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
94445398|NCT00791778|323417261|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
94445399|NCT00791778|323417260|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
94445400|NCT00791778|323417261|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
94445401|NCT00791778|323417260|FG000|Follow-up|Withdrawal by Subject|3|||
94445402|NCT00791778|323417261|FG001|Follow-up|Withdrawal by Subject|0|||
94445403|NCT00791778|323417260|FG000|Follow-up|Lost to Follow-up|2|||
94445404|NCT00791778|323417261|FG001|Follow-up|Lost to Follow-up|1|||
94445405|NCT01568892|323417262|FG000|Open-label Phase|Adverse Event|2|||
94445406|NCT01568892|323417263|FG001|Open-label Phase|Adverse Event|0|||
94445407|NCT01568892|323417262|FG000|Open-label Phase|Lack of Efficacy|4|||
94445408|NCT01568892|323417263|FG001|Open-label Phase|Lack of Efficacy|2|||
94445409|NCT01568892|323417262|FG000|Open-label Phase|Lost to Follow-up|0|||
94445410|NCT01568892|323417263|FG001|Open-label Phase|Lost to Follow-up|1|||
94445411|NCT03866512|323417264|FG000|Overall Study|Lost to Follow-up|1|||
94445412|NCT03866512|323417265|FG001|Overall Study|Lost to Follow-up|2|||
94445413|NCT03866512|323417266|FG002|Overall Study|Lost to Follow-up|1|||
94445414|NCT03866512|323417264|FG000|Overall Study|Cannulation issues|0|||
94445415|NCT03866512|323417265|FG001|Overall Study|Cannulation issues|1|||
94445416|NCT03866512|323417266|FG002|Overall Study|Cannulation issues|2|||
94445417|NCT00997373|323417267|FG000|Overall Study|Withdrawal by Subject|5|||
94445418|NCT00997373|323417268|FG001|Overall Study|Withdrawal by Subject|0|||
94445419|NCT00997373|323417267|FG000|Overall Study|wrong tumor type|4|||
94445420|NCT00997373|323417268|FG001|Overall Study|wrong tumor type|0|||
94445421|NCT00997373|323417267|FG000|Overall Study|could not have hysterectomy|6|||
94445422|NCT00997373|323417268|FG001|Overall Study|could not have hysterectomy|0|||
94445423|NCT02841995|323417270|FG000|Overall Study|Disease progression|5|||
94445424|NCT02841995|323417271|FG001|Overall Study|Disease progression|11|||
94445425|NCT02841995|323417272|FG002|Overall Study|Disease progression|8|||
94445426|NCT02841995|323417270|FG000|Overall Study|Withdrawal by Subject|2|||
94445427|NCT02841995|323417271|FG001|Overall Study|Withdrawal by Subject|4|||
94445428|NCT02841995|323417272|FG002|Overall Study|Withdrawal by Subject|4|||
94445429|NCT02841995|323417270|FG000|Overall Study|Adverse Event|2|||
94445430|NCT02841995|323417271|FG001|Overall Study|Adverse Event|0|||
94445431|NCT02841995|323417272|FG002|Overall Study|Adverse Event|1|||
94445432|NCT02841995|323417270|FG000|Overall Study|Investigator decision|2|||
94445433|NCT02841995|323417271|FG001|Overall Study|Investigator decision|0|||
94445434|NCT02841995|323417272|FG002|Overall Study|Investigator decision|1|||
94445435|NCT02841995|323417270|FG000|Overall Study|Death|0|||
94445436|NCT02841995|323417271|FG001|Overall Study|Death|0|||
94445437|NCT02841995|323417272|FG002|Overall Study|Death|2|||
94445438|NCT02841995|323417270|FG000|Overall Study|Noncompliance to protocol|1|||
94445439|NCT02841995|323417271|FG001|Overall Study|Noncompliance to protocol|0|||
94445440|NCT02841995|323417272|FG002|Overall Study|Noncompliance to protocol|0|||
94445441|NCT02841995|323417270|FG000|Overall Study|Sponsor decision|1|||
94445442|NCT02841995|323417271|FG001|Overall Study|Sponsor decision|0|||
94445443|NCT02841995|323417272|FG002|Overall Study|Sponsor decision|0|||
94445444|NCT02841995|323417270|FG000|Overall Study|Other|4|||
94445445|NCT02841995|323417271|FG001|Overall Study|Other|1|||
94445446|NCT02841995|323417272|FG002|Overall Study|Other|5|||
94445447|NCT02755103|323417274|FG000|Overall Study|Lost to Follow-up|17|||
94445448|NCT02755103|323417275|FG001|Overall Study|Lost to Follow-up|15|||
94445449|NCT02755103|323417274|FG000|Overall Study|Death|0|||
94445450|NCT02755103|323417275|FG001|Overall Study|Death|1|||
94445451|NCT02755103|323417274|FG000|Overall Study|Physician Decision|0|||
94445452|NCT02755103|323417275|FG001|Overall Study|Physician Decision|1|||
94445453|NCT02755103|323417274|FG000|Overall Study|Pregnancy|0|||
94445454|NCT02755103|323417275|FG001|Overall Study|Pregnancy|1|||
94445455|NCT02755103|323417274|FG000|Overall Study|Withdrawal by Subject|3|||
94445456|NCT02755103|323417275|FG001|Overall Study|Withdrawal by Subject|0|||
94445457|NCT02556775|323417281|FG000|Overall Study|Withdrawal by Subject|1|||
94445458|NCT02556775|323417282|FG001|Overall Study|Withdrawal by Subject|0|||
94445459|NCT02556775|323417283|FG002|Overall Study|Withdrawal by Subject|1|||
94445460|NCT02556775|323417284|FG003|Overall Study|Withdrawal by Subject|0|||
94445461|NCT02556775|323417281|FG000|Overall Study|Lost to Follow-up|1|||
94445462|NCT02556775|323417282|FG001|Overall Study|Lost to Follow-up|0|||
94445463|NCT02556775|323417283|FG002|Overall Study|Lost to Follow-up|0|||
94445464|NCT02556775|323417284|FG003|Overall Study|Lost to Follow-up|0|||
94445465|NCT02211209|323417285|FG000|Overall Study|Investigator judgment|0|||
94445466|NCT02211209|323417286|FG001|Overall Study|Investigator judgment|1|||
94445467|NCT02211209|323417285|FG000|Overall Study|Voluntary withdrawal|1|||
94445468|NCT02211209|323417286|FG001|Overall Study|Voluntary withdrawal|4|||
94445469|NCT02211209|323417285|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
94445470|NCT02211209|323417286|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
94445471|NCT02211209|323417285|FG000|Overall Study|Reason Not Specified|1|||
94445472|NCT02211209|323417286|FG001|Overall Study|Reason Not Specified|0|||
94445473|NCT00658723|323417291|FG000|Overall Study|Lost to Follow-up|0|||
94445474|NCT00658723|323417292|FG001|Overall Study|Lost to Follow-up|2|||
94445475|NCT00658723|323417293|FG002|Overall Study|Lost to Follow-up|2|||
94445476|NCT00658723|323417291|FG000|Overall Study|Death|2|||
94445477|NCT00658723|323417292|FG001|Overall Study|Death|1|||
94445478|NCT00658723|323417293|FG002|Overall Study|Death|4|||
94445479|NCT00658723|323417291|FG000|Overall Study|Scheduling Issue|1|||
94445480|NCT00658723|323417292|FG001|Overall Study|Scheduling Issue|1|||
94445481|NCT00658723|323417293|FG002|Overall Study|Scheduling Issue|0|||
94445482|NCT00658723|323417291|FG000|Overall Study|Withdrawal by Subject|1|||
94445483|NCT00658723|323417292|FG001|Overall Study|Withdrawal by Subject|0|||
94445484|NCT00658723|323417293|FG002|Overall Study|Withdrawal by Subject|1|||
94445485|NCT02446600|323417299|FG000|Overall Study|Never treated|20|||
94445486|NCT02446600|323417300|FG001|Overall Study|Never treated|2|||
94445487|NCT02446600|323417301|FG002|Overall Study|Never treated|6|||
94445488|NCT02446600|323417302|FG003|Overall Study|Never treated|0|||
94445489|NCT02446600|323417299|FG000|Overall Study|Withdrawal by Subject|19|||
94445490|NCT02446600|323417300|FG001|Overall Study|Withdrawal by Subject|5|||
94445491|NCT02446600|323417301|FG002|Overall Study|Withdrawal by Subject|17|||
94445492|NCT02446600|323417302|FG003|Overall Study|Withdrawal by Subject|0|||
94445493|NCT02446600|323417299|FG000|Overall Study|Ineligible|1|||
94445494|NCT02446600|323417300|FG001|Overall Study|Ineligible|4|||
94445495|NCT02446600|323417301|FG002|Overall Study|Ineligible|4|||
94445496|NCT02446600|323417302|FG003|Overall Study|Ineligible|1|||
94445497|NCT02446600|323417299|FG000|Overall Study|Duplicate Enrollment|0|||
94445498|NCT02446600|323417300|FG001|Overall Study|Duplicate Enrollment|1|||
94445499|NCT02446600|323417301|FG002|Overall Study|Duplicate Enrollment|0|||
94445500|NCT02446600|323417302|FG003|Overall Study|Duplicate Enrollment|0|||
94445501|NCT05000164|323417303|FG000|Overall Study|Adverse Event|1|||
94445502|NCT05000164|323417303|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
94445503|NCT05000164|323417303|FG000|Overall Study|Lens Discomfort|3|||
94445504|NCT05000164|323417303|FG000|Overall Study|Withdrew Consent during Study|2|||
94445505|NCT05000164|323417303|FG000|Overall Study|Subject Withdrawn by PI|2|||
94445506|NCT05000164|323417303|FG000|Overall Study|Other Fractured Test Article|1|||
94445507|NCT02172664|323417304|FG000|Overall Study|Lost to Follow-up|4|||
94445508|NCT02172664|323417305|FG001|Overall Study|Lost to Follow-up|4|||
94445509|NCT02172664|323417304|FG000|Overall Study|Death|1|||
94445510|NCT02172664|323417305|FG001|Overall Study|Death|1|||
94445511|NCT02172664|323417304|FG000|Overall Study|Moved out of area|1|||
94445512|NCT02172664|323417305|FG001|Overall Study|Moved out of area|1|||
94445513|NCT00739661|323417306|FG000|Overall Study|Adverse Event|2|||
94445514|NCT00739661|323417307|FG001|Overall Study|Adverse Event|0|||
94445515|NCT00739661|323417306|FG000|Overall Study|Physician decision to withdraw patient|1|||
94445516|NCT00739661|323417307|FG001|Overall Study|Physician decision to withdraw patient|0|||
94445517|NCT00739661|323417306|FG000|Overall Study|Patient decision to withdraw|9|||
94445518|NCT00739661|323417307|FG001|Overall Study|Patient decision to withdraw|4|||
94445519|NCT00739661|323417306|FG000|Overall Study|Disease progression, radiographic|33|||
94445520|NCT00739661|323417307|FG001|Overall Study|Disease progression, radiographic|37|||
94445521|NCT00739661|323417306|FG000|Overall Study|Reason for discontinuation not available|1|||
94445522|NCT00739661|323417307|FG001|Overall Study|Reason for discontinuation not available|1|||
94445523|NCT05343364|323417308|FG000|Overall Study|Miscellaneous|0|||
94445524|NCT05343364|323417309|FG001|Overall Study|Miscellaneous|1|||
94445525|NCT01262872|323417310|FG000|Step 2|Death|0|||
94445526|NCT01262872|323417311|FG001|Step 2|Death|0|||
94445527|NCT01262872|323417312|FG002|Step 2|Death|0|||
94445528|NCT01262872|323417313|FG003|Step 2|Death|1|||
94445529|NCT01262872|323417314|FG004|Step 2|Death|0|||
94445530|NCT01262872|323417315|FG005|Step 2|Death|2|||
94445531|NCT01262872|323417316|FG006|Step 2|Death|2|||
94445532|NCT01262872|323417317|FG007|Step 2|Death|1|||
94445533|NCT01262872|323417310|FG000|Step 2|Protocol Violation|0|||
94445534|NCT01262872|323417311|FG001|Step 2|Protocol Violation|0|||
94445535|NCT01262872|323417312|FG002|Step 2|Protocol Violation|1|||
94445536|NCT01262872|323417313|FG003|Step 2|Protocol Violation|0|||
94445537|NCT01262872|323417314|FG004|Step 2|Protocol Violation|0|||
94445538|NCT01262872|323417315|FG005|Step 2|Protocol Violation|0|||
94445539|NCT01262872|323417316|FG006|Step 2|Protocol Violation|3|||
94445540|NCT01262872|323417317|FG007|Step 2|Protocol Violation|1|||
94445541|NCT01262872|323417310|FG000|Step 2|Withdrawal by Subject|0|||
94445542|NCT01262872|323417311|FG001|Step 2|Withdrawal by Subject|0|||
94445543|NCT01262872|323417312|FG002|Step 2|Withdrawal by Subject|4|||
94445544|NCT01262872|323417313|FG003|Step 2|Withdrawal by Subject|6|||
94445545|NCT01262872|323417314|FG004|Step 2|Withdrawal by Subject|3|||
94445546|NCT01262872|323417315|FG005|Step 2|Withdrawal by Subject|1|||
94445547|NCT01262872|323417316|FG006|Step 2|Withdrawal by Subject|2|||
94445548|NCT01262872|323417317|FG007|Step 2|Withdrawal by Subject|1|||
94445549|NCT01262872|323417310|FG000|Step 2|Migrated/moved from study area|0|||
94445550|NCT01262872|323417311|FG001|Step 2|Migrated/moved from study area|0|||
94445551|NCT01262872|323417312|FG002|Step 2|Migrated/moved from study area|4|||
94445552|NCT01262872|323417313|FG003|Step 2|Migrated/moved from study area|3|||
94445553|NCT01262872|323417314|FG004|Step 2|Migrated/moved from study area|2|||
94445554|NCT01262872|323417315|FG005|Step 2|Migrated/moved from study area|6|||
94445555|NCT01262872|323417316|FG006|Step 2|Migrated/moved from study area|2|||
94445556|NCT01262872|323417317|FG007|Step 2|Migrated/moved from study area|3|||
94445557|NCT01000155|323417320|FG000|Overall Study|Withdrawal by Subject|1|||
94445558|NCT01000155|323417320|FG000|Overall Study|Adverse Event|1|||
94445559|NCT01791894|323417323|FG000|Overall Study|Adverse Event|1|||
94445560|NCT00765102|323417324|FG000|Overall Study|Progressive disease|18|||
94445561|NCT00765102|323417324|FG000|Overall Study|Adverse Event|6|||
94445562|NCT00765102|323417324|FG000|Overall Study|Physician Decision|4|||
94445563|NCT00765102|323417324|FG000|Overall Study|Withdrawal by Subject|2|||
94445564|NCT00765102|323417324|FG000|Overall Study|Protocol Violation|1|||
94445565|NCT00122382|323417340|FG000|Double-Blind Study|Adverse Event|9|||
94445566|NCT00122382|323417341|FG001|Double-Blind Study|Adverse Event|11|||
94445567|NCT00122382|323417342|FG002|Double-Blind Study|Adverse Event|0|||
94445568|NCT00122382|323417340|FG000|Double-Blind Study|Death|2|||
94445569|NCT00122382|323417341|FG001|Double-Blind Study|Death|2|||
94445570|NCT00122382|323417342|FG002|Double-Blind Study|Death|0|||
94445571|NCT00122382|323417340|FG000|Double-Blind Study|Lack of Efficacy|0|||
94445572|NCT00122382|323417341|FG001|Double-Blind Study|Lack of Efficacy|8|||
94445573|NCT00122382|323417342|FG002|Double-Blind Study|Lack of Efficacy|0|||
94445574|NCT00122382|323417340|FG000|Double-Blind Study|Lost to Follow-up|2|||
94445575|NCT00122382|323417341|FG001|Double-Blind Study|Lost to Follow-up|1|||
94445576|NCT00122382|323417342|FG002|Double-Blind Study|Lost to Follow-up|0|||
94445577|NCT00122382|323417340|FG000|Double-Blind Study|Pregnancy|2|||
94445578|NCT00122382|323417341|FG001|Double-Blind Study|Pregnancy|0|||
94445579|NCT00122382|323417342|FG002|Double-Blind Study|Pregnancy|0|||
94445580|NCT00122382|323417340|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
94552124|NCT01717326|323817123|FG011|Overall Study|Protocol Violation|0|||
94445581|NCT00122382|323417341|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
94552125|NCT01717326|323817124|FG012|Overall Study|Protocol Violation|0|||
94552126|NCT01717326|323817125|FG013|Overall Study|Protocol Violation|0|||
94552127|NCT01717326|323817126|FG014|Overall Study|Protocol Violation|0|||
94552128|NCT01717326|323817127|FG015|Overall Study|Protocol Violation|0|||
94552129|NCT01717326|323817128|FG016|Overall Study|Protocol Violation|0|||
94552130|NCT01717326|323817129|FG017|Overall Study|Protocol Violation|0|||
94552131|NCT01717326|323817130|FG018|Overall Study|Protocol Violation|0|||
94552132|NCT01717326|323817131|FG019|Overall Study|Protocol Violation|0|||
94552133|NCT01717326|323817112|FG000|Overall Study|Withdrawal by Subject|0|||
94552134|NCT01717326|323817113|FG001|Overall Study|Withdrawal by Subject|1|||
94552135|NCT01717326|323817114|FG002|Overall Study|Withdrawal by Subject|0|||
94552136|NCT01717326|323817115|FG003|Overall Study|Withdrawal by Subject|0|||
94552137|NCT01717326|323817116|FG004|Overall Study|Withdrawal by Subject|0|||
94552138|NCT01717326|323817117|FG005|Overall Study|Withdrawal by Subject|0|||
94552139|NCT01717326|323817118|FG006|Overall Study|Withdrawal by Subject|0|||
94552140|NCT01717326|323817119|FG007|Overall Study|Withdrawal by Subject|0|||
94552141|NCT01717326|323817120|FG008|Overall Study|Withdrawal by Subject|0|||
94552142|NCT01717326|323817121|FG009|Overall Study|Withdrawal by Subject|1|||
94552143|NCT01717326|323817122|FG010|Overall Study|Withdrawal by Subject|0|||
94552144|NCT01717326|323817123|FG011|Overall Study|Withdrawal by Subject|0|||
94552145|NCT01717326|323817124|FG012|Overall Study|Withdrawal by Subject|1|||
94552146|NCT01717326|323817125|FG013|Overall Study|Withdrawal by Subject|0|||
94552147|NCT01717326|323817126|FG014|Overall Study|Withdrawal by Subject|0|||
94552148|NCT01717326|323817127|FG015|Overall Study|Withdrawal by Subject|1|||
94552149|NCT01717326|323817128|FG016|Overall Study|Withdrawal by Subject|0|||
94552150|NCT01717326|323817129|FG017|Overall Study|Withdrawal by Subject|0|||
94552151|NCT01717326|323817130|FG018|Overall Study|Withdrawal by Subject|2|||
94552152|NCT01717326|323817131|FG019|Overall Study|Withdrawal by Subject|3|||
94552153|NCT01067469|323817133|FG000|Overall Study|Withdrawal by Subject|0|||
94552154|NCT01067469|323817134|FG001|Overall Study|Withdrawal by Subject|1|||
94552155|NCT01067469|323817133|FG000|Overall Study|Disease Progression|0|||
94552156|NCT01067469|323817134|FG001|Overall Study|Disease Progression|1|||
94552157|NCT00626405|323817137|FG000|Overall Study|Deemed Ineligible|1|||
94552158|NCT00626405|323817138|FG001|Overall Study|Deemed Ineligible|0|||
94552159|NCT00626405|323817137|FG000|Overall Study|Withdrawal by Subject|0|||
94552160|NCT00626405|323817138|FG001|Overall Study|Withdrawal by Subject|1|||
94552161|NCT04576897|323817145|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
94552162|NCT02593318|323817146|FG000|Overall Study|Withdrawal by Subject|1|||
94552163|NCT02593318|323817147|FG001|Overall Study|Withdrawal by Subject|1|||
94552164|NCT02974842|323817149|FG000|Overall Study|Withdrawal by Subject|4|||
94552165|NCT02974842|323817149|FG000|Overall Study|Screen failures|4|||
94552166|NCT02160145|323817153|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
94552167|NCT02160145|323817154|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
94552168|NCT02160145|323817155|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
94552169|NCT02160145|323817153|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
94552170|NCT02160145|323817154|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
94552171|NCT02160145|323817155|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
94552172|NCT02160145|323817153|FG000|Randomized Double-blind Period|Subject decision|0|||
94552173|NCT02160145|323817154|FG001|Randomized Double-blind Period|Subject decision|21|||
94552174|NCT02160145|323817155|FG002|Randomized Double-blind Period|Subject decision|20|||
94552175|NCT02160145|323817153|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
94552176|NCT02160145|323817154|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
94552177|NCT02160145|323817155|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
94552178|NCT02160145|323817153|FG000|Randomized Double-blind Period|Physician Decision|0|||
94552179|NCT02160145|323817154|FG001|Randomized Double-blind Period|Physician Decision|7|||
94552180|NCT02160145|323817155|FG002|Randomized Double-blind Period|Physician Decision|5|||
94552181|NCT03755661|323817156|FG000|Overall Study|Lost to Follow-up|1|||
94552182|NCT03755661|323817157|FG001|Overall Study|Lost to Follow-up|0|||
94552183|NCT01748825|323817158|FG000|Dose Escalation|Refused further treatment|2|||
94552184|NCT01748825|323817159|FG001|Dose Escalation|Refused further treatment|2|||
94552185|NCT01748825|323817160|FG002|Dose Escalation|Refused further treatment|0|||
94552186|NCT01748825|323817161|FG003|Dose Escalation|Refused further treatment|0|||
94552187|NCT01748825|323817162|FG004|Dose Escalation|Refused further treatment|1|||
94552188|NCT01748825|323817163|FG005|Dose Escalation|Refused further treatment|2|||
94552189|NCT01748825|323817164|FG006|Dose Escalation|Refused further treatment|0|||
94552190|NCT01748825|323817165|FG007|Dose Escalation|Refused further treatment|0|||
94552191|NCT01748825|323817166|FG008|Dose Escalation|Refused further treatment|0|||
94552192|NCT01748825|323817167|FG009|Dose Escalation|Refused further treatment|0|||
94343091|NCT03073200|323036051|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
94343092|NCT03073200|323036052|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
94343093|NCT03073200|323036053|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
94343094|NCT03073200|323036054|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
94343095|NCT03073200|323036055|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
94343096|NCT03073200|323036041|FG000|Extension Period|Lost to Follow-up|0|||
94343097|NCT03073200|323036042|FG001|Extension Period|Lost to Follow-up|0|||
94343098|NCT03073200|323036043|FG002|Extension Period|Lost to Follow-up|0|||
94343099|NCT03073200|323036044|FG003|Extension Period|Lost to Follow-up|0|||
94343100|NCT03073200|323036045|FG004|Extension Period|Lost to Follow-up|0|||
94343101|NCT03073200|323036046|FG005|Extension Period|Lost to Follow-up|0|||
94343102|NCT03073200|323036047|FG006|Extension Period|Lost to Follow-up|1|||
94343103|NCT03073200|323036048|FG007|Extension Period|Lost to Follow-up|1|||
94343104|NCT03073200|323036049|FG008|Extension Period|Lost to Follow-up|0|||
94343105|NCT03073200|323036050|FG009|Extension Period|Lost to Follow-up|0|||
94343106|NCT03073200|323036051|FG010|Extension Period|Lost to Follow-up|0|||
94343107|NCT03073200|323036052|FG011|Extension Period|Lost to Follow-up|0|||
94343108|NCT03073200|323036053|FG012|Extension Period|Lost to Follow-up|0|||
94343109|NCT03073200|323036054|FG013|Extension Period|Lost to Follow-up|0|||
94343110|NCT03073200|323036055|FG014|Extension Period|Lost to Follow-up|0|||
94343111|NCT03073200|323036041|FG000|Extension Period|Sponsor Decision|0|||
94343112|NCT03073200|323036042|FG001|Extension Period|Sponsor Decision|0|||
94343113|NCT03073200|323036043|FG002|Extension Period|Sponsor Decision|0|||
94343114|NCT03073200|323036044|FG003|Extension Period|Sponsor Decision|0|||
94343115|NCT03073200|323036045|FG004|Extension Period|Sponsor Decision|0|||
94343116|NCT03073200|323036046|FG005|Extension Period|Sponsor Decision|0|||
94343117|NCT03073200|323036047|FG006|Extension Period|Sponsor Decision|0|||
94343118|NCT03073200|323036048|FG007|Extension Period|Sponsor Decision|0|||
94343119|NCT03073200|323036049|FG008|Extension Period|Sponsor Decision|1|||
94343120|NCT03073200|323036050|FG009|Extension Period|Sponsor Decision|0|||
94343121|NCT03073200|323036051|FG010|Extension Period|Sponsor Decision|0|||
94343122|NCT03073200|323036052|FG011|Extension Period|Sponsor Decision|0|||
94343123|NCT03073200|323036053|FG012|Extension Period|Sponsor Decision|0|||
94343124|NCT03073200|323036054|FG013|Extension Period|Sponsor Decision|0|||
94343125|NCT03073200|323036055|FG014|Extension Period|Sponsor Decision|0|||
94343126|NCT03073200|323036041|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
94343127|NCT03073200|323036042|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
94343128|NCT03073200|323036043|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
94343129|NCT03073200|323036044|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
94343130|NCT03073200|323036045|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
94343131|NCT03073200|323036046|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
94343132|NCT03073200|323036047|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
94343133|NCT03073200|323036048|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
94343134|NCT03073200|323036049|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
94343135|NCT03073200|323036050|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
94343136|NCT03073200|323036051|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
94343137|NCT03073200|323036052|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
94343138|NCT03073200|323036053|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
94343139|NCT03073200|323036054|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
94343140|NCT03073200|323036055|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
94343141|NCT03073200|323036041|FG000|Extension Period|Withdrawal by Subject|0|||
94343142|NCT03073200|323036042|FG001|Extension Period|Withdrawal by Subject|0|||
94343143|NCT03073200|323036043|FG002|Extension Period|Withdrawal by Subject|0|||
94343144|NCT03073200|323036044|FG003|Extension Period|Withdrawal by Subject|0|||
94343145|NCT03073200|323036045|FG004|Extension Period|Withdrawal by Subject|0|||
94343146|NCT03073200|323036046|FG005|Extension Period|Withdrawal by Subject|0|||
94343147|NCT03073200|323036047|FG006|Extension Period|Withdrawal by Subject|1|||
94343148|NCT03073200|323036048|FG007|Extension Period|Withdrawal by Subject|2|||
94552193|NCT01748825|323817158|FG000|Dose Escalation|Switched to alternative treatment|0|||
94343149|NCT03073200|323036049|FG008|Extension Period|Withdrawal by Subject|0|||
94343150|NCT03073200|323036050|FG009|Extension Period|Withdrawal by Subject|0|||
94343151|NCT03073200|323036051|FG010|Extension Period|Withdrawal by Subject|0|||
94343152|NCT03073200|323036052|FG011|Extension Period|Withdrawal by Subject|0|||
94343153|NCT03073200|323036053|FG012|Extension Period|Withdrawal by Subject|0|||
94343154|NCT03073200|323036054|FG013|Extension Period|Withdrawal by Subject|0|||
94343155|NCT03073200|323036055|FG014|Extension Period|Withdrawal by Subject|0|||
94343156|NCT03073200|323036041|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
94343157|NCT03073200|323036042|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
94343158|NCT03073200|323036043|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
94343159|NCT03073200|323036044|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
94343160|NCT03073200|323036045|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
94343161|NCT03073200|323036046|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
94343162|NCT03073200|323036047|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
94343163|NCT03073200|323036048|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
94343164|NCT03073200|323036049|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
94343165|NCT03073200|323036050|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
94343166|NCT03073200|323036051|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
94343167|NCT03073200|323036052|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
94552194|NCT01748825|323817159|FG001|Dose Escalation|Switched to alternative treatment|0|||
94343168|NCT03073200|323036053|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
94343169|NCT03073200|323036054|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
94343170|NCT03073200|323036055|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
94343171|NCT03073200|323036041|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
94343172|NCT03073200|323036042|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
94343173|NCT03073200|323036043|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
94343174|NCT03073200|323036044|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
94343175|NCT03073200|323036045|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
94343176|NCT03073200|323036046|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
94343177|NCT03073200|323036047|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
94343178|NCT03073200|323036048|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
94343179|NCT03073200|323036049|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
94343180|NCT03073200|323036050|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
94343181|NCT03073200|323036051|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
94343182|NCT03073200|323036052|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
94343183|NCT03073200|323036053|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
94343184|NCT03073200|323036054|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
94343185|NCT03073200|323036055|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
94343186|NCT03073200|323036041|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
94343187|NCT03073200|323036042|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
94343188|NCT03073200|323036043|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
94343189|NCT03073200|323036044|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
94343190|NCT03073200|323036045|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
94343191|NCT03073200|323036046|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
94343192|NCT03073200|323036047|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
94343193|NCT03073200|323036048|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
94343194|NCT03073200|323036049|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
94343195|NCT03073200|323036050|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
94343196|NCT03073200|323036051|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
94343197|NCT03073200|323036052|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
94445582|NCT00122382|323417342|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
94445583|NCT00122382|323417340|FG000|Double-Blind Study|Withdrawal of Consent|7|||
94445584|NCT00122382|323417341|FG001|Double-Blind Study|Withdrawal of Consent|3|||
94445585|NCT00122382|323417342|FG002|Double-Blind Study|Withdrawal of Consent|0|||
94445586|NCT00122382|323417340|FG000|Double-Blind Study|Protocol Violation|1|||
94445587|NCT00122382|323417341|FG001|Double-Blind Study|Protocol Violation|0|||
94445588|NCT00122382|323417342|FG002|Double-Blind Study|Protocol Violation|0|||
94445589|NCT00122382|323417340|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
94552195|NCT01748825|323817160|FG002|Dose Escalation|Switched to alternative treatment|0|||
94445590|NCT00122382|323417341|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
94445591|NCT00122382|323417342|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
94343198|NCT03073200|323036053|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
94343199|NCT03073200|323036054|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
94343200|NCT03073200|323036055|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
94343201|NCT03073200|323036041|FG000|Randomized Withdrawal Period|Adverse Event|0|||
94343202|NCT03073200|323036042|FG001|Randomized Withdrawal Period|Adverse Event|0|||
94343203|NCT03073200|323036043|FG002|Randomized Withdrawal Period|Adverse Event|0|||
94343204|NCT03073200|323036044|FG003|Randomized Withdrawal Period|Adverse Event|0|||
94343205|NCT03073200|323036045|FG004|Randomized Withdrawal Period|Adverse Event|0|||
94343206|NCT03073200|323036046|FG005|Randomized Withdrawal Period|Adverse Event|0|||
94343207|NCT03073200|323036047|FG006|Randomized Withdrawal Period|Adverse Event|0|||
94343208|NCT03073200|323036048|FG007|Randomized Withdrawal Period|Adverse Event|0|||
94343209|NCT03073200|323036049|FG008|Randomized Withdrawal Period|Adverse Event|0|||
94343210|NCT03073200|323036050|FG009|Randomized Withdrawal Period|Adverse Event|0|||
94343211|NCT03073200|323036051|FG010|Randomized Withdrawal Period|Adverse Event|1|||
94343212|NCT03073200|323036052|FG011|Randomized Withdrawal Period|Adverse Event|0|||
94343213|NCT03073200|323036053|FG012|Randomized Withdrawal Period|Adverse Event|0|||
94343214|NCT03073200|323036054|FG013|Randomized Withdrawal Period|Adverse Event|0|||
94343215|NCT03073200|323036055|FG014|Randomized Withdrawal Period|Adverse Event|0|||
94343216|NCT03073200|323036041|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
94343217|NCT03073200|323036042|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
94343218|NCT03073200|323036043|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
94552196|NCT01748825|323817161|FG003|Dose Escalation|Switched to alternative treatment|1|||
94343219|NCT03073200|323036044|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
94343220|NCT03073200|323036045|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
94343221|NCT03073200|323036046|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
94552197|NCT01748825|323817162|FG004|Dose Escalation|Switched to alternative treatment|0|||
94552198|NCT01748825|323817163|FG005|Dose Escalation|Switched to alternative treatment|0|||
94552199|NCT01748825|323817164|FG006|Dose Escalation|Switched to alternative treatment|0|||
94552200|NCT01748825|323817165|FG007|Dose Escalation|Switched to alternative treatment|0|||
94552201|NCT01748825|323817166|FG008|Dose Escalation|Switched to alternative treatment|0|||
94552202|NCT01748825|323817167|FG009|Dose Escalation|Switched to alternative treatment|0|||
94552203|NCT01748825|323817158|FG000|Dose Escalation|Adverse Event|0|||
94552204|NCT01748825|323817159|FG001|Dose Escalation|Adverse Event|0|||
94552205|NCT01748825|323817160|FG002|Dose Escalation|Adverse Event|0|||
94552206|NCT01748825|323817161|FG003|Dose Escalation|Adverse Event|0|||
94552207|NCT01748825|323817162|FG004|Dose Escalation|Adverse Event|0|||
94552208|NCT01748825|323817163|FG005|Dose Escalation|Adverse Event|0|||
94552209|NCT01748825|323817164|FG006|Dose Escalation|Adverse Event|1|||
94552210|NCT01748825|323817165|FG007|Dose Escalation|Adverse Event|0|||
94552211|NCT01748825|323817166|FG008|Dose Escalation|Adverse Event|0|||
94552212|NCT01748825|323817167|FG009|Dose Escalation|Adverse Event|0|||
94552213|NCT01748825|323817158|FG000|Dose Expansion|Refused further treatment|0|||
94552214|NCT01748825|323817159|FG001|Dose Expansion|Refused further treatment|0|||
94552215|NCT01748825|323817160|FG002|Dose Expansion|Refused further treatment|0|||
94552216|NCT01748825|323817161|FG003|Dose Expansion|Refused further treatment|0|||
94552217|NCT01748825|323817162|FG004|Dose Expansion|Refused further treatment|0|||
94552218|NCT01748825|323817163|FG005|Dose Expansion|Refused further treatment|0|||
94552219|NCT01748825|323817164|FG006|Dose Expansion|Refused further treatment|0|||
94552220|NCT01748825|323817165|FG007|Dose Expansion|Refused further treatment|0|||
94552221|NCT01748825|323817166|FG008|Dose Expansion|Refused further treatment|1|||
94343222|NCT03073200|323036047|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
94343223|NCT03073200|323036048|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
94343224|NCT03073200|323036049|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
94343225|NCT03073200|323036050|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
94343226|NCT03073200|323036051|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
94343227|NCT03073200|323036052|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
94343228|NCT03073200|323036053|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
94343229|NCT03073200|323036054|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
94343230|NCT03073200|323036055|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
94552222|NCT01748825|323817167|FG009|Dose Expansion|Refused further treatment|1|||
94343231|NCT03073200|323036041|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94343232|NCT03073200|323036042|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94343233|NCT03073200|323036043|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94343234|NCT03073200|323036044|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94343235|NCT03073200|323036045|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94343236|NCT03073200|323036046|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94343237|NCT03073200|323036047|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94445592|NCT00122382|323417340|FG000|Double-Blind Study|Randomized but not treated|0|||
94445593|NCT00122382|323417341|FG001|Double-Blind Study|Randomized but not treated|2|||
94343238|NCT03073200|323036048|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94343239|NCT03073200|323036049|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94343240|NCT03073200|323036050|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94343241|NCT03073200|323036051|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94343242|NCT03073200|323036052|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94445594|NCT00122382|323417342|FG002|Double-Blind Study|Randomized but not treated|0|||
94445595|NCT00122382|323417340|FG000|Open-Label Study|Adverse Event|0|||
94343243|NCT03073200|323036053|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94343244|NCT03073200|323036054|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
94343245|NCT03073200|323036055|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94343246|NCT03073200|323036041|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
94343247|NCT03073200|323036042|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
94552223|NCT01748825|323817158|FG000|Dose Expansion|Switched to alternative treatment|0|||
94445596|NCT00122382|323417341|FG001|Open-Label Study|Adverse Event|0|||
94445597|NCT00122382|323417342|FG002|Open-Label Study|Adverse Event|11|||
94445598|NCT00122382|323417340|FG000|Open-Label Study|Death|0|||
94445599|NCT00122382|323417341|FG001|Open-Label Study|Death|0|||
94445600|NCT00122382|323417342|FG002|Open-Label Study|Death|2|||
94445601|NCT00122382|323417340|FG000|Open-Label Study|Lack of Efficacy|0|||
94552224|NCT01748825|323817159|FG001|Dose Expansion|Switched to alternative treatment|0|||
94552225|NCT01748825|323817160|FG002|Dose Expansion|Switched to alternative treatment|0|||
94552226|NCT01748825|323817161|FG003|Dose Expansion|Switched to alternative treatment|0|||
94343248|NCT03073200|323036043|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
94343249|NCT03073200|323036044|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
94343250|NCT03073200|323036045|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
94343251|NCT03073200|323036046|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
94445602|NCT00122382|323417341|FG001|Open-Label Study|Lack of Efficacy|0|||
94552227|NCT01748825|323817162|FG004|Dose Expansion|Switched to alternative treatment|0|||
94552228|NCT01748825|323817163|FG005|Dose Expansion|Switched to alternative treatment|0|||
94552229|NCT01748825|323817164|FG006|Dose Expansion|Switched to alternative treatment|0|||
94552230|NCT01748825|323817165|FG007|Dose Expansion|Switched to alternative treatment|0|||
94552231|NCT01748825|323817166|FG008|Dose Expansion|Switched to alternative treatment|0|||
94552232|NCT01748825|323817167|FG009|Dose Expansion|Switched to alternative treatment|1|||
94552233|NCT01748825|323817158|FG000|Dose Expansion|Adverse Event|0|||
94552234|NCT01748825|323817159|FG001|Dose Expansion|Adverse Event|0|||
94552235|NCT01748825|323817160|FG002|Dose Expansion|Adverse Event|0|||
94552236|NCT01748825|323817161|FG003|Dose Expansion|Adverse Event|0|||
94552237|NCT01748825|323817162|FG004|Dose Expansion|Adverse Event|0|||
94552238|NCT01748825|323817163|FG005|Dose Expansion|Adverse Event|0|||
94552239|NCT01748825|323817164|FG006|Dose Expansion|Adverse Event|0|||
94552240|NCT01748825|323817165|FG007|Dose Expansion|Adverse Event|0|||
94552241|NCT01748825|323817166|FG008|Dose Expansion|Adverse Event|0|||
94552242|NCT01748825|323817167|FG009|Dose Expansion|Adverse Event|3|||
94552243|NCT01748825|323817158|FG000|Dose Expansion|Physician Decision|0|||
94552244|NCT01748825|323817159|FG001|Dose Expansion|Physician Decision|0|||
94552245|NCT01748825|323817160|FG002|Dose Expansion|Physician Decision|0|||
94552246|NCT01748825|323817161|FG003|Dose Expansion|Physician Decision|0|||
94552247|NCT01748825|323817162|FG004|Dose Expansion|Physician Decision|0|||
94552248|NCT01748825|323817163|FG005|Dose Expansion|Physician Decision|0|||
94552249|NCT01748825|323817164|FG006|Dose Expansion|Physician Decision|0|||
94552250|NCT01748825|323817165|FG007|Dose Expansion|Physician Decision|0|||
94552251|NCT01748825|323817166|FG008|Dose Expansion|Physician Decision|1|||
94552252|NCT01748825|323817167|FG009|Dose Expansion|Physician Decision|0|||
94552253|NCT00852241|323817168|FG000|Overall Study|Physician Decision|18|||
94552254|NCT03848949|323817169|FG000|Overall Study|Lost to Follow-up|5|||
94552255|NCT03848949|323817170|FG001|Overall Study|Lost to Follow-up|7|||
94552256|NCT00118430|323817174|FG000|Overall Study|Withdrawal by Subject|6|||
94552257|NCT00118430|323817175|FG001|Overall Study|Withdrawal by Subject|2|||
94552258|NCT00118430|323817176|FG002|Overall Study|Withdrawal by Subject|0|||
94552259|NCT00118430|323817174|FG000|Overall Study|Lost to Follow-up|15|||
94552260|NCT00118430|323817175|FG001|Overall Study|Lost to Follow-up|22|||
94552261|NCT00118430|323817176|FG002|Overall Study|Lost to Follow-up|28|||
94552262|NCT03890367|323817177|FG000|Overall Study|Withdrawal by parent/guardian|1|||
94552263|NCT03890367|323817178|FG001|Overall Study|Withdrawal by parent/guardian|3|||
94552264|NCT03890367|323817179|FG002|Overall Study|Withdrawal by parent/guardian|0|||
94552265|NCT03890367|323817177|FG000|Overall Study|Protocol deviation|2|||
94552266|NCT03890367|323817178|FG001|Overall Study|Protocol deviation|2|||
94552267|NCT03890367|323817179|FG002|Overall Study|Protocol deviation|1|||
94552268|NCT03890367|323817177|FG000|Overall Study|Lost to Follow-up|1|||
94552269|NCT03890367|323817178|FG001|Overall Study|Lost to Follow-up|1|||
94552270|NCT03890367|323817179|FG002|Overall Study|Lost to Follow-up|0|||
94552271|NCT00707954|323818633|FG000|Overall Study|Physician Decision|0|||
94552272|NCT00707954|323818634|FG001|Overall Study|Physician Decision|0|||
94552273|NCT00707954|323818635|FG002|Overall Study|Physician Decision|0|||
94552274|NCT00707954|323818636|FG003|Overall Study|Physician Decision|0|||
94552275|NCT00707954|323818637|FG004|Overall Study|Physician Decision|1|||
94552276|NCT00126776|323818638|FG000|Overall Study|follow up complete on all patients|0|||
94552277|NCT00126776|323818639|FG001|Overall Study|follow up complete on all patients|0|||
94552278|NCT01286077|323818643|FG000|Overall Study|Adverse Event|2|||
94552279|NCT01286077|323818644|FG001|Overall Study|Adverse Event|0|||
94552280|NCT01286077|323818643|FG000|Overall Study|Death|1|||
94552281|NCT01286077|323818644|FG001|Overall Study|Death|0|||
94552282|NCT01286077|323818643|FG000|Overall Study|Protocol Violation|1|||
94552283|NCT01286077|323818644|FG001|Overall Study|Protocol Violation|1|||
94552284|NCT01286077|323818643|FG000|Overall Study|Withdrawal by Subject|0|||
94552285|NCT01286077|323818644|FG001|Overall Study|Withdrawal by Subject|2|||
94552286|NCT01286077|323818643|FG000|Overall Study|Intercurrent illness|1|||
94552287|NCT01286077|323818644|FG001|Overall Study|Intercurrent illness|0|||
94552288|NCT01286077|323818643|FG000|Overall Study|Non-compliance|1|||
94552289|NCT01286077|323818644|FG001|Overall Study|Non-compliance|0|||
94552290|NCT01286077|323818643|FG000|Overall Study|The subject starts with alternative MMY|0|||
94552291|NCT01286077|323818644|FG001|Overall Study|The subject starts with alternative MMY|3|||
94552292|NCT01286077|323818643|FG000|Overall Study|Patient's decision to stop treatment|3|||
94552293|NCT01286077|323818644|FG001|Overall Study|Patient's decision to stop treatment|0|||
94343252|NCT03073200|323036047|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
94343253|NCT03073200|323036048|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
94552294|NCT01286077|323818643|FG000|Overall Study|Progression of disease|0|||
94552295|NCT01286077|323818644|FG001|Overall Study|Progression of disease|1|||
94552296|NCT01286077|323818643|FG000|Overall Study|refill medication not received in time|1|||
94552297|NCT01286077|323818644|FG001|Overall Study|refill medication not received in time|0|||
94552298|NCT00568126|323818645|FG000|Overall Study|Adverse Event|3|||
94552299|NCT00568126|323818646|FG001|Overall Study|Adverse Event|0|||
94552300|NCT00568126|323818645|FG000|Overall Study|Withdrawal by Subject|2|||
94552301|NCT00568126|323818646|FG001|Overall Study|Withdrawal by Subject|3|||
94445603|NCT00122382|323417342|FG002|Open-Label Study|Lack of Efficacy|3|||
94445604|NCT00122382|323417340|FG000|Open-Label Study|Lost to Follow-up|0|||
94445605|NCT00122382|323417341|FG001|Open-Label Study|Lost to Follow-up|0|||
94445606|NCT00122382|323417342|FG002|Open-Label Study|Lost to Follow-up|3|||
94552302|NCT00568126|323818645|FG000|Overall Study|Lost to Follow-up|4|||
94552303|NCT00568126|323818646|FG001|Overall Study|Lost to Follow-up|3|||
94552304|NCT00568126|323818645|FG000|Overall Study|Lack of Efficacy|0|||
94552305|NCT00568126|323818646|FG001|Overall Study|Lack of Efficacy|1|||
94552306|NCT00568126|323818645|FG000|Overall Study|Physician Decision|2|||
94552307|NCT00568126|323818646|FG001|Overall Study|Physician Decision|2|||
94552308|NCT00434642|323818647|FG000|Blinded Treatment Phase|Adverse Event|12|||
94552309|NCT00434642|323818648|FG001|Blinded Treatment Phase|Adverse Event|58|||
94552310|NCT00434642|323818647|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
94445607|NCT00122382|323417340|FG000|Open-Label Study|Pregnancy|0|||
94445608|NCT00122382|323417341|FG001|Open-Label Study|Pregnancy|0|||
94445609|NCT00122382|323417342|FG002|Open-Label Study|Pregnancy|2|||
94343254|NCT03073200|323036049|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
94445610|NCT00122382|323417340|FG000|Open-Label Study|Poor/Non-Compliance|0|||
94445611|NCT00122382|323417341|FG001|Open-Label Study|Poor/Non-Compliance|0|||
94445612|NCT00122382|323417342|FG002|Open-Label Study|Poor/Non-Compliance|1|||
94445613|NCT00122382|323417340|FG000|Open-Label Study|Withdrawal of Consent|0|||
94445614|NCT00122382|323417341|FG001|Open-Label Study|Withdrawal of Consent|0|||
94343255|NCT03073200|323036050|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
94343256|NCT03073200|323036051|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
94343257|NCT03073200|323036052|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
94445615|NCT00122382|323417342|FG002|Open-Label Study|Withdrawal of Consent|4|||
94445616|NCT03170544|323417344|FG000|Part 1|Lost to Follow-up|1|||
94445617|NCT03170544|323417345|FG001|Part 1|Lost to Follow-up|0|||
94445618|NCT03170544|323417346|FG002|Part 1|Lost to Follow-up|0|||
94445619|NCT03170544|323417347|FG003|Part 1|Lost to Follow-up|0|||
94343258|NCT03073200|323036053|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
94552311|NCT00434642|323818648|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
94343259|NCT03073200|323036054|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
94343260|NCT03073200|323036055|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
94343261|NCT03073200|323036041|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94343262|NCT03073200|323036042|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94343263|NCT03073200|323036043|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94343264|NCT03073200|323036044|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94343265|NCT03073200|323036045|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94343266|NCT03073200|323036046|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94343267|NCT03073200|323036047|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94343268|NCT03073200|323036048|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94343269|NCT03073200|323036049|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94445620|NCT03170544|323417348|FG004|Part 1|Lost to Follow-up|0|||
94445621|NCT03170544|323417349|FG005|Part 1|Lost to Follow-up|0|||
94445622|NCT03170544|323417350|FG006|Part 1|Lost to Follow-up|0|||
94445623|NCT03170544|323417351|FG007|Part 1|Lost to Follow-up|0|||
94445624|NCT03170544|323417352|FG008|Part 1|Lost to Follow-up|0|||
94445625|NCT03170544|323417353|FG009|Part 1|Lost to Follow-up|0|||
94445626|NCT03170544|323417354|FG010|Part 1|Lost to Follow-up|0|||
94445627|NCT03170544|323417355|FG011|Part 1|Lost to Follow-up|0|||
94445628|NCT03170544|323417344|FG000|Part 1|Not treated|0|||
94445629|NCT03170544|323417345|FG001|Part 1|Not treated|0|||
94445630|NCT03170544|323417346|FG002|Part 1|Not treated|0|||
94445631|NCT03170544|323417347|FG003|Part 1|Not treated|1|||
94445632|NCT03170544|323417348|FG004|Part 1|Not treated|0|||
94445633|NCT03170544|323417349|FG005|Part 1|Not treated|0|||
94445634|NCT03170544|323417350|FG006|Part 1|Not treated|0|||
94445635|NCT03170544|323417351|FG007|Part 1|Not treated|0|||
94445636|NCT03170544|323417352|FG008|Part 1|Not treated|0|||
94445637|NCT03170544|323417353|FG009|Part 1|Not treated|0|||
94445638|NCT03170544|323417354|FG010|Part 1|Not treated|0|||
94445639|NCT03170544|323417355|FG011|Part 1|Not treated|0|||
94445640|NCT02174627|323417356|FG000|Overall Study|Missing|0|||
94445641|NCT02174627|323417357|FG001|Overall Study|Missing|1|||
94445642|NCT02174627|323417356|FG000|Overall Study|Incorrect enrolment before randomization|0|||
94445643|NCT02174627|323417357|FG001|Overall Study|Incorrect enrolment before randomization|1|||
94445644|NCT02174627|323417356|FG000|Overall Study|Participant decision|84|||
94445645|NCT02174627|323417357|FG001|Overall Study|Participant decision|128|||
94445646|NCT04495829|323417365|FG000|Overall Study|Lost to Follow-up|2|||
94445647|NCT04495829|323417365|FG000|Overall Study|Inclusion criterion not met|3|||
94445648|NCT02107131|323417366|FG000|Overall Study|Lost to Follow-up|4|||
94445649|NCT02107131|323417367|FG001|Overall Study|Lost to Follow-up|4|||
94445650|NCT02107131|323417366|FG000|Overall Study|Physician Decision|1|||
94445651|NCT02107131|323417367|FG001|Overall Study|Physician Decision|0|||
94552312|NCT00434642|323818647|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
94552313|NCT00434642|323818648|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
94552314|NCT00434642|323818647|FG000|Blinded Treatment Phase|Physician Decision|19|||
94552315|NCT00434642|323818648|FG001|Blinded Treatment Phase|Physician Decision|27|||
94445652|NCT02107131|323417366|FG000|Overall Study|Withdrawal by Subject|2|||
94445653|NCT02107131|323417367|FG001|Overall Study|Withdrawal by Subject|0|||
94445654|NCT02107131|323417366|FG000|Overall Study|mental instability|1|||
94445655|NCT02107131|323417367|FG001|Overall Study|mental instability|0|||
94445656|NCT02107131|323417366|FG000|Overall Study|Death|0|||
94445657|NCT02107131|323417367|FG001|Overall Study|Death|1|||
94445658|NCT02107131|323417366|FG000|Overall Study|Protocol Violation|0|||
94445659|NCT02107131|323417367|FG001|Overall Study|Protocol Violation|4|||
94445660|NCT00682786|323417368|FG000|Overall Study|Withdrawal by Subject|2|||
94445661|NCT00682786|323417369|FG001|Overall Study|Withdrawal by Subject|2|||
94227291|NCT03214250|322625765|FG003|Overall Study|Withdrawal by Subject|2|||
94227292|NCT03214250|322625766|FG004|Overall Study|Withdrawal by Subject|5|||
94227293|NCT03214250|322625767|FG005|Overall Study|Withdrawal by Subject|0|||
94227294|NCT03214250|322625768|FG006|Overall Study|Withdrawal by Subject|2|||
94227295|NCT00317603|322625769|FG000|Overall Study|Progressive Disease|3|||
94227296|NCT03463577|322625772|FG000|Overall Study|Lost to Follow-up|238|||
94227297|NCT03463577|322625773|FG001|Overall Study|Lost to Follow-up|435|||
94227298|NCT03463577|322625774|FG002|Overall Study|Lost to Follow-up|0|||
94227299|NCT03463577|322625775|FG003|Overall Study|Lost to Follow-up|0|||
94227300|NCT03463577|322625776|FG004|Overall Study|Lost to Follow-up|0|||
94227301|NCT03463577|322625777|FG005|Overall Study|Lost to Follow-up|0|||
94552316|NCT00434642|323818647|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
94552317|NCT00434642|323818648|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
94552318|NCT00434642|323818647|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
94552319|NCT00434642|323818648|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
94552320|NCT00434642|323818647|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
94227302|NCT03463577|322625772|FG000|Overall Study|With unknown pregnancy outcome|0|||
94227303|NCT03463577|322625773|FG001|Overall Study|With unknown pregnancy outcome|5|||
94227304|NCT03463577|322625774|FG002|Overall Study|With unknown pregnancy outcome|0|||
94227305|NCT03463577|322625775|FG003|Overall Study|With unknown pregnancy outcome|0|||
94227306|NCT03463577|322625776|FG004|Overall Study|With unknown pregnancy outcome|0|||
94227307|NCT03463577|322625777|FG005|Overall Study|With unknown pregnancy outcome|0|||
94227308|NCT03463577|322625772|FG000|Overall Study|Maternal death|2|||
94227309|NCT03463577|322625773|FG001|Overall Study|Maternal death|0|||
94227310|NCT03463577|322625774|FG002|Overall Study|Maternal death|0|||
94227311|NCT03463577|322625775|FG003|Overall Study|Maternal death|0|||
94227312|NCT03463577|322625776|FG004|Overall Study|Maternal death|0|||
94227313|NCT03463577|322625777|FG005|Overall Study|Maternal death|0|||
94227314|NCT03463577|322625772|FG000|Overall Study|Neonatal death|0|||
94227315|NCT03463577|322625773|FG001|Overall Study|Neonatal death|0|||
94227316|NCT03463577|322625774|FG002|Overall Study|Neonatal death|0|||
94227317|NCT03463577|322625775|FG003|Overall Study|Neonatal death|15|||
94227318|NCT03463577|322625776|FG004|Overall Study|Neonatal death|17|||
94227319|NCT03463577|322625777|FG005|Overall Study|Neonatal death|0|||
94227320|NCT00619983|322625780|FG000|Test Drug Alone|Withdrawal by Subject|1|||
94445662|NCT00682786|323417368|FG000|Overall Study|Did not receive irinotecan|0|||
94445663|NCT00682786|323417369|FG001|Overall Study|Did not receive irinotecan|1|||
94445664|NCT03644342|323417370|FG000|Overall Study|Adverse Event|2|||
94445665|NCT03644342|323417371|FG001|Overall Study|Adverse Event|0|||
94445666|NCT03644342|323417370|FG000|Overall Study|Protocol Violation|0|||
94445667|NCT03644342|323417371|FG001|Overall Study|Protocol Violation|1|||
94445668|NCT01991743|323417373|FG000|Overall Study|external cephalic version not performed|0|||
94445669|NCT01991743|323417374|FG001|Overall Study|external cephalic version not performed|0|||
94445670|NCT01991743|323417375|FG002|Overall Study|external cephalic version not performed|1|||
94445671|NCT01991743|323417376|FG003|Overall Study|external cephalic version not performed|0|||
94445672|NCT01445730|323417377|FG000|Overall Study|Adverse Event|1|||
94552321|NCT00434642|323818648|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
94227321|NCT00619983|322625781|FG001|Test Drug Alone|Withdrawal by Subject|0|||
94445673|NCT01445730|323417377|FG000|Overall Study|For the advice of a dentist|1|||
94227322|NCT00619983|322625782|FG002|Test Drug Alone|Withdrawal by Subject|0|||
94227323|NCT00619983|322625783|FG003|Test Drug Alone|Withdrawal by Subject|1|||
94227324|NCT00619983|322625780|FG000|Test Drug Alone|Failure of daily diary device|1|||
94227325|NCT00619983|322625781|FG001|Test Drug Alone|Failure of daily diary device|1|||
94227326|NCT00619983|322625782|FG002|Test Drug Alone|Failure of daily diary device|2|||
94227327|NCT00619983|322625783|FG003|Test Drug Alone|Failure of daily diary device|2|||
94445674|NCT01445730|323417377|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
94343270|NCT03073200|323036050|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94343271|NCT03073200|323036051|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94343272|NCT03073200|323036052|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94343273|NCT03073200|323036053|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94343274|NCT03073200|323036054|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
94343275|NCT03073200|323036055|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94343276|NCT03073200|323036041|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
94343277|NCT03073200|323036042|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
94343278|NCT03073200|323036043|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
94343279|NCT03073200|323036044|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
94343280|NCT03073200|323036045|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
94343281|NCT03073200|323036046|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
94343282|NCT03073200|323036047|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
94343283|NCT03073200|323036048|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
94343284|NCT03073200|323036049|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
94343285|NCT03073200|323036050|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
94343286|NCT03073200|323036051|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
94343287|NCT03073200|323036052|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
94343288|NCT03073200|323036053|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
94343289|NCT03073200|323036054|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
94343290|NCT03073200|323036055|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
94343291|NCT03073200|323036041|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
94343292|NCT03073200|323036042|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
94343293|NCT03073200|323036043|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
94343294|NCT03073200|323036044|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
94343295|NCT03073200|323036045|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
94343296|NCT03073200|323036046|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
94343297|NCT03073200|323036047|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
94343298|NCT03073200|323036048|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
94343299|NCT03073200|323036049|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
94343300|NCT03073200|323036050|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
94343301|NCT03073200|323036051|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
94343302|NCT03073200|323036052|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
94343303|NCT03073200|323036053|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
94343304|NCT03073200|323036054|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
94343305|NCT03073200|323036055|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
94343306|NCT03073200|323036041|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94343307|NCT03073200|323036042|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94343308|NCT03073200|323036043|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94343309|NCT03073200|323036044|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94343310|NCT03073200|323036045|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94343311|NCT03073200|323036046|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94343312|NCT03073200|323036047|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94343313|NCT03073200|323036048|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94343314|NCT03073200|323036049|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94343315|NCT03073200|323036050|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94343316|NCT03073200|323036051|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94343317|NCT03073200|323036052|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94343318|NCT03073200|323036053|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94343319|NCT03073200|323036054|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
94343320|NCT03073200|323036055|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94343321|NCT03073200|323036041|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
94343322|NCT03073200|323036042|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
94343323|NCT03073200|323036043|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
94343324|NCT03073200|323036044|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
94343325|NCT03073200|323036045|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
94343326|NCT03073200|323036046|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
94343327|NCT03073200|323036047|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
94343328|NCT03073200|323036048|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
94343329|NCT03073200|323036049|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
94445675|NCT01367886|323417378|FG000|Overall Study|Lost to Follow-up|4|||
94445676|NCT01367886|323417378|FG000|Overall Study|Lack of Efficacy|2|||
94445677|NCT01367886|323417378|FG000|Overall Study|Death|1|||
94445678|NCT01167140|323417379|FG000|Overall Study|Withdrawal by Subject|1|||
94445679|NCT03805412|323417386|FG000|Overall Study|Lost to Follow-up|0|||
94445680|NCT03805412|323417387|FG001|Overall Study|Lost to Follow-up|1|||
94445681|NCT02872714|323417393|FG000|Overall Study|Progressive Disease|1|||
94445682|NCT02872714|323417394|FG001|Overall Study|Progressive Disease|2|||
94445683|NCT02872714|323417395|FG002|Overall Study|Progressive Disease|0|||
94445684|NCT02872714|323417396|FG003|Overall Study|Progressive Disease|0|||
94445685|NCT02872714|323417397|FG004|Overall Study|Progressive Disease|0|||
94445686|NCT02872714|323417393|FG000|Overall Study|Death|87|||
94445687|NCT02872714|323417394|FG001|Overall Study|Death|36|||
94445688|NCT02872714|323417395|FG002|Overall Study|Death|8|||
94445689|NCT02872714|323417396|FG003|Overall Study|Death|81|||
94552322|NCT00434642|323818647|FG000|Open-label Treatment Phase|Adverse Event|0|||
94552323|NCT00434642|323818648|FG001|Open-label Treatment Phase|Adverse Event|5|||
94552324|NCT00434642|323818647|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
94552325|NCT00434642|323818648|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
94552326|NCT02428205|323818653|FG000|Overall Study|Lack of Efficacy|1|||
94552327|NCT02428205|323818654|FG001|Overall Study|Lack of Efficacy|0|||
94552328|NCT02428205|323818653|FG000|Overall Study|Lost to Follow-up|1|||
94552329|NCT02428205|323818654|FG001|Overall Study|Lost to Follow-up|1|||
94445690|NCT02872714|323417397|FG004|Overall Study|Death|2|||
94445691|NCT02872714|323417393|FG000|Overall Study|Lost to Follow-up|2|||
94445692|NCT02872714|323417394|FG001|Overall Study|Lost to Follow-up|1|||
94445693|NCT02872714|323417395|FG002|Overall Study|Lost to Follow-up|0|||
94445694|NCT02872714|323417396|FG003|Overall Study|Lost to Follow-up|3|||
94445695|NCT02872714|323417397|FG004|Overall Study|Lost to Follow-up|0|||
94445696|NCT02872714|323417393|FG000|Overall Study|Physician Decision|0|||
94445697|NCT02872714|323417394|FG001|Overall Study|Physician Decision|0|||
94445698|NCT02872714|323417395|FG002|Overall Study|Physician Decision|0|||
94445699|NCT02872714|323417396|FG003|Overall Study|Physician Decision|1|||
94445700|NCT02872714|323417397|FG004|Overall Study|Physician Decision|0|||
94445701|NCT02872714|323417393|FG000|Overall Study|Withdrawal by Subject|1|||
94445702|NCT02872714|323417394|FG001|Overall Study|Withdrawal by Subject|3|||
94445703|NCT02872714|323417395|FG002|Overall Study|Withdrawal by Subject|0|||
94445704|NCT02872714|323417396|FG003|Overall Study|Withdrawal by Subject|2|||
94552330|NCT02428205|323818653|FG000|Overall Study|Worse behavior|0|||
94552331|NCT02428205|323818654|FG001|Overall Study|Worse behavior|1|||
94552332|NCT00599638|323818655|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
94445705|NCT02872714|323417397|FG004|Overall Study|Withdrawal by Subject|0|||
94445706|NCT02872714|323417393|FG000|Overall Study|Captured as Other|2|||
94445707|NCT02872714|323417394|FG001|Overall Study|Captured as Other|0|||
94445708|NCT02872714|323417395|FG002|Overall Study|Captured as Other|0|||
94445709|NCT02872714|323417396|FG003|Overall Study|Captured as Other|1|||
94445710|NCT02872714|323417397|FG004|Overall Study|Captured as Other|0|||
94445711|NCT04390113|323417398|FG000|Overall Study|Not Treated|0|||
94445712|NCT04390113|323417399|FG001|Overall Study|Not Treated|1|||
94445713|NCT04390113|323417398|FG000|Overall Study|Adverse Event|1|||
94343330|NCT03073200|323036050|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
94343331|NCT03073200|323036051|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
94343332|NCT03073200|323036052|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
94343333|NCT03073200|323036053|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
94343334|NCT03073200|323036054|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
94343335|NCT03073200|323036055|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
94343336|NCT04474366|323036056|FG000|Overall Study|Lost to Follow-up|2|||
94343337|NCT04474366|323036057|FG001|Overall Study|Lost to Follow-up|5|||
94343338|NCT04757376|323036058|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
94343339|NCT04757376|323036059|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
94343340|NCT04757376|323036060|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
94445714|NCT04390113|323417399|FG001|Overall Study|Adverse Event|0|||
94445715|NCT04390113|323417398|FG000|Overall Study|Death|2|||
94227328|NCT00809341|322625784|FG000|Overall Study|Physician Decision|0|||
94445716|NCT04390113|323417399|FG001|Overall Study|Death|1|||
94445717|NCT04390113|323417398|FG000|Overall Study|Physician Decision|1|||
94445718|NCT04390113|323417399|FG001|Overall Study|Physician Decision|3|||
94445719|NCT04390113|323417398|FG000|Overall Study|Study Terminated by Sponsor|5|||
94445720|NCT04390113|323417399|FG001|Overall Study|Study Terminated by Sponsor|3|||
94445721|NCT04390113|323417398|FG000|Overall Study|Withdrawal by Subject|10|||
94445722|NCT04390113|323417399|FG001|Overall Study|Withdrawal by Subject|5|||
94445723|NCT04390113|323417398|FG000|Overall Study|Other|1|||
94445724|NCT04390113|323417399|FG001|Overall Study|Other|0|||
94445725|NCT04390113|323417398|FG000|Overall Study|Missing|0|||
94445726|NCT04390113|323417399|FG001|Overall Study|Missing|1|||
94445727|NCT02576847|323417405|FG000|Overall Study|Adverse Event|27|||
94445728|NCT02576847|323417405|FG000|Overall Study|Lost to Follow-up|22|||
94445729|NCT02576847|323417405|FG000|Overall Study|Physician Decision|1|||
94445730|NCT02576847|323417405|FG000|Overall Study|Pregnancy|1|||
94445731|NCT02576847|323417405|FG000|Overall Study|Protocol Violation|3|||
94445732|NCT02576847|323417405|FG000|Overall Study|Withdrawal by Subject|78|||
94445733|NCT02576847|323417405|FG000|Overall Study|Other|5|||
94445734|NCT02362360|323417406|FG000|Period 1|Lack of Efficacy|1|||
94445735|NCT02362360|323417407|FG001|Period 1|Lack of Efficacy|0|||
94445736|NCT02362360|323417406|FG000|Period 1|Withdrawal by Subject|2|||
94445737|NCT02362360|323417407|FG001|Period 1|Withdrawal by Subject|1|||
94445738|NCT04199104|323419169|FG000|Overall Study|Death|148|||
94445739|NCT04199104|323419170|FG001|Overall Study|Death|134|||
94445740|NCT04199104|323419169|FG000|Overall Study|Lost to Follow-up|1|||
94445741|NCT04199104|323419170|FG001|Overall Study|Lost to Follow-up|1|||
94445742|NCT04199104|323419169|FG000|Overall Study|Withdrawal by Subject|4|||
94445743|NCT04199104|323419170|FG001|Overall Study|Withdrawal by Subject|4|||
94445744|NCT04199104|323419169|FG000|Overall Study|Participants Ongoing|103|||
94445745|NCT04199104|323419170|FG001|Overall Study|Participants Ongoing|116|||
94445746|NCT04563754|323419173|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
94445747|NCT04563754|323419174|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
94445748|NCT04563754|323419175|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
94445749|NCT04563754|323419173|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
94445750|NCT04563754|323419174|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
94445751|NCT04563754|323419175|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
94445752|NCT04563754|323419173|FG000|Follow up|Lost to Follow-up|61|||
94445753|NCT04563754|323419174|FG001|Follow up|Lost to Follow-up|23|||
94445754|NCT04563754|323419175|FG002|Follow up|Lost to Follow-up|5|||
94445755|NCT04563754|323419173|FG000|Follow up|Death|0|||
94445756|NCT04563754|323419174|FG001|Follow up|Death|2|||
94445757|NCT04563754|323419175|FG002|Follow up|Death|0|||
94445758|NCT04563754|323419173|FG000|Follow up|Ongoing|0|||
94445759|NCT04563754|323419174|FG001|Follow up|Ongoing|28|||
94445760|NCT04563754|323419175|FG002|Follow up|Ongoing|0|||
94445761|NCT02513160|323419176|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
94445762|NCT02513160|323419177|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
94445763|NCT02513160|323419178|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
94445764|NCT02513160|323419179|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
94445765|NCT02513160|323419176|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
94445766|NCT02513160|323419177|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
94445767|NCT02513160|323419178|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
94445768|NCT02513160|323419179|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
94445769|NCT02513160|323419176|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
94445770|NCT02513160|323419177|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
94445771|NCT02513160|323419178|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
94445772|NCT02513160|323419179|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
94445773|NCT02513160|323419176|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
94445774|NCT02513160|323419177|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
94445775|NCT02513160|323419178|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
94445776|NCT02513160|323419179|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
94445777|NCT02513160|323419176|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
94445778|NCT02513160|323419177|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
94445779|NCT02513160|323419178|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
94445780|NCT02513160|323419179|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
94445781|NCT02513160|323419176|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
94445782|NCT02513160|323419177|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
94445783|NCT02513160|323419178|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
94445784|NCT02513160|323419179|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
94445785|NCT02513160|323419176|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
94445786|NCT02513160|323419177|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
94552333|NCT00599638|323818656|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
94552334|NCT00599638|323818657|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
94552335|NCT00599638|323818658|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
94227329|NCT00809341|322625785|FG001|Overall Study|Physician Decision|1|||
94445787|NCT02513160|323419178|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
94445788|NCT02513160|323419179|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
94445789|NCT02513160|323419176|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
94227330|NCT00225277|322625786|FG000|Overall Study|Adverse Event|30|||
94445790|NCT02513160|323419177|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
94445791|NCT02513160|323419178|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
94445792|NCT02513160|323419179|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
94445793|NCT02513160|323419176|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
94445794|NCT02513160|323419177|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
94445795|NCT02513160|323419178|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
94445796|NCT02513160|323419179|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
94445797|NCT02513160|323419176|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
94445798|NCT02513160|323419177|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
94445799|NCT02513160|323419178|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
94445800|NCT02513160|323419179|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
94445801|NCT02513160|323419176|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
94445802|NCT02513160|323419177|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
94445803|NCT02513160|323419178|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
94445804|NCT02513160|323419179|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
94445805|NCT02513160|323419176|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
94445806|NCT02513160|323419177|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
94445807|NCT02513160|323419178|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
94445808|NCT02513160|323419179|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
94445809|NCT04796909|323419182|FG000|Overall Study|Withdrawal by Subject|1|||
94445810|NCT04796909|323419183|FG001|Overall Study|Withdrawal by Subject|1|||
94445811|NCT03428958|323419186|FG000|Overall Study|Adverse Event|0|||
94445812|NCT03428958|323419187|FG001|Overall Study|Adverse Event|0|||
94445813|NCT03428958|323419188|FG002|Overall Study|Adverse Event|0|||
94445814|NCT03428958|323419189|FG003|Overall Study|Adverse Event|1|||
94445815|NCT03428958|323419190|FG004|Overall Study|Adverse Event|0|||
94445816|NCT03428958|323419191|FG005|Overall Study|Adverse Event|2|||
94445817|NCT03428958|323419192|FG006|Overall Study|Adverse Event|1|||
94445818|NCT03428958|323419193|FG007|Overall Study|Adverse Event|0|||
94445819|NCT03428958|323419194|FG008|Overall Study|Adverse Event|0|||
94445820|NCT03428958|323419195|FG009|Overall Study|Adverse Event|0|||
94445821|NCT03428958|323419196|FG010|Overall Study|Adverse Event|0|||
94445822|NCT03428958|323419197|FG011|Overall Study|Adverse Event|0|||
94445823|NCT03428958|323419198|FG012|Overall Study|Adverse Event|0|||
94445824|NCT03428958|323419199|FG013|Overall Study|Adverse Event|0|||
94445825|NCT03428958|323419200|FG014|Overall Study|Adverse Event|0|||
94445826|NCT03428958|323419201|FG015|Overall Study|Adverse Event|0|||
94445827|NCT03428958|323419202|FG016|Overall Study|Adverse Event|0|||
94445828|NCT03428958|323419186|FG000|Overall Study|Clinical Progression|2|||
94445829|NCT03428958|323419187|FG001|Overall Study|Clinical Progression|3|||
94445830|NCT03428958|323419188|FG002|Overall Study|Clinical Progression|2|||
94445831|NCT03428958|323419189|FG003|Overall Study|Clinical Progression|1|||
94445832|NCT03428958|323419190|FG004|Overall Study|Clinical Progression|0|||
94445833|NCT03428958|323419191|FG005|Overall Study|Clinical Progression|2|||
94445834|NCT03428958|323419192|FG006|Overall Study|Clinical Progression|0|||
94445835|NCT03428958|323419193|FG007|Overall Study|Clinical Progression|0|||
94445836|NCT03428958|323419194|FG008|Overall Study|Clinical Progression|0|||
94445837|NCT03428958|323419195|FG009|Overall Study|Clinical Progression|0|||
94445838|NCT03428958|323419196|FG010|Overall Study|Clinical Progression|0|||
94445839|NCT03428958|323419197|FG011|Overall Study|Clinical Progression|0|||
94445840|NCT03428958|323419198|FG012|Overall Study|Clinical Progression|0|||
94445841|NCT03428958|323419199|FG013|Overall Study|Clinical Progression|0|||
94445842|NCT03428958|323419200|FG014|Overall Study|Clinical Progression|0|||
94445843|NCT03428958|323419201|FG015|Overall Study|Clinical Progression|0|||
94445844|NCT03428958|323419202|FG016|Overall Study|Clinical Progression|0|||
94445845|NCT03428958|323419186|FG000|Overall Study|Progression per RECIST|6|||
94445846|NCT03428958|323419187|FG001|Overall Study|Progression per RECIST|6|||
94445847|NCT03428958|323419188|FG002|Overall Study|Progression per RECIST|7|||
94445848|NCT03428958|323419189|FG003|Overall Study|Progression per RECIST|4|||
94445849|NCT03428958|323419190|FG004|Overall Study|Progression per RECIST|0|||
94445850|NCT03428958|323419191|FG005|Overall Study|Progression per RECIST|7|||
94445851|NCT03428958|323419192|FG006|Overall Study|Progression per RECIST|8|||
94445852|NCT03428958|323419193|FG007|Overall Study|Progression per RECIST|0|||
94445853|NCT03428958|323419194|FG008|Overall Study|Progression per RECIST|0|||
94445854|NCT03428958|323419195|FG009|Overall Study|Progression per RECIST|0|||
94445855|NCT03428958|323419196|FG010|Overall Study|Progression per RECIST|0|||
94445856|NCT03428958|323419197|FG011|Overall Study|Progression per RECIST|0|||
94445857|NCT03428958|323419198|FG012|Overall Study|Progression per RECIST|1|||
94445858|NCT03428958|323419199|FG013|Overall Study|Progression per RECIST|0|||
94445859|NCT03428958|323419200|FG014|Overall Study|Progression per RECIST|0|||
94445860|NCT03428958|323419201|FG015|Overall Study|Progression per RECIST|0|||
94445861|NCT03428958|323419202|FG016|Overall Study|Progression per RECIST|0|||
94552336|NCT00599638|323818655|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
94445862|NCT03428958|323419186|FG000|Overall Study|Death|2|||
94445863|NCT03428958|323419187|FG001|Overall Study|Death|2|||
94445864|NCT03428958|323419188|FG002|Overall Study|Death|0|||
94445865|NCT03428958|323419189|FG003|Overall Study|Death|0|||
94445866|NCT03428958|323419190|FG004|Overall Study|Death|0|||
94445867|NCT03428958|323419191|FG005|Overall Study|Death|7|||
94445868|NCT03428958|323419192|FG006|Overall Study|Death|9|||
94445869|NCT03428958|323419193|FG007|Overall Study|Death|6|||
94445870|NCT03428958|323419194|FG008|Overall Study|Death|0|||
94445871|NCT03428958|323419195|FG009|Overall Study|Death|0|||
94445872|NCT03428958|323419196|FG010|Overall Study|Death|3|||
94445873|NCT03428958|323419197|FG011|Overall Study|Death|0|||
94445874|NCT03428958|323419198|FG012|Overall Study|Death|4|||
94445875|NCT03428958|323419199|FG013|Overall Study|Death|0|||
94445876|NCT03428958|323419200|FG014|Overall Study|Death|0|||
94445877|NCT03428958|323419201|FG015|Overall Study|Death|0|||
94445878|NCT03428958|323419202|FG016|Overall Study|Death|0|||
94445879|NCT03428958|323419186|FG000|Overall Study|Lost to Follow-up|0|||
94445880|NCT03428958|323419187|FG001|Overall Study|Lost to Follow-up|0|||
94445881|NCT03428958|323419188|FG002|Overall Study|Lost to Follow-up|0|||
94445882|NCT03428958|323419189|FG003|Overall Study|Lost to Follow-up|0|||
94445883|NCT03428958|323419190|FG004|Overall Study|Lost to Follow-up|0|||
94552337|NCT00599638|323818656|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
94552338|NCT00599638|323818657|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
94552339|NCT00599638|323818658|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
94552340|NCT00599638|323818655|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
94552341|NCT00599638|323818656|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
94552342|NCT00599638|323818657|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
94552343|NCT00599638|323818658|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
94552344|NCT00599638|323818655|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
94552345|NCT00599638|323818656|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
94552346|NCT00599638|323818657|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
94552347|NCT00599638|323818658|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
94552348|NCT00599638|323818655|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
94552349|NCT00599638|323818656|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
94552350|NCT00599638|323818657|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
94552351|NCT00599638|323818658|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
94552352|NCT00599638|323818655|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
94552353|NCT00599638|323818656|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
94552354|NCT00599638|323818657|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
94552355|NCT00599638|323818658|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
94552356|NCT00599638|323818655|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
94552357|NCT00599638|323818656|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
94552358|NCT00599638|323818657|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
94552359|NCT00599638|323818658|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
94552360|NCT00599638|323818655|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
94552361|NCT00599638|323818656|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
94552362|NCT00599638|323818657|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
94552363|NCT00599638|323818658|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
94552364|NCT00599638|323818655|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
94552365|NCT00599638|323818656|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
94552366|NCT00599638|323818657|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
94552367|NCT00599638|323818658|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
94552368|NCT04032080|323818660|FG000|Overall Study|Death|6|||
94552369|NCT03729245|323818661|FG000|Overall Study|Lost to Follow-up|5|||
94552370|NCT03729245|323818662|FG001|Overall Study|Lost to Follow-up|6|||
94552371|NCT03729245|323818661|FG000|Overall Study|Withdrawal by Subject|16|||
94552372|NCT03729245|323818662|FG001|Overall Study|Withdrawal by Subject|19|||
94552373|NCT03729245|323818661|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
94552374|NCT03729245|323818662|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
94343341|NCT04757376|323036061|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
94343342|NCT04757376|323036062|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
94343343|NCT04757376|323036058|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
94343344|NCT04757376|323036059|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
94343345|NCT04757376|323036060|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
94343346|NCT04757376|323036061|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
94343347|NCT04757376|323036062|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
94343348|NCT04757376|323036058|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
94343349|NCT04757376|323036059|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
94343350|NCT04757376|323036060|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
94343351|NCT04757376|323036061|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
94343352|NCT04757376|323036062|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
94343353|NCT04757376|323036058|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
94343354|NCT04757376|323036059|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
94343355|NCT04757376|323036060|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
94343356|NCT04757376|323036061|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
94343357|NCT04757376|323036062|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
94343358|NCT04757376|323036058|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
94343359|NCT04757376|323036059|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
94343360|NCT04757376|323036060|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
94343361|NCT04757376|323036061|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
94343362|NCT04757376|323036062|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
94343363|NCT04757376|323036058|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
94343364|NCT04757376|323036059|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
94552375|NCT02708485|323818663|FG000|Overall Study|Withdrawal by Subject|3|||
94552376|NCT02708485|323818664|FG001|Overall Study|Withdrawal by Subject|2|||
94552377|NCT01600092|323818665|FG000|Overall Study|Adverse Event|2|||
94552378|NCT01600092|323818666|FG001|Overall Study|Adverse Event|0|||
94445884|NCT03428958|323419191|FG005|Overall Study|Lost to Follow-up|1|||
94445885|NCT03428958|323419192|FG006|Overall Study|Lost to Follow-up|1|||
94445886|NCT03428958|323419193|FG007|Overall Study|Lost to Follow-up|0|||
94552379|NCT01600092|323818665|FG000|Overall Study|Lost to Follow-up|4|||
94227331|NCT00225277|322625787|FG001|Overall Study|Adverse Event|34|||
94343365|NCT04757376|323036060|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
94343366|NCT04757376|323036061|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
94343367|NCT04757376|323036062|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
94343368|NCT04757376|323036058|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
94343369|NCT04757376|323036059|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
94343370|NCT04757376|323036060|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
94343371|NCT04757376|323036061|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
94343372|NCT04757376|323036062|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
94343373|NCT04757376|323036058|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
94343374|NCT04757376|323036059|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
94343375|NCT04757376|323036060|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
94343376|NCT04757376|323036061|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
94365555|NCT01345058|323122418|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
94365556|NCT01345058|323122419|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
94365557|NCT01345058|323122418|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
94365558|NCT01345058|323122419|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
94365559|NCT01892020|323122420|FG000|Period 1|Adverse Event|1|||
94365560|NCT01892020|323122421|FG001|Period 1|Adverse Event|1|||
94365561|NCT01892020|323122420|FG000|Period 1|Protocol Violation|2|||
94365562|NCT01892020|323122421|FG001|Period 1|Protocol Violation|4|||
94365563|NCT01892020|323122420|FG000|Period 1|Unclassified|0|||
94365564|NCT01892020|323122421|FG001|Period 1|Unclassified|1|||
94365565|NCT01892020|323122420|FG000|Period 2|Protocol Violation|1|||
94365566|NCT01892020|323122421|FG001|Period 2|Protocol Violation|0|||
94365567|NCT03022799|323122423|FG000|Overall Study|Adverse Event|0|||
94365568|NCT03022799|323122424|FG001|Overall Study|Adverse Event|0|||
94365569|NCT03022799|323122425|FG002|Overall Study|Adverse Event|0|||
94365570|NCT03022799|323122426|FG003|Overall Study|Adverse Event|0|||
94365571|NCT03022799|323122427|FG004|Overall Study|Adverse Event|0|||
94365572|NCT03022799|323122428|FG005|Overall Study|Adverse Event|0|||
94365573|NCT03022799|323122429|FG006|Overall Study|Adverse Event|0|||
94365574|NCT03022799|323122430|FG007|Overall Study|Adverse Event|0|||
94365575|NCT03022799|323122431|FG008|Overall Study|Adverse Event|0|||
94365576|NCT03022799|323122432|FG009|Overall Study|Adverse Event|1|||
94365577|NCT03022799|323122433|FG010|Overall Study|Adverse Event|1|||
94365578|NCT03022799|323122434|FG011|Overall Study|Adverse Event|0|||
94365579|NCT03022799|323122435|FG012|Overall Study|Adverse Event|0|||
94365580|NCT00532779|323122442|FG000|Overall Study|Adverse Event|122|||
94365581|NCT00532779|323122443|FG001|Overall Study|Adverse Event|112|||
94365582|NCT00532779|323122444|FG002|Overall Study|Adverse Event|56|||
94365583|NCT00532779|323122442|FG000|Overall Study|Lost to Follow-up|76|||
94365584|NCT00532779|323122443|FG001|Overall Study|Lost to Follow-up|65|||
94365585|NCT00532779|323122444|FG002|Overall Study|Lost to Follow-up|66|||
94365586|NCT00532779|323122442|FG000|Overall Study|Withdrawal by Subject|63|||
94365587|NCT00532779|323122443|FG001|Overall Study|Withdrawal by Subject|60|||
94365588|NCT00532779|323122444|FG002|Overall Study|Withdrawal by Subject|90|||
94365589|NCT00532779|323122442|FG000|Overall Study|Lack of Efficacy|12|||
94365590|NCT00532779|323122443|FG001|Overall Study|Lack of Efficacy|12|||
94365591|NCT00532779|323122444|FG002|Overall Study|Lack of Efficacy|40|||
94365592|NCT00532779|323122442|FG000|Overall Study|Protocol Violation|5|||
94365593|NCT00532779|323122443|FG001|Overall Study|Protocol Violation|9|||
94365594|NCT00532779|323122444|FG002|Overall Study|Protocol Violation|7|||
94227332|NCT00225277|322625786|FG000|Overall Study|Lack of Efficacy|4|||
94227333|NCT00225277|322625787|FG001|Overall Study|Lack of Efficacy|1|||
94227334|NCT00225277|322625786|FG000|Overall Study|Lost to Follow-up|4|||
94227335|NCT00225277|322625787|FG001|Overall Study|Lost to Follow-up|6|||
94227336|NCT00225277|322625786|FG000|Overall Study|Physician Decision|6|||
94227337|NCT00225277|322625787|FG001|Overall Study|Physician Decision|8|||
94445887|NCT03428958|323419194|FG008|Overall Study|Lost to Follow-up|0|||
94227338|NCT00225277|322625786|FG000|Overall Study|Protocol Violation|6|||
94445888|NCT03428958|323419195|FG009|Overall Study|Lost to Follow-up|0|||
94445889|NCT03428958|323419196|FG010|Overall Study|Lost to Follow-up|0|||
94227339|NCT00225277|322625787|FG001|Overall Study|Protocol Violation|3|||
94227340|NCT00225277|322625786|FG000|Overall Study|Withdrawal by Subject|40|||
94445890|NCT03428958|323419197|FG011|Overall Study|Lost to Follow-up|0|||
94445891|NCT03428958|323419198|FG012|Overall Study|Lost to Follow-up|0|||
94445892|NCT03428958|323419199|FG013|Overall Study|Lost to Follow-up|0|||
94445893|NCT03428958|323419200|FG014|Overall Study|Lost to Follow-up|0|||
94445894|NCT03428958|323419201|FG015|Overall Study|Lost to Follow-up|0|||
94445895|NCT03428958|323419202|FG016|Overall Study|Lost to Follow-up|0|||
94445896|NCT03428958|323419186|FG000|Overall Study|Physician/Sponsor Decision|1|||
94445897|NCT03428958|323419187|FG001|Overall Study|Physician/Sponsor Decision|0|||
94445898|NCT03428958|323419188|FG002|Overall Study|Physician/Sponsor Decision|1|||
94445899|NCT03428958|323419189|FG003|Overall Study|Physician/Sponsor Decision|0|||
94445900|NCT03428958|323419190|FG004|Overall Study|Physician/Sponsor Decision|0|||
94445901|NCT03428958|323419191|FG005|Overall Study|Physician/Sponsor Decision|2|||
94445902|NCT03428958|323419192|FG006|Overall Study|Physician/Sponsor Decision|2|||
94445903|NCT03428958|323419193|FG007|Overall Study|Physician/Sponsor Decision|2|||
94445904|NCT03428958|323419194|FG008|Overall Study|Physician/Sponsor Decision|0|||
94445905|NCT03428958|323419195|FG009|Overall Study|Physician/Sponsor Decision|0|||
94445906|NCT03428958|323419196|FG010|Overall Study|Physician/Sponsor Decision|2|||
94445907|NCT03428958|323419197|FG011|Overall Study|Physician/Sponsor Decision|0|||
94445908|NCT03428958|323419198|FG012|Overall Study|Physician/Sponsor Decision|4|||
94445909|NCT03428958|323419199|FG013|Overall Study|Physician/Sponsor Decision|0|||
94445910|NCT03428958|323419200|FG014|Overall Study|Physician/Sponsor Decision|0|||
94445911|NCT03428958|323419201|FG015|Overall Study|Physician/Sponsor Decision|0|||
94445912|NCT03428958|323419202|FG016|Overall Study|Physician/Sponsor Decision|0|||
94445913|NCT03428958|323419186|FG000|Overall Study|Withdrawal by Subject|0|||
94445914|NCT03428958|323419187|FG001|Overall Study|Withdrawal by Subject|0|||
94445915|NCT03428958|323419188|FG002|Overall Study|Withdrawal by Subject|2|||
94445916|NCT03428958|323419189|FG003|Overall Study|Withdrawal by Subject|0|||
94445917|NCT03428958|323419190|FG004|Overall Study|Withdrawal by Subject|0|||
94445918|NCT03428958|323419191|FG005|Overall Study|Withdrawal by Subject|2|||
94445919|NCT03428958|323419192|FG006|Overall Study|Withdrawal by Subject|4|||
94445920|NCT03428958|323419193|FG007|Overall Study|Withdrawal by Subject|1|||
94445921|NCT03428958|323419194|FG008|Overall Study|Withdrawal by Subject|0|||
94445922|NCT03428958|323419195|FG009|Overall Study|Withdrawal by Subject|0|||
94445923|NCT03428958|323419196|FG010|Overall Study|Withdrawal by Subject|0|||
94445924|NCT03428958|323419197|FG011|Overall Study|Withdrawal by Subject|0|||
94445925|NCT03428958|323419198|FG012|Overall Study|Withdrawal by Subject|0|||
94445926|NCT03428958|323419199|FG013|Overall Study|Withdrawal by Subject|0|||
94445927|NCT03428958|323419200|FG014|Overall Study|Withdrawal by Subject|0|||
94445928|NCT03428958|323419201|FG015|Overall Study|Withdrawal by Subject|0|||
94445929|NCT03428958|323419202|FG016|Overall Study|Withdrawal by Subject|0|||
94445930|NCT05258773|323419203|FG000|Overall Study|Screen Failure|1|||
94445931|NCT05258773|323419204|FG001|Overall Study|Screen Failure|1|||
94445932|NCT05258773|323419203|FG000|Overall Study|Adverse Event|1|||
94445933|NCT05258773|323419204|FG001|Overall Study|Adverse Event|0|||
94445934|NCT05258773|323419203|FG000|Overall Study|Withdrawal by Subject|0|||
94445935|NCT05258773|323419204|FG001|Overall Study|Withdrawal by Subject|1|||
94445936|NCT03361306|323419207|FG000|Overall Study|Death|6|||
94445937|NCT04431726|323419210|FG000|Overall Study|Ongoing in the Study|55|||
94445938|NCT01127256|323419211|FG000|Overall Study|Adverse Event|13|||
94445939|NCT01127256|323419212|FG001|Overall Study|Adverse Event|13|||
94445940|NCT01127256|323419211|FG000|Overall Study|Lack of Efficacy|4|||
94445941|NCT01127256|323419212|FG001|Overall Study|Lack of Efficacy|0|||
94445942|NCT01127256|323419211|FG000|Overall Study|Lost to Follow-up|16|||
94445943|NCT01127256|323419212|FG001|Overall Study|Lost to Follow-up|17|||
94445944|NCT01127256|323419211|FG000|Overall Study|Withdrawal by Subject|5|||
94445945|NCT01127256|323419212|FG001|Overall Study|Withdrawal by Subject|9|||
94445946|NCT01127256|323419211|FG000|Overall Study|Protocol Violation|1|||
94445947|NCT01127256|323419212|FG001|Overall Study|Protocol Violation|0|||
94445948|NCT01415518|323419213|FG000|Overall Study|Withdrawal by Subject|2|||
94445949|NCT01415518|323419214|FG001|Overall Study|Withdrawal by Subject|12|||
94445950|NCT01415518|323419213|FG000|Overall Study|Protocol Violation|6|||
94445951|NCT01415518|323419214|FG001|Overall Study|Protocol Violation|8|||
94343377|NCT04757376|323036062|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
94343378|NCT04063865|323036063|FG000|Overall Study|Physician Decision|1|||
94227341|NCT00225277|322625787|FG001|Overall Study|Withdrawal by Subject|34|||
94227342|NCT00225277|322625786|FG000|Overall Study|Other|7|||
94227343|NCT00225277|322625787|FG001|Overall Study|Other|9|||
94227344|NCT03891641|322625793|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
94227345|NCT03891641|322625794|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
94227346|NCT01093222|322625795|FG000|Overall Study|Ineligible|6|||
94227347|NCT01093222|322625795|FG000|Overall Study|Adverse Event|7|||
94227348|NCT01093222|322625795|FG000|Overall Study|Progression/relapse|24|||
94227349|NCT01093222|322625795|FG000|Overall Study|Death|2|||
94227350|NCT01093222|322625795|FG000|Overall Study|Not protocol specified|1|||
94227351|NCT01281917|322625798|FG000|Overall Study|Withdrawal by Subject|1|||
94227352|NCT01013740|322625803|FG000|Overall Study|Lost to Follow-up|3|||
94227353|NCT01013740|322625804|FG001|Overall Study|Lost to Follow-up|5|||
94552380|NCT01600092|323818666|FG001|Overall Study|Lost to Follow-up|6|||
94552381|NCT01600092|323818665|FG000|Overall Study|Withdrawal by parent/guardian|8|||
94552382|NCT01600092|323818666|FG001|Overall Study|Withdrawal by parent/guardian|6|||
94552383|NCT01600092|323818665|FG000|Overall Study|Physician Decision|1|||
94552384|NCT01600092|323818666|FG001|Overall Study|Physician Decision|1|||
94552385|NCT01600092|323818665|FG000|Overall Study|Randomized but not vaccinated|3|||
94552386|NCT01600092|323818666|FG001|Overall Study|Randomized but not vaccinated|3|||
94552387|NCT01727336|323818667|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
94552388|NCT01727336|323818668|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
94552389|NCT01727336|323818669|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
94552390|NCT01727336|323818670|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
94552391|NCT01727336|323818671|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
94552392|NCT01727336|323818672|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
94552393|NCT01727336|323818667|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
94227354|NCT01013740|322625803|FG000|Overall Study|Physician Decision|2|||
94227355|NCT01013740|322625804|FG001|Overall Study|Physician Decision|0|||
94227356|NCT01013740|322625803|FG000|Overall Study|Withdrawal by Subject|2|||
94227357|NCT01013740|322625804|FG001|Overall Study|Withdrawal by Subject|10|||
94227358|NCT01013740|322625803|FG000|Overall Study|study close / terminated : done in error|2|||
94227359|NCT01013740|322625804|FG001|Overall Study|study close / terminated : done in error|1|||
94227360|NCT01013740|322625803|FG000|Overall Study|Missing|2|||
94227361|NCT01013740|322625804|FG001|Overall Study|Missing|1|||
94227362|NCT01013740|322625803|FG000|Overall Study|Ongoing: Study records not completed|0|||
94445952|NCT01415518|323419213|FG000|Overall Study|Lost to Follow-up|3|||
94445953|NCT01415518|323419214|FG001|Overall Study|Lost to Follow-up|5|||
94445954|NCT01415518|323419213|FG000|Overall Study|Adverse Event|3|||
94445955|NCT01415518|323419214|FG001|Overall Study|Adverse Event|4|||
94445956|NCT01415518|323419213|FG000|Overall Study|Death|1|||
94445957|NCT01415518|323419214|FG001|Overall Study|Death|1|||
94445958|NCT01415518|323419213|FG000|Overall Study|Condition under Investigation Worsened|1|||
94445959|NCT01415518|323419214|FG001|Overall Study|Condition under Investigation Worsened|1|||
94445960|NCT01749826|323419215|FG000|Overall Study|Study Terminated|20|||
94445961|NCT01749826|323419216|FG001|Overall Study|Study Terminated|0|||
94445962|NCT01922037|323419217|FG000|Overall Study|Withdrawal by Subject|2|||
94445963|NCT01922037|323419218|FG001|Overall Study|Withdrawal by Subject|44|||
94445964|NCT01922037|323419217|FG000|Overall Study|Adverse Event|1|||
94445965|NCT01922037|323419218|FG001|Overall Study|Adverse Event|7|||
94445966|NCT01922037|323419217|FG000|Overall Study|Death|0|||
94445967|NCT01922037|323419218|FG001|Overall Study|Death|5|||
94445968|NCT01922037|323419217|FG000|Overall Study|Pregnancy|0|||
94445969|NCT01922037|323419218|FG001|Overall Study|Pregnancy|2|||
94445970|NCT01922037|323419217|FG000|Overall Study|Participant non-compliance|4|||
94445971|NCT01922037|323419218|FG001|Overall Study|Participant non-compliance|46|||
94445972|NCT01922037|323419217|FG000|Overall Study|Investigator/Sponsor decision|1|||
94445973|NCT01922037|323419218|FG001|Overall Study|Investigator/Sponsor decision|4|||
94445974|NCT01922037|323419217|FG000|Overall Study|Other unspecified|2|||
94445975|NCT01922037|323419218|FG001|Overall Study|Other unspecified|66|||
94445976|NCT02068508|323419221|FG000|Overall Study|Case report forms uncollected|27|||
94445977|NCT02068508|323419221|FG000|Overall Study|Patient did not visit the study site|1|||
94445978|NCT02068508|323419221|FG000|Overall Study|Protocol Violation|4|||
94445979|NCT00813150|323419222|FG000|Treatment Period|Adverse Event|16|||
94445980|NCT00813150|323419223|FG001|Treatment Period|Adverse Event|15|||
94552394|NCT01727336|323818668|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
94445981|NCT00813150|323419222|FG000|Treatment Period|Death|2|||
94445982|NCT00813150|323419223|FG001|Treatment Period|Death|0|||
94445983|NCT00813150|323419222|FG000|Treatment Period|Progressive disease|1|||
94445984|NCT00813150|323419223|FG001|Treatment Period|Progressive disease|0|||
94445985|NCT00813150|323419222|FG000|Treatment Period|Complete response|0|||
94445986|NCT00813150|323419223|FG001|Treatment Period|Complete response|1|||
94227363|NCT01013740|322625804|FG001|Overall Study|Ongoing: Study records not completed|2|||
94227364|NCT00607997|322625805|FG000|Overall Study|Lack of Efficacy|6|||
94227365|NCT00607997|322625806|FG001|Overall Study|Lack of Efficacy|20|||
94227366|NCT00607997|322625807|FG002|Overall Study|Lack of Efficacy|14|||
94445987|NCT00813150|323419222|FG000|Treatment Period|Stable disease|1|||
94227367|NCT00607997|322625808|FG003|Overall Study|Lack of Efficacy|10|||
94227368|NCT00607997|322625805|FG000|Overall Study|Death|8|||
94227369|NCT00607997|322625806|FG001|Overall Study|Death|5|||
94227370|NCT00607997|322625807|FG002|Overall Study|Death|2|||
94227371|NCT00607997|322625808|FG003|Overall Study|Death|5|||
94227372|NCT00607997|322625805|FG000|Overall Study|Adverse Event|3|||
94227373|NCT00607997|322625806|FG001|Overall Study|Adverse Event|1|||
94227374|NCT00607997|322625807|FG002|Overall Study|Adverse Event|2|||
94227375|NCT00607997|322625808|FG003|Overall Study|Adverse Event|0|||
94227376|NCT00607997|322625805|FG000|Overall Study|Physician Decision|4|||
94227377|NCT00607997|322625806|FG001|Overall Study|Physician Decision|1|||
94227378|NCT00607997|322625807|FG002|Overall Study|Physician Decision|0|||
94227379|NCT00607997|322625808|FG003|Overall Study|Physician Decision|0|||
94227380|NCT00607997|322625805|FG000|Overall Study|Relapse, recurrent illness|4|||
94227381|NCT00607997|322625806|FG001|Overall Study|Relapse, recurrent illness|0|||
94227382|NCT00607997|322625807|FG002|Overall Study|Relapse, recurrent illness|2|||
94227383|NCT00607997|322625808|FG003|Overall Study|Relapse, recurrent illness|0|||
94227384|NCT00607997|322625805|FG000|Overall Study|Other without explanation|2|||
94227385|NCT00607997|322625806|FG001|Overall Study|Other without explanation|0|||
94227386|NCT00607997|322625807|FG002|Overall Study|Other without explanation|4|||
94227387|NCT00607997|322625808|FG003|Overall Study|Other without explanation|1|||
94227388|NCT00839332|322625809|FG000|Phase 1|Disease Progression|38|||
94227389|NCT00839332|322625810|FG001|Phase 1|Disease Progression|0|||
94227390|NCT00839332|322625811|FG002|Phase 1|Disease Progression|0|||
94227391|NCT00839332|322625809|FG000|Phase 1|Adverse Event|6|||
94227392|NCT00839332|322625810|FG001|Phase 1|Adverse Event|0|||
94227393|NCT00839332|322625811|FG002|Phase 1|Adverse Event|0|||
94227394|NCT00839332|322625809|FG000|Phase 1|Withdrawal by Subject|4|||
94227395|NCT00839332|322625810|FG001|Phase 1|Withdrawal by Subject|0|||
94227396|NCT00839332|322625811|FG002|Phase 1|Withdrawal by Subject|0|||
94227397|NCT00839332|322625809|FG000|Phase 1|Physician Decision|2|||
94227398|NCT00839332|322625810|FG001|Phase 1|Physician Decision|0|||
94227399|NCT00839332|322625811|FG002|Phase 1|Physician Decision|0|||
94227400|NCT00839332|322625809|FG000|Phase 2|Protocol Violation|0|||
94227401|NCT00839332|322625810|FG001|Phase 2|Protocol Violation|1|||
94227402|NCT00839332|322625811|FG002|Phase 2|Protocol Violation|0|||
94227403|NCT00839332|322625809|FG000|Phase 2|Disease Progression|0|||
94227404|NCT00839332|322625810|FG001|Phase 2|Disease Progression|46|||
94227405|NCT00839332|322625811|FG002|Phase 2|Disease Progression|21|||
94227406|NCT00839332|322625809|FG000|Phase 2|Adverse Event|0|||
94227407|NCT00839332|322625810|FG001|Phase 2|Adverse Event|8|||
94227408|NCT00839332|322625811|FG002|Phase 2|Adverse Event|6|||
94227409|NCT00839332|322625809|FG000|Phase 2|Death|0|||
94343379|NCT04063865|323036064|FG001|Overall Study|Physician Decision|3|||
94343380|NCT04063865|323036063|FG000|Overall Study|Study Closed Prior to Completion|4|||
94343381|NCT04063865|323036064|FG001|Overall Study|Study Closed Prior to Completion|4|||
94343382|NCT04063865|323036063|FG000|Overall Study|Withdrawal by Subject|1|||
94343383|NCT04063865|323036064|FG001|Overall Study|Withdrawal by Subject|1|||
94343384|NCT00609167|323036065|FG000|Overall Study|Withdrawal by Subject|1|||
94343385|NCT00609167|323036066|FG001|Overall Study|Withdrawal by Subject|0|||
94343386|NCT00609167|323036065|FG000|Overall Study|Lack of Efficacy|1|||
94343387|NCT00609167|323036066|FG001|Overall Study|Lack of Efficacy|0|||
94343388|NCT00609167|323036065|FG000|Overall Study|Adverse Event|5|||
94343389|NCT00609167|323036066|FG001|Overall Study|Adverse Event|1|||
94343390|NCT00609167|323036065|FG000|Overall Study|Disease Progression|1|||
94343391|NCT00609167|323036066|FG001|Overall Study|Disease Progression|0|||
94343392|NCT00609167|323036065|FG000|Overall Study|Stem Cell Transplant|0|||
94343393|NCT00609167|323036066|FG001|Overall Study|Stem Cell Transplant|6|||
94343394|NCT01307046|323036067|FG000|Overall Study|Adverse Event|3|||
94343395|NCT01307046|323036068|FG001|Overall Study|Adverse Event|3|||
94343396|NCT01307046|323036067|FG000|Overall Study|Lack of Efficacy|0|||
94343397|NCT01307046|323036068|FG001|Overall Study|Lack of Efficacy|2|||
94343398|NCT01307046|323036067|FG000|Overall Study|Physician Decision|2|||
94343399|NCT01307046|323036068|FG001|Overall Study|Physician Decision|0|||
94343400|NCT01307046|323036067|FG000|Overall Study|Withdrawal by Subject|1|||
94343401|NCT01307046|323036068|FG001|Overall Study|Withdrawal by Subject|1|||
94343402|NCT01307046|323036067|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
94227410|NCT00839332|322625810|FG001|Phase 2|Death|4|||
94227411|NCT00839332|322625811|FG002|Phase 2|Death|2|||
94227412|NCT00839332|322625809|FG000|Phase 2|Withdrawal by Subject|0|||
94227413|NCT00839332|322625810|FG001|Phase 2|Withdrawal by Subject|5|||
94227414|NCT00839332|322625811|FG002|Phase 2|Withdrawal by Subject|8|||
94227415|NCT00839332|322625809|FG000|Phase 2|Physician Decision|0|||
94227416|NCT00839332|322625810|FG001|Phase 2|Physician Decision|4|||
94227417|NCT00839332|322625811|FG002|Phase 2|Physician Decision|1|||
94227418|NCT00839332|322625809|FG000|Phase 2|Lost to Follow-up|0|||
94227419|NCT00839332|322625810|FG001|Phase 2|Lost to Follow-up|0|||
94227420|NCT00839332|322625811|FG002|Phase 2|Lost to Follow-up|1|||
94227421|NCT03188536|322625812|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
94343403|NCT01307046|323036068|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
94445988|NCT00813150|323419223|FG001|Treatment Period|Stable disease|2|||
94445989|NCT00813150|323419222|FG000|Treatment Period|Protocol Violation|3|||
94445990|NCT00813150|323419223|FG001|Treatment Period|Protocol Violation|4|||
94445991|NCT00813150|323419222|FG000|Treatment Period|Withdrawal by Subject|5|||
94445992|NCT00813150|323419223|FG001|Treatment Period|Withdrawal by Subject|3|||
94445993|NCT00813150|323419222|FG000|Treatment Period|Non compliance|0|||
94445994|NCT00813150|323419223|FG001|Treatment Period|Non compliance|1|||
94445995|NCT00813150|323419222|FG000|Treatment Period|Reason not specified|3|||
94445996|NCT00813150|323419223|FG001|Treatment Period|Reason not specified|4|||
94227422|NCT03188536|322625812|FG000|Overall Study|Not participated/met inclusion criteria|1|||
94227423|NCT01930214|322625814|FG000|Overall Study|Death|4|||
94227424|NCT01930214|322625815|FG001|Overall Study|Death|4|||
94227425|NCT01930214|322625816|FG002|Overall Study|Death|11|||
94227426|NCT01930214|322625814|FG000|Overall Study|Lost to Follow-up|12|||
94227427|NCT01930214|322625815|FG001|Overall Study|Lost to Follow-up|13|||
94227428|NCT01930214|322625816|FG002|Overall Study|Lost to Follow-up|12|||
94227429|NCT01930214|322625814|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
94227430|NCT01930214|322625815|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
94227431|NCT01930214|322625816|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
94227432|NCT01930214|322625814|FG000|Overall Study|Physician Decision|2|||
94227433|NCT01930214|322625815|FG001|Overall Study|Physician Decision|0|||
94227434|NCT01930214|322625816|FG002|Overall Study|Physician Decision|0|||
94227435|NCT02864342|322625821|FG000|Overall Study|Eligibility Criteria Deviation|2|||
94365595|NCT00532779|323122442|FG000|Overall Study|Pregnancy|2|||
94365596|NCT00532779|323122443|FG001|Overall Study|Pregnancy|5|||
94365597|NCT00532779|323122444|FG002|Overall Study|Pregnancy|3|||
94365598|NCT00532779|323122442|FG000|Overall Study|Death|0|||
94365599|NCT00532779|323122443|FG001|Overall Study|Death|1|||
94365600|NCT00532779|323122444|FG002|Overall Study|Death|0|||
94227436|NCT02864342|322625822|FG001|Overall Study|Eligibility Criteria Deviation|3|||
94227437|NCT02864342|322625821|FG000|Overall Study|Withdrawal by Subject|4|||
94227438|NCT02864342|322625822|FG001|Overall Study|Withdrawal by Subject|2|||
94227439|NCT02864342|322625821|FG000|Overall Study|Device Technology Issue|6|||
94227440|NCT02864342|322625822|FG001|Overall Study|Device Technology Issue|7|||
94227441|NCT02864342|322625821|FG000|Overall Study|Death|0|||
94227442|NCT02864342|322625822|FG001|Overall Study|Death|1|||
94227443|NCT02864342|322625821|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
94227444|NCT02864342|322625822|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
94227445|NCT02864342|322625821|FG000|Overall Study|Lost to Follow-up|1|||
94227446|NCT02864342|322625822|FG001|Overall Study|Lost to Follow-up|5|||
94227447|NCT02864342|322625821|FG000|Overall Study|Lost Device|1|||
94343404|NCT01307046|323036067|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
94343405|NCT01307046|323036068|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
94343406|NCT02574520|323036069|FG000|Overall Study|Not dosed|2|||
94227448|NCT02864342|322625822|FG001|Overall Study|Lost Device|0|||
94227449|NCT02864342|322625821|FG000|Overall Study|Adverse Event|1|||
94227450|NCT02864342|322625822|FG001|Overall Study|Adverse Event|0|||
94343407|NCT02574520|323036070|FG001|Overall Study|Not dosed|0|||
94227451|NCT02604342|322625823|FG000|Overall Study|Death|32|||
94227452|NCT02604342|322625824|FG001|Overall Study|Death|16|||
94227453|NCT02604342|322625823|FG000|Overall Study|Progression of disease|1|||
94227454|NCT02604342|322625824|FG001|Overall Study|Progression of disease|0|||
94227455|NCT02604342|322625823|FG000|Overall Study|Withdrawal by Subject|5|||
94227456|NCT02604342|322625824|FG001|Overall Study|Withdrawal by Subject|6|||
94227457|NCT02604342|322625823|FG000|Overall Study|Other|1|||
94227458|NCT02604342|322625824|FG001|Overall Study|Other|0|||
94227459|NCT02604342|322625823|FG000|Overall Study|Study Termination by Sponsor|1|||
94227460|NCT02604342|322625824|FG001|Overall Study|Study Termination by Sponsor|0|||
94227461|NCT02604342|322625823|FG000|Overall Study|Lost to Follow-up|1|||
94227462|NCT02604342|322625824|FG001|Overall Study|Lost to Follow-up|1|||
94227463|NCT02604342|322625823|FG000|Overall Study|Physician Decision|2|||
94227464|NCT02604342|322625824|FG001|Overall Study|Physician Decision|0|||
94227465|NCT02261285|322625825|FG000|Overall Study|Disease progression|0|||
94227466|NCT02261285|322625826|FG001|Overall Study|Disease progression|0|||
94227467|NCT02261285|322625827|FG002|Overall Study|Disease progression|1|||
94227468|NCT03605368|322625833|FG000|Overall Study|Lost to Follow-up|2|||
94227469|NCT03605368|322625834|FG001|Overall Study|Lost to Follow-up|1|||
94227470|NCT03605368|322625835|FG002|Overall Study|Lost to Follow-up|3|||
94227471|NCT03605368|322625836|FG003|Overall Study|Lost to Follow-up|2|||
94227472|NCT03605368|322625833|FG000|Overall Study|Withdrawal by Subject|0|||
94227473|NCT03605368|322625834|FG001|Overall Study|Withdrawal by Subject|0|||
94227474|NCT03605368|322625835|FG002|Overall Study|Withdrawal by Subject|4|||
94227475|NCT03605368|322625836|FG003|Overall Study|Withdrawal by Subject|3|||
94227476|NCT01424189|322625837|FG000|Overall Study|Adverse Event|1|||
94227477|NCT01424189|322625838|FG001|Overall Study|Adverse Event|0|||
94227478|NCT01424189|322625837|FG000|Overall Study|Lost to Follow-up|4|||
94227479|NCT01424189|322625838|FG001|Overall Study|Lost to Follow-up|1|||
94227480|NCT01424189|322625837|FG000|Overall Study|Withdrawal by Subject|4|||
94227481|NCT01424189|322625838|FG001|Overall Study|Withdrawal by Subject|4|||
94227482|NCT01424189|322625837|FG000|Overall Study|Subject moved|1|||
94227483|NCT01424189|322625838|FG001|Overall Study|Subject moved|0|||
94227484|NCT01424189|322625837|FG000|Overall Study|Death|3|||
94227485|NCT01424189|322625838|FG001|Overall Study|Death|1|||
94227486|NCT01329419|322625841|FG000|Overall Study|Protocol Violation|235|||
94227487|NCT01024036|322625846|FG000|Blinded Treatment|Adverse Event|1|||
94227488|NCT01024036|322625847|FG001|Blinded Treatment|Adverse Event|1|||
94227489|NCT01024036|322625846|FG000|Blinded Treatment|Lack of Efficacy|16|||
94227490|NCT01024036|322625847|FG001|Blinded Treatment|Lack of Efficacy|14|||
94227491|NCT01024036|322625846|FG000|Blinded Treatment|Physician Decision|1|||
94227492|NCT01024036|322625847|FG001|Blinded Treatment|Physician Decision|0|||
94227493|NCT01024036|322625846|FG000|Blinded Treatment|Death|0|||
94227494|NCT01024036|322625847|FG001|Blinded Treatment|Death|2|||
94227495|NCT01024036|322625846|FG000|Blinded Treatment|Withdrawal by Subject|4|||
94227496|NCT01024036|322625847|FG001|Blinded Treatment|Withdrawal by Subject|3|||
94227497|NCT01024036|322625846|FG000|Unblinded Treatment|Adverse Event|0|||
94227498|NCT01024036|322625847|FG001|Unblinded Treatment|Adverse Event|1|||
94227499|NCT01024036|322625846|FG000|Unblinded Treatment|Lack of Efficacy|0|||
94227500|NCT01024036|322625847|FG001|Unblinded Treatment|Lack of Efficacy|2|||
94227501|NCT01024036|322625846|FG000|Follow-Up Period|Lost to Follow-up|1|||
94227502|NCT01024036|322625847|FG001|Follow-Up Period|Lost to Follow-up|1|||
94227503|NCT01024036|322625846|FG000|Follow-Up Period|Withdrawal by Subject|0|||
94227504|NCT01024036|322625847|FG001|Follow-Up Period|Withdrawal by Subject|1|||
94227505|NCT01024036|322625846|FG000|Follow-Up Period|Adverse Event|4|||
94227506|NCT01024036|322625847|FG001|Follow-Up Period|Adverse Event|1|||
94227507|NCT02212197|322625848|FG000|Overall Study|Need for radiotherapy|1|||
94227508|NCT02212197|322625849|FG001|Overall Study|Need for radiotherapy|0|||
94227509|NCT02212197|322625850|FG002|Overall Study|Need for radiotherapy|0|||
94227510|NCT02998918|322625853|FG000|Overall Study|Withdrawal by Subject|1|||
94227511|NCT02998918|322625854|FG001|Overall Study|Withdrawal by Subject|0|||
94227512|NCT01066936|322627356|FG000|Overall Study|Death|2|||
94227513|NCT01066936|322627356|FG000|Overall Study|Device revised/removed|1|||
94227514|NCT01066936|322627356|FG000|Overall Study|Lost to Follow-up|3|||
94227515|NCT01066936|322627356|FG000|Overall Study|Withdrawal by Subject|4|||
94343408|NCT02574520|323036071|FG002|Overall Study|Not dosed|5|||
94343409|NCT02574520|323036072|FG003|Overall Study|Not dosed|4|||
94552395|NCT01727336|323818669|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
94227516|NCT02507687|322627358|FG000|Overall Study|Adverse Event|3|||
94227517|NCT02507687|322627359|FG001|Overall Study|Adverse Event|2|||
94227518|NCT02507687|322627360|FG002|Overall Study|Adverse Event|2|||
94227519|NCT02507687|322627361|FG003|Overall Study|Adverse Event|2|||
94227520|NCT02507687|322627358|FG000|Overall Study|Withdrawal by Subject|1|||
94227521|NCT02507687|322627359|FG001|Overall Study|Withdrawal by Subject|4|||
94227522|NCT02507687|322627360|FG002|Overall Study|Withdrawal by Subject|6|||
94227523|NCT02507687|322627361|FG003|Overall Study|Withdrawal by Subject|6|||
94227524|NCT02507687|322627358|FG000|Overall Study|Protocol Violation|1|||
94227525|NCT02507687|322627359|FG001|Overall Study|Protocol Violation|0|||
94227526|NCT02507687|322627360|FG002|Overall Study|Protocol Violation|2|||
94227527|NCT02507687|322627361|FG003|Overall Study|Protocol Violation|0|||
94227528|NCT02507687|322627358|FG000|Overall Study|Lost to Follow-up|0|||
94552396|NCT01727336|323818670|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
94552397|NCT01727336|323818671|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
94552398|NCT01727336|323818672|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
94552399|NCT01727336|323818667|FG000|Part 2 Blinded|Death|0|||
94552400|NCT01727336|323818668|FG001|Part 2 Blinded|Death|0|||
94552401|NCT01727336|323818669|FG002|Part 2 Blinded|Death|0|||
94552402|NCT01727336|323818670|FG003|Part 2 Blinded|Death|0|||
94552403|NCT01727336|323818671|FG004|Part 2 Blinded|Death|20|||
94552404|NCT01727336|323818672|FG005|Part 2 Blinded|Death|16|||
94552405|NCT01727336|323818667|FG000|Part 2 Blinded|Lack of Efficacy|0|||
94552406|NCT01727336|323818668|FG001|Part 2 Blinded|Lack of Efficacy|0|||
94552407|NCT01727336|323818669|FG002|Part 2 Blinded|Lack of Efficacy|0|||
94552408|NCT01727336|323818670|FG003|Part 2 Blinded|Lack of Efficacy|0|||
94552409|NCT01727336|323818671|FG004|Part 2 Blinded|Lack of Efficacy|42|||
94552410|NCT01727336|323818672|FG005|Part 2 Blinded|Lack of Efficacy|44|||
94552411|NCT01727336|323818667|FG000|Part 2 Blinded|Lost to Follow-up|0|||
94552412|NCT01727336|323818668|FG001|Part 2 Blinded|Lost to Follow-up|0|||
94552413|NCT01727336|323818669|FG002|Part 2 Blinded|Lost to Follow-up|0|||
94552414|NCT01727336|323818670|FG003|Part 2 Blinded|Lost to Follow-up|0|||
94552415|NCT01727336|323818671|FG004|Part 2 Blinded|Lost to Follow-up|0|||
94552416|NCT01727336|323818672|FG005|Part 2 Blinded|Lost to Follow-up|1|||
94552417|NCT01727336|323818667|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
94552418|NCT01727336|323818668|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
94552419|NCT01727336|323818669|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
94552420|NCT01727336|323818670|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
94552421|NCT01727336|323818671|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
94552422|NCT01727336|323818672|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
94552423|NCT01727336|323818667|FG000|Part 2 Blinded|use of prohibited medications|0|||
94552424|NCT01727336|323818668|FG001|Part 2 Blinded|use of prohibited medications|0|||
94552425|NCT01727336|323818669|FG002|Part 2 Blinded|use of prohibited medications|0|||
94552426|NCT01727336|323818670|FG003|Part 2 Blinded|use of prohibited medications|0|||
94552427|NCT01727336|323818671|FG004|Part 2 Blinded|use of prohibited medications|1|||
94552428|NCT01727336|323818672|FG005|Part 2 Blinded|use of prohibited medications|3|||
94552429|NCT00565136|323818673|FG000|Overall Study|Lost to Follow-up|1|||
94552430|NCT00565136|323818673|FG000|Overall Study|Withdrawal by Subject|1|||
94552431|NCT00565136|323818673|FG000|Overall Study|Protocol Violation|1|||
94552432|NCT00084656|323818674|FG000|Overall Study|Other reasons|0|||
94445997|NCT00813150|323419222|FG000|Treatment Period|Data not available|1|||
94445998|NCT00813150|323419223|FG001|Treatment Period|Data not available|2|||
94445999|NCT00813150|323419222|FG000|Long Term Follow-up|Death|0|||
94446000|NCT00813150|323419223|FG001|Long Term Follow-up|Death|4|||
94446001|NCT00813150|323419222|FG000|Long Term Follow-up|Other|0|||
94446002|NCT00813150|323419223|FG001|Long Term Follow-up|Other|3|||
94446003|NCT00813150|323419222|FG000|Long Term Follow-up|Lost to Follow-up|2|||
94446004|NCT00813150|323419223|FG001|Long Term Follow-up|Lost to Follow-up|0|||
94446005|NCT00813150|323419222|FG000|Long Term Follow-up|Progression/Relapse|22|||
94446006|NCT00813150|323419223|FG001|Long Term Follow-up|Progression/Relapse|24|||
94446007|NCT01470248|323419224|FG000|Overall Study|Withdrawal by Subject|1|||
94446008|NCT04247282|323419225|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
94446009|NCT04247282|323419226|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
94446010|NCT04247282|323419227|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
94446011|NCT04247282|323419228|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
94446012|NCT04247282|323419225|FG000|Overall Study|Refused further treatment|0|||
94446013|NCT04247282|323419226|FG001|Overall Study|Refused further treatment|1|||
94552433|NCT00084656|323818675|FG001|Overall Study|Other reasons|12|||
94552434|NCT00084656|323818676|FG002|Overall Study|Other reasons|11|||
94552435|NCT00084656|323818674|FG000|Overall Study|Withdrawal by Subject|15|||
94227529|NCT02507687|322627359|FG001|Overall Study|Lost to Follow-up|0|||
94446014|NCT04247282|323419227|FG002|Overall Study|Refused further treatment|0|||
94552436|NCT00084656|323818675|FG001|Overall Study|Withdrawal by Subject|4|||
94446015|NCT04247282|323419228|FG003|Overall Study|Refused further treatment|0|||
94446016|NCT03103087|323419229|FG000|Overall Study|Did not receive any study drug|1|||
94446017|NCT03103087|323419230|FG001|Overall Study|Did not receive any study drug|0|||
94446018|NCT03103087|323419231|FG002|Overall Study|Did not receive any study drug|0|||
94446019|NCT03103087|323419229|FG000|Overall Study|Protocol Violation|1|||
94446020|NCT03103087|323419230|FG001|Overall Study|Protocol Violation|2|||
94446021|NCT03103087|323419231|FG002|Overall Study|Protocol Violation|1|||
94446022|NCT03103087|323419229|FG000|Overall Study|Lack of Efficacy|2|||
94446023|NCT03103087|323419230|FG001|Overall Study|Lack of Efficacy|1|||
94446024|NCT03103087|323419231|FG002|Overall Study|Lack of Efficacy|1|||
94446025|NCT03103087|323419229|FG000|Overall Study|Pregnancy|0|||
94446026|NCT03103087|323419230|FG001|Overall Study|Pregnancy|0|||
94446027|NCT03103087|323419231|FG002|Overall Study|Pregnancy|1|||
94446028|NCT03103087|323419229|FG000|Overall Study|Adverse Event|2|||
94446029|NCT03103087|323419230|FG001|Overall Study|Adverse Event|15|||
94446030|NCT03103087|323419231|FG002|Overall Study|Adverse Event|6|||
94446031|NCT03103087|323419229|FG000|Overall Study|Withdrawal by Subject|13|||
94446032|NCT03103087|323419230|FG001|Overall Study|Withdrawal by Subject|6|||
94446033|NCT03103087|323419231|FG002|Overall Study|Withdrawal by Subject|6|||
94446034|NCT03103087|323419229|FG000|Overall Study|Lost to Follow-up|4|||
94446035|NCT03103087|323419230|FG001|Overall Study|Lost to Follow-up|2|||
94446036|NCT03103087|323419231|FG002|Overall Study|Lost to Follow-up|7|||
94446037|NCT03103087|323419229|FG000|Overall Study|Other reason not reported|1|||
94446038|NCT03103087|323419230|FG001|Overall Study|Other reason not reported|3|||
94446039|NCT03103087|323419231|FG002|Overall Study|Other reason not reported|5|||
94446040|NCT00075816|323419232|FG000|Overall Study|Did not undergo transplantation|14|||
94446041|NCT00075816|323419233|FG001|Overall Study|Did not undergo transplantation|11|||
94446042|NCT03511105|323419234|FG000|Overall Study|Adverse Event|1|||
94552437|NCT00084656|323818676|FG002|Overall Study|Withdrawal by Subject|4|||
94446043|NCT03511105|323419235|FG001|Overall Study|Adverse Event|0|||
94446044|NCT03511105|323419234|FG000|Overall Study|Withdrew consent|1|||
94446045|NCT03511105|323419235|FG001|Overall Study|Withdrew consent|0|||
94446046|NCT02019472|323419236|FG000|Overall Study|Adverse Event|14|||
94446047|NCT02019472|323419237|FG001|Overall Study|Adverse Event|23|||
94446048|NCT02019472|323419238|FG002|Overall Study|Adverse Event|17|||
94446049|NCT02019472|323419236|FG000|Overall Study|Death|0|||
94446050|NCT02019472|323419237|FG001|Overall Study|Death|1|||
94446051|NCT02019472|323419238|FG002|Overall Study|Death|1|||
94227530|NCT02507687|322627360|FG002|Overall Study|Lost to Follow-up|2|||
94227531|NCT02507687|322627361|FG003|Overall Study|Lost to Follow-up|1|||
94227532|NCT02507687|322627358|FG000|Overall Study|Screen Failure|0|||
94227533|NCT02507687|322627359|FG001|Overall Study|Screen Failure|0|||
94227534|NCT02507687|322627360|FG002|Overall Study|Screen Failure|1|||
94552438|NCT00084656|323818674|FG000|Overall Study|Disease relapse|0|||
94227535|NCT02507687|322627361|FG003|Overall Study|Screen Failure|0|||
94227536|NCT02507687|322627358|FG000|Overall Study|Other, Not Specified|0|||
94227537|NCT02507687|322627359|FG001|Overall Study|Other, Not Specified|0|||
94227538|NCT02507687|322627360|FG002|Overall Study|Other, Not Specified|2|||
94227539|NCT02507687|322627361|FG003|Overall Study|Other, Not Specified|4|||
94227540|NCT03440047|322627363|FG000|Overall Study|Withdrawal by Subject|2|||
94227541|NCT00197106|322627368|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
94227542|NCT00197106|322627369|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
94227543|NCT00197106|322627370|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
94227544|NCT00197106|322627368|FG000|Overall Treatment Period|Lack of Efficacy|0|||
94227545|NCT00197106|322627369|FG001|Overall Treatment Period|Lack of Efficacy|1|||
94227546|NCT00197106|322627370|FG002|Overall Treatment Period|Lack of Efficacy|0|||
94227547|NCT00197106|322627368|FG000|Overall Treatment Period|Lost to Follow-up|0|||
94227548|NCT00197106|322627369|FG001|Overall Treatment Period|Lost to Follow-up|0|||
94227549|NCT00197106|322627370|FG002|Overall Treatment Period|Lost to Follow-up|2|||
94227550|NCT00197106|322627368|FG000|Overall Treatment Period|Protocol Violation|0|||
94227551|NCT00197106|322627369|FG001|Overall Treatment Period|Protocol Violation|0|||
94227552|NCT00197106|322627370|FG002|Overall Treatment Period|Protocol Violation|2|||
94227553|NCT00197106|322627368|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
94227554|NCT00197106|322627369|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
94227555|NCT00197106|322627370|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
94227556|NCT00511836|322627371|FG000|Double-blind Period|Lost to Follow-up|1|||
94227557|NCT00511836|322627372|FG001|Double-blind Period|Lost to Follow-up|0|||
94227558|NCT03511378|322627373|FG000|Overall Study|Withdrawal by Subject|2|||
94227559|NCT03511378|322627374|FG001|Overall Study|Withdrawal by Subject|2|||
94227560|NCT03511378|322627373|FG000|Overall Study|Patient not coming or schedule visit|1|||
94227561|NCT03511378|322627374|FG001|Overall Study|Patient not coming or schedule visit|0|||
94227562|NCT00730847|322627377|FG000|Overall Study|Adverse Event|1|||
94227563|NCT00730847|322627377|FG000|Overall Study|Protocol Violation|2|||
94227564|NCT00730847|322627377|FG000|Overall Study|Withdrawal by Subject|16|||
94227565|NCT00730847|322627377|FG000|Overall Study|Lost to Follow-up|67|||
94227566|NCT00730847|322627377|FG000|Overall Study|Unknown completion status|21|||
94446052|NCT02019472|323419236|FG000|Overall Study|Lack of Efficacy|7|||
94446053|NCT02019472|323419237|FG001|Overall Study|Lack of Efficacy|4|||
94446054|NCT02019472|323419238|FG002|Overall Study|Lack of Efficacy|4|||
94446055|NCT02019472|323419236|FG000|Overall Study|Lost to Follow-up|0|||
94446056|NCT02019472|323419237|FG001|Overall Study|Lost to Follow-up|2|||
94446057|NCT02019472|323419238|FG002|Overall Study|Lost to Follow-up|1|||
94446058|NCT02019472|323419236|FG000|Overall Study|Physician Decision|1|||
94446059|NCT02019472|323419237|FG001|Overall Study|Physician Decision|2|||
94446060|NCT02019472|323419238|FG002|Overall Study|Physician Decision|0|||
94446061|NCT02019472|323419236|FG000|Overall Study|Pregnancy|1|||
94446062|NCT02019472|323419237|FG001|Overall Study|Pregnancy|2|||
94446063|NCT02019472|323419238|FG002|Overall Study|Pregnancy|2|||
94446064|NCT02019472|323419236|FG000|Overall Study|Withdrawal by Subject|11|||
94446065|NCT02019472|323419237|FG001|Overall Study|Withdrawal by Subject|10|||
94446066|NCT02019472|323419238|FG002|Overall Study|Withdrawal by Subject|11|||
94446067|NCT02019472|323419236|FG000|Overall Study|Other|3|||
94446068|NCT02019472|323419237|FG001|Overall Study|Other|8|||
94446069|NCT02019472|323419238|FG002|Overall Study|Other|6|||
94446070|NCT01662635|323419239|FG000|Overall Study|scarce samples for evaluation|30|||
94446071|NCT02445248|323419244|FG000|Overall Study|Death|45|||
94446072|NCT02445248|323419245|FG001|Overall Study|Death|12|||
94446073|NCT02445248|323419244|FG000|Overall Study|Progressive disease|13|||
94446074|NCT02445248|323419245|FG001|Overall Study|Progressive disease|1|||
94446075|NCT02445248|323419244|FG000|Overall Study|Subject decision|8|||
94446076|NCT02445248|323419245|FG001|Overall Study|Subject decision|0|||
94446077|NCT02445248|323419244|FG000|Overall Study|Physician Decision|5|||
94446078|NCT02445248|323419245|FG001|Overall Study|Physician Decision|0|||
94446079|NCT02445248|323419244|FG000|Overall Study|Adverse Event|1|||
94446080|NCT02445248|323419245|FG001|Overall Study|Adverse Event|0|||
94446081|NCT02445248|323419244|FG000|Overall Study|Lost to Follow-up|1|||
94446082|NCT02445248|323419245|FG001|Overall Study|Lost to Follow-up|0|||
94446083|NCT03192488|323419246|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
94446084|NCT03192488|323419247|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
94446085|NCT03192488|323419248|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
94446086|NCT03192488|323419249|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
94446087|NCT03192488|323419250|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
94446088|NCT03192488|323419251|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
94446089|NCT03192488|323419246|FG000|Third Intervention (d1)|Adverse Event|0|||
94446090|NCT03192488|323419247|FG001|Third Intervention (d1)|Adverse Event|0|||
94227567|NCT00730847|322627377|FG000|Overall Study|Other|24|||
94227568|NCT00721214|322627378|FG000|Overall Study|Chose another center for transplant|1|||
94227569|NCT00721214|322627378|FG000|Overall Study|Death|3|||
94227570|NCT05006417|322627379|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
94446091|NCT03192488|323419248|FG002|Third Intervention (d1)|Adverse Event|0|||
94446092|NCT03192488|323419249|FG003|Third Intervention (d1)|Adverse Event|0|||
94552439|NCT00084656|323818675|FG001|Overall Study|Disease relapse|9|||
94227571|NCT00280683|322627380|FG000|Overall Study|Withdrawal by Subject|1|||
94552440|NCT00084656|323818676|FG002|Overall Study|Disease relapse|10|||
94552441|NCT00084656|323818674|FG000|Overall Study|Disease progression|9|||
94552442|NCT00084656|323818675|FG001|Overall Study|Disease progression|0|||
94227572|NCT00280683|322627381|FG001|Overall Study|Withdrawal by Subject|2|||
94227573|NCT00280683|322627380|FG000|Overall Study|Adverse Event|1|||
94227574|NCT00280683|322627381|FG001|Overall Study|Adverse Event|1|||
94227575|NCT02705625|322627384|FG000|Overall Study|Protocol Violation|1|||
94227576|NCT02705625|322627385|FG001|Overall Study|Protocol Violation|0|||
94227577|NCT02705625|322627386|FG002|Overall Study|Protocol Violation|0|||
94227578|NCT02705625|322627384|FG000|Overall Study|Adverse Event|6|||
94227579|NCT02705625|322627385|FG001|Overall Study|Adverse Event|5|||
94227580|NCT02705625|322627386|FG002|Overall Study|Adverse Event|2|||
94227581|NCT02705625|322627384|FG000|Overall Study|Death|0|||
94227582|NCT02705625|322627385|FG001|Overall Study|Death|0|||
94227583|NCT02705625|322627386|FG002|Overall Study|Death|1|||
94227584|NCT02705625|322627384|FG000|Overall Study|Withdrawal by Subject|1|||
94227585|NCT02705625|322627385|FG001|Overall Study|Withdrawal by Subject|4|||
94227586|NCT02705625|322627386|FG002|Overall Study|Withdrawal by Subject|5|||
94227587|NCT02705625|322627384|FG000|Overall Study|Lost to Follow-up|0|||
94227588|NCT02705625|322627385|FG001|Overall Study|Lost to Follow-up|0|||
94227589|NCT02705625|322627386|FG002|Overall Study|Lost to Follow-up|1|||
94227590|NCT02705625|322627384|FG000|Overall Study|Non-compliance|0|||
94227591|NCT02705625|322627385|FG001|Overall Study|Non-compliance|1|||
94227592|NCT02705625|322627386|FG002|Overall Study|Non-compliance|1|||
94227593|NCT02705625|322627384|FG000|Overall Study|Overdosing|0|||
94227594|NCT02705625|322627385|FG001|Overall Study|Overdosing|0|||
94227595|NCT02705625|322627386|FG002|Overall Study|Overdosing|1|||
94227596|NCT00494026|322627387|FG000|Overall Study|Sponsor Decision|4|||
94227597|NCT03357471|322627392|FG000|Overall Study|Adverse Event|1|||
94227598|NCT03357471|322627393|FG001|Overall Study|Adverse Event|0|||
94227599|NCT03357471|322627392|FG000|Overall Study|Lost to Follow-up|1|||
94227600|NCT03357471|322627393|FG001|Overall Study|Lost to Follow-up|0|||
94227601|NCT02330562|322627394|FG000|Overall Study|Adverse Event|0|||
94227602|NCT02330562|322627395|FG001|Overall Study|Adverse Event|0|||
94227603|NCT02330562|322627396|FG002|Overall Study|Adverse Event|3|||
94227604|NCT02330562|322627397|FG003|Overall Study|Adverse Event|0|||
94227605|NCT02330562|322627398|FG004|Overall Study|Adverse Event|3|||
94227606|NCT02330562|322627399|FG005|Overall Study|Adverse Event|1|||
94227607|NCT02330562|322627400|FG006|Overall Study|Adverse Event|0|||
94227608|NCT02330562|322627401|FG007|Overall Study|Adverse Event|0|||
94227609|NCT02330562|322627402|FG008|Overall Study|Adverse Event|0|||
94227610|NCT02330562|322627403|FG009|Overall Study|Adverse Event|1|||
94227611|NCT02330562|322627404|FG010|Overall Study|Adverse Event|1|||
94227612|NCT02330562|322627394|FG000|Overall Study|Participant decision|1|||
94227613|NCT02330562|322627395|FG001|Overall Study|Participant decision|0|||
94227614|NCT02330562|322627396|FG002|Overall Study|Participant decision|4|||
94227615|NCT02330562|322627397|FG003|Overall Study|Participant decision|1|||
94227616|NCT02330562|322627398|FG004|Overall Study|Participant decision|5|||
94227617|NCT02330562|322627399|FG005|Overall Study|Participant decision|2|||
94227618|NCT02330562|322627400|FG006|Overall Study|Participant decision|0|||
94227619|NCT02330562|322627401|FG007|Overall Study|Participant decision|0|||
94227620|NCT02330562|322627402|FG008|Overall Study|Participant decision|0|||
94227621|NCT02330562|322627403|FG009|Overall Study|Participant decision|3|||
94227622|NCT02330562|322627404|FG010|Overall Study|Participant decision|0|||
94227623|NCT02330562|322627394|FG000|Overall Study|Disease progression|5|||
94227624|NCT02330562|322627395|FG001|Overall Study|Disease progression|3|||
94227625|NCT02330562|322627396|FG002|Overall Study|Disease progression|20|||
94227626|NCT02330562|322627397|FG003|Overall Study|Disease progression|28|||
94227627|NCT02330562|322627398|FG004|Overall Study|Disease progression|23|||
94227628|NCT02330562|322627399|FG005|Overall Study|Disease progression|7|||
94227629|NCT02330562|322627400|FG006|Overall Study|Disease progression|1|||
94446093|NCT03192488|323419250|FG004|Third Intervention (d1)|Adverse Event|1|||
94446094|NCT03192488|323419251|FG005|Third Intervention (d1)|Adverse Event|0|||
94446095|NCT03048747|323419257|FG000|Overall Study|Adverse Event|2|||
94446096|NCT03048747|323419257|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
94446097|NCT03048747|323419257|FG000|Overall Study|Physician Decision|1|||
94446098|NCT00824772|323419258|FG000|Overall Study|Withdrawal by Subject|8|||
94446099|NCT00611923|323419259|FG000|Overall Study|Withdrawal by Subject|2|||
94446100|NCT00611923|323419260|FG001|Overall Study|Withdrawal by Subject|2|||
94446101|NCT00838903|323419261|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
94446102|NCT00838903|323419262|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
94552443|NCT00084656|323818676|FG002|Overall Study|Disease progression|0|||
94227630|NCT02330562|322627401|FG007|Overall Study|Disease progression|1|||
94227631|NCT02330562|322627402|FG008|Overall Study|Disease progression|1|||
94227632|NCT02330562|322627403|FG009|Overall Study|Disease progression|0|||
94227633|NCT02330562|322627404|FG010|Overall Study|Disease progression|5|||
94227634|NCT02330562|322627394|FG000|Overall Study|Other reasons|0|||
94227635|NCT02330562|322627395|FG001|Overall Study|Other reasons|0|||
94227636|NCT02330562|322627396|FG002|Overall Study|Other reasons|0|||
94227637|NCT02330562|322627397|FG003|Overall Study|Other reasons|1|||
94227638|NCT02330562|322627398|FG004|Overall Study|Other reasons|0|||
94227639|NCT02330562|322627399|FG005|Overall Study|Other reasons|0|||
94227640|NCT02330562|322627400|FG006|Overall Study|Other reasons|0|||
94227641|NCT02330562|322627401|FG007|Overall Study|Other reasons|0|||
94227642|NCT02330562|322627402|FG008|Overall Study|Other reasons|0|||
94227643|NCT02330562|322627403|FG009|Overall Study|Other reasons|0|||
94227644|NCT02330562|322627404|FG010|Overall Study|Other reasons|0|||
94227645|NCT02330562|322627394|FG000|Overall Study|Withdrawal by Subject|0|||
94227646|NCT02330562|322627395|FG001|Overall Study|Withdrawal by Subject|0|||
94227647|NCT02330562|322627396|FG002|Overall Study|Withdrawal by Subject|0|||
94227648|NCT02330562|322627397|FG003|Overall Study|Withdrawal by Subject|0|||
94227649|NCT02330562|322627398|FG004|Overall Study|Withdrawal by Subject|0|||
94227650|NCT02330562|322627399|FG005|Overall Study|Withdrawal by Subject|0|||
94227651|NCT02330562|322627400|FG006|Overall Study|Withdrawal by Subject|0|||
94227652|NCT02330562|322627401|FG007|Overall Study|Withdrawal by Subject|0|||
94227653|NCT02330562|322627402|FG008|Overall Study|Withdrawal by Subject|0|||
94227654|NCT02330562|322627403|FG009|Overall Study|Withdrawal by Subject|1|||
94227655|NCT02330562|322627404|FG010|Overall Study|Withdrawal by Subject|0|||
94227656|NCT00875615|322627405|FG000|Overall Study|Withdrawal by Subject|1|||
94227657|NCT01751165|322627406|FG000|Overall Study|Adverse event, serious fatal|1|||
94227658|NCT01751165|322627407|FG001|Overall Study|Adverse event, serious fatal|0|||
94227659|NCT01751165|322627408|FG002|Overall Study|Adverse event, serious fatal|1|||
94227660|NCT01751165|322627406|FG000|Overall Study|Withdrawal by Subject|0|||
94227661|NCT01751165|322627407|FG001|Overall Study|Withdrawal by Subject|0|||
94227662|NCT01751165|322627408|FG002|Overall Study|Withdrawal by Subject|1|||
94227663|NCT01751165|322627406|FG000|Overall Study|Serious adverse event|0|||
94227664|NCT01751165|322627407|FG001|Overall Study|Serious adverse event|2|||
94227665|NCT01751165|322627408|FG002|Overall Study|Serious adverse event|0|||
94227666|NCT01751165|322627406|FG000|Overall Study|Lost to Follow-up|1|||
94227667|NCT01751165|322627407|FG001|Overall Study|Lost to Follow-up|1|||
94227668|NCT01751165|322627408|FG002|Overall Study|Lost to Follow-up|1|||
94227669|NCT01402063|322627411|FG000|Overall Study|Withdrawal by Subject|3|||
94227670|NCT01402063|322627412|FG001|Overall Study|Withdrawal by Subject|3|||
94446103|NCT00838903|323419263|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
94446104|NCT00838903|323419264|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
94446105|NCT00838903|323419261|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
94446106|NCT00838903|323419262|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
94446107|NCT00838903|323419263|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
94446108|NCT00838903|323419264|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
94446109|NCT00838903|323419261|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
94446110|NCT00838903|323419262|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
94446111|NCT00838903|323419263|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
94446112|NCT00838903|323419264|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
94446113|NCT00838903|323419261|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
94446114|NCT00838903|323419262|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
94446115|NCT00838903|323419263|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
94446116|NCT00838903|323419264|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
94446117|NCT00838903|323419261|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
94446118|NCT00838903|323419262|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
94446119|NCT00838903|323419263|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
94446120|NCT00838903|323419264|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
94446121|NCT00838903|323419261|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
94446122|NCT00838903|323419262|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
94446123|NCT00838903|323419263|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
94446124|NCT00838903|323419264|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
94446125|NCT00838903|323419261|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
94446126|NCT00838903|323419262|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
94446127|NCT00838903|323419263|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
94446128|NCT00838903|323419264|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
94446129|NCT00838903|323419261|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
94446130|NCT00838903|323419262|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
94446131|NCT00838903|323419263|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
94446132|NCT00838903|323419264|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
94446133|NCT00838903|323419261|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
94227671|NCT01441583|322627413|FG000|Overall Study|Withdrawal by Subject|1|||
94227672|NCT01441583|322627414|FG001|Overall Study|Withdrawal by Subject|1|||
94227673|NCT01441583|322627415|FG002|Overall Study|Withdrawal by Subject|1|||
94227674|NCT01441583|322627413|FG000|Overall Study|Death|1|||
94446134|NCT00838903|323419262|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
94465677|NCT01440569|323494896|FG000|Main Study|Investigator's Discretion|1|||
94227675|NCT01441583|322627414|FG001|Overall Study|Death|0|||
94227676|NCT01441583|322627415|FG002|Overall Study|Death|4|||
94227677|NCT01441583|322627413|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
94227678|NCT01441583|322627414|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
94227679|NCT01441583|322627415|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
94227680|NCT02512861|322627418|FG000|Overall Study|Protocol Violation|3|||
94227681|NCT02512861|322627419|FG001|Overall Study|Protocol Violation|7|||
94227682|NCT02512861|322627418|FG000|Overall Study|Physician Decision|3|||
94227683|NCT02512861|322627419|FG001|Overall Study|Physician Decision|1|||
94227684|NCT02512861|322627418|FG000|Overall Study|Withdrawal by Subject|0|||
94227685|NCT02512861|322627419|FG001|Overall Study|Withdrawal by Subject|1|||
94227686|NCT01885936|322627423|FG000|Overall Study|Withdrawal by Subject|1|||
94227687|NCT01885936|322627424|FG001|Overall Study|Withdrawal by Subject|0|||
94227688|NCT00427778|322627428|FG000|First Intervention (4 Weeks)|no longer interested|1|||
94227689|NCT00427778|322627429|FG001|First Intervention (4 Weeks)|no longer interested|0|||
94227690|NCT00427778|322627428|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
94227691|NCT00427778|322627429|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
94227692|NCT00427778|322627428|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
94227693|NCT00427778|322627429|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
94227694|NCT00427778|322627428|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
94227695|NCT00427778|322627429|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
94227696|NCT00292981|322627430|FG000|Overall Study|Adverse Event|1|||
94227697|NCT00292981|322627430|FG000|Overall Study|Lost to Follow-up|13|||
94227698|NCT00292981|322627430|FG000|Overall Study|Withdrawal by Subject|22|||
94227699|NCT00292981|322627430|FG000|Overall Study|Other|3|||
94227700|NCT00594178|322627431|FG000|Overall Study|Physician Decision|5|||
94227701|NCT03544229|322627434|FG000|Overall Study|Adverse Event|1|||
94227702|NCT03544229|322627435|FG001|Overall Study|Adverse Event|0|||
94227703|NCT03544229|322627436|FG002|Overall Study|Adverse Event|1|||
94227704|NCT03544229|322627437|FG003|Overall Study|Adverse Event|0|||
94227705|NCT03544229|322627434|FG000|Overall Study|Protocol Deviation|0|||
94227706|NCT03544229|322627435|FG001|Overall Study|Protocol Deviation|0|||
94227707|NCT03544229|322627436|FG002|Overall Study|Protocol Deviation|1|||
94227708|NCT03544229|322627437|FG003|Overall Study|Protocol Deviation|0|||
94227709|NCT03544229|322627434|FG000|Overall Study|Lost to Follow-up|3|||
94227710|NCT03544229|322627435|FG001|Overall Study|Lost to Follow-up|0|||
94227711|NCT03544229|322627436|FG002|Overall Study|Lost to Follow-up|0|||
94227712|NCT03544229|322627437|FG003|Overall Study|Lost to Follow-up|2|||
94227713|NCT03544229|322627434|FG000|Overall Study|Voluntary Withdrawal|2|||
94227714|NCT03544229|322627435|FG001|Overall Study|Voluntary Withdrawal|1|||
94227715|NCT03544229|322627436|FG002|Overall Study|Voluntary Withdrawal|3|||
94227716|NCT03544229|322627437|FG003|Overall Study|Voluntary Withdrawal|0|||
94227717|NCT03544229|322627434|FG000|Overall Study|Lack of Efficacy|0|||
94227718|NCT03544229|322627435|FG001|Overall Study|Lack of Efficacy|1|||
94227719|NCT03544229|322627436|FG002|Overall Study|Lack of Efficacy|0|||
94227720|NCT03544229|322627437|FG003|Overall Study|Lack of Efficacy|0|||
94227721|NCT00363649|322627438|FG000|Overall Study|Withdrawal by Subject|1|||
94227722|NCT00363649|322627439|FG001|Overall Study|Withdrawal by Subject|1|||
94227723|NCT00363649|322627438|FG000|Overall Study|Adverse Event|6|||
94227724|NCT00363649|322627439|FG001|Overall Study|Adverse Event|0|||
94227725|NCT00338949|322627440|FG000|Subject Screening|Screen failures|11|||
94227726|NCT00338949|322627441|FG001|Subject Screening|Screen failures|11|||
94227727|NCT00338949|322627440|FG000|Randomization|Withdrawal by Subject|1|||
94227728|NCT00338949|322627441|FG001|Randomization|Withdrawal by Subject|0|||
94227729|NCT00338949|322627440|FG000|Randomization|Adverse Event|0|||
94227730|NCT00338949|322627441|FG001|Randomization|Adverse Event|5|||
94227731|NCT03811834|322627442|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
94227732|NCT02143063|322627443|FG000|Overall Study|Lost to Follow-up|16|||
94227733|NCT02143063|322627444|FG001|Overall Study|Lost to Follow-up|28|||
94227734|NCT02143063|322627445|FG002|Overall Study|Lost to Follow-up|29|||
94227735|NCT02143063|322627443|FG000|Overall Study|Withdrawal by Subject|0|||
94227736|NCT02143063|322627444|FG001|Overall Study|Withdrawal by Subject|1|||
94227737|NCT02143063|322627445|FG002|Overall Study|Withdrawal by Subject|0|||
94227738|NCT02143063|322627443|FG000|Overall Study|Death|0|||
94446135|NCT00838903|323419263|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
94446136|NCT00838903|323419264|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
94446137|NCT00838903|323419261|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
94446138|NCT00838903|323419262|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
94446139|NCT00838903|323419263|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
94446140|NCT00838903|323419264|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
94227739|NCT02143063|322627444|FG001|Overall Study|Death|1|||
94227740|NCT02143063|322627445|FG002|Overall Study|Death|1|||
94227741|NCT00025662|322627446|FG000|Overall Study|Withdrawal by Subject|2|||
94227742|NCT00025662|322627446|FG000|Overall Study|Technical failure of manipulation|1|||
94227743|NCT04947436|322627449|FG000|Overall Study|Lost to Follow-up|3|||
94227744|NCT04947436|322627450|FG001|Overall Study|Lost to Follow-up|7|||
94227745|NCT04947436|322627451|FG002|Overall Study|Lost to Follow-up|5|||
94227746|NCT04947436|322627449|FG000|Overall Study|Death|1|||
94227747|NCT04947436|322627450|FG001|Overall Study|Death|1|||
94227748|NCT04947436|322627451|FG002|Overall Study|Death|1|||
94227749|NCT02630706|322627455|FG000|Overall Study|Adverse Event|2|||
94227750|NCT02630706|322627456|FG001|Overall Study|Adverse Event|1|||
94227751|NCT02630706|322627457|FG002|Overall Study|Adverse Event|1|||
94227752|NCT02630706|322627455|FG000|Overall Study|Lost to Follow-up|0|||
94227753|NCT02630706|322627456|FG001|Overall Study|Lost to Follow-up|1|||
94227754|NCT02630706|322627457|FG002|Overall Study|Lost to Follow-up|2|||
94227755|NCT02630706|322627455|FG000|Overall Study|Physician Decision|1|||
94227756|NCT02630706|322627456|FG001|Overall Study|Physician Decision|1|||
94552444|NCT00084656|323818674|FG000|Overall Study|Lost to Follow-up|1|||
94552445|NCT00084656|323818675|FG001|Overall Study|Lost to Follow-up|0|||
94552446|NCT00084656|323818676|FG002|Overall Study|Lost to Follow-up|1|||
94552447|NCT02540993|323818677|FG000|Overall Study|Lost to Follow-up|5|||
94552448|NCT02540993|323818678|FG001|Overall Study|Lost to Follow-up|3|||
94552449|NCT02540993|323818677|FG000|Overall Study|Withdrawal by Subject|4|||
94552450|NCT02540993|323818678|FG001|Overall Study|Withdrawal by Subject|6|||
94552451|NCT02540993|323818677|FG000|Overall Study|GCP violations|33|||
94552452|NCT02540993|323818678|FG001|Overall Study|GCP violations|27|||
94552453|NCT00576576|323818679|FG000|Overall Study|Lost to Follow-up|6|||
94552454|NCT00576576|323818679|FG000|Overall Study|Protocol Violation|1|||
94552455|NCT03135210|323818680|FG000|Overall Study|Death|0|||
94552456|NCT03135210|323818681|FG001|Overall Study|Death|1|||
94552457|NCT01805037|323818682|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
94552458|NCT01805037|323818683|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
94552459|NCT01805037|323818682|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
94552460|NCT01805037|323818683|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
94552461|NCT01805037|323818682|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
94552462|NCT01805037|323818683|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
94552463|NCT01805037|323818682|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
94552464|NCT01805037|323818683|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
94552465|NCT01805037|323818682|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
94552466|NCT01805037|323818683|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
94552467|NCT01805037|323818682|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
94552468|NCT01805037|323818683|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
94552469|NCT01805037|323818682|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
94552470|NCT01805037|323818683|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
94552471|NCT01805037|323818682|FG000|Follow Up (up to 3 Years)|Death|0|||
94552472|NCT01805037|323818683|FG001|Follow Up (up to 3 Years)|Death|2|||
94552473|NCT01805037|323818682|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
94552474|NCT01805037|323818683|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
94552475|NCT01805037|323818682|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
94552476|NCT01805037|323818683|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
94552477|NCT01424228|323818684|FG000|Overall Study|Withdrawal by Subject|27|||
94552478|NCT01424228|323818685|FG001|Overall Study|Withdrawal by Subject|11|||
94552479|NCT01424228|323818684|FG000|Overall Study|Adverse Event|10|||
94552480|NCT01424228|323818685|FG001|Overall Study|Adverse Event|14|||
94552481|NCT01424228|323818684|FG000|Overall Study|Sponsor's decision|9|||
94227757|NCT02630706|322627457|FG002|Overall Study|Physician Decision|0|||
94227758|NCT02630706|322627455|FG000|Overall Study|Pregnancy|0|||
94227759|NCT02630706|322627456|FG001|Overall Study|Pregnancy|1|||
94227760|NCT02630706|322627457|FG002|Overall Study|Pregnancy|0|||
94227761|NCT02630706|322627455|FG000|Overall Study|Withdrawal by Subject|4|||
94552482|NCT01424228|323818685|FG001|Overall Study|Sponsor's decision|12|||
94552483|NCT01424228|323818684|FG000|Overall Study|Lack of Efficacy|5|||
94227762|NCT02630706|322627456|FG001|Overall Study|Withdrawal by Subject|5|||
94552484|NCT01424228|323818685|FG001|Overall Study|Lack of Efficacy|7|||
94552485|NCT01424228|323818684|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
94552486|NCT01424228|323818685|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
94227763|NCT02630706|322627457|FG002|Overall Study|Withdrawal by Subject|7|||
94227764|NCT00372255|322627459|FG000|Overall Study|Withdrawn for other reasons|2|||
94227765|NCT00372255|322627460|FG001|Overall Study|Withdrawn for other reasons|1|||
94552487|NCT01424228|323818684|FG000|Overall Study|Non-compliance|2|||
94552488|NCT01424228|323818685|FG001|Overall Study|Non-compliance|0|||
94227766|NCT00519285|322627461|FG000|Overall Study|Adverse Event|127|||
94552489|NCT01424228|323818684|FG000|Overall Study|Worsening of symptoms|1|||
94227767|NCT00519285|322627462|FG001|Overall Study|Adverse Event|266|||
94227768|NCT00519285|322627461|FG000|Overall Study|Disease progression|334|||
94227769|NCT00519285|322627462|FG001|Overall Study|Disease progression|186|||
94552490|NCT01424228|323818685|FG001|Overall Study|Worsening of symptoms|0|||
94552491|NCT01424228|323818684|FG000|Overall Study|Unplanned journey|0|||
94552492|NCT01424228|323818685|FG001|Overall Study|Unplanned journey|1|||
94552493|NCT00820222|323818686|FG000|Overall Study|Lost to Follow-up|10|||
94552494|NCT00820222|323818687|FG001|Overall Study|Lost to Follow-up|9|||
94552495|NCT00820222|323818686|FG000|Overall Study|Withdrawal by Subject|19|||
94552496|NCT00820222|323818687|FG001|Overall Study|Withdrawal by Subject|21|||
94552497|NCT00820222|323818686|FG000|Overall Study|Physician Decision|93|||
94552498|NCT00820222|323818687|FG001|Overall Study|Physician Decision|88|||
94552499|NCT00820222|323818686|FG000|Overall Study|Sponsor Terminated Study|43|||
94552500|NCT00820222|323818687|FG001|Overall Study|Sponsor Terminated Study|65|||
94552501|NCT00820222|323818686|FG000|Overall Study|Unkown|11|||
94552502|NCT00820222|323818687|FG001|Overall Study|Unkown|7|||
94552503|NCT00671437|323818688|FG000|Overall Study|Progressive disease before C1 week 8|8|||
94552504|NCT00671437|323818688|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
94552505|NCT00671437|323818688|FG000|Overall Study|Adverse Event|3|||
94552506|NCT00671437|323818688|FG000|Overall Study|Ineligible post-hoc|1|||
94552507|NCT00932165|323818689|FG000|Overall Study|Lost to Follow-up|1|||
94552508|NCT03927404|323818690|FG000|Overall Study|Withdrawal by Subject|1|||
94552509|NCT04311463|323818691|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
94552510|NCT04311463|323818692|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
94552511|NCT04311463|323818691|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
94552512|NCT04311463|323818692|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
94552513|NCT04311463|323818691|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
94552514|NCT04311463|323818692|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
94552515|NCT03101085|323818693|FG000|Overall Study|Lost to Follow-up|0|||
94552516|NCT03101085|323818694|FG001|Overall Study|Lost to Follow-up|1|||
94552517|NCT00410605|323818695|FG000|Overall Study|Adverse Event|12|||
94552518|NCT00410605|323818695|FG000|Overall Study|Physician Decision|3|||
94552519|NCT00410605|323818695|FG000|Overall Study|Withdrawal by Subject|5|||
94552520|NCT00410605|323818695|FG000|Overall Study|Started Non-Protocol Therapy|3|||
94552521|NCT00410605|323818695|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
94552522|NCT00410605|323818695|FG000|Overall Study|Transferred to another Institution|1|||
94552523|NCT02651220|323818696|FG000|Overall Study|Adverse Event|1|||
94552524|NCT02651220|323818697|FG001|Overall Study|Adverse Event|5|||
94552525|NCT02651220|323818698|FG002|Overall Study|Adverse Event|1|||
94552526|NCT02651220|323818696|FG000|Overall Study|Lost to Follow-up|8|||
94552527|NCT02651220|323818697|FG001|Overall Study|Lost to Follow-up|14|||
94552528|NCT02651220|323818698|FG002|Overall Study|Lost to Follow-up|14|||
94552529|NCT02651220|323818696|FG000|Overall Study|Non-Compliance with Study Drug|4|||
94552530|NCT02651220|323818697|FG001|Overall Study|Non-Compliance with Study Drug|0|||
94552531|NCT02651220|323818698|FG002|Overall Study|Non-Compliance with Study Drug|1|||
94552532|NCT02651220|323818696|FG000|Overall Study|Pregnancy|1|||
94552533|NCT02651220|323818697|FG001|Overall Study|Pregnancy|0|||
94552534|NCT02651220|323818698|FG002|Overall Study|Pregnancy|1|||
94552535|NCT02651220|323818696|FG000|Overall Study|Protocol Violation|0|||
94552536|NCT02651220|323818697|FG001|Overall Study|Protocol Violation|0|||
94552537|NCT02651220|323818698|FG002|Overall Study|Protocol Violation|1|||
94552538|NCT02651220|323818696|FG000|Overall Study|Withdrawal by Subject|5|||
94552539|NCT02651220|323818697|FG001|Overall Study|Withdrawal by Subject|6|||
94552540|NCT02651220|323818698|FG002|Overall Study|Withdrawal by Subject|8|||
94552541|NCT02651220|323818696|FG000|Overall Study|Miscellaneous|4|||
94552542|NCT02651220|323818697|FG001|Overall Study|Miscellaneous|1|||
94552543|NCT02651220|323818698|FG002|Overall Study|Miscellaneous|2|||
94552544|NCT02651220|323818696|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94552545|NCT02651220|323818697|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
94552546|NCT02651220|323818698|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
94552547|NCT00383162|323818699|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
94552548|NCT00383162|323818700|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
94552549|NCT00383162|323818699|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
94552550|NCT00383162|323818700|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
94552551|NCT00383162|323818699|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
94343410|NCT02574520|323036069|FG000|Overall Study|Adverse Event|0|||
94343411|NCT02574520|323036070|FG001|Overall Study|Adverse Event|0|||
94552552|NCT00383162|323818700|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
94552553|NCT00383162|323818699|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
94552554|NCT00383162|323818700|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
94552555|NCT00383162|323818699|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
94552556|NCT00383162|323818700|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
94552557|NCT00383162|323818699|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
94552558|NCT00383162|323818700|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
94552559|NCT00383162|323818699|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
94552560|NCT00383162|323818700|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
94446141|NCT00838903|323419261|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
94446142|NCT00838903|323419262|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
94446143|NCT00838903|323419263|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
94446144|NCT00838903|323419264|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
94446145|NCT00838903|323419261|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
94446146|NCT00838903|323419262|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
94446147|NCT00838903|323419263|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
94446148|NCT00838903|323419264|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
94446149|NCT00838903|323419261|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
94446150|NCT00838903|323419262|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
94446151|NCT00838903|323419263|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
94446152|NCT00838903|323419264|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
94552561|NCT00383162|323818699|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
94552562|NCT00383162|323818700|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
94552563|NCT00383162|323818699|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
94552564|NCT00383162|323818700|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
94552565|NCT04583956|323818704|FG000|Overall Study|Death|9|||
94552566|NCT04583956|323818705|FG001|Overall Study|Death|11|||
94446153|NCT00838903|323419261|FG000|Treatment Period (156 Weeks)|Site closed|0|||
94552567|NCT04583956|323818704|FG000|Overall Study|Lost to Follow-up|7|||
94552568|NCT04583956|323818705|FG001|Overall Study|Lost to Follow-up|9|||
94552569|NCT04583956|323818704|FG000|Overall Study|Protocol Violation|2|||
94552570|NCT04583956|323818705|FG001|Overall Study|Protocol Violation|0|||
94552571|NCT04583956|323818704|FG000|Overall Study|Withdrawal by Subject|0|||
94552572|NCT04583956|323818705|FG001|Overall Study|Withdrawal by Subject|2|||
94552573|NCT04583956|323818704|FG000|Overall Study|Randomized but not dosed|2|||
94552574|NCT04583956|323818705|FG001|Overall Study|Randomized but not dosed|3|||
94552575|NCT04583956|323818704|FG000|Overall Study|Withdrawal of consent before product administration|1|||
94552576|NCT04583956|323818705|FG001|Overall Study|Withdrawal of consent before product administration|0|||
94552577|NCT04058886|323818708|FG000|Overall Study|Withdrawal by Subject|4|||
94552578|NCT04058886|323818708|FG000|Overall Study|Inadequate deafness interpreter service|1|||
94552579|NCT02726022|323818714|FG000|Overall Study|Adverse Event|14|||
94446154|NCT00838903|323419262|FG001|Treatment Period (156 Weeks)|Site closed|0|||
94552580|NCT02726022|323818714|FG000|Overall Study|Treatment Failure|8|||
94552581|NCT02726022|323818714|FG000|Overall Study|Poor Compliance|13|||
94552582|NCT02726022|323818714|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
94552583|NCT01371305|323818715|FG000|Overall Study|Adverse Event|0|||
94552584|NCT01371305|323818716|FG001|Overall Study|Adverse Event|0|||
94552585|NCT01371305|323818717|FG002|Overall Study|Adverse Event|0|||
94552586|NCT01371305|323818718|FG003|Overall Study|Adverse Event|2|||
94552587|NCT01371305|323818719|FG004|Overall Study|Adverse Event|1|||
94552588|NCT01371305|323818720|FG005|Overall Study|Adverse Event|0|||
94552589|NCT01371305|323818715|FG000|Overall Study|Study terminated by sponsor|0|||
94552590|NCT01371305|323818716|FG001|Overall Study|Study terminated by sponsor|0|||
94552591|NCT01371305|323818717|FG002|Overall Study|Study terminated by sponsor|0|||
94552592|NCT01371305|323818718|FG003|Overall Study|Study terminated by sponsor|0|||
94552593|NCT01371305|323818719|FG004|Overall Study|Study terminated by sponsor|3|||
94552594|NCT01371305|323818720|FG005|Overall Study|Study terminated by sponsor|1|||
94552595|NCT01371305|323818715|FG000|Overall Study|Subject request|0|||
94552596|NCT01371305|323818716|FG001|Overall Study|Subject request|0|||
94552597|NCT01371305|323818717|FG002|Overall Study|Subject request|0|||
94552598|NCT01371305|323818718|FG003|Overall Study|Subject request|0|||
94552599|NCT01371305|323818719|FG004|Overall Study|Subject request|0|||
94552600|NCT01371305|323818720|FG005|Overall Study|Subject request|1|||
94552601|NCT02220712|323818721|FG000|Overall Study|Adverse Event|1|||
94552602|NCT02220712|323818721|FG000|Overall Study|Withdrawal by Subject|2|||
94552603|NCT02220712|323818721|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
94552604|NCT00504894|323818722|FG000|Overall Study|fMRI technical problems|1|||
94552605|NCT00504894|323818723|FG001|Overall Study|fMRI technical problems|1|||
94552606|NCT00504894|323818724|FG002|Overall Study|fMRI technical problems|0|||
94552607|NCT00504894|323818722|FG000|Overall Study|Withdrawal by Subject|0|||
94552608|NCT00504894|323818723|FG001|Overall Study|Withdrawal by Subject|1|||
94552609|NCT00504894|323818724|FG002|Overall Study|Withdrawal by Subject|0|||
94552610|NCT00504894|323818722|FG000|Overall Study|Infusion technical problems|0|||
94552611|NCT00504894|323818723|FG001|Overall Study|Infusion technical problems|1|||
94552612|NCT00504894|323818724|FG002|Overall Study|Infusion technical problems|0|||
94552613|NCT00504894|323818722|FG000|Overall Study|poor subject data|2|||
94552614|NCT00504894|323818723|FG001|Overall Study|poor subject data|0|||
94552615|NCT00504894|323818724|FG002|Overall Study|poor subject data|0|||
94552616|NCT03565237|323818729|FG000|Overall Study|Non-compliance of Investigational Product|1|||
94552617|NCT03565237|323818729|FG000|Overall Study|Physician Decision|1|||
94552618|NCT01008449|323818730|FG000|Overall Study|Lost to Follow-up|29|||
94552619|NCT01008449|323818731|FG001|Overall Study|Lost to Follow-up|19|||
94552620|NCT01220180|323818732|FG000|Overall Study|Lost to Follow-up|76|||
94552621|NCT01220180|323818732|FG000|Overall Study|Other|72|||
94552622|NCT01220180|323818732|FG000|Overall Study|Adverse Event|35|||
94552623|NCT01220180|323818732|FG000|Overall Study|Lack of Efficacy|22|||
94552624|NCT01220180|323818732|FG000|Overall Study|Death|1|||
94552625|NCT01220180|323818732|FG000|Overall Study|Randomized but not treated|1|||
94552626|NCT01990859|323818733|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
94552627|NCT01990859|323818733|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
94552628|NCT00348309|323818734|FG000|Overall Study|Adverse Event|56|||
94552629|NCT00348309|323818735|FG001|Overall Study|Adverse Event|28|||
94552630|NCT00348309|323818736|FG002|Overall Study|Adverse Event|63|||
94552631|NCT00348309|323818734|FG000|Overall Study|Lost to Follow-up|6|||
94552632|NCT00348309|323818735|FG001|Overall Study|Lost to Follow-up|7|||
94552633|NCT00348309|323818736|FG002|Overall Study|Lost to Follow-up|4|||
94552634|NCT00348309|323818734|FG000|Overall Study|Protocol Violation|7|||
94552635|NCT00348309|323818735|FG001|Overall Study|Protocol Violation|12|||
94552636|NCT00348309|323818736|FG002|Overall Study|Protocol Violation|7|||
94552637|NCT00348309|323818734|FG000|Overall Study|Withdrawal by Subject|33|||
94552638|NCT00348309|323818735|FG001|Overall Study|Withdrawal by Subject|37|||
94552639|NCT00348309|323818736|FG002|Overall Study|Withdrawal by Subject|40|||
94552640|NCT00348309|323818734|FG000|Overall Study|Non-compliance|8|||
94552641|NCT00348309|323818735|FG001|Overall Study|Non-compliance|6|||
94552642|NCT00348309|323818736|FG002|Overall Study|Non-compliance|8|||
94552643|NCT00348309|323818734|FG000|Overall Study|Death of caregiver|1|||
94552644|NCT00348309|323818735|FG001|Overall Study|Death of caregiver|0|||
94552645|NCT00348309|323818736|FG002|Overall Study|Death of caregiver|1|||
94552646|NCT00348309|323818734|FG000|Overall Study|Lack of insight, dementia|1|||
94552647|NCT00348309|323818735|FG001|Overall Study|Lack of insight, dementia|0|||
94552648|NCT00348309|323818736|FG002|Overall Study|Lack of insight, dementia|0|||
94552649|NCT00348309|323818734|FG000|Overall Study|Wrong bottle allocated|1|||
94552650|NCT00348309|323818735|FG001|Overall Study|Wrong bottle allocated|0|||
94552651|NCT00348309|323818736|FG002|Overall Study|Wrong bottle allocated|0|||
94552652|NCT00348309|323818734|FG000|Overall Study|Caregiver sick|1|||
94552653|NCT00348309|323818735|FG001|Overall Study|Caregiver sick|0|||
94552654|NCT00348309|323818736|FG002|Overall Study|Caregiver sick|0|||
94552655|NCT00348309|323818734|FG000|Overall Study|Use of prohibited medication|5|||
94552656|NCT00348309|323818735|FG001|Overall Study|Use of prohibited medication|2|||
94552657|NCT00348309|323818736|FG002|Overall Study|Use of prohibited medication|2|||
94552658|NCT00348309|323818734|FG000|Overall Study|Caregiver withdrawal|3|||
94552659|NCT00348309|323818735|FG001|Overall Study|Caregiver withdrawal|0|||
94552660|NCT00348309|323818736|FG002|Overall Study|Caregiver withdrawal|7|||
94552661|NCT00348309|323818734|FG000|Overall Study|Unable to complete ET visit|1|||
94552662|NCT00348309|323818735|FG001|Overall Study|Unable to complete ET visit|0|||
94552663|NCT00348309|323818736|FG002|Overall Study|Unable to complete ET visit|0|||
94552664|NCT00348309|323818734|FG000|Overall Study|PI closing medical practice|1|||
94552665|NCT00348309|323818735|FG001|Overall Study|PI closing medical practice|0|||
94552666|NCT00348309|323818736|FG002|Overall Study|PI closing medical practice|0|||
94552667|NCT00348309|323818734|FG000|Overall Study|Principal investigator's decision|1|||
94552668|NCT00348309|323818735|FG001|Overall Study|Principal investigator's decision|0|||
94552669|NCT00348309|323818736|FG002|Overall Study|Principal investigator's decision|0|||
94552670|NCT00348309|323818734|FG000|Overall Study|No disponibility of medication|1|||
94552671|NCT00348309|323818735|FG001|Overall Study|No disponibility of medication|0|||
94552672|NCT00348309|323818736|FG002|Overall Study|No disponibility of medication|0|||
94552673|NCT00348309|323818734|FG000|Overall Study|Worsened neurodegenerative disease|1|||
94552674|NCT00348309|323818735|FG001|Overall Study|Worsened neurodegenerative disease|0|||
94552675|NCT00348309|323818736|FG002|Overall Study|Worsened neurodegenerative disease|0|||
94552676|NCT00348309|323818734|FG000|Overall Study|Cognitive and behaviour worsening|2|||
94552677|NCT00348309|323818735|FG001|Overall Study|Cognitive and behaviour worsening|0|||
94552678|NCT00348309|323818736|FG002|Overall Study|Cognitive and behaviour worsening|0|||
94552679|NCT00348309|323818734|FG000|Overall Study|Worsening of alzheimer|1|||
94552680|NCT00348309|323818735|FG001|Overall Study|Worsening of alzheimer|0|||
94552681|NCT00348309|323818736|FG002|Overall Study|Worsening of alzheimer|1|||
94552682|NCT00348309|323818734|FG000|Overall Study|Did not appear in time for Visit 3|1|||
94552683|NCT00348309|323818735|FG001|Overall Study|Did not appear in time for Visit 3|0|||
94552684|NCT00348309|323818736|FG002|Overall Study|Did not appear in time for Visit 3|0|||
94552685|NCT00348309|323818734|FG000|Overall Study|Participant died|2|||
94552686|NCT00348309|323818735|FG001|Overall Study|Participant died|1|||
94552687|NCT00348309|323818736|FG002|Overall Study|Participant died|1|||
94552688|NCT00348309|323818734|FG000|Overall Study|Decision of sponsor|1|||
94552689|NCT00348309|323818735|FG001|Overall Study|Decision of sponsor|0|||
94552690|NCT00348309|323818736|FG002|Overall Study|Decision of sponsor|0|||
94552691|NCT00348309|323818734|FG000|Overall Study|Ineffectiveness of treatment|0|||
94552692|NCT00348309|323818735|FG001|Overall Study|Ineffectiveness of treatment|1|||
94552693|NCT00348309|323818736|FG002|Overall Study|Ineffectiveness of treatment|0|||
94552694|NCT00348309|323818734|FG000|Overall Study|A foul of exclusion criteria|0|||
94552695|NCT00348309|323818735|FG001|Overall Study|A foul of exclusion criteria|1|||
94227770|NCT00519285|322627461|FG000|Overall Study|Physician Decision|75|||
94227771|NCT00519285|322627462|FG001|Overall Study|Physician Decision|47|||
94227772|NCT00519285|322627461|FG000|Overall Study|Participant's request|53|||
94227773|NCT00519285|322627462|FG001|Overall Study|Participant's request|84|||
94227774|NCT00519285|322627461|FG000|Overall Study|Consent withdrawn|4|||
94227775|NCT00519285|322627462|FG001|Overall Study|Consent withdrawn|5|||
94227776|NCT00519285|322627461|FG000|Overall Study|Poor compliance to protocol|5|||
94227777|NCT00519285|322627462|FG001|Overall Study|Poor compliance to protocol|7|||
94227778|NCT00519285|322627461|FG000|Overall Study|Reason unspecified|5|||
94227779|NCT00519285|322627462|FG001|Overall Study|Reason unspecified|8|||
94227780|NCT00519285|322627461|FG000|Overall Study|Not treated|8|||
94227781|NCT00519285|322627462|FG001|Overall Study|Not treated|7|||
94227782|NCT00519285|322627461|FG000|Overall Study|Treatment ongoing|1|||
94227783|NCT00519285|322627462|FG001|Overall Study|Treatment ongoing|2|||
94227784|NCT01837797|322627463|FG000|Period 1|Adverse Event|9|||
94227785|NCT01837797|322627464|FG001|Period 1|Adverse Event|0|||
94227786|NCT01837797|322627465|FG002|Period 1|Adverse Event|0|||
94552696|NCT00348309|323818736|FG002|Overall Study|A foul of exclusion criteria|0|||
94552697|NCT00348309|323818734|FG000|Overall Study|Participant was hospitalized|0|||
94552698|NCT00348309|323818735|FG001|Overall Study|Participant was hospitalized|1|||
94552699|NCT00348309|323818736|FG002|Overall Study|Participant was hospitalized|0|||
94552700|NCT00348309|323818734|FG000|Overall Study|Sponsor refuseal|0|||
94552701|NCT00348309|323818735|FG001|Overall Study|Sponsor refuseal|1|||
94552702|NCT00348309|323818736|FG002|Overall Study|Sponsor refuseal|1|||
94552703|NCT00348309|323818734|FG000|Overall Study|Forgot often medication|0|||
94552704|NCT00348309|323818735|FG001|Overall Study|Forgot often medication|1|||
94552705|NCT00348309|323818736|FG002|Overall Study|Forgot often medication|0|||
94552706|NCT00348309|323818734|FG000|Overall Study|Medical Monitor decision|0|||
94552707|NCT00348309|323818735|FG001|Overall Study|Medical Monitor decision|0|||
94552708|NCT00348309|323818736|FG002|Overall Study|Medical Monitor decision|1|||
94552709|NCT00348309|323818734|FG000|Overall Study|Increased dose of Aricept|0|||
94552710|NCT00348309|323818735|FG001|Overall Study|Increased dose of Aricept|0|||
94227787|NCT01837797|322627466|FG003|Period 1|Adverse Event|0|||
94227788|NCT01837797|322627467|FG004|Period 1|Adverse Event|0|||
94227789|NCT01837797|322627463|FG000|Period 1|Withdrawal by Subject|6|||
94227790|NCT01837797|322627464|FG001|Period 1|Withdrawal by Subject|0|||
94227791|NCT01837797|322627465|FG002|Period 1|Withdrawal by Subject|0|||
94227792|NCT01837797|322627466|FG003|Period 1|Withdrawal by Subject|0|||
94227793|NCT01837797|322627467|FG004|Period 1|Withdrawal by Subject|0|||
94227794|NCT01837797|322627463|FG000|Period 1|Administrative reasons|76|||
94227795|NCT01837797|322627464|FG001|Period 1|Administrative reasons|0|||
94552711|NCT00348309|323818736|FG002|Overall Study|Increased dose of Aricept|1|||
94552712|NCT00348309|323818734|FG000|Overall Study|Site closure|0|||
94552713|NCT00348309|323818735|FG001|Overall Study|Site closure|0|||
94552714|NCT00348309|323818736|FG002|Overall Study|Site closure|1|||
94552715|NCT00348309|323818734|FG000|Overall Study|Adverse event not attended|0|||
94552716|NCT00348309|323818735|FG001|Overall Study|Adverse event not attended|0|||
94552717|NCT00348309|323818736|FG002|Overall Study|Adverse event not attended|1|||
94552718|NCT00348309|323818734|FG000|Overall Study|ECG abnormal|0|||
94552719|NCT00348309|323818735|FG001|Overall Study|ECG abnormal|0|||
94552720|NCT00348309|323818736|FG002|Overall Study|ECG abnormal|2|||
94552721|NCT00348309|323818734|FG000|Overall Study|Cardiologist recommendations|0|||
94552722|NCT00348309|323818735|FG001|Overall Study|Cardiologist recommendations|0|||
94552723|NCT00348309|323818736|FG002|Overall Study|Cardiologist recommendations|1|||
94552724|NCT00348309|323818734|FG000|Overall Study|HCV career|0|||
94552725|NCT00348309|323818735|FG001|Overall Study|HCV career|0|||
94552726|NCT00348309|323818736|FG002|Overall Study|HCV career|1|||
94552727|NCT00830180|323818737|FG000|Overall Study|Adverse Event|6|||
94552728|NCT00830180|323818737|FG000|Overall Study|Death|11|||
94552729|NCT00830180|323818737|FG000|Overall Study|Insufficient clinical response|1|||
94227796|NCT01837797|322627465|FG002|Period 1|Administrative reasons|0|||
94552730|NCT00830180|323818737|FG000|Overall Study|Withdrawal by Subject|5|||
94552731|NCT00830180|323818737|FG000|Overall Study|Progressive disease|2|||
94552732|NCT00830180|323818737|FG000|Overall Study|Other - Unspecified|1|||
94552733|NCT01990612|323818738|FG000|Overall Study|Lost to Follow-up|2|||
94552734|NCT01990612|323818739|FG001|Overall Study|Lost to Follow-up|1|||
94552735|NCT01990612|323818738|FG000|Overall Study|Withdrawal by Subject|5|||
94552736|NCT01990612|323818739|FG001|Overall Study|Withdrawal by Subject|2|||
94552737|NCT02126839|323818742|FG000|Overall Study|Adverse Event|0|||
94552738|NCT02126839|323818743|FG001|Overall Study|Adverse Event|1|||
94552739|NCT02126839|323818742|FG000|Overall Study|Withdrawal by Subject|1|||
94552740|NCT02126839|323818743|FG001|Overall Study|Withdrawal by Subject|0|||
94552741|NCT02126839|323818742|FG000|Overall Study|Withdrawal by parent/guardian|1|||
94552742|NCT02126839|323818743|FG001|Overall Study|Withdrawal by parent/guardian|0|||
94552743|NCT02126839|323818742|FG000|Overall Study|Protocol Violation|2|||
94552744|NCT02126839|323818743|FG001|Overall Study|Protocol Violation|3|||
94552745|NCT02126839|323818742|FG000|Overall Study|Sponsor request|0|||
94552746|NCT02126839|323818743|FG001|Overall Study|Sponsor request|1|||
94552747|NCT02126839|323818742|FG000|Overall Study|Lost to Follow-up|1|||
94552748|NCT02126839|323818743|FG001|Overall Study|Lost to Follow-up|4|||
94552749|NCT02126839|323818742|FG000|Overall Study|Other|5|||
94552750|NCT02126839|323818743|FG001|Overall Study|Other|5|||
94552751|NCT00566254|323818744|FG000|Overall Study|Adverse Event|3|||
94552752|NCT00566254|323818745|FG001|Overall Study|Adverse Event|1|||
94552753|NCT00566254|323818744|FG000|Overall Study|Protocol Violation|1|||
94552754|NCT00566254|323818745|FG001|Overall Study|Protocol Violation|3|||
94552755|NCT00566254|323818744|FG000|Overall Study|Withdrawal by Subject|1|||
94552756|NCT00566254|323818745|FG001|Overall Study|Withdrawal by Subject|2|||
94552757|NCT00566254|323818744|FG000|Overall Study|Lack of Efficacy|5|||
94552758|NCT00566254|323818745|FG001|Overall Study|Lack of Efficacy|6|||
94552759|NCT00566254|323818744|FG000|Overall Study|Other|0|||
94552760|NCT00566254|323818745|FG001|Overall Study|Other|2|||
94552761|NCT02478255|323818748|FG000|Overall Study|Physician Decision|6|||
94552762|NCT02478255|323818749|FG001|Overall Study|Physician Decision|0|||
94552763|NCT02478255|323818748|FG000|Overall Study|Withdrawal by Subject|2|||
94552764|NCT02478255|323818749|FG001|Overall Study|Withdrawal by Subject|0|||
94552765|NCT00761527|323818750|FG000|Overall Study|Adverse Event|3|||
94552766|NCT00761527|323818750|FG000|Overall Study|Poor Compliance|8|||
94552767|NCT00761527|323818750|FG000|Overall Study|Lost to Follow-up|9|||
94552768|NCT00761527|323818750|FG000|Overall Study|Unknown reason|2|||
94552769|NCT00619307|323818751|FG000|Overall Study|Adverse Event|0|||
94552770|NCT00619307|323818752|FG001|Overall Study|Adverse Event|1|||
94552771|NCT00619307|323818751|FG000|Overall Study|Lost to Follow-up|0|||
94552772|NCT00619307|323818752|FG001|Overall Study|Lost to Follow-up|1|||
94552773|NCT00619307|323818751|FG000|Overall Study|Protocol Violation|3|||
94552774|NCT00619307|323818752|FG001|Overall Study|Protocol Violation|0|||
94552775|NCT00619307|323818751|FG000|Overall Study|Withdrew consent|1|||
94552776|NCT00619307|323818752|FG001|Overall Study|Withdrew consent|0|||
94343412|NCT02574520|323036071|FG002|Overall Study|Adverse Event|0|||
94552777|NCT00619307|323818751|FG000|Overall Study|Severe migraine|0|||
94552778|NCT00619307|323818752|FG001|Overall Study|Severe migraine|1|||
94552779|NCT00619307|323818751|FG000|Overall Study|MS attack plus steroids|0|||
94552780|NCT00619307|323818752|FG001|Overall Study|MS attack plus steroids|1|||
94552781|NCT03268941|323820662|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
94552782|NCT03268941|323820663|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
94552783|NCT03268941|323820664|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
94552784|NCT03268941|323820665|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
94552785|NCT03268941|323820666|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
94552786|NCT03268941|323820667|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
94552787|NCT03268941|323820668|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
94446155|NCT00838903|323419263|FG002|Treatment Period (156 Weeks)|Site closed|1|||
94446156|NCT00838903|323419264|FG003|Treatment Period (156 Weeks)|Site closed|0|||
94446157|NCT00838903|323419261|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
94446158|NCT00838903|323419262|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
94446159|NCT00838903|323419263|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
94446160|NCT00838903|323419264|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
94446161|NCT00838903|323419261|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
94446162|NCT00838903|323419262|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
94446163|NCT00838903|323419263|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
94446164|NCT00838903|323419264|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
94446165|NCT00838903|323419261|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
94446166|NCT00838903|323419262|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
94446167|NCT00838903|323419263|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
94446168|NCT00838903|323419264|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
94446169|NCT00838903|323419261|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
94446170|NCT00838903|323419262|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
94446171|NCT00838903|323419263|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
94446172|NCT00838903|323419264|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
94446173|NCT00838903|323419261|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
94446174|NCT00838903|323419262|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
94446175|NCT00838903|323419263|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
94446176|NCT00838903|323419264|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
94446177|NCT00838903|323419261|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
94446178|NCT00838903|323419262|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
94446179|NCT00838903|323419263|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
94446180|NCT00838903|323419264|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
94446181|NCT00838903|323419261|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
94446182|NCT00838903|323419262|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
94446183|NCT00838903|323419263|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
94552788|NCT03268941|323820662|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
94552789|NCT03268941|323820663|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
94552790|NCT03268941|323820664|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
94552791|NCT03268941|323820665|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
94552792|NCT03268941|323820666|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
94552793|NCT03268941|323820667|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
94552794|NCT03268941|323820668|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
94552795|NCT03268941|323820662|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
94552796|NCT03268941|323820663|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
94552797|NCT03268941|323820664|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
94552798|NCT03268941|323820665|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
94552799|NCT03268941|323820666|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
94552800|NCT03268941|323820667|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
94552801|NCT03268941|323820668|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
94552802|NCT03268941|323820662|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
94552803|NCT03268941|323820663|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
94552804|NCT03268941|323820664|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
94552805|NCT03268941|323820665|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
94552806|NCT03268941|323820666|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
94552807|NCT03268941|323820667|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
94552808|NCT03268941|323820668|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
94552809|NCT03268941|323820662|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
94552810|NCT03268941|323820663|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
94552811|NCT03268941|323820664|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
94552812|NCT03268941|323820665|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
94552813|NCT03268941|323820666|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
94552814|NCT03268941|323820667|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
94552815|NCT03268941|323820668|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
94552816|NCT02720692|323820674|FG000|Overall Study|Withdrawal by Subject|3|||
94552817|NCT02720692|323820675|FG001|Overall Study|Withdrawal by Subject|0|||
94552818|NCT02720692|323820674|FG000|Overall Study|Physician Decision|1|||
94552819|NCT02720692|323820675|FG001|Overall Study|Physician Decision|0|||
94552820|NCT02720692|323820674|FG000|Overall Study|Lost to Follow-up|8|||
94552821|NCT02720692|323820675|FG001|Overall Study|Lost to Follow-up|3|||
94552822|NCT02720692|323820674|FG000|Overall Study|Subject unable to return for visit|1|||
94552823|NCT02720692|323820675|FG001|Overall Study|Subject unable to return for visit|0|||
94552824|NCT05011513|323820678|FG000|Overall Study|Death|0|||
94552825|NCT05011513|323820679|FG001|Overall Study|Death|1|||
94552826|NCT05011513|323820678|FG000|Overall Study|Lost to Follow-up|4|||
94552827|NCT05011513|323820679|FG001|Overall Study|Lost to Follow-up|0|||
94552828|NCT05011513|323820678|FG000|Overall Study|Withdrawal by Subject|18|||
94227797|NCT01837797|322627466|FG003|Period 1|Administrative reasons|0|||
94552829|NCT05011513|323820679|FG001|Overall Study|Withdrawal by Subject|17|||
94552830|NCT05011513|323820678|FG000|Overall Study|Other|4|||
94552831|NCT05011513|323820679|FG001|Overall Study|Other|2|||
94552832|NCT02503501|323820680|FG000|Overall Study|Physician Decision|1|||
94552833|NCT02503501|323820681|FG001|Overall Study|Physician Decision|0|||
94552834|NCT02503501|323820680|FG000|Overall Study|Protocol Violation|0|||
94552835|NCT02503501|323820681|FG001|Overall Study|Protocol Violation|1|||
94552836|NCT02503501|323820680|FG000|Overall Study|Withdrawal by Subject|0|||
94552837|NCT02503501|323820681|FG001|Overall Study|Withdrawal by Subject|2|||
94552838|NCT01740401|323820682|FG000|Overall Study|Progression of disease|6|||
94552839|NCT01740401|323820682|FG000|Overall Study|Adverse Event|2|||
94552840|NCT01740401|323820682|FG000|Overall Study|Did not reach primary endpoint|2|||
94552841|NCT02806960|323820683|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
94552842|NCT02806960|323820684|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
94552843|NCT02806960|323820685|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
94552844|NCT02806960|323820686|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
94552845|NCT03878758|323820687|FG000|Overall Study|Withdrawal by Subject|1|||
94552846|NCT03878758|323820687|FG000|Overall Study|Protocol defined|2|||
94552847|NCT03878758|323820687|FG000|Overall Study|Improper consent documentation|1|||
94552848|NCT02315560|323820688|FG000|Overall Study|noncompliance by subjects|3|||
94552849|NCT04599465|323820689|FG000|Overall Study|Physician Decision|1|||
94552850|NCT04599465|323820689|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
94552851|NCT02516592|323820692|FG000|Overall Study|Patient withdrew consent|5|||
94552852|NCT02516592|323820693|FG001|Overall Study|Patient withdrew consent|2|||
94552853|NCT02516592|323820692|FG000|Overall Study|Protocol deviation|4|||
94552854|NCT02516592|323820693|FG001|Overall Study|Protocol deviation|4|||
94552855|NCT02516592|323820692|FG000|Overall Study|Lost to Follow-up|2|||
94552856|NCT02516592|323820693|FG001|Overall Study|Lost to Follow-up|3|||
94552857|NCT02516592|323820692|FG000|Overall Study|Patient/guardian decision|2|||
94227798|NCT01837797|322627467|FG004|Period 1|Administrative reasons|0|||
94227799|NCT01837797|322627463|FG000|Period 1|Withdrawal of consent before treatment|1|||
94227800|NCT01837797|322627464|FG001|Period 1|Withdrawal of consent before treatment|0|||
94227801|NCT01837797|322627465|FG002|Period 1|Withdrawal of consent before treatment|0|||
94227802|NCT01837797|322627466|FG003|Period 1|Withdrawal of consent before treatment|0|||
94552858|NCT02516592|323820693|FG001|Overall Study|Patient/guardian decision|1|||
94227803|NCT01837797|322627467|FG004|Period 1|Withdrawal of consent before treatment|0|||
94227804|NCT01837797|322627463|FG000|Period 1|Other|10|||
94227805|NCT01837797|322627464|FG001|Period 1|Other|0|||
94227806|NCT01837797|322627465|FG002|Period 1|Other|0|||
94227807|NCT01837797|322627466|FG003|Period 1|Other|0|||
94227808|NCT01837797|322627467|FG004|Period 1|Other|0|||
94227809|NCT01837797|322627463|FG000|Period 2|Administrative or other reasons|0|||
94227810|NCT01837797|322627464|FG001|Period 2|Administrative or other reasons|5|||
94227811|NCT01837797|322627465|FG002|Period 2|Administrative or other reasons|2|||
94227812|NCT01837797|322627466|FG003|Period 2|Administrative or other reasons|4|||
94227813|NCT01837797|322627467|FG004|Period 2|Administrative or other reasons|0|||
94227814|NCT01837797|322627463|FG000|Period 2|Adverse Event|0|||
94227815|NCT01837797|322627464|FG001|Period 2|Adverse Event|0|||
94227816|NCT01837797|322627465|FG002|Period 2|Adverse Event|0|||
94227817|NCT01837797|322627466|FG003|Period 2|Adverse Event|1|||
94227818|NCT01837797|322627467|FG004|Period 2|Adverse Event|0|||
94227819|NCT01837797|322627463|FG000|Period 3|Adverse Event|0|||
94227820|NCT01837797|322627464|FG001|Period 3|Adverse Event|0|||
94227821|NCT01837797|322627465|FG002|Period 3|Adverse Event|0|||
94227822|NCT01837797|322627466|FG003|Period 3|Adverse Event|0|||
94227823|NCT01837797|322627467|FG004|Period 3|Adverse Event|1|||
94227824|NCT01837797|322627463|FG000|Period 3|Administrative reasons|0|||
94227825|NCT01837797|322627464|FG001|Period 3|Administrative reasons|0|||
94227826|NCT01837797|322627465|FG002|Period 3|Administrative reasons|0|||
94227827|NCT01837797|322627466|FG003|Period 3|Administrative reasons|0|||
94227828|NCT01837797|322627467|FG004|Period 3|Administrative reasons|20|||
94227829|NCT01837797|322627463|FG000|Period 3|Other|0|||
94227830|NCT01837797|322627464|FG001|Period 3|Other|0|||
94227831|NCT01837797|322627465|FG002|Period 3|Other|0|||
94227832|NCT01837797|322627466|FG003|Period 3|Other|0|||
94227833|NCT01837797|322627467|FG004|Period 3|Other|2|||
94227834|NCT00988117|322627468|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
94227835|NCT00988117|322627468|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
94227836|NCT01203956|322627469|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
94227837|NCT01203956|322627470|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
94227838|NCT04522778|322627471|FG000|Overall Study|Patient did not want to wear the device|1|||
94227839|NCT04522778|322627472|FG001|Overall Study|Patient did not want to wear the device|0|||
94227840|NCT04522778|322627471|FG000|Overall Study|Lost to Follow-up|0|||
94552859|NCT02516592|323820692|FG000|Overall Study|Adverse Event|1|||
94552860|NCT02516592|323820693|FG001|Overall Study|Adverse Event|2|||
94552861|NCT02516592|323820692|FG000|Overall Study|Abnormal test procedure result|1|||
94552862|NCT02516592|323820693|FG001|Overall Study|Abnormal test procedure result|0|||
94552863|NCT02516592|323820692|FG000|Overall Study|Death|1|||
94552864|NCT02516592|323820693|FG001|Overall Study|Death|1|||
94552865|NCT01079936|323820696|FG000|Phase I: MTD|First Remission Status|2|||
94552866|NCT01079936|323820697|FG001|Phase I: MTD|First Remission Status|0|||
94552867|NCT01079936|323820698|FG002|Phase I: MTD|First Remission Status|0|||
94552868|NCT01079936|323820699|FG003|Phase I: MTD|First Remission Status|0|||
94552869|NCT01079936|323820700|FG004|Phase I: MTD|First Remission Status|0|||
94552870|NCT01079936|323820696|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
94552871|NCT01079936|323820697|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
94552872|NCT01079936|323820698|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
94227841|NCT04522778|322627472|FG001|Overall Study|Lost to Follow-up|1|||
94552873|NCT01079936|323820699|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
94552874|NCT01079936|323820700|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
94552875|NCT01079936|323820696|FG000|Phase II|Adverse Event|0|||
94227842|NCT00069277|322627473|FG000|Overall Study|Adverse Event|3|||
94227843|NCT00069277|322627473|FG000|Overall Study|Withdrawal by Subject|1|||
94227844|NCT00069277|322627473|FG000|Overall Study|Progressive Disease|15|||
94227845|NCT00069277|322627473|FG000|Overall Study|Physician Decision|2|||
94227846|NCT02230306|322627474|FG000|Overall Study|Did not receive study treatment|1|||
94552876|NCT01079936|323820697|FG001|Phase II|Adverse Event|0|||
94552877|NCT01079936|323820698|FG002|Phase II|Adverse Event|1|||
94552878|NCT01079936|323820699|FG003|Phase II|Adverse Event|0|||
94552879|NCT01079936|323820700|FG004|Phase II|Adverse Event|0|||
94552880|NCT01079936|323820696|FG000|Phase II|Insurance Issue|0|||
94552881|NCT01079936|323820697|FG001|Phase II|Insurance Issue|0|||
94227847|NCT01225159|322627475|FG000|Overall Study|Change operation|1|||
94227848|NCT01225159|322627476|FG001|Overall Study|Change operation|0|||
94227849|NCT01260142|322627477|FG000|Treatment Period 1|Study on hold|1|||
94227850|NCT01260142|322627478|FG001|Treatment Period 1|Study on hold|1|||
94227851|NCT01260142|322627479|FG002|Treatment Period 1|Study on hold|0|||
94227852|NCT01260142|322627480|FG003|Treatment Period 1|Study on hold|0|||
94552882|NCT01079936|323820698|FG002|Phase II|Insurance Issue|0|||
94552883|NCT01079936|323820699|FG003|Phase II|Insurance Issue|0|||
94552884|NCT01079936|323820700|FG004|Phase II|Insurance Issue|1|||
94552885|NCT03847909|323820703|FG000|Overall Study|Withdrawal by Subject|1|||
94552886|NCT03847909|323820704|FG001|Overall Study|Withdrawal by Subject|1|||
94552887|NCT01753401|323820705|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
94552888|NCT01753401|323820706|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
94552889|NCT01753401|323820707|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
94552890|NCT01753401|323820708|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
94552891|NCT01753401|323820705|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
94552892|NCT01753401|323820706|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
94552893|NCT01753401|323820707|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
94552894|NCT01753401|323820708|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
94552895|NCT01753401|323820705|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
94552896|NCT01753401|323820706|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
94552897|NCT01753401|323820707|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
94552898|NCT01753401|323820708|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
94552899|NCT01753401|323820705|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
94552900|NCT01753401|323820706|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
94552901|NCT01753401|323820707|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
94552902|NCT01753401|323820708|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
94552903|NCT01753401|323820705|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
94552904|NCT01753401|323820706|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
94552905|NCT01753401|323820707|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
94552906|NCT01753401|323820708|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
94552907|NCT01753401|323820705|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
94552908|NCT01753401|323820706|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
94552909|NCT01753401|323820707|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
94552910|NCT01753401|323820708|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
94552911|NCT01753401|323820705|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
94552912|NCT01753401|323820706|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
94552913|NCT01753401|323820707|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
94552914|NCT01753401|323820708|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
94552915|NCT03129360|323820709|FG000|Overall Study|Did not meet entry criteria|0|||
94552916|NCT03129360|323820710|FG001|Overall Study|Did not meet entry criteria|2|||
94552917|NCT03129360|323820711|FG002|Overall Study|Did not meet entry criteria|1|||
94552918|NCT03129360|323820709|FG000|Overall Study|Excluded due to motion in scanner|1|||
94552919|NCT03129360|323820710|FG001|Overall Study|Excluded due to motion in scanner|0|||
94552920|NCT03129360|323820711|FG002|Overall Study|Excluded due to motion in scanner|0|||
94552921|NCT02895945|323820715|FG000|Overall Study|Physician Decision|2|||
94552922|NCT02895945|323820716|FG001|Overall Study|Physician Decision|1|||
94552923|NCT00462748|323820719|FG000|Overall Study|Adverse Event|7|||
94552924|NCT00462748|323820720|FG001|Overall Study|Adverse Event|5|||
94552925|NCT00462748|323820721|FG002|Overall Study|Adverse Event|9|||
94552926|NCT00462748|323820719|FG000|Overall Study|Protocol Violation|0|||
94552927|NCT00462748|323820720|FG001|Overall Study|Protocol Violation|2|||
94552928|NCT00462748|323820721|FG002|Overall Study|Protocol Violation|1|||
94552929|NCT00462748|323820719|FG000|Overall Study|Withdrew consent|3|||
94552930|NCT00462748|323820720|FG001|Overall Study|Withdrew consent|3|||
94552931|NCT00462748|323820721|FG002|Overall Study|Withdrew consent|0|||
94552932|NCT00462748|323820719|FG000|Overall Study|Lost to Follow-up|1|||
94552933|NCT00462748|323820720|FG001|Overall Study|Lost to Follow-up|1|||
94552934|NCT00462748|323820721|FG002|Overall Study|Lost to Follow-up|1|||
94552935|NCT00462748|323820719|FG000|Overall Study|Discontinued after 41 days Rx|1|||
94552936|NCT00462748|323820720|FG001|Overall Study|Discontinued after 41 days Rx|0|||
94552937|NCT00462748|323820721|FG002|Overall Study|Discontinued after 41 days Rx|0|||
94552938|NCT02345330|323820724|FG000|Overall Study|Death|1|||
94552939|NCT02345330|323820724|FG000|Overall Study|Progressive Disease|2|||
94552940|NCT02437084|323820727|FG000|Overall Study|Withdrawal by Subject|2|||
94552941|NCT02437084|323820727|FG000|Overall Study|Physician Decision|1|||
94552942|NCT00454181|323820728|FG000|Overall Study|Adverse Event|1|||
94552943|NCT00454181|323820729|FG001|Overall Study|Adverse Event|1|||
94552944|NCT00454181|323820728|FG000|Overall Study|Lost to Follow-up|11|||
94552945|NCT00454181|323820729|FG001|Overall Study|Lost to Follow-up|1|||
94552946|NCT00454181|323820728|FG000|Overall Study|Protocol Violation|1|||
94552947|NCT00454181|323820729|FG001|Overall Study|Protocol Violation|1|||
94552948|NCT00454181|323820728|FG000|Overall Study|Withdrawal by Subject|2|||
94552949|NCT00454181|323820729|FG001|Overall Study|Withdrawal by Subject|0|||
94552950|NCT05096312|323820731|FG000|Overall Study|Lost to Follow-up|2|||
94552951|NCT05096312|323820732|FG001|Overall Study|Lost to Follow-up|4|||
94552952|NCT05096312|323820731|FG000|Overall Study|Adverse Event|1|||
94552953|NCT05096312|323820732|FG001|Overall Study|Adverse Event|0|||
94552954|NCT00293020|323820733|FG000|Overall Study|Withdrawal by Subject|34|||
94552955|NCT00293020|323820733|FG000|Overall Study|Adverse Event|30|||
94552956|NCT00293020|323820733|FG000|Overall Study|Death|32|||
94343413|NCT02574520|323036072|FG003|Overall Study|Adverse Event|1|||
94552957|NCT00293020|323820733|FG000|Overall Study|Lack of Efficacy|12|||
94552958|NCT00293020|323820733|FG000|Overall Study|Lost to Follow-up|4|||
94552959|NCT00293020|323820733|FG000|Overall Study|Protocol Violation|6|||
94552960|NCT00293020|323820733|FG000|Overall Study|Physician Decision|21|||
94552961|NCT00293020|323820733|FG000|Overall Study|Other Reason|22|||
94552962|NCT00293020|323820733|FG000|Overall Study|No dose taken|1|||
94552963|NCT01147848|323820734|FG000|Run-in Period|Screen Failure|623|||
94552964|NCT01147848|323820735|FG001|Run-in Period|Screen Failure|0|||
94552965|NCT01147848|323820736|FG002|Run-in Period|Screen Failure|0|||
94552966|NCT01147848|323820734|FG000|Run-in Period|Run-in Failure|135|||
94552967|NCT01147848|323820735|FG001|Run-in Period|Run-in Failure|0|||
94552968|NCT01147848|323820736|FG002|Run-in Period|Run-in Failure|0|||
94552969|NCT01147848|323820734|FG000|Randomized Phase|Adverse Event|0|||
94552970|NCT01147848|323820735|FG001|Randomized Phase|Adverse Event|6|||
94552971|NCT01147848|323820736|FG002|Randomized Phase|Adverse Event|8|||
94552972|NCT01147848|323820734|FG000|Randomized Phase|Lack of Efficacy|0|||
94552973|NCT01147848|323820735|FG001|Randomized Phase|Lack of Efficacy|20|||
94552974|NCT01147848|323820736|FG002|Randomized Phase|Lack of Efficacy|11|||
94552975|NCT01147848|323820734|FG000|Randomized Phase|Protocol Violation|0|||
94552976|NCT01147848|323820735|FG001|Randomized Phase|Protocol Violation|7|||
94552977|NCT01147848|323820736|FG002|Randomized Phase|Protocol Violation|10|||
94552978|NCT01147848|323820734|FG000|Randomized Phase|Lost to Follow-up|0|||
94552979|NCT01147848|323820735|FG001|Randomized Phase|Lost to Follow-up|5|||
94552980|NCT01147848|323820736|FG002|Randomized Phase|Lost to Follow-up|7|||
94552981|NCT01147848|323820734|FG000|Randomized Phase|Physician Decision|0|||
94552982|NCT01147848|323820735|FG001|Randomized Phase|Physician Decision|0|||
94552983|NCT01147848|323820736|FG002|Randomized Phase|Physician Decision|1|||
94552984|NCT01147848|323820734|FG000|Randomized Phase|Withdrawal by Subject|0|||
94552985|NCT01147848|323820735|FG001|Randomized Phase|Withdrawal by Subject|7|||
94552986|NCT01147848|323820736|FG002|Randomized Phase|Withdrawal by Subject|9|||
94552987|NCT03180307|323820737|FG000|Overall Study|Lost to Follow-up|2|||
94552988|NCT03180307|323820738|FG001|Overall Study|Lost to Follow-up|0|||
94552989|NCT03180307|323820737|FG000|Overall Study|Death|1|||
94552990|NCT03180307|323820738|FG001|Overall Study|Death|0|||
94552991|NCT03180307|323820737|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
94552992|NCT03180307|323820738|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
94552993|NCT00498355|323820747|FG000|Overall Study|Lost to Follow-up|1|||
94552994|NCT02332291|323820758|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
94552995|NCT02332291|323820759|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
94552996|NCT02332291|323820758|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
94552997|NCT02332291|323820759|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
94552998|NCT02332291|323820758|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
94552999|NCT02332291|323820759|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
94553000|NCT02332291|323820758|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
94553001|NCT02332291|323820759|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
94553002|NCT02332291|323820758|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
94553003|NCT02332291|323820759|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
94553004|NCT02332291|323820758|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
94553005|NCT02332291|323820759|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
94553006|NCT00760838|323820765|FG000|Overall Study|Adverse Event|1|||
94553007|NCT00760838|323820766|FG001|Overall Study|Adverse Event|1|||
94553008|NCT00760838|323820765|FG000|Overall Study|Lack of Efficacy|1|||
94553009|NCT00760838|323820766|FG001|Overall Study|Lack of Efficacy|0|||
94553010|NCT00760838|323820765|FG000|Overall Study|Lost to Follow-up|2|||
94553011|NCT00760838|323820766|FG001|Overall Study|Lost to Follow-up|0|||
94553012|NCT00760838|323820765|FG000|Overall Study|Withdrawal by Subject|1|||
94553013|NCT00760838|323820766|FG001|Overall Study|Withdrawal by Subject|1|||
94553014|NCT01545050|323820767|FG000|Overall Study|Lack of Efficacy|0|||
94553015|NCT01545050|323820768|FG001|Overall Study|Lack of Efficacy|0|||
94553016|NCT01545050|323820769|FG002|Overall Study|Lack of Efficacy|0|||
94553017|NCT01545050|323820770|FG003|Overall Study|Lack of Efficacy|3|||
94553018|NCT01545050|323820771|FG004|Overall Study|Lack of Efficacy|2|||
94553019|NCT01545050|323820767|FG000|Overall Study|Adverse Event|1|||
94553020|NCT01545050|323820768|FG001|Overall Study|Adverse Event|1|||
94553021|NCT01545050|323820769|FG002|Overall Study|Adverse Event|2|||
94553022|NCT01545050|323820770|FG003|Overall Study|Adverse Event|2|||
94553023|NCT01545050|323820771|FG004|Overall Study|Adverse Event|0|||
94553024|NCT01545050|323820767|FG000|Overall Study|Discontinued study treatment|1|||
94553025|NCT01545050|323820768|FG001|Overall Study|Discontinued study treatment|0|||
94553026|NCT01545050|323820769|FG002|Overall Study|Discontinued study treatment|0|||
94553027|NCT01545050|323820770|FG003|Overall Study|Discontinued study treatment|0|||
94553028|NCT01545050|323820771|FG004|Overall Study|Discontinued study treatment|0|||
94553029|NCT01545050|323820767|FG000|Overall Study|Withdrawal by Subject|1|||
94553030|NCT01545050|323820768|FG001|Overall Study|Withdrawal by Subject|0|||
94553031|NCT01545050|323820769|FG002|Overall Study|Withdrawal by Subject|0|||
94553032|NCT01545050|323820770|FG003|Overall Study|Withdrawal by Subject|2|||
94553033|NCT01545050|323820771|FG004|Overall Study|Withdrawal by Subject|1|||
94553034|NCT01545050|323820767|FG000|Overall Study|Participant no longer meets study criteria|0|||
94553035|NCT01545050|323820768|FG001|Overall Study|Participant no longer meets study criteria|2|||
94553036|NCT01545050|323820769|FG002|Overall Study|Participant no longer meets study criteria|0|||
94553037|NCT01545050|323820770|FG003|Overall Study|Participant no longer meets study criteria|0|||
94553038|NCT01545050|323820771|FG004|Overall Study|Participant no longer meets study criteria|1|||
94553039|NCT01545050|323820767|FG000|Overall Study|Administrative reason by sponsor|4|||
94553040|NCT01545050|323820768|FG001|Overall Study|Administrative reason by sponsor|2|||
94553041|NCT01545050|323820769|FG002|Overall Study|Administrative reason by sponsor|3|||
94553042|NCT01545050|323820770|FG003|Overall Study|Administrative reason by sponsor|5|||
94553043|NCT01545050|323820771|FG004|Overall Study|Administrative reason by sponsor|5|||
94553044|NCT02607228|323820772|FG000|Overall Study|Progressive Disease|4|||
94553045|NCT02607228|323820773|FG001|Overall Study|Progressive Disease|3|||
94553046|NCT02607228|323820774|FG002|Overall Study|Progressive Disease|1|||
94553047|NCT02607228|323820775|FG003|Overall Study|Progressive Disease|5|||
94553048|NCT02607228|323820776|FG004|Overall Study|Progressive Disease|4|||
94553049|NCT02607228|323820777|FG005|Overall Study|Progressive Disease|3|||
94553050|NCT02607228|323820778|FG006|Overall Study|Progressive Disease|1|||
94553051|NCT02607228|323820772|FG000|Overall Study|Adverse Event|1|||
94553052|NCT02607228|323820773|FG001|Overall Study|Adverse Event|0|||
94553053|NCT02607228|323820774|FG002|Overall Study|Adverse Event|1|||
94553054|NCT02607228|323820775|FG003|Overall Study|Adverse Event|0|||
94553055|NCT02607228|323820776|FG004|Overall Study|Adverse Event|1|||
94553056|NCT02607228|323820777|FG005|Overall Study|Adverse Event|1|||
94553057|NCT02607228|323820778|FG006|Overall Study|Adverse Event|1|||
94553058|NCT02607228|323820772|FG000|Overall Study|Investigator's Discretion|0|||
94553059|NCT02607228|323820773|FG001|Overall Study|Investigator's Discretion|0|||
94553060|NCT02607228|323820774|FG002|Overall Study|Investigator's Discretion|1|||
94553061|NCT02607228|323820775|FG003|Overall Study|Investigator's Discretion|0|||
94553062|NCT02607228|323820776|FG004|Overall Study|Investigator's Discretion|0|||
94553063|NCT02607228|323820777|FG005|Overall Study|Investigator's Discretion|1|||
94553064|NCT02607228|323820778|FG006|Overall Study|Investigator's Discretion|0|||
94553065|NCT02607228|323820772|FG000|Overall Study|Withdrew Consent|0|||
94553066|NCT02607228|323820773|FG001|Overall Study|Withdrew Consent|1|||
94553067|NCT02607228|323820774|FG002|Overall Study|Withdrew Consent|0|||
94553068|NCT02607228|323820775|FG003|Overall Study|Withdrew Consent|0|||
94553069|NCT02607228|323820776|FG004|Overall Study|Withdrew Consent|0|||
94553070|NCT02607228|323820777|FG005|Overall Study|Withdrew Consent|1|||
94553071|NCT02607228|323820778|FG006|Overall Study|Withdrew Consent|0|||
94553072|NCT02607228|323820772|FG000|Overall Study|Study Terminated by Sponsor|0|||
94553073|NCT02607228|323820773|FG001|Overall Study|Study Terminated by Sponsor|0|||
94553074|NCT02607228|323820774|FG002|Overall Study|Study Terminated by Sponsor|0|||
94553075|NCT02607228|323820775|FG003|Overall Study|Study Terminated by Sponsor|1|||
94553076|NCT02607228|323820776|FG004|Overall Study|Study Terminated by Sponsor|0|||
94553077|NCT02607228|323820777|FG005|Overall Study|Study Terminated by Sponsor|0|||
94553078|NCT02607228|323820778|FG006|Overall Study|Study Terminated by Sponsor|0|||
94553079|NCT03235089|323820779|FG000|Overall Study|Lost to Follow-up|1|||
94553080|NCT03235089|323820780|FG001|Overall Study|Lost to Follow-up|1|||
94553081|NCT03235089|323820779|FG000|Overall Study|Physician Decision|2|||
94553082|NCT03235089|323820780|FG001|Overall Study|Physician Decision|2|||
94553083|NCT02249182|323820784|FG000|Treatment Phase|Lost to Follow-up|4|||
94553084|NCT02249182|323820785|FG001|Treatment Phase|Lost to Follow-up|0|||
94553085|NCT02249182|323820786|FG002|Treatment Phase|Lost to Follow-up|0|||
94553086|NCT02249182|323820787|FG003|Treatment Phase|Lost to Follow-up|0|||
94553087|NCT02249182|323820788|FG004|Treatment Phase|Lost to Follow-up|0|||
94553088|NCT02188849|323820793|FG000|Overall Study|Lost to Follow-up|3|||
94553089|NCT02188849|323820794|FG001|Overall Study|Lost to Follow-up|8|||
94553090|NCT02678923|323820800|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
94553091|NCT02678923|323820801|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
94553092|NCT02678923|323820800|FG000|Overall Study|Withdrawal by Subject|3|||
94553093|NCT02678923|323820801|FG001|Overall Study|Withdrawal by Subject|2|||
94553094|NCT02678923|323820800|FG000|Overall Study|Lost to Follow-up|1|||
94553095|NCT02678923|323820801|FG001|Overall Study|Lost to Follow-up|0|||
94553096|NCT02678923|323820800|FG000|Overall Study|Did Not Return for Study Visits|1|||
94553097|NCT02678923|323820801|FG001|Overall Study|Did Not Return for Study Visits|0|||
94553098|NCT02828020|323820805|FG000|Treatment Period|Adverse Event|3|||
94553099|NCT02828020|323820806|FG001|Treatment Period|Adverse Event|1|||
94553100|NCT02828020|323820807|FG002|Treatment Period|Adverse Event|1|||
94553101|NCT02828020|323820805|FG000|Treatment Period|Withdrawal of Consent|10|||
94553102|NCT02828020|323820806|FG001|Treatment Period|Withdrawal of Consent|14|||
94553103|NCT02828020|323820807|FG002|Treatment Period|Withdrawal of Consent|9|||
94553104|NCT02828020|323820805|FG000|Treatment Period|Lost to Follow-up|21|||
94553105|NCT02828020|323820806|FG001|Treatment Period|Lost to Follow-up|24|||
94553106|NCT02828020|323820807|FG002|Treatment Period|Lost to Follow-up|18|||
94553107|NCT02828020|323820805|FG000|Treatment Period|Lack of Qualifying Event|44|||
94553108|NCT02828020|323820806|FG001|Treatment Period|Lack of Qualifying Event|53|||
94553109|NCT02828020|323820807|FG002|Treatment Period|Lack of Qualifying Event|43|||
94553110|NCT02828020|323820805|FG000|Treatment Period|Pregnancy|0|||
94553111|NCT02828020|323820806|FG001|Treatment Period|Pregnancy|2|||
94553112|NCT02828020|323820807|FG002|Treatment Period|Pregnancy|0|||
94553113|NCT02828020|323820805|FG000|Treatment Period|Protocol Violation|2|||
94553114|NCT02828020|323820806|FG001|Treatment Period|Protocol Violation|4|||
94553115|NCT02828020|323820807|FG002|Treatment Period|Protocol Violation|7|||
94446184|NCT00838903|323419264|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
94446185|NCT00838903|323419261|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
94446186|NCT00838903|323419262|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
94446187|NCT00838903|323419263|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
94446188|NCT00838903|323419264|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
94446189|NCT00838903|323419261|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
94446190|NCT00838903|323419262|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
94446191|NCT00838903|323419263|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
94446192|NCT00838903|323419264|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
94446193|NCT00838903|323419261|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
94446194|NCT00838903|323419262|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
94446195|NCT00838903|323419263|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
94446196|NCT00838903|323419264|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
94446197|NCT00838903|323419261|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
94446198|NCT00838903|323419262|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
94446199|NCT00838903|323419263|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
94446200|NCT00838903|323419264|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
94446201|NCT00838903|323419261|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
94446202|NCT00838903|323419262|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
94446203|NCT00838903|323419263|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
94446204|NCT00838903|323419264|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
94446205|NCT00838903|323419261|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
94446206|NCT00838903|323419262|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
94446207|NCT00838903|323419263|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
94553116|NCT02828020|323820805|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
94553117|NCT02828020|323820806|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
94553118|NCT02828020|323820807|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
94553119|NCT02828020|323820805|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
94553120|NCT02828020|323820806|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
94553121|NCT02828020|323820807|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
94227853|NCT01260142|322627481|FG004|Treatment Period 1|Study on hold|1|||
94446208|NCT00838903|323419264|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
94446209|NCT00838903|323419261|FG000|Follow-up Period (8 Weeks)|Missing|1|||
94553122|NCT02828020|323820805|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
94553123|NCT02828020|323820806|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
94227854|NCT01260142|322627482|FG005|Treatment Period 1|Study on hold|2|||
94227855|NCT01260142|322627477|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
94227856|NCT01260142|322627478|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
94227857|NCT01260142|322627479|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
94227858|NCT01260142|322627480|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
94227859|NCT01260142|322627481|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
94227860|NCT01260142|322627482|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
94227861|NCT01260142|322627477|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94227862|NCT01260142|322627478|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94227863|NCT01260142|322627479|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94227864|NCT01260142|322627480|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94227865|NCT01260142|322627481|FG004|Treatment Period 1|Withdrawal by Subject|0|||
94227866|NCT01260142|322627482|FG005|Treatment Period 1|Withdrawal by Subject|1|||
94227867|NCT00691678|322627484|FG000|Overall Study|Adverse Event|5|||
94227868|NCT00691678|322627484|FG000|Overall Study|life events, pain|11|||
94227869|NCT01393613|322627488|FG000|Overall Study|Adverse Event|11|||
94227870|NCT01393613|322627489|FG001|Overall Study|Adverse Event|11|||
94227871|NCT01393613|322627490|FG002|Overall Study|Adverse Event|13|||
94227872|NCT01393613|322627491|FG003|Overall Study|Adverse Event|22|||
94227873|NCT01393613|322627488|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
94227874|NCT01393613|322627489|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
94227875|NCT01393613|322627490|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
94227876|NCT01393613|322627491|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
94227877|NCT01393613|322627488|FG000|Overall Study|Physician Decision|2|||
94553124|NCT02828020|323820807|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
94553125|NCT02828020|323820805|FG000|Safety Follow-up Period|Protocol Violation|0|||
94553126|NCT02828020|323820806|FG001|Safety Follow-up Period|Protocol Violation|2|||
94553127|NCT02828020|323820807|FG002|Safety Follow-up Period|Protocol Violation|1|||
94553128|NCT02828020|323820805|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
94227878|NCT01393613|322627489|FG001|Overall Study|Physician Decision|0|||
94553129|NCT02828020|323820806|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
94553130|NCT02828020|323820807|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
94553131|NCT03688620|323820808|FG000|Overall Study|Other|0|||
94553132|NCT03688620|323820809|FG001|Overall Study|Other|0|||
94553133|NCT03688620|323820810|FG002|Overall Study|Other|1|||
94553134|NCT03688620|323820808|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
94553135|NCT03688620|323820809|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
94227879|NCT01393613|322627490|FG002|Overall Study|Physician Decision|0|||
94553136|NCT03688620|323820810|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
94553137|NCT03688620|323820808|FG000|Overall Study|Lost to Follow-up|16|||
94553138|NCT03688620|323820809|FG001|Overall Study|Lost to Follow-up|0|||
94553139|NCT03688620|323820810|FG002|Overall Study|Lost to Follow-up|1|||
94553140|NCT03688620|323820808|FG000|Overall Study|Withdrawal by Subject|0|||
94553141|NCT03688620|323820809|FG001|Overall Study|Withdrawal by Subject|0|||
94553142|NCT03688620|323820810|FG002|Overall Study|Withdrawal by Subject|6|||
94227880|NCT01393613|322627491|FG003|Overall Study|Physician Decision|1|||
94553143|NCT03043651|323820812|FG000|Overall Study|Death|1|||
94553144|NCT03043651|323820812|FG000|Overall Study|Progressive Disease|2|||
94553145|NCT03043651|323820812|FG000|Overall Study|Adverse Event|2|||
94227881|NCT01393613|322627488|FG000|Overall Study|Withdrawal by Subject|15|||
94553146|NCT03043651|323820812|FG000|Overall Study|Withdrawal by Subject|4|||
94553147|NCT03043651|323820812|FG000|Overall Study|Study Terminated by Sponsor|39|||
94553148|NCT01630889|323820813|FG000|Overall Study|Death|2|||
94553149|NCT01630889|323820813|FG000|Overall Study|Withdrawal by Subject|1|||
94553150|NCT01630889|323820813|FG000|Overall Study|Other than Specified|2|||
94553151|NCT01630889|323820813|FG000|Overall Study|Lost to Follow-up|4|||
94553152|NCT01630889|323820813|FG000|Overall Study|Other|1|||
94553153|NCT03597061|323820814|FG000|Overall Study|Lost to Follow-up|1|||
94553154|NCT03597061|323820815|FG001|Overall Study|Lost to Follow-up|0|||
94553155|NCT03597061|323820814|FG000|Overall Study|Protocol Violation|0|||
94553156|NCT03597061|323820815|FG001|Overall Study|Protocol Violation|1|||
94553157|NCT00375518|323820816|FG000|Overall Study|Withdrawal by Subject|2|||
94553158|NCT00375518|323820817|FG001|Overall Study|Withdrawal by Subject|10|||
94553159|NCT00375518|323820816|FG000|Overall Study|Patient Not Treated|6|||
94553160|NCT00375518|323820817|FG001|Overall Study|Patient Not Treated|6|||
94553161|NCT00375518|323820816|FG000|Overall Study|Death|0|||
94553162|NCT00375518|323820817|FG001|Overall Study|Death|1|||
94553163|NCT00620113|323820821|FG000|Overall Study|Adverse Event|3|||
94553164|NCT00620113|323820822|FG001|Overall Study|Adverse Event|2|||
94553165|NCT00620113|323820823|FG002|Overall Study|Adverse Event|2|||
94553166|NCT00620113|323820824|FG003|Overall Study|Adverse Event|1|||
94553167|NCT00620113|323820821|FG000|Overall Study|Lack of Efficacy|2|||
94553168|NCT00620113|323820822|FG001|Overall Study|Lack of Efficacy|3|||
94553169|NCT00620113|323820823|FG002|Overall Study|Lack of Efficacy|0|||
94553170|NCT00620113|323820824|FG003|Overall Study|Lack of Efficacy|2|||
94553171|NCT00620113|323820821|FG000|Overall Study|Physician Decision|1|||
94553172|NCT00620113|323820822|FG001|Overall Study|Physician Decision|0|||
94553173|NCT00620113|323820823|FG002|Overall Study|Physician Decision|0|||
94553174|NCT00620113|323820824|FG003|Overall Study|Physician Decision|2|||
94553175|NCT00620113|323820821|FG000|Overall Study|Protocol Violation|2|||
94553176|NCT00620113|323820822|FG001|Overall Study|Protocol Violation|1|||
94553177|NCT00620113|323820823|FG002|Overall Study|Protocol Violation|0|||
94553178|NCT00620113|323820824|FG003|Overall Study|Protocol Violation|0|||
94553179|NCT00620113|323820821|FG000|Overall Study|Withdrawal by Subject|5|||
94553180|NCT00620113|323820822|FG001|Overall Study|Withdrawal by Subject|1|||
94553181|NCT00620113|323820823|FG002|Overall Study|Withdrawal by Subject|3|||
94553182|NCT00620113|323820824|FG003|Overall Study|Withdrawal by Subject|5|||
94553183|NCT00211887|323820825|FG000|Overall Study|Adverse Event|8|||
94553184|NCT00211887|323820826|FG001|Overall Study|Adverse Event|4|||
94553185|NCT00211887|323820827|FG002|Overall Study|Adverse Event|6|||
94553186|NCT00211887|323820825|FG000|Overall Study|Death|1|||
94553187|NCT00211887|323820826|FG001|Overall Study|Death|1|||
94343414|NCT02574520|323036069|FG000|Overall Study|Withdrawal by Subject|0|||
94553188|NCT00211887|323820827|FG002|Overall Study|Death|1|||
94553189|NCT00211887|323820825|FG000|Overall Study|Lost to Follow-up|28|||
94553190|NCT00211887|323820826|FG001|Overall Study|Lost to Follow-up|13|||
94553191|NCT00211887|323820827|FG002|Overall Study|Lost to Follow-up|9|||
94553192|NCT00211887|323820825|FG000|Overall Study|Non-medical reason|31|||
94227882|NCT01393613|322627489|FG001|Overall Study|Withdrawal by Subject|25|||
94227883|NCT01393613|322627490|FG002|Overall Study|Withdrawal by Subject|23|||
94227884|NCT01393613|322627491|FG003|Overall Study|Withdrawal by Subject|21|||
94227885|NCT01393613|322627488|FG000|Overall Study|Protocol Deviation|2|||
94227886|NCT01393613|322627489|FG001|Overall Study|Protocol Deviation|1|||
94227887|NCT01393613|322627490|FG002|Overall Study|Protocol Deviation|0|||
94227888|NCT01393613|322627491|FG003|Overall Study|Protocol Deviation|0|||
94227889|NCT01393613|322627488|FG000|Overall Study|Lack of Efficacy|9|||
94227890|NCT01393613|322627489|FG001|Overall Study|Lack of Efficacy|20|||
94227891|NCT01393613|322627490|FG002|Overall Study|Lack of Efficacy|16|||
94227892|NCT01393613|322627491|FG003|Overall Study|Lack of Efficacy|21|||
94227893|NCT00443599|322627494|FG000|Overall Study|Physician Decision|2|||
94227894|NCT00443599|322627495|FG001|Overall Study|Physician Decision|1|||
94227895|NCT00443599|322627494|FG000|Overall Study|Death|1|||
94227896|NCT00443599|322627495|FG001|Overall Study|Death|1|||
94227897|NCT00443599|322627494|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
94227898|NCT00443599|322627495|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
94227899|NCT05896696|322627498|FG000|Overall Study|Screening Failure|7|||
94227900|NCT05896696|322627498|FG000|Overall Study|Withdrawal by Subject|2|||
94227901|NCT02972242|322629037|FG000|Overall Study|Withdrawal by Subject|1|||
94227902|NCT02972242|322629038|FG001|Overall Study|Withdrawal by Subject|0|||
94227903|NCT04572997|322629039|FG000|Overall Study|Adverse Event|1|||
94227904|NCT00381888|322629047|FG000|Overall Study|Death|1|||
94227905|NCT00381888|322629047|FG000|Overall Study|Withdrawal by Subject|1|||
94227906|NCT00381888|322629047|FG000|Overall Study|Physician Decision|1|||
94227907|NCT00381888|322629047|FG000|Overall Study|Protocol Violation|9|||
94227908|NCT00381888|322629047|FG000|Overall Study|Had laparoscopic surgery|2|||
94227909|NCT00381888|322629047|FG000|Overall Study|Surgery was cancelled|2|||
94227910|NCT00381888|322629047|FG000|Overall Study|Adverse Event|1|||
94227911|NCT01171183|322629048|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
94343415|NCT02574520|323036070|FG001|Overall Study|Withdrawal by Subject|0|||
94343416|NCT02574520|323036071|FG002|Overall Study|Withdrawal by Subject|0|||
94343417|NCT02574520|323036072|FG003|Overall Study|Withdrawal by Subject|1|||
94343418|NCT02574520|323036069|FG000|Overall Study|Other|0|||
94343419|NCT02574520|323036070|FG001|Overall Study|Other|0|||
94227912|NCT01171183|322629049|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
94227913|NCT01171183|322629048|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
94227914|NCT01171183|322629049|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
94227915|NCT01171183|322629048|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
94343420|NCT02574520|323036071|FG002|Overall Study|Other|0|||
94343421|NCT02574520|323036072|FG003|Overall Study|Other|2|||
94227916|NCT01171183|322629049|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
94227917|NCT01171183|322629048|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
94227918|NCT01171183|322629049|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
94343422|NCT01435122|323036083|FG000|Overall Study|Early withdrawal due to toxicity|8|||
94553193|NCT00211887|323820826|FG001|Overall Study|Non-medical reason|14|||
94553194|NCT00211887|323820827|FG002|Overall Study|Non-medical reason|8|||
94553195|NCT00211887|323820825|FG000|Overall Study|Other medical reason|15|||
94553196|NCT00211887|323820826|FG001|Overall Study|Other medical reason|11|||
94553197|NCT00211887|323820827|FG002|Overall Study|Other medical reason|7|||
94553198|NCT00211887|323820825|FG000|Overall Study|Side effects|19|||
94553199|NCT00211887|323820826|FG001|Overall Study|Side effects|13|||
94553200|NCT00211887|323820827|FG002|Overall Study|Side effects|5|||
94553201|NCT00358436|323822801|FG000|Overall Study|Adverse Event|29|||
94553202|NCT00358436|323822802|FG001|Overall Study|Adverse Event|13|||
94553203|NCT00358436|323822801|FG000|Overall Study|Lack of Efficacy|34|||
94553204|NCT00358436|323822802|FG001|Overall Study|Lack of Efficacy|36|||
94553205|NCT00358436|323822801|FG000|Overall Study|Lost to Follow-up|11|||
94553206|NCT00358436|323822802|FG001|Overall Study|Lost to Follow-up|6|||
94553207|NCT00358436|323822801|FG000|Overall Study|Protocol Violation|8|||
94553208|NCT00358436|323822802|FG001|Overall Study|Protocol Violation|3|||
94553209|NCT00358436|323822801|FG000|Overall Study|Withdrawal by Subject|40|||
94553210|NCT00358436|323822802|FG001|Overall Study|Withdrawal by Subject|17|||
94553211|NCT00358436|323822801|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
94553212|NCT00358436|323822802|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
94553213|NCT00358436|323822801|FG000|Overall Study|COPD exacerbation|22|||
94553214|NCT00358436|323822802|FG001|Overall Study|COPD exacerbation|10|||
94553215|NCT00358436|323822801|FG000|Overall Study|Other|6|||
94553216|NCT00358436|323822802|FG001|Overall Study|Other|1|||
94553217|NCT04327024|323822803|FG000|Overall Study|Death|1|||
94553218|NCT04327024|323822804|FG001|Overall Study|Death|2|||
94553219|NCT04327024|323822805|FG002|Overall Study|Death|1|||
94553220|NCT04327024|323822803|FG000|Overall Study|Non-compliance with study drug|0|||
94553221|NCT04327024|323822804|FG001|Overall Study|Non-compliance with study drug|1|||
94553222|NCT04327024|323822805|FG002|Overall Study|Non-compliance with study drug|0|||
94553223|NCT04327024|323822803|FG000|Overall Study|Withdrawal by Subject|1|||
94553224|NCT04327024|323822804|FG001|Overall Study|Withdrawal by Subject|1|||
94553225|NCT04327024|323822805|FG002|Overall Study|Withdrawal by Subject|2|||
94553226|NCT03416127|323822813|FG000|Overall Study|Withdrawal by Subject|0|||
94553227|NCT03416127|323822814|FG001|Overall Study|Withdrawal by Subject|1|||
94553228|NCT03416127|323822815|FG002|Overall Study|Withdrawal by Subject|1|||
94553229|NCT00567359|323822816|FG000|Overall Study|Withdrawal by Subject|1|||
94553230|NCT00599755|323822817|FG000|Overall Study|Adverse Event|11|||
94553231|NCT00599755|323822817|FG000|Overall Study|Withdrawal by Subject|2|||
94553232|NCT00599755|323822817|FG000|Overall Study|Progression of Disease|3|||
94553233|NCT00599755|323822817|FG000|Overall Study|Other Reason|2|||
94553234|NCT00599755|323822817|FG000|Overall Study|No data available|1|||
94553235|NCT01023672|323822830|FG000|Overall Study|Worsening disease|2|||
94553236|NCT01023672|323822830|FG000|Overall Study|Death|1|||
94553237|NCT00372697|323822831|FG000|Overall Study|Protocol Violation|1|||
94553238|NCT00372697|323822832|FG001|Overall Study|Protocol Violation|1|||
94553239|NCT03221842|323822833|FG000|Period 1 (Open-label)|Adverse Event|4|||
94553240|NCT03221842|323822834|FG001|Period 1 (Open-label)|Adverse Event|0|||
94553241|NCT03221842|323822833|FG000|Period 1 (Open-label)|Physician Decision|2|||
94553242|NCT03221842|323822834|FG001|Period 1 (Open-label)|Physician Decision|0|||
94553243|NCT03221842|323822833|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
94553244|NCT03221842|323822834|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
94553245|NCT03221842|323822833|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
94553246|NCT03221842|323822834|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
94553247|NCT03221842|323822833|FG000|Period 1 (Open-label)|Other|2|||
94553248|NCT03221842|323822834|FG001|Period 1 (Open-label)|Other|0|||
94553249|NCT03221842|323822833|FG000|Period 2 (Randomized, Blinded)|Death|0|||
94553250|NCT03221842|323822834|FG001|Period 2 (Randomized, Blinded)|Death|1|||
94553251|NCT03221842|323822833|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
94553252|NCT03221842|323822834|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
94553253|NCT00448747|323822835|FG000|Overall Study|collapsed veins|1|||
94553254|NCT00448747|323822836|FG001|Overall Study|collapsed veins|0|||
94553255|NCT00704288|323822837|FG000|Overall Treatment Period|Adverse Event|11|||
94553256|NCT00704288|323822838|FG001|Overall Treatment Period|Adverse Event|8|||
94553257|NCT00704288|323822839|FG002|Overall Treatment Period|Adverse Event|22|||
94553258|NCT00704288|323822837|FG000|Overall Treatment Period|Death|0|||
94553259|NCT00704288|323822838|FG001|Overall Treatment Period|Death|0|||
94553260|NCT00704288|323822839|FG002|Overall Treatment Period|Death|1|||
94553261|NCT00704288|323822837|FG000|Overall Treatment Period|Physician Decision|0|||
94553262|NCT00704288|323822838|FG001|Overall Treatment Period|Physician Decision|2|||
94553263|NCT00704288|323822839|FG002|Overall Treatment Period|Physician Decision|0|||
94553264|NCT00704288|323822837|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
94553265|NCT00704288|323822838|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
94553266|NCT00704288|323822839|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
94553267|NCT00704288|323822837|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
94553268|NCT00704288|323822838|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
94553269|NCT00704288|323822839|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
94553270|NCT00704288|323822837|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
94553271|NCT00704288|323822838|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
94553272|NCT00704288|323822839|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
94553273|NCT00704288|323822837|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
94553274|NCT00704288|323822838|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
94553275|NCT00704288|323822839|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
94553276|NCT00704288|323822837|FG000|Overall Treatment Period|Roll-over to another study|1|||
94553277|NCT00704288|323822838|FG001|Overall Treatment Period|Roll-over to another study|0|||
94553278|NCT00704288|323822839|FG002|Overall Treatment Period|Roll-over to another study|4|||
94553279|NCT00704288|323822837|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
94553280|NCT00704288|323822838|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
94553281|NCT00704288|323822839|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
94553282|NCT00704288|323822837|FG000|Extended Post Treatment Follow Up Period|Death|41|||
94553283|NCT00704288|323822838|FG001|Extended Post Treatment Follow Up Period|Death|50|||
94553284|NCT00704288|323822839|FG002|Extended Post Treatment Follow Up Period|Death|93|||
94553285|NCT00704288|323822837|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
94553286|NCT00704288|323822838|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
94553287|NCT00704288|323822839|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
94553288|NCT00704288|323822837|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
94553289|NCT00704288|323822838|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
94553290|NCT00704288|323822839|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
94553291|NCT00704288|323822837|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
94553292|NCT00704288|323822838|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
94553293|NCT00704288|323822839|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
94553294|NCT01055314|323822840|FG000|Overall Study|Adverse Event|7|||
94553295|NCT01055314|323822841|FG001|Overall Study|Adverse Event|4|||
94553296|NCT01055314|323822840|FG000|Overall Study|Death|2|||
94553297|NCT01055314|323822841|FG001|Overall Study|Death|1|||
94553298|NCT01055314|323822840|FG000|Overall Study|Lack of Efficacy|11|||
94553299|NCT01055314|323822841|FG001|Overall Study|Lack of Efficacy|19|||
94553300|NCT01055314|323822840|FG000|Overall Study|Physician Decision|10|||
94553301|NCT01055314|323822841|FG001|Overall Study|Physician Decision|5|||
94553302|NCT01055314|323822840|FG000|Overall Study|Withdrawal by Subject|1|||
94553303|NCT01055314|323822841|FG001|Overall Study|Withdrawal by Subject|0|||
94553304|NCT01055314|323822840|FG000|Overall Study|Ineligible|3|||
94553305|NCT01055314|323822841|FG001|Overall Study|Ineligible|5|||
94553306|NCT01055314|323822840|FG000|Overall Study|Refusal of further protocol therapy|10|||
94553307|NCT01055314|323822841|FG001|Overall Study|Refusal of further protocol therapy|4|||
94553308|NCT01055314|323822840|FG000|Overall Study|No treatment|1|||
94553309|NCT01055314|323822841|FG001|Overall Study|No treatment|0|||
94553310|NCT04395690|323822842|FG000|Overall Study|Lost to Follow-up|1|||
94553311|NCT04395690|323822843|FG001|Overall Study|Lost to Follow-up|1|||
94553312|NCT02462720|323822844|FG000|Part 2|Withdrawal by Subject|1|||
94553313|NCT02462720|323822845|FG001|Part 2|Withdrawal by Subject|0|||
94553314|NCT02462720|323822844|FG000|Part 2|Protocol Violation|0|||
94553315|NCT02462720|323822845|FG001|Part 2|Protocol Violation|1|||
94553316|NCT00527982|323822848|FG000|Overall Study|Physician Decision|1|||
94553317|NCT00527982|323822849|FG001|Overall Study|Physician Decision|0|||
94553318|NCT03270891|323822852|FG000|Overall Study|Lost to Follow-up|3|||
94553319|NCT03270891|323822853|FG001|Overall Study|Lost to Follow-up|6|||
94553320|NCT03270891|323822854|FG002|Overall Study|Lost to Follow-up|0|||
94553321|NCT03270891|323822852|FG000|Overall Study|Withdrawal by Subject|1|||
94553322|NCT03270891|323822853|FG001|Overall Study|Withdrawal by Subject|0|||
94553323|NCT03270891|323822854|FG002|Overall Study|Withdrawal by Subject|0|||
94553324|NCT03270891|323822852|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
94553325|NCT03270891|323822853|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
94553326|NCT03270891|323822854|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
94553327|NCT04071158|323822855|FG000|Overall Study|Lost to Follow-up|1|||
94553328|NCT04071158|323822856|FG001|Overall Study|Lost to Follow-up|2|||
94553329|NCT04071158|323822857|FG002|Overall Study|Lost to Follow-up|3|||
94553330|NCT04071158|323822858|FG003|Overall Study|Lost to Follow-up|3|||
94553331|NCT04071158|323822859|FG004|Overall Study|Lost to Follow-up|5|||
94553332|NCT04071158|323822855|FG000|Overall Study|Randomized but not treated|2|||
94553333|NCT04071158|323822856|FG001|Overall Study|Randomized but not treated|2|||
94553334|NCT04071158|323822857|FG002|Overall Study|Randomized but not treated|0|||
94553335|NCT04071158|323822858|FG003|Overall Study|Randomized but not treated|0|||
94553336|NCT04071158|323822859|FG004|Overall Study|Randomized but not treated|0|||
94553337|NCT01966445|323822860|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
94553338|NCT01966445|323822861|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
94553339|NCT01966445|323822862|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
94553340|NCT01966445|323822863|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
94553341|NCT01966445|323822864|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
94553342|NCT01966445|323822865|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
94553343|NCT01966445|323822866|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
94553344|NCT01966445|323822860|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
94553345|NCT01966445|323822861|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
94553346|NCT01966445|323822862|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
94553347|NCT01966445|323822863|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
94553348|NCT01966445|323822864|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
94553349|NCT01966445|323822865|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
94553350|NCT01966445|323822866|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
94227919|NCT01171183|322629048|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
94227920|NCT01171183|322629049|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
94227921|NCT01171183|322629048|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
94227922|NCT01171183|322629049|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
94227923|NCT02517528|322629062|FG000|Overall Study|Withdrawal by Subject|1|||
94227924|NCT01093599|322629065|FG000|Overall Study|Lost to Follow-up|32|||
94227925|NCT01093599|322629066|FG001|Overall Study|Lost to Follow-up|46|||
94227926|NCT01703845|322629067|FG000|Overall Study|Adverse Event|1|||
94227927|NCT01703845|322629068|FG001|Overall Study|Adverse Event|0|||
94227928|NCT01703845|322629067|FG000|Overall Study|Protocol Violation|1|||
94227929|NCT01703845|322629068|FG001|Overall Study|Protocol Violation|0|||
94227930|NCT01703845|322629067|FG000|Overall Study|other than stated above|1|||
94227931|NCT01703845|322629068|FG001|Overall Study|other than stated above|0|||
94227932|NCT00684203|322629069|FG000|Overall Study|Adverse Event|6|||
94227933|NCT00684203|322629070|FG001|Overall Study|Adverse Event|4|||
94227934|NCT00684203|322629071|FG002|Overall Study|Adverse Event|8|||
94227935|NCT00684203|322629072|FG003|Overall Study|Adverse Event|0|||
94227936|NCT00684203|322629073|FG004|Overall Study|Adverse Event|0|||
94227937|NCT00684203|322629074|FG005|Overall Study|Adverse Event|0|||
94227938|NCT00684203|322629069|FG000|Overall Study|Protocol-defined clinical event|3|||
94227939|NCT00684203|322629070|FG001|Overall Study|Protocol-defined clinical event|1|||
94227940|NCT00684203|322629071|FG002|Overall Study|Protocol-defined clinical event|0|||
94227941|NCT00684203|322629072|FG003|Overall Study|Protocol-defined clinical event|0|||
94227942|NCT00684203|322629073|FG004|Overall Study|Protocol-defined clinical event|0|||
94227943|NCT00684203|322629074|FG005|Overall Study|Protocol-defined clinical event|0|||
94227944|NCT00684203|322629069|FG000|Overall Study|Withdrawal by Subject|0|||
94227945|NCT00684203|322629070|FG001|Overall Study|Withdrawal by Subject|2|||
94227946|NCT00684203|322629071|FG002|Overall Study|Withdrawal by Subject|1|||
94227947|NCT00684203|322629072|FG003|Overall Study|Withdrawal by Subject|0|||
94227948|NCT00684203|322629073|FG004|Overall Study|Withdrawal by Subject|0|||
94227949|NCT00684203|322629074|FG005|Overall Study|Withdrawal by Subject|0|||
94227950|NCT00684203|322629069|FG000|Overall Study|Did not meet protocol eligibility|0|||
94227951|NCT00684203|322629070|FG001|Overall Study|Did not meet protocol eligibility|1|||
94227952|NCT00684203|322629071|FG002|Overall Study|Did not meet protocol eligibility|0|||
94227953|NCT00684203|322629072|FG003|Overall Study|Did not meet protocol eligibility|0|||
94227954|NCT00684203|322629073|FG004|Overall Study|Did not meet protocol eligibility|0|||
94553351|NCT01966445|323822860|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
94553352|NCT01966445|323822861|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
94553353|NCT01966445|323822862|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
94553354|NCT01966445|323822863|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
94553355|NCT01966445|323822864|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
94227955|NCT00684203|322629074|FG005|Overall Study|Did not meet protocol eligibility|0|||
94227956|NCT01547117|322629075|FG000|Overall Study|Physician Decision|0|||
94227957|NCT01547117|322629076|FG001|Overall Study|Physician Decision|1|||
94227958|NCT01547117|322629077|FG002|Overall Study|Physician Decision|1|||
94227959|NCT01547117|322629078|FG003|Overall Study|Physician Decision|3|||
94227960|NCT01547117|322629075|FG000|Overall Study|Withdrawal by Subject|1|||
94227961|NCT01547117|322629076|FG001|Overall Study|Withdrawal by Subject|2|||
94227962|NCT01547117|322629077|FG002|Overall Study|Withdrawal by Subject|1|||
94227963|NCT01547117|322629078|FG003|Overall Study|Withdrawal by Subject|2|||
94227964|NCT01850823|322629079|FG000|Overall Study|Early Visit Window|0|||
94227965|NCT01850823|322629080|FG001|Overall Study|Early Visit Window|1|||
94227966|NCT01850823|322629081|FG002|Overall Study|Early Visit Window|4|||
94227967|NCT01850823|322629079|FG000|Overall Study|Enrolled in Error|0|||
94227968|NCT01850823|322629080|FG001|Overall Study|Enrolled in Error|1|||
94227969|NCT01850823|322629081|FG002|Overall Study|Enrolled in Error|2|||
94227970|NCT01850823|322629079|FG000|Overall Study|Lack of Efficacy|1|||
94227971|NCT01850823|322629080|FG001|Overall Study|Lack of Efficacy|0|||
94227972|NCT01850823|322629081|FG002|Overall Study|Lack of Efficacy|0|||
94227973|NCT01850823|322629079|FG000|Overall Study|Lost to Follow-up|0|||
94227974|NCT01850823|322629080|FG001|Overall Study|Lost to Follow-up|0|||
94227975|NCT01850823|322629081|FG002|Overall Study|Lost to Follow-up|1|||
94227976|NCT01850823|322629079|FG000|Overall Study|Restricted Medication|0|||
94227977|NCT01850823|322629080|FG001|Overall Study|Restricted Medication|0|||
94227978|NCT01850823|322629081|FG002|Overall Study|Restricted Medication|2|||
94227979|NCT01850823|322629079|FG000|Overall Study|Significant worstening of SAR|0|||
94446210|NCT00838903|323419262|FG001|Follow-up Period (8 Weeks)|Missing|2|||
94446211|NCT00838903|323419263|FG002|Follow-up Period (8 Weeks)|Missing|1|||
94446212|NCT00838903|323419264|FG003|Follow-up Period (8 Weeks)|Missing|1|||
94446213|NCT00536939|323419265|FG000|Overall Study|Withdrawal by Subject|1|||
94446214|NCT00536939|323419266|FG001|Overall Study|Withdrawal by Subject|0|||
94446215|NCT00536939|323419265|FG000|Overall Study|Other Complicating Disease|1|||
94446216|NCT00536939|323419266|FG001|Overall Study|Other Complicating Disease|0|||
94446217|NCT01930162|323419269|FG000|Overall Study|Abnormal test procedure result(s)|4|||
94446218|NCT01930162|323419269|FG000|Overall Study|Death|1|||
94446219|NCT00712712|323419270|FG000|Overall Study|Protocol Violation|11|||
94446220|NCT00712712|323419270|FG000|Overall Study|Radiofrequency not done|3|||
94446221|NCT00712712|323419270|FG000|Overall Study|Death|8|||
94446222|NCT00712712|323419270|FG000|Overall Study|Withdrawal by Subject|1|||
94446223|NCT03809663|323419276|FG000|Overall Study|Decision by sponsor|24|||
94446224|NCT03809663|323419277|FG001|Overall Study|Decision by sponsor|18|||
94446225|NCT03809663|323419278|FG002|Overall Study|Decision by sponsor|20|||
94446226|NCT03809663|323419279|FG003|Overall Study|Decision by sponsor|20|||
94446227|NCT03809663|323419280|FG004|Overall Study|Decision by sponsor|0|||
94446228|NCT03809663|323419281|FG005|Overall Study|Decision by sponsor|0|||
94446229|NCT03809663|323419276|FG000|Overall Study|Withdrawal by Subject|26|||
94446230|NCT03809663|323419277|FG001|Overall Study|Withdrawal by Subject|22|||
94446231|NCT03809663|323419278|FG002|Overall Study|Withdrawal by Subject|27|||
94446232|NCT03809663|323419279|FG003|Overall Study|Withdrawal by Subject|26|||
94446233|NCT03809663|323419280|FG004|Overall Study|Withdrawal by Subject|0|||
94446234|NCT03809663|323419281|FG005|Overall Study|Withdrawal by Subject|0|||
94446235|NCT03809663|323419276|FG000|Overall Study|Lost to Follow-up|1|||
94446236|NCT03809663|323419277|FG001|Overall Study|Lost to Follow-up|4|||
94446237|NCT03809663|323419278|FG002|Overall Study|Lost to Follow-up|1|||
94446238|NCT03809663|323419279|FG003|Overall Study|Lost to Follow-up|1|||
94446239|NCT03809663|323419280|FG004|Overall Study|Lost to Follow-up|0|||
94446240|NCT03809663|323419281|FG005|Overall Study|Lost to Follow-up|0|||
94446241|NCT00630825|323419290|FG000|Overall Study|Adverse Event|4|||
94446242|NCT00630825|323419291|FG001|Overall Study|Adverse Event|4|||
94446243|NCT00630825|323419292|FG002|Overall Study|Adverse Event|3|||
94446244|NCT00630825|323419293|FG003|Overall Study|Adverse Event|1|||
94446245|NCT00630825|323419290|FG000|Overall Study|Entry Criteria Not Met|1|||
94446246|NCT00630825|323419291|FG001|Overall Study|Entry Criteria Not Met|0|||
94446247|NCT00630825|323419292|FG002|Overall Study|Entry Criteria Not Met|2|||
94446248|NCT00630825|323419293|FG003|Overall Study|Entry Criteria Not Met|1|||
94446249|NCT00630825|323419290|FG000|Overall Study|Lost to Follow-up|1|||
94446250|NCT00630825|323419291|FG001|Overall Study|Lost to Follow-up|1|||
94446251|NCT00630825|323419292|FG002|Overall Study|Lost to Follow-up|1|||
94446252|NCT00630825|323419293|FG003|Overall Study|Lost to Follow-up|1|||
94446253|NCT00630825|323419290|FG000|Overall Study|Physician Decision|1|||
94446254|NCT00630825|323419291|FG001|Overall Study|Physician Decision|0|||
94446255|NCT00630825|323419292|FG002|Overall Study|Physician Decision|0|||
94446256|NCT00630825|323419293|FG003|Overall Study|Physician Decision|0|||
94227980|NCT01850823|322629080|FG001|Overall Study|Significant worstening of SAR|1|||
94227981|NCT01850823|322629081|FG002|Overall Study|Significant worstening of SAR|0|||
94227982|NCT01850823|322629079|FG000|Overall Study|Withdrawal by Subject|2|||
94227983|NCT01850823|322629080|FG001|Overall Study|Withdrawal by Subject|0|||
94446257|NCT00630825|323419290|FG000|Overall Study|Withdrawal by Subject|2|||
94446258|NCT00630825|323419291|FG001|Overall Study|Withdrawal by Subject|2|||
94343423|NCT00683774|323036086|FG000|Overall Study|Withdrawal by Subject|0|||
94553356|NCT01966445|323822865|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
94553357|NCT01966445|323822866|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
94553358|NCT01966445|323822860|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
94553359|NCT01966445|323822861|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
94553360|NCT01966445|323822862|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
94553361|NCT01966445|323822863|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
94553362|NCT01966445|323822864|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
94553363|NCT01966445|323822865|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
94553364|NCT01966445|323822866|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
94553365|NCT01966445|323822860|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
94553366|NCT01966445|323822861|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
94553367|NCT01966445|323822862|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
94553368|NCT01966445|323822863|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
94553369|NCT01966445|323822864|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
94553370|NCT01966445|323822865|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
94553371|NCT01966445|323822866|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
94553372|NCT01374178|323822867|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
94553373|NCT01374178|323822868|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
94553374|NCT01374178|323822867|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
94553375|NCT01374178|323822868|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
94553376|NCT02760810|323822869|FG000|Overall Study|Protocol Violation|1|||
94553377|NCT00470418|323822870|FG000|Overall Study|Withdrawal by Subject|1|||
94553378|NCT00470418|323822871|FG001|Overall Study|Withdrawal by Subject|0|||
94553379|NCT03615066|323822872|FG000|Main Study|Withdrew Consent|0|||
94553380|NCT03615066|323822873|FG001|Main Study|Withdrew Consent|1|||
94553381|NCT03615066|323822874|FG002|Main Study|Withdrew Consent|1|||
94553382|NCT03615066|323822872|FG000|Main Study|Lost to Follow-up|0|||
94553383|NCT03615066|323822873|FG001|Main Study|Lost to Follow-up|0|||
94553384|NCT03615066|323822874|FG002|Main Study|Lost to Follow-up|1|||
94553385|NCT03615066|323822872|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
94553386|NCT03615066|323822873|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
94553387|NCT03615066|323822874|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
94553388|NCT03615066|323822872|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
94553389|NCT03615066|323822873|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
94553390|NCT03615066|323822874|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
94553391|NCT03615066|323822872|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
94553392|NCT03615066|323822873|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
94553393|NCT03615066|323822874|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
94553394|NCT00109577|323822875|FG000|Overall Study|Withdrawal by Subject|3|||
94553395|NCT00109577|323822876|FG001|Overall Study|Withdrawal by Subject|3|||
94553396|NCT02479139|323822880|FG000|Overall Study|Lost to Follow-up|2|||
94553397|NCT02479139|323822881|FG001|Overall Study|Lost to Follow-up|4|||
94553398|NCT02479139|323822882|FG002|Overall Study|Lost to Follow-up|4|||
94553399|NCT02479139|323822883|FG003|Overall Study|Lost to Follow-up|2|||
94553400|NCT02479139|323822884|FG004|Overall Study|Lost to Follow-up|3|||
94553401|NCT02479139|323822885|FG005|Overall Study|Lost to Follow-up|5|||
94553402|NCT02479139|323822880|FG000|Overall Study|Withdrew Consent|5|||
94553403|NCT02479139|323822881|FG001|Overall Study|Withdrew Consent|6|||
94553404|NCT02479139|323822882|FG002|Overall Study|Withdrew Consent|1|||
94553405|NCT02479139|323822883|FG003|Overall Study|Withdrew Consent|4|||
94343424|NCT00683774|323036087|FG001|Overall Study|Withdrawal by Subject|1|||
94343425|NCT00683774|323036086|FG000|Overall Study|Physician Decision|3|||
94343426|NCT00683774|323036087|FG001|Overall Study|Physician Decision|0|||
94343427|NCT01868594|323036088|FG000|Overall Study|Do not meet inclusion criteria|4|||
94343428|NCT01868594|323036089|FG001|Overall Study|Do not meet inclusion criteria|3|||
94343429|NCT00636155|323037701|FG000|Overall Study|Adverse Event|8|||
94343430|NCT00636155|323037701|FG000|Overall Study|Lack of Efficacy|1|||
94343431|NCT00636155|323037701|FG000|Overall Study|Withdrawal by Subject|3|||
94343432|NCT00636155|323037701|FG000|Overall Study|Stem cell transplant|1|||
94553406|NCT02479139|323822884|FG004|Overall Study|Withdrew Consent|1|||
94553407|NCT02479139|323822885|FG005|Overall Study|Withdrew Consent|1|||
94553408|NCT02479139|323822880|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
94553409|NCT02479139|323822881|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
94553410|NCT02479139|323822882|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
94553411|NCT02479139|323822883|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
94553412|NCT02479139|323822884|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
94553413|NCT02479139|323822885|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
94553414|NCT02479139|323822880|FG000|Overall Study|Other Miscellaneous Reasons|1|||
94553415|NCT02479139|323822881|FG001|Overall Study|Other Miscellaneous Reasons|0|||
94553416|NCT02479139|323822882|FG002|Overall Study|Other Miscellaneous Reasons|1|||
94553417|NCT02479139|323822883|FG003|Overall Study|Other Miscellaneous Reasons|1|||
94553418|NCT02479139|323822884|FG004|Overall Study|Other Miscellaneous Reasons|1|||
94553419|NCT02479139|323822885|FG005|Overall Study|Other Miscellaneous Reasons|0|||
94553420|NCT00619099|323822886|FG000|Overall Study|Progressive Disease|7|||
94553421|NCT00619099|323822887|FG001|Overall Study|Progressive Disease|5|||
94553422|NCT00619099|323822886|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
94553423|NCT00619099|323822887|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
94553424|NCT00619099|323822886|FG000|Overall Study|Adverse Event|4|||
94553425|NCT00619099|323822887|FG001|Overall Study|Adverse Event|3|||
94553426|NCT00619099|323822886|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
94553427|NCT00619099|323822887|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
94553428|NCT00619099|323822886|FG000|Overall Study|Withdrawal by Subject|10|||
94553429|NCT00619099|323822887|FG001|Overall Study|Withdrawal by Subject|2|||
94553430|NCT00619099|323822886|FG000|Overall Study|Physician Decision|9|||
94553431|NCT00619099|323822887|FG001|Overall Study|Physician Decision|6|||
94553432|NCT00885482|323822888|FG000|Overall Study|Pregnancy|1|||
94553433|NCT00885482|323822888|FG000|Overall Study|Lack of Efficacy|1|||
94553434|NCT00885482|323822888|FG000|Overall Study|Death|1|||
94553435|NCT00885482|323822888|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
94553436|NCT00778895|323822891|FG000|Active Phase|Adverse Event|3|||
94553437|NCT00778895|323822892|FG001|Active Phase|Adverse Event|1|||
94553438|NCT00778895|323822893|FG002|Active Phase|Adverse Event|0|||
94553439|NCT00778895|323822891|FG000|Active Phase|Withdrawal by Subject|1|||
94553440|NCT00778895|323822892|FG001|Active Phase|Withdrawal by Subject|4|||
94553441|NCT00778895|323822893|FG002|Active Phase|Withdrawal by Subject|0|||
94553442|NCT00778895|323822891|FG000|Active Phase|Lost to Follow-up|1|||
94553443|NCT00778895|323822892|FG001|Active Phase|Lost to Follow-up|1|||
94553444|NCT00778895|323822893|FG002|Active Phase|Lost to Follow-up|0|||
94553445|NCT00778895|323822891|FG000|Active Phase|Other|2|||
94553446|NCT00778895|323822892|FG001|Active Phase|Other|0|||
94553447|NCT00778895|323822893|FG002|Active Phase|Other|0|||
94553448|NCT00778895|323822891|FG000|ESFU Phase|Adverse Event|2|||
94553449|NCT00778895|323822892|FG001|ESFU Phase|Adverse Event|1|||
94553450|NCT00778895|323822893|FG002|ESFU Phase|Adverse Event|0|||
94553451|NCT00778895|323822891|FG000|ESFU Phase|Withdrawal by Subject|1|||
94553452|NCT00778895|323822892|FG001|ESFU Phase|Withdrawal by Subject|4|||
94553453|NCT00778895|323822893|FG002|ESFU Phase|Withdrawal by Subject|0|||
94553454|NCT00778895|323822891|FG000|ESFU Phase|Lost to Follow-up|6|||
94553455|NCT00778895|323822892|FG001|ESFU Phase|Lost to Follow-up|7|||
94553456|NCT00778895|323822893|FG002|ESFU Phase|Lost to Follow-up|2|||
94553457|NCT00778895|323822891|FG000|ESFU Phase|Other|2|||
94553458|NCT00778895|323822892|FG001|ESFU Phase|Other|0|||
94553459|NCT00778895|323822893|FG002|ESFU Phase|Other|0|||
94553460|NCT03517566|323822894|FG000|Overall Study|Adverse Event|5|||
94553461|NCT03517566|323822895|FG001|Overall Study|Adverse Event|2|||
94553462|NCT03517566|323822896|FG002|Overall Study|Adverse Event|2|||
94553463|NCT03517566|323822897|FG003|Overall Study|Adverse Event|8|||
94553464|NCT03517566|323822898|FG004|Overall Study|Adverse Event|7|||
94553465|NCT03517566|323822894|FG000|Overall Study|Lack of Efficacy|3|||
94553466|NCT03517566|323822895|FG001|Overall Study|Lack of Efficacy|2|||
94227984|NCT01850823|322629081|FG002|Overall Study|Withdrawal by Subject|1|||
94227985|NCT00988533|322629082|FG000|Overall Study|Lost to Follow-up|3|||
94227986|NCT00805285|322629084|FG000|Overall Study|Lack of Efficacy|1|||
94227987|NCT00858247|322629087|FG000|Baseline Assessment|Withdrawal by Subject|1|||
94553467|NCT03517566|323822896|FG002|Overall Study|Lack of Efficacy|1|||
94553468|NCT03517566|323822897|FG003|Overall Study|Lack of Efficacy|1|||
94553469|NCT03517566|323822898|FG004|Overall Study|Lack of Efficacy|4|||
94553470|NCT03517566|323822894|FG000|Overall Study|Lost to Follow-up|3|||
94553471|NCT03517566|323822895|FG001|Overall Study|Lost to Follow-up|1|||
94553472|NCT03517566|323822896|FG002|Overall Study|Lost to Follow-up|1|||
94553473|NCT03517566|323822897|FG003|Overall Study|Lost to Follow-up|1|||
94553474|NCT03517566|323822898|FG004|Overall Study|Lost to Follow-up|0|||
94553475|NCT03517566|323822894|FG000|Overall Study|Physician Decision|1|||
94553476|NCT03517566|323822895|FG001|Overall Study|Physician Decision|1|||
94553477|NCT03517566|323822896|FG002|Overall Study|Physician Decision|0|||
94227988|NCT00858247|322629088|FG001|Baseline Assessment|Withdrawal by Subject|1|||
94553478|NCT03517566|323822897|FG003|Overall Study|Physician Decision|1|||
94553479|NCT03517566|323822898|FG004|Overall Study|Physician Decision|0|||
94227989|NCT00858247|322629087|FG000|Baseline Assessment|Poor IV access|1|||
94227990|NCT00858247|322629088|FG001|Baseline Assessment|Poor IV access|0|||
94227991|NCT00858247|322629087|FG000|Baseline Assessment|Protocol Violation|0|||
94227992|NCT00858247|322629088|FG001|Baseline Assessment|Protocol Violation|1|||
94227993|NCT00858247|322629087|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
94227994|NCT00858247|322629088|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
94227995|NCT00553605|322629089|FG000|Overall Study|Did not meet entrance criteria|1|||
94227996|NCT00553605|322629090|FG001|Overall Study|Did not meet entrance criteria|3|||
94227997|NCT00553605|322629089|FG000|Overall Study|Did not receive full dose|1|||
94227998|NCT00553605|322629090|FG001|Overall Study|Did not receive full dose|0|||
94227999|NCT00553605|322629089|FG000|Overall Study|Randomized but not treated|2|||
94228000|NCT00553605|322629090|FG001|Overall Study|Randomized but not treated|0|||
94228001|NCT04191148|322629096|FG000|Overall Study|Withdrawal by Subject|1|||
94228002|NCT04191148|322629097|FG001|Overall Study|Withdrawal by Subject|0|||
94228003|NCT04191148|322629096|FG000|Overall Study|Adverse Event|1|||
94228004|NCT04191148|322629097|FG001|Overall Study|Adverse Event|0|||
94228005|NCT01874665|322629098|FG000|Overall Study|Adverse Event|6|||
94228006|NCT01874665|322629099|FG001|Overall Study|Adverse Event|2|||
94228007|NCT01874665|322629098|FG000|Overall Study|Withdrawal by Subject|4|||
94228008|NCT01874665|322629099|FG001|Overall Study|Withdrawal by Subject|1|||
94228009|NCT01874665|322629098|FG000|Overall Study|Physician Decision|3|||
94228010|NCT01874665|322629099|FG001|Overall Study|Physician Decision|0|||
94228011|NCT01874665|322629098|FG000|Overall Study|Clinical Progressive Disease|4|||
94228012|NCT01874665|322629099|FG001|Overall Study|Clinical Progressive Disease|3|||
94228013|NCT01874665|322629098|FG000|Overall Study|Study Terminated by Sponsor|0|||
94228014|NCT01874665|322629099|FG001|Overall Study|Study Terminated by Sponsor|2|||
94228015|NCT01874665|322629098|FG000|Overall Study|Documented Progressive Disease|11|||
94228016|NCT01874665|322629099|FG001|Overall Study|Documented Progressive Disease|7|||
94228017|NCT01874665|322629098|FG000|Overall Study|Other|2|||
94228018|NCT01874665|322629099|FG001|Overall Study|Other|0|||
94228019|NCT00591409|322629102|FG000|Overall Study|Not Treated|0|||
94228020|NCT00591409|322629103|FG001|Overall Study|Not Treated|0|||
94228021|NCT00591409|322629104|FG002|Overall Study|Not Treated|0|||
94228022|NCT00591409|322629105|FG003|Overall Study|Not Treated|0|||
94228023|NCT00591409|322629106|FG004|Overall Study|Not Treated|1|||
94228024|NCT00591409|322629107|FG005|Overall Study|Not Treated|0|||
94228025|NCT00591409|322629108|FG006|Overall Study|Not Treated|0|||
94228026|NCT00591409|322629109|FG007|Overall Study|Not Treated|0|||
94228027|NCT00591409|322629110|FG008|Overall Study|Not Treated|0|||
94228028|NCT00591409|322629111|FG009|Overall Study|Not Treated|1|||
94228029|NCT00853229|322629114|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
94228030|NCT00853229|322629115|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
94228031|NCT04772313|322629116|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
94228032|NCT04772313|322629116|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
94228033|NCT02460562|322629117|FG000|Overall Study|Lost to Follow-up|15|||
94228034|NCT02460562|322629118|FG001|Overall Study|Lost to Follow-up|16|||
94228035|NCT03723915|322629126|FG000|Screening|Failed to meet screening requirements.|2|||
94228036|NCT03723915|322629126|FG000|On Treatment|Failed to meet treatment requirements|2|||
94228037|NCT02287883|322629127|FG000|Overall Study|Death|8|||
94228038|NCT02287883|322629128|FG001|Overall Study|Death|7|||
94228039|NCT02287883|322629127|FG000|Overall Study|No longer eligible|222|||
94228040|NCT02287883|322629128|FG001|Overall Study|No longer eligible|182|||
94228041|NCT02287883|322629127|FG000|Overall Study|Non-response to survey|229|||
94228042|NCT02287883|322629128|FG001|Overall Study|Non-response to survey|237|||
94228043|NCT01187407|322629136|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
94228044|NCT01187407|322629137|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
94228045|NCT01187407|322629138|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
94228046|NCT01187407|322629139|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
94228047|NCT01187407|322629140|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
94228048|NCT01187407|322629136|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
94228049|NCT01187407|322629137|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
94228050|NCT01187407|322629138|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
94228051|NCT01187407|322629139|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
94228052|NCT01187407|322629140|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
94228053|NCT01187407|322629136|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
94228054|NCT01187407|322629137|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
94228055|NCT01187407|322629138|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
94343433|NCT00636155|323037701|FG000|Overall Study|Physician Decision|5|||
94228056|NCT01187407|322629139|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
94228057|NCT01187407|322629140|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
94228058|NCT01187407|322629136|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
94228059|NCT01187407|322629137|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
94228060|NCT01187407|322629138|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
94228061|NCT01187407|322629139|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
94553480|NCT03517566|323822894|FG000|Overall Study|Pregnancy|0|||
94553481|NCT03517566|323822895|FG001|Overall Study|Pregnancy|1|||
94553482|NCT03517566|323822896|FG002|Overall Study|Pregnancy|0|||
94553483|NCT03517566|323822897|FG003|Overall Study|Pregnancy|0|||
94553484|NCT03517566|323822898|FG004|Overall Study|Pregnancy|0|||
94553485|NCT03517566|323822894|FG000|Overall Study|Protocol Deviation|0|||
94553486|NCT03517566|323822895|FG001|Overall Study|Protocol Deviation|1|||
94553487|NCT03517566|323822896|FG002|Overall Study|Protocol Deviation|0|||
94553488|NCT03517566|323822897|FG003|Overall Study|Protocol Deviation|1|||
94553489|NCT03517566|323822898|FG004|Overall Study|Protocol Deviation|1|||
94553490|NCT03517566|323822894|FG000|Overall Study|Study terminated by Sponsor|11|||
94553491|NCT03517566|323822895|FG001|Overall Study|Study terminated by Sponsor|5|||
94553492|NCT03517566|323822896|FG002|Overall Study|Study terminated by Sponsor|6|||
94553493|NCT03517566|323822897|FG003|Overall Study|Study terminated by Sponsor|14|||
94553494|NCT03517566|323822898|FG004|Overall Study|Study terminated by Sponsor|12|||
94228062|NCT01187407|322629140|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
94553495|NCT03517566|323822894|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
94553496|NCT03517566|323822895|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
94553497|NCT03517566|323822896|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
94553498|NCT03517566|323822897|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
94553499|NCT03517566|323822898|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
94553500|NCT01229449|323822903|FG000|Overall Study|Withdrawal by Subject|0|||
94553501|NCT01229449|323822904|FG001|Overall Study|Withdrawal by Subject|3|||
94553502|NCT01229449|323822905|FG002|Overall Study|Withdrawal by Subject|0|||
94553503|NCT01229449|323822906|FG003|Overall Study|Withdrawal by Subject|1|||
94553504|NCT01229449|323822907|FG004|Overall Study|Withdrawal by Subject|1|||
94553505|NCT01229449|323822903|FG000|Overall Study|Lost to Follow-up|1|||
94553506|NCT01229449|323822904|FG001|Overall Study|Lost to Follow-up|1|||
94553507|NCT01229449|323822905|FG002|Overall Study|Lost to Follow-up|1|||
94553508|NCT01229449|323822906|FG003|Overall Study|Lost to Follow-up|0|||
94553509|NCT01229449|323822907|FG004|Overall Study|Lost to Follow-up|0|||
94553510|NCT01229449|323822903|FG000|Overall Study|Physician Decision|0|||
94553511|NCT01229449|323822904|FG001|Overall Study|Physician Decision|0|||
94553512|NCT01229449|323822905|FG002|Overall Study|Physician Decision|1|||
94553513|NCT01229449|323822906|FG003|Overall Study|Physician Decision|0|||
94553514|NCT01229449|323822907|FG004|Overall Study|Physician Decision|0|||
94553515|NCT03262441|323822912|FG000|Overall Study|Withdrawal by Subject|1|||
94553516|NCT01455194|323822919|FG000|Overall Study|Screen Failure|20|||
94553517|NCT01455194|323822920|FG001|Overall Study|Screen Failure|0|||
94553518|NCT01455194|323822921|FG002|Overall Study|Screen Failure|0|||
94553519|NCT01455194|323822922|FG003|Overall Study|Screen Failure|0|||
94553520|NCT01455194|323822919|FG000|Overall Study|Randomisation Failure|90|||
94553521|NCT01455194|323822920|FG001|Overall Study|Randomisation Failure|0|||
94553522|NCT01455194|323822921|FG002|Overall Study|Randomisation Failure|0|||
94553523|NCT01455194|323822922|FG003|Overall Study|Randomisation Failure|0|||
94553524|NCT01455194|323822919|FG000|Overall Study|Deterioration in asthma|12|||
94553525|NCT01455194|323822920|FG001|Overall Study|Deterioration in asthma|6|||
94553526|NCT01455194|323822921|FG002|Overall Study|Deterioration in asthma|14|||
94553527|NCT01455194|323822922|FG003|Overall Study|Deterioration in asthma|9|||
94553528|NCT01455194|323822919|FG000|Overall Study|Adverse Event|1|||
94553529|NCT01455194|323822920|FG001|Overall Study|Adverse Event|1|||
94228063|NCT01187407|322629136|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
94228064|NCT01187407|322629137|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
94228065|NCT01187407|322629138|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
94553530|NCT01455194|323822921|FG002|Overall Study|Adverse Event|1|||
94553531|NCT01455194|323822922|FG003|Overall Study|Adverse Event|3|||
94553532|NCT01455194|323822919|FG000|Overall Study|Withdrawal by Subject|21|||
94553533|NCT01455194|323822920|FG001|Overall Study|Withdrawal by Subject|16|||
94553534|NCT01455194|323822921|FG002|Overall Study|Withdrawal by Subject|12|||
94553535|NCT01455194|323822922|FG003|Overall Study|Withdrawal by Subject|9|||
94553536|NCT01455194|323822919|FG000|Overall Study|Lost to Follow-up|2|||
94553537|NCT01455194|323822920|FG001|Overall Study|Lost to Follow-up|0|||
94553538|NCT01455194|323822921|FG002|Overall Study|Lost to Follow-up|1|||
94228066|NCT01187407|322629139|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
94228067|NCT01187407|322629140|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
94228068|NCT01187407|322629136|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
94228069|NCT01187407|322629137|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
94228070|NCT01187407|322629138|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
94228071|NCT01187407|322629139|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
94228072|NCT01187407|322629140|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
94228073|NCT01187407|322629136|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
94228074|NCT01187407|322629137|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
94228075|NCT01187407|322629138|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
94228076|NCT01187407|322629139|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
94228077|NCT01187407|322629140|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
94228078|NCT01187407|322629136|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
94228079|NCT01187407|322629137|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
94228080|NCT01187407|322629138|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
94228081|NCT01187407|322629139|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
94228082|NCT01187407|322629140|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
94228083|NCT01187407|322629136|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
94228084|NCT01187407|322629137|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
94228085|NCT01187407|322629138|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
94228086|NCT01187407|322629139|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
94228087|NCT01187407|322629140|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
94228088|NCT01187407|322629136|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
94228089|NCT01187407|322629137|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
94228090|NCT01187407|322629138|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
94228091|NCT01187407|322629139|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
94228092|NCT01187407|322629140|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
94228093|NCT01187407|322629136|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
94228094|NCT01187407|322629137|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
94228095|NCT01187407|322629138|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
94228096|NCT01187407|322629139|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
94228097|NCT01187407|322629140|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
94228098|NCT01187407|322629136|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
94228099|NCT01187407|322629137|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
94228100|NCT01187407|322629138|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
94228101|NCT01187407|322629139|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
94228102|NCT01187407|322629140|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
94228103|NCT01187407|322629136|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
94228104|NCT01187407|322629137|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
94228105|NCT01187407|322629138|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
94228106|NCT01187407|322629139|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
94228107|NCT01187407|322629140|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
94228108|NCT01187407|322629136|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
94228109|NCT01187407|322629137|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
94228110|NCT01187407|322629138|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
94228111|NCT01187407|322629139|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
94228112|NCT01187407|322629140|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
94228113|NCT00740870|322629141|FG000|Overall Study|Not Catheterized|4|||
94228114|NCT00740870|322629141|FG000|Overall Study|Further testing contraindicated implant|17|||
94228115|NCT01193218|322629142|FG000|0-12 Weeks|Adverse Event|6|||
94228116|NCT01193218|322629143|FG001|0-12 Weeks|Adverse Event|0|||
94228117|NCT01193218|322629144|FG002|0-12 Weeks|Adverse Event|1|||
94228118|NCT01193218|322629145|FG003|0-12 Weeks|Adverse Event|0|||
94228119|NCT01193218|322629146|FG004|0-12 Weeks|Adverse Event|0|||
94228120|NCT01193218|322629147|FG005|0-12 Weeks|Adverse Event|2|||
94228121|NCT01193218|322629148|FG006|0-12 Weeks|Adverse Event|2|||
94228122|NCT01193218|322629149|FG007|0-12 Weeks|Adverse Event|0|||
94228123|NCT01193218|322629142|FG000|0-12 Weeks|Protocol Violation|0|||
94228124|NCT01193218|322629143|FG001|0-12 Weeks|Protocol Violation|0|||
94228125|NCT01193218|322629144|FG002|0-12 Weeks|Protocol Violation|0|||
94228126|NCT01193218|322629145|FG003|0-12 Weeks|Protocol Violation|0|||
94228127|NCT01193218|322629146|FG004|0-12 Weeks|Protocol Violation|1|||
94228128|NCT01193218|322629147|FG005|0-12 Weeks|Protocol Violation|1|||
94228129|NCT01193218|322629148|FG006|0-12 Weeks|Protocol Violation|0|||
94228130|NCT01193218|322629149|FG007|0-12 Weeks|Protocol Violation|0|||
94228131|NCT01193218|322629142|FG000|0-12 Weeks|Withdrawal by Subject|3|||
94228132|NCT01193218|322629143|FG001|0-12 Weeks|Withdrawal by Subject|0|||
94228133|NCT01193218|322629144|FG002|0-12 Weeks|Withdrawal by Subject|2|||
94343434|NCT02358863|323037702|FG000|Overall Study|Physician Decision|3|||
94553539|NCT01455194|323822922|FG003|Overall Study|Lost to Follow-up|1|||
94553540|NCT01455194|323822919|FG000|Overall Study|Pregnancy|0|||
94553541|NCT01455194|323822920|FG001|Overall Study|Pregnancy|1|||
94553542|NCT01455194|323822921|FG002|Overall Study|Pregnancy|1|||
94553543|NCT01455194|323822922|FG003|Overall Study|Pregnancy|0|||
94553544|NCT01455194|323822919|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
94553545|NCT01455194|323822920|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
94553546|NCT01455194|323822921|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
94553547|NCT01455194|323822922|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
94553548|NCT01455194|323822919|FG000|Overall Study|Miscellaneous|4|||
94553549|NCT01455194|323822920|FG001|Overall Study|Miscellaneous|5|||
94553550|NCT01455194|323822921|FG002|Overall Study|Miscellaneous|1|||
94553551|NCT01455194|323822922|FG003|Overall Study|Miscellaneous|4|||
94553552|NCT03916484|323822925|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
94553553|NCT03916484|323822926|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
94553554|NCT03916484|323822927|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
94553555|NCT03916484|323822928|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
94553556|NCT03916484|323822925|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
94553557|NCT03916484|323822926|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
94553558|NCT03916484|323822927|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
94553559|NCT03916484|323822928|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
94553560|NCT01092663|323822931|FG000|Overall Study|Withdrawal by Subject|3|||
94553561|NCT01092663|323822932|FG001|Overall Study|Withdrawal by Subject|2|||
94553562|NCT01092663|323822931|FG000|Overall Study|Glucose >300mg/dL|1|||
94553563|NCT01092663|323822932|FG001|Overall Study|Glucose >300mg/dL|0|||
94553564|NCT01092663|323822931|FG000|Overall Study|High fasting triglyceride|2|||
94553565|NCT01092663|323822932|FG001|Overall Study|High fasting triglyceride|0|||
94553566|NCT01092663|323822931|FG000|Overall Study|Adverse Event|1|||
94553567|NCT01092663|323822932|FG001|Overall Study|Adverse Event|1|||
94553568|NCT01092663|323822931|FG000|Overall Study|Protocol Violation|0|||
94553569|NCT01092663|323822932|FG001|Overall Study|Protocol Violation|1|||
94553570|NCT02409342|323822933|FG000|Overall Study|Death|211|||
94553571|NCT02409342|323822934|FG001|Overall Study|Death|201|||
94553572|NCT02409342|323822933|FG000|Overall Study|Withdrawal by Subject|24|||
94553573|NCT02409342|323822934|FG001|Overall Study|Withdrawal by Subject|17|||
94553574|NCT02409342|323822933|FG000|Overall Study|Study Terminated By Sponsor|48|||
94553575|NCT02409342|323822934|FG001|Overall Study|Study Terminated By Sponsor|59|||
94553576|NCT02409342|323822933|FG000|Overall Study|Lost to Follow-up|3|||
94553577|NCT02409342|323822934|FG001|Overall Study|Lost to Follow-up|5|||
94553578|NCT02409342|323822933|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
94553579|NCT02409342|323822934|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
94553580|NCT02409342|323822933|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
94553581|NCT02409342|323822934|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
94553582|NCT02409342|323822933|FG000|Overall Study|Sponsor Decision|1|||
94553583|NCT02409342|323822934|FG001|Overall Study|Sponsor Decision|0|||
94553584|NCT01008904|323822935|FG000|Overall Study|Lost to Follow-up|1|||
94553585|NCT01008904|323822935|FG000|Overall Study|Adverse Event|2|||
94553586|NCT01008904|323822935|FG000|Overall Study|unexpected unrelated surgery|1|||
94553587|NCT00416455|323822936|FG000|Overall Study|PET / CT not done|3|||
94553588|NCT00416455|323822937|FG001|Overall Study|PET / CT not done|5|||
94553589|NCT00416455|323822936|FG000|Overall Study|PET / CT poor quality|2|||
94553590|NCT00416455|323822937|FG001|Overall Study|PET / CT poor quality|1|||
94553591|NCT00416455|323822936|FG000|Overall Study|Inadequate pathology|11|||
94553592|NCT00416455|323822937|FG001|Overall Study|Inadequate pathology|2|||
94553593|NCT00781859|323822939|FG000|Overall Study|Adverse Event|2|||
94343435|NCT01594749|323037705|FG000|Overall Study|Adverse Event|2|||
94553594|NCT00781859|323822940|FG001|Overall Study|Adverse Event|2|||
94553595|NCT00781859|323822939|FG000|Overall Study|Withdrawal by Subject|8|||
94553596|NCT00781859|323822940|FG001|Overall Study|Withdrawal by Subject|4|||
94228134|NCT01193218|322629145|FG003|0-12 Weeks|Withdrawal by Subject|0|||
94228135|NCT01193218|322629146|FG004|0-12 Weeks|Withdrawal by Subject|0|||
94228136|NCT01193218|322629147|FG005|0-12 Weeks|Withdrawal by Subject|0|||
94228137|NCT01193218|322629148|FG006|0-12 Weeks|Withdrawal by Subject|1|||
94228138|NCT01193218|322629149|FG007|0-12 Weeks|Withdrawal by Subject|0|||
94228139|NCT01193218|322629142|FG000|12-52 Weeks|Adverse Event|1|||
94228140|NCT01193218|322629143|FG001|12-52 Weeks|Adverse Event|0|||
94228141|NCT01193218|322629144|FG002|12-52 Weeks|Adverse Event|1|||
94228142|NCT01193218|322629145|FG003|12-52 Weeks|Adverse Event|2|||
94228143|NCT01193218|322629146|FG004|12-52 Weeks|Adverse Event|3|||
94228144|NCT01193218|322629147|FG005|12-52 Weeks|Adverse Event|3|||
94228145|NCT01193218|322629148|FG006|12-52 Weeks|Adverse Event|1|||
94228146|NCT01193218|322629149|FG007|12-52 Weeks|Adverse Event|2|||
94228147|NCT01193218|322629142|FG000|12-52 Weeks|Lack of Efficacy|0|||
94228148|NCT01193218|322629143|FG001|12-52 Weeks|Lack of Efficacy|0|||
94228149|NCT01193218|322629144|FG002|12-52 Weeks|Lack of Efficacy|0|||
94228150|NCT01193218|322629145|FG003|12-52 Weeks|Lack of Efficacy|0|||
94228151|NCT01193218|322629146|FG004|12-52 Weeks|Lack of Efficacy|0|||
94228152|NCT01193218|322629147|FG005|12-52 Weeks|Lack of Efficacy|0|||
94228153|NCT01193218|322629148|FG006|12-52 Weeks|Lack of Efficacy|1|||
94228154|NCT01193218|322629149|FG007|12-52 Weeks|Lack of Efficacy|0|||
94228155|NCT01193218|322629142|FG000|12-52 Weeks|Withdrawal by Subject|3|||
94228156|NCT01193218|322629143|FG001|12-52 Weeks|Withdrawal by Subject|0|||
94228157|NCT01193218|322629144|FG002|12-52 Weeks|Withdrawal by Subject|3|||
94228158|NCT01193218|322629145|FG003|12-52 Weeks|Withdrawal by Subject|0|||
94228159|NCT01193218|322629146|FG004|12-52 Weeks|Withdrawal by Subject|0|||
94228160|NCT01193218|322629147|FG005|12-52 Weeks|Withdrawal by Subject|2|||
94228161|NCT01193218|322629148|FG006|12-52 Weeks|Withdrawal by Subject|1|||
94228162|NCT01193218|322629149|FG007|12-52 Weeks|Withdrawal by Subject|2|||
94228163|NCT01193218|322629142|FG000|12-52 Weeks|Other reason than above|1|||
94228164|NCT01193218|322629143|FG001|12-52 Weeks|Other reason than above|0|||
94228165|NCT01193218|322629144|FG002|12-52 Weeks|Other reason than above|0|||
94228166|NCT01193218|322629145|FG003|12-52 Weeks|Other reason than above|1|||
94228167|NCT01193218|322629146|FG004|12-52 Weeks|Other reason than above|1|||
94228168|NCT01193218|322629147|FG005|12-52 Weeks|Other reason than above|0|||
94228169|NCT01193218|322629148|FG006|12-52 Weeks|Other reason than above|0|||
94228170|NCT01193218|322629149|FG007|12-52 Weeks|Other reason than above|0|||
94228171|NCT01438840|322629152|FG000|Core Study|Adverse Event|0|||
94228172|NCT01438840|322629153|FG001|Core Study|Adverse Event|3|||
94228173|NCT01438840|322629154|FG002|Core Study|Adverse Event|0|||
94228174|NCT01438840|322629152|FG000|Core Study|Lack of Efficacy|15|||
94228175|NCT01438840|322629153|FG001|Core Study|Lack of Efficacy|7|||
94228176|NCT01438840|322629154|FG002|Core Study|Lack of Efficacy|0|||
94228177|NCT01438840|322629152|FG000|Core Study|Withdrawal of consent|1|||
94228178|NCT01438840|322629153|FG001|Core Study|Withdrawal of consent|0|||
94228179|NCT01438840|322629154|FG002|Core Study|Withdrawal of consent|0|||
94228180|NCT01438840|322629152|FG000|Extension Phase|Adverse Event|0|||
94228181|NCT01438840|322629153|FG001|Extension Phase|Adverse Event|0|||
94228182|NCT01438840|322629154|FG002|Extension Phase|Adverse Event|3|||
94228183|NCT01438840|322629152|FG000|Extension Phase|Lost to Follow-up|0|||
94228184|NCT01438840|322629153|FG001|Extension Phase|Lost to Follow-up|0|||
94228185|NCT01438840|322629154|FG002|Extension Phase|Lost to Follow-up|1|||
94228186|NCT01438840|322629152|FG000|Extension Phase|Withdrawal by Subject|0|||
94228187|NCT01438840|322629153|FG001|Extension Phase|Withdrawal by Subject|0|||
94228188|NCT01438840|322629154|FG002|Extension Phase|Withdrawal by Subject|3|||
94228189|NCT01438840|322629152|FG000|Extension Phase|Lack of Efficacy|0|||
94228190|NCT01438840|322629153|FG001|Extension Phase|Lack of Efficacy|0|||
94228191|NCT01438840|322629154|FG002|Extension Phase|Lack of Efficacy|2|||
94228192|NCT01438840|322629152|FG000|Extension Phase|Other|0|||
94228193|NCT01438840|322629153|FG001|Extension Phase|Other|0|||
94228194|NCT01438840|322629154|FG002|Extension Phase|Other|1|||
94228195|NCT00904722|322629159|FG000|Overall Study|Physician Decision|1|||
94228196|NCT01209286|322629160|FG000|Overall Study|Adverse Event|4|||
94228197|NCT01209286|322629161|FG001|Overall Study|Adverse Event|3|||
94228198|NCT01209286|322629162|FG002|Overall Study|Adverse Event|1|||
94228199|NCT01209286|322629160|FG000|Overall Study|Hematological Relapse After Remission|0|||
94228200|NCT01209286|322629161|FG001|Overall Study|Hematological Relapse After Remission|1|||
94228201|NCT01209286|322629162|FG002|Overall Study|Hematological Relapse After Remission|1|||
94228202|NCT01209286|322629160|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
94228203|NCT01209286|322629161|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
94228204|NCT01209286|322629162|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
94228205|NCT01209286|322629160|FG000|Overall Study|Physician Decision|0|||
94228206|NCT01209286|322629161|FG001|Overall Study|Physician Decision|2|||
94228207|NCT01209286|322629162|FG002|Overall Study|Physician Decision|0|||
94228208|NCT01209286|322629160|FG000|Overall Study|Other|0|||
94228209|NCT01209286|322629161|FG001|Overall Study|Other|1|||
94228210|NCT01209286|322629162|FG002|Overall Study|Other|0|||
94228211|NCT01349036|322629163|FG000|Overall Study|Disease progression|13|||
94228212|NCT01349036|322629164|FG001|Overall Study|Disease progression|22|||
94228213|NCT01349036|322629163|FG000|Overall Study|Other|1|||
94228214|NCT01349036|322629164|FG001|Overall Study|Other|0|||
94228215|NCT01349036|322629163|FG000|Overall Study|Withdrawal by Subject|0|||
94228216|NCT01349036|322629164|FG001|Overall Study|Withdrawal by Subject|2|||
94228217|NCT01125566|322629166|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
94228218|NCT01125566|322629167|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
94228219|NCT01125566|322629168|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
94228220|NCT01125566|322629166|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
94228221|NCT01125566|322629167|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
94228222|NCT01125566|322629168|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
94228223|NCT01125566|322629166|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
94228224|NCT01125566|322629167|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
94228225|NCT01125566|322629168|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
94228226|NCT01125566|322629166|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
94228227|NCT01125566|322629167|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
94228228|NCT01125566|322629168|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
94228229|NCT01125566|322629166|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
94228230|NCT01125566|322629167|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
94228231|NCT01125566|322629168|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
94228232|NCT01125566|322629166|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
94228233|NCT01125566|322629167|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
94228234|NCT01125566|322629168|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
94228235|NCT01125566|322629166|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
94228236|NCT01125566|322629167|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
94228237|NCT01125566|322629168|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
94228238|NCT01125566|322629166|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
94228239|NCT01125566|322629167|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
94228240|NCT01125566|322629168|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
94228241|NCT01125566|322629166|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
94228242|NCT01125566|322629167|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
94228243|NCT01125566|322629168|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
94228244|NCT01125566|322629166|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
94228245|NCT01125566|322629167|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
94228246|NCT01125566|322629168|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
94228247|NCT01125566|322629166|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
94228248|NCT01125566|322629167|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
94228249|NCT01125566|322629168|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
94228250|NCT01125566|322629166|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
94228251|NCT01125566|322629167|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
94228252|NCT01125566|322629168|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
94228253|NCT01560585|322629171|FG000|Overall Study|Physician Decision|3|||
94228254|NCT01020747|322629172|FG000|Overall Study|Withdrawal by Subject|1|||
94228255|NCT01222078|322629173|FG000|Overall Study|Early termination of the study|1|||
94228256|NCT00983892|322629174|FG000|Overall Study|Withdrawal by Subject|10|||
94228257|NCT00983892|322629175|FG001|Overall Study|Withdrawal by Subject|12|||
94228258|NCT02881047|322629176|FG000|Overall Study|Adverse Event|1|||
94228259|NCT02881047|322629176|FG000|Overall Study|Withdrawal by Subject|1|||
94228260|NCT03028012|322629177|FG000|Overall Study|Lost to Follow-up|2|||
94228261|NCT03028012|322629178|FG001|Overall Study|Lost to Follow-up|3|||
94228262|NCT03028012|322629179|FG002|Overall Study|Lost to Follow-up|3|||
94228263|NCT00573651|322629188|FG000|Overall Study|Lost to Follow-up|3|||
94228264|NCT00573651|322629188|FG000|Overall Study|Withdrawal by Subject|1|||
94228265|NCT03765164|322629189|FG000|Pre-intervention|Withdrawal by Subject|5|||
94228266|NCT03765164|322629190|FG001|Pre-intervention|Withdrawal by Subject|6|||
94228267|NCT01831726|322629196|FG000|Overall Study|Adverse Event|16|||
94228268|NCT01831726|322629196|FG000|Overall Study|Death|7|||
94228269|NCT01831726|322629196|FG000|Overall Study|Disease Progression|49|||
94228270|NCT01831726|322629196|FG000|Overall Study|Physician Decision|1|||
94228271|NCT01831726|322629196|FG000|Overall Study|Subject/guardian decision|7|||
94228272|NCT03821064|322629199|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
94228273|NCT02598934|322629202|FG000|Overall Study|Adverse Event|11|||
94228274|NCT02598934|322629203|FG001|Overall Study|Adverse Event|13|||
94228275|NCT02598934|322629202|FG000|Overall Study|Failure to Return|3|||
94228276|NCT02598934|322629203|FG001|Overall Study|Failure to Return|3|||
94228277|NCT02598934|322629202|FG000|Overall Study|Withdrawal by Subject|2|||
94228278|NCT02598934|322629203|FG001|Overall Study|Withdrawal by Subject|3|||
94228279|NCT02598934|322629202|FG000|Overall Study|Administrative|2|||
94228280|NCT02598934|322629203|FG001|Overall Study|Administrative|1|||
94228281|NCT02598934|322629202|FG000|Overall Study|Protocol Violation|1|||
94228282|NCT02598934|322629203|FG001|Overall Study|Protocol Violation|2|||
94228283|NCT00143598|322629206|FG000|Overall Study|Lost to Follow-up|23|||
94228284|NCT00143598|322629207|FG001|Overall Study|Lost to Follow-up|21|||
94228285|NCT00143598|322629206|FG000|Overall Study|Withdrawal by Subject|33|||
94228286|NCT00143598|322629207|FG001|Overall Study|Withdrawal by Subject|37|||
94228287|NCT00143598|322629206|FG000|Overall Study|Death|36|||
94228288|NCT00143598|322629207|FG001|Overall Study|Death|36|||
94228289|NCT03900715|322629210|FG000|Overall Study|Protocol Deviation|1|||
94228290|NCT03900715|322629210|FG000|Overall Study|Lack of Efficacy|1|||
94228291|NCT03900715|322629210|FG000|Overall Study|Progressive Disease|6|||
94228292|NCT03900715|322629210|FG000|Overall Study|Adverse Event|2|||
94228293|NCT03900715|322629210|FG000|Overall Study|Other reasons|11|||
94228294|NCT00746785|322630927|FG000|Overall Study|Lost to Follow-up|29|||
94228295|NCT00746785|322630928|FG001|Overall Study|Lost to Follow-up|25|||
94228296|NCT00746785|322630929|FG002|Overall Study|Lost to Follow-up|27|||
94228297|NCT01181609|322630931|FG000|Overall Study|Adverse Event|1|||
94228298|NCT01181609|322630931|FG000|Overall Study|Withdrawal by Subject|1|||
94228299|NCT01181609|322630931|FG000|Overall Study|Lost to Follow-up|1|||
94228300|NCT01181609|322630931|FG000|Overall Study|Death|50|||
94228301|NCT03458728|322630939|FG000|Overall Study|Adverse Event|1|||
94228302|NCT03458728|322630940|FG001|Overall Study|Adverse Event|0|||
94228303|NCT03458728|322630939|FG000|Overall Study|Physician Decision|1|||
94228304|NCT03458728|322630940|FG001|Overall Study|Physician Decision|0|||
94228305|NCT03458728|322630939|FG000|Overall Study|Progressive disease - clinical assessment|1|||
94228306|NCT03458728|322630940|FG001|Overall Study|Progressive disease - clinical assessment|0|||
94228307|NCT03458728|322630939|FG000|Overall Study|Progressive disease - radiological progression|21|||
94228308|NCT03458728|322630940|FG001|Overall Study|Progressive disease - radiological progression|6|||
94228309|NCT03458728|322630939|FG000|Overall Study|Withdrawal by Subject|0|||
94228310|NCT03458728|322630940|FG001|Overall Study|Withdrawal by Subject|1|||
94228311|NCT01644188|322630941|FG000|Overall Study|Adverse Event|44|||
94228312|NCT01644188|322630942|FG001|Overall Study|Adverse Event|20|||
94228313|NCT01644188|322630941|FG000|Overall Study|Poor compliance to protocol|26|||
94228314|NCT01644188|322630942|FG001|Overall Study|Poor compliance to protocol|14|||
94228315|NCT01644188|322630941|FG000|Overall Study|Physician Decision|1|||
94228316|NCT01644188|322630942|FG001|Overall Study|Physician Decision|3|||
94228317|NCT01644188|322630941|FG000|Overall Study|Participant moved|7|||
94228318|NCT01644188|322630942|FG001|Overall Study|Participant moved|2|||
94228319|NCT01644188|322630941|FG000|Overall Study|Related to auto-injector administration|2|||
94228320|NCT01644188|322630942|FG001|Overall Study|Related to auto-injector administration|2|||
94228321|NCT01644188|322630941|FG000|Overall Study|Consent withdrawn by participant|14|||
94228322|NCT01644188|322630942|FG001|Overall Study|Consent withdrawn by participant|7|||
94228323|NCT01644188|322630941|FG000|Overall Study|Selection criteria finally not met|2|||
94228324|NCT01644188|322630942|FG001|Overall Study|Selection criteria finally not met|0|||
94228325|NCT01644188|322630941|FG000|Overall Study|Lost to Follow-up|1|||
94228326|NCT01644188|322630942|FG001|Overall Study|Lost to Follow-up|0|||
94228327|NCT01644188|322630941|FG000|Overall Study|Death|4|||
94228328|NCT01644188|322630942|FG001|Overall Study|Death|3|||
94228329|NCT01644188|322630941|FG000|Overall Study|Last visit outside protocol visit window|14|||
94228330|NCT01644188|322630942|FG001|Overall Study|Last visit outside protocol visit window|16|||
94228331|NCT01644188|322630941|FG000|Overall Study|Site closure|1|||
94228332|NCT01644188|322630942|FG001|Overall Study|Site closure|1|||
94228333|NCT01644188|322630941|FG000|Overall Study|Other than specified above|6|||
94228334|NCT01644188|322630942|FG001|Overall Study|Other than specified above|7|||
94228335|NCT00766142|322630943|FG000|Overall Study|Protocol Violation|4|||
94446259|NCT00630825|323419292|FG002|Overall Study|Withdrawal by Subject|2|||
94446260|NCT00630825|323419293|FG003|Overall Study|Withdrawal by Subject|3|||
94446261|NCT00777296|323419294|FG000|Overall Study|Adverse Event|0|||
94446262|NCT00777296|323419295|FG001|Overall Study|Adverse Event|1|||
94446263|NCT00777296|323419296|FG002|Overall Study|Adverse Event|0|||
94446264|NCT00777296|323419297|FG003|Overall Study|Adverse Event|1|||
94446265|NCT00777296|323419294|FG000|Overall Study|Withdrawal by Subject|1|||
94446266|NCT00777296|323419295|FG001|Overall Study|Withdrawal by Subject|0|||
94446267|NCT00777296|323419296|FG002|Overall Study|Withdrawal by Subject|0|||
94228336|NCT00598871|322630947|FG000|Overall Study|Adverse Event|0|||
94228337|NCT00598871|322630948|FG001|Overall Study|Adverse Event|1|||
94228338|NCT01845649|322630951|FG000|Overall Study|Adverse Event|7|||
94228339|NCT01845649|322630952|FG001|Overall Study|Adverse Event|10|||
94446268|NCT00777296|323419297|FG003|Overall Study|Withdrawal by Subject|0|||
94228340|NCT01845649|322630951|FG000|Overall Study|Lack of Efficacy|1|||
94228341|NCT01845649|322630952|FG001|Overall Study|Lack of Efficacy|1|||
94228342|NCT01845649|322630951|FG000|Overall Study|Lost to Follow-up|2|||
94228343|NCT01845649|322630952|FG001|Overall Study|Lost to Follow-up|2|||
94228344|NCT01845649|322630951|FG000|Overall Study|Withdrew Consent|12|||
94228345|NCT01845649|322630952|FG001|Overall Study|Withdrew Consent|4|||
94228346|NCT01845649|322630951|FG000|Overall Study|Protocol Deviation|7|||
94228347|NCT01845649|322630952|FG001|Overall Study|Protocol Deviation|4|||
94446269|NCT00777296|323419294|FG000|Overall Study|CRF form not completed|0|||
94228348|NCT01845649|322630951|FG000|Overall Study|Reason not Specified|2|||
94228349|NCT01845649|322630952|FG001|Overall Study|Reason not Specified|1|||
94228350|NCT00478647|322630953|FG000|Overall Study|Adverse Event|1|||
94228351|NCT00478647|322630953|FG000|Overall Study|Withdrawal by Subject|1|||
94228352|NCT00526097|322630954|FG000|Overall Study|Adverse Event|6|||
94228353|NCT00526097|322630955|FG001|Overall Study|Adverse Event|44|||
94228354|NCT00526097|322630954|FG000|Overall Study|Protocol Violation|4|||
94228355|NCT00526097|322630955|FG001|Overall Study|Protocol Violation|10|||
94228356|NCT00526097|322630954|FG000|Overall Study|Withdrawal by Subject|3|||
94228357|NCT00526097|322630955|FG001|Overall Study|Withdrawal by Subject|1|||
94228358|NCT00526097|322630954|FG000|Overall Study|Other|2|||
94228359|NCT00526097|322630955|FG001|Overall Study|Other|1|||
94228360|NCT00460564|322630956|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
94228361|NCT00460564|322630957|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
94228362|NCT00460564|322630958|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
94228363|NCT00460564|322630959|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
94228364|NCT00460564|322630960|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
94228365|NCT00460564|322630961|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
94228366|NCT00460564|322630962|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
94228367|NCT00460564|322630963|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
94228368|NCT00460564|322630956|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
94228369|NCT00460564|322630957|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
94228370|NCT00460564|322630958|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
94228371|NCT00460564|322630959|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
94228372|NCT00460564|322630960|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
94228373|NCT00460564|322630961|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
94228374|NCT00460564|322630962|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
94228375|NCT00460564|322630963|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
94228376|NCT00460564|322630956|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
94228377|NCT00460564|322630957|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
94228378|NCT00460564|322630958|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
94228379|NCT00460564|322630959|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
94228380|NCT00460564|322630960|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
94228381|NCT00460564|322630961|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
94228382|NCT00460564|322630962|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
94228383|NCT00460564|322630963|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
94228384|NCT00460564|322630956|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
94228385|NCT00460564|322630957|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
94228386|NCT00460564|322630958|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
94228387|NCT00460564|322630959|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
94446270|NCT00777296|323419295|FG001|Overall Study|CRF form not completed|0|||
94446271|NCT00777296|323419296|FG002|Overall Study|CRF form not completed|2|||
94446272|NCT00777296|323419297|FG003|Overall Study|CRF form not completed|0|||
94446273|NCT00931255|323419303|FG000|Overall Study|Follow up biopsy not done|2|||
94446274|NCT00931255|323419304|FG001|Overall Study|Follow up biopsy not done|3|||
94446275|NCT01372995|323419305|FG000|Overall Study|Spouse withdrew participant from study|0|||
94446276|NCT01372995|323419306|FG001|Overall Study|Spouse withdrew participant from study|1|||
94446277|NCT01372995|323419307|FG002|Overall Study|Spouse withdrew participant from study|0|||
94446278|NCT01372995|323419305|FG000|Overall Study|Physician Decision|0|||
94446279|NCT01372995|323419306|FG001|Overall Study|Physician Decision|0|||
94446280|NCT01372995|323419307|FG002|Overall Study|Physician Decision|1|||
94446281|NCT03889418|323419311|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
94446282|NCT03889418|323419312|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
94446283|NCT03889418|323419313|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
94446284|NCT03889418|323419314|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
94446285|NCT03889418|323419315|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
94446286|NCT03889418|323419316|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
94446287|NCT03889418|323419317|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
94446288|NCT03889418|323419318|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
94446289|NCT03889418|323419319|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
94446290|NCT03889418|323419320|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
94446291|NCT03889418|323419311|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
94446292|NCT03889418|323419312|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
94446293|NCT03889418|323419313|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
94446294|NCT03889418|323419314|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
94446295|NCT03889418|323419315|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
94446296|NCT03889418|323419316|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
94228388|NCT00460564|322630960|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
94228389|NCT00460564|322630961|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
94228390|NCT00460564|322630962|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
94228391|NCT00460564|322630963|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
94553597|NCT00781859|323822939|FG000|Overall Study|Lost to Follow-up|6|||
94228392|NCT00460564|322630956|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
94228393|NCT00460564|322630957|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
94228394|NCT00460564|322630958|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
94228395|NCT00460564|322630959|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
94228396|NCT00460564|322630960|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
94228397|NCT00460564|322630961|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
94228398|NCT00460564|322630962|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
94228399|NCT00460564|322630963|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
94228400|NCT00966979|322630966|FG000|Overall Study|Death|1|||
94446297|NCT03889418|323419317|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
94446298|NCT03889418|323419318|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
94446299|NCT03889418|323419319|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
94446300|NCT03889418|323419320|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
94446301|NCT03889418|323419311|FG000|October-December 2019 (Month 7-9)|Death|0|||
94446302|NCT03889418|323419312|FG001|October-December 2019 (Month 7-9)|Death|0|||
94446303|NCT03889418|323419313|FG002|October-December 2019 (Month 7-9)|Death|0|||
94446304|NCT03889418|323419314|FG003|October-December 2019 (Month 7-9)|Death|0|||
94446305|NCT03889418|323419315|FG004|October-December 2019 (Month 7-9)|Death|0|||
94446306|NCT03889418|323419316|FG005|October-December 2019 (Month 7-9)|Death|0|||
94446307|NCT03889418|323419317|FG006|October-December 2019 (Month 7-9)|Death|0|||
94446308|NCT03889418|323419318|FG007|October-December 2019 (Month 7-9)|Death|0|||
94446309|NCT03889418|323419319|FG008|October-December 2019 (Month 7-9)|Death|1|||
94446310|NCT03889418|323419320|FG009|October-December 2019 (Month 7-9)|Death|0|||
94446311|NCT03889418|323419311|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
94446312|NCT03889418|323419312|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
94446313|NCT03889418|323419313|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
94446314|NCT03889418|323419314|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
94446315|NCT03889418|323419315|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
94446316|NCT03889418|323419316|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
94446317|NCT03889418|323419317|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
94446318|NCT03889418|323419318|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
94446319|NCT03889418|323419319|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
94446320|NCT03889418|323419320|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
94446321|NCT03889418|323419311|FG000|April - June 2020 (Month 13-15)|Death|0|||
94446322|NCT03889418|323419312|FG001|April - June 2020 (Month 13-15)|Death|1|||
94446323|NCT03889418|323419313|FG002|April - June 2020 (Month 13-15)|Death|0|||
94446324|NCT03889418|323419314|FG003|April - June 2020 (Month 13-15)|Death|0|||
94446325|NCT03889418|323419315|FG004|April - June 2020 (Month 13-15)|Death|0|||
94446326|NCT03889418|323419316|FG005|April - June 2020 (Month 13-15)|Death|0|||
94446327|NCT03889418|323419317|FG006|April - June 2020 (Month 13-15)|Death|0|||
94446328|NCT03889418|323419318|FG007|April - June 2020 (Month 13-15)|Death|0|||
94446329|NCT03889418|323419319|FG008|April - June 2020 (Month 13-15)|Death|0|||
94446330|NCT03889418|323419320|FG009|April - June 2020 (Month 13-15)|Death|0|||
94446331|NCT03889418|323419311|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
94446332|NCT03889418|323419312|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
94446333|NCT03889418|323419313|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
94446334|NCT03889418|323419314|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
94446335|NCT03889418|323419315|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
94446336|NCT03889418|323419316|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
94446337|NCT03889418|323419317|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
94446338|NCT03889418|323419318|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
94446339|NCT03889418|323419319|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
94228401|NCT00966979|322630966|FG000|Overall Study|Lost to Follow-up|6|||
94228402|NCT00966979|322630966|FG000|Overall Study|Withdrawal by Subject|14|||
94228403|NCT00966979|322630966|FG000|Overall Study|Adverse Event|5|||
94228404|NCT00966979|322630966|FG000|Overall Study|Sponsor terminated early|49|||
94228405|NCT00966979|322630966|FG000|Overall Study|Censored because surgery not done|2|||
94228406|NCT00966979|322630966|FG000|Overall Study|Censored because study device was not implanted|14|||
94228407|NCT00966979|322630966|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
94228408|NCT00030823|322630969|FG000|Overall Study|Withdrawal by Subject|1|||
94228409|NCT03119688|322630970|FG000|Overall Study|Adverse Event|4|||
94228410|NCT01169636|322630972|FG000|Overall Study|Adverse Event|0|||
94228411|NCT01169636|322630973|FG001|Overall Study|Adverse Event|0|||
94228412|NCT01169636|322630974|FG002|Overall Study|Adverse Event|1|||
94446340|NCT03889418|323419320|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
94446341|NCT03889418|323419311|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
94446342|NCT03889418|323419312|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
94446343|NCT03889418|323419313|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
94228413|NCT01169636|322630975|FG003|Overall Study|Adverse Event|1|||
94228414|NCT01169636|322630976|FG004|Overall Study|Adverse Event|0|||
94446344|NCT03889418|323419314|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
94446345|NCT03889418|323419315|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
94446346|NCT03889418|323419316|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
94446347|NCT03889418|323419317|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
94446348|NCT03889418|323419318|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
94446349|NCT03889418|323419319|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
94446350|NCT03889418|323419320|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
94553598|NCT00781859|323822940|FG001|Overall Study|Lost to Follow-up|3|||
94553599|NCT00781859|323822939|FG000|Overall Study|Death|3|||
94553600|NCT00781859|323822940|FG001|Overall Study|Death|0|||
94553601|NCT00621140|323822946|FG000|Overall Study|Adverse Event|4|||
94553602|NCT00621140|323822947|FG001|Overall Study|Adverse Event|5|||
94553603|NCT00621140|323822946|FG000|Overall Study|Lost to Follow-up|1|||
94553604|NCT00621140|323822947|FG001|Overall Study|Lost to Follow-up|2|||
94553605|NCT00621140|323822946|FG000|Overall Study|Withdrawal by Subject|4|||
94553606|NCT00621140|323822947|FG001|Overall Study|Withdrawal by Subject|6|||
94553607|NCT00621140|323822946|FG000|Overall Study|Other incl. lack of efficacy|6|||
94553608|NCT00621140|323822947|FG001|Overall Study|Other incl. lack of efficacy|5|||
94553609|NCT00360568|323822949|FG000|Overall Study|Adverse Event|1|||
94553610|NCT00360568|323822950|FG001|Overall Study|Adverse Event|2|||
94553611|NCT00360568|323822949|FG000|Overall Study|Lack of Efficacy|1|||
94553612|NCT00360568|323822950|FG001|Overall Study|Lack of Efficacy|0|||
94553613|NCT00360568|323822949|FG000|Overall Study|Withdrawal by Subject|0|||
94553614|NCT00360568|323822950|FG001|Overall Study|Withdrawal by Subject|3|||
94553615|NCT04378114|323822956|FG000|Overall Study|Withdrawal by Subject|5|||
94553616|NCT00629798|323822957|FG000|Overall Study|Not Treated|4|||
94553617|NCT01364389|323822959|FG000|Overall Study|Withdrawal by Subject|0|||
94553618|NCT01364389|323822960|FG001|Overall Study|Withdrawal by Subject|1|||
94553619|NCT01364389|323822961|FG002|Overall Study|Withdrawal by Subject|0|||
94553620|NCT01364389|323822959|FG000|Overall Study|Protocol deviation|0|||
94553621|NCT01364389|323822960|FG001|Overall Study|Protocol deviation|0|||
94553622|NCT01364389|323822961|FG002|Overall Study|Protocol deviation|1|||
94553623|NCT01364389|323822959|FG000|Overall Study|Administrative problems|1|||
94553624|NCT01364389|323822960|FG001|Overall Study|Administrative problems|0|||
94553625|NCT01364389|323822961|FG002|Overall Study|Administrative problems|0|||
94228415|NCT01169636|322630972|FG000|Overall Study|Screen failure|0|||
94553626|NCT01364389|323822959|FG000|Overall Study|Adverse Event|1|||
94446351|NCT03889418|323419311|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
94446352|NCT03889418|323419312|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
94446353|NCT03889418|323419313|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
94446354|NCT03889418|323419314|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
94446355|NCT03889418|323419315|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
94446356|NCT03889418|323419316|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
94446357|NCT03889418|323419317|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
94343436|NCT01594749|323037706|FG001|Overall Study|Adverse Event|1|||
94343437|NCT01594749|323037705|FG000|Overall Study|Withdrawal by Subject|2|||
94343438|NCT01594749|323037706|FG001|Overall Study|Withdrawal by Subject|2|||
94343439|NCT01594749|323037705|FG000|Overall Study|Protocol Violation|2|||
94343440|NCT01594749|323037706|FG001|Overall Study|Protocol Violation|0|||
94446358|NCT03889418|323419318|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
94446359|NCT03889418|323419319|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
94446360|NCT03889418|323419320|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
94446361|NCT03103152|323419321|FG000|Overall Study|Physician Decision|5|||
94343441|NCT01594749|323037705|FG000|Overall Study|Physician Decision|1|||
94343442|NCT01594749|323037706|FG001|Overall Study|Physician Decision|1|||
94343443|NCT01594749|323037705|FG000|Overall Study|Non-compliance with Protocol|0|||
94343444|NCT01594749|323037706|FG001|Overall Study|Non-compliance with Protocol|1|||
94343445|NCT01594749|323037705|FG000|Overall Study|Lost to Follow-up|1|||
94343446|NCT01594749|323037706|FG001|Overall Study|Lost to Follow-up|0|||
94343447|NCT01594749|323037705|FG000|Overall Study|Death|9|||
94343448|NCT01594749|323037706|FG001|Overall Study|Death|3|||
94343449|NCT01594749|323037705|FG000|Overall Study|Not Treated|4|||
94343450|NCT01594749|323037706|FG001|Overall Study|Not Treated|10|||
94343451|NCT01594749|323037705|FG000|Overall Study|Lost Source Documentation|1|||
94343452|NCT01594749|323037706|FG001|Overall Study|Lost Source Documentation|0|||
94343453|NCT02903966|323037711|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
94343454|NCT02903966|323037712|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
94343455|NCT02903966|323037711|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
94343456|NCT02903966|323037712|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
94343457|NCT02903966|323037711|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
94343458|NCT02903966|323037712|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
94343459|NCT02943577|323037720|FG000|Overall Study|Protocol Violation|0|||
94343460|NCT02943577|323037721|FG001|Overall Study|Protocol Violation|1|||
94343461|NCT02943577|323037720|FG000|Overall Study|Adverse Event|3|||
94343462|NCT02943577|323037721|FG001|Overall Study|Adverse Event|2|||
94343463|NCT02943577|323037720|FG000|Overall Study|Lost to Follow-up|0|||
94343464|NCT02943577|323037721|FG001|Overall Study|Lost to Follow-up|1|||
94343465|NCT02943577|323037720|FG000|Overall Study|Withdrawal by Subject|1|||
94343466|NCT02943577|323037721|FG001|Overall Study|Withdrawal by Subject|1|||
94343467|NCT02943577|323037720|FG000|Overall Study|Pregnancy|1|||
94343468|NCT02943577|323037721|FG001|Overall Study|Pregnancy|0|||
94553627|NCT01364389|323822960|FG001|Overall Study|Adverse Event|0|||
94553628|NCT01364389|323822961|FG002|Overall Study|Adverse Event|0|||
94553629|NCT01959243|323822962|FG000|Overall Study|Investigator Decision|3|||
94553630|NCT01959243|323822963|FG001|Overall Study|Investigator Decision|0|||
94553631|NCT01959243|323822962|FG000|Overall Study|Adverse Event|5|||
94553632|NCT01959243|323822963|FG001|Overall Study|Adverse Event|2|||
94446362|NCT03103152|323419322|FG001|Overall Study|Physician Decision|2|||
94446363|NCT03103152|323419323|FG002|Overall Study|Physician Decision|6|||
94553633|NCT01959243|323822962|FG000|Overall Study|Administrative reasons|2|||
94446364|NCT03103152|323419324|FG003|Overall Study|Physician Decision|3|||
94446365|NCT03103152|323419325|FG004|Overall Study|Physician Decision|3|||
94446366|NCT03103152|323419326|FG005|Overall Study|Physician Decision|1|||
94446367|NCT03103152|323419321|FG000|Overall Study|Protocol Violation|2|||
94446368|NCT03103152|323419322|FG001|Overall Study|Protocol Violation|2|||
94446369|NCT03103152|323419323|FG002|Overall Study|Protocol Violation|1|||
94446370|NCT03103152|323419324|FG003|Overall Study|Protocol Violation|2|||
94553634|NCT01959243|323822963|FG001|Overall Study|Administrative reasons|1|||
94553635|NCT01959243|323822962|FG000|Overall Study|Lost to Follow-up|3|||
94553636|NCT01959243|323822963|FG001|Overall Study|Lost to Follow-up|1|||
94553637|NCT02554981|323822968|FG000|Overall Study|Adverse Event|1|||
94553638|NCT02554981|323822968|FG000|Overall Study|Administrative Reasons|1|||
94553639|NCT02554981|323822968|FG000|Overall Study|Other Miscellaneous Reasons|3|||
94553640|NCT01114438|323822969|FG000|Overall Study|Adverse Event|10|||
94553641|NCT01114438|323822969|FG000|Overall Study|concomitant medication|1|||
94553642|NCT01114438|323822969|FG000|Overall Study|Physician Decision|1|||
94553643|NCT01114438|323822969|FG000|Overall Study|Withdrawal by Subject|2|||
94553644|NCT02980133|323822973|FG000|Overall Study|Other than specified|1|||
94553645|NCT02980133|323822974|FG001|Overall Study|Other than specified|1|||
94553646|NCT02980133|323822975|FG002|Overall Study|Other than specified|2|||
94553647|NCT02980133|323822976|FG003|Overall Study|Other than specified|2|||
94553648|NCT02980133|323822973|FG000|Overall Study|Lost to Follow-up|0|||
94553649|NCT02980133|323822974|FG001|Overall Study|Lost to Follow-up|0|||
94553650|NCT02980133|323822975|FG002|Overall Study|Lost to Follow-up|1|||
94553651|NCT02980133|323822976|FG003|Overall Study|Lost to Follow-up|3|||
94553652|NCT02980133|323822973|FG000|Overall Study|Protocol Violation|0|||
94553653|NCT02980133|323822974|FG001|Overall Study|Protocol Violation|1|||
94553654|NCT02980133|323822975|FG002|Overall Study|Protocol Violation|0|||
94553655|NCT02980133|323822976|FG003|Overall Study|Protocol Violation|0|||
94553656|NCT02980133|323822973|FG000|Overall Study|Withdrawal by parent/guardian|6|||
94553657|NCT02980133|323822974|FG001|Overall Study|Withdrawal by parent/guardian|3|||
94553658|NCT02980133|323822975|FG002|Overall Study|Withdrawal by parent/guardian|3|||
94553659|NCT02980133|323822976|FG003|Overall Study|Withdrawal by parent/guardian|1|||
94553660|NCT02980133|323822973|FG000|Overall Study|Withdrawal by Subject|0|||
94553661|NCT02980133|323822974|FG001|Overall Study|Withdrawal by Subject|0|||
94553662|NCT02980133|323822975|FG002|Overall Study|Withdrawal by Subject|1|||
94553663|NCT02980133|323822976|FG003|Overall Study|Withdrawal by Subject|0|||
94553664|NCT03824587|323822985|FG000|Run-in Period|Screen Failure|0|||
94553665|NCT03824587|323822986|FG001|Run-in Period|Screen Failure|275|||
94553666|NCT03824587|323822985|FG000|Treatment Period|Adverse Event|4|||
94553667|NCT03824587|323822986|FG001|Treatment Period|Adverse Event|1|||
94553668|NCT03824587|323822985|FG000|Treatment Period|Withdrawal by Subject|0|||
94553669|NCT03824587|323822986|FG001|Treatment Period|Withdrawal by Subject|1|||
94553670|NCT03824587|323822985|FG000|Treatment Period|Kidney Transplant|1|||
94553671|NCT03824587|323822986|FG001|Treatment Period|Kidney Transplant|1|||
94553672|NCT03170193|323822989|FG000|Overall Study|Withdrawal by Subject|0|||
94553673|NCT03170193|323822990|FG001|Overall Study|Withdrawal by Subject|0|||
94553674|NCT03170193|323822991|FG002|Overall Study|Withdrawal by Subject|0|||
94553675|NCT03170193|323822992|FG003|Overall Study|Withdrawal by Subject|1|||
94553676|NCT03170193|323822993|FG004|Overall Study|Withdrawal by Subject|0|||
94553677|NCT03170193|323822994|FG005|Overall Study|Withdrawal by Subject|0|||
94553678|NCT03170193|323822995|FG006|Overall Study|Withdrawal by Subject|0|||
94553679|NCT03170193|323822989|FG000|Overall Study|Lost to Follow-up|1|||
94553680|NCT03170193|323822990|FG001|Overall Study|Lost to Follow-up|1|||
94553681|NCT03170193|323822991|FG002|Overall Study|Lost to Follow-up|0|||
94553682|NCT03170193|323822992|FG003|Overall Study|Lost to Follow-up|0|||
94553683|NCT03170193|323822993|FG004|Overall Study|Lost to Follow-up|0|||
94446371|NCT03103152|323419325|FG004|Overall Study|Protocol Violation|1|||
94446372|NCT03103152|323419326|FG005|Overall Study|Protocol Violation|1|||
94553684|NCT03170193|323822994|FG005|Overall Study|Lost to Follow-up|0|||
94553685|NCT03170193|323822995|FG006|Overall Study|Lost to Follow-up|0|||
94553686|NCT03068767|323823001|FG000|Overall Study|Lost to Follow-up|7|||
94446373|NCT03103152|323419321|FG000|Overall Study|Inter-current illness|0|||
94553687|NCT03068767|323823002|FG001|Overall Study|Lost to Follow-up|3|||
94446374|NCT03103152|323419322|FG001|Overall Study|Inter-current illness|0|||
94446375|NCT03103152|323419323|FG002|Overall Study|Inter-current illness|1|||
94553688|NCT03068767|323823001|FG000|Overall Study|Protocol Violation|3|||
94553689|NCT03068767|323823002|FG001|Overall Study|Protocol Violation|0|||
94553690|NCT00687531|323823005|FG000|Overall Study|Did not meet protocol eligibility|104|||
94446376|NCT03103152|323419324|FG003|Overall Study|Inter-current illness|0|||
94446377|NCT03103152|323419325|FG004|Overall Study|Inter-current illness|0|||
94553691|NCT00687531|323823005|FG000|Overall Study|Adverse Event|5|||
94553692|NCT00687531|323823005|FG000|Overall Study|Lost to Follow-up|26|||
94228416|NCT01169636|322630973|FG001|Overall Study|Screen failure|0|||
94228417|NCT01169636|322630974|FG002|Overall Study|Screen failure|2|||
94228418|NCT01169636|322630975|FG003|Overall Study|Screen failure|0|||
94228419|NCT01169636|322630976|FG004|Overall Study|Screen failure|0|||
94228420|NCT01169636|322630972|FG000|Overall Study|Withdrawal by Subject|0|||
94228421|NCT01169636|322630973|FG001|Overall Study|Withdrawal by Subject|0|||
94228422|NCT01169636|322630974|FG002|Overall Study|Withdrawal by Subject|0|||
94228423|NCT01169636|322630975|FG003|Overall Study|Withdrawal by Subject|0|||
94228424|NCT01169636|322630976|FG004|Overall Study|Withdrawal by Subject|3|||
94228425|NCT01951378|322630977|FG000|Overall Study|Study Terminated-Not completed|23|||
94228426|NCT01951378|322630978|FG001|Overall Study|Study Terminated-Not completed|17|||
94446378|NCT03103152|323419326|FG005|Overall Study|Inter-current illness|0|||
94446379|NCT03103152|323419321|FG000|Overall Study|Death|0|||
94446380|NCT03103152|323419322|FG001|Overall Study|Death|1|||
94446381|NCT03103152|323419323|FG002|Overall Study|Death|0|||
94446382|NCT03103152|323419324|FG003|Overall Study|Death|0|||
94446383|NCT03103152|323419325|FG004|Overall Study|Death|0|||
94446384|NCT03103152|323419326|FG005|Overall Study|Death|0|||
94446385|NCT03103152|323419321|FG000|Overall Study|Adverse Event|0|||
94446386|NCT03103152|323419322|FG001|Overall Study|Adverse Event|0|||
94446387|NCT03103152|323419323|FG002|Overall Study|Adverse Event|1|||
94446388|NCT03103152|323419324|FG003|Overall Study|Adverse Event|0|||
94446389|NCT03103152|323419325|FG004|Overall Study|Adverse Event|0|||
94446390|NCT03103152|323419326|FG005|Overall Study|Adverse Event|1|||
94446391|NCT03103152|323419321|FG000|Overall Study|Withdrawal by Subject|1|||
94446392|NCT03103152|323419322|FG001|Overall Study|Withdrawal by Subject|0|||
94446393|NCT03103152|323419323|FG002|Overall Study|Withdrawal by Subject|1|||
94446394|NCT03103152|323419324|FG003|Overall Study|Withdrawal by Subject|1|||
94553693|NCT00547521|323823006|FG000|Short Term Study (4 Months)|Adverse Event|1|||
94553694|NCT00547521|323823007|FG001|Short Term Study (4 Months)|Adverse Event|0|||
94553695|NCT00547521|323823006|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
94553696|NCT00547521|323823007|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
94228427|NCT00337285|322630981|FG000|Overall Study|Withdrawal by Subject|42|||
94228428|NCT00337285|322630981|FG000|Overall Study|Lost to Follow-up|41|||
94228429|NCT00337285|322630981|FG000|Overall Study|Adverse Event|28|||
94228430|NCT00337285|322630981|FG000|Overall Study|Protocol Violation|27|||
94446395|NCT03103152|323419325|FG004|Overall Study|Withdrawal by Subject|1|||
94446396|NCT03103152|323419326|FG005|Overall Study|Withdrawal by Subject|1|||
94446397|NCT03103152|323419321|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
94446398|NCT03103152|323419322|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
94446399|NCT03103152|323419323|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
94446400|NCT03103152|323419324|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
94446401|NCT03103152|323419325|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
94446402|NCT03103152|323419326|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
94446403|NCT03103152|323419321|FG000|Overall Study|Unacceptable side effects|0|||
94446404|NCT03103152|323419322|FG001|Overall Study|Unacceptable side effects|0|||
94446405|NCT03103152|323419323|FG002|Overall Study|Unacceptable side effects|0|||
94446406|NCT03103152|323419324|FG003|Overall Study|Unacceptable side effects|0|||
94553697|NCT00547521|323823006|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
94553698|NCT00547521|323823007|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
94553699|NCT00547521|323823006|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
94553700|NCT00547521|323823007|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
94553701|NCT00547521|323823006|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
94553702|NCT00547521|323823007|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
94553703|NCT00547521|323823006|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
94553704|NCT00547521|323823007|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
94553705|NCT00547521|323823006|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
94553706|NCT00547521|323823007|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
94553707|NCT00547521|323823006|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
94553708|NCT00547521|323823007|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
94553709|NCT00547521|323823006|FG000|Long Term Extension (LTE) Study|Other|0|||
94553710|NCT00547521|323823007|FG001|Long Term Extension (LTE) Study|Other|2|||
94553711|NCT00547521|323823006|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
94553712|NCT00547521|323823007|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
94553713|NCT02241343|323824457|FG000|Overall Study|Adverse Event|1|||
94553714|NCT04680975|323824458|FG000|Overall Study|Adverse Event|3|||
94446407|NCT03103152|323419325|FG004|Overall Study|Unacceptable side effects|0|||
94446408|NCT03103152|323419326|FG005|Overall Study|Unacceptable side effects|1|||
94446409|NCT03103152|323419321|FG000|Overall Study|Lost to Follow-up|0|||
94446410|NCT03103152|323419322|FG001|Overall Study|Lost to Follow-up|1|||
94446411|NCT03103152|323419323|FG002|Overall Study|Lost to Follow-up|0|||
94446412|NCT03103152|323419324|FG003|Overall Study|Lost to Follow-up|1|||
94446413|NCT03103152|323419325|FG004|Overall Study|Lost to Follow-up|0|||
94446414|NCT03103152|323419326|FG005|Overall Study|Lost to Follow-up|1|||
94446415|NCT03103152|323419321|FG000|Overall Study|Testicular pain|0|||
94446416|NCT03103152|323419322|FG001|Overall Study|Testicular pain|0|||
94446417|NCT03103152|323419323|FG002|Overall Study|Testicular pain|0|||
94446418|NCT03103152|323419324|FG003|Overall Study|Testicular pain|1|||
94446419|NCT03103152|323419325|FG004|Overall Study|Testicular pain|0|||
94446420|NCT03103152|323419326|FG005|Overall Study|Testicular pain|0|||
94446421|NCT02220764|323419327|FG000|Overall Study|Lost to Follow-up|3|||
94553715|NCT04680975|323824458|FG000|Overall Study|Death|1|||
94553716|NCT04680975|323824458|FG000|Overall Study|Progressive Disease|1|||
94553717|NCT04680975|323824458|FG000|Overall Study|Withdrawal by Subject|1|||
94553718|NCT00753454|323824459|FG000|Overall Study|Adverse Event|4|||
94553719|NCT00753454|323824459|FG000|Overall Study|Lack of Efficacy|1|||
94553720|NCT00753454|323824459|FG000|Overall Study|Lost to Follow-up|3|||
94553721|NCT00753454|323824459|FG000|Overall Study|Withdrawal by Subject|5|||
94553722|NCT00753454|323824459|FG000|Overall Study|Investigator Decision|1|||
94553723|NCT03927144|323824460|FG000|Core Phase|Adverse Event|9|||
94553724|NCT03927144|323824461|FG001|Core Phase|Adverse Event|5|||
94553725|NCT03927144|323824460|FG000|Core Phase|Lost to Follow-up|3|||
94553726|NCT03927144|323824461|FG001|Core Phase|Lost to Follow-up|2|||
94553727|NCT03927144|323824460|FG000|Core Phase|New Therapy for Study Indication|0|||
94553728|NCT03927144|323824461|FG001|Core Phase|New Therapy for Study Indication|1|||
94553729|NCT03927144|323824460|FG000|Core Phase|No Longer Clinically Benefiting|4|||
94553730|NCT03927144|323824461|FG001|Core Phase|No Longer Clinically Benefiting|4|||
94553731|NCT03927144|323824460|FG000|Core Phase|Physician Decision|2|||
94553732|NCT03927144|323824461|FG001|Core Phase|Physician Decision|8|||
94553733|NCT03927144|323824460|FG000|Core Phase|Protocol Violation|2|||
94553734|NCT03927144|323824461|FG001|Core Phase|Protocol Violation|2|||
94553735|NCT03927144|323824460|FG000|Core Phase|Withdrawal by Subject|16|||
94553736|NCT03927144|323824461|FG001|Core Phase|Withdrawal by Subject|40|||
94553737|NCT03927144|323824460|FG000|Extension Phase|Adverse Event|2|||
94553738|NCT03927144|323824461|FG001|Extension Phase|Adverse Event|1|||
94553739|NCT03927144|323824460|FG000|Extension Phase|No longer clinically benefiting|4|||
94553740|NCT03927144|323824461|FG001|Extension Phase|No longer clinically benefiting|5|||
94553741|NCT03927144|323824460|FG000|Extension Phase|Pregnancy|1|||
94553742|NCT03927144|323824461|FG001|Extension Phase|Pregnancy|0|||
94553743|NCT03927144|323824460|FG000|Extension Phase|Protocol Violation|0|||
94553744|NCT03927144|323824461|FG001|Extension Phase|Protocol Violation|1|||
94553745|NCT03927144|323824460|FG000|Extension Phase|Withdrawal by Subject|8|||
94553746|NCT03927144|323824461|FG001|Extension Phase|Withdrawal by Subject|3|||
94553747|NCT02702414|323824464|FG000|Overall Study|Death|96|||
94553748|NCT02702414|323824465|FG001|Overall Study|Death|42|||
94553749|NCT02702414|323824464|FG000|Overall Study|Lost to Follow-up|0|||
94553750|NCT02702414|323824465|FG001|Overall Study|Lost to Follow-up|1|||
94228431|NCT00337285|322630981|FG000|Overall Study|Lack of Efficacy|11|||
94343469|NCT01327573|323037727|FG000|Overall Study|Physician Decision|3|||
94553751|NCT02702414|323824464|FG000|Overall Study|Withdrawal by Subject|0|||
94553752|NCT02702414|323824465|FG001|Overall Study|Withdrawal by Subject|1|||
94553753|NCT02702414|323824464|FG000|Overall Study|Protocol Violation|1|||
94553754|NCT02702414|323824465|FG001|Overall Study|Protocol Violation|0|||
94553755|NCT02702414|323824464|FG000|Overall Study|Sponsor Decision|8|||
94553756|NCT02702414|323824465|FG001|Overall Study|Sponsor Decision|7|||
94553757|NCT04541628|323824466|FG000|Overall Study|Study Terminated|1|||
94553758|NCT04541628|323824467|FG001|Overall Study|Study Terminated|1|||
94553759|NCT04541628|323824468|FG002|Overall Study|Study Terminated|1|||
94553760|NCT01452919|323824469|FG000|Open-Label Treatment|Adverse Event|5|||
94553761|NCT01452919|323824470|FG001|Open-Label Treatment|Adverse Event|0|||
94553762|NCT01452919|323824471|FG002|Open-Label Treatment|Adverse Event|0|||
94553763|NCT01452919|323824469|FG000|Open-Label Treatment|Lost to Follow-up|4|||
94553764|NCT01452919|323824470|FG001|Open-Label Treatment|Lost to Follow-up|0|||
94553765|NCT01452919|323824471|FG002|Open-Label Treatment|Lost to Follow-up|0|||
94553766|NCT01452919|323824469|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
94553767|NCT01452919|323824470|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
94553768|NCT01452919|323824471|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
94553769|NCT01452919|323824469|FG000|Open-Label Treatment|Protocol Violation|4|||
94553770|NCT01452919|323824470|FG001|Open-Label Treatment|Protocol Violation|0|||
94553771|NCT01452919|323824471|FG002|Open-Label Treatment|Protocol Violation|0|||
94553772|NCT01452919|323824469|FG000|Open-Label Treatment|Sponsor Decision|1|||
94553773|NCT01452919|323824470|FG001|Open-Label Treatment|Sponsor Decision|0|||
94553774|NCT01452919|323824471|FG002|Open-Label Treatment|Sponsor Decision|0|||
94553775|NCT01452919|323824469|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
94553776|NCT01452919|323824470|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
94553777|NCT01452919|323824471|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
94553778|NCT01452919|323824469|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
94553779|NCT01452919|323824470|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
94553780|NCT01452919|323824471|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
94553781|NCT01452919|323824469|FG000|Randomization Treatment|Adverse Event|0|||
94343470|NCT01327573|323037728|FG001|Overall Study|Physician Decision|1|||
94343471|NCT00911144|323037729|FG000|Overall Study|Withdrawal by Subject|16|||
94343472|NCT00911144|323037730|FG001|Overall Study|Withdrawal by Subject|5|||
94343473|NCT01685372|323037731|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
94343474|NCT01685372|323037732|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
94343475|NCT01408732|323037733|FG000|Overall Study|Withdrawal by Subject|2|||
94553782|NCT01452919|323824470|FG001|Randomization Treatment|Adverse Event|0|||
94553783|NCT01452919|323824471|FG002|Randomization Treatment|Adverse Event|2|||
94553784|NCT01452919|323824469|FG000|Randomization Treatment|Sponsor Decision|0|||
94553785|NCT01452919|323824470|FG001|Randomization Treatment|Sponsor Decision|1|||
94553786|NCT01452919|323824471|FG002|Randomization Treatment|Sponsor Decision|0|||
94553787|NCT01452919|323824469|FG000|Randomization Treatment|Withdrawal by Subject|0|||
94553788|NCT01452919|323824470|FG001|Randomization Treatment|Withdrawal by Subject|1|||
94553789|NCT01452919|323824471|FG002|Randomization Treatment|Withdrawal by Subject|0|||
94553790|NCT01452919|323824469|FG000|Randomization Treatment|Subject is moving or has moved|0|||
94553791|NCT01452919|323824470|FG001|Randomization Treatment|Subject is moving or has moved|1|||
94553792|NCT01452919|323824471|FG002|Randomization Treatment|Subject is moving or has moved|0|||
94553793|NCT01192412|323824473|FG000|Overall Study|Lost to Follow-up|2|||
94553794|NCT01192412|323824474|FG001|Overall Study|Lost to Follow-up|1|||
94553795|NCT01192412|323824473|FG000|Overall Study|Withdrawal by Subject|2|||
94553796|NCT01192412|323824474|FG001|Overall Study|Withdrawal by Subject|1|||
94553797|NCT02421588|323824475|FG000|Overall Study|Non-treatment-related AE|8|||
94553798|NCT02421588|323824476|FG001|Overall Study|Non-treatment-related AE|8|||
94553799|NCT02421588|323824475|FG000|Overall Study|Progressive disease|152|||
94553800|NCT02421588|323824476|FG001|Overall Study|Progressive disease|135|||
94553801|NCT02421588|323824475|FG000|Overall Study|Death|11|||
94553802|NCT02421588|323824476|FG001|Overall Study|Death|3|||
94553803|NCT02421588|323824475|FG000|Overall Study|Physician Decision|8|||
94553804|NCT02421588|323824476|FG001|Overall Study|Physician Decision|17|||
94553805|NCT02421588|323824475|FG000|Overall Study|Other reason not specified|3|||
94553806|NCT02421588|323824476|FG001|Overall Study|Other reason not specified|1|||
94553807|NCT02421588|323824475|FG000|Overall Study|Symptomatic deterioration|13|||
94553808|NCT02421588|323824476|FG001|Overall Study|Symptomatic deterioration|19|||
94553809|NCT02421588|323824475|FG000|Overall Study|Treatment-related AE|10|||
94553810|NCT02421588|323824476|FG001|Overall Study|Treatment-related AE|14|||
94553811|NCT02421588|323824475|FG000|Overall Study|Withdrawal by Subject|14|||
94553812|NCT02421588|323824476|FG001|Overall Study|Withdrawal by Subject|16|||
94553813|NCT02421588|323824475|FG000|Overall Study|Not treated|2|||
94553814|NCT02421588|323824476|FG001|Overall Study|Not treated|8|||
94553815|NCT00615030|323824477|FG000|Period I|Administrative problem|0|||
94553816|NCT00615030|323824478|FG001|Period I|Administrative problem|0|||
94553817|NCT00615030|323824479|FG002|Period I|Administrative problem|0|||
94553818|NCT00615030|323824480|FG003|Period I|Administrative problem|0|||
94553819|NCT00615030|323824481|FG004|Period I|Administrative problem|1|||
94553820|NCT00615030|323824482|FG005|Period I|Administrative problem|0|||
94553821|NCT00615030|323824483|FG006|Period I|Administrative problem|0|||
94553822|NCT00615030|323824484|FG007|Period I|Administrative problem|0|||
94553823|NCT00615030|323824485|FG008|Period I|Administrative problem|0|||
94553824|NCT00615030|323824486|FG009|Period I|Administrative problem|0|||
94553825|NCT00615030|323824487|FG010|Period I|Administrative problem|0|||
94553826|NCT00615030|323824488|FG011|Period I|Administrative problem|0|||
94553827|NCT00615030|323824477|FG000|Period I|Protocol deviation|1|||
94553828|NCT00615030|323824478|FG001|Period I|Protocol deviation|0|||
94553829|NCT00615030|323824479|FG002|Period I|Protocol deviation|0|||
94553830|NCT00615030|323824480|FG003|Period I|Protocol deviation|0|||
94553831|NCT00615030|323824481|FG004|Period I|Protocol deviation|0|||
94553832|NCT00615030|323824482|FG005|Period I|Protocol deviation|0|||
94553833|NCT00615030|323824483|FG006|Period I|Protocol deviation|0|||
94553834|NCT00615030|323824484|FG007|Period I|Protocol deviation|0|||
94553835|NCT00615030|323824485|FG008|Period I|Protocol deviation|0|||
94553836|NCT00615030|323824486|FG009|Period I|Protocol deviation|0|||
94553837|NCT00615030|323824487|FG010|Period I|Protocol deviation|0|||
94553838|NCT00615030|323824488|FG011|Period I|Protocol deviation|0|||
94553839|NCT00615030|323824477|FG000|Period I|Subject withdrew consent|0|||
94553840|NCT00615030|323824478|FG001|Period I|Subject withdrew consent|0|||
94553841|NCT00615030|323824479|FG002|Period I|Subject withdrew consent|0|||
94553842|NCT00615030|323824480|FG003|Period I|Subject withdrew consent|0|||
94553843|NCT00615030|323824481|FG004|Period I|Subject withdrew consent|0|||
94553844|NCT00615030|323824482|FG005|Period I|Subject withdrew consent|0|||
94553845|NCT00615030|323824483|FG006|Period I|Subject withdrew consent|0|||
94553846|NCT00615030|323824484|FG007|Period I|Subject withdrew consent|0|||
94553847|NCT00615030|323824485|FG008|Period I|Subject withdrew consent|1|||
94553848|NCT00615030|323824486|FG009|Period I|Subject withdrew consent|0|||
94553849|NCT00615030|323824487|FG010|Period I|Subject withdrew consent|1|||
94553850|NCT00615030|323824488|FG011|Period I|Subject withdrew consent|1|||
94553851|NCT00615030|323824477|FG000|Period I|Abnormal laboratory value(s)|0|||
94553852|NCT00615030|323824478|FG001|Period I|Abnormal laboratory value(s)|0|||
94553853|NCT00615030|323824479|FG002|Period I|Abnormal laboratory value(s)|0|||
94553854|NCT00615030|323824480|FG003|Period I|Abnormal laboratory value(s)|0|||
94553855|NCT00615030|323824481|FG004|Period I|Abnormal laboratory value(s)|0|||
94553856|NCT00615030|323824482|FG005|Period I|Abnormal laboratory value(s)|1|||
94553857|NCT00615030|323824483|FG006|Period I|Abnormal laboratory value(s)|0|||
94553858|NCT00615030|323824484|FG007|Period I|Abnormal laboratory value(s)|0|||
94553859|NCT00615030|323824485|FG008|Period I|Abnormal laboratory value(s)|0|||
94553860|NCT00615030|323824486|FG009|Period I|Abnormal laboratory value(s)|0|||
94553861|NCT00615030|323824487|FG010|Period I|Abnormal laboratory value(s)|0|||
94553862|NCT00615030|323824488|FG011|Period I|Abnormal laboratory value(s)|0|||
94553863|NCT00615030|323824477|FG000|Period II|Adverse Event|0|||
94553864|NCT00615030|323824478|FG001|Period II|Adverse Event|0|||
94553865|NCT00615030|323824479|FG002|Period II|Adverse Event|1|||
94553866|NCT00615030|323824480|FG003|Period II|Adverse Event|0|||
94553867|NCT00615030|323824481|FG004|Period II|Adverse Event|0|||
94553868|NCT00615030|323824482|FG005|Period II|Adverse Event|0|||
94553869|NCT00615030|323824483|FG006|Period II|Adverse Event|0|||
94553870|NCT00615030|323824484|FG007|Period II|Adverse Event|0|||
94553871|NCT00615030|323824485|FG008|Period II|Adverse Event|1|||
94553872|NCT00615030|323824486|FG009|Period II|Adverse Event|0|||
94553873|NCT00615030|323824487|FG010|Period II|Adverse Event|0|||
94553874|NCT00615030|323824488|FG011|Period II|Adverse Event|0|||
94553875|NCT00615030|323824477|FG000|Period II|Subject withdrew consent|0|||
94553876|NCT00615030|323824478|FG001|Period II|Subject withdrew consent|0|||
94553877|NCT00615030|323824479|FG002|Period II|Subject withdrew consent|0|||
94553878|NCT00615030|323824480|FG003|Period II|Subject withdrew consent|1|||
94553879|NCT00615030|323824481|FG004|Period II|Subject withdrew consent|0|||
94553880|NCT00615030|323824482|FG005|Period II|Subject withdrew consent|0|||
94553881|NCT00615030|323824483|FG006|Period II|Subject withdrew consent|1|||
94553882|NCT00615030|323824484|FG007|Period II|Subject withdrew consent|0|||
94553883|NCT00615030|323824485|FG008|Period II|Subject withdrew consent|0|||
94553884|NCT00615030|323824486|FG009|Period II|Subject withdrew consent|0|||
94553885|NCT00615030|323824487|FG010|Period II|Subject withdrew consent|0|||
94553886|NCT00615030|323824488|FG011|Period II|Subject withdrew consent|0|||
94446422|NCT02220764|323419328|FG001|Overall Study|Lost to Follow-up|1|||
94446423|NCT02220764|323419327|FG000|Overall Study|Death|1|||
94228432|NCT00337285|322630981|FG000|Overall Study|Death|1|||
94228433|NCT00337285|322630981|FG000|Overall Study|Physician Decision|1|||
94228434|NCT00337285|322630981|FG000|Overall Study|Lack of protocol compliance|7|||
94228435|NCT02741713|322630982|FG000|Overall Study|Surgery type changed intra-operatively|2|||
94228436|NCT02741713|322630983|FG001|Overall Study|Surgery type changed intra-operatively|1|||
94228437|NCT02171130|322630987|FG000|Overall Study|Death|1|||
94228438|NCT02171130|322630987|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
94228439|NCT02171130|322630987|FG000|Overall Study|Discontinued; Site Termination|5|||
94228440|NCT02171130|322630987|FG000|Overall Study|Withdrawal by Subject|3|||
94228441|NCT02171130|322630987|FG000|Overall Study|Physician Decision|1|||
94228442|NCT02171130|322630987|FG000|Overall Study|Lost to Follow-up|1|||
94228443|NCT02171130|322630987|FG000|Overall Study|Met Exclusion Criteria|1|||
94228444|NCT01836198|322630990|FG000|Part A, Period 2|Protocol Violation|0|||
94228445|NCT01836198|322630991|FG001|Part A, Period 2|Protocol Violation|1|||
94228446|NCT01836198|322630992|FG002|Part A, Period 2|Protocol Violation|0|||
94228447|NCT02560389|322630993|FG000|Overall Study|Lost to Follow-up|1|||
94228448|NCT02560389|322630994|FG001|Overall Study|Lost to Follow-up|2|||
94228449|NCT02560389|322630995|FG002|Overall Study|Lost to Follow-up|2|||
94228450|NCT02560389|322630993|FG000|Overall Study|Tested positive for illicit substance|0|||
94228451|NCT02560389|322630994|FG001|Overall Study|Tested positive for illicit substance|1|||
94446424|NCT02220764|323419328|FG001|Overall Study|Death|0|||
94446425|NCT02677922|323419331|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
94228452|NCT02560389|322630995|FG002|Overall Study|Tested positive for illicit substance|0|||
94228453|NCT02716298|322630996|FG000|First Intervention (1 Month)|Lens discomfort|1|||
94228454|NCT02716298|322630997|FG001|First Intervention (1 Month)|Lens discomfort|1|||
94228455|NCT02246218|322631001|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94228456|NCT02246218|322631002|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
94228457|NCT02246218|322631001|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
94228458|NCT02246218|322631002|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
94228459|NCT02246218|322631001|FG000|Overall Study|Adverse Event|1|||
94228460|NCT02246218|322631002|FG001|Overall Study|Adverse Event|1|||
94228461|NCT02246218|322631001|FG000|Overall Study|Lost to Follow-up|1|||
94228462|NCT02246218|322631002|FG001|Overall Study|Lost to Follow-up|0|||
94228463|NCT00713206|322631003|FG000|Overall Study|Lost to Follow-up|4|||
94228464|NCT00713206|322631004|FG001|Overall Study|Lost to Follow-up|4|||
94228465|NCT00713206|322631003|FG000|Overall Study|Death|1|||
94228466|NCT00713206|322631004|FG001|Overall Study|Death|0|||
94228467|NCT02547441|322631008|FG000|Double-Blind Study Period|Adverse Event|4|||
94228468|NCT02547441|322631009|FG001|Double-Blind Study Period|Adverse Event|9|||
94228469|NCT02547441|322631008|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
94228470|NCT02547441|322631009|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
94228471|NCT02547441|322631008|FG000|Double-Blind Study Period|Physician Decision|1|||
94228472|NCT02547441|322631009|FG001|Double-Blind Study Period|Physician Decision|0|||
94228473|NCT02547441|322631008|FG000|Double-Blind Study Period|Protocol Violation|1|||
94228474|NCT02547441|322631009|FG001|Double-Blind Study Period|Protocol Violation|2|||
94228475|NCT02547441|322631008|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
94228476|NCT02547441|322631009|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
94228477|NCT02547441|322631008|FG000|Double-Blind Study Period|Sponsor Decision|1|||
94228478|NCT02547441|322631009|FG001|Double-Blind Study Period|Sponsor Decision|0|||
94228479|NCT02547441|322631008|FG000|Open-Label Study Period|Adverse Event|10|||
94228480|NCT02547441|322631009|FG001|Open-Label Study Period|Adverse Event|11|||
94228481|NCT02547441|322631008|FG000|Open-Label Study Period|Lack of Efficacy|3|||
94228482|NCT02547441|322631009|FG001|Open-Label Study Period|Lack of Efficacy|2|||
94228483|NCT02547441|322631008|FG000|Open-Label Study Period|Lost to Follow-up|7|||
94228484|NCT02547441|322631009|FG001|Open-Label Study Period|Lost to Follow-up|8|||
94228485|NCT02547441|322631008|FG000|Open-Label Study Period|Physician Decision|1|||
94228486|NCT02547441|322631009|FG001|Open-Label Study Period|Physician Decision|0|||
94228487|NCT02547441|322631008|FG000|Open-Label Study Period|Protocol Violation|2|||
94446426|NCT02677922|323419332|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
94446427|NCT02677922|323419333|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
94446428|NCT02677922|323419334|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
94446429|NCT02677922|323419335|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
94446430|NCT02677922|323419336|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
94446431|NCT02677922|323419331|FG000|Treatment Period|Adverse Event|0|||
94446432|NCT02677922|323419332|FG001|Treatment Period|Adverse Event|0|||
94446433|NCT02677922|323419333|FG002|Treatment Period|Adverse Event|1|||
94228488|NCT02547441|322631009|FG001|Open-Label Study Period|Protocol Violation|0|||
94228489|NCT02547441|322631008|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
94228490|NCT02547441|322631009|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
94228491|NCT02547441|322631008|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
94228492|NCT02547441|322631009|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
94228493|NCT03927222|322631010|FG000|Overall Study|Progression|3|||
94228494|NCT03927222|322631010|FG000|Overall Study|CMV testing results inconclusive|1|||
94228495|NCT03927222|322631010|FG000|Overall Study|Unable to generate enough vaccines|1|||
94228496|NCT03927222|322631010|FG000|Overall Study|Early study termination|1|||
94446434|NCT02677922|323419334|FG003|Treatment Period|Adverse Event|3|||
94446435|NCT02677922|323419335|FG004|Treatment Period|Adverse Event|5|||
94446436|NCT02677922|323419336|FG005|Treatment Period|Adverse Event|2|||
94228497|NCT02299427|322631012|FG000|Overall Study|Withdrawal by Subject|1|||
94228498|NCT02299427|322631013|FG001|Overall Study|Withdrawal by Subject|0|||
94446437|NCT02677922|323419331|FG000|Treatment Period|Progressive Disease|1|||
94228499|NCT02299427|322631012|FG000|Overall Study|Lost to Follow-up|1|||
94228500|NCT02299427|322631013|FG001|Overall Study|Lost to Follow-up|3|||
94228501|NCT02299427|322631012|FG000|Overall Study|not adherent to dog website use|21|||
94228502|NCT02299427|322631013|FG001|Overall Study|not adherent to dog website use|0|||
94228503|NCT03974100|322631014|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
94228504|NCT03974100|322631015|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
94228505|NCT03974100|322631016|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
94228506|NCT03974100|322631017|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
94228507|NCT03974100|322631018|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
94228508|NCT03974100|322631014|FG000|TP1 - Day 1 to Week 52|Death|1|||
94228509|NCT03974100|322631015|FG001|TP1 - Day 1 to Week 52|Death|0|||
94228510|NCT03974100|322631016|FG002|TP1 - Day 1 to Week 52|Death|0|||
94228511|NCT03974100|322631017|FG003|TP1 - Day 1 to Week 52|Death|0|||
94228512|NCT03974100|322631018|FG004|TP1 - Day 1 to Week 52|Death|0|||
94228513|NCT03974100|322631014|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
94228514|NCT03974100|322631015|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
94228515|NCT03974100|322631016|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
94228516|NCT03974100|322631017|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
94228517|NCT03974100|322631018|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
94228518|NCT03974100|322631014|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
94228519|NCT03974100|322631015|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
94228520|NCT03974100|322631016|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
94228521|NCT03974100|322631017|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
94228522|NCT03974100|322631018|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
94228523|NCT03974100|322631014|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
94228524|NCT03974100|322631015|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
94228525|NCT03974100|322631016|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
94228526|NCT03974100|322631017|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
94228527|NCT03974100|322631018|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
94228528|NCT03974100|322631014|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
94228529|NCT03974100|322631015|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
94228530|NCT03974100|322631016|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
94228531|NCT03974100|322631017|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
94228532|NCT03974100|322631018|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
94228533|NCT03974100|322631014|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
94228534|NCT03974100|322631015|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
94228535|NCT03974100|322631016|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
94228536|NCT03974100|322631017|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
94228537|NCT03974100|322631018|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
94553887|NCT00615030|323824477|FG000|Period III|Administrative problems|1|||
94553888|NCT00615030|323824478|FG001|Period III|Administrative problems|0|||
94553889|NCT00615030|323824479|FG002|Period III|Administrative problems|0|||
94553890|NCT00615030|323824480|FG003|Period III|Administrative problems|1|||
94553891|NCT00615030|323824481|FG004|Period III|Administrative problems|0|||
94553892|NCT00615030|323824482|FG005|Period III|Administrative problems|0|||
94553893|NCT00615030|323824483|FG006|Period III|Administrative problems|0|||
94553894|NCT00615030|323824484|FG007|Period III|Administrative problems|0|||
94553895|NCT00615030|323824485|FG008|Period III|Administrative problems|0|||
94553896|NCT00615030|323824486|FG009|Period III|Administrative problems|0|||
94553897|NCT00615030|323824487|FG010|Period III|Administrative problems|0|||
94553898|NCT00615030|323824488|FG011|Period III|Administrative problems|0|||
94553899|NCT00320424|323824493|FG000|Overall Study|Adverse Event|3|||
94553900|NCT00320424|323824493|FG000|Overall Study|Other|3|||
94553901|NCT02942485|323824494|FG000|Overall Study|Lost to Follow-up|1|||
94553902|NCT02942485|323824495|FG001|Overall Study|Lost to Follow-up|0|||
94553903|NCT01240200|323824496|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
94553904|NCT01240200|323824497|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
94553905|NCT03178669|323824499|FG000|Overall Study|Adverse Event|4|||
94553906|NCT03178669|323824500|FG001|Overall Study|Adverse Event|1|||
94228538|NCT00001941|322631019|FG000|Overall Study|not treated- rapidly progressing disease|0|||
94228539|NCT00001941|322631020|FG001|Overall Study|not treated- rapidly progressing disease|0|||
94228540|NCT00001941|322631021|FG002|Overall Study|not treated- rapidly progressing disease|0|||
94553907|NCT03178669|323824501|FG002|Overall Study|Adverse Event|4|||
94553908|NCT03178669|323824502|FG003|Overall Study|Adverse Event|2|||
94553909|NCT03178669|323824503|FG004|Overall Study|Adverse Event|2|||
94553910|NCT03178669|323824499|FG000|Overall Study|Lack of Efficacy|0|||
94553911|NCT03178669|323824500|FG001|Overall Study|Lack of Efficacy|0|||
94553912|NCT03178669|323824501|FG002|Overall Study|Lack of Efficacy|2|||
94553913|NCT03178669|323824502|FG003|Overall Study|Lack of Efficacy|0|||
94553914|NCT03178669|323824503|FG004|Overall Study|Lack of Efficacy|1|||
94553915|NCT03178669|323824499|FG000|Overall Study|Physician Decision|0|||
94228541|NCT00001941|322631022|FG003|Overall Study|not treated- rapidly progressing disease|0|||
94553916|NCT03178669|323824500|FG001|Overall Study|Physician Decision|0|||
94228542|NCT00001941|322631023|FG004|Overall Study|not treated- rapidly progressing disease|1|||
94228543|NCT00802438|322631024|FG000|Overall Study|Screen Failure|20|||
94228544|NCT00802438|322631024|FG000|Overall Study|Withdrawal by Subject|7|||
94228545|NCT00802438|322631024|FG000|Overall Study|Physician Decision|1|||
94228546|NCT00505414|322631025|FG000|Titration Phase|Adverse Event|0|||
94228547|NCT00505414|322631026|FG001|Titration Phase|Adverse Event|0|||
94228548|NCT00505414|322631027|FG002|Titration Phase|Adverse Event|0|||
94228549|NCT00505414|322631028|FG003|Titration Phase|Adverse Event|8|||
94228550|NCT00505414|322631029|FG004|Titration Phase|Adverse Event|3|||
94228551|NCT00505414|322631025|FG000|Titration Phase|Death|0|||
94228552|NCT00505414|322631026|FG001|Titration Phase|Death|0|||
94553917|NCT03178669|323824501|FG002|Overall Study|Physician Decision|0|||
94228553|NCT00505414|322631027|FG002|Titration Phase|Death|0|||
94228554|NCT00505414|322631028|FG003|Titration Phase|Death|2|||
94228555|NCT00505414|322631029|FG004|Titration Phase|Death|0|||
94228556|NCT00505414|322631025|FG000|Titration Phase|Lack of Efficacy|0|||
94228557|NCT00505414|322631026|FG001|Titration Phase|Lack of Efficacy|0|||
94228558|NCT00505414|322631027|FG002|Titration Phase|Lack of Efficacy|0|||
94228559|NCT00505414|322631028|FG003|Titration Phase|Lack of Efficacy|10|||
94228560|NCT00505414|322631029|FG004|Titration Phase|Lack of Efficacy|1|||
94228561|NCT00505414|322631025|FG000|Titration Phase|Protocol Violation|0|||
94228562|NCT00505414|322631026|FG001|Titration Phase|Protocol Violation|0|||
94228563|NCT00505414|322631027|FG002|Titration Phase|Protocol Violation|0|||
94228564|NCT00505414|322631028|FG003|Titration Phase|Protocol Violation|0|||
94228565|NCT00505414|322631029|FG004|Titration Phase|Protocol Violation|1|||
94228566|NCT00505414|322631025|FG000|Titration Phase|Withdrawal by Subject|0|||
94228567|NCT00505414|322631026|FG001|Titration Phase|Withdrawal by Subject|0|||
94228568|NCT00505414|322631027|FG002|Titration Phase|Withdrawal by Subject|0|||
94228569|NCT00505414|322631028|FG003|Titration Phase|Withdrawal by Subject|3|||
94228570|NCT00505414|322631029|FG004|Titration Phase|Withdrawal by Subject|4|||
94228571|NCT00505414|322631025|FG000|Titration Phase|Underlying disease and therapy required|0|||
94228572|NCT00505414|322631026|FG001|Titration Phase|Underlying disease and therapy required|0|||
94228573|NCT00505414|322631027|FG002|Titration Phase|Underlying disease and therapy required|0|||
94228574|NCT00505414|322631028|FG003|Titration Phase|Underlying disease and therapy required|7|||
94228575|NCT00505414|322631029|FG004|Titration Phase|Underlying disease and therapy required|3|||
94228576|NCT00505414|322631025|FG000|Maintenance Phase|Adverse Event|2|||
94228577|NCT00505414|322631026|FG001|Maintenance Phase|Adverse Event|2|||
94228578|NCT00505414|322631027|FG002|Maintenance Phase|Adverse Event|3|||
94228579|NCT00505414|322631028|FG003|Maintenance Phase|Adverse Event|0|||
94553918|NCT03178669|323824502|FG003|Overall Study|Physician Decision|0|||
94553919|NCT03178669|323824503|FG004|Overall Study|Physician Decision|1|||
94553920|NCT03178669|323824499|FG000|Overall Study|Withdrawal by Subject|1|||
94553921|NCT03178669|323824500|FG001|Overall Study|Withdrawal by Subject|0|||
94553922|NCT03178669|323824501|FG002|Overall Study|Withdrawal by Subject|1|||
94228580|NCT00505414|322631029|FG004|Maintenance Phase|Adverse Event|0|||
94228581|NCT00505414|322631025|FG000|Maintenance Phase|Death|2|||
94553923|NCT03178669|323824502|FG003|Overall Study|Withdrawal by Subject|1|||
94553924|NCT03178669|323824503|FG004|Overall Study|Withdrawal by Subject|0|||
94228582|NCT00505414|322631026|FG001|Maintenance Phase|Death|0|||
94228583|NCT00505414|322631027|FG002|Maintenance Phase|Death|1|||
94228584|NCT00505414|322631028|FG003|Maintenance Phase|Death|0|||
94228585|NCT00505414|322631029|FG004|Maintenance Phase|Death|0|||
94228586|NCT00505414|322631025|FG000|Maintenance Phase|Lack of Efficacy|2|||
94228587|NCT00505414|322631026|FG001|Maintenance Phase|Lack of Efficacy|1|||
94228588|NCT00505414|322631027|FG002|Maintenance Phase|Lack of Efficacy|1|||
94228589|NCT00505414|322631028|FG003|Maintenance Phase|Lack of Efficacy|0|||
94228590|NCT00505414|322631029|FG004|Maintenance Phase|Lack of Efficacy|0|||
94228591|NCT00505414|322631025|FG000|Maintenance Phase|Withdrawal by Subject|0|||
94228592|NCT00505414|322631026|FG001|Maintenance Phase|Withdrawal by Subject|0|||
94228593|NCT00505414|322631027|FG002|Maintenance Phase|Withdrawal by Subject|1|||
94228594|NCT00505414|322631028|FG003|Maintenance Phase|Withdrawal by Subject|0|||
94228595|NCT00505414|322631029|FG004|Maintenance Phase|Withdrawal by Subject|0|||
94228596|NCT00505414|322631025|FG000|Maintenance Phase|underlying disease and therapy required|0|||
94228597|NCT00505414|322631026|FG001|Maintenance Phase|underlying disease and therapy required|2|||
94228598|NCT00505414|322631027|FG002|Maintenance Phase|underlying disease and therapy required|2|||
94228599|NCT00505414|322631028|FG003|Maintenance Phase|underlying disease and therapy required|0|||
94228600|NCT00505414|322631029|FG004|Maintenance Phase|underlying disease and therapy required|0|||
94228601|NCT00634920|322631030|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
94228602|NCT00634920|322631031|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
94228603|NCT00634920|322631032|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
94228604|NCT00634920|322631030|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
94228605|NCT00634920|322631031|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
94228606|NCT00634920|322631032|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
94228607|NCT00634920|322631030|FG000|Period 1 - Pre-Randomization|Rejections|0|||
94228608|NCT00634920|322631031|FG001|Period 1 - Pre-Randomization|Rejections|0|||
94228609|NCT00634920|322631032|FG002|Period 1 - Pre-Randomization|Rejections|55|||
94228610|NCT00634920|322631030|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
94228611|NCT00634920|322631031|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
94228612|NCT00634920|322631032|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
94228613|NCT00634920|322631030|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
94228614|NCT00634920|322631031|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
94228615|NCT00634920|322631032|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
94228616|NCT00634920|322631030|FG000|Period 1 - Pre-Randomization|Other issues|0|||
94228617|NCT00634920|322631031|FG001|Period 1 - Pre-Randomization|Other issues|0|||
94228618|NCT00634920|322631032|FG002|Period 1 - Pre-Randomization|Other issues|6|||
94228619|NCT00634920|322631030|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
94228620|NCT00634920|322631031|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
94228621|NCT00634920|322631032|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
94228622|NCT00634920|322631030|FG000|Period 2 - Post-Randomization|Rejection|11|||
94228623|NCT00634920|322631031|FG001|Period 2 - Post-Randomization|Rejection|5|||
94228624|NCT00634920|322631032|FG002|Period 2 - Post-Randomization|Rejection|0|||
94228625|NCT00634920|322631030|FG000|Period 2 - Post-Randomization|Death|2|||
94228626|NCT00634920|322631031|FG001|Period 2 - Post-Randomization|Death|5|||
94228627|NCT00634920|322631032|FG002|Period 2 - Post-Randomization|Death|0|||
94228628|NCT00634920|322631030|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
94228629|NCT00634920|322631031|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
94553925|NCT03178669|323824499|FG000|Overall Study|Lost to Follow-up|0|||
94228630|NCT00634920|322631032|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
94228631|NCT00634920|322631030|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
94228632|NCT00634920|322631031|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
94553926|NCT03178669|323824500|FG001|Overall Study|Lost to Follow-up|0|||
94553927|NCT03178669|323824501|FG002|Overall Study|Lost to Follow-up|0|||
94553928|NCT03178669|323824502|FG003|Overall Study|Lost to Follow-up|1|||
94553929|NCT03178669|323824503|FG004|Overall Study|Lost to Follow-up|0|||
94553930|NCT00666965|323824522|FG000|Overall Study|Adverse Event|0|||
94553931|NCT00666965|323824523|FG001|Overall Study|Adverse Event|2|||
94553932|NCT00666965|323824524|FG002|Overall Study|Adverse Event|1|||
94553933|NCT00666965|323824525|FG003|Overall Study|Adverse Event|9|||
94553934|NCT00666965|323824522|FG000|Overall Study|Lack of Efficacy|1|||
94553935|NCT00666965|323824523|FG001|Overall Study|Lack of Efficacy|1|||
94553936|NCT00666965|323824524|FG002|Overall Study|Lack of Efficacy|0|||
94553937|NCT00666965|323824525|FG003|Overall Study|Lack of Efficacy|0|||
94553938|NCT00666965|323824522|FG000|Overall Study|Protocol Violation|0|||
94553939|NCT00666965|323824523|FG001|Overall Study|Protocol Violation|0|||
94553940|NCT00666965|323824524|FG002|Overall Study|Protocol Violation|0|||
94553941|NCT00666965|323824525|FG003|Overall Study|Protocol Violation|2|||
94553942|NCT00666965|323824522|FG000|Overall Study|Discontinuation criteria|2|||
94553943|NCT00666965|323824523|FG001|Overall Study|Discontinuation criteria|1|||
94553944|NCT00666965|323824524|FG002|Overall Study|Discontinuation criteria|1|||
94553945|NCT00666965|323824525|FG003|Overall Study|Discontinuation criteria|2|||
94553946|NCT00666965|323824522|FG000|Overall Study|Withdrawal by Subject|0|||
94553947|NCT00666965|323824523|FG001|Overall Study|Withdrawal by Subject|0|||
94553948|NCT00666965|323824524|FG002|Overall Study|Withdrawal by Subject|0|||
94553949|NCT00666965|323824525|FG003|Overall Study|Withdrawal by Subject|2|||
94553950|NCT00695864|323824526|FG000|Placebo|Withdrawal by Subject|1|||
94553951|NCT00695864|323824526|FG000|Placebo|Physician Decision|4|||
94553952|NCT05392803|323824527|FG000|Overall Study|Lost to Follow-up|0|||
94553953|NCT05392803|323824528|FG001|Overall Study|Lost to Follow-up|2|||
94553954|NCT01069705|323824531|FG000|Overall Study|Adverse Event|1|||
94553955|NCT01069705|323824531|FG000|Overall Study|Withdrawal by Subject|2|||
94553956|NCT03624127|323824532|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
94553957|NCT03624127|323824533|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
94553958|NCT03624127|323824534|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
94553959|NCT03624127|323824532|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
94553960|NCT03624127|323824533|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
94553961|NCT03624127|323824534|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
94553962|NCT03624127|323824532|FG000|Treatment Week 0 - Week 16|Death|0|||
94553963|NCT03624127|323824533|FG001|Treatment Week 0 - Week 16|Death|1|||
94553964|NCT03624127|323824534|FG002|Treatment Week 0 - Week 16|Death|0|||
94553965|NCT03624127|323824532|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
94553966|NCT03624127|323824533|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
94553967|NCT03624127|323824534|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
94553968|NCT03624127|323824532|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
94553969|NCT03624127|323824533|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
94553970|NCT03624127|323824534|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
94553971|NCT03624127|323824532|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
94553972|NCT03624127|323824533|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
94553973|NCT03624127|323824534|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
94553974|NCT03624127|323824532|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
94553975|NCT03624127|323824533|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
94553976|NCT03624127|323824534|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
94553977|NCT03624127|323824532|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
94553978|NCT03624127|323824533|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
94553979|NCT03624127|323824534|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
94553980|NCT03624127|323824532|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
94553981|NCT03624127|323824533|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
94553982|NCT03624127|323824534|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
94553983|NCT03624127|323824532|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
94553984|NCT03624127|323824533|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
94553985|NCT03624127|323824534|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
94553986|NCT03624127|323824532|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
94553987|NCT03624127|323824533|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
94553988|NCT03624127|323824534|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
94553989|NCT03624127|323824532|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
94553990|NCT03624127|323824533|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
94553991|NCT03624127|323824534|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
94553992|NCT03624127|323824532|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
94553993|NCT03624127|323824533|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
94553994|NCT03624127|323824534|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
94553995|NCT03624127|323824532|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
94553996|NCT03624127|323824533|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
94553997|NCT03624127|323824534|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
94553998|NCT03624127|323824532|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
94553999|NCT03624127|323824533|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
94554000|NCT03624127|323824534|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
94554001|NCT03624127|323824532|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
94228633|NCT00634920|322631032|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
94228634|NCT02101268|322631033|FG000|Randomized Treatment Phase|Subject Decision|8|||
94228635|NCT02101268|322631034|FG001|Randomized Treatment Phase|Subject Decision|4|||
94228636|NCT02101268|322631035|FG002|Randomized Treatment Phase|Subject Decision|0|||
94228637|NCT02101268|322631036|FG003|Randomized Treatment Phase|Subject Decision|0|||
94228638|NCT02101268|322631033|FG000|Randomized Treatment Phase|Physician Decision|4|||
94228639|NCT02101268|322631034|FG001|Randomized Treatment Phase|Physician Decision|1|||
94228640|NCT02101268|322631035|FG002|Randomized Treatment Phase|Physician Decision|0|||
94228641|NCT02101268|322631036|FG003|Randomized Treatment Phase|Physician Decision|0|||
94228642|NCT02101268|322631033|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
94228643|NCT02101268|322631034|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
94228644|NCT02101268|322631035|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
94228645|NCT02101268|322631036|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
94228646|NCT02101268|322631033|FG000|Randomized Treatment Phase|Adverse Event|6|||
94228647|NCT02101268|322631034|FG001|Randomized Treatment Phase|Adverse Event|0|||
94228648|NCT02101268|322631035|FG002|Randomized Treatment Phase|Adverse Event|0|||
94228649|NCT02101268|322631036|FG003|Randomized Treatment Phase|Adverse Event|0|||
94228650|NCT02101268|322631033|FG000|Randomized Treatment Phase|Death|5|||
94228651|NCT02101268|322631034|FG001|Randomized Treatment Phase|Death|4|||
94228652|NCT02101268|322631035|FG002|Randomized Treatment Phase|Death|0|||
94228653|NCT02101268|322631036|FG003|Randomized Treatment Phase|Death|0|||
94228654|NCT02101268|322631033|FG000|Randomized Treatment Phase|Disease Progression|4|||
94228655|NCT02101268|322631034|FG001|Randomized Treatment Phase|Disease Progression|1|||
94228656|NCT02101268|322631035|FG002|Randomized Treatment Phase|Disease Progression|0|||
94228657|NCT02101268|322631036|FG003|Randomized Treatment Phase|Disease Progression|0|||
94228658|NCT02101268|322631033|FG000|Extended Treatment Phase|Subject Decision|0|||
94228659|NCT02101268|322631034|FG001|Extended Treatment Phase|Subject Decision|0|||
94228660|NCT02101268|322631035|FG002|Extended Treatment Phase|Subject Decision|3|||
94228661|NCT02101268|322631036|FG003|Extended Treatment Phase|Subject Decision|2|||
94228662|NCT02101268|322631033|FG000|Extended Treatment Phase|Physician Decision|0|||
94228663|NCT02101268|322631034|FG001|Extended Treatment Phase|Physician Decision|0|||
94228664|NCT02101268|322631035|FG002|Extended Treatment Phase|Physician Decision|5|||
94228665|NCT02101268|322631036|FG003|Extended Treatment Phase|Physician Decision|2|||
94228666|NCT02101268|322631033|FG000|Extended Treatment Phase|Adverse Event|0|||
94228667|NCT02101268|322631034|FG001|Extended Treatment Phase|Adverse Event|0|||
94228668|NCT02101268|322631035|FG002|Extended Treatment Phase|Adverse Event|14|||
94228669|NCT02101268|322631036|FG003|Extended Treatment Phase|Adverse Event|18|||
94228670|NCT02101268|322631033|FG000|Extended Treatment Phase|Death|0|||
94228671|NCT02101268|322631034|FG001|Extended Treatment Phase|Death|0|||
94228672|NCT02101268|322631035|FG002|Extended Treatment Phase|Death|5|||
94228673|NCT02101268|322631036|FG003|Extended Treatment Phase|Death|1|||
94228674|NCT02101268|322631033|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
94228675|NCT02101268|322631034|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
94228676|NCT02101268|322631035|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
94228677|NCT02101268|322631036|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
94228678|NCT02101268|322631033|FG000|Extended Treatment Phase|Disease Progression|0|||
94228679|NCT02101268|322631034|FG001|Extended Treatment Phase|Disease Progression|0|||
94228680|NCT02101268|322631035|FG002|Extended Treatment Phase|Disease Progression|13|||
94228681|NCT02101268|322631036|FG003|Extended Treatment Phase|Disease Progression|6|||
94228682|NCT02101268|322631033|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
94228683|NCT02101268|322631034|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
94228684|NCT02101268|322631035|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
94228685|NCT02101268|322631036|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
94228686|NCT04358068|322631037|FG000|Overall Study|Did not initiate study treatment|2|||
94228687|NCT04358068|322631038|FG001|Overall Study|Did not initiate study treatment|2|||
94228688|NCT04353817|322631039|FG000|Overall Study|Adverse Event|0|||
94228689|NCT04353817|322631040|FG001|Overall Study|Adverse Event|1|||
94228690|NCT00239681|322631043|FG000|Overall Study|Adverse Event|100|||
94228691|NCT00239681|322631044|FG001|Overall Study|Adverse Event|99|||
94228692|NCT00239681|322631043|FG000|Overall Study|Withdrawal by Subject|458|||
94228693|NCT00239681|322631044|FG001|Overall Study|Withdrawal by Subject|489|||
94228694|NCT00239681|322631043|FG000|Overall Study|Lost to Follow-up|28|||
94228695|NCT00239681|322631044|FG001|Overall Study|Lost to Follow-up|22|||
94228696|NCT00239681|322631043|FG000|Overall Study|Protocol Violation|4|||
94228697|NCT00239681|322631044|FG001|Overall Study|Protocol Violation|4|||
94228698|NCT00239681|322631043|FG000|Overall Study|Physician Decision|13|||
94228699|NCT00239681|322631044|FG001|Overall Study|Physician Decision|17|||
94228700|NCT00239681|322631043|FG000|Overall Study|No information chacked on CaseReportForm|90|||
94228701|NCT00239681|322631044|FG001|Overall Study|No information chacked on CaseReportForm|84|||
94228702|NCT03589300|322631050|FG000|Overall Study|Adverse Event|2|||
94228703|NCT03589300|322631050|FG000|Overall Study|Death|4|||
94228704|NCT03589300|322631050|FG000|Overall Study|Lost to Follow-up|12|||
94228705|NCT03589300|322631050|FG000|Overall Study|Withdrawal by Subject|5|||
94446438|NCT02677922|323419332|FG001|Treatment Period|Progressive Disease|1|||
94446439|NCT02677922|323419333|FG002|Treatment Period|Progressive Disease|0|||
94446440|NCT02677922|323419334|FG003|Treatment Period|Progressive Disease|0|||
94446441|NCT02677922|323419335|FG004|Treatment Period|Progressive Disease|8|||
94446442|NCT02677922|323419336|FG005|Treatment Period|Progressive Disease|7|||
94446443|NCT02677922|323419331|FG000|Treatment Period|Lack of Efficacy|0|||
94446444|NCT02677922|323419332|FG001|Treatment Period|Lack of Efficacy|0|||
94446445|NCT02677922|323419333|FG002|Treatment Period|Lack of Efficacy|0|||
94446446|NCT02677922|323419334|FG003|Treatment Period|Lack of Efficacy|1|||
94446447|NCT02677922|323419335|FG004|Treatment Period|Lack of Efficacy|1|||
94446448|NCT02677922|323419336|FG005|Treatment Period|Lack of Efficacy|6|||
94446449|NCT02677922|323419331|FG000|Treatment Period|Withdrawal by Subject|0|||
94446450|NCT02677922|323419332|FG001|Treatment Period|Withdrawal by Subject|0|||
94446451|NCT02677922|323419333|FG002|Treatment Period|Withdrawal by Subject|1|||
94446452|NCT02677922|323419334|FG003|Treatment Period|Withdrawal by Subject|3|||
94446453|NCT02677922|323419335|FG004|Treatment Period|Withdrawal by Subject|5|||
94446454|NCT02677922|323419336|FG005|Treatment Period|Withdrawal by Subject|5|||
94446455|NCT02677922|323419331|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
94446456|NCT02677922|323419332|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
94446457|NCT02677922|323419333|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
94446458|NCT02677922|323419334|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
94446459|NCT02677922|323419335|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
94228706|NCT01182207|322631051|FG000|First Intervention|Positive Hepatitis Results|0|||
94446460|NCT02677922|323419336|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
94554002|NCT03624127|323824533|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
94228707|NCT01182207|322631052|FG001|First Intervention|Positive Hepatitis Results|1|||
94228708|NCT01182207|322631051|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
94228709|NCT01182207|322631052|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
94228710|NCT01891890|322631053|FG000|Overall Study|Lost to Follow-up|0|||
94228711|NCT01891890|322631054|FG001|Overall Study|Lost to Follow-up|0|||
94228712|NCT01891890|322631055|FG002|Overall Study|Lost to Follow-up|1|||
94228713|NCT01891890|322631053|FG000|Overall Study|Study ended before endpoint reached|7|||
94228714|NCT01891890|322631054|FG001|Overall Study|Study ended before endpoint reached|3|||
94228715|NCT01891890|322631055|FG002|Overall Study|Study ended before endpoint reached|6|||
94228716|NCT01161628|322631056|FG000|Overall Study|Death|6|||
94228717|NCT01161628|322631056|FG000|Overall Study|Lack of Efficacy|2|||
94228718|NCT04969224|322631057|FG000|Overall Study|Adverse Event|1|||
94228719|NCT04969224|322631057|FG000|Overall Study|Enrolled but never dosed|1|||
94228720|NCT01801982|322631061|FG000|Overall Study|Lost to Follow-up|1|||
94228721|NCT01215032|322631062|FG000|Overall Study|Adverse Event|3|||
94228722|NCT01215032|322631062|FG000|Overall Study|Lack of Efficacy|17|||
94228723|NCT02725008|322631063|FG000|Overall Study|Lost to Follow-up|7|||
94228724|NCT02725008|322631064|FG001|Overall Study|Lost to Follow-up|9|||
94228725|NCT02725008|322631063|FG000|Overall Study|Withdrawal by Subject|2|||
94228726|NCT02725008|322631064|FG001|Overall Study|Withdrawal by Subject|2|||
94228727|NCT02725008|322631063|FG000|Overall Study|Admitted to hospital|0|||
94228728|NCT02725008|322631064|FG001|Overall Study|Admitted to hospital|1|||
94228729|NCT02970305|322631066|FG000|Overall Study|Adverse Event|10|||
94228730|NCT02970305|322631067|FG001|Overall Study|Adverse Event|6|||
94228731|NCT02970305|322631066|FG000|Overall Study|Lack of Efficacy|1|||
94228732|NCT02970305|322631067|FG001|Overall Study|Lack of Efficacy|1|||
94228733|NCT02970305|322631066|FG000|Overall Study|Noncompliance with study drug|2|||
94228734|NCT02970305|322631067|FG001|Overall Study|Noncompliance with study drug|4|||
94228735|NCT02970305|322631066|FG000|Overall Study|Protocol Violation|2|||
94228736|NCT02970305|322631067|FG001|Overall Study|Protocol Violation|2|||
94228737|NCT02970305|322631066|FG000|Overall Study|Withdrawal by Subject|12|||
94228738|NCT02970305|322631067|FG001|Overall Study|Withdrawal by Subject|11|||
94228739|NCT02970305|322631066|FG000|Overall Study|Not further specified|1|||
94228740|NCT02970305|322631067|FG001|Overall Study|Not further specified|2|||
94228741|NCT02970305|322631066|FG000|Overall Study|Lost to Follow-up|1|||
94228742|NCT02970305|322631067|FG001|Overall Study|Lost to Follow-up|2|||
94228743|NCT02650466|322631068|FG000|Overall Study|Physician Decision|1|||
94228744|NCT02650466|322631068|FG000|Overall Study|Withdrawal by Subject|5|||
94228745|NCT02650466|322631068|FG000|Overall Study|Lost to Follow-up|1|||
94228746|NCT00808899|322631070|FG000|Overall Study|Death|1|||
94228747|NCT00808899|322631070|FG000|Overall Study|Physician Decision|3|||
94228748|NCT03774875|322631071|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
94228749|NCT03774875|322631072|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
94228750|NCT03774875|322631071|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
94228751|NCT03774875|322631072|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
94228752|NCT03774875|322631071|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
94228753|NCT03774875|322631072|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
94228754|NCT03774875|322631071|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
94228755|NCT03774875|322631072|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
94228756|NCT03774875|322631071|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
94228757|NCT03774875|322631072|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
94228758|NCT03774875|322631071|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
94228759|NCT03774875|322631072|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
94228760|NCT03774875|322631071|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
94228761|NCT03774875|322631072|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
94228762|NCT03774875|322631071|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
94446461|NCT02677922|323419331|FG000|Treatment Period|Disease Relapse|0|||
94446462|NCT02677922|323419332|FG001|Treatment Period|Disease Relapse|0|||
94446463|NCT02677922|323419333|FG002|Treatment Period|Disease Relapse|0|||
94446464|NCT02677922|323419334|FG003|Treatment Period|Disease Relapse|3|||
94446465|NCT02677922|323419335|FG004|Treatment Period|Disease Relapse|6|||
94446466|NCT02677922|323419336|FG005|Treatment Period|Disease Relapse|1|||
94446467|NCT02677922|323419331|FG000|Treatment Period|Allogeneic HSCT|1|||
94446468|NCT02677922|323419332|FG001|Treatment Period|Allogeneic HSCT|0|||
94446469|NCT02677922|323419333|FG002|Treatment Period|Allogeneic HSCT|0|||
94446470|NCT02677922|323419334|FG003|Treatment Period|Allogeneic HSCT|1|||
94446471|NCT02677922|323419335|FG004|Treatment Period|Allogeneic HSCT|4|||
94446472|NCT02677922|323419336|FG005|Treatment Period|Allogeneic HSCT|1|||
94446473|NCT02677922|323419331|FG000|Treatment Period|Other Reasons|0|||
94446474|NCT02677922|323419332|FG001|Treatment Period|Other Reasons|0|||
94446475|NCT02677922|323419333|FG002|Treatment Period|Other Reasons|0|||
94446476|NCT02677922|323419334|FG003|Treatment Period|Other Reasons|1|||
94446477|NCT02677922|323419335|FG004|Treatment Period|Other Reasons|3|||
94446478|NCT02677922|323419336|FG005|Treatment Period|Other Reasons|5|||
94446479|NCT02677922|323419331|FG000|Treatment Period|Death|0|||
94446480|NCT02677922|323419332|FG001|Treatment Period|Death|0|||
94554003|NCT03624127|323824534|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
94554004|NCT03624127|323824532|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
94343476|NCT01408732|323037734|FG001|Overall Study|Withdrawal by Subject|2|||
94343477|NCT00732472|323037737|FG000|Overall Study|Adverse Event|0|||
94343478|NCT00732472|323037738|FG001|Overall Study|Adverse Event|1|||
94343479|NCT00732472|323037739|FG002|Overall Study|Adverse Event|1|||
94343480|NCT00732472|323037740|FG003|Overall Study|Adverse Event|1|||
94343481|NCT00732472|323037737|FG000|Overall Study|Protocol Violation|0|||
94343482|NCT00732472|323037738|FG001|Overall Study|Protocol Violation|0|||
94343483|NCT00732472|323037739|FG002|Overall Study|Protocol Violation|0|||
94343484|NCT00732472|323037740|FG003|Overall Study|Protocol Violation|1|||
94343485|NCT00732472|323037737|FG000|Overall Study|Withdrawal by Subject|0|||
94343486|NCT00732472|323037738|FG001|Overall Study|Withdrawal by Subject|2|||
94343487|NCT00732472|323037739|FG002|Overall Study|Withdrawal by Subject|0|||
94343488|NCT00732472|323037740|FG003|Overall Study|Withdrawal by Subject|1|||
94343489|NCT02354690|323037741|FG000|Overall Study|Physician Decision|1|||
94343490|NCT01426009|323037748|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
94343491|NCT01426009|323037748|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
94343492|NCT01426009|323037748|FG000|Washout 1|Withdrawal by Subject|1|||
94343493|NCT01426009|323037748|FG000|Washout 1|Personal Reasons|1|||
94343494|NCT01426009|323037748|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
94343495|NCT01426009|323037748|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
94343496|NCT01426009|323037748|FG000|Washout 2|electrive surgery|1|||
94343497|NCT01426009|323037748|FG000|Washout 3|personal reasons|1|||
94343498|NCT01426009|323037748|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
94343499|NCT01426009|323037748|FG000|Washout 4|Lost to Follow-up|1|||
94343500|NCT01849562|323037749|FG000|Overall Study|Lost to Follow-up|1|||
94343501|NCT01849562|323037750|FG001|Overall Study|Lost to Follow-up|0|||
94343502|NCT01849562|323037751|FG002|Overall Study|Lost to Follow-up|0|||
94554005|NCT03624127|323824533|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
94554006|NCT03624127|323824534|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
94554007|NCT03624127|323824532|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
94554008|NCT03624127|323824533|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
94554009|NCT03624127|323824534|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
94554010|NCT03624127|323824532|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
94554011|NCT03624127|323824533|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
94554012|NCT03624127|323824534|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
94554013|NCT03624127|323824532|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
94554014|NCT03624127|323824533|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
94554015|NCT03624127|323824534|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
94554016|NCT03624127|323824532|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
94554017|NCT03624127|323824533|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
94554018|NCT03624127|323824534|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
94554019|NCT00923845|323824535|FG000|Induction Therapy|Poor performance status|0|||
94554020|NCT00923845|323824536|FG001|Induction Therapy|Poor performance status|2|||
94554021|NCT03576716|323824537|FG000|Overall Study|Withdrawal by Subject|0|||
94554022|NCT03576716|323824538|FG001|Overall Study|Withdrawal by Subject|1|||
94554023|NCT00559988|323824539|FG000|Overall Study|Death|147|||
94554024|NCT00559988|323824540|FG001|Overall Study|Death|140|||
94554025|NCT00559988|323824539|FG000|Overall Study|Withdrawal by Subject|152|||
94554026|NCT00559988|323824540|FG001|Overall Study|Withdrawal by Subject|139|||
94554027|NCT00559988|323824539|FG000|Overall Study|Lost to Follow-up|42|||
94554028|NCT00559988|323824540|FG001|Overall Study|Lost to Follow-up|56|||
94554029|NCT00559988|323824539|FG000|Overall Study|ICD device explanted|10|||
94554030|NCT00559988|323824540|FG001|Overall Study|ICD device explanted|17|||
94554031|NCT02456857|323824541|FG000|Overall Study|Disease Progression|4|||
94554032|NCT00428844|323824546|FG000|Completed Study Drug Treatment|Adverse Event|2|||
94554033|NCT00428844|323824547|FG001|Completed Study Drug Treatment|Adverse Event|4|||
94554034|NCT00428844|323824548|FG002|Completed Study Drug Treatment|Adverse Event|4|||
94554035|NCT00428844|323824546|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
94554036|NCT00428844|323824547|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
94554037|NCT00428844|323824548|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
94554038|NCT00428844|323824546|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
94554039|NCT00428844|323824547|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
94554040|NCT00428844|323824548|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
94554041|NCT00428844|323824546|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
94554042|NCT00428844|323824547|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
94554043|NCT00428844|323824548|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
94554044|NCT00428844|323824546|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
94554045|NCT00428844|323824547|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
94554046|NCT00428844|323824548|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
94554047|NCT00428844|323824546|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
94554048|NCT00428844|323824547|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
94554049|NCT00428844|323824548|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
94554050|NCT00428844|323824546|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
94554051|NCT00428844|323824547|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
94554052|NCT00428844|323824548|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
94554053|NCT00428844|323824546|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
94554054|NCT00428844|323824547|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
94554055|NCT00428844|323824548|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
94554056|NCT00428844|323824546|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
94554057|NCT00428844|323824547|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
94554058|NCT00428844|323824548|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
94554059|NCT02725866|323824549|FG000|Overall Study|Failure to return|6|||
94554060|NCT02725866|323824549|FG000|Overall Study|Withdrew consent|3|||
94554061|NCT02725866|323824549|FG000|Overall Study|Insufficient virological response|1|||
94554062|NCT02725866|323824549|FG000|Overall Study|Other, not specified|4|||
94554063|NCT00605345|323824556|FG000|Overall Study|Withdrawal by Subject|1|||
94554064|NCT00605345|323824557|FG001|Overall Study|Withdrawal by Subject|0|||
94554065|NCT00605345|323824556|FG000|Overall Study|Adverse Event|0|||
94554066|NCT00605345|323824557|FG001|Overall Study|Adverse Event|1|||
94554067|NCT00605345|323824556|FG000|Overall Study|Protocol Violation|0|||
94554068|NCT00605345|323824557|FG001|Overall Study|Protocol Violation|2|||
94554069|NCT00411632|323824559|FG000|Overall Study|Death|1|||
94554070|NCT00238238|323824560|FG000|Overall Study|Withdrawal by Subject|0|||
94554071|NCT00238238|323824561|FG001|Overall Study|Withdrawal by Subject|3|||
94554072|NCT00238238|323824562|FG002|Overall Study|Withdrawal by Subject|0|||
94554073|NCT01108523|323824563|FG000|Overall Study|Protocol Violation|4|||
94554074|NCT02277119|323824565|FG000|Overall Study|Lack of Efficacy|1|||
94554075|NCT02277119|323824566|FG001|Overall Study|Lack of Efficacy|1|||
94554076|NCT02277119|323824567|FG002|Overall Study|Lack of Efficacy|1|||
94554077|NCT02277119|323824565|FG000|Overall Study|Protocol Violation|2|||
94554078|NCT02277119|323824566|FG001|Overall Study|Protocol Violation|3|||
94554079|NCT02277119|323824567|FG002|Overall Study|Protocol Violation|7|||
94554080|NCT04699461|323824568|FG000|Overall Study|Withdrawal by Subject|1|||
94554081|NCT04699461|323824569|FG001|Overall Study|Withdrawal by Subject|0|||
94554082|NCT04699461|323824568|FG000|Overall Study|Study termination by sponsor|2|||
94554083|NCT04699461|323824569|FG001|Overall Study|Study termination by sponsor|1|||
94554084|NCT04699461|323824568|FG000|Overall Study|Death|1|||
94554085|NCT04699461|323824569|FG001|Overall Study|Death|0|||
94554086|NCT04699461|323824568|FG000|Overall Study|Radiographic progression|0|||
94554087|NCT04699461|323824569|FG001|Overall Study|Radiographic progression|1|||
94554088|NCT01793883|323824570|FG000|Overall Study|Withdrawal by Subject|3|||
94554089|NCT01793883|323824571|FG001|Overall Study|Withdrawal by Subject|7|||
94554090|NCT01793883|323824572|FG002|Overall Study|Withdrawal by Subject|3|||
94554091|NCT01793883|323824570|FG000|Overall Study|Subject noncompliance|0|||
94554092|NCT01793883|323824571|FG001|Overall Study|Subject noncompliance|1|||
94554093|NCT01793883|323824572|FG002|Overall Study|Subject noncompliance|1|||
94554094|NCT01793883|323824570|FG000|Overall Study|Lost to Follow-up|5|||
94554095|NCT01793883|323824571|FG001|Overall Study|Lost to Follow-up|1|||
94554096|NCT01793883|323824572|FG002|Overall Study|Lost to Follow-up|3|||
94554097|NCT01793883|323824570|FG000|Overall Study|Randomized in error|1|||
94554098|NCT01793883|323824571|FG001|Overall Study|Randomized in error|0|||
94554099|NCT01793883|323824572|FG002|Overall Study|Randomized in error|0|||
94228763|NCT03774875|322631072|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
94446481|NCT02677922|323419333|FG002|Treatment Period|Death|0|||
94446482|NCT02677922|323419334|FG003|Treatment Period|Death|0|||
94446483|NCT02677922|323419335|FG004|Treatment Period|Death|12|||
94446484|NCT02677922|323419336|FG005|Treatment Period|Death|1|||
94446485|NCT02677922|323419331|FG000|Treatment Period|Non-compliance with Study Drug|0|||
94446486|NCT02677922|323419332|FG001|Treatment Period|Non-compliance with Study Drug|0|||
94446487|NCT02677922|323419333|FG002|Treatment Period|Non-compliance with Study Drug|0|||
94446488|NCT02677922|323419334|FG003|Treatment Period|Non-compliance with Study Drug|0|||
94446489|NCT02677922|323419335|FG004|Treatment Period|Non-compliance with Study Drug|1|||
94446490|NCT02677922|323419336|FG005|Treatment Period|Non-compliance with Study Drug|0|||
94446491|NCT02677922|323419331|FG000|Treatment Period|Physician Decision|0|||
94446492|NCT02677922|323419332|FG001|Treatment Period|Physician Decision|0|||
94446493|NCT02677922|323419333|FG002|Treatment Period|Physician Decision|0|||
94446494|NCT02677922|323419334|FG003|Treatment Period|Physician Decision|0|||
94446495|NCT02677922|323419335|FG004|Treatment Period|Physician Decision|0|||
94446496|NCT02677922|323419336|FG005|Treatment Period|Physician Decision|1|||
94446497|NCT02677922|323419331|FG000|Treatment Period|Symptomatic Deterioration|0|||
94446498|NCT02677922|323419332|FG001|Treatment Period|Symptomatic Deterioration|0|||
94446499|NCT02677922|323419333|FG002|Treatment Period|Symptomatic Deterioration|0|||
94446500|NCT02677922|323419334|FG003|Treatment Period|Symptomatic Deterioration|0|||
94228764|NCT03774875|322631071|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
94228765|NCT03774875|322631072|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
94228766|NCT03774875|322631071|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
94228767|NCT03774875|322631072|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
94228768|NCT03774875|322631071|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
94228769|NCT03774875|322631072|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
94228770|NCT03774875|322631071|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
94228771|NCT03774875|322631072|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
94228772|NCT03774875|322631071|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
94228773|NCT03774875|322631072|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
94228774|NCT01665599|322631077|FG000|Overall Study|Adverse Event|1|||
94228775|NCT01665599|322631077|FG000|Overall Study|Consent Withdrawn|1|||
94228776|NCT01665599|322631077|FG000|Overall Study|Investigator/Sponsor decision|1|||
94228777|NCT01665599|322631077|FG000|Overall Study|Death|1|||
94228778|NCT01665599|322631077|FG000|Overall Study|Lost to Follow-up|2|||
94228779|NCT01665599|322631077|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
94228780|NCT01665599|322631077|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
94228781|NCT00853021|322631078|FG000|Overall Study|Adverse Event|2|||
94228782|NCT00853021|322631078|FG000|Overall Study|Withdrawal by Subject|2|||
94228783|NCT00853021|322631078|FG000|Overall Study|Death|1|||
94228784|NCT04052997|322631079|FG000|Overall Study|Withdrawal by Subject|17|||
94228785|NCT04052997|322631079|FG000|Overall Study|Physician Decision|50|||
94228786|NCT04052997|322631079|FG000|Overall Study|Death|43|||
94228787|NCT04052997|322631079|FG000|Overall Study|Lost to Follow-up|5|||
94228788|NCT04052997|322631079|FG000|Overall Study|Progression of Disease|1|||
94228789|NCT00361842|322631082|FG000|Overall Study|Withdrawal by Subject|2|||
94228790|NCT00361842|322631083|FG001|Overall Study|Withdrawal by Subject|3|||
94228791|NCT00361842|322631082|FG000|Overall Study|Death|2|||
94228792|NCT00361842|322631083|FG001|Overall Study|Death|1|||
94228793|NCT00361842|322631082|FG000|Overall Study|Disease progression|19|||
94228794|NCT00361842|322631083|FG001|Overall Study|Disease progression|20|||
94228795|NCT00361842|322631082|FG000|Overall Study|Adverse Event|2|||
94228796|NCT00361842|322631083|FG001|Overall Study|Adverse Event|3|||
94228797|NCT00361842|322631082|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
94228798|NCT00361842|322631083|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
94228799|NCT00361842|322631082|FG000|Overall Study|Other|1|||
94228800|NCT00361842|322631083|FG001|Overall Study|Other|0|||
94228801|NCT00361842|322631082|FG000|Overall Study|Other|0|||
94228802|NCT00361842|322631083|FG001|Overall Study|Other|2|||
94228803|NCT01220856|322631084|FG000|Overall Study|graft loss|3|||
94228804|NCT01220856|322631085|FG001|Overall Study|graft loss|3|||
94228805|NCT01220856|322631084|FG000|Overall Study|Lost to Follow-up|1|||
94228806|NCT01220856|322631085|FG001|Overall Study|Lost to Follow-up|0|||
94228807|NCT04814992|322631086|FG000|Overall Study|Withdrawal by Subject|6|||
94228808|NCT04814992|322631087|FG001|Overall Study|Withdrawal by Subject|3|||
94228809|NCT04814992|322631086|FG000|Overall Study|Lost to Follow-up|1|||
94228810|NCT04814992|322631087|FG001|Overall Study|Lost to Follow-up|4|||
94228811|NCT01091519|322631093|FG000|Overall Study|Adverse Event|12|||
94228812|NCT01091519|322631094|FG001|Overall Study|Adverse Event|16|||
94228813|NCT01091519|322631093|FG000|Overall Study|Death|1|||
94228814|NCT01091519|322631094|FG001|Overall Study|Death|0|||
94228815|NCT01091519|322631093|FG000|Overall Study|Lack of Efficacy|16|||
94228816|NCT01091519|322631094|FG001|Overall Study|Lack of Efficacy|19|||
94228817|NCT01091519|322631093|FG000|Overall Study|Lost to Follow-up|14|||
94228818|NCT01091519|322631094|FG001|Overall Study|Lost to Follow-up|24|||
94228819|NCT01091519|322631093|FG000|Overall Study|Withdrawal by Subject|2|||
94446501|NCT02677922|323419335|FG004|Treatment Period|Symptomatic Deterioration|1|||
94446502|NCT02677922|323419336|FG005|Treatment Period|Symptomatic Deterioration|0|||
94446503|NCT00359424|323419347|FG000|Overall Study|Death|99|||
94446504|NCT00359424|323419348|FG001|Overall Study|Death|58|||
94446505|NCT00359424|323419347|FG000|Overall Study|Lost to Follow-up|19|||
94446506|NCT00359424|323419348|FG001|Overall Study|Lost to Follow-up|7|||
94446507|NCT00359424|323419347|FG000|Overall Study|Withdrawal by Subject|10|||
94228820|NCT01091519|322631094|FG001|Overall Study|Withdrawal by Subject|2|||
94228821|NCT01091519|322631093|FG000|Overall Study|Other|6|||
94228822|NCT01091519|322631094|FG001|Overall Study|Other|8|||
94228823|NCT01091519|322631093|FG000|Overall Study|Randomized not treated|4|||
94228824|NCT01091519|322631094|FG001|Overall Study|Randomized not treated|4|||
94228825|NCT01929876|322632538|FG000|Period 2|Non-Compliance|1|||
94228826|NCT01983462|322632541|FG000|Overall Study|Adverse Event|1|||
94228827|NCT01983462|322632542|FG001|Overall Study|Adverse Event|0|||
94228828|NCT01983462|322632543|FG002|Overall Study|Adverse Event|0|||
94228829|NCT03991988|322632544|FG000|Overall Study|Withdrawal by Subject|2|||
94228830|NCT03991988|322632545|FG001|Overall Study|Withdrawal by Subject|2|||
94228831|NCT00761956|322632546|FG000|Overall Study|Lost to Follow-up|6|||
94446508|NCT00359424|323419348|FG001|Overall Study|Withdrawal by Subject|2|||
94446509|NCT00359424|323419347|FG000|Overall Study|follow up not conducted|2|||
94446510|NCT00359424|323419348|FG001|Overall Study|follow up not conducted|0|||
94446511|NCT02259010|323419349|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
94446512|NCT02462603|323419352|FG000|Overall Study|Investigator Decision|1|||
94446513|NCT02462603|323419352|FG000|Overall Study|Non-Compliance|1|||
94446514|NCT02462603|323419352|FG000|Overall Study|Withdrawal by Subject|2|||
94446515|NCT03194542|323419353|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
94446516|NCT03194542|323419354|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
94446517|NCT03194542|323419355|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
94446518|NCT03194542|323419356|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
94446519|NCT03194542|323419353|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
94446520|NCT03194542|323419354|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
94446521|NCT03194542|323419355|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
94446522|NCT03194542|323419356|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
94446523|NCT03194542|323419353|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
94446524|NCT03194542|323419354|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
94446525|NCT03194542|323419355|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
94446526|NCT03194542|323419356|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
94446527|NCT03194542|323419353|FG000|Overall Study|Loss of Response|4|||
94446528|NCT03194542|323419354|FG001|Overall Study|Loss of Response|2|||
94446529|NCT03194542|323419355|FG002|Overall Study|Loss of Response|3|||
94446530|NCT03194542|323419356|FG003|Overall Study|Loss of Response|4|||
94446531|NCT03194542|323419353|FG000|Overall Study|Physician Decision|0|||
94446532|NCT03194542|323419354|FG001|Overall Study|Physician Decision|1|||
94446533|NCT03194542|323419355|FG002|Overall Study|Physician Decision|0|||
94446534|NCT03194542|323419356|FG003|Overall Study|Physician Decision|0|||
94446535|NCT03194542|323419353|FG000|Overall Study|Lack of Efficacy|2|||
94446536|NCT03194542|323419354|FG001|Overall Study|Lack of Efficacy|2|||
94446537|NCT03194542|323419355|FG002|Overall Study|Lack of Efficacy|2|||
94446538|NCT03194542|323419356|FG003|Overall Study|Lack of Efficacy|6|||
94446539|NCT03194542|323419353|FG000|Overall Study|Withdrawal by Subject|2|||
94446540|NCT03194542|323419354|FG001|Overall Study|Withdrawal by Subject|1|||
94446541|NCT03194542|323419355|FG002|Overall Study|Withdrawal by Subject|5|||
94446542|NCT03194542|323419356|FG003|Overall Study|Withdrawal by Subject|4|||
94446543|NCT03194542|323419353|FG000|Overall Study|Progressive Disease|1|||
94446544|NCT03194542|323419354|FG001|Overall Study|Progressive Disease|0|||
94446545|NCT03194542|323419355|FG002|Overall Study|Progressive Disease|1|||
94446546|NCT03194542|323419356|FG003|Overall Study|Progressive Disease|1|||
94446547|NCT03194542|323419353|FG000|Overall Study|Adverse Event|1|||
94446548|NCT03194542|323419354|FG001|Overall Study|Adverse Event|2|||
94446549|NCT03194542|323419355|FG002|Overall Study|Adverse Event|0|||
94446550|NCT03194542|323419356|FG003|Overall Study|Adverse Event|5|||
94446551|NCT03194542|323419353|FG000|Overall Study|Death|1|||
94446552|NCT03194542|323419354|FG001|Overall Study|Death|2|||
94446553|NCT03194542|323419355|FG002|Overall Study|Death|0|||
94446554|NCT03194542|323419356|FG003|Overall Study|Death|5|||
94446555|NCT03194542|323419353|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
94446556|NCT03194542|323419354|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
94446557|NCT03194542|323419355|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
94446558|NCT03194542|323419356|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
94446559|NCT00634036|323419357|FG000|Overall Study|Lost to Follow-up|1|||
94446560|NCT00634036|323419358|FG001|Overall Study|Lost to Follow-up|1|||
94446561|NCT00634036|323419357|FG000|Overall Study|Withdrawal by Subject|1|||
94446562|NCT00634036|323419358|FG001|Overall Study|Withdrawal by Subject|1|||
94446563|NCT04762160|323419361|FG000|Overall Study|Study terminated early due to business reasons|5|||
94446564|NCT01804946|323419363|FG000|Overall Study|Protocol Violation|1|||
94446565|NCT01804946|323419364|FG001|Overall Study|Protocol Violation|0|||
94446566|NCT01804946|323419363|FG000|Overall Study|Adverse Event|0|||
94446567|NCT01804946|323419364|FG001|Overall Study|Adverse Event|1|||
94228832|NCT00761956|322632547|FG001|Overall Study|Lost to Follow-up|11|||
94228833|NCT00761956|322632546|FG000|Overall Study|Withdrawal by Subject|3|||
94228834|NCT00761956|322632547|FG001|Overall Study|Withdrawal by Subject|8|||
94228835|NCT00761956|322632546|FG000|Overall Study|Death|0|||
94228836|NCT00761956|322632547|FG001|Overall Study|Death|1|||
94228837|NCT00761956|322632546|FG000|Overall Study|Adverse Event|26|||
94228838|NCT00761956|322632547|FG001|Overall Study|Adverse Event|34|||
94228839|NCT01222533|322632548|FG000|Overall Study|Adverse Event|5|||
94228840|NCT01222533|322632548|FG000|Overall Study|Withdrawal by Subject|5|||
94228841|NCT01222533|322632548|FG000|Overall Study|Other|4|||
94228842|NCT03418493|322632549|FG000|Overall Study|Adverse Event|1|||
94228843|NCT03418493|322632550|FG001|Overall Study|Adverse Event|0|||
94228844|NCT03418493|322632551|FG002|Overall Study|Adverse Event|0|||
94228845|NCT03418493|322632552|FG003|Overall Study|Adverse Event|0|||
94228846|NCT03418493|322632553|FG004|Overall Study|Adverse Event|0|||
94228847|NCT03418493|322632554|FG005|Overall Study|Adverse Event|0|||
94228848|NCT03418493|322632555|FG006|Overall Study|Adverse Event|0|||
94228849|NCT03418493|322632556|FG007|Overall Study|Adverse Event|0|||
94228850|NCT03418493|322632557|FG008|Overall Study|Adverse Event|0|||
94228851|NCT03418493|322632558|FG009|Overall Study|Adverse Event|0|||
94228852|NCT03418493|322632559|FG010|Overall Study|Adverse Event|0|||
94228853|NCT03418493|322632549|FG000|Overall Study|Protocol Violation|0|||
94228854|NCT03418493|322632550|FG001|Overall Study|Protocol Violation|0|||
94228855|NCT03418493|322632551|FG002|Overall Study|Protocol Violation|0|||
94228856|NCT03418493|322632552|FG003|Overall Study|Protocol Violation|0|||
94228857|NCT03418493|322632553|FG004|Overall Study|Protocol Violation|0|||
94228858|NCT03418493|322632554|FG005|Overall Study|Protocol Violation|0|||
94228859|NCT03418493|322632555|FG006|Overall Study|Protocol Violation|0|||
94228860|NCT03418493|322632556|FG007|Overall Study|Protocol Violation|0|||
94228861|NCT03418493|322632557|FG008|Overall Study|Protocol Violation|0|||
94228862|NCT03418493|322632558|FG009|Overall Study|Protocol Violation|1|||
94228863|NCT03418493|322632559|FG010|Overall Study|Protocol Violation|0|||
94228864|NCT00719212|322632560|FG000|Overall Study|Death|41|||
94228865|NCT00719212|322632560|FG000|Overall Study|Lost to Follow-up|2|||
94228866|NCT00719212|322632560|FG000|Overall Study|Withdrawal by Subject|1|||
94228867|NCT05446714|322632564|FG000|Overall Study|Lost to Follow-up|1|||
94228868|NCT05446714|322632565|FG001|Overall Study|Lost to Follow-up|3|||
94343503|NCT01849562|323037749|FG000|Overall Study|Non-compliance with Study Drug|1|||
94343504|NCT01849562|323037750|FG001|Overall Study|Non-compliance with Study Drug|0|||
94343505|NCT01849562|323037751|FG002|Overall Study|Non-compliance with Study Drug|0|||
94228869|NCT05446714|322632566|FG002|Overall Study|Lost to Follow-up|2|||
94228870|NCT05446714|322632564|FG000|Overall Study|Protocol Violation|2|||
94228871|NCT05446714|322632565|FG001|Overall Study|Protocol Violation|0|||
94228872|NCT05446714|322632566|FG002|Overall Study|Protocol Violation|0|||
94228873|NCT00983905|322632570|FG000|Theophylline Alone|Adverse Event|1|||
94228874|NCT00983905|322632570|FG000|Colchicine Alone|Adverse Event|2|||
94228875|NCT01114139|322632571|FG000|Overall Study|Adverse Event|3|||
94228876|NCT01114139|322632572|FG001|Overall Study|Adverse Event|2|||
94228877|NCT01114139|322632571|FG000|Overall Study|Lost to Follow-up|15|||
94228878|NCT01114139|322632572|FG001|Overall Study|Lost to Follow-up|3|||
94228879|NCT01114139|322632571|FG000|Overall Study|Withdrawal by Subject|17|||
94228880|NCT01114139|322632572|FG001|Overall Study|Withdrawal by Subject|6|||
94228881|NCT01114139|322632571|FG000|Overall Study|Other-Missed 1 visit|1|||
94343506|NCT02756845|323037756|FG000|Overall Study|Death|12|||
94343507|NCT02756845|323037757|FG001|Overall Study|Death|2|||
94343508|NCT02756845|323037756|FG000|Overall Study|Withdrawal by Subject|1|||
94343509|NCT02756845|323037757|FG001|Overall Study|Withdrawal by Subject|0|||
94343510|NCT00958191|323037760|FG000|Overall Study|Death|4|||
94343511|NCT00958191|323037760|FG000|Overall Study|Lost to Follow-up|5|||
94343512|NCT00958191|323037760|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
94343513|NCT00958191|323037760|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
94343514|NCT00958191|323037760|FG000|Overall Study|Revision of study device|4|||
94343515|NCT00958191|323037760|FG000|Overall Study|Site termination|11|||
94343516|NCT00958191|323037760|FG000|Overall Study|No 5 yr x-rays|56|||
94343517|NCT00611767|323037761|FG000|Overall Study|Withdrawal by Subject|4|||
94343518|NCT00611767|323037762|FG001|Overall Study|Withdrawal by Subject|1|||
94343519|NCT00611767|323037761|FG000|Overall Study|Thiopental not available|3|||
94343520|NCT00611767|323037762|FG001|Overall Study|Thiopental not available|0|||
94343521|NCT00611767|323037761|FG000|Overall Study|didn't like the medication|1|||
94343522|NCT00611767|323037762|FG001|Overall Study|didn't like the medication|1|||
94343523|NCT00611767|323037761|FG000|Overall Study|Physician Decision|1|||
94343524|NCT00611767|323037762|FG001|Overall Study|Physician Decision|0|||
94343525|NCT02972593|323037764|FG000|Overall Study|Lost to Follow-up|19|||
94343526|NCT02972593|323037765|FG001|Overall Study|Lost to Follow-up|15|||
94343527|NCT02972593|323037764|FG000|Overall Study|Protocol Violation|1|||
94228882|NCT01114139|322632572|FG001|Overall Study|Other-Missed 1 visit|0|||
94343528|NCT02972593|323037765|FG001|Overall Study|Protocol Violation|0|||
94343529|NCT01818765|323037766|FG000|Overall Study|Death|2|||
94343530|NCT00414973|323037768|FG000|Overall Study|Withdrawal by Subject|14|||
94446568|NCT01804946|323419363|FG000|Overall Study|Insufficient data available|0|||
94446569|NCT01804946|323419364|FG001|Overall Study|Insufficient data available|1|||
94446570|NCT01804946|323419363|FG000|Overall Study|Do not meet inclusion criteria|1|||
94446571|NCT01804946|323419364|FG001|Overall Study|Do not meet inclusion criteria|2|||
94446572|NCT01217112|323421270|FG000|Overall Study|Adverse Event|0|||
94446573|NCT01217112|323421271|FG001|Overall Study|Adverse Event|2|||
94446574|NCT01217112|323421272|FG002|Overall Study|Adverse Event|0|||
94446575|NCT01217112|323421273|FG003|Overall Study|Adverse Event|2|||
94446576|NCT01217112|323421274|FG004|Overall Study|Adverse Event|0|||
94446577|NCT01217112|323421270|FG000|Overall Study|Withdrawal by Subject|0|||
94446578|NCT01217112|323421271|FG001|Overall Study|Withdrawal by Subject|0|||
94554100|NCT01793883|323824570|FG000|Overall Study|Unable to complete spriometry|1|||
94554101|NCT01793883|323824571|FG001|Overall Study|Unable to complete spriometry|0|||
94446579|NCT01217112|323421272|FG002|Overall Study|Withdrawal by Subject|1|||
94554102|NCT01793883|323824572|FG002|Overall Study|Unable to complete spriometry|0|||
94446580|NCT01217112|323421273|FG003|Overall Study|Withdrawal by Subject|0|||
94446581|NCT01217112|323421274|FG004|Overall Study|Withdrawal by Subject|0|||
94446582|NCT01217112|323421270|FG000|Overall Study|Physician Decision|0|||
94446583|NCT01217112|323421271|FG001|Overall Study|Physician Decision|0|||
94446584|NCT01217112|323421272|FG002|Overall Study|Physician Decision|0|||
94446585|NCT01217112|323421273|FG003|Overall Study|Physician Decision|0|||
94446586|NCT01217112|323421274|FG004|Overall Study|Physician Decision|1|||
94446587|NCT01120184|323421275|FG000|Overall Study|Adverse Event|0|||
94446588|NCT01120184|323421276|FG001|Overall Study|Adverse Event|1|||
94446589|NCT01120184|323421277|FG002|Overall Study|Adverse Event|0|||
94446590|NCT01120184|323421275|FG000|Overall Study|Lost to Follow-up|13|||
94446591|NCT01120184|323421276|FG001|Overall Study|Lost to Follow-up|13|||
94446592|NCT01120184|323421277|FG002|Overall Study|Lost to Follow-up|11|||
94446593|NCT01120184|323421275|FG000|Overall Study|Physician Decision|9|||
94446594|NCT01120184|323421276|FG001|Overall Study|Physician Decision|1|||
94446595|NCT01120184|323421277|FG002|Overall Study|Physician Decision|3|||
94446596|NCT01120184|323421275|FG000|Overall Study|Reason not Specified|8|||
94446597|NCT01120184|323421276|FG001|Overall Study|Reason not Specified|3|||
94446598|NCT01120184|323421277|FG002|Overall Study|Reason not Specified|12|||
94446599|NCT01120184|323421275|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
94446600|NCT01120184|323421276|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
94446601|NCT01120184|323421277|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
94446602|NCT01120184|323421275|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
94446603|NCT01120184|323421276|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
94446604|NCT01120184|323421277|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
94554103|NCT01793883|323824570|FG000|Overall Study|Unable to complete measurements|1|||
94554104|NCT01793883|323824571|FG001|Overall Study|Unable to complete measurements|0|||
94554105|NCT01793883|323824572|FG002|Overall Study|Unable to complete measurements|0|||
94446605|NCT01120184|323421275|FG000|Overall Study|Death|170|||
94446606|NCT01120184|323421276|FG001|Overall Study|Death|176|||
94446607|NCT01120184|323421277|FG002|Overall Study|Death|169|||
94446608|NCT02596971|323421278|FG000|Overall Study|Death|5|||
94446609|NCT02596971|323421279|FG001|Overall Study|Death|1|||
94554106|NCT01793883|323824570|FG000|Overall Study|Met exclusion criteria|1|||
94554107|NCT01793883|323824571|FG001|Overall Study|Met exclusion criteria|0|||
94554108|NCT01793883|323824572|FG002|Overall Study|Met exclusion criteria|0|||
94554109|NCT01793883|323824570|FG000|Overall Study|Dosing error|0|||
94554110|NCT01793883|323824571|FG001|Overall Study|Dosing error|1|||
94554111|NCT01793883|323824572|FG002|Overall Study|Dosing error|0|||
94554112|NCT01793883|323824570|FG000|Overall Study|Respiratory distress during spirometry|0|||
94554113|NCT01793883|323824571|FG001|Overall Study|Respiratory distress during spirometry|0|||
94554114|NCT01793883|323824572|FG002|Overall Study|Respiratory distress during spirometry|1|||
94554115|NCT01736618|323824575|FG000|Overall Study|Death|294|||
94554116|NCT01736618|323824575|FG000|Overall Study|Lost to Follow-up|193|||
94554117|NCT01736618|323824575|FG000|Overall Study|Withdrawal by Subject|54|||
94554118|NCT01736618|323824575|FG000|Overall Study|Subject unable to be followed at study location|223|||
94554119|NCT01736618|323824575|FG000|Overall Study|Physician Decision|33|||
94554120|NCT01736618|323824575|FG000|Overall Study|Transplant or removal of target organ|19|||
94554121|NCT01736618|323824575|FG000|Overall Study|Change in indication or condition|78|||
94554122|NCT01736618|323824575|FG000|Overall Study|Study device explant|103|||
94554123|NCT01736618|323824575|FG000|Overall Study|Unable to complete implant|2|||
94554124|NCT04167137|323824577|FG000|Overall Study|Disease progression|1|||
94554125|NCT04167137|323824578|FG001|Overall Study|Disease progression|1|||
94554126|NCT04167137|323824579|FG002|Overall Study|Disease progression|3|||
94554127|NCT04167137|323824580|FG003|Overall Study|Disease progression|3|||
94554128|NCT04167137|323824581|FG004|Overall Study|Disease progression|2|||
94554129|NCT04167137|323824582|FG005|Overall Study|Disease progression|3|||
94554130|NCT04167137|323824583|FG006|Overall Study|Disease progression|2|||
94554131|NCT04167137|323824584|FG007|Overall Study|Disease progression|2|||
94554132|NCT04167137|323824577|FG000|Overall Study|Withdrawal by Subject|1|||
94554133|NCT04167137|323824578|FG001|Overall Study|Withdrawal by Subject|0|||
94554134|NCT04167137|323824579|FG002|Overall Study|Withdrawal by Subject|0|||
94554135|NCT04167137|323824580|FG003|Overall Study|Withdrawal by Subject|1|||
94554136|NCT04167137|323824581|FG004|Overall Study|Withdrawal by Subject|0|||
94554137|NCT04167137|323824582|FG005|Overall Study|Withdrawal by Subject|2|||
94554138|NCT04167137|323824583|FG006|Overall Study|Withdrawal by Subject|1|||
94554139|NCT04167137|323824584|FG007|Overall Study|Withdrawal by Subject|0|||
94554140|NCT04167137|323824577|FG000|Overall Study|Adverse Event|0|||
94554141|NCT04167137|323824578|FG001|Overall Study|Adverse Event|0|||
94554142|NCT04167137|323824579|FG002|Overall Study|Adverse Event|0|||
94554143|NCT04167137|323824580|FG003|Overall Study|Adverse Event|0|||
94554144|NCT04167137|323824581|FG004|Overall Study|Adverse Event|0|||
94554145|NCT04167137|323824582|FG005|Overall Study|Adverse Event|1|||
94554146|NCT04167137|323824583|FG006|Overall Study|Adverse Event|0|||
94554147|NCT04167137|323824584|FG007|Overall Study|Adverse Event|1|||
94554148|NCT04167137|323824577|FG000|Overall Study|Physician Decision|0|||
94554149|NCT04167137|323824578|FG001|Overall Study|Physician Decision|0|||
94554150|NCT04167137|323824579|FG002|Overall Study|Physician Decision|0|||
94554151|NCT04167137|323824580|FG003|Overall Study|Physician Decision|1|||
94554152|NCT04167137|323824581|FG004|Overall Study|Physician Decision|0|||
94554153|NCT04167137|323824582|FG005|Overall Study|Physician Decision|0|||
94554154|NCT04167137|323824583|FG006|Overall Study|Physician Decision|1|||
94554155|NCT04167137|323824584|FG007|Overall Study|Physician Decision|0|||
94554156|NCT04167137|323824577|FG000|Overall Study|Death|0|||
94554157|NCT04167137|323824578|FG001|Overall Study|Death|1|||
94554158|NCT04167137|323824579|FG002|Overall Study|Death|0|||
94554159|NCT04167137|323824580|FG003|Overall Study|Death|0|||
94228883|NCT01114139|322632571|FG000|Overall Study|Other-Protocol Violation|1|||
94228884|NCT01114139|322632572|FG001|Overall Study|Other-Protocol Violation|0|||
94554160|NCT04167137|323824581|FG004|Overall Study|Death|0|||
94554161|NCT04167137|323824582|FG005|Overall Study|Death|0|||
94554162|NCT04167137|323824583|FG006|Overall Study|Death|0|||
94554163|NCT04167137|323824584|FG007|Overall Study|Death|0|||
94554164|NCT04167137|323824577|FG000|Overall Study|Study terminated by Sponsor|0|||
94554165|NCT04167137|323824578|FG001|Overall Study|Study terminated by Sponsor|0|||
94554166|NCT04167137|323824579|FG002|Overall Study|Study terminated by Sponsor|0|||
94554167|NCT04167137|323824580|FG003|Overall Study|Study terminated by Sponsor|0|||
94554168|NCT04167137|323824581|FG004|Overall Study|Study terminated by Sponsor|0|||
94554169|NCT04167137|323824582|FG005|Overall Study|Study terminated by Sponsor|0|||
94228885|NCT01114139|322632571|FG000|Overall Study|Other-Out of window for study drug dose|1|||
94228886|NCT01114139|322632572|FG001|Overall Study|Other-Out of window for study drug dose|0|||
94554170|NCT04167137|323824583|FG006|Overall Study|Study terminated by Sponsor|0|||
94554171|NCT04167137|323824584|FG007|Overall Study|Study terminated by Sponsor|1|||
94554172|NCT00400569|323824590|FG000|Overall Study|Death|1|||
94228887|NCT01114139|322632571|FG000|Overall Study|Other-Participant falsified records|0|||
94554173|NCT01811186|323824594|FG000|Overall Study|Adverse Event|54|||
94554174|NCT01811186|323824595|FG001|Overall Study|Adverse Event|38|||
94554175|NCT01811186|323824594|FG000|Overall Study|Protocol Violation|5|||
94228888|NCT01114139|322632572|FG001|Overall Study|Other-Participant falsified records|1|||
94228889|NCT01114139|322632571|FG000|Overall Study|Other-Participant went on hospice|0|||
94228890|NCT01114139|322632572|FG001|Overall Study|Other-Participant went on hospice|1|||
94228891|NCT01114139|322632571|FG000|Overall Study|Other-Physician changed treatment|1|||
94228892|NCT01114139|322632572|FG001|Overall Study|Other-Physician changed treatment|0|||
94228893|NCT01114139|322632571|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
94228894|NCT01114139|322632572|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
94228895|NCT01243411|322632573|FG000|Overall Study|Withdrawal by Subject|18|||
94228896|NCT01243411|322632573|FG000|Overall Study|Lost to Follow-up|10|||
94228897|NCT01243411|322632573|FG000|Overall Study|Adverse Event|5|||
94228898|NCT01243411|322632573|FG000|Overall Study|Other|8|||
94228899|NCT00639769|322632574|FG000|Overall Study|Death|2|||
94228900|NCT00639769|322632574|FG000|Overall Study|Adverse Event|7|||
94228901|NCT00639769|322632574|FG000|Overall Study|Lack of Efficacy|1|||
94228902|NCT00639769|322632574|FG000|Overall Study|Disease progression|26|||
94228903|NCT00639769|322632574|FG000|Overall Study|Withdrawal by Subject|4|||
94228904|NCT00863798|322632575|FG000|Overall Study|Adverse Event|5|||
94228905|NCT00863798|322632576|FG001|Overall Study|Adverse Event|2|||
94228906|NCT00863798|322632577|FG002|Overall Study|Adverse Event|4|||
94228907|NCT00863798|322632575|FG000|Overall Study|Participant failed to return|2|||
94228908|NCT00863798|322632576|FG001|Overall Study|Participant failed to return|1|||
94228909|NCT00863798|322632577|FG002|Overall Study|Participant failed to return|0|||
94228910|NCT00863798|322632575|FG000|Overall Study|Investigator request|1|||
94228911|NCT00863798|322632576|FG001|Overall Study|Investigator request|2|||
94228912|NCT00863798|322632577|FG002|Overall Study|Investigator request|1|||
94228913|NCT00863798|322632575|FG000|Overall Study|Lack of Efficacy|4|||
94228914|NCT00863798|322632576|FG001|Overall Study|Lack of Efficacy|3|||
94228915|NCT00863798|322632577|FG002|Overall Study|Lack of Efficacy|6|||
94228916|NCT00863798|322632575|FG000|Overall Study|Lost to Follow-up|6|||
94228917|NCT00863798|322632576|FG001|Overall Study|Lost to Follow-up|9|||
94228918|NCT00863798|322632577|FG002|Overall Study|Lost to Follow-up|5|||
94228919|NCT00863798|322632575|FG000|Overall Study|Other|2|||
94228920|NCT00863798|322632576|FG001|Overall Study|Other|3|||
94228921|NCT00863798|322632577|FG002|Overall Study|Other|1|||
94228922|NCT00863798|322632575|FG000|Overall Study|Protocol Violation|0|||
94228923|NCT00863798|322632576|FG001|Overall Study|Protocol Violation|1|||
94228924|NCT00863798|322632577|FG002|Overall Study|Protocol Violation|1|||
94228925|NCT00863798|322632575|FG000|Overall Study|Withdrawal by Subject|8|||
94228926|NCT00863798|322632576|FG001|Overall Study|Withdrawal by Subject|7|||
94228927|NCT00863798|322632577|FG002|Overall Study|Withdrawal by Subject|4|||
94228928|NCT00863798|322632575|FG000|Overall Study|Randomized not treated|4|||
94228929|NCT00863798|322632576|FG001|Overall Study|Randomized not treated|2|||
94446610|NCT02596971|323421280|FG002|Overall Study|Death|5|||
94446611|NCT02596971|323421278|FG000|Overall Study|Withdrawal by Subject|5|||
94228930|NCT00863798|322632577|FG002|Overall Study|Randomized not treated|3|||
94228931|NCT01470599|322632578|FG000|Overall Study|Did not meet entrance criteria|1|||
94228932|NCT01470599|322632579|FG001|Overall Study|Did not meet entrance criteria|0|||
94228933|NCT01470599|322632578|FG000|Overall Study|Lost to Follow-up|2|||
94228934|NCT01470599|322632579|FG001|Overall Study|Lost to Follow-up|1|||
94228935|NCT01470599|322632578|FG000|Overall Study|Withdrawal by Subject|3|||
94228936|NCT01470599|322632579|FG001|Overall Study|Withdrawal by Subject|4|||
94228937|NCT01470599|322632578|FG000|Overall Study|Other|1|||
94228938|NCT01470599|322632579|FG001|Overall Study|Other|0|||
94228939|NCT01470599|322632578|FG000|Overall Study|Protocol Violation|3|||
94228940|NCT01470599|322632579|FG001|Overall Study|Protocol Violation|1|||
94228941|NCT01470599|322632578|FG000|Overall Study|Adverse event related to study drug|2|||
94228942|NCT01470599|322632579|FG001|Overall Study|Adverse event related to study drug|5|||
94228943|NCT01470599|322632578|FG000|Overall Study|Insufficient clinical response|6|||
94228944|NCT01470599|322632579|FG001|Overall Study|Insufficient clinical response|27|||
94228945|NCT01470599|322632578|FG000|Overall Study|Adverse event not related to study drug|1|||
94228946|NCT01470599|322632579|FG001|Overall Study|Adverse event not related to study drug|5|||
94228947|NCT00195442|322632580|FG000|Overall Study|Less than expected therapeutic effect|38|||
94228948|NCT00195442|322632580|FG000|Overall Study|Lost to Follow-up|27|||
94228949|NCT00195442|322632580|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
94228950|NCT00195442|322632580|FG000|Overall Study|Intermittent product shortage|21|||
94228951|NCT00195442|322632580|FG000|Overall Study|Death|7|||
94228952|NCT00195442|322632580|FG000|Overall Study|No reason specified|4|||
94228953|NCT00195442|322632580|FG000|Overall Study|Poor cooperation|2|||
94228954|NCT00195442|322632580|FG000|Overall Study|Other|14|||
94228955|NCT00847132|322632583|FG000|Overall Study|Death|1|||
94228956|NCT00847132|322632584|FG001|Overall Study|Death|1|||
94228957|NCT02637856|322632585|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
94228958|NCT02637856|322632586|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
94228959|NCT02637856|322632585|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
94228960|NCT02637856|322632586|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
94228961|NCT02637856|322632585|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
94228962|NCT02637856|322632586|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
94228963|NCT02637856|322632585|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
94228964|NCT02637856|322632586|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
94228965|NCT02637856|322632585|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
94228966|NCT02637856|322632586|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
94228967|NCT02637856|322632585|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
94228968|NCT02637856|322632586|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
94228969|NCT02637856|322632585|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
94228970|NCT02637856|322632586|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
94228971|NCT02637856|322632585|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
94228972|NCT02637856|322632586|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
94228973|NCT02637856|322632585|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
94228974|NCT02637856|322632586|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
94228975|NCT02637856|322632585|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
94228976|NCT02637856|322632586|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
94228977|NCT02637856|322632585|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
94228978|NCT02637856|322632586|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
94228979|NCT02637856|322632585|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
94446612|NCT02596971|323421279|FG001|Overall Study|Withdrawal by Subject|1|||
94446613|NCT02596971|323421280|FG002|Overall Study|Withdrawal by Subject|4|||
94446614|NCT02525783|323421281|FG000|Overall Study|Lost to Follow-up|10|||
94446615|NCT04003636|323421282|FG000|Overall Study|Death|409|||
94554176|NCT01811186|323824595|FG001|Overall Study|Protocol Violation|6|||
94554177|NCT01811186|323824594|FG000|Overall Study|Withdrawal by Subject|5|||
94554178|NCT01811186|323824595|FG001|Overall Study|Withdrawal by Subject|10|||
94554179|NCT01811186|323824594|FG000|Overall Study|Lack of Efficacy|3|||
94554180|NCT01811186|323824595|FG001|Overall Study|Lack of Efficacy|6|||
94554181|NCT01811186|323824594|FG000|Overall Study|Lost to Follow-up|4|||
94554182|NCT01811186|323824595|FG001|Overall Study|Lost to Follow-up|2|||
94554183|NCT01730586|323824596|FG000|Overall Study|Progressive Disease|2|||
94554184|NCT01730586|323824596|FG000|Overall Study|Inadequate Trial|8|||
94554185|NCT01730586|323824596|FG000|Overall Study|Adverse Event|2|||
94554186|NCT01730586|323824596|FG000|Overall Study|Hospice|1|||
94554187|NCT01431963|323824597|FG000|Overall Study|Adverse Event|18|||
94554188|NCT01431963|323824597|FG000|Overall Study|Lack of Efficacy|7|||
94554189|NCT01431963|323824597|FG000|Overall Study|Protocol Violation|1|||
94554190|NCT01431963|323824597|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
94554191|NCT01431963|323824597|FG000|Overall Study|Physician Decision|4|||
94554192|NCT01431963|323824597|FG000|Overall Study|Withdrawal by Subject|3|||
94554193|NCT02461745|323824604|FG000|Overall Study|Lack of Efficacy|9|||
94554194|NCT02461745|323824605|FG001|Overall Study|Lack of Efficacy|1|||
94554195|NCT02461745|323824604|FG000|Overall Study|Lost to Follow-up|2|||
94554196|NCT02461745|323824605|FG001|Overall Study|Lost to Follow-up|2|||
94554197|NCT02461745|323824604|FG000|Overall Study|Withdrawal by Subject|3|||
94554198|NCT02461745|323824605|FG001|Overall Study|Withdrawal by Subject|1|||
94228980|NCT02637856|322632586|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
94228981|NCT02637856|322632585|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
94228982|NCT02637856|322632586|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
94228983|NCT01057251|322632587|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
94228984|NCT01057251|322632588|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
94228985|NCT01057251|322632587|FG000|Overall Study|Adverse Event|4|||
94228986|NCT01057251|322632588|FG001|Overall Study|Adverse Event|2|||
94228987|NCT01057251|322632587|FG000|Overall Study|Lack of Efficacy|2|||
94228988|NCT01057251|322632588|FG001|Overall Study|Lack of Efficacy|11|||
94228989|NCT01057251|322632587|FG000|Overall Study|Protocol Violation|6|||
94228990|NCT01057251|322632588|FG001|Overall Study|Protocol Violation|2|||
94228991|NCT01057251|322632587|FG000|Overall Study|Withdrawal by Subject|4|||
94228992|NCT01057251|322632588|FG001|Overall Study|Withdrawal by Subject|5|||
94228993|NCT01057251|322632587|FG000|Overall Study|Lost to Follow-up|7|||
94228994|NCT01057251|322632588|FG001|Overall Study|Lost to Follow-up|6|||
94228995|NCT01057251|322632587|FG000|Overall Study|Other Reason|1|||
94228996|NCT01057251|322632588|FG001|Overall Study|Other Reason|1|||
94228997|NCT00784147|322632589|FG000|Overall Study|Lost to Follow-up|2|||
94228998|NCT00784147|322632590|FG001|Overall Study|Lost to Follow-up|4|||
94228999|NCT00784147|322632589|FG000|Overall Study|Withdrawal by Subject|1|||
94446616|NCT04003636|323421283|FG001|Overall Study|Death|443|||
94229000|NCT00784147|322632590|FG001|Overall Study|Withdrawal by Subject|3|||
94446617|NCT04003636|323421282|FG000|Overall Study|Lost to Follow-up|0|||
94343531|NCT00414973|323037769|FG001|Overall Study|Withdrawal by Subject|4|||
94343532|NCT00414973|323037770|FG002|Overall Study|Withdrawal by Subject|1|||
94343533|NCT00414973|323037771|FG003|Overall Study|Withdrawal by Subject|0|||
94343534|NCT00414973|323037768|FG000|Overall Study|Adverse Event|10|||
94343535|NCT00414973|323037769|FG001|Overall Study|Adverse Event|0|||
94343536|NCT00414973|323037770|FG002|Overall Study|Adverse Event|1|||
94343537|NCT00414973|323037771|FG003|Overall Study|Adverse Event|0|||
94343538|NCT00414973|323037768|FG000|Overall Study|Protocol Violation|3|||
94343539|NCT00414973|323037769|FG001|Overall Study|Protocol Violation|4|||
94343540|NCT00414973|323037770|FG002|Overall Study|Protocol Violation|0|||
94343541|NCT00414973|323037771|FG003|Overall Study|Protocol Violation|0|||
94343542|NCT00414973|323037768|FG000|Overall Study|Lost to Follow-up|0|||
94343543|NCT00414973|323037769|FG001|Overall Study|Lost to Follow-up|2|||
94343544|NCT00414973|323037770|FG002|Overall Study|Lost to Follow-up|0|||
94343545|NCT00414973|323037771|FG003|Overall Study|Lost to Follow-up|0|||
94343546|NCT00414973|323037768|FG000|Overall Study|Sponsor Decision|1|||
94343547|NCT00414973|323037769|FG001|Overall Study|Sponsor Decision|0|||
94343548|NCT00414973|323037770|FG002|Overall Study|Sponsor Decision|0|||
94343549|NCT00414973|323037771|FG003|Overall Study|Sponsor Decision|0|||
94343550|NCT00414973|323037768|FG000|Overall Study|Death|0|||
94343551|NCT00414973|323037769|FG001|Overall Study|Death|0|||
94343552|NCT00414973|323037770|FG002|Overall Study|Death|1|||
94343553|NCT00414973|323037771|FG003|Overall Study|Death|0|||
94343554|NCT01196091|323037776|FG000|Overall Study|Adverse Event|22|||
94343555|NCT01196091|323037777|FG001|Overall Study|Adverse Event|27|||
94343556|NCT01196091|323037778|FG002|Overall Study|Adverse Event|26|||
94343557|NCT01196091|323037776|FG000|Overall Study|Death|3|||
94343558|NCT01196091|323037777|FG001|Overall Study|Death|2|||
94343559|NCT01196091|323037778|FG002|Overall Study|Death|2|||
94343560|NCT01196091|323037776|FG000|Overall Study|Entry Criteria Not Met|11|||
94343561|NCT01196091|323037777|FG001|Overall Study|Entry Criteria Not Met|11|||
94343562|NCT01196091|323037778|FG002|Overall Study|Entry Criteria Not Met|10|||
94343563|NCT01196091|323037776|FG000|Overall Study|Lack of Efficacy|15|||
94343564|NCT01196091|323037777|FG001|Overall Study|Lack of Efficacy|12|||
94343565|NCT01196091|323037778|FG002|Overall Study|Lack of Efficacy|17|||
94343566|NCT01196091|323037776|FG000|Overall Study|Lost to Follow-up|5|||
94343567|NCT01196091|323037777|FG001|Overall Study|Lost to Follow-up|5|||
94343568|NCT01196091|323037778|FG002|Overall Study|Lost to Follow-up|6|||
94343569|NCT01196091|323037776|FG000|Overall Study|Parent/Caregiver Decision|0|||
94343570|NCT01196091|323037777|FG001|Overall Study|Parent/Caregiver Decision|0|||
94343571|NCT01196091|323037778|FG002|Overall Study|Parent/Caregiver Decision|1|||
94343572|NCT01196091|323037776|FG000|Overall Study|Withdrawal by Subject|16|||
94343573|NCT01196091|323037777|FG001|Overall Study|Withdrawal by Subject|19|||
94343574|NCT01196091|323037778|FG002|Overall Study|Withdrawal by Subject|22|||
94343575|NCT01196091|323037776|FG000|Overall Study|Physician Decision|3|||
94343576|NCT01196091|323037777|FG001|Overall Study|Physician Decision|3|||
94343577|NCT01196091|323037778|FG002|Overall Study|Physician Decision|4|||
94343578|NCT01196091|323037776|FG000|Overall Study|Protocol Violation|1|||
94343579|NCT01196091|323037777|FG001|Overall Study|Protocol Violation|3|||
94343580|NCT01196091|323037778|FG002|Overall Study|Protocol Violation|3|||
94343581|NCT01196091|323037776|FG000|Overall Study|Sponsor Decision|6|||
94343582|NCT01196091|323037777|FG001|Overall Study|Sponsor Decision|5|||
94343583|NCT01196091|323037778|FG002|Overall Study|Sponsor Decision|4|||
94343584|NCT01196091|323037776|FG000|Overall Study|Excluded Site|5|||
94343585|NCT01196091|323037777|FG001|Overall Study|Excluded Site|11|||
94343586|NCT01196091|323037778|FG002|Overall Study|Excluded Site|8|||
94343587|NCT01196091|323037776|FG000|Overall Study|Randomized, No Study Drug Received|1|||
94343588|NCT01196091|323037777|FG001|Overall Study|Randomized, No Study Drug Received|0|||
94343589|NCT01196091|323037778|FG002|Overall Study|Randomized, No Study Drug Received|1|||
94343590|NCT03330106|323037779|FG000|Part A|Withdrawal by Subject|1|||
94343591|NCT03330106|323037780|FG001|Part A|Withdrawal by Subject|1|||
94343592|NCT03330106|323037781|FG002|Part A|Withdrawal by Subject|0|||
94343593|NCT03330106|323037782|FG003|Part A|Withdrawal by Subject|0|||
94343594|NCT03330106|323037779|FG000|Part A|Death|2|||
94343595|NCT03330106|323037780|FG001|Part A|Death|1|||
94343596|NCT03330106|323037781|FG002|Part A|Death|0|||
94554199|NCT02921087|323824606|FG000|Overall Study|Withdrawal by Subject|0|||
94343597|NCT03330106|323037782|FG003|Part A|Death|0|||
94343598|NCT03330106|323037779|FG000|Part A|Adverse Event|0|||
94343599|NCT03330106|323037780|FG001|Part A|Adverse Event|1|||
94343600|NCT03330106|323037781|FG002|Part A|Adverse Event|0|||
94343601|NCT03330106|323037782|FG003|Part A|Adverse Event|0|||
94343602|NCT03330106|323037779|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
94343603|NCT03330106|323037780|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
94343604|NCT03330106|323037781|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
94343605|NCT03330106|323037782|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
94343606|NCT03330106|323037779|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
94343607|NCT03330106|323037780|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
94554200|NCT02921087|323824607|FG001|Overall Study|Withdrawal by Subject|1|||
94554201|NCT03369236|323824608|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
94554202|NCT03369236|323824609|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
94554203|NCT03369236|323824608|FG000|Open-label Extension Period|Lack of Efficacy|2|||
94554204|NCT03369236|323824609|FG001|Open-label Extension Period|Lack of Efficacy|1|||
94554205|NCT03369236|323824608|FG000|Open-label Extension Period|Adverse Event|0|||
94554206|NCT03369236|323824609|FG001|Open-label Extension Period|Adverse Event|1|||
94554207|NCT03369236|323824608|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
94554208|NCT03369236|323824609|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
94554209|NCT04230213|323824612|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
94554210|NCT04230213|323824613|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
94554211|NCT04230213|323824614|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
94554212|NCT04230213|323824612|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
94554213|NCT04230213|323824613|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
94554214|NCT04230213|323824614|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
94554215|NCT04230213|323824612|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
94554216|NCT04230213|323824613|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
94554217|NCT04230213|323824614|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
94554218|NCT04230213|323824612|FG000|TP2: Week 10 to Week 16|Other|0|||
94554219|NCT04230213|323824613|FG001|TP2: Week 10 to Week 16|Other|2|||
94554220|NCT04230213|323824614|FG002|TP2: Week 10 to Week 16|Other|1|||
94554221|NCT04230213|323824612|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
94554222|NCT04230213|323824613|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
94554223|NCT04230213|323824614|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
94554224|NCT04230213|323824612|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
94554225|NCT04230213|323824613|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
94554226|NCT04230213|323824614|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
94554227|NCT04230213|323824612|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
94554228|NCT04230213|323824613|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
94554229|NCT04230213|323824614|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
94554230|NCT04230213|323824612|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
94554231|NCT04230213|323824613|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
94554232|NCT04230213|323824614|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
94554233|NCT04230213|323824612|FG000|TP3: Week 16 to Week 22|Other|0|||
94554234|NCT04230213|323824613|FG001|TP3: Week 16 to Week 22|Other|1|||
94554235|NCT04230213|323824614|FG002|TP3: Week 16 to Week 22|Other|3|||
94554236|NCT04230213|323824612|FG000|TP4: Week 22 to Week 32|Other|0|||
94554237|NCT04230213|323824613|FG001|TP4: Week 22 to Week 32|Other|5|||
94554238|NCT04230213|323824614|FG002|TP4: Week 22 to Week 32|Other|5|||
94554239|NCT04230213|323824612|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
94554240|NCT04230213|323824613|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
94554241|NCT04230213|323824614|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
94554242|NCT04230213|323824612|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
94554243|NCT04230213|323824613|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
94554244|NCT04230213|323824614|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
94554245|NCT04230213|323824612|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
94554246|NCT04230213|323824613|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
94554247|NCT04230213|323824614|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
94554248|NCT04230213|323824612|FG000|Follow up: Week 32 to Week 36|Other|0|||
94554249|NCT04230213|323824613|FG001|Follow up: Week 32 to Week 36|Other|1|||
94554250|NCT04230213|323824614|FG002|Follow up: Week 32 to Week 36|Other|1|||
94554251|NCT00895310|323824615|FG000|Overall Study|Withdrawal by Subject|1|||
94554252|NCT00861471|323824616|FG000|Overall Study|Withdrawal by Subject|1|||
94554253|NCT00861471|323824616|FG000|Overall Study|Adverse Event|2|||
94554254|NCT00861471|323824616|FG000|Overall Study|Lack of Efficacy|3|||
94554255|NCT00861471|323824616|FG000|Overall Study|treatment for lumbar laminectomy|1|||
94554256|NCT00861471|323824616|FG000|Overall Study|Physician Decision|2|||
94554257|NCT02069392|323824619|FG000|Overall Study|Withdrawal by Subject|4|||
94554258|NCT02069392|323824620|FG001|Overall Study|Withdrawal by Subject|2|||
94554259|NCT00965419|323824621|FG000|Open Label Treatment for Responders|Adverse Event|33|||
94554260|NCT00965419|323824621|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
94554261|NCT00965419|323824621|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
94554262|NCT00965419|323824621|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
94554263|NCT00965419|323824621|FG000|Open Label Treatment for Responders|Physician Decision|6|||
94554264|NCT00965419|323824621|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
94554265|NCT00965419|323824621|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
94343608|NCT03330106|323037781|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
94554266|NCT00965419|323824621|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
94554267|NCT00965419|323824621|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
94554268|NCT00965419|323824621|FG000|Follow-up Phase|Adverse Event|9|||
94554269|NCT00965419|323824621|FG000|Follow-up Phase|Protocol Violation|4|||
94554270|NCT00965419|323824621|FG000|Follow-up Phase|Withdrawal by Subject|8|||
94554271|NCT00965419|323824621|FG000|Follow-up Phase|Physician Decision|4|||
94554272|NCT00965419|323824621|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
94554273|NCT00965419|323824621|FG000|Follow-up Phase|Lack of Efficacy|28|||
94554274|NCT04412707|323824622|FG000|Cycle 1|Death|0|||
94554275|NCT04412707|323824623|FG001|Cycle 1|Death|3|||
94554276|NCT04412707|323824622|FG000|Cycle 1|Disease progression|1|||
94554277|NCT04412707|323824623|FG001|Cycle 1|Disease progression|2|||
94554278|NCT04412707|323824622|FG000|Cycle 2|Death|0|||
94554279|NCT04412707|323824623|FG001|Cycle 2|Death|1|||
94554280|NCT04412707|323824622|FG000|Cycle 2|Disease progression|3|||
94554281|NCT04412707|323824623|FG001|Cycle 2|Disease progression|0|||
94554282|NCT04412707|323824622|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
94554283|NCT04412707|323824623|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
94554284|NCT04412707|323824622|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
94554285|NCT04412707|323824623|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
94554286|NCT04412707|323824622|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
94554287|NCT04412707|323824623|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
94554288|NCT04412707|323824622|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
94554289|NCT04412707|323824623|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
94554290|NCT02927938|323824624|FG000|Overall Study|Death|0|||
94554291|NCT02927938|323824625|FG001|Overall Study|Death|1|||
94554292|NCT02927938|323824626|FG002|Overall Study|Death|0|||
94554293|NCT02927938|323824627|FG003|Overall Study|Death|4|||
94554294|NCT02927938|323824624|FG000|Overall Study|Early Study Termination|1|||
94554295|NCT02927938|323824625|FG001|Overall Study|Early Study Termination|5|||
94554296|NCT02927938|323824626|FG002|Overall Study|Early Study Termination|4|||
94554297|NCT02927938|323824627|FG003|Overall Study|Early Study Termination|3|||
94554298|NCT03495102|323826367|FG000|Overall Study|Adverse Event|5|||
94554299|NCT03495102|323826368|FG001|Overall Study|Adverse Event|7|||
94554300|NCT03495102|323826369|FG002|Overall Study|Adverse Event|10|||
94554301|NCT03495102|323826367|FG000|Overall Study|Death|3|||
94554302|NCT03495102|323826368|FG001|Overall Study|Death|4|||
94554303|NCT03495102|323826369|FG002|Overall Study|Death|4|||
94554304|NCT03495102|323826367|FG000|Overall Study|Lost to Follow-up|15|||
94554305|NCT03495102|323826368|FG001|Overall Study|Lost to Follow-up|16|||
94554306|NCT03495102|323826369|FG002|Overall Study|Lost to Follow-up|17|||
94554307|NCT03495102|323826367|FG000|Overall Study|Physician Decision|2|||
94554308|NCT03495102|323826368|FG001|Overall Study|Physician Decision|0|||
94554309|NCT03495102|323826369|FG002|Overall Study|Physician Decision|2|||
94554310|NCT03495102|323826367|FG000|Overall Study|Withdrawal by Subject|25|||
94554311|NCT03495102|323826368|FG001|Overall Study|Withdrawal by Subject|36|||
94554312|NCT03495102|323826369|FG002|Overall Study|Withdrawal by Subject|18|||
94229001|NCT00784147|322632589|FG000|Overall Study|Physician Decision|2|||
94229002|NCT00784147|322632590|FG001|Overall Study|Physician Decision|1|||
94554313|NCT03495102|323826367|FG000|Overall Study|Protocol Violation|1|||
94554314|NCT03495102|323826368|FG001|Overall Study|Protocol Violation|1|||
94554315|NCT03495102|323826369|FG002|Overall Study|Protocol Violation|0|||
94554316|NCT03495102|323826367|FG000|Overall Study|Site Closure|3|||
94554317|NCT03495102|323826368|FG001|Overall Study|Site Closure|1|||
94554318|NCT03495102|323826369|FG002|Overall Study|Site Closure|2|||
94229003|NCT00784147|322632589|FG000|Overall Study|Protocol Violation|1|||
94554319|NCT03495102|323826367|FG000|Overall Study|Non-compliance|1|||
94229004|NCT00784147|322632590|FG001|Overall Study|Protocol Violation|1|||
94229005|NCT00784147|322632589|FG000|Overall Study|Death|2|||
94229006|NCT00784147|322632590|FG001|Overall Study|Death|0|||
94229007|NCT03596242|322632592|FG000|Overall Study|Lost to Follow-up|2|||
94229008|NCT03596242|322632593|FG001|Overall Study|Lost to Follow-up|2|||
94229009|NCT02509312|322632596|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
94229010|NCT02509312|322632597|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
94229011|NCT02509312|322632596|FG000|Overall Study|Obstetrician refusal|0|||
94229012|NCT02509312|322632597|FG001|Overall Study|Obstetrician refusal|1|||
94229013|NCT02509312|322632596|FG000|Overall Study|Patient elected for TOLAC|1|||
94229014|NCT02509312|322632597|FG001|Overall Study|Patient elected for TOLAC|0|||
94229015|NCT02509312|322632596|FG000|Overall Study|Cesarean deemed stat|1|||
94229016|NCT02509312|322632597|FG001|Overall Study|Cesarean deemed stat|0|||
94229017|NCT02509312|322632596|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
94229018|NCT02509312|322632597|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
94229019|NCT02973802|322632600|FG000|Overall Study|Lost to Follow-up|1|||
94229020|NCT02973802|322632600|FG000|Overall Study|Withdrawal by Subject|1|||
94229021|NCT03294941|322632601|FG000|Overall Study|Withdrawal by Subject|0|||
94229022|NCT03294941|322632602|FG001|Overall Study|Withdrawal by Subject|2|||
94229023|NCT00943722|322632608|FG000|Base Study|Adverse Event|0|||
94229024|NCT00943722|322632609|FG001|Base Study|Adverse Event|0|||
94229025|NCT00943722|322632610|FG002|Base Study|Adverse Event|0|||
94229026|NCT00943722|322632611|FG003|Base Study|Adverse Event|1|||
94229027|NCT00943722|322632612|FG004|Base Study|Adverse Event|0|||
94229028|NCT00943722|322632613|FG005|Base Study|Adverse Event|0|||
94229029|NCT00943722|322632614|FG006|Base Study|Adverse Event|0|||
94229030|NCT00943722|322632608|FG000|Base Study|Lost to Follow-up|12|||
94229031|NCT00943722|322632609|FG001|Base Study|Lost to Follow-up|8|||
94229032|NCT00943722|322632610|FG002|Base Study|Lost to Follow-up|10|||
94229033|NCT00943722|322632611|FG003|Base Study|Lost to Follow-up|8|||
94229034|NCT00943722|322632612|FG004|Base Study|Lost to Follow-up|11|||
94229035|NCT00943722|322632613|FG005|Base Study|Lost to Follow-up|0|||
94229036|NCT00943722|322632614|FG006|Base Study|Lost to Follow-up|0|||
94229037|NCT00943722|322632608|FG000|Base Study|Physician Decision|1|||
94229038|NCT00943722|322632609|FG001|Base Study|Physician Decision|0|||
94229039|NCT00943722|322632610|FG002|Base Study|Physician Decision|0|||
94229040|NCT00943722|322632611|FG003|Base Study|Physician Decision|0|||
94229041|NCT00943722|322632612|FG004|Base Study|Physician Decision|1|||
94229042|NCT00943722|322632613|FG005|Base Study|Physician Decision|0|||
94229043|NCT00943722|322632614|FG006|Base Study|Physician Decision|0|||
94229044|NCT00943722|322632608|FG000|Base Study|Pregnancy|0|||
94229045|NCT00943722|322632609|FG001|Base Study|Pregnancy|0|||
94229046|NCT00943722|322632610|FG002|Base Study|Pregnancy|1|||
94229047|NCT00943722|322632611|FG003|Base Study|Pregnancy|0|||
94229048|NCT00943722|322632612|FG004|Base Study|Pregnancy|2|||
94229049|NCT00943722|322632613|FG005|Base Study|Pregnancy|0|||
94229050|NCT00943722|322632614|FG006|Base Study|Pregnancy|0|||
94229051|NCT00943722|322632608|FG000|Base Study|Protocol Violation|0|||
94229052|NCT00943722|322632609|FG001|Base Study|Protocol Violation|1|||
94229053|NCT00943722|322632610|FG002|Base Study|Protocol Violation|0|||
94446618|NCT04003636|323421283|FG001|Overall Study|Lost to Follow-up|1|||
94229054|NCT00943722|322632611|FG003|Base Study|Protocol Violation|0|||
94229055|NCT00943722|322632612|FG004|Base Study|Protocol Violation|2|||
94229056|NCT00943722|322632613|FG005|Base Study|Protocol Violation|0|||
94229057|NCT00943722|322632614|FG006|Base Study|Protocol Violation|0|||
94229058|NCT00943722|322632608|FG000|Base Study|Withdrawal by Subject|12|||
94229059|NCT00943722|322632609|FG001|Base Study|Withdrawal by Subject|13|||
94229060|NCT00943722|322632610|FG002|Base Study|Withdrawal by Subject|2|||
94229061|NCT00943722|322632611|FG003|Base Study|Withdrawal by Subject|13|||
94229062|NCT00943722|322632612|FG004|Base Study|Withdrawal by Subject|8|||
94229063|NCT00943722|322632613|FG005|Base Study|Withdrawal by Subject|0|||
94229064|NCT00943722|322632614|FG006|Base Study|Withdrawal by Subject|0|||
94229065|NCT00943722|322632608|FG000|Base Study|Month 12 visit not completed|0|||
94229066|NCT00943722|322632609|FG001|Base Study|Month 12 visit not completed|0|||
94229067|NCT00943722|322632610|FG002|Base Study|Month 12 visit not completed|0|||
94229068|NCT00943722|322632611|FG003|Base Study|Month 12 visit not completed|0|||
94446619|NCT04003636|323421282|FG000|Overall Study|Withdrawal by Subject|5|||
94446620|NCT04003636|323421283|FG001|Overall Study|Withdrawal by Subject|2|||
94229069|NCT00943722|322632612|FG004|Base Study|Month 12 visit not completed|2|||
94229070|NCT00943722|322632613|FG005|Base Study|Month 12 visit not completed|0|||
94229071|NCT00943722|322632614|FG006|Base Study|Month 12 visit not completed|0|||
94229072|NCT00943722|322632608|FG000|First Extension Study: EXT 1|Adverse Event|0|||
94229073|NCT00943722|322632609|FG001|First Extension Study: EXT 1|Adverse Event|0|||
94229074|NCT00943722|322632610|FG002|First Extension Study: EXT 1|Adverse Event|0|||
94229075|NCT00943722|322632611|FG003|First Extension Study: EXT 1|Adverse Event|0|||
94229076|NCT00943722|322632612|FG004|First Extension Study: EXT 1|Adverse Event|0|||
94229077|NCT00943722|322632613|FG005|First Extension Study: EXT 1|Adverse Event|1|||
94229078|NCT00943722|322632614|FG006|First Extension Study: EXT 1|Adverse Event|0|||
94229079|NCT00943722|322632608|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
94229080|NCT00943722|322632609|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
94229081|NCT00943722|322632610|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
94229082|NCT00943722|322632611|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
94229083|NCT00943722|322632612|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
94229084|NCT00943722|322632613|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
94229085|NCT00943722|322632614|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
94229086|NCT00943722|322632608|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
94229087|NCT00943722|322632609|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
94229088|NCT00943722|322632610|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
94229089|NCT00943722|322632611|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
94229090|NCT00943722|322632612|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
94229091|NCT00943722|322632613|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
94229092|NCT00943722|322632614|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
94229093|NCT00943722|322632608|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
94229094|NCT00943722|322632609|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
94229095|NCT00943722|322632610|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
94229096|NCT00943722|322632611|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
94343609|NCT03330106|323037782|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
94229097|NCT00943722|322632612|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
94343610|NCT03330106|323037779|FG000|Part A|Progressive Disease|0|||
94343611|NCT03330106|323037780|FG001|Part A|Progressive Disease|1|||
94446621|NCT04003636|323421282|FG000|Overall Study|Participant On-going|119|||
94446622|NCT04003636|323421283|FG001|Overall Study|Participant On-going|90|||
94446623|NCT01401361|323421284|FG000|Overall Study|Withdrawal by Subject|16|||
94446624|NCT01401361|323421284|FG000|Overall Study|Lack of Efficacy|6|||
94446625|NCT01401361|323421284|FG000|Overall Study|Physician Decision|1|||
94446626|NCT01401361|323421284|FG000|Overall Study|Lost to Follow-up|3|||
94446627|NCT01401361|323421284|FG000|Overall Study|Subject/family decision post procedure|2|||
94446628|NCT00595920|323421285|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
94446629|NCT00351468|323421286|FG000|Overall Study|Adverse Event|42|||
94446630|NCT00351468|323421286|FG000|Overall Study|Withdrawal by Subject|39|||
94446631|NCT00351468|323421286|FG000|Overall Study|Various -follow up w clinical team|39|||
94446632|NCT00351468|323421286|FG000|Overall Study|Lack of Efficacy|32|||
94446633|NCT00351468|323421286|FG000|Overall Study|Non-compliance|8|||
94446634|NCT00351468|323421286|FG000|Overall Study|Lost to Follow-up|4|||
94446635|NCT00351468|323421286|FG000|Overall Study|Protocol Violation|3|||
94446636|NCT03588910|323421287|FG000|Overall Study|Withdrawal by Subject|1|||
94446637|NCT03588910|323421288|FG001|Overall Study|Withdrawal by Subject|0|||
94446638|NCT03588910|323421287|FG000|Overall Study|Allergy|2|||
94446639|NCT03588910|323421288|FG001|Overall Study|Allergy|0|||
94446640|NCT03588910|323421287|FG000|Overall Study|Protocol Violation|0|||
94446641|NCT03588910|323421288|FG001|Overall Study|Protocol Violation|3|||
94446642|NCT03588910|323421287|FG000|Overall Study|Did not complete Day 1 Survey|5|||
94554320|NCT03495102|323826368|FG001|Overall Study|Non-compliance|0|||
94554321|NCT03495102|323826369|FG002|Overall Study|Non-compliance|0|||
94554322|NCT03495102|323826367|FG000|Overall Study|Participant Duplicated at Another Site|0|||
94229098|NCT00943722|322632613|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
94229099|NCT00943722|322632614|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
94229100|NCT00943722|322632608|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
94229101|NCT00943722|322632609|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
94229102|NCT00943722|322632610|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
94229103|NCT00943722|322632611|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
94229104|NCT00943722|322632612|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
94229105|NCT00943722|322632613|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
94229106|NCT00943722|322632614|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
94229107|NCT00943722|322632608|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
94229108|NCT00943722|322632609|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
94229109|NCT00943722|322632610|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
94229110|NCT00943722|322632611|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
94229111|NCT00943722|322632612|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
94229112|NCT00943722|322632613|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
94229113|NCT00943722|322632614|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
94229114|NCT00943722|322632608|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
94229115|NCT00943722|322632609|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
94229116|NCT00943722|322632610|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
94229117|NCT00943722|322632611|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
94229118|NCT00943722|322632612|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
94229119|NCT00943722|322632613|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
94229120|NCT00943722|322632614|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
94229121|NCT00943722|322632608|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
94554323|NCT03495102|323826368|FG001|Overall Study|Participant Duplicated at Another Site|0|||
94229122|NCT00943722|322632609|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
94229123|NCT00943722|322632610|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
94229124|NCT00943722|322632611|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
94229125|NCT00943722|322632612|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
94229126|NCT00943722|322632613|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
94229127|NCT00943722|322632614|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
94229128|NCT00943722|322632608|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
94229129|NCT00943722|322632609|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
94229130|NCT00943722|322632610|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
94229131|NCT00943722|322632611|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
94229132|NCT00943722|322632612|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
94229133|NCT00943722|322632613|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
94229134|NCT00943722|322632614|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
94229135|NCT03712449|322632615|FG000|Overall Study|Withdraw Consent|0|||
94229136|NCT03712449|322632616|FG001|Overall Study|Withdraw Consent|1|||
94229137|NCT00666198|322632619|FG000|Overall Study|Protocol Violation|10|||
94229138|NCT00666198|322632619|FG000|Overall Study|No Visit After First Day of Treatment|13|||
94229139|NCT00666198|322632619|FG000|Overall Study|Safety Not Assessable|6|||
94229140|NCT00666198|322632619|FG000|Overall Study|No Drug Administration|4|||
94229141|NCT01202409|322632623|FG000|Overall Study|Adverse Event|1|||
94229142|NCT01202409|322632623|FG000|Overall Study|Ineligible - KRAS mutants|7|||
94229143|NCT01746108|322632625|FG000|Overall Study|Migrated /moved from study area|0|||
94229144|NCT01746108|322632626|FG001|Overall Study|Migrated /moved from study area|1|||
94229145|NCT01746108|322632627|FG002|Overall Study|Migrated /moved from study area|0|||
94229146|NCT01746108|322632625|FG000|Overall Study|Adverse event, non-fatal|0|||
94229147|NCT01746108|322632626|FG001|Overall Study|Adverse event, non-fatal|1|||
94229148|NCT01746108|322632627|FG002|Overall Study|Adverse event, non-fatal|0|||
94229149|NCT01746108|322632625|FG000|Overall Study|Withdrawal by Subject|0|||
94229150|NCT01746108|322632626|FG001|Overall Study|Withdrawal by Subject|1|||
94229151|NCT01746108|322632627|FG002|Overall Study|Withdrawal by Subject|0|||
94229152|NCT01746108|322632625|FG000|Overall Study|Lost to Follow-up|0|||
94343612|NCT03330106|323037781|FG002|Part A|Progressive Disease|0|||
94229153|NCT01746108|322632626|FG001|Overall Study|Lost to Follow-up|1|||
94229154|NCT01746108|322632627|FG002|Overall Study|Lost to Follow-up|0|||
94229155|NCT01774019|322632630|FG000|Overall Study|No longer meets protocol criteria|2|||
94229156|NCT01774019|322632631|FG001|Overall Study|No longer meets protocol criteria|0|||
94229157|NCT01774019|322632630|FG000|Overall Study|Withdrawal by Subject|1|||
94229158|NCT01774019|322632631|FG001|Overall Study|Withdrawal by Subject|0|||
94229159|NCT01774019|322632630|FG000|Overall Study|Surgery delayed > 120 days|1|||
94229160|NCT01774019|322632631|FG001|Overall Study|Surgery delayed > 120 days|0|||
94229161|NCT01774019|322632630|FG000|Overall Study|Patient refused surgery|1|||
94229162|NCT01774019|322632631|FG001|Overall Study|Patient refused surgery|1|||
94229163|NCT01774019|322632630|FG000|Overall Study|Unable to implant study device|1|||
94229164|NCT01774019|322632631|FG001|Overall Study|Unable to implant study device|0|||
94229165|NCT01774019|322632630|FG000|Overall Study|Lost to Follow-up|0|||
94229166|NCT01774019|322632631|FG001|Overall Study|Lost to Follow-up|3|||
94229167|NCT02777242|322632648|FG000|Overall Study|Other|2|||
94229168|NCT02777242|322632648|FG000|Overall Study|Lost to Follow-up|1|||
94229169|NCT02777242|322632648|FG000|Overall Study|Multiple|1|||
94229170|NCT02777242|322632648|FG000|Overall Study|Sponsor's request|1|||
94229171|NCT02777242|322632648|FG000|Overall Study|Withdrawal by Subject|1|||
94229172|NCT04545476|322632649|FG000|Overall Study|Lost to Follow-up|1|||
94229173|NCT04545476|322632650|FG001|Overall Study|Lost to Follow-up|1|||
94229174|NCT04545476|322632651|FG002|Overall Study|Lost to Follow-up|0|||
94343613|NCT03330106|323037782|FG003|Part A|Progressive Disease|0|||
94343614|NCT03330106|323037779|FG000|Part B|Lost to Follow-up|0|||
94343615|NCT03330106|323037780|FG001|Part B|Lost to Follow-up|0|||
94343616|NCT03330106|323037781|FG002|Part B|Lost to Follow-up|0|||
94343617|NCT03330106|323037782|FG003|Part B|Lost to Follow-up|1|||
94343618|NCT03330106|323037779|FG000|Part B|Withdrawal by Subject|0|||
94343619|NCT03330106|323037780|FG001|Part B|Withdrawal by Subject|0|||
94343620|NCT03330106|323037781|FG002|Part B|Withdrawal by Subject|4|||
94343621|NCT03330106|323037782|FG003|Part B|Withdrawal by Subject|0|||
94343622|NCT03330106|323037779|FG000|Part B|Death|0|||
94343623|NCT03330106|323037780|FG001|Part B|Death|0|||
94343624|NCT03330106|323037781|FG002|Part B|Death|2|||
94343625|NCT03330106|323037782|FG003|Part B|Death|0|||
94343626|NCT03330106|323037779|FG000|Part B|Clinical Progression|0|||
94343627|NCT03330106|323037780|FG001|Part B|Clinical Progression|0|||
94343628|NCT03330106|323037781|FG002|Part B|Clinical Progression|1|||
94343629|NCT03330106|323037782|FG003|Part B|Clinical Progression|1|||
94343630|NCT03330106|323037779|FG000|Part B|Symptomatic Deterioration|0|||
94343631|NCT03330106|323037780|FG001|Part B|Symptomatic Deterioration|0|||
94343632|NCT03330106|323037781|FG002|Part B|Symptomatic Deterioration|0|||
94343633|NCT03330106|323037782|FG003|Part B|Symptomatic Deterioration|1|||
94343634|NCT03330106|323037779|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
94343635|NCT03330106|323037780|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
94343636|NCT03330106|323037781|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
94343637|NCT03330106|323037782|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
94343638|NCT03330106|323037779|FG000|Part B|Progressive Disease|0|||
94343639|NCT03330106|323037780|FG001|Part B|Progressive Disease|0|||
94343640|NCT03330106|323037781|FG002|Part B|Progressive Disease|11|||
94343641|NCT03330106|323037782|FG003|Part B|Progressive Disease|4|||
94343642|NCT04247828|323037784|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
94343643|NCT00893763|323037785|FG000|Overall Study|extubated|110|||
94343644|NCT00893763|323037786|FG001|Overall Study|extubated|110|||
94343645|NCT02324049|323037787|FG000|Part C|Study terminated|11|||
94343646|NCT02159365|323037790|FG000|Overall Study|Disease Progression|23|||
94343647|NCT02159365|323037790|FG000|Overall Study|Other reasons|11|||
94343648|NCT02159365|323037790|FG000|Overall Study|Administrative reason by Sponsor|9|||
94343649|NCT02159365|323037790|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
94343650|NCT02159365|323037790|FG000|Overall Study|Study drug toxicity|7|||
94343651|NCT02159365|323037790|FG000|Overall Study|Maximum clinical benefit|3|||
94343652|NCT02159365|323037790|FG000|Overall Study|Subject request to discontinue treatment|3|||
94343653|NCT02159365|323037790|FG000|Overall Study|Subject withdrew consent|3|||
94343654|NCT02159365|323037790|FG000|Overall Study|Death|1|||
94343655|NCT02159365|323037790|FG000|Overall Study|Lost to Follow-up|1|||
94343656|NCT00796549|323037791|FG000|Overall Study|Adverse Event|11|||
94343657|NCT00796549|323037791|FG000|Overall Study|not entered|149|||
94343658|NCT00796549|323037791|FG000|Overall Study|Other|2|||
94343659|NCT00796549|323037791|FG000|Overall Study|Progressive disease|56|||
94343660|NCT02139280|323037793|FG000|Overall Study|No longer eligible|2|||
94343661|NCT02139280|323037794|FG001|Overall Study|No longer eligible|0|||
94343662|NCT00654368|323037804|FG000|Overall Study|Ineligibility determined|6|||
94343663|NCT00654368|323037805|FG001|Overall Study|Ineligibility determined|0|||
94343664|NCT00654368|323037806|FG002|Overall Study|Ineligibility determined|0|||
94343665|NCT00654368|323037804|FG000|Overall Study|Protocol deviation|3|||
94343666|NCT00654368|323037805|FG001|Overall Study|Protocol deviation|2|||
94343667|NCT00654368|323037806|FG002|Overall Study|Protocol deviation|1|||
94343668|NCT00654368|323037804|FG000|Overall Study|Non-compliance|2|||
94343669|NCT00654368|323037805|FG001|Overall Study|Non-compliance|1|||
94343670|NCT00654368|323037806|FG002|Overall Study|Non-compliance|2|||
94343671|NCT00654368|323037804|FG000|Overall Study|Withdrawal by Subject|5|||
94343672|NCT00654368|323037805|FG001|Overall Study|Withdrawal by Subject|2|||
94343673|NCT00654368|323037806|FG002|Overall Study|Withdrawal by Subject|2|||
94343674|NCT00654368|323037804|FG000|Overall Study|Disease progression|21|||
94229175|NCT04545476|322632652|FG003|Overall Study|Lost to Follow-up|0|||
94229176|NCT00690378|322632658|FG000|Overall Study|Adverse Event|1|||
94229177|NCT00690378|322632659|FG001|Overall Study|Adverse Event|0|||
94229178|NCT00690378|322632658|FG000|Overall Study|Withdrawal by Subject|2|||
94229179|NCT00690378|322632659|FG001|Overall Study|Withdrawal by Subject|0|||
94229180|NCT00690378|322632658|FG000|Overall Study|Protocol Violation|1|||
94229181|NCT00690378|322632659|FG001|Overall Study|Protocol Violation|0|||
94229182|NCT00690378|322632658|FG000|Overall Study|Lost to Follow-up|2|||
94229183|NCT00690378|322632659|FG001|Overall Study|Lost to Follow-up|3|||
94229184|NCT00690378|322632658|FG000|Overall Study|Did not meet inc/exc criteria|13|||
94229185|NCT00690378|322632659|FG001|Overall Study|Did not meet inc/exc criteria|11|||
94229186|NCT00690378|322632658|FG000|Overall Study|Social problem|1|||
94446643|NCT03588910|323421288|FG001|Overall Study|Did not complete Day 1 Survey|10|||
94446644|NCT03588910|323421287|FG000|Overall Study|Did not complete Day 7 Survey|5|||
94446645|NCT03588910|323421288|FG001|Overall Study|Did not complete Day 7 Survey|2|||
94446646|NCT00866281|323421289|FG000|Overall Study|Adverse Event|1|||
94446647|NCT00866281|323421290|FG001|Overall Study|Adverse Event|0|||
94229187|NCT00690378|322632659|FG001|Overall Study|Social problem|0|||
94229188|NCT03318783|322632660|FG000|Overall Study|Withdrawal by Subject|0|||
94229189|NCT03318783|322632661|FG001|Overall Study|Withdrawal by Subject|1|||
94446648|NCT00866281|323421289|FG000|Overall Study|Withdrawal by participants|3|||
94446649|NCT00866281|323421290|FG001|Overall Study|Withdrawal by participants|0|||
94229190|NCT03318783|322632660|FG000|Overall Study|Death|0|||
94446650|NCT00866281|323421289|FG000|Overall Study|Disease progression|3|||
94229191|NCT03318783|322632661|FG001|Overall Study|Death|1|||
94229192|NCT00591591|322632662|FG000|Overall Study|Withdrawal by Subject|1|||
94229193|NCT00591591|322632663|FG001|Overall Study|Withdrawal by Subject|37|||
94229194|NCT00591591|322632662|FG000|Overall Study|Lack of Efficacy|10|||
94229195|NCT00591591|322632663|FG001|Overall Study|Lack of Efficacy|2|||
94229196|NCT00002597|322632664|FG000|Overall Study|Protocol Violation|19|||
94229197|NCT00002597|322632665|FG001|Overall Study|Protocol Violation|17|||
94229198|NCT00002597|322632664|FG000|Overall Study|Withdrawal by Subject|7|||
94229199|NCT00002597|322632665|FG001|Overall Study|Withdrawal by Subject|6|||
94229200|NCT01841112|322632668|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
94229201|NCT01841112|322632669|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
94446651|NCT00866281|323421290|FG001|Overall Study|Disease progression|11|||
94446652|NCT00866281|323421289|FG000|Overall Study|New cancer therapy|0|||
94229202|NCT01841112|322632670|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
94343675|NCT00654368|323037805|FG001|Overall Study|Disease progression|31|||
94343676|NCT00654368|323037806|FG002|Overall Study|Disease progression|13|||
94229203|NCT01841112|322632671|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
94229204|NCT01841112|322632672|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
94229205|NCT01242371|322632675|FG000|Overall Study|Withdrawal by Subject|2|||
94229206|NCT01242371|322632676|FG001|Overall Study|Withdrawal by Subject|2|||
94229207|NCT01242371|322632675|FG000|Overall Study|Protocol Violation|0|||
94229208|NCT01242371|322632676|FG001|Overall Study|Protocol Violation|3|||
94229209|NCT00510146|322632677|FG000|Double-Blind Treatment|Adverse Event|30|||
94229210|NCT00510146|322632678|FG001|Double-Blind Treatment|Adverse Event|13|||
94229211|NCT00510146|322632677|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
94229212|NCT00510146|322632678|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
94229213|NCT00510146|322632677|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
94446653|NCT00866281|323421290|FG001|Overall Study|New cancer therapy|4|||
94446654|NCT01894841|323421293|FG000|Overall Study|Withdrawal by Subject|9|||
94446655|NCT01894841|323421294|FG001|Overall Study|Withdrawal by Subject|4|||
94446656|NCT01894841|323421293|FG000|Overall Study|Withdrawn by investigator|2|||
94446657|NCT01894841|323421294|FG001|Overall Study|Withdrawn by investigator|2|||
94446658|NCT01894841|323421293|FG000|Overall Study|Lost to Follow-up|7|||
94446659|NCT01894841|323421294|FG001|Overall Study|Lost to Follow-up|3|||
94446660|NCT01100086|323421295|FG000|Period 1|Withdrawal by Subject|1|||
94446661|NCT01100086|323421296|FG001|Period 1|Withdrawal by Subject|0|||
94446662|NCT02954601|323421301|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
94446663|NCT02954601|323421302|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
94446664|NCT02954601|323421303|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
94446665|NCT02954601|323421304|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
94446666|NCT05140915|323421305|FG000|Overall Study|Lost to Follow-up|2|||
94446667|NCT05140915|323421306|FG001|Overall Study|Lost to Follow-up|1|||
94446668|NCT00455403|323421311|FG000|Overall Study|Lost to Follow-up|2|||
94446669|NCT00455403|323421312|FG001|Overall Study|Lost to Follow-up|1|||
94446670|NCT00455403|323421311|FG000|Overall Study|Withdrawal by Subject|1|||
94446671|NCT00455403|323421312|FG001|Overall Study|Withdrawal by Subject|3|||
94446672|NCT00455403|323421311|FG000|Overall Study|Protocol Violation|0|||
94446673|NCT00455403|323421312|FG001|Overall Study|Protocol Violation|2|||
94446674|NCT00495391|323421315|FG000|Overall Study|Lack of Efficacy|34|||
94446675|NCT00495391|323421316|FG001|Overall Study|Lack of Efficacy|18|||
94446676|NCT00495391|323421315|FG000|Overall Study|Withdrawal by Subject|2|||
94446677|NCT00495391|323421316|FG001|Overall Study|Withdrawal by Subject|3|||
94446678|NCT03875508|323421317|FG000|Overall Study|Adverse Event|1|||
94446679|NCT03875508|323421317|FG000|Overall Study|Lost to Follow-up|8|||
94446680|NCT03875508|323421317|FG000|Overall Study|Lack of Efficacy|1|||
94446681|NCT03875508|323421317|FG000|Overall Study|Other, not specified|2|||
94446682|NCT03802825|323421326|FG000|Overall Study|Lost to follow-up for intervention|12|||
94446683|NCT03802825|323421327|FG001|Overall Study|Lost to follow-up for intervention|3|||
94446684|NCT03802825|323421326|FG000|Overall Study|Received only 1 component of intervention|0|||
94446685|NCT03802825|323421327|FG001|Overall Study|Received only 1 component of intervention|13|||
94446686|NCT00063934|323421328|FG000|Overall Study|Ineligible|1|||
94446687|NCT03428152|323421329|FG000|Overall Study|Physician Decision|4|||
94446688|NCT03428152|323421330|FG001|Overall Study|Physician Decision|2|||
94446689|NCT03428152|323421329|FG000|Overall Study|Protocol Violation|3|||
94446690|NCT03428152|323421330|FG001|Overall Study|Protocol Violation|5|||
94446691|NCT03428152|323421329|FG000|Overall Study|Lack of Efficacy|0|||
94446692|NCT03428152|323421330|FG001|Overall Study|Lack of Efficacy|4|||
94446693|NCT00925704|323421331|FG000|First Intervention|Withdrew consent|0|||
94446694|NCT00925704|323421332|FG001|First Intervention|Withdrew consent|0|||
94446695|NCT00925704|323421333|FG002|First Intervention|Withdrew consent|0|||
94446696|NCT00925704|323421334|FG003|First Intervention|Withdrew consent|1|||
94446697|NCT00925704|323421335|FG004|First Intervention|Withdrew consent|1|||
94446698|NCT00925704|323421336|FG005|First Intervention|Withdrew consent|0|||
94446699|NCT00925704|323421331|FG000|Second Intervention|Withdrawal by Subject|1|||
94446700|NCT00925704|323421332|FG001|Second Intervention|Withdrawal by Subject|0|||
94446701|NCT00925704|323421333|FG002|Second Intervention|Withdrawal by Subject|0|||
94446702|NCT00925704|323421334|FG003|Second Intervention|Withdrawal by Subject|0|||
94446703|NCT00925704|323421335|FG004|Second Intervention|Withdrawal by Subject|1|||
94554324|NCT03495102|323826369|FG002|Overall Study|Participant Duplicated at Another Site|1|||
94554325|NCT03495102|323826367|FG000|Overall Study|Primary Care Physician Recommendation|0|||
94229214|NCT00510146|322632678|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
94229215|NCT00510146|322632677|FG000|Double-Blind Treatment|Physician Decision|6|||
94229216|NCT00510146|322632678|FG001|Double-Blind Treatment|Physician Decision|0|||
94229217|NCT00510146|322632677|FG000|Double-Blind Treatment|Protocol Violation|1|||
94229218|NCT00510146|322632678|FG001|Double-Blind Treatment|Protocol Violation|2|||
94229219|NCT00510146|322632677|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
94229220|NCT00510146|322632678|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
94446704|NCT00925704|323421336|FG005|Second Intervention|Withdrawal by Subject|0|||
94446705|NCT00925704|323421331|FG000|Third Intervention|Withdrew consent|0|||
94446706|NCT00925704|323421332|FG001|Third Intervention|Withdrew consent|0|||
94446707|NCT00925704|323421333|FG002|Third Intervention|Withdrew consent|0|||
94446708|NCT00925704|323421334|FG003|Third Intervention|Withdrew consent|0|||
94446709|NCT00925704|323421335|FG004|Third Intervention|Withdrew consent|0|||
94229221|NCT00510146|322632677|FG000|Double-Blind Treatment|Clinical Relapse|0|||
94229222|NCT00510146|322632678|FG001|Double-Blind Treatment|Clinical Relapse|1|||
94229223|NCT00510146|322632677|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
94229224|NCT00510146|322632678|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
94229225|NCT00510146|322632677|FG000|Open-Label Treatment|Adverse Event|22|||
94229226|NCT00510146|322632678|FG001|Open-Label Treatment|Adverse Event|8|||
94229227|NCT00510146|322632677|FG000|Open-Label Treatment|Death|1|||
94229228|NCT00510146|322632678|FG001|Open-Label Treatment|Death|1|||
94446710|NCT00925704|323421336|FG005|Third Intervention|Withdrew consent|1|||
94446711|NCT01293695|323421337|FG000|Overall Study|Withdrawal by Subject|7|||
94446712|NCT01293695|323421338|FG001|Overall Study|Withdrawal by Subject|1|||
94446713|NCT01293695|323421337|FG000|Overall Study|Lost to Follow-up|8|||
94446714|NCT01293695|323421338|FG001|Overall Study|Lost to Follow-up|6|||
94446715|NCT02570308|323421339|FG000|Overall Study|Death|1|||
94446716|NCT02570308|323421340|FG001|Overall Study|Death|5|||
94446717|NCT02570308|323421341|FG002|Overall Study|Death|4|||
94446718|NCT02570308|323421342|FG003|Overall Study|Death|4|||
94446719|NCT02570308|323421343|FG004|Overall Study|Death|69|||
94446720|NCT02570308|323421339|FG000|Overall Study|Lost to Follow-up|0|||
94446721|NCT02570308|323421340|FG001|Overall Study|Lost to Follow-up|0|||
94446722|NCT02570308|323421341|FG002|Overall Study|Lost to Follow-up|0|||
94446723|NCT02570308|323421342|FG003|Overall Study|Lost to Follow-up|0|||
94446724|NCT02570308|323421343|FG004|Overall Study|Lost to Follow-up|2|||
94446725|NCT02570308|323421339|FG000|Overall Study|Withdrawal by Subject|0|||
94446726|NCT02570308|323421340|FG001|Overall Study|Withdrawal by Subject|0|||
94446727|NCT02570308|323421341|FG002|Overall Study|Withdrawal by Subject|0|||
94446728|NCT02570308|323421342|FG003|Overall Study|Withdrawal by Subject|0|||
94446729|NCT02570308|323421343|FG004|Overall Study|Withdrawal by Subject|1|||
94446730|NCT02570308|323421339|FG000|Overall Study|Other|0|||
94446731|NCT02570308|323421340|FG001|Overall Study|Other|0|||
94446732|NCT02570308|323421341|FG002|Overall Study|Other|0|||
94446733|NCT02570308|323421342|FG003|Overall Study|Other|0|||
94446734|NCT02570308|323421343|FG004|Overall Study|Other|2|||
94446735|NCT04548193|323421347|FG000|Overall Study|Lost to Follow-up|0|||
94446736|NCT04548193|323421348|FG001|Overall Study|Lost to Follow-up|1|||
94446737|NCT04548193|323421347|FG000|Overall Study|Death|0|||
94446738|NCT04548193|323421348|FG001|Overall Study|Death|1|||
94446739|NCT04548193|323421347|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
94446740|NCT04548193|323421348|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
94446741|NCT04548193|323421347|FG000|Overall Study|Withdrawal by Subject|2|||
94446742|NCT04548193|323421348|FG001|Overall Study|Withdrawal by Subject|2|||
94446743|NCT02042014|323421349|FG000|Overall Study|Adverse Event|1|||
94446744|NCT02042014|323421349|FG000|Overall Study|Physician Decision|7|||
94446745|NCT04177095|323421350|FG000|Overall Study|Withdrawal by Subject|3|||
94446746|NCT04177095|323421350|FG000|Overall Study|Screen Failure|3|||
94446747|NCT04177095|323421350|FG000|Overall Study|Problems with the Trugraf assay|1|||
94446748|NCT03493854|323421352|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
94446749|NCT03493854|323421353|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
94446750|NCT03493854|323421352|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
94446751|NCT03493854|323421353|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
94446752|NCT03493854|323421352|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
94446753|NCT03493854|323421353|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
94446754|NCT03493854|323421352|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
94446755|NCT03493854|323421353|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
94446756|NCT03493854|323421352|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
94446757|NCT03493854|323421353|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
94446758|NCT03493854|323421352|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
94446759|NCT03493854|323421353|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
94446760|NCT03493854|323421352|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
94446761|NCT03493854|323421353|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
94446762|NCT03493854|323421352|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
94446763|NCT03493854|323421353|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
94446764|NCT03493854|323421352|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
94446765|NCT03493854|323421353|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
94229229|NCT00510146|322632677|FG000|Open-Label Treatment|Lack of Efficacy|4|||
94446766|NCT03493854|323421352|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
94446767|NCT03493854|323421353|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
94446768|NCT03493854|323421352|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
94446769|NCT03493854|323421353|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
94446770|NCT03493854|323421352|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
94446771|NCT03493854|323421353|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
94446772|NCT03493854|323421352|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
94446773|NCT03493854|323421353|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
94554326|NCT03495102|323826368|FG001|Overall Study|Primary Care Physician Recommendation|1|||
94554327|NCT03495102|323826369|FG002|Overall Study|Primary Care Physician Recommendation|0|||
94554328|NCT03495102|323826367|FG000|Overall Study|Relocated to Another Country|0|||
94554329|NCT03495102|323826368|FG001|Overall Study|Relocated to Another Country|1|||
94554330|NCT03495102|323826369|FG002|Overall Study|Relocated to Another Country|0|||
94554331|NCT03495102|323826367|FG000|Overall Study|Participant was in Rehabilitation|1|||
94554332|NCT03495102|323826368|FG001|Overall Study|Participant was in Rehabilitation|0|||
94554333|NCT03495102|323826369|FG002|Overall Study|Participant was in Rehabilitation|0|||
94554334|NCT00765063|323826378|FG000|Overall Study|Lack of Efficacy|5|||
94554335|NCT00765063|323826378|FG000|Overall Study|Withdrawal by Subject|1|||
94554336|NCT00765063|323826378|FG000|Overall Study|Other|16|||
94554337|NCT00765063|323826378|FG000|Overall Study|Protocol Violation|6|||
94554338|NCT00765063|323826378|FG000|Overall Study|Adverse Event|4|||
94554339|NCT03614325|323826379|FG000|Overall Study|Withdrawal by Subject|0|||
94554340|NCT03614325|323826380|FG001|Overall Study|Withdrawal by Subject|2|||
94229230|NCT00510146|322632678|FG001|Open-Label Treatment|Lack of Efficacy|0|||
94229231|NCT00510146|322632677|FG000|Open-Label Treatment|Lost to Follow-up|10|||
94229232|NCT00510146|322632678|FG001|Open-Label Treatment|Lost to Follow-up|1|||
94229233|NCT00510146|322632677|FG000|Open-Label Treatment|Physician Decision|3|||
94229234|NCT00510146|322632678|FG001|Open-Label Treatment|Physician Decision|1|||
94229235|NCT00510146|322632677|FG000|Open-Label Treatment|Protocol Violation|4|||
94229236|NCT00510146|322632678|FG001|Open-Label Treatment|Protocol Violation|2|||
94229237|NCT00510146|322632677|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
94229238|NCT00510146|322632678|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
94229239|NCT00510146|322632677|FG000|Open-Label Treatment|Clinical Relapse|1|||
94229240|NCT00510146|322632678|FG001|Open-Label Treatment|Clinical Relapse|1|||
94229241|NCT00510146|322632677|FG000|Open-Label Treatment|Sponsor Decision|2|||
94229242|NCT00510146|322632678|FG001|Open-Label Treatment|Sponsor Decision|0|||
94229243|NCT02037256|322632682|FG000|Overall Study|Protocol Violation|0|||
94229244|NCT02037256|322632683|FG001|Overall Study|Protocol Violation|1|||
94229245|NCT02037256|322632682|FG000|Overall Study|Withdrawn prior to Velcade|0|||
94229246|NCT02037256|322632683|FG001|Overall Study|Withdrawn prior to Velcade|2|||
94229247|NCT00934700|322632684|FG000|Overall Study|missing scan|5|||
94229248|NCT00934700|322632685|FG001|Overall Study|missing scan|9|||
94229249|NCT00934700|322632684|FG000|Overall Study|Death|8|||
94229250|NCT00934700|322632685|FG001|Overall Study|Death|3|||
94229251|NCT00474383|322632688|FG000|Main Study|Adverse Event|11|||
94229252|NCT00474383|322632689|FG001|Main Study|Adverse Event|0|||
94229253|NCT00474383|322632688|FG000|Main Study|Symptomatic Deterioration|1|||
94229254|NCT00474383|322632689|FG001|Main Study|Symptomatic Deterioration|0|||
94229255|NCT00474383|322632688|FG000|Main Study|Progressive Disease|23|||
94229256|NCT00474383|322632689|FG001|Main Study|Progressive Disease|0|||
94229257|NCT00474383|322632688|FG000|Main Study|Other|1|||
94229258|NCT00474383|322632689|FG001|Main Study|Other|0|||
94229259|NCT00474383|322632688|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
94229260|NCT00474383|322632689|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
94229261|NCT00474383|322632688|FG000|Extension|Progressive Disease|0|||
94229262|NCT00474383|322632689|FG001|Extension|Progressive Disease|5|||
94229263|NCT03036124|322632692|FG000|Overall Study|Lost to Follow-up|0|||
94229264|NCT03036124|322632693|FG001|Overall Study|Lost to Follow-up|2|||
94229265|NCT03036124|322632692|FG000|Overall Study|Withdrawal by Subject|5|||
94229266|NCT03036124|322632693|FG001|Overall Study|Withdrawal by Subject|4|||
94229267|NCT03326193|322632694|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
94229268|NCT03326193|322632694|FG000|Overall Study|Death|19|||
94554341|NCT03614325|323826379|FG000|Overall Study|Surgery Cancelled|2|||
94554342|NCT03614325|323826380|FG001|Overall Study|Surgery Cancelled|1|||
94229269|NCT03326193|322632694|FG000|Overall Study|Withdrawal by Subject|8|||
94229270|NCT03464383|322635390|FG000|Overall Study|Lost to Follow-up|1|||
94229271|NCT03464383|322635391|FG001|Overall Study|Lost to Follow-up|0|||
94229272|NCT03464383|322635392|FG002|Overall Study|Lost to Follow-up|0|||
94229273|NCT03464383|322635390|FG000|Overall Study|Withdrawal by Subject|0|||
94229274|NCT03464383|322635391|FG001|Overall Study|Withdrawal by Subject|1|||
94229275|NCT03464383|322635392|FG002|Overall Study|Withdrawal by Subject|0|||
94229276|NCT01816685|322635395|FG000|Overall Study|Lost to Follow-up|7|||
94229277|NCT01816685|322635396|FG001|Overall Study|Lost to Follow-up|9|||
94229278|NCT01816685|322635395|FG000|Overall Study|Surgery Cancelled|3|||
94229279|NCT01816685|322635396|FG001|Overall Study|Surgery Cancelled|2|||
94229280|NCT01101334|322635397|FG000|Overall Study|Adverse Event|9|||
94229281|NCT01101334|322635398|FG001|Overall Study|Adverse Event|4|||
94229282|NCT01101334|322635397|FG000|Overall Study|Death|7|||
94554343|NCT03614325|323826379|FG000|Overall Study|Lost to Follow-up|2|||
94229283|NCT01101334|322635398|FG001|Overall Study|Death|1|||
94229284|NCT01101334|322635397|FG000|Overall Study|Withdrawal by Subject|4|||
94229285|NCT01101334|322635398|FG001|Overall Study|Withdrawal by Subject|3|||
94229286|NCT01101334|322635397|FG000|Overall Study|Withdrawal by Sponsor|1|||
94229287|NCT01101334|322635398|FG001|Overall Study|Withdrawal by Sponsor|1|||
94229288|NCT01101334|322635397|FG000|Overall Study|Progressive Disease|22|||
94229289|NCT01101334|322635398|FG001|Overall Study|Progressive Disease|35|||
94229290|NCT01101334|322635397|FG000|Overall Study|Other|2|||
94229291|NCT01101334|322635398|FG001|Overall Study|Other|1|||
94229292|NCT00695136|322635399|FG000|Overall Study|Withdrawal by Subject|1|||
94229293|NCT00695136|322635399|FG000|Overall Study|unrelated adverse event|1|||
94229294|NCT01726049|322635401|FG000|Overall Study|Death|1|||
94229295|NCT01726049|322635402|FG001|Overall Study|Death|1|||
94229296|NCT01726049|322635401|FG000|Overall Study|Adverse Event|4|||
94229297|NCT01726049|322635402|FG001|Overall Study|Adverse Event|1|||
94229298|NCT01726049|322635401|FG000|Overall Study|refused second HC|0|||
94229299|NCT01726049|322635402|FG001|Overall Study|refused second HC|2|||
94229300|NCT00853372|322635403|FG000|Overall Study|Death|30|||
94229301|NCT00853372|322635404|FG001|Overall Study|Death|26|||
94229302|NCT00853372|322635403|FG000|Overall Study|Lost to Follow-up|1|||
94229303|NCT00853372|322635404|FG001|Overall Study|Lost to Follow-up|2|||
94229304|NCT00853372|322635403|FG000|Overall Study|Full Consent Withdrawn|1|||
94229305|NCT00853372|322635404|FG001|Overall Study|Full Consent Withdrawn|1|||
94343677|NCT00654368|323037804|FG000|Overall Study|Requirement for alternative therapy|1|||
94343678|NCT00654368|323037805|FG001|Overall Study|Requirement for alternative therapy|1|||
94554344|NCT03614325|323826380|FG001|Overall Study|Lost to Follow-up|1|||
94229306|NCT01268098|322635405|FG000|Overall Study|Adverse Event|1|||
94229307|NCT01268098|322635406|FG001|Overall Study|Adverse Event|0|||
94229308|NCT04156399|322635407|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
94554345|NCT03614325|323826379|FG000|Overall Study|Surgery never scheduled|1|||
94229309|NCT04156399|322635407|FG000|Overall Study|study suspension due to COVID pandemic|3|||
94229310|NCT04732871|322635408|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
94229311|NCT04732871|322635409|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
94229312|NCT04732871|322635410|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
94229313|NCT04732871|322635408|FG000|Overall Study|Lost to Follow-up|7|||
94229314|NCT04732871|322635409|FG001|Overall Study|Lost to Follow-up|4|||
94229315|NCT04732871|322635410|FG002|Overall Study|Lost to Follow-up|3|||
94229316|NCT04732871|322635408|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
94229317|NCT04732871|322635409|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
94343679|NCT00654368|323037806|FG002|Overall Study|Requirement for alternative therapy|1|||
94229318|NCT04732871|322635410|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
94343680|NCT00654368|323037804|FG000|Overall Study|Physician Decision|0|||
94343681|NCT00654368|323037805|FG001|Overall Study|Physician Decision|0|||
94343682|NCT00654368|323037806|FG002|Overall Study|Physician Decision|2|||
94343683|NCT00654368|323037804|FG000|Overall Study|Death|1|||
94343684|NCT00654368|323037805|FG001|Overall Study|Death|0|||
94446774|NCT03493854|323421352|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
94446775|NCT03493854|323421353|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
94229319|NCT04732871|322635408|FG000|Overall Study|Migrated / moved from the study area|5|||
94229320|NCT04732871|322635409|FG001|Overall Study|Migrated / moved from the study area|0|||
94229321|NCT04732871|322635410|FG002|Overall Study|Migrated / moved from the study area|0|||
94229322|NCT04732871|322635408|FG000|Overall Study|Other|1|||
94229323|NCT04732871|322635409|FG001|Overall Study|Other|0|||
94229324|NCT04732871|322635410|FG002|Overall Study|Other|1|||
94229325|NCT04732871|322635408|FG000|Overall Study|Ongoing|6|||
94229326|NCT04732871|322635409|FG001|Overall Study|Ongoing|0|||
94229327|NCT04732871|322635410|FG002|Overall Study|Ongoing|1|||
94229328|NCT04732871|322635408|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
94229329|NCT04732871|322635409|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
94229330|NCT04732871|322635410|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
94229331|NCT01755546|322635414|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
94229332|NCT01755546|322635414|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
94229333|NCT01755546|322635414|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
94229334|NCT01755546|322635414|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
94229335|NCT01755546|322635414|FG000|Titration Phase|Adverse Event|11|||
94229336|NCT01755546|322635414|FG000|Titration Phase|Lack of Efficacy|18|||
94229337|NCT01755546|322635414|FG000|Titration Phase|Protocol Violation|9|||
94229338|NCT01755546|322635414|FG000|Titration Phase|Lost to Follow-up|2|||
94229339|NCT01755546|322635414|FG000|Titration Phase|Other and Continuing|22|||
94229340|NCT01755546|322635414|FG000|Titration Phase|Withdrawal by Subject|8|||
94229341|NCT01755546|322635414|FG000|Long Term Treatment|Adverse Event|12|||
94229342|NCT01755546|322635414|FG000|Long Term Treatment|Lack of Efficacy|6|||
94229343|NCT01755546|322635414|FG000|Long Term Treatment|Protocol Violation|10|||
94229344|NCT01755546|322635414|FG000|Long Term Treatment|Withdrawal by Subject|35|||
94229345|NCT01755546|322635414|FG000|Long Term Treatment|Lost to Follow-up|17|||
94229346|NCT01755546|322635414|FG000|Long Term Treatment|other and ongoing|41|||
94229347|NCT02166476|322635418|FG000|Overall Study|Withdrawal by Subject|5|||
94229348|NCT02166476|322635419|FG001|Overall Study|Withdrawal by Subject|7|||
94229349|NCT02166476|322635418|FG000|Overall Study|Adverse Event|3|||
94229350|NCT02166476|322635419|FG001|Overall Study|Adverse Event|3|||
94229351|NCT02166476|322635418|FG000|Overall Study|Lost to Follow-up|5|||
94229352|NCT02166476|322635419|FG001|Overall Study|Lost to Follow-up|10|||
94229353|NCT02166476|322635418|FG000|Overall Study|Physician Decision|1|||
94229354|NCT02166476|322635419|FG001|Overall Study|Physician Decision|0|||
94229355|NCT02166476|322635418|FG000|Overall Study|Unable to Come for Visit|0|||
94229356|NCT02166476|322635419|FG001|Overall Study|Unable to Come for Visit|3|||
94229357|NCT04333147|322635420|FG000|Overall Study|Adverse Event|43|||
94229358|NCT04333147|322635421|FG001|Overall Study|Adverse Event|40|||
94229359|NCT04333147|322635420|FG000|Overall Study|Lack of Efficacy|49|||
94229360|NCT04333147|322635421|FG001|Overall Study|Lack of Efficacy|48|||
94229361|NCT04333147|322635420|FG000|Overall Study|Lost to Follow-up|19|||
94446776|NCT03493854|323421352|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
94446777|NCT03493854|323421353|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
94446778|NCT03493854|323421352|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
94446779|NCT03493854|323421353|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
94446780|NCT03493854|323421352|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
94446781|NCT03493854|323421353|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
94446782|NCT03493854|323421352|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
94446783|NCT03493854|323421353|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
94446784|NCT02198664|323421354|FG000|Overall Study|Adverse Event|2|||
94446785|NCT02198664|323421355|FG001|Overall Study|Adverse Event|0|||
94446786|NCT02198664|323421354|FG000|Overall Study|Withdrawal by Subject|11|||
94554346|NCT03614325|323826380|FG001|Overall Study|Surgery never scheduled|0|||
94229362|NCT04333147|322635421|FG001|Overall Study|Lost to Follow-up|16|||
94229363|NCT04333147|322635420|FG000|Overall Study|Physician Decision|17|||
94229364|NCT04333147|322635421|FG001|Overall Study|Physician Decision|20|||
94343685|NCT00654368|323037806|FG002|Overall Study|Death|0|||
94343686|NCT00654368|323037804|FG000|Overall Study|Pregnancy|0|||
94343687|NCT00654368|323037805|FG001|Overall Study|Pregnancy|0|||
94343688|NCT00654368|323037806|FG002|Overall Study|Pregnancy|2|||
94343689|NCT00654368|323037804|FG000|Overall Study|Other|0|||
94343690|NCT00654368|323037805|FG001|Overall Study|Other|2|||
94343691|NCT00654368|323037806|FG002|Overall Study|Other|3|||
94343692|NCT00654368|323037804|FG000|Overall Study|Adverse Event|14|||
94343693|NCT00654368|323037805|FG001|Overall Study|Adverse Event|9|||
94343694|NCT00654368|323037806|FG002|Overall Study|Adverse Event|6|||
94343695|NCT02187224|323037807|FG000|Overall Study|Did not show up for test day|1|||
94343696|NCT02187224|323037808|FG001|Overall Study|Did not show up for test day|0|||
94343697|NCT03924427|323037816|FG000|Overall Study|Adverse Event|4|||
94343698|NCT03924427|323037816|FG000|Overall Study|Lack of Efficacy|1|||
94229365|NCT04333147|322635420|FG000|Overall Study|Withdrawal by Subject|65|||
94229366|NCT04333147|322635421|FG001|Overall Study|Withdrawal by Subject|68|||
94229367|NCT04333147|322635420|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
94446787|NCT02198664|323421355|FG001|Overall Study|Withdrawal by Subject|8|||
94446788|NCT02198664|323421354|FG000|Overall Study|Failure to tolerate|2|||
94343699|NCT03924427|323037816|FG000|Overall Study|Withdrawal by Subject|1|||
94229368|NCT04333147|322635421|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
94229369|NCT04333147|322635420|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
94229370|NCT04333147|322635421|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
94229371|NCT04333147|322635420|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
94229372|NCT04333147|322635421|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
94229373|NCT03713281|322635422|FG000|Overall Study|Lens handling difficuluties|2|||
94229374|NCT03713281|322635422|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
94229375|NCT01772823|322635429|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
94229376|NCT01772823|322635430|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
94229377|NCT01772823|322635429|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
94229378|NCT01772823|322635430|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
94229379|NCT01772823|322635429|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
94229380|NCT01772823|322635430|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
94229381|NCT01772823|322635429|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
94229382|NCT01772823|322635430|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
94229383|NCT01772823|322635429|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
94446789|NCT02198664|323421355|FG001|Overall Study|Failure to tolerate|0|||
94446790|NCT02198664|323421354|FG000|Overall Study|Not stated|1|||
94229384|NCT01772823|322635430|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
94229385|NCT01772823|322635429|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
94446791|NCT02198664|323421355|FG001|Overall Study|Not stated|0|||
94446792|NCT01252095|323421356|FG000|Overall Study|Disease progression|1|||
94446793|NCT01252095|323421357|FG001|Overall Study|Disease progression|0|||
94446794|NCT01139775|323421358|FG000|Overall Study|Adverse Event|0|||
94446795|NCT01139775|323421359|FG001|Overall Study|Adverse Event|6|||
94446796|NCT01139775|323421360|FG002|Overall Study|Adverse Event|2|||
94446797|NCT01139775|323421358|FG000|Overall Study|Protocol Violation|0|||
94446798|NCT01139775|323421359|FG001|Overall Study|Protocol Violation|5|||
94446799|NCT01139775|323421360|FG002|Overall Study|Protocol Violation|0|||
94446800|NCT01139775|323421358|FG000|Overall Study|Withdrawal by Subject|1|||
94446801|NCT01139775|323421359|FG001|Overall Study|Withdrawal by Subject|0|||
94446802|NCT01139775|323421360|FG002|Overall Study|Withdrawal by Subject|2|||
94446803|NCT01139775|323421358|FG000|Overall Study|Physician Decision|0|||
94446804|NCT01139775|323421359|FG001|Overall Study|Physician Decision|2|||
94446805|NCT01139775|323421360|FG002|Overall Study|Physician Decision|2|||
94446806|NCT00806403|323421365|FG000|Overall Study|Death|4|||
94446807|NCT00806403|323421366|FG001|Overall Study|Death|3|||
94446808|NCT00884117|323421367|FG000|Overall Study|Adverse Event|2|||
94446809|NCT00884117|323421367|FG000|Overall Study|Withdrawal by Subject|89|||
94446810|NCT00884117|323421367|FG000|Overall Study|Death|3|||
94446811|NCT00884117|323421367|FG000|Overall Study|Lost to Follow-up|143|||
94446812|NCT00884117|323421367|FG000|Overall Study|Other|12|||
94446813|NCT04739800|323421376|FG000|Overall Study|Adverse Event|2|||
94446814|NCT04739800|323421377|FG001|Overall Study|Adverse Event|1|||
94446815|NCT04739800|323421378|FG002|Overall Study|Adverse Event|4|||
94446816|NCT04739800|323421379|FG003|Overall Study|Adverse Event|5|||
94446817|NCT04739800|323421376|FG000|Overall Study|Never Treated|2|||
94446818|NCT04739800|323421377|FG001|Overall Study|Never Treated|0|||
94554347|NCT00321464|323826383|FG000|Overall Study|Death|169|||
94446819|NCT04739800|323421378|FG002|Overall Study|Never Treated|1|||
94446820|NCT04739800|323421379|FG003|Overall Study|Never Treated|1|||
94446821|NCT04739800|323421376|FG000|Overall Study|On Treatment|5|||
94554348|NCT00321464|323826384|FG001|Overall Study|Death|174|||
94554349|NCT00321464|323826383|FG000|Overall Study|Disease progression|124|||
94554350|NCT00321464|323826384|FG001|Overall Study|Disease progression|124|||
94554351|NCT00321464|323826383|FG000|Overall Study|Withdrawal by Subject|117|||
94554352|NCT00321464|323826384|FG001|Overall Study|Withdrawal by Subject|118|||
94554353|NCT00321464|323826383|FG000|Overall Study|Participant request|57|||
94554354|NCT00321464|323826384|FG001|Overall Study|Participant request|61|||
94554355|NCT00321464|323826383|FG000|Overall Study|Adverse Event|43|||
94554356|NCT00321464|323826384|FG001|Overall Study|Adverse Event|28|||
94554357|NCT00321464|323826383|FG000|Overall Study|Physician Decision|15|||
94554358|NCT00321464|323826384|FG001|Overall Study|Physician Decision|14|||
94554359|NCT00321464|323826383|FG000|Overall Study|Noncompliance|4|||
94554360|NCT00321464|323826384|FG001|Overall Study|Noncompliance|10|||
94554361|NCT00321464|323826383|FG000|Overall Study|Lost to Follow-up|7|||
94554362|NCT00321464|323826384|FG001|Overall Study|Lost to Follow-up|8|||
94554363|NCT00321464|323826383|FG000|Overall Study|Protocol deviation|0|||
94554364|NCT00321464|323826384|FG001|Overall Study|Protocol deviation|2|||
94554365|NCT00321464|323826383|FG000|Overall Study|Ineligibility determined|2|||
94554366|NCT00321464|323826384|FG001|Overall Study|Ineligibility determined|1|||
94554367|NCT00321464|323826383|FG000|Overall Study|Other|21|||
94554368|NCT00321464|323826384|FG001|Overall Study|Other|18|||
94554369|NCT00652951|323826388|FG000|Booster Phase|Adverse event, non-fatal|0|||
94554370|NCT00652951|323826389|FG001|Booster Phase|Adverse event, non-fatal|1|||
94554371|NCT00652951|323826390|FG002|Booster Phase|Adverse event, non-fatal|0|||
94554372|NCT00652951|323826388|FG000|Booster Phase|Other|1|||
94554373|NCT00652951|323826389|FG001|Booster Phase|Other|0|||
94554374|NCT00652951|323826390|FG002|Booster Phase|Other|0|||
94554375|NCT01363661|323826393|FG000|Overall Study|Adverse Event|9|||
94554376|NCT01363661|323826394|FG001|Overall Study|Adverse Event|2|||
94554377|NCT01363661|323826393|FG000|Overall Study|Withdrawal by Subject|1|||
94554378|NCT01363661|323826394|FG001|Overall Study|Withdrawal by Subject|1|||
94554379|NCT01363661|323826393|FG000|Overall Study|Protocol Violation|1|||
94554380|NCT01363661|323826394|FG001|Overall Study|Protocol Violation|0|||
94554381|NCT01363661|323826393|FG000|Overall Study|Lost to Follow-up|3|||
94554382|NCT01363661|323826394|FG001|Overall Study|Lost to Follow-up|1|||
94554383|NCT00495625|323826399|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
94554384|NCT01378325|323826400|FG000|Overall Study|Protocol Violation|0|||
94554385|NCT01378325|323826401|FG001|Overall Study|Protocol Violation|1|||
94554386|NCT01754493|323826402|FG000|Overall Study|Adverse Event|1|||
94554387|NCT01754493|323826402|FG000|Overall Study|Lost to Follow-up|3|||
94554388|NCT01754493|323826402|FG000|Overall Study|Withdrawal by Subject|1|||
94554389|NCT01754493|323826402|FG000|Overall Study|Moved out of town|1|||
94554390|NCT01754493|323826402|FG000|Overall Study|Scheduling conflict|1|||
94554391|NCT00511134|323826403|FG000|Overall Study|Withdrawal by Subject|0|||
94554392|NCT00511134|323826404|FG001|Overall Study|Withdrawal by Subject|2|||
94554393|NCT01949090|323826405|FG000|Overall Study|Serious Adverse Event|0|||
94554394|NCT01949090|323826406|FG001|Overall Study|Serious Adverse Event|1|||
94554395|NCT01949090|323826407|FG002|Overall Study|Serious Adverse Event|2|||
94554396|NCT01949090|323826408|FG003|Overall Study|Serious Adverse Event|0|||
94554397|NCT01949090|323826409|FG004|Overall Study|Serious Adverse Event|1|||
94554398|NCT01949090|323826405|FG000|Overall Study|Withdrawal by Subject|2|||
94554399|NCT01949090|323826406|FG001|Overall Study|Withdrawal by Subject|0|||
94554400|NCT01949090|323826407|FG002|Overall Study|Withdrawal by Subject|0|||
94554401|NCT01949090|323826408|FG003|Overall Study|Withdrawal by Subject|0|||
94554402|NCT01949090|323826409|FG004|Overall Study|Withdrawal by Subject|1|||
94554403|NCT01949090|323826405|FG000|Overall Study|Protocol non-compliance|0|||
94554404|NCT01949090|323826406|FG001|Overall Study|Protocol non-compliance|0|||
94554405|NCT01949090|323826407|FG002|Overall Study|Protocol non-compliance|0|||
94554406|NCT01949090|323826408|FG003|Overall Study|Protocol non-compliance|0|||
94554407|NCT01949090|323826409|FG004|Overall Study|Protocol non-compliance|1|||
94554408|NCT01949090|323826405|FG000|Overall Study|Lost to Follow-up|2|||
94554409|NCT01949090|323826406|FG001|Overall Study|Lost to Follow-up|1|||
94554410|NCT01949090|323826407|FG002|Overall Study|Lost to Follow-up|0|||
94554411|NCT01949090|323826408|FG003|Overall Study|Lost to Follow-up|1|||
94554412|NCT01949090|323826409|FG004|Overall Study|Lost to Follow-up|1|||
94554413|NCT01272635|323826410|FG000|Overall Study|Lost to Follow-up|31|||
94229386|NCT01772823|322635430|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
94229387|NCT01772823|322635429|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
94229388|NCT01772823|322635430|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
94229389|NCT01772823|322635429|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
94229390|NCT01772823|322635430|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
94229391|NCT01772823|322635429|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
94229392|NCT01772823|322635430|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
94229393|NCT01772823|322635429|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
94229394|NCT01772823|322635430|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
94229395|NCT01772823|322635429|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
94229396|NCT01772823|322635430|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
94229397|NCT01772823|322635429|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
94229398|NCT01772823|322635430|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
94229399|NCT01772823|322635429|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
94229400|NCT01772823|322635430|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
94229401|NCT01772823|322635429|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
94229402|NCT01772823|322635430|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
94229403|NCT01772823|322635429|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
94229404|NCT01772823|322635430|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
94229405|NCT01772823|322635429|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
94229406|NCT01772823|322635430|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
94229407|NCT01036165|322635431|FG000|Overall Study|Adverse Event|6|||
94229408|NCT01036165|322635431|FG000|Overall Study|Lost to Follow-up|2|||
94229409|NCT01036165|322635431|FG000|Overall Study|Withdrawal by Subject|3|||
94229410|NCT01036165|322635431|FG000|Overall Study|Device Related Issues|3|||
94229411|NCT01036165|322635431|FG000|Overall Study|Problems finding proper area to inject|1|||
94229412|NCT01844726|322635435|FG000|Overall Study|Withdrawal by Subject|0|||
94229413|NCT01844726|322635436|FG001|Overall Study|Withdrawal by Subject|1|||
94229414|NCT01844726|322635435|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
94446822|NCT04739800|323421377|FG001|Overall Study|On Treatment|9|||
94446823|NCT04739800|323421378|FG002|Overall Study|On Treatment|9|||
94446824|NCT04739800|323421379|FG003|Overall Study|On Treatment|9|||
94229415|NCT01844726|322635436|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
94446825|NCT04739800|323421376|FG000|Overall Study|Symptomatic Deterioration|1|||
94446826|NCT04739800|323421377|FG001|Overall Study|Symptomatic Deterioration|1|||
94446827|NCT04739800|323421378|FG002|Overall Study|Symptomatic Deterioration|3|||
94554414|NCT01272635|323826411|FG001|Overall Study|Lost to Follow-up|20|||
94554415|NCT01272635|323826412|FG002|Overall Study|Lost to Follow-up|31|||
94554416|NCT01272635|323826413|FG003|Overall Study|Lost to Follow-up|23|||
94554417|NCT00344500|323826414|FG000|Overall Study|Adverse Event|6|||
94554418|NCT00344500|323826415|FG001|Overall Study|Adverse Event|2|||
94554419|NCT00344500|323826416|FG002|Overall Study|Adverse Event|0|||
94554420|NCT00344500|323826414|FG000|Overall Study|Lost to Follow-up|5|||
94554421|NCT00344500|323826415|FG001|Overall Study|Lost to Follow-up|13|||
94554422|NCT00344500|323826416|FG002|Overall Study|Lost to Follow-up|1|||
94554423|NCT00344500|323826414|FG000|Overall Study|Withdrawal by Subject|7|||
94554424|NCT00344500|323826415|FG001|Overall Study|Withdrawal by Subject|10|||
94554425|NCT00344500|323826416|FG002|Overall Study|Withdrawal by Subject|0|||
94554426|NCT00344500|323826414|FG000|Overall Study|Protocol Violation|4|||
94554427|NCT00344500|323826415|FG001|Overall Study|Protocol Violation|7|||
94554428|NCT00344500|323826416|FG002|Overall Study|Protocol Violation|1|||
94554429|NCT00344500|323826414|FG000|Overall Study|Not Noted|1|||
94554430|NCT00344500|323826415|FG001|Overall Study|Not Noted|3|||
94554431|NCT00344500|323826416|FG002|Overall Study|Not Noted|0|||
94554432|NCT02207491|323826417|FG000|Overall Study|Adverse Event|20|||
94554433|NCT02207491|323826418|FG001|Overall Study|Adverse Event|4|||
94554434|NCT02207491|323826417|FG000|Overall Study|Withdrawal by Subject|3|||
94554435|NCT02207491|323826418|FG001|Overall Study|Withdrawal by Subject|2|||
94554436|NCT02207491|323826417|FG000|Overall Study|Non-compliant|0|||
94554437|NCT02207491|323826418|FG001|Overall Study|Non-compliant|1|||
94554438|NCT02207491|323826417|FG000|Overall Study|Lost to Follow-up|0|||
94554439|NCT02207491|323826418|FG001|Overall Study|Lost to Follow-up|1|||
94554440|NCT02207491|323826417|FG000|Overall Study|Lack of Efficacy|3|||
94554441|NCT02207491|323826418|FG001|Overall Study|Lack of Efficacy|0|||
94554442|NCT02207491|323826417|FG000|Overall Study|Physician Decision|2|||
94554443|NCT02207491|323826418|FG001|Overall Study|Physician Decision|0|||
94554444|NCT02207491|323826417|FG000|Overall Study|Protocol Violation|3|||
94554445|NCT02207491|323826418|FG001|Overall Study|Protocol Violation|5|||
94554446|NCT00539305|323826419|FG000|Overall Study|Adverse Event|1|||
94554447|NCT00539305|323826420|FG001|Overall Study|Adverse Event|0|||
94554448|NCT00539305|323826419|FG000|Overall Study|Substance Use|0|||
94554449|NCT00539305|323826420|FG001|Overall Study|Substance Use|1|||
94554450|NCT00539305|323826419|FG000|Overall Study|Withdrawal by Subject|0|||
94554451|NCT00539305|323826420|FG001|Overall Study|Withdrawal by Subject|1|||
94554452|NCT01363908|323826421|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
94554453|NCT01363908|323826422|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
94554454|NCT01363908|323826421|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
94554455|NCT01363908|323826422|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
94554456|NCT01363908|323826421|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
94554457|NCT01363908|323826422|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
94554458|NCT01363908|323826421|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
94554459|NCT01363908|323826422|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
94554460|NCT00793325|323826426|FG000|Overall Study|Protocol Violation|18|||
94554461|NCT00793325|323826426|FG000|Overall Study|Lost to Follow-up|1|||
94554462|NCT02783599|323826427|FG000|Overall Study|Progressive disease|23|||
94446828|NCT04739800|323421379|FG003|Overall Study|Symptomatic Deterioration|0|||
94446829|NCT04739800|323421376|FG000|Overall Study|Withdrawal by Subject|1|||
94446830|NCT04739800|323421377|FG001|Overall Study|Withdrawal by Subject|2|||
94229416|NCT03021551|322635439|FG000|Overall Study|Equipment Issues|2|||
94554463|NCT02783599|323826427|FG000|Overall Study|Surgical Resection|10|||
94554464|NCT02783599|323826427|FG000|Overall Study|Adverse Event|4|||
94229417|NCT03021551|322635439|FG000|Overall Study|Protocol Violation|1|||
94229418|NCT00307164|322635440|FG000|Overall Study|Death|1|||
94229419|NCT00307164|322635441|FG001|Overall Study|Death|0|||
94229420|NCT00307164|322635440|FG000|Overall Study|Severe debilitation, unable to continue|1|||
94229421|NCT00307164|322635441|FG001|Overall Study|Severe debilitation, unable to continue|0|||
94229422|NCT00307164|322635440|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
94229423|NCT00307164|322635441|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
94229424|NCT00307164|322635440|FG000|Overall Study|Withdrawal by Subject|1|||
94229425|NCT00307164|322635441|FG001|Overall Study|Withdrawal by Subject|8|||
94229426|NCT00307164|322635440|FG000|Overall Study|Not compliant with requirements|4|||
94229427|NCT00307164|322635441|FG001|Overall Study|Not compliant with requirements|4|||
94229428|NCT00307164|322635440|FG000|Overall Study|Lost to Follow-up|6|||
94229429|NCT00307164|322635441|FG001|Overall Study|Lost to Follow-up|1|||
94229430|NCT01162135|322635448|FG000|Overall Study|Withdrawal by Subject|1|||
94229431|NCT01162135|322635448|FG000|Overall Study|Severe back pain|1|||
94446831|NCT04739800|323421378|FG002|Overall Study|Withdrawal by Subject|1|||
94446832|NCT04739800|323421379|FG003|Overall Study|Withdrawal by Subject|3|||
94229432|NCT01162135|322635448|FG000|Overall Study|Ineligible|1|||
94229433|NCT03297398|322635451|FG000|Overall Study|Sponsor's decision|6|||
94229434|NCT03297398|322635452|FG001|Overall Study|Sponsor's decision|9|||
94229435|NCT03297398|322635453|FG002|Overall Study|Sponsor's decision|7|||
94229436|NCT03297398|322635451|FG000|Overall Study|Adverse Event|1|||
94229437|NCT03297398|322635452|FG001|Overall Study|Adverse Event|4|||
94343700|NCT01885104|323037817|FG000|Overall Study|Withdrawal of Consent|1|||
94343701|NCT01885104|323037818|FG001|Overall Study|Withdrawal of Consent|0|||
94343702|NCT01885104|323037817|FG000|Overall Study|Lost to Follow-up|0|||
94343703|NCT01885104|323037818|FG001|Overall Study|Lost to Follow-up|1|||
94343704|NCT01885104|323037817|FG000|Overall Study|Physician Decision|1|||
94343705|NCT01885104|323037818|FG001|Overall Study|Physician Decision|0|||
94343706|NCT01894776|323037819|FG000|Overall Study|Withdrawal by Subject|1|||
94343707|NCT02485860|323037820|FG000|Overall Study|Lost to Follow-up|4|||
94343708|NCT02485860|323037821|FG001|Overall Study|Lost to Follow-up|1|||
94343709|NCT02485860|323037820|FG000|Overall Study|Physician Decision|1|||
94343710|NCT02485860|323037821|FG001|Overall Study|Physician Decision|2|||
94343711|NCT02485860|323037820|FG000|Overall Study|Health context (COVID-19)|1|||
94343712|NCT02485860|323037821|FG001|Overall Study|Health context (COVID-19)|0|||
94343713|NCT00471315|323037826|FG000|Overall Study|Adverse Event|7|||
94343714|NCT00471315|323037826|FG000|Overall Study|Withdrawal by Subject|1|||
94343715|NCT02614261|323037827|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
94343716|NCT02614261|323037828|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
94343717|NCT02614261|323037829|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
94343718|NCT02614261|323037830|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
94343719|NCT02614261|323037827|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
94343720|NCT02614261|323037828|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
94343721|NCT02614261|323037829|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
94343722|NCT02614261|323037830|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
94343723|NCT02614261|323037827|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
94343724|NCT02614261|323037828|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
94343725|NCT02614261|323037829|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
94343726|NCT02614261|323037830|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
94343727|NCT02614261|323037827|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
94343728|NCT02614261|323037828|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
94343729|NCT02614261|323037829|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
94343730|NCT02614261|323037830|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
94343731|NCT02614261|323037827|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
94343732|NCT02614261|323037828|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
94343733|NCT02614261|323037829|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
94343734|NCT02614261|323037830|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
94343735|NCT02614261|323037827|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
94343736|NCT02614261|323037828|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
94343737|NCT02614261|323037829|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
94343738|NCT02614261|323037830|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
94554465|NCT02783599|323826427|FG000|Overall Study|Physician Decision|2|||
94554466|NCT02783599|323826427|FG000|Overall Study|Death|1|||
94554467|NCT00296140|323826429|FG000|Overall Study|Lost to Follow-up|1|||
94554468|NCT00296140|323826430|FG001|Overall Study|Lost to Follow-up|0|||
94554469|NCT00296140|323826429|FG000|Overall Study|Withdrawal by Subject|1|||
94554470|NCT00296140|323826430|FG001|Overall Study|Withdrawal by Subject|0|||
94554471|NCT00296140|323826429|FG000|Overall Study|Discharge to Nursing Home|1|||
94554472|NCT00296140|323826430|FG001|Overall Study|Discharge to Nursing Home|0|||
94554473|NCT00989963|323826432|FG000|Overall Study|Adverse Event|1|||
94554474|NCT00989963|323826433|FG001|Overall Study|Adverse Event|1|||
94554475|NCT00989963|323826434|FG002|Overall Study|Adverse Event|1|||
94554476|NCT00887926|323826435|FG000|Overall Study|Withdrawal by Subject|0|||
94554477|NCT00887926|323826436|FG001|Overall Study|Withdrawal by Subject|1|||
94554478|NCT00887926|323826437|FG002|Overall Study|Withdrawal by Subject|0|||
94554479|NCT00887926|323826438|FG003|Overall Study|Withdrawal by Subject|0|||
94554480|NCT02649894|323826443|FG000|Overall Study|Adverse Event|1|||
94554481|NCT02649894|323826444|FG001|Overall Study|Adverse Event|0|||
94554482|NCT02649894|323826443|FG000|Overall Study|Physician Decision|0|||
94554483|NCT02649894|323826444|FG001|Overall Study|Physician Decision|1|||
94554484|NCT02649894|323826443|FG000|Overall Study|Withdrawal by Subject|5|||
94554485|NCT02649894|323826444|FG001|Overall Study|Withdrawal by Subject|2|||
94554486|NCT02649894|323826443|FG000|Overall Study|Lost to Follow-up|2|||
94554487|NCT02649894|323826444|FG001|Overall Study|Lost to Follow-up|1|||
94554488|NCT02649894|323826443|FG000|Overall Study|Death|30|||
94554489|NCT02649894|323826444|FG001|Overall Study|Death|7|||
94554490|NCT02649894|323826443|FG000|Overall Study|Other, not specified|6|||
94554491|NCT02649894|323826444|FG001|Overall Study|Other, not specified|0|||
94554492|NCT02540668|323826445|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
94554493|NCT02540668|323826446|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
94554494|NCT02409719|323826447|FG000|Overall Study|Lost to Follow-up|3|||
94554495|NCT02409719|323826448|FG001|Overall Study|Lost to Follow-up|3|||
94554496|NCT01009086|323826449|FG000|Overall Study|Lack of Efficacy|16|||
94554497|NCT01009086|323826450|FG001|Overall Study|Lack of Efficacy|15|||
94554498|NCT01009086|323826451|FG002|Overall Study|Lack of Efficacy|9|||
94554499|NCT01009086|323826449|FG000|Overall Study|Lost to Follow-up|4|||
94554500|NCT01009086|323826450|FG001|Overall Study|Lost to Follow-up|5|||
94554501|NCT01009086|323826451|FG002|Overall Study|Lost to Follow-up|3|||
94554502|NCT01009086|323826449|FG000|Overall Study|Adverse Event|12|||
94554503|NCT01009086|323826450|FG001|Overall Study|Adverse Event|11|||
94554504|NCT01009086|323826451|FG002|Overall Study|Adverse Event|8|||
94554505|NCT01009086|323826449|FG000|Overall Study|Withdrawal by Subject|9|||
94554506|NCT01009086|323826450|FG001|Overall Study|Withdrawal by Subject|11|||
94554507|NCT01009086|323826451|FG002|Overall Study|Withdrawal by Subject|13|||
94554508|NCT01009086|323826449|FG000|Overall Study|Other|3|||
94554509|NCT01009086|323826450|FG001|Overall Study|Other|5|||
94554510|NCT01009086|323826451|FG002|Overall Study|Other|1|||
94554511|NCT01336023|323826455|FG000|Week 0 to Week 26|Adverse Event|8|||
94554512|NCT01336023|323826456|FG001|Week 0 to Week 26|Adverse Event|10|||
94554513|NCT01336023|323826457|FG002|Week 0 to Week 26|Adverse Event|24|||
94554514|NCT01336023|323826455|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
94554515|NCT01336023|323826456|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
94554516|NCT01336023|323826457|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
94554517|NCT01336023|323826455|FG000|Week 0 to Week 26|Protocol Violation|1|||
94554518|NCT01336023|323826456|FG001|Week 0 to Week 26|Protocol Violation|2|||
94554519|NCT01336023|323826457|FG002|Week 0 to Week 26|Protocol Violation|0|||
94554520|NCT01336023|323826455|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
94554521|NCT01336023|323826456|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
94554522|NCT01336023|323826457|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
94554523|NCT01336023|323826455|FG000|Week 0 to Week 26|Unclassified|5|||
94554524|NCT01336023|323826456|FG001|Week 0 to Week 26|Unclassified|16|||
94554525|NCT01336023|323826457|FG002|Week 0 to Week 26|Unclassified|9|||
94554526|NCT01336023|323826455|FG000|Week 27 to 52|Adverse Event|1|||
94554527|NCT01336023|323826456|FG001|Week 27 to 52|Adverse Event|5|||
94554528|NCT01336023|323826457|FG002|Week 27 to 52|Adverse Event|2|||
94554529|NCT01336023|323826455|FG000|Week 27 to 52|Protocol Violation|0|||
94554530|NCT01336023|323826456|FG001|Week 27 to 52|Protocol Violation|2|||
94554531|NCT01336023|323826457|FG002|Week 27 to 52|Protocol Violation|1|||
94554532|NCT01336023|323826455|FG000|Week 27 to 52|Withdrawal Criteria|14|||
94554533|NCT01336023|323826456|FG001|Week 27 to 52|Withdrawal Criteria|19|||
94554534|NCT01336023|323826457|FG002|Week 27 to 52|Withdrawal Criteria|16|||
94554535|NCT01336023|323826455|FG000|Week 27 to 52|Unclassified|13|||
94554536|NCT01336023|323826456|FG001|Week 27 to 52|Unclassified|18|||
94554537|NCT01336023|323826457|FG002|Week 27 to 52|Unclassified|9|||
94554538|NCT02951429|323826464|FG000|Overall Study|Adverse Event|3|||
94554539|NCT02951429|323826465|FG001|Overall Study|Adverse Event|7|||
94554540|NCT02951429|323826464|FG000|Overall Study|Death|28|||
94554541|NCT02951429|323826465|FG001|Overall Study|Death|36|||
94554542|NCT02951429|323826464|FG000|Overall Study|Lack of Efficacy|0|||
94554543|NCT02951429|323826465|FG001|Overall Study|Lack of Efficacy|1|||
94554544|NCT02951429|323826464|FG000|Overall Study|Lost to Follow-up|0|||
94554545|NCT02951429|323826465|FG001|Overall Study|Lost to Follow-up|1|||
94554546|NCT02951429|323826464|FG000|Overall Study|Lung Transplantation|9|||
94554547|NCT02951429|323826465|FG001|Overall Study|Lung Transplantation|6|||
94554548|NCT02951429|323826464|FG000|Overall Study|Other|1|||
94554549|NCT02951429|323826465|FG001|Overall Study|Other|3|||
94554550|NCT02951429|323826464|FG000|Overall Study|Progressive Disease|1|||
94554551|NCT02951429|323826465|FG001|Overall Study|Progressive Disease|1|||
94554552|NCT02951429|323826464|FG000|Overall Study|Withdrawal by Subject|7|||
94554553|NCT02951429|323826465|FG001|Overall Study|Withdrawal by Subject|11|||
94554554|NCT02951429|323826464|FG000|Overall Study|Participant ongoing in the study|23|||
94554555|NCT02951429|323826465|FG001|Overall Study|Participant ongoing in the study|17|||
94554556|NCT02202538|323826468|FG000|Overall Study|Withdrawal by Subject|5|||
94554557|NCT02202538|323826468|FG000|Overall Study|Did not meet all inclusion criteria|2|||
94229438|NCT03297398|322635453|FG002|Overall Study|Adverse Event|4|||
94229439|NCT03297398|322635451|FG000|Overall Study|Withdrawal by Subject|1|||
94229440|NCT03297398|322635452|FG001|Overall Study|Withdrawal by Subject|2|||
94229441|NCT03297398|322635453|FG002|Overall Study|Withdrawal by Subject|2|||
94229442|NCT03297398|322635451|FG000|Overall Study|Protocol Violation|0|||
94229443|NCT03297398|322635452|FG001|Overall Study|Protocol Violation|2|||
94229444|NCT03297398|322635453|FG002|Overall Study|Protocol Violation|0|||
94229445|NCT03297398|322635451|FG000|Overall Study|Physician Decision|0|||
94229446|NCT03297398|322635452|FG001|Overall Study|Physician Decision|0|||
94229447|NCT03297398|322635453|FG002|Overall Study|Physician Decision|1|||
94229448|NCT03297398|322635451|FG000|Overall Study|Lost to Follow-up|0|||
94229449|NCT03297398|322635452|FG001|Overall Study|Lost to Follow-up|0|||
94446833|NCT04739800|323421376|FG000|Overall Study|Other Reason|1|||
94446834|NCT04739800|323421377|FG001|Overall Study|Other Reason|3|||
94446835|NCT04739800|323421378|FG002|Overall Study|Other Reason|5|||
94229450|NCT03297398|322635453|FG002|Overall Study|Lost to Follow-up|1|||
94229451|NCT01101997|322635454|FG000|Overall Study|Withdrawal by Subject|2|||
94229452|NCT00611715|322635461|FG000|Overall Study|Disease Progression|24|||
94229453|NCT00611715|322635462|FG001|Overall Study|Disease Progression|4|||
94446836|NCT04739800|323421379|FG003|Overall Study|Other Reason|4|||
94446837|NCT00226499|323421382|FG000|Overall Study|Adverse Event|10|||
94446838|NCT00226499|323421383|FG001|Overall Study|Adverse Event|6|||
94446839|NCT00226499|323421384|FG002|Overall Study|Adverse Event|3|||
94446840|NCT00226499|323421382|FG000|Overall Study|Others|1064|||
94446841|NCT00226499|323421383|FG001|Overall Study|Others|1066|||
94446842|NCT00226499|323421384|FG002|Overall Study|Others|356|||
94229454|NCT00611715|322635461|FG000|Overall Study|Withdrawal by Subject|5|||
94446843|NCT00468819|323421385|FG000|Overall Study|Withdrawal by Subject|4|||
94446844|NCT00468819|323421386|FG001|Overall Study|Withdrawal by Subject|0|||
94446845|NCT00468819|323421387|FG002|Overall Study|Withdrawal by Subject|1|||
94446846|NCT00468819|323421385|FG000|Overall Study|Lost to Follow-up|0|||
94229455|NCT00611715|322635462|FG001|Overall Study|Withdrawal by Subject|1|||
94446847|NCT00468819|323421386|FG001|Overall Study|Lost to Follow-up|0|||
94446848|NCT00468819|323421387|FG002|Overall Study|Lost to Follow-up|1|||
94446849|NCT00468819|323421385|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
94446850|NCT00468819|323421386|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
94554558|NCT02202538|323826468|FG000|Overall Study|Investigator Decision|1|||
94554559|NCT00915551|323826469|FG000|Overall Study|Withdrawal by Subject|0|||
94554560|NCT00915551|323826470|FG001|Overall Study|Withdrawal by Subject|1|||
94229456|NCT00611715|322635461|FG000|Overall Study|Adverse Event|9|||
94229457|NCT00611715|322635462|FG001|Overall Study|Adverse Event|1|||
94554561|NCT00235716|323826471|FG000|Overall Study|Death|26|||
94229458|NCT00611715|322635461|FG000|Overall Study|Death|1|||
94229459|NCT00611715|322635462|FG001|Overall Study|Death|0|||
94229460|NCT00611715|322635461|FG000|Overall Study|two patients are still on treatment|2|||
94229461|NCT00611715|322635462|FG001|Overall Study|two patients are still on treatment|0|||
94229462|NCT00107978|322635465|FG000|Overall Study|Adverse Event|1|||
94229463|NCT00107978|322635466|FG001|Overall Study|Adverse Event|5|||
94229464|NCT00107978|322635465|FG000|Overall Study|Death|3|||
94229465|NCT00107978|322635466|FG001|Overall Study|Death|3|||
94229466|NCT00107978|322635465|FG000|Overall Study|Lost to Follow-up|20|||
94229467|NCT00107978|322635466|FG001|Overall Study|Lost to Follow-up|28|||
94229468|NCT00107978|322635465|FG000|Overall Study|Withdrawal by Subject|4|||
94229469|NCT00107978|322635466|FG001|Overall Study|Withdrawal by Subject|9|||
94229470|NCT00107978|322635465|FG000|Overall Study|Protocol Violation|0|||
94229471|NCT00107978|322635466|FG001|Overall Study|Protocol Violation|1|||
94229472|NCT00107978|322635465|FG000|Overall Study|Other|5|||
94229473|NCT00107978|322635466|FG001|Overall Study|Other|4|||
94229474|NCT02669407|322635467|FG000|Overall Study|Physician Decision|3|||
94229475|NCT00677092|322635468|FG000|Overall Study|Adverse Event|1|||
94229476|NCT00677092|322635468|FG000|Overall Study|Lost to Follow-up|1|||
94229477|NCT00677092|322635468|FG000|Overall Study|Withdrawal by Subject|3|||
94446851|NCT00468819|323421387|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
94229478|NCT00677092|322635468|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
94229479|NCT03245619|322635469|FG000|Part A (Up to Day 22)|Physician Decision|4|||
94229480|NCT03245619|322635470|FG001|Part A (Up to Day 22)|Physician Decision|6|||
94229481|NCT03245619|322635471|FG002|Part A (Up to Day 22)|Physician Decision|6|||
94229482|NCT03245619|322635472|FG003|Part A (Up to Day 22)|Physician Decision|0|||
94446852|NCT01537042|323421392|FG000|Overall Study|Adverse Event|0|||
94446853|NCT01537042|323421393|FG001|Overall Study|Adverse Event|2|||
94554562|NCT00235716|323826472|FG001|Overall Study|Death|39|||
94554563|NCT00235716|323826473|FG002|Overall Study|Death|32|||
94554564|NCT00235716|323826474|FG003|Overall Study|Death|31|||
94554565|NCT00235716|323826471|FG000|Overall Study|Withdrawal by Subject|23|||
94554566|NCT00235716|323826472|FG001|Overall Study|Withdrawal by Subject|19|||
94554567|NCT00235716|323826473|FG002|Overall Study|Withdrawal by Subject|17|||
94554568|NCT00235716|323826474|FG003|Overall Study|Withdrawal by Subject|18|||
94554569|NCT00235716|323826471|FG000|Overall Study|Lost to Follow-up|12|||
94554570|NCT00235716|323826472|FG001|Overall Study|Lost to Follow-up|7|||
94554571|NCT00235716|323826473|FG002|Overall Study|Lost to Follow-up|14|||
94554572|NCT00235716|323826474|FG003|Overall Study|Lost to Follow-up|10|||
94554573|NCT00235716|323826471|FG000|Overall Study|Adverse Event|1|||
94554574|NCT00235716|323826472|FG001|Overall Study|Adverse Event|1|||
94554575|NCT00235716|323826473|FG002|Overall Study|Adverse Event|1|||
94554576|NCT00235716|323826474|FG003|Overall Study|Adverse Event|0|||
94554577|NCT00235716|323826471|FG000|Overall Study|Physician Decision|0|||
94554578|NCT00235716|323826472|FG001|Overall Study|Physician Decision|1|||
94554579|NCT00235716|323826473|FG002|Overall Study|Physician Decision|1|||
94554580|NCT00235716|323826474|FG003|Overall Study|Physician Decision|3|||
94554581|NCT01772576|323826475|FG000|Overall Study|Death|15|||
94554582|NCT01772576|323826475|FG000|Overall Study|Protocol Violation|1|||
94554583|NCT01772576|323826475|FG000|Overall Study|Lost to Follow-up|3|||
94554584|NCT01772576|323826475|FG000|Overall Study|Study device not used|3|||
94554585|NCT01772576|323826475|FG000|Overall Study|Adverse Event|6|||
94554586|NCT01772576|323826475|FG000|Overall Study|Withdrawal by Subject|6|||
94554587|NCT04390841|323826476|FG000|Overall Study|Withdrawal by Subject|2|||
94554588|NCT01817959|323826477|FG000|Overall Study|Graft loss|1|||
94554589|NCT01817959|323826478|FG001|Overall Study|Graft loss|1|||
94554590|NCT01817959|323826477|FG000|Overall Study|forbidden medication|1|||
94554591|NCT01817959|323826478|FG001|Overall Study|forbidden medication|1|||
94554592|NCT01817959|323826477|FG000|Overall Study|Adverse Event|1|||
94554593|NCT01817959|323826478|FG001|Overall Study|Adverse Event|0|||
94554594|NCT01817959|323826477|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
94554595|NCT01817959|323826478|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
94554596|NCT02673684|323826485|FG000|Overall Study|Study not completed d/t loss of funding|9|||
94554597|NCT02673684|323826486|FG001|Overall Study|Study not completed d/t loss of funding|8|||
94554598|NCT00330681|323826487|FG000|Overall Study|Adverse Event|3|||
94554599|NCT00330681|323826488|FG001|Overall Study|Adverse Event|6|||
94554600|NCT00330681|323826487|FG000|Overall Study|Protocol Violation|0|||
94554601|NCT00330681|323826488|FG001|Overall Study|Protocol Violation|1|||
94554602|NCT00330681|323826487|FG000|Overall Study|Withdrawal by Subject|5|||
94554603|NCT00330681|323826488|FG001|Overall Study|Withdrawal by Subject|5|||
94554604|NCT00330681|323826487|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
94554605|NCT00330681|323826488|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
94554606|NCT01371734|323826489|FG000|Overall Study|Other|2|||
94554607|NCT01371734|323826490|FG001|Overall Study|Other|1|||
94554608|NCT01371734|323826491|FG002|Overall Study|Other|2|||
94554609|NCT01371734|323826489|FG000|Overall Study|Withdrawal by Subject|3|||
94554610|NCT01371734|323826490|FG001|Overall Study|Withdrawal by Subject|4|||
94554611|NCT01371734|323826491|FG002|Overall Study|Withdrawal by Subject|9|||
94554612|NCT01371734|323826489|FG000|Overall Study|Lost to Follow-up|5|||
94554613|NCT01371734|323826490|FG001|Overall Study|Lost to Follow-up|3|||
94554614|NCT01371734|323826491|FG002|Overall Study|Lost to Follow-up|1|||
94554615|NCT01371734|323826489|FG000|Overall Study|Protocol Violation|3|||
94554616|NCT01371734|323826490|FG001|Overall Study|Protocol Violation|1|||
94554617|NCT01371734|323826491|FG002|Overall Study|Protocol Violation|2|||
94554618|NCT01371734|323826489|FG000|Overall Study|Adverse Event|8|||
94554619|NCT01371734|323826490|FG001|Overall Study|Adverse Event|8|||
94554620|NCT01371734|323826491|FG002|Overall Study|Adverse Event|3|||
94446854|NCT01537042|323421392|FG000|Overall Study|Lack of Efficacy|0|||
94446855|NCT01537042|323421393|FG001|Overall Study|Lack of Efficacy|1|||
94446856|NCT01537042|323421392|FG000|Overall Study|Protocol Violation|0|||
94446857|NCT01537042|323421393|FG001|Overall Study|Protocol Violation|1|||
94446858|NCT01537042|323421392|FG000|Overall Study|Other|0|||
94446859|NCT01537042|323421393|FG001|Overall Study|Other|1|||
94446860|NCT00979654|323421394|FG000|Overall Study|Lost to Follow-up|1|||
94446861|NCT00979654|323421394|FG000|Overall Study|Withdrawal by Subject|22|||
94446862|NCT00979654|323421394|FG000|Overall Study|Death|1|||
94446863|NCT00979654|323421394|FG000|Overall Study|Lack of Efficacy|6|||
94446864|NCT00979654|323421394|FG000|Overall Study|Adverse Event|1|||
94446865|NCT00979654|323421394|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
94554621|NCT01371734|323826489|FG000|Overall Study|Lack of Efficacy|2|||
94554622|NCT01371734|323826490|FG001|Overall Study|Lack of Efficacy|2|||
94446866|NCT00979654|323421394|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
94446867|NCT00979654|323421394|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
94554623|NCT01371734|323826491|FG002|Overall Study|Lack of Efficacy|0|||
94229483|NCT03245619|322635473|FG004|Part A (Up to Day 22)|Physician Decision|0|||
94229484|NCT03245619|322635474|FG005|Part A (Up to Day 22)|Physician Decision|0|||
94229485|NCT03245619|322635475|FG006|Part A (Up to Day 22)|Physician Decision|0|||
94229486|NCT03245619|322635476|FG007|Part A (Up to Day 22)|Physician Decision|0|||
94229487|NCT03245619|322635477|FG008|Part A (Up to Day 22)|Physician Decision|0|||
94229488|NCT03245619|322635478|FG009|Part A (Up to Day 22)|Physician Decision|0|||
94229489|NCT03245619|322635479|FG010|Part A (Up to Day 22)|Physician Decision|0|||
94229490|NCT03245619|322635480|FG011|Part A (Up to Day 22)|Physician Decision|0|||
94229491|NCT03245619|322635481|FG012|Part A (Up to Day 22)|Physician Decision|0|||
94229492|NCT03245619|322635482|FG013|Part A (Up to Day 22)|Physician Decision|0|||
94229493|NCT03245619|322635483|FG014|Part A (Up to Day 22)|Physician Decision|0|||
94229494|NCT03245619|322635484|FG015|Part A (Up to Day 22)|Physician Decision|0|||
94229495|NCT03245619|322635485|FG016|Part A (Up to Day 22)|Physician Decision|0|||
94229496|NCT03187353|322635486|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
94229497|NCT03187353|322635487|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
94229498|NCT03187353|322635486|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
94229499|NCT03187353|322635487|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
94229500|NCT03187353|322635486|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
94229501|NCT03187353|322635487|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
94229502|NCT03187353|322635486|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
94229503|NCT03187353|322635487|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
94229504|NCT03187353|322635486|FG000|Washout (2 Weeks)|Adverse Event|2|||
94229505|NCT03187353|322635487|FG001|Washout (2 Weeks)|Adverse Event|0|||
94229506|NCT03187353|322635486|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
94229507|NCT03187353|322635487|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
94229508|NCT01167192|322635488|FG000|Overall Study|Adverse Event|1|||
94229509|NCT01167192|322635488|FG000|Overall Study|Death|1|||
94229510|NCT01167192|322635488|FG000|Overall Study|Withdrawal by Subject|1|||
94446868|NCT00979654|323421394|FG000|Overall Study|Serious Adverse Event|1|||
94446869|NCT00979654|323421394|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
94446870|NCT03655405|323421395|FG000|Overall Study|Death after initial data collection|4|||
94446871|NCT03655405|323421396|FG001|Overall Study|Death after initial data collection|2|||
94446872|NCT03655405|323421395|FG000|Overall Study|Died before initial data collection|1|||
94446873|NCT03655405|323421396|FG001|Overall Study|Died before initial data collection|2|||
94446874|NCT03655405|323421395|FG000|Overall Study|Protocol Violation|0|||
94446875|NCT03655405|323421396|FG001|Overall Study|Protocol Violation|1|||
94446876|NCT01205269|323421397|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
94446877|NCT01205269|323421398|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
94446878|NCT01205269|323421399|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
94446879|NCT01205269|323421400|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
94446880|NCT01205269|323421401|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
94446881|NCT01205269|323421402|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
94446882|NCT01408303|323421403|FG000|Overall Study|Adverse Event|3|||
94446883|NCT01408303|323421404|FG001|Overall Study|Adverse Event|7|||
94446884|NCT01408303|323421405|FG002|Overall Study|Adverse Event|2|||
94446885|NCT01408303|323421403|FG000|Overall Study|Lost to Follow-up|0|||
94446886|NCT01408303|323421404|FG001|Overall Study|Lost to Follow-up|1|||
94446887|NCT01408303|323421405|FG002|Overall Study|Lost to Follow-up|2|||
94446888|NCT01408303|323421403|FG000|Overall Study|Withdrawal by Subject|2|||
94446889|NCT01408303|323421404|FG001|Overall Study|Withdrawal by Subject|3|||
94446890|NCT01408303|323421405|FG002|Overall Study|Withdrawal by Subject|1|||
94446891|NCT01408303|323421403|FG000|Overall Study|Protocol Violation|0|||
94446892|NCT01408303|323421404|FG001|Overall Study|Protocol Violation|1|||
94446893|NCT01408303|323421405|FG002|Overall Study|Protocol Violation|0|||
94446894|NCT01408303|323421403|FG000|Overall Study|Noncompliance|1|||
94446895|NCT01408303|323421404|FG001|Overall Study|Noncompliance|0|||
94446896|NCT01408303|323421405|FG002|Overall Study|Noncompliance|1|||
94446897|NCT00722137|323421406|FG000|Overall Study|Overt Disease Progression|5|||
94446898|NCT00722137|323421407|FG001|Overall Study|Overt Disease Progression|4|||
94554624|NCT01339897|323826492|FG000|Overall Study|Adverse Event|1|||
94554625|NCT01339897|323826493|FG001|Overall Study|Adverse Event|0|||
94229511|NCT01167192|322635488|FG000|Overall Study|Insurance denial|1|||
94229512|NCT00550446|322635495|FG000|Up To Week 12|Adverse Event|2|||
94446899|NCT00722137|323421406|FG000|Overall Study|Adverse Event|17|||
94446900|NCT00722137|323421407|FG001|Overall Study|Adverse Event|21|||
94446901|NCT00722137|323421406|FG000|Overall Study|Death|12|||
94446902|NCT00722137|323421407|FG001|Overall Study|Death|7|||
94446903|NCT00722137|323421406|FG000|Overall Study|Withdrawal by Subject|6|||
94229513|NCT00550446|322635496|FG001|Up To Week 12|Adverse Event|2|||
94229514|NCT00550446|322635497|FG002|Up To Week 12|Adverse Event|0|||
94446904|NCT00722137|323421407|FG001|Overall Study|Withdrawal by Subject|9|||
94446905|NCT00722137|323421406|FG000|Overall Study|Other Reason Unknown|3|||
94229515|NCT00550446|322635498|FG003|Up To Week 12|Adverse Event|0|||
94229516|NCT00550446|322635499|FG004|Up To Week 12|Adverse Event|2|||
94229517|NCT00550446|322635500|FG005|Up To Week 12|Adverse Event|2|||
94554626|NCT01339897|323826494|FG002|Overall Study|Adverse Event|0|||
94446906|NCT00722137|323421407|FG001|Overall Study|Other Reason Unknown|4|||
94446907|NCT00722137|323421406|FG000|Overall Study|Randomized But Not Treated|2|||
94446908|NCT00722137|323421407|FG001|Overall Study|Randomized But Not Treated|3|||
94446909|NCT03830333|323421408|FG000|Overall Study|Death|0|||
94446910|NCT03830333|323421409|FG001|Overall Study|Death|1|||
94446911|NCT03830333|323421408|FG000|Overall Study|Withdrawal by Subject|5|||
94446912|NCT03830333|323421409|FG001|Overall Study|Withdrawal by Subject|1|||
94446913|NCT03830333|323421408|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
94446914|NCT03830333|323421409|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
94446915|NCT01129557|323421410|FG000|Overall Study|Adverse Event|1|||
94446916|NCT01129557|323421411|FG001|Overall Study|Adverse Event|2|||
94554627|NCT01339897|323826495|FG003|Overall Study|Adverse Event|1|||
94554628|NCT01140061|323826496|FG000|Part I|Adverse Event|1|||
94554629|NCT01140061|323826497|FG001|Part I|Adverse Event|0|||
94554630|NCT01140061|323826498|FG002|Part I|Adverse Event|0|||
94554631|NCT01140061|323826499|FG003|Part I|Adverse Event|0|||
94554632|NCT01140061|323826500|FG004|Part I|Adverse Event|0|||
94554633|NCT01140061|323826501|FG005|Part I|Adverse Event|0|||
94554634|NCT01140061|323826502|FG006|Part I|Adverse Event|0|||
94554635|NCT01140061|323826503|FG007|Part I|Adverse Event|0|||
94554636|NCT01140061|323826504|FG008|Part I|Adverse Event|0|||
94554637|NCT01140061|323826505|FG009|Part I|Adverse Event|0|||
94554638|NCT01140061|323826496|FG000|Extension|Laboratory Adverse Event|0|||
94554639|NCT01140061|323826497|FG001|Extension|Laboratory Adverse Event|0|||
94554640|NCT01140061|323826498|FG002|Extension|Laboratory Adverse Event|0|||
94554641|NCT01140061|323826499|FG003|Extension|Laboratory Adverse Event|0|||
94554642|NCT01140061|323826500|FG004|Extension|Laboratory Adverse Event|0|||
94554643|NCT01140061|323826501|FG005|Extension|Laboratory Adverse Event|0|||
94554644|NCT01140061|323826502|FG006|Extension|Laboratory Adverse Event|0|||
94554645|NCT01140061|323826503|FG007|Extension|Laboratory Adverse Event|0|||
94554646|NCT01140061|323826504|FG008|Extension|Laboratory Adverse Event|0|||
94554647|NCT01140061|323826505|FG009|Extension|Laboratory Adverse Event|1|||
94554648|NCT04006392|323826506|FG000|Overall Study|Lost to Follow-up|0|||
94554649|NCT04006392|323826507|FG001|Overall Study|Lost to Follow-up|1|||
94554650|NCT01299116|323826508|FG000|Overall Study|Lost to Follow-up|65|||
94554651|NCT01299116|323826509|FG001|Overall Study|Lost to Follow-up|9|||
94554652|NCT01299116|323826510|FG002|Overall Study|Lost to Follow-up|11|||
94554653|NCT01123707|323826511|FG000|Overall Study|Lost to Follow-up|3|||
94554654|NCT01123707|323826512|FG001|Overall Study|Lost to Follow-up|1|||
94554655|NCT01123707|323826513|FG002|Overall Study|Lost to Follow-up|3|||
94554656|NCT01123707|323826514|FG003|Overall Study|Lost to Follow-up|2|||
94554657|NCT01123707|323826511|FG000|Overall Study|Adverse Event|5|||
94554658|NCT01123707|323826512|FG001|Overall Study|Adverse Event|7|||
94554659|NCT01123707|323826513|FG002|Overall Study|Adverse Event|5|||
94554660|NCT01123707|323826514|FG003|Overall Study|Adverse Event|3|||
94554661|NCT01123707|323826511|FG000|Overall Study|Sponsor Discontinued Study|30|||
94229518|NCT00550446|322635501|FG006|Up To Week 12|Adverse Event|1|||
94229519|NCT00550446|322635502|FG007|Up To Week 12|Adverse Event|0|||
94229520|NCT00550446|322635503|FG008|Up To Week 12|Adverse Event|0|||
94229521|NCT00550446|322635504|FG009|Up To Week 12|Adverse Event|0|||
94229522|NCT00550446|322635505|FG010|Up To Week 12|Adverse Event|0|||
94229523|NCT00550446|322635495|FG000|Up To Week 12|Lack of Efficacy|3|||
94229524|NCT00550446|322635496|FG001|Up To Week 12|Lack of Efficacy|1|||
94229525|NCT00550446|322635497|FG002|Up To Week 12|Lack of Efficacy|0|||
94229526|NCT00550446|322635498|FG003|Up To Week 12|Lack of Efficacy|1|||
94229527|NCT00550446|322635499|FG004|Up To Week 12|Lack of Efficacy|0|||
94229528|NCT00550446|322635500|FG005|Up To Week 12|Lack of Efficacy|3|||
94229529|NCT00550446|322635501|FG006|Up To Week 12|Lack of Efficacy|3|||
94229530|NCT00550446|322635502|FG007|Up To Week 12|Lack of Efficacy|0|||
94229531|NCT00550446|322635503|FG008|Up To Week 12|Lack of Efficacy|0|||
94229532|NCT00550446|322635504|FG009|Up To Week 12|Lack of Efficacy|0|||
94229533|NCT00550446|322635505|FG010|Up To Week 12|Lack of Efficacy|0|||
94229534|NCT00550446|322635495|FG000|Up To Week 12|Lost to Follow-up|0|||
94229535|NCT00550446|322635496|FG001|Up To Week 12|Lost to Follow-up|1|||
94229536|NCT00550446|322635497|FG002|Up To Week 12|Lost to Follow-up|0|||
94229537|NCT00550446|322635498|FG003|Up To Week 12|Lost to Follow-up|0|||
94229538|NCT00550446|322635499|FG004|Up To Week 12|Lost to Follow-up|1|||
94229539|NCT00550446|322635500|FG005|Up To Week 12|Lost to Follow-up|1|||
94229540|NCT00550446|322635501|FG006|Up To Week 12|Lost to Follow-up|2|||
94229541|NCT00550446|322635502|FG007|Up To Week 12|Lost to Follow-up|0|||
94229542|NCT00550446|322635503|FG008|Up To Week 12|Lost to Follow-up|0|||
94229543|NCT00550446|322635504|FG009|Up To Week 12|Lost to Follow-up|0|||
94229544|NCT00550446|322635505|FG010|Up To Week 12|Lost to Follow-up|0|||
94229545|NCT00550446|322635495|FG000|Up To Week 12|Withdrawal by Subject|2|||
94229546|NCT00550446|322635496|FG001|Up To Week 12|Withdrawal by Subject|0|||
94229547|NCT00550446|322635497|FG002|Up To Week 12|Withdrawal by Subject|3|||
94229548|NCT00550446|322635498|FG003|Up To Week 12|Withdrawal by Subject|2|||
94229549|NCT00550446|322635499|FG004|Up To Week 12|Withdrawal by Subject|0|||
94229550|NCT00550446|322635500|FG005|Up To Week 12|Withdrawal by Subject|1|||
94229551|NCT00550446|322635501|FG006|Up To Week 12|Withdrawal by Subject|3|||
94229552|NCT00550446|322635502|FG007|Up To Week 12|Withdrawal by Subject|0|||
94229553|NCT00550446|322635503|FG008|Up To Week 12|Withdrawal by Subject|0|||
94229554|NCT00550446|322635504|FG009|Up To Week 12|Withdrawal by Subject|0|||
94229555|NCT00550446|322635505|FG010|Up To Week 12|Withdrawal by Subject|0|||
94229556|NCT00550446|322635495|FG000|Up To Week 12|Other|3|||
94229557|NCT00550446|322635496|FG001|Up To Week 12|Other|0|||
94229558|NCT00550446|322635497|FG002|Up To Week 12|Other|0|||
94229559|NCT00550446|322635498|FG003|Up To Week 12|Other|0|||
94229560|NCT00550446|322635499|FG004|Up To Week 12|Other|0|||
94229561|NCT00550446|322635500|FG005|Up To Week 12|Other|1|||
94554662|NCT01123707|323826512|FG001|Overall Study|Sponsor Discontinued Study|24|||
94554663|NCT01123707|323826513|FG002|Overall Study|Sponsor Discontinued Study|25|||
94554664|NCT01123707|323826514|FG003|Overall Study|Sponsor Discontinued Study|40|||
94554665|NCT01123707|323826511|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
94554666|NCT01123707|323826512|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
94229562|NCT00550446|322635501|FG006|Up To Week 12|Other|4|||
94229563|NCT00550446|322635502|FG007|Up To Week 12|Other|0|||
94229564|NCT00550446|322635503|FG008|Up To Week 12|Other|0|||
94554667|NCT01123707|323826513|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
94554668|NCT01123707|323826514|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
94554669|NCT01123707|323826511|FG000|Overall Study|Investigator Withdrew Participant|0|||
94554670|NCT01123707|323826512|FG001|Overall Study|Investigator Withdrew Participant|1|||
94554671|NCT01123707|323826513|FG002|Overall Study|Investigator Withdrew Participant|1|||
94554672|NCT01123707|323826514|FG003|Overall Study|Investigator Withdrew Participant|1|||
94554673|NCT01123707|323826511|FG000|Overall Study|Subject Withdrew Consent|4|||
94554674|NCT01123707|323826512|FG001|Overall Study|Subject Withdrew Consent|5|||
94554675|NCT01123707|323826513|FG002|Overall Study|Subject Withdrew Consent|1|||
94554676|NCT01123707|323826514|FG003|Overall Study|Subject Withdrew Consent|2|||
94554677|NCT01123707|323826511|FG000|Overall Study|Lack of Efficacy|1|||
94554678|NCT01123707|323826512|FG001|Overall Study|Lack of Efficacy|2|||
94554679|NCT01123707|323826513|FG002|Overall Study|Lack of Efficacy|1|||
94554680|NCT01123707|323826514|FG003|Overall Study|Lack of Efficacy|0|||
94554681|NCT01123707|323826511|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
94554682|NCT01123707|323826512|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
94554683|NCT01123707|323826513|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
94554684|NCT01123707|323826514|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
94229565|NCT00550446|322635504|FG009|Up To Week 12|Other|0|||
94229566|NCT00550446|322635505|FG010|Up To Week 12|Other|0|||
94229567|NCT00550446|322635495|FG000|Up To Week 12|Randomized not treated|0|||
94554685|NCT00488826|323826515|FG000|Overall Study|Withdrawal by Subject|40|||
94229568|NCT00550446|322635496|FG001|Up To Week 12|Randomized not treated|1|||
94554686|NCT00488826|323826516|FG001|Overall Study|Withdrawal by Subject|35|||
94554687|NCT00488826|323826517|FG002|Overall Study|Withdrawal by Subject|19|||
94554688|NCT00488826|323826515|FG000|Overall Study|Protocol Violation|0|||
94554689|NCT00488826|323826516|FG001|Overall Study|Protocol Violation|0|||
94229569|NCT00550446|322635497|FG002|Up To Week 12|Randomized not treated|1|||
94229570|NCT00550446|322635498|FG003|Up To Week 12|Randomized not treated|0|||
94229571|NCT00550446|322635499|FG004|Up To Week 12|Randomized not treated|0|||
94229572|NCT00550446|322635500|FG005|Up To Week 12|Randomized not treated|0|||
94229573|NCT00550446|322635501|FG006|Up To Week 12|Randomized not treated|0|||
94229574|NCT00550446|322635502|FG007|Up To Week 12|Randomized not treated|0|||
94229575|NCT00550446|322635503|FG008|Up To Week 12|Randomized not treated|0|||
94229576|NCT00550446|322635504|FG009|Up To Week 12|Randomized not treated|0|||
94229577|NCT00550446|322635505|FG010|Up To Week 12|Randomized not treated|0|||
94229578|NCT00550446|322635495|FG000|Post Week 12|Adverse Event|2|||
94446917|NCT01129557|323421412|FG002|Overall Study|Adverse Event|2|||
94446918|NCT01129557|323421410|FG000|Overall Study|Novartis terminated study early|3|||
94446919|NCT01129557|323421411|FG001|Overall Study|Novartis terminated study early|3|||
94446920|NCT01129557|323421412|FG002|Overall Study|Novartis terminated study early|2|||
94446921|NCT01611883|323421419|FG000|Overall Study|Adverse Event|1|||
94446922|NCT01611883|323421420|FG001|Overall Study|Adverse Event|1|||
94229579|NCT00550446|322635496|FG001|Post Week 12|Adverse Event|1|||
94229580|NCT00550446|322635497|FG002|Post Week 12|Adverse Event|1|||
94229581|NCT00550446|322635498|FG003|Post Week 12|Adverse Event|1|||
94229582|NCT00550446|322635499|FG004|Post Week 12|Adverse Event|1|||
94229583|NCT00550446|322635500|FG005|Post Week 12|Adverse Event|1|||
94229584|NCT00550446|322635501|FG006|Post Week 12|Adverse Event|0|||
94229585|NCT00550446|322635502|FG007|Post Week 12|Adverse Event|0|||
94229586|NCT00550446|322635503|FG008|Post Week 12|Adverse Event|0|||
94229587|NCT00550446|322635504|FG009|Post Week 12|Adverse Event|4|||
94229588|NCT00550446|322635505|FG010|Post Week 12|Adverse Event|0|||
94229589|NCT00550446|322635495|FG000|Post Week 12|Lack of Efficacy|0|||
94229590|NCT00550446|322635496|FG001|Post Week 12|Lack of Efficacy|0|||
94229591|NCT00550446|322635497|FG002|Post Week 12|Lack of Efficacy|1|||
94229592|NCT00550446|322635498|FG003|Post Week 12|Lack of Efficacy|0|||
94229593|NCT00550446|322635499|FG004|Post Week 12|Lack of Efficacy|0|||
94229594|NCT00550446|322635500|FG005|Post Week 12|Lack of Efficacy|0|||
94446923|NCT04200651|323421421|FG000|Overall Study|Moved to another country during follow-up|2|||
94446924|NCT04200651|323421422|FG001|Overall Study|Moved to another country during follow-up|2|||
94229595|NCT00550446|322635501|FG006|Post Week 12|Lack of Efficacy|0|||
94229596|NCT00550446|322635502|FG007|Post Week 12|Lack of Efficacy|1|||
94446925|NCT04200651|323421421|FG000|Overall Study|Lost to Follow-up|1|||
94229597|NCT00550446|322635503|FG008|Post Week 12|Lack of Efficacy|1|||
94229598|NCT00550446|322635504|FG009|Post Week 12|Lack of Efficacy|2|||
94229599|NCT00550446|322635505|FG010|Post Week 12|Lack of Efficacy|1|||
94343739|NCT02614261|323037827|FG000|Double-Blind Treatment Phase|Screen failure|0|||
94343740|NCT02614261|323037828|FG001|Double-Blind Treatment Phase|Screen failure|1|||
94343741|NCT02614261|323037829|FG002|Double-Blind Treatment Phase|Screen failure|2|||
94446926|NCT04200651|323421422|FG001|Overall Study|Lost to Follow-up|3|||
94446927|NCT04031846|323421423|FG000|Overall Study|Lost to Follow-up|4|||
94446928|NCT04031846|323421424|FG001|Overall Study|Lost to Follow-up|4|||
94446929|NCT04031846|323421423|FG000|Overall Study|Physician Decision|0|||
94446930|NCT04031846|323421424|FG001|Overall Study|Physician Decision|1|||
94446931|NCT04031846|323421423|FG000|Overall Study|Protocol Violation|1|||
94446932|NCT04031846|323421424|FG001|Overall Study|Protocol Violation|1|||
94446933|NCT04031846|323421423|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
94446934|NCT04031846|323421424|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
94446935|NCT06868654|323421425|FG000|Overall Study|Death|4|||
94446936|NCT06868654|323421426|FG001|Overall Study|Death|14|||
94446937|NCT06868654|323421425|FG000|Overall Study|Lost to Follow-up|0|||
94446938|NCT06868654|323421426|FG001|Overall Study|Lost to Follow-up|1|||
94446939|NCT06868654|323421425|FG000|Overall Study|Withdrawal by Subject|5|||
94446940|NCT06868654|323421426|FG001|Overall Study|Withdrawal by Subject|3|||
94446941|NCT06868654|323421425|FG000|Overall Study|Physician Decision|0|||
94446942|NCT06868654|323421426|FG001|Overall Study|Physician Decision|1|||
94446943|NCT06868654|323421425|FG000|Overall Study|Ongoing|23|||
94446944|NCT06868654|323421426|FG001|Overall Study|Ongoing|21|||
94446945|NCT01777282|323421431|FG000|Overall Study|Persistent Hyperglycemia|0|||
94446946|NCT01777282|323421432|FG001|Overall Study|Persistent Hyperglycemia|0|||
94343742|NCT02614261|323037830|FG003|Double-Blind Treatment Phase|Screen failure|0|||
94343743|NCT02614261|323037827|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
94343744|NCT02614261|323037828|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
94343745|NCT02614261|323037829|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
94343746|NCT02614261|323037830|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
94343747|NCT02614261|323037827|FG000|Open-Label Extension Phase|Adverse Event|23|||
94343748|NCT02614261|323037828|FG001|Open-Label Extension Phase|Adverse Event|12|||
94343749|NCT02614261|323037829|FG002|Open-Label Extension Phase|Adverse Event|11|||
94446947|NCT01777282|323421433|FG002|Overall Study|Persistent Hyperglycemia|1|||
94446948|NCT01777282|323421434|FG003|Overall Study|Persistent Hyperglycemia|0|||
94229600|NCT00550446|322635495|FG000|Post Week 12|Lost to Follow-up|0|||
94229601|NCT00550446|322635496|FG001|Post Week 12|Lost to Follow-up|0|||
94229602|NCT00550446|322635497|FG002|Post Week 12|Lost to Follow-up|1|||
94229603|NCT00550446|322635498|FG003|Post Week 12|Lost to Follow-up|1|||
94229604|NCT00550446|322635499|FG004|Post Week 12|Lost to Follow-up|0|||
94229605|NCT00550446|322635500|FG005|Post Week 12|Lost to Follow-up|0|||
94229606|NCT00550446|322635501|FG006|Post Week 12|Lost to Follow-up|1|||
94229607|NCT00550446|322635502|FG007|Post Week 12|Lost to Follow-up|0|||
94229608|NCT00550446|322635503|FG008|Post Week 12|Lost to Follow-up|0|||
94229609|NCT00550446|322635504|FG009|Post Week 12|Lost to Follow-up|0|||
94229610|NCT00550446|322635505|FG010|Post Week 12|Lost to Follow-up|0|||
94229611|NCT00550446|322635495|FG000|Post Week 12|Withdrawal by Subject|0|||
94229612|NCT00550446|322635496|FG001|Post Week 12|Withdrawal by Subject|0|||
94229613|NCT00550446|322635497|FG002|Post Week 12|Withdrawal by Subject|0|||
94229614|NCT00550446|322635498|FG003|Post Week 12|Withdrawal by Subject|0|||
94229615|NCT00550446|322635499|FG004|Post Week 12|Withdrawal by Subject|1|||
94229616|NCT00550446|322635500|FG005|Post Week 12|Withdrawal by Subject|0|||
94229617|NCT00550446|322635501|FG006|Post Week 12|Withdrawal by Subject|0|||
94229618|NCT00550446|322635502|FG007|Post Week 12|Withdrawal by Subject|0|||
94229619|NCT00550446|322635503|FG008|Post Week 12|Withdrawal by Subject|0|||
94229620|NCT00550446|322635504|FG009|Post Week 12|Withdrawal by Subject|0|||
94229621|NCT00550446|322635505|FG010|Post Week 12|Withdrawal by Subject|0|||
94229622|NCT00550446|322635495|FG000|Post Week 12|Other|1|||
94229623|NCT00550446|322635496|FG001|Post Week 12|Other|1|||
94229624|NCT00550446|322635497|FG002|Post Week 12|Other|0|||
94229625|NCT00550446|322635498|FG003|Post Week 12|Other|1|||
94229626|NCT00550446|322635499|FG004|Post Week 12|Other|0|||
94229627|NCT00550446|322635500|FG005|Post Week 12|Other|0|||
94229628|NCT00550446|322635501|FG006|Post Week 12|Other|1|||
94229629|NCT00550446|322635502|FG007|Post Week 12|Other|0|||
94229630|NCT00550446|322635503|FG008|Post Week 12|Other|1|||
94229631|NCT00550446|322635504|FG009|Post Week 12|Other|1|||
94229632|NCT00550446|322635505|FG010|Post Week 12|Other|0|||
94229633|NCT02561806|322635508|FG000|Induction Period|Adverse Event|0|||
94229634|NCT02561806|322635509|FG001|Induction Period|Adverse Event|2|||
94229635|NCT02561806|322635508|FG000|Induction Period|Lack of Efficacy|1|||
94229636|NCT02561806|322635509|FG001|Induction Period|Lack of Efficacy|0|||
94229637|NCT02561806|322635508|FG000|Induction Period|Withdrawal by Subject|0|||
94229638|NCT02561806|322635509|FG001|Induction Period|Withdrawal by Subject|2|||
94229639|NCT02561806|322635508|FG000|Induction Period|Site staff became unblinded|1|||
94229640|NCT02561806|322635509|FG001|Induction Period|Site staff became unblinded|0|||
94229641|NCT02561806|322635508|FG000|Induction Period|Randomized but not treated|0|||
94229642|NCT02561806|322635509|FG001|Induction Period|Randomized but not treated|1|||
94229643|NCT02561806|322635508|FG000|Maintenance Period|Adverse Event|2|||
94229644|NCT02561806|322635509|FG001|Maintenance Period|Adverse Event|1|||
94229645|NCT02561806|322635508|FG000|Maintenance Period|Lack of Efficacy|3|||
94229646|NCT02561806|322635509|FG001|Maintenance Period|Lack of Efficacy|1|||
94229647|NCT02561806|322635508|FG000|Maintenance Period|Lost to Follow-up|2|||
94229648|NCT02561806|322635509|FG001|Maintenance Period|Lost to Follow-up|2|||
94229649|NCT02561806|322635508|FG000|Maintenance Period|Protocol Violation|1|||
94229650|NCT02561806|322635509|FG001|Maintenance Period|Protocol Violation|0|||
94229651|NCT02561806|322635508|FG000|Maintenance Period|Withdrawal by Subject|5|||
94229652|NCT02561806|322635509|FG001|Maintenance Period|Withdrawal by Subject|3|||
94229653|NCT02561806|322635508|FG000|Maintenance Period|Site staff became unblinded|0|||
94554690|NCT00488826|323826517|FG002|Overall Study|Protocol Violation|2|||
94554691|NCT00488826|323826515|FG000|Overall Study|Adverse Event|9|||
94554692|NCT00488826|323826516|FG001|Overall Study|Adverse Event|15|||
94554693|NCT00488826|323826517|FG002|Overall Study|Adverse Event|4|||
94554694|NCT00488826|323826515|FG000|Overall Study|Lost to Follow-up|5|||
94554695|NCT00488826|323826516|FG001|Overall Study|Lost to Follow-up|1|||
94554696|NCT00488826|323826517|FG002|Overall Study|Lost to Follow-up|0|||
94554697|NCT00488826|323826515|FG000|Overall Study|Protocol Deviations|2|||
94554698|NCT00488826|323826516|FG001|Overall Study|Protocol Deviations|1|||
94554699|NCT00488826|323826517|FG002|Overall Study|Protocol Deviations|1|||
94554700|NCT02577016|323826525|FG000|Overall Study|Adverse Event|2|||
94554701|NCT02577016|323826526|FG001|Overall Study|Adverse Event|1|||
94554702|NCT02577016|323826525|FG000|Overall Study|Physician Decision|0|||
94554703|NCT02577016|323826526|FG001|Overall Study|Physician Decision|1|||
94554704|NCT00986362|323826527|FG000|Overall Study|Death|2|||
94554705|NCT00986362|323826528|FG001|Overall Study|Death|0|||
94554706|NCT00986362|323826527|FG000|Overall Study|Lost to Follow-up|0|||
94554707|NCT00986362|323826528|FG001|Overall Study|Lost to Follow-up|1|||
94554708|NCT00812565|323826529|FG000|Overall Study|Did Not Receive Study Medication|1|||
94229654|NCT02561806|322635509|FG001|Maintenance Period|Site staff became unblinded|1|||
94229655|NCT02561806|322635508|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
94229656|NCT02561806|322635509|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
94229657|NCT02561806|322635508|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
94229658|NCT02561806|322635509|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
94229659|NCT01657877|322635510|FG000|Overall Study|Withdrawal by Subject|4|||
94229660|NCT01657877|322635510|FG000|Overall Study|Protocol Violation|6|||
94229661|NCT01657877|322635510|FG000|Overall Study|Adverse Event|2|||
94229662|NCT01657877|322635510|FG000|Overall Study|Other Reason|2|||
94229663|NCT02872311|322635511|FG000|Overall Study|Death|2|||
94229664|NCT02872311|322635512|FG001|Overall Study|Death|0|||
94229665|NCT02872311|322635513|FG002|Overall Study|Death|0|||
94229666|NCT02872311|322635514|FG003|Overall Study|Death|0|||
94229667|NCT02872311|322635515|FG004|Overall Study|Death|0|||
94229668|NCT02872311|322635511|FG000|Overall Study|Lost to Follow-up|2|||
94229669|NCT02872311|322635512|FG001|Overall Study|Lost to Follow-up|0|||
94229670|NCT02872311|322635513|FG002|Overall Study|Lost to Follow-up|0|||
94229671|NCT02872311|322635514|FG003|Overall Study|Lost to Follow-up|0|||
94229672|NCT02872311|322635515|FG004|Overall Study|Lost to Follow-up|0|||
94229673|NCT02872311|322635511|FG000|Overall Study|Protocol Violation|0|||
94229674|NCT02872311|322635512|FG001|Overall Study|Protocol Violation|2|||
94229675|NCT02872311|322635513|FG002|Overall Study|Protocol Violation|1|||
94229676|NCT02872311|322635514|FG003|Overall Study|Protocol Violation|0|||
94229677|NCT02872311|322635515|FG004|Overall Study|Protocol Violation|0|||
94229678|NCT01898442|322635516|FG000|Overall Study|Hemolysis/technical problems|1|||
94229679|NCT01898442|322635517|FG001|Overall Study|Hemolysis/technical problems|2|||
94229680|NCT01898442|322635518|FG002|Overall Study|Hemolysis/technical problems|2|||
94229681|NCT01898442|322635516|FG000|Overall Study|Patient vomited pills|0|||
94229682|NCT01898442|322635517|FG001|Overall Study|Patient vomited pills|0|||
94554709|NCT00812565|323826530|FG001|Overall Study|Did Not Receive Study Medication|1|||
94554710|NCT00812565|323826531|FG002|Overall Study|Did Not Receive Study Medication|0|||
94554711|NCT00812565|323826532|FG003|Overall Study|Did Not Receive Study Medication|0|||
94554712|NCT00812565|323826533|FG004|Overall Study|Did Not Receive Study Medication|0|||
94554713|NCT00812565|323826534|FG005|Overall Study|Did Not Receive Study Medication|0|||
94554714|NCT00812565|323826535|FG006|Overall Study|Did Not Receive Study Medication|0|||
94554715|NCT00812565|323826536|FG007|Overall Study|Did Not Receive Study Medication|0|||
94229683|NCT01898442|322635518|FG002|Overall Study|Patient vomited pills|1|||
94229684|NCT01435798|322635519|FG000|Overall Study|Withdrawal by Subject|1|||
94554716|NCT00812565|323826529|FG000|Overall Study|Adverse Event|0|||
94554717|NCT00812565|323826530|FG001|Overall Study|Adverse Event|0|||
94554718|NCT00812565|323826531|FG002|Overall Study|Adverse Event|0|||
94554719|NCT00812565|323826532|FG003|Overall Study|Adverse Event|2|||
94554720|NCT00812565|323826533|FG004|Overall Study|Adverse Event|0|||
94554721|NCT00812565|323826534|FG005|Overall Study|Adverse Event|0|||
94554722|NCT00812565|323826535|FG006|Overall Study|Adverse Event|0|||
94554723|NCT00812565|323826536|FG007|Overall Study|Adverse Event|1|||
94554724|NCT00812565|323826529|FG000|Overall Study|Did Not Come to Study Visit|1|||
94554725|NCT00812565|323826530|FG001|Overall Study|Did Not Come to Study Visit|0|||
94446949|NCT01777282|323421435|FG004|Overall Study|Persistent Hyperglycemia|0|||
94446950|NCT01777282|323421431|FG000|Overall Study|New Antidiabetic Medication|0|||
94446951|NCT01777282|323421432|FG001|Overall Study|New Antidiabetic Medication|0|||
94446952|NCT01777282|323421433|FG002|Overall Study|New Antidiabetic Medication|1|||
94446953|NCT01777282|323421434|FG003|Overall Study|New Antidiabetic Medication|0|||
94446954|NCT01777282|323421435|FG004|Overall Study|New Antidiabetic Medication|0|||
94446955|NCT01777282|323421431|FG000|Overall Study|Adverse Event|4|||
94446956|NCT01777282|323421432|FG001|Overall Study|Adverse Event|4|||
94446957|NCT01777282|323421433|FG002|Overall Study|Adverse Event|2|||
94554726|NCT00812565|323826531|FG002|Overall Study|Did Not Come to Study Visit|0|||
94554727|NCT00812565|323826532|FG003|Overall Study|Did Not Come to Study Visit|0|||
94554728|NCT00812565|323826533|FG004|Overall Study|Did Not Come to Study Visit|0|||
94554729|NCT00812565|323826534|FG005|Overall Study|Did Not Come to Study Visit|0|||
94554730|NCT00812565|323826535|FG006|Overall Study|Did Not Come to Study Visit|0|||
94554731|NCT00812565|323826536|FG007|Overall Study|Did Not Come to Study Visit|0|||
94554732|NCT00812565|323826529|FG000|Overall Study|Withdrawal of Consent|1|||
94554733|NCT00812565|323826530|FG001|Overall Study|Withdrawal of Consent|0|||
94554734|NCT00812565|323826531|FG002|Overall Study|Withdrawal of Consent|0|||
94446958|NCT01777282|323421434|FG003|Overall Study|Adverse Event|1|||
94446959|NCT01777282|323421435|FG004|Overall Study|Adverse Event|3|||
94554735|NCT00812565|323826532|FG003|Overall Study|Withdrawal of Consent|0|||
94446960|NCT01777282|323421431|FG000|Overall Study|Withdrawal by Subject|4|||
94554736|NCT00812565|323826533|FG004|Overall Study|Withdrawal of Consent|1|||
94446961|NCT01777282|323421432|FG001|Overall Study|Withdrawal by Subject|0|||
94554737|NCT00812565|323826534|FG005|Overall Study|Withdrawal of Consent|0|||
94554738|NCT00812565|323826535|FG006|Overall Study|Withdrawal of Consent|0|||
94229685|NCT02427958|322635520|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
94229686|NCT02427958|322635520|FG000|Overall Study|Lost to Follow-up|6|||
94229687|NCT02427958|322635520|FG000|Overall Study|Withdrawal by Subject|14|||
94229688|NCT02427958|322635520|FG000|Overall Study|Lack of Efficacy|1|||
94229689|NCT00866918|322635521|FG000|Overall Study|Death|1|||
94229690|NCT00866918|322635522|FG001|Overall Study|Death|5|||
94229691|NCT00866918|322635521|FG000|Overall Study|Lack of Efficacy|1|||
94229692|NCT00866918|322635522|FG001|Overall Study|Lack of Efficacy|1|||
94229693|NCT00866918|322635521|FG000|Overall Study|Physician Decision|10|||
94229694|NCT00866918|322635522|FG001|Overall Study|Physician Decision|2|||
94229695|NCT00866918|322635521|FG000|Overall Study|Ineligible|2|||
94229696|NCT00866918|322635522|FG001|Overall Study|Ineligible|4|||
94229697|NCT00866918|322635521|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
94229698|NCT00866918|322635522|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
94229699|NCT00866918|322635521|FG000|Overall Study|Secondary malignancy|1|||
94229700|NCT00866918|322635522|FG001|Overall Study|Secondary malignancy|0|||
94229701|NCT00511797|322635523|FG000|Overall Study|Adverse Event|1|||
94229702|NCT00511797|322635524|FG001|Overall Study|Adverse Event|2|||
94229703|NCT00511797|322635525|FG002|Overall Study|Adverse Event|2|||
94229704|NCT00511797|322635526|FG003|Overall Study|Adverse Event|2|||
94229705|NCT00511797|322635523|FG000|Overall Study|Lost to Follow-up|1|||
94229706|NCT00511797|322635524|FG001|Overall Study|Lost to Follow-up|0|||
94229707|NCT00511797|322635525|FG002|Overall Study|Lost to Follow-up|0|||
94229708|NCT00511797|322635526|FG003|Overall Study|Lost to Follow-up|1|||
94446962|NCT01777282|323421433|FG002|Overall Study|Withdrawal by Subject|0|||
94446963|NCT01777282|323421434|FG003|Overall Study|Withdrawal by Subject|1|||
94446964|NCT01777282|323421435|FG004|Overall Study|Withdrawal by Subject|2|||
94446965|NCT01777282|323421431|FG000|Overall Study|Protocol Violation|2|||
94446966|NCT01777282|323421432|FG001|Overall Study|Protocol Violation|0|||
94446967|NCT01777282|323421433|FG002|Overall Study|Protocol Violation|1|||
94446968|NCT01777282|323421434|FG003|Overall Study|Protocol Violation|0|||
94446969|NCT01777282|323421435|FG004|Overall Study|Protocol Violation|2|||
94446970|NCT01777282|323421431|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
94446971|NCT01777282|323421432|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
94446972|NCT01777282|323421433|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
94446973|NCT01777282|323421434|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
94446974|NCT01777282|323421435|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
94446975|NCT00764660|323421436|FG000|Overall Study|Adverse Event|6|||
94446976|NCT00764660|323421437|FG001|Overall Study|Adverse Event|3|||
94446977|NCT00764660|323421436|FG000|Overall Study|Lost to Follow-up|3|||
94446978|NCT00764660|323421437|FG001|Overall Study|Lost to Follow-up|4|||
94446979|NCT00764660|323421436|FG000|Overall Study|Withdrawal by Subject|7|||
94446980|NCT00764660|323421437|FG001|Overall Study|Withdrawal by Subject|3|||
94446981|NCT00764660|323421436|FG000|Overall Study|Noncompliance With Protocol|5|||
94446982|NCT00764660|323421437|FG001|Overall Study|Noncompliance With Protocol|1|||
94446983|NCT00764660|323421436|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
94446984|NCT00764660|323421437|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
94446985|NCT02844543|323423251|FG000|Overall Study|Withdrawal by Subject|4|||
94446986|NCT02844543|323423251|FG000|Overall Study|Did not meet eligibility criteria|1|||
94446987|NCT03349060|323423252|FG000|Overall Study|Adverse Event|9|||
94446988|NCT03349060|323423253|FG001|Overall Study|Adverse Event|9|||
94446989|NCT03349060|323423254|FG002|Overall Study|Adverse Event|7|||
94446990|NCT03349060|323423252|FG000|Overall Study|Lack of Efficacy|1|||
94446991|NCT03349060|323423253|FG001|Overall Study|Lack of Efficacy|0|||
94446992|NCT03349060|323423254|FG002|Overall Study|Lack of Efficacy|2|||
94446993|NCT03349060|323423252|FG000|Overall Study|Lost to Follow-up|2|||
94446994|NCT03349060|323423253|FG001|Overall Study|Lost to Follow-up|1|||
94446995|NCT03349060|323423254|FG002|Overall Study|Lost to Follow-up|1|||
94446996|NCT03349060|323423252|FG000|Overall Study|Protocol Violation|2|||
94446997|NCT03349060|323423253|FG001|Overall Study|Protocol Violation|2|||
94446998|NCT03349060|323423254|FG002|Overall Study|Protocol Violation|1|||
94446999|NCT03349060|323423252|FG000|Overall Study|Withdrawal by Subject|5|||
94554739|NCT00812565|323826536|FG007|Overall Study|Withdrawal of Consent|0|||
94554740|NCT00812565|323826529|FG000|Overall Study|Reason Not Specified|0|||
94229709|NCT00511797|322635523|FG000|Overall Study|Pregnancy|0|||
94229710|NCT00511797|322635524|FG001|Overall Study|Pregnancy|0|||
94229711|NCT00511797|322635525|FG002|Overall Study|Pregnancy|0|||
94229712|NCT00511797|322635526|FG003|Overall Study|Pregnancy|1|||
94447000|NCT03349060|323423253|FG001|Overall Study|Withdrawal by Subject|3|||
94447001|NCT03349060|323423254|FG002|Overall Study|Withdrawal by Subject|4|||
94447002|NCT03349060|323423252|FG000|Overall Study|Medication error,no linked adverse event|0|||
94447003|NCT03349060|323423253|FG001|Overall Study|Medication error,no linked adverse event|0|||
94229713|NCT00511797|322635523|FG000|Overall Study|Protocol Violation|0|||
94447004|NCT03349060|323423254|FG002|Overall Study|Medication error,no linked adverse event|1|||
94554741|NCT00812565|323826530|FG001|Overall Study|Reason Not Specified|0|||
94229714|NCT00511797|322635524|FG001|Overall Study|Protocol Violation|2|||
94229715|NCT00511797|322635525|FG002|Overall Study|Protocol Violation|2|||
94229716|NCT00511797|322635526|FG003|Overall Study|Protocol Violation|3|||
94229717|NCT00511797|322635523|FG000|Overall Study|Withdrawal by Subject|3|||
94229718|NCT00511797|322635524|FG001|Overall Study|Withdrawal by Subject|3|||
94229719|NCT00511797|322635525|FG002|Overall Study|Withdrawal by Subject|4|||
94229720|NCT00511797|322635526|FG003|Overall Study|Withdrawal by Subject|2|||
94229721|NCT00511797|322635523|FG000|Overall Study|Never dispensed|1|||
94229722|NCT00511797|322635524|FG001|Overall Study|Never dispensed|0|||
94229723|NCT00511797|322635525|FG002|Overall Study|Never dispensed|1|||
94447005|NCT03349060|323423252|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
94447006|NCT03349060|323423253|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
94447007|NCT03349060|323423254|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
94447008|NCT03349060|323423252|FG000|Overall Study|Other|2|||
94447009|NCT03349060|323423253|FG001|Overall Study|Other|1|||
94447010|NCT03349060|323423254|FG002|Overall Study|Other|0|||
94447011|NCT00485732|323423258|FG000|Overall Study|Protocol Violation|1|||
94447012|NCT00485732|323423259|FG001|Overall Study|Protocol Violation|3|||
94447013|NCT00485732|323423258|FG000|Overall Study|Withdrawal by Subject|5|||
94447014|NCT00485732|323423259|FG001|Overall Study|Withdrawal by Subject|4|||
94447015|NCT00485732|323423258|FG000|Overall Study|Lost to Follow-up|2|||
94447016|NCT00485732|323423259|FG001|Overall Study|Lost to Follow-up|2|||
94447017|NCT00803790|323423260|FG000|Period 1|Adverse Event|0|||
94447018|NCT00803790|323423261|FG001|Period 1|Adverse Event|1|||
94447019|NCT00803790|323423262|FG002|Period 1|Adverse Event|0|||
94447020|NCT00803790|323423263|FG003|Period 1|Adverse Event|0|||
94447021|NCT00803790|323423260|FG000|Period 1|Lost to Follow-up|1|||
94447022|NCT00803790|323423261|FG001|Period 1|Lost to Follow-up|2|||
94447023|NCT00803790|323423262|FG002|Period 1|Lost to Follow-up|0|||
94447024|NCT00803790|323423263|FG003|Period 1|Lost to Follow-up|0|||
94229724|NCT00511797|322635526|FG003|Overall Study|Never dispensed|3|||
94447025|NCT00803790|323423260|FG000|Period 1|Withdrawal by Subject|8|||
94447026|NCT00803790|323423261|FG001|Period 1|Withdrawal by Subject|6|||
94447027|NCT00803790|323423262|FG002|Period 1|Withdrawal by Subject|0|||
94447028|NCT00803790|323423263|FG003|Period 1|Withdrawal by Subject|0|||
94447029|NCT00803790|323423260|FG000|Period 1|positive drug screen or personal reasons|0|||
94447030|NCT00803790|323423261|FG001|Period 1|positive drug screen or personal reasons|3|||
94229725|NCT00511797|322635523|FG000|Overall Study|Study drug not taken|0|||
94229726|NCT00511797|322635524|FG001|Overall Study|Study drug not taken|1|||
94229727|NCT00511797|322635525|FG002|Overall Study|Study drug not taken|0|||
94229728|NCT00511797|322635526|FG003|Overall Study|Study drug not taken|1|||
94229729|NCT00511797|322635523|FG000|Overall Study|Partially missing diary|0|||
94229730|NCT00511797|322635524|FG001|Overall Study|Partially missing diary|0|||
94229731|NCT00511797|322635525|FG002|Overall Study|Partially missing diary|1|||
94229732|NCT00511797|322635526|FG003|Overall Study|Partially missing diary|0|||
94229733|NCT00511797|322635523|FG000|Overall Study|Other (moving etc)|1|||
94229734|NCT00511797|322635524|FG001|Overall Study|Other (moving etc)|0|||
94229735|NCT00511797|322635525|FG002|Overall Study|Other (moving etc)|1|||
94229736|NCT00511797|322635526|FG003|Overall Study|Other (moving etc)|2|||
94229737|NCT01121913|322635527|FG000|First Intervention Period|Adverse Event|0|||
94229738|NCT01121913|322635528|FG001|First Intervention Period|Adverse Event|0|||
94229739|NCT01121913|322635529|FG002|First Intervention Period|Adverse Event|1|||
94229740|NCT01121913|322635530|FG003|First Intervention Period|Adverse Event|0|||
94229741|NCT01121913|322635527|FG000|First Washout Period|Withdrawal by Subject|1|||
94229742|NCT01121913|322635528|FG001|First Washout Period|Withdrawal by Subject|0|||
94229743|NCT01121913|322635529|FG002|First Washout Period|Withdrawal by Subject|0|||
94229744|NCT01121913|322635530|FG003|First Washout Period|Withdrawal by Subject|0|||
94229745|NCT01121913|322635527|FG000|Second Intervention Period|Adverse Event|0|||
94229746|NCT01121913|322635528|FG001|Second Intervention Period|Adverse Event|0|||
94229747|NCT01121913|322635529|FG002|Second Intervention Period|Adverse Event|1|||
94229748|NCT01121913|322635530|FG003|Second Intervention Period|Adverse Event|0|||
94229749|NCT01121913|322635527|FG000|Second Washout Period|Withdrawal by Subject|0|||
94229750|NCT01121913|322635528|FG001|Second Washout Period|Withdrawal by Subject|0|||
94229751|NCT01121913|322635529|FG002|Second Washout Period|Withdrawal by Subject|1|||
94229752|NCT01121913|322635530|FG003|Second Washout Period|Withdrawal by Subject|0|||
94229753|NCT01121913|322635527|FG000|Third Washout Period|Adverse Event|1|||
94229754|NCT01121913|322635528|FG001|Third Washout Period|Adverse Event|0|||
94229755|NCT01121913|322635529|FG002|Third Washout Period|Adverse Event|0|||
94229756|NCT01121913|322635530|FG003|Third Washout Period|Adverse Event|0|||
94229757|NCT01704547|322635531|FG000|Overall Study|Physician Decision|4|||
94229758|NCT01704547|322635531|FG000|Overall Study|Withdrawal by Subject|1|||
94229759|NCT00874497|322635534|FG000|Overall Study|Lost to Follow-up|2|||
94229760|NCT00874497|322635535|FG001|Overall Study|Lost to Follow-up|4|||
94229761|NCT00874497|322635534|FG000|Overall Study|Adverse Event|9|||
94229762|NCT00874497|322635535|FG001|Overall Study|Adverse Event|4|||
94229763|NCT00874497|322635534|FG000|Overall Study|Sponsor Discontinued Trial|7|||
94229764|NCT00874497|322635535|FG001|Overall Study|Sponsor Discontinued Trial|3|||
94229765|NCT00874497|322635534|FG000|Overall Study|Met Withdrawal Criteria|4|||
94229766|NCT00874497|322635535|FG001|Overall Study|Met Withdrawal Criteria|2|||
94229767|NCT00874497|322635534|FG000|Overall Study|Physician Decision|1|||
94229768|NCT00874497|322635535|FG001|Overall Study|Physician Decision|1|||
94229769|NCT00874497|322635534|FG000|Overall Study|Withdrawal by Subject|5|||
94229770|NCT00874497|322635535|FG001|Overall Study|Withdrawal by Subject|4|||
94447031|NCT00803790|323423262|FG002|Period 1|positive drug screen or personal reasons|0|||
94447032|NCT00803790|323423263|FG003|Period 1|positive drug screen or personal reasons|4|||
94229771|NCT01426113|322635536|FG000|Overall Study|Study Discontinued|1|||
94229772|NCT01426113|322635537|FG001|Overall Study|Study Discontinued|1|||
94447033|NCT00803790|323423260|FG000|Period 1|Protocol Violation|0|||
94447034|NCT00803790|323423261|FG001|Period 1|Protocol Violation|0|||
94447035|NCT00803790|323423262|FG002|Period 1|Protocol Violation|1|||
94447036|NCT00803790|323423263|FG003|Period 1|Protocol Violation|0|||
94229773|NCT01426113|322635536|FG000|Overall Study|Adverse Event|0|||
94229774|NCT01426113|322635537|FG001|Overall Study|Adverse Event|1|||
94229775|NCT00436956|322635538|FG000|Overall Study|Not evaluable|1|||
94229776|NCT00436956|322635539|FG001|Overall Study|Not evaluable|0|||
94229777|NCT00878553|322635541|FG000|Sleep Study|Withdrawal by Subject|2|||
94229778|NCT00878553|322635542|FG001|Sleep Study|Withdrawal by Subject|0|||
94229779|NCT00878553|322635543|FG002|Sleep Study|Withdrawal by Subject|0|||
94229780|NCT00878553|322635544|FG003|Sleep Study|Withdrawal by Subject|0|||
94447037|NCT00803790|323423260|FG000|Period 2|Adverse Event|0|||
94229781|NCT00878553|322635545|FG004|Sleep Study|Withdrawal by Subject|0|||
94229782|NCT00878553|322635541|FG000|Sleep Study|Lost to Follow-up|1|||
94229783|NCT00878553|322635542|FG001|Sleep Study|Lost to Follow-up|0|||
94447038|NCT00803790|323423261|FG001|Period 2|Adverse Event|0|||
94447039|NCT00803790|323423262|FG002|Period 2|Adverse Event|1|||
94447040|NCT00803790|323423263|FG003|Period 2|Adverse Event|1|||
94229784|NCT00878553|322635543|FG002|Sleep Study|Lost to Follow-up|0|||
94229785|NCT00878553|322635544|FG003|Sleep Study|Lost to Follow-up|0|||
94229786|NCT00878553|322635545|FG004|Sleep Study|Lost to Follow-up|0|||
94229787|NCT00878553|322635541|FG000|Sleep Study|car accident|1|||
94229788|NCT00878553|322635542|FG001|Sleep Study|car accident|0|||
94229789|NCT00878553|322635543|FG002|Sleep Study|car accident|0|||
94229790|NCT00878553|322635544|FG003|Sleep Study|car accident|0|||
94229791|NCT00878553|322635545|FG004|Sleep Study|car accident|0|||
94229792|NCT00878553|322635541|FG000|Sleep Study|family emergency|1|||
94447041|NCT00803790|323423260|FG000|Period 2|Withdrawal by Subject|1|||
94229793|NCT00878553|322635542|FG001|Sleep Study|family emergency|0|||
94229794|NCT00878553|322635543|FG002|Sleep Study|family emergency|0|||
94229795|NCT00878553|322635544|FG003|Sleep Study|family emergency|0|||
94229796|NCT00878553|322635545|FG004|Sleep Study|family emergency|0|||
94229797|NCT00878553|322635541|FG000|PK Study|Withdrawal by Subject|0|||
94229798|NCT00878553|322635542|FG001|PK Study|Withdrawal by Subject|0|||
94229799|NCT00878553|322635543|FG002|PK Study|Withdrawal by Subject|0|||
94229800|NCT00878553|322635544|FG003|PK Study|Withdrawal by Subject|1|||
94229801|NCT00878553|322635545|FG004|PK Study|Withdrawal by Subject|0|||
94229802|NCT00623363|322635546|FG000|Overall Study|Adverse Event|2|||
94229803|NCT00623363|322635547|FG001|Overall Study|Adverse Event|2|||
94229804|NCT04354168|322635548|FG000|Overall Study|Lost to Follow-up|22|||
94229805|NCT01163474|322635549|FG000|Overall Study|Withdrawal by Subject|1|||
94229806|NCT01163474|322635549|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
94229807|NCT01163474|322635549|FG000|Overall Study|Lost to Follow-up|3|||
94229808|NCT01813305|322635552|FG000|Overall Study|Withdrawal by Subject|12|||
94229809|NCT01813305|322635553|FG001|Overall Study|Withdrawal by Subject|5|||
94447042|NCT00803790|323423261|FG001|Period 2|Withdrawal by Subject|0|||
94447043|NCT00803790|323423262|FG002|Period 2|Withdrawal by Subject|0|||
94447044|NCT00803790|323423263|FG003|Period 2|Withdrawal by Subject|0|||
94447045|NCT00803790|323423260|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
94447046|NCT00803790|323423261|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
94229810|NCT01813305|322635552|FG000|Overall Study|Safety Concern|4|||
94229811|NCT01813305|322635553|FG001|Overall Study|Safety Concern|0|||
94229812|NCT01813305|322635552|FG000|Overall Study|Ulcer became worse|4|||
94229813|NCT01813305|322635553|FG001|Overall Study|Ulcer became worse|0|||
94229814|NCT01813305|322635552|FG000|Overall Study|Physician Decision|4|||
94229815|NCT01813305|322635553|FG001|Overall Study|Physician Decision|0|||
94229816|NCT01813305|322635552|FG000|Overall Study|Lost to Follow-up|3|||
94229817|NCT01813305|322635553|FG001|Overall Study|Lost to Follow-up|1|||
94229818|NCT01813305|322635552|FG000|Overall Study|Protocol Violation|1|||
94229819|NCT01813305|322635553|FG001|Overall Study|Protocol Violation|0|||
94229820|NCT01813305|322635552|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
94229821|NCT01813305|322635553|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
94229822|NCT01982448|322635558|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
94229823|NCT01982448|322635559|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
94229824|NCT01982448|322635558|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
94229825|NCT01982448|322635559|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
94229826|NCT01982448|322635558|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
94229827|NCT01982448|322635559|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
94229828|NCT01982448|322635558|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
94229829|NCT01982448|322635559|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
94229830|NCT00604188|322635560|FG000|Overall Study|Adverse Event|1|||
94229831|NCT00604188|322635561|FG001|Overall Study|Adverse Event|4|||
94229832|NCT00604188|322635560|FG000|Overall Study|Lost to Follow-up|17|||
94229833|NCT00604188|322635561|FG001|Overall Study|Lost to Follow-up|15|||
94229834|NCT00604188|322635560|FG000|Overall Study|Withdrawal by Subject|5|||
94229835|NCT00604188|322635561|FG001|Overall Study|Withdrawal by Subject|1|||
94229836|NCT00604188|322635560|FG000|Overall Study|Non-compliance with protocol|4|||
94229837|NCT00604188|322635561|FG001|Overall Study|Non-compliance with protocol|4|||
94229838|NCT00604188|322635560|FG000|Overall Study|Did not receive study drug|0|||
94229839|NCT00604188|322635561|FG001|Overall Study|Did not receive study drug|1|||
94229840|NCT01227928|322635564|FG000|Overall Study|Lost to Follow-up|4|||
94229841|NCT01227928|322635565|FG001|Overall Study|Lost to Follow-up|2|||
94229842|NCT01227928|322635564|FG000|Overall Study|Withdrawal by Subject|4|||
94229843|NCT01227928|322635565|FG001|Overall Study|Withdrawal by Subject|3|||
94229844|NCT01227928|322635564|FG000|Overall Study|Death|14|||
94229845|NCT01227928|322635565|FG001|Overall Study|Death|12|||
94229846|NCT02930837|322635566|FG000|Overall Study|Adverse Event|6|||
94229847|NCT02930837|322635566|FG000|Overall Study|Lost to Follow-up|5|||
94229848|NCT02930837|322635566|FG000|Overall Study|Withdrawal by Subject|1|||
94229849|NCT02633397|322635567|FG000|Overall Study|Adverse Event|8|||
94229850|NCT02633397|322635568|FG001|Overall Study|Adverse Event|8|||
94229851|NCT02633397|322635567|FG000|Overall Study|Study Burden|4|||
94229852|NCT02633397|322635568|FG001|Overall Study|Study Burden|1|||
94554742|NCT00812565|323826531|FG002|Overall Study|Reason Not Specified|0|||
94554743|NCT00812565|323826532|FG003|Overall Study|Reason Not Specified|0|||
94554744|NCT00812565|323826533|FG004|Overall Study|Reason Not Specified|0|||
94554745|NCT00812565|323826534|FG005|Overall Study|Reason Not Specified|1|||
94554746|NCT00812565|323826535|FG006|Overall Study|Reason Not Specified|0|||
94554747|NCT00812565|323826536|FG007|Overall Study|Reason Not Specified|0|||
94554748|NCT02596945|323826537|FG000|Overall Study|No documentation of study drug dosing|3|||
94554749|NCT02596945|323826537|FG000|Overall Study|Other|32|||
94554750|NCT02596945|323826537|FG000|Overall Study|Change to hemodialysis|15|||
94554751|NCT02596945|323826537|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
94554752|NCT02596945|323826537|FG000|Overall Study|Withdrawal by Subject|1|||
94554753|NCT02596945|323826537|FG000|Overall Study|Missing|1|||
94554754|NCT01345669|323826544|FG000|Overall Study|Primary tumour recurrence|53|||
94554755|NCT01345669|323826545|FG001|Overall Study|Primary tumour recurrence|32|||
94554756|NCT01345669|323826544|FG000|Overall Study|Second primary tumour|4|||
94554757|NCT01345669|323826545|FG001|Overall Study|Second primary tumour|3|||
94554758|NCT01345669|323826544|FG000|Overall Study|Adverse Event|63|||
94554759|NCT01345669|323826545|FG001|Overall Study|Adverse Event|9|||
94554760|NCT01345669|323826544|FG000|Overall Study|Protocol Violation|3|||
94554761|NCT01345669|323826545|FG001|Overall Study|Protocol Violation|1|||
94554762|NCT01345669|323826544|FG000|Overall Study|Lost to Follow-up|1|||
94554763|NCT01345669|323826545|FG001|Overall Study|Lost to Follow-up|1|||
94554764|NCT01345669|323826544|FG000|Overall Study|Withdrawal by Subject|52|||
94554765|NCT01345669|323826545|FG001|Overall Study|Withdrawal by Subject|13|||
94554766|NCT01345669|323826544|FG000|Overall Study|Other Reasons|111|||
94554767|NCT01345669|323826545|FG001|Overall Study|Other Reasons|60|||
94554768|NCT02100475|323828433|FG000|Overall Study|Unclassified|1|||
94554769|NCT02100475|323828434|FG001|Overall Study|Unclassified|2|||
94554770|NCT02100475|323828433|FG000|Overall Study|Withdrawal criteria|1|||
94554771|NCT02100475|323828434|FG001|Overall Study|Withdrawal criteria|0|||
94554772|NCT03592368|323828437|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
94554773|NCT03592368|323828438|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
94554774|NCT03592368|323828439|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
94554775|NCT03592368|323828440|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
94554776|NCT03592368|323828437|FG000|Overall Study|Adverse Event|0|||
94554777|NCT03592368|323828438|FG001|Overall Study|Adverse Event|0|||
94554778|NCT03592368|323828439|FG002|Overall Study|Adverse Event|0|||
94554779|NCT03592368|323828440|FG003|Overall Study|Adverse Event|1|||
94554780|NCT03592368|323828437|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
94554781|NCT03592368|323828438|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
94554782|NCT03592368|323828439|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
94229853|NCT02633397|322635567|FG000|Overall Study|Treatment interruption|2|||
94554783|NCT03592368|323828440|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
94229854|NCT02633397|322635568|FG001|Overall Study|Treatment interruption|5|||
94229855|NCT02633397|322635567|FG000|Overall Study|Death|2|||
94229856|NCT02633397|322635568|FG001|Overall Study|Death|2|||
94229857|NCT02633397|322635567|FG000|Overall Study|Physician Decision|0|||
94229858|NCT02633397|322635568|FG001|Overall Study|Physician Decision|1|||
94229859|NCT02394925|322635569|FG000|Overall Study|Adverse Event|1|||
94229860|NCT02394925|322635569|FG000|Overall Study|Lens Discomfort|3|||
94229861|NCT02394925|322635569|FG000|Overall Study|Lens handling difficulities|5|||
94229862|NCT02394925|322635569|FG000|Overall Study|Lost to Follow-up|9|||
94229863|NCT02394925|322635569|FG000|Overall Study|Protocol Violation|5|||
94229864|NCT02394925|322635569|FG000|Overall Study|No longer meet eligibility criteria|1|||
94229865|NCT02394925|322635569|FG000|Overall Study|Unsatisfactory Visual Response|5|||
94229866|NCT00092521|322637371|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
94229867|NCT00092521|322637372|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
94229868|NCT00092521|322637373|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
94229869|NCT00092521|322637374|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
94229870|NCT00092521|322637371|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
94229871|NCT00092521|322637372|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
94229872|NCT00092521|322637373|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
94229873|NCT00092521|322637374|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
94229874|NCT00092521|322637371|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
94229875|NCT00092521|322637372|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
94229876|NCT00092521|322637373|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
94229877|NCT00092521|322637374|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
94229878|NCT00092521|322637371|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
94229879|NCT00092521|322637372|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
94229880|NCT00092521|322637373|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
94229881|NCT00092521|322637374|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
94229882|NCT00092521|322637371|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
94229883|NCT00092521|322637372|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
94229884|NCT00092521|322637373|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
94229885|NCT00092521|322637374|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
94229886|NCT00092521|322637371|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
94229887|NCT00092521|322637372|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
94229888|NCT00092521|322637373|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
94229889|NCT00092521|322637374|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
94229890|NCT00092521|322637371|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
94229891|NCT00092521|322637372|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
94229892|NCT00092521|322637373|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
94229893|NCT00092521|322637374|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
94229894|NCT00092521|322637371|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
94229895|NCT00092521|322637372|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
94229896|NCT00092521|322637373|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
94229897|NCT00092521|322637374|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
94229898|NCT00092521|322637371|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
94229899|NCT00092521|322637372|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
94229900|NCT00092521|322637373|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
94229901|NCT00092521|322637374|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
94229902|NCT00092521|322637371|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
94229903|NCT00092521|322637372|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
94229904|NCT00092521|322637373|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
94229905|NCT00092521|322637374|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
94229906|NCT00092521|322637371|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
94229907|NCT00092521|322637372|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
94229908|NCT00092521|322637373|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
94229909|NCT00092521|322637374|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
94229910|NCT00092521|322637371|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
94229911|NCT00092521|322637372|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
94229912|NCT00092521|322637373|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
94229913|NCT00092521|322637374|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
94229914|NCT00092521|322637371|FG000|Follow-Up (After Month 7)|Death|2|||
94229915|NCT00092521|322637372|FG001|Follow-Up (After Month 7)|Death|0|||
94447047|NCT00803790|323423262|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
94229916|NCT00092521|322637373|FG002|Follow-Up (After Month 7)|Death|1|||
94229917|NCT00092521|322637374|FG003|Follow-Up (After Month 7)|Death|0|||
94229918|NCT00092521|322637371|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
94229919|NCT00092521|322637372|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
94447048|NCT00803790|323423263|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
94229920|NCT00092521|322637373|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
94229921|NCT00092521|322637374|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
94447049|NCT04162847|323423265|FG000|Overall Study|Withdrawal by Subject|7|||
94447050|NCT04162847|323423266|FG001|Overall Study|Withdrawal by Subject|1|||
94447051|NCT00679211|323423267|FG000|Overall Study|Progressive disease|82|||
94447052|NCT00679211|323423267|FG000|Overall Study|Adverse Event|7|||
94554784|NCT01618695|323828441|FG000|Core Phase|Adverse Event|4|||
94554785|NCT01618695|323828442|FG001|Core Phase|Adverse Event|5|||
94554786|NCT01618695|323828443|FG002|Core Phase|Adverse Event|15|||
94229922|NCT00092521|322637371|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
94229923|NCT00092521|322637372|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
94229924|NCT00092521|322637373|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
94229925|NCT00092521|322637374|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
94229926|NCT00092521|322637371|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
94229927|NCT00092521|322637372|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
94229928|NCT00092521|322637373|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
94229929|NCT00092521|322637374|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
94229930|NCT00092521|322637371|FG000|Follow-Up (After Month 7)|Moved|32|||
94229931|NCT00092521|322637372|FG001|Follow-Up (After Month 7)|Moved|2|||
94229932|NCT00092521|322637373|FG002|Follow-Up (After Month 7)|Moved|28|||
94229933|NCT00092521|322637374|FG003|Follow-Up (After Month 7)|Moved|0|||
94229934|NCT00092521|322637371|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
94229935|NCT00092521|322637372|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
94229936|NCT00092521|322637373|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
94229937|NCT00092521|322637374|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
94229938|NCT00092521|322637371|FG000|Follow-Up (After Month 7)|Travel|2|||
94229939|NCT00092521|322637372|FG001|Follow-Up (After Month 7)|Travel|0|||
94229940|NCT00092521|322637373|FG002|Follow-Up (After Month 7)|Travel|0|||
94229941|NCT00092521|322637374|FG003|Follow-Up (After Month 7)|Travel|0|||
94229942|NCT00092521|322637371|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
94229943|NCT00092521|322637372|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
94229944|NCT00092521|322637373|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
94229945|NCT00092521|322637374|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
94229946|NCT00092521|322637371|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
94229947|NCT00092521|322637372|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
94229948|NCT00092521|322637373|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
94554787|NCT01618695|323828444|FG003|Core Phase|Adverse Event|20|||
94554788|NCT01618695|323828441|FG000|Core Phase|Lost to Follow-up|0|||
94554789|NCT01618695|323828442|FG001|Core Phase|Lost to Follow-up|0|||
94554790|NCT01618695|323828443|FG002|Core Phase|Lost to Follow-up|1|||
94554791|NCT01618695|323828444|FG003|Core Phase|Lost to Follow-up|0|||
94554792|NCT01618695|323828441|FG000|Core Phase|Withdrawal by Subject|16|||
94554793|NCT01618695|323828442|FG001|Core Phase|Withdrawal by Subject|11|||
94554794|NCT01618695|323828443|FG002|Core Phase|Withdrawal by Subject|9|||
94554795|NCT01618695|323828444|FG003|Core Phase|Withdrawal by Subject|13|||
94554796|NCT01618695|323828441|FG000|Core Phase|Pregnancy|2|||
94554797|NCT01618695|323828442|FG001|Core Phase|Pregnancy|0|||
94554798|NCT01618695|323828443|FG002|Core Phase|Pregnancy|0|||
94554799|NCT01618695|323828444|FG003|Core Phase|Pregnancy|0|||
94554800|NCT01618695|323828441|FG000|Core Phase|Lack of Efficacy|1|||
94554801|NCT01618695|323828442|FG001|Core Phase|Lack of Efficacy|2|||
94554802|NCT01618695|323828443|FG002|Core Phase|Lack of Efficacy|1|||
94554803|NCT01618695|323828444|FG003|Core Phase|Lack of Efficacy|1|||
94554804|NCT01618695|323828441|FG000|Core Phase|Other than specified|1|||
94554805|NCT01618695|323828442|FG001|Core Phase|Other than specified|2|||
94554806|NCT01618695|323828443|FG002|Core Phase|Other than specified|2|||
94554807|NCT01618695|323828444|FG003|Core Phase|Other than specified|2|||
94229949|NCT00092521|322637374|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
94229950|NCT00092521|322637371|FG000|Extension Study (Group 4)|Adverse Event|0|||
94229951|NCT00092521|322637372|FG001|Extension Study (Group 4)|Adverse Event|0|||
94229952|NCT00092521|322637373|FG002|Extension Study (Group 4)|Adverse Event|0|||
94229953|NCT00092521|322637374|FG003|Extension Study (Group 4)|Adverse Event|2|||
94554808|NCT01618695|323828441|FG000|Core Phase|Not treated|1|||
94554809|NCT01618695|323828442|FG001|Core Phase|Not treated|0|||
94554810|NCT01618695|323828443|FG002|Core Phase|Not treated|2|||
94554811|NCT01618695|323828444|FG003|Core Phase|Not treated|0|||
94554812|NCT01618695|323828441|FG000|Extension Phase|Lack of Efficacy|17|||
94554813|NCT01618695|323828442|FG001|Extension Phase|Lack of Efficacy|33|||
94554814|NCT01618695|323828443|FG002|Extension Phase|Lack of Efficacy|26|||
94554815|NCT01618695|323828444|FG003|Extension Phase|Lack of Efficacy|24|||
94554816|NCT01618695|323828441|FG000|Extension Phase|Pregnancy|2|||
94554817|NCT01618695|323828442|FG001|Extension Phase|Pregnancy|0|||
94554818|NCT01618695|323828443|FG002|Extension Phase|Pregnancy|1|||
94554819|NCT01618695|323828444|FG003|Extension Phase|Pregnancy|1|||
94554820|NCT01618695|323828441|FG000|Extension Phase|Withdrawal by Subject|43|||
94554821|NCT01618695|323828442|FG001|Extension Phase|Withdrawal by Subject|48|||
94554822|NCT01618695|323828443|FG002|Extension Phase|Withdrawal by Subject|42|||
94554823|NCT01618695|323828444|FG003|Extension Phase|Withdrawal by Subject|33|||
94554824|NCT01618695|323828441|FG000|Extension Phase|Adverse Event|18|||
94554825|NCT01618695|323828442|FG001|Extension Phase|Adverse Event|16|||
94229954|NCT00092521|322637371|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
94229955|NCT00092521|322637372|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
94229956|NCT00092521|322637373|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
94554826|NCT01618695|323828443|FG002|Extension Phase|Adverse Event|9|||
94554827|NCT01618695|323828444|FG003|Extension Phase|Adverse Event|20|||
94554828|NCT01618695|323828441|FG000|Extension Phase|Lost to Follow-up|2|||
94554829|NCT01618695|323828442|FG001|Extension Phase|Lost to Follow-up|1|||
94554830|NCT01618695|323828443|FG002|Extension Phase|Lost to Follow-up|1|||
94554831|NCT01618695|323828444|FG003|Extension Phase|Lost to Follow-up|1|||
94229957|NCT00092521|322637374|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
94229958|NCT00092521|322637371|FG000|Extension Study (Group 4)|Pregnancy|0|||
94229959|NCT00092521|322637372|FG001|Extension Study (Group 4)|Pregnancy|0|||
94229960|NCT00092521|322637373|FG002|Extension Study (Group 4)|Pregnancy|0|||
94229961|NCT00092521|322637374|FG003|Extension Study (Group 4)|Pregnancy|4|||
94229962|NCT00092521|322637371|FG000|Extension Study (Group 4)|Protocol Violation|0|||
94229963|NCT00092521|322637372|FG001|Extension Study (Group 4)|Protocol Violation|0|||
94229964|NCT00092521|322637373|FG002|Extension Study (Group 4)|Protocol Violation|0|||
94229965|NCT00092521|322637374|FG003|Extension Study (Group 4)|Protocol Violation|2|||
94229966|NCT00092521|322637371|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
94229967|NCT00092521|322637372|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
94229968|NCT00092521|322637373|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
94229969|NCT00092521|322637374|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
94229970|NCT00092521|322637371|FG000|Extension Study (Group 4)|Moved|0|||
94229971|NCT00092521|322637372|FG001|Extension Study (Group 4)|Moved|0|||
94229972|NCT00092521|322637373|FG002|Extension Study (Group 4)|Moved|0|||
94229973|NCT00092521|322637374|FG003|Extension Study (Group 4)|Moved|16|||
94229974|NCT00092521|322637371|FG000|Extension Study (Group 4)|Site Terminated|0|||
94229975|NCT00092521|322637372|FG001|Extension Study (Group 4)|Site Terminated|0|||
94229976|NCT00092521|322637373|FG002|Extension Study (Group 4)|Site Terminated|0|||
94229977|NCT00092521|322637374|FG003|Extension Study (Group 4)|Site Terminated|4|||
94229978|NCT00092521|322637371|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
94229979|NCT00092521|322637372|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
94229980|NCT00092521|322637373|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
94229981|NCT00092521|322637374|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
94554832|NCT01618695|323828441|FG000|Extension Phase|Other than specified|13|||
94229982|NCT01878383|322637375|FG000|Overall Study|Lost to Follow-up|0|||
94229983|NCT01878383|322637376|FG001|Overall Study|Lost to Follow-up|1499|||
94229984|NCT01157351|322637377|FG000|Overall Study|Adverse Event|5|||
94229985|NCT01157351|322637378|FG001|Overall Study|Adverse Event|4|||
94229986|NCT01157351|322637377|FG000|Overall Study|Death|1|||
94229987|NCT01157351|322637378|FG001|Overall Study|Death|0|||
94229988|NCT01157351|322637377|FG000|Overall Study|Lost to Follow-up|53|||
94229989|NCT01157351|322637378|FG001|Overall Study|Lost to Follow-up|55|||
94229990|NCT01157351|322637377|FG000|Overall Study|Withdrawal by Subject|37|||
94229991|NCT01157351|322637378|FG001|Overall Study|Withdrawal by Subject|27|||
94229992|NCT01157351|322637377|FG000|Overall Study|Physician Decision|5|||
94229993|NCT01157351|322637378|FG001|Overall Study|Physician Decision|4|||
94229994|NCT01157351|322637377|FG000|Overall Study|Protocol Violation|0|||
94229995|NCT01157351|322637378|FG001|Overall Study|Protocol Violation|1|||
94229996|NCT01157351|322637377|FG000|Overall Study|Other|32|||
94229997|NCT01157351|322637378|FG001|Overall Study|Other|36|||
94554833|NCT01618695|323828442|FG001|Extension Phase|Other than specified|18|||
94229998|NCT01157351|322637377|FG000|Overall Study|Noncompliance with Study Drug|0|||
94229999|NCT01157351|322637378|FG001|Overall Study|Noncompliance with Study Drug|3|||
94447053|NCT00679211|323423267|FG000|Overall Study|Withdrawal by Subject|2|||
94447054|NCT00679211|323423267|FG000|Overall Study|Physician Decision|5|||
94447055|NCT00679211|323423267|FG000|Overall Study|Refused to undergo protocol procedures|1|||
94447056|NCT00679211|323423267|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
94447057|NCT00679211|323423267|FG000|Overall Study|Other|1|||
94447058|NCT01730053|323423268|FG000|Overall Study|Participant moved|0|||
94447059|NCT01730053|323423269|FG001|Overall Study|Participant moved|0|||
94447060|NCT01730053|323423270|FG002|Overall Study|Participant moved|1|||
94447061|NCT01730053|323423271|FG003|Overall Study|Participant moved|0|||
94447062|NCT01730053|323423272|FG004|Overall Study|Participant moved|0|||
94447063|NCT01730053|323423273|FG005|Overall Study|Participant moved|0|||
94447064|NCT01730053|323423268|FG000|Overall Study|Physician Decision|0|||
94447065|NCT01730053|323423269|FG001|Overall Study|Physician Decision|0|||
94447066|NCT01730053|323423270|FG002|Overall Study|Physician Decision|0|||
94447067|NCT01730053|323423271|FG003|Overall Study|Physician Decision|1|||
94447068|NCT01730053|323423272|FG004|Overall Study|Physician Decision|0|||
94447069|NCT01730053|323423273|FG005|Overall Study|Physician Decision|0|||
94447070|NCT01730053|323423268|FG000|Overall Study|Adverse Event|2|||
94447071|NCT01730053|323423269|FG001|Overall Study|Adverse Event|6|||
94447072|NCT01730053|323423270|FG002|Overall Study|Adverse Event|3|||
94447073|NCT01730053|323423271|FG003|Overall Study|Adverse Event|3|||
94447074|NCT01730053|323423272|FG004|Overall Study|Adverse Event|2|||
94447075|NCT01730053|323423273|FG005|Overall Study|Adverse Event|2|||
94447076|NCT01730053|323423268|FG000|Overall Study|Poor compliance to protocol|1|||
94447077|NCT01730053|323423269|FG001|Overall Study|Poor compliance to protocol|2|||
94447078|NCT01730053|323423270|FG002|Overall Study|Poor compliance to protocol|2|||
94447079|NCT01730053|323423271|FG003|Overall Study|Poor compliance to protocol|0|||
94447080|NCT01730053|323423272|FG004|Overall Study|Poor compliance to protocol|0|||
94447081|NCT01730053|323423273|FG005|Overall Study|Poor compliance to protocol|2|||
94447082|NCT01730053|323423268|FG000|Overall Study|Other than specified|2|||
94447083|NCT01730053|323423269|FG001|Overall Study|Other than specified|6|||
94447084|NCT01730053|323423270|FG002|Overall Study|Other than specified|5|||
94447085|NCT01730053|323423271|FG003|Overall Study|Other than specified|4|||
94447086|NCT01730053|323423272|FG004|Overall Study|Other than specified|7|||
94447087|NCT01730053|323423273|FG005|Overall Study|Other than specified|9|||
94447088|NCT01540487|323423274|FG000|Overall Study|Protocol Violation|1|||
94447089|NCT01540487|323423275|FG001|Overall Study|Protocol Violation|0|||
94447090|NCT04846569|323423280|FG000|Overall Study|Withdrawal by Subject|3|||
94447091|NCT04846569|323423281|FG001|Overall Study|Withdrawal by Subject|1|||
94447092|NCT04231825|323423282|FG000|Overall Study|Protocol Violation|3|||
94447093|NCT04231825|323423283|FG001|Overall Study|Protocol Violation|3|||
94447094|NCT04231825|323423282|FG000|Overall Study|Lost to Follow-up|0|||
94447095|NCT04231825|323423283|FG001|Overall Study|Lost to Follow-up|1|||
94447096|NCT02549859|323423284|FG000|Long-term 60 Hz DBS|Study Closed|1|||
94447097|NCT05344560|323423285|FG000|Period 1|Subject out of visit window|1|||
94447098|NCT05344560|323423286|FG001|Period 1|Subject out of visit window|1|||
94447099|NCT05344560|323423285|FG000|Period 2|Covid-19 Related|1|||
94447100|NCT05344560|323423286|FG001|Period 2|Covid-19 Related|0|||
94447101|NCT05344560|323423285|FG000|Period 2|Adverse Event|1|||
94447102|NCT05344560|323423286|FG001|Period 2|Adverse Event|0|||
94447103|NCT05344560|323423285|FG000|Period 2|Subject out of visit window|1|||
94447104|NCT05344560|323423286|FG001|Period 2|Subject out of visit window|1|||
94447105|NCT05344560|323423285|FG000|Period 3|Subject out of visit window|1|||
94447106|NCT05344560|323423286|FG001|Period 3|Subject out of visit window|0|||
94447107|NCT02375971|323423287|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
94447108|NCT02375971|323423288|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
94447109|NCT02375971|323423289|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
94447110|NCT02375971|323423287|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
94447111|NCT02375971|323423288|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
94447112|NCT02375971|323423289|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
94447113|NCT02375971|323423287|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
94447114|NCT02375971|323423288|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
94447115|NCT02375971|323423289|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
94447116|NCT02375971|323423287|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
94230000|NCT01157351|322637377|FG000|Overall Study|Randomized but not Treated|4|||
94230001|NCT01157351|322637378|FG001|Overall Study|Randomized but not Treated|2|||
94230002|NCT00605566|322637379|FG000|Overall Study|Adverse Event|1|||
94230003|NCT00605566|322637379|FG000|Overall Study|Clinical deterioration|1|||
94230004|NCT00605566|322637379|FG000|Overall Study|Poor compliance in run-in period|1|||
94230005|NCT00826228|322637380|FG000|Overall Study|Withdrawal by Subject|1|||
94230006|NCT03475056|322637381|FG000|Overall Study|Lost to Follow-up|0|||
94230007|NCT03475056|322637382|FG001|Overall Study|Lost to Follow-up|1|||
94230008|NCT03475056|322637381|FG000|Overall Study|Moved from Area|0|||
94230009|NCT03475056|322637382|FG001|Overall Study|Moved from Area|2|||
94230010|NCT03864341|322637383|FG000|Overall Study|Withdrawal by Subject|1|||
94230011|NCT01821729|322637384|FG000|Overall Study|Withdrawal by Subject|1|||
94230012|NCT02202109|322637388|FG000|Overall Study|Lost to Follow-up|88|||
94230013|NCT02202109|322637389|FG001|Overall Study|Lost to Follow-up|87|||
94230014|NCT02202109|322637388|FG000|Overall Study|Withdrawal by Subject|2|||
94230015|NCT02202109|322637389|FG001|Overall Study|Withdrawal by Subject|0|||
94230016|NCT01333111|322637397|FG000|Overall Study|patient undergoing major surgery|0|||
94230017|NCT01333111|322637398|FG001|Overall Study|patient undergoing major surgery|2|||
94230018|NCT01333111|322637399|FG002|Overall Study|patient undergoing major surgery|0|||
94230019|NCT01333111|322637397|FG000|Overall Study|personal reasons|0|||
94230020|NCT01333111|322637398|FG001|Overall Study|personal reasons|0|||
94230021|NCT01333111|322637399|FG002|Overall Study|personal reasons|1|||
94230022|NCT01333111|322637397|FG000|Overall Study|unclassified|1|||
94230023|NCT01333111|322637398|FG001|Overall Study|unclassified|0|||
94447117|NCT02375971|323423288|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
94447118|NCT02375971|323423289|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
94447119|NCT02375971|323423287|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
94447120|NCT02375971|323423288|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
94447121|NCT02375971|323423289|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
94230024|NCT01333111|322637399|FG002|Overall Study|unclassified|0|||
94230025|NCT01333111|322637397|FG000|Overall Study|withdrawal criteria|0|||
94230026|NCT01333111|322637398|FG001|Overall Study|withdrawal criteria|1|||
94230027|NCT01333111|322637399|FG002|Overall Study|withdrawal criteria|0|||
94230028|NCT01333111|322637397|FG000|Overall Study|Non-compliance|1|||
94230029|NCT01333111|322637398|FG001|Overall Study|Non-compliance|0|||
94230030|NCT01333111|322637399|FG002|Overall Study|Non-compliance|0|||
94230031|NCT01333111|322637397|FG000|Overall Study|Ineffective therapy|0|||
94230032|NCT01333111|322637398|FG001|Overall Study|Ineffective therapy|0|||
94230033|NCT01333111|322637399|FG002|Overall Study|Ineffective therapy|1|||
94230034|NCT00664105|322637402|FG000|Overall Study|Death|3|||
94230035|NCT00664105|322637402|FG000|Overall Study|Withdrawal by Subject|5|||
94230036|NCT00664105|322637402|FG000|Overall Study|Adverse Event|9|||
94230037|NCT00664105|322637402|FG000|Overall Study|Disease progression|7|||
94230038|NCT02412111|322637406|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
94230039|NCT02412111|322637407|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
94230040|NCT02412111|322637408|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
94230041|NCT02412111|322637406|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
94230042|NCT02412111|322637407|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
94230043|NCT02412111|322637408|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
94230044|NCT02412111|322637406|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
94230045|NCT02412111|322637407|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
94230046|NCT02412111|322637408|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
94230047|NCT02412111|322637406|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
94230048|NCT02412111|322637407|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
94230049|NCT02412111|322637408|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
94447122|NCT02375971|323423287|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
94447123|NCT02375971|323423288|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
94447124|NCT02375971|323423289|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
94447125|NCT02375971|323423287|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
94230050|NCT02412111|322637406|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
94230051|NCT02412111|322637407|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
94230052|NCT02412111|322637408|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
94447126|NCT02375971|323423288|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
94447127|NCT02375971|323423289|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
94230053|NCT02412111|322637406|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
94230054|NCT02412111|322637407|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
94230055|NCT02412111|322637408|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
94230056|NCT02412111|322637406|FG000|Active Comparator Period (8 Weeks)|Other|0|||
94230057|NCT02412111|322637407|FG001|Active Comparator Period (8 Weeks)|Other|0|||
94230058|NCT02412111|322637408|FG002|Active Comparator Period (8 Weeks)|Other|2|||
94230059|NCT00487552|322637409|FG000|Overall Study|Unsuccessful magnet placements|3|||
94230060|NCT00487552|322637409|FG000|Overall Study|Death due to progressive malignancy|2|||
94230061|NCT00487552|322637409|FG000|Overall Study|Stent not placed|1|||
94230062|NCT03927690|322637410|FG000|Overall Study|Withdrawal by Subject|3|||
94230063|NCT03927690|322637411|FG001|Overall Study|Withdrawal by Subject|1|||
94230064|NCT03927690|322637412|FG002|Overall Study|Withdrawal by Subject|1|||
94230065|NCT03927690|322637410|FG000|Overall Study|Adverse Event|1|||
94230066|NCT03927690|322637411|FG001|Overall Study|Adverse Event|0|||
94230067|NCT03927690|322637412|FG002|Overall Study|Adverse Event|0|||
94230068|NCT03927690|322637410|FG000|Overall Study|Death|1|||
94230069|NCT03927690|322637411|FG001|Overall Study|Death|0|||
94230070|NCT03927690|322637412|FG002|Overall Study|Death|0|||
94230071|NCT03927690|322637410|FG000|Overall Study|Lost to Follow-up|2|||
94230072|NCT03927690|322637411|FG001|Overall Study|Lost to Follow-up|2|||
94230073|NCT03927690|322637412|FG002|Overall Study|Lost to Follow-up|1|||
94447128|NCT02375971|323423287|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
94447129|NCT02375971|323423288|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
94447130|NCT02375971|323423289|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
94447131|NCT02792062|323423294|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
94447132|NCT02792062|323423295|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
94447133|NCT02792062|323423296|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
94230074|NCT02165397|322637413|FG000|Overall Study|Death|7|||
94230075|NCT02165397|322637414|FG001|Overall Study|Death|10|||
94230076|NCT02165397|322637415|FG002|Overall Study|Death|8|||
94447134|NCT02792062|323423297|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
94447135|NCT02792062|323423298|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
94447136|NCT02792062|323423299|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
94230077|NCT02165397|322637413|FG000|Overall Study|Lost to Follow-up|1|||
94230078|NCT02165397|322637414|FG001|Overall Study|Lost to Follow-up|3|||
94230079|NCT02165397|322637415|FG002|Overall Study|Lost to Follow-up|0|||
94230080|NCT02165397|322637413|FG000|Overall Study|Withdrawal by Subject|6|||
94230081|NCT02165397|322637414|FG001|Overall Study|Withdrawal by Subject|6|||
94230082|NCT02165397|322637415|FG002|Overall Study|Withdrawal by Subject|1|||
94230083|NCT02165397|322637413|FG000|Overall Study|Other, Not Specified|0|||
94230084|NCT02165397|322637414|FG001|Overall Study|Other, Not Specified|0|||
94230085|NCT02165397|322637415|FG002|Overall Study|Other, Not Specified|1|||
94230086|NCT00468858|322637416|FG000|Overall Study|Adverse Event|0|||
94230087|NCT00468858|322637417|FG001|Overall Study|Adverse Event|1|||
94230088|NCT00468858|322637418|FG002|Overall Study|Adverse Event|0|||
94230089|NCT00468858|322637416|FG000|Overall Study|Withdrawal by Subject|7|||
94230090|NCT00468858|322637417|FG001|Overall Study|Withdrawal by Subject|4|||
94230091|NCT00468858|322637418|FG002|Overall Study|Withdrawal by Subject|5|||
94230092|NCT00468858|322637416|FG000|Overall Study|Relocation|1|||
94230093|NCT00468858|322637417|FG001|Overall Study|Relocation|3|||
94230094|NCT00468858|322637418|FG002|Overall Study|Relocation|3|||
94230095|NCT00468858|322637416|FG000|Overall Study|Lost to Follow-up|1|||
94230096|NCT00468858|322637417|FG001|Overall Study|Lost to Follow-up|2|||
94230097|NCT00468858|322637418|FG002|Overall Study|Lost to Follow-up|5|||
94447137|NCT03876743|323423300|FG000|Overall Study|Lost to Follow-up|6|||
94447138|NCT03876743|323423301|FG001|Overall Study|Lost to Follow-up|4|||
94447139|NCT03876743|323423302|FG002|Overall Study|Lost to Follow-up|4|||
94447140|NCT03876743|323423303|FG003|Overall Study|Lost to Follow-up|7|||
94447141|NCT02019264|323423306|FG000|Overall Study|Not treated|6|||
94447142|NCT02019264|323423307|FG001|Overall Study|Not treated|4|||
94447143|NCT02019264|323423306|FG000|Overall Study|Lost to Follow-up|50|||
94447144|NCT02019264|323423307|FG001|Overall Study|Lost to Follow-up|47|||
94230098|NCT00468858|322637416|FG000|Overall Study|Other|0|||
94230099|NCT00468858|322637417|FG001|Overall Study|Other|0|||
94230100|NCT00468858|322637418|FG002|Overall Study|Other|1|||
94230101|NCT01004185|322637419|FG000|Overall Study|Adverse Event|1|||
94230102|NCT01004185|322637420|FG001|Overall Study|Adverse Event|1|||
94230103|NCT01004185|322637419|FG000|Overall Study|Lost to Follow-up|0|||
94447145|NCT02019264|323423306|FG000|Overall Study|Withdrawal by Subject|142|||
94447146|NCT02019264|323423307|FG001|Overall Study|Withdrawal by Subject|117|||
94447147|NCT02019264|323423306|FG000|Overall Study|Administrative reason|36|||
94447148|NCT02019264|323423307|FG001|Overall Study|Administrative reason|28|||
94447149|NCT02019264|323423306|FG000|Overall Study|Missing|14|||
94447150|NCT02019264|323423307|FG001|Overall Study|Missing|11|||
94343750|NCT02614261|323037830|FG003|Open-Label Extension Phase|Adverse Event|0|||
94230104|NCT01004185|322637420|FG001|Overall Study|Lost to Follow-up|1|||
94230105|NCT01004185|322637419|FG000|Overall Study|Lack of Efficacy|2|||
94230106|NCT01004185|322637420|FG001|Overall Study|Lack of Efficacy|1|||
94230107|NCT01004185|322637419|FG000|Overall Study|Sponsor Terminated Study|4|||
94230108|NCT01004185|322637420|FG001|Overall Study|Sponsor Terminated Study|5|||
94230109|NCT01004185|322637419|FG000|Overall Study|Withdrawal by Subject|2|||
94230110|NCT01004185|322637420|FG001|Overall Study|Withdrawal by Subject|1|||
94230111|NCT01379703|322637421|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
94230112|NCT01379703|322637422|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
94230113|NCT01379703|322637423|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
94230114|NCT01379703|322637421|FG000|Study Start Through 9 Months|Adverse Event|0|||
94230115|NCT01379703|322637422|FG001|Study Start Through 9 Months|Adverse Event|14|||
94230116|NCT01379703|322637423|FG002|Study Start Through 9 Months|Adverse Event|10|||
94230117|NCT01379703|322637421|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
94230118|NCT01379703|322637422|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
94230119|NCT01379703|322637423|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
94230120|NCT01379703|322637421|FG000|Study Start Through 9 Months|Treatment Failure|0|||
94230121|NCT01379703|322637422|FG001|Study Start Through 9 Months|Treatment Failure|2|||
94230122|NCT01379703|322637423|FG002|Study Start Through 9 Months|Treatment Failure|2|||
94230123|NCT01379703|322637421|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
94230124|NCT01379703|322637422|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
94230125|NCT01379703|322637423|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
94230126|NCT01379703|322637421|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
94230127|NCT01379703|322637422|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
94230128|NCT01379703|322637423|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
94230129|NCT01379703|322637421|FG000|Study Start Through 9 Months|Medication not available|0|||
94230130|NCT01379703|322637422|FG001|Study Start Through 9 Months|Medication not available|2|||
94230131|NCT01379703|322637423|FG002|Study Start Through 9 Months|Medication not available|1|||
94230132|NCT01379703|322637421|FG000|Study Start Through 9 Months|Poor general condition|0|||
94230133|NCT01379703|322637422|FG001|Study Start Through 9 Months|Poor general condition|1|||
94230134|NCT01379703|322637423|FG002|Study Start Through 9 Months|Poor general condition|0|||
94230135|NCT01379703|322637421|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
94230136|NCT01379703|322637422|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
94230137|NCT01379703|322637423|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
94230138|NCT01379703|322637421|FG000|Study Start Through 9 Months|Reason unknown|2|||
94230139|NCT01379703|322637422|FG001|Study Start Through 9 Months|Reason unknown|31|||
94230140|NCT01379703|322637423|FG002|Study Start Through 9 Months|Reason unknown|24|||
94230141|NCT01379703|322637421|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
94230142|NCT01379703|322637422|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
94230143|NCT01379703|322637423|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
94230144|NCT01379703|322637421|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
94230145|NCT01379703|322637422|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
94230146|NCT01379703|322637423|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
94230147|NCT01379703|322637421|FG000|9 Months Through 18 Months|Adverse Event|0|||
94230148|NCT01379703|322637422|FG001|9 Months Through 18 Months|Adverse Event|6|||
94230149|NCT01379703|322637423|FG002|9 Months Through 18 Months|Adverse Event|0|||
94230150|NCT01379703|322637421|FG000|9 Months Through 18 Months|Treatment failure|0|||
94230151|NCT01379703|322637422|FG001|9 Months Through 18 Months|Treatment failure|5|||
94230152|NCT01379703|322637423|FG002|9 Months Through 18 Months|Treatment failure|0|||
94230153|NCT01379703|322637421|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
94230154|NCT01379703|322637422|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
94230155|NCT01379703|322637423|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
94230156|NCT01379703|322637421|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
94447151|NCT01139125|323423310|FG000|Overall Study|Withdrawal by Subject|1|||
94230157|NCT01379703|322637422|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
94230158|NCT01379703|322637423|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
94230159|NCT01379703|322637421|FG000|9 Months Through 18 Months|Fatigue|0|||
94554834|NCT01618695|323828443|FG002|Extension Phase|Other than specified|13|||
94554835|NCT01618695|323828444|FG003|Extension Phase|Other than specified|18|||
94554836|NCT00666224|323828451|FG000|Double-Blind|Adverse Event|15|||
94554837|NCT00666224|323828452|FG001|Double-Blind|Adverse Event|5|||
94554838|NCT00666224|323828451|FG000|Double-Blind|Lost to Follow-up|2|||
94230160|NCT01379703|322637422|FG001|9 Months Through 18 Months|Fatigue|1|||
94230161|NCT01379703|322637423|FG002|9 Months Through 18 Months|Fatigue|0|||
94230162|NCT01379703|322637421|FG000|9 Months Through 18 Months|Reason Unknown|0|||
94230163|NCT01379703|322637422|FG001|9 Months Through 18 Months|Reason Unknown|23|||
94554839|NCT00666224|323828452|FG001|Double-Blind|Lost to Follow-up|2|||
94554840|NCT00666224|323828451|FG000|Double-Blind|Withdrawal by Subject|18|||
94554841|NCT00666224|323828452|FG001|Double-Blind|Withdrawal by Subject|14|||
94554842|NCT00666224|323828451|FG000|Double-Blind|Physician Decision|0|||
94554843|NCT00666224|323828452|FG001|Double-Blind|Physician Decision|3|||
94554844|NCT00666224|323828451|FG000|Double-Blind|Sponsor decision|1|||
94554845|NCT00666224|323828452|FG001|Double-Blind|Sponsor decision|0|||
94554846|NCT00666224|323828451|FG000|Double-Blind|Pregnancy|3|||
94554847|NCT00666224|323828452|FG001|Double-Blind|Pregnancy|2|||
94554848|NCT00666224|323828451|FG000|Double-Blind|Noncompliance|1|||
94554849|NCT00666224|323828452|FG001|Double-Blind|Noncompliance|0|||
94554850|NCT00666224|323828451|FG000|Double-Blind|Death|1|||
94554851|NCT00666224|323828452|FG001|Double-Blind|Death|0|||
94554852|NCT00666224|323828451|FG000|Double-Blind|Undefined/Unknown|4|||
94554853|NCT00666224|323828452|FG001|Double-Blind|Undefined/Unknown|1|||
94554854|NCT00666224|323828451|FG000|Open-Label|Adverse Event|8|||
94554855|NCT00666224|323828452|FG001|Open-Label|Adverse Event|43|||
94554856|NCT00666224|323828451|FG000|Open-Label|Lost to Follow-up|4|||
94554857|NCT00666224|323828452|FG001|Open-Label|Lost to Follow-up|5|||
94554858|NCT00666224|323828451|FG000|Open-Label|Withdrawal by Subject|12|||
94554859|NCT00666224|323828452|FG001|Open-Label|Withdrawal by Subject|25|||
94554860|NCT00666224|323828451|FG000|Open-Label|Physician Decision|7|||
94554861|NCT00666224|323828452|FG001|Open-Label|Physician Decision|5|||
94554862|NCT00666224|323828451|FG000|Open-Label|Pregnancy|1|||
94554863|NCT00666224|323828452|FG001|Open-Label|Pregnancy|5|||
94554864|NCT00666224|323828451|FG000|Open-Label|Noncompliance|2|||
94554865|NCT00666224|323828452|FG001|Open-Label|Noncompliance|1|||
94554866|NCT00666224|323828451|FG000|Open-Label|Undefined/Unknown|1|||
94554867|NCT00666224|323828452|FG001|Open-Label|Undefined/Unknown|1|||
94554868|NCT01450098|323828453|FG000|Period 3|Protocol Violation|0|||
94554869|NCT01450098|323828454|FG001|Period 3|Protocol Violation|1|||
94554870|NCT01450098|323828453|FG000|Period 3|Withdrawal by Subject|0|||
94554871|NCT01450098|323828454|FG001|Period 3|Withdrawal by Subject|2|||
94343751|NCT02614261|323037827|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
94447152|NCT00427648|323423311|FG000|Overall Study|Protocol Violation|1|||
94554872|NCT03521141|323828455|FG000|Overall Study|Death|1|||
94554873|NCT03521141|323828456|FG001|Overall Study|Death|0|||
94554874|NCT03521141|323828457|FG002|Overall Study|Death|1|||
94554875|NCT03464019|323828463|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
94554876|NCT03464019|323828464|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
94554877|NCT03464019|323828465|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
94554878|NCT03464019|323828463|FG000|NODE-301 Part 1|Ablation|0|||
94554879|NCT03464019|323828464|FG001|NODE-301 Part 1|Ablation|0|||
94554880|NCT03464019|323828465|FG002|NODE-301 Part 1|Ablation|16|||
94554881|NCT03464019|323828463|FG000|NODE-301 Part 1|Test Dose Failure|0|||
94554882|NCT03464019|323828464|FG001|NODE-301 Part 1|Test Dose Failure|0|||
94554883|NCT03464019|323828465|FG002|NODE-301 Part 1|Test Dose Failure|8|||
94554884|NCT03464019|323828463|FG000|NODE-301 Part 1|Adverse Event|0|||
94554885|NCT03464019|323828464|FG001|NODE-301 Part 1|Adverse Event|0|||
94554886|NCT03464019|323828465|FG002|NODE-301 Part 1|Adverse Event|5|||
94554887|NCT03464019|323828463|FG000|NODE-301 Part 1|Physician Decision|0|||
94554888|NCT03464019|323828464|FG001|NODE-301 Part 1|Physician Decision|0|||
94554889|NCT03464019|323828465|FG002|NODE-301 Part 1|Physician Decision|4|||
94554890|NCT03464019|323828463|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
94554891|NCT03464019|323828464|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
94554892|NCT03464019|323828465|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
94554893|NCT03464019|323828463|FG000|NODE-301 Part 1|Protocol Violation|0|||
94554894|NCT03464019|323828464|FG001|NODE-301 Part 1|Protocol Violation|0|||
94554895|NCT03464019|323828465|FG002|NODE-301 Part 1|Protocol Violation|2|||
94554896|NCT03464019|323828463|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
94230164|NCT01379703|322637423|FG002|9 Months Through 18 Months|Reason Unknown|0|||
94230165|NCT01085812|322637424|FG000|Open-Label Period|Adverse Event|0|||
94230166|NCT01085812|322637425|FG001|Open-Label Period|Adverse Event|80|||
94230167|NCT01085812|322637424|FG000|Open-Label Period|Lack of Efficacy|0|||
94230168|NCT01085812|322637425|FG001|Open-Label Period|Lack of Efficacy|26|||
94230169|NCT01085812|322637424|FG000|Open-Label Period|Protocol Violation|0|||
94230170|NCT01085812|322637425|FG001|Open-Label Period|Protocol Violation|39|||
94230171|NCT01085812|322637424|FG000|Open-Label Period|Withdrawal by Subject|0|||
94230172|NCT01085812|322637425|FG001|Open-Label Period|Withdrawal by Subject|53|||
94230173|NCT01085812|322637424|FG000|Open-Label Period|Lost to Follow-up|0|||
94230174|NCT01085812|322637425|FG001|Open-Label Period|Lost to Follow-up|42|||
94230175|NCT01085812|322637424|FG000|Double-Blind Period|Adverse Event|3|||
94230176|NCT01085812|322637425|FG001|Double-Blind Period|Adverse Event|8|||
94230177|NCT01085812|322637424|FG000|Double-Blind Period|Protocol Violation|2|||
94230178|NCT01085812|322637425|FG001|Double-Blind Period|Protocol Violation|7|||
94230179|NCT01085812|322637424|FG000|Double-Blind Period|Withdrawal by Subject|11|||
94230180|NCT01085812|322637425|FG001|Double-Blind Period|Withdrawal by Subject|24|||
94230181|NCT01085812|322637424|FG000|Double-Blind Period|Lost to Follow-up|5|||
94230182|NCT01085812|322637425|FG001|Double-Blind Period|Lost to Follow-up|17|||
94230183|NCT01085812|322637424|FG000|Double-Blind Period|Other Reasons|0|||
94230184|NCT01085812|322637425|FG001|Double-Blind Period|Other Reasons|2|||
94230185|NCT01085812|322637424|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
94230186|NCT01085812|322637425|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
94230187|NCT01085812|322637424|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
94230188|NCT01085812|322637425|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
94343752|NCT02614261|323037828|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
94230189|NCT01085812|322637424|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
94230190|NCT01085812|322637425|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
94230191|NCT01085812|322637424|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
94343753|NCT02614261|323037829|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
94230192|NCT01085812|322637425|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
94230193|NCT01085812|322637424|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
94230194|NCT01085812|322637425|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
94230195|NCT01172639|322637426|FG000|Overall Study|Death|1|||
94230196|NCT01172639|322637427|FG001|Overall Study|Death|1|||
94230197|NCT01172639|322637428|FG002|Overall Study|Death|0|||
94230198|NCT01172639|322637429|FG003|Overall Study|Death|0|||
94230199|NCT01172639|322637430|FG004|Overall Study|Death|0|||
94230200|NCT01172639|322637426|FG000|Overall Study|Lost to Follow-up|9|||
94230201|NCT01172639|322637427|FG001|Overall Study|Lost to Follow-up|7|||
94230202|NCT01172639|322637428|FG002|Overall Study|Lost to Follow-up|11|||
94230203|NCT01172639|322637429|FG003|Overall Study|Lost to Follow-up|6|||
94230204|NCT01172639|322637430|FG004|Overall Study|Lost to Follow-up|6|||
94230205|NCT01172639|322637426|FG000|Overall Study|Withdrawal by Subject|3|||
94230206|NCT01172639|322637427|FG001|Overall Study|Withdrawal by Subject|3|||
94230207|NCT01172639|322637428|FG002|Overall Study|Withdrawal by Subject|5|||
94230208|NCT01172639|322637429|FG003|Overall Study|Withdrawal by Subject|5|||
94230209|NCT01172639|322637430|FG004|Overall Study|Withdrawal by Subject|0|||
94230210|NCT02599688|322637431|FG000|Overall Study|Lack of Efficacy|1|||
94230211|NCT02599688|322637431|FG000|Overall Study|Withdrawal by Subject|1|||
94230212|NCT02599688|322637431|FG000|Overall Study|Termination by Sponsor|2|||
94230213|NCT00727415|322637434|FG000|Phase I|Dose Limiting Toxicity|2|||
94230214|NCT03414047|322637437|FG000|Overall Study|Adverse Event|0|||
94230215|NCT03414047|322637438|FG001|Overall Study|Adverse Event|0|||
94230216|NCT03414047|322637439|FG002|Overall Study|Adverse Event|1|||
94230217|NCT03414047|322637440|FG003|Overall Study|Adverse Event|1|||
94230218|NCT03414047|322637437|FG000|Overall Study|Physician Decision|1|||
94230219|NCT03414047|322637438|FG001|Overall Study|Physician Decision|0|||
94230220|NCT03414047|322637439|FG002|Overall Study|Physician Decision|0|||
94230221|NCT03414047|322637440|FG003|Overall Study|Physician Decision|1|||
94230222|NCT03414047|322637437|FG000|Overall Study|Withdrawal by Subject|1|||
94230223|NCT03414047|322637438|FG001|Overall Study|Withdrawal by Subject|0|||
94230224|NCT03414047|322637439|FG002|Overall Study|Withdrawal by Subject|2|||
94230225|NCT03414047|322637440|FG003|Overall Study|Withdrawal by Subject|0|||
94230226|NCT00817336|322637441|FG000|Overall Study|Withdrawal by Subject|1|||
94230227|NCT00817336|322637442|FG001|Overall Study|Withdrawal by Subject|1|||
94230228|NCT00935259|322637451|FG000|Period 1|Administrative (scheduling conflict)|1|||
94230229|NCT00935259|322637452|FG001|Period 1|Administrative (scheduling conflict)|1|||
94230230|NCT00937521|322637453|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
94230231|NCT00937521|322637454|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
94230232|NCT00937521|322637455|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
94230233|NCT00937521|322637456|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
94230234|NCT00937521|322637457|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
94230235|NCT00937521|322637458|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
94230236|NCT00937521|322637459|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
94230237|NCT00937521|322637460|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
94230238|NCT00937521|322637453|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
94230239|NCT00937521|322637454|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
94230240|NCT00937521|322637455|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
94230241|NCT00937521|322637456|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
94230242|NCT00937521|322637457|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
94230243|NCT00937521|322637458|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
94230244|NCT00937521|322637459|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
94230245|NCT00937521|322637460|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
94230246|NCT00937521|322637453|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
94230247|NCT00937521|322637454|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
94230248|NCT00937521|322637455|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
94230249|NCT00937521|322637456|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
94230250|NCT00937521|322637457|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
94230251|NCT00937521|322637458|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
94230252|NCT00937521|322637459|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
94230253|NCT00937521|322637460|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
94343754|NCT02614261|323037830|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
94554897|NCT03464019|323828464|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
94230254|NCT00937521|322637453|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
94230255|NCT00937521|322637454|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
94230256|NCT00937521|322637455|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
94230257|NCT00937521|322637456|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
94343755|NCT02614261|323037827|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
94343756|NCT02614261|323037828|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
94343757|NCT02614261|323037829|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
94343758|NCT02614261|323037830|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
94230258|NCT00937521|322637457|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
94230259|NCT00937521|322637458|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
94230260|NCT00937521|322637459|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
94230261|NCT00937521|322637460|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
94230262|NCT00937521|322637453|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
94230263|NCT00937521|322637454|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
94230264|NCT00937521|322637455|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
94343759|NCT02614261|323037827|FG000|Open-Label Extension Phase|Physician Decision|2|||
94343760|NCT02614261|323037828|FG001|Open-Label Extension Phase|Physician Decision|0|||
94343761|NCT02614261|323037829|FG002|Open-Label Extension Phase|Physician Decision|0|||
94343762|NCT02614261|323037830|FG003|Open-Label Extension Phase|Physician Decision|0|||
94343763|NCT02614261|323037827|FG000|Open-Label Extension Phase|Pregnancy|1|||
94343764|NCT02614261|323037828|FG001|Open-Label Extension Phase|Pregnancy|2|||
94343765|NCT02614261|323037829|FG002|Open-Label Extension Phase|Pregnancy|1|||
94343766|NCT02614261|323037830|FG003|Open-Label Extension Phase|Pregnancy|0|||
94343767|NCT02614261|323037827|FG000|Open-Label Extension Phase|Protocol Violation|3|||
94343768|NCT02614261|323037828|FG001|Open-Label Extension Phase|Protocol Violation|4|||
94230265|NCT00937521|322637456|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
94230266|NCT00937521|322637457|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
94230267|NCT00937521|322637458|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
94230268|NCT00937521|322637459|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
94230269|NCT00937521|322637460|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
94230270|NCT00937521|322637453|FG000|Booster Phase|Adverse Event|0|||
94230271|NCT00937521|322637454|FG001|Booster Phase|Adverse Event|0|||
94230272|NCT00937521|322637455|FG002|Booster Phase|Adverse Event|0|||
94230273|NCT00937521|322637456|FG003|Booster Phase|Adverse Event|0|||
94230274|NCT00937521|322637457|FG004|Booster Phase|Adverse Event|0|||
94230275|NCT00937521|322637458|FG005|Booster Phase|Adverse Event|0|||
94230276|NCT00937521|322637459|FG006|Booster Phase|Adverse Event|1|||
94230277|NCT00937521|322637460|FG007|Booster Phase|Adverse Event|0|||
94230278|NCT00937521|322637453|FG000|Booster Phase|Withdrawal by Subject|1|||
94230279|NCT00937521|322637454|FG001|Booster Phase|Withdrawal by Subject|0|||
94230280|NCT00937521|322637455|FG002|Booster Phase|Withdrawal by Subject|0|||
94230281|NCT00937521|322637456|FG003|Booster Phase|Withdrawal by Subject|1|||
94230282|NCT00937521|322637457|FG004|Booster Phase|Withdrawal by Subject|0|||
94230283|NCT00937521|322637458|FG005|Booster Phase|Withdrawal by Subject|0|||
94447153|NCT00427648|323423312|FG001|Overall Study|Protocol Violation|2|||
94447154|NCT00427648|323423311|FG000|Overall Study|Adverse Event|0|||
94230284|NCT00937521|322637459|FG006|Booster Phase|Withdrawal by Subject|0|||
94230285|NCT00937521|322637460|FG007|Booster Phase|Withdrawal by Subject|2|||
94230286|NCT00937521|322637453|FG000|Booster Phase|Lost to Follow-up|2|||
94447155|NCT00427648|323423312|FG001|Overall Study|Adverse Event|1|||
94230287|NCT00937521|322637454|FG001|Booster Phase|Lost to Follow-up|2|||
94230288|NCT00937521|322637455|FG002|Booster Phase|Lost to Follow-up|4|||
94554898|NCT03464019|323828465|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
94554899|NCT03464019|323828463|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
94554900|NCT03464019|323828464|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
94447156|NCT01297517|323423313|FG000|Overall Study|Adverse Event|21|||
94447157|NCT01297517|323423314|FG001|Overall Study|Adverse Event|7|||
94447158|NCT01297517|323423315|FG002|Overall Study|Adverse Event|16|||
94447159|NCT01297517|323423313|FG000|Overall Study|Lost to Follow-up|1|||
94447160|NCT01297517|323423314|FG001|Overall Study|Lost to Follow-up|0|||
94447161|NCT01297517|323423315|FG002|Overall Study|Lost to Follow-up|1|||
94447162|NCT01297517|323423313|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
94447163|NCT01297517|323423314|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
94447164|NCT01297517|323423315|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
94230289|NCT00937521|322637456|FG003|Booster Phase|Lost to Follow-up|2|||
94447165|NCT01297517|323423313|FG000|Overall Study|Noncompliance|1|||
94230290|NCT00937521|322637457|FG004|Booster Phase|Lost to Follow-up|4|||
94447166|NCT01297517|323423314|FG001|Overall Study|Noncompliance|0|||
94230291|NCT00937521|322637458|FG005|Booster Phase|Lost to Follow-up|4|||
94230292|NCT00937521|322637459|FG006|Booster Phase|Lost to Follow-up|3|||
94230293|NCT00937521|322637460|FG007|Booster Phase|Lost to Follow-up|0|||
94230294|NCT00937521|322637453|FG000|Booster Phase|Administrative Reason|0|||
94230295|NCT00937521|322637454|FG001|Booster Phase|Administrative Reason|0|||
94230296|NCT00937521|322637455|FG002|Booster Phase|Administrative Reason|1|||
94230297|NCT00937521|322637456|FG003|Booster Phase|Administrative Reason|0|||
94230298|NCT00937521|322637457|FG004|Booster Phase|Administrative Reason|1|||
94230299|NCT00937521|322637458|FG005|Booster Phase|Administrative Reason|1|||
94230300|NCT00937521|322637459|FG006|Booster Phase|Administrative Reason|0|||
94230301|NCT00937521|322637460|FG007|Booster Phase|Administrative Reason|0|||
94230302|NCT00937521|322637453|FG000|Booster Phase|Protocol Deviation|0|||
94230303|NCT00937521|322637454|FG001|Booster Phase|Protocol Deviation|0|||
94230304|NCT00937521|322637455|FG002|Booster Phase|Protocol Deviation|0|||
94230305|NCT00937521|322637456|FG003|Booster Phase|Protocol Deviation|0|||
94230306|NCT00937521|322637457|FG004|Booster Phase|Protocol Deviation|0|||
94230307|NCT00937521|322637458|FG005|Booster Phase|Protocol Deviation|0|||
94230308|NCT00937521|322637459|FG006|Booster Phase|Protocol Deviation|1|||
94230309|NCT00937521|322637460|FG007|Booster Phase|Protocol Deviation|0|||
94230310|NCT04016805|322637461|FG000|Overall Study|Sponsor's Discretion|30|||
94230311|NCT04016805|322637462|FG001|Overall Study|Sponsor's Discretion|6|||
94447167|NCT01297517|323423315|FG002|Overall Study|Noncompliance|0|||
94447168|NCT01297517|323423313|FG000|Overall Study|Protocol Violation|1|||
94447169|NCT01297517|323423314|FG001|Overall Study|Protocol Violation|1|||
94230312|NCT04016805|322637463|FG002|Overall Study|Sponsor's Discretion|5|||
94230313|NCT03269695|322637466|FG000|Overall Study|Adverse Event|2|||
94230314|NCT03269695|322637467|FG001|Overall Study|Adverse Event|1|||
94230315|NCT03269695|322637466|FG000|Overall Study|Lack of Efficacy|0|||
94230316|NCT03269695|322637467|FG001|Overall Study|Lack of Efficacy|1|||
94230317|NCT03269695|322637466|FG000|Overall Study|Withdrawal by Subject|0|||
94447170|NCT01297517|323423315|FG002|Overall Study|Protocol Violation|1|||
94554901|NCT03464019|323828465|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
94554902|NCT03464019|323828463|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
94554903|NCT03464019|323828464|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
94554904|NCT03464019|323828465|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
94554905|NCT03464019|323828463|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
94554906|NCT03464019|323828464|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
94554907|NCT03464019|323828465|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
94554908|NCT03464019|323828463|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
94554909|NCT03464019|323828464|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
94554910|NCT03464019|323828465|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
94554911|NCT03464019|323828463|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
94554912|NCT03464019|323828464|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
94554913|NCT03464019|323828465|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
94554914|NCT03464019|323828463|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
94230318|NCT03269695|322637467|FG001|Overall Study|Withdrawal by Subject|1|||
94230319|NCT00644878|322637468|FG000|Overall Study|Adverse Event|2|||
94230320|NCT00644878|322637468|FG000|Overall Study|Abnormal laboratory value|3|||
94230321|NCT00644878|322637468|FG000|Overall Study|Protocol deviation|2|||
94554915|NCT03464019|323828464|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
94554916|NCT03464019|323828465|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
94554917|NCT03464019|323828463|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
94554918|NCT03464019|323828464|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
94554919|NCT03464019|323828465|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
94554920|NCT03464019|323828463|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
94230322|NCT00644878|322637468|FG000|Overall Study|Treatment duration completed as per protocol|11|||
94230323|NCT01880437|322637469|FG000|Overall Study|Death|12|||
94230324|NCT01880437|322637470|FG001|Overall Study|Death|4|||
94230325|NCT01880437|322637471|FG002|Overall Study|Death|17|||
94230326|NCT01880437|322637469|FG000|Overall Study|Study terminated by Sponsor|3|||
94230327|NCT01880437|322637470|FG001|Overall Study|Study terminated by Sponsor|0|||
94230328|NCT01880437|322637471|FG002|Overall Study|Study terminated by Sponsor|2|||
94230329|NCT01781832|322637472|FG000|Overall Study|Withdrawal by Subject|1|||
94447171|NCT01297517|323423313|FG000|Overall Study|Inadequate Control of IOP|1|||
94447172|NCT01297517|323423314|FG001|Overall Study|Inadequate Control of IOP|1|||
94447173|NCT01297517|323423315|FG002|Overall Study|Inadequate Control of IOP|2|||
94230330|NCT02168478|322637475|FG000|Overall Study|Withdrawal by Subject|1|||
94447174|NCT03751098|323423316|FG000|Overall Study|Withdrawal by Subject|0|||
94447175|NCT03751098|323423317|FG001|Overall Study|Withdrawal by Subject|1|||
94447176|NCT01882985|323423332|FG000|Overall Study|Lost to Follow-up|1|||
94447177|NCT01882985|323423332|FG000|Overall Study|Withdrawal by Subject|1|||
94447178|NCT02857816|323423333|FG000|Overall Study|Screen Failure|33|||
94447179|NCT02857816|323423333|FG000|Overall Study|Withdrawal by Subject|4|||
94447180|NCT02857816|323423333|FG000|Overall Study|Lost to Follow-up|1|||
94447181|NCT00984542|323423334|FG000|Overall Study|disease progression|19|||
94447182|NCT00984542|323423334|FG000|Overall Study|toxicity|7|||
94447183|NCT00984542|323423334|FG000|Overall Study|Death|7|||
94447184|NCT00984542|323423334|FG000|Overall Study|complicating disease|3|||
94447185|NCT00984542|323423334|FG000|Overall Study|Withdrawal by Subject|3|||
94447186|NCT00984542|323423334|FG000|Overall Study|clinical deterioration|2|||
94447187|NCT00594165|323423369|FG000|Overall Study|Major protocol violation|1|||
94447188|NCT00594165|323423369|FG000|Overall Study|Lack of Efficacy|12|||
94447189|NCT00594165|323423369|FG000|Overall Study|Adverse Event|52|||
94447190|NCT00594165|323423369|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
94447191|NCT00594165|323423369|FG000|Overall Study|Subject withdrew consent|27|||
94230331|NCT02168478|322637475|FG000|Overall Study|Did Not Consent to Participation|2|||
94447192|NCT00594165|323423369|FG000|Overall Study|Study ended per sponsor|102|||
94447193|NCT00594165|323423369|FG000|Overall Study|Lost to Follow-up|4|||
94447194|NCT00594165|323423369|FG000|Overall Study|Other: PI discretion|5|||
94447195|NCT00594165|323423369|FG000|Overall Study|Other: Subject moving|3|||
94447196|NCT00594165|323423369|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
94447197|NCT00594165|323423369|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
94230332|NCT02168478|322637475|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
94230333|NCT01157377|322637476|FG000|Overall Study|Lost to Follow-up|0|||
94230334|NCT01157377|322637477|FG001|Overall Study|Lost to Follow-up|0|||
94230335|NCT01157377|322637478|FG002|Overall Study|Lost to Follow-up|1|||
94554921|NCT03464019|323828464|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
94230336|NCT01157377|322637479|FG003|Overall Study|Lost to Follow-up|0|||
94230337|NCT01157377|322637480|FG004|Overall Study|Lost to Follow-up|1|||
94554922|NCT03464019|323828465|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
94554923|NCT03464019|323828463|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
94554924|NCT03464019|323828464|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
94230338|NCT01157377|322637481|FG005|Overall Study|Lost to Follow-up|1|||
94554925|NCT03464019|323828465|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
94554926|NCT03464019|323828463|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
94554927|NCT03464019|323828464|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
94554928|NCT03464019|323828465|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
94554929|NCT03464019|323828463|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
94554930|NCT03464019|323828464|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
94343769|NCT02614261|323037829|FG002|Open-Label Extension Phase|Protocol Violation|1|||
94343770|NCT02614261|323037830|FG003|Open-Label Extension Phase|Protocol Violation|0|||
94343771|NCT02614261|323037827|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
94343772|NCT02614261|323037828|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
94343773|NCT02614261|323037829|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
94343774|NCT02614261|323037830|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
94343775|NCT02614261|323037827|FG000|Follow-up Phase|Adverse Event|2|||
94343776|NCT02614261|323037828|FG001|Follow-up Phase|Adverse Event|0|||
94343777|NCT02614261|323037829|FG002|Follow-up Phase|Adverse Event|1|||
94343778|NCT02614261|323037830|FG003|Follow-up Phase|Adverse Event|0|||
94343779|NCT02614261|323037827|FG000|Follow-up Phase|Lost to Follow-up|12|||
94343780|NCT02614261|323037828|FG001|Follow-up Phase|Lost to Follow-up|5|||
94343781|NCT02614261|323037829|FG002|Follow-up Phase|Lost to Follow-up|2|||
94343782|NCT02614261|323037830|FG003|Follow-up Phase|Lost to Follow-up|0|||
94343783|NCT02614261|323037827|FG000|Follow-up Phase|Physician Decision|5|||
94343784|NCT02614261|323037828|FG001|Follow-up Phase|Physician Decision|1|||
94343785|NCT02614261|323037829|FG002|Follow-up Phase|Physician Decision|0|||
94343786|NCT02614261|323037830|FG003|Follow-up Phase|Physician Decision|0|||
94343787|NCT02614261|323037827|FG000|Follow-up Phase|Pregnancy|0|||
94343788|NCT02614261|323037828|FG001|Follow-up Phase|Pregnancy|1|||
94343789|NCT02614261|323037829|FG002|Follow-up Phase|Pregnancy|0|||
94343790|NCT02614261|323037830|FG003|Follow-up Phase|Pregnancy|0|||
94343791|NCT02614261|323037827|FG000|Follow-up Phase|Protocol Violation|1|||
94343792|NCT02614261|323037828|FG001|Follow-up Phase|Protocol Violation|0|||
94343793|NCT02614261|323037829|FG002|Follow-up Phase|Protocol Violation|0|||
94343794|NCT02614261|323037830|FG003|Follow-up Phase|Protocol Violation|0|||
94343795|NCT02614261|323037827|FG000|Follow-up Phase|Withdrawal by Subject|12|||
94343796|NCT02614261|323037828|FG001|Follow-up Phase|Withdrawal by Subject|4|||
94343797|NCT02614261|323037829|FG002|Follow-up Phase|Withdrawal by Subject|11|||
94343798|NCT02614261|323037830|FG003|Follow-up Phase|Withdrawal by Subject|0|||
94343799|NCT02614261|323037827|FG000|Israel Addendum|Withdrawal by Subject|0|||
94343800|NCT02614261|323037828|FG001|Israel Addendum|Withdrawal by Subject|0|||
94230339|NCT01157377|322637482|FG006|Overall Study|Lost to Follow-up|0|||
94447198|NCT00594165|323423369|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
94447199|NCT00594165|323423369|FG000|Overall Study|Other: Site terminated participation|2|||
94447200|NCT01753310|323423370|FG000|Overall Study|Entered into open label extension study|25|||
94447201|NCT01753310|323423371|FG001|Overall Study|Entered into open label extension study|22|||
94447202|NCT01753310|323423370|FG000|Overall Study|Adverse Event|1|||
94447203|NCT01753310|323423371|FG001|Overall Study|Adverse Event|0|||
94230340|NCT01157377|322637476|FG000|Overall Study|Personal Reasons|2|||
94230341|NCT01157377|322637477|FG001|Overall Study|Personal Reasons|1|||
94230342|NCT01157377|322637478|FG002|Overall Study|Personal Reasons|0|||
94230343|NCT01157377|322637479|FG003|Overall Study|Personal Reasons|1|||
94230344|NCT01157377|322637480|FG004|Overall Study|Personal Reasons|0|||
94230345|NCT01157377|322637481|FG005|Overall Study|Personal Reasons|0|||
94230346|NCT01157377|322637482|FG006|Overall Study|Personal Reasons|0|||
94230347|NCT01157377|322637476|FG000|Overall Study|Protocol Violation|0|||
94230348|NCT01157377|322637477|FG001|Overall Study|Protocol Violation|0|||
94230349|NCT01157377|322637478|FG002|Overall Study|Protocol Violation|0|||
94230350|NCT01157377|322637479|FG003|Overall Study|Protocol Violation|0|||
94230351|NCT01157377|322637480|FG004|Overall Study|Protocol Violation|0|||
94230352|NCT01157377|322637481|FG005|Overall Study|Protocol Violation|1|||
94230353|NCT01157377|322637482|FG006|Overall Study|Protocol Violation|0|||
94230354|NCT01157377|322637476|FG000|Overall Study|Lack of Efficacy|0|||
94230355|NCT01157377|322637477|FG001|Overall Study|Lack of Efficacy|0|||
94230356|NCT01157377|322637478|FG002|Overall Study|Lack of Efficacy|0|||
94230357|NCT01157377|322637479|FG003|Overall Study|Lack of Efficacy|0|||
94230358|NCT01157377|322637480|FG004|Overall Study|Lack of Efficacy|0|||
94230359|NCT01157377|322637481|FG005|Overall Study|Lack of Efficacy|0|||
94230360|NCT01157377|322637482|FG006|Overall Study|Lack of Efficacy|1|||
94230361|NCT01157377|322637476|FG000|Overall Study|Other Miscellaneous Reasons|0|||
94230362|NCT01157377|322637477|FG001|Overall Study|Other Miscellaneous Reasons|2|||
94230363|NCT01157377|322637478|FG002|Overall Study|Other Miscellaneous Reasons|0|||
94230364|NCT01157377|322637479|FG003|Overall Study|Other Miscellaneous Reasons|0|||
94230365|NCT01157377|322637480|FG004|Overall Study|Other Miscellaneous Reasons|1|||
94230366|NCT01157377|322637481|FG005|Overall Study|Other Miscellaneous Reasons|1|||
94230367|NCT01157377|322637482|FG006|Overall Study|Other Miscellaneous Reasons|1|||
94230368|NCT00582114|322637483|FG000|Overall Study|Death|4|||
94230369|NCT00582114|322637484|FG001|Overall Study|Death|4|||
94230370|NCT00582114|322637483|FG000|Overall Study|Kidney Transplant|3|||
94230371|NCT00582114|322637484|FG001|Overall Study|Kidney Transplant|1|||
94230372|NCT00582114|322637483|FG000|Overall Study|Lost to Follow-up|7|||
94230373|NCT00582114|322637484|FG001|Overall Study|Lost to Follow-up|6|||
94230374|NCT00582114|322637483|FG000|Overall Study|Withdrawal by Subject|8|||
94230375|NCT00582114|322637484|FG001|Overall Study|Withdrawal by Subject|16|||
94230376|NCT00582114|322637483|FG000|Overall Study|Adverse Event|1|||
94230377|NCT00582114|322637484|FG001|Overall Study|Adverse Event|1|||
94230378|NCT00582114|322637483|FG000|Overall Study|Physician Decision|0|||
94230379|NCT00582114|322637484|FG001|Overall Study|Physician Decision|6|||
94447204|NCT01753310|323423370|FG000|Overall Study|Lost to Follow-up|2|||
94447205|NCT01753310|323423371|FG001|Overall Study|Lost to Follow-up|0|||
94230380|NCT00582114|322637483|FG000|Overall Study|Stopped by data safety monitoring board|19|||
94230381|NCT00582114|322637484|FG001|Overall Study|Stopped by data safety monitoring board|20|||
94230382|NCT00461123|322637485|FG000|Overall Study|Adverse Event|1|||
94230383|NCT00461123|322637486|FG001|Overall Study|Adverse Event|0|||
94230384|NCT00461123|322637485|FG000|Overall Study|Lost to Follow-up|1|||
94230385|NCT00461123|322637486|FG001|Overall Study|Lost to Follow-up|1|||
94230386|NCT00461123|322637485|FG000|Overall Study|Protocol Violation|3|||
94230387|NCT00461123|322637486|FG001|Overall Study|Protocol Violation|2|||
94230388|NCT00461123|322637485|FG000|Overall Study|Withdrawal by Subject|1|||
94230389|NCT00461123|322637486|FG001|Overall Study|Withdrawal by Subject|3|||
94230390|NCT05523219|322637487|FG000|Overall Study|Wrong inclusion|1|||
94230391|NCT05523219|322637487|FG000|Overall Study|Lost to Follow-up|7|||
94230392|NCT02024750|322637488|FG000|Overall Study|Withdrawal by Subject|2|||
94447206|NCT01753310|323423370|FG000|Overall Study|Subject decision|2|||
94447207|NCT01753310|323423371|FG001|Overall Study|Subject decision|2|||
94447208|NCT01753310|323423370|FG000|Overall Study|Sponsor decision|1|||
94447209|NCT01753310|323423371|FG001|Overall Study|Sponsor decision|0|||
94447210|NCT01753310|323423370|FG000|Overall Study|Withdrawal by Subject|1|||
94447211|NCT01753310|323423371|FG001|Overall Study|Withdrawal by Subject|0|||
94447212|NCT02946463|323423372|FG000|Primary Evaluation Period|Physician Decision|0|||
94447213|NCT02946463|323423373|FG001|Primary Evaluation Period|Physician Decision|1|||
94447214|NCT02946463|323423374|FG002|Primary Evaluation Period|Physician Decision|0|||
94447215|NCT02946463|323423375|FG003|Primary Evaluation Period|Physician Decision|0|||
94447216|NCT02946463|323423372|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
94447217|NCT02946463|323423373|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
94447218|NCT02946463|323423374|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
94447219|NCT02946463|323423375|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
94447220|NCT02946463|323423372|FG000|Extension Period|Death|4|||
94447221|NCT02946463|323423373|FG001|Extension Period|Death|4|||
94447222|NCT02946463|323423374|FG002|Extension Period|Death|0|||
94447223|NCT02946463|323423375|FG003|Extension Period|Death|0|||
94230393|NCT02024750|322637489|FG001|Overall Study|Withdrawal by Subject|1|||
94230394|NCT02760485|322637494|FG000|Phase 1|Death|3|||
94230395|NCT02760485|322637495|FG001|Phase 1|Death|6|||
94447224|NCT02946463|323423372|FG000|Extension Period|Withdrawal by Subject|4|||
94447225|NCT02946463|323423373|FG001|Extension Period|Withdrawal by Subject|3|||
94447226|NCT02946463|323423374|FG002|Extension Period|Withdrawal by Subject|0|||
94447227|NCT02946463|323423375|FG003|Extension Period|Withdrawal by Subject|0|||
94447228|NCT02946463|323423372|FG000|Extension Period|Other than specified|2|||
94447229|NCT02946463|323423373|FG001|Extension Period|Other than specified|3|||
94447230|NCT02946463|323423374|FG002|Extension Period|Other than specified|2|||
94447231|NCT02946463|323423375|FG003|Extension Period|Other than specified|0|||
94447232|NCT02946463|323423372|FG000|Extension Period|Physician Decision|1|||
94447233|NCT02946463|323423373|FG001|Extension Period|Physician Decision|4|||
94554931|NCT03464019|323828465|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
94554932|NCT03464019|323828463|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
94554933|NCT03464019|323828464|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
94554934|NCT03464019|323828465|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
94554935|NCT03464019|323828463|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
94554936|NCT03464019|323828464|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
94554937|NCT03464019|323828465|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
94554938|NCT00193180|323828466|FG000|Overall Study|Lack of Efficacy|1|||
94554939|NCT00193180|323828466|FG000|Overall Study|Adverse Event|8|||
94554940|NCT00193180|323828466|FG000|Overall Study|Protocol Violation|1|||
94554941|NCT01357551|323828467|FG000|Overall Study|Withdrawal by Subject|6|||
94554942|NCT01357551|323828468|FG001|Overall Study|Withdrawal by Subject|4|||
94554943|NCT01357551|323828467|FG000|Overall Study|Death|0|||
94554944|NCT01357551|323828468|FG001|Overall Study|Death|1|||
94554945|NCT01357551|323828467|FG000|Overall Study|Lost to Follow-up|16|||
94554946|NCT01357551|323828468|FG001|Overall Study|Lost to Follow-up|6|||
94554947|NCT02489942|323828469|FG000|Overall Study|Request by patient|602|||
94554948|NCT02489942|323828469|FG000|Overall Study|Improvement/remission|157|||
94554949|NCT02489942|323828469|FG000|Overall Study|No change/Progressive disease|263|||
94554950|NCT02489942|323828469|FG000|Overall Study|Adverse Event|522|||
94554951|NCT02489942|323828469|FG000|Overall Study|Other personal reasons|1218|||
94554952|NCT02489942|323828469|FG000|Overall Study|Lost to Follow-up|456|||
94554953|NCT02489942|323828469|FG000|Overall Study|Not continuously investigated|7|||
94554954|NCT02489942|323828469|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
94554955|NCT02489942|323828469|FG000|Overall Study|Multiple registration|1|||
94554956|NCT02489942|323828469|FG000|Overall Study|No patient visit after entry|100|||
94554957|NCT02489942|323828469|FG000|Overall Study|No treatment with Jardiance|2|||
94554958|NCT02489942|323828469|FG000|Overall Study|Patient received Jardiance before registration|1|||
94554959|NCT02489942|323828469|FG000|Overall Study|No CRF collected|86|||
94554960|NCT00891228|323828470|FG000|Overall Study|Adverse Event|0|||
94554961|NCT00891228|323828471|FG001|Overall Study|Adverse Event|2|||
94554962|NCT00891228|323828472|FG002|Overall Study|Adverse Event|3|||
94230396|NCT02760485|322637496|FG002|Phase 1|Death|0|||
94230397|NCT02760485|322637494|FG000|Phase 1|Withdrawal by Subject|2|||
94554963|NCT00891228|323828470|FG000|Overall Study|Withdrawal by Subject|2|||
94343801|NCT02614261|323037829|FG002|Israel Addendum|Withdrawal by Subject|0|||
94343802|NCT02614261|323037830|FG003|Israel Addendum|Withdrawal by Subject|4|||
94343803|NCT02736474|323037838|FG000|Overall Study|Lost to Follow-up|0|||
94343804|NCT02736474|323037839|FG001|Overall Study|Lost to Follow-up|1|||
94343805|NCT00691054|323037840|FG000|Overall Study|Withdrawal by Subject|1|||
94343806|NCT00736385|323039960|FG000|Overall Study|Withdrawal by Subject|2|||
94554964|NCT00891228|323828471|FG001|Overall Study|Withdrawal by Subject|4|||
94554965|NCT00891228|323828472|FG002|Overall Study|Withdrawal by Subject|5|||
94554966|NCT00891228|323828470|FG000|Overall Study|Protocol Violation|3|||
94554967|NCT00891228|323828471|FG001|Overall Study|Protocol Violation|1|||
94230398|NCT02760485|322637495|FG001|Phase 1|Withdrawal by Subject|0|||
94230399|NCT02760485|322637496|FG002|Phase 1|Withdrawal by Subject|0|||
94554968|NCT00891228|323828472|FG002|Overall Study|Protocol Violation|2|||
94230400|NCT02760485|322637494|FG000|Phase 1|Progressive Disease|1|||
94230401|NCT02760485|322637495|FG001|Phase 1|Progressive Disease|0|||
94230402|NCT02760485|322637496|FG002|Phase 1|Progressive Disease|0|||
94230403|NCT02760485|322637494|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
94230404|NCT02760485|322637495|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
94230405|NCT02760485|322637496|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
94230406|NCT02760485|322637494|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
94230407|NCT02760485|322637495|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
94343807|NCT00736385|323039961|FG001|Overall Study|Withdrawal by Subject|2|||
94343808|NCT00736385|323039960|FG000|Overall Study|Adverse Event|0|||
94343809|NCT00736385|323039961|FG001|Overall Study|Adverse Event|1|||
94343810|NCT00098865|323039962|FG000|Overall Study|Progressive Disease|6|||
94343811|NCT00098865|323039962|FG000|Overall Study|Adverse Event|2|||
94343812|NCT00098865|323039962|FG000|Overall Study|Alternative Therapy|1|||
94554969|NCT00891228|323828470|FG000|Overall Study|Physician Decision|2|||
94230408|NCT02760485|322637496|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
94230409|NCT02760485|322637494|FG000|Phase 2|Death|0|||
94230410|NCT02760485|322637495|FG001|Phase 2|Death|0|||
94230411|NCT02760485|322637496|FG002|Phase 2|Death|12|||
94230412|NCT02760485|322637494|FG000|Phase 2|Withdrawal by Subject|0|||
94230413|NCT02760485|322637495|FG001|Phase 2|Withdrawal by Subject|0|||
94230414|NCT02760485|322637496|FG002|Phase 2|Withdrawal by Subject|3|||
94230415|NCT02760485|322637494|FG000|Phase 2|Progressive Disease|0|||
94230416|NCT02760485|322637495|FG001|Phase 2|Progressive Disease|0|||
94230417|NCT02760485|322637496|FG002|Phase 2|Progressive Disease|1|||
94230418|NCT02760485|322637494|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
94230419|NCT02760485|322637495|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
94230420|NCT02760485|322637496|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
94230421|NCT03845023|322637497|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
94230422|NCT03845023|322637498|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
94230423|NCT03845023|322637499|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
94230424|NCT03845023|322637500|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
94230425|NCT03845023|322637497|FG000|Follow-Up (14 Days)|Adverse Event|0|||
94230426|NCT03845023|322637498|FG001|Follow-Up (14 Days)|Adverse Event|0|||
94230427|NCT03845023|322637499|FG002|Follow-Up (14 Days)|Adverse Event|1|||
94230428|NCT03845023|322637500|FG003|Follow-Up (14 Days)|Adverse Event|1|||
94230429|NCT01702519|322637501|FG000|Washout Period|Lost to Follow-up|1|||
94230430|NCT01702519|322637502|FG001|Washout Period|Lost to Follow-up|0|||
94230431|NCT01702519|322637501|FG000|Washout Period|Withdrawal by Subject|0|||
94230432|NCT01702519|322637502|FG001|Washout Period|Withdrawal by Subject|2|||
94230433|NCT03738397|322637503|FG000|Overall Study|Adverse Event|3|||
94230434|NCT03738397|322637504|FG001|Overall Study|Adverse Event|7|||
94230435|NCT03738397|322637503|FG000|Overall Study|Withdrawal by Subject|8|||
94230436|NCT03738397|322637504|FG001|Overall Study|Withdrawal by Subject|11|||
94230437|NCT03738397|322637503|FG000|Overall Study|Lost to Follow-up|7|||
94230438|NCT03738397|322637504|FG001|Overall Study|Lost to Follow-up|5|||
94230439|NCT03738397|322637503|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
94230440|NCT03738397|322637504|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
94230441|NCT03738397|322637503|FG000|Overall Study|Other|4|||
94230442|NCT03738397|322637504|FG001|Overall Study|Other|6|||
94230443|NCT03772613|322637505|FG000|Overall Study|Lost to Follow-up|0|||
94230444|NCT03772613|322637506|FG001|Overall Study|Lost to Follow-up|1|||
94230445|NCT03772613|322637507|FG002|Overall Study|Lost to Follow-up|1|||
94230446|NCT00661713|322637508|FG000|Overall Study|Death|1|||
94230447|NCT00661713|322637509|FG001|Overall Study|Death|0|||
94230448|NCT00661713|322637510|FG002|Overall Study|Death|0|||
94230449|NCT00661713|322637511|FG003|Overall Study|Death|0|||
94230450|NCT00661713|322637512|FG004|Overall Study|Death|1|||
94230451|NCT00661713|322637513|FG005|Overall Study|Death|0|||
94230452|NCT00661713|322637514|FG006|Overall Study|Death|0|||
94230453|NCT00661713|322637515|FG007|Overall Study|Death|0|||
94230454|NCT00661713|322637508|FG000|Overall Study|Unable to Classify|1|||
94230455|NCT00661713|322637509|FG001|Overall Study|Unable to Classify|0|||
94230456|NCT00661713|322637510|FG002|Overall Study|Unable to Classify|0|||
94230457|NCT00661713|322637511|FG003|Overall Study|Unable to Classify|0|||
94230458|NCT00661713|322637512|FG004|Overall Study|Unable to Classify|0|||
94230459|NCT00661713|322637513|FG005|Overall Study|Unable to Classify|0|||
94230460|NCT00661713|322637514|FG006|Overall Study|Unable to Classify|0|||
94230461|NCT00661713|322637515|FG007|Overall Study|Unable to Classify|0|||
94230462|NCT00661713|322637508|FG000|Overall Study|Protocol Violation|1|||
94230463|NCT00661713|322637509|FG001|Overall Study|Protocol Violation|6|||
94230464|NCT00661713|322637510|FG002|Overall Study|Protocol Violation|3|||
94230465|NCT00661713|322637511|FG003|Overall Study|Protocol Violation|3|||
94230466|NCT00661713|322637512|FG004|Overall Study|Protocol Violation|0|||
94230467|NCT00661713|322637513|FG005|Overall Study|Protocol Violation|2|||
94230468|NCT00661713|322637514|FG006|Overall Study|Protocol Violation|2|||
94230469|NCT00661713|322637515|FG007|Overall Study|Protocol Violation|1|||
94230470|NCT00661713|322637508|FG000|Overall Study|Withdrawal by Subject|11|||
94230471|NCT00661713|322637509|FG001|Overall Study|Withdrawal by Subject|25|||
94554970|NCT00891228|323828471|FG001|Overall Study|Physician Decision|1|||
94554971|NCT00891228|323828472|FG002|Overall Study|Physician Decision|0|||
94554972|NCT00891228|323828470|FG000|Overall Study|Lost to Follow-up|4|||
94554973|NCT00891228|323828471|FG001|Overall Study|Lost to Follow-up|4|||
94554974|NCT00891228|323828472|FG002|Overall Study|Lost to Follow-up|5|||
94554975|NCT00891228|323828470|FG000|Overall Study|Pregnancy|0|||
94554976|NCT00891228|323828471|FG001|Overall Study|Pregnancy|1|||
94554977|NCT00891228|323828472|FG002|Overall Study|Pregnancy|0|||
94554978|NCT01393639|323828475|FG000|Overall Study|Protocol Violation|0|||
94554979|NCT01393639|323828476|FG001|Overall Study|Protocol Violation|0|||
94554980|NCT01393639|323828477|FG002|Overall Study|Protocol Violation|0|||
94554981|NCT01393639|323828478|FG003|Overall Study|Protocol Violation|1|||
94554982|NCT01393639|323828479|FG004|Overall Study|Protocol Violation|0|||
94554983|NCT01393639|323828480|FG005|Overall Study|Protocol Violation|0|||
94554984|NCT01393639|323828481|FG006|Overall Study|Protocol Violation|0|||
94554985|NCT01393639|323828475|FG000|Overall Study|Other|0|||
94554986|NCT01393639|323828476|FG001|Overall Study|Other|2|||
94554987|NCT01393639|323828477|FG002|Overall Study|Other|0|||
94554988|NCT01393639|323828478|FG003|Overall Study|Other|2|||
94554989|NCT01393639|323828479|FG004|Overall Study|Other|1|||
94554990|NCT01393639|323828480|FG005|Overall Study|Other|0|||
94554991|NCT01393639|323828481|FG006|Overall Study|Other|1|||
94554992|NCT01393639|323828475|FG000|Overall Study|Withdrawal by Subject|1|||
94554993|NCT01393639|323828476|FG001|Overall Study|Withdrawal by Subject|1|||
94554994|NCT01393639|323828477|FG002|Overall Study|Withdrawal by Subject|0|||
94554995|NCT01393639|323828478|FG003|Overall Study|Withdrawal by Subject|0|||
94554996|NCT01393639|323828479|FG004|Overall Study|Withdrawal by Subject|0|||
94554997|NCT01393639|323828480|FG005|Overall Study|Withdrawal by Subject|0|||
94554998|NCT01393639|323828481|FG006|Overall Study|Withdrawal by Subject|1|||
94554999|NCT01393639|323828475|FG000|Overall Study|Medication error without associated AE|0|||
94555000|NCT01393639|323828476|FG001|Overall Study|Medication error without associated AE|0|||
94555001|NCT01393639|323828477|FG002|Overall Study|Medication error without associated AE|0|||
94555002|NCT01393639|323828478|FG003|Overall Study|Medication error without associated AE|0|||
94555003|NCT01393639|323828479|FG004|Overall Study|Medication error without associated AE|0|||
94555004|NCT01393639|323828480|FG005|Overall Study|Medication error without associated AE|0|||
94555005|NCT01393639|323828481|FG006|Overall Study|Medication error without associated AE|1|||
94555006|NCT01393639|323828475|FG000|Overall Study|Lost to Follow-up|0|||
94555007|NCT01393639|323828476|FG001|Overall Study|Lost to Follow-up|1|||
94555008|NCT01393639|323828477|FG002|Overall Study|Lost to Follow-up|0|||
94555009|NCT01393639|323828478|FG003|Overall Study|Lost to Follow-up|0|||
94555010|NCT01393639|323828479|FG004|Overall Study|Lost to Follow-up|0|||
94555011|NCT01393639|323828480|FG005|Overall Study|Lost to Follow-up|0|||
94555012|NCT01393639|323828481|FG006|Overall Study|Lost to Follow-up|1|||
94555013|NCT01393639|323828475|FG000|Overall Study|Lack of Efficacy|0|||
94555014|NCT01393639|323828476|FG001|Overall Study|Lack of Efficacy|0|||
94555015|NCT01393639|323828477|FG002|Overall Study|Lack of Efficacy|0|||
94555016|NCT01393639|323828478|FG003|Overall Study|Lack of Efficacy|0|||
94555017|NCT01393639|323828479|FG004|Overall Study|Lack of Efficacy|0|||
94555018|NCT01393639|323828480|FG005|Overall Study|Lack of Efficacy|0|||
94555019|NCT01393639|323828481|FG006|Overall Study|Lack of Efficacy|1|||
94555020|NCT01393639|323828475|FG000|Overall Study|Adverse Event|2|||
94555021|NCT01393639|323828476|FG001|Overall Study|Adverse Event|3|||
94555022|NCT01393639|323828477|FG002|Overall Study|Adverse Event|1|||
94555023|NCT01393639|323828478|FG003|Overall Study|Adverse Event|2|||
94555024|NCT01393639|323828479|FG004|Overall Study|Adverse Event|0|||
94555025|NCT01393639|323828480|FG005|Overall Study|Adverse Event|2|||
94555026|NCT01393639|323828481|FG006|Overall Study|Adverse Event|3|||
94555027|NCT02504580|323828482|FG000|Overall Study|Other|1|||
94555028|NCT02504580|323828483|FG001|Overall Study|Other|0|||
94555029|NCT02504580|323828484|FG002|Overall Study|Other|0|||
94555030|NCT02504580|323828485|FG003|Overall Study|Other|2|||
94555031|NCT02504580|323828486|FG004|Overall Study|Other|1|||
94555032|NCT02504580|323828487|FG005|Overall Study|Other|1|||
94555033|NCT02504580|323828488|FG006|Overall Study|Other|1|||
94555034|NCT02504580|323828489|FG007|Overall Study|Other|2|||
94555035|NCT02504580|323828490|FG008|Overall Study|Other|0|||
94555036|NCT02504580|323828491|FG009|Overall Study|Other|0|||
94555037|NCT02504580|323828492|FG010|Overall Study|Other|0|||
94555038|NCT02504580|323828493|FG011|Overall Study|Other|2|||
94555039|NCT02504580|323828482|FG000|Overall Study|Subject refusal to continue|0|||
94555040|NCT02504580|323828483|FG001|Overall Study|Subject refusal to continue|1|||
94555041|NCT02504580|323828484|FG002|Overall Study|Subject refusal to continue|0|||
94555042|NCT02504580|323828485|FG003|Overall Study|Subject refusal to continue|0|||
94555043|NCT02504580|323828486|FG004|Overall Study|Subject refusal to continue|0|||
94555044|NCT02504580|323828487|FG005|Overall Study|Subject refusal to continue|0|||
94555045|NCT02504580|323828488|FG006|Overall Study|Subject refusal to continue|0|||
94555046|NCT02504580|323828489|FG007|Overall Study|Subject refusal to continue|0|||
94555047|NCT02504580|323828490|FG008|Overall Study|Subject refusal to continue|0|||
94555048|NCT02504580|323828491|FG009|Overall Study|Subject refusal to continue|0|||
94555049|NCT02504580|323828492|FG010|Overall Study|Subject refusal to continue|0|||
94555050|NCT02504580|323828493|FG011|Overall Study|Subject refusal to continue|0|||
94555051|NCT02596230|323828495|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
94555052|NCT02596230|323828496|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
94555053|NCT02596230|323828497|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
94555054|NCT02596230|323828498|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
94555055|NCT02596230|323828499|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
94555056|NCT02596230|323828495|FG000|Objective 2, One Year|Lost to Follow-up|0|||
94555057|NCT02596230|323828496|FG001|Objective 2, One Year|Lost to Follow-up|41|||
94555058|NCT02596230|323828497|FG002|Objective 2, One Year|Lost to Follow-up|41|||
94555059|NCT02596230|323828498|FG003|Objective 2, One Year|Lost to Follow-up|32|||
94555060|NCT02596230|323828499|FG004|Objective 2, One Year|Lost to Follow-up|46|||
94555061|NCT02596230|323828495|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
94555062|NCT02596230|323828496|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
94555063|NCT02596230|323828497|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
94555064|NCT02596230|323828498|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
94555065|NCT02596230|323828499|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
94555066|NCT02596230|323828495|FG000|Objective 2, One Year|Adverse drug reaction|0|||
94555067|NCT02596230|323828496|FG001|Objective 2, One Year|Adverse drug reaction|1|||
94555068|NCT02596230|323828497|FG002|Objective 2, One Year|Adverse drug reaction|0|||
94555069|NCT02596230|323828498|FG003|Objective 2, One Year|Adverse drug reaction|0|||
94555070|NCT02596230|323828499|FG004|Objective 2, One Year|Adverse drug reaction|0|||
94555071|NCT02596230|323828495|FG000|Objective 2, One Year|Death|0|||
94555072|NCT02596230|323828496|FG001|Objective 2, One Year|Death|12|||
94555073|NCT02596230|323828497|FG002|Objective 2, One Year|Death|41|||
94555074|NCT02596230|323828498|FG003|Objective 2, One Year|Death|21|||
94555075|NCT02596230|323828499|FG004|Objective 2, One Year|Death|30|||
94555076|NCT02596230|323828495|FG000|Objective 2, One Year|Other|0|||
94555077|NCT02596230|323828496|FG001|Objective 2, One Year|Other|3|||
94555078|NCT02596230|323828497|FG002|Objective 2, One Year|Other|2|||
94555079|NCT02596230|323828498|FG003|Objective 2, One Year|Other|0|||
94555080|NCT02596230|323828499|FG004|Objective 2, One Year|Other|0|||
94555081|NCT01359943|323828501|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
94555082|NCT01359943|323828502|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
94555083|NCT01359943|323828503|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
94555084|NCT01359943|323828501|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
94555085|NCT01359943|323828502|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
94555086|NCT01359943|323828503|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
94555087|NCT01359943|323828501|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
94555088|NCT01359943|323828502|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
94555089|NCT01359943|323828503|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
94555090|NCT01359943|323828501|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
94555091|NCT01359943|323828502|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
94555092|NCT01359943|323828503|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
94555093|NCT01359943|323828501|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
94555094|NCT01359943|323828502|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
94555095|NCT01359943|323828503|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
94555096|NCT01359943|323828501|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
94555097|NCT01359943|323828502|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
94555098|NCT01359943|323828503|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
94555099|NCT01359943|323828501|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
94555100|NCT01359943|323828502|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
94555101|NCT01359943|323828503|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
94555102|NCT01359943|323828501|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
94555103|NCT01359943|323828502|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
94555104|NCT01359943|323828503|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
94555105|NCT01359943|323828501|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
94555106|NCT01359943|323828502|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
94555107|NCT01359943|323828503|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
94555108|NCT01359943|323828501|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
94555109|NCT01359943|323828502|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
94555110|NCT01359943|323828503|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
94555111|NCT01359943|323828501|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
94447234|NCT02946463|323423374|FG002|Extension Period|Physician Decision|0|||
94447235|NCT02946463|323423375|FG003|Extension Period|Physician Decision|0|||
94447236|NCT02946463|323423372|FG000|Extension Period|Pregnancy|3|||
94447237|NCT02946463|323423373|FG001|Extension Period|Pregnancy|1|||
94447238|NCT02946463|323423374|FG002|Extension Period|Pregnancy|0|||
94447239|NCT02946463|323423375|FG003|Extension Period|Pregnancy|0|||
94447240|NCT02946463|323423372|FG000|Extension Period|Adverse Event|1|||
94447241|NCT02946463|323423373|FG001|Extension Period|Adverse Event|2|||
94447242|NCT02946463|323423374|FG002|Extension Period|Adverse Event|0|||
94447243|NCT02946463|323423375|FG003|Extension Period|Adverse Event|0|||
94447244|NCT02946463|323423372|FG000|Extension Period|Lost to Follow-up|1|||
94447245|NCT02946463|323423373|FG001|Extension Period|Lost to Follow-up|0|||
94447246|NCT02946463|323423374|FG002|Extension Period|Lost to Follow-up|0|||
94447247|NCT02946463|323423375|FG003|Extension Period|Lost to Follow-up|0|||
94447248|NCT03193853|323423376|FG000|Overall Study|Death|6|||
94447249|NCT01153815|323423377|FG000|Overall Study|Adverse Event|3|||
94447250|NCT01153815|323423378|FG001|Overall Study|Adverse Event|1|||
94447251|NCT01153815|323423377|FG000|Overall Study|Withdrawal by Subject|6|||
94447252|NCT01153815|323423378|FG001|Overall Study|Withdrawal by Subject|4|||
94447253|NCT00697463|323423385|FG000|Overall Study|Withdrawal by Subject|1|||
94447254|NCT03564119|323423386|FG000|Overall Study|Adverse Event|4|||
94447255|NCT03564119|323423387|FG001|Overall Study|Adverse Event|0|||
94555112|NCT01359943|323828502|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
94555113|NCT01359943|323828503|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
94555114|NCT01359943|323828501|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
94555115|NCT01359943|323828502|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
94555116|NCT01359943|323828503|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
94555117|NCT01359943|323828501|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
94555118|NCT01359943|323828502|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
94555119|NCT01359943|323828503|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
94555120|NCT01359943|323828501|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
94555121|NCT01359943|323828502|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
94555122|NCT01359943|323828503|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
94555123|NCT01359943|323828501|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
94555124|NCT01359943|323828502|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
94555125|NCT01359943|323828503|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
94555126|NCT01329939|323828505|FG000|Overall Study|Lost to Follow-up|3|||
94555127|NCT01329939|323828506|FG001|Overall Study|Lost to Follow-up|0|||
94555128|NCT01329939|323828507|FG002|Overall Study|Lost to Follow-up|1|||
94555129|NCT01329939|323828508|FG003|Overall Study|Lost to Follow-up|2|||
94555130|NCT01329939|323828505|FG000|Overall Study|Withdrawal by Subject|0|||
94555131|NCT01329939|323828506|FG001|Overall Study|Withdrawal by Subject|1|||
94555132|NCT01329939|323828507|FG002|Overall Study|Withdrawal by Subject|0|||
94555133|NCT01329939|323828508|FG003|Overall Study|Withdrawal by Subject|0|||
94555134|NCT01329939|323828505|FG000|Overall Study|Adverse Event|0|||
94555135|NCT01329939|323828506|FG001|Overall Study|Adverse Event|0|||
94555136|NCT01329939|323828507|FG002|Overall Study|Adverse Event|0|||
94555137|NCT01329939|323828508|FG003|Overall Study|Adverse Event|3|||
94555138|NCT03722524|323828509|FG000|Overall Study|Protocol Violation|86|||
94555139|NCT03722524|323828509|FG000|Overall Study|Adverse Event|7|||
94555140|NCT03722524|323828509|FG000|Overall Study|Lost to Follow-up|1|||
94555141|NCT03722524|323828509|FG000|Overall Study|Reason is not stated|1|||
94555142|NCT03722524|323828509|FG000|Overall Study|Physician Decision|1|||
94555143|NCT03722524|323828509|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
94555144|NCT01331109|323828510|FG000|Overall Study|Adverse Event|6|||
94555145|NCT01331109|323828510|FG000|Overall Study|Lack of Efficacy|2|||
94555146|NCT01331109|323828510|FG000|Overall Study|Protocol Violation|3|||
94555147|NCT01331109|323828510|FG000|Overall Study|Withdrawal by Subject|7|||
94555148|NCT01331109|323828510|FG000|Overall Study|Lost to Follow-up|1|||
94555149|NCT01331109|323828510|FG000|Overall Study|Study Terminated by Sponsor|38|||
94555150|NCT00988091|323828511|FG000|Double-blind Period|Withdrawal by Subject|15|||
94555151|NCT00988091|323828512|FG001|Double-blind Period|Withdrawal by Subject|13|||
94555152|NCT00988091|323828511|FG000|Double-blind Period|Lost to Follow-up|12|||
94555153|NCT00988091|323828512|FG001|Double-blind Period|Lost to Follow-up|14|||
94555154|NCT00988091|323828511|FG000|Double-blind Period|Other|8|||
94555155|NCT00988091|323828512|FG001|Double-blind Period|Other|8|||
94555156|NCT00988091|323828511|FG000|Double-blind Period|Adverse Event|6|||
94555157|NCT00988091|323828512|FG001|Double-blind Period|Adverse Event|9|||
94555158|NCT00988091|323828511|FG000|Double-blind Period|Use of exclusionary medication|2|||
94555159|NCT00988091|323828512|FG001|Double-blind Period|Use of exclusionary medication|3|||
94555160|NCT00988091|323828511|FG000|Open-label Period|Adverse Event|4|||
94555161|NCT00988091|323828512|FG001|Open-label Period|Adverse Event|7|||
94555162|NCT00988091|323828511|FG000|Open-label Period|Use of exclusionary medication|1|||
94555163|NCT00988091|323828512|FG001|Open-label Period|Use of exclusionary medication|1|||
94555164|NCT00988091|323828511|FG000|Open-label Period|Protocol Violation|1|||
94555165|NCT00988091|323828512|FG001|Open-label Period|Protocol Violation|1|||
94555166|NCT00988091|323828511|FG000|Open-label Period|Withdrawal by Subject|10|||
94555167|NCT00988091|323828512|FG001|Open-label Period|Withdrawal by Subject|16|||
94555168|NCT00988091|323828511|FG000|Open-label Period|Lost to Follow-up|3|||
94555169|NCT00988091|323828512|FG001|Open-label Period|Lost to Follow-up|5|||
94555170|NCT00988091|323828511|FG000|Open-label Period|Other|2|||
94555171|NCT00988091|323828512|FG001|Open-label Period|Other|3|||
94555172|NCT00719680|323828513|FG000|Overall Study|Adverse Event|1|||
94555173|NCT00719680|323828513|FG000|Overall Study|Lost to Follow-up|1|||
94555174|NCT00719680|323828513|FG000|Overall Study|Withdrawal by Subject|3|||
94555175|NCT00588094|323828518|FG000|Overall Study|Adverse Event|3|||
94555176|NCT00588094|323828518|FG000|Overall Study|Progression of Disease|2|||
94555177|NCT00095173|323828519|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
94555178|NCT00095173|323828520|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
94555179|NCT00095173|323828521|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
94555180|NCT00095173|323828522|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
94555181|NCT00095173|323828523|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
94555182|NCT00095173|323828524|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
94555183|NCT00095173|323828519|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
94555184|NCT00095173|323828520|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
94555185|NCT00095173|323828521|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
94555186|NCT00095173|323828522|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
94447256|NCT03564119|323423386|FG000|Overall Study|Lost to Follow-up|1|||
94447257|NCT03564119|323423387|FG001|Overall Study|Lost to Follow-up|4|||
94447258|NCT03564119|323423386|FG000|Overall Study|Protocol Violation|1|||
94447259|NCT03564119|323423387|FG001|Overall Study|Protocol Violation|0|||
94447260|NCT03564119|323423386|FG000|Overall Study|Withdrawal by Subject|9|||
94447261|NCT03564119|323423387|FG001|Overall Study|Withdrawal by Subject|4|||
94447262|NCT03564119|323423386|FG000|Overall Study|Other Than Specified|0|||
94447263|NCT03564119|323423387|FG001|Overall Study|Other Than Specified|1|||
94447264|NCT03307252|323423388|FG000|Part 2, Period 1|Treatment not received|0|||
94447265|NCT03307252|323423389|FG001|Part 2, Period 1|Treatment not received|0|||
94447266|NCT03307252|323423390|FG002|Part 2, Period 1|Treatment not received|0|||
94447267|NCT03307252|323423391|FG003|Part 2, Period 1|Treatment not received|0|||
94447268|NCT03307252|323423392|FG004|Part 2, Period 1|Treatment not received|0|||
94447269|NCT03307252|323423393|FG005|Part 2, Period 1|Treatment not received|1|||
94447270|NCT03307252|323423394|FG006|Part 2, Period 1|Treatment not received|0|||
94447271|NCT03307252|323423395|FG007|Part 2, Period 1|Treatment not received|0|||
94447272|NCT03307252|323423396|FG008|Part 2, Period 1|Treatment not received|0|||
94447273|NCT03307252|323423397|FG009|Part 2, Period 1|Treatment not received|0|||
94447274|NCT03307252|323423398|FG010|Part 2, Period 1|Treatment not received|0|||
94447275|NCT03307252|323423388|FG000|Part 2, Period 3|Other than listed|0|||
94447276|NCT03307252|323423389|FG001|Part 2, Period 3|Other than listed|0|||
94447277|NCT03307252|323423390|FG002|Part 2, Period 3|Other than listed|0|||
94447278|NCT03307252|323423391|FG003|Part 2, Period 3|Other than listed|0|||
94447279|NCT03307252|323423392|FG004|Part 2, Period 3|Other than listed|1|||
94447280|NCT03307252|323423393|FG005|Part 2, Period 3|Other than listed|0|||
94447281|NCT03307252|323423394|FG006|Part 2, Period 3|Other than listed|0|||
94447282|NCT03307252|323423395|FG007|Part 2, Period 3|Other than listed|0|||
94447283|NCT03307252|323423396|FG008|Part 2, Period 3|Other than listed|0|||
94447284|NCT03307252|323423397|FG009|Part 2, Period 3|Other than listed|0|||
94447285|NCT03307252|323423398|FG010|Part 2, Period 3|Other than listed|0|||
94447286|NCT03307252|323423388|FG000|Part 2, Period 4|Other than listed|0|||
94447287|NCT03307252|323423389|FG001|Part 2, Period 4|Other than listed|0|||
94447288|NCT03307252|323423390|FG002|Part 2, Period 4|Other than listed|0|||
94447289|NCT03307252|323423391|FG003|Part 2, Period 4|Other than listed|0|||
94447290|NCT03307252|323423392|FG004|Part 2, Period 4|Other than listed|0|||
94447291|NCT03307252|323423393|FG005|Part 2, Period 4|Other than listed|0|||
94447292|NCT03307252|323423394|FG006|Part 2, Period 4|Other than listed|1|||
94447293|NCT03307252|323423395|FG007|Part 2, Period 4|Other than listed|0|||
94447294|NCT03307252|323423396|FG008|Part 2, Period 4|Other than listed|0|||
94447295|NCT03307252|323423397|FG009|Part 2, Period 4|Other than listed|0|||
94447296|NCT03307252|323423398|FG010|Part 2, Period 4|Other than listed|0|||
94447297|NCT03307252|323423388|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
94447298|NCT03307252|323423389|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
94447299|NCT03307252|323423390|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
94447300|NCT03307252|323423391|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
94447301|NCT03307252|323423392|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
94447302|NCT03307252|323423393|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
94447303|NCT03307252|323423394|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
94447304|NCT03307252|323423395|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
94447305|NCT03307252|323423396|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
94447306|NCT03307252|323423397|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
94447307|NCT03307252|323423398|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
94447308|NCT03859427|323423400|FG000|Overall Study|Withdrawal by Subject|4|||
94447309|NCT03859427|323423401|FG001|Overall Study|Withdrawal by Subject|7|||
94447310|NCT03859427|323423400|FG000|Overall Study|Decision by sponsor|0|||
94447311|NCT03859427|323423401|FG001|Overall Study|Decision by sponsor|3|||
94447312|NCT03859427|323423400|FG000|Overall Study|Lost to Follow-up|3|||
94447313|NCT03859427|323423401|FG001|Overall Study|Lost to Follow-up|2|||
94447314|NCT03859427|323423400|FG000|Overall Study|Death|22|||
94447315|NCT03859427|323423401|FG001|Overall Study|Death|25|||
94447316|NCT01052480|323423402|FG000|Overall Study|Lost to Follow-up|3|||
94447317|NCT01052480|323423403|FG001|Overall Study|Lost to Follow-up|3|||
94555187|NCT00095173|323828523|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
94555188|NCT00095173|323828524|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
94555189|NCT00095173|323828519|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
94555190|NCT00095173|323828520|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
94555191|NCT00095173|323828521|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
94555192|NCT00095173|323828522|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
94230472|NCT00661713|322637510|FG002|Overall Study|Withdrawal by Subject|12|||
94230473|NCT00661713|322637511|FG003|Overall Study|Withdrawal by Subject|21|||
94555193|NCT00095173|323828523|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
94555194|NCT00095173|323828524|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
94555195|NCT00095173|323828519|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
94555196|NCT00095173|323828520|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
94555197|NCT00095173|323828521|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
94555198|NCT00095173|323828522|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
94555199|NCT00095173|323828523|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
94555200|NCT00095173|323828524|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
94230474|NCT00661713|322637512|FG004|Overall Study|Withdrawal by Subject|12|||
94230475|NCT00661713|322637513|FG005|Overall Study|Withdrawal by Subject|26|||
94230476|NCT00661713|322637514|FG006|Overall Study|Withdrawal by Subject|45|||
94230477|NCT00661713|322637515|FG007|Overall Study|Withdrawal by Subject|9|||
94230478|NCT00661713|322637508|FG000|Overall Study|Lost to Follow-up|2|||
94230479|NCT00661713|322637509|FG001|Overall Study|Lost to Follow-up|7|||
94230480|NCT00661713|322637510|FG002|Overall Study|Lost to Follow-up|2|||
94555201|NCT00095173|323828519|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
94555202|NCT00095173|323828520|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
94555203|NCT00095173|323828521|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
94555204|NCT00095173|323828522|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
94230481|NCT00661713|322637511|FG003|Overall Study|Lost to Follow-up|2|||
94230482|NCT00661713|322637512|FG004|Overall Study|Lost to Follow-up|5|||
94230483|NCT00661713|322637513|FG005|Overall Study|Lost to Follow-up|7|||
94230484|NCT00661713|322637514|FG006|Overall Study|Lost to Follow-up|14|||
94230485|NCT00661713|322637515|FG007|Overall Study|Lost to Follow-up|1|||
94230486|NCT00661713|322637508|FG000|Overall Study|Administrative Reason|0|||
94230487|NCT00661713|322637509|FG001|Overall Study|Administrative Reason|1|||
94230488|NCT00661713|322637510|FG002|Overall Study|Administrative Reason|0|||
94230489|NCT00661713|322637511|FG003|Overall Study|Administrative Reason|2|||
94230490|NCT00661713|322637512|FG004|Overall Study|Administrative Reason|2|||
94230491|NCT00661713|322637513|FG005|Overall Study|Administrative Reason|2|||
94230492|NCT00661713|322637514|FG006|Overall Study|Administrative Reason|1|||
94230493|NCT00661713|322637515|FG007|Overall Study|Administrative Reason|0|||
94230494|NCT00661713|322637508|FG000|Overall Study|Adverse Event|0|||
94230495|NCT00661713|322637509|FG001|Overall Study|Adverse Event|0|||
94230496|NCT00661713|322637510|FG002|Overall Study|Adverse Event|0|||
94230497|NCT00661713|322637511|FG003|Overall Study|Adverse Event|0|||
94230498|NCT00661713|322637512|FG004|Overall Study|Adverse Event|0|||
94230499|NCT00661713|322637513|FG005|Overall Study|Adverse Event|0|||
94230500|NCT00661713|322637514|FG006|Overall Study|Adverse Event|1|||
94230501|NCT00661713|322637515|FG007|Overall Study|Adverse Event|0|||
94230502|NCT00661713|322637508|FG000|Overall Study|Inappropriate Enrollment|0|||
94230503|NCT00661713|322637509|FG001|Overall Study|Inappropriate Enrollment|0|||
94230504|NCT00661713|322637510|FG002|Overall Study|Inappropriate Enrollment|0|||
94230505|NCT00661713|322637511|FG003|Overall Study|Inappropriate Enrollment|0|||
94230506|NCT00661713|322637512|FG004|Overall Study|Inappropriate Enrollment|0|||
94230507|NCT00661713|322637513|FG005|Overall Study|Inappropriate Enrollment|0|||
94230508|NCT00661713|322637514|FG006|Overall Study|Inappropriate Enrollment|1|||
94230509|NCT00661713|322637515|FG007|Overall Study|Inappropriate Enrollment|0|||
94230510|NCT02353871|322637516|FG000|Overall Study|Protocol deviation|0|||
94230511|NCT02353871|322637517|FG001|Overall Study|Protocol deviation|1|||
94230512|NCT02353871|322637516|FG000|Overall Study|Consent withdrawn|1|||
94555205|NCT00095173|323828523|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
94230513|NCT02353871|322637517|FG001|Overall Study|Consent withdrawn|8|||
94230514|NCT02353871|322637516|FG000|Overall Study|Lost to Follow-up|2|||
94230515|NCT02353871|322637517|FG001|Overall Study|Lost to Follow-up|0|||
94555206|NCT00095173|323828524|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
94230516|NCT00746356|322637518|FG000|Overall Study|Withdrawal by Subject|2|||
94230517|NCT00746356|322637519|FG001|Overall Study|Withdrawal by Subject|3|||
94230518|NCT00746356|322637518|FG000|Overall Study|Death|7|||
94555207|NCT00095173|323828519|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
94230519|NCT00746356|322637519|FG001|Overall Study|Death|3|||
94230520|NCT00746356|322637518|FG000|Overall Study|Lost to Follow-up|1|||
94230521|NCT00746356|322637519|FG001|Overall Study|Lost to Follow-up|0|||
94230522|NCT00746356|322637518|FG000|Overall Study|Removal of Device|0|||
94230523|NCT00746356|322637519|FG001|Overall Study|Removal of Device|1|||
94230524|NCT00746356|322637518|FG000|Overall Study|Patient relocated|1|||
94230525|NCT00746356|322637519|FG001|Overall Study|Patient relocated|0|||
94555208|NCT00095173|323828520|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
94447318|NCT01052480|323423402|FG000|Overall Study|Protocol Violation|1|||
94447319|NCT01052480|323423403|FG001|Overall Study|Protocol Violation|0|||
94447320|NCT01052480|323423402|FG000|Overall Study|Withdrawal by Subject|3|||
94447321|NCT01052480|323423403|FG001|Overall Study|Withdrawal by Subject|7|||
94447322|NCT01052480|323423402|FG000|Overall Study|Physician Decision|0|||
94447323|NCT01052480|323423403|FG001|Overall Study|Physician Decision|2|||
94447324|NCT01052480|323423402|FG000|Overall Study|Death|1|||
94447325|NCT01052480|323423403|FG001|Overall Study|Death|5|||
94447326|NCT00529373|323423404|FG000|Base Study|Adverse Event|525|||
94447327|NCT00529373|323423405|FG001|Base Study|Adverse Event|470|||
94447328|NCT00529373|323423404|FG000|Base Study|Lack of Efficacy|16|||
94447329|NCT00529373|323423405|FG001|Base Study|Lack of Efficacy|75|||
94447330|NCT00529373|323423404|FG000|Base Study|Lost to Follow-up|221|||
94447331|NCT00529373|323423405|FG001|Base Study|Lost to Follow-up|208|||
94447332|NCT00529373|323423404|FG000|Base Study|Other Protocol Specified Criteria|19|||
94447333|NCT00529373|323423405|FG001|Base Study|Other Protocol Specified Criteria|20|||
94447334|NCT00529373|323423404|FG000|Base Study|Physician Decision|60|||
94447335|NCT00529373|323423405|FG001|Base Study|Physician Decision|52|||
94447336|NCT00529373|323423404|FG000|Base Study|Protocol Violation|48|||
94447337|NCT00529373|323423405|FG001|Base Study|Protocol Violation|38|||
94447338|NCT00529373|323423404|FG000|Base Study|Withdrawal by Subject|1062|||
94447339|NCT00529373|323423405|FG001|Base Study|Withdrawal by Subject|967|||
94447340|NCT00529373|323423404|FG000|Base Study|Did not continue into Extension|1795|||
94447341|NCT00529373|323423405|FG001|Base Study|Did not continue into Extension|2238|||
94447342|NCT00529373|323423404|FG000|First Extension Study|Adverse Event|162|||
94447343|NCT00529373|323423405|FG001|First Extension Study|Adverse Event|142|||
94447344|NCT00529373|323423404|FG000|First Extension Study|Lack of Efficacy|65|||
94447345|NCT00529373|323423405|FG001|First Extension Study|Lack of Efficacy|427|||
94447346|NCT00529373|323423404|FG000|First Extension Study|Lost to Follow-up|41|||
94447347|NCT00529373|323423405|FG001|First Extension Study|Lost to Follow-up|37|||
94447348|NCT00529373|323423404|FG000|First Extension Study|Other|27|||
94447349|NCT00529373|323423405|FG001|First Extension Study|Other|47|||
94447350|NCT00529373|323423404|FG000|First Extension Study|Physician Decision|50|||
94447351|NCT00529373|323423405|FG001|First Extension Study|Physician Decision|45|||
94447352|NCT00529373|323423404|FG000|First Extension Study|Protocol Violation|16|||
94555209|NCT00095173|323828521|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
94555210|NCT00095173|323828522|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
94555211|NCT00095173|323828523|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
94555212|NCT00095173|323828524|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
94555213|NCT00095173|323828519|FG000|Open-Label Extension Phase (Period C)|Death|0|||
94555214|NCT00095173|323828520|FG001|Open-Label Extension Phase (Period C)|Death|0|||
94555215|NCT00095173|323828521|FG002|Open-Label Extension Phase (Period C)|Death|0|||
94555216|NCT00095173|323828522|FG003|Open-Label Extension Phase (Period C)|Death|0|||
94555217|NCT00095173|323828523|FG004|Open-Label Extension Phase (Period C)|Death|0|||
94555218|NCT00095173|323828524|FG005|Open-Label Extension Phase (Period C)|Death|1|||
94555219|NCT00095173|323828519|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
94555220|NCT00095173|323828520|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
94555221|NCT00095173|323828521|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
94555222|NCT00095173|323828522|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
94555223|NCT00095173|323828523|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
94555224|NCT00095173|323828524|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
94555225|NCT00095173|323828519|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
94555226|NCT00095173|323828520|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
94555227|NCT00095173|323828521|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
94555228|NCT00095173|323828522|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
94555229|NCT00095173|323828523|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
94555230|NCT00095173|323828524|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
94555231|NCT00095173|323828519|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
94555232|NCT00095173|323828520|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
94555233|NCT00095173|323828521|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
94555234|NCT00095173|323828522|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
94555235|NCT00095173|323828523|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
94555236|NCT00095173|323828524|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
94555237|NCT00095173|323828519|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
94555238|NCT00095173|323828520|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
94555239|NCT00095173|323828521|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
94555240|NCT00095173|323828522|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
94555241|NCT00095173|323828523|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
94555242|NCT00095173|323828524|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
94555243|NCT00095173|323828519|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
94555244|NCT00095173|323828520|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
94555245|NCT00095173|323828521|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
94555246|NCT00095173|323828522|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
94555247|NCT00095173|323828523|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
94555248|NCT00095173|323828524|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
94555249|NCT00095173|323828519|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
94555250|NCT00095173|323828520|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
94555251|NCT00095173|323828521|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
94555252|NCT00095173|323828522|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
94555253|NCT00095173|323828523|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
94555254|NCT00095173|323828524|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
94555255|NCT00095173|323828519|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
94555256|NCT00095173|323828520|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
94555257|NCT00095173|323828521|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
94555258|NCT00095173|323828522|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
94555259|NCT00095173|323828523|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
94555260|NCT00095173|323828524|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
94555261|NCT00095173|323828519|FG000|Open-Label Extension Phase (Period C)|Other|0|||
94555262|NCT00095173|323828520|FG001|Open-Label Extension Phase (Period C)|Other|0|||
94555263|NCT00095173|323828521|FG002|Open-Label Extension Phase (Period C)|Other|0|||
94555264|NCT00095173|323828522|FG003|Open-Label Extension Phase (Period C)|Other|4|||
94555265|NCT00095173|323828523|FG004|Open-Label Extension Phase (Period C)|Other|6|||
94555266|NCT00095173|323828524|FG005|Open-Label Extension Phase (Period C)|Other|8|||
94555267|NCT01620528|323828526|FG000|Treatment Period|Did Not Receive Study Drug|0|||
94555268|NCT01620528|323828527|FG001|Treatment Period|Did Not Receive Study Drug|0|||
94555269|NCT01620528|323828528|FG002|Treatment Period|Did Not Receive Study Drug|1|||
94555270|NCT01620528|323828526|FG000|Treatment Period|Withdrawal by Subject|35|||
94555271|NCT01620528|323828527|FG001|Treatment Period|Withdrawal by Subject|21|||
94555272|NCT01620528|323828528|FG002|Treatment Period|Withdrawal by Subject|16|||
94555273|NCT01620528|323828526|FG000|Treatment Period|Adverse Event|17|||
94555274|NCT01620528|323828527|FG001|Treatment Period|Adverse Event|13|||
94555275|NCT01620528|323828528|FG002|Treatment Period|Adverse Event|21|||
94230526|NCT03029819|322637521|FG000|Overall Study|Lost to Follow-up|3|||
94230527|NCT03029819|322637522|FG001|Overall Study|Lost to Follow-up|5|||
94230528|NCT03029819|322637521|FG000|Overall Study|Removed due to disruptive behavior|0|||
94230529|NCT03029819|322637522|FG001|Overall Study|Removed due to disruptive behavior|1|||
94230530|NCT02918292|322637525|FG000|Study Enrollment Prior to Transplant|Death|1|||
94230531|NCT02918292|322637525|FG000|Study Follow up After Transplant|Death|6|||
94230532|NCT00715117|322637529|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
94230533|NCT00715117|322637530|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
94230534|NCT01482429|322637531|FG000|Care Usual|Protocol Violation|0|||
94230535|NCT01482429|322637532|FG001|Care Usual|Protocol Violation|172|||
94230536|NCT01482429|322637531|FG000|Care Usual|Lost to Follow-up|0|||
94230537|NCT01482429|322637532|FG001|Care Usual|Lost to Follow-up|1|||
94230538|NCT01482429|322637531|FG000|Protocol|Protocol Violation|275|||
94230539|NCT01482429|322637532|FG001|Protocol|Protocol Violation|0|||
94230540|NCT02484547|322637536|FG000|Placebo-Controlled Period|Adverse Event|10|||
94230541|NCT02484547|322637537|FG001|Placebo-Controlled Period|Adverse Event|13|||
94230542|NCT02484547|322637538|FG002|Placebo-Controlled Period|Adverse Event|20|||
94230543|NCT02484547|322637539|FG003|Placebo-Controlled Period|Adverse Event|0|||
94230544|NCT02484547|322637540|FG004|Placebo-Controlled Period|Adverse Event|0|||
94230545|NCT02484547|322637541|FG005|Placebo-Controlled Period|Adverse Event|0|||
94230546|NCT02484547|322637542|FG006|Placebo-Controlled Period|Adverse Event|0|||
94230547|NCT02484547|322637536|FG000|Placebo-Controlled Period|Change of Treatment|0|||
94555276|NCT01620528|323828526|FG000|Treatment Period|Lost to Follow-up|16|||
94555277|NCT01620528|323828527|FG001|Treatment Period|Lost to Follow-up|8|||
94230548|NCT02484547|322637537|FG001|Placebo-Controlled Period|Change of Treatment|0|||
94230549|NCT02484547|322637538|FG002|Placebo-Controlled Period|Change of Treatment|1|||
94555278|NCT01620528|323828528|FG002|Treatment Period|Lost to Follow-up|14|||
94555279|NCT01620528|323828526|FG000|Treatment Period|Other|9|||
94555280|NCT01620528|323828527|FG001|Treatment Period|Other|5|||
94555281|NCT01620528|323828528|FG002|Treatment Period|Other|7|||
94555282|NCT01620528|323828526|FG000|Treatment Period|Subject Noncompliant|11|||
94555283|NCT01620528|323828527|FG001|Treatment Period|Subject Noncompliant|2|||
94555284|NCT01620528|323828528|FG002|Treatment Period|Subject Noncompliant|2|||
94555285|NCT01620528|323828526|FG000|Treatment Period|Pregnancy|7|||
94555286|NCT01620528|323828527|FG001|Treatment Period|Pregnancy|2|||
94555287|NCT01620528|323828528|FG002|Treatment Period|Pregnancy|2|||
94555288|NCT01620528|323828526|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
94555289|NCT01620528|323828527|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
94555290|NCT01620528|323828528|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
94230550|NCT02484547|322637539|FG003|Placebo-Controlled Period|Change of Treatment|0|||
94555291|NCT01620528|323828526|FG000|Treatment Period|Exclusionary Medication Received|0|||
94555292|NCT01620528|323828527|FG001|Treatment Period|Exclusionary Medication Received|1|||
94555293|NCT01620528|323828528|FG002|Treatment Period|Exclusionary Medication Received|0|||
94555294|NCT01620528|323828526|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
94555295|NCT01620528|323828527|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
94555296|NCT01620528|323828528|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
94555297|NCT01620528|323828526|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
94555298|NCT01620528|323828527|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
94555299|NCT01620528|323828528|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
94555300|NCT01620528|323828526|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
94555301|NCT01620528|323828527|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
94555302|NCT01620528|323828528|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
94555303|NCT01620528|323828526|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
94555304|NCT01620528|323828527|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
94555305|NCT01620528|323828528|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
94555306|NCT01620528|323828526|FG000|Post-Treatment Follow-Up Period|Other|6|||
94555307|NCT01620528|323828527|FG001|Post-Treatment Follow-Up Period|Other|4|||
94555308|NCT01620528|323828528|FG002|Post-Treatment Follow-Up Period|Other|2|||
94555309|NCT02891382|323828529|FG000|Overall Study|Lost to Follow-up|3|||
94230551|NCT02484547|322637540|FG004|Placebo-Controlled Period|Change of Treatment|0|||
94230552|NCT02484547|322637541|FG005|Placebo-Controlled Period|Change of Treatment|0|||
94555310|NCT02891382|323828530|FG001|Overall Study|Lost to Follow-up|4|||
94555311|NCT02891382|323828531|FG002|Overall Study|Lost to Follow-up|5|||
94555312|NCT02891382|323828532|FG003|Overall Study|Lost to Follow-up|3|||
94230553|NCT02484547|322637542|FG006|Placebo-Controlled Period|Change of Treatment|0|||
94230554|NCT02484547|322637536|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
94555313|NCT02891382|323828533|FG004|Overall Study|Lost to Follow-up|4|||
94555314|NCT05090852|323828537|FG000|Overall Study|Physician Decision|5|||
94555315|NCT01196416|323828538|FG000|Overall Study|Withdrawal by Subject|2|||
94230555|NCT02484547|322637537|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
94555316|NCT03244826|323828539|FG000|Overall Study|Withdrawal by Subject|2|||
94555317|NCT03244826|323828540|FG001|Overall Study|Withdrawal by Subject|0|||
94555318|NCT03244826|323828539|FG000|Overall Study|Transplant delayed or withdrawn|12|||
94230556|NCT02484547|322637538|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
94230557|NCT02484547|322637539|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
94555319|NCT03244826|323828540|FG001|Overall Study|Transplant delayed or withdrawn|10|||
94555320|NCT04356040|323828541|FG000|Overall Study|Death|2|||
94555321|NCT04356040|323828542|FG001|Overall Study|Death|0|||
94555322|NCT04356040|323828541|FG000|Overall Study|Lost to Follow-up|1|||
94555323|NCT04356040|323828542|FG001|Overall Study|Lost to Follow-up|0|||
94555324|NCT04356040|323828541|FG000|Overall Study|Physician Decision|0|||
94555325|NCT04356040|323828542|FG001|Overall Study|Physician Decision|1|||
94555326|NCT04356040|323828541|FG000|Overall Study|Withdrawal by Subject|13|||
94555327|NCT04356040|323828542|FG001|Overall Study|Withdrawal by Subject|1|||
94555328|NCT04356040|323828541|FG000|Overall Study|Enrollment Pause|10|||
94555329|NCT04356040|323828542|FG001|Overall Study|Enrollment Pause|0|||
94555330|NCT04356040|323828541|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
94555331|NCT04356040|323828542|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
94555332|NCT04356040|323828541|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
94555333|NCT04356040|323828542|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
94555334|NCT04356040|323828541|FG000|Overall Study|PI left institution|3|||
94555335|NCT04356040|323828542|FG001|Overall Study|PI left institution|0|||
94555336|NCT00379912|323828543|FG000|Overall Study|Lack of Efficacy|1|||
94555337|NCT00379912|323828544|FG001|Overall Study|Lack of Efficacy|0|||
94555338|NCT01128946|323828545|FG000|Period I|Protocol Violation|0|||
94555339|NCT01128946|323828546|FG001|Period I|Protocol Violation|1|||
94555340|NCT01128946|323828547|FG002|Period I|Protocol Violation|0|||
94555341|NCT01128946|323828548|FG003|Period I|Protocol Violation|0|||
94555342|NCT01128946|323828545|FG000|Period I|Withdrawal by Subject|0|||
94555343|NCT01128946|323828546|FG001|Period I|Withdrawal by Subject|0|||
94555344|NCT01128946|323828547|FG002|Period I|Withdrawal by Subject|1|||
94555345|NCT01128946|323828548|FG003|Period I|Withdrawal by Subject|1|||
94555346|NCT01128946|323828545|FG000|Period II|Protocol Violation|0|||
94555347|NCT01128946|323828546|FG001|Period II|Protocol Violation|1|||
94555348|NCT01128946|323828547|FG002|Period II|Protocol Violation|0|||
94555349|NCT01128946|323828548|FG003|Period II|Protocol Violation|0|||
94555350|NCT01128946|323828545|FG000|Period II|Withdrawal by Subject|0|||
94555351|NCT01128946|323828546|FG001|Period II|Withdrawal by Subject|0|||
94555352|NCT01128946|323828547|FG002|Period II|Withdrawal by Subject|0|||
94555353|NCT01128946|323828548|FG003|Period II|Withdrawal by Subject|1|||
94555354|NCT01128946|323828545|FG000|Period III|Protocol Violation|1|||
94555355|NCT01128946|323828546|FG001|Period III|Protocol Violation|0|||
94555356|NCT01128946|323828547|FG002|Period III|Protocol Violation|0|||
94555357|NCT01128946|323828548|FG003|Period III|Protocol Violation|0|||
94555358|NCT02578186|323828549|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
94555359|NCT02578186|323828550|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
94555360|NCT02578186|323828549|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
94555361|NCT02578186|323828550|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
94555362|NCT01138501|323828552|FG000|Overall Study|Protocol Violation|2|||
94555363|NCT01138501|323828552|FG000|Overall Study|Withdrawal by Subject|3|||
94555364|NCT02873338|323828553|FG000|Overall Study|Adverse Event|0|||
94555365|NCT02873338|323828554|FG001|Overall Study|Adverse Event|2|||
94555366|NCT02873338|323828555|FG002|Overall Study|Adverse Event|1|||
94555367|NCT02873338|323828553|FG000|Overall Study|Death|2|||
94555368|NCT02873338|323828554|FG001|Overall Study|Death|1|||
94555369|NCT02873338|323828555|FG002|Overall Study|Death|1|||
94555370|NCT02873338|323828553|FG000|Overall Study|Withdrawal by Subject|2|||
94555371|NCT02873338|323828554|FG001|Overall Study|Withdrawal by Subject|1|||
94555372|NCT02873338|323828555|FG002|Overall Study|Withdrawal by Subject|3|||
94555373|NCT02873338|323828553|FG000|Overall Study|Lack of Efficacy|0|||
94555374|NCT02873338|323828554|FG001|Overall Study|Lack of Efficacy|2|||
94555375|NCT02873338|323828555|FG002|Overall Study|Lack of Efficacy|0|||
94555376|NCT02873338|323828553|FG000|Overall Study|Other or Missing|14|||
94555377|NCT02873338|323828554|FG001|Overall Study|Other or Missing|15|||
94555378|NCT02873338|323828555|FG002|Overall Study|Other or Missing|13|||
94555379|NCT03657095|323828556|FG000|Overall Study|Withdrawal by Subject|1|||
94555380|NCT03657095|323828557|FG001|Overall Study|Withdrawal by Subject|1|||
94555381|NCT03657095|323828556|FG000|Overall Study|Adverse Event|0|||
94555382|NCT03657095|323828557|FG001|Overall Study|Adverse Event|3|||
94555383|NCT03657095|323828556|FG000|Overall Study|Study Terminated by Sponsor|58|||
94555384|NCT03657095|323828557|FG001|Overall Study|Study Terminated by Sponsor|49|||
94555385|NCT00847197|323828558|FG000|Overall Study|Adverse Event|21|||
94555386|NCT00847197|323828559|FG001|Overall Study|Adverse Event|3|||
94555387|NCT00847197|323828558|FG000|Overall Study|Protocol Violation|0|||
94555388|NCT00847197|323828559|FG001|Overall Study|Protocol Violation|1|||
94555389|NCT00847197|323828558|FG000|Overall Study|Withdrawal by Subject|3|||
94555390|NCT00847197|323828559|FG001|Overall Study|Withdrawal by Subject|1|||
94555391|NCT02708355|323828560|FG000|Overall Study|Adverse Event|1|||
94555392|NCT02708355|323828561|FG001|Overall Study|Adverse Event|0|||
94555393|NCT02708355|323828562|FG002|Overall Study|Adverse Event|0|||
94555394|NCT04384523|323828563|FG000|Overall Study|Lost to Follow-up|0|||
94555395|NCT04384523|323828564|FG001|Overall Study|Lost to Follow-up|0|||
94555396|NCT04384523|323828565|FG002|Overall Study|Lost to Follow-up|0|||
94555397|NCT04384523|323828566|FG003|Overall Study|Lost to Follow-up|0|||
94555398|NCT04384523|323828567|FG004|Overall Study|Lost to Follow-up|0|||
94555399|NCT04384523|323828568|FG005|Overall Study|Lost to Follow-up|1|||
94555400|NCT04384523|323828563|FG000|Overall Study|Protocol Violation|0|||
94555401|NCT04384523|323828564|FG001|Overall Study|Protocol Violation|1|||
94555402|NCT04384523|323828565|FG002|Overall Study|Protocol Violation|0|||
94555403|NCT04384523|323828566|FG003|Overall Study|Protocol Violation|0|||
94555404|NCT04384523|323828567|FG004|Overall Study|Protocol Violation|0|||
94555405|NCT04384523|323828568|FG005|Overall Study|Protocol Violation|0|||
94555406|NCT04384523|323828563|FG000|Overall Study|Withdrawal by Subject|1|||
94555407|NCT04384523|323828564|FG001|Overall Study|Withdrawal by Subject|0|||
94555408|NCT04384523|323828565|FG002|Overall Study|Withdrawal by Subject|0|||
94555409|NCT04384523|323828566|FG003|Overall Study|Withdrawal by Subject|0|||
94555410|NCT04384523|323828567|FG004|Overall Study|Withdrawal by Subject|0|||
94555411|NCT04384523|323828568|FG005|Overall Study|Withdrawal by Subject|0|||
94555412|NCT02687581|323828569|FG000|Overall Study|Withdrawal by Subject|1|||
94555413|NCT02687581|323828570|FG001|Overall Study|Withdrawal by Subject|0|||
94555414|NCT02687581|323828571|FG002|Overall Study|Withdrawal by Subject|0|||
94555415|NCT02687581|323828572|FG003|Overall Study|Withdrawal by Subject|1|||
94555416|NCT02687581|323828569|FG000|Overall Study|Lost to Follow-up|2|||
94555417|NCT02687581|323828570|FG001|Overall Study|Lost to Follow-up|2|||
94555418|NCT02687581|323828571|FG002|Overall Study|Lost to Follow-up|0|||
94555419|NCT02687581|323828572|FG003|Overall Study|Lost to Follow-up|0|||
94555420|NCT02687581|323828569|FG000|Overall Study|the device is too small for the patient.|1|||
94555421|NCT02687581|323828570|FG001|Overall Study|the device is too small for the patient.|0|||
94555422|NCT02687581|323828571|FG002|Overall Study|the device is too small for the patient.|0|||
94555423|NCT02687581|323828572|FG003|Overall Study|the device is too small for the patient.|0|||
94555424|NCT02305238|323828573|FG000|Overall Study|Death|2|||
94555425|NCT02305238|323828574|FG001|Overall Study|Death|1|||
94555426|NCT02305238|323828575|FG002|Overall Study|Death|0|||
94555427|NCT02305238|323828573|FG000|Overall Study|Progressive disease|4|||
94555428|NCT02305238|323828574|FG001|Overall Study|Progressive disease|4|||
94555429|NCT02305238|323828575|FG002|Overall Study|Progressive disease|0|||
94555430|NCT02305238|323828573|FG000|Overall Study|Logistical difficulties|1|||
94555431|NCT02305238|323828574|FG001|Overall Study|Logistical difficulties|3|||
94555432|NCT02305238|323828575|FG002|Overall Study|Logistical difficulties|0|||
94555433|NCT02305238|323828573|FG000|Overall Study|Protocol Violation|0|||
94555434|NCT02305238|323828574|FG001|Overall Study|Protocol Violation|3|||
94555435|NCT02305238|323828575|FG002|Overall Study|Protocol Violation|0|||
94555436|NCT02305238|323828573|FG000|Overall Study|Physician Decision|2|||
94555437|NCT02305238|323828574|FG001|Overall Study|Physician Decision|1|||
94555438|NCT02305238|323828575|FG002|Overall Study|Physician Decision|0|||
94555439|NCT02305238|323828573|FG000|Overall Study|Adverse Event|4|||
94555440|NCT02305238|323828574|FG001|Overall Study|Adverse Event|2|||
94555441|NCT02305238|323828575|FG002|Overall Study|Adverse Event|0|||
94555442|NCT02305238|323828573|FG000|Overall Study|Withdrawal by Subject|3|||
94555443|NCT02305238|323828574|FG001|Overall Study|Withdrawal by Subject|4|||
94555444|NCT02305238|323828575|FG002|Overall Study|Withdrawal by Subject|0|||
94555445|NCT02305238|323828573|FG000|Overall Study|Randomized failure|0|||
94555446|NCT02305238|323828574|FG001|Overall Study|Randomized failure|0|||
94555447|NCT02305238|323828575|FG002|Overall Study|Randomized failure|8|||
94555448|NCT02305238|323828573|FG000|Overall Study|Required procedure failed|0|||
94555449|NCT02305238|323828574|FG001|Overall Study|Required procedure failed|1|||
94555450|NCT02305238|323828575|FG002|Overall Study|Required procedure failed|0|||
94555451|NCT02292706|323828578|FG000|Overall Study|Lost to Follow-up|20|||
94555452|NCT02292706|323828579|FG001|Overall Study|Lost to Follow-up|44|||
94555453|NCT02292706|323828580|FG002|Overall Study|Lost to Follow-up|24|||
94555454|NCT02292706|323828581|FG003|Overall Study|Lost to Follow-up|61|||
94555455|NCT02292706|323828582|FG004|Overall Study|Lost to Follow-up|21|||
94555456|NCT02292706|323828583|FG005|Overall Study|Lost to Follow-up|52|||
94555457|NCT02292706|323828584|FG006|Overall Study|Lost to Follow-up|25|||
94555458|NCT02292706|323828585|FG007|Overall Study|Lost to Follow-up|0|||
94555459|NCT02292706|323828578|FG000|Overall Study|Withdrew consent|15|||
94555460|NCT02292706|323828579|FG001|Overall Study|Withdrew consent|56|||
94555461|NCT02292706|323828580|FG002|Overall Study|Withdrew consent|43|||
94555462|NCT02292706|323828581|FG003|Overall Study|Withdrew consent|36|||
94555463|NCT02292706|323828582|FG004|Overall Study|Withdrew consent|13|||
94555464|NCT02292706|323828583|FG005|Overall Study|Withdrew consent|51|||
94555465|NCT02292706|323828584|FG006|Overall Study|Withdrew consent|20|||
94555466|NCT02292706|323828585|FG007|Overall Study|Withdrew consent|0|||
94555467|NCT02292706|323828578|FG000|Overall Study|Death|3|||
94555468|NCT02292706|323828579|FG001|Overall Study|Death|11|||
94555469|NCT02292706|323828580|FG002|Overall Study|Death|16|||
94555470|NCT02292706|323828581|FG003|Overall Study|Death|22|||
94555471|NCT02292706|323828582|FG004|Overall Study|Death|8|||
94555472|NCT02292706|323828583|FG005|Overall Study|Death|17|||
94555473|NCT02292706|323828584|FG006|Overall Study|Death|3|||
94555474|NCT02292706|323828585|FG007|Overall Study|Death|0|||
94555475|NCT02292706|323828578|FG000|Overall Study|Study terminated by sponsor|0|||
94555476|NCT02292706|323828579|FG001|Overall Study|Study terminated by sponsor|9|||
94555477|NCT02292706|323828580|FG002|Overall Study|Study terminated by sponsor|4|||
94555478|NCT02292706|323828581|FG003|Overall Study|Study terminated by sponsor|21|||
94555479|NCT02292706|323828582|FG004|Overall Study|Study terminated by sponsor|11|||
94555480|NCT02292706|323828583|FG005|Overall Study|Study terminated by sponsor|13|||
94555481|NCT02292706|323828584|FG006|Overall Study|Study terminated by sponsor|3|||
94555482|NCT02292706|323828585|FG007|Overall Study|Study terminated by sponsor|0|||
94555483|NCT02292706|323828578|FG000|Overall Study|Investigator's discretion|4|||
94555484|NCT02292706|323828579|FG001|Overall Study|Investigator's discretion|9|||
94555485|NCT02292706|323828580|FG002|Overall Study|Investigator's discretion|7|||
94555486|NCT02292706|323828581|FG003|Overall Study|Investigator's discretion|11|||
94555487|NCT02292706|323828582|FG004|Overall Study|Investigator's discretion|4|||
94555488|NCT02292706|323828583|FG005|Overall Study|Investigator's discretion|10|||
94555489|NCT02292706|323828584|FG006|Overall Study|Investigator's discretion|1|||
94555490|NCT02292706|323828585|FG007|Overall Study|Investigator's discretion|0|||
94555491|NCT02292706|323828578|FG000|Overall Study|Liver transplant|1|||
94555492|NCT02292706|323828579|FG001|Overall Study|Liver transplant|1|||
94555493|NCT02292706|323828580|FG002|Overall Study|Liver transplant|11|||
94555494|NCT02292706|323828581|FG003|Overall Study|Liver transplant|16|||
94555495|NCT02292706|323828582|FG004|Overall Study|Liver transplant|5|||
94555496|NCT02292706|323828583|FG005|Overall Study|Liver transplant|6|||
94555497|NCT02292706|323828584|FG006|Overall Study|Liver transplant|5|||
94555498|NCT02292706|323828585|FG007|Overall Study|Liver transplant|0|||
94555499|NCT02292706|323828578|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
94555500|NCT02292706|323828579|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
94555501|NCT02292706|323828580|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
94555502|NCT02292706|323828581|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
94555503|NCT02292706|323828582|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
94555504|NCT02292706|323828583|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
94555505|NCT02292706|323828584|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
94555506|NCT02292706|323828585|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
94555507|NCT02292706|323828578|FG000|Overall Study|Subject terminated by sponsor|1|||
94555508|NCT02292706|323828579|FG001|Overall Study|Subject terminated by sponsor|0|||
94555509|NCT02292706|323828580|FG002|Overall Study|Subject terminated by sponsor|0|||
94555510|NCT02292706|323828581|FG003|Overall Study|Subject terminated by sponsor|2|||
94555511|NCT02292706|323828582|FG004|Overall Study|Subject terminated by sponsor|1|||
94555512|NCT02292706|323828583|FG005|Overall Study|Subject terminated by sponsor|0|||
94555513|NCT02292706|323828584|FG006|Overall Study|Subject terminated by sponsor|0|||
94555514|NCT02292706|323828585|FG007|Overall Study|Subject terminated by sponsor|0|||
94555515|NCT02292706|323828578|FG000|Overall Study|Missing|0|||
94555516|NCT02292706|323828579|FG001|Overall Study|Missing|0|||
94555517|NCT02292706|323828580|FG002|Overall Study|Missing|1|||
94555518|NCT02292706|323828581|FG003|Overall Study|Missing|1|||
94555519|NCT02292706|323828582|FG004|Overall Study|Missing|0|||
94555520|NCT02292706|323828583|FG005|Overall Study|Missing|1|||
94555521|NCT02292706|323828584|FG006|Overall Study|Missing|0|||
94555522|NCT02292706|323828585|FG007|Overall Study|Missing|0|||
94555523|NCT02292706|323828578|FG000|Overall Study|Virologic relapse or reinfection|1|||
94555524|NCT02292706|323828579|FG001|Overall Study|Virologic relapse or reinfection|0|||
94555525|NCT02292706|323828580|FG002|Overall Study|Virologic relapse or reinfection|0|||
94555526|NCT02292706|323828581|FG003|Overall Study|Virologic relapse or reinfection|1|||
94555527|NCT02292706|323828582|FG004|Overall Study|Virologic relapse or reinfection|0|||
94555528|NCT02292706|323828583|FG005|Overall Study|Virologic relapse or reinfection|1|||
94555529|NCT02292706|323828584|FG006|Overall Study|Virologic relapse or reinfection|0|||
94555530|NCT02292706|323828585|FG007|Overall Study|Virologic relapse or reinfection|0|||
94555531|NCT04565951|323828587|FG000|Overall Study|Lost to Follow-up|66|||
94555532|NCT04565951|323828588|FG001|Overall Study|Lost to Follow-up|38|||
94555533|NCT04565951|323828587|FG000|Overall Study|Withdrawal by Subject|14|||
94555534|NCT04565951|323828588|FG001|Overall Study|Withdrawal by Subject|7|||
94555535|NCT04565951|323828587|FG000|Overall Study|Death|0|||
94555536|NCT04565951|323828588|FG001|Overall Study|Death|1|||
94555537|NCT01068158|323828589|FG000|Overall Study|Withdrawal by Subject|1|||
94555538|NCT01068158|323828590|FG001|Overall Study|Withdrawal by Subject|2|||
94555539|NCT01068158|323828589|FG000|Overall Study|Lost to Follow-up|7|||
94555540|NCT01068158|323828590|FG001|Overall Study|Lost to Follow-up|0|||
94555541|NCT01068158|323828589|FG000|Overall Study|Protocol Violation|0|||
94555542|NCT01068158|323828590|FG001|Overall Study|Protocol Violation|2|||
94555543|NCT00422383|323828591|FG000|Overall Study|Adverse Event|5|||
94555544|NCT00422383|323828592|FG001|Overall Study|Adverse Event|3|||
94555545|NCT00422383|323828593|FG002|Overall Study|Adverse Event|1|||
94555546|NCT00422383|323828594|FG003|Overall Study|Adverse Event|1|||
94230558|NCT02484547|322637540|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
94230559|NCT02484547|322637541|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
94230560|NCT02484547|322637542|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
94230561|NCT02484547|322637536|FG000|Placebo-Controlled Period|Death|5|||
94230562|NCT02484547|322637537|FG001|Placebo-Controlled Period|Death|0|||
94230563|NCT02484547|322637538|FG002|Placebo-Controlled Period|Death|6|||
94230564|NCT02484547|322637539|FG003|Placebo-Controlled Period|Death|0|||
94230565|NCT02484547|322637540|FG004|Placebo-Controlled Period|Death|0|||
94230566|NCT02484547|322637541|FG005|Placebo-Controlled Period|Death|0|||
94230567|NCT02484547|322637542|FG006|Placebo-Controlled Period|Death|0|||
94230568|NCT02484547|322637536|FG000|Placebo-Controlled Period|Disease Progression|2|||
94230569|NCT02484547|322637537|FG001|Placebo-Controlled Period|Disease Progression|0|||
94230570|NCT02484547|322637538|FG002|Placebo-Controlled Period|Disease Progression|1|||
94230571|NCT02484547|322637539|FG003|Placebo-Controlled Period|Disease Progression|0|||
94230572|NCT02484547|322637540|FG004|Placebo-Controlled Period|Disease Progression|0|||
94230573|NCT02484547|322637541|FG005|Placebo-Controlled Period|Disease Progression|0|||
94230574|NCT02484547|322637542|FG006|Placebo-Controlled Period|Disease Progression|0|||
94230575|NCT02484547|322637536|FG000|Placebo-Controlled Period|Investigator Decision|2|||
94230576|NCT02484547|322637537|FG001|Placebo-Controlled Period|Investigator Decision|2|||
94230577|NCT02484547|322637538|FG002|Placebo-Controlled Period|Investigator Decision|5|||
94230578|NCT02484547|322637539|FG003|Placebo-Controlled Period|Investigator Decision|0|||
94230579|NCT02484547|322637540|FG004|Placebo-Controlled Period|Investigator Decision|0|||
94230580|NCT02484547|322637541|FG005|Placebo-Controlled Period|Investigator Decision|0|||
94230581|NCT02484547|322637542|FG006|Placebo-Controlled Period|Investigator Decision|0|||
94230582|NCT02484547|322637536|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
94230583|NCT02484547|322637537|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
94230584|NCT02484547|322637538|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
94230585|NCT02484547|322637539|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
94230586|NCT02484547|322637540|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
94230587|NCT02484547|322637541|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
94230588|NCT02484547|322637542|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
94230589|NCT02484547|322637536|FG000|Placebo-Controlled Period|Relocation|1|||
94230590|NCT02484547|322637537|FG001|Placebo-Controlled Period|Relocation|1|||
94230591|NCT02484547|322637538|FG002|Placebo-Controlled Period|Relocation|1|||
94230592|NCT02484547|322637539|FG003|Placebo-Controlled Period|Relocation|0|||
94230593|NCT02484547|322637540|FG004|Placebo-Controlled Period|Relocation|0|||
94230594|NCT02484547|322637541|FG005|Placebo-Controlled Period|Relocation|0|||
94555547|NCT00422383|323828595|FG004|Overall Study|Adverse Event|0|||
94555548|NCT00422383|323828591|FG000|Overall Study|Lack of Efficacy|4|||
94555549|NCT00422383|323828592|FG001|Overall Study|Lack of Efficacy|4|||
94230595|NCT02484547|322637542|FG006|Placebo-Controlled Period|Relocation|0|||
94230596|NCT02484547|322637536|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
94230597|NCT02484547|322637537|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
94230598|NCT02484547|322637538|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
94230599|NCT02484547|322637539|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
94230600|NCT02484547|322637540|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
94230601|NCT02484547|322637541|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
94555550|NCT00422383|323828593|FG002|Overall Study|Lack of Efficacy|2|||
94555551|NCT00422383|323828594|FG003|Overall Study|Lack of Efficacy|1|||
94555552|NCT00422383|323828595|FG004|Overall Study|Lack of Efficacy|1|||
94555553|NCT00422383|323828591|FG000|Overall Study|Lost to Follow-up|0|||
94555554|NCT00422383|323828592|FG001|Overall Study|Lost to Follow-up|1|||
94230602|NCT02484547|322637542|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
94230603|NCT02484547|322637536|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
94230604|NCT02484547|322637537|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
94230605|NCT02484547|322637538|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
94555555|NCT00422383|323828593|FG002|Overall Study|Lost to Follow-up|0|||
94555556|NCT00422383|323828594|FG003|Overall Study|Lost to Follow-up|0|||
94555557|NCT00422383|323828595|FG004|Overall Study|Lost to Follow-up|1|||
94555558|NCT00422383|323828591|FG000|Overall Study|Protocol Violation|1|||
94555559|NCT00422383|323828592|FG001|Overall Study|Protocol Violation|1|||
94555560|NCT00422383|323828593|FG002|Overall Study|Protocol Violation|1|||
94555561|NCT00422383|323828594|FG003|Overall Study|Protocol Violation|0|||
94555562|NCT00422383|323828595|FG004|Overall Study|Protocol Violation|0|||
94555563|NCT00422383|323828591|FG000|Overall Study|Withdrawal by Subject|5|||
94555564|NCT00422383|323828592|FG001|Overall Study|Withdrawal by Subject|5|||
94230606|NCT02484547|322637539|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
94343813|NCT01183104|323039963|FG000|Overall Study|Adverse Event|8|||
94343814|NCT01183104|323039964|FG001|Overall Study|Adverse Event|6|||
94555565|NCT00422383|323828593|FG002|Overall Study|Withdrawal by Subject|0|||
94555566|NCT00422383|323828594|FG003|Overall Study|Withdrawal by Subject|0|||
94555567|NCT00422383|323828595|FG004|Overall Study|Withdrawal by Subject|1|||
94555568|NCT02560012|323828596|FG000|Overall Study|Study Terminated|2|||
94230607|NCT02484547|322637540|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
94447353|NCT00529373|323423405|FG001|First Extension Study|Protocol Violation|13|||
94447354|NCT00529373|323423404|FG000|First Extension Study|Withdrawal by Subject|296|||
94447355|NCT00529373|323423405|FG001|First Extension Study|Withdrawal by Subject|287|||
94447356|NCT00529373|323423404|FG000|First Extension Study|Disposition record non-existing|0|||
94447357|NCT00529373|323423405|FG001|First Extension Study|Disposition record non-existing|1|||
94447358|NCT00529373|323423404|FG000|First Extension Study|Discontinued after 5 years completion|208|||
94447359|NCT00529373|323423405|FG001|First Extension Study|Discontinued after 5 years completion|346|||
94447360|NCT00529373|323423404|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
94447361|NCT00529373|323423405|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
94447362|NCT00529373|323423404|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
94447363|NCT00529373|323423405|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
94447364|NCT00529373|323423404|FG000|Second Extension Study|Adverse Event|101|||
94447365|NCT00529373|323423405|FG001|Second Extension Study|Adverse Event|51|||
94343815|NCT01183104|323039963|FG000|Overall Study|Death|0|||
94343816|NCT01183104|323039964|FG001|Overall Study|Death|1|||
94343817|NCT01183104|323039963|FG000|Overall Study|Lost to Follow-up|14|||
94343818|NCT01183104|323039964|FG001|Overall Study|Lost to Follow-up|7|||
94343819|NCT01183104|323039963|FG000|Overall Study|Physician Decision|5|||
94343820|NCT01183104|323039964|FG001|Overall Study|Physician Decision|8|||
94343821|NCT01183104|323039963|FG000|Overall Study|Withdrawal by Subject|6|||
94343822|NCT01183104|323039964|FG001|Overall Study|Withdrawal by Subject|11|||
94343823|NCT01183104|323039963|FG000|Overall Study|Nonparticipation in Extension Study|39|||
94343824|NCT01183104|323039964|FG001|Overall Study|Nonparticipation in Extension Study|50|||
94343825|NCT01183104|323039963|FG000|Overall Study|Did not receive study drug|5|||
94343826|NCT01183104|323039964|FG001|Overall Study|Did not receive study drug|9|||
94343827|NCT03267511|323039965|FG000|Overall Study|Lost to Follow-up|0|||
94343828|NCT03267511|323039966|FG001|Overall Study|Lost to Follow-up|0|||
94343829|NCT03267511|323039967|FG002|Overall Study|Lost to Follow-up|0|||
94343830|NCT03267511|323039968|FG003|Overall Study|Lost to Follow-up|1|||
94343831|NCT00364351|323039969|FG000|Overall Study|Adverse Event|90|||
94343832|NCT00364351|323039970|FG001|Overall Study|Adverse Event|44|||
94343833|NCT00364351|323039969|FG000|Overall Study|Condition under investigation worsened|469|||
94343834|NCT00364351|323039970|FG001|Overall Study|Condition under investigation worsened|497|||
94343835|NCT00364351|323039969|FG000|Overall Study|Prohibited concomitant medication|0|||
94343836|NCT00364351|323039970|FG001|Overall Study|Prohibited concomitant medication|2|||
94343837|NCT00364351|323039969|FG000|Overall Study|Lost to Follow-up|1|||
94343838|NCT00364351|323039970|FG001|Overall Study|Lost to Follow-up|1|||
94343839|NCT00364351|323039969|FG000|Overall Study|Withdrawal by Subject|30|||
94343840|NCT00364351|323039970|FG001|Overall Study|Withdrawal by Subject|29|||
94343841|NCT00364351|323039969|FG000|Overall Study|Incorrect enrollment|1|||
94343842|NCT00364351|323039970|FG001|Overall Study|Incorrect enrollment|1|||
94343843|NCT00364351|323039969|FG000|Overall Study|Sponsor decision|1|||
94343844|NCT00364351|323039970|FG001|Overall Study|Sponsor decision|0|||
94343845|NCT00364351|323039969|FG000|Overall Study|Poor treatment compliance|0|||
94343846|NCT00364351|323039970|FG001|Overall Study|Poor treatment compliance|3|||
94343847|NCT00364351|323039969|FG000|Overall Study|Investigator error|0|||
94343848|NCT00364351|323039970|FG001|Overall Study|Investigator error|2|||
94343849|NCT00364351|323039969|FG000|Overall Study|Patient could not travel to site|0|||
94343850|NCT00364351|323039970|FG001|Overall Study|Patient could not travel to site|1|||
94343851|NCT00364351|323039969|FG000|Overall Study|Randomised treatment not started|0|||
94343852|NCT00364351|323039970|FG001|Overall Study|Randomised treatment not started|3|||
94343853|NCT03793010|323039975|FG000|Overall Study|Withdrawal by Subject|5|||
94343854|NCT03793010|323039976|FG001|Overall Study|Withdrawal by Subject|7|||
94343855|NCT03793010|323039975|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
94343856|NCT03793010|323039976|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
94343857|NCT03793010|323039975|FG000|Overall Study|Lost to Follow-up|1|||
94343858|NCT03793010|323039976|FG001|Overall Study|Lost to Follow-up|2|||
94343859|NCT03793010|323039975|FG000|Overall Study|Patient couldn't sit still for injection|1|||
94343860|NCT03793010|323039976|FG001|Overall Study|Patient couldn't sit still for injection|0|||
94343861|NCT03793010|323039975|FG000|Overall Study|Withdrew to pursue other treatment|1|||
94343862|NCT03793010|323039976|FG001|Overall Study|Withdrew to pursue other treatment|0|||
94343863|NCT03793010|323039975|FG000|Overall Study|Did not meet eligibility criteria|1|||
94343864|NCT03793010|323039976|FG001|Overall Study|Did not meet eligibility criteria|0|||
94343865|NCT01977040|323039977|FG000|Overall Study|Vasa previa not confirmed|2|||
94343866|NCT01998906|323039978|FG000|Overall Study|Participants ongoing in follow-up|77|||
94343867|NCT01998906|323039979|FG001|Overall Study|Participants ongoing in follow-up|60|||
94343868|NCT01998906|323039980|FG002|Overall Study|Participants ongoing in follow-up|58|||
94343869|NCT01998906|323039978|FG000|Overall Study|Death|21|||
94343870|NCT01998906|323039979|FG001|Overall Study|Death|30|||
94343871|NCT01998906|323039980|FG002|Overall Study|Death|17|||
94343872|NCT01998906|323039978|FG000|Overall Study|Lack of Efficacy|10|||
94230608|NCT02484547|322637541|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
94230609|NCT02484547|322637542|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
94230610|NCT02484547|322637536|FG000|Placebo-Controlled Period|Reason not Specified|216|||
94230611|NCT02484547|322637537|FG001|Placebo-Controlled Period|Reason not Specified|194|||
94230612|NCT02484547|322637538|FG002|Placebo-Controlled Period|Reason not Specified|183|||
94230613|NCT02484547|322637539|FG003|Placebo-Controlled Period|Reason not Specified|0|||
94230614|NCT02484547|322637540|FG004|Placebo-Controlled Period|Reason not Specified|0|||
94230615|NCT02484547|322637541|FG005|Placebo-Controlled Period|Reason not Specified|0|||
94230616|NCT02484547|322637542|FG006|Placebo-Controlled Period|Reason not Specified|0|||
94230617|NCT02484547|322637536|FG000|Long-Term Extension Period|Adverse Event|0|||
94230618|NCT02484547|322637537|FG001|Long-Term Extension Period|Adverse Event|0|||
94230619|NCT02484547|322637538|FG002|Long-Term Extension Period|Adverse Event|0|||
94230620|NCT02484547|322637539|FG003|Long-Term Extension Period|Adverse Event|0|||
94230621|NCT02484547|322637540|FG004|Long-Term Extension Period|Adverse Event|1|||
94230622|NCT02484547|322637541|FG005|Long-Term Extension Period|Adverse Event|3|||
94230623|NCT02484547|322637542|FG006|Long-Term Extension Period|Adverse Event|2|||
94230624|NCT02484547|322637536|FG000|Long-Term Extension Period|Death|0|||
94230625|NCT02484547|322637537|FG001|Long-Term Extension Period|Death|0|||
94230626|NCT02484547|322637538|FG002|Long-Term Extension Period|Death|0|||
94230627|NCT02484547|322637539|FG003|Long-Term Extension Period|Death|0|||
94230628|NCT02484547|322637540|FG004|Long-Term Extension Period|Death|0|||
94230629|NCT02484547|322637541|FG005|Long-Term Extension Period|Death|3|||
94230630|NCT02484547|322637542|FG006|Long-Term Extension Period|Death|0|||
94230631|NCT02484547|322637536|FG000|Long-Term Extension Period|Disease Progression|0|||
94230632|NCT02484547|322637537|FG001|Long-Term Extension Period|Disease Progression|0|||
94230633|NCT02484547|322637538|FG002|Long-Term Extension Period|Disease Progression|0|||
94230634|NCT02484547|322637539|FG003|Long-Term Extension Period|Disease Progression|0|||
94230635|NCT02484547|322637540|FG004|Long-Term Extension Period|Disease Progression|2|||
94230636|NCT02484547|322637541|FG005|Long-Term Extension Period|Disease Progression|4|||
94230637|NCT02484547|322637542|FG006|Long-Term Extension Period|Disease Progression|0|||
94230638|NCT02484547|322637536|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
94230639|NCT02484547|322637537|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
94230640|NCT02484547|322637538|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
94230641|NCT02484547|322637539|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
94230642|NCT02484547|322637540|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
94230643|NCT02484547|322637541|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
94230644|NCT02484547|322637542|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
94447366|NCT00529373|323423404|FG000|Second Extension Study|Lack of Efficacy|7|||
94447367|NCT00529373|323423405|FG001|Second Extension Study|Lack of Efficacy|15|||
94447368|NCT00529373|323423404|FG000|Second Extension Study|Lost to Follow-up|18|||
94447369|NCT00529373|323423405|FG001|Second Extension Study|Lost to Follow-up|12|||
94447370|NCT00529373|323423404|FG000|Second Extension Study|Other|7|||
94447371|NCT00529373|323423405|FG001|Second Extension Study|Other|12|||
94447372|NCT00529373|323423404|FG000|Second Extension Study|Physician Decision|63|||
94447373|NCT00529373|323423405|FG001|Second Extension Study|Physician Decision|26|||
94447374|NCT00529373|323423404|FG000|Second Extension Study|Protocol Violation|2|||
94447375|NCT00529373|323423405|FG001|Second Extension Study|Protocol Violation|1|||
94447376|NCT00529373|323423404|FG000|Second Extension Study|Withdrawal by Subject|97|||
94447377|NCT00529373|323423405|FG001|Second Extension Study|Withdrawal by Subject|75|||
94447378|NCT00529373|323423404|FG000|Second Extension Study|Status Missing|5|||
94447379|NCT00529373|323423405|FG001|Second Extension Study|Status Missing|5|||
94447380|NCT02503540|323423412|FG000|Overall Study|Death|2|||
94447381|NCT02503540|323423412|FG000|Overall Study|Withdrawal by Subject|1|||
94447382|NCT01779440|323423414|FG000|Overall Study|Withdrawal by Subject|3|||
94447383|NCT01779440|323423415|FG001|Overall Study|Withdrawal by Subject|5|||
94447384|NCT01207687|323423416|FG000|Overall Study|Adverse Event|1|||
94447385|NCT01207687|323423416|FG000|Overall Study|Withdrawal by Subject|1|||
94447386|NCT00523848|323423417|FG000|Overall Study|Adverse Event|11|||
94447387|NCT00523848|323423417|FG000|Overall Study|Withdrawal by Subject|2|||
94447388|NCT00523848|323423417|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
94447389|NCT00523848|323423417|FG000|Overall Study|Disease Progression|5|||
94230645|NCT02484547|322637536|FG000|Long-Term Extension Period|Loss of Capacity|0|||
94230646|NCT02484547|322637537|FG001|Long-Term Extension Period|Loss of Capacity|0|||
94230647|NCT02484547|322637538|FG002|Long-Term Extension Period|Loss of Capacity|0|||
94230648|NCT02484547|322637539|FG003|Long-Term Extension Period|Loss of Capacity|0|||
94230649|NCT02484547|322637540|FG004|Long-Term Extension Period|Loss of Capacity|1|||
94230650|NCT02484547|322637541|FG005|Long-Term Extension Period|Loss of Capacity|0|||
94230651|NCT02484547|322637542|FG006|Long-Term Extension Period|Loss of Capacity|0|||
94447390|NCT00523848|323423417|FG000|Overall Study|Other, unspecified|4|||
94447391|NCT01801865|323423418|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
94447392|NCT01801865|323423418|FG000|Overall Study|Physician Decision|7|||
94447393|NCT00985504|323423421|FG000|Acute Treatment Period|Adverse Event|3|||
94447394|NCT00985504|323423422|FG001|Acute Treatment Period|Adverse Event|4|||
94447395|NCT00985504|323423421|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
94230652|NCT02484547|322637536|FG000|Long-Term Extension Period|Change of Treatment|0|||
94230653|NCT02484547|322637537|FG001|Long-Term Extension Period|Change of Treatment|0|||
94230654|NCT02484547|322637538|FG002|Long-Term Extension Period|Change of Treatment|0|||
94230655|NCT02484547|322637539|FG003|Long-Term Extension Period|Change of Treatment|0|||
94230656|NCT02484547|322637540|FG004|Long-Term Extension Period|Change of Treatment|0|||
94230657|NCT02484547|322637541|FG005|Long-Term Extension Period|Change of Treatment|0|||
94230658|NCT02484547|322637542|FG006|Long-Term Extension Period|Change of Treatment|1|||
94230659|NCT02484547|322637536|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
94230660|NCT02484547|322637537|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
94230661|NCT02484547|322637538|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
94230662|NCT02484547|322637539|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
94230663|NCT02484547|322637540|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
94230664|NCT02484547|322637541|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
94230665|NCT02484547|322637542|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
94230666|NCT02484547|322637536|FG000|Long-Term Extension Period|Investigator Decision|0|||
94230667|NCT02484547|322637537|FG001|Long-Term Extension Period|Investigator Decision|0|||
94230668|NCT02484547|322637538|FG002|Long-Term Extension Period|Investigator Decision|0|||
94230669|NCT02484547|322637539|FG003|Long-Term Extension Period|Investigator Decision|2|||
94230670|NCT02484547|322637540|FG004|Long-Term Extension Period|Investigator Decision|1|||
94230671|NCT02484547|322637541|FG005|Long-Term Extension Period|Investigator Decision|0|||
94230672|NCT02484547|322637542|FG006|Long-Term Extension Period|Investigator Decision|1|||
94230673|NCT02484547|322637536|FG000|Long-Term Extension Period|Relocation|0|||
94230674|NCT02484547|322637537|FG001|Long-Term Extension Period|Relocation|0|||
94230675|NCT02484547|322637538|FG002|Long-Term Extension Period|Relocation|0|||
94230676|NCT02484547|322637539|FG003|Long-Term Extension Period|Relocation|1|||
94230677|NCT02484547|322637540|FG004|Long-Term Extension Period|Relocation|1|||
94230678|NCT02484547|322637541|FG005|Long-Term Extension Period|Relocation|0|||
94230679|NCT02484547|322637542|FG006|Long-Term Extension Period|Relocation|0|||
94230680|NCT02484547|322637536|FG000|Long-Term Extension Period|Study Visit Burden|0|||
94230681|NCT02484547|322637537|FG001|Long-Term Extension Period|Study Visit Burden|0|||
94230682|NCT02484547|322637538|FG002|Long-Term Extension Period|Study Visit Burden|0|||
94230683|NCT02484547|322637539|FG003|Long-Term Extension Period|Study Visit Burden|2|||
94230684|NCT02484547|322637540|FG004|Long-Term Extension Period|Study Visit Burden|0|||
94230685|NCT02484547|322637541|FG005|Long-Term Extension Period|Study Visit Burden|0|||
94230686|NCT02484547|322637542|FG006|Long-Term Extension Period|Study Visit Burden|3|||
94230687|NCT02484547|322637536|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
94230688|NCT02484547|322637537|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
94230689|NCT02484547|322637538|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
94230690|NCT02484547|322637539|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
94447396|NCT00985504|323423422|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
94230691|NCT02484547|322637540|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
94230692|NCT02484547|322637541|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
94230693|NCT02484547|322637542|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
94230694|NCT02484547|322637536|FG000|Long-Term Extension Period|Reason not Specified|0|||
94230695|NCT02484547|322637537|FG001|Long-Term Extension Period|Reason not Specified|0|||
94230696|NCT02484547|322637538|FG002|Long-Term Extension Period|Reason not Specified|0|||
94230697|NCT02484547|322637539|FG003|Long-Term Extension Period|Reason not Specified|119|||
94230698|NCT02484547|322637540|FG004|Long-Term Extension Period|Reason not Specified|117|||
94230699|NCT02484547|322637541|FG005|Long-Term Extension Period|Reason not Specified|223|||
94230700|NCT02484547|322637542|FG006|Long-Term Extension Period|Reason not Specified|231|||
94230701|NCT04680637|322637547|FG000|Overall Study|Lost to Follow-up|0|||
94230702|NCT04680637|322637548|FG001|Overall Study|Lost to Follow-up|1|||
94230703|NCT04680637|322637549|FG002|Overall Study|Lost to Follow-up|0|||
94230704|NCT04680637|322637550|FG003|Overall Study|Lost to Follow-up|1|||
94230705|NCT04680637|322637547|FG000|Overall Study|Death|1|||
94230706|NCT04680637|322637548|FG001|Overall Study|Death|0|||
94230707|NCT04680637|322637549|FG002|Overall Study|Death|0|||
94230708|NCT04680637|322637550|FG003|Overall Study|Death|0|||
94230709|NCT04680637|322637547|FG000|Overall Study|Withdrawal by Subject|7|||
94230710|NCT04680637|322637548|FG001|Overall Study|Withdrawal by Subject|10|||
94230711|NCT04680637|322637549|FG002|Overall Study|Withdrawal by Subject|17|||
94230712|NCT04680637|322637550|FG003|Overall Study|Withdrawal by Subject|15|||
94230713|NCT04680637|322637547|FG000|Overall Study|Decision by Sponsor|21|||
94230714|NCT04680637|322637548|FG001|Overall Study|Decision by Sponsor|15|||
94230715|NCT04680637|322637549|FG002|Overall Study|Decision by Sponsor|7|||
94230716|NCT04680637|322637550|FG003|Overall Study|Decision by Sponsor|32|||
94230717|NCT01503164|322637551|FG000|Overall Study|Withdrawal by Subject|2|||
94230718|NCT01503164|322637552|FG001|Overall Study|Withdrawal by Subject|1|||
94230719|NCT02647645|322637553|FG000|Overall Study|Lost to Follow-up|2|||
94230720|NCT02647645|322637554|FG001|Overall Study|Lost to Follow-up|1|||
94230721|NCT00356759|322637555|FG000|Overall Study|Death|5|||
94230722|NCT00356759|322637556|FG001|Overall Study|Death|2|||
94230723|NCT00356759|322637555|FG000|Overall Study|Withdrawal by Subject|2|||
94230724|NCT00356759|322637556|FG001|Overall Study|Withdrawal by Subject|2|||
94230725|NCT00356759|322637555|FG000|Overall Study|Adverse Event|1|||
94230726|NCT00356759|322637556|FG001|Overall Study|Adverse Event|3|||
94230727|NCT00356759|322637555|FG000|Overall Study|Lost to Follow-up|1|||
94230728|NCT00356759|322637556|FG001|Overall Study|Lost to Follow-up|1|||
94230729|NCT00356759|322637555|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
94230730|NCT00356759|322637556|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
94230731|NCT01251887|322637558|FG000|Overall Study|Scheduling conflict|1|||
94230732|NCT01251887|322637559|FG001|Overall Study|Scheduling conflict|2|||
94230733|NCT01251887|322637560|FG002|Overall Study|Scheduling conflict|2|||
94230734|NCT01251887|322637558|FG000|Overall Study|Physician Decision|0|||
94230735|NCT01251887|322637559|FG001|Overall Study|Physician Decision|1|||
94230736|NCT01251887|322637560|FG002|Overall Study|Physician Decision|0|||
94230737|NCT04811339|322637561|FG000|Overall Study|lack of transportation not wanting to return|4|||
94230738|NCT04811339|322637562|FG001|Overall Study|lack of transportation not wanting to return|8|||
94230739|NCT04811339|322637563|FG002|Overall Study|lack of transportation not wanting to return|0|||
94230740|NCT04811339|322637561|FG000|Overall Study|Adverse Event|3|||
94230741|NCT04811339|322637562|FG001|Overall Study|Adverse Event|0|||
94230742|NCT04811339|322637563|FG002|Overall Study|Adverse Event|0|||
94230743|NCT04811339|322637561|FG000|Overall Study|Lost to Follow-up|1|||
94230744|NCT04811339|322637562|FG001|Overall Study|Lost to Follow-up|0|||
94230745|NCT04811339|322637563|FG002|Overall Study|Lost to Follow-up|0|||
94230746|NCT04811339|322637561|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
94230747|NCT04811339|322637562|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
94230748|NCT04811339|322637563|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
94447397|NCT00985504|323423421|FG000|Acute Treatment Period|Protocol Violation|2|||
94230749|NCT04811339|322637561|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
94230750|NCT04811339|322637562|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
94230751|NCT04811339|322637563|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
94230752|NCT04811339|322637561|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
94343873|NCT01998906|323039979|FG001|Overall Study|Lack of Efficacy|9|||
94343874|NCT01998906|323039980|FG002|Overall Study|Lack of Efficacy|8|||
94343875|NCT01998906|323039978|FG000|Overall Study|Failure to return|0|||
94343876|NCT01998906|323039979|FG001|Overall Study|Failure to return|2|||
94343877|NCT01998906|323039980|FG002|Overall Study|Failure to return|4|||
94343878|NCT01998906|323039978|FG000|Overall Study|Violation of Selection Criteria|0|||
94343879|NCT01998906|323039979|FG001|Overall Study|Violation of Selection Criteria|0|||
94343880|NCT01998906|323039980|FG002|Overall Study|Violation of Selection Criteria|1|||
94343881|NCT01998906|323039978|FG000|Overall Study|Withdrawal by Subject|1|||
94343882|NCT01998906|323039979|FG001|Overall Study|Withdrawal by Subject|4|||
94343883|NCT01998906|323039980|FG002|Overall Study|Withdrawal by Subject|3|||
94343884|NCT01998906|323039978|FG000|Overall Study|Administrative/Other|2|||
94343885|NCT01998906|323039979|FG001|Overall Study|Administrative/Other|1|||
94343886|NCT01998906|323039980|FG002|Overall Study|Administrative/Other|3|||
94343887|NCT01998906|323039978|FG000|Overall Study|Other|3|||
94343888|NCT01998906|323039979|FG001|Overall Study|Other|8|||
94343889|NCT01998906|323039980|FG002|Overall Study|Other|4|||
94343890|NCT01693562|323039981|FG000|Escalation Phase|Withdrawal by Subject|0|||
94343891|NCT01693562|323039982|FG001|Escalation Phase|Withdrawal by Subject|1|||
94343892|NCT01693562|323039983|FG002|Escalation Phase|Withdrawal by Subject|0|||
94343893|NCT01693562|323039984|FG003|Escalation Phase|Withdrawal by Subject|0|||
94343894|NCT01693562|323039985|FG004|Escalation Phase|Withdrawal by Subject|0|||
94343895|NCT01693562|323039986|FG005|Escalation Phase|Withdrawal by Subject|2|||
94343896|NCT01693562|323039987|FG006|Escalation Phase|Withdrawal by Subject|0|||
94343897|NCT01693562|323039988|FG007|Escalation Phase|Withdrawal by Subject|0|||
94343898|NCT01693562|323039989|FG008|Escalation Phase|Withdrawal by Subject|0|||
94343899|NCT01693562|323039990|FG009|Escalation Phase|Withdrawal by Subject|0|||
94343900|NCT01693562|323039991|FG010|Escalation Phase|Withdrawal by Subject|0|||
94343901|NCT01693562|323039992|FG011|Escalation Phase|Withdrawal by Subject|0|||
94343902|NCT01693562|323039993|FG012|Escalation Phase|Withdrawal by Subject|0|||
94343903|NCT01693562|323039994|FG013|Escalation Phase|Withdrawal by Subject|0|||
94343904|NCT01693562|323039995|FG014|Escalation Phase|Withdrawal by Subject|0|||
94343905|NCT01693562|323039996|FG015|Escalation Phase|Withdrawal by Subject|0|||
94343906|NCT01693562|323039997|FG016|Escalation Phase|Withdrawal by Subject|0|||
94343907|NCT01693562|323039998|FG017|Escalation Phase|Withdrawal by Subject|0|||
94343908|NCT01693562|323039999|FG018|Escalation Phase|Withdrawal by Subject|0|||
94343909|NCT01693562|323040000|FG019|Escalation Phase|Withdrawal by Subject|0|||
94343910|NCT01693562|323040001|FG020|Escalation Phase|Withdrawal by Subject|0|||
94343911|NCT01693562|323040002|FG021|Escalation Phase|Withdrawal by Subject|0|||
94343912|NCT01693562|323040003|FG022|Escalation Phase|Withdrawal by Subject|0|||
94343913|NCT01693562|323039981|FG000|Escalation Phase|Death|4|||
94343914|NCT01693562|323039982|FG001|Escalation Phase|Death|2|||
94343915|NCT01693562|323039983|FG002|Escalation Phase|Death|0|||
94230753|NCT04811339|322637562|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
94230754|NCT04811339|322637563|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
94230755|NCT04811339|322637561|FG000|Overall Study|Withdrawal by Subject|0|||
94230756|NCT04811339|322637562|FG001|Overall Study|Withdrawal by Subject|3|||
94230757|NCT04811339|322637563|FG002|Overall Study|Withdrawal by Subject|0|||
94230758|NCT04811339|322637561|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
94230759|NCT04811339|322637562|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
94230760|NCT04811339|322637563|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
94230761|NCT04811339|322637561|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
94230762|NCT04811339|322637562|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
94230763|NCT04811339|322637563|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
94230764|NCT02600897|322637564|FG000|Overall Study|Death|1|||
94230765|NCT02600897|322637565|FG001|Overall Study|Death|2|||
94230766|NCT02600897|322637566|FG002|Overall Study|Death|1|||
94230767|NCT02600897|322637567|FG003|Overall Study|Death|2|||
94230768|NCT02600897|322637568|FG004|Overall Study|Death|3|||
94230769|NCT02600897|322637569|FG005|Overall Study|Death|2|||
94230770|NCT02600897|322637570|FG006|Overall Study|Death|10|||
94555569|NCT00455143|323828599|FG000|Overall Study|Physician Decision|1|||
94555570|NCT00455143|323828599|FG000|Overall Study|Withdrawal by Subject|1|||
94555571|NCT00455143|323828599|FG000|Overall Study|Staff was not avail to follow patient|2|||
94555572|NCT00455143|323828599|FG000|Overall Study|No longer met Inclusion Criteria|1|||
94555573|NCT00455143|323828599|FG000|Overall Study|Surgical time, staff not available|1|||
94555574|NCT03052816|323828602|FG000|Overall Study|Withdrawal by Subject|1|||
94555575|NCT03052816|323828603|FG001|Overall Study|Withdrawal by Subject|0|||
94230771|NCT02600897|322637571|FG007|Overall Study|Death|7|||
94343916|NCT01693562|323039984|FG003|Escalation Phase|Death|3|||
94343917|NCT01693562|323039985|FG004|Escalation Phase|Death|6|||
94343918|NCT01693562|323039986|FG005|Escalation Phase|Death|4|||
94343919|NCT01693562|323039987|FG006|Escalation Phase|Death|0|||
94343920|NCT01693562|323039988|FG007|Escalation Phase|Death|0|||
94343921|NCT01693562|323039989|FG008|Escalation Phase|Death|0|||
94343922|NCT01693562|323039990|FG009|Escalation Phase|Death|0|||
94343923|NCT01693562|323039991|FG010|Escalation Phase|Death|0|||
94343924|NCT01693562|323039992|FG011|Escalation Phase|Death|0|||
94343925|NCT01693562|323039993|FG012|Escalation Phase|Death|0|||
94343926|NCT01693562|323039994|FG013|Escalation Phase|Death|0|||
94343927|NCT01693562|323039995|FG014|Escalation Phase|Death|0|||
94343928|NCT01693562|323039996|FG015|Escalation Phase|Death|0|||
94343929|NCT01693562|323039997|FG016|Escalation Phase|Death|0|||
94343930|NCT01693562|323039998|FG017|Escalation Phase|Death|0|||
94343931|NCT01693562|323039999|FG018|Escalation Phase|Death|0|||
94343932|NCT01693562|323040000|FG019|Escalation Phase|Death|0|||
94343933|NCT01693562|323040001|FG020|Escalation Phase|Death|0|||
94343934|NCT01693562|323040002|FG021|Escalation Phase|Death|0|||
94343935|NCT01693562|323040003|FG022|Escalation Phase|Death|0|||
94343936|NCT01693562|323039981|FG000|Escalation Phase|Lost to Follow-up|0|||
94343937|NCT01693562|323039982|FG001|Escalation Phase|Lost to Follow-up|1|||
94343938|NCT01693562|323039983|FG002|Escalation Phase|Lost to Follow-up|1|||
94343939|NCT01693562|323039984|FG003|Escalation Phase|Lost to Follow-up|0|||
94343940|NCT01693562|323039985|FG004|Escalation Phase|Lost to Follow-up|0|||
94343941|NCT01693562|323039986|FG005|Escalation Phase|Lost to Follow-up|0|||
94343942|NCT01693562|323039987|FG006|Escalation Phase|Lost to Follow-up|0|||
94343943|NCT01693562|323039988|FG007|Escalation Phase|Lost to Follow-up|0|||
94343944|NCT01693562|323039989|FG008|Escalation Phase|Lost to Follow-up|0|||
94343945|NCT01693562|323039990|FG009|Escalation Phase|Lost to Follow-up|0|||
94343946|NCT01693562|323039991|FG010|Escalation Phase|Lost to Follow-up|0|||
94343947|NCT01693562|323039992|FG011|Escalation Phase|Lost to Follow-up|0|||
94343948|NCT01693562|323039993|FG012|Escalation Phase|Lost to Follow-up|0|||
94343949|NCT01693562|323039994|FG013|Escalation Phase|Lost to Follow-up|0|||
94343950|NCT01693562|323039995|FG014|Escalation Phase|Lost to Follow-up|0|||
94343951|NCT01693562|323039996|FG015|Escalation Phase|Lost to Follow-up|0|||
94343952|NCT01693562|323039997|FG016|Escalation Phase|Lost to Follow-up|0|||
94343953|NCT01693562|323039998|FG017|Escalation Phase|Lost to Follow-up|0|||
94343954|NCT01693562|323039999|FG018|Escalation Phase|Lost to Follow-up|0|||
94343955|NCT01693562|323040000|FG019|Escalation Phase|Lost to Follow-up|0|||
94343956|NCT01693562|323040001|FG020|Escalation Phase|Lost to Follow-up|0|||
94343957|NCT01693562|323040002|FG021|Escalation Phase|Lost to Follow-up|0|||
94343958|NCT01693562|323040003|FG022|Escalation Phase|Lost to Follow-up|0|||
94343959|NCT01693562|323039981|FG000|Escalation Phase|Other|0|||
94343960|NCT01693562|323039982|FG001|Escalation Phase|Other|0|||
94343961|NCT01693562|323039983|FG002|Escalation Phase|Other|2|||
94230772|NCT02600897|322637572|FG008|Overall Study|Death|20|||
94230773|NCT02600897|322637564|FG000|Overall Study|Lost to Follow-up|1|||
94343962|NCT01693562|323039984|FG003|Escalation Phase|Other|0|||
94343963|NCT01693562|323039985|FG004|Escalation Phase|Other|0|||
94343964|NCT01693562|323039986|FG005|Escalation Phase|Other|1|||
94343965|NCT01693562|323039987|FG006|Escalation Phase|Other|0|||
94447398|NCT00985504|323423422|FG001|Acute Treatment Period|Protocol Violation|0|||
94447399|NCT00985504|323423421|FG000|Acute Treatment Period|Sponsor Decision|0|||
94447400|NCT00985504|323423422|FG001|Acute Treatment Period|Sponsor Decision|1|||
94447401|NCT00985504|323423421|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
94447402|NCT00985504|323423422|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
94447403|NCT00985504|323423421|FG000|Optimization Period|Adverse Event|7|||
94447404|NCT00985504|323423422|FG001|Optimization Period|Adverse Event|9|||
94447405|NCT00985504|323423421|FG000|Optimization Period|Death|0|||
94447406|NCT00985504|323423422|FG001|Optimization Period|Death|1|||
94447407|NCT00985504|323423421|FG000|Optimization Period|Lack of Efficacy|5|||
94447408|NCT00985504|323423422|FG001|Optimization Period|Lack of Efficacy|3|||
94447409|NCT00985504|323423421|FG000|Optimization Period|Lost to Follow-up|0|||
94447410|NCT00985504|323423422|FG001|Optimization Period|Lost to Follow-up|1|||
94447411|NCT00985504|323423421|FG000|Optimization Period|Physician Decision|1|||
94447412|NCT00985504|323423422|FG001|Optimization Period|Physician Decision|0|||
94447413|NCT00985504|323423421|FG000|Optimization Period|Protocol Violation|3|||
94447414|NCT00985504|323423422|FG001|Optimization Period|Protocol Violation|1|||
94447415|NCT00985504|323423421|FG000|Optimization Period|Withdrawal by Subject|10|||
94447416|NCT00985504|323423422|FG001|Optimization Period|Withdrawal by Subject|8|||
94447417|NCT04577404|323423423|FG000|Overall Study|Adverse Event|31|||
94447418|NCT04577404|323423423|FG000|Overall Study|Death|1|||
94447419|NCT04577404|323423423|FG000|Overall Study|Lack of Efficacy|3|||
94447420|NCT04577404|323423423|FG000|Overall Study|Physician Decision|7|||
94447421|NCT04577404|323423423|FG000|Overall Study|Withdrawal by Subject|21|||
94447422|NCT04577404|323423423|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
94447423|NCT04075825|323425977|FG000|Overall Study|Withdrawal by Subject|6|||
94447424|NCT04075825|323425978|FG001|Overall Study|Withdrawal by Subject|8|||
94447425|NCT04075825|323425977|FG000|Overall Study|Physician Decision|3|||
94447426|NCT04075825|323425978|FG001|Overall Study|Physician Decision|1|||
94447427|NCT04075825|323425977|FG000|Overall Study|Lost to Follow-up|5|||
94447428|NCT04075825|323425978|FG001|Overall Study|Lost to Follow-up|1|||
94447429|NCT04075825|323425977|FG000|Overall Study|Participation in New Clinical Trial|1|||
94447430|NCT04075825|323425978|FG001|Overall Study|Participation in New Clinical Trial|1|||
94447431|NCT04075825|323425977|FG000|Overall Study|Reason Not Specified|2|||
94447432|NCT04075825|323425978|FG001|Overall Study|Reason Not Specified|2|||
94447433|NCT04021914|323425979|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
94447434|NCT00955409|323425983|FG000|Overall Study|Lack of Efficacy|1|||
94447435|NCT00955409|323425984|FG001|Overall Study|Lack of Efficacy|0|||
94447436|NCT00955409|323425985|FG002|Overall Study|Lack of Efficacy|0|||
94447437|NCT00955409|323425986|FG003|Overall Study|Lack of Efficacy|0|||
94447438|NCT00955409|323425987|FG004|Overall Study|Lack of Efficacy|0|||
94447439|NCT00955409|323425988|FG005|Overall Study|Lack of Efficacy|0|||
94447440|NCT00955409|323425989|FG006|Overall Study|Lack of Efficacy|0|||
94447441|NCT00955409|323425990|FG007|Overall Study|Lack of Efficacy|0|||
94447442|NCT00955409|323425991|FG008|Overall Study|Lack of Efficacy|0|||
94447443|NCT00955409|323425992|FG009|Overall Study|Lack of Efficacy|0|||
94447444|NCT00955409|323425983|FG000|Overall Study|Withdrawal by Subject|1|||
94447445|NCT00955409|323425984|FG001|Overall Study|Withdrawal by Subject|0|||
94447446|NCT00955409|323425985|FG002|Overall Study|Withdrawal by Subject|5|||
94447447|NCT00955409|323425986|FG003|Overall Study|Withdrawal by Subject|2|||
94447448|NCT00955409|323425987|FG004|Overall Study|Withdrawal by Subject|0|||
94447449|NCT00955409|323425988|FG005|Overall Study|Withdrawal by Subject|0|||
94447450|NCT00955409|323425989|FG006|Overall Study|Withdrawal by Subject|2|||
94447451|NCT00955409|323425990|FG007|Overall Study|Withdrawal by Subject|0|||
94447452|NCT00955409|323425991|FG008|Overall Study|Withdrawal by Subject|1|||
94447453|NCT00955409|323425992|FG009|Overall Study|Withdrawal by Subject|0|||
94447454|NCT00955409|323425983|FG000|Overall Study|Caregiver Request|2|||
94447455|NCT00955409|323425984|FG001|Overall Study|Caregiver Request|0|||
94447456|NCT00955409|323425985|FG002|Overall Study|Caregiver Request|6|||
94447457|NCT00955409|323425986|FG003|Overall Study|Caregiver Request|5|||
94447458|NCT00955409|323425987|FG004|Overall Study|Caregiver Request|0|||
94447459|NCT00955409|323425988|FG005|Overall Study|Caregiver Request|2|||
94447460|NCT00955409|323425989|FG006|Overall Study|Caregiver Request|3|||
94447461|NCT00955409|323425990|FG007|Overall Study|Caregiver Request|1|||
94447462|NCT00955409|323425991|FG008|Overall Study|Caregiver Request|3|||
94447463|NCT00955409|323425992|FG009|Overall Study|Caregiver Request|0|||
94447464|NCT00955409|323425983|FG000|Overall Study|Investigator Request|0|||
94447465|NCT00955409|323425984|FG001|Overall Study|Investigator Request|0|||
94447466|NCT00955409|323425985|FG002|Overall Study|Investigator Request|1|||
94447467|NCT00955409|323425986|FG003|Overall Study|Investigator Request|0|||
94447468|NCT00955409|323425987|FG004|Overall Study|Investigator Request|0|||
94447469|NCT00955409|323425988|FG005|Overall Study|Investigator Request|0|||
94447470|NCT00955409|323425989|FG006|Overall Study|Investigator Request|0|||
94447471|NCT00955409|323425990|FG007|Overall Study|Investigator Request|0|||
94447472|NCT00955409|323425991|FG008|Overall Study|Investigator Request|0|||
94447473|NCT00955409|323425992|FG009|Overall Study|Investigator Request|0|||
94447474|NCT00955409|323425983|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
94447475|NCT00955409|323425984|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
94447476|NCT00955409|323425985|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
94447477|NCT00955409|323425986|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
94447478|NCT00955409|323425987|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
94447479|NCT00955409|323425988|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
94447480|NCT00955409|323425989|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
94447481|NCT00955409|323425990|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
94447482|NCT00955409|323425991|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
94447483|NCT00955409|323425992|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
94447484|NCT00955409|323425983|FG000|Overall Study|Lost to Follow-up|0|||
94447485|NCT00955409|323425984|FG001|Overall Study|Lost to Follow-up|0|||
94447486|NCT00955409|323425985|FG002|Overall Study|Lost to Follow-up|1|||
94447487|NCT00955409|323425986|FG003|Overall Study|Lost to Follow-up|0|||
94447488|NCT00955409|323425987|FG004|Overall Study|Lost to Follow-up|0|||
94447489|NCT00955409|323425988|FG005|Overall Study|Lost to Follow-up|0|||
94447490|NCT00955409|323425989|FG006|Overall Study|Lost to Follow-up|1|||
94447491|NCT00955409|323425990|FG007|Overall Study|Lost to Follow-up|0|||
94447492|NCT00955409|323425991|FG008|Overall Study|Lost to Follow-up|0|||
94447493|NCT00955409|323425992|FG009|Overall Study|Lost to Follow-up|0|||
94447494|NCT00955409|323425983|FG000|Overall Study|Failed to Return|2|||
94447495|NCT00955409|323425984|FG001|Overall Study|Failed to Return|0|||
94447496|NCT00955409|323425985|FG002|Overall Study|Failed to Return|0|||
94447497|NCT00955409|323425986|FG003|Overall Study|Failed to Return|0|||
94447498|NCT00955409|323425987|FG004|Overall Study|Failed to Return|0|||
94447499|NCT00955409|323425988|FG005|Overall Study|Failed to Return|0|||
94447500|NCT00955409|323425989|FG006|Overall Study|Failed to Return|0|||
94447501|NCT00955409|323425990|FG007|Overall Study|Failed to Return|2|||
94447502|NCT00955409|323425991|FG008|Overall Study|Failed to Return|0|||
94447503|NCT00955409|323425992|FG009|Overall Study|Failed to Return|0|||
94447504|NCT00955409|323425983|FG000|Overall Study|Adverse Event (AE)|2|||
94447505|NCT00955409|323425984|FG001|Overall Study|Adverse Event (AE)|0|||
94447506|NCT00955409|323425985|FG002|Overall Study|Adverse Event (AE)|0|||
94447507|NCT00955409|323425986|FG003|Overall Study|Adverse Event (AE)|0|||
94447508|NCT00955409|323425987|FG004|Overall Study|Adverse Event (AE)|0|||
94447509|NCT00955409|323425988|FG005|Overall Study|Adverse Event (AE)|1|||
94447510|NCT00955409|323425989|FG006|Overall Study|Adverse Event (AE)|2|||
94447511|NCT00955409|323425990|FG007|Overall Study|Adverse Event (AE)|0|||
94447512|NCT00955409|323425991|FG008|Overall Study|Adverse Event (AE)|2|||
94447513|NCT00955409|323425992|FG009|Overall Study|Adverse Event (AE)|0|||
94447514|NCT00955409|323425983|FG000|Overall Study|Reason not Specified|2|||
94447515|NCT00955409|323425984|FG001|Overall Study|Reason not Specified|1|||
94447516|NCT00955409|323425985|FG002|Overall Study|Reason not Specified|13|||
94447517|NCT00955409|323425986|FG003|Overall Study|Reason not Specified|1|||
94447518|NCT00955409|323425987|FG004|Overall Study|Reason not Specified|2|||
94447519|NCT00955409|323425988|FG005|Overall Study|Reason not Specified|0|||
94447520|NCT00955409|323425989|FG006|Overall Study|Reason not Specified|16|||
94447521|NCT00955409|323425990|FG007|Overall Study|Reason not Specified|0|||
94447522|NCT00955409|323425991|FG008|Overall Study|Reason not Specified|8|||
94447523|NCT00955409|323425992|FG009|Overall Study|Reason not Specified|1|||
94447524|NCT02151851|323425993|FG000|Overall Study|Lack of Efficacy|67|||
94447525|NCT02151851|323425994|FG001|Overall Study|Lack of Efficacy|94|||
94447526|NCT02151851|323425993|FG000|Overall Study|Protocol Violation|0|||
94447527|NCT02151851|323425994|FG001|Overall Study|Protocol Violation|1|||
94447528|NCT02151851|323425993|FG000|Overall Study|Withdrawal by Subject|2|||
94447529|NCT02151851|323425994|FG001|Overall Study|Withdrawal by Subject|5|||
94447530|NCT02151851|323425993|FG000|Overall Study|Medical impairment|1|||
94447531|NCT02151851|323425994|FG001|Overall Study|Medical impairment|0|||
94447532|NCT02151851|323425993|FG000|Overall Study|Low compliance to study visits|0|||
94447533|NCT02151851|323425994|FG001|Overall Study|Low compliance to study visits|1|||
94447534|NCT02151851|323425993|FG000|Overall Study|Subject entered into study in error|0|||
94447535|NCT02151851|323425994|FG001|Overall Study|Subject entered into study in error|1|||
94447536|NCT02151851|323425993|FG000|Overall Study|Adverse Event|6|||
94447537|NCT02151851|323425994|FG001|Overall Study|Adverse Event|28|||
94447538|NCT02159053|323425995|FG000|Overall Study|Death|2|||
94447539|NCT02159053|323425996|FG001|Overall Study|Death|0|||
94447540|NCT02159053|323425997|FG002|Overall Study|Death|1|||
94555576|NCT03052816|323828602|FG000|Overall Study|Desired opioids|2|||
94555577|NCT03052816|323828603|FG001|Overall Study|Desired opioids|0|||
94555578|NCT02218008|323828604|FG000|Stage 1 (S1)|Adverse Event|6|||
94555579|NCT02218008|323828605|FG001|Stage 1 (S1)|Adverse Event|5|||
94555580|NCT02218008|323828606|FG002|Stage 1 (S1)|Adverse Event|11|||
94555581|NCT02218008|323828607|FG003|Stage 1 (S1)|Adverse Event|0|||
94555582|NCT02218008|323828608|FG004|Stage 1 (S1)|Adverse Event|0|||
94230774|NCT02600897|322637565|FG001|Overall Study|Lost to Follow-up|0|||
94230775|NCT02600897|322637566|FG002|Overall Study|Lost to Follow-up|0|||
94230776|NCT02600897|322637567|FG003|Overall Study|Lost to Follow-up|0|||
94230777|NCT02600897|322637568|FG004|Overall Study|Lost to Follow-up|0|||
94230778|NCT02600897|322637569|FG005|Overall Study|Lost to Follow-up|0|||
94230779|NCT02600897|322637570|FG006|Overall Study|Lost to Follow-up|0|||
94230780|NCT02600897|322637571|FG007|Overall Study|Lost to Follow-up|1|||
94230781|NCT02600897|322637572|FG008|Overall Study|Lost to Follow-up|0|||
94230782|NCT02600897|322637564|FG000|Overall Study|Withdrawal by Subject|0|||
94230783|NCT02600897|322637565|FG001|Overall Study|Withdrawal by Subject|0|||
94230784|NCT02600897|322637566|FG002|Overall Study|Withdrawal by Subject|0|||
94230785|NCT02600897|322637567|FG003|Overall Study|Withdrawal by Subject|0|||
94230786|NCT02600897|322637568|FG004|Overall Study|Withdrawal by Subject|0|||
94230787|NCT02600897|322637569|FG005|Overall Study|Withdrawal by Subject|0|||
94230788|NCT02600897|322637570|FG006|Overall Study|Withdrawal by Subject|0|||
94230789|NCT02600897|322637571|FG007|Overall Study|Withdrawal by Subject|4|||
94230790|NCT02600897|322637572|FG008|Overall Study|Withdrawal by Subject|2|||
94230791|NCT02600897|322637564|FG000|Overall Study|Reason Not Specified|0|||
94230792|NCT02600897|322637565|FG001|Overall Study|Reason Not Specified|0|||
94230793|NCT02600897|322637566|FG002|Overall Study|Reason Not Specified|0|||
94230794|NCT02600897|322637567|FG003|Overall Study|Reason Not Specified|0|||
94230795|NCT02600897|322637568|FG004|Overall Study|Reason Not Specified|0|||
94230796|NCT02600897|322637569|FG005|Overall Study|Reason Not Specified|0|||
94230797|NCT02600897|322637570|FG006|Overall Study|Reason Not Specified|0|||
94230798|NCT02600897|322637571|FG007|Overall Study|Reason Not Specified|0|||
94230799|NCT02600897|322637572|FG008|Overall Study|Reason Not Specified|1|||
94230800|NCT02210208|322639727|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
94230801|NCT02210208|322639727|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
94230802|NCT02210208|322639727|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
94230803|NCT01904136|322639728|FG000|Overall Study|Physician Decision|0|||
94230804|NCT01904136|322639729|FG001|Overall Study|Physician Decision|0|||
94230805|NCT01904136|322639730|FG002|Overall Study|Physician Decision|0|||
94230806|NCT01904136|322639731|FG003|Overall Study|Physician Decision|0|||
94230807|NCT01904136|322639732|FG004|Overall Study|Physician Decision|0|||
94230808|NCT01904136|322639733|FG005|Overall Study|Physician Decision|1|||
94230809|NCT01904136|322639734|FG006|Overall Study|Physician Decision|0|||
94230810|NCT01904136|322639735|FG007|Overall Study|Physician Decision|0|||
94230811|NCT01904136|322639736|FG008|Overall Study|Physician Decision|0|||
94343966|NCT01693562|323039988|FG007|Escalation Phase|Other|0|||
94343967|NCT01693562|323039989|FG008|Escalation Phase|Other|0|||
94343968|NCT01693562|323039990|FG009|Escalation Phase|Other|0|||
94343969|NCT01693562|323039991|FG010|Escalation Phase|Other|0|||
94343970|NCT01693562|323039992|FG011|Escalation Phase|Other|0|||
94343971|NCT01693562|323039993|FG012|Escalation Phase|Other|0|||
94343972|NCT01693562|323039994|FG013|Escalation Phase|Other|0|||
94343973|NCT01693562|323039995|FG014|Escalation Phase|Other|0|||
94343974|NCT01693562|323039996|FG015|Escalation Phase|Other|0|||
94343975|NCT01693562|323039997|FG016|Escalation Phase|Other|0|||
94343976|NCT01693562|323039998|FG017|Escalation Phase|Other|0|||
94343977|NCT01693562|323039999|FG018|Escalation Phase|Other|0|||
94555583|NCT02218008|323828609|FG005|Stage 1 (S1)|Adverse Event|0|||
94230812|NCT02826798|322639737|FG000|Overall Study|Withdrawal by Subject|0|||
94230813|NCT02826798|322639738|FG001|Overall Study|Withdrawal by Subject|1|||
94230814|NCT02826798|322639739|FG002|Overall Study|Withdrawal by Subject|0|||
94230815|NCT02826798|322639740|FG003|Overall Study|Withdrawal by Subject|1|||
94230816|NCT02826798|322639741|FG004|Overall Study|Withdrawal by Subject|0|||
94230817|NCT01722045|322639742|FG000|Overall Study|Adverse Event|8|||
94230818|NCT01722045|322639742|FG000|Overall Study|Death|3|||
94230819|NCT01722045|322639742|FG000|Overall Study|Withdrawal by Subject|8|||
94230820|NCT01722045|322639742|FG000|Overall Study|Lost to Follow-up|4|||
94230821|NCT01722045|322639742|FG000|Overall Study|Protocol Deviation|1|||
94230822|NCT01722045|322639742|FG000|Overall Study|Physician Decision|3|||
94343978|NCT01693562|323040000|FG019|Escalation Phase|Other|0|||
94230823|NCT01722045|322639742|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
94230824|NCT03834623|322639743|FG000|Overall Study|Progression|0|||
94230825|NCT03834623|322639744|FG001|Overall Study|Progression|1|||
94230826|NCT03062449|322639750|FG000|Overall Study|Withdrawal by Subject|7|||
94230827|NCT03062449|322639751|FG001|Overall Study|Withdrawal by Subject|1|||
94343979|NCT01693562|323040001|FG020|Escalation Phase|Other|0|||
94343980|NCT01693562|323040002|FG021|Escalation Phase|Other|0|||
94343981|NCT01693562|323040003|FG022|Escalation Phase|Other|0|||
94555584|NCT02218008|323828604|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
94230828|NCT04702893|322639752|FG000|Overall Study|Other reasons than listed|11|||
94230829|NCT04702893|322639752|FG000|Overall Study|Withdrawal by Subject|3|||
94230830|NCT04702893|322639752|FG000|Overall Study|Lost to Follow-up|7|||
94230831|NCT04702893|322639752|FG000|Overall Study|Death|10|||
94230832|NCT04702893|322639752|FG000|Overall Study|Not treated|6|||
94230833|NCT00630552|322639753|FG000|Overall Study|Adverse Event|0|||
94230834|NCT00630552|322639754|FG001|Overall Study|Adverse Event|1|||
94230835|NCT00630552|322639755|FG002|Overall Study|Adverse Event|5|||
94230836|NCT00630552|322639756|FG003|Overall Study|Adverse Event|4|||
94230837|NCT00630552|322639757|FG004|Overall Study|Adverse Event|2|||
94230838|NCT00630552|322639753|FG000|Overall Study|Disease progression|5|||
94230839|NCT00630552|322639754|FG001|Overall Study|Disease progression|6|||
94230840|NCT00630552|322639755|FG002|Overall Study|Disease progression|27|||
94230841|NCT00630552|322639756|FG003|Overall Study|Disease progression|22|||
94230842|NCT00630552|322639757|FG004|Overall Study|Disease progression|31|||
94230843|NCT00630552|322639753|FG000|Overall Study|Never received IP|0|||
94230844|NCT00630552|322639754|FG001|Overall Study|Never received IP|0|||
94230845|NCT00630552|322639755|FG002|Overall Study|Never received IP|0|||
94230846|NCT00630552|322639756|FG003|Overall Study|Never received IP|2|||
94230847|NCT00630552|322639757|FG004|Overall Study|Never received IP|2|||
94230848|NCT00630552|322639753|FG000|Overall Study|Ineligibility determined|0|||
94230849|NCT00630552|322639754|FG001|Overall Study|Ineligibility determined|0|||
94230850|NCT00630552|322639755|FG002|Overall Study|Ineligibility determined|0|||
94230851|NCT00630552|322639756|FG003|Overall Study|Ineligibility determined|0|||
94230852|NCT00630552|322639757|FG004|Overall Study|Ineligibility determined|1|||
94230853|NCT00630552|322639753|FG000|Overall Study|Protocol Violation|0|||
94230854|NCT00630552|322639754|FG001|Overall Study|Protocol Violation|0|||
94230855|NCT00630552|322639755|FG002|Overall Study|Protocol Violation|0|||
94230856|NCT00630552|322639756|FG003|Overall Study|Protocol Violation|1|||
94230857|NCT00630552|322639757|FG004|Overall Study|Protocol Violation|0|||
94230858|NCT00630552|322639753|FG000|Overall Study|Physician Decision|0|||
94230859|NCT00630552|322639754|FG001|Overall Study|Physician Decision|0|||
94230860|NCT00630552|322639755|FG002|Overall Study|Physician Decision|0|||
94230861|NCT00630552|322639756|FG003|Overall Study|Physician Decision|0|||
94230862|NCT00630552|322639757|FG004|Overall Study|Physician Decision|1|||
94230863|NCT00630552|322639753|FG000|Overall Study|Death|0|||
94230864|NCT00630552|322639754|FG001|Overall Study|Death|0|||
94230865|NCT00630552|322639755|FG002|Overall Study|Death|1|||
94230866|NCT00630552|322639756|FG003|Overall Study|Death|2|||
94230867|NCT00630552|322639757|FG004|Overall Study|Death|2|||
94230868|NCT00630552|322639753|FG000|Overall Study|Withdrawal by Subject|0|||
94230869|NCT00630552|322639754|FG001|Overall Study|Withdrawal by Subject|0|||
94230870|NCT00630552|322639755|FG002|Overall Study|Withdrawal by Subject|0|||
94230871|NCT00630552|322639756|FG003|Overall Study|Withdrawal by Subject|1|||
94230872|NCT00630552|322639757|FG004|Overall Study|Withdrawal by Subject|0|||
94230873|NCT00630552|322639753|FG000|Overall Study|Other|0|||
94230874|NCT00630552|322639754|FG001|Overall Study|Other|0|||
94230875|NCT00630552|322639755|FG002|Overall Study|Other|4|||
94230876|NCT00630552|322639756|FG003|Overall Study|Other|2|||
94230877|NCT00630552|322639757|FG004|Overall Study|Other|0|||
94230878|NCT04606199|322639758|FG000|Overall Study|Withdrawal by Subject|2|||
94230879|NCT04349644|322639759|FG000|Allocation/Pretest|Lost to pretest|0|||
94230880|NCT04349644|322639760|FG001|Allocation/Pretest|Lost to pretest|3|||
94230881|NCT04349644|322639759|FG000|Posttest|Lost to posttest|0|||
94230882|NCT04349644|322639760|FG001|Posttest|Lost to posttest|8|||
94343982|NCT01693562|323039981|FG000|Exploration Phase|Withdrawal by Subject|0|||
94343983|NCT01693562|323039982|FG001|Exploration Phase|Withdrawal by Subject|0|||
94343984|NCT01693562|323039983|FG002|Exploration Phase|Withdrawal by Subject|0|||
94343985|NCT01693562|323039984|FG003|Exploration Phase|Withdrawal by Subject|0|||
94343986|NCT01693562|323039985|FG004|Exploration Phase|Withdrawal by Subject|0|||
94230883|NCT04349644|322639759|FG000|Posttest|Discontinued intervention|6|||
94230884|NCT04349644|322639760|FG001|Posttest|Discontinued intervention|0|||
94230885|NCT04349644|322639759|FG000|Follow-up|Lost to Follow-up|0|||
94230886|NCT04349644|322639760|FG001|Follow-up|Lost to Follow-up|2|||
94230887|NCT00408928|322639762|FG000|Overall Study|Withdrawal by Subject|1|||
94230888|NCT00408928|322639762|FG000|Overall Study|Death|1|||
94230889|NCT00408928|322639762|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
94230890|NCT04469465|322639764|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
94230891|NCT04469465|322639765|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
94230892|NCT04469465|322639764|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
94230893|NCT04469465|322639765|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
94230894|NCT04469465|322639764|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
94343987|NCT01693562|323039986|FG005|Exploration Phase|Withdrawal by Subject|0|||
94343988|NCT01693562|323039987|FG006|Exploration Phase|Withdrawal by Subject|2|||
94343989|NCT01693562|323039988|FG007|Exploration Phase|Withdrawal by Subject|0|||
94230895|NCT04469465|322639765|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
94230896|NCT04469465|322639764|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
94230897|NCT04469465|322639765|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
94230898|NCT04469465|322639764|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
94555585|NCT02218008|323828605|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
94555586|NCT02218008|323828606|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
94555587|NCT02218008|323828607|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
94555588|NCT02218008|323828608|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
94555589|NCT02218008|323828609|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
94230899|NCT04469465|322639765|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
94230900|NCT04469465|322639764|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
94230901|NCT04469465|322639765|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
94230902|NCT04469465|322639764|FG000|Long-Term Extension (LTE)|Death|0|||
94230903|NCT04469465|322639765|FG001|Long-Term Extension (LTE)|Death|1|||
94230904|NCT04469465|322639764|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
94230905|NCT04469465|322639765|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
94230906|NCT02624869|322639766|FG000|Overall Study|Lost to Follow-up|0|||
94230907|NCT02624869|322639767|FG001|Overall Study|Lost to Follow-up|0|||
94230908|NCT02624869|322639768|FG002|Overall Study|Lost to Follow-up|1|||
94230909|NCT02624869|322639766|FG000|Overall Study|Withdrawal by Subject|1|||
94230910|NCT02624869|322639767|FG001|Overall Study|Withdrawal by Subject|3|||
94230911|NCT02624869|322639768|FG002|Overall Study|Withdrawal by Subject|1|||
94230912|NCT04075292|322639770|FG000|Overall Study|Withdrawal by Subject|1|||
94230913|NCT04075292|322639771|FG001|Overall Study|Withdrawal by Subject|9|||
94230914|NCT04075292|322639770|FG000|Overall Study|Death|2|||
94230915|NCT04075292|322639771|FG001|Overall Study|Death|5|||
94230916|NCT04075292|322639770|FG000|Overall Study|Remained on study at time of DCO|74|||
94230917|NCT04075292|322639771|FG001|Overall Study|Remained on study at time of DCO|64|||
94230918|NCT03491215|322639772|FG000|Overall Study|Death|6|||
94230919|NCT03491215|322639773|FG001|Overall Study|Death|2|||
94230920|NCT03491215|322639774|FG002|Overall Study|Death|1|||
94230921|NCT03491215|322639775|FG003|Overall Study|Death|0|||
94230922|NCT03491215|322639772|FG000|Overall Study|Physician Decision|1|||
94230923|NCT03491215|322639773|FG001|Overall Study|Physician Decision|0|||
94230924|NCT03491215|322639774|FG002|Overall Study|Physician Decision|0|||
94230925|NCT03491215|322639775|FG003|Overall Study|Physician Decision|0|||
94230926|NCT00551135|322639778|FG000|Overall Study|Adverse Event|1|||
94230927|NCT00551135|322639779|FG001|Overall Study|Adverse Event|0|||
94230928|NCT00551135|322639780|FG002|Overall Study|Adverse Event|1|||
94230929|NCT00551135|322639781|FG003|Overall Study|Adverse Event|1|||
94447541|NCT02159053|323425995|FG000|Overall Study|Physician Decision|0|||
94447542|NCT02159053|323425996|FG001|Overall Study|Physician Decision|1|||
94447543|NCT02159053|323425997|FG002|Overall Study|Physician Decision|1|||
94447544|NCT02159053|323425995|FG000|Overall Study|Lack of Efficacy|3|||
94447545|NCT02159053|323425996|FG001|Overall Study|Lack of Efficacy|4|||
94447546|NCT02159053|323425997|FG002|Overall Study|Lack of Efficacy|7|||
94447547|NCT02159053|323425995|FG000|Overall Study|Adverse Event|7|||
94447548|NCT02159053|323425996|FG001|Overall Study|Adverse Event|6|||
94447549|NCT02159053|323425997|FG002|Overall Study|Adverse Event|5|||
94447550|NCT02159053|323425995|FG000|Overall Study|Participants/guardian decision|8|||
94447551|NCT02159053|323425996|FG001|Overall Study|Participants/guardian decision|10|||
94447552|NCT02159053|323425997|FG002|Overall Study|Participants/guardian decision|6|||
94447553|NCT01467713|323426011|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
94447554|NCT01467713|323426012|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
94447555|NCT01467713|323426013|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
94447556|NCT01467713|323426014|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
94447557|NCT01467713|323426011|FG000|Overall Study|Major Protocol Deviation|2|||
94447558|NCT01467713|323426012|FG001|Overall Study|Major Protocol Deviation|4|||
94447559|NCT01467713|323426013|FG002|Overall Study|Major Protocol Deviation|4|||
94447560|NCT01467713|323426014|FG003|Overall Study|Major Protocol Deviation|1|||
94447561|NCT01467713|323426011|FG000|Overall Study|Lost to Follow-up|9|||
94447562|NCT01467713|323426012|FG001|Overall Study|Lost to Follow-up|12|||
94447563|NCT01467713|323426013|FG002|Overall Study|Lost to Follow-up|6|||
94447564|NCT01467713|323426014|FG003|Overall Study|Lost to Follow-up|9|||
94447565|NCT01467713|323426011|FG000|Overall Study|Voluntary Withdrawal|18|||
94447566|NCT01467713|323426012|FG001|Overall Study|Voluntary Withdrawal|14|||
94447567|NCT01467713|323426013|FG002|Overall Study|Voluntary Withdrawal|21|||
94447568|NCT01467713|323426014|FG003|Overall Study|Voluntary Withdrawal|20|||
94447569|NCT01467713|323426011|FG000|Overall Study|Study Termination|23|||
94447570|NCT01467713|323426012|FG001|Overall Study|Study Termination|33|||
94447571|NCT01467713|323426013|FG002|Overall Study|Study Termination|28|||
94447572|NCT01467713|323426014|FG003|Overall Study|Study Termination|29|||
94447573|NCT01467713|323426011|FG000|Overall Study|Pregnancy|0|||
94447574|NCT01467713|323426012|FG001|Overall Study|Pregnancy|1|||
94447575|NCT01467713|323426013|FG002|Overall Study|Pregnancy|1|||
94447576|NCT01467713|323426014|FG003|Overall Study|Pregnancy|3|||
94447577|NCT01467713|323426011|FG000|Overall Study|Relapse|35|||
94555590|NCT02218008|323828604|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
94230930|NCT00551135|322639778|FG000|Overall Study|Lost to Follow-up|0|||
94230931|NCT00551135|322639779|FG001|Overall Study|Lost to Follow-up|0|||
94447578|NCT01467713|323426012|FG001|Overall Study|Relapse|25|||
94447579|NCT01467713|323426013|FG002|Overall Study|Relapse|28|||
94343990|NCT01693562|323039989|FG008|Exploration Phase|Withdrawal by Subject|0|||
94343991|NCT01693562|323039990|FG009|Exploration Phase|Withdrawal by Subject|0|||
94343992|NCT01693562|323039991|FG010|Exploration Phase|Withdrawal by Subject|0|||
94343993|NCT01693562|323039992|FG011|Exploration Phase|Withdrawal by Subject|0|||
94343994|NCT01693562|323039993|FG012|Exploration Phase|Withdrawal by Subject|0|||
94343995|NCT01693562|323039994|FG013|Exploration Phase|Withdrawal by Subject|0|||
94343996|NCT01693562|323039995|FG014|Exploration Phase|Withdrawal by Subject|0|||
94343997|NCT01693562|323039996|FG015|Exploration Phase|Withdrawal by Subject|0|||
94343998|NCT01693562|323039997|FG016|Exploration Phase|Withdrawal by Subject|0|||
94343999|NCT01693562|323039998|FG017|Exploration Phase|Withdrawal by Subject|0|||
94344000|NCT01693562|323039999|FG018|Exploration Phase|Withdrawal by Subject|0|||
94344001|NCT01693562|323040000|FG019|Exploration Phase|Withdrawal by Subject|0|||
94344002|NCT01693562|323040001|FG020|Exploration Phase|Withdrawal by Subject|0|||
94344003|NCT01693562|323040002|FG021|Exploration Phase|Withdrawal by Subject|0|||
94344004|NCT01693562|323040003|FG022|Exploration Phase|Withdrawal by Subject|0|||
94344005|NCT01693562|323039981|FG000|Exploration Phase|Death|0|||
94344006|NCT01693562|323039982|FG001|Exploration Phase|Death|0|||
94344007|NCT01693562|323039983|FG002|Exploration Phase|Death|0|||
94344008|NCT01693562|323039984|FG003|Exploration Phase|Death|0|||
94344009|NCT01693562|323039985|FG004|Exploration Phase|Death|0|||
94344010|NCT01693562|323039986|FG005|Exploration Phase|Death|0|||
94344011|NCT01693562|323039987|FG006|Exploration Phase|Death|17|||
94344012|NCT01693562|323039988|FG007|Exploration Phase|Death|0|||
94344013|NCT01693562|323039989|FG008|Exploration Phase|Death|0|||
94344014|NCT01693562|323039990|FG009|Exploration Phase|Death|0|||
94344015|NCT01693562|323039991|FG010|Exploration Phase|Death|0|||
94344016|NCT01693562|323039992|FG011|Exploration Phase|Death|0|||
94344017|NCT01693562|323039993|FG012|Exploration Phase|Death|0|||
94344018|NCT01693562|323039994|FG013|Exploration Phase|Death|0|||
94344019|NCT01693562|323039995|FG014|Exploration Phase|Death|0|||
94344020|NCT01693562|323039996|FG015|Exploration Phase|Death|0|||
94344021|NCT01693562|323039997|FG016|Exploration Phase|Death|0|||
94344022|NCT01693562|323039998|FG017|Exploration Phase|Death|0|||
94344023|NCT01693562|323039999|FG018|Exploration Phase|Death|0|||
94344024|NCT01693562|323040000|FG019|Exploration Phase|Death|0|||
94344025|NCT01693562|323040001|FG020|Exploration Phase|Death|0|||
94344026|NCT01693562|323040002|FG021|Exploration Phase|Death|0|||
94344027|NCT01693562|323040003|FG022|Exploration Phase|Death|0|||
94344028|NCT01693562|323039981|FG000|Exploration Phase|Other|0|||
94344029|NCT01693562|323039982|FG001|Exploration Phase|Other|0|||
94344030|NCT01693562|323039983|FG002|Exploration Phase|Other|0|||
94344031|NCT01693562|323039984|FG003|Exploration Phase|Other|0|||
94344032|NCT01693562|323039985|FG004|Exploration Phase|Other|0|||
94344033|NCT01693562|323039986|FG005|Exploration Phase|Other|0|||
94344034|NCT01693562|323039987|FG006|Exploration Phase|Other|2|||
94344035|NCT01693562|323039988|FG007|Exploration Phase|Other|0|||
94344036|NCT01693562|323039989|FG008|Exploration Phase|Other|0|||
94344037|NCT01693562|323039990|FG009|Exploration Phase|Other|0|||
94344038|NCT01693562|323039991|FG010|Exploration Phase|Other|0|||
94344039|NCT01693562|323039992|FG011|Exploration Phase|Other|0|||
94344040|NCT01693562|323039993|FG012|Exploration Phase|Other|0|||
94344041|NCT01693562|323039994|FG013|Exploration Phase|Other|0|||
94344042|NCT01693562|323039995|FG014|Exploration Phase|Other|0|||
94344043|NCT01693562|323039996|FG015|Exploration Phase|Other|0|||
94344044|NCT01693562|323039997|FG016|Exploration Phase|Other|0|||
94344045|NCT01693562|323039998|FG017|Exploration Phase|Other|0|||
94344046|NCT01693562|323039999|FG018|Exploration Phase|Other|0|||
94344047|NCT01693562|323040000|FG019|Exploration Phase|Other|0|||
94344048|NCT01693562|323040001|FG020|Exploration Phase|Other|0|||
94344049|NCT01693562|323040002|FG021|Exploration Phase|Other|0|||
94344050|NCT01693562|323040003|FG022|Exploration Phase|Other|0|||
94344051|NCT01693562|323039981|FG000|Expansion Phase|Withdrawal by Subject|0|||
94344052|NCT01693562|323039982|FG001|Expansion Phase|Withdrawal by Subject|0|||
94344053|NCT01693562|323039983|FG002|Expansion Phase|Withdrawal by Subject|0|||
94344054|NCT01693562|323039984|FG003|Expansion Phase|Withdrawal by Subject|0|||
94344055|NCT01693562|323039985|FG004|Expansion Phase|Withdrawal by Subject|0|||
94344056|NCT01693562|323039986|FG005|Expansion Phase|Withdrawal by Subject|0|||
94447580|NCT01467713|323426014|FG003|Overall Study|Relapse|35|||
94447581|NCT01467713|323426011|FG000|Overall Study|Reason not Specified|6|||
94447582|NCT01467713|323426012|FG001|Overall Study|Reason not Specified|11|||
94447583|NCT01467713|323426013|FG002|Overall Study|Reason not Specified|8|||
94447584|NCT01467713|323426014|FG003|Overall Study|Reason not Specified|7|||
94447585|NCT00683618|323426015|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
94447586|NCT00683618|323426016|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
94447587|NCT00683618|323426017|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
94447588|NCT00683618|323426015|FG000|Randomised Treatment Period|Protocol Violation|0|||
94447589|NCT00683618|323426016|FG001|Randomised Treatment Period|Protocol Violation|1|||
94447590|NCT00683618|323426017|FG002|Randomised Treatment Period|Protocol Violation|0|||
94447591|NCT00683618|323426015|FG000|Randomised Treatment Period|Adverse Event|2|||
94447592|NCT00683618|323426016|FG001|Randomised Treatment Period|Adverse Event|0|||
94447593|NCT00683618|323426017|FG002|Randomised Treatment Period|Adverse Event|2|||
94447594|NCT00683618|323426015|FG000|Randomised Treatment Period|Reason not provided|0|||
94447595|NCT00683618|323426016|FG001|Randomised Treatment Period|Reason not provided|0|||
94447596|NCT00683618|323426017|FG002|Randomised Treatment Period|Reason not provided|2|||
94447597|NCT00683618|323426015|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
94447598|NCT00683618|323426016|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
94447599|NCT00683618|323426017|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
94447600|NCT00683618|323426015|FG000|Extension Treatment Period|Adverse Event|1|||
94447601|NCT00683618|323426016|FG001|Extension Treatment Period|Adverse Event|0|||
94447602|NCT00683618|323426017|FG002|Extension Treatment Period|Adverse Event|0|||
94447603|NCT00683618|323426015|FG000|Extension Treatment Period|Protocol Violation|1|||
94447604|NCT00683618|323426016|FG001|Extension Treatment Period|Protocol Violation|0|||
94447605|NCT00683618|323426017|FG002|Extension Treatment Period|Protocol Violation|0|||
94447606|NCT00529087|323426019|FG000|Overall Study|Adverse Event|10|||
94447607|NCT00529087|323426020|FG001|Overall Study|Adverse Event|13|||
94447608|NCT00529087|323426021|FG002|Overall Study|Adverse Event|4|||
94447609|NCT00529087|323426019|FG000|Overall Study|Lost to Follow-up|6|||
94447610|NCT00529087|323426020|FG001|Overall Study|Lost to Follow-up|4|||
94447611|NCT00529087|323426021|FG002|Overall Study|Lost to Follow-up|1|||
94447612|NCT00529087|323426019|FG000|Overall Study|Protocol Violation|8|||
94447613|NCT00529087|323426020|FG001|Overall Study|Protocol Violation|7|||
94447614|NCT00529087|323426021|FG002|Overall Study|Protocol Violation|6|||
94447615|NCT00529087|323426019|FG000|Overall Study|Withdrawal by Subject|3|||
94447616|NCT00529087|323426020|FG001|Overall Study|Withdrawal by Subject|3|||
94447617|NCT00529087|323426021|FG002|Overall Study|Withdrawal by Subject|3|||
94447618|NCT00529087|323426019|FG000|Overall Study|Protocol deviation|1|||
94447619|NCT00529087|323426020|FG001|Overall Study|Protocol deviation|1|||
94447620|NCT00529087|323426021|FG002|Overall Study|Protocol deviation|2|||
94447621|NCT00318474|323426022|FG000|Overall Study|Adverse Event|1|||
94447622|NCT00318474|323426023|FG001|Overall Study|Adverse Event|1|||
94447623|NCT00318474|323426022|FG000|Overall Study|Lost to Follow-up|0|||
94447624|NCT00318474|323426023|FG001|Overall Study|Lost to Follow-up|1|||
94447625|NCT00318474|323426022|FG000|Overall Study|Pregnancy|0|||
94447626|NCT00318474|323426023|FG001|Overall Study|Pregnancy|2|||
94447627|NCT00318474|323426022|FG000|Overall Study|Protocol Violation|1|||
94447628|NCT00318474|323426023|FG001|Overall Study|Protocol Violation|0|||
94447629|NCT00318474|323426022|FG000|Overall Study|Withdrawal by Subject|3|||
94447630|NCT00318474|323426023|FG001|Overall Study|Withdrawal by Subject|2|||
94447631|NCT00318474|323426022|FG000|Overall Study|Fall in GFR|3|||
94447632|NCT00318474|323426023|FG001|Overall Study|Fall in GFR|3|||
94447633|NCT00318474|323426022|FG000|Overall Study|Post-therapy hyperflycemia|0|||
94447634|NCT00318474|323426023|FG001|Overall Study|Post-therapy hyperflycemia|1|||
94447635|NCT00318474|323426022|FG000|Overall Study|Trial terminated|10|||
94447636|NCT00318474|323426023|FG001|Overall Study|Trial terminated|7|||
94447637|NCT01611935|323426024|FG000|Overall Study|Family Declined Participation|1|||
94447638|NCT01611935|323426025|FG001|Overall Study|Family Declined Participation|0|||
94447639|NCT00457002|323426026|FG000|Overall Study|Death|40|||
94447640|NCT00457002|323426027|FG001|Overall Study|Death|47|||
94447641|NCT00457002|323426026|FG000|Overall Study|Adverse Event|284|||
94447642|NCT00457002|323426027|FG001|Overall Study|Adverse Event|260|||
94447643|NCT00457002|323426026|FG000|Overall Study|Withdrawal by Subject|299|||
94447644|NCT00457002|323426027|FG001|Overall Study|Withdrawal by Subject|271|||
94447645|NCT00457002|323426026|FG000|Overall Study|Lost to Follow-up|72|||
94447646|NCT00457002|323426027|FG001|Overall Study|Lost to Follow-up|71|||
94447647|NCT00457002|323426026|FG000|Overall Study|Poor/Non-compliance|46|||
94447648|NCT00457002|323426027|FG001|Overall Study|Poor/Non-compliance|33|||
94447649|NCT00457002|323426026|FG000|Overall Study|No longer met criteria|41|||
94447650|NCT00457002|323426027|FG001|Overall Study|No longer met criteria|37|||
94447651|NCT00457002|323426026|FG000|Overall Study|Administrative reason by Sponsor|1|||
94447652|NCT00457002|323426027|FG001|Overall Study|Administrative reason by Sponsor|0|||
94447653|NCT00457002|323426026|FG000|Overall Study|non-specified|29|||
94447654|NCT00457002|323426027|FG001|Overall Study|non-specified|38|||
94447655|NCT00457002|323426026|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
94447656|NCT00457002|323426027|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
94555591|NCT02218008|323828605|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
94555592|NCT02218008|323828606|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
94555593|NCT02218008|323828607|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
94555594|NCT02218008|323828608|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
94555595|NCT02218008|323828609|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
94555596|NCT02218008|323828604|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
94555597|NCT02218008|323828605|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
94555598|NCT02218008|323828606|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
94555599|NCT02218008|323828607|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
94555600|NCT02218008|323828608|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
94555601|NCT02218008|323828609|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
94555602|NCT02218008|323828604|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
94555603|NCT02218008|323828605|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
94555604|NCT02218008|323828606|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
94555605|NCT02218008|323828607|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
94555606|NCT02218008|323828608|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
94555607|NCT02218008|323828609|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
94555608|NCT02218008|323828604|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
94555609|NCT02218008|323828605|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
94555610|NCT02218008|323828606|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
94555611|NCT02218008|323828607|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
94555612|NCT02218008|323828608|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
94555613|NCT02218008|323828609|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
94555614|NCT02218008|323828604|FG000|Stage 1 (S1)|Pregnancy|0|||
94230932|NCT00551135|322639780|FG002|Overall Study|Lost to Follow-up|0|||
94230933|NCT00551135|322639781|FG003|Overall Study|Lost to Follow-up|1|||
94230934|NCT00551135|322639778|FG000|Overall Study|Other|3|||
94230935|NCT00551135|322639779|FG001|Overall Study|Other|2|||
94230936|NCT00551135|322639780|FG002|Overall Study|Other|1|||
94230937|NCT00551135|322639781|FG003|Overall Study|Other|2|||
94230938|NCT00551135|322639778|FG000|Overall Study|Withdrawal by Subject|1|||
94230939|NCT00551135|322639779|FG001|Overall Study|Withdrawal by Subject|0|||
94230940|NCT00551135|322639780|FG002|Overall Study|Withdrawal by Subject|3|||
94230941|NCT00551135|322639781|FG003|Overall Study|Withdrawal by Subject|1|||
94230942|NCT00548847|322639782|FG000|Overall Study|Disease progression|7|||
94230943|NCT03481556|322639783|FG000|Overall Study|Adverse Event|1|||
94344057|NCT01693562|323039987|FG006|Expansion Phase|Withdrawal by Subject|0|||
94344058|NCT01693562|323039988|FG007|Expansion Phase|Withdrawal by Subject|16|||
94344059|NCT01693562|323039989|FG008|Expansion Phase|Withdrawal by Subject|2|||
94555615|NCT02218008|323828605|FG001|Stage 1 (S1)|Pregnancy|0|||
94555616|NCT02218008|323828606|FG002|Stage 1 (S1)|Pregnancy|1|||
94555617|NCT02218008|323828607|FG003|Stage 1 (S1)|Pregnancy|0|||
94555618|NCT02218008|323828608|FG004|Stage 1 (S1)|Pregnancy|0|||
94230944|NCT03481556|322639784|FG001|Overall Study|Adverse Event|0|||
94230945|NCT03481556|322639785|FG002|Overall Study|Adverse Event|0|||
94230946|NCT03481556|322639786|FG003|Overall Study|Adverse Event|0|||
94230947|NCT03481556|322639783|FG000|Overall Study|Death|4|||
94230948|NCT03481556|322639784|FG001|Overall Study|Death|2|||
94344060|NCT01693562|323039990|FG009|Expansion Phase|Withdrawal by Subject|54|||
94344061|NCT01693562|323039991|FG010|Expansion Phase|Withdrawal by Subject|2|||
94344062|NCT01693562|323039992|FG011|Expansion Phase|Withdrawal by Subject|2|||
94344063|NCT01693562|323039993|FG012|Expansion Phase|Withdrawal by Subject|3|||
94344064|NCT01693562|323039994|FG013|Expansion Phase|Withdrawal by Subject|5|||
94344065|NCT01693562|323039995|FG014|Expansion Phase|Withdrawal by Subject|16|||
94344066|NCT01693562|323039996|FG015|Expansion Phase|Withdrawal by Subject|7|||
94344067|NCT01693562|323039997|FG016|Expansion Phase|Withdrawal by Subject|40|||
94344068|NCT01693562|323039998|FG017|Expansion Phase|Withdrawal by Subject|4|||
94344069|NCT01693562|323039999|FG018|Expansion Phase|Withdrawal by Subject|8|||
94344070|NCT01693562|323040000|FG019|Expansion Phase|Withdrawal by Subject|3|||
94344071|NCT01693562|323040001|FG020|Expansion Phase|Withdrawal by Subject|1|||
94344072|NCT01693562|323040002|FG021|Expansion Phase|Withdrawal by Subject|8|||
94344073|NCT01693562|323040003|FG022|Expansion Phase|Withdrawal by Subject|1|||
94344074|NCT01693562|323039981|FG000|Expansion Phase|Death|0|||
94344075|NCT01693562|323039982|FG001|Expansion Phase|Death|0|||
94344076|NCT01693562|323039983|FG002|Expansion Phase|Death|0|||
94344077|NCT01693562|323039984|FG003|Expansion Phase|Death|0|||
94344078|NCT01693562|323039985|FG004|Expansion Phase|Death|0|||
94344079|NCT01693562|323039986|FG005|Expansion Phase|Death|0|||
94344080|NCT01693562|323039987|FG006|Expansion Phase|Death|0|||
94344081|NCT01693562|323039988|FG007|Expansion Phase|Death|42|||
94344082|NCT01693562|323039989|FG008|Expansion Phase|Death|17|||
94344083|NCT01693562|323039990|FG009|Expansion Phase|Death|208|||
94555619|NCT02218008|323828609|FG005|Stage 1 (S1)|Pregnancy|0|||
94555620|NCT02218008|323828604|FG000|Stage 1 (S1)|Protocol Violation|0|||
94555621|NCT02218008|323828605|FG001|Stage 1 (S1)|Protocol Violation|0|||
94555622|NCT02218008|323828606|FG002|Stage 1 (S1)|Protocol Violation|1|||
94555623|NCT02218008|323828607|FG003|Stage 1 (S1)|Protocol Violation|0|||
94230949|NCT03481556|322639785|FG002|Overall Study|Death|3|||
94344084|NCT01693562|323039991|FG010|Expansion Phase|Death|30|||
94344085|NCT01693562|323039992|FG011|Expansion Phase|Death|8|||
94230950|NCT03481556|322639786|FG003|Overall Study|Death|16|||
94230951|NCT03481556|322639783|FG000|Overall Study|Study Terminated by Sponsor|10|||
94230952|NCT03481556|322639784|FG001|Overall Study|Study Terminated by Sponsor|5|||
94230953|NCT03481556|322639785|FG002|Overall Study|Study Terminated by Sponsor|2|||
94230954|NCT03481556|322639786|FG003|Overall Study|Study Terminated by Sponsor|9|||
94230955|NCT01316887|322639789|FG000|Overall Study|Adverse Event|13|||
94230956|NCT01316887|322639790|FG001|Overall Study|Adverse Event|21|||
94230957|NCT01316887|322639791|FG002|Overall Study|Adverse Event|17|||
94447657|NCT03318861|323426035|FG000|Overall Study|Death|2|||
94447658|NCT03318861|323426036|FG001|Overall Study|Death|3|||
94447659|NCT03318861|323426037|FG002|Overall Study|Death|3|||
94447660|NCT03318861|323426038|FG003|Overall Study|Death|2|||
94447661|NCT03318861|323426039|FG004|Overall Study|Death|2|||
94447662|NCT03318861|323426035|FG000|Overall Study|Enrolled But Never Treated|0|||
94447663|NCT03318861|323426036|FG001|Overall Study|Enrolled But Never Treated|1|||
94447664|NCT03318861|323426037|FG002|Overall Study|Enrolled But Never Treated|0|||
94447665|NCT03318861|323426038|FG003|Overall Study|Enrolled But Never Treated|1|||
94447666|NCT03318861|323426039|FG004|Overall Study|Enrolled But Never Treated|1|||
94447667|NCT03318861|323426035|FG000|Overall Study|Informed Consent Withdraw|0|||
94447668|NCT03318861|323426036|FG001|Overall Study|Informed Consent Withdraw|0|||
94447669|NCT03318861|323426037|FG002|Overall Study|Informed Consent Withdraw|0|||
94447670|NCT03318861|323426038|FG003|Overall Study|Informed Consent Withdraw|1|||
94447671|NCT03318861|323426039|FG004|Overall Study|Informed Consent Withdraw|0|||
94447672|NCT03318861|323426035|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
94447673|NCT03318861|323426036|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
94447674|NCT03318861|323426037|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
94447675|NCT03318861|323426038|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
94447676|NCT03318861|323426039|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
94447677|NCT01735916|323426041|FG000|Overall Study|Subject not eligible to be randomized|11|||
94447678|NCT01735916|323426042|FG001|Overall Study|Subject not eligible to be randomized|0|||
94447679|NCT01735916|323426043|FG002|Overall Study|Subject not eligible to be randomized|0|||
94447680|NCT01735916|323426041|FG000|Overall Study|Early termination of study by sponsor|4|||
94447681|NCT01735916|323426042|FG001|Overall Study|Early termination of study by sponsor|19|||
94447682|NCT01735916|323426043|FG002|Overall Study|Early termination of study by sponsor|7|||
94447683|NCT01735916|323426041|FG000|Overall Study|Withdrawal by Subject|3|||
94447684|NCT01735916|323426042|FG001|Overall Study|Withdrawal by Subject|0|||
94447685|NCT01735916|323426043|FG002|Overall Study|Withdrawal by Subject|0|||
94447686|NCT00471081|323426044|FG000|Active Phase|Protocol Violation|1|||
94447687|NCT00471081|323426045|FG001|Active Phase|Protocol Violation|1|||
94447688|NCT00471081|323426044|FG000|Active Phase|Withdrawal by Subject|0|||
94447689|NCT00471081|323426045|FG001|Active Phase|Withdrawal by Subject|3|||
94447690|NCT00471081|323426044|FG000|Active Phase|Lost to Follow-up|0|||
94447691|NCT00471081|323426045|FG001|Active Phase|Lost to Follow-up|1|||
94447692|NCT00471081|323426044|FG000|Active Phase|Lost health plan/insurance|1|||
94447693|NCT00471081|323426045|FG001|Active Phase|Lost health plan/insurance|8|||
94447694|NCT00471081|323426044|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
94447695|NCT00471081|323426045|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
94447696|NCT00471081|323426044|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
94447697|NCT00471081|323426045|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
94447698|NCT00471081|323426044|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
94447699|NCT00471081|323426045|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
94447700|NCT02844933|323426046|FG000|Overall Study|Discontinued due to premature termination of study|3|||
94447701|NCT02844933|323426047|FG001|Overall Study|Discontinued due to premature termination of study|2|||
94447702|NCT02275546|323426048|FG000|Treatment Period 2|Withdrawal by Subject|2|||
94447703|NCT02275546|323426049|FG001|Treatment Period 2|Withdrawal by Subject|1|||
94447704|NCT02275546|323426048|FG000|Treatment Period 2|Protocol Violation|0|||
94447705|NCT02275546|323426049|FG001|Treatment Period 2|Protocol Violation|1|||
94447706|NCT00454246|323426058|FG000|Overall Study|Adverse Event|2|||
94447707|NCT00454246|323426059|FG001|Overall Study|Adverse Event|2|||
94447708|NCT00454246|323426060|FG002|Overall Study|Adverse Event|0|||
94447709|NCT00454246|323426058|FG000|Overall Study|Violation of selection criteria at entry|6|||
94447710|NCT00454246|323426059|FG001|Overall Study|Violation of selection criteria at entry|0|||
94447711|NCT00454246|323426060|FG002|Overall Study|Violation of selection criteria at entry|0|||
94447712|NCT00454246|323426058|FG000|Overall Study|Protocol Violation|1|||
94447713|NCT00454246|323426059|FG001|Overall Study|Protocol Violation|0|||
94447714|NCT00454246|323426060|FG002|Overall Study|Protocol Violation|0|||
94447715|NCT00454246|323426058|FG000|Overall Study|Refused Treatment|1|||
94230958|NCT01316887|322639789|FG000|Overall Study|Lack of Efficacy|9|||
94230959|NCT01316887|322639790|FG001|Overall Study|Lack of Efficacy|3|||
94230960|NCT01316887|322639791|FG002|Overall Study|Lack of Efficacy|1|||
94230961|NCT01316887|322639789|FG000|Overall Study|Protocol Violation|2|||
94447716|NCT00454246|323426059|FG001|Overall Study|Refused Treatment|1|||
94447717|NCT00454246|323426060|FG002|Overall Study|Refused Treatment|0|||
94230962|NCT01316887|322639790|FG001|Overall Study|Protocol Violation|6|||
94555624|NCT02218008|323828608|FG004|Stage 1 (S1)|Protocol Violation|0|||
94555625|NCT02218008|323828609|FG005|Stage 1 (S1)|Protocol Violation|0|||
94555626|NCT02218008|323828604|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
94555627|NCT02218008|323828605|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
94555628|NCT02218008|323828606|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
94555629|NCT02218008|323828607|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
94555630|NCT02218008|323828608|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
94555631|NCT02218008|323828609|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
94555632|NCT02218008|323828604|FG000|Stage 2 (S2)|Adverse Event|0|||
94555633|NCT02218008|323828605|FG001|Stage 2 (S2)|Adverse Event|0|||
94555634|NCT02218008|323828606|FG002|Stage 2 (S2)|Adverse Event|0|||
94555635|NCT02218008|323828607|FG003|Stage 2 (S2)|Adverse Event|2|||
94555636|NCT02218008|323828608|FG004|Stage 2 (S2)|Adverse Event|3|||
94555637|NCT02218008|323828609|FG005|Stage 2 (S2)|Adverse Event|3|||
94555638|NCT02218008|323828604|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
94555639|NCT02218008|323828605|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
94555640|NCT02218008|323828606|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
94555641|NCT02218008|323828607|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
94555642|NCT02218008|323828608|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
94555643|NCT02218008|323828609|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
94555644|NCT02218008|323828604|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
94555645|NCT02218008|323828605|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
94555646|NCT02218008|323828606|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
94555647|NCT02218008|323828607|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
94555648|NCT02218008|323828608|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
94555649|NCT02218008|323828609|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
94555650|NCT02218008|323828604|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
94555651|NCT02218008|323828605|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
94555652|NCT02218008|323828606|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
94555653|NCT02218008|323828607|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
94555654|NCT02218008|323828608|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
94555655|NCT02218008|323828609|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
94555656|NCT02218008|323828604|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
94555657|NCT02218008|323828605|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
94555658|NCT02218008|323828606|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
94555659|NCT02218008|323828607|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
94555660|NCT02218008|323828608|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
94555661|NCT02218008|323828609|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
94555662|NCT00408434|323828610|FG000|Overall Study|Adverse Event|0|||
94555663|NCT00408434|323828611|FG001|Overall Study|Adverse Event|0|||
94555664|NCT00408434|323828612|FG002|Overall Study|Adverse Event|1|||
94555665|NCT00408434|323828613|FG003|Overall Study|Adverse Event|0|||
94555666|NCT00408434|323828614|FG004|Overall Study|Adverse Event|0|||
94555667|NCT00408434|323828615|FG005|Overall Study|Adverse Event|0|||
94555668|NCT00408434|323828616|FG006|Overall Study|Adverse Event|0|||
94555669|NCT00408434|323828610|FG000|Overall Study|Progressive disease|6|||
94555670|NCT00408434|323828611|FG001|Overall Study|Progressive disease|3|||
94555671|NCT00408434|323828612|FG002|Overall Study|Progressive disease|4|||
94555672|NCT00408434|323828613|FG003|Overall Study|Progressive disease|3|||
94555673|NCT00408434|323828614|FG004|Overall Study|Progressive disease|3|||
94555674|NCT00408434|323828615|FG005|Overall Study|Progressive disease|1|||
94555675|NCT00408434|323828616|FG006|Overall Study|Progressive disease|4|||
94555676|NCT00408434|323828610|FG000|Overall Study|Other|0|||
94555677|NCT00408434|323828611|FG001|Overall Study|Other|0|||
94555678|NCT00408434|323828612|FG002|Overall Study|Other|1|||
94555679|NCT00408434|323828613|FG003|Overall Study|Other|0|||
94555680|NCT00408434|323828614|FG004|Overall Study|Other|2|||
94555681|NCT00408434|323828615|FG005|Overall Study|Other|1|||
94555682|NCT00408434|323828616|FG006|Overall Study|Other|0|||
94555683|NCT00408434|323828610|FG000|Overall Study|Terminated by Investigator|0|||
94555684|NCT00408434|323828611|FG001|Overall Study|Terminated by Investigator|0|||
94555685|NCT00408434|323828612|FG002|Overall Study|Terminated by Investigator|0|||
94555686|NCT00408434|323828613|FG003|Overall Study|Terminated by Investigator|0|||
94555687|NCT00408434|323828614|FG004|Overall Study|Terminated by Investigator|1|||
94555688|NCT00408434|323828615|FG005|Overall Study|Terminated by Investigator|1|||
94555689|NCT00408434|323828616|FG006|Overall Study|Terminated by Investigator|0|||
94555690|NCT00895453|323828617|FG000|Overall Study|Lost to Follow-up|25|||
94555691|NCT00895453|323828618|FG001|Overall Study|Lost to Follow-up|25|||
94555692|NCT00895453|323828619|FG002|Overall Study|Lost to Follow-up|23|||
94555693|NCT02353728|323828620|FG000|Overall Study|Subject non-compliance|1|||
94555694|NCT02301624|323828621|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
94555695|NCT02301624|323828622|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
94555696|NCT02301624|323828621|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
94555697|NCT02301624|323828622|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
94555698|NCT02301624|323828621|FG000|Open-label Maintenance Phase|Adverse Event|2|||
94555699|NCT02301624|323828622|FG001|Open-label Maintenance Phase|Adverse Event|5|||
94447718|NCT00454246|323426058|FG000|Overall Study|Failure to return|1|||
94447719|NCT00454246|323426059|FG001|Overall Study|Failure to return|0|||
94447720|NCT00454246|323426060|FG002|Overall Study|Failure to return|0|||
94447721|NCT00454246|323426058|FG000|Overall Study|Early termination of study|62|||
94447722|NCT00454246|323426059|FG001|Overall Study|Early termination of study|26|||
94447723|NCT00454246|323426060|FG002|Overall Study|Early termination of study|9|||
94447724|NCT02283268|323426061|FG000|Overall Study|Withdrawal by Subject|1|||
94447725|NCT02955355|323426062|FG000|Overall Study|Adverse Event|4|||
94447726|NCT02955355|323426062|FG000|Overall Study|Death|1|||
94447727|NCT02955355|323426062|FG000|Overall Study|Physician Decision|21|||
94447728|NCT02955355|323426062|FG000|Overall Study|Site Terminated by Sponsor|35|||
94447729|NCT02955355|323426062|FG000|Overall Study|Withdrawal by Subject|19|||
94447730|NCT02955355|323426062|FG000|Overall Study|Reason Not Specified|5|||
94447731|NCT02612623|323426063|FG000|Overall Study|Withdrawal by Subject|0|||
94447732|NCT02612623|323426064|FG001|Overall Study|Withdrawal by Subject|1|||
94447733|NCT02612623|323426065|FG002|Overall Study|Withdrawal by Subject|0|||
94447734|NCT02612623|323426066|FG003|Overall Study|Withdrawal by Subject|0|||
94447735|NCT02612623|323426063|FG000|Overall Study|Adverse Event|1|||
94447736|NCT02612623|323426064|FG001|Overall Study|Adverse Event|0|||
94447737|NCT02612623|323426065|FG002|Overall Study|Adverse Event|1|||
94447738|NCT02612623|323426066|FG003|Overall Study|Adverse Event|0|||
94447739|NCT04227197|323426067|FG000|Randomization|Protocol Violation|1|||
94447740|NCT04227197|323426068|FG001|Randomization|Protocol Violation|0|||
94447741|NCT04227197|323426067|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
94447742|NCT04227197|323426068|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
94447743|NCT04227197|323426067|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
94447744|NCT04227197|323426068|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
94447745|NCT04227197|323426067|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
94447746|NCT04227197|323426068|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
94447747|NCT04227197|323426067|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
94447748|NCT04227197|323426068|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
94447749|NCT04227197|323426067|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
94447750|NCT04227197|323426068|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
94447751|NCT04227197|323426067|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
94447752|NCT04227197|323426068|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
94447753|NCT00333983|323426069|FG000|Overall Study|Lost to Follow-up|2|||
94447754|NCT00333983|323426070|FG001|Overall Study|Lost to Follow-up|1|||
94447755|NCT00333983|323426071|FG002|Overall Study|Lost to Follow-up|0|||
94447756|NCT00333983|323426069|FG000|Overall Study|Adverse Event|1|||
94447757|NCT00333983|323426070|FG001|Overall Study|Adverse Event|1|||
94447758|NCT00333983|323426071|FG002|Overall Study|Adverse Event|1|||
94447759|NCT00333983|323426069|FG000|Overall Study|Withdrawal by Subject|0|||
94447760|NCT00333983|323426070|FG001|Overall Study|Withdrawal by Subject|3|||
94447761|NCT00333983|323426071|FG002|Overall Study|Withdrawal by Subject|1|||
94447762|NCT03656068|323426076|FG000|Overall Study|Withdrawal by Subject|4|||
94447763|NCT03656068|323426076|FG000|Overall Study|Adverse Event|1|||
94447764|NCT00570141|323426077|FG000|Overall Study|Adverse Event|1|||
94447765|NCT00570141|323426077|FG000|Overall Study|Missed visits|1|||
94447766|NCT00570141|323426077|FG000|Overall Study|Lost to Follow-up|1|||
94447767|NCT01295671|323426084|FG000|Overall Study|Lost to Follow-up|4|||
94447768|NCT01295671|323426085|FG001|Overall Study|Lost to Follow-up|6|||
94447769|NCT01295671|323426086|FG002|Overall Study|Lost to Follow-up|3|||
94447770|NCT01295671|323426084|FG000|Overall Study|Withdrawal by Subject|3|||
94447771|NCT01295671|323426085|FG001|Overall Study|Withdrawal by Subject|1|||
94447772|NCT01295671|323426086|FG002|Overall Study|Withdrawal by Subject|0|||
94447773|NCT00729612|323426087|FG000|Overall Study|Non evaluable for response|10|||
94447774|NCT00708552|323426088|FG000|Overall Study|Adverse Event|10|||
94447775|NCT00708552|323426089|FG001|Overall Study|Adverse Event|3|||
94447776|NCT00708552|323426090|FG002|Overall Study|Adverse Event|4|||
94447777|NCT00708552|323426091|FG003|Overall Study|Adverse Event|6|||
94447778|NCT00708552|323426088|FG000|Overall Study|Lack of Efficacy|0|||
94447779|NCT00708552|323426089|FG001|Overall Study|Lack of Efficacy|4|||
94447780|NCT00708552|323426090|FG002|Overall Study|Lack of Efficacy|1|||
94555700|NCT02301624|323828621|FG000|Open-label Maintenance Phase|Physician Decision|3|||
94555701|NCT02301624|323828622|FG001|Open-label Maintenance Phase|Physician Decision|3|||
94555702|NCT02301624|323828621|FG000|Open-label Maintenance Phase|Death|2|||
94555703|NCT02301624|323828622|FG001|Open-label Maintenance Phase|Death|1|||
94555704|NCT02301624|323828621|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
94555705|NCT02301624|323828622|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
94555706|NCT00269633|323828623|FG000|Overall Study|Withdrawal by Subject|1|||
94555707|NCT00269633|323828624|FG001|Overall Study|Withdrawal by Subject|0|||
94555708|NCT03857542|323828625|FG000|Overall Study|Adverse Event|1|||
94555709|NCT03857542|323828626|FG001|Overall Study|Adverse Event|3|||
94555710|NCT03857542|323828625|FG000|Overall Study|Withdrawal by Subject|2|||
94555711|NCT03857542|323828626|FG001|Overall Study|Withdrawal by Subject|1|||
94555712|NCT03857542|323828625|FG000|Overall Study|Lost to Follow-up|2|||
94555713|NCT03857542|323828626|FG001|Overall Study|Lost to Follow-up|1|||
94555714|NCT03857542|323828625|FG000|Overall Study|Reason not Specified|1|||
94555715|NCT03857542|323828626|FG001|Overall Study|Reason not Specified|0|||
94555716|NCT03831100|323830481|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
94555717|NCT03831100|323830482|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
94555718|NCT01216683|323830483|FG000|Induction|Never started treatment|0|||
94555719|NCT01216683|323830484|FG001|Induction|Never started treatment|6|||
94555720|NCT01216683|323830485|FG002|Induction|Never started treatment|3|||
94555721|NCT01216683|323830483|FG000|Induction|Lack of Efficacy|4|||
94555722|NCT01216683|323830484|FG001|Induction|Lack of Efficacy|3|||
94555723|NCT01216683|323830485|FG002|Induction|Lack of Efficacy|7|||
94555724|NCT01216683|323830483|FG000|Induction|Adverse Event|0|||
94555725|NCT01216683|323830484|FG001|Induction|Adverse Event|5|||
94555726|NCT01216683|323830485|FG002|Induction|Adverse Event|5|||
94555727|NCT01216683|323830483|FG000|Induction|Death|0|||
94555728|NCT01216683|323830484|FG001|Induction|Death|0|||
94555729|NCT01216683|323830485|FG002|Induction|Death|2|||
94555730|NCT01216683|323830483|FG000|Induction|Withdrawal by Subject|0|||
94555731|NCT01216683|323830484|FG001|Induction|Withdrawal by Subject|4|||
94555732|NCT01216683|323830485|FG002|Induction|Withdrawal by Subject|2|||
94555733|NCT01216683|323830483|FG000|Induction|Other disease|0|||
94555734|NCT01216683|323830484|FG001|Induction|Other disease|1|||
94555735|NCT01216683|323830485|FG002|Induction|Other disease|2|||
94555736|NCT01216683|323830483|FG000|Continuation|Lack of Efficacy|3|||
94555737|NCT01216683|323830484|FG001|Continuation|Lack of Efficacy|2|||
94555738|NCT01216683|323830485|FG002|Continuation|Lack of Efficacy|7|||
94555739|NCT01216683|323830483|FG000|Continuation|Adverse Event|5|||
94555740|NCT01216683|323830484|FG001|Continuation|Adverse Event|3|||
94555741|NCT01216683|323830485|FG002|Continuation|Adverse Event|16|||
94555742|NCT01216683|323830483|FG000|Continuation|Death|1|||
94555743|NCT01216683|323830484|FG001|Continuation|Death|0|||
94555744|NCT01216683|323830485|FG002|Continuation|Death|2|||
94555745|NCT01216683|323830483|FG000|Continuation|Withdrawal by Subject|4|||
94555746|NCT01216683|323830484|FG001|Continuation|Withdrawal by Subject|5|||
94230963|NCT01316887|322639791|FG002|Overall Study|Protocol Violation|6|||
94230964|NCT01316887|322639789|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
94230965|NCT01316887|322639790|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
94230966|NCT01316887|322639791|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
94230967|NCT01316887|322639789|FG000|Overall Study|Study Closed/Terminated|2|||
94447781|NCT00708552|323426091|FG003|Overall Study|Lack of Efficacy|0|||
94447782|NCT00708552|323426088|FG000|Overall Study|Protocol Violation|0|||
94447783|NCT00708552|323426089|FG001|Overall Study|Protocol Violation|0|||
94447784|NCT00708552|323426090|FG002|Overall Study|Protocol Violation|2|||
94447785|NCT00708552|323426091|FG003|Overall Study|Protocol Violation|4|||
94447786|NCT00708552|323426088|FG000|Overall Study|Lost to Follow-up|4|||
94447787|NCT00708552|323426089|FG001|Overall Study|Lost to Follow-up|2|||
94447788|NCT00708552|323426090|FG002|Overall Study|Lost to Follow-up|0|||
94447789|NCT00708552|323426091|FG003|Overall Study|Lost to Follow-up|1|||
94447790|NCT00708552|323426088|FG000|Overall Study|Physician Decision|1|||
94447791|NCT00708552|323426089|FG001|Overall Study|Physician Decision|2|||
94447792|NCT00708552|323426090|FG002|Overall Study|Physician Decision|0|||
94447793|NCT00708552|323426091|FG003|Overall Study|Physician Decision|0|||
94447794|NCT00708552|323426088|FG000|Overall Study|Withdrawal by Subject|12|||
94447795|NCT00708552|323426089|FG001|Overall Study|Withdrawal by Subject|7|||
94447796|NCT00708552|323426090|FG002|Overall Study|Withdrawal by Subject|8|||
94555747|NCT01216683|323830485|FG002|Continuation|Withdrawal by Subject|9|||
94555748|NCT01216683|323830483|FG000|Continuation|Other diseases|0|||
94555749|NCT01216683|323830484|FG001|Continuation|Other diseases|2|||
94555750|NCT01216683|323830485|FG002|Continuation|Other diseases|1|||
94555751|NCT01216683|323830483|FG000|Continuation|Physician Decision|1|||
94555752|NCT01216683|323830484|FG001|Continuation|Physician Decision|0|||
94555753|NCT01216683|323830485|FG002|Continuation|Physician Decision|1|||
94447797|NCT00708552|323426091|FG003|Overall Study|Withdrawal by Subject|10|||
94555754|NCT01216683|323830483|FG000|Continuation|Non-compliance|1|||
94555755|NCT01216683|323830484|FG001|Continuation|Non-compliance|0|||
94447798|NCT00300885|323426092|FG000|Treatment|Adverse Event|134|||
94447799|NCT00300885|323426093|FG001|Treatment|Adverse Event|82|||
94447800|NCT00300885|323426092|FG000|Treatment|Death|20|||
94447801|NCT00300885|323426093|FG001|Treatment|Death|7|||
94447802|NCT00300885|323426092|FG000|Treatment|Lack of Efficacy|1|||
94447803|NCT00300885|323426093|FG001|Treatment|Lack of Efficacy|1|||
94447804|NCT00300885|323426092|FG000|Treatment|Lost to Follow-up|3|||
94447805|NCT00300885|323426093|FG001|Treatment|Lost to Follow-up|2|||
94447806|NCT00300885|323426092|FG000|Treatment|Physician Decision|4|||
94447807|NCT00300885|323426093|FG001|Treatment|Physician Decision|5|||
94447808|NCT00300885|323426092|FG000|Treatment|Protocol Violation|11|||
94447809|NCT00300885|323426093|FG001|Treatment|Protocol Violation|11|||
94447810|NCT00300885|323426092|FG000|Treatment|Withdrawal by Subject|26|||
94447811|NCT00300885|323426093|FG001|Treatment|Withdrawal by Subject|23|||
94447812|NCT00300885|323426092|FG000|Treatment|Disease progression|171|||
94447813|NCT00300885|323426093|FG001|Treatment|Disease progression|238|||
94447814|NCT00300885|323426092|FG000|Treatment|Random code broken (subject died)|0|||
94447815|NCT00300885|323426093|FG001|Treatment|Random code broken (subject died)|1|||
94447816|NCT00300885|323426092|FG000|Treatment|Non-compliant with study medication|3|||
94447817|NCT00300885|323426093|FG001|Treatment|Non-compliant with study medication|4|||
94447818|NCT00300885|323426092|FG000|Follow-up|Death|141|||
94447819|NCT00300885|323426093|FG001|Follow-up|Death|163|||
94447820|NCT00300885|323426092|FG000|Follow-up|Lost to Follow-up|11|||
94447821|NCT00300885|323426093|FG001|Follow-up|Lost to Follow-up|7|||
94447822|NCT00300885|323426092|FG000|Follow-up|Withdrawal by Subject|26|||
94447823|NCT00300885|323426093|FG001|Follow-up|Withdrawal by Subject|25|||
94447824|NCT04335123|323426094|FG000|Overall Study|Withdrawal by Subject|2|||
94447825|NCT04335123|323426095|FG001|Overall Study|Withdrawal by Subject|0|||
94447826|NCT04335123|323426094|FG000|Overall Study|Physician Decision|2|||
94447827|NCT04335123|323426095|FG001|Overall Study|Physician Decision|0|||
94447828|NCT03664232|323426098|FG000|Overall Study|Withdrawal by Subject|0|||
94447829|NCT03664232|323426099|FG001|Overall Study|Withdrawal by Subject|1|||
94447830|NCT03664232|323426100|FG002|Overall Study|Withdrawal by Subject|0|||
94447831|NCT03664232|323426101|FG003|Overall Study|Withdrawal by Subject|1|||
94447832|NCT03664232|323426098|FG000|Overall Study|Adverse Event|0|||
94447833|NCT03664232|323426099|FG001|Overall Study|Adverse Event|0|||
94447834|NCT03664232|323426100|FG002|Overall Study|Adverse Event|1|||
94447835|NCT03664232|323426101|FG003|Overall Study|Adverse Event|0|||
94447836|NCT03664232|323426098|FG000|Overall Study|Other-Non-compliance with study drug|0|||
94447837|NCT03664232|323426099|FG001|Overall Study|Other-Non-compliance with study drug|1|||
94447838|NCT03664232|323426100|FG002|Overall Study|Other-Non-compliance with study drug|0|||
94447839|NCT03664232|323426101|FG003|Overall Study|Other-Non-compliance with study drug|2|||
94447840|NCT03664232|323426098|FG000|Overall Study|Other-Unspecified|0|||
94447841|NCT03664232|323426099|FG001|Overall Study|Other-Unspecified|3|||
94447842|NCT03664232|323426100|FG002|Overall Study|Other-Unspecified|0|||
94447843|NCT03664232|323426101|FG003|Overall Study|Other-Unspecified|1|||
94447844|NCT03664232|323426098|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
94447845|NCT03664232|323426099|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
94447846|NCT03664232|323426100|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
94447847|NCT03664232|323426101|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
94447848|NCT05266053|323426102|FG000|Overall Study|Withdrawal by Subject|8|||
94447849|NCT05266053|323426103|FG001|Overall Study|Withdrawal by Subject|4|||
94447850|NCT00808210|323426104|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
94447851|NCT00808210|323426105|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
94447852|NCT00808210|323426104|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
94447853|NCT00808210|323426105|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
94447854|NCT00808210|323426104|FG000|Double-Blind TX Period|Adverse Event|0|||
94447855|NCT00808210|323426105|FG001|Double-Blind TX Period|Adverse Event|1|||
94447856|NCT00808210|323426104|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
94447857|NCT00808210|323426105|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
94447858|NCT00808210|323426104|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
94447859|NCT00808210|323426105|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
94447860|NCT00808210|323426104|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
94447861|NCT00808210|323426105|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
94447862|NCT00391768|323426106|FG000|Overall Study|Withdrawal by Subject|0|||
94447863|NCT00391768|323426107|FG001|Overall Study|Withdrawal by Subject|0|||
94447864|NCT00391768|323426108|FG002|Overall Study|Withdrawal by Subject|1|||
94447865|NCT00391768|323426109|FG003|Overall Study|Withdrawal by Subject|0|||
94447866|NCT00391768|323426110|FG004|Overall Study|Withdrawal by Subject|0|||
94447867|NCT00391768|323426111|FG005|Overall Study|Withdrawal by Subject|1|||
94447868|NCT00391768|323426112|FG006|Overall Study|Withdrawal by Subject|1|||
94230968|NCT01316887|322639790|FG001|Overall Study|Study Closed/Terminated|4|||
94230969|NCT01316887|322639791|FG002|Overall Study|Study Closed/Terminated|3|||
94230970|NCT01316887|322639789|FG000|Overall Study|Lost to Follow-up|1|||
94230971|NCT01316887|322639790|FG001|Overall Study|Lost to Follow-up|7|||
94230972|NCT01316887|322639791|FG002|Overall Study|Lost to Follow-up|5|||
94230973|NCT01316887|322639789|FG000|Overall Study|Withdrawal by Subject|8|||
94230974|NCT01316887|322639790|FG001|Overall Study|Withdrawal by Subject|16|||
94230975|NCT01316887|322639791|FG002|Overall Study|Withdrawal by Subject|15|||
94230976|NCT00704171|322639795|FG000|Overall Study|Withdrawal by Subject|1|||
94230977|NCT00704171|322639796|FG001|Overall Study|Withdrawal by Subject|0|||
94230978|NCT00350298|322639799|FG000|Overall Study|Death|7|||
94230979|NCT00350298|322639800|FG001|Overall Study|Death|8|||
94230980|NCT00350298|322639799|FG000|Overall Study|Lost to Follow-up|1|||
94230981|NCT00350298|322639800|FG001|Overall Study|Lost to Follow-up|2|||
94230982|NCT00350298|322639799|FG000|Overall Study|Withdrawal by Subject|1|||
94230983|NCT00350298|322639800|FG001|Overall Study|Withdrawal by Subject|3|||
94230984|NCT00233389|322639803|FG000|Overall Study|Adverse Event|5|||
94230985|NCT00233389|322639804|FG001|Overall Study|Adverse Event|5|||
94230986|NCT00233389|322639803|FG000|Overall Study|Lack of Efficacy|11|||
94230987|NCT00233389|322639804|FG001|Overall Study|Lack of Efficacy|8|||
94230988|NCT00233389|322639803|FG000|Overall Study|Lost to Follow-up|1|||
94230989|NCT00233389|322639804|FG001|Overall Study|Lost to Follow-up|1|||
94230990|NCT00233389|322639803|FG000|Overall Study|Physician Decision|1|||
94230991|NCT00233389|322639804|FG001|Overall Study|Physician Decision|0|||
94230992|NCT00233389|322639803|FG000|Overall Study|Protocol Violation|0|||
94447869|NCT00391768|323426106|FG000|Overall Study|Lost to Follow-up|0|||
94447870|NCT00391768|323426107|FG001|Overall Study|Lost to Follow-up|0|||
94447871|NCT00391768|323426108|FG002|Overall Study|Lost to Follow-up|0|||
94230993|NCT00233389|322639804|FG001|Overall Study|Protocol Violation|1|||
94230994|NCT00233389|322639803|FG000|Overall Study|Withdrawal by Subject|0|||
94230995|NCT00233389|322639804|FG001|Overall Study|Withdrawal by Subject|1|||
94230996|NCT01588366|322639807|FG000|Overall Study|Adverse Event|0|||
94555756|NCT01216683|323830485|FG002|Continuation|Non-compliance|1|||
94555757|NCT01216683|323830483|FG000|Continuation|Insurance change|0|||
94555758|NCT01216683|323830484|FG001|Continuation|Insurance change|1|||
94555759|NCT01216683|323830485|FG002|Continuation|Insurance change|0|||
94555760|NCT01216683|323830483|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
94555761|NCT01216683|323830484|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
94555762|NCT01216683|323830485|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
94555763|NCT01216683|323830483|FG000|Continuation|Not reported|0|||
94555764|NCT01216683|323830484|FG001|Continuation|Not reported|0|||
94555765|NCT01216683|323830485|FG002|Continuation|Not reported|1|||
94555766|NCT01216683|323830483|FG000|Continuation|Never started treatment|0|||
94555767|NCT01216683|323830484|FG001|Continuation|Never started treatment|1|||
94555768|NCT01216683|323830485|FG002|Continuation|Never started treatment|5|||
94555769|NCT02814175|323830486|FG000|Part 1|Adverse Event|2|||
94555770|NCT02814175|323830487|FG001|Part 1|Adverse Event|3|||
94555771|NCT02814175|323830488|FG002|Part 1|Adverse Event|0|||
94555772|NCT02814175|323830489|FG003|Part 1|Adverse Event|0|||
94555773|NCT02814175|323830490|FG004|Part 1|Adverse Event|0|||
94555774|NCT02814175|323830491|FG005|Part 1|Adverse Event|0|||
94555775|NCT02814175|323830486|FG000|Part 1|Withdrawal Consent|8|||
94555776|NCT02814175|323830487|FG001|Part 1|Withdrawal Consent|1|||
94555777|NCT02814175|323830488|FG002|Part 1|Withdrawal Consent|0|||
94555778|NCT02814175|323830489|FG003|Part 1|Withdrawal Consent|0|||
94555779|NCT02814175|323830490|FG004|Part 1|Withdrawal Consent|0|||
94555780|NCT02814175|323830491|FG005|Part 1|Withdrawal Consent|0|||
94555781|NCT02814175|323830486|FG000|Part 1|Lost to Follow-up|1|||
94555782|NCT02814175|323830487|FG001|Part 1|Lost to Follow-up|0|||
94555783|NCT02814175|323830488|FG002|Part 1|Lost to Follow-up|0|||
94555784|NCT02814175|323830489|FG003|Part 1|Lost to Follow-up|0|||
94555785|NCT02814175|323830490|FG004|Part 1|Lost to Follow-up|0|||
94555786|NCT02814175|323830491|FG005|Part 1|Lost to Follow-up|0|||
94555787|NCT02814175|323830486|FG000|Part 1|Lack of Efficacy|1|||
94555788|NCT02814175|323830487|FG001|Part 1|Lack of Efficacy|2|||
94555789|NCT02814175|323830488|FG002|Part 1|Lack of Efficacy|0|||
94555790|NCT02814175|323830489|FG003|Part 1|Lack of Efficacy|0|||
94555791|NCT02814175|323830490|FG004|Part 1|Lack of Efficacy|0|||
94555792|NCT02814175|323830491|FG005|Part 1|Lack of Efficacy|0|||
94555793|NCT02814175|323830486|FG000|Part 2|Adverse Event|0|||
94555794|NCT02814175|323830487|FG001|Part 2|Adverse Event|0|||
94555795|NCT02814175|323830488|FG002|Part 2|Adverse Event|0|||
94555796|NCT02814175|323830489|FG003|Part 2|Adverse Event|1|||
94230997|NCT01588366|322639808|FG001|Overall Study|Adverse Event|1|||
94230998|NCT01588366|322639809|FG002|Overall Study|Adverse Event|0|||
94230999|NCT01588366|322639810|FG003|Overall Study|Adverse Event|1|||
94231000|NCT01588366|322639811|FG004|Overall Study|Adverse Event|0|||
94231001|NCT01588366|322639812|FG005|Overall Study|Adverse Event|2|||
94555797|NCT02814175|323830490|FG004|Part 2|Adverse Event|1|||
94555798|NCT02814175|323830491|FG005|Part 2|Adverse Event|2|||
94555799|NCT02814175|323830486|FG000|Part 2|Withdrawal Consent|0|||
94555800|NCT02814175|323830487|FG001|Part 2|Withdrawal Consent|0|||
94555801|NCT02814175|323830488|FG002|Part 2|Withdrawal Consent|0|||
94555802|NCT02814175|323830489|FG003|Part 2|Withdrawal Consent|2|||
94555803|NCT02814175|323830490|FG004|Part 2|Withdrawal Consent|1|||
94555804|NCT02814175|323830491|FG005|Part 2|Withdrawal Consent|1|||
94555805|NCT02814175|323830486|FG000|Part 2|Lost to Follow-up|0|||
94555806|NCT02814175|323830487|FG001|Part 2|Lost to Follow-up|0|||
94555807|NCT02814175|323830488|FG002|Part 2|Lost to Follow-up|0|||
94555808|NCT02814175|323830489|FG003|Part 2|Lost to Follow-up|1|||
94555809|NCT02814175|323830490|FG004|Part 2|Lost to Follow-up|0|||
94555810|NCT02814175|323830491|FG005|Part 2|Lost to Follow-up|0|||
94555811|NCT02814175|323830486|FG000|Part 2|Lack of Efficacy|0|||
94555812|NCT02814175|323830487|FG001|Part 2|Lack of Efficacy|0|||
94555813|NCT02814175|323830488|FG002|Part 2|Lack of Efficacy|0|||
94555814|NCT02814175|323830489|FG003|Part 2|Lack of Efficacy|0|||
94555815|NCT02814175|323830490|FG004|Part 2|Lack of Efficacy|0|||
94555816|NCT02814175|323830491|FG005|Part 2|Lack of Efficacy|3|||
94555817|NCT03679624|323830492|FG000|Overall Study|Adverse Event|1|||
94555818|NCT03679624|323830493|FG001|Overall Study|Adverse Event|0|||
94555819|NCT02702180|323830494|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
94555820|NCT02702180|323830495|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
94231002|NCT01274559|322639813|FG000|Overall Study|Adverse Event|57|||
94555821|NCT02702180|323830496|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
94555822|NCT02702180|323830494|FG000|Double-blind Treatment Period|Adverse Event|0|||
94555823|NCT02702180|323830495|FG001|Double-blind Treatment Period|Adverse Event|0|||
94555824|NCT02702180|323830496|FG002|Double-blind Treatment Period|Adverse Event|1|||
94555825|NCT02702180|323830494|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
94555826|NCT02702180|323830495|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
94555827|NCT02702180|323830496|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
94231003|NCT01274559|322639814|FG001|Overall Study|Adverse Event|13|||
94231004|NCT01274559|322639813|FG000|Overall Study|Death|1|||
94231005|NCT01274559|322639814|FG001|Overall Study|Death|1|||
94231006|NCT01274559|322639813|FG000|Overall Study|Lost to Follow-up|3|||
94231007|NCT01274559|322639814|FG001|Overall Study|Lost to Follow-up|3|||
94231008|NCT01274559|322639813|FG000|Overall Study|Non-compliance with Study Drug|2|||
94231009|NCT01274559|322639814|FG001|Overall Study|Non-compliance with Study Drug|4|||
94231010|NCT01274559|322639813|FG000|Overall Study|Physician Decision|2|||
94231011|NCT01274559|322639814|FG001|Overall Study|Physician Decision|1|||
94231012|NCT01274559|322639813|FG000|Overall Study|Protocol Violation|28|||
94231013|NCT01274559|322639814|FG001|Overall Study|Protocol Violation|23|||
94231014|NCT01274559|322639813|FG000|Overall Study|Study Terminated by Sponsor|79|||
94231015|NCT01274559|322639814|FG001|Overall Study|Study Terminated by Sponsor|87|||
94231016|NCT01274559|322639813|FG000|Overall Study|Withdrawal by Subject|25|||
94231017|NCT01274559|322639814|FG001|Overall Study|Withdrawal by Subject|13|||
94447872|NCT00391768|323426109|FG003|Overall Study|Lost to Follow-up|1|||
94447873|NCT00391768|323426110|FG004|Overall Study|Lost to Follow-up|2|||
94447874|NCT00391768|323426111|FG005|Overall Study|Lost to Follow-up|2|||
94447875|NCT00391768|323426112|FG006|Overall Study|Lost to Follow-up|3|||
94447876|NCT00314340|323426113|FG000|Overall Study|lost interest|1|||
94447877|NCT02069015|323426114|FG000|Overall Study|Lost to Follow-up|39|||
94447878|NCT02069015|323426115|FG001|Overall Study|Lost to Follow-up|32|||
94447879|NCT02069015|323426114|FG000|Overall Study|Withdrawal by Subject|1|||
94447880|NCT02069015|323426115|FG001|Overall Study|Withdrawal by Subject|1|||
94447881|NCT01082328|323426116|FG000|Overall Study|Adverse Event|1|||
94447882|NCT00444535|323426119|FG000|Overall Study|Withdrawal by Subject|5|||
94447883|NCT00444535|323426119|FG000|Overall Study|Physician Decision|5|||
94447884|NCT00444535|323426119|FG000|Overall Study|progressive disease|1|||
94447885|NCT00444535|323426119|FG000|Overall Study|Adverse Event|2|||
94447886|NCT00406367|323426120|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
94447887|NCT00406367|323426121|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
94447888|NCT00406367|323426120|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
94447889|NCT00406367|323426121|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
94447890|NCT00406367|323426120|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
94447891|NCT00406367|323426121|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
94447892|NCT00406367|323426120|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
94447893|NCT00406367|323426121|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
94447894|NCT00406367|323426120|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
94447895|NCT00406367|323426121|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
94447896|NCT00406367|323426120|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
94447897|NCT00406367|323426121|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
94447898|NCT00406367|323426120|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
94447899|NCT00406367|323426121|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
94447900|NCT00406367|323426120|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
94447901|NCT00406367|323426121|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
94447902|NCT00406367|323426120|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
94447903|NCT00406367|323426121|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
94447904|NCT00406367|323426120|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
94447905|NCT00406367|323426121|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
94447906|NCT00406367|323426120|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
94447907|NCT00406367|323426121|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
94447908|NCT00406367|323426120|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
94447909|NCT00406367|323426121|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
94447910|NCT00171210|323426122|FG000|Overall Study|Adverse Event|16|||
94447911|NCT00171210|323426123|FG001|Overall Study|Adverse Event|27|||
94447912|NCT00171210|323426122|FG000|Overall Study|Abnormal laboratory value(s)|6|||
94447913|NCT00171210|323426123|FG001|Overall Study|Abnormal laboratory value(s)|3|||
94447914|NCT00171210|323426122|FG000|Overall Study|Abnormal test procedure result(s)|0|||
94447915|NCT00171210|323426123|FG001|Overall Study|Abnormal test procedure result(s)|1|||
94447916|NCT00171210|323426122|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
94447917|NCT00171210|323426123|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
94447918|NCT00171210|323426122|FG000|Overall Study|Protocol Violation|0|||
94555828|NCT02702180|323830494|FG000|Double-blind Treatment Period|Protocol Violation|0|||
94555829|NCT02702180|323830495|FG001|Double-blind Treatment Period|Protocol Violation|0|||
94231018|NCT03201900|322639815|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
94447919|NCT00171210|323426123|FG001|Overall Study|Protocol Violation|2|||
94447920|NCT00171210|323426122|FG000|Overall Study|Withdrawal by Subject|32|||
94555830|NCT02702180|323830496|FG002|Double-blind Treatment Period|Protocol Violation|2|||
94231019|NCT03201900|322639815|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
94231020|NCT03201900|322639815|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
94231021|NCT03201900|322639815|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
94555831|NCT02702180|323830494|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
94555832|NCT02702180|323830495|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
94555833|NCT02702180|323830496|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
94555834|NCT02702180|323830494|FG000|Open-label Treatment Period|Withdrawn in error|0|||
94555835|NCT02702180|323830495|FG001|Open-label Treatment Period|Withdrawn in error|0|||
94555836|NCT02702180|323830496|FG002|Open-label Treatment Period|Withdrawn in error|1|||
94555837|NCT00785980|323830497|FG000|7 Day Washout Period|Protocol Violation|3|||
94555838|NCT02397057|323830498|FG000|Overall Study|Withdrawal by Subject|6|||
94555839|NCT02397057|323830499|FG001|Overall Study|Withdrawal by Subject|7|||
94555840|NCT02397057|323830498|FG000|Overall Study|Lost to Follow-up|4|||
94555841|NCT02397057|323830499|FG001|Overall Study|Lost to Follow-up|3|||
94555842|NCT02397057|323830498|FG000|Overall Study|Death|1|||
94555843|NCT02397057|323830499|FG001|Overall Study|Death|0|||
94555844|NCT02397057|323830498|FG000|Overall Study|Adverse Event|0|||
94555845|NCT02397057|323830499|FG001|Overall Study|Adverse Event|1|||
94555846|NCT02397057|323830498|FG000|Overall Study|Physician Decision|0|||
94555847|NCT02397057|323830499|FG001|Overall Study|Physician Decision|1|||
94555848|NCT02397057|323830498|FG000|Overall Study|Subject did not receive study drug|0|||
94555849|NCT02397057|323830499|FG001|Overall Study|Subject did not receive study drug|1|||
94555850|NCT03100058|323830505|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
94555851|NCT03100058|323830506|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
94555852|NCT03100058|323830507|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
94555853|NCT03100058|323830508|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
94555854|NCT03100058|323830509|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
94555855|NCT03100058|323830510|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
94555856|NCT03100058|323830511|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
94555857|NCT03100058|323830512|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
94555858|NCT03100058|323830513|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
94555859|NCT03100058|323830514|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
94555860|NCT03100058|323830515|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
94555861|NCT03100058|323830516|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
94555862|NCT03100058|323830517|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
94555863|NCT03100058|323830505|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
94555864|NCT03100058|323830506|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
94555865|NCT03100058|323830507|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
94555866|NCT03100058|323830508|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
94555867|NCT03100058|323830509|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
94555868|NCT03100058|323830510|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
94555869|NCT03100058|323830511|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
94555870|NCT03100058|323830512|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
94555871|NCT03100058|323830513|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
94555872|NCT03100058|323830514|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
94555873|NCT03100058|323830515|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
94555874|NCT03100058|323830516|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
94555875|NCT03100058|323830517|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
94555876|NCT03100058|323830505|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
94555877|NCT03100058|323830506|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
94555878|NCT03100058|323830507|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
94555879|NCT03100058|323830508|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
94555880|NCT03100058|323830509|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
94555881|NCT03100058|323830510|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
94555882|NCT03100058|323830511|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
94555883|NCT03100058|323830512|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
94555884|NCT03100058|323830513|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
94555885|NCT03100058|323830514|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
94555886|NCT03100058|323830515|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
94555887|NCT03100058|323830516|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
94555888|NCT03100058|323830517|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
94555889|NCT03100058|323830505|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
94555890|NCT03100058|323830506|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
94555891|NCT03100058|323830507|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
94555892|NCT03100058|323830508|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
94555893|NCT03100058|323830509|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
94555894|NCT03100058|323830510|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
94555895|NCT03100058|323830511|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
94555896|NCT03100058|323830512|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
94555897|NCT03100058|323830513|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
94555898|NCT03100058|323830514|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
94231022|NCT03201900|322639815|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
94231023|NCT03201900|322639815|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
94231024|NCT03201900|322639815|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
94231025|NCT03201900|322639815|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
94231026|NCT03201900|322639815|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
94231027|NCT03201900|322639815|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
94231028|NCT03201900|322639815|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
94231029|NCT03201900|322639815|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
94231030|NCT03201900|322639815|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
94231031|NCT02971228|322639831|FG000|Overall Study|Withdrawal by Subject|1|||
94231032|NCT02971228|322639832|FG001|Overall Study|Withdrawal by Subject|1|||
94231033|NCT02971228|322639833|FG002|Overall Study|Withdrawal by Subject|0|||
94231034|NCT02971228|322639834|FG003|Overall Study|Withdrawal by Subject|0|||
94231035|NCT02971228|322639835|FG004|Overall Study|Withdrawal by Subject|0|||
94231036|NCT02971228|322639831|FG000|Overall Study|Logistical challenges|0|||
94231037|NCT02971228|322639832|FG001|Overall Study|Logistical challenges|1|||
94231038|NCT02971228|322639833|FG002|Overall Study|Logistical challenges|0|||
94231039|NCT02971228|322639834|FG003|Overall Study|Logistical challenges|0|||
94231040|NCT02971228|322639835|FG004|Overall Study|Logistical challenges|0|||
94231041|NCT01664923|322639836|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
94231042|NCT01664923|322639837|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
94231043|NCT01664923|322639836|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
94231044|NCT01664923|322639837|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
94231045|NCT01664923|322639836|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
94231046|NCT01664923|322639837|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
94231047|NCT01664923|322639836|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
94231048|NCT01664923|322639837|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
94231049|NCT01664923|322639836|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
94231050|NCT01664923|322639837|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
94231051|NCT01664923|322639836|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
94231052|NCT01664923|322639837|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
94231053|NCT01664923|322639836|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
94231054|NCT01664923|322639837|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
94231055|NCT01664923|322639836|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
94231056|NCT01664923|322639837|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
94231057|NCT01664923|322639836|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
94231058|NCT01664923|322639837|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
94231059|NCT01664923|322639836|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
94231060|NCT01664923|322639837|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
94231061|NCT01664923|322639836|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
94231062|NCT01664923|322639837|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
94231063|NCT01664923|322639836|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
94231064|NCT01664923|322639837|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
94231065|NCT01664923|322639836|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
94231066|NCT01664923|322639837|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
94231067|NCT01664923|322639836|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
94231068|NCT01664923|322639837|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
94231069|NCT02482935|322639843|FG000|Period 1|Withdrawal by Subject|1|||
94231070|NCT02482935|322639844|FG001|Period 1|Withdrawal by Subject|0|||
94231071|NCT01321723|322639845|FG000|Overall Study|Adverse Event|3|||
94231072|NCT01321723|322639846|FG001|Overall Study|Adverse Event|5|||
94231073|NCT01321723|322639847|FG002|Overall Study|Adverse Event|2|||
94231074|NCT01321723|322639845|FG000|Overall Study|Withdrawal by Subject|2|||
94231075|NCT01321723|322639846|FG001|Overall Study|Withdrawal by Subject|0|||
94231076|NCT01321723|322639847|FG002|Overall Study|Withdrawal by Subject|2|||
94231077|NCT02019641|322639850|FG000|10-Week Follow up|Withdrawal by investigator|2|||
94231078|NCT02019641|322639851|FG001|10-Week Follow up|Withdrawal by investigator|0|||
94231079|NCT02019641|322639852|FG002|10-Week Follow up|Withdrawal by investigator|0|||
94447921|NCT00171210|323426123|FG001|Overall Study|Withdrawal by Subject|30|||
94231080|NCT02019641|322639850|FG000|10-Week Follow up|Withdrawal by Subject|1|||
94231081|NCT02019641|322639851|FG001|10-Week Follow up|Withdrawal by Subject|1|||
94231082|NCT02019641|322639852|FG002|10-Week Follow up|Withdrawal by Subject|0|||
94231083|NCT02019641|322639850|FG000|20-Week Follow up|Withdrawal by investigator|0|||
94447922|NCT00171210|323426122|FG000|Overall Study|Lost to Follow-up|1|||
94447923|NCT00171210|323426123|FG001|Overall Study|Lost to Follow-up|0|||
94447924|NCT00171210|323426122|FG000|Overall Study|Administrative problems|1|||
94447925|NCT00171210|323426123|FG001|Overall Study|Administrative problems|1|||
94447926|NCT00171210|323426122|FG000|Overall Study|Death|2|||
94447927|NCT00171210|323426123|FG001|Overall Study|Death|3|||
94447928|NCT00171210|323426122|FG000|Overall Study|Stopped at end of core|0|||
94231084|NCT02019641|322639851|FG001|20-Week Follow up|Withdrawal by investigator|0|||
94231085|NCT02019641|322639852|FG002|20-Week Follow up|Withdrawal by investigator|1|||
94231086|NCT00104637|322639854|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
94231087|NCT00104637|322639855|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
94231088|NCT01560871|322639856|FG000|Overall Study|transportation issues|2|||
94231089|NCT01560871|322639857|FG001|Overall Study|transportation issues|1|||
94231090|NCT01560871|322639856|FG000|Overall Study|relocation|1|||
94231091|NCT01560871|322639857|FG001|Overall Study|relocation|0|||
94231092|NCT01560871|322639856|FG000|Overall Study|readmission to a hospital|2|||
94231093|NCT01560871|322639857|FG001|Overall Study|readmission to a hospital|1|||
94231094|NCT01560871|322639856|FG000|Overall Study|Lost to Follow-up|1|||
94231095|NCT01560871|322639857|FG001|Overall Study|Lost to Follow-up|0|||
94231096|NCT02980705|322639858|FG000|Overall Study|Adverse Event|0|||
94231097|NCT02980705|322639859|FG001|Overall Study|Adverse Event|1|||
94231098|NCT02980705|322639858|FG000|Overall Study|Withdrawal by Subject|6|||
94231099|NCT02980705|322639859|FG001|Overall Study|Withdrawal by Subject|9|||
94231100|NCT02980705|322639858|FG000|Overall Study|withdrew participation|0|||
94231101|NCT02980705|322639859|FG001|Overall Study|withdrew participation|1|||
94231102|NCT02980705|322639858|FG000|Overall Study|Lost to Follow-up|2|||
94231103|NCT02980705|322639859|FG001|Overall Study|Lost to Follow-up|0|||
94231104|NCT01721746|322639860|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
94231105|NCT01721746|322639861|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
94231106|NCT01721746|322639860|FG000|Pre-Treatment|Withdrawal by Subject|1|||
94231107|NCT01721746|322639861|FG001|Pre-Treatment|Withdrawal by Subject|16|||
94231108|NCT01721746|322639860|FG000|Pre-Treatment|Poor/Non-compliance|1|||
94231109|NCT01721746|322639861|FG001|Pre-Treatment|Poor/Non-compliance|0|||
94231110|NCT01721746|322639860|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
94231111|NCT01721746|322639861|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
94231112|NCT01721746|322639860|FG000|Treatment|Disease Progression|192|||
94231113|NCT01721746|322639861|FG001|Treatment|Disease Progression|74|||
94231114|NCT01721746|322639860|FG000|Treatment|Study Drug Toxicity|19|||
94231115|NCT01721746|322639861|FG001|Treatment|Study Drug Toxicity|11|||
94231116|NCT01721746|322639860|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
94231117|NCT01721746|322639861|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
94231118|NCT01721746|322639860|FG000|Treatment|Participant request to discontinue Study treatment|26|||
94231119|NCT01721746|322639861|FG001|Treatment|Participant request to discontinue Study treatment|7|||
94231120|NCT01721746|322639860|FG000|Treatment|Participant withdrew consent|4|||
94231121|NCT01721746|322639861|FG001|Treatment|Participant withdrew consent|2|||
94231122|NCT01721746|322639860|FG000|Treatment|Maximum Clinical Benefit|9|||
94231123|NCT01721746|322639861|FG001|Treatment|Maximum Clinical Benefit|3|||
94231124|NCT01721746|322639860|FG000|Treatment|Poor/Non-compliance|2|||
94231125|NCT01721746|322639861|FG001|Treatment|Poor/Non-compliance|0|||
94231126|NCT01721746|322639860|FG000|Treatment|Participant no longer met Study criteria|4|||
94231127|NCT01721746|322639861|FG001|Treatment|Participant no longer met Study criteria|0|||
94231128|NCT01721746|322639860|FG000|Treatment|Other reasons|6|||
94231129|NCT01721746|322639861|FG001|Treatment|Other reasons|2|||
94231130|NCT00665223|322639862|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
94231131|NCT00665223|322639863|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
94231132|NCT00665223|322639864|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
94231133|NCT00665223|322639862|FG000|Randomized Phase (26 Weeks)|Death|0|||
94231134|NCT00665223|322639863|FG001|Randomized Phase (26 Weeks)|Death|0|||
94231135|NCT00665223|322639864|FG002|Randomized Phase (26 Weeks)|Death|1|||
94231136|NCT00665223|322639862|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
94231137|NCT00665223|322639863|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
94231138|NCT00665223|322639864|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
94231139|NCT00665223|322639862|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
94231140|NCT00665223|322639863|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
94231141|NCT00665223|322639864|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
94231142|NCT00665223|322639862|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
94231143|NCT00665223|322639863|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
94231144|NCT00665223|322639864|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
94231145|NCT00665223|322639862|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
94231146|NCT00665223|322639863|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
94231147|NCT00665223|322639864|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
94231148|NCT00665223|322639862|FG000|Open-Label Period (26 Weeks)|Death|0|||
94231149|NCT00665223|322639863|FG001|Open-Label Period (26 Weeks)|Death|1|||
94231150|NCT00665223|322639864|FG002|Open-Label Period (26 Weeks)|Death|0|||
94231151|NCT00665223|322639862|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
94231152|NCT00665223|322639863|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
94231153|NCT00665223|322639864|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
94231154|NCT00665223|322639862|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
94231155|NCT00665223|322639863|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
94231156|NCT00665223|322639864|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
94555899|NCT03100058|323830515|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
94555900|NCT03100058|323830516|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
94555901|NCT03100058|323830517|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
94555902|NCT03100058|323830505|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
94555903|NCT03100058|323830506|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
94555904|NCT03100058|323830507|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
94555905|NCT03100058|323830508|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
94555906|NCT03100058|323830509|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
94555907|NCT03100058|323830510|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
94555908|NCT03100058|323830511|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
94555909|NCT03100058|323830512|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
94555910|NCT03100058|323830513|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
94555911|NCT03100058|323830514|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
94555912|NCT03100058|323830515|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
94555913|NCT03100058|323830516|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
94555914|NCT03100058|323830517|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
94555915|NCT03100058|323830505|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
94555916|NCT03100058|323830506|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
94555917|NCT03100058|323830507|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
94555918|NCT03100058|323830508|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
94555919|NCT03100058|323830509|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
94555920|NCT03100058|323830510|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
94555921|NCT03100058|323830511|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
94555922|NCT03100058|323830512|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
94555923|NCT03100058|323830513|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
94555924|NCT03100058|323830514|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
94555925|NCT03100058|323830515|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
94555926|NCT03100058|323830516|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
94555927|NCT03100058|323830517|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
94555928|NCT03100058|323830505|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
94555929|NCT03100058|323830506|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
94231157|NCT00665223|322639862|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
94231158|NCT00665223|322639863|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
94231159|NCT00665223|322639864|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
94231160|NCT00665223|322639862|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
94231161|NCT00665223|322639863|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
94231162|NCT00665223|322639864|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
94231163|NCT01278615|322639865|FG000|Overall Study|Withdrawal by Subject|2|||
94231164|NCT02138253|322639866|FG000|Overall Study|Adverse Event|3|||
94231165|NCT02138253|322639867|FG001|Overall Study|Adverse Event|3|||
94231166|NCT02138253|322639866|FG000|Overall Study|Lost to Follow-up|2|||
94231167|NCT02138253|322639867|FG001|Overall Study|Lost to Follow-up|1|||
94231168|NCT02138253|322639866|FG000|Overall Study|Physician Decision|2|||
94231169|NCT02138253|322639867|FG001|Overall Study|Physician Decision|0|||
94231170|NCT02138253|322639866|FG000|Overall Study|Non compliance|1|||
94231171|NCT02138253|322639867|FG001|Overall Study|Non compliance|0|||
94231172|NCT02138253|322639866|FG000|Overall Study|Withdrawal by Subject|1|||
94231173|NCT02138253|322639867|FG001|Overall Study|Withdrawal by Subject|0|||
94231174|NCT04706793|322639868|FG000|Treatment|Disease worsening|10|||
94231175|NCT04706793|322639869|FG001|Treatment|Disease worsening|10|||
94231176|NCT04706793|322639868|FG000|Follow-up|Lack of Efficacy|1|||
94231177|NCT04706793|322639869|FG001|Follow-up|Lack of Efficacy|0|||
94231178|NCT04706793|322639868|FG000|Follow-up|Disease worsening|8|||
94231179|NCT04706793|322639869|FG001|Follow-up|Disease worsening|10|||
94231180|NCT04706793|322639868|FG000|Follow-up|Adverse Event|1|||
94231181|NCT04706793|322639869|FG001|Follow-up|Adverse Event|0|||
94231182|NCT02725528|322639870|FG000|Overall Study|Lost to Follow-up|1|||
94231183|NCT02725528|322639871|FG001|Overall Study|Lost to Follow-up|4|||
94231184|NCT02725528|322639870|FG000|Overall Study|Withdrawal by Subject|0|||
94231185|NCT02725528|322639871|FG001|Overall Study|Withdrawal by Subject|1|||
94231186|NCT02062645|322639872|FG000|Overall Study|Adverse Event|2|||
94231187|NCT02062645|322639872|FG000|Overall Study|Protocol Violation|8|||
94231188|NCT02062645|322639872|FG000|Overall Study|Lost to Follow-up|5|||
94231189|NCT00087555|322639873|FG000|Overall Study|Adverse Event|3|||
94231190|NCT00087555|322639874|FG001|Overall Study|Adverse Event|6|||
94231191|NCT00087555|322639875|FG002|Overall Study|Adverse Event|14|||
94231192|NCT00087555|322639873|FG000|Overall Study|Lost to Follow-up|0|||
94231193|NCT00087555|322639874|FG001|Overall Study|Lost to Follow-up|1|||
94231194|NCT00087555|322639875|FG002|Overall Study|Lost to Follow-up|1|||
94231195|NCT00087555|322639873|FG000|Overall Study|Non - Compliance|1|||
94231196|NCT00087555|322639874|FG001|Overall Study|Non - Compliance|0|||
94555930|NCT03100058|323830507|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
94555931|NCT03100058|323830508|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
94555932|NCT03100058|323830509|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
94555933|NCT03100058|323830510|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
94555934|NCT03100058|323830511|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
94555935|NCT03100058|323830512|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
94555936|NCT03100058|323830513|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
94555937|NCT03100058|323830514|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
94555938|NCT03100058|323830515|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
94555939|NCT03100058|323830516|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
94555940|NCT03100058|323830517|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
94555941|NCT03100058|323830505|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
94555942|NCT03100058|323830506|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
94555943|NCT03100058|323830507|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
94555944|NCT03100058|323830508|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
94231197|NCT00087555|322639875|FG002|Overall Study|Non - Compliance|0|||
94231198|NCT00087555|322639873|FG000|Overall Study|Protocol Violation|0|||
94231199|NCT00087555|322639874|FG001|Overall Study|Protocol Violation|0|||
94231200|NCT00087555|322639875|FG002|Overall Study|Protocol Violation|2|||
94231201|NCT00087555|322639873|FG000|Overall Study|Screen Failure|1|||
94231202|NCT00087555|322639874|FG001|Overall Study|Screen Failure|1|||
94231203|NCT00087555|322639875|FG002|Overall Study|Screen Failure|0|||
94231204|NCT00087555|322639873|FG000|Overall Study|Pregnancy|0|||
94555945|NCT03100058|323830509|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
94231205|NCT00087555|322639874|FG001|Overall Study|Pregnancy|1|||
94231206|NCT00087555|322639875|FG002|Overall Study|Pregnancy|1|||
94231207|NCT00087555|322639873|FG000|Overall Study|Withdrawal by Subject|3|||
94231208|NCT00087555|322639874|FG001|Overall Study|Withdrawal by Subject|2|||
94231209|NCT00087555|322639875|FG002|Overall Study|Withdrawal by Subject|1|||
94231210|NCT00087555|322639873|FG000|Overall Study|Lack of Efficacy|2|||
94231211|NCT00087555|322639874|FG001|Overall Study|Lack of Efficacy|0|||
94231212|NCT00087555|322639875|FG002|Overall Study|Lack of Efficacy|1|||
94231213|NCT00087555|322639873|FG000|Overall Study|Non Compliance|0|||
94231214|NCT00087555|322639874|FG001|Overall Study|Non Compliance|0|||
94231215|NCT00087555|322639875|FG002|Overall Study|Non Compliance|1|||
94231216|NCT00087555|322639873|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
94231217|NCT00087555|322639874|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
94231218|NCT00087555|322639875|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
94231219|NCT00087555|322639873|FG000|Overall Study|Patient wanted to go back on Med|1|||
94231220|NCT00087555|322639874|FG001|Overall Study|Patient wanted to go back on Med|0|||
94231221|NCT00087555|322639875|FG002|Overall Study|Patient wanted to go back on Med|0|||
94231222|NCT01530087|322639876|FG000|Overall Study|Physician Decision|2|||
94231223|NCT02344173|322639881|FG000|Procedure|Ablation Procedure Not Performed|7|||
94231224|NCT02344173|322639881|FG000|12-month Visit|Death|8|||
94231225|NCT02344173|322639881|FG000|12-month Visit|Withdrawal by Subject|30|||
94231226|NCT02344173|322639881|FG000|12-month Visit|Lost to Follow-up|58|||
94231227|NCT03783871|322639903|FG000|Overall Study|Withdrawal by Subject|15|||
94231228|NCT03783871|322639903|FG000|Overall Study|Death|13|||
94231229|NCT03783871|322639903|FG000|Overall Study|Lost to Follow-up|2|||
94231230|NCT04599907|322639908|FG000|Overall Study|Withdrawal by Subject|1|||
94231231|NCT04599907|322639909|FG001|Overall Study|Withdrawal by Subject|7|||
94231232|NCT04599907|322639910|FG002|Overall Study|Withdrawal by Subject|6|||
94231233|NCT04599907|322639908|FG000|Overall Study|Lost to Follow-up|0|||
94231234|NCT04599907|322639909|FG001|Overall Study|Lost to Follow-up|1|||
94231235|NCT04599907|322639910|FG002|Overall Study|Lost to Follow-up|0|||
94231236|NCT03595878|322639911|FG000|Overall Study|Death|2|||
94231237|NCT03595878|322639912|FG001|Overall Study|Death|1|||
94231238|NCT03595878|322639913|FG002|Overall Study|Death|0|||
94231239|NCT03595878|322639911|FG000|Overall Study|Disease progression|2|||
94231240|NCT03595878|322639912|FG001|Overall Study|Disease progression|1|||
94231241|NCT03595878|322639913|FG002|Overall Study|Disease progression|2|||
94231242|NCT02806505|322641116|FG000|Overall Study|Adverse event/intercurrent illness|1|||
94231243|NCT02806505|322641117|FG001|Overall Study|Adverse event/intercurrent illness|3|||
94231244|NCT02806505|322641116|FG000|Overall Study|Death|4|||
94231245|NCT02806505|322641117|FG001|Overall Study|Death|0|||
94231246|NCT02806505|322641116|FG000|Overall Study|Did not cooperate/refused treatment|3|||
94231247|NCT02806505|322641117|FG001|Overall Study|Did not cooperate/refused treatment|3|||
94231248|NCT02806505|322641116|FG000|Overall Study|Failure to return|0|||
94231249|NCT02806505|322641117|FG001|Overall Study|Failure to return|1|||
94344086|NCT01693562|323039993|FG012|Expansion Phase|Death|19|||
94344087|NCT01693562|323039994|FG013|Expansion Phase|Death|42|||
94344088|NCT01693562|323039995|FG014|Expansion Phase|Death|23|||
94344089|NCT01693562|323039996|FG015|Expansion Phase|Death|23|||
94344090|NCT01693562|323039997|FG016|Expansion Phase|Death|128|||
94344091|NCT01693562|323039998|FG017|Expansion Phase|Death|16|||
94344092|NCT01693562|323039999|FG018|Expansion Phase|Death|36|||
94344093|NCT01693562|323040000|FG019|Expansion Phase|Death|16|||
94344094|NCT01693562|323040001|FG020|Expansion Phase|Death|17|||
94344095|NCT01693562|323040002|FG021|Expansion Phase|Death|35|||
94344096|NCT01693562|323040003|FG022|Expansion Phase|Death|7|||
94344097|NCT01693562|323039981|FG000|Expansion Phase|Lost to Follow-up|0|||
94344098|NCT01693562|323039982|FG001|Expansion Phase|Lost to Follow-up|0|||
94344099|NCT01693562|323039983|FG002|Expansion Phase|Lost to Follow-up|0|||
94344100|NCT01693562|323039984|FG003|Expansion Phase|Lost to Follow-up|0|||
94344101|NCT01693562|323039985|FG004|Expansion Phase|Lost to Follow-up|0|||
94344102|NCT01693562|323039986|FG005|Expansion Phase|Lost to Follow-up|0|||
94344103|NCT01693562|323039987|FG006|Expansion Phase|Lost to Follow-up|0|||
94344104|NCT01693562|323039988|FG007|Expansion Phase|Lost to Follow-up|1|||
94344105|NCT01693562|323039989|FG008|Expansion Phase|Lost to Follow-up|2|||
94344106|NCT01693562|323039990|FG009|Expansion Phase|Lost to Follow-up|10|||
94344107|NCT01693562|323039991|FG010|Expansion Phase|Lost to Follow-up|4|||
94344108|NCT01693562|323039992|FG011|Expansion Phase|Lost to Follow-up|4|||
94344109|NCT01693562|323039993|FG012|Expansion Phase|Lost to Follow-up|1|||
94344110|NCT01693562|323039994|FG013|Expansion Phase|Lost to Follow-up|3|||
94344111|NCT01693562|323039995|FG014|Expansion Phase|Lost to Follow-up|0|||
94344112|NCT01693562|323039996|FG015|Expansion Phase|Lost to Follow-up|1|||
94344113|NCT01693562|323039997|FG016|Expansion Phase|Lost to Follow-up|1|||
94344114|NCT01693562|323039998|FG017|Expansion Phase|Lost to Follow-up|0|||
94344115|NCT01693562|323039999|FG018|Expansion Phase|Lost to Follow-up|2|||
94344116|NCT01693562|323040000|FG019|Expansion Phase|Lost to Follow-up|1|||
94344117|NCT01693562|323040001|FG020|Expansion Phase|Lost to Follow-up|2|||
94344118|NCT01693562|323040002|FG021|Expansion Phase|Lost to Follow-up|2|||
94344119|NCT01693562|323040003|FG022|Expansion Phase|Lost to Follow-up|1|||
94344120|NCT01693562|323039981|FG000|Expansion Phase|Other|0|||
94344121|NCT01693562|323039982|FG001|Expansion Phase|Other|0|||
94344122|NCT01693562|323039983|FG002|Expansion Phase|Other|0|||
94344123|NCT01693562|323039984|FG003|Expansion Phase|Other|0|||
94344124|NCT01693562|323039985|FG004|Expansion Phase|Other|0|||
94344125|NCT01693562|323039986|FG005|Expansion Phase|Other|0|||
94344126|NCT01693562|323039987|FG006|Expansion Phase|Other|0|||
94344127|NCT01693562|323039988|FG007|Expansion Phase|Other|3|||
94344128|NCT01693562|323039989|FG008|Expansion Phase|Other|1|||
94344129|NCT01693562|323039990|FG009|Expansion Phase|Other|28|||
94344130|NCT01693562|323039991|FG010|Expansion Phase|Other|4|||
94344131|NCT01693562|323039992|FG011|Expansion Phase|Other|7|||
94344132|NCT01693562|323039993|FG012|Expansion Phase|Other|0|||
94344133|NCT01693562|323039994|FG013|Expansion Phase|Other|1|||
94344134|NCT01693562|323039995|FG014|Expansion Phase|Other|1|||
94231250|NCT02806505|322641116|FG000|Overall Study|Insufficient therapeutic response|2|||
94447929|NCT00171210|323426123|FG001|Overall Study|Stopped at end of core|32|||
94447930|NCT00171210|323426122|FG000|Overall Study|Stopped at end of extension 1|0|||
94447931|NCT00171210|323426123|FG001|Overall Study|Stopped at end of extension 1|1|||
94447932|NCT03150719|323426124|FG000|Overall Study|Adverse Event|0|||
94447933|NCT03150719|323426125|FG001|Overall Study|Adverse Event|1|||
94447934|NCT03150719|323426124|FG000|Overall Study|Death|0|||
94447935|NCT03150719|323426125|FG001|Overall Study|Death|1|||
94447936|NCT03150719|323426124|FG000|Overall Study|Other|1|||
94447937|NCT03150719|323426125|FG001|Overall Study|Other|0|||
94447938|NCT01704495|323426132|FG000|Subjects Randomized|Other Reason|3|||
94447939|NCT01704495|323426133|FG001|Subjects Randomized|Other Reason|2|||
94447940|NCT01704495|323426134|FG002|Subjects Randomized|Other Reason|3|||
94447941|NCT01704495|323426135|FG003|Subjects Randomized|Other Reason|2|||
94447942|NCT01704495|323426132|FG000|Subjects Randomized|Discontinuation criteria met|4|||
94447943|NCT01704495|323426133|FG001|Subjects Randomized|Discontinuation criteria met|2|||
94447944|NCT01704495|323426134|FG002|Subjects Randomized|Discontinuation criteria met|2|||
94447945|NCT01704495|323426135|FG003|Subjects Randomized|Discontinuation criteria met|0|||
94447946|NCT01704495|323426132|FG000|Subjects Randomized|Adverse Event|8|||
94447947|NCT01704495|323426133|FG001|Subjects Randomized|Adverse Event|2|||
94447948|NCT01704495|323426134|FG002|Subjects Randomized|Adverse Event|0|||
94447949|NCT01704495|323426135|FG003|Subjects Randomized|Adverse Event|7|||
94447950|NCT01704495|323426132|FG000|Subjects Randomized|Withdrawal by Subject|5|||
94447951|NCT01704495|323426133|FG001|Subjects Randomized|Withdrawal by Subject|5|||
94447952|NCT01704495|323426134|FG002|Subjects Randomized|Withdrawal by Subject|5|||
94447953|NCT01704495|323426135|FG003|Subjects Randomized|Withdrawal by Subject|5|||
94447954|NCT01704495|323426132|FG000|Subjects Randomized|Protocol Violation|1|||
94447955|NCT01704495|323426133|FG001|Subjects Randomized|Protocol Violation|1|||
94447956|NCT01704495|323426134|FG002|Subjects Randomized|Protocol Violation|2|||
94447957|NCT01704495|323426135|FG003|Subjects Randomized|Protocol Violation|0|||
94447958|NCT01704495|323426132|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
94447959|NCT01704495|323426133|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
94447960|NCT01704495|323426134|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
94447961|NCT01704495|323426135|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
94447962|NCT01704495|323426132|FG000|Optional Safety Extension|Adverse Event|0|||
94447963|NCT01704495|323426133|FG001|Optional Safety Extension|Adverse Event|4|||
94447964|NCT01704495|323426134|FG002|Optional Safety Extension|Adverse Event|0|||
94447965|NCT01704495|323426135|FG003|Optional Safety Extension|Adverse Event|1|||
94447966|NCT01704495|323426132|FG000|Optional Safety Extension|Other reason|27|||
94447967|NCT01704495|323426133|FG001|Optional Safety Extension|Other reason|29|||
94447968|NCT01704495|323426134|FG002|Optional Safety Extension|Other reason|30|||
94447969|NCT01704495|323426135|FG003|Optional Safety Extension|Other reason|28|||
94447970|NCT01704495|323426132|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
94447971|NCT01704495|323426133|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
94447972|NCT01704495|323426134|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
94447973|NCT01704495|323426135|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
94447974|NCT00891020|323426137|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
94447975|NCT00891020|323426138|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
94447976|NCT00891020|323426139|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
94447977|NCT00891020|323426137|FG000|24 Week Treatment Period|Death|0|||
94555946|NCT03100058|323830510|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
94555947|NCT03100058|323830511|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
94555948|NCT03100058|323830512|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
94555949|NCT03100058|323830513|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
94555950|NCT03100058|323830514|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
94555951|NCT03100058|323830515|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
94555952|NCT03100058|323830516|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
94555953|NCT03100058|323830517|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
94555954|NCT03100058|323830505|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
94555955|NCT03100058|323830506|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
94555956|NCT03100058|323830507|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
94555957|NCT03100058|323830508|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
94555958|NCT03100058|323830509|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
94555959|NCT03100058|323830510|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
94555960|NCT03100058|323830511|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
94555961|NCT03100058|323830512|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
94555962|NCT03100058|323830513|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
94555963|NCT03100058|323830514|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
94555964|NCT03100058|323830515|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
94555965|NCT03100058|323830516|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
94555966|NCT03100058|323830517|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
94555967|NCT03100058|323830505|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
94555968|NCT03100058|323830506|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
94231251|NCT02806505|322641117|FG001|Overall Study|Insufficient therapeutic response|4|||
94231252|NCT01947517|322641118|FG000|Overall Study|Withdrawal by Subject|1|||
94231253|NCT01947517|322641119|FG001|Overall Study|Withdrawal by Subject|1|||
94231254|NCT00891046|322641121|FG000|Overall Study|Protocol Violation|1|||
94231255|NCT00891046|322641122|FG001|Overall Study|Protocol Violation|1|||
94231256|NCT00891046|322641123|FG002|Overall Study|Protocol Violation|0|||
94231257|NCT00891046|322641124|FG003|Overall Study|Protocol Violation|0|||
94231258|NCT00891046|322641125|FG004|Overall Study|Protocol Violation|1|||
94231259|NCT00891046|322641121|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
94231260|NCT00891046|322641122|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
94231261|NCT00891046|322641123|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
94555969|NCT03100058|323830507|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
94555970|NCT03100058|323830508|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
94555971|NCT03100058|323830509|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
94555972|NCT03100058|323830510|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
94555973|NCT03100058|323830511|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
94555974|NCT03100058|323830512|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
94555975|NCT03100058|323830513|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
94555976|NCT03100058|323830514|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
94555977|NCT03100058|323830515|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
94555978|NCT03100058|323830516|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
94555979|NCT03100058|323830517|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
94555980|NCT03100058|323830505|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
94555981|NCT03100058|323830506|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
94555982|NCT03100058|323830507|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
94555983|NCT03100058|323830508|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
94555984|NCT03100058|323830509|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
94555985|NCT03100058|323830510|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
94555986|NCT03100058|323830511|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
94555987|NCT03100058|323830512|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
94555988|NCT03100058|323830513|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
94555989|NCT03100058|323830514|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
94555990|NCT03100058|323830515|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
94555991|NCT03100058|323830516|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
94555992|NCT03100058|323830517|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
94555993|NCT03100058|323830505|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
94555994|NCT03100058|323830506|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
94231262|NCT00891046|322641124|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
94231263|NCT00891046|322641125|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
94231264|NCT00891046|322641121|FG000|Overall Study|Administrative problems|0|||
94231265|NCT00891046|322641122|FG001|Overall Study|Administrative problems|0|||
94231266|NCT00891046|322641123|FG002|Overall Study|Administrative problems|0|||
94231267|NCT00891046|322641124|FG003|Overall Study|Administrative problems|0|||
94231268|NCT00891046|322641125|FG004|Overall Study|Administrative problems|1|||
94555995|NCT03100058|323830507|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
94555996|NCT03100058|323830508|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
94555997|NCT03100058|323830509|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
94555998|NCT03100058|323830510|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
94344135|NCT01693562|323039996|FG015|Expansion Phase|Other|0|||
94344136|NCT01693562|323039997|FG016|Expansion Phase|Other|28|||
94344137|NCT01693562|323039998|FG017|Expansion Phase|Other|0|||
94344138|NCT01693562|323039999|FG018|Expansion Phase|Other|1|||
94344139|NCT01693562|323040000|FG019|Expansion Phase|Other|0|||
94344140|NCT01693562|323040001|FG020|Expansion Phase|Other|1|||
94344141|NCT01693562|323040002|FG021|Expansion Phase|Other|17|||
94344142|NCT01693562|323040003|FG022|Expansion Phase|Other|1|||
94344143|NCT02531633|323040004|FG000|Part A (52 Weeks)|Sponsor request|24|||
94344144|NCT02531633|323040005|FG001|Part A (52 Weeks)|Sponsor request|24|||
94344145|NCT02531633|323040006|FG002|Part A (52 Weeks)|Sponsor request|18|||
94344146|NCT02531633|323040007|FG003|Part A (52 Weeks)|Sponsor request|18|||
94344147|NCT02531633|323040008|FG004|Part A (52 Weeks)|Sponsor request|19|||
94344148|NCT02531633|323040009|FG005|Part A (52 Weeks)|Sponsor request|0|||
94344149|NCT02531633|323040010|FG006|Part A (52 Weeks)|Sponsor request|0|||
94344150|NCT02531633|323040011|FG007|Part A (52 Weeks)|Sponsor request|0|||
94344151|NCT02531633|323040012|FG008|Part A (52 Weeks)|Sponsor request|0|||
94344152|NCT02531633|323040013|FG009|Part A (52 Weeks)|Sponsor request|0|||
94344153|NCT02531633|323040004|FG000|Part A (52 Weeks)|Protocol Violation|1|||
94344154|NCT02531633|323040005|FG001|Part A (52 Weeks)|Protocol Violation|0|||
94344155|NCT02531633|323040006|FG002|Part A (52 Weeks)|Protocol Violation|0|||
94344156|NCT02531633|323040007|FG003|Part A (52 Weeks)|Protocol Violation|0|||
94344157|NCT02531633|323040008|FG004|Part A (52 Weeks)|Protocol Violation|0|||
94344158|NCT02531633|323040009|FG005|Part A (52 Weeks)|Protocol Violation|0|||
94344159|NCT02531633|323040010|FG006|Part A (52 Weeks)|Protocol Violation|0|||
94344160|NCT02531633|323040011|FG007|Part A (52 Weeks)|Protocol Violation|0|||
94344161|NCT02531633|323040012|FG008|Part A (52 Weeks)|Protocol Violation|0|||
94344162|NCT02531633|323040013|FG009|Part A (52 Weeks)|Protocol Violation|0|||
94344163|NCT02531633|323040004|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
94344164|NCT02531633|323040005|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
94344165|NCT02531633|323040006|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
94344166|NCT02531633|323040007|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
94344167|NCT02531633|323040008|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
94344168|NCT02531633|323040009|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
94344169|NCT02531633|323040010|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
94344170|NCT02531633|323040011|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
94344171|NCT02531633|323040012|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
94344172|NCT02531633|323040013|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
94344173|NCT02531633|323040004|FG000|Part A (52 Weeks)|Physician Decision|1|||
94344174|NCT02531633|323040005|FG001|Part A (52 Weeks)|Physician Decision|4|||
94344175|NCT02531633|323040006|FG002|Part A (52 Weeks)|Physician Decision|3|||
94344176|NCT02531633|323040007|FG003|Part A (52 Weeks)|Physician Decision|1|||
94344177|NCT02531633|323040008|FG004|Part A (52 Weeks)|Physician Decision|0|||
94344178|NCT02531633|323040009|FG005|Part A (52 Weeks)|Physician Decision|0|||
94344179|NCT02531633|323040010|FG006|Part A (52 Weeks)|Physician Decision|0|||
94344180|NCT02531633|323040011|FG007|Part A (52 Weeks)|Physician Decision|0|||
94344181|NCT02531633|323040012|FG008|Part A (52 Weeks)|Physician Decision|0|||
94344182|NCT02531633|323040013|FG009|Part A (52 Weeks)|Physician Decision|0|||
94344183|NCT02531633|323040004|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
94344184|NCT02531633|323040005|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
94344185|NCT02531633|323040006|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
94344186|NCT02531633|323040007|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
94344187|NCT02531633|323040008|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
94344188|NCT02531633|323040009|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
94344189|NCT02531633|323040010|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
94344190|NCT02531633|323040011|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
94344191|NCT02531633|323040012|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
94344192|NCT02531633|323040013|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
94344193|NCT02531633|323040004|FG000|Part A (52 Weeks)|Other|2|||
94344194|NCT02531633|323040005|FG001|Part A (52 Weeks)|Other|0|||
94344195|NCT02531633|323040006|FG002|Part A (52 Weeks)|Other|0|||
94344196|NCT02531633|323040007|FG003|Part A (52 Weeks)|Other|0|||
94344197|NCT02531633|323040008|FG004|Part A (52 Weeks)|Other|0|||
94344198|NCT02531633|323040009|FG005|Part A (52 Weeks)|Other|0|||
94344199|NCT02531633|323040010|FG006|Part A (52 Weeks)|Other|0|||
94344200|NCT02531633|323040011|FG007|Part A (52 Weeks)|Other|0|||
94344201|NCT02531633|323040012|FG008|Part A (52 Weeks)|Other|0|||
94344202|NCT02531633|323040013|FG009|Part A (52 Weeks)|Other|0|||
94344203|NCT02531633|323040004|FG000|Part B (104 Weeks)|Sponsor request|0|||
94344204|NCT02531633|323040005|FG001|Part B (104 Weeks)|Sponsor request|0|||
94344205|NCT02531633|323040006|FG002|Part B (104 Weeks)|Sponsor request|0|||
94344206|NCT02531633|323040007|FG003|Part B (104 Weeks)|Sponsor request|0|||
94344207|NCT02531633|323040008|FG004|Part B (104 Weeks)|Sponsor request|0|||
94344208|NCT02531633|323040009|FG005|Part B (104 Weeks)|Sponsor request|8|||
94447978|NCT00891020|323426138|FG001|24 Week Treatment Period|Death|2|||
94447979|NCT00891020|323426139|FG002|24 Week Treatment Period|Death|0|||
94447980|NCT00891020|323426137|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
94447981|NCT00891020|323426138|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
94447982|NCT00891020|323426139|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
94447983|NCT00891020|323426137|FG000|24 Week Treatment Period|Failure to return|4|||
94447984|NCT00891020|323426138|FG001|24 Week Treatment Period|Failure to return|5|||
94447985|NCT00891020|323426139|FG002|24 Week Treatment Period|Failure to return|5|||
94447986|NCT00891020|323426137|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
94447987|NCT00891020|323426138|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
94447988|NCT00891020|323426139|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
94447989|NCT00891020|323426137|FG000|24 Week Treatment Period|Other protocol violation|1|||
94447990|NCT00891020|323426138|FG001|24 Week Treatment Period|Other protocol violation|1|||
94447991|NCT00891020|323426139|FG002|24 Week Treatment Period|Other protocol violation|2|||
94447992|NCT00891020|323426137|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
94447993|NCT00891020|323426138|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
94447994|NCT00891020|323426139|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
94447995|NCT00891020|323426137|FG000|24 Week Treatment Period|Withdrew consent|6|||
94447996|NCT00891020|323426138|FG001|24 Week Treatment Period|Withdrew consent|3|||
94447997|NCT00891020|323426139|FG002|24 Week Treatment Period|Withdrew consent|15|||
94447998|NCT00891020|323426137|FG000|24 Week Treatment Period|Administrative/Other|5|||
94447999|NCT00891020|323426138|FG001|24 Week Treatment Period|Administrative/Other|6|||
94448000|NCT00891020|323426139|FG002|24 Week Treatment Period|Administrative/Other|1|||
94448001|NCT00891020|323426137|FG000|Long-term Extension Period|Adverse Event|1|||
94448002|NCT00891020|323426138|FG001|Long-term Extension Period|Adverse Event|11|||
94448003|NCT00891020|323426139|FG002|Long-term Extension Period|Adverse Event|10|||
94448004|NCT00891020|323426137|FG000|Long-term Extension Period|Death|0|||
94448005|NCT00891020|323426138|FG001|Long-term Extension Period|Death|0|||
94448006|NCT00891020|323426139|FG002|Long-term Extension Period|Death|1|||
94448007|NCT00891020|323426137|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
94448008|NCT00891020|323426138|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
94448009|NCT00891020|323426139|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
94448010|NCT00891020|323426137|FG000|Long-term Extension Period|Protocol Violation|0|||
94448011|NCT00891020|323426138|FG001|Long-term Extension Period|Protocol Violation|1|||
94448012|NCT00891020|323426139|FG002|Long-term Extension Period|Protocol Violation|1|||
94448013|NCT00891020|323426137|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
94448014|NCT00891020|323426138|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
94448015|NCT00891020|323426139|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
94448016|NCT00891020|323426137|FG000|Long-term Extension Period|Failure to return|0|||
94448017|NCT00891020|323426138|FG001|Long-term Extension Period|Failure to return|2|||
94448018|NCT00891020|323426139|FG002|Long-term Extension Period|Failure to return|3|||
94448019|NCT00891020|323426137|FG000|Long-term Extension Period|Administrative|1|||
94448020|NCT00891020|323426138|FG001|Long-term Extension Period|Administrative|2|||
94448021|NCT00891020|323426139|FG002|Long-term Extension Period|Administrative|2|||
94448022|NCT04578457|323426143|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
94448023|NCT04578457|323426143|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
94448024|NCT04578457|323426143|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
94448025|NCT04578457|323426143|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
94448026|NCT03376789|323426150|FG000|Overall Study|Withdrawal by Subject|3|||
94448027|NCT03376789|323426151|FG001|Overall Study|Withdrawal by Subject|5|||
94448028|NCT03376789|323426150|FG000|Overall Study|Protocol Violation|0|||
94448029|NCT03376789|323426151|FG001|Overall Study|Protocol Violation|1|||
94448030|NCT03376789|323426150|FG000|Overall Study|Adverse Event|0|||
94448031|NCT03376789|323426151|FG001|Overall Study|Adverse Event|1|||
94448032|NCT03376789|323426150|FG000|Overall Study|Lost to Follow-up|1|||
94448033|NCT03376789|323426151|FG001|Overall Study|Lost to Follow-up|1|||
94448034|NCT03376789|323426150|FG000|Overall Study|Per sponsor due to noncompliance|1|||
94448035|NCT03376789|323426151|FG001|Overall Study|Per sponsor due to noncompliance|0|||
94448036|NCT03376789|323426150|FG000|Overall Study|Subject off study medication|0|||
94448037|NCT03376789|323426151|FG001|Overall Study|Subject off study medication|1|||
94448038|NCT00365794|323426155|FG000|Overall Study|Withdrawal by Subject|2|||
94448039|NCT04830969|323426156|FG000|Overall Study|Withdrawal by Subject|6|||
94448040|NCT04830969|323426157|FG001|Overall Study|Withdrawal by Subject|2|||
94448041|NCT04830969|323426156|FG000|Overall Study|Protocol Violation|3|||
94448042|NCT04830969|323426157|FG001|Overall Study|Protocol Violation|9|||
94448043|NCT04830969|323426156|FG000|Overall Study|Lost to Follow-up|4|||
94448044|NCT04830969|323426157|FG001|Overall Study|Lost to Follow-up|4|||
94448045|NCT02568189|323426158|FG000|Overall Study|Protocol Violation|0|||
94448046|NCT02568189|323426159|FG001|Overall Study|Protocol Violation|0|||
94555999|NCT03100058|323830511|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
94556000|NCT03100058|323830512|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
94556001|NCT03100058|323830513|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
94556002|NCT03100058|323830514|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
94556003|NCT03100058|323830515|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
94556004|NCT03100058|323830516|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
94556005|NCT03100058|323830517|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
94556006|NCT03100058|323830505|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
94556007|NCT03100058|323830506|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
94556008|NCT03100058|323830507|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
94556009|NCT03100058|323830508|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
94556010|NCT03100058|323830509|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
94556011|NCT03100058|323830510|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
94556012|NCT03100058|323830511|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
94556013|NCT03100058|323830512|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
94556014|NCT03100058|323830513|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
94556015|NCT03100058|323830514|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
94556016|NCT03100058|323830515|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
94556017|NCT03100058|323830516|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
94556018|NCT03100058|323830517|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
94556019|NCT03100058|323830505|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
94448047|NCT02568189|323426160|FG002|Overall Study|Protocol Violation|19|||
94448048|NCT02568189|323426161|FG003|Overall Study|Protocol Violation|18|||
94448049|NCT02712554|323426162|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
94448050|NCT02712554|323426163|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
94448051|NCT02712554|323426162|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
94448052|NCT02712554|323426163|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
94448053|NCT02712554|323426162|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
94556020|NCT03100058|323830506|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
94556021|NCT03100058|323830507|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
94556022|NCT03100058|323830508|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
94556023|NCT03100058|323830509|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
94556024|NCT03100058|323830510|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
94556025|NCT03100058|323830511|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
94556026|NCT03100058|323830512|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
94556027|NCT03100058|323830513|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
94556028|NCT03100058|323830514|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
94556029|NCT03100058|323830515|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
94556030|NCT03100058|323830516|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
94556031|NCT03100058|323830517|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
94556032|NCT03100058|323830505|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
94556033|NCT03100058|323830506|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
94556034|NCT03100058|323830507|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
94556035|NCT03100058|323830508|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
94556036|NCT03100058|323830509|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
94556037|NCT03100058|323830510|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
94556038|NCT03100058|323830511|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
94556039|NCT03100058|323830512|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
94556040|NCT03100058|323830513|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
94556041|NCT03100058|323830514|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
94556042|NCT03100058|323830515|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
94556043|NCT03100058|323830516|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
94556044|NCT03100058|323830517|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
94556045|NCT03671304|323830518|FG000|Overall Study|study terminated|7|||
94556046|NCT02718716|323830519|FG000|Overall Study|Lack of Efficacy|1|||
94556047|NCT02718716|323830520|FG001|Overall Study|Lack of Efficacy|0|||
94556048|NCT02718716|323830521|FG002|Overall Study|Lack of Efficacy|0|||
94556049|NCT02718716|323830522|FG003|Overall Study|Lack of Efficacy|0|||
94556050|NCT02718716|323830523|FG004|Overall Study|Lack of Efficacy|0|||
94556051|NCT00880191|323830526|FG000|Overall Study|Refused further treatment|4|||
94556052|NCT00880191|323830527|FG001|Overall Study|Refused further treatment|1|||
94448054|NCT02712554|323426163|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
94448055|NCT02712554|323426162|FG000|Part B: Qualification Phase|Adverse Event|0|||
94448056|NCT02712554|323426163|FG001|Part B: Qualification Phase|Adverse Event|1|||
94448057|NCT02712554|323426162|FG000|Part B: Treatment Phase|Adverse Event|0|||
94448058|NCT02712554|323426163|FG001|Part B: Treatment Phase|Adverse Event|1|||
94448059|NCT02712554|323426162|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
94448060|NCT02712554|323426163|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
94448061|NCT02712554|323426162|FG000|Part B: Treatment Phase|Other|0|||
94448062|NCT02712554|323426163|FG001|Part B: Treatment Phase|Other|1|||
94448063|NCT01554527|323426164|FG000|Overall Study|Withdrawal by Subject|1|||
94448064|NCT01554527|323426165|FG001|Overall Study|Withdrawal by Subject|0|||
94448065|NCT01554527|323426166|FG002|Overall Study|Withdrawal by Subject|3|||
94448066|NCT01554527|323426164|FG000|Overall Study|Lost to Follow-up|0|||
94448067|NCT01554527|323426165|FG001|Overall Study|Lost to Follow-up|0|||
94448068|NCT01554527|323426166|FG002|Overall Study|Lost to Follow-up|4|||
94448069|NCT01554527|323426164|FG000|Overall Study|Physician Decision|0|||
94448070|NCT01554527|323426165|FG001|Overall Study|Physician Decision|0|||
94448071|NCT01554527|323426166|FG002|Overall Study|Physician Decision|1|||
94448072|NCT02157376|323426167|FG000|Overall Study|Death|10|||
94448073|NCT02157376|323426168|FG001|Overall Study|Death|4|||
94556053|NCT00880191|323830526|FG000|Overall Study|Adverse Event|8|||
94556054|NCT00880191|323830527|FG001|Overall Study|Adverse Event|6|||
94556055|NCT00880191|323830526|FG000|Overall Study|Hospitalization/efficacy|1|||
94556056|NCT00880191|323830527|FG001|Overall Study|Hospitalization/efficacy|1|||
94556057|NCT01677858|323830530|FG000|Overall Study|Adverse Event|0|||
94556058|NCT01677858|323830531|FG001|Overall Study|Adverse Event|0|||
94556059|NCT01677858|323830532|FG002|Overall Study|Adverse Event|2|||
94556060|NCT01677858|323830533|FG003|Overall Study|Adverse Event|3|||
94556061|NCT01677858|323830534|FG004|Overall Study|Adverse Event|13|||
94556062|NCT01677858|323830530|FG000|Overall Study|Death|0|||
94231269|NCT00891046|322641121|FG000|Overall Study|Participant no longer required drug|0|||
94556063|NCT01677858|323830531|FG001|Overall Study|Death|0|||
94556064|NCT01677858|323830532|FG002|Overall Study|Death|0|||
94556065|NCT01677858|323830533|FG003|Overall Study|Death|0|||
94556066|NCT01677858|323830534|FG004|Overall Study|Death|1|||
94556067|NCT01677858|323830530|FG000|Overall Study|Physician Decision|1|||
94556068|NCT01677858|323830531|FG001|Overall Study|Physician Decision|0|||
94556069|NCT01677858|323830532|FG002|Overall Study|Physician Decision|2|||
94556070|NCT01677858|323830533|FG003|Overall Study|Physician Decision|0|||
94556071|NCT01677858|323830534|FG004|Overall Study|Physician Decision|12|||
94556072|NCT01677858|323830530|FG000|Overall Study|Progressive Disease|2|||
94556073|NCT01677858|323830531|FG001|Overall Study|Progressive Disease|1|||
94231270|NCT00891046|322641122|FG001|Overall Study|Participant no longer required drug|2|||
94231271|NCT00891046|322641123|FG002|Overall Study|Participant no longer required drug|0|||
94231272|NCT00891046|322641124|FG003|Overall Study|Participant no longer required drug|0|||
94231273|NCT00891046|322641125|FG004|Overall Study|Participant no longer required drug|1|||
94556074|NCT01677858|323830532|FG002|Overall Study|Progressive Disease|9|||
94556075|NCT01677858|323830533|FG003|Overall Study|Progressive Disease|3|||
94556076|NCT01677858|323830534|FG004|Overall Study|Progressive Disease|43|||
94556077|NCT01677858|323830530|FG000|Overall Study|Withdrawal by Subject|0|||
94556078|NCT01677858|323830531|FG001|Overall Study|Withdrawal by Subject|1|||
94556079|NCT01677858|323830532|FG002|Overall Study|Withdrawal by Subject|1|||
94556080|NCT01677858|323830533|FG003|Overall Study|Withdrawal by Subject|0|||
94556081|NCT01677858|323830534|FG004|Overall Study|Withdrawal by Subject|15|||
94231274|NCT00891046|322641121|FG000|Overall Study|Adverse Event|4|||
94231275|NCT00891046|322641122|FG001|Overall Study|Adverse Event|3|||
94231276|NCT00891046|322641123|FG002|Overall Study|Adverse Event|2|||
94231277|NCT00891046|322641124|FG003|Overall Study|Adverse Event|0|||
94231278|NCT00891046|322641125|FG004|Overall Study|Adverse Event|14|||
94231279|NCT00891046|322641121|FG000|Overall Study|Withdrawal by Subject|2|||
94231280|NCT00891046|322641122|FG001|Overall Study|Withdrawal by Subject|1|||
94231281|NCT00891046|322641123|FG002|Overall Study|Withdrawal by Subject|2|||
94231282|NCT00891046|322641124|FG003|Overall Study|Withdrawal by Subject|1|||
94231283|NCT00891046|322641125|FG004|Overall Study|Withdrawal by Subject|1|||
94231284|NCT00891046|322641121|FG000|Overall Study|Lost to Follow-up|0|||
94231285|NCT00891046|322641122|FG001|Overall Study|Lost to Follow-up|0|||
94231286|NCT00891046|322641123|FG002|Overall Study|Lost to Follow-up|0|||
94231287|NCT00891046|322641124|FG003|Overall Study|Lost to Follow-up|0|||
94231288|NCT00891046|322641125|FG004|Overall Study|Lost to Follow-up|1|||
94231289|NCT02106195|322641126|FG000|Overall Study|Adverse Event|2|||
94231290|NCT02106195|322641126|FG000|Overall Study|Protocol Violation|1|||
94231291|NCT04523207|322641127|FG000|Overall Study|Adverse Event|5|||
94231292|NCT04523207|322641128|FG001|Overall Study|Adverse Event|1|||
94231293|NCT04523207|322641127|FG000|Overall Study|Lost to Follow-up|2|||
94231294|NCT04523207|322641128|FG001|Overall Study|Lost to Follow-up|0|||
94231295|NCT04523207|322641127|FG000|Overall Study|Withdrawal by Subject|2|||
94344209|NCT02531633|323040010|FG006|Part B (104 Weeks)|Sponsor request|5|||
94344210|NCT02531633|323040011|FG007|Part B (104 Weeks)|Sponsor request|3|||
94556082|NCT01677858|323830530|FG000|Overall Study|Lost to Follow-up|0|||
94556083|NCT01677858|323830531|FG001|Overall Study|Lost to Follow-up|0|||
94556084|NCT01677858|323830532|FG002|Overall Study|Lost to Follow-up|0|||
94556085|NCT01677858|323830533|FG003|Overall Study|Lost to Follow-up|0|||
94556086|NCT01677858|323830534|FG004|Overall Study|Lost to Follow-up|1|||
94231296|NCT04523207|322641128|FG001|Overall Study|Withdrawal by Subject|0|||
94231297|NCT04523207|322641127|FG000|Overall Study|Progressive Disease|2|||
94344211|NCT02531633|323040012|FG008|Part B (104 Weeks)|Sponsor request|5|||
94556087|NCT03549104|323830535|FG000|Overall Study|Withdrawal by Subject|5|||
94556088|NCT03549104|323830536|FG001|Overall Study|Withdrawal by Subject|2|||
94556089|NCT03549104|323830535|FG000|Overall Study|Covid shelter in place|1|||
94556090|NCT03549104|323830536|FG001|Overall Study|Covid shelter in place|2|||
94556091|NCT00479856|323830538|FG000|Overall Study|Adverse Event|1|||
94556092|NCT00479856|323830538|FG000|Overall Study|Withdrawal by Subject|1|||
94556093|NCT00479856|323830538|FG000|Overall Study|Physician Decision|1|||
94556094|NCT00646399|323830539|FG000|Overall Study|Death|63|||
94556095|NCT00646399|323830540|FG001|Overall Study|Death|53|||
94556096|NCT00646399|323830539|FG000|Overall Study|Withdrawal by Subject|9|||
94556097|NCT00646399|323830540|FG001|Overall Study|Withdrawal by Subject|10|||
94556098|NCT00646399|323830539|FG000|Overall Study|Other Reason|11|||
94556099|NCT00646399|323830540|FG001|Overall Study|Other Reason|11|||
94231298|NCT04523207|322641128|FG001|Overall Study|Progressive Disease|1|||
94231299|NCT04523207|322641127|FG000|Overall Study|Other|7|||
94231300|NCT04523207|322641128|FG001|Overall Study|Other|1|||
94231301|NCT00320398|322641129|FG000|Overall Study|Adverse Event|1|||
94231302|NCT00320398|322641130|FG001|Overall Study|Adverse Event|4|||
94231303|NCT00320398|322641129|FG000|Overall Study|Other|1|||
94231304|NCT00320398|322641130|FG001|Overall Study|Other|0|||
94231305|NCT04238520|322641131|FG000|Overall Study|Withdrawal by Subject|1|||
94231306|NCT04238520|322641132|FG001|Overall Study|Withdrawal by Subject|1|||
94231307|NCT04238520|322641131|FG000|Overall Study|Lost to Follow-up|1|||
94231308|NCT04238520|322641132|FG001|Overall Study|Lost to Follow-up|2|||
94231309|NCT04238520|322641131|FG000|Overall Study|Death|0|||
94231310|NCT04238520|322641132|FG001|Overall Study|Death|2|||
94231311|NCT04238520|322641131|FG000|Overall Study|Unsafe home environment for research staff|0|||
94448074|NCT02157376|323426167|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
94448075|NCT02157376|323426168|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
94448076|NCT02157376|323426167|FG000|Overall Study|Withdrawal by Subject|3|||
94448077|NCT02157376|323426168|FG001|Overall Study|Withdrawal by Subject|8|||
94448078|NCT02157376|323426167|FG000|Overall Study|Not treated|8|||
94448079|NCT02157376|323426168|FG001|Overall Study|Not treated|3|||
94448080|NCT02157376|323426167|FG000|Overall Study|Investigator's misjudgement|1|||
94448081|NCT02157376|323426168|FG001|Overall Study|Investigator's misjudgement|2|||
94448082|NCT00669669|323426169|FG000|Overall Study|To late to start treatment|1|||
94448083|NCT02748213|323426170|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
94448084|NCT02748213|323426171|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
94448085|NCT02748213|323426170|FG000|Overall Study|Abnormal Laboratory Test|1|||
94448086|NCT02748213|323426171|FG001|Overall Study|Abnormal Laboratory Test|0|||
94448087|NCT02748213|323426170|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
94448088|NCT02748213|323426171|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
94448089|NCT02748213|323426170|FG000|Overall Study|Death|5|||
94448090|NCT02748213|323426171|FG001|Overall Study|Death|3|||
94448091|NCT02748213|323426170|FG000|Overall Study|Insufficient Therapeutic Response|56|||
94448092|NCT02748213|323426171|FG001|Overall Study|Insufficient Therapeutic Response|57|||
94448093|NCT02748213|323426170|FG000|Overall Study|Violation of Selection Criteria|2|||
94448094|NCT02748213|323426171|FG001|Overall Study|Violation of Selection Criteria|0|||
94448095|NCT02748213|323426170|FG000|Overall Study|Protocol Violation|6|||
94448096|NCT02748213|323426171|FG001|Overall Study|Protocol Violation|4|||
94448097|NCT02748213|323426170|FG000|Overall Study|Refused Treatment*|6|||
94448098|NCT02748213|323426171|FG001|Overall Study|Refused Treatment*|6|||
94448099|NCT02748213|323426170|FG000|Overall Study|Failure to Return|1|||
94448100|NCT02748213|323426171|FG001|Overall Study|Failure to Return|0|||
94448101|NCT02748213|323426170|FG000|Overall Study|Other|30|||
94448102|NCT02748213|323426171|FG001|Overall Study|Other|29|||
94448103|NCT00030901|323426174|FG000|Initial Registration|Ineligible|167|||
94448104|NCT00030901|323426175|FG001|Initial Registration|Ineligible|0|||
94448105|NCT00030901|323426176|FG002|Initial Registration|Ineligible|0|||
94448106|NCT00030901|323426174|FG000|Randomization|Adverse Event|0|||
94448107|NCT00030901|323426175|FG001|Randomization|Adverse Event|11|||
94448108|NCT00030901|323426176|FG002|Randomization|Adverse Event|7|||
94448109|NCT00030901|323426174|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
94448110|NCT00030901|323426175|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
94448111|NCT00030901|323426176|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
94448112|NCT00030901|323426174|FG000|Randomization|Progression/Relapse|0|||
94448113|NCT00030901|323426175|FG001|Randomization|Progression/Relapse|22|||
94448114|NCT00030901|323426176|FG002|Randomization|Progression/Relapse|21|||
94448115|NCT00030901|323426174|FG000|Randomization|Death|0|||
94448116|NCT00030901|323426175|FG001|Randomization|Death|1|||
94448117|NCT00030901|323426176|FG002|Randomization|Death|3|||
94448118|NCT00030901|323426174|FG000|Randomization|Other|0|||
94448119|NCT00030901|323426175|FG001|Randomization|Other|36|||
94448120|NCT00030901|323426176|FG002|Randomization|Other|33|||
94448121|NCT00030901|323426174|FG000|Randomization|Ineligible|0|||
94448122|NCT00030901|323426175|FG001|Randomization|Ineligible|15|||
94448123|NCT00030901|323426176|FG002|Randomization|Ineligible|14|||
94448124|NCT02431676|323426177|FG000|Overall Study|no lab obtained|0|||
94448125|NCT02431676|323426178|FG001|Overall Study|no lab obtained|1|||
94448126|NCT02431676|323426179|FG002|Overall Study|no lab obtained|2|||
94448127|NCT01131455|323426180|FG000|Overall Study|Death of PI|6|||
94448128|NCT01131455|323426181|FG001|Overall Study|Death of PI|4|||
94448129|NCT01131455|323426182|FG002|Overall Study|Death of PI|0|||
94448130|NCT02861586|323428528|FG000|Overall Study|Withdrawal by Subject|1|||
94448131|NCT02861586|323428529|FG001|Overall Study|Withdrawal by Subject|2|||
94448132|NCT02861586|323428530|FG002|Overall Study|Withdrawal by Subject|0|||
94448133|NCT02861586|323428531|FG003|Overall Study|Withdrawal by Subject|0|||
94448134|NCT02861586|323428532|FG004|Overall Study|Withdrawal by Subject|0|||
94448135|NCT02861586|323428533|FG005|Overall Study|Withdrawal by Subject|1|||
94448136|NCT02861586|323428534|FG006|Overall Study|Withdrawal by Subject|1|||
94448137|NCT02861586|323428535|FG007|Overall Study|Withdrawal by Subject|0|||
94448138|NCT02861586|323428528|FG000|Overall Study|Lost to Follow-up|3|||
94556100|NCT01178099|323830544|FG000|Overall Study|Physician Decision|0|||
94556101|NCT01178099|323830545|FG001|Overall Study|Physician Decision|1|||
94556102|NCT05198843|323830547|FG000|Overall Study|Lack of Efficacy|1|||
94556103|NCT02473367|323830550|FG000|Wait 1|Withdrawal by Subject|1|||
94556104|NCT02473367|323830550|FG000|Period 4|Lost to Follow-up|1|||
94556105|NCT01286740|323830555|FG000|Overall Study|Enrolled but not treated|1|||
94556106|NCT01286740|323830555|FG000|Overall Study|Protocol Violation|1|||
94556107|NCT00098306|323830557|FG000|Double Blind|Randomized, not treated|9|||
94556108|NCT00098306|323830558|FG001|Double Blind|Randomized, not treated|5|||
94556109|NCT00098306|323830559|FG002|Double Blind|Randomized, not treated|2|||
94556110|NCT00098306|323830560|FG003|Double Blind|Randomized, not treated|0|||
94556111|NCT00098306|323830561|FG004|Double Blind|Randomized, not treated|0|||
94556112|NCT00098306|323830562|FG005|Double Blind|Randomized, not treated|0|||
94556113|NCT00098306|323830563|FG006|Double Blind|Randomized, not treated|0|||
94556114|NCT00098306|323830557|FG000|Double Blind|Ongoing at cut-off date|151|||
94556115|NCT00098306|323830558|FG001|Double Blind|Ongoing at cut-off date|166|||
94556116|NCT00098306|323830559|FG002|Double Blind|Ongoing at cut-off date|72|||
94556117|NCT00098306|323830560|FG003|Double Blind|Ongoing at cut-off date|0|||
94556118|NCT00098306|323830561|FG004|Double Blind|Ongoing at cut-off date|0|||
94556119|NCT00098306|323830562|FG005|Double Blind|Ongoing at cut-off date|0|||
94556120|NCT00098306|323830563|FG006|Double Blind|Ongoing at cut-off date|0|||
94556121|NCT00098306|323830557|FG000|Double Blind|Adverse Event|11|||
94556122|NCT00098306|323830558|FG001|Double Blind|Adverse Event|10|||
94556123|NCT00098306|323830559|FG002|Double Blind|Adverse Event|6|||
94556124|NCT00098306|323830560|FG003|Double Blind|Adverse Event|0|||
94556125|NCT00098306|323830561|FG004|Double Blind|Adverse Event|0|||
94556126|NCT00098306|323830562|FG005|Double Blind|Adverse Event|0|||
94556127|NCT00098306|323830563|FG006|Double Blind|Adverse Event|0|||
94556128|NCT00098306|323830557|FG000|Double Blind|Lack of Efficacy|43|||
94556129|NCT00098306|323830558|FG001|Double Blind|Lack of Efficacy|34|||
94556130|NCT00098306|323830559|FG002|Double Blind|Lack of Efficacy|17|||
94556131|NCT00098306|323830560|FG003|Double Blind|Lack of Efficacy|0|||
94556132|NCT00098306|323830561|FG004|Double Blind|Lack of Efficacy|0|||
94556133|NCT00098306|323830562|FG005|Double Blind|Lack of Efficacy|0|||
94556134|NCT00098306|323830563|FG006|Double Blind|Lack of Efficacy|0|||
94556135|NCT00098306|323830557|FG000|Double Blind|Death|1|||
94556136|NCT00098306|323830558|FG001|Double Blind|Death|4|||
94556137|NCT00098306|323830559|FG002|Double Blind|Death|1|||
94556138|NCT00098306|323830560|FG003|Double Blind|Death|0|||
94556139|NCT00098306|323830561|FG004|Double Blind|Death|0|||
94556140|NCT00098306|323830562|FG005|Double Blind|Death|0|||
94556141|NCT00098306|323830563|FG006|Double Blind|Death|0|||
94556142|NCT00098306|323830557|FG000|Double Blind|Participant defaulted|19|||
94556143|NCT00098306|323830558|FG001|Double Blind|Participant defaulted|18|||
94556144|NCT00098306|323830559|FG002|Double Blind|Participant defaulted|11|||
94556145|NCT00098306|323830560|FG003|Double Blind|Participant defaulted|0|||
94556146|NCT00098306|323830561|FG004|Double Blind|Participant defaulted|0|||
94231312|NCT04238520|322641132|FG001|Overall Study|Unsafe home environment for research staff|1|||
94231313|NCT01917006|322641133|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
94231314|NCT01917006|322641134|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
94231315|NCT01917006|322641135|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
94231316|NCT01917006|322641136|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
94231317|NCT01917006|322641137|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
94231318|NCT01917006|322641138|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
94231319|NCT01917006|322641139|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
94231320|NCT01917006|322641140|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
94231321|NCT01917006|322641133|FG000|Randomized-treatment Period|Personal Reasons|0|||
94231322|NCT01917006|322641134|FG001|Randomized-treatment Period|Personal Reasons|0|||
94231323|NCT01917006|322641135|FG002|Randomized-treatment Period|Personal Reasons|0|||
94231324|NCT01917006|322641136|FG003|Randomized-treatment Period|Personal Reasons|0|||
94231325|NCT01917006|322641137|FG004|Randomized-treatment Period|Personal Reasons|0|||
94231326|NCT01917006|322641138|FG005|Randomized-treatment Period|Personal Reasons|1|||
94231327|NCT01917006|322641139|FG006|Randomized-treatment Period|Personal Reasons|0|||
94231328|NCT01917006|322641140|FG007|Randomized-treatment Period|Personal Reasons|0|||
94231329|NCT01917006|322641133|FG000|Randomized-treatment Period|Protocol Violation|1|||
94448139|NCT02861586|323428529|FG001|Overall Study|Lost to Follow-up|1|||
94448140|NCT02861586|323428530|FG002|Overall Study|Lost to Follow-up|1|||
94448141|NCT02861586|323428531|FG003|Overall Study|Lost to Follow-up|0|||
94448142|NCT02861586|323428532|FG004|Overall Study|Lost to Follow-up|0|||
94448143|NCT02861586|323428533|FG005|Overall Study|Lost to Follow-up|3|||
94448144|NCT02861586|323428534|FG006|Overall Study|Lost to Follow-up|0|||
94448145|NCT02861586|323428535|FG007|Overall Study|Lost to Follow-up|0|||
94448146|NCT02861586|323428528|FG000|Overall Study|Adverse Event|0|||
94448147|NCT02861586|323428529|FG001|Overall Study|Adverse Event|0|||
94448148|NCT02861586|323428530|FG002|Overall Study|Adverse Event|0|||
94448149|NCT02861586|323428531|FG003|Overall Study|Adverse Event|0|||
94448150|NCT02861586|323428532|FG004|Overall Study|Adverse Event|0|||
94448151|NCT02861586|323428533|FG005|Overall Study|Adverse Event|1|||
94448152|NCT02861586|323428534|FG006|Overall Study|Adverse Event|0|||
94448153|NCT02861586|323428535|FG007|Overall Study|Adverse Event|0|||
94448154|NCT00570687|323428536|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448155|NCT00570687|323428537|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448156|NCT00570687|323428538|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448157|NCT00570687|323428539|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448158|NCT00570687|323428540|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
94448159|NCT00570687|323428541|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
94448160|NCT00570687|323428542|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
94448161|NCT00570687|323428543|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
94448162|NCT00570687|323428544|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
94448163|NCT00570687|323428545|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
94448164|NCT00570687|323428536|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448165|NCT00570687|323428537|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448166|NCT00570687|323428538|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448167|NCT00570687|323428539|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448168|NCT00570687|323428540|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448169|NCT00570687|323428541|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448170|NCT00570687|323428542|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448171|NCT00570687|323428543|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448172|NCT00570687|323428544|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
94448173|NCT00570687|323428545|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448174|NCT00570687|323428536|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448175|NCT00570687|323428537|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448176|NCT00570687|323428538|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448177|NCT00570687|323428539|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448178|NCT00570687|323428540|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448179|NCT00570687|323428541|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448180|NCT00570687|323428542|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
94448181|NCT00570687|323428543|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448182|NCT00570687|323428544|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448183|NCT00570687|323428545|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
94448184|NCT03055338|323428546|FG000|Overall Study|Lost to Follow-up|9|||
94448185|NCT03055338|323428547|FG001|Overall Study|Lost to Follow-up|2|||
94448186|NCT03055338|323428548|FG002|Overall Study|Lost to Follow-up|3|||
94448187|NCT03055338|323428546|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
94448188|NCT03055338|323428547|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
94231330|NCT01917006|322641134|FG001|Randomized-treatment Period|Protocol Violation|0|||
94231331|NCT01917006|322641135|FG002|Randomized-treatment Period|Protocol Violation|0|||
94231332|NCT01917006|322641136|FG003|Randomized-treatment Period|Protocol Violation|0|||
94231333|NCT01917006|322641137|FG004|Randomized-treatment Period|Protocol Violation|0|||
94231334|NCT01917006|322641138|FG005|Randomized-treatment Period|Protocol Violation|0|||
94231335|NCT01917006|322641139|FG006|Randomized-treatment Period|Protocol Violation|0|||
94231336|NCT01917006|322641140|FG007|Randomized-treatment Period|Protocol Violation|0|||
94231337|NCT01917006|322641133|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
94231338|NCT01917006|322641134|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
94231339|NCT01917006|322641135|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
94231340|NCT01917006|322641136|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
94231341|NCT01917006|322641137|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
94231342|NCT01917006|322641138|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
94231343|NCT01917006|322641139|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
94231344|NCT01917006|322641140|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
94231345|NCT01917006|322641133|FG000|Open-label Period|Adverse Event|0|||
94231346|NCT01917006|322641134|FG001|Open-label Period|Adverse Event|0|||
94231347|NCT01917006|322641135|FG002|Open-label Period|Adverse Event|0|||
94231348|NCT01917006|322641136|FG003|Open-label Period|Adverse Event|0|||
94231349|NCT01917006|322641137|FG004|Open-label Period|Adverse Event|0|||
94231350|NCT01917006|322641138|FG005|Open-label Period|Adverse Event|0|||
94231351|NCT01917006|322641139|FG006|Open-label Period|Adverse Event|0|||
94231352|NCT01917006|322641140|FG007|Open-label Period|Adverse Event|1|||
94231353|NCT01917006|322641133|FG000|Open-label Period|Lost to Follow-up|0|||
94448189|NCT03055338|323428548|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
94448190|NCT03055338|323428546|FG000|Overall Study|Physician Decision|0|||
94448191|NCT03055338|323428547|FG001|Overall Study|Physician Decision|0|||
94448192|NCT03055338|323428548|FG002|Overall Study|Physician Decision|2|||
94448193|NCT03055338|323428546|FG000|Overall Study|Withdrawal by Subject|9|||
94448194|NCT03055338|323428547|FG001|Overall Study|Withdrawal by Subject|8|||
94448195|NCT03055338|323428548|FG002|Overall Study|Withdrawal by Subject|7|||
94448196|NCT00917852|323428553|FG000|Overall Study|Death|6|||
94448197|NCT04168112|323428554|FG000|Overall Study|Lost to Follow-up|1|||
94448198|NCT04168112|323428555|FG001|Overall Study|Lost to Follow-up|0|||
94448199|NCT04168112|323428554|FG000|Overall Study|Withdrawal by Subject|1|||
94448200|NCT04168112|323428555|FG001|Overall Study|Withdrawal by Subject|0|||
94448201|NCT00833105|323428564|FG000|Overall Study|Withdrawal by Subject|1|||
94448202|NCT00833105|323428564|FG000|Overall Study|Adverse Event|2|||
94448203|NCT01379768|323428568|FG000|Overall Study|Adverse Event|1|||
94448204|NCT01379768|323428569|FG001|Overall Study|Adverse Event|1|||
94448205|NCT01379768|323428570|FG002|Overall Study|Adverse Event|0|||
94448206|NCT01379768|323428568|FG000|Overall Study|Lost to Follow-up|2|||
94448207|NCT01379768|323428569|FG001|Overall Study|Lost to Follow-up|0|||
94448208|NCT01379768|323428570|FG002|Overall Study|Lost to Follow-up|0|||
94448209|NCT02044302|323428574|FG000|Overall Study|study terminated|2|||
94448210|NCT02044302|323428575|FG001|Overall Study|study terminated|0|||
94448211|NCT00092118|323428580|FG000|Overall Study|Adverse Event|35|||
94448212|NCT00092118|323428581|FG001|Overall Study|Adverse Event|32|||
94448213|NCT00092118|323428580|FG000|Overall Study|Lack of Efficacy|12|||
94448214|NCT00092118|323428581|FG001|Overall Study|Lack of Efficacy|14|||
94448215|NCT00092118|323428580|FG000|Overall Study|Lost to Follow-up|4|||
94448216|NCT00092118|323428581|FG001|Overall Study|Lost to Follow-up|3|||
94448217|NCT00092118|323428580|FG000|Overall Study|Protocol Violation|23|||
94448218|NCT00092118|323428581|FG001|Overall Study|Protocol Violation|25|||
94448219|NCT00092118|323428580|FG000|Overall Study|Withdrawal by Subject|4|||
94448220|NCT00092118|323428581|FG001|Overall Study|Withdrawal by Subject|10|||
94448221|NCT00092118|323428580|FG000|Overall Study|Other|6|||
94448222|NCT00092118|323428581|FG001|Overall Study|Other|5|||
94448223|NCT00558701|323428582|FG000|Overall Study|Protocol Deviations|1|||
94448224|NCT00558701|323428583|FG001|Overall Study|Protocol Deviations|4|||
94448225|NCT01609296|323428591|FG000|Overall Study|Death|253|||
94448226|NCT01609296|323428591|FG000|Overall Study|Withdrawal by Subject|151|||
94448227|NCT01609296|323428591|FG000|Overall Study|Lost to Follow-up|21|||
94448228|NCT01609296|323428591|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
94231354|NCT01917006|322641134|FG001|Open-label Period|Lost to Follow-up|0|||
94556147|NCT00098306|323830562|FG005|Double Blind|Participant defaulted|0|||
94231355|NCT01917006|322641135|FG002|Open-label Period|Lost to Follow-up|0|||
94448229|NCT01609296|323428591|FG000|Overall Study|missed visit but known to be alive|28|||
94448230|NCT00386360|323428592|FG000|Overall Study|Adverse Event|4|||
94448231|NCT00386360|323428593|FG001|Overall Study|Adverse Event|2|||
94448232|NCT00386360|323428592|FG000|Overall Study|Physician Decision|2|||
94448233|NCT00386360|323428593|FG001|Overall Study|Physician Decision|2|||
94448234|NCT00386360|323428592|FG000|Overall Study|Lost to Follow-up|0|||
94448235|NCT00386360|323428593|FG001|Overall Study|Lost to Follow-up|2|||
94448236|NCT00386360|323428592|FG000|Overall Study|Protocol Violation|0|||
94448237|NCT00386360|323428593|FG001|Overall Study|Protocol Violation|3|||
94556148|NCT00098306|323830563|FG006|Double Blind|Participant defaulted|0|||
94231356|NCT01917006|322641136|FG003|Open-label Period|Lost to Follow-up|0|||
94231357|NCT01917006|322641137|FG004|Open-label Period|Lost to Follow-up|0|||
94231358|NCT01917006|322641138|FG005|Open-label Period|Lost to Follow-up|0|||
94231359|NCT01917006|322641139|FG006|Open-label Period|Lost to Follow-up|0|||
94231360|NCT01917006|322641140|FG007|Open-label Period|Lost to Follow-up|1|||
94231361|NCT00816556|322641141|FG000|Overall Study|Adverse Event|1|||
94231362|NCT00816556|322641142|FG001|Overall Study|Adverse Event|1|||
94231363|NCT00816556|322641143|FG002|Overall Study|Adverse Event|1|||
94231364|NCT00816556|322641141|FG000|Overall Study|Withdrawal by Subject|1|||
94231365|NCT00816556|322641142|FG001|Overall Study|Withdrawal by Subject|1|||
94231366|NCT00816556|322641143|FG002|Overall Study|Withdrawal by Subject|1|||
94231367|NCT00816556|322641141|FG000|Overall Study|Lost to Follow-up|0|||
94231368|NCT00816556|322641142|FG001|Overall Study|Lost to Follow-up|0|||
94231369|NCT00816556|322641143|FG002|Overall Study|Lost to Follow-up|1|||
94231370|NCT04014790|322641144|FG000|Overall Study|Death|4|||
94231371|NCT04014790|322641144|FG000|Overall Study|Adverse Event|1|||
94231372|NCT04014790|322641144|FG000|Overall Study|Withdrawal by Subject|1|||
94231373|NCT03546816|322641145|FG000|Overall Study|Adverse Event|5|||
94231374|NCT03546816|322641146|FG001|Overall Study|Adverse Event|3|||
94231375|NCT03546816|322641145|FG000|Overall Study|Lack of Efficacy|2|||
94231376|NCT03546816|322641146|FG001|Overall Study|Lack of Efficacy|4|||
94231377|NCT03546816|322641145|FG000|Overall Study|Pregnancy|1|||
94231378|NCT03546816|322641146|FG001|Overall Study|Pregnancy|0|||
94231379|NCT03546816|322641145|FG000|Overall Study|Physician Decision|2|||
94231380|NCT03546816|322641146|FG001|Overall Study|Physician Decision|0|||
94231381|NCT03546816|322641145|FG000|Overall Study|Withdrawal by Subject|8|||
94231382|NCT03546816|322641146|FG001|Overall Study|Withdrawal by Subject|10|||
94231383|NCT03546816|322641145|FG000|Overall Study|Lost to Follow-up|3|||
94448238|NCT00386360|323428592|FG000|Overall Study|Withdrawal by Subject|3|||
94448239|NCT00386360|323428593|FG001|Overall Study|Withdrawal by Subject|6|||
94448240|NCT00386360|323428592|FG000|Overall Study|Did not take any study medication|0|||
94448241|NCT00386360|323428593|FG001|Overall Study|Did not take any study medication|2|||
94448242|NCT02025725|323428596|FG000|Overall Study|Adverse Event|5|||
94448243|NCT02025725|323428597|FG001|Overall Study|Adverse Event|0|||
94448244|NCT02025725|323428596|FG000|Overall Study|Lost to Follow-up|2|||
94448245|NCT02025725|323428597|FG001|Overall Study|Lost to Follow-up|0|||
94448246|NCT02025725|323428596|FG000|Overall Study|Protocol Violation|1|||
94448247|NCT02025725|323428597|FG001|Overall Study|Protocol Violation|1|||
94448248|NCT02025725|323428596|FG000|Overall Study|Withdrawal by Subject|3|||
94448249|NCT02025725|323428597|FG001|Overall Study|Withdrawal by Subject|2|||
94448250|NCT02025725|323428596|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
94448251|NCT02025725|323428597|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
94448252|NCT02418949|323428602|FG000|Overall Study|Withdrawal by Subject|1|||
94448253|NCT02418949|323428603|FG001|Overall Study|Withdrawal by Subject|0|||
94448254|NCT02418949|323428604|FG002|Overall Study|Withdrawal by Subject|1|||
94448255|NCT02418949|323428605|FG003|Overall Study|Withdrawal by Subject|1|||
94448256|NCT02418949|323428602|FG000|Overall Study|Lost to Follow-up|1|||
94448257|NCT02418949|323428603|FG001|Overall Study|Lost to Follow-up|0|||
94448258|NCT02418949|323428604|FG002|Overall Study|Lost to Follow-up|1|||
94448259|NCT02418949|323428605|FG003|Overall Study|Lost to Follow-up|0|||
94448260|NCT02418949|323428602|FG000|Overall Study|Physician Decision|1|||
94448261|NCT02418949|323428603|FG001|Overall Study|Physician Decision|1|||
94448262|NCT02418949|323428604|FG002|Overall Study|Physician Decision|1|||
94448263|NCT02418949|323428605|FG003|Overall Study|Physician Decision|0|||
94448264|NCT01422889|323428606|FG000|Overall Study|No Data Entered for Study Stent|9|||
94448265|NCT02343939|323428607|FG000|Overall Study|Death|0|||
94448266|NCT02343939|323428608|FG001|Overall Study|Death|15|||
94448267|NCT02343939|323428609|FG002|Overall Study|Death|4|||
94448268|NCT02343939|323428610|FG003|Overall Study|Death|2|||
94448269|NCT02343939|323428611|FG004|Overall Study|Death|5|||
94448270|NCT02343939|323428612|FG005|Overall Study|Death|11|||
94231384|NCT03546816|322641146|FG001|Overall Study|Lost to Follow-up|2|||
94231385|NCT01010204|322641147|FG000|Overall Study|Lost to Follow-up|2|||
94231386|NCT01010204|322641148|FG001|Overall Study|Lost to Follow-up|2|||
94231387|NCT01010204|322641147|FG000|Overall Study|Adverse Event|1|||
94231388|NCT01010204|322641148|FG001|Overall Study|Adverse Event|3|||
94448271|NCT02343939|323428613|FG006|Overall Study|Death|8|||
94448272|NCT02343939|323428614|FG007|Overall Study|Death|22|||
94448273|NCT02343939|323428615|FG008|Overall Study|Death|1|||
94448274|NCT02343939|323428607|FG000|Overall Study|Study terminated by sponsor|0|||
94448275|NCT02343939|323428608|FG001|Overall Study|Study terminated by sponsor|27|||
94448276|NCT02343939|323428609|FG002|Overall Study|Study terminated by sponsor|0|||
94448277|NCT02343939|323428610|FG003|Overall Study|Study terminated by sponsor|1|||
94448278|NCT02343939|323428611|FG004|Overall Study|Study terminated by sponsor|1|||
94448279|NCT02343939|323428612|FG005|Overall Study|Study terminated by sponsor|5|||
94448280|NCT02343939|323428613|FG006|Overall Study|Study terminated by sponsor|3|||
94448281|NCT02343939|323428614|FG007|Overall Study|Study terminated by sponsor|4|||
94448282|NCT02343939|323428615|FG008|Overall Study|Study terminated by sponsor|0|||
94231389|NCT01010204|322641147|FG000|Overall Study|Withdrawal by Subject|2|||
94231390|NCT01010204|322641148|FG001|Overall Study|Withdrawal by Subject|3|||
94231391|NCT01010204|322641147|FG000|Overall Study|psychiatric hospitalization|2|||
94231392|NCT01010204|322641148|FG001|Overall Study|psychiatric hospitalization|1|||
94231393|NCT00913523|322641153|FG000|Overall Study|Withdrawal by Subject|3|||
94231394|NCT00913523|322641154|FG001|Overall Study|Withdrawal by Subject|2|||
94231395|NCT00913523|322641155|FG002|Overall Study|Withdrawal by Subject|2|||
94231396|NCT00913523|322641153|FG000|Overall Study|Lost to Follow-up|1|||
94231397|NCT00913523|322641154|FG001|Overall Study|Lost to Follow-up|1|||
94231398|NCT00913523|322641155|FG002|Overall Study|Lost to Follow-up|1|||
94231399|NCT00913523|322641153|FG000|Overall Study|Adverse Event|1|||
94231400|NCT00913523|322641154|FG001|Overall Study|Adverse Event|0|||
94231401|NCT00913523|322641155|FG002|Overall Study|Adverse Event|0|||
94231402|NCT00913523|322641153|FG000|Overall Study|Protocol Violation|5|||
94448283|NCT02343939|323428607|FG000|Overall Study|Withdrew consent|3|||
94448284|NCT02343939|323428608|FG001|Overall Study|Withdrew consent|6|||
94448285|NCT02343939|323428609|FG002|Overall Study|Withdrew consent|1|||
94448286|NCT02343939|323428610|FG003|Overall Study|Withdrew consent|2|||
94448287|NCT02343939|323428611|FG004|Overall Study|Withdrew consent|2|||
94448288|NCT02343939|323428612|FG005|Overall Study|Withdrew consent|0|||
94448289|NCT02343939|323428613|FG006|Overall Study|Withdrew consent|0|||
94448290|NCT02343939|323428614|FG007|Overall Study|Withdrew consent|8|||
94448291|NCT02343939|323428615|FG008|Overall Study|Withdrew consent|6|||
94448292|NCT02343939|323428607|FG000|Overall Study|Treatment failure|0|||
94448293|NCT02343939|323428608|FG001|Overall Study|Treatment failure|0|||
94448294|NCT02343939|323428609|FG002|Overall Study|Treatment failure|0|||
94448295|NCT02343939|323428610|FG003|Overall Study|Treatment failure|0|||
94448296|NCT02343939|323428611|FG004|Overall Study|Treatment failure|0|||
94448297|NCT02343939|323428612|FG005|Overall Study|Treatment failure|0|||
94448298|NCT02343939|323428613|FG006|Overall Study|Treatment failure|2|||
94448299|NCT02343939|323428614|FG007|Overall Study|Treatment failure|1|||
94448300|NCT02343939|323428615|FG008|Overall Study|Treatment failure|0|||
94448301|NCT02343939|323428607|FG000|Overall Study|Investigator's discretion|0|||
94448302|NCT02343939|323428608|FG001|Overall Study|Investigator's discretion|0|||
94448303|NCT02343939|323428609|FG002|Overall Study|Investigator's discretion|0|||
94448304|NCT02343939|323428610|FG003|Overall Study|Investigator's discretion|1|||
94448305|NCT02343939|323428611|FG004|Overall Study|Investigator's discretion|0|||
94448306|NCT02343939|323428612|FG005|Overall Study|Investigator's discretion|0|||
94448307|NCT02343939|323428613|FG006|Overall Study|Investigator's discretion|1|||
94448308|NCT02343939|323428614|FG007|Overall Study|Investigator's discretion|0|||
94448309|NCT02343939|323428615|FG008|Overall Study|Investigator's discretion|0|||
94448310|NCT02343939|323428607|FG000|Overall Study|Adverse Event|0|||
94448311|NCT02343939|323428608|FG001|Overall Study|Adverse Event|0|||
94448312|NCT02343939|323428609|FG002|Overall Study|Adverse Event|0|||
94448313|NCT02343939|323428610|FG003|Overall Study|Adverse Event|0|||
94448314|NCT02343939|323428611|FG004|Overall Study|Adverse Event|0|||
94448315|NCT02343939|323428612|FG005|Overall Study|Adverse Event|1|||
94448316|NCT02343939|323428613|FG006|Overall Study|Adverse Event|0|||
94448317|NCT02343939|323428614|FG007|Overall Study|Adverse Event|0|||
94448318|NCT02343939|323428615|FG008|Overall Study|Adverse Event|0|||
94448319|NCT02343939|323428607|FG000|Overall Study|Never Treated With ENTO|0|||
94448320|NCT02343939|323428608|FG001|Overall Study|Never Treated With ENTO|0|||
94448321|NCT02343939|323428609|FG002|Overall Study|Never Treated With ENTO|0|||
94448322|NCT02343939|323428610|FG003|Overall Study|Never Treated With ENTO|0|||
94448323|NCT02343939|323428611|FG004|Overall Study|Never Treated With ENTO|0|||
94448324|NCT02343939|323428612|FG005|Overall Study|Never Treated With ENTO|0|||
94448325|NCT02343939|323428613|FG006|Overall Study|Never Treated With ENTO|1|||
94448326|NCT02343939|323428614|FG007|Overall Study|Never Treated With ENTO|2|||
94448327|NCT02343939|323428615|FG008|Overall Study|Never Treated With ENTO|0|||
94448328|NCT01303172|323428620|FG000|Overall Study|Physician Decision|9|||
94448329|NCT01303172|323428621|FG001|Overall Study|Physician Decision|6|||
94448330|NCT01303172|323428620|FG000|Overall Study|Adverse Event|5|||
94448331|NCT01303172|323428621|FG001|Overall Study|Adverse Event|2|||
94448332|NCT01303172|323428620|FG000|Overall Study|Withdrawal by Subject|4|||
94448333|NCT01303172|323428621|FG001|Overall Study|Withdrawal by Subject|2|||
94448334|NCT01303172|323428620|FG000|Overall Study|Death|20|||
94448335|NCT01303172|323428621|FG001|Overall Study|Death|7|||
94556149|NCT00098306|323830557|FG000|Double Blind|Un-specified|7|||
94556150|NCT00098306|323830558|FG001|Double Blind|Un-specified|3|||
94231403|NCT00913523|322641154|FG001|Overall Study|Protocol Violation|8|||
94231404|NCT00913523|322641155|FG002|Overall Study|Protocol Violation|8|||
94448336|NCT01303172|323428620|FG000|Overall Study|Lack of Efficacy|25|||
94448337|NCT01303172|323428621|FG001|Overall Study|Lack of Efficacy|17|||
94448338|NCT00462709|323428624|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
94448339|NCT00462709|323428624|FG000|Overall Study|Lost to Follow-up|10|||
94448340|NCT00462709|323428624|FG000|Overall Study|Withdrawal by Subject|8|||
94448341|NCT00462709|323428624|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
94448342|NCT00462709|323428624|FG000|Overall Study|Death|2|||
94448343|NCT00462709|323428624|FG000|Overall Study|Logistical reasons|2|||
94448344|NCT00462709|323428624|FG000|Overall Study|Physician Decision|1|||
94556151|NCT00098306|323830559|FG002|Double Blind|Un-specified|11|||
94556152|NCT00098306|323830560|FG003|Double Blind|Un-specified|0|||
94556153|NCT00098306|323830561|FG004|Double Blind|Un-specified|0|||
94556154|NCT00098306|323830562|FG005|Double Blind|Un-specified|0|||
94556155|NCT00098306|323830563|FG006|Double Blind|Un-specified|0|||
94556156|NCT00098306|323830557|FG000|Open Label|Lack of Efficacy|0|||
94556157|NCT00098306|323830558|FG001|Open Label|Lack of Efficacy|0|||
94556158|NCT00098306|323830559|FG002|Open Label|Lack of Efficacy|0|||
94556159|NCT00098306|323830560|FG003|Open Label|Lack of Efficacy|13|||
94556160|NCT00098306|323830561|FG004|Open Label|Lack of Efficacy|0|||
94556161|NCT00098306|323830562|FG005|Open Label|Lack of Efficacy|0|||
94556162|NCT00098306|323830563|FG006|Open Label|Lack of Efficacy|0|||
94556163|NCT00098306|323830557|FG000|Open Label|Adverse Event|0|||
94556164|NCT00098306|323830558|FG001|Open Label|Adverse Event|0|||
94556165|NCT00098306|323830559|FG002|Open Label|Adverse Event|0|||
94556166|NCT00098306|323830560|FG003|Open Label|Adverse Event|2|||
94556167|NCT00098306|323830561|FG004|Open Label|Adverse Event|0|||
94556168|NCT00098306|323830562|FG005|Open Label|Adverse Event|0|||
94556169|NCT00098306|323830563|FG006|Open Label|Adverse Event|0|||
94556170|NCT00098306|323830557|FG000|Open Label|Death|0|||
94556171|NCT00098306|323830558|FG001|Open Label|Death|0|||
94556172|NCT00098306|323830559|FG002|Open Label|Death|0|||
94556173|NCT00098306|323830560|FG003|Open Label|Death|4|||
94556174|NCT00098306|323830561|FG004|Open Label|Death|0|||
94556175|NCT00098306|323830562|FG005|Open Label|Death|0|||
94556176|NCT00098306|323830563|FG006|Open Label|Death|0|||
94556177|NCT00098306|323830557|FG000|Open Label|Participant defaulted|0|||
94556178|NCT00098306|323830558|FG001|Open Label|Participant defaulted|0|||
94556179|NCT00098306|323830559|FG002|Open Label|Participant defaulted|0|||
94556180|NCT00098306|323830560|FG003|Open Label|Participant defaulted|24|||
94556181|NCT00098306|323830561|FG004|Open Label|Participant defaulted|0|||
94556182|NCT00098306|323830562|FG005|Open Label|Participant defaulted|0|||
94556183|NCT00098306|323830563|FG006|Open Label|Participant defaulted|0|||
94556184|NCT00098306|323830557|FG000|Open Label|Un-specified|0|||
94556185|NCT00098306|323830558|FG001|Open Label|Un-specified|0|||
94556186|NCT00098306|323830559|FG002|Open Label|Un-specified|0|||
94556187|NCT00098306|323830560|FG003|Open Label|Un-specified|15|||
94556188|NCT00098306|323830561|FG004|Open Label|Un-specified|0|||
94556189|NCT00098306|323830562|FG005|Open Label|Un-specified|0|||
94556190|NCT00098306|323830563|FG006|Open Label|Un-specified|0|||
94556191|NCT00098306|323830557|FG000|Open Label|Ongoing at cut-off date|0|||
94556192|NCT00098306|323830558|FG001|Open Label|Ongoing at cut-off date|0|||
94556193|NCT00098306|323830559|FG002|Open Label|Ongoing at cut-off date|0|||
94556194|NCT00098306|323830560|FG003|Open Label|Ongoing at cut-off date|269|||
94231405|NCT00913523|322641153|FG000|Overall Study|Pregnancy|1|||
94556195|NCT00098306|323830561|FG004|Open Label|Ongoing at cut-off date|62|||
94556196|NCT00098306|323830562|FG005|Open Label|Ongoing at cut-off date|0|||
94556197|NCT00098306|323830563|FG006|Open Label|Ongoing at cut-off date|0|||
94556198|NCT00098306|323830557|FG000|Observational Phase|Death|0|||
94556199|NCT00098306|323830558|FG001|Observational Phase|Death|0|||
94231406|NCT00913523|322641154|FG001|Overall Study|Pregnancy|3|||
94231407|NCT00913523|322641155|FG002|Overall Study|Pregnancy|0|||
94231408|NCT00913523|322641153|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
94231409|NCT00913523|322641154|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
94231410|NCT00913523|322641155|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
94231411|NCT02895360|322641156|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
94231412|NCT02895360|322641157|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
94231413|NCT02895360|322641158|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
94231414|NCT02895360|322641159|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
94231415|NCT02895360|322641160|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
94231416|NCT02895360|322641161|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
94231417|NCT02895360|322641156|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
94231418|NCT02895360|322641157|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
94231419|NCT02895360|322641158|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
94231420|NCT02895360|322641159|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
94231421|NCT02895360|322641160|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
94231422|NCT02895360|322641161|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
94231423|NCT02895360|322641156|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
94231424|NCT02895360|322641157|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
94231425|NCT02895360|322641158|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
94231426|NCT02895360|322641159|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
94231427|NCT02895360|322641160|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
94231428|NCT02895360|322641161|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
94231429|NCT02895360|322641156|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
94231430|NCT02895360|322641157|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
94231431|NCT02895360|322641158|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
94231432|NCT02895360|322641159|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
94231433|NCT02895360|322641160|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
94231434|NCT02895360|322641161|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
94231435|NCT02895360|322641156|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
94231436|NCT02895360|322641157|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
94231437|NCT02895360|322641158|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
94231438|NCT02895360|322641159|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
94231439|NCT02895360|322641160|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
94231440|NCT02895360|322641161|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
94231441|NCT02895360|322641156|FG000|Phase 2a|Adverse Event|0|||
94231442|NCT02895360|322641157|FG001|Phase 2a|Adverse Event|0|||
94231443|NCT02895360|322641158|FG002|Phase 2a|Adverse Event|0|||
94231444|NCT02895360|322641159|FG003|Phase 2a|Adverse Event|0|||
94231445|NCT02895360|322641160|FG004|Phase 2a|Adverse Event|0|||
94231446|NCT02895360|322641161|FG005|Phase 2a|Adverse Event|1|||
94231447|NCT02895360|322641156|FG000|Phase 2a|Progressive disease|0|||
94231448|NCT02895360|322641157|FG001|Phase 2a|Progressive disease|0|||
94231449|NCT02895360|322641158|FG002|Phase 2a|Progressive disease|0|||
94231450|NCT02895360|322641159|FG003|Phase 2a|Progressive disease|0|||
94231451|NCT02895360|322641160|FG004|Phase 2a|Progressive disease|11|||
94231452|NCT02895360|322641161|FG005|Phase 2a|Progressive disease|11|||
94231453|NCT00916305|322641162|FG000|Overall Study|Lost to Follow-up|21|||
94231454|NCT00916305|322641163|FG001|Overall Study|Lost to Follow-up|27|||
94231455|NCT00916305|322641162|FG000|Overall Study|Withdrawal by Subject|0|||
94231456|NCT00916305|322641163|FG001|Overall Study|Withdrawal by Subject|1|||
94231457|NCT04051242|322641164|FG000|Overall Study|Withdrawal by Subject|1|||
94344212|NCT02531633|323040013|FG009|Part B (104 Weeks)|Sponsor request|4|||
94344213|NCT02531633|323040004|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
94344214|NCT02531633|323040005|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
94344215|NCT02531633|323040006|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
94344216|NCT02531633|323040007|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
94344217|NCT02531633|323040008|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
94344218|NCT02531633|323040009|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
94344219|NCT02531633|323040010|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
94344220|NCT02531633|323040011|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
94344221|NCT02531633|323040012|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
94344222|NCT02531633|323040013|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
94344223|NCT01572844|323040014|FG000|Overall Study|Physician Decision|1|||
94344224|NCT01572844|323040015|FG001|Overall Study|Physician Decision|1|||
94344225|NCT03661983|323040017|FG000|Open Label Stabilization Phase|Adverse Event|5|||
94344226|NCT03661983|323040018|FG001|Open Label Stabilization Phase|Adverse Event|0|||
94344227|NCT03661983|323040019|FG002|Open Label Stabilization Phase|Adverse Event|0|||
94344228|NCT03661983|323040020|FG003|Open Label Stabilization Phase|Adverse Event|0|||
94344229|NCT03661983|323040017|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
94344230|NCT03661983|323040018|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
94344231|NCT03661983|323040019|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
94231458|NCT04051242|322641164|FG000|Overall Study|Physician Decision|1|||
94344232|NCT03661983|323040020|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
94556200|NCT00098306|323830559|FG002|Observational Phase|Death|0|||
94344233|NCT03661983|323040017|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
94344234|NCT03661983|323040018|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
94344235|NCT03661983|323040019|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
94344236|NCT03661983|323040020|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
94344237|NCT03661983|323040017|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
94344238|NCT03661983|323040018|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
94344239|NCT03661983|323040019|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
94344240|NCT03661983|323040020|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
94344241|NCT03661983|323040017|FG000|Double-blind Randomized Phase|Adverse Event|0|||
94344242|NCT03661983|323040018|FG001|Double-blind Randomized Phase|Adverse Event|1|||
94344243|NCT03661983|323040019|FG002|Double-blind Randomized Phase|Adverse Event|0|||
94344244|NCT03661983|323040020|FG003|Double-blind Randomized Phase|Adverse Event|0|||
94344245|NCT03661983|323040017|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
94344246|NCT03661983|323040018|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
94344247|NCT03661983|323040019|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
94344248|NCT03661983|323040020|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
94344249|NCT03661983|323040017|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
94344250|NCT03661983|323040018|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
94344251|NCT03661983|323040019|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
94344252|NCT03661983|323040020|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
94344253|NCT03661983|323040017|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
94344254|NCT03661983|323040018|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
94344255|NCT03661983|323040019|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
94344256|NCT03661983|323040020|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
94344257|NCT01320033|323040023|FG000|Overall Study|Lack of Efficacy|0|||
94344258|NCT01320033|323040024|FG001|Overall Study|Lack of Efficacy|0|||
94344259|NCT01320033|323040025|FG002|Overall Study|Lack of Efficacy|1|||
94344260|NCT01320033|323040023|FG000|Overall Study|Adverse Event|9|||
94344261|NCT01320033|323040024|FG001|Overall Study|Adverse Event|7|||
94344262|NCT01320033|323040025|FG002|Overall Study|Adverse Event|8|||
94344263|NCT01320033|323040023|FG000|Overall Study|Withdrawal by Subject|22|||
94344264|NCT01320033|323040024|FG001|Overall Study|Withdrawal by Subject|23|||
94344265|NCT01320033|323040025|FG002|Overall Study|Withdrawal by Subject|23|||
94344266|NCT01320033|323040023|FG000|Overall Study|Protocol Violation|3|||
94344267|NCT01320033|323040024|FG001|Overall Study|Protocol Violation|5|||
94344268|NCT01320033|323040025|FG002|Overall Study|Protocol Violation|3|||
94344269|NCT01320033|323040023|FG000|Overall Study|Lost to Follow-up|22|||
94344270|NCT01320033|323040024|FG001|Overall Study|Lost to Follow-up|26|||
94344271|NCT01320033|323040025|FG002|Overall Study|Lost to Follow-up|17|||
94344272|NCT01320033|323040023|FG000|Overall Study|Other|2|||
94344273|NCT01320033|323040024|FG001|Overall Study|Other|3|||
94344274|NCT01320033|323040025|FG002|Overall Study|Other|1|||
94344275|NCT01938391|323040031|FG000|6 Month Follow up|Withdrawal by Subject|1|||
94344276|NCT01938391|323040031|FG000|12 Month Follow up|Physician Decision|1|||
94344277|NCT01938391|323040031|FG000|12 Month Follow up|Withdrawal by Subject|1|||
94448345|NCT00462709|323428624|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
94448346|NCT00425750|323428625|FG000|Overall Study|Death|1|||
94448347|NCT00425750|323428625|FG000|Overall Study|Withdrawal by Subject|3|||
94448348|NCT00425750|323428625|FG000|Overall Study|Adverse Event|3|||
94448349|NCT00425750|323428625|FG000|Overall Study|Progression of disease|18|||
94448350|NCT04339062|323428626|FG000|Overall Study|Death|0|||
94448351|NCT04339062|323428627|FG001|Overall Study|Death|1|||
94448352|NCT01197534|323428628|FG000|Overall Study|Not reported|16|||
94448353|NCT01197534|323428629|FG001|Overall Study|Not reported|10|||
94448354|NCT01197534|323428630|FG002|Overall Study|Not reported|16|||
94448355|NCT01197534|323428628|FG000|Overall Study|Enrolment in long term extension|57|||
94448356|NCT01197534|323428629|FG001|Overall Study|Enrolment in long term extension|66|||
94448357|NCT01197534|323428630|FG002|Overall Study|Enrolment in long term extension|119|||
94448358|NCT01197534|323428628|FG000|Overall Study|Severe non-compliance to protocol|3|||
94448359|NCT01197534|323428629|FG001|Overall Study|Severe non-compliance to protocol|4|||
94448360|NCT01197534|323428630|FG002|Overall Study|Severe non-compliance to protocol|1|||
94448361|NCT01197534|323428628|FG000|Overall Study|Lack of therapeutic response|9|||
94448362|NCT01197534|323428629|FG001|Overall Study|Lack of therapeutic response|4|||
94448363|NCT01197534|323428630|FG002|Overall Study|Lack of therapeutic response|9|||
94448364|NCT01197534|323428628|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
94344278|NCT01077193|323040038|FG000|Overall Study|Lost to Follow-up|1|||
94344279|NCT01077193|323040038|FG000|Overall Study|Withdrawal by Subject|2|||
94448365|NCT01197534|323428629|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
94448366|NCT01197534|323428630|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
94448367|NCT01197534|323428628|FG000|Overall Study|Lost to Follow-up|1|||
94448368|NCT01197534|323428629|FG001|Overall Study|Lost to Follow-up|4|||
94448369|NCT01197534|323428630|FG002|Overall Study|Lost to Follow-up|2|||
94556201|NCT00098306|323830560|FG003|Observational Phase|Death|0|||
94556202|NCT00098306|323830561|FG004|Observational Phase|Death|0|||
94556203|NCT00098306|323830562|FG005|Observational Phase|Death|5|||
94556204|NCT00098306|323830563|FG006|Observational Phase|Death|4|||
94556205|NCT00098306|323830557|FG000|Observational Phase|Participant defaulted|0|||
94556206|NCT00098306|323830558|FG001|Observational Phase|Participant defaulted|0|||
94556207|NCT00098306|323830559|FG002|Observational Phase|Participant defaulted|0|||
94556208|NCT00098306|323830560|FG003|Observational Phase|Participant defaulted|0|||
94556209|NCT00098306|323830561|FG004|Observational Phase|Participant defaulted|0|||
94556210|NCT00098306|323830562|FG005|Observational Phase|Participant defaulted|34|||
94556211|NCT00098306|323830563|FG006|Observational Phase|Participant defaulted|18|||
94556212|NCT00098306|323830557|FG000|Observational Phase|Un-specified|0|||
94556213|NCT00098306|323830558|FG001|Observational Phase|Un-specified|0|||
94556214|NCT00098306|323830559|FG002|Observational Phase|Un-specified|0|||
94556215|NCT00098306|323830560|FG003|Observational Phase|Un-specified|0|||
94556216|NCT00098306|323830561|FG004|Observational Phase|Un-specified|0|||
94556217|NCT00098306|323830562|FG005|Observational Phase|Un-specified|7|||
94556218|NCT00098306|323830563|FG006|Observational Phase|Un-specified|4|||
94556219|NCT01423916|323830564|FG000|Overall Study|Adverse Event|5|||
94556220|NCT01423916|323830565|FG001|Overall Study|Adverse Event|9|||
94556221|NCT01423916|323830566|FG002|Overall Study|Adverse Event|2|||
94556222|NCT01423916|323830564|FG000|Overall Study|Met Withdrawal Criteria|1|||
94556223|NCT01423916|323830565|FG001|Overall Study|Met Withdrawal Criteria|1|||
94556224|NCT01423916|323830566|FG002|Overall Study|Met Withdrawal Criteria|1|||
94556225|NCT01423916|323830564|FG000|Overall Study|Physician Decision|1|||
94556226|NCT01423916|323830565|FG001|Overall Study|Physician Decision|0|||
94556227|NCT01423916|323830566|FG002|Overall Study|Physician Decision|1|||
94556228|NCT01423916|323830564|FG000|Overall Study|Withdrawal by Subject|3|||
94556229|NCT01423916|323830565|FG001|Overall Study|Withdrawal by Subject|10|||
94556230|NCT01423916|323830566|FG002|Overall Study|Withdrawal by Subject|3|||
94556231|NCT01423916|323830564|FG000|Overall Study|Protocol Deviation|1|||
94556232|NCT01423916|323830565|FG001|Overall Study|Protocol Deviation|0|||
94556233|NCT01423916|323830566|FG002|Overall Study|Protocol Deviation|0|||
94344280|NCT01077193|323040038|FG000|Overall Study|Lack of Efficacy|1|||
94344281|NCT01077193|323040038|FG000|Overall Study|Study Terminated by Sponsor|40|||
94556234|NCT00077649|323830577|FG000|Overall Study|Adverse Event|5|||
94556235|NCT00077649|323830578|FG001|Overall Study|Adverse Event|1|||
94556236|NCT00077649|323830579|FG002|Overall Study|Adverse Event|7|||
94556237|NCT00077649|323830580|FG003|Overall Study|Adverse Event|9|||
94344282|NCT02094612|323040047|FG000|Overall Study|Lost to Follow-up|47|||
94344283|NCT02094612|323040048|FG001|Overall Study|Lost to Follow-up|47|||
94344284|NCT02094612|323040047|FG000|Overall Study|Never started ADHD medication|32|||
94344285|NCT02094612|323040048|FG001|Overall Study|Never started ADHD medication|23|||
94344286|NCT00378534|323040051|FG000|Overall Study|Participants did not receive transplant|3|||
94344287|NCT00378534|323040052|FG001|Overall Study|Participants did not receive transplant|0|||
94344288|NCT03345849|323040053|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
94344289|NCT03345849|323040054|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
94344290|NCT03345849|323040055|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
94344291|NCT03345849|323040056|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
94344292|NCT03345849|323040053|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
94344293|NCT03345849|323040054|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
94344294|NCT03345849|323040055|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
94344295|NCT03345849|323040056|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
94344296|NCT03345849|323040053|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
94344297|NCT03345849|323040054|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
94344298|NCT03345849|323040055|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
94344299|NCT03345849|323040056|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
94344300|NCT03345849|323040053|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
94344301|NCT03345849|323040054|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
94344302|NCT03345849|323040055|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
94344303|NCT03345849|323040056|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
94344304|NCT03345849|323040053|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
94344305|NCT03345849|323040054|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
94344306|NCT03345849|323040055|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
94556238|NCT00077649|323830577|FG000|Overall Study|Lack of Efficacy|5|||
94231459|NCT00302159|322641167|FG000|Overall Study|pt declined before treatment started|1|||
94231460|NCT00302159|322641167|FG000|Overall Study|pt started Avastin|1|||
94231461|NCT00025506|322641168|FG000|Overall Study|Ineligible: clerical error|1|||
94556239|NCT00077649|323830578|FG001|Overall Study|Lack of Efficacy|3|||
94556240|NCT00077649|323830579|FG002|Overall Study|Lack of Efficacy|3|||
94556241|NCT00077649|323830580|FG003|Overall Study|Lack of Efficacy|2|||
94556242|NCT00077649|323830577|FG000|Overall Study|Withdrawal by Subject|0|||
94556243|NCT00077649|323830578|FG001|Overall Study|Withdrawal by Subject|1|||
94556244|NCT00077649|323830579|FG002|Overall Study|Withdrawal by Subject|1|||
94556245|NCT00077649|323830580|FG003|Overall Study|Withdrawal by Subject|2|||
94231462|NCT00025506|322641168|FG000|Overall Study|Ineligible: wrong cell type|5|||
94231463|NCT00025506|322641168|FG000|Overall Study|Ineligible: inadequate pathology|2|||
94231464|NCT00025506|322641168|FG000|Overall Study|Never Treated|2|||
94231465|NCT00827775|322641170|FG000|Overall Study|Withdrawal by Subject|0|||
94231466|NCT00827775|322641171|FG001|Overall Study|Withdrawal by Subject|5|||
94231467|NCT01585298|322641174|FG000|Overall Study|Study completion was not documented.|1|||
94231468|NCT01585298|322641174|FG000|Overall Study|Protocol deviation|1|||
94231469|NCT01585298|322641174|FG000|Overall Study|Administrative problems|4|||
94231470|NCT01585298|322641174|FG000|Overall Study|Lost to Follow-up|2|||
94231471|NCT01585298|322641174|FG000|Overall Study|Withdrawal by Subject|4|||
94231472|NCT01585298|322641174|FG000|Overall Study|Abnormal test procedure results|1|||
94231473|NCT01585298|322641174|FG000|Overall Study|Adverse Event|24|||
94231474|NCT01747837|322641176|FG000|Overall Study|Lost to Follow-up|5|||
94231475|NCT01747837|322641177|FG001|Overall Study|Lost to Follow-up|2|||
94231476|NCT01747837|322641176|FG000|Overall Study|Death|4|||
94231477|NCT01747837|322641177|FG001|Overall Study|Death|4|||
94231478|NCT02108652|322641179|FG000|Overall Study|Death|253|||
94231479|NCT02108652|322641179|FG000|Overall Study|Lost to Follow-up|2|||
94231480|NCT02108652|322641179|FG000|Overall Study|Withdrawal by Subject|16|||
94231481|NCT02108652|322641179|FG000|Overall Study|Study Terminated By Sponsor|31|||
94231482|NCT02108652|322641179|FG000|Overall Study|Non-Compliance|1|||
94231483|NCT02108652|322641179|FG000|Overall Study|Physician Decision|6|||
94231484|NCT02108652|322641179|FG000|Overall Study|Progression Of Disease|1|||
94556246|NCT00077649|323830577|FG000|Overall Study|Lost to Follow-up|2|||
94556247|NCT00077649|323830578|FG001|Overall Study|Lost to Follow-up|2|||
94231485|NCT01182181|322641182|FG000|First Intervention|Adverse Event|1|||
94231486|NCT01182181|322641183|FG001|First Intervention|Adverse Event|0|||
94231487|NCT01182181|322641182|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
94231488|NCT01182181|322641183|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
94231489|NCT06390826|322641184|FG000|Overall Study|Never Start Protocol Therapy|1|||
94231490|NCT06390826|322641184|FG000|Overall Study|Adverse Event|1|||
94231491|NCT06390826|322641184|FG000|Overall Study|Disease Progression|8|||
94231492|NCT00545571|322641186|FG000|Overall Study|Administrative Reasons|1|||
94231493|NCT00545571|322641186|FG000|Overall Study|Adverse Event|2|||
94231494|NCT00545571|322641186|FG000|Overall Study|Death|5|||
94231495|NCT00545571|322641186|FG000|Overall Study|Lack of Efficacy|1|||
94231496|NCT00545571|322641186|FG000|Overall Study|Protocol Violation|2|||
94231497|NCT00545571|322641186|FG000|Overall Study|Refused Treatment|1|||
94231498|NCT00545571|322641186|FG000|Overall Study|Screen Failure|16|||
94231499|NCT00545571|322641186|FG000|Overall Study|Transfusion|12|||
94231500|NCT00545571|322641186|FG000|Overall Study|Early Termination of Study|24|||
94231501|NCT00545571|322641186|FG000|Overall Study|Kidney Transplantation|3|||
94231502|NCT04035577|322641187|FG000|Overall Study|Lost to Follow-up|1|||
94231503|NCT04035577|322641187|FG000|Overall Study|Withdrawal by Subject|1|||
94231504|NCT01313624|322641188|FG000|Double-Blind Phase|Adverse Event|27|||
94231505|NCT01313624|322641189|FG001|Double-Blind Phase|Adverse Event|4|||
94231506|NCT01313624|322641188|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
94231507|NCT01313624|322641189|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
94231508|NCT01313624|322641188|FG000|Double-Blind Phase|Lost to Follow-up|0|||
94231509|NCT01313624|322641189|FG001|Double-Blind Phase|Lost to Follow-up|2|||
94231510|NCT01313624|322641188|FG000|Double-Blind Phase|Physician Decision|1|||
94556248|NCT00077649|323830579|FG002|Overall Study|Lost to Follow-up|3|||
94556249|NCT00077649|323830580|FG003|Overall Study|Lost to Follow-up|2|||
94231511|NCT01313624|322641189|FG001|Double-Blind Phase|Physician Decision|0|||
94231512|NCT01313624|322641188|FG000|Double-Blind Phase|Lack of Efficacy|1|||
94231513|NCT01313624|322641189|FG001|Double-Blind Phase|Lack of Efficacy|0|||
94344307|NCT03345849|323040056|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
94231514|NCT01313624|322641188|FG000|Open-Label Phase|Adverse Event|1|||
94231515|NCT01313624|322641189|FG001|Open-Label Phase|Adverse Event|10|||
94231516|NCT01313624|322641188|FG000|Open-Label Phase|Withdrawal by Subject|2|||
94231517|NCT01313624|322641189|FG001|Open-Label Phase|Withdrawal by Subject|2|||
94231518|NCT01313624|322641188|FG000|Open-Label Phase|Lost to Follow-up|1|||
94231519|NCT01313624|322641189|FG001|Open-Label Phase|Lost to Follow-up|1|||
94231520|NCT01017263|322641190|FG000|Overall Study|not eligible|12|||
94231521|NCT00846768|322641191|FG000|Overall Study|Adverse Event|0|||
94556250|NCT00077649|323830577|FG000|Overall Study|Abnormality of Laboratory Test|1|||
94231522|NCT00846768|322641192|FG001|Overall Study|Adverse Event|1|||
94556251|NCT00077649|323830578|FG001|Overall Study|Abnormality of Laboratory Test|2|||
94231523|NCT00846768|322641193|FG002|Overall Study|Adverse Event|0|||
94231524|NCT00846768|322641194|FG003|Overall Study|Adverse Event|0|||
94231525|NCT00857233|322641195|FG000|Overall Study|Adverse Event|24|||
94231526|NCT00857233|322641195|FG000|Overall Study|Lack of Efficacy|1|||
94231527|NCT00857233|322641195|FG000|Overall Study|Non-compliance|1|||
94231528|NCT00857233|322641195|FG000|Overall Study|Withdrawal of Consent|9|||
94231529|NCT00857233|322641195|FG000|Overall Study|Lost to Follow-up|4|||
94231530|NCT00857233|322641195|FG000|Overall Study|Nursing Home Placement|14|||
94231531|NCT00857233|322641195|FG000|Overall Study|Other Reasons|2|||
94231532|NCT01587118|322641196|FG000|Overall Study|Adverse Event|3|||
94231533|NCT01587118|322641196|FG000|Overall Study|Lost to Follow-up|2|||
94231534|NCT01587118|322641196|FG000|Overall Study|Relocation|1|||
94231535|NCT01587118|322641196|FG000|Overall Study|nonresponse|1|||
94231536|NCT03599622|322641197|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
94231537|NCT03599622|322641198|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
94231538|NCT03599622|322641199|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
94231539|NCT03599622|322641200|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
94231540|NCT03599622|322641197|FG000|Pre-Treatment Period|Other reasons|1|||
94231541|NCT03599622|322641198|FG001|Pre-Treatment Period|Other reasons|1|||
94231542|NCT03599622|322641199|FG002|Pre-Treatment Period|Other reasons|1|||
94231543|NCT03599622|322641200|FG003|Pre-Treatment Period|Other reasons|0|||
94231544|NCT03599622|322641197|FG000|Treatment Period|Adverse Event|11|||
94231545|NCT03599622|322641198|FG001|Treatment Period|Adverse Event|20|||
94231546|NCT03599622|322641199|FG002|Treatment Period|Adverse Event|18|||
94231547|NCT03599622|322641200|FG003|Treatment Period|Adverse Event|2|||
94231548|NCT03599622|322641197|FG000|Treatment Period|Lack of Efficacy|18|||
94231549|NCT03599622|322641198|FG001|Treatment Period|Lack of Efficacy|12|||
94231550|NCT03599622|322641199|FG002|Treatment Period|Lack of Efficacy|13|||
94231551|NCT03599622|322641200|FG003|Treatment Period|Lack of Efficacy|2|||
94231552|NCT03599622|322641197|FG000|Treatment Period|Withdrawal by Subject|5|||
94231553|NCT03599622|322641198|FG001|Treatment Period|Withdrawal by Subject|11|||
94231554|NCT03599622|322641199|FG002|Treatment Period|Withdrawal by Subject|16|||
94231555|NCT03599622|322641200|FG003|Treatment Period|Withdrawal by Subject|1|||
94231556|NCT03599622|322641197|FG000|Treatment Period|Other reasons|4|||
94231557|NCT03599622|322641198|FG001|Treatment Period|Other reasons|6|||
94231558|NCT03599622|322641199|FG002|Treatment Period|Other reasons|7|||
94231559|NCT03599622|322641200|FG003|Treatment Period|Other reasons|0|||
94231560|NCT03599622|322641197|FG000|Treatment Period|Lost to Follow-up|1|||
94231561|NCT03599622|322641198|FG001|Treatment Period|Lost to Follow-up|0|||
94231562|NCT03599622|322641199|FG002|Treatment Period|Lost to Follow-up|0|||
94344308|NCT03345849|323040053|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
94344309|NCT03345849|323040054|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
94344310|NCT03345849|323040055|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
94344311|NCT03345849|323040056|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
94344312|NCT03345849|323040053|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
94344313|NCT03345849|323040054|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
94344314|NCT03345849|323040055|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
94344315|NCT03345849|323040056|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
94344316|NCT03345849|323040053|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
94344317|NCT03345849|323040054|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
94344318|NCT03345849|323040055|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
94344319|NCT03345849|323040056|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
94344320|NCT03345849|323040053|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
94344321|NCT03345849|323040054|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
94344322|NCT03345849|323040055|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
94344323|NCT03345849|323040056|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
94344324|NCT03345849|323040053|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
94344325|NCT03345849|323040054|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
94344326|NCT03345849|323040055|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
94344327|NCT03345849|323040056|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
94344328|NCT03345849|323040053|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
94344329|NCT03345849|323040054|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
94556252|NCT00077649|323830579|FG002|Overall Study|Abnormality of Laboratory Test|1|||
94231563|NCT03599622|322641200|FG003|Treatment Period|Lost to Follow-up|0|||
94231564|NCT03599622|322641197|FG000|Treatment Period|Study terminated by sponsor|7|||
94231565|NCT03599622|322641198|FG001|Treatment Period|Study terminated by sponsor|20|||
94231566|NCT03599622|322641199|FG002|Treatment Period|Study terminated by sponsor|15|||
94231567|NCT03599622|322641200|FG003|Treatment Period|Study terminated by sponsor|0|||
94231568|NCT03599622|322641197|FG000|Treatment Period|Site terminated by sponsor|0|||
94231569|NCT03599622|322641198|FG001|Treatment Period|Site terminated by sponsor|1|||
94231570|NCT03599622|322641199|FG002|Treatment Period|Site terminated by sponsor|0|||
94556253|NCT00077649|323830580|FG003|Overall Study|Abnormality of Laboratory Test|2|||
94556254|NCT00077649|323830577|FG000|Overall Study|Randomized but never dosed|1|||
94556255|NCT00077649|323830578|FG001|Overall Study|Randomized but never dosed|0|||
94556256|NCT00077649|323830579|FG002|Overall Study|Randomized but never dosed|0|||
94556257|NCT00077649|323830580|FG003|Overall Study|Randomized but never dosed|0|||
94556258|NCT01894022|323830584|FG000|Overall Study|Death|1|||
94556259|NCT01894022|323830585|FG001|Overall Study|Death|0|||
94556260|NCT01894022|323830584|FG000|Overall Study|Adverse Event, non-fatal|1|||
94556261|NCT01894022|323830585|FG001|Overall Study|Adverse Event, non-fatal|0|||
94556262|NCT01894022|323830584|FG000|Overall Study|Study Closed/terminated|7|||
94556263|NCT01894022|323830585|FG001|Overall Study|Study Closed/terminated|10|||
94556264|NCT01361178|323830588|FG000|Overall Study|Death|13|||
94556265|NCT01361178|323830589|FG001|Overall Study|Death|0|||
94556266|NCT03916081|323830594|FG000|Overall Study|Adverse Event|1|||
94556267|NCT03916081|323830595|FG001|Overall Study|Adverse Event|0|||
94556268|NCT03916081|323830596|FG002|Overall Study|Adverse Event|0|||
94556269|NCT03916081|323830594|FG000|Overall Study|Physician Decision|0|||
94556270|NCT03916081|323830595|FG001|Overall Study|Physician Decision|0|||
94556271|NCT03916081|323830596|FG002|Overall Study|Physician Decision|1|||
94556272|NCT03916081|323830594|FG000|Overall Study|Lost to Follow-up|0|||
94556273|NCT03916081|323830595|FG001|Overall Study|Lost to Follow-up|1|||
94556274|NCT03916081|323830596|FG002|Overall Study|Lost to Follow-up|0|||
94231571|NCT03599622|322641200|FG003|Treatment Period|Site terminated by sponsor|0|||
94231572|NCT00905359|322641205|FG000|Overall Study|Lost to Follow-up|17|||
94231573|NCT00905359|322641206|FG001|Overall Study|Lost to Follow-up|10|||
94231574|NCT00905359|322641205|FG000|Overall Study|Death|2|||
94231575|NCT00905359|322641206|FG001|Overall Study|Death|0|||
94231576|NCT00905359|322641205|FG000|Overall Study|Withdrawal consent|5|||
94556275|NCT03916081|323830594|FG000|Overall Study|Withdrawal by Subject|3|||
94556276|NCT03916081|323830595|FG001|Overall Study|Withdrawal by Subject|0|||
94556277|NCT03916081|323830596|FG002|Overall Study|Withdrawal by Subject|1|||
94556278|NCT03916081|323830594|FG000|Overall Study|Worsening of AD|0|||
94556279|NCT03916081|323830595|FG001|Overall Study|Worsening of AD|0|||
94556280|NCT03916081|323830596|FG002|Overall Study|Worsening of AD|1|||
94231577|NCT00905359|322641206|FG001|Overall Study|Withdrawal consent|6|||
94231578|NCT02654132|322641209|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
94231579|NCT02654132|322641210|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
94231580|NCT02654132|322641209|FG000|Treatment Period|Disease progression|43|||
94231581|NCT02654132|322641210|FG001|Treatment Period|Disease progression|38|||
94231582|NCT02654132|322641209|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
94231583|NCT02654132|322641210|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
94556281|NCT00465647|323830599|FG000|Overall Study|Administrative|2|||
94231584|NCT02654132|322641209|FG000|Treatment Period|Other reasons|4|||
94231585|NCT02654132|322641210|FG001|Treatment Period|Other reasons|2|||
94231586|NCT02654132|322641209|FG000|Treatment Period|Study drug toxicity|2|||
94231587|NCT02654132|322641210|FG001|Treatment Period|Study drug toxicity|2|||
94231588|NCT02654132|322641209|FG000|Treatment Period|Withdrawal by Subject|2|||
94231589|NCT02654132|322641210|FG001|Treatment Period|Withdrawal by Subject|1|||
94231590|NCT02654132|322641209|FG000|Treatment Period|Maximum Clinical Benefit|0|||
94231591|NCT02654132|322641210|FG001|Treatment Period|Maximum Clinical Benefit|2|||
94231592|NCT02654132|322641209|FG000|Treatment Period|Participant request to discontinue|2|||
94231593|NCT02654132|322641210|FG001|Treatment Period|Participant request to discontinue|0|||
94231594|NCT02654132|322641209|FG000|Treatment Period|Administrative reasons by sponsor|0|||
94231595|NCT02654132|322641210|FG001|Treatment Period|Administrative reasons by sponsor|1|||
94231596|NCT02654132|322641209|FG000|Treatment Period|Death|1|||
94231597|NCT02654132|322641210|FG001|Treatment Period|Death|0|||
94231598|NCT00468130|322641215|FG000|Overall Study|Adverse Event|2|||
94231599|NCT00468130|322641216|FG001|Overall Study|Adverse Event|1|||
94231600|NCT00468130|322641215|FG000|Overall Study|Withdrawal by Subject|0|||
94231601|NCT00468130|322641216|FG001|Overall Study|Withdrawal by Subject|1|||
94231602|NCT02485899|322641217|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
94231603|NCT02485899|322641218|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
94556282|NCT00465647|323830600|FG001|Overall Study|Administrative|2|||
94556283|NCT00465647|323830601|FG002|Overall Study|Administrative|3|||
94556284|NCT00465647|323830602|FG003|Overall Study|Administrative|2|||
94556285|NCT00465647|323830599|FG000|Overall Study|Adverse Event|2|||
94231604|NCT02485899|322641217|FG000|Overall Study|Withdrawal by Subject|1|||
94231605|NCT02485899|322641218|FG001|Overall Study|Withdrawal by Subject|0|||
94231606|NCT02485899|322641217|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
94231607|NCT02485899|322641218|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
94231608|NCT01006889|322641219|FG000|Overall Study|Withdrawal by Subject|3|||
94231609|NCT00912223|322641222|FG000|Overall Study|Withdrawal by Subject|1|||
94231610|NCT00912223|322641222|FG000|Overall Study|Not transplanted|1|||
94556286|NCT00465647|323830600|FG001|Overall Study|Adverse Event|0|||
94556287|NCT00465647|323830601|FG002|Overall Study|Adverse Event|3|||
94556288|NCT00465647|323830602|FG003|Overall Study|Adverse Event|2|||
94556289|NCT00465647|323830599|FG000|Overall Study|Withdrawal by Subject|1|||
94448370|NCT01197534|323428628|FG000|Overall Study|Adverse Event|35|||
94448371|NCT01197534|323428629|FG001|Overall Study|Adverse Event|36|||
94448372|NCT01197534|323428630|FG002|Overall Study|Adverse Event|24|||
94448373|NCT00450437|323428635|FG000|Overall Study|Withdrawal by Subject|10|||
94448374|NCT00450437|323428636|FG001|Overall Study|Withdrawal by Subject|2|||
94448375|NCT00450437|323428637|FG002|Overall Study|Withdrawal by Subject|0|||
94448376|NCT00450437|323428638|FG003|Overall Study|Withdrawal by Subject|1|||
94448377|NCT00450437|323428635|FG000|Overall Study|Lost to Follow-up|31|||
94448378|NCT00450437|323428636|FG001|Overall Study|Lost to Follow-up|12|||
94448379|NCT00450437|323428637|FG002|Overall Study|Lost to Follow-up|19|||
94448380|NCT00450437|323428638|FG003|Overall Study|Lost to Follow-up|9|||
94448381|NCT00450437|323428635|FG000|Overall Study|Protocol Violation|0|||
94448382|NCT00450437|323428636|FG001|Overall Study|Protocol Violation|1|||
94448383|NCT00450437|323428637|FG002|Overall Study|Protocol Violation|0|||
94448384|NCT00450437|323428638|FG003|Overall Study|Protocol Violation|1|||
94448385|NCT00450437|323428635|FG000|Overall Study|Inappropriate enrollment|4|||
94448386|NCT00450437|323428636|FG001|Overall Study|Inappropriate enrollment|1|||
94448387|NCT00450437|323428637|FG002|Overall Study|Inappropriate enrollment|3|||
94448388|NCT00450437|323428638|FG003|Overall Study|Inappropriate enrollment|0|||
94448389|NCT00450437|323428635|FG000|Overall Study|Administrative reason|0|||
94556290|NCT00465647|323830600|FG001|Overall Study|Withdrawal by Subject|2|||
94556291|NCT00465647|323830601|FG002|Overall Study|Withdrawal by Subject|2|||
94556292|NCT00465647|323830602|FG003|Overall Study|Withdrawal by Subject|7|||
94556293|NCT00465647|323830599|FG000|Overall Study|"The other reasons included loss of IV"|8|||
94556294|NCT00465647|323830600|FG001|Overall Study|"The other reasons included loss of IV"|4|||
94556295|NCT00465647|323830601|FG002|Overall Study|"The other reasons included loss of IV"|3|||
94556296|NCT00465647|323830602|FG003|Overall Study|"The other reasons included loss of IV"|2|||
94556297|NCT01240135|323830603|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
94556298|NCT01240135|323830604|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
94556299|NCT01240135|323830603|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
94556300|NCT01240135|323830604|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
94556301|NCT02106403|323830605|FG000|Follow-Up Visit 3|Other Reason|0|||
94556302|NCT02106403|323830606|FG001|Follow-Up Visit 3|Other Reason|0|||
94556303|NCT02106403|323830607|FG002|Follow-Up Visit 3|Other Reason|0|||
94556304|NCT02106403|323830608|FG003|Follow-Up Visit 3|Other Reason|0|||
94556305|NCT02106403|323830609|FG004|Follow-Up Visit 3|Other Reason|0|||
94556306|NCT02106403|323830610|FG005|Follow-Up Visit 3|Other Reason|1|||
94556307|NCT00699335|323830611|FG000|Overall Study|Combination of multiple reasons|176|||
94556308|NCT00699335|323830611|FG000|Overall Study|Missing data|52|||
94556309|NCT01887353|323830612|FG000|Overall Study|Study stopped early|4|||
94556310|NCT01887353|323830613|FG001|Overall Study|Study stopped early|3|||
94556311|NCT01496846|323830614|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
94556312|NCT01496846|323830615|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
94556313|NCT01496846|323830616|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
94556314|NCT01496846|323830617|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
94556315|NCT01496846|323830618|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
94556316|NCT01496846|323830619|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
94556317|NCT04038567|323830620|FG000|Overall Study|Lost to Follow-up|6|||
94556318|NCT04038567|323830621|FG001|Overall Study|Lost to Follow-up|4|||
94556319|NCT04038567|323830622|FG002|Overall Study|Lost to Follow-up|5|||
94556320|NCT04038567|323830623|FG003|Overall Study|Lost to Follow-up|4|||
94556321|NCT04038567|323830624|FG004|Overall Study|Lost to Follow-up|6|||
94556322|NCT04038567|323830625|FG005|Overall Study|Lost to Follow-up|4|||
94556323|NCT04038567|323830626|FG006|Overall Study|Lost to Follow-up|4|||
94556324|NCT04038567|323830627|FG007|Overall Study|Lost to Follow-up|1|||
94556325|NCT04038567|323830620|FG000|Overall Study|Withdrawal by Subject|2|||
94556326|NCT04038567|323830621|FG001|Overall Study|Withdrawal by Subject|1|||
94556327|NCT04038567|323830622|FG002|Overall Study|Withdrawal by Subject|1|||
94556328|NCT04038567|323830623|FG003|Overall Study|Withdrawal by Subject|1|||
94556329|NCT04038567|323830624|FG004|Overall Study|Withdrawal by Subject|4|||
94556330|NCT04038567|323830625|FG005|Overall Study|Withdrawal by Subject|1|||
94556331|NCT04038567|323830626|FG006|Overall Study|Withdrawal by Subject|1|||
94556332|NCT04038567|323830627|FG007|Overall Study|Withdrawal by Subject|1|||
94556333|NCT04038567|323830620|FG000|Overall Study|missed survey window|1|||
94556334|NCT04038567|323830621|FG001|Overall Study|missed survey window|2|||
94556335|NCT04038567|323830622|FG002|Overall Study|missed survey window|0|||
94556336|NCT04038567|323830623|FG003|Overall Study|missed survey window|0|||
94556337|NCT04038567|323830624|FG004|Overall Study|missed survey window|1|||
94231611|NCT00912223|322641222|FG000|Overall Study|Transformed disease|1|||
94556338|NCT04038567|323830625|FG005|Overall Study|missed survey window|1|||
94556339|NCT04038567|323830626|FG006|Overall Study|missed survey window|2|||
94556340|NCT04038567|323830627|FG007|Overall Study|missed survey window|2|||
94556341|NCT04038567|323830620|FG000|Overall Study|technical issues|0|||
94556342|NCT04038567|323830621|FG001|Overall Study|technical issues|0|||
94556343|NCT04038567|323830622|FG002|Overall Study|technical issues|0|||
94556344|NCT04038567|323830623|FG003|Overall Study|technical issues|0|||
94556345|NCT04038567|323830624|FG004|Overall Study|technical issues|0|||
94556346|NCT04038567|323830625|FG005|Overall Study|technical issues|0|||
94556347|NCT04038567|323830626|FG006|Overall Study|technical issues|1|||
94556348|NCT04038567|323830627|FG007|Overall Study|technical issues|0|||
94556349|NCT04038567|323830620|FG000|Overall Study|Medical issues (i.e., illness)|0|||
94556350|NCT04038567|323830621|FG001|Overall Study|Medical issues (i.e., illness)|1|||
94556351|NCT04038567|323830622|FG002|Overall Study|Medical issues (i.e., illness)|2|||
94556352|NCT04038567|323830623|FG003|Overall Study|Medical issues (i.e., illness)|1|||
94556353|NCT04038567|323830624|FG004|Overall Study|Medical issues (i.e., illness)|1|||
94556354|NCT04038567|323830625|FG005|Overall Study|Medical issues (i.e., illness)|1|||
94556355|NCT04038567|323830626|FG006|Overall Study|Medical issues (i.e., illness)|0|||
94556356|NCT04038567|323830627|FG007|Overall Study|Medical issues (i.e., illness)|0|||
94556357|NCT04038567|323830620|FG000|Overall Study|Death|0|||
94556358|NCT04038567|323830621|FG001|Overall Study|Death|0|||
94556359|NCT04038567|323830622|FG002|Overall Study|Death|0|||
94556360|NCT04038567|323830623|FG003|Overall Study|Death|1|||
94556361|NCT04038567|323830624|FG004|Overall Study|Death|1|||
94448390|NCT00450437|323428636|FG001|Overall Study|Administrative reason|0|||
94448391|NCT00450437|323428637|FG002|Overall Study|Administrative reason|1|||
94448392|NCT00450437|323428638|FG003|Overall Study|Administrative reason|0|||
94448393|NCT00450437|323428635|FG000|Overall Study|Unable to Classify|1|||
94448394|NCT00450437|323428636|FG001|Overall Study|Unable to Classify|0|||
94448395|NCT00450437|323428637|FG002|Overall Study|Unable to Classify|1|||
94448396|NCT00450437|323428638|FG003|Overall Study|Unable to Classify|0|||
94448397|NCT01827111|323428639|FG000|Overall Study|Disease Progression|1|||
94448398|NCT01890122|323428640|FG000|Overall Study|Adverse Event|1|||
94448399|NCT01890122|323428641|FG001|Overall Study|Adverse Event|1|||
94448400|NCT01890122|323428642|FG002|Overall Study|Adverse Event|1|||
94448401|NCT01890122|323428643|FG003|Overall Study|Adverse Event|2|||
94556362|NCT04038567|323830625|FG005|Overall Study|Death|0|||
94556363|NCT04038567|323830626|FG006|Overall Study|Death|0|||
94556364|NCT04038567|323830627|FG007|Overall Study|Death|1|||
94556365|NCT03182907|323830628|FG000|Overall Study|Death|3|||
94556366|NCT03182907|323830629|FG001|Overall Study|Death|0|||
94231612|NCT01130168|322641223|FG000|Period 1|Withdrawal by Subject|0|||
94556367|NCT03182907|323830628|FG000|Overall Study|Protocol Violation|4|||
94448402|NCT01890122|323428640|FG000|Overall Study|Major Protocol Deviation|3|||
94448403|NCT01890122|323428641|FG001|Overall Study|Major Protocol Deviation|1|||
94448404|NCT01890122|323428642|FG002|Overall Study|Major Protocol Deviation|0|||
94448405|NCT01890122|323428643|FG003|Overall Study|Major Protocol Deviation|1|||
94556368|NCT03182907|323830629|FG001|Overall Study|Protocol Violation|0|||
94448406|NCT01890122|323428640|FG000|Overall Study|Lost to Follow-up|0|||
94448407|NCT01890122|323428641|FG001|Overall Study|Lost to Follow-up|1|||
94448408|NCT01890122|323428642|FG002|Overall Study|Lost to Follow-up|2|||
94448409|NCT01890122|323428643|FG003|Overall Study|Lost to Follow-up|2|||
94448410|NCT01890122|323428640|FG000|Overall Study|Voluntary Withdrawal|8|||
94448411|NCT01890122|323428641|FG001|Overall Study|Voluntary Withdrawal|8|||
94448412|NCT01890122|323428642|FG002|Overall Study|Voluntary Withdrawal|2|||
94448413|NCT01890122|323428643|FG003|Overall Study|Voluntary Withdrawal|11|||
94448414|NCT01890122|323428640|FG000|Overall Study|Lack of Efficacy|14|||
94448415|NCT01890122|323428641|FG001|Overall Study|Lack of Efficacy|24|||
94448416|NCT01890122|323428642|FG002|Overall Study|Lack of Efficacy|7|||
94556369|NCT03182907|323830628|FG000|Overall Study|Lost to Follow-up|1|||
94556370|NCT03182907|323830629|FG001|Overall Study|Lost to Follow-up|0|||
94556371|NCT03182907|323830628|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94448417|NCT01890122|323428643|FG003|Overall Study|Lack of Efficacy|41|||
94448418|NCT01890122|323428640|FG000|Overall Study|Reason not Specified|0|||
94556372|NCT03182907|323830629|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
94556373|NCT03208088|323830631|FG000|Period 2|Withdrawal by Subject|0|||
94448419|NCT01890122|323428641|FG001|Overall Study|Reason not Specified|1|||
94448420|NCT01890122|323428642|FG002|Overall Study|Reason not Specified|1|||
94448421|NCT01890122|323428643|FG003|Overall Study|Reason not Specified|2|||
94556374|NCT03208088|323830632|FG001|Period 2|Withdrawal by Subject|0|||
94448422|NCT01890122|323428640|FG000|Overall Study|Randomized but not Treated|1|||
94448423|NCT01890122|323428641|FG001|Overall Study|Randomized but not Treated|1|||
94556375|NCT03208088|323830633|FG002|Period 2|Withdrawal by Subject|0|||
94556376|NCT03208088|323830634|FG003|Period 2|Withdrawal by Subject|0|||
94556377|NCT03208088|323830635|FG004|Period 2|Withdrawal by Subject|0|||
94556378|NCT03208088|323830636|FG005|Period 2|Withdrawal by Subject|0|||
94556379|NCT03208088|323830637|FG006|Period 2|Withdrawal by Subject|0|||
94556380|NCT03208088|323830638|FG007|Period 2|Withdrawal by Subject|0|||
94231613|NCT01130168|322641224|FG001|Period 1|Withdrawal by Subject|1|||
94231614|NCT01130168|322641225|FG002|Period 1|Withdrawal by Subject|0|||
94231615|NCT01130168|322641226|FG003|Period 1|Withdrawal by Subject|1|||
94231616|NCT01130168|322641227|FG004|Period 1|Withdrawal by Subject|0|||
94231617|NCT01130168|322641228|FG005|Period 1|Withdrawal by Subject|0|||
94231618|NCT01130168|322641223|FG000|Period 1|Discontinued For Other Reason|0|||
94231619|NCT01130168|322641224|FG001|Period 1|Discontinued For Other Reason|0|||
94231620|NCT01130168|322641225|FG002|Period 1|Discontinued For Other Reason|1|||
94231621|NCT01130168|322641226|FG003|Period 1|Discontinued For Other Reason|1|||
94231622|NCT01130168|322641227|FG004|Period 1|Discontinued For Other Reason|0|||
94231623|NCT01130168|322641228|FG005|Period 1|Discontinued For Other Reason|0|||
94231624|NCT01130168|322641223|FG000|Period 1|Adverse Event|0|||
94231625|NCT01130168|322641224|FG001|Period 1|Adverse Event|0|||
94231626|NCT01130168|322641225|FG002|Period 1|Adverse Event|0|||
94231627|NCT01130168|322641226|FG003|Period 1|Adverse Event|1|||
94231628|NCT01130168|322641227|FG004|Period 1|Adverse Event|0|||
94231629|NCT01130168|322641228|FG005|Period 1|Adverse Event|0|||
94231630|NCT02804399|322641231|FG000|Period 2|Adverse Event|0|||
94231631|NCT02804399|322641232|FG001|Period 2|Adverse Event|1|||
94231632|NCT01062971|322641235|FG000|Overall Study|Protocol Violation|1|||
94231633|NCT01062971|322641236|FG001|Overall Study|Protocol Violation|3|||
94231634|NCT01062971|322641235|FG000|Overall Study|Lost to Follow-up|3|||
94231635|NCT01062971|322641236|FG001|Overall Study|Lost to Follow-up|4|||
94231636|NCT03797989|322641237|FG000|VAC069A|Withdrawal by Subject|0|||
94231637|NCT03797989|322641238|FG001|VAC069A|Withdrawal by Subject|0|||
94231638|NCT03797989|322641239|FG002|VAC069A|Withdrawal by Subject|1|||
94231639|NCT03797989|322641240|FG003|VAC069A|Withdrawal by Subject|0|||
94231640|NCT03797989|322641241|FG004|VAC069A|Withdrawal by Subject|0|||
94231641|NCT03797989|322641242|FG005|VAC069A|Withdrawal by Subject|0|||
94231642|NCT03797989|322641243|FG006|VAC069A|Withdrawal by Subject|0|||
94231643|NCT03797989|322641244|FG007|VAC069A|Withdrawal by Subject|0|||
94231644|NCT03797989|322641245|FG008|VAC069A|Withdrawal by Subject|0|||
94231645|NCT03797989|322641246|FG009|VAC069A|Withdrawal by Subject|0|||
94231646|NCT03797989|322641247|FG010|VAC069A|Withdrawal by Subject|0|||
94231647|NCT03797989|322641248|FG011|VAC069A|Withdrawal by Subject|0|||
94231648|NCT00815919|322641249|FG000|Overall Study|Unrelated Fungal Infection|1|||
94231649|NCT00815919|322641249|FG000|Overall Study|AML Relapse|1|||
94231650|NCT00815919|322641249|FG000|Overall Study|Lack of Efficacy|2|||
94231651|NCT04750577|322641250|FG000|Overall Study|Adverse Event|2|||
94231652|NCT04750577|322641251|FG001|Overall Study|Adverse Event|10|||
94344330|NCT03345849|323040055|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
94556381|NCT03208088|323830639|FG008|Period 2|Withdrawal by Subject|1|||
94556382|NCT03208088|323830640|FG009|Period 2|Withdrawal by Subject|0|||
94556383|NCT03208088|323830631|FG000|Period 3|Unsatisfactory Test Article|0|||
94556384|NCT03208088|323830632|FG001|Period 3|Unsatisfactory Test Article|0|||
94556385|NCT03208088|323830633|FG002|Period 3|Unsatisfactory Test Article|0|||
94556386|NCT03208088|323830634|FG003|Period 3|Unsatisfactory Test Article|1|||
94556387|NCT03208088|323830635|FG004|Period 3|Unsatisfactory Test Article|0|||
94556388|NCT03208088|323830636|FG005|Period 3|Unsatisfactory Test Article|0|||
94556389|NCT03208088|323830637|FG006|Period 3|Unsatisfactory Test Article|0|||
94556390|NCT03208088|323830638|FG007|Period 3|Unsatisfactory Test Article|0|||
94556391|NCT03208088|323830639|FG008|Period 3|Unsatisfactory Test Article|0|||
94556392|NCT03208088|323830640|FG009|Period 3|Unsatisfactory Test Article|0|||
94556393|NCT03208088|323830631|FG000|Period 4|Unsatisfactory Test Article|0|||
94556394|NCT03208088|323830632|FG001|Period 4|Unsatisfactory Test Article|0|||
94556395|NCT03208088|323830633|FG002|Period 4|Unsatisfactory Test Article|0|||
94556396|NCT03208088|323830634|FG003|Period 4|Unsatisfactory Test Article|1|||
94556397|NCT03208088|323830635|FG004|Period 4|Unsatisfactory Test Article|0|||
94556398|NCT03208088|323830636|FG005|Period 4|Unsatisfactory Test Article|0|||
94556399|NCT03208088|323830637|FG006|Period 4|Unsatisfactory Test Article|0|||
94344331|NCT03345849|323040056|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
94231653|NCT04750577|322641252|FG002|Overall Study|Adverse Event|8|||
94231654|NCT04750577|322641253|FG003|Overall Study|Adverse Event|1|||
94231655|NCT04750577|322641250|FG000|Overall Study|Change of residence|0|||
94556400|NCT03208088|323830638|FG007|Period 4|Unsatisfactory Test Article|0|||
94556401|NCT03208088|323830639|FG008|Period 4|Unsatisfactory Test Article|0|||
94231656|NCT04750577|322641251|FG001|Overall Study|Change of residence|0|||
94231657|NCT04750577|322641252|FG002|Overall Study|Change of residence|1|||
94231658|NCT04750577|322641253|FG003|Overall Study|Change of residence|0|||
94231659|NCT04750577|322641250|FG000|Overall Study|Burden of study procedures|0|||
94231660|NCT04750577|322641251|FG001|Overall Study|Burden of study procedures|2|||
94556402|NCT03208088|323830640|FG009|Period 4|Unsatisfactory Test Article|0|||
94556403|NCT00991406|323830643|FG000|Overall Study|One participant did not respond to FES.|1|||
94448424|NCT01890122|323428642|FG002|Overall Study|Randomized but not Treated|0|||
94448425|NCT01890122|323428643|FG003|Overall Study|Randomized but not Treated|0|||
94448426|NCT02169271|323428644|FG000|Overall Study|Protocol Violation|1|||
94556404|NCT01300572|323830644|FG000|Overall Study|HAMA + post dosimetry|1|||
94556405|NCT00172042|323830646|FG000|Overall Study|Adverse Event|27|||
94448427|NCT02169271|323428645|FG001|Overall Study|Protocol Violation|2|||
94448428|NCT02593097|323428646|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
94448429|NCT02593097|323428647|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
94448430|NCT02593097|323428646|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
94448431|NCT02593097|323428647|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
94448432|NCT02593097|323428646|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
94448433|NCT02593097|323428647|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
94556406|NCT00172042|323830647|FG001|Overall Study|Adverse Event|13|||
94556407|NCT00172042|323830646|FG000|Overall Study|Abnormal laboratory value(s)|5|||
94556408|NCT00172042|323830647|FG001|Overall Study|Abnormal laboratory value(s)|1|||
94556409|NCT00172042|323830646|FG000|Overall Study|Abnormal test procedure(s)|0|||
94556410|NCT00172042|323830647|FG001|Overall Study|Abnormal test procedure(s)|3|||
94556411|NCT00172042|323830646|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
94556412|NCT00172042|323830647|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
94448434|NCT02593097|323428646|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
94556413|NCT00172042|323830646|FG000|Overall Study|Patient no longer requires study drug|10|||
94556414|NCT00172042|323830647|FG001|Overall Study|Patient no longer requires study drug|8|||
94556415|NCT00172042|323830646|FG000|Overall Study|Protocol Violation|8|||
94556416|NCT00172042|323830647|FG001|Overall Study|Protocol Violation|7|||
94556417|NCT00172042|323830646|FG000|Overall Study|Withdrawal by Subject|37|||
94556418|NCT00172042|323830647|FG001|Overall Study|Withdrawal by Subject|25|||
94556419|NCT00172042|323830646|FG000|Overall Study|Lost to Follow-up|3|||
94556420|NCT00172042|323830647|FG001|Overall Study|Lost to Follow-up|5|||
94556421|NCT00172042|323830646|FG000|Overall Study|Administrative problems|13|||
94556422|NCT00172042|323830647|FG001|Overall Study|Administrative problems|10|||
94556423|NCT00172042|323830646|FG000|Overall Study|Death|42|||
94556424|NCT00172042|323830647|FG001|Overall Study|Death|42|||
94556425|NCT00384332|323830648|FG000|Overall Study|Lost to Follow-up|4|||
94556426|NCT00384332|323830649|FG001|Overall Study|Lost to Follow-up|0|||
94556427|NCT02006979|323830650|FG000|Overall Study|Withdrawal by Subject|1|||
94556428|NCT02006979|323830651|FG001|Overall Study|Withdrawal by Subject|1|||
94556429|NCT02006979|323830650|FG000|Overall Study|Protocol Violation|0|||
94556430|NCT02006979|323830651|FG001|Overall Study|Protocol Violation|1|||
94556431|NCT00588354|323830652|FG000|Baseline to 2 Weeks|Adverse Event|1|||
94556432|NCT00588354|323830653|FG001|Baseline to 2 Weeks|Adverse Event|0|||
94556433|NCT00588354|323830652|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
94556434|NCT00588354|323830653|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
94556435|NCT00588354|323830652|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
94556436|NCT00588354|323830653|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
94556437|NCT00061633|323830658|FG000|Overall Study|Adverse Event|1|||
94556438|NCT00061633|323830659|FG001|Overall Study|Adverse Event|2|||
94556439|NCT00061633|323830658|FG000|Overall Study|Withdrawal by Subject|2|||
94556440|NCT00061633|323830659|FG001|Overall Study|Withdrawal by Subject|2|||
94556441|NCT00061633|323830658|FG000|Overall Study|Lost to Follow-up|1|||
94556442|NCT00061633|323830659|FG001|Overall Study|Lost to Follow-up|4|||
94556443|NCT00061633|323830658|FG000|Overall Study|Other|1|||
94556444|NCT00061633|323830659|FG001|Overall Study|Other|1|||
94556445|NCT00061633|323830658|FG000|Overall Study|Never received study treatment|0|||
94556446|NCT00061633|323830659|FG001|Overall Study|Never received study treatment|2|||
94556447|NCT02123576|323830662|FG000|Overall Study|Adverse Event|1|||
94556448|NCT02123576|323830663|FG001|Overall Study|Adverse Event|0|||
94556449|NCT02834247|323830667|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
94556450|NCT02834247|323830668|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
94556451|NCT02834247|323830669|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
94556452|NCT02834247|323830670|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
94556453|NCT02834247|323830667|FG000|Dose Escalation Phase|Death|5|||
94556454|NCT02834247|323830668|FG001|Dose Escalation Phase|Death|6|||
94556455|NCT02834247|323830669|FG002|Dose Escalation Phase|Death|5|||
94556456|NCT02834247|323830670|FG003|Dose Escalation Phase|Death|0|||
94556457|NCT02834247|323830667|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
94556458|NCT02834247|323830668|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
94556459|NCT02834247|323830669|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
94556460|NCT02834247|323830670|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
94556461|NCT02834247|323830667|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
94556462|NCT02834247|323830668|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
94556463|NCT02834247|323830669|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
94556464|NCT02834247|323830670|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
94556465|NCT02834247|323830667|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
94556466|NCT02834247|323830668|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
94556467|NCT02834247|323830669|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
94556468|NCT02834247|323830670|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
94556469|NCT02834247|323830667|FG000|Dose Expansion Phase|Death|0|||
94556470|NCT02834247|323830668|FG001|Dose Expansion Phase|Death|0|||
94556471|NCT02834247|323830669|FG002|Dose Expansion Phase|Death|0|||
94556472|NCT02834247|323830670|FG003|Dose Expansion Phase|Death|8|||
94556473|NCT02834247|323830667|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
94556474|NCT02834247|323830668|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
94556475|NCT02834247|323830669|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
94556476|NCT02834247|323830670|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
94556477|NCT02834247|323830667|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
94556478|NCT02834247|323830668|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
94556479|NCT02834247|323830669|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
94556480|NCT02834247|323830670|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
94556481|NCT02476006|323830677|FG000|Overall Study|Death|4|||
94556482|NCT02476006|323830677|FG000|Overall Study|Lack of treatment efficacy|2|||
94556483|NCT02476006|323830677|FG000|Overall Study|Pregnancy|1|||
94556484|NCT02476006|323830677|FG000|Overall Study|Participant did not wish to continue|39|||
94556485|NCT02476006|323830677|FG000|Overall Study|Adverse Event|41|||
94556486|NCT02476006|323830677|FG000|Overall Study|Poor compliance to study protocol|3|||
94556487|NCT02476006|323830677|FG000|Overall Study|Sponsor decision|6|||
94556488|NCT02476006|323830677|FG000|Overall Study|Lost to Follow-up|5|||
94556489|NCT02476006|323830677|FG000|Overall Study|Physician Decision|5|||
94556490|NCT02476006|323830677|FG000|Overall Study|Study ended treatment not available|4|||
94448435|NCT02593097|323428647|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
94448436|NCT02593097|323428646|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
94448437|NCT02593097|323428647|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
94448438|NCT00570063|323428654|FG000|Overall Study|Adverse Event|4|||
94448439|NCT00570063|323428655|FG001|Overall Study|Adverse Event|1|||
94448440|NCT00570063|323428654|FG000|Overall Study|Lack of Efficacy|0|||
94448441|NCT00570063|323428655|FG001|Overall Study|Lack of Efficacy|1|||
94448442|NCT00570063|323428654|FG000|Overall Study|Withdrawal by Subject|4|||
94448443|NCT00570063|323428655|FG001|Overall Study|Withdrawal by Subject|3|||
94448444|NCT00570063|323428654|FG000|Overall Study|Sponsor's Decision|7|||
94448445|NCT00570063|323428655|FG001|Overall Study|Sponsor's Decision|3|||
94448446|NCT03517540|323428656|FG000|Overall Study|Protocol Violation|2|||
94448447|NCT03517540|323428657|FG001|Overall Study|Protocol Violation|0|||
94448448|NCT03517540|323428658|FG002|Overall Study|Protocol Violation|0|||
94448449|NCT03517540|323428659|FG003|Overall Study|Protocol Violation|1|||
94448450|NCT03517540|323428656|FG000|Overall Study|Adverse Event|9|||
94448451|NCT03517540|323428657|FG001|Overall Study|Adverse Event|3|||
94448452|NCT03517540|323428658|FG002|Overall Study|Adverse Event|8|||
94448453|NCT03517540|323428659|FG003|Overall Study|Adverse Event|1|||
94448454|NCT03517540|323428656|FG000|Overall Study|Withdrawal by Subject|3|||
94448455|NCT03517540|323428657|FG001|Overall Study|Withdrawal by Subject|4|||
94448456|NCT03517540|323428658|FG002|Overall Study|Withdrawal by Subject|1|||
94448457|NCT03517540|323428659|FG003|Overall Study|Withdrawal by Subject|3|||
94448458|NCT03896022|323428666|FG000|Overall Study|Withdrawal by Subject|1|||
94448459|NCT03896022|323428667|FG001|Overall Study|Withdrawal by Subject|0|||
94448460|NCT03896022|323428668|FG002|Overall Study|Withdrawal by Subject|0|||
94448461|NCT03896022|323428666|FG000|Overall Study|Did not have procedure|3|||
94448462|NCT03896022|323428667|FG001|Overall Study|Did not have procedure|0|||
94448463|NCT03896022|323428668|FG002|Overall Study|Did not have procedure|0|||
94448464|NCT01863667|323428673|FG000|Overall Study|Adverse Event|1|||
94448465|NCT01863667|323428674|FG001|Overall Study|Adverse Event|0|||
94448466|NCT01863667|323428673|FG000|Overall Study|Study terminated by Sponsor|30|||
94448467|NCT01863667|323428674|FG001|Overall Study|Study terminated by Sponsor|30|||
94448468|NCT01863667|323428673|FG000|Overall Study|Withdrawal by Subject|2|||
94448469|NCT01863667|323428674|FG001|Overall Study|Withdrawal by Subject|2|||
94448470|NCT00615550|323428675|FG000|Overall Study|Lost to Follow-up|6|||
94448471|NCT00615550|323428676|FG001|Overall Study|Lost to Follow-up|1|||
94448472|NCT02741076|323428679|FG000|Overall Study|Adverse Event|0|||
94448473|NCT02741076|323428680|FG001|Overall Study|Adverse Event|1|||
94448474|NCT02741076|323428681|FG002|Overall Study|Adverse Event|1|||
94448475|NCT02741076|323428682|FG003|Overall Study|Adverse Event|0|||
94448476|NCT02741076|323428679|FG000|Overall Study|Lack of Efficacy|1|||
94448477|NCT02741076|323428680|FG001|Overall Study|Lack of Efficacy|0|||
94448478|NCT02741076|323428681|FG002|Overall Study|Lack of Efficacy|0|||
94448479|NCT02741076|323428682|FG003|Overall Study|Lack of Efficacy|0|||
94448480|NCT02741076|323428679|FG000|Overall Study|Withdrawal by Subject|0|||
94448481|NCT02741076|323428680|FG001|Overall Study|Withdrawal by Subject|1|||
94448482|NCT02741076|323428681|FG002|Overall Study|Withdrawal by Subject|0|||
94448483|NCT02741076|323428682|FG003|Overall Study|Withdrawal by Subject|0|||
94448484|NCT02741076|323428679|FG000|Overall Study|Sponsor Request|2|||
94448485|NCT02741076|323428680|FG001|Overall Study|Sponsor Request|3|||
94448486|NCT02741076|323428681|FG002|Overall Study|Sponsor Request|0|||
94448487|NCT02741076|323428682|FG003|Overall Study|Sponsor Request|1|||
94448488|NCT02741076|323428679|FG000|Overall Study|No additional information available|0|||
94448489|NCT02741076|323428680|FG001|Overall Study|No additional information available|0|||
94448490|NCT02741076|323428681|FG002|Overall Study|No additional information available|1|||
94448491|NCT02741076|323428682|FG003|Overall Study|No additional information available|1|||
94448492|NCT02837731|323428683|FG000|Allocation|Admitted to General Floor|3|||
94448493|NCT02837731|323428684|FG001|Allocation|Admitted to General Floor|4|||
94448494|NCT02837731|323428683|FG000|Allocation|Immediate surgery/withdrew|2|||
94448495|NCT02837731|323428684|FG001|Allocation|Immediate surgery/withdrew|0|||
94448496|NCT02837731|323428683|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
94448497|NCT02837731|323428684|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
94448498|NCT02837731|323428683|FG000|Allocation|Withdrawal by Subject|2|||
94448499|NCT02837731|323428684|FG001|Allocation|Withdrawal by Subject|0|||
94556491|NCT02476006|323830677|FG000|Overall Study|Switched to commercial drug|4|||
94556492|NCT02476006|323830677|FG000|Overall Study|Excluded from study|1|||
94556493|NCT02476006|323830677|FG000|Overall Study|Protocol Violation|1|||
94231661|NCT04750577|322641252|FG002|Overall Study|Burden of study procedures|2|||
94231662|NCT04750577|322641253|FG003|Overall Study|Burden of study procedures|0|||
94231663|NCT04750577|322641250|FG000|Overall Study|Prematurely discontinued|0|||
94231664|NCT04750577|322641251|FG001|Overall Study|Prematurely discontinued|0|||
94231665|NCT04750577|322641252|FG002|Overall Study|Prematurely discontinued|0|||
94231666|NCT04750577|322641253|FG003|Overall Study|Prematurely discontinued|2|||
94556494|NCT02476006|323830677|FG000|Overall Study|Enrolled but not treated|4|||
94556495|NCT03775512|323831968|FG000|Overall Study|Death|1|||
94556496|NCT03775512|323831969|FG001|Overall Study|Death|1|||
94556497|NCT03775512|323831968|FG000|Overall Study|Withdrawal by Subject|7|||
94556498|NCT03775512|323831969|FG001|Overall Study|Withdrawal by Subject|4|||
94556499|NCT03775512|323831968|FG000|Overall Study|Lost to Follow-up|5|||
94556500|NCT03775512|323831969|FG001|Overall Study|Lost to Follow-up|5|||
94556501|NCT03775512|323831968|FG000|Overall Study|Excluded before Catheter insertion|14|||
94556502|NCT03775512|323831969|FG001|Overall Study|Excluded before Catheter insertion|5|||
94556503|NCT03775512|323831968|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
94556504|NCT03775512|323831969|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
94556505|NCT03775512|323831968|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
94556506|NCT03775512|323831969|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
94556507|NCT00767806|323831970|FG000|Overall Study|Adverse Event|30|||
94556508|NCT00767806|323831971|FG001|Overall Study|Adverse Event|11|||
94556509|NCT00767806|323831970|FG000|Overall Study|Withdrawal by Subject|8|||
94556510|NCT00767806|323831971|FG001|Overall Study|Withdrawal by Subject|13|||
94556511|NCT00767806|323831970|FG000|Overall Study|Protocol Violation|6|||
94556512|NCT00767806|323831971|FG001|Overall Study|Protocol Violation|5|||
94556513|NCT00767806|323831970|FG000|Overall Study|Lack of Efficacy|1|||
94556514|NCT00767806|323831971|FG001|Overall Study|Lack of Efficacy|9|||
94556515|NCT00767806|323831970|FG000|Overall Study|Physician Decision|4|||
94556516|NCT00767806|323831971|FG001|Overall Study|Physician Decision|3|||
94556517|NCT00767806|323831970|FG000|Overall Study|Lost to Follow-up|1|||
94556518|NCT00767806|323831971|FG001|Overall Study|Lost to Follow-up|4|||
94556519|NCT00767806|323831970|FG000|Overall Study|Entry Criteria Not Met|1|||
94556520|NCT00767806|323831971|FG001|Overall Study|Entry Criteria Not Met|1|||
94556521|NCT00767806|323831970|FG000|Overall Study|Sponsor Decision|0|||
94556522|NCT00767806|323831971|FG001|Overall Study|Sponsor Decision|1|||
94556523|NCT00858208|323831973|FG000|Overall Study|Adverse Event|3|||
94556524|NCT00858208|323831973|FG000|Overall Study|Lost to Follow-up|26|||
94556525|NCT00858208|323831973|FG000|Overall Study|Participant refused|40|||
94556526|NCT00858208|323831973|FG000|Overall Study|Other|10|||
94556527|NCT02688985|323831976|FG000|Overall Study|Adverse Event|1|||
94556528|NCT02688985|323831977|FG001|Overall Study|Adverse Event|2|||
94556529|NCT02688985|323831978|FG002|Overall Study|Adverse Event|2|||
94556530|NCT02688985|323831979|FG003|Overall Study|Adverse Event|0|||
94556531|NCT02688985|323831980|FG004|Overall Study|Adverse Event|0|||
94556532|NCT02688985|323831976|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
94556533|NCT02688985|323831977|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
94556534|NCT02688985|323831978|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
94556535|NCT02688985|323831979|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
94556536|NCT02688985|323831980|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
94556537|NCT02688985|323831976|FG000|Overall Study|Death|0|||
94556538|NCT02688985|323831977|FG001|Overall Study|Death|0|||
94556539|NCT02688985|323831978|FG002|Overall Study|Death|0|||
94556540|NCT02688985|323831979|FG003|Overall Study|Death|0|||
94556541|NCT02688985|323831980|FG004|Overall Study|Death|1|||
94556542|NCT02688985|323831976|FG000|Overall Study|Lack of Efficacy|0|||
94556543|NCT02688985|323831977|FG001|Overall Study|Lack of Efficacy|0|||
94231667|NCT04750577|322641250|FG000|Overall Study|Protocol deviation|1|||
94231668|NCT04750577|322641251|FG001|Overall Study|Protocol deviation|1|||
94231669|NCT04750577|322641252|FG002|Overall Study|Protocol deviation|1|||
94231670|NCT04750577|322641253|FG003|Overall Study|Protocol deviation|1|||
94231671|NCT04750577|322641250|FG000|Overall Study|Other than listed|3|||
94556544|NCT02688985|323831978|FG002|Overall Study|Lack of Efficacy|0|||
94556545|NCT02688985|323831979|FG003|Overall Study|Lack of Efficacy|0|||
94556546|NCT02688985|323831980|FG004|Overall Study|Lack of Efficacy|1|||
94556547|NCT02688985|323831976|FG000|Overall Study|Lost to Follow-up|2|||
94556548|NCT02688985|323831977|FG001|Overall Study|Lost to Follow-up|0|||
94556549|NCT02688985|323831978|FG002|Overall Study|Lost to Follow-up|1|||
94556550|NCT02688985|323831979|FG003|Overall Study|Lost to Follow-up|1|||
94556551|NCT02688985|323831980|FG004|Overall Study|Lost to Follow-up|1|||
94556552|NCT02688985|323831976|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94556553|NCT02688985|323831977|FG001|Overall Study|Non-Compliance With Study Drug|3|||
94556554|NCT02688985|323831978|FG002|Overall Study|Non-Compliance With Study Drug|1|||
94556555|NCT02688985|323831979|FG003|Overall Study|Non-Compliance With Study Drug|0|||
94556556|NCT02688985|323831980|FG004|Overall Study|Non-Compliance With Study Drug|1|||
94448500|NCT02837731|323428683|FG000|Allocation|Device not available|1|||
94448501|NCT02837731|323428684|FG001|Allocation|Device not available|0|||
94448502|NCT02837731|323428683|FG000|Allocation|Protocol not implemented|7|||
94448503|NCT02837731|323428684|FG001|Allocation|Protocol not implemented|0|||
94448504|NCT02837731|323428683|FG000|Allocation|Moribund/Do not resuscitate|2|||
94448505|NCT02837731|323428684|FG001|Allocation|Moribund/Do not resuscitate|0|||
94448506|NCT02837731|323428683|FG000|Allocation|Did not meet sepsis criteria|1|||
94448507|NCT02837731|323428684|FG001|Allocation|Did not meet sepsis criteria|2|||
94448508|NCT02837731|323428683|FG000|Allocation|Known aortic abnormalities|0|||
94448509|NCT02837731|323428684|FG001|Allocation|Known aortic abnormalities|1|||
94448510|NCT02965573|323428685|FG000|Overall Study|Lack of Efficacy|1|||
94448511|NCT02965573|323428686|FG001|Overall Study|Lack of Efficacy|0|||
94448512|NCT00315458|323428687|FG000|Overall Study|Administrative|0|||
94448513|NCT00315458|323428688|FG001|Overall Study|Administrative|3|||
94448514|NCT00315458|323428689|FG002|Overall Study|Administrative|8|||
94448515|NCT00315458|323428690|FG003|Overall Study|Administrative|21|||
94448516|NCT00315458|323428687|FG000|Overall Study|Adverse Event|2|||
94448517|NCT00315458|323428688|FG001|Overall Study|Adverse Event|4|||
94448518|NCT00315458|323428689|FG002|Overall Study|Adverse Event|23|||
94448519|NCT00315458|323428690|FG003|Overall Study|Adverse Event|3|||
94448520|NCT00315458|323428687|FG000|Overall Study|Lost to Follow-up|1|||
94448521|NCT00315458|323428688|FG001|Overall Study|Lost to Follow-up|2|||
94448522|NCT00315458|323428689|FG002|Overall Study|Lost to Follow-up|0|||
94448523|NCT00315458|323428690|FG003|Overall Study|Lost to Follow-up|2|||
94448524|NCT00315458|323428687|FG000|Overall Study|Withdrawal by Subject|0|||
94448525|NCT00315458|323428688|FG001|Overall Study|Withdrawal by Subject|3|||
94448526|NCT00315458|323428689|FG002|Overall Study|Withdrawal by Subject|0|||
94448527|NCT00315458|323428690|FG003|Overall Study|Withdrawal by Subject|2|||
94448528|NCT00315458|323428687|FG000|Overall Study|Lack of Efficacy|0|||
94448529|NCT00315458|323428688|FG001|Overall Study|Lack of Efficacy|0|||
94448530|NCT00315458|323428689|FG002|Overall Study|Lack of Efficacy|20|||
94448531|NCT00315458|323428690|FG003|Overall Study|Lack of Efficacy|1|||
94448532|NCT00315458|323428687|FG000|Overall Study|Did not qualify|0|||
94448533|NCT00315458|323428688|FG001|Overall Study|Did not qualify|0|||
94448534|NCT00315458|323428689|FG002|Overall Study|Did not qualify|1|||
94448535|NCT00315458|323428690|FG003|Overall Study|Did not qualify|0|||
94448536|NCT02859337|323428691|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
94448537|NCT02859337|323428692|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
94448538|NCT02859337|323428693|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
94448539|NCT02859337|323428691|FG000|Overall Study|Withdrawal by Subject|3|||
94448540|NCT02859337|323428692|FG001|Overall Study|Withdrawal by Subject|1|||
94448541|NCT02859337|323428693|FG002|Overall Study|Withdrawal by Subject|0|||
94448542|NCT02859337|323428691|FG000|Overall Study|Lost to Follow-up|1|||
94448543|NCT02859337|323428692|FG001|Overall Study|Lost to Follow-up|0|||
94448544|NCT02859337|323428693|FG002|Overall Study|Lost to Follow-up|0|||
94448545|NCT01486446|323428694|FG000|Overall Study|Adverse Event|1|||
94448546|NCT01486446|323428695|FG001|Overall Study|Adverse Event|0|||
94448547|NCT03711786|323428696|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
94448548|NCT03711786|323428697|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
94448549|NCT03711786|323428696|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
94448550|NCT03711786|323428697|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
94448551|NCT03711786|323428696|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
94448552|NCT03711786|323428697|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
94448553|NCT03711786|323428696|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
94448554|NCT03711786|323428697|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
94448555|NCT03711786|323428696|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
94448556|NCT03711786|323428697|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
94448557|NCT03711786|323428696|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
94448558|NCT03711786|323428697|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
94556557|NCT02688985|323831976|FG000|Overall Study|Other|3|||
94556558|NCT02688985|323831977|FG001|Overall Study|Other|4|||
94556559|NCT02688985|323831978|FG002|Overall Study|Other|1|||
94556560|NCT02688985|323831979|FG003|Overall Study|Other|0|||
94448559|NCT00848718|323428698|FG000|Overall Study|Adverse Event|2|||
94448560|NCT00848718|323428699|FG001|Overall Study|Adverse Event|2|||
94448561|NCT00848718|323428700|FG002|Overall Study|Adverse Event|1|||
94448562|NCT00848718|323428701|FG003|Overall Study|Adverse Event|1|||
94448563|NCT00848718|323428702|FG004|Overall Study|Adverse Event|1|||
94556561|NCT02688985|323831980|FG004|Overall Study|Other|0|||
94556562|NCT02688985|323831976|FG000|Overall Study|Physician Decision|2|||
94231672|NCT04750577|322641251|FG001|Overall Study|Other than listed|2|||
94448564|NCT00848718|323428703|FG005|Overall Study|Adverse Event|0|||
94448565|NCT00848718|323428704|FG006|Overall Study|Adverse Event|0|||
94448566|NCT00848718|323428705|FG007|Overall Study|Adverse Event|1|||
94448567|NCT00848718|323428706|FG008|Overall Study|Adverse Event|1|||
94556563|NCT02688985|323831977|FG001|Overall Study|Physician Decision|2|||
94556564|NCT02688985|323831978|FG002|Overall Study|Physician Decision|0|||
94556565|NCT02688985|323831979|FG003|Overall Study|Physician Decision|0|||
94556566|NCT02688985|323831980|FG004|Overall Study|Physician Decision|1|||
94556567|NCT02688985|323831976|FG000|Overall Study|Pregnancy|0|||
94556568|NCT02688985|323831977|FG001|Overall Study|Pregnancy|0|||
94556569|NCT02688985|323831978|FG002|Overall Study|Pregnancy|2|||
94556570|NCT02688985|323831979|FG003|Overall Study|Pregnancy|1|||
94556571|NCT02688985|323831980|FG004|Overall Study|Pregnancy|0|||
94556572|NCT02688985|323831976|FG000|Overall Study|Study Terminated By Sponsor|0|||
94556573|NCT02688985|323831977|FG001|Overall Study|Study Terminated By Sponsor|0|||
94556574|NCT02688985|323831978|FG002|Overall Study|Study Terminated By Sponsor|0|||
94556575|NCT02688985|323831979|FG003|Overall Study|Study Terminated By Sponsor|1|||
94556576|NCT02688985|323831980|FG004|Overall Study|Study Terminated By Sponsor|0|||
94556577|NCT02688985|323831976|FG000|Overall Study|Withdrawal by Subject|2|||
94556578|NCT02688985|323831977|FG001|Overall Study|Withdrawal by Subject|8|||
94556579|NCT02688985|323831978|FG002|Overall Study|Withdrawal by Subject|7|||
94556580|NCT02688985|323831979|FG003|Overall Study|Withdrawal by Subject|1|||
94556581|NCT02688985|323831980|FG004|Overall Study|Withdrawal by Subject|4|||
94556582|NCT03350815|323831981|FG000|Period 1|Adverse Event|10|||
94556583|NCT03350815|323831982|FG001|Period 1|Adverse Event|0|||
94556584|NCT03350815|323831983|FG002|Period 1|Adverse Event|0|||
94556585|NCT03350815|323831984|FG003|Period 1|Adverse Event|0|||
94556586|NCT03350815|323831981|FG000|Period 1|Technical problems|1|||
94556587|NCT03350815|323831982|FG001|Period 1|Technical problems|0|||
94556588|NCT03350815|323831983|FG002|Period 1|Technical problems|0|||
94556589|NCT03350815|323831984|FG003|Period 1|Technical problems|0|||
94556590|NCT03350815|323831981|FG000|Period 1|Lost to Follow-up|3|||
94556591|NCT03350815|323831982|FG001|Period 1|Lost to Follow-up|0|||
94556592|NCT03350815|323831983|FG002|Period 1|Lost to Follow-up|0|||
94556593|NCT03350815|323831984|FG003|Period 1|Lost to Follow-up|0|||
94556594|NCT03350815|323831981|FG000|Period 1|Physician Decision|1|||
94556595|NCT03350815|323831982|FG001|Period 1|Physician Decision|0|||
94556596|NCT03350815|323831983|FG002|Period 1|Physician Decision|0|||
94556597|NCT03350815|323831984|FG003|Period 1|Physician Decision|0|||
94556598|NCT03350815|323831981|FG000|Period 1|Withdrawal by Subject|8|||
94556599|NCT03350815|323831982|FG001|Period 1|Withdrawal by Subject|0|||
94556600|NCT03350815|323831983|FG002|Period 1|Withdrawal by Subject|0|||
94556601|NCT03350815|323831984|FG003|Period 1|Withdrawal by Subject|0|||
94556602|NCT03350815|323831981|FG000|Period 1|Lack of Efficacy|15|||
94556603|NCT03350815|323831982|FG001|Period 1|Lack of Efficacy|0|||
94556604|NCT03350815|323831983|FG002|Period 1|Lack of Efficacy|0|||
94556605|NCT03350815|323831984|FG003|Period 1|Lack of Efficacy|0|||
94556606|NCT03350815|323831981|FG000|Period 1|Non-compliance with study treatment|2|||
94556607|NCT03350815|323831982|FG001|Period 1|Non-compliance with study treatment|0|||
94556608|NCT03350815|323831983|FG002|Period 1|Non-compliance with study treatment|0|||
94556609|NCT03350815|323831984|FG003|Period 1|Non-compliance with study treatment|0|||
94556610|NCT03350815|323831981|FG000|Period 1|Protocol Violation|3|||
94556611|NCT03350815|323831982|FG001|Period 1|Protocol Violation|0|||
94556612|NCT03350815|323831983|FG002|Period 1|Protocol Violation|0|||
94556613|NCT03350815|323831984|FG003|Period 1|Protocol Violation|0|||
94556614|NCT03350815|323831981|FG000|Period 2|Adverse Event|0|||
94556615|NCT03350815|323831982|FG001|Period 2|Adverse Event|3|||
94556616|NCT03350815|323831983|FG002|Period 2|Adverse Event|5|||
94556617|NCT03350815|323831984|FG003|Period 2|Adverse Event|0|||
94556618|NCT03350815|323831981|FG000|Period 2|Technical problem|0|||
94556619|NCT03350815|323831982|FG001|Period 2|Technical problem|1|||
94556620|NCT03350815|323831983|FG002|Period 2|Technical problem|0|||
94556621|NCT03350815|323831984|FG003|Period 2|Technical problem|0|||
94556622|NCT03350815|323831981|FG000|Period 2|Lost to Follow-up|0|||
94556623|NCT03350815|323831982|FG001|Period 2|Lost to Follow-up|3|||
94556624|NCT03350815|323831983|FG002|Period 2|Lost to Follow-up|3|||
94556625|NCT03350815|323831984|FG003|Period 2|Lost to Follow-up|0|||
94556626|NCT03350815|323831981|FG000|Period 2|Physician Decision|0|||
94556627|NCT03350815|323831982|FG001|Period 2|Physician Decision|0|||
94556628|NCT03350815|323831983|FG002|Period 2|Physician Decision|1|||
94556629|NCT03350815|323831984|FG003|Period 2|Physician Decision|0|||
94344332|NCT01852591|323040058|FG000|Overall Study|Withdrawal by Subject|2|||
94556630|NCT03350815|323831981|FG000|Period 2|Withdrawal by Subject|0|||
94556631|NCT03350815|323831982|FG001|Period 2|Withdrawal by Subject|3|||
94556632|NCT03350815|323831983|FG002|Period 2|Withdrawal by Subject|4|||
94556633|NCT03350815|323831984|FG003|Period 2|Withdrawal by Subject|0|||
94556634|NCT03350815|323831981|FG000|Period 2|Lack of Efficacy|0|||
94556635|NCT03350815|323831982|FG001|Period 2|Lack of Efficacy|6|||
94556636|NCT03350815|323831983|FG002|Period 2|Lack of Efficacy|2|||
94556637|NCT03350815|323831984|FG003|Period 2|Lack of Efficacy|0|||
94556638|NCT03350815|323831981|FG000|Period 2|Protocol Violation|0|||
94556639|NCT03350815|323831982|FG001|Period 2|Protocol Violation|0|||
94556640|NCT03350815|323831983|FG002|Period 2|Protocol Violation|1|||
94556641|NCT03350815|323831984|FG003|Period 2|Protocol Violation|0|||
94556642|NCT03350815|323831981|FG000|Period 2|New therapy for study indication|0|||
94556643|NCT03350815|323831982|FG001|Period 2|New therapy for study indication|0|||
94556644|NCT03350815|323831983|FG002|Period 2|New therapy for study indication|1|||
94231673|NCT04750577|322641252|FG002|Overall Study|Other than listed|2|||
94231674|NCT04750577|322641253|FG003|Overall Study|Other than listed|1|||
94231675|NCT04750577|322641250|FG000|Overall Study|Not treated|0|||
94231676|NCT04750577|322641251|FG001|Overall Study|Not treated|0|||
94448568|NCT00848718|323428707|FG009|Overall Study|Adverse Event|0|||
94448569|NCT00848718|323428708|FG010|Overall Study|Adverse Event|0|||
94448570|NCT00848718|323428709|FG011|Overall Study|Adverse Event|0|||
94448571|NCT00848718|323428710|FG012|Overall Study|Adverse Event|2|||
94448572|NCT00848718|323428698|FG000|Overall Study|Lack of Efficacy|0|||
94448573|NCT00848718|323428699|FG001|Overall Study|Lack of Efficacy|0|||
94448574|NCT00848718|323428700|FG002|Overall Study|Lack of Efficacy|1|||
94448575|NCT00848718|323428701|FG003|Overall Study|Lack of Efficacy|0|||
94448576|NCT00848718|323428702|FG004|Overall Study|Lack of Efficacy|0|||
94448577|NCT00848718|323428703|FG005|Overall Study|Lack of Efficacy|0|||
94448578|NCT00848718|323428704|FG006|Overall Study|Lack of Efficacy|1|||
94448579|NCT00848718|323428705|FG007|Overall Study|Lack of Efficacy|0|||
94448580|NCT00848718|323428706|FG008|Overall Study|Lack of Efficacy|0|||
94448581|NCT00848718|323428707|FG009|Overall Study|Lack of Efficacy|0|||
94448582|NCT00848718|323428708|FG010|Overall Study|Lack of Efficacy|0|||
94448583|NCT00848718|323428709|FG011|Overall Study|Lack of Efficacy|0|||
94448584|NCT00848718|323428710|FG012|Overall Study|Lack of Efficacy|0|||
94448585|NCT00848718|323428698|FG000|Overall Study|Physician Decision|0|||
94448586|NCT00848718|323428699|FG001|Overall Study|Physician Decision|1|||
94448587|NCT00848718|323428700|FG002|Overall Study|Physician Decision|0|||
94448588|NCT00848718|323428701|FG003|Overall Study|Physician Decision|0|||
94448589|NCT00848718|323428702|FG004|Overall Study|Physician Decision|1|||
94448590|NCT00848718|323428703|FG005|Overall Study|Physician Decision|1|||
94448591|NCT00848718|323428704|FG006|Overall Study|Physician Decision|0|||
94448592|NCT00848718|323428705|FG007|Overall Study|Physician Decision|0|||
94448593|NCT00848718|323428706|FG008|Overall Study|Physician Decision|1|||
94448594|NCT00848718|323428707|FG009|Overall Study|Physician Decision|2|||
94448595|NCT00848718|323428708|FG010|Overall Study|Physician Decision|0|||
94448596|NCT00848718|323428709|FG011|Overall Study|Physician Decision|0|||
94556645|NCT03350815|323831984|FG003|Period 2|New therapy for study indication|0|||
94556646|NCT00930553|323831987|FG000|Overall Study|Adverse Event|1|||
94556647|NCT00930553|323831987|FG000|Overall Study|Lack of Efficacy|7|||
94556648|NCT00930553|323831987|FG000|Overall Study|Physician Decision|39|||
94556649|NCT00930553|323831987|FG000|Overall Study|Protocol Violation|1|||
94556650|NCT00930553|323831987|FG000|Overall Study|Pregnancy|1|||
94556651|NCT00930553|323831987|FG000|Overall Study|Withdrawal by Subject|88|||
94556652|NCT00930553|323831987|FG000|Overall Study|Lost to Follow-up|25|||
94556653|NCT00930553|323831987|FG000|Overall Study|Death|9|||
94556654|NCT00930553|323831987|FG000|Overall Study|Study terminated by sponsor|24|||
94556655|NCT00930553|323831987|FG000|Overall Study|Other than specified above|28|||
94556656|NCT03250182|323831988|FG000|Overall Study|Withdrawal by Subject|1|||
94556657|NCT01068769|323831991|FG000|Overall Study|Ineligible|1|||
94556658|NCT04303572|323831994|FG000|Overall Study|Study closed due to poor enrollment|1|||
94556659|NCT03245398|323832002|FG000|Overall Study|Travelled to another island|1|||
94556660|NCT03245398|323832003|FG001|Overall Study|Travelled to another island|0|||
94556661|NCT04369950|323832004|FG000|Overall Study|Protocol Violation|2|||
94556662|NCT04369950|323832005|FG001|Overall Study|Protocol Violation|2|||
94556663|NCT00774800|323832006|FG000|Intervention 4|Withdrawal by Subject|1|||
94556664|NCT01529034|323832011|FG000|Overall Study|Discontinued prior to study treatment|14|||
94556665|NCT01529034|323832011|FG000|Overall Study|Site closure|62|||
94556666|NCT01529034|323832011|FG000|Overall Study|Study termination|29|||
94556667|NCT01529034|323832011|FG000|Overall Study|Withdrawal by Subject|25|||
94556668|NCT01529034|323832011|FG000|Overall Study|No treated SCs within protocol window|13|||
94556669|NCT01529034|323832011|FG000|Overall Study|Noncompliance|8|||
94556670|NCT01529034|323832011|FG000|Overall Study|Caregiver no longer available|7|||
94556671|NCT01529034|323832011|FG000|Overall Study|Adverse Event|4|||
94556672|NCT01529034|323832011|FG000|Overall Study|Protocol Violation|4|||
94556673|NCT01529034|323832011|FG000|Overall Study|Lack of Efficacy|4|||
94556674|NCT01529034|323832011|FG000|Overall Study|Investigator no longer available|2|||
94448597|NCT00848718|323428710|FG012|Overall Study|Physician Decision|1|||
94448598|NCT00848718|323428698|FG000|Overall Study|Progressive disease before treatment|1|||
94448599|NCT00848718|323428699|FG001|Overall Study|Progressive disease before treatment|5|||
94448600|NCT00848718|323428700|FG002|Overall Study|Progressive disease before treatment|1|||
94448601|NCT00848718|323428701|FG003|Overall Study|Progressive disease before treatment|3|||
94556675|NCT01529034|323832011|FG000|Overall Study|Study drug not available|2|||
94556676|NCT00773747|323832012|FG000|Overall Study|Lack of Efficacy|112|||
94556677|NCT00773747|323832013|FG001|Overall Study|Lack of Efficacy|144|||
94556678|NCT00773747|323832012|FG000|Overall Study|Physician Decision|26|||
94448602|NCT00848718|323428702|FG004|Overall Study|Progressive disease before treatment|4|||
94448603|NCT00848718|323428703|FG005|Overall Study|Progressive disease before treatment|4|||
94556679|NCT00773747|323832013|FG001|Overall Study|Physician Decision|18|||
94556680|NCT00773747|323832012|FG000|Overall Study|Lost to Follow-up|0|||
94556681|NCT00773747|323832013|FG001|Overall Study|Lost to Follow-up|1|||
94556682|NCT00773747|323832012|FG000|Overall Study|Protocol Violation|2|||
94556683|NCT00773747|323832013|FG001|Overall Study|Protocol Violation|2|||
94556684|NCT00773747|323832012|FG000|Overall Study|Withdrawal by Subject|89|||
94231677|NCT04750577|322641252|FG002|Overall Study|Not treated|0|||
94231678|NCT04750577|322641253|FG003|Overall Study|Not treated|2|||
94556685|NCT00773747|323832013|FG001|Overall Study|Withdrawal by Subject|61|||
94556686|NCT00773747|323832012|FG000|Overall Study|Adverse Event|61|||
94556687|NCT00773747|323832013|FG001|Overall Study|Adverse Event|62|||
94556688|NCT00773747|323832012|FG000|Overall Study|Death|5|||
94556689|NCT00773747|323832013|FG001|Overall Study|Death|8|||
94556690|NCT00773747|323832012|FG000|Overall Study|Not Treated|2|||
94556691|NCT00773747|323832013|FG001|Overall Study|Not Treated|0|||
94556692|NCT03422536|323832020|FG000|Randomized|Physician Decision|1|||
94556693|NCT03422536|323832021|FG001|Randomized|Physician Decision|1|||
94556694|NCT03422536|323832020|FG000|Allocation - Received Intervention|Disease progression|19|||
94556695|NCT03422536|323832021|FG001|Allocation - Received Intervention|Disease progression|25|||
94556696|NCT03422536|323832020|FG000|Allocation - Received Intervention|Death|1|||
94556697|NCT03422536|323832021|FG001|Allocation - Received Intervention|Death|3|||
94556698|NCT03422536|323832020|FG000|Allocation - Received Intervention|Adverse Event|1|||
94556699|NCT03422536|323832021|FG001|Allocation - Received Intervention|Adverse Event|0|||
94556700|NCT03422536|323832020|FG000|Allocation - Received Intervention|Physician Decision|1|||
94556701|NCT03422536|323832021|FG001|Allocation - Received Intervention|Physician Decision|1|||
94556702|NCT03422536|323832020|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
94556703|NCT03422536|323832021|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
94556704|NCT03422536|323832020|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
94556705|NCT03422536|323832021|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
94556706|NCT02141360|323832022|FG000|Overall Study|Withdrawal by Subject|6|||
94556707|NCT02141360|323832023|FG001|Overall Study|Withdrawal by Subject|0|||
94556708|NCT02141360|323832024|FG002|Overall Study|Withdrawal by Subject|0|||
94556709|NCT02141360|323832022|FG000|Overall Study|Study Terminated before Visit|1|||
94556710|NCT02141360|323832023|FG001|Overall Study|Study Terminated before Visit|0|||
94556711|NCT02141360|323832024|FG002|Overall Study|Study Terminated before Visit|0|||
94556712|NCT03068754|323832027|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
94556713|NCT03068754|323832028|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
94556714|NCT03068754|323832029|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
94556715|NCT03068754|323832030|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
94448604|NCT00848718|323428704|FG006|Overall Study|Progressive disease before treatment|2|||
94448605|NCT00848718|323428705|FG007|Overall Study|Progressive disease before treatment|1|||
94448606|NCT00848718|323428706|FG008|Overall Study|Progressive disease before treatment|2|||
94448607|NCT00848718|323428707|FG009|Overall Study|Progressive disease before treatment|7|||
94448608|NCT00848718|323428708|FG010|Overall Study|Progressive disease before treatment|3|||
94448609|NCT00848718|323428709|FG011|Overall Study|Progressive disease before treatment|6|||
94448610|NCT00848718|323428710|FG012|Overall Study|Progressive disease before treatment|2|||
94448611|NCT00848718|323428698|FG000|Overall Study|Protocol Violation|0|||
94448612|NCT00848718|323428699|FG001|Overall Study|Protocol Violation|1|||
94448613|NCT00848718|323428700|FG002|Overall Study|Protocol Violation|0|||
94448614|NCT00848718|323428701|FG003|Overall Study|Protocol Violation|0|||
94448615|NCT00848718|323428702|FG004|Overall Study|Protocol Violation|0|||
94448616|NCT00848718|323428703|FG005|Overall Study|Protocol Violation|0|||
94448617|NCT00848718|323428704|FG006|Overall Study|Protocol Violation|0|||
94448618|NCT00848718|323428705|FG007|Overall Study|Protocol Violation|1|||
94448619|NCT00848718|323428706|FG008|Overall Study|Protocol Violation|0|||
94448620|NCT00848718|323428707|FG009|Overall Study|Protocol Violation|0|||
94448621|NCT00848718|323428708|FG010|Overall Study|Protocol Violation|0|||
94448622|NCT00848718|323428709|FG011|Overall Study|Protocol Violation|0|||
94448623|NCT00848718|323428710|FG012|Overall Study|Protocol Violation|1|||
94448624|NCT00848718|323428698|FG000|Overall Study|Withdrawal by Subject|1|||
94448625|NCT00848718|323428699|FG001|Overall Study|Withdrawal by Subject|0|||
94448626|NCT00848718|323428700|FG002|Overall Study|Withdrawal by Subject|0|||
94448627|NCT00848718|323428701|FG003|Overall Study|Withdrawal by Subject|1|||
94448628|NCT00848718|323428702|FG004|Overall Study|Withdrawal by Subject|0|||
94448629|NCT00848718|323428703|FG005|Overall Study|Withdrawal by Subject|0|||
94448630|NCT00848718|323428704|FG006|Overall Study|Withdrawal by Subject|0|||
94448631|NCT00848718|323428705|FG007|Overall Study|Withdrawal by Subject|0|||
94448632|NCT00848718|323428706|FG008|Overall Study|Withdrawal by Subject|0|||
94448633|NCT00848718|323428707|FG009|Overall Study|Withdrawal by Subject|0|||
94448634|NCT00848718|323428708|FG010|Overall Study|Withdrawal by Subject|1|||
94556716|NCT03068754|323832027|FG000|Randomized Treatment Period (RTP)|Death|2|||
94556717|NCT03068754|323832028|FG001|Randomized Treatment Period (RTP)|Death|2|||
94556718|NCT03068754|323832029|FG002|Randomized Treatment Period (RTP)|Death|0|||
94556719|NCT03068754|323832030|FG003|Randomized Treatment Period (RTP)|Death|0|||
94556720|NCT03068754|323832027|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
94231679|NCT02034162|322642837|FG000|Double-blind|Lost to Follow-up|3|||
94448635|NCT00848718|323428709|FG011|Overall Study|Withdrawal by Subject|0|||
94448636|NCT00848718|323428710|FG012|Overall Study|Withdrawal by Subject|0|||
94231680|NCT02034162|322642838|FG001|Double-blind|Lost to Follow-up|0|||
94231681|NCT02034162|322642839|FG002|Double-blind|Lost to Follow-up|0|||
94231682|NCT02034162|322642837|FG000|Double-blind|Physician Decision|1|||
94231683|NCT02034162|322642838|FG001|Double-blind|Physician Decision|0|||
94231684|NCT02034162|322642839|FG002|Double-blind|Physician Decision|0|||
94556721|NCT03068754|323832028|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
94556722|NCT03068754|323832029|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
94556723|NCT03068754|323832030|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
94556724|NCT03068754|323832027|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
94556725|NCT03068754|323832028|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
94556726|NCT03068754|323832029|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
94556727|NCT03068754|323832030|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
94556728|NCT03068754|323832027|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
94556729|NCT03068754|323832028|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
94556730|NCT03068754|323832029|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
94556731|NCT03068754|323832030|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
94556732|NCT03068754|323832027|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
94556733|NCT03068754|323832028|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
94556734|NCT03068754|323832029|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
94556735|NCT03068754|323832030|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
94556736|NCT03068754|323832027|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
94556737|NCT03068754|323832028|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
94556738|NCT03068754|323832029|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
94556739|NCT03068754|323832030|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
94556740|NCT03068754|323832027|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
94556741|NCT03068754|323832028|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
94556742|NCT03068754|323832029|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
94556743|NCT03068754|323832030|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
94556744|NCT03068754|323832027|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
94556745|NCT03068754|323832028|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
94556746|NCT03068754|323832029|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
94556747|NCT03068754|323832030|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
94556748|NCT03068754|323832027|FG000|Open Label Extension Period (OLE)|Death|0|||
94556749|NCT03068754|323832028|FG001|Open Label Extension Period (OLE)|Death|0|||
94556750|NCT03068754|323832029|FG002|Open Label Extension Period (OLE)|Death|0|||
94556751|NCT03068754|323832030|FG003|Open Label Extension Period (OLE)|Death|1|||
94556752|NCT03068754|323832027|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
94556753|NCT03068754|323832028|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
94556754|NCT03068754|323832029|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
94556755|NCT03068754|323832030|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
94556756|NCT03068754|323832027|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
94556757|NCT03068754|323832028|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
94556758|NCT03068754|323832029|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
94556759|NCT03068754|323832030|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
94556760|NCT03068754|323832027|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
94556761|NCT03068754|323832028|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
94556762|NCT03068754|323832029|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
94556763|NCT03068754|323832030|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
94556764|NCT03068754|323832027|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
94556765|NCT03068754|323832028|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
94556766|NCT03068754|323832029|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
94556767|NCT03068754|323832030|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
94556768|NCT04856904|323832031|FG000|Overall Study|Physician Decision|1|||
94556769|NCT04856904|323832032|FG001|Overall Study|Physician Decision|1|||
94556770|NCT04856904|323832031|FG000|Overall Study|Withdrawal by Subject|13|||
94556771|NCT04856904|323832032|FG001|Overall Study|Withdrawal by Subject|13|||
94556772|NCT04856904|323832031|FG000|Overall Study|Adverse Event|1|||
94556773|NCT04856904|323832032|FG001|Overall Study|Adverse Event|1|||
94556774|NCT04856904|323832031|FG000|Overall Study|Non-compliance with study drug|1|||
94556775|NCT04856904|323832032|FG001|Overall Study|Non-compliance with study drug|1|||
94556776|NCT04856904|323832031|FG000|Overall Study|Lost to Follow-up|4|||
94556777|NCT04856904|323832032|FG001|Overall Study|Lost to Follow-up|4|||
94556778|NCT04856904|323832031|FG000|Overall Study|Withdrawal by Subject|1|||
94556779|NCT04856904|323832032|FG001|Overall Study|Withdrawal by Subject|1|||
94556780|NCT04856904|323832031|FG000|Overall Study|Protocol Violation|1|||
94556781|NCT04856904|323832032|FG001|Overall Study|Protocol Violation|1|||
94556782|NCT01844778|323832038|FG000|Overall Study|Protocol deviation|0|||
94231685|NCT02034162|322642837|FG000|Double-blind|Protocol Violation|0|||
94556783|NCT01844778|323832039|FG001|Overall Study|Protocol deviation|1|||
94556784|NCT01844778|323832040|FG002|Overall Study|Protocol deviation|2|||
94556785|NCT01844778|323832038|FG000|Overall Study|Withdrawal by Subject|2|||
94556786|NCT01844778|323832039|FG001|Overall Study|Withdrawal by Subject|0|||
94556787|NCT01844778|323832040|FG002|Overall Study|Withdrawal by Subject|0|||
94556788|NCT01844778|323832038|FG000|Overall Study|Adverse Event|0|||
94556789|NCT01844778|323832039|FG001|Overall Study|Adverse Event|2|||
94556790|NCT01844778|323832040|FG002|Overall Study|Adverse Event|2|||
94556791|NCT02690714|323832041|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
94556792|NCT02690714|323832041|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
94556793|NCT00705146|323832042|FG000|Overall Study|Lost to Follow-up|1|||
94556794|NCT00705146|323832043|FG001|Overall Study|Lost to Follow-up|1|||
94556795|NCT04294147|323832050|FG000|Overall Study|Protocol Violation|2|||
94556796|NCT04294147|323832051|FG001|Overall Study|Protocol Violation|0|||
94556797|NCT01628965|323832052|FG000|Overall Study|Adverse Event|30|||
94556798|NCT01628965|323832052|FG000|Overall Study|Lack of Efficacy|7|||
94556799|NCT01628965|323832052|FG000|Overall Study|Withdrawal by Subject|3|||
94556800|NCT01628965|323832052|FG000|Overall Study|Lost to Follow-up|1|||
94556801|NCT01628965|323832052|FG000|Overall Study|Discontinuation criteria|8|||
94556802|NCT04356352|323832053|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
94556803|NCT04356352|323832054|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
94556804|NCT04356352|323832055|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
94556805|NCT04356352|323832053|FG000|Overall Study|Protocol Violation|0|||
94556806|NCT04356352|323832054|FG001|Overall Study|Protocol Violation|3|||
94556807|NCT04356352|323832055|FG002|Overall Study|Protocol Violation|1|||
94556808|NCT04698993|323832056|FG000|Overall Study|PCR results not accessible|2|||
94556809|NCT04698993|323832057|FG001|Overall Study|PCR results not accessible|7|||
94556810|NCT04698993|323832056|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
94556811|NCT04698993|323832057|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
94556812|NCT00527904|323832058|FG000|Overall Study|Adverse Event|45|||
94556813|NCT00527904|323832058|FG000|Overall Study|Withdrawal by Subject|21|||
94556814|NCT00527904|323832058|FG000|Overall Study|Lost to Follow-up|8|||
94556815|NCT00527904|323832058|FG000|Overall Study|misc|22|||
94556816|NCT00622388|323832059|FG000|Overall Study|Disease Progression|47|||
94556817|NCT00622388|323832059|FG000|Overall Study|Adverse Event|6|||
94556818|NCT00622388|323832059|FG000|Overall Study|Protocol Violation|3|||
94556819|NCT00622388|323832059|FG000|Overall Study|Participant Refusal|1|||
94556820|NCT00622388|323832059|FG000|Overall Study|Death|3|||
94556821|NCT00622388|323832059|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
94556822|NCT00622388|323832059|FG000|Overall Study|Took Prohibited Medication|2|||
94556823|NCT00622388|323832059|FG000|Overall Study|Withdrew Consent|1|||
94556824|NCT00622388|323832059|FG000|Overall Study|Insurance Expired|1|||
94556825|NCT01743040|323832060|FG000|Overall Study|Death|1|||
94556826|NCT01743040|323832060|FG000|Overall Study|Lost to Follow-up|66|||
94556827|NCT01743040|323832060|FG000|Overall Study|Physician Decision|40|||
94556828|NCT01743040|323832060|FG000|Overall Study|Protocol Violation|1|||
94556829|NCT01743040|323832060|FG000|Overall Study|Withdrawal by Subject|121|||
94556830|NCT01894243|323832061|FG000|Overall Study|Adverse Event|0|||
94556831|NCT01894243|323832062|FG001|Overall Study|Adverse Event|1|||
94556832|NCT01894243|323832063|FG002|Overall Study|Adverse Event|2|||
94556833|NCT01894243|323832061|FG000|Overall Study|Death|0|||
94556834|NCT01894243|323832062|FG001|Overall Study|Death|0|||
94556835|NCT01894243|323832063|FG002|Overall Study|Death|3|||
94556836|NCT01894243|323832061|FG000|Overall Study|Lack of Efficacy|3|||
94556837|NCT01894243|323832062|FG001|Overall Study|Lack of Efficacy|3|||
94556838|NCT01894243|323832063|FG002|Overall Study|Lack of Efficacy|1|||
94556839|NCT01894243|323832061|FG000|Overall Study|Condition under investigation worsened|8|||
94556840|NCT01894243|323832062|FG001|Overall Study|Condition under investigation worsened|6|||
94556841|NCT01894243|323832063|FG002|Overall Study|Condition under investigation worsened|2|||
94556842|NCT01894243|323832061|FG000|Overall Study|Subject decision|1|||
94556843|NCT01894243|323832062|FG001|Overall Study|Subject decision|0|||
94556844|NCT01894243|323832063|FG002|Overall Study|Subject decision|0|||
94556845|NCT01894243|323832061|FG000|Overall Study|Other|1|||
94556846|NCT01894243|323832062|FG001|Overall Study|Other|0|||
94556847|NCT01894243|323832063|FG002|Overall Study|Other|0|||
94556848|NCT00428389|323832067|FG000|Core Phase|Adverse Event|6|||
94556849|NCT00428389|323832068|FG001|Core Phase|Adverse Event|4|||
94556850|NCT00428389|323832067|FG000|Core Phase|Lack of Efficacy|2|||
94556851|NCT00428389|323832068|FG001|Core Phase|Lack of Efficacy|0|||
94556852|NCT00428389|323832067|FG000|Core Phase|Abnormal test procedure result(s)|0|||
94556853|NCT00428389|323832068|FG001|Core Phase|Abnormal test procedure result(s)|1|||
94556854|NCT00428389|323832067|FG000|Core Phase|Withdrawal by Subject|3|||
94556855|NCT00428389|323832068|FG001|Core Phase|Withdrawal by Subject|4|||
94556856|NCT00428389|323832067|FG000|Core Phase|Protocol deviation|0|||
94556857|NCT00428389|323832068|FG001|Core Phase|Protocol deviation|2|||
94556858|NCT00428389|323832067|FG000|Extension Phase|Adverse Event|17|||
94556859|NCT00428389|323832068|FG001|Extension Phase|Adverse Event|11|||
94231686|NCT02034162|322642838|FG001|Double-blind|Protocol Violation|1|||
94231687|NCT02034162|322642839|FG002|Double-blind|Protocol Violation|0|||
94231688|NCT02034162|322642837|FG000|Double-blind|Withdrawal by Subject|5|||
94231689|NCT02034162|322642838|FG001|Double-blind|Withdrawal by Subject|7|||
94231690|NCT02034162|322642839|FG002|Double-blind|Withdrawal by Subject|0|||
94231691|NCT00908349|322642841|FG000|Overall Study|Adverse Event|10|||
94231692|NCT00908349|322642841|FG000|Overall Study|Withdrawal by Subject|9|||
94231693|NCT00908349|322642841|FG000|Overall Study|Physician Decision|5|||
94231694|NCT00908349|322642841|FG000|Overall Study|Lost to Follow-up|5|||
94231695|NCT00908349|322642841|FG000|Overall Study|Various|6|||
94231696|NCT00362375|322642842|FG000|Overall Study|Lost to Follow-up|40|||
94231697|NCT00362375|322642843|FG001|Overall Study|Lost to Follow-up|35|||
94231698|NCT04190225|322642854|FG000|Overall Study|Lost to Follow-up|2|||
94231699|NCT04190225|322642855|FG001|Overall Study|Lost to Follow-up|3|||
94231700|NCT04190225|322642854|FG000|Overall Study|Withdrawal by Subject|3|||
94231701|NCT04190225|322642855|FG001|Overall Study|Withdrawal by Subject|2|||
94231702|NCT04190225|322642854|FG000|Overall Study|Unrelated health condition|2|||
94231703|NCT04190225|322642855|FG001|Overall Study|Unrelated health condition|0|||
94231704|NCT03305809|322642860|FG000|Overall Study|Adverse Event|2|||
94231705|NCT03305809|322642861|FG001|Overall Study|Adverse Event|2|||
94231706|NCT03305809|322642862|FG002|Overall Study|Adverse Event|6|||
94231707|NCT03305809|322642863|FG003|Overall Study|Adverse Event|6|||
94231708|NCT03305809|322642860|FG000|Overall Study|Death|0|||
94231709|NCT03305809|322642861|FG001|Overall Study|Death|0|||
94231710|NCT03305809|322642862|FG002|Overall Study|Death|1|||
94231711|NCT03305809|322642863|FG003|Overall Study|Death|1|||
94231712|NCT03305809|322642860|FG000|Overall Study|Lost to Follow-up|1|||
94231713|NCT03305809|322642861|FG001|Overall Study|Lost to Follow-up|2|||
94231714|NCT03305809|322642862|FG002|Overall Study|Lost to Follow-up|0|||
94231715|NCT03305809|322642863|FG003|Overall Study|Lost to Follow-up|0|||
94231716|NCT03305809|322642860|FG000|Overall Study|Sponsor Decision|1|||
94231717|NCT03305809|322642861|FG001|Overall Study|Sponsor Decision|0|||
94231718|NCT03305809|322642862|FG002|Overall Study|Sponsor Decision|1|||
94231719|NCT03305809|322642863|FG003|Overall Study|Sponsor Decision|8|||
94231720|NCT03305809|322642860|FG000|Overall Study|Physician Decision|0|||
94231721|NCT03305809|322642861|FG001|Overall Study|Physician Decision|0|||
94231722|NCT03305809|322642862|FG002|Overall Study|Physician Decision|2|||
94231723|NCT03305809|322642863|FG003|Overall Study|Physician Decision|4|||
94231724|NCT03305809|322642860|FG000|Overall Study|Progressive Disease|0|||
94231725|NCT03305809|322642861|FG001|Overall Study|Progressive Disease|0|||
94231726|NCT03305809|322642862|FG002|Overall Study|Progressive Disease|1|||
94231727|NCT03305809|322642863|FG003|Overall Study|Progressive Disease|0|||
94231728|NCT03305809|322642860|FG000|Overall Study|Protocol Violation|1|||
94231729|NCT03305809|322642861|FG001|Overall Study|Protocol Violation|0|||
94231730|NCT03305809|322642862|FG002|Overall Study|Protocol Violation|2|||
94231731|NCT03305809|322642863|FG003|Overall Study|Protocol Violation|3|||
94231732|NCT03305809|322642860|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
94231733|NCT03305809|322642861|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
94231734|NCT03305809|322642862|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
94231735|NCT03305809|322642863|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
94231736|NCT03305809|322642860|FG000|Overall Study|Withdrawal by Subject|2|||
94231737|NCT03305809|322642861|FG001|Overall Study|Withdrawal by Subject|4|||
94231738|NCT03305809|322642862|FG002|Overall Study|Withdrawal by Subject|5|||
94231739|NCT03305809|322642863|FG003|Overall Study|Withdrawal by Subject|2|||
94231740|NCT03305809|322642860|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
94231741|NCT03305809|322642861|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
94231742|NCT03305809|322642862|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
94231743|NCT03305809|322642863|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
94231744|NCT02438371|322642864|FG000|Overall Study|Lost to Follow-up|3|||
94231745|NCT02438371|322642865|FG001|Overall Study|Lost to Follow-up|2|||
94231746|NCT02438371|322642864|FG000|Overall Study|Withdrawal by Subject|1|||
94231747|NCT02438371|322642865|FG001|Overall Study|Withdrawal by Subject|1|||
94231748|NCT04486313|322642866|FG000|Overall Study|Lost to Follow-up|7|||
94231749|NCT04486313|322642867|FG001|Overall Study|Lost to Follow-up|9|||
94556860|NCT00428389|323832067|FG000|Extension Phase|Lack of Efficacy|4|||
94231750|NCT04486313|322642866|FG000|Overall Study|Withdrawal by Subject|8|||
94231751|NCT04486313|322642867|FG001|Overall Study|Withdrawal by Subject|6|||
94231752|NCT04486313|322642866|FG000|Overall Study|Physician Decision|1|||
94231753|NCT04486313|322642867|FG001|Overall Study|Physician Decision|1|||
94231754|NCT04486313|322642866|FG000|Overall Study|Death|2|||
94231755|NCT04486313|322642867|FG001|Overall Study|Death|0|||
94231756|NCT04486313|322642866|FG000|Overall Study|Protocol Violation|1|||
94231757|NCT04486313|322642867|FG001|Overall Study|Protocol Violation|1|||
94231758|NCT01843777|322642871|FG000|Overall Study|Withdrawal by Subject|1|||
94231759|NCT01843777|322642872|FG001|Overall Study|Withdrawal by Subject|0|||
94231760|NCT02088554|322642873|FG000|Overall Study|Exited before procedure|130|||
94231761|NCT02088554|322642873|FG000|Overall Study|Attempted but not implanted|31|||
94231762|NCT02088554|322642873|FG000|Overall Study|Implant not attempted|19|||
94556861|NCT00428389|323832068|FG001|Extension Phase|Lack of Efficacy|3|||
94556862|NCT00428389|323832067|FG000|Extension Phase|Withdrawal by Subject|6|||
94556863|NCT00428389|323832068|FG001|Extension Phase|Withdrawal by Subject|6|||
94556864|NCT00428389|323832067|FG000|Extension Phase|Lost to Follow-up|0|||
94556865|NCT00428389|323832068|FG001|Extension Phase|Lost to Follow-up|3|||
94556866|NCT00428389|323832067|FG000|Extension Phase|Death|1|||
94556867|NCT00428389|323832068|FG001|Extension Phase|Death|0|||
94556868|NCT00428389|323832067|FG000|Extension Phase|Protocol Violation|3|||
94556869|NCT00428389|323832068|FG001|Extension Phase|Protocol Violation|2|||
94556870|NCT00428389|323832067|FG000|Extension Phase|Administrative problems|1|||
94556871|NCT00428389|323832068|FG001|Extension Phase|Administrative problems|1|||
94556872|NCT01620944|323832069|FG000|Overall Study|Early termination of Study|2|||
94556873|NCT01620944|323832070|FG001|Overall Study|Early termination of Study|1|||
94556874|NCT04079114|323832071|FG000|Overall Study|Study prematuely terminated.|166|||
94556875|NCT03216746|323832072|FG000|Overall Study|Lost to Follow-up|6|||
94556876|NCT03216746|323832073|FG001|Overall Study|Lost to Follow-up|8|||
94231763|NCT02088554|322642873|FG000|Overall Study|Pending next visit|532|||
94231764|NCT02088554|322642873|FG000|Overall Study|Death|170|||
94344333|NCT01852591|323040058|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
94344334|NCT01263470|323040059|FG000|Overall Study|Adverse Event|2|||
94344335|NCT01263470|323040060|FG001|Overall Study|Adverse Event|2|||
94344336|NCT01263470|323040061|FG002|Overall Study|Adverse Event|1|||
94344337|NCT01263470|323040062|FG003|Overall Study|Adverse Event|1|||
94344338|NCT01263470|323040063|FG004|Overall Study|Adverse Event|2|||
94231765|NCT02088554|322642873|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
94231766|NCT02088554|322642873|FG000|Overall Study|Lost to Follow-up|23|||
94231767|NCT02088554|322642873|FG000|Overall Study|Explanted|32|||
94231768|NCT02088554|322642873|FG000|Overall Study|Any other reason not covered by previous categories|11|||
94231769|NCT03898960|322642877|FG000|Overall Study|Death|10|||
94231770|NCT03634839|322642878|FG000|First Intervention (2 Hours)|Adverse Event|0|||
94231771|NCT03634839|322642879|FG001|First Intervention (2 Hours)|Adverse Event|2|||
94231772|NCT02447432|322642880|FG000|Epoch 001|Adverse Event|1|||
94231773|NCT02447432|322642881|FG001|Epoch 001|Adverse Event|1|||
94231774|NCT02447432|322642880|FG000|Epoch 001|Withdrawal by Subject|0|||
94231775|NCT02447432|322642881|FG001|Epoch 001|Withdrawal by Subject|4|||
94231776|NCT02447432|322642880|FG000|Epoch 001|Migrated/moved from study area|3|||
94231777|NCT02447432|322642881|FG001|Epoch 001|Migrated/moved from study area|5|||
94231778|NCT02447432|322642880|FG000|Epoch 001|Lost to Follow-up|1|||
94231779|NCT02447432|322642881|FG001|Epoch 001|Lost to Follow-up|3|||
94231780|NCT04962698|322642884|FG000|Motor Imagery|Technical difficulty|1|||
94231781|NCT04962698|322642885|FG001|Motor Imagery|Technical difficulty|0|||
94231782|NCT04962698|322642884|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
94231783|NCT04962698|322642885|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
94231784|NCT04962698|322642884|FG000|Kinesthetic MI|Technical difficulty|1|||
94231785|NCT04962698|322642885|FG001|Kinesthetic MI|Technical difficulty|0|||
94231786|NCT04962698|322642884|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
94231787|NCT04962698|322642885|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
94231788|NCT04962698|322642884|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
94231789|NCT04962698|322642885|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
94231790|NCT04962698|322642884|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
94231791|NCT04962698|322642885|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
94231792|NCT04962698|322642884|FG000|Virtual-hand Interaction|Technical difficulty|1|||
94231793|NCT04962698|322642885|FG001|Virtual-hand Interaction|Technical difficulty|0|||
94231794|NCT04962698|322642884|FG000|Robotic Action Observation|Technical difficulty|1|||
94231795|NCT04962698|322642885|FG001|Robotic Action Observation|Technical difficulty|0|||
94231796|NCT04962698|322642884|FG000|Rest|Technical difficulty|1|||
94231797|NCT04962698|322642885|FG001|Rest|Technical difficulty|0|||
94231798|NCT04962698|322642884|FG000|Rest|Exclusion criteria met after enrollment|0|||
94231799|NCT04962698|322642885|FG001|Rest|Exclusion criteria met after enrollment|2|||
94231800|NCT01233999|322642889|FG000|Overall Study|Withdrawal by Subject|1|||
94231801|NCT01233999|322642889|FG000|Overall Study|Lost to Follow-up|1|||
94231802|NCT03082612|322642890|FG000|Overall Study|Lost to Follow-up|2|||
94231803|NCT03082612|322642891|FG001|Overall Study|Lost to Follow-up|0|||
94231804|NCT00129649|322642896|FG000|Overall Study|Withdrawal by Subject|76|||
94344339|NCT01263470|323040064|FG005|Overall Study|Adverse Event|2|||
94556877|NCT03216746|323832074|FG002|Overall Study|Lost to Follow-up|5|||
94556878|NCT03216746|323832075|FG003|Overall Study|Lost to Follow-up|6|||
94556879|NCT01019369|323832076|FG000|Overall Study|Lost to Follow-up|10|||
94556880|NCT01019369|323832077|FG001|Overall Study|Lost to Follow-up|6|||
94231805|NCT00129649|322642897|FG001|Overall Study|Withdrawal by Subject|65|||
94231806|NCT00394589|322642898|FG000|Overall Study|Adverse Event|2|||
94231807|NCT00394589|322642899|FG001|Overall Study|Adverse Event|1|||
94344340|NCT01263470|323040059|FG000|Overall Study|Protocol Violation|0|||
94344341|NCT01263470|323040060|FG001|Overall Study|Protocol Violation|1|||
94344342|NCT01263470|323040061|FG002|Overall Study|Protocol Violation|0|||
94556881|NCT01019369|323832076|FG000|Overall Study|Withdrawal by Subject|0|||
94556882|NCT01019369|323832077|FG001|Overall Study|Withdrawal by Subject|1|||
94556883|NCT00392990|323832078|FG000|Treatment on Study|Adverse Event|3|||
94556884|NCT00392990|323832079|FG001|Treatment on Study|Adverse Event|1|||
94556885|NCT00392990|323832078|FG000|Follow up for 2 Years|Death|4|||
94556886|NCT00392990|323832079|FG001|Follow up for 2 Years|Death|0|||
94556887|NCT04667104|323832082|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
94556888|NCT04667104|323832083|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
94556889|NCT04667104|323832084|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
94556890|NCT04677504|323832085|FG000|Overall Study|Death|51|||
94556891|NCT04677504|323832086|FG001|Overall Study|Death|49|||
94556892|NCT04677504|323832085|FG000|Overall Study|Progressive Disease|1|||
94556893|NCT04677504|323832086|FG001|Overall Study|Progressive Disease|0|||
94556894|NCT04677504|323832085|FG000|Overall Study|Symptomatic Deterioration|1|||
94556895|NCT04677504|323832086|FG001|Overall Study|Symptomatic Deterioration|0|||
94556896|NCT04677504|323832085|FG000|Overall Study|Withdrawal by Subject|2|||
94556897|NCT04677504|323832086|FG001|Overall Study|Withdrawal by Subject|5|||
94556898|NCT04677504|323832085|FG000|Overall Study|Study Terminated By Sponsor|28|||
94556899|NCT04677504|323832086|FG001|Overall Study|Study Terminated By Sponsor|24|||
94556900|NCT04677504|323832085|FG000|Overall Study|Adverse Event|0|||
94556901|NCT04677504|323832086|FG001|Overall Study|Adverse Event|1|||
94556902|NCT00659230|323832091|FG000|Overall Study|Lost to Follow-up|2|||
94556903|NCT00659230|323832092|FG001|Overall Study|Lost to Follow-up|5|||
94556904|NCT00659230|323832091|FG000|Overall Study|Lost source documentation|5|||
94556905|NCT00659230|323832092|FG001|Overall Study|Lost source documentation|4|||
94556906|NCT00659230|323832091|FG000|Overall Study|Did not return post-randomization|2|||
94556907|NCT00659230|323832092|FG001|Overall Study|Did not return post-randomization|3|||
94556908|NCT00534976|323832093|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
94556909|NCT00534976|323832094|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
94556910|NCT00534976|323832093|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
94556911|NCT00534976|323832094|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
94556912|NCT00534976|323832093|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
94556913|NCT00534976|323832094|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
94556914|NCT02147288|323832095|FG000|Overall Study|post-operative hematoma|1|||
94556915|NCT02147288|323832096|FG001|Overall Study|post-operative hematoma|1|||
94556916|NCT02147288|323832097|FG002|Overall Study|post-operative hematoma|0|||
94556917|NCT02147288|323832098|FG003|Overall Study|post-operative hematoma|0|||
94556918|NCT02147288|323832099|FG004|Overall Study|post-operative hematoma|0|||
94556919|NCT02147288|323832100|FG005|Overall Study|post-operative hematoma|0|||
94556920|NCT02147288|323832101|FG006|Overall Study|post-operative hematoma|0|||
94556921|NCT02147288|323832102|FG007|Overall Study|post-operative hematoma|0|||
94556922|NCT02147288|323832103|FG008|Overall Study|post-operative hematoma|0|||
94556923|NCT02147288|323832104|FG009|Overall Study|post-operative hematoma|0|||
94556924|NCT02147288|323832095|FG000|Overall Study|complications from concurrent hernia rep|0|||
94556925|NCT02147288|323832096|FG001|Overall Study|complications from concurrent hernia rep|1|||
94556926|NCT02147288|323832097|FG002|Overall Study|complications from concurrent hernia rep|0|||
94556927|NCT02147288|323832098|FG003|Overall Study|complications from concurrent hernia rep|0|||
94556928|NCT02147288|323832099|FG004|Overall Study|complications from concurrent hernia rep|0|||
94556929|NCT02147288|323832100|FG005|Overall Study|complications from concurrent hernia rep|0|||
94556930|NCT02147288|323832101|FG006|Overall Study|complications from concurrent hernia rep|0|||
94556931|NCT02147288|323832102|FG007|Overall Study|complications from concurrent hernia rep|0|||
94556932|NCT02147288|323832103|FG008|Overall Study|complications from concurrent hernia rep|0|||
94556933|NCT02147288|323832104|FG009|Overall Study|complications from concurrent hernia rep|0|||
94556934|NCT03887221|323832105|FG000|Overall Study|Protocol Violation|1|||
94556935|NCT03887221|323832106|FG001|Overall Study|Protocol Violation|0|||
94556936|NCT00445770|323832107|FG000|Overall Study|Adverse Event|9|||
94556937|NCT00445770|323832108|FG001|Overall Study|Adverse Event|15|||
94556938|NCT00445770|323832109|FG002|Overall Study|Adverse Event|19|||
94556939|NCT00445770|323832107|FG000|Overall Study|Lack of Efficacy|38|||
94556940|NCT00445770|323832108|FG001|Overall Study|Lack of Efficacy|13|||
94556941|NCT00445770|323832109|FG002|Overall Study|Lack of Efficacy|6|||
94556942|NCT00445770|323832107|FG000|Overall Study|Lost to Follow-up|0|||
94556943|NCT00445770|323832108|FG001|Overall Study|Lost to Follow-up|2|||
94556944|NCT00445770|323832109|FG002|Overall Study|Lost to Follow-up|0|||
94556945|NCT00445770|323832107|FG000|Overall Study|Other|6|||
94556946|NCT00445770|323832108|FG001|Overall Study|Other|5|||
94556947|NCT00445770|323832109|FG002|Overall Study|Other|6|||
94556948|NCT02352753|323833848|FG000|6-Month Dosing Period|Decision by sponsor|2|||
94556949|NCT02352753|323833848|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
94556950|NCT02352753|323833848|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
94556951|NCT02352753|323833848|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
94556952|NCT02352753|323833848|FG000|3-Month Dosing Period|Decision by sponsor|14|||
94556953|NCT02352753|323833848|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
94556954|NCT00711971|323833849|FG000|Overall Study|Lost to Follow-up|3|||
94556955|NCT00711971|323833850|FG001|Overall Study|Lost to Follow-up|4|||
94556956|NCT00711971|323833851|FG002|Overall Study|Lost to Follow-up|1|||
94556957|NCT01815840|323833852|FG000|Overall Study|Missing|1|||
94556958|NCT01815840|323833853|FG001|Overall Study|Missing|0|||
94556959|NCT01815840|323833852|FG000|Overall Study|Withdrew Consent|31|||
94556960|NCT01815840|323833853|FG001|Overall Study|Withdrew Consent|30|||
94556961|NCT01815840|323833852|FG000|Overall Study|Administrative/Other|1|||
94556962|NCT01815840|323833853|FG001|Overall Study|Administrative/Other|3|||
94556963|NCT01815840|323833852|FG000|Overall Study|Adverse Event|10|||
94556964|NCT01815840|323833853|FG001|Overall Study|Adverse Event|16|||
94556965|NCT01815840|323833852|FG000|Overall Study|Death|2|||
94556966|NCT01815840|323833853|FG001|Overall Study|Death|2|||
94556967|NCT01815840|323833852|FG000|Overall Study|Disease progression|3|||
94556968|NCT01815840|323833853|FG001|Overall Study|Disease progression|2|||
94556969|NCT01815840|323833852|FG000|Overall Study|Investigators Decision|2|||
94556970|NCT01815840|323833853|FG001|Overall Study|Investigators Decision|3|||
94556971|NCT01815840|323833852|FG000|Overall Study|Lost to Follow-up|3|||
94556972|NCT01815840|323833853|FG001|Overall Study|Lost to Follow-up|6|||
94556973|NCT01815840|323833852|FG000|Overall Study|Refused Treatment|5|||
94556974|NCT01815840|323833853|FG001|Overall Study|Refused Treatment|1|||
94556975|NCT01815840|323833852|FG000|Overall Study|Sponsor Termination Treatment|1|||
94556976|NCT01815840|323833853|FG001|Overall Study|Sponsor Termination Treatment|0|||
94556977|NCT00856544|323833854|FG000|Overall Study|Randomized but not treated|3|||
94556978|NCT00856544|323833855|FG001|Overall Study|Randomized but not treated|0|||
94556979|NCT00856544|323833856|FG002|Overall Study|Randomized but not treated|0|||
94556980|NCT00856544|323833857|FG003|Overall Study|Randomized but not treated|0|||
94556981|NCT00856544|323833854|FG000|Overall Study|Death|0|||
94556982|NCT00856544|323833855|FG001|Overall Study|Death|2|||
94556983|NCT00856544|323833856|FG002|Overall Study|Death|0|||
94556984|NCT00856544|323833857|FG003|Overall Study|Death|0|||
94556985|NCT00856544|323833854|FG000|Overall Study|Adverse Event|20|||
94556986|NCT00856544|323833855|FG001|Overall Study|Adverse Event|29|||
94556987|NCT00856544|323833856|FG002|Overall Study|Adverse Event|2|||
94556988|NCT00856544|323833857|FG003|Overall Study|Adverse Event|3|||
94556989|NCT00856544|323833854|FG000|Overall Study|Lack of Efficacy|16|||
94556990|NCT00856544|323833855|FG001|Overall Study|Lack of Efficacy|12|||
94556991|NCT00856544|323833856|FG002|Overall Study|Lack of Efficacy|3|||
94556992|NCT00856544|323833857|FG003|Overall Study|Lack of Efficacy|3|||
94448637|NCT00848718|323428698|FG000|Overall Study|Progressive disease during treatment|3|||
94556993|NCT00856544|323833854|FG000|Overall Study|Other|9|||
94556994|NCT00856544|323833855|FG001|Overall Study|Other|16|||
94556995|NCT00856544|323833856|FG002|Overall Study|Other|1|||
94556996|NCT00856544|323833857|FG003|Overall Study|Other|6|||
94556997|NCT00856544|323833854|FG000|Overall Study|Lost to Follow-up|1|||
94556998|NCT00856544|323833855|FG001|Overall Study|Lost to Follow-up|2|||
94556999|NCT00856544|323833856|FG002|Overall Study|Lost to Follow-up|2|||
94557000|NCT00856544|323833857|FG003|Overall Study|Lost to Follow-up|0|||
94557001|NCT00856544|323833854|FG000|Overall Study|Withdrawal by Subject|8|||
94557002|NCT00856544|323833855|FG001|Overall Study|Withdrawal by Subject|5|||
94557003|NCT00856544|323833856|FG002|Overall Study|Withdrawal by Subject|0|||
94448638|NCT00848718|323428699|FG001|Overall Study|Progressive disease during treatment|0|||
94557004|NCT00856544|323833857|FG003|Overall Study|Withdrawal by Subject|1|||
94557005|NCT01832155|323833858|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
94557006|NCT01832155|323833859|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
94557007|NCT01832155|323833858|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
94557008|NCT01832155|323833859|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
94557009|NCT01279616|323833860|FG000|Overall Study|donor could not be located|5|||
94557010|NCT01279616|323833860|FG000|Overall Study|no signs of sickle cell disease|2|||
94557011|NCT03282097|323833863|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
94557012|NCT03282097|323833864|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
94557013|NCT03282097|323833863|FG000|Intervention Visit Complete|Patient Death|13|||
94557014|NCT03282097|323833864|FG001|Intervention Visit Complete|Patient Death|15|||
94557015|NCT03282097|323833863|FG000|Intervention Visit Complete|Caregiver Death|0|||
94557016|NCT03282097|323833864|FG001|Intervention Visit Complete|Caregiver Death|3|||
94557017|NCT03282097|323833863|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
94557018|NCT03282097|323833864|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
94557019|NCT03282097|323833863|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
94557020|NCT03282097|323833864|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
94557021|NCT03282097|323833863|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
94557022|NCT03282097|323833864|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
94557023|NCT03282097|323833863|FG000|Primary Outcome Data Collection Complete|Missing|2|||
94557024|NCT03282097|323833864|FG001|Primary Outcome Data Collection Complete|Missing|3|||
94557025|NCT03282097|323833863|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
94557026|NCT03282097|323833864|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
94557027|NCT03282097|323833863|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
94557028|NCT03282097|323833864|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
94557029|NCT03282097|323833863|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
94557030|NCT03282097|323833864|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
94557031|NCT00709618|323833866|FG000|Overall Study|Withdrawal by Subject|4|||
94557032|NCT00709618|323833866|FG000|Overall Study|Lost to Follow-up|1|||
94557033|NCT00709618|323833866|FG000|Overall Study|Study Closed/Terminated|25|||
94557034|NCT05249569|323833867|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
94557035|NCT01948063|323833869|FG000|Overall Study|Boston MCI halted research protocol|0|||
94557036|NCT01948063|323833870|FG001|Overall Study|Boston MCI halted research protocol|1|||
94557037|NCT01948063|323833869|FG000|Overall Study|Discovered an enrollment in other study|0|||
94448639|NCT00848718|323428700|FG002|Overall Study|Progressive disease during treatment|3|||
94448640|NCT00848718|323428701|FG003|Overall Study|Progressive disease during treatment|0|||
94448641|NCT00848718|323428702|FG004|Overall Study|Progressive disease during treatment|0|||
94448642|NCT00848718|323428703|FG005|Overall Study|Progressive disease during treatment|0|||
94448643|NCT00848718|323428704|FG006|Overall Study|Progressive disease during treatment|0|||
94448644|NCT00848718|323428705|FG007|Overall Study|Progressive disease during treatment|2|||
94448645|NCT00848718|323428706|FG008|Overall Study|Progressive disease during treatment|0|||
94448646|NCT00848718|323428707|FG009|Overall Study|Progressive disease during treatment|0|||
94448647|NCT00848718|323428708|FG010|Overall Study|Progressive disease during treatment|0|||
94231808|NCT00394589|322642900|FG002|Overall Study|Adverse Event|2|||
94448648|NCT00848718|323428709|FG011|Overall Study|Progressive disease during treatment|0|||
94231809|NCT00394589|322642898|FG000|Overall Study|Lack of Efficacy|2|||
94231810|NCT00394589|322642899|FG001|Overall Study|Lack of Efficacy|2|||
94231811|NCT00394589|322642900|FG002|Overall Study|Lack of Efficacy|3|||
94231812|NCT00394589|322642898|FG000|Overall Study|Protocol Violation|4|||
94231813|NCT00394589|322642899|FG001|Overall Study|Protocol Violation|0|||
94231814|NCT00394589|322642900|FG002|Overall Study|Protocol Violation|2|||
94231815|NCT03409731|322642901|FG000|Overall Study|Withdrawal by Subject|17|||
94231816|NCT03409731|322642901|FG000|Overall Study|Death|4|||
94231817|NCT01114672|322642902|FG000|Overall Study|Death|0|||
94231818|NCT01114672|322642903|FG001|Overall Study|Death|1|||
94231819|NCT01114672|322642902|FG000|Overall Study|Withdrawal by Subject|2|||
94231820|NCT01114672|322642903|FG001|Overall Study|Withdrawal by Subject|1|||
94231821|NCT01114672|322642902|FG000|Overall Study|Lost to Follow-up|1|||
94231822|NCT01114672|322642903|FG001|Overall Study|Lost to Follow-up|0|||
94231823|NCT01114672|322642902|FG000|Overall Study|transplanted|1|||
94231824|NCT01114672|322642903|FG001|Overall Study|transplanted|0|||
94231825|NCT01710800|322642904|FG000|Overall Study|Withdrawal by Subject|21|||
94231826|NCT01710800|322642904|FG000|Overall Study|Protocol Violation|1|||
94231827|NCT02586415|322642905|FG000|Overall Study|Death|13|||
94231828|NCT02586415|322642906|FG001|Overall Study|Death|23|||
94231829|NCT02586415|322642905|FG000|Overall Study|Lost to Follow-up|1|||
94231830|NCT02586415|322642906|FG001|Overall Study|Lost to Follow-up|2|||
94231831|NCT02725567|322642911|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
94231832|NCT02725567|322642912|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
94231833|NCT02725567|322642911|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
94231834|NCT02725567|322642912|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
94231835|NCT02725567|322642911|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
94231836|NCT02725567|322642912|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
94231837|NCT02413593|322642913|FG000|Overall Study|Lost to Follow-up|3|||
94231838|NCT02413593|322642913|FG000|Overall Study|Adverse Event|1|||
94231839|NCT03845075|322642914|FG000|Part 1 - DB|Withdrawal by Subject|1|||
94231840|NCT03845075|322642915|FG001|Part 1 - DB|Withdrawal by Subject|1|||
94231841|NCT03845075|322642916|FG002|Part 1 - DB|Withdrawal by Subject|0|||
94231842|NCT03845075|322642917|FG003|Part 1 - DB|Withdrawal by Subject|0|||
94231843|NCT03845075|322642914|FG000|Part 1 - DB|Adverse Event|0|||
94448649|NCT00848718|323428710|FG012|Overall Study|Progressive disease during treatment|2|||
94448650|NCT01806051|323428714|FG000|Overall Study|Withdrawal by Subject|6|||
94448651|NCT01205776|323428717|FG000|Overall Study|Lost to Follow-up|53|||
94448652|NCT01205776|323428718|FG001|Overall Study|Lost to Follow-up|61|||
94448653|NCT01205776|323428717|FG000|Overall Study|Withdrawal by Subject|11|||
94557038|NCT01948063|323833870|FG001|Overall Study|Discovered an enrollment in other study|1|||
94557039|NCT01948063|323833869|FG000|Overall Study|Blood samples were accidentally thawed|1|||
94557040|NCT01948063|323833870|FG001|Overall Study|Blood samples were accidentally thawed|0|||
94557041|NCT04752358|323833877|FG000|Overall Study|Death|2|||
94557042|NCT04752358|323833878|FG001|Overall Study|Death|1|||
94557043|NCT03364738|323833879|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
94557044|NCT03364738|323833879|FG000|Overall Study|Withdrawal by Subject|1|||
94557045|NCT03364738|323833879|FG000|Overall Study|Adverse Event|1|||
94231844|NCT03845075|322642915|FG001|Part 1 - DB|Adverse Event|1|||
94231845|NCT03845075|322642916|FG002|Part 1 - DB|Adverse Event|0|||
94448654|NCT01205776|323428718|FG001|Overall Study|Withdrawal by Subject|34|||
94448655|NCT02418182|323428719|FG000|Overall Study|Unable to re-consent|18|||
94448656|NCT02418182|323428720|FG001|Overall Study|Unable to re-consent|15|||
94448657|NCT02418182|323428719|FG000|Overall Study|Lost to Follow-up|0|||
94448658|NCT02418182|323428720|FG001|Overall Study|Lost to Follow-up|2|||
94448659|NCT00734994|323428721|FG000|Overall Study|Withdrawal by Subject|1|||
94448660|NCT03225105|323428726|FG000|Overall Study|Withdrawal by Subject|1|||
94448661|NCT03225105|323428727|FG001|Overall Study|Withdrawal by Subject|0|||
94448662|NCT03225105|323428728|FG002|Overall Study|Withdrawal by Subject|0|||
94448663|NCT03225105|323428729|FG003|Overall Study|Withdrawal by Subject|0|||
94448664|NCT03225105|323428726|FG000|Overall Study|Death|0|||
94448665|NCT03225105|323428727|FG001|Overall Study|Death|4|||
94448666|NCT03225105|323428728|FG002|Overall Study|Death|2|||
94448667|NCT03225105|323428729|FG003|Overall Study|Death|0|||
94448668|NCT03225105|323428726|FG000|Overall Study|Study termination per Sponsor Decision|2|||
94448669|NCT03225105|323428727|FG001|Overall Study|Study termination per Sponsor Decision|0|||
94448670|NCT03225105|323428728|FG002|Overall Study|Study termination per Sponsor Decision|3|||
94231846|NCT03845075|322642917|FG003|Part 1 - DB|Adverse Event|0|||
94231847|NCT03845075|322642914|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
94231848|NCT03845075|322642915|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
94231849|NCT03845075|322642916|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
94231850|NCT03845075|322642917|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
94448671|NCT03225105|323428729|FG003|Overall Study|Study termination per Sponsor Decision|3|||
94448672|NCT00571727|323428730|FG000|Overall Study|Did not enter in this study|1|||
94448673|NCT00571727|323428730|FG000|Overall Study|Non-compliance|4|||
94231851|NCT02564718|322642918|FG000|Overall Study|Withdrew from treatment|0|||
94231852|NCT02564718|322642919|FG001|Overall Study|Withdrew from treatment|1|||
94231853|NCT01101061|322642921|FG000|Overall Study|Adverse Event|0|||
94231854|NCT01101061|322642922|FG001|Overall Study|Adverse Event|0|||
94231855|NCT01101061|322642923|FG002|Overall Study|Adverse Event|1|||
94231856|NCT01101061|322642924|FG003|Overall Study|Adverse Event|0|||
94231857|NCT01101061|322642925|FG004|Overall Study|Adverse Event|0|||
94231858|NCT01101061|322642926|FG005|Overall Study|Adverse Event|0|||
94231859|NCT03517111|322642927|FG000|Enrolled|Withdrawal by Subject|0|||
94231860|NCT03517111|322642928|FG001|Enrolled|Withdrawal by Subject|1|||
94231861|NCT03517111|322642929|FG002|Enrolled|Withdrawal by Subject|0|||
94231862|NCT03517111|322642927|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
94231863|NCT03517111|322642928|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
94231864|NCT03517111|322642929|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
94231865|NCT03517111|322642927|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
94231866|NCT03517111|322642928|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
94231867|NCT03517111|322642929|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
94231868|NCT03517111|322642927|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
94231869|NCT03517111|322642928|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
94231870|NCT03517111|322642929|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
94231871|NCT03517111|322642927|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
94231872|NCT03517111|322642928|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
94231873|NCT03517111|322642929|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
94231874|NCT01209598|322642933|FG000|Overall Study|Withdrawal by Subject|1|||
94231875|NCT01209598|322642934|FG001|Overall Study|Withdrawal by Subject|0|||
94231876|NCT01087814|322642937|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
94231877|NCT01087814|322642938|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
94231878|NCT01087814|322642937|FG000|Second Intervention (5 Days)|Physician Decision|1|||
94231879|NCT01087814|322642938|FG001|Second Intervention (5 Days)|Physician Decision|0|||
94231880|NCT01427738|322642939|FG000|Overall Study|Death|12|||
94231881|NCT01427738|322642940|FG001|Overall Study|Death|9|||
94231882|NCT01427738|322642939|FG000|Overall Study|Severe debilitation, unable to continue|0|||
94231883|NCT01427738|322642940|FG001|Overall Study|Severe debilitation, unable to continue|1|||
94231884|NCT01427738|322642939|FG000|Overall Study|Subject unable to get to clinic|5|||
94231885|NCT01427738|322642940|FG001|Overall Study|Subject unable to get to clinic|2|||
94231886|NCT01427738|322642939|FG000|Overall Study|Withdrawal by Subject|0|||
94557046|NCT00596830|323833882|FG000|Overall Study|Death|258|||
94557047|NCT00596830|323833883|FG001|Overall Study|Death|247|||
94557048|NCT00596830|323833882|FG000|Overall Study|Lost to Follow-up|7|||
94557049|NCT00596830|323833883|FG001|Overall Study|Lost to Follow-up|11|||
94557050|NCT00596830|323833882|FG000|Overall Study|Withdrawal by Subject|22|||
94557051|NCT00596830|323833883|FG001|Overall Study|Withdrawal by Subject|12|||
94557052|NCT00596830|323833882|FG000|Overall Study|Study terminated by sponsor|51|||
94557053|NCT00596830|323833883|FG001|Overall Study|Study terminated by sponsor|62|||
94557054|NCT00596830|323833882|FG000|Overall Study|Follow-up was discontinued|1|||
94557055|NCT00596830|323833883|FG001|Overall Study|Follow-up was discontinued|0|||
94557056|NCT00596830|323833882|FG000|Overall Study|Randomized but not treated|3|||
94557057|NCT00596830|323833883|FG001|Overall Study|Randomized but not treated|7|||
94557058|NCT00532298|323833886|FG000|Overall Study|Adverse Event|1|||
94557059|NCT00532298|323833887|FG001|Overall Study|Adverse Event|0|||
94557060|NCT00532298|323833888|FG002|Overall Study|Adverse Event|0|||
94557061|NCT00532298|323833889|FG003|Overall Study|Adverse Event|0|||
94557062|NCT00532298|323833890|FG004|Overall Study|Adverse Event|1|||
94557063|NCT00532298|323833891|FG005|Overall Study|Adverse Event|1|||
94557064|NCT00532298|323833886|FG000|Overall Study|Lost to Follow-up|1|||
94557065|NCT00532298|323833887|FG001|Overall Study|Lost to Follow-up|1|||
94231887|NCT01427738|322642940|FG001|Overall Study|Withdrawal by Subject|2|||
94231888|NCT01427738|322642939|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
94231889|NCT01427738|322642940|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
94231890|NCT01427738|322642939|FG000|Overall Study|Lost to Follow-up|1|||
94557066|NCT00532298|323833888|FG002|Overall Study|Lost to Follow-up|1|||
94557067|NCT00532298|323833889|FG003|Overall Study|Lost to Follow-up|0|||
94231891|NCT01427738|322642940|FG001|Overall Study|Lost to Follow-up|5|||
94231892|NCT05314374|322642941|FG000|Overall Study|Adverse Event|2|||
94231893|NCT05314374|322642942|FG001|Overall Study|Adverse Event|2|||
94231894|NCT03561597|322642945|FG000|Overall Study|Lost to Follow-up|20|||
94231895|NCT02781311|322642946|FG000|Overall Study|Adverse Event|2|||
94231896|NCT02781311|322642947|FG001|Overall Study|Adverse Event|6|||
94231897|NCT02781311|322642948|FG002|Overall Study|Adverse Event|1|||
94231898|NCT02781311|322642946|FG000|Overall Study|Withdrawal of Consent|11|||
94231899|NCT02781311|322642947|FG001|Overall Study|Withdrawal of Consent|12|||
94231900|NCT02781311|322642948|FG002|Overall Study|Withdrawal of Consent|2|||
94231901|NCT02781311|322642946|FG000|Overall Study|Lost to Follow-up|11|||
94231902|NCT02781311|322642947|FG001|Overall Study|Lost to Follow-up|8|||
94231903|NCT02781311|322642948|FG002|Overall Study|Lost to Follow-up|1|||
94231904|NCT02781311|322642946|FG000|Overall Study|Non-Compliance with Study Drug|2|||
94231905|NCT02781311|322642947|FG001|Overall Study|Non-Compliance with Study Drug|0|||
94231906|NCT02781311|322642948|FG002|Overall Study|Non-Compliance with Study Drug|0|||
94231907|NCT00699842|322642949|FG000|Overall Study|Death|0|||
94231908|NCT00699842|322642950|FG001|Overall Study|Death|1|||
94231909|NCT00699842|322642951|FG002|Overall Study|Death|0|||
94231910|NCT04594733|322642954|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
94231911|NCT04594733|322642955|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
94231912|NCT04594733|322642954|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
94231913|NCT04594733|322642955|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
94231914|NCT04594733|322642954|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
94231915|NCT04594733|322642955|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
94231916|NCT03170518|322642956|FG000|Overall Study|Lost to Follow-up|4|||
94231917|NCT03170518|322642957|FG001|Overall Study|Lost to Follow-up|1|||
94231918|NCT03170518|322642958|FG002|Overall Study|Lost to Follow-up|0|||
94231919|NCT03170518|322642956|FG000|Overall Study|Physician Decision|1|||
94231920|NCT03170518|322642957|FG001|Overall Study|Physician Decision|0|||
94231921|NCT03170518|322642958|FG002|Overall Study|Physician Decision|0|||
94231922|NCT03170518|322642956|FG000|Overall Study|Withdrawal by Subject|4|||
94231923|NCT03170518|322642957|FG001|Overall Study|Withdrawal by Subject|5|||
94231924|NCT03170518|322642958|FG002|Overall Study|Withdrawal by Subject|2|||
94231925|NCT03170518|322642956|FG000|Overall Study|Site terminated by sponsor|0|||
94231926|NCT03170518|322642957|FG001|Overall Study|Site terminated by sponsor|1|||
94231927|NCT03170518|322642958|FG002|Overall Study|Site terminated by sponsor|0|||
94231928|NCT03170518|322642956|FG000|Overall Study|Non-compliance with study drug|1|||
94231929|NCT03170518|322642957|FG001|Overall Study|Non-compliance with study drug|0|||
94231930|NCT03170518|322642958|FG002|Overall Study|Non-compliance with study drug|1|||
94231931|NCT03170518|322642956|FG000|Overall Study|Withdrawal by parent/guardian|2|||
94231932|NCT03170518|322642957|FG001|Overall Study|Withdrawal by parent/guardian|0|||
94231933|NCT03170518|322642958|FG002|Overall Study|Withdrawal by parent/guardian|0|||
94231934|NCT02257918|322642959|FG000|Overall Study|Lost to Follow-up|4|||
94231935|NCT02257918|322642960|FG001|Overall Study|Lost to Follow-up|1|||
94231936|NCT02257918|322642961|FG002|Overall Study|Lost to Follow-up|0|||
94231937|NCT02257918|322642959|FG000|Overall Study|Withdrawal by Subject|0|||
94231938|NCT02257918|322642960|FG001|Overall Study|Withdrawal by Subject|0|||
94231939|NCT02257918|322642961|FG002|Overall Study|Withdrawal by Subject|1|||
94231940|NCT02257918|322642959|FG000|Overall Study|Pregnancy|0|||
94231941|NCT02257918|322642960|FG001|Overall Study|Pregnancy|0|||
94231942|NCT02257918|322642961|FG002|Overall Study|Pregnancy|1|||
94231943|NCT03494985|322642964|FG000|Overall Study|Adverse Event|3|||
94231944|NCT03494985|322642965|FG001|Overall Study|Adverse Event|2|||
94231945|NCT03494985|322642966|FG002|Overall Study|Adverse Event|3|||
94231946|NCT03494985|322642967|FG003|Overall Study|Adverse Event|0|||
94231947|NCT03494985|322642964|FG000|Overall Study|Other (Withdrawal of consent)|2|||
94231948|NCT03494985|322642965|FG001|Overall Study|Other (Withdrawal of consent)|3|||
94231949|NCT03494985|322642966|FG002|Overall Study|Other (Withdrawal of consent)|2|||
94231950|NCT03494985|322642967|FG003|Overall Study|Other (Withdrawal of consent)|5|||
94231951|NCT03494985|322642964|FG000|Overall Study|Other (Not specified)|0|||
94231952|NCT03494985|322642965|FG001|Overall Study|Other (Not specified)|1|||
94231953|NCT03494985|322642966|FG002|Overall Study|Other (Not specified)|1|||
94231954|NCT03494985|322642967|FG003|Overall Study|Other (Not specified)|0|||
94231955|NCT03668223|322642968|FG000|Overall Study|Death|10|||
94231956|NCT03668223|322642969|FG001|Overall Study|Death|5|||
94231957|NCT03668223|322642968|FG000|Overall Study|Lost to Follow-up|12|||
94231958|NCT03668223|322642969|FG001|Overall Study|Lost to Follow-up|12|||
94231959|NCT03668223|322642968|FG000|Overall Study|Withdrawal by Subject|8|||
94231960|NCT03668223|322642969|FG001|Overall Study|Withdrawal by Subject|3|||
94231961|NCT05347485|322642970|FG000|Overall Study|Death|14|||
94231962|NCT05347485|322642970|FG000|Overall Study|Lost to Follow-up|2|||
94231963|NCT05347485|322642970|FG000|Overall Study|Withdrawal by Subject|13|||
94231964|NCT05347485|322642970|FG000|Overall Study|Progressive Disease|1|||
94231965|NCT05347485|322642970|FG000|Overall Study|Study Terminated by Sponsor|49|||
94231966|NCT05347485|322642970|FG000|Overall Study|Other|1|||
94231967|NCT05347485|322642970|FG000|Overall Study|Enrolled (consented) but not treated|4|||
94557068|NCT00532298|323833890|FG004|Overall Study|Lost to Follow-up|0|||
94557069|NCT00532298|323833891|FG005|Overall Study|Lost to Follow-up|1|||
94557070|NCT04302545|323833892|FG000|Overall Study|Lost to Follow-up|3|||
94557071|NCT04302545|323833893|FG001|Overall Study|Lost to Follow-up|4|||
94557072|NCT00395850|323833894|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
94557073|NCT00395850|323833895|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
94557074|NCT00395850|323833896|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
94557075|NCT00395850|323833897|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
94557076|NCT00395850|323833894|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
94557077|NCT00395850|323833895|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
94557078|NCT00395850|323833896|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
94557079|NCT00395850|323833897|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
94557080|NCT00395850|323833894|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
94557081|NCT00395850|323833895|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
94557082|NCT00395850|323833896|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
94557083|NCT00395850|323833897|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
94557084|NCT00395850|323833894|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
94557085|NCT00395850|323833895|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
94557086|NCT00395850|323833896|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
94557087|NCT00395850|323833897|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
94557088|NCT00395850|323833894|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
94557089|NCT00395850|323833895|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
94557090|NCT00395850|323833896|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
94557091|NCT00395850|323833897|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
94557092|NCT00395850|323833894|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
94557093|NCT00395850|323833895|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
94557094|NCT00395850|323833896|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
94557095|NCT00395850|323833897|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
94557096|NCT00395850|323833894|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
94557097|NCT00395850|323833895|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
94557098|NCT00395850|323833896|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
94557099|NCT00395850|323833897|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
94557100|NCT02104947|323833898|FG000|Overall Study|Withdrawal by Subject|10|||
94557101|NCT02104947|323833899|FG001|Overall Study|Withdrawal by Subject|3|||
94557102|NCT02104947|323833898|FG000|Overall Study|Lost to Follow-up|4|||
94557103|NCT02104947|323833899|FG001|Overall Study|Lost to Follow-up|4|||
94557104|NCT02104947|323833898|FG000|Overall Study|Protocol Violation|6|||
94557105|NCT02104947|323833899|FG001|Overall Study|Protocol Violation|8|||
94557106|NCT02104947|323833898|FG000|Overall Study|Adverse Event|57|||
94557107|NCT02104947|323833899|FG001|Overall Study|Adverse Event|38|||
94557108|NCT02104947|323833898|FG000|Overall Study|Other than stated above|2|||
94557109|NCT02104947|323833899|FG001|Overall Study|Other than stated above|3|||
94557110|NCT01620762|323833900|FG000|Overall Study|Protocol Violation|1|||
94557111|NCT01620762|323833901|FG001|Overall Study|Protocol Violation|1|||
94557112|NCT01620762|323833902|FG002|Overall Study|Protocol Violation|1|||
94557113|NCT01620762|323833900|FG000|Overall Study|Adverse Event|9|||
94557114|NCT01620762|323833901|FG001|Overall Study|Adverse Event|5|||
94557115|NCT01620762|323833902|FG002|Overall Study|Adverse Event|2|||
94557116|NCT01620762|323833900|FG000|Overall Study|Withdrawal by Subject|23|||
94557117|NCT01620762|323833901|FG001|Overall Study|Withdrawal by Subject|26|||
94557118|NCT01620762|323833902|FG002|Overall Study|Withdrawal by Subject|27|||
94557119|NCT01620762|323833900|FG000|Overall Study|Lost to Follow-up|11|||
94557120|NCT01620762|323833901|FG001|Overall Study|Lost to Follow-up|17|||
94557121|NCT01620762|323833902|FG002|Overall Study|Lost to Follow-up|10|||
94557122|NCT01620762|323833900|FG000|Overall Study|Protocol deviation|1|||
94557123|NCT01620762|323833901|FG001|Overall Study|Protocol deviation|1|||
94557124|NCT01620762|323833902|FG002|Overall Study|Protocol deviation|6|||
94557125|NCT01620762|323833900|FG000|Overall Study|Subject deterioration|0|||
94557126|NCT01620762|323833901|FG001|Overall Study|Subject deterioration|1|||
94557127|NCT01620762|323833902|FG002|Overall Study|Subject deterioration|1|||
94557128|NCT01620762|323833900|FG000|Overall Study|Non-specified|3|||
94557129|NCT01620762|323833901|FG001|Overall Study|Non-specified|6|||
94557130|NCT01620762|323833902|FG002|Overall Study|Non-specified|5|||
94557131|NCT01620762|323833900|FG000|Overall Study|Use of prohibted therapies|0|||
94557132|NCT01620762|323833901|FG001|Overall Study|Use of prohibted therapies|1|||
94557133|NCT01620762|323833902|FG002|Overall Study|Use of prohibted therapies|1|||
94557134|NCT01853878|323833908|FG000|Overall Study|Recurrence|2|||
94557135|NCT01853878|323833909|FG001|Overall Study|Recurrence|0|||
94557136|NCT01853878|323833908|FG000|Overall Study|Adverse Event|2|||
94557137|NCT01853878|323833909|FG001|Overall Study|Adverse Event|0|||
94557138|NCT01853878|323833908|FG000|Overall Study|Withdrawal by Subject|3|||
94344343|NCT01263470|323040062|FG003|Overall Study|Protocol Violation|0|||
94344344|NCT01263470|323040063|FG004|Overall Study|Protocol Violation|0|||
94344345|NCT01263470|323040064|FG005|Overall Study|Protocol Violation|1|||
94344346|NCT01263470|323040059|FG000|Overall Study|Withdrawal by Subject|0|||
94344347|NCT01263470|323040060|FG001|Overall Study|Withdrawal by Subject|1|||
94344348|NCT01263470|323040061|FG002|Overall Study|Withdrawal by Subject|1|||
94344349|NCT01263470|323040062|FG003|Overall Study|Withdrawal by Subject|2|||
94344350|NCT01263470|323040063|FG004|Overall Study|Withdrawal by Subject|0|||
94344351|NCT01263470|323040064|FG005|Overall Study|Withdrawal by Subject|2|||
94344352|NCT01263470|323040059|FG000|Overall Study|Lack of Efficacy|0|||
94344353|NCT01263470|323040060|FG001|Overall Study|Lack of Efficacy|0|||
94344354|NCT01263470|323040061|FG002|Overall Study|Lack of Efficacy|2|||
94344355|NCT01263470|323040062|FG003|Overall Study|Lack of Efficacy|0|||
94344356|NCT01263470|323040063|FG004|Overall Study|Lack of Efficacy|0|||
94344357|NCT01263470|323040064|FG005|Overall Study|Lack of Efficacy|0|||
94344358|NCT01263470|323040059|FG000|Overall Study|Participant Unavailability|0|||
94344359|NCT01263470|323040060|FG001|Overall Study|Participant Unavailability|1|||
94344360|NCT01263470|323040061|FG002|Overall Study|Participant Unavailability|0|||
94448674|NCT00571727|323428730|FG000|Overall Study|Lost to Follow-up|30|||
94448675|NCT00571727|323428730|FG000|Overall Study|Poor growth|1|||
94557139|NCT01853878|323833909|FG001|Overall Study|Withdrawal by Subject|1|||
94557140|NCT01853878|323833908|FG000|Overall Study|Migrated/moved from the study area|1|||
94557141|NCT01853878|323833909|FG001|Overall Study|Migrated/moved from the study area|0|||
94557142|NCT01853878|323833908|FG000|Overall Study|Other|55|||
94557143|NCT01853878|323833909|FG001|Overall Study|Other|43|||
94557144|NCT03997825|323833910|FG000|Overall Study|Death|3|||
94557145|NCT03997825|323833910|FG000|Overall Study|Lost to Follow-up|10|||
94557146|NCT03997825|323833910|FG000|Overall Study|Withdrawal by Subject|3|||
94557147|NCT03997825|323833910|FG000|Overall Study|Refused participation|1|||
94557148|NCT00391625|323833911|FG000|Month 14|Withdrawal by Subject|1|||
94557149|NCT00391625|323833911|FG000|Month 50|Physician Decision|1|||
94557150|NCT03664765|323833914|FG000|Overall Study|Withdrawal by Subject|4|||
94557151|NCT03664765|323833915|FG001|Overall Study|Withdrawal by Subject|1|||
94557152|NCT03664765|323833914|FG000|Overall Study|Lost to Follow-up|0|||
94557153|NCT03664765|323833915|FG001|Overall Study|Lost to Follow-up|1|||
94557154|NCT00767819|323833918|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
94557155|NCT00767819|323833919|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
94557156|NCT00767819|323833920|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
94557157|NCT00767819|323833918|FG000|Overall Study|Withdrawal by Subject|1|||
94557158|NCT00767819|323833919|FG001|Overall Study|Withdrawal by Subject|1|||
94557159|NCT00767819|323833920|FG002|Overall Study|Withdrawal by Subject|0|||
94557160|NCT00767819|323833918|FG000|Overall Study|Administrative problems|0|||
94557161|NCT00767819|323833919|FG001|Overall Study|Administrative problems|1|||
94557162|NCT00767819|323833920|FG002|Overall Study|Administrative problems|0|||
94557163|NCT00767819|323833918|FG000|Overall Study|Death|2|||
94557164|NCT00767819|323833919|FG001|Overall Study|Death|3|||
94557165|NCT00767819|323833920|FG002|Overall Study|Death|0|||
94557166|NCT00767819|323833918|FG000|Overall Study|Adverse Event|2|||
94557167|NCT00767819|323833919|FG001|Overall Study|Adverse Event|0|||
94557168|NCT00767819|323833920|FG002|Overall Study|Adverse Event|0|||
94557169|NCT00767819|323833918|FG000|Overall Study|Abnormal lab values|1|||
94557170|NCT00767819|323833919|FG001|Overall Study|Abnormal lab values|0|||
94557171|NCT00767819|323833920|FG002|Overall Study|Abnormal lab values|0|||
94557172|NCT00767819|323833918|FG000|Overall Study|Lost to Follow-up|1|||
94557173|NCT00767819|323833919|FG001|Overall Study|Lost to Follow-up|0|||
94557174|NCT00767819|323833920|FG002|Overall Study|Lost to Follow-up|0|||
94557175|NCT01153698|323833921|FG000|Overall Study|Adverse Event|12|||
94557176|NCT01153698|323833921|FG000|Overall Study|Lost to Follow-up|4|||
94557177|NCT01153698|323833921|FG000|Overall Study|Withdrawal by Subject|2|||
94557178|NCT01153698|323833921|FG000|Overall Study|Switch to other anticoagulants|4|||
94344361|NCT01263470|323040062|FG003|Overall Study|Participant Unavailability|0|||
94344362|NCT01263470|323040063|FG004|Overall Study|Participant Unavailability|0|||
94344363|NCT01263470|323040064|FG005|Overall Study|Participant Unavailability|0|||
94344364|NCT01263470|323040059|FG000|Overall Study|Study Drug Non-compliance|0|||
94448676|NCT00571727|323428730|FG000|Overall Study|Parent/patient decision|2|||
94448677|NCT00571727|323428730|FG000|Overall Study|Participant transferred to commercial drug|14|||
94448678|NCT00571727|323428730|FG000|Overall Study|Unable to provide study drug|6|||
94448679|NCT00571727|323428730|FG000|Overall Study|On-treatment at end of study|8|||
94448680|NCT02195869|323428731|FG000|Overall Study|cGVHD Progression|5|||
94448681|NCT02195869|323428731|FG000|Overall Study|Malignancy Progression/relapse|2|||
94557179|NCT01153698|323833921|FG000|Overall Study|Other|2|||
94557180|NCT01153698|323833921|FG000|Overall Study|Not treated with Pradaxa|5|||
94557181|NCT00148941|323833935|FG000|Overall Study|Lost to Follow-up|17|||
94557182|NCT00148941|323833936|FG001|Overall Study|Lost to Follow-up|24|||
94557183|NCT00148941|323833937|FG002|Overall Study|Lost to Follow-up|18|||
94344365|NCT01263470|323040060|FG001|Overall Study|Study Drug Non-compliance|0|||
94557184|NCT00148941|323833938|FG003|Overall Study|Lost to Follow-up|22|||
94557185|NCT00148941|323833935|FG000|Overall Study|Withdrawal by Subject|1|||
94231968|NCT05347485|322642970|FG000|Overall Study|Disease Relapse|2|||
94231969|NCT01932762|322644255|FG000|Overall Study|Withdrawal by Subject|1|||
94231970|NCT01932762|322644256|FG001|Overall Study|Withdrawal by Subject|2|||
94231971|NCT01932762|322644257|FG002|Overall Study|Withdrawal by Subject|0|||
94231972|NCT01932762|322644258|FG003|Overall Study|Withdrawal by Subject|0|||
94231973|NCT01932762|322644255|FG000|Overall Study|Lost to Follow-up|4|||
94231974|NCT01932762|322644256|FG001|Overall Study|Lost to Follow-up|0|||
94231975|NCT01932762|322644257|FG002|Overall Study|Lost to Follow-up|0|||
94231976|NCT01932762|322644258|FG003|Overall Study|Lost to Follow-up|1|||
94231977|NCT01932762|322644255|FG000|Overall Study|Physician Decision|1|||
94231978|NCT01932762|322644256|FG001|Overall Study|Physician Decision|0|||
94231979|NCT01932762|322644257|FG002|Overall Study|Physician Decision|0|||
94231980|NCT01932762|322644258|FG003|Overall Study|Physician Decision|0|||
94231981|NCT02080403|322644261|FG000|Overall Study|Adverse Event|5|||
94231982|NCT02080403|322644262|FG001|Overall Study|Adverse Event|1|||
94231983|NCT02080403|322644261|FG000|Overall Study|Death|0|||
94231984|NCT02080403|322644262|FG001|Overall Study|Death|2|||
94231985|NCT02080403|322644261|FG000|Overall Study|Lost to Follow-up|2|||
94231986|NCT02080403|322644262|FG001|Overall Study|Lost to Follow-up|0|||
94231987|NCT02080403|322644261|FG000|Overall Study|Pregnancy|0|||
94231988|NCT02080403|322644262|FG001|Overall Study|Pregnancy|1|||
94231989|NCT02080403|322644261|FG000|Overall Study|Protocol Violation|3|||
94231990|NCT02080403|322644262|FG001|Overall Study|Protocol Violation|7|||
94231991|NCT02080403|322644261|FG000|Overall Study|Withdrawal by Subject|5|||
94231992|NCT02080403|322644262|FG001|Overall Study|Withdrawal by Subject|1|||
94231993|NCT01999972|322644263|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
94231994|NCT01999972|322644264|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
94231995|NCT01999972|322644265|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
94231996|NCT01999972|322644266|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
94231997|NCT01999972|322644267|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
94231998|NCT01999972|322644268|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
94448682|NCT02195869|323428731|FG000|Overall Study|Adverse Event|15|||
94448683|NCT02195869|323428731|FG000|Overall Study|Withdrawal by Subject|7|||
94448684|NCT02195869|323428731|FG000|Overall Study|Physician Decision|4|||
94448685|NCT02195869|323428731|FG000|Overall Study|Study Terminated by Sponsor|7|||
94448686|NCT02195869|323428731|FG000|Overall Study|Noncompliance with study drug|2|||
94448687|NCT01609010|323430340|FG000|Overall Study|Stable disease (SD)|22|||
94448688|NCT01609010|323430341|FG001|Overall Study|Stable disease (SD)|16|||
94448689|NCT01609010|323430340|FG000|Overall Study|Progressive disease (PD)|8|||
94448690|NCT01609010|323430341|FG001|Overall Study|Progressive disease (PD)|10|||
94448691|NCT01609010|323430340|FG000|Overall Study|Adverse Event|3|||
94448692|NCT01609010|323430341|FG001|Overall Study|Adverse Event|6|||
94448693|NCT01609010|323430340|FG000|Overall Study|Withdrawal by Subject|2|||
94448694|NCT01609010|323430341|FG001|Overall Study|Withdrawal by Subject|2|||
94448695|NCT01609010|323430340|FG000|Overall Study|Other|2|||
94448696|NCT01609010|323430341|FG001|Overall Study|Other|0|||
94448697|NCT01609010|323430340|FG000|Overall Study|Other malignancy|1|||
94448698|NCT01609010|323430341|FG001|Overall Study|Other malignancy|0|||
94448699|NCT01609010|323430340|FG000|Overall Study|Pathology review|2|||
94448700|NCT01609010|323430341|FG001|Overall Study|Pathology review|1|||
94448701|NCT01609010|323430340|FG000|Overall Study|Protocol Violation|1|||
94448702|NCT01609010|323430341|FG001|Overall Study|Protocol Violation|1|||
94448703|NCT01609010|323430340|FG000|Overall Study|New cancer|1|||
94448704|NCT01609010|323430341|FG001|Overall Study|New cancer|0|||
94448705|NCT01609010|323430340|FG000|Overall Study|Lost to Follow-up|1|||
94448706|NCT01609010|323430341|FG001|Overall Study|Lost to Follow-up|1|||
94448707|NCT05486091|323430342|FG000|Overall Study|Withdrawal by Subject|1|||
94448708|NCT05486091|323430342|FG000|Overall Study|Lost to Follow-up|2|||
94448709|NCT04509076|323430343|FG000|Overall Study|Withdrawal by Subject|1|||
94448710|NCT04509076|323430344|FG001|Overall Study|Withdrawal by Subject|2|||
94448711|NCT04509076|323430343|FG000|Overall Study|Lost to Follow-up|1|||
94448712|NCT04509076|323430344|FG001|Overall Study|Lost to Follow-up|2|||
94448713|NCT01620138|323430345|FG000|Overall Study|Withdrawal by Subject|3|||
94448714|NCT01620138|323430346|FG001|Overall Study|Withdrawal by Subject|0|||
94448715|NCT01620138|323430345|FG000|Overall Study|Lack of Efficacy|1|||
94448716|NCT01620138|323430346|FG001|Overall Study|Lack of Efficacy|0|||
94448717|NCT01620138|323430345|FG000|Overall Study|Adverse Event|2|||
94231999|NCT01999972|322644263|FG000|Dose Escalation Part|Death|0|||
94232000|NCT01999972|322644264|FG001|Dose Escalation Part|Death|1|||
94232001|NCT01999972|322644265|FG002|Dose Escalation Part|Death|0|||
94448718|NCT01620138|323430346|FG001|Overall Study|Adverse Event|0|||
94448719|NCT00957801|323430347|FG000|Overall Study|Withdrawal by Subject|0|||
94448720|NCT00957801|323430348|FG001|Overall Study|Withdrawal by Subject|0|||
94232002|NCT01999972|322644266|FG003|Dose Escalation Part|Death|0|||
94232003|NCT01999972|322644267|FG004|Dose Escalation Part|Death|0|||
94232004|NCT01999972|322644268|FG005|Dose Escalation Part|Death|0|||
94232005|NCT01999972|322644263|FG000|Dose Escalation Part|Enrolled but not treated|0|||
94232006|NCT01999972|322644264|FG001|Dose Escalation Part|Enrolled but not treated|0|||
94344366|NCT01263470|323040061|FG002|Overall Study|Study Drug Non-compliance|0|||
94344367|NCT01263470|323040062|FG003|Overall Study|Study Drug Non-compliance|0|||
94344368|NCT01263470|323040063|FG004|Overall Study|Study Drug Non-compliance|1|||
94344369|NCT01263470|323040064|FG005|Overall Study|Study Drug Non-compliance|0|||
94344370|NCT00729560|323040065|FG000|Overall Study|Withdrawal by Subject|3|||
94344371|NCT00976963|323040068|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
94344372|NCT00976963|323040069|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
94344373|NCT00976963|323040068|FG000|Overall Study|administrative error|1|||
94344374|NCT00976963|323040069|FG001|Overall Study|administrative error|0|||
94344375|NCT00976963|323040068|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
94344376|NCT00976963|323040069|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
94344377|NCT02723019|323040070|FG000|Overall Study|Death|17|||
94344378|NCT02723019|323040071|FG001|Overall Study|Death|13|||
94344379|NCT02723019|323040070|FG000|Overall Study|Withdrawal by Subject|11|||
94344380|NCT02723019|323040071|FG001|Overall Study|Withdrawal by Subject|7|||
94344381|NCT02723019|323040070|FG000|Overall Study|Lost to Follow-up|57|||
94344382|NCT02723019|323040071|FG001|Overall Study|Lost to Follow-up|70|||
94344383|NCT00592072|323040073|FG000|Wash Out Period|Lost to Follow-up|1|||
94344384|NCT00592072|323040074|FG001|Wash Out Period|Lost to Follow-up|1|||
94344385|NCT02148952|323040075|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
94344386|NCT02148952|323040076|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
94344387|NCT02148952|323040075|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
94344388|NCT02148952|323040076|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
94344389|NCT02148952|323040075|FG000|Follow-Up|Lost to Follow-up|219|||
94344390|NCT02148952|323040076|FG001|Follow-Up|Lost to Follow-up|231|||
94344391|NCT02148952|323040075|FG000|Follow-Up|Withdrawal by Subject|46|||
94344392|NCT02148952|323040076|FG001|Follow-Up|Withdrawal by Subject|48|||
94344393|NCT05333289|323040077|FG000|Overall Study|Other|1|||
94344394|NCT05333289|323040078|FG001|Overall Study|Other|0|||
94344395|NCT05333289|323040079|FG002|Overall Study|Other|0|||
94344396|NCT05333289|323040080|FG003|Overall Study|Other|1|||
94344397|NCT05333289|323040081|FG004|Overall Study|Other|1|||
94344398|NCT05333289|323040082|FG005|Overall Study|Other|2|||
94344399|NCT05333289|323040083|FG006|Overall Study|Other|2|||
94344400|NCT05333289|323040084|FG007|Overall Study|Other|0|||
94344401|NCT05333289|323040077|FG000|Overall Study|Withdrawal by Subject|1|||
94344402|NCT05333289|323040078|FG001|Overall Study|Withdrawal by Subject|2|||
94344403|NCT05333289|323040079|FG002|Overall Study|Withdrawal by Subject|2|||
94344404|NCT05333289|323040080|FG003|Overall Study|Withdrawal by Subject|1|||
94344405|NCT05333289|323040081|FG004|Overall Study|Withdrawal by Subject|1|||
94344406|NCT05333289|323040082|FG005|Overall Study|Withdrawal by Subject|2|||
94344407|NCT05333289|323040083|FG006|Overall Study|Withdrawal by Subject|1|||
94344408|NCT05333289|323040084|FG007|Overall Study|Withdrawal by Subject|3|||
94344409|NCT05333289|323040077|FG000|Overall Study|Protocol Violation|1|||
94344410|NCT05333289|323040078|FG001|Overall Study|Protocol Violation|0|||
94344411|NCT05333289|323040079|FG002|Overall Study|Protocol Violation|0|||
94232007|NCT01999972|322644265|FG002|Dose Escalation Part|Enrolled but not treated|1|||
94344412|NCT05333289|323040080|FG003|Overall Study|Protocol Violation|0|||
94344413|NCT05333289|323040081|FG004|Overall Study|Protocol Violation|0|||
94344414|NCT05333289|323040082|FG005|Overall Study|Protocol Violation|0|||
94344415|NCT05333289|323040083|FG006|Overall Study|Protocol Violation|0|||
94344416|NCT05333289|323040084|FG007|Overall Study|Protocol Violation|0|||
94344417|NCT05333289|323040077|FG000|Overall Study|Physician Decision|0|||
94344418|NCT05333289|323040078|FG001|Overall Study|Physician Decision|0|||
94344419|NCT05333289|323040079|FG002|Overall Study|Physician Decision|1|||
94344420|NCT05333289|323040080|FG003|Overall Study|Physician Decision|0|||
94344421|NCT05333289|323040081|FG004|Overall Study|Physician Decision|0|||
94344422|NCT05333289|323040082|FG005|Overall Study|Physician Decision|2|||
94344423|NCT05333289|323040083|FG006|Overall Study|Physician Decision|0|||
94344424|NCT05333289|323040084|FG007|Overall Study|Physician Decision|0|||
94344425|NCT05333289|323040077|FG000|Overall Study|Lost to Follow-up|6|||
94344426|NCT05333289|323040078|FG001|Overall Study|Lost to Follow-up|0|||
94344427|NCT05333289|323040079|FG002|Overall Study|Lost to Follow-up|1|||
94344428|NCT05333289|323040080|FG003|Overall Study|Lost to Follow-up|6|||
94344429|NCT05333289|323040081|FG004|Overall Study|Lost to Follow-up|3|||
94344430|NCT05333289|323040082|FG005|Overall Study|Lost to Follow-up|3|||
94344431|NCT05333289|323040083|FG006|Overall Study|Lost to Follow-up|2|||
94344432|NCT05333289|323040084|FG007|Overall Study|Lost to Follow-up|1|||
94344433|NCT05333289|323040077|FG000|Overall Study|Death|1|||
94344434|NCT05333289|323040078|FG001|Overall Study|Death|0|||
94344435|NCT05333289|323040079|FG002|Overall Study|Death|0|||
94344436|NCT05333289|323040080|FG003|Overall Study|Death|0|||
94344437|NCT05333289|323040081|FG004|Overall Study|Death|0|||
94344438|NCT05333289|323040082|FG005|Overall Study|Death|0|||
94344439|NCT05333289|323040083|FG006|Overall Study|Death|0|||
94344440|NCT05333289|323040084|FG007|Overall Study|Death|0|||
94344441|NCT02010567|323040089|FG000|Overall Study|Adverse Event|0|||
94344442|NCT02010567|323040090|FG001|Overall Study|Adverse Event|0|||
94344443|NCT02010567|323040091|FG002|Overall Study|Adverse Event|1|||
94344444|NCT02010567|323040092|FG003|Overall Study|Adverse Event|0|||
94344445|NCT02010567|323040093|FG004|Overall Study|Adverse Event|1|||
94344446|NCT00850135|323040095|FG000|Overall Study|Physician Decision|1|||
94344447|NCT03685643|323040096|FG000|Overall Study|Lost to Follow-up|14|||
94344448|NCT03685643|323040097|FG001|Overall Study|Lost to Follow-up|22|||
94344449|NCT03523715|323040098|FG000|Overall Study|Lost to Follow-up|11|||
94344450|NCT03523715|323040099|FG001|Overall Study|Lost to Follow-up|14|||
94344451|NCT03523715|323040098|FG000|Overall Study|Did not meet inclusion criteria|1|||
94344452|NCT03523715|323040099|FG001|Overall Study|Did not meet inclusion criteria|0|||
94344453|NCT03523715|323040098|FG000|Overall Study|Internally inconsistent reporting|0|||
94344454|NCT03523715|323040099|FG001|Overall Study|Internally inconsistent reporting|2|||
94344455|NCT01526928|323040100|FG000|Overall Study|Progressive Disease|35|||
94344456|NCT01526928|323040101|FG001|Overall Study|Progressive Disease|17|||
94344457|NCT01526928|323040102|FG002|Overall Study|Progressive Disease|150|||
94344458|NCT01526928|323040103|FG003|Overall Study|Progressive Disease|182|||
94344459|NCT01526928|323040104|FG004|Overall Study|Progressive Disease|76|||
94344460|NCT01526928|323040105|FG005|Overall Study|Progressive Disease|4|||
94344461|NCT01526928|323040100|FG000|Overall Study|Adverse Event|2|||
94344462|NCT01526928|323040101|FG001|Overall Study|Adverse Event|1|||
94344463|NCT01526928|323040102|FG002|Overall Study|Adverse Event|29|||
94344464|NCT01526928|323040103|FG003|Overall Study|Adverse Event|40|||
94344465|NCT01526928|323040104|FG004|Overall Study|Adverse Event|13|||
94344466|NCT01526928|323040105|FG005|Overall Study|Adverse Event|2|||
94344467|NCT01526928|323040100|FG000|Overall Study|Death|0|||
94344468|NCT01526928|323040101|FG001|Overall Study|Death|0|||
94344469|NCT01526928|323040102|FG002|Overall Study|Death|3|||
94344470|NCT01526928|323040103|FG003|Overall Study|Death|0|||
94344471|NCT01526928|323040104|FG004|Overall Study|Death|0|||
94344472|NCT01526928|323040105|FG005|Overall Study|Death|0|||
94344473|NCT01526928|323040100|FG000|Overall Study|Withdrawal by Subject|1|||
94344474|NCT01526928|323040101|FG001|Overall Study|Withdrawal by Subject|0|||
94448721|NCT00957801|323430349|FG002|Overall Study|Withdrawal by Subject|0|||
94344475|NCT01526928|323040102|FG002|Overall Study|Withdrawal by Subject|13|||
94344476|NCT01526928|323040103|FG003|Overall Study|Withdrawal by Subject|11|||
94344477|NCT01526928|323040104|FG004|Overall Study|Withdrawal by Subject|3|||
94344478|NCT01526928|323040105|FG005|Overall Study|Withdrawal by Subject|0|||
94344479|NCT01526928|323040100|FG000|Overall Study|Physician Decision|0|||
94344480|NCT01526928|323040101|FG001|Overall Study|Physician Decision|0|||
94344481|NCT01526928|323040102|FG002|Overall Study|Physician Decision|2|||
94344482|NCT01526928|323040103|FG003|Overall Study|Physician Decision|5|||
94344483|NCT01526928|323040104|FG004|Overall Study|Physician Decision|0|||
94344484|NCT01526928|323040105|FG005|Overall Study|Physician Decision|0|||
94344485|NCT01526928|323040100|FG000|Overall Study|Other Reason|0|||
94344486|NCT01526928|323040101|FG001|Overall Study|Other Reason|1|||
94344487|NCT01526928|323040102|FG002|Overall Study|Other Reason|11|||
94344488|NCT01526928|323040103|FG003|Overall Study|Other Reason|4|||
94344489|NCT01526928|323040104|FG004|Overall Study|Other Reason|1|||
94344490|NCT01526928|323040105|FG005|Overall Study|Other Reason|0|||
94344491|NCT01526928|323040100|FG000|Overall Study|Lost to Follow-up|0|||
94344492|NCT01526928|323040101|FG001|Overall Study|Lost to Follow-up|0|||
94344493|NCT01526928|323040102|FG002|Overall Study|Lost to Follow-up|0|||
94344494|NCT01526928|323040103|FG003|Overall Study|Lost to Follow-up|1|||
94344495|NCT01526928|323040104|FG004|Overall Study|Lost to Follow-up|0|||
94448722|NCT00957801|323430350|FG003|Overall Study|Withdrawal by Subject|1|||
94344496|NCT01526928|323040105|FG005|Overall Study|Lost to Follow-up|0|||
94344497|NCT01526928|323040100|FG000|Overall Study|Protocol Deviation|0|||
94344498|NCT01526928|323040101|FG001|Overall Study|Protocol Deviation|0|||
94344499|NCT01526928|323040102|FG002|Overall Study|Protocol Deviation|0|||
94344500|NCT01526928|323040103|FG003|Overall Study|Protocol Deviation|2|||
94344501|NCT01526928|323040104|FG004|Overall Study|Protocol Deviation|0|||
94344502|NCT01526928|323040105|FG005|Overall Study|Protocol Deviation|0|||
94344503|NCT01526928|323040100|FG000|Overall Study|Missing|0|||
94344504|NCT01526928|323040101|FG001|Overall Study|Missing|0|||
94344505|NCT01526928|323040102|FG002|Overall Study|Missing|1|||
94344506|NCT01526928|323040103|FG003|Overall Study|Missing|0|||
94344507|NCT01526928|323040104|FG004|Overall Study|Missing|2|||
94344508|NCT01526928|323040105|FG005|Overall Study|Missing|0|||
94344509|NCT00836953|323040106|FG000|Overall Study|Withdrawal by Subject|1|||
94344510|NCT00836953|323040106|FG000|Overall Study|Lost to Follow-up|1|||
94344511|NCT04445051|323040107|FG000|Overall Study|Adverse Event|0|||
94344512|NCT04445051|323040108|FG001|Overall Study|Adverse Event|0|||
94344513|NCT04445051|323040109|FG002|Overall Study|Adverse Event|1|||
94344514|NCT04445051|323040110|FG003|Overall Study|Adverse Event|0|||
94344515|NCT04445051|323040111|FG004|Overall Study|Adverse Event|0|||
94344516|NCT04445051|323040112|FG005|Overall Study|Adverse Event|0|||
94344517|NCT00572728|323040113|FG000|Overall Study|Withdrawal by Subject|10|||
94557186|NCT00148941|323833936|FG001|Overall Study|Withdrawal by Subject|0|||
94557187|NCT00148941|323833937|FG002|Overall Study|Withdrawal by Subject|1|||
94557188|NCT00148941|323833938|FG003|Overall Study|Withdrawal by Subject|0|||
94557189|NCT00148941|323833935|FG000|Overall Study|Other|0|||
94557190|NCT00148941|323833936|FG001|Overall Study|Other|0|||
94557191|NCT00148941|323833937|FG002|Overall Study|Other|1|||
94557192|NCT00148941|323833938|FG003|Overall Study|Other|2|||
94557193|NCT00635882|323833939|FG000|Overall Study|Protocol Violation|1|||
94557194|NCT00635882|323833940|FG001|Overall Study|Protocol Violation|0|||
94557195|NCT00635882|323833941|FG002|Overall Study|Protocol Violation|0|||
94557196|NCT00635882|323833942|FG003|Overall Study|Protocol Violation|0|||
94557197|NCT00635882|323833943|FG004|Overall Study|Protocol Violation|0|||
94557198|NCT00635882|323833944|FG005|Overall Study|Protocol Violation|0|||
94557199|NCT01320202|323833945|FG000|Overall Study|Adverse Event|5|||
94557200|NCT01320202|323833946|FG001|Overall Study|Adverse Event|5|||
94557201|NCT01320202|323833945|FG000|Overall Study|Death|5|||
94557202|NCT01320202|323833946|FG001|Overall Study|Death|3|||
94557203|NCT01320202|323833945|FG000|Overall Study|Lost to Follow-up|1|||
94557204|NCT01320202|323833946|FG001|Overall Study|Lost to Follow-up|0|||
94557205|NCT01320202|323833945|FG000|Overall Study|Physician Decision|3|||
94557206|NCT01320202|323833946|FG001|Overall Study|Physician Decision|1|||
94557207|NCT01320202|323833945|FG000|Overall Study|Protocol Violation|2|||
94557208|NCT01320202|323833946|FG001|Overall Study|Protocol Violation|1|||
94557209|NCT01320202|323833945|FG000|Overall Study|Withdrawal by Subject|10|||
94557210|NCT01320202|323833946|FG001|Overall Study|Withdrawal by Subject|3|||
94557211|NCT01320202|323833945|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
94557212|NCT01320202|323833946|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
94557213|NCT01320202|323833945|FG000|Overall Study|kidney transplant|1|||
94557214|NCT01320202|323833946|FG001|Overall Study|kidney transplant|2|||
94557215|NCT01320202|323833945|FG000|Overall Study|blood transfusion|1|||
94557216|NCT01320202|323833946|FG001|Overall Study|blood transfusion|7|||
94557217|NCT01320202|323833945|FG000|Overall Study|moved/changed dialysis|5|||
94557218|NCT01320202|323833946|FG001|Overall Study|moved/changed dialysis|2|||
94557219|NCT01320202|323833945|FG000|Overall Study|sponsor request|2|||
94557220|NCT01320202|323833946|FG001|Overall Study|sponsor request|0|||
94557221|NCT01320202|323833945|FG000|Overall Study|ineligible|3|||
94557222|NCT01320202|323833946|FG001|Overall Study|ineligible|0|||
94557223|NCT01320202|323833945|FG000|Overall Study|regained renal function|1|||
94557224|NCT01320202|323833946|FG001|Overall Study|regained renal function|0|||
94557225|NCT00835341|323833947|FG000|Overall Study|Lost to Follow-up|3|||
94344518|NCT00572728|323040113|FG000|Overall Study|Ineligible|3|||
94344519|NCT00572728|323040113|FG000|Overall Study|Enrolled under Amendment 4|5|||
94344520|NCT00572728|323040113|FG000|Overall Study|Offstudy due to complicating disease|1|||
94344521|NCT00572728|323040113|FG000|Overall Study|FLT1 not completed|4|||
94344522|NCT00572728|323040113|FG000|Overall Study|First Chemotherapy not initiated|2|||
94344523|NCT00572728|323040113|FG000|Overall Study|FLT2 not completed|5|||
94557226|NCT00835341|323833948|FG001|Overall Study|Lost to Follow-up|12|||
94557227|NCT02513472|323833949|FG000|Overall Study|Radiological Disease Progression|45|||
94557228|NCT02513472|323833950|FG001|Overall Study|Radiological Disease Progression|57|||
94557229|NCT02513472|323833949|FG000|Overall Study|Clinical Disease Progression|5|||
94557230|NCT02513472|323833950|FG001|Overall Study|Clinical Disease Progression|13|||
94557231|NCT02513472|323833949|FG000|Overall Study|Adverse Event|8|||
94344524|NCT00572728|323040113|FG000|Overall Study|Second chemotherapy not initiated|1|||
94344525|NCT00572728|323040113|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
94557232|NCT02513472|323833950|FG001|Overall Study|Adverse Event|11|||
94557233|NCT02513472|323833949|FG000|Overall Study|Withdrawal by Subject|0|||
94344526|NCT00572728|323040113|FG000|Overall Study|Pathology missing|1|||
94557234|NCT02513472|323833950|FG001|Overall Study|Withdrawal by Subject|4|||
94557235|NCT02513472|323833949|FG000|Overall Study|Subject Choice|2|||
94557236|NCT02513472|323833950|FG001|Overall Study|Subject Choice|7|||
94557237|NCT02513472|323833949|FG000|Overall Study|Treatment Completed as per Protocol|3|||
94557238|NCT02513472|323833950|FG001|Overall Study|Treatment Completed as per Protocol|3|||
94557239|NCT02513472|323833949|FG000|Overall Study|Other|3|||
94557240|NCT02513472|323833950|FG001|Overall Study|Other|6|||
94557241|NCT04405076|323833951|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
94557242|NCT04405076|323833952|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
94557243|NCT04405076|323833953|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
94557244|NCT04405076|323833954|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
94557245|NCT04405076|323833955|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
94557246|NCT04405076|323833956|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
94557247|NCT04405076|323833957|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
94557248|NCT04405076|323833958|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
94557249|NCT04405076|323833959|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
94557250|NCT04405076|323833951|FG000|Part A (Blinded Phase)|Physician Decision|1|||
94557251|NCT04405076|323833952|FG001|Part A (Blinded Phase)|Physician Decision|2|||
94557252|NCT04405076|323833953|FG002|Part A (Blinded Phase)|Physician Decision|0|||
94557253|NCT04405076|323833954|FG003|Part A (Blinded Phase)|Physician Decision|0|||
94557254|NCT04405076|323833955|FG004|Part A (Blinded Phase)|Physician Decision|0|||
94557255|NCT04405076|323833956|FG005|Part A (Blinded Phase)|Physician Decision|0|||
94557256|NCT04405076|323833957|FG006|Part A (Blinded Phase)|Physician Decision|0|||
94557257|NCT04405076|323833958|FG007|Part A (Blinded Phase)|Physician Decision|0|||
94557258|NCT04405076|323833959|FG008|Part A (Blinded Phase)|Physician Decision|0|||
94557259|NCT04405076|323833951|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
94557260|NCT04405076|323833952|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
94557261|NCT04405076|323833953|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
94557262|NCT04405076|323833954|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
94557263|NCT04405076|323833955|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
94557264|NCT04405076|323833956|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
94557265|NCT04405076|323833957|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
94557266|NCT04405076|323833958|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
94557267|NCT04405076|323833959|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
94557268|NCT04405076|323833951|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
94557269|NCT04405076|323833952|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
94557270|NCT04405076|323833953|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
94557271|NCT04405076|323833954|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
94557272|NCT04405076|323833955|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
94557273|NCT04405076|323833956|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
94557274|NCT04405076|323833957|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
94557275|NCT04405076|323833958|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
94557276|NCT04405076|323833959|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
94557277|NCT04405076|323833951|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
94557278|NCT04405076|323833952|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
94557279|NCT04405076|323833953|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
94557280|NCT04405076|323833954|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
94557281|NCT04405076|323833955|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
94557282|NCT04405076|323833956|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
94557283|NCT04405076|323833957|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
94557284|NCT04405076|323833958|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
94557285|NCT04405076|323833959|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
94557286|NCT04405076|323833951|FG000|Part A (Blinded Phase)|Other than Specified|0|||
94557287|NCT04405076|323833952|FG001|Part A (Blinded Phase)|Other than Specified|0|||
94557288|NCT04405076|323833953|FG002|Part A (Blinded Phase)|Other than Specified|3|||
94557289|NCT04405076|323833954|FG003|Part A (Blinded Phase)|Other than Specified|0|||
94557290|NCT04405076|323833955|FG004|Part A (Blinded Phase)|Other than Specified|0|||
94557291|NCT04405076|323833956|FG005|Part A (Blinded Phase)|Other than Specified|0|||
94557292|NCT04405076|323833957|FG006|Part A (Blinded Phase)|Other than Specified|0|||
94557293|NCT04405076|323833958|FG007|Part A (Blinded Phase)|Other than Specified|0|||
94557294|NCT04405076|323833959|FG008|Part A (Blinded Phase)|Other than Specified|0|||
94557295|NCT04405076|323833951|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
94557296|NCT04405076|323833952|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
94557297|NCT04405076|323833953|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
94557298|NCT04405076|323833954|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
94557299|NCT04405076|323833955|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
94557300|NCT04405076|323833956|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
94557301|NCT04405076|323833957|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
94557302|NCT04405076|323833958|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
94557303|NCT04405076|323833959|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
94557304|NCT04405076|323833951|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
94557305|NCT04405076|323833952|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
94557306|NCT04405076|323833953|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
94557307|NCT04405076|323833954|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
94557308|NCT04405076|323833955|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
94557309|NCT04405076|323833956|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
94557310|NCT04405076|323833957|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
94557311|NCT04405076|323833958|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
94557312|NCT04405076|323833959|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
94557313|NCT04405076|323833951|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
94557314|NCT04405076|323833952|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
94557315|NCT04405076|323833953|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
94557316|NCT04405076|323833954|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
94344527|NCT01387594|323040114|FG000|Overall Study|Withdrawal by Subject|0|||
94344528|NCT01387594|323040115|FG001|Overall Study|Withdrawal by Subject|2|||
94344529|NCT01387594|323040114|FG000|Overall Study|Lost to Follow-up|0|||
94344530|NCT01387594|323040115|FG001|Overall Study|Lost to Follow-up|1|||
94344531|NCT03935594|323040116|FG000|Overall Study|Physician Decision|3|||
94344532|NCT03954704|323040119|FG000|Overall Study|Death|1|||
94344533|NCT03954704|323040120|FG001|Overall Study|Death|1|||
94344534|NCT03954704|323040121|FG002|Overall Study|Death|1|||
94557317|NCT04405076|323833955|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
94344535|NCT03954704|323040122|FG003|Overall Study|Death|3|||
94344536|NCT03954704|323040123|FG004|Overall Study|Death|2|||
94344537|NCT03954704|323040124|FG005|Overall Study|Death|2|||
94344538|NCT03954704|323040125|FG006|Overall Study|Death|0|||
94344539|NCT03954704|323040119|FG000|Overall Study|Withdrew Consent|0|||
94344540|NCT03954704|323040120|FG001|Overall Study|Withdrew Consent|0|||
94448723|NCT00449865|323430351|FG000|Overall Study|Withdrawal by Subject|110|||
94448724|NCT00449865|323430352|FG001|Overall Study|Withdrawal by Subject|110|||
94448725|NCT00449865|323430351|FG000|Overall Study|Lost to Follow-up|36|||
94448726|NCT00449865|323430352|FG001|Overall Study|Lost to Follow-up|37|||
94448727|NCT00449865|323430351|FG000|Overall Study|Physician Decision|13|||
94448728|NCT00449865|323430352|FG001|Overall Study|Physician Decision|12|||
94448729|NCT00449865|323430351|FG000|Overall Study|Death|31|||
94448730|NCT00449865|323430352|FG001|Overall Study|Death|40|||
94448731|NCT00449865|323430351|FG000|Overall Study|Protocol Violation|8|||
94448732|NCT00449865|323430352|FG001|Overall Study|Protocol Violation|7|||
94448733|NCT00449865|323430351|FG000|Overall Study|Study was stopped|324|||
94448734|NCT00449865|323430352|FG001|Overall Study|Study was stopped|328|||
94448735|NCT02626026|323430353|FG000|Overall Study|Randomized but Never Treated|0|||
94448736|NCT02626026|323430354|FG001|Overall Study|Randomized but Never Treated|0|||
94448737|NCT02626026|323430355|FG002|Overall Study|Randomized but Never Treated|0|||
94448738|NCT02626026|323430356|FG003|Overall Study|Randomized but Never Treated|0|||
94448739|NCT02626026|323430357|FG004|Overall Study|Randomized but Never Treated|1|||
94448740|NCT02626026|323430358|FG005|Overall Study|Randomized but Never Treated|0|||
94448741|NCT01778855|323430359|FG000|Overall Study|Death|0|||
94448742|NCT01778855|323430360|FG001|Overall Study|Death|1|||
94448743|NCT01790984|323430370|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
94448744|NCT01790984|323430371|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
94448745|NCT01790984|323430372|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
94448746|NCT01790984|323430373|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
94448747|NCT03187301|323430374|FG000|Titration Period|Adverse Event|0|||
94557318|NCT04405076|323833956|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
94232008|NCT01999972|322644266|FG003|Dose Escalation Part|Enrolled but not treated|1|||
94344541|NCT03954704|323040121|FG002|Overall Study|Withdrew Consent|1|||
94344542|NCT03954704|323040122|FG003|Overall Study|Withdrew Consent|0|||
94344543|NCT03954704|323040123|FG004|Overall Study|Withdrew Consent|0|||
94448748|NCT03187301|323430375|FG001|Titration Period|Adverse Event|0|||
94448749|NCT03187301|323430376|FG002|Titration Period|Adverse Event|0|||
94448750|NCT03187301|323430377|FG003|Titration Period|Adverse Event|0|||
94448751|NCT03187301|323430378|FG004|Titration Period|Adverse Event|0|||
94448752|NCT03187301|323430379|FG005|Titration Period|Adverse Event|0|||
94344544|NCT03954704|323040124|FG005|Overall Study|Withdrew Consent|1|||
94344545|NCT03954704|323040125|FG006|Overall Study|Withdrew Consent|0|||
94344546|NCT03954704|323040119|FG000|Overall Study|Lost to Follow-up|0|||
94557319|NCT04405076|323833957|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
94557320|NCT04405076|323833958|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
94557321|NCT04405076|323833959|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
94557322|NCT04405076|323833951|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
94557323|NCT04405076|323833952|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
94557324|NCT04405076|323833953|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
94557325|NCT04405076|323833954|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
94557326|NCT04405076|323833955|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
94557327|NCT04405076|323833956|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
94557328|NCT04405076|323833957|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
94557329|NCT04405076|323833958|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
94557330|NCT04405076|323833959|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
94557331|NCT04405076|323833951|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
94232009|NCT01999972|322644267|FG004|Dose Escalation Part|Enrolled but not treated|0|||
94232010|NCT01999972|322644268|FG005|Dose Escalation Part|Enrolled but not treated|0|||
94232011|NCT01999972|322644263|FG000|Dose Escalation Part|Disease progression|3|||
94232012|NCT01999972|322644264|FG001|Dose Escalation Part|Disease progression|2|||
94557332|NCT04405076|323833952|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
94557333|NCT04405076|323833953|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
94557334|NCT04405076|323833954|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
94557335|NCT04405076|323833955|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
94557336|NCT04405076|323833956|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
94557337|NCT04405076|323833957|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
94557338|NCT04405076|323833958|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
94557339|NCT04405076|323833959|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
94557340|NCT01380834|323833960|FG000|Overall Study|Physician Decision|1|||
94557341|NCT01380834|323833961|FG001|Overall Study|Physician Decision|0|||
94557342|NCT01098305|323833966|FG000|Overall Study|Lost to Follow-up|31|||
94557343|NCT01098305|323833967|FG001|Overall Study|Lost to Follow-up|33|||
94557344|NCT01746173|323833973|FG000|Overall Study|Disease Progression|2|||
94557345|NCT00999518|323833982|FG000|Overall Study|Adverse Event|1|||
94557346|NCT00999518|323833983|FG001|Overall Study|Adverse Event|6|||
94557347|NCT00999518|323833984|FG002|Overall Study|Adverse Event|3|||
94557348|NCT00999518|323833985|FG003|Overall Study|Adverse Event|1|||
94557349|NCT00999518|323833986|FG004|Overall Study|Adverse Event|2|||
94557350|NCT00999518|323833982|FG000|Overall Study|Lack of Efficacy|2|||
94232013|NCT01999972|322644265|FG002|Dose Escalation Part|Disease progression|3|||
94557351|NCT00999518|323833983|FG001|Overall Study|Lack of Efficacy|0|||
94557352|NCT00999518|323833984|FG002|Overall Study|Lack of Efficacy|0|||
94557353|NCT00999518|323833985|FG003|Overall Study|Lack of Efficacy|2|||
94557354|NCT00999518|323833986|FG004|Overall Study|Lack of Efficacy|2|||
94557355|NCT00999518|323833982|FG000|Overall Study|Lost to Follow-up|0|||
94557356|NCT00999518|323833983|FG001|Overall Study|Lost to Follow-up|0|||
94557357|NCT00999518|323833984|FG002|Overall Study|Lost to Follow-up|0|||
94232014|NCT01999972|322644266|FG003|Dose Escalation Part|Disease progression|6|||
94232015|NCT01999972|322644267|FG004|Dose Escalation Part|Disease progression|0|||
94232016|NCT01999972|322644268|FG005|Dose Escalation Part|Disease progression|0|||
94232017|NCT01999972|322644263|FG000|Dose Escalation Part|Adverse Event|0|||
94232018|NCT01999972|322644264|FG001|Dose Escalation Part|Adverse Event|0|||
94232019|NCT01999972|322644265|FG002|Dose Escalation Part|Adverse Event|0|||
94232020|NCT01999972|322644266|FG003|Dose Escalation Part|Adverse Event|2|||
94232021|NCT01999972|322644267|FG004|Dose Escalation Part|Adverse Event|0|||
94232022|NCT01999972|322644268|FG005|Dose Escalation Part|Adverse Event|0|||
94232023|NCT01999972|322644263|FG000|Dose Escalation Part|Global deterioration of health status|1|||
94232024|NCT01999972|322644264|FG001|Dose Escalation Part|Global deterioration of health status|0|||
94232025|NCT01999972|322644265|FG002|Dose Escalation Part|Global deterioration of health status|0|||
94232026|NCT01999972|322644266|FG003|Dose Escalation Part|Global deterioration of health status|1|||
94557358|NCT00999518|323833985|FG003|Overall Study|Lost to Follow-up|4|||
94557359|NCT00999518|323833986|FG004|Overall Study|Lost to Follow-up|1|||
94557360|NCT00999518|323833982|FG000|Overall Study|Did not meet entrance criteria|0|||
94557361|NCT00999518|323833983|FG001|Overall Study|Did not meet entrance criteria|0|||
94557362|NCT00999518|323833984|FG002|Overall Study|Did not meet entrance criteria|0|||
94557363|NCT00999518|323833985|FG003|Overall Study|Did not meet entrance criteria|0|||
94557364|NCT00999518|323833986|FG004|Overall Study|Did not meet entrance criteria|1|||
94232027|NCT01999972|322644267|FG004|Dose Escalation Part|Global deterioration of health status|0|||
94232028|NCT01999972|322644268|FG005|Dose Escalation Part|Global deterioration of health status|0|||
94557365|NCT00999518|323833982|FG000|Overall Study|Study terminated by sponsor|10|||
94557366|NCT00999518|323833983|FG001|Overall Study|Study terminated by sponsor|6|||
94557367|NCT00999518|323833984|FG002|Overall Study|Study terminated by sponsor|5|||
94557368|NCT00999518|323833985|FG003|Overall Study|Study terminated by sponsor|5|||
94557369|NCT00999518|323833986|FG004|Overall Study|Study terminated by sponsor|9|||
94557370|NCT00999518|323833982|FG000|Overall Study|Pregnancy|0|||
94557371|NCT00999518|323833983|FG001|Overall Study|Pregnancy|0|||
94557372|NCT00999518|323833984|FG002|Overall Study|Pregnancy|1|||
94557373|NCT00999518|323833985|FG003|Overall Study|Pregnancy|0|||
94232029|NCT01999972|322644263|FG000|Dose Expansion Part|Death|0|||
94232030|NCT01999972|322644264|FG001|Dose Expansion Part|Death|0|||
94232031|NCT01999972|322644265|FG002|Dose Expansion Part|Death|0|||
94232032|NCT01999972|322644266|FG003|Dose Expansion Part|Death|0|||
94232033|NCT01999972|322644267|FG004|Dose Expansion Part|Death|2|||
94557374|NCT00999518|323833986|FG004|Overall Study|Pregnancy|0|||
94557375|NCT00999518|323833982|FG000|Overall Study|Protocol Violation|0|||
94557376|NCT00999518|323833983|FG001|Overall Study|Protocol Violation|1|||
94557377|NCT00999518|323833984|FG002|Overall Study|Protocol Violation|0|||
94557378|NCT00999518|323833985|FG003|Overall Study|Protocol Violation|0|||
94557379|NCT00999518|323833986|FG004|Overall Study|Protocol Violation|2|||
94557380|NCT00999518|323833982|FG000|Overall Study|Withdrawal by Subject|5|||
94557381|NCT00999518|323833983|FG001|Overall Study|Withdrawal by Subject|4|||
94557382|NCT00999518|323833984|FG002|Overall Study|Withdrawal by Subject|10|||
94557383|NCT00999518|323833985|FG003|Overall Study|Withdrawal by Subject|6|||
94557384|NCT00999518|323833986|FG004|Overall Study|Withdrawal by Subject|1|||
94557385|NCT00999518|323833982|FG000|Overall Study|Other|5|||
94557386|NCT00999518|323833983|FG001|Overall Study|Other|7|||
94557387|NCT00999518|323833984|FG002|Overall Study|Other|1|||
94557388|NCT00999518|323833985|FG003|Overall Study|Other|4|||
94557389|NCT00999518|323833986|FG004|Overall Study|Other|5|||
94557390|NCT00999518|323833982|FG000|Overall Study|Randomized but not Treated|1|||
94557391|NCT00999518|323833983|FG001|Overall Study|Randomized but not Treated|1|||
94557392|NCT00999518|323833984|FG002|Overall Study|Randomized but not Treated|2|||
94557393|NCT00999518|323833985|FG003|Overall Study|Randomized but not Treated|0|||
94557394|NCT00999518|323833986|FG004|Overall Study|Randomized but not Treated|1|||
94557395|NCT03210961|323836086|FG000|Overall Study|Adverse Event|0|||
94557396|NCT03210961|323836087|FG001|Overall Study|Adverse Event|0|||
94557397|NCT03210961|323836088|FG002|Overall Study|Adverse Event|0|||
94557398|NCT03210961|323836089|FG003|Overall Study|Adverse Event|0|||
94557399|NCT03210961|323836090|FG004|Overall Study|Adverse Event|0|||
94557400|NCT03210961|323836091|FG005|Overall Study|Adverse Event|0|||
94557401|NCT03210961|323836092|FG006|Overall Study|Adverse Event|0|||
94557402|NCT03210961|323836093|FG007|Overall Study|Adverse Event|0|||
94557403|NCT03210961|323836094|FG008|Overall Study|Adverse Event|0|||
94557404|NCT03210961|323836095|FG009|Overall Study|Adverse Event|0|||
94557405|NCT03210961|323836096|FG010|Overall Study|Adverse Event|0|||
94557406|NCT03210961|323836097|FG011|Overall Study|Adverse Event|0|||
94557407|NCT03210961|323836098|FG012|Overall Study|Adverse Event|0|||
94557408|NCT03210961|323836099|FG013|Overall Study|Adverse Event|1|||
94557409|NCT03210961|323836100|FG014|Overall Study|Adverse Event|0|||
94557410|NCT03210961|323836086|FG000|Overall Study|Lost to Follow-up|0|||
94557411|NCT03210961|323836087|FG001|Overall Study|Lost to Follow-up|0|||
94557412|NCT03210961|323836088|FG002|Overall Study|Lost to Follow-up|0|||
94557413|NCT03210961|323836089|FG003|Overall Study|Lost to Follow-up|0|||
94557414|NCT03210961|323836090|FG004|Overall Study|Lost to Follow-up|0|||
94557415|NCT03210961|323836091|FG005|Overall Study|Lost to Follow-up|0|||
94557416|NCT03210961|323836092|FG006|Overall Study|Lost to Follow-up|0|||
94232034|NCT01999972|322644268|FG005|Dose Expansion Part|Death|1|||
94232035|NCT01999972|322644263|FG000|Dose Expansion Part|Disease progression|0|||
94232036|NCT01999972|322644264|FG001|Dose Expansion Part|Disease progression|0|||
94232037|NCT01999972|322644265|FG002|Dose Expansion Part|Disease progression|0|||
94232038|NCT01999972|322644266|FG003|Dose Expansion Part|Disease progression|0|||
94232039|NCT01999972|322644267|FG004|Dose Expansion Part|Disease progression|9|||
94232040|NCT01999972|322644268|FG005|Dose Expansion Part|Disease progression|3|||
94232041|NCT01999972|322644263|FG000|Dose Expansion Part|Sponsor decision|0|||
94232042|NCT01999972|322644264|FG001|Dose Expansion Part|Sponsor decision|0|||
94232043|NCT01999972|322644265|FG002|Dose Expansion Part|Sponsor decision|0|||
94232044|NCT01999972|322644266|FG003|Dose Expansion Part|Sponsor decision|0|||
94557417|NCT03210961|323836093|FG007|Overall Study|Lost to Follow-up|0|||
94557418|NCT03210961|323836094|FG008|Overall Study|Lost to Follow-up|0|||
94557419|NCT03210961|323836095|FG009|Overall Study|Lost to Follow-up|0|||
94557420|NCT03210961|323836096|FG010|Overall Study|Lost to Follow-up|0|||
94232045|NCT01999972|322644267|FG004|Dose Expansion Part|Sponsor decision|1|||
94344547|NCT03954704|323040120|FG001|Overall Study|Lost to Follow-up|0|||
94557421|NCT03210961|323836097|FG011|Overall Study|Lost to Follow-up|0|||
94557422|NCT03210961|323836098|FG012|Overall Study|Lost to Follow-up|0|||
94557423|NCT03210961|323836099|FG013|Overall Study|Lost to Follow-up|0|||
94557424|NCT03210961|323836100|FG014|Overall Study|Lost to Follow-up|1|||
94557425|NCT03210961|323836086|FG000|Overall Study|Withdrawal by Subject|0|||
94232046|NCT01999972|322644268|FG005|Dose Expansion Part|Sponsor decision|0|||
94232047|NCT01999972|322644263|FG000|Dose Expansion Part|Adverse Event|0|||
94557426|NCT03210961|323836087|FG001|Overall Study|Withdrawal by Subject|0|||
94557427|NCT03210961|323836088|FG002|Overall Study|Withdrawal by Subject|0|||
94557428|NCT03210961|323836089|FG003|Overall Study|Withdrawal by Subject|0|||
94557429|NCT03210961|323836090|FG004|Overall Study|Withdrawal by Subject|0|||
94344548|NCT03954704|323040121|FG002|Overall Study|Lost to Follow-up|0|||
94344549|NCT03954704|323040122|FG003|Overall Study|Lost to Follow-up|0|||
94344550|NCT03954704|323040123|FG004|Overall Study|Lost to Follow-up|0|||
94344551|NCT03954704|323040124|FG005|Overall Study|Lost to Follow-up|0|||
94344552|NCT03954704|323040125|FG006|Overall Study|Lost to Follow-up|1|||
94344553|NCT03954704|323040119|FG000|Overall Study|Study Terminated by Sponsor|0|||
94344554|NCT03954704|323040120|FG001|Overall Study|Study Terminated by Sponsor|0|||
94344555|NCT03954704|323040121|FG002|Overall Study|Study Terminated by Sponsor|1|||
94344556|NCT03954704|323040122|FG003|Overall Study|Study Terminated by Sponsor|0|||
94344557|NCT03954704|323040123|FG004|Overall Study|Study Terminated by Sponsor|1|||
94344558|NCT03954704|323040124|FG005|Overall Study|Study Terminated by Sponsor|4|||
94344559|NCT03954704|323040125|FG006|Overall Study|Study Terminated by Sponsor|2|||
94344560|NCT03954704|323040119|FG000|Overall Study|Enrolled but not Treated|0|||
94344561|NCT03954704|323040120|FG001|Overall Study|Enrolled but not Treated|0|||
94232048|NCT01999972|322644264|FG001|Dose Expansion Part|Adverse Event|0|||
94232049|NCT01999972|322644265|FG002|Dose Expansion Part|Adverse Event|0|||
94232050|NCT01999972|322644266|FG003|Dose Expansion Part|Adverse Event|0|||
94232051|NCT01999972|322644267|FG004|Dose Expansion Part|Adverse Event|4|||
94232052|NCT01999972|322644268|FG005|Dose Expansion Part|Adverse Event|2|||
94232053|NCT01999972|322644263|FG000|Dose Expansion Part|Participant's non-compliance|0|||
94232054|NCT01999972|322644264|FG001|Dose Expansion Part|Participant's non-compliance|0|||
94232055|NCT01999972|322644265|FG002|Dose Expansion Part|Participant's non-compliance|0|||
94232056|NCT01999972|322644266|FG003|Dose Expansion Part|Participant's non-compliance|0|||
94232057|NCT01999972|322644267|FG004|Dose Expansion Part|Participant's non-compliance|0|||
94232058|NCT01999972|322644268|FG005|Dose Expansion Part|Participant's non-compliance|1|||
94232059|NCT01999972|322644263|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
94232060|NCT01999972|322644264|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
94232061|NCT01999972|322644265|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
94232062|NCT01999972|322644266|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
94232063|NCT01999972|322644267|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
94232064|NCT01999972|322644268|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
94232065|NCT01999972|322644263|FG000|Dose Expansion Part|Changed to standard of care|0|||
94232066|NCT01999972|322644264|FG001|Dose Expansion Part|Changed to standard of care|0|||
94232067|NCT01999972|322644265|FG002|Dose Expansion Part|Changed to standard of care|0|||
94232068|NCT01999972|322644266|FG003|Dose Expansion Part|Changed to standard of care|0|||
94232069|NCT01999972|322644267|FG004|Dose Expansion Part|Changed to standard of care|1|||
94232070|NCT01999972|322644268|FG005|Dose Expansion Part|Changed to standard of care|0|||
94232071|NCT02161406|322644269|FG000|Overall Study|Death|2|||
94232072|NCT02161406|322644270|FG001|Overall Study|Death|1|||
94232073|NCT02161406|322644269|FG000|Overall Study|Lost to Follow-up|2|||
94232074|NCT02161406|322644270|FG001|Overall Study|Lost to Follow-up|1|||
94232075|NCT02161406|322644269|FG000|Overall Study|Withdrawal by Subject|2|||
94232076|NCT02161406|322644270|FG001|Overall Study|Withdrawal by Subject|4|||
94232077|NCT02161406|322644269|FG000|Overall Study|investigator withdrew subject|3|||
94232078|NCT02161406|322644270|FG001|Overall Study|investigator withdrew subject|1|||
94232079|NCT02161406|322644269|FG000|Overall Study|Lack of Efficacy|1|||
94232080|NCT02161406|322644270|FG001|Overall Study|Lack of Efficacy|1|||
94232081|NCT02161406|322644269|FG000|Overall Study|relocation|0|||
94344562|NCT03954704|323040121|FG002|Overall Study|Enrolled but not Treated|0|||
94344563|NCT03954704|323040122|FG003|Overall Study|Enrolled but not Treated|0|||
94344564|NCT03954704|323040123|FG004|Overall Study|Enrolled but not Treated|0|||
94344565|NCT03954704|323040124|FG005|Overall Study|Enrolled but not Treated|1|||
94344566|NCT03954704|323040125|FG006|Overall Study|Enrolled but not Treated|0|||
94344567|NCT00102804|323040126|FG000|Overall Study|Progressive Disease (PD)|307|||
94232082|NCT02161406|322644270|FG001|Overall Study|relocation|1|||
94344568|NCT00102804|323040127|FG001|Overall Study|Progressive Disease (PD)|196|||
94344569|NCT00102804|323040126|FG000|Overall Study|Withdrawal by Subject|46|||
94344570|NCT00102804|323040127|FG001|Overall Study|Withdrawal by Subject|7|||
94344571|NCT00102804|323040126|FG000|Overall Study|Adverse Event|37|||
94344572|NCT00102804|323040127|FG001|Overall Study|Adverse Event|3|||
94344573|NCT00102804|323040126|FG000|Overall Study|Physician Decision|24|||
94232083|NCT00263211|322644271|FG000|Overall Study|Death|1|||
94232084|NCT00263211|322644272|FG001|Overall Study|Death|0|||
94232085|NCT00263211|322644271|FG000|Overall Study|Withdrawal by Subject|3|||
94657535|NCT00274716|324204324|FG004|Phase A|Met criteria for discontinuation|0|||
94344574|NCT00102804|323040127|FG001|Overall Study|Physician Decision|6|||
94344575|NCT00102804|323040126|FG000|Overall Study|Death|5|||
94344576|NCT00102804|323040127|FG001|Overall Study|Death|6|||
94344577|NCT00102804|323040126|FG000|Overall Study|Enrollment Criteria Not Met|6|||
94232086|NCT00263211|322644272|FG001|Overall Study|Withdrawal by Subject|0|||
94232087|NCT00263211|322644271|FG000|Overall Study|Protocol Violation|1|||
94232088|NCT00263211|322644272|FG001|Overall Study|Protocol Violation|0|||
94232089|NCT00263211|322644271|FG000|Overall Study|Disease Progression|0|||
94344578|NCT00102804|323040127|FG001|Overall Study|Enrollment Criteria Not Met|0|||
94232090|NCT00263211|322644272|FG001|Overall Study|Disease Progression|1|||
94232091|NCT00760513|322644273|FG000|Overall Study|Withdrawal by Subject|5|||
94557430|NCT03210961|323836091|FG005|Overall Study|Withdrawal by Subject|0|||
94557431|NCT03210961|323836092|FG006|Overall Study|Withdrawal by Subject|0|||
94557432|NCT03210961|323836093|FG007|Overall Study|Withdrawal by Subject|0|||
94557433|NCT03210961|323836094|FG008|Overall Study|Withdrawal by Subject|0|||
94557434|NCT03210961|323836095|FG009|Overall Study|Withdrawal by Subject|0|||
94557435|NCT03210961|323836096|FG010|Overall Study|Withdrawal by Subject|0|||
94557436|NCT03210961|323836097|FG011|Overall Study|Withdrawal by Subject|0|||
94557437|NCT03210961|323836098|FG012|Overall Study|Withdrawal by Subject|0|||
94557438|NCT03210961|323836099|FG013|Overall Study|Withdrawal by Subject|0|||
94557439|NCT03210961|323836100|FG014|Overall Study|Withdrawal by Subject|1|||
94557440|NCT03210961|323836086|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
94557441|NCT03210961|323836087|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
94557442|NCT03210961|323836088|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
94557443|NCT03210961|323836089|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
94557444|NCT03210961|323836090|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
94557445|NCT03210961|323836091|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
94557446|NCT03210961|323836092|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
94557447|NCT03210961|323836093|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
94557448|NCT03210961|323836094|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
94557449|NCT03210961|323836095|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
94557450|NCT03210961|323836096|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
94557451|NCT03210961|323836097|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
94557452|NCT03210961|323836098|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
94557453|NCT03210961|323836099|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
94557454|NCT03210961|323836100|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
94557455|NCT03210961|323836086|FG000|Overall Study|Other|0|||
94557456|NCT03210961|323836087|FG001|Overall Study|Other|0|||
94557457|NCT03210961|323836088|FG002|Overall Study|Other|0|||
94557458|NCT03210961|323836089|FG003|Overall Study|Other|1|||
94557459|NCT03210961|323836090|FG004|Overall Study|Other|0|||
94557460|NCT03210961|323836091|FG005|Overall Study|Other|0|||
94557461|NCT03210961|323836092|FG006|Overall Study|Other|1|||
94557462|NCT03210961|323836093|FG007|Overall Study|Other|0|||
94557463|NCT03210961|323836094|FG008|Overall Study|Other|0|||
94557464|NCT03210961|323836095|FG009|Overall Study|Other|0|||
94557465|NCT03210961|323836096|FG010|Overall Study|Other|1|||
94557466|NCT03210961|323836097|FG011|Overall Study|Other|0|||
94557467|NCT03210961|323836098|FG012|Overall Study|Other|2|||
94557468|NCT03210961|323836099|FG013|Overall Study|Other|2|||
94557469|NCT03210961|323836100|FG014|Overall Study|Other|0|||
94557470|NCT00649428|323836101|FG000|Overall Study|Adverse Event|2|||
94557471|NCT00649428|323836102|FG001|Overall Study|Adverse Event|2|||
94557472|NCT00649428|323836101|FG000|Overall Study|Withdrawal by Subject|6|||
94557473|NCT00649428|323836102|FG001|Overall Study|Withdrawal by Subject|6|||
94557474|NCT00649428|323836101|FG000|Overall Study|Lost to Follow-up|1|||
94557475|NCT00649428|323836102|FG001|Overall Study|Lost to Follow-up|3|||
94557476|NCT00649428|323836101|FG000|Overall Study|Insufficient manufacturing yield|5|||
94232092|NCT00760513|322644274|FG001|Overall Study|Withdrawal by Subject|7|||
94232093|NCT04795336|322644275|FG000|Overall Study|Withdrawal by Subject|3|||
94232094|NCT04795336|322644276|FG001|Overall Study|Withdrawal by Subject|4|||
94232095|NCT04795336|322644277|FG002|Overall Study|Withdrawal by Subject|3|||
94232096|NCT04795336|322644278|FG003|Overall Study|Withdrawal by Subject|12|||
94232097|NCT04795336|322644275|FG000|Overall Study|Lost study logs|0|||
94232098|NCT04795336|322644276|FG001|Overall Study|Lost study logs|1|||
94232099|NCT04795336|322644277|FG002|Overall Study|Lost study logs|0|||
94232100|NCT04795336|322644278|FG003|Overall Study|Lost study logs|2|||
94232101|NCT04795336|322644275|FG000|Overall Study|Did not take study medication|2|||
94232102|NCT04795336|322644276|FG001|Overall Study|Did not take study medication|0|||
94232103|NCT04795336|322644277|FG002|Overall Study|Did not take study medication|0|||
94232104|NCT04795336|322644278|FG003|Overall Study|Did not take study medication|0|||
94232105|NCT03616964|322644279|FG000|Overall Study|Adverse Event|15|||
94232106|NCT03616964|322644280|FG001|Overall Study|Adverse Event|10|||
94232107|NCT03616964|322644281|FG002|Overall Study|Adverse Event|16|||
94557477|NCT00649428|323836102|FG001|Overall Study|Insufficient manufacturing yield|1|||
94557478|NCT00649428|323836101|FG000|Overall Study|Protocol Violation|6|||
94557479|NCT00649428|323836102|FG001|Overall Study|Protocol Violation|2|||
94232108|NCT03616964|322644279|FG000|Overall Study|Death|3|||
94557480|NCT00649428|323836101|FG000|Overall Study|Physician Decision|0|||
94232109|NCT03616964|322644280|FG001|Overall Study|Death|0|||
94232110|NCT03616964|322644281|FG002|Overall Study|Death|4|||
94557481|NCT00649428|323836102|FG001|Overall Study|Physician Decision|1|||
94557482|NCT00965575|323836106|FG000|Overall Study|subject unwillingness to swallow study c|1|||
94557483|NCT00965575|323836107|FG001|Overall Study|subject unwillingness to swallow study c|0|||
94557484|NCT01271725|323836108|FG000|Part A|Progressive disease according to RECIST|8|||
94557485|NCT01271725|323836109|FG001|Part A|Progressive disease according to RECIST|0|||
94232111|NCT03616964|322644279|FG000|Overall Study|Lack of Efficacy|4|||
94557486|NCT01271725|323836108|FG000|Part A|Clinical signs/symptoms of progression|2|||
94557487|NCT01271725|323836109|FG001|Part A|Clinical signs/symptoms of progression|0|||
94557488|NCT01271725|323836108|FG000|Part A|Other Adverse Event|8|||
94557489|NCT01271725|323836109|FG001|Part A|Other Adverse Event|0|||
94557490|NCT01271725|323836108|FG000|Part A|Lost to Follow-up|1|||
94557491|NCT01271725|323836109|FG001|Part A|Lost to Follow-up|0|||
94557492|NCT01271725|323836108|FG000|Part A|Withdrawal by Subject|12|||
94557493|NCT01271725|323836109|FG001|Part A|Withdrawal by Subject|0|||
94557494|NCT01271725|323836108|FG000|Part A|Other than specified|3|||
94557495|NCT01271725|323836109|FG001|Part A|Other than specified|0|||
94557496|NCT01271725|323836108|FG000|Part A|Protocol Violation|1|||
94557497|NCT01271725|323836109|FG001|Part A|Protocol Violation|0|||
94557498|NCT01271725|323836108|FG000|Part B|Other than specified|0|||
94557499|NCT01271725|323836109|FG001|Part B|Other than specified|2|||
94557500|NCT01271725|323836108|FG000|Part B|Clinical signs/symptoms of progression|0|||
94557501|NCT01271725|323836109|FG001|Part B|Clinical signs/symptoms of progression|2|||
94557502|NCT01271725|323836108|FG000|Part B|Other Adverse Event|0|||
94557503|NCT01271725|323836109|FG001|Part B|Other Adverse Event|1|||
94557504|NCT01271725|323836108|FG000|Part B|Protocol Violation|0|||
94557505|NCT01271725|323836109|FG001|Part B|Protocol Violation|1|||
94557506|NCT01271725|323836108|FG000|Part B|Withdrawal by Subject|0|||
94557507|NCT01271725|323836109|FG001|Part B|Withdrawal by Subject|6|||
94557508|NCT03354273|323836110|FG000|Overall Study|Adverse Event|5|||
94557509|NCT03354273|323836110|FG000|Overall Study|Screen Failure|21|||
94557510|NCT03354273|323836110|FG000|Overall Study|Withdrawal by Subject|34|||
94557511|NCT03354273|323836110|FG000|Overall Study|Technical Problems|30|||
94557512|NCT03354273|323836110|FG000|Overall Study|Lost to Follow-up|4|||
94557513|NCT03354273|323836110|FG000|Overall Study|Investigator Decision|3|||
94557514|NCT03354273|323836110|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
94557515|NCT03354273|323836110|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
94557516|NCT03354273|323836110|FG000|Overall Study|COVID-19 Restrictions|9|||
94557517|NCT03354273|323836110|FG000|Overall Study|Other|5|||
94557518|NCT04207749|323836113|FG000|Overall Study|Lost to Follow-up|0|||
94557519|NCT04207749|323836114|FG001|Overall Study|Lost to Follow-up|2|||
94344579|NCT00102804|323040126|FG000|Overall Study|Lost to Follow-up|4|||
94344580|NCT00102804|323040127|FG001|Overall Study|Lost to Follow-up|1|||
94557520|NCT04207749|323836113|FG000|Overall Study|Protocol Violation|0|||
94557521|NCT04207749|323836114|FG001|Overall Study|Protocol Violation|1|||
94557522|NCT04207749|323836113|FG000|Overall Study|Withdrawal by Subject|3|||
94557523|NCT04207749|323836114|FG001|Overall Study|Withdrawal by Subject|0|||
94557524|NCT04207749|323836113|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
94557525|NCT04207749|323836114|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
94557526|NCT00655629|323836115|FG000|Overall Study|Adverse Event|4|||
94557527|NCT00655629|323836116|FG001|Overall Study|Adverse Event|1|||
94557528|NCT00655629|323836115|FG000|Overall Study|Lack of Efficacy|2|||
94557529|NCT00655629|323836116|FG001|Overall Study|Lack of Efficacy|12|||
94557530|NCT00655629|323836115|FG000|Overall Study|Lost to Follow-up|4|||
94557531|NCT00655629|323836116|FG001|Overall Study|Lost to Follow-up|3|||
94557532|NCT00655629|323836115|FG000|Overall Study|Protocol Violation|5|||
94557533|NCT00655629|323836116|FG001|Overall Study|Protocol Violation|3|||
94557534|NCT00655629|323836115|FG000|Overall Study|consent withdrawn|6|||
94557535|NCT00655629|323836116|FG001|Overall Study|consent withdrawn|4|||
94557536|NCT00705367|323836123|FG000|Long-term Extension Period|Adverse Event|2|||
94557537|NCT00705367|323836124|FG001|Long-term Extension Period|Adverse Event|0|||
94557538|NCT00705367|323836123|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
94557539|NCT00705367|323836124|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
94557540|NCT00705367|323836123|FG000|Long-term Extension Period|Lack of Efficacy|1|||
94344581|NCT00102804|323040126|FG000|Overall Study|Protocol Violation|2|||
94557541|NCT00705367|323836124|FG001|Long-term Extension Period|Lack of Efficacy|0|||
94557542|NCT00705367|323836123|FG000|Long-term Extension Period|No longer met study criteria|1|||
94557543|NCT00705367|323836124|FG001|Long-term Extension Period|No longer met study criteria|0|||
94557544|NCT00705367|323836123|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
94557545|NCT00705367|323836124|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
94557546|NCT00303485|323836128|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
94557547|NCT00303485|323836129|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
94557548|NCT00303485|323836128|FG000|Overall Study|Failure to return|0|||
94557549|NCT00303485|323836129|FG001|Overall Study|Failure to return|1|||
94557550|NCT00303485|323836128|FG000|Overall Study|Withdrawal by Subject|1|||
94557551|NCT00303485|323836129|FG001|Overall Study|Withdrawal by Subject|0|||
94557552|NCT01504841|323836133|FG000|Overall Study|Withdrawal by Subject|1|||
94557553|NCT01504841|323836134|FG001|Overall Study|Withdrawal by Subject|1|||
94557554|NCT01504841|323836135|FG002|Overall Study|Withdrawal by Subject|0|||
94344582|NCT00102804|323040127|FG001|Overall Study|Protocol Violation|1|||
94344583|NCT00102804|323040126|FG000|Overall Study|Satisfactory Response|2|||
94557555|NCT03149055|323836136|FG000|Overall Study|Not treated|4|||
94344584|NCT00102804|323040127|FG001|Overall Study|Satisfactory Response|0|||
94344585|NCT00102804|323040126|FG000|Overall Study|Sponsor Decision|1|||
94344586|NCT00102804|323040127|FG001|Overall Study|Sponsor Decision|0|||
94344587|NCT00102804|323040126|FG000|Overall Study|Alive, Receiving Treatment|7|||
94344588|NCT00102804|323040127|FG001|Overall Study|Alive, Receiving Treatment|2|||
94344589|NCT03858686|323040128|FG000|Period 1|Adverse Event|1|||
94344590|NCT03858686|323040129|FG001|Period 1|Adverse Event|1|||
94344591|NCT03858686|323040128|FG000|Period 1|Lack of compliance|0|||
94344592|NCT03858686|323040129|FG001|Period 1|Lack of compliance|1|||
94344593|NCT03858686|323040128|FG000|Period 1|Adverse Event|0|||
94344594|NCT03858686|323040129|FG001|Period 1|Adverse Event|1|||
94344595|NCT03858686|323040128|FG000|Period 2|Adverse Event|0|||
94344596|NCT03858686|323040129|FG001|Period 2|Adverse Event|1|||
94344597|NCT04964557|323040130|FG000|Overall Study|Withdrawal by Subject|3|||
94344598|NCT04964557|323040131|FG001|Overall Study|Withdrawal by Subject|2|||
94344599|NCT04964557|323040130|FG000|Overall Study|Lost to Follow-up|1|||
94344600|NCT04964557|323040131|FG001|Overall Study|Lost to Follow-up|2|||
94344601|NCT04964557|323040130|FG000|Overall Study|Physician Decision|2|||
94344602|NCT04964557|323040131|FG001|Overall Study|Physician Decision|0|||
94344603|NCT04964557|323040130|FG000|Overall Study|Death|3|||
94344604|NCT04964557|323040131|FG001|Overall Study|Death|0|||
94344605|NCT04964557|323040130|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
94344606|NCT04964557|323040131|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
94344607|NCT01432756|323042233|FG000|Overall Study|Lost to Follow-up|1|||
94344608|NCT01432756|323042234|FG001|Overall Study|Lost to Follow-up|0|||
94232112|NCT03616964|322644280|FG001|Overall Study|Lack of Efficacy|8|||
94232113|NCT03616964|322644281|FG002|Overall Study|Lack of Efficacy|8|||
94232114|NCT03616964|322644279|FG000|Overall Study|Lost to Follow-up|2|||
94232115|NCT03616964|322644280|FG001|Overall Study|Lost to Follow-up|1|||
94232116|NCT03616964|322644281|FG002|Overall Study|Lost to Follow-up|3|||
94232117|NCT03616964|322644279|FG000|Overall Study|Withdrawal by Subject|18|||
94232118|NCT03616964|322644280|FG001|Overall Study|Withdrawal by Subject|14|||
94344609|NCT01432756|323042235|FG002|Overall Study|Lost to Follow-up|2|||
94344610|NCT01432756|323042236|FG003|Overall Study|Lost to Follow-up|1|||
94232119|NCT03616964|322644281|FG002|Overall Study|Withdrawal by Subject|21|||
94344611|NCT03958149|323042240|FG000|Overall Study|Withdrawal by Subject|0|||
94344612|NCT03958149|323042241|FG001|Overall Study|Withdrawal by Subject|1|||
94344613|NCT00621764|323042242|FG000|Overall Study|Protocol Violation|0|||
94448753|NCT03187301|323430380|FG006|Titration Period|Adverse Event|5|||
94448754|NCT03187301|323430374|FG000|Titration Period|Withdrawal by Subject|0|||
94448755|NCT03187301|323430375|FG001|Titration Period|Withdrawal by Subject|0|||
94448756|NCT03187301|323430376|FG002|Titration Period|Withdrawal by Subject|0|||
94448757|NCT03187301|323430377|FG003|Titration Period|Withdrawal by Subject|0|||
94448758|NCT03187301|323430378|FG004|Titration Period|Withdrawal by Subject|0|||
94448759|NCT03187301|323430379|FG005|Titration Period|Withdrawal by Subject|0|||
94448760|NCT03187301|323430380|FG006|Titration Period|Withdrawal by Subject|1|||
94448761|NCT03187301|323430374|FG000|Titration Period|Exclusion Criteria Met|0|||
94448762|NCT03187301|323430375|FG001|Titration Period|Exclusion Criteria Met|0|||
94448763|NCT03187301|323430376|FG002|Titration Period|Exclusion Criteria Met|0|||
94448764|NCT03187301|323430377|FG003|Titration Period|Exclusion Criteria Met|0|||
94448765|NCT03187301|323430378|FG004|Titration Period|Exclusion Criteria Met|0|||
94448766|NCT03187301|323430379|FG005|Titration Period|Exclusion Criteria Met|0|||
94448767|NCT03187301|323430380|FG006|Titration Period|Exclusion Criteria Met|1|||
94448768|NCT03187301|323430374|FG000|Pre-Intervention|Withdrawal by Subject|1|||
94448769|NCT03187301|323430375|FG001|Pre-Intervention|Withdrawal by Subject|0|||
94448770|NCT03187301|323430376|FG002|Pre-Intervention|Withdrawal by Subject|0|||
94448771|NCT03187301|323430377|FG003|Pre-Intervention|Withdrawal by Subject|0|||
94448772|NCT03187301|323430378|FG004|Pre-Intervention|Withdrawal by Subject|0|||
94448773|NCT03187301|323430379|FG005|Pre-Intervention|Withdrawal by Subject|0|||
94448774|NCT03187301|323430380|FG006|Pre-Intervention|Withdrawal by Subject|0|||
94557556|NCT02629822|323836137|FG000|Base Study|Lost to Follow-up|2|||
94232120|NCT03616964|322644279|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
94344614|NCT00621764|323042243|FG001|Overall Study|Protocol Violation|0|||
94344615|NCT00621764|323042244|FG002|Overall Study|Protocol Violation|0|||
94344616|NCT00621764|323042245|FG003|Overall Study|Protocol Violation|1|||
94344617|NCT01004159|323042246|FG000|Overall Study|Adverse Event|2|||
94344618|NCT01004159|323042246|FG000|Overall Study|Disease Progression|18|||
94344619|NCT01997892|323042249|FG000|Overall Study|Physician Decision|2|||
94448775|NCT01812109|323430381|FG000|Overall Study|research personnel delay|16|||
94448776|NCT01812109|323430381|FG000|Overall Study|NIRS Unattainable|17|||
94448777|NCT03313180|323430383|FG000|Overall Study|Adverse Event|120|||
94448778|NCT03313180|323430383|FG000|Overall Study|Lost to Follow-up|3|||
94448779|NCT03313180|323430383|FG000|Overall Study|Withdrawal by Subject|39|||
94344620|NCT01997892|323042249|FG000|Overall Study|Lost to Follow-up|6|||
94344621|NCT01997892|323042249|FG000|Overall Study|Death|14|||
94344622|NCT01997892|323042249|FG000|Overall Study|Renal transplant|8|||
94344623|NCT01997892|323042249|FG000|Overall Study|Other|3|||
94557557|NCT02629822|323836137|FG000|Base Study|Non-Compliance With Study Drug|1|||
94557558|NCT02629822|323836137|FG000|Extension Study|Adverse Event|1|||
94232121|NCT03616964|322644280|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
94232122|NCT03616964|322644281|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
94232123|NCT03616964|322644279|FG000|Overall Study|Sponsor's Decision|1|||
94232124|NCT03616964|322644280|FG001|Overall Study|Sponsor's Decision|0|||
94232125|NCT03616964|322644281|FG002|Overall Study|Sponsor's Decision|0|||
94232126|NCT03616964|322644279|FG000|Overall Study|Physician Decision|0|||
94232127|NCT03616964|322644280|FG001|Overall Study|Physician Decision|2|||
94232128|NCT03616964|322644281|FG002|Overall Study|Physician Decision|0|||
94232129|NCT03616964|322644279|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
94232130|NCT03616964|322644280|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
94232131|NCT03616964|322644281|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
94232132|NCT03616964|322644279|FG000|Overall Study|Protocol Violation|0|||
94232133|NCT03616964|322644280|FG001|Overall Study|Protocol Violation|1|||
94232134|NCT03616964|322644281|FG002|Overall Study|Protocol Violation|0|||
94232135|NCT03616964|322644279|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
94232136|NCT03616964|322644280|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
94232137|NCT03616964|322644281|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
94232138|NCT03616964|322644279|FG000|Overall Study|Randomized but Never Treated|1|||
94232139|NCT03616964|322644280|FG001|Overall Study|Randomized but Never Treated|1|||
94232140|NCT03616964|322644281|FG002|Overall Study|Randomized but Never Treated|1|||
94232141|NCT04984239|322644282|FG000|Overall Study|Lost to Follow-up|1|||
94232142|NCT02994784|322644283|FG000|6 Months Follow-up|Lost to Follow-up|3|||
94232143|NCT03568812|322644284|FG000|Overall Study|Physician Decision|0|||
94557559|NCT02629822|323836137|FG000|Extension Study|Lost to Follow-up|1|||
94557560|NCT04440813|323836138|FG000|Overall Study|Lost to Follow-up|5|||
94557561|NCT04440813|323836139|FG001|Overall Study|Lost to Follow-up|5|||
94557562|NCT01610336|323836140|FG000|Overall Study|Progressive Disease|4|||
94557563|NCT01610336|323836141|FG001|Overall Study|Progressive Disease|6|||
94557564|NCT01610336|323836142|FG002|Overall Study|Progressive Disease|6|||
94557565|NCT01610336|323836143|FG003|Overall Study|Progressive Disease|5|||
94557566|NCT01610336|323836144|FG004|Overall Study|Progressive Disease|3|||
94557567|NCT01610336|323836145|FG005|Overall Study|Progressive Disease|10|||
94557568|NCT01610336|323836146|FG006|Overall Study|Progressive Disease|1|||
94557569|NCT01610336|323836147|FG007|Overall Study|Progressive Disease|6|||
94557570|NCT01610336|323836148|FG008|Overall Study|Progressive Disease|6|||
94557571|NCT01610336|323836149|FG009|Overall Study|Progressive Disease|40|||
94557572|NCT01610336|323836150|FG010|Overall Study|Progressive Disease|36|||
94557573|NCT01610336|323836140|FG000|Overall Study|Adverse Event|0|||
94557574|NCT01610336|323836141|FG001|Overall Study|Adverse Event|0|||
94557575|NCT01610336|323836142|FG002|Overall Study|Adverse Event|0|||
94557576|NCT01610336|323836143|FG003|Overall Study|Adverse Event|1|||
94557577|NCT01610336|323836144|FG004|Overall Study|Adverse Event|1|||
94557578|NCT01610336|323836145|FG005|Overall Study|Adverse Event|1|||
94557579|NCT01610336|323836146|FG006|Overall Study|Adverse Event|0|||
94557580|NCT01610336|323836147|FG007|Overall Study|Adverse Event|0|||
94557581|NCT01610336|323836148|FG008|Overall Study|Adverse Event|2|||
94557582|NCT01610336|323836149|FG009|Overall Study|Adverse Event|8|||
94557583|NCT01610336|323836150|FG010|Overall Study|Adverse Event|6|||
94557584|NCT01610336|323836140|FG000|Overall Study|Subject/Guardian decision|1|||
94557585|NCT01610336|323836141|FG001|Overall Study|Subject/Guardian decision|1|||
94557586|NCT01610336|323836142|FG002|Overall Study|Subject/Guardian decision|0|||
94557587|NCT01610336|323836143|FG003|Overall Study|Subject/Guardian decision|1|||
94557588|NCT01610336|323836144|FG004|Overall Study|Subject/Guardian decision|0|||
94557589|NCT01610336|323836145|FG005|Overall Study|Subject/Guardian decision|0|||
94557590|NCT01610336|323836146|FG006|Overall Study|Subject/Guardian decision|0|||
94557591|NCT01610336|323836147|FG007|Overall Study|Subject/Guardian decision|1|||
94557592|NCT01610336|323836148|FG008|Overall Study|Subject/Guardian decision|0|||
94557593|NCT01610336|323836149|FG009|Overall Study|Subject/Guardian decision|2|||
94557594|NCT01610336|323836150|FG010|Overall Study|Subject/Guardian decision|2|||
94557595|NCT01610336|323836140|FG000|Overall Study|Death|0|||
94557596|NCT01610336|323836141|FG001|Overall Study|Death|0|||
94557597|NCT01610336|323836142|FG002|Overall Study|Death|0|||
94557598|NCT01610336|323836143|FG003|Overall Study|Death|0|||
94557599|NCT01610336|323836144|FG004|Overall Study|Death|0|||
94232144|NCT03568812|322644285|FG001|Overall Study|Physician Decision|1|||
94232145|NCT04629443|322644289|FG000|Overall Study|Adverse Event|2|||
94232146|NCT04629443|322644290|FG001|Overall Study|Adverse Event|1|||
94232147|NCT04629443|322644291|FG002|Overall Study|Adverse Event|2|||
94232148|NCT04629443|322644289|FG000|Overall Study|Progressive Disease|2|||
94232149|NCT04629443|322644290|FG001|Overall Study|Progressive Disease|3|||
94557600|NCT01610336|323836145|FG005|Overall Study|Death|1|||
94557601|NCT01610336|323836146|FG006|Overall Study|Death|3|||
94557602|NCT01610336|323836147|FG007|Overall Study|Death|0|||
94557603|NCT01610336|323836148|FG008|Overall Study|Death|0|||
94557604|NCT01610336|323836149|FG009|Overall Study|Death|1|||
94557605|NCT01610336|323836150|FG010|Overall Study|Death|2|||
94557606|NCT01610336|323836140|FG000|Overall Study|Non-Compliance with study treatment|0|||
94557607|NCT01610336|323836141|FG001|Overall Study|Non-Compliance with study treatment|0|||
94557608|NCT01610336|323836142|FG002|Overall Study|Non-Compliance with study treatment|0|||
94557609|NCT01610336|323836143|FG003|Overall Study|Non-Compliance with study treatment|0|||
94557610|NCT01610336|323836144|FG004|Overall Study|Non-Compliance with study treatment|0|||
94557611|NCT01610336|323836145|FG005|Overall Study|Non-Compliance with study treatment|0|||
94557612|NCT01610336|323836146|FG006|Overall Study|Non-Compliance with study treatment|0|||
94557613|NCT01610336|323836147|FG007|Overall Study|Non-Compliance with study treatment|0|||
94557614|NCT01610336|323836148|FG008|Overall Study|Non-Compliance with study treatment|0|||
94557615|NCT01610336|323836149|FG009|Overall Study|Non-Compliance with study treatment|1|||
94557616|NCT01610336|323836150|FG010|Overall Study|Non-Compliance with study treatment|0|||
94557617|NCT01610336|323836140|FG000|Overall Study|Physician Decision|0|||
94557618|NCT01610336|323836141|FG001|Overall Study|Physician Decision|0|||
94557619|NCT01610336|323836142|FG002|Overall Study|Physician Decision|0|||
94557620|NCT01610336|323836143|FG003|Overall Study|Physician Decision|0|||
94557621|NCT01610336|323836144|FG004|Overall Study|Physician Decision|0|||
94344624|NCT01997892|323042249|FG000|Overall Study|Study completion data not recorded|35|||
94344625|NCT00963469|323042250|FG000|Overall Study|Adverse Event|15|||
94344626|NCT00963469|323042251|FG001|Overall Study|Adverse Event|11|||
94344627|NCT00963469|323042252|FG002|Overall Study|Adverse Event|1|||
94344628|NCT00963469|323042250|FG000|Overall Study|Lack of Efficacy|10|||
94344629|NCT00963469|323042251|FG001|Overall Study|Lack of Efficacy|7|||
94344630|NCT00963469|323042252|FG002|Overall Study|Lack of Efficacy|2|||
94557622|NCT01610336|323836145|FG005|Overall Study|Physician Decision|0|||
94557623|NCT01610336|323836146|FG006|Overall Study|Physician Decision|1|||
94344631|NCT00963469|323042250|FG000|Overall Study|Lost to Follow-up|1|||
94344632|NCT00963469|323042251|FG001|Overall Study|Lost to Follow-up|1|||
94344633|NCT00963469|323042252|FG002|Overall Study|Lost to Follow-up|0|||
94344634|NCT00963469|323042250|FG000|Overall Study|Protocol Violation|5|||
94344635|NCT00963469|323042251|FG001|Overall Study|Protocol Violation|5|||
94344636|NCT00963469|323042252|FG002|Overall Study|Protocol Violation|3|||
94344637|NCT00963469|323042250|FG000|Overall Study|Withdrawal by Subject|4|||
94344638|NCT00963469|323042251|FG001|Overall Study|Withdrawal by Subject|1|||
94344639|NCT00963469|323042252|FG002|Overall Study|Withdrawal by Subject|1|||
94344640|NCT00963469|323042250|FG000|Overall Study|Pre-randomization Adverse Event|1|||
94344641|NCT00963469|323042251|FG001|Overall Study|Pre-randomization Adverse Event|2|||
94344642|NCT00963469|323042252|FG002|Overall Study|Pre-randomization Adverse Event|0|||
94344643|NCT00963469|323042250|FG000|Overall Study|Moved|1|||
94344644|NCT00963469|323042251|FG001|Overall Study|Moved|0|||
94344645|NCT00963469|323042252|FG002|Overall Study|Moved|0|||
94344646|NCT00963469|323042250|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
94344647|NCT00963469|323042251|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
94344648|NCT00963469|323042252|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
94344649|NCT02274311|323042253|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
94344650|NCT04785144|323042255|FG000|Overall Study|Withdrawal by Subject|4|||
94344651|NCT04785144|323042256|FG001|Overall Study|Withdrawal by Subject|1|||
94344652|NCT04785144|323042257|FG002|Overall Study|Withdrawal by Subject|0|||
94344653|NCT04785144|323042258|FG003|Overall Study|Withdrawal by Subject|0|||
94344654|NCT04785144|323042259|FG004|Overall Study|Withdrawal by Subject|0|||
94344655|NCT04785144|323042260|FG005|Overall Study|Withdrawal by Subject|2|||
94344656|NCT04785144|323042261|FG006|Overall Study|Withdrawal by Subject|2|||
94344657|NCT04785144|323042262|FG007|Overall Study|Withdrawal by Subject|0|||
94344658|NCT04785144|323042263|FG008|Overall Study|Withdrawal by Subject|1|||
94344659|NCT04785144|323042264|FG009|Overall Study|Withdrawal by Subject|0|||
94344660|NCT04785144|323042255|FG000|Overall Study|Lost to Follow-up|1|||
94344661|NCT04785144|323042256|FG001|Overall Study|Lost to Follow-up|0|||
94344662|NCT04785144|323042257|FG002|Overall Study|Lost to Follow-up|0|||
94344663|NCT04785144|323042258|FG003|Overall Study|Lost to Follow-up|0|||
94344664|NCT04785144|323042259|FG004|Overall Study|Lost to Follow-up|1|||
94344665|NCT04785144|323042260|FG005|Overall Study|Lost to Follow-up|2|||
94344666|NCT04785144|323042261|FG006|Overall Study|Lost to Follow-up|1|||
94232150|NCT04629443|322644291|FG002|Overall Study|Progressive Disease|3|||
94232151|NCT04629443|322644289|FG000|Overall Study|Physician Decision|1|||
94344667|NCT04785144|323042262|FG007|Overall Study|Lost to Follow-up|2|||
94344668|NCT04785144|323042263|FG008|Overall Study|Lost to Follow-up|4|||
94344669|NCT04785144|323042264|FG009|Overall Study|Lost to Follow-up|1|||
94344670|NCT04785144|323042255|FG000|Overall Study|Protocol Violation|0|||
94344671|NCT04785144|323042256|FG001|Overall Study|Protocol Violation|0|||
94448780|NCT03313180|323430383|FG000|Overall Study|Other than listed above|15|||
94448781|NCT03313180|323430383|FG000|Overall Study|Covid-19 related|2|||
94448782|NCT00442897|323430389|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
94448783|NCT00442897|323430390|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
94232152|NCT04629443|322644290|FG001|Overall Study|Physician Decision|3|||
94232153|NCT04629443|322644291|FG002|Overall Study|Physician Decision|0|||
94232154|NCT00412880|322644294|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
94232155|NCT00412880|322644294|FG000|Overall Study|Consent withdrawn|1|||
94232156|NCT00412880|322644294|FG000|Overall Study|Adverse Event|1|||
94232157|NCT00412880|322644294|FG000|Overall Study|Progressive disease|20|||
94232158|NCT01496365|322644295|FG000|Overall Study|Adverse Event|2|||
94232159|NCT01496365|322644296|FG001|Overall Study|Adverse Event|3|||
94232160|NCT01496365|322644297|FG002|Overall Study|Adverse Event|3|||
94344672|NCT04785144|323042257|FG002|Overall Study|Protocol Violation|0|||
94448784|NCT00442897|323430389|FG000|Base Study (12 Week Follow-up)|Death|0|||
94448785|NCT00442897|323430390|FG001|Base Study (12 Week Follow-up)|Death|1|||
94448786|NCT00442897|323430389|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
94448787|NCT00442897|323430390|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
94448788|NCT00442897|323430389|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
94448789|NCT00442897|323430390|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
94448790|NCT00442897|323430389|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
94448791|NCT00442897|323430390|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
94557624|NCT01610336|323836147|FG007|Overall Study|Physician Decision|0|||
94557625|NCT01610336|323836148|FG008|Overall Study|Physician Decision|0|||
94232161|NCT01496365|322644298|FG003|Overall Study|Adverse Event|2|||
94344673|NCT04785144|323042258|FG003|Overall Study|Protocol Violation|0|||
94344674|NCT04785144|323042259|FG004|Overall Study|Protocol Violation|0|||
94344675|NCT04785144|323042260|FG005|Overall Study|Protocol Violation|0|||
94557626|NCT01610336|323836149|FG009|Overall Study|Physician Decision|0|||
94557627|NCT01610336|323836150|FG010|Overall Study|Physician Decision|0|||
94557628|NCT01610336|323836140|FG000|Overall Study|Protocol Deviation|0|||
94344676|NCT04785144|323042261|FG006|Overall Study|Protocol Violation|1|||
94344677|NCT04785144|323042262|FG007|Overall Study|Protocol Violation|0|||
94344678|NCT04785144|323042263|FG008|Overall Study|Protocol Violation|0|||
94557629|NCT01610336|323836141|FG001|Overall Study|Protocol Deviation|0|||
94557630|NCT01610336|323836142|FG002|Overall Study|Protocol Deviation|0|||
94557631|NCT01610336|323836143|FG003|Overall Study|Protocol Deviation|0|||
94557632|NCT01610336|323836144|FG004|Overall Study|Protocol Deviation|0|||
94557633|NCT01610336|323836145|FG005|Overall Study|Protocol Deviation|0|||
94557634|NCT01610336|323836146|FG006|Overall Study|Protocol Deviation|0|||
94557635|NCT01610336|323836147|FG007|Overall Study|Protocol Deviation|0|||
94557636|NCT01610336|323836148|FG008|Overall Study|Protocol Deviation|0|||
94557637|NCT01610336|323836149|FG009|Overall Study|Protocol Deviation|1|||
94557638|NCT01610336|323836150|FG010|Overall Study|Protocol Deviation|0|||
94557639|NCT01610336|323836140|FG000|Overall Study|Transfer to another trial|0|||
94557640|NCT01610336|323836141|FG001|Overall Study|Transfer to another trial|0|||
94557641|NCT01610336|323836142|FG002|Overall Study|Transfer to another trial|0|||
94557642|NCT01610336|323836143|FG003|Overall Study|Transfer to another trial|0|||
94557643|NCT01610336|323836144|FG004|Overall Study|Transfer to another trial|0|||
94557644|NCT01610336|323836145|FG005|Overall Study|Transfer to another trial|0|||
94557645|NCT01610336|323836146|FG006|Overall Study|Transfer to another trial|0|||
94557646|NCT01610336|323836147|FG007|Overall Study|Transfer to another trial|0|||
94557647|NCT01610336|323836148|FG008|Overall Study|Transfer to another trial|0|||
94557648|NCT01610336|323836149|FG009|Overall Study|Transfer to another trial|0|||
94557649|NCT01610336|323836150|FG010|Overall Study|Transfer to another trial|1|||
94557650|NCT03056339|323836158|FG000|Overall Study|Failed Requirements|0|||
94557651|NCT03056339|323836159|FG001|Overall Study|Failed Requirements|2|||
94557652|NCT03056339|323836160|FG002|Overall Study|Failed Requirements|7|||
94557653|NCT03056339|323836161|FG003|Overall Study|Failed Requirements|1|||
94344679|NCT04785144|323042264|FG009|Overall Study|Protocol Violation|0|||
94557654|NCT00630344|323836162|FG000|Overall Study|Adverse Event|5|||
94557655|NCT00630344|323836162|FG000|Overall Study|Progressive Disease|19|||
94557656|NCT00630344|323836162|FG000|Overall Study|Physician Decision|9|||
94557657|NCT00630344|323836162|FG000|Overall Study|Withdrawal by Subject|1|||
94557658|NCT00630344|323836162|FG000|Overall Study|Intercurrent Illness|1|||
94557659|NCT00630344|323836162|FG000|Overall Study|Other|1|||
94557660|NCT01128244|323836163|FG000|Overall Study|Adverse Event|1|||
94344680|NCT04785144|323042255|FG000|Overall Study|Physician Decision|0|||
94344681|NCT04785144|323042256|FG001|Overall Study|Physician Decision|0|||
94344682|NCT04785144|323042257|FG002|Overall Study|Physician Decision|0|||
94344683|NCT04785144|323042258|FG003|Overall Study|Physician Decision|0|||
94344684|NCT04785144|323042259|FG004|Overall Study|Physician Decision|0|||
94344685|NCT04785144|323042260|FG005|Overall Study|Physician Decision|0|||
94344686|NCT04785144|323042261|FG006|Overall Study|Physician Decision|0|||
94344687|NCT04785144|323042262|FG007|Overall Study|Physician Decision|0|||
94344688|NCT04785144|323042263|FG008|Overall Study|Physician Decision|0|||
94344689|NCT04785144|323042264|FG009|Overall Study|Physician Decision|1|||
94344690|NCT04785144|323042255|FG000|Overall Study|Unable to continue due to work schedule|0|||
94344691|NCT04785144|323042256|FG001|Overall Study|Unable to continue due to work schedule|0|||
94344692|NCT04785144|323042257|FG002|Overall Study|Unable to continue due to work schedule|0|||
94344693|NCT04785144|323042258|FG003|Overall Study|Unable to continue due to work schedule|0|||
94344694|NCT04785144|323042259|FG004|Overall Study|Unable to continue due to work schedule|0|||
94344695|NCT04785144|323042260|FG005|Overall Study|Unable to continue due to work schedule|0|||
94344696|NCT04785144|323042261|FG006|Overall Study|Unable to continue due to work schedule|0|||
94344697|NCT04785144|323042262|FG007|Overall Study|Unable to continue due to work schedule|0|||
94344698|NCT04785144|323042263|FG008|Overall Study|Unable to continue due to work schedule|0|||
94344699|NCT04785144|323042264|FG009|Overall Study|Unable to continue due to work schedule|1|||
94344700|NCT00764322|323042267|FG000|Overall Study|Withdrawal by Subject|11|||
94344701|NCT00764322|323042267|FG000|Overall Study|No CYP2D6 genotyping|9|||
94344702|NCT03662789|323042268|FG000|Overall Study|Lost to Follow-up|1|||
94344703|NCT03662789|323042269|FG001|Overall Study|Lost to Follow-up|2|||
94344704|NCT03662789|323042268|FG000|Overall Study|Could not perform treadmill test|4|||
94344705|NCT03662789|323042269|FG001|Overall Study|Could not perform treadmill test|4|||
94344706|NCT03662789|323042268|FG000|Overall Study|Death|0|||
94344707|NCT03662789|323042269|FG001|Overall Study|Death|1|||
94344708|NCT03598140|323042270|FG000|Overall Study|enrolled but didn't start|1|||
94344709|NCT03598140|323042271|FG001|Overall Study|enrolled but didn't start|0|||
94344710|NCT02155712|323042273|FG000|Overall Study|Death|12|||
94344711|NCT02155712|323042274|FG001|Overall Study|Death|0|||
94344712|NCT02155712|323042273|FG000|Overall Study|Lost to Follow-up|37|||
94344713|NCT02155712|323042274|FG001|Overall Study|Lost to Follow-up|22|||
94344714|NCT02155712|323042273|FG000|Overall Study|Revision of device|4|||
94557661|NCT01128244|323836163|FG000|Overall Study|Scheduling conflict|2|||
94448792|NCT00442897|323430389|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
94448793|NCT00442897|323430390|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
94448794|NCT00442897|323430389|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
94448795|NCT00442897|323430390|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
94448796|NCT00442897|323430389|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
94448797|NCT00442897|323430390|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
94448798|NCT04498182|323430392|FG000|Overall Study|Adverse Event|2|||
94448799|NCT04498182|323430393|FG001|Overall Study|Adverse Event|3|||
94448800|NCT04498182|323430394|FG002|Overall Study|Adverse Event|2|||
94448801|NCT04498182|323430392|FG000|Overall Study|Withdrawal of Consent|3|||
94448802|NCT04498182|323430393|FG001|Overall Study|Withdrawal of Consent|4|||
94448803|NCT04498182|323430394|FG002|Overall Study|Withdrawal of Consent|3|||
94448804|NCT04498182|323430392|FG000|Overall Study|Non-Compliant|1|||
94448805|NCT04498182|323430393|FG001|Overall Study|Non-Compliant|0|||
94448806|NCT04498182|323430394|FG002|Overall Study|Non-Compliant|1|||
94448807|NCT04498182|323430392|FG000|Overall Study|Lost to Follow-up|0|||
94448808|NCT04498182|323430393|FG001|Overall Study|Lost to Follow-up|0|||
94448809|NCT04498182|323430394|FG002|Overall Study|Lost to Follow-up|1|||
94448810|NCT04498182|323430392|FG000|Overall Study|Investigator Decision|0|||
94448811|NCT04498182|323430393|FG001|Overall Study|Investigator Decision|0|||
94448812|NCT04498182|323430394|FG002|Overall Study|Investigator Decision|1|||
94448813|NCT04498182|323430392|FG000|Overall Study|Protocol Violation|1|||
94448814|NCT04498182|323430393|FG001|Overall Study|Protocol Violation|0|||
94448815|NCT04498182|323430394|FG002|Overall Study|Protocol Violation|2|||
94448816|NCT02588612|323430398|FG000|Overall Study|Physician Decision|1|||
94448817|NCT02588612|323430398|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
94557662|NCT05362058|323836164|FG000|Treatment Period|Adverse Event|3|||
94557663|NCT05362058|323836165|FG001|Treatment Period|Adverse Event|3|||
94232162|NCT01496365|322644299|FG004|Overall Study|Adverse Event|5|||
94232163|NCT01496365|322644300|FG005|Overall Study|Adverse Event|6|||
94232164|NCT01496365|322644301|FG006|Overall Study|Adverse Event|4|||
94232165|NCT01496365|322644295|FG000|Overall Study|Withdrawal by Subject|6|||
94232166|NCT01496365|322644296|FG001|Overall Study|Withdrawal by Subject|6|||
94232167|NCT01496365|322644297|FG002|Overall Study|Withdrawal by Subject|0|||
94557664|NCT05362058|323836164|FG000|Treatment Period|Assigned treatment by mistake|3|||
94557665|NCT05362058|323836165|FG001|Treatment Period|Assigned treatment by mistake|4|||
94557666|NCT05362058|323836164|FG000|Treatment Period|Death|1|||
94557667|NCT05362058|323836165|FG001|Treatment Period|Death|1|||
94557668|NCT05362058|323836164|FG000|Treatment Period|Lost to Follow-up|6|||
94557669|NCT05362058|323836165|FG001|Treatment Period|Lost to Follow-up|3|||
94557670|NCT05362058|323836164|FG000|Treatment Period|Non-compliance with study drug|0|||
94232168|NCT01496365|322644298|FG003|Overall Study|Withdrawal by Subject|1|||
94232169|NCT01496365|322644299|FG004|Overall Study|Withdrawal by Subject|3|||
94232170|NCT01496365|322644300|FG005|Overall Study|Withdrawal by Subject|2|||
94232171|NCT01496365|322644301|FG006|Overall Study|Withdrawal by Subject|1|||
94557671|NCT05362058|323836165|FG001|Treatment Period|Non-compliance with study drug|1|||
94557672|NCT05362058|323836164|FG000|Treatment Period|Physician Decision|1|||
94557673|NCT05362058|323836165|FG001|Treatment Period|Physician Decision|0|||
94557674|NCT05362058|323836164|FG000|Treatment Period|Protocol deviation|1|||
94557675|NCT05362058|323836165|FG001|Treatment Period|Protocol deviation|0|||
94557676|NCT05362058|323836164|FG000|Treatment Period|Withdrawal by Subject|10|||
94557677|NCT05362058|323836165|FG001|Treatment Period|Withdrawal by Subject|11|||
94557678|NCT05362058|323836164|FG000|Follow-Up Period|Death|1|||
94557679|NCT05362058|323836165|FG001|Follow-Up Period|Death|0|||
94557680|NCT05362058|323836164|FG000|Follow-Up Period|Lost to Follow-up|2|||
94557681|NCT05362058|323836165|FG001|Follow-Up Period|Lost to Follow-up|1|||
94557682|NCT05362058|323836164|FG000|Follow-Up Period|Protocol deviation|1|||
94557683|NCT05362058|323836165|FG001|Follow-Up Period|Protocol deviation|1|||
94557684|NCT05362058|323836164|FG000|Follow-Up Period|Withdrawal by Subject|0|||
94557685|NCT05362058|323836165|FG001|Follow-Up Period|Withdrawal by Subject|3|||
94557686|NCT01964963|323836168|FG000|Overall Study|Case Report Forms Uncollected|888|||
94557687|NCT01964963|323836168|FG000|Overall Study|Protocol Deviation|50|||
94557688|NCT01964963|323836168|FG000|Overall Study|Data Reliability was not Assured|5|||
94557689|NCT03437577|323836173|FG000|Pre-Randomization|Withdrawal by Subject|0|||
94557690|NCT03437577|323836174|FG001|Pre-Randomization|Withdrawal by Subject|0|||
94557691|NCT03437577|323836175|FG002|Pre-Randomization|Withdrawal by Subject|10|||
94557692|NCT03437577|323836173|FG000|Post-Randomization|Physician Decision|0|||
94557693|NCT03437577|323836174|FG001|Post-Randomization|Physician Decision|2|||
94557694|NCT03437577|323836175|FG002|Post-Randomization|Physician Decision|0|||
94557695|NCT01440816|323836180|FG000|Overall Study|Disease Progression|0|||
94557696|NCT01440816|323836181|FG001|Overall Study|Disease Progression|9|||
94557697|NCT01440816|323836180|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
94232172|NCT01496365|322644295|FG000|Overall Study|Protocol Violation|2|||
94232173|NCT01496365|322644296|FG001|Overall Study|Protocol Violation|1|||
94232174|NCT01496365|322644297|FG002|Overall Study|Protocol Violation|1|||
94232175|NCT01496365|322644298|FG003|Overall Study|Protocol Violation|0|||
94557698|NCT01440816|323836181|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
94557699|NCT03387020|323836182|FG000|Overall Study|Adverse Event|0|||
94557700|NCT03387020|323836183|FG001|Overall Study|Adverse Event|2|||
94557701|NCT03387020|323836184|FG002|Overall Study|Adverse Event|0|||
94557702|NCT03387020|323836182|FG000|Overall Study|Withdrawal by Subject|2|||
94557703|NCT03387020|323836183|FG001|Overall Study|Withdrawal by Subject|0|||
94557704|NCT03387020|323836184|FG002|Overall Study|Withdrawal by Subject|0|||
94557705|NCT00183625|323836185|FG000|Overall Study|Withdrawal by Subject|18|||
94557706|NCT00183625|323836186|FG001|Overall Study|Withdrawal by Subject|18|||
94557707|NCT00183625|323836187|FG002|Overall Study|Withdrawal by Subject|19|||
94557708|NCT00183625|323836188|FG003|Overall Study|Withdrawal by Subject|14|||
94557709|NCT01846741|323836224|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
94557710|NCT01090063|323836225|FG000|Screen|Screen Failed|4|||
94557711|NCT01090063|323836225|FG000|Treatment|Withdrawal by Subject|4|||
94557712|NCT01832532|323836235|FG000|Overall Study|Withdrawal by Subject|5|||
94557713|NCT01832532|323836236|FG001|Overall Study|Withdrawal by Subject|2|||
94557714|NCT01534195|323836237|FG000|Overall Study|Withdrawal by Subject|1|||
94557715|NCT01534195|323836238|FG001|Overall Study|Withdrawal by Subject|1|||
94557716|NCT03302247|323836239|FG000|Overall Study|the study has closed prematurely|2|||
94557717|NCT03302247|323836239|FG000|Overall Study|Death|1|||
94557718|NCT02669121|323836240|FG000|Overall Study|Adverse Event|4|||
94557719|NCT02669121|323836241|FG001|Overall Study|Adverse Event|5|||
94557720|NCT02669121|323836240|FG000|Overall Study|Lost to Follow-up|15|||
94557721|NCT02669121|323836241|FG001|Overall Study|Lost to Follow-up|27|||
94557722|NCT02669121|323836240|FG000|Overall Study|Withdrawal by Subject|132|||
94557723|NCT02669121|323836241|FG001|Overall Study|Withdrawal by Subject|140|||
94232176|NCT01496365|322644299|FG004|Overall Study|Protocol Violation|0|||
94448818|NCT02588612|323430398|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
94448819|NCT02588612|323430398|FG000|Overall Study|Death prior to T-cell infusion|1|||
94448820|NCT03337113|323430404|FG000|Overall Study|Adverse Event|1|||
94448821|NCT03337113|323430405|FG001|Overall Study|Adverse Event|1|||
94448822|NCT03337113|323430406|FG002|Overall Study|Adverse Event|0|||
94448823|NCT03337113|323430407|FG003|Overall Study|Adverse Event|1|||
94448824|NCT03337113|323430404|FG000|Overall Study|Physician Decision|0|||
94448825|NCT03337113|323430405|FG001|Overall Study|Physician Decision|2|||
94448826|NCT03337113|323430406|FG002|Overall Study|Physician Decision|0|||
94448827|NCT03337113|323430407|FG003|Overall Study|Physician Decision|1|||
94448828|NCT03337113|323430404|FG000|Overall Study|Withdrawal by Subject|0|||
94448829|NCT03337113|323430405|FG001|Overall Study|Withdrawal by Subject|0|||
94448830|NCT03337113|323430406|FG002|Overall Study|Withdrawal by Subject|1|||
94448831|NCT03337113|323430407|FG003|Overall Study|Withdrawal by Subject|0|||
94448832|NCT01346059|323430408|FG000|Overall Study|Withdrawal by Subject|1|||
94448833|NCT01346059|323430409|FG001|Overall Study|Withdrawal by Subject|0|||
94448834|NCT00558467|323430412|FG000|Overall Study|Adverse Event|1|||
94448835|NCT00558467|323430413|FG001|Overall Study|Adverse Event|2|||
94448836|NCT00558467|323430412|FG000|Overall Study|Lack of Efficacy|0|||
94448837|NCT00558467|323430413|FG001|Overall Study|Lack of Efficacy|1|||
94448838|NCT00558467|323430412|FG000|Overall Study|Patient moving out of state|0|||
94448839|NCT00558467|323430413|FG001|Overall Study|Patient moving out of state|1|||
94448840|NCT03309943|323430414|FG000|Overall Study|Withdrawal by Subject|0|||
94448841|NCT03309943|323430415|FG001|Overall Study|Withdrawal by Subject|1|||
94448842|NCT03309943|323430414|FG000|Overall Study|Inappropriate behavior towards staff|0|||
94448843|NCT03309943|323430415|FG001|Overall Study|Inappropriate behavior towards staff|1|||
94448844|NCT00507455|323430416|FG000|Overall Study|Adverse Event|3|||
94448845|NCT00507455|323430417|FG001|Overall Study|Adverse Event|3|||
94448846|NCT00507455|323430418|FG002|Overall Study|Adverse Event|6|||
94448847|NCT00507455|323430416|FG000|Overall Study|Withdrawal by Subject|2|||
94448848|NCT00507455|323430417|FG001|Overall Study|Withdrawal by Subject|1|||
94448849|NCT00507455|323430418|FG002|Overall Study|Withdrawal by Subject|2|||
94448850|NCT00507455|323430416|FG000|Overall Study|Protocol Violation|4|||
94232177|NCT01496365|322644300|FG005|Overall Study|Protocol Violation|1|||
94232178|NCT01496365|322644301|FG006|Overall Study|Protocol Violation|0|||
94232179|NCT01496365|322644295|FG000|Overall Study|Lack of Efficacy|1|||
94232180|NCT01496365|322644296|FG001|Overall Study|Lack of Efficacy|0|||
94448851|NCT00507455|323430417|FG001|Overall Study|Protocol Violation|1|||
94448852|NCT00507455|323430418|FG002|Overall Study|Protocol Violation|1|||
94448853|NCT00507455|323430416|FG000|Overall Study|Lost to Follow-up|2|||
94448854|NCT00507455|323430417|FG001|Overall Study|Lost to Follow-up|0|||
94448855|NCT00507455|323430418|FG002|Overall Study|Lost to Follow-up|2|||
94448856|NCT00507455|323430416|FG000|Overall Study|Lack of Efficacy|0|||
94448857|NCT00507455|323430417|FG001|Overall Study|Lack of Efficacy|1|||
94448858|NCT00507455|323430418|FG002|Overall Study|Lack of Efficacy|0|||
94448859|NCT00507455|323430416|FG000|Overall Study|Other - miscellaneous reason|1|||
94448860|NCT00507455|323430417|FG001|Overall Study|Other - miscellaneous reason|0|||
94448861|NCT00507455|323430418|FG002|Overall Study|Other - miscellaneous reason|1|||
94448862|NCT03123393|323430422|FG000|Overall Study|Study Terminated by Sponsor|6|||
94448863|NCT03123393|323430423|FG001|Overall Study|Study Terminated by Sponsor|9|||
94448864|NCT03123393|323430422|FG000|Overall Study|Withdrawal by Subject|2|||
94448865|NCT03123393|323430423|FG001|Overall Study|Withdrawal by Subject|1|||
94448866|NCT03123393|323430422|FG000|Overall Study|Reason not Specified|13|||
94448867|NCT03123393|323430423|FG001|Overall Study|Reason not Specified|13|||
94448868|NCT00628212|323430426|FG000|Overall Study|Adverse Event|2|||
94448869|NCT00628212|323430427|FG001|Overall Study|Adverse Event|0|||
94448870|NCT00628212|323430428|FG002|Overall Study|Adverse Event|1|||
94448871|NCT00628212|323430429|FG003|Overall Study|Adverse Event|2|||
94448872|NCT00628212|323430426|FG000|Overall Study|Physician Decision|1|||
94448873|NCT00628212|323430427|FG001|Overall Study|Physician Decision|1|||
94448874|NCT00628212|323430428|FG002|Overall Study|Physician Decision|2|||
94448875|NCT00628212|323430429|FG003|Overall Study|Physician Decision|3|||
94448876|NCT01592786|323430430|FG000|Overall Study|Adverse Event|60|||
94448877|NCT01592786|323430430|FG000|Overall Study|Lack of Efficacy|19|||
94448878|NCT01592786|323430430|FG000|Overall Study|Protocol Violation|14|||
94448879|NCT01592786|323430430|FG000|Overall Study|Withdrawal by Subject|23|||
94448880|NCT01592786|323430430|FG000|Overall Study|Lost to Follow-up|19|||
94448881|NCT01592786|323430430|FG000|Overall Study|Other|3|||
94448882|NCT05047211|323430431|FG000|Overall Study|Lost to Follow-up|8|||
94448883|NCT05047211|323430432|FG001|Overall Study|Lost to Follow-up|5|||
94448884|NCT01737710|323430435|FG000|Overall Study|Lost to Follow-up|0|||
94448885|NCT01737710|323430436|FG001|Overall Study|Lost to Follow-up|2|||
94448886|NCT01737710|323430437|FG002|Overall Study|Lost to Follow-up|2|||
94448887|NCT01737710|323430438|FG003|Overall Study|Lost to Follow-up|0|||
94448888|NCT01737710|323430439|FG004|Overall Study|Lost to Follow-up|0|||
94448889|NCT01737710|323430435|FG000|Overall Study|Withdrawal by Subject|1|||
94448890|NCT01737710|323430436|FG001|Overall Study|Withdrawal by Subject|1|||
94448891|NCT01737710|323430437|FG002|Overall Study|Withdrawal by Subject|1|||
94448892|NCT01737710|323430438|FG003|Overall Study|Withdrawal by Subject|0|||
94448893|NCT01737710|323430439|FG004|Overall Study|Withdrawal by Subject|0|||
94448894|NCT01737710|323430435|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
94448895|NCT01737710|323430436|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
94448896|NCT01737710|323430437|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
94448897|NCT01737710|323430438|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
94448898|NCT01737710|323430439|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
94448899|NCT02282813|323430447|FG000|Overall Study|Withdrawal by Subject|4|||
94448900|NCT02282813|323430448|FG001|Overall Study|Withdrawal by Subject|5|||
94448901|NCT02282813|323430449|FG002|Overall Study|Withdrawal by Subject|0|||
94448902|NCT02282813|323430447|FG000|Overall Study|Adverse Event|3|||
94448903|NCT02282813|323430448|FG001|Overall Study|Adverse Event|10|||
94448904|NCT02282813|323430449|FG002|Overall Study|Adverse Event|1|||
94448905|NCT02282813|323430447|FG000|Overall Study|Subject non-compliance|1|||
94448906|NCT02282813|323430448|FG001|Overall Study|Subject non-compliance|4|||
94448907|NCT02282813|323430449|FG002|Overall Study|Subject non-compliance|0|||
94448908|NCT02282813|323430447|FG000|Overall Study|Physician Decision|0|||
94448909|NCT02282813|323430448|FG001|Overall Study|Physician Decision|3|||
94448910|NCT02282813|323430449|FG002|Overall Study|Physician Decision|1|||
94448911|NCT02282813|323430447|FG000|Overall Study|Lost to Follow-up|2|||
94448912|NCT02282813|323430448|FG001|Overall Study|Lost to Follow-up|0|||
94232181|NCT01496365|322644297|FG002|Overall Study|Lack of Efficacy|0|||
94232182|NCT01496365|322644298|FG003|Overall Study|Lack of Efficacy|0|||
94232183|NCT01496365|322644299|FG004|Overall Study|Lack of Efficacy|0|||
94232184|NCT01496365|322644300|FG005|Overall Study|Lack of Efficacy|1|||
94232185|NCT01496365|322644301|FG006|Overall Study|Lack of Efficacy|0|||
94232186|NCT01496365|322644295|FG000|Overall Study|Lost to Follow-up|0|||
94232187|NCT01496365|322644296|FG001|Overall Study|Lost to Follow-up|1|||
94232188|NCT01496365|322644297|FG002|Overall Study|Lost to Follow-up|0|||
94232189|NCT01496365|322644298|FG003|Overall Study|Lost to Follow-up|0|||
94232190|NCT01496365|322644299|FG004|Overall Study|Lost to Follow-up|2|||
94232191|NCT01496365|322644300|FG005|Overall Study|Lost to Follow-up|0|||
94232192|NCT01496365|322644301|FG006|Overall Study|Lost to Follow-up|0|||
94232193|NCT01496365|322644295|FG000|Overall Study|Other|4|||
94232194|NCT01496365|322644296|FG001|Overall Study|Other|4|||
94232195|NCT01496365|322644297|FG002|Overall Study|Other|2|||
94232196|NCT01496365|322644298|FG003|Overall Study|Other|1|||
94232197|NCT01496365|322644299|FG004|Overall Study|Other|3|||
94232198|NCT01496365|322644300|FG005|Overall Study|Other|0|||
94232199|NCT01496365|322644301|FG006|Overall Study|Other|1|||
94232200|NCT01015677|322644302|FG000|Overall Study|Adverse Event|0|||
94232201|NCT01015677|322644303|FG001|Overall Study|Adverse Event|1|||
94232202|NCT01015677|322644304|FG002|Overall Study|Adverse Event|0|||
94232203|NCT01015677|322644302|FG000|Overall Study|Lack of Efficacy|0|||
94232204|NCT01015677|322644303|FG001|Overall Study|Lack of Efficacy|1|||
94232205|NCT01015677|322644304|FG002|Overall Study|Lack of Efficacy|0|||
94232206|NCT01015677|322644302|FG000|Overall Study|Protocol Violation|0|||
94232207|NCT01015677|322644303|FG001|Overall Study|Protocol Violation|1|||
94232208|NCT01015677|322644304|FG002|Overall Study|Protocol Violation|0|||
94232209|NCT01015677|322644302|FG000|Overall Study|Withdrawal by Subject|1|||
94232210|NCT01015677|322644303|FG001|Overall Study|Withdrawal by Subject|1|||
94232211|NCT01015677|322644304|FG002|Overall Study|Withdrawal by Subject|0|||
94232212|NCT01660256|322644305|FG000|Overall Study|Adverse Event|4|||
94232213|NCT01660256|322644306|FG001|Overall Study|Adverse Event|0|||
94232214|NCT01660256|322644307|FG002|Overall Study|Adverse Event|2|||
94232215|NCT01660256|322644305|FG000|Overall Study|Withdrawal by Subject|1|||
94344715|NCT02155712|323042274|FG001|Overall Study|Revision of device|3|||
94344716|NCT02155712|323042273|FG000|Overall Study|Withdrawal by Subject|39|||
94344717|NCT02155712|323042274|FG001|Overall Study|Withdrawal by Subject|21|||
94557724|NCT02669121|323836240|FG000|Overall Study|Pregnancy|0|||
94232216|NCT01660256|322644306|FG001|Overall Study|Withdrawal by Subject|0|||
94232217|NCT01660256|322644307|FG002|Overall Study|Withdrawal by Subject|2|||
94232218|NCT04599855|322644312|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
94232219|NCT04599855|322644313|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
94232220|NCT04599855|322644314|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
94232221|NCT04599855|322644312|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
94344718|NCT02155712|323042273|FG000|Overall Study|Site termination|77|||
94232222|NCT04599855|322644313|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
94344719|NCT02155712|323042274|FG001|Overall Study|Site termination|19|||
94557725|NCT02669121|323836241|FG001|Overall Study|Pregnancy|1|||
94232223|NCT04599855|322644314|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
94232224|NCT04599855|322644312|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
94232225|NCT04599855|322644313|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
94232226|NCT04599855|322644314|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
94232227|NCT04599855|322644312|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
94232228|NCT04599855|322644313|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
94232229|NCT04599855|322644314|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
94232230|NCT04599855|322644312|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
94232231|NCT04599855|322644313|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
94232232|NCT04599855|322644314|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
94232233|NCT04599855|322644312|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
94232234|NCT04599855|322644313|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
94232235|NCT04599855|322644314|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
94232236|NCT04599855|322644312|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
94232237|NCT04599855|322644313|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
94232238|NCT04599855|322644314|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
94232239|NCT04599855|322644312|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
94232240|NCT04599855|322644313|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
94232241|NCT04599855|322644314|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
94232242|NCT04599855|322644312|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
94232243|NCT04599855|322644313|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
94232244|NCT04599855|322644314|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
94232245|NCT04599855|322644312|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
94344720|NCT02155712|323042273|FG000|Overall Study|Sponsor terminated study early|150|||
94557726|NCT02669121|323836240|FG000|Overall Study|Discharged from US Military Active Service|117|||
94557727|NCT02669121|323836241|FG001|Overall Study|Discharged from US Military Active Service|91|||
94557728|NCT02669121|323836240|FG000|Overall Study|Reason not Specified|22|||
94557729|NCT02669121|323836241|FG001|Overall Study|Reason not Specified|18|||
94557730|NCT00429169|323836242|FG000|Overall Study|Lost to Follow-up|0|||
94557731|NCT00429169|323836243|FG001|Overall Study|Lost to Follow-up|1|||
94557732|NCT00429169|323836242|FG000|Overall Study|Ineligibility discovered after entry|2|||
94557733|NCT00429169|323836243|FG001|Overall Study|Ineligibility discovered after entry|1|||
94557734|NCT02396589|323836244|FG000|Intervention|Lost to Follow-up|1|||
94557735|NCT02396589|323836245|FG001|Intervention|Lost to Follow-up|0|||
94557736|NCT02396589|323836244|FG000|6 Month Follow-up|change in health status|0|||
94557737|NCT02396589|323836245|FG001|6 Month Follow-up|change in health status|1|||
94557738|NCT02396589|323836244|FG000|9 Month Follow-up|Death|0|||
94557739|NCT02396589|323836245|FG001|9 Month Follow-up|Death|1|||
94557740|NCT02396589|323836244|FG000|12 Month Follow up|Lost to Follow-up|0|||
94557741|NCT02396589|323836245|FG001|12 Month Follow up|Lost to Follow-up|2|||
94557742|NCT05513053|323836246|FG000|Overall Study|Lost to Follow-up|9|||
94557743|NCT05513053|323836247|FG001|Overall Study|Lost to Follow-up|11|||
94557744|NCT05513053|323836246|FG000|Overall Study|Withdrawal by parent/guardian|2|||
94557745|NCT05513053|323836247|FG001|Overall Study|Withdrawal by parent/guardian|0|||
94557746|NCT05513053|323836246|FG000|Overall Study|Withdrawal by Subject|2|||
94557747|NCT05513053|323836247|FG001|Overall Study|Withdrawal by Subject|9|||
94557748|NCT05513053|323836246|FG000|Overall Study|Protocol Violation|6|||
94557749|NCT05513053|323836247|FG001|Overall Study|Protocol Violation|3|||
94557750|NCT05513053|323836246|FG000|Overall Study|Adverse Event|0|||
94557751|NCT05513053|323836247|FG001|Overall Study|Adverse Event|2|||
94557752|NCT01368081|323836248|FG000|Overall Study|Adverse Event|4|||
94557753|NCT01368081|323836249|FG001|Overall Study|Adverse Event|4|||
94448913|NCT02282813|323430449|FG002|Overall Study|Lost to Follow-up|1|||
94557754|NCT01368081|323836250|FG002|Overall Study|Adverse Event|3|||
94557755|NCT01368081|323836251|FG003|Overall Study|Adverse Event|2|||
94557756|NCT01368081|323836252|FG004|Overall Study|Adverse Event|2|||
94557757|NCT01368081|323836253|FG005|Overall Study|Adverse Event|5|||
94232246|NCT04599855|322644313|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
94232247|NCT04599855|322644314|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
94232248|NCT04599855|322644312|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
94232249|NCT04599855|322644313|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
94557758|NCT01368081|323836254|FG006|Overall Study|Adverse Event|6|||
94232250|NCT04599855|322644314|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
94232251|NCT04599855|322644312|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
94232252|NCT04599855|322644313|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
94232253|NCT04599855|322644314|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
94232254|NCT04599855|322644312|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
94232255|NCT04599855|322644313|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
94232256|NCT04599855|322644314|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
94232257|NCT04599855|322644312|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
94232258|NCT04599855|322644313|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
94232259|NCT04599855|322644314|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
94232260|NCT04175912|322644315|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
94232261|NCT04175912|322644316|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
94232262|NCT04175912|322644315|FG000|Overall Study|Adverse Event|0|||
94232263|NCT04175912|322644316|FG001|Overall Study|Adverse Event|3|||
94232264|NCT04175912|322644315|FG000|Overall Study|Never started treatment|3|||
94232265|NCT04175912|322644316|FG001|Overall Study|Never started treatment|3|||
94232266|NCT04175912|322644315|FG000|Overall Study|Death|0|||
94232267|NCT04175912|322644316|FG001|Overall Study|Death|1|||
94232268|NCT00469456|322644319|FG000|Overall Study|Adverse Event|4|||
94232269|NCT00469456|322644320|FG001|Overall Study|Adverse Event|3|||
94232270|NCT00469456|322644319|FG000|Overall Study|Protocol Violation|1|||
94232271|NCT00469456|322644320|FG001|Overall Study|Protocol Violation|0|||
94232272|NCT00469456|322644319|FG000|Overall Study|Withdrawal by Subject|4|||
94232273|NCT00469456|322644320|FG001|Overall Study|Withdrawal by Subject|1|||
94232274|NCT02818998|322644321|FG000|Overall Study|Adverse Event|3|||
94232275|NCT02818998|322644322|FG001|Overall Study|Adverse Event|2|||
94232276|NCT02818998|322644323|FG002|Overall Study|Adverse Event|1|||
94232277|NCT02818998|322644321|FG000|Overall Study|Lost to Follow-up|4|||
94232278|NCT02818998|322644322|FG001|Overall Study|Lost to Follow-up|1|||
94344721|NCT02155712|323042274|FG001|Overall Study|Sponsor terminated study early|0|||
94344722|NCT02155712|323042273|FG000|Overall Study|Missed final 5-year protocol visit|0|||
94232279|NCT02818998|322644323|FG002|Overall Study|Lost to Follow-up|2|||
94232280|NCT02818998|322644321|FG000|Overall Study|Withdrawal by sponsor|0|||
94232281|NCT02818998|322644322|FG001|Overall Study|Withdrawal by sponsor|1|||
94344723|NCT02155712|323042274|FG001|Overall Study|Missed final 5-year protocol visit|32|||
94344724|NCT02155712|323042273|FG000|Overall Study|Censored because surgery cancelled|6|||
94344725|NCT02155712|323042274|FG001|Overall Study|Censored because surgery cancelled|10|||
94344726|NCT02155712|323042273|FG000|Overall Study|Censored because study device was not implanted|61|||
94344727|NCT02155712|323042274|FG001|Overall Study|Censored because study device was not implanted|66|||
94344728|NCT02155712|323042273|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
94344729|NCT02155712|323042274|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
94344730|NCT02559115|323042276|FG000|Overall Study|Withdrawal by Subject|3|||
94344731|NCT02060903|323042281|FG000|Overall Study|Lost to Follow-up|4|||
94344732|NCT02060903|323042282|FG001|Overall Study|Lost to Follow-up|0|||
94344733|NCT02060903|323042281|FG000|Overall Study|Withdrawal by Subject|0|||
94344734|NCT02060903|323042282|FG001|Overall Study|Withdrawal by Subject|7|||
94344735|NCT01058395|323042283|FG000|Overall Study|Death|2|||
94344736|NCT01058395|323042284|FG001|Overall Study|Death|1|||
94557759|NCT01368081|323836255|FG007|Overall Study|Adverse Event|2|||
94557760|NCT01368081|323836256|FG008|Overall Study|Adverse Event|3|||
94557761|NCT01368081|323836257|FG009|Overall Study|Adverse Event|5|||
94557762|NCT01368081|323836258|FG010|Overall Study|Adverse Event|6|||
94557763|NCT01368081|323836259|FG011|Overall Study|Adverse Event|1|||
94557764|NCT01368081|323836260|FG012|Overall Study|Adverse Event|3|||
94557765|NCT01368081|323836248|FG000|Overall Study|Lack of Efficacy|0|||
94557766|NCT01368081|323836249|FG001|Overall Study|Lack of Efficacy|1|||
94557767|NCT01368081|323836250|FG002|Overall Study|Lack of Efficacy|0|||
94557768|NCT01368081|323836251|FG003|Overall Study|Lack of Efficacy|1|||
94557769|NCT01368081|323836252|FG004|Overall Study|Lack of Efficacy|0|||
94557770|NCT01368081|323836253|FG005|Overall Study|Lack of Efficacy|0|||
94557771|NCT01368081|323836254|FG006|Overall Study|Lack of Efficacy|0|||
94557772|NCT01368081|323836255|FG007|Overall Study|Lack of Efficacy|2|||
94557773|NCT01368081|323836256|FG008|Overall Study|Lack of Efficacy|0|||
94557774|NCT01368081|323836257|FG009|Overall Study|Lack of Efficacy|0|||
94557775|NCT01368081|323836258|FG010|Overall Study|Lack of Efficacy|0|||
94557776|NCT01368081|323836259|FG011|Overall Study|Lack of Efficacy|0|||
94557777|NCT01368081|323836260|FG012|Overall Study|Lack of Efficacy|0|||
94557778|NCT01368081|323836248|FG000|Overall Study|Protocol Violation|0|||
94557779|NCT01368081|323836249|FG001|Overall Study|Protocol Violation|0|||
94557780|NCT01368081|323836250|FG002|Overall Study|Protocol Violation|0|||
94557781|NCT01368081|323836251|FG003|Overall Study|Protocol Violation|0|||
94557782|NCT01368081|323836252|FG004|Overall Study|Protocol Violation|0|||
94557783|NCT01368081|323836253|FG005|Overall Study|Protocol Violation|1|||
94557784|NCT01368081|323836254|FG006|Overall Study|Protocol Violation|0|||
94557785|NCT01368081|323836255|FG007|Overall Study|Protocol Violation|1|||
94557786|NCT01368081|323836256|FG008|Overall Study|Protocol Violation|0|||
94557787|NCT01368081|323836257|FG009|Overall Study|Protocol Violation|0|||
94557788|NCT01368081|323836258|FG010|Overall Study|Protocol Violation|0|||
94557789|NCT01368081|323836259|FG011|Overall Study|Protocol Violation|0|||
94557790|NCT01368081|323836260|FG012|Overall Study|Protocol Violation|0|||
94557791|NCT01368081|323836248|FG000|Overall Study|Lost to Follow-up|0|||
94557792|NCT01368081|323836249|FG001|Overall Study|Lost to Follow-up|0|||
94557793|NCT01368081|323836250|FG002|Overall Study|Lost to Follow-up|0|||
94557794|NCT01368081|323836251|FG003|Overall Study|Lost to Follow-up|0|||
94557795|NCT01368081|323836252|FG004|Overall Study|Lost to Follow-up|0|||
94557796|NCT01368081|323836253|FG005|Overall Study|Lost to Follow-up|0|||
94557797|NCT01368081|323836254|FG006|Overall Study|Lost to Follow-up|0|||
94557798|NCT01368081|323836255|FG007|Overall Study|Lost to Follow-up|0|||
94557799|NCT01368081|323836256|FG008|Overall Study|Lost to Follow-up|0|||
94557800|NCT01368081|323836257|FG009|Overall Study|Lost to Follow-up|0|||
94557801|NCT01368081|323836258|FG010|Overall Study|Lost to Follow-up|0|||
94557802|NCT01368081|323836259|FG011|Overall Study|Lost to Follow-up|0|||
94557803|NCT01368081|323836260|FG012|Overall Study|Lost to Follow-up|1|||
94557804|NCT01368081|323836248|FG000|Overall Study|Withdrawal by Subject|4|||
94557805|NCT01368081|323836249|FG001|Overall Study|Withdrawal by Subject|4|||
94557806|NCT01368081|323836250|FG002|Overall Study|Withdrawal by Subject|1|||
94557807|NCT01368081|323836251|FG003|Overall Study|Withdrawal by Subject|1|||
94557808|NCT01368081|323836252|FG004|Overall Study|Withdrawal by Subject|0|||
94557809|NCT01368081|323836253|FG005|Overall Study|Withdrawal by Subject|3|||
94557810|NCT01368081|323836254|FG006|Overall Study|Withdrawal by Subject|4|||
94557811|NCT01368081|323836255|FG007|Overall Study|Withdrawal by Subject|2|||
94557812|NCT01368081|323836256|FG008|Overall Study|Withdrawal by Subject|5|||
94557813|NCT01368081|323836257|FG009|Overall Study|Withdrawal by Subject|4|||
94557814|NCT01368081|323836258|FG010|Overall Study|Withdrawal by Subject|3|||
94557815|NCT01368081|323836259|FG011|Overall Study|Withdrawal by Subject|2|||
94557816|NCT01368081|323836260|FG012|Overall Study|Withdrawal by Subject|0|||
94557817|NCT01368081|323836248|FG000|Overall Study|Other reason not defined above|2|||
94557818|NCT01368081|323836249|FG001|Overall Study|Other reason not defined above|0|||
94557819|NCT01368081|323836250|FG002|Overall Study|Other reason not defined above|0|||
94557820|NCT01368081|323836251|FG003|Overall Study|Other reason not defined above|1|||
94557821|NCT01368081|323836252|FG004|Overall Study|Other reason not defined above|0|||
94557822|NCT01368081|323836253|FG005|Overall Study|Other reason not defined above|1|||
94557823|NCT01368081|323836254|FG006|Overall Study|Other reason not defined above|2|||
94557824|NCT01368081|323836255|FG007|Overall Study|Other reason not defined above|0|||
94557825|NCT01368081|323836256|FG008|Overall Study|Other reason not defined above|0|||
94557826|NCT01368081|323836257|FG009|Overall Study|Other reason not defined above|1|||
94557827|NCT01368081|323836258|FG010|Overall Study|Other reason not defined above|0|||
94557828|NCT01368081|323836259|FG011|Overall Study|Other reason not defined above|0|||
94557829|NCT01368081|323836260|FG012|Overall Study|Other reason not defined above|3|||
94557830|NCT00166439|323836261|FG000|Overall Study|Ineligible|5|||
94557831|NCT02038075|323836266|FG000|Overall Study|Withdrawal by Subject|3|||
94557832|NCT02038075|323836267|FG001|Overall Study|Withdrawal by Subject|0|||
94557833|NCT04039217|323836268|FG000|Overall Study|Lost to Follow-up|1|||
94557834|NCT00106353|323836269|FG000|Part 1|Disease progression|3|||
94557835|NCT00106353|323836270|FG001|Part 1|Disease progression|4|||
94557836|NCT00106353|323836271|FG002|Part 1|Disease progression|1|||
94557837|NCT00106353|323836272|FG003|Part 1|Disease progression|3|||
94557838|NCT00106353|323836273|FG004|Part 1|Disease progression|0|||
94557839|NCT00106353|323836274|FG005|Part 1|Disease progression|0|||
94557840|NCT00106353|323836275|FG006|Part 1|Disease progression|0|||
94557841|NCT00106353|323836269|FG000|Part 1|Withdrawal by Subject|0|||
94557842|NCT00106353|323836270|FG001|Part 1|Withdrawal by Subject|0|||
94557843|NCT00106353|323836271|FG002|Part 1|Withdrawal by Subject|1|||
94557844|NCT00106353|323836272|FG003|Part 1|Withdrawal by Subject|2|||
94557845|NCT00106353|323836273|FG004|Part 1|Withdrawal by Subject|0|||
94557846|NCT00106353|323836274|FG005|Part 1|Withdrawal by Subject|0|||
94557847|NCT00106353|323836275|FG006|Part 1|Withdrawal by Subject|0|||
94557848|NCT00106353|323836269|FG000|Part 1|Symptomatic deterioration|0|||
94557849|NCT00106353|323836270|FG001|Part 1|Symptomatic deterioration|0|||
94557850|NCT00106353|323836271|FG002|Part 1|Symptomatic deterioration|1|||
94557851|NCT00106353|323836272|FG003|Part 1|Symptomatic deterioration|0|||
94557852|NCT00106353|323836273|FG004|Part 1|Symptomatic deterioration|0|||
94557853|NCT00106353|323836274|FG005|Part 1|Symptomatic deterioration|0|||
94557854|NCT00106353|323836275|FG006|Part 1|Symptomatic deterioration|0|||
94557855|NCT00106353|323836269|FG000|Part 1|Entered follow-up phase|1|||
94557856|NCT00106353|323836270|FG001|Part 1|Entered follow-up phase|1|||
94557857|NCT00106353|323836271|FG002|Part 1|Entered follow-up phase|0|||
94557858|NCT00106353|323836272|FG003|Part 1|Entered follow-up phase|1|||
94557859|NCT00106353|323836273|FG004|Part 1|Entered follow-up phase|0|||
94557860|NCT00106353|323836274|FG005|Part 1|Entered follow-up phase|0|||
94557861|NCT00106353|323836275|FG006|Part 1|Entered follow-up phase|0|||
94557862|NCT00106353|323836269|FG000|Part 1|Adverse Event|0|||
94557863|NCT00106353|323836270|FG001|Part 1|Adverse Event|0|||
94557864|NCT00106353|323836271|FG002|Part 1|Adverse Event|0|||
94557865|NCT00106353|323836272|FG003|Part 1|Adverse Event|1|||
94557866|NCT00106353|323836273|FG004|Part 1|Adverse Event|0|||
94557867|NCT00106353|323836274|FG005|Part 1|Adverse Event|0|||
94557868|NCT00106353|323836275|FG006|Part 1|Adverse Event|0|||
94557869|NCT00106353|323836269|FG000|Part 2|Disease progression|0|||
94557870|NCT00106353|323836270|FG001|Part 2|Disease progression|0|||
94557871|NCT00106353|323836271|FG002|Part 2|Disease progression|0|||
94557872|NCT00106353|323836272|FG003|Part 2|Disease progression|0|||
94557873|NCT00106353|323836273|FG004|Part 2|Disease progression|8|||
94557874|NCT00106353|323836274|FG005|Part 2|Disease progression|14|||
94557875|NCT00106353|323836275|FG006|Part 2|Disease progression|13|||
94557876|NCT00106353|323836269|FG000|Part 2|Death|0|||
94557877|NCT00106353|323836270|FG001|Part 2|Death|0|||
94557878|NCT00106353|323836271|FG002|Part 2|Death|0|||
94557879|NCT00106353|323836272|FG003|Part 2|Death|0|||
94557880|NCT00106353|323836273|FG004|Part 2|Death|3|||
94557881|NCT00106353|323836274|FG005|Part 2|Death|0|||
94557882|NCT00106353|323836275|FG006|Part 2|Death|1|||
94557883|NCT00106353|323836269|FG000|Part 2|Symptomatic deterioration|0|||
94557884|NCT00106353|323836270|FG001|Part 2|Symptomatic deterioration|0|||
94557885|NCT00106353|323836271|FG002|Part 2|Symptomatic deterioration|0|||
94557886|NCT00106353|323836272|FG003|Part 2|Symptomatic deterioration|0|||
94557887|NCT00106353|323836273|FG004|Part 2|Symptomatic deterioration|3|||
94557888|NCT00106353|323836274|FG005|Part 2|Symptomatic deterioration|0|||
94557889|NCT00106353|323836275|FG006|Part 2|Symptomatic deterioration|0|||
94557890|NCT00106353|323836269|FG000|Part 2|Adverse Event|0|||
94557891|NCT00106353|323836270|FG001|Part 2|Adverse Event|0|||
94557892|NCT00106353|323836271|FG002|Part 2|Adverse Event|0|||
94557893|NCT00106353|323836272|FG003|Part 2|Adverse Event|0|||
94557894|NCT00106353|323836273|FG004|Part 2|Adverse Event|0|||
94557895|NCT00106353|323836274|FG005|Part 2|Adverse Event|2|||
94557896|NCT00106353|323836275|FG006|Part 2|Adverse Event|1|||
94557897|NCT00106353|323836269|FG000|Part 2|Other|0|||
94557898|NCT00106353|323836270|FG001|Part 2|Other|0|||
94557899|NCT00106353|323836271|FG002|Part 2|Other|0|||
94557900|NCT00106353|323836272|FG003|Part 2|Other|0|||
94557901|NCT00106353|323836273|FG004|Part 2|Other|1|||
94557902|NCT00106353|323836274|FG005|Part 2|Other|1|||
94557903|NCT00106353|323836275|FG006|Part 2|Other|1|||
94557904|NCT00106353|323836269|FG000|Part 2|Withdrawal by Subject|0|||
94557905|NCT00106353|323836270|FG001|Part 2|Withdrawal by Subject|0|||
94557906|NCT00106353|323836271|FG002|Part 2|Withdrawal by Subject|0|||
94557907|NCT00106353|323836272|FG003|Part 2|Withdrawal by Subject|0|||
94557908|NCT00106353|323836273|FG004|Part 2|Withdrawal by Subject|1|||
94557909|NCT00106353|323836274|FG005|Part 2|Withdrawal by Subject|0|||
94557910|NCT00106353|323836275|FG006|Part 2|Withdrawal by Subject|0|||
94557911|NCT00106353|323836269|FG000|Part 2|Physician Decision|0|||
94557912|NCT00106353|323836270|FG001|Part 2|Physician Decision|0|||
94557913|NCT00106353|323836271|FG002|Part 2|Physician Decision|0|||
94557914|NCT00106353|323836272|FG003|Part 2|Physician Decision|0|||
94557915|NCT00106353|323836273|FG004|Part 2|Physician Decision|0|||
94557916|NCT00106353|323836274|FG005|Part 2|Physician Decision|1|||
94557917|NCT00106353|323836275|FG006|Part 2|Physician Decision|0|||
94557918|NCT01278797|323836276|FG000|Period 1|Adverse Event|0|||
94557919|NCT01278797|323836277|FG001|Period 1|Adverse Event|1|||
94557920|NCT01278797|323836276|FG000|Period 1|Protocol Violation|1|||
94557921|NCT01278797|323836277|FG001|Period 1|Protocol Violation|0|||
94557922|NCT04000581|323836278|FG000|Overall Study|Withdrawal by Subject|0|||
94557923|NCT04000581|323836279|FG001|Overall Study|Withdrawal by Subject|1|||
94557924|NCT03477838|323836280|FG000|Overall Study|Lost to Follow-up|14|||
94557925|NCT00250276|323836284|FG000|Overall Study|Serious Adverse Event|0|||
94557926|NCT00250276|323836285|FG001|Overall Study|Serious Adverse Event|0|||
94557927|NCT00250276|323836286|FG002|Overall Study|Serious Adverse Event|1|||
94557928|NCT00250276|323836287|FG003|Overall Study|Serious Adverse Event|0|||
94557929|NCT00250276|323836284|FG000|Overall Study|Non-serious Adverse Event|2|||
94557930|NCT00250276|323836285|FG001|Overall Study|Non-serious Adverse Event|0|||
94557931|NCT00250276|323836286|FG002|Overall Study|Non-serious Adverse Event|0|||
94557932|NCT00250276|323836287|FG003|Overall Study|Non-serious Adverse Event|2|||
94557933|NCT00250276|323836284|FG000|Overall Study|Protocol Violation|0|||
94557934|NCT00250276|323836285|FG001|Overall Study|Protocol Violation|1|||
94557935|NCT00250276|323836286|FG002|Overall Study|Protocol Violation|0|||
94557936|NCT00250276|323836287|FG003|Overall Study|Protocol Violation|0|||
94557937|NCT00250276|323836284|FG000|Overall Study|Withdrawal by Subject|1|||
94557938|NCT00250276|323836285|FG001|Overall Study|Withdrawal by Subject|2|||
94557939|NCT00250276|323836286|FG002|Overall Study|Withdrawal by Subject|3|||
94557940|NCT00250276|323836287|FG003|Overall Study|Withdrawal by Subject|2|||
94557941|NCT00250276|323836284|FG000|Overall Study|Migrated/moved from study area|3|||
94557942|NCT00250276|323836285|FG001|Overall Study|Migrated/moved from study area|0|||
94557943|NCT00250276|323836286|FG002|Overall Study|Migrated/moved from study area|2|||
94557944|NCT00250276|323836287|FG003|Overall Study|Migrated/moved from study area|7|||
94557945|NCT00250276|323836284|FG000|Overall Study|Lost to Follow-up|11|||
94557946|NCT00250276|323836285|FG001|Overall Study|Lost to Follow-up|18|||
94557947|NCT00250276|323836286|FG002|Overall Study|Lost to Follow-up|13|||
94557948|NCT00250276|323836287|FG003|Overall Study|Lost to Follow-up|8|||
94557949|NCT01868477|323836288|FG000|Overall Study|Adverse Event|2|||
94557950|NCT01868477|323836289|FG001|Overall Study|Adverse Event|4|||
94557951|NCT01868477|323836288|FG000|Overall Study|Disease progression|1|||
94557952|NCT01868477|323836289|FG001|Overall Study|Disease progression|1|||
94557953|NCT01868477|323836288|FG000|Overall Study|Withdrawal by Subject|1|||
94557954|NCT01868477|323836289|FG001|Overall Study|Withdrawal by Subject|0|||
94557955|NCT02508428|323836290|FG000|Overall Study|Death|32|||
94557956|NCT02508428|323836291|FG001|Overall Study|Death|33|||
94557957|NCT02508428|323836290|FG000|Overall Study|Liner revised|3|||
94557958|NCT02508428|323836291|FG001|Overall Study|Liner revised|19|||
94557959|NCT02508428|323836290|FG000|Overall Study|Incomplete follow-up|17|||
94557960|NCT02508428|323836291|FG001|Overall Study|Incomplete follow-up|15|||
94557961|NCT04371666|323836292|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
94557962|NCT04371666|323836293|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
94557963|NCT04371666|323836292|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
94557964|NCT04371666|323836293|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
94557965|NCT04371666|323836292|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
94557966|NCT04371666|323836293|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
94557967|NCT04371666|323836292|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
94557968|NCT04371666|323836293|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
94557969|NCT04371666|323836292|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
94557970|NCT04371666|323836293|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
94557971|NCT04371666|323836292|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
94557972|NCT04371666|323836293|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
94557973|NCT03109184|323838734|FG000|Overall Study|Lost to Follow-up|6|||
94557974|NCT03109184|323838735|FG001|Overall Study|Lost to Follow-up|6|||
94557975|NCT03109184|323838734|FG000|Overall Study|Withdrawal by Subject|1|||
94557976|NCT03109184|323838735|FG001|Overall Study|Withdrawal by Subject|1|||
94557977|NCT03343626|323838736|FG000|Overall Study|Lost to Follow-up|4|||
94557978|NCT03343626|323838737|FG001|Overall Study|Lost to Follow-up|3|||
94557979|NCT03343626|323838738|FG002|Overall Study|Lost to Follow-up|2|||
94557980|NCT03343626|323838739|FG003|Overall Study|Lost to Follow-up|5|||
94557981|NCT03343626|323838740|FG004|Overall Study|Lost to Follow-up|4|||
94557982|NCT03343626|323838741|FG005|Overall Study|Lost to Follow-up|4|||
94557983|NCT03343626|323838742|FG006|Overall Study|Lost to Follow-up|4|||
94557984|NCT03343626|323838743|FG007|Overall Study|Lost to Follow-up|7|||
94557985|NCT03343626|323838736|FG000|Overall Study|Withdrawal of Consent|2|||
94557986|NCT03343626|323838737|FG001|Overall Study|Withdrawal of Consent|1|||
94657536|NCT00274716|324204325|FG005|Phase A|Met criteria for discontinuation|0|||
94657537|NCT00274716|324204320|FG000|Phase A|Withdrawal by Subject|2|||
94557987|NCT03343626|323838738|FG002|Overall Study|Withdrawal of Consent|0|||
94557988|NCT03343626|323838739|FG003|Overall Study|Withdrawal of Consent|3|||
94557989|NCT03343626|323838740|FG004|Overall Study|Withdrawal of Consent|3|||
94657538|NCT00274716|324204321|FG001|Phase A|Withdrawal by Subject|2|||
94232282|NCT02818998|322644323|FG002|Overall Study|Withdrawal by sponsor|1|||
94232283|NCT02818998|322644321|FG000|Overall Study|Death|3|||
94232284|NCT02818998|322644322|FG001|Overall Study|Death|6|||
94232285|NCT02818998|322644323|FG002|Overall Study|Death|8|||
94232286|NCT02818998|322644321|FG000|Overall Study|Withdrawal by Subject|7|||
94232287|NCT02818998|322644322|FG001|Overall Study|Withdrawal by Subject|6|||
94232288|NCT02818998|322644323|FG002|Overall Study|Withdrawal by Subject|6|||
94557990|NCT03343626|323838741|FG005|Overall Study|Withdrawal of Consent|1|||
94557991|NCT03343626|323838742|FG006|Overall Study|Withdrawal of Consent|1|||
94557992|NCT03343626|323838743|FG007|Overall Study|Withdrawal of Consent|2|||
94232289|NCT02818998|322644321|FG000|Overall Study|Physician Decision|1|||
94232290|NCT02818998|322644322|FG001|Overall Study|Physician Decision|0|||
94232291|NCT02818998|322644323|FG002|Overall Study|Physician Decision|0|||
94557993|NCT03343626|323838736|FG000|Overall Study|Reason not Specified|0|||
94557994|NCT03343626|323838737|FG001|Overall Study|Reason not Specified|1|||
94557995|NCT03343626|323838738|FG002|Overall Study|Reason not Specified|0|||
94557996|NCT03343626|323838739|FG003|Overall Study|Reason not Specified|0|||
94557997|NCT03343626|323838740|FG004|Overall Study|Reason not Specified|0|||
94557998|NCT03343626|323838741|FG005|Overall Study|Reason not Specified|0|||
94557999|NCT03343626|323838742|FG006|Overall Study|Reason not Specified|0|||
94558000|NCT03343626|323838743|FG007|Overall Study|Reason not Specified|1|||
94558001|NCT03343626|323838736|FG000|Overall Study|Data Entry Error|0|||
94558002|NCT03343626|323838737|FG001|Overall Study|Data Entry Error|0|||
94558003|NCT03343626|323838738|FG002|Overall Study|Data Entry Error|0|||
94558004|NCT03343626|323838739|FG003|Overall Study|Data Entry Error|0|||
94558005|NCT03343626|323838740|FG004|Overall Study|Data Entry Error|0|||
94232292|NCT00905034|322644328|FG000|Overall Study|Withdrawal by Subject|1|||
94558006|NCT03343626|323838741|FG005|Overall Study|Data Entry Error|0|||
94232293|NCT00217022|322644329|FG000|Overall Study|Withdrawal by Subject|1|||
94232294|NCT00217022|322644330|FG001|Overall Study|Withdrawal by Subject|1|||
94558007|NCT03343626|323838742|FG006|Overall Study|Data Entry Error|0|||
94558008|NCT03343626|323838743|FG007|Overall Study|Data Entry Error|1|||
94558009|NCT03738618|323838744|FG000|Overall Study|Protocol deviation|23|||
94558010|NCT03738618|323838745|FG001|Overall Study|Protocol deviation|0|||
94558011|NCT03738618|323838744|FG000|Overall Study|Adverse Event|4|||
94558012|NCT03738618|323838745|FG001|Overall Study|Adverse Event|0|||
94558013|NCT03738618|323838744|FG000|Overall Study|Lost to Follow-up|2|||
94558014|NCT03738618|323838745|FG001|Overall Study|Lost to Follow-up|0|||
94558015|NCT03738618|323838744|FG000|Overall Study|Randomization failure|1|||
94558016|NCT03738618|323838745|FG001|Overall Study|Randomization failure|0|||
94558017|NCT03738618|323838744|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
94558018|NCT03738618|323838745|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
94558019|NCT03738618|323838744|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
94558020|NCT03738618|323838745|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
94558021|NCT02008227|323838746|FG000|Overall Study|Lost to Follow-up|7|||
94558022|NCT02008227|323838747|FG001|Overall Study|Lost to Follow-up|9|||
94558023|NCT02008227|323838746|FG000|Overall Study|Death|494|||
94558024|NCT02008227|323838747|FG001|Overall Study|Death|485|||
94558025|NCT02008227|323838746|FG000|Overall Study|Withdrawal by Subject|67|||
94558026|NCT02008227|323838747|FG001|Overall Study|Withdrawal by Subject|36|||
94558027|NCT02008227|323838746|FG000|Overall Study|Study Terminated By Sponsor|44|||
94558028|NCT02008227|323838747|FG001|Overall Study|Study Terminated By Sponsor|83|||
94558029|NCT01769196|323838750|FG000|Overall Study|Adverse Event|24|||
94558030|NCT01769196|323838751|FG001|Overall Study|Adverse Event|20|||
94558031|NCT01769196|323838750|FG000|Overall Study|Death|21|||
94558032|NCT01769196|323838751|FG001|Overall Study|Death|26|||
94558033|NCT01769196|323838750|FG000|Overall Study|Investigator Discretion|7|||
94558034|NCT01769196|323838751|FG001|Overall Study|Investigator Discretion|3|||
94558035|NCT01769196|323838750|FG000|Overall Study|Lack of Efficacy|3|||
94558036|NCT01769196|323838751|FG001|Overall Study|Lack of Efficacy|2|||
94558037|NCT01769196|323838750|FG000|Overall Study|Progressive disease|11|||
94558038|NCT01769196|323838751|FG001|Overall Study|Progressive disease|6|||
94558039|NCT01769196|323838750|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
94558040|NCT01769196|323838751|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
94558041|NCT01769196|323838750|FG000|Overall Study|Protocol Violation|0|||
94558042|NCT01769196|323838751|FG001|Overall Study|Protocol Violation|3|||
94558043|NCT01769196|323838750|FG000|Overall Study|Study terminated by sponsor|160|||
94558044|NCT01769196|323838751|FG001|Overall Study|Study terminated by sponsor|161|||
94558045|NCT01769196|323838750|FG000|Overall Study|Participant never dosed with study drug|1|||
94558046|NCT01769196|323838751|FG001|Overall Study|Participant never dosed with study drug|0|||
94558047|NCT01769196|323838750|FG000|Overall Study|Withdrew consent|36|||
94558048|NCT01769196|323838751|FG001|Overall Study|Withdrew consent|40|||
94558049|NCT00742417|323838752|FG000|Randomized|Withdrawal by legal representative|0|||
94558050|NCT00742417|323838753|FG001|Randomized|Withdrawal by legal representative|1|||
94558051|NCT00742417|323838752|FG000|Randomized|Withdrawal by Subject|1|||
94558052|NCT00742417|323838753|FG001|Randomized|Withdrawal by Subject|0|||
94558053|NCT00742417|323838752|FG000|Randomized|Physician Decision|1|||
94558054|NCT00742417|323838753|FG001|Randomized|Physician Decision|0|||
94558055|NCT00742417|323838752|FG000|Intensive Period|Withdrawal by Subject|1|||
94558056|NCT00742417|323838753|FG001|Intensive Period|Withdrawal by Subject|1|||
94558057|NCT00742417|323838752|FG000|Intensive Period|Adverse Event|2|||
94558058|NCT00742417|323838753|FG001|Intensive Period|Adverse Event|0|||
94558059|NCT04566601|323838758|FG000|Overall Study|Other than listed|13|||
94558060|NCT04566601|323838759|FG001|Overall Study|Other than listed|4|||
94558061|NCT04566601|323838760|FG002|Overall Study|Other than listed|2|||
94558062|NCT04566601|323838761|FG003|Overall Study|Other than listed|1|||
94558063|NCT04566601|323838762|FG004|Overall Study|Other than listed|4|||
94558064|NCT04566601|323838758|FG000|Overall Study|Protocol deviation|3|||
94558065|NCT04566601|323838759|FG001|Overall Study|Protocol deviation|0|||
94558066|NCT04566601|323838760|FG002|Overall Study|Protocol deviation|1|||
94558067|NCT04566601|323838761|FG003|Overall Study|Protocol deviation|1|||
94558068|NCT04566601|323838762|FG004|Overall Study|Protocol deviation|1|||
94558069|NCT04566601|323838758|FG000|Overall Study|Technical problems|0|||
94558070|NCT04566601|323838759|FG001|Overall Study|Technical problems|0|||
94558071|NCT04566601|323838760|FG002|Overall Study|Technical problems|1|||
94558072|NCT04566601|323838761|FG003|Overall Study|Technical problems|0|||
94558073|NCT04566601|323838762|FG004|Overall Study|Technical problems|0|||
94558074|NCT04566601|323838758|FG000|Overall Study|No reason available|3|||
94558075|NCT04566601|323838759|FG001|Overall Study|No reason available|2|||
94558076|NCT04566601|323838760|FG002|Overall Study|No reason available|7|||
94558077|NCT04566601|323838761|FG003|Overall Study|No reason available|1|||
94558078|NCT04566601|323838762|FG004|Overall Study|No reason available|5|||
94558079|NCT04566601|323838758|FG000|Overall Study|Burden of study procedures|3|||
94558080|NCT04566601|323838759|FG001|Overall Study|Burden of study procedures|0|||
94558081|NCT04566601|323838760|FG002|Overall Study|Burden of study procedures|0|||
94558082|NCT04566601|323838761|FG003|Overall Study|Burden of study procedures|3|||
94558083|NCT04566601|323838762|FG004|Overall Study|Burden of study procedures|1|||
94558084|NCT04566601|323838758|FG000|Overall Study|Change of residence|2|||
94558085|NCT04566601|323838759|FG001|Overall Study|Change of residence|2|||
94558086|NCT04566601|323838760|FG002|Overall Study|Change of residence|0|||
94558087|NCT04566601|323838761|FG003|Overall Study|Change of residence|1|||
94558088|NCT04566601|323838762|FG004|Overall Study|Change of residence|2|||
94558089|NCT04566601|323838758|FG000|Overall Study|Perceived lack of efficacy|2|||
94558090|NCT04566601|323838759|FG001|Overall Study|Perceived lack of efficacy|0|||
94558091|NCT04566601|323838760|FG002|Overall Study|Perceived lack of efficacy|1|||
94558092|NCT04566601|323838761|FG003|Overall Study|Perceived lack of efficacy|1|||
94558093|NCT04566601|323838762|FG004|Overall Study|Perceived lack of efficacy|2|||
94558094|NCT04566601|323838758|FG000|Overall Study|Adverse Event|7|||
94558095|NCT04566601|323838759|FG001|Overall Study|Adverse Event|4|||
94558096|NCT04566601|323838760|FG002|Overall Study|Adverse Event|6|||
94558097|NCT04566601|323838761|FG003|Overall Study|Adverse Event|5|||
94558098|NCT04566601|323838762|FG004|Overall Study|Adverse Event|12|||
94558099|NCT03499314|323838763|FG000|Overall Study|Time Commitment|1|||
94558100|NCT03499314|323838764|FG001|Overall Study|Time Commitment|2|||
94558101|NCT03499314|323838763|FG000|Overall Study|Medical issue unrelated to research study|1|||
94558102|NCT03499314|323838764|FG001|Overall Study|Medical issue unrelated to research study|1|||
94558103|NCT02454478|323838766|FG000|Overall Study|Incomplete DLT Evaluation|1|||
94558104|NCT02291419|323838767|FG000|Overall Study|Early study termination|1|||
94558105|NCT02291419|323838768|FG001|Overall Study|Early study termination|5|||
94558106|NCT01732770|323838770|FG000|Overall Study|Lost to Follow-up|2|||
94558107|NCT01732770|323838771|FG001|Overall Study|Lost to Follow-up|3|||
94558108|NCT01732770|323838770|FG000|Overall Study|Withdrawal by Subject|5|||
94558109|NCT01732770|323838771|FG001|Overall Study|Withdrawal by Subject|3|||
94558110|NCT01732770|323838770|FG000|Overall Study|Decision by Sponsor|2|||
94558111|NCT01732770|323838771|FG001|Overall Study|Decision by Sponsor|2|||
94558112|NCT01732770|323838770|FG000|Overall Study|Death|1|||
94558113|NCT01732770|323838771|FG001|Overall Study|Death|0|||
94558114|NCT00931606|323838772|FG000|Overall Study|Death|1|||
94558115|NCT00931606|323838773|FG001|Overall Study|Death|3|||
94558116|NCT00931606|323838774|FG002|Overall Study|Death|2|||
94558117|NCT00931606|323838775|FG003|Overall Study|Death|0|||
94558118|NCT00931606|323838772|FG000|Overall Study|Lost to Follow-up|0|||
94558119|NCT00931606|323838773|FG001|Overall Study|Lost to Follow-up|1|||
94558120|NCT00931606|323838774|FG002|Overall Study|Lost to Follow-up|0|||
94558121|NCT00931606|323838775|FG003|Overall Study|Lost to Follow-up|0|||
94558122|NCT00931606|323838772|FG000|Overall Study|Physician Decision|0|||
94558123|NCT00931606|323838773|FG001|Overall Study|Physician Decision|0|||
94558124|NCT00931606|323838774|FG002|Overall Study|Physician Decision|3|||
94558125|NCT00931606|323838775|FG003|Overall Study|Physician Decision|0|||
94558126|NCT00931606|323838772|FG000|Overall Study|Sponsor Decision|1|||
94558127|NCT00931606|323838773|FG001|Overall Study|Sponsor Decision|4|||
94558128|NCT00931606|323838774|FG002|Overall Study|Sponsor Decision|0|||
94558129|NCT00931606|323838775|FG003|Overall Study|Sponsor Decision|2|||
94558130|NCT00931606|323838772|FG000|Overall Study|Withdrawal by Subject|3|||
94558131|NCT00931606|323838773|FG001|Overall Study|Withdrawal by Subject|1|||
94558132|NCT00931606|323838774|FG002|Overall Study|Withdrawal by Subject|1|||
94558133|NCT00931606|323838775|FG003|Overall Study|Withdrawal by Subject|1|||
94558134|NCT05111249|323838779|FG000|Overall Study|Lost to Follow-up|0|||
94558135|NCT05111249|323838780|FG001|Overall Study|Lost to Follow-up|2|||
94558136|NCT05111249|323838779|FG000|Overall Study|Physician Decision|0|||
94558137|NCT05111249|323838780|FG001|Overall Study|Physician Decision|1|||
94558138|NCT05111249|323838779|FG000|Overall Study|Participant decision|1|||
94558139|NCT05111249|323838780|FG001|Overall Study|Participant decision|5|||
94558140|NCT05128578|323838781|FG000|Overall Study|Withdrawal by Subject|9|||
94558141|NCT05128578|323838781|FG000|Overall Study|Lost to Follow-up|5|||
94558142|NCT03047031|323838782|FG000|Overall Study|Other than listed|1|||
94558143|NCT03047031|323838783|FG001|Overall Study|Other than listed|0|||
94558144|NCT03047031|323838784|FG002|Overall Study|Other than listed|0|||
94558145|NCT03047031|323838782|FG000|Overall Study|Lost to Follow-up|4|||
94558146|NCT03047031|323838783|FG001|Overall Study|Lost to Follow-up|0|||
94558147|NCT03047031|323838784|FG002|Overall Study|Lost to Follow-up|0|||
94558148|NCT03047031|323838782|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
94558149|NCT03047031|323838783|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
94558150|NCT03047031|323838784|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
94558151|NCT03047031|323838782|FG000|Overall Study|Adverse Event|1|||
94558152|NCT03047031|323838783|FG001|Overall Study|Adverse Event|0|||
94558153|NCT03047031|323838784|FG002|Overall Study|Adverse Event|0|||
94558154|NCT03047031|323838782|FG000|Overall Study|Withdrawal by Subject|2|||
94558155|NCT03047031|323838783|FG001|Overall Study|Withdrawal by Subject|0|||
94558156|NCT03047031|323838784|FG002|Overall Study|Withdrawal by Subject|0|||
94558157|NCT03047031|323838782|FG000|Overall Study|Change to other medication|2|||
94558158|NCT03047031|323838783|FG001|Overall Study|Change to other medication|0|||
94558159|NCT03047031|323838784|FG002|Overall Study|Change to other medication|0|||
94558160|NCT03047031|323838782|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
94558161|NCT03047031|323838783|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
94558162|NCT03047031|323838784|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
94558163|NCT01959841|323838785|FG000|Overall Study|Adverse Event|1|||
94558164|NCT01959841|323838786|FG001|Overall Study|Adverse Event|3|||
94558165|NCT01959841|323838787|FG002|Overall Study|Adverse Event|2|||
94558166|NCT01959841|323838785|FG000|Overall Study|Lack of Efficacy|5|||
94558167|NCT01959841|323838786|FG001|Overall Study|Lack of Efficacy|0|||
94558168|NCT01959841|323838787|FG002|Overall Study|Lack of Efficacy|0|||
94558169|NCT01959841|323838785|FG000|Overall Study|Lost to Follow-up|1|||
94558170|NCT01959841|323838786|FG001|Overall Study|Lost to Follow-up|1|||
94558171|NCT01959841|323838787|FG002|Overall Study|Lost to Follow-up|0|||
94558172|NCT01959841|323838785|FG000|Overall Study|Physician Decision|0|||
94558173|NCT01959841|323838786|FG001|Overall Study|Physician Decision|2|||
94558174|NCT01959841|323838787|FG002|Overall Study|Physician Decision|3|||
94558175|NCT01959841|323838785|FG000|Overall Study|Protocol Violation|16|||
94558176|NCT01959841|323838786|FG001|Overall Study|Protocol Violation|23|||
94558177|NCT01959841|323838787|FG002|Overall Study|Protocol Violation|16|||
94558178|NCT01959841|323838785|FG000|Overall Study|Withdrawal by Subject|7|||
94558179|NCT01959841|323838786|FG001|Overall Study|Withdrawal by Subject|7|||
94558180|NCT01959841|323838787|FG002|Overall Study|Withdrawal by Subject|5|||
94558181|NCT01959841|323838785|FG000|Overall Study|Clinical laboratory value|2|||
94558182|NCT01959841|323838786|FG001|Overall Study|Clinical laboratory value|6|||
94558183|NCT01959841|323838787|FG002|Overall Study|Clinical laboratory value|6|||
94558184|NCT01959841|323838785|FG000|Overall Study|Platelet count below on day1 or 4|11|||
94558185|NCT01959841|323838786|FG001|Overall Study|Platelet count below on day1 or 4|15|||
94558186|NCT01959841|323838787|FG002|Overall Study|Platelet count below on day1 or 4|11|||
94558187|NCT00780416|323838789|FG000|Overall Study|Physician Decision|3|||
94558188|NCT00780416|323838790|FG001|Overall Study|Physician Decision|3|||
94558189|NCT00780416|323838789|FG000|Overall Study|Protocol Violation|1|||
94558190|NCT00780416|323838790|FG001|Overall Study|Protocol Violation|0|||
94558191|NCT00780416|323838789|FG000|Overall Study|Withdrawal by Subject|8|||
94558192|NCT00780416|323838790|FG001|Overall Study|Withdrawal by Subject|6|||
94558193|NCT01702025|323838793|FG000|Overall Study|Equipment failure|1|||
94558194|NCT01702025|323838794|FG001|Overall Study|Equipment failure|0|||
94558195|NCT01702025|323838795|FG002|Overall Study|Equipment failure|0|||
94558196|NCT01702025|323838796|FG003|Overall Study|Equipment failure|0|||
94558197|NCT01702025|323838793|FG000|Overall Study|Adverse Event|1|||
94232295|NCT00832000|322644331|FG000|Overall Study|Adverse Event|2|||
94558198|NCT01702025|323838794|FG001|Overall Study|Adverse Event|1|||
94558199|NCT01702025|323838795|FG002|Overall Study|Adverse Event|1|||
94558200|NCT01702025|323838796|FG003|Overall Study|Adverse Event|0|||
94232296|NCT00832000|322644332|FG001|Overall Study|Adverse Event|0|||
94558201|NCT01424501|323838797|FG000|Overall Study|Withdrawal by Subject|1|||
94558202|NCT01424501|323838798|FG001|Overall Study|Withdrawal by Subject|0|||
94558203|NCT01424501|323838799|FG002|Overall Study|Withdrawal by Subject|1|||
94558204|NCT01424501|323838800|FG003|Overall Study|Withdrawal by Subject|0|||
94558205|NCT01424501|323838801|FG004|Overall Study|Withdrawal by Subject|0|||
94558206|NCT01424501|323838802|FG005|Overall Study|Withdrawal by Subject|0|||
94558207|NCT01424501|323838797|FG000|Overall Study|Lost to Follow-up|0|||
94558208|NCT01424501|323838798|FG001|Overall Study|Lost to Follow-up|1|||
94558209|NCT01424501|323838799|FG002|Overall Study|Lost to Follow-up|1|||
94558210|NCT01424501|323838800|FG003|Overall Study|Lost to Follow-up|0|||
94558211|NCT01424501|323838801|FG004|Overall Study|Lost to Follow-up|0|||
94558212|NCT01424501|323838802|FG005|Overall Study|Lost to Follow-up|0|||
94558213|NCT02737475|323838803|FG000|Overall Study|Other reasons|0|||
94558214|NCT02737475|323838804|FG001|Overall Study|Other reasons|0|||
94558215|NCT02737475|323838805|FG002|Overall Study|Other reasons|0|||
94558216|NCT02737475|323838806|FG003|Overall Study|Other reasons|0|||
94558217|NCT02737475|323838807|FG004|Overall Study|Other reasons|1|||
94558218|NCT02737475|323838808|FG005|Overall Study|Other reasons|1|||
94558219|NCT02737475|323838809|FG006|Overall Study|Other reasons|0|||
94558220|NCT02737475|323838810|FG007|Overall Study|Other reasons|0|||
94558221|NCT02737475|323838811|FG008|Overall Study|Other reasons|1|||
94558222|NCT02737475|323838812|FG009|Overall Study|Other reasons|0|||
94558223|NCT02737475|323838813|FG010|Overall Study|Other reasons|1|||
94558224|NCT02737475|323838814|FG011|Overall Study|Other reasons|0|||
94558225|NCT02737475|323838815|FG012|Overall Study|Other reasons|0|||
94558226|NCT02737475|323838816|FG013|Overall Study|Other reasons|0|||
94558227|NCT02737475|323838817|FG014|Overall Study|Other reasons|0|||
94558228|NCT02737475|323838818|FG015|Overall Study|Other reasons|0|||
94558229|NCT02737475|323838819|FG016|Overall Study|Other reasons|0|||
94558230|NCT02737475|323838820|FG017|Overall Study|Other reasons|0|||
94558231|NCT02737475|323838821|FG018|Overall Study|Other reasons|0|||
94558232|NCT02737475|323838822|FG019|Overall Study|Other reasons|0|||
94558233|NCT02737475|323838823|FG020|Overall Study|Other reasons|0|||
94558234|NCT02737475|323838824|FG021|Overall Study|Other reasons|1|||
94558235|NCT02737475|323838825|FG022|Overall Study|Other reasons|0|||
94558236|NCT02737475|323838826|FG023|Overall Study|Other reasons|1|||
94558237|NCT02737475|323838827|FG024|Overall Study|Other reasons|1|||
94558238|NCT02737475|323838828|FG025|Overall Study|Other reasons|1|||
94558239|NCT02737475|323838829|FG026|Overall Study|Other reasons|0|||
94558240|NCT02737475|323838803|FG000|Overall Study|Death|1|||
94558241|NCT02737475|323838804|FG001|Overall Study|Death|0|||
94558242|NCT02737475|323838805|FG002|Overall Study|Death|0|||
94558243|NCT02737475|323838806|FG003|Overall Study|Death|1|||
94558244|NCT02737475|323838807|FG004|Overall Study|Death|0|||
94558245|NCT02737475|323838808|FG005|Overall Study|Death|0|||
94558246|NCT02737475|323838809|FG006|Overall Study|Death|0|||
94558247|NCT02737475|323838810|FG007|Overall Study|Death|2|||
94558248|NCT02737475|323838811|FG008|Overall Study|Death|0|||
94558249|NCT02737475|323838812|FG009|Overall Study|Death|0|||
94558250|NCT02737475|323838813|FG010|Overall Study|Death|0|||
94558251|NCT02737475|323838814|FG011|Overall Study|Death|4|||
94558252|NCT02737475|323838815|FG012|Overall Study|Death|2|||
94558253|NCT02737475|323838816|FG013|Overall Study|Death|2|||
94558254|NCT02737475|323838817|FG014|Overall Study|Death|0|||
94558255|NCT02737475|323838818|FG015|Overall Study|Death|2|||
94558256|NCT02737475|323838819|FG016|Overall Study|Death|2|||
94558257|NCT02737475|323838820|FG017|Overall Study|Death|2|||
94558258|NCT02737475|323838821|FG018|Overall Study|Death|1|||
94558259|NCT02737475|323838822|FG019|Overall Study|Death|0|||
94558260|NCT02737475|323838823|FG020|Overall Study|Death|0|||
94558261|NCT02737475|323838824|FG021|Overall Study|Death|0|||
94558262|NCT02737475|323838825|FG022|Overall Study|Death|0|||
94558263|NCT02737475|323838826|FG023|Overall Study|Death|0|||
94558264|NCT02737475|323838827|FG024|Overall Study|Death|0|||
94558265|NCT02737475|323838828|FG025|Overall Study|Death|0|||
94558266|NCT02737475|323838829|FG026|Overall Study|Death|0|||
94558267|NCT02737475|323838803|FG000|Overall Study|Participant withdrew consent|0|||
94558268|NCT02737475|323838804|FG001|Overall Study|Participant withdrew consent|0|||
94558269|NCT02737475|323838805|FG002|Overall Study|Participant withdrew consent|0|||
94558270|NCT02737475|323838806|FG003|Overall Study|Participant withdrew consent|0|||
94558271|NCT02737475|323838807|FG004|Overall Study|Participant withdrew consent|0|||
94558272|NCT02737475|323838808|FG005|Overall Study|Participant withdrew consent|2|||
94558273|NCT02737475|323838809|FG006|Overall Study|Participant withdrew consent|0|||
94558274|NCT02737475|323838810|FG007|Overall Study|Participant withdrew consent|0|||
94558275|NCT02737475|323838811|FG008|Overall Study|Participant withdrew consent|0|||
94558276|NCT02737475|323838812|FG009|Overall Study|Participant withdrew consent|0|||
94558277|NCT02737475|323838813|FG010|Overall Study|Participant withdrew consent|0|||
94558278|NCT02737475|323838814|FG011|Overall Study|Participant withdrew consent|0|||
94558279|NCT02737475|323838815|FG012|Overall Study|Participant withdrew consent|0|||
94558280|NCT02737475|323838816|FG013|Overall Study|Participant withdrew consent|0|||
94558281|NCT02737475|323838817|FG014|Overall Study|Participant withdrew consent|1|||
94558282|NCT02737475|323838818|FG015|Overall Study|Participant withdrew consent|0|||
94558283|NCT02737475|323838819|FG016|Overall Study|Participant withdrew consent|0|||
94558284|NCT02737475|323838820|FG017|Overall Study|Participant withdrew consent|2|||
94558285|NCT02737475|323838821|FG018|Overall Study|Participant withdrew consent|1|||
94558286|NCT02737475|323838822|FG019|Overall Study|Participant withdrew consent|0|||
94558287|NCT02737475|323838823|FG020|Overall Study|Participant withdrew consent|2|||
94558288|NCT02737475|323838824|FG021|Overall Study|Participant withdrew consent|0|||
94558289|NCT02737475|323838825|FG022|Overall Study|Participant withdrew consent|0|||
94558290|NCT02737475|323838826|FG023|Overall Study|Participant withdrew consent|0|||
94558291|NCT02737475|323838827|FG024|Overall Study|Participant withdrew consent|0|||
94558292|NCT02737475|323838828|FG025|Overall Study|Participant withdrew consent|0|||
94558293|NCT02737475|323838829|FG026|Overall Study|Participant withdrew consent|0|||
94558294|NCT02737475|323838803|FG000|Overall Study|Lost to Follow-up|0|||
94558295|NCT02737475|323838804|FG001|Overall Study|Lost to Follow-up|0|||
94558296|NCT02737475|323838805|FG002|Overall Study|Lost to Follow-up|0|||
94558297|NCT02737475|323838806|FG003|Overall Study|Lost to Follow-up|0|||
94558298|NCT02737475|323838807|FG004|Overall Study|Lost to Follow-up|0|||
94558299|NCT02737475|323838808|FG005|Overall Study|Lost to Follow-up|0|||
94558300|NCT02737475|323838809|FG006|Overall Study|Lost to Follow-up|0|||
94558301|NCT02737475|323838810|FG007|Overall Study|Lost to Follow-up|0|||
94558302|NCT02737475|323838811|FG008|Overall Study|Lost to Follow-up|0|||
94558303|NCT02737475|323838812|FG009|Overall Study|Lost to Follow-up|0|||
94558304|NCT02737475|323838813|FG010|Overall Study|Lost to Follow-up|0|||
94558305|NCT02737475|323838814|FG011|Overall Study|Lost to Follow-up|0|||
94558306|NCT02737475|323838815|FG012|Overall Study|Lost to Follow-up|0|||
94558307|NCT02737475|323838816|FG013|Overall Study|Lost to Follow-up|0|||
94558308|NCT02737475|323838817|FG014|Overall Study|Lost to Follow-up|0|||
94558309|NCT02737475|323838818|FG015|Overall Study|Lost to Follow-up|1|||
94558310|NCT02737475|323838819|FG016|Overall Study|Lost to Follow-up|0|||
94558311|NCT02737475|323838820|FG017|Overall Study|Lost to Follow-up|0|||
94558312|NCT02737475|323838821|FG018|Overall Study|Lost to Follow-up|0|||
94558313|NCT02737475|323838822|FG019|Overall Study|Lost to Follow-up|0|||
94558314|NCT02737475|323838823|FG020|Overall Study|Lost to Follow-up|0|||
94558315|NCT02737475|323838824|FG021|Overall Study|Lost to Follow-up|0|||
94558316|NCT02737475|323838825|FG022|Overall Study|Lost to Follow-up|0|||
94558317|NCT02737475|323838826|FG023|Overall Study|Lost to Follow-up|0|||
94558318|NCT02737475|323838827|FG024|Overall Study|Lost to Follow-up|0|||
94558319|NCT02737475|323838828|FG025|Overall Study|Lost to Follow-up|0|||
94558320|NCT02737475|323838829|FG026|Overall Study|Lost to Follow-up|0|||
94558321|NCT02737475|323838803|FG000|Overall Study|Disease Progression|0|||
94558322|NCT02737475|323838804|FG001|Overall Study|Disease Progression|0|||
94558323|NCT02737475|323838805|FG002|Overall Study|Disease Progression|0|||
94558324|NCT02737475|323838806|FG003|Overall Study|Disease Progression|0|||
94558325|NCT02737475|323838807|FG004|Overall Study|Disease Progression|0|||
94558326|NCT02737475|323838808|FG005|Overall Study|Disease Progression|0|||
94558327|NCT02737475|323838809|FG006|Overall Study|Disease Progression|0|||
94558328|NCT02737475|323838810|FG007|Overall Study|Disease Progression|0|||
94558329|NCT02737475|323838811|FG008|Overall Study|Disease Progression|0|||
94558330|NCT02737475|323838812|FG009|Overall Study|Disease Progression|0|||
94558331|NCT02737475|323838813|FG010|Overall Study|Disease Progression|0|||
94558332|NCT02737475|323838814|FG011|Overall Study|Disease Progression|0|||
94558333|NCT02737475|323838815|FG012|Overall Study|Disease Progression|0|||
94558334|NCT02737475|323838816|FG013|Overall Study|Disease Progression|0|||
94558335|NCT02737475|323838817|FG014|Overall Study|Disease Progression|0|||
94232297|NCT00832000|322644331|FG000|Overall Study|Withdrawal by Subject|1|||
94232298|NCT00832000|322644332|FG001|Overall Study|Withdrawal by Subject|0|||
94344737|NCT01058395|323042283|FG000|Overall Study|Lost to Follow-up|1|||
94344738|NCT01058395|323042284|FG001|Overall Study|Lost to Follow-up|0|||
94558336|NCT02737475|323838818|FG015|Overall Study|Disease Progression|0|||
94558337|NCT02737475|323838819|FG016|Overall Study|Disease Progression|0|||
94558338|NCT02737475|323838820|FG017|Overall Study|Disease Progression|0|||
94558339|NCT02737475|323838821|FG018|Overall Study|Disease Progression|0|||
94558340|NCT02737475|323838822|FG019|Overall Study|Disease Progression|0|||
94558341|NCT02737475|323838823|FG020|Overall Study|Disease Progression|0|||
94558342|NCT02737475|323838824|FG021|Overall Study|Disease Progression|0|||
94558343|NCT02737475|323838825|FG022|Overall Study|Disease Progression|0|||
94558344|NCT02737475|323838826|FG023|Overall Study|Disease Progression|0|||
94657539|NCT00274716|324204322|FG002|Phase A|Withdrawal by Subject|1|||
94657540|NCT00274716|324204323|FG003|Phase A|Withdrawal by Subject|3|||
94657541|NCT00274716|324204324|FG004|Phase A|Withdrawal by Subject|0|||
94657542|NCT00274716|324204325|FG005|Phase A|Withdrawal by Subject|1|||
94657543|NCT00274716|324204320|FG000|Phase A|Adverse Event|2|||
94657544|NCT00274716|324204321|FG001|Phase A|Adverse Event|3|||
94657545|NCT00274716|324204322|FG002|Phase A|Adverse Event|3|||
94657546|NCT00274716|324204323|FG003|Phase A|Adverse Event|0|||
94657547|NCT00274716|324204324|FG004|Phase A|Adverse Event|2|||
94657548|NCT00274716|324204325|FG005|Phase A|Adverse Event|0|||
94657549|NCT00274716|324204320|FG000|Phase A|Completed but did not enter Phase B|1|||
94657550|NCT00274716|324204321|FG001|Phase A|Completed but did not enter Phase B|2|||
94657551|NCT00274716|324204322|FG002|Phase A|Completed but did not enter Phase B|2|||
94657552|NCT00274716|324204323|FG003|Phase A|Completed but did not enter Phase B|2|||
94657553|NCT00274716|324204324|FG004|Phase A|Completed but did not enter Phase B|1|||
94657554|NCT00274716|324204325|FG005|Phase A|Completed but did not enter Phase B|1|||
94657555|NCT00274716|324204320|FG000|Phase B|Adverse Event|0|||
94657556|NCT00274716|324204321|FG001|Phase B|Adverse Event|0|||
94657557|NCT00274716|324204322|FG002|Phase B|Adverse Event|2|||
94657558|NCT00274716|324204323|FG003|Phase B|Adverse Event|0|||
94657559|NCT00274716|324204324|FG004|Phase B|Adverse Event|0|||
94657560|NCT00274716|324204325|FG005|Phase B|Adverse Event|1|||
94657561|NCT00274716|324204320|FG000|Phase B|Protocol Violation|0|||
94657562|NCT00274716|324204321|FG001|Phase B|Protocol Violation|2|||
94657563|NCT00274716|324204322|FG002|Phase B|Protocol Violation|0|||
94657564|NCT00274716|324204323|FG003|Phase B|Protocol Violation|0|||
94657565|NCT00274716|324204324|FG004|Phase B|Protocol Violation|0|||
94657566|NCT00274716|324204325|FG005|Phase B|Protocol Violation|0|||
94657567|NCT00274716|324204320|FG000|Phase B|Withdrawal by Subject|0|||
94657568|NCT00274716|324204321|FG001|Phase B|Withdrawal by Subject|1|||
94657569|NCT00274716|324204322|FG002|Phase B|Withdrawal by Subject|0|||
94657570|NCT00274716|324204323|FG003|Phase B|Withdrawal by Subject|0|||
94657571|NCT00274716|324204324|FG004|Phase B|Withdrawal by Subject|0|||
94657572|NCT00274716|324204325|FG005|Phase B|Withdrawal by Subject|0|||
94448914|NCT02282813|323430447|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
94448915|NCT02282813|323430448|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
94448916|NCT02282813|323430449|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
94448917|NCT02282813|323430447|FG000|Overall Study|Lack of Efficacy|1|||
94448918|NCT02282813|323430448|FG001|Overall Study|Lack of Efficacy|0|||
94448919|NCT02282813|323430449|FG002|Overall Study|Lack of Efficacy|0|||
94448920|NCT02282813|323430447|FG000|Overall Study|Administrative reasons|0|||
94448921|NCT02282813|323430448|FG001|Overall Study|Administrative reasons|1|||
94448922|NCT02282813|323430449|FG002|Overall Study|Administrative reasons|0|||
94448923|NCT03020992|323430452|FG000|Overall Study|Adverse Event|5|||
94448924|NCT03020992|323430452|FG000|Overall Study|Withdrawal by Subject|1|||
94448925|NCT02861807|323430453|FG000|Overall Study|Lost to Follow-up|7|||
94448926|NCT02861807|323430454|FG001|Overall Study|Lost to Follow-up|6|||
94448927|NCT02861807|323430453|FG000|Overall Study|Withdrawal by Subject|5|||
94448928|NCT02861807|323430454|FG001|Overall Study|Withdrawal by Subject|8|||
94448929|NCT01431716|323430455|FG000|Overall Study|Withdrawal of consent|1|||
94448930|NCT05027451|323430456|FG000|Overall Study|Lost to Follow-up|1|||
94448931|NCT05027451|323430457|FG001|Overall Study|Lost to Follow-up|1|||
94448932|NCT05310071|323430459|FG000|Overall Study|Death|0|||
94448933|NCT05310071|323430460|FG001|Overall Study|Death|3|||
94448934|NCT05310071|323430459|FG000|Overall Study|Adverse Event|4|||
94448935|NCT05310071|323430460|FG001|Overall Study|Adverse Event|31|||
94448936|NCT05310071|323430459|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
94448937|NCT05310071|323430460|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
94448938|NCT05310071|323430459|FG000|Overall Study|Protocol Deviation|2|||
94448939|NCT05310071|323430460|FG001|Overall Study|Protocol Deviation|0|||
94448940|NCT05310071|323430459|FG000|Overall Study|Randomized by Mistake|0|||
94448941|NCT05310071|323430460|FG001|Overall Study|Randomized by Mistake|1|||
94448942|NCT05310071|323430459|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
94657573|NCT00274716|324204320|FG000|Phase B|Participant moved|1|||
94657574|NCT00274716|324204321|FG001|Phase B|Participant moved|0|||
94657575|NCT00274716|324204322|FG002|Phase B|Participant moved|0|||
94657576|NCT00274716|324204323|FG003|Phase B|Participant moved|0|||
94657577|NCT00274716|324204324|FG004|Phase B|Participant moved|0|||
94657578|NCT00274716|324204325|FG005|Phase B|Participant moved|0|||
94657579|NCT00274716|324204320|FG000|Phase B|Other non-reported reason|0|||
94657580|NCT00274716|324204321|FG001|Phase B|Other non-reported reason|0|||
94657581|NCT00274716|324204322|FG002|Phase B|Other non-reported reason|1|||
94657582|NCT00274716|324204323|FG003|Phase B|Other non-reported reason|1|||
94657583|NCT00274716|324204324|FG004|Phase B|Other non-reported reason|0|||
94657584|NCT00274716|324204325|FG005|Phase B|Other non-reported reason|0|||
94657585|NCT00274716|324204320|FG000|Phase B|Lost to Follow-up|0|||
94657586|NCT00274716|324204321|FG001|Phase B|Lost to Follow-up|1|||
94657587|NCT00274716|324204322|FG002|Phase B|Lost to Follow-up|0|||
94657588|NCT00274716|324204323|FG003|Phase B|Lost to Follow-up|0|||
94657589|NCT00274716|324204324|FG004|Phase B|Lost to Follow-up|0|||
94232299|NCT00832000|322644331|FG000|Overall Study|No calls to IVR in either period|1|||
94558345|NCT02737475|323838827|FG024|Overall Study|Disease Progression|0|||
94558346|NCT02737475|323838828|FG025|Overall Study|Disease Progression|0|||
94558347|NCT02737475|323838829|FG026|Overall Study|Disease Progression|1|||
94558348|NCT02510001|323838830|FG000|Overall Study|Early disease progression|0|||
94558349|NCT02510001|323838831|FG001|Overall Study|Early disease progression|0|||
94558350|NCT02510001|323838832|FG002|Overall Study|Early disease progression|0|||
94558351|NCT02510001|323838833|FG003|Overall Study|Early disease progression|1|||
94558352|NCT02510001|323838834|FG004|Overall Study|Early disease progression|1|||
94558353|NCT02510001|323838835|FG005|Overall Study|Early disease progression|1|||
94558354|NCT02510001|323838836|FG006|Overall Study|Early disease progression|0|||
94558355|NCT02510001|323838837|FG007|Overall Study|Early disease progression|0|||
94558356|NCT02510001|323838830|FG000|Overall Study|Adverse Event|0|||
94558357|NCT02510001|323838831|FG001|Overall Study|Adverse Event|0|||
94558358|NCT02510001|323838832|FG002|Overall Study|Adverse Event|0|||
94558359|NCT02510001|323838833|FG003|Overall Study|Adverse Event|1|||
94558360|NCT02510001|323838834|FG004|Overall Study|Adverse Event|2|||
94558361|NCT02510001|323838835|FG005|Overall Study|Adverse Event|1|||
94558362|NCT02510001|323838836|FG006|Overall Study|Adverse Event|2|||
94558363|NCT02510001|323838837|FG007|Overall Study|Adverse Event|5|||
94558364|NCT02510001|323838830|FG000|Overall Study|Physician Decision|0|||
94558365|NCT02510001|323838831|FG001|Overall Study|Physician Decision|0|||
94558366|NCT02510001|323838832|FG002|Overall Study|Physician Decision|0|||
94558367|NCT02510001|323838833|FG003|Overall Study|Physician Decision|0|||
94558368|NCT02510001|323838834|FG004|Overall Study|Physician Decision|1|||
94558369|NCT02510001|323838835|FG005|Overall Study|Physician Decision|0|||
94558370|NCT02510001|323838836|FG006|Overall Study|Physician Decision|0|||
94558371|NCT02510001|323838837|FG007|Overall Study|Physician Decision|0|||
94558372|NCT02510001|323838830|FG000|Overall Study|Withdrawal by Subject|0|||
94558373|NCT02510001|323838831|FG001|Overall Study|Withdrawal by Subject|0|||
94558374|NCT02510001|323838832|FG002|Overall Study|Withdrawal by Subject|0|||
94558375|NCT02510001|323838833|FG003|Overall Study|Withdrawal by Subject|0|||
94558376|NCT02510001|323838834|FG004|Overall Study|Withdrawal by Subject|0|||
94558377|NCT02510001|323838835|FG005|Overall Study|Withdrawal by Subject|0|||
94558378|NCT02510001|323838836|FG006|Overall Study|Withdrawal by Subject|0|||
94558379|NCT02510001|323838837|FG007|Overall Study|Withdrawal by Subject|2|||
94558380|NCT02950480|323838845|FG000|Overall Study|Withdrawal by Subject|1|||
94558381|NCT02950480|323838846|FG001|Overall Study|Withdrawal by Subject|0|||
94558382|NCT03229109|323838850|FG000|Overall Study|Withdrawal by Subject|0|||
94558383|NCT03229109|323838851|FG001|Overall Study|Withdrawal by Subject|0|||
94558384|NCT03229109|323838852|FG002|Overall Study|Withdrawal by Subject|0|||
94558385|NCT03229109|323838853|FG003|Overall Study|Withdrawal by Subject|1|||
94558386|NCT03688074|323838854|FG000|Overall Study|Adverse Event|0|||
94558387|NCT03688074|323838855|FG001|Overall Study|Adverse Event|1|||
94558388|NCT03688074|323838854|FG000|Overall Study|Other|1|||
94558389|NCT03688074|323838855|FG001|Overall Study|Other|0|||
94558390|NCT01835223|323838856|FG000|Overall Study|Adverse Event|1|||
94558391|NCT01835223|323838857|FG001|Overall Study|Adverse Event|0|||
94558392|NCT01835223|323838856|FG000|Overall Study|Withdrawal by Subject|2|||
94558393|NCT01835223|323838857|FG001|Overall Study|Withdrawal by Subject|0|||
94232300|NCT00832000|322644332|FG001|Overall Study|No calls to IVR in either period|1|||
94558394|NCT01835223|323838856|FG000|Overall Study|Disease progression|2|||
94558395|NCT01835223|323838857|FG001|Overall Study|Disease progression|1|||
94558396|NCT01835223|323838856|FG000|Overall Study|Became Inelligible|4|||
94232301|NCT00832000|322644331|FG000|Overall Study|No calls to IVR in period 2|2|||
94558397|NCT01835223|323838857|FG001|Overall Study|Became Inelligible|0|||
94558398|NCT00660179|323838858|FG000|Overall Study|Death|44|||
94558399|NCT00660179|323838859|FG001|Overall Study|Death|47|||
94558400|NCT00660179|323838860|FG002|Overall Study|Death|34|||
94558401|NCT00660179|323838858|FG000|Overall Study|Withdrawal of consent|4|||
94558402|NCT00660179|323838859|FG001|Overall Study|Withdrawal of consent|6|||
94558403|NCT00660179|323838860|FG002|Overall Study|Withdrawal of consent|4|||
94558404|NCT00660179|323838858|FG000|Overall Study|Lost to Follow-up|7|||
94558405|NCT00660179|323838859|FG001|Overall Study|Lost to Follow-up|5|||
94558406|NCT00660179|323838860|FG002|Overall Study|Lost to Follow-up|2|||
94558407|NCT00660179|323838858|FG000|Overall Study|Administrative reason|0|||
94558408|NCT00660179|323838859|FG001|Overall Study|Administrative reason|0|||
94558409|NCT00660179|323838860|FG002|Overall Study|Administrative reason|1|||
94558410|NCT00660179|323838858|FG000|Overall Study|Incorrect randomization|1|||
94558411|NCT00660179|323838859|FG001|Overall Study|Incorrect randomization|0|||
94558412|NCT00660179|323838860|FG002|Overall Study|Incorrect randomization|0|||
94558413|NCT01496469|323838867|FG000|Overall Study|Adverse Event|1|||
94558414|NCT01496469|323838868|FG001|Overall Study|Adverse Event|0|||
94558415|NCT01496469|323838867|FG000|Overall Study|Protocol Violation|2|||
94558416|NCT01496469|323838868|FG001|Overall Study|Protocol Violation|0|||
94558417|NCT01496469|323838867|FG000|Overall Study|Lost to Follow-up|1|||
94344739|NCT01553591|323042299|FG000|Overall Study|Voluntarily withdrew|94|||
94558418|NCT01496469|323838868|FG001|Overall Study|Lost to Follow-up|1|||
94558419|NCT01496469|323838867|FG000|Overall Study|Withdrawal by Subject|4|||
94344740|NCT01553591|323042300|FG001|Overall Study|Voluntarily withdrew|79|||
94344741|NCT01553591|323042301|FG002|Overall Study|Voluntarily withdrew|96|||
94558420|NCT01496469|323838868|FG001|Overall Study|Withdrawal by Subject|4|||
94558421|NCT01496469|323838867|FG000|Overall Study|BP exceeds protocol limits|1|||
94558422|NCT01496469|323838868|FG001|Overall Study|BP exceeds protocol limits|2|||
94558423|NCT01496469|323838867|FG000|Overall Study|Other|1|||
94558424|NCT01496469|323838868|FG001|Overall Study|Other|1|||
94558425|NCT00082407|323838872|FG000|Overall Study|Adverse Event|20|||
94558426|NCT00082407|323838873|FG001|Overall Study|Adverse Event|0|||
94558427|NCT00082407|323838872|FG000|Overall Study|Protocol Violation|14|||
94558428|NCT00082407|323838873|FG001|Overall Study|Protocol Violation|12|||
94558429|NCT00082407|323838872|FG000|Overall Study|Patient Decision|13|||
94558430|NCT00082407|323838873|FG001|Overall Study|Patient Decision|6|||
94558431|NCT00082407|323838872|FG000|Overall Study|Physician Decision|5|||
94558432|NCT00082407|323838873|FG001|Overall Study|Physician Decision|3|||
94657590|NCT00274716|324204325|FG005|Phase B|Lost to Follow-up|0|||
94448943|NCT05310071|323430460|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
94448944|NCT05310071|323430459|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
94448945|NCT05310071|323430460|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
94448946|NCT05310071|323430459|FG000|Overall Study|Site Terminated by Sponsor|0|||
94448947|NCT05310071|323430460|FG001|Overall Study|Site Terminated by Sponsor|2|||
94558433|NCT00082407|323838872|FG000|Overall Study|Loss of Glucose Control|2|||
94558434|NCT00082407|323838873|FG001|Overall Study|Loss of Glucose Control|2|||
94448948|NCT05310071|323430459|FG000|Overall Study|Study Terminated by Sponsor|282|||
94448949|NCT05310071|323430460|FG001|Overall Study|Study Terminated by Sponsor|559|||
94448950|NCT05310071|323430459|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
94465678|NCT01440569|323494897|FG001|Main Study|Investigator's Discretion|1|||
94558435|NCT00082407|323838872|FG000|Overall Study|Death|2|||
94558436|NCT00082407|323838873|FG001|Overall Study|Death|1|||
94558437|NCT00082407|323838872|FG000|Overall Study|Lost to Follow-up|0|||
94558438|NCT00082407|323838873|FG001|Overall Study|Lost to Follow-up|3|||
94465679|NCT01440569|323494896|FG000|Main Study|Withdrew Consent|7|||
94465680|NCT01440569|323494897|FG001|Main Study|Withdrew Consent|1|||
94465681|NCT01440569|323494896|FG000|Main Study|Lost to Follow-up|13|||
94465682|NCT01440569|323494897|FG001|Main Study|Lost to Follow-up|2|||
94465683|NCT01440569|323494896|FG000|Main Study|Subject Non-Compliance|3|||
94465684|NCT01440569|323494897|FG001|Main Study|Subject Non-Compliance|0|||
94465685|NCT01440569|323494896|FG000|Main Study|Protocol Violation|1|||
94465686|NCT01440569|323494897|FG001|Main Study|Protocol Violation|0|||
94465687|NCT01440569|323494896|FG000|Open-Label Rollover Phase|Adverse Event|3|||
94558439|NCT05274269|323838874|FG000|Overall Study|Adverse Event|0|||
94558440|NCT05274269|323838875|FG001|Overall Study|Adverse Event|3|||
94558441|NCT05274269|323838874|FG000|Overall Study|Death|0|||
94558442|NCT05274269|323838875|FG001|Overall Study|Death|1|||
94558443|NCT05274269|323838874|FG000|Overall Study|Other|0|||
94558444|NCT05274269|323838875|FG001|Overall Study|Other|2|||
94558445|NCT05274269|323838874|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
94558446|NCT05274269|323838875|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
94558447|NCT02936843|323838876|FG000|Overall Study|Lost to Follow-up|3|||
94558448|NCT02936843|323838877|FG001|Overall Study|Lost to Follow-up|1|||
94558449|NCT02936843|323838876|FG000|Overall Study|Withdrawal by Subject|1|||
94558450|NCT02936843|323838877|FG001|Overall Study|Withdrawal by Subject|1|||
94558451|NCT03668613|323838878|FG000|Overall Study|Adverse Event|1|||
94558452|NCT03668613|323838879|FG001|Overall Study|Adverse Event|2|||
94558453|NCT03668613|323838878|FG000|Overall Study|Lack of Efficacy|5|||
94558454|NCT03668613|323838879|FG001|Overall Study|Lack of Efficacy|1|||
94465688|NCT01440569|323494897|FG001|Open-Label Rollover Phase|Adverse Event|0|||
94558455|NCT03668613|323838878|FG000|Overall Study|Pregnancy|0|||
94558456|NCT03668613|323838879|FG001|Overall Study|Pregnancy|2|||
94465689|NCT01440569|323494896|FG000|Open-Label Rollover Phase|Pregnancy|1|||
94465690|NCT01440569|323494897|FG001|Open-Label Rollover Phase|Pregnancy|0|||
94465691|NCT01440569|323494896|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
94465692|NCT01440569|323494897|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
94465693|NCT01440569|323494896|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
94465694|NCT01440569|323494897|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
94465695|NCT01440569|323494896|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
94465696|NCT01440569|323494897|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
94465697|NCT01440569|323494896|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
94465698|NCT01440569|323494897|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
94465699|NCT01440569|323494896|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
94465700|NCT01440569|323494897|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
94465701|NCT02584959|323494898|FG000|Period 1|Withdrawn from study|3|||
94465702|NCT02584959|323494899|FG001|Period 1|Withdrawn from study|4|||
94465703|NCT02584959|323494900|FG002|Period 1|Withdrawn from study|0|||
94465704|NCT02584959|323494898|FG000|Period 2|Withdrawn from study|6|||
94465705|NCT02584959|323494899|FG001|Period 2|Withdrawn from study|1|||
94465706|NCT02584959|323494900|FG002|Period 2|Withdrawn from study|2|||
94558457|NCT03668613|323838878|FG000|Overall Study|Protocol Violation|1|||
94558458|NCT03668613|323838879|FG001|Overall Study|Protocol Violation|0|||
94558459|NCT03668613|323838878|FG000|Overall Study|Physician Decision|1|||
94558460|NCT03668613|323838879|FG001|Overall Study|Physician Decision|0|||
94558461|NCT03668613|323838878|FG000|Overall Study|Withdrawal by Subject|2|||
94465707|NCT01870297|323494903|FG000|Overall Study|Adverse Event|0|||
94232302|NCT00832000|322644332|FG001|Overall Study|No calls to IVR in period 2|0|||
94232303|NCT05178979|322644333|FG000|Overall Study|Death|0|||
94232304|NCT05178979|322644334|FG001|Overall Study|Death|5|||
94232305|NCT05178979|322644335|FG002|Overall Study|Death|0|||
94232306|NCT05178979|322644336|FG003|Overall Study|Death|3|||
94232307|NCT05178979|322644333|FG000|Overall Study|Adverse Event|0|||
94232308|NCT05178979|322644334|FG001|Overall Study|Adverse Event|1|||
94232309|NCT05178979|322644335|FG002|Overall Study|Adverse Event|0|||
94232310|NCT05178979|322644336|FG003|Overall Study|Adverse Event|0|||
94232311|NCT05178979|322644333|FG000|Overall Study|Lost to Follow-up|1|||
94232312|NCT05178979|322644334|FG001|Overall Study|Lost to Follow-up|8|||
94232313|NCT05178979|322644335|FG002|Overall Study|Lost to Follow-up|3|||
94232314|NCT05178979|322644336|FG003|Overall Study|Lost to Follow-up|8|||
94232315|NCT00255944|322644337|FG000|Overall Study|Lost to Follow-up|797|||
94232316|NCT00255944|322644338|FG001|Overall Study|Lost to Follow-up|834|||
94232317|NCT01129115|322644339|FG000|Overall Study|Adverse Event|1|||
94232318|NCT01129115|322644340|FG001|Overall Study|Adverse Event|2|||
94232319|NCT01129115|322644341|FG002|Overall Study|Adverse Event|3|||
94232320|NCT01129115|322644342|FG003|Overall Study|Adverse Event|3|||
94232321|NCT01129115|322644339|FG000|Overall Study|Withdrawal by Subject|1|||
94344742|NCT01553591|323042299|FG000|Overall Study|Adverse Event|36|||
94344743|NCT01553591|323042300|FG001|Overall Study|Adverse Event|45|||
94344744|NCT01553591|323042301|FG002|Overall Study|Adverse Event|16|||
94344745|NCT01553591|323042299|FG000|Overall Study|Lost to Follow-up|25|||
94344746|NCT01553591|323042300|FG001|Overall Study|Lost to Follow-up|23|||
94344747|NCT01553591|323042301|FG002|Overall Study|Lost to Follow-up|16|||
94344748|NCT01553591|323042299|FG000|Overall Study|Physician decision: other|11|||
94344749|NCT01553591|323042300|FG001|Overall Study|Physician decision: other|14|||
94344750|NCT01553591|323042301|FG002|Overall Study|Physician decision: other|16|||
94344751|NCT01553591|323042299|FG000|Overall Study|Physician decision: lack of efficacy|2|||
94232322|NCT01129115|322644340|FG001|Overall Study|Withdrawal by Subject|3|||
94344752|NCT01553591|323042300|FG001|Overall Study|Physician decision: lack of efficacy|3|||
94344753|NCT01553591|323042301|FG002|Overall Study|Physician decision: lack of efficacy|7|||
94344754|NCT01553591|323042299|FG000|Overall Study|Protocol Violation|3|||
94344755|NCT01553591|323042300|FG001|Overall Study|Protocol Violation|4|||
94232323|NCT01129115|322644341|FG002|Overall Study|Withdrawal by Subject|1|||
94232324|NCT01129115|322644342|FG003|Overall Study|Withdrawal by Subject|4|||
94232325|NCT01129115|322644339|FG000|Overall Study|Protocol Violation|0|||
94232326|NCT01129115|322644340|FG001|Overall Study|Protocol Violation|2|||
94232327|NCT01129115|322644341|FG002|Overall Study|Protocol Violation|2|||
94232328|NCT01129115|322644342|FG003|Overall Study|Protocol Violation|2|||
94232329|NCT05043883|322644343|FG000|Overall Study|Minimum required measurements could not be taken|4|||
94232330|NCT02049515|322644344|FG000|Overall Study|Adverse Event|46|||
94232331|NCT02049515|322644345|FG001|Overall Study|Adverse Event|2|||
94232332|NCT02049515|322644344|FG000|Overall Study|Protocol-specified Disease Progression|23|||
94232333|NCT02049515|322644345|FG001|Overall Study|Protocol-specified Disease Progression|2|||
94232334|NCT02049515|322644344|FG000|Overall Study|Death|6|||
94232335|NCT02049515|322644345|FG001|Overall Study|Death|0|||
94558462|NCT03668613|323838879|FG001|Overall Study|Withdrawal by Subject|1|||
94558463|NCT03668613|323838878|FG000|Overall Study|Guardian decision|1|||
94232336|NCT02049515|322644344|FG000|Overall Study|Physician Decision|5|||
94448951|NCT05310071|323430460|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
94448952|NCT05310071|323430459|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
94448953|NCT05310071|323430460|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
94448954|NCT05310071|323430459|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
94232337|NCT02049515|322644345|FG001|Overall Study|Physician Decision|1|||
94232338|NCT02049515|322644344|FG000|Overall Study|Withdrawal by Subject|3|||
94232339|NCT02049515|322644345|FG001|Overall Study|Withdrawal by Subject|0|||
94232340|NCT02049515|322644344|FG000|Overall Study|Termination of the Study by Sponsor|2|||
94232341|NCT02049515|322644345|FG001|Overall Study|Termination of the Study by Sponsor|0|||
94232342|NCT02049515|322644344|FG000|Overall Study|Protocol Violation|1|||
94232343|NCT02049515|322644345|FG001|Overall Study|Protocol Violation|1|||
94232344|NCT02049515|322644344|FG000|Overall Study|Clinical Deterioration|1|||
94232345|NCT02049515|322644345|FG001|Overall Study|Clinical Deterioration|0|||
94232346|NCT02049515|322644344|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
94232347|NCT02049515|322644345|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
94232348|NCT02049515|322644344|FG000|Overall Study|Treatment Interruption >42 Days|1|||
94232349|NCT02049515|322644345|FG001|Overall Study|Treatment Interruption >42 Days|0|||
94232350|NCT02049515|322644344|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
94232351|NCT02049515|322644345|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
94232352|NCT01918371|322644346|FG000|Overall Study|Missing Data|1|||
94232353|NCT01918371|322644347|FG001|Overall Study|Missing Data|1|||
94232354|NCT00572533|322644352|FG000|Overall Study|Death|4|||
94232355|NCT00572533|322644353|FG001|Overall Study|Death|1|||
94232356|NCT00572533|322644352|FG000|Overall Study|Received Kidney Transplant|2|||
94232357|NCT00572533|322644353|FG001|Overall Study|Received Kidney Transplant|1|||
94232358|NCT00572533|322644352|FG000|Overall Study|Social Issues|1|||
94232359|NCT00572533|322644353|FG001|Overall Study|Social Issues|0|||
94344756|NCT01553591|323042301|FG002|Overall Study|Protocol Violation|4|||
94344757|NCT01553591|323042299|FG000|Overall Study|Sponsor decision|1|||
94344758|NCT01553591|323042300|FG001|Overall Study|Sponsor decision|0|||
94344759|NCT01553591|323042301|FG002|Overall Study|Sponsor decision|3|||
94344760|NCT01553591|323042299|FG000|Overall Study|Randomized and never dispensed drug|0|||
94344761|NCT01553591|323042300|FG001|Overall Study|Randomized and never dispensed drug|1|||
94232360|NCT00572533|322644352|FG000|Overall Study|Transfer out of Facility|0|||
94232361|NCT00572533|322644353|FG001|Overall Study|Transfer out of Facility|1|||
94344762|NCT01553591|323042301|FG002|Overall Study|Randomized and never dispensed drug|0|||
94448955|NCT05310071|323430460|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
94232362|NCT02058836|322644356|FG000|Overall Study|Withdrawal by Subject|1|||
94344763|NCT00129376|323042305|FG000|Overall Study|Adverse Event|1|||
94448956|NCT05310071|323430459|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
94232363|NCT02058836|322644357|FG001|Overall Study|Withdrawal by Subject|1|||
94232364|NCT02689453|322644363|FG000|Overall Study|Progressive disease|0|||
94232365|NCT02689453|322644364|FG001|Overall Study|Progressive disease|1|||
94558464|NCT03668613|323838879|FG001|Overall Study|Guardian decision|0|||
94232366|NCT02689453|322644365|FG002|Overall Study|Progressive disease|1|||
94232367|NCT01658020|322644366|FG000|Overall Study|Adverse Event|3|||
94232368|NCT01658020|322644367|FG001|Overall Study|Adverse Event|3|||
94232369|NCT01658020|322644366|FG000|Overall Study|Lost to Follow-up|1|||
94232370|NCT01658020|322644367|FG001|Overall Study|Lost to Follow-up|0|||
94232371|NCT01658020|322644366|FG000|Overall Study|Withdrawal by Subject|4|||
94232372|NCT01658020|322644367|FG001|Overall Study|Withdrawal by Subject|5|||
94232373|NCT01658020|322644366|FG000|Overall Study|Protocol Violation|0|||
94232374|NCT01658020|322644367|FG001|Overall Study|Protocol Violation|1|||
94558465|NCT01393821|323838880|FG000|Overall Study|Cancel|1|||
94558466|NCT01393821|323838881|FG001|Overall Study|Cancel|1|||
94558467|NCT01393821|323838880|FG000|Overall Study|not evaluable for primary endpoint|4|||
94558468|NCT01393821|323838881|FG001|Overall Study|not evaluable for primary endpoint|2|||
94558469|NCT01858740|323838882|FG000|Overall Study|Death|4|||
94232375|NCT00115336|322644371|FG000|Overall Study|Hospital discharge before study drug|0|||
94232376|NCT00115336|322644372|FG001|Overall Study|Hospital discharge before study drug|1|||
94232377|NCT04577573|322644382|FG000|Overall Study|Technical - invalid protocol|0|||
94232378|NCT04577573|322644383|FG001|Overall Study|Technical - invalid protocol|2|||
94232379|NCT04577573|322644384|FG002|Overall Study|Technical - invalid protocol|0|||
94232380|NCT04886518|322644385|FG000|Overall Study|Noncompliance with study drug|1|||
94232381|NCT04886518|322644386|FG001|Overall Study|Noncompliance with study drug|0|||
94232382|NCT04886518|322644387|FG002|Overall Study|Noncompliance with study drug|0|||
94232383|NCT04886518|322644385|FG000|Overall Study|Adverse Event|0|||
94232384|NCT04886518|322644386|FG001|Overall Study|Adverse Event|1|||
94232385|NCT04886518|322644387|FG002|Overall Study|Adverse Event|0|||
94232386|NCT04886518|322644385|FG000|Overall Study|Withdrawal by Subject|1|||
94232387|NCT04886518|322644386|FG001|Overall Study|Withdrawal by Subject|0|||
94232388|NCT04886518|322644387|FG002|Overall Study|Withdrawal by Subject|0|||
94232389|NCT02726945|322644388|FG000|Overall Study|Withdrawal by Subject|0|||
94232390|NCT02726945|322644389|FG001|Overall Study|Withdrawal by Subject|0|||
94232391|NCT02726945|322644390|FG002|Overall Study|Withdrawal by Subject|1|||
94558470|NCT00842543|323838883|FG000|Overall Study|Withdrawal by Subject|2|||
94558471|NCT00842543|323838884|FG001|Overall Study|Withdrawal by Subject|0|||
94558472|NCT00842543|323838885|FG002|Overall Study|Withdrawal by Subject|3|||
94558473|NCT00842543|323838886|FG003|Overall Study|Withdrawal by Subject|4|||
94558474|NCT00894361|323838889|FG000|Overall Study|deaths and less than 2 years followup|24|||
94558475|NCT00894361|323838890|FG001|Overall Study|deaths and less than 2 years followup|64|||
94558476|NCT01007838|323838892|FG000|Overall Study|Withdrawal by Subject|1|||
94232392|NCT02726945|322644388|FG000|Overall Study|Elected to have total knee replacement|0|||
94232393|NCT02726945|322644389|FG001|Overall Study|Elected to have total knee replacement|1|||
94232394|NCT02726945|322644390|FG002|Overall Study|Elected to have total knee replacement|0|||
94232395|NCT01266018|322646177|FG000|Overall Study|Physician Decision|1|||
94232396|NCT01266018|322646178|FG001|Overall Study|Physician Decision|0|||
94558477|NCT01007838|323838893|FG001|Overall Study|Withdrawal by Subject|0|||
94558478|NCT01007838|323838894|FG002|Overall Study|Withdrawal by Subject|0|||
94558479|NCT01007838|323838895|FG003|Overall Study|Withdrawal by Subject|0|||
94558480|NCT01007838|323838892|FG000|Overall Study|Physician Decision|1|||
94558481|NCT01007838|323838893|FG001|Overall Study|Physician Decision|0|||
94558482|NCT01007838|323838894|FG002|Overall Study|Physician Decision|0|||
94558483|NCT01007838|323838895|FG003|Overall Study|Physician Decision|0|||
94558484|NCT01007838|323838892|FG000|Overall Study|Started home haemodialysis|1|||
94558485|NCT01007838|323838893|FG001|Overall Study|Started home haemodialysis|0|||
94558486|NCT01007838|323838894|FG002|Overall Study|Started home haemodialysis|0|||
94558487|NCT01007838|323838895|FG003|Overall Study|Started home haemodialysis|0|||
94558488|NCT00483938|323838896|FG000|Overall Study|Protocol Violation|0|||
94558489|NCT00483938|323838897|FG001|Overall Study|Protocol Violation|0|||
94558490|NCT00483938|323838898|FG002|Overall Study|Protocol Violation|0|||
94558491|NCT00483938|323838899|FG003|Overall Study|Protocol Violation|0|||
94558492|NCT00483938|323838900|FG004|Overall Study|Protocol Violation|0|||
94558493|NCT00483938|323838901|FG005|Overall Study|Protocol Violation|0|||
94558494|NCT00483938|323838902|FG006|Overall Study|Protocol Violation|3|||
94558495|NCT00483938|323838896|FG000|Overall Study|Withdrawal by Subject|1|||
94558496|NCT00483938|323838897|FG001|Overall Study|Withdrawal by Subject|6|||
94558497|NCT00483938|323838898|FG002|Overall Study|Withdrawal by Subject|0|||
94558498|NCT00483938|323838899|FG003|Overall Study|Withdrawal by Subject|0|||
94657591|NCT01075321|324204326|FG000|Overall Study|Withdrawal by Subject|0|||
94558499|NCT00483938|323838900|FG004|Overall Study|Withdrawal by Subject|1|||
94558500|NCT00483938|323838901|FG005|Overall Study|Withdrawal by Subject|3|||
94232397|NCT01266018|322646177|FG000|Overall Study|Progressive disease|0|||
94232398|NCT01266018|322646178|FG001|Overall Study|Progressive disease|1|||
94232399|NCT02418845|322646179|FG000|Overall Study|Lost to Follow-up|7|||
94232400|NCT02418845|322646180|FG001|Overall Study|Lost to Follow-up|2|||
94232401|NCT02418845|322646179|FG000|Overall Study|Lack of Efficacy|0|||
94232402|NCT02418845|322646180|FG001|Overall Study|Lack of Efficacy|3|||
94465708|NCT01870297|323494904|FG001|Overall Study|Adverse Event|0|||
94344764|NCT00129376|323042305|FG000|Overall Study|Lack of Efficacy|1|||
94344765|NCT04005755|323042306|FG000|Overall Study|Adverse Event|6|||
94344766|NCT04005755|323042306|FG000|Overall Study|Physician Decision|3|||
94344767|NCT04005755|323042306|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
94344768|NCT04005755|323042306|FG000|Overall Study|Withdrawal by Subject|3|||
94344769|NCT04005755|323042306|FG000|Overall Study|Lost to Follow-up|1|||
94344770|NCT02005211|323042313|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
94344771|NCT02005211|323042314|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
94344772|NCT02005211|323042315|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
94344773|NCT02005211|323042316|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
94344774|NCT02005211|323042317|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
94344775|NCT02005211|323042318|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
94344776|NCT02005211|323042319|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
94232403|NCT02418845|322646179|FG000|Overall Study|Physician Decision|5|||
94232404|NCT02418845|322646180|FG001|Overall Study|Physician Decision|5|||
94232405|NCT02418845|322646179|FG000|Overall Study|Protocol Violation|1|||
94232406|NCT02418845|322646180|FG001|Overall Study|Protocol Violation|0|||
94344777|NCT02607865|323042323|FG000|Overall Study|Lost to Follow-up|9|||
94344778|NCT02607865|323042324|FG001|Overall Study|Lost to Follow-up|7|||
94344779|NCT02607865|323042325|FG002|Overall Study|Lost to Follow-up|7|||
94344780|NCT02607865|323042326|FG003|Overall Study|Lost to Follow-up|5|||
94344781|NCT02607865|323042323|FG000|Overall Study|Withdrawal by Subject|18|||
94232407|NCT02418845|322646179|FG000|Overall Study|Withdrawal by Subject|3|||
94232408|NCT02418845|322646180|FG001|Overall Study|Withdrawal by Subject|2|||
94232409|NCT00943618|322646181|FG000|Overall Study|Lost to Follow-up|38|||
94232410|NCT00943618|322646182|FG001|Overall Study|Lost to Follow-up|48|||
94232411|NCT00943618|322646183|FG002|Overall Study|Lost to Follow-up|20|||
94344782|NCT02607865|323042324|FG001|Overall Study|Withdrawal by Subject|18|||
94344783|NCT02607865|323042325|FG002|Overall Study|Withdrawal by Subject|17|||
94344784|NCT02607865|323042326|FG003|Overall Study|Withdrawal by Subject|8|||
94344785|NCT02607865|323042323|FG000|Overall Study|Death|5|||
94344786|NCT02607865|323042324|FG001|Overall Study|Death|4|||
94344787|NCT02607865|323042325|FG002|Overall Study|Death|1|||
94344788|NCT02607865|323042326|FG003|Overall Study|Death|3|||
94344789|NCT02607865|323042323|FG000|Overall Study|Unclassified|1|||
94344790|NCT02607865|323042324|FG001|Overall Study|Unclassified|1|||
94344791|NCT02607865|323042325|FG002|Overall Study|Unclassified|2|||
94344792|NCT02607865|323042326|FG003|Overall Study|Unclassified|0|||
94344793|NCT00528840|323042327|FG000|Overall Study|Lost to Follow-up|10|||
94344794|NCT00528840|323042327|FG000|Overall Study|Adverse Event|1|||
94344795|NCT00528840|323042327|FG000|Overall Study|Withdrawal by Subject|17|||
94344796|NCT00528840|323042327|FG000|Overall Study|Death|2|||
94344797|NCT00528840|323042327|FG000|Overall Study|Administrative Reasons|1|||
94344798|NCT00528840|323042327|FG000|Overall Study|Other|2|||
94344799|NCT03733249|323042328|FG000|Overall Study|Death|7|||
94344800|NCT03733249|323042328|FG000|Overall Study|Disease relapse|16|||
94344801|NCT03733249|323042328|FG000|Overall Study|Lost to Follow-up|4|||
94344802|NCT03733249|323042328|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
94344803|NCT03733249|323042328|FG000|Overall Study|Withdrawal by Subject|1|||
94344804|NCT01657253|323042329|FG000|Overall Study|Lost to Follow-up|6|||
94344805|NCT01657253|323042330|FG001|Overall Study|Lost to Follow-up|5|||
94344806|NCT01657253|323042329|FG000|Overall Study|Withdrawal by Subject|11|||
94344807|NCT01657253|323042330|FG001|Overall Study|Withdrawal by Subject|12|||
94344808|NCT01657253|323042329|FG000|Overall Study|Adverse Event|0|||
94448957|NCT05310071|323430460|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
94448958|NCT05310071|323430459|FG000|Overall Study|Withdrawal by Participant - Other|25|||
94448959|NCT05310071|323430460|FG001|Overall Study|Withdrawal by Participant - Other|30|||
94448960|NCT05310071|323430459|FG000|Overall Study|Lost to Follow-up|2|||
94448961|NCT05310071|323430460|FG001|Overall Study|Lost to Follow-up|4|||
94448962|NCT05310071|323430459|FG000|Overall Study|Reason Not Specified|1|||
94232412|NCT00943618|322646181|FG000|Overall Study|Discontinued Medication|17|||
94232413|NCT00943618|322646182|FG001|Overall Study|Discontinued Medication|29|||
94232414|NCT00943618|322646183|FG002|Overall Study|Discontinued Medication|11|||
94344809|NCT01657253|323042330|FG001|Overall Study|Adverse Event|1|||
94344810|NCT00397631|323042331|FG000|Overall Study|Adverse Event|5|||
94344811|NCT00397631|323042332|FG001|Overall Study|Adverse Event|6|||
94448963|NCT05310071|323430460|FG001|Overall Study|Reason Not Specified|3|||
94344812|NCT00397631|323042331|FG000|Overall Study|Lack of Efficacy|7|||
94344813|NCT00397631|323042332|FG001|Overall Study|Lack of Efficacy|10|||
94344814|NCT00397631|323042331|FG000|Overall Study|Lost to Follow-up|8|||
94344815|NCT00397631|323042332|FG001|Overall Study|Lost to Follow-up|9|||
94232415|NCT02053610|322646184|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
94232416|NCT02053610|322646185|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
94232417|NCT02053610|322646184|FG000|Overall Study|Withdrew Consent|2|||
94344816|NCT00397631|323042331|FG000|Overall Study|Physician Decision|2|||
94344817|NCT00397631|323042332|FG001|Overall Study|Physician Decision|0|||
94465709|NCT01870297|323494905|FG002|Overall Study|Adverse Event|0|||
94232418|NCT02053610|322646185|FG001|Overall Study|Withdrew Consent|9|||
94558501|NCT00483938|323838902|FG006|Overall Study|Withdrawal by Subject|2|||
94558502|NCT00483938|323838896|FG000|Overall Study|Lost to Follow-up|1|||
94558503|NCT00483938|323838897|FG001|Overall Study|Lost to Follow-up|2|||
94558504|NCT00483938|323838898|FG002|Overall Study|Lost to Follow-up|0|||
94558505|NCT00483938|323838899|FG003|Overall Study|Lost to Follow-up|2|||
94558506|NCT00483938|323838900|FG004|Overall Study|Lost to Follow-up|1|||
94558507|NCT00483938|323838901|FG005|Overall Study|Lost to Follow-up|1|||
94558508|NCT00483938|323838902|FG006|Overall Study|Lost to Follow-up|3|||
94558509|NCT00483938|323838896|FG000|Overall Study|Death|0|||
94558510|NCT00483938|323838897|FG001|Overall Study|Death|2|||
94558511|NCT00483938|323838898|FG002|Overall Study|Death|0|||
94558512|NCT00483938|323838899|FG003|Overall Study|Death|0|||
94558513|NCT00483938|323838900|FG004|Overall Study|Death|0|||
94558514|NCT00483938|323838901|FG005|Overall Study|Death|0|||
94344818|NCT00397631|323042331|FG000|Overall Study|Protocol Violation|0|||
94558515|NCT00483938|323838902|FG006|Overall Study|Death|0|||
94232419|NCT02053610|322646184|FG000|Overall Study|Death|5|||
94558516|NCT00483938|323838896|FG000|Overall Study|Other|3|||
94558517|NCT00483938|323838897|FG001|Overall Study|Other|9|||
94558518|NCT00483938|323838898|FG002|Overall Study|Other|0|||
94558519|NCT00483938|323838899|FG003|Overall Study|Other|4|||
94558520|NCT00483938|323838900|FG004|Overall Study|Other|0|||
94232420|NCT02053610|322646185|FG001|Overall Study|Death|5|||
94232421|NCT02053610|322646184|FG000|Overall Study|Administrative/Other|1|||
94232422|NCT02053610|322646185|FG001|Overall Study|Administrative/Other|1|||
94232423|NCT02053610|322646184|FG000|Overall Study|Disease Progression|2|||
94232424|NCT02053610|322646185|FG001|Overall Study|Disease Progression|3|||
94232425|NCT02053610|322646184|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
94232426|NCT02053610|322646185|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
94232427|NCT02053610|322646184|FG000|Overall Study|Did not Receive Treatment|4|||
94232428|NCT02053610|322646185|FG001|Overall Study|Did not Receive Treatment|2|||
94232429|NCT02053610|322646184|FG000|Overall Study|Insufficient Therapeutic Response|1|||
94232430|NCT02053610|322646185|FG001|Overall Study|Insufficient Therapeutic Response|1|||
94232431|NCT02053610|322646184|FG000|Overall Study|Violation of Selection Criteria|1|||
94232432|NCT02053610|322646185|FG001|Overall Study|Violation of Selection Criteria|0|||
94448964|NCT01420068|323430461|FG000|Overall Study|Administrative problems|1|||
94448965|NCT01420068|323430462|FG001|Overall Study|Administrative problems|3|||
94448966|NCT01420068|323430461|FG000|Overall Study|Withdrawal by Subject|1|||
94448967|NCT01420068|323430462|FG001|Overall Study|Withdrawal by Subject|2|||
94448968|NCT04331067|323430474|FG000|Overall Study|Adverse Event|1|||
94448969|NCT04331067|323430475|FG001|Overall Study|Adverse Event|3|||
94448970|NCT04331067|323430476|FG002|Overall Study|Adverse Event|1|||
94448971|NCT04331067|323430474|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
94448972|NCT04331067|323430475|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
94448973|NCT04331067|323430476|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
94448974|NCT02062450|323430477|FG000|Overall Study|No follow-up visit|124|||
94448975|NCT00987337|323430478|FG000|Overall Study|Adverse Event|10|||
94448976|NCT00987337|323430479|FG001|Overall Study|Adverse Event|9|||
94448977|NCT00987337|323430480|FG002|Overall Study|Adverse Event|8|||
94448978|NCT00987337|323430478|FG000|Overall Study|Insufficient Virologic Response|10|||
94448979|NCT00987337|323430479|FG001|Overall Study|Insufficient Virologic Response|7|||
94448980|NCT00987337|323430480|FG002|Overall Study|Insufficient Virologic Response|12|||
94448981|NCT00987337|323430478|FG000|Overall Study|Virologic Breakthrough|2|||
94448982|NCT00987337|323430479|FG001|Overall Study|Virologic Breakthrough|2|||
94448983|NCT00987337|323430480|FG002|Overall Study|Virologic Breakthrough|8|||
94448984|NCT00987337|323430478|FG000|Overall Study|Lost to Follow-up|10|||
94448985|NCT00987337|323430479|FG001|Overall Study|Lost to Follow-up|6|||
94448986|NCT00987337|323430480|FG002|Overall Study|Lost to Follow-up|2|||
94448987|NCT00987337|323430478|FG000|Overall Study|Withdrawal by Subject|6|||
94448988|NCT00987337|323430479|FG001|Overall Study|Withdrawal by Subject|9|||
94448989|NCT00987337|323430480|FG002|Overall Study|Withdrawal by Subject|9|||
94448990|NCT00987337|323430478|FG000|Overall Study|Other|0|||
94448991|NCT00987337|323430479|FG001|Overall Study|Other|2|||
94448992|NCT00987337|323430480|FG002|Overall Study|Other|5|||
94448993|NCT00987337|323430478|FG000|Overall Study|Protocol Violation|1|||
94232433|NCT02232399|322646186|FG000|Overall Study|Adverse Event|1|||
94232434|NCT02232399|322646187|FG001|Overall Study|Adverse Event|0|||
94232435|NCT02232399|322646186|FG000|Overall Study|Withdrawal by Subject|0|||
94448994|NCT00987337|323430479|FG001|Overall Study|Protocol Violation|0|||
94448995|NCT00987337|323430480|FG002|Overall Study|Protocol Violation|2|||
94558521|NCT00483938|323838901|FG005|Overall Study|Other|4|||
94558522|NCT00483938|323838902|FG006|Overall Study|Other|32|||
94558523|NCT00615992|323838905|FG000|Overall Study|Protocol Violation|67|||
94558524|NCT03052049|323838911|FG000|Overall Study|Withdrawal by Subject|2|||
94558525|NCT02328027|323838912|FG000|Overall Study|Withdrawal by Subject|0|||
94558526|NCT02328027|323838913|FG001|Overall Study|Withdrawal by Subject|1|||
94558527|NCT00186901|323838914|FG000|Overall Study|Pregnancy|6|||
94558528|NCT00186901|323838915|FG001|Overall Study|Pregnancy|3|||
94558529|NCT00186901|323838916|FG002|Overall Study|Pregnancy|0|||
94558530|NCT00186901|323838914|FG000|Overall Study|Lost to Follow-up|6|||
94558531|NCT00186901|323838915|FG001|Overall Study|Lost to Follow-up|3|||
94232436|NCT02232399|322646187|FG001|Overall Study|Withdrawal by Subject|1|||
94232437|NCT01216072|322646188|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
94232438|NCT01216072|322646189|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
94232439|NCT01216072|322646188|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
94232440|NCT01216072|322646189|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
94232441|NCT01216072|322646188|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
94232442|NCT01216072|322646189|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
94232443|NCT01216072|322646188|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
94232444|NCT01216072|322646189|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
94232445|NCT01216072|322646188|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
94232446|NCT01216072|322646189|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
94558532|NCT00186901|323838916|FG002|Overall Study|Lost to Follow-up|0|||
94558533|NCT00186901|323838914|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
94558534|NCT00186901|323838915|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
94558535|NCT00186901|323838916|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
94558536|NCT00186901|323838914|FG000|Overall Study|ALL relapse or second malignancy|1|||
94558537|NCT00186901|323838915|FG001|Overall Study|ALL relapse or second malignancy|2|||
94558538|NCT00186901|323838916|FG002|Overall Study|ALL relapse or second malignancy|0|||
94558539|NCT00186901|323838914|FG000|Overall Study|Withdrawal by Subject|4|||
94558540|NCT00186901|323838915|FG001|Overall Study|Withdrawal by Subject|5|||
94558541|NCT00186901|323838916|FG002|Overall Study|Withdrawal by Subject|0|||
94558542|NCT00186901|323838914|FG000|Overall Study|Open label|3|||
94558543|NCT00186901|323838915|FG001|Overall Study|Open label|2|||
94558544|NCT00186901|323838916|FG002|Overall Study|Open label|0|||
94558545|NCT00186901|323838914|FG000|Overall Study|Limited adherence to study requirements|20|||
94558546|NCT00186901|323838915|FG001|Overall Study|Limited adherence to study requirements|23|||
94558547|NCT00186901|323838916|FG002|Overall Study|Limited adherence to study requirements|0|||
94558548|NCT00186901|323838914|FG000|Overall Study|Bone Mineral Density > 0|0|||
94558549|NCT00186901|323838915|FG001|Overall Study|Bone Mineral Density > 0|0|||
94232447|NCT01216072|322646188|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
94232448|NCT01216072|322646189|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
94232449|NCT01216072|322646188|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
94232450|NCT01216072|322646189|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
94232451|NCT01216072|322646188|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
94344819|NCT00397631|323042332|FG001|Overall Study|Protocol Violation|1|||
94558550|NCT00186901|323838916|FG002|Overall Study|Bone Mineral Density > 0|149|||
94558551|NCT02465203|323838919|FG000|Overall Study|Protocol Violation|1|||
94558552|NCT02465203|323838920|FG001|Overall Study|Protocol Violation|1|||
94558553|NCT02465203|323838921|FG002|Overall Study|Protocol Violation|1|||
94558554|NCT02465203|323838919|FG000|Overall Study|Study terminated by sponsor|50|||
94558555|NCT02465203|323838920|FG001|Overall Study|Study terminated by sponsor|34|||
94558556|NCT02465203|323838921|FG002|Overall Study|Study terminated by sponsor|11|||
94558557|NCT02465203|323838919|FG000|Overall Study|New therapy for study indication|4|||
94558558|NCT02465203|323838920|FG001|Overall Study|New therapy for study indication|0|||
94558559|NCT02465203|323838921|FG002|Overall Study|New therapy for study indication|0|||
94558560|NCT02465203|323838919|FG000|Overall Study|Patient/guardian decision|1|||
94558561|NCT02465203|323838920|FG001|Overall Study|Patient/guardian decision|1|||
94558562|NCT02465203|323838921|FG002|Overall Study|Patient/guardian decision|1|||
94558563|NCT00042991|323838922|FG000|Overall Study|Adverse Event|1|||
94558564|NCT00042991|323838923|FG001|Overall Study|Adverse Event|4|||
94558565|NCT00042991|323838924|FG002|Overall Study|Adverse Event|2|||
94558566|NCT00042991|323838925|FG003|Overall Study|Adverse Event|0|||
94558567|NCT00042991|323838926|FG004|Overall Study|Adverse Event|0|||
94558568|NCT00042991|323838927|FG005|Overall Study|Adverse Event|1|||
94558569|NCT00042991|323838928|FG006|Overall Study|Adverse Event|0|||
94232452|NCT01216072|322646189|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
94558570|NCT00042991|323838922|FG000|Overall Study|Withdrawal by Subject|0|||
94232453|NCT01216072|322646188|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
94558571|NCT00042991|323838923|FG001|Overall Study|Withdrawal by Subject|7|||
94558572|NCT00042991|323838924|FG002|Overall Study|Withdrawal by Subject|2|||
94232454|NCT01216072|322646189|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
94465710|NCT01870297|323494906|FG003|Overall Study|Adverse Event|0|||
94465711|NCT01870297|323494907|FG004|Overall Study|Adverse Event|2|||
94465712|NCT01870297|323494908|FG005|Overall Study|Adverse Event|0|||
94465713|NCT01870297|323494909|FG006|Overall Study|Adverse Event|0|||
94465714|NCT01870297|323494903|FG000|Overall Study|Lost to Follow-up|0|||
94465715|NCT01870297|323494904|FG001|Overall Study|Lost to Follow-up|1|||
94465716|NCT01870297|323494905|FG002|Overall Study|Lost to Follow-up|1|||
94465717|NCT01870297|323494906|FG003|Overall Study|Lost to Follow-up|0|||
94465718|NCT01870297|323494907|FG004|Overall Study|Lost to Follow-up|0|||
94465719|NCT01870297|323494908|FG005|Overall Study|Lost to Follow-up|0|||
94465720|NCT01870297|323494909|FG006|Overall Study|Lost to Follow-up|0|||
94465721|NCT01870297|323494903|FG000|Overall Study|Withdrawal by Subject|0|||
94465722|NCT01870297|323494904|FG001|Overall Study|Withdrawal by Subject|0|||
94465723|NCT01870297|323494905|FG002|Overall Study|Withdrawal by Subject|0|||
94465724|NCT01870297|323494906|FG003|Overall Study|Withdrawal by Subject|0|||
94465725|NCT01870297|323494907|FG004|Overall Study|Withdrawal by Subject|1|||
94465726|NCT01870297|323494908|FG005|Overall Study|Withdrawal by Subject|1|||
94465727|NCT01870297|323494909|FG006|Overall Study|Withdrawal by Subject|1|||
94465728|NCT01870297|323494903|FG000|Overall Study|Sponsor Decision|0|||
94465729|NCT01870297|323494904|FG001|Overall Study|Sponsor Decision|6|||
94465730|NCT01870297|323494905|FG002|Overall Study|Sponsor Decision|0|||
94465731|NCT01870297|323494906|FG003|Overall Study|Sponsor Decision|0|||
94465732|NCT01870297|323494907|FG004|Overall Study|Sponsor Decision|0|||
94465733|NCT01870297|323494908|FG005|Overall Study|Sponsor Decision|0|||
94465734|NCT01870297|323494909|FG006|Overall Study|Sponsor Decision|1|||
94465735|NCT00195494|323494914|FG000|Year 1|Adverse Event|0|||
94465736|NCT00195494|323494915|FG001|Year 1|Adverse Event|0|||
94465737|NCT00195494|323494916|FG002|Year 1|Adverse Event|0|||
94465738|NCT00195494|323494917|FG003|Year 1|Adverse Event|0|||
94465739|NCT00195494|323494918|FG004|Year 1|Adverse Event|34|||
94465740|NCT00195494|323494919|FG005|Year 1|Adverse Event|27|||
94465741|NCT00195494|323494914|FG000|Year 1|System Toxicity|0|||
94465742|NCT00195494|323494915|FG001|Year 1|System Toxicity|0|||
94465743|NCT00195494|323494916|FG002|Year 1|System Toxicity|0|||
94465744|NCT00195494|323494917|FG003|Year 1|System Toxicity|0|||
94465745|NCT00195494|323494918|FG004|Year 1|System Toxicity|0|||
94465746|NCT00195494|323494919|FG005|Year 1|System Toxicity|1|||
94465747|NCT00195494|323494914|FG000|Year 1|Lack of Efficacy|0|||
94558573|NCT00042991|323838925|FG003|Overall Study|Withdrawal by Subject|0|||
94558574|NCT00042991|323838926|FG004|Overall Study|Withdrawal by Subject|1|||
94558575|NCT00042991|323838927|FG005|Overall Study|Withdrawal by Subject|0|||
94558576|NCT00042991|323838928|FG006|Overall Study|Withdrawal by Subject|0|||
94558577|NCT00042991|323838922|FG000|Overall Study|Disease Progression|5|||
94558578|NCT00042991|323838923|FG001|Overall Study|Disease Progression|29|||
94558579|NCT00042991|323838924|FG002|Overall Study|Disease Progression|2|||
94558580|NCT00042991|323838925|FG003|Overall Study|Disease Progression|2|||
94558581|NCT00042991|323838926|FG004|Overall Study|Disease Progression|1|||
94558582|NCT00042991|323838927|FG005|Overall Study|Disease Progression|4|||
94558583|NCT00042991|323838928|FG006|Overall Study|Disease Progression|2|||
94558584|NCT00042991|323838922|FG000|Overall Study|Alternative Therapy|0|||
94558585|NCT00042991|323838923|FG001|Overall Study|Alternative Therapy|0|||
94558586|NCT00042991|323838924|FG002|Overall Study|Alternative Therapy|0|||
94558587|NCT00042991|323838925|FG003|Overall Study|Alternative Therapy|0|||
94558588|NCT00042991|323838926|FG004|Overall Study|Alternative Therapy|1|||
94558589|NCT00042991|323838927|FG005|Overall Study|Alternative Therapy|0|||
94558590|NCT00042991|323838928|FG006|Overall Study|Alternative Therapy|0|||
94558591|NCT05066165|323840443|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
94558592|NCT05066165|323840444|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
94558593|NCT05066165|323840443|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
94558594|NCT05066165|323840444|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
94558595|NCT02467582|323840446|FG000|Allocation|Withdrawal by Subject|1|||
94558596|NCT02467582|323840447|FG001|Allocation|Withdrawal by Subject|0|||
94558597|NCT02467582|323840446|FG000|Follow-up|Death|5|||
94558598|NCT02467582|323840447|FG001|Follow-up|Death|4|||
94558599|NCT02467582|323840446|FG000|Follow-up|Lost to Follow-up|6|||
94558600|NCT02467582|323840447|FG001|Follow-up|Lost to Follow-up|5|||
94558601|NCT03077919|323840448|FG000|Overall Study|Lost to Follow-up|4|||
94558602|NCT03077919|323840449|FG001|Overall Study|Lost to Follow-up|1|||
94558603|NCT01487265|323840452|FG000|Overall Study|Adverse Event|8|||
94558604|NCT01487265|323840452|FG000|Overall Study|Withdrawal by Subject|5|||
94558605|NCT01487265|323840452|FG000|Overall Study|Disease Progression|21|||
94558606|NCT01487265|323840452|FG000|Overall Study|Death|2|||
94558607|NCT01487265|323840452|FG000|Overall Study|Still on Treatment|1|||
94558608|NCT03412812|323840455|FG000|Level 1|Death|3|||
94558609|NCT03412812|323840456|FG001|Level 1|Death|0|||
94558610|NCT03412812|323840455|FG000|Level 1|Adverse Event|0|||
94558611|NCT03412812|323840456|FG001|Level 1|Adverse Event|1|||
94558612|NCT00871338|323840463|FG000|Prior to Booster|Withdrawal by Subject|1|||
94558613|NCT00871338|323840464|FG001|Prior to Booster|Withdrawal by Subject|3|||
94558614|NCT00871338|323840463|FG000|Prior to Booster|Lost to Follow-up|1|||
94558615|NCT00871338|323840464|FG001|Prior to Booster|Lost to Follow-up|0|||
94558616|NCT02391363|323840465|FG000|Overall Study|Lost to Follow-up|5|||
94558617|NCT02391363|323840466|FG001|Overall Study|Lost to Follow-up|5|||
94558618|NCT02391363|323840465|FG000|Overall Study|Withdrawal by Subject|6|||
94558619|NCT02391363|323840466|FG001|Overall Study|Withdrawal by Subject|3|||
94558620|NCT01016600|323840467|FG000|Overall Study|Did not start treatment|1|||
94558621|NCT01016600|323840468|FG001|Overall Study|Did not start treatment|0|||
94558622|NCT01016600|323840469|FG002|Overall Study|Did not start treatment|0|||
94558623|NCT01016600|323840470|FG003|Overall Study|Did not start treatment|0|||
94558624|NCT00872599|323840471|FG000|Second Washout Period|Adverse Event|1|||
94558625|NCT00872599|323840472|FG001|Second Washout Period|Adverse Event|1|||
94558626|NCT00265317|323840475|FG000|Lead-In|Objective progression or relapse|6|||
94558627|NCT00265317|323840476|FG001|Lead-In|Objective progression or relapse|11|||
94558628|NCT00265317|323840477|FG002|Lead-In|Objective progression or relapse|0|||
94558629|NCT00265317|323840478|FG003|Lead-In|Objective progression or relapse|0|||
94558630|NCT00265317|323840475|FG000|Lead-In|Adverse Event|2|||
94558631|NCT00265317|323840476|FG001|Lead-In|Adverse Event|1|||
94558632|NCT00265317|323840477|FG002|Lead-In|Adverse Event|0|||
94558633|NCT00265317|323840478|FG003|Lead-In|Adverse Event|0|||
94558634|NCT00265317|323840475|FG000|Lead-In|Death|3|||
94558635|NCT00265317|323840476|FG001|Lead-In|Death|5|||
94558636|NCT00265317|323840477|FG002|Lead-In|Death|0|||
94558637|NCT00265317|323840478|FG003|Lead-In|Death|0|||
94558638|NCT00265317|323840475|FG000|Lead-In|Withdrawal/other than adverse event|1|||
94558639|NCT00265317|323840476|FG001|Lead-In|Withdrawal/other than adverse event|0|||
94558640|NCT00265317|323840477|FG002|Lead-In|Withdrawal/other than adverse event|0|||
94558641|NCT00265317|323840478|FG003|Lead-In|Withdrawal/other than adverse event|0|||
94558642|NCT00265317|323840475|FG000|Phase 2|Objective progression or relapse|0|||
94558643|NCT00265317|323840476|FG001|Phase 2|Objective progression or relapse|0|||
94448996|NCT00987337|323430478|FG000|Overall Study|Participant Relapsed|18|||
94448997|NCT00987337|323430479|FG001|Overall Study|Participant Relapsed|20|||
94448998|NCT00987337|323430480|FG002|Overall Study|Participant Relapsed|5|||
94558644|NCT00265317|323840477|FG002|Phase 2|Objective progression or relapse|37|||
94558645|NCT00265317|323840478|FG003|Phase 2|Objective progression or relapse|38|||
94558646|NCT00265317|323840475|FG000|Phase 2|Global deterioration of health status|0|||
94558647|NCT00265317|323840476|FG001|Phase 2|Global deterioration of health status|0|||
94558648|NCT00265317|323840477|FG002|Phase 2|Global deterioration of health status|3|||
94558649|NCT00265317|323840478|FG003|Phase 2|Global deterioration of health status|0|||
94558650|NCT00265317|323840475|FG000|Phase 2|Adverse Event|0|||
94558651|NCT00265317|323840476|FG001|Phase 2|Adverse Event|0|||
94558652|NCT00265317|323840477|FG002|Phase 2|Adverse Event|7|||
94558653|NCT00265317|323840478|FG003|Phase 2|Adverse Event|5|||
94558654|NCT00265317|323840475|FG000|Phase 2|Death|0|||
94558655|NCT00265317|323840476|FG001|Phase 2|Death|0|||
94558656|NCT00265317|323840477|FG002|Phase 2|Death|12|||
94558657|NCT00265317|323840478|FG003|Phase 2|Death|15|||
94558658|NCT00265317|323840475|FG000|Phase 2|Protocol Violation|0|||
94558659|NCT00265317|323840476|FG001|Phase 2|Protocol Violation|0|||
94558660|NCT00265317|323840477|FG002|Phase 2|Protocol Violation|1|||
94558661|NCT00265317|323840478|FG003|Phase 2|Protocol Violation|4|||
94558662|NCT00265317|323840475|FG000|Phase 2|Lost to Follow-up|0|||
94558663|NCT00265317|323840476|FG001|Phase 2|Lost to Follow-up|0|||
94558664|NCT00265317|323840477|FG002|Phase 2|Lost to Follow-up|0|||
94232455|NCT01216072|322646188|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
94232456|NCT01216072|322646189|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
94232457|NCT04294667|322646191|FG000|Overall Study|Lack of Efficacy|4|||
94232458|NCT04294667|322646192|FG001|Overall Study|Lack of Efficacy|4|||
94232459|NCT04294667|322646191|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
94232460|NCT04294667|322646192|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
94232461|NCT04294667|322646191|FG000|Overall Study|Patient has a Renal Flare|1|||
94232462|NCT04294667|322646192|FG001|Overall Study|Patient has a Renal Flare|0|||
94232463|NCT04294667|322646191|FG000|Overall Study|SLE Worsening|0|||
94232464|NCT04294667|322646192|FG001|Overall Study|SLE Worsening|1|||
94232465|NCT04294667|322646191|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
94232466|NCT04294667|322646192|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
94232467|NCT04294667|322646191|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
94232468|NCT04294667|322646192|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
94232469|NCT04294667|322646191|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
94232470|NCT04294667|322646192|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
94232471|NCT04294667|322646191|FG000|Overall Study|Subject Moved to Another State|0|||
94232472|NCT04294667|322646192|FG001|Overall Study|Subject Moved to Another State|1|||
94232473|NCT04294667|322646191|FG000|Overall Study|Adverse event, serious fatal|0|||
94232474|NCT04294667|322646192|FG001|Overall Study|Adverse event, serious fatal|1|||
94232475|NCT04294667|322646191|FG000|Overall Study|Adverse event, non-fatal|3|||
94232476|NCT04294667|322646192|FG001|Overall Study|Adverse event, non-fatal|4|||
94232477|NCT02647788|322646197|FG000|Overall Study|Lost to Follow-up|13|||
94232478|NCT02647788|322646198|FG001|Overall Study|Lost to Follow-up|11|||
94232479|NCT02647788|322646197|FG000|Overall Study|Did not want opiate|0|||
94232480|NCT02647788|322646198|FG001|Overall Study|Did not want opiate|1|||
94232481|NCT02647788|322646197|FG000|Overall Study|Withdrawal by Subject|1|||
94232482|NCT02647788|322646198|FG001|Overall Study|Withdrawal by Subject|0|||
94232483|NCT02647788|322646197|FG000|Overall Study|Felt itchy with assigned medication|1|||
94232484|NCT02647788|322646198|FG001|Overall Study|Felt itchy with assigned medication|0|||
94232485|NCT02647788|322646197|FG000|Overall Study|Felt nauseous with assigned medication|1|||
94232486|NCT02647788|322646198|FG001|Overall Study|Felt nauseous with assigned medication|1|||
94232487|NCT03470545|322646201|FG000|Overall Study|Death|0|||
94232488|NCT03470545|322646202|FG001|Overall Study|Death|1|||
94558665|NCT00265317|323840478|FG003|Phase 2|Lost to Follow-up|1|||
94558666|NCT00265317|323840475|FG000|Phase 2|Withdrawal/other than adverse event|0|||
94558667|NCT00265317|323840476|FG001|Phase 2|Withdrawal/other than adverse event|0|||
94558668|NCT00265317|323840477|FG002|Phase 2|Withdrawal/other than adverse event|2|||
94558669|NCT00265317|323840478|FG003|Phase 2|Withdrawal/other than adverse event|1|||
94558670|NCT00265317|323840475|FG000|Phase 2|Study terminated by sponsor|0|||
94558671|NCT00265317|323840476|FG001|Phase 2|Study terminated by sponsor|0|||
94558672|NCT00265317|323840477|FG002|Phase 2|Study terminated by sponsor|1|||
94558673|NCT00265317|323840478|FG003|Phase 2|Study terminated by sponsor|0|||
94558674|NCT00265317|323840475|FG000|Phase 2|Other|0|||
94558675|NCT00265317|323840476|FG001|Phase 2|Other|0|||
94558676|NCT00265317|323840477|FG002|Phase 2|Other|1|||
94558677|NCT00265317|323840478|FG003|Phase 2|Other|1|||
94558678|NCT00801229|323840479|FG000|Signed Consent|Withdrawal by Subject|2|||
94558679|NCT00801229|323840480|FG001|Signed Consent|Withdrawal by Subject|2|||
94558680|NCT00801229|323840479|FG000|Signed Consent|Found Ineligible|1|||
94558681|NCT00801229|323840480|FG001|Signed Consent|Found Ineligible|1|||
94558682|NCT00801229|323840479|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
94558683|NCT00801229|323840480|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
94558684|NCT00801229|323840479|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
94558685|NCT00801229|323840480|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
94558686|NCT00801229|323840479|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
94558687|NCT00801229|323840480|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
94558688|NCT00801229|323840479|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
94232489|NCT03470545|322646201|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
94232490|NCT03470545|322646202|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
94558689|NCT00801229|323840480|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
94558690|NCT00801229|323840479|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
94558691|NCT00801229|323840480|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
94558692|NCT00801229|323840479|FG000|Received Study Drug/Placebo|Adverse Event|1|||
94558693|NCT00801229|323840480|FG001|Received Study Drug/Placebo|Adverse Event|1|||
94558694|NCT00732875|323840483|FG000|Overall Study|Adverse Event|16|||
94558695|NCT00732875|323840483|FG000|Overall Study|Withdrawal by Subject|6|||
94232491|NCT03470545|322646201|FG000|Overall Study|Adverse Event|2|||
94232492|NCT03470545|322646202|FG001|Overall Study|Adverse Event|0|||
94232493|NCT03470545|322646201|FG000|Overall Study|Withdrawal by Subject|1|||
94558696|NCT00732875|323840483|FG000|Overall Study|Lack of Efficacy|13|||
94558697|NCT02255461|323840486|FG000|Overall Study|Adverse Event|0|||
94558698|NCT02255461|323840487|FG001|Overall Study|Adverse Event|1|||
94558699|NCT02255461|323840488|FG002|Overall Study|Adverse Event|0|||
94344820|NCT00397631|323042331|FG000|Overall Study|Withdrawal by Subject|7|||
94558700|NCT02255461|323840489|FG003|Overall Study|Adverse Event|0|||
94344821|NCT00397631|323042332|FG001|Overall Study|Withdrawal by Subject|14|||
94344822|NCT00397631|323042331|FG000|Overall Study|protocol discontinuation criteria|1|||
94344823|NCT00397631|323042332|FG001|Overall Study|protocol discontinuation criteria|4|||
94344824|NCT02202161|323042335|FG000|Overall Study|Adverse Event|1|||
94344825|NCT02202161|323042336|FG001|Overall Study|Adverse Event|1|||
94344826|NCT02202161|323042337|FG002|Overall Study|Adverse Event|0|||
94344827|NCT02202161|323042338|FG003|Overall Study|Adverse Event|0|||
94344828|NCT02202161|323042339|FG004|Overall Study|Adverse Event|0|||
94558701|NCT02255461|323840490|FG004|Overall Study|Adverse Event|1|||
94558702|NCT02255461|323840486|FG000|Overall Study|Withdrawal by Subject|0|||
94558703|NCT02255461|323840487|FG001|Overall Study|Withdrawal by Subject|0|||
94558704|NCT02255461|323840488|FG002|Overall Study|Withdrawal by Subject|1|||
94558705|NCT02255461|323840489|FG003|Overall Study|Withdrawal by Subject|0|||
94558706|NCT02255461|323840490|FG004|Overall Study|Withdrawal by Subject|1|||
94558707|NCT02255461|323840486|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
94558708|NCT02255461|323840487|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
94558709|NCT02255461|323840488|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
94558710|NCT02255461|323840489|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
94558711|NCT02255461|323840490|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
94558712|NCT04774926|323840497|FG000|Overall Study|Adverse Event|15|||
94558713|NCT04774926|323840497|FG000|Overall Study|Lost to Follow-up|3|||
94558714|NCT04774926|323840497|FG000|Overall Study|Physician Decision|6|||
94558715|NCT04774926|323840497|FG000|Overall Study|Withdrawal by Subject|3|||
94558716|NCT04774926|323840497|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
94558717|NCT00787189|323840498|FG000|Overall Study|Lost to Follow-up|2|||
94558718|NCT00787189|323840499|FG001|Overall Study|Lost to Follow-up|2|||
94558719|NCT01564732|323840500|FG000|Overall Study|Early termination by the study sponsor|6|||
94558720|NCT01564732|323840501|FG001|Overall Study|Early termination by the study sponsor|5|||
94558721|NCT03920254|323840507|FG000|Overall Study|Adverse Event|1|||
94558722|NCT03920254|323840508|FG001|Overall Study|Adverse Event|0|||
94558723|NCT03920254|323840509|FG002|Overall Study|Adverse Event|0|||
94558724|NCT03920254|323840507|FG000|Overall Study|Physician Decision|0|||
94558725|NCT03920254|323840508|FG001|Overall Study|Physician Decision|1|||
94558726|NCT03920254|323840509|FG002|Overall Study|Physician Decision|2|||
94558727|NCT03920254|323840507|FG000|Overall Study|Study Terminated By Sponsor|12|||
94558728|NCT03920254|323840508|FG001|Overall Study|Study Terminated By Sponsor|17|||
94558729|NCT03920254|323840509|FG002|Overall Study|Study Terminated By Sponsor|12|||
94558730|NCT03920254|323840507|FG000|Overall Study|Withdrawal by Subject|0|||
94558731|NCT03920254|323840508|FG001|Overall Study|Withdrawal by Subject|0|||
94558732|NCT03920254|323840509|FG002|Overall Study|Withdrawal by Subject|1|||
94558733|NCT02652156|323840510|FG000|Overall Study|Physician Decision|1|||
94558734|NCT02652156|323840511|FG001|Overall Study|Physician Decision|0|||
94558735|NCT02652156|323840512|FG002|Overall Study|Physician Decision|0|||
94558736|NCT03040674|323840513|FG000|Overall Study|Lost to Follow-up|225|||
94558737|NCT03040674|323840513|FG000|Overall Study|Death|23|||
94232494|NCT03470545|322646202|FG001|Overall Study|Withdrawal by Subject|1|||
94232495|NCT03470545|322646201|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
94232496|NCT03470545|322646202|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
94232497|NCT00776659|322646203|FG000|Overall Study|Lost to Follow-up|15|||
94232498|NCT00776659|322646203|FG000|Overall Study|Withdrawal by Subject|10|||
94232499|NCT00776659|322646203|FG000|Overall Study|Study Terminated by Sponsor|1|||
94232500|NCT02312206|322646204|FG000|Overall Study|Adverse Event|3|||
94344829|NCT02202161|323042340|FG005|Overall Study|Adverse Event|1|||
94344830|NCT02202161|323042341|FG006|Overall Study|Adverse Event|0|||
94344831|NCT02202161|323042342|FG007|Overall Study|Adverse Event|0|||
94232501|NCT02312206|322646205|FG001|Overall Study|Adverse Event|6|||
94344832|NCT02202161|323042335|FG000|Overall Study|Did not meet continuation criteria|0|||
94558738|NCT02206035|323840514|FG000|Overall Study|Physician Decision|10|||
94344833|NCT02202161|323042336|FG001|Overall Study|Did not meet continuation criteria|0|||
94344834|NCT02202161|323042337|FG002|Overall Study|Did not meet continuation criteria|0|||
94344835|NCT02202161|323042338|FG003|Overall Study|Did not meet continuation criteria|0|||
94344836|NCT02202161|323042339|FG004|Overall Study|Did not meet continuation criteria|0|||
94344837|NCT02202161|323042340|FG005|Overall Study|Did not meet continuation criteria|0|||
94344838|NCT02202161|323042341|FG006|Overall Study|Did not meet continuation criteria|0|||
94344839|NCT02202161|323042342|FG007|Overall Study|Did not meet continuation criteria|3|||
94344840|NCT02202161|323042335|FG000|Overall Study|Physician Decision|0|||
94344841|NCT02202161|323042336|FG001|Overall Study|Physician Decision|0|||
94344842|NCT02202161|323042337|FG002|Overall Study|Physician Decision|0|||
94344843|NCT02202161|323042338|FG003|Overall Study|Physician Decision|0|||
94448999|NCT02887183|323430481|FG000|Overall Study|Adverse Event|44|||
94449000|NCT02887183|323430481|FG000|Overall Study|Death|30|||
94449001|NCT02887183|323430481|FG000|Overall Study|Pregnancy|1|||
94558739|NCT02206035|323840515|FG001|Overall Study|Physician Decision|0|||
94232502|NCT02312206|322646204|FG000|Overall Study|Withdrawal by Subject|6|||
94232503|NCT02312206|322646205|FG001|Overall Study|Withdrawal by Subject|6|||
94344844|NCT02202161|323042339|FG004|Overall Study|Physician Decision|0|||
94344845|NCT02202161|323042340|FG005|Overall Study|Physician Decision|0|||
94344846|NCT02202161|323042341|FG006|Overall Study|Physician Decision|0|||
94344847|NCT02202161|323042342|FG007|Overall Study|Physician Decision|3|||
94449002|NCT02887183|323430481|FG000|Overall Study|Protocol Violation|6|||
94558740|NCT02206035|323840516|FG002|Overall Study|Physician Decision|175|||
94558741|NCT01934010|323840517|FG000|Overall Study|Adverse Event|1|||
94558742|NCT01934010|323840518|FG001|Overall Study|Adverse Event|1|||
94558743|NCT01934010|323840519|FG002|Overall Study|Adverse Event|0|||
94558744|NCT01934010|323840517|FG000|Overall Study|Withdrawal by Subject|15|||
94232504|NCT02312206|322646204|FG000|Overall Study|Physician Decision|7|||
94232505|NCT02312206|322646205|FG001|Overall Study|Physician Decision|6|||
94232506|NCT02312206|322646204|FG000|Overall Study|Death|31|||
94232507|NCT02312206|322646205|FG001|Overall Study|Death|36|||
94232508|NCT02312206|322646204|FG000|Overall Study|Study Terminated by Sponsor|81|||
94232509|NCT02312206|322646205|FG001|Overall Study|Study Terminated by Sponsor|74|||
94232510|NCT02312206|322646204|FG000|Overall Study|Patient transferred to hospice|0|||
94232511|NCT02312206|322646205|FG001|Overall Study|Patient transferred to hospice|1|||
94232512|NCT02312206|322646204|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
94344848|NCT02202161|323042335|FG000|Overall Study|Withdrawal by Subject|0|||
94232513|NCT02312206|322646205|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
94232514|NCT02312206|322646204|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
94232515|NCT02312206|322646205|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
94232516|NCT02312206|322646204|FG000|Overall Study|Disease Progression|1|||
94232517|NCT02312206|322646205|FG001|Overall Study|Disease Progression|0|||
94232518|NCT00585975|322646206|FG000|Overall Study|Withdrawal by Subject|3|||
94232519|NCT00585975|322646207|FG001|Overall Study|Withdrawal by Subject|3|||
94232520|NCT00585975|322646206|FG000|Overall Study|Lost to Follow-up|2|||
94232521|NCT00585975|322646207|FG001|Overall Study|Lost to Follow-up|1|||
94232522|NCT00585975|322646206|FG000|Overall Study|Enrollment met/over-enrolled|10|||
94232523|NCT00585975|322646207|FG001|Overall Study|Enrollment met/over-enrolled|9|||
94232524|NCT01336205|322646210|FG000|Overall Study|Other|22|||
94232525|NCT01336205|322646211|FG001|Overall Study|Other|9|||
94232526|NCT01336205|322646210|FG000|Overall Study|Lost to Follow-up|40|||
94232527|NCT01336205|322646211|FG001|Overall Study|Lost to Follow-up|20|||
94232528|NCT01336205|322646210|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
94232529|NCT01336205|322646211|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
94232530|NCT01336205|322646210|FG000|Overall Study|Lack of Efficacy|4|||
94232531|NCT01336205|322646211|FG001|Overall Study|Lack of Efficacy|0|||
94232532|NCT01336205|322646210|FG000|Overall Study|Severe noncompliance with protocol|9|||
94232533|NCT01336205|322646211|FG001|Overall Study|Severe noncompliance with protocol|2|||
94232534|NCT01336205|322646210|FG000|Overall Study|Adverse Event|56|||
94232535|NCT01336205|322646211|FG001|Overall Study|Adverse Event|6|||
94232536|NCT01336205|322646210|FG000|Overall Study|Death|1|||
94232537|NCT01336205|322646211|FG001|Overall Study|Death|1|||
94232538|NCT01336205|322646210|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
94232539|NCT01336205|322646211|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
94232540|NCT01336205|322646210|FG000|Overall Study|Withdrawal by Subject|72|||
94232541|NCT01336205|322646211|FG001|Overall Study|Withdrawal by Subject|38|||
94232542|NCT01336205|322646210|FG000|Overall Study|Did not receive treatment|4|||
94232543|NCT01336205|322646211|FG001|Overall Study|Did not receive treatment|0|||
94232544|NCT01006616|322646212|FG000|Period 1 (6 Months)|Adverse Event|10|||
94232545|NCT01006616|322646213|FG001|Period 1 (6 Months)|Adverse Event|31|||
94232546|NCT01006616|322646214|FG002|Period 1 (6 Months)|Adverse Event|37|||
94232547|NCT01006616|322646215|FG003|Period 1 (6 Months)|Adverse Event|9|||
94232548|NCT01006616|322646212|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
94232549|NCT01006616|322646213|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
94232550|NCT01006616|322646214|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
94232551|NCT01006616|322646215|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
94344849|NCT02202161|323042336|FG001|Overall Study|Withdrawal by Subject|0|||
94232552|NCT01006616|322646212|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
94232553|NCT01006616|322646213|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
94232554|NCT01006616|322646214|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
94232555|NCT01006616|322646215|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
94232556|NCT01006616|322646212|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
94232557|NCT01006616|322646213|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
94232558|NCT01006616|322646214|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
94232559|NCT01006616|322646215|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
94232560|NCT01006616|322646212|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
94232561|NCT01006616|322646213|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
94232562|NCT01006616|322646214|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
94232563|NCT01006616|322646215|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
94232564|NCT01006616|322646212|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
94232565|NCT01006616|322646213|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
94232566|NCT01006616|322646214|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
94232567|NCT01006616|322646215|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
94449003|NCT02887183|323430481|FG000|Overall Study|Technical Problems|2|||
94449004|NCT02887183|323430481|FG000|Overall Study|Lost to Follow-up|13|||
94449005|NCT02887183|323430481|FG000|Overall Study|Physician Decision|10|||
94449006|NCT02887183|323430481|FG000|Overall Study|Withdrawal by Subject|35|||
94449007|NCT03058705|323432585|FG000|Overall Study|Withdrawal by Subject|2|||
94449008|NCT03058705|323432585|FG000|Overall Study|Physician Decision|2|||
94449009|NCT02898597|323432586|FG000|Overall Study|Protocol Violation|4|||
94449010|NCT02898597|323432587|FG001|Overall Study|Protocol Violation|2|||
94449011|NCT02898597|323432586|FG000|Overall Study|Lost to Follow-up|0|||
94449012|NCT02898597|323432587|FG001|Overall Study|Lost to Follow-up|9|||
94449013|NCT02898597|323432586|FG000|Overall Study|Death|0|||
94558745|NCT01934010|323840518|FG001|Overall Study|Withdrawal by Subject|6|||
94558746|NCT01934010|323840519|FG002|Overall Study|Withdrawal by Subject|2|||
94558747|NCT01934010|323840517|FG000|Overall Study|Lost to Follow-up|7|||
94558748|NCT01934010|323840518|FG001|Overall Study|Lost to Follow-up|4|||
94558749|NCT01934010|323840519|FG002|Overall Study|Lost to Follow-up|0|||
94558750|NCT03386487|323840520|FG000|Overall Study|Lost to Follow-up|5|||
94558751|NCT03386487|323840521|FG001|Overall Study|Lost to Follow-up|6|||
94558752|NCT03386487|323840520|FG000|Overall Study|Withdrawal by Subject|11|||
94558753|NCT03386487|323840521|FG001|Overall Study|Withdrawal by Subject|7|||
94558754|NCT03386487|323840520|FG000|Overall Study|Physician Decision|11|||
94558755|NCT03386487|323840521|FG001|Overall Study|Physician Decision|8|||
94558756|NCT03534141|323840522|FG000|Overall Study|Enrolled in other clinical trial|1|||
94558757|NCT03534141|323840523|FG001|Overall Study|Enrolled in other clinical trial|0|||
94558758|NCT03534141|323840522|FG000|Overall Study|Liver transplant aborted after randomization|0|||
94558759|NCT03534141|323840523|FG001|Overall Study|Liver transplant aborted after randomization|2|||
94558760|NCT03534141|323840522|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
94558761|NCT03534141|323840523|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
94558762|NCT02703324|323840524|FG000|Period Two|Withdrawal by Subject|0|||
94558763|NCT02703324|323840525|FG001|Period Two|Withdrawal by Subject|0|||
94558764|NCT02703324|323840526|FG002|Period Two|Withdrawal by Subject|1|||
94558765|NCT02703324|323840527|FG003|Period Two|Withdrawal by Subject|0|||
94558766|NCT02703324|323840528|FG004|Period Two|Withdrawal by Subject|0|||
94558767|NCT02703324|323840529|FG005|Period Two|Withdrawal by Subject|0|||
94558768|NCT04042909|323840530|FG000|Overall Study|Withdrawal by Subject|1|||
94558769|NCT04042909|323840531|FG001|Overall Study|Withdrawal by Subject|0|||
94558770|NCT04042909|323840532|FG002|Overall Study|Withdrawal by Subject|0|||
94558771|NCT04042909|323840530|FG000|Overall Study|duplicate cases|2|||
94558772|NCT04042909|323840531|FG001|Overall Study|duplicate cases|0|||
94558773|NCT04042909|323840532|FG002|Overall Study|duplicate cases|0|||
94558774|NCT04042909|323840530|FG000|Overall Study|technical problem|0|||
94558775|NCT04042909|323840531|FG001|Overall Study|technical problem|1|||
94558776|NCT04042909|323840532|FG002|Overall Study|technical problem|0|||
94558777|NCT04390880|323840535|FG000|Overall Study|Withdrawal by Subject|1|||
94558778|NCT02557542|323840536|FG000|Overall Study|Poor recruitment|3|||
94558779|NCT02557542|323840537|FG001|Overall Study|Poor recruitment|0|||
94558780|NCT01858766|323840538|FG000|Overall Study|Randomized but Never Treated|0|||
94558781|NCT01858766|323840539|FG001|Overall Study|Randomized but Never Treated|0|||
94558782|NCT01858766|323840540|FG002|Overall Study|Randomized but Never Treated|0|||
94558783|NCT01858766|323840541|FG003|Overall Study|Randomized but Never Treated|0|||
94558784|NCT01858766|323840542|FG004|Overall Study|Randomized but Never Treated|0|||
94558785|NCT01858766|323840543|FG005|Overall Study|Randomized but Never Treated|1|||
94558786|NCT01858766|323840544|FG006|Overall Study|Randomized but Never Treated|0|||
94558787|NCT01858766|323840545|FG007|Overall Study|Randomized but Never Treated|0|||
94558788|NCT01858766|323840546|FG008|Overall Study|Randomized but Never Treated|0|||
94558789|NCT01858766|323840547|FG009|Overall Study|Randomized but Never Treated|0|||
94558790|NCT01858766|323840548|FG010|Overall Study|Randomized but Never Treated|0|||
94558791|NCT01858766|323840549|FG011|Overall Study|Randomized but Never Treated|0|||
94558792|NCT01858766|323840550|FG012|Overall Study|Randomized but Never Treated|0|||
94558793|NCT01858766|323840551|FG013|Overall Study|Randomized but Never Treated|0|||
94558794|NCT01858766|323840552|FG014|Overall Study|Randomized but Never Treated|0|||
94558795|NCT01858766|323840553|FG015|Overall Study|Randomized but Never Treated|0|||
94558796|NCT01858766|323840554|FG016|Overall Study|Randomized but Never Treated|0|||
94558797|NCT01858766|323840555|FG017|Overall Study|Randomized but Never Treated|1|||
94558798|NCT01858766|323840556|FG018|Overall Study|Randomized but Never Treated|0|||
94558799|NCT01858766|323840538|FG000|Overall Study|Death|0|||
94558800|NCT01858766|323840539|FG001|Overall Study|Death|0|||
94558801|NCT01858766|323840540|FG002|Overall Study|Death|1|||
94558802|NCT01858766|323840541|FG003|Overall Study|Death|0|||
94558803|NCT01858766|323840542|FG004|Overall Study|Death|0|||
94558804|NCT01858766|323840543|FG005|Overall Study|Death|0|||
94558805|NCT01858766|323840544|FG006|Overall Study|Death|0|||
94558806|NCT01858766|323840545|FG007|Overall Study|Death|0|||
94558807|NCT01858766|323840546|FG008|Overall Study|Death|0|||
94558808|NCT01858766|323840547|FG009|Overall Study|Death|0|||
94558809|NCT01858766|323840548|FG010|Overall Study|Death|0|||
94558810|NCT01858766|323840549|FG011|Overall Study|Death|0|||
94558811|NCT01858766|323840550|FG012|Overall Study|Death|0|||
94558812|NCT01858766|323840551|FG013|Overall Study|Death|0|||
94558813|NCT01858766|323840552|FG014|Overall Study|Death|0|||
94558814|NCT01858766|323840553|FG015|Overall Study|Death|0|||
94558815|NCT01858766|323840554|FG016|Overall Study|Death|0|||
94558816|NCT01858766|323840555|FG017|Overall Study|Death|0|||
94558817|NCT01858766|323840556|FG018|Overall Study|Death|0|||
94558818|NCT01858766|323840538|FG000|Overall Study|Lack of Efficacy|1|||
94558819|NCT01858766|323840539|FG001|Overall Study|Lack of Efficacy|0|||
94558820|NCT01858766|323840540|FG002|Overall Study|Lack of Efficacy|0|||
94558821|NCT01858766|323840541|FG003|Overall Study|Lack of Efficacy|0|||
94558822|NCT01858766|323840542|FG004|Overall Study|Lack of Efficacy|1|||
94558823|NCT01858766|323840543|FG005|Overall Study|Lack of Efficacy|2|||
94558824|NCT01858766|323840544|FG006|Overall Study|Lack of Efficacy|0|||
94558825|NCT01858766|323840545|FG007|Overall Study|Lack of Efficacy|0|||
94558826|NCT01858766|323840546|FG008|Overall Study|Lack of Efficacy|0|||
94232568|NCT01006616|322646212|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
94232569|NCT01006616|322646213|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
94232570|NCT01006616|322646214|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
94344850|NCT02202161|323042337|FG002|Overall Study|Withdrawal by Subject|0|||
94558827|NCT01858766|323840547|FG009|Overall Study|Lack of Efficacy|0|||
94558828|NCT01858766|323840548|FG010|Overall Study|Lack of Efficacy|0|||
94558829|NCT01858766|323840549|FG011|Overall Study|Lack of Efficacy|3|||
94558830|NCT01858766|323840550|FG012|Overall Study|Lack of Efficacy|5|||
94558831|NCT01858766|323840551|FG013|Overall Study|Lack of Efficacy|3|||
94558832|NCT01858766|323840552|FG014|Overall Study|Lack of Efficacy|5|||
94558833|NCT01858766|323840553|FG015|Overall Study|Lack of Efficacy|5|||
94558834|NCT01858766|323840554|FG016|Overall Study|Lack of Efficacy|2|||
94558835|NCT01858766|323840555|FG017|Overall Study|Lack of Efficacy|3|||
94558836|NCT01858766|323840556|FG018|Overall Study|Lack of Efficacy|3|||
94558837|NCT01858766|323840538|FG000|Overall Study|Lost to Follow-up|0|||
94558838|NCT01858766|323840539|FG001|Overall Study|Lost to Follow-up|0|||
94558839|NCT01858766|323840540|FG002|Overall Study|Lost to Follow-up|0|||
94558840|NCT01858766|323840541|FG003|Overall Study|Lost to Follow-up|0|||
94558841|NCT01858766|323840542|FG004|Overall Study|Lost to Follow-up|0|||
94558842|NCT01858766|323840543|FG005|Overall Study|Lost to Follow-up|1|||
94558843|NCT01858766|323840544|FG006|Overall Study|Lost to Follow-up|0|||
94558844|NCT01858766|323840545|FG007|Overall Study|Lost to Follow-up|2|||
94558845|NCT01858766|323840546|FG008|Overall Study|Lost to Follow-up|0|||
94558846|NCT01858766|323840547|FG009|Overall Study|Lost to Follow-up|0|||
94558847|NCT01858766|323840548|FG010|Overall Study|Lost to Follow-up|0|||
94558848|NCT01858766|323840549|FG011|Overall Study|Lost to Follow-up|1|||
94558849|NCT01858766|323840550|FG012|Overall Study|Lost to Follow-up|0|||
94558850|NCT01858766|323840551|FG013|Overall Study|Lost to Follow-up|0|||
94558851|NCT01858766|323840552|FG014|Overall Study|Lost to Follow-up|3|||
94558852|NCT01858766|323840553|FG015|Overall Study|Lost to Follow-up|1|||
94558853|NCT01858766|323840554|FG016|Overall Study|Lost to Follow-up|1|||
94558854|NCT01858766|323840555|FG017|Overall Study|Lost to Follow-up|0|||
94558855|NCT01858766|323840556|FG018|Overall Study|Lost to Follow-up|1|||
94558856|NCT01858766|323840538|FG000|Overall Study|Withdrew Consent|0|||
94558857|NCT01858766|323840539|FG001|Overall Study|Withdrew Consent|0|||
94558858|NCT01858766|323840540|FG002|Overall Study|Withdrew Consent|0|||
94558859|NCT01858766|323840541|FG003|Overall Study|Withdrew Consent|0|||
94232571|NCT01006616|322646215|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
94558860|NCT01858766|323840542|FG004|Overall Study|Withdrew Consent|0|||
94558861|NCT01858766|323840543|FG005|Overall Study|Withdrew Consent|0|||
94558862|NCT01858766|323840544|FG006|Overall Study|Withdrew Consent|0|||
94558863|NCT01858766|323840545|FG007|Overall Study|Withdrew Consent|0|||
94558864|NCT01858766|323840546|FG008|Overall Study|Withdrew Consent|0|||
94558865|NCT01858766|323840547|FG009|Overall Study|Withdrew Consent|0|||
94449014|NCT02898597|323432587|FG001|Overall Study|Death|1|||
94449015|NCT02530125|323432588|FG000|Completed Treatment|Early termination of study|1|||
94449016|NCT02530125|323432588|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
94449017|NCT05326529|323432589|FG000|Overall Study|Lack of Efficacy|0|||
94449018|NCT05326529|323432590|FG001|Overall Study|Lack of Efficacy|1|||
94232572|NCT01006616|322646212|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
94232573|NCT01006616|322646213|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
94232574|NCT01006616|322646214|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
94232575|NCT01006616|322646215|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
94232576|NCT01006616|322646212|FG000|Period 1 (6 Months)|Not Treated|0|||
94232577|NCT01006616|322646213|FG001|Period 1 (6 Months)|Not Treated|0|||
94232578|NCT01006616|322646214|FG002|Period 1 (6 Months)|Not Treated|1|||
94232579|NCT01006616|322646215|FG003|Period 1 (6 Months)|Not Treated|1|||
94232580|NCT01006616|322646212|FG000|Period 2 (18 Months)|Adverse Event|6|||
94232581|NCT01006616|322646213|FG001|Period 2 (18 Months)|Adverse Event|6|||
94232582|NCT01006616|322646214|FG002|Period 2 (18 Months)|Adverse Event|6|||
94232583|NCT01006616|322646215|FG003|Period 2 (18 Months)|Adverse Event|4|||
94232584|NCT01006616|322646212|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
94232585|NCT01006616|322646213|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
94232586|NCT01006616|322646214|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
94232587|NCT01006616|322646215|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
94232588|NCT01006616|322646212|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
94232589|NCT01006616|322646213|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
94232590|NCT01006616|322646214|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
94232591|NCT01006616|322646215|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
94232592|NCT01006616|322646212|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
94232593|NCT01006616|322646213|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
94232594|NCT01006616|322646214|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
94232595|NCT01006616|322646215|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
94232596|NCT01006616|322646212|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
94232597|NCT01006616|322646213|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
94232598|NCT01006616|322646214|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
94232599|NCT01006616|322646215|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
94232600|NCT01006616|322646212|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
94232601|NCT01006616|322646213|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
94232602|NCT01006616|322646214|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
94232603|NCT01006616|322646215|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
94232604|NCT01006616|322646212|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
94232605|NCT01006616|322646213|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
94232606|NCT01006616|322646214|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
94232607|NCT01006616|322646215|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
94232608|NCT01006616|322646212|FG000|Period 2 (18 Months)|Study Terminated|63|||
94232609|NCT01006616|322646213|FG001|Period 2 (18 Months)|Study Terminated|46|||
94232610|NCT01006616|322646214|FG002|Period 2 (18 Months)|Study Terminated|44|||
94232611|NCT01006616|322646215|FG003|Period 2 (18 Months)|Study Terminated|70|||
94232612|NCT03672175|322646216|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
94232613|NCT03672175|322646217|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
94232614|NCT03672175|322646218|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
94232615|NCT03672175|322646216|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
94232616|NCT03672175|322646217|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
94232617|NCT03672175|322646218|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
94232618|NCT03672175|322646216|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
94232619|NCT03672175|322646217|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
94232620|NCT03672175|322646218|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
94232621|NCT03672175|322646216|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
94558866|NCT01858766|323840548|FG010|Overall Study|Withdrew Consent|0|||
94558867|NCT01858766|323840549|FG011|Overall Study|Withdrew Consent|1|||
94558868|NCT01858766|323840550|FG012|Overall Study|Withdrew Consent|0|||
94558869|NCT01858766|323840551|FG013|Overall Study|Withdrew Consent|0|||
94558870|NCT01858766|323840552|FG014|Overall Study|Withdrew Consent|0|||
94232622|NCT03672175|322646217|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
94232623|NCT03672175|322646218|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
94558871|NCT01858766|323840553|FG015|Overall Study|Withdrew Consent|0|||
94558872|NCT01858766|323840554|FG016|Overall Study|Withdrew Consent|0|||
94558873|NCT01858766|323840555|FG017|Overall Study|Withdrew Consent|0|||
94558874|NCT01858766|323840556|FG018|Overall Study|Withdrew Consent|0|||
94558875|NCT04034004|323840559|FG000|Overall Study|Withdrawal by Subject|1|||
94558876|NCT04034004|323840560|FG001|Overall Study|Withdrawal by Subject|2|||
94558877|NCT04034004|323840561|FG002|Overall Study|Withdrawal by Subject|2|||
94558878|NCT04034004|323840562|FG003|Overall Study|Withdrawal by Subject|3|||
94558879|NCT04034004|323840559|FG000|Overall Study|could not find vein to administer IV|2|||
94558880|NCT04034004|323840560|FG001|Overall Study|could not find vein to administer IV|1|||
94558881|NCT04034004|323840561|FG002|Overall Study|could not find vein to administer IV|0|||
94558882|NCT04034004|323840562|FG003|Overall Study|could not find vein to administer IV|0|||
94558883|NCT04034004|323840559|FG000|Overall Study|nurse accidentally unblinded subject|0|||
94558884|NCT04034004|323840560|FG001|Overall Study|nurse accidentally unblinded subject|0|||
94558885|NCT04034004|323840561|FG002|Overall Study|nurse accidentally unblinded subject|0|||
94558886|NCT04034004|323840562|FG003|Overall Study|nurse accidentally unblinded subject|1|||
94558887|NCT01483183|323840567|FG000|Overall Study|Physician Decision|0|||
94558888|NCT01483183|323840568|FG001|Overall Study|Physician Decision|0|||
94558889|NCT01483183|323840569|FG002|Overall Study|Physician Decision|0|||
94558890|NCT01483183|323840570|FG003|Overall Study|Physician Decision|0|||
94558891|NCT01483183|323840571|FG004|Overall Study|Physician Decision|0|||
94558892|NCT01483183|323840572|FG005|Overall Study|Physician Decision|0|||
94558893|NCT01483183|323840573|FG006|Overall Study|Physician Decision|2|||
94558894|NCT01483183|323840574|FG007|Overall Study|Physician Decision|0|||
94558895|NCT01483183|323840575|FG008|Overall Study|Physician Decision|0|||
94558896|NCT01483183|323840576|FG009|Overall Study|Physician Decision|0|||
94558897|NCT01483183|323840567|FG000|Overall Study|Withdrawal by Subject|0|||
94558898|NCT01483183|323840568|FG001|Overall Study|Withdrawal by Subject|0|||
94558899|NCT01483183|323840569|FG002|Overall Study|Withdrawal by Subject|0|||
94558900|NCT01483183|323840570|FG003|Overall Study|Withdrawal by Subject|0|||
94558901|NCT01483183|323840571|FG004|Overall Study|Withdrawal by Subject|0|||
94558902|NCT01483183|323840572|FG005|Overall Study|Withdrawal by Subject|0|||
94558903|NCT01483183|323840573|FG006|Overall Study|Withdrawal by Subject|0|||
94558904|NCT01483183|323840574|FG007|Overall Study|Withdrawal by Subject|0|||
94558905|NCT01483183|323840575|FG008|Overall Study|Withdrawal by Subject|0|||
94558906|NCT01483183|323840576|FG009|Overall Study|Withdrawal by Subject|1|||
94558907|NCT04207060|323840577|FG000|Overall Study|Lost to Follow-up|2|||
94558908|NCT04207060|323840578|FG001|Overall Study|Lost to Follow-up|0|||
94558909|NCT05438576|323840579|FG000|Overall Study|Death|1|||
94558910|NCT05438576|323840580|FG001|Overall Study|Death|1|||
94558911|NCT05438576|323840579|FG000|Overall Study|Withdrawal by Subject|4|||
94558912|NCT05438576|323840580|FG001|Overall Study|Withdrawal by Subject|2|||
94558913|NCT05438576|323840579|FG000|Overall Study|Not Eligible|2|||
94558914|NCT05438576|323840580|FG001|Overall Study|Not Eligible|1|||
94558915|NCT05438576|323840579|FG000|Overall Study|Did not complete baseline testing|22|||
94558916|NCT05438576|323840580|FG001|Overall Study|Did not complete baseline testing|4|||
94558917|NCT00206440|323840589|FG000|Overall Study|Protocol Violation|1|||
94558918|NCT00206440|323840590|FG001|Overall Study|Protocol Violation|2|||
94558919|NCT00206440|323840589|FG000|Overall Study|Adverse Event|4|||
94558920|NCT00206440|323840590|FG001|Overall Study|Adverse Event|2|||
94558921|NCT00828750|323840591|FG000|Overall Study|Lack of Efficacy|3|||
94558922|NCT00828750|323840591|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
94558923|NCT03214406|323840594|FG000|Overall Study|did not meet enrollment criteria|9|||
94558924|NCT03214406|323840595|FG001|Overall Study|did not meet enrollment criteria|13|||
94558925|NCT03214406|323840594|FG000|Overall Study|Withdrawal by Subject|1|||
94558926|NCT03214406|323840595|FG001|Overall Study|Withdrawal by Subject|0|||
94558927|NCT03214406|323840594|FG000|Overall Study|Lost to Follow-up|0|||
94558928|NCT03214406|323840595|FG001|Overall Study|Lost to Follow-up|2|||
94558929|NCT01371552|323840603|FG000|Part 1, First 3 Days|Inconvenience|0|||
94558930|NCT01371552|323840604|FG001|Part 1, First 3 Days|Inconvenience|0|||
94558931|NCT01371552|323840605|FG002|Part 1, First 3 Days|Inconvenience|1|||
94558932|NCT01371552|323840606|FG003|Part 1, First 3 Days|Inconvenience|0|||
94232624|NCT03672175|322646216|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
94558933|NCT01371552|323840607|FG004|Part 1, First 3 Days|Inconvenience|0|||
94558934|NCT01371552|323840608|FG005|Part 1, First 3 Days|Inconvenience|0|||
94558935|NCT03790917|323840609|FG000|Overall Study|Death|1|||
94232625|NCT03672175|322646217|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
94344851|NCT02202161|323042338|FG003|Overall Study|Withdrawal by Subject|0|||
94344852|NCT02202161|323042339|FG004|Overall Study|Withdrawal by Subject|1|||
94344853|NCT02202161|323042340|FG005|Overall Study|Withdrawal by Subject|0|||
94344854|NCT02202161|323042341|FG006|Overall Study|Withdrawal by Subject|0|||
94344855|NCT02202161|323042342|FG007|Overall Study|Withdrawal by Subject|0|||
94344856|NCT02750501|323042343|FG000|Overall Study|Adverse Event|4|||
94344857|NCT02750501|323042343|FG000|Overall Study|Physician Decision|1|||
94344858|NCT02750501|323042343|FG000|Overall Study|Protocol Violation|1|||
94344859|NCT02750501|323042343|FG000|Overall Study|G-tube came out|1|||
94344860|NCT02750501|323042343|FG000|Overall Study|Non-compliant use of PERT|1|||
94344861|NCT01756833|323042350|FG000|Overall Study|Withdrawal by Subject|4|||
94344862|NCT01756833|323042351|FG001|Overall Study|Withdrawal by Subject|3|||
94344863|NCT04051944|323042352|FG000|Overall Study|Study ending|1|||
94344864|NCT04051944|323042353|FG001|Overall Study|Study ending|1|||
94344865|NCT04051944|323042352|FG000|Overall Study|Early study termination by participant|1|||
94344866|NCT04051944|323042353|FG001|Overall Study|Early study termination by participant|0|||
94344867|NCT04051944|323042352|FG000|Overall Study|Withdrawal by Subject|2|||
94344868|NCT04051944|323042353|FG001|Overall Study|Withdrawal by Subject|2|||
94344869|NCT04051944|323042352|FG000|Overall Study|Lack of Efficacy|3|||
94344870|NCT04051944|323042353|FG001|Overall Study|Lack of Efficacy|0|||
94344871|NCT04051944|323042352|FG000|Overall Study|Adverse event, non- fatal|1|||
94344872|NCT04051944|323042353|FG001|Overall Study|Adverse event, non- fatal|1|||
94344873|NCT01950364|323042354|FG000|Overall Study|Adverse Event|3|||
94344874|NCT01950364|323042355|FG001|Overall Study|Adverse Event|0|||
94344875|NCT01950364|323042354|FG000|Overall Study|Stem Cell Transplant|2|||
94344876|NCT01950364|323042355|FG001|Overall Study|Stem Cell Transplant|6|||
94344877|NCT01950364|323042354|FG000|Overall Study|Disease Progression|5|||
94344878|NCT01950364|323042355|FG001|Overall Study|Disease Progression|2|||
94344879|NCT01950364|323042354|FG000|Overall Study|Withdrawal by Subject|0|||
94344880|NCT01950364|323042355|FG001|Overall Study|Withdrawal by Subject|1|||
94344881|NCT01950364|323042354|FG000|Overall Study|Protocol Violation|0|||
94344882|NCT01950364|323042355|FG001|Overall Study|Protocol Violation|1|||
94344883|NCT02181504|323042356|FG000|Overall Study|Adverse Event|1|||
94344884|NCT02181504|323042357|FG001|Overall Study|Adverse Event|1|||
94344885|NCT02181504|323042358|FG002|Overall Study|Adverse Event|1|||
94344886|NCT01010776|323042365|FG000|Main Phase|Withdrawal by Subject|14|||
94344887|NCT01010776|323042365|FG000|Main Phase|Lack of Efficacy|8|||
94344888|NCT01010776|323042365|FG000|Main Phase|Adverse Event|7|||
94344889|NCT01010776|323042365|FG000|Main Phase|Lost to Follow-up|6|||
94344890|NCT01010776|323042365|FG000|Main Phase|Non-compliance to study medication|5|||
94344891|NCT01010776|323042365|FG000|Main Phase|Selection failure|2|||
94344892|NCT01010776|323042365|FG000|Main Phase|Inform consent withdrawal|1|||
94344893|NCT01010776|323042365|FG000|Main Phase|Other|1|||
94344894|NCT01010776|323042365|FG000|Main Phase|Did not received study medication|5|||
94344895|NCT01010776|323042365|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
94344896|NCT01010776|323042365|FG000|Extension Phase|Other|3|||
94344897|NCT02332876|323042367|FG000|Overall Study|Lost to Follow-up|1|||
94344898|NCT02332876|323042368|FG001|Overall Study|Lost to Follow-up|1|||
94344899|NCT02415595|323042369|FG000|Overall Study|Administrative reason by sponsor|39|||
94344900|NCT02415595|323042370|FG001|Overall Study|Administrative reason by sponsor|40|||
94344901|NCT02415595|323042371|FG002|Overall Study|Administrative reason by sponsor|41|||
94344902|NCT02415595|323042372|FG003|Overall Study|Administrative reason by sponsor|39|||
94344903|NCT02415595|323042369|FG000|Overall Study|Adverse Event|1|||
94344904|NCT02415595|323042370|FG001|Overall Study|Adverse Event|3|||
94344905|NCT02415595|323042371|FG002|Overall Study|Adverse Event|5|||
94344906|NCT02415595|323042372|FG003|Overall Study|Adverse Event|10|||
94344907|NCT02415595|323042369|FG000|Overall Study|Lack of Efficacy|4|||
94344908|NCT02415595|323042370|FG001|Overall Study|Lack of Efficacy|4|||
94344909|NCT02415595|323042371|FG002|Overall Study|Lack of Efficacy|0|||
94344910|NCT02415595|323042372|FG003|Overall Study|Lack of Efficacy|0|||
94449019|NCT05326529|323432591|FG002|Overall Study|Lack of Efficacy|0|||
94344911|NCT02415595|323042369|FG000|Overall Study|Lost to Follow-up|1|||
94344912|NCT02415595|323042370|FG001|Overall Study|Lost to Follow-up|3|||
94344913|NCT02415595|323042371|FG002|Overall Study|Lost to Follow-up|1|||
94344914|NCT02415595|323042372|FG003|Overall Study|Lost to Follow-up|1|||
94344915|NCT02415595|323042369|FG000|Overall Study|Poor/Non-compliance|1|||
94344916|NCT02415595|323042370|FG001|Overall Study|Poor/Non-compliance|0|||
94344917|NCT02415595|323042371|FG002|Overall Study|Poor/Non-compliance|1|||
94344918|NCT02415595|323042372|FG003|Overall Study|Poor/Non-compliance|0|||
94344919|NCT02415595|323042369|FG000|Overall Study|Reached stopping criteria|0|||
94344920|NCT02415595|323042370|FG001|Overall Study|Reached stopping criteria|1|||
94449020|NCT05326529|323432589|FG000|Overall Study|Physician Decision|0|||
94449021|NCT05326529|323432590|FG001|Overall Study|Physician Decision|0|||
94449022|NCT05326529|323432591|FG002|Overall Study|Physician Decision|2|||
94449023|NCT01344824|323432592|FG000|Overall Study|Adverse Event|15|||
94449024|NCT01344824|323432592|FG000|Overall Study|Withdrawal by Subject|6|||
94449025|NCT01344824|323432592|FG000|Overall Study|Other complicating disease|1|||
94449026|NCT01344824|323432592|FG000|Overall Study|Progression|15|||
94449027|NCT01085630|323432598|FG000|Overall Study|Insufficient data|1|||
94558936|NCT02519595|323840610|FG000|Overall Study|Protocol Violation|8|||
94558937|NCT02519595|323840611|FG001|Overall Study|Protocol Violation|22|||
94558938|NCT02519595|323840612|FG002|Overall Study|Protocol Violation|16|||
94558939|NCT03319212|323840613|FG000|Overall Study|Discontinued as moving out of local area|0|||
94558940|NCT03319212|323840614|FG001|Overall Study|Discontinued as moving out of local area|1|||
94558941|NCT03319212|323840613|FG000|Overall Study|Adverse Event|2|||
94558942|NCT03319212|323840614|FG001|Overall Study|Adverse Event|2|||
94558943|NCT03319212|323840613|FG000|Overall Study|Withdrawal by Subject|0|||
94558944|NCT03319212|323840614|FG001|Overall Study|Withdrawal by Subject|1|||
94558945|NCT03319212|323840613|FG000|Overall Study|Lost to Follow-up|0|||
94558946|NCT03319212|323840614|FG001|Overall Study|Lost to Follow-up|1|||
94558947|NCT03319212|323840613|FG000|Overall Study|Physician Decision|1|||
94558948|NCT03319212|323840614|FG001|Overall Study|Physician Decision|0|||
94558949|NCT01088399|323840615|FG000|Overall Study|Adverse Event|211|||
94558950|NCT01088399|323840616|FG001|Overall Study|Adverse Event|16|||
94558951|NCT01088399|323840617|FG002|Overall Study|Adverse Event|0|||
94558952|NCT01088399|323840615|FG000|Overall Study|Death|204|||
94558953|NCT01088399|323840616|FG001|Overall Study|Death|45|||
94558954|NCT01088399|323840617|FG002|Overall Study|Death|0|||
94558955|NCT01088399|323840615|FG000|Overall Study|Lack of Efficacy|298|||
94558956|NCT01088399|323840616|FG001|Overall Study|Lack of Efficacy|7|||
94344921|NCT02415595|323042371|FG002|Overall Study|Reached stopping criteria|1|||
94344922|NCT02415595|323042372|FG003|Overall Study|Reached stopping criteria|0|||
94344923|NCT02415595|323042369|FG000|Overall Study|Withdrawal by Subject|4|||
94449028|NCT01085630|323432599|FG001|Overall Study|Insufficient data|0|||
94558957|NCT01088399|323840617|FG002|Overall Study|Lack of Efficacy|5|||
94558958|NCT01088399|323840615|FG000|Overall Study|Lost to Follow-up|1070|||
94558959|NCT01088399|323840616|FG001|Overall Study|Lost to Follow-up|278|||
94558960|NCT01088399|323840617|FG002|Overall Study|Lost to Follow-up|58|||
94558961|NCT01088399|323840615|FG000|Overall Study|Physician Decision|531|||
94558962|NCT01088399|323840616|FG001|Overall Study|Physician Decision|88|||
94558963|NCT01088399|323840617|FG002|Overall Study|Physician Decision|16|||
94558964|NCT01088399|323840615|FG000|Overall Study|Withdrawal by Subject|544|||
94558965|NCT01088399|323840616|FG001|Overall Study|Withdrawal by Subject|195|||
94558966|NCT01088399|323840617|FG002|Overall Study|Withdrawal by Subject|33|||
94232626|NCT03672175|322646218|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
94232627|NCT03672175|322646216|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
94232628|NCT03672175|322646217|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
94232629|NCT03672175|322646218|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
94232630|NCT03672175|322646216|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
94232631|NCT03672175|322646217|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
94232632|NCT03672175|322646218|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
94232633|NCT03672175|322646216|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
94232634|NCT03672175|322646217|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
94232635|NCT03672175|322646218|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
94232636|NCT03672175|322646216|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
94232637|NCT03672175|322646217|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
94232638|NCT03672175|322646218|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
94232639|NCT03672175|322646216|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
94232640|NCT03672175|322646217|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
94232641|NCT03672175|322646218|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
94232642|NCT03672175|322646216|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
94232643|NCT03672175|322646217|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
94232644|NCT03672175|322646218|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
94232645|NCT03672175|322646216|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
94232646|NCT03672175|322646217|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
94232647|NCT03672175|322646218|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
94232648|NCT02835092|322646219|FG000|Overall Study|Withdrawal by Subject|3|||
94232649|NCT02835092|322646220|FG001|Overall Study|Withdrawal by Subject|6|||
94232650|NCT02835092|322646221|FG002|Overall Study|Withdrawal by Subject|3|||
94232651|NCT02835092|322646219|FG000|Overall Study|Lost to Follow-up|0|||
94232652|NCT02835092|322646220|FG001|Overall Study|Lost to Follow-up|2|||
94232653|NCT02835092|322646221|FG002|Overall Study|Lost to Follow-up|0|||
94232654|NCT04952701|322646222|FG000|Control Lens|Physician Decision|4|||
94232655|NCT04952701|322646222|FG000|Test Lens|Physician Decision|1|||
94232656|NCT01322009|322646223|FG000|Overall Study|Death|0|||
94232657|NCT01322009|322646224|FG001|Overall Study|Death|1|||
94232658|NCT01322009|322646223|FG000|Overall Study|Adverse Event|0|||
94232659|NCT01322009|322646224|FG001|Overall Study|Adverse Event|1|||
94558967|NCT01088399|323840615|FG000|Overall Study|Change to or start of somatropin therapy|234|||
94232660|NCT01322009|322646223|FG000|Overall Study|ng tube discontinued|0|||
94232661|NCT01322009|322646224|FG001|Overall Study|ng tube discontinued|1|||
94232662|NCT00409409|322646226|FG000|Overall Study|Adverse Event|7|||
94232663|NCT00409409|322646227|FG001|Overall Study|Adverse Event|2|||
94232664|NCT00409409|322646226|FG000|Overall Study|Withdrawal by Subject|1|||
94232665|NCT00409409|322646227|FG001|Overall Study|Withdrawal by Subject|1|||
94232666|NCT00409409|322646226|FG000|Overall Study|Any other reason not above-mentioned|0|||
94232667|NCT00409409|322646227|FG001|Overall Study|Any other reason not above-mentioned|1|||
94232668|NCT02447718|322646228|FG000|Overall Study|Lost to Follow-up|8|||
94232669|NCT02447718|322646229|FG001|Overall Study|Lost to Follow-up|0|||
94232670|NCT02447718|322646228|FG000|Overall Study|Withdrawal by Subject|3|||
94232671|NCT02447718|322646229|FG001|Overall Study|Withdrawal by Subject|0|||
94232672|NCT02447718|322646228|FG000|Overall Study|Screen Failure|1|||
94232673|NCT02447718|322646229|FG001|Overall Study|Screen Failure|0|||
94232674|NCT00770588|322646230|FG000|Overall Study|Adverse Event|9|||
94232675|NCT00770588|322646231|FG001|Overall Study|Adverse Event|2|||
94232676|NCT00770588|322646230|FG000|Overall Study|Death caused by progression of disease|70|||
94232677|NCT00770588|322646231|FG001|Overall Study|Death caused by progression of disease|91|||
94232678|NCT00770588|322646230|FG000|Overall Study|Lost to Follow-up|1|||
94232679|NCT00770588|322646231|FG001|Overall Study|Lost to Follow-up|1|||
94232680|NCT00770588|322646230|FG000|Overall Study|Withdrawal by Subject|1|||
94232681|NCT00770588|322646231|FG001|Overall Study|Withdrawal by Subject|1|||
94232682|NCT01728623|322646236|FG000|Overall Study|Disease progression|26|||
94232683|NCT01728623|322646236|FG000|Overall Study|Adverse Event|1|||
94232684|NCT01728623|322646236|FG000|Overall Study|Withdrawal by Subject|1|||
94232685|NCT00723125|322646237|FG000|Overall Study|Met Dx|1|||
94232686|NCT00723125|322646238|FG001|Overall Study|Met Dx|0|||
94232687|NCT00723125|322646237|FG000|Overall Study|Withdrawal by Subject|15|||
94232688|NCT00723125|322646238|FG001|Overall Study|Withdrawal by Subject|6|||
94232689|NCT00723125|322646237|FG000|Overall Study|Adverse Event|2|||
94232690|NCT00723125|322646238|FG001|Overall Study|Adverse Event|0|||
94232691|NCT00621192|322646243|FG000|Overall Study|Withdrawal by Subject|0|||
94232692|NCT00621192|322646244|FG001|Overall Study|Withdrawal by Subject|0|||
94232693|NCT00621192|322646245|FG002|Overall Study|Withdrawal by Subject|2|||
94232694|NCT00621192|322646246|FG003|Overall Study|Withdrawal by Subject|0|||
94232695|NCT00621192|322646243|FG000|Overall Study|Physician Decision|1|||
94232696|NCT00621192|322646244|FG001|Overall Study|Physician Decision|3|||
94232697|NCT00621192|322646245|FG002|Overall Study|Physician Decision|0|||
94232698|NCT00621192|322646246|FG003|Overall Study|Physician Decision|0|||
94232699|NCT00621192|322646243|FG000|Overall Study|Protocol Violation|1|||
94232700|NCT00621192|322646244|FG001|Overall Study|Protocol Violation|0|||
94232701|NCT00621192|322646245|FG002|Overall Study|Protocol Violation|0|||
94232702|NCT00621192|322646246|FG003|Overall Study|Protocol Violation|1|||
94232703|NCT00621192|322646243|FG000|Overall Study|Adverse Event|0|||
94232704|NCT00621192|322646244|FG001|Overall Study|Adverse Event|1|||
94232705|NCT00621192|322646245|FG002|Overall Study|Adverse Event|0|||
94232706|NCT00621192|322646246|FG003|Overall Study|Adverse Event|1|||
94232707|NCT00621192|322646243|FG000|Overall Study|Death|2|||
94232708|NCT00621192|322646244|FG001|Overall Study|Death|5|||
94232709|NCT00621192|322646245|FG002|Overall Study|Death|0|||
94449029|NCT01085630|323432598|FG000|Overall Study|Ineligible|3|||
94449030|NCT01085630|323432599|FG001|Overall Study|Ineligible|0|||
94449031|NCT03351608|323432600|FG000|Overall Study|Lost to Follow-up|0|||
94449032|NCT03351608|323432601|FG001|Overall Study|Lost to Follow-up|1|||
94449033|NCT03351608|323432602|FG002|Overall Study|Lost to Follow-up|1|||
94449034|NCT03351608|323432603|FG003|Overall Study|Lost to Follow-up|1|||
94449035|NCT03351608|323432604|FG004|Overall Study|Lost to Follow-up|1|||
94449036|NCT03351608|323432600|FG000|Overall Study|Physician Decision|1|||
94449037|NCT03351608|323432601|FG001|Overall Study|Physician Decision|0|||
94558968|NCT01088399|323840616|FG001|Overall Study|Change to or start of somatropin therapy|17|||
94232710|NCT00621192|322646246|FG003|Overall Study|Death|0|||
94232711|NCT00621192|322646243|FG000|Overall Study|Final Assessments not Completed|0|||
94232712|NCT00621192|322646244|FG001|Overall Study|Final Assessments not Completed|0|||
94232713|NCT00621192|322646245|FG002|Overall Study|Final Assessments not Completed|3|||
94232714|NCT00621192|322646246|FG003|Overall Study|Final Assessments not Completed|1|||
94232715|NCT03713320|322646247|FG000|Randomized Period|Adverse Event|1|||
94232716|NCT03713320|322646248|FG001|Randomized Period|Adverse Event|5|||
94232717|NCT03713320|322646249|FG002|Randomized Period|Adverse Event|0|||
94232718|NCT03713320|322646247|FG000|Randomized Period|Physician Decision|1|||
94232719|NCT03713320|322646248|FG001|Randomized Period|Physician Decision|1|||
94232720|NCT03713320|322646249|FG002|Randomized Period|Physician Decision|0|||
94232721|NCT03713320|322646247|FG000|Randomized Period|Withdrawal by Subject|4|||
94232722|NCT03713320|322646248|FG001|Randomized Period|Withdrawal by Subject|0|||
94232723|NCT03713320|322646249|FG002|Randomized Period|Withdrawal by Subject|0|||
94232724|NCT03713320|322646247|FG000|Randomized Period|Participant decision|3|||
94449038|NCT03351608|323432602|FG002|Overall Study|Physician Decision|0|||
94449039|NCT03351608|323432603|FG003|Overall Study|Physician Decision|2|||
94449040|NCT03351608|323432604|FG004|Overall Study|Physician Decision|1|||
94558969|NCT01088399|323840617|FG002|Overall Study|Change to or start of somatropin therapy|12|||
94558970|NCT01088399|323840615|FG000|Overall Study|Sponsor decision|1573|||
94558971|NCT01088399|323840616|FG001|Overall Study|Sponsor decision|298|||
94558972|NCT01088399|323840617|FG002|Overall Study|Sponsor decision|7|||
94558973|NCT01088399|323840615|FG000|Overall Study|Protocol Violation|10|||
94558974|NCT01088399|323840616|FG001|Overall Study|Protocol Violation|1|||
94558975|NCT01088399|323840617|FG002|Overall Study|Protocol Violation|0|||
94558976|NCT01088399|323840615|FG000|Overall Study|Enrollment criteria not met|48|||
94558977|NCT01088399|323840616|FG001|Overall Study|Enrollment criteria not met|119|||
94558978|NCT01088399|323840617|FG002|Overall Study|Enrollment criteria not met|70|||
94558979|NCT01088399|323840615|FG000|Overall Study|Study summary visit not completed|2398|||
94558980|NCT01088399|323840616|FG001|Overall Study|Study summary visit not completed|283|||
94558981|NCT01088399|323840617|FG002|Overall Study|Study summary visit not completed|80|||
94558982|NCT01546688|323840618|FG000|Overall Study|Adverse Event|0|||
94558983|NCT01546688|323840619|FG001|Overall Study|Adverse Event|4|||
94344924|NCT02415595|323042370|FG001|Overall Study|Withdrawal by Subject|0|||
94344925|NCT02415595|323042371|FG002|Overall Study|Withdrawal by Subject|1|||
94344926|NCT02415595|323042372|FG003|Overall Study|Withdrawal by Subject|3|||
94344927|NCT02415595|323042369|FG000|Overall Study|Other|0|||
94344928|NCT02415595|323042370|FG001|Overall Study|Other|1|||
94344929|NCT02415595|323042371|FG002|Overall Study|Other|1|||
94344930|NCT02415595|323042372|FG003|Overall Study|Other|0|||
94344931|NCT01040728|323042376|FG000|Overall Study|Adverse Event|4|||
94344932|NCT01040728|323042377|FG001|Overall Study|Adverse Event|8|||
94344933|NCT01040728|323042378|FG002|Overall Study|Adverse Event|0|||
94344934|NCT01040728|323042379|FG003|Overall Study|Adverse Event|4|||
94344935|NCT01040728|323042376|FG000|Overall Study|Withdrawal by Subject|0|||
94344936|NCT01040728|323042377|FG001|Overall Study|Withdrawal by Subject|1|||
94344937|NCT01040728|323042378|FG002|Overall Study|Withdrawal by Subject|1|||
94344938|NCT01040728|323042379|FG003|Overall Study|Withdrawal by Subject|0|||
94344939|NCT01040728|323042376|FG000|Overall Study|Protocol Violation|0|||
94344940|NCT01040728|323042377|FG001|Overall Study|Protocol Violation|0|||
94344941|NCT01040728|323042378|FG002|Overall Study|Protocol Violation|0|||
94344942|NCT01040728|323042379|FG003|Overall Study|Protocol Violation|1|||
94344943|NCT01040728|323042376|FG000|Overall Study|Lack of Efficacy|0|||
94344944|NCT01040728|323042377|FG001|Overall Study|Lack of Efficacy|1|||
94344945|NCT01040728|323042378|FG002|Overall Study|Lack of Efficacy|0|||
94344946|NCT01040728|323042379|FG003|Overall Study|Lack of Efficacy|1|||
94344947|NCT01040728|323042376|FG000|Overall Study|Other reasons not listed above|0|||
94344948|NCT01040728|323042377|FG001|Overall Study|Other reasons not listed above|1|||
94344949|NCT01040728|323042378|FG002|Overall Study|Other reasons not listed above|0|||
94344950|NCT01040728|323042379|FG003|Overall Study|Other reasons not listed above|0|||
94449041|NCT03351608|323432600|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
94449042|NCT03351608|323432601|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
94449043|NCT03351608|323432602|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
94449044|NCT03351608|323432603|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
94449045|NCT03351608|323432604|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
94449046|NCT03351608|323432600|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94449047|NCT03351608|323432601|FG001|Overall Study|Withdrawal by parent/guardian|0|||
94449048|NCT03351608|323432602|FG002|Overall Study|Withdrawal by parent/guardian|1|||
94449049|NCT03351608|323432603|FG003|Overall Study|Withdrawal by parent/guardian|1|||
94449050|NCT03351608|323432604|FG004|Overall Study|Withdrawal by parent/guardian|0|||
94558984|NCT01546688|323840618|FG000|Overall Study|Withdrawal by Subject|2|||
94344951|NCT00712270|323042380|FG000|Overall Study|Withdrawal by Subject|11|||
94344952|NCT00712270|323042380|FG000|Overall Study|Screen Failure|3|||
94344953|NCT01012037|323042381|FG000|Overall Study|Adverse Event|0|||
94449051|NCT03351608|323432600|FG000|Overall Study|Other|0|||
94449052|NCT03351608|323432601|FG001|Overall Study|Other|1|||
94344954|NCT01012037|323042382|FG001|Overall Study|Adverse Event|8|||
94558985|NCT01546688|323840619|FG001|Overall Study|Withdrawal by Subject|1|||
94558986|NCT01546688|323840618|FG000|Overall Study|Lack of Efficacy|1|||
94344955|NCT01012037|323042383|FG002|Overall Study|Adverse Event|3|||
94232725|NCT03713320|322646248|FG001|Randomized Period|Participant decision|1|||
94232726|NCT03713320|322646249|FG002|Randomized Period|Participant decision|0|||
94232727|NCT03713320|322646247|FG000|Randomized Period|Study terminated by sponsor|6|||
94232728|NCT03713320|322646248|FG001|Randomized Period|Study terminated by sponsor|3|||
94232729|NCT03713320|322646249|FG002|Randomized Period|Study terminated by sponsor|0|||
94232730|NCT03713320|322646247|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
94232731|NCT03713320|322646248|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
94232732|NCT03713320|322646249|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
94232733|NCT03713320|322646247|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
94232734|NCT03713320|322646248|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
94344956|NCT01012037|323042381|FG000|Overall Study|Protocol Violation|0|||
94558987|NCT01546688|323840619|FG001|Overall Study|Lack of Efficacy|0|||
94558988|NCT00782483|323840620|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
94558989|NCT01370265|323842386|FG000|First Intervention|Adverse Event|1|||
94558990|NCT01370265|323842387|FG001|First Intervention|Adverse Event|1|||
94558991|NCT00602420|323842388|FG000|Overall Study|Death|1|||
94558992|NCT00602420|323842389|FG001|Overall Study|Death|4|||
94558993|NCT00602420|323842388|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
94558994|NCT00602420|323842389|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
94558995|NCT00602420|323842388|FG000|Overall Study|Withdrawal by Subject|18|||
94558996|NCT00602420|323842389|FG001|Overall Study|Withdrawal by Subject|17|||
94558997|NCT00602420|323842388|FG000|Overall Study|Adverse Event|1|||
94558998|NCT00602420|323842389|FG001|Overall Study|Adverse Event|0|||
94558999|NCT00703924|323842400|FG000|Overall Study|Withdrawal by Subject|1|||
94559000|NCT00703924|323842401|FG001|Overall Study|Withdrawal by Subject|1|||
94559001|NCT02475278|323842410|FG000|Overall Study|Lost to Follow-up|1|||
94559002|NCT02475278|323842410|FG000|Overall Study|Reason Not Specified|1|||
94559003|NCT01031979|323842413|FG000|Overall Study|Lost to Follow-up|5|||
94559004|NCT01031979|323842414|FG001|Overall Study|Lost to Follow-up|4|||
94559005|NCT00826618|323842415|FG000|Overall Study|Withdrawal by Subject|1|||
94559006|NCT03828617|323842416|FG000|Overall Study|Lost to Follow-up|22|||
94559007|NCT03828617|323842417|FG001|Overall Study|Lost to Follow-up|12|||
94559008|NCT03828617|323842418|FG002|Overall Study|Lost to Follow-up|23|||
94559009|NCT03828617|323842419|FG003|Overall Study|Lost to Follow-up|7|||
94559010|NCT03828617|323842416|FG000|Overall Study|No longer met eligibility criteria|0|||
94559011|NCT03828617|323842417|FG001|Overall Study|No longer met eligibility criteria|1|||
94559012|NCT03828617|323842418|FG002|Overall Study|No longer met eligibility criteria|1|||
94559013|NCT03828617|323842419|FG003|Overall Study|No longer met eligibility criteria|3|||
94559014|NCT03828617|323842416|FG000|Overall Study|Protocol Violation|0|||
94559015|NCT03828617|323842417|FG001|Overall Study|Protocol Violation|2|||
94559016|NCT03828617|323842418|FG002|Overall Study|Protocol Violation|0|||
94559017|NCT03828617|323842419|FG003|Overall Study|Protocol Violation|0|||
94559018|NCT03828617|323842416|FG000|Overall Study|Withdrawal by Subject|2|||
94559019|NCT03828617|323842417|FG001|Overall Study|Withdrawal by Subject|0|||
94559020|NCT03828617|323842418|FG002|Overall Study|Withdrawal by Subject|2|||
94559021|NCT03828617|323842419|FG003|Overall Study|Withdrawal by Subject|0|||
94559022|NCT03038126|323842424|FG000|Overall Study|Death|1|||
94559023|NCT03038126|323842425|FG001|Overall Study|Death|1|||
94559024|NCT03038126|323842424|FG000|Overall Study|Withdrawal by Subject|5|||
94232735|NCT03713320|322646249|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
94232736|NCT00823836|322646250|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
94344957|NCT01012037|323042382|FG001|Overall Study|Protocol Violation|3|||
94559025|NCT03038126|323842425|FG001|Overall Study|Withdrawal by Subject|0|||
94559026|NCT03038126|323842424|FG000|Overall Study|Lost to Follow-up|0|||
94559027|NCT03038126|323842425|FG001|Overall Study|Lost to Follow-up|1|||
94559028|NCT03038126|323842424|FG000|Overall Study|Long Term Hospitalization|2|||
94559029|NCT03038126|323842425|FG001|Overall Study|Long Term Hospitalization|0|||
94559030|NCT03038126|323842424|FG000|Overall Study|Too Ill to Participate|1|||
94559031|NCT03038126|323842425|FG001|Overall Study|Too Ill to Participate|2|||
94559032|NCT03826186|323842426|FG000|Overall Study|Protocol Violation|2|||
94559033|NCT03826186|323842427|FG001|Overall Study|Protocol Violation|0|||
94232737|NCT00823836|322646251|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
94232738|NCT00823836|322646250|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
94232739|NCT00823836|322646251|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
94232740|NCT00823836|322646250|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
94344958|NCT01012037|323042383|FG002|Overall Study|Protocol Violation|5|||
94344959|NCT01012037|323042381|FG000|Overall Study|Withdrawal by Subject|0|||
94344960|NCT01012037|323042382|FG001|Overall Study|Withdrawal by Subject|4|||
94344961|NCT01012037|323042383|FG002|Overall Study|Withdrawal by Subject|1|||
94344962|NCT01012037|323042381|FG000|Overall Study|Other reason (not specified)|1|||
94559034|NCT03826186|323842426|FG000|Overall Study|Withdrawal by Subject|1|||
94344963|NCT01012037|323042382|FG001|Overall Study|Other reason (not specified)|1|||
94344964|NCT01012037|323042383|FG002|Overall Study|Other reason (not specified)|1|||
94344965|NCT02583711|323042384|FG000|Overall Study|Withdrawal by Subject|0|||
94559035|NCT03826186|323842427|FG001|Overall Study|Withdrawal by Subject|0|||
94344966|NCT02583711|323042385|FG001|Overall Study|Withdrawal by Subject|10|||
94232741|NCT00823836|322646251|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
94232742|NCT00823836|322646250|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
94232743|NCT00823836|322646251|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
94232744|NCT00823836|322646250|FG000|Long-term Phase|Adverse Event|3|||
94232745|NCT00823836|322646251|FG001|Long-term Phase|Adverse Event|2|||
94232746|NCT00823836|322646250|FG000|Long-term Phase|Physician Decision|1|||
94232747|NCT00823836|322646251|FG001|Long-term Phase|Physician Decision|2|||
94232748|NCT00823836|322646250|FG000|Long-term Phase|Withdrawal by Subject|1|||
94232749|NCT00823836|322646251|FG001|Long-term Phase|Withdrawal by Subject|1|||
94232750|NCT02569957|322646252|FG000|Overall Study|Withdrawal by Subject|0|||
94232751|NCT02569957|322646253|FG001|Overall Study|Withdrawal by Subject|1|||
94232752|NCT03636373|322646254|FG000|Overall Study|Study closure due to Covid-19|1|||
94232753|NCT03636373|322646255|FG001|Overall Study|Study closure due to Covid-19|0|||
94232754|NCT04211389|322646259|FG000|Overall Study|Adverse Event|1|||
94232755|NCT04211389|322646260|FG001|Overall Study|Adverse Event|2|||
94232756|NCT04211389|322646259|FG000|Overall Study|Lost to Follow-up|15|||
94232757|NCT04211389|322646260|FG001|Overall Study|Lost to Follow-up|7|||
94232758|NCT04211389|322646259|FG000|Overall Study|Protocol Violation|0|||
94232759|NCT04211389|322646260|FG001|Overall Study|Protocol Violation|1|||
94232760|NCT04211389|322646259|FG000|Overall Study|Withdrawal by Subject|10|||
94232761|NCT04211389|322646260|FG001|Overall Study|Withdrawal by Subject|11|||
94232762|NCT00725543|322646263|FG000|Overall Study|Adverse Event|10|||
94232763|NCT00725543|322646263|FG000|Overall Study|Lack of Efficacy|3|||
94232764|NCT00725543|322646263|FG000|Overall Study|Withdrawal by Subject|10|||
94232765|NCT00725543|322646263|FG000|Overall Study|Physician Decision|5|||
94232766|NCT00725543|322646263|FG000|Overall Study|Lost to Follow-up|4|||
94232767|NCT00725543|322646263|FG000|Overall Study|Non-compliance|2|||
94232768|NCT00725543|322646263|FG000|Overall Study|Other|119|||
94232769|NCT00927901|322646266|FG000|Treatment Period 1|Subject withdrew consent|0|||
94232770|NCT00927901|322646267|FG001|Treatment Period 1|Subject withdrew consent|0|||
94232771|NCT00927901|322646268|FG002|Treatment Period 1|Subject withdrew consent|1|||
94232772|NCT00927901|322646269|FG003|Treatment Period 1|Subject withdrew consent|0|||
94232773|NCT00927901|322646266|FG000|Treatment Period 4|Adverse Event|0|||
94232774|NCT00927901|322646267|FG001|Treatment Period 4|Adverse Event|0|||
94232775|NCT00927901|322646268|FG002|Treatment Period 4|Adverse Event|0|||
94232776|NCT00927901|322646269|FG003|Treatment Period 4|Adverse Event|1|||
94232777|NCT00927901|322646266|FG000|Treatment Period 4|Subject withdrew consent|0|||
94232778|NCT00927901|322646267|FG001|Treatment Period 4|Subject withdrew consent|0|||
94232779|NCT00927901|322646268|FG002|Treatment Period 4|Subject withdrew consent|1|||
94232780|NCT00927901|322646269|FG003|Treatment Period 4|Subject withdrew consent|0|||
94232781|NCT01536171|322646271|FG000|Overall Study|Withdrawal by Subject|1|||
94232782|NCT01255761|322646272|FG000|Overall Study|Adverse Event|29|||
94232783|NCT01255761|322646273|FG001|Overall Study|Adverse Event|43|||
94232784|NCT01255761|322646272|FG000|Overall Study|Lack of Efficacy|86|||
94232785|NCT01255761|322646273|FG001|Overall Study|Lack of Efficacy|74|||
94232786|NCT01255761|322646272|FG000|Overall Study|Protocol Violation|9|||
94232787|NCT01255761|322646273|FG001|Overall Study|Protocol Violation|5|||
94232788|NCT01255761|322646272|FG000|Overall Study|Lost to Follow-up|10|||
94232789|NCT01255761|322646273|FG001|Overall Study|Lost to Follow-up|8|||
94232790|NCT01255761|322646272|FG000|Overall Study|Withdrawal by Subject|11|||
94232791|NCT01255761|322646273|FG001|Overall Study|Withdrawal by Subject|27|||
94232792|NCT01255761|322646272|FG000|Overall Study|Other Reasons|37|||
94232793|NCT01255761|322646273|FG001|Overall Study|Other Reasons|18|||
94232794|NCT03023423|322646287|FG000|Overall Study|Death|5|||
94232795|NCT03023423|322646288|FG001|Overall Study|Death|12|||
94232796|NCT03023423|322646289|FG002|Overall Study|Death|20|||
94232797|NCT03023423|322646287|FG000|Overall Study|Other|0|||
94232798|NCT03023423|322646288|FG001|Overall Study|Other|2|||
94232799|NCT03023423|322646289|FG002|Overall Study|Other|2|||
94232800|NCT03023423|322646287|FG000|Overall Study|Ongoing|2|||
94232801|NCT03023423|322646288|FG001|Overall Study|Ongoing|32|||
94344967|NCT02583711|323042386|FG002|Overall Study|Withdrawal by Subject|0|||
94232802|NCT03023423|322646289|FG002|Overall Study|Ongoing|24|||
94232803|NCT03512197|322646290|FG000|Overall Study|Guardian decision|1|||
94232804|NCT03512197|322646291|FG001|Overall Study|Guardian decision|1|||
94232805|NCT03512197|322646290|FG000|Overall Study|Lack of Efficacy|19|||
94232806|NCT03512197|322646291|FG001|Overall Study|Lack of Efficacy|11|||
94232807|NCT03512197|322646290|FG000|Overall Study|New Therapy for Study Indication|16|||
94232808|NCT03512197|322646291|FG001|Overall Study|New Therapy for Study Indication|16|||
94232809|NCT03512197|322646290|FG000|Overall Study|Physician Decision|60|||
94232810|NCT03512197|322646291|FG001|Overall Study|Physician Decision|60|||
94232811|NCT03512197|322646290|FG000|Overall Study|Protocol Violation|0|||
94232812|NCT03512197|322646291|FG001|Overall Study|Protocol Violation|2|||
94232813|NCT03512197|322646290|FG000|Overall Study|Terminated by Sponsored|46|||
94232814|NCT03512197|322646291|FG001|Overall Study|Terminated by Sponsored|50|||
94232815|NCT03512197|322646290|FG000|Overall Study|Subject Decision|15|||
94232816|NCT03512197|322646291|FG001|Overall Study|Subject Decision|12|||
94344968|NCT01060124|323042393|FG000|Overall Study|Other|16|||
94559036|NCT01980095|323842430|FG000|Overall Study|Lost to Follow-up|6|||
94344969|NCT01060124|323042393|FG000|Overall Study|Adverse Event|14|||
94344970|NCT01060124|323042393|FG000|Overall Study|Withdrawal by Subject|7|||
94344971|NCT05307523|323042396|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
94344972|NCT05307523|323042397|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
94344973|NCT05307523|323042396|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
94344974|NCT05307523|323042397|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
94344975|NCT00901394|323042399|FG000|Overall Study|Physician Decision|1|||
94344976|NCT00901394|323042400|FG001|Overall Study|Physician Decision|1|||
94449053|NCT03351608|323432602|FG002|Overall Study|Other|1|||
94449054|NCT03351608|323432603|FG003|Overall Study|Other|3|||
94449055|NCT03351608|323432604|FG004|Overall Study|Other|0|||
94449056|NCT02877004|323432605|FG000|Overall Study|Pregnancy|0|||
94449057|NCT02877004|323432606|FG001|Overall Study|Pregnancy|0|||
94449058|NCT02877004|323432607|FG002|Overall Study|Pregnancy|1|||
94449059|NCT02727478|323432608|FG000|Overall Study|Withdrawal by Subject|8|||
94449060|NCT02727478|323432609|FG001|Overall Study|Withdrawal by Subject|10|||
94449061|NCT02633293|323432610|FG000|Overall Study|Death|56|||
94449062|NCT02633293|323432610|FG000|Overall Study|Progressive Disease|12|||
94449063|NCT02633293|323432610|FG000|Overall Study|Adverse Event|29|||
94449064|NCT02633293|323432610|FG000|Overall Study|Withdrawal by Subject|41|||
94449065|NCT02633293|323432610|FG000|Overall Study|Protocol Violation|1|||
94449066|NCT02633293|323432610|FG000|Overall Study|Lost to Follow-up|1|||
94449067|NCT02633293|323432610|FG000|Overall Study|Study Terminated by Sponsor|24|||
94449068|NCT02633293|323432610|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
94449069|NCT02633293|323432610|FG000|Overall Study|Lung Transplant|5|||
94449070|NCT02633293|323432610|FG000|Overall Study|Lack of Efficacy|2|||
94449071|NCT02633293|323432610|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
94449072|NCT02509507|323432611|FG000|Overall Study|Death|21|||
94449073|NCT02509507|323432612|FG001|Overall Study|Death|3|||
94449074|NCT02509507|323432613|FG002|Overall Study|Death|22|||
94449075|NCT02509507|323432614|FG003|Overall Study|Death|14|||
94449076|NCT02509507|323432615|FG004|Overall Study|Death|8|||
94449077|NCT02509507|323432616|FG005|Overall Study|Death|12|||
94449078|NCT02509507|323432617|FG006|Overall Study|Death|5|||
94449079|NCT02509507|323432618|FG007|Overall Study|Death|4|||
94449080|NCT02509507|323432619|FG008|Overall Study|Death|8|||
94449081|NCT02509507|323432611|FG000|Overall Study|Lost to Follow-up|0|||
94449082|NCT02509507|323432612|FG001|Overall Study|Lost to Follow-up|1|||
94449083|NCT02509507|323432613|FG002|Overall Study|Lost to Follow-up|0|||
94449084|NCT02509507|323432614|FG003|Overall Study|Lost to Follow-up|0|||
94449085|NCT02509507|323432615|FG004|Overall Study|Lost to Follow-up|0|||
94449086|NCT02509507|323432616|FG005|Overall Study|Lost to Follow-up|2|||
94449087|NCT02509507|323432617|FG006|Overall Study|Lost to Follow-up|0|||
94449088|NCT02509507|323432618|FG007|Overall Study|Lost to Follow-up|0|||
94449089|NCT02509507|323432619|FG008|Overall Study|Lost to Follow-up|0|||
94449090|NCT02509507|323432611|FG000|Overall Study|Withdrawal by Subject|2|||
94449091|NCT02509507|323432612|FG001|Overall Study|Withdrawal by Subject|0|||
94449092|NCT02509507|323432613|FG002|Overall Study|Withdrawal by Subject|1|||
94449093|NCT02509507|323432614|FG003|Overall Study|Withdrawal by Subject|4|||
94449094|NCT02509507|323432615|FG004|Overall Study|Withdrawal by Subject|1|||
94449095|NCT02509507|323432616|FG005|Overall Study|Withdrawal by Subject|3|||
94449096|NCT02509507|323432617|FG006|Overall Study|Withdrawal by Subject|4|||
94449097|NCT02509507|323432618|FG007|Overall Study|Withdrawal by Subject|0|||
94449098|NCT02509507|323432619|FG008|Overall Study|Withdrawal by Subject|1|||
94449099|NCT01966120|323432623|FG000|Overall Study|Withdrawal by Subject|0|||
94559037|NCT01980095|323842431|FG001|Overall Study|Lost to Follow-up|7|||
94344977|NCT00901394|323042401|FG002|Overall Study|Physician Decision|2|||
94344978|NCT01474889|323042402|FG000|Overall Study|Physician Decision|1|||
94449100|NCT01966120|323432624|FG001|Overall Study|Withdrawal by Subject|5|||
94449101|NCT01966120|323432623|FG000|Overall Study|Lost to Follow-up|1|||
94449102|NCT01966120|323432624|FG001|Overall Study|Lost to Follow-up|1|||
94449103|NCT04630002|323432625|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
94449104|NCT04630002|323432626|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
94449105|NCT04630002|323432627|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
94449106|NCT04630002|323432625|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
94449107|NCT04630002|323432626|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
94449108|NCT04630002|323432627|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
94232817|NCT03512197|322646290|FG000|Overall Study|Withdrawal of informed consent|20|||
94232818|NCT03512197|322646291|FG001|Overall Study|Withdrawal of informed consent|14|||
94232819|NCT03512197|322646290|FG000|Overall Study|Adverse Event|30|||
94232820|NCT03512197|322646291|FG001|Overall Study|Adverse Event|34|||
94344979|NCT01474889|323042403|FG001|Overall Study|Physician Decision|0|||
94559038|NCT01980095|323842430|FG000|Overall Study|Withdrawal by Subject|2|||
94559039|NCT01980095|323842431|FG001|Overall Study|Withdrawal by Subject|3|||
94559040|NCT01980095|323842430|FG000|Overall Study|Poor compliance|5|||
94559041|NCT01980095|323842431|FG001|Overall Study|Poor compliance|0|||
94559042|NCT01980095|323842430|FG000|Overall Study|Safety issue|0|||
94559043|NCT01980095|323842431|FG001|Overall Study|Safety issue|1|||
94559044|NCT01980095|323842430|FG000|Overall Study|Study drug discontinued|1|||
94559045|NCT01980095|323842431|FG001|Overall Study|Study drug discontinued|0|||
94559046|NCT01980095|323842430|FG000|Overall Study|Randomized by mistake|1|||
94559047|NCT01980095|323842431|FG001|Overall Study|Randomized by mistake|0|||
94559048|NCT00741013|323842440|FG000|Overall Study|Adverse Event|1|||
94559049|NCT00741013|323842441|FG001|Overall Study|Adverse Event|0|||
94232821|NCT03512197|322646290|FG000|Overall Study|Death|14|||
94232822|NCT03512197|322646291|FG001|Overall Study|Death|9|||
94232823|NCT03512197|322646290|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
94232824|NCT03512197|322646291|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
94232825|NCT03512197|322646290|FG000|Overall Study|Missing|3|||
94232826|NCT03512197|322646291|FG001|Overall Study|Missing|13|||
94232827|NCT00356811|322646294|FG000|Overall Study|Death|35|||
94232828|NCT00356811|322646294|FG000|Overall Study|Lost to Follow-up|2|||
94559050|NCT00741013|323842442|FG002|Overall Study|Adverse Event|0|||
94559051|NCT00741013|323842440|FG000|Overall Study|Withdrawal by Subject|0|||
94559052|NCT00741013|323842441|FG001|Overall Study|Withdrawal by Subject|0|||
94232829|NCT00356811|322646294|FG000|Overall Study|Withdrawal by Subject|6|||
94232830|NCT00356811|322646294|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
94559053|NCT00741013|323842442|FG002|Overall Study|Withdrawal by Subject|1|||
94344980|NCT01474889|323042404|FG002|Overall Study|Physician Decision|0|||
94232831|NCT00356811|322646294|FG000|Overall Study|Study Is Terminating|3|||
94344981|NCT01474889|323042402|FG000|Overall Study|Did not meet inclusion|1|||
94344982|NCT01474889|323042403|FG001|Overall Study|Did not meet inclusion|0|||
94344983|NCT01474889|323042404|FG002|Overall Study|Did not meet inclusion|0|||
94232832|NCT00356811|322646294|FG000|Overall Study|Site Closed during Follow-up|2|||
94232833|NCT02386839|322646295|FG000|Overall Study|Death|1|||
94232834|NCT02386839|322646296|FG001|Overall Study|Death|0|||
94232835|NCT02386839|322646295|FG000|Overall Study|Withdrawal by Subject|9|||
94559054|NCT00741013|323842440|FG000|Overall Study|Discovered failed screen after enrolled|0|||
94559055|NCT00741013|323842441|FG001|Overall Study|Discovered failed screen after enrolled|2|||
94559056|NCT00741013|323842442|FG002|Overall Study|Discovered failed screen after enrolled|0|||
94559057|NCT00291018|323842443|FG000|Overall Study|Not Consented or Declined PAS|12|||
94559058|NCT00291018|323842444|FG001|Overall Study|Not Consented or Declined PAS|15|||
94559059|NCT00291018|323842445|FG002|Overall Study|Not Consented or Declined PAS|15|||
94559060|NCT00291018|323842443|FG000|Overall Study|Death|3|||
94559061|NCT00291018|323842444|FG001|Overall Study|Death|3|||
94559062|NCT00291018|323842445|FG002|Overall Study|Death|4|||
94559063|NCT00291018|323842443|FG000|Overall Study|Withdrawal by Subject|2|||
94559064|NCT00291018|323842444|FG001|Overall Study|Withdrawal by Subject|8|||
94559065|NCT00291018|323842445|FG002|Overall Study|Withdrawal by Subject|1|||
94559066|NCT00291018|323842443|FG000|Overall Study|Failures|5|||
94559067|NCT00291018|323842444|FG001|Overall Study|Failures|12|||
94559068|NCT00291018|323842445|FG002|Overall Study|Failures|5|||
94559069|NCT00291018|323842443|FG000|Overall Study|Lost to Follow-up|3|||
94559070|NCT00291018|323842444|FG001|Overall Study|Lost to Follow-up|4|||
94559071|NCT00291018|323842445|FG002|Overall Study|Lost to Follow-up|18|||
94559072|NCT04171219|323842448|FG000|Overall Study|Adverse Event|1|||
94559073|NCT04171219|323842449|FG001|Overall Study|Adverse Event|0|||
94559074|NCT04171219|323842448|FG000|Overall Study|Death|0|||
94559075|NCT04171219|323842449|FG001|Overall Study|Death|1|||
94559076|NCT04171219|323842448|FG000|Overall Study|Lack of Efficacy|9|||
94559077|NCT04171219|323842449|FG001|Overall Study|Lack of Efficacy|13|||
94559078|NCT04171219|323842448|FG000|Overall Study|Withdrawal by Subject|1|||
94559079|NCT04171219|323842449|FG001|Overall Study|Withdrawal by Subject|2|||
94559080|NCT04171219|323842448|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
94559081|NCT04171219|323842449|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
94559082|NCT04171219|323842448|FG000|Overall Study|Clinical PD/Patient choice|1|||
94559083|NCT04171219|323842449|FG001|Overall Study|Clinical PD/Patient choice|0|||
94559084|NCT04171219|323842448|FG000|Overall Study|Toxicity/ Patient choice|1|||
94559085|NCT04171219|323842449|FG001|Overall Study|Toxicity/ Patient choice|0|||
94559086|NCT03704688|323842456|FG000|Overall Study|Adverse Event|0|||
94559087|NCT03704688|323842457|FG001|Overall Study|Adverse Event|0|||
94559088|NCT03704688|323842458|FG002|Overall Study|Adverse Event|0|||
94559089|NCT03704688|323842459|FG003|Overall Study|Adverse Event|4|||
94232836|NCT02386839|322646296|FG001|Overall Study|Withdrawal by Subject|10|||
94232837|NCT02386839|322646295|FG000|Overall Study|Lost to Follow-up|4|||
94232838|NCT02386839|322646296|FG001|Overall Study|Lost to Follow-up|4|||
94232839|NCT02386839|322646295|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
94232840|NCT02386839|322646296|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
94232841|NCT02386839|322646295|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
94559090|NCT03704688|323842460|FG004|Overall Study|Adverse Event|1|||
94559091|NCT03704688|323842461|FG005|Overall Study|Adverse Event|0|||
94232842|NCT02386839|322646296|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
94232843|NCT02386839|322646295|FG000|Overall Study|Other (unspecified)|1|||
94559092|NCT03704688|323842456|FG000|Overall Study|Disease Progression|0|||
94559093|NCT03704688|323842457|FG001|Overall Study|Disease Progression|0|||
94559094|NCT03704688|323842458|FG002|Overall Study|Disease Progression|0|||
94559095|NCT03704688|323842459|FG003|Overall Study|Disease Progression|3|||
94559096|NCT03704688|323842460|FG004|Overall Study|Disease Progression|1|||
94344984|NCT01474889|323042402|FG000|Overall Study|Withdrawal by Subject|0|||
94344985|NCT01474889|323042403|FG001|Overall Study|Withdrawal by Subject|1|||
94344986|NCT01474889|323042404|FG002|Overall Study|Withdrawal by Subject|0|||
94344987|NCT00112840|323042405|FG000|Overall Study|Physician Decision|1|||
94344988|NCT00112840|323042406|FG001|Overall Study|Physician Decision|0|||
94344989|NCT00112840|323042407|FG002|Overall Study|Physician Decision|0|||
94344990|NCT00112840|323042405|FG000|Overall Study|Withdrawal by Subject|1|||
94344991|NCT00112840|323042406|FG001|Overall Study|Withdrawal by Subject|0|||
94344992|NCT00112840|323042407|FG002|Overall Study|Withdrawal by Subject|1|||
94344993|NCT00112840|323042405|FG000|Overall Study|Protocol Violation|0|||
94344994|NCT00112840|323042406|FG001|Overall Study|Protocol Violation|0|||
94449109|NCT04630002|323432625|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
94449110|NCT04630002|323432626|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
94449111|NCT04630002|323432627|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
94449112|NCT04630002|323432625|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
94449113|NCT04630002|323432626|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
94449114|NCT04630002|323432627|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
94232844|NCT02386839|322646296|FG001|Overall Study|Other (unspecified)|0|||
94449115|NCT04630002|323432625|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
94449116|NCT04630002|323432626|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
94449117|NCT04630002|323432627|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
94232845|NCT04855734|322646298|FG000|Overall Study|Lost to Follow-up|2|||
94232846|NCT04855734|322646299|FG001|Overall Study|Lost to Follow-up|2|||
94232847|NCT06385483|322646300|FG000|Overall Study|Withdrawal by Subject|2|||
94232848|NCT06385483|322646300|FG000|Overall Study|Never start protocol therapy|2|||
94232849|NCT06385483|322646300|FG000|Overall Study|Disease progression|15|||
94232850|NCT04535544|322646301|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
94232851|NCT04535544|322646302|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
94232852|NCT04535544|322646303|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
94232853|NCT04535544|322646304|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
94232854|NCT04535544|322646301|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
94232855|NCT04535544|322646302|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
94232856|NCT04535544|322646303|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
94232857|NCT04535544|322646304|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
94344995|NCT00112840|323042407|FG002|Overall Study|Protocol Violation|5|||
94344996|NCT02299206|323042409|FG000|Overall Study|Lost to Follow-up|1|||
94344997|NCT02299206|323042409|FG000|Overall Study|Withdrawal by Subject|1|||
94344998|NCT05643170|323043862|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
94559097|NCT03704688|323842461|FG005|Overall Study|Disease Progression|0|||
94232858|NCT04535544|322646301|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
94232859|NCT04535544|322646302|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
94232860|NCT04535544|322646303|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
94344999|NCT05643170|323043862|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
94345000|NCT00740116|323043863|FG000|Overall Study|Withdrawal by Subject|1|||
94345001|NCT00740116|323043864|FG001|Overall Study|Withdrawal by Subject|1|||
94345002|NCT00740116|323043863|FG000|Overall Study|Protocol Violation|1|||
94345003|NCT00740116|323043864|FG001|Overall Study|Protocol Violation|4|||
94345004|NCT00121485|323043865|FG000|Overall Study|Not implanted|1|||
94345005|NCT00121485|323043866|FG001|Overall Study|Not implanted|5|||
94345006|NCT00121485|323043865|FG000|Overall Study|Crossover|0|||
94345007|NCT00121485|323043866|FG001|Overall Study|Crossover|2|||
94345008|NCT00669240|323043869|FG000|Overall Study|Lack of Efficacy|33|||
94345009|NCT00669240|323043869|FG000|Overall Study|Withdrawal by Subject|42|||
94345010|NCT00669240|323043869|FG000|Overall Study|Lost to Follow-up|34|||
94345011|NCT00669240|323043869|FG000|Overall Study|Adverse Event|21|||
94345012|NCT00669240|323043869|FG000|Overall Study|Other|19|||
94345013|NCT00669240|323043869|FG000|Overall Study|Enrolled but not treated|15|||
94345014|NCT00669240|323043869|FG000|Overall Study|Enrolled but no dosing record|1|||
94345015|NCT01673373|323043870|FG000|Overall Study|Death|2|||
94345016|NCT02583399|323043871|FG000|Overall Study|Able to be discharged|3|||
94345017|NCT02583399|323043871|FG000|Overall Study|Wanted to use a restricted medication|3|||
94345018|NCT00003389|323043872|FG000|Overall Study|Disease progression|6|||
94345019|NCT00003389|323043873|FG001|Overall Study|Disease progression|1|||
94345020|NCT00003389|323043872|FG000|Overall Study|Adverse Event|13|||
94345021|NCT00003389|323043873|FG001|Overall Study|Adverse Event|2|||
94345022|NCT00003389|323043872|FG000|Overall Study|Death|0|||
94345023|NCT00003389|323043873|FG001|Overall Study|Death|3|||
94345024|NCT00003389|323043872|FG000|Overall Study|Withdrawal by Subject|12|||
94345025|NCT00003389|323043873|FG001|Overall Study|Withdrawal by Subject|5|||
94345026|NCT00003389|323043872|FG000|Overall Study|Alternative therapy|2|||
94345027|NCT00003389|323043873|FG001|Overall Study|Alternative therapy|1|||
94345028|NCT00003389|323043872|FG000|Overall Study|Complicating disease|1|||
94345029|NCT00003389|323043873|FG001|Overall Study|Complicating disease|0|||
94345030|NCT00003389|323043872|FG000|Overall Study|Off-treatment reason missing|31|||
94345031|NCT00003389|323043873|FG001|Overall Study|Off-treatment reason missing|21|||
94345032|NCT00003389|323043872|FG000|Overall Study|Ineligible|33|||
94559098|NCT03704688|323842456|FG000|Overall Study|Death|0|||
94559099|NCT03704688|323842457|FG001|Overall Study|Death|0|||
94559100|NCT03704688|323842458|FG002|Overall Study|Death|0|||
94559101|NCT03704688|323842459|FG003|Overall Study|Death|0|||
94559102|NCT03704688|323842460|FG004|Overall Study|Death|3|||
94559103|NCT03704688|323842461|FG005|Overall Study|Death|0|||
94559104|NCT01957202|323842466|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
94559105|NCT01957202|323842467|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
94559106|NCT01957202|323842468|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
94559107|NCT01957202|323842469|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
94559108|NCT01957202|323842470|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
94559109|NCT01957202|323842471|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
94559110|NCT01957202|323842472|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
94559111|NCT01957202|323842473|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
94559112|NCT01957202|323842474|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
94559113|NCT01957202|323842475|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
94559114|NCT01957202|323842476|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
94559115|NCT01957202|323842477|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
94559116|NCT01957202|323842478|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
94559117|NCT01957202|323842479|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
94559118|NCT01957202|323842480|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
94559119|NCT01957202|323842481|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
94559120|NCT01957202|323842482|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
94559121|NCT01957202|323842483|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
94559122|NCT01957202|323842466|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
94559123|NCT01957202|323842467|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
94559124|NCT01957202|323842468|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
94559125|NCT01957202|323842469|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
94559126|NCT01957202|323842470|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
94559127|NCT01957202|323842471|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
94559128|NCT01957202|323842472|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
94559129|NCT01957202|323842473|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
94559130|NCT01957202|323842474|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
94559131|NCT01957202|323842475|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
94559132|NCT01957202|323842476|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
94559133|NCT01957202|323842477|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
94559134|NCT01957202|323842478|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
94559135|NCT01957202|323842479|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
94559136|NCT01957202|323842480|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
94559137|NCT01957202|323842481|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
94559138|NCT01957202|323842482|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
94559139|NCT01957202|323842483|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
94559140|NCT01369641|323842486|FG000|Overall Study|Withdrawal by Subject|1|||
94559141|NCT00195091|323842487|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
94559142|NCT02881762|323842488|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
94559143|NCT02881762|323842489|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
94559144|NCT00245037|323842490|FG000|Overall Study|Death|17|||
94559145|NCT02524158|323842491|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
94559146|NCT02524158|323842492|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
94559147|NCT02524158|323842491|FG000|12-weeks Assessment|Lost to Follow-up|18|||
94559148|NCT02524158|323842492|FG001|12-weeks Assessment|Lost to Follow-up|12|||
94559149|NCT02524158|323842491|FG000|6-month Assessment|Withdrawal by Subject|1|||
94559150|NCT02524158|323842492|FG001|6-month Assessment|Withdrawal by Subject|1|||
94559151|NCT02524158|323842491|FG000|6-month Assessment|Lost to Follow-up|21|||
94559152|NCT02524158|323842492|FG001|6-month Assessment|Lost to Follow-up|20|||
94559153|NCT01067144|323842496|FG000|Treatment|Did not receive allocated intervention|4|||
94559154|NCT01067144|323842497|FG001|Treatment|Did not receive allocated intervention|7|||
94559155|NCT01067144|323842496|FG000|Follow-up|Lost to Follow-up|22|||
94559156|NCT01067144|323842497|FG001|Follow-up|Lost to Follow-up|12|||
94559157|NCT01067144|323842496|FG000|Follow-up|Censored owing to second surgery|19|||
94559158|NCT01067144|323842497|FG001|Follow-up|Censored owing to second surgery|28|||
94559159|NCT01067144|323842496|FG000|Follow-up|Withdrawal by Subject|18|||
94559160|NCT01067144|323842497|FG001|Follow-up|Withdrawal by Subject|14|||
94559161|NCT01067144|323842496|FG000|Follow-up|Surgery cancelled|0|||
94559162|NCT01067144|323842497|FG001|Follow-up|Surgery cancelled|1|||
94559163|NCT01067144|323842496|FG000|Follow-up|Death|0|||
94559164|NCT01067144|323842497|FG001|Follow-up|Death|1|||
94559165|NCT00719355|323842523|FG000|Overall Study|Death|0|||
94559166|NCT00719355|323842524|FG001|Overall Study|Death|1|||
94559167|NCT00719355|323842523|FG000|Overall Study|Medical|14|||
94559168|NCT00719355|323842524|FG001|Overall Study|Medical|5|||
94559169|NCT00719355|323842523|FG000|Overall Study|Compliance|4|||
94559170|NCT00719355|323842524|FG001|Overall Study|Compliance|6|||
94559171|NCT00719355|323842523|FG000|Overall Study|Moved|0|||
94559172|NCT00719355|323842524|FG001|Overall Study|Moved|1|||
94559173|NCT02735343|323842525|FG000|Overall Study|screen fail|0|||
94559174|NCT02735343|323842526|FG001|Overall Study|screen fail|2|||
94559175|NCT04079816|323842527|FG000|Overall Study|Request of Subject|2|||
94559176|NCT04079816|323842527|FG000|Overall Study|Unable to draw samples|1|||
94559177|NCT04124705|323842528|FG000|Titration Period|Adverse Event|9|||
94559178|NCT04124705|323842529|FG001|Titration Period|Adverse Event|5|||
94559179|NCT04124705|323842528|FG000|Titration Period|Withdrawal by Subject|6|||
94559180|NCT04124705|323842529|FG001|Titration Period|Withdrawal by Subject|3|||
94559181|NCT04124705|323842528|FG000|Titration Period|Lost to Follow-up|0|||
94559182|NCT04124705|323842529|FG001|Titration Period|Lost to Follow-up|1|||
94559183|NCT04124705|323842528|FG000|Titration Period|Death|1|||
94559184|NCT04124705|323842529|FG001|Titration Period|Death|1|||
94559185|NCT04124705|323842528|FG000|Titration Period|Lack of Efficacy|2|||
94559186|NCT04124705|323842529|FG001|Titration Period|Lack of Efficacy|0|||
94559187|NCT04124705|323842528|FG000|Titration Period|Physician Decision|2|||
94559188|NCT04124705|323842529|FG001|Titration Period|Physician Decision|0|||
94559189|NCT04124705|323842528|FG000|Titration Period|Non-compliance with Study Drug|2|||
94559190|NCT04124705|323842529|FG001|Titration Period|Non-compliance with Study Drug|0|||
94559191|NCT04124705|323842528|FG000|Titration Period|Other|4|||
94559192|NCT04124705|323842529|FG001|Titration Period|Other|9|||
94559193|NCT04124705|323842528|FG000|Stabilization Period|Adverse Event|4|||
94559194|NCT04124705|323842529|FG001|Stabilization Period|Adverse Event|2|||
94559195|NCT04124705|323842528|FG000|Stabilization Period|Withdrawal by Subject|1|||
94559196|NCT04124705|323842529|FG001|Stabilization Period|Withdrawal by Subject|1|||
94559197|NCT04124705|323842528|FG000|Stabilization Period|Lost to Follow-up|0|||
94559198|NCT04124705|323842529|FG001|Stabilization Period|Lost to Follow-up|1|||
94559199|NCT04124705|323842528|FG000|Stabilization Period|Lack of Efficacy|4|||
94559200|NCT04124705|323842529|FG001|Stabilization Period|Lack of Efficacy|2|||
94559201|NCT04124705|323842528|FG000|Stabilization Period|Protocol Deviation|0|||
94232861|NCT04535544|322646304|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
94232862|NCT04535544|322646301|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
94232863|NCT04535544|322646302|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
94232864|NCT04535544|322646303|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
94232865|NCT04535544|322646304|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
94232866|NCT04535544|322646301|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
94232867|NCT04535544|322646302|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
94232868|NCT04535544|322646303|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
94345033|NCT00003389|323043873|FG001|Overall Study|Ineligible|27|||
94345034|NCT02554721|323043874|FG000|Overall Study|Adverse Event|1|||
94345035|NCT02554721|323043875|FG001|Overall Study|Adverse Event|0|||
94345036|NCT02554721|323043876|FG002|Overall Study|Adverse Event|0|||
94345037|NCT02554721|323043877|FG003|Overall Study|Adverse Event|0|||
94345038|NCT02554721|323043878|FG004|Overall Study|Adverse Event|1|||
94345039|NCT02554721|323043874|FG000|Overall Study|Noncompliance|0|||
94345040|NCT02554721|323043875|FG001|Overall Study|Noncompliance|0|||
94345041|NCT02554721|323043876|FG002|Overall Study|Noncompliance|0|||
94345042|NCT02554721|323043877|FG003|Overall Study|Noncompliance|0|||
94345043|NCT02554721|323043878|FG004|Overall Study|Noncompliance|1|||
94345044|NCT01888965|323043880|FG000|Overall Study|Adverse Event|5|||
94345045|NCT01888965|323043880|FG000|Overall Study|Lack of Efficacy|4|||
94345046|NCT04610827|323043881|FG000|Overall Study|Withdrawal by Subject|1|||
94345047|NCT04610827|323043882|FG001|Overall Study|Withdrawal by Subject|1|||
94345048|NCT04610827|323043883|FG002|Overall Study|Withdrawal by Subject|0|||
94345049|NCT00366444|323043885|FG000|Overall Study|Withdrawal by Subject|1|||
94345050|NCT00366444|323043886|FG001|Overall Study|Withdrawal by Subject|1|||
94345051|NCT00366444|323043885|FG000|Overall Study|Lack of Efficacy|0|||
94345052|NCT00366444|323043886|FG001|Overall Study|Lack of Efficacy|1|||
94345053|NCT03225833|323043889|FG000|Overall Study|Adverse Event|0|||
94345054|NCT03225833|323043890|FG001|Overall Study|Adverse Event|1|||
94345055|NCT03225833|323043891|FG002|Overall Study|Adverse Event|2|||
94345056|NCT03225833|323043892|FG003|Overall Study|Adverse Event|0|||
94345057|NCT03225833|323043893|FG004|Overall Study|Adverse Event|0|||
94345058|NCT03225833|323043894|FG005|Overall Study|Adverse Event|2|||
94345059|NCT03225833|323043889|FG000|Overall Study|Withdrawal by Subject|1|||
94345060|NCT03225833|323043890|FG001|Overall Study|Withdrawal by Subject|0|||
94345061|NCT03225833|323043891|FG002|Overall Study|Withdrawal by Subject|0|||
94345062|NCT03225833|323043892|FG003|Overall Study|Withdrawal by Subject|0|||
94345063|NCT03225833|323043893|FG004|Overall Study|Withdrawal by Subject|1|||
94345064|NCT03225833|323043894|FG005|Overall Study|Withdrawal by Subject|0|||
94345065|NCT03225833|323043889|FG000|Overall Study|Termination of Study by Sponsor|4|||
94345066|NCT03225833|323043890|FG001|Overall Study|Termination of Study by Sponsor|0|||
94345067|NCT03225833|323043891|FG002|Overall Study|Termination of Study by Sponsor|0|||
94345068|NCT03225833|323043892|FG003|Overall Study|Termination of Study by Sponsor|0|||
94345069|NCT03225833|323043893|FG004|Overall Study|Termination of Study by Sponsor|0|||
94345070|NCT03225833|323043894|FG005|Overall Study|Termination of Study by Sponsor|7|||
94345071|NCT03225833|323043889|FG000|Overall Study|Sponsor Decision|0|||
94345072|NCT03225833|323043890|FG001|Overall Study|Sponsor Decision|0|||
94345073|NCT03225833|323043891|FG002|Overall Study|Sponsor Decision|0|||
94345074|NCT03225833|323043892|FG003|Overall Study|Sponsor Decision|0|||
94345075|NCT03225833|323043893|FG004|Overall Study|Sponsor Decision|0|||
94345076|NCT03225833|323043894|FG005|Overall Study|Sponsor Decision|1|||
94345077|NCT00672139|323043895|FG000|Overall Study|Death|14|||
94345078|NCT00672139|323043896|FG001|Overall Study|Death|23|||
94345079|NCT00672139|323043895|FG000|Overall Study|Withdrawal by Subject|2|||
94345080|NCT00672139|323043896|FG001|Overall Study|Withdrawal by Subject|11|||
94345081|NCT00672139|323043895|FG000|Overall Study|Adverse Event|4|||
94345082|NCT00672139|323043896|FG001|Overall Study|Adverse Event|7|||
94345083|NCT00672139|323043895|FG000|Overall Study|Physician Decision|2|||
94345084|NCT00672139|323043896|FG001|Overall Study|Physician Decision|0|||
94345085|NCT00672139|323043895|FG000|Overall Study|Lack of Efficacy|4|||
94345086|NCT00672139|323043896|FG001|Overall Study|Lack of Efficacy|1|||
94345087|NCT00672139|323043895|FG000|Overall Study|Protocol Violation|1|||
94345088|NCT00672139|323043896|FG001|Overall Study|Protocol Violation|1|||
94345089|NCT00672139|323043895|FG000|Overall Study|hospice discharge, caregiver requests|3|||
94559202|NCT04124705|323842529|FG001|Stabilization Period|Protocol Deviation|2|||
94559203|NCT04124705|323842528|FG000|Stabilization Period|Other|2|||
94559204|NCT04124705|323842529|FG001|Stabilization Period|Other|2|||
94559205|NCT01973998|323842530|FG000|Overall Study|Death|2|||
94559206|NCT01973998|323842531|FG001|Overall Study|Death|2|||
94559207|NCT04869358|323842532|FG000|Overall Study|Wish to have children.|1|||
94559208|NCT04869358|323842533|FG001|Overall Study|Wish to have children.|0|||
94559209|NCT04869358|323842534|FG002|Overall Study|Wish to have children.|0|||
94559210|NCT04869358|323842535|FG003|Overall Study|Wish to have children.|0|||
94559211|NCT04164732|323842536|FG000|Treatment run-in Period|Adverse Event|4|||
94559212|NCT04164732|323842537|FG001|Treatment run-in Period|Adverse Event|0|||
94559213|NCT04164732|323842538|FG002|Treatment run-in Period|Adverse Event|0|||
94559214|NCT04164732|323842536|FG000|Treatment run-in Period|Physician Decision|1|||
94559215|NCT04164732|323842537|FG001|Treatment run-in Period|Physician Decision|0|||
94559216|NCT04164732|323842538|FG002|Treatment run-in Period|Physician Decision|0|||
94559217|NCT04164732|323842536|FG000|Treatment run-in Period|Screen Failure|1|||
94559218|NCT04164732|323842537|FG001|Treatment run-in Period|Screen Failure|0|||
94559219|NCT04164732|323842538|FG002|Treatment run-in Period|Screen Failure|0|||
94559220|NCT04164732|323842536|FG000|Randomized Treatment Period|Adverse Event|0|||
94559221|NCT04164732|323842537|FG001|Randomized Treatment Period|Adverse Event|1|||
94559222|NCT04164732|323842538|FG002|Randomized Treatment Period|Adverse Event|0|||
94559223|NCT04164732|323842536|FG000|Randomized Treatment Period|Protocol Deviation|0|||
94559224|NCT04164732|323842537|FG001|Randomized Treatment Period|Protocol Deviation|1|||
94559225|NCT04164732|323842538|FG002|Randomized Treatment Period|Protocol Deviation|1|||
94559226|NCT04164732|323842536|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
94559227|NCT04164732|323842537|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
94559228|NCT04164732|323842538|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
94559229|NCT03144674|323842551|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
94559230|NCT03144674|323842552|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
94559231|NCT03144674|323842553|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
94559232|NCT03144674|323842554|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
94559233|NCT03144674|323842551|FG000|Overall Study|Death|3|||
94559234|NCT03144674|323842552|FG001|Overall Study|Death|2|||
94559235|NCT03144674|323842553|FG002|Overall Study|Death|6|||
94559236|NCT03144674|323842554|FG003|Overall Study|Death|24|||
94559237|NCT03144674|323842551|FG000|Overall Study|Lost to Follow-up|0|||
94559238|NCT03144674|323842552|FG001|Overall Study|Lost to Follow-up|1|||
94559239|NCT03144674|323842553|FG002|Overall Study|Lost to Follow-up|0|||
94559240|NCT03144674|323842554|FG003|Overall Study|Lost to Follow-up|4|||
94559241|NCT03144674|323842551|FG000|Overall Study|Withdrawal by Participant|0|||
94559242|NCT03144674|323842552|FG001|Overall Study|Withdrawal by Participant|0|||
94559243|NCT03144674|323842553|FG002|Overall Study|Withdrawal by Participant|2|||
94559244|NCT03144674|323842554|FG003|Overall Study|Withdrawal by Participant|6|||
94559245|NCT03144674|323842551|FG000|Overall Study|Discharged from the Trust|0|||
94559246|NCT03144674|323842552|FG001|Overall Study|Discharged from the Trust|0|||
94559247|NCT03144674|323842553|FG002|Overall Study|Discharged from the Trust|1|||
94559248|NCT03144674|323842554|FG003|Overall Study|Discharged from the Trust|0|||
94559249|NCT03144674|323842551|FG000|Overall Study|Exclusion Criteria Met|0|||
94559250|NCT03144674|323842552|FG001|Overall Study|Exclusion Criteria Met|0|||
94559251|NCT03144674|323842553|FG002|Overall Study|Exclusion Criteria Met|1|||
94559252|NCT03144674|323842554|FG003|Overall Study|Exclusion Criteria Met|0|||
94559253|NCT03144674|323842551|FG000|Overall Study|Changed Physicians|0|||
94559254|NCT03144674|323842552|FG001|Overall Study|Changed Physicians|0|||
94559255|NCT03144674|323842553|FG002|Overall Study|Changed Physicians|0|||
94559256|NCT03144674|323842554|FG003|Overall Study|Changed Physicians|1|||
94559257|NCT03144674|323842551|FG000|Overall Study|Removed for Safety|0|||
94559258|NCT03144674|323842552|FG001|Overall Study|Removed for Safety|0|||
94345090|NCT00672139|323043896|FG001|Overall Study|hospice discharge, caregiver requests|2|||
94345091|NCT03233308|323043897|FG000|Overall Study|Adverse Event|1|||
94345092|NCT03233308|323043897|FG000|Overall Study|Protocol Violation|1|||
94559259|NCT03144674|323842553|FG002|Overall Study|Removed for Safety|0|||
94559260|NCT03144674|323842554|FG003|Overall Study|Removed for Safety|1|||
94559261|NCT03144674|323842551|FG000|Overall Study|Site Closed|0|||
94559262|NCT03144674|323842552|FG001|Overall Study|Site Closed|0|||
94559263|NCT03144674|323842553|FG002|Overall Study|Site Closed|0|||
94345093|NCT01023516|323043898|FG000|Overall Study|Voluntary discontinuation|7|||
94559264|NCT03144674|323842554|FG003|Overall Study|Site Closed|1|||
94559265|NCT03144674|323842551|FG000|Overall Study|Histological Criteria Not Met|0|||
94559266|NCT03144674|323842552|FG001|Overall Study|Histological Criteria Not Met|0|||
94559267|NCT03144674|323842553|FG002|Overall Study|Histological Criteria Not Met|0|||
94559268|NCT03144674|323842554|FG003|Overall Study|Histological Criteria Not Met|1|||
94559269|NCT03144674|323842551|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
94559270|NCT03144674|323842552|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
94559271|NCT03144674|323842553|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
94559272|NCT03144674|323842554|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
94559273|NCT03144674|323842551|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
94232869|NCT04535544|322646304|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
94232870|NCT04535544|322646301|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
94232871|NCT04535544|322646302|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
94232872|NCT04535544|322646303|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
94232873|NCT04535544|322646304|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
94232874|NCT04535544|322646301|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
94232875|NCT04535544|322646302|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
94232876|NCT04535544|322646303|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
94232877|NCT04535544|322646304|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
94232878|NCT04535544|322646301|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
94232879|NCT04535544|322646302|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
94232880|NCT04535544|322646303|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
94232881|NCT04535544|322646304|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
94232882|NCT01124838|322646309|FG000|Overall Study|Miscellaneous|4|||
94232883|NCT01124838|322646310|FG001|Overall Study|Miscellaneous|2|||
94232884|NCT01124838|322646309|FG000|Overall Study|Adverse Event|7|||
94232885|NCT01124838|322646310|FG001|Overall Study|Adverse Event|11|||
94232886|NCT01124838|322646309|FG000|Overall Study|Lack of Efficacy|2|||
94232887|NCT01124838|322646310|FG001|Overall Study|Lack of Efficacy|0|||
94345094|NCT01023516|323043899|FG001|Overall Study|Voluntary discontinuation|5|||
94345095|NCT01023516|323043898|FG000|Overall Study|Adverse Event|9|||
94232888|NCT01124838|322646309|FG000|Overall Study|Withdrawal by Subject|3|||
94232889|NCT01124838|322646310|FG001|Overall Study|Withdrawal by Subject|2|||
94232890|NCT01124838|322646309|FG000|Overall Study|Lost to Follow-up|2|||
94232891|NCT01124838|322646310|FG001|Overall Study|Lost to Follow-up|0|||
94232892|NCT03733899|322646311|FG000|Period 1|Protocol Violation|0|||
94559274|NCT03144674|323842552|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
94559275|NCT03144674|323842553|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
94559276|NCT03144674|323842554|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
94559277|NCT00145574|323842558|FG000|Double Blind|Adverse Event|0|||
94559278|NCT00145574|323842559|FG001|Double Blind|Adverse Event|3|||
94559279|NCT00145574|323842560|FG002|Double Blind|Adverse Event|1|||
94559280|NCT00145574|323842558|FG000|Double Blind|Withdrawal by Subject|1|||
94559281|NCT00145574|323842559|FG001|Double Blind|Withdrawal by Subject|1|||
94559282|NCT00145574|323842560|FG002|Double Blind|Withdrawal by Subject|1|||
94559283|NCT00145574|323842558|FG000|Double Blind|required restricted medicine|0|||
94559284|NCT00145574|323842559|FG001|Double Blind|required restricted medicine|1|||
94559285|NCT00145574|323842560|FG002|Double Blind|required restricted medicine|0|||
94559286|NCT00145574|323842558|FG000|Open Label Long-term Extension|Adverse Event|0|||
94559287|NCT00145574|323842559|FG001|Open Label Long-term Extension|Adverse Event|0|||
94559288|NCT00145574|323842560|FG002|Open Label Long-term Extension|Adverse Event|5|||
94559289|NCT00145574|323842558|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
94559290|NCT00145574|323842559|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
94559291|NCT00145574|323842560|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
94559292|NCT00145574|323842558|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
94559293|NCT00145574|323842559|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
94559294|NCT00145574|323842560|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
94559295|NCT00145574|323842558|FG000|Open Label Long-term Extension|required restricted medicine|0|||
94559296|NCT00145574|323842559|FG001|Open Label Long-term Extension|required restricted medicine|0|||
94559297|NCT00145574|323842560|FG002|Open Label Long-term Extension|required restricted medicine|1|||
94559298|NCT01298765|323842561|FG000|Titration Period|Adverse Event|26|||
94559299|NCT01298765|323842561|FG000|Titration Period|Death|1|||
94559300|NCT01298765|323842561|FG000|Titration Period|Lack of Efficacy|21|||
94559301|NCT01298765|323842561|FG000|Titration Period|Lost to Follow-up|9|||
94559302|NCT01298765|323842561|FG000|Titration Period|Physician Decision|1|||
94559303|NCT01298765|323842561|FG000|Titration Period|Withdrawal by Subject|10|||
94559304|NCT01298765|323842561|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
94559305|NCT01298765|323842561|FG000|Long-Term Treatment Period|Adverse Event|19|||
94559306|NCT01298765|323842561|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
94559307|NCT01298765|323842561|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
94559308|NCT01298765|323842561|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
94559309|NCT01298765|323842561|FG000|Long-Term Treatment Period|Physician Decision|1|||
94559310|NCT01298765|323842561|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
94559311|NCT01771250|323842562|FG000|Period 1|Met exclusion criteria|1|||
94559312|NCT01771250|323842563|FG001|Period 1|Met exclusion criteria|0|||
94559313|NCT01180296|323842564|FG000|Overall Study|Protocol Violation|1|||
94559314|NCT01180296|323842565|FG001|Overall Study|Protocol Violation|2|||
94559315|NCT03364309|323842566|FG000|Induction Period|Adverse Event|4|||
94559316|NCT03364309|323842567|FG001|Induction Period|Adverse Event|0|||
94559317|NCT03364309|323842568|FG002|Induction Period|Adverse Event|1|||
94559318|NCT03364309|323842569|FG003|Induction Period|Adverse Event|0|||
94559319|NCT03364309|323842570|FG004|Induction Period|Adverse Event|0|||
94559320|NCT03364309|323842571|FG005|Induction Period|Adverse Event|0|||
94559321|NCT03364309|323842572|FG006|Induction Period|Adverse Event|0|||
94559322|NCT03364309|323842573|FG007|Induction Period|Adverse Event|0|||
94559323|NCT03364309|323842574|FG008|Induction Period|Adverse Event|0|||
94559324|NCT03364309|323842575|FG009|Induction Period|Adverse Event|0|||
94559325|NCT03364309|323842576|FG010|Induction Period|Adverse Event|0|||
94559326|NCT03364309|323842577|FG011|Induction Period|Adverse Event|0|||
94559327|NCT03364309|323842578|FG012|Induction Period|Adverse Event|0|||
94559328|NCT03364309|323842579|FG013|Induction Period|Adverse Event|0|||
94559329|NCT03364309|323842580|FG014|Induction Period|Adverse Event|0|||
94559330|NCT03364309|323842581|FG015|Induction Period|Adverse Event|0|||
94559331|NCT03364309|323842582|FG016|Induction Period|Adverse Event|0|||
94559332|NCT03364309|323842583|FG017|Induction Period|Adverse Event|0|||
94559333|NCT03364309|323842584|FG018|Induction Period|Adverse Event|0|||
94559334|NCT03364309|323842566|FG000|Induction Period|Withdrawal by Subject|1|||
94559335|NCT03364309|323842567|FG001|Induction Period|Withdrawal by Subject|3|||
94559336|NCT03364309|323842568|FG002|Induction Period|Withdrawal by Subject|0|||
94559337|NCT03364309|323842569|FG003|Induction Period|Withdrawal by Subject|0|||
94559338|NCT03364309|323842570|FG004|Induction Period|Withdrawal by Subject|0|||
94559339|NCT03364309|323842571|FG005|Induction Period|Withdrawal by Subject|0|||
94559340|NCT03364309|323842572|FG006|Induction Period|Withdrawal by Subject|0|||
94345096|NCT01023516|323043899|FG001|Overall Study|Adverse Event|6|||
94345097|NCT01023516|323043898|FG000|Overall Study|Safety reason|0|||
94559341|NCT03364309|323842573|FG007|Induction Period|Withdrawal by Subject|0|||
94559342|NCT03364309|323842574|FG008|Induction Period|Withdrawal by Subject|0|||
94449118|NCT04630002|323432625|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
94449119|NCT04630002|323432626|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
94449120|NCT04630002|323432627|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
94449121|NCT04630002|323432625|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
94449122|NCT04630002|323432626|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
94449123|NCT04630002|323432627|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
94449124|NCT04630002|323432625|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
94449125|NCT04630002|323432626|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
94449126|NCT04630002|323432627|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
94449127|NCT02182843|323432628|FG000|Overall Study|Withdrawal by Subject|7|||
94449128|NCT02182843|323432628|FG000|Overall Study|Lost to Follow-up|2|||
94449129|NCT02182843|323432628|FG000|Overall Study|Adverse Event|1|||
94449130|NCT01051791|323432630|FG000|Overall Study|Failed screening|3|||
94449131|NCT01051791|323432630|FG000|Overall Study|Withdrawal by Subject|1|||
94449132|NCT00320710|323432637|FG000|Overall Study|Disease progression|24|||
94449133|NCT00320710|323432638|FG001|Overall Study|Disease progression|19|||
94449134|NCT00320710|323432639|FG002|Overall Study|Disease progression|2|||
94449135|NCT00320710|323432637|FG000|Overall Study|Death|10|||
94449136|NCT00320710|323432638|FG001|Overall Study|Death|7|||
94449137|NCT00320710|323432639|FG002|Overall Study|Death|1|||
94449138|NCT00320710|323432637|FG000|Overall Study|Administrative problems|1|||
94449139|NCT00320710|323432638|FG001|Overall Study|Administrative problems|2|||
94449140|NCT00320710|323432639|FG002|Overall Study|Administrative problems|0|||
94449141|NCT00320710|323432637|FG000|Overall Study|Withdrawal by Subject|20|||
94449142|NCT00320710|323432638|FG001|Overall Study|Withdrawal by Subject|26|||
94449143|NCT00320710|323432639|FG002|Overall Study|Withdrawal by Subject|1|||
94449144|NCT00320710|323432637|FG000|Overall Study|Protocol Violation|6|||
94449145|NCT00320710|323432638|FG001|Overall Study|Protocol Violation|5|||
94449146|NCT00320710|323432639|FG002|Overall Study|Protocol Violation|0|||
94449147|NCT00320710|323432637|FG000|Overall Study|Abnormal test procedure result(s)|2|||
94449148|NCT00320710|323432638|FG001|Overall Study|Abnormal test procedure result(s)|0|||
94449149|NCT00320710|323432639|FG002|Overall Study|Abnormal test procedure result(s)|0|||
94449150|NCT00320710|323432637|FG000|Overall Study|Abnormal laboratory value(s)|12|||
94449151|NCT00320710|323432638|FG001|Overall Study|Abnormal laboratory value(s)|3|||
94449152|NCT00320710|323432639|FG002|Overall Study|Abnormal laboratory value(s)|0|||
94449153|NCT00320710|323432637|FG000|Overall Study|Adverse Event|18|||
94449154|NCT00320710|323432638|FG001|Overall Study|Adverse Event|14|||
94449155|NCT00320710|323432639|FG002|Overall Study|Adverse Event|1|||
94449156|NCT00320710|323432637|FG000|Overall Study|Lost to Follow-up|1|||
94449157|NCT00320710|323432638|FG001|Overall Study|Lost to Follow-up|0|||
94449158|NCT00320710|323432639|FG002|Overall Study|Lost to Follow-up|0|||
94449159|NCT03448419|323432640|FG000|Overall Study|Adverse Event|10|||
94449160|NCT03448419|323432641|FG001|Overall Study|Adverse Event|9|||
94449161|NCT03448419|323432640|FG000|Overall Study|Lost to Follow-up|0|||
94449162|NCT03448419|323432641|FG001|Overall Study|Lost to Follow-up|2|||
94449163|NCT03448419|323432640|FG000|Overall Study|Withdrawal by Subject|3|||
94449164|NCT03448419|323432641|FG001|Overall Study|Withdrawal by Subject|1|||
94449165|NCT03448419|323432640|FG000|Overall Study|Not treated|0|||
94449166|NCT03448419|323432641|FG001|Overall Study|Not treated|1|||
94449167|NCT03448419|323432640|FG000|Overall Study|Patient did not attend all visits|0|||
94449168|NCT03448419|323432641|FG001|Overall Study|Patient did not attend all visits|2|||
94449169|NCT03448419|323432640|FG000|Overall Study|Withdrawn by Sponsor|0|||
94449170|NCT03448419|323432641|FG001|Overall Study|Withdrawn by Sponsor|1|||
94465748|NCT00195494|323494915|FG001|Year 1|Lack of Efficacy|0|||
94559343|NCT03364309|323842575|FG009|Induction Period|Withdrawal by Subject|0|||
94559344|NCT03364309|323842576|FG010|Induction Period|Withdrawal by Subject|0|||
94559345|NCT03364309|323842577|FG011|Induction Period|Withdrawal by Subject|0|||
94449171|NCT00506415|323432642|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
94449172|NCT00506415|323432643|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
94449173|NCT00506415|323432644|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
94449174|NCT00506415|323432645|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
94449175|NCT00506415|323432642|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
94449176|NCT00506415|323432643|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
94449177|NCT00506415|323432644|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
94449178|NCT00506415|323432645|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
94449179|NCT00506415|323432642|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
94449180|NCT00506415|323432643|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
94449181|NCT00506415|323432644|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
94449182|NCT00506415|323432645|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
94449183|NCT00506415|323432642|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
94449184|NCT00506415|323432643|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
94449185|NCT00506415|323432644|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
94449186|NCT00506415|323432645|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
94449187|NCT00506415|323432642|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
94449188|NCT00506415|323432643|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
94449189|NCT00506415|323432644|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
94449190|NCT00506415|323432645|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
94449191|NCT00506415|323432642|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
94449192|NCT00506415|323432643|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
94449193|NCT00506415|323432644|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
94559346|NCT03364309|323842578|FG012|Induction Period|Withdrawal by Subject|0|||
94559347|NCT03364309|323842579|FG013|Induction Period|Withdrawal by Subject|0|||
94559348|NCT03364309|323842580|FG014|Induction Period|Withdrawal by Subject|0|||
94345098|NCT01023516|323043899|FG001|Overall Study|Safety reason|3|||
94345099|NCT01023516|323043898|FG000|Overall Study|Study-specific criteria|4|||
94345100|NCT01023516|323043899|FG001|Overall Study|Study-specific criteria|2|||
94345101|NCT01023516|323043898|FG000|Overall Study|Incorrect enrolment|4|||
94345102|NCT01023516|323043899|FG001|Overall Study|Incorrect enrolment|2|||
94345103|NCT00137267|323043900|FG000|Overall Study|Lost to Follow-up|15|||
94345104|NCT00137267|323043901|FG001|Overall Study|Lost to Follow-up|21|||
94345105|NCT03696576|323043902|FG000|Overall Study|Soreness of throat after therapy|1|||
94345106|NCT03696576|323043903|FG001|Overall Study|Soreness of throat after therapy|1|||
94345107|NCT03696576|323043902|FG000|Overall Study|Lost to Follow-up|2|||
94345108|NCT03696576|323043903|FG001|Overall Study|Lost to Follow-up|4|||
94345109|NCT03077711|323043904|FG000|Overall Study|Lost to Follow-up|2|||
94345110|NCT03077711|323043905|FG001|Overall Study|Lost to Follow-up|2|||
94345111|NCT03077711|323043904|FG000|Overall Study|noncompliant taking medication|2|||
94345112|NCT03077711|323043905|FG001|Overall Study|noncompliant taking medication|0|||
94345113|NCT01602744|323043906|FG000|Overall Study|Death|17|||
94559349|NCT03364309|323842581|FG015|Induction Period|Withdrawal by Subject|0|||
94559350|NCT03364309|323842582|FG016|Induction Period|Withdrawal by Subject|0|||
94559351|NCT03364309|323842583|FG017|Induction Period|Withdrawal by Subject|0|||
94559352|NCT03364309|323842584|FG018|Induction Period|Withdrawal by Subject|0|||
94559353|NCT03364309|323842566|FG000|Induction Period|Lost to Follow-up|1|||
94559354|NCT03364309|323842567|FG001|Induction Period|Lost to Follow-up|0|||
94559355|NCT03364309|323842568|FG002|Induction Period|Lost to Follow-up|0|||
94559356|NCT03364309|323842569|FG003|Induction Period|Lost to Follow-up|0|||
94559357|NCT03364309|323842570|FG004|Induction Period|Lost to Follow-up|0|||
94559358|NCT03364309|323842571|FG005|Induction Period|Lost to Follow-up|0|||
94559359|NCT03364309|323842572|FG006|Induction Period|Lost to Follow-up|0|||
94559360|NCT03364309|323842573|FG007|Induction Period|Lost to Follow-up|0|||
94657592|NCT01075321|324204327|FG001|Overall Study|Withdrawal by Subject|0|||
94657593|NCT01075321|324204328|FG002|Overall Study|Withdrawal by Subject|1|||
94657594|NCT01075321|324204329|FG003|Overall Study|Withdrawal by Subject|1|||
94657595|NCT01075321|324204326|FG000|Overall Study|Protocol Violation|0|||
94657596|NCT01075321|324204327|FG001|Overall Study|Protocol Violation|0|||
94657597|NCT01075321|324204328|FG002|Overall Study|Protocol Violation|1|||
94559361|NCT03364309|323842574|FG008|Induction Period|Lost to Follow-up|0|||
94657598|NCT01075321|324204329|FG003|Overall Study|Protocol Violation|0|||
94657599|NCT01075321|324204326|FG000|Overall Study|Treatment Incomplete due to progression|1|||
94657600|NCT01075321|324204327|FG001|Overall Study|Treatment Incomplete due to progression|0|||
94657601|NCT01075321|324204328|FG002|Overall Study|Treatment Incomplete due to progression|0|||
94657602|NCT01075321|324204329|FG003|Overall Study|Treatment Incomplete due to progression|0|||
94449194|NCT00506415|323432645|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
94449195|NCT00506415|323432642|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
94449196|NCT00506415|323432643|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
94449197|NCT00506415|323432644|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
94449198|NCT00506415|323432645|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
94449199|NCT00506415|323432642|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
94449200|NCT00506415|323432643|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
94449201|NCT00506415|323432644|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
94449202|NCT00506415|323432645|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
94449203|NCT00506415|323432642|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
94449204|NCT00506415|323432643|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
94449205|NCT00506415|323432644|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
94449206|NCT00506415|323432645|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
94449207|NCT00506415|323432642|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
94449208|NCT00506415|323432643|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
94449209|NCT00506415|323432644|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
94449210|NCT00506415|323432645|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
94449211|NCT00506415|323432642|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
94449212|NCT00506415|323432643|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
94449213|NCT00506415|323432644|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
94449214|NCT00506415|323432645|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
94449215|NCT00506415|323432642|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
94657603|NCT01075321|324204326|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
94657604|NCT01075321|324204327|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
94657605|NCT01075321|324204328|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
94657606|NCT01075321|324204329|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
94449216|NCT00506415|323432643|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
94449217|NCT00506415|323432644|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
94449218|NCT00506415|323432645|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
94449219|NCT00506415|323432642|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
94465749|NCT00195494|323494916|FG002|Year 1|Lack of Efficacy|0|||
94657607|NCT00262834|324204330|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
94449220|NCT00506415|323432643|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
94449221|NCT00506415|323432644|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
94449222|NCT00506415|323432645|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
94449223|NCT00506415|323432642|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
94449224|NCT00506415|323432643|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
94449225|NCT00506415|323432644|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
94449226|NCT00506415|323432645|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
94449227|NCT00506415|323432642|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
94449228|NCT00506415|323432643|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
94449229|NCT00506415|323432644|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
94449230|NCT00506415|323432645|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
94449231|NCT00506415|323432642|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
94449232|NCT00506415|323432643|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
94449233|NCT00506415|323432644|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
94449234|NCT00506415|323432645|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
94449235|NCT00506415|323432642|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
94449236|NCT00506415|323432643|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
94449237|NCT00506415|323432644|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
94449238|NCT00506415|323432645|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
94449239|NCT00506415|323432642|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
94449240|NCT00506415|323432643|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
94465750|NCT00195494|323494917|FG003|Year 1|Lack of Efficacy|0|||
94465751|NCT00195494|323494918|FG004|Year 1|Lack of Efficacy|24|||
94465752|NCT00195494|323494919|FG005|Year 1|Lack of Efficacy|9|||
94465753|NCT00195494|323494914|FG000|Year 1|Compliance|0|||
94465754|NCT00195494|323494915|FG001|Year 1|Compliance|0|||
94345114|NCT01602744|323043907|FG001|Overall Study|Death|15|||
94345115|NCT01602744|323043906|FG000|Overall Study|Lost to Follow-up|13|||
94345116|NCT01602744|323043907|FG001|Overall Study|Lost to Follow-up|8|||
94345117|NCT02120469|323043909|FG000|Overall Study|HER-2/neu-amplified|1|||
94345118|NCT02120469|323043910|FG001|Overall Study|HER-2/neu-amplified|0|||
94345119|NCT02120469|323043911|FG002|Overall Study|HER-2/neu-amplified|1|||
94345120|NCT00126425|323043915|FG000|Overall Study|Withdrawal by Subject|17|||
94345121|NCT00126425|323043916|FG001|Overall Study|Withdrawal by Subject|1|||
94559362|NCT03364309|323842575|FG009|Induction Period|Lost to Follow-up|0|||
94559363|NCT03364309|323842576|FG010|Induction Period|Lost to Follow-up|0|||
94559364|NCT03364309|323842577|FG011|Induction Period|Lost to Follow-up|0|||
94449241|NCT00506415|323432644|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
94449242|NCT00506415|323432645|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
94449243|NCT00506415|323432642|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
94449244|NCT00506415|323432643|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
94449245|NCT00506415|323432644|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
94449246|NCT00506415|323432645|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
94449247|NCT00506415|323432642|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
94449248|NCT00506415|323432643|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
94449249|NCT00506415|323432644|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
94449250|NCT00506415|323432645|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
94449251|NCT00506415|323432642|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
94449252|NCT00506415|323432643|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
94449253|NCT00506415|323432644|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
94449254|NCT00506415|323432645|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
94449255|NCT00506415|323432642|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
94449256|NCT00506415|323432643|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
94449257|NCT00506415|323432644|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
94449258|NCT00506415|323432645|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
94449259|NCT00506415|323432642|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
94449260|NCT00506415|323432643|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
94449261|NCT00506415|323432644|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
94449262|NCT00506415|323432645|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
94449263|NCT00506415|323432642|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
94449264|NCT00506415|323432643|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
94449265|NCT00506415|323432644|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
94449266|NCT00506415|323432645|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
94449267|NCT01954056|323432646|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
94449268|NCT01954056|323432647|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
94449269|NCT00832455|323432648|FG000|Overall Study|Adverse Event|13|||
94449270|NCT00832455|323432648|FG000|Overall Study|Lost to Follow-up|26|||
94449271|NCT00832455|323432648|FG000|Overall Study|Protocol Violation|4|||
94449272|NCT00832455|323432648|FG000|Overall Study|Withdrawal by Subject|17|||
94449273|NCT00832455|323432648|FG000|Overall Study|Screening Failure|2|||
94449274|NCT00832455|323432648|FG000|Overall Study|Stopped Medication|4|||
94449275|NCT00832455|323432648|FG000|Overall Study|Parent misunderstood study|1|||
94449276|NCT00832455|323432648|FG000|Overall Study|Parent dissatisfied|1|||
94449277|NCT00832455|323432648|FG000|Overall Study|No improvement|3|||
94449278|NCT00832455|323432648|FG000|Overall Study|Patient moved|1|||
94449279|NCT04090060|323432649|FG000|Overall Study|Lost to Follow-up|76|||
94449280|NCT04090060|323432650|FG001|Overall Study|Lost to Follow-up|77|||
94449281|NCT01575834|323432652|FG000|Overall Study|Withdrawal by Subject|352|||
94559365|NCT03364309|323842578|FG012|Induction Period|Lost to Follow-up|0|||
94559366|NCT03364309|323842579|FG013|Induction Period|Lost to Follow-up|0|||
94559367|NCT03364309|323842580|FG014|Induction Period|Lost to Follow-up|0|||
94559368|NCT03364309|323842581|FG015|Induction Period|Lost to Follow-up|0|||
94559369|NCT03364309|323842582|FG016|Induction Period|Lost to Follow-up|0|||
94559370|NCT03364309|323842583|FG017|Induction Period|Lost to Follow-up|0|||
94559371|NCT03364309|323842584|FG018|Induction Period|Lost to Follow-up|0|||
94559372|NCT03364309|323842566|FG000|Induction Period|Physician Decision|0|||
94559373|NCT03364309|323842567|FG001|Induction Period|Physician Decision|1|||
94559374|NCT03364309|323842568|FG002|Induction Period|Physician Decision|0|||
94559375|NCT03364309|323842569|FG003|Induction Period|Physician Decision|0|||
94559376|NCT03364309|323842570|FG004|Induction Period|Physician Decision|0|||
94559377|NCT03364309|323842571|FG005|Induction Period|Physician Decision|0|||
94559378|NCT03364309|323842572|FG006|Induction Period|Physician Decision|0|||
94345122|NCT00126425|323043915|FG000|Overall Study|Lost to Follow-up|8|||
94345123|NCT00126425|323043916|FG001|Overall Study|Lost to Follow-up|4|||
94345124|NCT00126425|323043915|FG000|Overall Study|Protocol Violation|9|||
94559379|NCT03364309|323842573|FG007|Induction Period|Physician Decision|0|||
94559380|NCT03364309|323842574|FG008|Induction Period|Physician Decision|0|||
94559381|NCT03364309|323842575|FG009|Induction Period|Physician Decision|0|||
94559382|NCT03364309|323842576|FG010|Induction Period|Physician Decision|0|||
94559383|NCT03364309|323842577|FG011|Induction Period|Physician Decision|0|||
94559384|NCT03364309|323842578|FG012|Induction Period|Physician Decision|0|||
94559385|NCT03364309|323842579|FG013|Induction Period|Physician Decision|0|||
94559386|NCT03364309|323842580|FG014|Induction Period|Physician Decision|0|||
94559387|NCT03364309|323842581|FG015|Induction Period|Physician Decision|0|||
94559388|NCT03364309|323842582|FG016|Induction Period|Physician Decision|0|||
94559389|NCT03364309|323842583|FG017|Induction Period|Physician Decision|0|||
94559390|NCT03364309|323842584|FG018|Induction Period|Physician Decision|0|||
94559391|NCT03364309|323842566|FG000|Maintenance Period|Withdrawal by Subject|0|||
94559392|NCT03364309|323842567|FG001|Maintenance Period|Withdrawal by Subject|0|||
94559393|NCT03364309|323842568|FG002|Maintenance Period|Withdrawal by Subject|0|||
94559394|NCT03364309|323842569|FG003|Maintenance Period|Withdrawal by Subject|1|||
94559395|NCT03364309|323842570|FG004|Maintenance Period|Withdrawal by Subject|3|||
94559396|NCT03364309|323842571|FG005|Maintenance Period|Withdrawal by Subject|1|||
94559397|NCT03364309|323842572|FG006|Maintenance Period|Withdrawal by Subject|3|||
94559398|NCT03364309|323842573|FG007|Maintenance Period|Withdrawal by Subject|0|||
94559399|NCT03364309|323842574|FG008|Maintenance Period|Withdrawal by Subject|1|||
94559400|NCT03364309|323842575|FG009|Maintenance Period|Withdrawal by Subject|1|||
94559401|NCT03364309|323842576|FG010|Maintenance Period|Withdrawal by Subject|2|||
94559402|NCT03364309|323842577|FG011|Maintenance Period|Withdrawal by Subject|0|||
94345125|NCT00126425|323043916|FG001|Overall Study|Protocol Violation|6|||
94345126|NCT00126425|323043915|FG000|Overall Study|Adverse Event|1|||
94345127|NCT00126425|323043916|FG001|Overall Study|Adverse Event|0|||
94345128|NCT00126425|323043915|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
94345129|NCT00126425|323043916|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
94345130|NCT00126425|323043915|FG000|Overall Study|Other|5|||
94559403|NCT03364309|323842578|FG012|Maintenance Period|Withdrawal by Subject|0|||
94559404|NCT03364309|323842579|FG013|Maintenance Period|Withdrawal by Subject|0|||
94559405|NCT03364309|323842580|FG014|Maintenance Period|Withdrawal by Subject|0|||
94559406|NCT03364309|323842581|FG015|Maintenance Period|Withdrawal by Subject|0|||
94559407|NCT03364309|323842582|FG016|Maintenance Period|Withdrawal by Subject|0|||
94559408|NCT03364309|323842583|FG017|Maintenance Period|Withdrawal by Subject|0|||
94559409|NCT03364309|323842584|FG018|Maintenance Period|Withdrawal by Subject|0|||
94657608|NCT00262834|324204331|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
94559410|NCT03364309|323842566|FG000|Maintenance Period|Adverse Event|0|||
94559411|NCT03364309|323842567|FG001|Maintenance Period|Adverse Event|0|||
94559412|NCT03364309|323842568|FG002|Maintenance Period|Adverse Event|0|||
94559413|NCT03364309|323842569|FG003|Maintenance Period|Adverse Event|0|||
94559414|NCT03364309|323842570|FG004|Maintenance Period|Adverse Event|2|||
94559415|NCT03364309|323842571|FG005|Maintenance Period|Adverse Event|0|||
94559416|NCT03364309|323842572|FG006|Maintenance Period|Adverse Event|3|||
94559417|NCT03364309|323842573|FG007|Maintenance Period|Adverse Event|0|||
94559418|NCT03364309|323842574|FG008|Maintenance Period|Adverse Event|1|||
94559419|NCT03364309|323842575|FG009|Maintenance Period|Adverse Event|0|||
94559420|NCT03364309|323842576|FG010|Maintenance Period|Adverse Event|2|||
94559421|NCT03364309|323842577|FG011|Maintenance Period|Adverse Event|0|||
94559422|NCT03364309|323842578|FG012|Maintenance Period|Adverse Event|0|||
94559423|NCT03364309|323842579|FG013|Maintenance Period|Adverse Event|0|||
94559424|NCT03364309|323842580|FG014|Maintenance Period|Adverse Event|0|||
94559425|NCT03364309|323842581|FG015|Maintenance Period|Adverse Event|0|||
94559426|NCT03364309|323842582|FG016|Maintenance Period|Adverse Event|0|||
94559427|NCT03364309|323842583|FG017|Maintenance Period|Adverse Event|0|||
94559428|NCT03364309|323842584|FG018|Maintenance Period|Adverse Event|0|||
94559429|NCT03364309|323842566|FG000|Maintenance Period|Relapsed|0|||
94559430|NCT03364309|323842567|FG001|Maintenance Period|Relapsed|0|||
94559431|NCT03364309|323842568|FG002|Maintenance Period|Relapsed|0|||
94559432|NCT03364309|323842569|FG003|Maintenance Period|Relapsed|43|||
94559433|NCT03364309|323842570|FG004|Maintenance Period|Relapsed|7|||
94559434|NCT03364309|323842571|FG005|Maintenance Period|Relapsed|45|||
94559435|NCT03364309|323842572|FG006|Maintenance Period|Relapsed|10|||
94559436|NCT03364309|323842573|FG007|Maintenance Period|Relapsed|2|||
94559437|NCT03364309|323842574|FG008|Maintenance Period|Relapsed|0|||
94559438|NCT03364309|323842575|FG009|Maintenance Period|Relapsed|0|||
94559439|NCT03364309|323842576|FG010|Maintenance Period|Relapsed|0|||
94345131|NCT00126425|323043916|FG001|Overall Study|Other|0|||
94559440|NCT03364309|323842577|FG011|Maintenance Period|Relapsed|0|||
94559441|NCT03364309|323842578|FG012|Maintenance Period|Relapsed|0|||
94559442|NCT03364309|323842579|FG013|Maintenance Period|Relapsed|0|||
94559443|NCT03364309|323842580|FG014|Maintenance Period|Relapsed|0|||
94559444|NCT03364309|323842581|FG015|Maintenance Period|Relapsed|0|||
94559445|NCT03364309|323842582|FG016|Maintenance Period|Relapsed|0|||
94559446|NCT03364309|323842583|FG017|Maintenance Period|Relapsed|0|||
94559447|NCT03364309|323842584|FG018|Maintenance Period|Relapsed|0|||
94559448|NCT03364309|323842566|FG000|Maintenance Period|Lack of Efficacy|0|||
94559449|NCT03364309|323842567|FG001|Maintenance Period|Lack of Efficacy|0|||
94559450|NCT03364309|323842568|FG002|Maintenance Period|Lack of Efficacy|0|||
94559451|NCT03364309|323842569|FG003|Maintenance Period|Lack of Efficacy|0|||
94559452|NCT03364309|323842570|FG004|Maintenance Period|Lack of Efficacy|0|||
94559453|NCT03364309|323842571|FG005|Maintenance Period|Lack of Efficacy|0|||
94559454|NCT03364309|323842572|FG006|Maintenance Period|Lack of Efficacy|0|||
94559455|NCT03364309|323842573|FG007|Maintenance Period|Lack of Efficacy|0|||
94559456|NCT03364309|323842574|FG008|Maintenance Period|Lack of Efficacy|1|||
94559457|NCT03364309|323842575|FG009|Maintenance Period|Lack of Efficacy|3|||
94559458|NCT03364309|323842576|FG010|Maintenance Period|Lack of Efficacy|2|||
94559459|NCT03364309|323842577|FG011|Maintenance Period|Lack of Efficacy|0|||
94559460|NCT03364309|323842578|FG012|Maintenance Period|Lack of Efficacy|0|||
94559461|NCT03364309|323842579|FG013|Maintenance Period|Lack of Efficacy|0|||
94559462|NCT03364309|323842580|FG014|Maintenance Period|Lack of Efficacy|0|||
94559463|NCT03364309|323842581|FG015|Maintenance Period|Lack of Efficacy|0|||
94559464|NCT03364309|323842582|FG016|Maintenance Period|Lack of Efficacy|0|||
94559465|NCT03364309|323842583|FG017|Maintenance Period|Lack of Efficacy|0|||
94559466|NCT03364309|323842584|FG018|Maintenance Period|Lack of Efficacy|0|||
94559467|NCT03364309|323842566|FG000|Maintenance Period|Death|0|||
94345132|NCT02774291|323043917|FG000|Overall Study|Lost to Follow-up|1|||
94345133|NCT01347840|323043922|FG000|Overall Study|Withdrawal by Subject|1|||
94345134|NCT00149890|323043925|FG000|Overall Study|Adverse Event|1|||
94345135|NCT00149890|323043926|FG001|Overall Study|Adverse Event|8|||
94345136|NCT00149890|323043925|FG000|Overall Study|Lack of Efficacy|8|||
94232893|NCT03733899|322646312|FG001|Period 1|Protocol Violation|0|||
94345137|NCT00149890|323043926|FG001|Overall Study|Lack of Efficacy|9|||
94345138|NCT00149890|323043925|FG000|Overall Study|Protocol Violation|1|||
94345139|NCT00149890|323043926|FG001|Overall Study|Protocol Violation|0|||
94345140|NCT00149890|323043925|FG000|Overall Study|Lost to Follow-up|1|||
94345141|NCT00149890|323043926|FG001|Overall Study|Lost to Follow-up|0|||
94345142|NCT00149890|323043925|FG000|Overall Study|Graft Loss|2|||
94345143|NCT00149890|323043926|FG001|Overall Study|Graft Loss|1|||
94345144|NCT03512275|323043930|FG000|Overall Study|Withdrawal by Subject|1|||
94345145|NCT03512275|323043931|FG001|Overall Study|Withdrawal by Subject|3|||
94345146|NCT03512275|323043930|FG000|Overall Study|Physician Decision|0|||
94345147|NCT03512275|323043931|FG001|Overall Study|Physician Decision|1|||
94345148|NCT03512275|323043930|FG000|Overall Study|Lost to Follow-up|0|||
94345149|NCT03512275|323043931|FG001|Overall Study|Lost to Follow-up|3|||
94345150|NCT03512275|323043930|FG000|Overall Study|Other|1|||
94345151|NCT03512275|323043931|FG001|Overall Study|Other|0|||
94345152|NCT00113555|323043932|FG000|Overall Study|Baseline Failure|59|||
94345153|NCT00113555|323043932|FG000|Overall Study|Permanently Explanted|7|||
94345154|NCT00113555|323043932|FG000|Overall Study|Death|1|||
94345155|NCT00113555|323043932|FG000|Overall Study|Missed Followup|4|||
94345156|NCT00113555|323043932|FG000|Overall Study|Lost to Follow-up|8|||
94345157|NCT02573012|323043943|FG000|Overall Study|Adverse Event|5|||
94345158|NCT02573012|323043944|FG001|Overall Study|Adverse Event|5|||
94345159|NCT02573012|323043943|FG000|Overall Study|Lack of Efficacy|5|||
94345160|NCT02573012|323043944|FG001|Overall Study|Lack of Efficacy|4|||
94345161|NCT02573012|323043943|FG000|Overall Study|Non-compliance|1|||
94345162|NCT02573012|323043944|FG001|Overall Study|Non-compliance|2|||
94345163|NCT02573012|323043943|FG000|Overall Study|Withdrawal by Subject|2|||
94345164|NCT02573012|323043944|FG001|Overall Study|Withdrawal by Subject|2|||
94232894|NCT03733899|322646313|FG002|Period 1|Protocol Violation|0|||
94232895|NCT03733899|322646314|FG003|Period 1|Protocol Violation|0|||
94345165|NCT02573012|323043943|FG000|Overall Study|Study Ended per Protocol|1|||
94232896|NCT03733899|322646315|FG004|Period 1|Protocol Violation|0|||
94465755|NCT00195494|323494916|FG002|Year 1|Compliance|0|||
94232897|NCT03733899|322646316|FG005|Period 1|Protocol Violation|1|||
94449282|NCT01575834|323432653|FG001|Overall Study|Withdrawal by Subject|390|||
94449283|NCT01575834|323432652|FG000|Overall Study|Death|81|||
94449284|NCT01575834|323432653|FG001|Overall Study|Death|74|||
94449285|NCT01575834|323432652|FG000|Overall Study|Other|70|||
94232898|NCT03733899|322646311|FG000|Period 2|Unscuccessful Treatment|0|||
94232899|NCT03733899|322646312|FG001|Period 2|Unscuccessful Treatment|1|||
94232900|NCT03733899|322646313|FG002|Period 2|Unscuccessful Treatment|0|||
94232901|NCT03733899|322646314|FG003|Period 2|Unscuccessful Treatment|0|||
94232902|NCT03733899|322646315|FG004|Period 2|Unscuccessful Treatment|0|||
94232903|NCT03733899|322646316|FG005|Period 2|Unscuccessful Treatment|0|||
94232904|NCT03733899|322646311|FG000|Period 3|Withdrawal by Subject|1|||
94232905|NCT03733899|322646312|FG001|Period 3|Withdrawal by Subject|0|||
94232906|NCT03733899|322646313|FG002|Period 3|Withdrawal by Subject|0|||
94232907|NCT03733899|322646314|FG003|Period 3|Withdrawal by Subject|0|||
94232908|NCT03733899|322646315|FG004|Period 3|Withdrawal by Subject|0|||
94232909|NCT03733899|322646316|FG005|Period 3|Withdrawal by Subject|0|||
94232910|NCT06840769|322646317|FG000|Overall Study|Withdrawal by Subject|1|||
94232911|NCT06840769|322646318|FG001|Overall Study|Withdrawal by Subject|0|||
94232912|NCT06840769|322646319|FG002|Overall Study|Withdrawal by Subject|0|||
94232913|NCT06840769|322646320|FG003|Overall Study|Withdrawal by Subject|0|||
94232914|NCT06840769|322646321|FG004|Overall Study|Withdrawal by Subject|0|||
94559468|NCT03364309|323842567|FG001|Maintenance Period|Death|0|||
94559469|NCT03364309|323842568|FG002|Maintenance Period|Death|0|||
94232915|NCT04398368|322648136|FG000|Overall Study|Withdrawal by Subject|2|||
94232916|NCT03024996|322648137|FG000|Overall Study|Death|57|||
94232917|NCT03024996|322648138|FG001|Overall Study|Death|55|||
94232918|NCT03024996|322648137|FG000|Overall Study|Disease relapse|1|||
94232919|NCT03024996|322648138|FG001|Overall Study|Disease relapse|0|||
94232920|NCT03024996|322648137|FG000|Overall Study|Lost to Follow-up|5|||
94232921|NCT03024996|322648138|FG001|Overall Study|Lost to Follow-up|10|||
94232922|NCT03024996|322648137|FG000|Overall Study|Other|3|||
94232923|NCT03024996|322648138|FG001|Overall Study|Other|3|||
94232924|NCT03024996|322648137|FG000|Overall Study|Physician Decision|0|||
94232925|NCT03024996|322648138|FG001|Overall Study|Physician Decision|1|||
94232926|NCT03024996|322648137|FG000|Overall Study|Study terminated by sponsor|303|||
94232927|NCT03024996|322648138|FG001|Overall Study|Study terminated by sponsor|283|||
94232928|NCT03024996|322648137|FG000|Overall Study|Withdrawal by Subject|21|||
94232929|NCT03024996|322648138|FG001|Overall Study|Withdrawal by Subject|36|||
94559470|NCT03364309|323842569|FG003|Maintenance Period|Death|0|||
94559471|NCT03364309|323842570|FG004|Maintenance Period|Death|0|||
94559472|NCT03364309|323842571|FG005|Maintenance Period|Death|0|||
94559473|NCT03364309|323842572|FG006|Maintenance Period|Death|0|||
94559474|NCT03364309|323842573|FG007|Maintenance Period|Death|0|||
94559475|NCT03364309|323842574|FG008|Maintenance Period|Death|1|||
94559476|NCT03364309|323842575|FG009|Maintenance Period|Death|0|||
94559477|NCT03364309|323842576|FG010|Maintenance Period|Death|0|||
94232930|NCT03602586|322648139|FG000|Overall Study|Withdrawal by Subject|3|||
94232931|NCT01161446|322648146|FG000|Overall Study|Lost to Follow-up|18|||
94345166|NCT02573012|323043944|FG001|Overall Study|Study Ended per Protocol|0|||
94345167|NCT02573012|323043943|FG000|Overall Study|Physician Decision|1|||
94232932|NCT01161446|322648147|FG001|Overall Study|Lost to Follow-up|14|||
94232933|NCT01161446|322648146|FG000|Overall Study|Withdrawal by Subject|0|||
94232934|NCT01161446|322648147|FG001|Overall Study|Withdrawal by Subject|1|||
94232935|NCT04504630|322648152|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
94232936|NCT04504630|322648153|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
94232937|NCT04504630|322648152|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
94232938|NCT04504630|322648153|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
94345168|NCT02573012|323043944|FG001|Overall Study|Physician Decision|2|||
94345169|NCT01846208|323043945|FG000|Overall Study|Withdrew prior to treatment|1|||
94559478|NCT03364309|323842577|FG011|Maintenance Period|Death|0|||
94559479|NCT03364309|323842578|FG012|Maintenance Period|Death|0|||
94559480|NCT03364309|323842579|FG013|Maintenance Period|Death|0|||
94232939|NCT01657799|322648156|FG000|Overall Study|Adverse Event Related to progression|6|||
94232940|NCT01657799|322648157|FG001|Overall Study|Adverse Event Related to progression|8|||
94232941|NCT01657799|322648158|FG002|Overall Study|Adverse Event Related to progression|12|||
94232942|NCT01657799|322648156|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
94232943|NCT01657799|322648157|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
94232944|NCT01657799|322648158|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
94232945|NCT01657799|322648156|FG000|Overall Study|Withdrawal by Subject|13|||
94232946|NCT01657799|322648157|FG001|Overall Study|Withdrawal by Subject|10|||
94232947|NCT01657799|322648158|FG002|Overall Study|Withdrawal by Subject|10|||
94232948|NCT01657799|322648156|FG000|Overall Study|Lost to Follow-up|1|||
94232949|NCT01657799|322648157|FG001|Overall Study|Lost to Follow-up|0|||
94232950|NCT01657799|322648158|FG002|Overall Study|Lost to Follow-up|1|||
94232951|NCT01657799|322648156|FG000|Overall Study|Disease Progression|2|||
94232952|NCT01657799|322648157|FG001|Overall Study|Disease Progression|4|||
94232953|NCT01657799|322648158|FG002|Overall Study|Disease Progression|4|||
94232954|NCT01657799|322648156|FG000|Overall Study|Progressive Disease Clinical|7|||
94232955|NCT01657799|322648157|FG001|Overall Study|Progressive Disease Clinical|4|||
94449286|NCT01575834|323432653|FG001|Overall Study|Other|70|||
94232956|NCT01657799|322648158|FG002|Overall Study|Progressive Disease Clinical|7|||
94232957|NCT01657799|322648156|FG000|Overall Study|Radiographic & Clinical Progression|16|||
94232958|NCT01657799|322648157|FG001|Overall Study|Radiographic & Clinical Progression|11|||
94232959|NCT01657799|322648158|FG002|Overall Study|Radiographic & Clinical Progression|15|||
94232960|NCT01657799|322648156|FG000|Overall Study|Other|52|||
94232961|NCT01657799|322648157|FG001|Overall Study|Other|62|||
94232962|NCT01657799|322648158|FG002|Overall Study|Other|49|||
94232963|NCT01841697|322648167|FG000|Overall Study|Death|0|||
94232964|NCT01841697|322648168|FG001|Overall Study|Death|1|||
94232965|NCT01841697|322648167|FG000|Overall Study|Lost to Follow-up|4|||
94232966|NCT01841697|322648168|FG001|Overall Study|Lost to Follow-up|1|||
94232967|NCT01841697|322648167|FG000|Overall Study|Withdrawal by Subject|16|||
94232968|NCT01841697|322648168|FG001|Overall Study|Withdrawal by Subject|16|||
94232969|NCT00756457|322648169|FG000|Overall Study|Lost to Follow-up|1|||
94232970|NCT00756457|322648170|FG001|Overall Study|Lost to Follow-up|2|||
94232971|NCT00719043|322648177|FG000|Overall Study|Adverse Event|5|||
94232972|NCT00719043|322648178|FG001|Overall Study|Adverse Event|1|||
94232973|NCT00719043|322648179|FG002|Overall Study|Adverse Event|2|||
94232974|NCT00719043|322648180|FG003|Overall Study|Adverse Event|2|||
94232975|NCT00719043|322648181|FG004|Overall Study|Adverse Event|1|||
94232976|NCT00719043|322648182|FG005|Overall Study|Adverse Event|4|||
94232977|NCT00719043|322648183|FG006|Overall Study|Adverse Event|4|||
94232978|NCT00719043|322648177|FG000|Overall Study|Lost to Follow-up|14|||
94232979|NCT00719043|322648178|FG001|Overall Study|Lost to Follow-up|10|||
94232980|NCT00719043|322648179|FG002|Overall Study|Lost to Follow-up|8|||
94232981|NCT00719043|322648180|FG003|Overall Study|Lost to Follow-up|9|||
94232982|NCT00719043|322648181|FG004|Overall Study|Lost to Follow-up|10|||
94232983|NCT00719043|322648182|FG005|Overall Study|Lost to Follow-up|9|||
94232984|NCT00719043|322648183|FG006|Overall Study|Lost to Follow-up|9|||
94232985|NCT00719043|322648177|FG000|Overall Study|Protocol Violation|0|||
94232986|NCT00719043|322648178|FG001|Overall Study|Protocol Violation|0|||
94232987|NCT00719043|322648179|FG002|Overall Study|Protocol Violation|0|||
94232988|NCT00719043|322648180|FG003|Overall Study|Protocol Violation|0|||
94232989|NCT00719043|322648181|FG004|Overall Study|Protocol Violation|0|||
94232990|NCT00719043|322648182|FG005|Overall Study|Protocol Violation|1|||
94232991|NCT00719043|322648183|FG006|Overall Study|Protocol Violation|0|||
94232992|NCT00719043|322648177|FG000|Overall Study|Other|1|||
94232993|NCT00719043|322648178|FG001|Overall Study|Other|0|||
94232994|NCT00719043|322648179|FG002|Overall Study|Other|1|||
94232995|NCT00719043|322648180|FG003|Overall Study|Other|2|||
94232996|NCT00719043|322648181|FG004|Overall Study|Other|0|||
94232997|NCT00719043|322648182|FG005|Overall Study|Other|2|||
94232998|NCT00719043|322648183|FG006|Overall Study|Other|1|||
94232999|NCT00719043|322648177|FG000|Overall Study|Withdrawal by Subject|12|||
94233000|NCT00719043|322648178|FG001|Overall Study|Withdrawal by Subject|14|||
94233001|NCT00719043|322648179|FG002|Overall Study|Withdrawal by Subject|9|||
94233002|NCT00719043|322648180|FG003|Overall Study|Withdrawal by Subject|10|||
94233003|NCT00719043|322648181|FG004|Overall Study|Withdrawal by Subject|16|||
94233004|NCT00719043|322648182|FG005|Overall Study|Withdrawal by Subject|18|||
94233005|NCT00719043|322648183|FG006|Overall Study|Withdrawal by Subject|14|||
94233006|NCT00813098|322648184|FG000|Overall Study|Adverse Event|2|||
94233007|NCT00813098|322648185|FG001|Overall Study|Adverse Event|4|||
94233008|NCT00813098|322648186|FG002|Overall Study|Adverse Event|1|||
94233009|NCT00813098|322648184|FG000|Overall Study|Withdrawal by Subject|0|||
94233010|NCT00813098|322648185|FG001|Overall Study|Withdrawal by Subject|1|||
94233011|NCT00813098|322648186|FG002|Overall Study|Withdrawal by Subject|0|||
94233012|NCT00813098|322648184|FG000|Overall Study|Inability to complete study procedures|1|||
94345170|NCT01846208|323043946|FG001|Overall Study|Withdrew prior to treatment|1|||
94345171|NCT01846208|323043947|FG002|Overall Study|Withdrew prior to treatment|1|||
94345172|NCT01846208|323043945|FG000|Overall Study|Dosing Symptoms|1|||
94345173|NCT01846208|323043946|FG001|Overall Study|Dosing Symptoms|2|||
94345174|NCT01846208|323043947|FG002|Overall Study|Dosing Symptoms|6|||
94345175|NCT01846208|323043945|FG000|Overall Study|Withdrawal by Subject|5|||
94345176|NCT01846208|323043946|FG001|Overall Study|Withdrawal by Subject|0|||
94345177|NCT01846208|323043947|FG002|Overall Study|Withdrawal by Subject|0|||
94345178|NCT01846208|323043945|FG000|Overall Study|Non-compliance|1|||
94345179|NCT01846208|323043946|FG001|Overall Study|Non-compliance|1|||
94345180|NCT01846208|323043947|FG002|Overall Study|Non-compliance|0|||
94345181|NCT01846208|323043945|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
94345182|NCT01846208|323043946|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
94345183|NCT01846208|323043947|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
94345184|NCT01846208|323043945|FG000|Overall Study|Refused SU OFC|0|||
94345185|NCT01846208|323043946|FG001|Overall Study|Refused SU OFC|0|||
94345186|NCT01846208|323043947|FG002|Overall Study|Refused SU OFC|1|||
94345187|NCT01875874|323043948|FG000|Overall Study|Death|3|||
94345188|NCT02520141|323043957|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
94345189|NCT00518336|323043958|FG000|Year 7|Lost to Follow-up|2|||
94345190|NCT00518336|323043959|FG001|Year 7|Lost to Follow-up|0|||
94345191|NCT00518336|323043958|FG000|Year 7|Could not attend in time|0|||
94559481|NCT03364309|323842580|FG014|Maintenance Period|Death|0|||
94559482|NCT03364309|323842581|FG015|Maintenance Period|Death|0|||
94559483|NCT03364309|323842582|FG016|Maintenance Period|Death|0|||
94559484|NCT03364309|323842583|FG017|Maintenance Period|Death|0|||
94559485|NCT03364309|323842584|FG018|Maintenance Period|Death|0|||
94559486|NCT03364309|323842566|FG000|Maintenance Period|Lost to Follow-up|0|||
94559487|NCT03364309|323842567|FG001|Maintenance Period|Lost to Follow-up|0|||
94559488|NCT03364309|323842568|FG002|Maintenance Period|Lost to Follow-up|0|||
94559489|NCT03364309|323842569|FG003|Maintenance Period|Lost to Follow-up|0|||
94559490|NCT03364309|323842570|FG004|Maintenance Period|Lost to Follow-up|0|||
94559491|NCT03364309|323842571|FG005|Maintenance Period|Lost to Follow-up|0|||
94559492|NCT03364309|323842572|FG006|Maintenance Period|Lost to Follow-up|0|||
94559493|NCT03364309|323842573|FG007|Maintenance Period|Lost to Follow-up|0|||
94559494|NCT03364309|323842574|FG008|Maintenance Period|Lost to Follow-up|1|||
94559495|NCT03364309|323842575|FG009|Maintenance Period|Lost to Follow-up|0|||
94559496|NCT03364309|323842576|FG010|Maintenance Period|Lost to Follow-up|0|||
94559497|NCT03364309|323842577|FG011|Maintenance Period|Lost to Follow-up|0|||
94559498|NCT03364309|323842578|FG012|Maintenance Period|Lost to Follow-up|0|||
94559499|NCT03364309|323842579|FG013|Maintenance Period|Lost to Follow-up|0|||
94559500|NCT03364309|323842580|FG014|Maintenance Period|Lost to Follow-up|0|||
94559501|NCT03364309|323842581|FG015|Maintenance Period|Lost to Follow-up|0|||
94559502|NCT03364309|323842582|FG016|Maintenance Period|Lost to Follow-up|0|||
94559503|NCT03364309|323842583|FG017|Maintenance Period|Lost to Follow-up|0|||
94559504|NCT03364309|323842584|FG018|Maintenance Period|Lost to Follow-up|0|||
94559505|NCT03364309|323842566|FG000|Maintenance Period|Miscellaneous|0|||
94559506|NCT03364309|323842567|FG001|Maintenance Period|Miscellaneous|0|||
94559507|NCT03364309|323842568|FG002|Maintenance Period|Miscellaneous|0|||
94559508|NCT03364309|323842569|FG003|Maintenance Period|Miscellaneous|0|||
94559509|NCT03364309|323842570|FG004|Maintenance Period|Miscellaneous|0|||
94559510|NCT03364309|323842571|FG005|Maintenance Period|Miscellaneous|0|||
94559511|NCT03364309|323842572|FG006|Maintenance Period|Miscellaneous|0|||
94449287|NCT01575834|323432652|FG000|Overall Study|Adverse Event|63|||
94449288|NCT01575834|323432653|FG001|Overall Study|Adverse Event|61|||
94449289|NCT01575834|323432652|FG000|Overall Study|Lost to Follow-up|55|||
94449290|NCT01575834|323432653|FG001|Overall Study|Lost to Follow-up|68|||
94449291|NCT01575834|323432652|FG000|Overall Study|Noncompliance|52|||
94449292|NCT01575834|323432653|FG001|Overall Study|Noncompliance|27|||
94449293|NCT01575834|323432652|FG000|Overall Study|Administrative decision|15|||
94449294|NCT01575834|323432653|FG001|Overall Study|Administrative decision|33|||
94449295|NCT01575834|323432652|FG000|Overall Study|Ineligibility Determined|5|||
94449296|NCT01575834|323432653|FG001|Overall Study|Ineligibility Determined|8|||
94449297|NCT01575834|323432652|FG000|Overall Study|Protocol Deviation|4|||
94449298|NCT01575834|323432653|FG001|Overall Study|Protocol Deviation|3|||
94449299|NCT01575834|323432652|FG000|Overall Study|Requirement for Alternative Therapy|2|||
94449300|NCT01575834|323432653|FG001|Overall Study|Requirement for Alternative Therapy|4|||
94449301|NCT00463047|323432654|FG000|Titration Period 1|Adverse Event|10|||
94559512|NCT03364309|323842573|FG007|Maintenance Period|Miscellaneous|0|||
94559513|NCT03364309|323842574|FG008|Maintenance Period|Miscellaneous|1|||
94559514|NCT03364309|323842575|FG009|Maintenance Period|Miscellaneous|0|||
94559515|NCT03364309|323842576|FG010|Maintenance Period|Miscellaneous|0|||
94449302|NCT00463047|323432655|FG001|Titration Period 1|Adverse Event|8|||
94559516|NCT03364309|323842577|FG011|Maintenance Period|Miscellaneous|0|||
94449303|NCT00463047|323432654|FG000|Titration Period 1|Lack of Efficacy|10|||
94345192|NCT00518336|323043959|FG001|Year 7|Could not attend in time|3|||
94345193|NCT00518336|323043958|FG000|Year 8|Lost to Follow-up|1|||
94345194|NCT00518336|323043959|FG001|Year 8|Lost to Follow-up|1|||
94345195|NCT00518336|323043958|FG000|Year 8|Could not attend in time|0|||
94345196|NCT00518336|323043959|FG001|Year 8|Could not attend in time|1|||
94345197|NCT00518336|323043958|FG000|Year 9|Migrated/moved from study area|1|||
94345198|NCT00518336|323043959|FG001|Year 9|Migrated/moved from study area|1|||
94345199|NCT00518336|323043958|FG000|Year 9|Lost to Follow-up|3|||
94345200|NCT00518336|323043959|FG001|Year 9|Lost to Follow-up|0|||
94345201|NCT00518336|323043958|FG000|Year 9|Personal reasons|1|||
94345202|NCT00518336|323043959|FG001|Year 9|Personal reasons|0|||
94345203|NCT00703781|323043960|FG000|Overall Study|Withdrawal by Subject|1|||
94345204|NCT00703781|323043961|FG001|Overall Study|Withdrawal by Subject|2|||
94345205|NCT00703781|323043960|FG000|Overall Study|Cancelled surgery|1|||
94345206|NCT00703781|323043961|FG001|Overall Study|Cancelled surgery|0|||
94345207|NCT02735044|323043963|FG000|Overall Study|Adverse Event|3|||
94345208|NCT02735044|323043964|FG001|Overall Study|Adverse Event|3|||
94345209|NCT02735044|323043963|FG000|Overall Study|Lack of Efficacy|1|||
94345210|NCT02735044|323043964|FG001|Overall Study|Lack of Efficacy|0|||
94345211|NCT02735044|323043963|FG000|Overall Study|Poor compliance to protocol|7|||
94345212|NCT02735044|323043964|FG001|Overall Study|Poor compliance to protocol|7|||
94345213|NCT02735044|323043963|FG000|Overall Study|Randomized and not treated|0|||
94345214|NCT02735044|323043964|FG001|Overall Study|Randomized and not treated|2|||
94345215|NCT02735044|323043963|FG000|Overall Study|Other, not specified above|5|||
94345216|NCT02735044|323043964|FG001|Overall Study|Other, not specified above|11|||
94345217|NCT01682759|323043965|FG000|Overall Study|Death|2|||
94345218|NCT01682759|323043966|FG001|Overall Study|Death|1|||
94345219|NCT01682759|323043965|FG000|Overall Study|Lost to Follow-up|10|||
94345220|NCT01682759|323043966|FG001|Overall Study|Lost to Follow-up|13|||
94345221|NCT01682759|323043965|FG000|Overall Study|Physician Decision|1|||
94345222|NCT01682759|323043966|FG001|Overall Study|Physician Decision|1|||
94345223|NCT01682759|323043965|FG000|Overall Study|Withdrawal by Subject|56|||
94345224|NCT01682759|323043966|FG001|Overall Study|Withdrawal by Subject|55|||
94345225|NCT00397891|323043968|FG000|Overall Study|Withdrawal by Subject|1|||
94345226|NCT00397891|323043969|FG001|Overall Study|Withdrawal by Subject|0|||
94345227|NCT00397891|323043970|FG002|Overall Study|Withdrawal by Subject|0|||
94345228|NCT00397891|323043971|FG003|Overall Study|Withdrawal by Subject|0|||
94345229|NCT00397891|323043972|FG004|Overall Study|Withdrawal by Subject|1|||
94345230|NCT02691468|323043973|FG000|Overall Study|Bronchial blocker use|2|||
94345231|NCT02691468|323043974|FG001|Overall Study|Bronchial blocker use|1|||
94345232|NCT02691468|323043973|FG000|Overall Study|Lost to Follow-up|2|||
94345233|NCT02691468|323043974|FG001|Overall Study|Lost to Follow-up|1|||
94345234|NCT02691468|323043973|FG000|Overall Study|Failure to advance FOB|2|||
94345235|NCT02691468|323043974|FG001|Overall Study|Failure to advance FOB|0|||
94345236|NCT00410514|323043975|FG000|Overall Study|Adverse Event|2|||
94345237|NCT00410514|323043976|FG001|Overall Study|Adverse Event|2|||
94345238|NCT00410514|323043977|FG002|Overall Study|Adverse Event|2|||
94345239|NCT00410514|323043975|FG000|Overall Study|Protocol Violation|0|||
94345240|NCT00410514|323043976|FG001|Overall Study|Protocol Violation|1|||
94345241|NCT00410514|323043977|FG002|Overall Study|Protocol Violation|1|||
94233013|NCT00813098|322648185|FG001|Overall Study|Inability to complete study procedures|0|||
94233014|NCT00813098|322648186|FG002|Overall Study|Inability to complete study procedures|0|||
94233015|NCT00813098|322648184|FG000|Overall Study|Lost to Follow-up|0|||
94233016|NCT00813098|322648185|FG001|Overall Study|Lost to Follow-up|1|||
94233017|NCT00813098|322648186|FG002|Overall Study|Lost to Follow-up|0|||
94233018|NCT00813098|322648184|FG000|Overall Study|Protocol Violation|0|||
94233019|NCT00813098|322648185|FG001|Overall Study|Protocol Violation|0|||
94233020|NCT00813098|322648186|FG002|Overall Study|Protocol Violation|1|||
94233021|NCT00813098|322648184|FG000|Overall Study|Principal Investigator decision|0|||
94233022|NCT00813098|322648185|FG001|Overall Study|Principal Investigator decision|1|||
94233023|NCT00813098|322648186|FG002|Overall Study|Principal Investigator decision|0|||
94233024|NCT00813098|322648184|FG000|Overall Study|Withdrew Consent|0|||
94233025|NCT00813098|322648185|FG001|Overall Study|Withdrew Consent|1|||
94233026|NCT00813098|322648186|FG002|Overall Study|Withdrew Consent|0|||
94233027|NCT04081389|322648189|FG000|Overall Study|Withdrawal by Subject|0|||
94233028|NCT04081389|322648190|FG001|Overall Study|Withdrawal by Subject|0|||
94233029|NCT04081389|322648191|FG002|Overall Study|Withdrawal by Subject|1|||
94233030|NCT04081389|322648192|FG003|Overall Study|Withdrawal by Subject|0|||
94233031|NCT01086384|322648195|FG000|2-week Run-in Period|Adverse Event|1|||
94233032|NCT01086384|322648196|FG001|2-week Run-in Period|Adverse Event|0|||
94233033|NCT01086384|322648197|FG002|2-week Run-in Period|Adverse Event|0|||
94233034|NCT01086384|322648195|FG000|2-week Run-in Period|Protocol Violation|1|||
94233035|NCT01086384|322648196|FG001|2-week Run-in Period|Protocol Violation|0|||
94345242|NCT00410514|323043975|FG000|Overall Study|Lost to Follow-up|0|||
94345243|NCT00410514|323043976|FG001|Overall Study|Lost to Follow-up|0|||
94559517|NCT03364309|323842578|FG012|Maintenance Period|Miscellaneous|0|||
94559518|NCT03364309|323842579|FG013|Maintenance Period|Miscellaneous|0|||
94559519|NCT03364309|323842580|FG014|Maintenance Period|Miscellaneous|0|||
94345244|NCT00410514|323043977|FG002|Overall Study|Lost to Follow-up|2|||
94559520|NCT03364309|323842581|FG015|Maintenance Period|Miscellaneous|0|||
94559521|NCT03364309|323842582|FG016|Maintenance Period|Miscellaneous|0|||
94559522|NCT03364309|323842583|FG017|Maintenance Period|Miscellaneous|0|||
94345245|NCT00410514|323043975|FG000|Overall Study|Non-compliant with study procedures|0|||
94345246|NCT00410514|323043976|FG001|Overall Study|Non-compliant with study procedures|0|||
94345247|NCT00410514|323043977|FG002|Overall Study|Non-compliant with study procedures|2|||
94559523|NCT03364309|323842584|FG018|Maintenance Period|Miscellaneous|0|||
94233036|NCT01086384|322648197|FG002|2-week Run-in Period|Protocol Violation|0|||
94559524|NCT03364309|323842566|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
94559525|NCT03364309|323842567|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
94559526|NCT03364309|323842568|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
94559527|NCT03364309|323842569|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
94559528|NCT03364309|323842570|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
94559529|NCT03364309|323842571|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
94559530|NCT03364309|323842572|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
94465756|NCT00195494|323494917|FG003|Year 1|Compliance|0|||
94465757|NCT00195494|323494918|FG004|Year 1|Compliance|5|||
94465758|NCT00195494|323494919|FG005|Year 1|Compliance|1|||
94465759|NCT00195494|323494914|FG000|Year 1|Lost to Follow-up|0|||
94465760|NCT00195494|323494915|FG001|Year 1|Lost to Follow-up|0|||
94465761|NCT00195494|323494916|FG002|Year 1|Lost to Follow-up|0|||
94465762|NCT00195494|323494917|FG003|Year 1|Lost to Follow-up|0|||
94465763|NCT00195494|323494918|FG004|Year 1|Lost to Follow-up|1|||
94465764|NCT00195494|323494919|FG005|Year 1|Lost to Follow-up|0|||
94465765|NCT00195494|323494914|FG000|Year 1|Missed >4 consecutive doses|0|||
94465766|NCT00195494|323494915|FG001|Year 1|Missed >4 consecutive doses|0|||
94465767|NCT00195494|323494916|FG002|Year 1|Missed >4 consecutive doses|0|||
94465768|NCT00195494|323494917|FG003|Year 1|Missed >4 consecutive doses|0|||
94465769|NCT00195494|323494918|FG004|Year 1|Missed >4 consecutive doses|3|||
94465770|NCT00195494|323494919|FG005|Year 1|Missed >4 consecutive doses|2|||
94465771|NCT00195494|323494914|FG000|Year 1|Protocol deviation|0|||
94465772|NCT00195494|323494915|FG001|Year 1|Protocol deviation|0|||
94465773|NCT00195494|323494916|FG002|Year 1|Protocol deviation|0|||
94465774|NCT00195494|323494917|FG003|Year 1|Protocol deviation|0|||
94465775|NCT00195494|323494918|FG004|Year 1|Protocol deviation|2|||
94465776|NCT00195494|323494919|FG005|Year 1|Protocol deviation|3|||
94465777|NCT00195494|323494914|FG000|Year 1|Physician Decision|0|||
94465778|NCT00195494|323494915|FG001|Year 1|Physician Decision|0|||
94465779|NCT00195494|323494916|FG002|Year 1|Physician Decision|0|||
94465780|NCT00195494|323494917|FG003|Year 1|Physician Decision|0|||
94465781|NCT00195494|323494918|FG004|Year 1|Physician Decision|1|||
94465782|NCT00195494|323494919|FG005|Year 1|Physician Decision|0|||
94465783|NCT00195494|323494914|FG000|Year 1|Withdrawal by Subject|0|||
94465784|NCT00195494|323494915|FG001|Year 1|Withdrawal by Subject|0|||
94465785|NCT00195494|323494916|FG002|Year 1|Withdrawal by Subject|0|||
94465786|NCT00195494|323494917|FG003|Year 1|Withdrawal by Subject|0|||
94465787|NCT00195494|323494918|FG004|Year 1|Withdrawal by Subject|8|||
94465788|NCT00195494|323494919|FG005|Year 1|Withdrawal by Subject|9|||
94465789|NCT00195494|323494914|FG000|Year 1|Protocol Violation|0|||
94465790|NCT00195494|323494915|FG001|Year 1|Protocol Violation|0|||
94465791|NCT00195494|323494916|FG002|Year 1|Protocol Violation|0|||
94465792|NCT00195494|323494917|FG003|Year 1|Protocol Violation|0|||
94465793|NCT00195494|323494918|FG004|Year 1|Protocol Violation|1|||
94465794|NCT00195494|323494919|FG005|Year 1|Protocol Violation|1|||
94465795|NCT00195494|323494914|FG000|Year 2|Adverse Event|3|||
94465796|NCT00195494|323494915|FG001|Year 2|Adverse Event|7|||
94465797|NCT00195494|323494916|FG002|Year 2|Adverse Event|5|||
94465798|NCT00195494|323494917|FG003|Year 2|Adverse Event|9|||
94465799|NCT00195494|323494918|FG004|Year 2|Adverse Event|0|||
94465800|NCT00195494|323494919|FG005|Year 2|Adverse Event|0|||
94465801|NCT00195494|323494914|FG000|Year 2|Lack of Efficacy|0|||
94465802|NCT00195494|323494915|FG001|Year 2|Lack of Efficacy|1|||
94465803|NCT00195494|323494916|FG002|Year 2|Lack of Efficacy|7|||
94465804|NCT00195494|323494917|FG003|Year 2|Lack of Efficacy|7|||
94465805|NCT00195494|323494918|FG004|Year 2|Lack of Efficacy|0|||
94465806|NCT00195494|323494919|FG005|Year 2|Lack of Efficacy|0|||
94465807|NCT00195494|323494914|FG000|Year 2|Compliance|1|||
94465808|NCT00195494|323494915|FG001|Year 2|Compliance|0|||
94465809|NCT00195494|323494916|FG002|Year 2|Compliance|0|||
94465810|NCT00195494|323494917|FG003|Year 2|Compliance|2|||
94465811|NCT00195494|323494918|FG004|Year 2|Compliance|0|||
94465812|NCT00195494|323494919|FG005|Year 2|Compliance|0|||
94465813|NCT00195494|323494914|FG000|Year 2|Lost to Follow-up|0|||
94465814|NCT00195494|323494915|FG001|Year 2|Lost to Follow-up|0|||
94465815|NCT00195494|323494916|FG002|Year 2|Lost to Follow-up|1|||
94465816|NCT00195494|323494917|FG003|Year 2|Lost to Follow-up|1|||
94465817|NCT00195494|323494918|FG004|Year 2|Lost to Follow-up|0|||
94465818|NCT00195494|323494919|FG005|Year 2|Lost to Follow-up|0|||
94465819|NCT00195494|323494914|FG000|Year 2|Missed >4 consecutive doses|1|||
94465820|NCT00195494|323494915|FG001|Year 2|Missed >4 consecutive doses|1|||
94465821|NCT00195494|323494916|FG002|Year 2|Missed >4 consecutive doses|1|||
94465822|NCT00195494|323494917|FG003|Year 2|Missed >4 consecutive doses|0|||
94465823|NCT00195494|323494918|FG004|Year 2|Missed >4 consecutive doses|0|||
94465824|NCT00195494|323494919|FG005|Year 2|Missed >4 consecutive doses|0|||
94465825|NCT00195494|323494914|FG000|Year 2|Protocol deviation|0|||
94233037|NCT01086384|322648195|FG000|2-week Run-in Period|Lost to Follow-up|1|||
94233038|NCT01086384|322648196|FG001|2-week Run-in Period|Lost to Follow-up|0|||
94233039|NCT01086384|322648197|FG002|2-week Run-in Period|Lost to Follow-up|0|||
94233040|NCT01086384|322648195|FG000|2-week Run-in Period|Physician Decision|6|||
94233041|NCT01086384|322648196|FG001|2-week Run-in Period|Physician Decision|0|||
94449304|NCT00463047|323432655|FG001|Titration Period 1|Lack of Efficacy|4|||
94449305|NCT00463047|323432654|FG000|Titration Period 1|Lost to Follow-up|2|||
94449306|NCT00463047|323432655|FG001|Titration Period 1|Lost to Follow-up|0|||
94449307|NCT00463047|323432654|FG000|Titration Period 1|Non-compliance with study medication|3|||
94449308|NCT00463047|323432655|FG001|Titration Period 1|Non-compliance with study medication|5|||
94449309|NCT00463047|323432654|FG000|Titration Period 1|Protocol Violation|5|||
94449310|NCT00463047|323432655|FG001|Titration Period 1|Protocol Violation|5|||
94233042|NCT01086384|322648197|FG002|2-week Run-in Period|Physician Decision|0|||
94449311|NCT00463047|323432654|FG000|Titration Period 1|Withdrawal by Subject|3|||
94559531|NCT03364309|323842573|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
94559532|NCT03364309|323842574|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
94559533|NCT03364309|323842575|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
94233043|NCT01086384|322648195|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
94233044|NCT01086384|322648196|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
94233045|NCT01086384|322648197|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
94233046|NCT01086384|322648195|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
94233047|NCT01086384|322648196|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
94233048|NCT01086384|322648197|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
94233049|NCT01086384|322648195|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
94233050|NCT01086384|322648196|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
94233051|NCT01086384|322648197|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
94233052|NCT01086384|322648195|FG000|2-week Run-in Period|Randomized in Error|1|||
94559534|NCT03364309|323842576|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
94233053|NCT01086384|322648196|FG001|2-week Run-in Period|Randomized in Error|0|||
94559535|NCT03364309|323842577|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
94233054|NCT01086384|322648197|FG002|2-week Run-in Period|Randomized in Error|0|||
94559536|NCT03364309|323842578|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
94559537|NCT03364309|323842579|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
94559538|NCT03364309|323842580|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
94559539|NCT03364309|323842581|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
94559540|NCT03364309|323842582|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
94559541|NCT03364309|323842583|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
94559542|NCT03364309|323842584|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
94559543|NCT03364309|323842566|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
94559544|NCT03364309|323842567|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
94559545|NCT03364309|323842568|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
94559546|NCT03364309|323842569|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
94559547|NCT03364309|323842570|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
94559548|NCT03364309|323842571|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
94559549|NCT03364309|323842572|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
94559550|NCT03364309|323842573|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
94559551|NCT03364309|323842574|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
94559552|NCT03364309|323842575|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
94559553|NCT03364309|323842576|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
94559554|NCT03364309|323842577|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
94559555|NCT03364309|323842578|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
94559556|NCT03364309|323842579|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
94559557|NCT03364309|323842580|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
94559558|NCT03364309|323842581|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
94559559|NCT03364309|323842582|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
94559560|NCT03364309|323842583|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
94559561|NCT03364309|323842584|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
94559562|NCT03364309|323842566|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
94559563|NCT03364309|323842567|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
94559564|NCT03364309|323842568|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
94559565|NCT03364309|323842569|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
94559566|NCT03364309|323842570|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
94559567|NCT03364309|323842571|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
94233055|NCT01086384|322648195|FG000|Treatment Period|Withdrawal by Subject|0|||
94449312|NCT00463047|323432655|FG001|Titration Period 1|Withdrawal by Subject|5|||
94449313|NCT00463047|323432654|FG000|Titration Period 1|Non-compliance procedures|4|||
94233056|NCT01086384|322648196|FG001|Treatment Period|Withdrawal by Subject|53|||
94233057|NCT01086384|322648197|FG002|Treatment Period|Withdrawal by Subject|55|||
94449314|NCT00463047|323432655|FG001|Titration Period 1|Non-compliance procedures|10|||
94449315|NCT00463047|323432654|FG000|Titration Period 1|Other|0|||
94449316|NCT00463047|323432655|FG001|Titration Period 1|Other|2|||
94449317|NCT00463047|323432654|FG000|Titration Period 2|Adverse Event|9|||
94449318|NCT00463047|323432655|FG001|Titration Period 2|Adverse Event|9|||
94345248|NCT00286156|323043980|FG000|Overall Study|Missed 12 month visit|0|||
94345249|NCT00286156|323043981|FG001|Overall Study|Missed 12 month visit|0|||
94559568|NCT03364309|323842572|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
94559569|NCT03364309|323842573|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
94559570|NCT03364309|323842574|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
94559571|NCT03364309|323842575|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
94559572|NCT03364309|323842576|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
94559573|NCT03364309|323842577|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
94559574|NCT03364309|323842578|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
94559575|NCT03364309|323842579|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
94559576|NCT03364309|323842580|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
94559577|NCT03364309|323842581|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
94559578|NCT03364309|323842582|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
94559579|NCT03364309|323842583|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
94559580|NCT03364309|323842584|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
94559581|NCT03364309|323842566|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
94559582|NCT03364309|323842567|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
94559583|NCT03364309|323842568|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
94559584|NCT03364309|323842569|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
94559585|NCT03364309|323842570|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
94559586|NCT03364309|323842571|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
94559587|NCT03364309|323842572|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
94559588|NCT03364309|323842573|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
94559589|NCT03364309|323842574|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
94559590|NCT03364309|323842575|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
94559591|NCT03364309|323842576|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
94559592|NCT03364309|323842577|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
94559593|NCT03364309|323842578|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
94559594|NCT03364309|323842579|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
94559595|NCT03364309|323842580|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
94345250|NCT00286156|323043982|FG002|Overall Study|Missed 12 month visit|1|||
94345251|NCT00286156|323043980|FG000|Overall Study|AE: pulmonary embolus|0|||
94345252|NCT00286156|323043981|FG001|Overall Study|AE: pulmonary embolus|1|||
94345253|NCT00286156|323043982|FG002|Overall Study|AE: pulmonary embolus|0|||
94345254|NCT00286156|323043980|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
94345255|NCT00286156|323043981|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
94345256|NCT00286156|323043982|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
94345257|NCT00286156|323043980|FG000|Overall Study|AE: pneumonia|1|||
94345258|NCT00286156|323043981|FG001|Overall Study|AE: pneumonia|0|||
94345259|NCT00286156|323043982|FG002|Overall Study|AE: pneumonia|0|||
94345260|NCT02985684|323043983|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
94345261|NCT02985684|323043983|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
94345262|NCT02985684|323043983|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
94345263|NCT03458234|323043984|FG000|Overall Study|Withdrawal by Subject|1|||
94345264|NCT01436357|323043985|FG000|Overall Study|Death|5|||
94345265|NCT01436357|323043986|FG001|Overall Study|Death|1|||
94345266|NCT01436357|323043985|FG000|Overall Study|Enrolled but not vaccinated|1|||
94345267|NCT01436357|323043986|FG001|Overall Study|Enrolled but not vaccinated|1|||
94345268|NCT01436357|323043985|FG000|Overall Study|Incarceration|18|||
94345269|NCT01436357|323043986|FG001|Overall Study|Incarceration|20|||
94345270|NCT01436357|323043985|FG000|Overall Study|Lost to Follow-up|67|||
94345271|NCT01436357|323043986|FG001|Overall Study|Lost to Follow-up|61|||
94345272|NCT01436357|323043985|FG000|Overall Study|Protocol Violation|1|||
94345273|NCT01436357|323043986|FG001|Overall Study|Protocol Violation|0|||
94345274|NCT01436357|323043985|FG000|Overall Study|Withdrawal by Subject|26|||
94345275|NCT01436357|323043986|FG001|Overall Study|Withdrawal by Subject|38|||
94345276|NCT01436357|323043985|FG000|Overall Study|Physician Decision|3|||
94345277|NCT01436357|323043986|FG001|Overall Study|Physician Decision|4|||
94345278|NCT01436357|323043985|FG000|Overall Study|Moved out of area|1|||
94345279|NCT01436357|323043986|FG001|Overall Study|Moved out of area|2|||
94345280|NCT01436357|323043985|FG000|Overall Study|Subject in rehab|0|||
94345281|NCT01436357|323043986|FG001|Overall Study|Subject in rehab|1|||
94345282|NCT04363944|323043989|FG000|Overall Study|Withdrawal by Subject|2|||
94345283|NCT04363944|323043990|FG001|Overall Study|Withdrawal by Subject|0|||
94345284|NCT04728815|323043993|FG000|Overall Study|Lost to Follow-up|3|||
94345285|NCT04728815|323043994|FG001|Overall Study|Lost to Follow-up|0|||
94345286|NCT04728815|323043995|FG002|Overall Study|Lost to Follow-up|0|||
94345287|NCT04728815|323043996|FG003|Overall Study|Lost to Follow-up|1|||
94345288|NCT04728815|323043997|FG004|Overall Study|Lost to Follow-up|1|||
94345289|NCT04728815|323043998|FG005|Overall Study|Lost to Follow-up|0|||
94345290|NCT04728815|323043999|FG006|Overall Study|Lost to Follow-up|2|||
94345291|NCT04728815|323044000|FG007|Overall Study|Lost to Follow-up|0|||
94345292|NCT04728815|323043993|FG000|Overall Study|Physician Decision|0|||
94345293|NCT04728815|323043994|FG001|Overall Study|Physician Decision|0|||
94345294|NCT04728815|323043995|FG002|Overall Study|Physician Decision|1|||
94345295|NCT04728815|323043996|FG003|Overall Study|Physician Decision|0|||
94345296|NCT04728815|323043997|FG004|Overall Study|Physician Decision|0|||
94345297|NCT04728815|323043998|FG005|Overall Study|Physician Decision|0|||
94345298|NCT04728815|323043999|FG006|Overall Study|Physician Decision|0|||
94345299|NCT04728815|323044000|FG007|Overall Study|Physician Decision|0|||
94345300|NCT04728815|323043993|FG000|Overall Study|Treatment drop|0|||
94345301|NCT04728815|323043994|FG001|Overall Study|Treatment drop|2|||
94345302|NCT04728815|323043995|FG002|Overall Study|Treatment drop|1|||
94345303|NCT04728815|323043996|FG003|Overall Study|Treatment drop|0|||
94345304|NCT04728815|323043997|FG004|Overall Study|Treatment drop|3|||
94345305|NCT04728815|323043998|FG005|Overall Study|Treatment drop|1|||
94449319|NCT00463047|323432654|FG000|Titration Period 2|Lack of Efficacy|6|||
94449320|NCT00463047|323432655|FG001|Titration Period 2|Lack of Efficacy|4|||
94449321|NCT00463047|323432654|FG000|Titration Period 2|Withdrawal by Subject|1|||
94449322|NCT00463047|323432655|FG001|Titration Period 2|Withdrawal by Subject|0|||
94449323|NCT00463047|323432654|FG000|Titration Period 2|Protocol Violation|2|||
94345306|NCT04728815|323043999|FG006|Overall Study|Treatment drop|3|||
94465826|NCT00195494|323494915|FG001|Year 2|Protocol deviation|1|||
94559596|NCT03364309|323842581|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
94559597|NCT03364309|323842582|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
94559598|NCT03364309|323842583|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
94559599|NCT03364309|323842584|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
94233058|NCT01086384|322648195|FG000|Treatment Period|Protocol Violation|0|||
94233059|NCT01086384|322648196|FG001|Treatment Period|Protocol Violation|26|||
94233060|NCT01086384|322648197|FG002|Treatment Period|Protocol Violation|17|||
94233061|NCT01086384|322648195|FG000|Treatment Period|Lack of Efficacy|0|||
94233062|NCT01086384|322648196|FG001|Treatment Period|Lack of Efficacy|22|||
94233063|NCT01086384|322648197|FG002|Treatment Period|Lack of Efficacy|13|||
94233064|NCT01086384|322648195|FG000|Treatment Period|Adverse Event|0|||
94233065|NCT01086384|322648196|FG001|Treatment Period|Adverse Event|19|||
94233066|NCT01086384|322648197|FG002|Treatment Period|Adverse Event|15|||
94233067|NCT01086384|322648195|FG000|Treatment Period|Lost to Follow-up|0|||
94233068|NCT01086384|322648196|FG001|Treatment Period|Lost to Follow-up|11|||
94233069|NCT01086384|322648197|FG002|Treatment Period|Lost to Follow-up|9|||
94233070|NCT01086384|322648195|FG000|Treatment Period|Physician Decision|0|||
94233071|NCT01086384|322648196|FG001|Treatment Period|Physician Decision|9|||
94233072|NCT01086384|322648197|FG002|Treatment Period|Physician Decision|6|||
94233073|NCT01086384|322648195|FG000|Treatment Period|Study Closed/Terminated|0|||
94233074|NCT01086384|322648196|FG001|Treatment Period|Study Closed/Terminated|7|||
94233075|NCT01086384|322648197|FG002|Treatment Period|Study Closed/Terminated|8|||
94233076|NCT01086384|322648195|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
94233077|NCT01086384|322648196|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
94233078|NCT01086384|322648197|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
94233079|NCT01086384|322648195|FG000|Treatment Period|Received Treatment in Error|0|||
94233080|NCT01086384|322648196|FG001|Treatment Period|Received Treatment in Error|1|||
94233081|NCT01086384|322648197|FG002|Treatment Period|Received Treatment in Error|0|||
94233082|NCT00952848|322648200|FG000|Overall Study|Withdrawal by Subject|4|||
94233083|NCT03856047|322648201|FG000|Overall Study|Withdrawal by Subject|0|||
94233084|NCT03856047|322648202|FG001|Overall Study|Withdrawal by Subject|1|||
94233085|NCT03856047|322648203|FG002|Overall Study|Withdrawal by Subject|1|||
94233086|NCT03856047|322648204|FG003|Overall Study|Withdrawal by Subject|0|||
94233087|NCT03856047|322648205|FG004|Overall Study|Withdrawal by Subject|3|||
94233088|NCT03856047|322648206|FG005|Overall Study|Withdrawal by Subject|0|||
94233089|NCT03856047|322648207|FG006|Overall Study|Withdrawal by Subject|2|||
94233090|NCT03856047|322648201|FG000|Overall Study|Lost to Follow-up|4|||
94233091|NCT03856047|322648202|FG001|Overall Study|Lost to Follow-up|2|||
94233092|NCT03856047|322648203|FG002|Overall Study|Lost to Follow-up|3|||
94233093|NCT03856047|322648204|FG003|Overall Study|Lost to Follow-up|1|||
94233094|NCT03856047|322648205|FG004|Overall Study|Lost to Follow-up|4|||
94233095|NCT03856047|322648206|FG005|Overall Study|Lost to Follow-up|4|||
94233096|NCT03856047|322648207|FG006|Overall Study|Lost to Follow-up|4|||
94233097|NCT00263575|322648211|FG000|Titration Period|Adverse Event|14|||
94233098|NCT00263575|322648211|FG000|Titration Period|Withdrawal by Subject|10|||
94233099|NCT00263575|322648211|FG000|Titration Period|Protocol Violation|9|||
94233100|NCT00263575|322648211|FG000|Titration Period|Sponsor Decision|2|||
94233101|NCT00263575|322648211|FG000|Titration Period|Other|2|||
94233102|NCT00263575|322648211|FG000|Titration Period|Lack of Efficacy|6|||
94233103|NCT00263575|322648211|FG000|Maintence Period|Adverse Event|23|||
94233104|NCT00263575|322648211|FG000|Maintence Period|Withdrawal by Subject|8|||
94233105|NCT00263575|322648211|FG000|Maintence Period|Protocol Violation|4|||
94559600|NCT03364309|323842566|FG000|Post-Treatment Followup Period|Adverse Event|0|||
94559601|NCT03364309|323842567|FG001|Post-Treatment Followup Period|Adverse Event|0|||
94233106|NCT00263575|322648211|FG000|Maintence Period|Lack of Efficacy|4|||
94233107|NCT00263575|322648211|FG000|Maintence Period|Physician Decision|6|||
94233108|NCT00263575|322648211|FG000|Maintence Period|Lost to Follow-up|1|||
94233109|NCT00263575|322648211|FG000|Maintence Period|Sponsor Decision|24|||
94233110|NCT00263575|322648211|FG000|Maintence Period|Other|7|||
94233111|NCT00224029|322648212|FG000|Overall Study|Lost to Follow-up|1|||
94559602|NCT03364309|323842568|FG002|Post-Treatment Followup Period|Adverse Event|0|||
94233112|NCT00224029|322648212|FG000|Overall Study|Withdrawal by Subject|4|||
94233113|NCT00224029|322648212|FG000|Overall Study|Other|1|||
94233114|NCT00243022|322648213|FG000|Overall Study|Withdrawal by Subject|1|||
94559603|NCT03364309|323842569|FG003|Post-Treatment Followup Period|Adverse Event|0|||
94559604|NCT03364309|323842570|FG004|Post-Treatment Followup Period|Adverse Event|0|||
94559605|NCT03364309|323842571|FG005|Post-Treatment Followup Period|Adverse Event|0|||
94559606|NCT03364309|323842572|FG006|Post-Treatment Followup Period|Adverse Event|0|||
94559607|NCT03364309|323842573|FG007|Post-Treatment Followup Period|Adverse Event|0|||
94345307|NCT04728815|323044000|FG007|Overall Study|Treatment drop|0|||
94233115|NCT00243022|322648214|FG001|Overall Study|Withdrawal by Subject|0|||
94233116|NCT00243022|322648213|FG000|Overall Study|Death|1|||
94233117|NCT00243022|322648214|FG001|Overall Study|Death|0|||
94233118|NCT00243022|322648213|FG000|Overall Study|Difficult Travel Distance|0|||
94233119|NCT00243022|322648214|FG001|Overall Study|Difficult Travel Distance|1|||
94233120|NCT00778921|322648215|FG000|Overall Study|Adverse Event|9|||
94233121|NCT00778921|322648216|FG001|Overall Study|Adverse Event|10|||
94233122|NCT00778921|322648217|FG002|Overall Study|Adverse Event|14|||
94233123|NCT00778921|322648215|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
94233124|NCT00778921|322648216|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
94233125|NCT00778921|322648217|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
94233126|NCT00778921|322648215|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
94233127|NCT00778921|322648216|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
94233128|NCT00778921|322648217|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
94233129|NCT00778921|322648215|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
94233130|NCT00778921|322648216|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
94233131|NCT00778921|322648217|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
94233132|NCT00778921|322648215|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
94233133|NCT00778921|322648216|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
94233134|NCT00778921|322648217|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
94233135|NCT00778921|322648215|FG000|Overall Study|Patient withdrew request|3|||
94233136|NCT00778921|322648216|FG001|Overall Study|Patient withdrew request|1|||
94233137|NCT00778921|322648217|FG002|Overall Study|Patient withdrew request|6|||
94233138|NCT00778921|322648215|FG000|Overall Study|Lost to Follow-up|0|||
94233139|NCT00778921|322648216|FG001|Overall Study|Lost to Follow-up|2|||
94233140|NCT00778921|322648217|FG002|Overall Study|Lost to Follow-up|1|||
94233141|NCT00778921|322648215|FG000|Overall Study|Administrative Problems|1|||
94233142|NCT00778921|322648216|FG001|Overall Study|Administrative Problems|2|||
94233143|NCT00778921|322648217|FG002|Overall Study|Administrative Problems|0|||
94233144|NCT00778921|322648215|FG000|Overall Study|Protocol Violation|3|||
94233145|NCT00778921|322648216|FG001|Overall Study|Protocol Violation|0|||
94233146|NCT00778921|322648217|FG002|Overall Study|Protocol Violation|2|||
94233147|NCT00778921|322648215|FG000|Overall Study|Not treated|0|||
94233148|NCT00778921|322648216|FG001|Overall Study|Not treated|2|||
94233149|NCT00778921|322648217|FG002|Overall Study|Not treated|2|||
94233150|NCT04016272|322648228|FG000|Overall Study|Withdrawal by Subject|1|||
94233151|NCT04016272|322648229|FG001|Overall Study|Withdrawal by Subject|2|||
94233152|NCT03432390|322648232|FG000|Apnea Period|Protocol Violation|2|||
94233153|NCT03432390|322648233|FG001|Apnea Period|Protocol Violation|2|||
94233154|NCT01236352|322648234|FG000|Overall Study|Death|0|||
94233155|NCT01236352|322648235|FG001|Overall Study|Death|0|||
94233156|NCT01236352|322648236|FG002|Overall Study|Death|0|||
94233157|NCT01236352|322648237|FG003|Overall Study|Death|0|||
94233158|NCT01236352|322648238|FG004|Overall Study|Death|0|||
94233159|NCT01236352|322648239|FG005|Overall Study|Death|0|||
94233160|NCT01236352|322648240|FG006|Overall Study|Death|0|||
94233161|NCT01236352|322648241|FG007|Overall Study|Death|1|||
94233162|NCT01236352|322648242|FG008|Overall Study|Death|0|||
94233163|NCT01236352|322648243|FG009|Overall Study|Death|0|||
94233164|NCT01236352|322648244|FG010|Overall Study|Death|0|||
94233165|NCT01236352|322648234|FG000|Overall Study|Withdrawal by Subject|0|||
94233166|NCT01236352|322648235|FG001|Overall Study|Withdrawal by Subject|0|||
94233167|NCT01236352|322648236|FG002|Overall Study|Withdrawal by Subject|0|||
94345308|NCT04728815|323043993|FG000|Overall Study|Study drop|0|||
94345309|NCT04728815|323043994|FG001|Overall Study|Study drop|3|||
94233168|NCT01236352|322648237|FG003|Overall Study|Withdrawal by Subject|0|||
94233169|NCT01236352|322648238|FG004|Overall Study|Withdrawal by Subject|0|||
94233170|NCT01236352|322648239|FG005|Overall Study|Withdrawal by Subject|0|||
94233171|NCT01236352|322648240|FG006|Overall Study|Withdrawal by Subject|0|||
94233172|NCT01236352|322648241|FG007|Overall Study|Withdrawal by Subject|0|||
94233173|NCT01236352|322648242|FG008|Overall Study|Withdrawal by Subject|0|||
94233174|NCT01236352|322648243|FG009|Overall Study|Withdrawal by Subject|2|||
94233175|NCT01236352|322648244|FG010|Overall Study|Withdrawal by Subject|1|||
94233176|NCT01236352|322648234|FG000|Overall Study|Adverse Event|0|||
94233177|NCT01236352|322648235|FG001|Overall Study|Adverse Event|0|||
94233178|NCT01236352|322648236|FG002|Overall Study|Adverse Event|0|||
94233179|NCT01236352|322648237|FG003|Overall Study|Adverse Event|0|||
94345310|NCT04728815|323043995|FG002|Overall Study|Study drop|3|||
94345311|NCT04728815|323043996|FG003|Overall Study|Study drop|0|||
94345312|NCT04728815|323043997|FG004|Overall Study|Study drop|0|||
94345313|NCT04728815|323043998|FG005|Overall Study|Study drop|0|||
94345314|NCT04728815|323043999|FG006|Overall Study|Study drop|7|||
94345315|NCT04728815|323044000|FG007|Overall Study|Study drop|0|||
94345316|NCT00908895|323045875|FG000|Overall Study|Lost to Follow-up|1|||
94233180|NCT01236352|322648238|FG004|Overall Study|Adverse Event|0|||
94233181|NCT01236352|322648239|FG005|Overall Study|Adverse Event|0|||
94233182|NCT01236352|322648240|FG006|Overall Study|Adverse Event|2|||
94233183|NCT01236352|322648241|FG007|Overall Study|Adverse Event|0|||
94233184|NCT01236352|322648242|FG008|Overall Study|Adverse Event|0|||
94233185|NCT01236352|322648243|FG009|Overall Study|Adverse Event|4|||
94233186|NCT01236352|322648244|FG010|Overall Study|Adverse Event|1|||
94233187|NCT01236352|322648234|FG000|Overall Study|Study drug toxicity|0|||
94345317|NCT00908895|323045876|FG001|Overall Study|Lost to Follow-up|3|||
94345318|NCT00908895|323045875|FG000|Overall Study|algodystrophy|2|||
94559608|NCT03364309|323842574|FG008|Post-Treatment Followup Period|Adverse Event|0|||
94559609|NCT03364309|323842575|FG009|Post-Treatment Followup Period|Adverse Event|0|||
94559610|NCT03364309|323842576|FG010|Post-Treatment Followup Period|Adverse Event|0|||
94559611|NCT03364309|323842577|FG011|Post-Treatment Followup Period|Adverse Event|0|||
94233188|NCT01236352|322648235|FG001|Overall Study|Study drug toxicity|0|||
94233189|NCT01236352|322648236|FG002|Overall Study|Study drug toxicity|0|||
94233190|NCT01236352|322648237|FG003|Overall Study|Study drug toxicity|0|||
94233191|NCT01236352|322648238|FG004|Overall Study|Study drug toxicity|0|||
94233192|NCT01236352|322648239|FG005|Overall Study|Study drug toxicity|1|||
94233193|NCT01236352|322648240|FG006|Overall Study|Study drug toxicity|1|||
94233194|NCT01236352|322648241|FG007|Overall Study|Study drug toxicity|0|||
94233195|NCT01236352|322648242|FG008|Overall Study|Study drug toxicity|0|||
94233196|NCT01236352|322648243|FG009|Overall Study|Study drug toxicity|2|||
94233197|NCT01236352|322648244|FG010|Overall Study|Study drug toxicity|2|||
94233198|NCT01236352|322648234|FG000|Overall Study|Disease progression|1|||
94233199|NCT01236352|322648235|FG001|Overall Study|Disease progression|2|||
94233200|NCT01236352|322648236|FG002|Overall Study|Disease progression|1|||
94233201|NCT01236352|322648237|FG003|Overall Study|Disease progression|2|||
94233202|NCT01236352|322648238|FG004|Overall Study|Disease progression|2|||
94233203|NCT01236352|322648239|FG005|Overall Study|Disease progression|2|||
94233204|NCT01236352|322648240|FG006|Overall Study|Disease progression|1|||
94233205|NCT01236352|322648241|FG007|Overall Study|Disease progression|3|||
94233206|NCT01236352|322648242|FG008|Overall Study|Disease progression|2|||
94233207|NCT01236352|322648243|FG009|Overall Study|Disease progression|2|||
94233208|NCT01236352|322648244|FG010|Overall Study|Disease progression|2|||
94233209|NCT01236352|322648234|FG000|Overall Study|Poor/Non-compliance|1|||
94233210|NCT01236352|322648235|FG001|Overall Study|Poor/Non-compliance|0|||
94233211|NCT01236352|322648236|FG002|Overall Study|Poor/Non-compliance|0|||
94233212|NCT01236352|322648237|FG003|Overall Study|Poor/Non-compliance|0|||
94233213|NCT01236352|322648238|FG004|Overall Study|Poor/Non-compliance|0|||
94233214|NCT01236352|322648239|FG005|Overall Study|Poor/Non-compliance|0|||
94233215|NCT01236352|322648240|FG006|Overall Study|Poor/Non-compliance|0|||
94233216|NCT01236352|322648241|FG007|Overall Study|Poor/Non-compliance|0|||
94233217|NCT01236352|322648242|FG008|Overall Study|Poor/Non-compliance|0|||
94233218|NCT01236352|322648243|FG009|Overall Study|Poor/Non-compliance|0|||
94233219|NCT01236352|322648244|FG010|Overall Study|Poor/Non-compliance|0|||
94233220|NCT01236352|322648234|FG000|Overall Study|Maximum clinical benefit|1|||
94233221|NCT01236352|322648235|FG001|Overall Study|Maximum clinical benefit|1|||
94233222|NCT01236352|322648236|FG002|Overall Study|Maximum clinical benefit|1|||
94233223|NCT01236352|322648237|FG003|Overall Study|Maximum clinical benefit|0|||
94233224|NCT01236352|322648238|FG004|Overall Study|Maximum clinical benefit|2|||
94233225|NCT01236352|322648239|FG005|Overall Study|Maximum clinical benefit|0|||
94233226|NCT01236352|322648240|FG006|Overall Study|Maximum clinical benefit|3|||
94233227|NCT01236352|322648241|FG007|Overall Study|Maximum clinical benefit|1|||
94233228|NCT01236352|322648242|FG008|Overall Study|Maximum clinical benefit|1|||
94233229|NCT01236352|322648243|FG009|Overall Study|Maximum clinical benefit|4|||
94233230|NCT01236352|322648244|FG010|Overall Study|Maximum clinical benefit|2|||
94233231|NCT01236352|322648234|FG000|Overall Study|Subject request to discontinue treatment|0|||
94233232|NCT01236352|322648235|FG001|Overall Study|Subject request to discontinue treatment|0|||
94233233|NCT01236352|322648236|FG002|Overall Study|Subject request to discontinue treatment|1|||
94233234|NCT01236352|322648237|FG003|Overall Study|Subject request to discontinue treatment|1|||
94233235|NCT01236352|322648238|FG004|Overall Study|Subject request to discontinue treatment|0|||
94233236|NCT01236352|322648239|FG005|Overall Study|Subject request to discontinue treatment|1|||
94233237|NCT01236352|322648240|FG006|Overall Study|Subject request to discontinue treatment|0|||
94233238|NCT01236352|322648241|FG007|Overall Study|Subject request to discontinue treatment|0|||
94233239|NCT01236352|322648242|FG008|Overall Study|Subject request to discontinue treatment|0|||
94233240|NCT01236352|322648243|FG009|Overall Study|Subject request to discontinue treatment|1|||
94233241|NCT01236352|322648244|FG010|Overall Study|Subject request to discontinue treatment|4|||
94233242|NCT01236352|322648234|FG000|Overall Study|Subject to receive drug via EAP|1|||
94345319|NCT00908895|323045876|FG001|Overall Study|algodystrophy|2|||
94233243|NCT01236352|322648235|FG001|Overall Study|Subject to receive drug via EAP|1|||
94233244|NCT01236352|322648236|FG002|Overall Study|Subject to receive drug via EAP|1|||
94233245|NCT01236352|322648237|FG003|Overall Study|Subject to receive drug via EAP|0|||
94233246|NCT01236352|322648238|FG004|Overall Study|Subject to receive drug via EAP|0|||
94345320|NCT00908895|323045875|FG000|Overall Study|Adverse Event|1|||
94345321|NCT00908895|323045876|FG001|Overall Study|Adverse Event|1|||
94559612|NCT03364309|323842578|FG012|Post-Treatment Followup Period|Adverse Event|0|||
94559613|NCT03364309|323842579|FG013|Post-Treatment Followup Period|Adverse Event|0|||
94559614|NCT03364309|323842580|FG014|Post-Treatment Followup Period|Adverse Event|0|||
94559615|NCT03364309|323842581|FG015|Post-Treatment Followup Period|Adverse Event|0|||
94559616|NCT03364309|323842582|FG016|Post-Treatment Followup Period|Adverse Event|2|||
94559617|NCT03364309|323842583|FG017|Post-Treatment Followup Period|Adverse Event|6|||
94559618|NCT03364309|323842584|FG018|Post-Treatment Followup Period|Adverse Event|1|||
94559619|NCT03364309|323842566|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
94559620|NCT03364309|323842567|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
94559621|NCT03364309|323842568|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
94559622|NCT03364309|323842569|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
94559623|NCT03364309|323842570|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
94559624|NCT03364309|323842571|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
94559625|NCT03364309|323842572|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
94559626|NCT03364309|323842573|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
94559627|NCT03364309|323842574|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
94559628|NCT03364309|323842575|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
94559629|NCT03364309|323842576|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
94559630|NCT03364309|323842577|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
94559631|NCT03364309|323842578|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
94345322|NCT00443534|323045877|FG000|Overall Study|Lack of Efficacy|67|||
94233247|NCT01236352|322648239|FG005|Overall Study|Subject to receive drug via EAP|0|||
94233248|NCT01236352|322648240|FG006|Overall Study|Subject to receive drug via EAP|0|||
94233249|NCT01236352|322648241|FG007|Overall Study|Subject to receive drug via EAP|2|||
94233250|NCT01236352|322648242|FG008|Overall Study|Subject to receive drug via EAP|0|||
94233251|NCT01236352|322648243|FG009|Overall Study|Subject to receive drug via EAP|4|||
94233252|NCT01236352|322648244|FG010|Overall Study|Subject to receive drug via EAP|0|||
94233253|NCT01236352|322648234|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
94233254|NCT01236352|322648235|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
94233255|NCT01236352|322648236|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
94233256|NCT01236352|322648237|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
94233257|NCT01236352|322648238|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
94233258|NCT01236352|322648239|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
94233259|NCT01236352|322648240|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
94233260|NCT01236352|322648241|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
94233261|NCT01236352|322648242|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
94233262|NCT01236352|322648243|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
94233263|NCT01236352|322648244|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
94233264|NCT01236352|322648234|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
94233265|NCT01236352|322648235|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
94233266|NCT01236352|322648236|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
94233267|NCT01236352|322648237|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
94233268|NCT01236352|322648238|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
94233269|NCT01236352|322648239|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
94233270|NCT01236352|322648240|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
94233271|NCT01236352|322648241|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
94233272|NCT01236352|322648242|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
94233273|NCT01236352|322648243|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
94233274|NCT01236352|322648244|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
94233275|NCT01236352|322648234|FG000|Overall Study|Lack of response to drug|0|||
94233276|NCT01236352|322648235|FG001|Overall Study|Lack of response to drug|0|||
94233277|NCT01236352|322648236|FG002|Overall Study|Lack of response to drug|0|||
94233278|NCT01236352|322648237|FG003|Overall Study|Lack of response to drug|0|||
94233279|NCT01236352|322648238|FG004|Overall Study|Lack of response to drug|0|||
94233280|NCT01236352|322648239|FG005|Overall Study|Lack of response to drug|0|||
94233281|NCT01236352|322648240|FG006|Overall Study|Lack of response to drug|0|||
94233282|NCT01236352|322648241|FG007|Overall Study|Lack of response to drug|0|||
94233283|NCT01236352|322648242|FG008|Overall Study|Lack of response to drug|0|||
94233284|NCT01236352|322648243|FG009|Overall Study|Lack of response to drug|1|||
94233285|NCT01236352|322648244|FG010|Overall Study|Lack of response to drug|1|||
94233286|NCT01236352|322648234|FG000|Overall Study|Patient transferred to IST|0|||
94233287|NCT01236352|322648235|FG001|Overall Study|Patient transferred to IST|0|||
94233288|NCT01236352|322648236|FG002|Overall Study|Patient transferred to IST|0|||
94233289|NCT01236352|322648237|FG003|Overall Study|Patient transferred to IST|0|||
94233290|NCT01236352|322648238|FG004|Overall Study|Patient transferred to IST|0|||
94233291|NCT01236352|322648239|FG005|Overall Study|Patient transferred to IST|0|||
94233292|NCT01236352|322648240|FG006|Overall Study|Patient transferred to IST|0|||
94449324|NCT00463047|323432655|FG001|Titration Period 2|Protocol Violation|3|||
94449325|NCT00463047|323432654|FG000|Titration Period 2|Lost to Follow-up|1|||
94449326|NCT00463047|323432655|FG001|Titration Period 2|Lost to Follow-up|2|||
94449327|NCT00463047|323432654|FG000|Titration Period 2|Non-compliance study medication|4|||
94449328|NCT00463047|323432655|FG001|Titration Period 2|Non-compliance study medication|2|||
94449329|NCT00463047|323432654|FG000|Titration Period 2|Non-compliance procedures|4|||
94449330|NCT00463047|323432655|FG001|Titration Period 2|Non-compliance procedures|1|||
94449331|NCT00463047|323432654|FG000|Titration Period 2|Other|3|||
94449332|NCT00463047|323432655|FG001|Titration Period 2|Other|2|||
94449333|NCT00463047|323432654|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
94449334|NCT00463047|323432655|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
94449335|NCT00463047|323432654|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
94449336|NCT00463047|323432655|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
94449337|NCT00463047|323432654|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
94449338|NCT00463047|323432655|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
94449339|NCT00463047|323432654|FG000|Double-Blind Treatment Period 1|Other|1|||
94449340|NCT00463047|323432655|FG001|Double-Blind Treatment Period 1|Other|0|||
94449341|NCT00463047|323432654|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
94449342|NCT00463047|323432655|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
94449343|NCT00463047|323432654|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
94449344|NCT00463047|323432655|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
94449345|NCT00463047|323432654|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
94449346|NCT00463047|323432655|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
94449347|NCT03363776|323432659|FG000|Overall Study|Progressive disease|2|||
94345323|NCT00443534|323045877|FG000|Overall Study|Adverse Event|16|||
94345324|NCT00443534|323045877|FG000|Overall Study|Death|9|||
94345325|NCT00443534|323045877|FG000|Overall Study|Withdrawal by Subject|8|||
94345326|NCT00443534|323045877|FG000|Overall Study|Study Terminated by Sponsor|12|||
94345327|NCT00443534|323045877|FG000|Overall Study|Other|10|||
94345328|NCT00443534|323045877|FG000|Overall Study|Enrolled, Not Treated|1|||
94559632|NCT03364309|323842579|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
94559633|NCT03364309|323842580|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
94559634|NCT03364309|323842581|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
94559635|NCT03364309|323842582|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
94559636|NCT03364309|323842583|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
94559637|NCT03364309|323842584|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
94559638|NCT03364309|323842566|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
94559639|NCT03364309|323842567|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
94559640|NCT03364309|323842568|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
94559641|NCT03364309|323842569|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
94559642|NCT03364309|323842570|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
94559643|NCT03364309|323842571|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
94559644|NCT03364309|323842572|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
94559645|NCT03364309|323842573|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
94559646|NCT03364309|323842574|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
94559647|NCT03364309|323842575|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
94559648|NCT03364309|323842576|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
94559649|NCT03364309|323842577|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
94559650|NCT03364309|323842578|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
94559651|NCT03364309|323842579|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
94559652|NCT03364309|323842580|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
94559653|NCT03364309|323842581|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
94559654|NCT03364309|323842582|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
94345329|NCT00364611|323045879|FG000|Overall Study|Did not receive study medication|0|||
94345330|NCT00364611|323045880|FG001|Overall Study|Did not receive study medication|1|||
94345331|NCT00364611|323045879|FG000|Overall Study|Adverse Event|7|||
94345332|NCT00364611|323045880|FG001|Overall Study|Adverse Event|4|||
94345333|NCT00364611|323045879|FG000|Overall Study|Participant's Request|3|||
94345334|NCT00364611|323045880|FG001|Overall Study|Participant's Request|4|||
94345335|NCT00364611|323045879|FG000|Overall Study|Disease Progression|38|||
94345336|NCT00364611|323045880|FG001|Overall Study|Disease Progression|8|||
94345337|NCT00364611|323045879|FG000|Overall Study|Investigator decision|2|||
94345338|NCT00364611|323045880|FG001|Overall Study|Investigator decision|2|||
94345339|NCT00364611|323045879|FG000|Overall Study|Found Ineligible|1|||
94345340|NCT00364611|323045880|FG001|Overall Study|Found Ineligible|0|||
94345341|NCT00364611|323045879|FG000|Overall Study|Presumed CR on Study|0|||
94345342|NCT00364611|323045880|FG001|Overall Study|Presumed CR on Study|1|||
94345343|NCT00364611|323045879|FG000|Overall Study|Receiving Liver Ablation|0|||
94345344|NCT00364611|323045880|FG001|Overall Study|Receiving Liver Ablation|1|||
94345345|NCT02710422|323045881|FG000|Overall Study|Termination of study|9|||
94345346|NCT02710422|323045882|FG001|Overall Study|Termination of study|9|||
94345347|NCT04397757|323045909|FG000|Overall Study|Death|3|||
94345348|NCT04397757|323045910|FG001|Overall Study|Death|11|||
94345349|NCT04397757|323045909|FG000|Overall Study|Withdrawal by Subject|2|||
94345350|NCT04397757|323045910|FG001|Overall Study|Withdrawal by Subject|0|||
94345351|NCT04397757|323045909|FG000|Overall Study|Lost to Follow-up|4|||
94345352|NCT04397757|323045910|FG001|Overall Study|Lost to Follow-up|3|||
94345353|NCT02608099|323045911|FG000|Overall Study|Ablation procedure not initiated|3|||
94345354|NCT02608099|323045912|FG001|Overall Study|Ablation procedure not initiated|2|||
94345355|NCT00186121|323045919|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
94345356|NCT00186121|323045919|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
94345357|NCT00186121|323045919|FG000|Overall Study|Not eligible (no treatment)|1|||
94345358|NCT00166504|323045923|FG000|Overall Study|Adverse Event|3|||
94345359|NCT00166504|323045924|FG001|Overall Study|Adverse Event|3|||
94345360|NCT00166504|323045923|FG000|Overall Study|Lost to Follow-up|1|||
94345361|NCT00166504|323045924|FG001|Overall Study|Lost to Follow-up|1|||
94449348|NCT03363776|323432660|FG001|Overall Study|Progressive disease|3|||
94449349|NCT03363776|323432661|FG002|Overall Study|Progressive disease|1|||
94559655|NCT03364309|323842583|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
94449350|NCT03363776|323432659|FG000|Overall Study|Study drug toxicity|0|||
94345362|NCT00166504|323045923|FG000|Overall Study|Withdrawal by Subject|1|||
94345363|NCT00166504|323045924|FG001|Overall Study|Withdrawal by Subject|0|||
94559656|NCT03364309|323842584|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
94559657|NCT03188510|323842586|FG000|Overall Study|Inappropriate behavior with site staff|0|||
94559658|NCT03188510|323842587|FG001|Overall Study|Inappropriate behavior with site staff|1|||
94559659|NCT03188510|323842588|FG002|Overall Study|Inappropriate behavior with site staff|0|||
94559660|NCT03304873|323842589|FG000|Overall Study|Lost to Follow-up|1|||
94559661|NCT03304873|323842590|FG001|Overall Study|Lost to Follow-up|8|||
94559662|NCT03193736|323842592|FG000|Overall Study|Death|2|||
94559663|NCT03193736|323842592|FG000|Overall Study|Withdrawal by Subject|1|||
94559664|NCT03193736|323842592|FG000|Overall Study|Lost to Follow-up|1|||
94559665|NCT03193736|323842592|FG000|Overall Study|implant not received|1|||
94559666|NCT00856297|323842593|FG000|Overall Study|Unable to classify|2|||
94559667|NCT00856297|323842594|FG001|Overall Study|Unable to classify|0|||
94559668|NCT00856297|323842595|FG002|Overall Study|Unable to classify|0|||
94559669|NCT00856297|323842596|FG003|Overall Study|Unable to classify|0|||
94559670|NCT00856297|323842597|FG004|Overall Study|Unable to classify|0|||
94559671|NCT04506502|323844342|FG000|Overall Study|Withdrawal by Subject|1|||
94233293|NCT01236352|322648241|FG007|Overall Study|Patient transferred to IST|0|||
94233294|NCT01236352|322648242|FG008|Overall Study|Patient transferred to IST|0|||
94233295|NCT01236352|322648243|FG009|Overall Study|Patient transferred to IST|2|||
94233296|NCT01236352|322648244|FG010|Overall Study|Patient transferred to IST|6|||
94233297|NCT01774305|322648245|FG000|Overall Study|Physician Decision|1|||
94233298|NCT01774305|322648246|FG001|Overall Study|Physician Decision|0|||
94233299|NCT02658175|322648249|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
94559672|NCT04506502|323844342|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
94559673|NCT04838626|323844344|FG000|Overall Study|Adverse Event|2|||
94559674|NCT04838626|323844344|FG000|Overall Study|Physician Decision|6|||
94559675|NCT04838626|323844344|FG000|Overall Study|Protocol Violation|3|||
94559676|NCT04838626|323844344|FG000|Overall Study|Withdrawal by Subject|9|||
94559677|NCT04838626|323844344|FG000|Overall Study|Technical Problems|2|||
94559678|NCT01726582|323844349|FG000|Overall Study|Physician Decision|99|||
94559679|NCT01726582|323844349|FG000|Overall Study|Death|85|||
94559680|NCT01235234|323844350|FG000|Overall Study|Adverse Event|2|||
94559681|NCT01235234|323844351|FG001|Overall Study|Adverse Event|2|||
94559682|NCT01235234|323844352|FG002|Overall Study|Adverse Event|1|||
94559683|NCT02828436|323844353|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
94559684|NCT02828436|323844354|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
94559685|NCT02828436|323844353|FG000|Period 1|Lost to Follow-up|0|||
94559686|NCT02828436|323844354|FG001|Period 1|Lost to Follow-up|1|||
94559687|NCT02828436|323844353|FG000|Period 2|Withdrawal by Subject|4|||
94559688|NCT02828436|323844354|FG001|Period 2|Withdrawal by Subject|0|||
94559689|NCT02828436|323844353|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
94559690|NCT02828436|323844354|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
94559691|NCT02828436|323844353|FG000|Period 2|Lost to Follow-up|1|||
94559692|NCT02828436|323844354|FG001|Period 2|Lost to Follow-up|0|||
94559693|NCT02644343|323844357|FG000|Overall Study|Withdrawal by Subject|1|||
94559694|NCT00536471|323844358|FG000|Overall Study|Lost to Follow-up|48|||
94559695|NCT00536471|323844359|FG001|Overall Study|Lost to Follow-up|23|||
94559696|NCT00536471|323844360|FG002|Overall Study|Lost to Follow-up|48|||
94559697|NCT00536471|323844361|FG003|Overall Study|Lost to Follow-up|22|||
94559698|NCT00536471|323844358|FG000|Overall Study|Adverse Event|32|||
94559699|NCT00536471|323844359|FG001|Overall Study|Adverse Event|16|||
94559700|NCT00536471|323844360|FG002|Overall Study|Adverse Event|28|||
94559701|NCT00536471|323844361|FG003|Overall Study|Adverse Event|13|||
94559702|NCT00536471|323844358|FG000|Overall Study|Withdrawal by Subject|40|||
94559703|NCT00536471|323844359|FG001|Overall Study|Withdrawal by Subject|24|||
94559704|NCT00536471|323844360|FG002|Overall Study|Withdrawal by Subject|43|||
94559705|NCT00536471|323844361|FG003|Overall Study|Withdrawal by Subject|21|||
94559706|NCT00536471|323844358|FG000|Overall Study|Lack of Efficacy|17|||
94559707|NCT00536471|323844359|FG001|Overall Study|Lack of Efficacy|18|||
94559708|NCT00536471|323844360|FG002|Overall Study|Lack of Efficacy|11|||
94559709|NCT00536471|323844361|FG003|Overall Study|Lack of Efficacy|9|||
94559710|NCT00536471|323844358|FG000|Overall Study|Protocol Violation|8|||
94559711|NCT00536471|323844359|FG001|Overall Study|Protocol Violation|1|||
94559712|NCT00536471|323844360|FG002|Overall Study|Protocol Violation|2|||
94559713|NCT00536471|323844361|FG003|Overall Study|Protocol Violation|3|||
94559714|NCT00536471|323844358|FG000|Overall Study|Physician Decision|11|||
94559715|NCT00536471|323844359|FG001|Overall Study|Physician Decision|1|||
94559716|NCT00536471|323844360|FG002|Overall Study|Physician Decision|3|||
94559717|NCT00536471|323844361|FG003|Overall Study|Physician Decision|2|||
94559718|NCT00536471|323844358|FG000|Overall Study|Death|0|||
94559719|NCT00536471|323844359|FG001|Overall Study|Death|0|||
94559720|NCT00536471|323844360|FG002|Overall Study|Death|1|||
94559721|NCT00536471|323844361|FG003|Overall Study|Death|2|||
94559722|NCT00536471|323844358|FG000|Overall Study|Sponsor Decision|0|||
94559723|NCT00536471|323844359|FG001|Overall Study|Sponsor Decision|1|||
94559724|NCT00536471|323844360|FG002|Overall Study|Sponsor Decision|3|||
94559725|NCT00536471|323844361|FG003|Overall Study|Sponsor Decision|2|||
94559726|NCT00413036|323844362|FG000|Overall Study|Adverse Event|44|||
94559727|NCT00413036|323844362|FG000|Overall Study|Lack of Efficacy|129|||
94345364|NCT02987205|323045925|FG000|Overall Study|Adverse Event|1|||
94345365|NCT02987205|323045925|FG000|Overall Study|Withdrawal by Subject|3|||
94345366|NCT03261037|323045926|FG000|Overall Study|Withdrawal by Subject|2|||
94345367|NCT03261037|323045927|FG001|Overall Study|Withdrawal by Subject|13|||
94345368|NCT03261037|323045928|FG002|Overall Study|Withdrawal by Subject|0|||
94345369|NCT03261037|323045929|FG003|Overall Study|Withdrawal by Subject|18|||
94345370|NCT03261037|323045926|FG000|Overall Study|Non-compliance with study procedures|0|||
94345371|NCT03261037|323045927|FG001|Overall Study|Non-compliance with study procedures|2|||
94345372|NCT03261037|323045928|FG002|Overall Study|Non-compliance with study procedures|0|||
94345373|NCT03261037|323045929|FG003|Overall Study|Non-compliance with study procedures|6|||
94345374|NCT03261037|323045926|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
94345375|NCT03261037|323045927|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
94345376|NCT03261037|323045928|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
94345377|NCT03261037|323045929|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
94345378|NCT03261037|323045926|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
94345379|NCT03261037|323045927|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
94365601|NCT00532779|323122442|FG000|Overall Study|Drug noncompliance, moved, other|14|||
94233300|NCT02658175|322648250|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
94233301|NCT02658175|322648251|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
94233302|NCT02658175|322648249|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
94233303|NCT02658175|322648250|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
94233304|NCT02658175|322648251|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
94233305|NCT02658175|322648249|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
94233306|NCT02658175|322648250|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
94233307|NCT02658175|322648251|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
94233308|NCT02658175|322648249|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
94233309|NCT02658175|322648250|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
94233310|NCT02658175|322648251|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
94233311|NCT02658175|322648249|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
94233312|NCT02658175|322648250|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
94233313|NCT02658175|322648251|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
94233314|NCT02658175|322648249|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
94233315|NCT02658175|322648250|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
94233316|NCT02658175|322648251|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
94233317|NCT02658175|322648249|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
94233318|NCT02658175|322648250|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
94233319|NCT02658175|322648251|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
94233320|NCT02658175|322648249|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
94233321|NCT02658175|322648250|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
94233322|NCT02658175|322648251|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
94233323|NCT02658175|322648249|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
94233324|NCT02658175|322648250|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
94233325|NCT02658175|322648251|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
94233326|NCT02658175|322648249|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
94233327|NCT02658175|322648250|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
94233328|NCT02658175|322648251|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
94233329|NCT01263925|322648252|FG000|Overall Study|Protocol Violation|1|||
94233330|NCT01263925|322648253|FG001|Overall Study|Protocol Violation|0|||
94233331|NCT01263925|322648252|FG000|Overall Study|Lack of Efficacy|0|||
94233332|NCT01263925|322648253|FG001|Overall Study|Lack of Efficacy|1|||
94233333|NCT01263925|322648252|FG000|Overall Study|Adverse Event|23|||
94233334|NCT01263925|322648253|FG001|Overall Study|Adverse Event|22|||
94233335|NCT01263925|322648252|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
94233336|NCT01263925|322648253|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
94233337|NCT01263925|322648252|FG000|Overall Study|Withdrawal by Subject|6|||
94233338|NCT01263925|322648253|FG001|Overall Study|Withdrawal by Subject|8|||
94233339|NCT01263925|322648252|FG000|Overall Study|Other|4|||
94233340|NCT01263925|322648253|FG001|Overall Study|Other|4|||
94233341|NCT01263925|322648252|FG000|Overall Study|Lost to Follow-up|3|||
94233342|NCT01263925|322648253|FG001|Overall Study|Lost to Follow-up|1|||
94233343|NCT01263925|322648252|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
94233344|NCT01263925|322648253|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
94233345|NCT01263925|322648252|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
94233346|NCT01263925|322648253|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
94233347|NCT01263925|322648252|FG000|Overall Study|AE/ Withdrawal|1|||
94233348|NCT01263925|322648253|FG001|Overall Study|AE/ Withdrawal|4|||
94233349|NCT01263925|322648252|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
94449351|NCT03363776|323432660|FG001|Overall Study|Study drug toxicity|0|||
94449352|NCT03363776|323432661|FG002|Overall Study|Study drug toxicity|1|||
94449353|NCT03363776|323432659|FG000|Overall Study|Death|1|||
94449354|NCT03363776|323432660|FG001|Overall Study|Death|0|||
94449355|NCT03363776|323432661|FG002|Overall Study|Death|0|||
94449356|NCT00410813|323432662|FG000|Overall Study|Adverse Event|6|||
94449357|NCT00410813|323432663|FG001|Overall Study|Adverse Event|11|||
94449358|NCT00410813|323432662|FG000|Overall Study|Progression|32|||
94449359|NCT00410813|323432663|FG001|Overall Study|Progression|21|||
94449360|NCT00410813|323432662|FG000|Overall Study|Not protocol specified|3|||
94449361|NCT00410813|323432663|FG001|Overall Study|Not protocol specified|4|||
94449362|NCT00410813|323432662|FG000|Overall Study|Ineligible|2|||
94449363|NCT00410813|323432663|FG001|Overall Study|Ineligible|4|||
94449364|NCT00410813|323432662|FG000|Overall Study|Death|0|||
94449365|NCT00410813|323432663|FG001|Overall Study|Death|2|||
94449366|NCT00954941|323432664|FG000|Overall Study|Received treatment at home|1|||
94449367|NCT00954941|323432665|FG001|Overall Study|Received treatment at home|0|||
94449368|NCT00954941|323432664|FG000|Overall Study|Withdrawal by Subject|1|||
94449369|NCT00954941|323432665|FG001|Overall Study|Withdrawal by Subject|0|||
94449370|NCT00954941|323432664|FG000|Overall Study|Insurance Denial|2|||
94559728|NCT00413036|323844362|FG000|Overall Study|Withdrawal by Subject|7|||
94559729|NCT00413036|323844362|FG000|Overall Study|Death|9|||
94559730|NCT00413036|323844362|FG000|Overall Study|Other|26|||
94559731|NCT00413036|323844362|FG000|Overall Study|Missing|2|||
94559732|NCT05173012|323844365|FG000|Overall Study|Adverse Event|2|||
94559733|NCT05173012|323844366|FG001|Overall Study|Adverse Event|3|||
94559734|NCT05173012|323844367|FG002|Overall Study|Adverse Event|4|||
94559735|NCT05173012|323844368|FG003|Overall Study|Adverse Event|13|||
94559736|NCT05173012|323844369|FG004|Overall Study|Adverse Event|0|||
94559737|NCT05173012|323844370|FG005|Overall Study|Adverse Event|0|||
94559738|NCT05173012|323844371|FG006|Overall Study|Adverse Event|2|||
94559739|NCT05173012|323844372|FG007|Overall Study|Adverse Event|4|||
94559740|NCT05173012|323844365|FG000|Overall Study|Lost to Follow-up|0|||
94559741|NCT05173012|323844366|FG001|Overall Study|Lost to Follow-up|0|||
94559742|NCT05173012|323844367|FG002|Overall Study|Lost to Follow-up|0|||
94559743|NCT05173012|323844368|FG003|Overall Study|Lost to Follow-up|1|||
94559744|NCT05173012|323844369|FG004|Overall Study|Lost to Follow-up|0|||
94559745|NCT05173012|323844370|FG005|Overall Study|Lost to Follow-up|0|||
94559746|NCT05173012|323844371|FG006|Overall Study|Lost to Follow-up|0|||
94559747|NCT05173012|323844372|FG007|Overall Study|Lost to Follow-up|0|||
94559748|NCT05173012|323844365|FG000|Overall Study|Withdrawal by Subject|1|||
94559749|NCT05173012|323844366|FG001|Overall Study|Withdrawal by Subject|0|||
94559750|NCT05173012|323844367|FG002|Overall Study|Withdrawal by Subject|1|||
94559751|NCT05173012|323844368|FG003|Overall Study|Withdrawal by Subject|3|||
94559752|NCT05173012|323844369|FG004|Overall Study|Withdrawal by Subject|1|||
94559753|NCT05173012|323844370|FG005|Overall Study|Withdrawal by Subject|0|||
94449371|NCT00954941|323432665|FG001|Overall Study|Insurance Denial|2|||
94559754|NCT05173012|323844371|FG006|Overall Study|Withdrawal by Subject|1|||
94559755|NCT05173012|323844372|FG007|Overall Study|Withdrawal by Subject|0|||
94559756|NCT05173012|323844365|FG000|Overall Study|Protocol Deviation|0|||
94559757|NCT05173012|323844366|FG001|Overall Study|Protocol Deviation|0|||
94559758|NCT05173012|323844367|FG002|Overall Study|Protocol Deviation|0|||
94559759|NCT05173012|323844368|FG003|Overall Study|Protocol Deviation|1|||
94449372|NCT00954941|323432664|FG000|Overall Study|Physician Decision|2|||
94449373|NCT00954941|323432665|FG001|Overall Study|Physician Decision|2|||
94449374|NCT00954941|323432664|FG000|Overall Study|Ineligible|2|||
94449375|NCT00954941|323432665|FG001|Overall Study|Ineligible|2|||
94449376|NCT00954941|323432664|FG000|Overall Study|Adverse Event|0|||
94449377|NCT00954941|323432665|FG001|Overall Study|Adverse Event|1|||
94449378|NCT00529308|323432666|FG000|Overall Study|Withdrawal by Subject|1|||
94449379|NCT00529308|323432667|FG001|Overall Study|Withdrawal by Subject|1|||
94449380|NCT02268916|323432674|FG000|Overall Study|Lost to Follow-up|1|||
94449381|NCT02268916|323432675|FG001|Overall Study|Lost to Follow-up|1|||
94449382|NCT02268916|323432674|FG000|Overall Study|Withdrawal by Subject|6|||
94449383|NCT02268916|323432675|FG001|Overall Study|Withdrawal by Subject|5|||
94449384|NCT02268916|323432674|FG000|Overall Study|Participant did not have diabetes|1|||
94449385|NCT02268916|323432675|FG001|Overall Study|Participant did not have diabetes|0|||
94449386|NCT02268916|323432674|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
94449387|NCT02268916|323432675|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
94449388|NCT03926117|323432676|FG000|Overall Study|Unclassified|1|||
94449389|NCT03926117|323432677|FG001|Overall Study|Unclassified|4|||
94449390|NCT03926117|323432678|FG002|Overall Study|Unclassified|1|||
94449391|NCT03926117|323432679|FG003|Overall Study|Unclassified|4|||
94449392|NCT03926117|323432676|FG000|Overall Study|Withdrawal by Subject|3|||
94449393|NCT03926117|323432677|FG001|Overall Study|Withdrawal by Subject|0|||
94449394|NCT03926117|323432678|FG002|Overall Study|Withdrawal by Subject|1|||
94449395|NCT03926117|323432679|FG003|Overall Study|Withdrawal by Subject|1|||
94449396|NCT03926117|323432676|FG000|Overall Study|Lost to Follow-up|0|||
94449397|NCT03926117|323432677|FG001|Overall Study|Lost to Follow-up|2|||
94449398|NCT03926117|323432678|FG002|Overall Study|Lost to Follow-up|1|||
94449399|NCT03926117|323432679|FG003|Overall Study|Lost to Follow-up|0|||
94449400|NCT03926117|323432676|FG000|Overall Study|Adverse Event|1|||
94449401|NCT03926117|323432677|FG001|Overall Study|Adverse Event|2|||
94449402|NCT03926117|323432678|FG002|Overall Study|Adverse Event|3|||
94449403|NCT03926117|323432679|FG003|Overall Study|Adverse Event|1|||
94449404|NCT03926117|323432676|FG000|Overall Study|Randomized but not treated|1|||
94449405|NCT03926117|323432677|FG001|Overall Study|Randomized but not treated|1|||
94449406|NCT03926117|323432678|FG002|Overall Study|Randomized but not treated|0|||
94449407|NCT03926117|323432679|FG003|Overall Study|Randomized but not treated|1|||
94449408|NCT00745901|323432681|FG000|Overall Study|Adverse Event|3|||
94449409|NCT00745901|323432682|FG001|Overall Study|Adverse Event|4|||
94449410|NCT00745901|323432681|FG000|Overall Study|Protocol Violation|0|||
94449411|NCT00745901|323432682|FG001|Overall Study|Protocol Violation|1|||
94449412|NCT00745901|323432681|FG000|Overall Study|Withdrawal by Subject|1|||
94449413|NCT00745901|323432682|FG001|Overall Study|Withdrawal by Subject|0|||
94449414|NCT00745901|323432681|FG000|Overall Study|Lost to Follow-up|7|||
94449415|NCT00745901|323432682|FG001|Overall Study|Lost to Follow-up|4|||
94449416|NCT00745901|323432681|FG000|Overall Study|Pregnancy|2|||
94449417|NCT00745901|323432682|FG001|Overall Study|Pregnancy|4|||
94449418|NCT00745901|323432681|FG000|Overall Study|Lack of compliance|2|||
94449419|NCT00745901|323432682|FG001|Overall Study|Lack of compliance|2|||
94449420|NCT00745901|323432681|FG000|Overall Study|Patient's next menses did not start with|1|||
94449421|NCT00745901|323432682|FG001|Overall Study|Patient's next menses did not start with|0|||
94449422|NCT00745901|323432681|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
94449423|NCT00745901|323432682|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
94449424|NCT00745901|323432681|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
94449425|NCT00745901|323432682|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
94559760|NCT05173012|323844369|FG004|Overall Study|Protocol Deviation|0|||
94559761|NCT05173012|323844370|FG005|Overall Study|Protocol Deviation|0|||
94559762|NCT05173012|323844371|FG006|Overall Study|Protocol Deviation|0|||
94559763|NCT05173012|323844372|FG007|Overall Study|Protocol Deviation|0|||
94559764|NCT05173012|323844365|FG000|Overall Study|Other|0|||
94559765|NCT05173012|323844366|FG001|Overall Study|Other|0|||
94559766|NCT05173012|323844367|FG002|Overall Study|Other|0|||
94559767|NCT05173012|323844368|FG003|Overall Study|Other|2|||
94559768|NCT05173012|323844369|FG004|Overall Study|Other|0|||
94559769|NCT05173012|323844370|FG005|Overall Study|Other|0|||
94559770|NCT05173012|323844371|FG006|Overall Study|Other|0|||
94559771|NCT05173012|323844372|FG007|Overall Study|Other|0|||
94559772|NCT00517361|323844375|FG000|Overall Study|Death|6|||
94559773|NCT00517361|323844375|FG000|Overall Study|The study was terminated|5|||
94559774|NCT01685697|323844376|FG000|Overall Study|Protocol Violation|3|||
94559775|NCT01685697|323844377|FG001|Overall Study|Protocol Violation|3|||
94559776|NCT02221674|323844378|FG000|Overall Study|Lost to Follow-up|1|||
94559777|NCT02221674|323844379|FG001|Overall Study|Lost to Follow-up|0|||
94559778|NCT02221674|323844380|FG002|Overall Study|Lost to Follow-up|0|||
94559779|NCT06312592|323844381|FG000|Overall Study|Lost to Follow-up|29|||
94559780|NCT06312592|323844382|FG001|Overall Study|Lost to Follow-up|13|||
94559781|NCT06136897|323844384|FG000|Overall Study|Ineligible|3|||
94559782|NCT06136897|323844384|FG000|Overall Study|Mutation status not confirmed|7|||
94559783|NCT06136897|323844384|FG000|Overall Study|Adverse Event|2|||
94559784|NCT06136897|323844384|FG000|Overall Study|Death|1|||
94559785|NCT06136897|323844384|FG000|Overall Study|Disease progression|18|||
94559786|NCT06136897|323844384|FG000|Overall Study|Other complicating disease|1|||
94559787|NCT06136897|323844384|FG000|Overall Study|Withdrawal by Subject|1|||
94559788|NCT06136897|323844384|FG000|Overall Study|Still on treatment|1|||
94559789|NCT06136897|323844384|FG000|Overall Study|Lost to Follow-up|1|||
94559790|NCT03517228|323844385|FG000|Overall Study|Withdrawal by Subject|2|||
94559791|NCT03517228|323844385|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
94559792|NCT03517228|323844385|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
94559793|NCT03517228|323844385|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
94559794|NCT03517228|323844385|FG000|Overall Study|Canceled due to device being updated|1|||
94559795|NCT03517228|323844385|FG000|Overall Study|No V Cares in stock|1|||
94559796|NCT03517228|323844385|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
94559797|NCT00239928|323844386|FG000|Overall Study|Lack of Efficacy|1|||
94559798|NCT00239928|323844386|FG000|Overall Study|Adverse Event|4|||
94559799|NCT00239928|323844386|FG000|Overall Study|Not need to continue study|3|||
94559800|NCT00239928|323844386|FG000|Overall Study|Withdrawal by Subject|2|||
94559801|NCT00555672|323844389|FG000|Overall Study|Death|0|||
94559802|NCT00555672|323844390|FG001|Overall Study|Death|2|||
94559803|NCT00555672|323844389|FG000|Overall Study|Adverse Event|8|||
94345380|NCT03261037|323045928|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
94559804|NCT00555672|323844390|FG001|Overall Study|Adverse Event|2|||
94559805|NCT00555672|323844389|FG000|Overall Study|Objective progression or relapse|11|||
94559806|NCT00555672|323844390|FG001|Overall Study|Objective progression or relapse|5|||
94559807|NCT00555672|323844389|FG000|Overall Study|Other|3|||
94559808|NCT00555672|323844390|FG001|Overall Study|Other|1|||
94559809|NCT00555672|323844389|FG000|Overall Study|Participant refused|2|||
94559810|NCT00555672|323844390|FG001|Overall Study|Participant refused|0|||
94559811|NCT04181762|323844391|FG000|Overall Study|Adverse Event|1|||
94559812|NCT04181762|323844392|FG001|Overall Study|Adverse Event|3|||
94559813|NCT04181762|323844391|FG000|Overall Study|Lost to Follow-up|1|||
94559814|NCT04181762|323844392|FG001|Overall Study|Lost to Follow-up|1|||
94559815|NCT04181762|323844391|FG000|Overall Study|Physician Decision|1|||
94559816|NCT04181762|323844392|FG001|Overall Study|Physician Decision|3|||
94559817|NCT04181762|323844391|FG000|Overall Study|Pregnancy|0|||
94559818|NCT04181762|323844392|FG001|Overall Study|Pregnancy|1|||
94559819|NCT04181762|323844391|FG000|Overall Study|Lack of Efficacy|2|||
94559820|NCT04181762|323844392|FG001|Overall Study|Lack of Efficacy|2|||
94559821|NCT04181762|323844391|FG000|Overall Study|Study terminated by sponsor|95|||
94559822|NCT04181762|323844392|FG001|Overall Study|Study terminated by sponsor|97|||
94559823|NCT04181762|323844391|FG000|Overall Study|Subject decision|11|||
94559824|NCT04181762|323844392|FG001|Overall Study|Subject decision|4|||
94559825|NCT04181762|323844391|FG000|Overall Study|Death|1|||
94559826|NCT04181762|323844392|FG001|Overall Study|Death|1|||
94559827|NCT04181762|323844391|FG000|Overall Study|Protocol deviation|1|||
94559828|NCT04181762|323844392|FG001|Overall Study|Protocol deviation|0|||
94559829|NCT04181762|323844391|FG000|Overall Study|Withdrawal of informed consent|1|||
94559830|NCT04181762|323844392|FG001|Overall Study|Withdrawal of informed consent|3|||
94559831|NCT01856582|323844394|FG000|Overall Study|Died prior to Boost infusion|1|||
94559832|NCT02097030|323844396|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
94559833|NCT02097030|323844397|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
94559834|NCT02097030|323844396|FG000|First Intervention (3 Days)|Visual Acuity|0|||
94559835|NCT02097030|323844397|FG001|First Intervention (3 Days)|Visual Acuity|1|||
94559836|NCT02669212|323844398|FG000|Overall Study|Lost to Follow-up|1|||
94559837|NCT02669212|323844399|FG001|Overall Study|Lost to Follow-up|0|||
94559838|NCT02669212|323844398|FG000|Overall Study|Medical Condition|3|||
94559839|NCT02669212|323844399|FG001|Overall Study|Medical Condition|4|||
94559840|NCT02669212|323844398|FG000|Overall Study|Withdrawal by Subject|0|||
94559841|NCT02669212|323844399|FG001|Overall Study|Withdrawal by Subject|2|||
94559842|NCT02669212|323844398|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
94559843|NCT02669212|323844399|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
94559844|NCT00577824|323844407|FG000|Overall Study|Adverse Event|6|||
94559845|NCT00577824|323844408|FG001|Overall Study|Adverse Event|18|||
94559846|NCT00577824|323844409|FG002|Overall Study|Adverse Event|1|||
94559847|NCT00577824|323844407|FG000|Overall Study|Patient decision|0|||
94559848|NCT00577824|323844408|FG001|Overall Study|Patient decision|1|||
94559849|NCT00577824|323844409|FG002|Overall Study|Patient decision|1|||
94559850|NCT00577824|323844407|FG000|Overall Study|Protocol Violation|1|||
94559851|NCT00577824|323844408|FG001|Overall Study|Protocol Violation|1|||
94559852|NCT00577824|323844409|FG002|Overall Study|Protocol Violation|0|||
94559853|NCT00391027|323844410|FG000|Overall Study|Adverse Event|8|||
94559854|NCT00391027|323844411|FG001|Overall Study|Adverse Event|8|||
94559855|NCT00391027|323844410|FG000|Overall Study|Lack of Efficacy|3|||
94559856|NCT00391027|323844411|FG001|Overall Study|Lack of Efficacy|0|||
94559857|NCT00391027|323844410|FG000|Overall Study|Withdrawal by Subject|10|||
94559858|NCT00391027|323844411|FG001|Overall Study|Withdrawal by Subject|1|||
94559859|NCT00391027|323844410|FG000|Overall Study|Other|4|||
94559860|NCT00391027|323844411|FG001|Overall Study|Other|3|||
94559861|NCT00836186|323844412|FG000|Overall Study|Blood could not be drawn|1|||
94559862|NCT02717611|323844413|FG000|Overall Study|Death|13|||
94559863|NCT02717611|323844413|FG000|Overall Study|Withdrawal by Subject|6|||
94559864|NCT02717611|323844413|FG000|Overall Study|Active, not recruiting|40|||
94559865|NCT02717611|323844413|FG000|Overall Study|Complicating disease|1|||
94559866|NCT04300309|323844414|FG000|Overall Study|Lost to Follow-up|1|||
94559867|NCT04300309|323844415|FG001|Overall Study|Lost to Follow-up|0|||
94559868|NCT00661622|323844416|FG000|Overall Study|Protocol Violation|1|||
94559869|NCT00661622|323844417|FG001|Overall Study|Protocol Violation|0|||
94233350|NCT01263925|322648253|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
94449426|NCT00745901|323432681|FG000|Overall Study|Patient didn't take any study medication|7|||
94465827|NCT00195494|323494916|FG002|Year 2|Protocol deviation|0|||
94465828|NCT00195494|323494917|FG003|Year 2|Protocol deviation|0|||
94465829|NCT00195494|323494918|FG004|Year 2|Protocol deviation|0|||
94465830|NCT00195494|323494919|FG005|Year 2|Protocol deviation|0|||
94465831|NCT00195494|323494914|FG000|Year 2|Physician Decision|1|||
94465832|NCT00195494|323494915|FG001|Year 2|Physician Decision|1|||
94465833|NCT00195494|323494916|FG002|Year 2|Physician Decision|0|||
94465834|NCT00195494|323494917|FG003|Year 2|Physician Decision|0|||
94465835|NCT00195494|323494918|FG004|Year 2|Physician Decision|0|||
94559870|NCT04427072|323844423|FG000|Randomized Treatment Phase|Progressive disease|9|||
94559871|NCT04427072|323844424|FG001|Randomized Treatment Phase|Progressive disease|4|||
94559872|NCT04427072|323844423|FG000|Randomized Treatment Phase|Adverse Event|3|||
94559873|NCT04427072|323844424|FG001|Randomized Treatment Phase|Adverse Event|1|||
94559874|NCT04427072|323844423|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
94559875|NCT04427072|323844424|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
94559876|NCT04427072|323844423|FG000|Randomized Treatment Phase|Death|0|||
94559877|NCT04427072|323844424|FG001|Randomized Treatment Phase|Death|1|||
94559878|NCT04427072|323844423|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
94559879|NCT04427072|323844424|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
94559880|NCT04427072|323844423|FG000|Extension Treatment Phase|Progressive disease|0|||
94559881|NCT04427072|323844424|FG001|Extension Treatment Phase|Progressive disease|5|||
94559882|NCT00465452|323844425|FG000|Overall Study|Adverse Event|1|||
94559883|NCT01636986|323844426|FG000|Overall Study|Withdrawal by Subject|0|||
94559884|NCT01636986|323844427|FG001|Overall Study|Withdrawal by Subject|1|||
94559885|NCT01636986|323844426|FG000|Overall Study|Corneal Staining|0|||
94559886|NCT01636986|323844427|FG001|Overall Study|Corneal Staining|1|||
94559887|NCT05870865|323844428|FG000|Randomized|Did not receive study treatment|2|||
94559888|NCT05870865|323844429|FG001|Randomized|Did not receive study treatment|4|||
94559889|NCT05870865|323844430|FG002|Randomized|Did not receive study treatment|4|||
94559890|NCT05870865|323844431|FG003|Randomized|Did not receive study treatment|3|||
94559891|NCT05870865|323844428|FG000|Treatment Period|Adverse Event|1|||
94559892|NCT05870865|323844429|FG001|Treatment Period|Adverse Event|1|||
94559893|NCT05870865|323844430|FG002|Treatment Period|Adverse Event|1|||
94559894|NCT05870865|323844431|FG003|Treatment Period|Adverse Event|1|||
94233351|NCT01263925|322648252|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
94365602|NCT00532779|323122443|FG001|Overall Study|Drug noncompliance, moved, other|23|||
94559895|NCT05870865|323844428|FG000|Treatment Period|Lost to Follow-up|0|||
94559896|NCT05870865|323844429|FG001|Treatment Period|Lost to Follow-up|1|||
94559897|NCT05870865|323844430|FG002|Treatment Period|Lost to Follow-up|2|||
94559898|NCT05870865|323844431|FG003|Treatment Period|Lost to Follow-up|0|||
94559899|NCT05870865|323844428|FG000|Treatment Period|Protocol Violation|0|||
94559900|NCT05870865|323844429|FG001|Treatment Period|Protocol Violation|0|||
94559901|NCT05870865|323844430|FG002|Treatment Period|Protocol Violation|0|||
94233352|NCT01263925|322648253|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
94233353|NCT01263925|322648252|FG000|Overall Study|Withdrawal/ Not specified|0|||
94233354|NCT01263925|322648253|FG001|Overall Study|Withdrawal/ Not specified|1|||
94233355|NCT01185171|322648256|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
94233356|NCT01185171|322648256|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
94233357|NCT01185171|322648256|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
94233358|NCT01185171|322648256|FG000|Maintenance|Elevated liver transaminases|3|||
94233359|NCT01185171|322648256|FG000|Maintenance|Rush|2|||
94233360|NCT01185171|322648256|FG000|Maintenance|Diarrhea|1|||
94559902|NCT05870865|323844431|FG003|Treatment Period|Protocol Violation|1|||
94559903|NCT05870865|323844428|FG000|Treatment Period|Withdrawal by Subject|0|||
94559904|NCT05870865|323844429|FG001|Treatment Period|Withdrawal by Subject|1|||
94559905|NCT05870865|323844430|FG002|Treatment Period|Withdrawal by Subject|1|||
94559906|NCT05870865|323844431|FG003|Treatment Period|Withdrawal by Subject|1|||
94559907|NCT00766051|323844436|FG000|Overall Study|Withdrawal by Subject|2|||
94559908|NCT00766051|323844437|FG001|Overall Study|Withdrawal by Subject|0|||
94559909|NCT00858637|323844438|FG000|Active Comparison Phase|Adverse Event|14|||
94559910|NCT00858637|323844439|FG001|Active Comparison Phase|Adverse Event|0|||
94559911|NCT00858637|323844440|FG002|Active Comparison Phase|Adverse Event|0|||
94559912|NCT00858637|323844441|FG003|Active Comparison Phase|Adverse Event|9|||
94559913|NCT00858637|323844442|FG004|Active Comparison Phase|Adverse Event|0|||
94559914|NCT00858637|323844443|FG005|Active Comparison Phase|Adverse Event|0|||
94559915|NCT00858637|323844438|FG000|Active Comparison Phase|Death|1|||
94559916|NCT00858637|323844439|FG001|Active Comparison Phase|Death|0|||
94559917|NCT00858637|323844440|FG002|Active Comparison Phase|Death|0|||
94559918|NCT00858637|323844441|FG003|Active Comparison Phase|Death|1|||
94559919|NCT00858637|323844442|FG004|Active Comparison Phase|Death|0|||
94559920|NCT00858637|323844443|FG005|Active Comparison Phase|Death|0|||
94559921|NCT00858637|323844438|FG000|Active Comparison Phase|Physician Decision|1|||
94559922|NCT00858637|323844439|FG001|Active Comparison Phase|Physician Decision|0|||
94559923|NCT00858637|323844440|FG002|Active Comparison Phase|Physician Decision|0|||
94559924|NCT00858637|323844441|FG003|Active Comparison Phase|Physician Decision|1|||
94559925|NCT00858637|323844442|FG004|Active Comparison Phase|Physician Decision|0|||
94559926|NCT00858637|323844443|FG005|Active Comparison Phase|Physician Decision|0|||
94559927|NCT00858637|323844438|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
94559928|NCT00858637|323844439|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
94559929|NCT00858637|323844440|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
94559930|NCT00858637|323844441|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
94559931|NCT00858637|323844442|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
94559932|NCT00858637|323844443|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
94559933|NCT00858637|323844438|FG000|Active Comparison Phase|Other Reasons|1|||
94559934|NCT00858637|323844439|FG001|Active Comparison Phase|Other Reasons|0|||
94559935|NCT00858637|323844440|FG002|Active Comparison Phase|Other Reasons|0|||
94559936|NCT00858637|323844441|FG003|Active Comparison Phase|Other Reasons|1|||
94559937|NCT00858637|323844442|FG004|Active Comparison Phase|Other Reasons|0|||
94559938|NCT00858637|323844443|FG005|Active Comparison Phase|Other Reasons|0|||
94559939|NCT00858637|323844438|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
94559940|NCT00858637|323844439|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
94559941|NCT00858637|323844440|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
94559942|NCT00858637|323844441|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
94559943|NCT00858637|323844442|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
94559944|NCT00858637|323844443|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
94559945|NCT00858637|323844438|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
94559946|NCT00858637|323844439|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
94559947|NCT00858637|323844440|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
94559948|NCT00858637|323844441|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
94559949|NCT00858637|323844442|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
94559950|NCT00858637|323844443|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
94559951|NCT04310566|323844447|FG000|Period 1|Study Termination due to COVID-19|15|||
94559952|NCT04310566|323844448|FG001|Period 1|Study Termination due to COVID-19|17|||
94559953|NCT04310566|323844447|FG000|Period 1|Protocol Violation|0|||
94559954|NCT04310566|323844448|FG001|Period 1|Protocol Violation|1|||
94559955|NCT04310566|323844447|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
94233361|NCT01185171|322648256|FG000|Maintenance|Xerostomia|1|||
94559956|NCT04310566|323844448|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
94559957|NCT04310566|323844447|FG000|Period 1|Lost to Follow-up|1|||
94559958|NCT04310566|323844448|FG001|Period 1|Lost to Follow-up|0|||
94559959|NCT04310566|323844447|FG000|Period 1|Withdrawal by Subject|0|||
94559960|NCT04310566|323844448|FG001|Period 1|Withdrawal by Subject|1|||
94559961|NCT04310566|323844447|FG000|Period 2|Study Termination|7|||
94559962|NCT04310566|323844448|FG001|Period 2|Study Termination|5|||
94559963|NCT00825812|323844449|FG000|Overall Study|Never entered follow up|0|||
94559964|NCT00825812|323844450|FG001|Overall Study|Never entered follow up|0|||
94559965|NCT00825812|323844451|FG002|Overall Study|Never entered follow up|0|||
94559966|NCT00825812|323844452|FG003|Overall Study|Never entered follow up|1|||
94559967|NCT00825812|323844449|FG000|Overall Study|Adverse Event|0|||
94559968|NCT00825812|323844450|FG001|Overall Study|Adverse Event|0|||
94559969|NCT00825812|323844451|FG002|Overall Study|Adverse Event|0|||
94559970|NCT00825812|323844452|FG003|Overall Study|Adverse Event|1|||
94559971|NCT00825812|323844449|FG000|Overall Study|Subject withdrew consent|0|||
94559972|NCT00825812|323844450|FG001|Overall Study|Subject withdrew consent|0|||
94559973|NCT00825812|323844451|FG002|Overall Study|Subject withdrew consent|3|||
94559974|NCT00825812|323844452|FG003|Overall Study|Subject withdrew consent|2|||
94559975|NCT00825812|323844449|FG000|Overall Study|Non-compliance with protocol|0|||
94559976|NCT00825812|323844450|FG001|Overall Study|Non-compliance with protocol|0|||
94559977|NCT00825812|323844451|FG002|Overall Study|Non-compliance with protocol|0|||
94559978|NCT00825812|323844452|FG003|Overall Study|Non-compliance with protocol|1|||
94559979|NCT00825812|323844449|FG000|Overall Study|Administrative|0|||
94559980|NCT00825812|323844450|FG001|Overall Study|Administrative|1|||
94559981|NCT00825812|323844451|FG002|Overall Study|Administrative|3|||
94559982|NCT00825812|323844452|FG003|Overall Study|Administrative|5|||
94233362|NCT01185171|322648256|FG000|Maintenance|Nausea|1|||
94233363|NCT01185171|322648256|FG000|Maintenance|Comorbid Illness|2|||
94233364|NCT01185171|322648256|FG000|Maintenance|Withdrawal by Subject|1|||
94233365|NCT01185171|322648256|FG000|Maintenance|Disease Recurrence|1|||
94233366|NCT01214421|322648257|FG000|Overall Study|Lost to Follow-up|7|||
94233367|NCT01214421|322648258|FG001|Overall Study|Lost to Follow-up|3|||
94233368|NCT01214421|322648259|FG002|Overall Study|Lost to Follow-up|7|||
94233369|NCT01214421|322648260|FG003|Overall Study|Lost to Follow-up|3|||
94233370|NCT01214421|322648257|FG000|Overall Study|Adverse Event|16|||
94233371|NCT01214421|322648258|FG001|Overall Study|Adverse Event|35|||
94233372|NCT01214421|322648259|FG002|Overall Study|Adverse Event|14|||
94233373|NCT01214421|322648260|FG003|Overall Study|Adverse Event|3|||
94233374|NCT01214421|322648257|FG000|Overall Study|Sponsor Discontinued Site|1|||
94233375|NCT01214421|322648258|FG001|Overall Study|Sponsor Discontinued Site|2|||
94233376|NCT01214421|322648259|FG002|Overall Study|Sponsor Discontinued Site|0|||
94233377|NCT01214421|322648260|FG003|Overall Study|Sponsor Discontinued Site|0|||
94233378|NCT01214421|322648257|FG000|Overall Study|Withdrawal Criteria Met|3|||
94233379|NCT01214421|322648258|FG001|Overall Study|Withdrawal Criteria Met|0|||
94233380|NCT01214421|322648259|FG002|Overall Study|Withdrawal Criteria Met|2|||
94233381|NCT01214421|322648260|FG003|Overall Study|Withdrawal Criteria Met|1|||
94233382|NCT01214421|322648257|FG000|Overall Study|Physician Decision|2|||
94233383|NCT01214421|322648258|FG001|Overall Study|Physician Decision|0|||
94233384|NCT01214421|322648259|FG002|Overall Study|Physician Decision|4|||
94233385|NCT01214421|322648260|FG003|Overall Study|Physician Decision|0|||
94233386|NCT01214421|322648257|FG000|Overall Study|Withdrawal by Subject|21|||
94233387|NCT01214421|322648258|FG001|Overall Study|Withdrawal by Subject|18|||
94233388|NCT01214421|322648259|FG002|Overall Study|Withdrawal by Subject|11|||
94559983|NCT02697435|323844457|FG000|Overall Study|Withdrawal by Subject|1|||
94559984|NCT02697435|323844458|FG001|Overall Study|Withdrawal by Subject|0|||
94559985|NCT02697435|323844457|FG000|Overall Study|Physician Decision|0|||
94559986|NCT02697435|323844458|FG001|Overall Study|Physician Decision|4|||
94233389|NCT01214421|322648260|FG003|Overall Study|Withdrawal by Subject|2|||
94233390|NCT04913948|322648261|FG000|Overall Study|Withdrawal by Subject|2|||
94233391|NCT04913948|322648261|FG000|Overall Study|Sample processing issues|1|||
94233392|NCT04913948|322648261|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
94233393|NCT01466790|322648263|FG000|Overall Study|Adverse Event|1|||
94233394|NCT01466790|322648264|FG001|Overall Study|Adverse Event|0|||
94233395|NCT01466790|322648265|FG002|Overall Study|Adverse Event|0|||
94233396|NCT01466790|322648266|FG003|Overall Study|Adverse Event|0|||
94233397|NCT01466790|322648267|FG004|Overall Study|Adverse Event|2|||
94233398|NCT01466790|322648268|FG005|Overall Study|Adverse Event|0|||
94233399|NCT01466790|322648269|FG006|Overall Study|Adverse Event|0|||
94233400|NCT01466790|322648270|FG007|Overall Study|Adverse Event|0|||
94559987|NCT01445080|323844473|FG000|Overall Study|Adverse Event|5|||
94559988|NCT01445080|323844474|FG001|Overall Study|Adverse Event|3|||
94559989|NCT01445080|323844475|FG002|Overall Study|Adverse Event|11|||
94559990|NCT01445080|323844476|FG003|Overall Study|Adverse Event|6|||
94233401|NCT01466790|322648263|FG000|Overall Study|Lost to Follow-up|2|||
94345381|NCT03261037|323045929|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
94449427|NCT00745901|323432682|FG001|Overall Study|Patient didn't take any study medication|3|||
94345382|NCT03261037|323045926|FG000|Overall Study|Diagnosed but protocol deviation|1|||
94345383|NCT03261037|323045927|FG001|Overall Study|Diagnosed but protocol deviation|0|||
94345384|NCT03261037|323045928|FG002|Overall Study|Diagnosed but protocol deviation|0|||
94345385|NCT03261037|323045929|FG003|Overall Study|Diagnosed but protocol deviation|0|||
94345386|NCT03261037|323045926|FG000|Overall Study|Participant did not want to continue the study|0|||
94345387|NCT03261037|323045927|FG001|Overall Study|Participant did not want to continue the study|1|||
94345388|NCT03261037|323045928|FG002|Overall Study|Participant did not want to continue the study|0|||
94345389|NCT03261037|323045929|FG003|Overall Study|Participant did not want to continue the study|0|||
94345390|NCT03261037|323045926|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
94345391|NCT03261037|323045927|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
94345392|NCT03261037|323045928|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
94345393|NCT03261037|323045929|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
94345394|NCT03261037|323045926|FG000|Overall Study|Participant presented clinical improvement|0|||
94345395|NCT03261037|323045927|FG001|Overall Study|Participant presented clinical improvement|2|||
94345396|NCT03261037|323045928|FG002|Overall Study|Participant presented clinical improvement|0|||
94345397|NCT03261037|323045929|FG003|Overall Study|Participant presented clinical improvement|0|||
94345398|NCT03261037|323045926|FG000|Overall Study|Technical difficulties|0|||
94345399|NCT03261037|323045927|FG001|Overall Study|Technical difficulties|0|||
94345400|NCT03261037|323045928|FG002|Overall Study|Technical difficulties|0|||
94345401|NCT03261037|323045929|FG003|Overall Study|Technical difficulties|1|||
94345402|NCT03261037|323045926|FG000|Overall Study|Equipment failed to work|0|||
94345403|NCT03261037|323045927|FG001|Overall Study|Equipment failed to work|0|||
94345404|NCT03261037|323045928|FG002|Overall Study|Equipment failed to work|0|||
94345405|NCT03261037|323045929|FG003|Overall Study|Equipment failed to work|1|||
94449428|NCT02554682|323432684|FG000|Overall Study|Lost to Follow-up|11|||
94345406|NCT03261037|323045926|FG000|Overall Study|End of study for participant and no follow up|0|||
94345407|NCT03261037|323045927|FG001|Overall Study|End of study for participant and no follow up|0|||
94345408|NCT03261037|323045928|FG002|Overall Study|End of study for participant and no follow up|0|||
94345409|NCT03261037|323045929|FG003|Overall Study|End of study for participant and no follow up|1|||
94345410|NCT03261037|323045926|FG000|Overall Study|Participant was too weak to continue in study|1|||
94657625|NCT00353704|324204336|FG000|Overall Study|Protocol Violation|3|||
94449429|NCT02554682|323432685|FG001|Overall Study|Lost to Follow-up|9|||
94657626|NCT00353704|324204337|FG001|Overall Study|Protocol Violation|1|||
94233402|NCT01466790|322648264|FG001|Overall Study|Lost to Follow-up|0|||
94233403|NCT01466790|322648265|FG002|Overall Study|Lost to Follow-up|0|||
94233404|NCT01466790|322648266|FG003|Overall Study|Lost to Follow-up|0|||
94233405|NCT01466790|322648267|FG004|Overall Study|Lost to Follow-up|0|||
94233406|NCT01466790|322648268|FG005|Overall Study|Lost to Follow-up|0|||
94233407|NCT01466790|322648269|FG006|Overall Study|Lost to Follow-up|0|||
94233408|NCT01466790|322648270|FG007|Overall Study|Lost to Follow-up|0|||
94233409|NCT01466790|322648263|FG000|Overall Study|Withdrawal by Subject|1|||
94233410|NCT01466790|322648264|FG001|Overall Study|Withdrawal by Subject|1|||
94233411|NCT01466790|322648265|FG002|Overall Study|Withdrawal by Subject|0|||
94233412|NCT01466790|322648266|FG003|Overall Study|Withdrawal by Subject|0|||
94233413|NCT01466790|322648267|FG004|Overall Study|Withdrawal by Subject|1|||
94233414|NCT01466790|322648268|FG005|Overall Study|Withdrawal by Subject|0|||
94233415|NCT01466790|322648269|FG006|Overall Study|Withdrawal by Subject|1|||
94449430|NCT02554682|323432686|FG002|Overall Study|Lost to Follow-up|4|||
94449431|NCT02554682|323432687|FG003|Overall Study|Lost to Follow-up|3|||
94449432|NCT02554682|323432688|FG004|Overall Study|Lost to Follow-up|2|||
94449433|NCT02554682|323432689|FG005|Overall Study|Lost to Follow-up|1|||
94449434|NCT02554682|323432690|FG006|Overall Study|Lost to Follow-up|6|||
94449435|NCT02554682|323432691|FG007|Overall Study|Lost to Follow-up|6|||
94449436|NCT02554682|323432692|FG008|Overall Study|Lost to Follow-up|2|||
94449437|NCT02554682|323432693|FG009|Overall Study|Lost to Follow-up|2|||
94449438|NCT02554682|323432684|FG000|Overall Study|Withdrawal by Subject|2|||
94449439|NCT02554682|323432685|FG001|Overall Study|Withdrawal by Subject|1|||
94449440|NCT02554682|323432686|FG002|Overall Study|Withdrawal by Subject|0|||
94449441|NCT02554682|323432687|FG003|Overall Study|Withdrawal by Subject|0|||
94449442|NCT02554682|323432688|FG004|Overall Study|Withdrawal by Subject|0|||
94449443|NCT02554682|323432689|FG005|Overall Study|Withdrawal by Subject|0|||
94449444|NCT02554682|323432690|FG006|Overall Study|Withdrawal by Subject|0|||
94449445|NCT02554682|323432691|FG007|Overall Study|Withdrawal by Subject|0|||
94449446|NCT02554682|323432692|FG008|Overall Study|Withdrawal by Subject|0|||
94449447|NCT02554682|323432693|FG009|Overall Study|Withdrawal by Subject|0|||
94449448|NCT02554682|323432684|FG000|Overall Study|Physician Decision|2|||
94449449|NCT02554682|323432685|FG001|Overall Study|Physician Decision|2|||
94449450|NCT02554682|323432686|FG002|Overall Study|Physician Decision|0|||
94449451|NCT02554682|323432687|FG003|Overall Study|Physician Decision|0|||
94449452|NCT02554682|323432688|FG004|Overall Study|Physician Decision|0|||
94449453|NCT02554682|323432689|FG005|Overall Study|Physician Decision|0|||
94449454|NCT02554682|323432690|FG006|Overall Study|Physician Decision|0|||
94449455|NCT02554682|323432691|FG007|Overall Study|Physician Decision|0|||
94449456|NCT02554682|323432692|FG008|Overall Study|Physician Decision|0|||
94449457|NCT02554682|323432693|FG009|Overall Study|Physician Decision|0|||
94449458|NCT04526288|323432694|FG000|Overall Study|Disease Progression|1|||
94449459|NCT04526288|323432695|FG001|Overall Study|Disease Progression|0|||
94449460|NCT01757535|323432698|FG000|Overall Study|Disease Relapse|143|||
94449461|NCT01757535|323432699|FG001|Overall Study|Disease Relapse|180|||
94449462|NCT01757535|323432698|FG000|Overall Study|Adverse Event|29|||
94449463|NCT01757535|323432699|FG001|Overall Study|Adverse Event|11|||
94449464|NCT01757535|323432698|FG000|Overall Study|Withdrawal by Subject|9|||
94449465|NCT01757535|323432699|FG001|Overall Study|Withdrawal by Subject|13|||
94449466|NCT01757535|323432698|FG000|Overall Study|Miscellaneous|5|||
94449467|NCT01757535|323432699|FG001|Overall Study|Miscellaneous|2|||
94449468|NCT01757535|323432698|FG000|Overall Study|Physician Decision|6|||
94449469|NCT01757535|323432699|FG001|Overall Study|Physician Decision|0|||
94449470|NCT01757535|323432698|FG000|Overall Study|Death|1|||
94449471|NCT01757535|323432699|FG001|Overall Study|Death|2|||
94449472|NCT00634803|323432700|FG000|Overall Study|Lost to Follow-up|6|||
94449473|NCT00634803|323432701|FG001|Overall Study|Lost to Follow-up|7|||
94449474|NCT00634803|323432702|FG002|Overall Study|Lost to Follow-up|7|||
94449475|NCT02091089|323432703|FG000|Overall Study|Lost to Follow-up|2|||
94449476|NCT02929589|323432704|FG000|Overall Study|Withdrawal by Subject|1|||
94449477|NCT02929589|323432705|FG001|Overall Study|Withdrawal by Subject|0|||
94233416|NCT01466790|322648270|FG007|Overall Study|Withdrawal by Subject|1|||
94233417|NCT01263054|322648275|FG000|Overall Study|Death|1|||
94465836|NCT00195494|323494919|FG005|Year 2|Physician Decision|0|||
94465837|NCT00195494|323494914|FG000|Year 2|Withdrawal by Subject|1|||
94559991|NCT01445080|323844477|FG004|Overall Study|Adverse Event|2|||
94559992|NCT01445080|323844478|FG005|Overall Study|Adverse Event|3|||
94559993|NCT01445080|323844479|FG006|Overall Study|Adverse Event|0|||
94559994|NCT01445080|323844480|FG007|Overall Study|Adverse Event|3|||
94559995|NCT01445080|323844481|FG008|Overall Study|Adverse Event|10|||
94559996|NCT01445080|323844473|FG000|Overall Study|Physician Decision|0|||
94559997|NCT01445080|323844474|FG001|Overall Study|Physician Decision|0|||
94559998|NCT01445080|323844475|FG002|Overall Study|Physician Decision|1|||
94559999|NCT01445080|323844476|FG003|Overall Study|Physician Decision|0|||
94560000|NCT01445080|323844477|FG004|Overall Study|Physician Decision|0|||
94560001|NCT01445080|323844478|FG005|Overall Study|Physician Decision|3|||
94560002|NCT01445080|323844479|FG006|Overall Study|Physician Decision|2|||
94560003|NCT01445080|323844480|FG007|Overall Study|Physician Decision|2|||
94560004|NCT01445080|323844481|FG008|Overall Study|Physician Decision|0|||
94560005|NCT01445080|323844473|FG000|Overall Study|Withdrawal by Subject|1|||
94560006|NCT01445080|323844474|FG001|Overall Study|Withdrawal by Subject|0|||
94465838|NCT00195494|323494915|FG001|Year 2|Withdrawal by Subject|5|||
94233418|NCT01263054|322648276|FG001|Overall Study|Death|0|||
94465839|NCT00195494|323494916|FG002|Year 2|Withdrawal by Subject|4|||
94465840|NCT00195494|323494917|FG003|Year 2|Withdrawal by Subject|3|||
94465841|NCT00195494|323494918|FG004|Year 2|Withdrawal by Subject|0|||
94465842|NCT00195494|323494919|FG005|Year 2|Withdrawal by Subject|0|||
94465843|NCT00195494|323494914|FG000|Year 2|System toxicity|0|||
94465844|NCT00195494|323494915|FG001|Year 2|System toxicity|0|||
94465845|NCT00195494|323494916|FG002|Year 2|System toxicity|0|||
94465846|NCT00195494|323494917|FG003|Year 2|System toxicity|1|||
94465847|NCT00195494|323494918|FG004|Year 2|System toxicity|0|||
94465848|NCT00195494|323494919|FG005|Year 2|System toxicity|0|||
94465849|NCT01162122|323494920|FG000|Overall Study|Withdrawal by Subject|52|||
94465850|NCT01162122|323494921|FG001|Overall Study|Withdrawal by Subject|43|||
94465851|NCT01162122|323494920|FG000|Overall Study|Lost to Follow-up|73|||
94465852|NCT01162122|323494921|FG001|Overall Study|Lost to Follow-up|91|||
94465853|NCT01162122|323494920|FG000|Overall Study|Adverse Event|3|||
94465854|NCT01162122|323494921|FG001|Overall Study|Adverse Event|2|||
94465855|NCT01162122|323494920|FG000|Overall Study|Death|51|||
94465856|NCT01162122|323494921|FG001|Overall Study|Death|46|||
94465857|NCT01162122|323494920|FG000|Overall Study|Protocol Violation|2|||
94465858|NCT01162122|323494921|FG001|Overall Study|Protocol Violation|2|||
94465859|NCT01162122|323494920|FG000|Overall Study|Inappropriate enrollment|5|||
94465860|NCT01162122|323494921|FG001|Overall Study|Inappropriate enrollment|4|||
94465861|NCT01162122|323494920|FG000|Overall Study|Administrative reason|1|||
94465862|NCT01162122|323494921|FG001|Overall Study|Administrative reason|1|||
94465863|NCT01162122|323494920|FG000|Overall Study|Unable to classify|3|||
94465864|NCT01162122|323494921|FG001|Overall Study|Unable to classify|7|||
94465865|NCT01162122|323494920|FG000|Overall Study|Missing primary reason|1|||
94465866|NCT01162122|323494921|FG001|Overall Study|Missing primary reason|0|||
94465867|NCT01074255|323494922|FG000|Overall Study|Did not receive EMEND|2|||
94465868|NCT02020512|323494923|FG000|Overall Study|Adverse Event|1|||
94465869|NCT02020512|323494923|FG000|Overall Study|Lost to Follow-up|3|||
94465870|NCT02020512|323494923|FG000|Overall Study|Protocol Violation|4|||
94465871|NCT01217385|323494924|FG000|Overall Study|Withdrawal by Subject|3|||
94465872|NCT01217385|323494924|FG000|Overall Study|DOSI not performed/not eval|12|||
94465873|NCT01217385|323494924|FG000|Overall Study|Central Path not Available|1|||
94465874|NCT01217385|323494924|FG000|Overall Study|Normal Breast TOI not available|10|||
94465875|NCT00090987|323494925|FG000|Overall Study|Adverse Event|5|||
94465876|NCT00090987|323494925|FG000|Overall Study|Lack of Efficacy|7|||
94465877|NCT00090987|323494925|FG000|Overall Study|Withdrawal by Subject|3|||
94465878|NCT00090987|323494925|FG000|Overall Study|alternative therapy|1|||
94560007|NCT01445080|323844475|FG002|Overall Study|Withdrawal by Subject|0|||
94560008|NCT01445080|323844476|FG003|Overall Study|Withdrawal by Subject|1|||
94560009|NCT01445080|323844477|FG004|Overall Study|Withdrawal by Subject|0|||
94560010|NCT01445080|323844478|FG005|Overall Study|Withdrawal by Subject|0|||
94560011|NCT01445080|323844479|FG006|Overall Study|Withdrawal by Subject|0|||
94560012|NCT01445080|323844480|FG007|Overall Study|Withdrawal by Subject|0|||
94560013|NCT01445080|323844481|FG008|Overall Study|Withdrawal by Subject|2|||
94560014|NCT01445080|323844473|FG000|Overall Study|Ineligible/Inevaluable|1|||
94560015|NCT01445080|323844474|FG001|Overall Study|Ineligible/Inevaluable|2|||
94560016|NCT01445080|323844475|FG002|Overall Study|Ineligible/Inevaluable|0|||
94560017|NCT01445080|323844476|FG003|Overall Study|Ineligible/Inevaluable|1|||
94560018|NCT01445080|323844477|FG004|Overall Study|Ineligible/Inevaluable|2|||
94560019|NCT01445080|323844478|FG005|Overall Study|Ineligible/Inevaluable|3|||
94560020|NCT01445080|323844479|FG006|Overall Study|Ineligible/Inevaluable|0|||
94560021|NCT01445080|323844480|FG007|Overall Study|Ineligible/Inevaluable|0|||
94560022|NCT01445080|323844481|FG008|Overall Study|Ineligible/Inevaluable|6|||
94560023|NCT03761810|323844482|FG000|Overall Study|Adverse Event|12|||
94560024|NCT03761810|323844483|FG001|Overall Study|Adverse Event|0|||
94560025|NCT03761810|323844482|FG000|Overall Study|Lost to Follow-up|15|||
94560026|NCT03761810|323844483|FG001|Overall Study|Lost to Follow-up|7|||
94560027|NCT03761810|323844482|FG000|Overall Study|Pregnancy|1|||
94560028|NCT03761810|323844483|FG001|Overall Study|Pregnancy|0|||
94560029|NCT03761810|323844482|FG000|Overall Study|Withdrawal by Subject|14|||
94560030|NCT03761810|323844483|FG001|Overall Study|Withdrawal by Subject|5|||
94560031|NCT03761810|323844482|FG000|Overall Study|Physician Decision|1|||
94560032|NCT03761810|323844483|FG001|Overall Study|Physician Decision|0|||
94560033|NCT03761810|323844482|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
94560034|NCT03761810|323844483|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94560035|NCT03761810|323844482|FG000|Overall Study|Other Than Specified|1|||
94560036|NCT03761810|323844483|FG001|Overall Study|Other Than Specified|0|||
94560037|NCT00934128|323844484|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
94560038|NCT00934128|323844485|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
94560039|NCT00934128|323844484|FG000|First Intervention (2 Hours)|Adverse Event|4|||
94560040|NCT00934128|323844485|FG001|First Intervention (2 Hours)|Adverse Event|1|||
94560041|NCT00934128|323844484|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
94560042|NCT00934128|323844485|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
94560043|NCT00934128|323844484|FG000|Washout Period (1 Hour)|Patient preference|1|||
94560044|NCT00934128|323844485|FG001|Washout Period (1 Hour)|Patient preference|3|||
94560045|NCT00934128|323844484|FG000|Washout Period (1 Hour)|Pain|1|||
94560046|NCT00934128|323844485|FG001|Washout Period (1 Hour)|Pain|0|||
94560047|NCT00934128|323844484|FG000|Washout Period (1 Hour)|Too tired|1|||
94560048|NCT00934128|323844485|FG001|Washout Period (1 Hour)|Too tired|0|||
94560049|NCT00934128|323844484|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
94560050|NCT00934128|323844485|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
94560051|NCT00934128|323844484|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
94560052|NCT00934128|323844485|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
94560053|NCT03712787|323846384|FG000|Overall Study|Adverse Event|2|||
94560054|NCT03712787|323846385|FG001|Overall Study|Adverse Event|3|||
94560055|NCT03712787|323846386|FG002|Overall Study|Adverse Event|0|||
94560056|NCT03712787|323846387|FG003|Overall Study|Adverse Event|4|||
94560057|NCT03712787|323846384|FG000|Overall Study|Withdrawal by Subject|4|||
94560058|NCT03712787|323846385|FG001|Overall Study|Withdrawal by Subject|14|||
94560059|NCT03712787|323846386|FG002|Overall Study|Withdrawal by Subject|12|||
94560060|NCT03712787|323846387|FG003|Overall Study|Withdrawal by Subject|8|||
94560061|NCT03712787|323846384|FG000|Overall Study|Lost to Follow-up|1|||
94560062|NCT03712787|323846385|FG001|Overall Study|Lost to Follow-up|1|||
94560063|NCT03712787|323846386|FG002|Overall Study|Lost to Follow-up|2|||
94233419|NCT01263054|322648275|FG000|Overall Study|Lost to Follow-up|2|||
94560064|NCT03712787|323846387|FG003|Overall Study|Lost to Follow-up|1|||
94560065|NCT03712787|323846384|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
94560066|NCT03712787|323846385|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
94560067|NCT03712787|323846386|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
94560068|NCT03712787|323846387|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
94560069|NCT03712787|323846384|FG000|Overall Study|COVID-19 Infection|0|||
94560070|NCT03712787|323846385|FG001|Overall Study|COVID-19 Infection|1|||
94560071|NCT03712787|323846386|FG002|Overall Study|COVID-19 Infection|0|||
94560072|NCT03712787|323846387|FG003|Overall Study|COVID-19 Infection|0|||
94560073|NCT03712787|323846384|FG000|Overall Study|Other, Not Specified|79|||
94560074|NCT03712787|323846385|FG001|Overall Study|Other, Not Specified|77|||
94560075|NCT03712787|323846386|FG002|Overall Study|Other, Not Specified|74|||
94560076|NCT03712787|323846387|FG003|Overall Study|Other, Not Specified|78|||
94560077|NCT01504412|323846391|FG000|Overall Study|Adverse Event|1|||
94560078|NCT01504412|323846392|FG001|Overall Study|Adverse Event|8|||
94560079|NCT01504412|323846393|FG002|Overall Study|Adverse Event|1|||
94233420|NCT01263054|322648276|FG001|Overall Study|Lost to Follow-up|2|||
94560080|NCT01504412|323846394|FG003|Overall Study|Adverse Event|7|||
94560081|NCT01504412|323846395|FG004|Overall Study|Adverse Event|10|||
94560082|NCT01504412|323846391|FG000|Overall Study|Withdrawal by Subject|2|||
94560083|NCT01504412|323846392|FG001|Overall Study|Withdrawal by Subject|1|||
94560084|NCT01504412|323846393|FG002|Overall Study|Withdrawal by Subject|1|||
94560085|NCT01504412|323846394|FG003|Overall Study|Withdrawal by Subject|5|||
94560086|NCT01504412|323846395|FG004|Overall Study|Withdrawal by Subject|1|||
94560087|NCT01504412|323846391|FG000|Overall Study|Other|2|||
94560088|NCT01504412|323846392|FG001|Overall Study|Other|1|||
94560089|NCT01504412|323846393|FG002|Overall Study|Other|1|||
94560090|NCT01504412|323846394|FG003|Overall Study|Other|6|||
94560091|NCT01504412|323846395|FG004|Overall Study|Other|1|||
94560092|NCT01504412|323846391|FG000|Overall Study|Lost to Follow-up|0|||
94560093|NCT01504412|323846392|FG001|Overall Study|Lost to Follow-up|2|||
94560094|NCT01504412|323846393|FG002|Overall Study|Lost to Follow-up|0|||
94560095|NCT01504412|323846394|FG003|Overall Study|Lost to Follow-up|0|||
94560096|NCT01504412|323846395|FG004|Overall Study|Lost to Follow-up|0|||
94560097|NCT01504412|323846391|FG000|Overall Study|Lack of Efficacy|0|||
94560098|NCT01504412|323846392|FG001|Overall Study|Lack of Efficacy|0|||
94560099|NCT01504412|323846393|FG002|Overall Study|Lack of Efficacy|1|||
94560100|NCT01504412|323846394|FG003|Overall Study|Lack of Efficacy|0|||
94560101|NCT01504412|323846395|FG004|Overall Study|Lack of Efficacy|1|||
94560102|NCT01504412|323846391|FG000|Overall Study|Death|0|||
94560103|NCT01504412|323846392|FG001|Overall Study|Death|0|||
94560104|NCT01504412|323846393|FG002|Overall Study|Death|0|||
94560105|NCT01504412|323846394|FG003|Overall Study|Death|1|||
94560106|NCT01504412|323846395|FG004|Overall Study|Death|0|||
94560107|NCT02034877|323846399|FG000|Overall Study|Lost to Follow-up|0|||
94560108|NCT02034877|323846400|FG001|Overall Study|Lost to Follow-up|3|||
94560109|NCT02034877|323846399|FG000|Overall Study|No Longer Willing to Participate|0|||
94560110|NCT02034877|323846400|FG001|Overall Study|No Longer Willing to Participate|3|||
94560111|NCT04878211|323846408|FG000|Overall Study|Lost to Follow-up|0|||
94560112|NCT04878211|323846409|FG001|Overall Study|Lost to Follow-up|0|||
94560113|NCT04878211|323846410|FG002|Overall Study|Lost to Follow-up|0|||
94560114|NCT04878211|323846411|FG003|Overall Study|Lost to Follow-up|1|||
94560115|NCT04878211|323846412|FG004|Overall Study|Lost to Follow-up|0|||
94560116|NCT04878211|323846413|FG005|Overall Study|Lost to Follow-up|1|||
94560117|NCT04878211|323846408|FG000|Overall Study|Protocol deviation|1|||
94560118|NCT04878211|323846409|FG001|Overall Study|Protocol deviation|0|||
94560119|NCT04878211|323846410|FG002|Overall Study|Protocol deviation|0|||
94560120|NCT04878211|323846411|FG003|Overall Study|Protocol deviation|0|||
94560121|NCT04878211|323846412|FG004|Overall Study|Protocol deviation|0|||
94560122|NCT04878211|323846413|FG005|Overall Study|Protocol deviation|0|||
94560123|NCT04878211|323846408|FG000|Overall Study|Study terminated by sponsor|0|||
94560124|NCT04878211|323846409|FG001|Overall Study|Study terminated by sponsor|0|||
94560125|NCT04878211|323846410|FG002|Overall Study|Study terminated by sponsor|0|||
94560126|NCT04878211|323846411|FG003|Overall Study|Study terminated by sponsor|0|||
94560127|NCT04878211|323846412|FG004|Overall Study|Study terminated by sponsor|9|||
94560128|NCT04878211|323846413|FG005|Overall Study|Study terminated by sponsor|4|||
94560129|NCT04878211|323846408|FG000|Overall Study|Subject decision|0|||
94560130|NCT04878211|323846409|FG001|Overall Study|Subject decision|0|||
94560131|NCT04878211|323846410|FG002|Overall Study|Subject decision|0|||
94560132|NCT04878211|323846411|FG003|Overall Study|Subject decision|0|||
94560133|NCT04878211|323846412|FG004|Overall Study|Subject decision|1|||
94560134|NCT04878211|323846413|FG005|Overall Study|Subject decision|0|||
94560135|NCT02287467|323846420|FG000|Overall Study|Protocol Violation|12|||
94560136|NCT02287467|323846421|FG001|Overall Study|Protocol Violation|9|||
94560137|NCT02152761|323846429|FG000|Epoch: Treatment Epoch|Technical problems|0|||
94560138|NCT02152761|323846430|FG001|Epoch: Treatment Epoch|Technical problems|0|||
94560139|NCT02152761|323846431|FG002|Epoch: Treatment Epoch|Technical problems|0|||
94560140|NCT02152761|323846432|FG003|Epoch: Treatment Epoch|Technical problems|1|||
94560141|NCT02152761|323846429|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
94560142|NCT02152761|323846430|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
94560143|NCT02152761|323846431|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
94560144|NCT02152761|323846432|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
94560145|NCT02152761|323846429|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
94560146|NCT02152761|323846430|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
94560147|NCT02152761|323846431|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
94560148|NCT02152761|323846432|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
94560149|NCT02152761|323846429|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
94560150|NCT02152761|323846430|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
94560151|NCT02152761|323846431|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
94560152|NCT02152761|323846432|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
94560153|NCT02152761|323846429|FG000|Epoch: Treatment Epoch|Death|0|||
94560154|NCT02152761|323846430|FG001|Epoch: Treatment Epoch|Death|3|||
94449478|NCT02929589|323432706|FG002|Overall Study|Withdrawal by Subject|0|||
94449479|NCT02929589|323432707|FG003|Overall Study|Withdrawal by Subject|0|||
94449480|NCT02929589|323432704|FG000|Overall Study|Physician Decision|2|||
94449481|NCT02929589|323432705|FG001|Overall Study|Physician Decision|0|||
94449482|NCT02929589|323432706|FG002|Overall Study|Physician Decision|0|||
94449483|NCT02929589|323432707|FG003|Overall Study|Physician Decision|0|||
94449484|NCT02630251|323432710|FG000|Overall Study|Physician Decision|0|||
94449485|NCT02630251|323432711|FG001|Overall Study|Physician Decision|0|||
94449486|NCT02630251|323432712|FG002|Overall Study|Physician Decision|1|||
94449487|NCT02630251|323432713|FG003|Overall Study|Physician Decision|0|||
94449488|NCT02670525|323432714|FG000|Overall Study|Death|94|||
94449489|NCT02670525|323432715|FG001|Overall Study|Death|14|||
94449490|NCT02670525|323432714|FG000|Overall Study|Lost to Follow-up|4|||
94449491|NCT02670525|323432715|FG001|Overall Study|Lost to Follow-up|1|||
94449492|NCT02670525|323432714|FG000|Overall Study|Subject withdrew consent|1|||
94449493|NCT02670525|323432715|FG001|Overall Study|Subject withdrew consent|0|||
94449494|NCT02670525|323432714|FG000|Overall Study|Unknown, data entry delayed|123|||
94449495|NCT02670525|323432715|FG001|Overall Study|Unknown, data entry delayed|78|||
94449496|NCT01796392|323432716|FG000|Overall Study|Withdrawal by Subject|2|||
94449497|NCT01796392|323432717|FG001|Overall Study|Withdrawal by Subject|0|||
94449498|NCT01796392|323432716|FG000|Overall Study|Death|5|||
94449499|NCT01796392|323432717|FG001|Overall Study|Death|1|||
94449500|NCT01796392|323432716|FG000|Overall Study|Excluded for medical reasons|1|||
94449501|NCT01796392|323432717|FG001|Overall Study|Excluded for medical reasons|2|||
94449502|NCT01796392|323432716|FG000|Overall Study|Lost to Follow-up|1|||
94449503|NCT01796392|323432717|FG001|Overall Study|Lost to Follow-up|0|||
94449504|NCT03627546|323432724|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
94449505|NCT03627546|323432725|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
94449506|NCT03627546|323432726|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
94449507|NCT03627546|323432724|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
94449508|NCT03627546|323432725|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
94449509|NCT03627546|323432726|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
94449510|NCT00564850|323432727|FG000|Overall Study|Protocol Violation|2|||
94449511|NCT00314327|323432732|FG000|Overall Study|Withdrawal by Subject|1|||
94449512|NCT01119859|323432734|FG000|Overall Study|Adverse Event|9|||
94449513|NCT01119859|323432735|FG001|Overall Study|Adverse Event|10|||
94449514|NCT01119859|323432734|FG000|Overall Study|Death|2|||
94449515|NCT01119859|323432735|FG001|Overall Study|Death|0|||
94449516|NCT01119859|323432734|FG000|Overall Study|Insufficient therapeutic response|7|||
94449517|NCT01119859|323432735|FG001|Overall Study|Insufficient therapeutic response|14|||
94449518|NCT01119859|323432734|FG000|Overall Study|Refused treatment|3|||
94449519|NCT01119859|323432735|FG001|Overall Study|Refused treatment|6|||
94449520|NCT01119859|323432734|FG000|Overall Study|Failure to return|3|||
94449521|NCT01119859|323432735|FG001|Overall Study|Failure to return|0|||
94449522|NCT01134939|323432743|FG000|Overall Study|Adverse Event|9|||
94449523|NCT01134939|323432744|FG001|Overall Study|Adverse Event|3|||
94449524|NCT01134939|323432745|FG002|Overall Study|Adverse Event|4|||
94449525|NCT01134939|323432746|FG003|Overall Study|Adverse Event|5|||
94449526|NCT01134939|323432747|FG004|Overall Study|Adverse Event|5|||
94449527|NCT01134939|323432748|FG005|Overall Study|Adverse Event|5|||
94449528|NCT01134939|323432749|FG006|Overall Study|Adverse Event|1|||
94449529|NCT01134939|323432750|FG007|Overall Study|Adverse Event|0|||
94449530|NCT01134939|323432743|FG000|Overall Study|Lack of Efficacy|2|||
94449531|NCT01134939|323432744|FG001|Overall Study|Lack of Efficacy|5|||
94449532|NCT01134939|323432745|FG002|Overall Study|Lack of Efficacy|1|||
94449533|NCT01134939|323432746|FG003|Overall Study|Lack of Efficacy|0|||
94449534|NCT01134939|323432747|FG004|Overall Study|Lack of Efficacy|3|||
94449535|NCT01134939|323432748|FG005|Overall Study|Lack of Efficacy|0|||
94449536|NCT01134939|323432749|FG006|Overall Study|Lack of Efficacy|1|||
94449537|NCT01134939|323432750|FG007|Overall Study|Lack of Efficacy|0|||
94449538|NCT01134939|323432743|FG000|Overall Study|Lost to Follow-up|2|||
94449539|NCT01134939|323432744|FG001|Overall Study|Lost to Follow-up|3|||
94449540|NCT01134939|323432745|FG002|Overall Study|Lost to Follow-up|0|||
94449541|NCT01134939|323432746|FG003|Overall Study|Lost to Follow-up|1|||
94560155|NCT02152761|323846431|FG002|Epoch: Treatment Epoch|Death|1|||
94560156|NCT02152761|323846432|FG003|Epoch: Treatment Epoch|Death|0|||
94560157|NCT02152761|323846429|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
94560158|NCT02152761|323846430|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
94560159|NCT02152761|323846431|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
94560160|NCT02152761|323846432|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
94560161|NCT02152761|323846429|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
94560162|NCT02152761|323846430|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
94560163|NCT02152761|323846431|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
94560164|NCT02152761|323846432|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
94560165|NCT02152761|323846429|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
94560166|NCT02152761|323846430|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
94560167|NCT02152761|323846431|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
94560168|NCT02152761|323846432|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
94560169|NCT02152761|323846429|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
94560170|NCT02152761|323846430|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
94560171|NCT02152761|323846431|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
94560172|NCT02152761|323846432|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
94560173|NCT02152761|323846429|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
94560174|NCT02152761|323846430|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
94560175|NCT02152761|323846431|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
94560176|NCT02152761|323846432|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
94560177|NCT01036321|323846435|FG000|Overall Study|Ineligible after randomization|0|||
94560178|NCT01036321|323846436|FG001|Overall Study|Ineligible after randomization|1|||
94560179|NCT01036321|323846435|FG000|Overall Study|Withdrawal by Subject|3|||
94560180|NCT01036321|323846436|FG001|Overall Study|Withdrawal by Subject|2|||
94560181|NCT01036321|323846435|FG000|Overall Study|Adverse Event|2|||
94560182|NCT01036321|323846436|FG001|Overall Study|Adverse Event|1|||
94560183|NCT00847886|323846437|FG000|Overall Study|Adverse Event|0|||
94560184|NCT00847886|323846438|FG001|Overall Study|Adverse Event|1|||
94560185|NCT03755882|323846439|FG000|Period 1|Protocol Violation|1|||
94560186|NCT03755882|323846440|FG001|Period 1|Protocol Violation|0|||
94560187|NCT03755882|323846439|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
94560188|NCT03755882|323846440|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
94560189|NCT02292446|323846441|FG000|Overall Study|Adverse Event|12|||
94560190|NCT02292446|323846441|FG000|Overall Study|Death|1|||
94560191|NCT02292446|323846441|FG000|Overall Study|Disease progression|2|||
94233421|NCT01263054|322648275|FG000|Overall Study|Withdrawal by Subject|1|||
94233422|NCT01263054|322648276|FG001|Overall Study|Withdrawal by Subject|3|||
94233423|NCT01263054|322648275|FG000|Overall Study|Qualification Violation|1|||
94560192|NCT02292446|323846441|FG000|Overall Study|Subject/guardian decision|2|||
94560193|NCT02292446|323846441|FG000|Overall Study|Withdrawal by Subject|3|||
94233424|NCT01263054|322648276|FG001|Overall Study|Qualification Violation|0|||
94560194|NCT01687101|323846442|FG000|Overall Study|Lost to Follow-up|7|||
94233425|NCT01263054|322648275|FG000|Overall Study|Other|0|||
94233426|NCT01263054|322648276|FG001|Overall Study|Other|1|||
94560195|NCT03785405|323846448|FG000|Overall Study|Adverse Event|16|||
94560196|NCT03785405|323846449|FG001|Overall Study|Adverse Event|1|||
94560197|NCT03785405|323846448|FG000|Overall Study|Death|6|||
94560198|NCT03785405|323846449|FG001|Overall Study|Death|4|||
94560199|NCT03785405|323846448|FG000|Overall Study|Guardian decision|4|||
94560200|NCT03785405|323846449|FG001|Overall Study|Guardian decision|1|||
94560201|NCT03785405|323846448|FG000|Overall Study|Lost to Follow-up|1|||
94560202|NCT03785405|323846449|FG001|Overall Study|Lost to Follow-up|0|||
94560203|NCT03785405|323846448|FG000|Overall Study|Physician Decision|8|||
94560204|NCT03785405|323846449|FG001|Overall Study|Physician Decision|5|||
94560205|NCT03785405|323846448|FG000|Overall Study|Participant decision|2|||
94560206|NCT03785405|323846449|FG001|Overall Study|Participant decision|0|||
94560207|NCT03785405|323846448|FG000|Overall Study|Other|1|||
94560208|NCT03785405|323846449|FG001|Overall Study|Other|0|||
94560209|NCT03785405|323846448|FG000|Overall Study|No treatment was received|0|||
94560210|NCT03785405|323846449|FG001|Overall Study|No treatment was received|1|||
94560211|NCT01979952|323846450|FG000|Overall Study|Adverse Event|4|||
94560212|NCT01979952|323846451|FG001|Overall Study|Adverse Event|5|||
94560213|NCT01979952|323846450|FG000|Overall Study|Protocol Violation|1|||
94560214|NCT01979952|323846451|FG001|Overall Study|Protocol Violation|0|||
94560215|NCT01979952|323846450|FG000|Overall Study|Withdrawal by Subject|2|||
94560216|NCT01979952|323846451|FG001|Overall Study|Withdrawal by Subject|1|||
94560217|NCT01979952|323846450|FG000|Overall Study|Other than specified above|1|||
94560218|NCT01979952|323846451|FG001|Overall Study|Other than specified above|0|||
94560219|NCT03781414|323846452|FG000|Overall Study|Study terminated by sponsor|39|||
94560220|NCT03781414|323846453|FG001|Overall Study|Study terminated by sponsor|34|||
94560221|NCT03781414|323846454|FG002|Overall Study|Study terminated by sponsor|25|||
94560222|NCT03781414|323846452|FG000|Overall Study|Adverse Event|3|||
94560223|NCT03781414|323846453|FG001|Overall Study|Adverse Event|6|||
94560224|NCT03781414|323846454|FG002|Overall Study|Adverse Event|3|||
94560225|NCT03781414|323846452|FG000|Overall Study|Physician Decision|2|||
94560226|NCT03781414|323846453|FG001|Overall Study|Physician Decision|0|||
94560227|NCT03781414|323846454|FG002|Overall Study|Physician Decision|1|||
94560228|NCT03781414|323846452|FG000|Overall Study|Withdrawal by Subject|2|||
94560229|NCT03781414|323846453|FG001|Overall Study|Withdrawal by Subject|3|||
94560230|NCT03781414|323846454|FG002|Overall Study|Withdrawal by Subject|3|||
94560231|NCT03781414|323846452|FG000|Overall Study|Death|1|||
94560232|NCT03781414|323846453|FG001|Overall Study|Death|4|||
94560233|NCT03781414|323846454|FG002|Overall Study|Death|0|||
94560234|NCT03781414|323846452|FG000|Overall Study|Lost to Follow-up|1|||
94560235|NCT03781414|323846453|FG001|Overall Study|Lost to Follow-up|1|||
94560236|NCT03781414|323846454|FG002|Overall Study|Lost to Follow-up|0|||
94560237|NCT04776317|323846455|FG000|Overall Study|Physician Decision|0|||
94560238|NCT04776317|323846456|FG001|Overall Study|Physician Decision|1|||
94560239|NCT04776317|323846457|FG002|Overall Study|Physician Decision|0|||
94560240|NCT04776317|323846458|FG003|Overall Study|Physician Decision|0|||
94560241|NCT04776317|323846459|FG004|Overall Study|Physician Decision|0|||
94560242|NCT04776317|323846460|FG005|Overall Study|Physician Decision|0|||
94560243|NCT04776317|323846461|FG006|Overall Study|Physician Decision|0|||
94560244|NCT04776317|323846462|FG007|Overall Study|Physician Decision|0|||
94560245|NCT04776317|323846463|FG008|Overall Study|Physician Decision|0|||
94560246|NCT04776317|323846464|FG009|Overall Study|Physician Decision|0|||
94560247|NCT04776317|323846465|FG010|Overall Study|Physician Decision|0|||
94560248|NCT04776317|323846466|FG011|Overall Study|Physician Decision|0|||
94560249|NCT04776317|323846467|FG012|Overall Study|Physician Decision|0|||
94560250|NCT04776317|323846468|FG013|Overall Study|Physician Decision|0|||
94560251|NCT04776317|323846469|FG014|Overall Study|Physician Decision|0|||
94560252|NCT04776317|323846455|FG000|Overall Study|Protocol Violation|0|||
94560253|NCT04776317|323846456|FG001|Overall Study|Protocol Violation|0|||
94560254|NCT04776317|323846457|FG002|Overall Study|Protocol Violation|1|||
94560255|NCT04776317|323846458|FG003|Overall Study|Protocol Violation|0|||
94560256|NCT04776317|323846459|FG004|Overall Study|Protocol Violation|0|||
94560257|NCT04776317|323846460|FG005|Overall Study|Protocol Violation|0|||
94560258|NCT04776317|323846461|FG006|Overall Study|Protocol Violation|0|||
94560259|NCT04776317|323846462|FG007|Overall Study|Protocol Violation|0|||
94560260|NCT04776317|323846463|FG008|Overall Study|Protocol Violation|0|||
94560261|NCT04776317|323846464|FG009|Overall Study|Protocol Violation|0|||
94560262|NCT04776317|323846465|FG010|Overall Study|Protocol Violation|0|||
94560263|NCT04776317|323846466|FG011|Overall Study|Protocol Violation|0|||
94560264|NCT04776317|323846467|FG012|Overall Study|Protocol Violation|0|||
94560265|NCT04776317|323846468|FG013|Overall Study|Protocol Violation|0|||
94560266|NCT04776317|323846469|FG014|Overall Study|Protocol Violation|0|||
94560267|NCT04776317|323846455|FG000|Overall Study|Withdrawal by Subject|0|||
94560268|NCT04776317|323846456|FG001|Overall Study|Withdrawal by Subject|0|||
94449542|NCT01134939|323432747|FG004|Overall Study|Lost to Follow-up|2|||
94560269|NCT04776317|323846457|FG002|Overall Study|Withdrawal by Subject|0|||
94560270|NCT04776317|323846458|FG003|Overall Study|Withdrawal by Subject|0|||
94560271|NCT04776317|323846459|FG004|Overall Study|Withdrawal by Subject|1|||
94560272|NCT04776317|323846460|FG005|Overall Study|Withdrawal by Subject|0|||
94560273|NCT04776317|323846461|FG006|Overall Study|Withdrawal by Subject|0|||
94560274|NCT04776317|323846462|FG007|Overall Study|Withdrawal by Subject|0|||
94560275|NCT04776317|323846463|FG008|Overall Study|Withdrawal by Subject|0|||
94560276|NCT04776317|323846464|FG009|Overall Study|Withdrawal by Subject|0|||
94560277|NCT04776317|323846465|FG010|Overall Study|Withdrawal by Subject|0|||
94560278|NCT04776317|323846466|FG011|Overall Study|Withdrawal by Subject|0|||
94560279|NCT04776317|323846467|FG012|Overall Study|Withdrawal by Subject|0|||
94560280|NCT04776317|323846468|FG013|Overall Study|Withdrawal by Subject|0|||
94560281|NCT04776317|323846469|FG014|Overall Study|Withdrawal by Subject|0|||
94560282|NCT00466921|323846470|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
94560283|NCT00466921|323846470|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
94560284|NCT00466921|323846470|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
94560285|NCT00466921|323846470|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
94560286|NCT00466921|323846470|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
94560287|NCT00466921|323846470|FG000|Follow up for a Minimum of 1 Year|Death|6|||
94560288|NCT00475709|323846471|FG000|Overall Study|Did not meet eligibility criteria|8|||
94560289|NCT00475709|323846471|FG000|Overall Study|Death|41|||
94560290|NCT00475709|323846471|FG000|Overall Study|Device Explant|6|||
94560291|NCT00475709|323846471|FG000|Overall Study|Lost to Follow-up|21|||
94560292|NCT01835158|323846472|FG000|Overall Study|Withdrawal by Subject|1|||
94560293|NCT01835158|323846473|FG001|Overall Study|Withdrawal by Subject|6|||
94560294|NCT01919801|323846474|FG000|Overall Study|Withdrawal by Subject|1|||
94560295|NCT01919801|323846475|FG001|Overall Study|Withdrawal by Subject|0|||
94560296|NCT01919801|323846474|FG000|Overall Study|Physician Decision|0|||
94560297|NCT01919801|323846475|FG001|Overall Study|Physician Decision|1|||
94560298|NCT01919801|323846474|FG000|Overall Study|Lost to Follow-up|0|||
94560299|NCT01919801|323846475|FG001|Overall Study|Lost to Follow-up|1|||
94560300|NCT01919801|323846474|FG000|Overall Study|Other|0|||
94560301|NCT01919801|323846475|FG001|Overall Study|Other|1|||
94560302|NCT01625000|323846477|FG000|Overall Study|Physician Decision|15|||
94560303|NCT01625000|323846478|FG001|Overall Study|Physician Decision|7|||
94560304|NCT01625000|323846479|FG002|Overall Study|Physician Decision|7|||
94560305|NCT01625000|323846480|FG003|Overall Study|Physician Decision|2|||
94560306|NCT01625000|323846481|FG004|Overall Study|Physician Decision|15|||
94560307|NCT01625000|323846477|FG000|Overall Study|Protocol Violation|3|||
94560308|NCT01625000|323846478|FG001|Overall Study|Protocol Violation|10|||
94560309|NCT01625000|323846479|FG002|Overall Study|Protocol Violation|4|||
94560310|NCT01625000|323846480|FG003|Overall Study|Protocol Violation|1|||
94560311|NCT01625000|323846481|FG004|Overall Study|Protocol Violation|2|||
94560312|NCT01625000|323846477|FG000|Overall Study|Withdrawal by Subject|19|||
94560313|NCT01625000|323846478|FG001|Overall Study|Withdrawal by Subject|16|||
94560314|NCT01625000|323846479|FG002|Overall Study|Withdrawal by Subject|11|||
94560315|NCT01625000|323846480|FG003|Overall Study|Withdrawal by Subject|9|||
94560316|NCT01625000|323846481|FG004|Overall Study|Withdrawal by Subject|17|||
94560317|NCT01625000|323846477|FG000|Overall Study|Adverse Event (including Death)|15|||
94560318|NCT01625000|323846478|FG001|Overall Study|Adverse Event (including Death)|19|||
94560319|NCT01625000|323846479|FG002|Overall Study|Adverse Event (including Death)|11|||
94560320|NCT01625000|323846480|FG003|Overall Study|Adverse Event (including Death)|7|||
94560321|NCT01625000|323846481|FG004|Overall Study|Adverse Event (including Death)|21|||
94560322|NCT03568461|323846482|FG000|Overall Study|Death|7|||
94560323|NCT03568461|323846482|FG000|Overall Study|Physician Decision|5|||
94560324|NCT03568461|323846482|FG000|Overall Study|Subject decision|5|||
94560325|NCT03568461|323846482|FG000|Overall Study|Lost to Follow-up|1|||
94560326|NCT04739761|323846483|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
94560327|NCT04739761|323846484|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
94560328|NCT04739761|323846483|FG000|Overall Study|By complete response from the participant|1|||
94560329|NCT04739761|323846484|FG001|Overall Study|By complete response from the participant|0|||
94560330|NCT04739761|323846483|FG000|Overall Study|Lost to Follow-up|3|||
94657627|NCT05282004|324204349|FG000|Overall Study|Adverse Event|2|||
94560331|NCT04739761|323846484|FG001|Overall Study|Lost to Follow-up|3|||
94560332|NCT04739761|323846483|FG000|Overall Study|Death|13|||
94657628|NCT04443218|324204353|FG000|Overall Study|Exited study for other reasons|9|||
94560333|NCT04739761|323846484|FG001|Overall Study|Death|13|||
94560334|NCT04739761|323846483|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
94560335|NCT04739761|323846484|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
94560336|NCT04739761|323846483|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
94560337|NCT04739761|323846484|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
94560338|NCT04739761|323846483|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
94560339|NCT04739761|323846484|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
94560340|NCT04739761|323846483|FG000|Overall Study|Adverse Event|0|||
94560341|NCT04739761|323846484|FG001|Overall Study|Adverse Event|3|||
94560342|NCT04739761|323846483|FG000|Overall Study|Participant decision|1|||
94560343|NCT04739761|323846484|FG001|Overall Study|Participant decision|0|||
94560344|NCT04739761|323846483|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
94560345|NCT04739761|323846484|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
94560346|NCT04739761|323846483|FG000|Overall Study|Participant immediately started next line of treatment|1|||
94560347|NCT04739761|323846484|FG001|Overall Study|Participant immediately started next line of treatment|0|||
94560348|NCT04739761|323846483|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
94560349|NCT04739761|323846484|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
94560350|NCT04739761|323846483|FG000|Overall Study|Lack of clinical benefit|1|||
94560351|NCT04739761|323846484|FG001|Overall Study|Lack of clinical benefit|0|||
94560352|NCT04739761|323846483|FG000|Overall Study|Disease progression|5|||
94560353|NCT04739761|323846484|FG001|Overall Study|Disease progression|5|||
94560354|NCT04739761|323846483|FG000|Overall Study|Withdrawal by Subject|14|||
94560355|NCT04739761|323846484|FG001|Overall Study|Withdrawal by Subject|13|||
94560356|NCT04739761|323846483|FG000|Overall Study|Protocol Violation|1|||
94560357|NCT04739761|323846484|FG001|Overall Study|Protocol Violation|0|||
94560358|NCT04739761|323846483|FG000|Overall Study|Physician Decision|2|||
94560359|NCT04739761|323846484|FG001|Overall Study|Physician Decision|0|||
94560360|NCT03828019|323846486|FG000|Overall Study|Withdrawal by Subject|3|||
94560361|NCT03828019|323846487|FG001|Overall Study|Withdrawal by Subject|8|||
94560362|NCT03828019|323846486|FG000|Overall Study|Lost to Follow-up|1|||
94560363|NCT03828019|323846487|FG001|Overall Study|Lost to Follow-up|6|||
94560364|NCT03828019|323846486|FG000|Overall Study|Incarcerated|1|||
94560365|NCT03828019|323846487|FG001|Overall Study|Incarcerated|0|||
94560366|NCT03828019|323846486|FG000|Overall Study|Adverse Event|0|||
94560367|NCT03828019|323846487|FG001|Overall Study|Adverse Event|1|||
94560368|NCT03400176|323846488|FG000|Dose Escalation|Progressive disease|1|||
94560369|NCT03400176|323846489|FG001|Dose Escalation|Progressive disease|1|||
94560370|NCT03400176|323846490|FG002|Dose Escalation|Progressive disease|0|||
94560371|NCT03400176|323846491|FG003|Dose Escalation|Progressive disease|0|||
94560372|NCT03400176|323846492|FG004|Dose Escalation|Progressive disease|1|||
94560373|NCT03400176|323846488|FG000|Dose Escalation|Patient decision|0|||
94560374|NCT03400176|323846489|FG001|Dose Escalation|Patient decision|0|||
94560375|NCT03400176|323846490|FG002|Dose Escalation|Patient decision|0|||
94560376|NCT03400176|323846491|FG003|Dose Escalation|Patient decision|0|||
94560377|NCT03400176|323846492|FG004|Dose Escalation|Patient decision|1|||
94560378|NCT03400176|323846488|FG000|Dose Expansion|Patient decision|0|||
94233427|NCT01310699|322648277|FG000|Overall Study|Patients did not complete tandem.|4|||
94233428|NCT01310699|322648278|FG001|Overall Study|Patients did not complete tandem.|6|||
94233429|NCT00936598|322648279|FG000|Overall Study|Withdrawal by Subject|1|||
94233430|NCT00936598|322648280|FG001|Overall Study|Withdrawal by Subject|0|||
94233431|NCT00936598|322648279|FG000|Overall Study|Ineligible after consent|1|||
94233432|NCT00936598|322648280|FG001|Overall Study|Ineligible after consent|0|||
94233433|NCT02201901|322648281|FG000|Overall Study|Randomized but never treated|0|||
94233434|NCT02201901|322648282|FG001|Overall Study|Randomized but never treated|1|||
94560379|NCT03400176|323846489|FG001|Dose Expansion|Patient decision|0|||
94560380|NCT03400176|323846490|FG002|Dose Expansion|Patient decision|0|||
94560381|NCT03400176|323846491|FG003|Dose Expansion|Patient decision|1|||
94560382|NCT03400176|323846492|FG004|Dose Expansion|Patient decision|0|||
94560383|NCT03400176|323846488|FG000|Dose Expansion|Adverse Event|0|||
94560384|NCT03400176|323846489|FG001|Dose Expansion|Adverse Event|0|||
94560385|NCT03400176|323846490|FG002|Dose Expansion|Adverse Event|0|||
94560386|NCT03400176|323846491|FG003|Dose Expansion|Adverse Event|1|||
94560387|NCT03400176|323846492|FG004|Dose Expansion|Adverse Event|0|||
94560388|NCT03400176|323846488|FG000|Dose Expansion|Physician Decision|0|||
94560389|NCT03400176|323846489|FG001|Dose Expansion|Physician Decision|0|||
94560390|NCT03400176|323846490|FG002|Dose Expansion|Physician Decision|0|||
94233435|NCT02201901|322648283|FG002|Overall Study|Randomized but never treated|0|||
94560391|NCT03400176|323846491|FG003|Dose Expansion|Physician Decision|1|||
94560392|NCT03400176|323846492|FG004|Dose Expansion|Physician Decision|0|||
94560393|NCT03400176|323846488|FG000|Dose Expansion|Progressive disease|0|||
94560394|NCT03400176|323846489|FG001|Dose Expansion|Progressive disease|0|||
94560395|NCT03400176|323846490|FG002|Dose Expansion|Progressive disease|1|||
94560396|NCT03400176|323846491|FG003|Dose Expansion|Progressive disease|1|||
94560397|NCT03400176|323846492|FG004|Dose Expansion|Progressive disease|0|||
94560398|NCT00604695|323846494|FG000|Overall Study|Did not receive first bolus.|0|||
94560399|NCT00604695|323846495|FG001|Overall Study|Did not receive first bolus.|4|||
94560400|NCT01059318|323846496|FG000|Core Study (26 Week)|Adverse Event|3|||
94560401|NCT01059318|323846496|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
94560402|NCT01059318|323846496|FG000|Extension (36 Week)|Adverse Event|3|||
94560403|NCT04186871|323846497|FG000|Overall Study|Lack of Efficacy|0|||
94560404|NCT04186871|323846498|FG001|Overall Study|Lack of Efficacy|1|||
94560405|NCT04186871|323846499|FG002|Overall Study|Lack of Efficacy|0|||
94560406|NCT04186871|323846500|FG003|Overall Study|Lack of Efficacy|0|||
94233436|NCT02201901|322648281|FG000|Overall Study|Lack of Efficacy|7|||
94233437|NCT02201901|322648282|FG001|Overall Study|Lack of Efficacy|1|||
94233438|NCT02201901|322648283|FG002|Overall Study|Lack of Efficacy|6|||
94233439|NCT02201901|322648281|FG000|Overall Study|Death|3|||
94233440|NCT02201901|322648282|FG001|Overall Study|Death|3|||
94345411|NCT03261037|323045927|FG001|Overall Study|Participant was too weak to continue in study|0|||
94345412|NCT03261037|323045928|FG002|Overall Study|Participant was too weak to continue in study|0|||
94345413|NCT03261037|323045929|FG003|Overall Study|Participant was too weak to continue in study|0|||
94345414|NCT00939055|323045930|FG000|Overall Study|Discontinuation prior to procedure|4|||
94560407|NCT04186871|323846501|FG004|Overall Study|Lack of Efficacy|1|||
94560408|NCT04186871|323846502|FG005|Overall Study|Lack of Efficacy|1|||
94560409|NCT04186871|323846497|FG000|Overall Study|Adverse Event|1|||
94560410|NCT04186871|323846498|FG001|Overall Study|Adverse Event|1|||
94560411|NCT04186871|323846499|FG002|Overall Study|Adverse Event|0|||
94560412|NCT04186871|323846500|FG003|Overall Study|Adverse Event|0|||
94560413|NCT04186871|323846501|FG004|Overall Study|Adverse Event|0|||
94560414|NCT04186871|323846502|FG005|Overall Study|Adverse Event|2|||
94560415|NCT04186871|323846497|FG000|Overall Study|Study terminated by sponsor|1|||
94560416|NCT04186871|323846498|FG001|Overall Study|Study terminated by sponsor|2|||
94560417|NCT04186871|323846499|FG002|Overall Study|Study terminated by sponsor|0|||
94345415|NCT00939055|323045931|FG001|Overall Study|Discontinuation prior to procedure|0|||
94233441|NCT02201901|322648283|FG002|Overall Study|Death|3|||
94560418|NCT04186871|323846500|FG003|Overall Study|Study terminated by sponsor|1|||
94233442|NCT02201901|322648281|FG000|Overall Study|Lost to Follow-up|2|||
94233443|NCT02201901|322648282|FG001|Overall Study|Lost to Follow-up|3|||
94233444|NCT02201901|322648283|FG002|Overall Study|Lost to Follow-up|2|||
94449543|NCT01134939|323432748|FG005|Overall Study|Lost to Follow-up|1|||
94449544|NCT01134939|323432749|FG006|Overall Study|Lost to Follow-up|0|||
94449545|NCT01134939|323432750|FG007|Overall Study|Lost to Follow-up|0|||
94449546|NCT01134939|323432743|FG000|Overall Study|Death|0|||
94449547|NCT01134939|323432744|FG001|Overall Study|Death|1|||
94449548|NCT01134939|323432745|FG002|Overall Study|Death|0|||
94449549|NCT01134939|323432746|FG003|Overall Study|Death|0|||
94449550|NCT01134939|323432747|FG004|Overall Study|Death|0|||
94449551|NCT01134939|323432748|FG005|Overall Study|Death|0|||
94449552|NCT01134939|323432749|FG006|Overall Study|Death|0|||
94449553|NCT01134939|323432750|FG007|Overall Study|Death|0|||
94449554|NCT01134939|323432743|FG000|Overall Study|Termination page not available|4|||
94449555|NCT01134939|323432744|FG001|Overall Study|Termination page not available|6|||
94449556|NCT01134939|323432745|FG002|Overall Study|Termination page not available|5|||
94449557|NCT01134939|323432746|FG003|Overall Study|Termination page not available|8|||
94449558|NCT01134939|323432747|FG004|Overall Study|Termination page not available|0|||
94449559|NCT01134939|323432748|FG005|Overall Study|Termination page not available|3|||
94449560|NCT01134939|323432749|FG006|Overall Study|Termination page not available|7|||
94449561|NCT01134939|323432750|FG007|Overall Study|Termination page not available|0|||
94449562|NCT02547220|323432753|FG000|Overall Study|Withdrawal by Subject|1|||
94449563|NCT02547220|323432754|FG001|Overall Study|Withdrawal by Subject|0|||
94449564|NCT02547220|323432753|FG000|Overall Study|Study terminated by sponsor|18|||
94449565|NCT02547220|323432754|FG001|Overall Study|Study terminated by sponsor|20|||
94449566|NCT00347958|323434204|FG000|Overall Study|Adverse Event|1|||
94449567|NCT00347958|323434204|FG000|Overall Study|Protocol Violation|2|||
94449568|NCT00347958|323434204|FG000|Overall Study|Withdrawal by Subject|1|||
94449569|NCT00754234|323434205|FG000|Overall Study|Withdrawal by Subject|3|||
94449570|NCT00975611|323434208|FG000|Overall Study|Screen Fail|16|||
94449571|NCT00975611|323434208|FG000|Overall Study|Physician Decision|1|||
94449572|NCT01102257|323434216|FG000|Overall Study|Adverse Event|1|||
94449573|NCT01102257|323434217|FG001|Overall Study|Adverse Event|0|||
94449574|NCT01102257|323434216|FG000|Overall Study|Adverse Event|1|||
94449575|NCT01102257|323434217|FG001|Overall Study|Adverse Event|0|||
94449576|NCT00298272|323434218|FG000|Double-blind Phase|Adverse Event|2|||
94449577|NCT00298272|323434219|FG001|Double-blind Phase|Adverse Event|0|||
94449578|NCT00298272|323434218|FG000|Double-blind Phase|Failure to Return|2|||
94449579|NCT00298272|323434219|FG001|Double-blind Phase|Failure to Return|0|||
94449580|NCT00298272|323434218|FG000|Double-blind Phase|Protocol Violation|2|||
94449581|NCT00298272|323434219|FG001|Double-blind Phase|Protocol Violation|0|||
94449582|NCT00298272|323434218|FG000|Double-blind Phase|Withdrawal by Subject|2|||
94449583|NCT00298272|323434219|FG001|Double-blind Phase|Withdrawal by Subject|0|||
94449584|NCT00298272|323434218|FG000|Open Label Retreatment Phase|Adverse Event|1|||
94449585|NCT00298272|323434219|FG001|Open Label Retreatment Phase|Adverse Event|2|||
94449586|NCT00298272|323434218|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
94233445|NCT02201901|322648281|FG000|Overall Study|Withdrew Consent|2|||
94449587|NCT00298272|323434219|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
94449588|NCT00298272|323434218|FG000|Open Label Retreatment Phase|Failure to Return|1|||
94449589|NCT00298272|323434219|FG001|Open Label Retreatment Phase|Failure to Return|0|||
94449590|NCT00298272|323434218|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
94465879|NCT00090987|323494925|FG000|Overall Study|Non-compliance|4|||
94560419|NCT04186871|323846501|FG004|Overall Study|Study terminated by sponsor|0|||
94560420|NCT04186871|323846502|FG005|Overall Study|Study terminated by sponsor|0|||
94560421|NCT04186871|323846497|FG000|Overall Study|Other reasons|0|||
94560422|NCT04186871|323846498|FG001|Overall Study|Other reasons|0|||
94560423|NCT04186871|323846499|FG002|Overall Study|Other reasons|0|||
94560424|NCT04186871|323846500|FG003|Overall Study|Other reasons|0|||
94560425|NCT04186871|323846501|FG004|Overall Study|Other reasons|0|||
94560426|NCT04186871|323846502|FG005|Overall Study|Other reasons|1|||
94560427|NCT04186871|323846497|FG000|Overall Study|Withdrawal by Subject|0|||
94560428|NCT04186871|323846498|FG001|Overall Study|Withdrawal by Subject|0|||
94560429|NCT04186871|323846499|FG002|Overall Study|Withdrawal by Subject|0|||
94560430|NCT04186871|323846500|FG003|Overall Study|Withdrawal by Subject|0|||
94560431|NCT04186871|323846501|FG004|Overall Study|Withdrawal by Subject|0|||
94560432|NCT04186871|323846502|FG005|Overall Study|Withdrawal by Subject|1|||
94560433|NCT04186871|323846497|FG000|Overall Study|Lost to Follow-up|0|||
94560434|NCT04186871|323846498|FG001|Overall Study|Lost to Follow-up|0|||
94560435|NCT04186871|323846499|FG002|Overall Study|Lost to Follow-up|0|||
94560436|NCT04186871|323846500|FG003|Overall Study|Lost to Follow-up|0|||
94560437|NCT04186871|323846501|FG004|Overall Study|Lost to Follow-up|0|||
94560438|NCT04186871|323846502|FG005|Overall Study|Lost to Follow-up|1|||
94560439|NCT00850538|323846504|FG000|Overall Study|unable/unwilling to complete MRI|13|||
94560440|NCT00850538|323846504|FG000|Overall Study|specimen missed due to scheduling error|14|||
94560441|NCT00850538|323846504|FG000|Overall Study|specimen unusable|7|||
94560442|NCT00850538|323846504|FG000|Overall Study|Withdrawal by Subject|3|||
94560443|NCT00850538|323846504|FG000|Overall Study|radiology error|2|||
94560444|NCT00850538|323846504|FG000|Overall Study|Protocol Violation|2|||
94560445|NCT00167310|323846505|FG000|Overall Study|Protocol Violation|5|||
94560446|NCT00167310|323846506|FG001|Overall Study|Protocol Violation|3|||
94560447|NCT00167310|323846505|FG000|Overall Study|Withdrawal by Subject|3|||
94560448|NCT00167310|323846506|FG001|Overall Study|Withdrawal by Subject|7|||
94560449|NCT04522141|323846507|FG000|Overall Study|Withdrawal by Subject|1|||
94560450|NCT04522141|323846508|FG001|Overall Study|Withdrawal by Subject|0|||
94560451|NCT03543137|323846509|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
94560452|NCT03543137|323846510|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
94560453|NCT03543137|323846509|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
94560454|NCT03543137|323846510|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
94560455|NCT03543137|323846509|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
94560456|NCT03543137|323846510|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
94560457|NCT01052077|323846511|FG000|Phase A|Lost to Follow-up|22|||
94560458|NCT01052077|323846512|FG001|Phase A|Lost to Follow-up|0|||
94560459|NCT01052077|323846513|FG002|Phase A|Lost to Follow-up|0|||
94560460|NCT01052077|323846514|FG003|Phase A|Lost to Follow-up|0|||
94560461|NCT01052077|323846511|FG000|Phase A|Adverse Event|32|||
94560462|NCT01052077|323846512|FG001|Phase A|Adverse Event|0|||
94560463|NCT01052077|323846513|FG002|Phase A|Adverse Event|0|||
94560464|NCT01052077|323846514|FG003|Phase A|Adverse Event|0|||
94560465|NCT01052077|323846511|FG000|Phase A|Met Withdrawal Criteria|26|||
94560466|NCT01052077|323846512|FG001|Phase A|Met Withdrawal Criteria|0|||
94560467|NCT01052077|323846513|FG002|Phase A|Met Withdrawal Criteria|0|||
94560468|NCT01052077|323846514|FG003|Phase A|Met Withdrawal Criteria|0|||
94560469|NCT01052077|323846511|FG000|Phase A|Physician Decision|10|||
94560470|NCT01052077|323846512|FG001|Phase A|Physician Decision|0|||
94560471|NCT01052077|323846513|FG002|Phase A|Physician Decision|0|||
94560472|NCT01052077|323846514|FG003|Phase A|Physician Decision|0|||
94560473|NCT01052077|323846511|FG000|Phase A|Withdrawal by Subject|29|||
94560474|NCT01052077|323846512|FG001|Phase A|Withdrawal by Subject|0|||
94560475|NCT01052077|323846513|FG002|Phase A|Withdrawal by Subject|0|||
94560476|NCT01052077|323846514|FG003|Phase A|Withdrawal by Subject|0|||
94560477|NCT01052077|323846511|FG000|Phase A|Protocol Deviation|27|||
94560478|NCT01052077|323846512|FG001|Phase A|Protocol Deviation|0|||
94560479|NCT01052077|323846513|FG002|Phase A|Protocol Deviation|0|||
94560480|NCT01052077|323846514|FG003|Phase A|Protocol Deviation|0|||
94560481|NCT01052077|323846511|FG000|Phase B|Lost to Follow-up|0|||
94560482|NCT01052077|323846512|FG001|Phase B|Lost to Follow-up|2|||
94560483|NCT01052077|323846513|FG002|Phase B|Lost to Follow-up|3|||
94560484|NCT01052077|323846514|FG003|Phase B|Lost to Follow-up|0|||
94560485|NCT01052077|323846511|FG000|Phase B|Adverse Event|0|||
94560486|NCT01052077|323846512|FG001|Phase B|Adverse Event|9|||
94560487|NCT01052077|323846513|FG002|Phase B|Adverse Event|2|||
94560488|NCT01052077|323846514|FG003|Phase B|Adverse Event|0|||
94560489|NCT01052077|323846511|FG000|Phase B|Met Withdrawal Criteria|0|||
94560490|NCT01052077|323846512|FG001|Phase B|Met Withdrawal Criteria|2|||
94560491|NCT01052077|323846513|FG002|Phase B|Met Withdrawal Criteria|1|||
94560492|NCT01052077|323846514|FG003|Phase B|Met Withdrawal Criteria|0|||
94560493|NCT01052077|323846511|FG000|Phase B|Physician Decision|0|||
94560494|NCT01052077|323846512|FG001|Phase B|Physician Decision|1|||
94560495|NCT01052077|323846513|FG002|Phase B|Physician Decision|1|||
94560496|NCT01052077|323846514|FG003|Phase B|Physician Decision|0|||
94560497|NCT01052077|323846511|FG000|Phase B|Withdrawal by Subject|0|||
94560498|NCT01052077|323846512|FG001|Phase B|Withdrawal by Subject|0|||
94560499|NCT01052077|323846513|FG002|Phase B|Withdrawal by Subject|5|||
94560500|NCT01052077|323846514|FG003|Phase B|Withdrawal by Subject|0|||
94560501|NCT01052077|323846511|FG000|Phase B|Protocol Deviation|0|||
94560502|NCT01052077|323846512|FG001|Phase B|Protocol Deviation|3|||
94560503|NCT01052077|323846513|FG002|Phase B|Protocol Deviation|4|||
94560504|NCT01052077|323846514|FG003|Phase B|Protocol Deviation|0|||
94560505|NCT01052077|323846511|FG000|Phase B|Lack of Efficacy|0|||
94560506|NCT01052077|323846512|FG001|Phase B|Lack of Efficacy|1|||
94560507|NCT01052077|323846513|FG002|Phase B|Lack of Efficacy|0|||
94560508|NCT01052077|323846514|FG003|Phase B|Lack of Efficacy|0|||
94560509|NCT01052077|323846511|FG000|Phase A+|Lost to Follow-up|0|||
94560510|NCT01052077|323846512|FG001|Phase A+|Lost to Follow-up|0|||
94560511|NCT01052077|323846513|FG002|Phase A+|Lost to Follow-up|0|||
94560512|NCT01052077|323846514|FG003|Phase A+|Lost to Follow-up|8|||
94560513|NCT01052077|323846511|FG000|Phase A+|Adverse Event|0|||
94560514|NCT01052077|323846512|FG001|Phase A+|Adverse Event|0|||
94560515|NCT01052077|323846513|FG002|Phase A+|Adverse Event|0|||
94560516|NCT01052077|323846514|FG003|Phase A+|Adverse Event|4|||
94560517|NCT01052077|323846511|FG000|Phase A+|Met Withdrawal Criteria|0|||
94560518|NCT01052077|323846512|FG001|Phase A+|Met Withdrawal Criteria|0|||
94560519|NCT01052077|323846513|FG002|Phase A+|Met Withdrawal Criteria|0|||
94560520|NCT01052077|323846514|FG003|Phase A+|Met Withdrawal Criteria|2|||
94560521|NCT01052077|323846511|FG000|Phase A+|Withdrawal by Subject|0|||
94560522|NCT01052077|323846512|FG001|Phase A+|Withdrawal by Subject|0|||
94560523|NCT01052077|323846513|FG002|Phase A+|Withdrawal by Subject|0|||
94560524|NCT01052077|323846514|FG003|Phase A+|Withdrawal by Subject|7|||
94560525|NCT04072887|323846515|FG000|Overall Study|Withdrawal by Subject|3|||
94560526|NCT04072887|323846516|FG001|Overall Study|Withdrawal by Subject|8|||
94560527|NCT04072887|323846517|FG002|Overall Study|Withdrawal by Subject|1|||
94560528|NCT04072887|323846518|FG003|Overall Study|Withdrawal by Subject|3|||
94560529|NCT04072887|323846519|FG004|Overall Study|Withdrawal by Subject|3|||
94560530|NCT04072887|323846520|FG005|Overall Study|Withdrawal by Subject|13|||
94560531|NCT04072887|323846515|FG000|Overall Study|Adverse Event|2|||
94560532|NCT04072887|323846516|FG001|Overall Study|Adverse Event|4|||
94560533|NCT04072887|323846517|FG002|Overall Study|Adverse Event|1|||
94560534|NCT04072887|323846518|FG003|Overall Study|Adverse Event|4|||
94560535|NCT04072887|323846519|FG004|Overall Study|Adverse Event|0|||
94560536|NCT04072887|323846520|FG005|Overall Study|Adverse Event|1|||
94560537|NCT04072887|323846515|FG000|Overall Study|Physician Decision|2|||
94560538|NCT04072887|323846516|FG001|Overall Study|Physician Decision|0|||
94560539|NCT04072887|323846517|FG002|Overall Study|Physician Decision|0|||
94560540|NCT04072887|323846518|FG003|Overall Study|Physician Decision|0|||
94560541|NCT04072887|323846519|FG004|Overall Study|Physician Decision|0|||
94560542|NCT04072887|323846520|FG005|Overall Study|Physician Decision|1|||
94560543|NCT04072887|323846515|FG000|Overall Study|Lost to Follow-up|1|||
94560544|NCT04072887|323846516|FG001|Overall Study|Lost to Follow-up|3|||
94560545|NCT04072887|323846517|FG002|Overall Study|Lost to Follow-up|0|||
94560546|NCT04072887|323846518|FG003|Overall Study|Lost to Follow-up|0|||
94560547|NCT04072887|323846519|FG004|Overall Study|Lost to Follow-up|0|||
94560548|NCT04072887|323846520|FG005|Overall Study|Lost to Follow-up|0|||
94560549|NCT04072887|323846515|FG000|Overall Study|Death|0|||
94560550|NCT04072887|323846516|FG001|Overall Study|Death|2|||
94560551|NCT04072887|323846517|FG002|Overall Study|Death|0|||
94560552|NCT04072887|323846518|FG003|Overall Study|Death|2|||
94560553|NCT04072887|323846519|FG004|Overall Study|Death|3|||
94560554|NCT04072887|323846520|FG005|Overall Study|Death|0|||
94560555|NCT01153724|323846522|FG000|Treatment Period 1|Withdrawal by Subject|1|||
94560556|NCT01153724|323846522|FG000|Treatment Period 2|Adverse Event|1|||
94560557|NCT01153724|323846522|FG000|Treatment Period 2|Other reason not defined above|1|||
94560558|NCT00367835|323846523|FG000|Overall Study|Adverse Event|14|||
94560559|NCT00367835|323846524|FG001|Overall Study|Adverse Event|1|||
94560560|NCT00367835|323846523|FG000|Overall Study|Protocol Violation|1|||
94233446|NCT02201901|322648282|FG001|Overall Study|Withdrew Consent|0|||
94560561|NCT00367835|323846524|FG001|Overall Study|Protocol Violation|7|||
94560562|NCT00367835|323846523|FG000|Overall Study|Withdrawal by Subject|7|||
94560563|NCT00367835|323846524|FG001|Overall Study|Withdrawal by Subject|6|||
94560564|NCT00367835|323846523|FG000|Overall Study|Lost to Follow-up|1|||
94560565|NCT00367835|323846524|FG001|Overall Study|Lost to Follow-up|4|||
94560566|NCT00367835|323846523|FG000|Overall Study|Lack of Efficacy|3|||
94560567|NCT00367835|323846524|FG001|Overall Study|Lack of Efficacy|12|||
94560568|NCT00367835|323846523|FG000|Overall Study|Subject in juvenile detention center|1|||
94560569|NCT00367835|323846524|FG001|Overall Study|Subject in juvenile detention center|0|||
94560570|NCT00367835|323846523|FG000|Overall Study|refused blood collection|1|||
94560571|NCT00367835|323846524|FG001|Overall Study|refused blood collection|0|||
94560572|NCT00367835|323846523|FG000|Overall Study|Did not respond to calls|1|||
94560573|NCT00367835|323846524|FG001|Overall Study|Did not respond to calls|0|||
94560574|NCT00367835|323846523|FG000|Overall Study|History of lead poisoning|0|||
94560575|NCT00367835|323846524|FG001|Overall Study|History of lead poisoning|1|||
94560576|NCT00869518|323846533|FG000|Overall Study|Lost to Follow-up|1|||
94560577|NCT00869518|323846534|FG001|Overall Study|Lost to Follow-up|1|||
94560578|NCT00947115|323846535|FG000|Overall Study|Missed reporting interval|3|||
94560579|NCT00947115|323846536|FG001|Overall Study|Missed reporting interval|4|||
94560580|NCT00947115|323846537|FG002|Overall Study|Missed reporting interval|2|||
94560581|NCT00947115|323846535|FG000|Overall Study|Physician Decision|0|||
94560582|NCT00947115|323846536|FG001|Overall Study|Physician Decision|2|||
94560583|NCT00947115|323846537|FG002|Overall Study|Physician Decision|0|||
94560584|NCT00947115|323846535|FG000|Overall Study|Death|0|||
94560585|NCT00947115|323846536|FG001|Overall Study|Death|1|||
94560586|NCT00947115|323846537|FG002|Overall Study|Death|1|||
94560587|NCT00947115|323846535|FG000|Overall Study|Migrated from study area|2|||
94560588|NCT00947115|323846536|FG001|Overall Study|Migrated from study area|0|||
94560589|NCT00947115|323846537|FG002|Overall Study|Migrated from study area|0|||
94560590|NCT00947115|323846535|FG000|Overall Study|Withdrawal by Subject|1|||
94560591|NCT00947115|323846536|FG001|Overall Study|Withdrawal by Subject|3|||
94560592|NCT00947115|323846537|FG002|Overall Study|Withdrawal by Subject|4|||
94560593|NCT00947115|323846535|FG000|Overall Study|Lost to Follow-up|11|||
94560594|NCT00947115|323846536|FG001|Overall Study|Lost to Follow-up|12|||
94560595|NCT00947115|323846537|FG002|Overall Study|Lost to Follow-up|8|||
94560596|NCT01223183|323846538|FG000|Imaging Day 1|Physician Decision|0|||
94560597|NCT01223183|323846539|FG001|Imaging Day 1|Physician Decision|1|||
94560598|NCT01223183|323846538|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
94560599|NCT01223183|323846539|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
94560600|NCT01223183|323846538|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
94560601|NCT01223183|323846539|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
94560602|NCT03228212|323846543|FG000|Period 1|Adverse Event|1|||
94560603|NCT03228212|323846544|FG001|Period 1|Adverse Event|0|||
94560604|NCT03228212|323846543|FG000|Period 1|no longer meets eligibility criteria|0|||
94560605|NCT03228212|323846544|FG001|Period 1|no longer meets eligibility criteria|1|||
94560606|NCT03228212|323846543|FG000|Period 2|Lost to Follow-up|1|||
94560607|NCT03228212|323846544|FG001|Period 2|Lost to Follow-up|0|||
94560608|NCT02709330|323846545|FG000|Overall Study|Death|5|||
94560609|NCT02709330|323846546|FG001|Overall Study|Death|0|||
94560610|NCT02709330|323846545|FG000|Overall Study|Lost to Follow-up|2|||
94560611|NCT02709330|323846546|FG001|Overall Study|Lost to Follow-up|0|||
94560612|NCT02709330|323846545|FG000|Overall Study|Physician Decision|2|||
94560613|NCT02709330|323846546|FG001|Overall Study|Physician Decision|0|||
94560614|NCT02709330|323846545|FG000|Overall Study|Withdrawal by Subject|4|||
94560615|NCT02709330|323846546|FG001|Overall Study|Withdrawal by Subject|0|||
94560616|NCT00811174|323846547|FG000|Overall Study|Protocol Violation|2|||
94560617|NCT00811174|323846547|FG000|Overall Study|Sponsors Decision|1|||
94560618|NCT02611817|323847671|FG000|Open-label Induction Phase|Reason not Specified|9|||
94560619|NCT02611817|323847672|FG001|Open-label Induction Phase|Reason not Specified|0|||
94560620|NCT02611817|323847673|FG002|Open-label Induction Phase|Reason not Specified|0|||
94560621|NCT02611817|323847671|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
94560622|NCT02611817|323847672|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
94560623|NCT02611817|323847673|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
94560624|NCT02611817|323847671|FG000|Open-label Induction Phase|Pregnancy|1|||
94560625|NCT02611817|323847672|FG001|Open-label Induction Phase|Pregnancy|0|||
94560626|NCT02611817|323847673|FG002|Open-label Induction Phase|Pregnancy|0|||
94560627|NCT02611817|323847671|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
94657629|NCT04443218|324204353|FG000|Overall Study|Withdrawal by Subject|1|||
94657630|NCT04443218|324204353|FG000|Overall Study|Lost to Follow-up|4|||
94233447|NCT02201901|322648283|FG002|Overall Study|Withdrew Consent|2|||
94560628|NCT02611817|323847672|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
94560629|NCT02611817|323847673|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
94560630|NCT02611817|323847671|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
94560631|NCT02611817|323847672|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
94560632|NCT02611817|323847673|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
94560633|NCT02611817|323847671|FG000|Open-label Induction Phase|Protocol Violation|5|||
94560634|NCT02611817|323847672|FG001|Open-label Induction Phase|Protocol Violation|0|||
94560635|NCT02611817|323847673|FG002|Open-label Induction Phase|Protocol Violation|0|||
94560636|NCT02611817|323847671|FG000|Open-label Induction Phase|Adverse Event|16|||
94560637|NCT02611817|323847672|FG001|Open-label Induction Phase|Adverse Event|0|||
94560638|NCT02611817|323847673|FG002|Open-label Induction Phase|Adverse Event|0|||
94560639|NCT02611817|323847671|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
94560640|NCT02611817|323847672|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
94560641|NCT02611817|323847673|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
94560642|NCT02611817|323847671|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
94560643|NCT02611817|323847672|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
94560644|NCT02611817|323847673|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
94560645|NCT02611817|323847671|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
94560646|NCT02611817|323847672|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
94560647|NCT02611817|323847673|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
94560648|NCT02611817|323847671|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
94560649|NCT02611817|323847672|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
94560650|NCT02611817|323847673|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
94560651|NCT02611817|323847671|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
94560652|NCT02611817|323847672|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
94560653|NCT02611817|323847673|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
94560654|NCT02611817|323847671|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
94560655|NCT02611817|323847672|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
94560656|NCT02611817|323847673|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
94560657|NCT02611817|323847671|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
94560658|NCT02611817|323847672|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
94560659|NCT02611817|323847673|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
94560660|NCT01525615|323847674|FG000|Overall Study|Adverse Event|11|||
94560661|NCT01525615|323847675|FG001|Overall Study|Adverse Event|7|||
94560662|NCT01525615|323847676|FG002|Overall Study|Adverse Event|5|||
94560663|NCT01525615|323847674|FG000|Overall Study|Lost to Follow-up|1|||
94560664|NCT01525615|323847675|FG001|Overall Study|Lost to Follow-up|0|||
94560665|NCT01525615|323847676|FG002|Overall Study|Lost to Follow-up|0|||
94560666|NCT01525615|323847674|FG000|Overall Study|Withdrawal by Subject|1|||
94560667|NCT01525615|323847675|FG001|Overall Study|Withdrawal by Subject|0|||
94560668|NCT01525615|323847676|FG002|Overall Study|Withdrawal by Subject|0|||
94560669|NCT01525615|323847674|FG000|Overall Study|Other reason not described above|1|||
94560670|NCT01525615|323847675|FG001|Overall Study|Other reason not described above|0|||
94560671|NCT01525615|323847676|FG002|Overall Study|Other reason not described above|1|||
94560672|NCT01946152|323847677|FG000|Overall Study|Adverse Event|1|||
94560673|NCT01946152|323847678|FG001|Overall Study|Adverse Event|0|||
94560674|NCT01946152|323847679|FG002|Overall Study|Adverse Event|0|||
94560675|NCT01946152|323847680|FG003|Overall Study|Adverse Event|0|||
94560676|NCT01946152|323847677|FG000|Overall Study|Withdrawal by Subject|0|||
94560677|NCT01946152|323847678|FG001|Overall Study|Withdrawal by Subject|2|||
94560678|NCT01946152|323847679|FG002|Overall Study|Withdrawal by Subject|0|||
94560679|NCT01946152|323847680|FG003|Overall Study|Withdrawal by Subject|0|||
94560680|NCT01946152|323847677|FG000|Overall Study|Progression|0|||
94560681|NCT01946152|323847678|FG001|Overall Study|Progression|1|||
94560682|NCT01946152|323847679|FG002|Overall Study|Progression|4|||
94560683|NCT01946152|323847680|FG003|Overall Study|Progression|7|||
94560684|NCT01946152|323847677|FG000|Overall Study|Physician Decision|0|||
94560685|NCT01946152|323847678|FG001|Overall Study|Physician Decision|0|||
94560686|NCT01946152|323847679|FG002|Overall Study|Physician Decision|1|||
94560687|NCT01946152|323847680|FG003|Overall Study|Physician Decision|0|||
94560688|NCT01946152|323847677|FG000|Overall Study|Second malignancy|0|||
94560689|NCT01946152|323847678|FG001|Overall Study|Second malignancy|0|||
94560690|NCT01946152|323847679|FG002|Overall Study|Second malignancy|1|||
94560691|NCT01946152|323847680|FG003|Overall Study|Second malignancy|0|||
94560692|NCT01946152|323847677|FG000|Overall Study|Adverse Event|0|||
94560693|NCT01946152|323847678|FG001|Overall Study|Adverse Event|0|||
94560694|NCT01946152|323847679|FG002|Overall Study|Adverse Event|0|||
94560695|NCT01946152|323847680|FG003|Overall Study|Adverse Event|1|||
94560696|NCT01865448|323847681|FG000|Overall Study|Adverse Event|1|||
94560697|NCT01865448|323847682|FG001|Overall Study|Adverse Event|1|||
94560698|NCT01865448|323847681|FG000|Overall Study|Pregnancy|0|||
94560699|NCT01865448|323847682|FG001|Overall Study|Pregnancy|1|||
94560700|NCT01865448|323847681|FG000|Overall Study|dropout unrelated to study|1|||
94560701|NCT01865448|323847682|FG001|Overall Study|dropout unrelated to study|1|||
94560702|NCT02679755|323847687|FG000|Overall Study|Death|0|||
94560703|NCT02679755|323847688|FG001|Overall Study|Death|3|||
94560704|NCT02679755|323847687|FG000|Overall Study|Global deterioration of health status|1|||
94560705|NCT02679755|323847688|FG001|Overall Study|Global deterioration of health status|8|||
94560706|NCT02679755|323847687|FG000|Overall Study|Lost to Follow-up|1|||
94560707|NCT02679755|323847688|FG001|Overall Study|Lost to Follow-up|0|||
94560708|NCT02679755|323847687|FG000|Overall Study|Objective progression or relapse|24|||
94560709|NCT02679755|323847688|FG001|Overall Study|Objective progression or relapse|83|||
94560710|NCT02679755|323847687|FG000|Overall Study|Not defined|0|||
94560711|NCT02679755|323847688|FG001|Overall Study|Not defined|2|||
94560712|NCT02679755|323847687|FG000|Overall Study|Withdrawal by participant|6|||
94560713|NCT02679755|323847688|FG001|Overall Study|Withdrawal by participant|3|||
94560714|NCT02679755|323847687|FG000|Overall Study|Adverse Event|1|||
94560715|NCT02679755|323847688|FG001|Overall Study|Adverse Event|4|||
94560716|NCT02679755|323847687|FG000|Overall Study|Adverse events not related to study drug|1|||
94560717|NCT02679755|323847688|FG001|Overall Study|Adverse events not related to study drug|2|||
94233448|NCT02201901|322648281|FG000|Overall Study|Adverse Event|1|||
94345416|NCT02881151|323045932|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
94560718|NCT01061359|323847689|FG000|Overall Study|Death|32|||
94560719|NCT01061359|323847689|FG000|Overall Study|Lost to Follow-up|1072|||
94560720|NCT01061359|323847689|FG000|Overall Study|Relapse|187|||
94560721|NCT01061359|323847689|FG000|Overall Study|Secondary neoplasm|11|||
94560722|NCT02300259|323847692|FG000|Period 1|Adverse Event|0|||
94560723|NCT02300259|323847693|FG001|Period 1|Adverse Event|0|||
94560724|NCT02300259|323847694|FG002|Period 1|Adverse Event|1|||
94560725|NCT02300259|323847692|FG000|Period 1|Withdrawal by Subject|0|||
94560726|NCT02300259|323847693|FG001|Period 1|Withdrawal by Subject|0|||
94560727|NCT02300259|323847694|FG002|Period 1|Withdrawal by Subject|1|||
94560728|NCT02300259|323847692|FG000|Period 2|Adverse Event|1|||
94560729|NCT02300259|323847693|FG001|Period 2|Adverse Event|0|||
94560730|NCT02300259|323847694|FG002|Period 2|Adverse Event|0|||
94560731|NCT02300259|323847692|FG000|Period 2|Withdrawal by Subject|0|||
94560732|NCT02300259|323847693|FG001|Period 2|Withdrawal by Subject|0|||
94560733|NCT02300259|323847694|FG002|Period 2|Withdrawal by Subject|1|||
94345417|NCT01222767|323045933|FG000|Overall Study|Progressive disease|13|||
94560734|NCT00546000|323847698|FG000|Overall Study|Adverse Event|1|||
94560735|NCT00546000|323847698|FG000|Overall Study|Lost to Follow-up|1|||
94560736|NCT00546000|323847698|FG000|Overall Study|Baseline HPA Axis Supression|2|||
94560737|NCT01959139|323847705|FG000|Phase II|Disease progression|0|||
94560738|NCT01959139|323847706|FG001|Phase II|Disease progression|0|||
94560739|NCT01959139|323847707|FG002|Phase II|Disease progression|26|||
94560740|NCT01959139|323847708|FG003|Phase II|Disease progression|34|||
94560741|NCT01959139|323847705|FG000|Phase II|Adverse Event|0|||
94560742|NCT01959139|323847706|FG001|Phase II|Adverse Event|0|||
94560743|NCT01959139|323847707|FG002|Phase II|Adverse Event|10|||
94560744|NCT01959139|323847708|FG003|Phase II|Adverse Event|11|||
94560745|NCT01959139|323847705|FG000|Phase II|Patient Refusal|0|||
94560746|NCT01959139|323847706|FG001|Phase II|Patient Refusal|0|||
94560747|NCT01959139|323847707|FG002|Phase II|Patient Refusal|5|||
94560748|NCT01959139|323847708|FG003|Phase II|Patient Refusal|4|||
94560749|NCT01959139|323847705|FG000|Phase II|Death|0|||
94560750|NCT01959139|323847706|FG001|Phase II|Death|0|||
94560751|NCT01959139|323847707|FG002|Phase II|Death|3|||
94560752|NCT01959139|323847708|FG003|Phase II|Death|1|||
94560753|NCT01959139|323847705|FG000|Phase II|Other/Unknown|0|||
94560754|NCT01959139|323847706|FG001|Phase II|Other/Unknown|0|||
94560755|NCT01959139|323847707|FG002|Phase II|Other/Unknown|8|||
94560756|NCT01959139|323847708|FG003|Phase II|Other/Unknown|5|||
94560757|NCT01959139|323847705|FG000|Phase II|On treatment|0|||
94560758|NCT01959139|323847706|FG001|Phase II|On treatment|0|||
94560759|NCT01959139|323847707|FG002|Phase II|On treatment|4|||
94560760|NCT01959139|323847708|FG003|Phase II|On treatment|0|||
94560761|NCT01559675|323847709|FG000|Overall Study|Protocol Violation|1|||
94560762|NCT01559675|323847710|FG001|Overall Study|Protocol Violation|2|||
94560763|NCT01559675|323847709|FG000|Overall Study|2nd operation on same patient excluded|14|||
94560764|NCT01559675|323847710|FG001|Overall Study|2nd operation on same patient excluded|12|||
94560765|NCT02630472|323847711|FG000|Overall Study|Physician Decision|10|||
94560766|NCT02630472|323847712|FG001|Overall Study|Physician Decision|0|||
94560767|NCT01510158|323847713|FG000|Overall Study|Adverse Event|7|||
94560768|NCT01510158|323847714|FG001|Overall Study|Adverse Event|8|||
94560769|NCT01510158|323847715|FG002|Overall Study|Adverse Event|5|||
94560770|NCT01510158|323847713|FG000|Overall Study|Gout flare|1|||
94345418|NCT01222767|323045933|FG000|Overall Study|Adverse Event|2|||
94560771|NCT01510158|323847714|FG001|Overall Study|Gout flare|0|||
94560772|NCT01510158|323847715|FG002|Overall Study|Gout flare|0|||
94560773|NCT01510158|323847713|FG000|Overall Study|Protocol Violation|17|||
94560774|NCT01510158|323847714|FG001|Overall Study|Protocol Violation|16|||
94560775|NCT01510158|323847715|FG002|Overall Study|Protocol Violation|24|||
94560776|NCT01510158|323847713|FG000|Overall Study|Sponsor terminated study.|2|||
94560777|NCT01510158|323847714|FG001|Overall Study|Sponsor terminated study.|0|||
94560778|NCT01510158|323847715|FG002|Overall Study|Sponsor terminated study.|2|||
94560779|NCT01510158|323847713|FG000|Overall Study|Lost to Follow-up|13|||
94560780|NCT01510158|323847714|FG001|Overall Study|Lost to Follow-up|16|||
94560781|NCT01510158|323847715|FG002|Overall Study|Lost to Follow-up|9|||
94560782|NCT01510158|323847713|FG000|Overall Study|Withdrawal by Subject|10|||
94560783|NCT01510158|323847714|FG001|Overall Study|Withdrawal by Subject|13|||
94345419|NCT01222767|323045933|FG000|Overall Study|Surgical resection|1|||
94560784|NCT01510158|323847715|FG002|Overall Study|Withdrawal by Subject|10|||
94560785|NCT01510158|323847713|FG000|Overall Study|Death|1|||
94560786|NCT01510158|323847714|FG001|Overall Study|Death|0|||
94560787|NCT01510158|323847715|FG002|Overall Study|Death|0|||
94560788|NCT00398567|323847718|FG000|Overall Study|Disease Progression|3|||
94560789|NCT00398567|323847719|FG001|Overall Study|Disease Progression|4|||
94560790|NCT00398567|323847720|FG002|Overall Study|Disease Progression|27|||
94560791|NCT00398567|323847718|FG000|Overall Study|Withdrawal by Subject|1|||
94560792|NCT00398567|323847719|FG001|Overall Study|Withdrawal by Subject|0|||
94560793|NCT00398567|323847720|FG002|Overall Study|Withdrawal by Subject|4|||
94560794|NCT00398567|323847718|FG000|Overall Study|Adverse Event|0|||
94560795|NCT00398567|323847719|FG001|Overall Study|Adverse Event|0|||
94560796|NCT00398567|323847720|FG002|Overall Study|Adverse Event|2|||
94560797|NCT00398567|323847718|FG000|Overall Study|Protocol Violation|0|||
94560798|NCT00398567|323847719|FG001|Overall Study|Protocol Violation|0|||
94345420|NCT01222767|323045933|FG000|Overall Study|Never treated|1|||
94560799|NCT00398567|323847720|FG002|Overall Study|Protocol Violation|1|||
94560800|NCT04421482|323847721|FG000|Overall Study|Physician Decision|1|||
94560801|NCT02751580|323847723|FG000|Overall Study|Lost to Follow-up|4|||
94560802|NCT02751580|323847723|FG000|Overall Study|Death|2|||
94345421|NCT00723489|323045934|FG000|Overall Study|Physician Decision|0|||
94345422|NCT00723489|323045935|FG001|Overall Study|Physician Decision|1|||
94345423|NCT00723489|323045936|FG002|Overall Study|Physician Decision|0|||
94345424|NCT00723489|323045937|FG003|Overall Study|Physician Decision|0|||
94345425|NCT00723489|323045934|FG000|Overall Study|Pregnancy|0|||
94345426|NCT00723489|323045935|FG001|Overall Study|Pregnancy|0|||
94345427|NCT00723489|323045936|FG002|Overall Study|Pregnancy|0|||
94345428|NCT00723489|323045937|FG003|Overall Study|Pregnancy|1|||
94345429|NCT00723489|323045934|FG000|Overall Study|Withdrawal by Subject|0|||
94345430|NCT00723489|323045935|FG001|Overall Study|Withdrawal by Subject|0|||
94345431|NCT00723489|323045936|FG002|Overall Study|Withdrawal by Subject|0|||
94345432|NCT00723489|323045937|FG003|Overall Study|Withdrawal by Subject|1|||
94345433|NCT00723489|323045934|FG000|Overall Study|Seropositive at baseline|1|||
94345434|NCT00723489|323045935|FG001|Overall Study|Seropositive at baseline|0|||
94345435|NCT00723489|323045936|FG002|Overall Study|Seropositive at baseline|0|||
94345436|NCT00723489|323045937|FG003|Overall Study|Seropositive at baseline|0|||
94345437|NCT00723489|323045934|FG000|Overall Study|Prohibited Medication|0|||
94345438|NCT00723489|323045935|FG001|Overall Study|Prohibited Medication|0|||
94345439|NCT00723489|323045936|FG002|Overall Study|Prohibited Medication|0|||
94345440|NCT00723489|323045937|FG003|Overall Study|Prohibited Medication|1|||
94345441|NCT00723489|323045934|FG000|Overall Study|Samples Collected Out of Window|0|||
94345442|NCT00723489|323045935|FG001|Overall Study|Samples Collected Out of Window|3|||
94345443|NCT00723489|323045936|FG002|Overall Study|Samples Collected Out of Window|0|||
94345444|NCT00723489|323045937|FG003|Overall Study|Samples Collected Out of Window|0|||
94345445|NCT01599585|323045941|FG000|Overall Study|Withdrawal by Subject|16|||
94345446|NCT01599585|323045942|FG001|Overall Study|Withdrawal by Subject|9|||
94345447|NCT01599585|323045941|FG000|Overall Study|Lost to Follow-up|3|||
94345448|NCT01599585|323045942|FG001|Overall Study|Lost to Follow-up|5|||
94345449|NCT01599585|323045941|FG000|Overall Study|randomized did not start treatment|3|||
94345450|NCT01599585|323045942|FG001|Overall Study|randomized did not start treatment|3|||
94345451|NCT01266876|323045944|FG000|Overall Study|Adverse Event|0|||
94345452|NCT01266876|323045945|FG001|Overall Study|Adverse Event|0|||
94345453|NCT01266876|323045946|FG002|Overall Study|Adverse Event|0|||
94345454|NCT01266876|323045947|FG003|Overall Study|Adverse Event|1|||
94345455|NCT01266876|323045948|FG004|Overall Study|Adverse Event|0|||
94345456|NCT00853112|323045949|FG000|Overall Study|Randomized but not treated|0|||
94345457|NCT00853112|323045950|FG001|Overall Study|Randomized but not treated|1|||
94345458|NCT00853112|323045951|FG002|Overall Study|Randomized but not treated|0|||
94345459|NCT00853112|323045952|FG003|Overall Study|Randomized but not treated|2|||
94345460|NCT00853112|323045953|FG004|Overall Study|Randomized but not treated|0|||
94345461|NCT00853112|323045954|FG005|Overall Study|Randomized but not treated|0|||
94345462|NCT00853112|323045955|FG006|Overall Study|Randomized but not treated|1|||
94345463|NCT02871791|323045958|FG000|Phase 1b|Death|0|||
94345464|NCT02871791|323045959|FG001|Phase 1b|Death|1|||
94345465|NCT02871791|323045958|FG000|Phase 1b|progressive disease|6|||
94345466|NCT02871791|323045959|FG001|Phase 1b|progressive disease|2|||
94345467|NCT02871791|323045958|FG000|Phase 2|Death|1|||
94345468|NCT02871791|323045959|FG001|Phase 2|Death|0|||
94345469|NCT02871791|323045958|FG000|Phase 2|Lost to Follow-up|2|||
94345470|NCT02871791|323045959|FG001|Phase 2|Lost to Follow-up|0|||
94345471|NCT00474539|323045960|FG000|Infant Series|Withdrawal by Subject|3|||
94345472|NCT00474539|323045961|FG001|Infant Series|Withdrawal by Subject|4|||
94345473|NCT00474539|323045960|FG000|Infant Series|Randomization error|5|||
94345474|NCT00474539|323045961|FG001|Infant Series|Randomization error|0|||
94345475|NCT00474539|323045960|FG000|Infant Series|Lost to Follow-up|2|||
94345476|NCT00474539|323045961|FG001|Infant Series|Lost to Follow-up|1|||
94345477|NCT00474539|323045960|FG000|Infant Series|Protocol Violation|0|||
94345478|NCT00474539|323045961|FG001|Infant Series|Protocol Violation|1|||
94345479|NCT00474539|323045960|FG000|After Infant Series|Lost to Follow-up|3|||
94345480|NCT00474539|323045961|FG001|After Infant Series|Lost to Follow-up|0|||
94345481|NCT00474539|323045960|FG000|After Infant Series|Withdrawal by Subject|1|||
94345482|NCT00474539|323045961|FG001|After Infant Series|Withdrawal by Subject|0|||
94345483|NCT00474539|323045960|FG000|Toddler Dose|Protocol Violation|1|||
94345484|NCT00474539|323045961|FG001|Toddler Dose|Protocol Violation|0|||
94345485|NCT02449915|323045969|FG000|Overall Study|Exclusion criteria - drug use|1|||
94345486|NCT02449915|323045970|FG001|Overall Study|Exclusion criteria - drug use|0|||
94345487|NCT02449915|323045969|FG000|Overall Study|Withdrawal by Subject|0|||
94345488|NCT02449915|323045970|FG001|Overall Study|Withdrawal by Subject|2|||
94345489|NCT02449915|323045969|FG000|Overall Study|Intraoperative surgical findings|1|||
94345490|NCT02449915|323045970|FG001|Overall Study|Intraoperative surgical findings|1|||
94345491|NCT02449915|323045969|FG000|Overall Study|Abnormal preop lab|0|||
94345492|NCT02449915|323045970|FG001|Overall Study|Abnormal preop lab|1|||
94345493|NCT03442595|323045973|FG000|Overall Study|Lost to Follow-up|94|||
94449591|NCT00298272|323434219|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
94449592|NCT00298272|323434218|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
94449593|NCT00298272|323434219|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
94449594|NCT00298272|323434218|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
94449595|NCT00298272|323434219|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
94449596|NCT00298272|323434218|FG000|Safety Follow-up Phase|Failure to Return|1|||
94449597|NCT00298272|323434219|FG001|Safety Follow-up Phase|Failure to Return|1|||
94449598|NCT00298272|323434218|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
94449599|NCT00298272|323434219|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
94449600|NCT00298272|323434218|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
94449601|NCT00298272|323434219|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
94449602|NCT00356603|323434220|FG000|Overall Study|Other|6|||
94449603|NCT00356603|323434221|FG001|Overall Study|Other|3|||
94449604|NCT00684411|323434223|FG000|Overall Study|New Primary Cancer|1|||
94449605|NCT00684411|323434223|FG000|Overall Study|Disease Progression|10|||
94449606|NCT00684411|323434223|FG000|Overall Study|Adverse Event|1|||
94449607|NCT05253573|323434224|FG000|Overall Study|Death|1|||
94449608|NCT05253573|323434225|FG001|Overall Study|Death|0|||
94449609|NCT00566020|323434226|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
94449610|NCT00566020|323434227|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
94449611|NCT00566020|323434226|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
94449612|NCT00566020|323434227|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
94449613|NCT00566020|323434226|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
94449614|NCT00566020|323434227|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
94449615|NCT00566020|323434226|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
94449616|NCT00566020|323434227|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
94449617|NCT00566020|323434226|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
94449618|NCT00566020|323434227|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
94449619|NCT00566020|323434226|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
94449620|NCT00566020|323434227|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
94449621|NCT02393950|323434228|FG000|Overall Study|Adverse Event|1|||
94449622|NCT02393950|323434229|FG001|Overall Study|Adverse Event|0|||
94449623|NCT02393950|323434228|FG000|Overall Study|Withdrawal by Subject|0|||
94449624|NCT02393950|323434229|FG001|Overall Study|Withdrawal by Subject|1|||
94449625|NCT01262287|323434230|FG000|Overall Study|Lost to Follow-up|2|||
94449626|NCT01262287|323434231|FG001|Overall Study|Lost to Follow-up|1|||
94449627|NCT01436370|323434234|FG000|Overall Study|Lost to Follow-up|0|||
94449628|NCT01436370|323434235|FG001|Overall Study|Lost to Follow-up|0|||
94449629|NCT01436370|323434236|FG002|Overall Study|Lost to Follow-up|0|||
94449630|NCT01436370|323434237|FG003|Overall Study|Lost to Follow-up|0|||
94449631|NCT01436370|323434238|FG004|Overall Study|Lost to Follow-up|1|||
94449632|NCT01436370|323434239|FG005|Overall Study|Lost to Follow-up|0|||
94449633|NCT01436370|323434240|FG006|Overall Study|Lost to Follow-up|0|||
94449634|NCT01436370|323434241|FG007|Overall Study|Lost to Follow-up|0|||
94449635|NCT02395848|323434242|FG000|Overall Study|Lost to Follow-up|2|||
94449636|NCT02276560|323434243|FG000|Overall Study|Adverse Event|1|||
94233449|NCT02201901|322648282|FG001|Overall Study|Adverse Event|1|||
94449637|NCT02276560|323434244|FG001|Overall Study|Adverse Event|0|||
94449638|NCT02276560|323434245|FG002|Overall Study|Adverse Event|0|||
94449639|NCT01754129|323434246|FG000|Overall Study|Death|13|||
94449640|NCT01754129|323434246|FG000|Overall Study|Duodopa discontinuation|9|||
94449641|NCT01754129|323434246|FG000|Overall Study|Lost to Follow-up|7|||
94449642|NCT01754129|323434246|FG000|Overall Study|Withdrew consent|1|||
94345494|NCT03442595|323045974|FG001|Overall Study|Lost to Follow-up|0|||
94560803|NCT03781778|323847724|FG000|Overall Study|Withdrawal by Subject|2|||
94560804|NCT03781778|323847725|FG001|Overall Study|Withdrawal by Subject|2|||
94560805|NCT04526145|323847726|FG000|Overall Study|Withdrawal by Subject|5|||
94560806|NCT01415401|323847729|FG000|Overall Study|Adverse Event|5|||
94560807|NCT01415401|323847729|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
94560808|NCT01415401|323847729|FG000|Overall Study|Terminated by Sponsor|1|||
94560809|NCT00994422|323847733|FG000|Overall Study|Lost to Follow-up|7|||
94560810|NCT00994422|323847734|FG001|Overall Study|Lost to Follow-up|1|||
94560811|NCT02534909|323847735|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
94560812|NCT04137731|323847739|FG000|Overall Study|Surgery Cancellation|1|||
94560813|NCT04137731|323847740|FG001|Overall Study|Surgery Cancellation|2|||
94560814|NCT04137731|323847739|FG000|Overall Study|Withdrawal by Subject|2|||
94560815|NCT04137731|323847740|FG001|Overall Study|Withdrawal by Subject|0|||
94560816|NCT04137731|323847739|FG000|Overall Study|Protocol Violation|0|||
94560817|NCT04137731|323847740|FG001|Overall Study|Protocol Violation|1|||
94560818|NCT03983304|323847741|FG000|Overall Study|Withdrawal by Subject|5|||
94560819|NCT03983304|323847741|FG000|Overall Study|Lost to Follow-up|2|||
94560820|NCT01702246|323847742|FG000|Overall Study|Lost to Follow-up|2|||
94560821|NCT01702246|323847742|FG000|Overall Study|Withdrawal by Subject|2|||
94560822|NCT01702246|323847742|FG000|Overall Study|Physician Decision|1|||
94560823|NCT01587040|323847743|FG000|Overall Study|Protocol Violation|0|||
94560824|NCT01587040|323847744|FG001|Overall Study|Protocol Violation|0|||
94560825|NCT01587040|323847745|FG002|Overall Study|Protocol Violation|1|||
94560826|NCT01587040|323847746|FG003|Overall Study|Protocol Violation|0|||
94560827|NCT01587040|323847743|FG000|Overall Study|Adverse Event|0|||
94560828|NCT01587040|323847744|FG001|Overall Study|Adverse Event|1|||
94657631|NCT04443218|324204353|FG000|Overall Study|Death|19|||
94657632|NCT01751568|324204354|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
94657633|NCT01751568|324204355|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
94657634|NCT01751568|324204356|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
94657635|NCT01731171|324204360|FG000|Overall Study|Withdrawal by Subject|4|||
94657636|NCT01731171|324204361|FG001|Overall Study|Withdrawal by Subject|1|||
94657637|NCT01731171|324204360|FG000|Overall Study|Lost to Follow-up|3|||
94657638|NCT01731171|324204361|FG001|Overall Study|Lost to Follow-up|2|||
94657639|NCT01731171|324204360|FG000|Overall Study|Moved out of Area|0|||
94233450|NCT02201901|322648283|FG002|Overall Study|Adverse Event|0|||
94233451|NCT04277507|322648284|FG000|Overall Study|Lost to Follow-up|17|||
94233452|NCT04277507|322648284|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
94233453|NCT04277507|322648284|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
94233454|NCT04277507|322648284|FG000|Overall Study|Withdrawal by Subject|3|||
94233455|NCT04277507|322648284|FG000|Overall Study|Death due to COVID-19|1|||
94233456|NCT04277507|322648284|FG000|Overall Study|Data missing for full evaluation|5|||
94233457|NCT03358238|322648285|FG000|Overall Study|Withdrawal by Subject|0|||
94233458|NCT03358238|322648286|FG001|Overall Study|Withdrawal by Subject|1|||
94233459|NCT02242643|322648287|FG000|Overall Study|Protocol Violation|1|||
94233460|NCT02242643|322648288|FG001|Overall Study|Protocol Violation|2|||
94233461|NCT02242643|322648287|FG000|Overall Study|Withdrawal by Subject|15|||
94233462|NCT02242643|322648288|FG001|Overall Study|Withdrawal by Subject|10|||
94233463|NCT02242643|322648287|FG000|Overall Study|Migrated/moved from study area|1|||
94233464|NCT02242643|322648288|FG001|Overall Study|Migrated/moved from study area|3|||
94233465|NCT02242643|322648287|FG000|Overall Study|Lost to Follow-up|54|||
94233466|NCT02242643|322648288|FG001|Overall Study|Lost to Follow-up|61|||
94233467|NCT02242643|322648287|FG000|Overall Study|Child placed in foster care by family|0|||
94233468|NCT02242643|322648288|FG001|Overall Study|Child placed in foster care by family|1|||
94233469|NCT02242643|322648287|FG000|Overall Study|Non-compliance|1|||
94233470|NCT02242643|322648288|FG001|Overall Study|Non-compliance|0|||
94233471|NCT02242643|322648287|FG000|Overall Study|Consent withdrawal by parent|1|||
94233472|NCT02242643|322648288|FG001|Overall Study|Consent withdrawal by parent|0|||
94233473|NCT02242643|322648287|FG000|Overall Study|Protocol requirements not followed|1|||
94233474|NCT02242643|322648288|FG001|Overall Study|Protocol requirements not followed|0|||
94233475|NCT02242643|322648287|FG000|Overall Study|Language barrier|1|||
94233476|NCT02242643|322648288|FG001|Overall Study|Language barrier|0|||
94233477|NCT02242643|322648287|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
94233478|NCT02242643|322648288|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
94233479|NCT01431950|322648291|FG000|Overall Study|Study Site Closed/Terminated|7|||
94560829|NCT01587040|323847745|FG002|Overall Study|Adverse Event|10|||
94560830|NCT01587040|323847746|FG003|Overall Study|Adverse Event|0|||
94560831|NCT01587040|323847743|FG000|Overall Study|Disease progression|12|||
94560832|NCT01587040|323847744|FG001|Overall Study|Disease progression|1|||
94657640|NCT01731171|324204361|FG001|Overall Study|Moved out of Area|2|||
94233480|NCT01431950|322648292|FG001|Overall Study|Study Site Closed/Terminated|3|||
94233481|NCT01431950|322648291|FG000|Overall Study|Withdrawal by Subject|4|||
94560833|NCT01587040|323847745|FG002|Overall Study|Disease progression|15|||
94449643|NCT01754129|323434246|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
94449644|NCT04134767|323434247|FG000|Overall Study|Death|0|||
94449645|NCT04134767|323434248|FG001|Overall Study|Death|1|||
94449646|NCT04134767|323434247|FG000|Overall Study|Removed for harassing staff|0|||
94449647|NCT04134767|323434248|FG001|Overall Study|Removed for harassing staff|1|||
94449648|NCT04134767|323434247|FG000|Overall Study|Lost to Follow-up|44|||
94449649|NCT04134767|323434248|FG001|Overall Study|Lost to Follow-up|40|||
94449650|NCT02582242|323434249|FG000|Overall Study|Adverse Event|4|||
94449651|NCT02582242|323434250|FG001|Overall Study|Adverse Event|3|||
94449652|NCT02582242|323434249|FG000|Overall Study|Protocol Violation|3|||
94449653|NCT02582242|323434250|FG001|Overall Study|Protocol Violation|1|||
94449654|NCT02582242|323434249|FG000|Overall Study|Lost to Follow-up|0|||
94449655|NCT02582242|323434250|FG001|Overall Study|Lost to Follow-up|1|||
94449656|NCT02582242|323434249|FG000|Overall Study|Withdrawal by Subject|11|||
94449657|NCT02582242|323434250|FG001|Overall Study|Withdrawal by Subject|11|||
94449658|NCT02582242|323434249|FG000|Overall Study|Unclassified|2|||
94449659|NCT02582242|323434250|FG001|Overall Study|Unclassified|1|||
94449660|NCT02058537|323434251|FG000|Overall Study|Withdrawal by Subject|1|||
94449661|NCT02126579|323434253|FG000|Overall Study|disease progression|0|||
94449662|NCT02126579|323434254|FG001|Overall Study|disease progression|0|||
94449663|NCT02126579|323434255|FG002|Overall Study|disease progression|0|||
94449664|NCT02126579|323434256|FG003|Overall Study|disease progression|1|||
94449665|NCT02126579|323434257|FG004|Overall Study|disease progression|0|||
94449666|NCT02126579|323434258|FG005|Overall Study|disease progression|0|||
94449667|NCT02126579|323434259|FG006|Overall Study|disease progression|1|||
94449668|NCT03168711|323434260|FG000|Overall Study|Adverse Event|2|||
94449669|NCT03168711|323434261|FG001|Overall Study|Adverse Event|0|||
94449670|NCT03168711|323434260|FG000|Overall Study|Withdrawal by Subject|0|||
94449671|NCT03168711|323434261|FG001|Overall Study|Withdrawal by Subject|1|||
94449672|NCT03168711|323434260|FG000|Overall Study|Death|0|||
94449673|NCT03168711|323434261|FG001|Overall Study|Death|1|||
94449674|NCT03656692|323434262|FG000|Overall Study|Worsening of disease activity|2|||
94449675|NCT03656692|323434262|FG000|Overall Study|Physician Decision|1|||
94449676|NCT01418378|323434263|FG000|Overall Study|Death|1|||
94449677|NCT01418378|323434264|FG001|Overall Study|Death|2|||
94449678|NCT01418378|323434263|FG000|Overall Study|Physician Decision|0|||
94449679|NCT01418378|323434264|FG001|Overall Study|Physician Decision|1|||
94449680|NCT01418378|323434263|FG000|Overall Study|ligament imbalance|0|||
94449681|NCT01418378|323434264|FG001|Overall Study|ligament imbalance|1|||
94449682|NCT01418378|323434263|FG000|Overall Study|developed chronic myopathy|0|||
94449683|NCT01418378|323434264|FG001|Overall Study|developed chronic myopathy|1|||
94449684|NCT01346696|323434266|FG000|Overall Study|Death|1|||
94449685|NCT00839800|323434267|FG000|Overall Study|Adverse Event|8|||
94449686|NCT00839800|323434268|FG001|Overall Study|Adverse Event|12|||
94449687|NCT00839800|323434267|FG000|Overall Study|Lost to Follow-up|31|||
94449688|NCT00839800|323434268|FG001|Overall Study|Lost to Follow-up|26|||
94449689|NCT00839800|323434267|FG000|Overall Study|Withdrawal by Subject|28|||
94449690|NCT00839800|323434268|FG001|Overall Study|Withdrawal by Subject|34|||
94449691|NCT00839800|323434267|FG000|Overall Study|Incorrect Enrolment|3|||
94449692|NCT00839800|323434268|FG001|Overall Study|Incorrect Enrolment|3|||
94449693|NCT00839800|323434267|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
94449694|NCT00839800|323434268|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
94449695|NCT00839800|323434267|FG000|Overall Study|Safety Reasons|2|||
94449696|NCT00839800|323434268|FG001|Overall Study|Safety Reasons|1|||
94449697|NCT00839800|323434267|FG000|Overall Study|Other|8|||
94449698|NCT00839800|323434268|FG001|Overall Study|Other|14|||
94449699|NCT00839800|323434267|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
94449700|NCT00839800|323434268|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
94449701|NCT02510664|323434269|FG000|Overall Study|Transferred Care|9|||
94449702|NCT02510664|323434270|FG001|Overall Study|Transferred Care|9|||
94449703|NCT02510664|323434271|FG002|Overall Study|Transferred Care|0|||
94449704|NCT02510664|323434269|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
94449705|NCT02510664|323434270|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
94449706|NCT02510664|323434271|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
94449707|NCT02510664|323434269|FG000|Overall Study|Time Constraints|1|||
94449708|NCT02510664|323434270|FG001|Overall Study|Time Constraints|1|||
94449709|NCT02510664|323434271|FG002|Overall Study|Time Constraints|0|||
94449710|NCT00288626|323434272|FG000|Overall Study|Death|3|||
94449711|NCT00288626|323434272|FG000|Overall Study|Withdrawal by Subject|4|||
94449712|NCT01081769|323434300|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
94449713|NCT01081769|323434301|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
94449714|NCT01081769|323434300|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
94449715|NCT01081769|323434301|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
94449716|NCT01081769|323434300|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
94449717|NCT01081769|323434301|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
94449718|NCT01081769|323434300|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
94449719|NCT01081769|323434301|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
94233482|NCT01431950|322648292|FG001|Overall Study|Withdrawal by Subject|3|||
94233483|NCT01431950|322648291|FG000|Overall Study|Protocol Violation|2|||
94233484|NCT01431950|322648292|FG001|Overall Study|Protocol Violation|3|||
94233485|NCT01431950|322648291|FG000|Overall Study|Adverse Event|2|||
94465880|NCT00090987|323494925|FG000|Overall Study|Incarcerated|1|||
94465881|NCT01080391|323494929|FG000|Overall Study|Randomized but not treated|7|||
94465882|NCT01080391|323494930|FG001|Overall Study|Randomized but not treated|4|||
94465883|NCT02117713|323494941|FG000|Week 48|Adverse Event|4|||
94465884|NCT02117713|323494941|FG000|Week 48|Withdrawal by caregiver|2|||
94465885|NCT02117713|323494941|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
94465886|NCT02117713|323494941|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
94465887|NCT02117713|323494941|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
94465888|NCT02117713|323494941|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
94465889|NCT03802565|323494942|FG000|Overall Study|Adverse Event|0|||
94465890|NCT03802565|323494943|FG001|Overall Study|Adverse Event|1|||
94465891|NCT03802565|323494944|FG002|Overall Study|Adverse Event|2|||
94465892|NCT03802565|323494945|FG003|Overall Study|Adverse Event|1|||
94465893|NCT03802565|323494946|FG004|Overall Study|Adverse Event|1|||
94465894|NCT03802565|323494942|FG000|Overall Study|Withdrawal by Subject|2|||
94465895|NCT03802565|323494943|FG001|Overall Study|Withdrawal by Subject|2|||
94465896|NCT03802565|323494944|FG002|Overall Study|Withdrawal by Subject|2|||
94465897|NCT03802565|323494945|FG003|Overall Study|Withdrawal by Subject|0|||
94465898|NCT03802565|323494946|FG004|Overall Study|Withdrawal by Subject|1|||
94465899|NCT03802565|323494942|FG000|Overall Study|Protocol Violation|2|||
94465900|NCT03802565|323494943|FG001|Overall Study|Protocol Violation|1|||
94465901|NCT03802565|323494944|FG002|Overall Study|Protocol Violation|4|||
94465902|NCT03802565|323494945|FG003|Overall Study|Protocol Violation|5|||
94465903|NCT03802565|323494946|FG004|Overall Study|Protocol Violation|1|||
94465904|NCT03802565|323494942|FG000|Overall Study|Lost to Follow-up|0|||
94465905|NCT03802565|323494943|FG001|Overall Study|Lost to Follow-up|0|||
94465906|NCT03802565|323494944|FG002|Overall Study|Lost to Follow-up|1|||
94465907|NCT03802565|323494945|FG003|Overall Study|Lost to Follow-up|0|||
94465908|NCT03802565|323494946|FG004|Overall Study|Lost to Follow-up|0|||
94465909|NCT03802565|323494942|FG000|Overall Study|Subjects Related to Each Other|1|||
94465910|NCT03802565|323494943|FG001|Overall Study|Subjects Related to Each Other|0|||
94465911|NCT03802565|323494944|FG002|Overall Study|Subjects Related to Each Other|0|||
94465912|NCT03802565|323494945|FG003|Overall Study|Subjects Related to Each Other|2|||
94465913|NCT03802565|323494946|FG004|Overall Study|Subjects Related to Each Other|1|||
94465914|NCT03802565|323494942|FG000|Overall Study|Elevated Enzymes|0|||
94465915|NCT03802565|323494943|FG001|Overall Study|Elevated Enzymes|0|||
94465916|NCT03802565|323494944|FG002|Overall Study|Elevated Enzymes|0|||
94465917|NCT03802565|323494945|FG003|Overall Study|Elevated Enzymes|0|||
94465918|NCT03802565|323494946|FG004|Overall Study|Elevated Enzymes|2|||
94465919|NCT05020899|323494947|FG000|8 Week Follow-up|Lost to Follow-up|3|||
94465920|NCT05020899|323494948|FG001|8 Week Follow-up|Lost to Follow-up|6|||
94465921|NCT05020899|323494947|FG000|12 Week Follow-up|Lost to Follow-up|1|||
94465922|NCT05020899|323494948|FG001|12 Week Follow-up|Lost to Follow-up|0|||
94465923|NCT05020899|323494947|FG000|12 Week Follow-up|Death|0|||
94465924|NCT05020899|323494948|FG001|12 Week Follow-up|Death|1|||
94465925|NCT02912455|323494949|FG000|Overall Study|Withdrawal by Subject|0|||
94465926|NCT02912455|323494950|FG001|Overall Study|Withdrawal by Subject|1|||
94465927|NCT02912455|323494949|FG000|Overall Study|Lack of Efficacy|0|||
94465928|NCT02912455|323494950|FG001|Overall Study|Lack of Efficacy|1|||
94465929|NCT02912455|323494949|FG000|Overall Study|Lost to Follow-up|2|||
94465930|NCT02912455|323494950|FG001|Overall Study|Lost to Follow-up|1|||
94465931|NCT01717391|323494953|FG000|Overall Study|Withdrawal by Subject|5|||
94465932|NCT01717391|323494953|FG000|Overall Study|Physician Decision|1|||
94465933|NCT01717391|323494953|FG000|Overall Study|FLT technical failure|3|||
94465934|NCT01380691|323494955|FG000|Washout (7 Days)|Protocol Violation|0|||
94465935|NCT01380691|323494956|FG001|Washout (7 Days)|Protocol Violation|0|||
94465936|NCT01380691|323494957|FG002|Washout (7 Days)|Protocol Violation|0|||
94465937|NCT01380691|323494958|FG003|Washout (7 Days)|Protocol Violation|1|||
94465938|NCT01380691|323494955|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
94465939|NCT01380691|323494956|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
94465940|NCT01380691|323494957|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
94465941|NCT01380691|323494958|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
94465942|NCT04769739|323494959|FG000|Overall Study|Colorectal cancer obstruction|2|||
94465943|NCT04769739|323494960|FG001|Overall Study|Colorectal cancer obstruction|0|||
94465944|NCT04769739|323494961|FG002|Overall Study|Colorectal cancer obstruction|0|||
94465945|NCT04769739|323494962|FG003|Overall Study|Colorectal cancer obstruction|0|||
94465946|NCT04769739|323494959|FG000|Overall Study|Failed cecal intubation|1|||
94465947|NCT04769739|323494960|FG001|Overall Study|Failed cecal intubation|0|||
94465948|NCT04769739|323494961|FG002|Overall Study|Failed cecal intubation|0|||
94465949|NCT04769739|323494962|FG003|Overall Study|Failed cecal intubation|1|||
94560834|NCT01587040|323847746|FG003|Overall Study|Disease progression|3|||
94560835|NCT01587040|323847743|FG000|Overall Study|Other than specified|5|||
94560836|NCT01587040|323847744|FG001|Overall Study|Other than specified|1|||
94560837|NCT01587040|323847745|FG002|Overall Study|Other than specified|11|||
94560838|NCT01587040|323847746|FG003|Overall Study|Other than specified|1|||
94560839|NCT02362464|323847749|FG000|Overall Study|Switched to alternative therapy|1|||
94560840|NCT02362464|323847749|FG000|Overall Study|Refused further treatment|1|||
94345495|NCT00515099|323045975|FG000|Overall Study|Lost to Follow-up|0|||
94345496|NCT00515099|323045976|FG001|Overall Study|Lost to Follow-up|4|||
94345497|NCT00515099|323045975|FG000|Overall Study|Withdrawal by Subject|2|||
94345498|NCT00515099|323045976|FG001|Overall Study|Withdrawal by Subject|0|||
94345499|NCT00515099|323045975|FG000|Overall Study|IRB Recommendation|1|||
94345500|NCT00515099|323045976|FG001|Overall Study|IRB Recommendation|0|||
94345501|NCT00170846|323045981|FG000|Overall Study|Subject withdrew Informed Consent|5|||
94345502|NCT00170846|323045982|FG001|Overall Study|Subject withdrew Informed Consent|12|||
94345503|NCT00170846|323045983|FG002|Overall Study|Subject withdrew Informed Consent|8|||
94345504|NCT00170846|323045981|FG000|Overall Study|Lost to Follow-up|6|||
94345505|NCT00170846|323045982|FG001|Overall Study|Lost to Follow-up|3|||
94345506|NCT00170846|323045983|FG002|Overall Study|Lost to Follow-up|2|||
94345507|NCT00170846|323045981|FG000|Overall Study|Death|0|||
94345508|NCT00170846|323045982|FG001|Overall Study|Death|3|||
94345509|NCT00170846|323045983|FG002|Overall Study|Death|3|||
94345510|NCT00170846|323045981|FG000|Overall Study|Reason Missing|0|||
94345511|NCT00170846|323045982|FG001|Overall Study|Reason Missing|1|||
94345512|NCT00170846|323045983|FG002|Overall Study|Reason Missing|0|||
94345513|NCT04652102|323045984|FG000|Overall Study|Adverse Event|14|||
94345514|NCT04652102|323045985|FG001|Overall Study|Adverse Event|13|||
94345515|NCT04652102|323045984|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
94345516|NCT04652102|323045985|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
94345517|NCT04652102|323045984|FG000|Overall Study|Physician Decision|78|||
94345518|NCT04652102|323045985|FG001|Overall Study|Physician Decision|40|||
94345519|NCT04652102|323045984|FG000|Overall Study|Study Ended by Sponsor|64|||
94345520|NCT04652102|323045985|FG001|Overall Study|Study Ended by Sponsor|17|||
94345521|NCT04652102|323045984|FG000|Overall Study|Withdrawal by Subject|4625|||
94345522|NCT04652102|323045985|FG001|Overall Study|Withdrawal by Subject|5594|||
94345523|NCT04652102|323045984|FG000|Overall Study|Lost to Follow-up|2019|||
94345524|NCT04652102|323045985|FG001|Overall Study|Lost to Follow-up|1082|||
94345525|NCT04652102|323045984|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
94345526|NCT04652102|323045985|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
94345527|NCT04652102|323045984|FG000|Overall Study|Miscellaneous|80|||
94345528|NCT04652102|323045985|FG001|Overall Study|Miscellaneous|64|||
94345529|NCT02516306|323045989|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
94345530|NCT02516306|323045990|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
94345531|NCT02192190|323045991|FG000|Overall Study|Adverse Event|1|||
94345532|NCT02192190|323045992|FG001|Overall Study|Adverse Event|1|||
94345533|NCT02192190|323045993|FG002|Overall Study|Adverse Event|0|||
94345534|NCT02192190|323045994|FG003|Overall Study|Adverse Event|0|||
94345535|NCT02192190|323045995|FG004|Overall Study|Adverse Event|0|||
94345536|NCT02192190|323045996|FG005|Overall Study|Adverse Event|0|||
94345537|NCT02192190|323045991|FG000|Overall Study|Lost to Follow-up|3|||
94345538|NCT02192190|323045992|FG001|Overall Study|Lost to Follow-up|3|||
94345539|NCT02192190|323045993|FG002|Overall Study|Lost to Follow-up|2|||
94345540|NCT02192190|323045994|FG003|Overall Study|Lost to Follow-up|1|||
94345541|NCT02192190|323045995|FG004|Overall Study|Lost to Follow-up|4|||
94345542|NCT02192190|323045996|FG005|Overall Study|Lost to Follow-up|3|||
94345543|NCT02192190|323045991|FG000|Overall Study|Physician Decision|2|||
94345544|NCT02192190|323045992|FG001|Overall Study|Physician Decision|0|||
94345545|NCT02192190|323045993|FG002|Overall Study|Physician Decision|0|||
94345546|NCT02192190|323045994|FG003|Overall Study|Physician Decision|0|||
94345547|NCT02192190|323045995|FG004|Overall Study|Physician Decision|0|||
94345548|NCT02192190|323045996|FG005|Overall Study|Physician Decision|0|||
94345549|NCT02192190|323045991|FG000|Overall Study|Terminated by Sponsor|43|||
94345550|NCT02192190|323045992|FG001|Overall Study|Terminated by Sponsor|23|||
94345551|NCT02192190|323045993|FG002|Overall Study|Terminated by Sponsor|20|||
94345552|NCT02192190|323045994|FG003|Overall Study|Terminated by Sponsor|23|||
94345553|NCT02192190|323045995|FG004|Overall Study|Terminated by Sponsor|21|||
94345554|NCT02192190|323045996|FG005|Overall Study|Terminated by Sponsor|23|||
94345555|NCT02192190|323045991|FG000|Overall Study|Withdrawal by Subject|4|||
94345556|NCT02192190|323045992|FG001|Overall Study|Withdrawal by Subject|1|||
94345557|NCT02192190|323045993|FG002|Overall Study|Withdrawal by Subject|2|||
94345558|NCT02192190|323045994|FG003|Overall Study|Withdrawal by Subject|1|||
94345559|NCT02192190|323045995|FG004|Overall Study|Withdrawal by Subject|5|||
94345560|NCT02192190|323045996|FG005|Overall Study|Withdrawal by Subject|3|||
94345561|NCT02192190|323045991|FG000|Overall Study|Could not Keep Visit Schedule|1|||
94345562|NCT02192190|323045992|FG001|Overall Study|Could not Keep Visit Schedule|0|||
94345563|NCT02192190|323045993|FG002|Overall Study|Could not Keep Visit Schedule|0|||
94345564|NCT02192190|323045994|FG003|Overall Study|Could not Keep Visit Schedule|0|||
94560841|NCT02362464|323847749|FG000|Overall Study|Physician Decision|4|||
94560842|NCT05232864|323847750|FG000|Overall Study|Adverse Event|0|||
94560843|NCT05232864|323847751|FG001|Overall Study|Adverse Event|1|||
94560844|NCT05232864|323847750|FG000|Overall Study|Study terminated by sponsor|16|||
94560845|NCT05232864|323847751|FG001|Overall Study|Study terminated by sponsor|14|||
94560846|NCT02023996|323847764|FG000|Overall Study|Protocol Violation|6|||
94560847|NCT04346654|323847766|FG000|Overall Study|Adverse Event|2|||
94560848|NCT04346654|323847767|FG001|Overall Study|Adverse Event|0|||
94560849|NCT04346654|323847766|FG000|Overall Study|Non-response|1|||
94560850|NCT04346654|323847767|FG001|Overall Study|Non-response|1|||
94560851|NCT04346654|323847766|FG000|Overall Study|Withdrawal by Subject|2|||
94560852|NCT04346654|323847767|FG001|Overall Study|Withdrawal by Subject|0|||
94560853|NCT04346654|323847766|FG000|Overall Study|Lost to Follow-up|0|||
94560854|NCT04346654|323847767|FG001|Overall Study|Lost to Follow-up|1|||
94560855|NCT04346654|323847766|FG000|Overall Study|Pregnancy|0|||
94560856|NCT04346654|323847767|FG001|Overall Study|Pregnancy|1|||
94560857|NCT04765202|323847772|FG000|Overall Study|Lost to Follow-up|1|||
94560858|NCT04765202|323847773|FG001|Overall Study|Lost to Follow-up|1|||
94560859|NCT04765202|323847774|FG002|Overall Study|Lost to Follow-up|2|||
94560860|NCT04765202|323847775|FG003|Overall Study|Lost to Follow-up|2|||
94560861|NCT04765202|323847772|FG000|Overall Study|Physician Decision|0|||
94560862|NCT04765202|323847773|FG001|Overall Study|Physician Decision|0|||
94560863|NCT04765202|323847774|FG002|Overall Study|Physician Decision|1|||
94560864|NCT04765202|323847775|FG003|Overall Study|Physician Decision|1|||
94560865|NCT04929249|323847776|FG000|Overall Study|Adverse Event|2|||
94560866|NCT04929249|323847777|FG001|Overall Study|Adverse Event|1|||
94560867|NCT04929249|323847776|FG000|Overall Study|Death|2|||
94560868|NCT04929249|323847777|FG001|Overall Study|Death|1|||
94560869|NCT04929249|323847776|FG000|Overall Study|Lost to Follow-up|3|||
94560870|NCT04929249|323847777|FG001|Overall Study|Lost to Follow-up|11|||
94560871|NCT04929249|323847776|FG000|Overall Study|Technical problems|0|||
94560872|NCT04929249|323847777|FG001|Overall Study|Technical problems|1|||
94560873|NCT04929249|323847776|FG000|Overall Study|Subject decision|6|||
94560874|NCT04929249|323847777|FG001|Overall Study|Subject decision|8|||
94560875|NCT04929249|323847776|FG000|Overall Study|Withdrew consent|0|||
94560876|NCT04929249|323847777|FG001|Overall Study|Withdrew consent|8|||
94560877|NCT04209205|323847785|FG000|Overall Study|Adverse Event|2|||
94560878|NCT04209205|323847786|FG001|Overall Study|Adverse Event|3|||
94560879|NCT04209205|323847785|FG000|Overall Study|Lost to Follow-up|3|||
94560880|NCT04209205|323847786|FG001|Overall Study|Lost to Follow-up|1|||
94560881|NCT04209205|323847785|FG000|Overall Study|Physician Decision|1|||
94560882|NCT04209205|323847786|FG001|Overall Study|Physician Decision|1|||
94560883|NCT04209205|323847785|FG000|Overall Study|Subject decision|10|||
94560884|NCT04209205|323847786|FG001|Overall Study|Subject decision|10|||
94560885|NCT04209205|323847785|FG000|Overall Study|Progressive disease|1|||
94560886|NCT04209205|323847786|FG001|Overall Study|Progressive disease|0|||
94560887|NCT04209205|323847785|FG000|Overall Study|Protocol deviation|0|||
94560888|NCT04209205|323847786|FG001|Overall Study|Protocol deviation|1|||
94560889|NCT04209205|323847785|FG000|Overall Study|New therapy for study indication|1|||
94560890|NCT04209205|323847786|FG001|Overall Study|New therapy for study indication|0|||
94560891|NCT04209205|323847785|FG000|Overall Study|Adverse event - placebo not switched|0|||
94560892|NCT04209205|323847786|FG001|Overall Study|Adverse event - placebo not switched|1|||
94560893|NCT04209205|323847785|FG000|Overall Study|Subject decision - placebo not switched|0|||
94560894|NCT04209205|323847786|FG001|Overall Study|Subject decision - placebo not switched|5|||
94560895|NCT04209205|323847785|FG000|Overall Study|Death - placebo not switched|0|||
94560896|NCT04209205|323847786|FG001|Overall Study|Death - placebo not switched|1|||
94560897|NCT01635855|323847788|FG000|Overall Study|Withdrawal by Subject|4|||
94560898|NCT00434109|323847791|FG000|Overall Study|Physician Decision|9|||
94560899|NCT00434109|323847791|FG000|Overall Study|Adverse Event|5|||
94560900|NCT00434109|323847791|FG000|Overall Study|Protocol Violation|1|||
94560901|NCT00434109|323847791|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
94560902|NCT02978833|323847794|FG000|Overall Study|Study terminated|1|||
94560903|NCT02978833|323847795|FG001|Overall Study|Study terminated|1|||
94560904|NCT01123395|323847796|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
94560905|NCT01123395|323847797|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
94560906|NCT02058563|323847798|FG000|Overall Study|Lost to Follow-up|26|||
94560907|NCT02058563|323847799|FG001|Overall Study|Lost to Follow-up|22|||
94560908|NCT02058563|323847798|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
94560909|NCT02058563|323847799|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
94560910|NCT02058563|323847798|FG000|Overall Study|Consent Withdrawal|1|||
94560911|NCT02058563|323847799|FG001|Overall Study|Consent Withdrawal|1|||
94560912|NCT02058563|323847798|FG000|Overall Study|Other (patient incarcerated)|0|||
94560913|NCT02058563|323847799|FG001|Overall Study|Other (patient incarcerated)|1|||
94345565|NCT02192190|323045995|FG004|Overall Study|Could not Keep Visit Schedule|0|||
94560914|NCT03691571|323847800|FG000|Overall Study|Withdrawal by Subject|9|||
94560915|NCT03691571|323847801|FG001|Overall Study|Withdrawal by Subject|2|||
94345566|NCT02192190|323045996|FG005|Overall Study|Could not Keep Visit Schedule|0|||
94345567|NCT02192190|323045991|FG000|Overall Study|Positive Drug Screen|0|||
94560916|NCT02610777|323849711|FG000|Overall Study|Lost to Follow-up|1|||
94560917|NCT02610777|323849712|FG001|Overall Study|Lost to Follow-up|0|||
94560918|NCT02610777|323849711|FG000|Overall Study|Site Terminated by Sponsor|9|||
94560919|NCT02610777|323849712|FG001|Overall Study|Site Terminated by Sponsor|8|||
94560920|NCT02610777|323849711|FG000|Overall Study|Withdrawal by Subject|2|||
94560921|NCT02610777|323849712|FG001|Overall Study|Withdrawal by Subject|2|||
94560922|NCT02610777|323849711|FG000|Overall Study|Reason not Specified|0|||
94560923|NCT02610777|323849712|FG001|Overall Study|Reason not Specified|1|||
94560924|NCT02610777|323849711|FG000|Overall Study|Death|50|||
94560925|NCT02610777|323849712|FG001|Overall Study|Death|47|||
94560926|NCT02219334|323849713|FG000|Overall Study|Withdrawal by Subject|1|||
94560927|NCT02219334|323849714|FG001|Overall Study|Withdrawal by Subject|0|||
94560928|NCT02219334|323849713|FG000|Overall Study|Protocol Violation|7|||
94560929|NCT02219334|323849714|FG001|Overall Study|Protocol Violation|3|||
94560930|NCT03078556|323849717|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
94560931|NCT03078556|323849718|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
94560932|NCT03078556|323849719|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
94560933|NCT03078556|323849720|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
94560934|NCT03078556|323849717|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
94560935|NCT03078556|323849718|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
94560936|NCT03078556|323849719|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
94560937|NCT03078556|323849720|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
94560938|NCT03078556|323849717|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
94560939|NCT03078556|323849718|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
94560940|NCT03078556|323849719|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
94560941|NCT03078556|323849720|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
94560942|NCT03078556|323849717|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
94560943|NCT03078556|323849718|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
94560944|NCT03078556|323849719|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
94560945|NCT03078556|323849720|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
94560946|NCT02588261|323849721|FG000|Overall Study|Study Terminated by Sponsor|157|||
94345568|NCT02192190|323045992|FG001|Overall Study|Positive Drug Screen|0|||
94345569|NCT02192190|323045993|FG002|Overall Study|Positive Drug Screen|0|||
94345570|NCT02192190|323045994|FG003|Overall Study|Positive Drug Screen|1|||
94345571|NCT02192190|323045995|FG004|Overall Study|Positive Drug Screen|0|||
94560947|NCT02588261|323849722|FG001|Overall Study|Study Terminated by Sponsor|142|||
94560948|NCT02588261|323849721|FG000|Overall Study|Protocol Deviation|1|||
94560949|NCT02588261|323849722|FG001|Overall Study|Protocol Deviation|0|||
94560950|NCT02588261|323849721|FG000|Overall Study|Death|1|||
94560951|NCT02588261|323849722|FG001|Overall Study|Death|2|||
94560952|NCT02588261|323849721|FG000|Overall Study|Withdrawal by Subject|12|||
94345572|NCT02192190|323045996|FG005|Overall Study|Positive Drug Screen|0|||
94560953|NCT02588261|323849722|FG001|Overall Study|Withdrawal by Subject|8|||
94560954|NCT02588261|323849721|FG000|Overall Study|Noncompliance with Study Drug|0|||
94560955|NCT02588261|323849722|FG001|Overall Study|Noncompliance with Study Drug|1|||
94560956|NCT02588261|323849721|FG000|Overall Study|Miscellaneous|5|||
94560957|NCT02588261|323849722|FG001|Overall Study|Miscellaneous|4|||
94560958|NCT02588261|323849721|FG000|Overall Study|Progressive Disease|61|||
94560959|NCT02588261|323849722|FG001|Overall Study|Progressive Disease|82|||
94560960|NCT02588261|323849721|FG000|Overall Study|Adverse Event|29|||
94560961|NCT02588261|323849722|FG001|Overall Study|Adverse Event|24|||
94560962|NCT02588261|323849721|FG000|Overall Study|Lost to Follow-up|1|||
94560963|NCT02588261|323849722|FG001|Overall Study|Lost to Follow-up|0|||
94560964|NCT00570310|323849723|FG000|Overall Study|Adverse Event|1|||
94560965|NCT00570310|323849724|FG001|Overall Study|Adverse Event|2|||
94560966|NCT00570310|323849723|FG000|Overall Study|Lack of Efficacy|1|||
94560967|NCT00570310|323849724|FG001|Overall Study|Lack of Efficacy|4|||
94560968|NCT00377858|323849730|FG000|Overall Study|Withdrawal by Subject|12|||
94560969|NCT00377858|323849731|FG001|Overall Study|Withdrawal by Subject|11|||
94560970|NCT00377858|323849730|FG000|Overall Study|Lost to Follow-up|6|||
94560971|NCT00377858|323849731|FG001|Overall Study|Lost to Follow-up|1|||
94560972|NCT00377858|323849730|FG000|Overall Study|Physician Decision|5|||
94560973|NCT00377858|323849731|FG001|Overall Study|Physician Decision|5|||
94560974|NCT00377858|323849730|FG000|Overall Study|Protocol Violation|3|||
94560975|NCT00377858|323849731|FG001|Overall Study|Protocol Violation|4|||
94560976|NCT00377858|323849730|FG000|Overall Study|Adverse Event|2|||
94233486|NCT01431950|322648292|FG001|Overall Study|Adverse Event|2|||
94233487|NCT01431950|322648291|FG000|Overall Study|Physician Decision|2|||
94233488|NCT01431950|322648292|FG001|Overall Study|Physician Decision|1|||
94233489|NCT01431950|322648291|FG000|Overall Study|Lack of Efficacy|2|||
94233490|NCT01431950|322648292|FG001|Overall Study|Lack of Efficacy|1|||
94233491|NCT01431950|322648291|FG000|Overall Study|Lost to Follow-up|0|||
94233492|NCT01431950|322648292|FG001|Overall Study|Lost to Follow-up|1|||
94233493|NCT01431950|322648291|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
94233494|NCT01431950|322648292|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
94233495|NCT02101983|322648293|FG000|Overall Study|Physician Decision|1|||
94233496|NCT02101983|322648294|FG001|Overall Study|Physician Decision|0|||
94233497|NCT02559310|322648297|FG000|Overall Study|Death|4|||
94233498|NCT02559310|322648298|FG001|Overall Study|Death|3|||
94233499|NCT02559310|322648297|FG000|Overall Study|Lost to Follow-up|5|||
94233500|NCT02559310|322648298|FG001|Overall Study|Lost to Follow-up|3|||
94233501|NCT02559310|322648297|FG000|Overall Study|Physician Decision|2|||
94233502|NCT02559310|322648298|FG001|Overall Study|Physician Decision|1|||
94233503|NCT02559310|322648297|FG000|Overall Study|Withdrawal by Subject|13|||
94233504|NCT02559310|322648298|FG001|Overall Study|Withdrawal by Subject|9|||
94233505|NCT02559310|322648297|FG000|Overall Study|Sponsor Decision|0|||
94560977|NCT00377858|323849731|FG001|Overall Study|Adverse Event|1|||
94560978|NCT00377858|323849730|FG000|Overall Study|Entry Criteria Not Met|2|||
94560979|NCT00377858|323849731|FG001|Overall Study|Entry Criteria Not Met|0|||
94560980|NCT00377858|323849730|FG000|Overall Study|Sponsor Decision|1|||
94560981|NCT00377858|323849731|FG001|Overall Study|Sponsor Decision|2|||
94560982|NCT00377858|323849730|FG000|Overall Study|Death|0|||
94560983|NCT00377858|323849731|FG001|Overall Study|Death|3|||
94560984|NCT03088917|323849737|FG000|Overall Study|In care/cured elsewhere|15|||
94560985|NCT03088917|323849737|FG000|Overall Study|Refuse re-evaluation|13|||
94233506|NCT02559310|322648298|FG001|Overall Study|Sponsor Decision|1|||
94560986|NCT03088917|323849737|FG000|Overall Study|Contact not established|13|||
94560987|NCT03088917|323849737|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
94560988|NCT03088917|323849737|FG000|Overall Study|Moved outside study region|50|||
94560989|NCT00286494|323849742|FG000|Overall Study|Hyperglycemic rescue|12|||
94560990|NCT00286494|323849743|FG001|Overall Study|Hyperglycemic rescue|19|||
94560991|NCT00286494|323849744|FG002|Overall Study|Hyperglycemic rescue|18|||
94560992|NCT00286494|323849742|FG000|Overall Study|Withdrawal by Subject|2|||
94233507|NCT02559310|322648297|FG000|Overall Study|Randomized but not treated|3|||
94560993|NCT00286494|323849743|FG001|Overall Study|Withdrawal by Subject|10|||
94560994|NCT00286494|323849744|FG002|Overall Study|Withdrawal by Subject|9|||
94560995|NCT00286494|323849742|FG000|Overall Study|Adverse Event|3|||
94560996|NCT00286494|323849743|FG001|Overall Study|Adverse Event|8|||
94560997|NCT00286494|323849744|FG002|Overall Study|Adverse Event|6|||
94560998|NCT00286494|323849742|FG000|Overall Study|Physician Decision|5|||
94560999|NCT00286494|323849743|FG001|Overall Study|Physician Decision|5|||
94561000|NCT00286494|323849744|FG002|Overall Study|Physician Decision|1|||
94657641|NCT01731171|324204360|FG000|Overall Study|Terminated for Lack of Adherence|0|||
94233508|NCT02559310|322648298|FG001|Overall Study|Randomized but not treated|2|||
94233509|NCT01740154|322648299|FG000|Overall Study|Adverse Event|1|||
94233510|NCT01103232|322648300|FG000|Overall Study|Withdrawal by Subject|1|||
94233511|NCT01103232|322648301|FG001|Overall Study|Withdrawal by Subject|1|||
94233512|NCT01103232|322648300|FG000|Overall Study|Protocol Violation|0|||
94233513|NCT01103232|322648301|FG001|Overall Study|Protocol Violation|1|||
94233514|NCT04013971|322648302|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
94233515|NCT04013971|322648303|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
94233516|NCT04013971|322648302|FG000|Overall Study|Missing biomechanical data|0|||
94233517|NCT04013971|322648303|FG001|Overall Study|Missing biomechanical data|1|||
94233518|NCT05093504|322648304|FG000|Overall Study|Death|0|||
94561001|NCT00286494|323849742|FG000|Overall Study|Lost to Follow-up|3|||
94233519|NCT05093504|322648305|FG001|Overall Study|Death|1|||
94233520|NCT04297618|322648324|FG000|Overall Study|Adverse Event|1|||
94233521|NCT04297618|322648324|FG000|Overall Study|Withdrawal by Subject|1|||
94561002|NCT00286494|323849743|FG001|Overall Study|Lost to Follow-up|1|||
94561003|NCT00286494|323849744|FG002|Overall Study|Lost to Follow-up|3|||
94561004|NCT00286494|323849742|FG000|Overall Study|Protocol Violation|1|||
94561005|NCT00286494|323849743|FG001|Overall Study|Protocol Violation|1|||
94561006|NCT00286494|323849744|FG002|Overall Study|Protocol Violation|2|||
94561007|NCT01345188|323849745|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
94561008|NCT01345188|323849745|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
94561009|NCT00203424|323849746|FG000|Treatment Period|Withdrawal by Subject|4|||
94561010|NCT00203424|323849746|FG000|Treatment Period|Adverse Event|5|||
94561011|NCT00203424|323849746|FG000|Treatment Period|progressive disease|2|||
94561012|NCT00203424|323849746|FG000|Follow-up Period|Withdrawal by Subject|1|||
94561013|NCT00203424|323849746|FG000|Follow-up Period|progressive disease|4|||
94561014|NCT00203424|323849746|FG000|Follow-up Period|Lost to Follow-up|1|||
94561015|NCT05447663|323849747|FG000|Overall Study|Study terminated by Sponsor|5|||
94561016|NCT05447663|323849747|FG000|Overall Study|Death|2|||
94561017|NCT05447663|323849747|FG000|Overall Study|Withdrawal by Subject|1|||
94233522|NCT05992922|322648326|FG000|Overall Study|Adverse Event|6|||
94233523|NCT05992922|322648327|FG001|Overall Study|Adverse Event|0|||
94233524|NCT05992922|322648326|FG000|Overall Study|Sponsor Termination of Study|14|||
94233525|NCT05992922|322648327|FG001|Overall Study|Sponsor Termination of Study|20|||
94233526|NCT01256671|322650158|FG000|Overall Study|Adverse Event|29|||
94561018|NCT01053988|323849748|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
94233527|NCT01256671|322650158|FG000|Overall Study|Lost to Follow-up|16|||
94233528|NCT01256671|322650158|FG000|Overall Study|Withdrawal by Subject|31|||
94233529|NCT01256671|322650158|FG000|Overall Study|Physician Decision|3|||
94233530|NCT01256671|322650158|FG000|Overall Study|Lack of Efficacy|4|||
94561019|NCT01053988|323849749|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
94561020|NCT01053988|323849750|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
94561021|NCT01053988|323849751|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
94233531|NCT01256671|322650158|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
94233532|NCT00612352|322650161|FG000|Overall Study|Adverse Event|1|||
94233533|NCT00612352|322650162|FG001|Overall Study|Adverse Event|0|||
94233534|NCT00612352|322650161|FG000|Overall Study|Withdrawal by Subject|3|||
94233535|NCT00612352|322650162|FG001|Overall Study|Withdrawal by Subject|5|||
94233536|NCT00612352|322650161|FG000|Overall Study|moved out of state|1|||
94233537|NCT00612352|322650162|FG001|Overall Study|moved out of state|0|||
94233538|NCT00612352|322650161|FG000|Overall Study|didn't return calls/show up on test date|4|||
94233539|NCT00612352|322650162|FG001|Overall Study|didn't return calls/show up on test date|1|||
94233540|NCT01986114|322650163|FG000|Overall Study|Adverse Event|59|||
94233541|NCT01986114|322650163|FG000|Overall Study|Lack of Efficacy|23|||
94233542|NCT01986114|322650163|FG000|Overall Study|Withdrawal by Subject|58|||
94233543|NCT01986114|322650163|FG000|Overall Study|Noncompliance|3|||
94233544|NCT01986114|322650163|FG000|Overall Study|Protocol Violation|1|||
94233545|NCT01986114|322650163|FG000|Overall Study|Lost to Follow-up|5|||
94345573|NCT02192190|323045991|FG000|Overall Study|Inadequate Pain Relief|0|||
94345574|NCT02192190|323045992|FG001|Overall Study|Inadequate Pain Relief|1|||
94345575|NCT02192190|323045993|FG002|Overall Study|Inadequate Pain Relief|1|||
94345576|NCT02192190|323045994|FG003|Overall Study|Inadequate Pain Relief|0|||
94345577|NCT02192190|323045995|FG004|Overall Study|Inadequate Pain Relief|0|||
94345578|NCT02192190|323045996|FG005|Overall Study|Inadequate Pain Relief|0|||
94345579|NCT03227692|323045997|FG000|Overall Study|Protocol Violation|1|||
94345580|NCT03227692|323045998|FG001|Overall Study|Protocol Violation|1|||
94345581|NCT03227692|323045997|FG000|Overall Study|Lost to Follow-up|4|||
94345582|NCT03227692|323045998|FG001|Overall Study|Lost to Follow-up|2|||
94345583|NCT03227692|323045997|FG000|Overall Study|Adverse Event|0|||
94233546|NCT01986114|322650163|FG000|Overall Study|Other reason|7|||
94233547|NCT01190644|322650164|FG000|Overall Study|Death|2|||
94233548|NCT01190644|322650164|FG000|Overall Study|Disease progression|1|||
94233549|NCT04009629|322650167|FG000|Overall Study|Withdrawal by Subject|2|||
94233550|NCT04009629|322650168|FG001|Overall Study|Withdrawal by Subject|0|||
94233551|NCT02808975|322650170|FG000|Overall Study|Adverse Event|3|||
94345584|NCT03227692|323045998|FG001|Overall Study|Adverse Event|2|||
94345585|NCT00355615|323045999|FG000|Randomized Double Blind Period|Adverse Event|1|||
94233552|NCT02808975|322650171|FG001|Overall Study|Adverse Event|4|||
94233553|NCT02808975|322650170|FG000|Overall Study|Withdrew consent|9|||
94233554|NCT02808975|322650171|FG001|Overall Study|Withdrew consent|8|||
94561022|NCT01053988|323849752|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
94561023|NCT01053988|323849753|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
94561024|NCT01053988|323849748|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
94561025|NCT01053988|323849749|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
94561026|NCT01053988|323849750|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
94561027|NCT01053988|323849751|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
94561028|NCT01053988|323849752|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
94561029|NCT01053988|323849753|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
94561030|NCT01053988|323849748|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
94561031|NCT01053988|323849749|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
94561032|NCT01053988|323849750|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
94561033|NCT01053988|323849751|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
94561034|NCT01053988|323849752|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
94561035|NCT01053988|323849753|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
94561036|NCT01053988|323849748|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
94561037|NCT01053988|323849749|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
94561038|NCT01053988|323849750|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
94561039|NCT01053988|323849751|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
94561040|NCT01053988|323849752|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
94561041|NCT01053988|323849753|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
94561042|NCT01053988|323849748|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
94561043|NCT01053988|323849749|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
94561044|NCT01053988|323849750|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
94561045|NCT01053988|323849751|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
94561046|NCT01053988|323849752|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
94561047|NCT01053988|323849753|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
94561048|NCT01053988|323849748|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
94561049|NCT01053988|323849749|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
94561050|NCT01053988|323849750|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
94561051|NCT01053988|323849751|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
94561052|NCT01053988|323849752|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
94561053|NCT01053988|323849753|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
94561054|NCT01053988|323849748|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
94561055|NCT01053988|323849749|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
94561056|NCT01053988|323849750|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
94561057|NCT01053988|323849751|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
94561058|NCT01053988|323849752|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
94561059|NCT01053988|323849753|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
94561060|NCT01053988|323849748|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
94561061|NCT01053988|323849749|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
94561062|NCT01053988|323849750|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
94561063|NCT01053988|323849751|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
94561064|NCT01053988|323849752|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
94561065|NCT01053988|323849753|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
94561066|NCT01053988|323849748|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
94561067|NCT01053988|323849749|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
94561068|NCT01053988|323849750|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
94561069|NCT01053988|323849751|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
94561070|NCT01053988|323849752|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
94561071|NCT01053988|323849753|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
94561072|NCT01053988|323849748|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
94561073|NCT01053988|323849749|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
94561074|NCT01053988|323849750|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
94561075|NCT01053988|323849751|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
94561076|NCT01053988|323849752|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
94561077|NCT01053988|323849753|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
94561078|NCT01053988|323849748|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
94561079|NCT01053988|323849749|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
94561080|NCT01053988|323849750|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
94561081|NCT01053988|323849751|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
94561082|NCT01053988|323849752|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
94561083|NCT01053988|323849753|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
94561084|NCT01053988|323849748|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
94561085|NCT01053988|323849749|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
94561086|NCT01053988|323849750|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
94561087|NCT01053988|323849751|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
94561088|NCT01053988|323849752|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
94561089|NCT01053988|323849753|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
94561090|NCT01053988|323849748|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
94561091|NCT01053988|323849749|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
94561092|NCT01053988|323849750|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
94561093|NCT01053988|323849751|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
94561094|NCT01053988|323849752|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
94561095|NCT01053988|323849753|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
94561096|NCT01053988|323849748|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
94561097|NCT01053988|323849749|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
94561098|NCT01053988|323849750|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
94561099|NCT01053988|323849751|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
94561100|NCT01053988|323849752|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
94561101|NCT01053988|323849753|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
94561102|NCT01397461|323849754|FG000|Overall Study|Withdrawal by Subject|2|||
94561103|NCT01397461|323849755|FG001|Overall Study|Withdrawal by Subject|1|||
94561104|NCT01397461|323849756|FG002|Overall Study|Withdrawal by Subject|0|||
94561105|NCT01397461|323849754|FG000|Overall Study|Lost to Follow-up|0|||
94561106|NCT01397461|323849755|FG001|Overall Study|Lost to Follow-up|2|||
94561107|NCT01397461|323849756|FG002|Overall Study|Lost to Follow-up|1|||
94561108|NCT01397461|323849754|FG000|Overall Study|Lack of Efficacy|0|||
94561109|NCT01397461|323849755|FG001|Overall Study|Lack of Efficacy|3|||
94561110|NCT01397461|323849756|FG002|Overall Study|Lack of Efficacy|0|||
94561111|NCT01397461|323849754|FG000|Overall Study|Not treated|0|||
94561112|NCT01397461|323849755|FG001|Overall Study|Not treated|0|||
94561113|NCT01397461|323849756|FG002|Overall Study|Not treated|1|||
94561114|NCT01922271|323849757|FG000|WASHOUT Period|Withdrawal by Subject|1|||
94561115|NCT01922271|323849758|FG001|WASHOUT Period|Withdrawal by Subject|0|||
94561116|NCT01502228|323849759|FG000|Overall Study|Death|1|||
94561117|NCT01219985|323849760|FG000|Overall Study|Physician Decision|20|||
94561118|NCT01843062|323849761|FG000|Overall Study|Protocol Violation|1|||
94561119|NCT01843062|323849762|FG001|Overall Study|Protocol Violation|0|||
94561120|NCT01843062|323849761|FG000|Overall Study|New treatment following progression|2|||
94561121|NCT01843062|323849762|FG001|Overall Study|New treatment following progression|0|||
94561122|NCT01843062|323849761|FG000|Overall Study|Pregnancy|1|||
94561123|NCT01843062|323849762|FG001|Overall Study|Pregnancy|0|||
94561124|NCT01843062|323849761|FG000|Overall Study|Adverse Event|2|||
94561125|NCT01843062|323849762|FG001|Overall Study|Adverse Event|0|||
94561126|NCT01843062|323849761|FG000|Overall Study|Incorrect randomisation|1|||
94561127|NCT01843062|323849762|FG001|Overall Study|Incorrect randomisation|0|||
94561128|NCT01843062|323849761|FG000|Overall Study|Withdrawal by Subject|12|||
94561129|NCT01843062|323849762|FG001|Overall Study|Withdrawal by Subject|3|||
94561130|NCT01843062|323849761|FG000|Overall Study|Death|1|||
94561131|NCT01843062|323849762|FG001|Overall Study|Death|2|||
94561132|NCT01843062|323849761|FG000|Overall Study|Lost to Follow-up|2|||
94561133|NCT01843062|323849762|FG001|Overall Study|Lost to Follow-up|4|||
94561134|NCT01221350|323849763|FG000|Overall Study|Discontinued intervention (GERD)|1|||
94561135|NCT01221350|323849764|FG001|Overall Study|Discontinued intervention (GERD)|0|||
94561136|NCT01221350|323849763|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
94561137|NCT01221350|323849764|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
94561138|NCT01221350|323849763|FG000|Overall Study|Withdrawal by Subject|4|||
94561139|NCT01221350|323849764|FG001|Overall Study|Withdrawal by Subject|2|||
94561140|NCT01514201|323849769|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
94561141|NCT01514201|323849770|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
94561142|NCT01514201|323849771|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
94561143|NCT01514201|323849772|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
94561144|NCT01514201|323849769|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
94561145|NCT01514201|323849770|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
94561146|NCT01514201|323849771|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
94561147|NCT01514201|323849772|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
94561148|NCT01514201|323849769|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
94561149|NCT01514201|323849770|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
94561150|NCT01514201|323849771|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
94561151|NCT01514201|323849772|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
94561152|NCT01514201|323849769|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
94561153|NCT01514201|323849770|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
94561154|NCT01514201|323849771|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
94561155|NCT01514201|323849772|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
94561156|NCT01514201|323849769|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
94561157|NCT01514201|323849770|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
94233555|NCT02808975|322650170|FG000|Overall Study|Lost to Follow-up|4|||
94233556|NCT02808975|322650171|FG001|Overall Study|Lost to Follow-up|6|||
94561158|NCT01514201|323849771|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
94561159|NCT01514201|323849772|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
94233557|NCT02808975|322650170|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
94233558|NCT02808975|322650171|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
94233559|NCT02808975|322650170|FG000|Overall Study|Other, not specified|5|||
94233560|NCT02808975|322650171|FG001|Overall Study|Other, not specified|1|||
94233561|NCT01458522|322650172|FG000|Overall Study|Withdrawal by Subject|2|||
94233562|NCT01458522|322650173|FG001|Overall Study|Withdrawal by Subject|2|||
94561160|NCT01514201|323849769|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
94561161|NCT01514201|323849770|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
94561162|NCT01514201|323849771|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
94561163|NCT01514201|323849772|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
94561164|NCT01514201|323849769|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
94561165|NCT01514201|323849770|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
94561166|NCT01514201|323849771|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
94561167|NCT01514201|323849772|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
94561168|NCT01514201|323849769|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
94561169|NCT01514201|323849770|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
94561170|NCT01514201|323849771|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
94561171|NCT01514201|323849772|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
94561172|NCT01514201|323849769|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
94561173|NCT01514201|323849770|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
94561174|NCT01514201|323849771|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
94561175|NCT01514201|323849772|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
94561176|NCT01514201|323849769|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
94561177|NCT01514201|323849770|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
94561178|NCT01514201|323849771|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
94561179|NCT01514201|323849772|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
94561180|NCT01514201|323849769|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
94561181|NCT01514201|323849770|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
94233563|NCT01458522|322650172|FG000|Overall Study|Physician Decision|1|||
94233564|NCT01458522|322650173|FG001|Overall Study|Physician Decision|9|||
94561182|NCT01514201|323849771|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
94561183|NCT01514201|323849772|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
94561184|NCT01514201|323849769|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
94561185|NCT01514201|323849770|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
94561186|NCT01514201|323849771|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
94561187|NCT01514201|323849772|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
94561188|NCT05888181|323849773|FG000|Overall Study|Lost to Follow-up|1|||
94561189|NCT05888181|323849774|FG001|Overall Study|Lost to Follow-up|1|||
94561190|NCT05888181|323849775|FG002|Overall Study|Lost to Follow-up|0|||
94561191|NCT05715242|323849777|FG000|Overall Study|Lost to Follow-up|0|||
94561192|NCT05715242|323849778|FG001|Overall Study|Lost to Follow-up|0|||
94561193|NCT05715242|323849779|FG002|Overall Study|Lost to Follow-up|1|||
94561194|NCT05715242|323849780|FG003|Overall Study|Lost to Follow-up|0|||
94561195|NCT05715242|323849781|FG004|Overall Study|Lost to Follow-up|0|||
94561196|NCT05715242|323849782|FG005|Overall Study|Lost to Follow-up|1|||
94561197|NCT05715242|323849783|FG006|Overall Study|Lost to Follow-up|0|||
94561198|NCT05715242|323849784|FG007|Overall Study|Lost to Follow-up|0|||
94561199|NCT05715242|323849785|FG008|Overall Study|Lost to Follow-up|0|||
94561200|NCT05715242|323849786|FG009|Overall Study|Lost to Follow-up|0|||
94233565|NCT02684123|322650174|FG000|Phase 1|Lack of Efficacy|5|||
94233566|NCT02684123|322650175|FG001|Phase 1|Lack of Efficacy|0|||
94233567|NCT02684123|322650174|FG000|Phase 1|Adverse Event|3|||
94233568|NCT02684123|322650175|FG001|Phase 1|Adverse Event|0|||
94233569|NCT02684123|322650174|FG000|Phase 1|Lost to Follow-up|0|||
94233570|NCT02684123|322650175|FG001|Phase 1|Lost to Follow-up|1|||
94233571|NCT02684123|322650174|FG000|Phase 2|Lack of Efficacy|1|||
94233572|NCT02684123|322650175|FG001|Phase 2|Lack of Efficacy|8|||
94233573|NCT00416598|322650176|FG000|Induction & Intensification|Adverse Event|38|||
94233574|NCT00416598|322650176|FG000|Induction & Intensification|Death|32|||
94233575|NCT00416598|322650176|FG000|Induction & Intensification|Withdrawal by Subject|46|||
94233576|NCT00416598|322650176|FG000|Induction & Intensification|Alternative Treatment|135|||
94233577|NCT00416598|322650176|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
94233578|NCT00416598|322650176|FG000|Induction & Intensification|Relapse/progression|29|||
94233579|NCT00416598|322650176|FG000|Induction & Intensification|Failed induction|87|||
94233580|NCT00416598|322650176|FG000|Decitabine Maintenance|Adverse Event|5|||
94233581|NCT00416598|322650176|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
94233582|NCT00416598|322650176|FG000|Decitabine Maintenance|Progression/relapse|38|||
94233583|NCT00416598|322650176|FG000|Decitabine Maintenance|Alternative treatment|2|||
94233584|NCT00416598|322650176|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
94233585|NCT00730015|322650183|FG000|Overall Study|Adverse Event|11|||
94233586|NCT00730015|322650184|FG001|Overall Study|Adverse Event|10|||
94233587|NCT00730015|322650185|FG002|Overall Study|Adverse Event|8|||
94233588|NCT00730015|322650183|FG000|Overall Study|Protocol Violation|2|||
94233589|NCT00730015|322650184|FG001|Overall Study|Protocol Violation|6|||
94233590|NCT00730015|322650185|FG002|Overall Study|Protocol Violation|4|||
94233591|NCT00730015|322650183|FG000|Overall Study|Withdrawal by Subject|12|||
94233592|NCT00730015|322650184|FG001|Overall Study|Withdrawal by Subject|12|||
94233593|NCT00730015|322650185|FG002|Overall Study|Withdrawal by Subject|8|||
94233594|NCT00730015|322650183|FG000|Overall Study|Lost to Follow-up|4|||
94233595|NCT00730015|322650184|FG001|Overall Study|Lost to Follow-up|10|||
94233596|NCT00730015|322650185|FG002|Overall Study|Lost to Follow-up|3|||
94233597|NCT00730015|322650183|FG000|Overall Study|Lack of Efficacy|1|||
94233598|NCT00730015|322650184|FG001|Overall Study|Lack of Efficacy|2|||
94233599|NCT00730015|322650185|FG002|Overall Study|Lack of Efficacy|8|||
94449720|NCT01081769|323434300|FG000|CORE Intent-To-Treat|Adverse Event|14|||
94233600|NCT00730015|322650183|FG000|Overall Study|Other Reason|1|||
94233601|NCT00730015|322650184|FG001|Overall Study|Other Reason|0|||
94233602|NCT00730015|322650185|FG002|Overall Study|Other Reason|1|||
94233603|NCT03113383|322650186|FG000|Overall Study|Death|4|||
94233604|NCT03113383|322650187|FG001|Overall Study|Death|0|||
94233605|NCT04120376|322650188|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
94233606|NCT04120376|322650189|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
94233607|NCT00781937|322650190|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
94233608|NCT00781937|322650191|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
94233609|NCT00781937|322650190|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
94233610|NCT00781937|322650191|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
94233611|NCT00781937|322650190|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
94233612|NCT00781937|322650191|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
94233613|NCT00781937|322650190|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
94233614|NCT00781937|322650191|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
94233615|NCT00781937|322650190|FG000|Main Trial Period Through Week 56|Unclassified|10|||
94449721|NCT01081769|323434301|FG001|CORE Intent-To-Treat|Adverse Event|11|||
94449722|NCT01081769|323434300|FG000|CORE Intent-To-Treat|Death|1|||
94449723|NCT01081769|323434301|FG001|CORE Intent-To-Treat|Death|1|||
94449724|NCT01081769|323434300|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
94449725|NCT01081769|323434301|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
94449726|NCT01081769|323434300|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
94449727|NCT01081769|323434301|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
94449728|NCT01081769|323434300|FG000|CORE Intent-To-Treat|Pregnancy|1|||
94449729|NCT01081769|323434301|FG001|CORE Intent-To-Treat|Pregnancy|0|||
94449730|NCT01081769|323434300|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
94449731|NCT01081769|323434301|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
94449732|NCT01081769|323434300|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
94449733|NCT01081769|323434301|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
94449734|NCT01081769|323434300|FG000|CORE Intent-To-Treat|Other|0|||
94449735|NCT01081769|323434301|FG001|CORE Intent-To-Treat|Other|1|||
94449736|NCT01081769|323434300|FG000|CORE Intent-To-Treat|Ineligibility|3|||
94449737|NCT01081769|323434301|FG001|CORE Intent-To-Treat|Ineligibility|4|||
94449738|NCT01081769|323434300|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
94449739|NCT01081769|323434301|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
94449740|NCT01081769|323434300|FG000|CORE Intent-To-Treat|Patient Moved|2|||
94449741|NCT01081769|323434301|FG001|CORE Intent-To-Treat|Patient Moved|2|||
94449742|NCT01580670|323434307|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
94449743|NCT01580670|323434307|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
94233616|NCT00781937|322650191|FG001|Main Trial Period Through Week 56|Unclassified|15|||
94233617|NCT00781937|322650190|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
94233618|NCT00781937|322650191|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
94233619|NCT00781937|322650190|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
94233620|NCT00781937|322650191|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
94449744|NCT02684097|323434308|FG000|Overall Study|Lack of Efficacy|13|||
94561201|NCT05715242|323849787|FG010|Overall Study|Lost to Follow-up|0|||
94561202|NCT05715242|323849788|FG011|Overall Study|Lost to Follow-up|0|||
94561203|NCT05715242|323849789|FG012|Overall Study|Lost to Follow-up|0|||
94561204|NCT05715242|323849790|FG013|Overall Study|Lost to Follow-up|0|||
94561205|NCT05715242|323849791|FG014|Overall Study|Lost to Follow-up|0|||
94561206|NCT05715242|323849792|FG015|Overall Study|Lost to Follow-up|0|||
94561207|NCT02777827|323849793|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
94561208|NCT02777827|323849794|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
94561209|NCT02777827|323849795|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
94561210|NCT02777827|323849796|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
94561211|NCT02777827|323849797|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
94561212|NCT02777827|323849798|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
94561213|NCT02343406|323849799|FG000|Overall Study|Progressive disease|72|||
94561214|NCT02343406|323849800|FG001|Overall Study|Progressive disease|70|||
94561215|NCT02343406|323849801|FG002|Overall Study|Progressive disease|43|||
94561216|NCT02343406|323849802|FG003|Overall Study|Progressive disease|15|||
94561217|NCT02343406|323849803|FG004|Overall Study|Progressive disease|5|||
94561218|NCT02343406|323849799|FG000|Overall Study|Adverse Event|6|||
94561219|NCT02343406|323849800|FG001|Overall Study|Adverse Event|8|||
94561220|NCT02343406|323849801|FG002|Overall Study|Adverse Event|6|||
94561221|NCT02343406|323849802|FG003|Overall Study|Adverse Event|3|||
94561222|NCT02343406|323849803|FG004|Overall Study|Adverse Event|0|||
94561223|NCT02343406|323849799|FG000|Overall Study|Withdrawal by Subject|6|||
94561224|NCT02343406|323849800|FG001|Overall Study|Withdrawal by Subject|4|||
94561225|NCT02343406|323849801|FG002|Overall Study|Withdrawal by Subject|8|||
94561226|NCT02343406|323849802|FG003|Overall Study|Withdrawal by Subject|3|||
94561227|NCT02343406|323849803|FG004|Overall Study|Withdrawal by Subject|0|||
94561228|NCT02343406|323849799|FG000|Overall Study|Death|2|||
94561229|NCT02343406|323849800|FG001|Overall Study|Death|1|||
94561230|NCT02343406|323849801|FG002|Overall Study|Death|0|||
94561231|NCT02343406|323849802|FG003|Overall Study|Death|0|||
94561232|NCT02343406|323849803|FG004|Overall Study|Death|0|||
94561233|NCT02343406|323849799|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
94561234|NCT02343406|323849800|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
94561235|NCT02343406|323849801|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
94561236|NCT02343406|323849802|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
94561237|NCT02343406|323849803|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
94561238|NCT02343406|323849799|FG000|Overall Study|Other primary malignancy|0|||
94561239|NCT02343406|323849800|FG001|Overall Study|Other primary malignancy|1|||
94561240|NCT02343406|323849801|FG002|Overall Study|Other primary malignancy|0|||
94561241|NCT02343406|323849802|FG003|Overall Study|Other primary malignancy|0|||
94561242|NCT02343406|323849803|FG004|Overall Study|Other primary malignancy|0|||
94561243|NCT02343406|323849799|FG000|Overall Study|Other, not specified|2|||
94561244|NCT02343406|323849800|FG001|Overall Study|Other, not specified|1|||
94561245|NCT02343406|323849801|FG002|Overall Study|Other, not specified|1|||
94561246|NCT02343406|323849802|FG003|Overall Study|Other, not specified|4|||
94561247|NCT02343406|323849803|FG004|Overall Study|Other, not specified|0|||
94561248|NCT00548145|323849804|FG000|Overall Study|Death|0|||
94561249|NCT00548145|323849805|FG001|Overall Study|Death|1|||
94561250|NCT00548145|323849804|FG000|Overall Study|Withdrawal by Subject|0|||
94561251|NCT00548145|323849805|FG001|Overall Study|Withdrawal by Subject|2|||
94561252|NCT00548145|323849804|FG000|Overall Study|Physician Decision|1|||
94561253|NCT00548145|323849805|FG001|Overall Study|Physician Decision|1|||
94561254|NCT02451124|323849808|FG000|Overall Study|Withdrawal by Subject|1|||
94561255|NCT02119663|323849811|FG000|Overall Study|Disease progression|26|||
94561256|NCT02119663|323849812|FG001|Overall Study|Disease progression|27|||
94561257|NCT02119663|323849811|FG000|Overall Study|Adverse Event|5|||
94561258|NCT02119663|323849812|FG001|Overall Study|Adverse Event|5|||
94561259|NCT02119663|323849811|FG000|Overall Study|Death|3|||
94561260|NCT02119663|323849812|FG001|Overall Study|Death|2|||
94561261|NCT02119663|323849811|FG000|Overall Study|Physician Decision|1|||
94561262|NCT02119663|323849812|FG001|Overall Study|Physician Decision|2|||
94561263|NCT02119663|323849811|FG000|Overall Study|Other unspecified|2|||
94561264|NCT02119663|323849812|FG001|Overall Study|Other unspecified|0|||
94561265|NCT02119663|323849811|FG000|Overall Study|Subject decision|0|||
94561266|NCT02119663|323849812|FG001|Overall Study|Subject decision|1|||
94657642|NCT01731171|324204361|FG001|Overall Study|Terminated for Lack of Adherence|1|||
94561267|NCT02119663|323849811|FG000|Overall Study|Study Terminated by the Sponsor|3|||
94561268|NCT02119663|323849812|FG001|Overall Study|Study Terminated by the Sponsor|4|||
94561269|NCT02863328|323849813|FG000|Overall Study|Lost to Follow-up|4|||
94561270|NCT02863328|323849814|FG001|Overall Study|Lost to Follow-up|10|||
94561271|NCT02863328|323849813|FG000|Overall Study|Withdrawal by Subject|7|||
94561272|NCT02863328|323849814|FG001|Overall Study|Withdrawal by Subject|12|||
94561273|NCT02863328|323849813|FG000|Overall Study|Died|0|||
94561274|NCT02863328|323849814|FG001|Overall Study|Died|1|||
94561275|NCT00699660|323849815|FG000|Overall Study|Lost to Follow-up|4|||
94561276|NCT00699660|323849816|FG001|Overall Study|Lost to Follow-up|2|||
94561277|NCT00699660|323849815|FG000|Overall Study|missing reports and recording failures|10|||
94561278|NCT00699660|323849816|FG001|Overall Study|missing reports and recording failures|6|||
94561279|NCT00398320|323849817|FG000|Overall Study|Death|1|||
94561280|NCT00398320|323849817|FG000|Overall Study|Adverse Event|4|||
94561281|NCT00398320|323849817|FG000|Overall Study|Physician Decision|1|||
94561282|NCT00064792|323849818|FG000|Overall Study|Withdrawal by Subject|2|||
94561283|NCT00064792|323849819|FG001|Overall Study|Withdrawal by Subject|0|||
94561284|NCT00064792|323849818|FG000|Overall Study|Adverse Event|3|||
94561285|NCT00064792|323849819|FG001|Overall Study|Adverse Event|0|||
94561286|NCT00195663|323849824|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
94561287|NCT00195663|323849825|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
94561288|NCT00195663|323849826|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
94561289|NCT00195663|323849824|FG000|2-year Double-blind Treatment Period|Death|0|||
94561290|NCT00195663|323849825|FG001|2-year Double-blind Treatment Period|Death|2|||
94561291|NCT00195663|323849826|FG002|2-year Double-blind Treatment Period|Death|0|||
94561292|NCT00195663|323849824|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
94561293|NCT00195663|323849825|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
94561294|NCT00195663|323849826|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
94561295|NCT00195663|323849824|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
94561296|NCT00195663|323849825|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
94561297|NCT00195663|323849826|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
94561298|NCT00195663|323849824|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
94561299|NCT00195663|323849825|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
94561300|NCT00195663|323849826|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
94561301|NCT00195663|323849824|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
94561302|NCT00195663|323849825|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
94561303|NCT00195663|323849826|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
94561304|NCT00195663|323849824|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
94561305|NCT00195663|323849825|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
94561306|NCT00195663|323849826|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
94561307|NCT00195663|323849824|FG000|2-year Double-blind Treatment Period|Recovery|1|||
94561308|NCT00195663|323849825|FG001|2-year Double-blind Treatment Period|Recovery|0|||
94561309|NCT00195663|323849826|FG002|2-year Double-blind Treatment Period|Recovery|1|||
94561310|NCT00195663|323849824|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
94561311|NCT00195663|323849825|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
94561312|NCT00195663|323849826|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
94561313|NCT00195663|323849824|FG000|Open-Label Extension Period|Adverse Event|21|||
94561314|NCT00195663|323849825|FG001|Open-Label Extension Period|Adverse Event|32|||
94561315|NCT00195663|323849826|FG002|Open-Label Extension Period|Adverse Event|36|||
94561316|NCT00195663|323849824|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
94561317|NCT00195663|323849825|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
94561318|NCT00195663|323849826|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
94561319|NCT00195663|323849824|FG000|Open-Label Extension Period|Recovery|0|||
94561320|NCT00195663|323849825|FG001|Open-Label Extension Period|Recovery|2|||
94561321|NCT00195663|323849826|FG002|Open-Label Extension Period|Recovery|2|||
94561322|NCT00195663|323849824|FG000|Open-Label Extension Period|Protocol Violation|3|||
94561323|NCT00195663|323849825|FG001|Open-Label Extension Period|Protocol Violation|4|||
94561324|NCT00195663|323849826|FG002|Open-Label Extension Period|Protocol Violation|4|||
94561325|NCT00195663|323849824|FG000|Open-Label Extension Period|Death|2|||
94561326|NCT00195663|323849825|FG001|Open-Label Extension Period|Death|2|||
94345586|NCT00355615|323046000|FG001|Randomized Double Blind Period|Adverse Event|0|||
94345587|NCT00355615|323046001|FG002|Randomized Double Blind Period|Adverse Event|0|||
94345588|NCT00355615|323046002|FG003|Randomized Double Blind Period|Adverse Event|0|||
94345589|NCT00355615|323046003|FG004|Randomized Double Blind Period|Adverse Event|0|||
94345590|NCT00355615|323045999|FG000|Randomized Double Blind Period|Protocol Violation|0|||
94561327|NCT00195663|323849826|FG002|Open-Label Extension Period|Death|2|||
94561328|NCT00195663|323849824|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
94561329|NCT00195663|323849825|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
94561330|NCT00195663|323849826|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
94561331|NCT00195663|323849824|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
94561332|NCT00195663|323849825|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
94345591|NCT00355615|323046000|FG001|Randomized Double Blind Period|Protocol Violation|0|||
94561333|NCT00195663|323849826|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
94561334|NCT00195663|323849824|FG000|Open-Label Extension Period|Administrative reasons|11|||
94561335|NCT00195663|323849825|FG001|Open-Label Extension Period|Administrative reasons|11|||
94561336|NCT00195663|323849826|FG002|Open-Label Extension Period|Administrative reasons|13|||
94561337|NCT01711645|323849827|FG000|Overall Study|Withdrawal by Subject|8|||
94561338|NCT01711645|323849827|FG000|Overall Study|Lost to Follow-up|6|||
94561339|NCT01711645|323849827|FG000|Overall Study|Physician Decision|5|||
94561340|NCT00176462|323849831|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
94561341|NCT00176462|323849832|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
94561342|NCT00176462|323849831|FG000|Induction (4 Weeks)|Death|1|||
94561343|NCT00176462|323849832|FG001|Induction (4 Weeks)|Death|2|||
94561344|NCT00176462|323849831|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
94561345|NCT00176462|323849832|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
94561346|NCT00176462|323849831|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
94561347|NCT00176462|323849832|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
94561348|NCT00176462|323849831|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
94561349|NCT00176462|323849832|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
94561350|NCT00176462|323849831|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
94561351|NCT00176462|323849832|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
94561352|NCT00176462|323849831|FG000|Consolidation (12 Weeks)|Not documented|0|||
94561353|NCT00176462|323849832|FG001|Consolidation (12 Weeks)|Not documented|1|||
94561354|NCT00176462|323849831|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
94561355|NCT00176462|323849832|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
94561356|NCT00176462|323849831|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
94561357|NCT00176462|323849832|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
94561358|NCT01045694|323849835|FG000|Overall Study|Withdrawal by Subject|2|||
94561359|NCT02363959|323849836|FG000|Overall Study|Medical instability|1|||
94561360|NCT02363959|323849837|FG001|Overall Study|Medical instability|0|||
94561361|NCT01408459|323849840|FG000|Overall Study|Withdrawal by Subject|1|||
94561362|NCT01408459|323849841|FG001|Overall Study|Withdrawal by Subject|1|||
94561363|NCT00950248|323849846|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
94561364|NCT00950248|323849847|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
94561365|NCT00950248|323849848|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
94561366|NCT00950248|323849846|FG000|Year 1: Baseline|worsening of symptoms|2|||
94561367|NCT00950248|323849847|FG001|Year 1: Baseline|worsening of symptoms|0|||
94561368|NCT00950248|323849848|FG002|Year 1: Baseline|worsening of symptoms|0|||
94561369|NCT00950248|323849846|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
94561370|NCT00950248|323849847|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
94561371|NCT00950248|323849848|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
94561372|NCT00950248|323849846|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
94561373|NCT00950248|323849847|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
94561374|NCT00950248|323849848|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
94561375|NCT00950248|323849846|FG000|Year 2&3 Treatment Randomization|Death|0|||
94561376|NCT00950248|323849847|FG001|Year 2&3 Treatment Randomization|Death|0|||
94561377|NCT00950248|323849848|FG002|Year 2&3 Treatment Randomization|Death|1|||
94561378|NCT00950248|323849846|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
94561379|NCT00950248|323849847|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
94561380|NCT00950248|323849848|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
94561381|NCT00003199|323849849|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
94561382|NCT00003199|323849849|FG000|Overall Study|Lack of insurance clearance|2|||
94561383|NCT00003199|323849849|FG000|Overall Study|Screen fail|15|||
94561384|NCT04178720|323849850|FG000|Overall Study|Withdrawal by Subject|2|||
94561385|NCT04178720|323849851|FG001|Overall Study|Withdrawal by Subject|0|||
94561386|NCT04178720|323849850|FG000|Overall Study|Relocation|0|||
94561387|NCT04178720|323849851|FG001|Overall Study|Relocation|1|||
94345592|NCT00355615|323046001|FG002|Randomized Double Blind Period|Protocol Violation|1|||
94345593|NCT00355615|323046002|FG003|Randomized Double Blind Period|Protocol Violation|1|||
94561388|NCT02487030|323849852|FG000|Overall Study|Lack of Efficacy|2|||
94561389|NCT02487030|323849853|FG001|Overall Study|Lack of Efficacy|4|||
94561390|NCT02487030|323849854|FG002|Overall Study|Lack of Efficacy|1|||
94345594|NCT00355615|323046003|FG004|Randomized Double Blind Period|Protocol Violation|0|||
94345595|NCT00355615|323045999|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
94561391|NCT02487030|323849855|FG003|Overall Study|Lack of Efficacy|0|||
94561392|NCT02487030|323849856|FG004|Overall Study|Lack of Efficacy|1|||
94561393|NCT02487030|323849857|FG005|Overall Study|Lack of Efficacy|0|||
94561394|NCT02487030|323849858|FG006|Overall Study|Lack of Efficacy|0|||
94561395|NCT02487030|323849852|FG000|Overall Study|Lost to Follow-up|0|||
94561396|NCT02487030|323849853|FG001|Overall Study|Lost to Follow-up|0|||
94561397|NCT02487030|323849854|FG002|Overall Study|Lost to Follow-up|1|||
94561398|NCT02487030|323849855|FG003|Overall Study|Lost to Follow-up|1|||
94449745|NCT02684097|323434309|FG001|Overall Study|Lack of Efficacy|6|||
94561399|NCT02487030|323849856|FG004|Overall Study|Lost to Follow-up|0|||
94561400|NCT02487030|323849857|FG005|Overall Study|Lost to Follow-up|1|||
94561401|NCT02487030|323849858|FG006|Overall Study|Lost to Follow-up|0|||
94449746|NCT02097745|323434310|FG000|Overall Study|Adverse Event|25|||
94449747|NCT02097745|323434310|FG000|Overall Study|Death|16|||
94449748|NCT02097745|323434310|FG000|Overall Study|Failure to Return|14|||
94449749|NCT02097745|323434310|FG000|Overall Study|Administrative/Other|27|||
94449750|NCT02097745|323434310|FG000|Overall Study|Reason Not Specified|96|||
94449751|NCT02748356|323434311|FG000|Overall Study|Withdrawal by Subject|1|||
94449752|NCT02821754|323434312|FG000|Overall Study|Procedure not required prior to amendment change|13|||
94449753|NCT02821754|323434313|FG001|Overall Study|Procedure not required prior to amendment change|11|||
94449754|NCT02821754|323434314|FG002|Overall Study|Procedure not required prior to amendment change|0|||
94449755|NCT02821754|323434312|FG000|Overall Study|Participant's Clinical status|2|||
94449756|NCT02821754|323434313|FG001|Overall Study|Participant's Clinical status|0|||
94449757|NCT02821754|323434314|FG002|Overall Study|Participant's Clinical status|0|||
94449758|NCT02821754|323434312|FG000|Overall Study|Participant removed for noncompliance|1|||
94449759|NCT02821754|323434313|FG001|Overall Study|Participant removed for noncompliance|0|||
94449760|NCT02821754|323434314|FG002|Overall Study|Participant removed for noncompliance|0|||
94449761|NCT02821754|323434312|FG000|Overall Study|Drug not available.|0|||
94449762|NCT02821754|323434313|FG001|Overall Study|Drug not available.|0|||
94449763|NCT02821754|323434314|FG002|Overall Study|Drug not available.|1|||
94449764|NCT02821754|323434312|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
94449765|NCT02821754|323434313|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
94449766|NCT02821754|323434314|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
94449767|NCT01757184|323434317|FG000|Double-blind Period|Adverse Event|1|||
94449768|NCT01757184|323434318|FG001|Double-blind Period|Adverse Event|0|||
94449769|NCT01757184|323434319|FG002|Double-blind Period|Adverse Event|0|||
94449770|NCT01757184|323434320|FG003|Double-blind Period|Adverse Event|0|||
94449771|NCT01757184|323434317|FG000|Open-label Period|Lost to Follow-up|0|||
94449772|NCT01757184|323434318|FG001|Open-label Period|Lost to Follow-up|0|||
94449773|NCT01757184|323434319|FG002|Open-label Period|Lost to Follow-up|2|||
94449774|NCT01757184|323434320|FG003|Open-label Period|Lost to Follow-up|0|||
94449775|NCT01757184|323434317|FG000|Open-label Period|Withdrawal by Subject|0|||
94449776|NCT01757184|323434318|FG001|Open-label Period|Withdrawal by Subject|0|||
94449777|NCT01757184|323434319|FG002|Open-label Period|Withdrawal by Subject|1|||
94449778|NCT01757184|323434320|FG003|Open-label Period|Withdrawal by Subject|1|||
94449779|NCT01757184|323434317|FG000|Open-label Period|Discontinued by Sponsor|0|||
94449780|NCT01757184|323434318|FG001|Open-label Period|Discontinued by Sponsor|0|||
94449781|NCT01757184|323434319|FG002|Open-label Period|Discontinued by Sponsor|1|||
94449782|NCT01757184|323434320|FG003|Open-label Period|Discontinued by Sponsor|2|||
94449783|NCT03515811|323434322|FG000|Overall Study|Lost to Follow-up|2|||
94449784|NCT03515811|323434323|FG001|Overall Study|Lost to Follow-up|1|||
94449785|NCT03515811|323434322|FG000|Overall Study|Protocol Violation|1|||
94449786|NCT03515811|323434323|FG001|Overall Study|Protocol Violation|1|||
94449787|NCT03515811|323434322|FG000|Overall Study|Death|1|||
94449788|NCT03515811|323434323|FG001|Overall Study|Death|1|||
94449789|NCT03515811|323434322|FG000|Overall Study|Withdrawal by Subject|0|||
94449790|NCT03515811|323434323|FG001|Overall Study|Withdrawal by Subject|2|||
94449791|NCT03515811|323434322|FG000|Overall Study|Technical Problems|1|||
94449792|NCT03515811|323434323|FG001|Overall Study|Technical Problems|0|||
94449793|NCT03515811|323434322|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
94449794|NCT03515811|323434323|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
94449795|NCT03515811|323434322|FG000|Overall Study|COVID-19|0|||
94449796|NCT03515811|323434323|FG001|Overall Study|COVID-19|1|||
94449797|NCT05870371|323434324|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
94449798|NCT05870371|323434325|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
94449799|NCT01786993|323434326|FG000|Overall Study|Death|6|||
94449800|NCT01786993|323434327|FG001|Overall Study|Death|7|||
94449801|NCT01786993|323434326|FG000|Overall Study|Withdrawal by Subject|3|||
94449802|NCT01786993|323434327|FG001|Overall Study|Withdrawal by Subject|2|||
94449803|NCT01786993|323434326|FG000|Overall Study|Lost to Follow-up|0|||
94449804|NCT01786993|323434327|FG001|Overall Study|Lost to Follow-up|1|||
94449805|NCT01786993|323434326|FG000|Overall Study|Subject Non-Compliance|1|||
94449806|NCT01786993|323434327|FG001|Overall Study|Subject Non-Compliance|0|||
94657643|NCT01731171|324204360|FG000|Overall Study|Terminated for Safety Reasons|0|||
94657644|NCT01731171|324204361|FG001|Overall Study|Terminated for Safety Reasons|1|||
94449807|NCT01786993|323434326|FG000|Overall Study|System Explant|1|||
94449808|NCT01786993|323434327|FG001|Overall Study|System Explant|0|||
94449809|NCT01786993|323434326|FG000|Overall Study|Hospice Admission|1|||
94449810|NCT01786993|323434327|FG001|Overall Study|Hospice Admission|0|||
94449811|NCT02203721|323434329|FG000|Overall Study|Lost to Follow-up|1|||
94449812|NCT02203721|323434330|FG001|Overall Study|Lost to Follow-up|0|||
94449813|NCT02203721|323434329|FG000|Overall Study|Death|0|||
94449814|NCT02203721|323434330|FG001|Overall Study|Death|2|||
94449815|NCT02203721|323434329|FG000|Overall Study|Illness|0|||
94561402|NCT02487030|323849852|FG000|Overall Study|Adverse Event|0|||
94561403|NCT02487030|323849853|FG001|Overall Study|Adverse Event|0|||
94561404|NCT02487030|323849854|FG002|Overall Study|Adverse Event|0|||
94561405|NCT02487030|323849855|FG003|Overall Study|Adverse Event|1|||
94561406|NCT02487030|323849856|FG004|Overall Study|Adverse Event|0|||
94561407|NCT02487030|323849857|FG005|Overall Study|Adverse Event|0|||
94561408|NCT02487030|323849858|FG006|Overall Study|Adverse Event|0|||
94561409|NCT02487030|323849852|FG000|Overall Study|Death|0|||
94561410|NCT02487030|323849853|FG001|Overall Study|Death|0|||
94561411|NCT02487030|323849854|FG002|Overall Study|Death|0|||
94561412|NCT02487030|323849855|FG003|Overall Study|Death|0|||
94561413|NCT02487030|323849856|FG004|Overall Study|Death|1|||
94561414|NCT02487030|323849857|FG005|Overall Study|Death|0|||
94561415|NCT02487030|323849858|FG006|Overall Study|Death|0|||
94561416|NCT00983385|323849859|FG000|Observation Period|Not eligible to be dosed|20|||
94561417|NCT00983385|323849859|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
94561418|NCT00264537|323849860|FG000|Overall Study|Death|0|||
94561419|NCT00264537|323849861|FG001|Overall Study|Death|3|||
94561420|NCT00264537|323849862|FG002|Overall Study|Death|3|||
94561421|NCT00264537|323849863|FG003|Overall Study|Death|2|||
94561422|NCT00264537|323849860|FG000|Overall Study|Lost to Follow-up|3|||
94561423|NCT00264537|323849861|FG001|Overall Study|Lost to Follow-up|4|||
94561424|NCT00264537|323849862|FG002|Overall Study|Lost to Follow-up|7|||
94561425|NCT00264537|323849863|FG003|Overall Study|Lost to Follow-up|6|||
94561426|NCT00264537|323849860|FG000|Overall Study|Adverse Event|21|||
94561427|NCT00264537|323849861|FG001|Overall Study|Adverse Event|32|||
94561428|NCT00264537|323849862|FG002|Overall Study|Adverse Event|24|||
94561429|NCT00264537|323849863|FG003|Overall Study|Adverse Event|34|||
94561430|NCT00264537|323849860|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
94561431|NCT00264537|323849861|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
94561432|NCT00264537|323849862|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
94561433|NCT00264537|323849863|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
94561434|NCT00264537|323849860|FG000|Overall Study|Other|21|||
94561435|NCT00264537|323849861|FG001|Overall Study|Other|11|||
94561436|NCT00264537|323849862|FG002|Overall Study|Other|10|||
94561437|NCT00264537|323849863|FG003|Overall Study|Other|11|||
94561438|NCT00264537|323849860|FG000|Overall Study|Not treated|0|||
94561439|NCT00264537|323849861|FG001|Overall Study|Not treated|2|||
94561440|NCT00264537|323849862|FG002|Overall Study|Not treated|1|||
94561441|NCT00264537|323849863|FG003|Overall Study|Not treated|0|||
94561442|NCT04725500|323849864|FG000|Screening|Screen Failure|26|||
94561443|NCT04725500|323849864|FG000|Screening|Withdrawal by Subject|1|||
94561444|NCT04725500|323849864|FG000|2 Week Take Home|Screen Fail|5|||
94561445|NCT01792115|323849865|FG000|Overall Study|Lost to Follow-up|0|||
94561446|NCT01792115|323849866|FG001|Overall Study|Lost to Follow-up|1|||
94657645|NCT00413413|324204362|FG000|Single-Blind|Adverse Event|0|||
94657646|NCT00413413|324204363|FG001|Single-Blind|Adverse Event|9|||
94657647|NCT00413413|324204364|FG002|Single-Blind|Adverse Event|0|||
94657648|NCT00413413|324204362|FG000|Single-Blind|Lack of Efficacy|0|||
94657649|NCT00413413|324204363|FG001|Single-Blind|Lack of Efficacy|5|||
94657650|NCT00413413|324204364|FG002|Single-Blind|Lack of Efficacy|0|||
94657651|NCT00413413|324204362|FG000|Single-Blind|Subject no longer requires study drug|0|||
94561447|NCT01792115|323849867|FG002|Overall Study|Lost to Follow-up|0|||
94561448|NCT04618744|323849868|FG000|Overall Study|Adverse Event|0|||
94561449|NCT04618744|323849869|FG001|Overall Study|Adverse Event|1|||
94561450|NCT04618744|323849868|FG000|Overall Study|Withdrawal by Subject|0|||
94561451|NCT04618744|323849869|FG001|Overall Study|Withdrawal by Subject|1|||
94561452|NCT00930930|323849870|FG000|Overall Study|Death|1|||
94561453|NCT00930930|323849871|FG001|Overall Study|Death|0|||
94561454|NCT00930930|323849870|FG000|Overall Study|Physician Decision|1|||
94561455|NCT00930930|323849871|FG001|Overall Study|Physician Decision|0|||
94561456|NCT00930930|323849870|FG000|Overall Study|Adverse Event|13|||
94561457|NCT00930930|323849871|FG001|Overall Study|Adverse Event|3|||
94561458|NCT00930930|323849870|FG000|Overall Study|Withdrawal by Subject|3|||
94561459|NCT00930930|323849871|FG001|Overall Study|Withdrawal by Subject|1|||
94561460|NCT00930930|323849870|FG000|Overall Study|Disease progression|2|||
94561461|NCT00930930|323849871|FG001|Overall Study|Disease progression|3|||
94561462|NCT00930930|323849870|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
94561463|NCT00930930|323849871|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
94561464|NCT00930930|323849870|FG000|Overall Study|patients not compliant|1|||
94561465|NCT00930930|323849871|FG001|Overall Study|patients not compliant|1|||
94657652|NCT00413413|324204363|FG001|Single-Blind|Subject no longer requires study drug|151|||
94449816|NCT02203721|323434330|FG001|Overall Study|Illness|1|||
94449817|NCT00708461|323434335|FG000|Overall Study|Lost to Follow-up|18|||
94449818|NCT00708461|323434336|FG001|Overall Study|Lost to Follow-up|11|||
94449819|NCT00708461|323434335|FG000|Overall Study|Withdrawal by Subject|8|||
94449820|NCT00708461|323434336|FG001|Overall Study|Withdrawal by Subject|9|||
94449821|NCT00708461|323434335|FG000|Overall Study|left workforce|115|||
94449822|NCT00708461|323434336|FG001|Overall Study|left workforce|180|||
94449823|NCT02968173|323434339|FG000|Overall Study|Withdrawal by Subject|1|||
94449824|NCT02640664|323434340|FG000|Epoch 1|Withdrawal of informed consent|1|||
94449825|NCT02640664|323434341|FG001|Epoch 1|Withdrawal of informed consent|0|||
94449826|NCT02640664|323434342|FG002|Epoch 1|Withdrawal of informed consent|0|||
94449827|NCT02640664|323434340|FG000|Epoch 1|Death|0|||
94449828|NCT02640664|323434341|FG001|Epoch 1|Death|0|||
94449829|NCT02640664|323434342|FG002|Epoch 1|Death|1|||
94449830|NCT02640664|323434340|FG000|Epoch 2|Withdrawal of informed consent|3|||
94449831|NCT02640664|323434341|FG001|Epoch 2|Withdrawal of informed consent|4|||
94449832|NCT02640664|323434342|FG002|Epoch 2|Withdrawal of informed consent|2|||
94449833|NCT02640664|323434340|FG000|Epoch 2|Subject/guardian decision|0|||
94449834|NCT02640664|323434341|FG001|Epoch 2|Subject/guardian decision|2|||
94449835|NCT02640664|323434342|FG002|Epoch 2|Subject/guardian decision|2|||
94449836|NCT02640664|323434340|FG000|Epoch 2|Lost to Follow-up|3|||
94449837|NCT02640664|323434341|FG001|Epoch 2|Lost to Follow-up|4|||
94449838|NCT02640664|323434342|FG002|Epoch 2|Lost to Follow-up|1|||
94449839|NCT02640664|323434340|FG000|Epoch 2|Death|0|||
94449840|NCT02640664|323434341|FG001|Epoch 2|Death|0|||
94449841|NCT02640664|323434342|FG002|Epoch 2|Death|1|||
94449842|NCT00603473|323434347|FG000|Overall Study|Adverse Event|4|||
94449843|NCT00603473|323434347|FG000|Overall Study|Lack of Efficacy|4|||
94449844|NCT00603473|323434347|FG000|Overall Study|Protocol Violation|1|||
94449845|NCT00733421|323434348|FG000|Overall Study|Withdrawal by Subject|1|||
94449846|NCT00733421|323434349|FG001|Overall Study|Withdrawal by Subject|1|||
94449847|NCT00550043|323434352|FG000|Overall Study|Adverse Event|0|||
94449848|NCT00550043|323434353|FG001|Overall Study|Adverse Event|0|||
94449849|NCT00550043|323434354|FG002|Overall Study|Adverse Event|0|||
94449850|NCT00550043|323434355|FG003|Overall Study|Adverse Event|1|||
94449851|NCT00550043|323434356|FG004|Overall Study|Adverse Event|1|||
94449852|NCT00550043|323434352|FG000|Overall Study|Subject Withdrew Consent|0|||
94449853|NCT00550043|323434353|FG001|Overall Study|Subject Withdrew Consent|2|||
94449854|NCT00550043|323434354|FG002|Overall Study|Subject Withdrew Consent|1|||
94449855|NCT00550043|323434355|FG003|Overall Study|Subject Withdrew Consent|0|||
94449856|NCT00550043|323434356|FG004|Overall Study|Subject Withdrew Consent|0|||
94449857|NCT00550043|323434352|FG000|Overall Study|Other Reasons- Unspecified|0|||
94449858|NCT00550043|323434353|FG001|Overall Study|Other Reasons- Unspecified|1|||
94449859|NCT00550043|323434354|FG002|Overall Study|Other Reasons- Unspecified|0|||
94449860|NCT00550043|323434355|FG003|Overall Study|Other Reasons- Unspecified|1|||
94449861|NCT00550043|323434356|FG004|Overall Study|Other Reasons- Unspecified|0|||
94449862|NCT01031680|323434357|FG000|Overall Study|Adverse Event|8|||
94449863|NCT01031680|323434358|FG001|Overall Study|Adverse Event|3|||
94449864|NCT01031680|323434357|FG000|Overall Study|Lost to Follow-up|2|||
94449865|NCT01031680|323434358|FG001|Overall Study|Lost to Follow-up|10|||
94449866|NCT01031680|323434357|FG000|Overall Study|Withdrawal by Subject|12|||
94449867|NCT01031680|323434358|FG001|Overall Study|Withdrawal by Subject|16|||
94449868|NCT01031680|323434357|FG000|Overall Study|Death|2|||
94449869|NCT01031680|323434358|FG001|Overall Study|Death|1|||
94449870|NCT01031680|323434357|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
94449871|NCT01031680|323434358|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
94449872|NCT01031680|323434357|FG000|Overall Study|Poor/Non-compliance|5|||
94449873|NCT01031680|323434358|FG001|Overall Study|Poor/Non-compliance|6|||
94449874|NCT01031680|323434357|FG000|Overall Study|Safety|1|||
94449875|NCT01031680|323434358|FG001|Overall Study|Safety|0|||
94449876|NCT01031680|323434357|FG000|Overall Study|Incorrect Enrolment|1|||
94449877|NCT01031680|323434358|FG001|Overall Study|Incorrect Enrolment|2|||
94449878|NCT01031680|323434357|FG000|Overall Study|Administrative Reason by Sponsor|0|||
94449879|NCT01031680|323434358|FG001|Overall Study|Administrative Reason by Sponsor|1|||
94449880|NCT01031680|323434357|FG000|Overall Study|Various|0|||
94449881|NCT01031680|323434358|FG001|Overall Study|Various|2|||
94449882|NCT00789373|323435312|FG000|Induction|Adverse Event|64|||
94449883|NCT00789373|323435313|FG001|Induction|Adverse Event|0|||
94449884|NCT00789373|323435314|FG002|Induction|Adverse Event|0|||
94449885|NCT00789373|323435312|FG000|Induction|Death Due to study disease|24|||
94449886|NCT00789373|323435313|FG001|Induction|Death Due to study disease|0|||
94449887|NCT00789373|323435314|FG002|Induction|Death Due to study disease|0|||
94449888|NCT00789373|323435312|FG000|Induction|Death due to adverse event|19|||
94345596|NCT00355615|323046000|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
94345597|NCT00355615|323046001|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
94345598|NCT00355615|323046002|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
94345599|NCT00355615|323046003|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
94345600|NCT00355615|323045999|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
94345601|NCT00355615|323046000|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
94345602|NCT00355615|323046001|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
94345603|NCT00355615|323046002|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
94345604|NCT00355615|323046003|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
94345605|NCT00355615|323045999|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
94345606|NCT00355615|323046000|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
94345607|NCT00355615|323046001|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
94345608|NCT00355615|323046002|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
94345609|NCT00355615|323046003|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
94345610|NCT00355615|323045999|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
94345611|NCT00355615|323046000|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
94345612|NCT00355615|323046001|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
94345613|NCT00355615|323046002|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
94345614|NCT00355615|323046003|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
94345615|NCT01603628|323046004|FG000|Overall Study|Personal Reasons|1|||
94345616|NCT01603628|323046005|FG001|Overall Study|Personal Reasons|1|||
94345617|NCT01603628|323046006|FG002|Overall Study|Personal Reasons|2|||
94345618|NCT01603628|323046004|FG000|Overall Study|Protocol Violation|1|||
94345619|NCT01603628|323046005|FG001|Overall Study|Protocol Violation|1|||
94345620|NCT01603628|323046006|FG002|Overall Study|Protocol Violation|0|||
94345621|NCT01603628|323046004|FG000|Overall Study|Lost to Follow-up|0|||
94345622|NCT01603628|323046005|FG001|Overall Study|Lost to Follow-up|1|||
94345623|NCT01603628|323046006|FG002|Overall Study|Lost to Follow-up|0|||
94345624|NCT01603628|323046004|FG000|Overall Study|Other Miscellaneous Reason|1|||
94345625|NCT01603628|323046005|FG001|Overall Study|Other Miscellaneous Reason|0|||
94345626|NCT01603628|323046006|FG002|Overall Study|Other Miscellaneous Reason|0|||
94449889|NCT00789373|323435313|FG001|Induction|Death due to adverse event|0|||
94449890|NCT00789373|323435314|FG002|Induction|Death due to adverse event|0|||
94449891|NCT00789373|323435312|FG000|Induction|Death due to toxicity|11|||
94449892|NCT00789373|323435313|FG001|Induction|Death due to toxicity|0|||
94449893|NCT00789373|323435314|FG002|Induction|Death due to toxicity|0|||
94449894|NCT00789373|323435312|FG000|Induction|Death due to procedure|1|||
94449895|NCT00789373|323435313|FG001|Induction|Death due to procedure|0|||
94449896|NCT00789373|323435314|FG002|Induction|Death due to procedure|0|||
94449897|NCT00789373|323435312|FG000|Induction|Investigator decision|7|||
94449898|NCT00789373|323435313|FG001|Induction|Investigator decision|0|||
94449899|NCT00789373|323435314|FG002|Induction|Investigator decision|0|||
94449900|NCT00789373|323435312|FG000|Induction|Protocol entry criteria not met|9|||
94449901|NCT00789373|323435313|FG001|Induction|Protocol entry criteria not met|0|||
94449902|NCT00789373|323435314|FG002|Induction|Protocol entry criteria not met|0|||
94449903|NCT00789373|323435312|FG000|Induction|Lost to Follow-up|6|||
94449904|NCT00789373|323435313|FG001|Induction|Lost to Follow-up|0|||
94449905|NCT00789373|323435314|FG002|Induction|Lost to Follow-up|0|||
94449906|NCT00789373|323435312|FG000|Induction|Protocol Violation|1|||
94449907|NCT00789373|323435313|FG001|Induction|Protocol Violation|0|||
94449908|NCT00789373|323435314|FG002|Induction|Protocol Violation|0|||
94449909|NCT00789373|323435312|FG000|Induction|Progressive Disease|220|||
94449910|NCT00789373|323435313|FG001|Induction|Progressive Disease|0|||
94449911|NCT00789373|323435314|FG002|Induction|Progressive Disease|0|||
94449912|NCT00789373|323435312|FG000|Induction|Withdrawal by Subject|37|||
94449913|NCT00789373|323435313|FG001|Induction|Withdrawal by Subject|0|||
94449914|NCT00789373|323435314|FG002|Induction|Withdrawal by Subject|0|||
94449915|NCT00789373|323435312|FG000|Maintenance|Adverse Event|0|||
94449916|NCT00789373|323435313|FG001|Maintenance|Adverse Event|65|||
94449917|NCT00789373|323435314|FG002|Maintenance|Adverse Event|12|||
94449918|NCT00789373|323435312|FG000|Maintenance|Death due to study disease|0|||
94561466|NCT01807299|323849872|FG000|Overall Study|Protocol Violation|3|||
94449919|NCT00789373|323435313|FG001|Maintenance|Death due to study disease|3|||
94449920|NCT00789373|323435314|FG002|Maintenance|Death due to study disease|1|||
94449921|NCT00789373|323435312|FG000|Maintenance|Death due to adverse event|0|||
94449922|NCT00789373|323435313|FG001|Maintenance|Death due to adverse event|4|||
94449923|NCT00789373|323435314|FG002|Maintenance|Death due to adverse event|1|||
94449924|NCT00789373|323435312|FG000|Maintenance|Death due to toxicity|0|||
94449925|NCT00789373|323435313|FG001|Maintenance|Death due to toxicity|1|||
94449926|NCT00789373|323435314|FG002|Maintenance|Death due to toxicity|2|||
94449927|NCT00789373|323435312|FG000|Maintenance|Investigator Decision|0|||
94561467|NCT01807299|323849873|FG001|Overall Study|Protocol Violation|1|||
94449928|NCT00789373|323435313|FG001|Maintenance|Investigator Decision|4|||
94449929|NCT00789373|323435314|FG002|Maintenance|Investigator Decision|2|||
94449930|NCT00789373|323435312|FG000|Maintenance|Protocol entry criteria not met|0|||
94449931|NCT00789373|323435313|FG001|Maintenance|Protocol entry criteria not met|2|||
94449932|NCT00789373|323435314|FG002|Maintenance|Protocol entry criteria not met|0|||
94449933|NCT00789373|323435312|FG000|Maintenance|Lost to Follow-up|0|||
94449934|NCT00789373|323435313|FG001|Maintenance|Lost to Follow-up|2|||
94449935|NCT00789373|323435314|FG002|Maintenance|Lost to Follow-up|0|||
94449936|NCT00789373|323435312|FG000|Maintenance|Progressive Disease|0|||
94449937|NCT00789373|323435313|FG001|Maintenance|Progressive Disease|253|||
94449938|NCT00789373|323435314|FG002|Maintenance|Progressive Disease|152|||
94449939|NCT00789373|323435312|FG000|Maintenance|Withdrawal by Subject|0|||
94449940|NCT00789373|323435313|FG001|Maintenance|Withdrawal by Subject|21|||
94449941|NCT00789373|323435314|FG002|Maintenance|Withdrawal by Subject|8|||
94449942|NCT00789373|323435312|FG000|Maintenance|Sponsor Decision|0|||
94449943|NCT00789373|323435313|FG001|Maintenance|Sponsor Decision|0|||
94449944|NCT00789373|323435314|FG002|Maintenance|Sponsor Decision|2|||
94449945|NCT00789373|323435312|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
94449946|NCT00789373|323435313|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
94449947|NCT00789373|323435314|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
94449948|NCT02476578|323435315|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
94449949|NCT02476578|323435316|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
94449950|NCT02476578|323435315|FG000|Overall Study|Lost to Follow-up|6|||
94449951|NCT02476578|323435316|FG001|Overall Study|Lost to Follow-up|13|||
94449952|NCT00546377|323435317|FG000|Overall Study|Deemed ineligible|1|||
94449953|NCT00546377|323435317|FG000|Overall Study|Adverse Event|6|||
94449954|NCT03321968|323435318|FG000|Overall Study|Withdrawal by Subject|1|||
94449955|NCT03321968|323435319|FG001|Overall Study|Withdrawal by Subject|2|||
94449956|NCT03321968|323435320|FG002|Overall Study|Withdrawal by Subject|1|||
94449957|NCT03321968|323435318|FG000|Overall Study|Lost to Follow-up|2|||
94449958|NCT03321968|323435319|FG001|Overall Study|Lost to Follow-up|0|||
94449959|NCT03321968|323435320|FG002|Overall Study|Lost to Follow-up|1|||
94449960|NCT03321968|323435318|FG000|Overall Study|Other than specified|0|||
94449961|NCT03321968|323435319|FG001|Overall Study|Other than specified|0|||
94449962|NCT03321968|323435320|FG002|Overall Study|Other than specified|1|||
94449963|NCT01964222|323435321|FG000|Overall Study|Lost to Follow-up|7|||
94449964|NCT01964222|323435322|FG001|Overall Study|Lost to Follow-up|5|||
94449965|NCT01964222|323435321|FG000|Overall Study|Withdrawal by Subject|6|||
94449966|NCT01964222|323435322|FG001|Overall Study|Withdrawal by Subject|6|||
94449967|NCT01964222|323435321|FG000|Overall Study|Screening Failure|2|||
94449968|NCT01964222|323435322|FG001|Overall Study|Screening Failure|0|||
94449969|NCT01455597|323435334|FG000|Overall Study|Adverse Event|7|||
94449970|NCT01455597|323435335|FG001|Overall Study|Adverse Event|0|||
94449971|NCT01455597|323435336|FG002|Overall Study|Adverse Event|5|||
94449972|NCT01455597|323435337|FG003|Overall Study|Adverse Event|1|||
94449973|NCT01455597|323435334|FG000|Overall Study|Lack of Efficacy|0|||
94449974|NCT01455597|323435335|FG001|Overall Study|Lack of Efficacy|1|||
94449975|NCT01455597|323435336|FG002|Overall Study|Lack of Efficacy|2|||
94449976|NCT01455597|323435337|FG003|Overall Study|Lack of Efficacy|0|||
94449977|NCT01455597|323435334|FG000|Overall Study|Lost to Follow-up|3|||
94449978|NCT01455597|323435335|FG001|Overall Study|Lost to Follow-up|0|||
94449979|NCT01455597|323435336|FG002|Overall Study|Lost to Follow-up|2|||
94449980|NCT01455597|323435337|FG003|Overall Study|Lost to Follow-up|1|||
94449981|NCT01455597|323435334|FG000|Overall Study|Withdrew Consent|6|||
94449982|NCT01455597|323435335|FG001|Overall Study|Withdrew Consent|5|||
94449983|NCT01455597|323435336|FG002|Overall Study|Withdrew Consent|8|||
94449984|NCT01455597|323435337|FG003|Overall Study|Withdrew Consent|5|||
94449985|NCT01455597|323435334|FG000|Overall Study|Reason not Specified|1|||
94449986|NCT01455597|323435335|FG001|Overall Study|Reason not Specified|2|||
94449987|NCT01455597|323435336|FG002|Overall Study|Reason not Specified|3|||
94449988|NCT01455597|323435337|FG003|Overall Study|Reason not Specified|3|||
94449989|NCT03412734|323435338|FG000|Overall Study|Incorrect labeling of samples|2|||
94449990|NCT03412734|323435339|FG001|Overall Study|Incorrect labeling of samples|0|||
94449991|NCT03412734|323435338|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
94449992|NCT03412734|323435339|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
94449993|NCT02155283|323435341|FG000|Overall Study|Lost to Follow-up|3|||
94449994|NCT02155283|323435341|FG000|Overall Study|Withdrawal by Subject|1|||
94449995|NCT02155283|323435341|FG000|Overall Study|Protocol Violation|3|||
94449996|NCT01741688|323435342|FG000|Overall Study|Lack of insurance coverage|2|||
94449997|NCT01741688|323435342|FG000|Overall Study|Withdrawal by Subject|1|||
94449998|NCT00267969|323435343|FG000|Controlled Period|Adverse Event|6|||
94449999|NCT00267969|323435344|FG001|Controlled Period|Adverse Event|0|||
94561468|NCT01807299|323849874|FG002|Overall Study|Protocol Violation|0|||
94561469|NCT01807299|323849875|FG003|Overall Study|Protocol Violation|2|||
94561470|NCT00511238|323849878|FG000|Overall Study|Adverse Event|13|||
94561471|NCT00511238|323849879|FG001|Overall Study|Adverse Event|33|||
94561472|NCT00511238|323849878|FG000|Overall Study|Withdrawal by Subject|2|||
94561473|NCT00511238|323849879|FG001|Overall Study|Withdrawal by Subject|22|||
94561474|NCT00511238|323849878|FG000|Overall Study|Progressive Disease|23|||
94561475|NCT00511238|323849879|FG001|Overall Study|Progressive Disease|157|||
94561476|NCT00511238|323849878|FG000|Overall Study|various reasons|4|||
94450000|NCT00267969|323435345|FG002|Controlled Period|Adverse Event|2|||
94450001|NCT00267969|323435346|FG003|Controlled Period|Adverse Event|0|||
94450002|NCT00267969|323435347|FG004|Controlled Period|Adverse Event|0|||
94450003|NCT00267969|323435348|FG005|Controlled Period|Adverse Event|0|||
94450004|NCT00267969|323435349|FG006|Controlled Period|Adverse Event|0|||
94450005|NCT00267969|323435343|FG000|Controlled Period|Lack of Efficacy|3|||
94450006|NCT00267969|323435344|FG001|Controlled Period|Lack of Efficacy|0|||
94450007|NCT00267969|323435345|FG002|Controlled Period|Lack of Efficacy|1|||
94450008|NCT00267969|323435346|FG003|Controlled Period|Lack of Efficacy|0|||
94450009|NCT00267969|323435347|FG004|Controlled Period|Lack of Efficacy|0|||
94450010|NCT00267969|323435348|FG005|Controlled Period|Lack of Efficacy|0|||
94450011|NCT00267969|323435349|FG006|Controlled Period|Lack of Efficacy|0|||
94450012|NCT00267969|323435343|FG000|Controlled Period|Lost to Follow-up|1|||
94450013|NCT00267969|323435344|FG001|Controlled Period|Lost to Follow-up|0|||
94450014|NCT00267969|323435345|FG002|Controlled Period|Lost to Follow-up|1|||
94450015|NCT00267969|323435346|FG003|Controlled Period|Lost to Follow-up|0|||
94450016|NCT00267969|323435347|FG004|Controlled Period|Lost to Follow-up|0|||
94450017|NCT00267969|323435348|FG005|Controlled Period|Lost to Follow-up|0|||
94450018|NCT00267969|323435349|FG006|Controlled Period|Lost to Follow-up|0|||
94450019|NCT00267969|323435343|FG000|Controlled Period|Randomized but not treated|0|||
94450020|NCT00267969|323435344|FG001|Controlled Period|Randomized but not treated|0|||
94450021|NCT00267969|323435345|FG002|Controlled Period|Randomized but not treated|1|||
94450022|NCT00267969|323435346|FG003|Controlled Period|Randomized but not treated|0|||
94450023|NCT00267969|323435347|FG004|Controlled Period|Randomized but not treated|0|||
94450024|NCT00267969|323435348|FG005|Controlled Period|Randomized but not treated|0|||
94450025|NCT00267969|323435349|FG006|Controlled Period|Randomized but not treated|0|||
94450026|NCT00267969|323435343|FG000|Controlled Period|Other|2|||
94450027|NCT00267969|323435344|FG001|Controlled Period|Other|1|||
94450028|NCT00267969|323435345|FG002|Controlled Period|Other|6|||
94450029|NCT00267969|323435346|FG003|Controlled Period|Other|0|||
94450030|NCT00267969|323435347|FG004|Controlled Period|Other|0|||
94450031|NCT00267969|323435348|FG005|Controlled Period|Other|0|||
94450032|NCT00267969|323435349|FG006|Controlled Period|Other|0|||
94450033|NCT00267969|323435343|FG000|After Controlled Period|Adverse Event|0|||
94450034|NCT00267969|323435344|FG001|After Controlled Period|Adverse Event|0|||
94450035|NCT00267969|323435345|FG002|After Controlled Period|Adverse Event|0|||
94450036|NCT00267969|323435346|FG003|After Controlled Period|Adverse Event|7|||
94450037|NCT00267969|323435347|FG004|After Controlled Period|Adverse Event|8|||
94450038|NCT00267969|323435348|FG005|After Controlled Period|Adverse Event|23|||
94450039|NCT00267969|323435349|FG006|After Controlled Period|Adverse Event|21|||
94450040|NCT00267969|323435343|FG000|After Controlled Period|Death|0|||
94450041|NCT00267969|323435344|FG001|After Controlled Period|Death|0|||
94450042|NCT00267969|323435345|FG002|After Controlled Period|Death|0|||
94450043|NCT00267969|323435346|FG003|After Controlled Period|Death|1|||
94450044|NCT00267969|323435347|FG004|After Controlled Period|Death|2|||
94450045|NCT00267969|323435348|FG005|After Controlled Period|Death|0|||
94450046|NCT00267969|323435349|FG006|After Controlled Period|Death|1|||
94450047|NCT00267969|323435343|FG000|After Controlled Period|Lack of Efficacy|0|||
94450048|NCT00267969|323435344|FG001|After Controlled Period|Lack of Efficacy|0|||
94450049|NCT00267969|323435345|FG002|After Controlled Period|Lack of Efficacy|0|||
94450050|NCT00267969|323435346|FG003|After Controlled Period|Lack of Efficacy|10|||
94450051|NCT00267969|323435347|FG004|After Controlled Period|Lack of Efficacy|6|||
94450052|NCT00267969|323435348|FG005|After Controlled Period|Lack of Efficacy|28|||
94450053|NCT00267969|323435349|FG006|After Controlled Period|Lack of Efficacy|15|||
94450054|NCT00267969|323435343|FG000|After Controlled Period|Lost to Follow-up|0|||
94450055|NCT00267969|323435344|FG001|After Controlled Period|Lost to Follow-up|0|||
94450056|NCT00267969|323435345|FG002|After Controlled Period|Lost to Follow-up|0|||
94561477|NCT00511238|323849879|FG001|Overall Study|various reasons|14|||
94561478|NCT03772665|323849880|FG000|Overall Study|Protocol Violation|1|||
94561479|NCT03772665|323849881|FG001|Overall Study|Protocol Violation|0|||
94561480|NCT00615017|323852003|FG000|Overall Study|Adverse Event|0|||
94561481|NCT00615017|323852004|FG001|Overall Study|Adverse Event|1|||
94561482|NCT00615017|323852005|FG002|Overall Study|Adverse Event|2|||
94561483|NCT00615017|323852006|FG003|Overall Study|Adverse Event|0|||
94561484|NCT00615017|323852007|FG004|Overall Study|Adverse Event|0|||
94561485|NCT00615017|323852008|FG005|Overall Study|Adverse Event|1|||
94561486|NCT00615017|323852003|FG000|Overall Study|Death|0|||
94561487|NCT00615017|323852004|FG001|Overall Study|Death|0|||
94561488|NCT00615017|323852005|FG002|Overall Study|Death|2|||
94561489|NCT00615017|323852006|FG003|Overall Study|Death|0|||
94561490|NCT00615017|323852007|FG004|Overall Study|Death|1|||
94561491|NCT00615017|323852008|FG005|Overall Study|Death|1|||
94561492|NCT00615017|323852003|FG000|Overall Study|Sepsis resolved|0|||
94561493|NCT00615017|323852004|FG001|Overall Study|Sepsis resolved|0|||
94561494|NCT00615017|323852005|FG002|Overall Study|Sepsis resolved|1|||
94561495|NCT00615017|323852006|FG003|Overall Study|Sepsis resolved|0|||
94561496|NCT00615017|323852007|FG004|Overall Study|Sepsis resolved|0|||
94561497|NCT00615017|323852008|FG005|Overall Study|Sepsis resolved|0|||
94561498|NCT00615017|323852003|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
94561499|NCT00615017|323852004|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
94561500|NCT00615017|323852005|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
94561501|NCT00615017|323852006|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
94561502|NCT00615017|323852007|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
94561503|NCT00615017|323852008|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
94561504|NCT00615017|323852003|FG000|Overall Study|Physician discontinued drug|0|||
94561505|NCT00615017|323852004|FG001|Overall Study|Physician discontinued drug|0|||
94561506|NCT00615017|323852005|FG002|Overall Study|Physician discontinued drug|0|||
94561507|NCT00615017|323852006|FG003|Overall Study|Physician discontinued drug|0|||
94561508|NCT00615017|323852007|FG004|Overall Study|Physician discontinued drug|0|||
94561509|NCT00615017|323852008|FG005|Overall Study|Physician discontinued drug|1|||
94561510|NCT02333799|323852009|FG000|Treatment Period|Withdrawal by Subject|1|||
94561511|NCT02333799|323852009|FG000|Treatment Period|Death|6|||
94561512|NCT02333799|323852009|FG000|6 Month Follow Up Period|Physician Decision|1|||
94561513|NCT02333799|323852009|FG000|6 Month Follow Up Period|Death|1|||
94345627|NCT01738594|323046007|FG000|Registration and Treatment Start|Adverse Event|0|||
94561514|NCT02333799|323852009|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
94561515|NCT02333799|323852009|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
94233621|NCT00464945|322650192|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
94345628|NCT01738594|323046008|FG001|Registration and Treatment Start|Adverse Event|1|||
94561516|NCT04014062|323852016|FG000|Period I: Dosing|Medical Grounds|4|||
94561517|NCT04014062|323852017|FG001|Period I: Dosing|Medical Grounds|5|||
94561518|NCT04014062|323852016|FG000|Period I: Dosing|Withdrawal by Subject|3|||
94561519|NCT04014062|323852017|FG001|Period I: Dosing|Withdrawal by Subject|1|||
94561520|NCT01362608|323852018|FG000|Overall Study|Protocol Violation|0|||
94561521|NCT01362608|323852019|FG001|Overall Study|Protocol Violation|1|||
94561522|NCT01362608|323852018|FG000|Overall Study|Lost to Follow-up|3|||
94561523|NCT01362608|323852019|FG001|Overall Study|Lost to Follow-up|1|||
94561524|NCT01362608|323852018|FG000|Overall Study|Withdrawal by Subject|1|||
94561525|NCT01362608|323852019|FG001|Overall Study|Withdrawal by Subject|2|||
94561526|NCT01362608|323852018|FG000|Overall Study|Lack of Efficacy|0|||
94561527|NCT01362608|323852019|FG001|Overall Study|Lack of Efficacy|2|||
94561528|NCT01362608|323852018|FG000|Overall Study|Adverse Event|0|||
94561529|NCT01362608|323852019|FG001|Overall Study|Adverse Event|2|||
94561530|NCT04809285|323852020|FG000|Phase 1|Lost to Follow-up|6|||
94561531|NCT04809285|323852020|FG000|Phase 1|Protocol Violation|2|||
94561532|NCT04809285|323852020|FG000|Phase 1|Physician Decision|3|||
94561533|NCT04809285|323852020|FG000|Phase 1|Withdrawal by Subject|29|||
94561534|NCT04809285|323852020|FG000|Phase 2|Protocol Violation|3|||
94561535|NCT04809285|323852020|FG000|Phase 2|Withdrawal by Subject|4|||
94561536|NCT03526146|323852021|FG000|Overall Study|Lost to Follow-up|5|||
94561537|NCT03526146|323852021|FG000|Overall Study|Withdrawal by Subject|6|||
94561538|NCT03526146|323852021|FG000|Overall Study|class canceled due to COVID-19|4|||
94561539|NCT02128724|323852024|FG000|Overall Study|Death|1|||
94561540|NCT02128724|323852025|FG001|Overall Study|Death|0|||
94561541|NCT02128724|323852026|FG002|Overall Study|Death|0|||
94561542|NCT02128724|323852027|FG003|Overall Study|Death|0|||
94561543|NCT02128724|323852024|FG000|Overall Study|Adverse Event|0|||
94561544|NCT02128724|323852025|FG001|Overall Study|Adverse Event|1|||
94561545|NCT02128724|323852026|FG002|Overall Study|Adverse Event|0|||
94561546|NCT02128724|323852027|FG003|Overall Study|Adverse Event|0|||
94561547|NCT02128724|323852024|FG000|Overall Study|Physician Decision|0|||
94561548|NCT02128724|323852025|FG001|Overall Study|Physician Decision|0|||
94561549|NCT02128724|323852026|FG002|Overall Study|Physician Decision|0|||
94561550|NCT02128724|323852027|FG003|Overall Study|Physician Decision|2|||
94561551|NCT02128724|323852024|FG000|Overall Study|Withdrawal by Subject|0|||
94561552|NCT02128724|323852025|FG001|Overall Study|Withdrawal by Subject|0|||
94561553|NCT02128724|323852026|FG002|Overall Study|Withdrawal by Subject|0|||
94561554|NCT02128724|323852027|FG003|Overall Study|Withdrawal by Subject|1|||
94561555|NCT03329092|323852028|FG000|Overall Study|Other|2|||
94561556|NCT03329092|323852029|FG001|Overall Study|Other|2|||
94561557|NCT03329092|323852028|FG000|Overall Study|Withdrawal by Subject|16|||
94561558|NCT03329092|323852029|FG001|Overall Study|Withdrawal by Subject|3|||
94561559|NCT03329092|323852028|FG000|Overall Study|Physician Decision|1|||
94561560|NCT03329092|323852029|FG001|Overall Study|Physician Decision|0|||
94561561|NCT03329092|323852028|FG000|Overall Study|Death|17|||
94561562|NCT03329092|323852029|FG001|Overall Study|Death|11|||
94561563|NCT03329092|323852028|FG000|Overall Study|Adverse Event|3|||
94561564|NCT03329092|323852029|FG001|Overall Study|Adverse Event|1|||
94561565|NCT03329092|323852028|FG000|Overall Study|Lost to Follow-up|1|||
94561566|NCT03329092|323852029|FG001|Overall Study|Lost to Follow-up|1|||
94561567|NCT04426318|323852030|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
94561568|NCT04426318|323852031|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
94561569|NCT04829916|323852034|FG000|Overall Study|Withdrawal by Subject|1|||
94561570|NCT04829916|323852035|FG001|Overall Study|Withdrawal by Subject|0|||
94561571|NCT04854551|323852040|FG000|Overall Study|Withdrawal by Subject|1|||
94561572|NCT04854551|323852041|FG001|Overall Study|Withdrawal by Subject|1|||
94561573|NCT02506192|323852042|FG000|Overall Study|Withdrawal by Subject|1|||
94561574|NCT02506192|323852043|FG001|Overall Study|Withdrawal by Subject|1|||
94561575|NCT02336230|323852044|FG000|Overall Study|Adverse Event|1|||
94561576|NCT02336230|323852044|FG000|Overall Study|Withdrawal of consent|1|||
94561577|NCT02336230|323852044|FG000|Overall Study|Death|9|||
94561578|NCT02336230|323852044|FG000|Overall Study|Dose not received due to shipping delay|1|||
94561579|NCT02336230|323852044|FG000|Overall Study|Discontinuation of MSC infusion|1|||
94561580|NCT03539601|323852045|FG000|Overall Study|Withdraw by parent/guardian|1|||
94561581|NCT03539601|323852046|FG001|Overall Study|Withdraw by parent/guardian|0|||
94657653|NCT00413413|324204364|FG002|Single-Blind|Subject no longer requires study drug|0|||
94657654|NCT00413413|324204362|FG000|Single-Blind|Protocol Violation|0|||
94657655|NCT00413413|324204363|FG001|Single-Blind|Protocol Violation|16|||
94657656|NCT00413413|324204364|FG002|Single-Blind|Protocol Violation|0|||
94657657|NCT00413413|324204362|FG000|Single-Blind|Withdrawal by Subject|0|||
94657658|NCT00413413|324204363|FG001|Single-Blind|Withdrawal by Subject|27|||
94657659|NCT00413413|324204364|FG002|Single-Blind|Withdrawal by Subject|0|||
94657660|NCT00413413|324204362|FG000|Single-Blind|Lost to Follow-up|0|||
94657661|NCT00413413|324204363|FG001|Single-Blind|Lost to Follow-up|8|||
94561582|NCT03539601|323852047|FG002|Overall Study|Withdraw by parent/guardian|1|||
94561583|NCT03539601|323852048|FG003|Overall Study|Withdraw by parent/guardian|0|||
94561584|NCT03539601|323852045|FG000|Overall Study|Adverse Event|0|||
94233622|NCT00464945|322650193|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
94561585|NCT03539601|323852046|FG001|Overall Study|Adverse Event|2|||
94657662|NCT00413413|324204364|FG002|Single-Blind|Lost to Follow-up|0|||
94233623|NCT00464945|322650192|FG000|Infant Series|Protocol Violation|1|||
94233624|NCT00464945|322650193|FG001|Infant Series|Protocol Violation|0|||
94233625|NCT00464945|322650192|FG000|Infant Series|Lost to Follow-up|1|||
94233626|NCT00464945|322650193|FG001|Infant Series|Lost to Follow-up|0|||
94233627|NCT00464945|322650192|FG000|After Infant Series|Withdrawal by Subject|0|||
94233628|NCT00464945|322650193|FG001|After Infant Series|Withdrawal by Subject|2|||
94233629|NCT00464945|322650192|FG000|Toddler Dose|Lost to Follow-up|0|||
94233630|NCT00464945|322650193|FG001|Toddler Dose|Lost to Follow-up|1|||
94233631|NCT01519778|322650194|FG000|Overall Study|Withdrawal by Subject|3|||
94233632|NCT01519778|322650194|FG000|Overall Study|Lost to Follow-up|10|||
94233633|NCT01519778|322650194|FG000|Overall Study|Physician Decision|1|||
94233634|NCT02250534|322650199|FG000|Overall Study|Lost to Follow-up|18|||
94233635|NCT02250534|322650200|FG001|Overall Study|Lost to Follow-up|28|||
94233636|NCT02250534|322650201|FG002|Overall Study|Lost to Follow-up|33|||
94233637|NCT02250534|322650199|FG000|Overall Study|Personal reasons|7|||
94233638|NCT02250534|322650200|FG001|Overall Study|Personal reasons|8|||
94233639|NCT02250534|322650201|FG002|Overall Study|Personal reasons|14|||
94233640|NCT02250534|322650199|FG000|Overall Study|Adverse Event|6|||
94233641|NCT02250534|322650200|FG001|Overall Study|Adverse Event|3|||
94233642|NCT02250534|322650201|FG002|Overall Study|Adverse Event|8|||
94233643|NCT02250534|322650199|FG000|Overall Study|incarcerated|2|||
94233644|NCT02250534|322650200|FG001|Overall Study|incarcerated|1|||
94233645|NCT02250534|322650201|FG002|Overall Study|incarcerated|2|||
94233646|NCT02250534|322650199|FG000|Overall Study|Withdrawal by Subject|0|||
94233647|NCT02250534|322650200|FG001|Overall Study|Withdrawal by Subject|1|||
94233648|NCT02250534|322650201|FG002|Overall Study|Withdrawal by Subject|2|||
94233649|NCT02250534|322650199|FG000|Overall Study|Death|0|||
94233650|NCT02250534|322650200|FG001|Overall Study|Death|1|||
94233651|NCT02250534|322650201|FG002|Overall Study|Death|1|||
94233652|NCT02250534|322650199|FG000|Overall Study|Physician Decision|1|||
94233653|NCT02250534|322650200|FG001|Overall Study|Physician Decision|3|||
94233654|NCT02250534|322650201|FG002|Overall Study|Physician Decision|1|||
94233655|NCT02250534|322650199|FG000|Overall Study|Protocol Violation|1|||
94233656|NCT02250534|322650200|FG001|Overall Study|Protocol Violation|0|||
94233657|NCT02250534|322650201|FG002|Overall Study|Protocol Violation|1|||
94233658|NCT02250534|322650199|FG000|Overall Study|Reason unknown|1|||
94233659|NCT02250534|322650200|FG001|Overall Study|Reason unknown|0|||
94233660|NCT02250534|322650201|FG002|Overall Study|Reason unknown|0|||
94233661|NCT02872012|322650202|FG000|Overall Study|Withdrawal by Subject|1|||
94233662|NCT02872012|322650203|FG001|Overall Study|Withdrawal by Subject|0|||
94233663|NCT02872012|322650204|FG002|Overall Study|Withdrawal by Subject|0|||
94233664|NCT02872012|322650205|FG003|Overall Study|Withdrawal by Subject|0|||
94233665|NCT02872012|322650206|FG004|Overall Study|Withdrawal by Subject|0|||
94233666|NCT01099579|322650208|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
94233667|NCT01099579|322650209|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
94233668|NCT01099579|322650210|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
94233669|NCT01099579|322650208|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
94233670|NCT01099579|322650209|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
94233671|NCT01099579|322650210|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
94233672|NCT01099579|322650208|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
94233673|NCT01099579|322650209|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
94233674|NCT01099579|322650210|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
94233675|NCT01099579|322650208|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
94233676|NCT01099579|322650209|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
94233677|NCT01099579|322650210|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
94657663|NCT00413413|324204362|FG000|Double-Blind|Adverse Event|6|||
94657664|NCT00413413|324204363|FG001|Double-Blind|Adverse Event|0|||
94233678|NCT01099579|322650208|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
94233679|NCT01099579|322650209|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
94233680|NCT01099579|322650210|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
94657665|NCT00413413|324204364|FG002|Double-Blind|Adverse Event|5|||
94657666|NCT00413413|324204362|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
94657667|NCT00413413|324204363|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
94233681|NCT01099579|322650208|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
94233682|NCT01099579|322650209|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
94233683|NCT01099579|322650210|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
94233684|NCT01099579|322650208|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
94233685|NCT01099579|322650209|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
94233686|NCT01099579|322650210|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
94233687|NCT01099579|322650208|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
94233688|NCT01099579|322650209|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
94233689|NCT01099579|322650210|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
94233690|NCT01099579|322650208|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
94233691|NCT01099579|322650209|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
94233692|NCT01099579|322650210|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
94233693|NCT01099579|322650208|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
94345629|NCT01738594|323046009|FG002|Registration and Treatment Start|Adverse Event|0|||
94345630|NCT01738594|323046010|FG003|Registration and Treatment Start|Adverse Event|0|||
94345631|NCT01738594|323046011|FG004|Registration and Treatment Start|Adverse Event|0|||
94345632|NCT01738594|323046012|FG005|Registration and Treatment Start|Adverse Event|0|||
94345633|NCT01738594|323046013|FG006|Registration and Treatment Start|Adverse Event|0|||
94345634|NCT01738594|323046014|FG007|Registration and Treatment Start|Adverse Event|0|||
94345635|NCT01738594|323046007|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
94345636|NCT01738594|323046008|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
94561586|NCT03539601|323852047|FG002|Overall Study|Adverse Event|0|||
94561587|NCT03539601|323852048|FG003|Overall Study|Adverse Event|0|||
94561588|NCT03539601|323852045|FG000|Overall Study|Lost to Follow-up|2|||
94561589|NCT03539601|323852046|FG001|Overall Study|Lost to Follow-up|4|||
94561590|NCT03539601|323852047|FG002|Overall Study|Lost to Follow-up|5|||
94561591|NCT03539601|323852048|FG003|Overall Study|Lost to Follow-up|0|||
94561592|NCT03539601|323852045|FG000|Overall Study|Withdrawal by Subject|2|||
94561593|NCT03539601|323852046|FG001|Overall Study|Withdrawal by Subject|0|||
94561594|NCT03539601|323852047|FG002|Overall Study|Withdrawal by Subject|0|||
94561595|NCT03539601|323852048|FG003|Overall Study|Withdrawal by Subject|1|||
94561596|NCT03539601|323852045|FG000|Overall Study|Randomized but not treated|1|||
94561597|NCT03539601|323852046|FG001|Overall Study|Randomized but not treated|1|||
94561598|NCT03539601|323852047|FG002|Overall Study|Randomized but not treated|0|||
94561599|NCT03539601|323852048|FG003|Overall Study|Randomized but not treated|0|||
94561600|NCT01427933|323852050|FG000|Overall Study|Withdrawal by Subject|5|||
94561601|NCT01427933|323852051|FG001|Overall Study|Withdrawal by Subject|8|||
94561602|NCT01427933|323852050|FG000|Overall Study|Lost to Follow-up|1|||
94561603|NCT01427933|323852051|FG001|Overall Study|Lost to Follow-up|5|||
94561604|NCT01427933|323852050|FG000|Overall Study|Other|1|||
94561605|NCT01427933|323852051|FG001|Overall Study|Other|0|||
94561606|NCT01427933|323852050|FG000|Overall Study|Investigator's Decision|1|||
94561607|NCT01427933|323852051|FG001|Overall Study|Investigator's Decision|0|||
94561608|NCT03472326|323852052|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
94561609|NCT03472326|323852053|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
94561610|NCT03472326|323852054|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
94561611|NCT03472326|323852055|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
94561612|NCT03472326|323852052|FG000|Part 2: Combination Therapy|Pregnancy|0|||
94561613|NCT03472326|323852053|FG001|Part 2: Combination Therapy|Pregnancy|0|||
94561614|NCT03472326|323852054|FG002|Part 2: Combination Therapy|Pregnancy|0|||
94561615|NCT03472326|323852055|FG003|Part 2: Combination Therapy|Pregnancy|1|||
94561616|NCT01824355|323852056|FG000|Overall Study|Adverse Event|2|||
94561617|NCT01824355|323852056|FG000|Overall Study|unevaluable reference method results per|1|||
94561618|NCT00637416|323852057|FG000|Overall Study|Lost to Follow-up|1|||
94561619|NCT00637416|323852058|FG001|Overall Study|Lost to Follow-up|1|||
94561620|NCT00637416|323852057|FG000|Overall Study|Unable to take study drug|0|||
94561621|NCT00637416|323852058|FG001|Overall Study|Unable to take study drug|1|||
94561622|NCT03078855|323852067|FG000|Overall Study|Lack of Efficacy|62|||
94561623|NCT03078855|323852068|FG001|Overall Study|Lack of Efficacy|31|||
94561624|NCT03078855|323852067|FG000|Overall Study|Death|1|||
94561625|NCT03078855|323852068|FG001|Overall Study|Death|0|||
94561626|NCT03078855|323852067|FG000|Overall Study|Withdrawal by Subject|12|||
94561627|NCT03078855|323852068|FG001|Overall Study|Withdrawal by Subject|6|||
94561628|NCT03078855|323852067|FG000|Overall Study|Physician Decision|3|||
94561629|NCT03078855|323852068|FG001|Overall Study|Physician Decision|2|||
94561630|NCT03078855|323852067|FG000|Overall Study|Second Malignancy|4|||
94561631|NCT03078855|323852068|FG001|Overall Study|Second Malignancy|0|||
94561632|NCT03078855|323852067|FG000|Overall Study|Ineligible|2|||
94561633|NCT03078855|323852068|FG001|Overall Study|Ineligible|0|||
94561634|NCT03078855|323852067|FG000|Overall Study|Withdrew before day 1 treatment|2|||
94561635|NCT03078855|323852068|FG001|Overall Study|Withdrew before day 1 treatment|1|||
94561636|NCT01327599|323852069|FG000|Overall Study|Adverse Event|1|||
94561637|NCT01327599|323852069|FG000|Overall Study|Could Not Attend Visit|1|||
94561638|NCT01327599|323852069|FG000|Overall Study|Withdrawal of Consent|1|||
94561639|NCT04531241|323852073|FG000|Period 1|Withdrawal by Subject|2|||
94561640|NCT04531241|323852074|FG001|Period 1|Withdrawal by Subject|0|||
94561641|NCT04531241|323852073|FG000|Period 1|Dispesed incorrect lens power|1|||
94561642|NCT04531241|323852074|FG001|Period 1|Dispesed incorrect lens power|0|||
94561643|NCT04531241|323852073|FG000|Period 1|Protocol Violation|1|||
94561644|NCT04531241|323852074|FG001|Period 1|Protocol Violation|0|||
94561645|NCT04531241|323852073|FG000|Period 1|No longer eligible|0|||
94561646|NCT04531241|323852074|FG001|Period 1|No longer eligible|1|||
94561647|NCT04531241|323852073|FG000|Period 1|Lens Discomfort|0|||
94561648|NCT04531241|323852074|FG001|Period 1|Lens Discomfort|1|||
94561649|NCT04531241|323852073|FG000|Period 2|Covid-19 Related|1|||
94561650|NCT04531241|323852074|FG001|Period 2|Covid-19 Related|1|||
94561651|NCT00362648|323852075|FG000|Overall Study|Adverse Event|12|||
94561652|NCT00362648|323852076|FG001|Overall Study|Adverse Event|21|||
94561653|NCT00362648|323852077|FG002|Overall Study|Adverse Event|1|||
94561654|NCT00362648|323852078|FG003|Overall Study|Adverse Event|0|||
94345637|NCT01738594|323046009|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
94345638|NCT01738594|323046010|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
94561655|NCT00362648|323852075|FG000|Overall Study|Lost to Follow-up|62|||
94561656|NCT00362648|323852076|FG001|Overall Study|Lost to Follow-up|69|||
94561657|NCT00362648|323852077|FG002|Overall Study|Lost to Follow-up|4|||
94561658|NCT00362648|323852078|FG003|Overall Study|Lost to Follow-up|3|||
94561659|NCT00362648|323852075|FG000|Overall Study|Protocol Violation|4|||
94561660|NCT00362648|323852076|FG001|Overall Study|Protocol Violation|2|||
94561661|NCT00362648|323852077|FG002|Overall Study|Protocol Violation|2|||
94561662|NCT00362648|323852078|FG003|Overall Study|Protocol Violation|2|||
94561663|NCT00362648|323852075|FG000|Overall Study|Withdrawal by Subject|48|||
94561664|NCT00362648|323852076|FG001|Overall Study|Withdrawal by Subject|42|||
94561665|NCT00362648|323852077|FG002|Overall Study|Withdrawal by Subject|2|||
94561666|NCT00362648|323852078|FG003|Overall Study|Withdrawal by Subject|6|||
94561667|NCT00310817|323852079|FG000|Overall Study|AE or Death|3|||
94561668|NCT00310817|323852080|FG001|Overall Study|AE or Death|1|||
94561669|NCT00310817|323852081|FG002|Overall Study|AE or Death|0|||
94561670|NCT00310817|323852082|FG003|Overall Study|AE or Death|0|||
94561671|NCT00310817|323852079|FG000|Overall Study|Withdrawal by Subject|1|||
94561672|NCT00310817|323852080|FG001|Overall Study|Withdrawal by Subject|4|||
94561673|NCT00310817|323852081|FG002|Overall Study|Withdrawal by Subject|6|||
94561674|NCT00310817|323852082|FG003|Overall Study|Withdrawal by Subject|7|||
94561675|NCT00310817|323852079|FG000|Overall Study|Lost to Follow-up|2|||
94561676|NCT00310817|323852080|FG001|Overall Study|Lost to Follow-up|1|||
94561677|NCT00310817|323852081|FG002|Overall Study|Lost to Follow-up|0|||
94561678|NCT00310817|323852082|FG003|Overall Study|Lost to Follow-up|0|||
94561679|NCT00310817|323852079|FG000|Overall Study|Inappropriate Enrollment|1|||
94561680|NCT00310817|323852080|FG001|Overall Study|Inappropriate Enrollment|0|||
94561681|NCT00310817|323852081|FG002|Overall Study|Inappropriate Enrollment|1|||
94561682|NCT00310817|323852082|FG003|Overall Study|Inappropriate Enrollment|0|||
94561683|NCT00310817|323852079|FG000|Overall Study|Protocol Violation|1|||
94561684|NCT00310817|323852080|FG001|Overall Study|Protocol Violation|1|||
94561685|NCT00310817|323852081|FG002|Overall Study|Protocol Violation|1|||
94561686|NCT00310817|323852082|FG003|Overall Study|Protocol Violation|1|||
94561687|NCT00310817|323852079|FG000|Overall Study|Unable to classify|3|||
94561688|NCT00310817|323852080|FG001|Overall Study|Unable to classify|1|||
94561689|NCT00310817|323852081|FG002|Overall Study|Unable to classify|0|||
94561690|NCT00310817|323852082|FG003|Overall Study|Unable to classify|0|||
94561691|NCT01518374|323852083|FG000|Overall Study|Withdrawal by Subject|2|||
94561692|NCT01518374|323852083|FG000|Overall Study|Protocol Violation|3|||
94561693|NCT01518374|323852083|FG000|Overall Study|Lost to Follow-up|2|||
94561694|NCT05236257|323852084|FG000|Overall Study|Ongoing with study treatment|29|||
94561695|NCT05236257|323852085|FG001|Overall Study|Ongoing with study treatment|1|||
94561696|NCT05236257|323852084|FG000|Overall Study|Discontinued study treatment|22|||
94561697|NCT05236257|323852085|FG001|Overall Study|Discontinued study treatment|41|||
94561698|NCT02915978|323852088|FG000|Overall Study|Adverse Event|2|||
94561699|NCT02915978|323852089|FG001|Overall Study|Adverse Event|1|||
94561700|NCT02915978|323852090|FG002|Overall Study|Adverse Event|0|||
94561701|NCT00924443|323852091|FG000|Overall Study|Physician Decision|2|||
94561702|NCT00924443|323852091|FG000|Overall Study|Protocol Violation|1|||
94561703|NCT04491136|323852092|FG000|Overall Study|Patient withdraw informed consent|9|||
94561704|NCT04491136|323852092|FG000|Overall Study|Adverse Event|2|||
94561705|NCT04491136|323852092|FG000|Overall Study|Death|3|||
94561706|NCT04491136|323852092|FG000|Overall Study|Lost to Follow-up|3|||
94561707|NCT04491136|323852092|FG000|Overall Study|Physician Decision|45|||
94561708|NCT04491136|323852092|FG000|Overall Study|sponsor terminated the study early|16|||
94561709|NCT04491136|323852092|FG000|Overall Study|Patient/guardian's decision|1|||
94561710|NCT00048347|323852096|FG000|Overall Study|Screen failure|2|||
94561711|NCT00892775|323852100|FG000|Overall Study|Protocol Violation|1|||
94561712|NCT00892775|323852101|FG001|Overall Study|Protocol Violation|0|||
94561713|NCT00892775|323852100|FG000|Overall Study|Subject difficulties with blood drawing|1|||
94561714|NCT00892775|323852101|FG001|Overall Study|Subject difficulties with blood drawing|0|||
94561715|NCT00892775|323852100|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
94561716|NCT00892775|323852101|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
94561717|NCT00892775|323852100|FG000|Overall Study|Migrated/ moved from study area|1|||
94561718|NCT00892775|323852101|FG001|Overall Study|Migrated/ moved from study area|0|||
94561719|NCT00892775|323852100|FG000|Overall Study|Withdrawal by Subject|0|||
94561720|NCT00892775|323852101|FG001|Overall Study|Withdrawal by Subject|1|||
94561721|NCT00892775|323852100|FG000|Overall Study|Lost to Follow-up|1|||
94561722|NCT00892775|323852101|FG001|Overall Study|Lost to Follow-up|0|||
94561723|NCT01870726|323852103|FG000|Overall Study|Withdrawal of informed consent|0|||
94561724|NCT01870726|323852104|FG001|Overall Study|Withdrawal of informed consent|0|||
94561725|NCT01870726|323852105|FG002|Overall Study|Withdrawal of informed consent|0|||
94561726|NCT01870726|323852106|FG003|Overall Study|Withdrawal of informed consent|1|||
94561727|NCT01870726|323852107|FG004|Overall Study|Withdrawal of informed consent|0|||
94233694|NCT01099579|322650209|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
94561728|NCT01870726|323852108|FG005|Overall Study|Withdrawal of informed consent|0|||
94561729|NCT01870726|323852109|FG006|Overall Study|Withdrawal of informed consent|0|||
94561730|NCT01870726|323852103|FG000|Overall Study|Withdrawal by Subject|0|||
94561731|NCT01870726|323852104|FG001|Overall Study|Withdrawal by Subject|1|||
94561732|NCT01870726|323852105|FG002|Overall Study|Withdrawal by Subject|0|||
94345639|NCT01738594|323046011|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
94345640|NCT01738594|323046012|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
94345641|NCT01738594|323046013|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
94345642|NCT01738594|323046014|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
94345643|NCT01738594|323046007|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
94345644|NCT01738594|323046008|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
94345645|NCT01738594|323046009|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
94561733|NCT01870726|323852106|FG003|Overall Study|Withdrawal by Subject|0|||
94561734|NCT01870726|323852107|FG004|Overall Study|Withdrawal by Subject|0|||
94561735|NCT01870726|323852108|FG005|Overall Study|Withdrawal by Subject|0|||
94561736|NCT01870726|323852109|FG006|Overall Study|Withdrawal by Subject|0|||
94561737|NCT01870726|323852103|FG000|Overall Study|Adverse Event|0|||
94561738|NCT01870726|323852104|FG001|Overall Study|Adverse Event|0|||
94561739|NCT01870726|323852105|FG002|Overall Study|Adverse Event|0|||
94561740|NCT01870726|323852106|FG003|Overall Study|Adverse Event|0|||
94561741|NCT01870726|323852107|FG004|Overall Study|Adverse Event|1|||
94561742|NCT01870726|323852108|FG005|Overall Study|Adverse Event|1|||
94561743|NCT01870726|323852109|FG006|Overall Study|Adverse Event|0|||
94561744|NCT01870726|323852103|FG000|Overall Study|Progressive disease|5|||
94561745|NCT01870726|323852104|FG001|Overall Study|Progressive disease|5|||
94561746|NCT01870726|323852105|FG002|Overall Study|Progressive disease|4|||
94561747|NCT01870726|323852106|FG003|Overall Study|Progressive disease|5|||
94561748|NCT01870726|323852107|FG004|Overall Study|Progressive disease|6|||
94561749|NCT01870726|323852108|FG005|Overall Study|Progressive disease|4|||
94561750|NCT01870726|323852109|FG006|Overall Study|Progressive disease|10|||
94561751|NCT01248949|323852110|FG000|Overall Study|Lost to Follow-up|2|||
94561752|NCT01248949|323852111|FG001|Overall Study|Lost to Follow-up|2|||
94561753|NCT01248949|323852112|FG002|Overall Study|Lost to Follow-up|2|||
94561754|NCT01248949|323852113|FG003|Overall Study|Lost to Follow-up|1|||
94561755|NCT01248949|323852114|FG004|Overall Study|Lost to Follow-up|0|||
94561756|NCT01248949|323852110|FG000|Overall Study|Withdrawal by Subject|5|||
94561757|NCT01248949|323852111|FG001|Overall Study|Withdrawal by Subject|3|||
94561758|NCT01248949|323852112|FG002|Overall Study|Withdrawal by Subject|11|||
94561759|NCT01248949|323852113|FG003|Overall Study|Withdrawal by Subject|3|||
94561760|NCT01248949|323852114|FG004|Overall Study|Withdrawal by Subject|1|||
94233695|NCT01099579|322650210|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
94233696|NCT00909532|322650212|FG000|Overall Study|Adverse Event|4|||
94233697|NCT00909532|322650213|FG001|Overall Study|Adverse Event|1|||
94233698|NCT00909532|322650212|FG000|Overall Study|Pregnancy|0|||
94233699|NCT00909532|322650213|FG001|Overall Study|Pregnancy|1|||
94233700|NCT00909532|322650212|FG000|Overall Study|Prohibited Medication|2|||
94233701|NCT00909532|322650213|FG001|Overall Study|Prohibited Medication|1|||
94233702|NCT00909532|322650212|FG000|Overall Study|Withdrawal of Consent|1|||
94233703|NCT00909532|322650213|FG001|Overall Study|Withdrawal of Consent|1|||
94233704|NCT00909532|322650212|FG000|Overall Study|Noncompliance with Study Requirements|0|||
94233705|NCT00909532|322650213|FG001|Overall Study|Noncompliance with Study Requirements|2|||
94233706|NCT00909532|322650212|FG000|Overall Study|Physician Decision|1|||
94233707|NCT00909532|322650213|FG001|Overall Study|Physician Decision|0|||
94233708|NCT00909532|322650212|FG000|Overall Study|Wrong Genotype|1|||
94233709|NCT00909532|322650213|FG001|Overall Study|Wrong Genotype|0|||
94233710|NCT00909532|322650212|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
94345646|NCT01738594|323046010|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
94345647|NCT01738594|323046011|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
94345648|NCT01738594|323046012|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
94345649|NCT01738594|323046013|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
94345650|NCT01738594|323046014|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
94561761|NCT01248949|323852110|FG000|Overall Study|Death|22|||
94561762|NCT01248949|323852111|FG001|Overall Study|Death|7|||
94561763|NCT01248949|323852112|FG002|Overall Study|Death|21|||
94345651|NCT01738594|323046007|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
94345652|NCT01738594|323046008|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
94561764|NCT01248949|323852113|FG003|Overall Study|Death|6|||
94561765|NCT01248949|323852114|FG004|Overall Study|Death|2|||
94561766|NCT01248949|323852110|FG000|Overall Study|Alternative Therapy|1|||
94561767|NCT01248949|323852111|FG001|Overall Study|Alternative Therapy|0|||
94561768|NCT01248949|323852112|FG002|Overall Study|Alternative Therapy|0|||
94561769|NCT01248949|323852113|FG003|Overall Study|Alternative Therapy|0|||
94561770|NCT01248949|323852114|FG004|Overall Study|Alternative Therapy|0|||
94561771|NCT01248949|323852110|FG000|Overall Study|Alternative Therapy.|1|||
94233711|NCT00909532|322650213|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
94450057|NCT00267969|323435346|FG003|After Controlled Period|Lost to Follow-up|5|||
94450058|NCT00267969|323435347|FG004|After Controlled Period|Lost to Follow-up|8|||
94450059|NCT00267969|323435348|FG005|After Controlled Period|Lost to Follow-up|9|||
94450060|NCT00267969|323435349|FG006|After Controlled Period|Lost to Follow-up|10|||
94450061|NCT00267969|323435343|FG000|After Controlled Period|Other|0|||
94450062|NCT00267969|323435344|FG001|After Controlled Period|Other|0|||
94450063|NCT00267969|323435345|FG002|After Controlled Period|Other|0|||
94450064|NCT00267969|323435346|FG003|After Controlled Period|Other|13|||
94450065|NCT00267969|323435347|FG004|After Controlled Period|Other|11|||
94450066|NCT00267969|323435348|FG005|After Controlled Period|Other|22|||
94450067|NCT00267969|323435349|FG006|After Controlled Period|Other|25|||
94450068|NCT00887315|323435352|FG000|Overall Study|Study termination|7|||
94450069|NCT00887315|323435353|FG001|Overall Study|Study termination|4|||
94450070|NCT00396656|323435358|FG000|First Treatment Period|Withdrawal by Subject|0|||
94450071|NCT00396656|323435359|FG001|First Treatment Period|Withdrawal by Subject|2|||
94450072|NCT00396656|323435358|FG000|Second Treatment Period|Adverse Event|0|||
94450073|NCT00396656|323435359|FG001|Second Treatment Period|Adverse Event|1|||
94450074|NCT00460811|323435361|FG000|Overall Study|Adverse Event|4|||
94450075|NCT00460811|323435362|FG001|Overall Study|Adverse Event|6|||
94450076|NCT00460811|323435363|FG002|Overall Study|Adverse Event|3|||
94450077|NCT00460811|323435364|FG003|Overall Study|Adverse Event|10|||
94450078|NCT00460811|323435365|FG004|Overall Study|Adverse Event|2|||
94450079|NCT00460811|323435361|FG000|Overall Study|Noncompliance|1|||
94450080|NCT00460811|323435362|FG001|Overall Study|Noncompliance|0|||
94450081|NCT00460811|323435363|FG002|Overall Study|Noncompliance|0|||
94450082|NCT00460811|323435364|FG003|Overall Study|Noncompliance|2|||
94450083|NCT00460811|323435365|FG004|Overall Study|Noncompliance|1|||
94450084|NCT00460811|323435361|FG000|Overall Study|Withdrawal by Subject|7|||
94450085|NCT00460811|323435362|FG001|Overall Study|Withdrawal by Subject|7|||
94450086|NCT00460811|323435363|FG002|Overall Study|Withdrawal by Subject|6|||
94450087|NCT00460811|323435364|FG003|Overall Study|Withdrawal by Subject|3|||
94450088|NCT00460811|323435365|FG004|Overall Study|Withdrawal by Subject|11|||
94450089|NCT00460811|323435361|FG000|Overall Study|Physician Decision|1|||
94450090|NCT00460811|323435362|FG001|Overall Study|Physician Decision|0|||
94450091|NCT00460811|323435363|FG002|Overall Study|Physician Decision|0|||
94450092|NCT00460811|323435364|FG003|Overall Study|Physician Decision|0|||
94450093|NCT00460811|323435365|FG004|Overall Study|Physician Decision|0|||
94561772|NCT01248949|323852111|FG001|Overall Study|Alternative Therapy.|0|||
94561773|NCT01248949|323852112|FG002|Overall Study|Alternative Therapy.|0|||
94561774|NCT01248949|323852113|FG003|Overall Study|Alternative Therapy.|0|||
94561775|NCT01248949|323852114|FG004|Overall Study|Alternative Therapy.|0|||
94561776|NCT01248949|323852110|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
94561777|NCT01248949|323852111|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
94561778|NCT01248949|323852112|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
94561779|NCT01248949|323852113|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
94450094|NCT00460811|323435361|FG000|Overall Study|Lost to Follow-up|3|||
94450095|NCT00460811|323435362|FG001|Overall Study|Lost to Follow-up|2|||
94450096|NCT00460811|323435363|FG002|Overall Study|Lost to Follow-up|5|||
94450097|NCT00460811|323435364|FG003|Overall Study|Lost to Follow-up|3|||
94561780|NCT01248949|323852114|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
94561781|NCT01248949|323852110|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
94561782|NCT01248949|323852111|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
94561783|NCT01248949|323852112|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
94561784|NCT01248949|323852113|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
94561785|NCT01248949|323852114|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
94561786|NCT01248949|323852110|FG000|Overall Study|Participant Went To Hospice|0|||
94561787|NCT01248949|323852111|FG001|Overall Study|Participant Went To Hospice|0|||
94561788|NCT01248949|323852112|FG002|Overall Study|Participant Went To Hospice|1|||
94561789|NCT01248949|323852113|FG003|Overall Study|Participant Went To Hospice|0|||
94561790|NCT01248949|323852114|FG004|Overall Study|Participant Went To Hospice|0|||
94561791|NCT01248949|323852110|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
94561792|NCT01248949|323852111|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
94561793|NCT01248949|323852112|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
94561794|NCT01248949|323852113|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
94561795|NCT01248949|323852114|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
94561796|NCT01248949|323852110|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
94561797|NCT01248949|323852111|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
94561798|NCT01248949|323852112|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
94561799|NCT01248949|323852113|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
94561800|NCT01248949|323852114|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
94561801|NCT01248949|323852110|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
94561802|NCT01248949|323852111|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
94561803|NCT01248949|323852112|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
94561804|NCT01248949|323852113|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
94561805|NCT01248949|323852114|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
94561806|NCT01248949|323852110|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
94561807|NCT01248949|323852111|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
94561808|NCT01248949|323852112|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
94561809|NCT01248949|323852113|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
94561810|NCT01248949|323852114|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
94561811|NCT00958165|323852115|FG000|Overall Study|Lost to Follow-up|5|||
94561812|NCT00958165|323852115|FG000|Overall Study|Not eligible|9|||
94561813|NCT01746225|323852116|FG000|Overall Study|Death|1|||
94561814|NCT01746225|323852117|FG001|Overall Study|Death|0|||
94561815|NCT01746225|323852118|FG002|Overall Study|Death|1|||
94561816|NCT01746225|323852116|FG000|Overall Study|Withdrawal by Subject|5|||
94561817|NCT01746225|323852117|FG001|Overall Study|Withdrawal by Subject|15|||
94561818|NCT01746225|323852118|FG002|Overall Study|Withdrawal by Subject|19|||
94561819|NCT01746225|323852116|FG000|Overall Study|Physician Decision|14|||
94561820|NCT01746225|323852117|FG001|Overall Study|Physician Decision|11|||
94561821|NCT01746225|323852118|FG002|Overall Study|Physician Decision|3|||
94561822|NCT01746225|323852116|FG000|Overall Study|Adverse Event|15|||
94561823|NCT01746225|323852117|FG001|Overall Study|Adverse Event|12|||
94561824|NCT01746225|323852118|FG002|Overall Study|Adverse Event|17|||
94561825|NCT01746225|323852116|FG000|Overall Study|Continuing Treatment|5|||
94561826|NCT01746225|323852117|FG001|Overall Study|Continuing Treatment|8|||
94561827|NCT01746225|323852118|FG002|Overall Study|Continuing Treatment|3|||
94561828|NCT03245775|323852124|FG000|Overall Study|Lost to Follow-up|25|||
94561829|NCT03245775|323852125|FG001|Overall Study|Lost to Follow-up|26|||
94561830|NCT03245775|323852126|FG002|Overall Study|Lost to Follow-up|16|||
94450098|NCT00460811|323435365|FG004|Overall Study|Lost to Follow-up|6|||
94561831|NCT03245775|323852127|FG003|Overall Study|Lost to Follow-up|16|||
94561832|NCT03405818|323852128|FG000|Overall Study|Withdrawal by Subject|4|||
94561833|NCT03405818|323852128|FG000|Overall Study|Lost to Follow-up|4|||
94561834|NCT02713828|323852129|FG000|Overall Study|Death|2|||
94561835|NCT02713828|323852130|FG001|Overall Study|Death|0|||
94561836|NCT02713828|323852129|FG000|Overall Study|Withdrawal by Subject|1|||
94561837|NCT02713828|323852130|FG001|Overall Study|Withdrawal by Subject|0|||
94561838|NCT02713828|323852129|FG000|Overall Study|study terminated but patient allowed to|2|||
94561839|NCT02713828|323852130|FG001|Overall Study|study terminated but patient allowed to|0|||
94561840|NCT03197376|323852131|FG000|Primary and Booster Phase|Adverse Event|0|||
94561841|NCT03197376|323852132|FG001|Primary and Booster Phase|Adverse Event|0|||
94561842|NCT03197376|323852133|FG002|Primary and Booster Phase|Adverse Event|0|||
94561843|NCT03197376|323852134|FG003|Primary and Booster Phase|Adverse Event|1|||
94561844|NCT03197376|323852131|FG000|Primary and Booster Phase|Death|1|||
94561845|NCT03197376|323852132|FG001|Primary and Booster Phase|Death|0|||
94561846|NCT03197376|323852133|FG002|Primary and Booster Phase|Death|0|||
94561847|NCT03197376|323852134|FG003|Primary and Booster Phase|Death|2|||
94561848|NCT03197376|323852131|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
94561849|NCT03197376|323852132|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
94561850|NCT03197376|323852133|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
94233712|NCT04092452|322650216|FG000|Overall Study|Adverse Event|1|||
94345653|NCT01738594|323046009|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
94345654|NCT01738594|323046010|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
94345655|NCT01738594|323046011|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
94345656|NCT01738594|323046012|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
94345657|NCT01738594|323046013|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
94345658|NCT01738594|323046014|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
94345659|NCT01738594|323046007|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
94345660|NCT01738594|323046008|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
94345661|NCT01738594|323046009|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
94345662|NCT01738594|323046010|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
94561851|NCT03197376|323852134|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
94561852|NCT03197376|323852131|FG000|Primary and Booster Phase|Physician Decision|1|||
94561853|NCT03197376|323852132|FG001|Primary and Booster Phase|Physician Decision|0|||
94561854|NCT03197376|323852133|FG002|Primary and Booster Phase|Physician Decision|1|||
94561855|NCT03197376|323852134|FG003|Primary and Booster Phase|Physician Decision|3|||
94561856|NCT03197376|323852131|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
94561857|NCT03197376|323852132|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
94561858|NCT03197376|323852133|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
94561859|NCT03197376|323852134|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
94561860|NCT03197376|323852131|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
94561861|NCT03197376|323852132|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
94561862|NCT03197376|323852133|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
94561863|NCT03197376|323852134|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
94561864|NCT03197376|323852131|FG000|Primary and Booster Phase|Not vaccine related|1|||
94561865|NCT03197376|323852132|FG001|Primary and Booster Phase|Not vaccine related|2|||
94561866|NCT03197376|323852133|FG002|Primary and Booster Phase|Not vaccine related|0|||
94561867|NCT03197376|323852134|FG003|Primary and Booster Phase|Not vaccine related|6|||
94561868|NCT03197376|323852131|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
94561869|NCT03197376|323852132|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
94561870|NCT03197376|323852133|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
94561871|NCT03197376|323852134|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
94561872|NCT03197376|323852131|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
94561873|NCT03197376|323852132|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
94561874|NCT03197376|323852133|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
94561875|NCT03197376|323852134|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
94561876|NCT03197376|323852131|FG000|Immune Persistence Phase|Not vaccine related|1|||
94561877|NCT03197376|323852132|FG001|Immune Persistence Phase|Not vaccine related|0|||
94561878|NCT03197376|323852133|FG002|Immune Persistence Phase|Not vaccine related|1|||
94561879|NCT03197376|323852134|FG003|Immune Persistence Phase|Not vaccine related|1|||
94561880|NCT04090242|323852135|FG000|Overall Study|Withdrawal by Subject|1|||
94345663|NCT01738594|323046011|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
94345664|NCT01738594|323046012|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
94345665|NCT01738594|323046013|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
94345666|NCT01738594|323046014|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
94345667|NCT01738594|323046007|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
94345668|NCT01738594|323046008|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
94345669|NCT01738594|323046009|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
94345670|NCT01738594|323046010|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
94345671|NCT01738594|323046011|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
94561881|NCT04090242|323852136|FG001|Overall Study|Withdrawal by Subject|0|||
94561882|NCT02464410|323852146|FG000|Overall Study|Death|3|||
94561883|NCT02464410|323852147|FG001|Overall Study|Death|4|||
94561884|NCT02464410|323852146|FG000|Overall Study|Lost to Follow-up|7|||
94561885|NCT02464410|323852147|FG001|Overall Study|Lost to Follow-up|9|||
94561886|NCT02464410|323852146|FG000|Overall Study|Withdrawal by Subject|12|||
94561887|NCT02464410|323852147|FG001|Overall Study|Withdrawal by Subject|3|||
94561888|NCT03508609|323852151|FG000|Overall Study|Withdrawal by Subject|1|||
94561889|NCT00555217|323852152|FG000|Overall Study|Withdrawal by Subject|35|||
94561890|NCT00555217|323852153|FG001|Overall Study|Withdrawal by Subject|31|||
94561891|NCT00555217|323852152|FG000|Overall Study|Lost to Follow-up|19|||
94561892|NCT00555217|323852153|FG001|Overall Study|Lost to Follow-up|20|||
94561893|NCT00555217|323852152|FG000|Overall Study|close out sites|21|||
94561894|NCT00555217|323852153|FG001|Overall Study|close out sites|17|||
94345672|NCT01738594|323046012|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
94345673|NCT01738594|323046013|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
94561895|NCT00291486|323852158|FG000|Overall Study|Adverse Event|0|||
94561896|NCT00291486|323852159|FG001|Overall Study|Adverse Event|3|||
94561897|NCT00291486|323852160|FG002|Overall Study|Adverse Event|0|||
94561898|NCT00291486|323852161|FG003|Overall Study|Adverse Event|1|||
94561899|NCT00291486|323852162|FG004|Overall Study|Adverse Event|0|||
94561900|NCT00291486|323852158|FG000|Overall Study|Withdrawal by Subject|0|||
94561901|NCT00291486|323852159|FG001|Overall Study|Withdrawal by Subject|0|||
94561902|NCT00291486|323852160|FG002|Overall Study|Withdrawal by Subject|0|||
94561903|NCT00291486|323852161|FG003|Overall Study|Withdrawal by Subject|0|||
94561904|NCT00291486|323852162|FG004|Overall Study|Withdrawal by Subject|1|||
94561905|NCT00291486|323852158|FG000|Overall Study|Disease progression|1|||
94561906|NCT00291486|323852159|FG001|Overall Study|Disease progression|0|||
94561907|NCT00291486|323852160|FG002|Overall Study|Disease progression|1|||
94561908|NCT00291486|323852161|FG003|Overall Study|Disease progression|0|||
94561909|NCT00291486|323852162|FG004|Overall Study|Disease progression|0|||
94561910|NCT02679287|323852163|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
94561911|NCT02679287|323852164|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
94561912|NCT02679287|323852163|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
94561913|NCT02679287|323852164|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
94561914|NCT02679287|323852163|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
94561915|NCT02679287|323852164|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
94561916|NCT02679287|323852163|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
94561917|NCT02679287|323852164|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
94561918|NCT02679287|323852163|FG000|Period 2|Work/Scheduling Conflict|1|||
94561919|NCT02679287|323852164|FG001|Period 2|Work/Scheduling Conflict|0|||
94561920|NCT02679287|323852163|FG000|Period 2|Disliked Mobile System|2|||
94561921|NCT02679287|323852164|FG001|Period 2|Disliked Mobile System|0|||
94561922|NCT02679287|323852163|FG000|Period 3|Work/Scheduling Conflict|0|||
94561923|NCT02679287|323852164|FG001|Period 3|Work/Scheduling Conflict|1|||
94561924|NCT00423449|323852165|FG000|Overall Study|Clinical Adverse Event|1|||
94561925|NCT00423449|323852166|FG001|Overall Study|Clinical Adverse Event|0|||
94561926|NCT00423449|323852167|FG002|Overall Study|Clinical Adverse Event|1|||
94561927|NCT00423449|323852168|FG003|Overall Study|Clinical Adverse Event|8|||
94561928|NCT00423449|323852169|FG004|Overall Study|Clinical Adverse Event|2|||
94561929|NCT00423449|323852165|FG000|Overall Study|Death|1|||
94233713|NCT04092452|322650217|FG001|Overall Study|Adverse Event|3|||
94233714|NCT04092452|322650218|FG002|Overall Study|Adverse Event|3|||
94233715|NCT04092452|322650219|FG003|Overall Study|Adverse Event|7|||
94233716|NCT04092452|322650216|FG000|Overall Study|Lack of Efficacy|1|||
94233717|NCT04092452|322650217|FG001|Overall Study|Lack of Efficacy|1|||
94233718|NCT04092452|322650218|FG002|Overall Study|Lack of Efficacy|1|||
94233719|NCT04092452|322650219|FG003|Overall Study|Lack of Efficacy|0|||
94233720|NCT04092452|322650216|FG000|Overall Study|Lost to Follow-up|4|||
94233721|NCT04092452|322650217|FG001|Overall Study|Lost to Follow-up|3|||
94233722|NCT04092452|322650218|FG002|Overall Study|Lost to Follow-up|5|||
94233723|NCT04092452|322650219|FG003|Overall Study|Lost to Follow-up|1|||
94561930|NCT00423449|323852166|FG001|Overall Study|Death|0|||
94561931|NCT00423449|323852167|FG002|Overall Study|Death|2|||
94561932|NCT00423449|323852168|FG003|Overall Study|Death|1|||
94561933|NCT00423449|323852169|FG004|Overall Study|Death|1|||
94561934|NCT00423449|323852165|FG000|Overall Study|Progressive Disease|1|||
94561935|NCT00423449|323852166|FG001|Overall Study|Progressive Disease|3|||
94561936|NCT00423449|323852167|FG002|Overall Study|Progressive Disease|8|||
94561937|NCT00423449|323852168|FG003|Overall Study|Progressive Disease|11|||
94561938|NCT00423449|323852169|FG004|Overall Study|Progressive Disease|4|||
94233724|NCT04092452|322650216|FG000|Overall Study|Non-Compliance With Study Drug|0|||
94233725|NCT04092452|322650217|FG001|Overall Study|Non-Compliance With Study Drug|0|||
94561939|NCT00423449|323852165|FG000|Overall Study|Laboratory Adverse Event|0|||
94561940|NCT00423449|323852166|FG001|Overall Study|Laboratory Adverse Event|1|||
94561941|NCT00423449|323852167|FG002|Overall Study|Laboratory Adverse Event|2|||
94561942|NCT00423449|323852168|FG003|Overall Study|Laboratory Adverse Event|0|||
94561943|NCT00423449|323852169|FG004|Overall Study|Laboratory Adverse Event|0|||
94561944|NCT00423449|323852165|FG000|Overall Study|Other|0|||
94561945|NCT00423449|323852166|FG001|Overall Study|Other|0|||
94561946|NCT00423449|323852167|FG002|Overall Study|Other|0|||
94561947|NCT00423449|323852168|FG003|Overall Study|Other|1|||
94561948|NCT00423449|323852169|FG004|Overall Study|Other|0|||
94561949|NCT00423449|323852165|FG000|Overall Study|Protocol Violation|0|||
94561950|NCT00423449|323852166|FG001|Overall Study|Protocol Violation|0|||
94561951|NCT00423449|323852167|FG002|Overall Study|Protocol Violation|2|||
94561952|NCT00423449|323852168|FG003|Overall Study|Protocol Violation|1|||
94561953|NCT00423449|323852169|FG004|Overall Study|Protocol Violation|0|||
94561954|NCT00543387|323852173|FG000|Panel 1 + Panel 2|Adverse Event|0|||
94561955|NCT00543387|323852174|FG001|Panel 1 + Panel 2|Adverse Event|1|||
94561956|NCT00543387|323852175|FG002|Panel 1 + Panel 2|Adverse Event|0|||
94561957|NCT00543387|323852176|FG003|Panel 1 + Panel 2|Adverse Event|0|||
94561958|NCT00543387|323852177|FG004|Panel 1 + Panel 2|Adverse Event|0|||
94561959|NCT00543387|323852178|FG005|Panel 1 + Panel 2|Adverse Event|0|||
94561960|NCT00543387|323852179|FG006|Panel 1 + Panel 2|Adverse Event|0|||
94561961|NCT00543387|323852180|FG007|Panel 1 + Panel 2|Adverse Event|1|||
94561962|NCT00543387|323852181|FG008|Panel 1 + Panel 2|Adverse Event|1|||
94561963|NCT00543387|323852182|FG009|Panel 1 + Panel 2|Adverse Event|0|||
94561964|NCT00543387|323852183|FG010|Panel 1 + Panel 2|Adverse Event|0|||
94561965|NCT00543387|323852173|FG000|Panel 1 + Panel 2|Physician Decision|0|||
94561966|NCT00543387|323852174|FG001|Panel 1 + Panel 2|Physician Decision|0|||
94561967|NCT00543387|323852175|FG002|Panel 1 + Panel 2|Physician Decision|1|||
94561968|NCT00543387|323852176|FG003|Panel 1 + Panel 2|Physician Decision|0|||
94561969|NCT00543387|323852177|FG004|Panel 1 + Panel 2|Physician Decision|0|||
94561970|NCT00543387|323852178|FG005|Panel 1 + Panel 2|Physician Decision|0|||
94561971|NCT00543387|323852179|FG006|Panel 1 + Panel 2|Physician Decision|0|||
94561972|NCT00543387|323852180|FG007|Panel 1 + Panel 2|Physician Decision|1|||
94561973|NCT00543387|323852181|FG008|Panel 1 + Panel 2|Physician Decision|0|||
94561974|NCT00543387|323852182|FG009|Panel 1 + Panel 2|Physician Decision|0|||
94561975|NCT00543387|323852183|FG010|Panel 1 + Panel 2|Physician Decision|0|||
94561976|NCT00543387|323852173|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
94561977|NCT00543387|323852174|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
94561978|NCT00543387|323852175|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
94561979|NCT00543387|323852176|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
94561980|NCT00543387|323852177|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
94561981|NCT00543387|323852178|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
94561982|NCT00543387|323852179|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
94561983|NCT00543387|323852180|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
94233726|NCT04092452|322650218|FG002|Overall Study|Non-Compliance With Study Drug|1|||
94233727|NCT04092452|322650219|FG003|Overall Study|Non-Compliance With Study Drug|1|||
94233728|NCT04092452|322650216|FG000|Overall Study|Physician Decision|1|||
94233729|NCT04092452|322650217|FG001|Overall Study|Physician Decision|0|||
94233730|NCT04092452|322650218|FG002|Overall Study|Physician Decision|1|||
94233731|NCT04092452|322650219|FG003|Overall Study|Physician Decision|0|||
94233732|NCT04092452|322650216|FG000|Overall Study|Pregnancy|2|||
94233733|NCT04092452|322650217|FG001|Overall Study|Pregnancy|0|||
94233734|NCT04092452|322650218|FG002|Overall Study|Pregnancy|0|||
94233735|NCT04092452|322650219|FG003|Overall Study|Pregnancy|0|||
94233736|NCT04092452|322650216|FG000|Overall Study|Protocol Deviation|1|||
94233737|NCT04092452|322650217|FG001|Overall Study|Protocol Deviation|0|||
94233738|NCT04092452|322650218|FG002|Overall Study|Protocol Deviation|0|||
94233739|NCT04092452|322650219|FG003|Overall Study|Protocol Deviation|0|||
94233740|NCT04092452|322650216|FG000|Overall Study|Withdrawal by Subject|3|||
94233741|NCT04092452|322650217|FG001|Overall Study|Withdrawal by Subject|10|||
94233742|NCT04092452|322650218|FG002|Overall Study|Withdrawal by Subject|3|||
94233743|NCT04092452|322650219|FG003|Overall Study|Withdrawal by Subject|5|||
94233744|NCT04092452|322650216|FG000|Overall Study|Other|0|||
94233745|NCT04092452|322650217|FG001|Overall Study|Other|0|||
94233746|NCT04092452|322650218|FG002|Overall Study|Other|1|||
94233747|NCT04092452|322650219|FG003|Overall Study|Other|2|||
94233748|NCT01174264|322650220|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
94233749|NCT01174264|322650221|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
94233750|NCT01174264|322650222|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
94233751|NCT01174264|322650220|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
94233752|NCT01174264|322650221|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
94233753|NCT01174264|322650222|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
94561984|NCT00543387|323852181|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
94561985|NCT00543387|323852182|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
94561986|NCT00543387|323852183|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
94561987|NCT00543387|323852173|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
94561988|NCT00543387|323852174|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
94233754|NCT01174264|322650220|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
94561989|NCT00543387|323852175|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
94561990|NCT00543387|323852176|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
94561991|NCT00543387|323852177|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
94561992|NCT00543387|323852178|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
94561993|NCT00543387|323852179|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
94561994|NCT00543387|323852180|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
94561995|NCT00543387|323852181|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
94561996|NCT00543387|323852182|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
94561997|NCT00543387|323852183|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
94233755|NCT01174264|322650221|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
94233756|NCT01174264|322650222|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
94233757|NCT00798304|322650223|FG000|Overall Study|Adverse Event|0|||
94233758|NCT00798304|322650224|FG001|Overall Study|Adverse Event|1|||
94233759|NCT00798304|322650225|FG002|Overall Study|Adverse Event|1|||
94233760|NCT00798304|322650223|FG000|Overall Study|Discontinuation by Sponsor|14|||
94233761|NCT00798304|322650224|FG001|Overall Study|Discontinuation by Sponsor|21|||
94561998|NCT00543387|323852173|FG000|Crossover Participants|Progressive Disease|0|||
94561999|NCT00543387|323852174|FG001|Crossover Participants|Progressive Disease|0|||
94562000|NCT00543387|323852175|FG002|Crossover Participants|Progressive Disease|0|||
94562001|NCT00543387|323852176|FG003|Crossover Participants|Progressive Disease|0|||
94562002|NCT00543387|323852177|FG004|Crossover Participants|Progressive Disease|0|||
94233762|NCT00798304|322650225|FG002|Overall Study|Discontinuation by Sponsor|9|||
94233763|NCT01018732|322650235|FG000|Overall Study|Lost to Follow-up|0|||
94233764|NCT01018732|322650236|FG001|Overall Study|Lost to Follow-up|0|||
94233765|NCT01018732|322650237|FG002|Overall Study|Lost to Follow-up|3|||
94233766|NCT01018732|322650235|FG000|Overall Study|Protocol Violation|1|||
94233767|NCT01018732|322650236|FG001|Overall Study|Protocol Violation|1|||
94562003|NCT00543387|323852178|FG005|Crossover Participants|Progressive Disease|0|||
94562004|NCT00543387|323852179|FG006|Crossover Participants|Progressive Disease|0|||
94562005|NCT00543387|323852180|FG007|Crossover Participants|Progressive Disease|0|||
94562006|NCT00543387|323852181|FG008|Crossover Participants|Progressive Disease|0|||
94562007|NCT00543387|323852182|FG009|Crossover Participants|Progressive Disease|1|||
94562008|NCT00543387|323852183|FG010|Crossover Participants|Progressive Disease|2|||
94233768|NCT01018732|322650237|FG002|Overall Study|Protocol Violation|0|||
94233769|NCT01018732|322650235|FG000|Overall Study|Inappropriate Enrollment|0|||
94233770|NCT01018732|322650236|FG001|Overall Study|Inappropriate Enrollment|1|||
94233771|NCT01018732|322650237|FG002|Overall Study|Inappropriate Enrollment|0|||
94233772|NCT01018732|322650235|FG000|Overall Study|Unable to Classify|0|||
94233773|NCT01018732|322650236|FG001|Overall Study|Unable to Classify|0|||
94233774|NCT01018732|322650237|FG002|Overall Study|Unable to Classify|1|||
94233775|NCT03783689|322650244|FG000|Overall Study|Adverse Event|2|||
94233776|NCT03783689|322650245|FG001|Overall Study|Adverse Event|0|||
94233777|NCT03783689|322650244|FG000|Overall Study|Lost to Follow-up|2|||
94233778|NCT03783689|322650245|FG001|Overall Study|Lost to Follow-up|1|||
94233779|NCT03783689|322650244|FG000|Overall Study|Physician Decision|2|||
94233780|NCT03783689|322650245|FG001|Overall Study|Physician Decision|1|||
94233781|NCT03783689|322650244|FG000|Overall Study|Withdrawal by Subject|3|||
94345674|NCT01738594|323046014|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
94345675|NCT01738594|323046007|FG000|Follow up for 1 Year|Death|0|||
94562009|NCT00543387|323852173|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
94345676|NCT01738594|323046008|FG001|Follow up for 1 Year|Death|0|||
94345677|NCT01738594|323046009|FG002|Follow up for 1 Year|Death|0|||
94345678|NCT01738594|323046010|FG003|Follow up for 1 Year|Death|0|||
94345679|NCT01738594|323046011|FG004|Follow up for 1 Year|Death|0|||
94345680|NCT01738594|323046012|FG005|Follow up for 1 Year|Death|1|||
94345681|NCT01738594|323046013|FG006|Follow up for 1 Year|Death|0|||
94345682|NCT01738594|323046014|FG007|Follow up for 1 Year|Death|0|||
94345683|NCT01738594|323046007|FG000|Follow up for 1 Year|Other|0|||
94345684|NCT01738594|323046008|FG001|Follow up for 1 Year|Other|0|||
94345685|NCT01738594|323046009|FG002|Follow up for 1 Year|Other|0|||
94345686|NCT01738594|323046010|FG003|Follow up for 1 Year|Other|0|||
94345687|NCT01738594|323046011|FG004|Follow up for 1 Year|Other|0|||
94345688|NCT01738594|323046012|FG005|Follow up for 1 Year|Other|2|||
94345689|NCT01738594|323046013|FG006|Follow up for 1 Year|Other|0|||
94345690|NCT01738594|323046014|FG007|Follow up for 1 Year|Other|0|||
94345691|NCT03083470|323046015|FG000|Overall Study|Lost to Follow-up|0|||
94345692|NCT03083470|323046016|FG001|Overall Study|Lost to Follow-up|0|||
94345693|NCT03083470|323046017|FG002|Overall Study|Lost to Follow-up|0|||
94345694|NCT03083470|323046018|FG003|Overall Study|Lost to Follow-up|0|||
94345695|NCT03083470|323046019|FG004|Overall Study|Lost to Follow-up|1|||
94345696|NCT03083470|323046015|FG000|Overall Study|Withdrawal by Subject|0|||
94345697|NCT03083470|323046016|FG001|Overall Study|Withdrawal by Subject|0|||
94345698|NCT03083470|323046017|FG002|Overall Study|Withdrawal by Subject|0|||
94345699|NCT03083470|323046018|FG003|Overall Study|Withdrawal by Subject|0|||
94345700|NCT03083470|323046019|FG004|Overall Study|Withdrawal by Subject|1|||
94345701|NCT01108068|323046020|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
94345702|NCT01108068|323046021|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
94345703|NCT01842334|323046023|FG000|Overall Study|Withdrawal by Subject|3|||
94345704|NCT01842334|323046024|FG001|Overall Study|Withdrawal by Subject|3|||
94345705|NCT01842334|323046023|FG000|Overall Study|Moved away mid-study|0|||
94345706|NCT01842334|323046024|FG001|Overall Study|Moved away mid-study|1|||
94345707|NCT00415623|323046029|FG000|Overall Study|Adverse Event|3|||
94345708|NCT00415623|323046030|FG001|Overall Study|Adverse Event|4|||
94345709|NCT00415623|323046029|FG000|Overall Study|Death|1|||
94345710|NCT00415623|323046030|FG001|Overall Study|Death|0|||
94345711|NCT00415623|323046029|FG000|Overall Study|Withdrawal by Subject|1|||
94233782|NCT03783689|322650245|FG001|Overall Study|Withdrawal by Subject|3|||
94233783|NCT02165826|322650246|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
94345712|NCT00415623|323046030|FG001|Overall Study|Withdrawal by Subject|1|||
94562010|NCT00543387|323852174|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
94562011|NCT00543387|323852175|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
94562012|NCT00543387|323852176|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
94562013|NCT00543387|323852177|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
94562014|NCT00543387|323852178|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
94562015|NCT00543387|323852179|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
94562016|NCT00543387|323852180|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
94562017|NCT00543387|323852181|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
94562018|NCT00543387|323852182|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
94562019|NCT00543387|323852183|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
94562020|NCT01574651|323852184|FG000|Overall Study|Lost to Follow-up|2|||
94562021|NCT01574651|323852185|FG001|Overall Study|Lost to Follow-up|4|||
94562022|NCT01574651|323852184|FG000|Overall Study|Administrative problems|0|||
94562023|NCT01574651|323852185|FG001|Overall Study|Administrative problems|1|||
94562024|NCT01574651|323852184|FG000|Overall Study|Death|3|||
94562025|NCT01574651|323852185|FG001|Overall Study|Death|3|||
94562026|NCT01574651|323852184|FG000|Overall Study|Patient's inability to use the device|0|||
94562027|NCT01574651|323852185|FG001|Overall Study|Patient's inability to use the device|1|||
94562028|NCT01574651|323852184|FG000|Overall Study|Adverse Event|36|||
94562029|NCT01574651|323852185|FG001|Overall Study|Adverse Event|27|||
94562030|NCT01574651|323852184|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94562031|NCT01574651|323852185|FG001|Overall Study|Abnormal laboratory value(s)|0|||
94562032|NCT01574651|323852184|FG000|Overall Study|Abnormal test procedure result(s)|1|||
94657668|NCT00413413|324204364|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
94657669|NCT00413413|324204362|FG000|Double-Blind|Protocol deviation|1|||
94657670|NCT00413413|324204363|FG001|Double-Blind|Protocol deviation|2|||
94657671|NCT00413413|324204364|FG002|Double-Blind|Protocol deviation|1|||
94657672|NCT00413413|324204362|FG000|Double-Blind|Subject withdrew consent|4|||
94657673|NCT00413413|324204363|FG001|Double-Blind|Subject withdrew consent|6|||
94562033|NCT01574651|323852185|FG001|Overall Study|Abnormal test procedure result(s)|1|||
94562034|NCT01574651|323852184|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
94562035|NCT01574651|323852185|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94562036|NCT01574651|323852184|FG000|Overall Study|Protocol Violation|3|||
94562037|NCT01574651|323852185|FG001|Overall Study|Protocol Violation|5|||
94562038|NCT01574651|323852184|FG000|Overall Study|Withdrawal by Subject|9|||
94562039|NCT01574651|323852185|FG001|Overall Study|Withdrawal by Subject|10|||
94562040|NCT03566082|323852188|FG000|Overall Study|Death|7|||
94562041|NCT03566082|323852188|FG000|Overall Study|Failures (revision required)|2|||
94562042|NCT03566082|323852188|FG000|Overall Study|Lost to Follow-up|8|||
94562043|NCT02092025|323852189|FG000|Overall Study|Case Report Forms Uncollected|44|||
94562044|NCT02092025|323852189|FG000|Overall Study|Protocol Deviation|24|||
94562045|NCT02837029|323853698|FG000|Screening|Failed to meet screening requirements.|7|||
94562046|NCT02837029|323853699|FG001|Screening|Failed to meet screening requirements.|3|||
94562047|NCT02837029|323853700|FG002|Screening|Failed to meet screening requirements.|0|||
94562048|NCT02837029|323853698|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
94562049|NCT02837029|323853699|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
94562050|NCT02837029|323853700|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
94562051|NCT02837029|323853698|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
94562052|NCT02837029|323853699|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
94562053|NCT02837029|323853700|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
94562054|NCT02837029|323853698|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
94562055|NCT02837029|323853699|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
94562056|NCT02837029|323853700|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
94562057|NCT02837029|323853698|FG000|Cycle 2 and Beyond|Adverse Event|1|||
94562058|NCT02837029|323853699|FG001|Cycle 2 and Beyond|Adverse Event|0|||
94562059|NCT02837029|323853700|FG002|Cycle 2 and Beyond|Adverse Event|0|||
94562060|NCT02837029|323853698|FG000|2 Year Follow-up|Death|6|||
94562061|NCT02837029|323853699|FG001|2 Year Follow-up|Death|7|||
94562062|NCT02837029|323853700|FG002|2 Year Follow-up|Death|0|||
94562063|NCT02114606|323853701|FG000|Overall Study|Unable to swallow Cytosponge|6|||
94562064|NCT00394706|323853714|FG000|Overall Study|Withdrawal by Subject|2|||
94562065|NCT00394706|323853715|FG001|Overall Study|Withdrawal by Subject|0|||
94562066|NCT00394706|323853716|FG002|Overall Study|Withdrawal by Subject|1|||
94562067|NCT00394706|323853717|FG003|Overall Study|Withdrawal by Subject|0|||
94562068|NCT00394706|323853718|FG004|Overall Study|Withdrawal by Subject|0|||
94562069|NCT00394706|323853719|FG005|Overall Study|Withdrawal by Subject|2|||
94562070|NCT00394706|323853720|FG006|Overall Study|Withdrawal by Subject|1|||
94562071|NCT00394706|323853721|FG007|Overall Study|Withdrawal by Subject|0|||
94562072|NCT00394706|323853714|FG000|Overall Study|Lost to Follow-up|2|||
94562073|NCT00394706|323853715|FG001|Overall Study|Lost to Follow-up|2|||
94562074|NCT00394706|323853716|FG002|Overall Study|Lost to Follow-up|8|||
94562075|NCT00394706|323853717|FG003|Overall Study|Lost to Follow-up|1|||
94562076|NCT00394706|323853718|FG004|Overall Study|Lost to Follow-up|2|||
94562077|NCT00394706|323853719|FG005|Overall Study|Lost to Follow-up|5|||
94562078|NCT00394706|323853720|FG006|Overall Study|Lost to Follow-up|2|||
94562079|NCT00394706|323853721|FG007|Overall Study|Lost to Follow-up|0|||
94562080|NCT04098809|323853722|FG000|Overall Study|Withdrawal by Subject|1|||
94562081|NCT04098809|323853723|FG001|Overall Study|Withdrawal by Subject|3|||
94562082|NCT04098809|323853722|FG000|Overall Study|Physician Decision|2|||
94562083|NCT04098809|323853723|FG001|Overall Study|Physician Decision|1|||
94562084|NCT00193206|323853724|FG000|Preoperative Therapy|Lack of Efficacy|2|||
94562085|NCT00193206|323853724|FG000|Preoperative Therapy|Adverse Event|2|||
94562086|NCT00193206|323853724|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
94562087|NCT00193206|323853724|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
94562088|NCT00193206|323853724|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
94562089|NCT00193206|323853724|FG000|Postoperative Therapy|Physician Decision|3|||
94562090|NCT00193206|323853724|FG000|Postoperative Therapy|Intercurrent Illness|2|||
94562091|NCT00193206|323853724|FG000|Postoperative Therapy|Lack of Efficacy|1|||
94562092|NCT00193206|323853724|FG000|Postoperative Therapy|Protocol Violation|1|||
94562093|NCT01200368|323853725|FG000|Infant Series|Adverse Event|2|||
94562094|NCT01200368|323853726|FG001|Infant Series|Adverse Event|2|||
94562095|NCT01200368|323853727|FG002|Infant Series|Adverse Event|3|||
94562096|NCT01200368|323853725|FG000|Infant Series|Withdrawal by Subject|0|||
94562097|NCT01200368|323853726|FG001|Infant Series|Withdrawal by Subject|2|||
94562098|NCT01200368|323853727|FG002|Infant Series|Withdrawal by Subject|2|||
94562099|NCT01200368|323853725|FG000|Infant Series|Did not meet entrance criteria|0|||
94562100|NCT01200368|323853726|FG001|Infant Series|Did not meet entrance criteria|1|||
94562101|NCT01200368|323853727|FG002|Infant Series|Did not meet entrance criteria|0|||
94562102|NCT01200368|323853725|FG000|Infant Series|Randomized, not vaccinated|0|||
94562103|NCT01200368|323853726|FG001|Infant Series|Randomized, not vaccinated|1|||
94562104|NCT01200368|323853727|FG002|Infant Series|Randomized, not vaccinated|1|||
94562105|NCT01200368|323853725|FG000|Infant Series|Other|1|||
94562106|NCT01200368|323853726|FG001|Infant Series|Other|0|||
94562107|NCT01200368|323853727|FG002|Infant Series|Other|0|||
94562108|NCT01200368|323853725|FG000|After Infant Series|Adverse Event|6|||
94562109|NCT01200368|323853726|FG001|After Infant Series|Adverse Event|6|||
94562110|NCT01200368|323853727|FG002|After Infant Series|Adverse Event|3|||
94562111|NCT01200368|323853725|FG000|After Infant Series|Withdrawal by Subject|10|||
94562112|NCT01200368|323853726|FG001|After Infant Series|Withdrawal by Subject|8|||
94562113|NCT01200368|323853727|FG002|After Infant Series|Withdrawal by Subject|4|||
94562114|NCT01200368|323853725|FG000|After Infant Series|Lost to Follow-up|1|||
94562115|NCT01200368|323853726|FG001|After Infant Series|Lost to Follow-up|0|||
94562116|NCT01200368|323853727|FG002|After Infant Series|Lost to Follow-up|0|||
94562117|NCT01200368|323853725|FG000|After Infant Series|Other|1|||
94562118|NCT01200368|323853726|FG001|After Infant Series|Other|2|||
94562119|NCT01200368|323853727|FG002|After Infant Series|Other|2|||
94562120|NCT01200368|323853725|FG000|Toddler Dose|Adverse Event|0|||
94562121|NCT01200368|323853726|FG001|Toddler Dose|Adverse Event|3|||
94562122|NCT01200368|323853727|FG002|Toddler Dose|Adverse Event|1|||
94562123|NCT03329846|323853729|FG000|Overall Study|Disease progression|4|||
94562124|NCT03329846|323853730|FG001|Overall Study|Disease progression|6|||
94562125|NCT03329846|323853729|FG000|Overall Study|Study drug toxicity|1|||
94562126|NCT03329846|323853730|FG001|Overall Study|Study drug toxicity|0|||
94562127|NCT03329846|323853729|FG000|Overall Study|Participant request to discontinue treatment|0|||
94562128|NCT03329846|323853730|FG001|Overall Study|Participant request to discontinue treatment|1|||
94562129|NCT03329846|323853729|FG000|Overall Study|Participant withdrew consent|1|||
94562130|NCT03329846|323853730|FG001|Overall Study|Participant withdrew consent|0|||
94562131|NCT03329846|323853729|FG000|Overall Study|Other reasons|2|||
94562132|NCT03329846|323853730|FG001|Overall Study|Other reasons|2|||
94562133|NCT02741596|323853731|FG000|Overall Study|Adverse Event|1|||
94562134|NCT02741596|323853732|FG001|Overall Study|Adverse Event|5|||
94562135|NCT02741596|323853731|FG000|Overall Study|Lost to Follow-up|1|||
94562136|NCT02741596|323853732|FG001|Overall Study|Lost to Follow-up|1|||
94562137|NCT02741596|323853731|FG000|Overall Study|Physician Decision|2|||
94562138|NCT02741596|323853732|FG001|Overall Study|Physician Decision|1|||
94562139|NCT02741596|323853731|FG000|Overall Study|Pregnancy|3|||
94562140|NCT02741596|323853732|FG001|Overall Study|Pregnancy|1|||
94562141|NCT02741596|323853731|FG000|Overall Study|Other (Unspecified)|0|||
94562142|NCT02741596|323853732|FG001|Overall Study|Other (Unspecified)|3|||
94562143|NCT02741596|323853731|FG000|Overall Study|Subject withdrawn-Other|17|||
94562144|NCT02741596|323853732|FG001|Overall Study|Subject withdrawn-Other|4|||
94562145|NCT02741596|323853731|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
94562146|NCT02741596|323853732|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
94562147|NCT00479336|323853733|FG000|Overall Study|Adverse Event|1|||
94562148|NCT00479336|323853734|FG001|Overall Study|Adverse Event|1|||
94562149|NCT00479336|323853735|FG002|Overall Study|Adverse Event|1|||
94562150|NCT00479336|323853736|FG003|Overall Study|Adverse Event|3|||
94562151|NCT00479336|323853733|FG000|Overall Study|Lack of Efficacy|1|||
94562152|NCT00479336|323853734|FG001|Overall Study|Lack of Efficacy|0|||
94562153|NCT00479336|323853735|FG002|Overall Study|Lack of Efficacy|0|||
94562154|NCT00479336|323853736|FG003|Overall Study|Lack of Efficacy|0|||
94562155|NCT00479336|323853733|FG000|Overall Study|Protocol Violation|0|||
94562156|NCT00479336|323853734|FG001|Overall Study|Protocol Violation|1|||
94562157|NCT00479336|323853735|FG002|Overall Study|Protocol Violation|0|||
94562158|NCT00479336|323853736|FG003|Overall Study|Protocol Violation|0|||
94562159|NCT00479336|323853733|FG000|Overall Study|Withdrawal by Subject|1|||
94562160|NCT00479336|323853734|FG001|Overall Study|Withdrawal by Subject|2|||
94562161|NCT00479336|323853735|FG002|Overall Study|Withdrawal by Subject|0|||
94562162|NCT00479336|323853736|FG003|Overall Study|Withdrawal by Subject|0|||
94562163|NCT00479336|323853733|FG000|Overall Study|Physician Decision|0|||
94562164|NCT00479336|323853734|FG001|Overall Study|Physician Decision|1|||
94562165|NCT00479336|323853735|FG002|Overall Study|Physician Decision|0|||
94562166|NCT00479336|323853736|FG003|Overall Study|Physician Decision|2|||
94562167|NCT00479336|323853733|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
94562168|NCT00479336|323853734|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
94562169|NCT00479336|323853735|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
94562170|NCT00479336|323853736|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
94562171|NCT00108862|323853737|FG000|Overall Study|Death|31|||
94562172|NCT00108862|323853738|FG001|Overall Study|Death|37|||
94562173|NCT00108862|323853737|FG000|Overall Study|Withdrawal by Subject|10|||
94562174|NCT00108862|323853738|FG001|Overall Study|Withdrawal by Subject|6|||
94562175|NCT00108862|323853737|FG000|Overall Study|Lost to Follow-up|27|||
94562176|NCT00108862|323853738|FG001|Overall Study|Lost to Follow-up|19|||
94562177|NCT03066193|323853739|FG000|Overall Study|Withdrawal by Subject|1|||
94562178|NCT02021643|323853740|FG000|Overall Study|Enrolled but Never Treated|1|||
94562179|NCT02021643|323853741|FG001|Overall Study|Enrolled but Never Treated|0|||
94562180|NCT02021643|323853742|FG002|Overall Study|Enrolled but Never Treated|0|||
94562181|NCT02021643|323853743|FG003|Overall Study|Enrolled but Never Treated|0|||
94562182|NCT02021643|323853740|FG000|Overall Study|Adverse Event|0|||
94657674|NCT00413413|324204364|FG002|Double-Blind|Subject withdrew consent|9|||
94562183|NCT02021643|323853741|FG001|Overall Study|Adverse Event|1|||
94562184|NCT02021643|323853742|FG002|Overall Study|Adverse Event|0|||
94562185|NCT02021643|323853743|FG003|Overall Study|Adverse Event|0|||
94562186|NCT02021643|323853740|FG000|Overall Study|Death|0|||
94562187|NCT02021643|323853741|FG001|Overall Study|Death|1|||
94562188|NCT02021643|323853742|FG002|Overall Study|Death|0|||
94345713|NCT03267576|323046032|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
94562189|NCT02021643|323853743|FG003|Overall Study|Death|0|||
94562190|NCT02021643|323853740|FG000|Overall Study|Investigator's Discretion|1|||
94562191|NCT02021643|323853741|FG001|Overall Study|Investigator's Discretion|0|||
94562192|NCT02021643|323853742|FG002|Overall Study|Investigator's Discretion|0|||
94562193|NCT02021643|323853743|FG003|Overall Study|Investigator's Discretion|0|||
94562194|NCT02021643|323853740|FG000|Overall Study|Lack of Efficacy|7|||
94562195|NCT02021643|323853741|FG001|Overall Study|Lack of Efficacy|6|||
94562196|NCT02021643|323853742|FG002|Overall Study|Lack of Efficacy|0|||
94562197|NCT02021643|323853743|FG003|Overall Study|Lack of Efficacy|12|||
94562198|NCT02021643|323853740|FG000|Overall Study|Lost to Follow-up|0|||
94562199|NCT02021643|323853741|FG001|Overall Study|Lost to Follow-up|1|||
94562200|NCT02021643|323853742|FG002|Overall Study|Lost to Follow-up|0|||
94562201|NCT02021643|323853743|FG003|Overall Study|Lost to Follow-up|0|||
94562202|NCT02021643|323853740|FG000|Overall Study|Withdrew Consent|0|||
94562203|NCT02021643|323853741|FG001|Overall Study|Withdrew Consent|1|||
94345714|NCT03267576|323046033|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
94345715|NCT03267576|323046032|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
94345716|NCT03267576|323046033|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
94345717|NCT01369069|323046034|FG000|Overall Study|Lost to Follow-up|8|||
94562204|NCT02021643|323853742|FG002|Overall Study|Withdrew Consent|0|||
94562205|NCT02021643|323853743|FG003|Overall Study|Withdrew Consent|0|||
94562206|NCT01461707|323853744|FG000|Overall Study|Withdrawal by Subject|1|||
94562207|NCT01461707|323853745|FG001|Overall Study|Withdrawal by Subject|0|||
94562208|NCT01450761|323853746|FG000|Randomization|Subject no longer meets study criteria|1|||
94562209|NCT01450761|323853747|FG001|Randomization|Subject no longer meets study criteria|2|||
94562210|NCT01450761|323853746|FG000|Randomization|Withdrawal by Subject|2|||
94562211|NCT01450761|323853747|FG001|Randomization|Withdrawal by Subject|0|||
94562212|NCT01450761|323853746|FG000|Randomization|Disease progression|0|||
94562213|NCT01450761|323853747|FG001|Randomization|Disease progression|2|||
94562214|NCT01450761|323853746|FG000|Randomization|Adverse Event unrelated to study drug|1|||
94562215|NCT01450761|323853747|FG001|Randomization|Adverse Event unrelated to study drug|0|||
94562216|NCT01450761|323853746|FG000|Randomization|Other|0|||
94562217|NCT01450761|323853747|FG001|Randomization|Other|1|||
94562218|NCT01450761|323853746|FG000|Lead-in Chemotherapy|Disease progression|33|||
94562219|NCT01450761|323853747|FG001|Lead-in Chemotherapy|Disease progression|32|||
94562220|NCT01450761|323853746|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
94562221|NCT01450761|323853747|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
94562222|NCT01450761|323853746|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
94562223|NCT01450761|323853747|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
94562224|NCT01450761|323853746|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
94562225|NCT01450761|323853747|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
94562226|NCT01450761|323853746|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
94562227|NCT01450761|323853747|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
94562228|NCT01450761|323853746|FG000|Lead-in Chemotherapy|Death|3|||
94345718|NCT01369069|323046035|FG001|Overall Study|Lost to Follow-up|9|||
94562229|NCT01450761|323853747|FG001|Lead-in Chemotherapy|Death|3|||
94562230|NCT01450761|323853746|FG000|Lead-in Chemotherapy|Other|2|||
94562231|NCT01450761|323853747|FG001|Lead-in Chemotherapy|Other|2|||
94562232|NCT01450761|323853746|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
94562233|NCT01450761|323853747|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
94562234|NCT01450761|323853746|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
94562235|NCT01450761|323853747|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
94562236|NCT01450761|323853746|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
94562237|NCT01450761|323853747|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
94562238|NCT01450761|323853746|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
94562239|NCT01450761|323853747|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
94562240|NCT01450761|323853746|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
94562241|NCT01450761|323853747|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
94562242|NCT01450761|323853746|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
94562243|NCT01450761|323853747|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
94562244|NCT01450761|323853746|FG000|Treatment With Blinded Study Therapy|Death|5|||
94562245|NCT01450761|323853747|FG001|Treatment With Blinded Study Therapy|Death|6|||
94562246|NCT01450761|323853746|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
94562247|NCT01450761|323853747|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
94562248|NCT01450761|323853746|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
94562249|NCT01450761|323853747|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
94562250|NCT01450761|323853746|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
94562251|NCT01450761|323853747|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
94562252|NCT01450761|323853746|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
94562253|NCT01450761|323853747|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
94562254|NCT01450761|323853746|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
94562255|NCT01450761|323853747|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
94562256|NCT01450761|323853746|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
94562257|NCT01450761|323853747|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
94450099|NCT00994461|323435369|FG000|Overall Study|Adverse Event|2|||
94562258|NCT01450761|323853746|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
94657675|NCT00413413|324204362|FG000|Double-Blind|Lost to Follow-up|3|||
94657676|NCT00413413|324204363|FG001|Double-Blind|Lost to Follow-up|4|||
94657677|NCT00413413|324204364|FG002|Double-Blind|Lost to Follow-up|2|||
94657678|NCT01732835|324204371|FG000|6-month Primary Endpoint|Did not receive device|19|||
94657679|NCT01732835|324204371|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
94657680|NCT01732835|324204371|FG000|6-month Primary Endpoint|Adverse Event|3|||
94657681|NCT01732835|324204371|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
94657682|NCT01732835|324204371|FG000|2-year Extended Follow-up|Adverse Event|3|||
94657683|NCT01732835|324204371|FG000|2-year Extended Follow-up|Death|1|||
94657684|NCT02673697|324204372|FG000|Overall Study|Adverse Event|2|||
94657685|NCT02673697|324204373|FG001|Overall Study|Adverse Event|0|||
94657686|NCT02673697|324204372|FG000|Overall Study|Death|32|||
94657687|NCT02673697|324204373|FG001|Overall Study|Death|24|||
94657688|NCT02673697|324204372|FG000|Overall Study|Lost to Follow-up|5|||
94657689|NCT02673697|324204373|FG001|Overall Study|Lost to Follow-up|2|||
94657690|NCT02673697|324204372|FG000|Overall Study|Physician Decision|2|||
94657691|NCT02673697|324204373|FG001|Overall Study|Physician Decision|1|||
94657692|NCT02673697|324204372|FG000|Overall Study|Withdrawal by Subject|10|||
94657693|NCT02673697|324204373|FG001|Overall Study|Withdrawal by Subject|7|||
94657694|NCT02673697|324204372|FG000|Overall Study|Change subj medical status|1|||
94657695|NCT02673697|324204373|FG001|Overall Study|Change subj medical status|2|||
94657696|NCT02673697|324204372|FG000|Overall Study|Explant|10|||
94657697|NCT02673697|324204373|FG001|Overall Study|Explant|5|||
94657698|NCT02673697|324204372|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
94657699|NCT02673697|324204373|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
94657700|NCT00437489|324204374|FG000|Overall Study|Study terminated by sponsor|23|||
94657701|NCT00437489|324204375|FG001|Overall Study|Study terminated by sponsor|21|||
94657702|NCT00437489|324204374|FG000|Overall Study|Lost to Follow-up|0|||
94657703|NCT00437489|324204375|FG001|Overall Study|Lost to Follow-up|1|||
94657704|NCT03893448|324204383|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
94562259|NCT01450761|323853747|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
94562260|NCT01818596|323853758|FG000|Overall Study|Enrolled but Not Treated|4|||
94562261|NCT01818596|323853759|FG001|Overall Study|Enrolled but Not Treated|0|||
94562262|NCT01818596|323853758|FG000|Overall Study|Adverse Event|7|||
94562263|NCT01818596|323853759|FG001|Overall Study|Adverse Event|0|||
94562264|NCT01818596|323853758|FG000|Overall Study|Death|3|||
94562265|NCT01818596|323853759|FG001|Overall Study|Death|0|||
94562266|NCT01818596|323853758|FG000|Overall Study|Investigator's Discretion|4|||
94562267|NCT01818596|323853759|FG001|Overall Study|Investigator's Discretion|0|||
94562268|NCT01818596|323853758|FG000|Overall Study|Protocol Violation|1|||
94562269|NCT01818596|323853759|FG001|Overall Study|Protocol Violation|0|||
94562270|NCT01818596|323853758|FG000|Overall Study|Withdrew Consent|5|||
94562271|NCT01818596|323853759|FG001|Overall Study|Withdrew Consent|0|||
94562272|NCT01818596|323853758|FG000|Overall Study|Lost to Follow-up|7|||
94562273|NCT01818596|323853759|FG001|Overall Study|Lost to Follow-up|0|||
94562274|NCT02073682|323853770|FG000|Overall Study|Low Creatinine Clearance|1|||
94562275|NCT02073682|323853771|FG001|Overall Study|Low Creatinine Clearance|2|||
94562276|NCT02073682|323853770|FG000|Overall Study|Death|86|||
94562277|NCT02073682|323853771|FG001|Overall Study|Death|100|||
94562278|NCT02073682|323853770|FG000|Overall Study|Cancer Cured|10|||
94562279|NCT02073682|323853771|FG001|Overall Study|Cancer Cured|15|||
94562280|NCT02073682|323853770|FG000|Overall Study|ID: Patient Noncompliance|1|||
94562281|NCT02073682|323853771|FG001|Overall Study|ID: Patient Noncompliance|2|||
94562282|NCT02073682|323853770|FG000|Overall Study|ID: Palliative Treatment Only|10|||
94562283|NCT02073682|323853771|FG001|Overall Study|ID: Palliative Treatment Only|7|||
94562284|NCT02073682|323853770|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
94562285|NCT02073682|323853771|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
94562286|NCT02073682|323853770|FG000|Overall Study|Platelet Count <50,000/mL|1|||
94562287|NCT02073682|323853771|FG001|Overall Study|Platelet Count <50,000/mL|2|||
94562288|NCT02073682|323853770|FG000|Overall Study|Surgery/Medical Procedure|3|||
94562289|NCT02073682|323853771|FG001|Overall Study|Surgery/Medical Procedure|1|||
94562290|NCT02073682|323853770|FG000|Overall Study|Withdrawal by Subject|6|||
94562291|NCT02073682|323853771|FG001|Overall Study|Withdrawal by Subject|8|||
94562292|NCT02073682|323853770|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
94562293|NCT02073682|323853771|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
94562294|NCT02073682|323853770|FG000|Overall Study|Cancer Progression|53|||
94562295|NCT02073682|323853771|FG001|Overall Study|Cancer Progression|33|||
94562296|NCT02073682|323853770|FG000|Overall Study|Protocol Violation|1|||
94562297|NCT02073682|323853771|FG001|Overall Study|Protocol Violation|0|||
94562298|NCT02073682|323853770|FG000|Overall Study|Adverse Event|79|||
94562299|NCT02073682|323853771|FG001|Overall Study|Adverse Event|62|||
94562300|NCT02073682|323853770|FG000|Overall Study|No reason provided|11|||
94562301|NCT02073682|323853771|FG001|Overall Study|No reason provided|9|||
94562302|NCT02073682|323853770|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
94562303|NCT02073682|323853771|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
94562304|NCT02073682|323853770|FG000|Overall Study|Lost to Follow-up|1|||
94562305|NCT02073682|323853771|FG001|Overall Study|Lost to Follow-up|1|||
94562306|NCT02073682|323853770|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
94562307|NCT02073682|323853771|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
94562308|NCT03461146|323853772|FG000|Overall Study|Adverse Event|2|||
94562309|NCT03461146|323853772|FG000|Overall Study|Physician Decision|1|||
94562310|NCT00855816|323853775|FG000|Overall Study|Withdrawal by Subject|22|||
94562311|NCT00855816|323853776|FG001|Overall Study|Withdrawal by Subject|15|||
94562312|NCT00855816|323853775|FG000|Overall Study|Lost to Follow-up|3|||
94657705|NCT03893448|324204384|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
94657706|NCT03893448|324204383|FG000|Overall Study|Physician Decision|8|||
94657707|NCT03893448|324204384|FG001|Overall Study|Physician Decision|14|||
94657708|NCT03893448|324204383|FG000|Overall Study|Lost to Follow-up|34|||
94657709|NCT03893448|324204384|FG001|Overall Study|Lost to Follow-up|27|||
94657710|NCT03893448|324204383|FG000|Overall Study|Death|1|||
94233784|NCT02165826|322650247|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
94233785|NCT02165826|322650248|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
94345719|NCT01369069|323046034|FG000|Overall Study|Withdrawal by Subject|9|||
94562313|NCT00855816|323853776|FG001|Overall Study|Lost to Follow-up|5|||
94562314|NCT00855816|323853775|FG000|Overall Study|Death|1|||
94562315|NCT00855816|323853776|FG001|Overall Study|Death|0|||
94562316|NCT00855816|323853775|FG000|Overall Study|Became ineligible|0|||
94562317|NCT00855816|323853776|FG001|Overall Study|Became ineligible|1|||
94562318|NCT01076036|323853777|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
94562319|NCT00726232|323853779|FG000|Initial Phase (Dose-finding)|Death|0|||
94562320|NCT00726232|323853780|FG001|Initial Phase (Dose-finding)|Death|0|||
94562321|NCT00726232|323853781|FG002|Initial Phase (Dose-finding)|Death|0|||
94562322|NCT00726232|323853782|FG003|Initial Phase (Dose-finding)|Death|0|||
94562323|NCT00726232|323853783|FG004|Initial Phase (Dose-finding)|Death|1|||
94562324|NCT00726232|323853784|FG005|Initial Phase (Dose-finding)|Death|0|||
94562325|NCT00726232|323853785|FG006|Initial Phase (Dose-finding)|Death|0|||
94657711|NCT03893448|324204384|FG001|Overall Study|Death|0|||
94562326|NCT00726232|323853786|FG007|Initial Phase (Dose-finding)|Death|0|||
94562327|NCT00726232|323853779|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
94562328|NCT00726232|323853780|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
94562329|NCT00726232|323853781|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
94562330|NCT00726232|323853782|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
94562331|NCT00726232|323853783|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
94562332|NCT00726232|323853784|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
94562333|NCT00726232|323853785|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
94562334|NCT00726232|323853786|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
94562335|NCT00726232|323853779|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
94562336|NCT00726232|323853780|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
94562337|NCT00726232|323853781|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
94562338|NCT00726232|323853782|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
94562339|NCT00726232|323853783|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
94562340|NCT00726232|323853784|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
94562341|NCT00726232|323853785|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
94562342|NCT00726232|323853786|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
94562343|NCT00726232|323853779|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
94562344|NCT00726232|323853780|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
94562345|NCT00726232|323853781|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
94562346|NCT00726232|323853782|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
94562347|NCT00726232|323853783|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
94562348|NCT00726232|323853784|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
94562349|NCT00726232|323853785|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
94562350|NCT00726232|323853786|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
94562351|NCT00726232|323853779|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
94562352|NCT00726232|323853780|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
94562353|NCT00726232|323853781|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
94562354|NCT00726232|323853782|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
94562355|NCT00726232|323853783|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
94562356|NCT00726232|323853784|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
94562357|NCT00726232|323853785|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
94562358|NCT00726232|323853786|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
94562359|NCT00726232|323853779|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
94562360|NCT00726232|323853780|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
94562361|NCT00726232|323853781|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
94562362|NCT00726232|323853782|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
94562363|NCT00726232|323853783|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
94233786|NCT02165826|322650246|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
94233787|NCT02165826|322650247|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
94233788|NCT02165826|322650248|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
94233789|NCT02165826|322650246|FG000|Main Treatment Period|Lost to Follow-up|4|||
94233790|NCT02165826|322650247|FG001|Main Treatment Period|Lost to Follow-up|2|||
94233791|NCT02165826|322650248|FG002|Main Treatment Period|Lost to Follow-up|1|||
94233792|NCT02165826|322650246|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
94233793|NCT02165826|322650247|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
94233794|NCT02165826|322650248|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
94233795|NCT02165826|322650246|FG000|Main Treatment Period|Lack of Efficacy|2|||
94233796|NCT02165826|322650247|FG001|Main Treatment Period|Lack of Efficacy|0|||
94233797|NCT02165826|322650248|FG002|Main Treatment Period|Lack of Efficacy|0|||
94233798|NCT02165826|322650246|FG000|Main Treatment Period|Reason Not Specified|8|||
94233799|NCT02165826|322650247|FG001|Main Treatment Period|Reason Not Specified|5|||
94233800|NCT02165826|322650248|FG002|Main Treatment Period|Reason Not Specified|16|||
94233801|NCT02165826|322650246|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
94233802|NCT02165826|322650247|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
94233803|NCT02165826|322650248|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
94233804|NCT02165826|322650246|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
94233805|NCT02165826|322650247|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
94233806|NCT02165826|322650248|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
94233807|NCT02165826|322650246|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
94233808|NCT02165826|322650247|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
94233809|NCT02165826|322650248|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
94233810|NCT02165826|322650246|FG000|Down-Titration Period|Reason Not Specified|1|||
94233811|NCT02165826|322650247|FG001|Down-Titration Period|Reason Not Specified|0|||
94562364|NCT00726232|323853784|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
94233812|NCT02165826|322650248|FG002|Down-Titration Period|Reason Not Specified|2|||
94233813|NCT02392104|322650249|FG000|Overall Study|discontinuation of warfarin|3|||
94345720|NCT01369069|323046035|FG001|Overall Study|Withdrawal by Subject|7|||
94345721|NCT02692560|323046036|FG000|Overall Study|Withdrawal by Subject|0|||
94345722|NCT02692560|323046037|FG001|Overall Study|Withdrawal by Subject|6|||
94345723|NCT03231228|323046038|FG000|Overall Study|Lost to Follow-up|2|||
94345724|NCT03231228|323046039|FG001|Overall Study|Lost to Follow-up|0|||
94345725|NCT03231228|323046038|FG000|Overall Study|Physician Decision|1|||
94345726|NCT03231228|323046039|FG001|Overall Study|Physician Decision|0|||
94345727|NCT01610414|323046040|FG000|Study Start - Month 13|Serious Adverse Event|65|||
94345728|NCT01610414|323046041|FG001|Study Start - Month 13|Serious Adverse Event|67|||
94345729|NCT01610414|323046040|FG000|Study Start - Month 13|Adverse Event|14|||
94345730|NCT01610414|323046041|FG001|Study Start - Month 13|Adverse Event|14|||
94345731|NCT01610414|323046040|FG000|Study Start - Month 13|Protocol Violation|3|||
94345732|NCT01610414|323046041|FG001|Study Start - Month 13|Protocol Violation|1|||
94562365|NCT00726232|323853785|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
94562366|NCT00726232|323853786|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
94562367|NCT00726232|323853779|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
94562368|NCT00726232|323853780|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
94562369|NCT00726232|323853781|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
94562370|NCT00726232|323853782|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
94562371|NCT00726232|323853783|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
94562372|NCT00726232|323853784|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
94562373|NCT00726232|323853785|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
94562374|NCT00726232|323853786|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
94562375|NCT00726232|323853779|FG000|Expansion Phase|Death|0|||
94562376|NCT00726232|323853780|FG001|Expansion Phase|Death|0|||
94562377|NCT00726232|323853781|FG002|Expansion Phase|Death|0|||
94562378|NCT00726232|323853782|FG003|Expansion Phase|Death|0|||
94345733|NCT01610414|323046040|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
94562379|NCT00726232|323853783|FG004|Expansion Phase|Death|0|||
94562380|NCT00726232|323853784|FG005|Expansion Phase|Death|0|||
94562381|NCT00726232|323853785|FG006|Expansion Phase|Death|0|||
94562382|NCT00726232|323853786|FG007|Expansion Phase|Death|1|||
94562383|NCT00726232|323853779|FG000|Expansion Phase|Adverse Event|0|||
94562384|NCT00726232|323853780|FG001|Expansion Phase|Adverse Event|0|||
94562385|NCT00726232|323853781|FG002|Expansion Phase|Adverse Event|0|||
94562386|NCT00726232|323853782|FG003|Expansion Phase|Adverse Event|0|||
94562387|NCT00726232|323853783|FG004|Expansion Phase|Adverse Event|0|||
94562388|NCT00726232|323853784|FG005|Expansion Phase|Adverse Event|0|||
94562389|NCT00726232|323853785|FG006|Expansion Phase|Adverse Event|6|||
94562390|NCT00726232|323853786|FG007|Expansion Phase|Adverse Event|11|||
94562391|NCT00726232|323853779|FG000|Expansion Phase|Withdrawal by Subject|0|||
94562392|NCT00726232|323853780|FG001|Expansion Phase|Withdrawal by Subject|0|||
94562393|NCT00726232|323853781|FG002|Expansion Phase|Withdrawal by Subject|0|||
94562394|NCT00726232|323853782|FG003|Expansion Phase|Withdrawal by Subject|0|||
94562395|NCT00726232|323853783|FG004|Expansion Phase|Withdrawal by Subject|0|||
94562396|NCT00726232|323853784|FG005|Expansion Phase|Withdrawal by Subject|0|||
94562397|NCT00726232|323853785|FG006|Expansion Phase|Withdrawal by Subject|2|||
94562398|NCT00726232|323853786|FG007|Expansion Phase|Withdrawal by Subject|3|||
94562399|NCT00726232|323853779|FG000|Expansion Phase|Disease progression|0|||
94562400|NCT00726232|323853780|FG001|Expansion Phase|Disease progression|0|||
94562401|NCT00726232|323853781|FG002|Expansion Phase|Disease progression|0|||
94562402|NCT00726232|323853782|FG003|Expansion Phase|Disease progression|0|||
94562403|NCT00726232|323853783|FG004|Expansion Phase|Disease progression|0|||
94562404|NCT00726232|323853784|FG005|Expansion Phase|Disease progression|0|||
94562405|NCT00726232|323853785|FG006|Expansion Phase|Disease progression|4|||
94562406|NCT00726232|323853786|FG007|Expansion Phase|Disease progression|0|||
94562407|NCT00726232|323853779|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
94562408|NCT00726232|323853780|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
94562409|NCT00726232|323853781|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
94562410|NCT00726232|323853782|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
94233814|NCT02392104|322650249|FG000|Overall Study|bleeding event|1|||
94345734|NCT01610414|323046041|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
94345735|NCT01610414|323046040|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
94562411|NCT00726232|323853783|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
94562412|NCT00726232|323853784|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
94562413|NCT00726232|323853785|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
94562414|NCT00726232|323853786|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
94562415|NCT00726232|323853779|FG000|Expansion Phase|Per Investigator: lack of response|0|||
94562416|NCT00726232|323853780|FG001|Expansion Phase|Per Investigator: lack of response|0|||
94562417|NCT00726232|323853781|FG002|Expansion Phase|Per Investigator: lack of response|0|||
94562418|NCT00726232|323853782|FG003|Expansion Phase|Per Investigator: lack of response|0|||
94562419|NCT00726232|323853783|FG004|Expansion Phase|Per Investigator: lack of response|0|||
94562420|NCT00726232|323853784|FG005|Expansion Phase|Per Investigator: lack of response|0|||
94562421|NCT00726232|323853785|FG006|Expansion Phase|Per Investigator: lack of response|1|||
94450100|NCT00994461|323435370|FG001|Overall Study|Adverse Event|1|||
94450101|NCT00994461|323435371|FG002|Overall Study|Adverse Event|0|||
94450102|NCT00237458|323435372|FG000|Overall Study|Lack of Efficacy|1|||
94450103|NCT00237458|323435372|FG000|Overall Study|Adverse Event|1|||
94450104|NCT00237458|323435372|FG000|Overall Study|Withdrawal by Subject|1|||
94450105|NCT00952068|323435374|FG000|Overall Study|Adverse Event|3|||
94450106|NCT00952068|323435374|FG000|Overall Study|Withdrawal by Subject|4|||
94450107|NCT00488644|323435375|FG000|Overall Study|Not Eligible|1|||
94450108|NCT00488644|323435375|FG000|Overall Study|Not Evaluable|1|||
94450109|NCT02522884|323435382|FG000|Overall Study|Withdrawal by Subject|6|||
94450110|NCT02522884|323435382|FG000|Overall Study|Death|3|||
94450111|NCT02522884|323435382|FG000|Overall Study|Missed 12-month Follow-up|9|||
94450112|NCT02347813|323435384|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
94450113|NCT02347813|323435385|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
94450114|NCT02347813|323435384|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
94450115|NCT02347813|323435385|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
94450116|NCT00086619|323435386|FG000|Overall Study|Withdrawal by Subject|6|||
94450117|NCT00086619|323435387|FG001|Overall Study|Withdrawal by Subject|6|||
94450118|NCT00086619|323435386|FG000|Overall Study|Adverse Event|8|||
94450119|NCT00086619|323435387|FG001|Overall Study|Adverse Event|10|||
94450120|NCT00086619|323435386|FG000|Overall Study|Protocol Violation|1|||
94450121|NCT00086619|323435387|FG001|Overall Study|Protocol Violation|1|||
94450122|NCT00489918|323435388|FG000|Overall Study|Withdrawal by Subject|2|||
94450123|NCT00489918|323435389|FG001|Overall Study|Withdrawal by Subject|1|||
94450124|NCT00489918|323435390|FG002|Overall Study|Withdrawal by Subject|1|||
94450125|NCT00489918|323435391|FG003|Overall Study|Withdrawal by Subject|0|||
94450126|NCT00489918|323435392|FG004|Overall Study|Withdrawal by Subject|1|||
94450127|NCT00489918|323435388|FG000|Overall Study|Adverse Event|0|||
94450128|NCT00489918|323435389|FG001|Overall Study|Adverse Event|1|||
94450129|NCT00489918|323435390|FG002|Overall Study|Adverse Event|1|||
94450130|NCT00489918|323435391|FG003|Overall Study|Adverse Event|0|||
94450131|NCT00489918|323435392|FG004|Overall Study|Adverse Event|0|||
94450132|NCT00489918|323435388|FG000|Overall Study|Lost to Follow-up|0|||
94450133|NCT00489918|323435389|FG001|Overall Study|Lost to Follow-up|0|||
94450134|NCT00489918|323435390|FG002|Overall Study|Lost to Follow-up|1|||
94450135|NCT00489918|323435391|FG003|Overall Study|Lost to Follow-up|1|||
94450136|NCT00489918|323435392|FG004|Overall Study|Lost to Follow-up|0|||
94450137|NCT00489918|323435388|FG000|Overall Study|Physician Decision|0|||
94450138|NCT00489918|323435389|FG001|Overall Study|Physician Decision|0|||
94450139|NCT00489918|323435390|FG002|Overall Study|Physician Decision|1|||
94450140|NCT00489918|323435391|FG003|Overall Study|Physician Decision|0|||
94450141|NCT00489918|323435392|FG004|Overall Study|Physician Decision|0|||
94450142|NCT01209520|323435394|FG000|Overall Study|Withdrawal by Subject|3|||
94450143|NCT02654977|323435397|FG000|Overall Study|Death|1|||
94450144|NCT02654977|323435397|FG000|Overall Study|Lost to Follow-up|1|||
94450145|NCT02654977|323435397|FG000|Overall Study|Adverse Event|1|||
94450146|NCT02654977|323435397|FG000|Overall Study|Withdrawal by Subject|1|||
94450147|NCT02654977|323435397|FG000|Overall Study|Lack of Efficacy|3|||
94450148|NCT01921101|323435398|FG000|Overall Study|Death|16|||
94450149|NCT01921101|323435399|FG001|Overall Study|Death|6|||
94450150|NCT03850483|323435402|FG000|Treatment for Stage 1|Adverse Event|1|||
94450151|NCT03850483|323435403|FG001|Treatment for Stage 1|Adverse Event|1|||
94450152|NCT03850483|323435404|FG002|Treatment for Stage 1|Adverse Event|3|||
94450153|NCT03850483|323435405|FG003|Treatment for Stage 1|Adverse Event|0|||
94450154|NCT03850483|323435406|FG004|Treatment for Stage 1|Adverse Event|2|||
94450155|NCT03850483|323435407|FG005|Treatment for Stage 1|Adverse Event|0|||
94450156|NCT03850483|323435408|FG006|Treatment for Stage 1|Adverse Event|2|||
94450157|NCT03850483|323435409|FG007|Treatment for Stage 1|Adverse Event|2|||
94450158|NCT03850483|323435410|FG008|Treatment for Stage 1|Adverse Event|0|||
94450159|NCT03850483|323435411|FG009|Treatment for Stage 1|Adverse Event|0|||
94450160|NCT03850483|323435402|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
94562422|NCT00726232|323853786|FG007|Expansion Phase|Per Investigator: lack of response|7|||
94562423|NCT00726232|323853779|FG000|Expansion Phase|Unspecified reason|0|||
94562424|NCT00726232|323853780|FG001|Expansion Phase|Unspecified reason|0|||
94562425|NCT00726232|323853781|FG002|Expansion Phase|Unspecified reason|0|||
94562426|NCT00726232|323853782|FG003|Expansion Phase|Unspecified reason|0|||
94562427|NCT00726232|323853783|FG004|Expansion Phase|Unspecified reason|0|||
94450161|NCT03850483|323435403|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
94450162|NCT03850483|323435404|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
94450163|NCT03850483|323435405|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
94450164|NCT03850483|323435406|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
94450165|NCT03850483|323435407|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
94450166|NCT03850483|323435408|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
94450167|NCT03850483|323435409|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
94450168|NCT03850483|323435410|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
94450169|NCT03850483|323435411|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
94450170|NCT03850483|323435402|FG000|Treatment for Stage 1|Protocol Violation|1|||
94450171|NCT03850483|323435403|FG001|Treatment for Stage 1|Protocol Violation|0|||
94450172|NCT03850483|323435404|FG002|Treatment for Stage 1|Protocol Violation|0|||
94450173|NCT03850483|323435405|FG003|Treatment for Stage 1|Protocol Violation|0|||
94450174|NCT03850483|323435406|FG004|Treatment for Stage 1|Protocol Violation|0|||
94450175|NCT03850483|323435407|FG005|Treatment for Stage 1|Protocol Violation|0|||
94450176|NCT03850483|323435408|FG006|Treatment for Stage 1|Protocol Violation|1|||
94450177|NCT03850483|323435409|FG007|Treatment for Stage 1|Protocol Violation|0|||
94450178|NCT03850483|323435410|FG008|Treatment for Stage 1|Protocol Violation|0|||
94450179|NCT03850483|323435411|FG009|Treatment for Stage 1|Protocol Violation|0|||
94450180|NCT03850483|323435402|FG000|Treatment for Stage 1|Physician Decision|0|||
94450181|NCT03850483|323435403|FG001|Treatment for Stage 1|Physician Decision|0|||
94450182|NCT03850483|323435404|FG002|Treatment for Stage 1|Physician Decision|0|||
94450183|NCT03850483|323435405|FG003|Treatment for Stage 1|Physician Decision|0|||
94450184|NCT03850483|323435406|FG004|Treatment for Stage 1|Physician Decision|0|||
94450185|NCT03850483|323435407|FG005|Treatment for Stage 1|Physician Decision|1|||
94450186|NCT03850483|323435408|FG006|Treatment for Stage 1|Physician Decision|0|||
94450187|NCT03850483|323435409|FG007|Treatment for Stage 1|Physician Decision|0|||
94450188|NCT03850483|323435410|FG008|Treatment for Stage 1|Physician Decision|0|||
94450189|NCT03850483|323435411|FG009|Treatment for Stage 1|Physician Decision|0|||
94450190|NCT03850483|323435402|FG000|Treatment for Stage 1|Other|0|||
94450191|NCT03850483|323435403|FG001|Treatment for Stage 1|Other|0|||
94450192|NCT03850483|323435404|FG002|Treatment for Stage 1|Other|0|||
94450193|NCT03850483|323435405|FG003|Treatment for Stage 1|Other|0|||
94450194|NCT03850483|323435406|FG004|Treatment for Stage 1|Other|2|||
94450195|NCT03850483|323435407|FG005|Treatment for Stage 1|Other|1|||
94450196|NCT03850483|323435408|FG006|Treatment for Stage 1|Other|0|||
94450197|NCT03850483|323435409|FG007|Treatment for Stage 1|Other|0|||
94450198|NCT03850483|323435410|FG008|Treatment for Stage 1|Other|0|||
94450199|NCT03850483|323435411|FG009|Treatment for Stage 1|Other|0|||
94450200|NCT03850483|323435402|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
94450201|NCT03850483|323435403|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
94450202|NCT03850483|323435404|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
94450203|NCT03850483|323435405|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
94450204|NCT03850483|323435406|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
94450205|NCT03850483|323435407|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
94450206|NCT03850483|323435408|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
94562428|NCT00726232|323853784|FG005|Expansion Phase|Unspecified reason|0|||
94562429|NCT00726232|323853785|FG006|Expansion Phase|Unspecified reason|1|||
94562430|NCT00726232|323853786|FG007|Expansion Phase|Unspecified reason|0|||
94450207|NCT03850483|323435409|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
94450208|NCT03850483|323435410|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
94450209|NCT03850483|323435411|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
94450210|NCT03850483|323435402|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
94450211|NCT03850483|323435403|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
94562431|NCT02754726|323853788|FG000|Overall Study|Progressive Disease by RECIST|13|||
94562432|NCT02754726|323853788|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
94562433|NCT02754726|323853788|FG000|Overall Study|Clinical Disease Progression|5|||
94562434|NCT02754726|323853788|FG000|Overall Study|Adverse Event|3|||
94562435|NCT02754726|323853788|FG000|Overall Study|Withdrawal by Subject|1|||
94562436|NCT02754726|323853788|FG000|Overall Study|Tolerability|1|||
94562437|NCT05292131|323853789|FG000|Overall Study|Lost to Follow-up|1|||
94562438|NCT05292131|323853790|FG001|Overall Study|Lost to Follow-up|1|||
94562439|NCT05292131|323853789|FG000|Overall Study|Withdrawal by Subject|0|||
94562440|NCT05292131|323853790|FG001|Overall Study|Withdrawal by Subject|1|||
94345736|NCT01610414|323046041|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
94345737|NCT01610414|323046040|FG000|Study Start - Month 13|Lost to Follow-up|4|||
94345738|NCT01610414|323046041|FG001|Study Start - Month 13|Lost to Follow-up|6|||
94345739|NCT01610414|323046040|FG000|Study Start - Month 13|Suspected HZ episode|1|||
94562441|NCT03705559|323853793|FG000|Overall Study|COVID Shut down|1|||
94345740|NCT01610414|323046041|FG001|Study Start - Month 13|Suspected HZ episode|3|||
94345741|NCT01610414|323046040|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
94345742|NCT01610414|323046041|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
94345743|NCT01610414|323046040|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
94345744|NCT01610414|323046041|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
94345745|NCT01610414|323046040|FG000|Month 13 - Month 25|Adverse Event|8|||
94345746|NCT01610414|323046041|FG001|Month 13 - Month 25|Adverse Event|4|||
94345747|NCT01610414|323046040|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
94345748|NCT01610414|323046041|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
94345749|NCT01610414|323046040|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
94345750|NCT01610414|323046041|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
94345751|NCT01610414|323046040|FG000|Month 13 - Month 25|Protocol Violation|0|||
94345752|NCT01610414|323046041|FG001|Month 13 - Month 25|Protocol Violation|2|||
94345753|NCT01610414|323046040|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
94345754|NCT01610414|323046041|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
94345755|NCT01610414|323046040|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
94345756|NCT01610414|323046041|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
94345757|NCT01610414|323046040|FG000|After Month 25|Study end not reached|48|||
94345758|NCT01610414|323046041|FG001|After Month 25|Study end not reached|53|||
94345759|NCT02382276|323046042|FG000|Overall Study|Withdrawal by Subject|4|||
94345760|NCT02382276|323046043|FG001|Overall Study|Withdrawal by Subject|8|||
94345761|NCT02382276|323046044|FG002|Overall Study|Withdrawal by Subject|5|||
94345762|NCT02382276|323046042|FG000|Overall Study|Adverse Event|7|||
94345763|NCT02382276|323046043|FG001|Overall Study|Adverse Event|2|||
94345764|NCT02382276|323046044|FG002|Overall Study|Adverse Event|32|||
94345765|NCT02382276|323046042|FG000|Overall Study|Physician Decision|0|||
94345766|NCT02382276|323046043|FG001|Overall Study|Physician Decision|0|||
94345767|NCT02382276|323046044|FG002|Overall Study|Physician Decision|2|||
94345768|NCT01646255|323046045|FG000|Overall Study|Adverse Event|7|||
94345769|NCT01646255|323046046|FG001|Overall Study|Adverse Event|8|||
94345770|NCT01646255|323046045|FG000|Overall Study|Lack of Efficacy|2|||
94345771|NCT01646255|323046046|FG001|Overall Study|Lack of Efficacy|0|||
94345772|NCT01646255|323046045|FG000|Overall Study|Withdrawal by Subject|10|||
94562442|NCT00837213|323853795|FG000|Overall Study|Lost to Follow-up|3|||
94562443|NCT00837213|323853796|FG001|Overall Study|Lost to Follow-up|2|||
94562444|NCT00837213|323853795|FG000|Overall Study|Withdrawal by Subject|2|||
94562445|NCT00837213|323853796|FG001|Overall Study|Withdrawal by Subject|2|||
94562446|NCT00837213|323853795|FG000|Overall Study|not stated|1|||
94562447|NCT00837213|323853796|FG001|Overall Study|not stated|1|||
94562448|NCT02915263|323853801|FG000|Overall Study|Covid|3|||
94233815|NCT02392104|322650249|FG000|Overall Study|transferred care to another doctor|2|||
94233816|NCT02392104|322650249|FG000|Overall Study|INR goal range changed|1|||
94233817|NCT02392104|322650249|FG000|Overall Study|admitted to skilled nursing facility|3|||
94233818|NCT02392104|322650249|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
94233819|NCT04547023|322650250|FG000|Overall Study|Did Not Receive Intervention|3|||
94562449|NCT02915263|323853802|FG001|Overall Study|Covid|2|||
94562450|NCT03672292|323853806|FG000|Overall Study|Adverse Event|3|||
94562451|NCT03672292|323853807|FG001|Overall Study|Adverse Event|1|||
94562452|NCT03672292|323853806|FG000|Overall Study|Physician Decision|0|||
94562453|NCT03672292|323853807|FG001|Overall Study|Physician Decision|1|||
94562454|NCT03672292|323853806|FG000|Overall Study|Withdrawal by Subject|1|||
94562455|NCT03672292|323853807|FG001|Overall Study|Withdrawal by Subject|2|||
94562456|NCT01369784|323853810|FG000|Overall Study|Protocol Violation|12|||
94562457|NCT00566852|323853813|FG000|Overall Study|Protocol Violation|22|||
94562458|NCT00566852|323853814|FG001|Overall Study|Protocol Violation|24|||
94562459|NCT00566852|323853813|FG000|Overall Study|Death|95|||
94562460|NCT00566852|323853814|FG001|Overall Study|Death|78|||
94562461|NCT00566852|323853813|FG000|Overall Study|Withdrawal by Subject|30|||
94562462|NCT00566852|323853814|FG001|Overall Study|Withdrawal by Subject|25|||
94562463|NCT00566852|323853813|FG000|Overall Study|Patient refusal|37|||
94562464|NCT00566852|323853814|FG001|Overall Study|Patient refusal|37|||
94562465|NCT00566852|323853813|FG000|Overall Study|Not tested due to disability|6|||
94562466|NCT00566852|323853814|FG001|Overall Study|Not tested due to disability|12|||
94562467|NCT00566852|323853813|FG000|Overall Study|Missing reason not specified|1|||
94562468|NCT00566852|323853814|FG001|Overall Study|Missing reason not specified|2|||
94562469|NCT00566852|323853813|FG000|Overall Study|Missing reason not reported|16|||
94562470|NCT00566852|323853814|FG001|Overall Study|Missing reason not reported|20|||
94562471|NCT00770601|323853815|FG000|Overall Study|Withdrawal by Subject|1|||
94562472|NCT04739436|323853816|FG000|Overall Study|Lost to Follow-up|21|||
94562473|NCT04739436|323853817|FG001|Overall Study|Lost to Follow-up|23|||
94562474|NCT04739436|323853816|FG000|Overall Study|Withdrawal by Subject|4|||
94562475|NCT04739436|323853817|FG001|Overall Study|Withdrawal by Subject|6|||
94562476|NCT04739436|323853816|FG000|Overall Study|not randomized properly|1|||
94562477|NCT04739436|323853817|FG001|Overall Study|not randomized properly|0|||
94562478|NCT02576795|323853818|FG000|Overall Study|Lost to Follow-up|0|||
94562479|NCT02576795|323853819|FG001|Overall Study|Lost to Follow-up|0|||
94562480|NCT02576795|323853820|FG002|Overall Study|Lost to Follow-up|1|||
94562481|NCT02576795|323853821|FG003|Overall Study|Lost to Follow-up|0|||
94562482|NCT03724890|323853822|FG000|Overall Study|Death|2|||
94562483|NCT03724890|323853823|FG001|Overall Study|Death|6|||
94562484|NCT03724890|323853824|FG002|Overall Study|Death|3|||
94562485|NCT03724890|323853825|FG003|Overall Study|Death|5|||
94562486|NCT03724890|323853826|FG004|Overall Study|Death|2|||
94562487|NCT03724890|323853827|FG005|Overall Study|Death|0|||
94562488|NCT03724890|323853828|FG006|Overall Study|Death|2|||
94562489|NCT03724890|323853829|FG007|Overall Study|Death|3|||
94562490|NCT03724890|323853830|FG008|Overall Study|Death|4|||
94562491|NCT03724890|323853831|FG009|Overall Study|Death|2|||
94562492|NCT03724890|323853832|FG010|Overall Study|Death|2|||
94562493|NCT03724890|323853822|FG000|Overall Study|Lost to Follow-up|0|||
94562494|NCT03724890|323853823|FG001|Overall Study|Lost to Follow-up|3|||
94233820|NCT04547023|322650251|FG001|Overall Study|Did Not Receive Intervention|2|||
94233821|NCT04547023|322650250|FG000|Overall Study|Lost to Follow-up|1|||
94233822|NCT04547023|322650251|FG001|Overall Study|Lost to Follow-up|1|||
94233823|NCT02394665|322650252|FG000|Overall Study|Physician Decision|1|||
94233824|NCT02394665|322650253|FG001|Overall Study|Physician Decision|0|||
94233825|NCT02394665|322650254|FG002|Overall Study|Physician Decision|0|||
94233826|NCT02636608|322650255|FG000|Overall Study|Failure to Return|4|||
94233827|NCT02636608|322650255|FG000|Overall Study|Insufficient Virological Response|1|||
94233828|NCT02636608|322650255|FG000|Overall Study|Death|3|||
94233829|NCT02636608|322650255|FG000|Overall Study|Other|2|||
94233830|NCT02636608|322650255|FG000|Overall Study|Did Not Receive Treatment|1|||
94233831|NCT04147858|322650257|FG000|Overall Study|Adverse Event|6|||
94233832|NCT04147858|322650258|FG001|Overall Study|Adverse Event|6|||
94233833|NCT04147858|322650259|FG002|Overall Study|Adverse Event|6|||
94562495|NCT03724890|323853824|FG002|Overall Study|Lost to Follow-up|0|||
94562496|NCT03724890|323853825|FG003|Overall Study|Lost to Follow-up|1|||
94562497|NCT03724890|323853826|FG004|Overall Study|Lost to Follow-up|2|||
94562498|NCT03724890|323853827|FG005|Overall Study|Lost to Follow-up|2|||
94562499|NCT03724890|323853828|FG006|Overall Study|Lost to Follow-up|1|||
94233834|NCT04147858|322650257|FG000|Overall Study|Lack of Efficacy|3|||
94233835|NCT04147858|322650258|FG001|Overall Study|Lack of Efficacy|3|||
94562500|NCT03724890|323853829|FG007|Overall Study|Lost to Follow-up|0|||
94562501|NCT03724890|323853830|FG008|Overall Study|Lost to Follow-up|2|||
94562502|NCT03724890|323853831|FG009|Overall Study|Lost to Follow-up|0|||
94562503|NCT03724890|323853832|FG010|Overall Study|Lost to Follow-up|0|||
94562504|NCT03724890|323853822|FG000|Overall Study|Withdrawal by Subject|1|||
94562505|NCT03724890|323853823|FG001|Overall Study|Withdrawal by Subject|2|||
94562506|NCT03724890|323853824|FG002|Overall Study|Withdrawal by Subject|1|||
94562507|NCT03724890|323853825|FG003|Overall Study|Withdrawal by Subject|0|||
94562508|NCT03724890|323853826|FG004|Overall Study|Withdrawal by Subject|0|||
94233836|NCT04147858|322650259|FG002|Overall Study|Lack of Efficacy|1|||
94233837|NCT04147858|322650257|FG000|Overall Study|Lost to Follow-up|1|||
94233838|NCT04147858|322650258|FG001|Overall Study|Lost to Follow-up|6|||
94233839|NCT04147858|322650259|FG002|Overall Study|Lost to Follow-up|2|||
94562509|NCT03724890|323853827|FG005|Overall Study|Withdrawal by Subject|1|||
94562510|NCT03724890|323853828|FG006|Overall Study|Withdrawal by Subject|0|||
94562511|NCT03724890|323853829|FG007|Overall Study|Withdrawal by Subject|0|||
94562512|NCT03724890|323853830|FG008|Overall Study|Withdrawal by Subject|2|||
94562513|NCT03724890|323853831|FG009|Overall Study|Withdrawal by Subject|2|||
94562514|NCT03724890|323853832|FG010|Overall Study|Withdrawal by Subject|1|||
94562515|NCT03724890|323853822|FG000|Overall Study|Other|1|||
94562516|NCT03724890|323853823|FG001|Overall Study|Other|0|||
94562517|NCT03724890|323853824|FG002|Overall Study|Other|0|||
94562518|NCT03724890|323853825|FG003|Overall Study|Other|0|||
94562519|NCT03724890|323853826|FG004|Overall Study|Other|0|||
94562520|NCT03724890|323853827|FG005|Overall Study|Other|0|||
94562521|NCT03724890|323853828|FG006|Overall Study|Other|0|||
94562522|NCT03724890|323853829|FG007|Overall Study|Other|1|||
94562523|NCT03724890|323853830|FG008|Overall Study|Other|1|||
94562524|NCT03724890|323853831|FG009|Overall Study|Other|0|||
94562525|NCT03724890|323853832|FG010|Overall Study|Other|2|||
94562526|NCT04896593|323853835|FG000|Overall Study|Withdrawal by Subject|2|||
94562527|NCT04896593|323853835|FG000|Overall Study|Lost to Follow-up|1|||
94562528|NCT04896593|323853835|FG000|Overall Study|Did not complete onboarding|2|||
94562529|NCT01900652|323853838|FG000|Overall Study|Progressive Disease|1|||
94562530|NCT01900652|323853839|FG001|Overall Study|Progressive Disease|0|||
94562531|NCT01900652|323853838|FG000|Overall Study|Consent withdrawn by subject|1|||
94562532|NCT01900652|323853839|FG001|Overall Study|Consent withdrawn by subject|1|||
94562533|NCT01900652|323853838|FG000|Overall Study|Death|3|||
94562534|NCT01900652|323853839|FG001|Overall Study|Death|0|||
94562535|NCT01900652|323853838|FG000|Overall Study|Adverse Event|2|||
94562536|NCT01900652|323853839|FG001|Overall Study|Adverse Event|1|||
94562537|NCT01900652|323853838|FG000|Overall Study|Physician Decision|1|||
94562538|NCT01900652|323853839|FG001|Overall Study|Physician Decision|1|||
94562539|NCT03922620|323853840|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
94562540|NCT03922620|323853841|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
94562541|NCT03058692|323855100|FG000|Overall Study|Lost to Follow-up|2|||
94562542|NCT03058692|323855101|FG001|Overall Study|Lost to Follow-up|1|||
94562543|NCT03058692|323855100|FG000|Overall Study|Withdrawal by Subject|1|||
94562544|NCT03058692|323855101|FG001|Overall Study|Withdrawal by Subject|1|||
94562545|NCT01478971|323855103|FG000|Standard of Care Period|Adverse Event|1|||
94562546|NCT01478971|323855103|FG000|Standard of Care Period|Withdrawal by Subject|3|||
94562547|NCT01478971|323855103|FG000|Standard of Care Period|Death|8|||
94562548|NCT01478971|323855103|FG000|Standard of Care Period|Lost to Follow-up|9|||
94562549|NCT01478971|323855103|FG000|Standard of Care Period|Other|4|||
94562550|NCT01478971|323855103|FG000|Peginesatide Treatment Period|Adverse Event|1|||
94562551|NCT01478971|323855103|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
94562552|NCT01478971|323855103|FG000|Peginesatide Treatment Period|Death|4|||
94562553|NCT01478971|323855103|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
94562554|NCT01478971|323855103|FG000|Peginesatide Treatment Period|Other|4|||
94562555|NCT00584012|323855104|FG000|Overall Study|Withdrawal by Subject|1|||
94562556|NCT01698814|323855105|FG000|Overall Study|Adverse Event|0|||
94562557|NCT01698814|323855106|FG001|Overall Study|Adverse Event|2|||
94562558|NCT01698814|323855105|FG000|Overall Study|Lost to Follow-up|0|||
94562559|NCT01698814|323855106|FG001|Overall Study|Lost to Follow-up|1|||
94562560|NCT01698814|323855105|FG000|Overall Study|Pregnancy|1|||
94562561|NCT01698814|323855106|FG001|Overall Study|Pregnancy|0|||
94562562|NCT01698814|323855105|FG000|Overall Study|Randomized in error|1|||
94562563|NCT01698814|323855106|FG001|Overall Study|Randomized in error|0|||
94562564|NCT00269919|323855107|FG000|Overall Study|Other|26|||
94562565|NCT00269919|323855107|FG000|Overall Study|Started but not treated|1|||
94562566|NCT02974257|323855110|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
94562567|NCT02974257|323855111|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
94562568|NCT02974257|323855110|FG000|Overall Study|Clinical indication for thiamine|1|||
94562569|NCT02974257|323855111|FG001|Overall Study|Clinical indication for thiamine|0|||
94562570|NCT02974257|323855110|FG000|Overall Study|Already on thiamine|1|||
94562571|NCT02974257|323855111|FG001|Overall Study|Already on thiamine|0|||
94562572|NCT02974257|323855110|FG000|Overall Study|Extubated prior to study drug|0|||
94562573|NCT02974257|323855111|FG001|Overall Study|Extubated prior to study drug|1|||
94562574|NCT02974257|323855110|FG000|Overall Study|Death|0|||
94562575|NCT02974257|323855111|FG001|Overall Study|Death|1|||
94562576|NCT01641601|323855112|FG000|Overall Study|Study discontinued.|3|||
94562577|NCT01641601|323855113|FG001|Overall Study|Study discontinued.|5|||
94562578|NCT01449006|323855114|FG000|Overall Study|Lost to Follow-up|1|||
94562579|NCT01449006|323855115|FG001|Overall Study|Lost to Follow-up|0|||
94562580|NCT01449006|323855114|FG000|Overall Study|Withdrawal by Subject|1|||
94562581|NCT01449006|323855115|FG001|Overall Study|Withdrawal by Subject|0|||
94562582|NCT01449006|323855114|FG000|Overall Study|Protocol Violation|1|||
94562583|NCT01449006|323855115|FG001|Overall Study|Protocol Violation|0|||
94562584|NCT03956550|323855116|FG000|Overall Study|Sponsor decision|65|||
94562585|NCT03956550|323855117|FG001|Overall Study|Sponsor decision|66|||
94562586|NCT03956550|323855118|FG002|Overall Study|Sponsor decision|64|||
94562587|NCT03956550|323855116|FG000|Overall Study|Adverse Event|0|||
94562588|NCT03956550|323855117|FG001|Overall Study|Adverse Event|1|||
94562589|NCT03956550|323855118|FG002|Overall Study|Adverse Event|0|||
94562590|NCT03956550|323855116|FG000|Overall Study|Withdrawal by Subject|5|||
94562591|NCT03956550|323855117|FG001|Overall Study|Withdrawal by Subject|5|||
94562592|NCT03956550|323855118|FG002|Overall Study|Withdrawal by Subject|6|||
94562593|NCT00950846|323855119|FG000|Overall Study|Death|6|||
94562594|NCT00950846|323855119|FG000|Overall Study|Lost to Follow-up|3|||
94562595|NCT00950846|323855119|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
94562596|NCT01136408|323855120|FG000|Overall Study|Adverse Event|4|||
94562597|NCT01136408|323855121|FG001|Overall Study|Adverse Event|8|||
94562598|NCT01136408|323855122|FG002|Overall Study|Adverse Event|4|||
94562599|NCT01136408|323855120|FG000|Overall Study|Protocol Violation|1|||
94562600|NCT01136408|323855121|FG001|Overall Study|Protocol Violation|1|||
94562601|NCT01136408|323855122|FG002|Overall Study|Protocol Violation|1|||
94562602|NCT05258149|323855123|FG000|Period 1|Protocol Deviation|1|||
94562603|NCT05258149|323855124|FG001|Period 1|Protocol Deviation|0|||
94562604|NCT05258149|323855123|FG000|Period 1|Adverse Event|0|||
94562605|NCT05258149|323855124|FG001|Period 1|Adverse Event|1|||
94562606|NCT05258149|323855123|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
94562607|NCT05258149|323855124|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
94562608|NCT05258149|323855123|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
94562609|NCT05258149|323855124|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
94562610|NCT05258149|323855123|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
94562611|NCT05258149|323855124|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
94562612|NCT01388907|323855125|FG000|Overall Study|Adverse Event|2|||
94562613|NCT01388907|323855126|FG001|Overall Study|Adverse Event|0|||
94233840|NCT04147858|322650257|FG000|Overall Study|Withdrawal by Subject|3|||
94233841|NCT04147858|322650258|FG001|Overall Study|Withdrawal by Subject|4|||
94562614|NCT04273893|323855130|FG000|Overall Study|Withdrawal by Subject|0|||
94562615|NCT04273893|323855131|FG001|Overall Study|Withdrawal by Subject|2|||
94562616|NCT04273893|323855130|FG000|Overall Study|Treatment of Disease Progression|0|||
94562617|NCT04273893|323855131|FG001|Overall Study|Treatment of Disease Progression|2|||
94562618|NCT04273893|323855130|FG000|Overall Study|Death|1|||
94562619|NCT04273893|323855131|FG001|Overall Study|Death|2|||
94562620|NCT04273893|323855130|FG000|Overall Study|Lost to Follow-up|0|||
94562621|NCT04273893|323855131|FG001|Overall Study|Lost to Follow-up|2|||
94562622|NCT04273893|323855130|FG000|Overall Study|Physician Decision|1|||
94562623|NCT04273893|323855131|FG001|Overall Study|Physician Decision|0|||
94562624|NCT00622505|323855134|FG000|Overall Study|Adverse Event|9|||
94562625|NCT00622505|323855135|FG001|Overall Study|Adverse Event|7|||
94562626|NCT00622505|323855134|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
94562627|NCT00622505|323855135|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
94562628|NCT00622505|323855134|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
94562629|NCT00622505|323855135|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
94562630|NCT00622505|323855134|FG000|Overall Study|Withdrawal by Subject|12|||
94562631|NCT00622505|323855135|FG001|Overall Study|Withdrawal by Subject|5|||
94562632|NCT00622505|323855134|FG000|Overall Study|Administrative Problems|2|||
94562633|NCT00622505|323855135|FG001|Overall Study|Administrative Problems|4|||
94562634|NCT00622505|323855134|FG000|Overall Study|Death|2|||
94562635|NCT00622505|323855135|FG001|Overall Study|Death|2|||
94562636|NCT00381693|323855136|FG000|Overall Study|Death|1|||
94562637|NCT00381693|323855136|FG000|Overall Study|Adverse Event|4|||
94562638|NCT00381693|323855136|FG000|Overall Study|Patient Choice|1|||
94562639|NCT00381693|323855136|FG000|Overall Study|Progression|2|||
94562640|NCT02003534|323855137|FG000|Overall Study|Lost to Follow-up|47|||
94562641|NCT01797263|323855138|FG000|Overall Study|Withdrawal by Subject|21|||
94562642|NCT01797263|323855139|FG001|Overall Study|Withdrawal by Subject|25|||
94562643|NCT01797263|323855138|FG000|Overall Study|Death|1|||
94562644|NCT01797263|323855139|FG001|Overall Study|Death|0|||
94562645|NCT01797263|323855138|FG000|Overall Study|Lost to Follow-up|15|||
94562646|NCT01797263|323855139|FG001|Overall Study|Lost to Follow-up|15|||
94562647|NCT03594773|323855140|FG000|Overall Study|Withdrawal by Subject|3|||
94562648|NCT03594773|323855141|FG001|Overall Study|Withdrawal by Subject|2|||
94562649|NCT03594773|323855140|FG000|Overall Study|Lost to Follow-up|3|||
94562650|NCT03594773|323855141|FG001|Overall Study|Lost to Follow-up|4|||
94562651|NCT02342223|323855148|FG000|Overall Study|Lost to Follow-up|1|||
94562652|NCT04112303|323855157|FG000|Overall Study|Death|1|||
94562653|NCT03472950|323855158|FG000|Overall Study|Lost to Follow-up|0|||
94562654|NCT03472950|323855159|FG001|Overall Study|Lost to Follow-up|1|||
94562655|NCT03472950|323855158|FG000|Overall Study|Adverse Event|0|||
94562656|NCT03472950|323855159|FG001|Overall Study|Adverse Event|3|||
94657712|NCT05061446|324204386|FG000|Overall Study|Adverse Event|2|||
94657713|NCT05061446|324204387|FG001|Overall Study|Adverse Event|0|||
94657714|NCT05061446|324204388|FG002|Overall Study|Adverse Event|0|||
94657715|NCT05061446|324204386|FG000|Overall Study|Participant no longer available due to personal reason|0|||
94657716|NCT05061446|324204387|FG001|Overall Study|Participant no longer available due to personal reason|1|||
94657717|NCT05061446|324204388|FG002|Overall Study|Participant no longer available due to personal reason|0|||
94657718|NCT02209324|324204393|FG000|Overall Study|Adverse Event|2|||
94657719|NCT02209324|324204393|FG000|Overall Study|Lack of Efficacy|1|||
94657720|NCT02209324|324204393|FG000|Overall Study|Lost to Follow-up|1|||
94657721|NCT02209324|324204393|FG000|Overall Study|Physician Decision|3|||
94657722|NCT02209324|324204393|FG000|Overall Study|Protocol Violation|14|||
94657723|NCT02209324|324204393|FG000|Overall Study|Withdrawal by Subject|8|||
94657724|NCT02209324|324204393|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
94657725|NCT02209324|324204393|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
94657726|NCT02209324|324204393|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
94657727|NCT01198600|324204394|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
94562657|NCT01134614|323855166|FG000|Overall Study|Still on treatment as of March 2013|21|||
94562658|NCT01134614|323855167|FG001|Overall Study|Still on treatment as of March 2013|13|||
94562659|NCT01134614|323855166|FG000|Overall Study|Progressive disease|60|||
94657728|NCT01198600|324204395|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
94657729|NCT01198600|324204396|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
94657730|NCT01198600|324204397|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
94657731|NCT01198600|324204394|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
94657732|NCT01198600|324204395|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
94657733|NCT01198600|324204396|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
94657734|NCT01198600|324204397|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
94562660|NCT01134614|323855167|FG001|Overall Study|Progressive disease|54|||
94562661|NCT01134614|323855166|FG000|Overall Study|Adverse Event|26|||
94562662|NCT01134614|323855167|FG001|Overall Study|Adverse Event|39|||
94562663|NCT01134614|323855166|FG000|Overall Study|Death|5|||
94562664|NCT01134614|323855167|FG001|Overall Study|Death|8|||
94562665|NCT01134614|323855166|FG000|Overall Study|Withdrawal by Subject|3|||
94562666|NCT01134614|323855167|FG001|Overall Study|Withdrawal by Subject|2|||
94562667|NCT01134614|323855166|FG000|Overall Study|Alternative therapy|2|||
94562668|NCT01134614|323855167|FG001|Overall Study|Alternative therapy|0|||
94562669|NCT01134614|323855166|FG000|Overall Study|Complicating disease|2|||
94562670|NCT01134614|323855167|FG001|Overall Study|Complicating disease|1|||
94562671|NCT01134614|323855166|FG000|Overall Study|Physician's decision|0|||
94562672|NCT01134614|323855167|FG001|Overall Study|Physician's decision|1|||
94562673|NCT01134614|323855166|FG000|Overall Study|Never started treatment|4|||
94562674|NCT01134614|323855167|FG001|Overall Study|Never started treatment|1|||
94562675|NCT01134614|323855166|FG000|Overall Study|Pt received tx not allowed on study|0|||
94562676|NCT01134614|323855167|FG001|Overall Study|Pt received tx not allowed on study|1|||
94562677|NCT01134614|323855166|FG000|Overall Study|Symptomatic deterioration|0|||
94562678|NCT01134614|323855167|FG001|Overall Study|Symptomatic deterioration|1|||
94345773|NCT01646255|323046046|FG001|Overall Study|Withdrawal by Subject|6|||
94345774|NCT01646255|323046045|FG000|Overall Study|Compliance is not well|1|||
94345775|NCT01646255|323046046|FG001|Overall Study|Compliance is not well|0|||
94345776|NCT01646255|323046045|FG000|Overall Study|Inclusion Criteria Deviation|1|||
94345777|NCT01646255|323046046|FG001|Overall Study|Inclusion Criteria Deviation|0|||
94345778|NCT02178592|323046049|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
94345779|NCT02178592|323046050|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
94345780|NCT02178592|323046049|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
94345781|NCT02178592|323046050|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
94345782|NCT02178592|323046049|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
94345783|NCT02178592|323046050|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
94345784|NCT02178592|323046049|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
94562679|NCT01134614|323855166|FG000|Overall Study|Patient in hospice care|0|||
94562680|NCT01134614|323855167|FG001|Overall Study|Patient in hospice care|1|||
94562681|NCT00080301|323855168|FG000|Overall Study|Randomized but Never Treated|5|||
94562682|NCT00080301|323855169|FG001|Overall Study|Randomized but Never Treated|10|||
94562683|NCT00080301|323855168|FG000|Overall Study|Still on Treatment as of CSR date|0|||
94562684|NCT00080301|323855169|FG001|Overall Study|Still on Treatment as of CSR date|1|||
94562685|NCT00991939|323855172|FG000|Overall Study|Lost to Follow-up|0|||
94562686|NCT00991939|323855173|FG001|Overall Study|Lost to Follow-up|1|||
94562687|NCT00991939|323855172|FG000|Overall Study|Withdrawal by Subject|1|||
94562688|NCT00991939|323855173|FG001|Overall Study|Withdrawal by Subject|0|||
94562689|NCT00991939|323855172|FG000|Overall Study|Entire study terminated|4|||
94562690|NCT00991939|323855173|FG001|Overall Study|Entire study terminated|1|||
94562691|NCT00740584|323855178|FG000|Overall Study|Withdrawal by Subject|1|||
94562692|NCT02491983|323855182|FG000|Overall Study|Physician Decision|1|||
94562693|NCT02491983|323855183|FG001|Overall Study|Physician Decision|0|||
94562694|NCT02491983|323855182|FG000|Overall Study|Not meet selection criteria|1|||
94562695|NCT02491983|323855183|FG001|Overall Study|Not meet selection criteria|0|||
94562696|NCT02491983|323855182|FG000|Overall Study|Withdrawal by Subject|0|||
94562697|NCT02491983|323855183|FG001|Overall Study|Withdrawal by Subject|1|||
94562698|NCT03301350|323855189|FG000|Overall Study|Withdrawal by Subject|4|||
94562699|NCT03301350|323855189|FG000|Overall Study|Adverse Event|1|||
94562700|NCT03301350|323855189|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
94562701|NCT03301350|323855189|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
94562702|NCT03301350|323855189|FG000|Overall Study|no detail provided|1|||
94562703|NCT03915470|323855194|FG000|Overall Study|Death|3|||
94562704|NCT03915470|323855195|FG001|Overall Study|Death|1|||
94562705|NCT03915470|323855194|FG000|Overall Study|Adverse Event|1|||
94562706|NCT03915470|323855195|FG001|Overall Study|Adverse Event|0|||
94562707|NCT03915470|323855194|FG000|Overall Study|Physician Decision|1|||
94562708|NCT03915470|323855195|FG001|Overall Study|Physician Decision|0|||
94562709|NCT03915470|323855194|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
94562710|NCT03915470|323855195|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
94562711|NCT00595478|323855196|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
94562712|NCT00595478|323855197|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
94562713|NCT00595478|323855196|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
94562714|NCT00595478|323855197|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
94562715|NCT00319254|323855201|FG000|Overall Study|Withdrawal by Subject|4|||
94562716|NCT00319254|323855201|FG000|Overall Study|Death|46|||
94657735|NCT01198600|324204394|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
94657736|NCT01198600|324204395|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
94657737|NCT01198600|324204396|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
94657738|NCT01198600|324204397|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
94657739|NCT01198600|324204394|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
94657740|NCT01198600|324204395|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
94657741|NCT01198600|324204396|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
94657742|NCT01198600|324204397|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
94657743|NCT01198600|324204394|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
94657744|NCT01198600|324204395|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
94657745|NCT01198600|324204396|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
94657746|NCT01198600|324204397|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
94657747|NCT01198600|324204394|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
94657748|NCT01198600|324204395|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
94657749|NCT01198600|324204396|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
94657750|NCT01198600|324204397|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
94657751|NCT01198600|324204394|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
94657752|NCT01198600|324204395|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
94657753|NCT01198600|324204396|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
94657754|NCT01198600|324204397|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
94657755|NCT04496258|324204398|FG000|Overall Study|Withdrawal by Subject|2|||
94657756|NCT04496258|324204399|FG001|Overall Study|Withdrawal by Subject|1|||
94657757|NCT01024387|324204403|FG000|Overall Study|Radiographic Progression|29|||
94657758|NCT01024387|324204403|FG000|Overall Study|Symptomatic Progression|10|||
94657759|NCT01024387|324204403|FG000|Overall Study|Physician Decision|5|||
94657760|NCT01024387|324204403|FG000|Overall Study|Withdrawal by Subject|5|||
94657761|NCT01024387|324204403|FG000|Overall Study|Death|2|||
94657762|NCT01024387|324204403|FG000|Overall Study|Prolonged Treatment Delay|1|||
94657763|NCT01024387|324204403|FG000|Overall Study|Adverse Event|3|||
94657764|NCT01024387|324204403|FG000|Overall Study|Other|5|||
94657765|NCT00803634|324204404|FG000|Overall Study|Withdrew Consent|1|||
94657766|NCT00803634|324204405|FG001|Overall Study|Withdrew Consent|0|||
94657767|NCT00803634|324204404|FG000|Overall Study|Lost to Follow-up|2|||
94657768|NCT00803634|324204405|FG001|Overall Study|Lost to Follow-up|3|||
94657769|NCT00803634|324204404|FG000|Overall Study|Death|3|||
94657770|NCT00803634|324204405|FG001|Overall Study|Death|2|||
94657771|NCT00861341|324204406|FG000|Overall Study|Withdrawal by Subject|2|||
94657772|NCT03965052|324204407|FG000|Overall Study|Protocol Violation|1|||
94657773|NCT03965052|324204408|FG001|Overall Study|Protocol Violation|0|||
94657774|NCT03791398|324204420|FG000|Overall Study|Progression of Disease Under Study|2|||
94657775|NCT03791398|324204421|FG001|Overall Study|Progression of Disease Under Study|0|||
94657776|NCT03791398|324204422|FG002|Overall Study|Progression of Disease Under Study|0|||
94657777|NCT01975389|324204423|FG000|Overall Study|Adverse Event|10|||
94657778|NCT01975389|324204424|FG001|Overall Study|Adverse Event|6|||
94657779|NCT01975389|324204423|FG000|Overall Study|Death|61|||
94657780|NCT01975389|324204424|FG001|Overall Study|Death|54|||
94657781|NCT01975389|324204423|FG000|Overall Study|Lost to Follow-up|81|||
94657782|NCT01975389|324204424|FG001|Overall Study|Lost to Follow-up|86|||
94657783|NCT01975389|324204423|FG000|Overall Study|Withdrawal by Subject|90|||
94657784|NCT01975389|324204424|FG001|Overall Study|Withdrawal by Subject|76|||
94657785|NCT01975389|324204423|FG000|Overall Study|Other|6|||
94657786|NCT01975389|324204424|FG001|Overall Study|Other|9|||
94657787|NCT01975389|324204423|FG000|Overall Study|Randomized, not treated|4|||
94657788|NCT01975389|324204424|FG001|Overall Study|Randomized, not treated|5|||
94657789|NCT00766376|324204427|FG000|Overall Study|Withdrawal by Subject|27|||
94657790|NCT02052466|324204428|FG000|Overall Study|Withdrawal by Subject|1|||
94657791|NCT02052466|324204428|FG000|Overall Study|Acromial fracture|1|||
94657792|NCT02460198|324204429|FG000|Overall Study|Adverse Event|1|||
94657793|NCT02460198|324204430|FG001|Overall Study|Adverse Event|3|||
94657794|NCT02460198|324204429|FG000|Overall Study|Death|36|||
94657795|NCT02460198|324204430|FG001|Overall Study|Death|28|||
94657796|NCT02460198|324204429|FG000|Overall Study|Lost to Follow-up|1|||
94657797|NCT02460198|324204430|FG001|Overall Study|Lost to Follow-up|1|||
94657798|NCT02460198|324204429|FG000|Overall Study|Transferred to Extension Study|15|||
94657799|NCT02460198|324204430|FG001|Overall Study|Transferred to Extension Study|15|||
94657800|NCT02460198|324204429|FG000|Overall Study|Withdrawal by Subject|2|||
94657801|NCT02460198|324204430|FG001|Overall Study|Withdrawal by Subject|4|||
94657802|NCT02460198|324204429|FG000|Overall Study|Site Terminated By Sponsor|0|||
94657803|NCT02460198|324204430|FG001|Overall Study|Site Terminated By Sponsor|1|||
94657804|NCT02460198|324204429|FG000|Overall Study|Did Not Continue on Extension Study|6|||
94562717|NCT00319254|323855201|FG000|Overall Study|Lost to Follow-up|2|||
94562718|NCT00319254|323855201|FG000|Overall Study|Enrolled, Not Treated|2|||
94562719|NCT01712204|323855207|FG000|Overall Study|Adverse Event|3|||
94562720|NCT01712204|323855208|FG001|Overall Study|Adverse Event|1|||
94562721|NCT01712204|323855207|FG000|Overall Study|Withdrawal by Subject|3|||
94562722|NCT01712204|323855208|FG001|Overall Study|Withdrawal by Subject|3|||
94562723|NCT01712204|323855207|FG000|Overall Study|Lost to Follow-up|1|||
94562724|NCT01712204|323855208|FG001|Overall Study|Lost to Follow-up|0|||
94562725|NCT01712204|323855207|FG000|Overall Study|Protocol Violation|1|||
94562726|NCT01712204|323855208|FG001|Overall Study|Protocol Violation|1|||
94562727|NCT02360228|323855209|FG000|Overall Study|Withdrawal by Subject|1|||
94562728|NCT02360228|323855210|FG001|Overall Study|Withdrawal by Subject|0|||
94562729|NCT02360228|323855211|FG002|Overall Study|Withdrawal by Subject|0|||
94562730|NCT02360228|323855209|FG000|Overall Study|Self-discontinued medication|0|||
94562731|NCT02360228|323855210|FG001|Overall Study|Self-discontinued medication|1|||
94562732|NCT02360228|323855211|FG002|Overall Study|Self-discontinued medication|0|||
94562733|NCT02360228|323855209|FG000|Overall Study|Unstable symptoms during screening|0|||
94562734|NCT02360228|323855210|FG001|Overall Study|Unstable symptoms during screening|0|||
94562735|NCT02360228|323855211|FG002|Overall Study|Unstable symptoms during screening|1|||
94562736|NCT02452424|323855214|FG000|Overall Study|Death|2|||
94562737|NCT02452424|323855215|FG001|Overall Study|Death|2|||
94562738|NCT02452424|323855216|FG002|Overall Study|Death|2|||
94562739|NCT02452424|323855217|FG003|Overall Study|Death|6|||
94562740|NCT02452424|323855218|FG004|Overall Study|Death|2|||
94562741|NCT02452424|323855219|FG005|Overall Study|Death|0|||
94562742|NCT02452424|323855220|FG006|Overall Study|Death|5|||
94562743|NCT02452424|323855221|FG007|Overall Study|Death|1|||
94562744|NCT02452424|323855222|FG008|Overall Study|Death|3|||
94562745|NCT02452424|323855223|FG009|Overall Study|Death|1|||
94562746|NCT02452424|323855224|FG010|Overall Study|Death|0|||
94562747|NCT02452424|323855214|FG000|Overall Study|Lost to Follow-up|0|||
94562748|NCT02452424|323855215|FG001|Overall Study|Lost to Follow-up|1|||
94562749|NCT02452424|323855216|FG002|Overall Study|Lost to Follow-up|1|||
94562750|NCT02452424|323855217|FG003|Overall Study|Lost to Follow-up|0|||
94562751|NCT02452424|323855218|FG004|Overall Study|Lost to Follow-up|0|||
94562752|NCT02452424|323855219|FG005|Overall Study|Lost to Follow-up|0|||
94562753|NCT02452424|323855220|FG006|Overall Study|Lost to Follow-up|0|||
94562754|NCT02452424|323855221|FG007|Overall Study|Lost to Follow-up|0|||
94562755|NCT02452424|323855222|FG008|Overall Study|Lost to Follow-up|0|||
94562756|NCT02452424|323855223|FG009|Overall Study|Lost to Follow-up|0|||
94562757|NCT02452424|323855224|FG010|Overall Study|Lost to Follow-up|0|||
94562758|NCT02452424|323855214|FG000|Overall Study|Withdrawal by Subject|0|||
94562759|NCT02452424|323855215|FG001|Overall Study|Withdrawal by Subject|0|||
94562760|NCT02452424|323855216|FG002|Overall Study|Withdrawal by Subject|3|||
94562761|NCT02452424|323855217|FG003|Overall Study|Withdrawal by Subject|2|||
94562762|NCT02452424|323855218|FG004|Overall Study|Withdrawal by Subject|0|||
94562763|NCT02452424|323855219|FG005|Overall Study|Withdrawal by Subject|0|||
94562764|NCT02452424|323855220|FG006|Overall Study|Withdrawal by Subject|1|||
94562765|NCT02452424|323855221|FG007|Overall Study|Withdrawal by Subject|0|||
94562766|NCT02452424|323855222|FG008|Overall Study|Withdrawal by Subject|1|||
94562767|NCT02452424|323855223|FG009|Overall Study|Withdrawal by Subject|1|||
94562768|NCT02452424|323855224|FG010|Overall Study|Withdrawal by Subject|0|||
94562769|NCT02452424|323855214|FG000|Overall Study|Other|0|||
94562770|NCT02452424|323855215|FG001|Overall Study|Other|0|||
94562771|NCT02452424|323855216|FG002|Overall Study|Other|1|||
94562772|NCT02452424|323855217|FG003|Overall Study|Other|0|||
94657805|NCT02460198|324204430|FG001|Overall Study|Did Not Continue on Extension Study|11|||
94657806|NCT04666441|324204431|FG000|Overall Study|Lost to Follow-up|1|||
94562773|NCT02452424|323855218|FG004|Overall Study|Other|0|||
94562774|NCT02452424|323855219|FG005|Overall Study|Other|1|||
94562775|NCT02452424|323855220|FG006|Overall Study|Other|4|||
94562776|NCT02452424|323855221|FG007|Overall Study|Other|3|||
94562777|NCT02452424|323855222|FG008|Overall Study|Other|0|||
94562778|NCT02452424|323855223|FG009|Overall Study|Other|0|||
94562779|NCT02452424|323855224|FG010|Overall Study|Other|1|||
94562780|NCT02452424|323855214|FG000|Overall Study|Progressive disease (per RECIST)|0|||
94562781|NCT02452424|323855215|FG001|Overall Study|Progressive disease (per RECIST)|0|||
94562782|NCT02452424|323855216|FG002|Overall Study|Progressive disease (per RECIST)|0|||
94562783|NCT02452424|323855217|FG003|Overall Study|Progressive disease (per RECIST)|0|||
94562784|NCT02452424|323855218|FG004|Overall Study|Progressive disease (per RECIST)|0|||
94657807|NCT04666441|324204432|FG001|Overall Study|Lost to Follow-up|4|||
94562785|NCT02452424|323855219|FG005|Overall Study|Progressive disease (per RECIST)|0|||
94562786|NCT02452424|323855220|FG006|Overall Study|Progressive disease (per RECIST)|0|||
94562787|NCT02452424|323855221|FG007|Overall Study|Progressive disease (per RECIST)|0|||
94562788|NCT02452424|323855222|FG008|Overall Study|Progressive disease (per RECIST)|2|||
94562789|NCT02452424|323855223|FG009|Overall Study|Progressive disease (per RECIST)|0|||
94562790|NCT02452424|323855224|FG010|Overall Study|Progressive disease (per RECIST)|0|||
94562791|NCT02452424|323855214|FG000|Overall Study|Adverse Event|0|||
94562792|NCT02452424|323855215|FG001|Overall Study|Adverse Event|0|||
94562793|NCT02452424|323855216|FG002|Overall Study|Adverse Event|0|||
94562794|NCT02452424|323855217|FG003|Overall Study|Adverse Event|0|||
94562795|NCT02452424|323855218|FG004|Overall Study|Adverse Event|0|||
94562796|NCT02452424|323855219|FG005|Overall Study|Adverse Event|0|||
94562797|NCT02452424|323855220|FG006|Overall Study|Adverse Event|0|||
94562798|NCT02452424|323855221|FG007|Overall Study|Adverse Event|0|||
94562799|NCT02452424|323855222|FG008|Overall Study|Adverse Event|0|||
94562800|NCT02452424|323855223|FG009|Overall Study|Adverse Event|0|||
94562801|NCT02452424|323855224|FG010|Overall Study|Adverse Event|1|||
94562802|NCT00103740|323855225|FG000|Period 1 - Core|Adverse Event|1|||
94562803|NCT00103740|323855226|FG001|Period 1 - Core|Adverse Event|0|||
94562804|NCT00103740|323855225|FG000|Period 1 - Core|Protocol Violation|3|||
94562805|NCT00103740|323855226|FG001|Period 1 - Core|Protocol Violation|2|||
94562806|NCT00103740|323855225|FG000|Period 1 - Core|Patient withdrew consent|3|||
94450212|NCT03850483|323435404|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
94450213|NCT03850483|323435405|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
94450214|NCT03850483|323435406|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
94450215|NCT03850483|323435407|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
94450216|NCT03850483|323435408|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
94450217|NCT03850483|323435409|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
94450218|NCT03850483|323435410|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
94450219|NCT03850483|323435411|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
94450220|NCT03850483|323435402|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
94450221|NCT03850483|323435403|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
94450222|NCT03850483|323435404|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
94450223|NCT03850483|323435405|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
94450224|NCT03850483|323435406|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
94450225|NCT03850483|323435407|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
94450226|NCT03850483|323435408|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
94450227|NCT03850483|323435409|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
94450228|NCT03850483|323435410|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
94450229|NCT03850483|323435411|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
94450230|NCT03850483|323435402|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
94450231|NCT03850483|323435403|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
94450232|NCT03850483|323435404|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
94450233|NCT03850483|323435405|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
94450234|NCT03850483|323435406|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
94450235|NCT03850483|323435407|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
94450236|NCT03850483|323435408|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
94450237|NCT03850483|323435409|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
94450238|NCT03850483|323435410|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
94450239|NCT03850483|323435411|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
94450240|NCT03850483|323435402|FG000|Treatment for Stage 1|Death|0|||
94450241|NCT03850483|323435403|FG001|Treatment for Stage 1|Death|0|||
94450242|NCT03850483|323435404|FG002|Treatment for Stage 1|Death|0|||
94450243|NCT03850483|323435405|FG003|Treatment for Stage 1|Death|0|||
94450244|NCT03850483|323435406|FG004|Treatment for Stage 1|Death|0|||
94450245|NCT03850483|323435407|FG005|Treatment for Stage 1|Death|1|||
94450246|NCT03850483|323435408|FG006|Treatment for Stage 1|Death|0|||
94450247|NCT03850483|323435409|FG007|Treatment for Stage 1|Death|0|||
94450248|NCT03850483|323435410|FG008|Treatment for Stage 1|Death|0|||
94450249|NCT03850483|323435411|FG009|Treatment for Stage 1|Death|0|||
94450250|NCT03850483|323435402|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
94450251|NCT03850483|323435403|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
94450252|NCT03850483|323435404|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
94450253|NCT03850483|323435405|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
94450254|NCT03850483|323435406|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
94450255|NCT03850483|323435407|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
94450256|NCT03850483|323435408|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
94450257|NCT03850483|323435409|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
94450258|NCT03850483|323435410|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
94562807|NCT00103740|323855226|FG001|Period 1 - Core|Patient withdrew consent|2|||
94562808|NCT00103740|323855225|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
94562809|NCT00103740|323855226|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
94562810|NCT00103740|323855225|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
94562811|NCT00103740|323855226|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
94562812|NCT00103740|323855225|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
94562813|NCT00103740|323855226|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
94562814|NCT00103740|323855225|FG000|Period 2 - Extended Observation Period|Death|6|||
94562815|NCT00103740|323855226|FG001|Period 2 - Extended Observation Period|Death|2|||
94562816|NCT00103740|323855225|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
94562817|NCT00103740|323855226|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
94562818|NCT01099397|323855243|FG000|Overall Study|Lost to Follow-up|4|||
94562819|NCT01099397|323855243|FG000|Overall Study|Protocol Violation|4|||
94562820|NCT01099397|323855243|FG000|Overall Study|Withdrawal by Subject|5|||
94562821|NCT00940498|323855244|FG000|Overall Study|Death|2|||
94562822|NCT00940498|323855245|FG001|Overall Study|Death|0|||
94562823|NCT00940498|323855246|FG002|Overall Study|Death|0|||
94562824|NCT00940498|323855247|FG003|Overall Study|Death|1|||
94562825|NCT00940498|323855248|FG004|Overall Study|Death|5|||
94562826|NCT00940498|323855249|FG005|Overall Study|Death|0|||
94562827|NCT00940498|323855250|FG006|Overall Study|Death|1|||
94562828|NCT00940498|323855251|FG007|Overall Study|Death|0|||
94562829|NCT00940498|323855244|FG000|Overall Study|Lost to Follow-up|1|||
94562830|NCT00940498|323855245|FG001|Overall Study|Lost to Follow-up|1|||
94562831|NCT00940498|323855246|FG002|Overall Study|Lost to Follow-up|2|||
94562832|NCT00940498|323855247|FG003|Overall Study|Lost to Follow-up|0|||
94562833|NCT00940498|323855248|FG004|Overall Study|Lost to Follow-up|1|||
94562834|NCT00940498|323855249|FG005|Overall Study|Lost to Follow-up|0|||
94562835|NCT00940498|323855250|FG006|Overall Study|Lost to Follow-up|0|||
94562836|NCT00940498|323855251|FG007|Overall Study|Lost to Follow-up|1|||
94562837|NCT00940498|323855244|FG000|Overall Study|Disease Progression|0|||
94562838|NCT00940498|323855245|FG001|Overall Study|Disease Progression|0|||
94562839|NCT00940498|323855246|FG002|Overall Study|Disease Progression|1|||
94562840|NCT00940498|323855247|FG003|Overall Study|Disease Progression|1|||
94562841|NCT00940498|323855248|FG004|Overall Study|Disease Progression|0|||
94562842|NCT00940498|323855249|FG005|Overall Study|Disease Progression|1|||
94562843|NCT00940498|323855250|FG006|Overall Study|Disease Progression|0|||
94562844|NCT00940498|323855251|FG007|Overall Study|Disease Progression|0|||
94562845|NCT00940498|323855244|FG000|Overall Study|Physician Decision|0|||
94562846|NCT00940498|323855245|FG001|Overall Study|Physician Decision|0|||
94562847|NCT00940498|323855246|FG002|Overall Study|Physician Decision|0|||
94562848|NCT00940498|323855247|FG003|Overall Study|Physician Decision|0|||
94562849|NCT00940498|323855248|FG004|Overall Study|Physician Decision|2|||
94562850|NCT00940498|323855249|FG005|Overall Study|Physician Decision|0|||
94562851|NCT00940498|323855250|FG006|Overall Study|Physician Decision|0|||
94562852|NCT00940498|323855251|FG007|Overall Study|Physician Decision|0|||
94562853|NCT00940498|323855244|FG000|Overall Study|Not treated due to disease related pain|0|||
94345785|NCT02178592|323046050|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
94562854|NCT00940498|323855245|FG001|Overall Study|Not treated due to disease related pain|0|||
94562855|NCT00940498|323855246|FG002|Overall Study|Not treated due to disease related pain|0|||
94562856|NCT00940498|323855247|FG003|Overall Study|Not treated due to disease related pain|0|||
94562857|NCT00940498|323855248|FG004|Overall Study|Not treated due to disease related pain|1|||
94562858|NCT00940498|323855249|FG005|Overall Study|Not treated due to disease related pain|0|||
94562859|NCT00940498|323855250|FG006|Overall Study|Not treated due to disease related pain|0|||
94562860|NCT00940498|323855251|FG007|Overall Study|Not treated due to disease related pain|0|||
94562861|NCT02663622|323855254|FG000|Overall Study|Death|3|||
94562862|NCT02663622|323855255|FG001|Overall Study|Death|1|||
94562863|NCT02663622|323855256|FG002|Overall Study|Death|1|||
94562864|NCT02663622|323855257|FG003|Overall Study|Death|8|||
94562865|NCT02663622|323855254|FG000|Overall Study|Protocol Violation|0|||
94562866|NCT02663622|323855255|FG001|Overall Study|Protocol Violation|0|||
94233842|NCT04147858|322650259|FG002|Overall Study|Withdrawal by Subject|10|||
94233843|NCT04147858|322650257|FG000|Overall Study|Subject Noncompliance, Other|4|||
94233844|NCT04147858|322650258|FG001|Overall Study|Subject Noncompliance, Other|3|||
94233845|NCT04147858|322650259|FG002|Overall Study|Subject Noncompliance, Other|1|||
94233846|NCT00838929|322650264|FG000|Overall Study|Protocol Violation|0|||
94233847|NCT00838929|322650265|FG001|Overall Study|Protocol Violation|1|||
94233848|NCT00838929|322650266|FG002|Overall Study|Protocol Violation|0|||
94233849|NCT00838929|322650264|FG000|Overall Study|Disease progression|0|||
94233850|NCT00838929|322650265|FG001|Overall Study|Disease progression|2|||
94233851|NCT00838929|322650266|FG002|Overall Study|Disease progression|1|||
94233852|NCT01068210|322650267|FG000|Overall Study|Lost to Follow-up|1|||
94233853|NCT01068210|322650268|FG001|Overall Study|Lost to Follow-up|2|||
94233854|NCT01068210|322650269|FG002|Overall Study|Lost to Follow-up|2|||
94562867|NCT02663622|323855256|FG002|Overall Study|Protocol Violation|0|||
94562868|NCT02663622|323855257|FG003|Overall Study|Protocol Violation|1|||
94562869|NCT00900029|323855258|FG000|Overall Study|Lost to Follow-up|0|||
94562870|NCT00900029|323855259|FG001|Overall Study|Lost to Follow-up|2|||
94562871|NCT00900029|323855260|FG002|Overall Study|Lost to Follow-up|1|||
94562872|NCT00900029|323855261|FG003|Overall Study|Lost to Follow-up|4|||
94562873|NCT00900029|323855262|FG004|Overall Study|Lost to Follow-up|4|||
94562874|NCT00900029|323855258|FG000|Overall Study|Withdrawal by Subject|2|||
94233855|NCT01068210|322650270|FG003|Overall Study|Lost to Follow-up|1|||
94233856|NCT01068210|322650267|FG000|Overall Study|Second cancer|0|||
94233857|NCT01068210|322650268|FG001|Overall Study|Second cancer|1|||
94233858|NCT01068210|322650269|FG002|Overall Study|Second cancer|0|||
94562875|NCT00900029|323855259|FG001|Overall Study|Withdrawal by Subject|2|||
94233859|NCT01068210|322650270|FG003|Overall Study|Second cancer|0|||
94233860|NCT01068210|322650267|FG000|Overall Study|Disease progression|0|||
94233861|NCT01068210|322650268|FG001|Overall Study|Disease progression|0|||
94562876|NCT00900029|323855260|FG002|Overall Study|Withdrawal by Subject|1|||
94562877|NCT00900029|323855261|FG003|Overall Study|Withdrawal by Subject|1|||
94233862|NCT01068210|322650269|FG002|Overall Study|Disease progression|0|||
94233863|NCT01068210|322650270|FG003|Overall Study|Disease progression|2|||
94233864|NCT03569891|322650271|FG000|Lead-in|Ineligible during lead-in|8|||
94233865|NCT03569891|322650271|FG000|Lead-in|Withdrawal by Subject|3|||
94450259|NCT03850483|323435411|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
94450260|NCT03850483|323435402|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
94450261|NCT03850483|323435403|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
94233866|NCT03569891|322650271|FG000|Lead-in|Risks related to COVID-19|2|||
94657808|NCT04666441|324204433|FG002|Overall Study|Lost to Follow-up|1|||
94562878|NCT00900029|323855262|FG004|Overall Study|Withdrawal by Subject|1|||
94562879|NCT00900029|323855258|FG000|Overall Study|Adverse Event|0|||
94450262|NCT03850483|323435404|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
94450263|NCT03850483|323435405|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
94450264|NCT03850483|323435406|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
94450265|NCT03850483|323435407|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
94450266|NCT03850483|323435408|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
94450267|NCT03850483|323435409|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
94450268|NCT03850483|323435410|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
94450269|NCT03850483|323435411|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
94450270|NCT03850483|323435402|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
94450271|NCT03850483|323435403|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
94450272|NCT03850483|323435404|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
94450273|NCT03850483|323435405|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
94562880|NCT00900029|323855259|FG001|Overall Study|Adverse Event|0|||
94233867|NCT03569891|322650271|FG000|AMT-061|Adverse Event|1|||
94233868|NCT00365547|322650272|FG000|Overall Study|Insurance did not cover Avastin|1|||
94233869|NCT00365547|322650272|FG000|Overall Study|Screen failure|1|||
94233870|NCT00365547|322650272|FG000|Overall Study|Withdrawal by Subject|1|||
94233871|NCT00546078|322650273|FG000|Overall Study|Lost to Follow-up|1|||
94233872|NCT00546078|322650274|FG001|Overall Study|Lost to Follow-up|3|||
94233873|NCT00546078|322650273|FG000|Overall Study|Withdrawal by Subject|2|||
94233874|NCT00546078|322650274|FG001|Overall Study|Withdrawal by Subject|3|||
94233875|NCT00546078|322650273|FG000|Overall Study|Other reason|1|||
94233876|NCT00546078|322650274|FG001|Overall Study|Other reason|1|||
94233877|NCT04969276|322650276|FG000|Overall Study|Protocol Deviation|0|||
94233878|NCT04969276|322650277|FG001|Overall Study|Protocol Deviation|1|||
94233879|NCT04969276|322650278|FG002|Overall Study|Protocol Deviation|0|||
94233880|NCT04969276|322650276|FG000|Overall Study|Withdrawal by Subject|1|||
94233881|NCT04969276|322650277|FG001|Overall Study|Withdrawal by Subject|10|||
94233882|NCT04969276|322650278|FG002|Overall Study|Withdrawal by Subject|0|||
94233883|NCT04969276|322650276|FG000|Overall Study|Lost to Follow-up|0|||
94233884|NCT04969276|322650277|FG001|Overall Study|Lost to Follow-up|1|||
94233885|NCT04969276|322650278|FG002|Overall Study|Lost to Follow-up|0|||
94233886|NCT00469859|322650279|FG000|Overall Study|Inevaluable|0|||
94233887|NCT00469859|322650280|FG001|Overall Study|Inevaluable|2|||
94233888|NCT02520310|322650281|FG000|At 6 Months Clinical Follow-up|Death|1|||
94233889|NCT02520310|322650281|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
94233890|NCT02520310|322650281|FG000|AT 3 Year Clinical Follow-up|Death|2|||
94233891|NCT02520310|322650281|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
94233892|NCT02520310|322650281|FG000|AT 4 Year Clinical Follow-up|Death|1|||
94233893|NCT02520310|322650281|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
94233894|NCT01340014|322650282|FG000|Period 1, First 7 Days|Adverse Event|1|||
94233895|NCT01340014|322650283|FG001|Period 1, First 7 Days|Adverse Event|0|||
94233896|NCT01340014|322650282|FG000|Period 1, First 7 Days|Personal Reasons|1|||
94233897|NCT01340014|322650283|FG001|Period 1, First 7 Days|Personal Reasons|0|||
94345786|NCT02178592|323046049|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
94345787|NCT02178592|323046050|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
94233898|NCT01340014|322650282|FG000|Period 2, Second 7 Days|Adverse Event|0|||
94233899|NCT01340014|322650283|FG001|Period 2, Second 7 Days|Adverse Event|1|||
94233900|NCT00344032|322650285|FG000|Overall Study|Adverse Event|0|||
94233901|NCT00344032|322650286|FG001|Overall Study|Adverse Event|1|||
94233902|NCT00344032|322650285|FG000|Overall Study|Withdrawal by Subject|6|||
94233903|NCT00344032|322650286|FG001|Overall Study|Withdrawal by Subject|2|||
94233904|NCT00344032|322650285|FG000|Overall Study|Lost to Follow-up|4|||
94233905|NCT00344032|322650286|FG001|Overall Study|Lost to Follow-up|6|||
94233906|NCT00344032|322650285|FG000|Overall Study|Physician Decision|4|||
94233907|NCT00344032|322650286|FG001|Overall Study|Physician Decision|1|||
94233908|NCT02194829|322650287|FG000|Overall Study|Adverse Event|2|||
94233909|NCT02194829|322650288|FG001|Overall Study|Adverse Event|2|||
94345788|NCT02178592|323046049|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
94345789|NCT02178592|323046050|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
94345790|NCT02178592|323046049|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
94345791|NCT02178592|323046050|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
94345792|NCT02178592|323046049|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
94345793|NCT02178592|323046050|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
94345794|NCT02178592|323046049|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
94345795|NCT02178592|323046050|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
94345796|NCT02178592|323046049|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
94345797|NCT02178592|323046050|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
94345798|NCT02178592|323046049|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
94345799|NCT02178592|323046050|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
94345800|NCT02178592|323046049|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
94345801|NCT02178592|323046050|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
94345802|NCT00939094|323046065|FG000|Overall Study|Adverse Event|9|||
94345803|NCT00939094|323046066|FG001|Overall Study|Adverse Event|0|||
94345804|NCT00939094|323046065|FG000|Overall Study|Withdrawal by Subject|1|||
94345805|NCT00939094|323046066|FG001|Overall Study|Withdrawal by Subject|6|||
94345806|NCT00939094|323046065|FG000|Overall Study|Lost to Follow-up|1|||
94345807|NCT00939094|323046066|FG001|Overall Study|Lost to Follow-up|1|||
94233910|NCT02194829|322650287|FG000|Overall Study|Death|0|||
94233911|NCT02194829|322650288|FG001|Overall Study|Death|1|||
94233912|NCT02194829|322650287|FG000|Overall Study|Disease progression|0|||
94233913|NCT02194829|322650288|FG001|Overall Study|Disease progression|1|||
94233914|NCT02194829|322650287|FG000|Overall Study|Withdrawal by Subject|0|||
94233915|NCT02194829|322650288|FG001|Overall Study|Withdrawal by Subject|1|||
94233916|NCT02194829|322650287|FG000|Overall Study|Never started protocol therapy|0|||
94233917|NCT02194829|322650288|FG001|Overall Study|Never started protocol therapy|1|||
94233918|NCT01689363|322652507|FG000|Overall Study|Protocol Violation|0|||
94233919|NCT01689363|322652508|FG001|Overall Study|Protocol Violation|1|||
94345808|NCT00939094|323046065|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
94345809|NCT00939094|323046066|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
94345810|NCT00939094|323046065|FG000|Overall Study|Severe non-compliance to protocol|0|||
94345811|NCT00939094|323046066|FG001|Overall Study|Severe non-compliance to protocol|1|||
94345812|NCT00939094|323046065|FG000|Overall Study|Study stopped by sponsor|0|||
94345813|NCT00939094|323046066|FG001|Overall Study|Study stopped by sponsor|2|||
94345814|NCT00939094|323046065|FG000|Overall Study|Abnormal ECG findings|1|||
94345815|NCT00939094|323046066|FG001|Overall Study|Abnormal ECG findings|0|||
94345816|NCT00768040|323047599|FG000|Overall Study|Adverse Event|3|||
94345817|NCT00768040|323047600|FG001|Overall Study|Adverse Event|2|||
94345818|NCT00768040|323047599|FG000|Overall Study|Abnormal laboratory value|1|||
94345819|NCT00768040|323047600|FG001|Overall Study|Abnormal laboratory value|1|||
94345820|NCT03650387|323047603|FG000|Overall Study|Withdrawal by Subject|13|||
94345821|NCT03650387|323047603|FG000|Overall Study|Lost to Follow-up|12|||
94345822|NCT03650387|323047603|FG000|Overall Study|Adverse Event (Not related)|1|||
94345823|NCT03650387|323047603|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
94345824|NCT00887822|323047604|FG000|Overall Study|Insufficient therapeutic response|53|||
94345825|NCT00887822|323047605|FG001|Overall Study|Insufficient therapeutic response|55|||
94345826|NCT00887822|323047604|FG000|Overall Study|Adverse Event|14|||
94345827|NCT00887822|323047605|FG001|Overall Study|Adverse Event|17|||
94345828|NCT00887822|323047604|FG000|Overall Study|Failure to return|11|||
94345829|NCT00887822|323047605|FG001|Overall Study|Failure to return|11|||
94345830|NCT00887822|323047604|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
94345831|NCT00887822|323047605|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
94345832|NCT00887822|323047604|FG000|Overall Study|Administrative/Other than specified|5|||
94345833|NCT00887822|323047605|FG001|Overall Study|Administrative/Other than specified|4|||
94345834|NCT00887822|323047604|FG000|Overall Study|Death|2|||
94345835|NCT00887822|323047605|FG001|Overall Study|Death|3|||
94345836|NCT00887822|323047604|FG000|Overall Study|Protocol Violation|0|||
94345837|NCT00887822|323047605|FG001|Overall Study|Protocol Violation|1|||
94345838|NCT00887822|323047604|FG000|Overall Study|Randomized but not treated|0|||
94345839|NCT00887822|323047605|FG001|Overall Study|Randomized but not treated|1|||
94345840|NCT00934791|323047606|FG000|Overall Study|Withdrawal by Subject|1|||
94345841|NCT00934791|323047607|FG001|Overall Study|Withdrawal by Subject|0|||
94345842|NCT02045979|323047609|FG000|Overall Study|Informed Consent Withdrawn|2|||
94345843|NCT02045979|323047610|FG001|Overall Study|Informed Consent Withdrawn|0|||
94345844|NCT02045979|323047611|FG002|Overall Study|Informed Consent Withdrawn|1|||
94345845|NCT02045979|323047609|FG000|Overall Study|not specified above|0|||
94345846|NCT02045979|323047610|FG001|Overall Study|not specified above|1|||
94345847|NCT02045979|323047611|FG002|Overall Study|not specified above|0|||
94345848|NCT00942422|323047628|FG000|Overall Study|Withdrawal by Subject|1|||
94345849|NCT00942422|323047628|FG000|Overall Study|Death|1|||
94345850|NCT00942422|323047628|FG000|Overall Study|Progressive diease|1|||
94345851|NCT02442765|323047629|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
94345852|NCT02442765|323047630|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
94345853|NCT02442765|323047631|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
94345854|NCT02442765|323047632|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
94345855|NCT02442765|323047633|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
94345856|NCT02442765|323047634|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
94345857|NCT02442765|323047635|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
94345858|NCT02442765|323047636|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
94345859|NCT02442765|323047629|FG000|Stage 2- (Days 43 to 85)|Death|0|||
94345860|NCT02442765|323047630|FG001|Stage 2- (Days 43 to 85)|Death|0|||
94345861|NCT02442765|323047631|FG002|Stage 2- (Days 43 to 85)|Death|0|||
94345862|NCT02442765|323047632|FG003|Stage 2- (Days 43 to 85)|Death|1|||
94345863|NCT02442765|323047633|FG004|Stage 2- (Days 43 to 85)|Death|1|||
94345864|NCT02442765|323047634|FG005|Stage 2- (Days 43 to 85)|Death|0|||
94345865|NCT02442765|323047635|FG006|Stage 2- (Days 43 to 85)|Death|2|||
94345866|NCT02442765|323047636|FG007|Stage 2- (Days 43 to 85)|Death|0|||
94450274|NCT03850483|323435406|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
94450275|NCT03850483|323435407|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
94450276|NCT03850483|323435408|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
94450277|NCT03850483|323435409|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
94450278|NCT03850483|323435410|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
94450279|NCT03850483|323435411|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
94450280|NCT03850483|323435402|FG000|Follow-up for Stage 1|Physician Decision|0|||
94450281|NCT03850483|323435403|FG001|Follow-up for Stage 1|Physician Decision|0|||
94450282|NCT03850483|323435404|FG002|Follow-up for Stage 1|Physician Decision|0|||
94450283|NCT03850483|323435405|FG003|Follow-up for Stage 1|Physician Decision|0|||
94450284|NCT03850483|323435406|FG004|Follow-up for Stage 1|Physician Decision|1|||
94450285|NCT03850483|323435407|FG005|Follow-up for Stage 1|Physician Decision|0|||
94450286|NCT03850483|323435408|FG006|Follow-up for Stage 1|Physician Decision|1|||
94450287|NCT03850483|323435409|FG007|Follow-up for Stage 1|Physician Decision|0|||
94450288|NCT03850483|323435410|FG008|Follow-up for Stage 1|Physician Decision|0|||
94450289|NCT03850483|323435411|FG009|Follow-up for Stage 1|Physician Decision|0|||
94450290|NCT03850483|323435402|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
94450291|NCT03850483|323435403|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
94450292|NCT03850483|323435404|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
94450293|NCT03850483|323435405|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
94450294|NCT03850483|323435406|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
94450295|NCT03850483|323435407|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
94450296|NCT03850483|323435408|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
94450297|NCT03850483|323435409|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
94450298|NCT03850483|323435410|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
94450299|NCT03850483|323435411|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
94450300|NCT03850483|323435402|FG000|Follow-up for Stage 1|Adverse Event|0|||
94450301|NCT03850483|323435403|FG001|Follow-up for Stage 1|Adverse Event|0|||
94450302|NCT03850483|323435404|FG002|Follow-up for Stage 1|Adverse Event|1|||
94450303|NCT03850483|323435405|FG003|Follow-up for Stage 1|Adverse Event|0|||
94450304|NCT03850483|323435406|FG004|Follow-up for Stage 1|Adverse Event|0|||
94450305|NCT03850483|323435407|FG005|Follow-up for Stage 1|Adverse Event|1|||
94450306|NCT03850483|323435408|FG006|Follow-up for Stage 1|Adverse Event|0|||
94450307|NCT03850483|323435409|FG007|Follow-up for Stage 1|Adverse Event|0|||
94450308|NCT03850483|323435410|FG008|Follow-up for Stage 1|Adverse Event|0|||
94450309|NCT03850483|323435411|FG009|Follow-up for Stage 1|Adverse Event|0|||
94450310|NCT03850483|323435402|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
94450311|NCT03850483|323435403|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
94450312|NCT03850483|323435404|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
94450313|NCT03850483|323435405|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
94450314|NCT03850483|323435406|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
94450315|NCT03850483|323435407|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
94450316|NCT03850483|323435408|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
94562881|NCT00900029|323855260|FG002|Overall Study|Adverse Event|1|||
94562882|NCT00900029|323855261|FG003|Overall Study|Adverse Event|1|||
94562883|NCT00900029|323855262|FG004|Overall Study|Adverse Event|1|||
94450317|NCT03850483|323435409|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
94450318|NCT03850483|323435410|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
94562884|NCT00900029|323855258|FG000|Overall Study|Death|1|||
94562885|NCT00900029|323855259|FG001|Overall Study|Death|0|||
94562886|NCT00900029|323855260|FG002|Overall Study|Death|0|||
94562887|NCT00900029|323855261|FG003|Overall Study|Death|1|||
94562888|NCT00900029|323855262|FG004|Overall Study|Death|0|||
94562889|NCT04050618|323858033|FG000|First Intervention|Withdrawal by Subject|2|||
94562890|NCT04050618|323858034|FG001|First Intervention|Withdrawal by Subject|0|||
94562891|NCT04050618|323858033|FG000|Second Intervention|Withdrawal by Subject|1|||
94562892|NCT04050618|323858034|FG001|Second Intervention|Withdrawal by Subject|0|||
94562893|NCT04775953|323858035|FG000|Overall Study|Lost to Follow-up|6|||
94562894|NCT04775953|323858036|FG001|Overall Study|Lost to Follow-up|11|||
94562895|NCT04775953|323858035|FG000|Overall Study|Death|5|||
94562896|NCT04775953|323858036|FG001|Overall Study|Death|4|||
94562897|NCT04775953|323858035|FG000|Overall Study|Withdrawal by Subject|3|||
94562898|NCT04775953|323858036|FG001|Overall Study|Withdrawal by Subject|3|||
94562899|NCT04775953|323858035|FG000|Overall Study|Protocol Violation|2|||
94562900|NCT04775953|323858036|FG001|Overall Study|Protocol Violation|0|||
94562901|NCT04775953|323858035|FG000|Overall Study|Participant non-compliance|0|||
94562902|NCT04775953|323858036|FG001|Overall Study|Participant non-compliance|1|||
94562903|NCT01142388|323858037|FG000|Overall Study|Lack of Efficacy|21|||
94562904|NCT01142388|323858038|FG001|Overall Study|Lack of Efficacy|31|||
94562905|NCT01142388|323858037|FG000|Overall Study|Adverse Event|9|||
94562906|NCT01142388|323858038|FG001|Overall Study|Adverse Event|5|||
94562907|NCT01142388|323858037|FG000|Overall Study|Death|3|||
94562908|NCT01142388|323858038|FG001|Overall Study|Death|2|||
94562909|NCT01142388|323858037|FG000|Overall Study|Withdrawal by Subject|5|||
94562910|NCT01142388|323858038|FG001|Overall Study|Withdrawal by Subject|3|||
94562911|NCT01142388|323858037|FG000|Overall Study|Alternative therapy|1|||
94562912|NCT01142388|323858038|FG001|Overall Study|Alternative therapy|0|||
94562913|NCT01142388|323858037|FG000|Overall Study|Other complications|0|||
94562914|NCT01142388|323858038|FG001|Overall Study|Other complications|2|||
94562915|NCT01142388|323858037|FG000|Overall Study|Other|1|||
94562916|NCT01142388|323858038|FG001|Overall Study|Other|1|||
94562917|NCT01142388|323858037|FG000|Overall Study|Never started therapy|7|||
94562918|NCT01142388|323858038|FG001|Overall Study|Never started therapy|3|||
94562919|NCT00799266|323858044|FG000|Overall Study|Adverse Event|0|||
94562920|NCT00799266|323858045|FG001|Overall Study|Adverse Event|1|||
94562921|NCT00799266|323858044|FG000|Overall Study|Subject withdrew consent|3|||
94562922|NCT00799266|323858045|FG001|Overall Study|Subject withdrew consent|0|||
94562923|NCT04794270|323858046|FG000|Period 1|Non Compliance|1|||
94562924|NCT04794270|323858047|FG001|Period 1|Non Compliance|0|||
94562925|NCT04794270|323858046|FG000|Period 1|Adverse Event|1|||
94450319|NCT03850483|323435411|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
94562926|NCT04794270|323858047|FG001|Period 1|Adverse Event|0|||
94562927|NCT04794270|323858046|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
94562928|NCT04794270|323858047|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
94562929|NCT02451917|323858048|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
94562930|NCT02451917|323858049|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
94562931|NCT02451917|323858048|FG000|First Intervention (24 Weeks)|Death|0|||
94562932|NCT02451917|323858049|FG001|First Intervention (24 Weeks)|Death|1|||
94562933|NCT02451917|323858048|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
94562934|NCT02451917|323858049|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
94562935|NCT01724866|323858050|FG000|Overall Study|Adverse Event|0|||
94562936|NCT01724866|323858051|FG001|Overall Study|Adverse Event|0|||
94562937|NCT01724866|323858052|FG002|Overall Study|Adverse Event|1|||
94562938|NCT01724866|323858053|FG003|Overall Study|Adverse Event|1|||
94562939|NCT01724866|323858050|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
94562940|NCT01724866|323858051|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
94562941|NCT01724866|323858052|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
94562942|NCT01724866|323858053|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
94562943|NCT01724866|323858050|FG000|Overall Study|Investigator's Discretion|0|||
94562944|NCT01724866|323858051|FG001|Overall Study|Investigator's Discretion|1|||
94562945|NCT01724866|323858052|FG002|Overall Study|Investigator's Discretion|1|||
94562946|NCT01724866|323858053|FG003|Overall Study|Investigator's Discretion|0|||
94562947|NCT01724866|323858050|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
94233920|NCT01689363|322652509|FG002|Overall Study|Protocol Violation|0|||
94233921|NCT01689363|322652510|FG003|Overall Study|Protocol Violation|0|||
94233922|NCT01689363|322652511|FG004|Overall Study|Protocol Violation|0|||
94233923|NCT01689363|322652512|FG005|Overall Study|Protocol Violation|0|||
94233924|NCT01689363|322652513|FG006|Overall Study|Protocol Violation|0|||
94233925|NCT01689363|322652514|FG007|Overall Study|Protocol Violation|0|||
94233926|NCT01845805|322652515|FG000|Overall Study|Withdrawal by Subject|1|||
94233927|NCT01845805|322652516|FG001|Overall Study|Withdrawal by Subject|2|||
94233928|NCT01845805|322652515|FG000|Overall Study|Disease Progression|13|||
94233929|NCT01845805|322652516|FG001|Overall Study|Disease Progression|14|||
94233930|NCT01845805|322652515|FG000|Overall Study|Drug-related Toxicity|4|||
94233931|NCT01845805|322652516|FG001|Overall Study|Drug-related Toxicity|0|||
94233932|NCT02366143|322652520|FG000|Overall Study|Death|307|||
94233933|NCT02366143|322652521|FG001|Overall Study|Death|278|||
94233934|NCT02366143|322652522|FG002|Overall Study|Death|280|||
94233935|NCT02366143|322652520|FG000|Overall Study|Lost to Follow-up|2|||
94233936|NCT02366143|322652521|FG001|Overall Study|Lost to Follow-up|4|||
94233937|NCT02366143|322652522|FG002|Overall Study|Lost to Follow-up|2|||
94233938|NCT02366143|322652520|FG000|Overall Study|Physician Decision|1|||
94233939|NCT02366143|322652521|FG001|Overall Study|Physician Decision|2|||
94233940|NCT02366143|322652522|FG002|Overall Study|Physician Decision|1|||
94233941|NCT02366143|322652520|FG000|Overall Study|Protocol Violation|0|||
94233942|NCT02366143|322652521|FG001|Overall Study|Protocol Violation|0|||
94233943|NCT02366143|322652522|FG002|Overall Study|Protocol Violation|2|||
94233944|NCT02366143|322652520|FG000|Overall Study|Withdrawal by Subject|16|||
94233945|NCT02366143|322652521|FG001|Overall Study|Withdrawal by Subject|17|||
94233946|NCT02366143|322652522|FG002|Overall Study|Withdrawal by Subject|22|||
94233947|NCT02366143|322652520|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
94233948|NCT02366143|322652521|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
94562948|NCT01724866|323858051|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
94562949|NCT01724866|323858052|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
94657809|NCT04666441|324204434|FG003|Overall Study|Lost to Follow-up|3|||
94657810|NCT04666441|324204435|FG004|Overall Study|Lost to Follow-up|0|||
94233949|NCT02366143|322652522|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
94233950|NCT02366143|322652520|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
94233951|NCT02366143|322652521|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
94450320|NCT03850483|323435402|FG000|Follow-up for Stage 1|Other|0|||
94233952|NCT02366143|322652522|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
94233953|NCT02366143|322652520|FG000|Overall Study|Randomization Error|1|||
94233954|NCT02366143|322652521|FG001|Overall Study|Randomization Error|0|||
94233955|NCT02366143|322652522|FG002|Overall Study|Randomization Error|0|||
94233956|NCT02366143|322652520|FG000|Overall Study|PI Move and Site Closure|1|||
94450321|NCT03850483|323435403|FG001|Follow-up for Stage 1|Other|2|||
94233957|NCT02366143|322652521|FG001|Overall Study|PI Move and Site Closure|0|||
94233958|NCT02366143|322652522|FG002|Overall Study|PI Move and Site Closure|1|||
94233959|NCT02366143|322652520|FG000|Overall Study|Study Terminated By Sponsor|0|||
94233960|NCT02366143|322652521|FG001|Overall Study|Study Terminated By Sponsor|0|||
94233961|NCT02366143|322652522|FG002|Overall Study|Study Terminated By Sponsor|2|||
94233962|NCT02366143|322652520|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
94233963|NCT02366143|322652521|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
94233964|NCT02366143|322652522|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
94233965|NCT02366143|322652520|FG000|Overall Study|Patient moved to roll-over study|1|||
94233966|NCT02366143|322652521|FG001|Overall Study|Patient moved to roll-over study|19|||
94233967|NCT02366143|322652522|FG002|Overall Study|Patient moved to roll-over study|28|||
94233968|NCT02366143|322652520|FG000|Overall Study|Patient moved to commercial stock|0|||
94233969|NCT02366143|322652521|FG001|Overall Study|Patient moved to commercial stock|0|||
94233970|NCT02366143|322652522|FG002|Overall Study|Patient moved to commercial stock|1|||
94233971|NCT02366143|322652520|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
94233972|NCT02366143|322652521|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
94233973|NCT02366143|322652522|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
94450322|NCT03850483|323435404|FG002|Follow-up for Stage 1|Other|0|||
94651345|NCT02460224|324179726|FG011|Overall Study|Subject/guardian decision|1|||
94233974|NCT02366143|322652520|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
94233975|NCT02366143|322652521|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
94233976|NCT02366143|322652522|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
94233977|NCT02366143|322652520|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
94233978|NCT02366143|322652521|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
94233979|NCT02366143|322652522|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
94233980|NCT02366143|322652520|FG000|Overall Study|Requester's instructions|1|||
94233981|NCT02366143|322652521|FG001|Overall Study|Requester's instructions|1|||
94233982|NCT02366143|322652522|FG002|Overall Study|Requester's instructions|1|||
94233983|NCT02366143|322652520|FG000|Overall Study|Uneligible|0|||
94562950|NCT01724866|323858053|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
94562951|NCT01724866|323858050|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
94562952|NCT01724866|323858051|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
94562953|NCT01724866|323858052|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
94562954|NCT01724866|323858053|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
94562955|NCT02871635|323858054|FG000|Overall Study|Primary lack of efficacy|4|||
94562956|NCT02871635|323858055|FG001|Overall Study|Primary lack of efficacy|4|||
94562957|NCT02871635|323858054|FG000|Overall Study|Protocol Violation|3|||
94562958|NCT02871635|323858055|FG001|Overall Study|Protocol Violation|1|||
94562959|NCT02871635|323858054|FG000|Overall Study|Lost to Follow-up|1|||
94562960|NCT02871635|323858055|FG001|Overall Study|Lost to Follow-up|2|||
94345867|NCT02442765|323047629|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
94345868|NCT02442765|323047630|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
94345869|NCT02442765|323047631|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
94345870|NCT02442765|323047632|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
94562961|NCT02871635|323858054|FG000|Overall Study|Pregnancy|0|||
94562962|NCT02871635|323858055|FG001|Overall Study|Pregnancy|2|||
94345871|NCT02442765|323047633|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
94233984|NCT02366143|322652521|FG001|Overall Study|Uneligible|1|||
94233985|NCT02366143|322652522|FG002|Overall Study|Uneligible|0|||
94233986|NCT02366143|322652520|FG000|Overall Study|Post Trial Migration|0|||
94233987|NCT02366143|322652521|FG001|Overall Study|Post Trial Migration|1|||
94233988|NCT02366143|322652522|FG002|Overall Study|Post Trial Migration|0|||
94233989|NCT02366143|322652520|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
94233990|NCT02366143|322652521|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
94233991|NCT02366143|322652522|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
94233992|NCT02366143|322652520|FG000|Overall Study|Patient switched to PTAP|0|||
94233993|NCT02366143|322652521|FG001|Overall Study|Patient switched to PTAP|1|||
94233994|NCT02366143|322652522|FG002|Overall Study|Patient switched to PTAP|0|||
94233995|NCT02366143|322652520|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
94233996|NCT02366143|322652521|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
94233997|NCT02366143|322652522|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
94233998|NCT03898700|322652523|FG000|Overall Study|Withdrawal by Subject|2|||
94233999|NCT01468077|322652528|FG000|Overall Study|Adverse Event|2|||
94234000|NCT01468077|322652529|FG001|Overall Study|Adverse Event|2|||
94234001|NCT01468077|322652528|FG000|Overall Study|Lack of Efficacy|1|||
94234002|NCT01468077|322652529|FG001|Overall Study|Lack of Efficacy|1|||
94234003|NCT01468077|322652528|FG000|Overall Study|Physician Decision|1|||
94234004|NCT01468077|322652529|FG001|Overall Study|Physician Decision|0|||
94234005|NCT03167151|322652534|FG000|Overall Study|Withdrawal by Subject|1|||
94234006|NCT03167151|322652535|FG001|Overall Study|Withdrawal by Subject|0|||
94234007|NCT03167151|322652536|FG002|Overall Study|Withdrawal by Subject|0|||
94234008|NCT03167151|322652534|FG000|Overall Study|No evidence of tumour at surgery|0|||
94234009|NCT03167151|322652535|FG001|Overall Study|No evidence of tumour at surgery|1|||
94234010|NCT03167151|322652536|FG002|Overall Study|No evidence of tumour at surgery|1|||
94234011|NCT00543062|322652539|FG000|Overall Study|Withdrawal by Subject|1|||
94234012|NCT00543062|322652540|FG001|Overall Study|Withdrawal by Subject|0|||
94234013|NCT00543062|322652541|FG002|Overall Study|Withdrawal by Subject|2|||
94234014|NCT00543062|322652542|FG003|Overall Study|Withdrawal by Subject|0|||
94234015|NCT00543062|322652539|FG000|Overall Study|Adverse Event|0|||
94234016|NCT00543062|322652540|FG001|Overall Study|Adverse Event|1|||
94234017|NCT00543062|322652541|FG002|Overall Study|Adverse Event|1|||
94345872|NCT02442765|323047634|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
94345873|NCT02442765|323047635|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
94345874|NCT02442765|323047636|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
94345875|NCT02442765|323047629|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
94345876|NCT02442765|323047630|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
94345877|NCT02442765|323047631|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
94345878|NCT02442765|323047632|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
94345879|NCT02442765|323047633|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
94562963|NCT02871635|323858054|FG000|Overall Study|Physician Decision|1|||
94562964|NCT02871635|323858055|FG001|Overall Study|Physician Decision|1|||
94562965|NCT02871635|323858054|FG000|Overall Study|Withdrawal by Subject|3|||
94234018|NCT00543062|322652542|FG003|Overall Study|Adverse Event|1|||
94345880|NCT02442765|323047634|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
94345881|NCT02442765|323047635|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
94450323|NCT03850483|323435405|FG003|Follow-up for Stage 1|Other|2|||
94562966|NCT02871635|323858055|FG001|Overall Study|Withdrawal by Subject|4|||
94562967|NCT02871635|323858054|FG000|Overall Study|Adverse Event|4|||
94562968|NCT02871635|323858055|FG001|Overall Study|Adverse Event|4|||
94562969|NCT02871635|323858054|FG000|Overall Study|Secondary lack of efficacy|2|||
94562970|NCT02871635|323858055|FG001|Overall Study|Secondary lack of efficacy|1|||
94562971|NCT04737278|323858059|FG000|Overall Study|Lost to Follow-up|1|||
94234019|NCT00543062|322652539|FG000|Overall Study|Protocol Violation|1|||
94234020|NCT00543062|322652540|FG001|Overall Study|Protocol Violation|0|||
94234021|NCT00543062|322652541|FG002|Overall Study|Protocol Violation|0|||
94234022|NCT00543062|322652542|FG003|Overall Study|Protocol Violation|0|||
94234023|NCT01271504|322652543|FG000|Overall Study|Death|7|||
94234024|NCT01271504|322652544|FG001|Overall Study|Death|6|||
94234025|NCT01271504|322652545|FG002|Overall Study|Death|32|||
94234026|NCT01271504|322652546|FG003|Overall Study|Death|32|||
94345882|NCT02442765|323047636|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
94562972|NCT04737278|323858060|FG001|Overall Study|Lost to Follow-up|1|||
94562973|NCT04737278|323858059|FG000|Overall Study|Withdrawal by Subject|1|||
94562974|NCT04737278|323858060|FG001|Overall Study|Withdrawal by Subject|0|||
94562975|NCT04737278|323858059|FG000|Overall Study|Protocol Violation|1|||
94562976|NCT04737278|323858060|FG001|Overall Study|Protocol Violation|1|||
94562977|NCT04737278|323858059|FG000|Overall Study|failure to complete questionnaire|1|||
94562978|NCT04737278|323858060|FG001|Overall Study|failure to complete questionnaire|1|||
94234027|NCT01271504|322652543|FG000|Overall Study|Lost to Follow-up|0|||
94234028|NCT01271504|322652544|FG001|Overall Study|Lost to Follow-up|1|||
94562979|NCT01217944|323858061|FG000|Overall Study|Protocol Violation|1|||
94562980|NCT01217944|323858062|FG001|Overall Study|Protocol Violation|1|||
94234029|NCT01271504|322652545|FG002|Overall Study|Lost to Follow-up|3|||
94234030|NCT01271504|322652546|FG003|Overall Study|Lost to Follow-up|1|||
94234031|NCT01271504|322652543|FG000|Overall Study|Protocol Violation|0|||
94234032|NCT01271504|322652544|FG001|Overall Study|Protocol Violation|0|||
94234033|NCT01271504|322652545|FG002|Overall Study|Protocol Violation|0|||
94234034|NCT01271504|322652546|FG003|Overall Study|Protocol Violation|2|||
94234035|NCT01271504|322652543|FG000|Overall Study|Administrative Reasons|0|||
94234036|NCT01271504|322652544|FG001|Overall Study|Administrative Reasons|0|||
94234037|NCT01271504|322652545|FG002|Overall Study|Administrative Reasons|6|||
94234038|NCT01271504|322652546|FG003|Overall Study|Administrative Reasons|5|||
94234039|NCT01271504|322652543|FG000|Overall Study|Withdrawal by Subject|0|||
94234040|NCT01271504|322652544|FG001|Overall Study|Withdrawal by Subject|0|||
94234041|NCT01271504|322652545|FG002|Overall Study|Withdrawal by Subject|1|||
94234042|NCT01271504|322652546|FG003|Overall Study|Withdrawal by Subject|3|||
94234043|NCT01271504|322652543|FG000|Overall Study|Other|0|||
94234044|NCT01271504|322652544|FG001|Overall Study|Other|1|||
94234045|NCT01271504|322652545|FG002|Overall Study|Other|2|||
94234046|NCT01271504|322652546|FG003|Overall Study|Other|0|||
94234047|NCT00882115|322652547|FG000|Overall Study|Withdrawal by Subject|3|||
94234048|NCT00882115|322652547|FG000|Overall Study|did not respond to DEP challe|6|||
94234049|NCT03865953|322652548|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
94234050|NCT03865953|322652549|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
94234051|NCT03865953|322652548|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
94234052|NCT03865953|322652549|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
94234053|NCT03865953|322652548|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
94234054|NCT03865953|322652549|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
94234055|NCT02375347|322652550|FG000|Overall Study|Protocol Violation|1|||
94234056|NCT01547598|322652551|FG000|Overall Study|Withdrew consent|1|||
94234057|NCT01547598|322652552|FG001|Overall Study|Withdrew consent|1|||
94234058|NCT01547598|322652551|FG000|Overall Study|Lost to Follow-up|1|||
94234059|NCT01547598|322652552|FG001|Overall Study|Lost to Follow-up|1|||
94234060|NCT01547598|322652551|FG000|Overall Study|Adverse Event|1|||
94234061|NCT01547598|322652552|FG001|Overall Study|Adverse Event|1|||
94234062|NCT01547598|322652551|FG000|Overall Study|Protocol Violation|1|||
94234063|NCT01547598|322652552|FG001|Overall Study|Protocol Violation|1|||
94234064|NCT01547598|322652551|FG000|Overall Study|Other Miscellaneous Reasons|2|||
94234065|NCT01547598|322652552|FG001|Overall Study|Other Miscellaneous Reasons|1|||
94234066|NCT02706951|322652554|FG000|Period 1|Adverse Event|1|||
94234067|NCT02706951|322652555|FG001|Period 1|Adverse Event|5|||
94234068|NCT02706951|322652556|FG002|Period 1|Adverse Event|3|||
94234069|NCT02706951|322652557|FG003|Period 1|Adverse Event|0|||
94234070|NCT02706951|322652558|FG004|Period 1|Adverse Event|0|||
94234071|NCT02706951|322652554|FG000|Period 1|Withdrawal by Subject|10|||
94234072|NCT02706951|322652555|FG001|Period 1|Withdrawal by Subject|6|||
94234073|NCT02706951|322652556|FG002|Period 1|Withdrawal by Subject|6|||
94234074|NCT02706951|322652557|FG003|Period 1|Withdrawal by Subject|0|||
94234075|NCT02706951|322652558|FG004|Period 1|Withdrawal by Subject|0|||
94234076|NCT02706951|322652554|FG000|Period 1|Lost to Follow-up|0|||
94234077|NCT02706951|322652555|FG001|Period 1|Lost to Follow-up|4|||
94234078|NCT02706951|322652556|FG002|Period 1|Lost to Follow-up|1|||
94234079|NCT02706951|322652557|FG003|Period 1|Lost to Follow-up|0|||
94234080|NCT02706951|322652558|FG004|Period 1|Lost to Follow-up|0|||
94234081|NCT02706951|322652554|FG000|Period 1|Other|2|||
94234082|NCT02706951|322652555|FG001|Period 1|Other|1|||
94234083|NCT02706951|322652556|FG002|Period 1|Other|0|||
94234084|NCT02706951|322652557|FG003|Period 1|Other|0|||
94234085|NCT02706951|322652558|FG004|Period 1|Other|0|||
94234086|NCT02706951|322652554|FG000|Period 2|Adverse Event|0|||
94234087|NCT02706951|322652555|FG001|Period 2|Adverse Event|0|||
94234088|NCT02706951|322652556|FG002|Period 2|Adverse Event|0|||
94234089|NCT02706951|322652557|FG003|Period 2|Adverse Event|25|||
94234090|NCT02706951|322652558|FG004|Period 2|Adverse Event|34|||
94234091|NCT02706951|322652554|FG000|Period 2|Withdrawal by Subject|0|||
94234092|NCT02706951|322652555|FG001|Period 2|Withdrawal by Subject|0|||
94234093|NCT02706951|322652556|FG002|Period 2|Withdrawal by Subject|0|||
94234094|NCT02706951|322652557|FG003|Period 2|Withdrawal by Subject|38|||
94234095|NCT02706951|322652558|FG004|Period 2|Withdrawal by Subject|44|||
94234096|NCT02706951|322652554|FG000|Period 2|Lost to Follow-up|0|||
94234097|NCT02706951|322652555|FG001|Period 2|Lost to Follow-up|0|||
94234098|NCT02706951|322652556|FG002|Period 2|Lost to Follow-up|0|||
94234099|NCT02706951|322652557|FG003|Period 2|Lost to Follow-up|17|||
94234100|NCT02706951|322652558|FG004|Period 2|Lost to Follow-up|9|||
94234101|NCT02706951|322652554|FG000|Period 2|COVID-19 Related|0|||
94234102|NCT02706951|322652555|FG001|Period 2|COVID-19 Related|0|||
94345883|NCT02442765|323047629|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
94365603|NCT00532779|323122444|FG002|Overall Study|Drug noncompliance, moved, other|29|||
94234103|NCT02706951|322652556|FG002|Period 2|COVID-19 Related|0|||
94234104|NCT02706951|322652557|FG003|Period 2|COVID-19 Related|1|||
94234105|NCT02706951|322652558|FG004|Period 2|COVID-19 Related|2|||
94234106|NCT02706951|322652554|FG000|Period 2|Other|0|||
94234107|NCT02706951|322652555|FG001|Period 2|Other|0|||
94234108|NCT02706951|322652556|FG002|Period 2|Other|0|||
94234109|NCT02706951|322652557|FG003|Period 2|Other|37|||
94562981|NCT01217944|323858063|FG002|Overall Study|Protocol Violation|0|||
94562982|NCT01217944|323858061|FG000|Overall Study|Lost to Follow-up|3|||
94562983|NCT01217944|323858062|FG001|Overall Study|Lost to Follow-up|1|||
94234110|NCT02706951|322652558|FG004|Period 2|Other|31|||
94365604|NCT02662556|323122446|FG000|Overall Study|Adverse Event|4|||
94450324|NCT03850483|323435406|FG004|Follow-up for Stage 1|Other|0|||
94450325|NCT03850483|323435407|FG005|Follow-up for Stage 1|Other|1|||
94450326|NCT03850483|323435408|FG006|Follow-up for Stage 1|Other|0|||
94450327|NCT03850483|323435409|FG007|Follow-up for Stage 1|Other|0|||
94450328|NCT03850483|323435410|FG008|Follow-up for Stage 1|Other|0|||
94234111|NCT01475461|322652564|FG000|Run-in Period|Not meet eligibility criteria|16|||
94234112|NCT01475461|322652565|FG001|Run-in Period|Not meet eligibility criteria|0|||
94234113|NCT01475461|322652566|FG002|Run-in Period|Not meet eligibility criteria|0|||
94234114|NCT01475461|322652567|FG003|Run-in Period|Not meet eligibility criteria|0|||
94234115|NCT01475461|322652568|FG004|Run-in Period|Not meet eligibility criteria|0|||
94234116|NCT01475461|322652569|FG005|Run-in Period|Not meet eligibility criteria|0|||
94234117|NCT01475461|322652570|FG006|Run-in Period|Not meet eligibility criteria|0|||
94234118|NCT01475461|322652564|FG000|Run-in Period|Lost to Follow-up|7|||
94234119|NCT01475461|322652565|FG001|Run-in Period|Lost to Follow-up|0|||
94234120|NCT01475461|322652566|FG002|Run-in Period|Lost to Follow-up|0|||
94234121|NCT01475461|322652567|FG003|Run-in Period|Lost to Follow-up|0|||
94234122|NCT01475461|322652568|FG004|Run-in Period|Lost to Follow-up|0|||
94234123|NCT01475461|322652569|FG005|Run-in Period|Lost to Follow-up|0|||
94234124|NCT01475461|322652570|FG006|Run-in Period|Lost to Follow-up|0|||
94234125|NCT01475461|322652564|FG000|Run-in Period|Withdrawal by Subject|11|||
94234126|NCT01475461|322652565|FG001|Run-in Period|Withdrawal by Subject|0|||
94234127|NCT01475461|322652566|FG002|Run-in Period|Withdrawal by Subject|0|||
94234128|NCT01475461|322652567|FG003|Run-in Period|Withdrawal by Subject|0|||
94234129|NCT01475461|322652568|FG004|Run-in Period|Withdrawal by Subject|0|||
94234130|NCT01475461|322652569|FG005|Run-in Period|Withdrawal by Subject|0|||
94234131|NCT01475461|322652570|FG006|Run-in Period|Withdrawal by Subject|0|||
94234132|NCT01475461|322652564|FG000|Run-in Period|Other|3|||
94562984|NCT01217944|323858063|FG002|Overall Study|Lost to Follow-up|0|||
94562985|NCT01217944|323858061|FG000|Overall Study|Withdrawal by Subject|1|||
94234133|NCT01475461|322652565|FG001|Run-in Period|Other|0|||
94234134|NCT01475461|322652566|FG002|Run-in Period|Other|0|||
94345884|NCT02442765|323047630|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
94345885|NCT02442765|323047631|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
94345886|NCT02442765|323047632|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
94345887|NCT02442765|323047633|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
94345888|NCT02442765|323047634|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
94345889|NCT02442765|323047635|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
94345890|NCT02442765|323047636|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
94345891|NCT02442765|323047629|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
94345892|NCT02442765|323047630|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
94345893|NCT02442765|323047631|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
94345894|NCT02442765|323047632|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
94345895|NCT02442765|323047633|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
94345896|NCT02442765|323047634|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
94345897|NCT02442765|323047635|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
94450329|NCT03850483|323435411|FG009|Follow-up for Stage 1|Other|0|||
94562986|NCT01217944|323858062|FG001|Overall Study|Withdrawal by Subject|2|||
94562987|NCT01217944|323858063|FG002|Overall Study|Withdrawal by Subject|0|||
94450330|NCT03850483|323435402|FG000|Treatment for Stage 2|Adverse Event|0|||
94450331|NCT03850483|323435403|FG001|Treatment for Stage 2|Adverse Event|0|||
94450332|NCT03850483|323435404|FG002|Treatment for Stage 2|Adverse Event|0|||
94450333|NCT03850483|323435405|FG003|Treatment for Stage 2|Adverse Event|0|||
94450334|NCT03850483|323435406|FG004|Treatment for Stage 2|Adverse Event|0|||
94450335|NCT03850483|323435407|FG005|Treatment for Stage 2|Adverse Event|0|||
94450336|NCT03850483|323435408|FG006|Treatment for Stage 2|Adverse Event|0|||
94450337|NCT03850483|323435409|FG007|Treatment for Stage 2|Adverse Event|0|||
94450338|NCT03850483|323435410|FG008|Treatment for Stage 2|Adverse Event|0|||
94450339|NCT03850483|323435411|FG009|Treatment for Stage 2|Adverse Event|1|||
94450340|NCT03850483|323435402|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
94450341|NCT03850483|323435403|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
94450342|NCT03850483|323435404|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
94657811|NCT04666441|324204436|FG005|Overall Study|Lost to Follow-up|2|||
94657812|NCT04666441|324204437|FG006|Overall Study|Lost to Follow-up|2|||
94450343|NCT03850483|323435405|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
94657813|NCT04666441|324204438|FG007|Overall Study|Lost to Follow-up|2|||
94657814|NCT04666441|324204431|FG000|Overall Study|Subject Decision|1|||
94562988|NCT01217944|323858061|FG000|Overall Study|Lack of Efficacy|1|||
94562989|NCT01217944|323858062|FG001|Overall Study|Lack of Efficacy|0|||
94562990|NCT01217944|323858063|FG002|Overall Study|Lack of Efficacy|0|||
94562991|NCT00853151|323858064|FG000|Overall Study|Adverse Event|1|||
94562992|NCT00853151|323858065|FG001|Overall Study|Adverse Event|4|||
94562993|NCT00853151|323858066|FG002|Overall Study|Adverse Event|2|||
94562994|NCT00853151|323858067|FG003|Overall Study|Adverse Event|0|||
94345898|NCT02442765|323047636|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
94345899|NCT02442765|323047629|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
94345900|NCT02442765|323047630|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
94234135|NCT01475461|322652567|FG003|Run-in Period|Other|0|||
94234136|NCT01475461|322652568|FG004|Run-in Period|Other|0|||
94234137|NCT01475461|322652569|FG005|Run-in Period|Other|0|||
94234138|NCT01475461|322652570|FG006|Run-in Period|Other|0|||
94234139|NCT01475461|322652564|FG000|Run-in Period|Protocol Violation|4|||
94345901|NCT02442765|323047631|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
94345902|NCT02442765|323047632|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
94345903|NCT02442765|323047633|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
94345904|NCT02442765|323047634|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
94562995|NCT00853151|323858064|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
94562996|NCT00853151|323858065|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
94562997|NCT00853151|323858066|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
94562998|NCT00853151|323858067|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
94562999|NCT00853151|323858064|FG000|Overall Study|Lost to Follow-up|2|||
94563000|NCT00853151|323858065|FG001|Overall Study|Lost to Follow-up|0|||
94563001|NCT00853151|323858066|FG002|Overall Study|Lost to Follow-up|3|||
94563002|NCT00853151|323858067|FG003|Overall Study|Lost to Follow-up|0|||
94563003|NCT00853151|323858064|FG000|Overall Study|Death|1|||
94563004|NCT00853151|323858065|FG001|Overall Study|Death|0|||
94563005|NCT00853151|323858066|FG002|Overall Study|Death|0|||
94657815|NCT04666441|324204432|FG001|Overall Study|Subject Decision|1|||
94657816|NCT04666441|324204433|FG002|Overall Study|Subject Decision|3|||
94234140|NCT01475461|322652565|FG001|Run-in Period|Protocol Violation|0|||
94234141|NCT01475461|322652566|FG002|Run-in Period|Protocol Violation|0|||
94234142|NCT01475461|322652567|FG003|Run-in Period|Protocol Violation|0|||
94234143|NCT01475461|322652568|FG004|Run-in Period|Protocol Violation|0|||
94234144|NCT01475461|322652569|FG005|Run-in Period|Protocol Violation|0|||
94234145|NCT01475461|322652570|FG006|Run-in Period|Protocol Violation|0|||
94234146|NCT01475461|322652564|FG000|Treatment Period|Death|0|||
94234147|NCT01475461|322652565|FG001|Treatment Period|Death|0|||
94234148|NCT01475461|322652566|FG002|Treatment Period|Death|0|||
94234149|NCT01475461|322652567|FG003|Treatment Period|Death|1|||
94234150|NCT01475461|322652568|FG004|Treatment Period|Death|0|||
94234151|NCT01475461|322652569|FG005|Treatment Period|Death|0|||
94234152|NCT01475461|322652570|FG006|Treatment Period|Death|0|||
94234153|NCT01475461|322652564|FG000|Treatment Period|Lost to Follow-up|0|||
94234154|NCT01475461|322652565|FG001|Treatment Period|Lost to Follow-up|3|||
94234155|NCT01475461|322652566|FG002|Treatment Period|Lost to Follow-up|2|||
94234156|NCT01475461|322652567|FG003|Treatment Period|Lost to Follow-up|3|||
94234157|NCT01475461|322652568|FG004|Treatment Period|Lost to Follow-up|1|||
94234158|NCT01475461|322652569|FG005|Treatment Period|Lost to Follow-up|2|||
94234159|NCT01475461|322652570|FG006|Treatment Period|Lost to Follow-up|1|||
94234160|NCT01475461|322652564|FG000|Treatment Period|Withdrawal by Subject|0|||
94234161|NCT01475461|322652565|FG001|Treatment Period|Withdrawal by Subject|2|||
94234162|NCT01475461|322652566|FG002|Treatment Period|Withdrawal by Subject|2|||
94450344|NCT03850483|323435406|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
94563006|NCT00853151|323858067|FG003|Overall Study|Death|1|||
94563007|NCT00853151|323858064|FG000|Overall Study|Protocol Violation|0|||
94563008|NCT00853151|323858065|FG001|Overall Study|Protocol Violation|0|||
94563009|NCT00853151|323858066|FG002|Overall Study|Protocol Violation|0|||
94657817|NCT04666441|324204434|FG003|Overall Study|Subject Decision|1|||
94657818|NCT04666441|324204435|FG004|Overall Study|Subject Decision|0|||
94234163|NCT01475461|322652567|FG003|Treatment Period|Withdrawal by Subject|0|||
94234164|NCT01475461|322652568|FG004|Treatment Period|Withdrawal by Subject|2|||
94234165|NCT01475461|322652569|FG005|Treatment Period|Withdrawal by Subject|2|||
94234166|NCT01475461|322652570|FG006|Treatment Period|Withdrawal by Subject|0|||
94234167|NCT01475461|322652564|FG000|Treatment Period|Other|0|||
94234168|NCT01475461|322652565|FG001|Treatment Period|Other|1|||
94234169|NCT01475461|322652566|FG002|Treatment Period|Other|0|||
94234170|NCT01475461|322652567|FG003|Treatment Period|Other|0|||
94234171|NCT01475461|322652568|FG004|Treatment Period|Other|0|||
94234172|NCT01475461|322652569|FG005|Treatment Period|Other|0|||
94234173|NCT01475461|322652570|FG006|Treatment Period|Other|0|||
94234174|NCT01475461|322652564|FG000|Treatment Period|Protocol Violation|0|||
94234175|NCT01475461|322652565|FG001|Treatment Period|Protocol Violation|1|||
94234176|NCT01475461|322652566|FG002|Treatment Period|Protocol Violation|0|||
94234177|NCT01475461|322652567|FG003|Treatment Period|Protocol Violation|0|||
94234178|NCT01475461|322652568|FG004|Treatment Period|Protocol Violation|0|||
94234179|NCT01475461|322652569|FG005|Treatment Period|Protocol Violation|0|||
94450345|NCT03850483|323435407|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
94450346|NCT03850483|323435408|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
94450347|NCT03850483|323435409|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
94450348|NCT03850483|323435410|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
94450349|NCT03850483|323435411|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
94450350|NCT03850483|323435402|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
94450351|NCT03850483|323435403|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
94450352|NCT03850483|323435404|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
94450353|NCT03850483|323435405|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
94450354|NCT03850483|323435406|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
94234180|NCT01475461|322652570|FG006|Treatment Period|Protocol Violation|1|||
94234181|NCT01475461|322652564|FG000|Treatment Period|Lack of Efficacy|0|||
94234182|NCT01475461|322652565|FG001|Treatment Period|Lack of Efficacy|2|||
94450355|NCT03850483|323435407|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
94345905|NCT02442765|323047635|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
94345906|NCT02442765|323047636|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
94345907|NCT02442765|323047629|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
94345908|NCT02442765|323047630|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
94345909|NCT02442765|323047631|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
94345910|NCT02442765|323047632|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
94345911|NCT02442765|323047633|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
94345912|NCT02442765|323047634|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
94345913|NCT02442765|323047635|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
94345914|NCT02442765|323047636|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
94345915|NCT00998985|323047642|FG000|Overall Study|Withdrawal by Subject|0|||
94345916|NCT00998985|323047643|FG001|Overall Study|Withdrawal by Subject|0|||
94345917|NCT00998985|323047644|FG002|Overall Study|Withdrawal by Subject|0|||
94345918|NCT00998985|323047645|FG003|Overall Study|Withdrawal by Subject|0|||
94345919|NCT00998985|323047646|FG004|Overall Study|Withdrawal by Subject|0|||
94345920|NCT00998985|323047647|FG005|Overall Study|Withdrawal by Subject|0|||
94345921|NCT00998985|323047648|FG006|Overall Study|Withdrawal by Subject|0|||
94345922|NCT00998985|323047649|FG007|Overall Study|Withdrawal by Subject|0|||
94345923|NCT00998985|323047650|FG008|Overall Study|Withdrawal by Subject|1|||
94345924|NCT00998985|323047651|FG009|Overall Study|Withdrawal by Subject|0|||
94345925|NCT00998985|323047652|FG010|Overall Study|Withdrawal by Subject|0|||
94345926|NCT00998985|323047653|FG011|Overall Study|Withdrawal by Subject|0|||
94345927|NCT00998985|323047654|FG012|Overall Study|Withdrawal by Subject|0|||
94345928|NCT00998985|323047655|FG013|Overall Study|Withdrawal by Subject|0|||
94345929|NCT00998985|323047642|FG000|Overall Study|Protocol Violation|0|||
94345930|NCT00998985|323047643|FG001|Overall Study|Protocol Violation|0|||
94345931|NCT00998985|323047644|FG002|Overall Study|Protocol Violation|0|||
94345932|NCT00998985|323047645|FG003|Overall Study|Protocol Violation|0|||
94345933|NCT00998985|323047646|FG004|Overall Study|Protocol Violation|0|||
94345934|NCT00998985|323047647|FG005|Overall Study|Protocol Violation|1|||
94345935|NCT00998985|323047648|FG006|Overall Study|Protocol Violation|0|||
94345936|NCT00998985|323047649|FG007|Overall Study|Protocol Violation|0|||
94345937|NCT00998985|323047650|FG008|Overall Study|Protocol Violation|0|||
94345938|NCT00998985|323047651|FG009|Overall Study|Protocol Violation|0|||
94345939|NCT00998985|323047652|FG010|Overall Study|Protocol Violation|0|||
94345940|NCT00998985|323047653|FG011|Overall Study|Protocol Violation|0|||
94345941|NCT00998985|323047654|FG012|Overall Study|Protocol Violation|0|||
94345942|NCT00998985|323047655|FG013|Overall Study|Protocol Violation|0|||
94234183|NCT01475461|322652566|FG002|Treatment Period|Lack of Efficacy|0|||
94234184|NCT01475461|322652567|FG003|Treatment Period|Lack of Efficacy|2|||
94657819|NCT04666441|324204436|FG005|Overall Study|Subject Decision|1|||
94657820|NCT04666441|324204437|FG006|Overall Study|Subject Decision|3|||
94657821|NCT04666441|324204438|FG007|Overall Study|Subject Decision|2|||
94657822|NCT00766415|324204439|FG000|Overall Study|Withdrawal by Subject|0|||
94657823|NCT00766415|324204440|FG001|Overall Study|Withdrawal by Subject|1|||
94657824|NCT02752048|324204441|FG000|Overall Study|Withdrawal by Subject|0|||
94657825|NCT02752048|324204442|FG001|Overall Study|Withdrawal by Subject|0|||
94657826|NCT02752048|324204443|FG002|Overall Study|Withdrawal by Subject|3|||
94657827|NCT01431508|324204444|FG000|Overall Study|Lack of Efficacy|1|||
94657828|NCT01431508|324204444|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
94345943|NCT03099304|323047658|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
94345944|NCT03099304|323047659|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
94345945|NCT03099304|323047660|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
94345946|NCT03099304|323047661|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
94345947|NCT03099304|323047662|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
94345948|NCT03099304|323047663|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
94345949|NCT03099304|323047658|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
94345950|NCT03099304|323047659|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
94345951|NCT03099304|323047660|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
94345952|NCT03099304|323047661|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
94345953|NCT03099304|323047662|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
94345954|NCT03099304|323047663|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
94345955|NCT03099304|323047658|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
94345956|NCT03099304|323047659|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
94345957|NCT03099304|323047660|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
94345958|NCT03099304|323047661|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
94563010|NCT00853151|323858067|FG003|Overall Study|Protocol Violation|1|||
94563011|NCT00853151|323858064|FG000|Overall Study|Withdrawal by Subject|5|||
94234185|NCT01475461|322652568|FG004|Treatment Period|Lack of Efficacy|1|||
94234186|NCT01475461|322652569|FG005|Treatment Period|Lack of Efficacy|1|||
94234187|NCT01475461|322652570|FG006|Treatment Period|Lack of Efficacy|0|||
94234188|NCT01475461|322652564|FG000|Treatment Period|Medication Error|0|||
94234189|NCT01475461|322652565|FG001|Treatment Period|Medication Error|0|||
94234190|NCT01475461|322652566|FG002|Treatment Period|Medication Error|0|||
94234191|NCT01475461|322652567|FG003|Treatment Period|Medication Error|1|||
94234192|NCT01475461|322652568|FG004|Treatment Period|Medication Error|0|||
94234193|NCT01475461|322652569|FG005|Treatment Period|Medication Error|0|||
94234194|NCT01475461|322652570|FG006|Treatment Period|Medication Error|0|||
94234195|NCT01475461|322652564|FG000|Treatment Period|Adverse Event|0|||
94234196|NCT01475461|322652565|FG001|Treatment Period|Adverse Event|0|||
94234197|NCT01475461|322652566|FG002|Treatment Period|Adverse Event|0|||
94234198|NCT01475461|322652567|FG003|Treatment Period|Adverse Event|1|||
94234199|NCT01475461|322652568|FG004|Treatment Period|Adverse Event|0|||
94234200|NCT01475461|322652569|FG005|Treatment Period|Adverse Event|0|||
94234201|NCT01475461|322652570|FG006|Treatment Period|Adverse Event|0|||
94234202|NCT03721172|322652571|FG000|Placebo-controlled Phase|Adverse Event|7|||
94234203|NCT03721172|322652572|FG001|Placebo-controlled Phase|Adverse Event|7|||
94234204|NCT03721172|322652573|FG002|Placebo-controlled Phase|Adverse Event|0|||
94234205|NCT03721172|322652571|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
94234206|NCT03721172|322652572|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
94234207|NCT03721172|322652573|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
94234208|NCT03721172|322652571|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
94234209|NCT03721172|322652572|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
94345959|NCT03099304|323047662|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
94345960|NCT03099304|323047663|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
94345961|NCT03099304|323047658|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
94234210|NCT03721172|322652573|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
94234211|NCT03721172|322652571|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
94234212|NCT03721172|322652572|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
94234213|NCT03721172|322652573|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
94345962|NCT03099304|323047659|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
94345963|NCT03099304|323047660|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
94345964|NCT03099304|323047661|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
94345965|NCT03099304|323047662|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
94345966|NCT03099304|323047663|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
94345967|NCT03099304|323047658|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
94345968|NCT03099304|323047659|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
94345969|NCT03099304|323047660|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
94345970|NCT03099304|323047661|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
94345971|NCT03099304|323047662|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
94345972|NCT03099304|323047663|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
94345973|NCT03099304|323047658|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
94345974|NCT03099304|323047659|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
94345975|NCT03099304|323047660|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
94345976|NCT03099304|323047661|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
94345977|NCT03099304|323047662|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
94345978|NCT03099304|323047663|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
94345979|NCT03099304|323047658|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
94345980|NCT03099304|323047659|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
94450356|NCT03850483|323435408|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
94450357|NCT03850483|323435409|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
94450358|NCT03850483|323435410|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
94450359|NCT03850483|323435411|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
94450360|NCT03850483|323435402|FG000|Treatment for Stage 2|Physician Decision|0|||
94450361|NCT03850483|323435403|FG001|Treatment for Stage 2|Physician Decision|0|||
94450362|NCT03850483|323435404|FG002|Treatment for Stage 2|Physician Decision|0|||
94450363|NCT03850483|323435405|FG003|Treatment for Stage 2|Physician Decision|0|||
94345981|NCT03099304|323047660|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
94345982|NCT03099304|323047661|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
94345983|NCT03099304|323047662|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
94345984|NCT03099304|323047663|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
94450364|NCT03850483|323435406|FG004|Treatment for Stage 2|Physician Decision|0|||
94450365|NCT03850483|323435407|FG005|Treatment for Stage 2|Physician Decision|0|||
94450366|NCT03850483|323435408|FG006|Treatment for Stage 2|Physician Decision|0|||
94345985|NCT03099304|323047658|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
94345986|NCT03099304|323047659|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
94345987|NCT03099304|323047660|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
94345988|NCT03099304|323047661|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
94345989|NCT03099304|323047662|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
94345990|NCT03099304|323047663|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
94345991|NCT03099304|323047658|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
94345992|NCT03099304|323047659|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
94345993|NCT03099304|323047660|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
94345994|NCT03099304|323047661|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
94345995|NCT03099304|323047662|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
94345996|NCT03099304|323047663|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
94345997|NCT03099304|323047658|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
94345998|NCT03099304|323047659|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
94345999|NCT03099304|323047660|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
94346000|NCT03099304|323047661|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
94346001|NCT03099304|323047662|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
94346002|NCT03099304|323047663|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
94346003|NCT03099304|323047658|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
94346004|NCT03099304|323047659|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
94346005|NCT03099304|323047660|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
94346006|NCT03099304|323047661|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
94346007|NCT03099304|323047662|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
94346008|NCT03099304|323047663|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
94346009|NCT03099304|323047658|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
94346010|NCT03099304|323047659|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
94346011|NCT03099304|323047660|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
94346012|NCT03099304|323047661|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
94346013|NCT03099304|323047662|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
94346014|NCT03099304|323047663|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
94346015|NCT03099304|323047658|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
94346016|NCT03099304|323047659|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
94346017|NCT03099304|323047660|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
94346018|NCT03099304|323047661|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
94346019|NCT03099304|323047662|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
94346020|NCT03099304|323047663|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
94346021|NCT03099304|323047658|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
94346022|NCT03099304|323047659|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
94346023|NCT03099304|323047660|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
94346024|NCT03099304|323047661|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
94346025|NCT03099304|323047662|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
94346026|NCT03099304|323047663|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
94346027|NCT03099304|323047658|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
94346028|NCT03099304|323047659|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
94346029|NCT03099304|323047660|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
94657829|NCT00132769|324204445|FG000|Overall Study|Withdrawal by Subject|1|||
94657830|NCT00132769|324204446|FG001|Overall Study|Withdrawal by Subject|3|||
94657831|NCT00132769|324204445|FG000|Overall Study|Lack of Efficacy|7|||
94657832|NCT00132769|324204446|FG001|Overall Study|Lack of Efficacy|6|||
94657833|NCT00132769|324204445|FG000|Overall Study|Adverse Event|2|||
94657834|NCT00132769|324204446|FG001|Overall Study|Adverse Event|1|||
94657835|NCT00132769|324204445|FG000|Overall Study|Protocol Violation|1|||
94657836|NCT00132769|324204446|FG001|Overall Study|Protocol Violation|1|||
94657837|NCT00129259|324204450|FG000|Overall Study|Lost to Follow-up|1|||
94657838|NCT00129259|324204451|FG001|Overall Study|Lost to Follow-up|1|||
94346030|NCT03099304|323047661|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
94346031|NCT03099304|323047662|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
94346032|NCT03099304|323047663|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
94346033|NCT03099304|323047658|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
94450367|NCT03850483|323435409|FG007|Treatment for Stage 2|Physician Decision|0|||
94450368|NCT03850483|323435410|FG008|Treatment for Stage 2|Physician Decision|0|||
94450369|NCT03850483|323435411|FG009|Treatment for Stage 2|Physician Decision|1|||
94450370|NCT03850483|323435402|FG000|Treatment for Stage 2|Protocol Violation|0|||
94450371|NCT03850483|323435403|FG001|Treatment for Stage 2|Protocol Violation|0|||
94450372|NCT03850483|323435404|FG002|Treatment for Stage 2|Protocol Violation|0|||
94450373|NCT03850483|323435405|FG003|Treatment for Stage 2|Protocol Violation|0|||
94450374|NCT03850483|323435406|FG004|Treatment for Stage 2|Protocol Violation|0|||
94450375|NCT03850483|323435407|FG005|Treatment for Stage 2|Protocol Violation|0|||
94450376|NCT03850483|323435408|FG006|Treatment for Stage 2|Protocol Violation|0|||
94657839|NCT00129259|324204450|FG000|Overall Study|Withdrawal by Subject|2|||
94657840|NCT00129259|324204451|FG001|Overall Study|Withdrawal by Subject|1|||
94234214|NCT03721172|322652571|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
94234215|NCT03721172|322652572|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
94234216|NCT03721172|322652573|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
94234217|NCT03721172|322652571|FG000|Placebo-controlled Phase|Other|3|||
94234218|NCT03721172|322652572|FG001|Placebo-controlled Phase|Other|0|||
94234219|NCT03721172|322652573|FG002|Placebo-controlled Phase|Other|0|||
94234220|NCT03721172|322652571|FG000|Apremilast Extension Phase|Adverse Event|0|||
94234221|NCT03721172|322652572|FG001|Apremilast Extension Phase|Adverse Event|0|||
94234222|NCT03721172|322652573|FG002|Apremilast Extension Phase|Adverse Event|10|||
94234223|NCT03721172|322652571|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
94234224|NCT03721172|322652572|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
94234225|NCT03721172|322652573|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
94234226|NCT03721172|322652571|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
94234227|NCT03721172|322652572|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
94563012|NCT00853151|323858065|FG001|Overall Study|Withdrawal by Subject|4|||
94563013|NCT00853151|323858066|FG002|Overall Study|Withdrawal by Subject|2|||
94563014|NCT00853151|323858067|FG003|Overall Study|Withdrawal by Subject|1|||
94563015|NCT00853151|323858064|FG000|Overall Study|Physician Decision|0|||
94563016|NCT00853151|323858065|FG001|Overall Study|Physician Decision|2|||
94563017|NCT00853151|323858066|FG002|Overall Study|Physician Decision|1|||
94563018|NCT00853151|323858067|FG003|Overall Study|Physician Decision|0|||
94563019|NCT00853151|323858064|FG000|Overall Study|Sponsor Decision|0|||
94563020|NCT00853151|323858065|FG001|Overall Study|Sponsor Decision|3|||
94346034|NCT03099304|323047659|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
94346035|NCT03099304|323047660|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
94365605|NCT02662556|323122446|FG000|Overall Study|Lack of Efficacy|4|||
94234228|NCT03721172|322652573|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
94234229|NCT03721172|322652571|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
94234230|NCT03721172|322652572|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
94234231|NCT03721172|322652573|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
94234232|NCT03721172|322652571|FG000|Apremilast Extension Phase|Protocol Violation|0|||
94234233|NCT03721172|322652572|FG001|Apremilast Extension Phase|Protocol Violation|0|||
94234234|NCT03721172|322652573|FG002|Apremilast Extension Phase|Protocol Violation|1|||
94234235|NCT03721172|322652571|FG000|Apremilast Extension Phase|Physician Decision|0|||
94234236|NCT03721172|322652572|FG001|Apremilast Extension Phase|Physician Decision|0|||
94234237|NCT03721172|322652573|FG002|Apremilast Extension Phase|Physician Decision|1|||
94234238|NCT03721172|322652571|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
94234239|NCT03721172|322652572|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
94234240|NCT03721172|322652573|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
94234241|NCT03721172|322652571|FG000|Apremilast Extension Phase|Other|0|||
94234242|NCT03721172|322652572|FG001|Apremilast Extension Phase|Other|0|||
94234243|NCT03721172|322652573|FG002|Apremilast Extension Phase|Other|3|||
94234244|NCT03721172|322652571|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
94234245|NCT03721172|322652572|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
94234246|NCT03721172|322652573|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
94234247|NCT00236184|322652579|FG000|Overall Study|Adverse Event|5|||
94234248|NCT00236184|322652580|FG001|Overall Study|Adverse Event|2|||
94234249|NCT00236184|322652579|FG000|Overall Study|Lack of Efficacy|0|||
94234250|NCT00236184|322652580|FG001|Overall Study|Lack of Efficacy|1|||
94234251|NCT00236184|322652579|FG000|Overall Study|Lost to Follow-up|3|||
94234252|NCT00236184|322652580|FG001|Overall Study|Lost to Follow-up|4|||
94234253|NCT00236184|322652579|FG000|Overall Study|Physician Decision|1|||
94234254|NCT00236184|322652580|FG001|Overall Study|Physician Decision|1|||
94234255|NCT00236184|322652579|FG000|Overall Study|Withdrawal by Subject|3|||
94234256|NCT00236184|322652580|FG001|Overall Study|Withdrawal by Subject|0|||
94234257|NCT00236184|322652579|FG000|Overall Study|Protocol Violation|3|||
94234258|NCT00236184|322652580|FG001|Overall Study|Protocol Violation|0|||
94234259|NCT00236184|322652579|FG000|Overall Study|non-compliance with study drug|2|||
94234260|NCT00236184|322652580|FG001|Overall Study|non-compliance with study drug|1|||
94234261|NCT00236184|322652579|FG000|Overall Study|other|1|||
94234262|NCT00236184|322652580|FG001|Overall Study|other|2|||
94234263|NCT03016598|322652581|FG000|Overall Study|Lost to Follow-up|0|||
94234264|NCT03016598|322652582|FG001|Overall Study|Lost to Follow-up|2|||
94234265|NCT00458393|322652589|FG000|Overall Study|Withdrawal by Subject|67|||
94234266|NCT00458393|322652590|FG001|Overall Study|Withdrawal by Subject|80|||
94234267|NCT00458393|322652589|FG000|Overall Study|Physician Decision|31|||
94234268|NCT00458393|322652590|FG001|Overall Study|Physician Decision|22|||
94234269|NCT00458393|322652589|FG000|Overall Study|Relocated|77|||
94234270|NCT00458393|322652590|FG001|Overall Study|Relocated|81|||
94234271|NCT00458393|322652589|FG000|Overall Study|Lost to Follow-up|115|||
94234272|NCT00458393|322652590|FG001|Overall Study|Lost to Follow-up|92|||
94234273|NCT00458393|322652589|FG000|Overall Study|Sites marked other on the form.|19|||
94234274|NCT00458393|322652590|FG001|Overall Study|Sites marked other on the form.|20|||
94234275|NCT01628692|322652591|FG000|Overall Study|Lack of Efficacy|4|||
94234276|NCT01628692|322652592|FG001|Overall Study|Lack of Efficacy|4|||
94234277|NCT01628692|322652593|FG002|Overall Study|Lack of Efficacy|5|||
94234278|NCT01628692|322652594|FG003|Overall Study|Lack of Efficacy|1|||
94234279|NCT01628692|322652595|FG004|Overall Study|Lack of Efficacy|4|||
94234280|NCT01628692|322652596|FG005|Overall Study|Lack of Efficacy|7|||
94234281|NCT01628692|322652591|FG000|Overall Study|Adverse Event|2|||
94234282|NCT01628692|322652592|FG001|Overall Study|Adverse Event|0|||
94234283|NCT01628692|322652593|FG002|Overall Study|Adverse Event|2|||
94234284|NCT01628692|322652594|FG003|Overall Study|Adverse Event|0|||
94234285|NCT01628692|322652595|FG004|Overall Study|Adverse Event|0|||
94234286|NCT01628692|322652596|FG005|Overall Study|Adverse Event|0|||
94234287|NCT01628692|322652591|FG000|Overall Study|Withdrawal by Subject|0|||
94234288|NCT01628692|322652592|FG001|Overall Study|Withdrawal by Subject|1|||
94234289|NCT01628692|322652593|FG002|Overall Study|Withdrawal by Subject|1|||
94450377|NCT03850483|323435409|FG007|Treatment for Stage 2|Protocol Violation|0|||
94450378|NCT03850483|323435410|FG008|Treatment for Stage 2|Protocol Violation|1|||
94657841|NCT00129259|324204450|FG000|Overall Study|Only available minimal phone assessments|0|||
94657842|NCT00129259|324204451|FG001|Overall Study|Only available minimal phone assessments|1|||
94234290|NCT01628692|322652594|FG003|Overall Study|Withdrawal by Subject|0|||
94234291|NCT01628692|322652595|FG004|Overall Study|Withdrawal by Subject|0|||
94234292|NCT01628692|322652596|FG005|Overall Study|Withdrawal by Subject|0|||
94234293|NCT01628692|322652591|FG000|Overall Study|Death|0|||
94234294|NCT01628692|322652592|FG001|Overall Study|Death|1|||
94234295|NCT01628692|322652593|FG002|Overall Study|Death|0|||
94234296|NCT01628692|322652594|FG003|Overall Study|Death|0|||
94234297|NCT01628692|322652595|FG004|Overall Study|Death|0|||
94450379|NCT03850483|323435411|FG009|Treatment for Stage 2|Protocol Violation|0|||
94450380|NCT03850483|323435402|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
94450381|NCT03850483|323435403|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
94234298|NCT01628692|322652596|FG005|Overall Study|Death|0|||
94234299|NCT01628692|322652591|FG000|Overall Study|Poor compliance/noncompliance|1|||
94234300|NCT01628692|322652592|FG001|Overall Study|Poor compliance/noncompliance|0|||
94234301|NCT01628692|322652593|FG002|Overall Study|Poor compliance/noncompliance|0|||
94234302|NCT01628692|322652594|FG003|Overall Study|Poor compliance/noncompliance|0|||
94234303|NCT01628692|322652595|FG004|Overall Study|Poor compliance/noncompliance|0|||
94234304|NCT01628692|322652596|FG005|Overall Study|Poor compliance/noncompliance|0|||
94234305|NCT01628692|322652591|FG000|Overall Study|Administrative reason by sponsor|0|||
94234306|NCT01628692|322652592|FG001|Overall Study|Administrative reason by sponsor|0|||
94234307|NCT01628692|322652593|FG002|Overall Study|Administrative reason by sponsor|0|||
94234308|NCT01628692|322652594|FG003|Overall Study|Administrative reason by sponsor|0|||
94234309|NCT01628692|322652595|FG004|Overall Study|Administrative reason by sponsor|0|||
94346036|NCT03099304|323047661|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
94346037|NCT03099304|323047662|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
94563021|NCT00853151|323858066|FG002|Overall Study|Sponsor Decision|0|||
94346038|NCT03099304|323047663|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
94563022|NCT00853151|323858067|FG003|Overall Study|Sponsor Decision|0|||
94234310|NCT01628692|322652596|FG005|Overall Study|Administrative reason by sponsor|1|||
94234311|NCT01628692|322652591|FG000|Overall Study|Completed 12 Week only|0|||
94563023|NCT00713544|323858068|FG000|Overall Study|Adverse Event|5|||
94563024|NCT00713544|323858069|FG001|Overall Study|Adverse Event|3|||
94563025|NCT00713544|323858070|FG002|Overall Study|Adverse Event|7|||
94563026|NCT00713544|323858071|FG003|Overall Study|Adverse Event|7|||
94563027|NCT00713544|323858072|FG004|Overall Study|Adverse Event|3|||
94563028|NCT00713544|323858073|FG005|Overall Study|Adverse Event|5|||
94563029|NCT00713544|323858068|FG000|Overall Study|Withdrawal by Subject|2|||
94563030|NCT00713544|323858069|FG001|Overall Study|Withdrawal by Subject|0|||
94563031|NCT00713544|323858070|FG002|Overall Study|Withdrawal by Subject|3|||
94563032|NCT00713544|323858071|FG003|Overall Study|Withdrawal by Subject|2|||
94563033|NCT00713544|323858072|FG004|Overall Study|Withdrawal by Subject|3|||
94563034|NCT00713544|323858073|FG005|Overall Study|Withdrawal by Subject|1|||
94563035|NCT00713544|323858068|FG000|Overall Study|Protocol Violation|0|||
94563036|NCT00713544|323858069|FG001|Overall Study|Protocol Violation|0|||
94563037|NCT00713544|323858070|FG002|Overall Study|Protocol Violation|0|||
94563038|NCT00713544|323858071|FG003|Overall Study|Protocol Violation|0|||
94563039|NCT00713544|323858072|FG004|Overall Study|Protocol Violation|0|||
94563040|NCT00713544|323858073|FG005|Overall Study|Protocol Violation|1|||
94563041|NCT00713544|323858068|FG000|Overall Study|Physician Decision|0|||
94563042|NCT00713544|323858069|FG001|Overall Study|Physician Decision|0|||
94563043|NCT00713544|323858070|FG002|Overall Study|Physician Decision|0|||
94563044|NCT00713544|323858071|FG003|Overall Study|Physician Decision|0|||
94563045|NCT00713544|323858072|FG004|Overall Study|Physician Decision|0|||
94563046|NCT00713544|323858073|FG005|Overall Study|Physician Decision|2|||
94563047|NCT00713544|323858068|FG000|Overall Study|Lack of Efficacy|0|||
94563048|NCT00713544|323858069|FG001|Overall Study|Lack of Efficacy|1|||
94563049|NCT00713544|323858070|FG002|Overall Study|Lack of Efficacy|0|||
94563050|NCT00713544|323858071|FG003|Overall Study|Lack of Efficacy|1|||
94563051|NCT00713544|323858072|FG004|Overall Study|Lack of Efficacy|1|||
94563052|NCT00713544|323858073|FG005|Overall Study|Lack of Efficacy|0|||
94563053|NCT00713544|323858068|FG000|Overall Study|Lost to Follow-up|0|||
94563054|NCT00713544|323858069|FG001|Overall Study|Lost to Follow-up|0|||
94563055|NCT00713544|323858070|FG002|Overall Study|Lost to Follow-up|1|||
94563056|NCT00713544|323858071|FG003|Overall Study|Lost to Follow-up|0|||
94563057|NCT00713544|323858072|FG004|Overall Study|Lost to Follow-up|0|||
94563058|NCT00713544|323858073|FG005|Overall Study|Lost to Follow-up|0|||
94563059|NCT00713544|323858068|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
94563060|NCT00713544|323858069|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
94563061|NCT00713544|323858070|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
94563062|NCT00713544|323858071|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
94563063|NCT00713544|323858072|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
94563064|NCT00713544|323858073|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
94563065|NCT00713544|323858068|FG000|Overall Study|Incorrect enrollment|0|||
94563066|NCT00713544|323858069|FG001|Overall Study|Incorrect enrollment|1|||
94563067|NCT00713544|323858070|FG002|Overall Study|Incorrect enrollment|0|||
94563068|NCT00713544|323858071|FG003|Overall Study|Incorrect enrollment|0|||
94563069|NCT00713544|323858072|FG004|Overall Study|Incorrect enrollment|0|||
94563070|NCT00713544|323858073|FG005|Overall Study|Incorrect enrollment|0|||
94563071|NCT00713544|323858068|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
94563072|NCT00713544|323858069|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
94563073|NCT00713544|323858070|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
94563074|NCT00713544|323858071|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
94563075|NCT00713544|323858072|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
94346039|NCT03099304|323047658|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
94346040|NCT03099304|323047659|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
94346041|NCT03099304|323047660|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
94346042|NCT03099304|323047661|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
94346043|NCT03099304|323047662|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
94346044|NCT03099304|323047663|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
94346045|NCT01700140|323047665|FG000|Overall Study|Use of rescue drugs|3|||
94346046|NCT01700140|323047666|FG001|Overall Study|Use of rescue drugs|3|||
94346047|NCT01700140|323047667|FG002|Overall Study|Use of rescue drugs|1|||
94346048|NCT01700140|323047665|FG000|Overall Study|Discontinuation of radiotherapy|1|||
94346049|NCT01700140|323047666|FG001|Overall Study|Discontinuation of radiotherapy|0|||
94346050|NCT01700140|323047667|FG002|Overall Study|Discontinuation of radiotherapy|0|||
94346051|NCT01700140|323047665|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
94346052|NCT01700140|323047666|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
94346053|NCT01700140|323047667|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
94346054|NCT01700140|323047665|FG000|Overall Study|Aggravation of symptoms|1|||
94346055|NCT01700140|323047666|FG001|Overall Study|Aggravation of symptoms|0|||
94346056|NCT01700140|323047667|FG002|Overall Study|Aggravation of symptoms|0|||
94346057|NCT01700140|323047665|FG000|Overall Study|Adverse Event|0|||
94346058|NCT01700140|323047666|FG001|Overall Study|Adverse Event|1|||
94657843|NCT01609556|324204455|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
94346059|NCT01700140|323047667|FG002|Overall Study|Adverse Event|0|||
94346060|NCT01700140|323047665|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
94346061|NCT01700140|323047666|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
94346062|NCT01700140|323047667|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
94234312|NCT01628692|322652592|FG001|Overall Study|Completed 12 Week only|0|||
94234313|NCT01628692|322652593|FG002|Overall Study|Completed 12 Week only|0|||
94234314|NCT01628692|322652594|FG003|Overall Study|Completed 12 Week only|0|||
94234315|NCT01628692|322652595|FG004|Overall Study|Completed 12 Week only|0|||
94234316|NCT01628692|322652596|FG005|Overall Study|Completed 12 Week only|1|||
94234317|NCT01253447|322652598|FG000|Overall Study|Adverse Event|2|||
94234318|NCT00537329|322652599|FG000|Overall Study|Death|10|||
94234319|NCT00537329|322652599|FG000|Overall Study|Adverse Event|3|||
94234320|NCT00537329|322652599|FG000|Overall Study|Lack of Efficacy|2|||
94234321|NCT00537329|322652599|FG000|Overall Study|Lost to Follow-up|6|||
94234322|NCT00537329|322652599|FG000|Overall Study|Withdrawal by Subject|4|||
94234323|NCT00537329|322652599|FG000|Overall Study|Other|1|||
94234324|NCT03635086|322652600|FG000|Overall Study|Withdrawal of consent|0|||
94234325|NCT03635086|322652601|FG001|Overall Study|Withdrawal of consent|0|||
94234326|NCT03635086|322652602|FG002|Overall Study|Withdrawal of consent|1|||
94234327|NCT03635086|322652603|FG003|Overall Study|Withdrawal of consent|0|||
94234328|NCT03635086|322652604|FG004|Overall Study|Withdrawal of consent|0|||
94234329|NCT03635086|322652600|FG000|Overall Study|Adverse Event|0|||
94234330|NCT03635086|322652601|FG001|Overall Study|Adverse Event|1|||
94234331|NCT03635086|322652602|FG002|Overall Study|Adverse Event|0|||
94234332|NCT03635086|322652603|FG003|Overall Study|Adverse Event|0|||
94234333|NCT03635086|322652604|FG004|Overall Study|Adverse Event|0|||
94234334|NCT03635086|322652600|FG000|Overall Study|Lost to Follow-up|1|||
94234335|NCT03635086|322652601|FG001|Overall Study|Lost to Follow-up|0|||
94234336|NCT03635086|322652602|FG002|Overall Study|Lost to Follow-up|0|||
94234337|NCT03635086|322652603|FG003|Overall Study|Lost to Follow-up|0|||
94234338|NCT03635086|322652604|FG004|Overall Study|Lost to Follow-up|0|||
94234339|NCT03000348|322652605|FG000|Overall Study|Adverse Event|1|||
94234340|NCT03000348|322652606|FG001|Overall Study|Adverse Event|1|||
94234341|NCT03000348|322652607|FG002|Overall Study|Adverse Event|1|||
94234342|NCT03000348|322652608|FG003|Overall Study|Adverse Event|1|||
94234343|NCT03000348|322652609|FG004|Overall Study|Adverse Event|1|||
94234344|NCT03000348|322652610|FG005|Overall Study|Adverse Event|1|||
94234345|NCT03000348|322652605|FG000|Overall Study|Lost to Follow-up|0|||
94234346|NCT03000348|322652606|FG001|Overall Study|Lost to Follow-up|0|||
94234347|NCT03000348|322652607|FG002|Overall Study|Lost to Follow-up|1|||
94234348|NCT03000348|322652608|FG003|Overall Study|Lost to Follow-up|0|||
94234349|NCT03000348|322652609|FG004|Overall Study|Lost to Follow-up|0|||
94234350|NCT03000348|322652610|FG005|Overall Study|Lost to Follow-up|0|||
94234351|NCT03000348|322652605|FG000|Overall Study|Withdrawal by Subject|0|||
94234352|NCT03000348|322652606|FG001|Overall Study|Withdrawal by Subject|1|||
94234353|NCT03000348|322652607|FG002|Overall Study|Withdrawal by Subject|0|||
94234354|NCT03000348|322652608|FG003|Overall Study|Withdrawal by Subject|0|||
94234355|NCT03000348|322652609|FG004|Overall Study|Withdrawal by Subject|0|||
94234356|NCT03000348|322652610|FG005|Overall Study|Withdrawal by Subject|0|||
94234357|NCT03000348|322652605|FG000|Overall Study|Consent|0|||
94234358|NCT03000348|322652606|FG001|Overall Study|Consent|0|||
94234359|NCT03000348|322652607|FG002|Overall Study|Consent|0|||
94234360|NCT03000348|322652608|FG003|Overall Study|Consent|0|||
94234361|NCT03000348|322652609|FG004|Overall Study|Consent|1|||
94234362|NCT03000348|322652610|FG005|Overall Study|Consent|0|||
94234363|NCT03000348|322652605|FG000|Overall Study|Failure to expectorate sputum|1|||
94234364|NCT03000348|322652606|FG001|Overall Study|Failure to expectorate sputum|0|||
94234365|NCT03000348|322652607|FG002|Overall Study|Failure to expectorate sputum|1|||
94346063|NCT01708915|323047668|FG000|Overall Study|Adverse Event|1|||
94346064|NCT01708915|323047669|FG001|Overall Study|Adverse Event|0|||
94346065|NCT01708915|323047670|FG002|Overall Study|Adverse Event|9|||
94346066|NCT01708915|323047671|FG003|Overall Study|Adverse Event|13|||
94346067|NCT01708915|323047668|FG000|Overall Study|Lack of Efficacy|84|||
94346068|NCT01708915|323047669|FG001|Overall Study|Lack of Efficacy|60|||
94346069|NCT01708915|323047670|FG002|Overall Study|Lack of Efficacy|35|||
94346070|NCT01708915|323047671|FG003|Overall Study|Lack of Efficacy|15|||
94346071|NCT01708915|323047668|FG000|Overall Study|Protocol Violation|0|||
94234366|NCT03000348|322652608|FG003|Overall Study|Failure to expectorate sputum|0|||
94234367|NCT03000348|322652609|FG004|Overall Study|Failure to expectorate sputum|1|||
94234368|NCT03000348|322652610|FG005|Overall Study|Failure to expectorate sputum|0|||
94234369|NCT03000348|322652605|FG000|Overall Study|No gram negative|1|||
94234370|NCT03000348|322652606|FG001|Overall Study|No gram negative|2|||
94234371|NCT03000348|322652607|FG002|Overall Study|No gram negative|1|||
94234372|NCT03000348|322652608|FG003|Overall Study|No gram negative|1|||
94234373|NCT03000348|322652609|FG004|Overall Study|No gram negative|1|||
94234374|NCT03000348|322652610|FG005|Overall Study|No gram negative|1|||
94234375|NCT03000348|322652605|FG000|Overall Study|Patient had no transport|0|||
94234376|NCT03000348|322652606|FG001|Overall Study|Patient had no transport|0|||
94234377|NCT03000348|322652607|FG002|Overall Study|Patient had no transport|0|||
94234378|NCT03000348|322652608|FG003|Overall Study|Patient had no transport|1|||
94346072|NCT01708915|323047669|FG001|Overall Study|Protocol Violation|0|||
94346073|NCT01708915|323047670|FG002|Overall Study|Protocol Violation|0|||
94346074|NCT01708915|323047671|FG003|Overall Study|Protocol Violation|1|||
94563076|NCT00713544|323858073|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
94563077|NCT02178995|323858074|FG000|Double Blind|Adverse Event|0|||
94563078|NCT02178995|323858075|FG001|Double Blind|Adverse Event|0|||
94563079|NCT02178995|323858076|FG002|Double Blind|Adverse Event|0|||
94563080|NCT02178995|323858077|FG003|Double Blind|Adverse Event|0|||
94563081|NCT02178995|323858078|FG004|Double Blind|Adverse Event|0|||
94346075|NCT01708915|323047668|FG000|Overall Study|Withdrawal by Subject|0|||
94563082|NCT02178995|323858079|FG005|Double Blind|Adverse Event|1|||
94563083|NCT02178995|323858080|FG006|Double Blind|Adverse Event|0|||
94563084|NCT02178995|323858081|FG007|Double Blind|Adverse Event|1|||
94563085|NCT02178995|323858082|FG008|Double Blind|Adverse Event|1|||
94234379|NCT03000348|322652609|FG004|Overall Study|Patient had no transport|0|||
94234380|NCT03000348|322652610|FG005|Overall Study|Patient had no transport|0|||
94234381|NCT03000348|322652605|FG000|Overall Study|Dosing|0|||
94234382|NCT03000348|322652606|FG001|Overall Study|Dosing|0|||
94234383|NCT03000348|322652607|FG002|Overall Study|Dosing|0|||
94234384|NCT03000348|322652608|FG003|Overall Study|Dosing|0|||
94234385|NCT03000348|322652609|FG004|Overall Study|Dosing|1|||
94234386|NCT03000348|322652610|FG005|Overall Study|Dosing|0|||
94234387|NCT01390441|322652611|FG000|Treatment Period|Protocol Violation|0|||
94234388|NCT01390441|322652612|FG001|Treatment Period|Protocol Violation|1|||
94234389|NCT01390441|322652613|FG002|Treatment Period|Protocol Violation|0|||
94234390|NCT01390441|322652614|FG003|Treatment Period|Protocol Violation|0|||
94234391|NCT01390441|322652615|FG004|Treatment Period|Protocol Violation|0|||
94234392|NCT01390441|322652611|FG000|Treatment Period|Physician Decision|0|||
94234393|NCT01390441|322652612|FG001|Treatment Period|Physician Decision|0|||
94234394|NCT01390441|322652613|FG002|Treatment Period|Physician Decision|0|||
94234395|NCT01390441|322652614|FG003|Treatment Period|Physician Decision|1|||
94234396|NCT01390441|322652615|FG004|Treatment Period|Physician Decision|0|||
94234397|NCT01390441|322652611|FG000|Treatment Period|Lack of Efficacy|0|||
94234398|NCT01390441|322652612|FG001|Treatment Period|Lack of Efficacy|0|||
94234399|NCT01390441|322652613|FG002|Treatment Period|Lack of Efficacy|0|||
94234400|NCT01390441|322652614|FG003|Treatment Period|Lack of Efficacy|0|||
94234401|NCT01390441|322652615|FG004|Treatment Period|Lack of Efficacy|1|||
94234402|NCT01390441|322652611|FG000|Treatment Period|Unknown due to early stopping of study|0|||
94234403|NCT01390441|322652612|FG001|Treatment Period|Unknown due to early stopping of study|0|||
94234404|NCT01390441|322652613|FG002|Treatment Period|Unknown due to early stopping of study|8|||
94234405|NCT01390441|322652614|FG003|Treatment Period|Unknown due to early stopping of study|11|||
94234406|NCT01390441|322652615|FG004|Treatment Period|Unknown due to early stopping of study|7|||
94234407|NCT01390441|322652611|FG000|Treatment Period|Adverse Event|0|||
94234408|NCT01390441|322652612|FG001|Treatment Period|Adverse Event|0|||
94234409|NCT01390441|322652613|FG002|Treatment Period|Adverse Event|1|||
94234410|NCT01390441|322652614|FG003|Treatment Period|Adverse Event|1|||
94234411|NCT01390441|322652615|FG004|Treatment Period|Adverse Event|2|||
94234412|NCT01390441|322652611|FG000|Treatment Period|Withdrawal by Subject|0|||
94234413|NCT01390441|322652612|FG001|Treatment Period|Withdrawal by Subject|0|||
94234414|NCT01390441|322652613|FG002|Treatment Period|Withdrawal by Subject|1|||
94234415|NCT01390441|322652614|FG003|Treatment Period|Withdrawal by Subject|0|||
94234416|NCT01390441|322652615|FG004|Treatment Period|Withdrawal by Subject|1|||
94234417|NCT01390441|322652611|FG000|Treatment Period|Lost to Follow-up|1|||
94234418|NCT01390441|322652612|FG001|Treatment Period|Lost to Follow-up|0|||
94234419|NCT01390441|322652613|FG002|Treatment Period|Lost to Follow-up|0|||
94346076|NCT01708915|323047669|FG001|Overall Study|Withdrawal by Subject|1|||
94346077|NCT01708915|323047670|FG002|Overall Study|Withdrawal by Subject|2|||
94346078|NCT01708915|323047671|FG003|Overall Study|Withdrawal by Subject|2|||
94346079|NCT01708915|323047668|FG000|Overall Study|Other reasons than stated above|1|||
94346080|NCT01708915|323047669|FG001|Overall Study|Other reasons than stated above|1|||
94346081|NCT01708915|323047670|FG002|Overall Study|Other reasons than stated above|0|||
94450382|NCT03850483|323435404|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
94234420|NCT01390441|322652614|FG003|Treatment Period|Lost to Follow-up|0|||
94234421|NCT01390441|322652615|FG004|Treatment Period|Lost to Follow-up|0|||
94234422|NCT01390441|322652611|FG000|Extension Period|Protocol Violation|3|||
94234423|NCT01390441|322652612|FG001|Extension Period|Protocol Violation|1|||
94234424|NCT01390441|322652613|FG002|Extension Period|Protocol Violation|0|||
94234425|NCT01390441|322652614|FG003|Extension Period|Protocol Violation|1|||
94234426|NCT01390441|322652615|FG004|Extension Period|Protocol Violation|0|||
94346082|NCT01708915|323047671|FG003|Overall Study|Other reasons than stated above|2|||
94234427|NCT01407276|322652616|FG000|Overall Study|Withdrawal by Subject|0|||
94234428|NCT01407276|322652617|FG001|Overall Study|Withdrawal by Subject|0|||
94234429|NCT01407276|322652618|FG002|Overall Study|Withdrawal by Subject|0|||
94234430|NCT01407276|322652619|FG003|Overall Study|Withdrawal by Subject|0|||
94234431|NCT01407276|322652620|FG004|Overall Study|Withdrawal by Subject|0|||
94234432|NCT01407276|322652621|FG005|Overall Study|Withdrawal by Subject|0|||
94234433|NCT01407276|322652622|FG006|Overall Study|Withdrawal by Subject|0|||
94234434|NCT01407276|322652623|FG007|Overall Study|Withdrawal by Subject|1|||
94234435|NCT02635386|322652624|FG000|Overall Study|Pregnancy|2|||
94234436|NCT02635386|322652625|FG001|Overall Study|Pregnancy|0|||
94234437|NCT02635386|322652626|FG002|Overall Study|Pregnancy|0|||
94234438|NCT02635386|322652627|FG003|Overall Study|Pregnancy|0|||
94234439|NCT02635386|322652628|FG004|Overall Study|Pregnancy|2|||
94234440|NCT02635386|322652624|FG000|Overall Study|Withdrawal by Subject|1|||
94234441|NCT02635386|322652625|FG001|Overall Study|Withdrawal by Subject|1|||
94234442|NCT02635386|322652626|FG002|Overall Study|Withdrawal by Subject|0|||
94234443|NCT02635386|322652627|FG003|Overall Study|Withdrawal by Subject|1|||
94234444|NCT02635386|322652628|FG004|Overall Study|Withdrawal by Subject|0|||
94234445|NCT02635386|322652624|FG000|Overall Study|Physician Decision|0|||
94234446|NCT02635386|322652625|FG001|Overall Study|Physician Decision|1|||
94234447|NCT02635386|322652626|FG002|Overall Study|Physician Decision|0|||
94234448|NCT02635386|322652627|FG003|Overall Study|Physician Decision|0|||
94234449|NCT02635386|322652628|FG004|Overall Study|Physician Decision|0|||
94234450|NCT02635386|322652624|FG000|Overall Study|Moved Out of State|0|||
94234451|NCT02635386|322652625|FG001|Overall Study|Moved Out of State|1|||
94234452|NCT02635386|322652626|FG002|Overall Study|Moved Out of State|0|||
94234453|NCT02635386|322652627|FG003|Overall Study|Moved Out of State|0|||
94234454|NCT02635386|322652628|FG004|Overall Study|Moved Out of State|0|||
94234455|NCT02635386|322652624|FG000|Overall Study|Noncompliant|0|||
94234456|NCT02635386|322652625|FG001|Overall Study|Noncompliant|2|||
94234457|NCT02635386|322652626|FG002|Overall Study|Noncompliant|1|||
94234458|NCT02635386|322652627|FG003|Overall Study|Noncompliant|1|||
94234459|NCT02635386|322652628|FG004|Overall Study|Noncompliant|1|||
94234460|NCT02635386|322652624|FG000|Overall Study|side effects|0|||
94234461|NCT02635386|322652625|FG001|Overall Study|side effects|0|||
94234462|NCT02635386|322652626|FG002|Overall Study|side effects|1|||
94234463|NCT02635386|322652627|FG003|Overall Study|side effects|4|||
94234464|NCT02635386|322652628|FG004|Overall Study|side effects|6|||
94234465|NCT02635386|322652624|FG000|Overall Study|needed other major surgery|0|||
94234466|NCT02635386|322652625|FG001|Overall Study|needed other major surgery|1|||
94234467|NCT02635386|322652626|FG002|Overall Study|needed other major surgery|0|||
94234468|NCT02635386|322652627|FG003|Overall Study|needed other major surgery|0|||
94234469|NCT02635386|322652628|FG004|Overall Study|needed other major surgery|0|||
94234470|NCT02635386|322652624|FG000|Overall Study|Other medical problems not drug related|0|||
94234471|NCT02635386|322652625|FG001|Overall Study|Other medical problems not drug related|0|||
94234472|NCT02635386|322652626|FG002|Overall Study|Other medical problems not drug related|0|||
94234473|NCT02635386|322652627|FG003|Overall Study|Other medical problems not drug related|1|||
94234474|NCT02635386|322652628|FG004|Overall Study|Other medical problems not drug related|0|||
94346083|NCT00882362|323047673|FG000|Overall Study|Adverse Event|13|||
94346084|NCT00882362|323047674|FG001|Overall Study|Adverse Event|10|||
94346085|NCT00882362|323047673|FG000|Overall Study|Withdrawal by Subject|13|||
94346086|NCT00882362|323047674|FG001|Overall Study|Withdrawal by Subject|10|||
94346087|NCT00882362|323047673|FG000|Overall Study|Lack of Efficacy|3|||
94346088|NCT00882362|323047674|FG001|Overall Study|Lack of Efficacy|0|||
94346089|NCT00882362|323047673|FG000|Overall Study|Protocol Violation|7|||
94346090|NCT00882362|323047674|FG001|Overall Study|Protocol Violation|2|||
94563086|NCT02178995|323858074|FG000|Double Blind|Lost to Follow-up|0|||
94346091|NCT00882362|323047673|FG000|Overall Study|Pregnancy|1|||
94346092|NCT00882362|323047674|FG001|Overall Study|Pregnancy|0|||
94346093|NCT00882362|323047673|FG000|Overall Study|Physician Decision|5|||
94346094|NCT00882362|323047674|FG001|Overall Study|Physician Decision|1|||
94563087|NCT02178995|323858075|FG001|Double Blind|Lost to Follow-up|1|||
94234475|NCT01776008|322652629|FG000|Overall Study|ineligible|2|||
94234476|NCT03513068|322652632|FG000|Overall Study|Death|1|||
94234477|NCT03513068|322652633|FG001|Overall Study|Death|0|||
94234478|NCT03513068|322652632|FG000|Overall Study|Withdrawal by Subject|4|||
94234479|NCT03513068|322652633|FG001|Overall Study|Withdrawal by Subject|6|||
94234480|NCT02719743|322652634|FG000|Overall Study|Consent withdrawal|0|||
94234481|NCT02719743|322652635|FG001|Overall Study|Consent withdrawal|2|||
94234482|NCT02719743|322652636|FG002|Overall Study|Consent withdrawal|0|||
94234483|NCT02719743|322652637|FG003|Overall Study|Consent withdrawal|1|||
94234484|NCT02719743|322652638|FG004|Overall Study|Consent withdrawal|0|||
94234485|NCT02719743|322652634|FG000|Overall Study|Migrated/moved from study area|0|||
94234486|NCT02719743|322652635|FG001|Overall Study|Migrated/moved from study area|0|||
94234487|NCT02719743|322652636|FG002|Overall Study|Migrated/moved from study area|0|||
94346095|NCT00882362|323047673|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
94365606|NCT00689273|323122448|FG000|Overall Study|Adverse Event|3|||
94365607|NCT00689273|323122449|FG001|Overall Study|Adverse Event|1|||
94657844|NCT01609556|324204456|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
94346096|NCT00882362|323047674|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
94346097|NCT00882362|323047673|FG000|Overall Study|change of residence or other commitments|5|||
94346098|NCT00882362|323047674|FG001|Overall Study|change of residence or other commitments|0|||
94346099|NCT01268514|323047675|FG000|Overall Study|Adverse Event|20|||
94234488|NCT02719743|322652637|FG003|Overall Study|Migrated/moved from study area|0|||
94234489|NCT02719743|322652638|FG004|Overall Study|Migrated/moved from study area|2|||
94234490|NCT02719743|322652634|FG000|Overall Study|Lost to Follow-up|1|||
94234491|NCT02719743|322652635|FG001|Overall Study|Lost to Follow-up|1|||
94234492|NCT02719743|322652636|FG002|Overall Study|Lost to Follow-up|0|||
94234493|NCT02719743|322652637|FG003|Overall Study|Lost to Follow-up|0|||
94234494|NCT02719743|322652638|FG004|Overall Study|Lost to Follow-up|0|||
94234495|NCT02287233|322652639|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
94234496|NCT02287233|322652640|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
94234497|NCT02287233|322652641|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
94234498|NCT02287233|322652639|FG000|Overall Study|Adverse Event Related to Progression|0|||
94234499|NCT02287233|322652640|FG001|Overall Study|Adverse Event Related to Progression|2|||
94234500|NCT02287233|322652641|FG002|Overall Study|Adverse Event Related to Progression|8|||
94234501|NCT02287233|322652639|FG000|Overall Study|Physician Decision|1|||
94234502|NCT02287233|322652640|FG001|Overall Study|Physician Decision|2|||
94234503|NCT02287233|322652641|FG002|Overall Study|Physician Decision|4|||
94234504|NCT02287233|322652639|FG000|Overall Study|Progressive Disease with Death|0|||
94234505|NCT02287233|322652640|FG001|Overall Study|Progressive Disease with Death|0|||
94234506|NCT02287233|322652641|FG002|Overall Study|Progressive Disease with Death|10|||
94234507|NCT02287233|322652639|FG000|Overall Study|Progressive Disease Without Death|2|||
94234508|NCT02287233|322652640|FG001|Overall Study|Progressive Disease Without Death|3|||
94234509|NCT02287233|322652641|FG002|Overall Study|Progressive Disease Without Death|20|||
94234510|NCT02287233|322652639|FG000|Overall Study|Withdrawal by Subject|1|||
94234511|NCT02287233|322652640|FG001|Overall Study|Withdrawal by Subject|1|||
94234512|NCT02287233|322652641|FG002|Overall Study|Withdrawal by Subject|7|||
94234513|NCT02287233|322652639|FG000|Overall Study|Other|3|||
94234514|NCT02287233|322652640|FG001|Overall Study|Other|0|||
94234515|NCT02287233|322652641|FG002|Overall Study|Other|15|||
94234516|NCT02287233|322652639|FG000|Overall Study|Did Not Receive Treatment|0|||
94234517|NCT02287233|322652640|FG001|Overall Study|Did Not Receive Treatment|0|||
94234518|NCT02287233|322652641|FG002|Overall Study|Did Not Receive Treatment|2|||
94234519|NCT02601209|322652643|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
94234520|NCT02601209|322652644|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
94234521|NCT02601209|322652645|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
94234522|NCT02601209|322652646|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
94234523|NCT02601209|322652647|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
94234524|NCT02601209|322652648|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
94234525|NCT02601209|322652649|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
94234526|NCT02601209|322652650|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
94563088|NCT02178995|323858076|FG002|Double Blind|Lost to Follow-up|0|||
94346100|NCT01268514|323047675|FG000|Overall Study|Death|8|||
94563089|NCT02178995|323858077|FG003|Double Blind|Lost to Follow-up|0|||
94234527|NCT02601209|322652651|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
94234528|NCT02601209|322652643|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
94234529|NCT02601209|322652644|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
94234530|NCT02601209|322652645|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
94234531|NCT02601209|322652646|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
94234532|NCT02601209|322652647|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
94234533|NCT02601209|322652648|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
94234534|NCT02601209|322652649|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
94234535|NCT02601209|322652650|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
94234536|NCT02601209|322652651|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
94234537|NCT00745498|322652652|FG000|Overall Study|Lost to Follow-up|1|||
94234538|NCT00745498|322652653|FG001|Overall Study|Lost to Follow-up|1|||
94234539|NCT00745498|322652654|FG002|Overall Study|Lost to Follow-up|3|||
94234540|NCT00745498|322652652|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
94234541|NCT00745498|322652653|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
94234542|NCT00745498|322652654|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
94234543|NCT00745498|322652652|FG000|Overall Study|Non-PDR related VH|0|||
94234544|NCT00745498|322652653|FG001|Overall Study|Non-PDR related VH|1|||
94234545|NCT00745498|322652654|FG002|Overall Study|Non-PDR related VH|1|||
94234546|NCT00745498|322652652|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
94234547|NCT00745498|322652653|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
94234548|NCT00745498|322652654|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
94234549|NCT04805073|322652655|FG000|Overall Study|study personnel not available|2|||
94234550|NCT04805073|322652656|FG001|Overall Study|study personnel not available|0|||
94234551|NCT04805073|322652655|FG000|Overall Study|spinal anesthesia failure|0|||
94234552|NCT04805073|322652656|FG001|Overall Study|spinal anesthesia failure|1|||
94234553|NCT04805073|322652655|FG000|Overall Study|Lost to Follow-up|0|||
94234554|NCT04805073|322652656|FG001|Overall Study|Lost to Follow-up|2|||
94563090|NCT02178995|323858078|FG004|Double Blind|Lost to Follow-up|0|||
94563091|NCT02178995|323858079|FG005|Double Blind|Lost to Follow-up|0|||
94563092|NCT02178995|323858080|FG006|Double Blind|Lost to Follow-up|0|||
94563093|NCT02178995|323858081|FG007|Double Blind|Lost to Follow-up|1|||
94563094|NCT02178995|323858082|FG008|Double Blind|Lost to Follow-up|0|||
94563095|NCT02178995|323858074|FG000|Open Label|Adverse Event|2|||
94563096|NCT02178995|323858075|FG001|Open Label|Adverse Event|0|||
94563097|NCT02178995|323858076|FG002|Open Label|Adverse Event|0|||
94563098|NCT02178995|323858077|FG003|Open Label|Adverse Event|0|||
94563099|NCT02178995|323858078|FG004|Open Label|Adverse Event|0|||
94563100|NCT02178995|323858079|FG005|Open Label|Adverse Event|0|||
94234555|NCT01078922|322652660|FG000|Overall Study|Adverse Event|1|||
94234556|NCT02706847|322652661|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
94234557|NCT02706847|322652662|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
94346101|NCT01268514|323047675|FG000|Overall Study|Lost to Follow-up|5|||
94563101|NCT02178995|323858080|FG006|Open Label|Adverse Event|0|||
94563102|NCT02178995|323858081|FG007|Open Label|Adverse Event|0|||
94563103|NCT02178995|323858082|FG008|Open Label|Adverse Event|0|||
94346102|NCT01268514|323047675|FG000|Overall Study|Withdrawal by Subject|3|||
94346103|NCT01268514|323047675|FG000|Overall Study|Withdrawal by Surgeon|5|||
94346104|NCT01424306|323047676|FG000|Overall Study|Protocol Violation|0|||
94346105|NCT01424306|323047677|FG001|Overall Study|Protocol Violation|0|||
94346106|NCT01424306|323047678|FG002|Overall Study|Protocol Violation|0|||
94346107|NCT01424306|323047679|FG003|Overall Study|Protocol Violation|0|||
94346108|NCT01424306|323047680|FG004|Overall Study|Protocol Violation|1|||
94346109|NCT01424306|323047681|FG005|Overall Study|Protocol Violation|0|||
94346110|NCT00590031|323047687|FG000|Overall Study|Adverse Event|3|||
94346111|NCT00590031|323047687|FG000|Overall Study|Withdrawal by Subject|1|||
94346112|NCT00590031|323047687|FG000|Overall Study|Metastatic Disease|1|||
94346113|NCT00590031|323047687|FG000|Overall Study|Admin Hold|1|||
94346114|NCT01601873|323047688|FG000|Overall Study|Lost to Follow-up|2|||
94346115|NCT01601873|323047689|FG001|Overall Study|Lost to Follow-up|3|||
94346116|NCT02096471|323047692|FG000|Overall Study|Adverse Event|1|||
94346117|NCT02096471|323047692|FG000|Overall Study|Lack of Efficacy|7|||
94346118|NCT02096471|323047692|FG000|Overall Study|Withdrawal by Subject|3|||
94346119|NCT02096471|323047692|FG000|Overall Study|Non-Compliant|2|||
94346120|NCT02463331|323047700|FG000|Overall Study|Adverse Event|4|||
94346121|NCT02463331|323047701|FG001|Overall Study|Adverse Event|2|||
94346122|NCT02463331|323047700|FG000|Overall Study|Lost to Follow-up|1|||
94346123|NCT02463331|323047701|FG001|Overall Study|Lost to Follow-up|1|||
94346124|NCT02463331|323047700|FG000|Overall Study|Pregnancy|2|||
94346125|NCT02463331|323047701|FG001|Overall Study|Pregnancy|3|||
94346126|NCT02463331|323047700|FG000|Overall Study|Lack of Efficacy|6|||
94346127|NCT02463331|323047701|FG001|Overall Study|Lack of Efficacy|0|||
94346128|NCT02463331|323047700|FG000|Overall Study|Physician Decision|3|||
94346129|NCT02463331|323047701|FG001|Overall Study|Physician Decision|0|||
94346130|NCT00826540|323047702|FG000|Overall Study|ineligible|3|||
94346131|NCT00826540|323047702|FG000|Overall Study|Withdrawal by Subject|1|||
94346132|NCT03147495|323047705|FG000|Overall Study|Physician Decision|0|||
94346133|NCT03147495|323047706|FG001|Overall Study|Physician Decision|6|||
94346134|NCT02483611|323047709|FG000|Overall Study|Protocol Violation|0|||
94346135|NCT02483611|323047710|FG001|Overall Study|Protocol Violation|0|||
94346136|NCT02483611|323047711|FG002|Overall Study|Protocol Violation|1|||
94346137|NCT02274766|323047712|FG000|Overall Study|Withdrawal by Subject|3|||
94346138|NCT02274766|323047713|FG001|Overall Study|Withdrawal by Subject|6|||
94346139|NCT02274766|323047712|FG000|Overall Study|Did Not Receive Study Drug|1|||
94346140|NCT02274766|323047713|FG001|Overall Study|Did Not Receive Study Drug|1|||
94346141|NCT02274766|323047712|FG000|Overall Study|Subject Unwilling to Proceed|0|||
94346142|NCT02274766|323047713|FG001|Overall Study|Subject Unwilling to Proceed|1|||
94346143|NCT02274766|323047712|FG000|Overall Study|Adverse Event|0|||
94346144|NCT02274766|323047713|FG001|Overall Study|Adverse Event|1|||
94346145|NCT01142791|323047714|FG000|Overall Study|Alternative Treatment|1|||
94346146|NCT01142791|323047715|FG001|Overall Study|Alternative Treatment|0|||
94346147|NCT01142791|323047714|FG000|Overall Study|Lost to Follow-up|1|||
94346148|NCT01142791|323047715|FG001|Overall Study|Lost to Follow-up|0|||
94346149|NCT01142791|323047714|FG000|Overall Study|Withdrawal by Subject|5|||
94346150|NCT01142791|323047715|FG001|Overall Study|Withdrawal by Subject|0|||
94346151|NCT01142791|323047714|FG000|Overall Study|Received only 1 sonication|0|||
94346152|NCT01142791|323047715|FG001|Overall Study|Received only 1 sonication|6|||
94346153|NCT03032523|323047716|FG000|Overall Study|Withdrawal by Subject|2|||
94346154|NCT03032523|323047717|FG001|Overall Study|Withdrawal by Subject|2|||
94346155|NCT03032523|323047716|FG000|Overall Study|Physician Decision|1|||
94346156|NCT03032523|323047717|FG001|Overall Study|Physician Decision|0|||
94346157|NCT00742391|323047720|FG000|Overall Study|Adverse Event|2|||
94346158|NCT00742391|323047721|FG001|Overall Study|Adverse Event|1|||
94346159|NCT00742391|323047720|FG000|Overall Study|Lost to Follow-up|1|||
94346160|NCT00742391|323047721|FG001|Overall Study|Lost to Follow-up|0|||
94346161|NCT00742391|323047720|FG000|Overall Study|Protocol Violation|1|||
94346162|NCT00742391|323047721|FG001|Overall Study|Protocol Violation|0|||
94346163|NCT02142712|323047722|FG000|Overall Study|Lost to Follow-up|1|||
94346164|NCT02142712|323047723|FG001|Overall Study|Lost to Follow-up|1|||
94346165|NCT02142712|323047724|FG002|Overall Study|Lost to Follow-up|1|||
94346166|NCT02142712|323047725|FG003|Overall Study|Lost to Follow-up|0|||
94346167|NCT01981096|323047728|FG000|Overall Study|Parent illness|1|||
94346168|NCT01981096|323047729|FG001|Overall Study|Parent illness|0|||
94346169|NCT01981096|323047728|FG000|Overall Study|Withdrawal by Subject|0|||
94346170|NCT01981096|323047729|FG001|Overall Study|Withdrawal by Subject|1|||
94346171|NCT01981096|323047728|FG000|Overall Study|Lost to Follow-up|2|||
94346172|NCT01981096|323047729|FG001|Overall Study|Lost to Follow-up|0|||
94346173|NCT02141854|323047732|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
94365608|NCT00689273|323122448|FG000|Overall Study|Lack of Efficacy|3|||
94346174|NCT02141854|323047733|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
94346175|NCT02141854|323047734|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
94346176|NCT02141854|323047735|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
94346177|NCT02141854|323047736|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
94346178|NCT02141854|323047737|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
94346179|NCT02141854|323047732|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
94346180|NCT02141854|323047733|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
94346181|NCT02141854|323047734|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
94346182|NCT02141854|323047735|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
94346183|NCT02141854|323047736|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
94234558|NCT02706847|322652663|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
94234559|NCT02706847|322652664|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
94234560|NCT02706847|322652661|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
94234561|NCT02706847|322652662|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
94234562|NCT02706847|322652663|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
94234563|NCT02706847|322652664|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
94234564|NCT02706847|322652661|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
94234565|NCT02706847|322652662|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
94234566|NCT02706847|322652663|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
94234567|NCT02706847|322652664|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
94234568|NCT02706847|322652661|FG000|Period 1: Day 1 to Week 12|Other|4|||
94234569|NCT02706847|322652662|FG001|Period 1: Day 1 to Week 12|Other|4|||
94234570|NCT02706847|322652663|FG002|Period 1: Day 1 to Week 12|Other|2|||
94234571|NCT02706847|322652664|FG003|Period 1: Day 1 to Week 12|Other|2|||
94234572|NCT02706847|322652661|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
94234573|NCT02706847|322652662|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
94234574|NCT02706847|322652663|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
94234575|NCT02706847|322652664|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
94234576|NCT02706847|322652661|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
94234577|NCT02706847|322652662|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
94234578|NCT02706847|322652663|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
94234579|NCT02706847|322652664|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
94234580|NCT02706847|322652661|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
94234581|NCT02706847|322652662|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
94234582|NCT02706847|322652663|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
94234583|NCT02706847|322652664|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
94234584|NCT02706847|322652661|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
94234585|NCT02706847|322652662|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
94234586|NCT02706847|322652663|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
94234587|NCT02706847|322652664|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
94234588|NCT02706847|322652661|FG000|Period 1: Week 12 to Week 24|Other|1|||
94234589|NCT02706847|322652662|FG001|Period 1: Week 12 to Week 24|Other|0|||
94234590|NCT02706847|322652663|FG002|Period 1: Week 12 to Week 24|Other|1|||
94346184|NCT02141854|323047737|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
94346185|NCT02141854|323047732|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
94346186|NCT02141854|323047733|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
94346187|NCT02141854|323047734|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
94234591|NCT02706847|322652664|FG003|Period 1: Week 12 to Week 24|Other|4|||
94234592|NCT02706847|322652661|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
94234593|NCT02706847|322652662|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
94234594|NCT02706847|322652663|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
94234595|NCT02706847|322652664|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
94234596|NCT02706847|322652661|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
94234597|NCT02706847|322652662|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
94234598|NCT02706847|322652663|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
94234599|NCT02706847|322652664|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
94234600|NCT02706847|322652661|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
94234601|NCT02706847|322652662|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
94234602|NCT02706847|322652663|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
94234603|NCT02706847|322652664|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
94234604|NCT02706847|322652661|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
94234605|NCT02706847|322652662|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
94234606|NCT02706847|322652663|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
94657845|NCT01609556|324204457|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
94657846|NCT01609556|324204458|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
94657847|NCT01609556|324204459|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
94234607|NCT02706847|322652664|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
94234608|NCT02706847|322652661|FG000|Period 2: Week 24 to Week 260|Other|8|||
94234609|NCT02706847|322652662|FG001|Period 2: Week 24 to Week 260|Other|5|||
94234610|NCT02706847|322652663|FG002|Period 2: Week 24 to Week 260|Other|15|||
94346188|NCT02141854|323047735|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
94346189|NCT02141854|323047736|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
94346190|NCT02141854|323047737|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
94346191|NCT02141854|323047732|FG000|Run-In Period (Pre-assignment)|Other|14|||
94346192|NCT02141854|323047733|FG001|Run-In Period (Pre-assignment)|Other|0|||
94346193|NCT02141854|323047734|FG002|Run-In Period (Pre-assignment)|Other|0|||
94346194|NCT02141854|323047735|FG003|Run-In Period (Pre-assignment)|Other|0|||
94346195|NCT02141854|323047736|FG004|Run-In Period (Pre-assignment)|Other|0|||
94346196|NCT02141854|323047737|FG005|Run-In Period (Pre-assignment)|Other|0|||
94346197|NCT02141854|323047732|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
94346198|NCT02141854|323047733|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
94657848|NCT01609556|324204460|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
94234611|NCT02706847|322652664|FG003|Period 2: Week 24 to Week 260|Other|15|||
94234612|NCT00003477|322652665|FG000|Overall Study|Not evalauable|4|||
94234613|NCT00547534|322652667|FG000|Overall Study|Adverse Event|7|||
94234614|NCT00547534|322652667|FG000|Overall Study|Disease Progression|4|||
94234615|NCT02688530|322652669|FG000|Overall Study|Withdrawal by Subject|0|||
94234616|NCT02688530|322652670|FG001|Overall Study|Withdrawal by Subject|1|||
94234617|NCT02688530|322652671|FG002|Overall Study|Withdrawal by Subject|0|||
94234618|NCT02688530|322652672|FG003|Overall Study|Withdrawal by Subject|0|||
94234619|NCT02688530|322652669|FG000|Overall Study|Lost to Follow-up|0|||
94657849|NCT01609556|324204461|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
94657850|NCT01609556|324204462|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
94657851|NCT01609556|324204463|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
94657852|NCT01609556|324204464|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
94657853|NCT01609556|324204465|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
94657854|NCT01609556|324204466|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
94657855|NCT01609556|324204467|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
94657856|NCT01609556|324204468|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
94657857|NCT01609556|324204469|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
94657858|NCT01609556|324204470|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
94657859|NCT01609556|324204455|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
94657860|NCT01609556|324204456|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
94657861|NCT01609556|324204457|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
94657862|NCT01609556|324204458|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
94657863|NCT01609556|324204459|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
94657864|NCT01609556|324204460|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
94657865|NCT01609556|324204461|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
94657866|NCT01609556|324204462|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
94657867|NCT01609556|324204463|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
94657868|NCT01609556|324204464|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
94657869|NCT01609556|324204465|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
94657870|NCT01609556|324204466|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
94657871|NCT01609556|324204467|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
94657872|NCT01609556|324204468|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
94657873|NCT01609556|324204469|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
94657874|NCT01609556|324204470|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
94657875|NCT01609556|324204455|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
94657876|NCT01609556|324204456|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
94657877|NCT01609556|324204457|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
94657878|NCT01609556|324204458|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
94657879|NCT01609556|324204459|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
94657880|NCT01609556|324204460|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
94657881|NCT01609556|324204461|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
94657882|NCT01609556|324204462|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
94657883|NCT01609556|324204463|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
94657884|NCT01609556|324204464|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
94657885|NCT01609556|324204465|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
94657886|NCT01609556|324204466|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
94657887|NCT01609556|324204467|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
94657888|NCT01609556|324204468|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
94657889|NCT01609556|324204469|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
94657890|NCT01609556|324204470|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
94657891|NCT01609556|324204455|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
94657892|NCT01609556|324204456|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
94657893|NCT01609556|324204457|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
94657894|NCT01609556|324204458|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
94657895|NCT01609556|324204459|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
94657896|NCT01609556|324204460|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
94657897|NCT01609556|324204461|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
94657898|NCT01609556|324204462|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
94657899|NCT01609556|324204463|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
94657900|NCT01609556|324204464|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
94657901|NCT01609556|324204465|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
94657902|NCT01609556|324204466|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
94657903|NCT01609556|324204467|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
94657904|NCT01609556|324204468|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
94657905|NCT01609556|324204469|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
94657906|NCT01609556|324204470|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
94657907|NCT01609556|324204455|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
94657908|NCT01609556|324204456|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
94657909|NCT01609556|324204457|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
94657910|NCT01609556|324204458|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
94450383|NCT03850483|323435405|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
94450384|NCT03850483|323435406|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
94450385|NCT03850483|323435407|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
94450386|NCT03850483|323435408|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
94346199|NCT02141854|323047734|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
94234620|NCT02688530|322652670|FG001|Overall Study|Lost to Follow-up|0|||
94234621|NCT02688530|322652671|FG002|Overall Study|Lost to Follow-up|2|||
94234622|NCT02688530|322652672|FG003|Overall Study|Lost to Follow-up|0|||
94234623|NCT04206085|322652673|FG000|Overall Study|Lost to Follow-up|0|||
94234624|NCT04206085|322652674|FG001|Overall Study|Lost to Follow-up|1|||
94234625|NCT04206085|322652675|FG002|Overall Study|Lost to Follow-up|0|||
94234626|NCT04206085|322652673|FG000|Overall Study|Lost to Follow-up|0|||
94234627|NCT04206085|322652674|FG001|Overall Study|Lost to Follow-up|0|||
94234628|NCT04206085|322652675|FG002|Overall Study|Lost to Follow-up|1|||
94234629|NCT00763451|322652676|FG000|Overall Study|Adverse Event|4|||
94234630|NCT00763451|322652677|FG001|Overall Study|Adverse Event|6|||
94234631|NCT00763451|322652678|FG002|Overall Study|Adverse Event|19|||
94234632|NCT00763451|322652679|FG003|Overall Study|Adverse Event|14|||
94234633|NCT00763451|322652676|FG000|Overall Study|Lack of Efficacy|1|||
94234634|NCT00763451|322652677|FG001|Overall Study|Lack of Efficacy|4|||
94234635|NCT00763451|322652678|FG002|Overall Study|Lack of Efficacy|3|||
94234636|NCT00763451|322652679|FG003|Overall Study|Lack of Efficacy|2|||
94234637|NCT00763451|322652676|FG000|Overall Study|Withdrawal by Subject|1|||
94234638|NCT00763451|322652677|FG001|Overall Study|Withdrawal by Subject|6|||
94234639|NCT00763451|322652678|FG002|Overall Study|Withdrawal by Subject|9|||
94234640|NCT00763451|322652679|FG003|Overall Study|Withdrawal by Subject|7|||
94234641|NCT00763451|322652676|FG000|Overall Study|Protocol Violation|0|||
94234642|NCT00763451|322652677|FG001|Overall Study|Protocol Violation|0|||
94234643|NCT00763451|322652678|FG002|Overall Study|Protocol Violation|1|||
94234644|NCT00763451|322652679|FG003|Overall Study|Protocol Violation|0|||
94234645|NCT00763451|322652676|FG000|Overall Study|Poor Compliance to Protocol|1|||
94234646|NCT00763451|322652677|FG001|Overall Study|Poor Compliance to Protocol|1|||
94234647|NCT00763451|322652678|FG002|Overall Study|Poor Compliance to Protocol|2|||
94234648|NCT00763451|322652679|FG003|Overall Study|Poor Compliance to Protocol|2|||
94234649|NCT00763451|322652676|FG000|Overall Study|Familial and Personal Reasons|5|||
94234650|NCT00763451|322652677|FG001|Overall Study|Familial and Personal Reasons|3|||
94234651|NCT00763451|322652678|FG002|Overall Study|Familial and Personal Reasons|5|||
94234652|NCT00763451|322652679|FG003|Overall Study|Familial and Personal Reasons|4|||
94234653|NCT00763451|322652676|FG000|Overall Study|Randomized but not Treated|1|||
94234654|NCT00763451|322652677|FG001|Overall Study|Randomized but not Treated|1|||
94234655|NCT00763451|322652678|FG002|Overall Study|Randomized but not Treated|0|||
94234656|NCT00763451|322652679|FG003|Overall Study|Randomized but not Treated|0|||
94234657|NCT00763451|322652676|FG000|Overall Study|Study Site Reason|0|||
94234658|NCT00763451|322652677|FG001|Overall Study|Study Site Reason|1|||
94234659|NCT00763451|322652678|FG002|Overall Study|Study Site Reason|1|||
94234660|NCT00763451|322652679|FG003|Overall Study|Study Site Reason|1|||
94234661|NCT00727506|322652680|FG000|Overall Study|Adverse Event|0|||
94234662|NCT00727506|322652681|FG001|Overall Study|Adverse Event|0|||
94234663|NCT00727506|322652682|FG002|Overall Study|Adverse Event|4|||
94234664|NCT00727506|322652683|FG003|Overall Study|Adverse Event|4|||
94234665|NCT00727506|322652684|FG004|Overall Study|Adverse Event|1|||
94234666|NCT00727506|322652685|FG005|Overall Study|Adverse Event|8|||
94234667|NCT00727506|322652680|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
94234668|NCT00727506|322652681|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94234669|NCT00727506|322652682|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
94234670|NCT00727506|322652683|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94234671|NCT00727506|322652684|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94234672|NCT00727506|322652685|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94234673|NCT00727506|322652680|FG000|Overall Study|Progressive disease|4|||
94234674|NCT00727506|322652681|FG001|Overall Study|Progressive disease|7|||
94234675|NCT00727506|322652682|FG002|Overall Study|Progressive disease|9|||
94234676|NCT00727506|322652683|FG003|Overall Study|Progressive disease|28|||
94234677|NCT00727506|322652684|FG004|Overall Study|Progressive disease|38|||
94234678|NCT00727506|322652685|FG005|Overall Study|Progressive disease|28|||
94234679|NCT00727506|322652680|FG000|Overall Study|Refused to continue medication|0|||
94234680|NCT00727506|322652681|FG001|Overall Study|Refused to continue medication|1|||
94234681|NCT00727506|322652682|FG002|Overall Study|Refused to continue medication|2|||
94234682|NCT00727506|322652683|FG003|Overall Study|Refused to continue medication|3|||
94234683|NCT00727506|322652684|FG004|Overall Study|Refused to continue medication|1|||
94234684|NCT00727506|322652685|FG005|Overall Study|Refused to continue medication|2|||
94234685|NCT00727506|322652680|FG000|Overall Study|Other reason not described above|0|||
94234686|NCT00727506|322652681|FG001|Overall Study|Other reason not described above|0|||
94234687|NCT00727506|322652682|FG002|Overall Study|Other reason not described above|1|||
94234688|NCT00727506|322652683|FG003|Overall Study|Other reason not described above|4|||
94234689|NCT00727506|322652684|FG004|Overall Study|Other reason not described above|1|||
94234690|NCT00727506|322652685|FG005|Overall Study|Other reason not described above|1|||
94234691|NCT00383123|322652689|FG000|Overall Study|Adverse Event|1|||
94234692|NCT00383123|322652690|FG001|Overall Study|Adverse Event|0|||
94234693|NCT00383123|322652689|FG000|Overall Study|Lost to Follow-up|68|||
94234694|NCT00383123|322652690|FG001|Overall Study|Lost to Follow-up|61|||
94234695|NCT00383123|322652689|FG000|Overall Study|Protocol Violation|5|||
94234696|NCT00383123|322652690|FG001|Overall Study|Protocol Violation|1|||
94234697|NCT00383123|322652689|FG000|Overall Study|Withdrawal by Subject|27|||
94234698|NCT00383123|322652690|FG001|Overall Study|Withdrawal by Subject|18|||
94234699|NCT00383123|322652689|FG000|Overall Study|Other reason|10|||
94234700|NCT00383123|322652690|FG001|Overall Study|Other reason|6|||
94234701|NCT03448536|322652691|FG000|Overall Study|Protocol Violation|2|||
94234702|NCT03448536|322652692|FG001|Overall Study|Protocol Violation|0|||
94234703|NCT03448536|322652691|FG000|Overall Study|Pregnancy|1|||
94234704|NCT03448536|322652692|FG001|Overall Study|Pregnancy|0|||
94234705|NCT03448536|322652691|FG000|Overall Study|Withdrawal by Subject|1|||
94234706|NCT03448536|322652692|FG001|Overall Study|Withdrawal by Subject|2|||
94234707|NCT03448536|322652691|FG000|Overall Study|Lost to Follow-up|3|||
94234708|NCT03448536|322652692|FG001|Overall Study|Lost to Follow-up|2|||
94234709|NCT03448536|322652691|FG000|Overall Study|Inadequate pain reporter|1|||
94234710|NCT03448536|322652692|FG001|Overall Study|Inadequate pain reporter|0|||
94234711|NCT03448536|322652691|FG000|Overall Study|Other|3|||
94234712|NCT03448536|322652692|FG001|Overall Study|Other|0|||
94234713|NCT03448536|322652691|FG000|Overall Study|Physician Decision|1|||
94234714|NCT03448536|322652692|FG001|Overall Study|Physician Decision|0|||
94234715|NCT01191008|322652695|FG000|Overall Study|Protocol Violation|7|||
94234716|NCT01191008|322652695|FG000|Overall Study|Lost to Follow-up|8|||
94234717|NCT03371823|322652696|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
94234718|NCT03371823|322652697|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
94234719|NCT00926575|322652700|FG000|Overall Study|Adverse Event|1|||
94234720|NCT00926575|322652701|FG001|Overall Study|Adverse Event|1|||
94234721|NCT00926575|322652700|FG000|Overall Study|Death|4|||
94234722|NCT00926575|322652701|FG001|Overall Study|Death|4|||
94234723|NCT00926575|322652700|FG000|Overall Study|Lost to Follow-up|1|||
94234724|NCT00926575|322652701|FG001|Overall Study|Lost to Follow-up|1|||
94234725|NCT00926575|322652700|FG000|Overall Study|Physician Decision|1|||
94234726|NCT00926575|322652701|FG001|Overall Study|Physician Decision|2|||
94234727|NCT00926575|322652700|FG000|Overall Study|Protocol Violation|1|||
94234728|NCT00926575|322652701|FG001|Overall Study|Protocol Violation|0|||
94234729|NCT00926575|322652700|FG000|Overall Study|Withdrawal by Subject|8|||
94234730|NCT00926575|322652701|FG001|Overall Study|Withdrawal by Subject|9|||
94234731|NCT01210651|322652709|FG000|Overall Study|Lost to Follow-up|1|||
94234732|NCT01210651|322652710|FG001|Overall Study|Lost to Follow-up|1|||
94234733|NCT01210651|322652709|FG000|Overall Study|schedule conflicts|1|||
94234734|NCT01210651|322652710|FG001|Overall Study|schedule conflicts|5|||
94234735|NCT01210651|322652709|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
94234736|NCT01210651|322652710|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
94234737|NCT01210651|322652709|FG000|Overall Study|Withdrawal by Subject|1|||
94234738|NCT01210651|322652710|FG001|Overall Study|Withdrawal by Subject|1|||
94234739|NCT01210651|322652709|FG000|Overall Study|Injury outside study|2|||
94234740|NCT01210651|322652710|FG001|Overall Study|Injury outside study|0|||
94234741|NCT02592707|322652711|FG000|Overall Study|Consent Withdrawn|0|||
94234742|NCT02592707|322652712|FG001|Overall Study|Consent Withdrawn|1|||
94234743|NCT02592707|322652713|FG002|Overall Study|Consent Withdrawn|2|||
94234744|NCT02592707|322652714|FG003|Overall Study|Consent Withdrawn|0|||
94234745|NCT02592707|322652711|FG000|Overall Study|Death|1|||
94234746|NCT02592707|322652712|FG001|Overall Study|Death|0|||
94234747|NCT02592707|322652713|FG002|Overall Study|Death|0|||
94234748|NCT02592707|322652714|FG003|Overall Study|Death|0|||
94234749|NCT02592707|322652711|FG000|Overall Study|Progressive Disease|4|||
94234750|NCT02592707|322652712|FG001|Overall Study|Progressive Disease|4|||
94234751|NCT02592707|322652713|FG002|Overall Study|Progressive Disease|3|||
94234752|NCT02592707|322652714|FG003|Overall Study|Progressive Disease|3|||
94234753|NCT02592707|322652711|FG000|Overall Study|Other|0|||
94234754|NCT02592707|322652712|FG001|Overall Study|Other|0|||
94234755|NCT02592707|322652713|FG002|Overall Study|Other|1|||
94450387|NCT03850483|323435409|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
94234756|NCT02592707|322652714|FG003|Overall Study|Other|2|||
94450388|NCT03850483|323435410|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
94450389|NCT03850483|323435411|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
94450390|NCT03850483|323435402|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
94450391|NCT03850483|323435403|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
94450392|NCT03850483|323435404|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
94450393|NCT03850483|323435405|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
94450394|NCT03850483|323435406|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
94450395|NCT03850483|323435407|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
94450396|NCT03850483|323435408|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
94234757|NCT02592707|322652711|FG000|Overall Study|Never entered LTFU period|1|||
94234758|NCT02592707|322652712|FG001|Overall Study|Never entered LTFU period|0|||
94234759|NCT02592707|322652713|FG002|Overall Study|Never entered LTFU period|0|||
94234760|NCT02592707|322652714|FG003|Overall Study|Never entered LTFU period|2|||
94450397|NCT03850483|323435409|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
94234761|NCT04124471|322652715|FG000|Overall Study|screen failure|1|||
94234762|NCT00966264|322654570|FG000|Overall Study|Lost to Follow-up|4|||
94234763|NCT00966264|322654571|FG001|Overall Study|Lost to Follow-up|3|||
94234764|NCT04650698|322654572|FG000|Overall Study|Protocol Violation|2|||
94234765|NCT04650698|322654573|FG001|Overall Study|Protocol Violation|1|||
94234766|NCT04650698|322654572|FG000|Overall Study|Withdrawal by Subject|0|||
94234767|NCT04650698|322654573|FG001|Overall Study|Withdrawal by Subject|1|||
94234768|NCT03614676|322654574|FG000|Overall Study|Delivery before planned visit|2|||
94234769|NCT03614676|322654575|FG001|Overall Study|Delivery before planned visit|0|||
94234770|NCT03614676|322654574|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
94234771|NCT03614676|322654575|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
94234772|NCT03614676|322654574|FG000|Overall Study|Migrated / moved from the study area|30|||
94234773|NCT03614676|322654575|FG001|Overall Study|Migrated / moved from the study area|22|||
94234774|NCT03614676|322654574|FG000|Overall Study|Lost to Follow-up|17|||
94234775|NCT03614676|322654575|FG001|Overall Study|Lost to Follow-up|42|||
94234776|NCT03614676|322654574|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
94234777|NCT03614676|322654575|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
94234778|NCT03614676|322654574|FG000|Overall Study|Other|16|||
94234779|NCT03614676|322654575|FG001|Overall Study|Other|47|||
94234780|NCT03614676|322654574|FG000|Overall Study|Protocol Violation|0|||
94234781|NCT03614676|322654575|FG001|Overall Study|Protocol Violation|2|||
94234782|NCT03614676|322654574|FG000|Overall Study|Neonatal event of interest|0|||
94234783|NCT03614676|322654575|FG001|Overall Study|Neonatal event of interest|6|||
94234784|NCT03614676|322654574|FG000|Overall Study|Death in infant greater than 28 days old|0|||
94234785|NCT03614676|322654575|FG001|Overall Study|Death in infant greater than 28 days old|12|||
94234786|NCT03614676|322654574|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
94234787|NCT03614676|322654575|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
94234788|NCT01090011|322654576|FG000|Overall Study|Progressive disease|128|||
94234789|NCT01090011|322654576|FG000|Overall Study|Adverse Event|32|||
94234790|NCT01090011|322654576|FG000|Overall Study|Protocol Violation|1|||
94234791|NCT01090011|322654576|FG000|Overall Study|Refusal to start/continue medication|5|||
94234792|NCT01090011|322654576|FG000|Overall Study|Other reason not defined above|5|||
94234793|NCT00903760|322654579|FG000|Overall Study|Disease Progression/Death|8|||
94234794|NCT00903760|322654580|FG001|Overall Study|Disease Progression/Death|6|||
94234795|NCT00903760|322654579|FG000|Overall Study|Stem Cell Transplant|8|||
94234796|NCT00903760|322654580|FG001|Overall Study|Stem Cell Transplant|4|||
94234797|NCT00903760|322654579|FG000|Overall Study|Physician Decision|1|||
94234798|NCT00903760|322654580|FG001|Overall Study|Physician Decision|2|||
94234799|NCT00903760|322654579|FG000|Overall Study|Death|0|||
94234800|NCT00903760|322654580|FG001|Overall Study|Death|1|||
94234801|NCT00903760|322654579|FG000|Overall Study|Lost to Follow-up|1|||
94234802|NCT00903760|322654580|FG001|Overall Study|Lost to Follow-up|0|||
94234803|NCT00903760|322654579|FG000|Overall Study|Withdrawal by Subject|1|||
94234804|NCT00903760|322654580|FG001|Overall Study|Withdrawal by Subject|2|||
94234805|NCT00903760|322654579|FG000|Overall Study|Off treatment for long period|0|||
94234806|NCT00903760|322654580|FG001|Overall Study|Off treatment for long period|1|||
94234807|NCT00379769|322654581|FG000|Main Study|Death|57|||
94234808|NCT00379769|322654582|FG001|Main Study|Death|67|||
94234809|NCT00379769|322654583|FG002|Main Study|Death|54|||
94234810|NCT00379769|322654584|FG003|Main Study|Death|72|||
94234811|NCT00379769|322654585|FG004|Main Study|Death|0|||
94234812|NCT00379769|322654586|FG005|Main Study|Death|0|||
94234813|NCT00379769|322654581|FG000|Main Study|Adverse Event|5|||
94234814|NCT00379769|322654582|FG001|Main Study|Adverse Event|8|||
94234815|NCT00379769|322654583|FG002|Main Study|Adverse Event|10|||
94234816|NCT00379769|322654584|FG003|Main Study|Adverse Event|11|||
94234817|NCT00379769|322654585|FG004|Main Study|Adverse Event|0|||
94234818|NCT00379769|322654586|FG005|Main Study|Adverse Event|0|||
94234819|NCT00379769|322654581|FG000|Main Study|Lost to Follow-up|29|||
94234820|NCT00379769|322654582|FG001|Main Study|Lost to Follow-up|29|||
94234821|NCT00379769|322654583|FG002|Main Study|Lost to Follow-up|25|||
94234822|NCT00379769|322654584|FG003|Main Study|Lost to Follow-up|26|||
94234823|NCT00379769|322654585|FG004|Main Study|Lost to Follow-up|0|||
94234824|NCT00379769|322654586|FG005|Main Study|Lost to Follow-up|0|||
94234825|NCT00379769|322654581|FG000|Main Study|Withdrawal by Subject|46|||
94234826|NCT00379769|322654582|FG001|Main Study|Withdrawal by Subject|56|||
94234827|NCT00379769|322654583|FG002|Main Study|Withdrawal by Subject|72|||
94234828|NCT00379769|322654584|FG003|Main Study|Withdrawal by Subject|70|||
94234829|NCT00379769|322654585|FG004|Main Study|Withdrawal by Subject|0|||
94234830|NCT00379769|322654586|FG005|Main Study|Withdrawal by Subject|0|||
94234831|NCT00379769|322654581|FG000|Main Study|Moved to survival status follow-up only|27|||
94234832|NCT00379769|322654582|FG001|Main Study|Moved to survival status follow-up only|25|||
94234833|NCT00379769|322654583|FG002|Main Study|Moved to survival status follow-up only|32|||
94234834|NCT00379769|322654584|FG003|Main Study|Moved to survival status follow-up only|36|||
94234835|NCT00379769|322654585|FG004|Main Study|Moved to survival status follow-up only|0|||
94234836|NCT00379769|322654586|FG005|Main Study|Moved to survival status follow-up only|0|||
94234837|NCT00379769|322654581|FG000|Main Study|Participant moved|3|||
94234838|NCT00379769|322654582|FG001|Main Study|Participant moved|2|||
94234839|NCT00379769|322654583|FG002|Main Study|Participant moved|3|||
94234840|NCT00379769|322654584|FG003|Main Study|Participant moved|3|||
94234841|NCT00379769|322654585|FG004|Main Study|Participant moved|0|||
94234842|NCT00379769|322654586|FG005|Main Study|Participant moved|0|||
94234843|NCT00379769|322654581|FG000|Main Study|Poor compliance|3|||
94234844|NCT00379769|322654582|FG001|Main Study|Poor compliance|2|||
94234845|NCT00379769|322654583|FG002|Main Study|Poor compliance|2|||
94234846|NCT00379769|322654584|FG003|Main Study|Poor compliance|1|||
94234847|NCT00379769|322654585|FG004|Main Study|Poor compliance|0|||
94234848|NCT00379769|322654586|FG005|Main Study|Poor compliance|0|||
94234849|NCT00379769|322654581|FG000|Main Study|Prohibited glucose lowering medication|0|||
94234850|NCT00379769|322654582|FG001|Main Study|Prohibited glucose lowering medication|3|||
94234851|NCT00379769|322654583|FG002|Main Study|Prohibited glucose lowering medication|0|||
94234852|NCT00379769|322654584|FG003|Main Study|Prohibited glucose lowering medication|1|||
94234853|NCT00379769|322654585|FG004|Main Study|Prohibited glucose lowering medication|0|||
94234854|NCT00379769|322654586|FG005|Main Study|Prohibited glucose lowering medication|0|||
94234855|NCT00379769|322654581|FG000|Main Study|Site closed|4|||
94234856|NCT00379769|322654582|FG001|Main Study|Site closed|4|||
94234857|NCT00379769|322654583|FG002|Main Study|Site closed|4|||
94234858|NCT00379769|322654584|FG003|Main Study|Site closed|8|||
94234859|NCT00379769|322654585|FG004|Main Study|Site closed|0|||
94234860|NCT00379769|322654586|FG005|Main Study|Site closed|0|||
94234861|NCT00379769|322654581|FG000|Main Study|Entry criteria violation|0|||
94234862|NCT00379769|322654582|FG001|Main Study|Entry criteria violation|0|||
94234863|NCT00379769|322654583|FG002|Main Study|Entry criteria violation|1|||
94234864|NCT00379769|322654584|FG003|Main Study|Entry criteria violation|1|||
94234865|NCT00379769|322654585|FG004|Main Study|Entry criteria violation|0|||
94234866|NCT00379769|322654586|FG005|Main Study|Entry criteria violation|0|||
94234867|NCT00379769|322654581|FG000|Main Study|Participant did not take study drug|0|||
94234868|NCT00379769|322654582|FG001|Main Study|Participant did not take study drug|0|||
94234869|NCT00379769|322654583|FG002|Main Study|Participant did not take study drug|1|||
94234870|NCT00379769|322654584|FG003|Main Study|Participant did not take study drug|0|||
94563104|NCT00587158|323858083|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
94234871|NCT00379769|322654585|FG004|Main Study|Participant did not take study drug|0|||
94234872|NCT00379769|322654586|FG005|Main Study|Participant did not take study drug|0|||
94234873|NCT00379769|322654581|FG000|Main Study|Physician Decision|2|||
94234874|NCT00379769|322654582|FG001|Main Study|Physician Decision|2|||
94234875|NCT00379769|322654583|FG002|Main Study|Physician Decision|1|||
94563105|NCT00587158|323858084|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
94234876|NCT00379769|322654584|FG003|Main Study|Physician Decision|1|||
94563106|NCT00587158|323858083|FG000|Overall Study|Physician Decision|0|||
94234877|NCT00379769|322654585|FG004|Main Study|Physician Decision|0|||
94234878|NCT00379769|322654586|FG005|Main Study|Physician Decision|0|||
94234879|NCT00379769|322654581|FG000|Main Study|Participant completed study at visit 27|1|||
94234880|NCT00379769|322654582|FG001|Main Study|Participant completed study at visit 27|0|||
94234881|NCT00379769|322654583|FG002|Main Study|Participant completed study at visit 27|0|||
94234882|NCT00379769|322654584|FG003|Main Study|Participant completed study at visit 27|0|||
94234883|NCT00379769|322654585|FG004|Main Study|Participant completed study at visit 27|0|||
94234884|NCT00379769|322654586|FG005|Main Study|Participant completed study at visit 27|0|||
94234885|NCT00379769|322654581|FG000|Main Study|Personal reasons|1|||
94234886|NCT00379769|322654582|FG001|Main Study|Personal reasons|0|||
94234887|NCT00379769|322654583|FG002|Main Study|Personal reasons|0|||
94346200|NCT02141854|323047735|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
94346201|NCT02141854|323047736|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
94346202|NCT02141854|323047737|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
94346203|NCT02141854|323047732|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
94346204|NCT02141854|323047733|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
94346205|NCT02141854|323047734|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
94346206|NCT02141854|323047735|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
94346207|NCT02141854|323047736|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
94346208|NCT02141854|323047737|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
94346209|NCT02141854|323047732|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
94346210|NCT02141854|323047733|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
94346211|NCT02141854|323047734|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
94346212|NCT02141854|323047735|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
94346213|NCT02141854|323047736|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
94346214|NCT02141854|323047737|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
94346215|NCT02141854|323047732|FG000|Treatment Period|Protocol Violation|0|||
94346216|NCT02141854|323047733|FG001|Treatment Period|Protocol Violation|1|||
94346217|NCT02141854|323047734|FG002|Treatment Period|Protocol Violation|0|||
94346218|NCT02141854|323047735|FG003|Treatment Period|Protocol Violation|2|||
94346219|NCT02141854|323047736|FG004|Treatment Period|Protocol Violation|2|||
94346220|NCT02141854|323047737|FG005|Treatment Period|Protocol Violation|1|||
94346221|NCT02141854|323047732|FG000|Treatment Period|Noncompliance|0|||
94346222|NCT02141854|323047733|FG001|Treatment Period|Noncompliance|0|||
94346223|NCT02141854|323047734|FG002|Treatment Period|Noncompliance|0|||
94346224|NCT02141854|323047735|FG003|Treatment Period|Noncompliance|1|||
94346225|NCT02141854|323047736|FG004|Treatment Period|Noncompliance|0|||
94346226|NCT02141854|323047737|FG005|Treatment Period|Noncompliance|0|||
94346227|NCT02141854|323047732|FG000|Treatment Period|Lack of Efficacy|0|||
94346228|NCT02141854|323047733|FG001|Treatment Period|Lack of Efficacy|0|||
94450398|NCT03850483|323435410|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
94450399|NCT03850483|323435411|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
94450400|NCT03850483|323435402|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
94450401|NCT03850483|323435403|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
94450402|NCT03850483|323435404|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
94450403|NCT03850483|323435405|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
94234888|NCT00379769|322654584|FG003|Main Study|Personal reasons|0|||
94234889|NCT00379769|322654585|FG004|Main Study|Personal reasons|0|||
94234890|NCT00379769|322654586|FG005|Main Study|Personal reasons|0|||
94234891|NCT00379769|322654581|FG000|Main Study|Risk of heart failure|0|||
94346229|NCT02141854|323047734|FG002|Treatment Period|Lack of Efficacy|0|||
94450404|NCT03850483|323435406|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
94346230|NCT02141854|323047735|FG003|Treatment Period|Lack of Efficacy|1|||
94346231|NCT02141854|323047736|FG004|Treatment Period|Lack of Efficacy|1|||
94346232|NCT02141854|323047737|FG005|Treatment Period|Lack of Efficacy|7|||
94346233|NCT02141854|323047732|FG000|Treatment Period|Pregnancy|0|||
94346234|NCT02141854|323047733|FG001|Treatment Period|Pregnancy|1|||
94346235|NCT02141854|323047734|FG002|Treatment Period|Pregnancy|0|||
94346236|NCT02141854|323047735|FG003|Treatment Period|Pregnancy|0|||
94346237|NCT02141854|323047736|FG004|Treatment Period|Pregnancy|0|||
94346238|NCT02141854|323047737|FG005|Treatment Period|Pregnancy|0|||
94346239|NCT02141854|323047732|FG000|Treatment Period|Other|0|||
94346240|NCT02141854|323047733|FG001|Treatment Period|Other|1|||
94346241|NCT02141854|323047734|FG002|Treatment Period|Other|2|||
94346242|NCT02141854|323047735|FG003|Treatment Period|Other|0|||
94346243|NCT02141854|323047736|FG004|Treatment Period|Other|1|||
94346244|NCT02141854|323047737|FG005|Treatment Period|Other|2|||
94346245|NCT02141854|323047732|FG000|Treatment Period|Adverse Event|0|||
94346246|NCT02141854|323047733|FG001|Treatment Period|Adverse Event|2|||
94346247|NCT02141854|323047734|FG002|Treatment Period|Adverse Event|2|||
94346248|NCT02141854|323047735|FG003|Treatment Period|Adverse Event|0|||
94346249|NCT02141854|323047736|FG004|Treatment Period|Adverse Event|2|||
94346250|NCT02141854|323047737|FG005|Treatment Period|Adverse Event|2|||
94346251|NCT02141854|323047732|FG000|Treatment Period|Withdrawal by Subject|0|||
94346252|NCT02141854|323047733|FG001|Treatment Period|Withdrawal by Subject|2|||
94346253|NCT02141854|323047734|FG002|Treatment Period|Withdrawal by Subject|3|||
94346254|NCT02141854|323047735|FG003|Treatment Period|Withdrawal by Subject|3|||
94346255|NCT02141854|323047736|FG004|Treatment Period|Withdrawal by Subject|4|||
94346256|NCT02141854|323047737|FG005|Treatment Period|Withdrawal by Subject|7|||
94346257|NCT02141854|323047732|FG000|Treatment Period|Disease progression|0|||
94346258|NCT02141854|323047733|FG001|Treatment Period|Disease progression|2|||
94346259|NCT02141854|323047734|FG002|Treatment Period|Disease progression|1|||
94346260|NCT02141854|323047735|FG003|Treatment Period|Disease progression|3|||
94346261|NCT02141854|323047736|FG004|Treatment Period|Disease progression|0|||
94346262|NCT02141854|323047737|FG005|Treatment Period|Disease progression|18|||
94346263|NCT02141854|323047732|FG000|Treatment Period|Lost to Follow-up|0|||
94346264|NCT02141854|323047733|FG001|Treatment Period|Lost to Follow-up|1|||
94346265|NCT02141854|323047734|FG002|Treatment Period|Lost to Follow-up|1|||
94346266|NCT02141854|323047735|FG003|Treatment Period|Lost to Follow-up|1|||
94346267|NCT02141854|323047736|FG004|Treatment Period|Lost to Follow-up|0|||
94346268|NCT02141854|323047737|FG005|Treatment Period|Lost to Follow-up|1|||
94563107|NCT00587158|323858084|FG001|Overall Study|Physician Decision|1|||
94234892|NCT00379769|322654582|FG001|Main Study|Risk of heart failure|1|||
94346269|NCT03452397|323047738|FG000|Overall Study|Adverse Event|1|||
94346270|NCT03452397|323047739|FG001|Overall Study|Adverse Event|0|||
94346271|NCT03452397|323047740|FG002|Overall Study|Adverse Event|0|||
94346272|NCT03452397|323047741|FG003|Overall Study|Adverse Event|0|||
94346273|NCT03452397|323047738|FG000|Overall Study|Administrative reason|0|||
94346274|NCT03452397|323047739|FG001|Overall Study|Administrative reason|0|||
94346275|NCT03452397|323047740|FG002|Overall Study|Administrative reason|1|||
94346276|NCT03452397|323047741|FG003|Overall Study|Administrative reason|1|||
94563108|NCT00587158|323858083|FG000|Overall Study|Lost to Follow-up|1|||
94346277|NCT03452397|323047738|FG000|Overall Study|Withdrawal by Subject|0|||
94346278|NCT03452397|323047739|FG001|Overall Study|Withdrawal by Subject|0|||
94346279|NCT03452397|323047740|FG002|Overall Study|Withdrawal by Subject|1|||
94346280|NCT03452397|323047741|FG003|Overall Study|Withdrawal by Subject|0|||
94346281|NCT00125268|323047742|FG000|Overall Study|Withdrawal by Subject|1|||
94346282|NCT00125268|323047743|FG001|Overall Study|Withdrawal by Subject|1|||
94346283|NCT03756285|323047744|FG000|Overall Study|Lost to Follow-up|0|||
94346284|NCT03756285|323047745|FG001|Overall Study|Lost to Follow-up|1|||
94346285|NCT03756285|323047744|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
94346286|NCT03756285|323047745|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
94346287|NCT03756285|323047744|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
94346288|NCT03756285|323047745|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
94346289|NCT03619902|323047746|FG000|Overall Study|Termination of Study by Investigator|1|||
94346290|NCT03619902|323047746|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
94346291|NCT00631969|323047749|FG000|Overall Study|Adverse Event|3|||
94346292|NCT00631969|323047750|FG001|Overall Study|Adverse Event|1|||
94346293|NCT00631969|323047749|FG000|Overall Study|Lack of Efficacy|2|||
94346294|NCT00631969|323047750|FG001|Overall Study|Lack of Efficacy|8|||
94346295|NCT00631969|323047749|FG000|Overall Study|Lost to Follow-up|2|||
94346296|NCT00631969|323047750|FG001|Overall Study|Lost to Follow-up|1|||
94346297|NCT00631969|323047749|FG000|Overall Study|Protocol Violation|1|||
94346298|NCT00631969|323047750|FG001|Overall Study|Protocol Violation|1|||
94346299|NCT00631969|323047749|FG000|Overall Study|Consent Withdrawn|5|||
94346300|NCT00631969|323047750|FG001|Overall Study|Consent Withdrawn|7|||
94346301|NCT00631969|323047749|FG000|Overall Study|Noncompliant With Study Medication|0|||
94346302|NCT00631969|323047750|FG001|Overall Study|Noncompliant With Study Medication|1|||
94346303|NCT00631969|323047749|FG000|Overall Study|No Drug Exposure|2|||
94346304|NCT00631969|323047750|FG001|Overall Study|No Drug Exposure|2|||
94346305|NCT00686699|323049000|FG000|Treatment Period 1|Adverse Event|0|||
94346306|NCT00686699|323049001|FG001|Treatment Period 1|Adverse Event|2|||
94346307|NCT02425891|323049008|FG000|Overall Study|Death|333|||
94346308|NCT02425891|323049009|FG001|Overall Study|Death|314|||
94346309|NCT02425891|323049008|FG000|Overall Study|Lost to Follow-up|4|||
94346310|NCT02425891|323049009|FG001|Overall Study|Lost to Follow-up|6|||
94346311|NCT02425891|323049008|FG000|Overall Study|Non-Compliance|1|||
94346312|NCT02425891|323049009|FG001|Overall Study|Non-Compliance|1|||
94346313|NCT02425891|323049008|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
94346314|NCT02425891|323049009|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
94346315|NCT02425891|323049008|FG000|Overall Study|Physician Decision|0|||
94346316|NCT02425891|323049009|FG001|Overall Study|Physician Decision|1|||
94346317|NCT02425891|323049008|FG000|Overall Study|Protocol Violation|1|||
94346318|NCT02425891|323049009|FG001|Overall Study|Protocol Violation|1|||
94346319|NCT02425891|323049008|FG000|Overall Study|Study Terminated By Sponsor|85|||
94346320|NCT02425891|323049009|FG001|Overall Study|Study Terminated By Sponsor|95|||
94346321|NCT02425891|323049008|FG000|Overall Study|Withdrawal by Subject|27|||
94346322|NCT02425891|323049009|FG001|Overall Study|Withdrawal by Subject|32|||
94346323|NCT00535236|323049010|FG000|Overall Study|Adverse Event|1|||
94346324|NCT00535236|323049011|FG001|Overall Study|Adverse Event|0|||
94346325|NCT00535236|323049012|FG002|Overall Study|Adverse Event|9|||
94346326|NCT00535236|323049013|FG003|Overall Study|Adverse Event|3|||
94346327|NCT00535236|323049014|FG004|Overall Study|Adverse Event|3|||
94346328|NCT00535236|323049015|FG005|Overall Study|Adverse Event|0|||
94346329|NCT00535236|323049016|FG006|Overall Study|Adverse Event|5|||
94563109|NCT00587158|323858084|FG001|Overall Study|Lost to Follow-up|2|||
94346330|NCT00535236|323049017|FG007|Overall Study|Adverse Event|1|||
94346331|NCT00535236|323049018|FG008|Overall Study|Adverse Event|2|||
94346332|NCT00535236|323049019|FG009|Overall Study|Adverse Event|1|||
94346333|NCT00535236|323049010|FG000|Overall Study|Lost to Follow-up|1|||
94346334|NCT00535236|323049011|FG001|Overall Study|Lost to Follow-up|2|||
94346335|NCT00535236|323049012|FG002|Overall Study|Lost to Follow-up|0|||
94346336|NCT00535236|323049013|FG003|Overall Study|Lost to Follow-up|0|||
94346337|NCT00535236|323049014|FG004|Overall Study|Lost to Follow-up|2|||
94234893|NCT00379769|322654583|FG002|Main Study|Risk of heart failure|0|||
94234894|NCT00379769|322654584|FG003|Main Study|Risk of heart failure|0|||
94234895|NCT00379769|322654585|FG004|Main Study|Risk of heart failure|0|||
94234896|NCT00379769|322654586|FG005|Main Study|Risk of heart failure|0|||
94234897|NCT00379769|322654581|FG000|Main Study|Investigator refused to log temperature|0|||
94234898|NCT00379769|322654582|FG001|Main Study|Investigator refused to log temperature|0|||
94234899|NCT00379769|322654583|FG002|Main Study|Investigator refused to log temperature|1|||
94234900|NCT00379769|322654584|FG003|Main Study|Investigator refused to log temperature|0|||
94234901|NCT00379769|322654585|FG004|Main Study|Investigator refused to log temperature|0|||
94234902|NCT00379769|322654586|FG005|Main Study|Investigator refused to log temperature|0|||
94234903|NCT00379769|322654581|FG000|Main Study|Reason unspecified|0|||
94234904|NCT00379769|322654582|FG001|Main Study|Reason unspecified|0|||
94234905|NCT00379769|322654583|FG002|Main Study|Reason unspecified|1|||
94234906|NCT00379769|322654584|FG003|Main Study|Reason unspecified|0|||
94234907|NCT00379769|322654585|FG004|Main Study|Reason unspecified|0|||
94234908|NCT00379769|322654586|FG005|Main Study|Reason unspecified|0|||
94234909|NCT00379769|322654581|FG000|Observational Follow-up|Death|0|||
94234910|NCT00379769|322654582|FG001|Observational Follow-up|Death|0|||
94234911|NCT00379769|322654583|FG002|Observational Follow-up|Death|0|||
94234912|NCT00379769|322654584|FG003|Observational Follow-up|Death|0|||
94234913|NCT00379769|322654585|FG004|Observational Follow-up|Death|78|||
94234914|NCT00379769|322654586|FG005|Observational Follow-up|Death|70|||
94234915|NCT00379769|322654581|FG000|Observational Follow-up|Adverse Event|0|||
94234916|NCT00379769|322654582|FG001|Observational Follow-up|Adverse Event|0|||
94234917|NCT00379769|322654583|FG002|Observational Follow-up|Adverse Event|0|||
94234918|NCT00379769|322654584|FG003|Observational Follow-up|Adverse Event|0|||
94234919|NCT00379769|322654585|FG004|Observational Follow-up|Adverse Event|1|||
94234920|NCT00379769|322654586|FG005|Observational Follow-up|Adverse Event|0|||
94234921|NCT00379769|322654581|FG000|Observational Follow-up|Lost to Follow-up|0|||
94234922|NCT00379769|322654582|FG001|Observational Follow-up|Lost to Follow-up|0|||
94234923|NCT00379769|322654583|FG002|Observational Follow-up|Lost to Follow-up|0|||
94234924|NCT00379769|322654584|FG003|Observational Follow-up|Lost to Follow-up|0|||
94563110|NCT00587158|323858083|FG000|Overall Study|Death|0|||
94234925|NCT00379769|322654585|FG004|Observational Follow-up|Lost to Follow-up|25|||
94234926|NCT00379769|322654586|FG005|Observational Follow-up|Lost to Follow-up|27|||
94234927|NCT00379769|322654581|FG000|Observational Follow-up|Withdrawal by Subject|0|||
94234928|NCT00379769|322654582|FG001|Observational Follow-up|Withdrawal by Subject|0|||
94234929|NCT00379769|322654583|FG002|Observational Follow-up|Withdrawal by Subject|0|||
94563111|NCT00587158|323858084|FG001|Overall Study|Death|1|||
94234930|NCT00379769|322654584|FG003|Observational Follow-up|Withdrawal by Subject|0|||
94234931|NCT00379769|322654585|FG004|Observational Follow-up|Withdrawal by Subject|12|||
94563112|NCT00587158|323858083|FG000|Overall Study|Subject did not want to take study med|0|||
94234932|NCT00379769|322654586|FG005|Observational Follow-up|Withdrawal by Subject|12|||
94563113|NCT00587158|323858084|FG001|Overall Study|Subject did not want to take study med|1|||
94234933|NCT00379769|322654581|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
94234934|NCT00379769|322654582|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
94234935|NCT00379769|322654583|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
94234936|NCT00379769|322654584|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
94234937|NCT00379769|322654585|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
94234938|NCT00379769|322654586|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
94234939|NCT00379769|322654581|FG000|Observational Follow-up|Physician Decision|0|||
94234940|NCT00379769|322654582|FG001|Observational Follow-up|Physician Decision|0|||
94234941|NCT00379769|322654583|FG002|Observational Follow-up|Physician Decision|0|||
94234942|NCT00379769|322654584|FG003|Observational Follow-up|Physician Decision|0|||
94234943|NCT00379769|322654585|FG004|Observational Follow-up|Physician Decision|8|||
94346338|NCT00535236|323049015|FG005|Overall Study|Lost to Follow-up|0|||
94346339|NCT00535236|323049016|FG006|Overall Study|Lost to Follow-up|0|||
94234944|NCT00379769|322654586|FG005|Observational Follow-up|Physician Decision|8|||
94234945|NCT00379769|322654581|FG000|Observational Follow-up|Site Closed Early|0|||
94234946|NCT00379769|322654582|FG001|Observational Follow-up|Site Closed Early|0|||
94234947|NCT00379769|322654583|FG002|Observational Follow-up|Site Closed Early|0|||
94234948|NCT00379769|322654584|FG003|Observational Follow-up|Site Closed Early|0|||
94234949|NCT00379769|322654585|FG004|Observational Follow-up|Site Closed Early|6|||
94234950|NCT00379769|322654586|FG005|Observational Follow-up|Site Closed Early|7|||
94234951|NCT00379769|322654581|FG000|Observational Follow-up|Participant Moved|0|||
94234952|NCT00379769|322654582|FG001|Observational Follow-up|Participant Moved|0|||
94234953|NCT00379769|322654583|FG002|Observational Follow-up|Participant Moved|0|||
94234954|NCT00379769|322654584|FG003|Observational Follow-up|Participant Moved|0|||
94234955|NCT00379769|322654585|FG004|Observational Follow-up|Participant Moved|0|||
94234956|NCT00379769|322654586|FG005|Observational Follow-up|Participant Moved|1|||
94234957|NCT00379769|322654581|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
94234958|NCT00379769|322654582|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
94234959|NCT00379769|322654583|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
94234960|NCT00379769|322654584|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
94234961|NCT00379769|322654585|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
94234962|NCT00379769|322654586|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
94234963|NCT02825251|322654588|FG000|Overall Study|Adverse Event|0|||
94234964|NCT02825251|322654589|FG001|Overall Study|Adverse Event|1|||
94234965|NCT02825251|322654588|FG000|Overall Study|Lost to Follow-up|0|||
94234966|NCT02825251|322654589|FG001|Overall Study|Lost to Follow-up|1|||
94234967|NCT02825251|322654588|FG000|Overall Study|Withdrawal by Subject|1|||
94234968|NCT02825251|322654589|FG001|Overall Study|Withdrawal by Subject|4|||
94234969|NCT02825251|322654588|FG000|Overall Study|Unclassified|2|||
94234970|NCT02825251|322654589|FG001|Overall Study|Unclassified|0|||
94234971|NCT00497874|322654590|FG000|Overall Study|Withdrawal by Subject|48|||
94234972|NCT00497874|322654591|FG001|Overall Study|Withdrawal by Subject|17|||
94234973|NCT00497874|322654590|FG000|Overall Study|Illness|8|||
94234974|NCT00497874|322654591|FG001|Overall Study|Illness|4|||
94234975|NCT00497874|322654590|FG000|Overall Study|Death|2|||
94234976|NCT00497874|322654591|FG001|Overall Study|Death|4|||
94234977|NCT00497874|322654590|FG000|Overall Study|Unable to contact|52|||
94234978|NCT00497874|322654591|FG001|Overall Study|Unable to contact|67|||
94234979|NCT00497874|322654590|FG000|Overall Study|Unable to schedule|37|||
94234980|NCT00497874|322654591|FG001|Overall Study|Unable to schedule|24|||
94234981|NCT02104505|322654593|FG000|First Intervention (14 Days)|Adverse Event|2|||
94234982|NCT02104505|322654594|FG001|First Intervention (14 Days)|Adverse Event|0|||
94234983|NCT02104505|322654593|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
94234984|NCT02104505|322654594|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
94234985|NCT02104505|322654593|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
94234986|NCT02104505|322654594|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
94234987|NCT02104505|322654593|FG000|First Intervention (14 Days)|exclusionary condition|0|||
94234988|NCT02104505|322654594|FG001|First Intervention (14 Days)|exclusionary condition|1|||
94234989|NCT02104505|322654593|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
94234990|NCT02104505|322654594|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
94234991|NCT02104505|322654593|FG000|Second Intervention (14 Days)|Adverse Event|2|||
94234992|NCT02104505|322654594|FG001|Second Intervention (14 Days)|Adverse Event|0|||
94234993|NCT02859064|322654595|FG000|Overall Study|Progressive Disease|3|||
94234994|NCT02859064|322654595|FG000|Overall Study|Physician Decision|1|||
94234995|NCT02859064|322654595|FG000|Overall Study|Withdrawal by Subject|1|||
94234996|NCT02859064|322654595|FG000|Overall Study|Death|1|||
94234997|NCT01639742|322654596|FG000|Overall Study|Study Ongoing|17|||
94234998|NCT01639742|322654596|FG000|Overall Study|Lost to Follow-up|1|||
94234999|NCT04411186|322654597|FG000|Overall Study|Withdrawn due to protocol violation|0|||
94235000|NCT04411186|322654598|FG001|Overall Study|Withdrawn due to protocol violation|1|||
94235001|NCT02172911|322654599|FG000|Overall Study|Serious Adverse Event|0|||
94235002|NCT02172911|322654600|FG001|Overall Study|Serious Adverse Event|1|||
94235003|NCT02172911|322654599|FG000|Overall Study|Progression of Disease|0|||
94235004|NCT02172911|322654600|FG001|Overall Study|Progression of Disease|1|||
94235005|NCT02172911|322654599|FG000|Overall Study|Loss of insurance coverage|1|||
94235006|NCT02172911|322654600|FG001|Overall Study|Loss of insurance coverage|0|||
94235007|NCT00127842|322654601|FG000|Overall Study|Adverse Event|15|||
94235008|NCT00127842|322654601|FG000|Overall Study|Withdrawal by Subject|3|||
94235009|NCT00127842|322654601|FG000|Overall Study|Lost to Follow-up|1|||
94235010|NCT00127842|322654601|FG000|Overall Study|Lack of Efficacy|12|||
94235011|NCT00127842|322654601|FG000|Overall Study|Noncompliance|2|||
94235012|NCT00127842|322654601|FG000|Overall Study|Protocol Violation|1|||
94235013|NCT00127842|322654601|FG000|Overall Study|Other|5|||
94235014|NCT02820597|322654602|FG000|Overall Study|Lost to Follow-up|12|||
94235015|NCT00575042|322654603|FG000|Overall Study|Adverse Event|2|||
94235016|NCT00575042|322654603|FG000|Overall Study|Lost to Follow-up|1|||
94235017|NCT01536587|322654604|FG000|Overall Study|Adverse Event|2|||
94235018|NCT01434680|322654605|FG000|Overall Study|Withdrawal by Subject|1|||
94235019|NCT01434680|322654606|FG001|Overall Study|Withdrawal by Subject|0|||
94235020|NCT01434680|322654607|FG002|Overall Study|Withdrawal by Subject|2|||
94235021|NCT01434680|322654608|FG003|Overall Study|Withdrawal by Subject|0|||
94235022|NCT01434680|322654605|FG000|Overall Study|Lost to Follow-up|1|||
94235023|NCT01434680|322654606|FG001|Overall Study|Lost to Follow-up|1|||
94235024|NCT01434680|322654607|FG002|Overall Study|Lost to Follow-up|0|||
94235025|NCT01434680|322654608|FG003|Overall Study|Lost to Follow-up|0|||
94235026|NCT01434680|322654605|FG000|Overall Study|Protocol Violation|1|||
94235027|NCT01434680|322654606|FG001|Overall Study|Protocol Violation|1|||
94235028|NCT01434680|322654607|FG002|Overall Study|Protocol Violation|0|||
94235029|NCT01434680|322654608|FG003|Overall Study|Protocol Violation|0|||
94235030|NCT03194867|322654612|FG000|Overall Study|Incorrect completion of end of study form|0|||
94235031|NCT03194867|322654613|FG001|Overall Study|Incorrect completion of end of study form|0|||
94235032|NCT03194867|322654614|FG002|Overall Study|Incorrect completion of end of study form|1|||
94235033|NCT03194867|322654615|FG003|Overall Study|Incorrect completion of end of study form|0|||
94235034|NCT03065933|322654619|FG000|Overall Study|study terminated|5|||
94235035|NCT01375751|322654625|FG000|Overall Study|Other|0|||
94235036|NCT01375751|322654626|FG001|Overall Study|Other|1|||
94235037|NCT01375751|322654627|FG002|Overall Study|Other|0|||
94235038|NCT03721705|322654631|FG000|Overall Study|Adverse Event|2|||
94235039|NCT03721705|322654632|FG001|Overall Study|Adverse Event|0|||
94235040|NCT03721705|322654631|FG000|Overall Study|Withdrawal by Subject|4|||
94235041|NCT03721705|322654632|FG001|Overall Study|Withdrawal by Subject|10|||
94235042|NCT03721705|322654631|FG000|Overall Study|No Suitable Study Partner|1|||
94235043|NCT03721705|322654632|FG001|Overall Study|No Suitable Study Partner|0|||
94235044|NCT03721705|322654631|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
94235045|NCT03721705|322654632|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
94235046|NCT03721705|322654631|FG000|Overall Study|Death|0|||
94235047|NCT03721705|322654632|FG001|Overall Study|Death|1|||
94235048|NCT01790295|322654633|FG000|Overall Study|Adverse Event|1|||
94450405|NCT03850483|323435407|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
94235049|NCT01790295|322654633|FG000|Overall Study|Death|4|||
94235050|NCT01790295|322654633|FG000|Overall Study|Lack of Efficacy|2|||
94235051|NCT01790295|322654633|FG000|Overall Study|Study closure|4|||
94235052|NCT01646385|322654634|FG000|Overall Study|Death|202|||
94235053|NCT01646385|322654635|FG001|Overall Study|Death|222|||
94235054|NCT01646385|322654634|FG000|Overall Study|Switched to alternate biologic|636|||
94235055|NCT01646385|322654635|FG001|Overall Study|Switched to alternate biologic|649|||
94235056|NCT01777334|322654641|FG000|Overall Study|Adverse Event|18|||
94235057|NCT01777334|322654642|FG001|Overall Study|Adverse Event|14|||
94235058|NCT01777334|322654641|FG000|Overall Study|Lack of Efficacy|15|||
94235059|NCT01777334|322654642|FG001|Overall Study|Lack of Efficacy|29|||
94235060|NCT01777334|322654641|FG000|Overall Study|Protocol Violation|3|||
94235061|NCT01777334|322654642|FG001|Overall Study|Protocol Violation|7|||
94235062|NCT01777334|322654641|FG000|Overall Study|Lost to Follow-up|3|||
94235063|NCT01777334|322654642|FG001|Overall Study|Lost to Follow-up|2|||
94235064|NCT01777334|322654641|FG000|Overall Study|Withdrawal by Subject|14|||
94450406|NCT03850483|323435408|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
94450407|NCT03850483|323435409|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
94450408|NCT03850483|323435410|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
94450409|NCT03850483|323435411|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
94235065|NCT01777334|322654642|FG001|Overall Study|Withdrawal by Subject|11|||
94235066|NCT02947100|322654645|FG000|Overall Study|study terminated early|3|||
94235067|NCT02947100|322654645|FG000|Overall Study|did not meet inclusion criteria|1|||
94235068|NCT00822770|322654648|FG000|Overall Study|Not treated|1|||
94450410|NCT03850483|323435402|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
94346340|NCT00535236|323049017|FG007|Overall Study|Lost to Follow-up|0|||
94346341|NCT00535236|323049018|FG008|Overall Study|Lost to Follow-up|6|||
94346342|NCT00535236|323049019|FG009|Overall Study|Lost to Follow-up|1|||
94346343|NCT00535236|323049010|FG000|Overall Study|Physician Decision|0|||
94346344|NCT00535236|323049011|FG001|Overall Study|Physician Decision|0|||
94235069|NCT00822770|322654649|FG001|Overall Study|Not treated|0|||
94346345|NCT00535236|323049012|FG002|Overall Study|Physician Decision|0|||
94563114|NCT00699608|323858085|FG000|First Intervention|Withdrawal by Subject|0|||
94563115|NCT00699608|323858086|FG001|First Intervention|Withdrawal by Subject|0|||
94563116|NCT00699608|323858087|FG002|First Intervention|Withdrawal by Subject|1|||
94563117|NCT00699608|323858088|FG003|First Intervention|Withdrawal by Subject|0|||
94563118|NCT00699608|323858089|FG004|First Intervention|Withdrawal by Subject|0|||
94563119|NCT00699608|323858090|FG005|First Intervention|Withdrawal by Subject|0|||
94563120|NCT00699608|323858085|FG000|First Intervention|Protocol Violation|0|||
94563121|NCT00699608|323858086|FG001|First Intervention|Protocol Violation|0|||
94563122|NCT00699608|323858087|FG002|First Intervention|Protocol Violation|0|||
94563123|NCT00699608|323858088|FG003|First Intervention|Protocol Violation|0|||
94563124|NCT00699608|323858089|FG004|First Intervention|Protocol Violation|1|||
94563125|NCT00699608|323858090|FG005|First Intervention|Protocol Violation|0|||
94563126|NCT00699608|323858085|FG000|Second Intervention|Adverse Event|0|||
94563127|NCT00699608|323858086|FG001|Second Intervention|Adverse Event|0|||
94563128|NCT00699608|323858087|FG002|Second Intervention|Adverse Event|1|||
94563129|NCT00699608|323858088|FG003|Second Intervention|Adverse Event|0|||
94563130|NCT00699608|323858089|FG004|Second Intervention|Adverse Event|0|||
94563131|NCT00699608|323858090|FG005|Second Intervention|Adverse Event|0|||
94563132|NCT00699608|323858085|FG000|Second Intervention|Withdrawal by Subject|0|||
94563133|NCT00699608|323858086|FG001|Second Intervention|Withdrawal by Subject|0|||
94563134|NCT00699608|323858087|FG002|Second Intervention|Withdrawal by Subject|0|||
94563135|NCT00699608|323858088|FG003|Second Intervention|Withdrawal by Subject|1|||
94563136|NCT00699608|323858089|FG004|Second Intervention|Withdrawal by Subject|0|||
94563137|NCT00699608|323858090|FG005|Second Intervention|Withdrawal by Subject|0|||
94563138|NCT00832416|323858093|FG000|Overall Study|Lack of Efficacy|17|||
94563139|NCT00832416|323858094|FG001|Overall Study|Lack of Efficacy|15|||
94563140|NCT00832416|323858095|FG002|Overall Study|Lack of Efficacy|13|||
94657911|NCT01609556|324204459|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
94657912|NCT01609556|324204460|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
94657913|NCT01609556|324204461|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
94657914|NCT01609556|324204462|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
94657915|NCT01609556|324204463|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
94657916|NCT01609556|324204464|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
94657917|NCT01609556|324204465|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
94657918|NCT01609556|324204466|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
94657919|NCT01609556|324204467|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
94657920|NCT01609556|324204468|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
94657921|NCT01609556|324204469|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
94657922|NCT01609556|324204470|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
94657923|NCT01609556|324204455|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
94657924|NCT01609556|324204456|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
94657925|NCT01609556|324204457|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
94657926|NCT01609556|324204458|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
94657927|NCT01609556|324204459|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
94657928|NCT01609556|324204460|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
94657929|NCT01609556|324204461|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
94657930|NCT01609556|324204462|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
94657931|NCT01609556|324204463|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
94657932|NCT01609556|324204464|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
94563141|NCT00832416|323858096|FG003|Overall Study|Lack of Efficacy|52|||
94563142|NCT00832416|323858093|FG000|Overall Study|Withdrawal by Subject|5|||
94563143|NCT00832416|323858094|FG001|Overall Study|Withdrawal by Subject|7|||
94563144|NCT00832416|323858095|FG002|Overall Study|Withdrawal by Subject|2|||
94563145|NCT00832416|323858096|FG003|Overall Study|Withdrawal by Subject|10|||
94563146|NCT00832416|323858093|FG000|Overall Study|Physician Decision|2|||
94563147|NCT00832416|323858094|FG001|Overall Study|Physician Decision|12|||
94563148|NCT00832416|323858095|FG002|Overall Study|Physician Decision|5|||
94563149|NCT00832416|323858096|FG003|Overall Study|Physician Decision|10|||
94563150|NCT00832416|323858093|FG000|Overall Study|Administrative|0|||
94563151|NCT00832416|323858094|FG001|Overall Study|Administrative|0|||
94563152|NCT00832416|323858095|FG002|Overall Study|Administrative|0|||
94563153|NCT00832416|323858096|FG003|Overall Study|Administrative|1|||
94563154|NCT00832416|323858093|FG000|Overall Study|Adverse Event|21|||
94563155|NCT00832416|323858094|FG001|Overall Study|Adverse Event|19|||
94563156|NCT00832416|323858095|FG002|Overall Study|Adverse Event|41|||
94346346|NCT00535236|323049013|FG003|Overall Study|Physician Decision|0|||
94346347|NCT00535236|323049014|FG004|Overall Study|Physician Decision|1|||
94346348|NCT00535236|323049015|FG005|Overall Study|Physician Decision|0|||
94346349|NCT00535236|323049016|FG006|Overall Study|Physician Decision|1|||
94346350|NCT00535236|323049017|FG007|Overall Study|Physician Decision|0|||
94346351|NCT00535236|323049018|FG008|Overall Study|Physician Decision|0|||
94346352|NCT00535236|323049019|FG009|Overall Study|Physician Decision|0|||
94346353|NCT00535236|323049010|FG000|Overall Study|Protocol Violation|2|||
94346354|NCT00535236|323049011|FG001|Overall Study|Protocol Violation|0|||
94346355|NCT00535236|323049012|FG002|Overall Study|Protocol Violation|1|||
94346356|NCT00535236|323049013|FG003|Overall Study|Protocol Violation|0|||
94346357|NCT00535236|323049014|FG004|Overall Study|Protocol Violation|0|||
94346358|NCT00535236|323049015|FG005|Overall Study|Protocol Violation|0|||
94346359|NCT00535236|323049016|FG006|Overall Study|Protocol Violation|0|||
94346360|NCT00535236|323049017|FG007|Overall Study|Protocol Violation|0|||
94346361|NCT00535236|323049018|FG008|Overall Study|Protocol Violation|1|||
94346362|NCT00535236|323049019|FG009|Overall Study|Protocol Violation|0|||
94346363|NCT00535236|323049010|FG000|Overall Study|Withdrawal by Subject|3|||
94346364|NCT00535236|323049011|FG001|Overall Study|Withdrawal by Subject|0|||
94346365|NCT00535236|323049012|FG002|Overall Study|Withdrawal by Subject|2|||
94346366|NCT00535236|323049013|FG003|Overall Study|Withdrawal by Subject|1|||
94346367|NCT00535236|323049014|FG004|Overall Study|Withdrawal by Subject|6|||
94346368|NCT00535236|323049015|FG005|Overall Study|Withdrawal by Subject|1|||
94346369|NCT00535236|323049016|FG006|Overall Study|Withdrawal by Subject|5|||
94346370|NCT00535236|323049017|FG007|Overall Study|Withdrawal by Subject|0|||
94346371|NCT00535236|323049018|FG008|Overall Study|Withdrawal by Subject|4|||
94346372|NCT00535236|323049019|FG009|Overall Study|Withdrawal by Subject|2|||
94346373|NCT04124952|323049020|FG000|Overall Study|Lost to Follow-up|1|||
94346374|NCT00141297|323049022|FG000|Overall Study|Adverse Event|0|||
94346375|NCT00141297|323049023|FG001|Overall Study|Adverse Event|0|||
94346376|NCT00141297|323049024|FG002|Overall Study|Adverse Event|1|||
94346377|NCT00141297|323049025|FG003|Overall Study|Adverse Event|0|||
94346378|NCT00141297|323049026|FG004|Overall Study|Adverse Event|1|||
94346379|NCT00141297|323049027|FG005|Overall Study|Adverse Event|1|||
94346380|NCT00141297|323049028|FG006|Overall Study|Adverse Event|0|||
94346381|NCT00141297|323049029|FG007|Overall Study|Adverse Event|1|||
94346382|NCT00141297|323049030|FG008|Overall Study|Adverse Event|1|||
94563157|NCT00832416|323858096|FG003|Overall Study|Adverse Event|10|||
94563158|NCT00832416|323858093|FG000|Overall Study|Death|1|||
94563159|NCT00832416|323858094|FG001|Overall Study|Death|0|||
94563160|NCT00832416|323858095|FG002|Overall Study|Death|0|||
94563161|NCT00832416|323858096|FG003|Overall Study|Death|0|||
94563162|NCT00981461|323858097|FG000|Overall Study|Lost to Follow-up|5|||
94563163|NCT00981461|323858098|FG001|Overall Study|Lost to Follow-up|2|||
94563164|NCT00483405|323858099|FG000|Overall Study|Adverse Event|8|||
94563165|NCT00483405|323858099|FG000|Overall Study|Lack of Efficacy|14|||
94563166|NCT00483405|323858099|FG000|Overall Study|Death|3|||
94563167|NCT00483405|323858099|FG000|Overall Study|Withdrawal by Subject|2|||
94563168|NCT00483405|323858099|FG000|Overall Study|Other complicating disease|1|||
94346383|NCT00141297|323049031|FG009|Overall Study|Adverse Event|0|||
94346384|NCT00141297|323049022|FG000|Overall Study|Death|1|||
94346385|NCT00141297|323049023|FG001|Overall Study|Death|0|||
94563169|NCT00571038|323858100|FG000|Overall Study|Lost to Follow-up|1|||
94563170|NCT00571038|323858101|FG001|Overall Study|Lost to Follow-up|4|||
94563171|NCT00571038|323858100|FG000|Overall Study|Death|7|||
94563172|NCT00571038|323858101|FG001|Overall Study|Death|5|||
94563173|NCT00571038|323858100|FG000|Overall Study|Withdrawal by Subject|1|||
94235070|NCT00822770|322654648|FG000|Overall Study|Complication/Incomplete treatment|1|||
94235071|NCT00822770|322654649|FG001|Overall Study|Complication/Incomplete treatment|0|||
94235072|NCT00822770|322654648|FG000|Overall Study|Death|1|||
94235073|NCT00822770|322654649|FG001|Overall Study|Death|1|||
94235074|NCT02402322|322654650|FG000|Pretreatment|Withdrawal by Subject|3|||
94235075|NCT02402322|322654651|FG001|Pretreatment|Withdrawal by Subject|1|||
94235076|NCT02402322|322654652|FG002|Pretreatment|Withdrawal by Subject|1|||
94235077|NCT02402322|322654650|FG000|Follow-up|Withdrawal by Subject|6|||
94235078|NCT02402322|322654651|FG001|Follow-up|Withdrawal by Subject|3|||
94235079|NCT02402322|322654652|FG002|Follow-up|Withdrawal by Subject|24|||
94235080|NCT01772563|322654653|FG000|Cycle 1|Dose limiting toxicity|2|||
94235081|NCT01772563|322654653|FG000|Cycle 1|Progressive disease|2|||
94235082|NCT01772563|322654653|FG000|Cycle 2 and Beyond|Progressive disease|17|||
94235083|NCT01772563|322654653|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
94235084|NCT01772563|322654653|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
94235085|NCT01192776|322654654|FG000|Overall Study|Death|8|||
94235086|NCT01192776|322654655|FG001|Overall Study|Death|15|||
94235087|NCT01192776|322654656|FG002|Overall Study|Death|18|||
94235088|NCT01192776|322654657|FG003|Overall Study|Death|15|||
94235089|NCT01192776|322654654|FG000|Overall Study|Lost to Follow-up|3|||
94235090|NCT01192776|322654655|FG001|Overall Study|Lost to Follow-up|6|||
94235091|NCT01192776|322654656|FG002|Overall Study|Lost to Follow-up|3|||
94235092|NCT01192776|322654657|FG003|Overall Study|Lost to Follow-up|5|||
94235093|NCT02993523|322654660|FG000|Overall Study|Withdrew Consent|0|||
94235094|NCT02993523|322654661|FG001|Overall Study|Withdrew Consent|0|||
94235095|NCT02993523|322654662|FG002|Overall Study|Withdrew Consent|2|||
94235096|NCT02993523|322654663|FG003|Overall Study|Withdrew Consent|9|||
94235097|NCT02993523|322654664|FG004|Overall Study|Withdrew Consent|0|||
94235098|NCT02993523|322654660|FG000|Overall Study|Lost to Follow-up|0|||
94235099|NCT02993523|322654661|FG001|Overall Study|Lost to Follow-up|0|||
94235100|NCT02993523|322654662|FG002|Overall Study|Lost to Follow-up|3|||
94235101|NCT02993523|322654663|FG003|Overall Study|Lost to Follow-up|6|||
94235102|NCT02993523|322654664|FG004|Overall Study|Lost to Follow-up|0|||
94235103|NCT02993523|322654660|FG000|Overall Study|Death|1|||
94235104|NCT02993523|322654661|FG001|Overall Study|Death|1|||
94235105|NCT02993523|322654662|FG002|Overall Study|Death|138|||
94235106|NCT02993523|322654663|FG003|Overall Study|Death|222|||
94235107|NCT02993523|322654664|FG004|Overall Study|Death|6|||
94346386|NCT00141297|323049024|FG002|Overall Study|Death|0|||
94346387|NCT00141297|323049025|FG003|Overall Study|Death|0|||
94346388|NCT00141297|323049026|FG004|Overall Study|Death|0|||
94346389|NCT00141297|323049027|FG005|Overall Study|Death|0|||
94346390|NCT00141297|323049028|FG006|Overall Study|Death|0|||
94657933|NCT01609556|324204465|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
94657934|NCT01609556|324204466|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
94346391|NCT00141297|323049029|FG007|Overall Study|Death|0|||
94346392|NCT00141297|323049030|FG008|Overall Study|Death|1|||
94346393|NCT00141297|323049031|FG009|Overall Study|Death|0|||
94346394|NCT00141297|323049022|FG000|Overall Study|Withdrawal by Subject|0|||
94346395|NCT00141297|323049023|FG001|Overall Study|Withdrawal by Subject|0|||
94346396|NCT00141297|323049024|FG002|Overall Study|Withdrawal by Subject|0|||
94346397|NCT00141297|323049025|FG003|Overall Study|Withdrawal by Subject|0|||
94346398|NCT00141297|323049026|FG004|Overall Study|Withdrawal by Subject|0|||
94346399|NCT00141297|323049027|FG005|Overall Study|Withdrawal by Subject|0|||
94346400|NCT00141297|323049028|FG006|Overall Study|Withdrawal by Subject|0|||
94346401|NCT00141297|323049029|FG007|Overall Study|Withdrawal by Subject|0|||
94346402|NCT00141297|323049030|FG008|Overall Study|Withdrawal by Subject|1|||
94346403|NCT00141297|323049031|FG009|Overall Study|Withdrawal by Subject|0|||
94346404|NCT00141297|323049022|FG000|Overall Study|Other|0|||
94346405|NCT00141297|323049023|FG001|Overall Study|Other|0|||
94450411|NCT03850483|323435403|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
94346406|NCT00141297|323049024|FG002|Overall Study|Other|0|||
94346407|NCT00141297|323049025|FG003|Overall Study|Other|1|||
94235108|NCT02993523|322654660|FG000|Overall Study|Reason not Specified|0|||
94346408|NCT00141297|323049026|FG004|Overall Study|Other|5|||
94346409|NCT00141297|323049027|FG005|Overall Study|Other|0|||
94346410|NCT00141297|323049028|FG006|Overall Study|Other|0|||
94346411|NCT00141297|323049029|FG007|Overall Study|Other|0|||
94346412|NCT00141297|323049030|FG008|Overall Study|Other|2|||
94346413|NCT00141297|323049031|FG009|Overall Study|Other|0|||
94346414|NCT00141297|323049022|FG000|Overall Study|Progressive Disease|2|||
94346415|NCT00141297|323049023|FG001|Overall Study|Progressive Disease|3|||
94346416|NCT00141297|323049024|FG002|Overall Study|Progressive Disease|6|||
94346417|NCT00141297|323049025|FG003|Overall Study|Progressive Disease|2|||
94346418|NCT00141297|323049026|FG004|Overall Study|Progressive Disease|15|||
94563174|NCT00571038|323858101|FG001|Overall Study|Withdrawal by Subject|3|||
94563175|NCT00571038|323858100|FG000|Overall Study|Moved out of state|2|||
94563176|NCT00571038|323858101|FG001|Overall Study|Moved out of state|2|||
94563177|NCT04306510|323858102|FG000|Overall Study|Voluntarily withdrawal|1|||
94563178|NCT04306510|323858102|FG000|Overall Study|Enrolled but Not Treated|1|||
94563179|NCT05786508|323858103|FG000|Overall Study|Withdrawal by Subject|2|||
94563180|NCT05786508|323858104|FG001|Overall Study|Withdrawal by Subject|0|||
94563181|NCT03314987|323858105|FG000|Overall Study|Lost to Follow-up|13|||
94563182|NCT03314987|323858106|FG001|Overall Study|Lost to Follow-up|13|||
94563183|NCT04343755|323858107|FG000|Overall Study|Death|11|||
94563184|NCT04343755|323858107|FG000|Overall Study|Screen Failure|1|||
94563185|NCT01456169|323858108|FG000|Overall Study|Adverse Event|1|||
94563186|NCT01456169|323858109|FG001|Overall Study|Adverse Event|2|||
94563187|NCT01456169|323858110|FG002|Overall Study|Adverse Event|7|||
94563188|NCT01456169|323858108|FG000|Overall Study|Major Protocol Deviation|3|||
94563189|NCT01456169|323858109|FG001|Overall Study|Major Protocol Deviation|2|||
94563190|NCT01456169|323858110|FG002|Overall Study|Major Protocol Deviation|3|||
94563191|NCT01456169|323858108|FG000|Overall Study|Voluntary Withdrawal|3|||
94563192|NCT01456169|323858109|FG001|Overall Study|Voluntary Withdrawal|0|||
94563193|NCT01456169|323858110|FG002|Overall Study|Voluntary Withdrawal|2|||
94563194|NCT01456169|323858108|FG000|Overall Study|Lack of Efficacy|2|||
94563195|NCT01456169|323858109|FG001|Overall Study|Lack of Efficacy|0|||
94563196|NCT01456169|323858110|FG002|Overall Study|Lack of Efficacy|0|||
94563197|NCT01456169|323858108|FG000|Overall Study|Other|1|||
94563198|NCT01456169|323858109|FG001|Overall Study|Other|1|||
94563199|NCT01456169|323858110|FG002|Overall Study|Other|0|||
94563200|NCT02045095|323858111|FG000|Overall Study|Other|0|||
94563201|NCT02045095|323858112|FG001|Overall Study|Other|0|||
94563202|NCT02045095|323858113|FG002|Overall Study|Other|1|||
94563203|NCT02045095|323858114|FG003|Overall Study|Other|0|||
94563204|NCT02045095|323858115|FG004|Overall Study|Other|0|||
94563205|NCT02045095|323858116|FG005|Overall Study|Other|2|||
94563206|NCT02045095|323858117|FG006|Overall Study|Other|0|||
94563207|NCT02045095|323858111|FG000|Overall Study|Progressive Disease|3|||
94563208|NCT02045095|323858112|FG001|Overall Study|Progressive Disease|3|||
94563209|NCT02045095|323858113|FG002|Overall Study|Progressive Disease|2|||
94563210|NCT02045095|323858114|FG003|Overall Study|Progressive Disease|4|||
94563211|NCT02045095|323858115|FG004|Overall Study|Progressive Disease|2|||
94563212|NCT02045095|323858116|FG005|Overall Study|Progressive Disease|4|||
94563213|NCT02045095|323858117|FG006|Overall Study|Progressive Disease|1|||
94563214|NCT02045095|323858111|FG000|Overall Study|Withdrawal by Subject|0|||
94563215|NCT02045095|323858112|FG001|Overall Study|Withdrawal by Subject|0|||
94563216|NCT02045095|323858113|FG002|Overall Study|Withdrawal by Subject|0|||
94563217|NCT02045095|323858114|FG003|Overall Study|Withdrawal by Subject|0|||
94563218|NCT02045095|323858115|FG004|Overall Study|Withdrawal by Subject|3|||
94563219|NCT02045095|323858116|FG005|Overall Study|Withdrawal by Subject|0|||
94563220|NCT02045095|323858117|FG006|Overall Study|Withdrawal by Subject|0|||
94563221|NCT02045095|323858111|FG000|Overall Study|Adverse Event|0|||
94563222|NCT02045095|323858112|FG001|Overall Study|Adverse Event|1|||
94563223|NCT02045095|323858113|FG002|Overall Study|Adverse Event|1|||
94563224|NCT02045095|323858114|FG003|Overall Study|Adverse Event|0|||
94563225|NCT02045095|323858115|FG004|Overall Study|Adverse Event|0|||
94563226|NCT02045095|323858116|FG005|Overall Study|Adverse Event|2|||
94563227|NCT02045095|323858117|FG006|Overall Study|Adverse Event|0|||
94563228|NCT02631551|323858118|FG000|Overall Study|Adverse Event|1|||
94563229|NCT02631551|323858119|FG001|Overall Study|Adverse Event|2|||
94563230|NCT02631551|323858120|FG002|Overall Study|Adverse Event|4|||
94563231|NCT02631551|323858121|FG003|Overall Study|Adverse Event|0|||
94563232|NCT02631551|323858118|FG000|Overall Study|Lack of Efficacy|0|||
94346419|NCT00141297|323049027|FG005|Overall Study|Progressive Disease|2|||
94450412|NCT03850483|323435404|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
94563233|NCT02631551|323858119|FG001|Overall Study|Lack of Efficacy|0|||
94563234|NCT02631551|323858120|FG002|Overall Study|Lack of Efficacy|1|||
94563235|NCT02631551|323858121|FG003|Overall Study|Lack of Efficacy|0|||
94346420|NCT00141297|323049028|FG006|Overall Study|Progressive Disease|3|||
94346421|NCT00141297|323049029|FG007|Overall Study|Progressive Disease|3|||
94563236|NCT02631551|323858118|FG000|Overall Study|Lost to Follow-up|1|||
94346422|NCT00141297|323049030|FG008|Overall Study|Progressive Disease|15|||
94563237|NCT02631551|323858119|FG001|Overall Study|Lost to Follow-up|2|||
94563238|NCT02631551|323858120|FG002|Overall Study|Lost to Follow-up|0|||
94563239|NCT02631551|323858121|FG003|Overall Study|Lost to Follow-up|3|||
94563240|NCT02631551|323858118|FG000|Overall Study|Withdrawal by Subject|2|||
94563241|NCT02631551|323858119|FG001|Overall Study|Withdrawal by Subject|2|||
94563242|NCT02631551|323858120|FG002|Overall Study|Withdrawal by Subject|0|||
94563243|NCT02631551|323858121|FG003|Overall Study|Withdrawal by Subject|5|||
94563244|NCT02631551|323858118|FG000|Overall Study|Protocol deviation|3|||
94563245|NCT02631551|323858119|FG001|Overall Study|Protocol deviation|6|||
94563246|NCT02631551|323858120|FG002|Overall Study|Protocol deviation|3|||
94563247|NCT02631551|323858121|FG003|Overall Study|Protocol deviation|0|||
94563248|NCT02631551|323858118|FG000|Overall Study|Non-compliance with study procedures|0|||
94563249|NCT02631551|323858119|FG001|Overall Study|Non-compliance with study procedures|0|||
94563250|NCT02631551|323858120|FG002|Overall Study|Non-compliance with study procedures|1|||
94563251|NCT02631551|323858121|FG003|Overall Study|Non-compliance with study procedures|1|||
94563252|NCT02631551|323858118|FG000|Overall Study|Non-compliance with study drug|1|||
94563253|NCT02631551|323858119|FG001|Overall Study|Non-compliance with study drug|0|||
94563254|NCT02631551|323858120|FG002|Overall Study|Non-compliance with study drug|0|||
94563255|NCT02631551|323858121|FG003|Overall Study|Non-compliance with study drug|0|||
94563256|NCT02631551|323858118|FG000|Overall Study|Other, specific reasons not collected|5|||
94563257|NCT02631551|323858119|FG001|Overall Study|Other, specific reasons not collected|7|||
94563258|NCT02631551|323858120|FG002|Overall Study|Other, specific reasons not collected|2|||
94563259|NCT02631551|323858121|FG003|Overall Study|Other, specific reasons not collected|2|||
94563260|NCT00100789|323858124|FG000|Overall Study|Adverse Event|10|||
94563261|NCT00100789|323858124|FG000|Overall Study|Withdrawal by Subject|1|||
94563262|NCT00100789|323858124|FG000|Overall Study|Progression/relapse|42|||
94563263|NCT00100789|323858124|FG000|Overall Study|Death|2|||
94563264|NCT00100789|323858124|FG000|Overall Study|Not protocol specified|5|||
94563265|NCT00100789|323858124|FG000|Overall Study|Ineligible|3|||
94563266|NCT00100789|323858124|FG000|Overall Study|Never received treatment|1|||
94563267|NCT02855268|323858125|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
94563268|NCT02855268|323858126|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
94563269|NCT02855268|323858125|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
94657935|NCT01609556|324204467|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
94346423|NCT00141297|323049031|FG009|Overall Study|Progressive Disease|6|||
94346424|NCT00141297|323049022|FG000|Overall Study|Transitioned|0|||
94563270|NCT02855268|323858126|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
94563271|NCT02855268|323858125|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
94563272|NCT02855268|323858126|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
94657936|NCT01609556|324204468|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
94657937|NCT01609556|324204469|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
94657938|NCT01609556|324204470|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
94657939|NCT01609556|324204455|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
94657940|NCT01609556|324204456|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
94657941|NCT01609556|324204457|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
94563273|NCT02855268|323858125|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
94563274|NCT02855268|323858126|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
94563275|NCT02855268|323858125|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
94563276|NCT02855268|323858126|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
94563277|NCT02855268|323858125|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
94563278|NCT02855268|323858126|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
94563279|NCT01177007|323858131|FG000|Overall Study|Lost to Follow-up|2|||
94563280|NCT01177007|323858131|FG000|Overall Study|Death|4|||
94563281|NCT01177007|323858131|FG000|Overall Study|Entered hospice care|5|||
94563282|NCT01177007|323858131|FG000|Overall Study|Required additional Y90 treatment|6|||
94563283|NCT01177007|323858131|FG000|Overall Study|Change in treatment modality|21|||
94563284|NCT01012258|323858132|FG000|Overall Study|Death|14|||
94563285|NCT01012258|323858132|FG000|Overall Study|Lost to Follow-up|1|||
94563286|NCT01012258|323858132|FG000|Overall Study|Adverse Event|1|||
94563287|NCT01012258|323858132|FG000|Overall Study|Progressive Disease (PD)|18|||
94657942|NCT01609556|324204458|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
94657943|NCT01609556|324204459|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
94657944|NCT01609556|324204460|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
94657945|NCT01609556|324204461|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
94657946|NCT01609556|324204462|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
94657947|NCT01609556|324204463|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
94657948|NCT01609556|324204464|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
94657949|NCT01609556|324204465|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
94657950|NCT01609556|324204466|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
94657951|NCT01609556|324204467|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
94657952|NCT01609556|324204468|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
94657953|NCT01609556|324204469|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
94657954|NCT01609556|324204470|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
94657955|NCT01609556|324204455|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
94657956|NCT01609556|324204456|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
94657957|NCT01609556|324204457|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
94657958|NCT01609556|324204458|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
94657959|NCT01609556|324204459|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
94657960|NCT01609556|324204460|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
94657961|NCT01609556|324204461|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
94657962|NCT01609556|324204462|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
94657963|NCT01609556|324204463|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
94657964|NCT01609556|324204464|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
94657965|NCT01609556|324204465|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
94657966|NCT01609556|324204466|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
94657967|NCT01609556|324204467|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
94657968|NCT01609556|324204468|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
94657969|NCT01609556|324204469|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
94657970|NCT01609556|324204470|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
94657971|NCT01609556|324204455|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
94657972|NCT01609556|324204456|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
94657973|NCT01609556|324204457|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
94657974|NCT01609556|324204458|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
94657975|NCT01609556|324204459|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
94657976|NCT01609556|324204460|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
94657977|NCT01609556|324204461|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
94657978|NCT01609556|324204462|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
94657979|NCT01609556|324204463|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
94657980|NCT01609556|324204464|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
94657981|NCT01609556|324204465|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
94657982|NCT01609556|324204466|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
94657983|NCT01609556|324204467|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
94657984|NCT01609556|324204468|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
94657985|NCT01609556|324204469|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
94657986|NCT01609556|324204470|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
94563288|NCT01012258|323858132|FG000|Overall Study|Symptomatic Deterioration|1|||
94563289|NCT01012258|323858132|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
94563290|NCT01012258|323858132|FG000|Overall Study|Another Tumor Discovered|1|||
94235109|NCT02993523|322654661|FG001|Overall Study|Reason not Specified|0|||
94235110|NCT02993523|322654662|FG002|Overall Study|Reason not Specified|1|||
94235111|NCT02993523|322654663|FG003|Overall Study|Reason not Specified|1|||
94235112|NCT02993523|322654664|FG004|Overall Study|Reason not Specified|0|||
94235113|NCT00632021|322654666|FG000|Overall Study|Withdrawal/death|4|||
94235114|NCT00632021|322654667|FG001|Overall Study|Withdrawal/death|7|||
94235115|NCT00992992|322654670|FG000|Overall Study|Lost to Follow-up|3|||
94235116|NCT00992992|322654670|FG000|Overall Study|Death|16|||
94235117|NCT00992992|322654670|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
94235118|NCT00992992|322654670|FG000|Overall Study|Sponsor Closed the Study|4|||
94235119|NCT00085566|322654672|FG000|Overall Study|Adverse Event|0|||
94235120|NCT00085566|322654673|FG001|Overall Study|Adverse Event|0|||
94235121|NCT00085566|322654674|FG002|Overall Study|Adverse Event|10|||
94235122|NCT00085566|322654672|FG000|Overall Study|Patient Not treated|0|||
94235123|NCT00085566|322654673|FG001|Overall Study|Patient Not treated|0|||
94235124|NCT00085566|322654674|FG002|Overall Study|Patient Not treated|3|||
94235125|NCT00085566|322654672|FG000|Overall Study|Clinical progression|0|||
94235126|NCT00085566|322654673|FG001|Overall Study|Clinical progression|0|||
94235127|NCT00085566|322654674|FG002|Overall Study|Clinical progression|1|||
94235128|NCT03174782|322654675|FG000|Overall Study|Protocol Violation|1|||
94235129|NCT03174782|322654676|FG001|Overall Study|Protocol Violation|0|||
94235130|NCT03174782|322654675|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
94235131|NCT03174782|322654676|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
94235132|NCT03178045|322654684|FG000|Overall Study|Withdrawal by Subject|5|||
94235133|NCT03178045|322654685|FG001|Overall Study|Withdrawal by Subject|7|||
94235134|NCT03178045|322654684|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
94235135|NCT03178045|322654685|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
94235136|NCT03178045|322654684|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
94235137|NCT03178045|322654685|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
94235138|NCT00267098|322654686|FG000|Overall Study|Death|0|||
94235139|NCT00267098|322654687|FG001|Overall Study|Death|0|||
94235140|NCT00267098|322654688|FG002|Overall Study|Death|57|||
94235141|NCT00267098|322654689|FG003|Overall Study|Death|66|||
94235142|NCT00267098|322654690|FG004|Overall Study|Death|14|||
94235143|NCT00267098|322654691|FG005|Overall Study|Death|23|||
94235144|NCT00267098|322654692|FG006|Overall Study|Death|28|||
94235145|NCT00267098|322654693|FG007|Overall Study|Death|9|||
94235146|NCT00267098|322654686|FG000|Overall Study|Lost to Follow-up|0|||
94235147|NCT00267098|322654687|FG001|Overall Study|Lost to Follow-up|0|||
94235148|NCT00267098|322654688|FG002|Overall Study|Lost to Follow-up|6|||
94235149|NCT00267098|322654689|FG003|Overall Study|Lost to Follow-up|5|||
94235150|NCT00267098|322654690|FG004|Overall Study|Lost to Follow-up|2|||
94346425|NCT00141297|323049023|FG001|Overall Study|Transitioned|0|||
94346426|NCT00141297|323049024|FG002|Overall Study|Transitioned|0|||
94346427|NCT00141297|323049025|FG003|Overall Study|Transitioned|0|||
94346428|NCT00141297|323049026|FG004|Overall Study|Transitioned|1|||
94346429|NCT00141297|323049027|FG005|Overall Study|Transitioned|0|||
94346430|NCT00141297|323049028|FG006|Overall Study|Transitioned|0|||
94346431|NCT00141297|323049029|FG007|Overall Study|Transitioned|0|||
94346432|NCT00141297|323049030|FG008|Overall Study|Transitioned|0|||
94346433|NCT00141297|323049031|FG009|Overall Study|Transitioned|0|||
94346434|NCT03763942|323049033|FG000|Overall Study|Lost to Follow-up|114|||
94346435|NCT03763942|323049034|FG001|Overall Study|Lost to Follow-up|54|||
94346436|NCT03763942|323049033|FG000|Overall Study|Protocol Violation|1|||
94346437|NCT03763942|323049034|FG001|Overall Study|Protocol Violation|0|||
94235151|NCT00267098|322654691|FG005|Overall Study|Lost to Follow-up|3|||
94346438|NCT03763942|323049033|FG000|Overall Study|Withdrawal by Subject|2|||
94346439|NCT03763942|323049034|FG001|Overall Study|Withdrawal by Subject|0|||
94346440|NCT03763942|323049033|FG000|Overall Study|Other|2|||
94346441|NCT03763942|323049034|FG001|Overall Study|Other|3|||
94346442|NCT03558503|323049035|FG000|Overall Study|Adverse Event|1|||
94346443|NCT03558503|323049035|FG000|Overall Study|Death|1|||
94346444|NCT03558503|323049035|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
94346445|NCT01108263|323049045|FG000|Overall Study|Adverse Event|0|||
94346446|NCT01108263|323049046|FG001|Overall Study|Adverse Event|1|||
94346447|NCT01029691|323049050|FG000|Continued APAP to Delivery|Death|0|||
94346448|NCT01029691|323049051|FG001|Continued APAP to Delivery|Death|0|||
94346449|NCT01029691|323049052|FG002|Continued APAP to Delivery|Death|1|||
94346450|NCT02061540|323049053|FG000|Overall Study|Adverse Event|2|||
94346451|NCT02061540|323049053|FG000|Overall Study|Withdrawal by Subject|2|||
94450413|NCT03850483|323435405|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
94450414|NCT03850483|323435406|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
94346452|NCT02289833|323049056|FG000|Overall Study|Study discontinuation|0|||
94450415|NCT03850483|323435407|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
94450416|NCT03850483|323435408|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
94450417|NCT03850483|323435409|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
94450418|NCT03850483|323435410|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
94450419|NCT03850483|323435411|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
94450420|NCT03850483|323435402|FG000|Follow-up For Stage 2|Other|0|||
94450421|NCT03850483|323435403|FG001|Follow-up For Stage 2|Other|0|||
94450422|NCT03850483|323435404|FG002|Follow-up For Stage 2|Other|0|||
94450423|NCT03850483|323435405|FG003|Follow-up For Stage 2|Other|0|||
94450424|NCT03850483|323435406|FG004|Follow-up For Stage 2|Other|0|||
94450425|NCT03850483|323435407|FG005|Follow-up For Stage 2|Other|0|||
94450426|NCT03850483|323435408|FG006|Follow-up For Stage 2|Other|0|||
94450427|NCT03850483|323435409|FG007|Follow-up For Stage 2|Other|0|||
94450428|NCT03850483|323435410|FG008|Follow-up For Stage 2|Other|0|||
94450429|NCT03850483|323435411|FG009|Follow-up For Stage 2|Other|1|||
94450430|NCT01068678|323436802|FG000|Overall Study|Lack of Efficacy|3|||
94450431|NCT01068678|323436803|FG001|Overall Study|Lack of Efficacy|2|||
94450432|NCT01068678|323436802|FG000|Overall Study|Protocol Violation|5|||
94450433|NCT01068678|323436803|FG001|Overall Study|Protocol Violation|1|||
94450434|NCT01068678|323436802|FG000|Overall Study|Withdrawal criteria|12|||
94450435|NCT01068678|323436803|FG001|Overall Study|Withdrawal criteria|6|||
94450436|NCT01068678|323436802|FG000|Overall Study|Unclassified|18|||
94450437|NCT01068678|323436803|FG001|Overall Study|Unclassified|15|||
94450438|NCT00617890|323436804|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
94450439|NCT00617890|323436805|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
94450440|NCT00617890|323436806|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
94450441|NCT00617890|323436807|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
94450442|NCT00617890|323436804|FG000|Overall Study|Lack of Efficacy|23|||
94450443|NCT00617890|323436805|FG001|Overall Study|Lack of Efficacy|26|||
94450444|NCT00617890|323436806|FG002|Overall Study|Lack of Efficacy|30|||
94450445|NCT00617890|323436807|FG003|Overall Study|Lack of Efficacy|97|||
94450446|NCT00617890|323436804|FG000|Overall Study|Lost to Follow-up|0|||
94450447|NCT00617890|323436805|FG001|Overall Study|Lost to Follow-up|0|||
94450448|NCT00617890|323436806|FG002|Overall Study|Lost to Follow-up|1|||
94450449|NCT00617890|323436807|FG003|Overall Study|Lost to Follow-up|2|||
94450450|NCT00617890|323436804|FG000|Overall Study|Withdrawal by Subject|4|||
94563291|NCT01012258|323858132|FG000|Overall Study|Ongoing|29|||
94563292|NCT00799903|323858133|FG000|Overall Study|Investigator Site Closed|25|||
94563293|NCT00799903|323858134|FG001|Overall Study|Investigator Site Closed|23|||
94563294|NCT00799903|323858133|FG000|Overall Study|Withdrawal by Subject|179|||
94563295|NCT00799903|323858134|FG001|Overall Study|Withdrawal by Subject|175|||
94563296|NCT00799903|323858133|FG000|Overall Study|Lost to Follow-up|69|||
94563297|NCT00799903|323858134|FG001|Overall Study|Lost to Follow-up|80|||
94563298|NCT02518971|323858135|FG000|Overall Study|Lost to Follow-up|0|||
94563299|NCT02518971|323858136|FG001|Overall Study|Lost to Follow-up|1|||
94563300|NCT02518971|323858135|FG000|Overall Study|Physician Decision|6|||
94563301|NCT02518971|323858136|FG001|Overall Study|Physician Decision|6|||
94563302|NCT02518971|323858135|FG000|Overall Study|Protocol Violation|6|||
94563303|NCT02518971|323858136|FG001|Overall Study|Protocol Violation|4|||
94563304|NCT02518971|323858135|FG000|Overall Study|Withdrawal by Subject|4|||
94346453|NCT02289833|323049057|FG001|Overall Study|Study discontinuation|1|||
94346454|NCT02289833|323049056|FG000|Overall Study|Lost to Follow-up|4|||
94346455|NCT02289833|323049057|FG001|Overall Study|Lost to Follow-up|0|||
94450451|NCT00617890|323436805|FG001|Overall Study|Withdrawal by Subject|1|||
94450452|NCT00617890|323436806|FG002|Overall Study|Withdrawal by Subject|0|||
94450453|NCT00617890|323436807|FG003|Overall Study|Withdrawal by Subject|2|||
94563305|NCT02518971|323858136|FG001|Overall Study|Withdrawal by Subject|5|||
94563306|NCT02518971|323858135|FG000|Overall Study|Side effects|1|||
94563307|NCT02518971|323858136|FG001|Overall Study|Side effects|0|||
94563308|NCT02518971|323858135|FG000|Overall Study|medication lost in mail|0|||
94235152|NCT00267098|322654692|FG006|Overall Study|Lost to Follow-up|1|||
94563309|NCT02518971|323858136|FG001|Overall Study|medication lost in mail|1|||
94563310|NCT02518971|323858135|FG000|Overall Study|eligibility criteria no longer met|6|||
94563311|NCT02518971|323858136|FG001|Overall Study|eligibility criteria no longer met|3|||
94563312|NCT00779025|323858138|FG000|Overall Study|Withdrawal by Subject|1|||
94563313|NCT03710642|323858139|FG000|Overall Study|Adverse Event|5|||
94563314|NCT03710642|323858140|FG001|Overall Study|Adverse Event|1|||
94563315|NCT03710642|323858139|FG000|Overall Study|non-site physician recommendation|1|||
94563316|NCT03710642|323858140|FG001|Overall Study|non-site physician recommendation|0|||
94563317|NCT03710642|323858139|FG000|Overall Study|Participant unwilling or unable to participate|1|||
94563318|NCT03710642|323858140|FG001|Overall Study|Participant unwilling or unable to participate|1|||
94563319|NCT03710642|323858139|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
94563320|NCT03710642|323858140|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
94563321|NCT03710642|323858139|FG000|Overall Study|NA-no code provided|1|||
94563322|NCT03710642|323858140|FG001|Overall Study|NA-no code provided|0|||
94563323|NCT03710642|323858139|FG000|Overall Study|Withdrawal by Subject|1|||
94563324|NCT03710642|323858140|FG001|Overall Study|Withdrawal by Subject|0|||
94563325|NCT01010971|323858141|FG000|Overall Study|Adverse Event|2|||
94563326|NCT01010971|323858142|FG001|Overall Study|Adverse Event|4|||
94563327|NCT01010971|323858143|FG002|Overall Study|Adverse Event|3|||
94563328|NCT01010971|323858141|FG000|Overall Study|Withdrawal by Subject|0|||
94563329|NCT01010971|323858142|FG001|Overall Study|Withdrawal by Subject|2|||
94563330|NCT01010971|323858143|FG002|Overall Study|Withdrawal by Subject|5|||
94563331|NCT01010971|323858141|FG000|Overall Study|Lost to Follow-up|0|||
94563332|NCT01010971|323858142|FG001|Overall Study|Lost to Follow-up|2|||
94563333|NCT01010971|323858143|FG002|Overall Study|Lost to Follow-up|3|||
94563334|NCT01010971|323858141|FG000|Overall Study|Other|1|||
94563335|NCT01010971|323858142|FG001|Overall Study|Other|0|||
94563336|NCT01010971|323858143|FG002|Overall Study|Other|2|||
94563337|NCT05730387|323858144|FG000|Overall Study|Stillbirth|0|||
94563338|NCT05730387|323858145|FG001|Overall Study|Stillbirth|262|||
94563339|NCT05730387|323858144|FG000|Overall Study|Died during or after delivery|2|||
94235153|NCT00267098|322654693|FG007|Overall Study|Lost to Follow-up|1|||
94563340|NCT05730387|323858145|FG001|Overall Study|Died during or after delivery|85|||
94563341|NCT05730387|323858144|FG000|Overall Study|Died after being admitted|0|||
94563342|NCT05730387|323858145|FG001|Overall Study|Died after being admitted|44|||
94563343|NCT05730387|323858144|FG000|Overall Study|Lost to Follow-up|69|||
94563344|NCT05730387|323858145|FG001|Overall Study|Lost to Follow-up|77|||
94563345|NCT02680665|323858146|FG000|Overall Study|No visit after the first prescription|5|||
94563346|NCT04797780|323858147|FG000|Overall Study|Lost to Follow-up|1|||
94563347|NCT04797780|323858148|FG001|Overall Study|Lost to Follow-up|1|||
94346456|NCT02289833|323049056|FG000|Overall Study|Death|23|||
94346457|NCT02289833|323049057|FG001|Overall Study|Death|16|||
94346458|NCT02561273|323049058|FG000|Overall Study|Protocol Violation|1|||
94346459|NCT02561273|323049059|FG001|Overall Study|Protocol Violation|0|||
94657987|NCT01609556|324204455|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
94657988|NCT01609556|324204456|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
94657989|NCT01609556|324204457|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
94346460|NCT02718625|323049061|FG000|Overall Study|Adverse Event|0|||
94346461|NCT02718625|323049062|FG001|Overall Study|Adverse Event|1|||
94657990|NCT01609556|324204458|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
94657991|NCT01609556|324204459|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
94657992|NCT01609556|324204460|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
94657993|NCT01609556|324204461|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
94657994|NCT01609556|324204462|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
94657995|NCT01609556|324204463|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
94657996|NCT01609556|324204464|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
94657997|NCT01609556|324204465|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
94235154|NCT00267098|322654686|FG000|Overall Study|Withdrawal by Subject|8|||
94346462|NCT02718625|323049061|FG000|Overall Study|Termination of Study by Sponsor|0|||
94346463|NCT02718625|323049062|FG001|Overall Study|Termination of Study by Sponsor|1|||
94346464|NCT01057394|323049063|FG000|Overall Study|Not eligible|0|||
94346465|NCT01057394|323049064|FG001|Overall Study|Not eligible|2|||
94346466|NCT00952588|323049065|FG000|Overall Study|Death|28|||
94346467|NCT00952588|323049066|FG001|Overall Study|Death|13|||
94346468|NCT00952588|323049065|FG000|Overall Study|Withdrawal by Subject|2|||
94346469|NCT00952588|323049066|FG001|Overall Study|Withdrawal by Subject|5|||
94346470|NCT00952588|323049065|FG000|Overall Study|Adverse Event|2|||
94346471|NCT00952588|323049066|FG001|Overall Study|Adverse Event|3|||
94346472|NCT00952588|323049065|FG000|Overall Study|Lost to Follow-up|2|||
94346473|NCT00952588|323049066|FG001|Overall Study|Lost to Follow-up|0|||
94346474|NCT00952588|323049065|FG000|Overall Study|Physician Decision|0|||
94346475|NCT00952588|323049066|FG001|Overall Study|Physician Decision|1|||
94346476|NCT00952588|323049065|FG000|Overall Study|Lack of Efficacy|2|||
94346477|NCT00952588|323049066|FG001|Overall Study|Lack of Efficacy|2|||
94346478|NCT02177942|323049067|FG000|Overall Study|Adverse Event|1|||
94346479|NCT02177942|323049068|FG001|Overall Study|Adverse Event|0|||
94346480|NCT02177942|323049067|FG000|Overall Study|Lost to Follow-up|1|||
94346481|NCT02177942|323049068|FG001|Overall Study|Lost to Follow-up|1|||
94346482|NCT02177942|323049067|FG000|Overall Study|Protocol Violation|4|||
94235155|NCT00267098|322654687|FG001|Overall Study|Withdrawal by Subject|0|||
94235156|NCT00267098|322654688|FG002|Overall Study|Withdrawal by Subject|24|||
94235157|NCT00267098|322654689|FG003|Overall Study|Withdrawal by Subject|21|||
94235158|NCT00267098|322654690|FG004|Overall Study|Withdrawal by Subject|12|||
94235159|NCT00267098|322654691|FG005|Overall Study|Withdrawal by Subject|9|||
94235160|NCT00267098|322654692|FG006|Overall Study|Withdrawal by Subject|12|||
94235161|NCT00267098|322654693|FG007|Overall Study|Withdrawal by Subject|5|||
94235162|NCT00267098|322654686|FG000|Overall Study|Physician Decision|5|||
94235163|NCT00267098|322654687|FG001|Overall Study|Physician Decision|0|||
94235164|NCT00267098|322654688|FG002|Overall Study|Physician Decision|7|||
94235165|NCT00267098|322654689|FG003|Overall Study|Physician Decision|11|||
94346483|NCT02177942|323049068|FG001|Overall Study|Protocol Violation|6|||
94235166|NCT00267098|322654690|FG004|Overall Study|Physician Decision|5|||
94235167|NCT00267098|322654691|FG005|Overall Study|Physician Decision|4|||
94450454|NCT00617890|323436804|FG000|Overall Study|Protocol Violation|2|||
94657998|NCT01609556|324204466|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
94235168|NCT00267098|322654692|FG006|Overall Study|Physician Decision|3|||
94235169|NCT00267098|322654693|FG007|Overall Study|Physician Decision|0|||
94235170|NCT00267098|322654686|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
94346484|NCT02177942|323049067|FG000|Overall Study|Withdrawal by Subject|71|||
94346485|NCT02177942|323049068|FG001|Overall Study|Withdrawal by Subject|81|||
94346486|NCT00886587|323049069|FG000|Overall Study|Adverse Event|2|||
94346487|NCT00886587|323049070|FG001|Overall Study|Adverse Event|1|||
94346488|NCT00886587|323049069|FG000|Overall Study|Protocol Violation|2|||
94346489|NCT00886587|323049070|FG001|Overall Study|Protocol Violation|0|||
94657999|NCT01609556|324204467|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
94658000|NCT01609556|324204468|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
94658001|NCT01609556|324204469|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
94658002|NCT01609556|324204470|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
94658003|NCT01609556|324204455|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
94658004|NCT01609556|324204456|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
94658005|NCT01609556|324204457|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
94658006|NCT01609556|324204458|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
94658007|NCT01609556|324204459|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
94658008|NCT01609556|324204460|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
94658009|NCT01609556|324204461|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
94658010|NCT01609556|324204462|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
94658011|NCT01609556|324204463|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
94658012|NCT01609556|324204464|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
94658013|NCT01609556|324204465|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
94658014|NCT01609556|324204466|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
94658015|NCT01609556|324204467|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
94658016|NCT01609556|324204468|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
94658017|NCT01609556|324204469|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
94658018|NCT01609556|324204470|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
94658019|NCT01609556|324204455|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
94658020|NCT01609556|324204456|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
94658021|NCT01609556|324204457|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
94658022|NCT01609556|324204458|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
94658023|NCT01609556|324204459|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
94658024|NCT01609556|324204460|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
94658025|NCT01609556|324204461|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
94658026|NCT01609556|324204462|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
94658027|NCT01609556|324204463|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
94658028|NCT01609556|324204464|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
94658029|NCT01609556|324204465|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
94658030|NCT01609556|324204466|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
94658031|NCT01609556|324204467|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
94658032|NCT01609556|324204468|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
94658033|NCT01609556|324204469|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
94658034|NCT01609556|324204470|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
94658035|NCT01609556|324204455|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
94658036|NCT01609556|324204456|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
94658037|NCT01609556|324204457|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
94658038|NCT01609556|324204458|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
94658039|NCT01609556|324204459|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
94658040|NCT01609556|324204460|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
94658041|NCT01609556|324204461|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
94658042|NCT01609556|324204462|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
94235171|NCT00267098|322654687|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
94235172|NCT00267098|322654688|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
94658043|NCT01609556|324204463|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
94658044|NCT01609556|324204464|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
94658045|NCT01609556|324204465|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
94658046|NCT01609556|324204466|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
94658047|NCT01609556|324204467|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
94658048|NCT01609556|324204468|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
94658049|NCT01609556|324204469|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
94658050|NCT01609556|324204470|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
94658051|NCT01609556|324204455|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
94658052|NCT01609556|324204456|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
94658053|NCT01609556|324204457|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
94658054|NCT01609556|324204458|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
94658055|NCT01609556|324204459|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
94658056|NCT01609556|324204460|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
94658057|NCT01609556|324204461|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
94658058|NCT01609556|324204462|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
94658059|NCT01609556|324204463|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
94658060|NCT01609556|324204464|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
94658061|NCT01609556|324204465|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
94235173|NCT00267098|322654689|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
94346490|NCT00886587|323049069|FG000|Overall Study|Withdrawal by Subject|0|||
94346491|NCT00886587|323049070|FG001|Overall Study|Withdrawal by Subject|1|||
94346492|NCT04107935|323049071|FG000|Overall Study|Death|1|||
94346493|NCT04107935|323049072|FG001|Overall Study|Death|0|||
94346494|NCT01021553|323049073|FG000|Overall Study|Adverse Event|1|||
94346495|NCT01021553|323049074|FG001|Overall Study|Adverse Event|0|||
94346496|NCT01021553|323049075|FG002|Overall Study|Adverse Event|0|||
94346497|NCT01021553|323049073|FG000|Overall Study|Lack of Efficacy|2|||
94346498|NCT01021553|323049074|FG001|Overall Study|Lack of Efficacy|2|||
94346499|NCT01021553|323049075|FG002|Overall Study|Lack of Efficacy|0|||
94346500|NCT01021553|323049073|FG000|Overall Study|Protocol Violation|0|||
94346501|NCT01021553|323049074|FG001|Overall Study|Protocol Violation|2|||
94346502|NCT01021553|323049075|FG002|Overall Study|Protocol Violation|2|||
94346503|NCT01021553|323049073|FG000|Overall Study|Lost to Follow-up|0|||
94346504|NCT01021553|323049074|FG001|Overall Study|Lost to Follow-up|0|||
94346505|NCT01021553|323049075|FG002|Overall Study|Lost to Follow-up|1|||
94346506|NCT01021553|323049073|FG000|Overall Study|Withdrawal by Subject|1|||
94346507|NCT01021553|323049074|FG001|Overall Study|Withdrawal by Subject|1|||
94346508|NCT01021553|323049075|FG002|Overall Study|Withdrawal by Subject|0|||
94346509|NCT00890201|323049082|FG000|Overall Study|Protocol Violation|5|||
94346510|NCT00890201|323049083|FG001|Overall Study|Protocol Violation|56|||
94346511|NCT00033293|323049084|FG000|Overall Study|Death|0|||
94346512|NCT00033293|323049085|FG001|Overall Study|Death|1|||
94346513|NCT00033293|323049084|FG000|Overall Study|Lack of Efficacy|5|||
94346514|NCT00033293|323049085|FG001|Overall Study|Lack of Efficacy|8|||
94346515|NCT00033293|323049084|FG000|Overall Study|Lost to Follow-up|0|||
94346516|NCT00033293|323049085|FG001|Overall Study|Lost to Follow-up|1|||
94346517|NCT00033293|323049084|FG000|Overall Study|Physician Decision|3|||
94346518|NCT00033293|323049085|FG001|Overall Study|Physician Decision|1|||
94346519|NCT00033293|323049084|FG000|Overall Study|Withdrawal by Subject|1|||
94346520|NCT00033293|323049085|FG001|Overall Study|Withdrawal by Subject|0|||
94346521|NCT00033293|323049084|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
94346522|NCT00033293|323049085|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
94346523|NCT00033293|323049084|FG000|Overall Study|Treatment refused|0|||
94346524|NCT00033293|323049085|FG001|Overall Study|Treatment refused|6|||
94346525|NCT00935701|323049086|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
94346526|NCT02087241|323049087|FG000|Overall Study|Death|2|||
94346527|NCT02087241|323049088|FG001|Overall Study|Death|1|||
94346528|NCT02087241|323049089|FG002|Overall Study|Death|1|||
94346529|NCT02087241|323049090|FG003|Overall Study|Death|1|||
94346530|NCT02087241|323049087|FG000|Overall Study|Withdrawal by Subject|1|||
94346531|NCT02087241|323049088|FG001|Overall Study|Withdrawal by Subject|0|||
94346532|NCT02087241|323049089|FG002|Overall Study|Withdrawal by Subject|0|||
94346533|NCT02087241|323049090|FG003|Overall Study|Withdrawal by Subject|1|||
94346534|NCT02087241|323049087|FG000|Overall Study|Progressive Disease|0|||
94346535|NCT02087241|323049088|FG001|Overall Study|Progressive Disease|0|||
94346536|NCT02087241|323049089|FG002|Overall Study|Progressive Disease|0|||
94346537|NCT02087241|323049090|FG003|Overall Study|Progressive Disease|1|||
94346538|NCT02087241|323049087|FG000|Overall Study|Study Terminated by Sponsor|0|||
94346539|NCT02087241|323049088|FG001|Overall Study|Study Terminated by Sponsor|2|||
94346540|NCT02087241|323049089|FG002|Overall Study|Study Terminated by Sponsor|0|||
94346541|NCT02087241|323049090|FG003|Overall Study|Study Terminated by Sponsor|4|||
94346542|NCT01809327|323049098|FG000|Overall Study|Lost to Follow-up|5|||
94346543|NCT01809327|323049099|FG001|Overall Study|Lost to Follow-up|2|||
94346544|NCT01809327|323049100|FG002|Overall Study|Lost to Follow-up|4|||
94346545|NCT01809327|323049101|FG003|Overall Study|Lost to Follow-up|2|||
94346546|NCT01809327|323049102|FG004|Overall Study|Lost to Follow-up|3|||
94346547|NCT01809327|323049098|FG000|Overall Study|Withdrawal by Subject|6|||
94346548|NCT01809327|323049099|FG001|Overall Study|Withdrawal by Subject|4|||
94346549|NCT01809327|323049100|FG002|Overall Study|Withdrawal by Subject|4|||
94658062|NCT01609556|324204466|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
94346550|NCT01809327|323049101|FG003|Overall Study|Withdrawal by Subject|2|||
94346551|NCT01809327|323049102|FG004|Overall Study|Withdrawal by Subject|5|||
94346552|NCT01809327|323049098|FG000|Overall Study|Adverse Event|4|||
94346553|NCT01809327|323049099|FG001|Overall Study|Adverse Event|3|||
94346554|NCT01809327|323049100|FG002|Overall Study|Adverse Event|7|||
94658063|NCT01609556|324204467|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
94346555|NCT01809327|323049101|FG003|Overall Study|Adverse Event|4|||
94346556|NCT01809327|323049102|FG004|Overall Study|Adverse Event|8|||
94346557|NCT01809327|323049098|FG000|Overall Study|Death|1|||
94346558|NCT01809327|323049099|FG001|Overall Study|Death|0|||
94346559|NCT01809327|323049100|FG002|Overall Study|Death|0|||
94346560|NCT01809327|323049101|FG003|Overall Study|Death|0|||
94346561|NCT01809327|323049102|FG004|Overall Study|Death|0|||
94346562|NCT01809327|323049098|FG000|Overall Study|Protocol Violation|0|||
94346563|NCT01809327|323049099|FG001|Overall Study|Protocol Violation|1|||
94346564|NCT01809327|323049100|FG002|Overall Study|Protocol Violation|0|||
94346565|NCT01809327|323049101|FG003|Overall Study|Protocol Violation|0|||
94346566|NCT01809327|323049102|FG004|Overall Study|Protocol Violation|0|||
94658064|NCT01609556|324204468|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
94346567|NCT01809327|323049098|FG000|Overall Study|Physician Decision|1|||
94346568|NCT01809327|323049099|FG001|Overall Study|Physician Decision|1|||
94346569|NCT01809327|323049100|FG002|Overall Study|Physician Decision|0|||
94346570|NCT01809327|323049101|FG003|Overall Study|Physician Decision|0|||
94346571|NCT01809327|323049102|FG004|Overall Study|Physician Decision|0|||
94346572|NCT01809327|323049098|FG000|Overall Study|Pregnancy|1|||
94346573|NCT01809327|323049099|FG001|Overall Study|Pregnancy|0|||
94346574|NCT01809327|323049100|FG002|Overall Study|Pregnancy|0|||
94346575|NCT01809327|323049101|FG003|Overall Study|Pregnancy|0|||
94346576|NCT01809327|323049102|FG004|Overall Study|Pregnancy|0|||
94346577|NCT01809327|323049098|FG000|Overall Study|Other|14|||
94346578|NCT01809327|323049099|FG001|Overall Study|Other|15|||
94346579|NCT01809327|323049100|FG002|Overall Study|Other|7|||
94346580|NCT01809327|323049101|FG003|Overall Study|Other|4|||
94346581|NCT01809327|323049102|FG004|Overall Study|Other|9|||
94346582|NCT01166386|323049104|FG000|Overall Study|Withdrawal by Subject|3|||
94346583|NCT01166386|323049105|FG001|Overall Study|Withdrawal by Subject|5|||
94346584|NCT00877890|323049106|FG000|Overall Study|Adverse Event|6|||
94346585|NCT00877890|323049107|FG001|Overall Study|Adverse Event|6|||
94563348|NCT04797780|323858147|FG000|Overall Study|Withdrawal by Subject|14|||
94563349|NCT04797780|323858148|FG001|Overall Study|Withdrawal by Subject|9|||
94346586|NCT00877890|323049106|FG000|Overall Study|Lost to Follow-up|5|||
94563350|NCT04797780|323858147|FG000|Overall Study|Death|49|||
94563351|NCT04797780|323858148|FG001|Overall Study|Death|20|||
94346587|NCT00877890|323049107|FG001|Overall Study|Lost to Follow-up|5|||
94346588|NCT00877890|323049106|FG000|Overall Study|Protocol Violation|0|||
94563352|NCT02586727|323858149|FG000|Overall Study|Lost to Follow-up|1|||
94563353|NCT02586727|323858150|FG001|Overall Study|Lost to Follow-up|0|||
94563354|NCT00731679|323858162|FG000|Overall Study|Adverse Event|7|||
94346589|NCT00877890|323049107|FG001|Overall Study|Protocol Violation|1|||
94346590|NCT00877890|323049106|FG000|Overall Study|Withdrawal of Consent|6|||
94346591|NCT00877890|323049107|FG001|Overall Study|Withdrawal of Consent|12|||
94346592|NCT00877890|323049106|FG000|Overall Study|Investigator Decision|0|||
94346593|NCT00877890|323049107|FG001|Overall Study|Investigator Decision|2|||
94346594|NCT00877890|323049106|FG000|Overall Study|Loss of Glucose Control|3|||
94346595|NCT00877890|323049107|FG001|Overall Study|Loss of Glucose Control|4|||
94563355|NCT00731679|323858163|FG001|Overall Study|Adverse Event|8|||
94563356|NCT00731679|323858162|FG000|Overall Study|Withdrawal by Subject|8|||
94563357|NCT00731679|323858163|FG001|Overall Study|Withdrawal by Subject|8|||
94658065|NCT01609556|324204469|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
94346596|NCT00984009|323049108|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
94346597|NCT01681836|323049109|FG000|Second Intervention|Withdrawal by Subject|0|||
94346598|NCT01681836|323049110|FG001|Second Intervention|Withdrawal by Subject|1|||
94346599|NCT02504424|323049111|FG000|Overall Study|Withdrawal by Subject|2|||
94346600|NCT03258762|323049112|FG000|Overall Study|Lost to Follow-up|0|||
94346601|NCT03258762|323049113|FG001|Overall Study|Lost to Follow-up|1|||
94346602|NCT01592773|323050741|FG000|Overall Study|Study Terminated by Sponsor|582|||
94346603|NCT01592773|323050741|FG000|Overall Study|Withdrawal by Subject|35|||
94346604|NCT01592773|323050741|FG000|Overall Study|Lost to Follow-up|19|||
94346605|NCT01592773|323050741|FG000|Overall Study|Adverse Event|17|||
94346606|NCT01592773|323050741|FG000|Overall Study|Lack of Efficacy|9|||
94346607|NCT01592773|323050741|FG000|Overall Study|Protocol Violation|2|||
94346608|NCT01592773|323050741|FG000|Overall Study|Inclusion/exclusion not meet|1|||
94346609|NCT01592773|323050741|FG000|Overall Study|Other Reason|1|||
94346610|NCT02972658|323050742|FG000|Overall Study|Adverse Event|0|||
94346611|NCT02972658|323050743|FG001|Overall Study|Adverse Event|3|||
94346612|NCT02972658|323050744|FG002|Overall Study|Adverse Event|0|||
94346613|NCT02972658|323050745|FG003|Overall Study|Adverse Event|2|||
94346614|NCT02972658|323050742|FG000|Overall Study|Other-determined by Investigator|1|||
94346615|NCT02972658|323050743|FG001|Overall Study|Other-determined by Investigator|1|||
94346616|NCT02972658|323050744|FG002|Overall Study|Other-determined by Investigator|0|||
94346617|NCT02972658|323050745|FG003|Overall Study|Other-determined by Investigator|0|||
94346618|NCT02972658|323050742|FG000|Overall Study|Death|0|||
94346619|NCT02972658|323050743|FG001|Overall Study|Death|0|||
94346620|NCT02972658|323050744|FG002|Overall Study|Death|0|||
94346621|NCT02972658|323050745|FG003|Overall Study|Death|1|||
94346622|NCT02972658|323050742|FG000|Overall Study|Lost to Follow-up|0|||
94346623|NCT02972658|323050743|FG001|Overall Study|Lost to Follow-up|1|||
94450455|NCT00617890|323436805|FG001|Overall Study|Protocol Violation|1|||
94658066|NCT01609556|324204470|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
94658067|NCT01609556|324204455|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
94658068|NCT01609556|324204456|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
94346624|NCT02972658|323050744|FG002|Overall Study|Lost to Follow-up|1|||
94346625|NCT02972658|323050745|FG003|Overall Study|Lost to Follow-up|2|||
94346626|NCT02972658|323050742|FG000|Overall Study|Progressive Disease|0|||
94346627|NCT02972658|323050743|FG001|Overall Study|Progressive Disease|1|||
94563358|NCT00731679|323858162|FG000|Overall Study|Lost to Follow-up|7|||
94563359|NCT00731679|323858163|FG001|Overall Study|Lost to Follow-up|8|||
94563360|NCT00731679|323858162|FG000|Overall Study|Noncompliance|0|||
94563361|NCT00731679|323858163|FG001|Overall Study|Noncompliance|1|||
94563362|NCT00731679|323858162|FG000|Overall Study|Pregnancy|0|||
94563363|NCT00731679|323858163|FG001|Overall Study|Pregnancy|1|||
94563364|NCT01147055|323858165|FG000|First Intervention Period|Lost to Follow-up|1|||
94563365|NCT01147055|323858166|FG001|First Intervention Period|Lost to Follow-up|0|||
94563366|NCT00132808|323858167|FG000|Stratum I|Adverse Event|2|||
94563367|NCT00132808|323858168|FG001|Stratum I|Adverse Event|1|||
94563368|NCT00132808|323858169|FG002|Stratum I|Adverse Event|0|||
94563369|NCT00132808|323858167|FG000|Stratum I|Lost to Follow-up|3|||
94563370|NCT00132808|323858168|FG001|Stratum I|Lost to Follow-up|4|||
94563371|NCT00132808|323858169|FG002|Stratum I|Lost to Follow-up|1|||
94563372|NCT00132808|323858167|FG000|Stratum I|Withdrawal by Subject|4|||
94235174|NCT00267098|322654690|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
94235175|NCT00267098|322654691|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
94235176|NCT00267098|322654692|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
94235177|NCT00267098|322654693|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
94235178|NCT00267098|322654686|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
94235179|NCT00267098|322654687|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
94235180|NCT00267098|322654688|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
94235181|NCT00267098|322654689|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
94235182|NCT00267098|322654690|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
94235183|NCT00267098|322654691|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
94235184|NCT00267098|322654692|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
94235185|NCT00267098|322654693|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
94235186|NCT00267098|322654686|FG000|Overall Study|Site closure|0|||
94235187|NCT00267098|322654687|FG001|Overall Study|Site closure|0|||
94235188|NCT00267098|322654688|FG002|Overall Study|Site closure|0|||
94235189|NCT00267098|322654689|FG003|Overall Study|Site closure|1|||
94235190|NCT00267098|322654690|FG004|Overall Study|Site closure|0|||
94235191|NCT00267098|322654691|FG005|Overall Study|Site closure|1|||
94235192|NCT00267098|322654692|FG006|Overall Study|Site closure|1|||
94235193|NCT00267098|322654693|FG007|Overall Study|Site closure|0|||
94235194|NCT00267098|322654686|FG000|Overall Study|Explanted Medtronic device|0|||
94235195|NCT00267098|322654687|FG001|Overall Study|Explanted Medtronic device|0|||
94235196|NCT00267098|322654688|FG002|Overall Study|Explanted Medtronic device|0|||
94235197|NCT00267098|322654689|FG003|Overall Study|Explanted Medtronic device|1|||
94563373|NCT00132808|323858168|FG001|Stratum I|Withdrawal by Subject|7|||
94235198|NCT00267098|322654690|FG004|Overall Study|Explanted Medtronic device|0|||
94235199|NCT00267098|322654691|FG005|Overall Study|Explanted Medtronic device|0|||
94235200|NCT00267098|322654692|FG006|Overall Study|Explanted Medtronic device|0|||
94563374|NCT00132808|323858169|FG002|Stratum I|Withdrawal by Subject|3|||
94450456|NCT00617890|323436806|FG002|Overall Study|Protocol Violation|0|||
94450457|NCT00617890|323436807|FG003|Overall Study|Protocol Violation|0|||
94450458|NCT00617890|323436804|FG000|Overall Study|Adverse Event|1|||
94450459|NCT00617890|323436805|FG001|Overall Study|Adverse Event|0|||
94450460|NCT00617890|323436806|FG002|Overall Study|Adverse Event|3|||
94450461|NCT00617890|323436807|FG003|Overall Study|Adverse Event|8|||
94450462|NCT00617890|323436804|FG000|Overall Study|Not treated|1|||
94450463|NCT00617890|323436805|FG001|Overall Study|Not treated|0|||
94450464|NCT00617890|323436806|FG002|Overall Study|Not treated|1|||
94450465|NCT00617890|323436807|FG003|Overall Study|Not treated|1|||
94450466|NCT00728468|323436810|FG000|Overall Study|Enrolled but not treated|1|||
94450467|NCT00728468|323436810|FG000|Overall Study|Death|1|||
94450468|NCT00728468|323436810|FG000|Overall Study|Protocol Violation|4|||
94450469|NCT00728468|323436810|FG000|Overall Study|Objective progression or relapse|9|||
94450470|NCT00728468|323436810|FG000|Overall Study|Study terminated by sponsor|1|||
94450471|NCT01209949|323436811|FG000|Overall Study|Lost to Follow-up|3|||
94450472|NCT01780038|323436820|FG000|Overall Study|Lost to Follow-up|4|||
94450473|NCT01780038|323436821|FG001|Overall Study|Lost to Follow-up|1|||
94450474|NCT00651261|323436827|FG000|Overall Study|Adverse Event|32|||
94450475|NCT00651261|323436828|FG001|Overall Study|Adverse Event|22|||
94450476|NCT00651261|323436827|FG000|Overall Study|Death|18|||
94450477|NCT00651261|323436828|FG001|Overall Study|Death|18|||
94563375|NCT00132808|323858167|FG000|Stratum I|Abnormal test procedure result (s)|0|||
94563376|NCT00132808|323858168|FG001|Stratum I|Abnormal test procedure result (s)|0|||
94563377|NCT00132808|323858169|FG002|Stratum I|Abnormal test procedure result (s)|1|||
94563378|NCT00132808|323858167|FG000|Stratum II|Adverse Event|1|||
94563379|NCT00132808|323858168|FG001|Stratum II|Adverse Event|2|||
94563380|NCT00132808|323858169|FG002|Stratum II|Adverse Event|1|||
94563381|NCT00132808|323858167|FG000|Stratum II|Death|1|||
94563382|NCT00132808|323858168|FG001|Stratum II|Death|0|||
94563383|NCT00132808|323858169|FG002|Stratum II|Death|0|||
94563384|NCT00132808|323858167|FG000|Stratum II|Lost to Follow-up|2|||
94563385|NCT00132808|323858168|FG001|Stratum II|Lost to Follow-up|2|||
94563386|NCT00132808|323858169|FG002|Stratum II|Lost to Follow-up|1|||
94563387|NCT00132808|323858167|FG000|Stratum II|Protocol Violation|0|||
94563388|NCT00132808|323858168|FG001|Stratum II|Protocol Violation|2|||
94563389|NCT00132808|323858169|FG002|Stratum II|Protocol Violation|1|||
94563390|NCT00132808|323858167|FG000|Stratum II|Withdrawal by Subject|4|||
94563391|NCT00132808|323858168|FG001|Stratum II|Withdrawal by Subject|9|||
94563392|NCT00132808|323858169|FG002|Stratum II|Withdrawal by Subject|6|||
94563393|NCT01288989|323858170|FG000|Overall Study|Death|0|||
94563394|NCT01288989|323858171|FG001|Overall Study|Death|0|||
94563395|NCT01288989|323858172|FG002|Overall Study|Death|0|||
94658069|NCT01609556|324204457|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
94658070|NCT01609556|324204458|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
94450478|NCT00651261|323436827|FG000|Overall Study|Withdrawal by Subject|22|||
94563396|NCT01288989|323858173|FG003|Overall Study|Death|1|||
94563397|NCT01288989|323858174|FG004|Overall Study|Death|0|||
94450479|NCT00651261|323436828|FG001|Overall Study|Withdrawal by Subject|40|||
94563398|NCT01288989|323858170|FG000|Overall Study|Dose limiting toxicity|1|||
94563399|NCT01288989|323858171|FG001|Overall Study|Dose limiting toxicity|0|||
94346628|NCT02972658|323050744|FG002|Overall Study|Progressive Disease|0|||
94346629|NCT02972658|323050745|FG003|Overall Study|Progressive Disease|1|||
94346630|NCT02972658|323050742|FG000|Overall Study|Withdrawal by Subject|4|||
94346631|NCT02972658|323050743|FG001|Overall Study|Withdrawal by Subject|4|||
94346632|NCT02972658|323050744|FG002|Overall Study|Withdrawal by Subject|1|||
94346633|NCT02972658|323050745|FG003|Overall Study|Withdrawal by Subject|6|||
94346634|NCT02972658|323050742|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
94346635|NCT02972658|323050743|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
94346636|NCT02972658|323050744|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
94346637|NCT02972658|323050745|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
94346638|NCT02972658|323050742|FG000|Overall Study|Sponsor Decision|70|||
94346639|NCT02972658|323050743|FG001|Overall Study|Sponsor Decision|127|||
94346640|NCT02972658|323050744|FG002|Overall Study|Sponsor Decision|72|||
94346641|NCT02972658|323050745|FG003|Overall Study|Sponsor Decision|119|||
94346642|NCT03037489|323050747|FG000|Overall Study|Adverse Event|4|||
94346643|NCT03037489|323050748|FG001|Overall Study|Adverse Event|0|||
94346644|NCT03037489|323050747|FG000|Overall Study|Withdrawal by Subject|3|||
94346645|NCT03037489|323050748|FG001|Overall Study|Withdrawal by Subject|0|||
94450480|NCT00651261|323436827|FG000|Overall Study|Induction failure|24|||
94450481|NCT00651261|323436828|FG001|Overall Study|Induction failure|35|||
94450482|NCT00651261|323436827|FG000|Overall Study|Disease progression|58|||
94450483|NCT00651261|323436828|FG001|Overall Study|Disease progression|58|||
94450484|NCT00651261|323436827|FG000|Overall Study|Alternative therapy|109|||
94450485|NCT00651261|323436828|FG001|Overall Study|Alternative therapy|107|||
94450486|NCT00651261|323436827|FG000|Overall Study|Other disease or participant decisions|23|||
94450487|NCT00651261|323436828|FG001|Overall Study|Other disease or participant decisions|23|||
94450488|NCT00651261|323436827|FG000|Overall Study|Never treated|5|||
94450489|NCT00651261|323436828|FG001|Overall Study|Never treated|3|||
94450490|NCT01134107|323436829|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
94450491|NCT01134107|323436830|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
94450492|NCT01134107|323436829|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
94450493|NCT01134107|323436830|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
94450494|NCT01134107|323436829|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
94450495|NCT01134107|323436830|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
94450496|NCT01134107|323436829|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
94450497|NCT01134107|323436830|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
94450498|NCT01134107|323436829|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
94563400|NCT01288989|323858172|FG002|Overall Study|Dose limiting toxicity|0|||
94563401|NCT01288989|323858173|FG003|Overall Study|Dose limiting toxicity|0|||
94563402|NCT01288989|323858174|FG004|Overall Study|Dose limiting toxicity|0|||
94563403|NCT01288989|323858170|FG000|Overall Study|Adverse Event|0|||
94563404|NCT01288989|323858171|FG001|Overall Study|Adverse Event|0|||
94563405|NCT01288989|323858172|FG002|Overall Study|Adverse Event|0|||
94563406|NCT01288989|323858173|FG003|Overall Study|Adverse Event|0|||
94563407|NCT01288989|323858174|FG004|Overall Study|Adverse Event|2|||
94563408|NCT01288989|323858170|FG000|Overall Study|Physician Decision|0|||
94563409|NCT01288989|323858171|FG001|Overall Study|Physician Decision|0|||
94563410|NCT01288989|323858172|FG002|Overall Study|Physician Decision|0|||
94563411|NCT01288989|323858173|FG003|Overall Study|Physician Decision|0|||
94563412|NCT01288989|323858174|FG004|Overall Study|Physician Decision|1|||
94563413|NCT01288989|323858170|FG000|Overall Study|Withdrawal by Subject|0|||
94563414|NCT01288989|323858171|FG001|Overall Study|Withdrawal by Subject|0|||
94563415|NCT01288989|323858172|FG002|Overall Study|Withdrawal by Subject|0|||
94563416|NCT01288989|323858173|FG003|Overall Study|Withdrawal by Subject|0|||
94563417|NCT01288989|323858174|FG004|Overall Study|Withdrawal by Subject|3|||
94563418|NCT03201419|323858178|FG000|Overall Study|Adverse Event|3|||
94563419|NCT03201419|323858179|FG001|Overall Study|Adverse Event|1|||
94563420|NCT03201419|323858180|FG002|Overall Study|Adverse Event|0|||
94563421|NCT03201419|323858181|FG003|Overall Study|Adverse Event|0|||
94563422|NCT03201419|323858182|FG004|Overall Study|Adverse Event|1|||
94563423|NCT03201419|323858183|FG005|Overall Study|Adverse Event|1|||
94563424|NCT03201419|323858184|FG006|Overall Study|Adverse Event|5|||
94658071|NCT01609556|324204459|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
94658072|NCT01609556|324204460|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
94346646|NCT02499172|323050750|FG000|Overall Study|Financial reason|0|||
94346647|NCT02499172|323050751|FG001|Overall Study|Financial reason|0|||
94450499|NCT01134107|323436830|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
94450500|NCT01134107|323436829|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
94563425|NCT03201419|323858185|FG007|Overall Study|Adverse Event|0|||
94563426|NCT03201419|323858186|FG008|Overall Study|Adverse Event|0|||
94346648|NCT02499172|323050752|FG002|Overall Study|Financial reason|523|||
94563427|NCT03201419|323858178|FG000|Overall Study|Lost to Follow-up|1|||
94346649|NCT02499172|323050753|FG003|Overall Study|Financial reason|436|||
94450501|NCT01134107|323436830|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
94563428|NCT03201419|323858179|FG001|Overall Study|Lost to Follow-up|0|||
94563429|NCT03201419|323858180|FG002|Overall Study|Lost to Follow-up|0|||
94563430|NCT03201419|323858181|FG003|Overall Study|Lost to Follow-up|0|||
94563431|NCT03201419|323858182|FG004|Overall Study|Lost to Follow-up|0|||
94563432|NCT03201419|323858183|FG005|Overall Study|Lost to Follow-up|0|||
94563433|NCT03201419|323858184|FG006|Overall Study|Lost to Follow-up|0|||
94563434|NCT03201419|323858185|FG007|Overall Study|Lost to Follow-up|0|||
94563435|NCT03201419|323858186|FG008|Overall Study|Lost to Follow-up|0|||
94563436|NCT03201419|323858178|FG000|Overall Study|Protocol Deviation|0|||
94563437|NCT03201419|323858179|FG001|Overall Study|Protocol Deviation|0|||
94346650|NCT02499172|323050750|FG000|Overall Study|Lost to Follow-up|65|||
94563438|NCT03201419|323858180|FG002|Overall Study|Protocol Deviation|0|||
94346651|NCT02499172|323050751|FG001|Overall Study|Lost to Follow-up|64|||
94346652|NCT02499172|323050752|FG002|Overall Study|Lost to Follow-up|0|||
94346653|NCT02499172|323050753|FG003|Overall Study|Lost to Follow-up|0|||
94346654|NCT01293123|323050754|FG000|Overall Study|Lost to Follow-up|0|||
94346655|NCT01293123|323050755|FG001|Overall Study|Lost to Follow-up|1|||
94346656|NCT04097925|323050763|FG000|Overall Study|Withdrawal by Subject|1|||
94346657|NCT00303329|323050767|FG000|Overall Study|Adverse Event|7|||
94346658|NCT00303329|323050768|FG001|Overall Study|Adverse Event|14|||
94346659|NCT00303329|323050767|FG000|Overall Study|Abnormal Laboratory Values|0|||
94346660|NCT00303329|323050768|FG001|Overall Study|Abnormal Laboratory Values|1|||
94346661|NCT00303329|323050767|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
94346662|NCT00303329|323050768|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
94346663|NCT00303329|323050767|FG000|Overall Study|Condition no longer requires study drug|0|||
94346664|NCT00303329|323050768|FG001|Overall Study|Condition no longer requires study drug|8|||
94346665|NCT00303329|323050767|FG000|Overall Study|Protocol Violation|3|||
94346666|NCT00303329|323050768|FG001|Overall Study|Protocol Violation|0|||
94346667|NCT00303329|323050767|FG000|Overall Study|Withdrawal by Subject|9|||
94346668|NCT00303329|323050768|FG001|Overall Study|Withdrawal by Subject|15|||
94346669|NCT00303329|323050767|FG000|Overall Study|Lost to Follow-up|0|||
94346670|NCT00303329|323050768|FG001|Overall Study|Lost to Follow-up|1|||
94346671|NCT00303329|323050767|FG000|Overall Study|Administrative problems|1|||
94346672|NCT00303329|323050768|FG001|Overall Study|Administrative problems|0|||
94346673|NCT00303329|323050767|FG000|Overall Study|Death|2|||
94346674|NCT00303329|323050768|FG001|Overall Study|Death|12|||
94346675|NCT00303329|323050767|FG000|Overall Study|Stopped at end of core|3|||
94346676|NCT00303329|323050768|FG001|Overall Study|Stopped at end of core|9|||
94346677|NCT00303329|323050767|FG000|Overall Study|Stopped at end of extension 1|1|||
94346678|NCT00303329|323050768|FG001|Overall Study|Stopped at end of extension 1|0|||
94346679|NCT02306148|323050769|FG000|Overall Study|Adverse Event|12|||
94346680|NCT02306148|323050770|FG001|Overall Study|Adverse Event|6|||
94346681|NCT02306148|323050769|FG000|Overall Study|Lost to Follow-up|1|||
94346682|NCT02306148|323050770|FG001|Overall Study|Lost to Follow-up|4|||
94346683|NCT04657003|323050771|FG000|Overall Study|Adverse Event|5|||
94346684|NCT04657003|323050772|FG001|Overall Study|Adverse Event|1|||
94346685|NCT04657003|323050773|FG002|Overall Study|Adverse Event|5|||
94346686|NCT04657003|323050771|FG000|Overall Study|Death|0|||
94346687|NCT04657003|323050772|FG001|Overall Study|Death|2|||
94346688|NCT04657003|323050773|FG002|Overall Study|Death|0|||
94346689|NCT04657003|323050771|FG000|Overall Study|Lost to Follow-up|8|||
94346690|NCT04657003|323050772|FG001|Overall Study|Lost to Follow-up|4|||
94346691|NCT04657003|323050773|FG002|Overall Study|Lost to Follow-up|10|||
94346692|NCT04657003|323050771|FG000|Overall Study|Other - As Reported by Investigator|3|||
94346693|NCT04657003|323050772|FG001|Overall Study|Other - As Reported by Investigator|2|||
94346694|NCT04657003|323050773|FG002|Overall Study|Other - As Reported by Investigator|2|||
94346695|NCT04657003|323050771|FG000|Overall Study|Pregnancy|2|||
94346696|NCT04657003|323050772|FG001|Overall Study|Pregnancy|0|||
94346697|NCT04657003|323050773|FG002|Overall Study|Pregnancy|2|||
94346698|NCT04657003|323050771|FG000|Overall Study|Withdrawal by Subject|16|||
94346699|NCT04657003|323050772|FG001|Overall Study|Withdrawal by Subject|7|||
94346700|NCT04657003|323050773|FG002|Overall Study|Withdrawal by Subject|10|||
94346701|NCT00626327|323050774|FG000|Overall Study|Withdrawal by Subject|21|||
94235201|NCT00267098|322654693|FG007|Overall Study|Explanted Medtronic device|0|||
94235202|NCT00267098|322654686|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
94235203|NCT00267098|322654687|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
94235204|NCT00267098|322654688|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
94235205|NCT00267098|322654689|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
94235206|NCT00267098|322654690|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
94235207|NCT00267098|322654691|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
94235208|NCT00267098|322654692|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
94235209|NCT00267098|322654693|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
94235210|NCT00267098|322654686|FG000|Overall Study|Subject listed for heart transplant|0|||
94235211|NCT00267098|322654687|FG001|Overall Study|Subject listed for heart transplant|0|||
94235212|NCT00267098|322654688|FG002|Overall Study|Subject listed for heart transplant|0|||
94235213|NCT00267098|322654689|FG003|Overall Study|Subject listed for heart transplant|0|||
94235214|NCT00267098|322654690|FG004|Overall Study|Subject listed for heart transplant|0|||
94235215|NCT00267098|322654691|FG005|Overall Study|Subject listed for heart transplant|0|||
94235216|NCT00267098|322654692|FG006|Overall Study|Subject listed for heart transplant|1|||
94235217|NCT00267098|322654693|FG007|Overall Study|Subject listed for heart transplant|0|||
94235218|NCT00267098|322654686|FG000|Overall Study|Sponsor withdrew subject|0|||
94235219|NCT00267098|322654687|FG001|Overall Study|Sponsor withdrew subject|0|||
94235220|NCT00267098|322654688|FG002|Overall Study|Sponsor withdrew subject|0|||
94235221|NCT00267098|322654689|FG003|Overall Study|Sponsor withdrew subject|1|||
94235222|NCT00267098|322654690|FG004|Overall Study|Sponsor withdrew subject|0|||
94235223|NCT00267098|322654691|FG005|Overall Study|Sponsor withdrew subject|0|||
94235224|NCT00267098|322654692|FG006|Overall Study|Sponsor withdrew subject|0|||
94235225|NCT00267098|322654693|FG007|Overall Study|Sponsor withdrew subject|0|||
94235226|NCT02031536|322654694|FG000|Overall Study|ineligible|1|||
94235227|NCT02031536|322654695|FG001|Overall Study|ineligible|0|||
94235228|NCT01850030|322654696|FG000|Overall Study|Adverse Event|64|||
94235229|NCT01850030|322654697|FG001|Overall Study|Adverse Event|82|||
94235230|NCT01850030|322654696|FG000|Overall Study|Lack of Efficacy|3|||
94235231|NCT01850030|322654697|FG001|Overall Study|Lack of Efficacy|1|||
94235232|NCT01850030|322654696|FG000|Overall Study|Lost to Follow-up|5|||
94235233|NCT01850030|322654697|FG001|Overall Study|Lost to Follow-up|5|||
94235234|NCT01850030|322654696|FG000|Overall Study|Withdrawal by Subject|3|||
94235235|NCT01850030|322654697|FG001|Overall Study|Withdrawal by Subject|4|||
94235236|NCT01850030|322654696|FG000|Overall Study|Protocol Violation|24|||
94235237|NCT01850030|322654697|FG001|Overall Study|Protocol Violation|28|||
94235238|NCT01850030|322654696|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
94235239|NCT01850030|322654697|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
94235240|NCT02554383|322654698|FG000|Overall Study|Ineligible|3|||
94235241|NCT02554383|322654699|FG001|Overall Study|Ineligible|2|||
94235242|NCT02554383|322654698|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
94235243|NCT02554383|322654699|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
94235244|NCT02554383|322654698|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
94235245|NCT02554383|322654699|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
94235246|NCT02554383|322654698|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
94235247|NCT02554383|322654699|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
94235248|NCT02581059|322654700|FG000|Study Treatment|Disease Progression|1|||
94235249|NCT02581059|322654701|FG001|Study Treatment|Disease Progression|1|||
94235250|NCT02581059|322654700|FG000|Study Treatment|Adverse Event|2|||
94235251|NCT02581059|322654701|FG001|Study Treatment|Adverse Event|1|||
94235252|NCT02581059|322654700|FG000|Study Treatment|Death|1|||
94235253|NCT02581059|322654701|FG001|Study Treatment|Death|1|||
94235254|NCT02581059|322654700|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
94235255|NCT02581059|322654701|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
94235256|NCT02581059|322654700|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
94235257|NCT02581059|322654701|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
94563439|NCT03201419|323858181|FG003|Overall Study|Protocol Deviation|0|||
94563440|NCT03201419|323858182|FG004|Overall Study|Protocol Deviation|0|||
94563441|NCT03201419|323858183|FG005|Overall Study|Protocol Deviation|0|||
94563442|NCT03201419|323858184|FG006|Overall Study|Protocol Deviation|1|||
94563443|NCT03201419|323858185|FG007|Overall Study|Protocol Deviation|0|||
94563444|NCT03201419|323858186|FG008|Overall Study|Protocol Deviation|0|||
94235258|NCT02581059|322654700|FG000|Follow up|Death|1|||
94235259|NCT02581059|322654701|FG001|Follow up|Death|3|||
94235260|NCT02581059|322654700|FG000|Follow up|study terminated|1|||
94235261|NCT02581059|322654701|FG001|Follow up|study terminated|1|||
94235262|NCT02581059|322654700|FG000|Follow up|screen failure|0|||
94235263|NCT02581059|322654701|FG001|Follow up|screen failure|1|||
94235264|NCT02581059|322654700|FG000|Follow up|Patient started new clinical trial|1|||
94346702|NCT00626327|323050775|FG001|Overall Study|Withdrawal by Subject|29|||
94235265|NCT02581059|322654701|FG001|Follow up|Patient started new clinical trial|0|||
94563445|NCT03201419|323858178|FG000|Overall Study|Withdrawal by Subject|4|||
94235266|NCT01056263|322654702|FG000|Overall Study|Adverse Event|12|||
94346703|NCT00626327|323050776|FG002|Overall Study|Withdrawal by Subject|30|||
94346704|NCT00626327|323050774|FG000|Overall Study|Adverse Event|1|||
94346705|NCT00626327|323050775|FG001|Overall Study|Adverse Event|0|||
94346706|NCT00626327|323050776|FG002|Overall Study|Adverse Event|0|||
94346707|NCT00626327|323050774|FG000|Overall Study|Lost to Follow-up|24|||
94346708|NCT00626327|323050775|FG001|Overall Study|Lost to Follow-up|21|||
94346709|NCT00626327|323050776|FG002|Overall Study|Lost to Follow-up|23|||
94346710|NCT00626327|323050774|FG000|Overall Study|Inappropriate enrollment|4|||
94346711|NCT00626327|323050775|FG001|Overall Study|Inappropriate enrollment|5|||
94346712|NCT00626327|323050776|FG002|Overall Study|Inappropriate enrollment|3|||
94346713|NCT00626327|323050774|FG000|Overall Study|Administrative Reason|2|||
94346714|NCT00626327|323050775|FG001|Overall Study|Administrative Reason|0|||
94346715|NCT00626327|323050776|FG002|Overall Study|Administrative Reason|6|||
94346716|NCT00626327|323050774|FG000|Overall Study|Protocol Violation|26|||
94346717|NCT00626327|323050775|FG001|Overall Study|Protocol Violation|4|||
94346718|NCT00626327|323050776|FG002|Overall Study|Protocol Violation|26|||
94346719|NCT01736176|323050777|FG000|Overall Study|Adverse Event|3|||
94563446|NCT03201419|323858179|FG001|Overall Study|Withdrawal by Subject|2|||
94346720|NCT01736176|323050777|FG000|Overall Study|Withdrawal by Subject|4|||
94563447|NCT03201419|323858180|FG002|Overall Study|Withdrawal by Subject|1|||
94563448|NCT03201419|323858181|FG003|Overall Study|Withdrawal by Subject|0|||
94563449|NCT03201419|323858182|FG004|Overall Study|Withdrawal by Subject|0|||
94346721|NCT01736176|323050777|FG000|Overall Study|Lack of Efficacy|3|||
94346722|NCT01736176|323050777|FG000|Overall Study|Unable to Complete PEG Placement|1|||
94365609|NCT00689273|323122449|FG001|Overall Study|Lack of Efficacy|0|||
94365610|NCT00689273|323122448|FG000|Overall Study|Lost to Follow-up|0|||
94365611|NCT00689273|323122449|FG001|Overall Study|Lost to Follow-up|2|||
94365612|NCT00689273|323122448|FG000|Overall Study|Other|6|||
94365613|NCT00689273|323122449|FG001|Overall Study|Other|2|||
94365614|NCT00689273|323122448|FG000|Overall Study|Randomized but not Treated|1|||
94365615|NCT00689273|323122449|FG001|Overall Study|Randomized but not Treated|0|||
94365616|NCT01556165|323122450|FG000|Overall Study|Adverse Event|5|||
94365617|NCT01556165|323122451|FG001|Overall Study|Adverse Event|3|||
94365618|NCT01556165|323122450|FG000|Overall Study|Protocol Violation|0|||
94365619|NCT01556165|323122451|FG001|Overall Study|Protocol Violation|3|||
94365620|NCT01556165|323122450|FG000|Overall Study|Withdrawal of Consent|7|||
94365621|NCT01556165|323122451|FG001|Overall Study|Withdrawal of Consent|1|||
94365622|NCT01238172|323122452|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
94365623|NCT01238172|323122453|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
94365624|NCT01238172|323122452|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
94365625|NCT01238172|323122453|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
94365626|NCT00701558|323122456|FG000|Overall Study|Death|7|||
94365627|NCT00701558|323122456|FG000|Overall Study|Lost to Follow-up|8|||
94365628|NCT00915473|323124732|FG000|Screening|Withdrawal by Subject|1|||
94365629|NCT00915473|323124733|FG001|Screening|Withdrawal by Subject|0|||
94365630|NCT00915473|323124732|FG000|4-week Follow Up|Lost to Follow-up|1|||
94365631|NCT00915473|323124733|FG001|4-week Follow Up|Lost to Follow-up|5|||
94365632|NCT03515837|323124734|FG000|Overall Study|Death|219|||
94365633|NCT03515837|323124735|FG001|Overall Study|Death|227|||
94365634|NCT03515837|323124734|FG000|Overall Study|Lost to Follow-up|0|||
94365635|NCT03515837|323124735|FG001|Overall Study|Lost to Follow-up|1|||
94365636|NCT03515837|323124734|FG000|Overall Study|Withdrawal by Subject|0|||
94365637|NCT03515837|323124735|FG001|Overall Study|Withdrawal by Subject|4|||
94365638|NCT03515837|323124734|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
94365639|NCT03515837|323124735|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
94365640|NCT02325401|323124736|FG000|Overall Study|Withdrawal by Subject|0|||
94365641|NCT02325401|323124737|FG001|Overall Study|Withdrawal by Subject|1|||
94365642|NCT02325401|323124738|FG002|Overall Study|Withdrawal by Subject|1|||
94365643|NCT01788163|323124739|FG000|Overall Study|Other|53|||
94365644|NCT01788163|323124740|FG001|Overall Study|Other|0|||
94365645|NCT01788163|323124741|FG002|Overall Study|Other|0|||
94365646|NCT01788163|323124742|FG003|Overall Study|Other|0|||
94365647|NCT01788163|323124743|FG004|Overall Study|Other|0|||
94365648|NCT01788163|323124744|FG005|Overall Study|Other|7|||
94365649|NCT01788163|323124745|FG006|Overall Study|Other|1|||
94365650|NCT01788163|323124746|FG007|Overall Study|Other|48|||
94365651|NCT01788163|323124747|FG008|Overall Study|Other|15|||
94365652|NCT01788163|323124739|FG000|Overall Study|Withdrawal by Subject|2|||
94365653|NCT01788163|323124740|FG001|Overall Study|Withdrawal by Subject|0|||
94365654|NCT01788163|323124741|FG002|Overall Study|Withdrawal by Subject|0|||
94365655|NCT01788163|323124742|FG003|Overall Study|Withdrawal by Subject|0|||
94235267|NCT01056263|322654702|FG000|Overall Study|Death|1|||
94235268|NCT01056263|322654702|FG000|Overall Study|Withdrawal by Subject|1|||
94235269|NCT01056263|322654702|FG000|Overall Study|Lack of Efficacy|29|||
94563450|NCT03201419|323858183|FG005|Overall Study|Withdrawal by Subject|0|||
94563451|NCT03201419|323858184|FG006|Overall Study|Withdrawal by Subject|0|||
94563452|NCT03201419|323858185|FG007|Overall Study|Withdrawal by Subject|1|||
94563453|NCT03201419|323858186|FG008|Overall Study|Withdrawal by Subject|2|||
94563454|NCT03201419|323858178|FG000|Overall Study|Other|0|||
94563455|NCT03201419|323858179|FG001|Overall Study|Other|0|||
94563456|NCT03201419|323858180|FG002|Overall Study|Other|1|||
94563457|NCT03201419|323858181|FG003|Overall Study|Other|0|||
94235270|NCT01056263|322654702|FG000|Overall Study|Progressive disease|2|||
94235271|NCT01056263|322654702|FG000|Overall Study|Neoplasm progression|1|||
94235272|NCT01056263|322654702|FG000|Overall Study|Objective progression or relapse|1|||
94235273|NCT01056263|322654702|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
94235274|NCT00658606|322654705|FG000|Overall Study|Adverse Event|2|||
94235275|NCT00658606|322654706|FG001|Overall Study|Adverse Event|1|||
94235276|NCT00658606|322654705|FG000|Overall Study|Lack of Efficacy|6|||
94235277|NCT00658606|322654706|FG001|Overall Study|Lack of Efficacy|3|||
94235278|NCT00658606|322654705|FG000|Overall Study|Lost to Follow-up|1|||
94235279|NCT00658606|322654706|FG001|Overall Study|Lost to Follow-up|0|||
94235280|NCT00658606|322654705|FG000|Overall Study|Withdrawal by Subject|7|||
94235281|NCT00658606|322654706|FG001|Overall Study|Withdrawal by Subject|16|||
94235282|NCT00658606|322654705|FG000|Overall Study|Lack of Compliance|0|||
94235283|NCT00658606|322654706|FG001|Overall Study|Lack of Compliance|3|||
94235284|NCT02282059|322654713|FG000|Overall Study|Other|15|||
94235285|NCT02282059|322654714|FG001|Overall Study|Other|3|||
94235286|NCT02282059|322654713|FG000|Overall Study|Participant refused further follow-up|8|||
94235287|NCT02282059|322654714|FG001|Overall Study|Participant refused further follow-up|4|||
94235288|NCT02282059|322654713|FG000|Overall Study|Lost to Follow-up|19|||
94235289|NCT02282059|322654714|FG001|Overall Study|Lost to Follow-up|3|||
94235290|NCT02282059|322654713|FG000|Overall Study|Death|40|||
94235291|NCT02282059|322654714|FG001|Overall Study|Death|8|||
94235292|NCT02035696|322656301|FG000|Overall Study|Lost to Follow-up|0|||
94235293|NCT02035696|322656302|FG001|Overall Study|Lost to Follow-up|3|||
94235294|NCT02035696|322656303|FG002|Overall Study|Lost to Follow-up|1|||
94235295|NCT02035696|322656304|FG003|Overall Study|Lost to Follow-up|2|||
94235296|NCT02035696|322656301|FG000|Overall Study|Withdrawal by Subject|3|||
94235297|NCT02035696|322656302|FG001|Overall Study|Withdrawal by Subject|0|||
94235298|NCT02035696|322656303|FG002|Overall Study|Withdrawal by Subject|2|||
94235299|NCT02035696|322656304|FG003|Overall Study|Withdrawal by Subject|1|||
94235300|NCT01867047|322656305|FG000|Overall Study|Lost to Follow-up|3|||
94235301|NCT01867047|322656306|FG001|Overall Study|Lost to Follow-up|3|||
94235302|NCT01867047|322656305|FG000|Overall Study|Withdrawal by Subject|2|||
94235303|NCT01867047|322656306|FG001|Overall Study|Withdrawal by Subject|0|||
94235304|NCT01867047|322656305|FG000|Overall Study|Physician Decision|2|||
94563458|NCT03201419|323858182|FG004|Overall Study|Other|0|||
94563459|NCT03201419|323858183|FG005|Overall Study|Other|0|||
94563460|NCT03201419|323858184|FG006|Overall Study|Other|0|||
94235305|NCT01867047|322656306|FG001|Overall Study|Physician Decision|0|||
94235306|NCT01867047|322656305|FG000|Overall Study|surgery not indicated in protocol|1|||
94235307|NCT01867047|322656306|FG001|Overall Study|surgery not indicated in protocol|2|||
94235308|NCT00590564|322656312|FG000|Overall Study|Withdrawal by Subject|4|||
94235309|NCT00590564|322656312|FG000|Overall Study|Lost to Follow-up|6|||
94235310|NCT00590564|322656312|FG000|Overall Study|Protocol Violation|1|||
94563461|NCT03201419|323858185|FG007|Overall Study|Other|0|||
94235311|NCT00590564|322656312|FG000|Overall Study|Patient Found to be Ineligible|1|||
94235312|NCT00590564|322656312|FG000|Overall Study|Patient Non-compliance|6|||
94563462|NCT03201419|323858186|FG008|Overall Study|Other|0|||
94563463|NCT05864586|323858187|FG000|Overall Study|Ineligible|4|||
94563464|NCT05864586|323858188|FG001|Overall Study|Ineligible|12|||
94563465|NCT05864586|323858187|FG000|Overall Study|Pregnancy|0|||
94563466|NCT05864586|323858188|FG001|Overall Study|Pregnancy|1|||
94563467|NCT05864586|323858187|FG000|Overall Study|Withdrawal by Subject|0|||
94563468|NCT05864586|323858188|FG001|Overall Study|Withdrawal by Subject|1|||
94563469|NCT00801216|323858221|FG000|Overall Study|Screening Failure|2|||
94563470|NCT05907395|323858222|FG000|Period 1|No longer met eligibility criteria|0|||
94563471|NCT05907395|323858223|FG001|Period 1|No longer met eligibility criteria|1|||
94563472|NCT05907395|323858224|FG002|Period 1|No longer met eligibility criteria|0|||
94563473|NCT05907395|323858225|FG003|Period 1|No longer met eligibility criteria|0|||
94563474|NCT05907395|323858226|FG004|Period 1|No longer met eligibility criteria|0|||
94563475|NCT05907395|323858227|FG005|Period 1|No longer met eligibility criteria|1|||
94563476|NCT05907395|323858228|FG006|Period 1|No longer met eligibility criteria|1|||
94563477|NCT05907395|323858229|FG007|Period 1|No longer met eligibility criteria|0|||
94563478|NCT05907395|323858230|FG008|Period 1|No longer met eligibility criteria|0|||
94563479|NCT05907395|323858231|FG009|Period 1|No longer met eligibility criteria|0|||
94563480|NCT05907395|323858232|FG010|Period 1|No longer met eligibility criteria|0|||
94563481|NCT05907395|323858233|FG011|Period 1|No longer met eligibility criteria|0|||
94563482|NCT05907395|323858222|FG000|Period 2|Adverse Event|0|||
94563483|NCT05907395|323858223|FG001|Period 2|Adverse Event|0|||
94563484|NCT05907395|323858224|FG002|Period 2|Adverse Event|0|||
94563485|NCT05907395|323858225|FG003|Period 2|Adverse Event|1|||
94563486|NCT05907395|323858226|FG004|Period 2|Adverse Event|0|||
94563487|NCT05907395|323858227|FG005|Period 2|Adverse Event|0|||
94563488|NCT05907395|323858228|FG006|Period 2|Adverse Event|0|||
94563489|NCT05907395|323858229|FG007|Period 2|Adverse Event|1|||
94563490|NCT05907395|323858230|FG008|Period 2|Adverse Event|0|||
94563491|NCT05907395|323858231|FG009|Period 2|Adverse Event|0|||
94563492|NCT05907395|323858232|FG010|Period 2|Adverse Event|0|||
94563493|NCT05907395|323858233|FG011|Period 2|Adverse Event|0|||
94563494|NCT05907395|323858222|FG000|Period 2|Personal reason|0|||
94563495|NCT05907395|323858223|FG001|Period 2|Personal reason|0|||
94563496|NCT05907395|323858224|FG002|Period 2|Personal reason|0|||
94563497|NCT05907395|323858225|FG003|Period 2|Personal reason|0|||
94563498|NCT05907395|323858226|FG004|Period 2|Personal reason|0|||
94563499|NCT05907395|323858227|FG005|Period 2|Personal reason|0|||
94563500|NCT05907395|323858228|FG006|Period 2|Personal reason|0|||
94563501|NCT05907395|323858229|FG007|Period 2|Personal reason|0|||
94563502|NCT05907395|323858230|FG008|Period 2|Personal reason|0|||
94563503|NCT05907395|323858231|FG009|Period 2|Personal reason|1|||
94563504|NCT05907395|323858232|FG010|Period 2|Personal reason|0|||
94563505|NCT05907395|323858233|FG011|Period 2|Personal reason|0|||
94563506|NCT05907395|323858222|FG000|Period 3|Adverse Event|0|||
94563507|NCT05907395|323858223|FG001|Period 3|Adverse Event|0|||
94563508|NCT05907395|323858224|FG002|Period 3|Adverse Event|0|||
94563509|NCT05907395|323858225|FG003|Period 3|Adverse Event|0|||
94563510|NCT05907395|323858226|FG004|Period 3|Adverse Event|1|||
94563511|NCT05907395|323858227|FG005|Period 3|Adverse Event|0|||
94563512|NCT05907395|323858228|FG006|Period 3|Adverse Event|0|||
94563513|NCT05907395|323858229|FG007|Period 3|Adverse Event|0|||
94563514|NCT05907395|323858230|FG008|Period 3|Adverse Event|0|||
94346723|NCT01823991|323050778|FG000|Overall Study|Withdrawal by Subject|8|||
94346724|NCT01823991|323050779|FG001|Overall Study|Withdrawal by Subject|5|||
94563515|NCT05907395|323858231|FG009|Period 3|Adverse Event|0|||
94563516|NCT05907395|323858232|FG010|Period 3|Adverse Event|0|||
94563517|NCT05907395|323858233|FG011|Period 3|Adverse Event|0|||
94563518|NCT00874848|323858235|FG000|Overall Study|Adverse Event|13|||
94563519|NCT00874848|323858236|FG001|Overall Study|Adverse Event|2|||
94563520|NCT00874848|323858235|FG000|Overall Study|Progressive neoplastic disease|38|||
94563521|NCT00874848|323858236|FG001|Overall Study|Progressive neoplastic disease|18|||
94563522|NCT00874848|323858235|FG000|Overall Study|Withdrawal by Subject|7|||
94563523|NCT00874848|323858236|FG001|Overall Study|Withdrawal by Subject|4|||
94563524|NCT00874848|323858235|FG000|Overall Study|Noncompliance|1|||
94563525|NCT00874848|323858236|FG001|Overall Study|Noncompliance|1|||
94563526|NCT00874848|323858235|FG000|Overall Study|Failure to comply with protocol|0|||
94563527|NCT00874848|323858236|FG001|Overall Study|Failure to comply with protocol|1|||
94563528|NCT00874848|323858235|FG000|Overall Study|Physician Decision|0|||
94563529|NCT00874848|323858236|FG001|Overall Study|Physician Decision|2|||
94563530|NCT00286429|323858237|FG000|Overall Study|Adverse Event|4|||
94563531|NCT00286429|323858238|FG001|Overall Study|Adverse Event|1|||
94563532|NCT00286429|323858239|FG002|Overall Study|Adverse Event|6|||
94563533|NCT00286429|323858237|FG000|Overall Study|Lack of Efficacy|52|||
94346725|NCT00417248|323050782|FG000|Overall Study|Study Terminated|6|||
94563534|NCT00286429|323858238|FG001|Overall Study|Lack of Efficacy|27|||
94563535|NCT00286429|323858239|FG002|Overall Study|Lack of Efficacy|25|||
94563536|NCT00286429|323858237|FG000|Overall Study|Lost to Follow-up|2|||
94563537|NCT00286429|323858238|FG001|Overall Study|Lost to Follow-up|4|||
94563538|NCT00286429|323858239|FG002|Overall Study|Lost to Follow-up|3|||
94563539|NCT00286429|323858237|FG000|Overall Study|Physician Decision|10|||
94563540|NCT00286429|323858238|FG001|Overall Study|Physician Decision|7|||
94563541|NCT00286429|323858239|FG002|Overall Study|Physician Decision|7|||
94563542|NCT00286429|323858237|FG000|Overall Study|Protocol Violation|3|||
94563543|NCT00286429|323858238|FG001|Overall Study|Protocol Violation|5|||
94563544|NCT00286429|323858239|FG002|Overall Study|Protocol Violation|4|||
94563545|NCT00286429|323858237|FG000|Overall Study|Withdrawal by Subject|3|||
94563546|NCT00286429|323858238|FG001|Overall Study|Withdrawal by Subject|2|||
94563547|NCT00286429|323858239|FG002|Overall Study|Withdrawal by Subject|6|||
94346726|NCT00417248|323050782|FG000|Overall Study|Death|1|||
94346727|NCT00417248|323050782|FG000|Overall Study|Lack of Efficacy|1|||
94346728|NCT03347279|323050783|FG000|Overall Study|Withdrawal by Subject|8|||
94563548|NCT00286429|323858237|FG000|Overall Study|Administrative Error|1|||
94563549|NCT00286429|323858238|FG001|Overall Study|Administrative Error|1|||
94346729|NCT03347279|323050784|FG001|Overall Study|Withdrawal by Subject|15|||
94450502|NCT01134107|323436829|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
94450503|NCT01134107|323436830|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
94346730|NCT03347279|323050783|FG000|Overall Study|Death|0|||
94346731|NCT03347279|323050784|FG001|Overall Study|Death|2|||
94346732|NCT03347279|323050783|FG000|Overall Study|Lost to Follow-up|5|||
94346733|NCT03347279|323050784|FG001|Overall Study|Lost to Follow-up|2|||
94346734|NCT03347279|323050783|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
94346735|NCT03347279|323050784|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
94346736|NCT03818399|323050786|FG000|Overall Study|Lost to Follow-up|11|||
94346737|NCT03818399|323050786|FG000|Overall Study|Withdrawal by Subject|1|||
94658073|NCT01609556|324204461|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
94658074|NCT01609556|324204462|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
94658075|NCT01609556|324204463|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
94658076|NCT01609556|324204464|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
94658077|NCT01609556|324204465|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
94658078|NCT01609556|324204466|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
94658079|NCT01609556|324204467|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
94658080|NCT01609556|324204468|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
94658081|NCT01609556|324204469|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
94658082|NCT01609556|324204470|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
94658083|NCT03832192|324204471|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
94658084|NCT03832192|324204472|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
94658085|NCT02758236|324204473|FG000|Overall Study|Investigator discretion|43|||
94658086|NCT04452344|324204474|FG000|Overall Study|Withdrawal by Subject|3|||
94658087|NCT04452344|324204475|FG001|Overall Study|Withdrawal by Subject|6|||
94658088|NCT04452344|324204474|FG000|Overall Study|Adverse Event|1|||
94658089|NCT04452344|324204475|FG001|Overall Study|Adverse Event|2|||
94658090|NCT04452344|324204474|FG000|Overall Study|Lost to Follow-up|2|||
94658091|NCT04452344|324204475|FG001|Overall Study|Lost to Follow-up|2|||
94658092|NCT04452344|324204474|FG000|Overall Study|No Post-Op Visit|6|||
94658093|NCT04452344|324204475|FG001|Overall Study|No Post-Op Visit|7|||
94658094|NCT00023452|324204476|FG000|Overall Study|Ineligible for Study|163|||
94658095|NCT00023452|324204477|FG001|Overall Study|Ineligible for Study|159|||
94658096|NCT00023452|324204476|FG000|Overall Study|Out of Window|129|||
94658097|NCT00023452|324204477|FG001|Overall Study|Out of Window|69|||
94658098|NCT00023452|324204476|FG000|Overall Study|Death|2|||
94658099|NCT00023452|324204477|FG001|Overall Study|Death|0|||
94346738|NCT03818399|323050786|FG000|Overall Study|Protocol Violation|2|||
94346739|NCT03557801|323050789|FG000|Overall Study|Protocol Violation|1|||
94346740|NCT03557801|323050790|FG001|Overall Study|Protocol Violation|0|||
94346741|NCT03557801|323050791|FG002|Overall Study|Protocol Violation|0|||
94563550|NCT00286429|323858239|FG002|Overall Study|Administrative Error|1|||
94563551|NCT00286429|323858237|FG000|Overall Study|Administrative Decision|0|||
94563552|NCT00286429|323858238|FG001|Overall Study|Administrative Decision|1|||
94563553|NCT00286429|323858239|FG002|Overall Study|Administrative Decision|0|||
94563554|NCT01463306|323858240|FG000|Overall Study|Adverse Event|6|||
94563555|NCT01463306|323858241|FG001|Overall Study|Adverse Event|9|||
94563556|NCT01463306|323858242|FG002|Overall Study|Adverse Event|3|||
94563557|NCT01463306|323858240|FG000|Overall Study|Death|3|||
94563558|NCT01463306|323858241|FG001|Overall Study|Death|3|||
94563559|NCT01463306|323858242|FG002|Overall Study|Death|0|||
94563560|NCT01463306|323858240|FG000|Overall Study|Lack of Efficacy|22|||
94563561|NCT01463306|323858241|FG001|Overall Study|Lack of Efficacy|16|||
94563562|NCT01463306|323858242|FG002|Overall Study|Lack of Efficacy|1|||
94563563|NCT01463306|323858240|FG000|Overall Study|Lost to Follow-up|5|||
94346742|NCT03557801|323050789|FG000|Overall Study|Withdrawal by Subject|1|||
94346743|NCT03557801|323050790|FG001|Overall Study|Withdrawal by Subject|0|||
94563564|NCT01463306|323858241|FG001|Overall Study|Lost to Follow-up|2|||
94563565|NCT01463306|323858242|FG002|Overall Study|Lost to Follow-up|0|||
94563566|NCT01463306|323858240|FG000|Overall Study|Protocol Violation|4|||
94235313|NCT01377389|322656315|FG000|Overall Study|Withdrawal by Subject|1|||
94235314|NCT01377389|322656315|FG000|Overall Study|Screen failure|2|||
94235315|NCT03020069|322656316|FG000|Overall Study|Lost to Follow-up|0|||
94235316|NCT03020069|322656317|FG001|Overall Study|Lost to Follow-up|1|||
94235317|NCT00589303|322656318|FG000|Overall Study|Withdrawal by Subject|2|||
94235318|NCT00589303|322656319|FG001|Overall Study|Withdrawal by Subject|1|||
94235319|NCT02641587|322656320|FG000|Confinement Period|Adverse Event|1|||
94235320|NCT02641587|322656321|FG001|Confinement Period|Adverse Event|0|||
94563567|NCT01463306|323858241|FG001|Overall Study|Protocol Violation|0|||
94563568|NCT01463306|323858242|FG002|Overall Study|Protocol Violation|0|||
94563569|NCT01463306|323858240|FG000|Overall Study|Withdrawal by Subject|19|||
94563570|NCT01463306|323858241|FG001|Overall Study|Withdrawal by Subject|9|||
94563571|NCT01463306|323858242|FG002|Overall Study|Withdrawal by Subject|1|||
94563572|NCT01463306|323858240|FG000|Overall Study|Other|26|||
94563573|NCT01463306|323858241|FG001|Overall Study|Other|13|||
94563574|NCT01463306|323858242|FG002|Overall Study|Other|0|||
94235321|NCT02641587|322656320|FG000|Confinement Period|Withdrawal by Subject|2|||
94235322|NCT02641587|322656321|FG001|Confinement Period|Withdrawal by Subject|1|||
94563575|NCT01463306|323858240|FG000|Overall Study|Approval expiry at site|1|||
94563576|NCT01463306|323858241|FG001|Overall Study|Approval expiry at site|0|||
94563577|NCT01463306|323858242|FG002|Overall Study|Approval expiry at site|0|||
94563578|NCT04177212|323858245|FG000|Overall Study|Withdrawal by Subject|9|||
94563579|NCT04177212|323858246|FG001|Overall Study|Withdrawal by Subject|7|||
94563580|NCT04177212|323858245|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
94563581|NCT04177212|323858246|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
94563582|NCT04177212|323858245|FG000|Overall Study|Physician Decision|1|||
94563583|NCT04177212|323858246|FG001|Overall Study|Physician Decision|0|||
94563584|NCT04177212|323858245|FG000|Overall Study|Lost to Follow-up|0|||
94563585|NCT04177212|323858246|FG001|Overall Study|Lost to Follow-up|3|||
94563586|NCT04177212|323858245|FG000|Overall Study|Adverse Event|0|||
94563587|NCT04177212|323858246|FG001|Overall Study|Adverse Event|1|||
94563588|NCT04177212|323858245|FG000|Overall Study|Other|1|||
94563589|NCT04177212|323858246|FG001|Overall Study|Other|2|||
94563590|NCT02587819|323858247|FG000|Overall Study|Adverse Event|1|||
94563591|NCT02587819|323858247|FG000|Overall Study|Lost to Follow-up|1|||
94563592|NCT00163020|323858248|FG000|Overall Study|Lost to Follow-up|0|||
94563593|NCT00163020|323858249|FG001|Overall Study|Lost to Follow-up|2|||
94563594|NCT01392547|323859734|FG000|Overall Study|Adverse Event|2|||
94563595|NCT01392547|323859734|FG000|Overall Study|Non-compliance|2|||
94563596|NCT01392547|323859734|FG000|Overall Study|Withdrawal criteria|3|||
94563597|NCT01392547|323859734|FG000|Overall Study|Unclassified|1|||
94563598|NCT02936635|323859735|FG000|Overall Study|Adverse Event|43|||
94563599|NCT02936635|323859736|FG001|Overall Study|Adverse Event|25|||
94235323|NCT02641587|322656320|FG000|Ambulatory Period|Withdrawal by Subject|1|||
94235324|NCT02641587|322656321|FG001|Ambulatory Period|Withdrawal by Subject|0|||
94563600|NCT02936635|323859735|FG000|Overall Study|Progressive Disease|10|||
94563601|NCT02936635|323859736|FG001|Overall Study|Progressive Disease|18|||
94563602|NCT02936635|323859735|FG000|Overall Study|Sponsor Discretion|10|||
94563603|NCT02936635|323859736|FG001|Overall Study|Sponsor Discretion|16|||
94563604|NCT02936635|323859735|FG000|Overall Study|Death|9|||
94563605|NCT02936635|323859736|FG001|Overall Study|Death|15|||
94563606|NCT02936635|323859735|FG000|Overall Study|Withdrawal by Subject|8|||
94563607|NCT02936635|323859736|FG001|Overall Study|Withdrawal by Subject|15|||
94563608|NCT02936635|323859735|FG000|Overall Study|Physician Decision|2|||
94563609|NCT02936635|323859736|FG001|Overall Study|Physician Decision|9|||
94563610|NCT02936635|323859735|FG000|Overall Study|Lost to Follow-up|1|||
94563611|NCT02936635|323859736|FG001|Overall Study|Lost to Follow-up|2|||
94235325|NCT01165177|322656322|FG000|Overall Study|Serious Adverse Event|227|||
94235326|NCT01165177|322656323|FG001|Overall Study|Serious Adverse Event|235|||
94563612|NCT02936635|323859735|FG000|Overall Study|Protocol Violation|1|||
94563613|NCT02936635|323859736|FG001|Overall Study|Protocol Violation|0|||
94563614|NCT02936635|323859735|FG000|Overall Study|Lack of effect/Entry into other study|31|||
94563615|NCT02936635|323859736|FG001|Overall Study|Lack of effect/Entry into other study|65|||
94235327|NCT01165177|322656322|FG000|Overall Study|Withdrawal by Subject|368|||
94235328|NCT01165177|322656323|FG001|Overall Study|Withdrawal by Subject|354|||
94563616|NCT01633788|323859737|FG000|Overall Study|Adverse Event|1|||
94563617|NCT01633788|323859738|FG001|Overall Study|Adverse Event|3|||
94563618|NCT01633788|323859739|FG002|Overall Study|Adverse Event|3|||
94346744|NCT03557801|323050791|FG002|Overall Study|Withdrawal by Subject|3|||
94346745|NCT03557801|323050789|FG000|Overall Study|Lost to Follow-up|0|||
94346746|NCT03557801|323050790|FG001|Overall Study|Lost to Follow-up|1|||
94346747|NCT03557801|323050791|FG002|Overall Study|Lost to Follow-up|0|||
94346748|NCT03288987|323050795|FG000|Overall Study|Protocol Violation|10|||
94346749|NCT03288987|323050796|FG001|Overall Study|Protocol Violation|4|||
94346750|NCT00846027|323050797|FG000|Overall Study|Death|3|||
94563619|NCT01633788|323859740|FG003|Overall Study|Adverse Event|3|||
94563620|NCT01633788|323859737|FG000|Overall Study|Lost to Follow-up|2|||
94563621|NCT01633788|323859738|FG001|Overall Study|Lost to Follow-up|2|||
94563622|NCT01633788|323859739|FG002|Overall Study|Lost to Follow-up|2|||
94563623|NCT01633788|323859740|FG003|Overall Study|Lost to Follow-up|0|||
94563624|NCT01633788|323859737|FG000|Overall Study|Personal Reasons|3|||
94563625|NCT01633788|323859738|FG001|Overall Study|Personal Reasons|1|||
94563626|NCT01633788|323859739|FG002|Overall Study|Personal Reasons|1|||
94563627|NCT01633788|323859740|FG003|Overall Study|Personal Reasons|3|||
94563628|NCT01633788|323859737|FG000|Overall Study|Protocol Violation|1|||
94563629|NCT01633788|323859738|FG001|Overall Study|Protocol Violation|0|||
94563630|NCT01633788|323859739|FG002|Overall Study|Protocol Violation|1|||
94563631|NCT01633788|323859740|FG003|Overall Study|Protocol Violation|0|||
94563632|NCT01633788|323859737|FG000|Overall Study|Other Reasons|0|||
94563633|NCT01633788|323859738|FG001|Overall Study|Other Reasons|2|||
94563634|NCT01633788|323859739|FG002|Overall Study|Other Reasons|3|||
94563635|NCT01633788|323859740|FG003|Overall Study|Other Reasons|7|||
94563636|NCT03777059|323859743|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
94563637|NCT03777059|323859744|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
94563638|NCT03777059|323859745|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
94563639|NCT03777059|323859746|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
94563640|NCT03777059|323859743|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
94563641|NCT03777059|323859744|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
94563642|NCT03777059|323859745|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
94563643|NCT03777059|323859746|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
94563644|NCT03777059|323859743|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
94563645|NCT03777059|323859744|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
94346751|NCT00846027|323050797|FG000|Overall Study|Disease Progression|30|||
94346752|NCT00846027|323050797|FG000|Overall Study|Toxicity|12|||
94346753|NCT00846027|323050797|FG000|Overall Study|Patient Decision|7|||
94346754|NCT00846027|323050797|FG000|Overall Study|Investigator Discretion|29|||
94346755|NCT00846027|323050797|FG000|Overall Study|Protocol Violation|2|||
94346756|NCT00846027|323050797|FG000|Overall Study|Subject Not Treated|7|||
94346757|NCT02646891|323050798|FG000|Overall Study|Adverse Event|0|||
94346758|NCT02646891|323050799|FG001|Overall Study|Adverse Event|1|||
94346759|NCT02646891|323050800|FG002|Overall Study|Adverse Event|0|||
94346760|NCT02646891|323050801|FG003|Overall Study|Adverse Event|0|||
94346761|NCT02646891|323050802|FG004|Overall Study|Adverse Event|0|||
94346762|NCT02646891|323050803|FG005|Overall Study|Adverse Event|0|||
94346763|NCT02646891|323050804|FG006|Overall Study|Adverse Event|0|||
94563646|NCT03777059|323859745|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
94563647|NCT03777059|323859746|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
94563648|NCT03777059|323859743|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
94563649|NCT03777059|323859744|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
94563650|NCT03777059|323859745|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
94563651|NCT03777059|323859746|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
94563652|NCT03777059|323859743|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
94563653|NCT03777059|323859744|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
94563654|NCT03777059|323859745|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
94563655|NCT03777059|323859746|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
94563656|NCT03777059|323859743|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
94563657|NCT03777059|323859744|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
94563658|NCT03777059|323859745|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
94563659|NCT03777059|323859746|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
94346764|NCT02646891|323050805|FG007|Overall Study|Adverse Event|0|||
94346765|NCT02646891|323050806|FG008|Overall Study|Adverse Event|0|||
94346766|NCT02646891|323050807|FG009|Overall Study|Adverse Event|0|||
94346767|NCT02646891|323050798|FG000|Overall Study|Lost to Follow-up|0|||
94346768|NCT02646891|323050799|FG001|Overall Study|Lost to Follow-up|0|||
94346769|NCT02646891|323050800|FG002|Overall Study|Lost to Follow-up|0|||
94346770|NCT02646891|323050801|FG003|Overall Study|Lost to Follow-up|0|||
94346771|NCT02646891|323050802|FG004|Overall Study|Lost to Follow-up|0|||
94563660|NCT03777059|323859743|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
94563661|NCT03777059|323859744|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
94563662|NCT03777059|323859745|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
94563663|NCT03777059|323859746|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
94563664|NCT03777059|323859743|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
94563665|NCT03777059|323859744|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
94346772|NCT02646891|323050803|FG005|Overall Study|Lost to Follow-up|0|||
94346773|NCT02646891|323050804|FG006|Overall Study|Lost to Follow-up|2|||
94346774|NCT02646891|323050805|FG007|Overall Study|Lost to Follow-up|2|||
94346775|NCT02646891|323050806|FG008|Overall Study|Lost to Follow-up|2|||
94346776|NCT02646891|323050807|FG009|Overall Study|Lost to Follow-up|2|||
94346777|NCT02646891|323050798|FG000|Overall Study|Protocol Violation|0|||
94346778|NCT02646891|323050799|FG001|Overall Study|Protocol Violation|0|||
94346779|NCT02646891|323050800|FG002|Overall Study|Protocol Violation|0|||
94346780|NCT02646891|323050801|FG003|Overall Study|Protocol Violation|0|||
94346781|NCT02646891|323050802|FG004|Overall Study|Protocol Violation|0|||
94346782|NCT02646891|323050803|FG005|Overall Study|Protocol Violation|0|||
94346783|NCT02646891|323050804|FG006|Overall Study|Protocol Violation|1|||
94346784|NCT02646891|323050805|FG007|Overall Study|Protocol Violation|1|||
94346785|NCT02646891|323050806|FG008|Overall Study|Protocol Violation|0|||
94346786|NCT02646891|323050807|FG009|Overall Study|Protocol Violation|0|||
94346787|NCT02646891|323050798|FG000|Overall Study|Withdrawal by Subject|2|||
94346788|NCT02646891|323050799|FG001|Overall Study|Withdrawal by Subject|0|||
94346789|NCT02646891|323050800|FG002|Overall Study|Withdrawal by Subject|1|||
94346790|NCT02646891|323050801|FG003|Overall Study|Withdrawal by Subject|0|||
94346791|NCT02646891|323050802|FG004|Overall Study|Withdrawal by Subject|0|||
94346792|NCT02646891|323050803|FG005|Overall Study|Withdrawal by Subject|0|||
94346793|NCT02646891|323050804|FG006|Overall Study|Withdrawal by Subject|5|||
94346794|NCT02646891|323050805|FG007|Overall Study|Withdrawal by Subject|9|||
94346795|NCT02646891|323050806|FG008|Overall Study|Withdrawal by Subject|7|||
94346796|NCT02646891|323050807|FG009|Overall Study|Withdrawal by Subject|3|||
94346797|NCT02646891|323050798|FG000|Overall Study|Death|0|||
94346798|NCT02646891|323050799|FG001|Overall Study|Death|0|||
94346799|NCT02646891|323050800|FG002|Overall Study|Death|0|||
94346800|NCT02646891|323050801|FG003|Overall Study|Death|0|||
94346801|NCT02646891|323050802|FG004|Overall Study|Death|0|||
94346802|NCT02646891|323050803|FG005|Overall Study|Death|0|||
94346803|NCT02646891|323050804|FG006|Overall Study|Death|1|||
94346804|NCT02646891|323050805|FG007|Overall Study|Death|1|||
94346805|NCT02646891|323050806|FG008|Overall Study|Death|1|||
94346806|NCT02646891|323050807|FG009|Overall Study|Death|0|||
94346807|NCT01944462|323050808|FG000|PPPP Educational Program|Lost to Follow-up|60|||
94346808|NCT00808028|323050809|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
94346809|NCT00808028|323050810|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
94346810|NCT00808028|323050811|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
94346811|NCT00808028|323050812|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
94346812|NCT00808028|323050809|FG000|Stage 1 (6 Months)|Other|1|||
94346813|NCT00808028|323050810|FG001|Stage 1 (6 Months)|Other|0|||
94346814|NCT00808028|323050811|FG002|Stage 1 (6 Months)|Other|2|||
94346815|NCT00808028|323050812|FG003|Stage 1 (6 Months)|Other|4|||
94346816|NCT00808028|323050809|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
94346817|NCT00808028|323050810|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
94346818|NCT00808028|323050811|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
94346819|NCT00808028|323050812|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
94346820|NCT00808028|323050809|FG000|Stage 1 (6 Months)|Adverse Event|0|||
94346821|NCT00808028|323050810|FG001|Stage 1 (6 Months)|Adverse Event|0|||
94346822|NCT00808028|323050811|FG002|Stage 1 (6 Months)|Adverse Event|1|||
94346823|NCT00808028|323050812|FG003|Stage 1 (6 Months)|Adverse Event|2|||
94346824|NCT00808028|323050809|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
94346825|NCT00808028|323050810|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
94346826|NCT00808028|323050811|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
94346827|NCT00808028|323050812|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
94346828|NCT00808028|323050809|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
94346829|NCT00808028|323050810|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
94346830|NCT00808028|323050811|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
94346831|NCT00808028|323050812|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
94346832|NCT00808028|323050809|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
94346833|NCT00808028|323050810|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
94346834|NCT00808028|323050811|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
94346835|NCT00808028|323050812|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
94346836|NCT00808028|323050809|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
94346837|NCT00808028|323050810|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
94346838|NCT00808028|323050811|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
94346839|NCT00808028|323050812|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
94346840|NCT00808028|323050809|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
94346841|NCT00808028|323050810|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
94346842|NCT00808028|323050811|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
94346843|NCT00808028|323050812|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
94346844|NCT00808028|323050809|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
94450504|NCT00687271|323436831|FG000|Overall Study|Adverse Event|1|||
94346845|NCT00808028|323050810|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
94450505|NCT00687271|323436832|FG001|Overall Study|Adverse Event|3|||
94346846|NCT00808028|323050811|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
94346847|NCT00808028|323050812|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
94346848|NCT00808028|323050809|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
94346849|NCT00808028|323050810|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
94346850|NCT00808028|323050811|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
94346851|NCT00808028|323050812|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
94346852|NCT00808028|323050809|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
94346853|NCT00808028|323050810|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
94346854|NCT00808028|323050811|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
94346855|NCT00808028|323050812|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
94346856|NCT00808028|323050809|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
94346857|NCT00808028|323050810|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
94346858|NCT00808028|323050811|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
94346859|NCT00808028|323050812|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
94346860|NCT00808028|323050809|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
94346861|NCT00808028|323050810|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
94346862|NCT00808028|323050811|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
94346863|NCT00808028|323050812|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
94346864|NCT00808028|323050809|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
94346865|NCT00808028|323050810|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
94346866|NCT00808028|323050811|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
94346867|NCT00808028|323050812|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
94346868|NCT01797302|323050813|FG000|Overall Study|Lost to Follow-up|16|||
94346869|NCT01797302|323050814|FG001|Overall Study|Lost to Follow-up|23|||
94346870|NCT01797302|323050815|FG002|Overall Study|Lost to Follow-up|22|||
94346871|NCT01797302|323050813|FG000|Overall Study|Withdrawal by Subject|1|||
94346872|NCT01797302|323050814|FG001|Overall Study|Withdrawal by Subject|3|||
94346873|NCT01797302|323050815|FG002|Overall Study|Withdrawal by Subject|4|||
94346874|NCT00081263|323050817|FG000|Overall Study|clerical error|1|||
94346875|NCT00081263|323050818|FG001|Overall Study|clerical error|0|||
94346876|NCT00081263|323050817|FG000|Overall Study|wrong cell type|7|||
94346877|NCT00081263|323050818|FG001|Overall Study|wrong cell type|5|||
94346878|NCT00081263|323050817|FG000|Overall Study|improper pre-protocol therapy|0|||
94346879|NCT00081263|323050818|FG001|Overall Study|improper pre-protocol therapy|1|||
94346880|NCT00081263|323050817|FG000|Overall Study|Inadequate pathology|0|||
94346881|NCT00081263|323050818|FG001|Overall Study|Inadequate pathology|1|||
94346882|NCT00081263|323050817|FG000|Overall Study|Never treated|4|||
94346883|NCT00081263|323050818|FG001|Overall Study|Never treated|5|||
94346884|NCT00081263|323050817|FG000|Overall Study|Inadequate data|5|||
94346885|NCT00081263|323050818|FG001|Overall Study|Inadequate data|10|||
94346886|NCT00106626|323050819|FG000|Overall Study|Adverse Event|5|||
94346887|NCT00106626|323050820|FG001|Overall Study|Adverse Event|4|||
94346888|NCT00106626|323050821|FG002|Overall Study|Adverse Event|3|||
94346889|NCT00106626|323050822|FG003|Overall Study|Adverse Event|3|||
94563666|NCT03777059|323859745|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
94563667|NCT03777059|323859746|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
94563668|NCT03777059|323859743|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
94563669|NCT03777059|323859744|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
94563670|NCT03777059|323859745|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
94563671|NCT03777059|323859746|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
94563672|NCT03777059|323859743|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
94563673|NCT03777059|323859744|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
94235329|NCT01165177|322656322|FG000|Overall Study|Protocol Violation|19|||
94563674|NCT03777059|323859745|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
94563675|NCT03777059|323859746|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
94563676|NCT03777059|323859743|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
94235330|NCT01165177|322656323|FG001|Overall Study|Protocol Violation|21|||
94563677|NCT03777059|323859744|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
94563678|NCT03777059|323859745|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
94563679|NCT03777059|323859746|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
94235331|NCT01165177|322656322|FG000|Overall Study|Non-serious adverse event|30|||
94235332|NCT01165177|322656323|FG001|Overall Study|Non-serious adverse event|18|||
94235333|NCT01165177|322656322|FG000|Overall Study|Other unspecified reasons|47|||
94235334|NCT01165177|322656323|FG001|Overall Study|Other unspecified reasons|35|||
94235335|NCT01165177|322656322|FG000|Overall Study|Suspected HZ episode|0|||
94235336|NCT01165177|322656323|FG001|Overall Study|Suspected HZ episode|2|||
94235337|NCT01165177|322656322|FG000|Overall Study|Lost to Follow-up|183|||
94235338|NCT01165177|322656323|FG001|Overall Study|Lost to Follow-up|194|||
94235339|NCT01165177|322656322|FG000|Overall Study|Migrated/ moved from study area|48|||
94235340|NCT01165177|322656323|FG001|Overall Study|Migrated/ moved from study area|43|||
94450506|NCT00687271|323436833|FG002|Overall Study|Adverse Event|1|||
94450507|NCT00687271|323436834|FG003|Overall Study|Adverse Event|0|||
94450508|NCT00687271|323436831|FG000|Overall Study|Lost to Follow-up|0|||
94450509|NCT00687271|323436832|FG001|Overall Study|Lost to Follow-up|1|||
94235341|NCT01663506|322656329|FG000|Overall Study|Lack of Efficacy|3|||
94235342|NCT01663506|322656329|FG000|Overall Study|Consent Withdrawal by Subject|1|||
94235343|NCT01663506|322656329|FG000|Overall Study|Lost to Follow-up|1|||
94450510|NCT00687271|323436833|FG002|Overall Study|Lost to Follow-up|0|||
94235344|NCT01663506|322656329|FG000|Overall Study|Adverse Event|1|||
94235345|NCT01663506|322656329|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
94235346|NCT02094898|322656335|FG000|Overall Study|Clinical Worsening|2|||
94235347|NCT02094898|322656335|FG000|Overall Study|Adverse Event|2|||
94235348|NCT02094898|322656335|FG000|Overall Study|Lack of Efficacy|1|||
94235349|NCT05144945|322656336|FG000|Overall Study|Withdrawal by Subject|1|||
94235350|NCT05144945|322656337|FG001|Overall Study|Withdrawal by Subject|0|||
94235351|NCT01432626|322656338|FG000|Overall Study|LV function recovered|2|||
94235352|NCT01432626|322656338|FG000|Overall Study|Withdrawal by Subject|2|||
94235353|NCT01432626|322656338|FG000|Overall Study|Only 1 image competed|2|||
94235354|NCT01432626|322656338|FG000|Overall Study|Imaging agent not available|1|||
94658100|NCT00023452|324204476|FG000|Overall Study|Withdrawal by Subject|66|||
94658101|NCT00023452|324204477|FG001|Overall Study|Withdrawal by Subject|54|||
94658102|NCT00023452|324204476|FG000|Overall Study|Adverse Event|139|||
94658103|NCT00023452|324204477|FG001|Overall Study|Adverse Event|196|||
94658104|NCT00023452|324204476|FG000|Overall Study|Lost to Follow-up|293|||
94658105|NCT00023452|324204477|FG001|Overall Study|Lost to Follow-up|60|||
94658106|NCT00023452|324204476|FG000|Overall Study|Physician Decision|49|||
94658107|NCT00023452|324204477|FG001|Overall Study|Physician Decision|21|||
94658108|NCT00023452|324204476|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
94658109|NCT00023452|324204477|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
94658110|NCT00023452|324204476|FG000|Overall Study|Pregnant|53|||
94658111|NCT00023452|324204477|FG001|Overall Study|Pregnant|20|||
94658112|NCT00023452|324204476|FG000|Overall Study|Other|204|||
94658113|NCT00023452|324204477|FG001|Overall Study|Other|69|||
94658114|NCT05789875|324204478|FG000|Overall Study|Lost to Follow-up|6|||
94658115|NCT02720484|324204483|FG000|Treatment on Study|Adverse Event|1|||
94658116|NCT02720484|324204483|FG000|Treatment on Study|Withdrawal by Subject|1|||
94658117|NCT02720484|324204483|FG000|Treatment on Study|Progressive Disease|4|||
94658118|NCT02720484|324204483|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
94658119|NCT02720484|324204483|FG000|Follow Up for 2 Years|Death|3|||
94658120|NCT02720484|324204483|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
94658121|NCT01663636|324204484|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
94658122|NCT01663636|324204485|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
94658123|NCT04095858|324204486|FG000|Overall Study|Death|1|||
94658124|NCT04095858|324204487|FG001|Overall Study|Death|0|||
94658125|NCT04095858|324204486|FG000|Overall Study|Study terminated by Sponsor|2|||
94658126|NCT04095858|324204487|FG001|Overall Study|Study terminated by Sponsor|4|||
94658127|NCT03483623|324204489|FG000|Overall Study|43 complete sets achieved|1|||
94658128|NCT01059617|324204492|FG000|Overall Study|Other|7|||
94658129|NCT01059617|324204493|FG001|Overall Study|Other|1|||
94658130|NCT01059617|324204494|FG002|Overall Study|Other|8|||
94658131|NCT01059617|324204495|FG003|Overall Study|Other|6|||
94658132|NCT01307501|324204496|FG000|Overall Study|Treatment Failure|1|||
94658133|NCT01307501|324204496|FG000|Overall Study|Death|20|||
94658134|NCT01307501|324204496|FG000|Overall Study|Lost to Follow-up|1|||
94658135|NCT01307501|324204496|FG000|Overall Study|Starting Hospice|1|||
94658136|NCT02345512|324204498|FG000|Overall Study|Adverse Event|1|||
94658137|NCT02345512|324204498|FG000|Overall Study|Withdrawal by Subject|1|||
94658138|NCT00659334|324204499|FG000|Overall Study|Screen Failure|8|||
94658139|NCT00659334|324204500|FG001|Overall Study|Screen Failure|5|||
94658140|NCT00659334|324204501|FG002|Overall Study|Screen Failure|0|||
94658141|NCT00659334|324204502|FG003|Overall Study|Screen Failure|0|||
94658142|NCT00659334|324204503|FG004|Overall Study|Screen Failure|0|||
94658143|NCT00659334|324204504|FG005|Overall Study|Screen Failure|0|||
94658144|NCT00659334|324204505|FG006|Overall Study|Screen Failure|1|||
94658145|NCT03096782|324204506|FG000|Overall Study|Death|1|||
94658146|NCT03096782|324204506|FG000|Overall Study|Participant Relapsed|1|||
94658147|NCT03662750|324204507|FG000|Overall Study|Withdrawal by Subject|1|||
94658148|NCT03823651|324204509|FG000|Overall Study|Death|5|||
94658149|NCT03823651|324204510|FG001|Overall Study|Death|0|||
94658150|NCT03823651|324204509|FG000|Overall Study|Physician Decision|1|||
94658151|NCT03823651|324204510|FG001|Overall Study|Physician Decision|0|||
94658152|NCT03823651|324204509|FG000|Overall Study|Caregiver to patient who died|0|||
94658153|NCT03823651|324204510|FG001|Overall Study|Caregiver to patient who died|5|||
94658154|NCT03823651|324204509|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
94658155|NCT03823651|324204510|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
94658156|NCT03864614|324204511|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
94658157|NCT03864614|324204512|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
94658158|NCT03864614|324204513|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
94658159|NCT03864614|324204514|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
94658160|NCT03864614|324204511|FG000|Overall Study|Withdrawal by Subject|72|||
94658161|NCT03864614|324204512|FG001|Overall Study|Withdrawal by Subject|100|||
94658162|NCT03864614|324204513|FG002|Overall Study|Withdrawal by Subject|1|||
94658163|NCT03864614|324204514|FG003|Overall Study|Withdrawal by Subject|21|||
94658164|NCT03864614|324204511|FG000|Overall Study|Lost to Follow-up|45|||
94658165|NCT03864614|324204512|FG001|Overall Study|Lost to Follow-up|54|||
94235355|NCT05382039|322656339|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
94235356|NCT05382039|322656340|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
94235357|NCT05382039|322656341|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
94235358|NCT05382039|322656339|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
94235359|NCT05382039|322656340|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
94235360|NCT05382039|322656341|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
94235361|NCT05382039|322656339|FG000|Overall Study|waiting for confirmation|0|||
94235362|NCT05382039|322656340|FG001|Overall Study|waiting for confirmation|0|||
94235363|NCT05382039|322656341|FG002|Overall Study|waiting for confirmation|1|||
94235364|NCT00328562|322656342|FG000|Overall Study|Disease progression|1|||
94235365|NCT00810342|322656343|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
94235366|NCT00810342|322656344|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
94235367|NCT00810342|322656343|FG000|Month 1 Follow-up|Pregnancy|1|||
94235368|NCT00810342|322656344|FG001|Month 1 Follow-up|Pregnancy|0|||
94235369|NCT00810342|322656343|FG000|6-month Follow-up|Lost to Follow-up|18|||
94235370|NCT00810342|322656344|FG001|6-month Follow-up|Lost to Follow-up|6|||
94235371|NCT00810342|322656343|FG000|6-month Follow-up|Pregnancy|6|||
94235372|NCT00810342|322656344|FG001|6-month Follow-up|Pregnancy|2|||
94235373|NCT00810342|322656343|FG000|12-month Followup|Pregnancy|9|||
94235374|NCT00810342|322656344|FG001|12-month Followup|Pregnancy|10|||
94235375|NCT00810342|322656343|FG000|12-month Followup|Lost to Follow-up|3|||
94235376|NCT00810342|322656344|FG001|12-month Followup|Lost to Follow-up|1|||
94235377|NCT02536742|322656346|FG000|Overall Study|Did not start protocol therapy|1|||
94235378|NCT02536742|322656346|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
94235379|NCT01513330|322656347|FG000|SenSura Mio First,|Adverse Event|2|||
94235380|NCT01513330|322656348|FG001|SenSura Mio First,|Adverse Event|0|||
94235381|NCT01513330|322656347|FG000|SenSura Mio First,|Lack of Efficacy|0|||
94235382|NCT01513330|322656348|FG001|SenSura Mio First,|Lack of Efficacy|1|||
94235383|NCT01513330|322656347|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
94235384|NCT01513330|322656348|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
94235385|NCT01513330|322656347|FG000|SenSura Mio First,|Other|1|||
94235386|NCT01513330|322656348|FG001|SenSura Mio First,|Other|0|||
94235387|NCT01513330|322656347|FG000|Standard Care First,|Lack of Efficacy|2|||
94235388|NCT01513330|322656348|FG001|Standard Care First,|Lack of Efficacy|2|||
94235389|NCT01513330|322656347|FG000|Standard Care First,|Withdrawal by Subject|1|||
94235390|NCT01513330|322656348|FG001|Standard Care First,|Withdrawal by Subject|2|||
94235391|NCT01513330|322656347|FG000|Standard Care First,|Other|1|||
94235392|NCT01513330|322656348|FG001|Standard Care First,|Other|0|||
94235393|NCT01677299|322656349|FG000|Overall Study|Adverse Event|0|||
94235394|NCT01677299|322656350|FG001|Overall Study|Adverse Event|2|||
94235395|NCT01677299|322656351|FG002|Overall Study|Adverse Event|1|||
94235396|NCT01677299|322656352|FG003|Overall Study|Adverse Event|0|||
94235397|NCT01677299|322656349|FG000|Overall Study|Withdrawal by Subject|0|||
94235398|NCT01677299|322656350|FG001|Overall Study|Withdrawal by Subject|1|||
94235399|NCT01677299|322656351|FG002|Overall Study|Withdrawal by Subject|0|||
94235400|NCT01677299|322656352|FG003|Overall Study|Withdrawal by Subject|1|||
94235401|NCT02367352|322656361|FG000|Overall Study|Progressive disease|7|||
94235402|NCT02367352|322656362|FG001|Overall Study|Progressive disease|0|||
94235403|NCT02367352|322656363|FG002|Overall Study|Progressive disease|0|||
94235404|NCT02367352|322656361|FG000|Overall Study|Participant Received Alternative Therapy|1|||
94235405|NCT02367352|322656362|FG001|Overall Study|Participant Received Alternative Therapy|0|||
94235406|NCT02367352|322656363|FG002|Overall Study|Participant Received Alternative Therapy|0|||
94235407|NCT02367352|322656361|FG000|Overall Study|Adverse Event|1|||
94235408|NCT02367352|322656362|FG001|Overall Study|Adverse Event|0|||
94235409|NCT02367352|322656363|FG002|Overall Study|Adverse Event|0|||
94235410|NCT00174447|322656364|FG000|Overall Study|Adverse Event|19|||
94235411|NCT00174447|322656364|FG000|Overall Study|Withdrawal by Subject|15|||
94235412|NCT00174447|322656364|FG000|Overall Study|Protocol Violation|1|||
94235413|NCT00174447|322656364|FG000|Overall Study|Lack of Efficacy|1|||
94235414|NCT00174447|322656364|FG000|Overall Study|Administrative reason/Other|2|||
94235415|NCT01437423|322656365|FG000|Overall Study|Lost to Follow-up|12|||
94235416|NCT01437423|322656365|FG000|Overall Study|Off label usage|3|||
94235417|NCT02229578|322656370|FG000|Overall Study|Withdrawal by Subject|1|||
94235418|NCT02229578|322656371|FG001|Overall Study|Withdrawal by Subject|3|||
94235419|NCT02229578|322656370|FG000|Overall Study|Protocol Violation|2|||
94235420|NCT02229578|322656371|FG001|Overall Study|Protocol Violation|0|||
94235421|NCT00943787|322656372|FG000|Overall Study|Physician Decision|4|||
94235422|NCT00943787|322656372|FG000|Overall Study|Withdrawal by Subject|3|||
94235423|NCT00490945|322656374|FG000|Overall Study|Adverse Event|0|||
94235424|NCT00490945|322656375|FG001|Overall Study|Adverse Event|1|||
94235425|NCT00490945|322656376|FG002|Overall Study|Adverse Event|0|||
94235426|NCT00490945|322656377|FG003|Overall Study|Adverse Event|0|||
94235427|NCT00490945|322656378|FG004|Overall Study|Adverse Event|0|||
94235428|NCT01288209|322656379|FG000|Overall Study|Withdrawal by Subject|1|||
94235429|NCT01288209|322656380|FG001|Overall Study|Withdrawal by Subject|3|||
94235430|NCT01288209|322656379|FG000|Overall Study|Other|1|||
94235431|NCT01288209|322656380|FG001|Overall Study|Other|0|||
94346890|NCT00106626|323050819|FG000|Overall Study|Progressive Disease|4|||
94563680|NCT01101035|323859753|FG000|Overall Study|Adverse Event|191|||
94563681|NCT01101035|323859754|FG001|Overall Study|Adverse Event|172|||
94563682|NCT01101035|323859753|FG000|Overall Study|Major Protocol Deviation|52|||
94563683|NCT01101035|323859754|FG001|Overall Study|Major Protocol Deviation|46|||
94563684|NCT01101035|323859753|FG000|Overall Study|Lost to Follow-up|226|||
94563685|NCT01101035|323859754|FG001|Overall Study|Lost to Follow-up|223|||
94563686|NCT01101035|323859753|FG000|Overall Study|Voluntary Withdrawal|595|||
94563687|NCT01101035|323859754|FG001|Overall Study|Voluntary Withdrawal|587|||
94563688|NCT01101035|323859753|FG000|Overall Study|Reason not Specified|333|||
94563689|NCT01101035|323859754|FG001|Overall Study|Reason not Specified|363|||
94563690|NCT00411671|323859762|FG000|Overall Study|Adverse Event|15|||
94563691|NCT00411671|323859762|FG000|Overall Study|Death|2|||
94563692|NCT00411671|323859762|FG000|Overall Study|Lost to Follow-up|3|||
94563693|NCT01173601|323859763|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
94563694|NCT01173601|323859764|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
94563695|NCT01173601|323859765|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
94563696|NCT01173601|323859766|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
94563697|NCT01173601|323859767|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
94563698|NCT01173601|323859763|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
94563699|NCT01173601|323859764|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
94563700|NCT01173601|323859765|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
94563701|NCT01173601|323859766|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
94563702|NCT01173601|323859767|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
94563703|NCT01173601|323859763|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
94563704|NCT01173601|323859764|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
94563705|NCT01173601|323859765|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
94563706|NCT01173601|323859766|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
94658166|NCT03864614|324204513|FG002|Overall Study|Lost to Follow-up|0|||
94658167|NCT03864614|324204514|FG003|Overall Study|Lost to Follow-up|9|||
94658168|NCT03864614|324204511|FG000|Overall Study|Adverse Event|42|||
94658169|NCT03864614|324204512|FG001|Overall Study|Adverse Event|30|||
94658170|NCT03864614|324204513|FG002|Overall Study|Adverse Event|1|||
94658171|NCT03864614|324204514|FG003|Overall Study|Adverse Event|9|||
94658172|NCT03864614|324204511|FG000|Overall Study|Protocol Deviation|6|||
94658173|NCT03864614|324204512|FG001|Overall Study|Protocol Deviation|26|||
94658174|NCT03864614|324204513|FG002|Overall Study|Protocol Deviation|0|||
94658175|NCT03864614|324204514|FG003|Overall Study|Protocol Deviation|1|||
94658176|NCT03864614|324204511|FG000|Overall Study|Physician Decision|7|||
94563707|NCT01173601|323859767|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
94563708|NCT01173601|323859763|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
94563709|NCT01173601|323859764|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
94563710|NCT01173601|323859765|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
94563711|NCT01173601|323859766|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
94563712|NCT01173601|323859767|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
94658177|NCT03864614|324204512|FG001|Overall Study|Physician Decision|10|||
94658178|NCT03864614|324204513|FG002|Overall Study|Physician Decision|1|||
94658179|NCT03864614|324204514|FG003|Overall Study|Physician Decision|5|||
94563713|NCT01173601|323859763|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
94563714|NCT01173601|323859764|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
94563715|NCT01173601|323859765|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
94563716|NCT01173601|323859766|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
94563717|NCT01173601|323859767|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
94563718|NCT01173601|323859763|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
94563719|NCT01173601|323859764|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
94563720|NCT01173601|323859765|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
94563721|NCT01173601|323859766|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
94235432|NCT02229227|322656385|FG000|Overall Study|Adverse Event|14|||
94563722|NCT01173601|323859767|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
94563723|NCT01173601|323859763|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
94658180|NCT03864614|324204511|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
94658181|NCT03864614|324204512|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
94658182|NCT03864614|324204513|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
94658183|NCT03864614|324204514|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
94658184|NCT03864614|324204511|FG000|Overall Study|Sponsor Decision|1|||
94658185|NCT03864614|324204512|FG001|Overall Study|Sponsor Decision|2|||
94658186|NCT03864614|324204513|FG002|Overall Study|Sponsor Decision|0|||
94658187|NCT03864614|324204514|FG003|Overall Study|Sponsor Decision|0|||
94658188|NCT03864614|324204511|FG000|Overall Study|Pregnancy|0|||
94658189|NCT03864614|324204512|FG001|Overall Study|Pregnancy|1|||
94658190|NCT03864614|324204513|FG002|Overall Study|Pregnancy|0|||
94658191|NCT03864614|324204514|FG003|Overall Study|Pregnancy|0|||
94658192|NCT03864614|324204511|FG000|Overall Study|Other|7|||
94658193|NCT03864614|324204512|FG001|Overall Study|Other|9|||
94658194|NCT03864614|324204513|FG002|Overall Study|Other|1|||
94658195|NCT03864614|324204514|FG003|Overall Study|Other|4|||
94658196|NCT03864614|324204511|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
94346891|NCT00106626|323050820|FG001|Overall Study|Progressive Disease|1|||
94346892|NCT00106626|323050821|FG002|Overall Study|Progressive Disease|9|||
94346893|NCT00106626|323050822|FG003|Overall Study|Progressive Disease|10|||
94346894|NCT00106626|323050819|FG000|Overall Study|Received radiation on new therapy|1|||
94346895|NCT00106626|323050820|FG001|Overall Study|Received radiation on new therapy|0|||
94346896|NCT00106626|323050821|FG002|Overall Study|Received radiation on new therapy|0|||
94346897|NCT00106626|323050822|FG003|Overall Study|Received radiation on new therapy|0|||
94346898|NCT00106626|323050819|FG000|Overall Study|> 14 day delay in therapy start|0|||
94346899|NCT00106626|323050820|FG001|Overall Study|> 14 day delay in therapy start|1|||
94346900|NCT00106626|323050821|FG002|Overall Study|> 14 day delay in therapy start|0|||
94346901|NCT00106626|323050822|FG003|Overall Study|> 14 day delay in therapy start|0|||
94346902|NCT02870348|323050823|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
94346903|NCT02176226|323050824|FG000|Overall Study|Lost to Follow-up|3|||
94346904|NCT02176226|323050824|FG000|Overall Study|Withdrew prior to treatment|6|||
94346905|NCT01072500|323050827|FG000|Overall Study|Death|2|||
94346906|NCT01072500|323050828|FG001|Overall Study|Death|2|||
94346907|NCT01072500|323050827|FG000|Overall Study|Lost to Follow-up|5|||
94346908|NCT01072500|323050828|FG001|Overall Study|Lost to Follow-up|2|||
94346909|NCT01072500|323050827|FG000|Overall Study|Withdrawal by Subject|17|||
94346910|NCT01072500|323050828|FG001|Overall Study|Withdrawal by Subject|10|||
94346911|NCT00103207|323050829|FG000|Overall Study|Adverse Event|3|||
94346912|NCT00103207|323050829|FG000|Overall Study|Death|1|||
94346913|NCT00103207|323050829|FG000|Overall Study|Withdrawal by Subject|2|||
94346914|NCT00103207|323050829|FG000|Overall Study|Other complicating disease|1|||
94346915|NCT00103207|323050829|FG000|Overall Study|Ineligible|4|||
94346916|NCT00103207|323050829|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
94346917|NCT03798366|323050830|FG000|Overall Study|Lost to Follow-up|0|||
94346918|NCT03798366|323050831|FG001|Overall Study|Lost to Follow-up|1|||
94346919|NCT04005885|323050833|FG000|First Intervention|Withdrawal by Subject|1|||
94346920|NCT04005885|323050834|FG001|First Intervention|Withdrawal by Subject|1|||
94346921|NCT04005885|323050833|FG000|Second Intervention|Withdrawal by Subject|0|||
94658197|NCT03864614|324204512|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
94346922|NCT04005885|323050834|FG001|Second Intervention|Withdrawal by Subject|2|||
94346923|NCT00638989|323050836|FG000|Overall Study|Lost to Follow-up|0|||
94346924|NCT00638989|323050837|FG001|Overall Study|Lost to Follow-up|0|||
94658198|NCT03864614|324204513|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
94658199|NCT03864614|324204514|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
94346925|NCT00638989|323050838|FG002|Overall Study|Lost to Follow-up|1|||
94346926|NCT01642004|323050848|FG000|Randomization|Adverse Event unrelated to study drug|1|||
94346927|NCT01642004|323050849|FG001|Randomization|Adverse Event unrelated to study drug|0|||
94346928|NCT01642004|323050848|FG000|Randomization|Participant withdrew consent|1|||
94235433|NCT02229227|322656386|FG001|Overall Study|Adverse Event|9|||
94346929|NCT01642004|323050849|FG001|Randomization|Participant withdrew consent|6|||
94346930|NCT01642004|323050848|FG000|Randomization|No longer meets study criteria|2|||
94658200|NCT00608829|324206118|FG000|Overall Study|Death|6|||
94235434|NCT02229227|322656385|FG000|Overall Study|Lack of Efficacy|3|||
94235435|NCT02229227|322656386|FG001|Overall Study|Lack of Efficacy|3|||
94235436|NCT02229227|322656385|FG000|Overall Study|Protocol Violation|6|||
94235437|NCT02229227|322656386|FG001|Overall Study|Protocol Violation|8|||
94235438|NCT02229227|322656385|FG000|Overall Study|Protocol defined stopping criteria|1|||
94235439|NCT02229227|322656386|FG001|Overall Study|Protocol defined stopping criteria|3|||
94235440|NCT02229227|322656385|FG000|Overall Study|Lost to Follow-up|3|||
94235441|NCT02229227|322656386|FG001|Overall Study|Lost to Follow-up|3|||
94235442|NCT02229227|322656385|FG000|Overall Study|Study terminated by sponsor|11|||
94235443|NCT02229227|322656386|FG001|Overall Study|Study terminated by sponsor|11|||
94235444|NCT02229227|322656385|FG000|Overall Study|Withdrawal by Subject|8|||
94235445|NCT02229227|322656386|FG001|Overall Study|Withdrawal by Subject|12|||
94235446|NCT02229227|322656385|FG000|Overall Study|Other|0|||
94235447|NCT02229227|322656386|FG001|Overall Study|Other|1|||
94235448|NCT02229227|322656385|FG000|Overall Study|Physician Decision|5|||
94235449|NCT02229227|322656386|FG001|Overall Study|Physician Decision|12|||
94235450|NCT00872001|322656387|FG000|Overall Study|Adverse Event|34|||
94235451|NCT00872001|322656388|FG001|Overall Study|Adverse Event|23|||
94450511|NCT00687271|323436834|FG003|Overall Study|Lost to Follow-up|0|||
94346931|NCT01642004|323050849|FG001|Randomization|No longer meets study criteria|2|||
94235452|NCT00872001|322656387|FG000|Overall Study|Protocol Defined Clinical Event|5|||
94235453|NCT00872001|322656388|FG001|Overall Study|Protocol Defined Clinical Event|7|||
94235454|NCT00872001|322656387|FG000|Overall Study|Lost to Follow-up|13|||
94235455|NCT00872001|322656388|FG001|Overall Study|Lost to Follow-up|12|||
94235456|NCT00872001|322656387|FG000|Overall Study|Withdrawal by Subject|18|||
94235457|NCT00872001|322656388|FG001|Overall Study|Withdrawal by Subject|30|||
94235458|NCT00872001|322656387|FG000|Overall Study|Protocol Violation|5|||
94235459|NCT00872001|322656388|FG001|Overall Study|Protocol Violation|8|||
94235460|NCT00872001|322656387|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
94235461|NCT00872001|322656388|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
94235462|NCT00872001|322656387|FG000|Overall Study|Administrative|23|||
94235463|NCT00872001|322656388|FG001|Overall Study|Administrative|15|||
94235464|NCT04468230|322656399|FG000|Overall Study|Adverse Event|2|||
94235465|NCT00983853|322656411|FG000|Overall Study|Lost to Follow-up|1|||
94235466|NCT00983853|322656412|FG001|Overall Study|Lost to Follow-up|1|||
94235467|NCT00983853|322656413|FG002|Overall Study|Lost to Follow-up|2|||
94235468|NCT00983853|322656414|FG003|Overall Study|Lost to Follow-up|2|||
94235469|NCT00983853|322656415|FG004|Overall Study|Lost to Follow-up|2|||
94235470|NCT00983853|322656416|FG005|Overall Study|Lost to Follow-up|1|||
94235471|NCT00983853|322656411|FG000|Overall Study|Withdrawal by Subject|0|||
94235472|NCT00983853|322656412|FG001|Overall Study|Withdrawal by Subject|0|||
94235473|NCT00983853|322656413|FG002|Overall Study|Withdrawal by Subject|1|||
94235474|NCT00983853|322656414|FG003|Overall Study|Withdrawal by Subject|0|||
94235475|NCT00983853|322656415|FG004|Overall Study|Withdrawal by Subject|1|||
94235476|NCT00983853|322656416|FG005|Overall Study|Withdrawal by Subject|0|||
94235477|NCT00983853|322656411|FG000|Overall Study|Unable to come to study follow-up visits|0|||
94235478|NCT00983853|322656412|FG001|Overall Study|Unable to come to study follow-up visits|1|||
94235479|NCT00983853|322656413|FG002|Overall Study|Unable to come to study follow-up visits|0|||
94235480|NCT00983853|322656414|FG003|Overall Study|Unable to come to study follow-up visits|0|||
94235481|NCT00983853|322656415|FG004|Overall Study|Unable to come to study follow-up visits|0|||
94235482|NCT00983853|322656416|FG005|Overall Study|Unable to come to study follow-up visits|0|||
94235483|NCT01777490|322656422|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
94235484|NCT01777490|322656423|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
94235485|NCT01777490|322656424|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
94235486|NCT01777490|322656425|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
94235487|NCT00443209|322656426|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
94235488|NCT00443209|322656427|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
94235489|NCT00443209|322656426|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
94235490|NCT00443209|322656427|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
94235491|NCT00443209|322656426|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
94235492|NCT00443209|322656427|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
94235493|NCT00443209|322656426|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
94235494|NCT00443209|322656427|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
94235495|NCT00443209|322656426|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
94235496|NCT00443209|322656427|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
94235497|NCT00443209|322656426|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
94235498|NCT00443209|322656427|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
94235499|NCT00443209|322656426|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
94235500|NCT00443209|322656427|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
94563724|NCT01173601|323859764|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
94235501|NCT00443209|322656426|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
94235502|NCT00443209|322656427|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
94346932|NCT01642004|323050848|FG000|Treatment|Disease progression|95|||
94346933|NCT01642004|323050849|FG001|Treatment|Disease progression|79|||
94346934|NCT01642004|323050848|FG000|Treatment|Study drug toxicity|10|||
94346935|NCT01642004|323050849|FG001|Treatment|Study drug toxicity|13|||
94346936|NCT01642004|323050848|FG000|Treatment|Death|1|||
94346937|NCT01642004|323050849|FG001|Treatment|Death|1|||
94346938|NCT01642004|323050848|FG000|Treatment|Adverse event unrelated to study drug|9|||
94346939|NCT01642004|323050849|FG001|Treatment|Adverse event unrelated to study drug|13|||
94346940|NCT01642004|323050848|FG000|Treatment|Maximum clinical benefit|1|||
94346941|NCT01642004|323050849|FG001|Treatment|Maximum clinical benefit|9|||
94346942|NCT01642004|323050848|FG000|Treatment|Poor/non-compliance|1|||
94346943|NCT01642004|323050849|FG001|Treatment|Poor/non-compliance|0|||
94346944|NCT01642004|323050848|FG000|Treatment|No longer meets study criteria|1|||
94346945|NCT01642004|323050849|FG001|Treatment|No longer meets study criteria|2|||
94346946|NCT01642004|323050848|FG000|Treatment|Other reasons|2|||
94346947|NCT01642004|323050849|FG001|Treatment|Other reasons|0|||
94346948|NCT01642004|323050848|FG000|Treatment|Not reported|0|||
94346949|NCT01642004|323050849|FG001|Treatment|Not reported|3|||
94346950|NCT01642004|323050848|FG000|Treatment|Participant request to discontinue study treatment|6|||
94346951|NCT01642004|323050849|FG001|Treatment|Participant request to discontinue study treatment|4|||
94346952|NCT01642004|323050848|FG000|Treatment|Participant withdrew consent|5|||
94346953|NCT01642004|323050849|FG001|Treatment|Participant withdrew consent|5|||
94346954|NCT00811395|323050850|FG000|Extension Treatment|Adverse Event|1|||
94346955|NCT00811395|323050851|FG001|Extension Treatment|Adverse Event|2|||
94346956|NCT00811395|323050852|FG002|Extension Treatment|Adverse Event|2|||
94346957|NCT00811395|323050853|FG003|Extension Treatment|Adverse Event|2|||
94346958|NCT00811395|323050854|FG004|Extension Treatment|Adverse Event|0|||
94346959|NCT00811395|323050855|FG005|Extension Treatment|Adverse Event|1|||
94346960|NCT00811395|323050850|FG000|Extension Treatment|Progressive disease|1|||
94346961|NCT00811395|323050851|FG001|Extension Treatment|Progressive disease|1|||
94346962|NCT00811395|323050852|FG002|Extension Treatment|Progressive disease|0|||
94346963|NCT00811395|323050853|FG003|Extension Treatment|Progressive disease|0|||
94346964|NCT00811395|323050854|FG004|Extension Treatment|Progressive disease|0|||
94346965|NCT00811395|323050855|FG005|Extension Treatment|Progressive disease|0|||
94346966|NCT00811395|323050850|FG000|Extension Treatment|Participant did not wish to continue|0|||
94346967|NCT00811395|323050851|FG001|Extension Treatment|Participant did not wish to continue|3|||
94346968|NCT00811395|323050852|FG002|Extension Treatment|Participant did not wish to continue|0|||
94346969|NCT00811395|323050853|FG003|Extension Treatment|Participant did not wish to continue|1|||
94346970|NCT00811395|323050854|FG004|Extension Treatment|Participant did not wish to continue|0|||
94346971|NCT00811395|323050855|FG005|Extension Treatment|Participant did not wish to continue|1|||
94658201|NCT00608829|324206118|FG000|Overall Study|Withdrawal by Subject|4|||
94235503|NCT00443209|322656426|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
94235504|NCT00443209|322656427|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
94563725|NCT01173601|323859765|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
94563726|NCT01173601|323859766|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
94235505|NCT00443209|322656426|FG000|Months 1 to 12 Treatment Period|Missing|2|||
94235506|NCT00443209|322656427|FG001|Months 1 to 12 Treatment Period|Missing|1|||
94235507|NCT00443209|322656426|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
94235508|NCT00443209|322656427|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
94235509|NCT00443209|322656426|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
94235510|NCT00443209|322656427|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
94235511|NCT00443209|322656426|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
94235512|NCT00443209|322656427|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
94235513|NCT00443209|322656426|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
94235514|NCT00443209|322656427|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
94235515|NCT00443209|322656426|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
94235516|NCT00443209|322656427|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
94235517|NCT00443209|322656426|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
94235518|NCT00443209|322656427|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
94235519|NCT00443209|322656426|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
94235520|NCT00443209|322656427|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
94235521|NCT02196077|322656428|FG000|Overall Study|Adverse Event|4|||
94235522|NCT02196077|322656428|FG000|Overall Study|Lack of Efficacy|1|||
94235523|NCT02196077|322656428|FG000|Overall Study|Withdrawal by Subject|14|||
94235524|NCT02196077|322656428|FG000|Overall Study|Physician Decision|1|||
94235525|NCT02196077|322656428|FG000|Overall Study|Lost to Follow-up|3|||
94235526|NCT02196077|322656428|FG000|Overall Study|Protocol Violation|24|||
94235527|NCT01825577|322656443|FG000|Overall Study|Physician Decision|2|||
94235528|NCT01825577|322656443|FG000|Overall Study|Withdrawal by Subject|1|||
94235529|NCT01825577|322656443|FG000|Overall Study|Withdrawn by family members|2|||
94235530|NCT01825577|322656443|FG000|Overall Study|Lack of Efficacy|3|||
94235531|NCT00307047|322657924|FG000|Overall Study|Lost to Follow-up|35|||
94563727|NCT01173601|323859767|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
94563728|NCT01173601|323859763|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
94235532|NCT00307047|322657925|FG001|Overall Study|Lost to Follow-up|24|||
94235533|NCT00307047|322657924|FG000|Overall Study|Withdrawal by Subject|6|||
94235534|NCT00307047|322657925|FG001|Overall Study|Withdrawal by Subject|6|||
94235535|NCT00307047|322657924|FG000|Overall Study|Physician Decision|1|||
94563729|NCT01173601|323859764|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
94563730|NCT01173601|323859765|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
94346972|NCT00811395|323050850|FG000|Extension Treatment|Other than above|0|||
94658202|NCT00608829|324206118|FG000|Overall Study|Subject refuses to follow up or return.|5|||
94658203|NCT02343458|324206119|FG000|Overall Study|Adverse Event|15|||
94658204|NCT02343458|324206120|FG001|Overall Study|Adverse Event|14|||
94658205|NCT02343458|324206121|FG002|Overall Study|Adverse Event|15|||
94658206|NCT02343458|324206122|FG003|Overall Study|Adverse Event|3|||
94658207|NCT02343458|324206119|FG000|Overall Study|Lack of Efficacy|3|||
94658208|NCT02343458|324206120|FG001|Overall Study|Lack of Efficacy|8|||
94658209|NCT02343458|324206121|FG002|Overall Study|Lack of Efficacy|4|||
94658210|NCT02343458|324206122|FG003|Overall Study|Lack of Efficacy|8|||
94658211|NCT02343458|324206119|FG000|Overall Study|Withdrawal by Subject|18|||
94658212|NCT02343458|324206120|FG001|Overall Study|Withdrawal by Subject|17|||
94658213|NCT02343458|324206121|FG002|Overall Study|Withdrawal by Subject|23|||
94658214|NCT02343458|324206122|FG003|Overall Study|Withdrawal by Subject|14|||
94658215|NCT02343458|324206119|FG000|Overall Study|Physician Decision|1|||
94658216|NCT02343458|324206120|FG001|Overall Study|Physician Decision|4|||
94658217|NCT02343458|324206121|FG002|Overall Study|Physician Decision|2|||
94658218|NCT02343458|324206122|FG003|Overall Study|Physician Decision|2|||
94658219|NCT02343458|324206119|FG000|Overall Study|Lost to Follow-up|5|||
94658220|NCT02343458|324206120|FG001|Overall Study|Lost to Follow-up|5|||
94658221|NCT02343458|324206121|FG002|Overall Study|Lost to Follow-up|3|||
94658222|NCT02343458|324206122|FG003|Overall Study|Lost to Follow-up|1|||
94658223|NCT02343458|324206119|FG000|Overall Study|Protocol Violation|2|||
94658224|NCT02343458|324206120|FG001|Overall Study|Protocol Violation|5|||
94658225|NCT02343458|324206121|FG002|Overall Study|Protocol Violation|2|||
94658226|NCT02343458|324206122|FG003|Overall Study|Protocol Violation|2|||
94658227|NCT02343458|324206119|FG000|Overall Study|Protocol Specified Criteria|17|||
94658228|NCT02343458|324206120|FG001|Overall Study|Protocol Specified Criteria|13|||
94658229|NCT02343458|324206121|FG002|Overall Study|Protocol Specified Criteria|14|||
94658230|NCT02343458|324206122|FG003|Overall Study|Protocol Specified Criteria|8|||
94450512|NCT00687271|323436831|FG000|Overall Study|Protocol Violation|2|||
94450513|NCT00687271|323436832|FG001|Overall Study|Protocol Violation|1|||
94450514|NCT00687271|323436833|FG002|Overall Study|Protocol Violation|1|||
94450515|NCT00687271|323436834|FG003|Overall Study|Protocol Violation|0|||
94450516|NCT00687271|323436831|FG000|Overall Study|Withdrawal by Subject|0|||
94450517|NCT00687271|323436832|FG001|Overall Study|Withdrawal by Subject|1|||
94450518|NCT00687271|323436833|FG002|Overall Study|Withdrawal by Subject|3|||
94563731|NCT01173601|323859766|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
94450519|NCT00687271|323436834|FG003|Overall Study|Withdrawal by Subject|0|||
94563732|NCT01173601|323859767|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
94563733|NCT01173601|323859763|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
94563734|NCT01173601|323859764|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
94563735|NCT01173601|323859765|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
94563736|NCT01173601|323859766|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
94563737|NCT01173601|323859767|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
94563738|NCT01173601|323859763|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
94563739|NCT01173601|323859764|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
94563740|NCT01173601|323859765|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
94563741|NCT01173601|323859766|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
94563742|NCT01173601|323859767|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
94563743|NCT01173601|323859763|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
94563744|NCT01173601|323859764|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
94563745|NCT01173601|323859765|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
94563746|NCT01173601|323859766|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
94563747|NCT01173601|323859767|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
94563748|NCT01173601|323859763|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
94563749|NCT01173601|323859764|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
94563750|NCT01173601|323859765|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
94563751|NCT01173601|323859766|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
94563752|NCT01173601|323859767|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
94563753|NCT01173601|323859763|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
94563754|NCT01173601|323859764|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
94563755|NCT01173601|323859765|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
94563756|NCT01173601|323859766|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
94563757|NCT01173601|323859767|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
94563758|NCT01173601|323859763|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
94563759|NCT01173601|323859764|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
94563760|NCT01173601|323859765|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
94563761|NCT01173601|323859766|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
94563762|NCT01173601|323859767|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
94563763|NCT03951077|323859771|FG000|Overall Study|Adverse Event|1|||
94563764|NCT03951077|323859772|FG001|Overall Study|Adverse Event|0|||
94563765|NCT03951077|323859773|FG002|Overall Study|Adverse Event|0|||
94235536|NCT00307047|322657925|FG001|Overall Study|Physician Decision|2|||
94235537|NCT00307047|322657924|FG000|Overall Study|Lost to follow-up for other reasons|0|||
94235538|NCT00307047|322657925|FG001|Overall Study|Lost to follow-up for other reasons|1|||
94235539|NCT00307047|322657924|FG000|Overall Study|All death, all MI, all Revascularization|27|||
94235540|NCT00307047|322657925|FG001|Overall Study|All death, all MI, all Revascularization|16|||
94235541|NCT00321685|322657926|FG000|Overall Study|Adverse Event|18|||
94235542|NCT00321685|322657926|FG000|Overall Study|Death|2|||
94235543|NCT00321685|322657926|FG000|Overall Study|Withdrawal by Subject|8|||
94235544|NCT00321685|322657926|FG000|Overall Study|Alternative therapy|1|||
94235545|NCT00321685|322657926|FG000|Overall Study|Complicating disese|1|||
94235546|NCT00321685|322657926|FG000|Overall Study|Other|5|||
94235547|NCT00321685|322657926|FG000|Overall Study|Not start protocol therapy|2|||
94235548|NCT00321685|322657926|FG000|Overall Study|Ineligible|2|||
94235549|NCT01053247|322657930|FG000|Overall Study|Withdrawal by Subject|9|||
94235550|NCT01053247|322657931|FG001|Overall Study|Withdrawal by Subject|4|||
94235551|NCT01053247|322657932|FG002|Overall Study|Withdrawal by Subject|15|||
94235552|NCT01053247|322657930|FG000|Overall Study|Lack of Efficacy|1|||
94563766|NCT03951077|323859774|FG003|Overall Study|Adverse Event|0|||
94563767|NCT03951077|323859775|FG004|Overall Study|Adverse Event|0|||
94563768|NCT03951077|323859776|FG005|Overall Study|Adverse Event|0|||
94563769|NCT03951077|323859771|FG000|Overall Study|Withdrawal by Subject|3|||
94563770|NCT03951077|323859772|FG001|Overall Study|Withdrawal by Subject|3|||
94563771|NCT03951077|323859773|FG002|Overall Study|Withdrawal by Subject|0|||
94563772|NCT03951077|323859774|FG003|Overall Study|Withdrawal by Subject|3|||
94563773|NCT03951077|323859775|FG004|Overall Study|Withdrawal by Subject|3|||
94563774|NCT03951077|323859776|FG005|Overall Study|Withdrawal by Subject|2|||
94563775|NCT03951077|323859771|FG000|Overall Study|Lost to Follow-up|1|||
94563776|NCT03951077|323859772|FG001|Overall Study|Lost to Follow-up|1|||
94563777|NCT03951077|323859773|FG002|Overall Study|Lost to Follow-up|2|||
94563778|NCT03951077|323859774|FG003|Overall Study|Lost to Follow-up|3|||
94563779|NCT03951077|323859775|FG004|Overall Study|Lost to Follow-up|2|||
94563780|NCT03951077|323859776|FG005|Overall Study|Lost to Follow-up|3|||
94563781|NCT03951077|323859771|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
94563782|NCT03951077|323859772|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
94563783|NCT03951077|323859773|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
94563784|NCT03951077|323859774|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
94563785|NCT03951077|323859775|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
94346973|NCT00811395|323050851|FG001|Extension Treatment|Other than above|0|||
94563786|NCT03951077|323859776|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
94563787|NCT03951077|323859771|FG000|Overall Study|Other, Not Specified|12|||
94563788|NCT03951077|323859772|FG001|Overall Study|Other, Not Specified|10|||
94563789|NCT03951077|323859773|FG002|Overall Study|Other, Not Specified|10|||
94563790|NCT03951077|323859774|FG003|Overall Study|Other, Not Specified|5|||
94563791|NCT03951077|323859775|FG004|Overall Study|Other, Not Specified|9|||
94563792|NCT03951077|323859776|FG005|Overall Study|Other, Not Specified|6|||
94563793|NCT03951077|323859771|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
94658231|NCT03019536|324206123|FG000|Overall Study|Withdrawal by Subject|1|||
94658232|NCT03019536|324206124|FG001|Overall Study|Withdrawal by Subject|1|||
94658233|NCT03019536|324206125|FG002|Overall Study|Withdrawal by Subject|0|||
94658234|NCT03019536|324206123|FG000|Overall Study|Adverse Event|0|||
94658235|NCT03019536|324206124|FG001|Overall Study|Adverse Event|0|||
94658236|NCT03019536|324206125|FG002|Overall Study|Adverse Event|2|||
94658237|NCT03859323|324206126|FG000|Overall Study|Lost to Follow-up|0|||
94658238|NCT03859323|324206127|FG001|Overall Study|Lost to Follow-up|0|||
94658239|NCT03859323|324206128|FG002|Overall Study|Lost to Follow-up|0|||
94658240|NCT03859323|324206129|FG003|Overall Study|Lost to Follow-up|0|||
94658241|NCT03859323|324206130|FG004|Overall Study|Lost to Follow-up|0|||
94658242|NCT03859323|324206131|FG005|Overall Study|Lost to Follow-up|0|||
94658243|NCT03859323|324206132|FG006|Overall Study|Lost to Follow-up|1|||
94658244|NCT03859323|324206133|FG007|Overall Study|Lost to Follow-up|0|||
94658245|NCT03859323|324206134|FG008|Overall Study|Lost to Follow-up|0|||
94658246|NCT03859323|324206135|FG009|Overall Study|Lost to Follow-up|0|||
94658247|NCT03859323|324206136|FG010|Overall Study|Lost to Follow-up|0|||
94658248|NCT03859323|324206137|FG011|Overall Study|Lost to Follow-up|0|||
94658249|NCT03859323|324206138|FG012|Overall Study|Lost to Follow-up|0|||
94658250|NCT03859323|324206126|FG000|Overall Study|Withdrawal by Subject|0|||
94658251|NCT03859323|324206127|FG001|Overall Study|Withdrawal by Subject|0|||
94658252|NCT03859323|324206128|FG002|Overall Study|Withdrawal by Subject|1|||
94658253|NCT03859323|324206129|FG003|Overall Study|Withdrawal by Subject|0|||
94235553|NCT01053247|322657931|FG001|Overall Study|Lack of Efficacy|0|||
94235554|NCT01053247|322657932|FG002|Overall Study|Lack of Efficacy|1|||
94235555|NCT01053247|322657930|FG000|Overall Study|Protocol Violation|2|||
94235556|NCT01053247|322657931|FG001|Overall Study|Protocol Violation|1|||
94235557|NCT01053247|322657932|FG002|Overall Study|Protocol Violation|2|||
94235558|NCT01053247|322657930|FG000|Overall Study|Lost to Follow-up|8|||
94235559|NCT01053247|322657931|FG001|Overall Study|Lost to Follow-up|5|||
94235560|NCT01053247|322657932|FG002|Overall Study|Lost to Follow-up|7|||
94235561|NCT01053247|322657930|FG000|Overall Study|Adverse Event|0|||
94235562|NCT01053247|322657931|FG001|Overall Study|Adverse Event|9|||
94235563|NCT01053247|322657932|FG002|Overall Study|Adverse Event|3|||
94235564|NCT00701909|322657935|FG000|Overall Study|Withdrawal by Subject|0|||
94235565|NCT00701909|322657936|FG001|Overall Study|Withdrawal by Subject|1|||
94235566|NCT03023722|322657941|FG000|Overall Study|No follow-up assessment|4|||
94235567|NCT00129935|322657942|FG000|Overall Study|Adverse Event|18|||
94235568|NCT00129935|322657943|FG001|Overall Study|Adverse Event|56|||
94235569|NCT00129935|322657942|FG000|Overall Study|Death|1|||
94235570|NCT00129935|322657943|FG001|Overall Study|Death|1|||
94235571|NCT00129935|322657942|FG000|Overall Study|Withdrawal by Subject|7|||
94235572|NCT00129935|322657943|FG001|Overall Study|Withdrawal by Subject|20|||
94235573|NCT00129935|322657942|FG000|Overall Study|Protocol Violation|0|||
94235574|NCT00129935|322657943|FG001|Overall Study|Protocol Violation|4|||
94235575|NCT00129935|322657942|FG000|Overall Study|Physician Decision|3|||
94235576|NCT00129935|322657943|FG001|Overall Study|Physician Decision|4|||
94235577|NCT00129935|322657942|FG000|Overall Study|Recurrence|1|||
94235578|NCT00129935|322657943|FG001|Overall Study|Recurrence|3|||
94235579|NCT00129935|322657942|FG000|Overall Study|Second primary|0|||
94235580|NCT00129935|322657943|FG001|Overall Study|Second primary|1|||
94235581|NCT00129935|322657942|FG000|Overall Study|Other|3|||
94235582|NCT00129935|322657943|FG001|Overall Study|Other|2|||
94235583|NCT00129935|322657942|FG000|Overall Study|Crossed to the other arm|2|||
94235584|NCT00129935|322657943|FG001|Overall Study|Crossed to the other arm|1|||
94235585|NCT00129935|322657942|FG000|Overall Study|Incorrect study treatment|1|||
94235586|NCT00129935|322657943|FG001|Overall Study|Incorrect study treatment|0|||
94235587|NCT01385748|322657944|FG000|Overall Study|Withdrawal by Subject|7|||
94235588|NCT01385748|322657945|FG001|Overall Study|Withdrawal by Subject|4|||
94235589|NCT01385748|322657946|FG002|Overall Study|Withdrawal by Subject|5|||
94235590|NCT01385748|322657944|FG000|Overall Study|Noncompliance|3|||
94235591|NCT01385748|322657945|FG001|Overall Study|Noncompliance|1|||
94235592|NCT01385748|322657946|FG002|Overall Study|Noncompliance|6|||
94450520|NCT03877068|323436840|FG000|Overall Study|Physician Decision|9|||
94450521|NCT03877068|323436841|FG001|Overall Study|Physician Decision|3|||
94450522|NCT02356588|323436842|FG000|Overall Study|Lack of Efficacy|4|||
94450523|NCT02356588|323436843|FG001|Overall Study|Lack of Efficacy|10|||
94450524|NCT02356588|323436842|FG000|Overall Study|Adverse Event|0|||
94450525|NCT02356588|323436843|FG001|Overall Study|Adverse Event|2|||
94450526|NCT02356588|323436842|FG000|Overall Study|Withdrawal by Subject|1|||
94450527|NCT02356588|323436843|FG001|Overall Study|Withdrawal by Subject|0|||
94450528|NCT02356588|323436842|FG000|Overall Study|Protocol Violation|0|||
94450529|NCT02356588|323436843|FG001|Overall Study|Protocol Violation|1|||
94450530|NCT00461630|323436846|FG000|Overall Study|Death|798|||
94450531|NCT00461630|323436847|FG001|Overall Study|Death|732|||
94450532|NCT00461630|323436846|FG000|Overall Study|Lost to Follow-up|108|||
94450533|NCT00461630|323436847|FG001|Overall Study|Lost to Follow-up|95|||
94450534|NCT02176655|323436849|FG000|Overall Study|Subjects did not treat|6|||
94450535|NCT06110494|323436852|FG000|Overall Study|Protocol Violation|2|||
94450536|NCT06110494|323436853|FG001|Overall Study|Protocol Violation|0|||
94450537|NCT06110494|323436854|FG002|Overall Study|Protocol Violation|1|||
94450538|NCT06110494|323436852|FG000|Overall Study|Dixon's test for outlier analysis|1|||
94450539|NCT06110494|323436853|FG001|Overall Study|Dixon's test for outlier analysis|1|||
94450540|NCT06110494|323436854|FG002|Overall Study|Dixon's test for outlier analysis|0|||
94450541|NCT00105079|323436855|FG000|Overall Study|Adverse Event|5|||
94450542|NCT00105079|323436856|FG001|Overall Study|Adverse Event|12|||
94450543|NCT00105079|323436855|FG000|Overall Study|Death|3|||
94450544|NCT00105079|323436856|FG001|Overall Study|Death|1|||
94563794|NCT03951077|323859772|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
94563795|NCT03951077|323859773|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
94563796|NCT03951077|323859774|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
94563797|NCT03951077|323859775|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
94563798|NCT03951077|323859776|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
94563799|NCT01395901|323859779|FG000|Overall Study|Lost to Follow-up|4|||
94563800|NCT01395901|323859780|FG001|Overall Study|Lost to Follow-up|0|||
94563801|NCT01395901|323859779|FG000|Overall Study|Randomized but not received study drug|5|||
94346974|NCT00811395|323050852|FG002|Extension Treatment|Other than above|1|||
94346975|NCT00811395|323050853|FG003|Extension Treatment|Other than above|0|||
94563802|NCT01395901|323859780|FG001|Overall Study|Randomized but not received study drug|4|||
94346976|NCT00811395|323050854|FG004|Extension Treatment|Other than above|0|||
94658254|NCT03859323|324206130|FG004|Overall Study|Withdrawal by Subject|0|||
94658255|NCT03859323|324206131|FG005|Overall Study|Withdrawal by Subject|1|||
94658256|NCT03859323|324206132|FG006|Overall Study|Withdrawal by Subject|0|||
94658257|NCT03859323|324206133|FG007|Overall Study|Withdrawal by Subject|0|||
94658258|NCT03859323|324206134|FG008|Overall Study|Withdrawal by Subject|0|||
94658259|NCT03859323|324206135|FG009|Overall Study|Withdrawal by Subject|1|||
94235593|NCT01385748|322657944|FG000|Overall Study|Other|1|||
94235594|NCT01385748|322657945|FG001|Overall Study|Other|7|||
94235595|NCT01385748|322657946|FG002|Overall Study|Other|1|||
94235596|NCT01385748|322657944|FG000|Overall Study|Adverse Event|4|||
94450545|NCT00105079|323436855|FG000|Overall Study|Lost to Follow-up|12|||
94450546|NCT00105079|323436856|FG001|Overall Study|Lost to Follow-up|12|||
94450547|NCT00105079|323436855|FG000|Overall Study|Lack of Efficacy|9|||
94450548|NCT00105079|323436856|FG001|Overall Study|Lack of Efficacy|3|||
94450549|NCT00105079|323436855|FG000|Overall Study|Refused treatment|6|||
94450550|NCT00105079|323436856|FG001|Overall Study|Refused treatment|4|||
94450551|NCT00105079|323436855|FG000|Overall Study|Violation of selection criteria at entry|0|||
94658260|NCT03859323|324206136|FG010|Overall Study|Withdrawal by Subject|1|||
94658261|NCT03859323|324206137|FG011|Overall Study|Withdrawal by Subject|2|||
94658262|NCT03859323|324206138|FG012|Overall Study|Withdrawal by Subject|1|||
94658263|NCT03859323|324206126|FG000|Overall Study|Pregnancy|0|||
94658264|NCT03859323|324206127|FG001|Overall Study|Pregnancy|0|||
94658265|NCT03859323|324206128|FG002|Overall Study|Pregnancy|0|||
94450552|NCT00105079|323436856|FG001|Overall Study|Violation of selection criteria at entry|2|||
94450553|NCT00105079|323436855|FG000|Overall Study|Protocol Violation|1|||
94450554|NCT00105079|323436856|FG001|Overall Study|Protocol Violation|0|||
94450555|NCT00105079|323436855|FG000|Overall Study|Other|3|||
94450556|NCT00105079|323436856|FG001|Overall Study|Other|1|||
94450557|NCT01288937|323436861|FG000|Overall Study|Adverse Event|1|||
94450558|NCT01288937|323436862|FG001|Overall Study|Adverse Event|0|||
94450559|NCT02230904|323436863|FG000|Overall Study|Safety follow up could not take place|0|||
94450560|NCT02230904|323436864|FG001|Overall Study|Safety follow up could not take place|1|||
94450561|NCT01681212|323436867|FG000|Overall Study|No longer met study criteria|5|||
94450562|NCT01681212|323436867|FG000|Overall Study|Administrative reason by sponsor|1|||
94450563|NCT01464424|323436870|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
94450564|NCT01464424|323436871|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
94450565|NCT01560234|323436872|FG000|Overall Study|Lost to Follow-up|3|||
94450566|NCT01560234|323436873|FG001|Overall Study|Lost to Follow-up|0|||
94450567|NCT01560234|323436874|FG002|Overall Study|Lost to Follow-up|1|||
94450568|NCT01560234|323436875|FG003|Overall Study|Lost to Follow-up|0|||
94450569|NCT01560234|323436876|FG004|Overall Study|Lost to Follow-up|0|||
94450570|NCT01560234|323436877|FG005|Overall Study|Lost to Follow-up|2|||
94450571|NCT01560234|323436878|FG006|Overall Study|Lost to Follow-up|0|||
94450572|NCT01560234|323436879|FG007|Overall Study|Lost to Follow-up|2|||
94450573|NCT02914613|323436881|FG000|Overall Study|Withdrawal by Subject|1|||
94450574|NCT02914613|323436882|FG001|Overall Study|Withdrawal by Subject|2|||
94450575|NCT02914613|323436881|FG000|Overall Study|Adverse Event|1|||
94450576|NCT02914613|323436882|FG001|Overall Study|Adverse Event|0|||
94450577|NCT01464333|323436887|FG000|Overall Study|Adverse Event|34|||
94450578|NCT01464333|323436887|FG000|Overall Study|Lack of Efficacy|72|||
94450579|NCT01464333|323436887|FG000|Overall Study|Withdrawal by Subject|11|||
94450580|NCT01464333|323436887|FG000|Overall Study|Other|4|||
94450581|NCT01464333|323436887|FG000|Overall Study|No Hospital Visit|42|||
94450582|NCT03482453|323436888|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
94450583|NCT03482453|323436889|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
94450584|NCT03482453|323436890|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
94450585|NCT03482453|323436891|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
94450586|NCT03482453|323436892|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
94450587|NCT03482453|323436893|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
94450588|NCT03482453|323436894|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
94658266|NCT03859323|324206129|FG003|Overall Study|Pregnancy|0|||
94658267|NCT03859323|324206130|FG004|Overall Study|Pregnancy|0|||
94658268|NCT03859323|324206131|FG005|Overall Study|Pregnancy|0|||
94563803|NCT01395901|323859779|FG000|Overall Study|Adverse Event|0|||
94563804|NCT01395901|323859780|FG001|Overall Study|Adverse Event|1|||
94563805|NCT01395901|323859779|FG000|Overall Study|Withdrawal of consent|1|||
94563806|NCT01395901|323859780|FG001|Overall Study|Withdrawal of consent|0|||
94563807|NCT00742183|323859783|FG000|Overall Study|Adverse Event|2|||
94563808|NCT00742183|323859784|FG001|Overall Study|Adverse Event|2|||
94563809|NCT00742183|323859783|FG000|Overall Study|Death|1|||
94563810|NCT00742183|323859784|FG001|Overall Study|Death|0|||
94563811|NCT00742183|323859783|FG000|Overall Study|Physician Decision|0|||
94563812|NCT00742183|323859784|FG001|Overall Study|Physician Decision|2|||
94563813|NCT00742183|323859783|FG000|Overall Study|Lost to Follow-up|4|||
94563814|NCT00742183|323859784|FG001|Overall Study|Lost to Follow-up|4|||
94563815|NCT00742183|323859783|FG000|Overall Study|Required skin-graft|1|||
94563816|NCT00742183|323859784|FG001|Overall Study|Required skin-graft|1|||
94563817|NCT00742183|323859783|FG000|Overall Study|Withdrawal by Subject|1|||
94563818|NCT00742183|323859784|FG001|Overall Study|Withdrawal by Subject|0|||
94563819|NCT00742183|323859783|FG000|Overall Study|Lack of Efficacy|0|||
94563820|NCT00742183|323859784|FG001|Overall Study|Lack of Efficacy|3|||
94563821|NCT00786799|323859787|FG000|Overall Study|Lost to Follow-up|1|||
94563822|NCT00786799|323859788|FG001|Overall Study|Lost to Follow-up|1|||
94563823|NCT02544503|323859789|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
94563824|NCT02544503|323859790|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
94563825|NCT02544503|323859789|FG000|Overall Study|Lost to Follow-up|9|||
94563826|NCT02544503|323859790|FG001|Overall Study|Lost to Follow-up|0|||
94563827|NCT02544503|323859789|FG000|Overall Study|Withdrawal by Subject|1|||
94563828|NCT02544503|323859790|FG001|Overall Study|Withdrawal by Subject|0|||
94563829|NCT04640311|323859791|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
94563830|NCT04640311|323859792|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563831|NCT04640311|323859793|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563832|NCT04640311|323859794|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563833|NCT04640311|323859795|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94658269|NCT03859323|324206132|FG006|Overall Study|Pregnancy|0|||
94563834|NCT04640311|323859796|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563835|NCT04640311|323859797|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563836|NCT04640311|323859798|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563837|NCT04640311|323859799|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563838|NCT04640311|323859800|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563839|NCT04640311|323859801|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563840|NCT04640311|323859802|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563841|NCT04640311|323859803|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563842|NCT04640311|323859791|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
94563843|NCT04640311|323859792|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
94563844|NCT04640311|323859793|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
94563845|NCT04640311|323859794|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
94346977|NCT00811395|323050855|FG005|Extension Treatment|Other than above|0|||
94346978|NCT01970540|323050858|FG000|Overall Study|Non-treatment-related AE|0|||
94346979|NCT01970540|323050859|FG001|Overall Study|Non-treatment-related AE|0|||
94346980|NCT01970540|323050860|FG002|Overall Study|Non-treatment-related AE|1|||
94563846|NCT04640311|323859795|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
94563847|NCT04640311|323859796|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
94563848|NCT04640311|323859797|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
94563849|NCT04640311|323859798|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
94563850|NCT04640311|323859799|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
94563851|NCT04640311|323859800|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
94563852|NCT04640311|323859801|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
94563853|NCT04640311|323859802|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
94563854|NCT04640311|323859803|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
94563855|NCT04640311|323859791|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563856|NCT04640311|323859792|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
94563857|NCT04640311|323859793|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563858|NCT04640311|323859794|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563859|NCT04640311|323859795|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563860|NCT04640311|323859796|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563861|NCT04640311|323859797|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563862|NCT04640311|323859798|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563863|NCT04640311|323859799|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563864|NCT04640311|323859800|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563865|NCT04640311|323859801|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563866|NCT04640311|323859802|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563867|NCT04640311|323859803|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563868|NCT04640311|323859791|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
94563869|NCT04640311|323859792|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
94563870|NCT04640311|323859793|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
94563871|NCT04640311|323859794|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563872|NCT04640311|323859795|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563873|NCT04640311|323859796|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563874|NCT04640311|323859797|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563875|NCT04640311|323859798|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563876|NCT04640311|323859799|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563877|NCT04640311|323859800|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563878|NCT04640311|323859801|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94651346|NCT02460224|324179727|FG012|Overall Study|Subject/guardian decision|0|||
94346981|NCT01970540|323050858|FG000|Overall Study|Progressive disease|55|||
94346982|NCT01970540|323050859|FG001|Overall Study|Progressive disease|23|||
94346983|NCT01970540|323050860|FG002|Overall Study|Progressive disease|10|||
94235597|NCT01385748|322657945|FG001|Overall Study|Adverse Event|2|||
94235598|NCT01385748|322657946|FG002|Overall Study|Adverse Event|1|||
94235599|NCT04843579|322657947|FG000|Overall Study|Adverse Event|1|||
94235600|NCT04843579|322657947|FG000|Overall Study|Disease Progression|1|||
94563879|NCT04640311|323859802|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94658270|NCT03859323|324206133|FG007|Overall Study|Pregnancy|0|||
94563880|NCT04640311|323859803|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
94563881|NCT04640311|323859791|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
94563882|NCT04640311|323859792|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
94563883|NCT04640311|323859793|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
94563884|NCT04640311|323859794|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
94563885|NCT04640311|323859795|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
94563886|NCT04640311|323859796|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
94563887|NCT04640311|323859797|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
94563888|NCT04640311|323859798|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
94235601|NCT01367847|322657950|FG000|Overall Study|Withdrawal by Subject|2|||
94235602|NCT01367847|322657951|FG001|Overall Study|Withdrawal by Subject|2|||
94235603|NCT00953147|322657952|FG000|Overall Study|Adverse Event|8|||
94235604|NCT00953147|322657953|FG001|Overall Study|Adverse Event|16|||
94235605|NCT00953147|322657954|FG002|Overall Study|Adverse Event|6|||
94235606|NCT00953147|322657952|FG000|Overall Study|Protocol Violation|2|||
94235607|NCT00953147|322657953|FG001|Overall Study|Protocol Violation|8|||
94235608|NCT00953147|322657954|FG002|Overall Study|Protocol Violation|4|||
94235609|NCT00953147|322657952|FG000|Overall Study|Withdrawal by Subject|13|||
94235610|NCT00953147|322657953|FG001|Overall Study|Withdrawal by Subject|15|||
94235611|NCT00953147|322657954|FG002|Overall Study|Withdrawal by Subject|12|||
94235612|NCT00953147|322657952|FG000|Overall Study|Lost to Follow-up|8|||
94235613|NCT00953147|322657953|FG001|Overall Study|Lost to Follow-up|9|||
94235614|NCT00953147|322657954|FG002|Overall Study|Lost to Follow-up|4|||
94235615|NCT00953147|322657952|FG000|Overall Study|Physician Decision|2|||
94235616|NCT00953147|322657953|FG001|Overall Study|Physician Decision|7|||
94346984|NCT01970540|323050858|FG000|Overall Study|Treatment delay over protocol|0|||
94658271|NCT03859323|324206134|FG008|Overall Study|Pregnancy|0|||
94658272|NCT03859323|324206135|FG009|Overall Study|Pregnancy|1|||
94658273|NCT03859323|324206136|FG010|Overall Study|Pregnancy|0|||
94658274|NCT03859323|324206137|FG011|Overall Study|Pregnancy|0|||
94658275|NCT03859323|324206138|FG012|Overall Study|Pregnancy|0|||
94658276|NCT02648698|324206141|FG000|Overall Study|Protocol Violation|1|||
94658277|NCT02648698|324206142|FG001|Overall Study|Protocol Violation|5|||
94658278|NCT01782131|324206146|FG000|Overall Study|Death|93|||
94658279|NCT01782131|324206147|FG001|Overall Study|Death|96|||
94658280|NCT01782131|324206146|FG000|Overall Study|Lost to Follow-up|1|||
94658281|NCT01782131|324206147|FG001|Overall Study|Lost to Follow-up|3|||
94658282|NCT01782131|324206146|FG000|Overall Study|Withdrawal by Subject|10|||
94658283|NCT01782131|324206147|FG001|Overall Study|Withdrawal by Subject|10|||
94658284|NCT01782131|324206146|FG000|Overall Study|Randomized but not treated|5|||
94658285|NCT01782131|324206147|FG001|Overall Study|Randomized but not treated|5|||
94658286|NCT01782131|324206146|FG000|Overall Study|Reason not provided|0|||
94658287|NCT01782131|324206147|FG001|Overall Study|Reason not provided|1|||
94658288|NCT00796718|324206148|FG000|Overall Study|Adverse Event|2|||
94658289|NCT00796718|324206148|FG000|Overall Study|Exclusion Criteria|1|||
94658290|NCT00796718|324206148|FG000|Overall Study|Lost to Follow-up|5|||
94658291|NCT00796718|324206148|FG000|Overall Study|Withdrawal by Informed Consent|1|||
94658292|NCT00767000|324206151|FG000|54-week Study|Adverse Event|4|||
94658293|NCT00767000|324206152|FG001|54-week Study|Adverse Event|6|||
94658294|NCT00767000|324206153|FG002|54-week Study|Adverse Event|6|||
94658295|NCT00767000|324206154|FG003|54-week Study|Adverse Event|8|||
94658296|NCT00767000|324206155|FG004|54-week Study|Adverse Event|4|||
94658297|NCT00767000|324206151|FG000|54-week Study|Creaninine/creatinine clearance|2|||
94658298|NCT00767000|324206152|FG001|54-week Study|Creaninine/creatinine clearance|1|||
94658299|NCT00767000|324206153|FG002|54-week Study|Creaninine/creatinine clearance|2|||
94658300|NCT00767000|324206154|FG003|54-week Study|Creaninine/creatinine clearance|2|||
94658301|NCT00767000|324206155|FG004|54-week Study|Creaninine/creatinine clearance|4|||
94658302|NCT00767000|324206151|FG000|54-week Study|Hyperglycemia|0|||
94658303|NCT00767000|324206152|FG001|54-week Study|Hyperglycemia|0|||
94658304|NCT00767000|324206153|FG002|54-week Study|Hyperglycemia|1|||
94658305|NCT00767000|324206154|FG003|54-week Study|Hyperglycemia|0|||
94658306|NCT00767000|324206155|FG004|54-week Study|Hyperglycemia|1|||
94658307|NCT00767000|324206151|FG000|54-week Study|Hypoglycemia|0|||
94658308|NCT00767000|324206152|FG001|54-week Study|Hypoglycemia|1|||
94658309|NCT00767000|324206153|FG002|54-week Study|Hypoglycemia|0|||
94658310|NCT00767000|324206154|FG003|54-week Study|Hypoglycemia|0|||
94658311|NCT00767000|324206155|FG004|54-week Study|Hypoglycemia|0|||
94658312|NCT00767000|324206151|FG000|54-week Study|Interruption of study medication|0|||
94658313|NCT00767000|324206152|FG001|54-week Study|Interruption of study medication|0|||
94658314|NCT00767000|324206153|FG002|54-week Study|Interruption of study medication|1|||
94658315|NCT00767000|324206154|FG003|54-week Study|Interruption of study medication|0|||
94235617|NCT00953147|322657954|FG002|Overall Study|Physician Decision|3|||
94346985|NCT01970540|323050859|FG001|Overall Study|Treatment delay over protocol|0|||
94346986|NCT01970540|323050860|FG002|Overall Study|Treatment delay over protocol|1|||
94658316|NCT00767000|324206155|FG004|54-week Study|Interruption of study medication|0|||
94658317|NCT00767000|324206151|FG000|54-week Study|Lack of Efficacy|2|||
94235618|NCT00953147|322657952|FG000|Overall Study|Other|4|||
94235619|NCT00953147|322657953|FG001|Overall Study|Other|11|||
94235620|NCT00953147|322657954|FG002|Overall Study|Other|13|||
94346987|NCT01970540|323050858|FG000|Overall Study|Physician Decision|7|||
94346988|NCT01970540|323050859|FG001|Overall Study|Physician Decision|2|||
94346989|NCT01970540|323050860|FG002|Overall Study|Physician Decision|0|||
94658318|NCT00767000|324206152|FG001|54-week Study|Lack of Efficacy|0|||
94658319|NCT00767000|324206153|FG002|54-week Study|Lack of Efficacy|1|||
94658320|NCT00767000|324206154|FG003|54-week Study|Lack of Efficacy|0|||
94658321|NCT00767000|324206155|FG004|54-week Study|Lack of Efficacy|5|||
94658322|NCT00767000|324206151|FG000|54-week Study|Lost to Follow-up|4|||
94658323|NCT00767000|324206152|FG001|54-week Study|Lost to Follow-up|0|||
94658324|NCT00767000|324206153|FG002|54-week Study|Lost to Follow-up|1|||
94563889|NCT04640311|323859799|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
94563890|NCT04640311|323859800|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
94563891|NCT04640311|323859801|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
94235621|NCT01888874|322657955|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
94235622|NCT01888874|322657956|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
94235623|NCT01888874|322657957|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
94235624|NCT01888874|322657958|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
94235625|NCT01888874|322657959|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
94235626|NCT01888874|322657960|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
94235627|NCT01888874|322657961|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
94235628|NCT01888874|322657955|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
94235629|NCT01888874|322657956|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
94235630|NCT01888874|322657957|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
94235631|NCT01888874|322657958|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
94235632|NCT01888874|322657959|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
94235633|NCT01888874|322657960|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
94235634|NCT01888874|322657961|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
94235635|NCT01888874|322657955|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
94235636|NCT01888874|322657956|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
94235637|NCT01888874|322657957|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
94235638|NCT01888874|322657958|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
94235639|NCT01888874|322657959|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
94235640|NCT01888874|322657960|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
94235641|NCT01888874|322657961|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
94235642|NCT01888874|322657955|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
94235643|NCT01888874|322657956|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
94235644|NCT01888874|322657957|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
94235645|NCT01888874|322657958|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
94235646|NCT01888874|322657959|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
94235647|NCT01888874|322657960|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
94235648|NCT01888874|322657961|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
94235649|NCT01888874|322657955|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
94235650|NCT01888874|322657956|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
94235651|NCT01888874|322657957|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
94235652|NCT01888874|322657958|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
94563892|NCT04640311|323859802|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
94563893|NCT04640311|323859803|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
94346990|NCT01970540|323050858|FG000|Overall Study|Clinical progression|0|||
94346991|NCT01970540|323050859|FG001|Overall Study|Clinical progression|1|||
94346992|NCT01970540|323050860|FG002|Overall Study|Clinical progression|1|||
94346993|NCT01970540|323050858|FG000|Overall Study|End of study|2|||
94346994|NCT01970540|323050859|FG001|Overall Study|End of study|0|||
94346995|NCT01970540|323050860|FG002|Overall Study|End of study|2|||
94346996|NCT01970540|323050858|FG000|Overall Study|Adverse Event|0|||
94346997|NCT01970540|323050859|FG001|Overall Study|Adverse Event|2|||
94346998|NCT01970540|323050860|FG002|Overall Study|Adverse Event|1|||
94346999|NCT01970540|323050858|FG000|Overall Study|Treatment-related AE|4|||
94347000|NCT01970540|323050859|FG001|Overall Study|Treatment-related AE|0|||
94347001|NCT01970540|323050860|FG002|Overall Study|Treatment-related AE|2|||
94347002|NCT01970540|323050858|FG000|Overall Study|Withdrawal by Subject|4|||
94347003|NCT01970540|323050859|FG001|Overall Study|Withdrawal by Subject|0|||
94347004|NCT01970540|323050860|FG002|Overall Study|Withdrawal by Subject|1|||
94347005|NCT01970540|323050858|FG000|Overall Study|Clinical deterioration|1|||
94347006|NCT01970540|323050859|FG001|Overall Study|Clinical deterioration|0|||
94347007|NCT01970540|323050860|FG002|Overall Study|Clinical deterioration|0|||
94347008|NCT04062240|323050861|FG000|Overall Study|equipment malfunction|1|||
94347009|NCT03196973|323050863|FG000|Overall Study|Adverse Event|1|||
94347010|NCT03196973|323050864|FG001|Overall Study|Adverse Event|1|||
94347011|NCT03196973|323050865|FG002|Overall Study|Adverse Event|2|||
94347012|NCT03196973|323050863|FG000|Overall Study|Lack of Efficacy|2|||
94347013|NCT03196973|323050864|FG001|Overall Study|Lack of Efficacy|6|||
94347014|NCT03196973|323050865|FG002|Overall Study|Lack of Efficacy|1|||
94347015|NCT03196973|323050863|FG000|Overall Study|Lost to Follow-up|4|||
94347016|NCT03196973|323050864|FG001|Overall Study|Lost to Follow-up|3|||
94347017|NCT03196973|323050865|FG002|Overall Study|Lost to Follow-up|2|||
94347018|NCT03196973|323050863|FG000|Overall Study|Consent withdrawn|2|||
94563894|NCT04640311|323859791|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
94563895|NCT04640311|323859792|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
94347019|NCT03196973|323050864|FG001|Overall Study|Consent withdrawn|1|||
94347020|NCT03196973|323050865|FG002|Overall Study|Consent withdrawn|0|||
94347021|NCT03196973|323050863|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
94347022|NCT03196973|323050864|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
94347023|NCT03196973|323050865|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
94347024|NCT03742271|323050866|FG000|Overall Study|Unsatisfactory Visual Response|1|||
94347025|NCT03742271|323050866|FG000|Overall Study|Withdrawal by Subject|3|||
94563896|NCT04640311|323859793|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
94563897|NCT04640311|323859794|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
94563898|NCT04640311|323859795|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
94563899|NCT04640311|323859796|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
94563900|NCT04640311|323859797|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
94563901|NCT04640311|323859798|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
94563902|NCT04640311|323859799|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
94563903|NCT04640311|323859800|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
94563904|NCT04640311|323859801|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
94563905|NCT04640311|323859802|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
94563906|NCT04640311|323859803|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
94563907|NCT04640311|323859791|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563908|NCT04640311|323859792|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563909|NCT04640311|323859793|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563910|NCT04640311|323859794|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563911|NCT04640311|323859795|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563912|NCT04640311|323859796|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
94563913|NCT04640311|323859797|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563914|NCT04640311|323859798|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94347026|NCT03742271|323050866|FG000|Overall Study|Lost to Follow-up|4|||
94347027|NCT03742271|323050866|FG000|Overall Study|Failed Insertion & removal|3|||
94347028|NCT03742271|323050866|FG000|Overall Study|Protocol Violation|1|||
94347029|NCT02545049|323050871|FG000|Overall Study|Withdrawal by Subject|1|||
94347030|NCT02545049|323050872|FG001|Overall Study|Withdrawal by Subject|7|||
94347031|NCT02545049|323050871|FG000|Overall Study|Lost to Follow-up|4|||
94347032|NCT02545049|323050872|FG001|Overall Study|Lost to Follow-up|6|||
94347033|NCT02545049|323050871|FG000|Overall Study|GCP violations|37|||
94347034|NCT02545049|323050872|FG001|Overall Study|GCP violations|48|||
94347035|NCT04009824|323050873|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
94347036|NCT04009824|323050874|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
94347037|NCT04009824|323050875|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
94347038|NCT04009824|323050876|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
94563915|NCT04640311|323859799|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
94563916|NCT04640311|323859800|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563917|NCT04640311|323859801|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94235653|NCT01888874|322657959|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
94235654|NCT01888874|322657960|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
94235655|NCT01888874|322657961|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
94235656|NCT01888874|322657955|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
94563918|NCT04640311|323859802|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563919|NCT04640311|323859803|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
94563920|NCT04640311|323859791|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
94563921|NCT04640311|323859792|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
94563922|NCT04640311|323859793|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
94563923|NCT04640311|323859794|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
94563924|NCT04640311|323859795|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
94563925|NCT04640311|323859796|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
94563926|NCT04640311|323859797|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
94563927|NCT04640311|323859798|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
94563928|NCT04640311|323859799|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
94563929|NCT04640311|323859800|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
94563930|NCT04640311|323859801|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
94563931|NCT04640311|323859802|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
94563932|NCT04640311|323859803|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
94563933|NCT04640311|323859791|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
94563934|NCT04640311|323859792|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
94563935|NCT04640311|323859793|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
94563936|NCT04640311|323859794|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
94563937|NCT04640311|323859795|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
94658325|NCT00767000|324206154|FG003|54-week Study|Lost to Follow-up|4|||
94235657|NCT01888874|322657956|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
94235658|NCT01888874|322657957|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
94235659|NCT01888874|322657958|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
94235660|NCT01888874|322657959|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
94235661|NCT01888874|322657960|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
94235662|NCT01888874|322657961|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
94235663|NCT01888874|322657955|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
94235664|NCT01888874|322657956|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
94235665|NCT01888874|322657957|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
94563938|NCT04640311|323859796|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
94563939|NCT04640311|323859797|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
94563940|NCT04640311|323859798|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
94563941|NCT04640311|323859799|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
94563942|NCT04640311|323859800|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
94563943|NCT04640311|323859801|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
94563944|NCT04640311|323859802|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
94563945|NCT04640311|323859803|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
94563946|NCT01799226|323859810|FG000|Overall Study|Withdrawal by Subject|1|||
94563947|NCT01799226|323859811|FG001|Overall Study|Withdrawal by Subject|0|||
94563948|NCT01799226|323859810|FG000|Overall Study|Disqualified at Day 14|1|||
94563949|NCT01799226|323859811|FG001|Overall Study|Disqualified at Day 14|0|||
94563950|NCT02517541|323859812|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
94235666|NCT01888874|322657958|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
94235667|NCT01888874|322657959|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
94563951|NCT02517541|323859812|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
94563952|NCT02517541|323859812|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
94563953|NCT02517541|323859812|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
94563954|NCT02517541|323859812|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
94563955|NCT02517541|323859812|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
94658326|NCT00767000|324206155|FG004|54-week Study|Lost to Follow-up|2|||
94658327|NCT00767000|324206151|FG000|54-week Study|Physician Decision|4|||
94235668|NCT01888874|322657960|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
94235669|NCT01888874|322657961|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
94563956|NCT00592904|323859813|FG000|Overall Study|Adverse Event|15|||
94563957|NCT00592904|323859814|FG001|Overall Study|Adverse Event|25|||
94563958|NCT00592904|323859815|FG002|Overall Study|Adverse Event|13|||
94563959|NCT00592904|323859816|FG003|Overall Study|Adverse Event|5|||
94563960|NCT00592904|323859813|FG000|Overall Study|Protocol Violation|1|||
94563961|NCT00592904|323859814|FG001|Overall Study|Protocol Violation|1|||
94563962|NCT00592904|323859815|FG002|Overall Study|Protocol Violation|0|||
94563963|NCT00592904|323859816|FG003|Overall Study|Protocol Violation|1|||
94563964|NCT00592904|323859813|FG000|Overall Study|Withdrawal by Subject|4|||
94563965|NCT00592904|323859814|FG001|Overall Study|Withdrawal by Subject|16|||
94563966|NCT00592904|323859815|FG002|Overall Study|Withdrawal by Subject|1|||
94563967|NCT00592904|323859816|FG003|Overall Study|Withdrawal by Subject|2|||
94563968|NCT00592904|323859813|FG000|Overall Study|Lack of Efficacy|2|||
94563969|NCT00592904|323859814|FG001|Overall Study|Lack of Efficacy|7|||
94563970|NCT00592904|323859815|FG002|Overall Study|Lack of Efficacy|2|||
94563971|NCT00592904|323859816|FG003|Overall Study|Lack of Efficacy|3|||
94563972|NCT00592904|323859813|FG000|Overall Study|Physician Decision|0|||
94450589|NCT03482453|323436895|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
94563973|NCT00592904|323859814|FG001|Overall Study|Physician Decision|3|||
94563974|NCT00592904|323859815|FG002|Overall Study|Physician Decision|1|||
94563975|NCT00592904|323859816|FG003|Overall Study|Physician Decision|0|||
94563976|NCT00592904|323859813|FG000|Overall Study|Other|3|||
94563977|NCT00592904|323859814|FG001|Overall Study|Other|3|||
94563978|NCT00592904|323859815|FG002|Overall Study|Other|0|||
94563979|NCT00592904|323859816|FG003|Overall Study|Other|0|||
94563980|NCT03361293|323859831|FG000|Overall Study|Lost to Follow-up|0|||
94563981|NCT03361293|323859832|FG001|Overall Study|Lost to Follow-up|2|||
94563982|NCT03361293|323859831|FG000|Overall Study|Withdrawal by Subject|1|||
94563983|NCT03361293|323859832|FG001|Overall Study|Withdrawal by Subject|3|||
94563984|NCT01910402|323859835|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
94563985|NCT01910402|323859836|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
94563986|NCT01910402|323859837|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
94563987|NCT01910402|323859835|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
94563988|NCT01910402|323859836|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
94563989|NCT01910402|323859837|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
94563990|NCT01910402|323859835|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
94563991|NCT01910402|323859836|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
94563992|NCT01910402|323859837|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
94563993|NCT01910402|323859835|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
94563994|NCT01910402|323859836|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
94563995|NCT01910402|323859837|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
94563996|NCT01910402|323859835|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
94563997|NCT01910402|323859836|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
94563998|NCT01910402|323859837|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
94563999|NCT01910402|323859835|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
94564000|NCT01910402|323859836|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
94564001|NCT01910402|323859837|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
94564002|NCT01910402|323859835|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
94564003|NCT01910402|323859836|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
94564004|NCT01910402|323859837|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
94564005|NCT01910402|323859835|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
94564006|NCT01910402|323859836|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
94564007|NCT01910402|323859837|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
94564008|NCT01910402|323859835|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
94564009|NCT01910402|323859836|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
94564010|NCT01910402|323859837|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
94564011|NCT01910402|323859835|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
94564012|NCT01910402|323859836|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
94564013|NCT01910402|323859837|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
94564014|NCT01910402|323859835|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
94564015|NCT01910402|323859836|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
94564016|NCT01910402|323859837|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
94564017|NCT01910402|323859835|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
94564018|NCT01910402|323859836|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
94564019|NCT01910402|323859837|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
94564020|NCT01910402|323859835|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
94564021|NCT01910402|323859836|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
94564022|NCT01910402|323859837|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
94564023|NCT00887549|323859839|FG000|Induction Therapy|Adverse Event|8|||
94564024|NCT00887549|323859839|FG000|Induction Therapy|Physician Decision|1|||
94564025|NCT00887549|323859839|FG000|Induction Therapy|Progressive Disease|13|||
94564026|NCT00887549|323859839|FG000|Induction Therapy|Death due to Study Disease|4|||
94564027|NCT00887549|323859839|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
94564028|NCT00887549|323859839|FG000|Maintenance Therapy|Adverse Event|16|||
94564029|NCT00887549|323859839|FG000|Maintenance Therapy|Physician Decision|1|||
94564030|NCT00887549|323859839|FG000|Maintenance Therapy|Progressive Disease|25|||
94564031|NCT00887549|323859839|FG000|Maintenance Therapy|Death due to adverse event|1|||
94564032|NCT02524171|323859841|FG000|6-month Follow-up|Lost to Follow-up|53|||
94564033|NCT02524171|323859842|FG001|6-month Follow-up|Lost to Follow-up|45|||
94564034|NCT02524171|323859841|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
94564035|NCT02524171|323859842|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
94564036|NCT00757237|323859845|FG000|Overall Study|Lost to Follow-up|0|||
94564037|NCT00757237|323859846|FG001|Overall Study|Lost to Follow-up|1|||
94564038|NCT00757237|323859845|FG000|Overall Study|Protocol Violation|0|||
94564039|NCT00757237|323859846|FG001|Overall Study|Protocol Violation|2|||
94564040|NCT00757237|323859845|FG000|Overall Study|Physician Decision|2|||
94564041|NCT00757237|323859846|FG001|Overall Study|Physician Decision|3|||
94564042|NCT00757237|323859845|FG000|Overall Study|Withdrawal by Subject|8|||
94564043|NCT00757237|323859846|FG001|Overall Study|Withdrawal by Subject|12|||
94564044|NCT00757237|323859845|FG000|Overall Study|Safety or Tolerability|3|||
94564045|NCT00757237|323859846|FG001|Overall Study|Safety or Tolerability|5|||
94564046|NCT00757237|323859845|FG000|Overall Study|Other|0|||
94564047|NCT00757237|323859846|FG001|Overall Study|Other|2|||
94564048|NCT00216671|323859848|FG000|Overall Study|Adverse Event|4|||
94564049|NCT00216671|323859849|FG001|Overall Study|Adverse Event|9|||
94564050|NCT00216671|323859848|FG000|Overall Study|Pregnancy|0|||
94564051|NCT00216671|323859849|FG001|Overall Study|Pregnancy|1|||
94564052|NCT00216671|323859848|FG000|Overall Study|Withdrawal by Subject|4|||
94564053|NCT00216671|323859849|FG001|Overall Study|Withdrawal by Subject|2|||
94564054|NCT00216671|323859848|FG000|Overall Study|Refused Injections|3|||
94564055|NCT00216671|323859849|FG001|Overall Study|Refused Injections|13|||
94564056|NCT00216671|323859848|FG000|Overall Study|No Need to Continue Medication|1|||
94564057|NCT00216671|323859849|FG001|Overall Study|No Need to Continue Medication|1|||
94564058|NCT00216671|323859848|FG000|Overall Study|Insufficient Response|9|||
94564059|NCT00216671|323859849|FG001|Overall Study|Insufficient Response|4|||
94564060|NCT00216671|323859848|FG000|Overall Study|Lost to Follow-up|3|||
94564061|NCT00216671|323859849|FG001|Overall Study|Lost to Follow-up|5|||
94564062|NCT00216671|323859848|FG000|Overall Study|Non compliant|2|||
94564063|NCT00216671|323859849|FG001|Overall Study|Non compliant|2|||
94564064|NCT00216671|323859848|FG000|Overall Study|Ineligible|0|||
94564065|NCT00216671|323859849|FG001|Overall Study|Ineligible|2|||
94564066|NCT00216671|323859848|FG000|Overall Study|Physician Decision|1|||
94564067|NCT00216671|323859849|FG001|Overall Study|Physician Decision|1|||
94564068|NCT00216671|323859848|FG000|Overall Study|Protocol Violation|3|||
94564069|NCT00216671|323859849|FG001|Overall Study|Protocol Violation|5|||
94564070|NCT00216671|323859848|FG000|Overall Study|Relapse|1|||
94564071|NCT00216671|323859849|FG001|Overall Study|Relapse|0|||
94564072|NCT00216671|323859848|FG000|Overall Study|Investigator Illness|0|||
94564073|NCT00216671|323859849|FG001|Overall Study|Investigator Illness|1|||
94564074|NCT00216671|323859848|FG000|Overall Study|Patient Moved|0|||
94564075|NCT00216671|323859849|FG001|Overall Study|Patient Moved|1|||
94564076|NCT00216671|323859848|FG000|Overall Study|Ineligible, no efficacy data|2|||
94564077|NCT00216671|323859849|FG001|Overall Study|Ineligible, no efficacy data|2|||
94564078|NCT00216671|323859848|FG000|Overall Study|Insufficient Response Adverse Event|2|||
94564079|NCT00216671|323859849|FG001|Overall Study|Insufficient Response Adverse Event|1|||
94564080|NCT01633541|323859850|FG000|Overall Study|Death|1|||
94564081|NCT01633541|323859851|FG001|Overall Study|Death|0|||
94564082|NCT03081884|323859852|FG000|Overall Study|deferred prostate cancer treatment|1|||
94564083|NCT03081884|323859852|FG000|Overall Study|metastasis managed with systemic therapy|3|||
94564084|NCT02294058|323859856|FG000|Overall Study|Adverse Event|16|||
94564085|NCT02294058|323859857|FG001|Overall Study|Adverse Event|7|||
94564086|NCT02294058|323859858|FG002|Overall Study|Adverse Event|13|||
94658328|NCT00767000|324206152|FG001|54-week Study|Physician Decision|0|||
94564087|NCT02294058|323859856|FG000|Overall Study|Lack of Efficacy|3|||
94564088|NCT02294058|323859857|FG001|Overall Study|Lack of Efficacy|3|||
94658329|NCT00767000|324206153|FG002|54-week Study|Physician Decision|1|||
94564089|NCT02294058|323859858|FG002|Overall Study|Lack of Efficacy|0|||
94564090|NCT02294058|323859856|FG000|Overall Study|Lost to Follow-up|1|||
94564091|NCT02294058|323859857|FG001|Overall Study|Lost to Follow-up|0|||
94564092|NCT02294058|323859858|FG002|Overall Study|Lost to Follow-up|2|||
94564093|NCT02294058|323859856|FG000|Overall Study|Withdrawal by Subject|10|||
94564094|NCT02294058|323859857|FG001|Overall Study|Withdrawal by Subject|14|||
94564095|NCT02294058|323859858|FG002|Overall Study|Withdrawal by Subject|13|||
94564096|NCT02294058|323859856|FG000|Overall Study|Physician Decision|2|||
94564097|NCT02294058|323859857|FG001|Overall Study|Physician Decision|1|||
94564098|NCT02294058|323859858|FG002|Overall Study|Physician Decision|0|||
94564099|NCT02294058|323859856|FG000|Overall Study|Miscellaneous|4|||
94564100|NCT02294058|323859857|FG001|Overall Study|Miscellaneous|1|||
94564101|NCT02294058|323859858|FG002|Overall Study|Miscellaneous|1|||
94564102|NCT03575403|323859859|FG000|Overall Study|Adverse Event|1|||
94564103|NCT03575403|323859860|FG001|Overall Study|Adverse Event|0|||
94564104|NCT03575403|323859861|FG002|Overall Study|Adverse Event|0|||
94564105|NCT03575403|323859859|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
94564106|NCT03575403|323859860|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
94564107|NCT03575403|323859861|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
94564108|NCT02330055|323859863|FG000|Overall Study|technical issues|2|||
94564109|NCT02330055|323859864|FG001|Overall Study|technical issues|0|||
94564110|NCT02330055|323859863|FG000|Overall Study|participant forgot to wear device|5|||
94564111|NCT02330055|323859864|FG001|Overall Study|participant forgot to wear device|5|||
94564112|NCT02330055|323859863|FG000|Overall Study|data for less than 60 minutes|3|||
94564113|NCT02330055|323859864|FG001|Overall Study|data for less than 60 minutes|3|||
94564114|NCT02330055|323859863|FG000|Overall Study|participant did not sleep|0|||
94564115|NCT02330055|323859864|FG001|Overall Study|participant did not sleep|1|||
94564116|NCT04980612|323859865|FG000|Overall Study|Withdrawal by Subject|7|||
94564117|NCT04980612|323859866|FG001|Overall Study|Withdrawal by Subject|5|||
94564118|NCT00782717|323859869|FG000|Overall Study|Adverse Event|2|||
94564119|NCT00782717|323859870|FG001|Overall Study|Adverse Event|5|||
94235670|NCT01888874|322657955|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
94564120|NCT00782717|323859869|FG000|Overall Study|Patient decision unrelated to AE|6|||
94564121|NCT00782717|323859870|FG001|Overall Study|Patient decision unrelated to AE|3|||
94564122|NCT00782717|323859869|FG000|Overall Study|Noncompliance|2|||
94564123|NCT00782717|323859870|FG001|Overall Study|Noncompliance|1|||
94564124|NCT00782717|323859869|FG000|Overall Study|Treatment failure|3|||
94564125|NCT00782717|323859870|FG001|Overall Study|Treatment failure|14|||
94564126|NCT00782717|323859869|FG000|Overall Study|Enrollment close prior to surgery|1|||
94564127|NCT00782717|323859870|FG001|Overall Study|Enrollment close prior to surgery|0|||
94564128|NCT00782717|323859869|FG000|Overall Study|Did not meet entrance criteria|1|||
94564129|NCT00782717|323859870|FG001|Overall Study|Did not meet entrance criteria|3|||
94564130|NCT00782717|323859869|FG000|Overall Study|Exited in error|0|||
94564131|NCT00782717|323859870|FG001|Overall Study|Exited in error|2|||
94564132|NCT02446717|323859871|FG000|Overall Study|Adverse Event|0|||
94564133|NCT02446717|323859872|FG001|Overall Study|Adverse Event|0|||
94564134|NCT02446717|323859873|FG002|Overall Study|Adverse Event|1|||
94564135|NCT02446717|323859874|FG003|Overall Study|Adverse Event|0|||
94564136|NCT02446717|323859875|FG004|Overall Study|Adverse Event|0|||
94564137|NCT02446717|323859871|FG000|Overall Study|Lost to Follow-up|0|||
94564138|NCT02446717|323859872|FG001|Overall Study|Lost to Follow-up|1|||
94564139|NCT02446717|323859873|FG002|Overall Study|Lost to Follow-up|1|||
94564140|NCT02446717|323859874|FG003|Overall Study|Lost to Follow-up|0|||
94564141|NCT02446717|323859875|FG004|Overall Study|Lost to Follow-up|1|||
94564142|NCT02446717|323859871|FG000|Overall Study|Withdrew consent|0|||
94564143|NCT02446717|323859872|FG001|Overall Study|Withdrew consent|0|||
94564144|NCT02446717|323859873|FG002|Overall Study|Withdrew consent|0|||
94564145|NCT02446717|323859874|FG003|Overall Study|Withdrew consent|1|||
94564146|NCT02446717|323859875|FG004|Overall Study|Withdrew consent|0|||
94564147|NCT00596752|323859879|FG000|Overall Study|Other Reason|44|||
94564148|NCT00596752|323859880|FG001|Overall Study|Other Reason|49|||
94564149|NCT00596752|323859879|FG000|Overall Study|Adverse Event|34|||
94564150|NCT00596752|323859880|FG001|Overall Study|Adverse Event|34|||
94564151|NCT00596752|323859879|FG000|Overall Study|Lost to Follow-up|22|||
94564152|NCT00596752|323859880|FG001|Overall Study|Lost to Follow-up|38|||
94564153|NCT00596752|323859879|FG000|Overall Study|Withdrawal by Subject|12|||
94564154|NCT00596752|323859880|FG001|Overall Study|Withdrawal by Subject|9|||
94564155|NCT00596752|323859879|FG000|Overall Study|Unsatisfactory Compliance|9|||
94564156|NCT00596752|323859880|FG001|Overall Study|Unsatisfactory Compliance|6|||
94564157|NCT00596752|323859879|FG000|Overall Study|Lack of Efficacy|4|||
94564158|NCT00596752|323859880|FG001|Overall Study|Lack of Efficacy|7|||
94564159|NCT00596752|323859879|FG000|Overall Study|Protocol Violation|1|||
94564160|NCT00596752|323859880|FG001|Overall Study|Protocol Violation|0|||
94564161|NCT01807598|323859881|FG000|Overall Study|Withdrawal by Subject|4|||
94564162|NCT01807598|323859881|FG000|Overall Study|Adverse Event|1|||
94564163|NCT01807598|323859881|FG000|Overall Study|Other Physician Decision|1|||
94564164|NCT02717494|323859883|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
94564165|NCT02717494|323859884|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
94564166|NCT02717494|323859885|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
94564167|NCT02717494|323859883|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
94564168|NCT02717494|323859884|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
94564169|NCT02717494|323859885|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
94564170|NCT02717494|323859883|FG000|First Intervention (Step 1)|Death|0|||
94564171|NCT02717494|323859884|FG001|First Intervention (Step 1)|Death|0|||
94347039|NCT04009824|323050877|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
94564172|NCT02717494|323859885|FG002|First Intervention (Step 1)|Death|1|||
94564173|NCT02717494|323859883|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
94564174|NCT02717494|323859884|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
94564175|NCT02717494|323859885|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
94564176|NCT02488005|323859886|FG000|Overall Study|Lost to Follow-up|2|||
94564177|NCT01156714|323859892|FG000|Overall Study|Withdrawal by Subject|9|||
94564178|NCT01156714|323859893|FG001|Overall Study|Withdrawal by Subject|4|||
94564179|NCT01156714|323859894|FG002|Overall Study|Withdrawal by Subject|3|||
94564180|NCT01279681|323859901|FG000|Overall Study|Disease Progression|9|||
94564181|NCT01279681|323859902|FG001|Overall Study|Disease Progression|6|||
94235671|NCT01888874|322657956|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
94235672|NCT01888874|322657957|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
94564182|NCT01279681|323859901|FG000|Overall Study|Withdrawal by Subject|3|||
94564183|NCT01279681|323859902|FG001|Overall Study|Withdrawal by Subject|4|||
94564184|NCT01279681|323859901|FG000|Overall Study|Adverse Event|2|||
94564185|NCT01279681|323859902|FG001|Overall Study|Adverse Event|3|||
94564186|NCT01279681|323859901|FG000|Overall Study|Death|0|||
94564187|NCT01279681|323859902|FG001|Overall Study|Death|1|||
94564188|NCT01279681|323859901|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
94564189|NCT01279681|323859902|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
94564190|NCT01279681|323859901|FG000|Overall Study|Physician Decision|1|||
94564191|NCT01279681|323859902|FG001|Overall Study|Physician Decision|0|||
94564192|NCT01279681|323859901|FG000|Overall Study|Other Reason|0|||
94564193|NCT01279681|323859902|FG001|Overall Study|Other Reason|2|||
94564194|NCT00855959|323860966|FG000|Overall Study|Adverse Event|2|||
94564195|NCT00855959|323860966|FG000|Overall Study|Lost to Follow-up|2|||
94564196|NCT00855959|323860966|FG000|Overall Study|Withdrawal by Subject|3|||
94564197|NCT00855959|323860966|FG000|Overall Study|Pregnancy|1|||
94564198|NCT00855959|323860966|FG000|Overall Study|Incorrect enrolment|1|||
94564199|NCT02420379|323860969|FG000|Overall Study|Withdrawal by Subject|0|||
94564200|NCT02420379|323860970|FG001|Overall Study|Withdrawal by Subject|3|||
94564201|NCT02420379|323860969|FG000|Overall Study|Unable to complete due to schooling|0|||
94564202|NCT02420379|323860970|FG001|Overall Study|Unable to complete due to schooling|1|||
94564203|NCT02420379|323860969|FG000|Overall Study|Transitioned to commercial drug|1|||
94564204|NCT02420379|323860970|FG001|Overall Study|Transitioned to commercial drug|0|||
94564205|NCT00681629|323860977|FG000|Overall Study|Study termination|4|||
94564206|NCT00681629|323860978|FG001|Overall Study|Study termination|2|||
94564207|NCT00681629|323860977|FG000|Overall Study|Adverse Event|1|||
94564208|NCT00681629|323860978|FG001|Overall Study|Adverse Event|0|||
94564209|NCT00412893|323860980|FG000|Overall Study|Adverse Event|31|||
94564210|NCT00412893|323860981|FG001|Overall Study|Adverse Event|53|||
94235673|NCT01888874|322657958|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
94235674|NCT01888874|322657959|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
94235675|NCT01888874|322657960|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
94235676|NCT01888874|322657961|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
94235677|NCT01888874|322657955|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
94235678|NCT01888874|322657956|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
94235679|NCT01888874|322657957|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
94235680|NCT01888874|322657958|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
94235681|NCT01888874|322657959|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
94235682|NCT01888874|322657960|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
94235683|NCT01888874|322657961|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
94235684|NCT01888874|322657955|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
94235685|NCT01888874|322657956|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
94235686|NCT01888874|322657957|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
94235687|NCT01888874|322657958|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
94235688|NCT01888874|322657959|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
94235689|NCT01888874|322657960|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
94235690|NCT01888874|322657961|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
94235691|NCT01888874|322657955|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
94235692|NCT01888874|322657956|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
94235693|NCT01888874|322657957|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
94235694|NCT01888874|322657958|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
94235695|NCT01888874|322657959|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
94235696|NCT01888874|322657960|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
94235697|NCT01888874|322657961|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
94235698|NCT01888874|322657955|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
94347040|NCT01024946|323050878|FG000|Overall Study|Screen Failure|3|||
94347041|NCT01024946|323050878|FG000|Overall Study|Withdrawal by Subject|1|||
94347042|NCT01024946|323050878|FG000|Overall Study|Adverse Event|1|||
94347043|NCT00957723|323050881|FG000|Overall Study|Death|3|||
94347044|NCT00957723|323050881|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
94347045|NCT00957723|323050881|FG000|Overall Study|Lost to Follow-up|8|||
94347046|NCT00957723|323050881|FG000|Overall Study|Withdrawal by Subject|24|||
94347047|NCT00957723|323050881|FG000|Overall Study|Investigative Site Terminated|61|||
94347048|NCT00957723|323050881|FG000|Overall Study|Intercurrent Illness|2|||
94347049|NCT00957723|323050881|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
94347050|NCT01468844|323050884|FG000|Overall Study|Adverse Event|1|||
94564211|NCT00412893|323860980|FG000|Overall Study|Death|17|||
94564212|NCT00412893|323860981|FG001|Overall Study|Death|21|||
94564213|NCT00412893|323860980|FG000|Overall Study|Insufficient Therapeutic Response|39|||
94564214|NCT00412893|323860981|FG001|Overall Study|Insufficient Therapeutic Response|23|||
94564215|NCT00412893|323860980|FG000|Overall Study|Lost to Follow-up|2|||
94564216|NCT00412893|323860981|FG001|Overall Study|Lost to Follow-up|1|||
94564217|NCT00412893|323860980|FG000|Overall Study|Violation of Selection at Entry|17|||
94564218|NCT00412893|323860981|FG001|Overall Study|Violation of Selection at Entry|10|||
94564219|NCT00412893|323860980|FG000|Overall Study|Other Protocol Violation|10|||
94564220|NCT00412893|323860981|FG001|Overall Study|Other Protocol Violation|6|||
94564221|NCT00412893|323860980|FG000|Overall Study|Did Not Cooperate|12|||
94564222|NCT00412893|323860981|FG001|Overall Study|Did Not Cooperate|9|||
94564223|NCT00412893|323860980|FG000|Overall Study|Administrative Reason|12|||
94347051|NCT01468844|323050885|FG001|Overall Study|Adverse Event|0|||
94564224|NCT00412893|323860981|FG001|Overall Study|Administrative Reason|15|||
94564225|NCT00412893|323860980|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
94564226|NCT00412893|323860981|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
94564227|NCT03010319|323860988|FG000|Overall Study|Adverse Event|15|||
94564228|NCT03010319|323860989|FG001|Overall Study|Adverse Event|9|||
94564229|NCT03010319|323860988|FG000|Overall Study|Withdrawal by Subject|1|||
94564230|NCT03010319|323860989|FG001|Overall Study|Withdrawal by Subject|6|||
94564231|NCT03010319|323860988|FG000|Overall Study|Physician Decision|2|||
94564232|NCT03010319|323860989|FG001|Overall Study|Physician Decision|4|||
94564233|NCT03010319|323860988|FG000|Overall Study|Sponsor requested withdrawal|2|||
94564234|NCT03010319|323860989|FG001|Overall Study|Sponsor requested withdrawal|2|||
94564235|NCT03010319|323860988|FG000|Overall Study|Death|1|||
94564236|NCT03010319|323860989|FG001|Overall Study|Death|0|||
94564237|NCT03010319|323860988|FG000|Overall Study|Lost to Follow-up|0|||
94564238|NCT03010319|323860989|FG001|Overall Study|Lost to Follow-up|1|||
94564239|NCT03010319|323860988|FG000|Overall Study|Other Reason|5|||
94564240|NCT03010319|323860989|FG001|Overall Study|Other Reason|7|||
94564241|NCT01442714|323860990|FG000|Overall Study|Death|11|||
94564242|NCT01442714|323860990|FG000|Overall Study|Withdrawal by Subject|1|||
94564243|NCT02598297|323860992|FG000|Overall Study|Study terminated by Sponsor|21|||
94564244|NCT02598297|323860993|FG001|Overall Study|Study terminated by Sponsor|23|||
94564245|NCT02598297|323860992|FG000|Overall Study|Adverse Event|1|||
94564246|NCT02598297|323860993|FG001|Overall Study|Adverse Event|1|||
94564247|NCT02598297|323860992|FG000|Overall Study|Physician Decision|1|||
94564248|NCT02598297|323860993|FG001|Overall Study|Physician Decision|0|||
94564249|NCT02598297|323860992|FG000|Overall Study|Subject/guardian decision|1|||
94564250|NCT02598297|323860993|FG001|Overall Study|Subject/guardian decision|0|||
94564251|NCT02598297|323860992|FG000|Overall Study|Followed for survival|1|||
94564252|NCT02598297|323860993|FG001|Overall Study|Followed for survival|0|||
94564253|NCT01746368|323860995|FG000|Overall Study|Lost to Follow-up|2|||
94564254|NCT01746368|323860996|FG001|Overall Study|Lost to Follow-up|0|||
94564255|NCT01746368|323860995|FG000|Overall Study|Withdrawal by Subject|0|||
94564256|NCT01746368|323860996|FG001|Overall Study|Withdrawal by Subject|1|||
94564257|NCT00714415|323860997|FG000|Overall Study|Lack of Efficacy|1|||
94564258|NCT00714415|323860998|FG001|Overall Study|Lack of Efficacy|0|||
94564259|NCT00714415|323860997|FG000|Overall Study|Death|1|||
94564260|NCT00714415|323860998|FG001|Overall Study|Death|0|||
94564261|NCT03801174|323860999|FG000|Overall Study|Withdrawal by Subject|14|||
94564262|NCT03801174|323861000|FG001|Overall Study|Withdrawal by Subject|15|||
94564263|NCT03801174|323860999|FG000|Overall Study|Death|1|||
94564264|NCT03801174|323861000|FG001|Overall Study|Death|0|||
94564265|NCT03801174|323860999|FG000|Overall Study|Pregnancy|2|||
94564266|NCT03801174|323861000|FG001|Overall Study|Pregnancy|2|||
94564267|NCT03801174|323860999|FG000|Overall Study|Lost to Follow-up|19|||
94564268|NCT03801174|323861000|FG001|Overall Study|Lost to Follow-up|10|||
94564269|NCT03801174|323860999|FG000|Overall Study|Other|4|||
94564270|NCT03801174|323861000|FG001|Overall Study|Other|3|||
94564271|NCT03801174|323860999|FG000|Overall Study|Lack of Efficacy|4|||
94564272|NCT03801174|323861000|FG001|Overall Study|Lack of Efficacy|0|||
94564273|NCT03801174|323860999|FG000|Overall Study|Unwilling to complete activities|5|||
94564274|NCT03801174|323861000|FG001|Overall Study|Unwilling to complete activities|6|||
94564275|NCT03801174|323860999|FG000|Overall Study|Moved out of area|3|||
94564276|NCT03801174|323861000|FG001|Overall Study|Moved out of area|0|||
94564277|NCT01965704|323861003|FG000|Overall Study|Withdrawal by Subject|2|||
94564278|NCT01965704|323861004|FG001|Overall Study|Withdrawal by Subject|2|||
94564279|NCT01965704|323861005|FG002|Overall Study|Withdrawal by Subject|1|||
94564280|NCT01965704|323861006|FG003|Overall Study|Withdrawal by Subject|1|||
94564281|NCT01965704|323861003|FG000|Overall Study|Delivered at home|1|||
94564282|NCT01965704|323861004|FG001|Overall Study|Delivered at home|1|||
94564283|NCT01965704|323861005|FG002|Overall Study|Delivered at home|0|||
94564284|NCT01965704|323861006|FG003|Overall Study|Delivered at home|0|||
94564285|NCT01965704|323861003|FG000|Overall Study|Experienced complications|0|||
94564286|NCT01965704|323861004|FG001|Overall Study|Experienced complications|0|||
94564287|NCT01965704|323861005|FG002|Overall Study|Experienced complications|2|||
94564288|NCT01965704|323861006|FG003|Overall Study|Experienced complications|2|||
94564289|NCT01965704|323861003|FG000|Overall Study|Adverse Event|0|||
94564290|NCT01965704|323861004|FG001|Overall Study|Adverse Event|0|||
94564291|NCT01965704|323861005|FG002|Overall Study|Adverse Event|1|||
94564292|NCT01965704|323861006|FG003|Overall Study|Adverse Event|1|||
94564293|NCT01965704|323861003|FG000|Overall Study|Did not meet inclusion criteria|0|||
94564294|NCT01965704|323861004|FG001|Overall Study|Did not meet inclusion criteria|0|||
94564295|NCT01965704|323861005|FG002|Overall Study|Did not meet inclusion criteria|1|||
94564296|NCT01965704|323861006|FG003|Overall Study|Did not meet inclusion criteria|1|||
94564297|NCT00687804|323861007|FG000|Core Study|Adverse Event|5|||
94564298|NCT00687804|323861008|FG001|Core Study|Adverse Event|3|||
94450590|NCT03482453|323436896|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
94450591|NCT03482453|323436897|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
94450592|NCT03482453|323436898|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
94450593|NCT03482453|323436899|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
94450594|NCT02187198|323436905|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
94450595|NCT02187198|323436906|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
94450596|NCT02187198|323436905|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
94450597|NCT02187198|323436906|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
94450598|NCT03018080|323436907|FG000|Overall Study|Death|12|||
94450599|NCT03018080|323436908|FG001|Overall Study|Death|19|||
94450600|NCT00561392|323436909|FG000|Overall Study|Adverse Event|38|||
94450601|NCT00561392|323436909|FG000|Overall Study|Lack of Efficacy|2|||
94450602|NCT00561392|323436909|FG000|Overall Study|Protocol Violation|1|||
94450603|NCT00561392|323436909|FG000|Overall Study|Withdrawal by Subject|8|||
94450604|NCT00561392|323436909|FG000|Overall Study|Administrative problems|4|||
94450605|NCT00740792|323436910|FG000|Overall Study|Adverse Event|3|||
94450606|NCT00740792|323436911|FG001|Overall Study|Adverse Event|1|||
94450607|NCT00740792|323436912|FG002|Overall Study|Adverse Event|1|||
94450608|NCT00740792|323436913|FG003|Overall Study|Adverse Event|3|||
94450609|NCT00740792|323436910|FG000|Overall Study|Lack of Efficacy|1|||
94450610|NCT00740792|323436911|FG001|Overall Study|Lack of Efficacy|1|||
94450611|NCT00740792|323436912|FG002|Overall Study|Lack of Efficacy|0|||
94450612|NCT00740792|323436913|FG003|Overall Study|Lack of Efficacy|3|||
94450613|NCT00740792|323436910|FG000|Overall Study|Lost to Follow-up|2|||
94450614|NCT00740792|323436911|FG001|Overall Study|Lost to Follow-up|1|||
94450615|NCT00740792|323436912|FG002|Overall Study|Lost to Follow-up|0|||
94450616|NCT00740792|323436913|FG003|Overall Study|Lost to Follow-up|0|||
94450617|NCT00740792|323436910|FG000|Overall Study|Protocol Violation|0|||
94450618|NCT00740792|323436911|FG001|Overall Study|Protocol Violation|1|||
94450619|NCT00740792|323436912|FG002|Overall Study|Protocol Violation|0|||
94450620|NCT00740792|323436913|FG003|Overall Study|Protocol Violation|2|||
94450621|NCT00740792|323436910|FG000|Overall Study|Withdrawal by Subject|1|||
94450622|NCT00740792|323436911|FG001|Overall Study|Withdrawal by Subject|1|||
94450623|NCT00740792|323436912|FG002|Overall Study|Withdrawal by Subject|0|||
94564299|NCT00687804|323861009|FG002|Core Study|Adverse Event|3|||
94564300|NCT00687804|323861007|FG000|Core Study|Abnormal laboratory value(s)|1|||
94564301|NCT00687804|323861008|FG001|Core Study|Abnormal laboratory value(s)|0|||
94564302|NCT00687804|323861009|FG002|Core Study|Abnormal laboratory value(s)|0|||
94450624|NCT00740792|323436913|FG003|Overall Study|Withdrawal by Subject|0|||
94564303|NCT00687804|323861007|FG000|Core Study|Lack of Efficacy|1|||
94564304|NCT00687804|323861008|FG001|Core Study|Lack of Efficacy|1|||
94564305|NCT00687804|323861009|FG002|Core Study|Lack of Efficacy|1|||
94564306|NCT00687804|323861007|FG000|Core Study|Withdrawal by Subject|4|||
94564307|NCT00687804|323861008|FG001|Core Study|Withdrawal by Subject|7|||
94564308|NCT00687804|323861009|FG002|Core Study|Withdrawal by Subject|7|||
94564309|NCT00687804|323861007|FG000|Core Study|Lost to Follow-up|0|||
94564310|NCT00687804|323861008|FG001|Core Study|Lost to Follow-up|1|||
94564311|NCT00687804|323861009|FG002|Core Study|Lost to Follow-up|0|||
94564312|NCT00687804|323861007|FG000|Core Study|Death|2|||
94564313|NCT00687804|323861008|FG001|Core Study|Death|2|||
94564314|NCT00687804|323861009|FG002|Core Study|Death|2|||
94564315|NCT00687804|323861007|FG000|Core Study|Protocol Violation|1|||
94564316|NCT00687804|323861008|FG001|Core Study|Protocol Violation|1|||
94564317|NCT00687804|323861009|FG002|Core Study|Protocol Violation|0|||
94564318|NCT00687804|323861007|FG000|Open-Label Extension Study|Adverse Event|2|||
94564319|NCT00687804|323861008|FG001|Open-Label Extension Study|Adverse Event|2|||
94564320|NCT00687804|323861009|FG002|Open-Label Extension Study|Adverse Event|2|||
94564321|NCT00687804|323861007|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
94564322|NCT00687804|323861008|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
94564323|NCT00687804|323861009|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
94564324|NCT00687804|323861007|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
94564325|NCT00687804|323861008|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
94564326|NCT00687804|323861009|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
94564327|NCT00687804|323861007|FG000|Open-Label Extension Study|Administrative problems|1|||
94564328|NCT00687804|323861008|FG001|Open-Label Extension Study|Administrative problems|1|||
94564329|NCT00687804|323861009|FG002|Open-Label Extension Study|Administrative problems|0|||
94450625|NCT00740792|323436910|FG000|Overall Study|administrative|3|||
94450626|NCT00740792|323436911|FG001|Overall Study|administrative|3|||
94450627|NCT00740792|323436912|FG002|Overall Study|administrative|8|||
94235699|NCT01888874|322657956|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
94450628|NCT00740792|323436913|FG003|Overall Study|administrative|2|||
94564330|NCT00687804|323861007|FG000|Open-Label Extension Study|Death|2|||
94564331|NCT00687804|323861008|FG001|Open-Label Extension Study|Death|3|||
94564332|NCT00687804|323861009|FG002|Open-Label Extension Study|Death|3|||
94564333|NCT04390243|323861010|FG000|Overall Study|Death|1|||
94235700|NCT01888874|322657957|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
94235701|NCT01888874|322657958|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
94235702|NCT01888874|322657959|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
94235703|NCT01888874|322657960|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
94235704|NCT01888874|322657961|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
94235705|NCT01888874|322657955|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
94450629|NCT01019694|323436916|FG000|Overall Study|Adverse Event|12|||
94450630|NCT01019694|323436917|FG001|Overall Study|Adverse Event|16|||
94450631|NCT01019694|323436918|FG002|Overall Study|Adverse Event|19|||
94450632|NCT01019694|323436916|FG000|Overall Study|Protocol Violation|2|||
94450633|NCT01019694|323436917|FG001|Overall Study|Protocol Violation|6|||
94450634|NCT01019694|323436918|FG002|Overall Study|Protocol Violation|4|||
94450635|NCT01019694|323436916|FG000|Overall Study|Lost to Follow-up|5|||
94450636|NCT01019694|323436917|FG001|Overall Study|Lost to Follow-up|3|||
94450637|NCT01019694|323436918|FG002|Overall Study|Lost to Follow-up|3|||
94564334|NCT04390243|323861010|FG000|Overall Study|Disease Progression|4|||
94450638|NCT01019694|323436916|FG000|Overall Study|Withdrawal by Subject|4|||
94564335|NCT04390243|323861010|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
94564336|NCT02698826|323861011|FG000|Overall Study|Death|13|||
94564337|NCT02698826|323861011|FG000|Overall Study|Adverse Event|1|||
94564338|NCT02478463|323861012|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
94564339|NCT02478463|323861012|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
94564340|NCT02478463|323861012|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
94564341|NCT01879683|323861015|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
94564342|NCT04950465|323861016|FG000|Overall Study|Lost to Follow-up|1|||
94564343|NCT04950465|323861017|FG001|Overall Study|Lost to Follow-up|0|||
94564344|NCT04950465|323861018|FG002|Overall Study|Lost to Follow-up|0|||
94564345|NCT00556998|323861019|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
94564346|NCT00556998|323861019|FG000|Voriconazole Intravenous (IV)|Other|4|||
94235706|NCT01888874|322657956|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
94564347|NCT00556998|323861019|FG000|Voriconazole Oral|Adverse Event|1|||
94564348|NCT00556998|323861019|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
94564349|NCT01970306|323861020|FG000|Overall Study|Not eligible|3|||
94564350|NCT01970306|323861020|FG000|Overall Study|Not able to be treated|9|||
94564351|NCT00226811|323861021|FG000|Overall Study|Death|8|||
94564352|NCT00226811|323861021|FG000|Overall Study|Adverse Event|11|||
94564353|NCT00226811|323861021|FG000|Overall Study|Lack of Efficacy|55|||
94564354|NCT00226811|323861021|FG000|Overall Study|Withdrawal by Subject|2|||
94564355|NCT00369577|323861024|FG000|Overall Study|Withdrawal by Subject|0|||
94564356|NCT00369577|323861025|FG001|Overall Study|Withdrawal by Subject|0|||
94564357|NCT00369577|323861026|FG002|Overall Study|Withdrawal by Subject|1|||
94564358|NCT02292719|323861027|FG000|Overall Study|Withdrawal by Subject|0|||
94564359|NCT02292719|323861028|FG001|Overall Study|Withdrawal by Subject|0|||
94564360|NCT02292719|323861029|FG002|Overall Study|Withdrawal by Subject|0|||
94564361|NCT02292719|323861030|FG003|Overall Study|Withdrawal by Subject|1|||
94564362|NCT02292719|323861031|FG004|Overall Study|Withdrawal by Subject|1|||
94564363|NCT02292719|323861032|FG005|Overall Study|Withdrawal by Subject|0|||
94564364|NCT02292719|323861027|FG000|Overall Study|Subject enrolled in new study.|0|||
94564365|NCT02292719|323861028|FG001|Overall Study|Subject enrolled in new study.|0|||
94564366|NCT02292719|323861029|FG002|Overall Study|Subject enrolled in new study.|1|||
94564367|NCT02292719|323861030|FG003|Overall Study|Subject enrolled in new study.|0|||
94564368|NCT02292719|323861031|FG004|Overall Study|Subject enrolled in new study.|0|||
94564369|NCT02292719|323861032|FG005|Overall Study|Subject enrolled in new study.|0|||
94564370|NCT03384940|323861035|FG000|Overall Study|Progressive disease|36|||
94564371|NCT03384940|323861036|FG001|Overall Study|Progressive disease|11|||
94564372|NCT03384940|323861037|FG002|Overall Study|Progressive disease|13|||
94564373|NCT03384940|323861035|FG000|Overall Study|Clinical progression|4|||
94450639|NCT01019694|323436917|FG001|Overall Study|Withdrawal by Subject|6|||
94564374|NCT03384940|323861036|FG001|Overall Study|Clinical progression|0|||
94564375|NCT03384940|323861037|FG002|Overall Study|Clinical progression|3|||
94564376|NCT03384940|323861035|FG000|Overall Study|Adverse Event|7|||
94564377|NCT03384940|323861036|FG001|Overall Study|Adverse Event|1|||
94564378|NCT03384940|323861037|FG002|Overall Study|Adverse Event|1|||
94564379|NCT03384940|323861035|FG000|Overall Study|Withdrawal by Subject|3|||
94347052|NCT01468844|323050884|FG000|Overall Study|Withdrawal by Subject|1|||
94347053|NCT01468844|323050885|FG001|Overall Study|Withdrawal by Subject|0|||
94564380|NCT03384940|323861036|FG001|Overall Study|Withdrawal by Subject|1|||
94564381|NCT03384940|323861037|FG002|Overall Study|Withdrawal by Subject|0|||
94564382|NCT03384940|323861035|FG000|Overall Study|Physician Decision|1|||
94564383|NCT03384940|323861036|FG001|Overall Study|Physician Decision|1|||
94564384|NCT03384940|323861037|FG002|Overall Study|Physician Decision|0|||
94564385|NCT03384940|323861035|FG000|Overall Study|Death|2|||
94564386|NCT03384940|323861036|FG001|Overall Study|Death|1|||
94564387|NCT03384940|323861037|FG002|Overall Study|Death|0|||
94564388|NCT03384940|323861035|FG000|Overall Study|Other|0|||
94564389|NCT03384940|323861036|FG001|Overall Study|Other|0|||
94564390|NCT03384940|323861037|FG002|Overall Study|Other|1|||
94564391|NCT03089580|323861040|FG000|Overall Study|Lost to Follow-up|2|||
94564392|NCT02326597|323861041|FG000|Overall Study|Lost to Follow-up|42|||
94564393|NCT02326597|323861042|FG001|Overall Study|Lost to Follow-up|32|||
94564394|NCT04037891|323861043|FG000|Open-label Period|Withdrawal by Subject|1|||
94564395|NCT04037891|323861044|FG001|Open-label Period|Withdrawal by Subject|0|||
94564396|NCT04037891|323861045|FG002|Open-label Period|Withdrawal by Subject|0|||
94564397|NCT04037891|323861043|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
94564398|NCT04037891|323861044|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
94564399|NCT04037891|323861045|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
94564400|NCT00866814|323861046|FG000|Overall Study|Lost to Follow-up|12|||
94564401|NCT00866814|323861046|FG000|Overall Study|Adverse Event|2|||
94564402|NCT00866814|323861046|FG000|Overall Study|Physician Decision|1|||
94564403|NCT00866814|323861046|FG000|Overall Study|Death|1|||
94564404|NCT00866814|323861046|FG000|Overall Study|No longer wished to participate|1|||
94564405|NCT00866814|323861046|FG000|Overall Study|Unable to meet follow-up requirements|2|||
94450640|NCT01019694|323436918|FG002|Overall Study|Withdrawal by Subject|12|||
94450641|NCT01019694|323436916|FG000|Overall Study|Not treated|0|||
94450642|NCT01019694|323436917|FG001|Overall Study|Not treated|2|||
94450643|NCT01019694|323436918|FG002|Overall Study|Not treated|3|||
94450644|NCT01019694|323436916|FG000|Overall Study|Other reason (not specified)|1|||
94450645|NCT01019694|323436917|FG001|Overall Study|Other reason (not specified)|5|||
94450646|NCT01019694|323436918|FG002|Overall Study|Other reason (not specified)|6|||
94450647|NCT00179660|323436920|FG000|Overall Study|Adverse Event|7|||
94450648|NCT00179660|323436920|FG000|Overall Study|Lack of therapeutic effect|28|||
94450649|NCT00179660|323436920|FG000|Overall Study|Withdrawal by Subject|2|||
94450650|NCT00179660|323436920|FG000|Overall Study|Lost to Follow-up|1|||
94450651|NCT00179660|323436920|FG000|Overall Study|Death|3|||
94450652|NCT00179660|323436920|FG000|Overall Study|Other - Unspecified|9|||
94450653|NCT03777436|323436923|FG000|Placebo-controlled Phase|Adverse Event|8|||
94235707|NCT01888874|322657957|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
94235708|NCT01888874|322657958|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
94235709|NCT01888874|322657959|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
94235710|NCT01888874|322657960|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
94235711|NCT01888874|322657961|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
94235712|NCT00475644|322657966|FG000|Overall Study|Protocol Violation|13|||
94235713|NCT02980042|322657967|FG000|Overall Study|Lost to Follow-up|5|||
94235714|NCT02980042|322657968|FG001|Overall Study|Lost to Follow-up|0|||
94235715|NCT02980042|322657967|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
94235716|NCT02980042|322657968|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
94235717|NCT01131104|322657969|FG000|Overall Study|Withdrawal by Subject|3|||
94235718|NCT01131104|322657969|FG000|Overall Study|Physician Decision|4|||
94235719|NCT01131104|322657969|FG000|Overall Study|Information Not Available|5|||
94235720|NCT01131104|322657969|FG000|Overall Study|No Information on Index Date of Onset|1|||
94235721|NCT00334542|322657972|FG000|Overall Study|Adverse Event|3|||
94235722|NCT00334542|322657972|FG000|Overall Study|Withdrawal by Subject|1|||
94235723|NCT00334542|322657972|FG000|Overall Study|New cancer diagnosis|1|||
94235724|NCT02370251|322657973|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
94235725|NCT02370251|322657973|FG000|Overall Study|Death|4|||
94235726|NCT00944229|322657977|FG000|Overall Study|Withdrawal by Subject|11|||
94235727|NCT00944229|322657977|FG000|Overall Study|Physician Decision|14|||
94235728|NCT01606319|322657978|FG000|Overall Study|Lost to Follow-up|17|||
94235729|NCT01606319|322657979|FG001|Overall Study|Lost to Follow-up|14|||
94235730|NCT01606319|322657978|FG000|Overall Study|Withdrawal by Subject|9|||
94235731|NCT01606319|322657979|FG001|Overall Study|Withdrawal by Subject|12|||
94235732|NCT01606319|322657978|FG000|Overall Study|Physician Decision|1|||
94235733|NCT01606319|322657979|FG001|Overall Study|Physician Decision|2|||
94235734|NCT01606319|322657978|FG000|Overall Study|Lack of Efficacy|6|||
94235735|NCT01606319|322657979|FG001|Overall Study|Lack of Efficacy|8|||
94235736|NCT01606319|322657978|FG000|Overall Study|Adverse Event|1|||
94235737|NCT01606319|322657979|FG001|Overall Study|Adverse Event|4|||
94235738|NCT04292470|322657981|FG000|Overall Study|Withdrawal by Subject|0|||
94235739|NCT04292470|322657982|FG001|Overall Study|Withdrawal by Subject|1|||
94235740|NCT04698915|322658005|FG000|Overall Study|Adverse Event|2|||
94235741|NCT04698915|322658006|FG001|Overall Study|Adverse Event|0|||
94235742|NCT04698915|322658005|FG000|Overall Study|Death|23|||
94450654|NCT03777436|323436924|FG001|Placebo-controlled Phase|Adverse Event|10|||
94450655|NCT03777436|323436925|FG002|Placebo-controlled Phase|Adverse Event|0|||
94450656|NCT03777436|323436923|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
94450657|NCT03777436|323436924|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
94450658|NCT03777436|323436925|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
94658330|NCT00767000|324206154|FG003|54-week Study|Physician Decision|1|||
94564406|NCT00866814|323861046|FG000|Overall Study|Moved to area without study site|1|||
94564407|NCT03160898|323861050|FG000|Overall Study|Adverse Event|4|||
94564408|NCT03160898|323861051|FG001|Overall Study|Adverse Event|8|||
94564409|NCT03160898|323861052|FG002|Overall Study|Adverse Event|7|||
94564410|NCT03160898|323861053|FG003|Overall Study|Adverse Event|10|||
94564411|NCT03160898|323861050|FG000|Overall Study|Death|1|||
94564412|NCT03160898|323861051|FG001|Overall Study|Death|0|||
94564413|NCT03160898|323861052|FG002|Overall Study|Death|0|||
94564414|NCT03160898|323861053|FG003|Overall Study|Death|1|||
94564415|NCT03160898|323861050|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
94564416|NCT03160898|323861051|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
94564417|NCT03160898|323861052|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
94564418|NCT03160898|323861053|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
94564419|NCT03160898|323861050|FG000|Overall Study|Lost to Follow-up|1|||
94564420|NCT03160898|323861051|FG001|Overall Study|Lost to Follow-up|1|||
94564421|NCT03160898|323861052|FG002|Overall Study|Lost to Follow-up|1|||
94564422|NCT03160898|323861053|FG003|Overall Study|Lost to Follow-up|2|||
94564423|NCT03160898|323861050|FG000|Overall Study|Physician Decision|1|||
94564424|NCT03160898|323861051|FG001|Overall Study|Physician Decision|0|||
94564425|NCT03160898|323861052|FG002|Overall Study|Physician Decision|0|||
94564426|NCT03160898|323861053|FG003|Overall Study|Physician Decision|1|||
94564427|NCT03160898|323861050|FG000|Overall Study|Progressive Disease|4|||
94564428|NCT03160898|323861051|FG001|Overall Study|Progressive Disease|1|||
94564429|NCT03160898|323861052|FG002|Overall Study|Progressive Disease|2|||
94564430|NCT03160898|323861053|FG003|Overall Study|Progressive Disease|1|||
94564431|NCT03160898|323861050|FG000|Overall Study|Protocol Violation|1|||
94564432|NCT03160898|323861051|FG001|Overall Study|Protocol Violation|0|||
94564433|NCT03160898|323861052|FG002|Overall Study|Protocol Violation|2|||
94564434|NCT03160898|323861053|FG003|Overall Study|Protocol Violation|0|||
94564435|NCT03160898|323861050|FG000|Overall Study|Sponsor Discretion|2|||
94564436|NCT03160898|323861051|FG001|Overall Study|Sponsor Discretion|0|||
94564437|NCT03160898|323861052|FG002|Overall Study|Sponsor Discretion|0|||
94564438|NCT03160898|323861053|FG003|Overall Study|Sponsor Discretion|0|||
94564439|NCT03160898|323861050|FG000|Overall Study|Withdrawal by Subject|1|||
94564440|NCT03160898|323861051|FG001|Overall Study|Withdrawal by Subject|3|||
94564441|NCT03160898|323861052|FG002|Overall Study|Withdrawal by Subject|2|||
94564442|NCT03160898|323861053|FG003|Overall Study|Withdrawal by Subject|1|||
94564443|NCT03160898|323861050|FG000|Overall Study|Other|2|||
94564444|NCT03160898|323861051|FG001|Overall Study|Other|0|||
94564445|NCT03160898|323861052|FG002|Overall Study|Other|2|||
94658331|NCT00767000|324206155|FG004|54-week Study|Physician Decision|1|||
94235743|NCT04698915|322658006|FG001|Overall Study|Death|20|||
94235744|NCT04698915|322658005|FG000|Overall Study|Physician Decision|1|||
94235745|NCT04698915|322658006|FG001|Overall Study|Physician Decision|1|||
94235746|NCT04698915|322658005|FG000|Overall Study|Lost to Follow-up|1|||
94235747|NCT04698915|322658006|FG001|Overall Study|Lost to Follow-up|0|||
94235748|NCT04698915|322658005|FG000|Overall Study|Study Terminated by Sponsor|55|||
94235749|NCT04698915|322658006|FG001|Overall Study|Study Terminated by Sponsor|60|||
94564446|NCT03160898|323861053|FG003|Overall Study|Other|2|||
94564447|NCT00320515|323861054|FG000|Overall Study|Death|33|||
94564448|NCT00320515|323861054|FG000|Overall Study|Lost to Follow-up|6|||
94564449|NCT00320515|323861054|FG000|Overall Study|Physician Decision|2|||
94564450|NCT00320515|323861054|FG000|Overall Study|Withdrawal by Subject|8|||
94564451|NCT01114828|323861055|FG000|Overall Study|Adverse Event|1|||
94564452|NCT01114828|323861056|FG001|Overall Study|Adverse Event|1|||
94564453|NCT01114828|323861055|FG000|Overall Study|Lack of Efficacy|0|||
94564454|NCT01114828|323861056|FG001|Overall Study|Lack of Efficacy|2|||
94564455|NCT01114828|323861055|FG000|Overall Study|Protocol Violation|2|||
94564456|NCT01114828|323861056|FG001|Overall Study|Protocol Violation|0|||
94658332|NCT00767000|324206151|FG000|54-week Study|Progressive disease|0|||
94347054|NCT02036476|323050891|FG000|Overall Study|Withdrawal by Subject|2|||
94347055|NCT02036476|323050891|FG000|Overall Study|Progressive Disease|4|||
94347056|NCT02036476|323050891|FG000|Overall Study|Unacceptable Toxicity|2|||
94564457|NCT01114828|323861055|FG000|Overall Study|Withdrawal by Subject|0|||
94564458|NCT01114828|323861056|FG001|Overall Study|Withdrawal by Subject|1|||
94564459|NCT02485704|323861057|FG000|Overall Study|Lost to Follow-up|4|||
94564460|NCT02485704|323861058|FG001|Overall Study|Lost to Follow-up|5|||
94564461|NCT02485704|323861057|FG000|Overall Study|Withdrawal by Subject|0|||
94564462|NCT02485704|323861058|FG001|Overall Study|Withdrawal by Subject|3|||
94564463|NCT02485704|323861057|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
94564464|NCT02485704|323861058|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
94347057|NCT02168816|323050892|FG000|Overall Study|Lost to Follow-up|2|||
94347058|NCT02168816|323050893|FG001|Overall Study|Lost to Follow-up|2|||
94564465|NCT01657292|323861059|FG000|Overall Study|Adverse Event|6|||
94564466|NCT01657292|323861059|FG000|Overall Study|Withdrawal by Subject|2|||
94564467|NCT01657292|323861059|FG000|Overall Study|Violation of eligibility criteria|1|||
94347059|NCT01987609|323050896|FG000|Overall Study|Adverse Event|1|||
94347060|NCT02417935|323050897|FG000|Treatment Period|Adverse Event|12|||
94564468|NCT01657292|323861059|FG000|Overall Study|Change of therapy|1|||
94235750|NCT04698915|322658005|FG000|Overall Study|Withdrawal by Subject|2|||
94235751|NCT04698915|322658006|FG001|Overall Study|Withdrawal by Subject|3|||
94347061|NCT02417935|323050898|FG001|Treatment Period|Adverse Event|10|||
94235752|NCT00013611|322658007|FG000|Overall Study|Lost to Follow-up|91|||
94235753|NCT00013611|322658008|FG001|Overall Study|Lost to Follow-up|100|||
94235754|NCT01150045|322658009|FG000|Overall Study|Protocol Violation|0|||
94235755|NCT01150045|322658010|FG001|Overall Study|Protocol Violation|1|||
94347062|NCT02417935|323050897|FG000|Treatment Period|Lost to Follow-up|1|||
94347063|NCT02417935|323050898|FG001|Treatment Period|Lost to Follow-up|0|||
94347064|NCT02417935|323050897|FG000|Treatment Period|Entry Criteria not met|0|||
94235756|NCT01150045|322658011|FG002|Overall Study|Protocol Violation|0|||
94235757|NCT01150045|322658012|FG003|Overall Study|Protocol Violation|1|||
94235758|NCT00634842|322658013|FG000|Overall Study|Adverse Event|2|||
94235759|NCT00634842|322658014|FG001|Overall Study|Adverse Event|3|||
94235760|NCT00634842|322658013|FG000|Overall Study|Protocol Violation|8|||
94235761|NCT00634842|322658014|FG001|Overall Study|Protocol Violation|4|||
94235762|NCT00634842|322658013|FG000|Overall Study|Move to another state|1|||
94235763|NCT00634842|322658014|FG001|Overall Study|Move to another state|0|||
94235764|NCT00634842|322658013|FG000|Overall Study|Inclusion criteria were not met|1|||
94235765|NCT00634842|322658014|FG001|Overall Study|Inclusion criteria were not met|0|||
94235766|NCT00634842|322658013|FG000|Overall Study|Lost to Follow-up|1|||
94564469|NCT00851786|323861061|FG000|Overall Study|Withdrawal by Subject|0|||
94564470|NCT00851786|323861062|FG001|Overall Study|Withdrawal by Subject|1|||
94564471|NCT00851786|323861061|FG000|Overall Study|Protocol Violation|0|||
94564472|NCT00851786|323861062|FG001|Overall Study|Protocol Violation|1|||
94564473|NCT00851786|323861061|FG000|Overall Study|Lost to Follow-up|1|||
94235767|NCT00634842|322658014|FG001|Overall Study|Lost to Follow-up|2|||
94235768|NCT00634842|322658013|FG000|Overall Study|Physician Decision|1|||
94235769|NCT00634842|322658014|FG001|Overall Study|Physician Decision|0|||
94235770|NCT00634842|322658013|FG000|Overall Study|Withdrawal by Subject|1|||
94235771|NCT00634842|322658014|FG001|Overall Study|Withdrawal by Subject|3|||
94235772|NCT00634842|322658013|FG000|Overall Study|Lack of time and intolerance to drug|0|||
94564474|NCT00851786|323861062|FG001|Overall Study|Lost to Follow-up|0|||
94564475|NCT00851786|323861061|FG000|Overall Study|Incarceration|1|||
94564476|NCT00851786|323861062|FG001|Overall Study|Incarceration|0|||
94235773|NCT00634842|322658014|FG001|Overall Study|Lack of time and intolerance to drug|1|||
94235774|NCT00634842|322658013|FG000|Overall Study|Discontinued due to injection|0|||
94235775|NCT00634842|322658014|FG001|Overall Study|Discontinued due to injection|2|||
94235776|NCT00634842|322658013|FG000|Overall Study|No need of study drug to treat diabetes|0|||
94235777|NCT00634842|322658014|FG001|Overall Study|No need of study drug to treat diabetes|1|||
94235778|NCT00634842|322658013|FG000|Overall Study|No wish to keep taking Avandia|0|||
94235779|NCT00634842|322658014|FG001|Overall Study|No wish to keep taking Avandia|1|||
94235780|NCT00634842|322658013|FG000|Overall Study|Subject off study drug for too long|0|||
94235781|NCT00634842|322658014|FG001|Overall Study|Subject off study drug for too long|1|||
94235782|NCT00884650|322658015|FG000|Overall Study|Did not return complete pain diaries|7|||
94235783|NCT00884650|322658016|FG001|Overall Study|Did not return complete pain diaries|7|||
94235784|NCT00884650|322658015|FG000|Overall Study|Admitted Post-Op|1|||
94235785|NCT00884650|322658016|FG001|Overall Study|Admitted Post-Op|0|||
94235786|NCT00884650|322658015|FG000|Overall Study|Femoral Stress Fracture|1|||
94235787|NCT00884650|322658016|FG001|Overall Study|Femoral Stress Fracture|0|||
94235788|NCT00884650|322658015|FG000|Overall Study|Pain Pump Complication|0|||
94235789|NCT00884650|322658016|FG001|Overall Study|Pain Pump Complication|1|||
94235790|NCT01124097|322658019|FG000|Overall Study|Withdrawal by Subject|4|||
94235791|NCT01124097|322658020|FG001|Overall Study|Withdrawal by Subject|3|||
94235792|NCT01124097|322658021|FG002|Overall Study|Withdrawal by Subject|2|||
94235793|NCT01124097|322658022|FG003|Overall Study|Withdrawal by Subject|3|||
94235794|NCT01124097|322658019|FG000|Overall Study|Lack of Efficacy|2|||
94235795|NCT01124097|322658020|FG001|Overall Study|Lack of Efficacy|3|||
94235796|NCT01124097|322658021|FG002|Overall Study|Lack of Efficacy|1|||
94235797|NCT01124097|322658022|FG003|Overall Study|Lack of Efficacy|3|||
94235798|NCT01124097|322658019|FG000|Overall Study|Adverse Event|24|||
94235799|NCT01124097|322658020|FG001|Overall Study|Adverse Event|15|||
94235800|NCT01124097|322658021|FG002|Overall Study|Adverse Event|15|||
94564477|NCT00851786|323861061|FG000|Overall Study|Site Closure|1|||
94564478|NCT00851786|323861062|FG001|Overall Study|Site Closure|0|||
94235801|NCT01124097|322658022|FG003|Overall Study|Adverse Event|7|||
94235802|NCT01124097|322658019|FG000|Overall Study|Protocol Violation|2|||
94235803|NCT01124097|322658020|FG001|Overall Study|Protocol Violation|0|||
94235804|NCT01124097|322658021|FG002|Overall Study|Protocol Violation|2|||
94235805|NCT01124097|322658022|FG003|Overall Study|Protocol Violation|1|||
94564479|NCT00851786|323861061|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
94564480|NCT00851786|323861062|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
94564481|NCT01943591|323861065|FG000|Overall Study|Lost to Follow-up|3|||
94564482|NCT01943591|323861066|FG001|Overall Study|Lost to Follow-up|4|||
94564483|NCT01943591|323861065|FG000|Overall Study|Death|2|||
94564484|NCT01943591|323861066|FG001|Overall Study|Death|7|||
94564485|NCT01467505|323864616|FG000|Overall Study|Adverse Event|1|||
94564486|NCT01467505|323864617|FG001|Overall Study|Adverse Event|0|||
94564487|NCT01467505|323864616|FG000|Overall Study|Withdrawal by Subject|4|||
94347065|NCT02417935|323050898|FG001|Treatment Period|Entry Criteria not met|1|||
94347066|NCT02417935|323050897|FG000|Treatment Period|Protocol Violation|2|||
94347067|NCT02417935|323050898|FG001|Treatment Period|Protocol Violation|1|||
94347068|NCT02417935|323050897|FG000|Treatment Period|Withdrawal by Subject|3|||
94347069|NCT02417935|323050898|FG001|Treatment Period|Withdrawal by Subject|3|||
94564488|NCT01467505|323864617|FG001|Overall Study|Withdrawal by Subject|0|||
94564489|NCT01467505|323864616|FG000|Overall Study|Study Terminated by Sponsor|28|||
94564490|NCT01467505|323864617|FG001|Overall Study|Study Terminated by Sponsor|3|||
94564491|NCT00806988|323864622|FG000|Overall Study|Death|15|||
94564492|NCT00806988|323864623|FG001|Overall Study|Death|16|||
94564493|NCT00806988|323864622|FG000|Overall Study|Withdrawal by Subject|8|||
94564494|NCT00806988|323864623|FG001|Overall Study|Withdrawal by Subject|8|||
94564495|NCT00806988|323864622|FG000|Overall Study|Lost to Follow-up|4|||
94658333|NCT00767000|324206152|FG001|54-week Study|Progressive disease|0|||
94235806|NCT01124097|322658019|FG000|Overall Study|Physician Decision|2|||
94235807|NCT01124097|322658020|FG001|Overall Study|Physician Decision|1|||
94564496|NCT00806988|323864623|FG001|Overall Study|Lost to Follow-up|19|||
94564497|NCT02796677|323864638|FG000|Overall Study|Adverse Event|11|||
94564498|NCT02796677|323864639|FG001|Overall Study|Adverse Event|22|||
94564499|NCT02796677|323864640|FG002|Overall Study|Adverse Event|14|||
94564500|NCT02796677|323864641|FG003|Overall Study|Adverse Event|14|||
94450659|NCT03777436|323436923|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
94450660|NCT03777436|323436924|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
94450661|NCT03777436|323436925|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
94450662|NCT03777436|323436923|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
94450663|NCT03777436|323436924|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
94450664|NCT03777436|323436925|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
94450665|NCT03777436|323436923|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
94450666|NCT03777436|323436924|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
94450667|NCT03777436|323436925|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
94450668|NCT03777436|323436923|FG000|Placebo-controlled Phase|Physician Decision|0|||
94450669|NCT03777436|323436924|FG001|Placebo-controlled Phase|Physician Decision|1|||
94450670|NCT03777436|323436925|FG002|Placebo-controlled Phase|Physician Decision|0|||
94450671|NCT03777436|323436923|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
94450672|NCT03777436|323436924|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
94450673|NCT03777436|323436925|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
94450674|NCT03777436|323436923|FG000|Apremilast Extension Phase|Adverse Event|0|||
94450675|NCT03777436|323436924|FG001|Apremilast Extension Phase|Adverse Event|0|||
94450676|NCT03777436|323436925|FG002|Apremilast Extension Phase|Adverse Event|6|||
94450677|NCT03777436|323436923|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
94450678|NCT03777436|323436924|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
94450679|NCT03777436|323436925|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
94450680|NCT03777436|323436923|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
94450681|NCT03777436|323436924|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
94450682|NCT03777436|323436925|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
94450683|NCT03777436|323436923|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
94450684|NCT03777436|323436924|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
94450685|NCT03777436|323436925|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
94450686|NCT03777436|323436923|FG000|Apremilast Extension Phase|Miscellaneous|0|||
94450687|NCT03777436|323436924|FG001|Apremilast Extension Phase|Miscellaneous|0|||
94450688|NCT03777436|323436925|FG002|Apremilast Extension Phase|Miscellaneous|1|||
94450689|NCT00869999|323436927|FG000|Overall Study|Withdrawal by Subject|1|||
94450690|NCT00869999|323436927|FG000|Overall Study|removed prior to starting therapy|1|||
94450691|NCT03259425|323436929|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
94450692|NCT00619892|323436936|FG000|Overall Study|Adverse Event|3|||
94450693|NCT00619892|323436937|FG001|Overall Study|Adverse Event|0|||
94450694|NCT00619892|323436936|FG000|Overall Study|Lost to Follow-up|0|||
94450695|NCT00619892|323436937|FG001|Overall Study|Lost to Follow-up|1|||
94450696|NCT00619892|323436936|FG000|Overall Study|Intercurrent illness|0|||
94450697|NCT00619892|323436937|FG001|Overall Study|Intercurrent illness|1|||
94450698|NCT01006122|323436940|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
94450699|NCT01006122|323436941|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
94450700|NCT01006122|323436940|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
94450701|NCT01006122|323436941|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
94450702|NCT01006122|323436940|FG000|First Double-blind Intervention Period|Pregnancy|0|||
94450703|NCT01006122|323436941|FG001|First Double-blind Intervention Period|Pregnancy|1|||
94450704|NCT01006122|323436940|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
94564501|NCT02796677|323864638|FG000|Overall Study|Protocol Violation|7|||
94564502|NCT02796677|323864639|FG001|Overall Study|Protocol Violation|5|||
94564503|NCT02796677|323864640|FG002|Overall Study|Protocol Violation|4|||
94564504|NCT02796677|323864641|FG003|Overall Study|Protocol Violation|8|||
94564505|NCT02796677|323864638|FG000|Overall Study|Lost to Follow-up|1|||
94564506|NCT02796677|323864639|FG001|Overall Study|Lost to Follow-up|5|||
94564507|NCT02796677|323864640|FG002|Overall Study|Lost to Follow-up|2|||
94564508|NCT02796677|323864641|FG003|Overall Study|Lost to Follow-up|2|||
94564509|NCT02796677|323864638|FG000|Overall Study|Lack of Efficacy|7|||
94564510|NCT02796677|323864639|FG001|Overall Study|Lack of Efficacy|9|||
94564511|NCT02796677|323864640|FG002|Overall Study|Lack of Efficacy|14|||
94564512|NCT02796677|323864641|FG003|Overall Study|Lack of Efficacy|20|||
94564513|NCT02796677|323864638|FG000|Overall Study|Withdrawal by Subject|4|||
94450705|NCT01006122|323436941|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
94564514|NCT02796677|323864639|FG001|Overall Study|Withdrawal by Subject|14|||
94564515|NCT02796677|323864640|FG002|Overall Study|Withdrawal by Subject|6|||
94564516|NCT02796677|323864641|FG003|Overall Study|Withdrawal by Subject|7|||
94450706|NCT01006122|323436940|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
94564517|NCT02796677|323864638|FG000|Overall Study|Progressive disease|6|||
94564518|NCT02796677|323864639|FG001|Overall Study|Progressive disease|15|||
94564519|NCT02796677|323864640|FG002|Overall Study|Progressive disease|13|||
94564520|NCT02796677|323864641|FG003|Overall Study|Progressive disease|18|||
94564521|NCT02796677|323864638|FG000|Overall Study|Reason not mentioned|2|||
94564522|NCT02796677|323864639|FG001|Overall Study|Reason not mentioned|3|||
94564523|NCT02796677|323864640|FG002|Overall Study|Reason not mentioned|0|||
94564524|NCT02796677|323864641|FG003|Overall Study|Reason not mentioned|5|||
94564525|NCT02813889|323864642|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
94564526|NCT02813889|323864643|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
94564527|NCT00502671|323864645|FG000|Overall Study|Disease Progression|13|||
94564528|NCT00502671|323864645|FG000|Overall Study|Personal Reasons|22|||
94564529|NCT00502671|323864645|FG000|Overall Study|Lost to Follow-up|7|||
94564530|NCT00502671|323864645|FG000|Overall Study|Protocol Violation|16|||
94564531|NCT00502671|323864645|FG000|Overall Study|Adverse Event|19|||
94564532|NCT01380769|323864652|FG000|Overall Study|Withdrawal by Subject|7|||
94564533|NCT01380769|323864653|FG001|Overall Study|Withdrawal by Subject|11|||
94564534|NCT01380769|323864652|FG000|Overall Study|Physician Decision|1|||
94564535|NCT01380769|323864653|FG001|Overall Study|Physician Decision|1|||
94564536|NCT01380769|323864652|FG000|Overall Study|Adverse Event|1|||
94564537|NCT01380769|323864653|FG001|Overall Study|Adverse Event|1|||
94564538|NCT01380769|323864652|FG000|Overall Study|Protocol Violation|0|||
94564539|NCT01380769|323864653|FG001|Overall Study|Protocol Violation|1|||
94564540|NCT02471014|323864659|FG000|Overall Study|Lost to Follow-up|2|||
94564541|NCT02471014|323864660|FG001|Overall Study|Lost to Follow-up|2|||
94564542|NCT02380287|323864664|FG000|Overall Study|Adverse Event|0|||
94564543|NCT02380287|323864665|FG001|Overall Study|Adverse Event|0|||
94564544|NCT02380287|323864666|FG002|Overall Study|Adverse Event|1|||
94564545|NCT02380287|323864667|FG003|Overall Study|Adverse Event|0|||
94564546|NCT02380287|323864668|FG004|Overall Study|Adverse Event|0|||
94564547|NCT02380287|323864669|FG005|Overall Study|Adverse Event|0|||
94564548|NCT02380287|323864670|FG006|Overall Study|Adverse Event|0|||
94564549|NCT02380287|323864671|FG007|Overall Study|Adverse Event|0|||
94564550|NCT01080807|323864672|FG000|Overall Study|Adverse Event|9|||
94564551|NCT01080807|323864673|FG001|Overall Study|Adverse Event|1|||
94564552|NCT01080807|323864672|FG000|Overall Study|Lack of Efficacy|0|||
94564553|NCT01080807|323864673|FG001|Overall Study|Lack of Efficacy|1|||
94235808|NCT01124097|322658021|FG002|Overall Study|Physician Decision|0|||
94347070|NCT02417935|323050897|FG000|Treatment Period|Physician Decision|3|||
94347071|NCT02417935|323050898|FG001|Treatment Period|Physician Decision|1|||
94564554|NCT01080807|323864672|FG000|Overall Study|Withdrawal by Subject|7|||
94564555|NCT01080807|323864673|FG001|Overall Study|Withdrawal by Subject|2|||
94564556|NCT01080807|323864672|FG000|Overall Study|Protocol Violation|7|||
94564557|NCT01080807|323864673|FG001|Overall Study|Protocol Violation|6|||
94564558|NCT01080807|323864672|FG000|Overall Study|Lost to Follow-up|6|||
94564559|NCT01080807|323864673|FG001|Overall Study|Lost to Follow-up|4|||
94564560|NCT01080807|323864672|FG000|Overall Study|Noncompliance with drug administration|1|||
94658334|NCT00767000|324206153|FG002|54-week Study|Progressive disease|1|||
94235809|NCT01124097|322658022|FG003|Overall Study|Physician Decision|0|||
94235810|NCT01821937|322658023|FG000|Overall Study|Adverse Event|0|||
94235811|NCT01821937|322658024|FG001|Overall Study|Adverse Event|3|||
94347072|NCT02853318|323050899|FG000|Overall Study|Withdrawal by Subject|1|||
94564561|NCT01080807|323864673|FG001|Overall Study|Noncompliance with drug administration|1|||
94564562|NCT01080807|323864672|FG000|Overall Study|Noncompliance to study procedures|1|||
94564563|NCT01080807|323864673|FG001|Overall Study|Noncompliance to study procedures|1|||
94347073|NCT02363322|323050900|FG000|Overall Study|Lost to Follow-up|1|||
94347074|NCT02363322|323050901|FG001|Overall Study|Lost to Follow-up|0|||
94347075|NCT01843933|323050902|FG000|Overall Study|Data lost|6|||
94347076|NCT01843933|323050903|FG001|Overall Study|Data lost|4|||
94564564|NCT01080807|323864672|FG000|Overall Study|Began working day shift|0|||
94564565|NCT01080807|323864673|FG001|Overall Study|Began working day shift|2|||
94564566|NCT01080807|323864672|FG000|Overall Study|Laid off or terminated from job|1|||
94347077|NCT00211536|323053868|FG000|Overall Study|Withdrawal by Subject|2|||
94564567|NCT01080807|323864673|FG001|Overall Study|Laid off or terminated from job|2|||
94564568|NCT01080807|323864672|FG000|Overall Study|Stopped working consistent night shifts|0|||
94564569|NCT01080807|323864673|FG001|Overall Study|Stopped working consistent night shifts|1|||
94564570|NCT01080807|323864672|FG000|Overall Study|Work schedule changing|1|||
94564571|NCT01080807|323864673|FG001|Overall Study|Work schedule changing|1|||
94564572|NCT01080807|323864672|FG000|Overall Study|Work schedule and travel|0|||
94564573|NCT01080807|323864673|FG001|Overall Study|Work schedule and travel|1|||
94564574|NCT01080807|323864672|FG000|Overall Study|Switched to first shift|1|||
94235812|NCT04351269|322658025|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
94235813|NCT04351269|322658026|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
94347078|NCT00211536|323053869|FG001|Overall Study|Withdrawal by Subject|2|||
94235814|NCT04351269|322658027|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
94235815|NCT04351269|322658025|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
94235816|NCT04351269|322658026|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
94235817|NCT04351269|322658027|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
94235818|NCT04351269|322658025|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
94235819|NCT04351269|322658026|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
94235820|NCT04351269|322658027|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
94235821|NCT04351269|322658025|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
94235822|NCT04351269|322658026|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
94235823|NCT04351269|322658027|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
94235824|NCT04351269|322658025|FG000|Overall Study|Lost to Follow-up|1|||
94235825|NCT04351269|322658026|FG001|Overall Study|Lost to Follow-up|3|||
94235826|NCT04351269|322658027|FG002|Overall Study|Lost to Follow-up|0|||
94235827|NCT03210519|322658028|FG000|Overall Study|Adverse Event|2|||
94235828|NCT03210519|322658029|FG001|Overall Study|Adverse Event|0|||
94235829|NCT04071301|322658032|FG000|Overall Study|Withdrawal by Subject|6|||
94235830|NCT04071301|322658032|FG000|Overall Study|Death|1|||
94235831|NCT00121667|322658033|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
94235832|NCT00121667|322658034|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
94235833|NCT00121667|322658035|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
94235834|NCT00121667|322658036|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
94235835|NCT00121667|322658033|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
94235836|NCT00121667|322658034|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
94235837|NCT00121667|322658035|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
94235838|NCT00121667|322658036|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
94235839|NCT00121667|322658033|FG000|Short Term (ST) Period|Adverse Event|5|||
94235840|NCT00121667|322658034|FG001|Short Term (ST) Period|Adverse Event|6|||
94235841|NCT00121667|322658035|FG002|Short Term (ST) Period|Adverse Event|5|||
94235842|NCT00121667|322658036|FG003|Short Term (ST) Period|Adverse Event|3|||
94235843|NCT00121667|322658033|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
94235844|NCT00121667|322658034|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
94235845|NCT00121667|322658035|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
94235846|NCT00121667|322658036|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
94235847|NCT00121667|322658033|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
94235848|NCT00121667|322658034|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
94235849|NCT00121667|322658035|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
94235850|NCT00121667|322658036|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
94235851|NCT00121667|322658033|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
94235852|NCT00121667|322658034|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
94235853|NCT00121667|322658035|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
94235854|NCT00121667|322658036|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
94235855|NCT00121667|322658033|FG000|Short Term (ST) Period|Other Reason|3|||
94235856|NCT00121667|322658034|FG001|Short Term (ST) Period|Other Reason|0|||
94235857|NCT00121667|322658035|FG002|Short Term (ST) Period|Other Reason|0|||
94235858|NCT00121667|322658036|FG003|Short Term (ST) Period|Other Reason|0|||
94235859|NCT00121667|322658033|FG000|Short Term (ST) Period|Death|0|||
94235860|NCT00121667|322658034|FG001|Short Term (ST) Period|Death|0|||
94564575|NCT01080807|323864673|FG001|Overall Study|Switched to first shift|0|||
94347079|NCT00211536|323053868|FG000|Overall Study|Physician Decision|0|||
94347080|NCT00211536|323053869|FG001|Overall Study|Physician Decision|5|||
94347081|NCT00211536|323053868|FG000|Overall Study|Adverse Event|2|||
94347082|NCT00211536|323053869|FG001|Overall Study|Adverse Event|0|||
94347083|NCT02059174|323053870|FG000|Period 1|Withdrawal by Subject|0|||
94347084|NCT02059174|323053871|FG001|Period 1|Withdrawal by Subject|2|||
94347085|NCT02059174|323053870|FG000|Period 2|Withdrawal by Subject|0|||
94564576|NCT01080807|323864672|FG000|Overall Study|Moved away without notifying center|1|||
94347086|NCT02059174|323053871|FG001|Period 2|Withdrawal by Subject|2|||
94347087|NCT02059174|323053870|FG000|Period 2|Protocol Violation|1|||
94564577|NCT01080807|323864673|FG001|Overall Study|Moved away without notifying center|0|||
94235861|NCT00121667|322658035|FG002|Short Term (ST) Period|Death|0|||
94347088|NCT02059174|323053871|FG001|Period 2|Protocol Violation|0|||
94347089|NCT02059174|323053870|FG000|Period 3|Physician Decision|1|||
94564578|NCT01751984|323864674|FG000|Overall Study|Adverse Event|5|||
94564579|NCT01751984|323864675|FG001|Overall Study|Adverse Event|3|||
94564580|NCT01751984|323864674|FG000|Overall Study|Withdrawal by Subject|0|||
94564581|NCT01751984|323864675|FG001|Overall Study|Withdrawal by Subject|1|||
94564582|NCT01751984|323864674|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
94564583|NCT01751984|323864675|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
94564584|NCT03922581|323864676|FG000|Overall Study|Lost to Follow-up|20|||
94564585|NCT03922581|323864677|FG001|Overall Study|Lost to Follow-up|9|||
94564586|NCT03922581|323864676|FG000|Overall Study|Physician Decision|1|||
94564587|NCT03922581|323864677|FG001|Overall Study|Physician Decision|1|||
94564588|NCT03922581|323864676|FG000|Overall Study|Withdrawal by Subject|1|||
94564589|NCT03922581|323864677|FG001|Overall Study|Withdrawal by Subject|0|||
94564590|NCT04473963|323864678|FG000|Overall Study|Withdrawal by Subject|1|||
94564591|NCT04473963|323864679|FG001|Overall Study|Withdrawal by Subject|1|||
94564592|NCT04473963|323864680|FG002|Overall Study|Withdrawal by Subject|0|||
94658335|NCT00767000|324206154|FG003|54-week Study|Progressive disease|0|||
94658336|NCT00767000|324206155|FG004|54-week Study|Progressive disease|0|||
94658337|NCT00767000|324206151|FG000|54-week Study|Protocol Violation|0|||
94658338|NCT00767000|324206152|FG001|54-week Study|Protocol Violation|0|||
94658339|NCT00767000|324206153|FG002|54-week Study|Protocol Violation|1|||
94658340|NCT00767000|324206154|FG003|54-week Study|Protocol Violation|2|||
94658341|NCT00767000|324206155|FG004|54-week Study|Protocol Violation|0|||
94658342|NCT00767000|324206151|FG000|54-week Study|Withdrawal by Subject|2|||
94658343|NCT00767000|324206152|FG001|54-week Study|Withdrawal by Subject|3|||
94658344|NCT00767000|324206153|FG002|54-week Study|Withdrawal by Subject|5|||
94658345|NCT00767000|324206154|FG003|54-week Study|Withdrawal by Subject|11|||
94658346|NCT00767000|324206155|FG004|54-week Study|Withdrawal by Subject|13|||
94658347|NCT00767000|324206151|FG000|54-week Study|Study terminated by sponsor|90|||
94658348|NCT00767000|324206152|FG001|54-week Study|Study terminated by sponsor|102|||
94658349|NCT00767000|324206153|FG002|54-week Study|Study terminated by sponsor|89|||
94658350|NCT00767000|324206154|FG003|54-week Study|Study terminated by sponsor|196|||
94658351|NCT00767000|324206155|FG004|54-week Study|Study terminated by sponsor|194|||
94658352|NCT00767000|324206151|FG000|54-week Study|Reason not reported|0|||
94658353|NCT00767000|324206152|FG001|54-week Study|Reason not reported|0|||
94658354|NCT00767000|324206153|FG002|54-week Study|Reason not reported|0|||
94658355|NCT00767000|324206154|FG003|54-week Study|Reason not reported|1|||
94658356|NCT00767000|324206155|FG004|54-week Study|Reason not reported|0|||
94658357|NCT00767000|324206151|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
94658358|NCT00767000|324206152|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
94658359|NCT00767000|324206153|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
94658360|NCT00767000|324206154|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
94658361|NCT00767000|324206155|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
94658362|NCT02032901|324206157|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
94658363|NCT02032901|324206158|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
94658364|NCT02032901|324206157|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
94658365|NCT02032901|324206158|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
94658366|NCT00982020|324206159|FG000|Overall Study|Adverse Event|19|||
94658367|NCT00982020|324206160|FG001|Overall Study|Adverse Event|15|||
94658368|NCT00982020|324206159|FG000|Overall Study|Withdrawal by Subject|11|||
94658369|NCT00982020|324206160|FG001|Overall Study|Withdrawal by Subject|14|||
94658370|NCT00982020|324206159|FG000|Overall Study|Lost to Follow-up|5|||
94658371|NCT00982020|324206160|FG001|Overall Study|Lost to Follow-up|11|||
94658372|NCT00982020|324206159|FG000|Overall Study|Lack of Efficacy|10|||
94658373|NCT00982020|324206160|FG001|Overall Study|Lack of Efficacy|4|||
94658374|NCT00982020|324206159|FG000|Overall Study|Parent/Caregiver Decision|5|||
94658375|NCT00982020|324206160|FG001|Overall Study|Parent/Caregiver Decision|5|||
94658376|NCT00982020|324206159|FG000|Overall Study|Treatment Non-compliance|3|||
94658377|NCT00982020|324206160|FG001|Overall Study|Treatment Non-compliance|6|||
94658378|NCT00982020|324206159|FG000|Overall Study|Physician Decision|2|||
94658379|NCT00982020|324206160|FG001|Overall Study|Physician Decision|5|||
94658380|NCT00982020|324206159|FG000|Overall Study|Entry Criteria Not Met|2|||
94658381|NCT00982020|324206160|FG001|Overall Study|Entry Criteria Not Met|1|||
94658382|NCT00982020|324206159|FG000|Overall Study|Protocol Violation|0|||
94658383|NCT00982020|324206160|FG001|Overall Study|Protocol Violation|2|||
94658384|NCT00982020|324206159|FG000|Overall Study|Clinical Relapse|0|||
94564593|NCT04473963|323864678|FG000|Overall Study|Not inducible in AF|0|||
94564594|NCT04473963|323864679|FG001|Overall Study|Not inducible in AF|0|||
94564595|NCT04473963|323864680|FG002|Overall Study|Not inducible in AF|2|||
94564596|NCT01485094|323864684|FG000|Overall Study|Adverse Event|1|||
94658385|NCT00982020|324206160|FG001|Overall Study|Clinical Relapse|1|||
94658386|NCT00086346|324206161|FG000|Randomization|Did not receive test article|4|||
94658387|NCT00086346|324206162|FG001|Randomization|Did not receive test article|4|||
94658388|NCT00086346|324206161|FG000|Patients Dosed With Test Article|Adverse Event|94|||
94235862|NCT00121667|322658036|FG003|Short Term (ST) Period|Death|1|||
94347090|NCT02059174|323053871|FG001|Period 3|Physician Decision|0|||
94235863|NCT00121667|322658033|FG000|Short Term (ST) Period|Pregnancy|0|||
94235864|NCT00121667|322658034|FG001|Short Term (ST) Period|Pregnancy|0|||
94235865|NCT00121667|322658035|FG002|Short Term (ST) Period|Pregnancy|0|||
94235866|NCT00121667|322658036|FG003|Short Term (ST) Period|Pregnancy|1|||
94235867|NCT00121667|322658033|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
94235868|NCT00121667|322658034|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
94235869|NCT00121667|322658035|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
94235870|NCT00121667|322658036|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
94235871|NCT00121667|322658033|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
94235872|NCT00121667|322658034|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
94235873|NCT00121667|322658035|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
94235874|NCT00121667|322658036|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
94235875|NCT00121667|322658033|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
94235876|NCT00121667|322658034|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
94235877|NCT00121667|322658035|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
94235878|NCT00121667|322658036|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
94235879|NCT00121667|322658033|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
94235880|NCT00121667|322658034|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
94235881|NCT00121667|322658035|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
94235882|NCT00121667|322658036|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
94235883|NCT00121667|322658033|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
94235884|NCT00121667|322658034|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
94235885|NCT00121667|322658035|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
94235886|NCT00121667|322658036|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
94235887|NCT00121667|322658033|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
94235888|NCT00121667|322658034|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
94235889|NCT00121667|322658035|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
94235890|NCT00121667|322658036|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
94235891|NCT00121667|322658033|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
94235892|NCT00121667|322658034|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
94235893|NCT00121667|322658035|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
94235894|NCT00121667|322658036|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
94235895|NCT00121667|322658033|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
94235896|NCT00121667|322658034|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
94235897|NCT00121667|322658035|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
94235898|NCT00121667|322658036|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
94235899|NCT00121667|322658033|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
94235900|NCT00121667|322658034|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
94235901|NCT00121667|322658035|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
94235902|NCT00121667|322658036|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
94235903|NCT02879383|322658037|FG000|First 24 Weeks|Physician Decision|0|||
94235904|NCT02879383|322658038|FG001|First 24 Weeks|Physician Decision|1|||
94235905|NCT02879383|322658039|FG002|First 24 Weeks|Physician Decision|0|||
94235906|NCT02879383|322658040|FG003|First 24 Weeks|Physician Decision|0|||
94235907|NCT05186311|322658041|FG000|Part A: Serum|Withdrawal by Subject|1|||
94235908|NCT01263509|322658045|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
94235909|NCT01263509|322658046|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
94235910|NCT01263509|322658047|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
94235911|NCT01263509|322658048|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
94235912|NCT01263509|322658045|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
94235913|NCT01263509|322658046|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
94450707|NCT01006122|323436941|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
94450708|NCT01006122|323436940|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
94564597|NCT01485094|323864685|FG001|Overall Study|Adverse Event|1|||
94564598|NCT01485094|323864686|FG002|Overall Study|Adverse Event|1|||
94235914|NCT01263509|322658047|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
94235915|NCT01263509|322658048|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
94235916|NCT01263509|322658045|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
94235917|NCT01263509|322658046|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
94235918|NCT01263509|322658047|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
94235919|NCT01263509|322658048|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
94235920|NCT01263509|322658045|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
94235921|NCT01263509|322658046|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
94235922|NCT01263509|322658047|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
94450709|NCT01006122|323436941|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
94450710|NCT01006122|323436940|FG000|First Double-blind Intervention Period|Other|3|||
94564599|NCT01485094|323864684|FG000|Overall Study|Lost to Follow-up|1|||
94564600|NCT01485094|323864685|FG001|Overall Study|Lost to Follow-up|0|||
94564601|NCT01485094|323864686|FG002|Overall Study|Lost to Follow-up|0|||
94564602|NCT01485094|323864684|FG000|Overall Study|Withdrawal by Subject|1|||
94564603|NCT01485094|323864685|FG001|Overall Study|Withdrawal by Subject|1|||
94564604|NCT01485094|323864686|FG002|Overall Study|Withdrawal by Subject|0|||
94564605|NCT00965081|323864687|FG000|Overall Study|Adverse Event|14|||
94564606|NCT00965081|323864688|FG001|Overall Study|Adverse Event|9|||
94564607|NCT00965081|323864687|FG000|Overall Study|Lack of Efficacy|2|||
94564608|NCT00965081|323864688|FG001|Overall Study|Lack of Efficacy|5|||
94564609|NCT00965081|323864687|FG000|Overall Study|Lost to Follow-up|4|||
94564610|NCT00965081|323864688|FG001|Overall Study|Lost to Follow-up|5|||
94564611|NCT00965081|323864687|FG000|Overall Study|Physician Decision|2|||
94564612|NCT00965081|323864688|FG001|Overall Study|Physician Decision|0|||
94564613|NCT00965081|323864687|FG000|Overall Study|Protocol Violation|2|||
94564614|NCT00965081|323864688|FG001|Overall Study|Protocol Violation|5|||
94564615|NCT00965081|323864687|FG000|Overall Study|Sponsor Decision|1|||
94564616|NCT00965081|323864688|FG001|Overall Study|Sponsor Decision|0|||
94564617|NCT00965081|323864687|FG000|Overall Study|Withdrawal by Subject|4|||
94564618|NCT00965081|323864688|FG001|Overall Study|Withdrawal by Subject|7|||
94564619|NCT00965081|323864687|FG000|Overall Study|Switched to Rescue Arm|5|||
94564620|NCT00965081|323864688|FG001|Overall Study|Switched to Rescue Arm|12|||
94564621|NCT00796666|323864689|FG000|Overall Study|Death|2|||
94564622|NCT00796666|323864690|FG001|Overall Study|Death|4|||
94564623|NCT00796666|323864689|FG000|Overall Study|Withdrawal by Subject|2|||
94564624|NCT00796666|323864690|FG001|Overall Study|Withdrawal by Subject|0|||
94564625|NCT00796666|323864689|FG000|Overall Study|Adverse Event|7|||
94564626|NCT00796666|323864690|FG001|Overall Study|Adverse Event|5|||
94564627|NCT00796666|323864689|FG000|Overall Study|Protocol Violation|1|||
94564628|NCT00796666|323864690|FG001|Overall Study|Protocol Violation|0|||
94564629|NCT00796666|323864689|FG000|Overall Study|Other|1|||
94564630|NCT00796666|323864690|FG001|Overall Study|Other|0|||
94564631|NCT00796666|323864689|FG000|Overall Study|Terminated by sponsor|53|||
94564632|NCT00796666|323864690|FG001|Overall Study|Terminated by sponsor|55|||
94564633|NCT00796666|323864689|FG000|Overall Study|Randomized and not treated|1|||
94564634|NCT00796666|323864690|FG001|Overall Study|Randomized and not treated|0|||
94564635|NCT01196026|323864691|FG000|Overall Study|Withdrawal by Subject|1|||
94564636|NCT01196026|323864692|FG001|Overall Study|Withdrawal by Subject|4|||
94564637|NCT01196026|323864693|FG002|Overall Study|Withdrawal by Subject|0|||
94564638|NCT01196026|323864694|FG003|Overall Study|Withdrawal by Subject|0|||
94564639|NCT01196026|323864695|FG004|Overall Study|Withdrawal by Subject|0|||
94564640|NCT01196026|323864696|FG005|Overall Study|Withdrawal by Subject|0|||
94564641|NCT01196026|323864691|FG000|Overall Study|Lost to Follow-up|0|||
94564642|NCT01196026|323864692|FG001|Overall Study|Lost to Follow-up|3|||
94564643|NCT01196026|323864693|FG002|Overall Study|Lost to Follow-up|0|||
94564644|NCT01196026|323864694|FG003|Overall Study|Lost to Follow-up|0|||
94564645|NCT01196026|323864695|FG004|Overall Study|Lost to Follow-up|1|||
94564646|NCT01196026|323864696|FG005|Overall Study|Lost to Follow-up|0|||
94564647|NCT01196026|323864691|FG000|Overall Study|Other|0|||
94564648|NCT01196026|323864692|FG001|Overall Study|Other|1|||
94564649|NCT01196026|323864693|FG002|Overall Study|Other|0|||
94564650|NCT01196026|323864694|FG003|Overall Study|Other|0|||
94564651|NCT01196026|323864695|FG004|Overall Study|Other|0|||
94564652|NCT01196026|323864696|FG005|Overall Study|Other|0|||
94564653|NCT01479868|323864698|FG000|Overall Study|Adverse Event|1|||
94564654|NCT01479868|323864698|FG000|Overall Study|Lost to Follow-up|4|||
94564655|NCT01479868|323864698|FG000|Overall Study|Protocol Violation|1|||
94564656|NCT01479868|323864698|FG000|Overall Study|Withdrawal by Subject|1|||
94564657|NCT01479868|323864698|FG000|Overall Study|Sponsor's Decision|1|||
94564658|NCT01479868|323864698|FG000|Overall Study|Initiation of new HCV Therapy|1|||
94564659|NCT01618669|323864699|FG000|Overall Study|Lost to Follow-up|1|||
94347091|NCT03384316|323053872|FG000|Overall Study|Screen failure|0|||
94347092|NCT03384316|323053873|FG001|Overall Study|Screen failure|1|||
94347093|NCT00087594|323053878|FG000|Overall Study|Adverse Event|2|||
94564660|NCT01618669|323864700|FG001|Overall Study|Lost to Follow-up|1|||
94564661|NCT01618669|323864699|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
94564662|NCT01618669|323864700|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
94564663|NCT01618669|323864699|FG000|Overall Study|Adverse Event|16|||
94564664|NCT01618669|323864700|FG001|Overall Study|Adverse Event|7|||
94564665|NCT01618669|323864699|FG000|Overall Study|Protocol Violation|5|||
94564666|NCT01618669|323864700|FG001|Overall Study|Protocol Violation|3|||
94564667|NCT01618669|323864699|FG000|Overall Study|Withdrawal by Subject|9|||
94564668|NCT01618669|323864700|FG001|Overall Study|Withdrawal by Subject|9|||
94564669|NCT01618669|323864699|FG000|Overall Study|Miscellaneous Reason|0|||
94564670|NCT01618669|323864700|FG001|Overall Study|Miscellaneous Reason|1|||
94564671|NCT04317040|323864701|FG000|Overall Study|Lost to Follow-up|2|||
94564672|NCT04317040|323864702|FG001|Overall Study|Lost to Follow-up|0|||
94564673|NCT04317040|323864701|FG000|Overall Study|Death|16|||
94564674|NCT04317040|323864702|FG001|Overall Study|Death|18|||
94564675|NCT04317040|323864701|FG000|Overall Study|Withdrawal by Subject|0|||
94564676|NCT04317040|323864702|FG001|Overall Study|Withdrawal by Subject|1|||
94564677|NCT04317040|323864701|FG000|Overall Study|Incomplete assessments|0|||
94564678|NCT04317040|323864702|FG001|Overall Study|Incomplete assessments|1|||
94564679|NCT01292187|323864703|FG000|Overall Study|Adverse Event|10|||
94564680|NCT01292187|323864704|FG001|Overall Study|Adverse Event|5|||
94564681|NCT01292187|323864703|FG000|Overall Study|Withdrawal by Subject|6|||
94564682|NCT01292187|323864704|FG001|Overall Study|Withdrawal by Subject|5|||
94564683|NCT01292187|323864703|FG000|Overall Study|All other reasons|1|||
94564684|NCT01292187|323864704|FG001|Overall Study|All other reasons|3|||
94564685|NCT01702558|323864705|FG000|Overall Study|Withdrawal by Subject|0|||
94564686|NCT01702558|323864706|FG001|Overall Study|Withdrawal by Subject|0|||
94564687|NCT01702558|323864707|FG002|Overall Study|Withdrawal by Subject|0|||
94564688|NCT01702558|323864708|FG003|Overall Study|Withdrawal by Subject|12|||
94564689|NCT01702558|323864709|FG004|Overall Study|Withdrawal by Subject|4|||
94564690|NCT01702558|323864705|FG000|Overall Study|Lost to Follow-up|0|||
94564691|NCT01702558|323864706|FG001|Overall Study|Lost to Follow-up|0|||
94564692|NCT01702558|323864707|FG002|Overall Study|Lost to Follow-up|0|||
94235923|NCT01263509|322658048|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
94235924|NCT01263509|322658045|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
94235925|NCT01263509|322658046|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
94235926|NCT01263509|322658047|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
94235927|NCT01263509|322658048|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
94235928|NCT01266161|322658049|FG000|Overall Study|Ineligible|1|||
94235929|NCT01266161|322658050|FG001|Overall Study|Ineligible|0|||
94235930|NCT01266161|322658049|FG000|Overall Study|Lack of Efficacy|0|||
94235931|NCT01266161|322658050|FG001|Overall Study|Lack of Efficacy|1|||
94235932|NCT01266161|322658049|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
94235933|NCT01266161|322658050|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
94235934|NCT00848484|322658052|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
94235935|NCT00848484|322658053|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
94235936|NCT00848484|322658052|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
94235937|NCT00848484|322658053|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
94235938|NCT00848484|322658052|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
94235939|NCT00848484|322658053|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
94235940|NCT00848484|322658052|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
94235941|NCT00848484|322658053|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
94235942|NCT00848484|322658052|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
94235943|NCT00848484|322658053|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
94235944|NCT04887506|322658062|FG000|Overall Study|Death|1|||
94235945|NCT04887506|322658063|FG001|Overall Study|Death|1|||
94235946|NCT04887506|322658062|FG000|Overall Study|Withdrawal by Subject|0|||
94235947|NCT04887506|322658063|FG001|Overall Study|Withdrawal by Subject|3|||
94235948|NCT04887506|322658062|FG000|Overall Study|Adverse Event|4|||
94235949|NCT04887506|322658063|FG001|Overall Study|Adverse Event|3|||
94235950|NCT04887506|322658062|FG000|Overall Study|Other - Not Reported|1|||
94235951|NCT04887506|322658063|FG001|Overall Study|Other - Not Reported|1|||
94235952|NCT00250432|322658068|FG000|Overall Study|Adverse Event|25|||
94235953|NCT00250432|322658069|FG001|Overall Study|Adverse Event|29|||
94235954|NCT00250432|322658068|FG000|Overall Study|Lack of Efficacy|2|||
94235955|NCT00250432|322658069|FG001|Overall Study|Lack of Efficacy|1|||
94235956|NCT00250432|322658068|FG000|Overall Study|Lost to Follow-up|6|||
94235957|NCT00250432|322658069|FG001|Overall Study|Lost to Follow-up|5|||
94235958|NCT00250432|322658068|FG000|Overall Study|Patient Moved|0|||
94235959|NCT00250432|322658069|FG001|Overall Study|Patient Moved|1|||
94235960|NCT00250432|322658068|FG000|Overall Study|Protocol Violation|0|||
94235961|NCT00250432|322658069|FG001|Overall Study|Protocol Violation|3|||
94235962|NCT00250432|322658068|FG000|Overall Study|Withdrawal by Subject|6|||
94235963|NCT00250432|322658069|FG001|Overall Study|Withdrawal by Subject|2|||
94235964|NCT00250432|322658068|FG000|Overall Study|Pt died out of posttherapy report period|6|||
94235965|NCT00250432|322658069|FG001|Overall Study|Pt died out of posttherapy report period|5|||
94235966|NCT00250432|322658068|FG000|Overall Study|Pt was considered untreatable|0|||
94235967|NCT00250432|322658069|FG001|Overall Study|Pt was considered untreatable|1|||
94235968|NCT01262092|322658073|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
94235969|NCT01262092|322658074|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
94235970|NCT01262092|322658073|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
94235971|NCT01262092|322658074|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
94235972|NCT01262092|322658073|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
94235973|NCT01262092|322658074|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
94235974|NCT01262092|322658073|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
94235975|NCT01262092|322658074|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
94235976|NCT00559377|322659662|FG000|Overall Study|Withdrawal by Subject|9|||
94235977|NCT00940875|322659663|FG000|Treatment Phase|Adverse Event|9|||
94235978|NCT00940875|322659664|FG001|Treatment Phase|Adverse Event|3|||
94235979|NCT00940875|322659663|FG000|Treatment Phase|Death|3|||
94235980|NCT00940875|322659664|FG001|Treatment Phase|Death|5|||
94235981|NCT00940875|322659663|FG000|Treatment Phase|Lack of Efficacy|1|||
94235982|NCT00940875|322659664|FG001|Treatment Phase|Lack of Efficacy|0|||
94235983|NCT00940875|322659663|FG000|Treatment Phase|Withdrawal by Subject|3|||
94235984|NCT00940875|322659664|FG001|Treatment Phase|Withdrawal by Subject|0|||
94235985|NCT00940875|322659663|FG000|Treatment Phase|Disease progression|9|||
94235986|NCT00940875|322659664|FG001|Treatment Phase|Disease progression|11|||
94235987|NCT00940875|322659663|FG000|Treatment Phase|Physician Decision|1|||
94235988|NCT00940875|322659664|FG001|Treatment Phase|Physician Decision|0|||
94235989|NCT00940875|322659663|FG000|Post-Study Treatment|Death|0|||
94235990|NCT00940875|322659664|FG001|Post-Study Treatment|Death|1|||
94235991|NCT00940875|322659663|FG000|Post-Study Treatment|Disease Progression|0|||
94235992|NCT00940875|322659664|FG001|Post-Study Treatment|Disease Progression|2|||
94235993|NCT00520845|322659665|FG000|Overall Study|Death|3|||
94235994|NCT00520845|322659665|FG000|Overall Study|Adverse Event|4|||
94235995|NCT00520845|322659665|FG000|Overall Study|Disease Progression, relapse|13|||
94564693|NCT01702558|323864708|FG003|Overall Study|Lost to Follow-up|3|||
94564694|NCT01702558|323864709|FG004|Overall Study|Lost to Follow-up|0|||
94564695|NCT01702558|323864705|FG000|Overall Study|Death|4|||
94564696|NCT01702558|323864706|FG001|Overall Study|Death|3|||
94564697|NCT01702558|323864707|FG002|Overall Study|Death|3|||
94564698|NCT01702558|323864708|FG003|Overall Study|Death|16|||
94564699|NCT01702558|323864709|FG004|Overall Study|Death|20|||
94564700|NCT01702558|323864705|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
94564701|NCT01702558|323864706|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
94564702|NCT01702558|323864707|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
94564703|NCT01702558|323864708|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
94564704|NCT01702558|323864709|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
94564705|NCT01702558|323864705|FG000|Overall Study|Study Terminated by Sponsor|0|||
94564706|NCT01702558|323864706|FG001|Overall Study|Study Terminated by Sponsor|1|||
94564707|NCT01702558|323864707|FG002|Overall Study|Study Terminated by Sponsor|0|||
94564708|NCT01702558|323864708|FG003|Overall Study|Study Terminated by Sponsor|0|||
94564709|NCT01702558|323864709|FG004|Overall Study|Study Terminated by Sponsor|1|||
94564710|NCT01702558|323864705|FG000|Overall Study|Other|0|||
94564711|NCT01702558|323864706|FG001|Overall Study|Other|0|||
94564712|NCT01702558|323864707|FG002|Overall Study|Other|0|||
94564713|NCT01702558|323864708|FG003|Overall Study|Other|16|||
94564714|NCT01702558|323864709|FG004|Overall Study|Other|17|||
94564715|NCT03571204|323864712|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
94564716|NCT03571204|323864713|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
94564717|NCT03571204|323864714|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
94564718|NCT03571204|323864712|FG000|Overall Study|Physician Decision|0|||
94564719|NCT03571204|323864713|FG001|Overall Study|Physician Decision|1|||
94235996|NCT00520845|322659665|FG000|Overall Study|Withdrawal by Subject|1|||
94564720|NCT03571204|323864714|FG002|Overall Study|Physician Decision|0|||
94564721|NCT02396212|323864715|FG000|Overall Study|Adverse Event|1|||
94564722|NCT02396212|323864715|FG000|Overall Study|Lack of Efficacy|2|||
94564723|NCT02562716|323864716|FG000|Overall Study|Adverse Event|7|||
94564724|NCT02562716|323864717|FG001|Overall Study|Adverse Event|14|||
94564725|NCT02562716|323864716|FG000|Overall Study|Withdrawal unrelated to AE|7|||
94564726|NCT02562716|323864717|FG001|Overall Study|Withdrawal unrelated to AE|1|||
94564727|NCT02562716|323864716|FG000|Overall Study|Progression|8|||
94564728|NCT02562716|323864717|FG001|Overall Study|Progression|10|||
94564729|NCT02562716|323864716|FG000|Overall Study|Death|2|||
94564730|NCT02562716|323864717|FG001|Overall Study|Death|1|||
94564731|NCT02562716|323864716|FG000|Overall Study|Not protocol specified|4|||
94235997|NCT00520845|322659665|FG000|Overall Study|Alternative Therapy|1|||
94347094|NCT00087594|323053879|FG001|Overall Study|Adverse Event|3|||
94564732|NCT02562716|323864717|FG001|Overall Study|Not protocol specified|2|||
94564733|NCT00684996|323864718|FG000|Overall Study|Adverse Event|1|||
94564734|NCT00684996|323864718|FG000|Overall Study|Refusal unrelated to adverse event|1|||
94564735|NCT00684996|323864718|FG000|Overall Study|Progression/relapse|2|||
94564736|NCT00684996|323864718|FG000|Overall Study|Other reasons not protocol specified|1|||
94564737|NCT03030417|323864725|FG000|Dose Expansion|Disease progression before treatment|0|||
94564738|NCT03030417|323864726|FG001|Dose Expansion|Disease progression before treatment|0|||
94564739|NCT03030417|323864727|FG002|Dose Expansion|Disease progression before treatment|0|||
94564740|NCT03030417|323864728|FG003|Dose Expansion|Disease progression before treatment|0|||
94564741|NCT03030417|323864729|FG004|Dose Expansion|Disease progression before treatment|0|||
94564742|NCT03030417|323864730|FG005|Dose Expansion|Disease progression before treatment|0|||
94564743|NCT03030417|323864731|FG006|Dose Expansion|Disease progression before treatment|0|||
94564744|NCT03030417|323864732|FG007|Dose Expansion|Disease progression before treatment|0|||
94564745|NCT03030417|323864733|FG008|Dose Expansion|Disease progression before treatment|0|||
94564746|NCT03030417|323864734|FG009|Dose Expansion|Disease progression before treatment|0|||
94564747|NCT03030417|323864735|FG010|Dose Expansion|Disease progression before treatment|0|||
94564748|NCT03030417|323864736|FG011|Dose Expansion|Disease progression before treatment|0|||
94564749|NCT03030417|323864737|FG012|Dose Expansion|Disease progression before treatment|1|||
94564750|NCT01539759|323864738|FG000|Overall Study|Lost to Follow-up|6|||
94564751|NCT01539759|323864739|FG001|Overall Study|Lost to Follow-up|8|||
94564752|NCT01076959|323864740|FG000|Overall Study|Adverse Event|767|||
94564753|NCT01076959|323864740|FG000|Overall Study|Lack of Efficacy|849|||
94564754|NCT01076959|323864740|FG000|Overall Study|Non-compliance|274|||
94564755|NCT01076959|323864740|FG000|Overall Study|Lost to Follow-up|241|||
94564756|NCT01076959|323864740|FG000|Overall Study|Other|119|||
94235998|NCT01453023|322659666|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
94235999|NCT01453023|322659667|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
94236000|NCT01453023|322659666|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
94236001|NCT01453023|322659667|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
94236002|NCT01453023|322659666|FG000|Treatment Period 2|Protocol Violation|0|||
94236003|NCT01453023|322659667|FG001|Treatment Period 2|Protocol Violation|1|||
94236004|NCT02125279|322659668|FG000|Overall Study|Lack of Efficacy|2|||
94236005|NCT02125279|322659668|FG000|Overall Study|Withdrawal by Subject|6|||
94450711|NCT01006122|323436941|FG001|First Double-blind Intervention Period|Other|0|||
94564757|NCT01425801|323864741|FG000|Period 1|Withdrawal by Subject|0|||
94564758|NCT01425801|323864742|FG001|Period 1|Withdrawal by Subject|0|||
94564759|NCT01425801|323864743|FG002|Period 1|Withdrawal by Subject|0|||
94564760|NCT01425801|323864744|FG003|Period 1|Withdrawal by Subject|0|||
94564761|NCT01425801|323864745|FG004|Period 1|Withdrawal by Subject|1|||
94564762|NCT01425801|323864746|FG005|Period 1|Withdrawal by Subject|0|||
94564763|NCT01425801|323864741|FG000|Period 2|Withdrawal by Subject|0|||
94564764|NCT01425801|323864742|FG001|Period 2|Withdrawal by Subject|0|||
94564765|NCT01425801|323864743|FG002|Period 2|Withdrawal by Subject|0|||
94564766|NCT01425801|323864744|FG003|Period 2|Withdrawal by Subject|0|||
94564767|NCT01425801|323864745|FG004|Period 2|Withdrawal by Subject|1|||
94564768|NCT01425801|323864746|FG005|Period 2|Withdrawal by Subject|0|||
94564769|NCT01425801|323864741|FG000|Period 3|Stability criteria not fullfilled|0|||
94564770|NCT01425801|323864742|FG001|Period 3|Stability criteria not fullfilled|0|||
94564771|NCT01425801|323864743|FG002|Period 3|Stability criteria not fullfilled|1|||
94564772|NCT01425801|323864744|FG003|Period 3|Stability criteria not fullfilled|0|||
94564773|NCT01425801|323864745|FG004|Period 3|Stability criteria not fullfilled|0|||
94564774|NCT01425801|323864746|FG005|Period 3|Stability criteria not fullfilled|0|||
94564775|NCT01425801|323864741|FG000|Period 4|Not able to maintain visit schedule|0|||
94564776|NCT01425801|323864742|FG001|Period 4|Not able to maintain visit schedule|0|||
94564777|NCT01425801|323864743|FG002|Period 4|Not able to maintain visit schedule|1|||
94564778|NCT01425801|323864744|FG003|Period 4|Not able to maintain visit schedule|0|||
94564779|NCT01425801|323864745|FG004|Period 4|Not able to maintain visit schedule|0|||
94564780|NCT01425801|323864746|FG005|Period 4|Not able to maintain visit schedule|0|||
94564781|NCT02175017|323864747|FG000|Overall Study|Did not receive the investigational product|1|||
94564782|NCT02175017|323864748|FG001|Overall Study|Did not receive the investigational product|2|||
94236006|NCT02125279|322659668|FG000|Overall Study|Protocol Violation|1|||
94236007|NCT02125279|322659668|FG000|Overall Study|Lost to Follow-up|4|||
94236008|NCT01850589|322659675|FG000|Overall Study|Withdrawal by Subject|8|||
94236009|NCT01850589|322659676|FG001|Overall Study|Withdrawal by Subject|0|||
94236010|NCT00609947|322659677|FG000|Overall Study|Death|1|||
94236011|NCT00420784|322659679|FG000|Overall Study|Adverse Event|11|||
94236012|NCT00420784|322659680|FG001|Overall Study|Adverse Event|29|||
94236013|NCT00420784|322659681|FG002|Overall Study|Adverse Event|10|||
94236014|NCT00420784|322659682|FG003|Overall Study|Adverse Event|5|||
94236015|NCT00420784|322659679|FG000|Overall Study|Withdrawal by Subject|0|||
94236016|NCT00420784|322659680|FG001|Overall Study|Withdrawal by Subject|1|||
94236017|NCT00420784|322659681|FG002|Overall Study|Withdrawal by Subject|0|||
94564783|NCT02175017|323864747|FG000|Overall Study|Withdrawal by Subject|6|||
94564784|NCT02175017|323864748|FG001|Overall Study|Withdrawal by Subject|3|||
94564785|NCT02175017|323864747|FG000|Overall Study|Met an exclusion criteria|0|||
94236018|NCT00420784|322659682|FG003|Overall Study|Withdrawal by Subject|0|||
94236019|NCT00420784|322659679|FG000|Overall Study|Lost to Follow-up|0|||
94236020|NCT00420784|322659680|FG001|Overall Study|Lost to Follow-up|0|||
94236021|NCT00420784|322659681|FG002|Overall Study|Lost to Follow-up|2|||
94236022|NCT00420784|322659682|FG003|Overall Study|Lost to Follow-up|1|||
94236023|NCT00420784|322659679|FG000|Overall Study|Virologic Stopping Rule|17|||
94236024|NCT00420784|322659680|FG001|Overall Study|Virologic Stopping Rule|26|||
94236025|NCT00420784|322659681|FG002|Overall Study|Virologic Stopping Rule|41|||
94236026|NCT00420784|322659682|FG003|Overall Study|Virologic Stopping Rule|67|||
94236027|NCT00420784|322659679|FG000|Overall Study|Other|1|||
94236028|NCT00420784|322659680|FG001|Overall Study|Other|2|||
94236029|NCT00420784|322659681|FG002|Overall Study|Other|0|||
94236030|NCT00420784|322659682|FG003|Overall Study|Other|5|||
94236031|NCT03603639|322659683|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
94236032|NCT03603639|322659684|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
94236033|NCT03603639|322659685|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
94236034|NCT03603639|322659686|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
94236035|NCT03603639|322659687|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
94236036|NCT03603639|322659688|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
94236037|NCT03603639|322659683|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
94236038|NCT03603639|322659684|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
94236039|NCT03603639|322659685|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
94236040|NCT03603639|322659686|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
94236041|NCT03603639|322659687|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
94236042|NCT03603639|322659688|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
94236043|NCT04593823|322659697|FG000|Overall Study|Withdrawal by Subject|1|||
94236044|NCT04593823|322659698|FG001|Overall Study|Withdrawal by Subject|1|||
94236045|NCT04593823|322659697|FG000|Overall Study|Lost to Follow-up|0|||
94236046|NCT04593823|322659698|FG001|Overall Study|Lost to Follow-up|1|||
94236047|NCT02472145|322659701|FG000|Overall Study|Death|10|||
94236048|NCT02472145|322659702|FG001|Overall Study|Death|101|||
94236049|NCT02472145|322659703|FG002|Overall Study|Death|99|||
94236050|NCT02472145|322659701|FG000|Overall Study|Lost to Follow-up|0|||
94236051|NCT02472145|322659702|FG001|Overall Study|Lost to Follow-up|1|||
94236052|NCT02472145|322659703|FG002|Overall Study|Lost to Follow-up|0|||
94236053|NCT02472145|322659701|FG000|Overall Study|Withdrawal by Subject|0|||
94236054|NCT02472145|322659702|FG001|Overall Study|Withdrawal by Subject|9|||
94236055|NCT02472145|322659703|FG002|Overall Study|Withdrawal by Subject|13|||
94236056|NCT02472145|322659701|FG000|Overall Study|Sponsor decision|0|||
94236057|NCT02472145|322659702|FG001|Overall Study|Sponsor decision|3|||
94236058|NCT02472145|322659703|FG002|Overall Study|Sponsor decision|2|||
94236059|NCT02472145|322659701|FG000|Overall Study|Other|0|||
94347095|NCT00087594|323053878|FG000|Overall Study|Lost to Follow-up|0|||
94236060|NCT02472145|322659702|FG001|Overall Study|Other|45|||
94236061|NCT02472145|322659703|FG002|Overall Study|Other|43|||
94236062|NCT03080493|322659704|FG000|Overall Study|Did not provide NRS pain results|1|||
94236063|NCT03080493|322659705|FG001|Overall Study|Did not provide NRS pain results|0|||
94236064|NCT03080493|322659704|FG000|Overall Study|Adverse Event|0|||
94236065|NCT03080493|322659705|FG001|Overall Study|Adverse Event|1|||
94236066|NCT03080493|322659704|FG000|Overall Study|Randomization error (parity group)|0|||
94236067|NCT03080493|322659705|FG001|Overall Study|Randomization error (parity group)|1|||
94236068|NCT00755417|322659708|FG000|Overall Study|Adverse Event|28|||
94236069|NCT00755417|322659709|FG001|Overall Study|Adverse Event|20|||
94236070|NCT00755417|322659710|FG002|Overall Study|Adverse Event|7|||
94236071|NCT00755417|322659708|FG000|Overall Study|Lack of Efficacy|8|||
94236072|NCT00755417|322659709|FG001|Overall Study|Lack of Efficacy|4|||
94236073|NCT00755417|322659710|FG002|Overall Study|Lack of Efficacy|9|||
94236074|NCT00755417|322659708|FG000|Overall Study|Protocol Violation|2|||
94236075|NCT00755417|322659709|FG001|Overall Study|Protocol Violation|1|||
94236076|NCT00755417|322659710|FG002|Overall Study|Protocol Violation|1|||
94236077|NCT00755417|322659708|FG000|Overall Study|Lost to Follow-up|3|||
94236078|NCT00755417|322659709|FG001|Overall Study|Lost to Follow-up|0|||
94236079|NCT00755417|322659710|FG002|Overall Study|Lost to Follow-up|1|||
94236080|NCT00755417|322659708|FG000|Overall Study|Withdrawal by Subject|12|||
94236081|NCT00755417|322659709|FG001|Overall Study|Withdrawal by Subject|12|||
94236082|NCT00755417|322659710|FG002|Overall Study|Withdrawal by Subject|12|||
94236083|NCT00755417|322659708|FG000|Overall Study|Not specified or missing data|9|||
94236084|NCT00755417|322659709|FG001|Overall Study|Not specified or missing data|18|||
94236085|NCT00755417|322659710|FG002|Overall Study|Not specified or missing data|12|||
94236086|NCT02643628|322659711|FG000|Overall Study|Lost to Follow-up|1|||
94236087|NCT02643628|322659712|FG001|Overall Study|Lost to Follow-up|4|||
94236088|NCT02643628|322659711|FG000|Overall Study|Withdrawal by Subject|0|||
94236089|NCT02643628|322659712|FG001|Overall Study|Withdrawal by Subject|1|||
94236090|NCT02643628|322659711|FG000|Overall Study|Relocated out of state|0|||
94236091|NCT02643628|322659712|FG001|Overall Study|Relocated out of state|1|||
94236092|NCT04042077|322659723|FG000|Overall Study|Adverse Event|0|||
94236093|NCT04042077|322659724|FG001|Overall Study|Adverse Event|1|||
94236094|NCT04042077|322659723|FG000|Overall Study|Death|2|||
94236095|NCT04042077|322659724|FG001|Overall Study|Death|1|||
94236096|NCT04042077|322659723|FG000|Overall Study|Physician Decision|2|||
94236097|NCT04042077|322659724|FG001|Overall Study|Physician Decision|0|||
94236098|NCT04042077|322659723|FG000|Overall Study|Withdrawal by Subject|3|||
94236099|NCT04042077|322659724|FG001|Overall Study|Withdrawal by Subject|2|||
94236100|NCT04042077|322659723|FG000|Overall Study|Lack of Efficacy|0|||
94236101|NCT04042077|322659724|FG001|Overall Study|Lack of Efficacy|1|||
94236102|NCT01667549|322659725|FG000|Overall Study|Withdrawal by Subject|3|||
94236103|NCT01667549|322659726|FG001|Overall Study|Withdrawal by Subject|5|||
94236104|NCT01667549|322659727|FG002|Overall Study|Withdrawal by Subject|7|||
94236105|NCT01667549|322659728|FG003|Overall Study|Withdrawal by Subject|6|||
94236106|NCT01667549|322659729|FG004|Overall Study|Withdrawal by Subject|1|||
94347096|NCT00087594|323053879|FG001|Overall Study|Lost to Follow-up|2|||
94347097|NCT00087594|323053878|FG000|Overall Study|Withdrawal by Subject|4|||
94347098|NCT00087594|323053879|FG001|Overall Study|Withdrawal by Subject|2|||
94347099|NCT00087594|323053878|FG000|Overall Study|Lack of Efficacy|2|||
94347100|NCT00087594|323053879|FG001|Overall Study|Lack of Efficacy|5|||
94347101|NCT01654224|323053880|FG000|Overall Study|Lost to Follow-up|2|||
94347102|NCT01654224|323053881|FG001|Overall Study|Lost to Follow-up|2|||
94347103|NCT01654224|323053880|FG000|Overall Study|Did not receive allocation|1|||
94347104|NCT01654224|323053881|FG001|Overall Study|Did not receive allocation|8|||
94347105|NCT01654224|323053880|FG000|Overall Study|Insufficient blood sample|3|||
94347106|NCT01654224|323053881|FG001|Overall Study|Insufficient blood sample|2|||
94347107|NCT02807376|323053882|FG000|Overall Study|Intra-operative exclusion criteria|3|||
94347108|NCT02807376|323053883|FG001|Overall Study|Intra-operative exclusion criteria|0|||
94347109|NCT02807376|323053882|FG000|Overall Study|Lost to Follow-up|0|||
94347110|NCT02807376|323053883|FG001|Overall Study|Lost to Follow-up|1|||
94347111|NCT02630459|323053884|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
94236107|NCT02844777|322659732|FG000|Overall Study|Withdrawal by Subject|2|||
94236108|NCT02844777|322659733|FG001|Overall Study|Withdrawal by Subject|0|||
94564786|NCT02175017|323864748|FG001|Overall Study|Met an exclusion criteria|1|||
94564787|NCT02175017|323864747|FG000|Overall Study|Adverse Event|3|||
94564788|NCT02175017|323864748|FG001|Overall Study|Adverse Event|10|||
94564789|NCT02175017|323864747|FG000|Overall Study|Disease progression|20|||
94564790|NCT02175017|323864748|FG001|Overall Study|Disease progression|27|||
94564791|NCT02175017|323864747|FG000|Overall Study|Other than above reasons|3|||
94564792|NCT02175017|323864748|FG001|Overall Study|Other than above reasons|0|||
94564793|NCT04961541|323864753|FG000|Overall Study|Adverse Event|0|||
94564794|NCT04961541|323864754|FG001|Overall Study|Adverse Event|0|||
94564795|NCT04961541|323864755|FG002|Overall Study|Adverse Event|0|||
94564796|NCT04961541|323864756|FG003|Overall Study|Adverse Event|0|||
94564797|NCT04961541|323864757|FG004|Overall Study|Adverse Event|0|||
94564798|NCT04961541|323864758|FG005|Overall Study|Adverse Event|1|||
94564799|NCT04961541|323864759|FG006|Overall Study|Adverse Event|0|||
94564800|NCT04961541|323864760|FG007|Overall Study|Adverse Event|0|||
94564801|NCT04961541|323864761|FG008|Overall Study|Adverse Event|0|||
94564802|NCT04961541|323864762|FG009|Overall Study|Adverse Event|0|||
94564803|NCT04961541|323864763|FG010|Overall Study|Adverse Event|0|||
94564804|NCT04961541|323864764|FG011|Overall Study|Adverse Event|0|||
94564805|NCT04961541|323864765|FG012|Overall Study|Adverse Event|0|||
94564806|NCT04961541|323864766|FG013|Overall Study|Adverse Event|0|||
94564807|NCT04961541|323864753|FG000|Overall Study|Lost to Follow-up|0|||
94564808|NCT04961541|323864754|FG001|Overall Study|Lost to Follow-up|0|||
94564809|NCT04961541|323864755|FG002|Overall Study|Lost to Follow-up|3|||
94564810|NCT04961541|323864756|FG003|Overall Study|Lost to Follow-up|0|||
94564811|NCT04961541|323864757|FG004|Overall Study|Lost to Follow-up|0|||
94564812|NCT04961541|323864758|FG005|Overall Study|Lost to Follow-up|0|||
94564813|NCT04961541|323864759|FG006|Overall Study|Lost to Follow-up|1|||
94564814|NCT04961541|323864760|FG007|Overall Study|Lost to Follow-up|1|||
94564815|NCT04961541|323864761|FG008|Overall Study|Lost to Follow-up|0|||
94564816|NCT04961541|323864762|FG009|Overall Study|Lost to Follow-up|1|||
94564817|NCT04961541|323864763|FG010|Overall Study|Lost to Follow-up|0|||
94564818|NCT04961541|323864764|FG011|Overall Study|Lost to Follow-up|0|||
94564819|NCT04961541|323864765|FG012|Overall Study|Lost to Follow-up|1|||
94564820|NCT04961541|323864766|FG013|Overall Study|Lost to Follow-up|0|||
94564821|NCT04961541|323864753|FG000|Overall Study|Withdrawal by Subject|0|||
94564822|NCT04961541|323864754|FG001|Overall Study|Withdrawal by Subject|0|||
94564823|NCT04961541|323864755|FG002|Overall Study|Withdrawal by Subject|1|||
94564824|NCT04961541|323864756|FG003|Overall Study|Withdrawal by Subject|1|||
94564825|NCT04961541|323864757|FG004|Overall Study|Withdrawal by Subject|0|||
94564826|NCT04961541|323864758|FG005|Overall Study|Withdrawal by Subject|0|||
94564827|NCT04961541|323864759|FG006|Overall Study|Withdrawal by Subject|0|||
94564828|NCT04961541|323864760|FG007|Overall Study|Withdrawal by Subject|0|||
94564829|NCT04961541|323864761|FG008|Overall Study|Withdrawal by Subject|0|||
94564830|NCT04961541|323864762|FG009|Overall Study|Withdrawal by Subject|1|||
94564831|NCT04961541|323864763|FG010|Overall Study|Withdrawal by Subject|0|||
94564832|NCT04961541|323864764|FG011|Overall Study|Withdrawal by Subject|0|||
94564833|NCT04961541|323864765|FG012|Overall Study|Withdrawal by Subject|0|||
94564834|NCT04961541|323864766|FG013|Overall Study|Withdrawal by Subject|0|||
94564835|NCT01684202|323864767|FG000|Dose-escalation Period|Adverse Event|0|||
94564836|NCT01684202|323864768|FG001|Dose-escalation Period|Adverse Event|1|||
94564837|NCT01684202|323864769|FG002|Dose-escalation Period|Adverse Event|0|||
94564838|NCT01684202|323864770|FG003|Dose-escalation Period|Adverse Event|0|||
94564839|NCT01684202|323864767|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
94564840|NCT01684202|323864768|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
94564841|NCT01684202|323864769|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
94564842|NCT01684202|323864770|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
94564843|NCT01684202|323864767|FG000|Maintenance Period|Adverse Event|1|||
94564844|NCT01684202|323864768|FG001|Maintenance Period|Adverse Event|1|||
94658389|NCT00086346|324206162|FG001|Patients Dosed With Test Article|Adverse Event|11|||
94236109|NCT02844777|322659734|FG002|Overall Study|Withdrawal by Subject|0|||
94236110|NCT00478205|322659735|FG000|Overall Study|Adverse Event|182|||
94236111|NCT00478205|322659736|FG001|Overall Study|Adverse Event|39|||
94236112|NCT00478205|322659735|FG000|Overall Study|Medication Non-compliance|9|||
94236113|NCT00478205|322659736|FG001|Overall Study|Medication Non-compliance|4|||
94658390|NCT00086346|324206161|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
94564845|NCT01684202|323864769|FG002|Maintenance Period|Adverse Event|1|||
94564846|NCT01684202|323864770|FG003|Maintenance Period|Adverse Event|1|||
94564847|NCT01684202|323864767|FG000|Maintenance Period|Physician Decision|0|||
94564848|NCT01684202|323864768|FG001|Maintenance Period|Physician Decision|1|||
94564849|NCT01684202|323864769|FG002|Maintenance Period|Physician Decision|0|||
94564850|NCT01684202|323864770|FG003|Maintenance Period|Physician Decision|0|||
94564851|NCT01684202|323864767|FG000|Maintenance Period|Withdrawal by Subject|0|||
94564852|NCT01684202|323864768|FG001|Maintenance Period|Withdrawal by Subject|1|||
94564853|NCT01684202|323864769|FG002|Maintenance Period|Withdrawal by Subject|0|||
94564854|NCT01684202|323864770|FG003|Maintenance Period|Withdrawal by Subject|0|||
94564855|NCT00191308|323864771|FG000|Overall Study|Adverse Event|1|||
94564856|NCT01433172|323864772|FG000|Overall Study|Withdrawal by Subject|0|||
94564857|NCT01433172|323864773|FG001|Overall Study|Withdrawal by Subject|1|||
94564858|NCT01433172|323864774|FG002|Overall Study|Withdrawal by Subject|0|||
94564859|NCT01433172|323864772|FG000|Overall Study|Disease Progression|0|||
94564860|NCT01433172|323864773|FG001|Overall Study|Disease Progression|0|||
94564861|NCT01433172|323864774|FG002|Overall Study|Disease Progression|1|||
94564862|NCT01433172|323864772|FG000|Overall Study|Death|0|||
94564863|NCT01433172|323864773|FG001|Overall Study|Death|2|||
94564864|NCT01433172|323864774|FG002|Overall Study|Death|0|||
94564865|NCT01843023|323864775|FG000|Overall Study|Death|1|||
94564866|NCT01843023|323864776|FG001|Overall Study|Death|0|||
94564867|NCT01843023|323864775|FG000|Overall Study|Lost to Follow-up|24|||
94564868|NCT01843023|323864776|FG001|Overall Study|Lost to Follow-up|29|||
94564869|NCT01843023|323864775|FG000|Overall Study|Withdrawal by Subject|8|||
94564870|NCT01843023|323864776|FG001|Overall Study|Withdrawal by Subject|6|||
94564871|NCT03305770|323864779|FG000|Overall Study|Physician Decision - prior to dispense|0|||
94564872|NCT03305770|323864780|FG001|Overall Study|Physician Decision - prior to dispense|1|||
94564873|NCT03305770|323864779|FG000|Overall Study|Subject moved|1|||
94564874|NCT03305770|323864780|FG001|Overall Study|Subject moved|0|||
94564875|NCT00104650|323864784|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
94564876|NCT00104650|323864785|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
94564877|NCT00104650|323864786|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
94564878|NCT00104650|323864784|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
94564879|NCT00104650|323864785|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
94658391|NCT00086346|324206162|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
94658392|NCT00086346|324206161|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
94658393|NCT00086346|324206162|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
94658394|NCT00086346|324206161|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
94658395|NCT00086346|324206162|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
94658396|NCT00086346|324206161|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
94658397|NCT00086346|324206162|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
94658398|NCT00086346|324206161|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
94658399|NCT00086346|324206162|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
94658400|NCT02473614|324206163|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
94658401|NCT02473614|324206164|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
94658402|NCT02525133|324206165|FG000|Overall Study|Adverse Event|0|||
94658403|NCT02525133|324206166|FG001|Overall Study|Adverse Event|1|||
94658404|NCT02525133|324206165|FG000|Overall Study|Death|0|||
94236114|NCT00478205|322659735|FG000|Overall Study|Protocol Violation|15|||
94564880|NCT00104650|323864786|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
94564881|NCT00104650|323864784|FG000|Treatment Period (25 Weeks)|Death|7|||
94564882|NCT00104650|323864785|FG001|Treatment Period (25 Weeks)|Death|5|||
94564883|NCT00104650|323864786|FG002|Treatment Period (25 Weeks)|Death|6|||
94564884|NCT00104650|323864784|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
94564885|NCT00104650|323864785|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
94564886|NCT00104650|323864786|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
94564887|NCT00104650|323864784|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
94564888|NCT00104650|323864785|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
94564889|NCT00104650|323864786|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
94658405|NCT02525133|324206166|FG001|Overall Study|Death|1|||
94658406|NCT02525133|324206165|FG000|Overall Study|did not meet randomization criteria|1|||
94658407|NCT02525133|324206166|FG001|Overall Study|did not meet randomization criteria|0|||
94236115|NCT00478205|322659736|FG001|Overall Study|Protocol Violation|5|||
94236116|NCT00478205|322659735|FG000|Overall Study|Request of Investigator or Sponsor|4|||
94236117|NCT00478205|322659736|FG001|Overall Study|Request of Investigator or Sponsor|5|||
94236118|NCT00478205|322659735|FG000|Overall Study|Withdrawal by Subject|61|||
94236119|NCT00478205|322659736|FG001|Overall Study|Withdrawal by Subject|22|||
94236120|NCT00478205|322659735|FG000|Overall Study|Lack of Efficacy|1|||
94236121|NCT00478205|322659736|FG001|Overall Study|Lack of Efficacy|0|||
94236122|NCT00478205|322659735|FG000|Overall Study|Other|24|||
94236123|NCT00478205|322659736|FG001|Overall Study|Other|12|||
94236124|NCT02990468|322659737|FG000|Phase 2: MTD|Change in treatment|0|||
94236125|NCT02990468|322659738|FG001|Phase 2: MTD|Change in treatment|0|||
94236126|NCT02990468|322659739|FG002|Phase 2: MTD|Change in treatment|1|||
94236127|NCT00825305|322659742|FG000|Overall Study|Adverse Event|1|||
94236128|NCT00825305|322659743|FG001|Overall Study|Adverse Event|1|||
94236129|NCT00825305|322659742|FG000|Overall Study|Withdrawal by Subject|6|||
94236130|NCT00825305|322659743|FG001|Overall Study|Withdrawal by Subject|12|||
94236131|NCT00825305|322659742|FG000|Overall Study|Inappropriate inclusion|1|||
94564890|NCT00104650|323864784|FG000|Treatment Period (25 Weeks)|Other|1|||
94564891|NCT00104650|323864785|FG001|Treatment Period (25 Weeks)|Other|0|||
94564892|NCT00104650|323864786|FG002|Treatment Period (25 Weeks)|Other|0|||
94564893|NCT00104650|323864784|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
94564894|NCT00104650|323864785|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
94564895|NCT00104650|323864786|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
94564896|NCT00104650|323864784|FG000|Follow-up Period|Physician Decision|1|||
94564897|NCT00104650|323864785|FG001|Follow-up Period|Physician Decision|1|||
94564898|NCT00104650|323864786|FG002|Follow-up Period|Physician Decision|0|||
94564899|NCT00104650|323864784|FG000|Follow-up Period|Adverse Event|1|||
94564900|NCT00104650|323864785|FG001|Follow-up Period|Adverse Event|0|||
94564901|NCT00104650|323864786|FG002|Follow-up Period|Adverse Event|1|||
94564902|NCT00104650|323864784|FG000|Follow-up Period|Withdrawal by Subject|0|||
94564903|NCT00104650|323864785|FG001|Follow-up Period|Withdrawal by Subject|3|||
94564904|NCT00104650|323864786|FG002|Follow-up Period|Withdrawal by Subject|3|||
94564905|NCT00104650|323864784|FG000|Follow-up Period|Death|6|||
94564906|NCT00104650|323864785|FG001|Follow-up Period|Death|6|||
94564907|NCT00104650|323864786|FG002|Follow-up Period|Death|4|||
94564908|NCT00104650|323864784|FG000|Follow-up Period|Disease progression|3|||
94564909|NCT00104650|323864785|FG001|Follow-up Period|Disease progression|1|||
94564910|NCT00104650|323864786|FG002|Follow-up Period|Disease progression|0|||
94564911|NCT00104650|323864784|FG000|Follow-up Period|Lost to Follow-up|0|||
94564912|NCT00104650|323864785|FG001|Follow-up Period|Lost to Follow-up|1|||
94564913|NCT00104650|323864786|FG002|Follow-up Period|Lost to Follow-up|2|||
94564914|NCT00104650|323864784|FG000|Follow-up Period|Other|0|||
94564915|NCT00104650|323864785|FG001|Follow-up Period|Other|1|||
94564916|NCT00104650|323864786|FG002|Follow-up Period|Other|0|||
94564917|NCT03386721|323864790|FG000|Overall Study|Death|12|||
94564918|NCT03386721|323864791|FG001|Overall Study|Death|21|||
94236132|NCT00825305|322659743|FG001|Overall Study|Inappropriate inclusion|0|||
94236133|NCT00825305|322659742|FG000|Overall Study|Protocol Violation|9|||
94236134|NCT00825305|322659743|FG001|Overall Study|Protocol Violation|9|||
94236135|NCT00825305|322659742|FG000|Overall Study|Can not be classified|0|||
94236136|NCT00825305|322659743|FG001|Overall Study|Can not be classified|1|||
94236137|NCT02493946|322659746|FG000|DB Period|Withdrawal by Subject|8|||
94236138|NCT02493946|322659747|FG001|DB Period|Withdrawal by Subject|5|||
94236139|NCT02493946|322659748|FG002|DB Period|Withdrawal by Subject|0|||
94236140|NCT02493946|322659746|FG000|Open Label Period|Withdrawal by Subject|0|||
94236141|NCT02493946|322659747|FG001|Open Label Period|Withdrawal by Subject|0|||
94236142|NCT02493946|322659748|FG002|Open Label Period|Withdrawal by Subject|74|||
94236143|NCT02493946|322659746|FG000|Open Label Period|Adverse Event|0|||
94236144|NCT02493946|322659747|FG001|Open Label Period|Adverse Event|0|||
94236145|NCT02493946|322659748|FG002|Open Label Period|Adverse Event|4|||
94236146|NCT02493946|322659746|FG000|Open Label Period|Lost to Follow-up|0|||
94236147|NCT02493946|322659747|FG001|Open Label Period|Lost to Follow-up|0|||
94236148|NCT02493946|322659748|FG002|Open Label Period|Lost to Follow-up|1|||
94236149|NCT02493946|322659746|FG000|Open Label Period|Investigator decision, non-compliance|0|||
94236150|NCT02493946|322659747|FG001|Open Label Period|Investigator decision, non-compliance|0|||
94236151|NCT02493946|322659748|FG002|Open Label Period|Investigator decision, non-compliance|2|||
94236152|NCT02493946|322659746|FG000|Open Label Period|Investigator decision, non-availability|0|||
94236153|NCT02493946|322659747|FG001|Open Label Period|Investigator decision, non-availability|0|||
94236154|NCT02493946|322659748|FG002|Open Label Period|Investigator decision, non-availability|1|||
94236155|NCT02493946|322659746|FG000|Open Label Period|Pregnancy|0|||
94236156|NCT02493946|322659747|FG001|Open Label Period|Pregnancy|0|||
94236157|NCT02493946|322659748|FG002|Open Label Period|Pregnancy|3|||
94236158|NCT02493946|322659746|FG000|Open Label Period|Site error|0|||
94236159|NCT02493946|322659747|FG001|Open Label Period|Site error|0|||
94564919|NCT03386721|323864792|FG002|Overall Study|Death|2|||
94236160|NCT02493946|322659748|FG002|Open Label Period|Site error|1|||
94236161|NCT02344342|322659749|FG000|Overall Study|Industry partner dropped out|11|||
94564920|NCT03386721|323864793|FG003|Overall Study|Death|5|||
94564921|NCT03386721|323864794|FG004|Overall Study|Death|1|||
94564922|NCT03386721|323864795|FG005|Overall Study|Death|12|||
94564923|NCT03386721|323864796|FG006|Overall Study|Death|1|||
94564924|NCT03386721|323864797|FG007|Overall Study|Death|1|||
94564925|NCT03386721|323864798|FG008|Overall Study|Death|12|||
94564926|NCT03386721|323864799|FG009|Overall Study|Death|20|||
94564927|NCT03386721|323864800|FG010|Overall Study|Death|21|||
94564928|NCT03386721|323864801|FG011|Overall Study|Death|21|||
94564929|NCT03386721|323864802|FG012|Overall Study|Death|14|||
94564930|NCT03386721|323864803|FG013|Overall Study|Death|2|||
94564931|NCT03386721|323864804|FG014|Overall Study|Death|1|||
94564932|NCT03386721|323864790|FG000|Overall Study|Lost to Follow-up|1|||
94564933|NCT03386721|323864791|FG001|Overall Study|Lost to Follow-up|3|||
94347112|NCT02630459|323053885|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
94347113|NCT02630459|323053886|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
94347114|NCT02630459|323053887|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
94347115|NCT02630459|323053888|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
94347116|NCT02630459|323053889|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
94347117|NCT02630459|323053890|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
94347118|NCT02630459|323053891|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
94347119|NCT02630459|323053884|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
94347120|NCT02630459|323053885|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
94347121|NCT02630459|323053886|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
94347122|NCT02630459|323053887|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
94347123|NCT02630459|323053888|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
94347124|NCT02630459|323053889|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
94347125|NCT02630459|323053890|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
94347126|NCT02630459|323053891|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
94347127|NCT02630459|323053884|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
94347128|NCT02630459|323053885|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
94347129|NCT02630459|323053886|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
94347130|NCT02630459|323053887|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
94347131|NCT02630459|323053888|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
94347132|NCT02630459|323053889|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
94347133|NCT02630459|323053890|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
94347134|NCT02630459|323053891|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
94347135|NCT02630459|323053884|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
94347136|NCT02630459|323053885|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
94347137|NCT02630459|323053886|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
94347138|NCT02630459|323053887|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
94347139|NCT02630459|323053888|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
94347140|NCT02630459|323053889|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
94347141|NCT02630459|323053890|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
94347142|NCT02630459|323053891|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
94347143|NCT02630459|323053884|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
94347144|NCT02630459|323053885|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
94347145|NCT02630459|323053886|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
94347146|NCT02630459|323053887|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
94347147|NCT02630459|323053888|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
94347148|NCT02630459|323053889|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
94347149|NCT02630459|323053890|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
94347150|NCT02630459|323053891|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
94347151|NCT02630459|323053884|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
94347152|NCT02630459|323053885|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
94347153|NCT02630459|323053886|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
94347154|NCT02630459|323053887|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
94347155|NCT02630459|323053888|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
94347156|NCT02630459|323053889|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
94347157|NCT02630459|323053890|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
94347158|NCT02630459|323053891|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
94347159|NCT02630459|323053884|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
94347160|NCT02630459|323053885|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
94347161|NCT02630459|323053886|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
94347162|NCT02630459|323053887|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
94347163|NCT02630459|323053888|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
94347164|NCT02630459|323053889|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
94564934|NCT03386721|323864792|FG002|Overall Study|Lost to Follow-up|0|||
94564935|NCT03386721|323864793|FG003|Overall Study|Lost to Follow-up|0|||
94564936|NCT03386721|323864794|FG004|Overall Study|Lost to Follow-up|0|||
94564937|NCT03386721|323864795|FG005|Overall Study|Lost to Follow-up|2|||
94564938|NCT03386721|323864796|FG006|Overall Study|Lost to Follow-up|1|||
94564939|NCT03386721|323864797|FG007|Overall Study|Lost to Follow-up|0|||
94564940|NCT03386721|323864798|FG008|Overall Study|Lost to Follow-up|1|||
94564941|NCT03386721|323864799|FG009|Overall Study|Lost to Follow-up|2|||
94564942|NCT03386721|323864800|FG010|Overall Study|Lost to Follow-up|1|||
94564943|NCT03386721|323864801|FG011|Overall Study|Lost to Follow-up|0|||
94564944|NCT03386721|323864802|FG012|Overall Study|Lost to Follow-up|0|||
94564945|NCT03386721|323864803|FG013|Overall Study|Lost to Follow-up|0|||
94564946|NCT03386721|323864804|FG014|Overall Study|Lost to Follow-up|0|||
94564947|NCT03386721|323864790|FG000|Overall Study|Reason not specified|3|||
94564948|NCT03386721|323864791|FG001|Overall Study|Reason not specified|0|||
94564949|NCT03386721|323864792|FG002|Overall Study|Reason not specified|0|||
94564950|NCT03386721|323864793|FG003|Overall Study|Reason not specified|0|||
94564951|NCT03386721|323864794|FG004|Overall Study|Reason not specified|0|||
94564952|NCT03386721|323864795|FG005|Overall Study|Reason not specified|3|||
94564953|NCT03386721|323864796|FG006|Overall Study|Reason not specified|1|||
94564954|NCT03386721|323864797|FG007|Overall Study|Reason not specified|0|||
94564955|NCT03386721|323864798|FG008|Overall Study|Reason not specified|0|||
94564956|NCT03386721|323864799|FG009|Overall Study|Reason not specified|1|||
94564957|NCT03386721|323864800|FG010|Overall Study|Reason not specified|2|||
94564958|NCT03386721|323864801|FG011|Overall Study|Reason not specified|6|||
94564959|NCT03386721|323864802|FG012|Overall Study|Reason not specified|1|||
94564960|NCT03386721|323864803|FG013|Overall Study|Reason not specified|0|||
94564961|NCT03386721|323864804|FG014|Overall Study|Reason not specified|0|||
94564962|NCT03386721|323864790|FG000|Overall Study|Progressive Disease|0|||
94564963|NCT03386721|323864791|FG001|Overall Study|Progressive Disease|0|||
94564964|NCT03386721|323864792|FG002|Overall Study|Progressive Disease|1|||
94564965|NCT03386721|323864793|FG003|Overall Study|Progressive Disease|0|||
94564966|NCT03386721|323864794|FG004|Overall Study|Progressive Disease|0|||
94564967|NCT03386721|323864795|FG005|Overall Study|Progressive Disease|1|||
94564968|NCT03386721|323864796|FG006|Overall Study|Progressive Disease|0|||
94564969|NCT03386721|323864797|FG007|Overall Study|Progressive Disease|0|||
94564970|NCT03386721|323864798|FG008|Overall Study|Progressive Disease|2|||
94564971|NCT03386721|323864799|FG009|Overall Study|Progressive Disease|1|||
94564972|NCT03386721|323864800|FG010|Overall Study|Progressive Disease|1|||
94564973|NCT03386721|323864801|FG011|Overall Study|Progressive Disease|0|||
94564974|NCT03386721|323864802|FG012|Overall Study|Progressive Disease|1|||
94564975|NCT03386721|323864803|FG013|Overall Study|Progressive Disease|0|||
94564976|NCT03386721|323864804|FG014|Overall Study|Progressive Disease|0|||
94564977|NCT03386721|323864790|FG000|Overall Study|Site Terminated by Sponsor|5|||
94564978|NCT03386721|323864791|FG001|Overall Study|Site Terminated by Sponsor|5|||
94564979|NCT03386721|323864792|FG002|Overall Study|Site Terminated by Sponsor|0|||
94564980|NCT03386721|323864793|FG003|Overall Study|Site Terminated by Sponsor|0|||
94564981|NCT03386721|323864794|FG004|Overall Study|Site Terminated by Sponsor|1|||
94564982|NCT03386721|323864795|FG005|Overall Study|Site Terminated by Sponsor|3|||
94564983|NCT03386721|323864796|FG006|Overall Study|Site Terminated by Sponsor|0|||
94564984|NCT03386721|323864797|FG007|Overall Study|Site Terminated by Sponsor|1|||
94564985|NCT03386721|323864798|FG008|Overall Study|Site Terminated by Sponsor|4|||
94564986|NCT03386721|323864799|FG009|Overall Study|Site Terminated by Sponsor|5|||
94564987|NCT03386721|323864800|FG010|Overall Study|Site Terminated by Sponsor|3|||
94564988|NCT03386721|323864801|FG011|Overall Study|Site Terminated by Sponsor|11|||
94564989|NCT03386721|323864802|FG012|Overall Study|Site Terminated by Sponsor|6|||
94564990|NCT03386721|323864803|FG013|Overall Study|Site Terminated by Sponsor|0|||
94564991|NCT03386721|323864804|FG014|Overall Study|Site Terminated by Sponsor|0|||
94564992|NCT03386721|323864790|FG000|Overall Study|Symptomatic Deterioration|0|||
94564993|NCT03386721|323864791|FG001|Overall Study|Symptomatic Deterioration|0|||
94564994|NCT03386721|323864792|FG002|Overall Study|Symptomatic Deterioration|0|||
94564995|NCT03386721|323864793|FG003|Overall Study|Symptomatic Deterioration|0|||
94564996|NCT03386721|323864794|FG004|Overall Study|Symptomatic Deterioration|0|||
94564997|NCT03386721|323864795|FG005|Overall Study|Symptomatic Deterioration|0|||
94564998|NCT03386721|323864796|FG006|Overall Study|Symptomatic Deterioration|0|||
94564999|NCT03386721|323864797|FG007|Overall Study|Symptomatic Deterioration|0|||
94565000|NCT03386721|323864798|FG008|Overall Study|Symptomatic Deterioration|1|||
94565001|NCT03386721|323864799|FG009|Overall Study|Symptomatic Deterioration|0|||
94565002|NCT03386721|323864800|FG010|Overall Study|Symptomatic Deterioration|0|||
94565003|NCT03386721|323864801|FG011|Overall Study|Symptomatic Deterioration|1|||
94565004|NCT03386721|323864802|FG012|Overall Study|Symptomatic Deterioration|0|||
94565005|NCT03386721|323864803|FG013|Overall Study|Symptomatic Deterioration|0|||
94565006|NCT03386721|323864804|FG014|Overall Study|Symptomatic Deterioration|0|||
94565007|NCT03386721|323864790|FG000|Overall Study|Withdrawal by Subject|1|||
94565008|NCT03386721|323864791|FG001|Overall Study|Withdrawal by Subject|2|||
94565009|NCT03386721|323864792|FG002|Overall Study|Withdrawal by Subject|0|||
94565010|NCT03386721|323864793|FG003|Overall Study|Withdrawal by Subject|0|||
94565011|NCT03386721|323864794|FG004|Overall Study|Withdrawal by Subject|0|||
94347165|NCT02630459|323053890|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
94347166|NCT02630459|323053891|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
94347167|NCT01453439|323053892|FG000|Treatment Phase|Withdrawal by Subject|13|||
94347168|NCT01453439|323053893|FG001|Treatment Phase|Withdrawal by Subject|10|||
94347169|NCT01453439|323053892|FG000|Treatment Phase|Suicidal Ideation|2|||
94347170|NCT01453439|323053893|FG001|Treatment Phase|Suicidal Ideation|0|||
94565012|NCT03386721|323864795|FG005|Overall Study|Withdrawal by Subject|0|||
94565013|NCT03386721|323864796|FG006|Overall Study|Withdrawal by Subject|0|||
94347171|NCT01453439|323053892|FG000|Treatment Phase|Need for higher level of care|1|||
94347172|NCT01453439|323053893|FG001|Treatment Phase|Need for higher level of care|1|||
94347173|NCT01453439|323053892|FG000|Treatment Phase|Therapist conflict of interest|1|||
94347174|NCT01453439|323053893|FG001|Treatment Phase|Therapist conflict of interest|0|||
94347175|NCT01453439|323053892|FG000|Follow-up|Withdrawal by Subject|0|||
94565014|NCT03386721|323864797|FG007|Overall Study|Withdrawal by Subject|0|||
94565015|NCT03386721|323864798|FG008|Overall Study|Withdrawal by Subject|2|||
94565016|NCT03386721|323864799|FG009|Overall Study|Withdrawal by Subject|1|||
94565017|NCT03386721|323864800|FG010|Overall Study|Withdrawal by Subject|3|||
94565018|NCT03386721|323864801|FG011|Overall Study|Withdrawal by Subject|2|||
94347176|NCT01453439|323053893|FG001|Follow-up|Withdrawal by Subject|1|||
94347177|NCT01453439|323053892|FG000|Follow-up|Lost to Follow-up|5|||
94347178|NCT01453439|323053893|FG001|Follow-up|Lost to Follow-up|10|||
94347179|NCT00290355|323053894|FG000|Overall Study|Serious adverse event|7|||
94347180|NCT00290355|323053895|FG001|Overall Study|Serious adverse event|4|||
94347181|NCT00290355|323053894|FG000|Overall Study|Study product reactogenicity|1|||
94347182|NCT00290355|323053895|FG001|Overall Study|Study product reactogenicity|0|||
94347183|NCT00290355|323053894|FG000|Overall Study|Protocol Violation|1|||
94347184|NCT00290355|323053895|FG001|Overall Study|Protocol Violation|0|||
94347185|NCT00290355|323053894|FG000|Overall Study|Withdrawal by Subject|2|||
94347186|NCT00290355|323053895|FG001|Overall Study|Withdrawal by Subject|0|||
94347187|NCT00290355|323053894|FG000|Overall Study|Migrated / moved from the study area|1|||
94347188|NCT00290355|323053895|FG001|Overall Study|Migrated / moved from the study area|0|||
94565019|NCT03386721|323864802|FG012|Overall Study|Withdrawal by Subject|3|||
94565020|NCT03386721|323864803|FG013|Overall Study|Withdrawal by Subject|0|||
94565021|NCT03386721|323864804|FG014|Overall Study|Withdrawal by Subject|0|||
94565022|NCT03948334|323864805|FG000|Overall Study|Adverse Event|1|||
94565023|NCT03948334|323864806|FG001|Overall Study|Adverse Event|4|||
94565024|NCT03948334|323864805|FG000|Overall Study|Lack of Efficacy|2|||
94565025|NCT03948334|323864806|FG001|Overall Study|Lack of Efficacy|0|||
94565026|NCT03948334|323864805|FG000|Overall Study|Lost to Follow-up|1|||
94565027|NCT03948334|323864806|FG001|Overall Study|Lost to Follow-up|0|||
94565028|NCT03948334|323864805|FG000|Overall Study|Physician Decision|1|||
94565029|NCT03948334|323864806|FG001|Overall Study|Physician Decision|0|||
94565030|NCT03948334|323864805|FG000|Overall Study|Pregnancy|0|||
94565031|NCT03948334|323864806|FG001|Overall Study|Pregnancy|1|||
94565032|NCT03948334|323864805|FG000|Overall Study|Protocol Deviation|1|||
94565033|NCT03948334|323864806|FG001|Overall Study|Protocol Deviation|0|||
94236162|NCT02344342|322659750|FG001|Overall Study|Industry partner dropped out|9|||
94236163|NCT02344342|322659751|FG002|Overall Study|Industry partner dropped out|14|||
94236164|NCT02344342|322659752|FG003|Overall Study|Industry partner dropped out|10|||
94236165|NCT01575873|322659755|FG000|Overall Study|Withdrawal by Subject|15|||
94236166|NCT01575873|322659756|FG001|Overall Study|Withdrawal by Subject|20|||
94236167|NCT01575873|322659757|FG002|Overall Study|Withdrawal by Subject|34|||
94236168|NCT01575873|322659758|FG003|Overall Study|Withdrawal by Subject|34|||
94236169|NCT01575873|322659755|FG000|Overall Study|Adverse Event|7|||
94236170|NCT01575873|322659756|FG001|Overall Study|Adverse Event|7|||
94236171|NCT01575873|322659757|FG002|Overall Study|Adverse Event|9|||
94236172|NCT01575873|322659758|FG003|Overall Study|Adverse Event|12|||
94236173|NCT01575873|322659755|FG000|Overall Study|Lost to Follow-up|1|||
94236174|NCT01575873|322659756|FG001|Overall Study|Lost to Follow-up|3|||
94347189|NCT00290355|323053894|FG000|Overall Study|Lost to Follow-up|3|||
94347190|NCT00290355|323053895|FG001|Overall Study|Lost to Follow-up|1|||
94347191|NCT00290355|323053894|FG000|Overall Study|Other|2|||
94565034|NCT03948334|323864805|FG000|Overall Study|Study terminated by Sponsor|50|||
94565035|NCT03948334|323864806|FG001|Overall Study|Study terminated by Sponsor|51|||
94565036|NCT03948334|323864805|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
94565037|NCT03948334|323864806|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
94236175|NCT01575873|322659757|FG002|Overall Study|Lost to Follow-up|13|||
94236176|NCT01575873|322659758|FG003|Overall Study|Lost to Follow-up|5|||
94236177|NCT01575873|322659755|FG000|Overall Study|Death|3|||
94236178|NCT01575873|322659756|FG001|Overall Study|Death|2|||
94347192|NCT00290355|323053895|FG001|Overall Study|Other|0|||
94347193|NCT00963820|323053900|FG000|Dose Escalation Phase|Progressive Disease|3|||
94347194|NCT00963820|323053901|FG001|Dose Escalation Phase|Progressive Disease|3|||
94565038|NCT00773513|323864807|FG000|Overall Study|Renal Transplant|254|||
94565039|NCT00773513|323864808|FG001|Overall Study|Renal Transplant|263|||
94565040|NCT00773513|323864807|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
94565041|NCT00773513|323864808|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
94565042|NCT00773513|323864807|FG000|Overall Study|Withdrew Consent|68|||
94565043|NCT00773513|323864808|FG001|Overall Study|Withdrew Consent|69|||
94565044|NCT00773513|323864807|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
94565045|NCT00773513|323864808|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
94565046|NCT00773513|323864807|FG000|Overall Study|Failure to Return|22|||
94565047|NCT00773513|323864808|FG001|Overall Study|Failure to Return|8|||
94565048|NCT00773513|323864807|FG000|Overall Study|Insufficient Therapeutic Response|1|||
94565049|NCT00773513|323864808|FG001|Overall Study|Insufficient Therapeutic Response|18|||
94565050|NCT00773513|323864807|FG000|Overall Study|Reason Not Specified|159|||
94565051|NCT00773513|323864808|FG001|Overall Study|Reason Not Specified|126|||
94236179|NCT01575873|322659757|FG002|Overall Study|Death|8|||
94236180|NCT01575873|322659758|FG003|Overall Study|Death|9|||
94236181|NCT01575873|322659755|FG000|Overall Study|Noncompliance|1|||
94236182|NCT01575873|322659756|FG001|Overall Study|Noncompliance|2|||
94236183|NCT01575873|322659757|FG002|Overall Study|Noncompliance|4|||
94236184|NCT01575873|322659758|FG003|Overall Study|Noncompliance|3|||
94236185|NCT01575873|322659755|FG000|Overall Study|Administrative decision|1|||
94236186|NCT01575873|322659756|FG001|Overall Study|Administrative decision|1|||
94236187|NCT01575873|322659757|FG002|Overall Study|Administrative decision|1|||
94236188|NCT01575873|322659758|FG003|Overall Study|Administrative decision|0|||
94236189|NCT01575873|322659755|FG000|Overall Study|Protocol deviation|0|||
94236190|NCT01575873|322659756|FG001|Overall Study|Protocol deviation|1|||
94236191|NCT01575873|322659757|FG002|Overall Study|Protocol deviation|0|||
94236192|NCT01575873|322659758|FG003|Overall Study|Protocol deviation|1|||
94236193|NCT01575873|322659755|FG000|Overall Study|Requirement for Alternative Therapy|0|||
94236194|NCT01575873|322659756|FG001|Overall Study|Requirement for Alternative Therapy|0|||
94236195|NCT01575873|322659757|FG002|Overall Study|Requirement for Alternative Therapy|1|||
94236196|NCT01575873|322659758|FG003|Overall Study|Requirement for Alternative Therapy|1|||
94236197|NCT01575873|322659755|FG000|Overall Study|Other|0|||
94236198|NCT01575873|322659756|FG001|Overall Study|Other|0|||
94236199|NCT01575873|322659757|FG002|Overall Study|Other|4|||
94236200|NCT01575873|322659758|FG003|Overall Study|Other|2|||
94236201|NCT03017742|322659759|FG000|Overall Study|Protocol Violation|36|||
94236202|NCT03017742|322659759|FG000|Overall Study|Withdrawal by Subject|37|||
94236203|NCT01721954|322659763|FG000|Overall Study|Death|58|||
94236204|NCT01721954|322659764|FG001|Overall Study|Death|64|||
94236205|NCT01721954|322659763|FG000|Overall Study|Withdrawal by Subject|8|||
94236206|NCT01721954|322659764|FG001|Overall Study|Withdrawal by Subject|4|||
94236207|NCT01721954|322659763|FG000|Overall Study|Adverse Event|2|||
94236208|NCT01721954|322659764|FG001|Overall Study|Adverse Event|0|||
94236209|NCT01721954|322659763|FG000|Overall Study|Lost to Follow-up|2|||
94236210|NCT01721954|322659764|FG001|Overall Study|Lost to Follow-up|1|||
94236211|NCT02956837|322659765|FG000|Overall Study|Serious Adverse Events|0|||
94565052|NCT00773513|323864807|FG000|Overall Study|Death|531|||
94565053|NCT00773513|323864808|FG001|Overall Study|Death|545|||
94565054|NCT00700713|323864809|FG000|Overall Study|Protocol Violation|1|||
94565055|NCT00700713|323864810|FG001|Overall Study|Protocol Violation|0|||
94565056|NCT00700713|323864811|FG002|Overall Study|Protocol Violation|1|||
94565057|NCT00700713|323864809|FG000|Overall Study|Withdrawal by Subject|0|||
94565058|NCT00700713|323864810|FG001|Overall Study|Withdrawal by Subject|0|||
94236212|NCT02956837|322659766|FG001|Overall Study|Serious Adverse Events|1|||
94236213|NCT02956837|322659767|FG002|Overall Study|Serious Adverse Events|0|||
94236214|NCT02956837|322659768|FG003|Overall Study|Serious Adverse Events|0|||
94236215|NCT02956837|322659765|FG000|Overall Study|Withdrawal by Subject|0|||
94236216|NCT02956837|322659766|FG001|Overall Study|Withdrawal by Subject|1|||
94236217|NCT02956837|322659767|FG002|Overall Study|Withdrawal by Subject|0|||
94236218|NCT02956837|322659768|FG003|Overall Study|Withdrawal by Subject|3|||
94236219|NCT02956837|322659765|FG000|Overall Study|Lost to Follow-up|0|||
94236220|NCT02956837|322659766|FG001|Overall Study|Lost to Follow-up|1|||
94236221|NCT02956837|322659767|FG002|Overall Study|Lost to Follow-up|2|||
94236222|NCT02956837|322659768|FG003|Overall Study|Lost to Follow-up|0|||
94236223|NCT00965497|322659770|FG000|Overall Study|Physician Decision|1|||
94236224|NCT03327831|322659771|FG000|Overall Study|Lost to Follow-up|2|||
94236225|NCT02838134|322659772|FG000|Overall Study|Lost to Follow-up|1|||
94236226|NCT02838134|322659773|FG001|Overall Study|Lost to Follow-up|2|||
94236227|NCT02838134|322659772|FG000|Overall Study|logistic problems|1|||
94236228|NCT02838134|322659773|FG001|Overall Study|logistic problems|1|||
94236229|NCT01162486|322659774|FG000|Overall Study|low ANC|1|||
94236230|NCT01162486|322659775|FG001|Overall Study|low ANC|0|||
94236231|NCT01162486|322659776|FG002|Overall Study|low ANC|0|||
94236232|NCT01162486|322659777|FG003|Overall Study|low ANC|0|||
94236233|NCT01162486|322659778|FG004|Overall Study|low ANC|0|||
94236234|NCT01162486|322659774|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
94236235|NCT01162486|322659775|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
94236236|NCT01162486|322659776|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
94236237|NCT01162486|322659777|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
94236238|NCT01162486|322659778|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
94236239|NCT01162486|322659774|FG000|Overall Study|elevated LFTs|0|||
94236240|NCT01162486|322659775|FG001|Overall Study|elevated LFTs|0|||
94236241|NCT01162486|322659776|FG002|Overall Study|elevated LFTs|1|||
94236242|NCT01162486|322659777|FG003|Overall Study|elevated LFTs|0|||
94236243|NCT01162486|322659778|FG004|Overall Study|elevated LFTs|0|||
94236244|NCT01162486|322659774|FG000|Overall Study|Pregnancy|0|||
94236245|NCT01162486|322659775|FG001|Overall Study|Pregnancy|0|||
94236246|NCT01162486|322659776|FG002|Overall Study|Pregnancy|0|||
94236247|NCT01162486|322659777|FG003|Overall Study|Pregnancy|1|||
94236248|NCT01162486|322659778|FG004|Overall Study|Pregnancy|0|||
94236249|NCT02296892|322659779|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
94236250|NCT02296892|322659780|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
94236251|NCT02296892|322659781|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
94236252|NCT02296892|322659779|FG000|Overall Study|Lost to Follow-up|5|||
94236253|NCT02296892|322659780|FG001|Overall Study|Lost to Follow-up|0|||
94236254|NCT02296892|322659781|FG002|Overall Study|Lost to Follow-up|1|||
94236255|NCT01814072|322659782|FG000|Overall Study|Lost to Follow-up|2|||
94236256|NCT01814072|322659783|FG001|Overall Study|Lost to Follow-up|2|||
94236257|NCT01814072|322659784|FG002|Overall Study|Lost to Follow-up|2|||
94236258|NCT01814072|322659785|FG003|Overall Study|Lost to Follow-up|0|||
94236259|NCT01814072|322659786|FG004|Overall Study|Lost to Follow-up|2|||
94236260|NCT01814072|322659787|FG005|Overall Study|Lost to Follow-up|3|||
94236261|NCT01814072|322659788|FG006|Overall Study|Lost to Follow-up|3|||
94236262|NCT01814072|322659789|FG007|Overall Study|Lost to Follow-up|1|||
94236263|NCT01814072|322659790|FG008|Overall Study|Lost to Follow-up|2|||
94236264|NCT01814072|322659791|FG009|Overall Study|Lost to Follow-up|3|||
94236265|NCT01814072|322659792|FG010|Overall Study|Lost to Follow-up|1|||
94236266|NCT01814072|322659793|FG011|Overall Study|Lost to Follow-up|2|||
94236267|NCT01814072|322659794|FG012|Overall Study|Lost to Follow-up|2|||
94236268|NCT01814072|322659795|FG013|Overall Study|Lost to Follow-up|1|||
94236269|NCT01814072|322659796|FG014|Overall Study|Lost to Follow-up|2|||
94236270|NCT01814072|322659797|FG015|Overall Study|Lost to Follow-up|1|||
94236271|NCT01814072|322659798|FG016|Overall Study|Lost to Follow-up|3|||
94236272|NCT01814072|322659799|FG017|Overall Study|Lost to Follow-up|1|||
94236273|NCT01814072|322659800|FG018|Overall Study|Lost to Follow-up|3|||
94565059|NCT00700713|323864811|FG002|Overall Study|Withdrawal by Subject|1|||
94565060|NCT04970654|323864825|FG000|Overall Study|Withdrawal by parents/guardian|1|||
94236274|NCT01814072|322659801|FG019|Overall Study|Lost to Follow-up|3|||
94236275|NCT01814072|322659802|FG020|Overall Study|Lost to Follow-up|2|||
94236276|NCT01814072|322659803|FG021|Overall Study|Lost to Follow-up|1|||
94236277|NCT01814072|322659804|FG022|Overall Study|Lost to Follow-up|3|||
94236278|NCT01814072|322659805|FG023|Overall Study|Lost to Follow-up|1|||
94236279|NCT01814072|322659806|FG024|Overall Study|Lost to Follow-up|4|||
94236280|NCT01814072|322659807|FG025|Overall Study|Lost to Follow-up|1|||
94236281|NCT01814072|322659808|FG026|Overall Study|Lost to Follow-up|1|||
94565061|NCT04970654|323864826|FG001|Overall Study|Withdrawal by parents/guardian|2|||
94658408|NCT02525133|324206165|FG000|Overall Study|Lost to Follow-up|5|||
94658409|NCT02525133|324206166|FG001|Overall Study|Lost to Follow-up|1|||
94658410|NCT02525133|324206165|FG000|Overall Study|randomized not enrolled|3|||
94658411|NCT02525133|324206166|FG001|Overall Study|randomized not enrolled|0|||
94658412|NCT02525133|324206165|FG000|Overall Study|Withdrawal by Subject|1|||
94658413|NCT02525133|324206166|FG001|Overall Study|Withdrawal by Subject|0|||
94658414|NCT01054729|324206168|FG000|Overall Study|Randomized but Not Treated|0|||
94658415|NCT01054729|324206169|FG001|Overall Study|Randomized but Not Treated|1|||
94658416|NCT01054729|324206170|FG002|Overall Study|Randomized but Not Treated|0|||
94658417|NCT01054729|324206171|FG003|Overall Study|Randomized but Not Treated|0|||
94658418|NCT01054729|324206168|FG000|Overall Study|Adverse Event|1|||
94347195|NCT00963820|323053902|FG002|Dose Escalation Phase|Progressive Disease|3|||
94658419|NCT01054729|324206169|FG001|Overall Study|Adverse Event|1|||
94658420|NCT01054729|324206170|FG002|Overall Study|Adverse Event|2|||
94658421|NCT01054729|324206171|FG003|Overall Study|Adverse Event|1|||
94658422|NCT01054729|324206168|FG000|Overall Study|Withdrawal by Subject|1|||
94236282|NCT01814072|322659809|FG027|Overall Study|Lost to Follow-up|2|||
94236283|NCT01814072|322659810|FG028|Overall Study|Lost to Follow-up|3|||
94236284|NCT01814072|322659811|FG029|Overall Study|Lost to Follow-up|3|||
94236285|NCT01814072|322659812|FG030|Overall Study|Lost to Follow-up|2|||
94236286|NCT01814072|322659813|FG031|Overall Study|Lost to Follow-up|0|||
94236287|NCT01814072|322659782|FG000|Overall Study|Withdrawal by Subject|2|||
94236288|NCT01814072|322659783|FG001|Overall Study|Withdrawal by Subject|0|||
94236289|NCT01814072|322659784|FG002|Overall Study|Withdrawal by Subject|1|||
94236290|NCT01814072|322659785|FG003|Overall Study|Withdrawal by Subject|0|||
94236291|NCT01814072|322659786|FG004|Overall Study|Withdrawal by Subject|2|||
94236292|NCT01814072|322659787|FG005|Overall Study|Withdrawal by Subject|3|||
94236293|NCT01814072|322659788|FG006|Overall Study|Withdrawal by Subject|1|||
94236294|NCT01814072|322659789|FG007|Overall Study|Withdrawal by Subject|0|||
94236295|NCT01814072|322659790|FG008|Overall Study|Withdrawal by Subject|1|||
94236296|NCT01814072|322659791|FG009|Overall Study|Withdrawal by Subject|2|||
94236297|NCT01814072|322659792|FG010|Overall Study|Withdrawal by Subject|0|||
94236298|NCT01814072|322659793|FG011|Overall Study|Withdrawal by Subject|0|||
94236299|NCT01814072|322659794|FG012|Overall Study|Withdrawal by Subject|1|||
94236300|NCT01814072|322659795|FG013|Overall Study|Withdrawal by Subject|1|||
94236301|NCT01814072|322659796|FG014|Overall Study|Withdrawal by Subject|1|||
94236302|NCT01814072|322659797|FG015|Overall Study|Withdrawal by Subject|1|||
94236303|NCT01814072|322659798|FG016|Overall Study|Withdrawal by Subject|0|||
94236304|NCT01814072|322659799|FG017|Overall Study|Withdrawal by Subject|0|||
94236305|NCT01814072|322659800|FG018|Overall Study|Withdrawal by Subject|0|||
94236306|NCT01814072|322659801|FG019|Overall Study|Withdrawal by Subject|2|||
94236307|NCT01814072|322659802|FG020|Overall Study|Withdrawal by Subject|0|||
94236308|NCT01814072|322659803|FG021|Overall Study|Withdrawal by Subject|0|||
94236309|NCT01814072|322659804|FG022|Overall Study|Withdrawal by Subject|1|||
94236310|NCT01814072|322659805|FG023|Overall Study|Withdrawal by Subject|0|||
94236311|NCT01814072|322659806|FG024|Overall Study|Withdrawal by Subject|2|||
94236312|NCT01814072|322659807|FG025|Overall Study|Withdrawal by Subject|1|||
94236313|NCT01814072|322659808|FG026|Overall Study|Withdrawal by Subject|1|||
94236314|NCT01814072|322659809|FG027|Overall Study|Withdrawal by Subject|2|||
94236315|NCT01814072|322659810|FG028|Overall Study|Withdrawal by Subject|1|||
94236316|NCT01814072|322659811|FG029|Overall Study|Withdrawal by Subject|0|||
94236317|NCT01814072|322659812|FG030|Overall Study|Withdrawal by Subject|0|||
94236318|NCT01814072|322659813|FG031|Overall Study|Withdrawal by Subject|0|||
94236319|NCT02762903|322659814|FG000|Overall Study|Lost to Follow-up|0|||
94236320|NCT02762903|322659815|FG001|Overall Study|Lost to Follow-up|1|||
94236321|NCT01889069|322659816|FG000|Overall Study|Death|18|||
94236322|NCT01889069|322659816|FG000|Overall Study|Progression of Disease|14|||
94236323|NCT01889069|322659816|FG000|Overall Study|Lost to Follow-up|6|||
94236324|NCT01889069|322659816|FG000|Overall Study|Other|4|||
94236325|NCT01889069|322659816|FG000|Overall Study|Consent Withdrawal|3|||
94236326|NCT01426347|322659821|FG000|Overall Study|Lost to Follow-up|0|||
94236327|NCT01426347|322659822|FG001|Overall Study|Lost to Follow-up|3|||
94236328|NCT01426347|322659821|FG000|Overall Study|Protocol Violation|2|||
94236329|NCT01426347|322659822|FG001|Overall Study|Protocol Violation|0|||
94236330|NCT01426347|322659821|FG000|Overall Study|Withdrawal by Subject|5|||
94236331|NCT01426347|322659822|FG001|Overall Study|Withdrawal by Subject|0|||
94236332|NCT04978090|322659823|FG000|Overall Study|unable to adequately fit device|2|||
94236333|NCT02336425|322659824|FG000|Overall Study|Study terminated.|2|||
94236334|NCT02336425|322659825|FG001|Overall Study|Study terminated.|2|||
94236335|NCT02336425|322659826|FG002|Overall Study|Study terminated.|3|||
94236336|NCT02336425|322659827|FG003|Overall Study|Study terminated.|3|||
94236337|NCT03842436|322659834|FG000|Overall Study|Lost to Follow-up|1|||
94236338|NCT01948076|322659835|FG000|Overall Study|Withdrawal by Subject|0|||
94236339|NCT01948076|322659836|FG001|Overall Study|Withdrawal by Subject|1|||
94236340|NCT01151423|322659837|FG000|Overall Study|Study terminated by Sponsor|9|||
94236341|NCT01151423|322659838|FG001|Overall Study|Study terminated by Sponsor|10|||
94236342|NCT01151423|322659837|FG000|Overall Study|Protocol Violation|0|||
94236343|NCT01151423|322659838|FG001|Overall Study|Protocol Violation|1|||
94236344|NCT01151423|322659837|FG000|Overall Study|Physician Decision|1|||
94236345|NCT01151423|322659838|FG001|Overall Study|Physician Decision|1|||
94236346|NCT01151423|322659837|FG000|Overall Study|Pregnancy|0|||
94236347|NCT01151423|322659838|FG001|Overall Study|Pregnancy|1|||
94236348|NCT01151423|322659837|FG000|Overall Study|Death|0|||
94236349|NCT01151423|322659838|FG001|Overall Study|Death|1|||
94236350|NCT01151423|322659837|FG000|Overall Study|Adverse Event|3|||
94236351|NCT01151423|322659838|FG001|Overall Study|Adverse Event|0|||
94236352|NCT01151423|322659837|FG000|Overall Study|Withdrawal by Subject|1|||
94236353|NCT01151423|322659838|FG001|Overall Study|Withdrawal by Subject|3|||
94236354|NCT01151423|322659837|FG000|Overall Study|Lost to Follow-up|1|||
94236355|NCT01151423|322659838|FG001|Overall Study|Lost to Follow-up|0|||
94236356|NCT01151423|322659837|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
94236357|NCT01151423|322659838|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
94236358|NCT01151423|322659837|FG000|Overall Study|Participated in other clinical trial|1|||
94565062|NCT04970654|323864825|FG000|Overall Study|Unclassified|2|||
94565063|NCT04970654|323864826|FG001|Overall Study|Unclassified|1|||
94565064|NCT04970654|323864825|FG000|Overall Study|Lost to Follow-up|1|||
94565065|NCT04970654|323864826|FG001|Overall Study|Lost to Follow-up|0|||
94565066|NCT04965688|323864827|FG000|Overall Study|Withdrawal by Subject|2|||
94565067|NCT03828292|323864828|FG000|Part 1 (Up to 141 Weeks)|Death|0|||
94565068|NCT03828292|323864829|FG001|Part 1 (Up to 141 Weeks)|Death|1|||
94565069|NCT03828292|323864830|FG002|Part 1 (Up to 141 Weeks)|Death|0|||
94565070|NCT03828292|323864831|FG003|Part 1 (Up to 141 Weeks)|Death|0|||
94565071|NCT03828292|323864828|FG000|Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
94565072|NCT03828292|323864829|FG001|Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
94565073|NCT03828292|323864830|FG002|Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
94565074|NCT03828292|323864831|FG003|Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
94565075|NCT03828292|323864828|FG000|Part 2 (Up to 212 Weeks)|Progressive disease|0|||
94565076|NCT03828292|323864829|FG001|Part 2 (Up to 212 Weeks)|Progressive disease|0|||
94565077|NCT03828292|323864830|FG002|Part 2 (Up to 212 Weeks)|Progressive disease|0|||
94565078|NCT03828292|323864831|FG003|Part 2 (Up to 212 Weeks)|Progressive disease|1|||
94565079|NCT03828292|323864828|FG000|Part 2 (Up to 212 Weeks)|Adverse Event|0|||
94565080|NCT03828292|323864829|FG001|Part 2 (Up to 212 Weeks)|Adverse Event|0|||
94565081|NCT03828292|323864830|FG002|Part 2 (Up to 212 Weeks)|Adverse Event|0|||
94565082|NCT03828292|323864831|FG003|Part 2 (Up to 212 Weeks)|Adverse Event|1|||
94565083|NCT03828292|323864828|FG000|Part 2 (Up to 212 Weeks)|Ongoing at the time of analysis|0|||
94565084|NCT03828292|323864829|FG001|Part 2 (Up to 212 Weeks)|Ongoing at the time of analysis|0|||
94565085|NCT03828292|323864830|FG002|Part 2 (Up to 212 Weeks)|Ongoing at the time of analysis|2|||
94565086|NCT03828292|323864831|FG003|Part 2 (Up to 212 Weeks)|Ongoing at the time of analysis|2|||
94565087|NCT01150097|323864832|FG000|Months 24 to 36 Post-transplantation|Death|2|||
94565088|NCT01150097|323864833|FG001|Months 24 to 36 Post-transplantation|Death|0|||
94565089|NCT01150097|323864834|FG002|Months 24 to 36 Post-transplantation|Death|0|||
94565090|NCT01150097|323864832|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
94565091|NCT01150097|323864833|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
94565092|NCT01150097|323864834|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
94565093|NCT01150097|323864832|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
94565094|NCT01150097|323864833|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
94565095|NCT01150097|323864834|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
94565096|NCT01150097|323864832|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
94565097|NCT01150097|323864833|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
94565098|NCT01150097|323864834|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
94565099|NCT01150097|323864832|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
94450712|NCT01006122|323436940|FG000|First Double-blind Intervention Period|Adverse Event|0|||
94450713|NCT01006122|323436941|FG001|First Double-blind Intervention Period|Adverse Event|4|||
94450714|NCT01006122|323436940|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
94450715|NCT01006122|323436941|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
94450716|NCT01006122|323436940|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
94450717|NCT01006122|323436941|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
94450718|NCT01006122|323436940|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
94450719|NCT01006122|323436941|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
94450720|NCT01006122|323436940|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
94450721|NCT01006122|323436941|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
94450722|NCT01006122|323436940|FG000|Second Double-blind Intervention Period|Death|0|||
94450723|NCT01006122|323436941|FG001|Second Double-blind Intervention Period|Death|1|||
94450724|NCT00356148|323436944|FG000|Overall Study|Reoperation within 30 days|2|||
94450725|NCT00356148|323436945|FG001|Overall Study|Reoperation within 30 days|1|||
94565100|NCT01150097|323864833|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
94450726|NCT00014495|323436946|FG000|Overall Study|Death|0|||
94450727|NCT00014495|323436947|FG001|Overall Study|Death|0|||
94450728|NCT00014495|323436948|FG002|Overall Study|Death|1|||
94450729|NCT00014495|323436949|FG003|Overall Study|Death|0|||
94450730|NCT00014495|323436946|FG000|Overall Study|Clinical deterioration|0|||
94450731|NCT00014495|323436947|FG001|Overall Study|Clinical deterioration|0|||
94450732|NCT00014495|323436948|FG002|Overall Study|Clinical deterioration|0|||
94658423|NCT01054729|324206169|FG001|Overall Study|Withdrawal by Subject|0|||
94450733|NCT00014495|323436949|FG003|Overall Study|Clinical deterioration|1|||
94450734|NCT00828568|323436951|FG000|Randomized|Withdrawal by Subject|1|||
94565101|NCT01150097|323864834|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
94565102|NCT01150097|323864832|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
94565103|NCT01150097|323864833|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
94565104|NCT01150097|323864834|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
94565105|NCT01150097|323864832|FG000|Months 24 to 48 Post-transplantation|Death|2|||
94565106|NCT01150097|323864833|FG001|Months 24 to 48 Post-transplantation|Death|0|||
94565107|NCT01150097|323864834|FG002|Months 24 to 48 Post-transplantation|Death|0|||
94565108|NCT00992459|323864835|FG000|Overall Study|Withdrawal by Subject|0|||
94565109|NCT00992459|323864836|FG001|Overall Study|Withdrawal by Subject|1|||
94565110|NCT00992459|323864835|FG000|Overall Study|Adverse Event|1|||
94565111|NCT00992459|323864836|FG001|Overall Study|Adverse Event|0|||
94565112|NCT01871519|323864837|FG000|Overall Study|Death|26|||
94565113|NCT01871519|323864837|FG000|Overall Study|Lost to Follow-up|15|||
94565114|NCT01871519|323864837|FG000|Overall Study|Withdrawal by Subject|49|||
94565115|NCT01402817|323866180|FG000|Overall Study|Withdrawal by Subject|3|||
94565116|NCT01402817|323866180|FG000|Overall Study|Study Suspended by FDA|8|||
94565117|NCT00086047|323866183|FG000|Overall Study|Lost to Follow-up|7|||
94565118|NCT00086047|323866184|FG001|Overall Study|Lost to Follow-up|6|||
94565119|NCT00086047|323866183|FG000|Overall Study|Physician Decision|0|||
94565120|NCT00086047|323866184|FG001|Overall Study|Physician Decision|1|||
94565121|NCT03654690|323866185|FG000|Overall Study|Withdrawal by Subject|1|||
94565122|NCT03654690|323866186|FG001|Overall Study|Withdrawal by Subject|0|||
94565123|NCT03654690|323866187|FG002|Overall Study|Withdrawal by Subject|0|||
94565124|NCT02223715|323866188|FG000|Overall Study|Death|31|||
94565125|NCT02223715|323866188|FG000|Overall Study|Lost to Follow-up|73|||
94565126|NCT03400852|323866189|FG000|Blinded Treatment Period|Physician Decision|0|||
94565127|NCT03400852|323866190|FG001|Blinded Treatment Period|Physician Decision|1|||
94565128|NCT03400852|323866191|FG002|Blinded Treatment Period|Physician Decision|0|||
94565129|NCT03400852|323866189|FG000|Blinded Treatment Period|Adverse Event|1|||
94565130|NCT03400852|323866190|FG001|Blinded Treatment Period|Adverse Event|1|||
94347196|NCT00963820|323053903|FG003|Dose Escalation Phase|Progressive Disease|3|||
94347197|NCT00963820|323053904|FG004|Dose Escalation Phase|Progressive Disease|4|||
94347198|NCT00963820|323053905|FG005|Dose Escalation Phase|Progressive Disease|3|||
94347199|NCT00963820|323053906|FG006|Dose Escalation Phase|Progressive Disease|3|||
94347200|NCT00963820|323053907|FG007|Dose Escalation Phase|Progressive Disease|2|||
94347201|NCT00963820|323053908|FG008|Dose Escalation Phase|Progressive Disease|0|||
94347202|NCT00963820|323053909|FG009|Dose Escalation Phase|Progressive Disease|0|||
94347203|NCT00963820|323053910|FG010|Dose Escalation Phase|Progressive Disease|0|||
94347204|NCT00963820|323053911|FG011|Dose Escalation Phase|Progressive Disease|0|||
94347205|NCT00963820|323053900|FG000|Dose Escalation Phase|Adverse Event|0|||
94347206|NCT00963820|323053901|FG001|Dose Escalation Phase|Adverse Event|0|||
94347207|NCT00963820|323053902|FG002|Dose Escalation Phase|Adverse Event|0|||
94347208|NCT00963820|323053903|FG003|Dose Escalation Phase|Adverse Event|0|||
94347209|NCT00963820|323053904|FG004|Dose Escalation Phase|Adverse Event|0|||
94347210|NCT00963820|323053905|FG005|Dose Escalation Phase|Adverse Event|0|||
94347211|NCT00963820|323053906|FG006|Dose Escalation Phase|Adverse Event|3|||
94347212|NCT00963820|323053907|FG007|Dose Escalation Phase|Adverse Event|1|||
94347213|NCT00963820|323053908|FG008|Dose Escalation Phase|Adverse Event|0|||
94347214|NCT00963820|323053909|FG009|Dose Escalation Phase|Adverse Event|0|||
94347215|NCT00963820|323053910|FG010|Dose Escalation Phase|Adverse Event|0|||
94347216|NCT00963820|323053911|FG011|Dose Escalation Phase|Adverse Event|0|||
94347217|NCT00963820|323053900|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
94347218|NCT00963820|323053901|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
94347219|NCT00963820|323053902|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
94347220|NCT00963820|323053903|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
94347221|NCT00963820|323053904|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
94347222|NCT00963820|323053905|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
94347223|NCT00963820|323053906|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
94347224|NCT00963820|323053907|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
94565131|NCT03400852|323866191|FG002|Blinded Treatment Period|Adverse Event|0|||
94565132|NCT03400852|323866189|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
94565133|NCT03400852|323866190|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
94347225|NCT00963820|323053908|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
94347226|NCT00963820|323053909|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
94565134|NCT03400852|323866191|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
94565135|NCT03400852|323866189|FG000|Open Label Period|Physician Decision|0|||
94565136|NCT03400852|323866190|FG001|Open Label Period|Physician Decision|0|||
94347227|NCT00963820|323053910|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
94347228|NCT00963820|323053911|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
94565137|NCT03400852|323866191|FG002|Open Label Period|Physician Decision|1|||
94347229|NCT00963820|323053900|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94347230|NCT00963820|323053901|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94347231|NCT00963820|323053902|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94565138|NCT03400852|323866189|FG000|Open Label Period|Study terminated by sponsor|0|||
94565139|NCT03400852|323866190|FG001|Open Label Period|Study terminated by sponsor|0|||
94565140|NCT03400852|323866191|FG002|Open Label Period|Study terminated by sponsor|21|||
94565141|NCT00936702|323866192|FG000|Overall Study|Disease progression|34|||
94565142|NCT00936702|323866192|FG000|Overall Study|Adverse Event|8|||
94565143|NCT00936702|323866192|FG000|Overall Study|Withdrawal by Subject|2|||
94565144|NCT00936702|323866192|FG000|Overall Study|Alternative Treatment|1|||
94565145|NCT00936702|323866192|FG000|Overall Study|Other|1|||
94565146|NCT01550757|323866194|FG000|Overall Study|Lost to Follow-up|21|||
94565147|NCT01550757|323866195|FG001|Overall Study|Lost to Follow-up|14|||
94565148|NCT01550757|323866196|FG002|Overall Study|Lost to Follow-up|42|||
94565149|NCT01550757|323866197|FG003|Overall Study|Lost to Follow-up|53|||
94565150|NCT01550757|323866194|FG000|Overall Study|Withdrawal by Subject|2|||
94565151|NCT01550757|323866195|FG001|Overall Study|Withdrawal by Subject|0|||
94565152|NCT01550757|323866196|FG002|Overall Study|Withdrawal by Subject|3|||
94565153|NCT01550757|323866197|FG003|Overall Study|Withdrawal by Subject|1|||
94565154|NCT03191630|323866198|FG000|Overall Study|Lost to Follow-up|7|||
94565155|NCT03191630|323866199|FG001|Overall Study|Lost to Follow-up|7|||
94565156|NCT00496080|323866200|FG000|Overall Study|Lost to Follow-up|9|||
94565157|NCT00496080|323866200|FG000|Overall Study|Surgical re-intervention|7|||
94565158|NCT00496080|323866200|FG000|Overall Study|Withdrawal by Subject|5|||
94565159|NCT00496080|323866200|FG000|Overall Study|Physician Decision|6|||
94565160|NCT03018691|323866202|FG000|Overall Study|Adverse Event|1|||
94565161|NCT03018691|323866203|FG001|Overall Study|Adverse Event|1|||
94565162|NCT03018691|323866204|FG002|Overall Study|Adverse Event|4|||
94565163|NCT03018691|323866202|FG000|Overall Study|Lack of Efficacy|0|||
94565164|NCT03018691|323866203|FG001|Overall Study|Lack of Efficacy|0|||
94565165|NCT03018691|323866204|FG002|Overall Study|Lack of Efficacy|1|||
94565166|NCT03018691|323866202|FG000|Overall Study|Withdrawal by Subject|0|||
94565167|NCT03018691|323866203|FG001|Overall Study|Withdrawal by Subject|0|||
94565168|NCT03018691|323866204|FG002|Overall Study|Withdrawal by Subject|1|||
94658424|NCT01054729|324206170|FG002|Overall Study|Withdrawal by Subject|1|||
94565169|NCT03018691|323866202|FG000|Overall Study|Withdrawal by parent/guardian|1|||
94565170|NCT03018691|323866203|FG001|Overall Study|Withdrawal by parent/guardian|0|||
94565171|NCT03018691|323866204|FG002|Overall Study|Withdrawal by parent/guardian|1|||
94565172|NCT01290757|323866205|FG000|Overall Study|Adverse Event|1|||
94565173|NCT01290757|323866206|FG001|Overall Study|Adverse Event|0|||
94565174|NCT01290757|323866205|FG000|Overall Study|Protocol Violation|1|||
94565175|NCT01290757|323866206|FG001|Overall Study|Protocol Violation|1|||
94565176|NCT01290757|323866205|FG000|Overall Study|Other|0|||
94565177|NCT01290757|323866206|FG001|Overall Study|Other|1|||
94565178|NCT03369418|323866208|FG000|Overall Study|Withdrawal by Subject|3|||
94565179|NCT03369418|323866209|FG001|Overall Study|Withdrawal by Subject|3|||
94565180|NCT01426958|323866210|FG000|Overall Study|Adverse Event|2|||
94565181|NCT00337207|323866230|FG000|Overall Study|Withdrawal by Subject|3|||
94565182|NCT00413218|323866239|FG000|Overall Study|Randomized but didn't receive study drug|2|||
94565183|NCT00413218|323866240|FG001|Overall Study|Randomized but didn't receive study drug|8|||
94565184|NCT00413218|323866239|FG000|Overall Study|Death|57|||
94565185|NCT00413218|323866240|FG001|Overall Study|Death|56|||
94565186|NCT00413218|323866239|FG000|Overall Study|Lost to Follow-up|14|||
94565187|NCT00413218|323866240|FG001|Overall Study|Lost to Follow-up|17|||
94565188|NCT00413218|323866239|FG000|Overall Study|Admin|20|||
94565189|NCT00413218|323866240|FG001|Overall Study|Admin|14|||
94565190|NCT00413218|323866239|FG000|Overall Study|Missing|1|||
94565191|NCT00413218|323866240|FG001|Overall Study|Missing|0|||
94565192|NCT00413218|323866239|FG000|Overall Study|Withdrawal by Subject|9|||
94565193|NCT00413218|323866240|FG001|Overall Study|Withdrawal by Subject|1|||
94565194|NCT01687296|323866241|FG000|Overall Study|Lack of Efficacy|1|||
94347232|NCT00963820|323053903|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94347233|NCT00963820|323053904|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94347234|NCT00963820|323053905|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94347235|NCT00963820|323053906|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
94347236|NCT00963820|323053907|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94347237|NCT00963820|323053908|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94347238|NCT00963820|323053909|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94347239|NCT00963820|323053910|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94347240|NCT00963820|323053911|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94347241|NCT00963820|323053900|FG000|Expansion Phase|Progressive Disease|0|||
94347242|NCT00963820|323053901|FG001|Expansion Phase|Progressive Disease|0|||
94347243|NCT00963820|323053902|FG002|Expansion Phase|Progressive Disease|0|||
94347244|NCT00963820|323053903|FG003|Expansion Phase|Progressive Disease|0|||
94347245|NCT00963820|323053904|FG004|Expansion Phase|Progressive Disease|0|||
94347246|NCT00963820|323053905|FG005|Expansion Phase|Progressive Disease|0|||
94347247|NCT00963820|323053906|FG006|Expansion Phase|Progressive Disease|0|||
94347248|NCT00963820|323053907|FG007|Expansion Phase|Progressive Disease|0|||
94347249|NCT00963820|323053908|FG008|Expansion Phase|Progressive Disease|8|||
94347250|NCT00963820|323053909|FG009|Expansion Phase|Progressive Disease|6|||
94347251|NCT00963820|323053910|FG010|Expansion Phase|Progressive Disease|4|||
94347252|NCT00963820|323053911|FG011|Expansion Phase|Progressive Disease|2|||
94347253|NCT00963820|323053900|FG000|Expansion Phase|Adverse Event|0|||
94347254|NCT00963820|323053901|FG001|Expansion Phase|Adverse Event|0|||
94347255|NCT00963820|323053902|FG002|Expansion Phase|Adverse Event|0|||
94347256|NCT00963820|323053903|FG003|Expansion Phase|Adverse Event|0|||
94347257|NCT00963820|323053904|FG004|Expansion Phase|Adverse Event|0|||
94565195|NCT01687296|323866242|FG001|Overall Study|Lack of Efficacy|1|||
94565196|NCT01687296|323866241|FG000|Overall Study|Protocol Violation|0|||
94565197|NCT01687296|323866242|FG001|Overall Study|Protocol Violation|1|||
94565198|NCT01687296|323866241|FG000|Overall Study|Withdrawal by Subject|6|||
94450735|NCT00828568|323436952|FG001|Randomized|Withdrawal by Subject|0|||
94347258|NCT00963820|323053905|FG005|Expansion Phase|Adverse Event|0|||
94450736|NCT00828568|323436953|FG002|Randomized|Withdrawal by Subject|2|||
94347259|NCT00963820|323053906|FG006|Expansion Phase|Adverse Event|0|||
94347260|NCT00963820|323053907|FG007|Expansion Phase|Adverse Event|0|||
94565199|NCT01687296|323866242|FG001|Overall Study|Withdrawal by Subject|3|||
94565200|NCT03259087|323866245|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
94347261|NCT00963820|323053908|FG008|Expansion Phase|Adverse Event|1|||
94565201|NCT03259087|323866246|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
94565202|NCT03259087|323866247|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
94565203|NCT03259087|323866248|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
94565204|NCT03259087|323866249|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
94565205|NCT03259087|323866245|FG000|Period 2 of Part 2|Adverse Event|0|||
94236359|NCT01151423|322659838|FG001|Overall Study|Participated in other clinical trial|0|||
94236360|NCT00975676|322659839|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
94236361|NCT00975676|322659840|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
94236362|NCT03128671|322659841|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
94236363|NCT03128671|322659842|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
94236364|NCT03128671|322659841|FG000|Allocation|Death|1|||
94236365|NCT03128671|322659842|FG001|Allocation|Death|0|||
94236366|NCT03128671|322659841|FG000|Allocation|Withdrawal by Subject|4|||
94236367|NCT03128671|322659842|FG001|Allocation|Withdrawal by Subject|0|||
94236368|NCT03128671|322659841|FG000|Intervention|Withdrawal by Subject|11|||
94236369|NCT03128671|322659842|FG001|Intervention|Withdrawal by Subject|10|||
94236370|NCT03128671|322659841|FG000|Intervention|Palliative/hospice care initiated|9|||
94236371|NCT03128671|322659842|FG001|Intervention|Palliative/hospice care initiated|10|||
94236372|NCT03128671|322659841|FG000|Intervention|Death|13|||
94236373|NCT03128671|322659842|FG001|Intervention|Death|11|||
94236374|NCT03128671|322659841|FG000|Intervention|Interrupted by hurricane|1|||
94236375|NCT03128671|322659842|FG001|Intervention|Interrupted by hurricane|0|||
94236376|NCT03128671|322659841|FG000|Intervention|Physician Decision|2|||
94236377|NCT03128671|322659842|FG001|Intervention|Physician Decision|3|||
94236378|NCT00738283|322659846|FG000|Overall Study|Death|1|||
94236379|NCT00738283|322659846|FG000|Overall Study|Transfer to another facility|2|||
94236380|NCT00738283|322659846|FG000|Overall Study|Discharge home prior to end of study|1|||
94236381|NCT00583947|322659847|FG000|Cross-over Period|Adverse Event|2|||
94236382|NCT00583947|322659848|FG001|Cross-over Period|Adverse Event|0|||
94236383|NCT00583947|322659847|FG000|Cross-over Period|Withdrawal by Subject|2|||
94236384|NCT00583947|322659848|FG001|Cross-over Period|Withdrawal by Subject|0|||
94236385|NCT00583947|322659847|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
94236386|NCT00583947|322659848|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
94236387|NCT00583947|322659847|FG000|Cross-over Period|Other|1|||
94236388|NCT00583947|322659848|FG001|Cross-over Period|Other|1|||
94236389|NCT01261247|322659849|FG000|Overall Study|Ineligible|2|||
94236390|NCT04463680|322659850|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
94236391|NCT04463680|322659850|FG000|Overall Study|Not eligible due to implant duration of use|1|||
94236392|NCT04463680|322659850|FG000|Overall Study|Withdrawal by Subject|3|||
94236393|NCT05239598|322659853|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
94236394|NCT05239598|322659854|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
94236395|NCT05239598|322659853|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
94236396|NCT05239598|322659854|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
94236397|NCT02397447|322659855|FG000|Overall Study|Lost to Follow-up|2|||
94236398|NCT02397447|322659856|FG001|Overall Study|Lost to Follow-up|2|||
94236399|NCT01246999|322661736|FG000|Overall Study|Lost to Follow-up|0|||
94236400|NCT01246999|322661737|FG001|Overall Study|Lost to Follow-up|1|||
94236401|NCT01246999|322661738|FG002|Overall Study|Lost to Follow-up|0|||
94236402|NCT01246999|322661739|FG003|Overall Study|Lost to Follow-up|0|||
94236403|NCT01246999|322661736|FG000|Overall Study|Withdrawal by Subject|0|||
94236404|NCT01246999|322661737|FG001|Overall Study|Withdrawal by Subject|0|||
94236405|NCT01246999|322661738|FG002|Overall Study|Withdrawal by Subject|0|||
94236406|NCT01246999|322661739|FG003|Overall Study|Withdrawal by Subject|2|||
94236407|NCT01638390|322661744|FG000|Overall Study|screening failures|21|||
94236408|NCT02666664|322661745|FG000|Overall Study|Physician Decision|0|||
94236409|NCT02666664|322661746|FG001|Overall Study|Physician Decision|1|||
94236410|NCT02666664|322661745|FG000|Overall Study|Protocol Violation|0|||
94236411|NCT02666664|322661746|FG001|Overall Study|Protocol Violation|2|||
94236412|NCT02666664|322661745|FG000|Overall Study|Other|0|||
94236413|NCT02666664|322661746|FG001|Overall Study|Other|1|||
94236414|NCT02666664|322661745|FG000|Overall Study|Adverse Event|12|||
94236415|NCT02666664|322661746|FG001|Overall Study|Adverse Event|37|||
94236416|NCT02666664|322661745|FG000|Overall Study|Withdrawal by participant|23|||
94236417|NCT02666664|322661746|FG001|Overall Study|Withdrawal by participant|40|||
94236418|NCT02666664|322661745|FG000|Overall Study|Sponsor decision|0|||
94236419|NCT02666664|322661746|FG001|Overall Study|Sponsor decision|1|||
94236420|NCT02666664|322661745|FG000|Overall Study|Lost to Follow-up|1|||
94236421|NCT02666664|322661746|FG001|Overall Study|Lost to Follow-up|2|||
94236422|NCT00971997|322661747|FG000|Overall Study|Adverse Event|2|||
94236423|NCT00971997|322661747|FG000|Overall Study|Death|1|||
94236424|NCT00971997|322661747|FG000|Overall Study|Protocol Violation|4|||
94236425|NCT00971997|322661747|FG000|Overall Study|Withdrawal by Subject|5|||
94236426|NCT00971997|322661747|FG000|Overall Study|Physician Decision|7|||
94236427|NCT02763215|322661748|FG000|Overall Study|Participants withdrew from study|3|||
94236428|NCT02763215|322661748|FG000|Overall Study|Missed visit|1|||
94236429|NCT02763215|322661748|FG000|Overall Study|Visit outside visit-window|1|||
94236430|NCT02763215|322661748|FG000|Overall Study|Death|1|||
94236431|NCT02763215|322661748|FG000|Overall Study|Lost to Follow-up|1|||
94236432|NCT01667926|322661749|FG000|Overall Study|Withdrawal by Subject|1|||
94236433|NCT01667926|322661750|FG001|Overall Study|Withdrawal by Subject|2|||
94450737|NCT00828568|323436951|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
94658425|NCT01054729|324206171|FG003|Overall Study|Withdrawal by Subject|0|||
94658426|NCT01054729|324206168|FG000|Overall Study|Lost to Follow-up|0|||
94658427|NCT01054729|324206169|FG001|Overall Study|Lost to Follow-up|1|||
94658428|NCT01054729|324206170|FG002|Overall Study|Lost to Follow-up|0|||
94658429|NCT01054729|324206171|FG003|Overall Study|Lost to Follow-up|0|||
94658430|NCT01054729|324206168|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
94658431|NCT01054729|324206169|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
94658432|NCT01054729|324206170|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
94658433|NCT01054729|324206171|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
94658434|NCT01054729|324206168|FG000|Overall Study|Non-responder|1|||
94658435|NCT01054729|324206169|FG001|Overall Study|Non-responder|0|||
94658436|NCT01054729|324206170|FG002|Overall Study|Non-responder|1|||
94658437|NCT01054729|324206171|FG003|Overall Study|Non-responder|1|||
94658438|NCT01054729|324206168|FG000|Overall Study|PEG/RBV Non-responder|1|||
94658439|NCT01054729|324206169|FG001|Overall Study|PEG/RBV Non-responder|0|||
94658440|NCT01054729|324206170|FG002|Overall Study|PEG/RBV Non-responder|1|||
94658441|NCT01054729|324206171|FG003|Overall Study|PEG/RBV Non-responder|0|||
94658442|NCT01054729|324206168|FG000|Overall Study|Personal/Obligations|0|||
94658443|NCT01054729|324206169|FG001|Overall Study|Personal/Obligations|1|||
94658444|NCT01054729|324206170|FG002|Overall Study|Personal/Obligations|0|||
94658445|NCT01054729|324206171|FG003|Overall Study|Personal/Obligations|0|||
94658446|NCT01054729|324206168|FG000|Overall Study|Subject moved|0|||
94658447|NCT01054729|324206169|FG001|Overall Study|Subject moved|0|||
94658448|NCT01054729|324206170|FG002|Overall Study|Subject moved|1|||
94658449|NCT01054729|324206171|FG003|Overall Study|Subject moved|0|||
94658450|NCT01054729|324206168|FG000|Overall Study|Lack of Efficacy|0|||
94658451|NCT01054729|324206169|FG001|Overall Study|Lack of Efficacy|0|||
94658452|NCT01054729|324206170|FG002|Overall Study|Lack of Efficacy|0|||
94658453|NCT01054729|324206171|FG003|Overall Study|Lack of Efficacy|1|||
94658454|NCT02496884|324206172|FG000|Overall Study|Counted twice as enrolled|2|||
94658455|NCT02496884|324206173|FG001|Overall Study|Counted twice as enrolled|0|||
94658456|NCT02496884|324206174|FG002|Overall Study|Counted twice as enrolled|0|||
94658457|NCT02496884|324206175|FG003|Overall Study|Counted twice as enrolled|0|||
94658458|NCT02496884|324206172|FG000|Overall Study|Withdrawal by Subject|0|||
94658459|NCT02496884|324206173|FG001|Overall Study|Withdrawal by Subject|3|||
94658460|NCT02496884|324206174|FG002|Overall Study|Withdrawal by Subject|0|||
94658461|NCT02496884|324206175|FG003|Overall Study|Withdrawal by Subject|0|||
94658462|NCT02530619|324206179|FG000|Registered for Study|Withdrawal by Subject|2|||
94658463|NCT02530619|324206179|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
94658464|NCT02530619|324206179|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
94658465|NCT02530619|324206179|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
94658466|NCT02530619|324206179|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
94658467|NCT02530619|324206179|FG000|Follow-up Period (6 Months)|Death|4|||
94658468|NCT02530619|324206179|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
94658469|NCT02530619|324206179|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
94658470|NCT01172938|324206182|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
94658471|NCT01172938|324206183|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
94658472|NCT01172938|324206184|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
94658473|NCT01172938|324206185|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
94658474|NCT01172938|324206186|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
94658475|NCT01172938|324206187|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
94658476|NCT01172938|324206188|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
94658477|NCT01172938|324206189|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
94658478|NCT01172938|324206190|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
94236434|NCT01667926|322661751|FG002|Overall Study|Withdrawal by Subject|2|||
94236435|NCT01667926|322661749|FG000|Overall Study|Physician Decision|0|||
94658479|NCT01172938|324206182|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
94658480|NCT01172938|324206183|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
94658481|NCT01172938|324206184|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
94658482|NCT01172938|324206185|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
94658483|NCT01172938|324206186|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
94658484|NCT01172938|324206187|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
94658485|NCT01172938|324206188|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
94658486|NCT01172938|324206189|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
94658487|NCT01172938|324206190|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
94658488|NCT01172938|324206182|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
94658489|NCT01172938|324206183|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
94658490|NCT01172938|324206184|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
94658491|NCT01172938|324206185|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
94658492|NCT01172938|324206186|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
94688601|NCT00390455|324315526|FG000|Overall Study|Withdrawal by Subject|8|||
94565206|NCT03259087|323866246|FG001|Period 2 of Part 2|Adverse Event|0|||
94565207|NCT03259087|323866247|FG002|Period 2 of Part 2|Adverse Event|0|||
94236436|NCT01667926|322661750|FG001|Overall Study|Physician Decision|0|||
94236437|NCT01667926|322661751|FG002|Overall Study|Physician Decision|1|||
94236438|NCT01667926|322661749|FG000|Overall Study|Time committment|0|||
94236439|NCT01667926|322661750|FG001|Overall Study|Time committment|0|||
94236440|NCT01667926|322661751|FG002|Overall Study|Time committment|2|||
94236441|NCT01667926|322661749|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
94236442|NCT01667926|322661750|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
94236443|NCT01667926|322661751|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
94236444|NCT01667926|322661749|FG000|Overall Study|Lost to Follow-up|1|||
94236445|NCT01667926|322661750|FG001|Overall Study|Lost to Follow-up|2|||
94236446|NCT01667926|322661751|FG002|Overall Study|Lost to Follow-up|1|||
94236447|NCT01667926|322661749|FG000|Overall Study|Side effects|3|||
94236448|NCT01667926|322661750|FG001|Overall Study|Side effects|0|||
94236449|NCT01667926|322661751|FG002|Overall Study|Side effects|0|||
94236450|NCT01411241|322661757|FG000|Overall Study|Protocol Violation|0|||
94236451|NCT01411241|322661758|FG001|Overall Study|Protocol Violation|5|||
94236452|NCT01411241|322661757|FG000|Overall Study|Withdrawal by Subject|9|||
94236453|NCT01411241|322661758|FG001|Overall Study|Withdrawal by Subject|10|||
94236454|NCT01411241|322661757|FG000|Overall Study|Serious Adverse Event|0|||
94236455|NCT01411241|322661758|FG001|Overall Study|Serious Adverse Event|3|||
94236456|NCT01411241|322661757|FG000|Overall Study|Lost to Follow-up|2|||
94236457|NCT01411241|322661758|FG001|Overall Study|Lost to Follow-up|4|||
94236458|NCT04367480|322661759|FG000|Overall Study|Adverse Event|1|||
94236459|NCT04367480|322661760|FG001|Overall Study|Adverse Event|1|||
94236460|NCT04367480|322661759|FG000|Overall Study|Death|1|||
94236461|NCT04367480|322661760|FG001|Overall Study|Death|0|||
94236462|NCT04367480|322661759|FG000|Overall Study|Lost to Follow-up|1|||
94236463|NCT04367480|322661760|FG001|Overall Study|Lost to Follow-up|1|||
94236464|NCT04367480|322661759|FG000|Overall Study|Withdrawal by Subject|0|||
94236465|NCT04367480|322661760|FG001|Overall Study|Withdrawal by Subject|3|||
94236466|NCT04367480|322661759|FG000|Overall Study|App glitch during the study|1|||
94236467|NCT04367480|322661760|FG001|Overall Study|App glitch during the study|0|||
94236468|NCT04367480|322661759|FG000|Overall Study|Device Distribution Error|0|||
94236469|NCT04367480|322661760|FG001|Overall Study|Device Distribution Error|2|||
94236470|NCT04367480|322661759|FG000|Overall Study|Ineligible after Randomization|0|||
94236471|NCT04367480|322661760|FG001|Overall Study|Ineligible after Randomization|1|||
94236472|NCT04367480|322661759|FG000|Overall Study|Other Medical Reasons|0|||
94236473|NCT04367480|322661760|FG001|Overall Study|Other Medical Reasons|2|||
94236474|NCT00863512|322661761|FG000|Overall Study|Adverse Event|2|||
94236475|NCT00863512|322661762|FG001|Overall Study|Adverse Event|0|||
94236476|NCT00863512|322661761|FG000|Overall Study|Withdrawal by Subject|11|||
94236477|NCT00863512|322661762|FG001|Overall Study|Withdrawal by Subject|0|||
94236478|NCT00863512|322661761|FG000|Overall Study|Physician Decision|1|||
94236479|NCT00863512|322661762|FG001|Overall Study|Physician Decision|0|||
94236480|NCT00078338|322661767|FG000|Overall Study|Adverse Event|31|||
94236481|NCT00078338|322661768|FG001|Overall Study|Adverse Event|24|||
94236482|NCT00078338|322661767|FG000|Overall Study|Lost to Follow-up|17|||
94236483|NCT00078338|322661768|FG001|Overall Study|Lost to Follow-up|2|||
94236484|NCT00078338|322661767|FG000|Overall Study|Protocol Violation|2|||
94236485|NCT00078338|322661768|FG001|Overall Study|Protocol Violation|2|||
94236486|NCT00078338|322661767|FG000|Overall Study|Disease Progression|4|||
94236487|NCT00078338|322661768|FG001|Overall Study|Disease Progression|7|||
94236488|NCT00078338|322661767|FG000|Overall Study|Other|28|||
94236489|NCT00078338|322661768|FG001|Overall Study|Other|16|||
94236490|NCT00078338|322661767|FG000|Overall Study|Subjects randomized, but not treated|3|||
94236491|NCT00078338|322661768|FG001|Overall Study|Subjects randomized, but not treated|3|||
94236492|NCT01245140|322661769|FG000|Overall Study|Adverse Event|1|||
94236493|NCT01245140|322661770|FG001|Overall Study|Adverse Event|3|||
94236494|NCT01245140|322661769|FG000|Overall Study|Lack of Efficacy|2|||
94236495|NCT01245140|322661770|FG001|Overall Study|Lack of Efficacy|4|||
94565208|NCT03259087|323866248|FG003|Period 2 of Part 2|Adverse Event|0|||
94565209|NCT03259087|323866249|FG004|Period 2 of Part 2|Adverse Event|1|||
94565210|NCT01338818|323866256|FG000|Overall Study|Adverse Event|8|||
94236496|NCT01245140|322661769|FG000|Overall Study|Protocol Violation|0|||
94236497|NCT01245140|322661770|FG001|Overall Study|Protocol Violation|1|||
94236498|NCT01245140|322661769|FG000|Overall Study|Withdrawal by Subject|0|||
94236499|NCT01245140|322661770|FG001|Overall Study|Withdrawal by Subject|1|||
94236500|NCT01245140|322661769|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
94236501|NCT01245140|322661770|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
94236502|NCT01907906|322661771|FG000|Overall Study|Withdrawal by Subject|1|||
94236503|NCT01907906|322661772|FG001|Overall Study|Withdrawal by Subject|0|||
94236504|NCT01907906|322661771|FG000|Overall Study|Physician Decision|3|||
94236505|NCT01907906|322661772|FG001|Overall Study|Physician Decision|1|||
94565211|NCT01338818|323866256|FG000|Overall Study|Lack of Efficacy|5|||
94565212|NCT01338818|323866256|FG000|Overall Study|no longer require study drug|1|||
94236506|NCT01594827|322661775|FG000|Overall Study|Adverse Event|1|||
94565213|NCT01338818|323866256|FG000|Overall Study|Withdrawal by Subject|11|||
94565214|NCT01338818|323866256|FG000|Overall Study|Lost to Follow-up|4|||
94565215|NCT01338818|323866256|FG000|Overall Study|Administrative problems|3|||
94565216|NCT01338818|323866256|FG000|Overall Study|Protocol Deviation|4|||
94565217|NCT01620086|323866257|FG000|Overall Study|Withdrawal by Subject|3|||
94565218|NCT01620086|323866258|FG001|Overall Study|Withdrawal by Subject|3|||
94565219|NCT01620086|323866259|FG002|Overall Study|Withdrawal by Subject|0|||
94565220|NCT01620086|323866257|FG000|Overall Study|failed study criteria|1|||
94565221|NCT01620086|323866258|FG001|Overall Study|failed study criteria|4|||
94565222|NCT01620086|323866259|FG002|Overall Study|failed study criteria|0|||
94565223|NCT01620086|323866257|FG000|Overall Study|Physician Decision|1|||
94565224|NCT01620086|323866258|FG001|Overall Study|Physician Decision|0|||
94565225|NCT01620086|323866259|FG002|Overall Study|Physician Decision|0|||
94565226|NCT02905266|323866264|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
94565227|NCT02905266|323866265|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
94565228|NCT02905266|323866264|FG000|Treatment Phase Part 1|Disease Progression|6|||
94565229|NCT02905266|323866265|FG001|Treatment Phase Part 1|Disease Progression|7|||
94565230|NCT02905266|323866264|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
94565231|NCT02905266|323866265|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
94565232|NCT02905266|323866264|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
94565233|NCT02905266|323866265|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
94565234|NCT02905266|323866264|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
94565235|NCT02905266|323866265|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
94565236|NCT02905266|323866264|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
94565237|NCT02905266|323866265|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
94565238|NCT02905266|323866264|FG000|Transition From Part 1 to Part 2|Death|0|||
94565239|NCT02905266|323866265|FG001|Transition From Part 1 to Part 2|Death|1|||
94565240|NCT02905266|323866264|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
94565241|NCT02905266|323866265|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
94565242|NCT02905266|323866264|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
94565243|NCT02905266|323866265|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
94565244|NCT02905266|323866264|FG000|Maintenance Phase Part 2|Disease Progression|9|||
94565245|NCT02905266|323866265|FG001|Maintenance Phase Part 2|Disease Progression|2|||
94565246|NCT02905266|323866264|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
94565247|NCT02905266|323866265|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
94565248|NCT02905266|323866264|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
94565249|NCT02905266|323866265|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
94565250|NCT02800863|323866271|FG000|Overall Study|Adverse Event|14|||
94565251|NCT02800863|323866271|FG000|Overall Study|Another Device Implanted|1|||
94565252|NCT02800863|323866271|FG000|Overall Study|Device Explanted|1|||
94565253|NCT02800863|323866271|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
94565254|NCT02800863|323866271|FG000|Overall Study|Health Issues|1|||
94565255|NCT02800863|323866271|FG000|Overall Study|Insurance Denial|8|||
94565256|NCT02800863|323866271|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
94565257|NCT02800863|323866271|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
94565258|NCT02800863|323866271|FG000|Overall Study|Screen Failure|1|||
94565259|NCT02800863|323866271|FG000|Overall Study|Sponsor Request|6|||
94347262|NCT00963820|323053909|FG009|Expansion Phase|Adverse Event|3|||
94347263|NCT00963820|323053910|FG010|Expansion Phase|Adverse Event|0|||
94347264|NCT00963820|323053911|FG011|Expansion Phase|Adverse Event|0|||
94347265|NCT00963820|323053900|FG000|Expansion Phase|Withdrawal by Subject|0|||
94347266|NCT00963820|323053901|FG001|Expansion Phase|Withdrawal by Subject|0|||
94347267|NCT00963820|323053902|FG002|Expansion Phase|Withdrawal by Subject|0|||
94347268|NCT00963820|323053903|FG003|Expansion Phase|Withdrawal by Subject|0|||
94347269|NCT00963820|323053904|FG004|Expansion Phase|Withdrawal by Subject|0|||
94347270|NCT00963820|323053905|FG005|Expansion Phase|Withdrawal by Subject|0|||
94347271|NCT00963820|323053906|FG006|Expansion Phase|Withdrawal by Subject|0|||
94347272|NCT00963820|323053907|FG007|Expansion Phase|Withdrawal by Subject|0|||
94347273|NCT00963820|323053908|FG008|Expansion Phase|Withdrawal by Subject|1|||
94347274|NCT00963820|323053909|FG009|Expansion Phase|Withdrawal by Subject|0|||
94347275|NCT00963820|323053910|FG010|Expansion Phase|Withdrawal by Subject|1|||
94565260|NCT02800863|323866271|FG000|Overall Study|Death|3|||
94565261|NCT02800863|323866271|FG000|Overall Study|Subject Implant at Another Facility|1|||
94565262|NCT02800863|323866271|FG000|Overall Study|Lost to Follow-up|26|||
94565263|NCT02800863|323866271|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
94565264|NCT02800863|323866271|FG000|Overall Study|Subject and/or Family Request|64|||
94347276|NCT00963820|323053911|FG011|Expansion Phase|Withdrawal by Subject|1|||
94565265|NCT02800863|323866271|FG000|Overall Study|Trial Failure|81|||
94565266|NCT02800863|323866271|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
94565267|NCT03622814|323866275|FG000|Overall Study|Lost to Follow-up|8|||
94347277|NCT00963820|323053900|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94347278|NCT00963820|323053901|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94347279|NCT00963820|323053902|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94347280|NCT00963820|323053903|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94347281|NCT00963820|323053904|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94347282|NCT00963820|323053905|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94347283|NCT00963820|323053906|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94347284|NCT00963820|323053907|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94347285|NCT00963820|323053908|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94565268|NCT03622814|323866276|FG001|Overall Study|Lost to Follow-up|14|||
94565269|NCT04303559|323866277|FG000|Overall Study|Study closed due to poor enrollment.|1|||
94347286|NCT00963820|323053909|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94347287|NCT00963820|323053910|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94347288|NCT00963820|323053911|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
94347289|NCT00089505|323053912|FG000|Overall Study|Death|4|||
94347290|NCT00089505|323053913|FG001|Overall Study|Death|1|||
94565270|NCT04378270|323866278|FG000|Overall Study|Lack of Efficacy|1|||
94565271|NCT04378270|323866278|FG000|Overall Study|Withdrawal by Subject|1|||
94565272|NCT04378270|323866278|FG000|Overall Study|Screen Failure|1|||
94565273|NCT04378270|323866278|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
94565274|NCT01132313|323866279|FG000|Overall Study|Lack of Efficacy|1|||
94347291|NCT00089505|323053914|FG002|Overall Study|Death|5|||
94347292|NCT00089505|323053915|FG003|Overall Study|Death|8|||
94347293|NCT00089505|323053912|FG000|Overall Study|Withdrawal by Subject|3|||
94347294|NCT00089505|323053913|FG001|Overall Study|Withdrawal by Subject|0|||
94347295|NCT00089505|323053914|FG002|Overall Study|Withdrawal by Subject|6|||
94347296|NCT00089505|323053915|FG003|Overall Study|Withdrawal by Subject|6|||
94347297|NCT00089505|323053912|FG000|Overall Study|Lost to Follow-up|1|||
94347298|NCT00089505|323053913|FG001|Overall Study|Lost to Follow-up|1|||
94347299|NCT00089505|323053914|FG002|Overall Study|Lost to Follow-up|9|||
94347300|NCT00089505|323053915|FG003|Overall Study|Lost to Follow-up|7|||
94347301|NCT00089505|323053912|FG000|Overall Study|Physician Decision|1|||
94347302|NCT00089505|323053913|FG001|Overall Study|Physician Decision|0|||
94347303|NCT00089505|323053914|FG002|Overall Study|Physician Decision|0|||
94347304|NCT00089505|323053915|FG003|Overall Study|Physician Decision|0|||
94347305|NCT00089505|323053912|FG000|Overall Study|Protocol Violation|0|||
94347306|NCT00089505|323053913|FG001|Overall Study|Protocol Violation|0|||
94347307|NCT00089505|323053914|FG002|Overall Study|Protocol Violation|1|||
94347308|NCT00089505|323053915|FG003|Overall Study|Protocol Violation|0|||
94347309|NCT02477800|323053916|FG000|Placebo-Controlled Period|Adverse Event|16|||
94347310|NCT02477800|323053917|FG001|Placebo-Controlled Period|Adverse Event|25|||
94347311|NCT02477800|323053918|FG002|Placebo-Controlled Period|Adverse Event|28|||
94347312|NCT02477800|323053919|FG003|Placebo-Controlled Period|Adverse Event|0|||
94347313|NCT02477800|323053920|FG004|Placebo-Controlled Period|Adverse Event|0|||
94347314|NCT02477800|323053921|FG005|Placebo-Controlled Period|Adverse Event|0|||
94347315|NCT02477800|323053922|FG006|Placebo-Controlled Period|Adverse Event|0|||
94347316|NCT02477800|323053916|FG000|Placebo-Controlled Period|Change of Treatment|1|||
94347317|NCT02477800|323053917|FG001|Placebo-Controlled Period|Change of Treatment|2|||
94347318|NCT02477800|323053918|FG002|Placebo-Controlled Period|Change of Treatment|1|||
94347319|NCT02477800|323053919|FG003|Placebo-Controlled Period|Change of Treatment|0|||
94347320|NCT02477800|323053920|FG004|Placebo-Controlled Period|Change of Treatment|0|||
94347321|NCT02477800|323053921|FG005|Placebo-Controlled Period|Change of Treatment|0|||
94347322|NCT02477800|323053922|FG006|Placebo-Controlled Period|Change of Treatment|0|||
94347323|NCT02477800|323053916|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
94347324|NCT02477800|323053917|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
94347325|NCT02477800|323053918|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
94347326|NCT02477800|323053919|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
94347327|NCT02477800|323053920|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
94347328|NCT02477800|323053921|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
94347329|NCT02477800|323053922|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
94347330|NCT02477800|323053916|FG000|Placebo-Controlled Period|Death|0|||
94347331|NCT02477800|323053917|FG001|Placebo-Controlled Period|Death|3|||
94347332|NCT02477800|323053918|FG002|Placebo-Controlled Period|Death|2|||
94347333|NCT02477800|323053919|FG003|Placebo-Controlled Period|Death|0|||
94565275|NCT01132313|323866280|FG001|Overall Study|Lack of Efficacy|0|||
94565276|NCT01132313|323866281|FG002|Overall Study|Lack of Efficacy|0|||
94565277|NCT01132313|323866282|FG003|Overall Study|Lack of Efficacy|0|||
94565278|NCT01132313|323866283|FG004|Overall Study|Lack of Efficacy|0|||
94347334|NCT02477800|323053920|FG004|Placebo-Controlled Period|Death|0|||
94347335|NCT02477800|323053921|FG005|Placebo-Controlled Period|Death|0|||
94347336|NCT02477800|323053922|FG006|Placebo-Controlled Period|Death|0|||
94347337|NCT02477800|323053916|FG000|Placebo-Controlled Period|Disease Progression|1|||
94347338|NCT02477800|323053917|FG001|Placebo-Controlled Period|Disease Progression|0|||
94347339|NCT02477800|323053918|FG002|Placebo-Controlled Period|Disease Progression|1|||
94565279|NCT01132313|323866284|FG005|Overall Study|Lack of Efficacy|0|||
94565280|NCT01132313|323866285|FG006|Overall Study|Lack of Efficacy|0|||
94450738|NCT00828568|323436952|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
94565281|NCT01132313|323866286|FG007|Overall Study|Lack of Efficacy|3|||
94565282|NCT01132313|323866287|FG008|Overall Study|Lack of Efficacy|14|||
94565283|NCT01132313|323866288|FG009|Overall Study|Lack of Efficacy|16|||
94565284|NCT01132313|323866289|FG010|Overall Study|Lack of Efficacy|0|||
94565285|NCT01132313|323866290|FG011|Overall Study|Lack of Efficacy|0|||
94565286|NCT01132313|323866279|FG000|Overall Study|Not treated|2|||
94565287|NCT01132313|323866280|FG001|Overall Study|Not treated|0|||
94565288|NCT01132313|323866281|FG002|Overall Study|Not treated|0|||
94565289|NCT01132313|323866282|FG003|Overall Study|Not treated|0|||
94565290|NCT01132313|323866283|FG004|Overall Study|Not treated|2|||
94565291|NCT01132313|323866284|FG005|Overall Study|Not treated|1|||
94565292|NCT01132313|323866285|FG006|Overall Study|Not treated|3|||
94658493|NCT01172938|324206187|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
94658494|NCT01172938|324206188|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
94658495|NCT01172938|324206189|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
94236507|NCT01594827|322661776|FG001|Overall Study|Adverse Event|0|||
94236508|NCT01594827|322661775|FG000|Overall Study|Physician Decision|3|||
94236509|NCT01594827|322661776|FG001|Overall Study|Physician Decision|0|||
94236510|NCT02980523|322661777|FG000|Overall Study|Lost to Follow-up|1|||
94236511|NCT02980523|322661778|FG001|Overall Study|Lost to Follow-up|4|||
94236512|NCT02980523|322661779|FG002|Overall Study|Lost to Follow-up|1|||
94236513|NCT02980523|322661780|FG003|Overall Study|Lost to Follow-up|2|||
94236514|NCT02980523|322661781|FG004|Overall Study|Lost to Follow-up|1|||
94236515|NCT02980523|322661777|FG000|Overall Study|Excluded from analysis|1|||
94236516|NCT02980523|322661778|FG001|Overall Study|Excluded from analysis|3|||
94236517|NCT02980523|322661779|FG002|Overall Study|Excluded from analysis|1|||
94236518|NCT02980523|322661780|FG003|Overall Study|Excluded from analysis|1|||
94236519|NCT02980523|322661781|FG004|Overall Study|Excluded from analysis|1|||
94236520|NCT02980523|322661777|FG000|Overall Study|Lack of Efficacy|1|||
94236521|NCT02980523|322661778|FG001|Overall Study|Lack of Efficacy|4|||
94236522|NCT02980523|322661779|FG002|Overall Study|Lack of Efficacy|4|||
94236523|NCT02980523|322661780|FG003|Overall Study|Lack of Efficacy|5|||
94236524|NCT02980523|322661781|FG004|Overall Study|Lack of Efficacy|8|||
94236525|NCT02980523|322661777|FG000|Overall Study|Did not receive intervention|0|||
94236526|NCT02980523|322661778|FG001|Overall Study|Did not receive intervention|0|||
94236527|NCT02980523|322661779|FG002|Overall Study|Did not receive intervention|0|||
94236528|NCT02980523|322661780|FG003|Overall Study|Did not receive intervention|1|||
94236529|NCT02980523|322661781|FG004|Overall Study|Did not receive intervention|0|||
94236530|NCT02153905|322661782|FG000|Overall Study|Death|1|||
94236531|NCT02153905|322661783|FG001|Overall Study|Death|0|||
94236532|NCT02552147|322661784|FG000|First Intervention (7 Days)|Protocol Violation|1|||
94236533|NCT02552147|322661785|FG001|First Intervention (7 Days)|Protocol Violation|0|||
94236534|NCT02552147|322661784|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
94236535|NCT02552147|322661785|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
94236536|NCT00079339|322661786|FG000|Overall Study|Adverse Event|1|||
94236537|NCT00079339|322661787|FG001|Overall Study|Adverse Event|7|||
94236538|NCT00079339|322661788|FG002|Overall Study|Adverse Event|2|||
94236539|NCT00079339|322661786|FG000|Overall Study|Death|1|||
94236540|NCT00079339|322661787|FG001|Overall Study|Death|0|||
94236541|NCT00079339|322661788|FG002|Overall Study|Death|0|||
94236542|NCT00079339|322661786|FG000|Overall Study|Non-compliance|0|||
94236543|NCT00079339|322661787|FG001|Overall Study|Non-compliance|0|||
94236544|NCT00079339|322661788|FG002|Overall Study|Non-compliance|1|||
94236545|NCT00079339|322661786|FG000|Overall Study|Withdrawal by Subject|0|||
94236546|NCT00079339|322661787|FG001|Overall Study|Withdrawal by Subject|4|||
94236547|NCT00079339|322661788|FG002|Overall Study|Withdrawal by Subject|1|||
94236548|NCT00079339|322661786|FG000|Overall Study|Disease progression|3|||
94236549|NCT00079339|322661787|FG001|Overall Study|Disease progression|28|||
94236550|NCT00079339|322661788|FG002|Overall Study|Disease progression|2|||
94236551|NCT02563548|322661789|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
94236552|NCT02563548|322661790|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
94236553|NCT02563548|322661791|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
94236554|NCT02563548|322661792|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
94236555|NCT02563548|322661793|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
94236556|NCT02563548|322661794|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
94236557|NCT02563548|322661789|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
94236558|NCT02563548|322661790|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
94236559|NCT02563548|322661791|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
94236560|NCT02563548|322661792|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
94236561|NCT02563548|322661793|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
94236562|NCT02563548|322661794|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
94565293|NCT01132313|323866286|FG007|Overall Study|Not treated|0|||
94565294|NCT01132313|323866287|FG008|Overall Study|Not treated|0|||
94565295|NCT01132313|323866288|FG009|Overall Study|Not treated|0|||
94565296|NCT01132313|323866289|FG010|Overall Study|Not treated|0|||
94565297|NCT01132313|323866290|FG011|Overall Study|Not treated|0|||
94565298|NCT01132313|323866279|FG000|Overall Study|Adverse Event|0|||
94565299|NCT01132313|323866280|FG001|Overall Study|Adverse Event|0|||
94565300|NCT01132313|323866281|FG002|Overall Study|Adverse Event|4|||
94565301|NCT01132313|323866282|FG003|Overall Study|Adverse Event|10|||
94565302|NCT01132313|323866283|FG004|Overall Study|Adverse Event|19|||
94565303|NCT01132313|323866284|FG005|Overall Study|Adverse Event|6|||
94565304|NCT01132313|323866285|FG006|Overall Study|Adverse Event|5|||
94565305|NCT01132313|323866286|FG007|Overall Study|Adverse Event|3|||
94565306|NCT01132313|323866287|FG008|Overall Study|Adverse Event|7|||
94565307|NCT01132313|323866288|FG009|Overall Study|Adverse Event|2|||
94565308|NCT01132313|323866289|FG010|Overall Study|Adverse Event|0|||
94565309|NCT01132313|323866290|FG011|Overall Study|Adverse Event|0|||
94565310|NCT01132313|323866279|FG000|Overall Study|Protocol Violation|0|||
94565311|NCT01132313|323866280|FG001|Overall Study|Protocol Violation|0|||
94565312|NCT01132313|323866281|FG002|Overall Study|Protocol Violation|0|||
94565313|NCT01132313|323866282|FG003|Overall Study|Protocol Violation|1|||
94565314|NCT01132313|323866283|FG004|Overall Study|Protocol Violation|0|||
94565315|NCT01132313|323866284|FG005|Overall Study|Protocol Violation|0|||
94565316|NCT01132313|323866285|FG006|Overall Study|Protocol Violation|0|||
94565317|NCT01132313|323866286|FG007|Overall Study|Protocol Violation|0|||
94565318|NCT01132313|323866287|FG008|Overall Study|Protocol Violation|0|||
94565319|NCT01132313|323866288|FG009|Overall Study|Protocol Violation|0|||
94565320|NCT01132313|323866289|FG010|Overall Study|Protocol Violation|0|||
94565321|NCT01132313|323866290|FG011|Overall Study|Protocol Violation|0|||
94565322|NCT01132313|323866279|FG000|Overall Study|Lost to Follow-up|0|||
94565323|NCT01132313|323866280|FG001|Overall Study|Lost to Follow-up|0|||
94565324|NCT01132313|323866281|FG002|Overall Study|Lost to Follow-up|1|||
94565325|NCT01132313|323866282|FG003|Overall Study|Lost to Follow-up|0|||
94565326|NCT01132313|323866283|FG004|Overall Study|Lost to Follow-up|0|||
94565327|NCT01132313|323866284|FG005|Overall Study|Lost to Follow-up|0|||
94565328|NCT01132313|323866285|FG006|Overall Study|Lost to Follow-up|0|||
94565329|NCT01132313|323866286|FG007|Overall Study|Lost to Follow-up|1|||
94565330|NCT01132313|323866287|FG008|Overall Study|Lost to Follow-up|0|||
94565331|NCT01132313|323866288|FG009|Overall Study|Lost to Follow-up|0|||
94347340|NCT02477800|323053919|FG003|Placebo-Controlled Period|Disease Progression|0|||
94347341|NCT02477800|323053920|FG004|Placebo-Controlled Period|Disease Progression|0|||
94347342|NCT02477800|323053921|FG005|Placebo-Controlled Period|Disease Progression|0|||
94347343|NCT02477800|323053922|FG006|Placebo-Controlled Period|Disease Progression|0|||
94347344|NCT02477800|323053916|FG000|Placebo-Controlled Period|Investigator Decision|3|||
94347345|NCT02477800|323053917|FG001|Placebo-Controlled Period|Investigator Decision|2|||
94347346|NCT02477800|323053918|FG002|Placebo-Controlled Period|Investigator Decision|1|||
94347347|NCT02477800|323053919|FG003|Placebo-Controlled Period|Investigator Decision|0|||
94565332|NCT01132313|323866289|FG010|Overall Study|Lost to Follow-up|0|||
94565333|NCT01132313|323866290|FG011|Overall Study|Lost to Follow-up|0|||
94565334|NCT01132313|323866279|FG000|Overall Study|Withdrawal by Subject|0|||
94565335|NCT01132313|323866280|FG001|Overall Study|Withdrawal by Subject|0|||
94565336|NCT01132313|323866281|FG002|Overall Study|Withdrawal by Subject|3|||
94565337|NCT01132313|323866282|FG003|Overall Study|Withdrawal by Subject|3|||
94565338|NCT01132313|323866283|FG004|Overall Study|Withdrawal by Subject|6|||
94565339|NCT01132313|323866284|FG005|Overall Study|Withdrawal by Subject|0|||
94565340|NCT01132313|323866285|FG006|Overall Study|Withdrawal by Subject|1|||
94565341|NCT01132313|323866286|FG007|Overall Study|Withdrawal by Subject|0|||
94565342|NCT01132313|323866287|FG008|Overall Study|Withdrawal by Subject|0|||
94565343|NCT01132313|323866288|FG009|Overall Study|Withdrawal by Subject|2|||
94565344|NCT01132313|323866289|FG010|Overall Study|Withdrawal by Subject|0|||
94565345|NCT01132313|323866290|FG011|Overall Study|Withdrawal by Subject|0|||
94565346|NCT01132313|323866279|FG000|Overall Study|Lack of antiviral response|0|||
94565347|NCT01132313|323866280|FG001|Overall Study|Lack of antiviral response|0|||
94565348|NCT01132313|323866281|FG002|Overall Study|Lack of antiviral response|12|||
94565349|NCT01132313|323866282|FG003|Overall Study|Lack of antiviral response|18|||
94565350|NCT01132313|323866283|FG004|Overall Study|Lack of antiviral response|18|||
94565351|NCT01132313|323866284|FG005|Overall Study|Lack of antiviral response|18|||
94565352|NCT01132313|323866285|FG006|Overall Study|Lack of antiviral response|21|||
94565353|NCT01132313|323866286|FG007|Overall Study|Lack of antiviral response|0|||
94658496|NCT01172938|324206190|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
94658497|NCT01172938|324206182|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
94347348|NCT02477800|323053920|FG004|Placebo-Controlled Period|Investigator Decision|0|||
94658498|NCT01172938|324206183|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
94347349|NCT02477800|323053921|FG005|Placebo-Controlled Period|Investigator Decision|0|||
94347350|NCT02477800|323053922|FG006|Placebo-Controlled Period|Investigator Decision|0|||
94347351|NCT02477800|323053916|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
94347352|NCT02477800|323053917|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
94347353|NCT02477800|323053918|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
94347354|NCT02477800|323053919|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
94347355|NCT02477800|323053920|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
94347356|NCT02477800|323053921|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
94347357|NCT02477800|323053922|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
94347358|NCT02477800|323053916|FG000|Placebo-Controlled Period|Relocation|2|||
94347359|NCT02477800|323053917|FG001|Placebo-Controlled Period|Relocation|0|||
94347360|NCT02477800|323053918|FG002|Placebo-Controlled Period|Relocation|0|||
94347361|NCT02477800|323053919|FG003|Placebo-Controlled Period|Relocation|0|||
94347362|NCT02477800|323053920|FG004|Placebo-Controlled Period|Relocation|0|||
94347363|NCT02477800|323053921|FG005|Placebo-Controlled Period|Relocation|0|||
94347364|NCT02477800|323053922|FG006|Placebo-Controlled Period|Relocation|0|||
94347365|NCT02477800|323053916|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
94347366|NCT02477800|323053917|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
94347367|NCT02477800|323053918|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
94347368|NCT02477800|323053919|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
94347369|NCT02477800|323053920|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
94347370|NCT02477800|323053921|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
94347371|NCT02477800|323053922|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
94347372|NCT02477800|323053916|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
94347373|NCT02477800|323053917|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
94347374|NCT02477800|323053918|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
94347375|NCT02477800|323053919|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
94347376|NCT02477800|323053920|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
94347377|NCT02477800|323053921|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
94347378|NCT02477800|323053922|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
94347379|NCT02477800|323053916|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
94347380|NCT02477800|323053917|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
94347381|NCT02477800|323053918|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
94347382|NCT02477800|323053919|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
94347383|NCT02477800|323053920|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
94347384|NCT02477800|323053921|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
94347385|NCT02477800|323053922|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
94347386|NCT02477800|323053916|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
94347387|NCT02477800|323053917|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
94347388|NCT02477800|323053918|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
94347389|NCT02477800|323053919|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
94347390|NCT02477800|323053920|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
94347391|NCT02477800|323053921|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
94347392|NCT02477800|323053922|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
94347393|NCT02477800|323053916|FG000|Placebo-Controlled Period|Reason not Specified|161|||
94347394|NCT02477800|323053917|FG001|Placebo-Controlled Period|Reason not Specified|161|||
94347395|NCT02477800|323053918|FG002|Placebo-Controlled Period|Reason not Specified|189|||
94347396|NCT02477800|323053919|FG003|Placebo-Controlled Period|Reason not Specified|0|||
94347397|NCT02477800|323053920|FG004|Placebo-Controlled Period|Reason not Specified|0|||
94347398|NCT02477800|323053921|FG005|Placebo-Controlled Period|Reason not Specified|0|||
94347399|NCT02477800|323053922|FG006|Placebo-Controlled Period|Reason not Specified|0|||
94347400|NCT02477800|323053916|FG000|Long Term Extension Period|Adverse Event|0|||
94347401|NCT02477800|323053917|FG001|Long Term Extension Period|Adverse Event|0|||
94347402|NCT02477800|323053918|FG002|Long Term Extension Period|Adverse Event|0|||
94347403|NCT02477800|323053919|FG003|Long Term Extension Period|Adverse Event|6|||
94347404|NCT02477800|323053920|FG004|Long Term Extension Period|Adverse Event|2|||
94347405|NCT02477800|323053921|FG005|Long Term Extension Period|Adverse Event|4|||
94347406|NCT02477800|323053922|FG006|Long Term Extension Period|Adverse Event|3|||
94347407|NCT02477800|323053916|FG000|Long Term Extension Period|Death|0|||
94347408|NCT02477800|323053917|FG001|Long Term Extension Period|Death|0|||
94347409|NCT02477800|323053918|FG002|Long Term Extension Period|Death|0|||
94347410|NCT02477800|323053919|FG003|Long Term Extension Period|Death|1|||
94347411|NCT02477800|323053920|FG004|Long Term Extension Period|Death|1|||
94347412|NCT02477800|323053921|FG005|Long Term Extension Period|Death|1|||
94347413|NCT02477800|323053922|FG006|Long Term Extension Period|Death|2|||
94658499|NCT01172938|324206184|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
94565354|NCT01132313|323866287|FG008|Overall Study|Lack of antiviral response|0|||
94565355|NCT01132313|323866288|FG009|Overall Study|Lack of antiviral response|0|||
94565356|NCT01132313|323866289|FG010|Overall Study|Lack of antiviral response|1|||
94565357|NCT01132313|323866290|FG011|Overall Study|Lack of antiviral response|0|||
94565358|NCT01132313|323866279|FG000|Overall Study|Other reason not defined above|0|||
94565359|NCT01132313|323866280|FG001|Overall Study|Other reason not defined above|0|||
94565360|NCT01132313|323866281|FG002|Overall Study|Other reason not defined above|0|||
94565361|NCT01132313|323866282|FG003|Overall Study|Other reason not defined above|0|||
94565362|NCT01132313|323866283|FG004|Overall Study|Other reason not defined above|0|||
94565363|NCT01132313|323866284|FG005|Overall Study|Other reason not defined above|0|||
94565364|NCT01132313|323866285|FG006|Overall Study|Other reason not defined above|0|||
94565365|NCT01132313|323866286|FG007|Overall Study|Other reason not defined above|1|||
94565366|NCT01132313|323866287|FG008|Overall Study|Other reason not defined above|0|||
94565367|NCT01132313|323866288|FG009|Overall Study|Other reason not defined above|0|||
94565368|NCT01132313|323866289|FG010|Overall Study|Other reason not defined above|0|||
94565369|NCT01132313|323866290|FG011|Overall Study|Other reason not defined above|0|||
94565370|NCT04158583|323866294|FG000|Overall Study|Withdrawal by Subject|1|||
94565371|NCT04158583|323866295|FG001|Overall Study|Withdrawal by Subject|1|||
94565372|NCT04158583|323866296|FG002|Overall Study|Withdrawal by Subject|0|||
94565373|NCT04158583|323866297|FG003|Overall Study|Withdrawal by Subject|0|||
94565374|NCT04158583|323866298|FG004|Overall Study|Withdrawal by Subject|1|||
94565375|NCT04158583|323866299|FG005|Overall Study|Withdrawal by Subject|0|||
94565376|NCT04158583|323866300|FG006|Overall Study|Withdrawal by Subject|0|||
94565377|NCT04158583|323866301|FG007|Overall Study|Withdrawal by Subject|0|||
94565378|NCT04158583|323866302|FG008|Overall Study|Withdrawal by Subject|2|||
94565379|NCT04158583|323866303|FG009|Overall Study|Withdrawal by Subject|0|||
94565380|NCT04158583|323866294|FG000|Overall Study|Study Terminated by Sponsor|0|||
94565381|NCT04158583|323866295|FG001|Overall Study|Study Terminated by Sponsor|0|||
94565382|NCT04158583|323866296|FG002|Overall Study|Study Terminated by Sponsor|0|||
94565383|NCT04158583|323866297|FG003|Overall Study|Study Terminated by Sponsor|1|||
94565384|NCT04158583|323866298|FG004|Overall Study|Study Terminated by Sponsor|0|||
94565385|NCT04158583|323866299|FG005|Overall Study|Study Terminated by Sponsor|0|||
94565386|NCT04158583|323866300|FG006|Overall Study|Study Terminated by Sponsor|0|||
94565387|NCT04158583|323866301|FG007|Overall Study|Study Terminated by Sponsor|0|||
94565388|NCT04158583|323866302|FG008|Overall Study|Study Terminated by Sponsor|0|||
94565389|NCT04158583|323866303|FG009|Overall Study|Study Terminated by Sponsor|0|||
94565390|NCT04158583|323866294|FG000|Overall Study|Progressive Disease|1|||
94565391|NCT04158583|323866295|FG001|Overall Study|Progressive Disease|0|||
94565392|NCT04158583|323866296|FG002|Overall Study|Progressive Disease|3|||
94565393|NCT04158583|323866297|FG003|Overall Study|Progressive Disease|5|||
94565394|NCT04158583|323866298|FG004|Overall Study|Progressive Disease|0|||
94565395|NCT04158583|323866299|FG005|Overall Study|Progressive Disease|1|||
94565396|NCT04158583|323866300|FG006|Overall Study|Progressive Disease|6|||
94565397|NCT04158583|323866301|FG007|Overall Study|Progressive Disease|2|||
94565398|NCT04158583|323866302|FG008|Overall Study|Progressive Disease|1|||
94565399|NCT04158583|323866303|FG009|Overall Study|Progressive Disease|2|||
94565400|NCT04158583|323866294|FG000|Overall Study|Lost to Follow-up|0|||
94565401|NCT04158583|323866295|FG001|Overall Study|Lost to Follow-up|0|||
94565402|NCT04158583|323866296|FG002|Overall Study|Lost to Follow-up|1|||
94565403|NCT04158583|323866297|FG003|Overall Study|Lost to Follow-up|1|||
94565404|NCT04158583|323866298|FG004|Overall Study|Lost to Follow-up|1|||
94565405|NCT04158583|323866299|FG005|Overall Study|Lost to Follow-up|0|||
94565406|NCT04158583|323866300|FG006|Overall Study|Lost to Follow-up|0|||
94565407|NCT04158583|323866301|FG007|Overall Study|Lost to Follow-up|0|||
94565408|NCT04158583|323866302|FG008|Overall Study|Lost to Follow-up|0|||
94565409|NCT04158583|323866303|FG009|Overall Study|Lost to Follow-up|0|||
94565410|NCT04158583|323866294|FG000|Overall Study|Due To Patient Status|0|||
94565411|NCT04158583|323866295|FG001|Overall Study|Due To Patient Status|0|||
94565412|NCT04158583|323866296|FG002|Overall Study|Due To Patient Status|0|||
94565413|NCT04158583|323866297|FG003|Overall Study|Due To Patient Status|0|||
94565414|NCT04158583|323866298|FG004|Overall Study|Due To Patient Status|0|||
94565415|NCT04158583|323866299|FG005|Overall Study|Due To Patient Status|0|||
94565416|NCT04158583|323866300|FG006|Overall Study|Due To Patient Status|0|||
94565417|NCT04158583|323866301|FG007|Overall Study|Due To Patient Status|0|||
94565418|NCT04158583|323866302|FG008|Overall Study|Due To Patient Status|1|||
94565419|NCT04158583|323866303|FG009|Overall Study|Due To Patient Status|0|||
94565420|NCT04158583|323866294|FG000|Overall Study|Death|3|||
94565421|NCT04158583|323866295|FG001|Overall Study|Death|4|||
94565422|NCT04158583|323866296|FG002|Overall Study|Death|2|||
94565423|NCT04158583|323866297|FG003|Overall Study|Death|2|||
94565424|NCT04158583|323866298|FG004|Overall Study|Death|4|||
94565425|NCT04158583|323866299|FG005|Overall Study|Death|3|||
94565426|NCT04158583|323866300|FG006|Overall Study|Death|5|||
94565427|NCT04158583|323866301|FG007|Overall Study|Death|2|||
94565428|NCT04158583|323866302|FG008|Overall Study|Death|0|||
94565429|NCT04158583|323866303|FG009|Overall Study|Death|1|||
94565430|NCT04158583|323866294|FG000|Overall Study|Clinical Progression Disease|0|||
94565431|NCT04158583|323866295|FG001|Overall Study|Clinical Progression Disease|0|||
94565432|NCT04158583|323866296|FG002|Overall Study|Clinical Progression Disease|0|||
94565433|NCT04158583|323866297|FG003|Overall Study|Clinical Progression Disease|1|||
94565434|NCT04158583|323866298|FG004|Overall Study|Clinical Progression Disease|0|||
94565435|NCT04158583|323866299|FG005|Overall Study|Clinical Progression Disease|0|||
94565436|NCT04158583|323866300|FG006|Overall Study|Clinical Progression Disease|0|||
94565437|NCT04158583|323866301|FG007|Overall Study|Clinical Progression Disease|0|||
94565438|NCT04158583|323866302|FG008|Overall Study|Clinical Progression Disease|0|||
94565439|NCT04158583|323866303|FG009|Overall Study|Clinical Progression Disease|0|||
94565440|NCT04158583|323866294|FG000|Overall Study|Clinical Progression|0|||
94565441|NCT04158583|323866295|FG001|Overall Study|Clinical Progression|0|||
94565442|NCT04158583|323866296|FG002|Overall Study|Clinical Progression|0|||
94565443|NCT04158583|323866297|FG003|Overall Study|Clinical Progression|0|||
94565444|NCT04158583|323866298|FG004|Overall Study|Clinical Progression|1|||
94565445|NCT04158583|323866299|FG005|Overall Study|Clinical Progression|0|||
94565446|NCT04158583|323866300|FG006|Overall Study|Clinical Progression|2|||
94565447|NCT04158583|323866301|FG007|Overall Study|Clinical Progression|0|||
94565448|NCT04158583|323866302|FG008|Overall Study|Clinical Progression|0|||
94565449|NCT04158583|323866303|FG009|Overall Study|Clinical Progression|0|||
94565450|NCT04158583|323866294|FG000|Overall Study|Clinical Deterioration|0|||
94565451|NCT04158583|323866295|FG001|Overall Study|Clinical Deterioration|0|||
94565452|NCT04158583|323866296|FG002|Overall Study|Clinical Deterioration|0|||
94565453|NCT04158583|323866297|FG003|Overall Study|Clinical Deterioration|1|||
94565454|NCT04158583|323866298|FG004|Overall Study|Clinical Deterioration|0|||
94565455|NCT04158583|323866299|FG005|Overall Study|Clinical Deterioration|0|||
94565456|NCT04158583|323866300|FG006|Overall Study|Clinical Deterioration|0|||
94565457|NCT04158583|323866301|FG007|Overall Study|Clinical Deterioration|0|||
94565458|NCT04158583|323866302|FG008|Overall Study|Clinical Deterioration|0|||
94565459|NCT04158583|323866303|FG009|Overall Study|Clinical Deterioration|1|||
94565460|NCT01063153|323866304|FG000|Overall Study|Found Ineligible During Screening|2|||
94565461|NCT01063153|323866305|FG001|Overall Study|Found Ineligible During Screening|0|||
94565462|NCT01063153|323866304|FG000|Overall Study|Lost to Follow-up|0|||
94565463|NCT01063153|323866305|FG001|Overall Study|Lost to Follow-up|7|||
94565464|NCT01063153|323866304|FG000|Overall Study|Withdrawal by Subject|0|||
94565465|NCT01063153|323866305|FG001|Overall Study|Withdrawal by Subject|1|||
94565466|NCT01063153|323866304|FG000|Overall Study|Physician Decision|0|||
94565467|NCT01063153|323866305|FG001|Overall Study|Physician Decision|4|||
94565468|NCT01777776|323866306|FG000|Overall Study|Adverse Event|2|||
94565469|NCT01777776|323866307|FG001|Overall Study|Adverse Event|4|||
94565470|NCT01777776|323866308|FG002|Overall Study|Adverse Event|0|||
94565471|NCT01777776|323866309|FG003|Overall Study|Adverse Event|0|||
94565472|NCT01777776|323866306|FG000|Overall Study|Disease Progression|4|||
94565473|NCT01777776|323866307|FG001|Overall Study|Disease Progression|8|||
94565474|NCT01777776|323866308|FG002|Overall Study|Disease Progression|6|||
94565475|NCT01777776|323866309|FG003|Overall Study|Disease Progression|3|||
94565476|NCT01777776|323866306|FG000|Overall Study|Withdrawal by Subject|0|||
94565477|NCT01777776|323866307|FG001|Overall Study|Withdrawal by Subject|0|||
94565478|NCT01777776|323866308|FG002|Overall Study|Withdrawal by Subject|0|||
94565479|NCT01777776|323866309|FG003|Overall Study|Withdrawal by Subject|1|||
94565480|NCT00650845|323866310|FG000|Overall Study|Withdrawal by Subject|5|||
94565481|NCT00650845|323866311|FG001|Overall Study|Withdrawal by Subject|0|||
94565482|NCT00650845|323866310|FG000|Overall Study|Protocol Violation|0|||
94565483|NCT00650845|323866311|FG001|Overall Study|Protocol Violation|13|||
94565484|NCT00549445|323866312|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
94565485|NCT00549445|323866313|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
94565486|NCT03932760|323866314|FG000|Overall Study|Became Ineligible|2|||
94565487|NCT03932760|323866315|FG001|Overall Study|Became Ineligible|5|||
94565488|NCT03932760|323866314|FG000|Overall Study|Withdrawal by Subject|6|||
94565489|NCT03932760|323866315|FG001|Overall Study|Withdrawal by Subject|6|||
94565490|NCT01301833|323866316|FG000|Overall Study|Adverse Event|7|||
94565491|NCT01301833|323866317|FG001|Overall Study|Adverse Event|5|||
94565492|NCT01301833|323866318|FG002|Overall Study|Adverse Event|5|||
94565493|NCT01301833|323866319|FG003|Overall Study|Adverse Event|5|||
94565494|NCT01301833|323866316|FG000|Overall Study|Lack of Efficacy|1|||
94565495|NCT01301833|323866317|FG001|Overall Study|Lack of Efficacy|1|||
94347414|NCT02477800|323053916|FG000|Long Term Extension Period|Consent Withdrawn|0|||
94347415|NCT02477800|323053917|FG001|Long Term Extension Period|Consent Withdrawn|0|||
94347416|NCT02477800|323053918|FG002|Long Term Extension Period|Consent Withdrawn|0|||
94565496|NCT01301833|323866318|FG002|Overall Study|Lack of Efficacy|0|||
94565497|NCT01301833|323866319|FG003|Overall Study|Lack of Efficacy|0|||
94565498|NCT01301833|323866316|FG000|Overall Study|Physician Decision|3|||
94565499|NCT01301833|323866317|FG001|Overall Study|Physician Decision|1|||
94565500|NCT01301833|323866318|FG002|Overall Study|Physician Decision|1|||
94565501|NCT01301833|323866319|FG003|Overall Study|Physician Decision|0|||
94565502|NCT01301833|323866316|FG000|Overall Study|Withdrawal by Subject|3|||
94565503|NCT01301833|323866317|FG001|Overall Study|Withdrawal by Subject|1|||
94565504|NCT01301833|323866318|FG002|Overall Study|Withdrawal by Subject|1|||
94565505|NCT01301833|323866319|FG003|Overall Study|Withdrawal by Subject|2|||
94565506|NCT01301833|323866316|FG000|Overall Study|Personal matter|1|||
94565507|NCT01301833|323866317|FG001|Overall Study|Personal matter|0|||
94565508|NCT01301833|323866318|FG002|Overall Study|Personal matter|0|||
94565509|NCT01301833|323866319|FG003|Overall Study|Personal matter|0|||
94565510|NCT02775916|323866320|FG000|Overall Study|Adverse Event|1|||
94565511|NCT02775916|323866321|FG001|Overall Study|Adverse Event|0|||
94565512|NCT02775916|323866320|FG000|Overall Study|Subject/Guardian Decision|2|||
94565513|NCT02775916|323866321|FG001|Overall Study|Subject/Guardian Decision|0|||
94565514|NCT00999544|323867697|FG000|Overall Study|Withdrawal by Subject|1|||
94565515|NCT01594931|323867700|FG000|Overall Study|Adverse Event|3|||
94565516|NCT01594931|323867701|FG001|Overall Study|Adverse Event|1|||
94565517|NCT01594931|323867702|FG002|Overall Study|Adverse Event|1|||
94565518|NCT01594931|323867700|FG000|Overall Study|Withdrawal by Subject|2|||
94565519|NCT01594931|323867701|FG001|Overall Study|Withdrawal by Subject|1|||
94565520|NCT01594931|323867702|FG002|Overall Study|Withdrawal by Subject|1|||
94565521|NCT01594931|323867700|FG000|Overall Study|Lack of Efficacy|7|||
94565522|NCT01594931|323867701|FG001|Overall Study|Lack of Efficacy|2|||
94565523|NCT01594931|323867702|FG002|Overall Study|Lack of Efficacy|2|||
94565524|NCT01594931|323867700|FG000|Overall Study|Lost to Follow-up|4|||
94565525|NCT01594931|323867701|FG001|Overall Study|Lost to Follow-up|3|||
94565526|NCT01594931|323867702|FG002|Overall Study|Lost to Follow-up|3|||
94565527|NCT01594931|323867700|FG000|Overall Study|Protocol Violation|2|||
94565528|NCT01594931|323867701|FG001|Overall Study|Protocol Violation|1|||
94565529|NCT01594931|323867702|FG002|Overall Study|Protocol Violation|0|||
94565530|NCT01594931|323867700|FG000|Overall Study|No defiined|11|||
94565531|NCT01594931|323867701|FG001|Overall Study|No defiined|4|||
94565532|NCT01594931|323867702|FG002|Overall Study|No defiined|7|||
94565533|NCT02407223|323867711|FG000|Overall Study|Adverse Event|1|||
94565534|NCT02407223|323867712|FG001|Overall Study|Adverse Event|0|||
94565535|NCT02407223|323867713|FG002|Overall Study|Adverse Event|1|||
94565536|NCT02407223|323867711|FG000|Overall Study|Lack of Efficacy|6|||
94565537|NCT02407223|323867712|FG001|Overall Study|Lack of Efficacy|6|||
94565538|NCT02407223|323867713|FG002|Overall Study|Lack of Efficacy|4|||
94565539|NCT02407223|323867711|FG000|Overall Study|Lost to Follow-up|1|||
94565540|NCT02407223|323867712|FG001|Overall Study|Lost to Follow-up|0|||
94565541|NCT02407223|323867713|FG002|Overall Study|Lost to Follow-up|2|||
94565542|NCT02407223|323867711|FG000|Overall Study|Withdrawal by Subject|2|||
94236563|NCT02563548|322661789|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
94236564|NCT02563548|322661790|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
94236565|NCT02563548|322661791|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
94236566|NCT02563548|322661792|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
94236567|NCT02563548|322661793|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
94236568|NCT02563548|322661794|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
94236569|NCT02563548|322661789|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
94236570|NCT02563548|322661790|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
94236571|NCT02563548|322661791|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
94236572|NCT02563548|322661792|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
94236573|NCT02563548|322661793|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
94236574|NCT02563548|322661794|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
94236575|NCT02563548|322661789|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
94236576|NCT02563548|322661790|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
94236577|NCT02563548|322661791|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
94236578|NCT02563548|322661792|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
94236579|NCT02563548|322661793|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
94236580|NCT02563548|322661794|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
94236581|NCT02563548|322661789|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
94236582|NCT02563548|322661790|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
94236583|NCT02563548|322661791|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
94236584|NCT02563548|322661792|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
94236585|NCT02563548|322661793|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
94236586|NCT02563548|322661794|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
94236587|NCT02563548|322661789|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
94236588|NCT02563548|322661790|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
94236589|NCT02563548|322661791|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
94236590|NCT02563548|322661792|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
94236591|NCT02563548|322661793|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
94236592|NCT02563548|322661794|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
94236593|NCT02563548|322661789|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
94236594|NCT02563548|322661790|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
94236595|NCT02563548|322661791|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
94565543|NCT02407223|323867712|FG001|Overall Study|Withdrawal by Subject|4|||
94565544|NCT02407223|323867713|FG002|Overall Study|Withdrawal by Subject|4|||
94565545|NCT02407223|323867711|FG000|Overall Study|Study Terminated by Sponsor|77|||
94565546|NCT02407223|323867712|FG001|Overall Study|Study Terminated by Sponsor|80|||
94565547|NCT02407223|323867713|FG002|Overall Study|Study Terminated by Sponsor|86|||
94565548|NCT02407223|323867711|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
94565549|NCT02407223|323867712|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
94565550|NCT02407223|323867713|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
94565551|NCT02407223|323867711|FG000|Overall Study|Other|29|||
94565552|NCT02407223|323867712|FG001|Overall Study|Other|27|||
94565553|NCT02407223|323867713|FG002|Overall Study|Other|25|||
94565554|NCT01929226|323867714|FG000|Overall Study|Lost to Follow-up|4|||
94565555|NCT01929226|323867715|FG001|Overall Study|Lost to Follow-up|0|||
94565556|NCT01929226|323867714|FG000|Overall Study|Withdrawal by Subject|1|||
94565557|NCT01929226|323867715|FG001|Overall Study|Withdrawal by Subject|1|||
94565558|NCT03553758|323867716|FG000|Overall Study|Lost to Follow-up|1|||
94565559|NCT04864639|323867717|FG000|Overall Study|Death|1|||
94565560|NCT04864639|323867717|FG000|Overall Study|Lost to Follow-up|1|||
94565561|NCT00447226|323867718|FG000|12-Week Open-label Phase|Adverse Event|0|||
94565562|NCT00447226|323867719|FG001|12-Week Open-label Phase|Adverse Event|3|||
94565563|NCT00447226|323867718|FG000|12-Week Open-label Phase|Protocol Violation|0|||
94565564|NCT00447226|323867719|FG001|12-Week Open-label Phase|Protocol Violation|1|||
94565565|NCT00447226|323867718|FG000|12-Week Open-label Phase|Disease Progression|0|||
94565566|NCT00447226|323867719|FG001|12-Week Open-label Phase|Disease Progression|20|||
94236596|NCT02563548|322661792|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
94236597|NCT02563548|322661793|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
94236598|NCT02563548|322661794|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
94236599|NCT02563548|322661789|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
94565567|NCT00447226|323867718|FG000|12-Week Open-label Phase|Physician Decision|0|||
94565568|NCT00447226|323867719|FG001|12-Week Open-label Phase|Physician Decision|1|||
94565569|NCT00447226|323867718|FG000|Double-blind Phase|Disease Progression|4|||
94565570|NCT00447226|323867719|FG001|Double-blind Phase|Disease Progression|3|||
94236600|NCT02563548|322661790|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
94236601|NCT02563548|322661791|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
94236602|NCT02563548|322661792|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
94236603|NCT02563548|322661793|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
94236604|NCT02563548|322661794|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
94236605|NCT02563548|322661789|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
94236606|NCT02563548|322661790|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
94236607|NCT02563548|322661791|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
94236608|NCT02563548|322661792|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
94236609|NCT02563548|322661793|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
94236610|NCT02563548|322661794|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
94236611|NCT02563548|322661789|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
94236612|NCT02563548|322661790|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
94236613|NCT02563548|322661791|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
94236614|NCT02563548|322661792|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
94236615|NCT02563548|322661793|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
94236616|NCT02563548|322661794|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
94236617|NCT02563548|322661789|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
94236618|NCT02563548|322661790|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
94236619|NCT02563548|322661791|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
94236620|NCT02563548|322661792|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
94236621|NCT02563548|322661793|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
94236622|NCT02563548|322661794|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
94236623|NCT02406248|322661795|FG000|Overall Study|Death|7|||
94236624|NCT02406248|322661795|FG000|Overall Study|Withdrawal by Subject|2|||
94236625|NCT00150618|322661797|FG000|Overall Study|Adverse Event|2|||
94236626|NCT00150618|322661798|FG001|Overall Study|Adverse Event|2|||
94236627|NCT00150618|322661799|FG002|Overall Study|Adverse Event|6|||
94236628|NCT00150618|322661800|FG003|Overall Study|Adverse Event|9|||
94236629|NCT00150618|322661801|FG004|Overall Study|Adverse Event|5|||
94236630|NCT00150618|322661797|FG000|Overall Study|Withdrawal by Subject|6|||
94236631|NCT00150618|322661798|FG001|Overall Study|Withdrawal by Subject|8|||
94565571|NCT02807623|323867724|FG000|Overall Study|Lost to Follow-up|23|||
94565572|NCT02807623|323867725|FG001|Overall Study|Lost to Follow-up|18|||
94236632|NCT00150618|322661799|FG002|Overall Study|Withdrawal by Subject|8|||
94565573|NCT02807623|323867726|FG002|Overall Study|Lost to Follow-up|22|||
94565574|NCT02807623|323867724|FG000|Overall Study|Drug intolerance|0|||
94565575|NCT02807623|323867725|FG001|Overall Study|Drug intolerance|1|||
94565576|NCT02807623|323867726|FG002|Overall Study|Drug intolerance|0|||
94236633|NCT00150618|322661800|FG003|Overall Study|Withdrawal by Subject|4|||
94236634|NCT00150618|322661801|FG004|Overall Study|Withdrawal by Subject|5|||
94565577|NCT02807623|323867724|FG000|Overall Study|incomplete blood draw|0|||
94565578|NCT02807623|323867725|FG001|Overall Study|incomplete blood draw|2|||
94565579|NCT02807623|323867726|FG002|Overall Study|incomplete blood draw|1|||
94565580|NCT00227721|323867727|FG000|Overall Study|On study, but never treated.|1|||
94565581|NCT01389882|323867730|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
94565582|NCT01389882|323867731|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
94565583|NCT01389882|323867730|FG000|Overall Study|Withdrawal by Subject|0|||
94565584|NCT01389882|323867731|FG001|Overall Study|Withdrawal by Subject|1|||
94565585|NCT02252146|323867732|FG000|Overall Study|Lack of Efficacy|4|||
94565586|NCT02252146|323867732|FG000|Overall Study|Entered hospice care|1|||
94565587|NCT02252146|323867732|FG000|Overall Study|Inability to travel to study site|1|||
94565588|NCT02098746|323867735|FG000|Overall Study|Changes of Investigator|2|||
94565589|NCT02098746|323867735|FG000|Overall Study|Other Miscellaneous Reasons|1|||
94565590|NCT02098746|323867735|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
94565591|NCT02098746|323867735|FG000|Overall Study|Data Not Available After Treatment|1|||
94565592|NCT00217425|323867736|FG000|Overall Study|Never started treatment|2|||
94565593|NCT00217425|323867736|FG000|Overall Study|Patient ineligible|5|||
94236635|NCT00150618|322661797|FG000|Overall Study|Lost to Follow-up|4|||
94565594|NCT00217425|323867736|FG000|Overall Study|Lack of Efficacy|13|||
94565595|NCT00217425|323867736|FG000|Overall Study|Adverse Event|8|||
94565596|NCT00217425|323867736|FG000|Overall Study|Withdrawal by Subject|4|||
94565597|NCT00217425|323867736|FG000|Overall Study|Other complicating disease|1|||
94565598|NCT00217425|323867736|FG000|Overall Study|Other|4|||
94347417|NCT02477800|323053919|FG003|Long Term Extension Period|Consent Withdrawn|10|||
94565599|NCT01745367|323867739|FG000|Overall Study|Death|1|||
94565600|NCT01745367|323867740|FG001|Overall Study|Death|0|||
94565601|NCT01745367|323867739|FG000|Overall Study|Withdrawal by Subject|1|||
94565602|NCT01745367|323867740|FG001|Overall Study|Withdrawal by Subject|2|||
94565603|NCT01745367|323867739|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
94565604|NCT01745367|323867740|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
94565605|NCT01745367|323867739|FG000|Overall Study|Other Reasons Unspecified|0|||
94565606|NCT01745367|323867740|FG001|Overall Study|Other Reasons Unspecified|2|||
94565607|NCT02274792|323867743|FG000|Overall Study|Withdrawal by Subject|13|||
94565608|NCT02274792|323867743|FG000|Overall Study|Lost to Follow-up|8|||
94347418|NCT02477800|323053920|FG004|Long Term Extension Period|Consent Withdrawn|4|||
94347419|NCT02477800|323053921|FG005|Long Term Extension Period|Consent Withdrawn|13|||
94658500|NCT01172938|324206185|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
94658501|NCT01172938|324206186|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
94658502|NCT01172938|324206187|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
94565609|NCT02274792|323867743|FG000|Overall Study|Protocol Specified Criteria|2|||
94565610|NCT02274792|323867743|FG000|Overall Study|Sponsor Decision|2|||
94565611|NCT01544920|323867752|FG000|Overall Study|Adverse Event|0|||
94565612|NCT01544920|323867753|FG001|Overall Study|Adverse Event|3|||
94565613|NCT01544920|323867752|FG000|Overall Study|Death|0|||
94565614|NCT01544920|323867753|FG001|Overall Study|Death|1|||
94565615|NCT01544920|323867752|FG000|Overall Study|Lost to Follow-up|11|||
94565616|NCT01544920|323867753|FG001|Overall Study|Lost to Follow-up|12|||
94565617|NCT01544920|323867752|FG000|Overall Study|Protocol Violation|0|||
94565618|NCT01544920|323867753|FG001|Overall Study|Protocol Violation|2|||
94565619|NCT01544920|323867752|FG000|Overall Study|Physician Decision|4|||
94565620|NCT01544920|323867753|FG001|Overall Study|Physician Decision|1|||
94565621|NCT01544920|323867752|FG000|Overall Study|Withdrawal by Subject|4|||
94565622|NCT01544920|323867753|FG001|Overall Study|Withdrawal by Subject|4|||
94565623|NCT01359904|323867754|FG000|Overall Study|Withdrawal by Subject|1|||
94565624|NCT01359904|323867755|FG001|Overall Study|Withdrawal by Subject|0|||
94347420|NCT02477800|323053922|FG006|Long Term Extension Period|Consent Withdrawn|16|||
94347421|NCT02477800|323053916|FG000|Long Term Extension Period|Disease Progression|0|||
94565625|NCT00466440|323867756|FG000|Overall Study|Adverse Event|0|||
94565626|NCT00466440|323867757|FG001|Overall Study|Adverse Event|3|||
94565627|NCT00466440|323867758|FG002|Overall Study|Adverse Event|1|||
94565628|NCT00466440|323867756|FG000|Overall Study|Death|1|||
94565629|NCT00466440|323867757|FG001|Overall Study|Death|1|||
94565630|NCT00466440|323867758|FG002|Overall Study|Death|0|||
94565631|NCT00466440|323867756|FG000|Overall Study|Progressive disease|13|||
94565632|NCT00466440|323867757|FG001|Overall Study|Progressive disease|5|||
94658503|NCT01172938|324206188|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
94347422|NCT02477800|323053917|FG001|Long Term Extension Period|Disease Progression|0|||
94347423|NCT02477800|323053918|FG002|Long Term Extension Period|Disease Progression|0|||
94347424|NCT02477800|323053919|FG003|Long Term Extension Period|Disease Progression|3|||
94347425|NCT02477800|323053920|FG004|Long Term Extension Period|Disease Progression|1|||
94565633|NCT00466440|323867758|FG002|Overall Study|Progressive disease|4|||
94565634|NCT00466440|323867756|FG000|Overall Study|Lost to Follow-up|0|||
94565635|NCT00466440|323867757|FG001|Overall Study|Lost to Follow-up|1|||
94565636|NCT00466440|323867758|FG002|Overall Study|Lost to Follow-up|0|||
94565637|NCT00466440|323867756|FG000|Overall Study|Physician Decision|0|||
94565638|NCT00466440|323867757|FG001|Overall Study|Physician Decision|1|||
94658504|NCT01172938|324206189|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
94658505|NCT01172938|324206190|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
94658506|NCT01172938|324206182|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
94347426|NCT02477800|323053921|FG005|Long Term Extension Period|Disease Progression|1|||
94347427|NCT02477800|323053922|FG006|Long Term Extension Period|Disease Progression|0|||
94347428|NCT02477800|323053916|FG000|Long Term Extension Period|Investigator Decision|0|||
94347429|NCT02477800|323053917|FG001|Long Term Extension Period|Investigator Decision|0|||
94565639|NCT00466440|323867758|FG002|Overall Study|Physician Decision|2|||
94565640|NCT00466440|323867756|FG000|Overall Study|Protocol entry criteria not met|0|||
94565641|NCT00466440|323867757|FG001|Overall Study|Protocol entry criteria not met|0|||
94565642|NCT00466440|323867758|FG002|Overall Study|Protocol entry criteria not met|4|||
94565643|NCT00466440|323867756|FG000|Overall Study|Withdrawal by Subject|0|||
94565644|NCT00466440|323867757|FG001|Overall Study|Withdrawal by Subject|1|||
94347430|NCT02477800|323053918|FG002|Long Term Extension Period|Investigator Decision|0|||
94347431|NCT02477800|323053919|FG003|Long Term Extension Period|Investigator Decision|0|||
94565645|NCT00466440|323867758|FG002|Overall Study|Withdrawal by Subject|0|||
94565646|NCT00466440|323867756|FG000|Overall Study|Sponsor decision|0|||
94565647|NCT00466440|323867757|FG001|Overall Study|Sponsor decision|0|||
94565648|NCT00466440|323867758|FG002|Overall Study|Sponsor decision|1|||
94565649|NCT03294590|323867764|FG000|Overall Study|Lost to Follow-up|105|||
94565650|NCT03294590|323867765|FG001|Overall Study|Lost to Follow-up|107|||
94658507|NCT01172938|324206183|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
94236636|NCT00150618|322661798|FG001|Overall Study|Lost to Follow-up|1|||
94236637|NCT00150618|322661799|FG002|Overall Study|Lost to Follow-up|5|||
94236638|NCT00150618|322661800|FG003|Overall Study|Lost to Follow-up|8|||
94236639|NCT00150618|322661801|FG004|Overall Study|Lost to Follow-up|4|||
94236640|NCT00150618|322661797|FG000|Overall Study|Protocol Violation|1|||
94236641|NCT00150618|322661798|FG001|Overall Study|Protocol Violation|0|||
94236642|NCT00150618|322661799|FG002|Overall Study|Protocol Violation|0|||
94236643|NCT00150618|322661800|FG003|Overall Study|Protocol Violation|0|||
94236644|NCT00150618|322661801|FG004|Overall Study|Protocol Violation|1|||
94236645|NCT00150618|322661797|FG000|Overall Study|Lack of Efficacy|1|||
94236646|NCT00150618|322661798|FG001|Overall Study|Lack of Efficacy|4|||
94236647|NCT00150618|322661799|FG002|Overall Study|Lack of Efficacy|7|||
94236648|NCT00150618|322661800|FG003|Overall Study|Lack of Efficacy|4|||
94236649|NCT00150618|322661801|FG004|Overall Study|Lack of Efficacy|6|||
94236650|NCT00150618|322661797|FG000|Overall Study|No study meds|0|||
94236651|NCT00150618|322661798|FG001|Overall Study|No study meds|0|||
94236652|NCT00150618|322661799|FG002|Overall Study|No study meds|0|||
94236653|NCT00150618|322661800|FG003|Overall Study|No study meds|0|||
94236654|NCT00150618|322661801|FG004|Overall Study|No study meds|2|||
94236655|NCT00150618|322661797|FG000|Overall Study|Physician Decision|0|||
94236656|NCT00150618|322661798|FG001|Overall Study|Physician Decision|2|||
94236657|NCT00150618|322661799|FG002|Overall Study|Physician Decision|0|||
94236658|NCT00150618|322661800|FG003|Overall Study|Physician Decision|0|||
94236659|NCT00150618|322661801|FG004|Overall Study|Physician Decision|1|||
94236660|NCT00150618|322661797|FG000|Overall Study|Lack of compliance|2|||
94236661|NCT00150618|322661798|FG001|Overall Study|Lack of compliance|1|||
94236662|NCT00150618|322661799|FG002|Overall Study|Lack of compliance|1|||
94236663|NCT00150618|322661800|FG003|Overall Study|Lack of compliance|0|||
94236664|NCT00150618|322661801|FG004|Overall Study|Lack of compliance|1|||
94236665|NCT00150618|322661797|FG000|Overall Study|Abnormal ECG|1|||
94236666|NCT00150618|322661798|FG001|Overall Study|Abnormal ECG|0|||
94236667|NCT00150618|322661799|FG002|Overall Study|Abnormal ECG|0|||
94236668|NCT00150618|322661800|FG003|Overall Study|Abnormal ECG|0|||
94236669|NCT00150618|322661801|FG004|Overall Study|Abnormal ECG|0|||
94236670|NCT00150618|322661797|FG000|Overall Study|Sponsor's decision|0|||
94236671|NCT00150618|322661798|FG001|Overall Study|Sponsor's decision|0|||
94347432|NCT02477800|323053920|FG004|Long Term Extension Period|Investigator Decision|0|||
94347433|NCT02477800|323053921|FG005|Long Term Extension Period|Investigator Decision|0|||
94347434|NCT02477800|323053922|FG006|Long Term Extension Period|Investigator Decision|2|||
94347435|NCT02477800|323053916|FG000|Long Term Extension Period|Lost to Follow-up|0|||
94347436|NCT02477800|323053917|FG001|Long Term Extension Period|Lost to Follow-up|0|||
94347437|NCT02477800|323053918|FG002|Long Term Extension Period|Lost to Follow-up|0|||
94347438|NCT02477800|323053919|FG003|Long Term Extension Period|Lost to Follow-up|0|||
94347439|NCT02477800|323053920|FG004|Long Term Extension Period|Lost to Follow-up|1|||
94347440|NCT02477800|323053921|FG005|Long Term Extension Period|Lost to Follow-up|3|||
94347441|NCT02477800|323053922|FG006|Long Term Extension Period|Lost to Follow-up|0|||
94347442|NCT02477800|323053916|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
94347443|NCT02477800|323053917|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
94347444|NCT02477800|323053918|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
94347445|NCT02477800|323053919|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
94347446|NCT02477800|323053920|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
94347447|NCT02477800|323053921|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
94347448|NCT02477800|323053922|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
94236672|NCT00150618|322661799|FG002|Overall Study|Sponsor's decision|0|||
94236673|NCT00150618|322661800|FG003|Overall Study|Sponsor's decision|1|||
94236674|NCT00150618|322661801|FG004|Overall Study|Sponsor's decision|0|||
94236675|NCT01099917|322661802|FG000|Overall Study|Adverse Event|3|||
94236676|NCT01099917|322661802|FG000|Overall Study|Not Treated|24|||
94236677|NCT01602510|322661803|FG000|Open Label Phase|Adverse Event|46|||
94236678|NCT01602510|322661804|FG001|Open Label Phase|Adverse Event|0|||
94347449|NCT02477800|323053916|FG000|Long Term Extension Period|Study Visit Burden|0|||
94347450|NCT02477800|323053917|FG001|Long Term Extension Period|Study Visit Burden|0|||
94347451|NCT02477800|323053918|FG002|Long Term Extension Period|Study Visit Burden|0|||
94347452|NCT02477800|323053919|FG003|Long Term Extension Period|Study Visit Burden|3|||
94347453|NCT02477800|323053920|FG004|Long Term Extension Period|Study Visit Burden|0|||
94347454|NCT02477800|323053921|FG005|Long Term Extension Period|Study Visit Burden|2|||
94347455|NCT02477800|323053922|FG006|Long Term Extension Period|Study Visit Burden|2|||
94347456|NCT02477800|323053916|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
94347457|NCT02477800|323053917|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
94347458|NCT02477800|323053918|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
94347459|NCT02477800|323053919|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
94347460|NCT02477800|323053920|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
94347461|NCT02477800|323053921|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
94347462|NCT02477800|323053922|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
94347463|NCT02477800|323053916|FG000|Long Term Extension Period|Reason not Specified|0|||
94347464|NCT02477800|323053917|FG001|Long Term Extension Period|Reason not Specified|0|||
94347465|NCT02477800|323053918|FG002|Long Term Extension Period|Reason not Specified|0|||
94347466|NCT02477800|323053919|FG003|Long Term Extension Period|Reason not Specified|126|||
94347467|NCT02477800|323053920|FG004|Long Term Extension Period|Reason not Specified|140|||
94347468|NCT02477800|323053921|FG005|Long Term Extension Period|Reason not Specified|270|||
94347469|NCT02477800|323053922|FG006|Long Term Extension Period|Reason not Specified|224|||
94347470|NCT01117428|323053923|FG000|Overall Study|Lack of Efficacy|1|||
94347471|NCT01117428|323053924|FG001|Overall Study|Lack of Efficacy|0|||
94347472|NCT01117428|323053925|FG002|Overall Study|Lack of Efficacy|0|||
94347473|NCT01117428|323053926|FG003|Overall Study|Lack of Efficacy|0|||
94347474|NCT01117428|323053927|FG004|Overall Study|Lack of Efficacy|0|||
94347475|NCT01117428|323053928|FG005|Overall Study|Lack of Efficacy|0|||
94347476|NCT01117428|323053923|FG000|Overall Study|Adverse Event|4|||
94347477|NCT01117428|323053924|FG001|Overall Study|Adverse Event|0|||
94347478|NCT01117428|323053925|FG002|Overall Study|Adverse Event|0|||
94347479|NCT01117428|323053926|FG003|Overall Study|Adverse Event|0|||
94347480|NCT01117428|323053927|FG004|Overall Study|Adverse Event|1|||
94347481|NCT01117428|323053928|FG005|Overall Study|Adverse Event|2|||
94347482|NCT01117428|323053923|FG000|Overall Study|Death|0|||
94347483|NCT01117428|323053924|FG001|Overall Study|Death|1|||
94347484|NCT01117428|323053925|FG002|Overall Study|Death|2|||
94347485|NCT01117428|323053926|FG003|Overall Study|Death|0|||
94347486|NCT01117428|323053927|FG004|Overall Study|Death|0|||
94347487|NCT01117428|323053928|FG005|Overall Study|Death|1|||
94347488|NCT01117428|323053923|FG000|Overall Study|Physician Decision|0|||
94347489|NCT01117428|323053924|FG001|Overall Study|Physician Decision|1|||
94347490|NCT01117428|323053925|FG002|Overall Study|Physician Decision|0|||
94347491|NCT01117428|323053926|FG003|Overall Study|Physician Decision|0|||
94236679|NCT01602510|322661805|FG002|Open Label Phase|Adverse Event|0|||
94236680|NCT01602510|322661803|FG000|Open Label Phase|Lack of Efficacy|22|||
94236681|NCT01602510|322661804|FG001|Open Label Phase|Lack of Efficacy|0|||
94236682|NCT01602510|322661805|FG002|Open Label Phase|Lack of Efficacy|0|||
94236683|NCT01602510|322661803|FG000|Open Label Phase|Protocol Violation|15|||
94236684|NCT01602510|322661804|FG001|Open Label Phase|Protocol Violation|0|||
94236685|NCT01602510|322661805|FG002|Open Label Phase|Protocol Violation|0|||
94236686|NCT01602510|322661803|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
94236687|NCT01602510|322661804|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
94236688|NCT01602510|322661805|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
94347492|NCT01117428|323053927|FG004|Overall Study|Physician Decision|0|||
94450739|NCT00828568|323436953|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
94450740|NCT00828568|323436951|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
94450741|NCT00828568|323436952|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
94450742|NCT00828568|323436953|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
94450743|NCT00828568|323436951|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
94450744|NCT00828568|323436952|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
94450745|NCT00828568|323436953|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
94450746|NCT00828568|323436951|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
94450747|NCT00828568|323436952|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
94450748|NCT00828568|323436953|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
94450749|NCT02099110|323436957|FG000|Overall Study|Protocol Violation|2|||
94450750|NCT02099110|323436958|FG001|Overall Study|Protocol Violation|1|||
94450751|NCT02099110|323436959|FG002|Overall Study|Protocol Violation|0|||
94450752|NCT02099110|323436960|FG003|Overall Study|Protocol Violation|3|||
94450753|NCT02099110|323436961|FG004|Overall Study|Protocol Violation|1|||
94450754|NCT02099110|323436957|FG000|Overall Study|Participant moved|1|||
94450755|NCT02099110|323436958|FG001|Overall Study|Participant moved|1|||
94450756|NCT02099110|323436959|FG002|Overall Study|Participant moved|1|||
94450757|NCT02099110|323436960|FG003|Overall Study|Participant moved|0|||
94450758|NCT02099110|323436961|FG004|Overall Study|Participant moved|2|||
94450759|NCT02099110|323436957|FG000|Overall Study|Withdrawal by Subject|7|||
94450760|NCT02099110|323436958|FG001|Overall Study|Withdrawal by Subject|11|||
94450761|NCT02099110|323436959|FG002|Overall Study|Withdrawal by Subject|13|||
94450762|NCT02099110|323436960|FG003|Overall Study|Withdrawal by Subject|9|||
94450763|NCT02099110|323436961|FG004|Overall Study|Withdrawal by Subject|13|||
94450764|NCT02099110|323436957|FG000|Overall Study|Adverse Event|3|||
94450765|NCT02099110|323436958|FG001|Overall Study|Adverse Event|5|||
94450766|NCT02099110|323436959|FG002|Overall Study|Adverse Event|2|||
94450767|NCT02099110|323436960|FG003|Overall Study|Adverse Event|3|||
94450768|NCT02099110|323436961|FG004|Overall Study|Adverse Event|2|||
94450769|NCT02099110|323436957|FG000|Overall Study|Lost to Follow-up|6|||
94450770|NCT02099110|323436958|FG001|Overall Study|Lost to Follow-up|12|||
94450771|NCT02099110|323436959|FG002|Overall Study|Lost to Follow-up|11|||
94450772|NCT02099110|323436960|FG003|Overall Study|Lost to Follow-up|5|||
94450773|NCT02099110|323436961|FG004|Overall Study|Lost to Follow-up|6|||
94450774|NCT02099110|323436957|FG000|Overall Study|Death|0|||
94565651|NCT03187132|323867768|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
94236689|NCT01602510|322661803|FG000|Open Label Phase|Lost to Follow-up|22|||
94236690|NCT01602510|322661804|FG001|Open Label Phase|Lost to Follow-up|0|||
94236691|NCT01602510|322661805|FG002|Open Label Phase|Lost to Follow-up|0|||
94236692|NCT01602510|322661803|FG000|Open Label Phase|Physician Decision|19|||
94236693|NCT01602510|322661804|FG001|Open Label Phase|Physician Decision|0|||
94236694|NCT01602510|322661805|FG002|Open Label Phase|Physician Decision|0|||
94236695|NCT01602510|322661803|FG000|Open Label Phase|Withdrawal by Subject|57|||
94236696|NCT01602510|322661804|FG001|Open Label Phase|Withdrawal by Subject|0|||
94236697|NCT01602510|322661805|FG002|Open Label Phase|Withdrawal by Subject|0|||
94236698|NCT01602510|322661803|FG000|Randomized Phase|Adverse Event|0|||
94236699|NCT01602510|322661804|FG001|Randomized Phase|Adverse Event|2|||
94236700|NCT01602510|322661805|FG002|Randomized Phase|Adverse Event|6|||
94236701|NCT01602510|322661803|FG000|Randomized Phase|Lack of Efficacy|0|||
94236702|NCT01602510|322661804|FG001|Randomized Phase|Lack of Efficacy|4|||
94236703|NCT01602510|322661805|FG002|Randomized Phase|Lack of Efficacy|4|||
94236704|NCT01602510|322661803|FG000|Randomized Phase|Protocol Violation|0|||
94236705|NCT01602510|322661804|FG001|Randomized Phase|Protocol Violation|3|||
94236706|NCT01602510|322661805|FG002|Randomized Phase|Protocol Violation|3|||
94236707|NCT01602510|322661803|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
94236708|NCT01602510|322661804|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
94236709|NCT01602510|322661805|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
94236710|NCT01602510|322661803|FG000|Randomized Phase|Lost to Follow-up|0|||
94236711|NCT01602510|322661804|FG001|Randomized Phase|Lost to Follow-up|1|||
94236712|NCT01602510|322661805|FG002|Randomized Phase|Lost to Follow-up|3|||
94236713|NCT01602510|322661803|FG000|Randomized Phase|Physician Decision|0|||
94236714|NCT01602510|322661804|FG001|Randomized Phase|Physician Decision|0|||
94236715|NCT01602510|322661805|FG002|Randomized Phase|Physician Decision|2|||
94236716|NCT01602510|322661803|FG000|Randomized Phase|Withdrawal by Subject|0|||
94236717|NCT01602510|322661804|FG001|Randomized Phase|Withdrawal by Subject|6|||
94236718|NCT01602510|322661805|FG002|Randomized Phase|Withdrawal by Subject|7|||
94236719|NCT01001390|322661806|FG000|Overall Study|Failure to wear AFO device|2|||
94236720|NCT01001390|322661807|FG001|Overall Study|Failure to wear AFO device|0|||
94236721|NCT01727505|322661814|FG000|First 24 Hours|Adverse Event|0|||
94450775|NCT02099110|323436958|FG001|Overall Study|Death|1|||
94450776|NCT02099110|323436959|FG002|Overall Study|Death|0|||
94450777|NCT02099110|323436960|FG003|Overall Study|Death|0|||
94450778|NCT02099110|323436961|FG004|Overall Study|Death|0|||
94450779|NCT02099110|323436957|FG000|Overall Study|Screen failure|0|||
94450780|NCT02099110|323436958|FG001|Overall Study|Screen failure|0|||
94565652|NCT03187132|323867769|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
94565653|NCT03187132|323867768|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
94565654|NCT03187132|323867769|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
94565655|NCT03187132|323867768|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
94565656|NCT03187132|323867769|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
94565657|NCT03187132|323867768|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
94347493|NCT01117428|323053928|FG005|Overall Study|Physician Decision|0|||
94347494|NCT01117428|323053923|FG000|Overall Study|Withdrawal by Subject|0|||
94347495|NCT01117428|323053924|FG001|Overall Study|Withdrawal by Subject|0|||
94347496|NCT01117428|323053925|FG002|Overall Study|Withdrawal by Subject|1|||
94565658|NCT03187132|323867769|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
94565659|NCT03187132|323867768|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
94565660|NCT03187132|323867769|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
94565661|NCT03187132|323867768|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
94565662|NCT03187132|323867769|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
94347497|NCT01117428|323053926|FG003|Overall Study|Withdrawal by Subject|0|||
94565663|NCT03187132|323867768|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
94565664|NCT03187132|323867769|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
94565665|NCT03187132|323867768|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
94565666|NCT03187132|323867769|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
94565667|NCT03187132|323867768|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
94565668|NCT03187132|323867769|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
94565669|NCT03187132|323867768|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
94565670|NCT03187132|323867769|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
94565671|NCT03187132|323867768|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
94565672|NCT03187132|323867769|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
94565673|NCT00743249|323867774|FG000|Overall Study|Adverse Event|0|||
94565674|NCT00743249|323867775|FG001|Overall Study|Adverse Event|4|||
94565675|NCT00743249|323867774|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
94565676|NCT00743249|323867775|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
94565677|NCT00743249|323867774|FG000|Overall Study|Unsuccessful insertion of stent|2|||
94565678|NCT00743249|323867775|FG001|Overall Study|Unsuccessful insertion of stent|1|||
94565679|NCT01858363|323867780|FG000|Overall Study|Death|35|||
94565680|NCT01858363|323867781|FG001|Overall Study|Death|9|||
94565681|NCT01858363|323867780|FG000|Overall Study|Withdrawal by Subject|28|||
94565682|NCT01858363|323867781|FG001|Overall Study|Withdrawal by Subject|14|||
94347498|NCT01117428|323053927|FG004|Overall Study|Withdrawal by Subject|0|||
94347499|NCT01117428|323053928|FG005|Overall Study|Withdrawal by Subject|0|||
94347500|NCT01117428|323053923|FG000|Overall Study|Progressive disease|15|||
94347501|NCT01117428|323053924|FG001|Overall Study|Progressive disease|27|||
94347502|NCT01117428|323053925|FG002|Overall Study|Progressive disease|10|||
94347503|NCT01117428|323053926|FG003|Overall Study|Progressive disease|12|||
94347504|NCT01117428|323053927|FG004|Overall Study|Progressive disease|16|||
94347505|NCT01117428|323053928|FG005|Overall Study|Progressive disease|17|||
94347506|NCT03961529|323053930|FG000|Overall Study|Adverse Event|13|||
94347507|NCT03961529|323053931|FG001|Overall Study|Adverse Event|5|||
94347508|NCT03961529|323053932|FG002|Overall Study|Adverse Event|2|||
94347509|NCT03961529|323053930|FG000|Overall Study|Withdrawal by Subject|17|||
94565683|NCT01858363|323867780|FG000|Overall Study|Lost to Follow-up|13|||
94565684|NCT01858363|323867781|FG001|Overall Study|Lost to Follow-up|3|||
94565685|NCT04276233|323867787|FG000|Overall Study|Adverse Event|1|||
94565686|NCT04276233|323867787|FG000|Overall Study|Lost to Follow-up|3|||
94565687|NCT04276233|323867787|FG000|Overall Study|Physician Decision|4|||
94565688|NCT04276233|323867787|FG000|Overall Study|Withdrawal by Subject|2|||
94565689|NCT02366195|323867796|FG000|Overall Study|Protocol-specified criteria|3|||
94565690|NCT02366195|323867796|FG000|Overall Study|Withdrawal by Subject|9|||
94347510|NCT03961529|323053931|FG001|Overall Study|Withdrawal by Subject|2|||
94347511|NCT03961529|323053932|FG002|Overall Study|Withdrawal by Subject|1|||
94347512|NCT03961529|323053930|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94347513|NCT03961529|323053931|FG001|Overall Study|Withdrawal by parent/guardian|7|||
94347514|NCT03961529|323053932|FG002|Overall Study|Withdrawal by parent/guardian|0|||
94565691|NCT02366195|323867796|FG000|Overall Study|Lost to Follow-up|1|||
94565692|NCT02366195|323867796|FG000|Overall Study|Death|41|||
94565693|NCT02872116|323867798|FG000|Pre-Treatment|Disease Progression|0|||
94565694|NCT02872116|323867799|FG001|Pre-Treatment|Disease Progression|1|||
94565695|NCT02872116|323867800|FG002|Pre-Treatment|Disease Progression|0|||
94565696|NCT02872116|323867798|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
94565697|NCT02872116|323867799|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
94565698|NCT02872116|323867800|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
94347515|NCT03961529|323053930|FG000|Overall Study|Physician Decision|2|||
94347516|NCT03961529|323053931|FG001|Overall Study|Physician Decision|1|||
94347517|NCT03961529|323053932|FG002|Overall Study|Physician Decision|1|||
94347518|NCT03961529|323053930|FG000|Overall Study|Lost to Follow-up|2|||
94347519|NCT03961529|323053931|FG001|Overall Study|Lost to Follow-up|1|||
94347520|NCT03961529|323053932|FG002|Overall Study|Lost to Follow-up|0|||
94347521|NCT03961529|323053930|FG000|Overall Study|Lack of Efficacy|2|||
94347522|NCT03961529|323053931|FG001|Overall Study|Lack of Efficacy|0|||
94347523|NCT03961529|323053932|FG002|Overall Study|Lack of Efficacy|1|||
94347524|NCT03961529|323053930|FG000|Overall Study|Other|6|||
94347525|NCT03961529|323053931|FG001|Overall Study|Other|1|||
94347526|NCT03961529|323053932|FG002|Overall Study|Other|0|||
94347527|NCT00403390|323053933|FG000|Overall Study|Withdrawal by Subject|1|||
94347528|NCT00403390|323053934|FG001|Overall Study|Withdrawal by Subject|0|||
94347529|NCT00403390|323053933|FG000|Overall Study|samples lost|1|||
94347530|NCT00403390|323053934|FG001|Overall Study|samples lost|0|||
94347531|NCT00403390|323053933|FG000|Overall Study|non-compliant|1|||
94450781|NCT02099110|323436959|FG002|Overall Study|Screen failure|0|||
94450782|NCT02099110|323436960|FG003|Overall Study|Screen failure|0|||
94450783|NCT02099110|323436961|FG004|Overall Study|Screen failure|1|||
94450784|NCT02099110|323436957|FG000|Overall Study|Non-compliance with study drug|2|||
94450785|NCT02099110|323436958|FG001|Overall Study|Non-compliance with study drug|0|||
94450786|NCT02099110|323436959|FG002|Overall Study|Non-compliance with study drug|0|||
94450787|NCT02099110|323436960|FG003|Overall Study|Non-compliance with study drug|0|||
94347532|NCT00403390|323053934|FG001|Overall Study|non-compliant|0|||
94347533|NCT03500419|323053935|FG000|Overall Study|Withdrawal by Subject|2|||
94347534|NCT03500419|323053936|FG001|Overall Study|Withdrawal by Subject|25|||
94347535|NCT04554394|323053937|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
94347536|NCT04554394|323053938|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
94347537|NCT04554394|323053937|FG000|Overall Study|Withdrawal by Subject|2|||
94347538|NCT04554394|323053938|FG001|Overall Study|Withdrawal by Subject|2|||
94347539|NCT04554394|323053937|FG000|Overall Study|Lost to Follow-up|2|||
94347540|NCT04554394|323053938|FG001|Overall Study|Lost to Follow-up|2|||
94347541|NCT04554394|323053937|FG000|Overall Study|Physician Decision|1|||
94347542|NCT04554394|323053938|FG001|Overall Study|Physician Decision|1|||
94347543|NCT00256204|323053942|FG000|Overall Study|Adverse Event|10|||
94347544|NCT00256204|323053943|FG001|Overall Study|Adverse Event|14|||
94347545|NCT00256204|323053944|FG002|Overall Study|Adverse Event|16|||
94347546|NCT00256204|323053945|FG003|Overall Study|Adverse Event|14|||
94347547|NCT00256204|323053942|FG000|Overall Study|Death|0|||
94347548|NCT00256204|323053943|FG001|Overall Study|Death|1|||
94347549|NCT00256204|323053944|FG002|Overall Study|Death|0|||
94347550|NCT00256204|323053945|FG003|Overall Study|Death|0|||
94347551|NCT00256204|323053942|FG000|Overall Study|Lost to Follow-up|1|||
94347552|NCT00256204|323053943|FG001|Overall Study|Lost to Follow-up|1|||
94347553|NCT00256204|323053944|FG002|Overall Study|Lost to Follow-up|1|||
94347554|NCT00256204|323053945|FG003|Overall Study|Lost to Follow-up|2|||
94347555|NCT00256204|323053942|FG000|Overall Study|Protocol Violation|1|||
94450788|NCT02099110|323436961|FG004|Overall Study|Non-compliance with study drug|1|||
94450789|NCT02099110|323436957|FG000|Overall Study|Physician Decision|3|||
94450790|NCT02099110|323436958|FG001|Overall Study|Physician Decision|0|||
94450791|NCT02099110|323436959|FG002|Overall Study|Physician Decision|1|||
94450792|NCT02099110|323436960|FG003|Overall Study|Physician Decision|2|||
94450793|NCT02099110|323436961|FG004|Overall Study|Physician Decision|1|||
94450794|NCT03340454|323436962|FG000|Overall Study|Lost to Follow-up|0|||
94450795|NCT03340454|323436963|FG001|Overall Study|Lost to Follow-up|4|||
94450796|NCT01074268|323436964|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
94450797|NCT01074268|323436965|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
94450798|NCT01074268|323436964|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
94450799|NCT01074268|323436965|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
94450800|NCT01074268|323436964|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
94450801|NCT01074268|323436965|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
94450802|NCT01074268|323436964|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
94450803|NCT01074268|323436965|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
94450804|NCT01074268|323436964|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
94450805|NCT01074268|323436965|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
94450806|NCT01074268|323436964|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
94450807|NCT01074268|323436965|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
94450808|NCT01074268|323436964|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
94450809|NCT01074268|323436965|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
94450810|NCT01074268|323436964|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
94450811|NCT01074268|323436965|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
94450812|NCT01074268|323436964|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
94450813|NCT01074268|323436965|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
94450814|NCT03379727|323436966|FG000|Overall Study|Lack of Efficacy|73|||
94450815|NCT03379727|323436966|FG000|Overall Study|Adverse Event|32|||
94450816|NCT03379727|323436966|FG000|Overall Study|Death|18|||
94450817|NCT03379727|323436966|FG000|Overall Study|Patient/guardian decision|17|||
94347556|NCT00256204|323053943|FG001|Overall Study|Protocol Violation|0|||
94347557|NCT00256204|323053944|FG002|Overall Study|Protocol Violation|2|||
94347558|NCT00256204|323053945|FG003|Overall Study|Protocol Violation|1|||
94347559|NCT00256204|323053942|FG000|Overall Study|Physician Decision|0|||
94347560|NCT00256204|323053943|FG001|Overall Study|Physician Decision|0|||
94347561|NCT00256204|323053944|FG002|Overall Study|Physician Decision|1|||
94565699|NCT02872116|323867798|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
94565700|NCT02872116|323867799|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
94565701|NCT02872116|323867800|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
94565702|NCT02872116|323867798|FG000|Pre-Treatment|Participant withdrew consent|2|||
94565703|NCT02872116|323867799|FG001|Pre-Treatment|Participant withdrew consent|20|||
94565704|NCT02872116|323867800|FG002|Pre-Treatment|Participant withdrew consent|3|||
94565705|NCT02872116|323867798|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
94565706|NCT02872116|323867799|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
94565707|NCT02872116|323867800|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
94565708|NCT02872116|323867798|FG000|Pre-Treatment|Other reasons|1|||
94565709|NCT02872116|323867799|FG001|Pre-Treatment|Other reasons|2|||
94565710|NCT02872116|323867800|FG002|Pre-Treatment|Other reasons|2|||
94565711|NCT02872116|323867798|FG000|Treatment|Death|122|||
94565712|NCT02872116|323867799|FG001|Treatment|Death|94|||
94236722|NCT01727505|322661815|FG001|First 24 Hours|Adverse Event|1|||
94450818|NCT03379727|323436966|FG000|Overall Study|Physician Decision|104|||
94347562|NCT00256204|323053945|FG003|Overall Study|Physician Decision|2|||
94347563|NCT00256204|323053942|FG000|Overall Study|Withdrawal by Subject|17|||
94347564|NCT00256204|323053943|FG001|Overall Study|Withdrawal by Subject|6|||
94347565|NCT00256204|323053944|FG002|Overall Study|Withdrawal by Subject|7|||
94565713|NCT02872116|323867800|FG002|Treatment|Death|68|||
94565714|NCT02872116|323867798|FG000|Treatment|Lost to Follow-up|5|||
94565715|NCT02872116|323867799|FG001|Treatment|Lost to Follow-up|7|||
94565716|NCT02872116|323867800|FG002|Treatment|Lost to Follow-up|3|||
94565717|NCT02872116|323867798|FG000|Treatment|Participant withdrew consent|20|||
94565718|NCT02872116|323867799|FG001|Treatment|Participant withdrew consent|40|||
94565719|NCT02872116|323867800|FG002|Treatment|Participant withdrew consent|8|||
94565720|NCT02872116|323867798|FG000|Treatment|Other reasons|12|||
94565721|NCT02872116|323867799|FG001|Treatment|Other reasons|12|||
94565722|NCT02872116|323867800|FG002|Treatment|Other reasons|5|||
94565723|NCT02714569|323867804|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
94565724|NCT02714569|323867805|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
94565725|NCT02714569|323867806|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
94565726|NCT02714569|323867807|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
94565727|NCT02714569|323867808|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
94565728|NCT02714569|323867809|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
94565729|NCT02714569|323867810|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
94565730|NCT02714569|323867811|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
94565731|NCT02714569|323867812|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
94565732|NCT02714569|323867813|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
94565733|NCT02714569|323867814|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
94565734|NCT02714569|323867804|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
94565735|NCT02714569|323867805|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
94565736|NCT02714569|323867806|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
94565737|NCT02714569|323867807|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
94565738|NCT02714569|323867808|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
94565739|NCT02714569|323867809|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
94565740|NCT02714569|323867810|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
94565741|NCT02714569|323867811|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
94565742|NCT02714569|323867812|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
94565743|NCT02714569|323867813|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
94565744|NCT02714569|323867814|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
94565745|NCT02714569|323867804|FG000|Part A Third Intervention|Adverse Event|0|||
94565746|NCT02714569|323867805|FG001|Part A Third Intervention|Adverse Event|0|||
94565747|NCT02714569|323867806|FG002|Part A Third Intervention|Adverse Event|1|||
94565748|NCT02714569|323867807|FG003|Part A Third Intervention|Adverse Event|0|||
94565749|NCT02714569|323867808|FG004|Part A Third Intervention|Adverse Event|0|||
94565750|NCT02714569|323867809|FG005|Part A Third Intervention|Adverse Event|0|||
94565751|NCT02714569|323867810|FG006|Part A Third Intervention|Adverse Event|0|||
94565752|NCT02714569|323867811|FG007|Part A Third Intervention|Adverse Event|0|||
94565753|NCT02714569|323867812|FG008|Part A Third Intervention|Adverse Event|0|||
94565754|NCT02714569|323867813|FG009|Part A Third Intervention|Adverse Event|0|||
94565755|NCT02714569|323867814|FG010|Part A Third Intervention|Adverse Event|0|||
94565756|NCT02714569|323867804|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
94565757|NCT02714569|323867805|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
94565758|NCT02714569|323867806|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
94565759|NCT02714569|323867807|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
94565760|NCT02714569|323867808|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
94565761|NCT02714569|323867809|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
94565762|NCT02714569|323867810|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
94565763|NCT02714569|323867811|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
94565764|NCT02714569|323867812|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
94565765|NCT02714569|323867813|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
94565766|NCT02714569|323867814|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
94565767|NCT02714569|323867804|FG000|Part B (Overall)|Lost to Follow-up|0|||
94565768|NCT02714569|323867805|FG001|Part B (Overall)|Lost to Follow-up|0|||
94565769|NCT02714569|323867806|FG002|Part B (Overall)|Lost to Follow-up|0|||
94565770|NCT02714569|323867807|FG003|Part B (Overall)|Lost to Follow-up|0|||
94565771|NCT02714569|323867808|FG004|Part B (Overall)|Lost to Follow-up|0|||
94565772|NCT02714569|323867809|FG005|Part B (Overall)|Lost to Follow-up|0|||
94565773|NCT02714569|323867810|FG006|Part B (Overall)|Lost to Follow-up|1|||
94565774|NCT02714569|323867811|FG007|Part B (Overall)|Lost to Follow-up|0|||
94565775|NCT02714569|323867812|FG008|Part B (Overall)|Lost to Follow-up|0|||
94565776|NCT02714569|323867813|FG009|Part B (Overall)|Lost to Follow-up|0|||
94565777|NCT02714569|323867814|FG010|Part B (Overall)|Lost to Follow-up|0|||
94565778|NCT02714569|323867804|FG000|Part B (Overall)|Withdrawal by Subject|0|||
94565779|NCT02714569|323867805|FG001|Part B (Overall)|Withdrawal by Subject|0|||
94565780|NCT02714569|323867806|FG002|Part B (Overall)|Withdrawal by Subject|0|||
94565781|NCT02714569|323867807|FG003|Part B (Overall)|Withdrawal by Subject|0|||
94565782|NCT02714569|323867808|FG004|Part B (Overall)|Withdrawal by Subject|0|||
94565783|NCT02714569|323867809|FG005|Part B (Overall)|Withdrawal by Subject|0|||
94565784|NCT02714569|323867810|FG006|Part B (Overall)|Withdrawal by Subject|0|||
94565785|NCT02714569|323867811|FG007|Part B (Overall)|Withdrawal by Subject|1|||
94565786|NCT02714569|323867812|FG008|Part B (Overall)|Withdrawal by Subject|0|||
94565787|NCT02714569|323867813|FG009|Part B (Overall)|Withdrawal by Subject|1|||
94565788|NCT02714569|323867814|FG010|Part B (Overall)|Withdrawal by Subject|0|||
94565789|NCT02714569|323867804|FG000|Part B (Overall)|Adverse Event|0|||
94565790|NCT02714569|323867805|FG001|Part B (Overall)|Adverse Event|0|||
94565791|NCT02714569|323867806|FG002|Part B (Overall)|Adverse Event|0|||
94565792|NCT02714569|323867807|FG003|Part B (Overall)|Adverse Event|0|||
94565793|NCT02714569|323867808|FG004|Part B (Overall)|Adverse Event|0|||
94565794|NCT02714569|323867809|FG005|Part B (Overall)|Adverse Event|0|||
94565795|NCT02714569|323867810|FG006|Part B (Overall)|Adverse Event|0|||
94565796|NCT02714569|323867811|FG007|Part B (Overall)|Adverse Event|0|||
94565797|NCT02714569|323867812|FG008|Part B (Overall)|Adverse Event|0|||
94565798|NCT02714569|323867813|FG009|Part B (Overall)|Adverse Event|1|||
94565799|NCT02714569|323867814|FG010|Part B (Overall)|Adverse Event|0|||
94565800|NCT05114473|323867821|FG000|Overall Study|Lost to Follow-up|2|||
94347566|NCT00256204|323053945|FG003|Overall Study|Withdrawal by Subject|5|||
94347567|NCT00256204|323053942|FG000|Overall Study|Need for additional prohibited treatment|38|||
94347568|NCT00256204|323053943|FG001|Overall Study|Need for additional prohibited treatment|28|||
94347569|NCT00256204|323053944|FG002|Overall Study|Need for additional prohibited treatment|27|||
94347570|NCT00256204|323053945|FG003|Overall Study|Need for additional prohibited treatment|25|||
94347571|NCT02364999|323053946|FG000|Overall Study|Death|136|||
94347572|NCT02364999|323053947|FG001|Overall Study|Death|138|||
94347573|NCT02364999|323053946|FG000|Overall Study|Lost to Follow-up|10|||
94347574|NCT02364999|323053947|FG001|Overall Study|Lost to Follow-up|15|||
94347575|NCT02364999|323053946|FG000|Overall Study|Protocol Violation|3|||
94347576|NCT02364999|323053947|FG001|Overall Study|Protocol Violation|2|||
94347577|NCT02364999|323053946|FG000|Overall Study|Withdrawal by Subject|14|||
94347578|NCT02364999|323053947|FG001|Overall Study|Withdrawal by Subject|14|||
94347579|NCT02364999|323053946|FG000|Overall Study|Other|0|||
94347580|NCT02364999|323053947|FG001|Overall Study|Other|1|||
94347581|NCT02364999|323053946|FG000|Overall Study|Randomized but did not receive treatment|2|||
94347582|NCT02364999|323053947|FG001|Overall Study|Randomized but did not receive treatment|3|||
94347583|NCT01566981|323053948|FG000|Overall Study|Lost to Follow-up|5|||
94347584|NCT01566981|323053949|FG001|Overall Study|Lost to Follow-up|8|||
94347585|NCT01766401|323053950|FG000|Overall Study|Adverse Event|7|||
94347586|NCT01766401|323053951|FG001|Overall Study|Adverse Event|22|||
94347587|NCT01766401|323053950|FG000|Overall Study|Lack of Efficacy|1|||
94347588|NCT01766401|323053951|FG001|Overall Study|Lack of Efficacy|2|||
94347589|NCT01766401|323053950|FG000|Overall Study|Protocol Violation|3|||
94347590|NCT01766401|323053951|FG001|Overall Study|Protocol Violation|8|||
94347591|NCT01766401|323053950|FG000|Overall Study|Withdrawal by Subject|15|||
94347592|NCT01766401|323053951|FG001|Overall Study|Withdrawal by Subject|12|||
94347593|NCT01766401|323053950|FG000|Overall Study|Lost to Follow-up|10|||
94347594|NCT01766401|323053951|FG001|Overall Study|Lost to Follow-up|11|||
94347595|NCT01766401|323053950|FG000|Overall Study|Pregnancy|1|||
94347596|NCT01766401|323053951|FG001|Overall Study|Pregnancy|1|||
94347597|NCT04430036|323053955|FG000|Safety Run in Phase|Progression of disease|2|||
94565801|NCT05114473|323867822|FG001|Overall Study|Lost to Follow-up|2|||
94347598|NCT00398086|323053958|FG000|Overall Study|Unacceptable Toxicity|2|||
94347599|NCT00398086|323053959|FG001|Overall Study|Unacceptable Toxicity|8|||
94347600|NCT00398086|323053960|FG002|Overall Study|Unacceptable Toxicity|2|||
94347601|NCT00398086|323053958|FG000|Overall Study|Adverse Event|1|||
94347602|NCT00398086|323053959|FG001|Overall Study|Adverse Event|4|||
94347603|NCT00398086|323053960|FG002|Overall Study|Adverse Event|0|||
94565802|NCT05114473|323867823|FG002|Overall Study|Lost to Follow-up|0|||
94347604|NCT00398086|323053958|FG000|Overall Study|Physician Decision|1|||
94347605|NCT00398086|323053959|FG001|Overall Study|Physician Decision|4|||
94565803|NCT01100320|323867824|FG000|Period 1|Withdrawal by Subject|2|||
94565804|NCT01100320|323867825|FG001|Period 1|Withdrawal by Subject|4|||
94565805|NCT01100320|323867824|FG000|Period 1|Positive Drug Screen|1|||
94565806|NCT01100320|323867825|FG001|Period 1|Positive Drug Screen|1|||
94565807|NCT01100320|323867824|FG000|Period 1|Adverse Event|2|||
94236723|NCT01727505|322661814|FG000|Second 24 Hours|Missing data|0|||
94347606|NCT00398086|323053960|FG002|Overall Study|Physician Decision|0|||
94347607|NCT00398086|323053958|FG000|Overall Study|Withdrawal by Subject|5|||
94347608|NCT00398086|323053959|FG001|Overall Study|Withdrawal by Subject|7|||
94565808|NCT01100320|323867825|FG001|Period 1|Adverse Event|2|||
94347609|NCT00398086|323053960|FG002|Overall Study|Withdrawal by Subject|0|||
94347610|NCT01948791|323053961|FG000|Overall Study|Adverse Event|12|||
94347611|NCT01948791|323053961|FG000|Overall Study|Lack of Efficacy|3|||
94347612|NCT01948791|323053961|FG000|Overall Study|Protocol Violation|2|||
94347613|NCT01948791|323053961|FG000|Overall Study|Withdrawal by Subject|5|||
94347614|NCT01948791|323053961|FG000|Overall Study|Lost to Follow-up|6|||
94347615|NCT01948791|323053961|FG000|Overall Study|Management issues|1|||
94347616|NCT01948791|323053961|FG000|Overall Study|Others|7|||
94347617|NCT01948791|323053961|FG000|Overall Study|Screening failure|35|||
94347618|NCT00696774|323053965|FG000|Period II|Adverse Event|0|||
94347619|NCT00696774|323053966|FG001|Period II|Adverse Event|0|||
94347620|NCT00696774|323053967|FG002|Period II|Adverse Event|15|||
94347621|NCT00696774|323053965|FG000|Period II|Lost to Follow-up|0|||
94347622|NCT00696774|323053966|FG001|Period II|Lost to Follow-up|0|||
94347623|NCT00696774|323053967|FG002|Period II|Lost to Follow-up|4|||
94347624|NCT00696774|323053965|FG000|Period II|Protocol Violation|0|||
94347625|NCT00696774|323053966|FG001|Period II|Protocol Violation|0|||
94347626|NCT00696774|323053967|FG002|Period II|Protocol Violation|11|||
94347627|NCT00696774|323053965|FG000|Period II|Withdrawal by Subject|0|||
94347628|NCT00696774|323053966|FG001|Period II|Withdrawal by Subject|0|||
94347629|NCT00696774|323053967|FG002|Period II|Withdrawal by Subject|4|||
94347630|NCT00696774|323053965|FG000|Period II|Sponsor Decision|0|||
94347631|NCT00696774|323053966|FG001|Period II|Sponsor Decision|0|||
94347632|NCT00696774|323053967|FG002|Period II|Sponsor Decision|0|||
94347633|NCT00696774|323053965|FG000|Period II|Lack of Efficacy|0|||
94347634|NCT00696774|323053966|FG001|Period II|Lack of Efficacy|0|||
94347635|NCT00696774|323053967|FG002|Period II|Lack of Efficacy|2|||
94347636|NCT00696774|323053965|FG000|Period III|Adverse Event|1|||
94347637|NCT00696774|323053966|FG001|Period III|Adverse Event|1|||
94347638|NCT00696774|323053967|FG002|Period III|Adverse Event|0|||
94347639|NCT00696774|323053965|FG000|Period III|Lost to Follow-up|2|||
94347640|NCT00696774|323053966|FG001|Period III|Lost to Follow-up|1|||
94347641|NCT00696774|323053967|FG002|Period III|Lost to Follow-up|0|||
94347642|NCT00696774|323053965|FG000|Period III|Protocol Violation|1|||
94347643|NCT00696774|323053966|FG001|Period III|Protocol Violation|1|||
94347644|NCT00696774|323053967|FG002|Period III|Protocol Violation|0|||
94347645|NCT00696774|323053965|FG000|Period III|Withdrawal by Subject|1|||
94347646|NCT00696774|323053966|FG001|Period III|Withdrawal by Subject|2|||
94347647|NCT00696774|323053967|FG002|Period III|Withdrawal by Subject|0|||
94347648|NCT00696774|323053965|FG000|Period III|Sponsor Decision|2|||
94347649|NCT00696774|323053966|FG001|Period III|Sponsor Decision|0|||
94450819|NCT03379727|323436966|FG000|Overall Study|Protocol Violation|4|||
94450820|NCT03379727|323436966|FG000|Overall Study|Lost to Follow-up|1|||
94450821|NCT06098339|323438341|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
94450822|NCT06098339|323438342|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
94450823|NCT06098339|323438341|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
94450824|NCT06098339|323438342|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
94450825|NCT00638404|323438345|FG000|Overall Study|Physician Decision|8|||
94450826|NCT00638404|323438346|FG001|Overall Study|Physician Decision|0|||
94450827|NCT02492984|323438350|FG000|Overall Study|Adverse Event|1|||
94450828|NCT02492984|323438351|FG001|Overall Study|Adverse Event|0|||
94450829|NCT02492984|323438350|FG000|Overall Study|Protocol Violation|1|||
94450830|NCT02492984|323438351|FG001|Overall Study|Protocol Violation|0|||
94450831|NCT02492984|323438350|FG000|Overall Study|Withdrawal by Subject|1|||
94450832|NCT02492984|323438351|FG001|Overall Study|Withdrawal by Subject|0|||
94450833|NCT03691207|323438352|FG000|Overall Study|Death|41|||
94450834|NCT03691207|323438353|FG001|Overall Study|Death|26|||
94450835|NCT03691207|323438352|FG000|Overall Study|Lost to Follow-up|1|||
94450836|NCT03691207|323438353|FG001|Overall Study|Lost to Follow-up|1|||
94450837|NCT03691207|323438352|FG000|Overall Study|Withdrawal by Subject|2|||
94450838|NCT03691207|323438353|FG001|Overall Study|Withdrawal by Subject|8|||
94450839|NCT03691207|323438352|FG000|Overall Study|Sponsor decision|1|||
94450840|NCT03691207|323438353|FG001|Overall Study|Sponsor decision|7|||
94565809|NCT01100320|323867824|FG000|Period 2|Withdrawal by Subject|1|||
94565810|NCT01100320|323867825|FG001|Period 2|Withdrawal by Subject|1|||
94565811|NCT02728089|323867827|FG000|Overall Study|Physician Decision|2|||
94347650|NCT00696774|323053967|FG002|Period III|Sponsor Decision|0|||
94450841|NCT01372618|323438356|FG000|Overall Study|PI Died. Study Terminated|9|||
94450842|NCT01703260|323438357|FG000|Overall Study|Adverse Event|1|||
94450843|NCT01703260|323438358|FG001|Overall Study|Adverse Event|2|||
94347651|NCT00696774|323053965|FG000|Period III|Lack of Efficacy|0|||
94347652|NCT00696774|323053966|FG001|Period III|Lack of Efficacy|2|||
94347653|NCT00696774|323053967|FG002|Period III|Lack of Efficacy|0|||
94347654|NCT03481634|323053972|FG000|Overall Study|Withdrawal by Subject|16|||
94347655|NCT03481634|323053973|FG001|Overall Study|Withdrawal by Subject|19|||
94450844|NCT01703260|323438359|FG002|Overall Study|Adverse Event|2|||
94450845|NCT01703260|323438357|FG000|Overall Study|Lost to Follow-up|1|||
94450846|NCT01703260|323438358|FG001|Overall Study|Lost to Follow-up|0|||
94565812|NCT02728089|323867827|FG000|Overall Study|Withdrawal by Subject|1|||
94347656|NCT03481634|323053974|FG002|Overall Study|Withdrawal by Subject|14|||
94347657|NCT03481634|323053972|FG000|Overall Study|Protocol Violation|1|||
94450847|NCT01703260|323438359|FG002|Overall Study|Lost to Follow-up|0|||
94450848|NCT01703260|323438357|FG000|Overall Study|Withdrawal by Subject|0|||
94450849|NCT01703260|323438358|FG001|Overall Study|Withdrawal by Subject|0|||
94450850|NCT01703260|323438359|FG002|Overall Study|Withdrawal by Subject|1|||
94450851|NCT01703260|323438357|FG000|Overall Study|Study Termination|1|||
94450852|NCT01703260|323438358|FG001|Overall Study|Study Termination|2|||
94450853|NCT01703260|323438359|FG002|Overall Study|Study Termination|0|||
94450854|NCT00026494|323438364|FG000|Overall Study|Withdrawal by Subject|1|||
94450855|NCT00026494|323438365|FG001|Overall Study|Withdrawal by Subject|0|||
94450856|NCT00026494|323438366|FG002|Overall Study|Withdrawal by Subject|1|||
94450857|NCT00026494|323438367|FG003|Overall Study|Withdrawal by Subject|0|||
94450858|NCT00026494|323438364|FG000|Overall Study|Patient non-compliance|1|||
94450859|NCT00026494|323438365|FG001|Overall Study|Patient non-compliance|0|||
94450860|NCT00026494|323438366|FG002|Overall Study|Patient non-compliance|0|||
94450861|NCT00026494|323438367|FG003|Overall Study|Patient non-compliance|0|||
94450862|NCT00026494|323438364|FG000|Overall Study|Patient not treated|0|||
94450863|NCT00026494|323438365|FG001|Overall Study|Patient not treated|0|||
94450864|NCT00026494|323438366|FG002|Overall Study|Patient not treated|2|||
94450865|NCT00026494|323438367|FG003|Overall Study|Patient not treated|0|||
94450866|NCT00026494|323438364|FG000|Overall Study|Clinical progression|0|||
94450867|NCT00026494|323438365|FG001|Overall Study|Clinical progression|0|||
94450868|NCT00026494|323438366|FG002|Overall Study|Clinical progression|3|||
94450869|NCT00026494|323438367|FG003|Overall Study|Clinical progression|0|||
94450870|NCT04478695|323438370|FG000|Overall Study|Death|1|||
94450871|NCT04478695|323438371|FG001|Overall Study|Death|0|||
94450872|NCT00644917|323438372|FG000|Overall Study|Withdrawal by Subject|2|||
94450873|NCT02347774|323438373|FG000|Study Participation|Lost to Follow-up|3|||
94450874|NCT02347774|323438374|FG001|Study Participation|Lost to Follow-up|6|||
94450875|NCT02347774|323438375|FG002|Study Participation|Lost to Follow-up|2|||
94450876|NCT02347774|323438373|FG000|Study Participation|Withdrawal by Subject|8|||
94450877|NCT02347774|323438374|FG001|Study Participation|Withdrawal by Subject|9|||
94450878|NCT02347774|323438375|FG002|Study Participation|Withdrawal by Subject|15|||
94450879|NCT02347774|323438373|FG000|Study Participation|Adverse Event|1|||
94450880|NCT02347774|323438374|FG001|Study Participation|Adverse Event|4|||
94450881|NCT02347774|323438375|FG002|Study Participation|Adverse Event|6|||
94450882|NCT02347774|323438373|FG000|Study Participation|withdrew consent|1|||
94450883|NCT02347774|323438374|FG001|Study Participation|withdrew consent|1|||
94450884|NCT02347774|323438375|FG002|Study Participation|withdrew consent|1|||
94450885|NCT02347774|323438373|FG000|Study Participation|Met Prolonged QT criteria|1|||
94450886|NCT02347774|323438374|FG001|Study Participation|Met Prolonged QT criteria|0|||
94450887|NCT02347774|323438375|FG002|Study Participation|Met Prolonged QT criteria|0|||
94450888|NCT02347774|323438373|FG000|Study Participation|non-compliance with study drug|0|||
94450889|NCT02347774|323438374|FG001|Study Participation|non-compliance with study drug|1|||
94450890|NCT02347774|323438375|FG002|Study Participation|non-compliance with study drug|0|||
94450891|NCT02347774|323438373|FG000|Study Participation|incarceration|1|||
94450892|NCT02347774|323438374|FG001|Study Participation|incarceration|0|||
94450893|NCT02347774|323438375|FG002|Study Participation|incarceration|0|||
94450894|NCT02347774|323438373|FG000|Study Participation|randomized in error|0|||
94450895|NCT02347774|323438374|FG001|Study Participation|randomized in error|0|||
94450896|NCT02347774|323438375|FG002|Study Participation|randomized in error|1|||
94450897|NCT02347774|323438373|FG000|On Study Treatment|Adverse Event|9|||
94450898|NCT02347774|323438374|FG001|On Study Treatment|Adverse Event|15|||
94450899|NCT02347774|323438375|FG002|On Study Treatment|Adverse Event|19|||
94450900|NCT02347774|323438373|FG000|On Study Treatment|Lack of Efficacy|3|||
94450901|NCT02347774|323438374|FG001|On Study Treatment|Lack of Efficacy|0|||
94450902|NCT02347774|323438375|FG002|On Study Treatment|Lack of Efficacy|2|||
94450903|NCT02347774|323438373|FG000|On Study Treatment|non-complicance with study medication|0|||
94450904|NCT02347774|323438374|FG001|On Study Treatment|non-complicance with study medication|2|||
94450905|NCT02347774|323438375|FG002|On Study Treatment|non-complicance with study medication|0|||
94450906|NCT02347774|323438373|FG000|On Study Treatment|Protocol Violation|0|||
94450907|NCT02347774|323438374|FG001|On Study Treatment|Protocol Violation|0|||
94450908|NCT02347774|323438375|FG002|On Study Treatment|Protocol Violation|1|||
94450909|NCT02347774|323438373|FG000|On Study Treatment|withdrew consent|9|||
94450910|NCT02347774|323438374|FG001|On Study Treatment|withdrew consent|8|||
94450911|NCT02347774|323438375|FG002|On Study Treatment|withdrew consent|12|||
94450912|NCT02347774|323438373|FG000|On Study Treatment|Lost to Follow-up|2|||
94450913|NCT02347774|323438374|FG001|On Study Treatment|Lost to Follow-up|6|||
94450914|NCT02347774|323438375|FG002|On Study Treatment|Lost to Follow-up|1|||
94450915|NCT02347774|323438373|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
94450916|NCT02347774|323438374|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
94450917|NCT02347774|323438375|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
94565813|NCT04417361|323867831|FG000|Overall Study|Withdrawal by Subject|1|||
94565814|NCT04417361|323867832|FG001|Overall Study|Withdrawal by Subject|0|||
94565815|NCT04417361|323867831|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
94565816|NCT04417361|323867832|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
94565817|NCT01987102|323867834|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
94565818|NCT01987102|323867835|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
94565819|NCT01987102|323867834|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
94565820|NCT01987102|323867835|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
94565821|NCT01987102|323867834|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
94565822|NCT01987102|323867835|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
94565823|NCT01987102|323867834|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
94565824|NCT01987102|323867835|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
94565825|NCT01987102|323867834|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
94565826|NCT01987102|323867835|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
94565827|NCT01987102|323867834|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
94565828|NCT01987102|323867835|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
94565829|NCT06172348|323867839|FG000|Treatment Period 2|Adverse Event|0|||
94565830|NCT06172348|323867840|FG001|Treatment Period 2|Adverse Event|0|||
94565831|NCT06172348|323867841|FG002|Treatment Period 2|Adverse Event|1|||
94565832|NCT06172348|323867842|FG003|Treatment Period 2|Adverse Event|0|||
94565833|NCT06172348|323867843|FG004|Treatment Period 2|Adverse Event|0|||
94565834|NCT06172348|323867844|FG005|Treatment Period 2|Adverse Event|0|||
94565835|NCT00763386|323869451|FG000|Overall Study|Adverse Event|43|||
94565836|NCT00763386|323869452|FG001|Overall Study|Adverse Event|33|||
94565837|NCT00763386|323869451|FG000|Overall Study|Death|1|||
94565838|NCT00763386|323869452|FG001|Overall Study|Death|2|||
94565839|NCT00763386|323869451|FG000|Overall Study|Lost to Follow-up|3|||
94565840|NCT00763386|323869452|FG001|Overall Study|Lost to Follow-up|3|||
94565841|NCT00763386|323869451|FG000|Overall Study|Withdrawal by Subject|0|||
94565842|NCT00763386|323869452|FG001|Overall Study|Withdrawal by Subject|1|||
94565843|NCT00763386|323869451|FG000|Overall Study|CRF missing|0|||
94565844|NCT00763386|323869452|FG001|Overall Study|CRF missing|1|||
94565845|NCT00763386|323869451|FG000|Overall Study|Study Prosthesis Removed|1|||
94565846|NCT00763386|323869452|FG001|Overall Study|Study Prosthesis Removed|0|||
94565847|NCT01121146|323869458|FG000|Overall Study|Death|17|||
94565848|NCT01121146|323869459|FG001|Overall Study|Death|15|||
94565849|NCT01121146|323869458|FG000|Overall Study|Adverse Event|2|||
94565850|NCT01121146|323869459|FG001|Overall Study|Adverse Event|11|||
94565851|NCT01121146|323869458|FG000|Overall Study|Lost to Follow-up|7|||
94565852|NCT01121146|323869459|FG001|Overall Study|Lost to Follow-up|16|||
94565853|NCT01220167|323869465|FG000|Period 3|Urine positive for substance abuse|0|||
94565854|NCT01220167|323869466|FG001|Period 3|Urine positive for substance abuse|1|||
94565855|NCT01220167|323869467|FG002|Period 3|Urine positive for substance abuse|0|||
94565856|NCT01367834|323869471|FG000|Overall Study|Withdrawal by Subject|2|||
94565857|NCT01367834|323869472|FG001|Overall Study|Withdrawal by Subject|2|||
94565858|NCT01367834|323869471|FG000|Overall Study|Study was ended.|0|||
94565859|NCT01367834|323869472|FG001|Overall Study|Study was ended.|1|||
94565860|NCT02859246|323869478|FG000|Overall Study|Screen fails|3|||
94565861|NCT02859246|323869478|FG000|Overall Study|Adverse Event|1|||
94565862|NCT02859246|323869478|FG000|Overall Study|Withdrawal by Subject|1|||
94565863|NCT00181766|323869482|FG000|Overall Study|Lost to Follow-up|6|||
94565864|NCT00181766|323869482|FG000|Overall Study|Adverse Event|4|||
94565865|NCT00181766|323869482|FG000|Overall Study|non-compliance|2|||
94565866|NCT00256724|323869483|FG000|Overall Study|Physician Decision|2|||
94565867|NCT00256724|323869484|FG001|Overall Study|Physician Decision|5|||
94565868|NCT00256724|323869483|FG000|Overall Study|Protocol Violation|3|||
94565869|NCT00256724|323869484|FG001|Overall Study|Protocol Violation|3|||
94565870|NCT01217463|323869485|FG000|Overall Study|Adverse Event|8|||
94565871|NCT01217463|323869486|FG001|Overall Study|Adverse Event|5|||
94565872|NCT01217463|323869485|FG000|Overall Study|Physician Decision|0|||
94565873|NCT01217463|323869486|FG001|Overall Study|Physician Decision|1|||
94565874|NCT01217463|323869485|FG000|Overall Study|Withdrawal by Subject|3|||
94565875|NCT01217463|323869486|FG001|Overall Study|Withdrawal by Subject|0|||
94565876|NCT01217463|323869485|FG000|Overall Study|Surgery on the Target Limb|0|||
94565877|NCT01217463|323869486|FG001|Overall Study|Surgery on the Target Limb|1|||
94565878|NCT01217463|323869485|FG000|Overall Study|Patient Non-compliant|1|||
94565879|NCT01217463|323869486|FG001|Overall Study|Patient Non-compliant|0|||
94565880|NCT01217463|323869485|FG000|Overall Study|Other|1|||
94565881|NCT01217463|323869486|FG001|Overall Study|Other|1|||
94565882|NCT01859923|323869498|FG000|Overall Study|Adverse Event|0|||
94565883|NCT01859923|323869499|FG001|Overall Study|Adverse Event|0|||
94565884|NCT01859923|323869500|FG002|Overall Study|Adverse Event|1|||
94565885|NCT01859923|323869501|FG003|Overall Study|Adverse Event|1|||
94565886|NCT00300755|323869502|FG000|Overall Study|Adverse Event|1|||
94565887|NCT00300755|323869503|FG001|Overall Study|Adverse Event|2|||
94565888|NCT00300755|323869504|FG002|Overall Study|Adverse Event|1|||
94565889|NCT00300755|323869502|FG000|Overall Study|Withdrawal by Subject|0|||
94565890|NCT00300755|323869503|FG001|Overall Study|Withdrawal by Subject|2|||
94565891|NCT00300755|323869504|FG002|Overall Study|Withdrawal by Subject|0|||
94565892|NCT00300755|323869502|FG000|Overall Study|Protocol Violation|0|||
94565893|NCT00300755|323869503|FG001|Overall Study|Protocol Violation|0|||
94565894|NCT00300755|323869504|FG002|Overall Study|Protocol Violation|1|||
94565895|NCT02090426|323869505|FG000|Overall Study|Lost to Follow-up|12|||
94565896|NCT02090426|323869506|FG001|Overall Study|Lost to Follow-up|6|||
94565897|NCT02079038|323869510|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
94565898|NCT02079038|323869511|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
94565899|NCT02079038|323869510|FG000|Modified Intent to Treat Population|Death|1|||
94565900|NCT02079038|323869511|FG001|Modified Intent to Treat Population|Death|0|||
94565901|NCT02079038|323869510|FG000|Completed 6 Months|Lost to Follow-up|2|||
94565902|NCT02079038|323869511|FG001|Completed 6 Months|Lost to Follow-up|1|||
94565903|NCT03573323|323869512|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
94565904|NCT03573323|323869513|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
94565905|NCT03573323|323869512|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
94565906|NCT03573323|323869513|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
94565907|NCT03573323|323869512|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
94565908|NCT03573323|323869513|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
94565909|NCT03573323|323869512|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
94565910|NCT03573323|323869513|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
94565911|NCT03573323|323869512|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
94565912|NCT03573323|323869513|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
94565913|NCT03573323|323869512|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
94565914|NCT03573323|323869513|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
94565915|NCT03573323|323869512|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
94565916|NCT03573323|323869513|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
94565917|NCT03573323|323869512|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
94565918|NCT03573323|323869513|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
94565919|NCT03573323|323869512|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
94565920|NCT03573323|323869513|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
94565921|NCT03573323|323869512|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
94565922|NCT03573323|323869513|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
94565923|NCT03573323|323869512|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
94565924|NCT03573323|323869513|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
94565925|NCT03573323|323869512|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
94565926|NCT03573323|323869513|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
94565927|NCT03573323|323869512|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
94565928|NCT03573323|323869513|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
94565929|NCT03573323|323869512|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
94565930|NCT03573323|323869513|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
94565931|NCT03573323|323869512|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
94565932|NCT03573323|323869513|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
94565933|NCT03573323|323869512|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
94565934|NCT03573323|323869513|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
94565935|NCT03573323|323869512|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
94565936|NCT03573323|323869513|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
94565937|NCT03573323|323869512|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
94565938|NCT03573323|323869513|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
94565939|NCT03573323|323869512|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
94565940|NCT03573323|323869513|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
94565941|NCT01946139|323869516|FG000|Overall Study|Withdrawal by Subject|8|||
94565942|NCT01946139|323869516|FG000|Overall Study|ineligible|8|||
94565943|NCT01946139|323869516|FG000|Overall Study|Specimens not available|4|||
94565944|NCT00296816|323869517|FG000|Overall Study|Disease Progression|37|||
94565945|NCT00296816|323869517|FG000|Overall Study|Adverse Event|18|||
94565946|NCT00296816|323869517|FG000|Overall Study|Investigator/Participant request|5|||
94347658|NCT03481634|323053973|FG001|Overall Study|Protocol Violation|0|||
94565947|NCT00296816|323869517|FG000|Overall Study|Non-compliance|1|||
94565948|NCT00296816|323869517|FG000|Overall Study|Missing for end of treatment|4|||
94347659|NCT03481634|323053974|FG002|Overall Study|Protocol Violation|1|||
94347660|NCT03481634|323053972|FG000|Overall Study|Progressive disease|0|||
94347661|NCT03481634|323053973|FG001|Overall Study|Progressive disease|1|||
94565949|NCT00296816|323869517|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
94565950|NCT00296816|323869517|FG000|Overall Study|Poor performance status|1|||
94565951|NCT00296816|323869517|FG000|Overall Study|Relocation to Florida|1|||
94347662|NCT03481634|323053974|FG002|Overall Study|Progressive disease|0|||
94565952|NCT00296816|323869517|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
94565953|NCT00296816|323869517|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
94565954|NCT00296816|323869517|FG000|Overall Study|Neuropathy/patient preference|1|||
94565955|NCT00296816|323869517|FG000|Overall Study|Proteinuria|1|||
94565956|NCT00296816|323869517|FG000|Overall Study|ineligibility due to radiation treatment|1|||
94565957|NCT03275740|323869521|FG000|Overall Study|Adverse Event|0|||
94565958|NCT03275740|323869522|FG001|Overall Study|Adverse Event|0|||
94565959|NCT03275740|323869523|FG002|Overall Study|Adverse Event|0|||
94565960|NCT03275740|323869524|FG003|Overall Study|Adverse Event|0|||
94565961|NCT03275740|323869525|FG004|Overall Study|Adverse Event|1|||
94565962|NCT03275740|323869526|FG005|Overall Study|Adverse Event|0|||
94565963|NCT03275740|323869527|FG006|Overall Study|Adverse Event|0|||
94565964|NCT03275740|323869528|FG007|Overall Study|Adverse Event|0|||
94565965|NCT03275740|323869529|FG008|Overall Study|Adverse Event|0|||
94565966|NCT03275740|323869530|FG009|Overall Study|Adverse Event|0|||
94565967|NCT03275740|323869531|FG010|Overall Study|Adverse Event|0|||
94565968|NCT03275740|323869532|FG011|Overall Study|Adverse Event|0|||
94565969|NCT03275740|323869521|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
94565970|NCT03275740|323869522|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
94565971|NCT03275740|323869523|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
94565972|NCT03275740|323869524|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
94565973|NCT03275740|323869525|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
94565974|NCT03275740|323869526|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
94565975|NCT03275740|323869527|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
94565976|NCT03275740|323869528|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
94565977|NCT03275740|323869529|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
94565978|NCT03275740|323869530|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
94565979|NCT03275740|323869531|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
94565980|NCT03275740|323869532|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
94565981|NCT03275740|323869521|FG000|Overall Study|Withdrawal by Subject|0|||
94565982|NCT03275740|323869522|FG001|Overall Study|Withdrawal by Subject|0|||
94565983|NCT03275740|323869523|FG002|Overall Study|Withdrawal by Subject|0|||
94565984|NCT03275740|323869524|FG003|Overall Study|Withdrawal by Subject|0|||
94565985|NCT03275740|323869525|FG004|Overall Study|Withdrawal by Subject|0|||
94565986|NCT03275740|323869526|FG005|Overall Study|Withdrawal by Subject|0|||
94565987|NCT03275740|323869527|FG006|Overall Study|Withdrawal by Subject|0|||
94565988|NCT03275740|323869528|FG007|Overall Study|Withdrawal by Subject|0|||
94565989|NCT03275740|323869529|FG008|Overall Study|Withdrawal by Subject|1|||
94565990|NCT03275740|323869530|FG009|Overall Study|Withdrawal by Subject|1|||
94565991|NCT03275740|323869531|FG010|Overall Study|Withdrawal by Subject|0|||
94565992|NCT03275740|323869532|FG011|Overall Study|Withdrawal by Subject|0|||
94565993|NCT01508169|323869535|FG000|Overall Study|Adverse Event|1|||
94565994|NCT01508169|323869536|FG001|Overall Study|Adverse Event|0|||
94565995|NCT01508169|323869535|FG000|Overall Study|Withdrawal by Subject|1|||
94565996|NCT01508169|323869536|FG001|Overall Study|Withdrawal by Subject|0|||
94565997|NCT01508169|323869535|FG000|Overall Study|Lost to Follow-up|1|||
94565998|NCT01508169|323869536|FG001|Overall Study|Lost to Follow-up|2|||
94565999|NCT02519439|323869543|FG000|Overall Study|Study Termination|19|||
94566000|NCT02519439|323869543|FG000|Overall Study|Withdrawal by Subject|1|||
94566001|NCT02519439|323869543|FG000|Overall Study|Adverse Event|1|||
94236724|NCT01727505|322661815|FG001|Second 24 Hours|Missing data|1|||
94236725|NCT02638103|322661816|FG000|Overall Study|Adverse Event|13|||
94236726|NCT02638103|322661817|FG001|Overall Study|Adverse Event|12|||
94236727|NCT02638103|322661818|FG002|Overall Study|Adverse Event|19|||
94236728|NCT02638103|322661819|FG003|Overall Study|Adverse Event|12|||
94236729|NCT02638103|322661816|FG000|Overall Study|Withdrawal by Subject|43|||
94236730|NCT02638103|322661817|FG001|Overall Study|Withdrawal by Subject|53|||
94236731|NCT02638103|322661818|FG002|Overall Study|Withdrawal by Subject|30|||
94236732|NCT02638103|322661819|FG003|Overall Study|Withdrawal by Subject|61|||
94236733|NCT02638103|322661816|FG000|Overall Study|Protocol Violation|1|||
94236734|NCT02638103|322661817|FG001|Overall Study|Protocol Violation|2|||
94236735|NCT02638103|322661818|FG002|Overall Study|Protocol Violation|1|||
94236736|NCT02638103|322661819|FG003|Overall Study|Protocol Violation|4|||
94236737|NCT02638103|322661816|FG000|Overall Study|Pregnancy|2|||
94236738|NCT02638103|322661817|FG001|Overall Study|Pregnancy|3|||
94236739|NCT02638103|322661818|FG002|Overall Study|Pregnancy|0|||
94236740|NCT02638103|322661819|FG003|Overall Study|Pregnancy|1|||
94236741|NCT02638103|322661816|FG000|Overall Study|Non-compliance to Study Procedures|2|||
94566002|NCT01078441|323869547|FG000|Overall Study|Withdrawal by Subject|1|||
94566003|NCT01329978|323869548|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
94236742|NCT02638103|322661817|FG001|Overall Study|Non-compliance to Study Procedures|1|||
94236743|NCT02638103|322661818|FG002|Overall Study|Non-compliance to Study Procedures|1|||
94566004|NCT01329978|323869549|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
94566005|NCT01329978|323869550|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
94658508|NCT01172938|324206184|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
94658509|NCT01172938|324206185|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
94658510|NCT01172938|324206186|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
94658511|NCT01172938|324206187|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
94658512|NCT01172938|324206188|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
94658513|NCT01172938|324206189|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
94658514|NCT01172938|324206190|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
94658515|NCT01172938|324206182|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
94450918|NCT02347774|323438373|FG000|On Study Treatment|ranomized in error|0|||
94450919|NCT02347774|323438374|FG001|On Study Treatment|ranomized in error|0|||
94450920|NCT02347774|323438375|FG002|On Study Treatment|ranomized in error|1|||
94450921|NCT00927862|323438376|FG000|Overall Study|Missing data needed for endpt analyses|27|||
94450922|NCT00927862|323438377|FG001|Overall Study|Missing data needed for endpt analyses|45|||
94450923|NCT00820248|323438378|FG000|Overall Study|No treated|4|||
94450924|NCT00820248|323438379|FG001|Overall Study|No treated|1|||
94450925|NCT00921557|323438380|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
94450926|NCT00921557|323438381|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
94450927|NCT00921557|323438382|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
94450928|NCT00921557|323438380|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
94450929|NCT00921557|323438381|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
94450930|NCT00921557|323438382|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
94450931|NCT00921557|323438380|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
94450932|NCT00921557|323438381|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
94450933|NCT00921557|323438382|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
94450934|NCT00921557|323438380|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
94450935|NCT00921557|323438381|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
94450936|NCT00921557|323438382|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
94450937|NCT00921557|323438380|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
94450938|NCT00921557|323438381|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
94450939|NCT00921557|323438382|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
94450940|NCT04157296|323438392|FG000|Overall Study|Withdrawal by Subject|0|||
94450941|NCT04157296|323438393|FG001|Overall Study|Withdrawal by Subject|1|||
94450942|NCT04157296|323438392|FG000|Overall Study|Did not obtain second fMRI.|0|||
94450943|NCT04157296|323438393|FG001|Overall Study|Did not obtain second fMRI.|1|||
94450944|NCT04157296|323438392|FG000|Overall Study|MRI failed/no second fMRI|0|||
94450945|NCT04157296|323438393|FG001|Overall Study|MRI failed/no second fMRI|1|||
94450946|NCT01750697|323438394|FG000|Overall Study|Transferred Back to Local Hospital|1|||
94450947|NCT01750697|323438394|FG000|Overall Study|Physician and Family Decision|1|||
94450948|NCT01750697|323438394|FG000|Overall Study|Transferred to Adult Services|5|||
94450949|NCT01750697|323438394|FG000|Overall Study|Physician Decision|1|||
94450950|NCT01750697|323438394|FG000|Overall Study|Withdrawal by Subject|1|||
94450951|NCT03645395|323438397|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
94450952|NCT03645395|323438398|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
94450953|NCT03645395|323438399|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
94450954|NCT03645395|323438400|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
94450955|NCT03645395|323438397|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
94450956|NCT03645395|323438398|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
94450957|NCT03645395|323438399|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
94450958|NCT03645395|323438400|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
94450959|NCT03645395|323438397|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
94450960|NCT03645395|323438398|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
94450961|NCT03645395|323438399|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
94450962|NCT03645395|323438400|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
94450963|NCT03645395|323438397|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
94450964|NCT03645395|323438398|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
94450965|NCT03645395|323438399|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
94450966|NCT03645395|323438400|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
94450967|NCT02088905|323438403|FG000|Overall Study|Withdrawal by Subject|5|||
94450968|NCT02088905|323438404|FG001|Overall Study|Withdrawal by Subject|1|||
94450969|NCT03674112|323438405|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
94450970|NCT03674112|323438406|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
94450971|NCT03674112|323438405|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
94450972|NCT03674112|323438406|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
94450973|NCT03674112|323438405|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
94450974|NCT03674112|323438406|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
94450975|NCT03674112|323438405|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
94450976|NCT03674112|323438406|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
94450977|NCT03674112|323438405|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
94658516|NCT01172938|324206183|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
94347663|NCT03481634|323053972|FG000|Overall Study|Physician Decision|3|||
94347664|NCT03481634|323053973|FG001|Overall Study|Physician Decision|0|||
94347665|NCT03481634|323053974|FG002|Overall Study|Physician Decision|1|||
94347666|NCT03481634|323053972|FG000|Overall Study|Lost to Follow-up|3|||
94347667|NCT03481634|323053973|FG001|Overall Study|Lost to Follow-up|4|||
94347668|NCT03481634|323053974|FG002|Overall Study|Lost to Follow-up|4|||
94347669|NCT03481634|323053972|FG000|Overall Study|Death|4|||
94347670|NCT03481634|323053973|FG001|Overall Study|Death|8|||
94658517|NCT01172938|324206184|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
94658518|NCT01172938|324206185|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
94658519|NCT01172938|324206186|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
94658520|NCT01172938|324206187|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
94658521|NCT01172938|324206188|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
94658522|NCT01172938|324206189|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
94236744|NCT02638103|322661819|FG003|Overall Study|Non-compliance to Study Procedures|1|||
94347671|NCT03481634|323053974|FG002|Overall Study|Death|7|||
94347672|NCT03481634|323053972|FG000|Overall Study|Adverse Event|6|||
94347673|NCT03481634|323053973|FG001|Overall Study|Adverse Event|3|||
94347674|NCT03481634|323053974|FG002|Overall Study|Adverse Event|7|||
94347675|NCT03490734|323053978|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
94347676|NCT03490734|323053979|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
94347677|NCT03490734|323053980|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
94347678|NCT03490734|323053981|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
94347679|NCT03490734|323053978|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
94347680|NCT03490734|323053979|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
94347681|NCT03490734|323053980|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
94347682|NCT03490734|323053981|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
94347683|NCT03490734|323053978|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
94347684|NCT03490734|323053979|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
94347685|NCT03490734|323053980|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
94347686|NCT03490734|323053981|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
94347687|NCT03490734|323053978|FG000|Post-intervention Scan Visit|Adverse Event|2|||
94347688|NCT03490734|323053979|FG001|Post-intervention Scan Visit|Adverse Event|0|||
94347689|NCT03490734|323053980|FG002|Post-intervention Scan Visit|Adverse Event|0|||
94347690|NCT03490734|323053981|FG003|Post-intervention Scan Visit|Adverse Event|0|||
94347691|NCT03490734|323053978|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
94347692|NCT03490734|323053979|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
94347693|NCT03490734|323053980|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
94347694|NCT03490734|323053981|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
94347695|NCT03490734|323053978|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
94347696|NCT03490734|323053979|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
94347697|NCT03490734|323053980|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
94347698|NCT03490734|323053981|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
94347699|NCT03323385|323053982|FG000|Overall Study|Withdrawal by Subject|1|||
94347700|NCT03323385|323053983|FG001|Overall Study|Withdrawal by Subject|2|||
94347701|NCT03323385|323053982|FG000|Overall Study|Noncompliance|0|||
94347702|NCT03323385|323053983|FG001|Overall Study|Noncompliance|1|||
94347703|NCT00352027|323053984|FG000|Overall Study|Progressive disease|3|||
94450978|NCT03674112|323438406|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
94450979|NCT03674112|323438405|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
94450980|NCT03674112|323438406|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
94450981|NCT03674112|323438405|FG000|Follow-Up Period (≥3 Years)|Death|2|||
94658523|NCT01172938|324206190|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
94658524|NCT01172938|324206182|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
94658525|NCT01172938|324206183|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
94347704|NCT00545584|323053985|FG000|Overall Study|Only one reason for discontinuation|62|||
94347705|NCT00545584|323053986|FG001|Overall Study|Only one reason for discontinuation|61|||
94347706|NCT00545584|323053987|FG002|Overall Study|Only one reason for discontinuation|48|||
94658526|NCT01172938|324206184|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
94658527|NCT01172938|324206185|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
94658528|NCT01172938|324206186|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
94566006|NCT01329978|323869551|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
94566007|NCT01329978|323869552|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
94566008|NCT01329978|323869548|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
94566009|NCT01329978|323869549|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
94566010|NCT01329978|323869550|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
94566011|NCT01329978|323869551|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
94566012|NCT01329978|323869552|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
94566013|NCT01329978|323869548|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
94566014|NCT01329978|323869549|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
94566015|NCT01329978|323869550|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
94566016|NCT01329978|323869551|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
94566017|NCT01329978|323869552|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
94566018|NCT01329978|323869548|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
94566019|NCT01329978|323869549|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
94566020|NCT01329978|323869550|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
94566021|NCT01329978|323869551|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
94566022|NCT01329978|323869552|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
94566023|NCT01329978|323869548|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
94566024|NCT01329978|323869549|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
94566025|NCT01329978|323869550|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
94566026|NCT01329978|323869551|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
94566027|NCT01329978|323869552|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
94566028|NCT01329978|323869548|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
94658529|NCT01172938|324206187|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
94658530|NCT01172938|324206188|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
94658531|NCT01172938|324206189|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
94658532|NCT01172938|324206190|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
94658533|NCT01172938|324206182|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
94236745|NCT02638103|322661816|FG000|Overall Study|Lost to Follow-up|26|||
94236746|NCT02638103|322661817|FG001|Overall Study|Lost to Follow-up|33|||
94236747|NCT02638103|322661818|FG002|Overall Study|Lost to Follow-up|20|||
94236748|NCT02638103|322661819|FG003|Overall Study|Lost to Follow-up|37|||
94236749|NCT02638103|322661816|FG000|Overall Study|Lack of Efficacy|14|||
94236750|NCT02638103|322661817|FG001|Overall Study|Lack of Efficacy|10|||
94566029|NCT01329978|323869549|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
94658534|NCT01172938|324206183|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
94658535|NCT01172938|324206184|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
94236751|NCT02638103|322661818|FG002|Overall Study|Lack of Efficacy|12|||
94236752|NCT02638103|322661819|FG003|Overall Study|Lack of Efficacy|22|||
94236753|NCT02638103|322661816|FG000|Overall Study|Other than specified|5|||
94236754|NCT02638103|322661817|FG001|Overall Study|Other than specified|4|||
94236755|NCT02638103|322661818|FG002|Overall Study|Other than specified|2|||
94236756|NCT02638103|322661819|FG003|Overall Study|Other than specified|4|||
94236757|NCT00358644|322661820|FG000|Overall Study|Progressive Disease|21|||
94236758|NCT00358644|322661820|FG000|Overall Study|Adverse Event|7|||
94236759|NCT00358644|322661820|FG000|Overall Study|Death|11|||
94236760|NCT00358644|322661820|FG000|Overall Study|Withdrawal by Subject|4|||
94236761|NCT00358644|322661820|FG000|Overall Study|Physician Decision|6|||
94236762|NCT00358644|322661820|FG000|Overall Study|Patient not eligible for study|1|||
94236763|NCT01358331|322661821|FG000|Overall Study|Lost to Follow-up|0|||
94236764|NCT01358331|322661822|FG001|Overall Study|Lost to Follow-up|0|||
94236765|NCT01358331|322661823|FG002|Overall Study|Lost to Follow-up|0|||
94236766|NCT01358331|322661824|FG003|Overall Study|Lost to Follow-up|1|||
94236767|NCT01358331|322661825|FG004|Overall Study|Lost to Follow-up|0|||
94236768|NCT01358331|322661826|FG005|Overall Study|Lost to Follow-up|0|||
94236769|NCT01358331|322661821|FG000|Overall Study|Withdrawal by Subject|0|||
94236770|NCT01358331|322661822|FG001|Overall Study|Withdrawal by Subject|0|||
94236771|NCT01358331|322661823|FG002|Overall Study|Withdrawal by Subject|0|||
94236772|NCT01358331|322661824|FG003|Overall Study|Withdrawal by Subject|1|||
94236773|NCT01358331|322661825|FG004|Overall Study|Withdrawal by Subject|1|||
94236774|NCT01358331|322661826|FG005|Overall Study|Withdrawal by Subject|1|||
94236775|NCT01358331|322661821|FG000|Overall Study|Adverse Events|1|||
94236776|NCT01358331|322661822|FG001|Overall Study|Adverse Events|1|||
94566030|NCT01329978|323869550|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
94566031|NCT01329978|323869551|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
94236777|NCT01358331|322661823|FG002|Overall Study|Adverse Events|1|||
94236778|NCT01358331|322661824|FG003|Overall Study|Adverse Events|0|||
94236779|NCT01358331|322661825|FG004|Overall Study|Adverse Events|1|||
94347707|NCT00545584|323053985|FG000|Overall Study|Two or more reasons for discontinuation|17|||
94347708|NCT00545584|323053986|FG001|Overall Study|Two or more reasons for discontinuation|19|||
94347709|NCT00545584|323053987|FG002|Overall Study|Two or more reasons for discontinuation|8|||
94347710|NCT01289028|323053988|FG000|Overall Study|Progressive Disease|49|||
94347711|NCT01289028|323053988|FG000|Overall Study|Adverse Event|14|||
94347712|NCT01289028|323053988|FG000|Overall Study|Withdrawal by Subject|6|||
94347713|NCT01289028|323053988|FG000|Overall Study|Death|4|||
94347714|NCT01289028|323053988|FG000|Overall Study|Lack of Efficacy|2|||
94347715|NCT01289028|323053988|FG000|Overall Study|No longer required|2|||
94347716|NCT01289028|323053988|FG000|Overall Study|Lost to Follow-up|2|||
94347717|NCT01289028|323053988|FG000|Overall Study|New Cancer Therapy|2|||
94347718|NCT01289028|323053988|FG000|Overall Study|Abnormal Lab Value|1|||
94347719|NCT01289028|323053988|FG000|Overall Study|Missing reason for discon|1|||
94347720|NCT03344562|323053991|FG000|Overall Study|Withdrawal by Subject|2|||
94347721|NCT03344562|323053992|FG001|Overall Study|Withdrawal by Subject|0|||
94347722|NCT00472043|323053993|FG000|Overall Study|Withdrawal by Subject|1|||
94347723|NCT00472043|323053994|FG001|Overall Study|Withdrawal by Subject|0|||
94347724|NCT00472043|323053993|FG000|Overall Study|Death|1|||
94347725|NCT00472043|323053994|FG001|Overall Study|Death|0|||
94347726|NCT01624974|323053996|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
94347727|NCT01624974|323053997|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
94347728|NCT01624974|323053996|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
94347729|NCT01624974|323053997|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
94450982|NCT03674112|323438406|FG001|Follow-Up Period (≥3 Years)|Death|0|||
94450983|NCT03674112|323438405|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
94450984|NCT03674112|323438406|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
94450985|NCT00862823|323438407|FG000|First Intervention|Withdrawal by Subject|1|||
94450986|NCT00862823|323438408|FG001|First Intervention|Withdrawal by Subject|1|||
94347730|NCT01624974|323053996|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
94347731|NCT01624974|323053997|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
94566032|NCT01329978|323869552|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
94566033|NCT01329978|323869548|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
94347732|NCT01624974|323053996|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
94347733|NCT01624974|323053997|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
94347734|NCT01624974|323053996|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
94347735|NCT01624974|323053997|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
94347736|NCT01624974|323053996|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
94347737|NCT01624974|323053997|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
94347738|NCT01624974|323053996|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
94347739|NCT01624974|323053997|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
94347740|NCT01624974|323053996|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
94347741|NCT01624974|323053997|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
94347742|NCT01624974|323053996|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
94347743|NCT01624974|323053997|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
94566034|NCT01329978|323869549|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
94566035|NCT01329978|323869550|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
94566036|NCT01329978|323869551|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
94566037|NCT01329978|323869552|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
94566038|NCT02868554|323869553|FG000|Overall Study|Lost to Follow-up|3|||
94566039|NCT02868554|323869554|FG001|Overall Study|Lost to Follow-up|0|||
94347744|NCT01624974|323053996|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
94347745|NCT01624974|323053997|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
94347746|NCT01624974|323053996|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
94347747|NCT01624974|323053997|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
94347748|NCT01624974|323053996|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
94347749|NCT01624974|323053997|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
94347750|NCT02802735|323053998|FG000|Overall Study|Withdrawal by Subject|0|||
94347751|NCT02802735|323053999|FG001|Overall Study|Withdrawal by Subject|1|||
94347752|NCT02802735|323054000|FG002|Overall Study|Withdrawal by Subject|0|||
94347753|NCT02802735|323054001|FG003|Overall Study|Withdrawal by Subject|0|||
94347754|NCT02802735|323054002|FG004|Overall Study|Withdrawal by Subject|0|||
94347755|NCT00715949|323054003|FG000|Overall Study|could not finish first test|4|||
94347756|NCT03922711|323054004|FG000|Overall Study|Adverse Event|3|||
94347757|NCT03922711|323054005|FG001|Overall Study|Adverse Event|2|||
94347758|NCT03922711|323054006|FG002|Overall Study|Adverse Event|2|||
94347759|NCT03922711|323054004|FG000|Overall Study|Protocol Violation|1|||
94347760|NCT03922711|323054005|FG001|Overall Study|Protocol Violation|0|||
94347761|NCT03922711|323054006|FG002|Overall Study|Protocol Violation|0|||
94347762|NCT03922711|323054004|FG000|Overall Study|Withdrawal by Subject|0|||
94347763|NCT03922711|323054005|FG001|Overall Study|Withdrawal by Subject|3|||
94347764|NCT03922711|323054006|FG002|Overall Study|Withdrawal by Subject|1|||
94347765|NCT03922711|323054004|FG000|Overall Study|Not further specified|0|||
94347766|NCT03922711|323054005|FG001|Overall Study|Not further specified|0|||
94347767|NCT03922711|323054006|FG002|Overall Study|Not further specified|1|||
94347768|NCT00420212|323054009|FG000|Overall Study|Adverse Event|22|||
94347769|NCT00420212|323054010|FG001|Overall Study|Adverse Event|40|||
94347770|NCT00420212|323054011|FG002|Overall Study|Adverse Event|36|||
94347771|NCT00420212|323054009|FG000|Overall Study|Lost to Follow-up|9|||
94347772|NCT00420212|323054010|FG001|Overall Study|Lost to Follow-up|11|||
94347773|NCT00420212|323054011|FG002|Overall Study|Lost to Follow-up|11|||
94347774|NCT00420212|323054009|FG000|Overall Study|Withdrawal by Subject|31|||
94566040|NCT02868554|323869555|FG002|Overall Study|Lost to Follow-up|1|||
94347775|NCT00420212|323054010|FG001|Overall Study|Withdrawal by Subject|22|||
94347776|NCT00420212|323054011|FG002|Overall Study|Withdrawal by Subject|19|||
94347777|NCT00420212|323054009|FG000|Overall Study|Physician Decision|4|||
94347778|NCT00420212|323054010|FG001|Overall Study|Physician Decision|4|||
94347779|NCT00420212|323054011|FG002|Overall Study|Physician Decision|3|||
94347780|NCT00420212|323054009|FG000|Overall Study|Protocol Violation|4|||
94566041|NCT04915729|323869557|FG000|Overall Study|Lost to Follow-up|20|||
94566042|NCT04915729|323869558|FG001|Overall Study|Lost to Follow-up|10|||
94566043|NCT04915729|323869557|FG000|Overall Study|Withdrawal by Subject|12|||
94566044|NCT04915729|323869558|FG001|Overall Study|Withdrawal by Subject|5|||
94566045|NCT04915729|323869557|FG000|Overall Study|Death|34|||
94347781|NCT00420212|323054010|FG001|Overall Study|Protocol Violation|4|||
94347782|NCT00420212|323054011|FG002|Overall Study|Protocol Violation|8|||
94347783|NCT00420212|323054009|FG000|Overall Study|Death|0|||
94347784|NCT00420212|323054010|FG001|Overall Study|Death|0|||
94347785|NCT00420212|323054011|FG002|Overall Study|Death|1|||
94347786|NCT00420212|323054009|FG000|Overall Study|Other-Unspecified|21|||
94347787|NCT00420212|323054010|FG001|Overall Study|Other-Unspecified|14|||
94347788|NCT00420212|323054011|FG002|Overall Study|Other-Unspecified|18|||
94347789|NCT00957034|323054012|FG000|Overall Study|Adverse Event|0|||
94347790|NCT00957034|323054013|FG001|Overall Study|Adverse Event|1|||
94347791|NCT00957034|323054014|FG002|Overall Study|Adverse Event|1|||
94347792|NCT00957034|323054012|FG000|Overall Study|Sponsor Terminated Study|6|||
94347793|NCT00957034|323054013|FG001|Overall Study|Sponsor Terminated Study|1|||
94347794|NCT00957034|323054014|FG002|Overall Study|Sponsor Terminated Study|5|||
94347795|NCT00957034|323054012|FG000|Overall Study|Withdrawal by Subject|0|||
94347796|NCT00957034|323054013|FG001|Overall Study|Withdrawal by Subject|2|||
94347797|NCT00957034|323054014|FG002|Overall Study|Withdrawal by Subject|0|||
94347798|NCT01326910|323054015|FG000|Overall Study|Withdrawal by Subject|3|||
94347799|NCT01326910|323054016|FG001|Overall Study|Withdrawal by Subject|2|||
94347800|NCT01326910|323054015|FG000|Overall Study|Protocol Violation|1|||
94347801|NCT01326910|323054016|FG001|Overall Study|Protocol Violation|1|||
94347802|NCT02608892|323054026|FG000|Overall Study|Lost to Follow-up|1|||
94347803|NCT02608892|323054027|FG001|Overall Study|Lost to Follow-up|0|||
94347804|NCT02590406|323054028|FG000|Overall Study|Adverse Event|1|||
94347805|NCT02590406|323054029|FG001|Overall Study|Adverse Event|0|||
94347806|NCT02590406|323054028|FG000|Overall Study|Saturometer malfunction|0|||
94347807|NCT02590406|323054029|FG001|Overall Study|Saturometer malfunction|1|||
94347808|NCT00281528|323054034|FG000|Overall Study|Progressive Disease|28|||
94347809|NCT00281528|323054035|FG001|Overall Study|Progressive Disease|18|||
94347810|NCT00281528|323054036|FG002|Overall Study|Progressive Disease|27|||
94347811|NCT00281528|323054034|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
94347812|NCT00281528|323054035|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
94347813|NCT00281528|323054036|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
94347814|NCT00281528|323054034|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
94347815|NCT00281528|323054035|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
94347816|NCT00281528|323054036|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
94347817|NCT00281528|323054034|FG000|Overall Study|Physician Decision|11|||
94347818|NCT00281528|323054035|FG001|Overall Study|Physician Decision|4|||
94347819|NCT00281528|323054036|FG002|Overall Study|Physician Decision|5|||
94347820|NCT00281528|323054034|FG000|Overall Study|Protocol Violation|1|||
94347821|NCT00281528|323054035|FG001|Overall Study|Protocol Violation|0|||
94347822|NCT00281528|323054036|FG002|Overall Study|Protocol Violation|1|||
94347823|NCT00281528|323054034|FG000|Overall Study|Withdrawal by Subject|5|||
94347824|NCT00281528|323054035|FG001|Overall Study|Withdrawal by Subject|5|||
94347825|NCT00281528|323054036|FG002|Overall Study|Withdrawal by Subject|7|||
94347826|NCT00281528|323054034|FG000|Overall Study|Other|6|||
94347827|NCT00281528|323054035|FG001|Overall Study|Other|3|||
94347828|NCT00281528|323054036|FG002|Overall Study|Other|5|||
94347829|NCT02394028|323054037|FG000|Induction Phase|Adverse Event|2|||
94347830|NCT02394028|323054038|FG001|Induction Phase|Adverse Event|4|||
94347831|NCT02394028|323054039|FG002|Induction Phase|Adverse Event|1|||
94347832|NCT02394028|323054040|FG003|Induction Phase|Adverse Event|2|||
94347833|NCT02394028|323054041|FG004|Induction Phase|Adverse Event|5|||
94347834|NCT02394028|323054042|FG005|Induction Phase|Adverse Event|2|||
94347835|NCT02394028|323054043|FG006|Induction Phase|Adverse Event|0|||
94566046|NCT04915729|323869558|FG001|Overall Study|Death|44|||
94566047|NCT04915729|323869557|FG000|Overall Study|not treated|3|||
94566048|NCT04915729|323869558|FG001|Overall Study|not treated|6|||
94566049|NCT04915729|323869557|FG000|Overall Study|Investigator removed subject|1|||
94347836|NCT02394028|323054044|FG007|Induction Phase|Adverse Event|0|||
94347837|NCT02394028|323054045|FG008|Induction Phase|Adverse Event|0|||
94347838|NCT02394028|323054046|FG009|Induction Phase|Adverse Event|0|||
94347839|NCT02394028|323054047|FG010|Induction Phase|Adverse Event|0|||
94347840|NCT02394028|323054037|FG000|Induction Phase|Lack of Efficacy|3|||
94347841|NCT02394028|323054038|FG001|Induction Phase|Lack of Efficacy|6|||
94347842|NCT02394028|323054039|FG002|Induction Phase|Lack of Efficacy|2|||
94347843|NCT02394028|323054040|FG003|Induction Phase|Lack of Efficacy|17|||
94347844|NCT02394028|323054041|FG004|Induction Phase|Lack of Efficacy|14|||
94347845|NCT02394028|323054042|FG005|Induction Phase|Lack of Efficacy|8|||
94347846|NCT02394028|323054043|FG006|Induction Phase|Lack of Efficacy|17|||
94347847|NCT02394028|323054044|FG007|Induction Phase|Lack of Efficacy|23|||
94347848|NCT02394028|323054045|FG008|Induction Phase|Lack of Efficacy|0|||
94347849|NCT02394028|323054046|FG009|Induction Phase|Lack of Efficacy|0|||
94347850|NCT02394028|323054047|FG010|Induction Phase|Lack of Efficacy|0|||
94347851|NCT02394028|323054037|FG000|Induction Phase|Lost to Follow-up|1|||
94347852|NCT02394028|323054038|FG001|Induction Phase|Lost to Follow-up|0|||
94566050|NCT04915729|323869558|FG001|Overall Study|Investigator removed subject|2|||
94566051|NCT04915729|323869557|FG000|Overall Study|questionnaire result not evaluated|1|||
94566052|NCT04915729|323869558|FG001|Overall Study|questionnaire result not evaluated|0|||
94566053|NCT04915729|323869557|FG000|Overall Study|refuse of hospital visit|1|||
94566054|NCT04915729|323869558|FG001|Overall Study|refuse of hospital visit|3|||
94566055|NCT04915729|323869557|FG000|Overall Study|Subject withdrew|1|||
94566056|NCT04915729|323869558|FG001|Overall Study|Subject withdrew|0|||
94566057|NCT02741635|323869560|FG000|Overall Study|Withdrawal by Subject|1|||
94566058|NCT00550953|323869562|FG000|Overall Study|Adverse Event|4|||
94566059|NCT00550953|323869563|FG001|Overall Study|Adverse Event|3|||
94566060|NCT00550953|323869562|FG000|Overall Study|Not able to visit the site|2|||
94566061|NCT00550953|323869563|FG001|Overall Study|Not able to visit the site|3|||
94566062|NCT04089761|323869564|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
94566063|NCT04089761|323869564|FG000|"Run In Phase"|Lost to Follow-up|1|||
94566064|NCT04089761|323869564|FG000|"Treatment Phase"|No evaluable data|5|||
94566065|NCT04089761|323869564|FG000|"Treatment Phase"|Lost to Follow-up|1|||
94566066|NCT00165672|323869568|FG000|Overall Study|Adverse Event|0|||
94566067|NCT00165672|323869569|FG001|Overall Study|Adverse Event|1|||
94566068|NCT02715609|323869574|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
94566069|NCT02715609|323869575|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
94566070|NCT02715609|323869576|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
94566071|NCT02715609|323869574|FG000|Overall Study|Withdrawal by Subject|0|||
94566072|NCT02715609|323869575|FG001|Overall Study|Withdrawal by Subject|0|||
94566073|NCT02715609|323869576|FG002|Overall Study|Withdrawal by Subject|1|||
94566074|NCT03370718|323869577|FG000|Overall Study|Withdrawal by Subject|1|||
94566075|NCT01670721|323869580|FG000|Overall Study|Participant's decision|15|||
94566076|NCT01670721|323869580|FG000|Overall Study|Other than specified above|38|||
94566077|NCT03116685|323869588|FG000|Overall Study|Physician Decision|0|||
94566078|NCT03116685|323869589|FG001|Overall Study|Physician Decision|1|||
94566079|NCT05579977|323869590|FG000|Treatment Phase|Other|0|||
94566080|NCT05579977|323869591|FG001|Treatment Phase|Other|0|||
94566081|NCT05579977|323869592|FG002|Treatment Phase|Other|0|||
94566082|NCT05579977|323869593|FG003|Treatment Phase|Other|2|||
94566083|NCT05579977|323869594|FG004|Treatment Phase|Other|1|||
94566084|NCT05579977|323869595|FG005|Treatment Phase|Other|2|||
94566085|NCT05579977|323869596|FG006|Treatment Phase|Other|1|||
94566086|NCT05579977|323869597|FG007|Treatment Phase|Other|2|||
94566087|NCT05579977|323869598|FG008|Treatment Phase|Other|2|||
94566088|NCT05579977|323869599|FG009|Treatment Phase|Other|1|||
94566089|NCT05579977|323869600|FG010|Treatment Phase|Other|0|||
94566090|NCT05579977|323869601|FG011|Treatment Phase|Other|0|||
94566091|NCT05579977|323869602|FG012|Treatment Phase|Other|3|||
94566092|NCT05579977|323869590|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
94566093|NCT05579977|323869591|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
94566094|NCT05579977|323869592|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
94566095|NCT05579977|323869593|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
94566096|NCT05579977|323869594|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
94566097|NCT05579977|323869595|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
94566098|NCT05579977|323869596|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
94658536|NCT01172938|324206185|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
94658537|NCT01172938|324206186|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
94236780|NCT01358331|322661826|FG005|Overall Study|Adverse Events|5|||
94236781|NCT01358331|322661821|FG000|Overall Study|Symptomatic Deterioration|0|||
94236782|NCT01358331|322661822|FG001|Overall Study|Symptomatic Deterioration|0|||
94236783|NCT01358331|322661823|FG002|Overall Study|Symptomatic Deterioration|0|||
94236784|NCT01358331|322661824|FG003|Overall Study|Symptomatic Deterioration|0|||
94236785|NCT01358331|322661825|FG004|Overall Study|Symptomatic Deterioration|1|||
94236786|NCT01358331|322661826|FG005|Overall Study|Symptomatic Deterioration|0|||
94236787|NCT01358331|322661821|FG000|Overall Study|Participants did not wish to continue|0|||
94236788|NCT01358331|322661822|FG001|Overall Study|Participants did not wish to continue|0|||
94236789|NCT01358331|322661823|FG002|Overall Study|Participants did not wish to continue|0|||
94236790|NCT01358331|322661824|FG003|Overall Study|Participants did not wish to continue|0|||
94236791|NCT01358331|322661825|FG004|Overall Study|Participants did not wish to continue|1|||
94566099|NCT05579977|323869597|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
94566100|NCT05579977|323869598|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
94566101|NCT05579977|323869599|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
94236792|NCT01358331|322661826|FG005|Overall Study|Participants did not wish to continue|0|||
94236793|NCT01358331|322661821|FG000|Overall Study|Progress of disease under investigation|1|||
94236794|NCT01358331|322661822|FG001|Overall Study|Progress of disease under investigation|2|||
94347853|NCT02394028|323054039|FG002|Induction Phase|Lost to Follow-up|0|||
94347854|NCT02394028|323054040|FG003|Induction Phase|Lost to Follow-up|1|||
94566102|NCT05579977|323869600|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
94566103|NCT05579977|323869601|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
94566104|NCT05579977|323869602|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
94566105|NCT05579977|323869590|FG000|Treatment Phase|Withdrawal by Subject|2|||
94566106|NCT05579977|323869591|FG001|Treatment Phase|Withdrawal by Subject|0|||
94566107|NCT05579977|323869592|FG002|Treatment Phase|Withdrawal by Subject|0|||
94566108|NCT05579977|323869593|FG003|Treatment Phase|Withdrawal by Subject|1|||
94566109|NCT05579977|323869594|FG004|Treatment Phase|Withdrawal by Subject|2|||
94566110|NCT05579977|323869595|FG005|Treatment Phase|Withdrawal by Subject|0|||
94566111|NCT05579977|323869596|FG006|Treatment Phase|Withdrawal by Subject|1|||
94566112|NCT05579977|323869597|FG007|Treatment Phase|Withdrawal by Subject|8|||
94566113|NCT05579977|323869598|FG008|Treatment Phase|Withdrawal by Subject|3|||
94566114|NCT05579977|323869599|FG009|Treatment Phase|Withdrawal by Subject|3|||
94566115|NCT05579977|323869600|FG010|Treatment Phase|Withdrawal by Subject|5|||
94566116|NCT05579977|323869601|FG011|Treatment Phase|Withdrawal by Subject|1|||
94566117|NCT05579977|323869602|FG012|Treatment Phase|Withdrawal by Subject|3|||
94566118|NCT05579977|323869590|FG000|Treatment Phase|Study terminated by sponsor|70|||
94566119|NCT05579977|323869591|FG001|Treatment Phase|Study terminated by sponsor|70|||
94566120|NCT05579977|323869592|FG002|Treatment Phase|Study terminated by sponsor|61|||
94566121|NCT05579977|323869593|FG003|Treatment Phase|Study terminated by sponsor|59|||
94566122|NCT05579977|323869594|FG004|Treatment Phase|Study terminated by sponsor|63|||
94566123|NCT05579977|323869595|FG005|Treatment Phase|Study terminated by sponsor|53|||
94566124|NCT05579977|323869596|FG006|Treatment Phase|Study terminated by sponsor|66|||
94566125|NCT05579977|323869597|FG007|Treatment Phase|Study terminated by sponsor|48|||
94566126|NCT05579977|323869598|FG008|Treatment Phase|Study terminated by sponsor|47|||
94566127|NCT05579977|323869599|FG009|Treatment Phase|Study terminated by sponsor|37|||
94566128|NCT05579977|323869600|FG010|Treatment Phase|Study terminated by sponsor|44|||
94566129|NCT05579977|323869601|FG011|Treatment Phase|Study terminated by sponsor|36|||
94566130|NCT05579977|323869602|FG012|Treatment Phase|Study terminated by sponsor|32|||
94566131|NCT05579977|323869590|FG000|Treatment Phase|Pregnancy|0|||
94566132|NCT05579977|323869591|FG001|Treatment Phase|Pregnancy|0|||
94566133|NCT05579977|323869592|FG002|Treatment Phase|Pregnancy|0|||
94566134|NCT05579977|323869593|FG003|Treatment Phase|Pregnancy|0|||
94566135|NCT05579977|323869594|FG004|Treatment Phase|Pregnancy|0|||
94566136|NCT05579977|323869595|FG005|Treatment Phase|Pregnancy|0|||
94566137|NCT05579977|323869596|FG006|Treatment Phase|Pregnancy|0|||
94566138|NCT05579977|323869597|FG007|Treatment Phase|Pregnancy|0|||
94566139|NCT05579977|323869598|FG008|Treatment Phase|Pregnancy|0|||
94566140|NCT05579977|323869599|FG009|Treatment Phase|Pregnancy|1|||
94566141|NCT05579977|323869600|FG010|Treatment Phase|Pregnancy|0|||
94566142|NCT05579977|323869601|FG011|Treatment Phase|Pregnancy|0|||
94566143|NCT05579977|323869602|FG012|Treatment Phase|Pregnancy|0|||
94566144|NCT05579977|323869590|FG000|Treatment Phase|Physician Decision|0|||
94566145|NCT05579977|323869591|FG001|Treatment Phase|Physician Decision|0|||
94566146|NCT05579977|323869592|FG002|Treatment Phase|Physician Decision|0|||
94566147|NCT05579977|323869593|FG003|Treatment Phase|Physician Decision|0|||
94566148|NCT05579977|323869594|FG004|Treatment Phase|Physician Decision|0|||
94566149|NCT05579977|323869595|FG005|Treatment Phase|Physician Decision|0|||
94566150|NCT05579977|323869596|FG006|Treatment Phase|Physician Decision|0|||
94566151|NCT05579977|323869597|FG007|Treatment Phase|Physician Decision|0|||
94566152|NCT05579977|323869598|FG008|Treatment Phase|Physician Decision|0|||
94566153|NCT05579977|323869599|FG009|Treatment Phase|Physician Decision|0|||
94566154|NCT05579977|323869600|FG010|Treatment Phase|Physician Decision|0|||
94566155|NCT05579977|323869601|FG011|Treatment Phase|Physician Decision|1|||
94566156|NCT05579977|323869602|FG012|Treatment Phase|Physician Decision|0|||
94566157|NCT05579977|323869590|FG000|Treatment Phase|Lost to Follow-up|0|||
94566158|NCT05579977|323869591|FG001|Treatment Phase|Lost to Follow-up|0|||
94566159|NCT05579977|323869592|FG002|Treatment Phase|Lost to Follow-up|0|||
94566160|NCT05579977|323869593|FG003|Treatment Phase|Lost to Follow-up|1|||
94566161|NCT05579977|323869594|FG004|Treatment Phase|Lost to Follow-up|1|||
94566162|NCT05579977|323869595|FG005|Treatment Phase|Lost to Follow-up|1|||
94566163|NCT05579977|323869596|FG006|Treatment Phase|Lost to Follow-up|0|||
94566164|NCT05579977|323869597|FG007|Treatment Phase|Lost to Follow-up|1|||
94566165|NCT05579977|323869598|FG008|Treatment Phase|Lost to Follow-up|2|||
94566166|NCT05579977|323869599|FG009|Treatment Phase|Lost to Follow-up|2|||
94566167|NCT05579977|323869600|FG010|Treatment Phase|Lost to Follow-up|1|||
94566168|NCT05579977|323869601|FG011|Treatment Phase|Lost to Follow-up|4|||
94566169|NCT05579977|323869602|FG012|Treatment Phase|Lost to Follow-up|3|||
94566170|NCT05579977|323869590|FG000|Treatment Phase|Death|1|||
94566171|NCT05579977|323869591|FG001|Treatment Phase|Death|0|||
94566172|NCT05579977|323869592|FG002|Treatment Phase|Death|0|||
94566173|NCT05579977|323869593|FG003|Treatment Phase|Death|0|||
94566174|NCT05579977|323869594|FG004|Treatment Phase|Death|0|||
94566175|NCT05579977|323869595|FG005|Treatment Phase|Death|0|||
94566176|NCT05579977|323869596|FG006|Treatment Phase|Death|0|||
94566177|NCT05579977|323869597|FG007|Treatment Phase|Death|0|||
94566178|NCT05579977|323869598|FG008|Treatment Phase|Death|0|||
94566179|NCT05579977|323869599|FG009|Treatment Phase|Death|0|||
94566180|NCT05579977|323869600|FG010|Treatment Phase|Death|0|||
94566181|NCT05579977|323869601|FG011|Treatment Phase|Death|0|||
94566182|NCT05579977|323869602|FG012|Treatment Phase|Death|0|||
94566183|NCT05579977|323869590|FG000|Treatment Phase|Adverse Event|0|||
94566184|NCT05579977|323869591|FG001|Treatment Phase|Adverse Event|3|||
94566185|NCT05579977|323869592|FG002|Treatment Phase|Adverse Event|11|||
94566186|NCT05579977|323869593|FG003|Treatment Phase|Adverse Event|10|||
94566187|NCT05579977|323869594|FG004|Treatment Phase|Adverse Event|5|||
94566188|NCT05579977|323869595|FG005|Treatment Phase|Adverse Event|17|||
94566189|NCT05579977|323869596|FG006|Treatment Phase|Adverse Event|5|||
94566190|NCT05579977|323869597|FG007|Treatment Phase|Adverse Event|5|||
94566191|NCT05579977|323869598|FG008|Treatment Phase|Adverse Event|12|||
94566192|NCT05579977|323869599|FG009|Treatment Phase|Adverse Event|20|||
94566193|NCT05579977|323869600|FG010|Treatment Phase|Adverse Event|15|||
94566194|NCT05579977|323869601|FG011|Treatment Phase|Adverse Event|24|||
94566195|NCT05579977|323869602|FG012|Treatment Phase|Adverse Event|23|||
94566196|NCT05579977|323869590|FG000|Treatment Phase|Randomized not treated|0|||
94566197|NCT05579977|323869591|FG001|Treatment Phase|Randomized not treated|0|||
94566198|NCT05579977|323869592|FG002|Treatment Phase|Randomized not treated|0|||
94566199|NCT05579977|323869593|FG003|Treatment Phase|Randomized not treated|0|||
94566200|NCT05579977|323869594|FG004|Treatment Phase|Randomized not treated|1|||
94566201|NCT05579977|323869595|FG005|Treatment Phase|Randomized not treated|0|||
94566202|NCT05579977|323869596|FG006|Treatment Phase|Randomized not treated|0|||
94566203|NCT05579977|323869597|FG007|Treatment Phase|Randomized not treated|0|||
94566204|NCT05579977|323869598|FG008|Treatment Phase|Randomized not treated|0|||
94236795|NCT01358331|322661823|FG002|Overall Study|Progress of disease under investigation|3|||
94236796|NCT01358331|322661824|FG003|Overall Study|Progress of disease under investigation|1|||
94236797|NCT01358331|322661825|FG004|Overall Study|Progress of disease under investigation|3|||
94236798|NCT01358331|322661826|FG005|Overall Study|Progress of disease under investigation|0|||
94236799|NCT01637077|322661830|FG000|Overall Study|Cancel|1|||
94236800|NCT01637077|322661831|FG001|Overall Study|Cancel|1|||
94236801|NCT01637077|322661830|FG000|Overall Study|Withdrawal by Subject|1|||
94236802|NCT01637077|322661831|FG001|Overall Study|Withdrawal by Subject|0|||
94236803|NCT01637077|322661830|FG000|Overall Study|No cycle 1 questionnaire data|2|||
94236804|NCT01637077|322661831|FG001|Overall Study|No cycle 1 questionnaire data|0|||
94236805|NCT00246090|322661832|FG000|Overall Study|Adverse Event|25|||
94236806|NCT00246090|322661832|FG000|Overall Study|Withdrawal by Subject|7|||
94236807|NCT00246090|322661832|FG000|Overall Study|Progressive Disease|212|||
94236808|NCT00246090|322661832|FG000|Overall Study|Clinical Progression|30|||
94236809|NCT00246090|322661832|FG000|Overall Study|Physician Decision|11|||
94236810|NCT00246090|322661832|FG000|Overall Study|Not Otherwise Specified|10|||
94236811|NCT02595372|322661836|FG000|Overall Study|Adverse Event|6|||
94236812|NCT02595372|322661836|FG000|Overall Study|Physician Decision|2|||
94236813|NCT02595372|322661836|FG000|Overall Study|Disease Progression|1|||
94236814|NCT00794924|322661840|FG000|Overall Study|Lost to Follow-up|6|||
94236815|NCT00794924|322661841|FG001|Overall Study|Lost to Follow-up|8|||
94236816|NCT00794924|322661840|FG000|Overall Study|Withdrawal by Subject|48|||
94236817|NCT00794924|322661841|FG001|Overall Study|Withdrawal by Subject|60|||
94236818|NCT00794924|322661840|FG000|Overall Study|Adverse Event|6|||
94236819|NCT00794924|322661841|FG001|Overall Study|Adverse Event|2|||
94236820|NCT01594970|322661842|FG000|Overall Study|Non-Adverse Event Related|4|||
94236821|NCT01594970|322661843|FG001|Overall Study|Non-Adverse Event Related|5|||
94236822|NCT01594970|322661844|FG002|Overall Study|Non-Adverse Event Related|6|||
94236823|NCT01594970|322661842|FG000|Overall Study|Adverse Event|17|||
94236824|NCT01594970|322661843|FG001|Overall Study|Adverse Event|23|||
94236825|NCT01594970|322661844|FG002|Overall Study|Adverse Event|23|||
94236826|NCT01594970|322661842|FG000|Overall Study|Lost to Follow-up|54|||
94236827|NCT01594970|322661843|FG001|Overall Study|Lost to Follow-up|54|||
94236828|NCT01594970|322661844|FG002|Overall Study|Lost to Follow-up|37|||
94236829|NCT03332784|322661845|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
94236830|NCT03332784|322661846|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
94236831|NCT03332784|322661847|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
94236832|NCT03332784|322661848|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
94236833|NCT03332784|322661849|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
94236834|NCT03332784|322661850|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
94236835|NCT03332784|322661851|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
94236836|NCT03332784|322661852|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
94236837|NCT03332784|322661853|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
94236838|NCT03332784|322661854|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
94566205|NCT05579977|323869599|FG009|Treatment Phase|Randomized not treated|0|||
94566206|NCT05579977|323869600|FG010|Treatment Phase|Randomized not treated|0|||
94566207|NCT05579977|323869601|FG011|Treatment Phase|Randomized not treated|0|||
94566208|NCT05579977|323869602|FG012|Treatment Phase|Randomized not treated|0|||
94566209|NCT05579977|323869590|FG000|Follow up|Death|1|||
94566210|NCT05579977|323869591|FG001|Follow up|Death|0|||
94566211|NCT05579977|323869592|FG002|Follow up|Death|0|||
94566212|NCT05579977|323869593|FG003|Follow up|Death|0|||
94566213|NCT05579977|323869594|FG004|Follow up|Death|0|||
94566214|NCT05579977|323869595|FG005|Follow up|Death|0|||
94566215|NCT05579977|323869596|FG006|Follow up|Death|0|||
94566216|NCT05579977|323869597|FG007|Follow up|Death|0|||
94236839|NCT03332784|322661855|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
94236840|NCT03332784|322661856|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
94236841|NCT03332784|322661857|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
94236842|NCT03332784|322661858|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
94236843|NCT03332784|322661859|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
94236844|NCT03332784|322661860|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
94566217|NCT05579977|323869598|FG008|Follow up|Death|0|||
94566218|NCT05579977|323869599|FG009|Follow up|Death|0|||
94566219|NCT05579977|323869600|FG010|Follow up|Death|0|||
94236845|NCT03332784|322661861|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
94236846|NCT03332784|322661862|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
94236847|NCT03332784|322661863|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
94566220|NCT05579977|323869601|FG011|Follow up|Death|0|||
94566221|NCT05579977|323869602|FG012|Follow up|Death|0|||
94236848|NCT03332784|322661864|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
94236849|NCT02498236|322661870|FG000|Overall Study|Did not show for testing|1|||
94566222|NCT05579977|323869590|FG000|Follow up|Lost to Follow-up|0|||
94566223|NCT05579977|323869591|FG001|Follow up|Lost to Follow-up|0|||
94566224|NCT05579977|323869592|FG002|Follow up|Lost to Follow-up|0|||
94566225|NCT05579977|323869593|FG003|Follow up|Lost to Follow-up|1|||
94566226|NCT05579977|323869594|FG004|Follow up|Lost to Follow-up|1|||
94566227|NCT05579977|323869595|FG005|Follow up|Lost to Follow-up|2|||
94566228|NCT05579977|323869596|FG006|Follow up|Lost to Follow-up|1|||
94566229|NCT05579977|323869597|FG007|Follow up|Lost to Follow-up|1|||
94566230|NCT05579977|323869598|FG008|Follow up|Lost to Follow-up|3|||
94566231|NCT05579977|323869599|FG009|Follow up|Lost to Follow-up|2|||
94566232|NCT05579977|323869600|FG010|Follow up|Lost to Follow-up|2|||
94566233|NCT05579977|323869601|FG011|Follow up|Lost to Follow-up|4|||
94566234|NCT05579977|323869602|FG012|Follow up|Lost to Follow-up|4|||
94566235|NCT05579977|323869590|FG000|Follow up|Withdrawal by Subject|2|||
94566236|NCT05579977|323869591|FG001|Follow up|Withdrawal by Subject|0|||
94566237|NCT05579977|323869592|FG002|Follow up|Withdrawal by Subject|0|||
94566238|NCT05579977|323869593|FG003|Follow up|Withdrawal by Subject|0|||
94566239|NCT05579977|323869594|FG004|Follow up|Withdrawal by Subject|1|||
94566240|NCT05579977|323869595|FG005|Follow up|Withdrawal by Subject|0|||
94566241|NCT05579977|323869596|FG006|Follow up|Withdrawal by Subject|1|||
94566242|NCT05579977|323869597|FG007|Follow up|Withdrawal by Subject|4|||
94566243|NCT05579977|323869598|FG008|Follow up|Withdrawal by Subject|2|||
94566244|NCT05579977|323869599|FG009|Follow up|Withdrawal by Subject|3|||
94566245|NCT05579977|323869600|FG010|Follow up|Withdrawal by Subject|3|||
94566246|NCT05579977|323869601|FG011|Follow up|Withdrawal by Subject|1|||
94566247|NCT05579977|323869602|FG012|Follow up|Withdrawal by Subject|3|||
94566248|NCT01611194|323869603|FG000|Overall Study|Lost to Follow-up|0|||
94236850|NCT02498236|322661871|FG001|Overall Study|Did not show for testing|0|||
94236851|NCT02498236|322661872|FG002|Overall Study|Did not show for testing|0|||
94236852|NCT02498236|322661873|FG003|Overall Study|Did not show for testing|0|||
94236853|NCT02498236|322661874|FG004|Overall Study|Did not show for testing|0|||
94236854|NCT02498236|322661875|FG005|Overall Study|Did not show for testing|0|||
94236855|NCT02498236|322661876|FG006|Overall Study|Did not show for testing|0|||
94236856|NCT02498236|322661877|FG007|Overall Study|Did not show for testing|1|||
94236857|NCT02498236|322661870|FG000|Overall Study|Equipment failure|0|||
94236858|NCT02498236|322661871|FG001|Overall Study|Equipment failure|0|||
94236859|NCT02498236|322661872|FG002|Overall Study|Equipment failure|0|||
94236860|NCT02498236|322661873|FG003|Overall Study|Equipment failure|0|||
94236861|NCT02498236|322661874|FG004|Overall Study|Equipment failure|0|||
94236862|NCT02498236|322661875|FG005|Overall Study|Equipment failure|0|||
94236863|NCT02498236|322661876|FG006|Overall Study|Equipment failure|1|||
94236864|NCT02498236|322661877|FG007|Overall Study|Equipment failure|0|||
94236865|NCT02498236|322661870|FG000|Overall Study|Withdrawal by Subject|0|||
94236866|NCT02498236|322661871|FG001|Overall Study|Withdrawal by Subject|0|||
94236867|NCT02498236|322661872|FG002|Overall Study|Withdrawal by Subject|0|||
94236868|NCT02498236|322661873|FG003|Overall Study|Withdrawal by Subject|0|||
94236869|NCT02498236|322661874|FG004|Overall Study|Withdrawal by Subject|1|||
94236870|NCT02498236|322661875|FG005|Overall Study|Withdrawal by Subject|0|||
94236871|NCT02498236|322661876|FG006|Overall Study|Withdrawal by Subject|0|||
94236872|NCT02498236|322661877|FG007|Overall Study|Withdrawal by Subject|0|||
94236873|NCT01461005|322661881|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
94236874|NCT00585078|322661882|FG000|Overall Study|Withdrawal by Subject|4|||
94566249|NCT01611194|323869604|FG001|Overall Study|Lost to Follow-up|1|||
94566250|NCT01611194|323869603|FG000|Overall Study|Withdrawal by Subject|0|||
94566251|NCT01611194|323869604|FG001|Overall Study|Withdrawal by Subject|1|||
94566252|NCT01611194|323869603|FG000|Overall Study|drug use|0|||
94566253|NCT01611194|323869604|FG001|Overall Study|drug use|1|||
94566254|NCT00452790|323869605|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
94566255|NCT00452790|323869606|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
94566256|NCT00452790|323869605|FG000|Infant Series|Parent/legal guardian request|8|||
94566257|NCT00452790|323869606|FG001|Infant Series|Parent/legal guardian request|6|||
94566258|NCT00452790|323869605|FG000|Infant Series|Failed to return|4|||
94566259|NCT00452790|323869606|FG001|Infant Series|Failed to return|1|||
94566260|NCT00452790|323869605|FG000|Infant Series|Protocol Violation|1|||
94566261|NCT00452790|323869606|FG001|Infant Series|Protocol Violation|3|||
94566262|NCT00452790|323869605|FG000|Infant Series|Lost to Follow-up|2|||
94566263|NCT00452790|323869606|FG001|Infant Series|Lost to Follow-up|2|||
94566264|NCT00452790|323869605|FG000|Infant Series|Adverse Event|1|||
94566265|NCT00452790|323869606|FG001|Infant Series|Adverse Event|2|||
94566266|NCT00452790|323869605|FG000|Infant Series|Other reasons|1|||
94566267|NCT00452790|323869606|FG001|Infant Series|Other reasons|2|||
94566268|NCT00452790|323869605|FG000|Infant Series|Investigator request|0|||
94566269|NCT00452790|323869606|FG001|Infant Series|Investigator request|1|||
94566270|NCT00452790|323869605|FG000|Infant Series|Death|0|||
94566271|NCT00452790|323869606|FG001|Infant Series|Death|1|||
94566272|NCT00452790|323869605|FG000|After Infant Series|Investigator request|10|||
94566273|NCT00452790|323869606|FG001|After Infant Series|Investigator request|10|||
94566274|NCT00452790|323869605|FG000|After Infant Series|Adverse Event|4|||
94566275|NCT00452790|323869606|FG001|After Infant Series|Adverse Event|1|||
94566276|NCT00452790|323869605|FG000|After Infant Series|Parent/legal guardian request|1|||
94566277|NCT00452790|323869606|FG001|After Infant Series|Parent/legal guardian request|3|||
94566278|NCT00452790|323869605|FG000|After Infant Series|Lost to Follow-up|4|||
94566279|NCT00452790|323869606|FG001|After Infant Series|Lost to Follow-up|0|||
94566280|NCT00452790|323869605|FG000|After Infant Series|Failed to return|1|||
94566281|NCT00452790|323869606|FG001|After Infant Series|Failed to return|0|||
94566282|NCT00452790|323869605|FG000|After Infant Series|Other reasons|1|||
94566283|NCT00452790|323869606|FG001|After Infant Series|Other reasons|0|||
94566284|NCT00452790|323869605|FG000|Toddler Dose|Failed to return|0|||
94566285|NCT00452790|323869606|FG001|Toddler Dose|Failed to return|1|||
94566286|NCT00452790|323869605|FG000|Toddler Dose|Parent/legal guardian request|0|||
94566287|NCT00452790|323869606|FG001|Toddler Dose|Parent/legal guardian request|1|||
94566288|NCT01505374|323869607|FG000|Overall Study|Lost to Follow-up|1|||
94566289|NCT01505374|323869608|FG001|Overall Study|Lost to Follow-up|0|||
94566290|NCT00350844|323869609|FG000|Overall Study|Lost to Follow-up|1|||
94566291|NCT03449758|323871013|FG000|Overall Study|Major protocol deviation|1|||
94566292|NCT03449758|323871013|FG000|Overall Study|Treatment inefficacy|5|||
94566293|NCT03449758|323871013|FG000|Overall Study|Adverse Event|9|||
94566294|NCT03449758|323871013|FG000|Overall Study|Consent withdrawal|1|||
94566295|NCT03449758|323871013|FG000|Overall Study|Other unspecified reason|3|||
94566296|NCT00961181|323871014|FG000|Overall Study|Death|2|||
94566297|NCT00961181|323871014|FG000|Overall Study|Withdrawal by Subject|2|||
94566298|NCT00961181|323871014|FG000|Overall Study|Lost to Follow-up|1|||
94566299|NCT02544321|323871015|FG000|Overall Study|Withdrawal by Subject|1|||
94566300|NCT02544321|323871016|FG001|Overall Study|Withdrawal by Subject|2|||
94566301|NCT02544321|323871015|FG000|Overall Study|Adverse Event|1|||
94566302|NCT02544321|323871016|FG001|Overall Study|Adverse Event|1|||
94566303|NCT02544321|323871015|FG000|Overall Study|Protocol Violation|0|||
94566304|NCT02544321|323871016|FG001|Overall Study|Protocol Violation|1|||
94566305|NCT01517750|323871017|FG000|Overall Study|Lost to Follow-up|1|||
94566306|NCT01517750|323871018|FG001|Overall Study|Lost to Follow-up|2|||
94566307|NCT01517750|323871019|FG002|Overall Study|Lost to Follow-up|4|||
94566308|NCT01517750|323871020|FG003|Overall Study|Lost to Follow-up|1|||
94566309|NCT01421017|323871029|FG000|Overall Study|Withdrawal by Subject|2|||
94566310|NCT01421017|323871030|FG001|Overall Study|Withdrawal by Subject|0|||
94566311|NCT01421017|323871031|FG002|Overall Study|Withdrawal by Subject|0|||
94566312|NCT01421017|323871029|FG000|Overall Study|POD|0|||
94566313|NCT01421017|323871030|FG001|Overall Study|POD|6|||
94566314|NCT01421017|323871031|FG002|Overall Study|POD|3|||
94566315|NCT03310723|323871032|FG000|Overall Study|Withdrawal by Subject|0|||
94566316|NCT03310723|323871033|FG001|Overall Study|Withdrawal by Subject|1|||
94566317|NCT03310723|323871032|FG000|Overall Study|Protocol Violation|0|||
94347855|NCT02394028|323054041|FG004|Induction Phase|Lost to Follow-up|0|||
94566318|NCT03310723|323871033|FG001|Overall Study|Protocol Violation|2|||
94566319|NCT01410890|323871035|FG000|Overall Study|Withdrawal by Subject|0|||
94566320|NCT01410890|323871036|FG001|Overall Study|Withdrawal by Subject|1|||
94566321|NCT01276639|323871039|FG000|Week 0 to 16|Death|1|||
94566322|NCT01276639|323871040|FG001|Week 0 to 16|Death|0|||
94566323|NCT01276639|323871041|FG002|Week 0 to 16|Death|0|||
94566324|NCT01276639|323871042|FG003|Week 0 to 16|Death|0|||
94566325|NCT01276639|323871043|FG004|Week 0 to 16|Death|0|||
94566326|NCT01276639|323871039|FG000|Week 0 to 16|Adverse Event|11|||
94566327|NCT01276639|323871040|FG001|Week 0 to 16|Adverse Event|8|||
94566328|NCT01276639|323871041|FG002|Week 0 to 16|Adverse Event|11|||
94566329|NCT01276639|323871042|FG003|Week 0 to 16|Adverse Event|0|||
94566330|NCT01276639|323871043|FG004|Week 0 to 16|Adverse Event|0|||
94566331|NCT01276639|323871039|FG000|Week 0 to 16|Lack of Efficacy|20|||
94566332|NCT01276639|323871040|FG001|Week 0 to 16|Lack of Efficacy|15|||
94566333|NCT01276639|323871041|FG002|Week 0 to 16|Lack of Efficacy|25|||
94566334|NCT01276639|323871042|FG003|Week 0 to 16|Lack of Efficacy|0|||
94566335|NCT01276639|323871043|FG004|Week 0 to 16|Lack of Efficacy|0|||
94566336|NCT01276639|323871039|FG000|Week 0 to 16|Lost to Follow-up|3|||
94566337|NCT01276639|323871040|FG001|Week 0 to 16|Lost to Follow-up|5|||
94566338|NCT01276639|323871041|FG002|Week 0 to 16|Lost to Follow-up|3|||
94566339|NCT01276639|323871042|FG003|Week 0 to 16|Lost to Follow-up|0|||
94566340|NCT01276639|323871043|FG004|Week 0 to 16|Lost to Follow-up|0|||
94566341|NCT01276639|323871039|FG000|Week 0 to 16|Withdrawal by Subject|8|||
94566342|NCT01276639|323871040|FG001|Week 0 to 16|Withdrawal by Subject|5|||
94566343|NCT01276639|323871041|FG002|Week 0 to 16|Withdrawal by Subject|4|||
94566344|NCT01276639|323871042|FG003|Week 0 to 16|Withdrawal by Subject|0|||
94566345|NCT01276639|323871043|FG004|Week 0 to 16|Withdrawal by Subject|0|||
94566346|NCT01276639|323871039|FG000|Week 0 to 16|Other|7|||
94566347|NCT01276639|323871040|FG001|Week 0 to 16|Other|7|||
94566348|NCT01276639|323871041|FG002|Week 0 to 16|Other|2|||
94566349|NCT01276639|323871042|FG003|Week 0 to 16|Other|0|||
94566350|NCT01276639|323871043|FG004|Week 0 to 16|Other|0|||
94566351|NCT01276639|323871039|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
94566352|NCT01276639|323871040|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
94566353|NCT01276639|323871041|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
94566354|NCT01276639|323871042|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
94566355|NCT01276639|323871043|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
94566356|NCT01276639|323871039|FG000|Week 16 to 52|Death|1|||
94566357|NCT01276639|323871040|FG001|Week 16 to 52|Death|0|||
94566358|NCT01276639|323871041|FG002|Week 16 to 52|Death|0|||
94566359|NCT01276639|323871042|FG003|Week 16 to 52|Death|0|||
94566360|NCT01276639|323871043|FG004|Week 16 to 52|Death|0|||
94566361|NCT01276639|323871039|FG000|Week 16 to 52|Adverse Event|10|||
94566362|NCT01276639|323871040|FG001|Week 16 to 52|Adverse Event|13|||
94566363|NCT01276639|323871041|FG002|Week 16 to 52|Adverse Event|0|||
94566364|NCT01276639|323871042|FG003|Week 16 to 52|Adverse Event|1|||
94566365|NCT01276639|323871043|FG004|Week 16 to 52|Adverse Event|3|||
94566366|NCT01276639|323871039|FG000|Week 16 to 52|Lack of Efficacy|99|||
94566367|NCT01276639|323871040|FG001|Week 16 to 52|Lack of Efficacy|71|||
94566368|NCT01276639|323871041|FG002|Week 16 to 52|Lack of Efficacy|0|||
94566369|NCT01276639|323871042|FG003|Week 16 to 52|Lack of Efficacy|14|||
94566370|NCT01276639|323871043|FG004|Week 16 to 52|Lack of Efficacy|13|||
94566371|NCT01276639|323871039|FG000|Week 16 to 52|Lost to Follow-up|3|||
94566372|NCT01276639|323871040|FG001|Week 16 to 52|Lost to Follow-up|1|||
94566373|NCT01276639|323871041|FG002|Week 16 to 52|Lost to Follow-up|0|||
94566374|NCT01276639|323871042|FG003|Week 16 to 52|Lost to Follow-up|0|||
94566375|NCT01276639|323871043|FG004|Week 16 to 52|Lost to Follow-up|1|||
94566376|NCT01276639|323871039|FG000|Week 16 to 52|Withdrawal by Subject|4|||
94566377|NCT01276639|323871040|FG001|Week 16 to 52|Withdrawal by Subject|4|||
94566378|NCT01276639|323871041|FG002|Week 16 to 52|Withdrawal by Subject|0|||
94566379|NCT01276639|323871042|FG003|Week 16 to 52|Withdrawal by Subject|0|||
94566380|NCT01276639|323871043|FG004|Week 16 to 52|Withdrawal by Subject|1|||
94566381|NCT01276639|323871039|FG000|Week 16 to 52|Other|10|||
94566382|NCT01276639|323871040|FG001|Week 16 to 52|Other|12|||
94566383|NCT01276639|323871041|FG002|Week 16 to 52|Other|0|||
94566384|NCT01276639|323871042|FG003|Week 16 to 52|Other|1|||
94566385|NCT01276639|323871043|FG004|Week 16 to 52|Other|3|||
94566386|NCT01473732|323871046|FG000|Overall Study|Adverse Event|1|||
94566387|NCT01473732|323871047|FG001|Overall Study|Adverse Event|0|||
94566388|NCT01473732|323871046|FG000|Overall Study|Death|1|||
94566389|NCT01473732|323871047|FG001|Overall Study|Death|0|||
94566390|NCT03579940|323871049|FG000|Period 2|Withdrawal by Subject|0|||
94566391|NCT03579940|323871050|FG001|Period 2|Withdrawal by Subject|0|||
94566392|NCT03579940|323871051|FG002|Period 2|Withdrawal by Subject|1|||
94236875|NCT00585078|322661882|FG000|Overall Study|Poor performance status|1|||
94236876|NCT00585078|322661882|FG000|Overall Study|Disease Progression|24|||
94236877|NCT00585078|322661882|FG000|Overall Study|Adverse Event|10|||
94236878|NCT00585078|322661882|FG000|Overall Study|Death|1|||
94236879|NCT00760747|322661887|FG000|Study Period II|Adverse Event|3|||
94236880|NCT00760747|322661888|FG001|Study Period II|Adverse Event|4|||
94566393|NCT03579940|323871052|FG003|Period 2|Withdrawal by Subject|0|||
94566394|NCT03579940|323871053|FG004|Period 2|Withdrawal by Subject|0|||
94566395|NCT03579940|323871054|FG005|Period 2|Withdrawal by Subject|0|||
94566396|NCT03579940|323871055|FG006|Period 2|Withdrawal by Subject|0|||
94566397|NCT03579940|323871056|FG007|Period 2|Withdrawal by Subject|0|||
94566398|NCT03579940|323871057|FG008|Period 2|Withdrawal by Subject|0|||
94236881|NCT00760747|322661887|FG000|Study Period II|Lack of Efficacy|0|||
94236882|NCT00760747|322661888|FG001|Study Period II|Lack of Efficacy|6|||
94566399|NCT03579940|323871058|FG009|Period 2|Withdrawal by Subject|0|||
94566400|NCT03579940|323871059|FG010|Period 2|Withdrawal by Subject|0|||
94566401|NCT01132807|323871060|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
94566402|NCT01132807|323871061|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
94566403|NCT01132807|323871062|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
94566404|NCT01132807|323871060|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
94566405|NCT01132807|323871061|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
94566406|NCT01132807|323871062|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
94566407|NCT00997035|323871063|FG000|3-week Followup Visit|Lost to Follow-up|9|||
94566408|NCT00997035|323871064|FG001|3-week Followup Visit|Lost to Follow-up|6|||
94566409|NCT00997035|323871063|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
94566410|NCT00997035|323871064|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
94566411|NCT04685798|323871067|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
94566412|NCT02222558|323871068|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
94566413|NCT02222558|323871069|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
94566414|NCT02222558|323871070|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
94566415|NCT02222558|323871071|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
94566416|NCT02222558|323871072|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
94566417|NCT02222558|323871073|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
94566418|NCT02222558|323871068|FG000|Period 3|Withdrawal by Subject|0|||
94566419|NCT02222558|323871069|FG001|Period 3|Withdrawal by Subject|0|||
94566420|NCT02222558|323871070|FG002|Period 3|Withdrawal by Subject|0|||
94566421|NCT02222558|323871071|FG003|Period 3|Withdrawal by Subject|0|||
94566422|NCT02222558|323871072|FG004|Period 3|Withdrawal by Subject|0|||
94566423|NCT02222558|323871073|FG005|Period 3|Withdrawal by Subject|1|||
94566424|NCT02763644|323871074|FG000|Overall Study|Patient/guardian decision|1|||
94566425|NCT02763644|323871075|FG001|Overall Study|Patient/guardian decision|0|||
94566426|NCT02763644|323871074|FG000|Overall Study|Death|1|||
94566427|NCT02763644|323871075|FG001|Overall Study|Death|1|||
94566428|NCT02763644|323871074|FG000|Overall Study|Adverse Event|1|||
94566429|NCT02763644|323871075|FG001|Overall Study|Adverse Event|1|||
94236883|NCT00760747|322661887|FG000|Study Period II|Parent/Caregiver Decision|3|||
94236884|NCT00760747|322661888|FG001|Study Period II|Parent/Caregiver Decision|0|||
94236885|NCT00760747|322661887|FG000|Study Period II|Protocol Violation|6|||
94236886|NCT00760747|322661888|FG001|Study Period II|Protocol Violation|3|||
94236887|NCT00760747|322661887|FG000|Study Period II|Withdrawal by Subject|1|||
94236888|NCT00760747|322661888|FG001|Study Period II|Withdrawal by Subject|0|||
94236889|NCT00760747|322661887|FG000|Study Period II|No drug administered|0|||
94566430|NCT02836652|323871076|FG000|Overall Study|Death|3|||
94658538|NCT01172938|324206187|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
94236890|NCT00760747|322661888|FG001|Study Period II|No drug administered|1|||
94236891|NCT00760747|322661887|FG000|Study Period III|Adverse Event|1|||
94236892|NCT00760747|322661888|FG001|Study Period III|Adverse Event|0|||
94236893|NCT00760747|322661887|FG000|Study Period III|Lack of Efficacy|1|||
94236894|NCT00760747|322661888|FG001|Study Period III|Lack of Efficacy|0|||
94236895|NCT00760747|322661887|FG000|Study Period III|Parent/Caregiver Decision|0|||
94236896|NCT00760747|322661888|FG001|Study Period III|Parent/Caregiver Decision|1|||
94236897|NCT00760747|322661887|FG000|Study Period III|Protocol Violation|1|||
94236898|NCT00760747|322661888|FG001|Study Period III|Protocol Violation|1|||
94236899|NCT00760747|322661887|FG000|Study Period III|Physician Decision|0|||
94236900|NCT00760747|322661888|FG001|Study Period III|Physician Decision|1|||
94236901|NCT00844597|322661889|FG000|Overall Study|Adverse Event|0|||
94236902|NCT00844597|322661890|FG001|Overall Study|Adverse Event|0|||
94566431|NCT02836652|323871077|FG001|Overall Study|Death|3|||
94566432|NCT02836652|323871076|FG000|Overall Study|Transplant/Explant|3|||
94566433|NCT02836652|323871077|FG001|Overall Study|Transplant/Explant|4|||
94566434|NCT02836652|323871076|FG000|Overall Study|Withdrawn|9|||
94566435|NCT02836652|323871077|FG001|Overall Study|Withdrawn|9|||
94566436|NCT02836652|323871076|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
94347856|NCT02394028|323054042|FG005|Induction Phase|Lost to Follow-up|0|||
94347857|NCT02394028|323054043|FG006|Induction Phase|Lost to Follow-up|1|||
94347858|NCT02394028|323054044|FG007|Induction Phase|Lost to Follow-up|0|||
94347859|NCT02394028|323054045|FG008|Induction Phase|Lost to Follow-up|0|||
94347860|NCT02394028|323054046|FG009|Induction Phase|Lost to Follow-up|0|||
94347861|NCT02394028|323054047|FG010|Induction Phase|Lost to Follow-up|0|||
94347862|NCT02394028|323054037|FG000|Induction Phase|Non-compliance|0|||
94347863|NCT02394028|323054038|FG001|Induction Phase|Non-compliance|1|||
94347864|NCT02394028|323054039|FG002|Induction Phase|Non-compliance|3|||
94347865|NCT02394028|323054040|FG003|Induction Phase|Non-compliance|1|||
94347866|NCT02394028|323054041|FG004|Induction Phase|Non-compliance|3|||
94347867|NCT02394028|323054042|FG005|Induction Phase|Non-compliance|0|||
94347868|NCT02394028|323054043|FG006|Induction Phase|Non-compliance|1|||
94347869|NCT02394028|323054044|FG007|Induction Phase|Non-compliance|1|||
94347870|NCT02394028|323054045|FG008|Induction Phase|Non-compliance|0|||
94347871|NCT02394028|323054046|FG009|Induction Phase|Non-compliance|0|||
94347872|NCT02394028|323054047|FG010|Induction Phase|Non-compliance|0|||
94347873|NCT02394028|323054037|FG000|Induction Phase|Physician Decision|0|||
94347874|NCT02394028|323054038|FG001|Induction Phase|Physician Decision|0|||
94347875|NCT02394028|323054039|FG002|Induction Phase|Physician Decision|1|||
94347876|NCT02394028|323054040|FG003|Induction Phase|Physician Decision|4|||
94566437|NCT02836652|323871077|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
94566438|NCT02640547|323871078|FG000|Overall Study|Failure to Return|1|||
94566439|NCT02640547|323871078|FG000|Overall Study|Withdrawal by Subject|1|||
94566440|NCT02640547|323871078|FG000|Overall Study|Death|6|||
94566441|NCT02640547|323871078|FG000|Overall Study|Miscellaneous|3|||
94566442|NCT01272232|323871081|FG000|Weeks 0-56|Adverse Event|39|||
94566443|NCT01272232|323871082|FG001|Weeks 0-56|Adverse Event|18|||
94566444|NCT01272232|323871083|FG002|Weeks 0-56|Adverse Event|7|||
94566445|NCT01272232|323871081|FG000|Weeks 0-56|Lack of Efficacy|0|||
94566446|NCT01272232|323871082|FG001|Weeks 0-56|Lack of Efficacy|0|||
94566447|NCT01272232|323871083|FG002|Weeks 0-56|Lack of Efficacy|3|||
94566448|NCT01272232|323871081|FG000|Weeks 0-56|Protocol Violation|12|||
94566449|NCT01272232|323871082|FG001|Weeks 0-56|Protocol Violation|8|||
94347877|NCT02394028|323054041|FG004|Induction Phase|Physician Decision|0|||
94347878|NCT02394028|323054042|FG005|Induction Phase|Physician Decision|2|||
94347879|NCT02394028|323054043|FG006|Induction Phase|Physician Decision|1|||
94347880|NCT02394028|323054044|FG007|Induction Phase|Physician Decision|0|||
94347881|NCT02394028|323054045|FG008|Induction Phase|Physician Decision|0|||
94347882|NCT02394028|323054046|FG009|Induction Phase|Physician Decision|0|||
94347883|NCT02394028|323054047|FG010|Induction Phase|Physician Decision|0|||
94347884|NCT02394028|323054037|FG000|Induction Phase|Protocol Violation|0|||
94347885|NCT02394028|323054038|FG001|Induction Phase|Protocol Violation|2|||
94347886|NCT02394028|323054039|FG002|Induction Phase|Protocol Violation|0|||
94347887|NCT02394028|323054040|FG003|Induction Phase|Protocol Violation|3|||
94347888|NCT02394028|323054041|FG004|Induction Phase|Protocol Violation|0|||
94347889|NCT02394028|323054042|FG005|Induction Phase|Protocol Violation|1|||
94347890|NCT02394028|323054043|FG006|Induction Phase|Protocol Violation|1|||
94566450|NCT01272232|323871083|FG002|Weeks 0-56|Protocol Violation|13|||
94566451|NCT01272232|323871081|FG000|Weeks 0-56|Withdrawal criteria|32|||
94566452|NCT01272232|323871082|FG001|Weeks 0-56|Withdrawal criteria|14|||
94566453|NCT01272232|323871083|FG002|Weeks 0-56|Withdrawal criteria|37|||
94347891|NCT02394028|323054044|FG007|Induction Phase|Protocol Violation|0|||
94347892|NCT02394028|323054045|FG008|Induction Phase|Protocol Violation|0|||
94347893|NCT02394028|323054046|FG009|Induction Phase|Protocol Violation|0|||
94347894|NCT02394028|323054047|FG010|Induction Phase|Protocol Violation|0|||
94347895|NCT02394028|323054037|FG000|Induction Phase|Withdrawal by Subject|1|||
94347896|NCT02394028|323054038|FG001|Induction Phase|Withdrawal by Subject|2|||
94566454|NCT01272232|323871081|FG000|Weeks 0-56|Unclassified|16|||
94347897|NCT02394028|323054039|FG002|Induction Phase|Withdrawal by Subject|4|||
94566455|NCT01272232|323871082|FG001|Weeks 0-56|Unclassified|7|||
94566456|NCT01272232|323871083|FG002|Weeks 0-56|Unclassified|12|||
94566457|NCT01272232|323871081|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
94566458|NCT01272232|323871082|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
94566459|NCT01272232|323871083|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
94566460|NCT01272232|323871081|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
94566461|NCT01272232|323871082|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
94566462|NCT01272232|323871083|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
94566463|NCT01272232|323871081|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
94566464|NCT01272232|323871082|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
94566465|NCT01272232|323871083|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
94566466|NCT01272232|323871081|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
94566467|NCT01272232|323871082|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
94566468|NCT01272232|323871083|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
94566469|NCT01272232|323871081|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
94566470|NCT01272232|323871082|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
94566471|NCT01272232|323871083|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
94566472|NCT00474955|323871086|FG000|Overall Study|Adverse Event|2|||
94566473|NCT00474955|323871086|FG000|Overall Study|Drug unavailability|1|||
94566474|NCT00474955|323871086|FG000|Overall Study|Personal reasons|5|||
94566475|NCT01135134|323871087|FG000|Overall Study|Adverse Event|1|||
94566476|NCT01135134|323871088|FG001|Overall Study|Adverse Event|1|||
94566477|NCT01135134|323871087|FG000|Overall Study|Did not meet protocol eligibility|1|||
94566478|NCT01135134|323871088|FG001|Overall Study|Did not meet protocol eligibility|0|||
94566479|NCT01172535|323871089|FG000|Overall Study|Death|3|||
94566480|NCT01172535|323871089|FG000|Overall Study|Withdrawal by Subject|2|||
94236903|NCT00844597|322661891|FG002|Overall Study|Adverse Event|0|||
94236904|NCT00844597|322661892|FG003|Overall Study|Adverse Event|1|||
94236905|NCT00844597|322661893|FG004|Overall Study|Adverse Event|0|||
94236906|NCT00844597|322661894|FG005|Overall Study|Adverse Event|0|||
94236907|NCT03566979|322661897|FG000|Overall Study|Withdrawal by Subject|2|||
94236908|NCT03566979|322661898|FG001|Overall Study|Withdrawal by Subject|0|||
94236909|NCT03566979|322661899|FG002|Overall Study|Withdrawal by Subject|1|||
94236910|NCT03566979|322661900|FG003|Overall Study|Withdrawal by Subject|1|||
94236911|NCT03566979|322661897|FG000|Overall Study|Lost to Follow-up|2|||
94236912|NCT03566979|322661898|FG001|Overall Study|Lost to Follow-up|7|||
94236913|NCT03566979|322661899|FG002|Overall Study|Lost to Follow-up|9|||
94236914|NCT03566979|322661900|FG003|Overall Study|Lost to Follow-up|5|||
94236915|NCT03566979|322661897|FG000|Overall Study|Adverse Event|1|||
94236916|NCT03566979|322661898|FG001|Overall Study|Adverse Event|0|||
94236917|NCT03566979|322661899|FG002|Overall Study|Adverse Event|0|||
94236918|NCT03566979|322661900|FG003|Overall Study|Adverse Event|0|||
94236919|NCT02670122|322661901|FG000|Overall Study|Lost to Follow-up|4|||
94236920|NCT00108745|322661902|FG000|Overall Study|Withdrawal by Subject|19|||
94236921|NCT00108745|322661903|FG001|Overall Study|Withdrawal by Subject|12|||
94236922|NCT00108745|322661904|FG002|Overall Study|Withdrawal by Subject|12|||
94236923|NCT00108745|322661902|FG000|Overall Study|Never Treated|8|||
94236924|NCT00108745|322661903|FG001|Overall Study|Never Treated|10|||
94236925|NCT00108745|322661904|FG002|Overall Study|Never Treated|12|||
94236926|NCT00108745|322661902|FG000|Overall Study|Ineligible|7|||
94236927|NCT00108745|322661903|FG001|Overall Study|Ineligible|13|||
94236928|NCT00108745|322661904|FG002|Overall Study|Ineligible|13|||
94236929|NCT00455741|322661905|FG000|Overall Study|Physician Decision|0|||
94236930|NCT00455741|322661906|FG001|Overall Study|Physician Decision|1|||
94236931|NCT00243074|322661908|FG000|Overall Study|Ineligible|6|||
94236932|NCT00243074|322661908|FG000|Overall Study|Adverse Event|6|||
94236933|NCT00243074|322661908|FG000|Overall Study|Withdrawal by Subject|2|||
94236934|NCT00243074|322661908|FG000|Overall Study|Lack of Efficacy|36|||
94236935|NCT00243074|322661908|FG000|Overall Study|Death|2|||
94236936|NCT00243074|322661908|FG000|Overall Study|not protocol specified|1|||
94236937|NCT00243074|322661908|FG000|Overall Study|Did not receive any treatment|1|||
94236938|NCT03784820|322661909|FG000|Overall Study|Lost to Follow-up|5|||
94236939|NCT03784820|322661910|FG001|Overall Study|Lost to Follow-up|5|||
94236940|NCT03784820|322661911|FG002|Overall Study|Lost to Follow-up|3|||
94236941|NCT03784820|322661912|FG003|Overall Study|Lost to Follow-up|3|||
94236942|NCT01806389|322661915|FG000|Overall Study|Withdrawal by Subject|4|||
94236943|NCT03277352|322661925|FG000|Overall Study|Study Terminated By Sponsor|2|||
94236944|NCT03277352|322661925|FG000|Overall Study|Withdrawal by Subject|4|||
94236945|NCT03277352|322661925|FG000|Overall Study|Death|4|||
94236946|NCT01435772|322661926|FG000|Overall Study|Adverse Event|1|||
94236947|NCT01435772|322661927|FG001|Overall Study|Adverse Event|0|||
94236948|NCT01435772|322661928|FG002|Overall Study|Adverse Event|2|||
94236949|NCT01435772|322661926|FG000|Overall Study|Withdrawal by Subject|0|||
94236950|NCT01435772|322661927|FG001|Overall Study|Withdrawal by Subject|1|||
94236951|NCT01435772|322661928|FG002|Overall Study|Withdrawal by Subject|3|||
94236952|NCT01435772|322661926|FG000|Overall Study|Other - study termination|2|||
94236953|NCT01435772|322661927|FG001|Overall Study|Other - study termination|2|||
94236954|NCT01435772|322661928|FG002|Overall Study|Other - study termination|10|||
94236955|NCT02388347|322664078|FG000|Overall Study|Withdrawal by Subject|0|||
94236956|NCT02388347|322664079|FG001|Overall Study|Withdrawal by Subject|0|||
94236957|NCT02388347|322664080|FG002|Overall Study|Withdrawal by Subject|1|||
94236958|NCT02388347|322664081|FG003|Overall Study|Withdrawal by Subject|0|||
94236959|NCT02388347|322664082|FG004|Overall Study|Withdrawal by Subject|0|||
94236960|NCT00487825|322664087|FG000|Overall Study|Adverse Event|2|||
94236961|NCT00487825|322664088|FG001|Overall Study|Adverse Event|2|||
94236962|NCT00487825|322664087|FG000|Overall Study|Lack of Efficacy|1|||
94236963|NCT00487825|322664088|FG001|Overall Study|Lack of Efficacy|1|||
94236964|NCT00487825|322664087|FG000|Overall Study|Other|3|||
94236965|NCT00487825|322664088|FG001|Overall Study|Other|2|||
94236966|NCT00078377|322664089|FG000|Overall Study|Adverse Event|2|||
94236967|NCT00078377|322664090|FG001|Overall Study|Adverse Event|5|||
94236968|NCT00078377|322664091|FG002|Overall Study|Adverse Event|1|||
94236969|NCT00078377|322664089|FG000|Overall Study|Lack of Efficacy|2|||
94236970|NCT00078377|322664090|FG001|Overall Study|Lack of Efficacy|0|||
94236971|NCT00078377|322664091|FG002|Overall Study|Lack of Efficacy|2|||
94236972|NCT00078377|322664089|FG000|Overall Study|Lost to Follow-up|0|||
94450987|NCT02308540|323438415|FG000|Overall Study|Lost to Follow-up|0|||
94450988|NCT02308540|323438416|FG001|Overall Study|Lost to Follow-up|0|||
94236973|NCT00078377|322664090|FG001|Overall Study|Lost to Follow-up|1|||
94236974|NCT00078377|322664091|FG002|Overall Study|Lost to Follow-up|1|||
94236975|NCT00078377|322664089|FG000|Overall Study|Physician Decision|2|||
94236976|NCT00078377|322664090|FG001|Overall Study|Physician Decision|0|||
94236977|NCT00078377|322664091|FG002|Overall Study|Physician Decision|0|||
94236978|NCT00078377|322664089|FG000|Overall Study|Withdrawal by Subject|3|||
94236979|NCT00078377|322664090|FG001|Overall Study|Withdrawal by Subject|4|||
94236980|NCT00078377|322664091|FG002|Overall Study|Withdrawal by Subject|4|||
94236981|NCT00078377|322664089|FG000|Overall Study|Miscellaneous|2|||
94236982|NCT00078377|322664090|FG001|Overall Study|Miscellaneous|6|||
94236983|NCT00078377|322664091|FG002|Overall Study|Miscellaneous|1|||
94236984|NCT04596995|322664092|FG000|Overall Study|Lack of Efficacy|8|||
94236985|NCT04596995|322664092|FG000|Overall Study|Lost to Follow-up|3|||
94236986|NCT04596995|322664092|FG000|Overall Study|Withdrawal by Subject|12|||
94236987|NCT04596995|322664092|FG000|Overall Study|Sponsor decision|3|||
94236988|NCT04596995|322664092|FG000|Overall Study|Enrolled in managed access program|3|||
94236989|NCT02354651|322664093|FG000|Overall Study|Withdrawal by Subject|2|||
94566481|NCT01172535|323871089|FG000|Overall Study|Lost to Follow-up|1|||
94566482|NCT01172535|323871089|FG000|Overall Study|Ineligible at study entry|1|||
94236990|NCT02354651|322664093|FG000|Overall Study|Physician Decision|1|||
94236991|NCT02783573|322664095|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
94236992|NCT02783573|322664096|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
94236993|NCT02783573|322664097|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
94236994|NCT02783573|322664095|FG000|Placebo-Controlled Treatment Period|Death|4|||
94236995|NCT02783573|322664096|FG001|Placebo-Controlled Treatment Period|Death|2|||
94236996|NCT02783573|322664097|FG002|Placebo-Controlled Treatment Period|Death|3|||
94236997|NCT02783573|322664095|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
94236998|NCT02783573|322664096|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
94236999|NCT02783573|322664097|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
94237000|NCT02783573|322664095|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
94237001|NCT02783573|322664096|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
94237002|NCT02783573|322664097|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
94237003|NCT02783573|322664095|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
94237004|NCT02783573|322664096|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
94237005|NCT02783573|322664097|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
94237006|NCT02783573|322664095|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
94237007|NCT02783573|322664096|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
94237008|NCT02783573|322664097|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
94237009|NCT02783573|322664095|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
94237010|NCT02783573|322664096|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
94237011|NCT02783573|322664097|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
94237012|NCT02783573|322664095|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
94237013|NCT02783573|322664096|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
94237014|NCT02783573|322664097|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
94237015|NCT02783573|322664095|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
94237016|NCT02783573|322664096|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
94450989|NCT02308540|323438417|FG002|Overall Study|Lost to Follow-up|0|||
94237017|NCT02783573|322664097|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
94237018|NCT02783573|322664095|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
94237019|NCT02783573|322664096|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
94237020|NCT02783573|322664097|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
94237021|NCT02783573|322664095|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
94237022|NCT02783573|322664096|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
94566483|NCT01172535|323871089|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
94566484|NCT01020786|323871090|FG000|Induction Period|Entry Criteria Not Met|2|||
94566485|NCT01020786|323871090|FG000|Induction Period|Adverse Event|10|||
94566486|NCT01020786|323871090|FG000|Induction Period|Progressive Disease|31|||
94347898|NCT02394028|323054040|FG003|Induction Phase|Withdrawal by Subject|6|||
94347899|NCT02394028|323054041|FG004|Induction Phase|Withdrawal by Subject|7|||
94347900|NCT02394028|323054042|FG005|Induction Phase|Withdrawal by Subject|4|||
94347901|NCT02394028|323054043|FG006|Induction Phase|Withdrawal by Subject|3|||
94347902|NCT02394028|323054044|FG007|Induction Phase|Withdrawal by Subject|6|||
94347903|NCT02394028|323054045|FG008|Induction Phase|Withdrawal by Subject|0|||
94347904|NCT02394028|323054046|FG009|Induction Phase|Withdrawal by Subject|0|||
94347905|NCT02394028|323054047|FG010|Induction Phase|Withdrawal by Subject|0|||
94347906|NCT02394028|323054037|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
94347907|NCT02394028|323054038|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
94347908|NCT02394028|323054039|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
94347909|NCT02394028|323054040|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
94347910|NCT02394028|323054041|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
94347911|NCT02394028|323054042|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
94347912|NCT02394028|323054043|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
94347913|NCT02394028|323054044|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
94347914|NCT02394028|323054045|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
94347915|NCT02394028|323054046|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
94347916|NCT02394028|323054047|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
94347917|NCT02394028|323054037|FG000|Induction Phase|Sponsor decision|0|||
94347918|NCT02394028|323054038|FG001|Induction Phase|Sponsor decision|1|||
94347919|NCT02394028|323054039|FG002|Induction Phase|Sponsor decision|2|||
94347920|NCT02394028|323054040|FG003|Induction Phase|Sponsor decision|0|||
94347921|NCT02394028|323054041|FG004|Induction Phase|Sponsor decision|0|||
94347922|NCT02394028|323054042|FG005|Induction Phase|Sponsor decision|0|||
94347923|NCT02394028|323054043|FG006|Induction Phase|Sponsor decision|0|||
94347924|NCT02394028|323054044|FG007|Induction Phase|Sponsor decision|0|||
94347925|NCT02394028|323054045|FG008|Induction Phase|Sponsor decision|0|||
94347926|NCT02394028|323054046|FG009|Induction Phase|Sponsor decision|0|||
94347927|NCT02394028|323054047|FG010|Induction Phase|Sponsor decision|0|||
94347928|NCT02394028|323054037|FG000|Induction Phase|Technical reason|0|||
94347929|NCT02394028|323054038|FG001|Induction Phase|Technical reason|0|||
94347930|NCT02394028|323054039|FG002|Induction Phase|Technical reason|0|||
94347931|NCT02394028|323054040|FG003|Induction Phase|Technical reason|1|||
94347932|NCT02394028|323054041|FG004|Induction Phase|Technical reason|0|||
94347933|NCT02394028|323054042|FG005|Induction Phase|Technical reason|0|||
94347934|NCT02394028|323054043|FG006|Induction Phase|Technical reason|0|||
94347935|NCT02394028|323054044|FG007|Induction Phase|Technical reason|0|||
94347936|NCT02394028|323054045|FG008|Induction Phase|Technical reason|0|||
94347937|NCT02394028|323054046|FG009|Induction Phase|Technical reason|0|||
94347938|NCT02394028|323054047|FG010|Induction Phase|Technical reason|0|||
94347939|NCT02394028|323054037|FG000|Induction Phase|:ack of calculation|0|||
94347940|NCT02394028|323054038|FG001|Induction Phase|:ack of calculation|0|||
94347941|NCT02394028|323054039|FG002|Induction Phase|:ack of calculation|0|||
94347942|NCT02394028|323054040|FG003|Induction Phase|:ack of calculation|0|||
94347943|NCT02394028|323054041|FG004|Induction Phase|:ack of calculation|0|||
94347944|NCT02394028|323054042|FG005|Induction Phase|:ack of calculation|0|||
94347945|NCT02394028|323054043|FG006|Induction Phase|:ack of calculation|0|||
94347946|NCT02394028|323054044|FG007|Induction Phase|:ack of calculation|1|||
94566487|NCT01020786|323871090|FG000|Induction Period|Investigator Decision|3|||
94566488|NCT01020786|323871090|FG000|Induction Period|Withdrawal by Subject|3|||
94566489|NCT01020786|323871090|FG000|Maintenance Period|Adverse Event|8|||
94347947|NCT02394028|323054045|FG008|Induction Phase|:ack of calculation|0|||
94347948|NCT02394028|323054046|FG009|Induction Phase|:ack of calculation|0|||
94347949|NCT02394028|323054047|FG010|Induction Phase|:ack of calculation|0|||
94347950|NCT02394028|323054037|FG000|Maintenance Phase|Protocol Violation|0|||
94347951|NCT02394028|323054038|FG001|Maintenance Phase|Protocol Violation|0|||
94347952|NCT02394028|323054039|FG002|Maintenance Phase|Protocol Violation|0|||
94347953|NCT02394028|323054040|FG003|Maintenance Phase|Protocol Violation|0|||
94347954|NCT02394028|323054041|FG004|Maintenance Phase|Protocol Violation|0|||
94347955|NCT02394028|323054042|FG005|Maintenance Phase|Protocol Violation|0|||
94347956|NCT02394028|323054043|FG006|Maintenance Phase|Protocol Violation|0|||
94347957|NCT02394028|323054044|FG007|Maintenance Phase|Protocol Violation|0|||
94566490|NCT01020786|323871090|FG000|Maintenance Period|Progressive Disease|43|||
94347958|NCT02394028|323054045|FG008|Maintenance Phase|Protocol Violation|0|||
94347959|NCT02394028|323054046|FG009|Maintenance Phase|Protocol Violation|0|||
94347960|NCT02394028|323054047|FG010|Maintenance Phase|Protocol Violation|1|||
94347961|NCT02394028|323054037|FG000|Maintenance Phase|Physician Decision|0|||
94658539|NCT01172938|324206188|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
94237023|NCT02783573|322664097|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
94237024|NCT02783573|322664095|FG000|Delayed-Start Period|Sponsor Decision|0|||
94237025|NCT02783573|322664096|FG001|Delayed-Start Period|Sponsor Decision|17|||
94237026|NCT02783573|322664097|FG002|Delayed-Start Period|Sponsor Decision|12|||
94237027|NCT02797522|322664098|FG000|Overall Study|Study Terminated by Sponsor|0|||
94237028|NCT02797522|322664099|FG001|Overall Study|Study Terminated by Sponsor|0|||
94237029|NCT02797522|322664100|FG002|Overall Study|Study Terminated by Sponsor|0|||
94237030|NCT02797522|322664101|FG003|Overall Study|Study Terminated by Sponsor|0|||
94237031|NCT02797522|322664102|FG004|Overall Study|Study Terminated by Sponsor|0|||
94237032|NCT02797522|322664103|FG005|Overall Study|Study Terminated by Sponsor|0|||
94237033|NCT02797522|322664104|FG006|Overall Study|Study Terminated by Sponsor|0|||
94237034|NCT02797522|322664105|FG007|Overall Study|Study Terminated by Sponsor|4|||
94237035|NCT02797522|322664106|FG008|Overall Study|Study Terminated by Sponsor|2|||
94237036|NCT02797522|322664107|FG009|Overall Study|Study Terminated by Sponsor|4|||
94237037|NCT02797522|322664108|FG010|Overall Study|Study Terminated by Sponsor|1|||
94237038|NCT00725712|322664109|FG000|Overall Study|Withdrawal by Subject|2|||
94237039|NCT00725712|322664110|FG001|Overall Study|Withdrawal by Subject|1|||
94237040|NCT00725712|322664109|FG000|Overall Study|Protocol Violation|1|||
94237041|NCT00725712|322664110|FG001|Overall Study|Protocol Violation|0|||
94237042|NCT00725712|322664109|FG000|Overall Study|Progressive disease|37|||
94237043|NCT00725712|322664110|FG001|Overall Study|Progressive disease|16|||
94237044|NCT00725712|322664109|FG000|Overall Study|Clinical progression not based on RECIST|0|||
94237045|NCT00725712|322664110|FG001|Overall Study|Clinical progression not based on RECIST|3|||
94237046|NCT00725712|322664109|FG000|Overall Study|Adverse Event|5|||
94237047|NCT00725712|322664110|FG001|Overall Study|Adverse Event|5|||
94237048|NCT00725712|322664109|FG000|Overall Study|Death|2|||
94237049|NCT00725712|322664110|FG001|Overall Study|Death|0|||
94237050|NCT00725712|322664109|FG000|Overall Study|Other: Death|1|||
94237051|NCT00725712|322664110|FG001|Overall Study|Other: Death|0|||
94237052|NCT00725712|322664109|FG000|Overall Study|Hospitalized, unable to continue|0|||
94237053|NCT00725712|322664110|FG001|Overall Study|Hospitalized, unable to continue|1|||
94237054|NCT00132678|322664111|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
94237055|NCT00132678|322664112|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
94237056|NCT00132678|322664113|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
94237057|NCT00132678|322664111|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
94237058|NCT00132678|322664112|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
94237059|NCT00132678|322664113|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
94237060|NCT00132678|322664111|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
94237061|NCT00132678|322664112|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
94237062|NCT00132678|322664113|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
94237063|NCT00132678|322664111|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
94237064|NCT00132678|322664112|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
94237065|NCT00132678|322664113|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
94237066|NCT00132678|322664111|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
94237067|NCT00132678|322664112|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
94237068|NCT00132678|322664113|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
94237069|NCT00132678|322664111|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
94347962|NCT02394028|323054038|FG001|Maintenance Phase|Physician Decision|0|||
94347963|NCT02394028|323054039|FG002|Maintenance Phase|Physician Decision|0|||
94347964|NCT02394028|323054040|FG003|Maintenance Phase|Physician Decision|0|||
94347965|NCT02394028|323054041|FG004|Maintenance Phase|Physician Decision|0|||
94347966|NCT02394028|323054042|FG005|Maintenance Phase|Physician Decision|0|||
94347967|NCT02394028|323054043|FG006|Maintenance Phase|Physician Decision|0|||
94347968|NCT02394028|323054044|FG007|Maintenance Phase|Physician Decision|0|||
94566491|NCT01020786|323871090|FG000|Maintenance Period|Withdrawal by Subject|8|||
94566492|NCT01020786|323871090|FG000|Maintenance Period|Sponsor Decision|1|||
94566493|NCT03367858|323871097|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
94566494|NCT03367858|323871098|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
94566495|NCT03367858|323871097|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
94566496|NCT03367858|323871098|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
94566497|NCT03367858|323871097|FG000|3 Month Follow Up|Lost to Follow-up|8|||
94566498|NCT03367858|323871098|FG001|3 Month Follow Up|Lost to Follow-up|3|||
94566499|NCT03367858|323871097|FG000|3 Month Follow Up|Moved out of study area|2|||
94566500|NCT03367858|323871098|FG001|3 Month Follow Up|Moved out of study area|6|||
94566501|NCT03367858|323871097|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
94566502|NCT03367858|323871098|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
94566503|NCT03367858|323871097|FG000|3 Month Follow Up|MRI contraindication|2|||
94566504|NCT03367858|323871098|FG001|3 Month Follow Up|MRI contraindication|1|||
94566505|NCT03367858|323871097|FG000|3 Month Follow Up|Incarcerated|0|||
94566506|NCT03367858|323871098|FG001|3 Month Follow Up|Incarcerated|1|||
94566507|NCT03367858|323871097|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
94450990|NCT02308540|323438418|FG003|Overall Study|Lost to Follow-up|0|||
94566508|NCT03367858|323871098|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
94237070|NCT00132678|322664112|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
94237071|NCT00132678|322664113|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
94237072|NCT00132678|322664111|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
94237073|NCT00132678|322664112|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
94237074|NCT00132678|322664113|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
94566509|NCT03367858|323871097|FG000|6 Month Follow Up|Lost to Follow-up|5|||
94566510|NCT03367858|323871098|FG001|6 Month Follow Up|Lost to Follow-up|2|||
94566511|NCT03367858|323871097|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
94566512|NCT03367858|323871098|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
94566513|NCT03367858|323871097|FG000|12 Month Follow Up|Lost to Follow-up|3|||
94566514|NCT03367858|323871098|FG001|12 Month Follow Up|Lost to Follow-up|3|||
94566515|NCT03367858|323871097|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
94566516|NCT03367858|323871098|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
94566517|NCT05280717|323871099|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
94566518|NCT05280717|323871100|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
94566519|NCT05280717|323871101|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
94566520|NCT05280717|323871102|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
94566521|NCT05280717|323871103|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
94566522|NCT05280717|323871104|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
94566523|NCT05280717|323871105|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
94566524|NCT05280717|323871099|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
94566525|NCT05280717|323871100|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
94566526|NCT05280717|323871101|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
94566527|NCT05280717|323871102|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
94566528|NCT05280717|323871103|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
94566529|NCT05280717|323871104|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
94566530|NCT05280717|323871105|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
94566531|NCT05280717|323871099|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
94566532|NCT05280717|323871100|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
94566533|NCT05280717|323871101|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
94566534|NCT05280717|323871102|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
94566535|NCT05280717|323871103|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
94566536|NCT05280717|323871104|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
94566537|NCT05280717|323871105|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
94566538|NCT05280717|323871099|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
94566539|NCT05280717|323871100|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
94566540|NCT05280717|323871101|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
94566541|NCT05280717|323871102|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
94566542|NCT05280717|323871103|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
94566543|NCT05280717|323871104|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
94566544|NCT05280717|323871105|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
94566545|NCT05280717|323871099|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
94566546|NCT05280717|323871100|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
94566547|NCT05280717|323871101|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
94566548|NCT05280717|323871102|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
94566549|NCT05280717|323871103|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
94566550|NCT05280717|323871104|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
94566551|NCT05280717|323871105|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
94566552|NCT05280717|323871099|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
94566553|NCT05280717|323871100|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
94566554|NCT05280717|323871101|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
94566555|NCT05280717|323871102|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
94566556|NCT05280717|323871103|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
94566557|NCT05280717|323871104|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
94566558|NCT05280717|323871105|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
94658540|NCT01172938|324206189|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
94658541|NCT01172938|324206190|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
94658542|NCT01172938|324206182|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
94658543|NCT01172938|324206183|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
94347969|NCT02394028|323054045|FG008|Maintenance Phase|Physician Decision|1|||
94347970|NCT02394028|323054046|FG009|Maintenance Phase|Physician Decision|3|||
94347971|NCT02394028|323054047|FG010|Maintenance Phase|Physician Decision|2|||
94347972|NCT02394028|323054037|FG000|Maintenance Phase|Lack of Efficacy|0|||
94347973|NCT02394028|323054038|FG001|Maintenance Phase|Lack of Efficacy|0|||
94347974|NCT02394028|323054039|FG002|Maintenance Phase|Lack of Efficacy|0|||
94347975|NCT02394028|323054040|FG003|Maintenance Phase|Lack of Efficacy|0|||
94347976|NCT02394028|323054041|FG004|Maintenance Phase|Lack of Efficacy|0|||
94347977|NCT02394028|323054042|FG005|Maintenance Phase|Lack of Efficacy|0|||
94347978|NCT02394028|323054043|FG006|Maintenance Phase|Lack of Efficacy|0|||
94347979|NCT02394028|323054044|FG007|Maintenance Phase|Lack of Efficacy|0|||
94347980|NCT02394028|323054045|FG008|Maintenance Phase|Lack of Efficacy|7|||
94347981|NCT02394028|323054046|FG009|Maintenance Phase|Lack of Efficacy|25|||
94347982|NCT02394028|323054047|FG010|Maintenance Phase|Lack of Efficacy|33|||
94347983|NCT02394028|323054037|FG000|Maintenance Phase|Death|0|||
94347984|NCT02394028|323054038|FG001|Maintenance Phase|Death|0|||
94347985|NCT02394028|323054039|FG002|Maintenance Phase|Death|0|||
94347986|NCT02394028|323054040|FG003|Maintenance Phase|Death|0|||
94347987|NCT02394028|323054041|FG004|Maintenance Phase|Death|0|||
94347988|NCT02394028|323054042|FG005|Maintenance Phase|Death|0|||
94347989|NCT02394028|323054043|FG006|Maintenance Phase|Death|0|||
94347990|NCT02394028|323054044|FG007|Maintenance Phase|Death|0|||
94347991|NCT02394028|323054045|FG008|Maintenance Phase|Death|0|||
94347992|NCT02394028|323054046|FG009|Maintenance Phase|Death|0|||
94347993|NCT02394028|323054047|FG010|Maintenance Phase|Death|1|||
94450991|NCT02308540|323438419|FG004|Overall Study|Lost to Follow-up|0|||
94450992|NCT02308540|323438420|FG005|Overall Study|Lost to Follow-up|1|||
94450993|NCT04109391|323438421|FG000|Overall Study|Adverse Event|2|||
94450994|NCT04109391|323438422|FG001|Overall Study|Adverse Event|2|||
94450995|NCT04109391|323438423|FG002|Overall Study|Adverse Event|0|||
94450996|NCT04109391|323438421|FG000|Overall Study|Withdrawal by Subject|2|||
94450997|NCT04109391|323438422|FG001|Overall Study|Withdrawal by Subject|0|||
94450998|NCT04109391|323438423|FG002|Overall Study|Withdrawal by Subject|0|||
94450999|NCT04109391|323438421|FG000|Overall Study|Pregnancy|1|||
94451000|NCT04109391|323438422|FG001|Overall Study|Pregnancy|0|||
94451001|NCT04109391|323438423|FG002|Overall Study|Pregnancy|0|||
94451002|NCT04109391|323438421|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
94451003|NCT04109391|323438422|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
94451004|NCT04109391|323438423|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
94451005|NCT04109391|323438421|FG000|Overall Study|Lost to Follow-up|0|||
94451006|NCT04109391|323438422|FG001|Overall Study|Lost to Follow-up|0|||
94451007|NCT04109391|323438423|FG002|Overall Study|Lost to Follow-up|1|||
94451008|NCT04109391|323438421|FG000|Overall Study|Lack of Efficacy|2|||
94451009|NCT04109391|323438422|FG001|Overall Study|Lack of Efficacy|2|||
94451010|NCT04109391|323438423|FG002|Overall Study|Lack of Efficacy|3|||
94451011|NCT01106911|323438426|FG000|Overall Study|Physician Decision|2|||
94451012|NCT01106911|323438426|FG000|Overall Study|deemed ineligible after screening|3|||
94451013|NCT01814696|323438427|FG000|Overall Study|Withdrawal by Subject|1|||
94451014|NCT01814696|323438428|FG001|Overall Study|Withdrawal by Subject|0|||
94451015|NCT01814696|323438427|FG000|Overall Study|Randomized to wrong group|1|||
94451016|NCT01814696|323438428|FG001|Overall Study|Randomized to wrong group|0|||
94451017|NCT02064816|323438430|FG000|Overall Study|Adverse Event|3|||
94451018|NCT02064816|323438431|FG001|Overall Study|Adverse Event|2|||
94451019|NCT02064816|323438430|FG000|Overall Study|Withdrawal by Subject|2|||
94451020|NCT02064816|323438431|FG001|Overall Study|Withdrawal by Subject|1|||
94451021|NCT02064816|323438430|FG000|Overall Study|Lost to Follow-up|2|||
94451022|NCT02064816|323438431|FG001|Overall Study|Lost to Follow-up|1|||
94347994|NCT02394028|323054037|FG000|Maintenance Phase|Adverse Event|0|||
94347995|NCT02394028|323054038|FG001|Maintenance Phase|Adverse Event|0|||
94347996|NCT02394028|323054039|FG002|Maintenance Phase|Adverse Event|0|||
94347997|NCT02394028|323054040|FG003|Maintenance Phase|Adverse Event|0|||
94347998|NCT02394028|323054041|FG004|Maintenance Phase|Adverse Event|0|||
94347999|NCT02394028|323054042|FG005|Maintenance Phase|Adverse Event|0|||
94348000|NCT02394028|323054043|FG006|Maintenance Phase|Adverse Event|0|||
94348001|NCT02394028|323054044|FG007|Maintenance Phase|Adverse Event|0|||
94348002|NCT02394028|323054045|FG008|Maintenance Phase|Adverse Event|1|||
94348003|NCT02394028|323054046|FG009|Maintenance Phase|Adverse Event|1|||
94348004|NCT02394028|323054047|FG010|Maintenance Phase|Adverse Event|3|||
94348005|NCT02394028|323054037|FG000|Maintenance Phase|Site closure|0|||
94451023|NCT02064816|323438430|FG000|Overall Study|Therapeutic failure|0|||
94451024|NCT02064816|323438431|FG001|Overall Study|Therapeutic failure|1|||
94451025|NCT02064816|323438430|FG000|Overall Study|Other|1|||
94451026|NCT02064816|323438431|FG001|Overall Study|Other|3|||
94451027|NCT00996125|323438432|FG000|Overall Study|Adverse Event|0|||
94451028|NCT00996125|323438433|FG001|Overall Study|Adverse Event|2|||
94451029|NCT00996125|323438432|FG000|Overall Study|Lost to Follow-up|1|||
94451030|NCT00996125|323438433|FG001|Overall Study|Lost to Follow-up|6|||
94451031|NCT00996125|323438432|FG000|Overall Study|Withdrawal by Subject|4|||
94348006|NCT02394028|323054038|FG001|Maintenance Phase|Site closure|0|||
94348007|NCT02394028|323054039|FG002|Maintenance Phase|Site closure|0|||
94348008|NCT02394028|323054040|FG003|Maintenance Phase|Site closure|0|||
94451032|NCT00996125|323438433|FG001|Overall Study|Withdrawal by Subject|3|||
94451033|NCT00554515|323438441|FG000|Overall Study|Withdrawal by Subject|3|||
94348009|NCT02394028|323054041|FG004|Maintenance Phase|Site closure|0|||
94348010|NCT02394028|323054042|FG005|Maintenance Phase|Site closure|0|||
94348011|NCT02394028|323054043|FG006|Maintenance Phase|Site closure|0|||
94348012|NCT02394028|323054044|FG007|Maintenance Phase|Site closure|0|||
94566559|NCT00539994|323871107|FG000|Overall Study|Lost to Follow-up|2|||
94566560|NCT00539994|323871108|FG001|Overall Study|Lost to Follow-up|1|||
94566561|NCT00539994|323871109|FG002|Overall Study|Lost to Follow-up|0|||
94566562|NCT00539994|323871107|FG000|Overall Study|Withdrawal by Subject|1|||
94566563|NCT00539994|323871108|FG001|Overall Study|Withdrawal by Subject|0|||
94566564|NCT00539994|323871109|FG002|Overall Study|Withdrawal by Subject|1|||
94566565|NCT00539994|323871107|FG000|Overall Study|Physician Decision|0|||
94566566|NCT00539994|323871108|FG001|Overall Study|Physician Decision|0|||
94566567|NCT00539994|323871109|FG002|Overall Study|Physician Decision|1|||
94566568|NCT01917747|323871110|FG000|Overall Study|Withdrawal by Subject|1|||
94566569|NCT01917747|323871111|FG001|Overall Study|Withdrawal by Subject|2|||
94566570|NCT01917747|323871110|FG000|Overall Study|Lost to Follow-up|18|||
94566571|NCT01917747|323871111|FG001|Overall Study|Lost to Follow-up|9|||
94566572|NCT00607087|323871118|FG000|Overall Study|Withdrawal by Subject|9|||
94566573|NCT00607087|323871119|FG001|Overall Study|Withdrawal by Subject|4|||
94566574|NCT00607087|323871120|FG002|Overall Study|Withdrawal by Subject|4|||
94566575|NCT00607087|323871118|FG000|Overall Study|Adverse Event|3|||
94566576|NCT00607087|323871119|FG001|Overall Study|Adverse Event|2|||
94566577|NCT00607087|323871120|FG002|Overall Study|Adverse Event|3|||
94566578|NCT00607087|323871118|FG000|Overall Study|Other reason|1|||
94566579|NCT00607087|323871119|FG001|Overall Study|Other reason|5|||
94566580|NCT00607087|323871120|FG002|Overall Study|Other reason|2|||
94566581|NCT00607087|323871118|FG000|Overall Study|Poor compliance to protocol|1|||
94566582|NCT00607087|323871119|FG001|Overall Study|Poor compliance to protocol|0|||
94566583|NCT00607087|323871120|FG002|Overall Study|Poor compliance to protocol|1|||
94566584|NCT00607087|323871118|FG000|Overall Study|Lost to Follow-up|1|||
94566585|NCT00607087|323871119|FG001|Overall Study|Lost to Follow-up|0|||
94566586|NCT00607087|323871120|FG002|Overall Study|Lost to Follow-up|0|||
94566587|NCT00607087|323871118|FG000|Period 1|Withdrawal by Subject|7|||
94566588|NCT00607087|323871119|FG001|Period 1|Withdrawal by Subject|2|||
94566589|NCT00607087|323871120|FG002|Period 1|Withdrawal by Subject|3|||
94566590|NCT00607087|323871118|FG000|Period 1|Adverse Event|3|||
94566591|NCT00607087|323871119|FG001|Period 1|Adverse Event|0|||
94566592|NCT00607087|323871120|FG002|Period 1|Adverse Event|0|||
94566593|NCT00607087|323871118|FG000|Period 1|Poor compliance to protocol|1|||
94566594|NCT00607087|323871119|FG001|Period 1|Poor compliance to protocol|0|||
94566595|NCT00607087|323871120|FG002|Period 1|Poor compliance to protocol|0|||
94566596|NCT00607087|323871118|FG000|Period 1|Lost to Follow-up|1|||
94566597|NCT00607087|323871119|FG001|Period 1|Lost to Follow-up|0|||
94566598|NCT00607087|323871120|FG002|Period 1|Lost to Follow-up|0|||
94566599|NCT00607087|323871118|FG000|Period 1|Other reason|0|||
94566600|NCT00607087|323871119|FG001|Period 1|Other reason|4|||
94566601|NCT00607087|323871120|FG002|Period 1|Other reason|2|||
94566602|NCT00607087|323871118|FG000|Period 2|Withdrawal by Subject|0|||
94566603|NCT00607087|323871119|FG001|Period 2|Withdrawal by Subject|1|||
94566604|NCT00607087|323871120|FG002|Period 2|Withdrawal by Subject|1|||
94566605|NCT00607087|323871118|FG000|Period 2|Other reason|1|||
94566606|NCT00607087|323871119|FG001|Period 2|Other reason|1|||
94566607|NCT00607087|323871120|FG002|Period 2|Other reason|0|||
94566608|NCT00607087|323871118|FG000|Period 2|Adverse Event|0|||
94566609|NCT00607087|323871119|FG001|Period 2|Adverse Event|1|||
94566610|NCT00607087|323871120|FG002|Period 2|Adverse Event|3|||
94566611|NCT00607087|323871118|FG000|Period 2|Poor compliance to protocol|0|||
94566612|NCT00607087|323871119|FG001|Period 2|Poor compliance to protocol|0|||
94566613|NCT00607087|323871120|FG002|Period 2|Poor compliance to protocol|1|||
94566614|NCT00607087|323871118|FG000|Period 3|Withdrawal by Subject|2|||
94566615|NCT00607087|323871119|FG001|Period 3|Withdrawal by Subject|1|||
94566616|NCT00607087|323871120|FG002|Period 3|Withdrawal by Subject|0|||
94566617|NCT00607087|323871118|FG000|Period 3|Adverse Event|0|||
94566618|NCT00607087|323871119|FG001|Period 3|Adverse Event|1|||
94566619|NCT00607087|323871120|FG002|Period 3|Adverse Event|0|||
94566620|NCT00279916|323871121|FG000|Overall Study|Withdrawal by Subject|4|||
94566621|NCT00279916|323871122|FG001|Overall Study|Withdrawal by Subject|3|||
94566622|NCT00279916|323871121|FG000|Overall Study|Lost to Follow-up|3|||
94566623|NCT00279916|323871122|FG001|Overall Study|Lost to Follow-up|2|||
94566624|NCT01236521|323871125|FG000|Overall Study|Withdrawal by Subject|12|||
94566625|NCT01236521|323871126|FG001|Overall Study|Withdrawal by Subject|17|||
94566626|NCT01236521|323871125|FG000|Overall Study|Death|2|||
94566627|NCT01236521|323871126|FG001|Overall Study|Death|1|||
94566628|NCT01236521|323871125|FG000|Overall Study|Lost to Follow-up|9|||
94566629|NCT01236521|323871126|FG001|Overall Study|Lost to Follow-up|7|||
94566630|NCT00479713|323871128|FG000|Overall Study|Adverse Event|8|||
94566631|NCT00479713|323871129|FG001|Overall Study|Adverse Event|6|||
94566632|NCT00479713|323871128|FG000|Overall Study|Death|1|||
94566633|NCT00479713|323871129|FG001|Overall Study|Death|0|||
94566634|NCT00479713|323871128|FG000|Overall Study|Lost to Follow-up|0|||
94566635|NCT00479713|323871129|FG001|Overall Study|Lost to Follow-up|1|||
94566636|NCT00479713|323871128|FG000|Overall Study|Protocol Violation|0|||
94566637|NCT00479713|323871129|FG001|Overall Study|Protocol Violation|1|||
94566638|NCT00479713|323871128|FG000|Overall Study|Withdrawal by Subject|4|||
94566639|NCT00479713|323871129|FG001|Overall Study|Withdrawal by Subject|1|||
94566640|NCT05481359|323871132|FG000|Overall Study|Lost to Follow-up|3|||
94566641|NCT05481359|323871132|FG000|Overall Study|Withdrawal by Subject|1|||
94566642|NCT03064490|323871137|FG000|Overall Study|Physician Decision|5|||
94566643|NCT00980460|323871138|FG000|Overall Study|Death|0|||
94566644|NCT00980460|323871139|FG001|Overall Study|Death|0|||
94566645|NCT00980460|323871140|FG002|Overall Study|Death|1|||
94566646|NCT00980460|323871141|FG003|Overall Study|Death|2|||
94566647|NCT00980460|323871142|FG004|Overall Study|Death|1|||
94566648|NCT00980460|323871138|FG000|Overall Study|Lack of Efficacy|0|||
94566649|NCT00980460|323871139|FG001|Overall Study|Lack of Efficacy|0|||
94566650|NCT00980460|323871140|FG002|Overall Study|Lack of Efficacy|10|||
94566651|NCT00980460|323871141|FG003|Overall Study|Lack of Efficacy|6|||
94566652|NCT00980460|323871142|FG004|Overall Study|Lack of Efficacy|8|||
94566653|NCT00980460|323871138|FG000|Overall Study|Lost to Follow-up|0|||
94566654|NCT00980460|323871139|FG001|Overall Study|Lost to Follow-up|0|||
94566655|NCT00980460|323871140|FG002|Overall Study|Lost to Follow-up|0|||
94566656|NCT00980460|323871141|FG003|Overall Study|Lost to Follow-up|1|||
94566657|NCT00980460|323871142|FG004|Overall Study|Lost to Follow-up|0|||
94566658|NCT00980460|323871138|FG000|Overall Study|Physician Decision|0|||
94566659|NCT00980460|323871139|FG001|Overall Study|Physician Decision|0|||
94566660|NCT00980460|323871140|FG002|Overall Study|Physician Decision|11|||
94566661|NCT00980460|323871141|FG003|Overall Study|Physician Decision|5|||
94566662|NCT00980460|323871142|FG004|Overall Study|Physician Decision|3|||
94566663|NCT00980460|323871138|FG000|Overall Study|Withdrawal by Subject|0|||
94566664|NCT00980460|323871139|FG001|Overall Study|Withdrawal by Subject|0|||
94566665|NCT00980460|323871140|FG002|Overall Study|Withdrawal by Subject|1|||
94566666|NCT00980460|323871141|FG003|Overall Study|Withdrawal by Subject|0|||
94566667|NCT00980460|323871142|FG004|Overall Study|Withdrawal by Subject|0|||
94566668|NCT00980460|323871138|FG000|Overall Study|Ineligible|0|||
94566669|NCT00980460|323871139|FG001|Overall Study|Ineligible|2|||
94566670|NCT00980460|323871140|FG002|Overall Study|Ineligible|3|||
94566671|NCT00980460|323871141|FG003|Overall Study|Ineligible|1|||
94566672|NCT00980460|323871142|FG004|Overall Study|Ineligible|4|||
94566673|NCT00980460|323871138|FG000|Overall Study|Refusal of further therapy|0|||
94566674|NCT00980460|323871139|FG001|Overall Study|Refusal of further therapy|2|||
94566675|NCT00980460|323871140|FG002|Overall Study|Refusal of further therapy|3|||
94566676|NCT00980460|323871141|FG003|Overall Study|Refusal of further therapy|2|||
94566677|NCT00980460|323871142|FG004|Overall Study|Refusal of further therapy|0|||
94566678|NCT00980460|323871138|FG000|Overall Study|No therapy within 42 days of resection|0|||
94566679|NCT00980460|323871139|FG001|Overall Study|No therapy within 42 days of resection|0|||
94566680|NCT00980460|323871140|FG002|Overall Study|No therapy within 42 days of resection|3|||
94566681|NCT00980460|323871141|FG003|Overall Study|No therapy within 42 days of resection|1|||
94566682|NCT00980460|323871142|FG004|Overall Study|No therapy within 42 days of resection|0|||
94566683|NCT00980460|323871138|FG000|Overall Study|No transplant by protocol timepoints|0|||
94566684|NCT00980460|323871139|FG001|Overall Study|No transplant by protocol timepoints|0|||
94566685|NCT00980460|323871140|FG002|Overall Study|No transplant by protocol timepoints|3|||
94566686|NCT00980460|323871141|FG003|Overall Study|No transplant by protocol timepoints|0|||
94566687|NCT00980460|323871142|FG004|Overall Study|No transplant by protocol timepoints|0|||
94566688|NCT01790594|323872438|FG000|Overall Study|Death|1|||
94566689|NCT01790594|323872439|FG001|Overall Study|Death|0|||
94566690|NCT01790594|323872440|FG002|Overall Study|Death|0|||
94566691|NCT01790594|323872438|FG000|Overall Study|Physician Decision|2|||
94566692|NCT01790594|323872439|FG001|Overall Study|Physician Decision|1|||
94566693|NCT01790594|323872440|FG002|Overall Study|Physician Decision|0|||
94566694|NCT01790594|323872438|FG000|Overall Study|Withdrawal by Subject|2|||
94566695|NCT01790594|323872439|FG001|Overall Study|Withdrawal by Subject|0|||
94566696|NCT01790594|323872440|FG002|Overall Study|Withdrawal by Subject|0|||
94658544|NCT01172938|324206184|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
94658545|NCT01172938|324206185|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
94658546|NCT01172938|324206186|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
94658547|NCT01172938|324206187|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
94566697|NCT01790594|323872438|FG000|Overall Study|Transplant was not done|0|||
94566698|NCT01790594|323872439|FG001|Overall Study|Transplant was not done|0|||
94566699|NCT01790594|323872440|FG002|Overall Study|Transplant was not done|3|||
94566700|NCT01790594|323872438|FG000|Overall Study|Terminated prior to week 76|0|||
94566701|NCT01790594|323872439|FG001|Overall Study|Terminated prior to week 76|2|||
94566702|NCT01790594|323872440|FG002|Overall Study|Terminated prior to week 76|0|||
94566703|NCT00859547|323872447|FG000|Overall Study|Lost to Follow-up|1|||
94566704|NCT00859547|323872447|FG000|Overall Study|Parent withdrew consent|1|||
94566705|NCT00330759|323872461|FG000|Overall Study|Death|316|||
94566706|NCT00330759|323872462|FG001|Overall Study|Death|310|||
94566707|NCT00330759|323872461|FG000|Overall Study|Disease progression|104|||
94566708|NCT00330759|323872462|FG001|Overall Study|Disease progression|126|||
94566709|NCT00330759|323872461|FG000|Overall Study|Withdrawal by Subject|143|||
94566710|NCT00330759|323872462|FG001|Overall Study|Withdrawal by Subject|124|||
94566711|NCT00330759|323872461|FG000|Overall Study|Adverse Event|48|||
94566712|NCT00330759|323872462|FG001|Overall Study|Adverse Event|36|||
94566713|NCT00330759|323872461|FG000|Overall Study|Participant request|31|||
94566714|NCT00330759|323872462|FG001|Overall Study|Participant request|22|||
94566715|NCT00330759|323872461|FG000|Overall Study|Lost to Follow-up|16|||
94566716|NCT00330759|323872462|FG001|Overall Study|Lost to Follow-up|22|||
94566717|NCT00330759|323872461|FG000|Overall Study|Noncompliance|15|||
94566718|NCT00330759|323872462|FG001|Overall Study|Noncompliance|17|||
94566719|NCT00330759|323872461|FG000|Overall Study|Physician Decision|1|||
94566720|NCT00330759|323872462|FG001|Overall Study|Physician Decision|2|||
94566721|NCT00330759|323872461|FG000|Overall Study|Protocol deviation|0|||
94566722|NCT00330759|323872462|FG001|Overall Study|Protocol deviation|2|||
94566723|NCT00330759|323872461|FG000|Overall Study|Ineligibility determined|2|||
94566724|NCT00330759|323872462|FG001|Overall Study|Ineligibility determined|1|||
94566725|NCT00330759|323872461|FG000|Overall Study|Other|36|||
94566726|NCT00330759|323872462|FG001|Overall Study|Other|44|||
94566727|NCT00671034|323872463|FG000|Overall Study|Adverse Event|5|||
94566728|NCT00671034|323872464|FG001|Overall Study|Adverse Event|7|||
94566729|NCT00671034|323872465|FG002|Overall Study|Adverse Event|1|||
94566730|NCT00671034|323872463|FG000|Overall Study|Death|3|||
94566731|NCT00671034|323872464|FG001|Overall Study|Death|2|||
94566732|NCT00671034|323872465|FG002|Overall Study|Death|1|||
94566733|NCT00671034|323872463|FG000|Overall Study|Physician Decision|12|||
94566734|NCT00671034|323872464|FG001|Overall Study|Physician Decision|4|||
94566735|NCT00671034|323872465|FG002|Overall Study|Physician Decision|5|||
94566736|NCT00671034|323872463|FG000|Overall Study|VHR ALL feature|8|||
94566737|NCT00671034|323872464|FG001|Overall Study|VHR ALL feature|3|||
94566738|NCT00671034|323872465|FG002|Overall Study|VHR ALL feature|5|||
94566739|NCT00671034|323872463|FG000|Overall Study|Refusal|5|||
94566740|NCT00671034|323872464|FG001|Overall Study|Refusal|3|||
94566741|NCT00671034|323872465|FG002|Overall Study|Refusal|5|||
94566742|NCT00671034|323872463|FG000|Overall Study|includes Alternative therapy, etc.|6|||
94566743|NCT00671034|323872464|FG001|Overall Study|includes Alternative therapy, etc.|1|||
94566744|NCT00671034|323872465|FG002|Overall Study|includes Alternative therapy, etc.|7|||
94566745|NCT01169103|323872468|FG000|Overall Study|Lost to Follow-up|3|||
94566746|NCT01169103|323872469|FG001|Overall Study|Lost to Follow-up|3|||
94566747|NCT01169103|323872468|FG000|Overall Study|Withdrawal by Subject|3|||
94566748|NCT01169103|323872469|FG001|Overall Study|Withdrawal by Subject|1|||
94566749|NCT03010527|323872470|FG000|Overall Study|Death|0|||
94566750|NCT03010527|323872471|FG001|Overall Study|Death|0|||
94566751|NCT03010527|323872472|FG002|Overall Study|Death|1|||
94566752|NCT03010527|323872470|FG000|Overall Study|Adverse Event|0|||
94566753|NCT03010527|323872471|FG001|Overall Study|Adverse Event|4|||
94566754|NCT03010527|323872472|FG002|Overall Study|Adverse Event|2|||
94566755|NCT03010527|323872470|FG000|Overall Study|Protocol Violation|0|||
94566756|NCT03010527|323872471|FG001|Overall Study|Protocol Violation|1|||
94566757|NCT03010527|323872472|FG002|Overall Study|Protocol Violation|0|||
94566758|NCT03010527|323872470|FG000|Overall Study|Lost to Follow-up|0|||
94566759|NCT03010527|323872471|FG001|Overall Study|Lost to Follow-up|2|||
94566760|NCT03010527|323872472|FG002|Overall Study|Lost to Follow-up|1|||
94566761|NCT03010527|323872470|FG000|Overall Study|Withdrawal by Subject|0|||
94566762|NCT03010527|323872471|FG001|Overall Study|Withdrawal by Subject|3|||
94566763|NCT03010527|323872472|FG002|Overall Study|Withdrawal by Subject|4|||
94566764|NCT03010527|323872470|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
94566765|NCT03010527|323872471|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
94566766|NCT03010527|323872472|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
94566767|NCT03010527|323872470|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
94566768|NCT03010527|323872471|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
94566769|NCT03010527|323872472|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
94566770|NCT03010527|323872470|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
94566771|NCT03010527|323872471|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
94566772|NCT03010527|323872472|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
94566773|NCT03309878|323872475|FG000|Overall Study|Adverse Event|1|||
94566774|NCT03309878|323872476|FG001|Overall Study|Adverse Event|0|||
94566775|NCT03309878|323872477|FG002|Overall Study|Adverse Event|0|||
94566776|NCT03309878|323872478|FG003|Overall Study|Adverse Event|0|||
94566777|NCT03309878|323872475|FG000|Overall Study|Did not maintain eligibility|2|||
94348013|NCT02394028|323054045|FG008|Maintenance Phase|Site closure|0|||
94566778|NCT03309878|323872476|FG001|Overall Study|Did not maintain eligibility|1|||
94566779|NCT03309878|323872477|FG002|Overall Study|Did not maintain eligibility|0|||
94566780|NCT03309878|323872478|FG003|Overall Study|Did not maintain eligibility|0|||
94566781|NCT03309878|323872475|FG000|Overall Study|Withdrawal by Subject|0|||
94566782|NCT03309878|323872476|FG001|Overall Study|Withdrawal by Subject|1|||
94566783|NCT03309878|323872477|FG002|Overall Study|Withdrawal by Subject|0|||
94566784|NCT03309878|323872478|FG003|Overall Study|Withdrawal by Subject|0|||
94566785|NCT02532465|323872482|FG000|Overall Study|Protocol Violation|1|||
94566786|NCT02532465|323872483|FG001|Overall Study|Protocol Violation|0|||
94566787|NCT02532465|323872482|FG000|Overall Study|Lack of Efficacy|0|||
94566788|NCT02532465|323872483|FG001|Overall Study|Lack of Efficacy|1|||
94566789|NCT00824473|323872484|FG000|Overall Study|Adverse Event|4|||
94566790|NCT00824473|323872485|FG001|Overall Study|Adverse Event|5|||
94566791|NCT00824473|323872484|FG000|Overall Study|Lack of Efficacy|2|||
94566792|NCT00824473|323872485|FG001|Overall Study|Lack of Efficacy|2|||
94566793|NCT00824473|323872484|FG000|Overall Study|Protocol Violation|2|||
94566794|NCT00824473|323872485|FG001|Overall Study|Protocol Violation|0|||
94566795|NCT00824473|323872484|FG000|Overall Study|Non-Compliance|4|||
94566796|NCT00824473|323872485|FG001|Overall Study|Non-Compliance|2|||
94566797|NCT00824473|323872484|FG000|Overall Study|Withdrawal by Subject|2|||
94566798|NCT00824473|323872485|FG001|Overall Study|Withdrawal by Subject|3|||
94566799|NCT00824473|323872484|FG000|Overall Study|Other|1|||
94566800|NCT00824473|323872485|FG001|Overall Study|Other|1|||
94566801|NCT00354679|323872486|FG000|Overall Study|Patient Not Treated|1|||
94566802|NCT00988598|323872488|FG000|Overall Study|Withdrawal by Subject|2|||
94566803|NCT00988598|323872489|FG001|Overall Study|Withdrawal by Subject|0|||
94566804|NCT01176058|323872490|FG000|Overall Study|Adverse Event|1|||
94566805|NCT01176058|323872491|FG001|Overall Study|Adverse Event|0|||
94566806|NCT01176058|323872490|FG000|Overall Study|Insufficient clinical response|2|||
94566807|NCT01176058|323872491|FG001|Overall Study|Insufficient clinical response|2|||
94566808|NCT01176058|323872490|FG000|Overall Study|Insufficient mycological response|0|||
94566809|NCT01176058|323872491|FG001|Overall Study|Insufficient mycological response|1|||
94566810|NCT01176058|323872490|FG000|Overall Study|Withdrawal by Subject|1|||
94566811|NCT01176058|323872491|FG001|Overall Study|Withdrawal by Subject|0|||
94566812|NCT00057863|323872502|FG000|Overall Study|Death|1|||
94566813|NCT00057863|323872502|FG000|Overall Study|Withdrawal by Subject|2|||
94566814|NCT01521507|323872503|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
94566815|NCT01521507|323872504|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
94566816|NCT01521507|323872503|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
94566817|NCT01521507|323872504|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
94566818|NCT01521507|323872503|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
94566819|NCT01521507|323872504|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
94566820|NCT01521507|323872503|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
94566821|NCT01521507|323872504|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
94566822|NCT01521507|323872503|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
94566823|NCT01521507|323872504|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
94566824|NCT01521507|323872503|FG000|Stage 2: Observational Design|Physician Decision|1|||
94566825|NCT01521507|323872504|FG001|Stage 2: Observational Design|Physician Decision|0|||
94566826|NCT03634085|323872505|FG000|Overall Study|Adverse Event|1|||
94566827|NCT03634085|323872506|FG001|Overall Study|Adverse Event|0|||
94566828|NCT03634085|323872505|FG000|Overall Study|Withdrawal by Subject|0|||
94566829|NCT03634085|323872506|FG001|Overall Study|Withdrawal by Subject|2|||
94566830|NCT02903160|323872507|FG000|Overall Study|Adverse Event|2|||
94566831|NCT02903160|323872507|FG000|Overall Study|Death|1|||
94566832|NCT02903160|323872507|FG000|Overall Study|Lost to Follow-up|2|||
94566833|NCT02903160|323872507|FG000|Overall Study|Withdrawal by Subject|1|||
94566834|NCT02903160|323872507|FG000|Overall Study|Medical Insurance Barriers|1|||
94566835|NCT00101686|323872508|FG000|Overall Study|Progressive Disease|37|||
94566836|NCT00101686|323872509|FG001|Overall Study|Progressive Disease|28|||
94566837|NCT00101686|323872510|FG002|Overall Study|Progressive Disease|37|||
94566838|NCT00101686|323872511|FG003|Overall Study|Progressive Disease|38|||
94566839|NCT00101686|323872512|FG004|Overall Study|Progressive Disease|28|||
94566840|NCT00101686|323872513|FG005|Overall Study|Progressive Disease|25|||
94566841|NCT00101686|323872514|FG006|Overall Study|Progressive Disease|5|||
94566842|NCT00101686|323872515|FG007|Overall Study|Progressive Disease|7|||
94566843|NCT00101686|323872516|FG008|Overall Study|Progressive Disease|10|||
94566844|NCT00101686|323872517|FG009|Overall Study|Progressive Disease|8|||
94566845|NCT00101686|323872508|FG000|Overall Study|initiation other anti-cancer treatment|4|||
94566846|NCT00101686|323872509|FG001|Overall Study|initiation other anti-cancer treatment|3|||
94566847|NCT00101686|323872510|FG002|Overall Study|initiation other anti-cancer treatment|4|||
94566848|NCT00101686|323872511|FG003|Overall Study|initiation other anti-cancer treatment|3|||
94566849|NCT00101686|323872512|FG004|Overall Study|initiation other anti-cancer treatment|1|||
94566850|NCT00101686|323872513|FG005|Overall Study|initiation other anti-cancer treatment|1|||
94566851|NCT00101686|323872514|FG006|Overall Study|initiation other anti-cancer treatment|2|||
94566852|NCT00101686|323872515|FG007|Overall Study|initiation other anti-cancer treatment|2|||
94566853|NCT00101686|323872516|FG008|Overall Study|initiation other anti-cancer treatment|3|||
94566854|NCT00101686|323872517|FG009|Overall Study|initiation other anti-cancer treatment|3|||
94566855|NCT00101686|323872508|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
94566856|NCT00101686|323872509|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
94566857|NCT00101686|323872510|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
94566858|NCT00101686|323872511|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
94566859|NCT00101686|323872512|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
94566860|NCT00101686|323872513|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
94566861|NCT00101686|323872514|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
94566862|NCT00101686|323872515|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
94566863|NCT00101686|323872516|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
94566864|NCT00101686|323872517|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
94566865|NCT00101686|323872508|FG000|Overall Study|unacceptable toxicity|3|||
94566866|NCT00101686|323872509|FG001|Overall Study|unacceptable toxicity|9|||
94566867|NCT00101686|323872510|FG002|Overall Study|unacceptable toxicity|10|||
94566868|NCT00101686|323872511|FG003|Overall Study|unacceptable toxicity|6|||
94566869|NCT00101686|323872512|FG004|Overall Study|unacceptable toxicity|16|||
94566870|NCT00101686|323872513|FG005|Overall Study|unacceptable toxicity|10|||
94566871|NCT00101686|323872514|FG006|Overall Study|unacceptable toxicity|4|||
94566872|NCT00101686|323872515|FG007|Overall Study|unacceptable toxicity|2|||
94566873|NCT00101686|323872516|FG008|Overall Study|unacceptable toxicity|1|||
94566874|NCT00101686|323872517|FG009|Overall Study|unacceptable toxicity|4|||
94566875|NCT00101686|323872508|FG000|Overall Study|Randomized but did not receive treament|1|||
94566876|NCT00101686|323872509|FG001|Overall Study|Randomized but did not receive treament|6|||
94566877|NCT00101686|323872510|FG002|Overall Study|Randomized but did not receive treament|2|||
94566878|NCT00101686|323872511|FG003|Overall Study|Randomized but did not receive treament|2|||
94566879|NCT00101686|323872512|FG004|Overall Study|Randomized but did not receive treament|2|||
94566880|NCT00101686|323872513|FG005|Overall Study|Randomized but did not receive treament|2|||
94566881|NCT00101686|323872514|FG006|Overall Study|Randomized but did not receive treament|0|||
94566882|NCT00101686|323872515|FG007|Overall Study|Randomized but did not receive treament|1|||
94566883|NCT00101686|323872516|FG008|Overall Study|Randomized but did not receive treament|0|||
94566884|NCT00101686|323872517|FG009|Overall Study|Randomized but did not receive treament|1|||
94566885|NCT00101686|323872508|FG000|Overall Study|intercurrent non-cancer related illness|0|||
94566886|NCT00101686|323872509|FG001|Overall Study|intercurrent non-cancer related illness|0|||
94566887|NCT00101686|323872510|FG002|Overall Study|intercurrent non-cancer related illness|2|||
94566888|NCT00101686|323872511|FG003|Overall Study|intercurrent non-cancer related illness|0|||
94566889|NCT00101686|323872512|FG004|Overall Study|intercurrent non-cancer related illness|1|||
94566890|NCT00101686|323872513|FG005|Overall Study|intercurrent non-cancer related illness|3|||
94566891|NCT00101686|323872514|FG006|Overall Study|intercurrent non-cancer related illness|1|||
94566892|NCT00101686|323872515|FG007|Overall Study|intercurrent non-cancer related illness|0|||
94566893|NCT00101686|323872516|FG008|Overall Study|intercurrent non-cancer related illness|1|||
94566894|NCT00101686|323872517|FG009|Overall Study|intercurrent non-cancer related illness|1|||
94566895|NCT00101686|323872508|FG000|Overall Study|Physician Decision|10|||
94566896|NCT00101686|323872509|FG001|Overall Study|Physician Decision|13|||
94566897|NCT00101686|323872510|FG002|Overall Study|Physician Decision|6|||
94566898|NCT00101686|323872511|FG003|Overall Study|Physician Decision|7|||
94566899|NCT00101686|323872512|FG004|Overall Study|Physician Decision|8|||
94566900|NCT00101686|323872513|FG005|Overall Study|Physician Decision|9|||
94566901|NCT00101686|323872514|FG006|Overall Study|Physician Decision|5|||
94566902|NCT00101686|323872515|FG007|Overall Study|Physician Decision|5|||
94566903|NCT00101686|323872516|FG008|Overall Study|Physician Decision|1|||
94566904|NCT00101686|323872517|FG009|Overall Study|Physician Decision|1|||
94566905|NCT00101686|323872508|FG000|Overall Study|Other|1|||
94566906|NCT00101686|323872509|FG001|Overall Study|Other|4|||
94566907|NCT00101686|323872510|FG002|Overall Study|Other|1|||
94566908|NCT00101686|323872511|FG003|Overall Study|Other|6|||
94566909|NCT00101686|323872512|FG004|Overall Study|Other|2|||
94566910|NCT00101686|323872513|FG005|Overall Study|Other|12|||
94566911|NCT00101686|323872514|FG006|Overall Study|Other|1|||
94566912|NCT00101686|323872515|FG007|Overall Study|Other|5|||
94566913|NCT00101686|323872516|FG008|Overall Study|Other|3|||
94566914|NCT00101686|323872517|FG009|Overall Study|Other|3|||
94566915|NCT00101686|323872508|FG000|Overall Study|Withdrawal by Subject|9|||
94566916|NCT00101686|323872509|FG001|Overall Study|Withdrawal by Subject|8|||
94566917|NCT00101686|323872510|FG002|Overall Study|Withdrawal by Subject|6|||
94566918|NCT00101686|323872511|FG003|Overall Study|Withdrawal by Subject|8|||
94566919|NCT00101686|323872512|FG004|Overall Study|Withdrawal by Subject|8|||
94566920|NCT00101686|323872513|FG005|Overall Study|Withdrawal by Subject|7|||
94566921|NCT00101686|323872514|FG006|Overall Study|Withdrawal by Subject|7|||
94566922|NCT00101686|323872515|FG007|Overall Study|Withdrawal by Subject|7|||
94566923|NCT00101686|323872516|FG008|Overall Study|Withdrawal by Subject|8|||
94566924|NCT00101686|323872517|FG009|Overall Study|Withdrawal by Subject|9|||
94566925|NCT01358825|323872518|FG000|Overall Study|Blood sample not drawn|0|||
94566926|NCT01358825|323872519|FG001|Overall Study|Blood sample not drawn|1|||
94566927|NCT00985465|323872520|FG000|Overall Study|Withdrawal by Subject|1|||
94566928|NCT00985465|323872521|FG001|Overall Study|Withdrawal by Subject|2|||
94566929|NCT00985465|323872520|FG000|Overall Study|Considered to be part of the other group|0|||
94566930|NCT00985465|323872521|FG001|Overall Study|Considered to be part of the other group|1|||
94566931|NCT00890825|323872522|FG000|Overall Study|Withdrawal by Subject|1|||
94566932|NCT00890825|323872523|FG001|Overall Study|Withdrawal by Subject|0|||
94566933|NCT00890825|323872522|FG000|Overall Study|Alive at data cut off (DCO)|13|||
94566934|NCT00890825|323872523|FG001|Overall Study|Alive at data cut off (DCO)|14|||
94237075|NCT00132678|322664111|FG000|Period III (Open-Label Stabilization)|Death|2|||
94237076|NCT00132678|322664112|FG001|Period III (Open-Label Stabilization)|Death|0|||
94237077|NCT00132678|322664113|FG002|Period III (Open-Label Stabilization)|Death|0|||
94237078|NCT00132678|322664111|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
94237079|NCT00132678|322664112|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
94237080|NCT00132678|322664113|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
94237081|NCT00132678|322664111|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
94237082|NCT00132678|322664112|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
94237083|NCT00132678|322664113|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
94237084|NCT00132678|322664111|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
94237085|NCT00132678|322664112|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
94237086|NCT00132678|322664113|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
94237087|NCT00132678|322664111|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
94237088|NCT00132678|322664112|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
94237089|NCT00132678|322664113|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
94237090|NCT00132678|322664111|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
94237091|NCT00132678|322664112|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
94237092|NCT00132678|322664113|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
94237093|NCT00132678|322664111|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
94237094|NCT00132678|322664112|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
94237095|NCT00132678|322664113|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
94237096|NCT00132678|322664111|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
94237097|NCT00132678|322664112|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
94237098|NCT00132678|322664113|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
94237099|NCT00132678|322664111|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
94237100|NCT00132678|322664112|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
94237101|NCT00132678|322664113|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
94237102|NCT00132678|322664111|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
94237103|NCT00132678|322664112|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
94237104|NCT00132678|322664113|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
94237105|NCT00132678|322664111|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
94237106|NCT00132678|322664112|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
94237107|NCT00132678|322664113|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
94237108|NCT00132678|322664111|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
94237109|NCT00132678|322664112|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
94237110|NCT00132678|322664113|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
94237111|NCT00132678|322664111|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
94348014|NCT02394028|323054046|FG009|Maintenance Phase|Site closure|1|||
94348015|NCT02394028|323054047|FG010|Maintenance Phase|Site closure|0|||
94348016|NCT02394028|323054037|FG000|Maintenance Phase|Withdrawal by Subject|0|||
94348017|NCT02394028|323054038|FG001|Maintenance Phase|Withdrawal by Subject|0|||
94348018|NCT02394028|323054039|FG002|Maintenance Phase|Withdrawal by Subject|0|||
94566935|NCT03600740|323872524|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
94566936|NCT01362348|323872525|FG000|Overall Study|Protocol-defined stopping criteria|9|||
94566937|NCT01362348|323872525|FG000|Overall Study|Study closed/terminated|5|||
94566938|NCT00580723|323872526|FG000|Overall Study|Did not want to participate in extension|3|||
94566939|NCT00580723|323872526|FG000|Overall Study|Lost to Follow-up|5|||
94566940|NCT00148759|323872527|FG000|Overall Study|Withdrawal by Subject|1|||
94566941|NCT00148759|323872528|FG001|Overall Study|Withdrawal by Subject|1|||
94566942|NCT00148759|323872527|FG000|Overall Study|Lost to Follow-up|1|||
94566943|NCT00148759|323872528|FG001|Overall Study|Lost to Follow-up|0|||
94566944|NCT02721875|323872530|FG000|Overall Study|Progressive disease/relapse|1|||
94566945|NCT02721875|323872531|FG001|Overall Study|Progressive disease/relapse|0|||
94566946|NCT00880698|323872532|FG000|Overall Study|Death|0|||
94566947|NCT00880698|323872533|FG001|Overall Study|Death|0|||
94566948|NCT00880698|323872534|FG002|Overall Study|Death|1|||
94566949|NCT00880698|323872535|FG003|Overall Study|Death|2|||
94566950|NCT00880698|323872532|FG000|Overall Study|Lost to Follow-up|1|||
94566951|NCT00880698|323872533|FG001|Overall Study|Lost to Follow-up|3|||
94566952|NCT00880698|323872534|FG002|Overall Study|Lost to Follow-up|0|||
94566953|NCT00880698|323872535|FG003|Overall Study|Lost to Follow-up|1|||
94566954|NCT03901144|323872545|FG000|Overall Study|Lost to Follow-up|1|||
94566955|NCT03901144|323872546|FG001|Overall Study|Lost to Follow-up|1|||
94566956|NCT03901144|323872547|FG002|Overall Study|Lost to Follow-up|1|||
94566957|NCT03901144|323872548|FG003|Overall Study|Lost to Follow-up|1|||
94348019|NCT02394028|323054040|FG003|Maintenance Phase|Withdrawal by Subject|0|||
94348020|NCT02394028|323054041|FG004|Maintenance Phase|Withdrawal by Subject|0|||
94566958|NCT05470985|323872556|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
94566959|NCT05470985|323872557|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
94566960|NCT05470985|323872556|FG000|Double Blind Treatment Period|Physician Decision|0|||
94451034|NCT00554515|323438441|FG000|Overall Study|Disease progression|52|||
94451035|NCT00554515|323438441|FG000|Overall Study|Physician Decision|18|||
94451036|NCT00554515|323438441|FG000|Overall Study|Withdrawal by Subject|11|||
94451037|NCT00554515|323438441|FG000|Overall Study|Adverse Event|9|||
94451038|NCT00554515|323438441|FG000|Overall Study|Death|2|||
94451039|NCT00554515|323438441|FG000|Overall Study|Achieved Stable Disease|7|||
94451040|NCT00554515|323438441|FG000|Overall Study|Other|1|||
94451041|NCT00554515|323438441|FG000|Overall Study|Misc|15|||
94451042|NCT01276756|323438442|FG000|Overall Study|Lost to Follow-up|2|||
94451043|NCT01276756|323438443|FG001|Overall Study|Lost to Follow-up|0|||
94451044|NCT01276756|323438442|FG000|Overall Study|Adverse Event|3|||
94451045|NCT01276756|323438443|FG001|Overall Study|Adverse Event|2|||
94451046|NCT02589639|323438444|FG000|Overall Study|Lost to Follow-up|1|||
94451047|NCT02589639|323438445|FG001|Overall Study|Lost to Follow-up|0|||
94451048|NCT02589639|323438446|FG002|Overall Study|Lost to Follow-up|0|||
94451049|NCT02589639|323438444|FG000|Overall Study|Protocol Violation|1|||
94451050|NCT02589639|323438445|FG001|Overall Study|Protocol Violation|0|||
94451051|NCT02589639|323438446|FG002|Overall Study|Protocol Violation|0|||
94451052|NCT02589639|323438444|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
94451053|NCT02589639|323438445|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
94451054|NCT02589639|323438446|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
94451055|NCT02589639|323438444|FG000|Overall Study|Adverse Event|4|||
94451056|NCT02589639|323438445|FG001|Overall Study|Adverse Event|5|||
94451057|NCT02589639|323438446|FG002|Overall Study|Adverse Event|3|||
94451058|NCT02589639|323438444|FG000|Overall Study|Other reason than specified above|1|||
94451059|NCT02589639|323438445|FG001|Overall Study|Other reason than specified above|2|||
94451060|NCT02589639|323438446|FG002|Overall Study|Other reason than specified above|1|||
94451061|NCT02589639|323438444|FG000|Overall Study|Not Treated|0|||
94451062|NCT02589639|323438445|FG001|Overall Study|Not Treated|3|||
94451063|NCT02589639|323438446|FG002|Overall Study|Not Treated|0|||
94451064|NCT00703157|323438454|FG000|Overall Study|Lost to Follow-up|0|||
94451065|NCT00703157|323438455|FG001|Overall Study|Lost to Follow-up|1|||
94451066|NCT00703157|323438454|FG000|Overall Study|source data permanently lost/ other|4|||
94451067|NCT00703157|323438455|FG001|Overall Study|source data permanently lost/ other|1|||
94451068|NCT03759587|323438456|FG000|Overall Study|Adverse Event|5|||
94451069|NCT03759587|323438456|FG000|Overall Study|Progressive Disease|10|||
94451070|NCT03759587|323438456|FG000|Overall Study|Site Terminated by Sponsor|3|||
94451071|NCT03759587|323438456|FG000|Overall Study|Withdrawal by Subject|1|||
94451072|NCT03170362|323438457|FG000|Overall Study|Death|2|||
94451073|NCT03170362|323438458|FG001|Overall Study|Death|2|||
94451074|NCT03170362|323438457|FG000|Overall Study|Withdrawal by Subject|23|||
94451075|NCT03170362|323438458|FG001|Overall Study|Withdrawal by Subject|22|||
94451076|NCT03170362|323438457|FG000|Overall Study|Lost to Follow-up|187|||
94451077|NCT03170362|323438458|FG001|Overall Study|Lost to Follow-up|167|||
94451078|NCT04615403|323438459|FG000|Overall Study|Death|1|||
94451079|NCT00665431|323438460|FG000|Overall Study|Adverse Event|16|||
94451080|NCT00665431|323438461|FG001|Overall Study|Adverse Event|22|||
94451081|NCT00665431|323438462|FG002|Overall Study|Adverse Event|6|||
94451082|NCT00665431|323438460|FG000|Overall Study|Withdrawal by Subject|17|||
94451083|NCT00665431|323438461|FG001|Overall Study|Withdrawal by Subject|25|||
94451084|NCT00665431|323438462|FG002|Overall Study|Withdrawal by Subject|15|||
94451085|NCT00665431|323438460|FG000|Overall Study|Lost to Follow-up|3|||
94451086|NCT00665431|323438461|FG001|Overall Study|Lost to Follow-up|3|||
94451087|NCT00665431|323438462|FG002|Overall Study|Lost to Follow-up|1|||
94451088|NCT00665431|323438460|FG000|Overall Study|Other|4|||
94451089|NCT00665431|323438461|FG001|Overall Study|Other|7|||
94451090|NCT00665431|323438462|FG002|Overall Study|Other|2|||
94451091|NCT00591565|323438467|FG000|Overall Study|lost follow up, withdrawn|5|||
94451092|NCT01578239|323438470|FG000|Treatment Period|Progressive Disease|19|||
94451093|NCT01578239|323438471|FG001|Treatment Period|Progressive Disease|64|||
94451094|NCT01578239|323438470|FG000|Treatment Period|Physician Decision|17|||
94451095|NCT01578239|323438471|FG001|Treatment Period|Physician Decision|17|||
94566961|NCT05470985|323872557|FG001|Double Blind Treatment Period|Physician Decision|1|||
94451096|NCT01578239|323438470|FG000|Treatment Period|Adverse Event|13|||
94451097|NCT01578239|323438471|FG001|Treatment Period|Adverse Event|10|||
94451098|NCT01578239|323438470|FG000|Treatment Period|Non-compliance|2|||
94451099|NCT01578239|323438471|FG001|Treatment Period|Non-compliance|0|||
94451100|NCT01578239|323438470|FG000|Treatment Period|Withdrawal by Subject|10|||
94451101|NCT01578239|323438471|FG001|Treatment Period|Withdrawal by Subject|9|||
94451102|NCT01578239|323438470|FG000|Treatment Period|Other|6|||
94451103|NCT01578239|323438471|FG001|Treatment Period|Other|1|||
94451104|NCT01578239|323438470|FG000|Long-term Follow-Up Period|Death|69|||
94451105|NCT01578239|323438471|FG001|Long-term Follow-Up Period|Death|64|||
94451106|NCT01578239|323438470|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
94451107|NCT01578239|323438471|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
94451108|NCT01578239|323438470|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
94451109|NCT01578239|323438471|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
94451110|NCT01578239|323438470|FG000|Long-term Follow-Up Period|Other|2|||
94566962|NCT05470985|323872556|FG000|Long Term Extension|Adverse Event|0|||
94237112|NCT00132678|322664112|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
94237113|NCT00132678|322664113|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
94237114|NCT00132678|322664111|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
94237115|NCT00132678|322664112|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
94237116|NCT00132678|322664113|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
94237117|NCT00132678|322664111|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
94237118|NCT00132678|322664112|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
94237119|NCT00132678|322664113|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
94237120|NCT00132678|322664111|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
94237121|NCT00132678|322664112|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
94237122|NCT00132678|322664113|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
94237123|NCT00516139|322664115|FG000|Overall Study|Adverse Event|27|||
94237124|NCT00516139|322664115|FG000|Overall Study|Lost to Follow-up|1|||
94237125|NCT00516139|322664115|FG000|Overall Study|Protocol Violation|1|||
94237126|NCT00516139|322664115|FG000|Overall Study|Withdrawal by Subject|8|||
94237127|NCT00516139|322664115|FG000|Overall Study|Lack of Efficacy|1|||
94237128|NCT01270828|322664118|FG000|Pregabalin CR SB|Reason Unspecified|0|||
94237129|NCT01270828|322664119|FG001|Pregabalin CR SB|Reason Unspecified|0|||
94237130|NCT01270828|322664120|FG002|Pregabalin CR SB|Reason Unspecified|8|||
94237131|NCT01270828|322664118|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
94237132|NCT01270828|322664119|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
94237133|NCT01270828|322664120|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
94237134|NCT01270828|322664118|FG000|Pregabalin CR SB|Related adverse event|0|||
94237135|NCT01270828|322664119|FG001|Pregabalin CR SB|Related adverse event|0|||
94237136|NCT01270828|322664120|FG002|Pregabalin CR SB|Related adverse event|46|||
94451111|NCT01578239|323438471|FG001|Long-term Follow-Up Period|Other|2|||
94451112|NCT02644668|323438473|FG000|Overall Study|Adverse Event|2|||
94451113|NCT02644668|323438474|FG001|Overall Study|Adverse Event|0|||
94451114|NCT02644668|323438475|FG002|Overall Study|Adverse Event|1|||
94451115|NCT02644668|323438473|FG000|Overall Study|Protocol Violation|0|||
94451116|NCT02644668|323438474|FG001|Overall Study|Protocol Violation|0|||
94451117|NCT02644668|323438475|FG002|Overall Study|Protocol Violation|1|||
94451118|NCT02644668|323438473|FG000|Overall Study|Withdrawal by Subject|0|||
94451119|NCT02644668|323438474|FG001|Overall Study|Withdrawal by Subject|0|||
94451120|NCT02644668|323438475|FG002|Overall Study|Withdrawal by Subject|1|||
94451121|NCT00961350|323438477|FG000|Overall Study|Adverse Event|18|||
94451122|NCT00961350|323438478|FG001|Overall Study|Adverse Event|33|||
94451123|NCT00961350|323438477|FG000|Overall Study|Withdrawal by Subject|10|||
94451124|NCT00961350|323438478|FG001|Overall Study|Withdrawal by Subject|10|||
94451125|NCT00961350|323438477|FG000|Overall Study|Lost to Follow-up|3|||
94451126|NCT00961350|323438478|FG001|Overall Study|Lost to Follow-up|3|||
94451127|NCT00961350|323438477|FG000|Overall Study|Misc|16|||
94451128|NCT00961350|323438478|FG001|Overall Study|Misc|21|||
94451129|NCT03291431|323438482|FG000|Overall Study|Protocol Violation|2|||
94451130|NCT03291431|323438483|FG001|Overall Study|Protocol Violation|1|||
94451131|NCT03291431|323438482|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
94451132|NCT03291431|323438483|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
94451133|NCT03291431|323438482|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
94451134|NCT03291431|323438483|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
94451135|NCT02134015|323438486|FG000|Overall Study|Protocol Violation|0|||
94451136|NCT02134015|323438487|FG001|Overall Study|Protocol Violation|1|||
94451137|NCT02134015|323438486|FG000|Overall Study|Death|2|||
94451138|NCT02134015|323438487|FG001|Overall Study|Death|1|||
94451139|NCT02134015|323438486|FG000|Overall Study|Reason not provided|1|||
94451140|NCT02134015|323438487|FG001|Overall Study|Reason not provided|2|||
94451141|NCT02134015|323438486|FG000|Overall Study|Clinical progression|14|||
94451142|NCT02134015|323438487|FG001|Overall Study|Clinical progression|7|||
94451143|NCT02134015|323438486|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
94451144|NCT02134015|323438487|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
94451145|NCT02134015|323438486|FG000|Overall Study|Study terminated by sponsor|2|||
94451146|NCT02134015|323438487|FG001|Overall Study|Study terminated by sponsor|3|||
94451147|NCT02134015|323438486|FG000|Overall Study|Adverse Event|9|||
94451148|NCT02134015|323438487|FG001|Overall Study|Adverse Event|10|||
94451149|NCT02134015|323438486|FG000|Overall Study|Withdrawal by Subject|3|||
94451150|NCT02134015|323438487|FG001|Overall Study|Withdrawal by Subject|7|||
94451151|NCT03668119|323439908|FG000|Pre-treatment|Disease Progression|1|||
94451152|NCT03668119|323439909|FG001|Pre-treatment|Disease Progression|0|||
94451153|NCT03668119|323439908|FG000|Treatment|Disease Progression|76|||
94451154|NCT03668119|323439909|FG001|Treatment|Disease Progression|57|||
94451155|NCT03668119|323439908|FG000|Treatment|Study drug toxicity|19|||
94451156|NCT03668119|323439909|FG001|Treatment|Study drug toxicity|1|||
94451157|NCT03668119|323439908|FG000|Treatment|Death|3|||
94451158|NCT03668119|323439909|FG001|Treatment|Death|0|||
94451159|NCT03668119|323439908|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
94237137|NCT01270828|322664118|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
94237138|NCT01270828|322664119|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
94237139|NCT01270828|322664120|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
94237140|NCT01270828|322664118|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
94237141|NCT01270828|322664119|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
94237142|NCT01270828|322664120|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
94237143|NCT01270828|322664118|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
94237144|NCT01270828|322664119|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
94237145|NCT01270828|322664120|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
94237146|NCT01270828|322664118|FG000|Pregabalin CR SB|Unrelated AE|0|||
94237147|NCT01270828|322664119|FG001|Pregabalin CR SB|Unrelated AE|0|||
94237148|NCT01270828|322664120|FG002|Pregabalin CR SB|Unrelated AE|8|||
94237149|NCT01270828|322664118|FG000|Pregabalin CR SB|Protocol Violation|0|||
94237150|NCT01270828|322664119|FG001|Pregabalin CR SB|Protocol Violation|0|||
94237151|NCT01270828|322664120|FG002|Pregabalin CR SB|Protocol Violation|8|||
94237152|NCT01270828|322664118|FG000|Double Blind Phase|Death|0|||
94237153|NCT01270828|322664119|FG001|Double Blind Phase|Death|1|||
94237154|NCT01270828|322664120|FG002|Double Blind Phase|Death|0|||
94237155|NCT01270828|322664118|FG000|Double Blind Phase|Protocol Violation|0|||
94451160|NCT03668119|323439909|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
94451161|NCT03668119|323439908|FG000|Treatment|Withdrawal by Subject|1|||
94451162|NCT03668119|323439909|FG001|Treatment|Withdrawal by Subject|1|||
94451163|NCT03668119|323439908|FG000|Treatment|Participant request to discontinue study treatment|3|||
94451164|NCT03668119|323439909|FG001|Treatment|Participant request to discontinue study treatment|1|||
94451165|NCT03668119|323439908|FG000|Treatment|Maximum Clinical Benefit|0|||
94451166|NCT03668119|323439909|FG001|Treatment|Maximum Clinical Benefit|1|||
94451167|NCT03668119|323439908|FG000|Treatment|Participants completed treatment|27|||
94451168|NCT03668119|323439909|FG001|Treatment|Participants completed treatment|11|||
94451169|NCT03668119|323439908|FG000|Treatment|Other reasons|2|||
94451170|NCT03668119|323439909|FG001|Treatment|Other reasons|1|||
94451171|NCT05336227|323439910|FG000|Overall Study|Adverse Event|1|||
94451172|NCT05336227|323439911|FG001|Overall Study|Adverse Event|0|||
94451173|NCT05336227|323439910|FG000|Overall Study|Lost to Follow-up|2|||
94451174|NCT05336227|323439911|FG001|Overall Study|Lost to Follow-up|0|||
94451175|NCT05336227|323439910|FG000|Overall Study|Withdrawal by Subject|1|||
94451176|NCT05336227|323439911|FG001|Overall Study|Withdrawal by Subject|0|||
94451177|NCT02640950|323439914|FG000|Overall Study|Adverse Event|1|||
94451178|NCT02640950|323439914|FG000|Overall Study|Withdrawal by Subject|1|||
94451179|NCT00915018|323439915|FG000|Overall Study|Death|75|||
94451180|NCT00915018|323439916|FG001|Overall Study|Death|70|||
94566963|NCT05470985|323872557|FG001|Long Term Extension|Adverse Event|1|||
94237156|NCT01270828|322664119|FG001|Double Blind Phase|Protocol Violation|1|||
94348021|NCT02394028|323054042|FG005|Maintenance Phase|Withdrawal by Subject|0|||
94348022|NCT02394028|323054043|FG006|Maintenance Phase|Withdrawal by Subject|0|||
94348023|NCT02394028|323054044|FG007|Maintenance Phase|Withdrawal by Subject|0|||
94348024|NCT02394028|323054045|FG008|Maintenance Phase|Withdrawal by Subject|3|||
94348025|NCT02394028|323054046|FG009|Maintenance Phase|Withdrawal by Subject|12|||
94348026|NCT02394028|323054047|FG010|Maintenance Phase|Withdrawal by Subject|12|||
94348027|NCT02975206|323054052|FG000|Overall Study|Withdrawal by Subject|14|||
94348028|NCT02975206|323054053|FG001|Overall Study|Withdrawal by Subject|11|||
94348029|NCT02975206|323054054|FG002|Overall Study|Withdrawal by Subject|11|||
94348030|NCT02975206|323054052|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
94348031|NCT02975206|323054053|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
94348032|NCT02975206|323054054|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
94348033|NCT01241318|323054058|FG000|Overall Study|Woman: false pregnancies|27|||
94348034|NCT01241318|323054059|FG001|Overall Study|Woman: false pregnancies|15|||
94348035|NCT01241318|323054058|FG000|Overall Study|Woman: miscarriage/abortion|46|||
94348036|NCT01241318|323054059|FG001|Overall Study|Woman: miscarriage/abortion|38|||
94348037|NCT01241318|323054058|FG000|Overall Study|Withdrawal by Subject|175|||
94348038|NCT01241318|323054059|FG001|Overall Study|Withdrawal by Subject|46|||
94348039|NCT01241318|323054058|FG000|Overall Study|Lost to Follow-up|740|||
94348040|NCT01241318|323054059|FG001|Overall Study|Lost to Follow-up|455|||
94348041|NCT01241318|323054058|FG000|Overall Study|Death|2|||
94348042|NCT01241318|323054059|FG001|Overall Study|Death|4|||
94348043|NCT01241318|323054058|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
94348044|NCT01241318|323054059|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
94348045|NCT01241318|323054058|FG000|Overall Study|Woman: Stillborn infant|129|||
94348046|NCT01241318|323054059|FG001|Overall Study|Woman: Stillborn infant|146|||
94348047|NCT02355665|323054069|FG000|Overall Study|Adverse Event|16|||
94451181|NCT00915018|323439915|FG000|Overall Study|Lost to Follow-up|10|||
94451182|NCT00915018|323439916|FG001|Overall Study|Lost to Follow-up|5|||
94451183|NCT00915018|323439915|FG000|Overall Study|Withdrawal by Subject|38|||
94451184|NCT00915018|323439916|FG001|Overall Study|Withdrawal by Subject|27|||
94237157|NCT01270828|322664120|FG002|Double Blind Phase|Protocol Violation|0|||
94451185|NCT00915018|323439915|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
94237158|NCT01270828|322664118|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
94566964|NCT05470985|323872556|FG000|Long Term Extension|Study terminated by sponsor|2|||
94566965|NCT05470985|323872557|FG001|Long Term Extension|Study terminated by sponsor|0|||
94566966|NCT01787461|323872559|FG000|Overall Study|Adverse Event|4|||
94566967|NCT01787461|323872560|FG001|Overall Study|Adverse Event|3|||
94566968|NCT01787461|323872559|FG000|Overall Study|Lost to Follow-up|3|||
94566969|NCT01787461|323872560|FG001|Overall Study|Lost to Follow-up|2|||
94566970|NCT01787461|323872559|FG000|Overall Study|No longer met eligibility criteria|1|||
94566971|NCT01787461|323872560|FG001|Overall Study|No longer met eligibility criteria|0|||
94566972|NCT01787461|323872559|FG000|Overall Study|Withdrawal by Subject|3|||
94566973|NCT01787461|323872560|FG001|Overall Study|Withdrawal by Subject|4|||
94566974|NCT01787461|323872559|FG000|Overall Study|Protocol Violation|3|||
94566975|NCT01787461|323872560|FG001|Overall Study|Protocol Violation|0|||
94566976|NCT03259555|323872561|FG000|Overall Study|Adverse Event|6|||
94566977|NCT03259555|323872562|FG001|Overall Study|Adverse Event|4|||
94566978|NCT03259555|323872561|FG000|Overall Study|Lack of Efficacy|6|||
94566979|NCT03259555|323872562|FG001|Overall Study|Lack of Efficacy|4|||
94566980|NCT03259555|323872561|FG000|Overall Study|Lost to Follow-up|0|||
94566981|NCT03259555|323872562|FG001|Overall Study|Lost to Follow-up|2|||
94566982|NCT03259555|323872561|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94566983|NCT03259555|323872562|FG001|Overall Study|Non-Compliance With Study Drug|0|||
94566984|NCT03259555|323872561|FG000|Overall Study|Progressive Disease|0|||
94566985|NCT03259555|323872562|FG001|Overall Study|Progressive Disease|2|||
94566986|NCT03259555|323872561|FG000|Overall Study|Withdrawal by Subject|19|||
94566987|NCT03259555|323872562|FG001|Overall Study|Withdrawal by Subject|16|||
94566988|NCT03259555|323872561|FG000|Overall Study|Physician Decision|1|||
94566989|NCT03259555|323872562|FG001|Overall Study|Physician Decision|2|||
94566990|NCT03259555|323872561|FG000|Overall Study|Other|1|||
94566991|NCT03259555|323872562|FG001|Overall Study|Other|0|||
94566992|NCT04170543|323872566|FG000|Overall Study|Death|1|||
94566993|NCT04170543|323872567|FG001|Overall Study|Death|1|||
94566994|NCT04170543|323872568|FG002|Overall Study|Death|1|||
94566995|NCT04170543|323872569|FG003|Overall Study|Death|1|||
94566996|NCT04170543|323872570|FG004|Overall Study|Death|1|||
94566997|NCT04170543|323872566|FG000|Overall Study|Lost to Follow-up|3|||
94566998|NCT04170543|323872567|FG001|Overall Study|Lost to Follow-up|3|||
94566999|NCT04170543|323872568|FG002|Overall Study|Lost to Follow-up|0|||
94567000|NCT04170543|323872569|FG003|Overall Study|Lost to Follow-up|3|||
94567001|NCT04170543|323872570|FG004|Overall Study|Lost to Follow-up|1|||
94567002|NCT04170543|323872566|FG000|Overall Study|Withdrawal by Subject|13|||
94567003|NCT04170543|323872567|FG001|Overall Study|Withdrawal by Subject|6|||
94567004|NCT04170543|323872568|FG002|Overall Study|Withdrawal by Subject|5|||
94567005|NCT04170543|323872569|FG003|Overall Study|Withdrawal by Subject|4|||
94567006|NCT04170543|323872570|FG004|Overall Study|Withdrawal by Subject|9|||
94567007|NCT04170543|323872566|FG000|Overall Study|Not able to transition to phase 2b|8|||
94567008|NCT04170543|323872567|FG001|Overall Study|Not able to transition to phase 2b|0|||
94567009|NCT04170543|323872568|FG002|Overall Study|Not able to transition to phase 2b|10|||
94567010|NCT04170543|323872569|FG003|Overall Study|Not able to transition to phase 2b|0|||
94567011|NCT04170543|323872570|FG004|Overall Study|Not able to transition to phase 2b|6|||
94567012|NCT04170543|323872566|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
94567013|NCT04170543|323872567|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
94567014|NCT04170543|323872568|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
94567015|NCT04170543|323872569|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
94567016|NCT04170543|323872570|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
94567017|NCT04170543|323872566|FG000|Overall Study|Not Treated|0|||
94567018|NCT04170543|323872567|FG001|Overall Study|Not Treated|0|||
94567019|NCT04170543|323872568|FG002|Overall Study|Not Treated|0|||
94567020|NCT04170543|323872569|FG003|Overall Study|Not Treated|0|||
94567021|NCT04170543|323872570|FG004|Overall Study|Not Treated|2|||
94567022|NCT04170543|323872566|FG000|Overall Study|(CRF)|16|||
94567023|NCT04170543|323872567|FG001|Overall Study|(CRF)|15|||
94567024|NCT04170543|323872568|FG002|Overall Study|(CRF)|12|||
94567025|NCT04170543|323872569|FG003|Overall Study|(CRF)|17|||
94567026|NCT04170543|323872570|FG004|Overall Study|(CRF)|17|||
94567027|NCT04170543|323872566|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
94567028|NCT04170543|323872567|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
94567029|NCT04170543|323872568|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
94567030|NCT04170543|323872569|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
94567031|NCT04170543|323872570|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
94567032|NCT02910466|323872571|FG000|Overall Study|Adverse Event|1|||
94658548|NCT01172938|324206188|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
94658549|NCT01172938|324206189|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
94567033|NCT02910466|323872571|FG000|Overall Study|Withdrawal by Subject|3|||
94567034|NCT02910466|323872571|FG000|Overall Study|Lost to Follow-up|5|||
94658550|NCT01172938|324206190|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
94567035|NCT02910466|323872571|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
94567036|NCT02910466|323872571|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
94567037|NCT04332107|323872575|FG000|Day 3|Lost to Follow-up|23|||
94567038|NCT04332107|323872576|FG001|Day 3|Lost to Follow-up|14|||
94567039|NCT04332107|323872575|FG000|Day 3|Missing outcome data|3|||
94567040|NCT04332107|323872576|FG001|Day 3|Missing outcome data|6|||
94567041|NCT04332107|323872575|FG000|Day 14|Lost to Follow-up|13|||
94567042|NCT04332107|323872576|FG001|Day 14|Lost to Follow-up|4|||
94567043|NCT04332107|323872575|FG000|Day 14|Missing outcome data|4|||
94567044|NCT04332107|323872576|FG001|Day 14|Missing outcome data|4|||
94567045|NCT04332107|323872575|FG000|Day 21|Lost to Follow-up|10|||
94567046|NCT04332107|323872576|FG001|Day 21|Lost to Follow-up|2|||
94567047|NCT05274958|323872579|FG000|Overall Study|Only completed 1 set of PROMs|22|||
94567048|NCT05274958|323872580|FG001|Overall Study|Only completed 1 set of PROMs|35|||
94567049|NCT00348673|323872592|FG000|Stage 1|Randomized but not Treated|0|||
94567050|NCT00348673|323872593|FG001|Stage 1|Randomized but not Treated|0|||
94567051|NCT00348673|323872594|FG002|Stage 1|Randomized but not Treated|1|||
94567052|NCT00348673|323872595|FG003|Stage 1|Randomized but not Treated|0|||
94567053|NCT00348673|323872596|FG004|Stage 1|Randomized but not Treated|0|||
94567054|NCT00348673|323872597|FG005|Stage 1|Randomized but not Treated|0|||
94567055|NCT00348673|323872598|FG006|Stage 1|Randomized but not Treated|0|||
94567056|NCT00348673|323872599|FG007|Stage 1|Randomized but not Treated|0|||
94567057|NCT00348673|323872600|FG008|Stage 1|Randomized but not Treated|0|||
94567058|NCT02926638|323872601|FG000|Overall Study|Progression|2|||
94567059|NCT02926638|323872602|FG001|Overall Study|Progression|5|||
94567060|NCT02926638|323872601|FG000|Overall Study|Ineligible|1|||
94567061|NCT02926638|323872602|FG001|Overall Study|Ineligible|0|||
94567062|NCT02926638|323872601|FG000|Overall Study|Not protocol specified|1|||
94567063|NCT02926638|323872602|FG001|Overall Study|Not protocol specified|0|||
94567064|NCT00794950|323872603|FG000|BCG Induction|Withdrawal by Subject|2|||
94567065|NCT00794950|323872603|FG000|BCG Induction|ineligible|3|||
94567066|NCT00794950|323872603|FG000|BCG Induction|noncompliant w. BCG|1|||
94567067|NCT00794950|323872603|FG000|BCG Induction|Adverse Event|1|||
94567068|NCT00794950|323872603|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
94567069|NCT00794950|323872603|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
94567070|NCT00794950|323872603|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
94567071|NCT00794950|323872603|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
94567072|NCT02525588|323874737|FG000|Overall Study|Death|3|||
94567073|NCT02525588|323874738|FG001|Overall Study|Death|1|||
94567074|NCT02525588|323874737|FG000|Overall Study|Lost to Follow-up|2|||
94567075|NCT02525588|323874738|FG001|Overall Study|Lost to Follow-up|0|||
94567076|NCT02525588|323874737|FG000|Overall Study|Withdrawal by Subject|1|||
94567077|NCT02525588|323874738|FG001|Overall Study|Withdrawal by Subject|1|||
94567078|NCT02525588|323874737|FG000|Overall Study|Adverse Event|0|||
94567079|NCT02525588|323874738|FG001|Overall Study|Adverse Event|1|||
94567080|NCT02634333|323874740|FG000|Overall Study|Completed out of Window|3|||
94567081|NCT02634333|323874741|FG001|Overall Study|Completed out of Window|2|||
94567082|NCT02634333|323874740|FG000|Overall Study|Missed Visit|5|||
94567083|NCT02634333|323874741|FG001|Overall Study|Missed Visit|2|||
94567084|NCT02634333|323874740|FG000|Overall Study|Lost to Follow-up|12|||
94567085|NCT02634333|323874741|FG001|Overall Study|Lost to Follow-up|7|||
94567086|NCT02634333|323874740|FG000|Overall Study|Withdrawal by Subject|9|||
94567087|NCT02634333|323874741|FG001|Overall Study|Withdrawal by Subject|13|||
94567088|NCT02634333|323874740|FG000|Overall Study|Death|11|||
94567089|NCT02634333|323874741|FG001|Overall Study|Death|8|||
94567090|NCT03001557|323874742|FG000|Core Phase|Randomized but not treated|0|||
94567091|NCT03001557|323874743|FG001|Core Phase|Randomized but not treated|0|||
94567092|NCT03001557|323874744|FG002|Core Phase|Randomized but not treated|1|||
94567093|NCT03001557|323874745|FG003|Core Phase|Randomized but not treated|0|||
94567094|NCT03001557|323874746|FG004|Core Phase|Randomized but not treated|0|||
94567095|NCT03001557|323874747|FG005|Core Phase|Randomized but not treated|0|||
94567096|NCT03001557|323874748|FG006|Core Phase|Randomized but not treated|0|||
94567097|NCT03001557|323874749|FG007|Core Phase|Randomized but not treated|0|||
94567098|NCT03001557|323874742|FG000|Extension Phase|Adverse Event|0|||
94567099|NCT03001557|323874743|FG001|Extension Phase|Adverse Event|0|||
94567100|NCT03001557|323874744|FG002|Extension Phase|Adverse Event|0|||
94567101|NCT03001557|323874745|FG003|Extension Phase|Adverse Event|0|||
94567102|NCT03001557|323874746|FG004|Extension Phase|Adverse Event|0|||
94567103|NCT03001557|323874747|FG005|Extension Phase|Adverse Event|2|||
94658551|NCT01172938|324206182|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
94348048|NCT02355665|323054070|FG001|Overall Study|Adverse Event|24|||
94567104|NCT03001557|323874748|FG006|Extension Phase|Adverse Event|0|||
94567105|NCT03001557|323874749|FG007|Extension Phase|Adverse Event|0|||
94567106|NCT03001557|323874742|FG000|Extension Phase|Withdrawal by Subject|0|||
94567107|NCT03001557|323874743|FG001|Extension Phase|Withdrawal by Subject|0|||
94567108|NCT03001557|323874744|FG002|Extension Phase|Withdrawal by Subject|0|||
94567109|NCT03001557|323874745|FG003|Extension Phase|Withdrawal by Subject|0|||
94567110|NCT03001557|323874746|FG004|Extension Phase|Withdrawal by Subject|0|||
94567111|NCT03001557|323874747|FG005|Extension Phase|Withdrawal by Subject|1|||
94567112|NCT03001557|323874748|FG006|Extension Phase|Withdrawal by Subject|5|||
94567113|NCT03001557|323874749|FG007|Extension Phase|Withdrawal by Subject|2|||
94658552|NCT01172938|324206183|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
94567114|NCT03001557|323874742|FG000|Extension Phase|Lost to Follow-up|0|||
94567115|NCT03001557|323874743|FG001|Extension Phase|Lost to Follow-up|0|||
94567116|NCT03001557|323874744|FG002|Extension Phase|Lost to Follow-up|0|||
94567117|NCT03001557|323874745|FG003|Extension Phase|Lost to Follow-up|0|||
94567118|NCT03001557|323874746|FG004|Extension Phase|Lost to Follow-up|0|||
94567119|NCT03001557|323874747|FG005|Extension Phase|Lost to Follow-up|0|||
94567120|NCT03001557|323874748|FG006|Extension Phase|Lost to Follow-up|2|||
94567121|NCT03001557|323874749|FG007|Extension Phase|Lost to Follow-up|1|||
94567122|NCT03001557|323874742|FG000|Extension Phase|Administrative Reason|0|||
94567123|NCT03001557|323874743|FG001|Extension Phase|Administrative Reason|0|||
94567124|NCT03001557|323874744|FG002|Extension Phase|Administrative Reason|0|||
94567125|NCT03001557|323874745|FG003|Extension Phase|Administrative Reason|0|||
94567126|NCT03001557|323874746|FG004|Extension Phase|Administrative Reason|0|||
94567127|NCT03001557|323874747|FG005|Extension Phase|Administrative Reason|1|||
94567128|NCT03001557|323874748|FG006|Extension Phase|Administrative Reason|3|||
94567129|NCT03001557|323874749|FG007|Extension Phase|Administrative Reason|3|||
94567130|NCT03001557|323874742|FG000|Extension Phase|Loss of caregiver|0|||
94567131|NCT03001557|323874743|FG001|Extension Phase|Loss of caregiver|0|||
94567132|NCT03001557|323874744|FG002|Extension Phase|Loss of caregiver|0|||
94567133|NCT03001557|323874745|FG003|Extension Phase|Loss of caregiver|0|||
94567134|NCT03001557|323874746|FG004|Extension Phase|Loss of caregiver|0|||
94567135|NCT03001557|323874747|FG005|Extension Phase|Loss of caregiver|0|||
94567136|NCT03001557|323874748|FG006|Extension Phase|Loss of caregiver|1|||
94567137|NCT03001557|323874749|FG007|Extension Phase|Loss of caregiver|0|||
94567138|NCT03001557|323874742|FG000|Extension Phase|Others|0|||
94567139|NCT03001557|323874743|FG001|Extension Phase|Others|0|||
94567140|NCT03001557|323874744|FG002|Extension Phase|Others|0|||
94348049|NCT02355665|323054069|FG000|Overall Study|Protocol Violation|2|||
94348050|NCT02355665|323054070|FG001|Overall Study|Protocol Violation|0|||
94348051|NCT02355665|323054069|FG000|Overall Study|Withdrawal by Subject|90|||
94348052|NCT02355665|323054070|FG001|Overall Study|Withdrawal by Subject|100|||
94348053|NCT02355665|323054069|FG000|Overall Study|Lost to Follow-up|131|||
94348054|NCT02355665|323054070|FG001|Overall Study|Lost to Follow-up|103|||
94348055|NCT02355665|323054069|FG000|Overall Study|Death|4|||
94348056|NCT02355665|323054070|FG001|Overall Study|Death|2|||
94567141|NCT03001557|323874745|FG003|Extension Phase|Others|0|||
94567142|NCT03001557|323874746|FG004|Extension Phase|Others|0|||
94567143|NCT03001557|323874747|FG005|Extension Phase|Others|1|||
94567144|NCT03001557|323874748|FG006|Extension Phase|Others|3|||
94567145|NCT03001557|323874749|FG007|Extension Phase|Others|0|||
94567146|NCT01794000|323874750|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
94567147|NCT01794000|323874751|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
94567148|NCT01794000|323874750|FG000|Double-Blind Phase (DBP)|Death|1|||
94567149|NCT01794000|323874751|FG001|Double-Blind Phase (DBP)|Death|2|||
94567150|NCT01794000|323874750|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
94567151|NCT01794000|323874751|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
94567152|NCT01794000|323874750|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
94567153|NCT01794000|323874751|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
94567154|NCT01794000|323874750|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
94658553|NCT01172938|324206184|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
94658554|NCT01172938|324206185|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
94348057|NCT02355665|323054069|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
94348058|NCT02355665|323054070|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
94348059|NCT01984294|323054071|FG000|Overall Study|Randomized but Never Treated|0|||
94348060|NCT01984294|323054072|FG001|Overall Study|Randomized but Never Treated|0|||
94567155|NCT01794000|323874751|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
94567156|NCT01794000|323874750|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
94567157|NCT01794000|323874751|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
94567158|NCT01794000|323874750|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
94237159|NCT01270828|322664119|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
94237160|NCT01270828|322664120|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
94237161|NCT01270828|322664118|FG000|Double Blind Phase|Reason Unspecified|7|||
94237162|NCT01270828|322664119|FG001|Double Blind Phase|Reason Unspecified|4|||
94237163|NCT01270828|322664120|FG002|Double Blind Phase|Reason Unspecified|0|||
94237164|NCT01270828|322664118|FG000|Double Blind Phase|Withdrawal by Subject|6|||
94237165|NCT01270828|322664119|FG001|Double Blind Phase|Withdrawal by Subject|15|||
94237166|NCT01270828|322664120|FG002|Double Blind Phase|Withdrawal by Subject|0|||
94237167|NCT01270828|322664118|FG000|Double Blind Phase|Lost to Follow-up|1|||
94237168|NCT01270828|322664119|FG001|Double Blind Phase|Lost to Follow-up|2|||
94237169|NCT01270828|322664120|FG002|Double Blind Phase|Lost to Follow-up|0|||
94237170|NCT01270828|322664118|FG000|Double Blind Phase|Lack of Efficacy|2|||
94237171|NCT01270828|322664119|FG001|Double Blind Phase|Lack of Efficacy|11|||
94237172|NCT01270828|322664120|FG002|Double Blind Phase|Lack of Efficacy|0|||
94237173|NCT01270828|322664118|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
94237174|NCT01270828|322664119|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
94237175|NCT01270828|322664120|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
94237176|NCT01270828|322664118|FG000|Double Blind Phase|Adverse event related to study drug|5|||
94237177|NCT01270828|322664119|FG001|Double Blind Phase|Adverse event related to study drug|7|||
94237178|NCT01270828|322664120|FG002|Double Blind Phase|Adverse event related to study drug|0|||
94237179|NCT01454739|322664121|FG000|Overall Study|Protocol Violation|2|||
94237180|NCT01454739|322664122|FG001|Overall Study|Protocol Violation|3|||
94237181|NCT01454739|322664121|FG000|Overall Study|Withdrawal by Subject|2|||
94237182|NCT01454739|322664122|FG001|Overall Study|Withdrawal by Subject|6|||
94237183|NCT01454739|322664121|FG000|Overall Study|Other|3|||
94237184|NCT01454739|322664122|FG001|Overall Study|Other|5|||
94237185|NCT01454739|322664121|FG000|Overall Study|Physician Decision|0|||
94237186|NCT01454739|322664122|FG001|Overall Study|Physician Decision|5|||
94237187|NCT01454739|322664121|FG000|Overall Study|Lost to Follow-up|0|||
94237188|NCT01454739|322664122|FG001|Overall Study|Lost to Follow-up|1|||
94237189|NCT01454739|322664121|FG000|Overall Study|Adverse Event|0|||
94237190|NCT01454739|322664122|FG001|Overall Study|Adverse Event|1|||
94237191|NCT01375673|322664123|FG000|Overall Study|Withdrawal by Subject|0|||
94237192|NCT01375673|322664124|FG001|Overall Study|Withdrawal by Subject|1|||
94237193|NCT00126659|322664132|FG000|Overall Study|Adverse Event|0|||
94237194|NCT00126659|322664133|FG001|Overall Study|Adverse Event|0|||
94237195|NCT00126659|322664134|FG002|Overall Study|Adverse Event|2|||
94237196|NCT01013961|322664135|FG000|Overall Study|Adverse Event|2|||
94237197|NCT01013961|322664136|FG001|Overall Study|Adverse Event|2|||
94237198|NCT01013961|322664135|FG000|Overall Study|Withdrawal by Subject|1|||
94237199|NCT01013961|322664136|FG001|Overall Study|Withdrawal by Subject|0|||
94237200|NCT01013961|322664135|FG000|Overall Study|Physician Decision|0|||
94237201|NCT01013961|322664136|FG001|Overall Study|Physician Decision|1|||
94237202|NCT00633945|322664141|FG000|Overall Study|Physician Decision|2|||
94237203|NCT00193479|322664152|FG000|Induction Chemotherapy|Adverse Event|2|||
94237204|NCT00193479|322664152|FG000|Induction Chemotherapy|Disease Progression|1|||
94237205|NCT00193479|322664152|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
94237206|NCT00193479|322664152|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
94237207|NCT03334253|322664155|FG000|Overall Study|Withdrawal by Subject|1|||
94237208|NCT03334253|322664156|FG001|Overall Study|Withdrawal by Subject|0|||
94451186|NCT00915018|323439916|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
94451187|NCT01623310|323439917|FG000|Overall Study|Adverse Event|21|||
94451188|NCT01623310|323439917|FG000|Overall Study|Lost to Follow-up|18|||
94451189|NCT01623310|323439917|FG000|Overall Study|Lack of Efficacy|6|||
94451190|NCT01623310|323439917|FG000|Overall Study|Protocol Violation|6|||
94451191|NCT01623310|323439917|FG000|Overall Study|Withdrawal by Subject|25|||
94451192|NCT01623310|323439917|FG000|Overall Study|Became potentially child-bearing|1|||
94451193|NCT01623310|323439917|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
94451194|NCT01623310|323439917|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
94567159|NCT01794000|323874751|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
94567160|NCT01794000|323874750|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
94567161|NCT01794000|323874751|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
94567162|NCT00718510|323874756|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
94237209|NCT03334253|322664155|FG000|Overall Study|Lost to Follow-up|4|||
94567163|NCT00718510|323874757|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
94567164|NCT00718510|323874756|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
94567165|NCT00718510|323874757|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
94237210|NCT03334253|322664156|FG001|Overall Study|Lost to Follow-up|3|||
94237211|NCT03334253|322664155|FG000|Overall Study|Moved residence|2|||
94237212|NCT03334253|322664156|FG001|Overall Study|Moved residence|2|||
94237213|NCT01592045|322664162|FG000|Overall Study|Disease Progression|1|||
94451195|NCT00326716|323439918|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
94237214|NCT01592045|322664163|FG001|Overall Study|Disease Progression|1|||
94237215|NCT01592045|322664162|FG000|Overall Study|Adverse Event|1|||
94237216|NCT01592045|322664163|FG001|Overall Study|Adverse Event|1|||
94237217|NCT01592045|322664162|FG000|Overall Study|Withdrawal by Subject|1|||
94237218|NCT01592045|322664163|FG001|Overall Study|Withdrawal by Subject|0|||
94237219|NCT01592045|322664162|FG000|Overall Study|Moved out of country|2|||
94237220|NCT01592045|322664163|FG001|Overall Study|Moved out of country|0|||
94237221|NCT02057575|322664164|FG000|Overall Study|Adverse Event|0|||
94237222|NCT02057575|322664165|FG001|Overall Study|Adverse Event|2|||
94237223|NCT02057575|322664166|FG002|Overall Study|Adverse Event|0|||
94237224|NCT02057575|322664167|FG003|Overall Study|Adverse Event|1|||
94237225|NCT02057575|322664164|FG000|Overall Study|Withdrawal by Subject|1|||
94237226|NCT02057575|322664165|FG001|Overall Study|Withdrawal by Subject|0|||
94237227|NCT02057575|322664166|FG002|Overall Study|Withdrawal by Subject|0|||
94237228|NCT02057575|322664167|FG003|Overall Study|Withdrawal by Subject|0|||
94237229|NCT02057575|322664164|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
94237230|NCT02057575|322664165|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
94237231|NCT02057575|322664166|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
94237232|NCT02057575|322664167|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
94237233|NCT02057575|322664164|FG000|Overall Study|Protocol Violation|0|||
94237234|NCT02057575|322664165|FG001|Overall Study|Protocol Violation|1|||
94237235|NCT02057575|322664166|FG002|Overall Study|Protocol Violation|0|||
94237236|NCT02057575|322664167|FG003|Overall Study|Protocol Violation|0|||
94237237|NCT01296555|322664168|FG000|Overall Study|Adverse Event|0|||
94237238|NCT01296555|322664169|FG001|Overall Study|Adverse Event|0|||
94237239|NCT01296555|322664170|FG002|Overall Study|Adverse Event|1|||
94237240|NCT01296555|322664171|FG003|Overall Study|Adverse Event|1|||
94237241|NCT01296555|322664172|FG004|Overall Study|Adverse Event|2|||
94237242|NCT01296555|322664173|FG005|Overall Study|Adverse Event|4|||
94237243|NCT01296555|322664174|FG006|Overall Study|Adverse Event|1|||
94237244|NCT01296555|322664175|FG007|Overall Study|Adverse Event|4|||
94237245|NCT01296555|322664176|FG008|Overall Study|Adverse Event|3|||
94237246|NCT01296555|322664177|FG009|Overall Study|Adverse Event|1|||
94237247|NCT01296555|322664178|FG010|Overall Study|Adverse Event|0|||
94237248|NCT01296555|322664179|FG011|Overall Study|Adverse Event|4|||
94237249|NCT01296555|322664180|FG012|Overall Study|Adverse Event|1|||
94237250|NCT01296555|322664181|FG013|Overall Study|Adverse Event|4|||
94237251|NCT01296555|322664182|FG014|Overall Study|Adverse Event|0|||
94237252|NCT01296555|322664183|FG015|Overall Study|Adverse Event|0|||
94237253|NCT01296555|322664184|FG016|Overall Study|Adverse Event|0|||
94237254|NCT01296555|322664185|FG017|Overall Study|Adverse Event|0|||
94237255|NCT01296555|322664186|FG018|Overall Study|Adverse Event|0|||
94237256|NCT01296555|322664187|FG019|Overall Study|Adverse Event|1|||
94237257|NCT01296555|322664188|FG020|Overall Study|Adverse Event|0|||
94237258|NCT01296555|322664189|FG021|Overall Study|Adverse Event|0|||
94237259|NCT01296555|322664190|FG022|Overall Study|Adverse Event|0|||
94237260|NCT01296555|322664191|FG023|Overall Study|Adverse Event|0|||
94237261|NCT01296555|322664192|FG024|Overall Study|Adverse Event|0|||
94237262|NCT01296555|322664193|FG025|Overall Study|Adverse Event|0|||
94237263|NCT01296555|322664194|FG026|Overall Study|Adverse Event|0|||
94237264|NCT01296555|322664195|FG027|Overall Study|Adverse Event|0|||
94237265|NCT01296555|322664196|FG028|Overall Study|Adverse Event|0|||
94237266|NCT01296555|322664168|FG000|Overall Study|Reason Not Specified|0|||
94237267|NCT01296555|322664169|FG001|Overall Study|Reason Not Specified|0|||
94237268|NCT01296555|322664170|FG002|Overall Study|Reason Not Specified|0|||
94237269|NCT01296555|322664171|FG003|Overall Study|Reason Not Specified|0|||
94237270|NCT01296555|322664172|FG004|Overall Study|Reason Not Specified|0|||
94237271|NCT01296555|322664173|FG005|Overall Study|Reason Not Specified|0|||
94567166|NCT01147666|323874758|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
94567167|NCT01147666|323874759|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
94567168|NCT01147666|323874760|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
94567169|NCT01147666|323874761|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
94567170|NCT01147666|323874762|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
94567171|NCT01147666|323874763|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
94567172|NCT01147666|323874764|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
94567173|NCT01147666|323874765|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
94237272|NCT01296555|322664174|FG006|Overall Study|Reason Not Specified|0|||
94567174|NCT01147666|323874766|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
94688602|NCT00390455|324315527|FG001|Overall Study|Withdrawal by Subject|8|||
94237273|NCT01296555|322664175|FG007|Overall Study|Reason Not Specified|0|||
94237274|NCT01296555|322664176|FG008|Overall Study|Reason Not Specified|0|||
94237275|NCT01296555|322664177|FG009|Overall Study|Reason Not Specified|0|||
94237276|NCT01296555|322664178|FG010|Overall Study|Reason Not Specified|0|||
94237277|NCT01296555|322664179|FG011|Overall Study|Reason Not Specified|0|||
94237278|NCT01296555|322664180|FG012|Overall Study|Reason Not Specified|0|||
94237279|NCT01296555|322664181|FG013|Overall Study|Reason Not Specified|1|||
94237280|NCT01296555|322664182|FG014|Overall Study|Reason Not Specified|2|||
94237281|NCT01296555|322664183|FG015|Overall Study|Reason Not Specified|3|||
94237282|NCT01296555|322664184|FG016|Overall Study|Reason Not Specified|7|||
94567175|NCT01147666|323874767|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
94567176|NCT01147666|323874768|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
94567177|NCT01147666|323874769|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
94567178|NCT01147666|323874770|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
94567179|NCT01147666|323874771|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
94567180|NCT01147666|323874772|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
94567181|NCT01147666|323874758|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
94567182|NCT01147666|323874759|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
94567183|NCT01147666|323874760|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
94567184|NCT01147666|323874761|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
94567185|NCT01147666|323874762|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
94567186|NCT01147666|323874763|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
94567187|NCT01147666|323874764|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
94567188|NCT01147666|323874765|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
94567189|NCT01147666|323874766|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
94567190|NCT01147666|323874767|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
94567191|NCT01147666|323874768|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
94567192|NCT01147666|323874769|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
94567193|NCT01147666|323874770|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
94567194|NCT01147666|323874771|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
94567195|NCT01147666|323874772|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
94567196|NCT01147666|323874758|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
94567197|NCT01147666|323874759|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
94567198|NCT01147666|323874760|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
94567199|NCT01147666|323874761|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
94567200|NCT01147666|323874762|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
94567201|NCT01147666|323874763|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
94567202|NCT01147666|323874764|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
94567203|NCT01147666|323874765|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
94567204|NCT01147666|323874766|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
94567205|NCT01147666|323874767|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
94567206|NCT01147666|323874768|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
94567207|NCT01147666|323874769|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
94567208|NCT01147666|323874770|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
94567209|NCT01147666|323874771|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
94567210|NCT01147666|323874772|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
94567211|NCT01147666|323874758|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
94567212|NCT01147666|323874759|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
94567213|NCT01147666|323874760|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
94567214|NCT01147666|323874761|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
94567215|NCT01147666|323874762|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
94567216|NCT01147666|323874763|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
94567217|NCT01147666|323874764|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
94567218|NCT01147666|323874765|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
94567219|NCT01147666|323874766|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
94567220|NCT01147666|323874767|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
94567221|NCT01147666|323874768|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
94567222|NCT01147666|323874769|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
94567223|NCT01147666|323874770|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
94567224|NCT01147666|323874771|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
94567225|NCT01147666|323874772|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
94567226|NCT01147666|323874758|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
94567227|NCT01147666|323874759|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
94567228|NCT01147666|323874760|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
94567229|NCT01147666|323874761|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
94567230|NCT01147666|323874762|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
94567231|NCT01147666|323874763|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
94567232|NCT01147666|323874764|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
94567233|NCT01147666|323874765|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
94567234|NCT01147666|323874766|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
94567235|NCT01147666|323874767|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
94567236|NCT01147666|323874768|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
94567237|NCT01147666|323874769|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
94658555|NCT01172938|324206186|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
94658556|NCT01172938|324206187|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
94658557|NCT01172938|324206188|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
94658558|NCT01172938|324206189|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
94658559|NCT01172938|324206190|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
94658560|NCT01172938|324206182|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
94658561|NCT01172938|324206183|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
94658562|NCT01172938|324206184|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
94658563|NCT01172938|324206185|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
94658564|NCT01172938|324206186|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
94658565|NCT01172938|324206187|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
94658566|NCT01172938|324206188|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
94658567|NCT01172938|324206189|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
94658568|NCT01172938|324206190|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
94658569|NCT01172938|324206182|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
94658570|NCT01172938|324206183|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
94658571|NCT01172938|324206184|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
94658572|NCT01172938|324206185|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
94237283|NCT01296555|322664185|FG017|Overall Study|Reason Not Specified|4|||
94567238|NCT01147666|323874770|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
94567239|NCT01147666|323874771|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
94567240|NCT01147666|323874772|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
94567241|NCT01147666|323874758|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
94567242|NCT01147666|323874759|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
94567243|NCT01147666|323874760|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
94567244|NCT01147666|323874761|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
94567245|NCT01147666|323874762|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
94567246|NCT01147666|323874763|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
94567247|NCT01147666|323874764|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
94567248|NCT01147666|323874765|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
94567249|NCT01147666|323874766|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
94567250|NCT01147666|323874767|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
94567251|NCT01147666|323874768|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
94567252|NCT01147666|323874769|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
94567253|NCT01147666|323874770|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
94567254|NCT01147666|323874771|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
94567255|NCT01147666|323874772|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
94567256|NCT01147666|323874758|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
94567257|NCT01147666|323874759|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
94567258|NCT01147666|323874760|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
94567259|NCT01147666|323874761|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
94567260|NCT01147666|323874762|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
94567261|NCT01147666|323874763|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
94567262|NCT01147666|323874764|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
94567263|NCT01147666|323874765|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
94567264|NCT01147666|323874766|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
94567265|NCT01147666|323874767|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
94567266|NCT01147666|323874768|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
94567267|NCT01147666|323874769|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
94567268|NCT01147666|323874770|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
94567269|NCT01147666|323874771|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
94567270|NCT01147666|323874772|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
94567271|NCT01147666|323874758|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
94567272|NCT01147666|323874759|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
94567273|NCT01147666|323874760|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
94567274|NCT01147666|323874761|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
94567275|NCT01147666|323874762|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
94567276|NCT01147666|323874763|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
94567277|NCT01147666|323874764|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
94658573|NCT01172938|324206186|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
94658574|NCT01172938|324206187|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
94658575|NCT01172938|324206188|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
94688603|NCT00390455|324315526|FG000|Overall Study|Alternate Treatment|0|||
94237284|NCT01296555|322664186|FG018|Overall Study|Reason Not Specified|3|||
94567278|NCT01147666|323874765|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
94567279|NCT01147666|323874766|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
94567280|NCT01147666|323874767|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
94567281|NCT01147666|323874768|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
94567282|NCT01147666|323874769|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
94567283|NCT01147666|323874770|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
94567284|NCT01147666|323874771|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
94567285|NCT01147666|323874772|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
94567286|NCT01147666|323874758|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
94567287|NCT01147666|323874759|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
94567288|NCT01147666|323874760|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
94567289|NCT01147666|323874761|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
94567290|NCT01147666|323874762|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
94567291|NCT01147666|323874763|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
94567292|NCT01147666|323874764|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
94567293|NCT01147666|323874765|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
94567294|NCT01147666|323874766|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
94567295|NCT01147666|323874767|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
94567296|NCT01147666|323874768|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
94567297|NCT01147666|323874769|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
94567298|NCT01147666|323874770|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
94567299|NCT01147666|323874771|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
94567300|NCT01147666|323874772|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
94567301|NCT01147666|323874758|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
94567302|NCT01147666|323874759|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
94567303|NCT01147666|323874760|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
94567304|NCT01147666|323874761|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
94567305|NCT01147666|323874762|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
94567306|NCT01147666|323874763|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
94567307|NCT01147666|323874764|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
94567308|NCT01147666|323874765|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
94567309|NCT01147666|323874766|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
94567310|NCT01147666|323874767|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
94567311|NCT01147666|323874768|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
94567312|NCT01147666|323874769|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
94567313|NCT01147666|323874770|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
94567314|NCT01147666|323874771|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
94567315|NCT01147666|323874772|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
94567316|NCT01147666|323874758|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
94567317|NCT01147666|323874759|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
94567318|NCT01147666|323874760|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
94567319|NCT01147666|323874761|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
94567320|NCT01147666|323874762|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
94567321|NCT01147666|323874763|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
94567322|NCT01147666|323874764|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
94688604|NCT00390455|324315527|FG001|Overall Study|Alternate Treatment|1|||
94567323|NCT01147666|323874765|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
94567324|NCT01147666|323874766|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
94567325|NCT01147666|323874767|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
94567326|NCT01147666|323874768|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
94567327|NCT01147666|323874769|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
94567328|NCT01147666|323874770|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
94567329|NCT01147666|323874771|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
94567330|NCT01147666|323874772|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
94567331|NCT01147666|323874758|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
94567332|NCT01147666|323874759|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
94567333|NCT01147666|323874760|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
94567334|NCT01147666|323874761|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
94567335|NCT01147666|323874762|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
94567336|NCT01147666|323874763|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
94567337|NCT01147666|323874764|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
94567338|NCT01147666|323874765|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
94567339|NCT01147666|323874766|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
94567340|NCT01147666|323874767|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
94567341|NCT01147666|323874768|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
94567342|NCT01147666|323874769|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
94567343|NCT01147666|323874770|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
94567344|NCT01147666|323874771|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
94567345|NCT01147666|323874772|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
94567346|NCT01147666|323874758|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
94567347|NCT01147666|323874759|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
94567348|NCT01147666|323874760|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
94567349|NCT01147666|323874761|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
94567350|NCT01147666|323874762|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
94567351|NCT01147666|323874763|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
94567352|NCT01147666|323874764|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
94567353|NCT01147666|323874765|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
94567354|NCT01147666|323874766|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
94567355|NCT01147666|323874767|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
94567356|NCT01147666|323874768|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
94567357|NCT01147666|323874769|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
94567358|NCT01147666|323874770|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
94567359|NCT01147666|323874771|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
94567360|NCT01147666|323874772|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
94567361|NCT01147666|323874758|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
94567362|NCT01147666|323874759|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
94567363|NCT01147666|323874760|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
94567364|NCT01147666|323874761|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
94567365|NCT01147666|323874762|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
94567366|NCT01147666|323874763|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
94567367|NCT01147666|323874764|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
94567368|NCT01147666|323874765|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
94567369|NCT01147666|323874766|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
94567370|NCT01147666|323874767|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
94567371|NCT01147666|323874768|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
94567372|NCT01147666|323874769|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
94567373|NCT01147666|323874770|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
94567374|NCT01147666|323874771|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
94567375|NCT01147666|323874772|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
94567376|NCT02748863|323874773|FG000|Treatment Period 1|Adverse Event|0|||
94567377|NCT02748863|323874774|FG001|Treatment Period 1|Adverse Event|1|||
94567378|NCT02748863|323874775|FG002|Treatment Period 1|Adverse Event|0|||
94567379|NCT02748863|323874776|FG003|Treatment Period 1|Adverse Event|0|||
94567380|NCT02748863|323874777|FG004|Treatment Period 1|Adverse Event|0|||
94567381|NCT02748863|323874773|FG000|Treatment Period 1|Lack of Efficacy|0|||
94237285|NCT01296555|322664187|FG019|Overall Study|Reason Not Specified|7|||
94237286|NCT01296555|322664188|FG020|Overall Study|Reason Not Specified|11|||
94237287|NCT01296555|322664189|FG021|Overall Study|Reason Not Specified|5|||
94567382|NCT02748863|323874774|FG001|Treatment Period 1|Lack of Efficacy|0|||
94567383|NCT02748863|323874775|FG002|Treatment Period 1|Lack of Efficacy|1|||
94567384|NCT02748863|323874776|FG003|Treatment Period 1|Lack of Efficacy|0|||
94567385|NCT02748863|323874777|FG004|Treatment Period 1|Lack of Efficacy|0|||
94237288|NCT01296555|322664190|FG022|Overall Study|Reason Not Specified|5|||
94567386|NCT02748863|323874773|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94567387|NCT02748863|323874774|FG001|Treatment Period 1|Withdrawal by Subject|1|||
94567388|NCT02748863|323874775|FG002|Treatment Period 1|Withdrawal by Subject|1|||
94567389|NCT02748863|323874776|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94567390|NCT02748863|323874777|FG004|Treatment Period 1|Withdrawal by Subject|0|||
94567391|NCT02748863|323874773|FG000|Treatment Period 2|Lost to Follow-up|2|||
94567392|NCT02748863|323874774|FG001|Treatment Period 2|Lost to Follow-up|0|||
94567393|NCT02748863|323874775|FG002|Treatment Period 2|Lost to Follow-up|0|||
94567394|NCT02748863|323874776|FG003|Treatment Period 2|Lost to Follow-up|0|||
94567395|NCT02748863|323874777|FG004|Treatment Period 2|Lost to Follow-up|0|||
94567396|NCT02748863|323874773|FG000|Treatment Period 2|Adverse Event|3|||
94567397|NCT02748863|323874774|FG001|Treatment Period 2|Adverse Event|2|||
94567398|NCT02748863|323874775|FG002|Treatment Period 2|Adverse Event|0|||
94567399|NCT02748863|323874776|FG003|Treatment Period 2|Adverse Event|2|||
94567400|NCT02748863|323874777|FG004|Treatment Period 2|Adverse Event|0|||
94567401|NCT02748863|323874773|FG000|Treatment Period 2|Lack of Efficacy|0|||
94567402|NCT02748863|323874774|FG001|Treatment Period 2|Lack of Efficacy|1|||
94567403|NCT02748863|323874775|FG002|Treatment Period 2|Lack of Efficacy|0|||
94567404|NCT02748863|323874776|FG003|Treatment Period 2|Lack of Efficacy|0|||
94567405|NCT02748863|323874777|FG004|Treatment Period 2|Lack of Efficacy|0|||
94567406|NCT02748863|323874773|FG000|Treatment Period 2|Pregnancy|0|||
94567407|NCT02748863|323874774|FG001|Treatment Period 2|Pregnancy|0|||
94567408|NCT02748863|323874775|FG002|Treatment Period 2|Pregnancy|0|||
94567409|NCT02748863|323874776|FG003|Treatment Period 2|Pregnancy|0|||
94567410|NCT02748863|323874777|FG004|Treatment Period 2|Pregnancy|1|||
94567411|NCT04033367|323874779|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
94567412|NCT04033367|323874780|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
94567413|NCT04033367|323874779|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
94567414|NCT04033367|323874780|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
94567415|NCT04033367|323874779|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
94567416|NCT04033367|323874780|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
94567417|NCT04033367|323874779|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
94567418|NCT04033367|323874780|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
94567419|NCT00255190|323874781|FG000|Overall Study|Adverse Event|17|||
94567420|NCT00255190|323874782|FG001|Overall Study|Adverse Event|36|||
94567421|NCT00255190|323874781|FG000|Overall Study|Protocol Violation|2|||
94567422|NCT00255190|323874782|FG001|Overall Study|Protocol Violation|2|||
94567423|NCT00255190|323874781|FG000|Overall Study|Lost to Follow-up|10|||
94567424|NCT00255190|323874782|FG001|Overall Study|Lost to Follow-up|27|||
94567425|NCT00255190|323874781|FG000|Overall Study|Withdrew Consent|17|||
94567426|NCT00255190|323874782|FG001|Overall Study|Withdrew Consent|48|||
94567427|NCT00255190|323874781|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
94567428|NCT00255190|323874782|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
94567429|NCT00255190|323874781|FG000|Overall Study|Erosive esophagitis not healed|0|||
94567430|NCT00255190|323874782|FG001|Overall Study|Erosive esophagitis not healed|20|||
94567431|NCT00255190|323874781|FG000|Overall Study|Various|4|||
94567432|NCT00255190|323874782|FG001|Overall Study|Various|23|||
94567433|NCT00628030|323874785|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
94567434|NCT00628030|323874786|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
94567435|NCT00628030|323874785|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
94567436|NCT00628030|323874786|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
94567437|NCT00628030|323874785|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
94567438|NCT00628030|323874786|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
94567439|NCT01582061|323874787|FG000|Overall Study|Lack of Efficacy|3|||
94567440|NCT01582061|323874788|FG001|Overall Study|Lack of Efficacy|23|||
94567441|NCT01582061|323874787|FG000|Overall Study|Adverse Event|12|||
94567442|NCT01582061|323874788|FG001|Overall Study|Adverse Event|8|||
94567443|NCT01582061|323874787|FG000|Overall Study|Withdrawal by Subject|10|||
94567444|NCT01582061|323874788|FG001|Overall Study|Withdrawal by Subject|4|||
94567445|NCT01582061|323874787|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94567446|NCT01582061|323874788|FG001|Overall Study|Abnormal laboratory value(s)|0|||
94567447|NCT01582061|323874787|FG000|Overall Study|Death|0|||
94567448|NCT01582061|323874788|FG001|Overall Study|Death|1|||
94567449|NCT01582061|323874787|FG000|Overall Study|condition no longer requires study drug|1|||
94567450|NCT01582061|323874788|FG001|Overall Study|condition no longer requires study drug|0|||
94567451|NCT01582061|323874787|FG000|Overall Study|Lost to Follow-up|1|||
94567452|NCT01582061|323874788|FG001|Overall Study|Lost to Follow-up|0|||
94567453|NCT04537793|323874789|FG000|Part B (24 Weeks)|Adverse Event|0|||
94567454|NCT04537793|323874790|FG001|Part B (24 Weeks)|Adverse Event|1|||
94567455|NCT05470387|323874791|FG000|Overall Study|Protocol Violation|0|||
94567456|NCT05470387|323874792|FG001|Overall Study|Protocol Violation|3|||
94567457|NCT00657046|323874793|FG000|Overall Study|Adverse Event|1|||
94567458|NCT00657046|323874794|FG001|Overall Study|Adverse Event|1|||
94567459|NCT00657046|323874795|FG002|Overall Study|Adverse Event|0|||
94567460|NCT00657046|323874793|FG000|Overall Study|Protocol Violation|2|||
94567461|NCT00657046|323874794|FG001|Overall Study|Protocol Violation|2|||
94567462|NCT00657046|323874795|FG002|Overall Study|Protocol Violation|0|||
94567463|NCT00657046|323874793|FG000|Overall Study|Withdrawal by Subject|1|||
94567464|NCT00657046|323874794|FG001|Overall Study|Withdrawal by Subject|0|||
94567465|NCT00657046|323874795|FG002|Overall Study|Withdrawal by Subject|0|||
94567466|NCT00657046|323874793|FG000|Overall Study|Death|0|||
94567467|NCT00657046|323874794|FG001|Overall Study|Death|0|||
94567468|NCT00657046|323874795|FG002|Overall Study|Death|1|||
94567469|NCT00657046|323874793|FG000|Overall Study|Surgery|0|||
94567470|NCT00657046|323874794|FG001|Overall Study|Surgery|0|||
94567471|NCT00657046|323874795|FG002|Overall Study|Surgery|1|||
94567472|NCT01569841|323874798|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
94567473|NCT01569841|323874799|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
94567474|NCT00088530|323874800|FG000|Overall Study|Progressive/Relapsed Disease|28|||
94567475|NCT00088530|323874801|FG001|Overall Study|Progressive/Relapsed Disease|39|||
94567476|NCT00088530|323874800|FG000|Overall Study|Adverse Event|15|||
94567477|NCT00088530|323874801|FG001|Overall Study|Adverse Event|9|||
94567478|NCT00088530|323874800|FG000|Overall Study|Withdrawal by Subject|2|||
94567479|NCT00088530|323874801|FG001|Overall Study|Withdrawal by Subject|5|||
94567480|NCT00088530|323874800|FG000|Overall Study|Lost to Follow-up|2|||
94567481|NCT00088530|323874801|FG001|Overall Study|Lost to Follow-up|0|||
94567482|NCT00088530|323874800|FG000|Overall Study|Physician Decision|2|||
94567483|NCT00088530|323874801|FG001|Overall Study|Physician Decision|0|||
94567484|NCT00088530|323874800|FG000|Overall Study|Sponsor decision|0|||
94567485|NCT00088530|323874801|FG001|Overall Study|Sponsor decision|1|||
94567486|NCT00088530|323874800|FG000|Overall Study|Patient never treated|1|||
94567487|NCT00088530|323874801|FG001|Overall Study|Patient never treated|0|||
94567488|NCT00764361|323874804|FG000|Overall Study|Withdrawal by Subject|2|||
94567489|NCT00764361|323874805|FG001|Overall Study|Withdrawal by Subject|3|||
94567490|NCT00764361|323874804|FG000|Overall Study|Adverse Event|0|||
94567491|NCT00764361|323874805|FG001|Overall Study|Adverse Event|1|||
94567492|NCT00867165|323874806|FG000|Overall Study|Adverse Event|3|||
94567493|NCT00867165|323874807|FG001|Overall Study|Adverse Event|0|||
94567494|NCT00867165|323874806|FG000|Overall Study|Withdrawal by Subject|1|||
94567495|NCT00867165|323874807|FG001|Overall Study|Withdrawal by Subject|0|||
94567496|NCT01168349|323874808|FG000|Overall Study|Death|157|||
94567497|NCT01168349|323874808|FG000|Overall Study|Lost to Follow-up|34|||
94567498|NCT01168349|323874808|FG000|Overall Study|Withdrawal by Subject|9|||
94567499|NCT01168349|323874808|FG000|Overall Study|Kidney transplantation|3|||
94567500|NCT01168349|323874808|FG000|Overall Study|Other|22|||
94567501|NCT01168349|323874808|FG000|Overall Study|Protocol Violation|76|||
94567502|NCT01623115|323874811|FG000|Overall Study|Randomized but not treated|0|||
94567503|NCT01623115|323874812|FG001|Overall Study|Randomized but not treated|1|||
94567504|NCT01623115|323874811|FG000|Overall Study|Physician Decision|1|||
94567505|NCT01623115|323874812|FG001|Overall Study|Physician Decision|0|||
94567506|NCT01623115|323874811|FG000|Overall Study|Participants moved|1|||
94567507|NCT01623115|323874812|FG001|Overall Study|Participants moved|5|||
94567508|NCT01623115|323874811|FG000|Overall Study|Adverse Event|10|||
94567509|NCT01623115|323874812|FG001|Overall Study|Adverse Event|13|||
94567510|NCT01623115|323874811|FG000|Overall Study|Poor compliance to protocol|4|||
94567511|NCT01623115|323874812|FG001|Overall Study|Poor compliance to protocol|10|||
94237289|NCT01296555|322664191|FG023|Overall Study|Reason Not Specified|7|||
94237290|NCT01296555|322664192|FG024|Overall Study|Reason Not Specified|2|||
94237291|NCT01296555|322664193|FG025|Overall Study|Reason Not Specified|2|||
94237292|NCT01296555|322664194|FG026|Overall Study|Reason Not Specified|19|||
94567512|NCT01623115|323874811|FG000|Overall Study|Consent withdrawn by participant|2|||
94237293|NCT01296555|322664195|FG027|Overall Study|Reason Not Specified|11|||
94237294|NCT01296555|322664196|FG028|Overall Study|Reason Not Specified|9|||
94237295|NCT01296555|322664168|FG000|Overall Study|Physician Decision|0|||
94567513|NCT01623115|323874812|FG001|Overall Study|Consent withdrawn by participant|6|||
94567514|NCT01623115|323874811|FG000|Overall Study|Related to study drug administration|0|||
94567515|NCT01623115|323874812|FG001|Overall Study|Related to study drug administration|2|||
94567516|NCT01623115|323874811|FG000|Overall Study|Last visit outside protocol visit window|14|||
94567517|NCT01623115|323874812|FG001|Overall Study|Last visit outside protocol visit window|26|||
94567518|NCT01623115|323874811|FG000|Overall Study|Site closure|1|||
94567519|NCT01623115|323874812|FG001|Overall Study|Site closure|7|||
94567520|NCT01623115|323874811|FG000|Overall Study|Death|0|||
94567521|NCT01623115|323874812|FG001|Overall Study|Death|4|||
94567522|NCT01623115|323874811|FG000|Overall Study|Other than specified above|0|||
94567523|NCT01623115|323874812|FG001|Overall Study|Other than specified above|3|||
94567524|NCT03827655|323874815|FG000|Overall Study|Death|0|||
94567525|NCT03827655|323874816|FG001|Overall Study|Death|0|||
94567526|NCT03827655|323874817|FG002|Overall Study|Death|0|||
94567527|NCT03827655|323874818|FG003|Overall Study|Death|0|||
94567528|NCT03827655|323874819|FG004|Overall Study|Death|1|||
94567529|NCT03827655|323874815|FG000|Overall Study|Protocol Deviation|1|||
94567530|NCT03827655|323874816|FG001|Overall Study|Protocol Deviation|0|||
94567531|NCT03827655|323874817|FG002|Overall Study|Protocol Deviation|1|||
94567532|NCT03827655|323874818|FG003|Overall Study|Protocol Deviation|1|||
94567533|NCT03827655|323874819|FG004|Overall Study|Protocol Deviation|0|||
94567534|NCT03827655|323874815|FG000|Overall Study|Withdrawal by Subject|3|||
94567535|NCT03827655|323874816|FG001|Overall Study|Withdrawal by Subject|2|||
94567536|NCT03827655|323874817|FG002|Overall Study|Withdrawal by Subject|2|||
94567537|NCT03827655|323874818|FG003|Overall Study|Withdrawal by Subject|0|||
94567538|NCT03827655|323874819|FG004|Overall Study|Withdrawal by Subject|1|||
94567539|NCT03827655|323874815|FG000|Overall Study|Reason not Specified|3|||
94567540|NCT03827655|323874816|FG001|Overall Study|Reason not Specified|1|||
94567541|NCT03827655|323874817|FG002|Overall Study|Reason not Specified|1|||
94567542|NCT03827655|323874818|FG003|Overall Study|Reason not Specified|1|||
94567543|NCT03827655|323874819|FG004|Overall Study|Reason not Specified|1|||
94567544|NCT00430716|323874834|FG000|Double Blind Phase|Death|1|||
94567545|NCT00430716|323874835|FG001|Double Blind Phase|Death|0|||
94567546|NCT00430716|323874836|FG002|Double Blind Phase|Death|0|||
94567547|NCT00430716|323874834|FG000|Double Blind Phase|No longer willing to participate|2|||
94567548|NCT00430716|323874835|FG001|Double Blind Phase|No longer willing to participate|1|||
94567549|NCT00430716|323874836|FG002|Double Blind Phase|No longer willing to participate|1|||
94567550|NCT00430716|323874834|FG000|Double Blind Phase|Other|0|||
94567551|NCT00430716|323874835|FG001|Double Blind Phase|Other|2|||
94567552|NCT00430716|323874836|FG002|Double Blind Phase|Other|0|||
94567553|NCT00430716|323874834|FG000|Double Blind Phase|Study terminated by sponsor|1|||
94567554|NCT00430716|323874835|FG001|Double Blind Phase|Study terminated by sponsor|1|||
94567555|NCT00430716|323874836|FG002|Double Blind Phase|Study terminated by sponsor|2|||
94567556|NCT00430716|323874834|FG000|Double Blind Phase|Adverse Event|1|||
94567557|NCT00430716|323874835|FG001|Double Blind Phase|Adverse Event|1|||
94567558|NCT00430716|323874836|FG002|Double Blind Phase|Adverse Event|3|||
94567559|NCT00430716|323874834|FG000|Double Blind Phase|Not treated|1|||
94567560|NCT00430716|323874835|FG001|Double Blind Phase|Not treated|0|||
94567561|NCT00430716|323874836|FG002|Double Blind Phase|Not treated|0|||
94567562|NCT00430716|323874834|FG000|Open Label Phase|Lost to Follow-up|1|||
94567563|NCT00430716|323874835|FG001|Open Label Phase|Lost to Follow-up|0|||
94567564|NCT00430716|323874836|FG002|Open Label Phase|Lost to Follow-up|1|||
94567565|NCT00430716|323874834|FG000|Open Label Phase|No longer willing to participate|0|||
94567566|NCT00430716|323874835|FG001|Open Label Phase|No longer willing to participate|1|||
94567567|NCT00430716|323874836|FG002|Open Label Phase|No longer willing to participate|1|||
94567568|NCT00430716|323874834|FG000|Open Label Phase|Other|3|||
94567569|NCT00430716|323874835|FG001|Open Label Phase|Other|1|||
94567570|NCT00430716|323874836|FG002|Open Label Phase|Other|1|||
94567571|NCT00430716|323874834|FG000|Open Label Phase|Protocol Violation|1|||
94567572|NCT00430716|323874835|FG001|Open Label Phase|Protocol Violation|0|||
94567573|NCT00430716|323874836|FG002|Open Label Phase|Protocol Violation|0|||
94567574|NCT00430716|323874834|FG000|Open Label Phase|Study terminated by sponsor|4|||
94567575|NCT00430716|323874835|FG001|Open Label Phase|Study terminated by sponsor|5|||
94567576|NCT00430716|323874836|FG002|Open Label Phase|Study terminated by sponsor|4|||
94567577|NCT01332994|323874839|FG000|Overall Study|Adverse Event|34|||
94567578|NCT01332994|323874839|FG000|Overall Study|Death|1|||
94567579|NCT01332994|323874839|FG000|Overall Study|Lack of Efficacy|1|||
94567580|NCT01332994|323874839|FG000|Overall Study|Lost to Follow-up|4|||
94567581|NCT01332994|323874839|FG000|Overall Study|Protocol Violation|6|||
94567582|NCT01332994|323874839|FG000|Overall Study|Withdrawal by Subject|15|||
94567583|NCT01332994|323874839|FG000|Overall Study|Administrative Problem|2|||
94567584|NCT01332994|323874839|FG000|Overall Study|Other|8|||
94567585|NCT03087513|323874843|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
94658576|NCT01172938|324206189|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
94567586|NCT00584415|323874844|FG000|Overall Study|Adverse Event|7|||
94567587|NCT04628780|323874845|FG000|Overall Study|Death|0|||
94567588|NCT04628780|323874846|FG001|Overall Study|Death|1|||
94567589|NCT04628780|323874847|FG002|Overall Study|Death|0|||
94567590|NCT04628780|323874848|FG003|Overall Study|Death|0|||
94567591|NCT04628780|323874849|FG004|Overall Study|Death|1|||
94567592|NCT04628780|323874850|FG005|Overall Study|Death|0|||
94567593|NCT04628780|323874845|FG000|Overall Study|Physician Decision|2|||
94567594|NCT04628780|323874846|FG001|Overall Study|Physician Decision|0|||
94567595|NCT04628780|323874847|FG002|Overall Study|Physician Decision|0|||
94567596|NCT04628780|323874848|FG003|Overall Study|Physician Decision|0|||
94567597|NCT04628780|323874849|FG004|Overall Study|Physician Decision|2|||
94567598|NCT04628780|323874850|FG005|Overall Study|Physician Decision|0|||
94567599|NCT04628780|323874845|FG000|Overall Study|Progressive disease|2|||
94567600|NCT04628780|323874846|FG001|Overall Study|Progressive disease|2|||
94567601|NCT04628780|323874847|FG002|Overall Study|Progressive disease|2|||
94567602|NCT04628780|323874848|FG003|Overall Study|Progressive disease|3|||
94567603|NCT04628780|323874849|FG004|Overall Study|Progressive disease|9|||
94567604|NCT04628780|323874850|FG005|Overall Study|Progressive disease|4|||
94567605|NCT04628780|323874845|FG000|Overall Study|Withdrawal by Subject|0|||
94567606|NCT04628780|323874846|FG001|Overall Study|Withdrawal by Subject|1|||
94567607|NCT04628780|323874847|FG002|Overall Study|Withdrawal by Subject|2|||
94567608|NCT04628780|323874848|FG003|Overall Study|Withdrawal by Subject|0|||
94567609|NCT04628780|323874849|FG004|Overall Study|Withdrawal by Subject|3|||
94567610|NCT04628780|323874850|FG005|Overall Study|Withdrawal by Subject|1|||
94567611|NCT04628780|323874845|FG000|Overall Study|Global deterioration of health status|0|||
94567612|NCT04628780|323874846|FG001|Overall Study|Global deterioration of health status|0|||
94567613|NCT04628780|323874847|FG002|Overall Study|Global deterioration of health status|0|||
94567614|NCT04628780|323874848|FG003|Overall Study|Global deterioration of health status|0|||
94567615|NCT04628780|323874849|FG004|Overall Study|Global deterioration of health status|1|||
94567616|NCT04628780|323874850|FG005|Overall Study|Global deterioration of health status|1|||
94567617|NCT00795704|323874851|FG000|Overall Study|Withdrawal by Subject|3|||
94567618|NCT00795704|323874852|FG001|Overall Study|Withdrawal by Subject|2|||
94567619|NCT00795704|323874851|FG000|Overall Study|Adverse Event|1|||
94567620|NCT00795704|323874852|FG001|Overall Study|Adverse Event|1|||
94567621|NCT00428948|323874854|FG000|Overall Study|Lost to Follow-up|15|||
94567622|NCT00428948|323874855|FG001|Overall Study|Lost to Follow-up|8|||
94567623|NCT00428948|323874854|FG000|Overall Study|Adverse Event|148|||
94567624|NCT00428948|323874855|FG001|Overall Study|Adverse Event|24|||
94567625|NCT00428948|323874854|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
94567626|NCT00428948|323874855|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
94567627|NCT00428948|323874854|FG000|Overall Study|Investigator Withdrew Subject|3|||
94567628|NCT00428948|323874855|FG001|Overall Study|Investigator Withdrew Subject|4|||
94567629|NCT00428948|323874854|FG000|Overall Study|Subject Withdrew Consent|50|||
94567630|NCT00428948|323874855|FG001|Overall Study|Subject Withdrew Consent|30|||
94567631|NCT00428948|323874854|FG000|Overall Study|Protocol Deviation|1|||
94567632|NCT00428948|323874855|FG001|Overall Study|Protocol Deviation|1|||
94567633|NCT00556894|323874856|FG000|Overall Study|Adverse Event|2|||
94567634|NCT00556894|323874857|FG001|Overall Study|Adverse Event|3|||
94567635|NCT00556894|323874858|FG002|Overall Study|Adverse Event|3|||
94567636|NCT00556894|323874856|FG000|Overall Study|Death|1|||
94567637|NCT00556894|323874857|FG001|Overall Study|Death|0|||
94567638|NCT00556894|323874858|FG002|Overall Study|Death|0|||
94567639|NCT00556894|323874856|FG000|Overall Study|regulatory decision in Bulgaria|10|||
94567640|NCT00556894|323874857|FG001|Overall Study|regulatory decision in Bulgaria|14|||
94567641|NCT00556894|323874858|FG002|Overall Study|regulatory decision in Bulgaria|13|||
94567642|NCT00556894|323874856|FG000|Overall Study|Change in therapy|2|||
94567643|NCT00556894|323874857|FG001|Overall Study|Change in therapy|1|||
94567644|NCT00556894|323874858|FG002|Overall Study|Change in therapy|2|||
94567645|NCT00556894|323874856|FG000|Overall Study|Withdrawal by Subject|1|||
94567646|NCT00556894|323874857|FG001|Overall Study|Withdrawal by Subject|1|||
94567647|NCT00556894|323874858|FG002|Overall Study|Withdrawal by Subject|1|||
94567648|NCT04393493|323874859|FG000|First 4 Days of Intervention|Early improvement|5|||
94567649|NCT04393493|323874860|FG001|First 4 Days of Intervention|Early improvement|7|||
94567650|NCT01125800|323874862|FG000|Phase I|Protocol Violation|0|||
94567651|NCT01125800|323874863|FG001|Phase I|Protocol Violation|3|||
94567652|NCT01125800|323874864|FG002|Phase I|Protocol Violation|1|||
94567653|NCT01125800|323874865|FG003|Phase I|Protocol Violation|1|||
94567654|NCT01125800|323874866|FG004|Phase I|Protocol Violation|0|||
94567655|NCT01125800|323874862|FG000|Phase I|Adverse Event|2|||
94567656|NCT01125800|323874863|FG001|Phase I|Adverse Event|2|||
94567657|NCT01125800|323874864|FG002|Phase I|Adverse Event|1|||
94567658|NCT01125800|323874865|FG003|Phase I|Adverse Event|7|||
94567659|NCT01125800|323874866|FG004|Phase I|Adverse Event|0|||
94567660|NCT01125800|323874862|FG000|Phase I|Administrative problems|1|||
94567661|NCT01125800|323874863|FG001|Phase I|Administrative problems|0|||
94567662|NCT01125800|323874864|FG002|Phase I|Administrative problems|0|||
94658577|NCT01172938|324206190|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
94658578|NCT01172938|324206182|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
94567663|NCT01125800|323874865|FG003|Phase I|Administrative problems|0|||
94567664|NCT01125800|323874866|FG004|Phase I|Administrative problems|0|||
94567665|NCT01125800|323874862|FG000|Phase I|Withdrawal by Subject|0|||
94567666|NCT01125800|323874863|FG001|Phase I|Withdrawal by Subject|0|||
94567667|NCT01125800|323874864|FG002|Phase I|Withdrawal by Subject|1|||
94567668|NCT01125800|323874865|FG003|Phase I|Withdrawal by Subject|0|||
94567669|NCT01125800|323874866|FG004|Phase I|Withdrawal by Subject|0|||
94567670|NCT01125800|323874862|FG000|Phase I|Disease progression|5|||
94567671|NCT01125800|323874863|FG001|Phase I|Disease progression|4|||
94567672|NCT01125800|323874864|FG002|Phase I|Disease progression|1|||
94567673|NCT01125800|323874865|FG003|Phase I|Disease progression|3|||
94567674|NCT01125800|323874866|FG004|Phase I|Disease progression|0|||
94567675|NCT01125800|323874862|FG000|Phase II|Protocol Violation|0|||
94567676|NCT01125800|323874863|FG001|Phase II|Protocol Violation|0|||
94567677|NCT01125800|323874864|FG002|Phase II|Protocol Violation|0|||
94567678|NCT01125800|323874865|FG003|Phase II|Protocol Violation|0|||
94567679|NCT01125800|323874866|FG004|Phase II|Protocol Violation|1|||
94567680|NCT01125800|323874862|FG000|Phase II|Adverse Event|0|||
94567681|NCT01125800|323874863|FG001|Phase II|Adverse Event|0|||
94567682|NCT01125800|323874864|FG002|Phase II|Adverse Event|0|||
94567683|NCT01125800|323874865|FG003|Phase II|Adverse Event|0|||
94567684|NCT01125800|323874866|FG004|Phase II|Adverse Event|2|||
94567685|NCT01125800|323874862|FG000|Phase II|Disease progression|0|||
94567686|NCT01125800|323874863|FG001|Phase II|Disease progression|0|||
94567687|NCT01125800|323874864|FG002|Phase II|Disease progression|0|||
94567688|NCT01125800|323874865|FG003|Phase II|Disease progression|1|||
94567689|NCT01125800|323874866|FG004|Phase II|Disease progression|8|||
94567690|NCT00717249|323874878|FG000|Overall Study|Lens Discomfort|4|||
94567691|NCT00717249|323874879|FG001|Overall Study|Lens Discomfort|1|||
94567692|NCT00717249|323874878|FG000|Overall Study|Unsatisfactory visual Response|0|||
94567693|NCT00717249|323874879|FG001|Overall Study|Unsatisfactory visual Response|2|||
94237296|NCT01296555|322664169|FG001|Overall Study|Physician Decision|0|||
94567694|NCT00717249|323874878|FG000|Overall Study|Adverse Event|4|||
94567695|NCT00717249|323874879|FG001|Overall Study|Adverse Event|2|||
94567696|NCT00717249|323874878|FG000|Overall Study|Lost to Follow-up|2|||
94567697|NCT00717249|323874879|FG001|Overall Study|Lost to Follow-up|0|||
94567698|NCT00717249|323874878|FG000|Overall Study|Withdrawal by Subject|1|||
94567699|NCT00717249|323874879|FG001|Overall Study|Withdrawal by Subject|2|||
94567700|NCT00717249|323874878|FG000|Overall Study|Pregnancy|6|||
94567701|NCT00717249|323874879|FG001|Overall Study|Pregnancy|3|||
94567702|NCT00717249|323874878|FG000|Overall Study|Protocol Violation|0|||
94567703|NCT00717249|323874879|FG001|Overall Study|Protocol Violation|2|||
94567704|NCT00717249|323874878|FG000|Overall Study|Subject became Ineligible|1|||
94567705|NCT00717249|323874879|FG001|Overall Study|Subject became Ineligible|1|||
94567706|NCT00717249|323874878|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
94567707|NCT00717249|323874879|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
94567708|NCT00717249|323874878|FG000|Overall Study|Gastric Surgery|0|||
94567709|NCT00717249|323874879|FG001|Overall Study|Gastric Surgery|1|||
94567710|NCT00717249|323874878|FG000|Overall Study|Diagnosed with Diabetes|1|||
94567711|NCT00717249|323874879|FG001|Overall Study|Diagnosed with Diabetes|0|||
94567712|NCT00717249|323874878|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
94567713|NCT00717249|323874879|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
94567714|NCT00717249|323874878|FG000|Overall Study|Subject relocated|1|||
94567715|NCT00717249|323874879|FG001|Overall Study|Subject relocated|0|||
94567716|NCT00717249|323874878|FG000|Overall Study|Headaches|1|||
94567717|NCT00717249|323874879|FG001|Overall Study|Headaches|0|||
94567718|NCT00141102|323874880|FG000|Overall Study|Adverse Event|233|||
94567719|NCT00141102|323874881|FG001|Overall Study|Adverse Event|305|||
94567720|NCT00141102|323874880|FG000|Overall Study|Laboratory Abnormality|9|||
94567721|NCT00141102|323874881|FG001|Overall Study|Laboratory Abnormality|33|||
94237297|NCT01296555|322664170|FG002|Overall Study|Physician Decision|0|||
94237298|NCT01296555|322664171|FG003|Overall Study|Physician Decision|0|||
94237299|NCT01296555|322664172|FG004|Overall Study|Physician Decision|1|||
94237300|NCT01296555|322664173|FG005|Overall Study|Physician Decision|0|||
94237301|NCT01296555|322664174|FG006|Overall Study|Physician Decision|0|||
94237302|NCT01296555|322664175|FG007|Overall Study|Physician Decision|0|||
94237303|NCT01296555|322664176|FG008|Overall Study|Physician Decision|0|||
94237304|NCT01296555|322664177|FG009|Overall Study|Physician Decision|0|||
94567722|NCT00141102|323874880|FG000|Overall Study|Lack of Efficacy|21|||
94567723|NCT00141102|323874881|FG001|Overall Study|Lack of Efficacy|26|||
94567724|NCT00141102|323874880|FG000|Overall Study|Lost to Follow-up|29|||
94567725|NCT00141102|323874881|FG001|Overall Study|Lost to Follow-up|32|||
94567726|NCT00141102|323874880|FG000|Overall Study|Other|87|||
94567727|NCT00141102|323874881|FG001|Overall Study|Other|76|||
94567728|NCT00141102|323874880|FG000|Overall Study|Withdrawal by Subject|112|||
94237305|NCT01296555|322664178|FG010|Overall Study|Physician Decision|0|||
94237306|NCT01296555|322664179|FG011|Overall Study|Physician Decision|0|||
94237307|NCT01296555|322664180|FG012|Overall Study|Physician Decision|0|||
94237308|NCT01296555|322664181|FG013|Overall Study|Physician Decision|1|||
94237309|NCT01296555|322664182|FG014|Overall Study|Physician Decision|0|||
94237310|NCT01296555|322664183|FG015|Overall Study|Physician Decision|0|||
94567729|NCT00141102|323874881|FG001|Overall Study|Withdrawal by Subject|142|||
94567730|NCT00141102|323874880|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
94567731|NCT00141102|323874881|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
94567732|NCT00141102|323874880|FG000|Overall Study|Death|2|||
94567733|NCT00141102|323874881|FG001|Overall Study|Death|2|||
94567734|NCT00191334|323874882|FG000|Overall Study|Adverse Event|4|||
94567735|NCT00191334|323874882|FG000|Overall Study|Disease Progression or Relapse|8|||
94237311|NCT01296555|322664184|FG016|Overall Study|Physician Decision|0|||
94237312|NCT01296555|322664185|FG017|Overall Study|Physician Decision|0|||
94567736|NCT00191334|323874882|FG000|Overall Study|Physician Decision|1|||
94567737|NCT00191334|323874882|FG000|Overall Study|Withdrawal by Subject|4|||
94567738|NCT02919761|323874883|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
94567739|NCT02919761|323874884|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
94567740|NCT02919761|323874885|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
94567741|NCT02919761|323874883|FG000|Part 1: Open Label|Adverse Event|1|||
94567742|NCT02919761|323874884|FG001|Part 1: Open Label|Adverse Event|0|||
94567743|NCT02919761|323874885|FG002|Part 1: Open Label|Adverse Event|0|||
94567744|NCT02919761|323874883|FG000|Part 1: Open Label|Lost to Follow-up|1|||
94567745|NCT02919761|323874884|FG001|Part 1: Open Label|Lost to Follow-up|0|||
94567746|NCT02919761|323874885|FG002|Part 1: Open Label|Lost to Follow-up|0|||
94567747|NCT02919761|323874883|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
94567748|NCT02919761|323874884|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
94567749|NCT02919761|323874885|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
94567750|NCT02919761|323874883|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
94567751|NCT02919761|323874884|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
94567752|NCT02919761|323874885|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
94567753|NCT02919761|323874883|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
94567754|NCT02919761|323874884|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
94567755|NCT02919761|323874885|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
94567756|NCT02919761|323874883|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
94567757|NCT02919761|323874884|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
94567758|NCT02919761|323874885|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
94567759|NCT02919761|323874883|FG000|Part 1: Open Label|Termination by Sponsor|1|||
94567760|NCT02919761|323874884|FG001|Part 1: Open Label|Termination by Sponsor|0|||
94567761|NCT02919761|323874885|FG002|Part 1: Open Label|Termination by Sponsor|0|||
94567762|NCT02919761|323874883|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
94567763|NCT02919761|323874884|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
94567764|NCT02919761|323874885|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
94567765|NCT02919761|323874883|FG000|Part 2: Double-blind|Adverse Event|0|||
94567766|NCT02919761|323874884|FG001|Part 2: Double-blind|Adverse Event|1|||
94567767|NCT02919761|323874885|FG002|Part 2: Double-blind|Adverse Event|0|||
94567768|NCT02919761|323874883|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
94567769|NCT02919761|323874884|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
94567770|NCT02919761|323874885|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
94567771|NCT02919761|323874883|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
94567772|NCT02919761|323874884|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
94567773|NCT02919761|323874885|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
94567774|NCT02919761|323874883|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
94567775|NCT02919761|323874884|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
94567776|NCT02919761|323874885|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
94567777|NCT02919761|323874883|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
94567778|NCT02919761|323874884|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
94567779|NCT02919761|323874885|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
94567780|NCT02919761|323874883|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
94567781|NCT02919761|323874884|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
94567782|NCT02919761|323874885|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
94567783|NCT02919761|323874883|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
94567784|NCT02919761|323874884|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
94567785|NCT02919761|323874885|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
94567786|NCT03446313|323874886|FG000|Overall Study|Lost to Follow-up|1|||
94567787|NCT03446313|323874887|FG001|Overall Study|Lost to Follow-up|2|||
94567788|NCT03446313|323874886|FG000|Overall Study|Failed primary screening|3|||
94567789|NCT03446313|323874887|FG001|Overall Study|Failed primary screening|0|||
94567790|NCT03446313|323874886|FG000|Overall Study|Diagnosed with terminal cancer|1|||
94567791|NCT03446313|323874887|FG001|Overall Study|Diagnosed with terminal cancer|0|||
94567792|NCT03446313|323874886|FG000|Overall Study|Excluded from analysis|1|||
94567793|NCT03446313|323874887|FG001|Overall Study|Excluded from analysis|1|||
94567794|NCT01420926|323874893|FG000|Overall Study|Adverse Event|6|||
94567795|NCT01420926|323874894|FG001|Overall Study|Adverse Event|4|||
94567796|NCT01420926|323874893|FG000|Overall Study|Death|18|||
94567797|NCT01420926|323874894|FG001|Overall Study|Death|17|||
94567798|NCT01420926|323874893|FG000|Overall Study|Withdrawal by Subject|11|||
94567799|NCT01420926|323874894|FG001|Overall Study|Withdrawal by Subject|17|||
94567800|NCT01420926|323874893|FG000|Overall Study|Non-protocol treatment|17|||
94567801|NCT01420926|323874894|FG001|Overall Study|Non-protocol treatment|20|||
94567802|NCT01420926|323874893|FG000|Overall Study|Physician Decision|8|||
94567803|NCT01420926|323874894|FG001|Overall Study|Physician Decision|5|||
94567804|NCT02831764|323877311|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
94567805|NCT02831764|323877312|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
94567806|NCT02831764|323877313|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
94567807|NCT02831764|323877314|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
94567808|NCT02831764|323877315|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
94567809|NCT02831764|323877311|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
94567810|NCT02831764|323877312|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
94567811|NCT02831764|323877313|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
94567812|NCT02831764|323877314|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
94567813|NCT02831764|323877315|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
94567814|NCT02831764|323877311|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
94567815|NCT02831764|323877312|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
94567816|NCT02831764|323877313|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
94567817|NCT02831764|323877314|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
94567818|NCT02831764|323877315|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
94567819|NCT02831764|323877311|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
94567820|NCT02831764|323877312|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
94567821|NCT02831764|323877313|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
94567822|NCT02831764|323877314|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
94567823|NCT02831764|323877315|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
94567824|NCT02831764|323877311|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
94567825|NCT02831764|323877312|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
94567826|NCT02831764|323877313|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
94567827|NCT02831764|323877314|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
94567828|NCT02831764|323877315|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
94567829|NCT02831764|323877311|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
94567830|NCT02831764|323877312|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
94567831|NCT02831764|323877313|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
94567832|NCT02831764|323877314|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
94567833|NCT02831764|323877315|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
94567834|NCT02831764|323877311|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
94567835|NCT02831764|323877312|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
94567836|NCT02831764|323877313|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
94567837|NCT02831764|323877314|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
94567838|NCT02831764|323877315|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
94567839|NCT02831764|323877311|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
94567840|NCT02831764|323877312|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
94567841|NCT02831764|323877313|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
94567842|NCT02831764|323877314|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
94567843|NCT02831764|323877315|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
94567844|NCT02831764|323877311|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
94567845|NCT02831764|323877312|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
94567846|NCT02831764|323877313|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
94567847|NCT02831764|323877314|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
94567848|NCT02831764|323877315|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
94567849|NCT02831764|323877311|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
94567850|NCT02831764|323877312|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
94567851|NCT02831764|323877313|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
94567852|NCT02831764|323877314|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
94567853|NCT02831764|323877315|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
94567854|NCT02831764|323877311|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
94567855|NCT02831764|323877312|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
94567856|NCT02831764|323877313|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
94567857|NCT02831764|323877314|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
94567858|NCT02831764|323877315|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
94567859|NCT02831764|323877311|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
94567860|NCT02831764|323877312|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
94567861|NCT02831764|323877313|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
94567862|NCT02831764|323877314|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
94567863|NCT02831764|323877315|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
94567864|NCT02831764|323877311|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
94567865|NCT02831764|323877312|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
94567866|NCT02831764|323877313|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
94567867|NCT02831764|323877314|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
94567868|NCT02831764|323877315|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
94567869|NCT02831764|323877311|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
94567870|NCT02831764|323877312|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
94567871|NCT02831764|323877313|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
94567872|NCT02831764|323877314|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
94567873|NCT02831764|323877315|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
94567874|NCT02831764|323877311|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
94567875|NCT02831764|323877312|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
94567876|NCT02831764|323877313|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
94567877|NCT02831764|323877314|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
94567878|NCT02831764|323877315|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
94567879|NCT02831764|323877311|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
94567880|NCT02831764|323877312|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
94567881|NCT02831764|323877313|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
94567882|NCT02831764|323877314|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
94567883|NCT02831764|323877315|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
94567884|NCT02831764|323877311|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
94567885|NCT02831764|323877312|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
94567886|NCT02831764|323877313|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
94567887|NCT02831764|323877314|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
94567888|NCT02831764|323877315|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
94567889|NCT02831764|323877311|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
94567890|NCT02831764|323877312|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
94567891|NCT02831764|323877313|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
94567892|NCT02831764|323877314|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
94567893|NCT02831764|323877315|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
94567894|NCT02831764|323877311|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
94567895|NCT02831764|323877312|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
94567896|NCT02831764|323877313|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
94567897|NCT02831764|323877314|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
94567898|NCT02831764|323877315|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
94567899|NCT01045967|323877321|FG000|Second Intervention|Protocol Violation|0|||
94567900|NCT01045967|323877322|FG001|Second Intervention|Protocol Violation|1|||
94567901|NCT00985673|323877323|FG000|Overall Study|Lost to Follow-up|6|||
94567902|NCT00985673|323877324|FG001|Overall Study|Lost to Follow-up|7|||
94567903|NCT00985673|323877325|FG002|Overall Study|Lost to Follow-up|6|||
94567904|NCT00985673|323877326|FG003|Overall Study|Lost to Follow-up|10|||
94567905|NCT00985673|323877327|FG004|Overall Study|Lost to Follow-up|5|||
94567906|NCT00985673|323877328|FG005|Overall Study|Lost to Follow-up|3|||
94567907|NCT00985673|323877323|FG000|Overall Study|Withdrawal by Subject|0|||
94567908|NCT00985673|323877324|FG001|Overall Study|Withdrawal by Subject|4|||
94567909|NCT00985673|323877325|FG002|Overall Study|Withdrawal by Subject|5|||
94567910|NCT00985673|323877326|FG003|Overall Study|Withdrawal by Subject|2|||
94567911|NCT00985673|323877327|FG004|Overall Study|Withdrawal by Subject|2|||
94567912|NCT00985673|323877328|FG005|Overall Study|Withdrawal by Subject|3|||
94567913|NCT00985673|323877323|FG000|Overall Study|Other|1|||
94567914|NCT00985673|323877324|FG001|Overall Study|Other|0|||
94567915|NCT00985673|323877325|FG002|Overall Study|Other|1|||
94567916|NCT00985673|323877326|FG003|Overall Study|Other|0|||
94567917|NCT00985673|323877327|FG004|Overall Study|Other|1|||
94567918|NCT00985673|323877328|FG005|Overall Study|Other|0|||
94567919|NCT00404651|323877333|FG000|Overall Study|Serious Adverse Event|0|||
94567920|NCT00404651|323877334|FG001|Overall Study|Serious Adverse Event|0|||
94567921|NCT00404651|323877335|FG002|Overall Study|Serious Adverse Event|2|||
94567922|NCT00404651|323877336|FG003|Overall Study|Serious Adverse Event|0|||
94567923|NCT00404651|323877333|FG000|Overall Study|Protocol Violation|10|||
94658579|NCT01172938|324206183|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
94348061|NCT01984294|323054073|FG002|Overall Study|Randomized but Never Treated|1|||
94567924|NCT00404651|323877334|FG001|Overall Study|Protocol Violation|5|||
94567925|NCT00404651|323877335|FG002|Overall Study|Protocol Violation|14|||
94348062|NCT01984294|323054071|FG000|Overall Study|Lack of Efficacy|4|||
94348063|NCT01984294|323054072|FG001|Overall Study|Lack of Efficacy|2|||
94348064|NCT01984294|323054073|FG002|Overall Study|Lack of Efficacy|6|||
94348065|NCT01984294|323054071|FG000|Overall Study|Adverse Event|0|||
94348066|NCT01984294|323054072|FG001|Overall Study|Adverse Event|1|||
94567926|NCT00404651|323877336|FG003|Overall Study|Protocol Violation|5|||
94567927|NCT00404651|323877333|FG000|Overall Study|Lost to Follow-up|15|||
94567928|NCT00404651|323877334|FG001|Overall Study|Lost to Follow-up|11|||
94567929|NCT00404651|323877335|FG002|Overall Study|Lost to Follow-up|13|||
94567930|NCT00404651|323877336|FG003|Overall Study|Lost to Follow-up|10|||
94567931|NCT00404651|323877333|FG000|Overall Study|Withdrawal by Subject|14|||
94567932|NCT00404651|323877334|FG001|Overall Study|Withdrawal by Subject|12|||
94567933|NCT00404651|323877335|FG002|Overall Study|Withdrawal by Subject|16|||
94567934|NCT00404651|323877336|FG003|Overall Study|Withdrawal by Subject|6|||
94567935|NCT02632344|323877337|FG000|Overall Study|Adverse Event|3|||
94567936|NCT02632344|323877337|FG000|Overall Study|Lack of Efficacy|3|||
94567937|NCT02632344|323877337|FG000|Overall Study|Withdrawal by Subject|2|||
94567938|NCT02469623|323877340|FG000|Overall Study|Not consented for long-term follow-up|4|||
94567939|NCT02469623|323877340|FG000|Overall Study|Lost to Follow-up|4|||
94567940|NCT02469623|323877340|FG000|Overall Study|Withdrawal by Subject|2|||
94567941|NCT02469623|323877340|FG000|Overall Study|Death|3|||
94567942|NCT04073186|323877341|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
94567943|NCT04073186|323877341|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
94237313|NCT01296555|322664186|FG018|Overall Study|Physician Decision|0|||
94237314|NCT01296555|322664187|FG019|Overall Study|Physician Decision|1|||
94237315|NCT01296555|322664188|FG020|Overall Study|Physician Decision|0|||
94237316|NCT01296555|322664189|FG021|Overall Study|Physician Decision|0|||
94237317|NCT01296555|322664190|FG022|Overall Study|Physician Decision|0|||
94237318|NCT01296555|322664191|FG023|Overall Study|Physician Decision|0|||
94237319|NCT01296555|322664192|FG024|Overall Study|Physician Decision|0|||
94237320|NCT01296555|322664193|FG025|Overall Study|Physician Decision|0|||
94237321|NCT01296555|322664194|FG026|Overall Study|Physician Decision|0|||
94237322|NCT01296555|322664195|FG027|Overall Study|Physician Decision|0|||
94237323|NCT01296555|322664196|FG028|Overall Study|Physician Decision|0|||
94237324|NCT01296555|322664168|FG000|Overall Study|Progressive Disease|6|||
94237325|NCT01296555|322664169|FG001|Overall Study|Progressive Disease|3|||
94237326|NCT01296555|322664170|FG002|Overall Study|Progressive Disease|3|||
94237327|NCT01296555|322664171|FG003|Overall Study|Progressive Disease|7|||
94237328|NCT01296555|322664172|FG004|Overall Study|Progressive Disease|6|||
94237329|NCT01296555|322664173|FG005|Overall Study|Progressive Disease|16|||
94237330|NCT01296555|322664174|FG006|Overall Study|Progressive Disease|16|||
94237331|NCT01296555|322664175|FG007|Overall Study|Progressive Disease|8|||
94237332|NCT01296555|322664176|FG008|Overall Study|Progressive Disease|7|||
94237333|NCT01296555|322664177|FG009|Overall Study|Progressive Disease|18|||
94237334|NCT01296555|322664178|FG010|Overall Study|Progressive Disease|7|||
94237335|NCT01296555|322664179|FG011|Overall Study|Progressive Disease|14|||
94237336|NCT01296555|322664180|FG012|Overall Study|Progressive Disease|5|||
94237337|NCT01296555|322664181|FG013|Overall Study|Progressive Disease|12|||
94237338|NCT01296555|322664182|FG014|Overall Study|Progressive Disease|1|||
94237339|NCT01296555|322664183|FG015|Overall Study|Progressive Disease|1|||
94237340|NCT01296555|322664184|FG016|Overall Study|Progressive Disease|0|||
94237341|NCT01296555|322664185|FG017|Overall Study|Progressive Disease|0|||
94237342|NCT01296555|322664186|FG018|Overall Study|Progressive Disease|0|||
94237343|NCT01296555|322664187|FG019|Overall Study|Progressive Disease|1|||
94237344|NCT01296555|322664188|FG020|Overall Study|Progressive Disease|0|||
94237345|NCT01296555|322664189|FG021|Overall Study|Progressive Disease|0|||
94237346|NCT01296555|322664190|FG022|Overall Study|Progressive Disease|0|||
94237347|NCT01296555|322664191|FG023|Overall Study|Progressive Disease|0|||
94237348|NCT01296555|322664192|FG024|Overall Study|Progressive Disease|1|||
94237349|NCT01296555|322664193|FG025|Overall Study|Progressive Disease|0|||
94237350|NCT01296555|322664194|FG026|Overall Study|Progressive Disease|5|||
94237351|NCT01296555|322664195|FG027|Overall Study|Progressive Disease|1|||
94237352|NCT01296555|322664196|FG028|Overall Study|Progressive Disease|0|||
94237353|NCT01296555|322664168|FG000|Overall Study|Protocol Violation|0|||
94237354|NCT01296555|322664169|FG001|Overall Study|Protocol Violation|0|||
94237355|NCT01296555|322664170|FG002|Overall Study|Protocol Violation|0|||
94237356|NCT01296555|322664171|FG003|Overall Study|Protocol Violation|0|||
94237357|NCT01296555|322664172|FG004|Overall Study|Protocol Violation|0|||
94237358|NCT01296555|322664173|FG005|Overall Study|Protocol Violation|0|||
94237359|NCT01296555|322664174|FG006|Overall Study|Protocol Violation|0|||
94237360|NCT01296555|322664175|FG007|Overall Study|Protocol Violation|0|||
94237361|NCT01296555|322664176|FG008|Overall Study|Protocol Violation|0|||
94451196|NCT00326716|323439919|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
94451197|NCT00326716|323439920|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
94451198|NCT00326716|323439921|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
94451199|NCT01568034|323439922|FG000|Overall Study|Withdrawal by Subject|1|||
94451200|NCT01568034|323439923|FG001|Overall Study|Withdrawal by Subject|0|||
94451201|NCT01568034|323439924|FG002|Overall Study|Withdrawal by Subject|0|||
94451202|NCT01568034|323439925|FG003|Overall Study|Withdrawal by Subject|0|||
94451203|NCT02101736|323439932|FG000|Overall Study|Protocol Violation|3|||
94451204|NCT02101736|323439933|FG001|Overall Study|Protocol Violation|0|||
94451205|NCT02101736|323439932|FG000|Overall Study|Withdrawal by Subject|1|||
94451206|NCT02101736|323439933|FG001|Overall Study|Withdrawal by Subject|1|||
94451207|NCT02498444|323439934|FG000|Overall Study|Withdrawal by Subject|3|||
94451208|NCT02498444|323439935|FG001|Overall Study|Withdrawal by Subject|0|||
94451209|NCT02498444|323439934|FG000|Overall Study|Physician Decision|1|||
94451210|NCT02498444|323439935|FG001|Overall Study|Physician Decision|0|||
94237362|NCT01296555|322664177|FG009|Overall Study|Protocol Violation|0|||
94237363|NCT01296555|322664178|FG010|Overall Study|Protocol Violation|0|||
94237364|NCT01296555|322664179|FG011|Overall Study|Protocol Violation|0|||
94237365|NCT01296555|322664180|FG012|Overall Study|Protocol Violation|0|||
94237366|NCT01296555|322664181|FG013|Overall Study|Protocol Violation|1|||
94237367|NCT01296555|322664182|FG014|Overall Study|Protocol Violation|0|||
94237368|NCT01296555|322664183|FG015|Overall Study|Protocol Violation|0|||
94237369|NCT01296555|322664184|FG016|Overall Study|Protocol Violation|0|||
94237370|NCT01296555|322664185|FG017|Overall Study|Protocol Violation|0|||
94237371|NCT01296555|322664186|FG018|Overall Study|Protocol Violation|0|||
94237372|NCT01296555|322664187|FG019|Overall Study|Protocol Violation|0|||
94237373|NCT01296555|322664188|FG020|Overall Study|Protocol Violation|0|||
94237374|NCT01296555|322664189|FG021|Overall Study|Protocol Violation|0|||
94237375|NCT01296555|322664190|FG022|Overall Study|Protocol Violation|0|||
94451211|NCT02027545|323439936|FG000|Overall Study|Failed to sign HIPAA|0|||
94237376|NCT01296555|322664191|FG023|Overall Study|Protocol Violation|0|||
94567944|NCT04073186|323877341|FG000|First Wearing Cycle|Protocol Violation|1|||
94567945|NCT04073186|323877341|FG000|First Wearing Cycle|Lens Discomfort|2|||
94567946|NCT04073186|323877341|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
94567947|NCT04073186|323877341|FG000|Second Wearing Cycle|Adverse Event|1|||
94567948|NCT01755234|323877342|FG000|Overall Study|Lost to Follow-up|11|||
94567949|NCT01755234|323877343|FG001|Overall Study|Lost to Follow-up|6|||
94567950|NCT01755234|323877342|FG000|Overall Study|Change in surgical case|2|||
94451212|NCT02027545|323439937|FG001|Overall Study|Failed to sign HIPAA|2|||
94451213|NCT02027545|323439936|FG000|Overall Study|Failed to attend study visit|2|||
94451214|NCT02027545|323439937|FG001|Overall Study|Failed to attend study visit|0|||
94451215|NCT02027545|323439936|FG000|Overall Study|Protocol Violation|1|||
94451216|NCT02027545|323439937|FG001|Overall Study|Protocol Violation|0|||
94451217|NCT00778817|323439943|FG000|Overall Study|Adverse Event|2|||
94451218|NCT00778817|323439943|FG000|Overall Study|Withdrawal by Subject|2|||
94451219|NCT02801617|323439944|FG000|Overall Study|Protocol Violation|2|||
94451220|NCT02801617|323439945|FG001|Overall Study|Protocol Violation|6|||
94451221|NCT01164579|323439946|FG000|Overall Study|Lack of Efficacy|0|||
94451222|NCT01164579|323439947|FG001|Overall Study|Lack of Efficacy|0|||
94451223|NCT01164579|323439948|FG002|Overall Study|Lack of Efficacy|6|||
94451224|NCT01164579|323439946|FG000|Overall Study|Lost to Follow-up|1|||
94451225|NCT01164579|323439947|FG001|Overall Study|Lost to Follow-up|1|||
94451226|NCT01164579|323439948|FG002|Overall Study|Lost to Follow-up|0|||
94451227|NCT01164579|323439946|FG000|Overall Study|Withdrawal by Subject|2|||
94451228|NCT01164579|323439947|FG001|Overall Study|Withdrawal by Subject|5|||
94451229|NCT01164579|323439948|FG002|Overall Study|Withdrawal by Subject|3|||
94451230|NCT01164579|323439946|FG000|Overall Study|Protocol Violation|0|||
94451231|NCT01164579|323439947|FG001|Overall Study|Protocol Violation|1|||
94451232|NCT01164579|323439948|FG002|Overall Study|Protocol Violation|2|||
94451233|NCT01164579|323439946|FG000|Overall Study|Adverse Event|4|||
94451234|NCT01164579|323439947|FG001|Overall Study|Adverse Event|2|||
94451235|NCT01164579|323439948|FG002|Overall Study|Adverse Event|5|||
94451236|NCT01164579|323439946|FG000|Overall Study|Reason not specified|1|||
94451237|NCT01164579|323439947|FG001|Overall Study|Reason not specified|0|||
94451238|NCT01164579|323439948|FG002|Overall Study|Reason not specified|0|||
94451239|NCT01464593|323439949|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
94451240|NCT00302328|323439950|FG000|Overall Study|Physician Decision|0|||
94451241|NCT00302328|323439951|FG001|Overall Study|Physician Decision|1|||
94451242|NCT00302328|323439952|FG002|Overall Study|Physician Decision|0|||
94451243|NCT04411810|323439953|FG000|Overall Study|Screen failure|1|||
94451244|NCT04411810|323439953|FG000|Overall Study|Withdrawal by Subject|1|||
94451245|NCT01920958|323439954|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
94451246|NCT02490371|323439955|FG000|Overall Study|Lost to Follow-up|1|||
94451247|NCT02490371|323439956|FG001|Overall Study|Lost to Follow-up|1|||
94451248|NCT01718535|323439957|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
94451249|NCT01718535|323439958|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
94451250|NCT01718535|323439959|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
94451251|NCT01718535|323439960|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
94451252|NCT01718535|323439961|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
94451253|NCT01718535|323439962|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
94451254|NCT01718535|323439963|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
94451255|NCT01718535|323439964|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
94451256|NCT01718535|323439965|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
94451257|NCT01718535|323439966|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
94451258|NCT01073605|323439969|FG000|Overall Study|Ongoing at Cutoff Date|1|||
94451259|NCT01073605|323439970|FG001|Overall Study|Ongoing at Cutoff Date|1|||
94451260|NCT01073605|323439971|FG002|Overall Study|Ongoing at Cutoff Date|0|||
94451261|NCT01073605|323439969|FG000|Overall Study|Adverse Event|2|||
94451262|NCT01073605|323439970|FG001|Overall Study|Adverse Event|1|||
94451263|NCT01073605|323439971|FG002|Overall Study|Adverse Event|0|||
94451264|NCT01073605|323439969|FG000|Overall Study|Lost to Follow-up|3|||
94451265|NCT01073605|323439970|FG001|Overall Study|Lost to Follow-up|4|||
94451266|NCT01073605|323439971|FG002|Overall Study|Lost to Follow-up|9|||
94451267|NCT01073605|323439969|FG000|Overall Study|Other|25|||
94451268|NCT01073605|323439970|FG001|Overall Study|Other|21|||
94451269|NCT01073605|323439971|FG002|Overall Study|Other|29|||
94451270|NCT01073605|323439969|FG000|Overall Study|Withdrawal by Subject|31|||
94567951|NCT01755234|323877343|FG001|Overall Study|Change in surgical case|1|||
94451271|NCT01073605|323439970|FG001|Overall Study|Withdrawal by Subject|39|||
94451272|NCT01073605|323439971|FG002|Overall Study|Withdrawal by Subject|22|||
94451273|NCT01073605|323439969|FG000|Overall Study|Randomized But Not Treated|0|||
94451274|NCT01073605|323439970|FG001|Overall Study|Randomized But Not Treated|1|||
94451275|NCT01073605|323439971|FG002|Overall Study|Randomized But Not Treated|1|||
94567952|NCT01755234|323877342|FG000|Overall Study|case cancelled|1|||
94451276|NCT04938180|323439972|FG000|Overall Study|Adverse Event|1|||
94567953|NCT01755234|323877343|FG001|Overall Study|case cancelled|0|||
94567954|NCT01755234|323877342|FG000|Overall Study|Withdrawal by Subject|0|||
94567955|NCT01755234|323877343|FG001|Overall Study|Withdrawal by Subject|1|||
94567956|NCT01755234|323877342|FG000|Overall Study|unblinded|1|||
94567957|NCT01755234|323877343|FG001|Overall Study|unblinded|0|||
94567958|NCT00248495|323877344|FG000|Overall Study|Withdrawal by Subject|1|||
94567959|NCT03719131|323877345|FG000|Overall Study|Death|1|||
94567960|NCT03719131|323877346|FG001|Overall Study|Death|2|||
94567961|NCT05789745|323877347|FG000|Overall Study|Withdrawal by Subject|0|||
94567962|NCT05789745|323877348|FG001|Overall Study|Withdrawal by Subject|0|||
94567963|NCT05789745|323877349|FG002|Overall Study|Withdrawal by Subject|0|||
94567964|NCT05789745|323877350|FG003|Overall Study|Withdrawal by Subject|0|||
94567965|NCT05789745|323877351|FG004|Overall Study|Withdrawal by Subject|1|||
94567966|NCT04581824|323877352|FG000|Overall Study|Ongoing|75|||
94567967|NCT04581824|323877353|FG001|Overall Study|Ongoing|69|||
94567968|NCT04581824|323877352|FG000|Overall Study|Withdrawal by Subject|3|||
94567969|NCT04581824|323877353|FG001|Overall Study|Withdrawal by Subject|5|||
94567970|NCT04581824|323877352|FG000|Overall Study|Lost to Follow-up|1|||
94567971|NCT04581824|323877353|FG001|Overall Study|Lost to Follow-up|0|||
94567972|NCT01453140|323877354|FG000|Overall Study|Adverse Event|3|||
94567973|NCT02576639|323877355|FG000|Overall Study|Withdrawal by Subject|1|||
94567974|NCT02576639|323877356|FG001|Overall Study|Withdrawal by Subject|2|||
94567975|NCT02576639|323877357|FG002|Overall Study|Withdrawal by Subject|1|||
94567976|NCT02576639|323877358|FG003|Overall Study|Withdrawal by Subject|0|||
94567977|NCT02576639|323877359|FG004|Overall Study|Withdrawal by Subject|1|||
94567978|NCT02576639|323877355|FG000|Overall Study|Adverse Event|1|||
94567979|NCT02576639|323877356|FG001|Overall Study|Adverse Event|0|||
94567980|NCT02576639|323877357|FG002|Overall Study|Adverse Event|1|||
94567981|NCT02576639|323877358|FG003|Overall Study|Adverse Event|1|||
94567982|NCT02576639|323877359|FG004|Overall Study|Adverse Event|2|||
94567983|NCT02576639|323877355|FG000|Overall Study|Physician Decision|0|||
94567984|NCT02576639|323877356|FG001|Overall Study|Physician Decision|0|||
94567985|NCT02576639|323877357|FG002|Overall Study|Physician Decision|0|||
94567986|NCT02576639|323877358|FG003|Overall Study|Physician Decision|0|||
94567987|NCT02576639|323877359|FG004|Overall Study|Physician Decision|1|||
94567988|NCT01141712|323877365|FG000|Overall Study|Disease progression|3|||
94567989|NCT01814527|323877369|FG000|Overall Study|RTP greater than 30 days|6|||
94567990|NCT01814527|323877370|FG001|Overall Study|RTP greater than 30 days|1|||
94567991|NCT04524858|323877371|FG000|Overall Study|Adverse Event|1|||
94567992|NCT01363700|323877374|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
94567993|NCT01363700|323877375|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
94567994|NCT01363700|323877376|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
94567995|NCT01363700|323877377|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
94567996|NCT01363700|323877378|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
94567997|NCT03649217|323877379|FG000|Overall Study|subject had severe ataxia not initially found|1|||
94567998|NCT03649217|323877379|FG000|Overall Study|subject had cognitive issues not initially found|1|||
94567999|NCT05202418|323877380|FG000|Overall Study|Withdrawal by Subject|2|||
94568000|NCT05202418|323877381|FG001|Overall Study|Withdrawal by Subject|1|||
94568001|NCT05202418|323877380|FG000|Overall Study|Lost to Follow-up|1|||
94568002|NCT05202418|323877381|FG001|Overall Study|Lost to Follow-up|1|||
94568003|NCT02753946|323877382|FG000|Overall Study|Adverse Event|7|||
94568004|NCT02753946|323877383|FG001|Overall Study|Adverse Event|6|||
94568005|NCT02753946|323877382|FG000|Overall Study|Withdrawal by Subject|6|||
94568006|NCT02753946|323877383|FG001|Overall Study|Withdrawal by Subject|1|||
94568007|NCT02753946|323877382|FG000|Overall Study|Lack of Efficacy|1|||
94568008|NCT02753946|323877383|FG001|Overall Study|Lack of Efficacy|0|||
94568009|NCT02753946|323877382|FG000|Overall Study|Physician Decision|0|||
94568010|NCT02753946|323877383|FG001|Overall Study|Physician Decision|2|||
94568011|NCT01454596|323877384|FG000|Overall Study|Death|0|||
94568012|NCT01454596|323877385|FG001|Overall Study|Death|0|||
94568013|NCT01454596|323877386|FG002|Overall Study|Death|0|||
94568014|NCT01454596|323877387|FG003|Overall Study|Death|0|||
94568015|NCT01454596|323877388|FG004|Overall Study|Death|0|||
94568016|NCT01454596|323877389|FG005|Overall Study|Death|0|||
94568017|NCT01454596|323877390|FG006|Overall Study|Death|0|||
94568018|NCT01454596|323877391|FG007|Overall Study|Death|0|||
94568019|NCT01454596|323877392|FG008|Overall Study|Death|0|||
94568020|NCT01454596|323877393|FG009|Overall Study|Death|1|||
94568021|NCT01454596|323877394|FG010|Overall Study|Death|1|||
94568022|NCT01454596|323877395|FG011|Overall Study|Death|0|||
94568023|NCT00982735|323877396|FG000|Overall Study|Lost to Follow-up|6|||
94568024|NCT00982735|323877396|FG000|Overall Study|Patient ineligible for trial|224|||
94568025|NCT03515824|323877399|FG000|Overall Study|Death|3|||
94568026|NCT03515824|323877400|FG001|Overall Study|Death|2|||
94568027|NCT03515824|323877401|FG002|Overall Study|Death|6|||
94568028|NCT03515824|323877402|FG003|Overall Study|Death|0|||
94658580|NCT01172938|324206184|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
94568029|NCT03515824|323877399|FG000|Overall Study|Lost to Follow-up|0|||
94568030|NCT03515824|323877400|FG001|Overall Study|Lost to Follow-up|1|||
94568031|NCT03515824|323877401|FG002|Overall Study|Lost to Follow-up|1|||
94568032|NCT03515824|323877402|FG003|Overall Study|Lost to Follow-up|0|||
94568033|NCT03515824|323877399|FG000|Overall Study|Study terminated by sponsor|0|||
94568034|NCT03515824|323877400|FG001|Overall Study|Study terminated by sponsor|1|||
94568035|NCT03515824|323877401|FG002|Overall Study|Study terminated by sponsor|6|||
94568036|NCT03515824|323877402|FG003|Overall Study|Study terminated by sponsor|0|||
94568037|NCT03515824|323877399|FG000|Overall Study|Status not recorded|0|||
94568038|NCT03515824|323877400|FG001|Overall Study|Status not recorded|0|||
94568039|NCT03515824|323877401|FG002|Overall Study|Status not recorded|2|||
94568040|NCT03515824|323877402|FG003|Overall Study|Status not recorded|0|||
94568041|NCT00920855|323877404|FG000|Overall Study|Adverse Event|1|||
94568042|NCT00920855|323877405|FG001|Overall Study|Adverse Event|1|||
94568043|NCT00920855|323877406|FG002|Overall Study|Adverse Event|4|||
94568044|NCT00920855|323877404|FG000|Overall Study|Withdrawal by Subject|2|||
94568045|NCT00920855|323877405|FG001|Overall Study|Withdrawal by Subject|1|||
94568046|NCT00920855|323877406|FG002|Overall Study|Withdrawal by Subject|6|||
94568047|NCT00920855|323877404|FG000|Overall Study|Disease progression|2|||
94568048|NCT00920855|323877405|FG001|Overall Study|Disease progression|1|||
94568049|NCT00920855|323877406|FG002|Overall Study|Disease progression|10|||
94568050|NCT00920855|323877404|FG000|Overall Study|Noncompliance to study medication|0|||
94568051|NCT00920855|323877405|FG001|Overall Study|Noncompliance to study medication|0|||
94568052|NCT00920855|323877406|FG002|Overall Study|Noncompliance to study medication|1|||
94568053|NCT00920855|323877404|FG000|Overall Study|Response plateau; started maintenance|0|||
94568054|NCT00920855|323877405|FG001|Overall Study|Response plateau; started maintenance|0|||
94568055|NCT00920855|323877406|FG002|Overall Study|Response plateau; started maintenance|1|||
94568056|NCT01384734|323877407|FG000|Overall Study|Adverse Event|0|||
94568057|NCT01384734|323877408|FG001|Overall Study|Adverse Event|3|||
94568058|NCT01384734|323877409|FG002|Overall Study|Adverse Event|0|||
94568059|NCT01384734|323877410|FG003|Overall Study|Adverse Event|2|||
94568060|NCT01384734|323877411|FG004|Overall Study|Adverse Event|7|||
94568061|NCT01384734|323877407|FG000|Overall Study|Death|1|||
94568062|NCT01384734|323877408|FG001|Overall Study|Death|0|||
94568063|NCT01384734|323877409|FG002|Overall Study|Death|1|||
94568064|NCT01384734|323877410|FG003|Overall Study|Death|0|||
94568065|NCT01384734|323877411|FG004|Overall Study|Death|0|||
94568066|NCT01384734|323877407|FG000|Overall Study|Continuation criteria not met|0|||
94658581|NCT01172938|324206185|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
94658582|NCT01172938|324206186|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
94658583|NCT01172938|324206187|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
94658584|NCT01172938|324206188|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
94658585|NCT01172938|324206189|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
94658586|NCT01172938|324206190|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
94658587|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
94658588|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
94658589|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
94658590|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
94568067|NCT01384734|323877408|FG001|Overall Study|Continuation criteria not met|0|||
94568068|NCT01384734|323877409|FG002|Overall Study|Continuation criteria not met|1|||
94658591|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
94658592|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
94658593|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
94658594|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
94658595|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
94658596|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
94658597|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
94658598|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
94658599|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
94658600|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
94658601|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
94658602|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
94658603|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
94658604|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
94658605|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
94658606|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
94658607|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
94658608|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
94658609|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
94568069|NCT01384734|323877410|FG003|Overall Study|Continuation criteria not met|1|||
94568070|NCT01384734|323877411|FG004|Overall Study|Continuation criteria not met|0|||
94568071|NCT01384734|323877407|FG000|Overall Study|Lack of Efficacy|3|||
94568072|NCT01384734|323877408|FG001|Overall Study|Lack of Efficacy|7|||
94568073|NCT01384734|323877409|FG002|Overall Study|Lack of Efficacy|4|||
94568074|NCT01384734|323877410|FG003|Overall Study|Lack of Efficacy|4|||
94568075|NCT01384734|323877411|FG004|Overall Study|Lack of Efficacy|2|||
94568076|NCT01384734|323877407|FG000|Overall Study|Lost to Follow-up|5|||
94568077|NCT01384734|323877408|FG001|Overall Study|Lost to Follow-up|3|||
94568078|NCT01384734|323877409|FG002|Overall Study|Lost to Follow-up|3|||
94568079|NCT01384734|323877410|FG003|Overall Study|Lost to Follow-up|8|||
94568080|NCT01384734|323877411|FG004|Overall Study|Lost to Follow-up|5|||
94568081|NCT01384734|323877407|FG000|Overall Study|Non-compliance with study drug|1|||
94568082|NCT01384734|323877408|FG001|Overall Study|Non-compliance with study drug|2|||
94568083|NCT01384734|323877409|FG002|Overall Study|Non-compliance with study drug|6|||
94568084|NCT01384734|323877410|FG003|Overall Study|Non-compliance with study drug|0|||
94568085|NCT01384734|323877411|FG004|Overall Study|Non-compliance with study drug|2|||
94568086|NCT01384734|323877407|FG000|Overall Study|Pregnancy|0|||
94568087|NCT01384734|323877408|FG001|Overall Study|Pregnancy|1|||
94568088|NCT01384734|323877409|FG002|Overall Study|Pregnancy|0|||
94568089|NCT01384734|323877410|FG003|Overall Study|Pregnancy|0|||
94568090|NCT01384734|323877411|FG004|Overall Study|Pregnancy|1|||
94568091|NCT01384734|323877407|FG000|Overall Study|Sponsor terminated|0|||
94568092|NCT01384734|323877408|FG001|Overall Study|Sponsor terminated|0|||
94568093|NCT01384734|323877409|FG002|Overall Study|Sponsor terminated|0|||
94568094|NCT01384734|323877410|FG003|Overall Study|Sponsor terminated|0|||
94568095|NCT01384734|323877411|FG004|Overall Study|Sponsor terminated|1|||
94568096|NCT01384734|323877407|FG000|Overall Study|Withdrawal by Subject|5|||
94568097|NCT01384734|323877408|FG001|Overall Study|Withdrawal by Subject|5|||
94568098|NCT01384734|323877409|FG002|Overall Study|Withdrawal by Subject|6|||
94568099|NCT01384734|323877410|FG003|Overall Study|Withdrawal by Subject|7|||
94568100|NCT01384734|323877411|FG004|Overall Study|Withdrawal by Subject|9|||
94568101|NCT01384734|323877407|FG000|Overall Study|Investigator relocating|0|||
94568102|NCT01384734|323877408|FG001|Overall Study|Investigator relocating|2|||
94568103|NCT01384734|323877409|FG002|Overall Study|Investigator relocating|0|||
94568104|NCT01384734|323877410|FG003|Overall Study|Investigator relocating|3|||
94568105|NCT01384734|323877411|FG004|Overall Study|Investigator relocating|1|||
94568106|NCT01384734|323877407|FG000|Overall Study|Unable to come back for visit|1|||
94568107|NCT01384734|323877408|FG001|Overall Study|Unable to come back for visit|0|||
94568108|NCT01384734|323877409|FG002|Overall Study|Unable to come back for visit|1|||
94568109|NCT01384734|323877410|FG003|Overall Study|Unable to come back for visit|1|||
94568110|NCT01384734|323877411|FG004|Overall Study|Unable to come back for visit|0|||
94568111|NCT01384734|323877407|FG000|Overall Study|Prison|0|||
94568112|NCT01384734|323877408|FG001|Overall Study|Prison|0|||
94568113|NCT01384734|323877409|FG002|Overall Study|Prison|1|||
94568114|NCT01384734|323877410|FG003|Overall Study|Prison|0|||
94568115|NCT01384734|323877411|FG004|Overall Study|Prison|0|||
94568116|NCT01384734|323877407|FG000|Overall Study|As per Exclusion criteria|0|||
94568117|NCT01384734|323877408|FG001|Overall Study|As per Exclusion criteria|1|||
94568118|NCT01384734|323877409|FG002|Overall Study|As per Exclusion criteria|0|||
94568119|NCT01384734|323877410|FG003|Overall Study|As per Exclusion criteria|0|||
94568120|NCT01384734|323877411|FG004|Overall Study|As per Exclusion criteria|0|||
94568121|NCT01384734|323877407|FG000|Overall Study|Missed End of treatment visit|0|||
94568122|NCT01384734|323877408|FG001|Overall Study|Missed End of treatment visit|0|||
94568123|NCT01384734|323877409|FG002|Overall Study|Missed End of treatment visit|0|||
94568124|NCT01384734|323877410|FG003|Overall Study|Missed End of treatment visit|1|||
94568125|NCT01384734|323877411|FG004|Overall Study|Missed End of treatment visit|0|||
94568126|NCT01384734|323877407|FG000|Overall Study|Adhesion problem|0|||
94568127|NCT01384734|323877408|FG001|Overall Study|Adhesion problem|0|||
94568128|NCT01384734|323877409|FG002|Overall Study|Adhesion problem|0|||
94568129|NCT01384734|323877410|FG003|Overall Study|Adhesion problem|1|||
94568130|NCT01384734|323877411|FG004|Overall Study|Adhesion problem|0|||
94568131|NCT01384734|323877407|FG000|Overall Study|Early termination|0|||
94568132|NCT01384734|323877408|FG001|Overall Study|Early termination|0|||
94568133|NCT01384734|323877409|FG002|Overall Study|Early termination|0|||
94568134|NCT01384734|323877410|FG003|Overall Study|Early termination|0|||
94568135|NCT01384734|323877411|FG004|Overall Study|Early termination|1|||
94568136|NCT01384734|323877407|FG000|Overall Study|Physician Decision|1|||
94568137|NCT01384734|323877408|FG001|Overall Study|Physician Decision|0|||
94568138|NCT01384734|323877409|FG002|Overall Study|Physician Decision|0|||
94568139|NCT01384734|323877410|FG003|Overall Study|Physician Decision|0|||
94568140|NCT01384734|323877411|FG004|Overall Study|Physician Decision|0|||
94568141|NCT01894607|323877412|FG000|Overall Study|Ineligible|1|||
94568142|NCT01290523|323877413|FG000|Overall Study|Death|3|||
94568143|NCT03071263|323877414|FG000|Overall Study|Adverse Event|1|||
94568144|NCT03071263|323877415|FG001|Overall Study|Adverse Event|3|||
94568145|NCT03071263|323877414|FG000|Overall Study|Withdrawal by Subject|1|||
94568146|NCT03071263|323877415|FG001|Overall Study|Withdrawal by Subject|3|||
94568147|NCT03071263|323877414|FG000|Overall Study|Physician Decision|1|||
94568148|NCT03071263|323877415|FG001|Overall Study|Physician Decision|0|||
94568149|NCT03071263|323877414|FG000|Overall Study|Participant moved to another city|0|||
94568150|NCT03071263|323877415|FG001|Overall Study|Participant moved to another city|1|||
94568151|NCT00525512|323877416|FG000|Double-Blind Phase|Adverse Event|48|||
94568152|NCT00525512|323877417|FG001|Double-Blind Phase|Adverse Event|28|||
94568153|NCT00525512|323877418|FG002|Double-Blind Phase|Adverse Event|0|||
94568154|NCT00525512|323877419|FG003|Double-Blind Phase|Adverse Event|0|||
94568155|NCT00525512|323877416|FG000|Double-Blind Phase|Protocol Violation|3|||
94568156|NCT00525512|323877417|FG001|Double-Blind Phase|Protocol Violation|1|||
94568157|NCT00525512|323877418|FG002|Double-Blind Phase|Protocol Violation|0|||
94568158|NCT00525512|323877419|FG003|Double-Blind Phase|Protocol Violation|0|||
94568159|NCT00525512|323877416|FG000|Double-Blind Phase|Lost to Follow-up|3|||
94568160|NCT00525512|323877417|FG001|Double-Blind Phase|Lost to Follow-up|7|||
94568161|NCT00525512|323877418|FG002|Double-Blind Phase|Lost to Follow-up|0|||
94568162|NCT00525512|323877419|FG003|Double-Blind Phase|Lost to Follow-up|0|||
94568163|NCT00525512|323877416|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
94568164|NCT00525512|323877417|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
94568165|NCT00525512|323877418|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
94568166|NCT00525512|323877419|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
94568167|NCT00525512|323877416|FG000|Double-Blind Phase|Lack of Efficacy|13|||
94568168|NCT00525512|323877417|FG001|Double-Blind Phase|Lack of Efficacy|5|||
94568169|NCT00525512|323877418|FG002|Double-Blind Phase|Lack of Efficacy|0|||
94568170|NCT00525512|323877419|FG003|Double-Blind Phase|Lack of Efficacy|0|||
94568171|NCT00525512|323877416|FG000|Double-Blind Phase|Other reason (not specified)|12|||
94568172|NCT00525512|323877417|FG001|Double-Blind Phase|Other reason (not specified)|13|||
94568173|NCT00525512|323877418|FG002|Double-Blind Phase|Other reason (not specified)|0|||
94568174|NCT00525512|323877419|FG003|Double-Blind Phase|Other reason (not specified)|0|||
94568175|NCT00525512|323877416|FG000|Open-Label Phase|Adverse Event|0|||
94568176|NCT00525512|323877417|FG001|Open-Label Phase|Adverse Event|0|||
94568177|NCT00525512|323877418|FG002|Open-Label Phase|Adverse Event|1|||
94568178|NCT00525512|323877419|FG003|Open-Label Phase|Adverse Event|0|||
94568179|NCT00525512|323877416|FG000|Open-Label Phase|Lost to Follow-up|0|||
94568180|NCT00525512|323877417|FG001|Open-Label Phase|Lost to Follow-up|0|||
94568181|NCT00525512|323877418|FG002|Open-Label Phase|Lost to Follow-up|1|||
94568182|NCT00525512|323877419|FG003|Open-Label Phase|Lost to Follow-up|0|||
94568183|NCT00525512|323877416|FG000|Open-Label Phase|Other reason (not specified)|0|||
94568184|NCT00525512|323877417|FG001|Open-Label Phase|Other reason (not specified)|0|||
94568185|NCT00525512|323877418|FG002|Open-Label Phase|Other reason (not specified)|4|||
94568186|NCT00525512|323877419|FG003|Open-Label Phase|Other reason (not specified)|5|||
94568187|NCT00510835|323877420|FG000|Overall Study|Withdrawal by Subject|6|||
94568188|NCT00510835|323877421|FG001|Overall Study|Withdrawal by Subject|2|||
94568189|NCT00510835|323877422|FG002|Overall Study|Withdrawal by Subject|2|||
94568190|NCT00647296|323877423|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
94568191|NCT00647296|323877424|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
94568192|NCT00647296|323877425|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
94568193|NCT00647296|323877426|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
94568194|NCT00647296|323877423|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
94568195|NCT00647296|323877424|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
94568196|NCT00647296|323877425|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
94568197|NCT00647296|323877426|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
94568198|NCT00647296|323877423|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
94568199|NCT00647296|323877424|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
94568200|NCT00647296|323877425|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
94568201|NCT00647296|323877426|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
94568202|NCT00647296|323877423|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
94568203|NCT00647296|323877424|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
94568204|NCT00647296|323877425|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
94568205|NCT00647296|323877426|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
94568206|NCT00647296|323877423|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
94568207|NCT00647296|323877424|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
94568208|NCT00647296|323877425|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
94568209|NCT00647296|323877426|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
94568210|NCT00647296|323877423|FG000|Part 2: 4-week Placebo Washout|Death|3|||
94568211|NCT00647296|323877424|FG001|Part 2: 4-week Placebo Washout|Death|0|||
94568212|NCT00647296|323877425|FG002|Part 2: 4-week Placebo Washout|Death|0|||
94568213|NCT00647296|323877426|FG003|Part 2: 4-week Placebo Washout|Death|0|||
94568214|NCT00647296|323877423|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
94568215|NCT00647296|323877424|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
94568216|NCT00647296|323877425|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
94568217|NCT00647296|323877426|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
94568218|NCT00647296|323877423|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
94568219|NCT00647296|323877424|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
94568220|NCT00647296|323877425|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
94568221|NCT00647296|323877426|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
94568222|NCT00647296|323877423|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
94568223|NCT00647296|323877424|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
94568224|NCT00647296|323877425|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
94568225|NCT00647296|323877426|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
94568226|NCT00647296|323877423|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
94568227|NCT00647296|323877424|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
94568228|NCT00647296|323877425|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
94568229|NCT00647296|323877426|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
94568230|NCT00647296|323877423|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
94568231|NCT00647296|323877424|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
94568232|NCT00647296|323877425|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
94658610|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
94658611|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
94658612|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
94658613|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
94658614|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
94658615|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
94658616|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
94658617|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
94658618|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
94658619|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
94658620|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
94658621|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
94658622|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
94658623|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
94658624|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
94658625|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
94658626|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
94658627|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
94658628|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
94658629|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
94658630|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
94658631|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
94658632|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
94658633|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
94658634|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
94658635|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
94658636|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
94658637|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
94658638|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
94568233|NCT00647296|323877426|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
94658639|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
94658640|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
94658641|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
94568234|NCT03084796|323877427|FG000|Overall Study|Adverse Event|4|||
94568235|NCT03084796|323877428|FG001|Overall Study|Adverse Event|5|||
94568236|NCT03084796|323877429|FG002|Overall Study|Adverse Event|6|||
94568237|NCT03084796|323877430|FG003|Overall Study|Adverse Event|2|||
94568238|NCT03084796|323877431|FG004|Overall Study|Adverse Event|3|||
94568239|NCT03084796|323877432|FG005|Overall Study|Adverse Event|5|||
94568240|NCT03084796|323877427|FG000|Overall Study|Withdrawal by Subject|3|||
94568241|NCT03084796|323877428|FG001|Overall Study|Withdrawal by Subject|5|||
94568242|NCT03084796|323877429|FG002|Overall Study|Withdrawal by Subject|2|||
94568243|NCT03084796|323877430|FG003|Overall Study|Withdrawal by Subject|1|||
94568244|NCT03084796|323877431|FG004|Overall Study|Withdrawal by Subject|3|||
94568245|NCT03084796|323877432|FG005|Overall Study|Withdrawal by Subject|0|||
94568246|NCT03084796|323877427|FG000|Overall Study|Protocol Violation|0|||
94568247|NCT03084796|323877428|FG001|Overall Study|Protocol Violation|0|||
94568248|NCT03084796|323877429|FG002|Overall Study|Protocol Violation|1|||
94568249|NCT03084796|323877430|FG003|Overall Study|Protocol Violation|0|||
94568250|NCT03084796|323877431|FG004|Overall Study|Protocol Violation|1|||
94568251|NCT03084796|323877432|FG005|Overall Study|Protocol Violation|1|||
94568252|NCT03084796|323877427|FG000|Overall Study|Lack of Efficacy|0|||
94568253|NCT03084796|323877428|FG001|Overall Study|Lack of Efficacy|0|||
94568254|NCT03084796|323877429|FG002|Overall Study|Lack of Efficacy|1|||
94568255|NCT03084796|323877430|FG003|Overall Study|Lack of Efficacy|0|||
94568256|NCT03084796|323877431|FG004|Overall Study|Lack of Efficacy|1|||
94568257|NCT03084796|323877432|FG005|Overall Study|Lack of Efficacy|0|||
94568258|NCT03084796|323877427|FG000|Overall Study|Lost to Follow-up|0|||
94568259|NCT03084796|323877428|FG001|Overall Study|Lost to Follow-up|0|||
94568260|NCT03084796|323877429|FG002|Overall Study|Lost to Follow-up|1|||
94568261|NCT03084796|323877430|FG003|Overall Study|Lost to Follow-up|1|||
94568262|NCT03084796|323877431|FG004|Overall Study|Lost to Follow-up|3|||
94568263|NCT03084796|323877432|FG005|Overall Study|Lost to Follow-up|1|||
94568264|NCT03084796|323877427|FG000|Overall Study|Randomization error|0|||
94568265|NCT03084796|323877428|FG001|Overall Study|Randomization error|0|||
94568266|NCT03084796|323877429|FG002|Overall Study|Randomization error|1|||
94568267|NCT03084796|323877430|FG003|Overall Study|Randomization error|0|||
94568268|NCT03084796|323877431|FG004|Overall Study|Randomization error|0|||
94568269|NCT03084796|323877432|FG005|Overall Study|Randomization error|0|||
94568270|NCT03359174|323877443|FG000|Overall Study|Adverse Event|1|||
94568271|NCT00650767|323877444|FG000|Overall Study|Adverse Event|0|||
94568272|NCT00650767|323877445|FG001|Overall Study|Adverse Event|3|||
94568273|NCT00650767|323877446|FG002|Overall Study|Adverse Event|10|||
94568274|NCT00650767|323877447|FG003|Overall Study|Adverse Event|8|||
94568275|NCT00650767|323877444|FG000|Overall Study|Death|1|||
94568276|NCT00650767|323877445|FG001|Overall Study|Death|0|||
94568277|NCT00650767|323877446|FG002|Overall Study|Death|0|||
94568278|NCT00650767|323877447|FG003|Overall Study|Death|0|||
94568279|NCT00650767|323877444|FG000|Overall Study|Withdrawal by Subject|2|||
94568280|NCT00650767|323877445|FG001|Overall Study|Withdrawal by Subject|4|||
94568281|NCT00650767|323877446|FG002|Overall Study|Withdrawal by Subject|3|||
94568282|NCT00650767|323877447|FG003|Overall Study|Withdrawal by Subject|3|||
94568283|NCT00650767|323877444|FG000|Overall Study|Lost to Follow-up|1|||
94568284|NCT00650767|323877445|FG001|Overall Study|Lost to Follow-up|1|||
94568285|NCT00650767|323877446|FG002|Overall Study|Lost to Follow-up|1|||
94568286|NCT00650767|323877447|FG003|Overall Study|Lost to Follow-up|0|||
94568287|NCT00650767|323877444|FG000|Overall Study|Other|1|||
94568288|NCT00650767|323877445|FG001|Overall Study|Other|1|||
94568289|NCT00650767|323877446|FG002|Overall Study|Other|0|||
94568290|NCT00650767|323877447|FG003|Overall Study|Other|0|||
94568291|NCT04816214|323877448|FG000|Overall Study|Progressive Disease|4|||
94568292|NCT04816214|323877449|FG001|Overall Study|Progressive Disease|0|||
94568293|NCT04816214|323877450|FG002|Overall Study|Progressive Disease|0|||
94568294|NCT04816214|323877448|FG000|Overall Study|Death|1|||
94568295|NCT04816214|323877449|FG001|Overall Study|Death|0|||
94568296|NCT04816214|323877450|FG002|Overall Study|Death|0|||
94237377|NCT01296555|322664192|FG024|Overall Study|Protocol Violation|0|||
94568297|NCT04816214|323877448|FG000|Overall Study|Study Terminated by Sponsor|1|||
94568298|NCT04816214|323877449|FG001|Overall Study|Study Terminated by Sponsor|0|||
94568299|NCT04816214|323877450|FG002|Overall Study|Study Terminated by Sponsor|0|||
94568300|NCT00550407|323877451|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
94568301|NCT00550407|323877452|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
94568302|NCT00550407|323877453|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
94568303|NCT00550407|323877451|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
94568304|NCT00550407|323877452|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
94568305|NCT00550407|323877453|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
94568306|NCT00550407|323877451|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
94568307|NCT00550407|323877452|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
94568308|NCT00550407|323877453|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
94568309|NCT00550407|323877451|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
94568310|NCT00550407|323877452|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
94568311|NCT00550407|323877453|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
94568312|NCT00550407|323877451|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
94568313|NCT00550407|323877452|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
94568314|NCT00550407|323877453|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
94568315|NCT00550407|323877451|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
94568316|NCT00550407|323877452|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
94568317|NCT00550407|323877453|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
94568318|NCT00550407|323877451|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
94568319|NCT00550407|323877452|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
94568320|NCT00550407|323877453|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
94568321|NCT00550407|323877451|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
94568322|NCT00550407|323877452|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
94568323|NCT00550407|323877453|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
94568324|NCT00550407|323877451|FG000|26-Week Randomized Phase|Adverse Event|0|||
94568325|NCT00550407|323877452|FG001|26-Week Randomized Phase|Adverse Event|5|||
94568326|NCT00550407|323877453|FG002|26-Week Randomized Phase|Adverse Event|2|||
94568327|NCT00550407|323877451|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
94568328|NCT00550407|323877452|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
94568329|NCT00550407|323877453|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
94568330|NCT00550407|323877451|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
94568331|NCT00550407|323877452|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
94568332|NCT00550407|323877453|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
94568333|NCT00550407|323877451|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
94568334|NCT00550407|323877452|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
94568335|NCT00550407|323877453|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
94568336|NCT01774799|323877454|FG000|Overall Study|Lost to Follow-up|1|||
94568337|NCT01774799|323877455|FG001|Overall Study|Lost to Follow-up|1|||
94568338|NCT01774799|323877456|FG002|Overall Study|Lost to Follow-up|0|||
94568339|NCT01774799|323877457|FG003|Overall Study|Lost to Follow-up|0|||
94568340|NCT02586623|323877458|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
94568341|NCT02586623|323877459|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
94568342|NCT02586623|323877460|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
94451277|NCT01532518|323439975|FG000|Overall Study|Withdrawal by Subject|0|||
94451278|NCT01532518|323439976|FG001|Overall Study|Withdrawal by Subject|0|||
94451279|NCT01532518|323439977|FG002|Overall Study|Withdrawal by Subject|1|||
94451280|NCT01684423|323439978|FG000|Overall Study|Withdrawal by Subject|0|||
94451281|NCT01684423|323439979|FG001|Overall Study|Withdrawal by Subject|0|||
94451282|NCT01684423|323439980|FG002|Overall Study|Withdrawal by Subject|1|||
94451283|NCT01684423|323439981|FG003|Overall Study|Withdrawal by Subject|0|||
94451284|NCT01684423|323439982|FG004|Overall Study|Withdrawal by Subject|0|||
94451285|NCT00912743|323439984|FG000|Overall Study|Adverse Event|3|||
94451286|NCT00912743|323439985|FG001|Overall Study|Adverse Event|1|||
94451287|NCT00912743|323439984|FG000|Overall Study|Lack of Efficacy|9|||
94451288|NCT00912743|323439985|FG001|Overall Study|Lack of Efficacy|18|||
94451289|NCT00912743|323439984|FG000|Overall Study|Toxicity|0|||
94451290|NCT00912743|323439985|FG001|Overall Study|Toxicity|1|||
94451291|NCT00912743|323439984|FG000|Overall Study|End of treatment form was not collected|1|||
94451292|NCT00912743|323439985|FG001|Overall Study|End of treatment form was not collected|0|||
94451293|NCT00423332|323439986|FG000|Overall Study|Adverse Event|6|||
94451294|NCT00423332|323439987|FG001|Overall Study|Adverse Event|2|||
94451295|NCT00423332|323439986|FG000|Overall Study|Withdrawal by Subject|1|||
94451296|NCT00423332|323439987|FG001|Overall Study|Withdrawal by Subject|0|||
94451297|NCT00423332|323439986|FG000|Overall Study|Condition under investigation worsened|1|||
94451298|NCT00423332|323439987|FG001|Overall Study|Condition under investigation worsened|1|||
94451299|NCT00423332|323439986|FG000|Overall Study|Progressive at Week 6|0|||
94451300|NCT00423332|323439987|FG001|Overall Study|Progressive at Week 6|1|||
94568343|NCT02586623|323877458|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
94568344|NCT02586623|323877459|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
94568345|NCT02586623|323877460|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
94568346|NCT02586623|323877458|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
94568347|NCT02586623|323877459|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
94568348|NCT02586623|323877460|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
94568349|NCT02586623|323877458|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
94568350|NCT02586623|323877459|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
94568351|NCT02586623|323877460|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
94568352|NCT02586623|323877458|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
94568353|NCT02586623|323877459|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
94568354|NCT02586623|323877460|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
94568355|NCT02586623|323877458|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
94568356|NCT02586623|323877459|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
94568357|NCT02586623|323877460|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
94568358|NCT02586623|323877458|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
94568359|NCT02586623|323877459|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
94568360|NCT02586623|323877460|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
94568361|NCT02586623|323877458|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
94568362|NCT02586623|323877459|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
94568363|NCT02586623|323877460|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
94568364|NCT02586623|323877458|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
94568365|NCT02586623|323877459|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
94568366|NCT02586623|323877460|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
94568367|NCT02586623|323877458|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
94568368|NCT02586623|323877459|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
94568369|NCT02586623|323877460|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
94568370|NCT02586623|323877458|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
94568371|NCT02586623|323877459|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
94568372|NCT02586623|323877460|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
94568373|NCT02586623|323877458|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
94568374|NCT02586623|323877459|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
94568375|NCT02586623|323877460|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
94568376|NCT02586623|323877458|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
94568377|NCT02586623|323877459|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
94568378|NCT02586623|323877460|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
94568379|NCT02586623|323877458|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
94568380|NCT02586623|323877459|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
94568381|NCT02586623|323877460|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
94568382|NCT02586623|323877458|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
94568383|NCT02586623|323877459|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
94568384|NCT02586623|323877460|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
94568385|NCT02586623|323877458|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
94568386|NCT02586623|323877459|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
94568387|NCT02586623|323877460|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
94568388|NCT02586623|323877458|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
94568389|NCT02586623|323877459|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
94568390|NCT02586623|323877460|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
94568391|NCT02586623|323877458|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
94568392|NCT02586623|323877459|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
94568393|NCT02586623|323877460|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
94568394|NCT02586623|323877458|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
94568395|NCT02586623|323877459|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
94568396|NCT02586623|323877460|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
94568397|NCT02586623|323877458|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
94568398|NCT02586623|323877459|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
94451301|NCT00423332|323439986|FG000|Overall Study|Unblinded before 12 weeks|1|||
94451302|NCT00423332|323439987|FG001|Overall Study|Unblinded before 12 weeks|3|||
94348067|NCT01984294|323054073|FG002|Overall Study|Adverse Event|0|||
94568399|NCT02586623|323877460|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
94568400|NCT02586623|323877458|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
94568401|NCT02586623|323877459|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
94568402|NCT02586623|323877460|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
94568403|NCT02429830|323877461|FG000|Overall Study|Lost to Follow-up|1|||
94568404|NCT02429830|323877461|FG000|Overall Study|Device Explant|2|||
94568405|NCT01928927|323877464|FG000|Overall Study|Lost to Follow-up|1|||
94568406|NCT01928927|323877465|FG001|Overall Study|Lost to Follow-up|0|||
94568407|NCT01928927|323877464|FG000|Overall Study|Withdrawal by Subject|1|||
94568408|NCT01928927|323877465|FG001|Overall Study|Withdrawal by Subject|1|||
94568409|NCT04617782|323878801|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
94568410|NCT04617782|323878801|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
94568411|NCT04617782|323878801|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
94568412|NCT04617782|323878801|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
94348068|NCT01058356|323054076|FG000|Overall Study|Adverse Event|5|||
94348069|NCT01058356|323054076|FG000|Overall Study|Administration of contraindicated drugs|12|||
94348070|NCT01058356|323054076|FG000|Overall Study|Withdrawal by Subject|21|||
94348071|NCT01058356|323054076|FG000|Overall Study|Lost to Follow-up|4|||
94348072|NCT00806494|323054079|FG000|Overall Study|Adverse Event|29|||
94348073|NCT00806494|323054079|FG000|Overall Study|Lack of Efficacy|6|||
94348074|NCT00806494|323054079|FG000|Overall Study|Lost to Follow-up|10|||
94348075|NCT00806494|323054079|FG000|Overall Study|Other|30|||
94348076|NCT00806494|323054079|FG000|Overall Study|Withdrawal by Subject|5|||
94348077|NCT02886338|323054085|FG000|Overall Study|Withdrawal by Subject|1|||
94348078|NCT00122317|323054086|FG000|Overall Study|Death|3|||
94348079|NCT00122317|323054086|FG000|Overall Study|Adverse Event|4|||
94348080|NCT00122317|323054086|FG000|Overall Study|Physician Decision|2|||
94568413|NCT04617782|323878801|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
94568414|NCT04617782|323878801|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
94568415|NCT04388111|323878805|FG000|Overall Study|Lost to Follow-up|5|||
94568416|NCT04388111|323878806|FG001|Overall Study|Lost to Follow-up|3|||
94568417|NCT04388111|323878805|FG000|Overall Study|Adverse Event|1|||
94568418|NCT04388111|323878806|FG001|Overall Study|Adverse Event|1|||
94568419|NCT04388111|323878805|FG000|Overall Study|Protocol Violation|2|||
94568420|NCT04388111|323878806|FG001|Overall Study|Protocol Violation|4|||
94568421|NCT04388111|323878805|FG000|Overall Study|Withdrawal by Subject|1|||
94568422|NCT04388111|323878806|FG001|Overall Study|Withdrawal by Subject|0|||
94568423|NCT02038153|323878815|FG000|Overall Study|Withdrawal by Subject|1|||
94568424|NCT01050634|323878816|FG000|Overall Study|Enrolled, but Not Treated|56|||
94568425|NCT01050634|323878816|FG000|Overall Study|Death|2|||
94568426|NCT01050634|323878816|FG000|Overall Study|Adverse Event|42|||
94568427|NCT01050634|323878816|FG000|Overall Study|Lost to Follow-up|2|||
94568428|NCT01050634|323878816|FG000|Overall Study|Other|21|||
94568429|NCT01050634|323878816|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
94568430|NCT00527735|323878817|FG000|Overall Study|Disease progression|47|||
94568431|NCT00527735|323878818|FG001|Overall Study|Disease progression|61|||
94568432|NCT00527735|323878819|FG002|Overall Study|Disease progression|53|||
94568433|NCT00527735|323878817|FG000|Overall Study|Death|23|||
94568434|NCT00527735|323878818|FG001|Overall Study|Death|13|||
94568435|NCT00527735|323878819|FG002|Overall Study|Death|15|||
94568436|NCT00527735|323878817|FG000|Overall Study|Completed treatment in treatment phase|14|||
94568437|NCT00527735|323878818|FG001|Overall Study|Completed treatment in treatment phase|13|||
94568438|NCT00527735|323878819|FG002|Overall Study|Completed treatment in treatment phase|18|||
94348081|NCT00122317|323054086|FG000|Overall Study|patient non-compliance|1|||
94568439|NCT00527735|323878817|FG000|Overall Study|Adverse Event|10|||
94568440|NCT00527735|323878818|FG001|Overall Study|Adverse Event|6|||
94568441|NCT00527735|323878819|FG002|Overall Study|Adverse Event|7|||
94348082|NCT00122317|323054086|FG000|Overall Study|Withdrawal by Subject|1|||
94348083|NCT00394654|323054087|FG000|Overall Study|Lost to Follow-up|1|||
94348084|NCT00394654|323054088|FG001|Overall Study|Lost to Follow-up|0|||
94568442|NCT00527735|323878817|FG000|Overall Study|Not identified|5|||
94568443|NCT00527735|323878818|FG001|Overall Study|Not identified|5|||
94568444|NCT00527735|323878819|FG002|Overall Study|Not identified|5|||
94568445|NCT00527735|323878817|FG000|Overall Study|Withdrawal by Subject|5|||
94568446|NCT00527735|323878818|FG001|Overall Study|Withdrawal by Subject|4|||
94568447|NCT00527735|323878819|FG002|Overall Study|Withdrawal by Subject|3|||
94568448|NCT00527735|323878817|FG000|Overall Study|No longer met study criteria|2|||
94568449|NCT00527735|323878818|FG001|Overall Study|No longer met study criteria|2|||
94568450|NCT00527735|323878819|FG002|Overall Study|No longer met study criteria|1|||
94568451|NCT00527735|323878817|FG000|Overall Study|Lost to Follow-up|0|||
94568452|NCT00527735|323878818|FG001|Overall Study|Lost to Follow-up|0|||
94568453|NCT00527735|323878819|FG002|Overall Study|Lost to Follow-up|3|||
94348085|NCT00394654|323054087|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
94348086|NCT00394654|323054088|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
94348087|NCT02098733|323054089|FG000|Overall Study|Data Not Available|5|||
94568454|NCT00527735|323878817|FG000|Overall Study|Poor compliance or noncompliance|0|||
94568455|NCT00527735|323878818|FG001|Overall Study|Poor compliance or noncompliance|1|||
94348088|NCT02098733|323054089|FG000|Overall Study|Lost to Follow-up|5|||
94568456|NCT00527735|323878819|FG002|Overall Study|Poor compliance or noncompliance|1|||
94568457|NCT00527735|323878817|FG000|Overall Study|Completed treatment during maintenance|2|||
94568458|NCT00527735|323878818|FG001|Overall Study|Completed treatment during maintenance|2|||
94568459|NCT00527735|323878819|FG002|Overall Study|Completed treatment during maintenance|1|||
94568460|NCT02210000|323878821|FG000|Overall Study|Study Terminated|11|||
94568461|NCT02210000|323878822|FG001|Overall Study|Study Terminated|12|||
94568462|NCT02210000|323878821|FG000|Overall Study|Withdrawal by Subject|7|||
94568463|NCT02210000|323878822|FG001|Overall Study|Withdrawal by Subject|1|||
94568464|NCT02210000|323878821|FG000|Overall Study|Adverse Event|1|||
94568465|NCT02210000|323878822|FG001|Overall Study|Adverse Event|5|||
94568466|NCT02210000|323878821|FG000|Overall Study|Lost to Follow-up|0|||
94568467|NCT02210000|323878822|FG001|Overall Study|Lost to Follow-up|2|||
94568468|NCT02210000|323878821|FG000|Overall Study|Physician Decision|0|||
94568469|NCT02210000|323878822|FG001|Overall Study|Physician Decision|1|||
94568470|NCT01329263|323878823|FG000|Overall Study|Lost to Follow-up|4|||
94568471|NCT01329263|323878824|FG001|Overall Study|Lost to Follow-up|21|||
94568472|NCT01329263|323878823|FG000|Overall Study|Withdrawal by Subject|1|||
94568473|NCT01329263|323878824|FG001|Overall Study|Withdrawal by Subject|2|||
94568474|NCT02123134|323878825|FG000|Overall Study|Withdrawal of consent|3|||
94568475|NCT02123134|323878826|FG001|Overall Study|Withdrawal of consent|2|||
94568476|NCT02123134|323878825|FG000|Overall Study|Administrative decision|0|||
94568477|NCT02123134|323878826|FG001|Overall Study|Administrative decision|1|||
94568478|NCT00768989|323878827|FG000|Prior to Week 24|Withdrawal by Subject|1|||
94568479|NCT00768989|323878828|FG001|Prior to Week 24|Withdrawal by Subject|0|||
94568480|NCT00768989|323878827|FG000|Prior to Week 24|Adverse Event|3|||
94237378|NCT01296555|322664193|FG025|Overall Study|Protocol Violation|0|||
94237379|NCT01296555|322664194|FG026|Overall Study|Protocol Violation|0|||
94237380|NCT01296555|322664195|FG027|Overall Study|Protocol Violation|0|||
94237381|NCT01296555|322664196|FG028|Overall Study|Protocol Violation|0|||
94237382|NCT01296555|322664168|FG000|Overall Study|Study Terminated By Sponsor|0|||
94237383|NCT01296555|322664169|FG001|Overall Study|Study Terminated By Sponsor|0|||
94237384|NCT01296555|322664170|FG002|Overall Study|Study Terminated By Sponsor|0|||
94237385|NCT01296555|322664171|FG003|Overall Study|Study Terminated By Sponsor|0|||
94237386|NCT01296555|322664172|FG004|Overall Study|Study Terminated By Sponsor|0|||
94237387|NCT01296555|322664173|FG005|Overall Study|Study Terminated By Sponsor|0|||
94237388|NCT01296555|322664174|FG006|Overall Study|Study Terminated By Sponsor|0|||
94237389|NCT01296555|322664175|FG007|Overall Study|Study Terminated By Sponsor|0|||
94348089|NCT01021293|323054090|FG000|Overall Study|Serious Adverse Event|2|||
94568481|NCT00768989|323878828|FG001|Prior to Week 24|Adverse Event|0|||
94568482|NCT00768989|323878827|FG000|Prior to Week 24|Lost to Follow-up|0|||
94568483|NCT00768989|323878828|FG001|Prior to Week 24|Lost to Follow-up|1|||
94568484|NCT00768989|323878827|FG000|Prior to Week 24|Protocol Violation|0|||
94568485|NCT00768989|323878828|FG001|Prior to Week 24|Protocol Violation|2|||
94568486|NCT00768989|323878827|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
94568487|NCT00768989|323878828|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
94568488|NCT00768989|323878827|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
94568489|NCT00768989|323878828|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
94568490|NCT00768989|323878827|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
94568491|NCT00768989|323878828|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
94568492|NCT00768989|323878827|FG000|On or After Week 36|Lack of Efficacy|1|||
94568493|NCT00768989|323878828|FG001|On or After Week 36|Lack of Efficacy|0|||
94568494|NCT00768989|323878827|FG000|On or After Week 36|Adverse Event|0|||
94568495|NCT00768989|323878828|FG001|On or After Week 36|Adverse Event|1|||
94237390|NCT01296555|322664176|FG008|Overall Study|Study Terminated By Sponsor|0|||
94237391|NCT01296555|322664177|FG009|Overall Study|Study Terminated By Sponsor|0|||
94237392|NCT01296555|322664178|FG010|Overall Study|Study Terminated By Sponsor|0|||
94237393|NCT01296555|322664179|FG011|Overall Study|Study Terminated By Sponsor|0|||
94237394|NCT01296555|322664180|FG012|Overall Study|Study Terminated By Sponsor|0|||
94348090|NCT01021293|323054091|FG001|Overall Study|Serious Adverse Event|1|||
94568496|NCT00768989|323878827|FG000|On or After Week 36|Lost to Follow-up|1|||
94568497|NCT00768989|323878828|FG001|On or After Week 36|Lost to Follow-up|0|||
94568498|NCT00768989|323878827|FG000|On or After Week 36|Poor Compliance|1|||
94568499|NCT00768989|323878828|FG001|On or After Week 36|Poor Compliance|0|||
94568500|NCT00768989|323878827|FG000|On or After Week 36|Protocol Violation|1|||
94568501|NCT00768989|323878828|FG001|On or After Week 36|Protocol Violation|0|||
94237395|NCT01296555|322664181|FG013|Overall Study|Study Terminated By Sponsor|0|||
94237396|NCT01296555|322664182|FG014|Overall Study|Study Terminated By Sponsor|0|||
94237397|NCT01296555|322664183|FG015|Overall Study|Study Terminated By Sponsor|0|||
94237398|NCT01296555|322664184|FG016|Overall Study|Study Terminated By Sponsor|0|||
94237399|NCT01296555|322664185|FG017|Overall Study|Study Terminated By Sponsor|0|||
94237400|NCT01296555|322664186|FG018|Overall Study|Study Terminated By Sponsor|0|||
94568502|NCT00768989|323878827|FG000|On or After Week 36|Did not attend termination visit|2|||
94348091|NCT01021293|323054090|FG000|Overall Study|Adverse Event|2|||
94348092|NCT01021293|323054091|FG001|Overall Study|Adverse Event|1|||
94348093|NCT01021293|323054090|FG000|Overall Study|Withdrawal by Subject|1|||
94348094|NCT01021293|323054091|FG001|Overall Study|Withdrawal by Subject|3|||
94348095|NCT01021293|323054090|FG000|Overall Study|Migrated/moved from study area|6|||
94348096|NCT01021293|323054091|FG001|Overall Study|Migrated/moved from study area|18|||
94348097|NCT01021293|323054090|FG000|Overall Study|Lost to Follow-up|1|||
94348098|NCT01021293|323054091|FG001|Overall Study|Lost to Follow-up|1|||
94348099|NCT00959192|323056039|FG000|Overall Study|Adverse Event|1|||
94348100|NCT00959192|323056040|FG001|Overall Study|Adverse Event|1|||
94348101|NCT00959192|323056041|FG002|Overall Study|Adverse Event|1|||
94348102|NCT00959192|323056042|FG003|Overall Study|Adverse Event|0|||
94348103|NCT00959192|323056039|FG000|Overall Study|Investigator Request|1|||
94348104|NCT00959192|323056040|FG001|Overall Study|Investigator Request|0|||
94348105|NCT00959192|323056041|FG002|Overall Study|Investigator Request|0|||
94348106|NCT00959192|323056042|FG003|Overall Study|Investigator Request|0|||
94348107|NCT00959192|323056039|FG000|Overall Study|Caregiver Request|0|||
94348108|NCT00959192|323056040|FG001|Overall Study|Caregiver Request|0|||
94348109|NCT00959192|323056041|FG002|Overall Study|Caregiver Request|2|||
94348110|NCT00959192|323056042|FG003|Overall Study|Caregiver Request|1|||
94348111|NCT01603615|323056043|FG000|Overall Study|Did not Receive Treatment|7|||
94348112|NCT01603615|323056043|FG000|Overall Study|Lost to Follow-up|9|||
94348113|NCT01603615|323056043|FG000|Overall Study|Personal Reasons|17|||
94348114|NCT01603615|323056043|FG000|Overall Study|Other Miscellaneous|1|||
94348115|NCT01952041|323056044|FG000|Overall Study|Lost to Follow-up|9|||
94348116|NCT01952041|323056045|FG001|Overall Study|Lost to Follow-up|16|||
94348117|NCT01952041|323056044|FG000|Overall Study|Withdrawal by Subject|7|||
94348118|NCT01952041|323056045|FG001|Overall Study|Withdrawal by Subject|5|||
94348119|NCT01952041|323056044|FG000|Overall Study|Death|1|||
94348120|NCT01952041|323056045|FG001|Overall Study|Death|0|||
94348121|NCT05158244|323056046|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
94348122|NCT05158244|323056047|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
94348123|NCT05158244|323056048|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
94348124|NCT05158244|323056049|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
94348125|NCT05158244|323056050|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
94348126|NCT05158244|323056046|FG000|Overall Study|Withdrawal by Subject|0|||
94348127|NCT05158244|323056047|FG001|Overall Study|Withdrawal by Subject|0|||
94348128|NCT05158244|323056048|FG002|Overall Study|Withdrawal by Subject|1|||
94348129|NCT05158244|323056049|FG003|Overall Study|Withdrawal by Subject|0|||
94348130|NCT05158244|323056050|FG004|Overall Study|Withdrawal by Subject|0|||
94348131|NCT01569568|323056051|FG000|Overall Study|Physician Decision|0|||
94348132|NCT01569568|323056052|FG001|Overall Study|Physician Decision|2|||
94348133|NCT02145429|323056053|FG000|Overall Study|Death|4|||
94348134|NCT02145429|323056054|FG001|Overall Study|Death|5|||
94348135|NCT02145429|323056053|FG000|Overall Study|Lost to Follow-up|4|||
94348136|NCT02145429|323056054|FG001|Overall Study|Lost to Follow-up|3|||
94348137|NCT02145429|323056053|FG000|Overall Study|Withdrawal by Subject|8|||
94348138|NCT02145429|323056054|FG001|Overall Study|Withdrawal by Subject|3|||
94348139|NCT04249076|323056058|FG000|Overall Study|Adverse Event|1|||
94348140|NCT04249076|323056059|FG001|Overall Study|Adverse Event|1|||
94348141|NCT04249076|323056058|FG000|Overall Study|Protocol Violation|1|||
94348142|NCT04249076|323056059|FG001|Overall Study|Protocol Violation|2|||
94348143|NCT04249076|323056058|FG000|Overall Study|Lack of Efficacy|0|||
94348144|NCT04249076|323056059|FG001|Overall Study|Lack of Efficacy|1|||
94348145|NCT04249076|323056058|FG000|Overall Study|Withdrawal by Subject|0|||
94348146|NCT04249076|323056059|FG001|Overall Study|Withdrawal by Subject|1|||
94348147|NCT00783263|323056060|FG000|Overall Study|Adverse Event|3|||
94348148|NCT00783263|323056061|FG001|Overall Study|Adverse Event|0|||
94348149|NCT00783263|323056062|FG002|Overall Study|Adverse Event|2|||
94348150|NCT00783263|323056063|FG003|Overall Study|Adverse Event|1|||
94348151|NCT00783263|323056060|FG000|Overall Study|Lost to Follow-up|1|||
94348152|NCT00783263|323056061|FG001|Overall Study|Lost to Follow-up|1|||
94348153|NCT00783263|323056062|FG002|Overall Study|Lost to Follow-up|0|||
94348154|NCT00783263|323056063|FG003|Overall Study|Lost to Follow-up|0|||
94348155|NCT00783263|323056060|FG000|Overall Study|Withdrawal by Subject|0|||
94348156|NCT00783263|323056061|FG001|Overall Study|Withdrawal by Subject|1|||
94348157|NCT00783263|323056062|FG002|Overall Study|Withdrawal by Subject|1|||
94348158|NCT00783263|323056063|FG003|Overall Study|Withdrawal by Subject|2|||
94348159|NCT00242710|323056064|FG000|Core Study (up to Year 1)|Adverse Event|30|||
94348160|NCT00242710|323056065|FG001|Core Study (up to Year 1)|Adverse Event|25|||
94348161|NCT00242710|323056066|FG002|Core Study (up to Year 1)|Adverse Event|23|||
94348162|NCT00242710|323056067|FG003|Core Study (up to Year 1)|Adverse Event|14|||
94348163|NCT00242710|323056064|FG000|Core Study (up to Year 1)|Death|0|||
94348164|NCT00242710|323056065|FG001|Core Study (up to Year 1)|Death|0|||
94568503|NCT00768989|323878828|FG001|On or After Week 36|Did not attend termination visit|0|||
94568504|NCT00768989|323878827|FG000|On or After Week 36|Sponsor Termination|45|||
94568505|NCT00768989|323878828|FG001|On or After Week 36|Sponsor Termination|26|||
94568506|NCT00962208|323878829|FG000|Overall Study|Could not achieve good vision|9|||
94568507|NCT00962208|323878830|FG001|Overall Study|Could not achieve good vision|0|||
94568508|NCT00962208|323878829|FG000|Overall Study|Contraindicated to continue study|5|||
94568509|NCT00962208|323878830|FG001|Overall Study|Contraindicated to continue study|1|||
94568510|NCT00962208|323878829|FG000|Overall Study|Lost to Follow-up|0|||
94568511|NCT00962208|323878830|FG001|Overall Study|Lost to Follow-up|9|||
94568512|NCT03924622|323878831|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
94237401|NCT01296555|322664187|FG019|Overall Study|Study Terminated By Sponsor|0|||
94237402|NCT01296555|322664188|FG020|Overall Study|Study Terminated By Sponsor|0|||
94237403|NCT01296555|322664189|FG021|Overall Study|Study Terminated By Sponsor|0|||
94237404|NCT01296555|322664190|FG022|Overall Study|Study Terminated By Sponsor|0|||
94237405|NCT01296555|322664191|FG023|Overall Study|Study Terminated By Sponsor|0|||
94237406|NCT01296555|322664192|FG024|Overall Study|Study Terminated By Sponsor|0|||
94237407|NCT01296555|322664193|FG025|Overall Study|Study Terminated By Sponsor|1|||
94237408|NCT01296555|322664194|FG026|Overall Study|Study Terminated By Sponsor|0|||
94237409|NCT01296555|322664195|FG027|Overall Study|Study Terminated By Sponsor|0|||
94237410|NCT01296555|322664196|FG028|Overall Study|Study Terminated By Sponsor|0|||
94237411|NCT01296555|322664168|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237412|NCT01296555|322664169|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94348165|NCT00242710|323056066|FG002|Core Study (up to Year 1)|Death|1|||
94568513|NCT03924622|323878832|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
94237413|NCT01296555|322664170|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94348166|NCT00242710|323056067|FG003|Core Study (up to Year 1)|Death|0|||
94348167|NCT00242710|323056064|FG000|Core Study (up to Year 1)|Physician Decision|0|||
94348168|NCT00242710|323056065|FG001|Core Study (up to Year 1)|Physician Decision|1|||
94348169|NCT00242710|323056066|FG002|Core Study (up to Year 1)|Physician Decision|0|||
94348170|NCT00242710|323056067|FG003|Core Study (up to Year 1)|Physician Decision|1|||
94348171|NCT00242710|323056064|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
94348172|NCT00242710|323056065|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
94348173|NCT00242710|323056066|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
94348174|NCT00242710|323056067|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
94348175|NCT00242710|323056064|FG000|Core Study (up to Year 1)|Other|6|||
94348176|NCT00242710|323056065|FG001|Core Study (up to Year 1)|Other|1|||
94348177|NCT00242710|323056066|FG002|Core Study (up to Year 1)|Other|0|||
94348178|NCT00242710|323056067|FG003|Core Study (up to Year 1)|Other|2|||
94348179|NCT00242710|323056064|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
94348180|NCT00242710|323056065|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
94348181|NCT00242710|323056066|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
94348182|NCT00242710|323056067|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
94348183|NCT00242710|323056064|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
94348184|NCT00242710|323056065|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
94348185|NCT00242710|323056066|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
94348186|NCT00242710|323056067|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
94348187|NCT00242710|323056064|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
94348188|NCT00242710|323056065|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
94348189|NCT00242710|323056066|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
94348190|NCT00242710|323056067|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
94348191|NCT00242710|323056064|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
94348192|NCT00242710|323056065|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
94348193|NCT00242710|323056066|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
94348194|NCT00242710|323056067|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
94348195|NCT00242710|323056064|FG000|Period Between Core Study and Extension|Adverse Event|2|||
94348196|NCT00242710|323056065|FG001|Period Between Core Study and Extension|Adverse Event|3|||
94348197|NCT00242710|323056066|FG002|Period Between Core Study and Extension|Adverse Event|5|||
94348198|NCT00242710|323056067|FG003|Period Between Core Study and Extension|Adverse Event|2|||
94348199|NCT00242710|323056064|FG000|Period Between Core Study and Extension|Physician Decision|1|||
94348200|NCT00242710|323056065|FG001|Period Between Core Study and Extension|Physician Decision|1|||
94348201|NCT00242710|323056066|FG002|Period Between Core Study and Extension|Physician Decision|0|||
94348202|NCT00242710|323056067|FG003|Period Between Core Study and Extension|Physician Decision|0|||
94348203|NCT00242710|323056064|FG000|Period Between Core Study and Extension|Other|24|||
94348204|NCT00242710|323056065|FG001|Period Between Core Study and Extension|Other|24|||
94348205|NCT00242710|323056066|FG002|Period Between Core Study and Extension|Other|9|||
94348206|NCT00242710|323056067|FG003|Period Between Core Study and Extension|Other|11|||
94348207|NCT00242710|323056064|FG000|Period Between Core Study and Extension|Extension not Available|17|||
94568514|NCT03924622|323878833|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
94237414|NCT01296555|322664171|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237415|NCT01296555|322664172|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94568515|NCT03924622|323878834|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
94568516|NCT03924622|323878835|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
94568517|NCT03924622|323878836|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
94568518|NCT02043938|323878846|FG000|Overall Study|Withdrawal by Subject|7|||
94568519|NCT02043938|323878846|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
94568520|NCT02043938|323878846|FG000|Overall Study|No show by subject|1|||
94568521|NCT02043938|323878846|FG000|Overall Study|Investigator decision|1|||
94568522|NCT02366312|323878851|FG000|Overall Study|Lost to Follow-up|0|||
94568523|NCT02366312|323878852|FG001|Overall Study|Lost to Follow-up|1|||
94568524|NCT03456076|323878853|FG000|Overall Study|Withdrawal by Subject|5|||
94568525|NCT03456076|323878854|FG001|Overall Study|Withdrawal by Subject|9|||
94568526|NCT03456076|323878853|FG000|Overall Study|Protocol deviation|0|||
94568527|NCT03456076|323878854|FG001|Overall Study|Protocol deviation|1|||
94568528|NCT03456076|323878853|FG000|Overall Study|Lost to Follow-up|0|||
94568529|NCT03456076|323878854|FG001|Overall Study|Lost to Follow-up|1|||
94568530|NCT03456076|323878853|FG000|Overall Study|Death|2|||
94568531|NCT03456076|323878854|FG001|Overall Study|Death|5|||
94568532|NCT03456076|323878853|FG000|Overall Study|Study ongoing|123|||
94568533|NCT03456076|323878854|FG001|Overall Study|Study ongoing|111|||
94568534|NCT02420093|323878859|FG000|Overall Study|Withdrawal by Subject|1|||
94568535|NCT02420093|323878860|FG001|Overall Study|Withdrawal by Subject|1|||
94568536|NCT04862065|323878861|FG000|Screening|Protocol Violation|54|||
94568537|NCT04862065|323878862|FG001|Screening|Protocol Violation|0|||
94568538|NCT04862065|323878863|FG002|Screening|Protocol Violation|0|||
94568539|NCT04862065|323878861|FG000|Screening|Insufficient Sample|1|||
94658642|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
94658643|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
94658644|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
94658645|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
94658646|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
94658647|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
94658648|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
94658649|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
94658650|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
94658651|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
94658652|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
94658653|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
94658654|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
94658655|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
94658656|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
94658657|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
94658658|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
94658659|NCT01172938|324206182|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
94658660|NCT01172938|324206183|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
94658661|NCT01172938|324206184|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
94658662|NCT01172938|324206185|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
94658663|NCT01172938|324206186|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
94658664|NCT01172938|324206187|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
94658665|NCT01172938|324206188|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
94658666|NCT01172938|324206189|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
94658667|NCT01172938|324206190|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
94658668|NCT01172938|324206182|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
94658669|NCT01172938|324206183|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
94658670|NCT01172938|324206184|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
94658671|NCT01172938|324206185|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
94658672|NCT01172938|324206186|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
94658673|NCT01172938|324206187|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
94658674|NCT01172938|324206188|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
94658675|NCT01172938|324206189|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
94658676|NCT01172938|324206190|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
94658677|NCT01172938|324206182|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
94658678|NCT01172938|324206183|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
94568540|NCT04862065|323878862|FG001|Screening|Insufficient Sample|0|||
94568541|NCT04862065|323878863|FG002|Screening|Insufficient Sample|0|||
94568542|NCT04862065|323878861|FG000|Follow-Up|Lost to Follow-up|3|||
94568543|NCT04862065|323878862|FG001|Follow-Up|Lost to Follow-up|0|||
94658679|NCT01172938|324206184|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
94658680|NCT01172938|324206185|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
94568544|NCT04862065|323878863|FG002|Follow-Up|Lost to Follow-up|0|||
94568545|NCT02055898|323878864|FG000|First Intervention (5 Days)|Physician Decision|2|||
94568546|NCT02055898|323878865|FG001|First Intervention (5 Days)|Physician Decision|0|||
94568547|NCT02055898|323878864|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
94568548|NCT02055898|323878865|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
94568549|NCT03244917|323878866|FG000|Overall Study|Lost to Follow-up|2|||
94568550|NCT03244917|323878867|FG001|Overall Study|Lost to Follow-up|2|||
94568551|NCT02314052|323878868|FG000|Cycle One|Adverse Event|0|||
94568552|NCT02314052|323878869|FG001|Cycle One|Adverse Event|0|||
94568553|NCT02314052|323878870|FG002|Cycle One|Adverse Event|0|||
94568554|NCT02314052|323878871|FG003|Cycle One|Adverse Event|1|||
94568555|NCT02314052|323878872|FG004|Cycle One|Adverse Event|0|||
94568556|NCT02314052|323878873|FG005|Cycle One|Adverse Event|0|||
94568557|NCT02653326|323878874|FG000|Overall Study|Lost to Follow-up|10|||
94568558|NCT02653326|323878875|FG001|Overall Study|Lost to Follow-up|7|||
94568559|NCT03480152|323878876|FG000|Phase I|Signed consent. Died before treatment.|1|||
94568560|NCT03480152|323878877|FG001|Phase I|Signed consent. Died before treatment.|0|||
94568561|NCT03480152|323878878|FG002|Phase I|Signed consent. Died before treatment.|0|||
94568562|NCT01054456|323878879|FG000|Overall Study|Other|1|||
94568563|NCT03535974|323878880|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
94568564|NCT03535974|323878881|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
94568565|NCT03535974|323878882|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
94568566|NCT03535974|323878880|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
94568567|NCT03535974|323878881|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
94568568|NCT03535974|323878882|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
94568569|NCT04701333|323878883|FG000|Overall Study|Lost to Follow-up|3|||
94568570|NCT04701333|323878884|FG001|Overall Study|Lost to Follow-up|7|||
94568571|NCT04701333|323878883|FG000|Overall Study|Withdrawal by Subject|0|||
94568572|NCT04701333|323878884|FG001|Overall Study|Withdrawal by Subject|1|||
94568573|NCT01919229|323878885|FG000|Overall Study|Subject/guardian decision|0|||
94568574|NCT01919229|323878886|FG001|Overall Study|Subject/guardian decision|0|||
94568575|NCT01919229|323878887|FG002|Overall Study|Subject/guardian decision|1|||
94568576|NCT01632020|323878888|FG000|Overall Study|Withdrawal by Subject|1|||
94568577|NCT01632020|323878889|FG001|Overall Study|Withdrawal by Subject|0|||
94568578|NCT01632020|323878888|FG000|Overall Study|Adverse Event|1|||
94568579|NCT01632020|323878889|FG001|Overall Study|Adverse Event|0|||
94568580|NCT00687401|323878890|FG000|Overall Study|Protocol Violation|7|||
94568581|NCT00687401|323878890|FG000|Overall Study|Adverse Event|6|||
94568582|NCT00687401|323878890|FG000|Overall Study|Lack of Efficacy|6|||
94568583|NCT00687401|323878890|FG000|Overall Study|Withdrawal by Subject|4|||
94568584|NCT00687401|323878890|FG000|Overall Study|Did not return for visit|3|||
94568585|NCT00687401|323878890|FG000|Overall Study|For reasons different from those above|4|||
94568586|NCT02920892|323878891|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
94568587|NCT02920892|323878892|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
94568588|NCT02920892|323878893|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
94568589|NCT02920892|323878891|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
94568590|NCT02920892|323878892|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
94568591|NCT02920892|323878893|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
94568592|NCT02920892|323878891|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
94568593|NCT02920892|323878892|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
94568594|NCT02920892|323878893|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
94568595|NCT02920892|323878891|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
94568596|NCT02920892|323878892|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
94568597|NCT02920892|323878893|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
94568598|NCT02920892|323878891|FG000|Placebo-Controlled Period|Physician Decision|0|||
94568599|NCT02920892|323878892|FG001|Placebo-Controlled Period|Physician Decision|0|||
94568600|NCT02920892|323878893|FG002|Placebo-Controlled Period|Physician Decision|1|||
94568601|NCT02920892|323878891|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
94568602|NCT02920892|323878892|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
94568603|NCT02920892|323878893|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
94568604|NCT02920892|323878891|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
94568605|NCT02920892|323878892|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
94568606|NCT02920892|323878893|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
94568607|NCT02920892|323878891|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
94568608|NCT02920892|323878892|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
94568609|NCT02920892|323878893|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
94568610|NCT04486235|323878894|FG000|Overall Study|Pregnancy|1|||
94568611|NCT04486235|323878895|FG001|Overall Study|Pregnancy|0|||
94568612|NCT04486235|323878894|FG000|Overall Study|Lost to Follow-up|1|||
94568613|NCT04486235|323878895|FG001|Overall Study|Lost to Follow-up|0|||
94568614|NCT00626275|323878896|FG000|Part A - Treatment Period 1|Adverse Event|1|||
94568615|NCT00626275|323878897|FG001|Part A - Treatment Period 1|Adverse Event|0|||
94568616|NCT00626275|323878898|FG002|Part A - Treatment Period 1|Adverse Event|0|||
94568617|NCT00626275|323878899|FG003|Part A - Treatment Period 1|Adverse Event|0|||
94568618|NCT00626275|323878900|FG004|Part A - Treatment Period 1|Adverse Event|0|||
94568619|NCT00626275|323878901|FG005|Part A - Treatment Period 1|Adverse Event|0|||
94568620|NCT00626275|323878902|FG006|Part A - Treatment Period 1|Adverse Event|0|||
94568621|NCT00626275|323878903|FG007|Part A - Treatment Period 1|Adverse Event|0|||
94568622|NCT00626275|323878896|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
94568623|NCT00626275|323878897|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
94568624|NCT00626275|323878898|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
94568625|NCT00626275|323878899|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
94568626|NCT00626275|323878900|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
94568627|NCT00626275|323878901|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
94568628|NCT00626275|323878902|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
94568629|NCT00626275|323878903|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
94568630|NCT00626275|323878896|FG000|Part B|Lost to Follow-up|0|||
94568631|NCT00626275|323878897|FG001|Part B|Lost to Follow-up|0|||
94568632|NCT00626275|323878898|FG002|Part B|Lost to Follow-up|0|||
94568633|NCT00626275|323878899|FG003|Part B|Lost to Follow-up|0|||
94568634|NCT00626275|323878900|FG004|Part B|Lost to Follow-up|0|||
94568635|NCT00626275|323878901|FG005|Part B|Lost to Follow-up|0|||
94568636|NCT00626275|323878902|FG006|Part B|Lost to Follow-up|1|||
94568637|NCT00626275|323878903|FG007|Part B|Lost to Follow-up|0|||
94568638|NCT00626275|323878896|FG000|Part B|Withdrawal by Subject|0|||
94568639|NCT00626275|323878897|FG001|Part B|Withdrawal by Subject|0|||
94568640|NCT00626275|323878898|FG002|Part B|Withdrawal by Subject|0|||
94568641|NCT00626275|323878899|FG003|Part B|Withdrawal by Subject|0|||
94568642|NCT00626275|323878900|FG004|Part B|Withdrawal by Subject|0|||
94568643|NCT00626275|323878901|FG005|Part B|Withdrawal by Subject|0|||
94568644|NCT00626275|323878902|FG006|Part B|Withdrawal by Subject|0|||
94568645|NCT00626275|323878903|FG007|Part B|Withdrawal by Subject|1|||
94568646|NCT00113841|323878905|FG000|Overall Study|Disease progression|0|||
94568647|NCT00113841|323878906|FG001|Overall Study|Disease progression|2|||
94568648|NCT00113841|323878905|FG000|Overall Study|Non-compliant|1|||
94568649|NCT00113841|323878906|FG001|Overall Study|Non-compliant|0|||
94568650|NCT01092728|323878907|FG000|Overall Study|Withdrawal by Subject|2|||
94568651|NCT01092728|323878908|FG001|Overall Study|Withdrawal by Subject|0|||
94568652|NCT01092728|323878907|FG000|Overall Study|Adverse Event|0|||
94568653|NCT01092728|323878908|FG001|Overall Study|Adverse Event|1|||
94568654|NCT01092728|323878907|FG000|Overall Study|Disease Progression|1|||
94568655|NCT01092728|323878908|FG001|Overall Study|Disease Progression|13|||
94568656|NCT01092728|323878907|FG000|Overall Study|Prohibited Concomitant Medications|1|||
94568657|NCT01092728|323878908|FG001|Overall Study|Prohibited Concomitant Medications|0|||
94568658|NCT02336607|323878909|FG000|Overall Study|Physician Decision|1|||
94568659|NCT02336607|323878910|FG001|Overall Study|Physician Decision|4|||
94568660|NCT02336607|323878911|FG002|Overall Study|Physician Decision|3|||
94568661|NCT02336607|323878912|FG003|Overall Study|Physician Decision|15|||
94568662|NCT02336607|323878909|FG000|Overall Study|Lack of Efficacy|1|||
94568663|NCT02336607|323878910|FG001|Overall Study|Lack of Efficacy|0|||
94568664|NCT02336607|323878911|FG002|Overall Study|Lack of Efficacy|0|||
94568665|NCT02336607|323878912|FG003|Overall Study|Lack of Efficacy|2|||
94568666|NCT02336607|323878909|FG000|Overall Study|Lost to Follow-up|2|||
94568667|NCT02336607|323878910|FG001|Overall Study|Lost to Follow-up|1|||
94568668|NCT02336607|323878911|FG002|Overall Study|Lost to Follow-up|0|||
94568669|NCT02336607|323878912|FG003|Overall Study|Lost to Follow-up|21|||
94568670|NCT02336607|323878909|FG000|Overall Study|Protocol Violation|0|||
94568671|NCT02336607|323878910|FG001|Overall Study|Protocol Violation|1|||
94568672|NCT02336607|323878911|FG002|Overall Study|Protocol Violation|1|||
94568673|NCT02336607|323878912|FG003|Overall Study|Protocol Violation|3|||
94568674|NCT02336607|323878909|FG000|Overall Study|Adverse Event|0|||
94568675|NCT02336607|323878910|FG001|Overall Study|Adverse Event|2|||
94568676|NCT02336607|323878911|FG002|Overall Study|Adverse Event|2|||
94568677|NCT02336607|323878912|FG003|Overall Study|Adverse Event|26|||
94568678|NCT02336607|323878909|FG000|Overall Study|Withdrawal by Subject|0|||
94568679|NCT02336607|323878910|FG001|Overall Study|Withdrawal by Subject|2|||
94568680|NCT02336607|323878911|FG002|Overall Study|Withdrawal by Subject|0|||
94568681|NCT02336607|323878912|FG003|Overall Study|Withdrawal by Subject|20|||
94568682|NCT01788566|323878913|FG000|Overall Study|Death|4|||
94568683|NCT01788566|323878913|FG000|Overall Study|Adverse Event|1|||
94568684|NCT01788566|323878913|FG000|Overall Study|Clinical Progressive Disease|3|||
94568685|NCT00721396|323878917|FG000|Overall Study|Adverse Event|4|||
94568686|NCT00721396|323878918|FG001|Overall Study|Adverse Event|7|||
94568687|NCT00721396|323878919|FG002|Overall Study|Adverse Event|2|||
94568688|NCT00721396|323878920|FG003|Overall Study|Adverse Event|0|||
94568689|NCT00721396|323878917|FG000|Overall Study|Withdrawal by Subject|12|||
94568690|NCT00721396|323878918|FG001|Overall Study|Withdrawal by Subject|15|||
94568691|NCT00721396|323878919|FG002|Overall Study|Withdrawal by Subject|3|||
94568692|NCT00721396|323878920|FG003|Overall Study|Withdrawal by Subject|7|||
94568693|NCT00721396|323878917|FG000|Overall Study|Lost to Follow-up|7|||
94568694|NCT00721396|323878918|FG001|Overall Study|Lost to Follow-up|9|||
94568695|NCT00721396|323878919|FG002|Overall Study|Lost to Follow-up|3|||
94568696|NCT00721396|323878920|FG003|Overall Study|Lost to Follow-up|3|||
94568697|NCT00721396|323878917|FG000|Overall Study|Protocol Violation|4|||
94568698|NCT00721396|323878918|FG001|Overall Study|Protocol Violation|3|||
94568699|NCT00721396|323878919|FG002|Overall Study|Protocol Violation|1|||
94568700|NCT00721396|323878920|FG003|Overall Study|Protocol Violation|0|||
94568701|NCT00721396|323878917|FG000|Overall Study|Inappropriate enrollment|0|||
94237416|NCT01296555|322664173|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94568702|NCT00721396|323878918|FG001|Overall Study|Inappropriate enrollment|2|||
94568703|NCT00721396|323878919|FG002|Overall Study|Inappropriate enrollment|0|||
94568704|NCT00721396|323878920|FG003|Overall Study|Inappropriate enrollment|0|||
94568705|NCT00721396|323878917|FG000|Overall Study|Administrative reason|3|||
94568706|NCT00721396|323878918|FG001|Overall Study|Administrative reason|0|||
94568707|NCT00721396|323878919|FG002|Overall Study|Administrative reason|1|||
94568708|NCT00721396|323878920|FG003|Overall Study|Administrative reason|0|||
94568709|NCT01695135|323878921|FG000|Double-blind Treatment Phase|Progressive disease|50|||
94568710|NCT01695135|323878922|FG001|Double-blind Treatment Phase|Progressive disease|110|||
94568711|NCT01695135|323878923|FG002|Double-blind Treatment Phase|Progressive disease|0|||
94568712|NCT01695135|323878924|FG003|Double-blind Treatment Phase|Progressive disease|0|||
94568713|NCT01695135|323878921|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
94568714|NCT01695135|323878922|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
94568715|NCT01695135|323878923|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
94568716|NCT01695135|323878924|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
94568717|NCT01695135|323878921|FG000|Double-blind Treatment Phase|Adverse Event|7|||
94568718|NCT01695135|323878922|FG001|Double-blind Treatment Phase|Adverse Event|7|||
94568719|NCT01695135|323878923|FG002|Double-blind Treatment Phase|Adverse Event|0|||
94568720|NCT01695135|323878924|FG003|Double-blind Treatment Phase|Adverse Event|0|||
94568721|NCT01695135|323878921|FG000|Double-blind Treatment Phase|Other|1|||
94568722|NCT01695135|323878922|FG001|Double-blind Treatment Phase|Other|3|||
94568723|NCT01695135|323878923|FG002|Double-blind Treatment Phase|Other|0|||
94568724|NCT01695135|323878924|FG003|Double-blind Treatment Phase|Other|0|||
94568725|NCT01695135|323878921|FG000|Double-blind Treatment Phase|Physician Decision|6|||
94568726|NCT01695135|323878922|FG001|Double-blind Treatment Phase|Physician Decision|3|||
94568727|NCT01695135|323878923|FG002|Double-blind Treatment Phase|Physician Decision|0|||
94568728|NCT01695135|323878924|FG003|Double-blind Treatment Phase|Physician Decision|0|||
94568729|NCT01695135|323878921|FG000|Double-blind Treatment Phase|Death|1|||
94568730|NCT01695135|323878922|FG001|Double-blind Treatment Phase|Death|1|||
94568731|NCT01695135|323878923|FG002|Double-blind Treatment Phase|Death|0|||
94568732|NCT01695135|323878924|FG003|Double-blind Treatment Phase|Death|0|||
94568733|NCT01695135|323878921|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
94568734|NCT01695135|323878922|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
94568735|NCT01695135|323878923|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
94568736|NCT01695135|323878924|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
94568737|NCT01695135|323878921|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
94568738|NCT01695135|323878922|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
94568739|NCT01695135|323878923|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
94568740|NCT01695135|323878924|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
94568741|NCT01695135|323878921|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
94568742|NCT01695135|323878922|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
94568743|NCT01695135|323878923|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
94568744|NCT01695135|323878924|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
94568745|NCT01695135|323878921|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
94568746|NCT01695135|323878922|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
94568747|NCT01695135|323878923|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
94568748|NCT01695135|323878924|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
94568749|NCT01695135|323878921|FG000|Open Label Extension Treatment Phase|Other|0|||
94568750|NCT01695135|323878922|FG001|Open Label Extension Treatment Phase|Other|0|||
94568751|NCT01695135|323878923|FG002|Open Label Extension Treatment Phase|Other|4|||
94568752|NCT01695135|323878924|FG003|Open Label Extension Treatment Phase|Other|7|||
94568753|NCT01695135|323878921|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
94568754|NCT01695135|323878922|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
94568755|NCT01695135|323878923|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
94568756|NCT01695135|323878924|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
94568757|NCT01695135|323878921|FG000|Open Label Extension Treatment Phase|Death|0|||
94568758|NCT01695135|323878922|FG001|Open Label Extension Treatment Phase|Death|0|||
94568759|NCT01695135|323878923|FG002|Open Label Extension Treatment Phase|Death|2|||
94568760|NCT01695135|323878924|FG003|Open Label Extension Treatment Phase|Death|7|||
94568761|NCT01695135|323878921|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
94568762|NCT01695135|323878922|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
94568763|NCT01695135|323878923|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
94568764|NCT01695135|323878924|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
94568765|NCT01188772|323878925|FG000|Overall Study|Randomized but Not Treated|0|||
94568766|NCT01188772|323878926|FG001|Overall Study|Randomized but Not Treated|1|||
94568767|NCT01188772|323878927|FG002|Overall Study|Randomized but Not Treated|0|||
94568768|NCT01188772|323878928|FG003|Overall Study|Randomized but Not Treated|0|||
94568769|NCT01188772|323878925|FG000|Overall Study|Adverse Event|0|||
94568770|NCT01188772|323878926|FG001|Overall Study|Adverse Event|1|||
94568771|NCT01188772|323878927|FG002|Overall Study|Adverse Event|2|||
94568772|NCT01188772|323878928|FG003|Overall Study|Adverse Event|0|||
94568773|NCT01188772|323878925|FG000|Overall Study|Lost to Follow-up|4|||
94568774|NCT01188772|323878926|FG001|Overall Study|Lost to Follow-up|1|||
94568775|NCT01188772|323878927|FG002|Overall Study|Lost to Follow-up|1|||
94237417|NCT01296555|322664174|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237418|NCT01296555|322664175|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94568776|NCT01188772|323878928|FG003|Overall Study|Lost to Follow-up|1|||
94568777|NCT01188772|323878925|FG000|Overall Study|Non-responder|0|||
94568778|NCT01188772|323878926|FG001|Overall Study|Non-responder|0|||
94568779|NCT01188772|323878927|FG002|Overall Study|Non-responder|3|||
94568780|NCT01188772|323878928|FG003|Overall Study|Non-responder|0|||
94568781|NCT01188772|323878925|FG000|Overall Study|Physician Decision|0|||
94568782|NCT01188772|323878926|FG001|Overall Study|Physician Decision|0|||
94568783|NCT01188772|323878927|FG002|Overall Study|Physician Decision|1|||
94568784|NCT01188772|323878928|FG003|Overall Study|Physician Decision|0|||
94568785|NCT01188772|323878925|FG000|Overall Study|Terminated by Sponsor|0|||
94568786|NCT01188772|323878926|FG001|Overall Study|Terminated by Sponsor|0|||
94568787|NCT01188772|323878927|FG002|Overall Study|Terminated by Sponsor|1|||
94568788|NCT01188772|323878928|FG003|Overall Study|Terminated by Sponsor|0|||
94568789|NCT01188772|323878925|FG000|Overall Study|Treatment Failure|0|||
94568790|NCT01188772|323878926|FG001|Overall Study|Treatment Failure|0|||
94568791|NCT01188772|323878927|FG002|Overall Study|Treatment Failure|1|||
94568792|NCT01188772|323878928|FG003|Overall Study|Treatment Failure|0|||
94568793|NCT01188772|323878925|FG000|Overall Study|Virologic Failure|1|||
94568794|NCT01188772|323878926|FG001|Overall Study|Virologic Failure|0|||
94568795|NCT01188772|323878927|FG002|Overall Study|Virologic Failure|0|||
94568796|NCT01188772|323878928|FG003|Overall Study|Virologic Failure|0|||
94568797|NCT01188772|323878925|FG000|Overall Study|Withdrawal by Subject|0|||
94568798|NCT01188772|323878926|FG001|Overall Study|Withdrawal by Subject|0|||
94568799|NCT01188772|323878927|FG002|Overall Study|Withdrawal by Subject|2|||
94568800|NCT01188772|323878928|FG003|Overall Study|Withdrawal by Subject|0|||
94568801|NCT00462306|323878929|FG000|Overall Study|insufficient data|0|||
94568802|NCT00462306|323878930|FG001|Overall Study|insufficient data|13|||
94568803|NCT02370420|323878933|FG000|Overall Study|Physician Decision|3|||
94568804|NCT02370420|323878934|FG001|Overall Study|Physician Decision|3|||
94568805|NCT02370420|323878933|FG000|Overall Study|Lost to Follow-up|11|||
94568806|NCT02370420|323878934|FG001|Overall Study|Lost to Follow-up|9|||
94568807|NCT03980730|323878935|FG000|Overall Study|Study Terminated by Sponsor|0|||
94568808|NCT03980730|323878936|FG001|Overall Study|Study Terminated by Sponsor|3|||
94568809|NCT03980730|323878935|FG000|Overall Study|Adverse Event|2|||
94568810|NCT03980730|323878936|FG001|Overall Study|Adverse Event|0|||
94568811|NCT03980730|323878935|FG000|Overall Study|Sponsor Request|0|||
94568812|NCT03980730|323878936|FG001|Overall Study|Sponsor Request|1|||
94568813|NCT00360412|323878939|FG000|Overall Study|Adverse Event|37|||
94568814|NCT00360412|323878940|FG001|Overall Study|Adverse Event|65|||
94568815|NCT00360412|323878939|FG000|Overall Study|Protocol Violation|2|||
94568816|NCT00360412|323878940|FG001|Overall Study|Protocol Violation|5|||
94568817|NCT00360412|323878939|FG000|Overall Study|Patient withdrew consent|27|||
94568818|NCT00360412|323878940|FG001|Overall Study|Patient withdrew consent|52|||
94568819|NCT00360412|323878939|FG000|Overall Study|Lack of therapeutic efficacy|46|||
94568820|NCT00360412|323878940|FG001|Overall Study|Lack of therapeutic efficacy|61|||
94568821|NCT00360412|323878939|FG000|Overall Study|Physician Decision|2|||
94568822|NCT00360412|323878940|FG001|Overall Study|Physician Decision|4|||
94568823|NCT00360412|323878939|FG000|Overall Study|Other|5|||
94568824|NCT00360412|323878940|FG001|Overall Study|Other|6|||
94568825|NCT00360412|323878939|FG000|Overall Study|Study termination by Sponsor|214|||
94568826|NCT00360412|323878940|FG001|Overall Study|Study termination by Sponsor|469|||
94568827|NCT01572480|323878943|FG000|Participants Enrolled|Withdrawal by Subject|1|||
94568828|NCT01572480|323878943|FG000|Drug Administration|Discontinued drug/Off Study|1|||
94568829|NCT01572480|323878943|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
94568830|NCT01572480|323878943|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
94568831|NCT00410956|323878944|FG000|Overall Study|Adverse Event|1|||
94568832|NCT00410956|323878944|FG000|Overall Study|Death|2|||
94568833|NCT00410956|323878944|FG000|Overall Study|Lack of Efficacy|10|||
94568834|NCT00410956|323878944|FG000|Overall Study|Physician Decision|6|||
94568835|NCT01650194|323878945|FG000|Overall Study|Progressive Disease (PD)|35|||
94568836|NCT01650194|323878945|FG000|Overall Study|Withdrawal by Subject|2|||
94568837|NCT01650194|323878945|FG000|Overall Study|Miscellaneous|10|||
94568838|NCT02719171|323881036|FG000|Overall Study|Adverse Event|1|||
94658681|NCT01172938|324206186|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
94658682|NCT01172938|324206187|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
94658683|NCT01172938|324206188|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
94568839|NCT02719171|323881037|FG001|Overall Study|Adverse Event|2|||
94568840|NCT02719171|323881038|FG002|Overall Study|Adverse Event|0|||
94568841|NCT02719171|323881039|FG003|Overall Study|Adverse Event|0|||
94658684|NCT01172938|324206189|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
94658685|NCT01172938|324206190|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
94658686|NCT01172938|324206182|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
94568842|NCT02719171|323881040|FG004|Overall Study|Adverse Event|2|||
94568843|NCT02719171|323881036|FG000|Overall Study|Lost to Follow-up|0|||
94568844|NCT02719171|323881037|FG001|Overall Study|Lost to Follow-up|0|||
94568845|NCT02719171|323881038|FG002|Overall Study|Lost to Follow-up|1|||
94568846|NCT02719171|323881039|FG003|Overall Study|Lost to Follow-up|0|||
94568847|NCT02719171|323881040|FG004|Overall Study|Lost to Follow-up|0|||
94568848|NCT02719171|323881036|FG000|Overall Study|Subject Withdrawal|0|||
94568849|NCT02719171|323881037|FG001|Overall Study|Subject Withdrawal|2|||
94568850|NCT02719171|323881038|FG002|Overall Study|Subject Withdrawal|2|||
94658687|NCT01172938|324206183|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
94568851|NCT02719171|323881039|FG003|Overall Study|Subject Withdrawal|1|||
94568852|NCT02719171|323881040|FG004|Overall Study|Subject Withdrawal|0|||
94568853|NCT02719171|323881036|FG000|Overall Study|Other|0|||
94568854|NCT02719171|323881037|FG001|Overall Study|Other|0|||
94568855|NCT02719171|323881038|FG002|Overall Study|Other|0|||
94568856|NCT02719171|323881039|FG003|Overall Study|Other|1|||
94568857|NCT02719171|323881040|FG004|Overall Study|Other|0|||
94568858|NCT02614729|323881041|FG000|Overall Study|Withdrawal by Subject|1|||
94568859|NCT02614729|323881042|FG001|Overall Study|Withdrawal by Subject|0|||
94568860|NCT03790111|323881043|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
94568861|NCT04564846|323881044|FG000|Overall Study|Withdrawal by Subject|2|||
94568862|NCT04564846|323881045|FG001|Overall Study|Withdrawal by Subject|1|||
94568863|NCT04564846|323881044|FG000|Overall Study|Physician Decision|0|||
94568864|NCT04564846|323881045|FG001|Overall Study|Physician Decision|1|||
94568865|NCT04564846|323881044|FG000|Overall Study|Lost to Follow-up|0|||
94568866|NCT04564846|323881045|FG001|Overall Study|Lost to Follow-up|1|||
94568867|NCT04564846|323881044|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
94568868|NCT04564846|323881045|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
94568869|NCT04564846|323881044|FG000|Overall Study|Subject non-compliance|1|||
94568870|NCT04564846|323881045|FG001|Overall Study|Subject non-compliance|0|||
94568871|NCT03798717|323881048|FG000|Overall Study|Failed Screening|0|||
94568872|NCT03798717|323881049|FG001|Overall Study|Failed Screening|0|||
94568873|NCT03798717|323881050|FG002|Overall Study|Failed Screening|0|||
94568874|NCT03798717|323881051|FG003|Overall Study|Failed Screening|0|||
94568875|NCT03798717|323881052|FG004|Overall Study|Failed Screening|0|||
94568876|NCT03798717|323881053|FG005|Overall Study|Failed Screening|1|||
94568877|NCT03798717|323881048|FG000|Overall Study|Physician Decision|1|||
94568878|NCT03798717|323881049|FG001|Overall Study|Physician Decision|0|||
94568879|NCT03798717|323881050|FG002|Overall Study|Physician Decision|1|||
94568880|NCT03798717|323881051|FG003|Overall Study|Physician Decision|0|||
94568881|NCT03798717|323881052|FG004|Overall Study|Physician Decision|0|||
94568882|NCT03798717|323881053|FG005|Overall Study|Physician Decision|0|||
94568883|NCT03798717|323881048|FG000|Overall Study|Withdrawal by Subject|0|||
94568884|NCT03798717|323881049|FG001|Overall Study|Withdrawal by Subject|0|||
94568885|NCT03798717|323881050|FG002|Overall Study|Withdrawal by Subject|0|||
94568886|NCT03798717|323881051|FG003|Overall Study|Withdrawal by Subject|1|||
94568887|NCT03798717|323881052|FG004|Overall Study|Withdrawal by Subject|0|||
94568888|NCT03798717|323881053|FG005|Overall Study|Withdrawal by Subject|0|||
94568889|NCT03798717|323881048|FG000|Overall Study|Lost to Follow-up|1|||
94568890|NCT03798717|323881049|FG001|Overall Study|Lost to Follow-up|0|||
94568891|NCT03798717|323881050|FG002|Overall Study|Lost to Follow-up|0|||
94568892|NCT03798717|323881051|FG003|Overall Study|Lost to Follow-up|1|||
94568893|NCT03798717|323881052|FG004|Overall Study|Lost to Follow-up|0|||
94568894|NCT03798717|323881053|FG005|Overall Study|Lost to Follow-up|0|||
94568895|NCT03798717|323881048|FG000|Overall Study|Adverse Event|0|||
94568896|NCT03798717|323881049|FG001|Overall Study|Adverse Event|1|||
94568897|NCT03798717|323881050|FG002|Overall Study|Adverse Event|0|||
94568898|NCT03798717|323881051|FG003|Overall Study|Adverse Event|0|||
94568899|NCT03798717|323881052|FG004|Overall Study|Adverse Event|0|||
94568900|NCT03798717|323881053|FG005|Overall Study|Adverse Event|0|||
94568901|NCT03798717|323881048|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
94568902|NCT03798717|323881049|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
94568903|NCT03798717|323881050|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
94568904|NCT03798717|323881051|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
94568905|NCT03798717|323881052|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
94568906|NCT03798717|323881053|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
94568907|NCT02219464|323881056|FG000|Overall Study|Withdrawal by Subject|1|||
94568908|NCT02219464|323881057|FG001|Overall Study|Withdrawal by Subject|0|||
94568909|NCT02219464|323881056|FG000|Overall Study|case cancelled|1|||
94568910|NCT02219464|323881057|FG001|Overall Study|case cancelled|0|||
94568911|NCT02219464|323881056|FG000|Overall Study|catheter malfunction|1|||
94568912|NCT02219464|323881057|FG001|Overall Study|catheter malfunction|0|||
94568913|NCT01307319|323881065|FG000|Overall Study|Adverse Event|2|||
94568914|NCT01307319|323881066|FG001|Overall Study|Adverse Event|2|||
94568915|NCT01307319|323881067|FG002|Overall Study|Adverse Event|1|||
94568916|NCT01307319|323881065|FG000|Overall Study|Lost to Follow-up|1|||
94568917|NCT01307319|323881066|FG001|Overall Study|Lost to Follow-up|0|||
94568918|NCT01307319|323881067|FG002|Overall Study|Lost to Follow-up|1|||
94568919|NCT01307319|323881065|FG000|Overall Study|Protocol Violation|1|||
94568920|NCT01307319|323881066|FG001|Overall Study|Protocol Violation|1|||
94568921|NCT01307319|323881067|FG002|Overall Study|Protocol Violation|0|||
94451303|NCT04747886|323439988|FG000|Overall Study|Withdrawal by Subject|1|||
94451304|NCT04747886|323439989|FG001|Overall Study|Withdrawal by Subject|4|||
94451305|NCT00402688|323439991|FG000|Overall Study|Adverse Event|12|||
94451306|NCT00402688|323439992|FG001|Overall Study|Adverse Event|9|||
94451307|NCT00402688|323439993|FG002|Overall Study|Adverse Event|3|||
94451308|NCT00402688|323439991|FG000|Overall Study|Withdrawal by Subject|3|||
94451309|NCT00402688|323439992|FG001|Overall Study|Withdrawal by Subject|1|||
94451310|NCT00402688|323439993|FG002|Overall Study|Withdrawal by Subject|1|||
94451311|NCT00402688|323439991|FG000|Overall Study|Physician Decision|0|||
94451312|NCT00402688|323439992|FG001|Overall Study|Physician Decision|0|||
94451313|NCT00402688|323439993|FG002|Overall Study|Physician Decision|1|||
94451314|NCT00402688|323439991|FG000|Overall Study|Lack of Efficacy|4|||
94451315|NCT00402688|323439992|FG001|Overall Study|Lack of Efficacy|4|||
94451316|NCT00402688|323439993|FG002|Overall Study|Lack of Efficacy|5|||
94451317|NCT00402688|323439991|FG000|Overall Study|Protocol Violation|1|||
94451318|NCT00402688|323439992|FG001|Overall Study|Protocol Violation|1|||
94451319|NCT00402688|323439993|FG002|Overall Study|Protocol Violation|1|||
94451320|NCT00402688|323439991|FG000|Overall Study|Lost to Follow-up|1|||
94451321|NCT00402688|323439992|FG001|Overall Study|Lost to Follow-up|0|||
94237419|NCT01296555|322664176|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237420|NCT01296555|322664177|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237421|NCT01296555|322664178|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237422|NCT01296555|322664179|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237423|NCT01296555|322664180|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237424|NCT01296555|322664181|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237425|NCT01296555|322664182|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237426|NCT01296555|322664183|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237427|NCT01296555|322664184|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237428|NCT01296555|322664185|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237429|NCT01296555|322664186|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237430|NCT01296555|322664187|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
94237431|NCT01296555|322664188|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237432|NCT01296555|322664189|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237433|NCT01296555|322664190|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237434|NCT01296555|322664191|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237435|NCT01296555|322664192|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237436|NCT01296555|322664193|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237437|NCT01296555|322664194|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237438|NCT01296555|322664195|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237439|NCT01296555|322664196|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
94237440|NCT01296555|322664168|FG000|Overall Study|Death|0|||
94237441|NCT01296555|322664169|FG001|Overall Study|Death|0|||
94237442|NCT01296555|322664170|FG002|Overall Study|Death|0|||
94237443|NCT01296555|322664171|FG003|Overall Study|Death|2|||
94237444|NCT01296555|322664172|FG004|Overall Study|Death|1|||
94237445|NCT01296555|322664173|FG005|Overall Study|Death|0|||
94237446|NCT01296555|322664174|FG006|Overall Study|Death|2|||
94237447|NCT01296555|322664175|FG007|Overall Study|Death|0|||
94237448|NCT01296555|322664176|FG008|Overall Study|Death|0|||
94237449|NCT01296555|322664177|FG009|Overall Study|Death|1|||
94237450|NCT01296555|322664178|FG010|Overall Study|Death|0|||
94237451|NCT01296555|322664179|FG011|Overall Study|Death|1|||
94237452|NCT01296555|322664180|FG012|Overall Study|Death|0|||
94237453|NCT01296555|322664181|FG013|Overall Study|Death|2|||
94237454|NCT01296555|322664182|FG014|Overall Study|Death|27|||
94237455|NCT01296555|322664183|FG015|Overall Study|Death|15|||
94568922|NCT01307319|323881065|FG000|Overall Study|Withdrawal by Subject|0|||
94237456|NCT01296555|322664184|FG016|Overall Study|Death|11|||
94237457|NCT01296555|322664185|FG017|Overall Study|Death|11|||
94237458|NCT01296555|322664186|FG018|Overall Study|Death|17|||
94237459|NCT01296555|322664187|FG019|Overall Study|Death|12|||
94237460|NCT01296555|322664188|FG020|Overall Study|Death|13|||
94237461|NCT01296555|322664189|FG021|Overall Study|Death|12|||
94237462|NCT01296555|322664190|FG022|Overall Study|Death|12|||
94237463|NCT01296555|322664191|FG023|Overall Study|Death|13|||
94237464|NCT01296555|322664192|FG024|Overall Study|Death|7|||
94237465|NCT01296555|322664193|FG025|Overall Study|Death|7|||
94237466|NCT01296555|322664194|FG026|Overall Study|Death|35|||
94237467|NCT01296555|322664195|FG027|Overall Study|Death|92|||
94237468|NCT01296555|322664196|FG028|Overall Study|Death|44|||
94237469|NCT01296555|322664168|FG000|Overall Study|Lost to Follow-up|0|||
94237470|NCT01296555|322664169|FG001|Overall Study|Lost to Follow-up|0|||
94237471|NCT01296555|322664170|FG002|Overall Study|Lost to Follow-up|0|||
94237472|NCT01296555|322664171|FG003|Overall Study|Lost to Follow-up|0|||
94237473|NCT01296555|322664172|FG004|Overall Study|Lost to Follow-up|0|||
94237474|NCT01296555|322664173|FG005|Overall Study|Lost to Follow-up|0|||
94451322|NCT00402688|323439993|FG002|Overall Study|Lost to Follow-up|2|||
94451323|NCT00402688|323439991|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
94451324|NCT00402688|323439992|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
94451325|NCT00402688|323439993|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
94451326|NCT00402688|323439991|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
94451327|NCT00402688|323439992|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
94451328|NCT00402688|323439993|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
94451329|NCT00402688|323439991|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
94451330|NCT00402688|323439992|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
94451331|NCT00402688|323439993|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
94451332|NCT00656292|323439995|FG000|Overall Study|Withdrawal by Subject|2|||
94451333|NCT00656292|323439996|FG001|Overall Study|Withdrawal by Subject|3|||
94451334|NCT00656292|323439995|FG000|Overall Study|Screen failure|1|||
94451335|NCT00656292|323439996|FG001|Overall Study|Screen failure|2|||
94451336|NCT04112043|323439997|FG000|Overall Study|Withdrawal by Subject|1|||
94451337|NCT04112043|323439998|FG001|Overall Study|Withdrawal by Subject|1|||
94451338|NCT04112043|323439999|FG002|Overall Study|Withdrawal by Subject|1|||
94237475|NCT01296555|322664174|FG006|Overall Study|Lost to Follow-up|0|||
94237476|NCT01296555|322664175|FG007|Overall Study|Lost to Follow-up|0|||
94237477|NCT01296555|322664176|FG008|Overall Study|Lost to Follow-up|0|||
94568923|NCT01307319|323881066|FG001|Overall Study|Withdrawal by Subject|1|||
94568924|NCT01307319|323881067|FG002|Overall Study|Withdrawal by Subject|2|||
94568925|NCT01307319|323881065|FG000|Overall Study|Other|0|||
94568926|NCT01307319|323881066|FG001|Overall Study|Other|4|||
94568927|NCT01307319|323881067|FG002|Overall Study|Other|3|||
94568928|NCT02735239|323881069|FG000|Overall Study|Adverse Event|0|||
94568929|NCT02735239|323881070|FG001|Overall Study|Adverse Event|0|||
94568930|NCT02735239|323881071|FG002|Overall Study|Adverse Event|4|||
94568931|NCT02735239|323881072|FG003|Overall Study|Adverse Event|0|||
94568932|NCT02735239|323881073|FG004|Overall Study|Adverse Event|0|||
94568933|NCT02735239|323881074|FG005|Overall Study|Adverse Event|0|||
94568934|NCT02735239|323881069|FG000|Overall Study|Death|1|||
94568935|NCT02735239|323881070|FG001|Overall Study|Death|1|||
94568936|NCT02735239|323881071|FG002|Overall Study|Death|0|||
94568937|NCT02735239|323881072|FG003|Overall Study|Death|0|||
94568938|NCT02735239|323881073|FG004|Overall Study|Death|0|||
94568939|NCT02735239|323881074|FG005|Overall Study|Death|0|||
94568940|NCT02735239|323881069|FG000|Overall Study|Physician Decision|0|||
94568941|NCT02735239|323881070|FG001|Overall Study|Physician Decision|0|||
94568942|NCT02735239|323881071|FG002|Overall Study|Physician Decision|1|||
94568943|NCT02735239|323881072|FG003|Overall Study|Physician Decision|0|||
94568944|NCT02735239|323881073|FG004|Overall Study|Physician Decision|0|||
94568945|NCT02735239|323881074|FG005|Overall Study|Physician Decision|0|||
94568946|NCT02735239|323881069|FG000|Overall Study|Progressive disease|3|||
94568947|NCT02735239|323881070|FG001|Overall Study|Progressive disease|1|||
94568948|NCT02735239|323881071|FG002|Overall Study|Progressive disease|3|||
94568949|NCT02735239|323881072|FG003|Overall Study|Progressive disease|0|||
94568950|NCT02735239|323881073|FG004|Overall Study|Progressive disease|0|||
94568951|NCT02735239|323881074|FG005|Overall Study|Progressive disease|2|||
94568952|NCT02735239|323881069|FG000|Overall Study|Withdrawal by Subject|0|||
94568953|NCT02735239|323881070|FG001|Overall Study|Withdrawal by Subject|1|||
94568954|NCT02735239|323881071|FG002|Overall Study|Withdrawal by Subject|0|||
94568955|NCT02735239|323881072|FG003|Overall Study|Withdrawal by Subject|0|||
94568956|NCT02735239|323881073|FG004|Overall Study|Withdrawal by Subject|0|||
94568957|NCT02735239|323881074|FG005|Overall Study|Withdrawal by Subject|0|||
94568958|NCT01342913|323881075|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
94568959|NCT01342913|323881076|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
94568960|NCT01342913|323881077|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
94568961|NCT01342913|323881075|FG000|2-week Run-in Period|Physician Decision|6|||
94568962|NCT01342913|323881076|FG001|2-week Run-in Period|Physician Decision|0|||
94568963|NCT01342913|323881077|FG002|2-week Run-in Period|Physician Decision|0|||
94568964|NCT01342913|323881075|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
94568965|NCT01342913|323881076|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
94568966|NCT01342913|323881077|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
94568967|NCT01342913|323881075|FG000|2-week Run-in Period|Adverse Event|2|||
94568968|NCT01342913|323881076|FG001|2-week Run-in Period|Adverse Event|0|||
94568969|NCT01342913|323881077|FG002|2-week Run-in Period|Adverse Event|0|||
94568970|NCT01342913|323881075|FG000|2-week Run-in Period|Protocol Violation|5|||
94568971|NCT01342913|323881076|FG001|2-week Run-in Period|Protocol Violation|0|||
94568972|NCT01342913|323881077|FG002|2-week Run-in Period|Protocol Violation|0|||
94568973|NCT01342913|323881075|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
94568974|NCT01342913|323881076|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
94568975|NCT01342913|323881077|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
94568976|NCT01342913|323881075|FG000|Double-Blind Treatment Period|Adverse Event|0|||
94568977|NCT01342913|323881076|FG001|Double-Blind Treatment Period|Adverse Event|3|||
94568978|NCT01342913|323881077|FG002|Double-Blind Treatment Period|Adverse Event|6|||
94568979|NCT01342913|323881075|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
94568980|NCT01342913|323881076|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
94568981|NCT01342913|323881077|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
94568982|NCT01342913|323881075|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
94568983|NCT01342913|323881076|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
94568984|NCT01342913|323881077|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
94568985|NCT01342913|323881075|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
94568986|NCT01342913|323881076|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
94568987|NCT01342913|323881077|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
94568988|NCT01342913|323881075|FG000|Double-Blind Treatment Period|Physician Decision|0|||
94568989|NCT01342913|323881076|FG001|Double-Blind Treatment Period|Physician Decision|2|||
94568990|NCT01342913|323881077|FG002|Double-Blind Treatment Period|Physician Decision|0|||
94568991|NCT01342913|323881075|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
94568992|NCT01342913|323881076|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
94568993|NCT01342913|323881077|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
94568994|NCT00683878|323881078|FG000|Overall Study|Lack of Efficacy|3|||
94568995|NCT00683878|323881079|FG001|Overall Study|Lack of Efficacy|0|||
94568996|NCT00683878|323881080|FG002|Overall Study|Lack of Efficacy|1|||
94568997|NCT00683878|323881078|FG000|Overall Study|Adverse Event|4|||
94568998|NCT00683878|323881079|FG001|Overall Study|Adverse Event|3|||
94568999|NCT00683878|323881080|FG002|Overall Study|Adverse Event|3|||
94569000|NCT00683878|323881078|FG000|Overall Study|Withdrawal by Subject|9|||
94569001|NCT00683878|323881079|FG001|Overall Study|Withdrawal by Subject|8|||
94569002|NCT00683878|323881080|FG002|Overall Study|Withdrawal by Subject|6|||
94569003|NCT00683878|323881078|FG000|Overall Study|Death|0|||
94569004|NCT00683878|323881079|FG001|Overall Study|Death|1|||
94569005|NCT00683878|323881080|FG002|Overall Study|Death|0|||
94569006|NCT00683878|323881078|FG000|Overall Study|Lost to Follow-up|4|||
94569007|NCT00683878|323881079|FG001|Overall Study|Lost to Follow-up|2|||
94658688|NCT01172938|324206184|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
94658689|NCT01172938|324206185|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
94658690|NCT01172938|324206186|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
94658691|NCT01172938|324206187|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
94658692|NCT01172938|324206188|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
94658693|NCT01172938|324206189|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
94658694|NCT01172938|324206190|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
94658695|NCT01172938|324206182|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
94658696|NCT01172938|324206183|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
94658697|NCT01172938|324206184|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
94658698|NCT01172938|324206185|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
94658699|NCT01172938|324206186|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
94658700|NCT01172938|324206187|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
94658701|NCT01172938|324206188|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
94658702|NCT01172938|324206189|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
94658703|NCT01172938|324206190|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
94658704|NCT01172938|324206182|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
94658705|NCT01172938|324206183|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
94658706|NCT01172938|324206184|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
94658707|NCT01172938|324206185|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
94658708|NCT01172938|324206186|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
94658709|NCT01172938|324206187|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
94658710|NCT01172938|324206188|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
94658711|NCT01172938|324206189|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
94237478|NCT01296555|322664177|FG009|Overall Study|Lost to Follow-up|0|||
94237479|NCT01296555|322664178|FG010|Overall Study|Lost to Follow-up|0|||
94237480|NCT01296555|322664179|FG011|Overall Study|Lost to Follow-up|0|||
94237481|NCT01296555|322664180|FG012|Overall Study|Lost to Follow-up|0|||
94237482|NCT01296555|322664181|FG013|Overall Study|Lost to Follow-up|0|||
94237483|NCT01296555|322664182|FG014|Overall Study|Lost to Follow-up|2|||
94237484|NCT01296555|322664183|FG015|Overall Study|Lost to Follow-up|1|||
94237485|NCT01296555|322664184|FG016|Overall Study|Lost to Follow-up|0|||
94237486|NCT01296555|322664185|FG017|Overall Study|Lost to Follow-up|2|||
94237487|NCT01296555|322664186|FG018|Overall Study|Lost to Follow-up|0|||
94237488|NCT01296555|322664187|FG019|Overall Study|Lost to Follow-up|2|||
94237489|NCT01296555|322664188|FG020|Overall Study|Lost to Follow-up|3|||
94237490|NCT01296555|322664189|FG021|Overall Study|Lost to Follow-up|2|||
94237491|NCT01296555|322664190|FG022|Overall Study|Lost to Follow-up|0|||
94237492|NCT01296555|322664191|FG023|Overall Study|Lost to Follow-up|0|||
94237493|NCT01296555|322664192|FG024|Overall Study|Lost to Follow-up|0|||
94237494|NCT01296555|322664193|FG025|Overall Study|Lost to Follow-up|0|||
94237495|NCT01296555|322664194|FG026|Overall Study|Lost to Follow-up|3|||
94237496|NCT01296555|322664195|FG027|Overall Study|Lost to Follow-up|13|||
94237497|NCT01296555|322664196|FG028|Overall Study|Lost to Follow-up|5|||
94237498|NCT01296555|322664168|FG000|Overall Study|Non-Compliance With Study Drug|0|||
94237499|NCT01296555|322664169|FG001|Overall Study|Non-Compliance With Study Drug|0|||
94237500|NCT01296555|322664170|FG002|Overall Study|Non-Compliance With Study Drug|0|||
94658712|NCT01172938|324206190|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
94658713|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
94658714|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
94658715|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
94237501|NCT01296555|322664171|FG003|Overall Study|Non-Compliance With Study Drug|0|||
94237502|NCT01296555|322664172|FG004|Overall Study|Non-Compliance With Study Drug|0|||
94237503|NCT01296555|322664173|FG005|Overall Study|Non-Compliance With Study Drug|0|||
94237504|NCT01296555|322664174|FG006|Overall Study|Non-Compliance With Study Drug|0|||
94569008|NCT00683878|323881080|FG002|Overall Study|Lost to Follow-up|4|||
94569009|NCT00683878|323881078|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
94237505|NCT01296555|322664175|FG007|Overall Study|Non-Compliance With Study Drug|1|||
94237506|NCT01296555|322664176|FG008|Overall Study|Non-Compliance With Study Drug|0|||
94569010|NCT00683878|323881079|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
94569011|NCT00683878|323881080|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
94569012|NCT06308822|323881088|FG000|Overall Study|Mutation Status Not Confirmed|17|||
94569013|NCT06308822|323881088|FG000|Overall Study|Adverse Event|1|||
94569014|NCT06308822|323881088|FG000|Overall Study|Death|5|||
94569015|NCT06308822|323881088|FG000|Overall Study|Disease progression|8|||
94569016|NCT06308822|323881088|FG000|Overall Study|Withdrawal by Subject|1|||
94569017|NCT06308822|323881088|FG000|Overall Study|Physician Decision|3|||
94569018|NCT00496015|323881089|FG000|Overall Study|Other|1|||
94569019|NCT00496015|323881090|FG001|Overall Study|Other|0|||
94569020|NCT00496015|323881091|FG002|Overall Study|Other|0|||
94569021|NCT00496015|323881092|FG003|Overall Study|Other|1|||
94569022|NCT00496015|323881093|FG004|Overall Study|Other|0|||
94569023|NCT01535807|323881094|FG000|Overall Study|Withdrawal by Subject|1|||
94569024|NCT01535807|323881095|FG001|Overall Study|Withdrawal by Subject|1|||
94569025|NCT01535807|323881094|FG000|Overall Study|Data collection error|1|||
94569026|NCT01535807|323881095|FG001|Overall Study|Data collection error|1|||
94569027|NCT01855412|323881096|FG000|Overall Study|Death|77|||
94569028|NCT01855412|323881097|FG001|Overall Study|Death|123|||
94569029|NCT01855412|323881098|FG002|Overall Study|Death|30|||
94569030|NCT01855412|323881096|FG000|Overall Study|Lost to Follow-up|28|||
94569031|NCT01855412|323881097|FG001|Overall Study|Lost to Follow-up|46|||
94569032|NCT01855412|323881098|FG002|Overall Study|Lost to Follow-up|15|||
94569033|NCT01855412|323881096|FG000|Overall Study|Withdrawal by Subject|77|||
94569034|NCT01855412|323881097|FG001|Overall Study|Withdrawal by Subject|123|||
94569035|NCT01855412|323881098|FG002|Overall Study|Withdrawal by Subject|24|||
94569036|NCT01855412|323881096|FG000|Overall Study|Physician Decision|25|||
94569037|NCT01855412|323881097|FG001|Overall Study|Physician Decision|31|||
94569038|NCT01855412|323881098|FG002|Overall Study|Physician Decision|3|||
94569039|NCT01855412|323881096|FG000|Overall Study|Site Closure|4|||
94569040|NCT01855412|323881097|FG001|Overall Study|Site Closure|18|||
94569041|NCT01855412|323881098|FG002|Overall Study|Site Closure|1|||
94569042|NCT01855412|323881096|FG000|Overall Study|Reason not Specified|1|||
94569043|NCT01855412|323881097|FG001|Overall Study|Reason not Specified|2|||
94569044|NCT01855412|323881098|FG002|Overall Study|Reason not Specified|3|||
94569045|NCT00308139|323881099|FG000|Overall Study|Adverse Event|20|||
94569046|NCT00308139|323881100|FG001|Overall Study|Adverse Event|14|||
94569047|NCT00308139|323881099|FG000|Overall Study|Lost to Follow-up|13|||
94569048|NCT00308139|323881100|FG001|Overall Study|Lost to Follow-up|8|||
94569049|NCT00308139|323881099|FG000|Overall Study|Protocol Violation|3|||
94569050|NCT00308139|323881100|FG001|Overall Study|Protocol Violation|2|||
94569051|NCT00308139|323881099|FG000|Overall Study|Withdrawal of Consent|40|||
94569052|NCT00308139|323881100|FG001|Overall Study|Withdrawal of Consent|42|||
94569053|NCT00308139|323881099|FG000|Overall Study|Investigator Decision|11|||
94569054|NCT00308139|323881100|FG001|Overall Study|Investigator Decision|10|||
94569055|NCT00308139|323881099|FG000|Overall Study|Loss of Glucose Control|5|||
94569056|NCT00308139|323881100|FG001|Overall Study|Loss of Glucose Control|7|||
94569057|NCT00308139|323881099|FG000|Overall Study|Administrative|1|||
94569058|NCT00308139|323881100|FG001|Overall Study|Administrative|4|||
94569059|NCT00308139|323881099|FG000|Overall Study|Other|1|||
94569060|NCT00308139|323881100|FG001|Overall Study|Other|0|||
94569061|NCT00833040|323881101|FG000|Overall Study|Adverse Event|0|||
94569062|NCT00833040|323881102|FG001|Overall Study|Adverse Event|0|||
94569063|NCT00833040|323881103|FG002|Overall Study|Adverse Event|0|||
94569064|NCT00833040|323881104|FG003|Overall Study|Adverse Event|0|||
94569065|NCT00833040|323881105|FG004|Overall Study|Adverse Event|0|||
94569066|NCT00833040|323881106|FG005|Overall Study|Adverse Event|1|||
94569067|NCT02313766|323881107|FG000|Overall Study|surgery cancelled|1|||
94569068|NCT02313766|323881108|FG001|Overall Study|surgery cancelled|0|||
94569069|NCT02313766|323881109|FG002|Overall Study|surgery cancelled|0|||
94569070|NCT02313766|323881107|FG000|Overall Study|Lost to Follow-up|0|||
94569071|NCT02313766|323881108|FG001|Overall Study|Lost to Follow-up|2|||
94569072|NCT02313766|323881109|FG002|Overall Study|Lost to Follow-up|0|||
94569073|NCT02313766|323881107|FG000|Overall Study|Adverse Event|0|||
94569074|NCT02313766|323881108|FG001|Overall Study|Adverse Event|1|||
94569075|NCT02313766|323881109|FG002|Overall Study|Adverse Event|0|||
94569076|NCT01702844|323881113|FG000|Overall Study|Adverse Event|9|||
94569077|NCT01702844|323881113|FG000|Overall Study|Death|1|||
94569078|NCT01702844|323881113|FG000|Overall Study|Withdrawal by Subject|3|||
94569079|NCT01702844|323881113|FG000|Overall Study|Physician Decision|6|||
94569080|NCT02193776|323881114|FG000|Overall Study|Consent withdrawn|1|||
94569081|NCT02193776|323881115|FG001|Overall Study|Consent withdrawn|0|||
94569082|NCT02193776|323881116|FG002|Overall Study|Consent withdrawn|0|||
94569083|NCT02193776|323881117|FG003|Overall Study|Consent withdrawn|0|||
94569084|NCT02193776|323881114|FG000|Overall Study|Failure to comply with protocol|0|||
94569085|NCT02193776|323881115|FG001|Overall Study|Failure to comply with protocol|1|||
94569086|NCT02193776|323881116|FG002|Overall Study|Failure to comply with protocol|0|||
94569087|NCT02193776|323881117|FG003|Overall Study|Failure to comply with protocol|0|||
94569088|NCT02193776|323881114|FG000|Overall Study|Investigator/Sponsor decision|1|||
94569089|NCT02193776|323881115|FG001|Overall Study|Investigator/Sponsor decision|1|||
94569090|NCT02193776|323881116|FG002|Overall Study|Investigator/Sponsor decision|0|||
94569091|NCT02193776|323881117|FG003|Overall Study|Investigator/Sponsor decision|0|||
94569092|NCT02193776|323881114|FG000|Overall Study|Death|1|||
94569093|NCT02193776|323881115|FG001|Overall Study|Death|0|||
94569094|NCT02193776|323881116|FG002|Overall Study|Death|0|||
94569095|NCT02193776|323881117|FG003|Overall Study|Death|0|||
94569096|NCT02193776|323881114|FG000|Overall Study|Adverse event/Specific toxicity|5|||
94569097|NCT02193776|323881115|FG001|Overall Study|Adverse event/Specific toxicity|5|||
94569098|NCT02193776|323881116|FG002|Overall Study|Adverse event/Specific toxicity|2|||
94569099|NCT02193776|323881117|FG003|Overall Study|Adverse event/Specific toxicity|2|||
94569100|NCT03431441|323881120|FG000|Overall Study|Withdrawal by Subject|2|||
94569101|NCT03431441|323881120|FG000|Overall Study|Adverse Event|2|||
94569102|NCT03431441|323881120|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
94569103|NCT00657540|323881121|FG000|Overall Study|Lost to Follow-up|1|||
94569104|NCT00657540|323881122|FG001|Overall Study|Lost to Follow-up|4|||
94569105|NCT02611479|323881123|FG000|Baseline Enrollment|Exited study|13|||
94569106|NCT02611479|323881123|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
94569107|NCT02611479|323881123|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
94569108|NCT02611479|323881123|FG000|Data Cleaning|No baseline function or pain metrics|2|||
94569109|NCT02903914|323881127|FG000|Overall Study|Adverse Event|0|||
94569110|NCT02903914|323881128|FG001|Overall Study|Adverse Event|0|||
94569111|NCT02903914|323881129|FG002|Overall Study|Adverse Event|1|||
94569112|NCT02903914|323881130|FG003|Overall Study|Adverse Event|0|||
94569113|NCT02903914|323881131|FG004|Overall Study|Adverse Event|0|||
94569114|NCT02903914|323881132|FG005|Overall Study|Adverse Event|0|||
94569115|NCT02903914|323881133|FG006|Overall Study|Adverse Event|2|||
94569116|NCT02903914|323881134|FG007|Overall Study|Adverse Event|0|||
94569117|NCT02903914|323881127|FG000|Overall Study|Withdrawal by Subject|3|||
94569118|NCT02903914|323881128|FG001|Overall Study|Withdrawal by Subject|1|||
94569119|NCT02903914|323881129|FG002|Overall Study|Withdrawal by Subject|28|||
94569120|NCT02903914|323881130|FG003|Overall Study|Withdrawal by Subject|0|||
94569121|NCT02903914|323881131|FG004|Overall Study|Withdrawal by Subject|1|||
94569122|NCT02903914|323881132|FG005|Overall Study|Withdrawal by Subject|2|||
94569123|NCT02903914|323881133|FG006|Overall Study|Withdrawal by Subject|12|||
94569124|NCT02903914|323881134|FG007|Overall Study|Withdrawal by Subject|0|||
94569125|NCT02903914|323881127|FG000|Overall Study|Progressive Disease|1|||
94569126|NCT02903914|323881128|FG001|Overall Study|Progressive Disease|0|||
94569127|NCT02903914|323881129|FG002|Overall Study|Progressive Disease|4|||
94569128|NCT02903914|323881130|FG003|Overall Study|Progressive Disease|0|||
94569129|NCT02903914|323881131|FG004|Overall Study|Progressive Disease|0|||
94569130|NCT02903914|323881132|FG005|Overall Study|Progressive Disease|0|||
94569131|NCT02903914|323881133|FG006|Overall Study|Progressive Disease|2|||
94569132|NCT02903914|323881134|FG007|Overall Study|Progressive Disease|0|||
94569133|NCT02903914|323881127|FG000|Overall Study|Death|0|||
94569134|NCT02903914|323881128|FG001|Overall Study|Death|0|||
94569135|NCT02903914|323881129|FG002|Overall Study|Death|9|||
94569136|NCT02903914|323881130|FG003|Overall Study|Death|0|||
94569137|NCT02903914|323881131|FG004|Overall Study|Death|1|||
94569138|NCT02903914|323881132|FG005|Overall Study|Death|3|||
94569139|NCT02903914|323881133|FG006|Overall Study|Death|24|||
94569140|NCT02903914|323881134|FG007|Overall Study|Death|2|||
94569141|NCT02903914|323881127|FG000|Overall Study|Lost to Follow-up|0|||
94569142|NCT02903914|323881128|FG001|Overall Study|Lost to Follow-up|1|||
94569143|NCT02903914|323881129|FG002|Overall Study|Lost to Follow-up|0|||
94569144|NCT02903914|323881130|FG003|Overall Study|Lost to Follow-up|0|||
94569145|NCT02903914|323881131|FG004|Overall Study|Lost to Follow-up|2|||
94569146|NCT02903914|323881132|FG005|Overall Study|Lost to Follow-up|0|||
94569147|NCT02903914|323881133|FG006|Overall Study|Lost to Follow-up|1|||
94569148|NCT02903914|323881134|FG007|Overall Study|Lost to Follow-up|0|||
94569149|NCT02903914|323881127|FG000|Overall Study|Physician Decision|0|||
94569150|NCT02903914|323881128|FG001|Overall Study|Physician Decision|0|||
94569151|NCT02903914|323881129|FG002|Overall Study|Physician Decision|1|||
94569152|NCT02903914|323881130|FG003|Overall Study|Physician Decision|0|||
94569153|NCT02903914|323881131|FG004|Overall Study|Physician Decision|0|||
94569154|NCT02903914|323881132|FG005|Overall Study|Physician Decision|0|||
94569155|NCT02903914|323881133|FG006|Overall Study|Physician Decision|1|||
94569156|NCT02903914|323881134|FG007|Overall Study|Physician Decision|0|||
94569157|NCT02903914|323881127|FG000|Overall Study|Symptomatic Deterioration|0|||
94569158|NCT02903914|323881128|FG001|Overall Study|Symptomatic Deterioration|0|||
94569159|NCT02903914|323881129|FG002|Overall Study|Symptomatic Deterioration|1|||
94569160|NCT02903914|323881130|FG003|Overall Study|Symptomatic Deterioration|0|||
94569161|NCT02903914|323881131|FG004|Overall Study|Symptomatic Deterioration|0|||
94569162|NCT02903914|323881132|FG005|Overall Study|Symptomatic Deterioration|0|||
94569163|NCT02903914|323881133|FG006|Overall Study|Symptomatic Deterioration|0|||
94569164|NCT02903914|323881134|FG007|Overall Study|Symptomatic Deterioration|0|||
94569165|NCT02903914|323881127|FG000|Overall Study|New Cancer Therapy|2|||
94569166|NCT02903914|323881128|FG001|Overall Study|New Cancer Therapy|2|||
94569167|NCT02903914|323881129|FG002|Overall Study|New Cancer Therapy|21|||
94569168|NCT02903914|323881130|FG003|Overall Study|New Cancer Therapy|4|||
94569169|NCT02903914|323881131|FG004|Overall Study|New Cancer Therapy|3|||
94569170|NCT02903914|323881132|FG005|Overall Study|New Cancer Therapy|6|||
94569171|NCT02903914|323881133|FG006|Overall Study|New Cancer Therapy|56|||
94569172|NCT02903914|323881134|FG007|Overall Study|New Cancer Therapy|3|||
94569173|NCT02903914|323881127|FG000|Overall Study|Didn't Return to Site|1|||
94569174|NCT02903914|323881128|FG001|Overall Study|Didn't Return to Site|0|||
94569175|NCT02903914|323881129|FG002|Overall Study|Didn't Return to Site|1|||
94569176|NCT02903914|323881130|FG003|Overall Study|Didn't Return to Site|1|||
94569177|NCT02903914|323881131|FG004|Overall Study|Didn't Return to Site|0|||
94569178|NCT02903914|323881132|FG005|Overall Study|Didn't Return to Site|0|||
94569179|NCT02903914|323881133|FG006|Overall Study|Didn't Return to Site|2|||
94569180|NCT02903914|323881134|FG007|Overall Study|Didn't Return to Site|0|||
94569181|NCT02903914|323881127|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
94569182|NCT02903914|323881128|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
94569183|NCT02903914|323881129|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
94569184|NCT02903914|323881130|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
94569185|NCT02903914|323881131|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
94569186|NCT02903914|323881132|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
94569187|NCT02903914|323881133|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
94569188|NCT02903914|323881134|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
94569189|NCT02903914|323881127|FG000|Overall Study|Follow-up Did Not Occur|0|||
94569190|NCT02903914|323881128|FG001|Overall Study|Follow-up Did Not Occur|1|||
94569191|NCT02903914|323881129|FG002|Overall Study|Follow-up Did Not Occur|1|||
94569192|NCT02903914|323881130|FG003|Overall Study|Follow-up Did Not Occur|0|||
94569193|NCT02903914|323881131|FG004|Overall Study|Follow-up Did Not Occur|2|||
94569194|NCT02903914|323881132|FG005|Overall Study|Follow-up Did Not Occur|0|||
94569195|NCT02903914|323881133|FG006|Overall Study|Follow-up Did Not Occur|8|||
94569196|NCT02903914|323881134|FG007|Overall Study|Follow-up Did Not Occur|0|||
94569197|NCT02903914|323881127|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
94569198|NCT02903914|323881128|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
94569199|NCT02903914|323881129|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
94569200|NCT02903914|323881130|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
94569201|NCT02903914|323881131|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
94569202|NCT02903914|323881132|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
94569203|NCT02903914|323881133|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
94569204|NCT02903914|323881134|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
94569205|NCT02903914|323881127|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
94569206|NCT02903914|323881128|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
94569207|NCT02903914|323881129|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
94569208|NCT02903914|323881130|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
94569209|NCT02903914|323881131|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
94569210|NCT02903914|323881132|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
94569211|NCT02903914|323881133|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
94569212|NCT02903914|323881134|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
94569213|NCT02903914|323881127|FG000|Overall Study|Clinical Disease Progression|0|||
94569214|NCT02903914|323881128|FG001|Overall Study|Clinical Disease Progression|0|||
94569215|NCT02903914|323881129|FG002|Overall Study|Clinical Disease Progression|2|||
94569216|NCT02903914|323881130|FG003|Overall Study|Clinical Disease Progression|0|||
94569217|NCT02903914|323881131|FG004|Overall Study|Clinical Disease Progression|0|||
94569218|NCT02903914|323881132|FG005|Overall Study|Clinical Disease Progression|0|||
94569219|NCT02903914|323881133|FG006|Overall Study|Clinical Disease Progression|0|||
94569220|NCT02903914|323881134|FG007|Overall Study|Clinical Disease Progression|0|||
94569221|NCT02903914|323881127|FG000|Overall Study|Completed Follow-up Period|0|||
94569222|NCT02903914|323881128|FG001|Overall Study|Completed Follow-up Period|0|||
94569223|NCT02903914|323881129|FG002|Overall Study|Completed Follow-up Period|6|||
94658716|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
94658717|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
94658718|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
94569224|NCT02903914|323881130|FG003|Overall Study|Completed Follow-up Period|2|||
94569225|NCT02903914|323881131|FG004|Overall Study|Completed Follow-up Period|1|||
94569226|NCT02903914|323881132|FG005|Overall Study|Completed Follow-up Period|0|||
94569227|NCT02903914|323881133|FG006|Overall Study|Completed Follow-up Period|9|||
94569228|NCT02903914|323881134|FG007|Overall Study|Completed Follow-up Period|1|||
94569229|NCT02903914|323881127|FG000|Overall Study|Taken off Treatment per Protocol|0|||
94569230|NCT02903914|323881128|FG001|Overall Study|Taken off Treatment per Protocol|0|||
94569231|NCT02903914|323881129|FG002|Overall Study|Taken off Treatment per Protocol|0|||
94569232|NCT02903914|323881130|FG003|Overall Study|Taken off Treatment per Protocol|0|||
94569233|NCT02903914|323881131|FG004|Overall Study|Taken off Treatment per Protocol|0|||
94569234|NCT02903914|323881132|FG005|Overall Study|Taken off Treatment per Protocol|1|||
94569235|NCT02903914|323881133|FG006|Overall Study|Taken off Treatment per Protocol|0|||
94569236|NCT02903914|323881134|FG007|Overall Study|Taken off Treatment per Protocol|0|||
94569237|NCT02903914|323881127|FG000|Overall Study|Refused Further Treatment/Contact|0|||
94569238|NCT02903914|323881128|FG001|Overall Study|Refused Further Treatment/Contact|0|||
94569239|NCT02903914|323881129|FG002|Overall Study|Refused Further Treatment/Contact|0|||
94569240|NCT02903914|323881130|FG003|Overall Study|Refused Further Treatment/Contact|0|||
94569241|NCT02903914|323881131|FG004|Overall Study|Refused Further Treatment/Contact|0|||
94569242|NCT02903914|323881132|FG005|Overall Study|Refused Further Treatment/Contact|0|||
94569243|NCT02903914|323881133|FG006|Overall Study|Refused Further Treatment/Contact|1|||
94569244|NCT02903914|323881134|FG007|Overall Study|Refused Further Treatment/Contact|0|||
94569245|NCT02903914|323881127|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
94569246|NCT02903914|323881128|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
94569247|NCT02903914|323881129|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
94569248|NCT02903914|323881130|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
94569249|NCT02903914|323881131|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
94569250|NCT02903914|323881132|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
94569251|NCT02903914|323881133|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
94569252|NCT02903914|323881134|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
94569253|NCT00231777|323881135|FG000|Overall Study|Lost to Follow-up|3|||
94569254|NCT00231777|323881136|FG001|Overall Study|Lost to Follow-up|0|||
94569255|NCT00231777|323881135|FG000|Overall Study|Other|3|||
94569256|NCT00231777|323881136|FG001|Overall Study|Other|2|||
94569257|NCT01308736|323881140|FG000|Overall Study|Did not attend a single session|6|||
94569258|NCT01308736|323881141|FG001|Overall Study|Did not attend a single session|5|||
94569259|NCT00844376|323881142|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
94569260|NCT00844376|323881143|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
94569261|NCT04059549|323881144|FG000|Overall Study|Withdrawal by Subject|2|||
94569262|NCT04059549|323881145|FG001|Overall Study|Withdrawal by Subject|0|||
94569263|NCT02678351|323881146|FG000|Overall Study|Withdrawal by Subject|1|||
94569264|NCT01011673|323881147|FG000|Randomized|Secondary headache|2|||
94569265|NCT01011673|323881148|FG001|Randomized|Secondary headache|1|||
94569266|NCT01011673|323881147|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
94569267|NCT01011673|323881148|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
94569268|NCT04621448|323881149|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
94569269|NCT04621448|323881150|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
94569270|NCT04621448|323881151|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
94569271|NCT04621448|323881152|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
94569272|NCT04621448|323881149|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
94569273|NCT04621448|323881150|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
94569274|NCT04621448|323881151|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
94569275|NCT04621448|323881152|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
94569276|NCT04621448|323881149|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
94569277|NCT04621448|323881150|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
94569278|NCT04621448|323881151|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
94569279|NCT04621448|323881152|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
94569280|NCT04621448|323881149|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
94569281|NCT04621448|323881150|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
94569282|NCT04621448|323881151|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
94569283|NCT04621448|323881152|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
94569284|NCT03550378|323881165|FG000|Overall Study|Death|0|||
94569285|NCT03550378|323881166|FG001|Overall Study|Death|1|||
94569286|NCT04590014|323881167|FG000|Overall Study|Withdrawal by Subject|1|||
94569287|NCT04590014|323881168|FG001|Overall Study|Withdrawal by Subject|0|||
94569288|NCT00468299|323881169|FG000|Overall Study|Withdrawal by Subject|0|||
94569289|NCT00468299|323881170|FG001|Overall Study|Withdrawal by Subject|1|||
94569290|NCT02520726|323881171|FG000|Overall Study|Lost to Follow-up|3|||
94569291|NCT02520726|323881172|FG001|Overall Study|Lost to Follow-up|2|||
94569292|NCT01216202|323881181|FG000|Overall Study|Withdrawal by Subject|8|||
94569293|NCT01216202|323881182|FG001|Overall Study|Withdrawal by Subject|0|||
94569294|NCT01216202|323881181|FG000|Overall Study|Death|0|||
94569295|NCT01216202|323881182|FG001|Overall Study|Death|2|||
94569296|NCT01216202|323881181|FG000|Overall Study|Lost to Follow-up|14|||
94569297|NCT01216202|323881182|FG001|Overall Study|Lost to Follow-up|0|||
94569298|NCT03546621|323881185|FG000|Overall Study|Withdrawal by Subject|0|||
94569299|NCT03546621|323881186|FG001|Overall Study|Withdrawal by Subject|1|||
94569300|NCT03546621|323881187|FG002|Overall Study|Withdrawal by Subject|2|||
94569301|NCT03546621|323881188|FG003|Overall Study|Withdrawal by Subject|1|||
94569302|NCT03546621|323881185|FG000|Overall Study|Lost to Follow-up|0|||
94569303|NCT03546621|323881186|FG001|Overall Study|Lost to Follow-up|1|||
94569304|NCT03546621|323881187|FG002|Overall Study|Lost to Follow-up|0|||
94569305|NCT03546621|323881188|FG003|Overall Study|Lost to Follow-up|0|||
94569306|NCT03546621|323881185|FG000|Overall Study|Adverse Event|0|||
94569307|NCT03546621|323881186|FG001|Overall Study|Adverse Event|1|||
94569308|NCT03546621|323881187|FG002|Overall Study|Adverse Event|0|||
94569309|NCT03546621|323881188|FG003|Overall Study|Adverse Event|1|||
94569310|NCT03546621|323881185|FG000|Overall Study|Progressive disease|0|||
94569311|NCT03546621|323881186|FG001|Overall Study|Progressive disease|0|||
94569312|NCT03546621|323881187|FG002|Overall Study|Progressive disease|0|||
94569313|NCT03546621|323881188|FG003|Overall Study|Progressive disease|1|||
94569314|NCT00377520|323881196|FG000|Overall Study|Ineligible (Prior radiation)|1|||
94569315|NCT00660192|323881197|FG000|Overall Study|Lost to Follow-up|2|||
94569316|NCT00660192|323881198|FG001|Overall Study|Lost to Follow-up|3|||
94569317|NCT01091675|323881199|FG000|Overall Study|Adverse Event|7|||
94569318|NCT01091675|323881199|FG000|Overall Study|Lack of Efficacy|27|||
94569319|NCT00614380|323881203|FG000|Overall Study|Adverse Event|14|||
94569320|NCT00614380|323881204|FG001|Overall Study|Adverse Event|4|||
94569321|NCT00614380|323881205|FG002|Overall Study|Adverse Event|0|||
94569322|NCT00614380|323881206|FG003|Overall Study|Adverse Event|0|||
94569323|NCT00614380|323881203|FG000|Overall Study|Lost to Follow-up|6|||
94569324|NCT00614380|323881204|FG001|Overall Study|Lost to Follow-up|1|||
94569325|NCT00614380|323881205|FG002|Overall Study|Lost to Follow-up|0|||
94569326|NCT00614380|323881206|FG003|Overall Study|Lost to Follow-up|0|||
94569327|NCT00614380|323881203|FG000|Overall Study|Non compliant with the protocol|12|||
94569328|NCT00614380|323881204|FG001|Overall Study|Non compliant with the protocol|2|||
94569329|NCT00614380|323881205|FG002|Overall Study|Non compliant with the protocol|1|||
94569330|NCT00614380|323881206|FG003|Overall Study|Non compliant with the protocol|2|||
94569331|NCT00614380|323881203|FG000|Overall Study|Consent withdrawn|3|||
94569332|NCT00614380|323881204|FG001|Overall Study|Consent withdrawn|1|||
94569333|NCT00614380|323881205|FG002|Overall Study|Consent withdrawn|0|||
94569334|NCT00614380|323881206|FG003|Overall Study|Consent withdrawn|0|||
94569335|NCT02888106|323881207|FG000|Overall Study|Withdrawal by Subject|1|||
94569336|NCT02888106|323881208|FG001|Overall Study|Withdrawal by Subject|2|||
94569337|NCT02888106|323881209|FG002|Overall Study|Withdrawal by Subject|0|||
94569338|NCT02888106|323881210|FG003|Overall Study|Withdrawal by Subject|1|||
94569339|NCT02888106|323881211|FG004|Overall Study|Withdrawal by Subject|0|||
94569340|NCT02888106|323881212|FG005|Overall Study|Withdrawal by Subject|0|||
94569341|NCT02888106|323881207|FG000|Overall Study|Lost to Follow-up|1|||
94569342|NCT02888106|323881208|FG001|Overall Study|Lost to Follow-up|0|||
94348208|NCT00242710|323056065|FG001|Period Between Core Study and Extension|Extension not Available|21|||
94348209|NCT00242710|323056066|FG002|Period Between Core Study and Extension|Extension not Available|8|||
94348210|NCT00242710|323056067|FG003|Period Between Core Study and Extension|Extension not Available|7|||
94348211|NCT00242710|323056064|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
94348212|NCT00242710|323056065|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
94348213|NCT00242710|323056066|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
94348214|NCT00242710|323056067|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
94348215|NCT00242710|323056064|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
94348216|NCT00242710|323056065|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
94348217|NCT00242710|323056066|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
94348218|NCT00242710|323056067|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
94348219|NCT00242710|323056064|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
94348220|NCT00242710|323056065|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
94348221|NCT00242710|323056066|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
94348222|NCT00242710|323056067|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
94348223|NCT00242710|323056064|FG000|Study Extension (up to Year 2)|Death|0|||
94348224|NCT00242710|323056065|FG001|Study Extension (up to Year 2)|Death|0|||
94348225|NCT00242710|323056066|FG002|Study Extension (up to Year 2)|Death|0|||
94348226|NCT00242710|323056067|FG003|Study Extension (up to Year 2)|Death|1|||
94569343|NCT02888106|323881209|FG002|Overall Study|Lost to Follow-up|0|||
94348227|NCT00242710|323056064|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
94348228|NCT00242710|323056065|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
94348229|NCT00242710|323056066|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
94569344|NCT02888106|323881210|FG003|Overall Study|Lost to Follow-up|1|||
94569345|NCT02888106|323881211|FG004|Overall Study|Lost to Follow-up|0|||
94569346|NCT02888106|323881212|FG005|Overall Study|Lost to Follow-up|1|||
94569347|NCT02888106|323881207|FG000|Overall Study|Adverse Event|2|||
94569348|NCT02888106|323881208|FG001|Overall Study|Adverse Event|0|||
94569349|NCT02888106|323881209|FG002|Overall Study|Adverse Event|0|||
94569350|NCT02888106|323881210|FG003|Overall Study|Adverse Event|0|||
94569351|NCT02888106|323881211|FG004|Overall Study|Adverse Event|0|||
94569352|NCT02888106|323881212|FG005|Overall Study|Adverse Event|0|||
94569353|NCT02888106|323881207|FG000|Overall Study|Withdrawal of consent|0|||
94569354|NCT02888106|323881208|FG001|Overall Study|Withdrawal of consent|0|||
94569355|NCT02888106|323881209|FG002|Overall Study|Withdrawal of consent|0|||
94569356|NCT02888106|323881210|FG003|Overall Study|Withdrawal of consent|0|||
94569357|NCT02888106|323881211|FG004|Overall Study|Withdrawal of consent|1|||
94569358|NCT02888106|323881212|FG005|Overall Study|Withdrawal of consent|0|||
94569359|NCT02888106|323881207|FG000|Overall Study|Pregnancy|1|||
94569360|NCT02888106|323881208|FG001|Overall Study|Pregnancy|0|||
94569361|NCT02888106|323881209|FG002|Overall Study|Pregnancy|0|||
94569362|NCT02888106|323881210|FG003|Overall Study|Pregnancy|0|||
94569363|NCT02888106|323881211|FG004|Overall Study|Pregnancy|0|||
94569364|NCT02888106|323881212|FG005|Overall Study|Pregnancy|0|||
94569365|NCT00857285|323881217|FG000|Overall Study|Adverse Event|4|||
94569366|NCT00857285|323881218|FG001|Overall Study|Adverse Event|2|||
94569367|NCT00857285|323881217|FG000|Overall Study|Lack of Efficacy|0|||
94569368|NCT00857285|323881218|FG001|Overall Study|Lack of Efficacy|2|||
94569369|NCT00857285|323881217|FG000|Overall Study|Protocol Violation|3|||
94569370|NCT00857285|323881218|FG001|Overall Study|Protocol Violation|1|||
94569371|NCT00857285|323881217|FG000|Overall Study|Withdrawal by Subject|4|||
94569372|NCT00857285|323881218|FG001|Overall Study|Withdrawal by Subject|0|||
94569373|NCT00857285|323881217|FG000|Overall Study|Randomization criteria not met|1|||
94569374|NCT00857285|323881218|FG001|Overall Study|Randomization criteria not met|1|||
94569375|NCT01506271|323881220|FG000|Overall Study|Progressive disease|0|||
94569376|NCT01506271|323881221|FG001|Overall Study|Progressive disease|1|||
94569377|NCT01506271|323881222|FG002|Overall Study|Progressive disease|0|||
94569378|NCT01506271|323881220|FG000|Overall Study|Protocol Violation|3|||
94569379|NCT01506271|323881221|FG001|Overall Study|Protocol Violation|1|||
94569380|NCT01506271|323881222|FG002|Overall Study|Protocol Violation|0|||
94569381|NCT01506271|323881220|FG000|Overall Study|Death|0|||
94569382|NCT01506271|323881221|FG001|Overall Study|Death|1|||
94569383|NCT01506271|323881222|FG002|Overall Study|Death|0|||
94569384|NCT01506271|323881220|FG000|Overall Study|Adverse Event|0|||
94569385|NCT01506271|323881221|FG001|Overall Study|Adverse Event|2|||
94569386|NCT01506271|323881222|FG002|Overall Study|Adverse Event|0|||
94569387|NCT01506271|323881220|FG000|Overall Study|Insufficient supply of study drug|1|||
94569388|NCT01506271|323881221|FG001|Overall Study|Insufficient supply of study drug|0|||
94569389|NCT01506271|323881222|FG002|Overall Study|Insufficient supply of study drug|0|||
94569390|NCT01506271|323881220|FG000|Overall Study|Withdrawal by Subject|0|||
94569391|NCT01506271|323881221|FG001|Overall Study|Withdrawal by Subject|1|||
94569392|NCT01506271|323881222|FG002|Overall Study|Withdrawal by Subject|1|||
94569393|NCT01506271|323881220|FG000|Overall Study|Lost to Follow-up|0|||
94569394|NCT01506271|323881221|FG001|Overall Study|Lost to Follow-up|1|||
94569395|NCT01506271|323881222|FG002|Overall Study|Lost to Follow-up|2|||
94569396|NCT00528957|323881225|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
94569397|NCT00528957|323881226|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
94569398|NCT00528957|323881225|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
94569399|NCT00528957|323881226|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
94569400|NCT00528957|323881225|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
94569401|NCT00528957|323881226|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
94569402|NCT00528957|323881225|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
94569403|NCT00528957|323881226|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
94569404|NCT00528957|323881225|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
94569405|NCT00528957|323881226|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
94569406|NCT00528957|323881225|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
94569407|NCT00528957|323881226|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
94569408|NCT00528957|323881225|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
94569409|NCT00528957|323881226|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
94569410|NCT00528957|323881225|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
94569411|NCT00528957|323881226|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
94569412|NCT00528957|323881225|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
94569413|NCT00528957|323881226|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
94569414|NCT00528957|323881225|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
94569415|NCT00528957|323881226|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
94569416|NCT00528957|323881225|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
94569417|NCT00528957|323881226|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
94569418|NCT00528957|323881225|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
94569419|NCT00528957|323881226|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
94569420|NCT00528957|323881225|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
94569421|NCT00528957|323881226|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
94569422|NCT00528957|323881225|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
94569423|NCT00528957|323881226|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
94569424|NCT00528957|323881225|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
94569425|NCT00528957|323881226|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
94569426|NCT00528957|323881225|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
94569427|NCT00528957|323881226|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
94569428|NCT01391663|323881231|FG000|Overall Study|Withdrawal by Subject|0|||
94569429|NCT01391663|323881232|FG001|Overall Study|Withdrawal by Subject|0|||
94569430|NCT01391663|323881233|FG002|Overall Study|Withdrawal by Subject|1|||
94569431|NCT01391663|323881234|FG003|Overall Study|Withdrawal by Subject|0|||
94569432|NCT05051579|323881235|FG000|Overall Study|Withdrawal by Subject|3|||
94569433|NCT05051579|323881236|FG001|Overall Study|Withdrawal by Subject|5|||
94569434|NCT05051579|323881237|FG002|Overall Study|Withdrawal by Subject|2|||
94569435|NCT05051579|323881238|FG003|Overall Study|Withdrawal by Subject|1|||
94569436|NCT05051579|323881239|FG004|Overall Study|Withdrawal by Subject|4|||
94569437|NCT05051579|323881240|FG005|Overall Study|Withdrawal by Subject|0|||
94569438|NCT05051579|323881241|FG006|Overall Study|Withdrawal by Subject|4|||
94569439|NCT05051579|323881235|FG000|Overall Study|Lost to Follow-up|1|||
94569440|NCT05051579|323881236|FG001|Overall Study|Lost to Follow-up|0|||
94569441|NCT05051579|323881237|FG002|Overall Study|Lost to Follow-up|0|||
94569442|NCT05051579|323881238|FG003|Overall Study|Lost to Follow-up|0|||
94569443|NCT05051579|323881239|FG004|Overall Study|Lost to Follow-up|1|||
94569444|NCT05051579|323881240|FG005|Overall Study|Lost to Follow-up|0|||
94569445|NCT05051579|323881241|FG006|Overall Study|Lost to Follow-up|1|||
94451339|NCT04112043|323439997|FG000|Overall Study|Taking NR supplement|1|||
94451340|NCT04112043|323439998|FG001|Overall Study|Taking NR supplement|0|||
94451341|NCT04112043|323439999|FG002|Overall Study|Taking NR supplement|0|||
94451342|NCT04112043|323439997|FG000|Overall Study|Adverse Event|0|||
94451343|NCT04112043|323439998|FG001|Overall Study|Adverse Event|1|||
94451344|NCT04112043|323439999|FG002|Overall Study|Adverse Event|0|||
94451345|NCT02237196|323440000|FG000|Overall Study|Adverse Event|0|||
94451346|NCT02237196|323440001|FG001|Overall Study|Adverse Event|1|||
94451347|NCT02237196|323440002|FG002|Overall Study|Adverse Event|1|||
94451348|NCT02237196|323440003|FG003|Overall Study|Adverse Event|0|||
94451349|NCT02237196|323440000|FG000|Overall Study|Lost to Follow-up|4|||
94451350|NCT02237196|323440001|FG001|Overall Study|Lost to Follow-up|2|||
94451351|NCT02237196|323440002|FG002|Overall Study|Lost to Follow-up|4|||
94451352|NCT02237196|323440003|FG003|Overall Study|Lost to Follow-up|6|||
94451353|NCT02237196|323440000|FG000|Overall Study|Physician Decision|2|||
94451354|NCT02237196|323440001|FG001|Overall Study|Physician Decision|0|||
94451355|NCT02237196|323440002|FG002|Overall Study|Physician Decision|0|||
94451356|NCT02237196|323440003|FG003|Overall Study|Physician Decision|1|||
94451357|NCT02237196|323440000|FG000|Overall Study|Pregnancy|0|||
94451358|NCT02237196|323440001|FG001|Overall Study|Pregnancy|0|||
94451359|NCT02237196|323440002|FG002|Overall Study|Pregnancy|1|||
94451360|NCT02237196|323440003|FG003|Overall Study|Pregnancy|1|||
94451361|NCT02237196|323440000|FG000|Overall Study|Withdrawal by Subject|1|||
94451362|NCT02237196|323440001|FG001|Overall Study|Withdrawal by Subject|1|||
94451363|NCT02237196|323440002|FG002|Overall Study|Withdrawal by Subject|4|||
94451364|NCT02237196|323440003|FG003|Overall Study|Withdrawal by Subject|1|||
94451365|NCT02237196|323440000|FG000|Overall Study|Site Error|1|||
94451366|NCT02237196|323440001|FG001|Overall Study|Site Error|2|||
94451367|NCT02237196|323440002|FG002|Overall Study|Site Error|0|||
94451368|NCT02237196|323440003|FG003|Overall Study|Site Error|2|||
94451369|NCT01562782|323440006|FG000|Overall Study|Withdrawal by Subject|3|||
94451370|NCT01562782|323440007|FG001|Overall Study|Withdrawal by Subject|3|||
94451371|NCT01562782|323440006|FG000|Overall Study|screen failure|1|||
94451372|NCT01562782|323440007|FG001|Overall Study|screen failure|2|||
94451373|NCT02285166|323440010|FG000|Overall Study|Case Report Forms Uncollected|564|||
94451374|NCT02285166|323440010|FG000|Overall Study|Protocol Deviation|402|||
94451375|NCT01421225|323440013|FG000|Overall Study|Withdrawal by Subject|0|||
94451376|NCT01421225|323440014|FG001|Overall Study|Withdrawal by Subject|1|||
94451377|NCT02484456|323440024|FG000|Washout Period|Withdrawal by Subject|0|||
94451378|NCT02484456|323440025|FG001|Washout Period|Withdrawal by Subject|1|||
94451379|NCT02484456|323440024|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
94451380|NCT02484456|323440025|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
94569446|NCT05051579|323881235|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
94569447|NCT05051579|323881236|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
94569448|NCT05051579|323881237|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
94451381|NCT02484456|323440024|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
94451382|NCT02484456|323440025|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
94451383|NCT02484456|323440024|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
94569449|NCT05051579|323881238|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
94569450|NCT05051579|323881239|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
94237507|NCT01296555|322664177|FG009|Overall Study|Non-Compliance With Study Drug|0|||
94237508|NCT01296555|322664178|FG010|Overall Study|Non-Compliance With Study Drug|0|||
94237509|NCT01296555|322664179|FG011|Overall Study|Non-Compliance With Study Drug|0|||
94237510|NCT01296555|322664180|FG012|Overall Study|Non-Compliance With Study Drug|0|||
94237511|NCT01296555|322664181|FG013|Overall Study|Non-Compliance With Study Drug|0|||
94237512|NCT01296555|322664182|FG014|Overall Study|Non-Compliance With Study Drug|0|||
94237513|NCT01296555|322664183|FG015|Overall Study|Non-Compliance With Study Drug|0|||
94237514|NCT01296555|322664184|FG016|Overall Study|Non-Compliance With Study Drug|0|||
94237515|NCT01296555|322664185|FG017|Overall Study|Non-Compliance With Study Drug|0|||
94237516|NCT01296555|322664186|FG018|Overall Study|Non-Compliance With Study Drug|0|||
94237517|NCT01296555|322664187|FG019|Overall Study|Non-Compliance With Study Drug|0|||
94237518|NCT01296555|322664188|FG020|Overall Study|Non-Compliance With Study Drug|0|||
94237519|NCT01296555|322664189|FG021|Overall Study|Non-Compliance With Study Drug|0|||
94237520|NCT01296555|322664190|FG022|Overall Study|Non-Compliance With Study Drug|0|||
94569451|NCT05051579|323881240|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
94569452|NCT05051579|323881241|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
94569453|NCT05051579|323881235|FG000|Overall Study|Adverse Event|2|||
94569454|NCT05051579|323881236|FG001|Overall Study|Adverse Event|1|||
94569455|NCT05051579|323881237|FG002|Overall Study|Adverse Event|0|||
94569456|NCT05051579|323881238|FG003|Overall Study|Adverse Event|4|||
94569457|NCT05051579|323881239|FG004|Overall Study|Adverse Event|1|||
94569458|NCT05051579|323881240|FG005|Overall Study|Adverse Event|2|||
94569459|NCT05051579|323881241|FG006|Overall Study|Adverse Event|0|||
94569460|NCT05051579|323881235|FG000|Overall Study|Inadvertent Enrollment|0|||
94569461|NCT05051579|323881236|FG001|Overall Study|Inadvertent Enrollment|0|||
94569462|NCT05051579|323881237|FG002|Overall Study|Inadvertent Enrollment|0|||
94569463|NCT05051579|323881238|FG003|Overall Study|Inadvertent Enrollment|0|||
94569464|NCT05051579|323881239|FG004|Overall Study|Inadvertent Enrollment|0|||
94569465|NCT05051579|323881240|FG005|Overall Study|Inadvertent Enrollment|0|||
94569466|NCT05051579|323881241|FG006|Overall Study|Inadvertent Enrollment|1|||
94569467|NCT05051579|323881235|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
94569468|NCT05051579|323881236|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
94569469|NCT05051579|323881237|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
94569470|NCT05051579|323881238|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
94569471|NCT05051579|323881239|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
94569472|NCT05051579|323881240|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
94569473|NCT05051579|323881241|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
94569474|NCT05051579|323881235|FG000|Overall Study|Sponsor Decision|0|||
94569475|NCT05051579|323881236|FG001|Overall Study|Sponsor Decision|0|||
94569476|NCT05051579|323881237|FG002|Overall Study|Sponsor Decision|0|||
94569477|NCT05051579|323881238|FG003|Overall Study|Sponsor Decision|0|||
94569478|NCT05051579|323881239|FG004|Overall Study|Sponsor Decision|1|||
94569479|NCT05051579|323881240|FG005|Overall Study|Sponsor Decision|0|||
94569480|NCT05051579|323881241|FG006|Overall Study|Sponsor Decision|0|||
94569481|NCT05051579|323881235|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
94569482|NCT05051579|323881236|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
94569483|NCT05051579|323881237|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
94569484|NCT05051579|323881238|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
94569485|NCT05051579|323881239|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
94569486|NCT05051579|323881240|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
94569487|NCT05051579|323881241|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
94569488|NCT01232868|323882890|FG000|Overall Study|Lost to Follow-up|2|||
94569489|NCT01232868|323882891|FG001|Overall Study|Lost to Follow-up|4|||
94569490|NCT04002960|323882895|FG000|Overall Study|Withdrawn prior to Completion|2|||
94569491|NCT03811340|323882896|FG000|Overall Study|subjects did not complete the survey.|90|||
94569492|NCT00865345|323882897|FG000|Overall Study|Withdrawal by Subject|2|||
94569493|NCT00531284|323882898|FG000|Overall Study|Progressive Disease|1|||
94237521|NCT01296555|322664191|FG023|Overall Study|Non-Compliance With Study Drug|0|||
94237522|NCT01296555|322664192|FG024|Overall Study|Non-Compliance With Study Drug|0|||
94237523|NCT01296555|322664193|FG025|Overall Study|Non-Compliance With Study Drug|0|||
94237524|NCT01296555|322664194|FG026|Overall Study|Non-Compliance With Study Drug|0|||
94237525|NCT01296555|322664195|FG027|Overall Study|Non-Compliance With Study Drug|0|||
94237526|NCT01296555|322664196|FG028|Overall Study|Non-Compliance With Study Drug|0|||
94237527|NCT01296555|322664168|FG000|Overall Study|Withdrawal by Subject|0|||
94569494|NCT00531284|323882899|FG001|Overall Study|Progressive Disease|3|||
94569495|NCT00531284|323882900|FG002|Overall Study|Progressive Disease|5|||
94569496|NCT00531284|323882901|FG003|Overall Study|Progressive Disease|42|||
94569497|NCT00531284|323882902|FG004|Overall Study|Progressive Disease|4|||
94569498|NCT00531284|323882903|FG005|Overall Study|Progressive Disease|4|||
94569499|NCT00531284|323882904|FG006|Overall Study|Progressive Disease|3|||
94569500|NCT00531284|323882905|FG007|Overall Study|Progressive Disease|8|||
94569501|NCT00531284|323882906|FG008|Overall Study|Progressive Disease|6|||
94569502|NCT00531284|323882907|FG009|Overall Study|Progressive Disease|3|||
94569503|NCT00531284|323882908|FG010|Overall Study|Progressive Disease|3|||
94569504|NCT00531284|323882909|FG011|Overall Study|Progressive Disease|14|||
94569505|NCT00531284|323882910|FG012|Overall Study|Progressive Disease|2|||
94569506|NCT00531284|323882911|FG013|Overall Study|Progressive Disease|1|||
94569507|NCT00531284|323882912|FG014|Overall Study|Progressive Disease|2|||
94569508|NCT00531284|323882913|FG015|Overall Study|Progressive Disease|11|||
94569509|NCT00531284|323882914|FG016|Overall Study|Progressive Disease|5|||
94569510|NCT00531284|323882898|FG000|Overall Study|Adverse Event|0|||
94569511|NCT00531284|323882899|FG001|Overall Study|Adverse Event|1|||
94569512|NCT00531284|323882900|FG002|Overall Study|Adverse Event|1|||
94569513|NCT00531284|323882901|FG003|Overall Study|Adverse Event|7|||
94569514|NCT00531284|323882902|FG004|Overall Study|Adverse Event|0|||
94569515|NCT00531284|323882903|FG005|Overall Study|Adverse Event|2|||
94569516|NCT00531284|323882904|FG006|Overall Study|Adverse Event|3|||
94569517|NCT00531284|323882905|FG007|Overall Study|Adverse Event|2|||
94569518|NCT00531284|323882906|FG008|Overall Study|Adverse Event|3|||
94569519|NCT00531284|323882907|FG009|Overall Study|Adverse Event|0|||
94569520|NCT00531284|323882908|FG010|Overall Study|Adverse Event|0|||
94569521|NCT00531284|323882909|FG011|Overall Study|Adverse Event|5|||
94569522|NCT00531284|323882910|FG012|Overall Study|Adverse Event|0|||
94569523|NCT00531284|323882911|FG013|Overall Study|Adverse Event|1|||
94569524|NCT00531284|323882912|FG014|Overall Study|Adverse Event|1|||
94569525|NCT00531284|323882913|FG015|Overall Study|Adverse Event|0|||
94569526|NCT00531284|323882914|FG016|Overall Study|Adverse Event|2|||
94569527|NCT00531284|323882898|FG000|Overall Study|Withdrawal by Subject|1|||
94569528|NCT00531284|323882899|FG001|Overall Study|Withdrawal by Subject|0|||
94569529|NCT00531284|323882900|FG002|Overall Study|Withdrawal by Subject|0|||
94569530|NCT00531284|323882901|FG003|Overall Study|Withdrawal by Subject|4|||
94569531|NCT00531284|323882902|FG004|Overall Study|Withdrawal by Subject|0|||
94569532|NCT00531284|323882903|FG005|Overall Study|Withdrawal by Subject|0|||
94569533|NCT00531284|323882904|FG006|Overall Study|Withdrawal by Subject|0|||
94569534|NCT00531284|323882905|FG007|Overall Study|Withdrawal by Subject|0|||
94569535|NCT00531284|323882906|FG008|Overall Study|Withdrawal by Subject|0|||
94569536|NCT00531284|323882907|FG009|Overall Study|Withdrawal by Subject|0|||
94569537|NCT00531284|323882908|FG010|Overall Study|Withdrawal by Subject|0|||
94569538|NCT00531284|323882909|FG011|Overall Study|Withdrawal by Subject|3|||
94569539|NCT00531284|323882910|FG012|Overall Study|Withdrawal by Subject|0|||
94569540|NCT00531284|323882911|FG013|Overall Study|Withdrawal by Subject|1|||
94569541|NCT00531284|323882912|FG014|Overall Study|Withdrawal by Subject|0|||
94569542|NCT00531284|323882913|FG015|Overall Study|Withdrawal by Subject|1|||
94237528|NCT01296555|322664169|FG001|Overall Study|Withdrawal by Subject|0|||
94569543|NCT00531284|323882914|FG016|Overall Study|Withdrawal by Subject|1|||
94569544|NCT00531284|323882898|FG000|Overall Study|Other|1|||
94569545|NCT00531284|323882899|FG001|Overall Study|Other|0|||
94569546|NCT00531284|323882900|FG002|Overall Study|Other|0|||
94569547|NCT00531284|323882901|FG003|Overall Study|Other|10|||
94237529|NCT01296555|322664170|FG002|Overall Study|Withdrawal by Subject|0|||
94569548|NCT00531284|323882902|FG004|Overall Study|Other|2|||
94569549|NCT00531284|323882903|FG005|Overall Study|Other|1|||
94348230|NCT00242710|323056067|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
94348231|NCT00242710|323056064|FG000|Study Extension (up to Year 2)|Other|3|||
94348232|NCT00242710|323056065|FG001|Study Extension (up to Year 2)|Other|5|||
94569550|NCT00531284|323882904|FG006|Overall Study|Other|0|||
94348233|NCT00242710|323056066|FG002|Study Extension (up to Year 2)|Other|4|||
94348234|NCT00242710|323056067|FG003|Study Extension (up to Year 2)|Other|3|||
94348235|NCT00242710|323056064|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
94348236|NCT00242710|323056065|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
94569551|NCT00531284|323882905|FG007|Overall Study|Other|0|||
94569552|NCT00531284|323882906|FG008|Overall Study|Other|2|||
94569553|NCT00531284|323882907|FG009|Overall Study|Other|1|||
94348237|NCT00242710|323056066|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
94451384|NCT02484456|323440025|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
94451385|NCT01996254|323440026|FG000|Overall Study|Change in Eligibility|0|||
94451386|NCT01996254|323440027|FG001|Overall Study|Change in Eligibility|2|||
94451387|NCT01996254|323440028|FG002|Overall Study|Change in Eligibility|0|||
94451388|NCT01996254|323440026|FG000|Overall Study|Withdrawal by Subject|0|||
94451389|NCT01996254|323440027|FG001|Overall Study|Withdrawal by Subject|3|||
94451390|NCT01996254|323440028|FG002|Overall Study|Withdrawal by Subject|4|||
94451391|NCT01996254|323440026|FG000|Overall Study|Lost to Follow-up|1|||
94451392|NCT01996254|323440027|FG001|Overall Study|Lost to Follow-up|0|||
94451393|NCT01996254|323440028|FG002|Overall Study|Lost to Follow-up|4|||
94451394|NCT02199795|323440031|FG000|Overall Study|no longer met inclusion criteria|1|||
94451395|NCT02199795|323440032|FG001|Overall Study|no longer met inclusion criteria|0|||
94451396|NCT02199795|323440031|FG000|Overall Study|withdrew due to shoulder pain|1|||
94451397|NCT02199795|323440032|FG001|Overall Study|withdrew due to shoulder pain|0|||
94451398|NCT01127451|323440034|FG000|Overall Study|Other|2|||
94569554|NCT00531284|323882908|FG010|Overall Study|Other|0|||
94451399|NCT01127451|323440035|FG001|Overall Study|Other|1|||
94658719|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
94658720|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
94658721|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
94658722|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
94658723|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
94658724|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
94658725|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
94658726|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
94658727|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
94658728|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
94658729|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
94658730|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
94658731|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
94658732|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
94658733|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
94658734|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
94658735|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
94658736|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
94658737|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
94658738|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
94658739|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
94658740|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
94658741|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
94658742|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
94658743|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
94658744|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
94658745|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
94658746|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
94658747|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
94658748|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
94658749|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
94658750|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
94658751|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
94658752|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
94658753|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
94658754|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
94658755|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
94658756|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
94658757|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
94658758|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
94658759|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
94658760|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
94658761|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
94658762|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
94658763|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
94658764|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
94658765|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
94658766|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
94658767|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
94658768|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
94658769|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
94658770|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
94658771|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
94569555|NCT00531284|323882909|FG011|Overall Study|Other|2|||
94569556|NCT00531284|323882910|FG012|Overall Study|Other|0|||
94237530|NCT01296555|322664171|FG003|Overall Study|Withdrawal by Subject|0|||
94237531|NCT01296555|322664172|FG004|Overall Study|Withdrawal by Subject|1|||
94237532|NCT01296555|322664173|FG005|Overall Study|Withdrawal by Subject|0|||
94237533|NCT01296555|322664174|FG006|Overall Study|Withdrawal by Subject|1|||
94237534|NCT01296555|322664175|FG007|Overall Study|Withdrawal by Subject|0|||
94237535|NCT01296555|322664176|FG008|Overall Study|Withdrawal by Subject|0|||
94237536|NCT01296555|322664177|FG009|Overall Study|Withdrawal by Subject|0|||
94237537|NCT01296555|322664178|FG010|Overall Study|Withdrawal by Subject|1|||
94348238|NCT00242710|323056067|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
94348239|NCT00242710|323056064|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
94569557|NCT00531284|323882911|FG013|Overall Study|Other|0|||
94451400|NCT01127451|323440034|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
94451401|NCT01127451|323440035|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
94451402|NCT01127451|323440034|FG000|Overall Study|Death|22|||
94451403|NCT01127451|323440035|FG001|Overall Study|Death|17|||
94451404|NCT01127451|323440034|FG000|Overall Study|Lost to Follow-up|3|||
94451405|NCT01127451|323440035|FG001|Overall Study|Lost to Follow-up|0|||
94451406|NCT01127451|323440034|FG000|Overall Study|Administrative Reason by Sponsor|2|||
94451407|NCT01127451|323440035|FG001|Overall Study|Administrative Reason by Sponsor|2|||
94451408|NCT02865499|323440037|FG000|Baseline|Adverse Event|1|||
94451409|NCT02865499|323440037|FG000|Baseline|Withdrawal by Subject|1|||
94451410|NCT00403481|323440038|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
94451411|NCT00403481|323440038|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
94451412|NCT00403481|323440038|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
94451413|NCT00403481|323440038|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
94451414|NCT00403481|323440038|FG000|Olm 40 mg|Adverse Event|2|||
94451415|NCT00403481|323440038|FG000|Olm 40 mg|Protocol Violation|1|||
94451416|NCT00403481|323440038|FG000|Olm 40 mg|Withdrawal by Subject|1|||
94451417|NCT00403481|323440038|FG000|Olm 40 mg|Other|1|||
94451418|NCT00403481|323440038|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
94451419|NCT00403481|323440038|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
94451420|NCT00403481|323440038|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
94451421|NCT00403481|323440038|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
94451422|NCT00403481|323440038|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
94451423|NCT00403481|323440038|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
94451424|NCT00364923|323440039|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
94451425|NCT00364923|323440039|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
94451426|NCT01732458|323440044|FG000|Overall Study|Lost to Follow-up|0|||
94451427|NCT01732458|323440045|FG001|Overall Study|Lost to Follow-up|2|||
94451428|NCT01732458|323440046|FG002|Overall Study|Lost to Follow-up|0|||
94451429|NCT01732458|323440047|FG003|Overall Study|Lost to Follow-up|0|||
94451430|NCT01732458|323440044|FG000|Overall Study|Non-Compliance With Study Drug|0|||
94451431|NCT01732458|323440045|FG001|Overall Study|Non-Compliance With Study Drug|0|||
94451432|NCT01732458|323440046|FG002|Overall Study|Non-Compliance With Study Drug|1|||
94451433|NCT01732458|323440047|FG003|Overall Study|Non-Compliance With Study Drug|0|||
94451434|NCT01732458|323440044|FG000|Overall Study|Physician Decision|1|||
94451435|NCT01732458|323440045|FG001|Overall Study|Physician Decision|2|||
94451436|NCT01732458|323440046|FG002|Overall Study|Physician Decision|2|||
94451437|NCT01732458|323440047|FG003|Overall Study|Physician Decision|0|||
94451438|NCT01732458|323440044|FG000|Overall Study|Protocol Violation|2|||
94451439|NCT01732458|323440045|FG001|Overall Study|Protocol Violation|0|||
94451440|NCT01732458|323440046|FG002|Overall Study|Protocol Violation|0|||
94451441|NCT01732458|323440047|FG003|Overall Study|Protocol Violation|2|||
94451442|NCT01732458|323440044|FG000|Overall Study|Screen Failure|0|||
94451443|NCT01732458|323440045|FG001|Overall Study|Screen Failure|1|||
94451444|NCT01732458|323440046|FG002|Overall Study|Screen Failure|0|||
94451445|NCT01732458|323440047|FG003|Overall Study|Screen Failure|0|||
94451446|NCT01435460|323440048|FG000|Overall Study|Adverse Event|2|||
94451447|NCT01435460|323440049|FG001|Overall Study|Adverse Event|1|||
94451448|NCT01435460|323440048|FG000|Overall Study|Lost to Follow-up|6|||
94451449|NCT01435460|323440049|FG001|Overall Study|Lost to Follow-up|1|||
94451450|NCT01435460|323440048|FG000|Overall Study|Withdrawal by Subject|1|||
94451451|NCT01435460|323440049|FG001|Overall Study|Withdrawal by Subject|3|||
94451452|NCT01435460|323440048|FG000|Overall Study|Protocol Violation|0|||
94451453|NCT01435460|323440049|FG001|Overall Study|Protocol Violation|1|||
94451454|NCT01435460|323440048|FG000|Overall Study|Did not meet eligibility criteria|2|||
94451455|NCT01435460|323440049|FG001|Overall Study|Did not meet eligibility criteria|0|||
94451456|NCT01218087|323440050|FG000|Overall Study|Death|2|||
94451457|NCT01218087|323440051|FG001|Overall Study|Death|1|||
94451458|NCT01218087|323440050|FG000|Overall Study|Withdrawal by Subject|5|||
94451459|NCT01218087|323440051|FG001|Overall Study|Withdrawal by Subject|0|||
94451460|NCT01218087|323440050|FG000|Overall Study|Transferred|8|||
94451461|NCT01218087|323440051|FG001|Overall Study|Transferred|5|||
94451462|NCT04185220|323440052|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
94451463|NCT04185220|323440053|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
94451464|NCT04185220|323440052|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
94569558|NCT00531284|323882912|FG014|Overall Study|Other|1|||
94569559|NCT00531284|323882913|FG015|Overall Study|Other|0|||
94569560|NCT00531284|323882914|FG016|Overall Study|Other|0|||
94451465|NCT04185220|323440053|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
94451466|NCT01682226|323441742|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
94451467|NCT01682226|323441742|FG000|Overall Study|Participants did not receive treatment|2|||
94451468|NCT01682226|323441742|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
94348240|NCT00242710|323056065|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
94348241|NCT00242710|323056066|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
94237538|NCT01296555|322664179|FG011|Overall Study|Withdrawal by Subject|1|||
94237539|NCT01296555|322664180|FG012|Overall Study|Withdrawal by Subject|0|||
94451469|NCT00679029|323441743|FG000|Overall Study|Adverse Event|3|||
94451470|NCT00679029|323441743|FG000|Overall Study|Withdrawal by Subject|1|||
94451471|NCT00679029|323441743|FG000|Overall Study|Lost to Follow-up|1|||
94451472|NCT03056638|323441746|FG000|Overall Study|Death|1|||
94451473|NCT03056638|323441747|FG001|Overall Study|Death|0|||
94348242|NCT00242710|323056067|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
94348243|NCT02795182|323056072|FG000|Overall Study|Death|5|||
94348244|NCT02795182|323056073|FG001|Overall Study|Death|4|||
94348245|NCT02795182|323056074|FG002|Overall Study|Death|4|||
94348246|NCT02795182|323056075|FG003|Overall Study|Death|18|||
94348247|NCT02795182|323056072|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
94348248|NCT02795182|323056073|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
94348249|NCT02795182|323056074|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
94348250|NCT02795182|323056075|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
94348251|NCT02795182|323056072|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
94348252|NCT02795182|323056073|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
94348253|NCT02795182|323056074|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
94348254|NCT02795182|323056075|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
94348255|NCT02795182|323056072|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
94348256|NCT02795182|323056073|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
94348257|NCT02795182|323056074|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
94348258|NCT02795182|323056075|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
94348259|NCT02795182|323056072|FG000|Overall Study|Withdrawal by Subject|4|||
94348260|NCT02795182|323056073|FG001|Overall Study|Withdrawal by Subject|0|||
94348261|NCT02795182|323056074|FG002|Overall Study|Withdrawal by Subject|0|||
94348262|NCT02795182|323056075|FG003|Overall Study|Withdrawal by Subject|3|||
94348263|NCT02795182|323056072|FG000|Overall Study|Lost to Follow-up|0|||
94348264|NCT02795182|323056073|FG001|Overall Study|Lost to Follow-up|0|||
94348265|NCT02795182|323056074|FG002|Overall Study|Lost to Follow-up|1|||
94348266|NCT02795182|323056075|FG003|Overall Study|Lost to Follow-up|1|||
94348267|NCT02795182|323056072|FG000|Overall Study|Roll Over to Long Term Extension|3|||
94348268|NCT02795182|323056073|FG001|Overall Study|Roll Over to Long Term Extension|3|||
94348269|NCT02795182|323056074|FG002|Overall Study|Roll Over to Long Term Extension|2|||
94348270|NCT02795182|323056075|FG003|Overall Study|Roll Over to Long Term Extension|5|||
94348271|NCT02795182|323056072|FG000|Overall Study|Progressive Disease|0|||
94348272|NCT02795182|323056073|FG001|Overall Study|Progressive Disease|1|||
94348273|NCT02795182|323056074|FG002|Overall Study|Progressive Disease|0|||
94348274|NCT02795182|323056075|FG003|Overall Study|Progressive Disease|4|||
94348275|NCT02795182|323056072|FG000|Overall Study|Physician Decision|0|||
94348276|NCT02795182|323056073|FG001|Overall Study|Physician Decision|0|||
94348277|NCT02795182|323056074|FG002|Overall Study|Physician Decision|0|||
94348278|NCT02795182|323056075|FG003|Overall Study|Physician Decision|1|||
94348279|NCT00550615|323056076|FG000|Overall Study|Withdrawal by Subject|0|||
94348280|NCT00550615|323056077|FG001|Overall Study|Withdrawal by Subject|0|||
94348281|NCT00550615|323056078|FG002|Overall Study|Withdrawal by Subject|2|||
94348282|NCT00550615|323056079|FG003|Overall Study|Withdrawal by Subject|3|||
94348283|NCT00550615|323056076|FG000|Overall Study|Not evaluable|0|||
94348284|NCT00550615|323056077|FG001|Overall Study|Not evaluable|0|||
94348285|NCT00550615|323056078|FG002|Overall Study|Not evaluable|2|||
94348286|NCT00550615|323056079|FG003|Overall Study|Not evaluable|7|||
94348287|NCT02584660|323056085|FG000|Overall Study|Adverse Event|4|||
94348288|NCT02584660|323056086|FG001|Overall Study|Adverse Event|0|||
94348289|NCT02584660|323056085|FG000|Overall Study|Lost to Follow-up|3|||
94348290|NCT02584660|323056086|FG001|Overall Study|Lost to Follow-up|4|||
94348291|NCT02584660|323056085|FG000|Overall Study|Protocol Violation|0|||
94348292|NCT02584660|323056086|FG001|Overall Study|Protocol Violation|1|||
94348293|NCT02584660|323056085|FG000|Overall Study|Withdrawal by Subject|0|||
94348294|NCT02584660|323056086|FG001|Overall Study|Withdrawal by Subject|2|||
94348295|NCT02584660|323056085|FG000|Overall Study|Other|0|||
94348296|NCT02584660|323056086|FG001|Overall Study|Other|1|||
94348297|NCT00461552|323056089|FG000|Overall Study|Drug Dispensing error|0|||
94348298|NCT00461552|323056090|FG001|Overall Study|Drug Dispensing error|2|||
94348299|NCT00636506|323056092|FG000|Overall Study|Lost to Follow-up|8|||
94348300|NCT00636506|323056092|FG000|Overall Study|Explanted|1|||
94348301|NCT00636506|323056092|FG000|Overall Study|Withdrawal by Subject|6|||
94348302|NCT00636506|323056092|FG000|Overall Study|Procedure aborted|1|||
94348303|NCT02390362|323056094|FG000|Overall Study|Withdrawal by Subject|0|||
94348304|NCT02390362|323056095|FG001|Overall Study|Withdrawal by Subject|1|||
94348305|NCT02607735|323056096|FG000|Primary Study|Randomized but Never Treated|1|||
94348306|NCT02607735|323056097|FG001|Primary Study|Randomized but Never Treated|0|||
94348307|NCT02607735|323056098|FG002|Primary Study|Randomized but Never Treated|0|||
94348308|NCT02607735|323056096|FG000|Primary Study|Lost to Follow-up|4|||
94348309|NCT02607735|323056097|FG001|Primary Study|Lost to Follow-up|0|||
94348310|NCT02607735|323056098|FG002|Primary Study|Lost to Follow-up|0|||
94348311|NCT02607735|323056096|FG000|Primary Study|Withdrew Consent|2|||
94348312|NCT02607735|323056097|FG001|Primary Study|Withdrew Consent|0|||
94348313|NCT02607735|323056098|FG002|Primary Study|Withdrew Consent|0|||
94348314|NCT02607735|323056096|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
94569561|NCT03629886|323882917|FG000|Overall Study|Migrated / moved from the study area|0|||
94237540|NCT01296555|322664181|FG013|Overall Study|Withdrawal by Subject|0|||
94237541|NCT01296555|322664182|FG014|Overall Study|Withdrawal by Subject|3|||
94237542|NCT01296555|322664183|FG015|Overall Study|Withdrawal by Subject|0|||
94237543|NCT01296555|322664184|FG016|Overall Study|Withdrawal by Subject|2|||
94237544|NCT01296555|322664185|FG017|Overall Study|Withdrawal by Subject|1|||
94237545|NCT01296555|322664186|FG018|Overall Study|Withdrawal by Subject|0|||
94237546|NCT01296555|322664187|FG019|Overall Study|Withdrawal by Subject|1|||
94237547|NCT01296555|322664188|FG020|Overall Study|Withdrawal by Subject|1|||
94237548|NCT01296555|322664189|FG021|Overall Study|Withdrawal by Subject|1|||
94237549|NCT01296555|322664190|FG022|Overall Study|Withdrawal by Subject|3|||
94237550|NCT01296555|322664191|FG023|Overall Study|Withdrawal by Subject|0|||
94237551|NCT01296555|322664192|FG024|Overall Study|Withdrawal by Subject|0|||
94237552|NCT01296555|322664193|FG025|Overall Study|Withdrawal by Subject|0|||
94237553|NCT01296555|322664194|FG026|Overall Study|Withdrawal by Subject|8|||
94237554|NCT01296555|322664195|FG027|Overall Study|Withdrawal by Subject|4|||
94237555|NCT01296555|322664196|FG028|Overall Study|Withdrawal by Subject|2|||
94237556|NCT01834586|322664197|FG000|Overall Study|Adverse Event|1|||
94237557|NCT03004404|322664198|FG000|Period 2|Adverse Event|0|||
94237558|NCT03004404|322664199|FG001|Period 2|Adverse Event|0|||
94237559|NCT03004404|322664200|FG002|Period 2|Adverse Event|0|||
94237560|NCT03004404|322664201|FG003|Period 2|Adverse Event|0|||
94237561|NCT03004404|322664202|FG004|Period 2|Adverse Event|0|||
94237562|NCT03004404|322664203|FG005|Period 2|Adverse Event|0|||
94237563|NCT03004404|322664204|FG006|Period 2|Adverse Event|0|||
94237564|NCT03004404|322664205|FG007|Period 2|Adverse Event|0|||
94237565|NCT03004404|322664206|FG008|Period 2|Adverse Event|1|||
94237566|NCT03004404|322664207|FG009|Period 2|Adverse Event|0|||
94237567|NCT03004404|322664208|FG010|Period 2|Adverse Event|0|||
94237568|NCT03004404|322664209|FG011|Period 2|Adverse Event|0|||
94237569|NCT03004404|322664210|FG012|Period 2|Adverse Event|0|||
94237570|NCT03004404|322664211|FG013|Period 2|Adverse Event|0|||
94237571|NCT03004404|322664212|FG014|Period 2|Adverse Event|0|||
94237572|NCT03004404|322664213|FG015|Period 2|Adverse Event|1|||
94237573|NCT03482752|322664218|FG000|Overall Study|Withdrawal by Subject|2|||
94237574|NCT03482752|322664218|FG000|Overall Study|Lost to Follow-up|1|||
94237575|NCT03482752|322664218|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
94237576|NCT01807182|322664219|FG000|Overall Study|Death|1|||
94237577|NCT01807182|322664219|FG000|Overall Study|New therapy|1|||
94237578|NCT01807182|322664219|FG000|Overall Study|Moved to hospice care|1|||
94237579|NCT01080300|322664220|FG000|Overall Study|Adverse Event|49|||
94237580|NCT01080300|322664221|FG001|Overall Study|Adverse Event|35|||
94237581|NCT01080300|322664220|FG000|Overall Study|Lack of Efficacy|12|||
94237582|NCT01080300|322664221|FG001|Overall Study|Lack of Efficacy|15|||
94237583|NCT01080300|322664220|FG000|Overall Study|Protocol Violation|7|||
94237584|NCT01080300|322664221|FG001|Overall Study|Protocol Violation|13|||
94237585|NCT01080300|322664220|FG000|Overall Study|Lost to Follow-up|10|||
94237586|NCT01080300|322664221|FG001|Overall Study|Lost to Follow-up|6|||
94237587|NCT01080300|322664220|FG000|Overall Study|Death|0|||
94237588|NCT01080300|322664221|FG001|Overall Study|Death|1|||
94237589|NCT01080300|322664220|FG000|Overall Study|Withdrawal by Subject|12|||
94237590|NCT01080300|322664221|FG001|Overall Study|Withdrawal by Subject|28|||
94237591|NCT01080300|322664220|FG000|Overall Study|Reasons not specified|4|||
94237592|NCT01080300|322664221|FG001|Overall Study|Reasons not specified|6|||
94237593|NCT04210843|322664222|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
94237594|NCT04210843|322664223|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
94237595|NCT04210843|322664222|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
94237596|NCT04210843|322664223|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
94237597|NCT04210843|322664222|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
94237598|NCT04210843|322664223|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
94237599|NCT04210843|322664222|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
94237600|NCT04210843|322664223|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
94237601|NCT04210843|322664222|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
94237602|NCT04210843|322664223|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
94237603|NCT04210843|322664222|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
94237604|NCT04210843|322664223|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
94237605|NCT04210843|322664222|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
94237606|NCT04210843|322664223|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
94237607|NCT04210843|322664222|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
94237608|NCT04210843|322664223|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
94237609|NCT04210843|322664222|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
94237610|NCT04210843|322664223|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
94237611|NCT04210843|322664222|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
94237612|NCT04210843|322664223|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
94237613|NCT04210843|322664222|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
94237614|NCT04210843|322664223|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
94237615|NCT04210843|322664222|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
94237616|NCT04210843|322664223|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
94237617|NCT04210843|322664222|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
94237618|NCT04210843|322664223|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
94237619|NCT04210843|322664222|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
94237620|NCT04210843|322664223|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
94237621|NCT04210843|322664222|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
94237622|NCT04210843|322664223|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
94237623|NCT04210843|322664222|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
94237624|NCT04210843|322664223|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
94237625|NCT04210843|322664222|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
94237626|NCT04210843|322664223|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
94237627|NCT04210843|322664222|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
94237628|NCT04210843|322664223|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
94237629|NCT04210843|322664222|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
94237630|NCT04210843|322664223|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
94237631|NCT04210843|322664222|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
94237632|NCT04210843|322664223|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
94237633|NCT04210843|322664222|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
94237634|NCT04210843|322664223|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
94237635|NCT04210843|322664222|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
94237636|NCT04210843|322664223|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
94237637|NCT04210843|322664222|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
94237638|NCT04210843|322664223|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
94237639|NCT04210843|322664222|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
94237640|NCT04210843|322664223|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
94237641|NCT01791413|322664224|FG000|Overall Study|Lost to Follow-up|5|||
94237642|NCT01791413|322664225|FG001|Overall Study|Lost to Follow-up|1|||
94237643|NCT02353468|322664226|FG000|Overall Study|Study terminated|3|||
94237644|NCT00706654|322664230|FG000|Conversion Phase|Lost to Follow-up|4|||
94237645|NCT00706654|322664231|FG001|Conversion Phase|Lost to Follow-up|0|||
94237646|NCT00706654|322664232|FG002|Conversion Phase|Lost to Follow-up|0|||
94237647|NCT00706654|322664233|FG003|Conversion Phase|Lost to Follow-up|0|||
94237648|NCT00706654|322664230|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
94237649|NCT00706654|322664231|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
94237650|NCT00706654|322664232|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
94237651|NCT00706654|322664233|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
94237652|NCT00706654|322664230|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
94237653|NCT00706654|322664231|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
94237654|NCT00706654|322664232|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
94237655|NCT00706654|322664233|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
94237656|NCT00706654|322664230|FG000|Conversion Phase|Withdrawn by Investigator|14|||
94237657|NCT00706654|322664231|FG001|Conversion Phase|Withdrawn by Investigator|0|||
94237658|NCT00706654|322664232|FG002|Conversion Phase|Withdrawn by Investigator|0|||
94237659|NCT00706654|322664233|FG003|Conversion Phase|Withdrawn by Investigator|0|||
94237660|NCT00706654|322664230|FG000|Conversion Phase|Withdrew Consent|38|||
94237661|NCT00706654|322664231|FG001|Conversion Phase|Withdrew Consent|0|||
94237662|NCT00706654|322664232|FG002|Conversion Phase|Withdrew Consent|0|||
94237663|NCT00706654|322664233|FG003|Conversion Phase|Withdrew Consent|0|||
94237664|NCT00706654|322664230|FG000|Conversion Phase|Adverse Event|18|||
94237665|NCT00706654|322664231|FG001|Conversion Phase|Adverse Event|0|||
94237666|NCT00706654|322664232|FG002|Conversion Phase|Adverse Event|0|||
94237667|NCT00706654|322664233|FG003|Conversion Phase|Adverse Event|0|||
94237668|NCT00706654|322664230|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
94237669|NCT00706654|322664231|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
94237670|NCT00706654|322664232|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
94237671|NCT00706654|322664233|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
94237672|NCT00706654|322664230|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
94237673|NCT00706654|322664231|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
94237674|NCT00706654|322664232|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
94237675|NCT00706654|322664233|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
94237676|NCT00706654|322664230|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
94237677|NCT00706654|322664231|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
94237678|NCT00706654|322664232|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
94237679|NCT00706654|322664233|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
94237680|NCT00706654|322664230|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
94237681|NCT00706654|322664231|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
94237682|NCT00706654|322664232|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
94237683|NCT00706654|322664233|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
94237684|NCT00706654|322664230|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
94237685|NCT00706654|322664231|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
94237686|NCT00706654|322664232|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
94237687|NCT00706654|322664233|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
94237688|NCT00706654|322664230|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
94237689|NCT00706654|322664231|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
94237690|NCT00706654|322664232|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
94237691|NCT00706654|322664233|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
94237692|NCT00706654|322664230|FG000|Oral Stabilization Phase|Withdrew consent|55|||
94237693|NCT00706654|322664231|FG001|Oral Stabilization Phase|Withdrew consent|0|||
94237694|NCT00706654|322664232|FG002|Oral Stabilization Phase|Withdrew consent|0|||
94237695|NCT00706654|322664233|FG003|Oral Stabilization Phase|Withdrew consent|0|||
94237696|NCT00706654|322664230|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
94237697|NCT00706654|322664231|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
94237698|NCT00706654|322664232|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
94237699|NCT00706654|322664233|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
94237700|NCT00706654|322664230|FG000|Oral Stabilization Phase|Adverse Event|21|||
94237701|NCT00706654|322664231|FG001|Oral Stabilization Phase|Adverse Event|0|||
94237702|NCT00706654|322664232|FG002|Oral Stabilization Phase|Adverse Event|0|||
94237703|NCT00706654|322664233|FG003|Oral Stabilization Phase|Adverse Event|0|||
94237704|NCT00706654|322664230|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
94237705|NCT00706654|322664231|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
94237706|NCT00706654|322664232|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
94237707|NCT00706654|322664233|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
94237708|NCT00706654|322664230|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
94237709|NCT00706654|322664231|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
94237710|NCT00706654|322664232|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
94237711|NCT00706654|322664233|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
94237712|NCT00706654|322664230|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
94237713|NCT00706654|322664231|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
94237714|NCT00706654|322664232|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
94237715|NCT00706654|322664233|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
94237716|NCT00706654|322664230|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
94237717|NCT00706654|322664231|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
94237718|NCT00706654|322664232|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
94237719|NCT00706654|322664233|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
94237720|NCT00706654|322664230|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
94237721|NCT00706654|322664231|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
94237722|NCT00706654|322664232|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
94237723|NCT00706654|322664233|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
94237724|NCT00706654|322664230|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
94237725|NCT00706654|322664231|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
94237726|NCT00706654|322664232|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
94237727|NCT00706654|322664233|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
94237728|NCT00706654|322664230|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
94237729|NCT00706654|322664231|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
94237730|NCT00706654|322664232|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
94237731|NCT00706654|322664233|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
94237732|NCT00706654|322664230|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
94237733|NCT00706654|322664231|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
94237734|NCT00706654|322664232|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
94237735|NCT00706654|322664233|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
94237736|NCT00706654|322664230|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
94237737|NCT00706654|322664231|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
94237738|NCT00706654|322664232|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
94237739|NCT00706654|322664233|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
94237740|NCT00706654|322664230|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
94237741|NCT00706654|322664231|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
94237742|NCT00706654|322664232|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
94237743|NCT00706654|322664233|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
94237744|NCT01151215|322664234|FG000|Overall Study|Worsening of condition under study|1|||
94237745|NCT01151215|322664235|FG001|Overall Study|Worsening of condition under study|1|||
94237746|NCT01151215|322664236|FG002|Overall Study|Worsening of condition under study|1|||
94237747|NCT01151215|322664234|FG000|Overall Study|Death|16|||
94237748|NCT01151215|322664235|FG001|Overall Study|Death|20|||
94237749|NCT01151215|322664236|FG002|Overall Study|Death|11|||
94237750|NCT01151215|322664234|FG000|Overall Study|Lost to Follow-up|0|||
94237751|NCT01151215|322664235|FG001|Overall Study|Lost to Follow-up|0|||
94237752|NCT01151215|322664236|FG002|Overall Study|Lost to Follow-up|3|||
94237753|NCT01151215|322664234|FG000|Overall Study|Withdrawal by Subject|3|||
94237754|NCT01151215|322664235|FG001|Overall Study|Withdrawal by Subject|1|||
94237755|NCT01151215|322664236|FG002|Overall Study|Withdrawal by Subject|2|||
94348315|NCT02607735|323056097|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
94237756|NCT01151215|322664234|FG000|Overall Study|Disease progression|0|||
94237757|NCT01151215|322664235|FG001|Overall Study|Disease progression|1|||
94237758|NCT01151215|322664236|FG002|Overall Study|Disease progression|1|||
94237759|NCT01151215|322664234|FG000|Overall Study|Safety as judged by the investigator|0|||
94237760|NCT01151215|322664235|FG001|Overall Study|Safety as judged by the investigator|0|||
94237761|NCT01151215|322664236|FG002|Overall Study|Safety as judged by the investigator|1|||
94237762|NCT00762476|322664237|FG000|Overall Study|Adverse Event|7|||
94569562|NCT03629886|323882918|FG001|Overall Study|Migrated / moved from the study area|55|||
94237763|NCT00762476|322664238|FG001|Overall Study|Adverse Event|1|||
94237764|NCT00762476|322664237|FG000|Overall Study|Lost to Follow-up|2|||
94237765|NCT00762476|322664238|FG001|Overall Study|Lost to Follow-up|0|||
94237766|NCT00762476|322664237|FG000|Overall Study|Protocol Violation|5|||
94237767|NCT00762476|322664238|FG001|Overall Study|Protocol Violation|6|||
94237768|NCT00762476|322664237|FG000|Overall Study|Physician Decision|2|||
94237769|NCT00762476|322664238|FG001|Overall Study|Physician Decision|14|||
94237770|NCT00762476|322664237|FG000|Overall Study|Withdrawal by Subject|6|||
94237771|NCT00762476|322664238|FG001|Overall Study|Withdrawal by Subject|12|||
94237772|NCT00762476|322664237|FG000|Overall Study|antibiotic use|0|||
94237773|NCT00762476|322664238|FG001|Overall Study|antibiotic use|1|||
94237774|NCT00762476|322664237|FG000|Overall Study|non-compliance with study visits|0|||
94237775|NCT00762476|322664238|FG001|Overall Study|non-compliance with study visits|2|||
94237776|NCT00762476|322664237|FG000|Overall Study|Seasonal allergies|1|||
94237777|NCT00762476|322664238|FG001|Overall Study|Seasonal allergies|0|||
94237778|NCT02637323|322664239|FG000|Overall Study|Lost to Follow-up|2|||
94237779|NCT02637323|322664240|FG001|Overall Study|Lost to Follow-up|0|||
94237780|NCT02637323|322664239|FG000|Overall Study|Protocol Violation|0|||
94569563|NCT03629886|323882917|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
94348316|NCT02607735|323056098|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
94348317|NCT02607735|323056096|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
94348318|NCT02607735|323056097|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
94348319|NCT02607735|323056098|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
94348320|NCT01376908|323056101|FG000|Overall Study|Protocol Violation|1|||
94348321|NCT01376908|323056102|FG001|Overall Study|Protocol Violation|1|||
94237781|NCT02637323|322664240|FG001|Overall Study|Protocol Violation|1|||
94237782|NCT00513708|322664241|FG000|Overall Study|Lost to Follow-up|4|||
94237783|NCT00513708|322664242|FG001|Overall Study|Lost to Follow-up|4|||
94237784|NCT00513708|322664243|FG002|Overall Study|Lost to Follow-up|4|||
94237785|NCT01289210|322664244|FG000|Overall Study|Adverse Event|1|||
94237786|NCT01969851|322664256|FG000|Overall Study|Adverse Event|0|||
94237787|NCT01969851|322664257|FG001|Overall Study|Adverse Event|0|||
94237788|NCT01969851|322664258|FG002|Overall Study|Adverse Event|3|||
94237789|NCT01969851|322664256|FG000|Overall Study|Lack of Efficacy|0|||
94237790|NCT01969851|322664257|FG001|Overall Study|Lack of Efficacy|3|||
94237791|NCT01969851|322664258|FG002|Overall Study|Lack of Efficacy|1|||
94237792|NCT01969851|322664256|FG000|Overall Study|Withdrawal by Subject|1|||
94237793|NCT01969851|322664257|FG001|Overall Study|Withdrawal by Subject|0|||
94237794|NCT01969851|322664258|FG002|Overall Study|Withdrawal by Subject|1|||
94237795|NCT01969851|322664256|FG000|Overall Study|No effective dose in Titration period|0|||
94237796|NCT01969851|322664257|FG001|Overall Study|No effective dose in Titration period|0|||
94237797|NCT01969851|322664258|FG002|Overall Study|No effective dose in Titration period|1|||
94237798|NCT01969851|322664256|FG000|Overall Study|Sponsor decision|0|||
94237799|NCT01969851|322664257|FG001|Overall Study|Sponsor decision|0|||
94237800|NCT01969851|322664258|FG002|Overall Study|Sponsor decision|1|||
94237801|NCT01299480|322664259|FG000|Overall Study|No longer willing to participate|19|||
94237802|NCT01299480|322664260|FG001|Overall Study|No longer willing to participate|17|||
94237803|NCT01299480|322664261|FG002|Overall Study|No longer willing to participate|14|||
94237804|NCT01299480|322664262|FG003|Overall Study|No longer willing to participate|13|||
94237805|NCT01299480|322664263|FG004|Overall Study|No longer willing to participate|10|||
94237806|NCT01299480|322664259|FG000|Overall Study|Protocol Violation|7|||
94237807|NCT01299480|322664260|FG001|Overall Study|Protocol Violation|5|||
94237808|NCT01299480|322664261|FG002|Overall Study|Protocol Violation|8|||
94237809|NCT01299480|322664262|FG003|Overall Study|Protocol Violation|1|||
94237810|NCT01299480|322664263|FG004|Overall Study|Protocol Violation|1|||
94237811|NCT01299480|322664259|FG000|Overall Study|Withdrawal by Subject|3|||
94237812|NCT01299480|322664260|FG001|Overall Study|Withdrawal by Subject|4|||
94237813|NCT01299480|322664261|FG002|Overall Study|Withdrawal by Subject|7|||
94237814|NCT01299480|322664262|FG003|Overall Study|Withdrawal by Subject|3|||
94237815|NCT01299480|322664263|FG004|Overall Study|Withdrawal by Subject|4|||
94237816|NCT01299480|322664259|FG000|Overall Study|Adverse Event|6|||
94237817|NCT01299480|322664260|FG001|Overall Study|Adverse Event|4|||
94237818|NCT01299480|322664261|FG002|Overall Study|Adverse Event|5|||
94237819|NCT01299480|322664262|FG003|Overall Study|Adverse Event|4|||
94237820|NCT01299480|322664263|FG004|Overall Study|Adverse Event|0|||
94237821|NCT01299480|322664259|FG000|Overall Study|Withdrawal due to pregnancy|0|||
94237822|NCT01299480|322664260|FG001|Overall Study|Withdrawal due to pregnancy|1|||
94237823|NCT01299480|322664261|FG002|Overall Study|Withdrawal due to pregnancy|1|||
94237824|NCT01299480|322664262|FG003|Overall Study|Withdrawal due to pregnancy|0|||
94237825|NCT01299480|322664263|FG004|Overall Study|Withdrawal due to pregnancy|0|||
94237826|NCT01299480|322664259|FG000|Overall Study|Physician Decision|1|||
94237827|NCT01299480|322664260|FG001|Overall Study|Physician Decision|1|||
94237828|NCT01299480|322664261|FG002|Overall Study|Physician Decision|0|||
94237829|NCT01299480|322664262|FG003|Overall Study|Physician Decision|2|||
94237830|NCT01299480|322664263|FG004|Overall Study|Physician Decision|0|||
94237831|NCT01299480|322664259|FG000|Overall Study|Lost to Follow-up|3|||
94237832|NCT01299480|322664260|FG001|Overall Study|Lost to Follow-up|1|||
94237833|NCT01299480|322664261|FG002|Overall Study|Lost to Follow-up|2|||
94237834|NCT01299480|322664262|FG003|Overall Study|Lost to Follow-up|1|||
94237835|NCT01299480|322664263|FG004|Overall Study|Lost to Follow-up|2|||
94237836|NCT01299480|322664259|FG000|Overall Study|Other|3|||
94237837|NCT01299480|322664260|FG001|Overall Study|Other|2|||
94237838|NCT01299480|322664261|FG002|Overall Study|Other|3|||
94237839|NCT01299480|322664262|FG003|Overall Study|Other|0|||
94237840|NCT01299480|322664263|FG004|Overall Study|Other|3|||
94237841|NCT01299480|322664259|FG000|Overall Study|Started, but not vaccinated|0|||
94237842|NCT01299480|322664260|FG001|Overall Study|Started, but not vaccinated|0|||
94237843|NCT01299480|322664261|FG002|Overall Study|Started, but not vaccinated|1|||
94237844|NCT01299480|322664262|FG003|Overall Study|Started, but not vaccinated|1|||
94237845|NCT01299480|322664263|FG004|Overall Study|Started, but not vaccinated|0|||
94237846|NCT02389764|322664265|FG000|Overall Study|Lack of Efficacy|9|||
94237847|NCT00617929|322664267|FG000|Overall Study|Physician Decision|1|||
94237848|NCT03229486|322664268|FG000|Overall Study|Protocol Violation|0|||
94237849|NCT03229486|322664269|FG001|Overall Study|Protocol Violation|1|||
94237850|NCT00600613|322664270|FG000|Overall Study|Protocol Deviation|1|||
94237851|NCT00935532|322664275|FG000|Overall Study|Adverse Event|11|||
94237852|NCT00935532|322664276|FG001|Overall Study|Adverse Event|6|||
94237853|NCT00935532|322664275|FG000|Overall Study|Death|1|||
94237854|NCT00935532|322664276|FG001|Overall Study|Death|0|||
94237855|NCT00935532|322664275|FG000|Overall Study|Lost to Follow-up|1|||
94348322|NCT01376908|323056101|FG000|Overall Study|Withdrawal by Subject|1|||
94348323|NCT01376908|323056102|FG001|Overall Study|Withdrawal by Subject|2|||
94348324|NCT05375838|323056103|FG000|Overall Study|Other|0|||
94237856|NCT00935532|322664276|FG001|Overall Study|Lost to Follow-up|0|||
94237857|NCT00935532|322664275|FG000|Overall Study|Physician Decision|1|||
94237858|NCT00935532|322664276|FG001|Overall Study|Physician Decision|2|||
94237859|NCT00935532|322664275|FG000|Overall Study|Protocol Violation|2|||
94237860|NCT00935532|322664276|FG001|Overall Study|Protocol Violation|1|||
94237861|NCT00935532|322664275|FG000|Overall Study|Subject Decision|2|||
94237862|NCT00935532|322664276|FG001|Overall Study|Subject Decision|1|||
94237863|NCT00935532|322664275|FG000|Overall Study|Sponsor Decision|0|||
94237864|NCT00935532|322664276|FG001|Overall Study|Sponsor Decision|1|||
94237865|NCT00935532|322664275|FG000|Overall Study|Loss Glucose Control|4|||
94237866|NCT00935532|322664276|FG001|Overall Study|Loss Glucose Control|0|||
94237867|NCT03197766|322664277|FG000|Overall Study|Withdrawal by Subject|2|||
94237868|NCT03197766|322664278|FG001|Overall Study|Withdrawal by Subject|0|||
94237869|NCT00996606|322664279|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
94237870|NCT00996606|322664279|FG000|Overall Study|Insufficient Therapeutic Response|2|||
94237871|NCT00996606|322664279|FG000|Overall Study|Protocol Violation|1|||
94237872|NCT00996606|322664279|FG000|Overall Study|Withdrawal by Subject|3|||
94237873|NCT00978562|322664281|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
94237874|NCT00632502|322664282|FG000|Overall Study|Adverse Event|0|||
94237875|NCT00632502|322664283|FG001|Overall Study|Adverse Event|1|||
94237876|NCT00632502|322664282|FG000|Overall Study|Randomized not treated|3|||
94237877|NCT00632502|322664283|FG001|Overall Study|Randomized not treated|0|||
94237878|NCT01077518|322664284|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
94237879|NCT01077518|322664285|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
94237880|NCT01077518|322664286|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
94237881|NCT01077518|322664284|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
94237882|NCT01077518|322664285|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
94237883|NCT01077518|322664286|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
94237884|NCT01077518|322664284|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
94237885|NCT01077518|322664285|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
94237886|NCT01077518|322664286|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
94237887|NCT01077518|322664284|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
94237888|NCT01077518|322664285|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
94237889|NCT01077518|322664286|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
94237890|NCT01077518|322664284|FG000|Optional Ofa Phase|Physician Decision|0|||
94237891|NCT01077518|322664285|FG001|Optional Ofa Phase|Physician Decision|0|||
94237892|NCT01077518|322664286|FG002|Optional Ofa Phase|Physician Decision|1|||
94237893|NCT01077518|322664284|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
94237894|NCT01077518|322664285|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
94237895|NCT01077518|322664286|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
94237896|NCT01077518|322664284|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
94237897|NCT01077518|322664285|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
94237898|NCT01077518|322664286|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
94237899|NCT04954326|322664287|FG000|Overall Study|Protocol Violation|0|||
94237900|NCT04954326|322664288|FG001|Overall Study|Protocol Violation|1|||
94237901|NCT04954326|322664287|FG000|Overall Study|Death|0|||
94237902|NCT04954326|322664288|FG001|Overall Study|Death|2|||
94237903|NCT04954326|322664287|FG000|Overall Study|Physician Decision|0|||
94237904|NCT04954326|322664288|FG001|Overall Study|Physician Decision|1|||
94237905|NCT01782690|322664289|FG000|Overall Study|Not reported|7|||
94237906|NCT01782690|322664289|FG000|Overall Study|Toxicity of gemcitabine|1|||
94237907|NCT01782690|322664289|FG000|Overall Study|Toxicity of erlotinib|1|||
94237908|NCT01782690|322664289|FG000|Overall Study|Lost to Follow-up|31|||
94237909|NCT01782690|322664289|FG000|Overall Study|Withdrawal of informed consent|2|||
94237910|NCT01782690|322664289|FG000|Overall Study|Absent rash|9|||
94237911|NCT01782690|322664289|FG000|Overall Study|Physician Decision|13|||
94237912|NCT01782690|322664289|FG000|Overall Study|Patient's wish|21|||
94237913|NCT01782690|322664289|FG000|Overall Study|Tumor progression|74|||
94237914|NCT01782690|322664289|FG000|Overall Study|Death|133|||
94237915|NCT01782690|322664289|FG000|Overall Study|Study completion unknown|7|||
94237916|NCT00277095|322664290|FG000|Overall Study|Death|2|||
94237917|NCT00277095|322664290|FG000|Overall Study|Explanted|7|||
94658772|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
94237918|NCT00277095|322664290|FG000|Overall Study|Lost to Follow-up|2|||
94237919|NCT00277095|322664290|FG000|Overall Study|Missed Follow-up|9|||
94658773|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
94658774|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
94237920|NCT00277095|322664290|FG000|Overall Study|Physician Decision|1|||
94237921|NCT01213524|322664293|FG000|Baseline|Withdrawal by Subject|5|||
94237922|NCT01213524|322664293|FG000|Baseline|high breath alcohol levels|1|||
94237923|NCT01213524|322664293|FG000|Baseline|Physician Decision|1|||
94237924|NCT01213524|322664293|FG000|Session 2|Withdrawal by Subject|5|||
94237925|NCT01213524|322664293|FG000|Session 3|Withdrawal by Subject|4|||
94237926|NCT01213524|322664293|FG000|Session 4|Physician Decision|1|||
94237927|NCT01213524|322664293|FG000|Session 4|Withdrawal by Subject|2|||
94237928|NCT01647542|322664294|FG000|Overall Study|Major Protocol Deviation|1|||
94237929|NCT01647542|322664295|FG001|Overall Study|Major Protocol Deviation|0|||
94237930|NCT01647542|322664296|FG002|Overall Study|Major Protocol Deviation|0|||
94237931|NCT01647542|322664294|FG000|Overall Study|Adverse Event|4|||
94237932|NCT01647542|322664295|FG001|Overall Study|Adverse Event|5|||
94237933|NCT01647542|322664296|FG002|Overall Study|Adverse Event|4|||
94237934|NCT01647542|322664294|FG000|Overall Study|Lost to Follow-up|0|||
94237935|NCT01647542|322664295|FG001|Overall Study|Lost to Follow-up|2|||
94237936|NCT01647542|322664296|FG002|Overall Study|Lost to Follow-up|2|||
94237937|NCT01647542|322664294|FG000|Overall Study|Withdrawal by Subject|6|||
94237938|NCT01647542|322664295|FG001|Overall Study|Withdrawal by Subject|4|||
94237939|NCT01647542|322664296|FG002|Overall Study|Withdrawal by Subject|0|||
94237940|NCT01647542|322664294|FG000|Overall Study|Study Termination|64|||
94237941|NCT01647542|322664295|FG001|Overall Study|Study Termination|61|||
94237942|NCT01647542|322664296|FG002|Overall Study|Study Termination|65|||
94237943|NCT01647542|322664294|FG000|Overall Study|Lack of Efficacy|1|||
94237944|NCT01647542|322664295|FG001|Overall Study|Lack of Efficacy|1|||
94237945|NCT01647542|322664296|FG002|Overall Study|Lack of Efficacy|0|||
94237946|NCT01647542|322664294|FG000|Overall Study|Death|0|||
94237947|NCT01647542|322664295|FG001|Overall Study|Death|0|||
94237948|NCT01647542|322664296|FG002|Overall Study|Death|1|||
94237949|NCT00281320|322664297|FG000|Overall Study|Adverse Event|12|||
94237950|NCT00281320|322664298|FG001|Overall Study|Adverse Event|9|||
94237951|NCT00281320|322664297|FG000|Overall Study|Lack of Efficacy|4|||
94237952|NCT00281320|322664298|FG001|Overall Study|Lack of Efficacy|3|||
94237953|NCT00281320|322664297|FG000|Overall Study|Withdrawal by Subject|5|||
94237954|NCT00281320|322664298|FG001|Overall Study|Withdrawal by Subject|6|||
94237955|NCT00281320|322664297|FG000|Overall Study|Lost to Follow-up|1|||
94237956|NCT00281320|322664298|FG001|Overall Study|Lost to Follow-up|2|||
94237957|NCT00281320|322664297|FG000|Overall Study|Other|3|||
94237958|NCT00281320|322664298|FG001|Overall Study|Other|1|||
94237959|NCT02209181|322664307|FG000|Overall Study|Adverse Event|1|||
94237960|NCT02209181|322664308|FG001|Overall Study|Adverse Event|0|||
94237961|NCT02209181|322664309|FG002|Overall Study|Adverse Event|1|||
94237962|NCT02209181|322664310|FG003|Overall Study|Adverse Event|0|||
94237963|NCT02209181|322664307|FG000|Overall Study|Withdrawal by Subject|0|||
94237964|NCT02209181|322664308|FG001|Overall Study|Withdrawal by Subject|1|||
94237965|NCT02209181|322664309|FG002|Overall Study|Withdrawal by Subject|0|||
94237966|NCT02209181|322664310|FG003|Overall Study|Withdrawal by Subject|0|||
94237967|NCT02737826|322666494|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
94237968|NCT02737826|322666495|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
94237969|NCT02737826|322666496|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
94237970|NCT00667459|322666497|FG000|Overall Study|Death|0|||
94237971|NCT00667459|322666498|FG001|Overall Study|Death|2|||
94237972|NCT00667459|322666497|FG000|Overall Study|Lost to Follow-up|8|||
94237973|NCT00667459|322666498|FG001|Overall Study|Lost to Follow-up|43|||
94237974|NCT02568397|322666499|FG000|Period 2|Withdrawal by Subject|0|||
94237975|NCT02568397|322666500|FG001|Period 2|Withdrawal by Subject|1|||
94237976|NCT02568397|322666499|FG000|Period 2|Physician Decision|0|||
94237977|NCT02568397|322666500|FG001|Period 2|Physician Decision|1|||
94237978|NCT00581893|322666501|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
94237979|NCT00581893|322666502|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
94237980|NCT00233480|322666503|FG000|Overall Study|Underwent status II heart transplant|0|||
94237981|NCT00233480|322666504|FG001|Overall Study|Underwent status II heart transplant|1|||
94237982|NCT01381575|322666505|FG000|Overall Study|Serious Adverse Event|1|||
94237983|NCT01381575|322666506|FG001|Overall Study|Serious Adverse Event|0|||
94237984|NCT01381575|322666507|FG002|Overall Study|Serious Adverse Event|0|||
94237985|NCT01381575|322666505|FG000|Overall Study|Non-Serious Adverse Event|0|||
94237986|NCT01381575|322666506|FG001|Overall Study|Non-Serious Adverse Event|0|||
94237987|NCT01381575|322666507|FG002|Overall Study|Non-Serious Adverse Event|1|||
94237988|NCT01381575|322666505|FG000|Overall Study|Protocol Violation|0|||
94237989|NCT01381575|322666506|FG001|Overall Study|Protocol Violation|1|||
94237990|NCT01381575|322666507|FG002|Overall Study|Protocol Violation|1|||
94237991|NCT01381575|322666505|FG000|Overall Study|Withdrawal by Subject|15|||
94237992|NCT01381575|322666506|FG001|Overall Study|Withdrawal by Subject|9|||
94237993|NCT01381575|322666507|FG002|Overall Study|Withdrawal by Subject|7|||
94237994|NCT01381575|322666505|FG000|Overall Study|Migrated/moved from study area|2|||
94237995|NCT01381575|322666506|FG001|Overall Study|Migrated/moved from study area|12|||
94237996|NCT01381575|322666507|FG002|Overall Study|Migrated/moved from study area|2|||
94237997|NCT01381575|322666505|FG000|Overall Study|Lost to Follow-up|8|||
94237998|NCT01381575|322666506|FG001|Overall Study|Lost to Follow-up|17|||
94237999|NCT01381575|322666507|FG002|Overall Study|Lost to Follow-up|9|||
94238000|NCT02271984|322666521|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
94238001|NCT02271984|322666522|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
94238002|NCT02271984|322666523|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
94238003|NCT02271984|322666524|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
94238004|NCT02271984|322666525|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
94348325|NCT05375838|323056104|FG001|Overall Study|Other|0|||
94569564|NCT03629886|323882918|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
94569565|NCT03629886|323882917|FG000|Overall Study|Study vaccine not administrated|0|||
94569566|NCT03629886|323882918|FG001|Overall Study|Study vaccine not administrated|3|||
94569567|NCT03629886|323882917|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
94569568|NCT03629886|323882918|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
94569569|NCT03629886|323882917|FG000|Overall Study|Refused vaccination step of the study|0|||
94569570|NCT03629886|323882918|FG001|Overall Study|Refused vaccination step of the study|44|||
94569571|NCT02152631|323882920|FG000|Overall Study|Adverse Event|32|||
94569572|NCT02152631|323882921|FG001|Overall Study|Adverse Event|4|||
94569573|NCT02152631|323882920|FG000|Overall Study|Withdrawal by Subject|13|||
94569574|NCT02152631|323882921|FG001|Overall Study|Withdrawal by Subject|16|||
94569575|NCT02152631|323882920|FG000|Overall Study|Noncompliance with study drug|1|||
94569576|NCT02152631|323882921|FG001|Overall Study|Noncompliance with study drug|0|||
94569577|NCT02152631|323882920|FG000|Overall Study|Physician Decision|1|||
94569578|NCT02152631|323882921|FG001|Overall Study|Physician Decision|2|||
94569579|NCT02152631|323882920|FG000|Overall Study|Lost to Follow-up|0|||
94569580|NCT02152631|323882921|FG001|Overall Study|Lost to Follow-up|1|||
94569581|NCT02152631|323882920|FG000|Overall Study|On Treatment|19|||
94569582|NCT02152631|323882921|FG001|Overall Study|On Treatment|3|||
94569583|NCT05473026|323882922|FG000|Overall Study|Lost to Follow-up|5|||
94569584|NCT05473026|323882923|FG001|Overall Study|Lost to Follow-up|2|||
94569585|NCT03683173|323882932|FG000|Completed Follow-up|Unavailable|235|||
94569586|NCT03683173|323882933|FG001|Completed Follow-up|Unavailable|217|||
94569587|NCT03683173|323882932|FG000|Completed Follow-up|Refused|69|||
94569588|NCT03683173|323882933|FG001|Completed Follow-up|Refused|59|||
94569589|NCT03683173|323882932|FG000|Completed Follow-up|Disconnected phone|65|||
94569590|NCT03683173|323882933|FG001|Completed Follow-up|Disconnected phone|95|||
94569591|NCT03683173|323882932|FG000|Completed Follow-up|Health issue/deceased|10|||
94569592|NCT03683173|323882933|FG001|Completed Follow-up|Health issue/deceased|4|||
94569593|NCT03683173|323882932|FG000|Completed Follow-up|Moved away|8|||
94569594|NCT03683173|323882933|FG001|Completed Follow-up|Moved away|1|||
94569595|NCT05801991|323882934|FG000|Overall Study|Lost to Follow-up|1|||
94658775|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
94658776|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
94658777|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
94658778|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
94658779|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
94658780|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
94658781|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
94658782|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
94658783|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
94658784|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
94658785|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
94658786|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
94348326|NCT05375838|323056105|FG002|Overall Study|Other|0|||
94348327|NCT05375838|323056106|FG003|Overall Study|Other|1|||
94348328|NCT05375838|323056107|FG004|Overall Study|Other|1|||
94348329|NCT05375838|323056108|FG005|Overall Study|Other|0|||
94348330|NCT05375838|323056103|FG000|Overall Study|Withdrawal by Subject|2|||
94348331|NCT05375838|323056104|FG001|Overall Study|Withdrawal by Subject|1|||
94348332|NCT05375838|323056105|FG002|Overall Study|Withdrawal by Subject|3|||
94348333|NCT05375838|323056106|FG003|Overall Study|Withdrawal by Subject|2|||
94348334|NCT05375838|323056107|FG004|Overall Study|Withdrawal by Subject|2|||
94348335|NCT05375838|323056108|FG005|Overall Study|Withdrawal by Subject|0|||
94348336|NCT05375838|323056103|FG000|Overall Study|Protocol Violation|0|||
94348337|NCT05375838|323056104|FG001|Overall Study|Protocol Violation|0|||
94348338|NCT05375838|323056105|FG002|Overall Study|Protocol Violation|0|||
94348339|NCT05375838|323056106|FG003|Overall Study|Protocol Violation|0|||
94348340|NCT05375838|323056107|FG004|Overall Study|Protocol Violation|1|||
94348341|NCT05375838|323056108|FG005|Overall Study|Protocol Violation|0|||
94348342|NCT05375838|323056103|FG000|Overall Study|Physician Decision|0|||
94348343|NCT05375838|323056104|FG001|Overall Study|Physician Decision|1|||
94348344|NCT05375838|323056105|FG002|Overall Study|Physician Decision|0|||
94348345|NCT05375838|323056106|FG003|Overall Study|Physician Decision|0|||
94348346|NCT05375838|323056107|FG004|Overall Study|Physician Decision|0|||
94348347|NCT05375838|323056108|FG005|Overall Study|Physician Decision|1|||
94348348|NCT05375838|323056103|FG000|Overall Study|Lost to Follow-up|2|||
94348349|NCT05375838|323056104|FG001|Overall Study|Lost to Follow-up|7|||
94348350|NCT05375838|323056105|FG002|Overall Study|Lost to Follow-up|0|||
94348351|NCT05375838|323056106|FG003|Overall Study|Lost to Follow-up|4|||
94348352|NCT05375838|323056107|FG004|Overall Study|Lost to Follow-up|2|||
94348353|NCT05375838|323056108|FG005|Overall Study|Lost to Follow-up|3|||
94569596|NCT05801991|323882935|FG001|Overall Study|Lost to Follow-up|0|||
94658787|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
94658788|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
94658789|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
94658790|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
94569597|NCT03016312|323882936|FG000|Overall Study|discontinued before the treatment started|0|||
94569598|NCT03016312|323882937|FG001|Overall Study|discontinued before the treatment started|1|||
94348354|NCT00656799|323056109|FG000|Overall Study|Death|2|||
94348355|NCT01225211|323056110|FG000|Overall Study|Adverse Event|0|||
94348356|NCT01225211|323056111|FG001|Overall Study|Adverse Event|0|||
94348357|NCT01225211|323056112|FG002|Overall Study|Adverse Event|1|||
94348358|NCT01225211|323056113|FG003|Overall Study|Adverse Event|0|||
94348359|NCT01225211|323056114|FG004|Overall Study|Adverse Event|0|||
94348360|NCT01225211|323056115|FG005|Overall Study|Adverse Event|0|||
94238005|NCT02271984|322666526|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
94238006|NCT02271984|322666527|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
94238007|NCT02271984|322666528|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
94238008|NCT02271984|322666529|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
94238009|NCT02271984|322666530|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
94238010|NCT02271984|322666531|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
94238011|NCT02271984|322666532|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
94238012|NCT03258723|322666533|FG000|Overall Study|COVID Interruption of study|54|||
94238013|NCT03258723|322666533|FG000|Overall Study|Lost to Follow-up|8|||
94238014|NCT01952847|322666536|FG000|Overall Study|Ineligible|1|||
94238015|NCT01952847|322666537|FG001|Overall Study|Ineligible|0|||
94238016|NCT01952847|322666538|FG002|Overall Study|Ineligible|0|||
94238017|NCT01952847|322666539|FG003|Overall Study|Ineligible|0|||
94238018|NCT01952847|322666536|FG000|Overall Study|Lack of Insurance Coverage|0|||
94238019|NCT01952847|322666537|FG001|Overall Study|Lack of Insurance Coverage|1|||
94348361|NCT01225211|323056116|FG006|Overall Study|Adverse Event|0|||
94238020|NCT01952847|322666538|FG002|Overall Study|Lack of Insurance Coverage|0|||
94238021|NCT01952847|322666539|FG003|Overall Study|Lack of Insurance Coverage|0|||
94238022|NCT01952847|322666536|FG000|Overall Study|Withdrawal by Subject|1|||
94238023|NCT01952847|322666537|FG001|Overall Study|Withdrawal by Subject|1|||
94569599|NCT03016312|323882936|FG000|Overall Study|Withdrawal by Subject|37|||
94569600|NCT03016312|323882937|FG001|Overall Study|Withdrawal by Subject|44|||
94569601|NCT03016312|323882936|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
94569602|NCT03016312|323882937|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
94569603|NCT03016312|323882936|FG000|Overall Study|Physician Decision|1|||
94569604|NCT03016312|323882937|FG001|Overall Study|Physician Decision|3|||
94569605|NCT03016312|323882936|FG000|Overall Study|Lost to Follow-up|12|||
94569606|NCT03016312|323882937|FG001|Overall Study|Lost to Follow-up|12|||
94569607|NCT03016312|323882936|FG000|Overall Study|Death|210|||
94569608|NCT03016312|323882937|FG001|Overall Study|Death|184|||
94569609|NCT03016312|323882936|FG000|Overall Study|loss to contact|1|||
94569610|NCT03016312|323882937|FG001|Overall Study|loss to contact|0|||
94569611|NCT03016312|323882936|FG000|Overall Study|started a new cancer therapy|1|||
94569612|NCT03016312|323882937|FG001|Overall Study|started a new cancer therapy|0|||
94569613|NCT01451723|323882941|FG000|Overall Study|study halted|6|||
94569614|NCT01451723|323882942|FG001|Overall Study|study halted|5|||
94569615|NCT02730728|323882943|FG000|Overall Study|Withdrawal by Subject|0|||
94569616|NCT02730728|323882944|FG001|Overall Study|Withdrawal by Subject|1|||
94569617|NCT02730728|323882945|FG002|Overall Study|Withdrawal by Subject|0|||
94569618|NCT02730728|323882943|FG000|Overall Study|Lack of Efficacy|0|||
94569619|NCT02730728|323882944|FG001|Overall Study|Lack of Efficacy|1|||
94569620|NCT02730728|323882945|FG002|Overall Study|Lack of Efficacy|1|||
94569621|NCT00922623|323882946|FG000|Overall Study|Other|4|||
94569622|NCT00922623|323882946|FG000|Overall Study|Lost to Follow-up|1|||
94569623|NCT03347123|323882948|FG000|Overall Study|Death|1|||
94569624|NCT03347123|323882949|FG001|Overall Study|Death|2|||
94569625|NCT03347123|323882950|FG002|Overall Study|Death|0|||
94569626|NCT03347123|323882951|FG003|Overall Study|Death|0|||
94569627|NCT03347123|323882952|FG004|Overall Study|Death|0|||
94569628|NCT03347123|323882953|FG005|Overall Study|Death|0|||
94569629|NCT03347123|323882954|FG006|Overall Study|Death|0|||
94569630|NCT03347123|323882948|FG000|Overall Study|Withdrawal by Subject|1|||
94569631|NCT03347123|323882949|FG001|Overall Study|Withdrawal by Subject|0|||
94569632|NCT03347123|323882950|FG002|Overall Study|Withdrawal by Subject|0|||
94569633|NCT03347123|323882951|FG003|Overall Study|Withdrawal by Subject|0|||
94569634|NCT03347123|323882952|FG004|Overall Study|Withdrawal by Subject|0|||
94569635|NCT03347123|323882953|FG005|Overall Study|Withdrawal by Subject|0|||
94569636|NCT03347123|323882954|FG006|Overall Study|Withdrawal by Subject|0|||
94569637|NCT03347123|323882948|FG000|Overall Study|Reason not Specified|3|||
94569638|NCT03347123|323882949|FG001|Overall Study|Reason not Specified|4|||
94569639|NCT03347123|323882950|FG002|Overall Study|Reason not Specified|0|||
94569640|NCT03347123|323882951|FG003|Overall Study|Reason not Specified|0|||
94569641|NCT03347123|323882952|FG004|Overall Study|Reason not Specified|0|||
94569642|NCT03347123|323882953|FG005|Overall Study|Reason not Specified|0|||
94569643|NCT03347123|323882954|FG006|Overall Study|Reason not Specified|0|||
94569644|NCT02995980|323882959|FG000|Overall Study|Lost to Follow-up|14|||
94569645|NCT01458639|323882964|FG000|Overall Study|Physician Decision|4|||
94569646|NCT01458639|323882964|FG000|Overall Study|Equipment issue|1|||
94569647|NCT01458639|323882964|FG000|Overall Study|Inability to obtain subject blood sample|1|||
94569648|NCT00866177|323882965|FG000|Overall Study|Withdrawal by Subject|1|||
94569649|NCT00866177|323882965|FG000|Overall Study|Not Treated|151|||
94569650|NCT02792231|323882977|FG000|Overall Study|Patient/guardian decision|32|||
94569651|NCT02792231|323882978|FG001|Overall Study|Patient/guardian decision|42|||
94569652|NCT02792231|323882977|FG000|Overall Study|Adverse Event|15|||
94569653|NCT02792231|323882978|FG001|Overall Study|Adverse Event|11|||
94238024|NCT01952847|322666538|FG002|Overall Study|Withdrawal by Subject|0|||
94569654|NCT02792231|323882977|FG000|Overall Study|Physician Decision|14|||
94569655|NCT02792231|323882978|FG001|Overall Study|Physician Decision|12|||
94569656|NCT02792231|323882977|FG000|Overall Study|Lack of Efficacy|7|||
94569657|NCT02792231|323882978|FG001|Overall Study|Lack of Efficacy|9|||
94569658|NCT02792231|323882977|FG000|Overall Study|Lost to Follow-up|9|||
94569659|NCT02792231|323882978|FG001|Overall Study|Lost to Follow-up|5|||
94569660|NCT02792231|323882977|FG000|Overall Study|Pregnancy|1|||
94569661|NCT02792231|323882978|FG001|Overall Study|Pregnancy|3|||
94569662|NCT02792231|323882977|FG000|Overall Study|Non-compliance with study treatment|2|||
94569663|NCT02792231|323882978|FG001|Overall Study|Non-compliance with study treatment|1|||
94569664|NCT02792231|323882977|FG000|Overall Study|Protocol deviation|2|||
94569665|NCT02792231|323882978|FG001|Overall Study|Protocol deviation|0|||
94569666|NCT02792231|323882977|FG000|Overall Study|Technical problems|0|||
94569667|NCT02792231|323882978|FG001|Overall Study|Technical problems|1|||
94569668|NCT01096316|323882979|FG000|Overall Study|Lost to Follow-up|15|||
94569669|NCT01096316|323882980|FG001|Overall Study|Lost to Follow-up|9|||
94569670|NCT01884077|323882981|FG000|Overall Study|screen fail|0|||
94569671|NCT01884077|323882982|FG001|Overall Study|screen fail|2|||
94569672|NCT01884077|323882981|FG000|Overall Study|canceled surgery|2|||
94569673|NCT01884077|323882982|FG001|Overall Study|canceled surgery|0|||
94569674|NCT01884077|323882981|FG000|Overall Study|Lost to Follow-up|0|||
94569675|NCT01884077|323882982|FG001|Overall Study|Lost to Follow-up|4|||
94569676|NCT01884077|323882981|FG000|Overall Study|study closed|6|||
94569677|NCT01884077|323882982|FG001|Overall Study|study closed|4|||
94569678|NCT02349633|323882984|FG000|Overall Study|Death|0|||
94569679|NCT02349633|323882985|FG001|Overall Study|Death|1|||
94569680|NCT02349633|323882986|FG002|Overall Study|Death|0|||
94569681|NCT02349633|323882987|FG003|Overall Study|Death|0|||
94569682|NCT02349633|323882988|FG004|Overall Study|Death|0|||
94569683|NCT02349633|323882989|FG005|Overall Study|Death|1|||
94569684|NCT02349633|323882990|FG006|Overall Study|Death|1|||
94569685|NCT02349633|323882991|FG007|Overall Study|Death|1|||
94569686|NCT02349633|323882992|FG008|Overall Study|Death|0|||
94569687|NCT02349633|323882993|FG009|Overall Study|Death|1|||
94569688|NCT02349633|323882994|FG010|Overall Study|Death|0|||
94569689|NCT02349633|323882995|FG011|Overall Study|Death|0|||
94569690|NCT02349633|323882996|FG012|Overall Study|Death|0|||
94569691|NCT02349633|323882997|FG013|Overall Study|Death|0|||
94569692|NCT02349633|323882984|FG000|Overall Study|Withdrawal by Subject|0|||
94569693|NCT02349633|323882985|FG001|Overall Study|Withdrawal by Subject|0|||
94569694|NCT02349633|323882986|FG002|Overall Study|Withdrawal by Subject|0|||
94569695|NCT02349633|323882987|FG003|Overall Study|Withdrawal by Subject|1|||
94569696|NCT02349633|323882988|FG004|Overall Study|Withdrawal by Subject|0|||
94569697|NCT02349633|323882989|FG005|Overall Study|Withdrawal by Subject|0|||
94569698|NCT02349633|323882990|FG006|Overall Study|Withdrawal by Subject|0|||
94569699|NCT02349633|323882991|FG007|Overall Study|Withdrawal by Subject|2|||
94569700|NCT02349633|323882992|FG008|Overall Study|Withdrawal by Subject|2|||
94569701|NCT02349633|323882993|FG009|Overall Study|Withdrawal by Subject|1|||
94569702|NCT02349633|323882994|FG010|Overall Study|Withdrawal by Subject|0|||
94569703|NCT02349633|323882995|FG011|Overall Study|Withdrawal by Subject|0|||
94569704|NCT02349633|323882996|FG012|Overall Study|Withdrawal by Subject|0|||
94569705|NCT02349633|323882997|FG013|Overall Study|Withdrawal by Subject|0|||
94569706|NCT02349633|323882984|FG000|Overall Study|Withdrawal of informed consent|0|||
94569707|NCT02349633|323882985|FG001|Overall Study|Withdrawal of informed consent|0|||
94569708|NCT02349633|323882986|FG002|Overall Study|Withdrawal of informed consent|0|||
94569709|NCT02349633|323882987|FG003|Overall Study|Withdrawal of informed consent|1|||
94569710|NCT02349633|323882988|FG004|Overall Study|Withdrawal of informed consent|1|||
94569711|NCT02349633|323882989|FG005|Overall Study|Withdrawal of informed consent|0|||
94569712|NCT02349633|323882990|FG006|Overall Study|Withdrawal of informed consent|0|||
94569713|NCT02349633|323882991|FG007|Overall Study|Withdrawal of informed consent|3|||
94569714|NCT02349633|323882992|FG008|Overall Study|Withdrawal of informed consent|0|||
94569715|NCT02349633|323882993|FG009|Overall Study|Withdrawal of informed consent|0|||
94569716|NCT02349633|323882994|FG010|Overall Study|Withdrawal of informed consent|0|||
94569717|NCT02349633|323882995|FG011|Overall Study|Withdrawal of informed consent|0|||
94569718|NCT02349633|323882996|FG012|Overall Study|Withdrawal of informed consent|0|||
94569719|NCT02349633|323882997|FG013|Overall Study|Withdrawal of informed consent|0|||
94569720|NCT02349633|323882984|FG000|Overall Study|Transition to compassionate use|0|||
94569721|NCT02349633|323882985|FG001|Overall Study|Transition to compassionate use|0|||
94569722|NCT02349633|323882986|FG002|Overall Study|Transition to compassionate use|0|||
94569723|NCT02349633|323882987|FG003|Overall Study|Transition to compassionate use|0|||
94569724|NCT02349633|323882988|FG004|Overall Study|Transition to compassionate use|1|||
94569725|NCT02349633|323882989|FG005|Overall Study|Transition to compassionate use|0|||
94569726|NCT02349633|323882990|FG006|Overall Study|Transition to compassionate use|0|||
94569727|NCT02349633|323882991|FG007|Overall Study|Transition to compassionate use|3|||
94569728|NCT02349633|323882992|FG008|Overall Study|Transition to compassionate use|0|||
94569729|NCT02349633|323882993|FG009|Overall Study|Transition to compassionate use|1|||
94569730|NCT02349633|323882994|FG010|Overall Study|Transition to compassionate use|0|||
94569731|NCT02349633|323882995|FG011|Overall Study|Transition to compassionate use|0|||
94569732|NCT02349633|323882996|FG012|Overall Study|Transition to compassionate use|0|||
94569733|NCT02349633|323882997|FG013|Overall Study|Transition to compassionate use|0|||
94569734|NCT02349633|323882984|FG000|Overall Study|Early termination of survival follow-up|0|||
94569735|NCT02349633|323882985|FG001|Overall Study|Early termination of survival follow-up|0|||
94569736|NCT02349633|323882986|FG002|Overall Study|Early termination of survival follow-up|0|||
94569737|NCT02349633|323882987|FG003|Overall Study|Early termination of survival follow-up|0|||
94569738|NCT02349633|323882988|FG004|Overall Study|Early termination of survival follow-up|0|||
94569739|NCT02349633|323882989|FG005|Overall Study|Early termination of survival follow-up|0|||
94569740|NCT02349633|323882990|FG006|Overall Study|Early termination of survival follow-up|0|||
94569741|NCT02349633|323882991|FG007|Overall Study|Early termination of survival follow-up|4|||
94569742|NCT02349633|323882992|FG008|Overall Study|Early termination of survival follow-up|0|||
94569743|NCT02349633|323882993|FG009|Overall Study|Early termination of survival follow-up|0|||
94569744|NCT02349633|323882994|FG010|Overall Study|Early termination of survival follow-up|0|||
94569745|NCT02349633|323882995|FG011|Overall Study|Early termination of survival follow-up|0|||
94569746|NCT02349633|323882996|FG012|Overall Study|Early termination of survival follow-up|0|||
94569747|NCT02349633|323882997|FG013|Overall Study|Early termination of survival follow-up|0|||
94569748|NCT02349633|323882984|FG000|Overall Study|Termination by sponsor|0|||
94569749|NCT02349633|323882985|FG001|Overall Study|Termination by sponsor|0|||
94569750|NCT02349633|323882986|FG002|Overall Study|Termination by sponsor|0|||
94569751|NCT02349633|323882987|FG003|Overall Study|Termination by sponsor|0|||
94569752|NCT02349633|323882988|FG004|Overall Study|Termination by sponsor|0|||
94569753|NCT02349633|323882989|FG005|Overall Study|Termination by sponsor|0|||
94569754|NCT02349633|323882990|FG006|Overall Study|Termination by sponsor|0|||
94569755|NCT02349633|323882991|FG007|Overall Study|Termination by sponsor|1|||
94569756|NCT02349633|323882992|FG008|Overall Study|Termination by sponsor|0|||
94569757|NCT02349633|323882993|FG009|Overall Study|Termination by sponsor|2|||
94569758|NCT02349633|323882994|FG010|Overall Study|Termination by sponsor|0|||
94569759|NCT02349633|323882995|FG011|Overall Study|Termination by sponsor|0|||
94569760|NCT02349633|323882996|FG012|Overall Study|Termination by sponsor|0|||
94569761|NCT02349633|323882997|FG013|Overall Study|Termination by sponsor|0|||
94569762|NCT02349633|323882984|FG000|Overall Study|Other|0|||
94569763|NCT02349633|323882985|FG001|Overall Study|Other|0|||
94569764|NCT02349633|323882986|FG002|Overall Study|Other|0|||
94569765|NCT02349633|323882987|FG003|Overall Study|Other|0|||
94569766|NCT02349633|323882988|FG004|Overall Study|Other|0|||
94569767|NCT02349633|323882989|FG005|Overall Study|Other|0|||
94569768|NCT02349633|323882990|FG006|Overall Study|Other|0|||
94569769|NCT02349633|323882991|FG007|Overall Study|Other|2|||
94569770|NCT02349633|323882992|FG008|Overall Study|Other|0|||
94569771|NCT02349633|323882993|FG009|Overall Study|Other|0|||
94569772|NCT02349633|323882994|FG010|Overall Study|Other|0|||
94569773|NCT02349633|323882995|FG011|Overall Study|Other|0|||
94569774|NCT02349633|323882996|FG012|Overall Study|Other|0|||
94569775|NCT02349633|323882997|FG013|Overall Study|Other|0|||
94569776|NCT00981149|323882999|FG000|Overall Study|Lost to Follow-up|1|||
94569777|NCT00981149|323883000|FG001|Overall Study|Lost to Follow-up|2|||
94569778|NCT00981149|323882999|FG000|Overall Study|Withdrawal by Subject|1|||
94569779|NCT00981149|323883000|FG001|Overall Study|Withdrawal by Subject|1|||
94569780|NCT01285401|323883001|FG000|Overall Study|Prematurely withdrawn from the study|17|||
94569781|NCT01285401|323883002|FG001|Overall Study|Prematurely withdrawn from the study|29|||
94569782|NCT01008943|323883006|FG000|Overall Study|Withdrawal by Subject|1|||
94569783|NCT00619515|323883007|FG000|Overall Study|Study Termination by IRB|73|||
94569784|NCT02159066|323883009|FG000|Part I|Adverse Event|7|||
94569785|NCT02159066|323883010|FG001|Part I|Adverse Event|5|||
94569786|NCT02159066|323883011|FG002|Part I|Adverse Event|0|||
94569787|NCT02159066|323883012|FG003|Part I|Adverse Event|0|||
94569788|NCT02159066|323883013|FG004|Part I|Adverse Event|0|||
94569789|NCT02159066|323883014|FG005|Part I|Adverse Event|0|||
94569790|NCT02159066|323883009|FG000|Part I|Death|11|||
94569791|NCT02159066|323883010|FG001|Part I|Death|9|||
94569792|NCT02159066|323883011|FG002|Part I|Death|0|||
94569793|NCT02159066|323883012|FG003|Part I|Death|0|||
94569794|NCT02159066|323883013|FG004|Part I|Death|0|||
94569795|NCT02159066|323883014|FG005|Part I|Death|0|||
94569796|NCT02159066|323883009|FG000|Part I|Progressive Disease|37|||
94569797|NCT02159066|323883010|FG001|Part I|Progressive Disease|46|||
94569798|NCT02159066|323883011|FG002|Part I|Progressive Disease|0|||
94569799|NCT02159066|323883012|FG003|Part I|Progressive Disease|0|||
94569800|NCT02159066|323883013|FG004|Part I|Progressive Disease|0|||
94569801|NCT02159066|323883014|FG005|Part I|Progressive Disease|0|||
94238025|NCT01952847|322666539|FG003|Overall Study|Withdrawal by Subject|1|||
94569802|NCT02159066|323883009|FG000|Part I|New Therapy for Study Indication|5|||
94569803|NCT02159066|323883010|FG001|Part I|New Therapy for Study Indication|4|||
94569804|NCT02159066|323883011|FG002|Part I|New Therapy for Study Indication|0|||
94569805|NCT02159066|323883012|FG003|Part I|New Therapy for Study Indication|0|||
94238026|NCT01784523|322666540|FG000|Overall Study|Study closed early|7|||
94238027|NCT01784523|322666541|FG001|Overall Study|Study closed early|4|||
94238028|NCT00979953|322666544|FG000|Overall Study|Adverse Event|5|||
94238029|NCT00979953|322666545|FG001|Overall Study|Adverse Event|2|||
94569806|NCT02159066|323883013|FG004|Part I|New Therapy for Study Indication|0|||
94569807|NCT02159066|323883014|FG005|Part I|New Therapy for Study Indication|0|||
94569808|NCT02159066|323883009|FG000|Part I|Termination of participants from the study|3|||
94569809|NCT02159066|323883010|FG001|Part I|Termination of participants from the study|3|||
94569810|NCT02159066|323883011|FG002|Part I|Termination of participants from the study|0|||
94569811|NCT02159066|323883012|FG003|Part I|Termination of participants from the study|0|||
94569812|NCT02159066|323883013|FG004|Part I|Termination of participants from the study|0|||
94569813|NCT02159066|323883014|FG005|Part I|Termination of participants from the study|0|||
94569814|NCT02159066|323883009|FG000|Part I|Physician Decision|2|||
94569815|NCT02159066|323883010|FG001|Part I|Physician Decision|9|||
94569816|NCT02159066|323883011|FG002|Part I|Physician Decision|0|||
94569817|NCT02159066|323883012|FG003|Part I|Physician Decision|0|||
94569818|NCT02159066|323883013|FG004|Part I|Physician Decision|0|||
94569819|NCT02159066|323883014|FG005|Part I|Physician Decision|0|||
94569820|NCT02159066|323883009|FG000|Part I|Participant/Guardian Decision|9|||
94569821|NCT02159066|323883010|FG001|Part I|Participant/Guardian Decision|3|||
94569822|NCT02159066|323883011|FG002|Part I|Participant/Guardian Decision|0|||
94569823|NCT02159066|323883012|FG003|Part I|Participant/Guardian Decision|0|||
94569824|NCT02159066|323883013|FG004|Part I|Participant/Guardian Decision|0|||
94569825|NCT02159066|323883014|FG005|Part I|Participant/Guardian Decision|0|||
94569826|NCT02159066|323883009|FG000|Part I|Missing Data|1|||
94569827|NCT02159066|323883010|FG001|Part I|Missing Data|0|||
94569828|NCT02159066|323883011|FG002|Part I|Missing Data|0|||
94569829|NCT02159066|323883012|FG003|Part I|Missing Data|0|||
94569830|NCT02159066|323883013|FG004|Part I|Missing Data|0|||
94569831|NCT02159066|323883014|FG005|Part I|Missing Data|0|||
94569832|NCT02159066|323883009|FG000|Part II|Adverse Event|0|||
94569833|NCT02159066|323883010|FG001|Part II|Adverse Event|0|||
94569834|NCT02159066|323883011|FG002|Part II|Adverse Event|1|||
94569835|NCT02159066|323883012|FG003|Part II|Adverse Event|0|||
94569836|NCT02159066|323883013|FG004|Part II|Adverse Event|1|||
94569837|NCT02159066|323883014|FG005|Part II|Adverse Event|1|||
94569838|NCT02159066|323883009|FG000|Part II|Death|0|||
94569839|NCT02159066|323883010|FG001|Part II|Death|0|||
94569840|NCT02159066|323883011|FG002|Part II|Death|1|||
94569841|NCT02159066|323883012|FG003|Part II|Death|0|||
94569842|NCT02159066|323883013|FG004|Part II|Death|2|||
94569843|NCT02159066|323883014|FG005|Part II|Death|1|||
94569844|NCT02159066|323883009|FG000|Part II|Progressive Disease|0|||
94569845|NCT02159066|323883010|FG001|Part II|Progressive Disease|0|||
94569846|NCT02159066|323883011|FG002|Part II|Progressive Disease|35|||
94569847|NCT02159066|323883012|FG003|Part II|Progressive Disease|1|||
94451474|NCT00154284|323441748|FG000|Overall Study|Adverse Event|6|||
94451475|NCT00154284|323441749|FG001|Overall Study|Adverse Event|9|||
94451476|NCT00154284|323441748|FG000|Overall Study|Abnormal laboratory value(s)|0|||
94451477|NCT00154284|323441749|FG001|Overall Study|Abnormal laboratory value(s)|1|||
94451478|NCT00154284|323441748|FG000|Overall Study|Lack of Efficacy|1|||
94451479|NCT00154284|323441749|FG001|Overall Study|Lack of Efficacy|2|||
94451480|NCT00154284|323441748|FG000|Overall Study|Protocol Violation|0|||
94451481|NCT00154284|323441749|FG001|Overall Study|Protocol Violation|1|||
94348362|NCT01225211|323056117|FG007|Overall Study|Adverse Event|0|||
94348363|NCT01225211|323056118|FG008|Overall Study|Adverse Event|0|||
94348364|NCT01225211|323056119|FG009|Overall Study|Adverse Event|1|||
94451482|NCT00593684|323441750|FG000|Overall Study|Death|2|||
94451483|NCT00593684|323441751|FG001|Overall Study|Death|1|||
94451484|NCT00078767|323441752|FG000|Overall Study|Withdrawal by Subject|1|||
94451485|NCT00078767|323441753|FG001|Overall Study|Withdrawal by Subject|1|||
94348365|NCT01225211|323056110|FG000|Overall Study|Withdrawal by Subject|0|||
94348366|NCT01225211|323056111|FG001|Overall Study|Withdrawal by Subject|0|||
94348367|NCT01225211|323056112|FG002|Overall Study|Withdrawal by Subject|0|||
94451486|NCT00932373|323441756|FG000|Overall Study|Progressive disease|3|||
94451487|NCT00932373|323441757|FG001|Overall Study|Progressive disease|1|||
94451488|NCT00932373|323441758|FG002|Overall Study|Progressive disease|0|||
94451489|NCT00932373|323441759|FG003|Overall Study|Progressive disease|0|||
94451490|NCT00932373|323441760|FG004|Overall Study|Progressive disease|10|||
94348368|NCT01225211|323056113|FG003|Overall Study|Withdrawal by Subject|0|||
94348369|NCT01225211|323056114|FG004|Overall Study|Withdrawal by Subject|0|||
94451491|NCT00932373|323441761|FG005|Overall Study|Progressive disease|1|||
94569848|NCT02159066|323883013|FG004|Part II|Progressive Disease|7|||
94569849|NCT02159066|323883014|FG005|Part II|Progressive Disease|4|||
94569850|NCT02159066|323883009|FG000|Part II|New Therapy for Study Indication|0|||
94451492|NCT00932373|323441762|FG006|Overall Study|Progressive disease|0|||
94451493|NCT00932373|323441763|FG007|Overall Study|Progressive disease|2|||
94569851|NCT02159066|323883010|FG001|Part II|New Therapy for Study Indication|0|||
94569852|NCT02159066|323883011|FG002|Part II|New Therapy for Study Indication|0|||
94569853|NCT02159066|323883012|FG003|Part II|New Therapy for Study Indication|0|||
94451494|NCT00932373|323441764|FG008|Overall Study|Progressive disease|1|||
94451495|NCT00932373|323441765|FG009|Overall Study|Progressive disease|9|||
94451496|NCT00932373|323441766|FG010|Overall Study|Progressive disease|2|||
94451497|NCT00932373|323441756|FG000|Overall Study|Adverse Event|0|||
94451498|NCT00932373|323441757|FG001|Overall Study|Adverse Event|0|||
94451499|NCT00932373|323441758|FG002|Overall Study|Adverse Event|0|||
94451500|NCT00932373|323441759|FG003|Overall Study|Adverse Event|0|||
94451501|NCT00932373|323441760|FG004|Overall Study|Adverse Event|2|||
94451502|NCT00932373|323441761|FG005|Overall Study|Adverse Event|1|||
94451503|NCT00932373|323441762|FG006|Overall Study|Adverse Event|0|||
94451504|NCT00932373|323441763|FG007|Overall Study|Adverse Event|1|||
94451505|NCT00932373|323441764|FG008|Overall Study|Adverse Event|0|||
94451506|NCT00932373|323441765|FG009|Overall Study|Adverse Event|2|||
94451507|NCT00932373|323441766|FG010|Overall Study|Adverse Event|1|||
94451508|NCT00932373|323441756|FG000|Overall Study|Physician Decision|0|||
94451509|NCT00932373|323441757|FG001|Overall Study|Physician Decision|0|||
94451510|NCT00932373|323441758|FG002|Overall Study|Physician Decision|1|||
94451511|NCT00932373|323441759|FG003|Overall Study|Physician Decision|0|||
94451512|NCT00932373|323441760|FG004|Overall Study|Physician Decision|2|||
94451513|NCT00932373|323441761|FG005|Overall Study|Physician Decision|0|||
94451514|NCT00932373|323441762|FG006|Overall Study|Physician Decision|0|||
94451515|NCT00932373|323441763|FG007|Overall Study|Physician Decision|0|||
94451516|NCT00932373|323441764|FG008|Overall Study|Physician Decision|0|||
94451517|NCT00932373|323441765|FG009|Overall Study|Physician Decision|1|||
94451518|NCT00932373|323441766|FG010|Overall Study|Physician Decision|0|||
94451519|NCT00932373|323441756|FG000|Overall Study|Dose limiting toxicity|0|||
94451520|NCT00932373|323441757|FG001|Overall Study|Dose limiting toxicity|0|||
94451521|NCT00932373|323441758|FG002|Overall Study|Dose limiting toxicity|0|||
94451522|NCT00932373|323441759|FG003|Overall Study|Dose limiting toxicity|0|||
94451523|NCT00932373|323441760|FG004|Overall Study|Dose limiting toxicity|0|||
94451524|NCT00932373|323441761|FG005|Overall Study|Dose limiting toxicity|1|||
94451525|NCT00932373|323441762|FG006|Overall Study|Dose limiting toxicity|0|||
94451526|NCT00932373|323441763|FG007|Overall Study|Dose limiting toxicity|0|||
94451527|NCT00932373|323441764|FG008|Overall Study|Dose limiting toxicity|0|||
94451528|NCT00932373|323441765|FG009|Overall Study|Dose limiting toxicity|0|||
94451529|NCT00932373|323441766|FG010|Overall Study|Dose limiting toxicity|0|||
94451530|NCT00932373|323441756|FG000|Overall Study|Withdrawal by Subject|0|||
94451531|NCT00932373|323441757|FG001|Overall Study|Withdrawal by Subject|0|||
94451532|NCT00932373|323441758|FG002|Overall Study|Withdrawal by Subject|0|||
94451533|NCT00932373|323441759|FG003|Overall Study|Withdrawal by Subject|0|||
94569854|NCT02159066|323883013|FG004|Part II|New Therapy for Study Indication|1|||
94569855|NCT02159066|323883014|FG005|Part II|New Therapy for Study Indication|0|||
94569856|NCT02159066|323883009|FG000|Part II|Physician Decision|0|||
94569857|NCT02159066|323883010|FG001|Part II|Physician Decision|0|||
94569858|NCT02159066|323883011|FG002|Part II|Physician Decision|1|||
94569859|NCT02159066|323883012|FG003|Part II|Physician Decision|0|||
94569860|NCT02159066|323883013|FG004|Part II|Physician Decision|0|||
94569861|NCT02159066|323883014|FG005|Part II|Physician Decision|0|||
94569862|NCT02159066|323883009|FG000|Part II|Participant/Guardian Decision|0|||
94569863|NCT02159066|323883010|FG001|Part II|Participant/Guardian Decision|0|||
94569864|NCT02159066|323883011|FG002|Part II|Participant/Guardian Decision|0|||
94569865|NCT02159066|323883012|FG003|Part II|Participant/Guardian Decision|0|||
94569866|NCT02159066|323883013|FG004|Part II|Participant/Guardian Decision|2|||
94569867|NCT02159066|323883014|FG005|Part II|Participant/Guardian Decision|0|||
94569868|NCT03206216|323883018|FG000|Overall Study|Withdrawal by Subject|0|||
94569869|NCT03206216|323883019|FG001|Overall Study|Withdrawal by Subject|1|||
94569870|NCT01156480|323883021|FG000|Overall Study|change in diagnosis|0|||
94569871|NCT01156480|323883022|FG001|Overall Study|change in diagnosis|1|||
94569872|NCT04739982|323883023|FG000|Overall Study|Lost to Follow-up|176|||
94569873|NCT04739982|323883024|FG001|Overall Study|Lost to Follow-up|65|||
94569874|NCT04739982|323883023|FG000|Overall Study|Withdrawal by Subject|19|||
94569875|NCT04739982|323883024|FG001|Overall Study|Withdrawal by Subject|0|||
94569876|NCT04739982|323883023|FG000|Overall Study|Protocol Violation|0|||
94569877|NCT04739982|323883024|FG001|Overall Study|Protocol Violation|5|||
94569878|NCT02525471|323883033|FG000|Overall Study|Screen Failure|6|||
94569879|NCT02525471|323883033|FG000|Overall Study|Withdrawal by Subject|4|||
94569880|NCT02525471|323883033|FG000|Overall Study|Death|1|||
94569881|NCT00988884|323883034|FG000|Overall Study|Adverse Event|0|||
94569882|NCT00988884|323883035|FG001|Overall Study|Adverse Event|1|||
94569883|NCT00988884|323883034|FG000|Overall Study|Lost to Follow-up|20|||
94451534|NCT00932373|323441760|FG004|Overall Study|Withdrawal by Subject|0|||
94451535|NCT00932373|323441761|FG005|Overall Study|Withdrawal by Subject|0|||
94451536|NCT00932373|323441762|FG006|Overall Study|Withdrawal by Subject|0|||
94451537|NCT00932373|323441763|FG007|Overall Study|Withdrawal by Subject|0|||
94451538|NCT00932373|323441764|FG008|Overall Study|Withdrawal by Subject|1|||
94451539|NCT00932373|323441765|FG009|Overall Study|Withdrawal by Subject|0|||
94451540|NCT00932373|323441766|FG010|Overall Study|Withdrawal by Subject|0|||
94451541|NCT00932373|323441756|FG000|Overall Study|Clinical progression|0|||
94569884|NCT00988884|323883035|FG001|Overall Study|Lost to Follow-up|16|||
94569885|NCT00988884|323883034|FG000|Overall Study|Protocol Violation|0|||
94569886|NCT00988884|323883035|FG001|Overall Study|Protocol Violation|1|||
94569887|NCT00988884|323883034|FG000|Overall Study|Withdrawal by Subject|15|||
94569888|NCT00988884|323883035|FG001|Overall Study|Withdrawal by Subject|18|||
94569889|NCT02738008|323883037|FG000|Overall Study|Study Terminated by Sponsor|1|||
94569890|NCT02738008|323883038|FG001|Overall Study|Study Terminated by Sponsor|5|||
94569891|NCT02738008|323883039|FG002|Overall Study|Study Terminated by Sponsor|3|||
94569892|NCT02738008|323883037|FG000|Overall Study|Adverse Event|0|||
94569893|NCT02738008|323883038|FG001|Overall Study|Adverse Event|1|||
94569894|NCT02738008|323883039|FG002|Overall Study|Adverse Event|2|||
94569895|NCT03883581|323883044|FG000|Overall Study|Withdrawal by Subject|4|||
94569896|NCT01808196|323883045|FG000|Overall Study|Lost to Follow-up|1|||
94569897|NCT04589650|323883048|FG000|Overall Study|Subject decision|6|||
94569898|NCT04589650|323883049|FG001|Overall Study|Subject decision|2|||
94569899|NCT04589650|323883050|FG002|Overall Study|Subject decision|2|||
94569900|NCT04589650|323883051|FG003|Overall Study|Subject decision|0|||
94569901|NCT04589650|323883052|FG004|Overall Study|Subject decision|0|||
94569902|NCT04589650|323883053|FG005|Overall Study|Subject decision|0|||
94569903|NCT04589650|323883048|FG000|Overall Study|Adverse Event|3|||
94569904|NCT04589650|323883049|FG001|Overall Study|Adverse Event|1|||
94569905|NCT04589650|323883050|FG002|Overall Study|Adverse Event|1|||
94569906|NCT04589650|323883051|FG003|Overall Study|Adverse Event|1|||
94569907|NCT04589650|323883052|FG004|Overall Study|Adverse Event|0|||
94569908|NCT04589650|323883053|FG005|Overall Study|Adverse Event|1|||
94569909|NCT04589650|323883048|FG000|Overall Study|Physician Decision|1|||
94569910|NCT04589650|323883049|FG001|Overall Study|Physician Decision|1|||
94569911|NCT04589650|323883050|FG002|Overall Study|Physician Decision|0|||
94569912|NCT04589650|323883051|FG003|Overall Study|Physician Decision|0|||
94569913|NCT04589650|323883052|FG004|Overall Study|Physician Decision|0|||
94569914|NCT04589650|323883053|FG005|Overall Study|Physician Decision|0|||
94569915|NCT04589650|323883048|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
94569916|NCT04589650|323883049|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94569917|NCT04589650|323883050|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
94569918|NCT04589650|323883051|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
94569919|NCT04589650|323883052|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
94569920|NCT04589650|323883053|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
94569921|NCT04589650|323883048|FG000|Overall Study|Death|0|||
94569922|NCT04589650|323883049|FG001|Overall Study|Death|0|||
94569923|NCT04589650|323883050|FG002|Overall Study|Death|0|||
94569924|NCT04589650|323883051|FG003|Overall Study|Death|1|||
94569925|NCT04589650|323883052|FG004|Overall Study|Death|0|||
94569926|NCT04589650|323883053|FG005|Overall Study|Death|0|||
94569927|NCT04589650|323883048|FG000|Overall Study|Guardian Decision|0|||
94569928|NCT04589650|323883049|FG001|Overall Study|Guardian Decision|0|||
94569929|NCT04589650|323883050|FG002|Overall Study|Guardian Decision|0|||
94569930|NCT04589650|323883051|FG003|Overall Study|Guardian Decision|1|||
94569931|NCT04589650|323883052|FG004|Overall Study|Guardian Decision|0|||
94569932|NCT04589650|323883053|FG005|Overall Study|Guardian Decision|0|||
94569933|NCT02539797|323884828|FG000|Overall Study|Lost to Follow-up|0|||
94569934|NCT02539797|323884829|FG001|Overall Study|Lost to Follow-up|1|||
94569935|NCT02539797|323884830|FG002|Overall Study|Lost to Follow-up|0|||
94569936|NCT03057496|323884831|FG000|Overall Study|Withdrawal by Subject|8|||
94569937|NCT03057496|323884831|FG000|Overall Study|Lost to Follow-up|5|||
94569938|NCT03057496|323884831|FG000|Overall Study|Did not use device during home trial|3|||
94569939|NCT03057496|323884831|FG000|Overall Study|Device failure|2|||
94569940|NCT04233801|323884832|FG000|Overall Study|Other than listed|0|||
94569941|NCT04233801|323884833|FG001|Overall Study|Other than listed|0|||
94569942|NCT04233801|323884834|FG002|Overall Study|Other than listed|1|||
94569943|NCT04233801|323884832|FG000|Overall Study|Withdrawal by Subject|0|||
94569944|NCT04233801|323884833|FG001|Overall Study|Withdrawal by Subject|2|||
94569945|NCT04233801|323884834|FG002|Overall Study|Withdrawal by Subject|3|||
94569946|NCT02869633|323884841|FG000|Overall Study|Death|2|||
94569947|NCT02869633|323884842|FG001|Overall Study|Death|1|||
94569948|NCT02869633|323884841|FG000|Overall Study|Patient refused follow-up|1|||
94569949|NCT02869633|323884842|FG001|Overall Study|Patient refused follow-up|0|||
94569950|NCT02869633|323884841|FG000|Overall Study|Provider discretion|1|||
94569951|NCT02869633|323884842|FG001|Overall Study|Provider discretion|0|||
94238030|NCT00979953|322666546|FG002|Overall Study|Adverse Event|17|||
94569952|NCT02869633|323884841|FG000|Overall Study|Investigator decision|1|||
94569953|NCT02869633|323884842|FG001|Overall Study|Investigator decision|0|||
94569954|NCT02869633|323884841|FG000|Overall Study|Lost to Follow-up|0|||
94569955|NCT02869633|323884842|FG001|Overall Study|Lost to Follow-up|1|||
94569956|NCT02869633|323884841|FG000|Overall Study|Not eligible|6|||
94569957|NCT02869633|323884842|FG001|Overall Study|Not eligible|1|||
94569958|NCT02869633|323884841|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
94569959|NCT02869633|323884842|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
94569960|NCT02869633|323884841|FG000|Overall Study|Withdrawal by Subject|0|||
94569961|NCT02869633|323884842|FG001|Overall Study|Withdrawal by Subject|1|||
94569962|NCT04024891|323884843|FG000|Overall Study|Pregnancy|0|||
94569963|NCT04024891|323884844|FG001|Overall Study|Pregnancy|1|||
94569964|NCT00453154|323884845|FG000|Double BIind Maintenance|Adverse Event|0|||
94569965|NCT00453154|323884846|FG001|Double BIind Maintenance|Adverse Event|0|||
94569966|NCT00453154|323884847|FG002|Double BIind Maintenance|Adverse Event|3|||
94569967|NCT00453154|323884848|FG003|Double BIind Maintenance|Adverse Event|12|||
94569968|NCT00453154|323884845|FG000|Double BIind Maintenance|Death|0|||
94569969|NCT00453154|323884846|FG001|Double BIind Maintenance|Death|0|||
94569970|NCT00453154|323884847|FG002|Double BIind Maintenance|Death|2|||
94569971|NCT00453154|323884848|FG003|Double BIind Maintenance|Death|1|||
94569972|NCT00453154|323884845|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
94569973|NCT00453154|323884846|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
94569974|NCT00453154|323884847|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
94569975|NCT00453154|323884848|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
94569976|NCT00453154|323884845|FG000|Double BIind Maintenance|Progression|0|||
94569977|NCT00453154|323884846|FG001|Double BIind Maintenance|Progression|0|||
94569978|NCT00453154|323884847|FG002|Double BIind Maintenance|Progression|29|||
94569979|NCT00453154|323884848|FG003|Double BIind Maintenance|Progression|26|||
94569980|NCT00453154|323884845|FG000|Double BIind Maintenance|Medical Issues|0|||
94569981|NCT00453154|323884846|FG001|Double BIind Maintenance|Medical Issues|0|||
94569982|NCT00453154|323884847|FG002|Double BIind Maintenance|Medical Issues|3|||
94569983|NCT00453154|323884848|FG003|Double BIind Maintenance|Medical Issues|1|||
94569984|NCT00453154|323884845|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
94569985|NCT00453154|323884846|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
94569986|NCT00453154|323884847|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
94569987|NCT00453154|323884848|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
94569988|NCT00791388|323884849|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
94569989|NCT00791388|323884850|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
94569990|NCT00791388|323884851|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
94569991|NCT00791388|323884852|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
94569992|NCT00791388|323884853|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
94569993|NCT00791388|323884849|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
94569994|NCT00791388|323884850|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
94569995|NCT00791388|323884851|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
94569996|NCT00791388|323884852|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
94569997|NCT00791388|323884853|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
94569998|NCT00791388|323884849|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
94569999|NCT00791388|323884850|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
94570000|NCT00791388|323884851|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
94570001|NCT00791388|323884852|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
94570002|NCT00791388|323884853|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
94570003|NCT03070392|323884860|FG000|Overall Study|Not Treated|7|||
94570004|NCT03070392|323884861|FG001|Overall Study|Not Treated|0|||
94570005|NCT03070392|323884862|FG002|Overall Study|Not Treated|3|||
94570006|NCT03070392|323884863|FG003|Overall Study|Not Treated|12|||
94570007|NCT03070392|323884860|FG000|Overall Study|Death|3|||
94570008|NCT03070392|323884861|FG001|Overall Study|Death|0|||
94570009|NCT03070392|323884862|FG002|Overall Study|Death|0|||
94570010|NCT03070392|323884863|FG003|Overall Study|Death|1|||
94570011|NCT03070392|323884860|FG000|Overall Study|Withdrawal by Subject|7|||
94570012|NCT03070392|323884861|FG001|Overall Study|Withdrawal by Subject|0|||
94570013|NCT03070392|323884862|FG002|Overall Study|Withdrawal by Subject|0|||
94570014|NCT03070392|323884863|FG003|Overall Study|Withdrawal by Subject|3|||
94570015|NCT03070392|323884860|FG000|Overall Study|Physician Decision|1|||
94570016|NCT03070392|323884861|FG001|Overall Study|Physician Decision|0|||
94570017|NCT03070392|323884862|FG002|Overall Study|Physician Decision|0|||
94570018|NCT03070392|323884863|FG003|Overall Study|Physician Decision|2|||
94570019|NCT03070392|323884860|FG000|Overall Study|Progressive Disease|154|||
94570020|NCT03070392|323884861|FG001|Overall Study|Progressive Disease|6|||
94570021|NCT03070392|323884862|FG002|Overall Study|Progressive Disease|2|||
94570022|NCT03070392|323884863|FG003|Overall Study|Progressive Disease|70|||
94570023|NCT03070392|323884860|FG000|Overall Study|Adverse Event|6|||
94570024|NCT03070392|323884861|FG001|Overall Study|Adverse Event|1|||
94570025|NCT03070392|323884862|FG002|Overall Study|Adverse Event|1|||
94570026|NCT03070392|323884863|FG003|Overall Study|Adverse Event|3|||
94570027|NCT03070392|323884860|FG000|Overall Study|Alternate anticancer treatment|1|||
94570028|NCT03070392|323884861|FG001|Overall Study|Alternate anticancer treatment|0|||
94570029|NCT03070392|323884862|FG002|Overall Study|Alternate anticancer treatment|0|||
94570030|NCT03070392|323884863|FG003|Overall Study|Alternate anticancer treatment|1|||
94570031|NCT03070392|323884860|FG000|Overall Study|Ongoing|73|||
94570032|NCT03070392|323884861|FG001|Overall Study|Ongoing|0|||
94570033|NCT03070392|323884862|FG002|Overall Study|Ongoing|0|||
94570034|NCT03070392|323884863|FG003|Overall Study|Ongoing|11|||
94238031|NCT00979953|322666547|FG003|Overall Study|Adverse Event|4|||
94238032|NCT00979953|322666544|FG000|Overall Study|Lack of Efficacy|1|||
94238033|NCT00979953|322666545|FG001|Overall Study|Lack of Efficacy|2|||
94570035|NCT03812380|323884865|FG000|Overall Study|Protocol Violation|3|||
94570036|NCT03812380|323884866|FG001|Overall Study|Protocol Violation|3|||
94570037|NCT03812380|323884865|FG000|Overall Study|Withdrawal by Subject|5|||
94570038|NCT03812380|323884866|FG001|Overall Study|Withdrawal by Subject|4|||
94570039|NCT03812380|323884865|FG000|Overall Study|Early termination of study|14|||
94570040|NCT03812380|323884866|FG001|Overall Study|Early termination of study|14|||
94570041|NCT00473434|323884867|FG000|Overall Study|Physician Decision|3|||
94570042|NCT00473434|323884867|FG000|Overall Study|Withdrawal by Subject|9|||
94570043|NCT00473434|323884867|FG000|Overall Study|Compliance|3|||
94570044|NCT00473434|323884867|FG000|Overall Study|Lack of Efficacy|3|||
94570045|NCT00473434|323884867|FG000|Overall Study|Adverse Event|3|||
94570046|NCT00473434|323884867|FG000|Overall Study|Patient was selling medication to others|1|||
94570047|NCT00473434|323884867|FG000|Overall Study|Safety evaluation|1|||
94570048|NCT00473434|323884867|FG000|Overall Study|Reason not specified|6|||
94570049|NCT00473434|323884867|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
94570050|NCT00473434|323884867|FG000|Overall Study|Switching to trial medication|1|||
94570051|NCT00473434|323884867|FG000|Overall Study|No longer required|1|||
94570052|NCT02648204|323884869|FG000|Overall Study|Withdrawal by Subject|12|||
94570053|NCT02648204|323884870|FG001|Overall Study|Withdrawal by Subject|8|||
94570054|NCT02648204|323884871|FG002|Overall Study|Withdrawal by Subject|2|||
94570055|NCT02648204|323884872|FG003|Overall Study|Withdrawal by Subject|6|||
94570056|NCT02648204|323884869|FG000|Overall Study|Lost to Follow-up|5|||
94570057|NCT02648204|323884870|FG001|Overall Study|Lost to Follow-up|8|||
94570058|NCT02648204|323884871|FG002|Overall Study|Lost to Follow-up|4|||
94570059|NCT02648204|323884872|FG003|Overall Study|Lost to Follow-up|6|||
94570060|NCT02648204|323884869|FG000|Overall Study|Missing follow-up information|4|||
94570061|NCT02648204|323884870|FG001|Overall Study|Missing follow-up information|4|||
94570062|NCT02648204|323884871|FG002|Overall Study|Missing follow-up information|4|||
94570063|NCT02648204|323884872|FG003|Overall Study|Missing follow-up information|2|||
94570064|NCT02648204|323884869|FG000|Overall Study|Death|1|||
94570065|NCT02648204|323884870|FG001|Overall Study|Death|1|||
94570066|NCT02648204|323884871|FG002|Overall Study|Death|2|||
94570067|NCT02648204|323884872|FG003|Overall Study|Death|2|||
94570068|NCT02648204|323884869|FG000|Overall Study|Adverse Event|0|||
94570069|NCT02648204|323884870|FG001|Overall Study|Adverse Event|0|||
94570070|NCT02648204|323884871|FG002|Overall Study|Adverse Event|1|||
94570071|NCT02648204|323884872|FG003|Overall Study|Adverse Event|0|||
94570072|NCT02322281|323884873|FG000|Overall Study|Progressive Disease|42|||
94570073|NCT02322281|323884874|FG001|Overall Study|Progressive Disease|14|||
94570074|NCT02322281|323884875|FG002|Overall Study|Progressive Disease|49|||
94570075|NCT02322281|323884873|FG000|Overall Study|Adverse Event|3|||
94570076|NCT02322281|323884874|FG001|Overall Study|Adverse Event|4|||
94570077|NCT02322281|323884875|FG002|Overall Study|Adverse Event|6|||
94570078|NCT02322281|323884873|FG000|Overall Study|Death|3|||
94570079|NCT02322281|323884874|FG001|Overall Study|Death|3|||
94570080|NCT02322281|323884875|FG002|Overall Study|Death|3|||
94238034|NCT00979953|322666546|FG002|Overall Study|Lack of Efficacy|0|||
94238035|NCT00979953|322666547|FG003|Overall Study|Lack of Efficacy|0|||
94238036|NCT00979953|322666544|FG000|Overall Study|Lost to Follow-up|1|||
94238037|NCT00979953|322666545|FG001|Overall Study|Lost to Follow-up|1|||
94238038|NCT00979953|322666546|FG002|Overall Study|Lost to Follow-up|1|||
94238039|NCT00979953|322666547|FG003|Overall Study|Lost to Follow-up|0|||
94570081|NCT02322281|323884873|FG000|Overall Study|Withdrawal by Subject|1|||
94570082|NCT02322281|323884874|FG001|Overall Study|Withdrawal by Subject|1|||
94570083|NCT02322281|323884875|FG002|Overall Study|Withdrawal by Subject|6|||
94570084|NCT02322281|323884873|FG000|Overall Study|Physician Decision|2|||
94570085|NCT02322281|323884874|FG001|Overall Study|Physician Decision|0|||
94570086|NCT02322281|323884875|FG002|Overall Study|Physician Decision|5|||
94570087|NCT02322281|323884873|FG000|Overall Study|Study Terminated by Sponsor|2|||
94570088|NCT02322281|323884874|FG001|Overall Study|Study Terminated by Sponsor|0|||
94570089|NCT02322281|323884875|FG002|Overall Study|Study Terminated by Sponsor|0|||
94570090|NCT02322281|323884873|FG000|Overall Study|Missing|0|||
94570091|NCT02322281|323884874|FG001|Overall Study|Missing|0|||
94570092|NCT02322281|323884875|FG002|Overall Study|Missing|1|||
94570093|NCT02322281|323884873|FG000|Overall Study|Miscellaneous|0|||
94570094|NCT02322281|323884874|FG001|Overall Study|Miscellaneous|0|||
94570095|NCT02322281|323884875|FG002|Overall Study|Miscellaneous|4|||
94570096|NCT02422498|323884879|FG000|Overall Study|Inevaluable|4|||
94570097|NCT01620060|323884880|FG000|Overall Study|Adverse Event|9|||
94570098|NCT01620060|323884880|FG000|Overall Study|Protocol Violation|1|||
94570099|NCT01620060|323884880|FG000|Overall Study|Withdrawal by Subject|1|||
94570100|NCT01620060|323884880|FG000|Overall Study|Did not comply with Study Produre|1|||
94238040|NCT00979953|322666544|FG000|Overall Study|Withdrawal by Subject|0|||
94238041|NCT00979953|322666545|FG001|Overall Study|Withdrawal by Subject|0|||
94238042|NCT00979953|322666546|FG002|Overall Study|Withdrawal by Subject|2|||
94238043|NCT00979953|322666547|FG003|Overall Study|Withdrawal by Subject|1|||
94238044|NCT00979953|322666544|FG000|Overall Study|Protocol Violation|1|||
94238045|NCT00979953|322666545|FG001|Overall Study|Protocol Violation|0|||
94238046|NCT00979953|322666546|FG002|Overall Study|Protocol Violation|2|||
94238047|NCT00979953|322666547|FG003|Overall Study|Protocol Violation|2|||
94238048|NCT04334278|322666551|FG000|Overall Study|Lost to Follow-up|0|||
94570101|NCT01620060|323884880|FG000|Overall Study|Family emergency|1|||
94570102|NCT01620060|323884880|FG000|Overall Study|Per Sponsor Decision|2|||
94570103|NCT01960140|323884881|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
94570104|NCT01255423|323884882|FG000|Overall Study|Abnormal Laboratory value|3|||
94570105|NCT01255423|323884883|FG001|Overall Study|Abnormal Laboratory value|2|||
94570106|NCT01255423|323884882|FG000|Overall Study|Use of prohibited medications|0|||
94570107|NCT01255423|323884883|FG001|Overall Study|Use of prohibited medications|1|||
94570108|NCT00286442|323884886|FG000|Overall Study|Hyperglycemic Rescue|19|||
94238049|NCT04334278|322666552|FG001|Overall Study|Lost to Follow-up|3|||
94238050|NCT04334278|322666551|FG000|Overall Study|Withdrawal by Subject|4|||
94238051|NCT04334278|322666552|FG001|Overall Study|Withdrawal by Subject|2|||
94238052|NCT02577003|322666553|FG000|Overall Study|Adverse Event|2|||
94238053|NCT02577003|322666554|FG001|Overall Study|Adverse Event|4|||
94238054|NCT02577003|322666553|FG000|Overall Study|Withdrawal by Subject|0|||
94238055|NCT02577003|322666554|FG001|Overall Study|Withdrawal by Subject|1|||
94238056|NCT02786004|322666555|FG000|Overall Study|Withdrawal by Subject|0|||
94238057|NCT02786004|322666556|FG001|Overall Study|Withdrawal by Subject|1|||
94238058|NCT01234883|322666557|FG000|Overall Study|Early treatment release|8|||
94238059|NCT01234883|322666558|FG001|Overall Study|Early treatment release|10|||
94238060|NCT01234883|322666557|FG000|Overall Study|Parent/guardian withdrew consent|1|||
94238061|NCT01234883|322666558|FG001|Overall Study|Parent/guardian withdrew consent|2|||
94238062|NCT01234883|322666557|FG000|Overall Study|Technical difficulties with IV infusion|0|||
94570109|NCT00286442|323884887|FG001|Overall Study|Hyperglycemic Rescue|17|||
94570110|NCT00286442|323884888|FG002|Overall Study|Hyperglycemic Rescue|25|||
94570111|NCT00286442|323884886|FG000|Overall Study|Adverse Event|7|||
94570112|NCT00286442|323884887|FG001|Overall Study|Adverse Event|6|||
94570113|NCT00286442|323884888|FG002|Overall Study|Adverse Event|1|||
94570114|NCT00286442|323884886|FG000|Overall Study|Protocol Violation|2|||
94570115|NCT00286442|323884887|FG001|Overall Study|Protocol Violation|4|||
94570116|NCT00286442|323884888|FG002|Overall Study|Protocol Violation|2|||
94570117|NCT00286442|323884886|FG000|Overall Study|Lost to Follow-up|5|||
94570118|NCT00286442|323884887|FG001|Overall Study|Lost to Follow-up|2|||
94570119|NCT00286442|323884888|FG002|Overall Study|Lost to Follow-up|1|||
94570120|NCT00286442|323884886|FG000|Overall Study|Physician Decision|1|||
94570121|NCT00286442|323884887|FG001|Overall Study|Physician Decision|1|||
94570122|NCT00286442|323884888|FG002|Overall Study|Physician Decision|1|||
94570123|NCT00286442|323884886|FG000|Overall Study|Administrative Error|1|||
94570124|NCT00286442|323884887|FG001|Overall Study|Administrative Error|1|||
94570125|NCT00286442|323884888|FG002|Overall Study|Administrative Error|0|||
94570126|NCT00286442|323884886|FG000|Overall Study|Withdrawal by Subject|2|||
94570127|NCT00286442|323884887|FG001|Overall Study|Withdrawal by Subject|14|||
94570128|NCT00286442|323884888|FG002|Overall Study|Withdrawal by Subject|2|||
94570129|NCT02756338|323884889|FG000|Overall Study|Withdrawn by Investigator|1|||
94570130|NCT02756338|323884889|FG000|Overall Study|Device Replaced with Pacemaker|4|||
94570131|NCT04678115|323884894|FG000|Overall Study|Lost to Follow-up|1|||
94570132|NCT04678115|323884895|FG001|Overall Study|Lost to Follow-up|0|||
94570133|NCT04999839|323884896|FG000|Overall Study|Adverse Event|1|||
94570134|NCT04999839|323884897|FG001|Overall Study|Adverse Event|1|||
94570135|NCT04999839|323884898|FG002|Overall Study|Adverse Event|1|||
94570136|NCT04999839|323884899|FG003|Overall Study|Adverse Event|1|||
94570137|NCT04999839|323884900|FG004|Overall Study|Adverse Event|1|||
94570138|NCT04999839|323884896|FG000|Overall Study|Lost to Follow-up|2|||
94570139|NCT04999839|323884897|FG001|Overall Study|Lost to Follow-up|0|||
94238063|NCT01234883|322666558|FG001|Overall Study|Technical difficulties with IV infusion|1|||
94238064|NCT01234883|322666557|FG000|Overall Study|Inclusion/exclusion failure|1|||
94238065|NCT01234883|322666558|FG001|Overall Study|Inclusion/exclusion failure|0|||
94238066|NCT02270671|322666559|FG000|Overall Study|Withdrawal by Subject|1|||
94238067|NCT02270671|322666560|FG001|Overall Study|Withdrawal by Subject|1|||
94570140|NCT04999839|323884898|FG002|Overall Study|Lost to Follow-up|2|||
94570141|NCT04999839|323884899|FG003|Overall Study|Lost to Follow-up|4|||
94570142|NCT04999839|323884900|FG004|Overall Study|Lost to Follow-up|1|||
94570143|NCT04999839|323884896|FG000|Overall Study|Withdrawal by Subject|6|||
94570144|NCT04999839|323884897|FG001|Overall Study|Withdrawal by Subject|5|||
94658791|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
94238068|NCT02270671|322666559|FG000|Overall Study|Protocol Violation|0|||
94238069|NCT02270671|322666560|FG001|Overall Study|Protocol Violation|1|||
94238070|NCT02270671|322666559|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
94570145|NCT04999839|323884898|FG002|Overall Study|Withdrawal by Subject|3|||
94570146|NCT04999839|323884899|FG003|Overall Study|Withdrawal by Subject|2|||
94570147|NCT04999839|323884900|FG004|Overall Study|Withdrawal by Subject|2|||
94570148|NCT04999839|323884896|FG000|Overall Study|Lack of Efficacy|0|||
94570149|NCT04999839|323884897|FG001|Overall Study|Lack of Efficacy|1|||
94570150|NCT04999839|323884898|FG002|Overall Study|Lack of Efficacy|0|||
94570151|NCT04999839|323884899|FG003|Overall Study|Lack of Efficacy|0|||
94238071|NCT02270671|322666560|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
94570152|NCT04999839|323884900|FG004|Overall Study|Lack of Efficacy|0|||
94570153|NCT04999839|323884896|FG000|Overall Study|Physician Decision|0|||
94238072|NCT02270671|322666559|FG000|Overall Study|Lost to Follow-up|2|||
94238073|NCT02270671|322666560|FG001|Overall Study|Lost to Follow-up|1|||
94238074|NCT03445533|322666563|FG000|Overall Study|Progressive Disease|48|||
94238075|NCT03445533|322666564|FG001|Overall Study|Progressive Disease|81|||
94238076|NCT03445533|322666563|FG000|Overall Study|Adverse Event|60|||
94238077|NCT03445533|322666564|FG001|Overall Study|Adverse Event|64|||
94238078|NCT03445533|322666563|FG000|Overall Study|Death|9|||
94238079|NCT03445533|322666564|FG001|Overall Study|Death|19|||
94238080|NCT03445533|322666563|FG000|Overall Study|Miscellaneous|0|||
94238081|NCT03445533|322666564|FG001|Overall Study|Miscellaneous|16|||
94238082|NCT03445533|322666563|FG000|Overall Study|Withdrawal by Subject|3|||
94238083|NCT03445533|322666564|FG001|Overall Study|Withdrawal by Subject|4|||
94238084|NCT03445533|322666563|FG000|Overall Study|Physician Decision|1|||
94238085|NCT03445533|322666564|FG001|Overall Study|Physician Decision|3|||
94238086|NCT03445533|322666563|FG000|Overall Study|Sponsor Decision|0|||
94238087|NCT03445533|322666564|FG001|Overall Study|Sponsor Decision|1|||
94238088|NCT03445533|322666563|FG000|Overall Study|Lost to Follow-up|0|||
94238089|NCT03445533|322666564|FG001|Overall Study|Lost to Follow-up|1|||
94238090|NCT03445533|322666563|FG000|Overall Study|Never Received any Study Treatment|7|||
94238091|NCT03445533|322666564|FG001|Overall Study|Never Received any Study Treatment|4|||
94238092|NCT00425607|322666565|FG000|Overall Study|Death|1|||
94238093|NCT00425607|322666565|FG000|Overall Study|Withdrawal by Subject|1|||
94238094|NCT00203047|322666566|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
94238095|NCT00203047|322666567|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
94238096|NCT00203047|322666566|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
94238097|NCT00203047|322666567|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
94238098|NCT00203047|322666566|FG000|Overall Study|Withdrawal by Subject|13|||
94238099|NCT00203047|322666567|FG001|Overall Study|Withdrawal by Subject|47|||
94238100|NCT00203047|322666566|FG000|Overall Study|Teva requested participant withdrawal|1|||
94238101|NCT00203047|322666567|FG001|Overall Study|Teva requested participant withdrawal|1|||
94238102|NCT00203047|322666566|FG000|Overall Study|Physician Decision|8|||
94238103|NCT00203047|322666567|FG001|Overall Study|Physician Decision|7|||
94238104|NCT00203047|322666566|FG000|Overall Study|Non-compliance|4|||
94238105|NCT00203047|322666567|FG001|Overall Study|Non-compliance|8|||
94238106|NCT00203047|322666566|FG000|Overall Study|Protocol Violation|1|||
94238107|NCT00203047|322666567|FG001|Overall Study|Protocol Violation|0|||
94238108|NCT00203047|322666566|FG000|Overall Study|Lost to Follow-up|11|||
94238109|NCT00203047|322666567|FG001|Overall Study|Lost to Follow-up|5|||
94238110|NCT00203047|322666566|FG000|Overall Study|Adverse Event|8|||
94238111|NCT00203047|322666567|FG001|Overall Study|Adverse Event|18|||
94238112|NCT00203047|322666566|FG000|Overall Study|Death|1|||
94570154|NCT04999839|323884897|FG001|Overall Study|Physician Decision|0|||
94570155|NCT04999839|323884898|FG002|Overall Study|Physician Decision|0|||
94570156|NCT04999839|323884899|FG003|Overall Study|Physician Decision|0|||
94570157|NCT04999839|323884900|FG004|Overall Study|Physician Decision|1|||
94570158|NCT04999839|323884896|FG000|Overall Study|Sponsor request|0|||
94570159|NCT04999839|323884897|FG001|Overall Study|Sponsor request|1|||
94570160|NCT04999839|323884898|FG002|Overall Study|Sponsor request|0|||
94570161|NCT04999839|323884899|FG003|Overall Study|Sponsor request|0|||
94570162|NCT04999839|323884900|FG004|Overall Study|Sponsor request|0|||
94570163|NCT04999839|323884896|FG000|Overall Study|Other|0|||
94570164|NCT04999839|323884897|FG001|Overall Study|Other|0|||
94238113|NCT00203047|322666567|FG001|Overall Study|Death|2|||
94238114|NCT00203047|322666566|FG000|Overall Study|Pregnancy|3|||
94238115|NCT00203047|322666567|FG001|Overall Study|Pregnancy|0|||
94238116|NCT00203047|322666566|FG000|Overall Study|Other|5|||
94238117|NCT00203047|322666567|FG001|Overall Study|Other|5|||
94238118|NCT00351377|322666569|FG000|Overall Study|Adverse Event|5|||
94570165|NCT04999839|323884898|FG002|Overall Study|Other|1|||
94570166|NCT04999839|323884899|FG003|Overall Study|Other|0|||
94570167|NCT04999839|323884900|FG004|Overall Study|Other|0|||
94238119|NCT00351377|322666569|FG000|Overall Study|Death|1|||
94238120|NCT00351377|322666569|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94238121|NCT03054337|322666570|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
94238122|NCT03054337|322666571|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
94238123|NCT03054337|322666572|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
94570168|NCT01721161|323884901|FG000|Overall Study|Adverse Event|2|||
94238124|NCT03054337|322666573|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
94238125|NCT03054337|322666574|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
94238126|NCT03054337|322666575|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
94570169|NCT01721161|323884902|FG001|Overall Study|Adverse Event|3|||
94570170|NCT01721161|323884901|FG000|Overall Study|Lost to Follow-up|1|||
94570171|NCT01721161|323884902|FG001|Overall Study|Lost to Follow-up|2|||
94570172|NCT01721161|323884901|FG000|Overall Study|Withdrawal by Subject|1|||
94238127|NCT03994731|322666576|FG000|Pegloticase + IMM Period|Death|2|||
94238128|NCT03994731|322666577|FG001|Pegloticase + IMM Period|Death|0|||
94570173|NCT01721161|323884902|FG001|Overall Study|Withdrawal by Subject|1|||
94570174|NCT01721161|323884901|FG000|Overall Study|Other|0|||
94570175|NCT01721161|323884902|FG001|Overall Study|Other|1|||
94570176|NCT00651924|323884912|FG000|Overall Study|Withdrawal by PI|0|||
94570177|NCT00651924|323884913|FG001|Overall Study|Withdrawal by PI|2|||
94570178|NCT00651924|323884912|FG000|Overall Study|Withdrawal by Subject|0|||
94570179|NCT00651924|323884913|FG001|Overall Study|Withdrawal by Subject|5|||
94570180|NCT00960063|323884914|FG000|Overall Study|Adverse Event|1|||
94570181|NCT00960063|323884915|FG001|Overall Study|Adverse Event|0|||
94570182|NCT00960063|323884916|FG002|Overall Study|Adverse Event|0|||
94570183|NCT00960063|323884914|FG000|Overall Study|Progression of Disease|0|||
94570184|NCT00960063|323884915|FG001|Overall Study|Progression of Disease|0|||
94570185|NCT00960063|323884916|FG002|Overall Study|Progression of Disease|3|||
94570186|NCT02675907|323884918|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
94570187|NCT02675907|323884919|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
94570188|NCT02675907|323884918|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
94570189|NCT02675907|323884919|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
94570190|NCT02675907|323884918|FG000|Study Overall|Lack of Efficacy|1|||
94570191|NCT02675907|323884919|FG001|Study Overall|Lack of Efficacy|0|||
94570192|NCT02675907|323884918|FG000|Study Overall|Withdrawal by Subject|2|||
94570193|NCT02675907|323884919|FG001|Study Overall|Withdrawal by Subject|2|||
94570194|NCT02675907|323884918|FG000|Study Overall|Lost to Follow-up|0|||
94570195|NCT02675907|323884919|FG001|Study Overall|Lost to Follow-up|2|||
94570196|NCT01611792|323884920|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
94570197|NCT01611792|323884921|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
94570198|NCT01611792|323884920|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
94570199|NCT01611792|323884921|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
94570200|NCT00960375|323884926|FG000|Overall Study|Lost to Follow-up|20|||
94570201|NCT00960375|323884927|FG001|Overall Study|Lost to Follow-up|22|||
94570202|NCT03557970|323884928|FG000|Overall Study|Study closure|1|||
94570203|NCT03557970|323884929|FG001|Overall Study|Study closure|0|||
94570204|NCT03557970|323884928|FG000|Overall Study|Physician Decision|0|||
94570205|NCT03557970|323884929|FG001|Overall Study|Physician Decision|1|||
94570206|NCT03557970|323884928|FG000|Overall Study|Death|0|||
94570207|NCT03557970|323884929|FG001|Overall Study|Death|1|||
94570208|NCT02021565|323884930|FG000|Baseline Through Intervention|Death|0|||
94570209|NCT02021565|323884931|FG001|Baseline Through Intervention|Death|1|||
94570210|NCT02021565|323884930|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
94570211|NCT02021565|323884931|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
94570212|NCT02021565|323884930|FG000|Baseline Through Intervention|Protocol Violation|0|||
94570213|NCT02021565|323884931|FG001|Baseline Through Intervention|Protocol Violation|7|||
94570214|NCT02021565|323884930|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
94570215|NCT02021565|323884931|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
94570216|NCT02021565|323884930|FG000|3-month Follow-up|Death|3|||
94570217|NCT02021565|323884931|FG001|3-month Follow-up|Death|0|||
94570218|NCT02021565|323884930|FG000|3-month Follow-up|Withdrawal by Subject|4|||
94570219|NCT02021565|323884931|FG001|3-month Follow-up|Withdrawal by Subject|0|||
94570220|NCT02021565|323884930|FG000|3-month Follow-up|Protocol Violation|3|||
94570221|NCT02021565|323884931|FG001|3-month Follow-up|Protocol Violation|2|||
94570222|NCT03318549|323884936|FG000|Overall Study|Withdrawal by Subject|5|||
94570223|NCT03318549|323884937|FG001|Overall Study|Withdrawal by Subject|19|||
94570224|NCT03318549|323884938|FG002|Overall Study|Withdrawal by Subject|2|||
94570225|NCT03318549|323884939|FG003|Overall Study|Withdrawal by Subject|0|||
94570226|NCT03318549|323884940|FG004|Overall Study|Withdrawal by Subject|0|||
94570227|NCT03318549|323884941|FG005|Overall Study|Withdrawal by Subject|0|||
94570228|NCT03318549|323884942|FG006|Overall Study|Withdrawal by Subject|0|||
94570229|NCT03318549|323884936|FG000|Overall Study|Physician Decision|0|||
94570230|NCT03318549|323884937|FG001|Overall Study|Physician Decision|4|||
94570231|NCT03318549|323884938|FG002|Overall Study|Physician Decision|1|||
94570232|NCT03318549|323884939|FG003|Overall Study|Physician Decision|0|||
94570233|NCT03318549|323884940|FG004|Overall Study|Physician Decision|0|||
94570234|NCT03318549|323884941|FG005|Overall Study|Physician Decision|0|||
94570235|NCT03318549|323884942|FG006|Overall Study|Physician Decision|0|||
94570236|NCT03318549|323884936|FG000|Overall Study|Lost to Follow-up|0|||
94570237|NCT03318549|323884937|FG001|Overall Study|Lost to Follow-up|3|||
94570238|NCT03318549|323884938|FG002|Overall Study|Lost to Follow-up|3|||
94570239|NCT03318549|323884939|FG003|Overall Study|Lost to Follow-up|0|||
94570240|NCT03318549|323884940|FG004|Overall Study|Lost to Follow-up|0|||
94570241|NCT03318549|323884941|FG005|Overall Study|Lost to Follow-up|0|||
94658792|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
94658793|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
94570242|NCT03318549|323884942|FG006|Overall Study|Lost to Follow-up|0|||
94570243|NCT03155724|323884943|FG000|Overall Study|Death|3|||
94570244|NCT03155724|323884943|FG000|Overall Study|Physician Decision|1|||
94570245|NCT03155724|323884943|FG000|Overall Study|Study closure|7|||
94570246|NCT00795535|323884944|FG000|Overall Study|incomplete data and technical problems|20|||
94238129|NCT03994731|322666576|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
94238130|NCT03994731|322666577|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
94238131|NCT03994731|322666576|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
94238132|NCT03994731|322666577|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
94238133|NCT02417441|322666578|FG000|Overall Study|Inconclusive due to missing data|52|||
94238134|NCT02417441|322666579|FG001|Overall Study|Inconclusive due to missing data|19|||
94238135|NCT01735175|322666580|FG000|Overall Study|Withdrawal by Subject|9|||
94238136|NCT01735175|322666581|FG001|Overall Study|Withdrawal by Subject|2|||
94238137|NCT01735175|322666580|FG000|Overall Study|Lost to Follow-up|4|||
94238138|NCT01735175|322666581|FG001|Overall Study|Lost to Follow-up|2|||
94238139|NCT01735175|322666580|FG000|Overall Study|Death|3|||
94238140|NCT01735175|322666581|FG001|Overall Study|Death|2|||
94238141|NCT01735175|322666580|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
94238142|NCT01735175|322666581|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
94238143|NCT01318876|322666582|FG000|Day 8 Survey|email address invalid|96|||
94238144|NCT01318876|322666582|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
94238145|NCT01318876|322666582|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
94238146|NCT02803593|322666583|FG000|Overall Study|Lost to Follow-up|17|||
94238147|NCT02803593|322666584|FG001|Overall Study|Lost to Follow-up|35|||
94238148|NCT04245345|322666585|FG000|Overall Study|Death|1|||
94238149|NCT04245345|322666585|FG000|Overall Study|Exited prior to implant|5|||
94238150|NCT04245345|322666585|FG000|Overall Study|Exited prior to 1-month|9|||
94238151|NCT04245345|322666585|FG000|Overall Study|Missed 1-month visit|3|||
94238152|NCT04245345|322666585|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
94238153|NCT04245345|322666585|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
94238154|NCT03443414|322666586|FG000|Overall Study|Adverse Event|6|||
94451542|NCT00932373|323441757|FG001|Overall Study|Clinical progression|0|||
94451543|NCT00932373|323441758|FG002|Overall Study|Clinical progression|0|||
94451544|NCT00932373|323441759|FG003|Overall Study|Clinical progression|0|||
94451545|NCT00932373|323441760|FG004|Overall Study|Clinical progression|0|||
94451546|NCT00932373|323441761|FG005|Overall Study|Clinical progression|0|||
94451547|NCT00932373|323441762|FG006|Overall Study|Clinical progression|1|||
94451548|NCT00932373|323441763|FG007|Overall Study|Clinical progression|0|||
94451549|NCT00932373|323441764|FG008|Overall Study|Clinical progression|0|||
94451550|NCT00932373|323441765|FG009|Overall Study|Clinical progression|0|||
94451551|NCT00932373|323441766|FG010|Overall Study|Clinical progression|0|||
94451552|NCT00932373|323441756|FG000|Overall Study|Lack of Efficacy|0|||
94451553|NCT00932373|323441757|FG001|Overall Study|Lack of Efficacy|0|||
94451554|NCT00932373|323441758|FG002|Overall Study|Lack of Efficacy|0|||
94451555|NCT00932373|323441759|FG003|Overall Study|Lack of Efficacy|0|||
94451556|NCT00932373|323441760|FG004|Overall Study|Lack of Efficacy|0|||
94451557|NCT00932373|323441761|FG005|Overall Study|Lack of Efficacy|0|||
94451558|NCT00932373|323441762|FG006|Overall Study|Lack of Efficacy|0|||
94451559|NCT00932373|323441763|FG007|Overall Study|Lack of Efficacy|0|||
94451560|NCT00932373|323441764|FG008|Overall Study|Lack of Efficacy|0|||
94451561|NCT00932373|323441765|FG009|Overall Study|Lack of Efficacy|1|||
94451562|NCT00932373|323441766|FG010|Overall Study|Lack of Efficacy|0|||
94451563|NCT01637922|323441767|FG000|Overall Study|Adverse Event|0|||
94451564|NCT01637922|323441768|FG001|Overall Study|Adverse Event|1|||
94451565|NCT01637922|323441767|FG000|Overall Study|Protocol Violation|0|||
94451566|NCT01637922|323441768|FG001|Overall Study|Protocol Violation|1|||
94451567|NCT01637922|323441767|FG000|Overall Study|Withdrawal by Subject|0|||
94451568|NCT01637922|323441768|FG001|Overall Study|Withdrawal by Subject|3|||
94451569|NCT01637922|323441767|FG000|Overall Study|Lost to Follow-up|2|||
94451570|NCT01637922|323441768|FG001|Overall Study|Lost to Follow-up|0|||
94451571|NCT01068730|323441769|FG000|Period 3|Personal reason|1|||
94451572|NCT01068730|323441770|FG001|Period 3|Personal reason|0|||
94451573|NCT01068730|323441771|FG002|Period 3|Personal reason|0|||
94451574|NCT01068730|323441772|FG003|Period 3|Personal reason|0|||
94451575|NCT01068730|323441769|FG000|Period 4|Family emergency|0|||
94451576|NCT01068730|323441770|FG001|Period 4|Family emergency|1|||
94451577|NCT01068730|323441771|FG002|Period 4|Family emergency|0|||
94451578|NCT01068730|323441772|FG003|Period 4|Family emergency|0|||
94451579|NCT03508726|323441773|FG000|Overall Study|Withdrawal by Subject|0|||
94451580|NCT03508726|323441774|FG001|Overall Study|Withdrawal by Subject|1|||
94238155|NCT03443414|322666587|FG001|Overall Study|Adverse Event|0|||
94238156|NCT03443414|322666588|FG002|Overall Study|Adverse Event|4|||
94451581|NCT02366637|323441775|FG000|First Intervention Period|Adverse Event|0|||
94451582|NCT02366637|323441776|FG001|First Intervention Period|Adverse Event|1|||
94451583|NCT02366637|323441775|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
94451584|NCT02366637|323441776|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
94451585|NCT02366637|323441775|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
94451586|NCT02366637|323441776|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
94451587|NCT02309411|323441777|FG000|Overall Study|Physician Decision|1|||
94451588|NCT02309411|323441778|FG001|Overall Study|Physician Decision|0|||
94451589|NCT02309411|323441779|FG002|Overall Study|Physician Decision|0|||
94451590|NCT02309411|323441777|FG000|Overall Study|Withdrawal by Subject|1|||
94570247|NCT05135871|323884950|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
94570248|NCT05135871|323884951|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
94570249|NCT05135871|323884952|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
94570250|NCT05135871|323884953|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
94570251|NCT03289208|323884956|FG000|Overall Study|Adverse Event|1|||
94570252|NCT03289208|323884957|FG001|Overall Study|Adverse Event|0|||
94570253|NCT03289208|323884958|FG002|Overall Study|Adverse Event|0|||
94570254|NCT04258423|323884959|FG000|Overall Study|Study Closure|2|||
94570255|NCT04258423|323884960|FG001|Overall Study|Study Closure|2|||
94570256|NCT01601535|323884963|FG000|Phase 1|Adverse Event|1|||
94570257|NCT01601535|323884964|FG001|Phase 1|Adverse Event|0|||
94570258|NCT01601535|323884965|FG002|Phase 1|Adverse Event|2|||
94570259|NCT01601535|323884966|FG003|Phase 1|Adverse Event|1|||
94570260|NCT01601535|323884967|FG004|Phase 1|Adverse Event|0|||
94570261|NCT01601535|323884968|FG005|Phase 1|Adverse Event|0|||
94570262|NCT01601535|323884963|FG000|Phase 1|Withdrawal by Subject|2|||
94570263|NCT01601535|323884964|FG001|Phase 1|Withdrawal by Subject|1|||
94570264|NCT01601535|323884965|FG002|Phase 1|Withdrawal by Subject|1|||
94570265|NCT01601535|323884966|FG003|Phase 1|Withdrawal by Subject|2|||
94570266|NCT01601535|323884967|FG004|Phase 1|Withdrawal by Subject|0|||
94570267|NCT01601535|323884968|FG005|Phase 1|Withdrawal by Subject|0|||
94570268|NCT01601535|323884963|FG000|Phase 1|Progressive Disease|2|||
94570269|NCT01601535|323884964|FG001|Phase 1|Progressive Disease|3|||
94570270|NCT01601535|323884965|FG002|Phase 1|Progressive Disease|2|||
94570271|NCT01601535|323884966|FG003|Phase 1|Progressive Disease|1|||
94570272|NCT01601535|323884967|FG004|Phase 1|Progressive Disease|0|||
94570273|NCT01601535|323884968|FG005|Phase 1|Progressive Disease|0|||
94570274|NCT01601535|323884963|FG000|Phase 1|Started Another Treatment|1|||
94570275|NCT01601535|323884964|FG001|Phase 1|Started Another Treatment|2|||
94570276|NCT01601535|323884965|FG002|Phase 1|Started Another Treatment|0|||
94570277|NCT01601535|323884966|FG003|Phase 1|Started Another Treatment|0|||
94570278|NCT01601535|323884967|FG004|Phase 1|Started Another Treatment|0|||
94570279|NCT01601535|323884968|FG005|Phase 1|Started Another Treatment|0|||
94570280|NCT01601535|323884963|FG000|Phase 2|Adverse Event|0|||
94570281|NCT01601535|323884964|FG001|Phase 2|Adverse Event|0|||
94570282|NCT01601535|323884965|FG002|Phase 2|Adverse Event|0|||
94570283|NCT01601535|323884966|FG003|Phase 2|Adverse Event|0|||
94570284|NCT01601535|323884967|FG004|Phase 2|Adverse Event|5|||
94570285|NCT01601535|323884968|FG005|Phase 2|Adverse Event|1|||
94570286|NCT01601535|323884963|FG000|Phase 2|Withdrawal by Subject|0|||
94570287|NCT01601535|323884964|FG001|Phase 2|Withdrawal by Subject|0|||
94570288|NCT01601535|323884965|FG002|Phase 2|Withdrawal by Subject|0|||
94570289|NCT01601535|323884966|FG003|Phase 2|Withdrawal by Subject|0|||
94570290|NCT01601535|323884967|FG004|Phase 2|Withdrawal by Subject|8|||
94570291|NCT01601535|323884968|FG005|Phase 2|Withdrawal by Subject|2|||
94570292|NCT01601535|323884963|FG000|Phase 2|Progressive Disease|0|||
94570293|NCT01601535|323884964|FG001|Phase 2|Progressive Disease|0|||
94570294|NCT01601535|323884965|FG002|Phase 2|Progressive Disease|0|||
94570295|NCT01601535|323884966|FG003|Phase 2|Progressive Disease|0|||
94570296|NCT01601535|323884967|FG004|Phase 2|Progressive Disease|5|||
94570297|NCT01601535|323884968|FG005|Phase 2|Progressive Disease|7|||
94570298|NCT01601535|323884963|FG000|Phase 2|Started Another Treatment|0|||
94570299|NCT01601535|323884964|FG001|Phase 2|Started Another Treatment|0|||
94570300|NCT01601535|323884965|FG002|Phase 2|Started Another Treatment|0|||
94570301|NCT01601535|323884966|FG003|Phase 2|Started Another Treatment|0|||
94570302|NCT01601535|323884967|FG004|Phase 2|Started Another Treatment|1|||
94570303|NCT01601535|323884968|FG005|Phase 2|Started Another Treatment|2|||
94570304|NCT00321789|323884969|FG000|Overall Study|Lost to Follow-up|4|||
94570305|NCT00321789|323884970|FG001|Overall Study|Lost to Follow-up|7|||
94570306|NCT00321789|323884969|FG000|Overall Study|Withdrawal by Subject|6|||
94570307|NCT00321789|323884970|FG001|Overall Study|Withdrawal by Subject|6|||
94570308|NCT00321789|323884969|FG000|Overall Study|Protocol Violation|5|||
94570309|NCT00321789|323884970|FG001|Overall Study|Protocol Violation|3|||
94570310|NCT00402168|323884973|FG000|Randomized|Lost to Follow-up|1|||
94570311|NCT00402168|323884974|FG001|Randomized|Lost to Follow-up|0|||
94570312|NCT00402168|323884973|FG000|Randomized|Withdrawal by Subject|0|||
94570313|NCT00402168|323884974|FG001|Randomized|Withdrawal by Subject|1|||
94570314|NCT00402168|323884973|FG000|Treatment (up to 12 Months)|Death|0|||
94570315|NCT00402168|323884974|FG001|Treatment (up to 12 Months)|Death|1|||
94570316|NCT00402168|323884973|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
94570317|NCT00402168|323884974|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
94570318|NCT00402168|323884973|FG000|Treatment (up to 12 Months)|non-specified|0|||
94570319|NCT00402168|323884974|FG001|Treatment (up to 12 Months)|non-specified|1|||
94570320|NCT00402168|323884973|FG000|Long Term (LT)|Adverse Event|1|||
94570321|NCT00402168|323884974|FG001|Long Term (LT)|Adverse Event|5|||
94570322|NCT00402168|323884973|FG000|Long Term (LT)|Withdrawal by Subject|4|||
94570323|NCT00402168|323884974|FG001|Long Term (LT)|Withdrawal by Subject|7|||
94570324|NCT00402168|323884973|FG000|Long Term (LT)|Pregnancy|0|||
94570325|NCT00402168|323884974|FG001|Long Term (LT)|Pregnancy|1|||
94570326|NCT00402168|323884973|FG000|Long Term (LT)|Lost to Follow-up|1|||
94570327|NCT00402168|323884974|FG001|Long Term (LT)|Lost to Follow-up|0|||
94570328|NCT00402168|323884973|FG000|Long Term (LT)|Death|4|||
94570329|NCT00402168|323884974|FG001|Long Term (LT)|Death|0|||
94570330|NCT00402168|323884973|FG000|Long Term (LT)|Lack of Efficacy|0|||
94570331|NCT00402168|323884974|FG001|Long Term (LT)|Lack of Efficacy|2|||
94238157|NCT03443414|322666589|FG003|Overall Study|Adverse Event|2|||
94238158|NCT03443414|322666590|FG004|Overall Study|Adverse Event|3|||
94238159|NCT03443414|322666586|FG000|Overall Study|Withdrawal by Subject|3|||
94570332|NCT00402168|323884973|FG000|Long Term (LT)|non-specified|1|||
94570333|NCT00402168|323884974|FG001|Long Term (LT)|non-specified|2|||
94570334|NCT00402168|323884973|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
94570335|NCT00402168|323884974|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
94570336|NCT00402168|323884973|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
94570337|NCT00402168|323884974|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
94570338|NCT00871871|323884976|FG000|Part I|Adverse Event|0|||
94570339|NCT00871871|323884977|FG001|Part I|Adverse Event|2|||
94570340|NCT00871871|323884978|FG002|Part I|Adverse Event|0|||
94570341|NCT00871871|323884979|FG003|Part I|Adverse Event|0|||
94570342|NCT00871871|323884976|FG000|Part I|Withdrawal by Subject|3|||
94570343|NCT00871871|323884977|FG001|Part I|Withdrawal by Subject|0|||
94570344|NCT00871871|323884978|FG002|Part I|Withdrawal by Subject|0|||
94570345|NCT00871871|323884979|FG003|Part I|Withdrawal by Subject|0|||
94570346|NCT00871871|323884976|FG000|Part I|Laboratory abnormality|0|||
94570347|NCT00871871|323884977|FG001|Part I|Laboratory abnormality|1|||
94570348|NCT00871871|323884978|FG002|Part I|Laboratory abnormality|0|||
94570349|NCT00871871|323884979|FG003|Part I|Laboratory abnormality|0|||
94570350|NCT00871871|323884976|FG000|Part II|Lack of Efficacy|0|||
94570351|NCT00871871|323884977|FG001|Part II|Lack of Efficacy|0|||
94570352|NCT00871871|323884978|FG002|Part II|Lack of Efficacy|1|||
94570353|NCT00871871|323884979|FG003|Part II|Lack of Efficacy|0|||
94570354|NCT00871871|323884976|FG000|Part II|Withdrawal by Subject|0|||
94570355|NCT00871871|323884977|FG001|Part II|Withdrawal by Subject|0|||
94570356|NCT00871871|323884978|FG002|Part II|Withdrawal by Subject|2|||
94570357|NCT00871871|323884979|FG003|Part II|Withdrawal by Subject|1|||
94570358|NCT00871871|323884976|FG000|Part II|Adverse Event|0|||
94570359|NCT00871871|323884977|FG001|Part II|Adverse Event|0|||
94570360|NCT00871871|323884978|FG002|Part II|Adverse Event|1|||
94570361|NCT00871871|323884979|FG003|Part II|Adverse Event|2|||
94570362|NCT00871871|323884976|FG000|Part II|Protocol Violation|0|||
94570363|NCT00871871|323884977|FG001|Part II|Protocol Violation|0|||
94570364|NCT00871871|323884978|FG002|Part II|Protocol Violation|0|||
94570365|NCT00871871|323884979|FG003|Part II|Protocol Violation|1|||
94570366|NCT04612725|323884980|FG000|Overall Study|Adverse Event|1|||
94570367|NCT04612725|323884981|FG001|Overall Study|Adverse Event|3|||
94570368|NCT04612725|323884982|FG002|Overall Study|Adverse Event|1|||
94570369|NCT04612725|323884983|FG003|Overall Study|Adverse Event|0|||
94570370|NCT04612725|323884984|FG004|Overall Study|Adverse Event|1|||
94570371|NCT04612725|323884980|FG000|Overall Study|Lost to Follow-up|0|||
94570372|NCT04612725|323884981|FG001|Overall Study|Lost to Follow-up|1|||
94570373|NCT04612725|323884982|FG002|Overall Study|Lost to Follow-up|0|||
94570374|NCT04612725|323884983|FG003|Overall Study|Lost to Follow-up|0|||
94570375|NCT04612725|323884984|FG004|Overall Study|Lost to Follow-up|0|||
94570376|NCT04612725|323884980|FG000|Overall Study|Physician Decision|2|||
94570377|NCT04612725|323884981|FG001|Overall Study|Physician Decision|0|||
94570378|NCT04612725|323884982|FG002|Overall Study|Physician Decision|0|||
94570379|NCT04612725|323884983|FG003|Overall Study|Physician Decision|0|||
94570380|NCT04612725|323884984|FG004|Overall Study|Physician Decision|0|||
94570381|NCT04612725|323884980|FG000|Overall Study|Study terminated by sponsor|3|||
94570382|NCT04612725|323884981|FG001|Overall Study|Study terminated by sponsor|1|||
94570383|NCT04612725|323884982|FG002|Overall Study|Study terminated by sponsor|2|||
94570384|NCT04612725|323884983|FG003|Overall Study|Study terminated by sponsor|4|||
94570385|NCT04612725|323884984|FG004|Overall Study|Study terminated by sponsor|5|||
94570386|NCT04612725|323884980|FG000|Overall Study|Withdrawal by Subject|8|||
94570387|NCT04612725|323884981|FG001|Overall Study|Withdrawal by Subject|3|||
94570388|NCT04612725|323884982|FG002|Overall Study|Withdrawal by Subject|5|||
94570389|NCT04612725|323884983|FG003|Overall Study|Withdrawal by Subject|1|||
94570390|NCT04612725|323884984|FG004|Overall Study|Withdrawal by Subject|9|||
94570391|NCT04612725|323884980|FG000|Overall Study|Other|0|||
94570392|NCT04612725|323884981|FG001|Overall Study|Other|0|||
94570393|NCT04612725|323884982|FG002|Overall Study|Other|0|||
94451591|NCT02309411|323441778|FG001|Overall Study|Withdrawal by Subject|1|||
94570394|NCT04612725|323884983|FG003|Overall Study|Other|0|||
94570395|NCT04612725|323884984|FG004|Overall Study|Other|1|||
94570396|NCT01777308|323887360|FG000|Overall Study|Withdrawal by Subject|5|||
94570397|NCT01777308|323887361|FG001|Overall Study|Withdrawal by Subject|1|||
94570398|NCT01777308|323887360|FG000|Overall Study|Migrated/moved from study area|1|||
94570399|NCT01777308|323887361|FG001|Overall Study|Migrated/moved from study area|0|||
94570400|NCT01777308|323887360|FG000|Overall Study|Lost to Follow-up|7|||
94570401|NCT01777308|323887361|FG001|Overall Study|Lost to Follow-up|2|||
94570402|NCT01777308|323887360|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
94570403|NCT01777308|323887361|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
94570404|NCT03212326|323887362|FG000|Overall Study|Physician Decision|4|||
94570405|NCT00984256|323887375|FG000|Overall Study|Withdrawal by Subject|0|||
94570406|NCT00984256|323887376|FG001|Overall Study|Withdrawal by Subject|1|||
94570407|NCT03737123|323887377|FG000|Study Treatment|Adverse Event|2|||
94570408|NCT03737123|323887378|FG001|Study Treatment|Adverse Event|0|||
94570409|NCT03737123|323887377|FG000|Study Treatment|Disease Progression|2|||
94570410|NCT03737123|323887378|FG001|Study Treatment|Disease Progression|0|||
94570411|NCT03737123|323887377|FG000|Study Treatment|Withdrawal by Subject|2|||
94570412|NCT03737123|323887378|FG001|Study Treatment|Withdrawal by Subject|0|||
94570413|NCT03737123|323887377|FG000|Follow up|Death|1|||
94570414|NCT03737123|323887378|FG001|Follow up|Death|0|||
94570415|NCT03737123|323887377|FG000|Follow up|Withdrawal by Subject|1|||
94570416|NCT03737123|323887378|FG001|Follow up|Withdrawal by Subject|0|||
94238160|NCT03443414|322666587|FG001|Overall Study|Withdrawal by Subject|2|||
94238161|NCT03443414|322666588|FG002|Overall Study|Withdrawal by Subject|2|||
94238162|NCT03443414|322666589|FG003|Overall Study|Withdrawal by Subject|2|||
94238163|NCT03443414|322666590|FG004|Overall Study|Withdrawal by Subject|1|||
94238164|NCT03443414|322666586|FG000|Overall Study|Death|0|||
94238165|NCT03443414|322666587|FG001|Overall Study|Death|1|||
94238166|NCT03443414|322666588|FG002|Overall Study|Death|0|||
94238167|NCT03443414|322666589|FG003|Overall Study|Death|1|||
94570417|NCT03737123|323887377|FG000|Follow up|Termination of study|4|||
94570418|NCT03737123|323887378|FG001|Follow up|Termination of study|0|||
94570419|NCT00262860|323887379|FG000|Overall Study|Adverse Event|2|||
94570420|NCT02741128|323887380|FG000|Overall Study|Protocol Violation|4|||
94570421|NCT02741128|323887381|FG001|Overall Study|Protocol Violation|1|||
94570422|NCT02741128|323887380|FG000|Overall Study|Withdrawal by Subject|2|||
94570423|NCT02741128|323887381|FG001|Overall Study|Withdrawal by Subject|0|||
94570424|NCT02741128|323887380|FG000|Overall Study|Lost to Follow-up|1|||
94570425|NCT02741128|323887381|FG001|Overall Study|Lost to Follow-up|0|||
94570426|NCT01519323|323887382|FG000|Overall Study|Death|3|||
94570427|NCT01519323|323887383|FG001|Overall Study|Death|2|||
94570428|NCT01519323|323887382|FG000|Overall Study|Study terminated by sponsor|0|||
94570429|NCT01519323|323887383|FG001|Overall Study|Study terminated by sponsor|1|||
94570430|NCT02973100|323887386|FG000|Overall Study|Adverse Event|1|||
94570431|NCT02973100|323887387|FG001|Overall Study|Adverse Event|2|||
94570432|NCT02973100|323887388|FG002|Overall Study|Adverse Event|1|||
94570433|NCT02973100|323887389|FG003|Overall Study|Adverse Event|2|||
94570434|NCT02973100|323887386|FG000|Overall Study|Lost to Follow-up|3|||
94570435|NCT02973100|323887387|FG001|Overall Study|Lost to Follow-up|1|||
94570436|NCT02973100|323887388|FG002|Overall Study|Lost to Follow-up|1|||
94570437|NCT02973100|323887389|FG003|Overall Study|Lost to Follow-up|0|||
94570438|NCT02973100|323887386|FG000|Overall Study|Withdrawal by Subject|3|||
94570439|NCT02973100|323887387|FG001|Overall Study|Withdrawal by Subject|5|||
94570440|NCT02973100|323887388|FG002|Overall Study|Withdrawal by Subject|1|||
94570441|NCT02973100|323887389|FG003|Overall Study|Withdrawal by Subject|4|||
94570442|NCT02973100|323887386|FG000|Overall Study|Notification of change in address|0|||
94570443|NCT02973100|323887387|FG001|Overall Study|Notification of change in address|0|||
94570444|NCT02973100|323887388|FG002|Overall Study|Notification of change in address|0|||
94570445|NCT02973100|323887389|FG003|Overall Study|Notification of change in address|1|||
94570446|NCT02973100|323887386|FG000|Overall Study|Failed to attend Safety followup period|0|||
94570447|NCT02973100|323887387|FG001|Overall Study|Failed to attend Safety followup period|0|||
94570448|NCT02973100|323887388|FG002|Overall Study|Failed to attend Safety followup period|1|||
94570449|NCT02973100|323887389|FG003|Overall Study|Failed to attend Safety followup period|0|||
94570450|NCT00445549|323887390|FG000|Overall Study|progressive disease|12|||
94570451|NCT01419769|323887391|FG000|Overall Study|Did not receive the AXIOS stent|3|||
94570452|NCT01419769|323887391|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
94570453|NCT00383552|323887394|FG000|Overall Study|Adverse Event|7|||
94570454|NCT00383552|323887395|FG001|Overall Study|Adverse Event|6|||
94570455|NCT00383552|323887396|FG002|Overall Study|Adverse Event|9|||
94570456|NCT00383552|323887397|FG003|Overall Study|Adverse Event|6|||
94570457|NCT00383552|323887394|FG000|Overall Study|Lack of Efficacy|4|||
94570458|NCT00383552|323887395|FG001|Overall Study|Lack of Efficacy|13|||
94570459|NCT00383552|323887396|FG002|Overall Study|Lack of Efficacy|29|||
94570460|NCT00383552|323887397|FG003|Overall Study|Lack of Efficacy|42|||
94570461|NCT00383552|323887394|FG000|Overall Study|Lost to Follow-up|0|||
94570462|NCT00383552|323887395|FG001|Overall Study|Lost to Follow-up|1|||
94570463|NCT00383552|323887396|FG002|Overall Study|Lost to Follow-up|5|||
94570464|NCT00383552|323887397|FG003|Overall Study|Lost to Follow-up|1|||
94570465|NCT00383552|323887394|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
94570466|NCT00383552|323887395|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
94570467|NCT00383552|323887396|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
94570468|NCT00383552|323887397|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
94570469|NCT00383552|323887394|FG000|Overall Study|Did not wish to continue (related)|1|||
94570470|NCT00383552|323887395|FG001|Overall Study|Did not wish to continue (related)|0|||
94570471|NCT00383552|323887396|FG002|Overall Study|Did not wish to continue (related)|2|||
94570472|NCT00383552|323887397|FG003|Overall Study|Did not wish to continue (related)|3|||
94570473|NCT00383552|323887394|FG000|Overall Study|Noncompliance with the protocol|11|||
94570474|NCT00383552|323887395|FG001|Overall Study|Noncompliance with the protocol|6|||
94570475|NCT00383552|323887396|FG002|Overall Study|Noncompliance with the protocol|8|||
94570476|NCT00383552|323887397|FG003|Overall Study|Noncompliance with the protocol|10|||
94570477|NCT00383552|323887394|FG000|Overall Study|Did not meet protocol eligibility|8|||
94570478|NCT00383552|323887395|FG001|Overall Study|Did not meet protocol eligibility|6|||
94570479|NCT00383552|323887396|FG002|Overall Study|Did not meet protocol eligibility|2|||
94570480|NCT00383552|323887397|FG003|Overall Study|Did not meet protocol eligibility|3|||
94570481|NCT00383552|323887394|FG000|Overall Study|Administrative|1|||
94570482|NCT00383552|323887395|FG001|Overall Study|Administrative|0|||
94570483|NCT00383552|323887396|FG002|Overall Study|Administrative|1|||
94570484|NCT00383552|323887397|FG003|Overall Study|Administrative|1|||
94570485|NCT01584232|323887402|FG000|Overall Study|Adverse Event|3|||
94570486|NCT01584232|323887403|FG001|Overall Study|Adverse Event|1|||
94570487|NCT01584232|323887402|FG000|Overall Study|Withdrawal by Subject|2|||
94570488|NCT01584232|323887403|FG001|Overall Study|Withdrawal by Subject|1|||
94570489|NCT01584232|323887402|FG000|Overall Study|Physician Decision|2|||
94570490|NCT01584232|323887403|FG001|Overall Study|Physician Decision|1|||
94570491|NCT01584232|323887402|FG000|Overall Study|Lost to Follow-up|1|||
94451592|NCT02309411|323441779|FG002|Overall Study|Withdrawal by Subject|0|||
94451593|NCT01163851|323441780|FG000|Overall Study|Site Closure|0|||
94451594|NCT01163851|323441781|FG001|Overall Study|Site Closure|1|||
94451595|NCT01163851|323441780|FG000|Overall Study|Enrolled but not treated|1|||
94451596|NCT01163851|323441781|FG001|Overall Study|Enrolled but not treated|0|||
94451597|NCT01284348|323441785|FG000|Overall Study|Death|1|||
94451598|NCT01284348|323441786|FG001|Overall Study|Death|1|||
94451599|NCT01284348|323441785|FG000|Overall Study|Withdrew consent|0|||
94451600|NCT01284348|323441786|FG001|Overall Study|Withdrew consent|1|||
94451601|NCT01284348|323441785|FG000|Overall Study|Status not recorded|9|||
94451602|NCT01284348|323441786|FG001|Overall Study|Status not recorded|10|||
94451603|NCT00384839|323441787|FG000|Overall Study|Adverse Event|4|||
94451604|NCT00384839|323441787|FG000|Overall Study|Investigator Request|1|||
94451605|NCT00384839|323441787|FG000|Overall Study|Patient Request|1|||
94451606|NCT00384839|323441787|FG000|Overall Study|Ineligible|2|||
94451607|NCT00443079|323441788|FG000|Overall Study|Lost to Follow-up|0|||
94451608|NCT00443079|323441789|FG001|Overall Study|Lost to Follow-up|1|||
94451609|NCT02649439|323441790|FG000|Overall Study|Switched to alternative treatment|6|||
94451610|NCT02649439|323441791|FG001|Overall Study|Switched to alternative treatment|4|||
94451611|NCT02649439|323441790|FG000|Overall Study|Patient decision|1|||
94451612|NCT02649439|323441791|FG001|Overall Study|Patient decision|0|||
94451613|NCT02649439|323441790|FG000|Overall Study|Patient going out of country|1|||
94451614|NCT02649439|323441791|FG001|Overall Study|Patient going out of country|0|||
94451615|NCT02649439|323441790|FG000|Overall Study|To start finasteride|1|||
94451616|NCT02649439|323441791|FG001|Overall Study|To start finasteride|0|||
94451617|NCT02649439|323441790|FG000|Overall Study|Physician Decision|1|||
94451618|NCT02649439|323441791|FG001|Overall Study|Physician Decision|0|||
94451619|NCT02649439|323441790|FG000|Overall Study|Disease progression on study|12|||
94451620|NCT02649439|323441791|FG001|Overall Study|Disease progression on study|13|||
94451621|NCT02649439|323441790|FG000|Overall Study|Refused further treatment|1|||
94451622|NCT02649439|323441791|FG001|Overall Study|Refused further treatment|0|||
94451623|NCT02649439|323441790|FG000|Overall Study|Refused further follow up|2|||
94451624|NCT02649439|323441791|FG001|Overall Study|Refused further follow up|7|||
94451625|NCT02649439|323441790|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
94451626|NCT02649439|323441791|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
94451627|NCT02649439|323441790|FG000|Overall Study|No treatment, per protocol|1|||
94451628|NCT02649439|323441791|FG001|Overall Study|No treatment, per protocol|0|||
94451629|NCT02649439|323441790|FG000|Overall Study|PSA DT makes ineligible|0|||
94451630|NCT02649439|323441791|FG001|Overall Study|PSA DT makes ineligible|1|||
94451631|NCT02649439|323441790|FG000|Overall Study|Rising PSA No Mets|0|||
94451632|NCT02649439|323441791|FG001|Overall Study|Rising PSA No Mets|1|||
94451633|NCT02649439|323441790|FG000|Overall Study|Rising PSA|0|||
94451634|NCT02649439|323441791|FG001|Overall Study|Rising PSA|1|||
94451635|NCT02649439|323441790|FG000|Overall Study|Signed follow up protocol|0|||
94451636|NCT02649439|323441791|FG001|Overall Study|Signed follow up protocol|1|||
94451637|NCT02993250|323441794|FG000|Overall Study|Lost to Follow-up|0|||
94451638|NCT02993250|323441795|FG001|Overall Study|Lost to Follow-up|1|||
94451639|NCT02527434|323441797|FG000|Overall Study|Lost to Follow-up|2|||
94451640|NCT02527434|323441798|FG001|Overall Study|Lost to Follow-up|2|||
94451641|NCT02527434|323441799|FG002|Overall Study|Lost to Follow-up|0|||
94570492|NCT01584232|323887403|FG001|Overall Study|Lost to Follow-up|0|||
94570493|NCT00387881|323887406|FG000|Overall Study|Lost to Follow-up|23|||
94451642|NCT02527434|323441797|FG000|Overall Study|Death|19|||
94451643|NCT02527434|323441798|FG001|Overall Study|Death|6|||
94451644|NCT02527434|323441799|FG002|Overall Study|Death|17|||
94451645|NCT02527434|323441797|FG000|Overall Study|Withdrawal by Subject|5|||
94451646|NCT02527434|323441798|FG001|Overall Study|Withdrawal by Subject|3|||
94451647|NCT02527434|323441799|FG002|Overall Study|Withdrawal by Subject|3|||
94451648|NCT02527434|323441797|FG000|Overall Study|Reason Not Specified|1|||
94451649|NCT02527434|323441798|FG001|Overall Study|Reason Not Specified|0|||
94451650|NCT02527434|323441799|FG002|Overall Study|Reason Not Specified|0|||
94451651|NCT02527434|323441797|FG000|Overall Study|Site closure|1|||
94451652|NCT02527434|323441798|FG001|Overall Study|Site closure|0|||
94570494|NCT00387881|323887407|FG001|Overall Study|Lost to Follow-up|23|||
94570495|NCT00387881|323887406|FG000|Overall Study|Protocol Violation|2|||
94570496|NCT00387881|323887407|FG001|Overall Study|Protocol Violation|12|||
94570497|NCT00387881|323887406|FG000|Overall Study|Withdrawal by Subject|15|||
94570498|NCT00387881|323887407|FG001|Overall Study|Withdrawal by Subject|18|||
94570499|NCT00387881|323887406|FG000|Overall Study|Sponsor terminated Study|0|||
94570500|NCT00387881|323887407|FG001|Overall Study|Sponsor terminated Study|1|||
94570501|NCT00387881|323887406|FG000|Overall Study|Not eligible|6|||
94570502|NCT00387881|323887407|FG001|Overall Study|Not eligible|7|||
94570503|NCT00387881|323887406|FG000|Overall Study|No opportunity to treat headache|32|||
94570504|NCT00387881|323887407|FG001|Overall Study|No opportunity to treat headache|34|||
94570505|NCT00387881|323887406|FG000|Overall Study|Not otherwise specified|11|||
94570506|NCT00387881|323887407|FG001|Overall Study|Not otherwise specified|7|||
94570507|NCT03095651|323887408|FG000|Overall Study|Lost to Follow-up|1|||
94570508|NCT03095651|323887409|FG001|Overall Study|Lost to Follow-up|1|||
94570509|NCT03095651|323887410|FG002|Overall Study|Lost to Follow-up|0|||
94570510|NCT03095651|323887411|FG003|Overall Study|Lost to Follow-up|1|||
94570511|NCT03095651|323887412|FG004|Overall Study|Lost to Follow-up|0|||
94570512|NCT03095651|323887413|FG005|Overall Study|Lost to Follow-up|0|||
94570513|NCT03095651|323887414|FG006|Overall Study|Lost to Follow-up|0|||
94570514|NCT03095651|323887415|FG007|Overall Study|Lost to Follow-up|0|||
94570515|NCT03095651|323887408|FG000|Overall Study|Withdrawal by Subject|0|||
94570516|NCT03095651|323887409|FG001|Overall Study|Withdrawal by Subject|0|||
94570517|NCT03095651|323887410|FG002|Overall Study|Withdrawal by Subject|0|||
94570518|NCT03095651|323887411|FG003|Overall Study|Withdrawal by Subject|0|||
94570519|NCT03095651|323887412|FG004|Overall Study|Withdrawal by Subject|0|||
94570520|NCT03095651|323887413|FG005|Overall Study|Withdrawal by Subject|1|||
94570521|NCT03095651|323887414|FG006|Overall Study|Withdrawal by Subject|0|||
94570522|NCT03095651|323887415|FG007|Overall Study|Withdrawal by Subject|0|||
94570523|NCT01381016|323887417|FG000|Overall Study|Lost to Follow-up|1|||
94570524|NCT01381016|323887418|FG001|Overall Study|Lost to Follow-up|1|||
94570525|NCT01381016|323887417|FG000|Overall Study|Screen Failure|2|||
94570526|NCT01381016|323887418|FG001|Overall Study|Screen Failure|2|||
94570527|NCT01381016|323887417|FG000|Overall Study|Withdrawal by Subject|0|||
94570528|NCT01381016|323887418|FG001|Overall Study|Withdrawal by Subject|1|||
94570529|NCT01381016|323887417|FG000|Overall Study|Physician Decision|0|||
94570530|NCT01381016|323887418|FG001|Overall Study|Physician Decision|2|||
94570531|NCT01631435|323887424|FG000|Overall Study|Adverse Event|2|||
94570532|NCT01631435|323887424|FG000|Overall Study|Withdrawal by Subject|2|||
94570533|NCT01631435|323887424|FG000|Overall Study|incomplete study procedure|5|||
94570534|NCT03489863|323887428|FG000|Overall Study|Withdrawal by Subject|0|||
94570535|NCT03489863|323887429|FG001|Overall Study|Withdrawal by Subject|1|||
94570536|NCT01005251|323887431|FG000|Overall Study|Withdrawal by Subject|2|||
94348370|NCT01225211|323056115|FG005|Overall Study|Withdrawal by Subject|0|||
94348371|NCT01225211|323056116|FG006|Overall Study|Withdrawal by Subject|1|||
94348372|NCT01225211|323056117|FG007|Overall Study|Withdrawal by Subject|0|||
94348373|NCT01225211|323056118|FG008|Overall Study|Withdrawal by Subject|1|||
94348374|NCT01225211|323056119|FG009|Overall Study|Withdrawal by Subject|3|||
94348375|NCT01225211|323056110|FG000|Overall Study|Other|0|||
94348376|NCT01225211|323056111|FG001|Overall Study|Other|0|||
94348377|NCT01225211|323056112|FG002|Overall Study|Other|0|||
94348378|NCT01225211|323056113|FG003|Overall Study|Other|0|||
94348379|NCT01225211|323056114|FG004|Overall Study|Other|0|||
94348380|NCT01225211|323056115|FG005|Overall Study|Other|0|||
94348381|NCT01225211|323056116|FG006|Overall Study|Other|0|||
94348382|NCT01225211|323056117|FG007|Overall Study|Other|0|||
94348383|NCT01225211|323056118|FG008|Overall Study|Other|0|||
94348384|NCT01225211|323056119|FG009|Overall Study|Other|1|||
94348385|NCT02993783|323056120|FG000|Overall Study|Reason not Specified|6|||
94348386|NCT02993783|323056121|FG001|Overall Study|Reason not Specified|9|||
94570537|NCT01005251|323887432|FG001|Overall Study|Withdrawal by Subject|5|||
94570538|NCT01005251|323887433|FG002|Overall Study|Withdrawal by Subject|3|||
94570539|NCT01005251|323887434|FG003|Overall Study|Withdrawal by Subject|4|||
94570540|NCT01005251|323887435|FG004|Overall Study|Withdrawal by Subject|9|||
94570541|NCT01005251|323887431|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
94570542|NCT01005251|323887432|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
94570543|NCT01005251|323887433|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
94570544|NCT01005251|323887434|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
94570545|NCT01005251|323887435|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
94348387|NCT00606021|323056124|FG000|Induction Phase|Death|73|||
94348388|NCT00606021|323056125|FG001|Induction Phase|Death|0|||
94348389|NCT00606021|323056126|FG002|Induction Phase|Death|0|||
94348390|NCT00606021|323056124|FG000|Induction Phase|Physician Decision|2|||
94348391|NCT00606021|323056125|FG001|Induction Phase|Physician Decision|0|||
94348392|NCT00606021|323056126|FG002|Induction Phase|Physician Decision|0|||
94570546|NCT01005251|323887431|FG000|Overall Study|Adverse Event|2|||
94570547|NCT01005251|323887432|FG001|Overall Study|Adverse Event|6|||
94570548|NCT01005251|323887433|FG002|Overall Study|Adverse Event|8|||
94570549|NCT01005251|323887434|FG003|Overall Study|Adverse Event|5|||
94570550|NCT01005251|323887435|FG004|Overall Study|Adverse Event|4|||
94570551|NCT01005251|323887431|FG000|Overall Study|Protocol Violation|1|||
94570552|NCT01005251|323887432|FG001|Overall Study|Protocol Violation|0|||
94570553|NCT01005251|323887433|FG002|Overall Study|Protocol Violation|0|||
94570554|NCT01005251|323887434|FG003|Overall Study|Protocol Violation|0|||
94570555|NCT01005251|323887435|FG004|Overall Study|Protocol Violation|2|||
94570556|NCT01005251|323887431|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
94570557|NCT01005251|323887432|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
94570558|NCT01005251|323887433|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
94570559|NCT01005251|323887434|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
94570560|NCT01005251|323887435|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
94570561|NCT01005251|323887431|FG000|Overall Study|Lost to Follow-up|1|||
94570562|NCT01005251|323887432|FG001|Overall Study|Lost to Follow-up|4|||
94570563|NCT01005251|323887433|FG002|Overall Study|Lost to Follow-up|2|||
94570564|NCT01005251|323887434|FG003|Overall Study|Lost to Follow-up|0|||
94570565|NCT01005251|323887435|FG004|Overall Study|Lost to Follow-up|0|||
94570566|NCT01005251|323887431|FG000|Overall Study|Physician Decision|0|||
94570567|NCT01005251|323887432|FG001|Overall Study|Physician Decision|0|||
94570568|NCT01005251|323887433|FG002|Overall Study|Physician Decision|0|||
94570569|NCT01005251|323887434|FG003|Overall Study|Physician Decision|0|||
94570570|NCT01005251|323887435|FG004|Overall Study|Physician Decision|2|||
94570571|NCT01005251|323887431|FG000|Overall Study|Patient moved|1|||
94570572|NCT01005251|323887432|FG001|Overall Study|Patient moved|0|||
94570573|NCT01005251|323887433|FG002|Overall Study|Patient moved|0|||
94570574|NCT01005251|323887434|FG003|Overall Study|Patient moved|0|||
94570575|NCT01005251|323887435|FG004|Overall Study|Patient moved|0|||
94570576|NCT01005251|323887431|FG000|Overall Study|Wrong drug dispensed|0|||
94570577|NCT01005251|323887432|FG001|Overall Study|Wrong drug dispensed|1|||
94570578|NCT01005251|323887433|FG002|Overall Study|Wrong drug dispensed|0|||
94570579|NCT01005251|323887434|FG003|Overall Study|Wrong drug dispensed|0|||
94570580|NCT01005251|323887435|FG004|Overall Study|Wrong drug dispensed|0|||
94570581|NCT01005251|323887431|FG000|Overall Study|Randomized in error|0|||
94570582|NCT01005251|323887432|FG001|Overall Study|Randomized in error|0|||
94570583|NCT01005251|323887433|FG002|Overall Study|Randomized in error|1|||
94570584|NCT01005251|323887434|FG003|Overall Study|Randomized in error|1|||
94570585|NCT01005251|323887435|FG004|Overall Study|Randomized in error|0|||
94570586|NCT01005251|323887431|FG000|Overall Study|Lack of Efficacy|0|||
94570587|NCT01005251|323887432|FG001|Overall Study|Lack of Efficacy|0|||
94570588|NCT01005251|323887433|FG002|Overall Study|Lack of Efficacy|1|||
94570589|NCT01005251|323887434|FG003|Overall Study|Lack of Efficacy|1|||
94570590|NCT01005251|323887435|FG004|Overall Study|Lack of Efficacy|0|||
94570591|NCT00346216|323887438|FG000|Overall Study|Other|181|||
94570592|NCT00346216|323887439|FG001|Overall Study|Other|231|||
94570593|NCT00346216|323887440|FG002|Overall Study|Other|205|||
94570594|NCT00346216|323887438|FG000|Overall Study|No longer willing to participate|600|||
94570595|NCT00346216|323887439|FG001|Overall Study|No longer willing to participate|606|||
94570596|NCT00346216|323887440|FG002|Overall Study|No longer willing to participate|585|||
94570597|NCT00346216|323887438|FG000|Overall Study|Withdrawal by Subject|661|||
94570598|NCT00346216|323887439|FG001|Overall Study|Withdrawal by Subject|692|||
94570599|NCT00346216|323887440|FG002|Overall Study|Withdrawal by Subject|651|||
94570600|NCT00346216|323887438|FG000|Overall Study|Lost to Follow-up|611|||
94570601|NCT00346216|323887439|FG001|Overall Study|Lost to Follow-up|588|||
94570602|NCT00346216|323887440|FG002|Overall Study|Lost to Follow-up|542|||
94570603|NCT00346216|323887438|FG000|Overall Study|Physician Decision|80|||
94570604|NCT00346216|323887439|FG001|Overall Study|Physician Decision|76|||
94570605|NCT00346216|323887440|FG002|Overall Study|Physician Decision|59|||
94570606|NCT00346216|323887438|FG000|Overall Study|Does not meet entrance criteria|13|||
94570607|NCT00346216|323887439|FG001|Overall Study|Does not meet entrance criteria|10|||
94570608|NCT00346216|323887440|FG002|Overall Study|Does not meet entrance criteria|8|||
94570609|NCT00346216|323887438|FG000|Overall Study|Death|189|||
94570610|NCT00346216|323887439|FG001|Overall Study|Death|192|||
94570611|NCT00346216|323887440|FG002|Overall Study|Death|228|||
94570612|NCT00346216|323887438|FG000|Overall Study|Study terminated by sponsor|11|||
94570613|NCT00346216|323887439|FG001|Overall Study|Study terminated by sponsor|4|||
94570614|NCT00346216|323887440|FG002|Overall Study|Study terminated by sponsor|8|||
94570615|NCT00346216|323887438|FG000|Overall Study|Missing Subject Summary Status|62|||
94570616|NCT00346216|323887439|FG001|Overall Study|Missing Subject Summary Status|61|||
94570617|NCT00346216|323887440|FG002|Overall Study|Missing Subject Summary Status|62|||
94570618|NCT03192176|323887447|FG000|Overall Study|Adverse Event|1|||
94570619|NCT03192176|323887448|FG001|Overall Study|Adverse Event|0|||
94570620|NCT03192176|323887449|FG002|Overall Study|Adverse Event|4|||
94570621|NCT03192176|323887450|FG003|Overall Study|Adverse Event|5|||
94570622|NCT03192176|323887451|FG004|Overall Study|Adverse Event|3|||
94570623|NCT03192176|323887452|FG005|Overall Study|Adverse Event|2|||
94570624|NCT03192176|323887453|FG006|Overall Study|Adverse Event|3|||
94570625|NCT03192176|323887454|FG007|Overall Study|Adverse Event|3|||
94570626|NCT03192176|323887447|FG000|Overall Study|Lost to Follow-up|0|||
94570627|NCT03192176|323887448|FG001|Overall Study|Lost to Follow-up|0|||
94570628|NCT03192176|323887449|FG002|Overall Study|Lost to Follow-up|1|||
94570629|NCT03192176|323887450|FG003|Overall Study|Lost to Follow-up|2|||
94570630|NCT03192176|323887451|FG004|Overall Study|Lost to Follow-up|3|||
94570631|NCT03192176|323887452|FG005|Overall Study|Lost to Follow-up|1|||
94570632|NCT03192176|323887453|FG006|Overall Study|Lost to Follow-up|1|||
94570633|NCT03192176|323887454|FG007|Overall Study|Lost to Follow-up|1|||
94570634|NCT03192176|323887447|FG000|Overall Study|Physician Decision|1|||
94570635|NCT03192176|323887448|FG001|Overall Study|Physician Decision|0|||
94570636|NCT03192176|323887449|FG002|Overall Study|Physician Decision|0|||
94570637|NCT03192176|323887450|FG003|Overall Study|Physician Decision|0|||
94570638|NCT03192176|323887451|FG004|Overall Study|Physician Decision|0|||
94570639|NCT03192176|323887452|FG005|Overall Study|Physician Decision|2|||
94570640|NCT03192176|323887453|FG006|Overall Study|Physician Decision|1|||
94570641|NCT03192176|323887454|FG007|Overall Study|Physician Decision|0|||
94570642|NCT03192176|323887447|FG000|Overall Study|Protocol Deviation|1|||
94570643|NCT03192176|323887448|FG001|Overall Study|Protocol Deviation|1|||
94570644|NCT03192176|323887449|FG002|Overall Study|Protocol Deviation|0|||
94570645|NCT03192176|323887450|FG003|Overall Study|Protocol Deviation|0|||
94570646|NCT03192176|323887451|FG004|Overall Study|Protocol Deviation|2|||
94570647|NCT03192176|323887452|FG005|Overall Study|Protocol Deviation|0|||
94570648|NCT03192176|323887453|FG006|Overall Study|Protocol Deviation|0|||
94570649|NCT03192176|323887454|FG007|Overall Study|Protocol Deviation|0|||
94570650|NCT03192176|323887447|FG000|Overall Study|Withdrawal by Subject|3|||
94570651|NCT03192176|323887448|FG001|Overall Study|Withdrawal by Subject|4|||
94570652|NCT03192176|323887449|FG002|Overall Study|Withdrawal by Subject|0|||
94570653|NCT03192176|323887450|FG003|Overall Study|Withdrawal by Subject|4|||
94570654|NCT03192176|323887451|FG004|Overall Study|Withdrawal by Subject|3|||
94570655|NCT03192176|323887452|FG005|Overall Study|Withdrawal by Subject|4|||
94570656|NCT03192176|323887453|FG006|Overall Study|Withdrawal by Subject|4|||
94570657|NCT03192176|323887454|FG007|Overall Study|Withdrawal by Subject|2|||
94570658|NCT03192176|323887447|FG000|Overall Study|Miscellaneous|1|||
94570659|NCT03192176|323887448|FG001|Overall Study|Miscellaneous|0|||
94570660|NCT03192176|323887449|FG002|Overall Study|Miscellaneous|1|||
94570661|NCT03192176|323887450|FG003|Overall Study|Miscellaneous|1|||
94570662|NCT03192176|323887451|FG004|Overall Study|Miscellaneous|1|||
94570663|NCT03192176|323887452|FG005|Overall Study|Miscellaneous|2|||
94570664|NCT03192176|323887453|FG006|Overall Study|Miscellaneous|0|||
94570665|NCT03192176|323887454|FG007|Overall Study|Miscellaneous|1|||
94570666|NCT04349891|323887455|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
94570667|NCT04349891|323887456|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
94570668|NCT04349891|323887455|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
94570669|NCT04349891|323887456|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
94570670|NCT04349891|323887455|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
94570671|NCT04349891|323887456|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
94570672|NCT04349891|323887455|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
94570673|NCT04349891|323887456|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
94570674|NCT00667628|323887459|FG000|Overall Study|Lost to Follow-up|1|||
94570675|NCT00667628|323887460|FG001|Overall Study|Lost to Follow-up|0|||
94570676|NCT00667628|323887459|FG000|Overall Study|Death|6|||
94570677|NCT00667628|323887460|FG001|Overall Study|Death|6|||
94570678|NCT00667628|323887459|FG000|Overall Study|Investigator Considers in Best Interest|1|||
94570679|NCT00667628|323887460|FG001|Overall Study|Investigator Considers in Best Interest|0|||
94451653|NCT02527434|323441799|FG002|Overall Study|Site closure|0|||
94451654|NCT01322490|323441800|FG000|Treatment Period|Adverse Event|12|||
94451655|NCT01322490|323441801|FG001|Treatment Period|Adverse Event|18|||
94451656|NCT01322490|323441802|FG002|Treatment Period|Adverse Event|15|||
94451657|NCT01322490|323441800|FG000|Treatment Period|Death|5|||
94451658|NCT01322490|323441801|FG001|Treatment Period|Death|7|||
94451659|NCT01322490|323441802|FG002|Treatment Period|Death|3|||
94451660|NCT01322490|323441800|FG000|Treatment Period|Lack of Efficacy|89|||
94570680|NCT00667628|323887459|FG000|Overall Study|Sponsor Terminated Study|17|||
94570681|NCT00667628|323887460|FG001|Overall Study|Sponsor Terminated Study|21|||
94570682|NCT01962441|323887461|FG000|Randomized Period|Randomized but Never Treated|4|||
94570683|NCT01962441|323887462|FG001|Randomized Period|Randomized but Never Treated|2|||
94570684|NCT01962441|323887463|FG002|Randomized Period|Randomized but Never Treated|3|||
94570685|NCT01962441|323887461|FG000|Randomized Period|Lost to Follow-up|2|||
94570686|NCT01962441|323887462|FG001|Randomized Period|Lost to Follow-up|4|||
94570687|NCT01962441|323887463|FG002|Randomized Period|Lost to Follow-up|4|||
94570688|NCT01962441|323887461|FG000|Randomized Period|Withdrew Consent|3|||
94570689|NCT01962441|323887462|FG001|Randomized Period|Withdrew Consent|3|||
94570690|NCT01962441|323887463|FG002|Randomized Period|Withdrew Consent|2|||
94451661|NCT01322490|323441801|FG001|Treatment Period|Lack of Efficacy|100|||
94451662|NCT01322490|323441802|FG002|Treatment Period|Lack of Efficacy|112|||
94451663|NCT01322490|323441800|FG000|Treatment Period|Physician Decision|0|||
94570691|NCT01962441|323887461|FG000|Randomized Period|Adverse Event|1|||
94570692|NCT01962441|323887462|FG001|Randomized Period|Adverse Event|1|||
94570693|NCT01962441|323887463|FG002|Randomized Period|Adverse Event|0|||
94570694|NCT01962441|323887461|FG000|Randomized Period|Death|0|||
94570695|NCT01962441|323887462|FG001|Randomized Period|Death|0|||
94570696|NCT01962441|323887463|FG002|Randomized Period|Death|2|||
94570697|NCT01962441|323887461|FG000|Randomized Period|Protocol Violation|0|||
94570698|NCT01962441|323887462|FG001|Randomized Period|Protocol Violation|1|||
94570699|NCT01962441|323887463|FG002|Randomized Period|Protocol Violation|0|||
94570700|NCT01962441|323887461|FG000|Retreatment Substudy|Lack of Efficacy|1|||
94570701|NCT01962441|323887462|FG001|Retreatment Substudy|Lack of Efficacy|0|||
94570702|NCT01962441|323887463|FG002|Retreatment Substudy|Lack of Efficacy|0|||
94570703|NCT01962441|323887461|FG000|Retreatment Substudy|Lost to Follow-up|1|||
94570704|NCT01962441|323887462|FG001|Retreatment Substudy|Lost to Follow-up|0|||
94570705|NCT01962441|323887463|FG002|Retreatment Substudy|Lost to Follow-up|0|||
94570706|NCT00423657|323887464|FG000|Overall Study|Withdrew consent|10|||
94570707|NCT00423657|323887465|FG001|Overall Study|Withdrew consent|8|||
94570708|NCT00423657|323887464|FG000|Overall Study|Non-compliance|0|||
94570709|NCT00423657|323887465|FG001|Overall Study|Non-compliance|1|||
94570710|NCT00423657|323887464|FG000|Overall Study|Other|15|||
94570711|NCT00423657|323887465|FG001|Overall Study|Other|16|||
94570712|NCT00423657|323887464|FG000|Overall Study|Request of sponsor/investigator|1|||
94570713|NCT00423657|323887465|FG001|Overall Study|Request of sponsor/investigator|0|||
94570714|NCT02542865|323887466|FG000|Overall Study|Identified as screen failure|1|||
94570715|NCT02542865|323887467|FG001|Overall Study|Identified as screen failure|0|||
94570716|NCT02542865|323887466|FG000|Overall Study|Withdrawal by Subject|16|||
94570717|NCT02542865|323887467|FG001|Overall Study|Withdrawal by Subject|0|||
94570718|NCT05083351|323887468|FG000|Overall Study|Adverse Event|3|||
94570719|NCT05083351|323887468|FG000|Overall Study|Did not meet data inclusion criteria|8|||
94570720|NCT05083351|323887468|FG000|Overall Study|Did not meet eligibility criteria|19|||
94570721|NCT05083351|323887468|FG000|Overall Study|Study Staff Decision|19|||
94570722|NCT00539981|323887469|FG000|Overall Study|Adverse events (AE)|3|||
94570723|NCT00539981|323887470|FG001|Overall Study|Adverse events (AE)|3|||
94570724|NCT00539981|323887469|FG000|Overall Study|Lost to Follow-up|260|||
94570725|NCT00539981|323887470|FG001|Overall Study|Lost to Follow-up|251|||
94570726|NCT00539981|323887469|FG000|Overall Study|Withdrew consent|22|||
94570727|NCT00539981|323887470|FG001|Overall Study|Withdrew consent|14|||
94570728|NCT00539981|323887469|FG000|Overall Study|Death|1|||
94570729|NCT00539981|323887470|FG001|Overall Study|Death|1|||
94570730|NCT00539981|323887469|FG000|Overall Study|Other reason-unspecified|9|||
94570731|NCT00539981|323887470|FG001|Overall Study|Other reason-unspecified|13|||
94570732|NCT03416868|323887472|FG000|Overall Study|Withdrawal by Subject|2|||
94570733|NCT03416868|323887472|FG000|Overall Study|Lost to Follow-up|1|||
94570734|NCT01323582|323887473|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
94570735|NCT01323582|323887474|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
94570736|NCT01323582|323887473|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
94570737|NCT01323582|323887474|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
94570738|NCT01323582|323887473|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
94570739|NCT01323582|323887474|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
94570740|NCT01759420|323887475|FG000|Overall Study|Screen failure|5|||
94570741|NCT01759420|323887475|FG000|Overall Study|Inaccurate EKG machine readings|1|||
94570742|NCT01129622|323887478|FG000|Overall Study|Withdrawal by Subject|2|||
94570743|NCT02898454|323887479|FG000|Overall Study|Adverse Event|4|||
94570744|NCT02898454|323887480|FG001|Overall Study|Adverse Event|1|||
94570745|NCT02898454|323887481|FG002|Overall Study|Adverse Event|2|||
94570746|NCT02898454|323887479|FG000|Overall Study|Protocol Violation|1|||
94570747|NCT02898454|323887480|FG001|Overall Study|Protocol Violation|0|||
94570748|NCT02898454|323887481|FG002|Overall Study|Protocol Violation|1|||
94570749|NCT02898454|323887479|FG000|Overall Study|Lack of Efficacy|4|||
94570750|NCT02898454|323887480|FG001|Overall Study|Lack of Efficacy|1|||
94570751|NCT02898454|323887481|FG002|Overall Study|Lack of Efficacy|0|||
94570752|NCT02898454|323887479|FG000|Overall Study|Withdrawal by Subject|6|||
94570753|NCT02898454|323887480|FG001|Overall Study|Withdrawal by Subject|3|||
94570754|NCT02898454|323887481|FG002|Overall Study|Withdrawal by Subject|3|||
94570755|NCT02898454|323887479|FG000|Overall Study|Lost to Follow-up|1|||
94570756|NCT02898454|323887480|FG001|Overall Study|Lost to Follow-up|0|||
94570757|NCT02898454|323887481|FG002|Overall Study|Lost to Follow-up|0|||
94570758|NCT02898454|323887479|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
94570759|NCT02898454|323887480|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
94451664|NCT01322490|323441801|FG001|Treatment Period|Physician Decision|2|||
94451665|NCT01322490|323441802|FG002|Treatment Period|Physician Decision|1|||
94451666|NCT01322490|323441800|FG000|Treatment Period|Protocol Violation|7|||
94570760|NCT02898454|323887481|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
94570761|NCT03040141|323887484|FG000|Overall Study|Death|1|||
94570762|NCT03040141|323887485|FG001|Overall Study|Death|2|||
94570763|NCT03040141|323887486|FG002|Overall Study|Death|3|||
94570764|NCT03040141|323887484|FG000|Overall Study|Withdrawal by Subject|3|||
94451667|NCT01322490|323441801|FG001|Treatment Period|Protocol Violation|5|||
94451668|NCT01322490|323441802|FG002|Treatment Period|Protocol Violation|4|||
94570765|NCT03040141|323887485|FG001|Overall Study|Withdrawal by Subject|1|||
94570766|NCT03040141|323887486|FG002|Overall Study|Withdrawal by Subject|1|||
94570767|NCT03040141|323887484|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
94570768|NCT03040141|323887485|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
94570769|NCT03040141|323887486|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
94570770|NCT03040141|323887484|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
94570771|NCT03040141|323887485|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
94570772|NCT03040141|323887486|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
94570773|NCT03473236|323887487|FG000|Overall Study|Withdrawal by Subject|0|||
94570774|NCT03473236|323887488|FG001|Overall Study|Withdrawal by Subject|0|||
94570775|NCT03473236|323887489|FG002|Overall Study|Withdrawal by Subject|0|||
94570776|NCT03473236|323887490|FG003|Overall Study|Withdrawal by Subject|0|||
94570777|NCT03473236|323887491|FG004|Overall Study|Withdrawal by Subject|0|||
94570778|NCT03473236|323887492|FG005|Overall Study|Withdrawal by Subject|1|||
94570779|NCT03473236|323887493|FG006|Overall Study|Withdrawal by Subject|0|||
94570780|NCT03473236|323887494|FG007|Overall Study|Withdrawal by Subject|0|||
94570781|NCT03473236|323887495|FG008|Overall Study|Withdrawal by Subject|1|||
94570782|NCT03473236|323887496|FG009|Overall Study|Withdrawal by Subject|0|||
94570783|NCT02922725|323887498|FG000|Overall Study|Withdrawal by Subject|1|||
94570784|NCT02922725|323887499|FG001|Overall Study|Withdrawal by Subject|0|||
94570785|NCT02922725|323887500|FG002|Overall Study|Withdrawal by Subject|0|||
94570786|NCT01300234|323887501|FG000|Overall Study|Adverse Event|1|||
94570787|NCT01300234|323887502|FG001|Overall Study|Adverse Event|1|||
94570788|NCT01300234|323887501|FG000|Overall Study|Protocol Violation|2|||
94570789|NCT01300234|323887502|FG001|Overall Study|Protocol Violation|3|||
94570790|NCT01300234|323887501|FG000|Overall Study|Withdrawal by Subject|5|||
94570791|NCT01300234|323887502|FG001|Overall Study|Withdrawal by Subject|9|||
94570792|NCT01300234|323887501|FG000|Overall Study|Lost to Follow-up|14|||
94570793|NCT01300234|323887502|FG001|Overall Study|Lost to Follow-up|12|||
94570794|NCT01300234|323887501|FG000|Overall Study|Pregnancy|2|||
94570795|NCT01300234|323887502|FG001|Overall Study|Pregnancy|1|||
94570796|NCT01300234|323887501|FG000|Overall Study|Participant reached stopping critera|2|||
94570797|NCT01300234|323887502|FG001|Overall Study|Participant reached stopping critera|0|||
94570798|NCT01300234|323887501|FG000|Overall Study|Participant stopped medication|1|||
94570799|NCT01300234|323887502|FG001|Overall Study|Participant stopped medication|1|||
94570800|NCT01300234|323887501|FG000|Overall Study|Participant refused return to hospital|1|||
94570801|NCT01300234|323887502|FG001|Overall Study|Participant refused return to hospital|0|||
94570802|NCT00154297|323887505|FG000|Overall Study|Death|5|||
94570803|NCT00154297|323887506|FG001|Overall Study|Death|2|||
94570804|NCT00154297|323887505|FG000|Overall Study|Withdrawal by Subject|0|||
94570805|NCT00154297|323887506|FG001|Overall Study|Withdrawal by Subject|5|||
94570806|NCT00154297|323887505|FG000|Overall Study|Lost to Follow-up|3|||
94570807|NCT00154297|323887506|FG001|Overall Study|Lost to Follow-up|0|||
94570808|NCT03077542|323887507|FG000|Overall Study|Death|4|||
94570809|NCT03077542|323887508|FG001|Overall Study|Death|0|||
94570810|NCT03077542|323887507|FG000|Overall Study|Physician Decision|6|||
94570811|NCT03077542|323887508|FG001|Overall Study|Physician Decision|1|||
94570812|NCT03077542|323887507|FG000|Overall Study|Withdrawal by Subject|0|||
94570813|NCT03077542|323887508|FG001|Overall Study|Withdrawal by Subject|1|||
94570814|NCT03649074|323887509|FG000|Overall Study|Lost to Follow-up|2|||
94570815|NCT03649074|323887510|FG001|Overall Study|Lost to Follow-up|1|||
94570816|NCT03649074|323887509|FG000|Overall Study|Adverse Event|1|||
94570817|NCT03649074|323887510|FG001|Overall Study|Adverse Event|0|||
94570818|NCT03649074|323887509|FG000|Overall Study|Physician Decision|1|||
94570819|NCT03649074|323887510|FG001|Overall Study|Physician Decision|0|||
94570820|NCT03649074|323887509|FG000|Overall Study|Withdrawal by Subject|0|||
94658794|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
94348393|NCT00606021|323056124|FG000|Induction Phase|Withdrawal by Subject|2|||
94348394|NCT00606021|323056125|FG001|Induction Phase|Withdrawal by Subject|0|||
94348395|NCT00606021|323056126|FG002|Induction Phase|Withdrawal by Subject|0|||
94348396|NCT00606021|323056124|FG000|Induction Phase|Lost to Follow-up|10|||
94348397|NCT00606021|323056125|FG001|Induction Phase|Lost to Follow-up|0|||
94348398|NCT00606021|323056126|FG002|Induction Phase|Lost to Follow-up|0|||
94348399|NCT00606021|323056124|FG000|Maintenance Phase|Death|0|||
94348400|NCT00606021|323056125|FG001|Maintenance Phase|Death|17|||
94348401|NCT00606021|323056126|FG002|Maintenance Phase|Death|15|||
94348402|NCT00606021|323056124|FG000|Maintenance Phase|Physician Decision|0|||
94570821|NCT03649074|323887510|FG001|Overall Study|Withdrawal by Subject|2|||
94570822|NCT03649074|323887509|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
94570823|NCT03649074|323887510|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
94570824|NCT03649074|323887509|FG000|Overall Study|Other|1|||
94570825|NCT03649074|323887510|FG001|Overall Study|Other|0|||
94570826|NCT00301808|323887516|FG000|Overall Study|Adverse Event|5|||
94348403|NCT00606021|323056125|FG001|Maintenance Phase|Physician Decision|1|||
94348404|NCT00606021|323056126|FG002|Maintenance Phase|Physician Decision|0|||
94570827|NCT00301808|323887516|FG000|Overall Study|Death|3|||
94570828|NCT00301808|323887516|FG000|Overall Study|Lack of Efficacy|4|||
94570829|NCT02354235|323887517|FG000|Overall Study|Adverse Event|2|||
94570830|NCT02354235|323887518|FG001|Overall Study|Adverse Event|2|||
94570831|NCT02354235|323887517|FG000|Overall Study|Physician Decision|0|||
94570832|NCT02354235|323887518|FG001|Overall Study|Physician Decision|1|||
94570833|NCT02354235|323887517|FG000|Overall Study|Withdrawal by Subject|1|||
94570834|NCT02354235|323887518|FG001|Overall Study|Withdrawal by Subject|3|||
94570835|NCT02354235|323887517|FG000|Overall Study|Conflict with the stopping criteria|0|||
94570836|NCT02354235|323887518|FG001|Overall Study|Conflict with the stopping criteria|1|||
94570837|NCT03863509|323887519|FG000|Overall Study|COVID-19 shutdown period|0|||
94570838|NCT03863509|323887520|FG001|Overall Study|COVID-19 shutdown period|4|||
94570839|NCT03863509|323887521|FG002|Overall Study|COVID-19 shutdown period|0|||
94570840|NCT03863509|323887519|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
94570841|NCT03863509|323887520|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
94570842|NCT03863509|323887521|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
94570843|NCT03863509|323887519|FG000|Overall Study|Lost to Follow-up|8|||
94570844|NCT03863509|323887520|FG001|Overall Study|Lost to Follow-up|0|||
94570845|NCT03863509|323887521|FG002|Overall Study|Lost to Follow-up|2|||
94570846|NCT03863509|323887519|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
94570847|NCT03863509|323887520|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
94570848|NCT03863509|323887521|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
94570849|NCT03863509|323887519|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
94570850|NCT03863509|323887520|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
94570851|NCT03863509|323887521|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
94570852|NCT02671435|323887522|FG000|Overall Study|Death|1|||
94570853|NCT02671435|323887523|FG001|Overall Study|Death|3|||
94570854|NCT02671435|323887524|FG002|Overall Study|Death|0|||
94570855|NCT02671435|323887525|FG003|Overall Study|Death|16|||
94570856|NCT02671435|323887526|FG004|Overall Study|Death|14|||
94570857|NCT02671435|323887527|FG005|Overall Study|Death|29|||
94570858|NCT02671435|323887528|FG006|Overall Study|Death|34|||
94570859|NCT02671435|323887529|FG007|Overall Study|Death|28|||
94570860|NCT02671435|323887530|FG008|Overall Study|Death|19|||
94570861|NCT02671435|323887531|FG009|Overall Study|Death|10|||
94570862|NCT02671435|323887532|FG010|Overall Study|Death|8|||
94570863|NCT02671435|323887533|FG011|Overall Study|Death|29|||
94570864|NCT02671435|323887534|FG012|Overall Study|Death|29|||
94570865|NCT02671435|323887535|FG013|Overall Study|Death|29|||
94570866|NCT02671435|323887536|FG014|Overall Study|Death|27|||
94570867|NCT02671435|323887522|FG000|Overall Study|Lost to Follow-up|0|||
94570868|NCT02671435|323887523|FG001|Overall Study|Lost to Follow-up|0|||
94570869|NCT02671435|323887524|FG002|Overall Study|Lost to Follow-up|1|||
94570870|NCT02671435|323887525|FG003|Overall Study|Lost to Follow-up|0|||
94570871|NCT02671435|323887526|FG004|Overall Study|Lost to Follow-up|1|||
94570872|NCT02671435|323887527|FG005|Overall Study|Lost to Follow-up|1|||
94348405|NCT00606021|323056124|FG000|Maintenance Phase|Lost to Follow-up|0|||
94348406|NCT00606021|323056125|FG001|Maintenance Phase|Lost to Follow-up|5|||
94348407|NCT00606021|323056126|FG002|Maintenance Phase|Lost to Follow-up|2|||
94348408|NCT02380703|323056127|FG000|Overall Study|Withdrawal by Subject|12|||
94570873|NCT02671435|323887528|FG006|Overall Study|Lost to Follow-up|2|||
94570874|NCT02671435|323887529|FG007|Overall Study|Lost to Follow-up|2|||
94570875|NCT02671435|323887530|FG008|Overall Study|Lost to Follow-up|0|||
94570876|NCT02671435|323887531|FG009|Overall Study|Lost to Follow-up|2|||
94570877|NCT02671435|323887532|FG010|Overall Study|Lost to Follow-up|0|||
94570878|NCT02671435|323887533|FG011|Overall Study|Lost to Follow-up|3|||
94570879|NCT02671435|323887534|FG012|Overall Study|Lost to Follow-up|3|||
94570880|NCT02671435|323887535|FG013|Overall Study|Lost to Follow-up|2|||
94570881|NCT02671435|323887536|FG014|Overall Study|Lost to Follow-up|0|||
94570882|NCT02671435|323887522|FG000|Overall Study|Withdrawal by Subject|2|||
94570883|NCT02671435|323887523|FG001|Overall Study|Withdrawal by Subject|0|||
94348409|NCT02380703|323056128|FG001|Overall Study|Withdrawal by Subject|9|||
94348410|NCT02380703|323056127|FG000|Overall Study|Lost to Follow-up|12|||
94348411|NCT02380703|323056128|FG001|Overall Study|Lost to Follow-up|12|||
94570884|NCT02671435|323887524|FG002|Overall Study|Withdrawal by Subject|2|||
94570885|NCT02671435|323887525|FG003|Overall Study|Withdrawal by Subject|2|||
94570886|NCT02671435|323887526|FG004|Overall Study|Withdrawal by Subject|2|||
94570887|NCT02671435|323887527|FG005|Overall Study|Withdrawal by Subject|7|||
94570888|NCT02671435|323887528|FG006|Overall Study|Withdrawal by Subject|2|||
94570889|NCT02671435|323887529|FG007|Overall Study|Withdrawal by Subject|7|||
94348412|NCT02380703|323056127|FG000|Overall Study|Caregiver death|1|||
94348413|NCT02380703|323056128|FG001|Overall Study|Caregiver death|0|||
94570890|NCT02671435|323887530|FG008|Overall Study|Withdrawal by Subject|1|||
94570891|NCT02671435|323887531|FG009|Overall Study|Withdrawal by Subject|1|||
94348414|NCT02380703|323056127|FG000|Overall Study|Person with dementia (PWD) death|7|||
94570892|NCT02671435|323887532|FG010|Overall Study|Withdrawal by Subject|2|||
94570893|NCT02671435|323887533|FG011|Overall Study|Withdrawal by Subject|4|||
94570894|NCT02671435|323887534|FG012|Overall Study|Withdrawal by Subject|4|||
94570895|NCT02671435|323887535|FG013|Overall Study|Withdrawal by Subject|4|||
94570896|NCT02671435|323887536|FG014|Overall Study|Withdrawal by Subject|2|||
94570897|NCT02671435|323887522|FG000|Overall Study|Un-specified|0|||
94570898|NCT02671435|323887523|FG001|Overall Study|Un-specified|0|||
94570899|NCT02671435|323887524|FG002|Overall Study|Un-specified|0|||
94570900|NCT02671435|323887525|FG003|Overall Study|Un-specified|0|||
94570901|NCT02671435|323887526|FG004|Overall Study|Un-specified|1|||
94570902|NCT02671435|323887527|FG005|Overall Study|Un-specified|3|||
94570903|NCT02671435|323887528|FG006|Overall Study|Un-specified|2|||
94570904|NCT02671435|323887529|FG007|Overall Study|Un-specified|3|||
94570905|NCT02671435|323887530|FG008|Overall Study|Un-specified|0|||
94570906|NCT02671435|323887531|FG009|Overall Study|Un-specified|5|||
94570907|NCT02671435|323887532|FG010|Overall Study|Un-specified|8|||
94570908|NCT02671435|323887533|FG011|Overall Study|Un-specified|4|||
94570909|NCT02671435|323887534|FG012|Overall Study|Un-specified|5|||
94570910|NCT02671435|323887535|FG013|Overall Study|Un-specified|9|||
94570911|NCT02671435|323887536|FG014|Overall Study|Un-specified|8|||
94570912|NCT05893862|323887537|FG000|Overall Study|Physician Decision|0|||
94570913|NCT05893862|323887538|FG001|Overall Study|Physician Decision|1|||
94570914|NCT05893862|323887539|FG002|Overall Study|Physician Decision|0|||
94570915|NCT05893862|323887540|FG003|Overall Study|Physician Decision|0|||
94570916|NCT05893862|323887541|FG004|Overall Study|Physician Decision|1|||
94570917|NCT05893862|323887542|FG005|Overall Study|Physician Decision|0|||
94570918|NCT05893862|323887537|FG000|Overall Study|Withdrawal by Subject|1|||
94570919|NCT05893862|323887538|FG001|Overall Study|Withdrawal by Subject|7|||
94570920|NCT05893862|323887539|FG002|Overall Study|Withdrawal by Subject|1|||
94570921|NCT05893862|323887540|FG003|Overall Study|Withdrawal by Subject|3|||
94570922|NCT05893862|323887541|FG004|Overall Study|Withdrawal by Subject|3|||
94570923|NCT05893862|323887542|FG005|Overall Study|Withdrawal by Subject|2|||
94570924|NCT05893862|323887537|FG000|Overall Study|Adverse Event|1|||
94238168|NCT03443414|322666590|FG004|Overall Study|Death|0|||
94238169|NCT03443414|322666586|FG000|Overall Study|Reason not specified|2|||
94238170|NCT03443414|322666587|FG001|Overall Study|Reason not specified|0|||
94238171|NCT03443414|322666588|FG002|Overall Study|Reason not specified|0|||
94238172|NCT03443414|322666589|FG003|Overall Study|Reason not specified|0|||
94570925|NCT05893862|323887538|FG001|Overall Study|Adverse Event|4|||
94570926|NCT05893862|323887539|FG002|Overall Study|Adverse Event|2|||
94570927|NCT05893862|323887540|FG003|Overall Study|Adverse Event|2|||
94570928|NCT05893862|323887541|FG004|Overall Study|Adverse Event|1|||
94570929|NCT05893862|323887542|FG005|Overall Study|Adverse Event|0|||
94570930|NCT00990106|323887545|FG000|Overall Study|"too busy to continue"|1|||
94570931|NCT00990106|323887546|FG001|Overall Study|"too busy to continue"|2|||
94570932|NCT00990106|323887545|FG000|Overall Study|Lost to Follow-up|1|||
94570933|NCT00990106|323887546|FG001|Overall Study|Lost to Follow-up|3|||
94570934|NCT00990106|323887545|FG000|Overall Study|Withdrawal by Subject|2|||
94570935|NCT00990106|323887546|FG001|Overall Study|Withdrawal by Subject|1|||
94570936|NCT00990106|323887545|FG000|Overall Study|opted for open label prazosin|1|||
94570937|NCT00990106|323887546|FG001|Overall Study|opted for open label prazosin|1|||
94570938|NCT00990106|323887545|FG000|Overall Study|relocation/deployment|4|||
94570939|NCT00990106|323887546|FG001|Overall Study|relocation/deployment|1|||
94570940|NCT00990106|323887545|FG000|Overall Study|started exclusionary medication|0|||
94570941|NCT00990106|323887546|FG001|Overall Study|started exclusionary medication|1|||
94570942|NCT00990106|323887545|FG000|Overall Study|planned major surgery|0|||
94570943|NCT00990106|323887546|FG001|Overall Study|planned major surgery|1|||
94570944|NCT00990106|323887545|FG000|Overall Study|scheduling conflicts|0|||
94570945|NCT00990106|323887546|FG001|Overall Study|scheduling conflicts|2|||
94570946|NCT02782949|323887548|FG000|Overall Study|Protocol Violation|1|||
94570947|NCT02782949|323887549|FG001|Overall Study|Protocol Violation|0|||
94570948|NCT02782949|323887548|FG000|Overall Study|Withdrawal by Subject|0|||
94570949|NCT02782949|323887549|FG001|Overall Study|Withdrawal by Subject|1|||
94570950|NCT00280917|323890249|FG000|Overall Study|Adverse Event|1|||
94570951|NCT00280917|323890250|FG001|Overall Study|Adverse Event|1|||
94570952|NCT00280917|323890251|FG002|Overall Study|Adverse Event|4|||
94570953|NCT00280917|323890252|FG003|Overall Study|Adverse Event|1|||
94570954|NCT00280917|323890249|FG000|Overall Study|Change Therapy|1|||
94570955|NCT00280917|323890250|FG001|Overall Study|Change Therapy|2|||
94570956|NCT00280917|323890251|FG002|Overall Study|Change Therapy|0|||
94570957|NCT00280917|323890252|FG003|Overall Study|Change Therapy|0|||
94570958|NCT00280917|323890249|FG000|Overall Study|Withdrawal by Subject|0|||
94570959|NCT00280917|323890250|FG001|Overall Study|Withdrawal by Subject|2|||
94570960|NCT00280917|323890251|FG002|Overall Study|Withdrawal by Subject|0|||
94570961|NCT00280917|323890252|FG003|Overall Study|Withdrawal by Subject|1|||
94570962|NCT00280917|323890249|FG000|Overall Study|Noncompliance|0|||
94570963|NCT00280917|323890250|FG001|Overall Study|Noncompliance|1|||
94570964|NCT00280917|323890251|FG002|Overall Study|Noncompliance|2|||
94570965|NCT00280917|323890252|FG003|Overall Study|Noncompliance|0|||
94570966|NCT00966654|323890253|FG000|Overall Study|Study was terminated,PI left institution|12|||
94570967|NCT03858049|323890256|FG000|Overall Study|Adverse Event|16|||
94570968|NCT03858049|323890257|FG001|Overall Study|Adverse Event|9|||
94570969|NCT03858049|323890256|FG000|Overall Study|Other|1|||
94570970|NCT03858049|323890257|FG001|Overall Study|Other|1|||
94570971|NCT00762359|323890258|FG000|Overall Study|Adverse Event|20|||
94570972|NCT00762359|323890259|FG001|Overall Study|Adverse Event|23|||
94570973|NCT00762359|323890258|FG000|Overall Study|Protocol Violation|21|||
94570974|NCT00762359|323890259|FG001|Overall Study|Protocol Violation|13|||
94570975|NCT00762359|323890258|FG000|Overall Study|Withdrawal by Subject|13|||
94570976|NCT00762359|323890259|FG001|Overall Study|Withdrawal by Subject|10|||
94570977|NCT00762359|323890258|FG000|Overall Study|Lack of Efficacy|0|||
94570978|NCT00762359|323890259|FG001|Overall Study|Lack of Efficacy|4|||
94570979|NCT00762359|323890258|FG000|Overall Study|Institution closed|2|||
94570980|NCT00762359|323890259|FG001|Overall Study|Institution closed|3|||
94570981|NCT00762359|323890258|FG000|Overall Study|Physician Decision|2|||
94570982|NCT00762359|323890259|FG001|Overall Study|Physician Decision|3|||
94570983|NCT00762359|323890258|FG000|Overall Study|Removal|0|||
94570984|NCT00762359|323890259|FG001|Overall Study|Removal|1|||
94570985|NCT00762359|323890258|FG000|Overall Study|Withdrew consent|1|||
94570986|NCT00762359|323890259|FG001|Overall Study|Withdrew consent|0|||
94570987|NCT01690052|323890260|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
94570988|NCT01690052|323890261|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
94570989|NCT01453049|323890262|FG000|Overall Study|Protocol Violation|2|||
94658795|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
94570990|NCT01453049|323890263|FG001|Overall Study|Protocol Violation|5|||
94570991|NCT01453049|323890262|FG000|Overall Study|Lost to Follow-up|2|||
94570992|NCT01453049|323890263|FG001|Overall Study|Lost to Follow-up|1|||
94658796|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
94658797|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
94570993|NCT01453049|323890262|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
94570994|NCT01453049|323890263|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
94570995|NCT01453049|323890262|FG000|Overall Study|Withdrawal by Subject|1|||
94570996|NCT01453049|323890263|FG001|Overall Study|Withdrawal by Subject|0|||
94570997|NCT01453049|323890262|FG000|Overall Study|Randomized in Error|1|||
94570998|NCT01453049|323890263|FG001|Overall Study|Randomized in Error|0|||
94570999|NCT00882440|323890264|FG000|Overall Study|Adverse Event|2|||
94571000|NCT00882440|323890265|FG001|Overall Study|Adverse Event|2|||
94571001|NCT00882440|323890266|FG002|Overall Study|Adverse Event|2|||
94571002|NCT00882440|323890267|FG003|Overall Study|Adverse Event|1|||
94571003|NCT00882440|323890268|FG004|Overall Study|Adverse Event|1|||
94571004|NCT00882440|323890269|FG005|Overall Study|Adverse Event|4|||
94571005|NCT00882440|323890270|FG006|Overall Study|Adverse Event|2|||
94571006|NCT00882440|323890264|FG000|Overall Study|Lack of Efficacy|3|||
94571007|NCT00882440|323890265|FG001|Overall Study|Lack of Efficacy|5|||
94571008|NCT00882440|323890266|FG002|Overall Study|Lack of Efficacy|2|||
94571009|NCT00882440|323890267|FG003|Overall Study|Lack of Efficacy|0|||
94571010|NCT00882440|323890268|FG004|Overall Study|Lack of Efficacy|0|||
94571011|NCT00882440|323890269|FG005|Overall Study|Lack of Efficacy|3|||
94571012|NCT00882440|323890270|FG006|Overall Study|Lack of Efficacy|0|||
94571013|NCT00882440|323890264|FG000|Overall Study|Lost to Follow-up|2|||
94571014|NCT00882440|323890265|FG001|Overall Study|Lost to Follow-up|0|||
94238173|NCT03443414|322666590|FG004|Overall Study|Reason not specified|1|||
94238174|NCT00732992|322666591|FG000|Overall Study|Adverse Event|1|||
94238175|NCT00732992|322666592|FG001|Overall Study|Adverse Event|1|||
94238176|NCT00732992|322666591|FG000|Overall Study|Objective Progression or Relapse|3|||
94238177|NCT00732992|322666592|FG001|Overall Study|Objective Progression or Relapse|5|||
94571015|NCT00882440|323890266|FG002|Overall Study|Lost to Follow-up|1|||
94571016|NCT00882440|323890267|FG003|Overall Study|Lost to Follow-up|1|||
94571017|NCT00882440|323890268|FG004|Overall Study|Lost to Follow-up|1|||
94571018|NCT00882440|323890269|FG005|Overall Study|Lost to Follow-up|0|||
94571019|NCT00882440|323890270|FG006|Overall Study|Lost to Follow-up|1|||
94571020|NCT00882440|323890264|FG000|Overall Study|Protocol Violation|0|||
94571021|NCT00882440|323890265|FG001|Overall Study|Protocol Violation|0|||
94571022|NCT00882440|323890266|FG002|Overall Study|Protocol Violation|1|||
94571023|NCT00882440|323890267|FG003|Overall Study|Protocol Violation|1|||
94571024|NCT00882440|323890268|FG004|Overall Study|Protocol Violation|1|||
94571025|NCT00882440|323890269|FG005|Overall Study|Protocol Violation|0|||
94571026|NCT00882440|323890270|FG006|Overall Study|Protocol Violation|0|||
94571027|NCT00882440|323890264|FG000|Overall Study|Withdrawal by Subject|2|||
94571028|NCT00882440|323890265|FG001|Overall Study|Withdrawal by Subject|1|||
94571029|NCT00882440|323890266|FG002|Overall Study|Withdrawal by Subject|1|||
94571030|NCT00882440|323890267|FG003|Overall Study|Withdrawal by Subject|0|||
94571031|NCT00882440|323890268|FG004|Overall Study|Withdrawal by Subject|6|||
94571032|NCT00882440|323890269|FG005|Overall Study|Withdrawal by Subject|0|||
94571033|NCT00882440|323890270|FG006|Overall Study|Withdrawal by Subject|1|||
94571034|NCT00882440|323890264|FG000|Overall Study|Patient Uncooperative|2|||
94571035|NCT00882440|323890265|FG001|Overall Study|Patient Uncooperative|0|||
94238178|NCT00732992|322666591|FG000|Overall Study|Global Deterioration of Health Status|1|||
94238179|NCT00732992|322666592|FG001|Overall Study|Global Deterioration of Health Status|0|||
94238180|NCT00732992|322666591|FG000|Overall Study|Withdrawal by Subject|1|||
94238181|NCT00732992|322666592|FG001|Overall Study|Withdrawal by Subject|0|||
94238182|NCT03126110|322666597|FG000|Phase 1|Death|2|||
94238183|NCT03126110|322666598|FG001|Phase 1|Death|2|||
94238184|NCT03126110|322666599|FG002|Phase 1|Death|4|||
94238185|NCT03126110|322666600|FG003|Phase 1|Death|3|||
94238186|NCT03126110|322666601|FG004|Phase 1|Death|4|||
94238187|NCT03126110|322666602|FG005|Phase 1|Death|4|||
94238188|NCT03126110|322666603|FG006|Phase 1|Death|3|||
94238189|NCT03126110|322666604|FG007|Phase 1|Death|4|||
94238190|NCT03126110|322666605|FG008|Phase 1|Death|5|||
94238191|NCT03126110|322666606|FG009|Phase 1|Death|2|||
94238192|NCT03126110|322666607|FG010|Phase 1|Death|6|||
94238193|NCT03126110|322666608|FG011|Phase 1|Death|0|||
94238194|NCT03126110|322666609|FG012|Phase 1|Death|0|||
94238195|NCT03126110|322666610|FG013|Phase 1|Death|0|||
94348415|NCT02380703|323056128|FG001|Overall Study|Person with dementia (PWD) death|8|||
94348416|NCT02380703|323056127|FG000|Overall Study|Entered Long-term Care|4|||
94348417|NCT02380703|323056128|FG001|Overall Study|Entered Long-term Care|7|||
94571036|NCT00882440|323890266|FG002|Overall Study|Patient Uncooperative|0|||
94571037|NCT00882440|323890267|FG003|Overall Study|Patient Uncooperative|0|||
94348418|NCT01362049|323056129|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
94571038|NCT00882440|323890268|FG004|Overall Study|Patient Uncooperative|1|||
94571039|NCT00882440|323890269|FG005|Overall Study|Patient Uncooperative|0|||
94571040|NCT00882440|323890270|FG006|Overall Study|Patient Uncooperative|0|||
94571041|NCT02723773|323890271|FG000|Overall Study|Adverse Event|934|||
94238196|NCT03126110|322666611|FG014|Phase 1|Death|0|||
94238197|NCT03126110|322666612|FG015|Phase 1|Death|0|||
94348419|NCT01362049|323056130|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
94348420|NCT01362049|323056131|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
94348421|NCT01362049|323056132|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
94571042|NCT02723773|323890272|FG001|Overall Study|Adverse Event|3|||
94571043|NCT02723773|323890273|FG002|Overall Study|Adverse Event|1|||
94238198|NCT03126110|322666613|FG016|Phase 1|Death|0|||
94238199|NCT03126110|322666597|FG000|Phase 1|Lost to Follow-up|0|||
94238200|NCT03126110|322666598|FG001|Phase 1|Lost to Follow-up|1|||
94571044|NCT02723773|323890274|FG003|Overall Study|Adverse Event|9|||
94571045|NCT02723773|323890271|FG000|Overall Study|Protocol Violation|1|||
94571046|NCT02723773|323890272|FG001|Overall Study|Protocol Violation|0|||
94571047|NCT02723773|323890273|FG002|Overall Study|Protocol Violation|0|||
94571048|NCT02723773|323890274|FG003|Overall Study|Protocol Violation|0|||
94571049|NCT02723773|323890271|FG000|Overall Study|Withdrawal by Subject|360|||
94571050|NCT02723773|323890272|FG001|Overall Study|Withdrawal by Subject|5|||
94571051|NCT02723773|323890273|FG002|Overall Study|Withdrawal by Subject|6|||
94571052|NCT02723773|323890274|FG003|Overall Study|Withdrawal by Subject|10|||
94571053|NCT02723773|323890271|FG000|Overall Study|Migrated/moved from study area|37|||
94571054|NCT02723773|323890272|FG001|Overall Study|Migrated/moved from study area|0|||
94571055|NCT02723773|323890273|FG002|Overall Study|Migrated/moved from study area|0|||
94571056|NCT02723773|323890274|FG003|Overall Study|Migrated/moved from study area|1|||
94571057|NCT02723773|323890271|FG000|Overall Study|Lost to Follow-up|198|||
94571058|NCT02723773|323890272|FG001|Overall Study|Lost to Follow-up|0|||
94571059|NCT02723773|323890273|FG002|Overall Study|Lost to Follow-up|0|||
94571060|NCT02723773|323890274|FG003|Overall Study|Lost to Follow-up|0|||
94571061|NCT02723773|323890271|FG000|Overall Study|Other|189|||
94571062|NCT02723773|323890272|FG001|Overall Study|Other|1|||
94571063|NCT02723773|323890273|FG002|Overall Study|Other|2|||
94658798|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
94238201|NCT03126110|322666599|FG002|Phase 1|Lost to Follow-up|0|||
94238202|NCT03126110|322666600|FG003|Phase 1|Lost to Follow-up|0|||
94238203|NCT03126110|322666601|FG004|Phase 1|Lost to Follow-up|0|||
94571064|NCT02723773|323890274|FG003|Overall Study|Other|2|||
94571065|NCT02250326|323890275|FG000|Treatment|Death|1|||
94571066|NCT02250326|323890276|FG001|Treatment|Death|13|||
94571067|NCT02250326|323890277|FG002|Treatment|Death|2|||
94571068|NCT02250326|323890275|FG000|Treatment|Adverse Event|8|||
94571069|NCT02250326|323890276|FG001|Treatment|Adverse Event|8|||
94571070|NCT02250326|323890277|FG002|Treatment|Adverse Event|9|||
94571071|NCT02250326|323890275|FG000|Treatment|Progressive Disease|42|||
94451669|NCT01322490|323441800|FG000|Treatment Period|Withdrawal by Subject|14|||
94451670|NCT01322490|323441801|FG001|Treatment Period|Withdrawal by Subject|16|||
94451671|NCT01322490|323441802|FG002|Treatment Period|Withdrawal by Subject|11|||
94451672|NCT01322490|323441800|FG000|Treatment Period|Non-compliance with study drug|0|||
94451673|NCT01322490|323441801|FG001|Treatment Period|Non-compliance with study drug|0|||
94451674|NCT01322490|323441802|FG002|Treatment Period|Non-compliance with study drug|1|||
94451675|NCT01322490|323441800|FG000|Treatment Period|Other per report|2|||
94451676|NCT01322490|323441801|FG001|Treatment Period|Other per report|2|||
94451677|NCT01322490|323441802|FG002|Treatment Period|Other per report|1|||
94451678|NCT01322490|323441800|FG000|Treatment Period|Randomized but Not Treated|3|||
94451679|NCT01322490|323441801|FG001|Treatment Period|Randomized but Not Treated|3|||
94451680|NCT01322490|323441802|FG002|Treatment Period|Randomized but Not Treated|5|||
94451681|NCT01322490|323441800|FG000|Long Term Follow-up Period|Death|235|||
94451682|NCT01322490|323441801|FG001|Long Term Follow-up Period|Death|239|||
94451683|NCT01322490|323441802|FG002|Long Term Follow-up Period|Death|236|||
94451684|NCT01322490|323441800|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
94451685|NCT01322490|323441801|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
94451686|NCT01322490|323441802|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
94451687|NCT01322490|323441800|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
94451688|NCT01322490|323441801|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
94451689|NCT01322490|323441802|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
94451690|NCT01322490|323441800|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
94451691|NCT01322490|323441801|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
94451692|NCT01322490|323441802|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
94451693|NCT01322490|323441800|FG000|Long Term Follow-up Period|Other per report|3|||
94451694|NCT01322490|323441801|FG001|Long Term Follow-up Period|Other per report|2|||
94451695|NCT01322490|323441802|FG002|Long Term Follow-up Period|Other per report|2|||
94451696|NCT01322490|323441800|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
94451697|NCT01322490|323441801|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
94451698|NCT01322490|323441802|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
94451699|NCT02257489|323441803|FG000|Overall Study|Withdrawal by Subject|0|||
94451700|NCT02257489|323441804|FG001|Overall Study|Withdrawal by Subject|0|||
94451701|NCT02257489|323441805|FG002|Overall Study|Withdrawal by Subject|0|||
94451702|NCT02257489|323441806|FG003|Overall Study|Withdrawal by Subject|1|||
94451703|NCT02257489|323441807|FG004|Overall Study|Withdrawal by Subject|0|||
94451704|NCT02257489|323441808|FG005|Overall Study|Withdrawal by Subject|0|||
94451705|NCT02257489|323441809|FG006|Overall Study|Withdrawal by Subject|0|||
94451706|NCT02257489|323441810|FG007|Overall Study|Withdrawal by Subject|0|||
94451707|NCT02257489|323441811|FG008|Overall Study|Withdrawal by Subject|0|||
94451708|NCT01896128|323441812|FG000|Overall Study|Withdrawal by Subject|3|||
94451709|NCT01896128|323441813|FG001|Overall Study|Withdrawal by Subject|3|||
94451710|NCT01972438|323441816|FG000|Baseline-Month 3 Crossover Period|Death|1|||
94451711|NCT01972438|323441817|FG001|Baseline-Month 3 Crossover Period|Death|0|||
94451712|NCT01972438|323441816|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
94451713|NCT01972438|323441817|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
94451714|NCT01972438|323441816|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
94451715|NCT01972438|323441817|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
94451716|NCT01972438|323441816|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
94451717|NCT01972438|323441817|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
94451718|NCT01972438|323441816|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
94451719|NCT01972438|323441817|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
94451720|NCT01972438|323441816|FG000|Months 6-12 Study Period|Death|1|||
94451721|NCT01972438|323441817|FG001|Months 6-12 Study Period|Death|0|||
94451722|NCT01972438|323441816|FG000|Months 6-12 Study Period|Early Study Closure|2|||
94451723|NCT01972438|323441817|FG001|Months 6-12 Study Period|Early Study Closure|2|||
94451724|NCT01972438|323441816|FG000|Post Month 12 Study Period|Early Study Closure|3|||
94451725|NCT01972438|323441817|FG001|Post Month 12 Study Period|Early Study Closure|4|||
94451726|NCT02693002|323441818|FG000|Overall Study|Withdrawal by Subject|1|||
94451727|NCT02693002|323441819|FG001|Overall Study|Withdrawal by Subject|0|||
94451728|NCT00812981|323441821|FG000|Overall Study|Other|0|||
94451729|NCT00812981|323441822|FG001|Overall Study|Other|1|||
94451730|NCT04468347|323441825|FG000|Overall Study|Withdrawal by Subject|0|||
94451731|NCT04468347|323441826|FG001|Overall Study|Withdrawal by Subject|1|||
94451732|NCT04468347|323441827|FG002|Overall Study|Withdrawal by Subject|3|||
94451733|NCT04468347|323441828|FG003|Overall Study|Withdrawal by Subject|3|||
94451734|NCT04468347|323441825|FG000|Overall Study|Lost to Follow-up|0|||
94451735|NCT04468347|323441826|FG001|Overall Study|Lost to Follow-up|0|||
94451736|NCT04468347|323441827|FG002|Overall Study|Lost to Follow-up|1|||
94451737|NCT04468347|323441828|FG003|Overall Study|Lost to Follow-up|1|||
94451738|NCT04468347|323441825|FG000|Overall Study|Physician Decision|1|||
94451739|NCT04468347|323441826|FG001|Overall Study|Physician Decision|0|||
94451740|NCT04468347|323441827|FG002|Overall Study|Physician Decision|2|||
94451741|NCT04468347|323441828|FG003|Overall Study|Physician Decision|0|||
94571072|NCT02250326|323890276|FG001|Treatment|Progressive Disease|40|||
94571073|NCT02250326|323890277|FG002|Treatment|Progressive Disease|47|||
94571074|NCT02250326|323890275|FG000|Treatment|Symptomatic Deterioration|9|||
94571075|NCT02250326|323890276|FG001|Treatment|Symptomatic Deterioration|4|||
94571076|NCT02250326|323890277|FG002|Treatment|Symptomatic Deterioration|10|||
94571077|NCT02250326|323890275|FG000|Treatment|Withdrawal by Subject|11|||
94571078|NCT02250326|323890276|FG001|Treatment|Withdrawal by Subject|6|||
94571079|NCT02250326|323890277|FG002|Treatment|Withdrawal by Subject|4|||
94571080|NCT02250326|323890275|FG000|Treatment|Other reasons|8|||
94571081|NCT02250326|323890276|FG001|Treatment|Other reasons|7|||
94571082|NCT02250326|323890277|FG002|Treatment|Other reasons|7|||
94571083|NCT02250326|323890275|FG000|Extension Period|Progressive Disease|0|||
94571084|NCT02250326|323890276|FG001|Extension Period|Progressive Disease|2|||
94571085|NCT02250326|323890277|FG002|Extension Period|Progressive Disease|0|||
94571086|NCT02250326|323890275|FG000|Extension Period|Withdrawal by Subject|0|||
94571087|NCT02250326|323890276|FG001|Extension Period|Withdrawal by Subject|1|||
94571088|NCT02250326|323890277|FG002|Extension Period|Withdrawal by Subject|0|||
94571089|NCT02250326|323890275|FG000|Extension Period|Withdrawal by investigator|0|||
94571090|NCT02250326|323890276|FG001|Extension Period|Withdrawal by investigator|1|||
94571091|NCT02250326|323890277|FG002|Extension Period|Withdrawal by investigator|0|||
94571092|NCT02647281|323890278|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
94571093|NCT02647281|323890279|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
94571094|NCT02647281|323890280|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
94238204|NCT03126110|322666602|FG005|Phase 1|Lost to Follow-up|0|||
94238205|NCT03126110|322666603|FG006|Phase 1|Lost to Follow-up|0|||
94238206|NCT03126110|322666604|FG007|Phase 1|Lost to Follow-up|0|||
94238207|NCT03126110|322666605|FG008|Phase 1|Lost to Follow-up|1|||
94238208|NCT03126110|322666606|FG009|Phase 1|Lost to Follow-up|0|||
94238209|NCT03126110|322666607|FG010|Phase 1|Lost to Follow-up|0|||
94238210|NCT03126110|322666608|FG011|Phase 1|Lost to Follow-up|0|||
94238211|NCT03126110|322666609|FG012|Phase 1|Lost to Follow-up|0|||
94238212|NCT03126110|322666610|FG013|Phase 1|Lost to Follow-up|0|||
94571095|NCT02647281|323890281|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
94571096|NCT02647281|323890282|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
94571097|NCT02647281|323890283|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
94238213|NCT03126110|322666611|FG014|Phase 1|Lost to Follow-up|0|||
94571098|NCT02647281|323890284|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
94571099|NCT02647281|323890285|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
94571100|NCT02647281|323890286|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
94571101|NCT01838694|323890287|FG000|Overall Study|Adverse Event|0|||
94571102|NCT01838694|323890288|FG001|Overall Study|Adverse Event|1|||
94571103|NCT01751061|323890289|FG000|Overall Study|Death|1|||
94571104|NCT01751061|323890290|FG001|Overall Study|Death|0|||
94571105|NCT01751061|323890289|FG000|Overall Study|patient death|5|||
94571106|NCT01751061|323890290|FG001|Overall Study|patient death|0|||
94571107|NCT01751061|323890289|FG000|Overall Study|Lost to Follow-up|40|||
94571108|NCT01751061|323890290|FG001|Overall Study|Lost to Follow-up|25|||
94571109|NCT01751061|323890289|FG000|Overall Study|patient regained decisional capacity|4|||
94571110|NCT01751061|323890290|FG001|Overall Study|patient regained decisional capacity|8|||
94571111|NCT01751061|323890289|FG000|Overall Study|Withdrawal by Subject|4|||
94571112|NCT01751061|323890290|FG001|Overall Study|Withdrawal by Subject|1|||
94571113|NCT01751061|323890289|FG000|Overall Study|Physician Decision|2|||
94238214|NCT03126110|322666612|FG015|Phase 1|Lost to Follow-up|0|||
94238215|NCT03126110|322666613|FG016|Phase 1|Lost to Follow-up|0|||
94238216|NCT03126110|322666597|FG000|Phase 1|Withdrawal by Subject|1|||
94238217|NCT03126110|322666598|FG001|Phase 1|Withdrawal by Subject|0|||
94238218|NCT03126110|322666599|FG002|Phase 1|Withdrawal by Subject|0|||
94238219|NCT03126110|322666600|FG003|Phase 1|Withdrawal by Subject|1|||
94238220|NCT03126110|322666601|FG004|Phase 1|Withdrawal by Subject|1|||
94238221|NCT03126110|322666602|FG005|Phase 1|Withdrawal by Subject|0|||
94238222|NCT03126110|322666603|FG006|Phase 1|Withdrawal by Subject|0|||
94238223|NCT03126110|322666604|FG007|Phase 1|Withdrawal by Subject|0|||
94238224|NCT03126110|322666605|FG008|Phase 1|Withdrawal by Subject|2|||
94238225|NCT03126110|322666606|FG009|Phase 1|Withdrawal by Subject|1|||
94238226|NCT03126110|322666607|FG010|Phase 1|Withdrawal by Subject|0|||
94238227|NCT03126110|322666608|FG011|Phase 1|Withdrawal by Subject|0|||
94348422|NCT01362049|323056129|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
94348423|NCT01362049|323056130|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
94238228|NCT03126110|322666609|FG012|Phase 1|Withdrawal by Subject|0|||
94238229|NCT03126110|322666610|FG013|Phase 1|Withdrawal by Subject|0|||
94571114|NCT01751061|323890290|FG001|Overall Study|Physician Decision|0|||
94571115|NCT01194830|323890291|FG000|Overall Study|Adverse Event|3|||
94571116|NCT01194830|323890292|FG001|Overall Study|Adverse Event|2|||
94571117|NCT01194830|323890291|FG000|Overall Study|Protocol Violation|5|||
94571118|NCT01194830|323890292|FG001|Overall Study|Protocol Violation|4|||
94571119|NCT01194830|323890291|FG000|Overall Study|Lost to Follow-up|9|||
94571120|NCT01194830|323890292|FG001|Overall Study|Lost to Follow-up|7|||
94571121|NCT01194830|323890291|FG000|Overall Study|Withdrawal by Subject|2|||
94571122|NCT01194830|323890292|FG001|Overall Study|Withdrawal by Subject|1|||
94571123|NCT01194830|323890291|FG000|Overall Study|Lack of Efficacy|1|||
94571124|NCT01194830|323890292|FG001|Overall Study|Lack of Efficacy|1|||
94571125|NCT01194830|323890291|FG000|Overall Study|Non-compliance issues|4|||
94571126|NCT01194830|323890292|FG001|Overall Study|Non-compliance issues|4|||
94571127|NCT01194830|323890291|FG000|Overall Study|Other Reason|12|||
94571128|NCT01194830|323890292|FG001|Overall Study|Other Reason|8|||
94571129|NCT03115359|323890293|FG000|Overall Study|Withdrawal by Subject|29|||
94571130|NCT03115359|323890294|FG001|Overall Study|Withdrawal by Subject|39|||
94571131|NCT03115359|323890293|FG000|Overall Study|Scheduling conflict|25|||
94571132|NCT03115359|323890294|FG001|Overall Study|Scheduling conflict|23|||
94571133|NCT03115359|323890293|FG000|Overall Study|Personal reasons including health|12|||
94571134|NCT03115359|323890294|FG001|Overall Study|Personal reasons including health|9|||
94571135|NCT03115359|323890293|FG000|Overall Study|Transportation barriers|3|||
94571136|NCT03115359|323890294|FG001|Overall Study|Transportation barriers|0|||
94571137|NCT03115359|323890293|FG000|Overall Study|No longer interested|5|||
94571138|NCT03115359|323890294|FG001|Overall Study|No longer interested|4|||
94571139|NCT03115359|323890293|FG000|Overall Study|No reason provided|45|||
94571140|NCT03115359|323890294|FG001|Overall Study|No reason provided|47|||
94571141|NCT03985761|323890295|FG000|Overall Study|Withdrawal by Subject|2|||
94571142|NCT03985761|323890296|FG001|Overall Study|Withdrawal by Subject|3|||
94571143|NCT01706458|323890297|FG000|Overall Study|Physician Decision|3|||
94571144|NCT01706458|323890298|FG001|Overall Study|Physician Decision|4|||
94571145|NCT00117637|323890301|FG000|First Intervention (Period 1)|Adverse Event|11|||
94571146|NCT00117637|323890302|FG001|First Intervention (Period 1)|Adverse Event|16|||
94571147|NCT00117637|323890301|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
94571148|NCT00117637|323890302|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
94571149|NCT00117637|323890301|FG000|First Intervention (Period 1)|Protocol Violation|1|||
94571150|NCT00117637|323890302|FG001|First Intervention (Period 1)|Protocol Violation|0|||
94571151|NCT00117637|323890301|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
94571152|NCT00117637|323890302|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
94571153|NCT00117637|323890301|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
94571154|NCT00117637|323890302|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
94571155|NCT00117637|323890301|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
94571156|NCT00117637|323890302|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
94571157|NCT00117637|323890301|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
94571158|NCT00117637|323890302|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
94571159|NCT00117637|323890301|FG000|First Intervention (Period 1)|reason not reported|0|||
94571160|NCT00117637|323890302|FG001|First Intervention (Period 1)|reason not reported|1|||
94571161|NCT00117637|323890301|FG000|Second Intervention (Period 2)|Adverse Event|0|||
94571162|NCT00117637|323890302|FG001|Second Intervention (Period 2)|Adverse Event|9|||
94571163|NCT00117637|323890301|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
94571164|NCT00117637|323890302|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
94571165|NCT00117637|323890301|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
94571166|NCT00117637|323890302|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
94571167|NCT00117637|323890301|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
94571168|NCT00117637|323890302|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
94571169|NCT00117637|323890301|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
94571170|NCT00117637|323890302|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
94571171|NCT00117637|323890301|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
94571172|NCT00117637|323890302|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
94571173|NCT00117637|323890301|FG000|Second Intervention (Period 2)|reason not reported|1|||
94571174|NCT00117637|323890302|FG001|Second Intervention (Period 2)|reason not reported|0|||
94571175|NCT00097500|323890303|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
94571176|NCT00097500|323890304|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
94571177|NCT00097500|323890303|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
94571178|NCT00097500|323890304|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
94238230|NCT03126110|322666611|FG014|Phase 1|Withdrawal by Subject|0|||
94238231|NCT03126110|322666612|FG015|Phase 1|Withdrawal by Subject|0|||
94571179|NCT00097500|323890303|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
94571180|NCT00097500|323890304|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
94571181|NCT00097500|323890303|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
94571182|NCT00097500|323890304|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
94571183|NCT00097500|323890303|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
94571184|NCT00097500|323890304|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
94571185|NCT00097500|323890303|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
94571186|NCT00097500|323890304|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
94571187|NCT00097500|323890303|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
94571188|NCT00097500|323890304|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
94571189|NCT04698343|323890321|FG000|Overall Study|Withdrawal by Subject|6|||
94571190|NCT04698343|323890321|FG000|Overall Study|Physician Decision|2|||
94571191|NCT04698343|323890321|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
94571192|NCT04698343|323890321|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
94571193|NCT04698343|323890321|FG000|Overall Study|Personal reasons|3|||
94571194|NCT04698343|323890321|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
94571195|NCT01176032|323890324|FG000|Overall Study|Adverse Event|1|||
94238232|NCT03126110|322666613|FG016|Phase 1|Withdrawal by Subject|0|||
94238233|NCT03126110|322666597|FG000|Phase 1|Safety follow-up no longer necessary|1|||
94238234|NCT03126110|322666598|FG001|Phase 1|Safety follow-up no longer necessary|0|||
94348424|NCT01362049|323056131|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
94348425|NCT01362049|323056132|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
94571196|NCT01176032|323890325|FG001|Overall Study|Adverse Event|0|||
94571197|NCT01176032|323890324|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94571198|NCT01176032|323890325|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
94571199|NCT01176032|323890324|FG000|Overall Study|Protocol Violation|1|||
94571200|NCT01176032|323890325|FG001|Overall Study|Protocol Violation|0|||
94571201|NCT01176032|323890324|FG000|Overall Study|Informed consent withdrawn|3|||
94571202|NCT01176032|323890325|FG001|Overall Study|Informed consent withdrawn|0|||
94571203|NCT01176032|323890324|FG000|Overall Study|Other|1|||
94571204|NCT01176032|323890325|FG001|Overall Study|Other|0|||
94571205|NCT00467740|323890329|FG000|Overall Study|Adverse Event|0|||
94571206|NCT00467740|323890330|FG001|Overall Study|Adverse Event|0|||
94571207|NCT00467740|323890331|FG002|Overall Study|Adverse Event|1|||
94571208|NCT00467740|323890332|FG003|Overall Study|Adverse Event|0|||
94571209|NCT00467740|323890333|FG004|Overall Study|Adverse Event|0|||
94571210|NCT00467740|323890329|FG000|Overall Study|Protocol Violation|0|||
94571211|NCT00467740|323890330|FG001|Overall Study|Protocol Violation|0|||
94571212|NCT00467740|323890331|FG002|Overall Study|Protocol Violation|1|||
94571213|NCT00467740|323890332|FG003|Overall Study|Protocol Violation|0|||
94571214|NCT00467740|323890333|FG004|Overall Study|Protocol Violation|0|||
94571215|NCT00467740|323890329|FG000|Overall Study|Lost to Follow-up|0|||
94571216|NCT00467740|323890330|FG001|Overall Study|Lost to Follow-up|1|||
94571217|NCT00467740|323890331|FG002|Overall Study|Lost to Follow-up|0|||
94571218|NCT00467740|323890332|FG003|Overall Study|Lost to Follow-up|0|||
94571219|NCT00467740|323890333|FG004|Overall Study|Lost to Follow-up|0|||
94571220|NCT00467740|323890329|FG000|Overall Study|Withdrawal by Subject|1|||
94571221|NCT00467740|323890330|FG001|Overall Study|Withdrawal by Subject|1|||
94571222|NCT00467740|323890331|FG002|Overall Study|Withdrawal by Subject|0|||
94571223|NCT00467740|323890332|FG003|Overall Study|Withdrawal by Subject|1|||
94571224|NCT00467740|323890333|FG004|Overall Study|Withdrawal by Subject|0|||
94571225|NCT00467740|323890329|FG000|Overall Study|Lack of Efficacy|0|||
94571226|NCT00467740|323890330|FG001|Overall Study|Lack of Efficacy|1|||
94571227|NCT00467740|323890331|FG002|Overall Study|Lack of Efficacy|0|||
94571228|NCT00467740|323890332|FG003|Overall Study|Lack of Efficacy|0|||
94571229|NCT00467740|323890333|FG004|Overall Study|Lack of Efficacy|0|||
94571230|NCT00953667|323890334|FG000|Overall Study|Lost to Follow-up|11|||
94571231|NCT00953667|323890334|FG000|Overall Study|Physician Decision|35|||
94571232|NCT00953667|323890334|FG000|Overall Study|Withdrawal by Subject|63|||
94571233|NCT00953667|323890334|FG000|Overall Study|Adverse Event|10|||
94571234|NCT00953667|323890334|FG000|Overall Study|poor venous access,unable to draw blood|4|||
94571235|NCT02913482|323890337|FG000|Overall Study|Death|0|||
94571236|NCT02913482|323890338|FG001|Overall Study|Death|2|||
94571237|NCT02913482|323890339|FG002|Overall Study|Death|2|||
94571238|NCT02913482|323890337|FG000|Overall Study|Progressive Disease|1|||
94571239|NCT02913482|323890338|FG001|Overall Study|Progressive Disease|1|||
94571240|NCT02913482|323890339|FG002|Overall Study|Progressive Disease|1|||
94571241|NCT02913482|323890337|FG000|Overall Study|Reason not specified|0|||
94571242|NCT02913482|323890338|FG001|Overall Study|Reason not specified|0|||
94348426|NCT03049852|323056133|FG000|Overall Study|Lost to Follow-up|0|||
94348427|NCT03049852|323056134|FG001|Overall Study|Lost to Follow-up|1|||
94348428|NCT03049852|323056135|FG002|Overall Study|Lost to Follow-up|0|||
94348429|NCT02067104|323056136|FG000|Overall Study|Study termination due to low accrual|4|||
94348430|NCT02067104|323056137|FG001|Overall Study|Study termination due to low accrual|5|||
94348431|NCT03607994|323056143|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
94348432|NCT03607994|323056144|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
94348433|NCT01279954|323056149|FG000|Overall Study|Lack of Efficacy|3|||
94348434|NCT01279954|323056150|FG001|Overall Study|Lack of Efficacy|4|||
94348435|NCT02140762|323056151|FG000|Overall Study|Adverse Event|1|||
94571243|NCT02913482|323890339|FG002|Overall Study|Reason not specified|1|||
94348436|NCT02140762|323056152|FG001|Overall Study|Adverse Event|1|||
94348437|NCT02140762|323056151|FG000|Overall Study|Lost to Follow-up|9|||
94348438|NCT02140762|323056152|FG001|Overall Study|Lost to Follow-up|5|||
94571244|NCT02913482|323890337|FG000|Overall Study|Withdrawal by Subject|0|||
94571245|NCT02913482|323890338|FG001|Overall Study|Withdrawal by Subject|1|||
94571246|NCT02913482|323890339|FG002|Overall Study|Withdrawal by Subject|1|||
94571247|NCT03935126|323890342|FG000|Overall Study|Study termination by sponsor|3|||
94571248|NCT02552966|323890343|FG000|Overall Study|Lost to Follow-up|2|||
94571249|NCT02552966|323890343|FG000|Overall Study|Withdrawal by Subject|3|||
94571250|NCT00399516|323890344|FG000|Overall Study|Lost to Follow-up|2|||
94571251|NCT01046565|323890345|FG000|Overall Study|Adverse Event|2|||
94571252|NCT01046565|323890345|FG000|Overall Study|Withdrawal by Subject|7|||
94571253|NCT01476722|323890346|FG000|Overall Study|Adverse Event|1|||
94571254|NCT02365649|323890347|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
94571255|NCT02365649|323890348|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
94571256|NCT02365649|323890349|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
94571257|NCT02365649|323890350|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
94571258|NCT02365649|323890351|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
94571259|NCT02365649|323890352|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
94571260|NCT02365649|323890353|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
94571261|NCT02365649|323890354|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
94571262|NCT02365649|323890355|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
94571263|NCT02365649|323890356|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
94571264|NCT02365649|323890347|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
94571265|NCT02365649|323890348|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
94571266|NCT02365649|323890349|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
94571267|NCT02365649|323890350|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
94571268|NCT02365649|323890351|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
94571269|NCT02365649|323890352|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
94571270|NCT02365649|323890353|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
94571271|NCT02365649|323890354|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
94571272|NCT02365649|323890355|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
94571273|NCT02365649|323890356|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
94571274|NCT02365649|323890347|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
94571275|NCT02365649|323890348|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
94571276|NCT02365649|323890349|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
94571277|NCT02365649|323890350|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
94571278|NCT02365649|323890351|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
94571279|NCT02365649|323890352|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
94571280|NCT02365649|323890353|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
94571281|NCT02365649|323890354|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
94571282|NCT02365649|323890355|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
94571283|NCT02365649|323890356|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
94571284|NCT02365649|323890347|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
94571285|NCT02365649|323890348|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
94571286|NCT02365649|323890349|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
94571287|NCT02365649|323890350|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
94571288|NCT02365649|323890351|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
94571289|NCT02365649|323890352|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
94571290|NCT02365649|323890353|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
94571291|NCT02365649|323890354|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
94571292|NCT02365649|323890355|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
94571293|NCT02365649|323890356|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
94571294|NCT02365649|323890347|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
94571295|NCT02365649|323890348|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
94571296|NCT02365649|323890349|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
94571297|NCT02365649|323890350|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
94571298|NCT02365649|323890351|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
94571299|NCT02365649|323890352|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
94571300|NCT02365649|323890353|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
94571301|NCT02365649|323890354|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
94571302|NCT02365649|323890355|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
94571303|NCT02365649|323890356|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
94571304|NCT02365649|323890347|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
94571305|NCT02365649|323890348|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
94571306|NCT02365649|323890349|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
94571307|NCT02365649|323890350|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
94571308|NCT02365649|323890351|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
94571309|NCT02365649|323890352|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
94571310|NCT02365649|323890353|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
94571311|NCT02365649|323890354|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
94571312|NCT02365649|323890355|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
94571313|NCT02365649|323890356|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
94571314|NCT02365649|323890347|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
94571315|NCT02365649|323890348|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
94571316|NCT02365649|323890349|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
94571317|NCT02365649|323890350|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
94571318|NCT02365649|323890351|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
94571319|NCT02365649|323890352|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
94571320|NCT02365649|323890353|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
94571321|NCT02365649|323890354|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
94571322|NCT02365649|323890355|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
94571323|NCT02365649|323890356|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
94571324|NCT02365649|323890347|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
94571325|NCT02365649|323890348|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
94571326|NCT02365649|323890349|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
94571327|NCT02365649|323890350|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
94571328|NCT02365649|323890351|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
94571329|NCT02365649|323890352|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
94571330|NCT02365649|323890353|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
94571331|NCT02365649|323890354|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
94571332|NCT02365649|323890355|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
94571333|NCT02365649|323890356|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
94571334|NCT02365649|323890347|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
94571335|NCT02365649|323890348|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
94571336|NCT02365649|323890349|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
94571337|NCT02365649|323890350|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
94571338|NCT02365649|323890351|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
94571339|NCT02365649|323890352|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
94571340|NCT02365649|323890353|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
94571341|NCT02365649|323890354|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
94571342|NCT02365649|323890355|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
94571343|NCT02365649|323890356|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
94571344|NCT02365649|323890347|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
94571345|NCT02365649|323890348|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
94571346|NCT02365649|323890349|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
94571347|NCT02365649|323890350|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
94571348|NCT02365649|323890351|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
94571349|NCT02365649|323890352|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
94571350|NCT02365649|323890353|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
94571351|NCT02365649|323890354|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
94571352|NCT02365649|323890355|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
94348439|NCT02140762|323056151|FG000|Overall Study|Protocol Violation|1|||
94571353|NCT02365649|323890356|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
94571354|NCT02365649|323890347|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
94571355|NCT02365649|323890348|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
94571356|NCT02365649|323890349|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
94571357|NCT02365649|323890350|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
94571358|NCT02365649|323890351|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
94571359|NCT02365649|323890352|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
94571360|NCT02365649|323890353|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
94571361|NCT02365649|323890354|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
94571362|NCT02365649|323890355|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
94571363|NCT02365649|323890356|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
94571364|NCT02365649|323890347|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
94571365|NCT02365649|323890348|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
94571366|NCT02365649|323890349|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
94571367|NCT02365649|323890350|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
94571368|NCT02365649|323890351|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
94571369|NCT02365649|323890352|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
94571370|NCT02365649|323890353|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
94571371|NCT02365649|323890354|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
94571372|NCT02365649|323890355|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
94571373|NCT02365649|323890356|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
94571374|NCT01069484|323890357|FG000|Overall Study|Death-in-near-family|1|||
94571375|NCT01069484|323890358|FG001|Overall Study|Death-in-near-family|0|||
94571376|NCT01069484|323890357|FG000|Overall Study|No specific reason|8|||
94571377|NCT01069484|323890358|FG001|Overall Study|No specific reason|2|||
94571378|NCT01069484|323890357|FG000|Overall Study|Illness mother or child|3|||
94571379|NCT01069484|323890358|FG001|Overall Study|Illness mother or child|1|||
94571380|NCT00689390|323890359|FG000|Overall Study|Adverse Event|19|||
94571381|NCT00689390|323890360|FG001|Overall Study|Adverse Event|0|||
94571382|NCT00689390|323890359|FG000|Overall Study|Lost to Follow-up|179|||
94571383|NCT00689390|323890360|FG001|Overall Study|Lost to Follow-up|7|||
94571384|NCT00689390|323890359|FG000|Overall Study|Withdrawal by Subject|117|||
94571385|NCT00689390|323890360|FG001|Overall Study|Withdrawal by Subject|3|||
94571386|NCT00689390|323890359|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
94571387|NCT00689390|323890360|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
94571388|NCT00689390|323890359|FG000|Overall Study|Non-Compliance With Protocol|21|||
94571389|NCT00689390|323890360|FG001|Overall Study|Non-Compliance With Protocol|0|||
94571390|NCT00689390|323890359|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
94571391|NCT00689390|323890360|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
94571392|NCT00689390|323890359|FG000|Overall Study|Administrative|37|||
94571393|NCT00689390|323890360|FG001|Overall Study|Administrative|0|||
94238235|NCT03126110|322666599|FG002|Phase 1|Safety follow-up no longer necessary|0|||
94571394|NCT00112736|323890361|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
94571395|NCT00112736|323890362|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
94238236|NCT03126110|322666600|FG003|Phase 1|Safety follow-up no longer necessary|0|||
94238237|NCT03126110|322666601|FG004|Phase 1|Safety follow-up no longer necessary|0|||
94238238|NCT03126110|322666602|FG005|Phase 1|Safety follow-up no longer necessary|0|||
94238239|NCT03126110|322666603|FG006|Phase 1|Safety follow-up no longer necessary|0|||
94238240|NCT03126110|322666604|FG007|Phase 1|Safety follow-up no longer necessary|0|||
94571396|NCT05435339|323890363|FG000|Overall Study|Death|1|||
94571397|NCT05435339|323890364|FG001|Overall Study|Death|0|||
94571398|NCT05435339|323890365|FG002|Overall Study|Death|3|||
94571399|NCT05435339|323890366|FG003|Overall Study|Death|1|||
94571400|NCT05435339|323890367|FG004|Overall Study|Death|3|||
94571401|NCT05435339|323890368|FG005|Overall Study|Death|2|||
94571402|NCT05435339|323890369|FG006|Overall Study|Death|4|||
94571403|NCT05435339|323890370|FG007|Overall Study|Death|6|||
94571404|NCT05435339|323890363|FG000|Overall Study|Sponsor Decision|0|||
94571405|NCT05435339|323890364|FG001|Overall Study|Sponsor Decision|1|||
94571406|NCT05435339|323890365|FG002|Overall Study|Sponsor Decision|0|||
94238241|NCT03126110|322666605|FG008|Phase 1|Safety follow-up no longer necessary|0|||
94571407|NCT05435339|323890366|FG003|Overall Study|Sponsor Decision|0|||
94571408|NCT05435339|323890367|FG004|Overall Study|Sponsor Decision|2|||
94571409|NCT05435339|323890368|FG005|Overall Study|Sponsor Decision|1|||
94658799|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
94658800|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
94658801|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
94451742|NCT04468347|323441825|FG000|Overall Study|Protocol Violation|1|||
94451743|NCT04468347|323441826|FG001|Overall Study|Protocol Violation|0|||
94571410|NCT05435339|323890369|FG006|Overall Study|Sponsor Decision|2|||
94571411|NCT05435339|323890370|FG007|Overall Study|Sponsor Decision|2|||
94571412|NCT05435339|323890363|FG000|Overall Study|Withdrawal by Subject|0|||
94571413|NCT05435339|323890364|FG001|Overall Study|Withdrawal by Subject|0|||
94451744|NCT04468347|323441827|FG002|Overall Study|Protocol Violation|0|||
94451745|NCT04468347|323441828|FG003|Overall Study|Protocol Violation|0|||
94451746|NCT02477332|323441836|FG000|Overall Study|Adverse Event|0|||
94451747|NCT02477332|323441837|FG001|Overall Study|Adverse Event|1|||
94451748|NCT02477332|323441838|FG002|Overall Study|Adverse Event|1|||
94451749|NCT02477332|323441839|FG003|Overall Study|Adverse Event|2|||
94451750|NCT02477332|323441840|FG004|Overall Study|Adverse Event|1|||
94451751|NCT02477332|323441841|FG005|Overall Study|Adverse Event|2|||
94451752|NCT02477332|323441836|FG000|Overall Study|Lack of Efficacy|1|||
94451753|NCT02477332|323441837|FG001|Overall Study|Lack of Efficacy|2|||
94451754|NCT02477332|323441838|FG002|Overall Study|Lack of Efficacy|1|||
94451755|NCT02477332|323441839|FG003|Overall Study|Lack of Efficacy|2|||
94451756|NCT02477332|323441840|FG004|Overall Study|Lack of Efficacy|1|||
94451757|NCT02477332|323441841|FG005|Overall Study|Lack of Efficacy|1|||
94451758|NCT02477332|323441836|FG000|Overall Study|Non-compliance with study treatment|0|||
94451759|NCT02477332|323441837|FG001|Overall Study|Non-compliance with study treatment|1|||
94451760|NCT02477332|323441838|FG002|Overall Study|Non-compliance with study treatment|2|||
94451761|NCT02477332|323441839|FG003|Overall Study|Non-compliance with study treatment|0|||
94451762|NCT02477332|323441840|FG004|Overall Study|Non-compliance with study treatment|0|||
94451763|NCT02477332|323441841|FG005|Overall Study|Non-compliance with study treatment|0|||
94451764|NCT02477332|323441836|FG000|Overall Study|Pregnancy|0|||
94451765|NCT02477332|323441837|FG001|Overall Study|Pregnancy|0|||
94451766|NCT02477332|323441838|FG002|Overall Study|Pregnancy|0|||
94451767|NCT02477332|323441839|FG003|Overall Study|Pregnancy|1|||
94451768|NCT02477332|323441840|FG004|Overall Study|Pregnancy|0|||
94451769|NCT02477332|323441841|FG005|Overall Study|Pregnancy|0|||
94451770|NCT02477332|323441836|FG000|Overall Study|Protocol Violation|2|||
94451771|NCT02477332|323441837|FG001|Overall Study|Protocol Violation|0|||
94451772|NCT02477332|323441838|FG002|Overall Study|Protocol Violation|3|||
94451773|NCT02477332|323441839|FG003|Overall Study|Protocol Violation|3|||
94451774|NCT02477332|323441840|FG004|Overall Study|Protocol Violation|1|||
94451775|NCT02477332|323441841|FG005|Overall Study|Protocol Violation|1|||
94451776|NCT02477332|323441836|FG000|Overall Study|Technical problems|0|||
94451777|NCT02477332|323441837|FG001|Overall Study|Technical problems|0|||
94451778|NCT02477332|323441838|FG002|Overall Study|Technical problems|1|||
94451779|NCT02477332|323441839|FG003|Overall Study|Technical problems|0|||
94451780|NCT02477332|323441840|FG004|Overall Study|Technical problems|0|||
94451781|NCT02477332|323441841|FG005|Overall Study|Technical problems|0|||
94451782|NCT02477332|323441836|FG000|Overall Study|Lost to Follow-up|0|||
94451783|NCT02477332|323441837|FG001|Overall Study|Lost to Follow-up|0|||
94451784|NCT02477332|323441838|FG002|Overall Study|Lost to Follow-up|2|||
94451785|NCT02477332|323441839|FG003|Overall Study|Lost to Follow-up|0|||
94451786|NCT02477332|323441840|FG004|Overall Study|Lost to Follow-up|0|||
94451787|NCT02477332|323441841|FG005|Overall Study|Lost to Follow-up|0|||
94451788|NCT02477332|323441836|FG000|Overall Study|Physician Decision|0|||
94451789|NCT02477332|323441837|FG001|Overall Study|Physician Decision|0|||
94451790|NCT02477332|323441838|FG002|Overall Study|Physician Decision|1|||
94451791|NCT02477332|323441839|FG003|Overall Study|Physician Decision|3|||
94451792|NCT02477332|323441840|FG004|Overall Study|Physician Decision|0|||
94451793|NCT02477332|323441841|FG005|Overall Study|Physician Decision|1|||
94451794|NCT02477332|323441836|FG000|Overall Study|Withdrawal by Subject|0|||
94451795|NCT02477332|323441837|FG001|Overall Study|Withdrawal by Subject|3|||
94451796|NCT02477332|323441838|FG002|Overall Study|Withdrawal by Subject|1|||
94451797|NCT02477332|323441839|FG003|Overall Study|Withdrawal by Subject|2|||
94451798|NCT02477332|323441840|FG004|Overall Study|Withdrawal by Subject|1|||
94451799|NCT02477332|323441841|FG005|Overall Study|Withdrawal by Subject|0|||
94451800|NCT01377922|323441848|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
94451801|NCT01377922|323441849|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
94451802|NCT01706939|323441853|FG000|Pre Randomization|Screen Failure|1|||
94451803|NCT01706939|323441854|FG001|Pre Randomization|Screen Failure|0|||
94451804|NCT01706939|323441855|FG002|Pre Randomization|Screen Failure|0|||
94451805|NCT01706939|323441853|FG000|Pre Randomization|Ineligible for Randomization|1|||
94451806|NCT01706939|323441854|FG001|Pre Randomization|Ineligible for Randomization|0|||
94451807|NCT01706939|323441855|FG002|Pre Randomization|Ineligible for Randomization|0|||
94451808|NCT01706939|323441853|FG000|Pre Randomization|Withdrawal by Subject|1|||
94571414|NCT05435339|323890365|FG002|Overall Study|Withdrawal by Subject|0|||
94571415|NCT05435339|323890366|FG003|Overall Study|Withdrawal by Subject|0|||
94571416|NCT05435339|323890367|FG004|Overall Study|Withdrawal by Subject|1|||
94451809|NCT01706939|323441854|FG001|Pre Randomization|Withdrawal by Subject|0|||
94571417|NCT05435339|323890368|FG005|Overall Study|Withdrawal by Subject|0|||
94451810|NCT01706939|323441855|FG002|Pre Randomization|Withdrawal by Subject|0|||
94451811|NCT01706939|323441853|FG000|Randomization|Insufficient QoL survey compliance|0|||
94451812|NCT01706939|323441854|FG001|Randomization|Insufficient QoL survey compliance|1|||
94451813|NCT01706939|323441855|FG002|Randomization|Insufficient QoL survey compliance|1|||
94451814|NCT01706939|323441853|FG000|Randomization|Progression of disease|0|||
94451815|NCT01706939|323441854|FG001|Randomization|Progression of disease|2|||
94451816|NCT01706939|323441855|FG002|Randomization|Progression of disease|1|||
94451817|NCT00347009|323441856|FG000|Overall Study|Death|1|||
94571418|NCT05435339|323890369|FG006|Overall Study|Withdrawal by Subject|1|||
94571419|NCT05435339|323890370|FG007|Overall Study|Withdrawal by Subject|1|||
94571420|NCT02343263|323890371|FG000|Overall Study|Physician Decision|5|||
94571421|NCT02343263|323890372|FG001|Overall Study|Physician Decision|3|||
94571422|NCT02343263|323890373|FG002|Overall Study|Physician Decision|1|||
94571423|NCT00685165|323890382|FG000|Washout Period of 14 Days|Adverse Event|1|||
94571424|NCT00685165|323890383|FG001|Washout Period of 14 Days|Adverse Event|0|||
94571425|NCT03253679|323890396|FG000|Overall Study|Screen Failure|1|||
94571426|NCT01300728|323890397|FG000|Overall Study|Withdrawal by Subject|1|||
94571427|NCT01300728|323890398|FG001|Overall Study|Withdrawal by Subject|1|||
94571428|NCT01300728|323890397|FG000|Overall Study|Physician Decision|1|||
94571429|NCT01300728|323890398|FG001|Overall Study|Physician Decision|0|||
94571430|NCT01486966|323890399|FG000|Overall Study|Adverse Event|0|||
94571431|NCT01486966|323890400|FG001|Overall Study|Adverse Event|1|||
94571432|NCT01486966|323890399|FG000|Overall Study|Withdrawal by Subject|0|||
94571433|NCT01486966|323890400|FG001|Overall Study|Withdrawal by Subject|1|||
94571434|NCT00880620|323890404|FG000|Overall Study|Adverse Event|4|||
94571435|NCT00880620|323890405|FG001|Overall Study|Adverse Event|5|||
94571436|NCT00880620|323890406|FG002|Overall Study|Adverse Event|15|||
94571437|NCT00880620|323890407|FG003|Overall Study|Adverse Event|15|||
94571438|NCT00880620|323890404|FG000|Overall Study|Death|0|||
94571439|NCT00880620|323890405|FG001|Overall Study|Death|0|||
94571440|NCT00880620|323890406|FG002|Overall Study|Death|1|||
94571441|NCT00880620|323890407|FG003|Overall Study|Death|0|||
94571442|NCT00880620|323890404|FG000|Overall Study|Lack of Efficacy|12|||
94571443|NCT00880620|323890405|FG001|Overall Study|Lack of Efficacy|4|||
94571444|NCT00880620|323890406|FG002|Overall Study|Lack of Efficacy|0|||
94571445|NCT00880620|323890407|FG003|Overall Study|Lack of Efficacy|1|||
94571446|NCT00880620|323890404|FG000|Overall Study|Lost to Follow-up|0|||
94571447|NCT00880620|323890405|FG001|Overall Study|Lost to Follow-up|1|||
94571448|NCT00880620|323890406|FG002|Overall Study|Lost to Follow-up|1|||
94571449|NCT00880620|323890407|FG003|Overall Study|Lost to Follow-up|0|||
94571450|NCT00880620|323890404|FG000|Overall Study|Protocol Violation|0|||
94571451|NCT00880620|323890405|FG001|Overall Study|Protocol Violation|1|||
94571452|NCT00880620|323890406|FG002|Overall Study|Protocol Violation|0|||
94571453|NCT00880620|323890407|FG003|Overall Study|Protocol Violation|2|||
94571454|NCT00880620|323890404|FG000|Overall Study|Withdrawal by Subject|4|||
94571455|NCT00880620|323890405|FG001|Overall Study|Withdrawal by Subject|3|||
94571456|NCT00880620|323890406|FG002|Overall Study|Withdrawal by Subject|1|||
94571457|NCT00880620|323890407|FG003|Overall Study|Withdrawal by Subject|3|||
94571458|NCT00880620|323890404|FG000|Overall Study|Noncompliance|0|||
94571459|NCT00880620|323890405|FG001|Overall Study|Noncompliance|0|||
94571460|NCT00880620|323890406|FG002|Overall Study|Noncompliance|1|||
94571461|NCT00880620|323890407|FG003|Overall Study|Noncompliance|1|||
94571462|NCT00880620|323890404|FG000|Overall Study|Other|1|||
94571463|NCT00880620|323890405|FG001|Overall Study|Other|1|||
94571464|NCT00880620|323890406|FG002|Overall Study|Other|2|||
94571465|NCT00880620|323890407|FG003|Overall Study|Other|2|||
94571466|NCT04750642|323890415|FG000|Overall Study|Adverse Event|1|||
94571467|NCT04750642|323890416|FG001|Overall Study|Adverse Event|0|||
94571468|NCT04750642|323890415|FG000|Overall Study|Withdrawal by Subject|0|||
94571469|NCT04750642|323890416|FG001|Overall Study|Withdrawal by Subject|1|||
94571470|NCT04750642|323890415|FG000|Overall Study|Protocol Violation|0|||
94571471|NCT04750642|323890416|FG001|Overall Study|Protocol Violation|1|||
94571472|NCT04481243|323891974|FG000|Overall Study|Withdrawal by Subject|4|||
94571473|NCT00383786|323891975|FG000|Overall Study|Protocol Violation|2|||
94571474|NCT00383786|323891976|FG001|Overall Study|Protocol Violation|6|||
94571475|NCT00383786|323891975|FG000|Overall Study|Withdrawal by Subject|2|||
94571476|NCT00383786|323891976|FG001|Overall Study|Withdrawal by Subject|5|||
94571477|NCT00383786|323891975|FG000|Overall Study|Physician Decision|0|||
94571478|NCT00383786|323891976|FG001|Overall Study|Physician Decision|1|||
94571479|NCT03346434|323891977|FG000|Overall Study|Randomized in Error|0|||
94571480|NCT03346434|323891978|FG001|Overall Study|Randomized in Error|0|||
94571481|NCT03346434|323891979|FG002|Overall Study|Randomized in Error|0|||
94571482|NCT03346434|323891980|FG003|Overall Study|Randomized in Error|0|||
94348440|NCT02140762|323056152|FG001|Overall Study|Protocol Violation|1|||
94571483|NCT03346434|323891981|FG004|Overall Study|Randomized in Error|1|||
94571484|NCT03346434|323891982|FG005|Overall Study|Randomized in Error|0|||
94571485|NCT03346434|323891977|FG000|Overall Study|Withdrawal by Subject|0|||
94571486|NCT03346434|323891978|FG001|Overall Study|Withdrawal by Subject|0|||
94571487|NCT03346434|323891979|FG002|Overall Study|Withdrawal by Subject|1|||
94571488|NCT03346434|323891980|FG003|Overall Study|Withdrawal by Subject|0|||
94571489|NCT03346434|323891981|FG004|Overall Study|Withdrawal by Subject|1|||
94571490|NCT03346434|323891982|FG005|Overall Study|Withdrawal by Subject|0|||
94571491|NCT03346434|323891977|FG000|Overall Study|Lost to Follow-up|0|||
94571492|NCT03346434|323891978|FG001|Overall Study|Lost to Follow-up|0|||
94571493|NCT03346434|323891979|FG002|Overall Study|Lost to Follow-up|0|||
94571494|NCT03346434|323891980|FG003|Overall Study|Lost to Follow-up|0|||
94571495|NCT03346434|323891981|FG004|Overall Study|Lost to Follow-up|1|||
94571496|NCT03346434|323891982|FG005|Overall Study|Lost to Follow-up|1|||
94571497|NCT03346434|323891977|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
94571498|NCT03346434|323891978|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
94571499|NCT03346434|323891979|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
94571500|NCT03346434|323891980|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
94571501|NCT03346434|323891981|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
94571502|NCT03346434|323891982|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
94571503|NCT03096834|323891983|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
94571504|NCT03096834|323891984|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
94571505|NCT03096834|323891985|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
94571506|NCT03096834|323891986|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
94571507|NCT03096834|323891983|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
94571508|NCT03096834|323891984|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
94571509|NCT03096834|323891985|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
94571510|NCT03096834|323891986|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
94571511|NCT03096834|323891983|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
94571512|NCT03096834|323891984|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
94571513|NCT03096834|323891985|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
94571514|NCT03096834|323891986|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
94571515|NCT03096834|323891983|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
94571516|NCT03096834|323891984|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
94571517|NCT03096834|323891985|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
94571518|NCT03096834|323891986|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
94571519|NCT03096834|323891983|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
94571520|NCT03096834|323891984|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
94571521|NCT03096834|323891985|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
94571522|NCT03096834|323891986|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
94571523|NCT03096834|323891983|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
94571524|NCT03096834|323891984|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
94571525|NCT03096834|323891985|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
94571526|NCT03096834|323891986|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
94571527|NCT03096834|323891983|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
94571528|NCT03096834|323891984|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
94571529|NCT03096834|323891985|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
94571530|NCT03096834|323891986|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
94571531|NCT03096834|323891983|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
94571532|NCT03096834|323891984|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
94571533|NCT03096834|323891985|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
94571534|NCT03096834|323891986|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
94571535|NCT03096834|323891983|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
94571536|NCT03096834|323891984|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
94571537|NCT03096834|323891985|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
94571538|NCT03096834|323891986|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
94571539|NCT03096834|323891983|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
94571540|NCT03096834|323891984|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
94571541|NCT03096834|323891985|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
94571542|NCT03096834|323891986|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
94571543|NCT03096834|323891983|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
94571544|NCT03096834|323891984|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
94571545|NCT03096834|323891985|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
94571546|NCT03096834|323891986|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
94571547|NCT03096834|323891983|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
94571548|NCT03096834|323891984|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
94571549|NCT03096834|323891985|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
94571550|NCT03096834|323891986|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
94571551|NCT04416204|323891989|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
94571552|NCT04416204|323891990|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
94571553|NCT04416204|323891991|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
94571554|NCT04416204|323891992|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
94571555|NCT01419236|323891993|FG000|Overall Study|Adverse Event|1|||
94571556|NCT01419236|323891994|FG001|Overall Study|Adverse Event|0|||
94571557|NCT01419236|323891993|FG000|Overall Study|Lack of Efficacy|0|||
94571558|NCT01419236|323891994|FG001|Overall Study|Lack of Efficacy|1|||
94571559|NCT01419236|323891993|FG000|Overall Study|Lost to Follow-up|1|||
94571560|NCT01419236|323891994|FG001|Overall Study|Lost to Follow-up|0|||
94571561|NCT01419236|323891993|FG000|Overall Study|Physician Decision|1|||
94571562|NCT01419236|323891994|FG001|Overall Study|Physician Decision|0|||
94571563|NCT01419236|323891993|FG000|Overall Study|Withdrawal by Subject|1|||
94571564|NCT01419236|323891994|FG001|Overall Study|Withdrawal by Subject|4|||
94571565|NCT01419236|323891993|FG000|Overall Study|Entry Criteria Not Met|1|||
94571566|NCT01419236|323891994|FG001|Overall Study|Entry Criteria Not Met|0|||
94571567|NCT03633396|323891995|FG000|Overall Study|Withdrawal by Subject|4|||
94571568|NCT03633396|323891996|FG001|Overall Study|Withdrawal by Subject|4|||
94571569|NCT03633396|323891995|FG000|Overall Study|Adverse Event|1|||
94571570|NCT03633396|323891996|FG001|Overall Study|Adverse Event|1|||
94571571|NCT03633396|323891995|FG000|Overall Study|Lack of Efficacy|1|||
94571572|NCT03633396|323891996|FG001|Overall Study|Lack of Efficacy|0|||
94571573|NCT03633396|323891995|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
94571574|NCT03633396|323891996|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
94571575|NCT02421172|323891997|FG000|Period 1|Adverse Event|1|||
94571576|NCT02421172|323891998|FG001|Period 1|Adverse Event|0|||
94571577|NCT02421172|323891999|FG002|Period 1|Adverse Event|0|||
94571578|NCT02421172|323892000|FG003|Period 1|Adverse Event|0|||
94571579|NCT02421172|323892001|FG004|Period 1|Adverse Event|0|||
94571580|NCT02421172|323891997|FG000|Period 1|Lost to Follow-up|3|||
94571581|NCT02421172|323891998|FG001|Period 1|Lost to Follow-up|1|||
94571582|NCT02421172|323891999|FG002|Period 1|Lost to Follow-up|0|||
94571583|NCT02421172|323892000|FG003|Period 1|Lost to Follow-up|0|||
94571584|NCT02421172|323892001|FG004|Period 1|Lost to Follow-up|0|||
94571585|NCT02421172|323891997|FG000|Period 1|Patient/guardian decision|0|||
94571586|NCT02421172|323891998|FG001|Period 1|Patient/guardian decision|1|||
94571587|NCT02421172|323891999|FG002|Period 1|Patient/guardian decision|0|||
94571588|NCT02421172|323892000|FG003|Period 1|Patient/guardian decision|0|||
94571589|NCT02421172|323892001|FG004|Period 1|Patient/guardian decision|0|||
94571590|NCT02421172|323891997|FG000|Period 2|Adverse Event|0|||
94571591|NCT02421172|323891998|FG001|Period 2|Adverse Event|0|||
94571592|NCT02421172|323891999|FG002|Period 2|Adverse Event|4|||
94571593|NCT02421172|323892000|FG003|Period 2|Adverse Event|0|||
94571594|NCT02421172|323892001|FG004|Period 2|Adverse Event|0|||
94571595|NCT02421172|323891997|FG000|Period 2|Lost to Follow-up|0|||
94571596|NCT02421172|323891998|FG001|Period 2|Lost to Follow-up|0|||
94571597|NCT02421172|323891999|FG002|Period 2|Lost to Follow-up|0|||
94571598|NCT02421172|323892000|FG003|Period 2|Lost to Follow-up|1|||
94571599|NCT02421172|323892001|FG004|Period 2|Lost to Follow-up|0|||
94571600|NCT02421172|323891997|FG000|Period 2|Patient/guardian decision|0|||
94571601|NCT02421172|323891998|FG001|Period 2|Patient/guardian decision|0|||
94571602|NCT02421172|323891999|FG002|Period 2|Patient/guardian decision|3|||
94571603|NCT02421172|323892000|FG003|Period 2|Patient/guardian decision|2|||
94571604|NCT02421172|323892001|FG004|Period 2|Patient/guardian decision|1|||
94571605|NCT00928486|323892002|FG000|Overall Study|Adverse Event|2|||
94571606|NCT00928486|323892002|FG000|Overall Study|Disease Progression|7|||
94571607|NCT00928486|323892002|FG000|Overall Study|Withdrawal by Subject|1|||
94571608|NCT03287791|323892005|FG000|Overall Study|Insufficient Therapeutic Response|0|||
94571609|NCT03287791|323892006|FG001|Overall Study|Insufficient Therapeutic Response|0|||
94571610|NCT03287791|323892007|FG002|Overall Study|Insufficient Therapeutic Response|1|||
94571611|NCT03287791|323892005|FG000|Overall Study|Adverse Event|0|||
94571612|NCT03287791|323892006|FG001|Overall Study|Adverse Event|4|||
94571613|NCT03287791|323892007|FG002|Overall Study|Adverse Event|3|||
94571614|NCT03287791|323892005|FG000|Overall Study|Withdrawal by Subject|12|||
94571615|NCT03287791|323892006|FG001|Overall Study|Withdrawal by Subject|12|||
94571616|NCT03287791|323892007|FG002|Overall Study|Withdrawal by Subject|17|||
94571617|NCT03287791|323892005|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
94571618|NCT03287791|323892006|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
94571619|NCT03287791|323892007|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
94571620|NCT03287791|323892005|FG000|Overall Study|Lost to Follow-up|8|||
94571621|NCT03287791|323892006|FG001|Overall Study|Lost to Follow-up|14|||
94571622|NCT03287791|323892007|FG002|Overall Study|Lost to Follow-up|11|||
94571623|NCT03287791|323892005|FG000|Overall Study|Protocol Violation|7|||
94571624|NCT03287791|323892006|FG001|Overall Study|Protocol Violation|2|||
94571625|NCT03287791|323892007|FG002|Overall Study|Protocol Violation|1|||
94571626|NCT03287791|323892005|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
94571627|NCT03287791|323892006|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
94451818|NCT00347009|323441856|FG000|Overall Study|Adverse Event|6|||
94451819|NCT00347009|323441856|FG000|Overall Study|Withdrawal by Subject|3|||
94571628|NCT03287791|323892007|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
94571629|NCT03287791|323892005|FG000|Overall Study|Too much time between 2 visits|0|||
94571630|NCT03287791|323892006|FG001|Overall Study|Too much time between 2 visits|1|||
94571631|NCT03287791|323892007|FG002|Overall Study|Too much time between 2 visits|0|||
94571632|NCT03287791|323892005|FG000|Overall Study|Non-compliance|0|||
94571633|NCT03287791|323892006|FG001|Overall Study|Non-compliance|1|||
94571634|NCT03287791|323892007|FG002|Overall Study|Non-compliance|0|||
94571635|NCT03287791|323892005|FG000|Overall Study|Did not meet inclusion criteria|1|||
94451820|NCT00347009|323441856|FG000|Overall Study|Physician Decision|5|||
94571636|NCT03287791|323892006|FG001|Overall Study|Did not meet inclusion criteria|0|||
94571637|NCT03287791|323892007|FG002|Overall Study|Did not meet inclusion criteria|0|||
94571638|NCT03291067|323892012|FG000|Overall Study|Adverse Event|0|||
94571639|NCT03291067|323892013|FG001|Overall Study|Adverse Event|2|||
94571640|NCT03291067|323892014|FG002|Overall Study|Adverse Event|17|||
94571641|NCT03291067|323892015|FG003|Overall Study|Adverse Event|3|||
94571642|NCT03291067|323892012|FG000|Overall Study|Lost to Follow-up|2|||
94571643|NCT03291067|323892013|FG001|Overall Study|Lost to Follow-up|1|||
94571644|NCT03291067|323892014|FG002|Overall Study|Lost to Follow-up|0|||
94571645|NCT03291067|323892015|FG003|Overall Study|Lost to Follow-up|1|||
94571646|NCT03291067|323892012|FG000|Overall Study|Physician Decision|0|||
94571647|NCT03291067|323892013|FG001|Overall Study|Physician Decision|0|||
94571648|NCT03291067|323892014|FG002|Overall Study|Physician Decision|1|||
94571649|NCT03291067|323892015|FG003|Overall Study|Physician Decision|0|||
94571650|NCT03291067|323892012|FG000|Overall Study|Protocol Violation|5|||
94571651|NCT03291067|323892013|FG001|Overall Study|Protocol Violation|3|||
94571652|NCT03291067|323892014|FG002|Overall Study|Protocol Violation|4|||
94571653|NCT03291067|323892015|FG003|Overall Study|Protocol Violation|2|||
94571654|NCT03291067|323892012|FG000|Overall Study|Withdrawal by Subject|3|||
94571655|NCT03291067|323892013|FG001|Overall Study|Withdrawal by Subject|4|||
94571656|NCT03291067|323892014|FG002|Overall Study|Withdrawal by Subject|7|||
94571657|NCT03291067|323892015|FG003|Overall Study|Withdrawal by Subject|5|||
94571658|NCT03291067|323892012|FG000|Overall Study|Other|0|||
94571659|NCT03291067|323892013|FG001|Overall Study|Other|4|||
94571660|NCT03291067|323892014|FG002|Overall Study|Other|4|||
94571661|NCT03291067|323892015|FG003|Overall Study|Other|6|||
94571662|NCT01693029|323892016|FG000|Overall Study|Withdrawal by Subject|15|||
94571663|NCT01693029|323892017|FG001|Overall Study|Withdrawal by Subject|22|||
94571664|NCT01693029|323892016|FG000|Overall Study|Kidney transplantation|7|||
94571665|NCT01693029|323892017|FG001|Overall Study|Kidney transplantation|7|||
94571666|NCT01693029|323892016|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
94571667|NCT01693029|323892017|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
94571668|NCT01693029|323892016|FG000|Overall Study|Protocol Violation|6|||
94571669|NCT01693029|323892017|FG001|Overall Study|Protocol Violation|7|||
94571670|NCT01693029|323892016|FG000|Overall Study|Change in dialysis modality|2|||
94571671|NCT01693029|323892017|FG001|Overall Study|Change in dialysis modality|1|||
94571672|NCT01693029|323892016|FG000|Overall Study|Physician Decision|0|||
94571673|NCT01693029|323892017|FG001|Overall Study|Physician Decision|2|||
94571674|NCT01693029|323892016|FG000|Overall Study|Lost to Follow-up|0|||
94571675|NCT01693029|323892017|FG001|Overall Study|Lost to Follow-up|1|||
94571676|NCT01693029|323892016|FG000|Overall Study|Adverse Event|1|||
94571677|NCT01693029|323892017|FG001|Overall Study|Adverse Event|6|||
94571678|NCT01693029|323892016|FG000|Overall Study|Death|5|||
94571679|NCT01693029|323892017|FG001|Overall Study|Death|8|||
94571680|NCT01693029|323892016|FG000|Overall Study|Non-compliance|2|||
94571681|NCT01693029|323892017|FG001|Overall Study|Non-compliance|1|||
94571682|NCT01731912|323892018|FG000|Overall Study|noncompliance|2|||
94571683|NCT02927301|323892021|FG000|Overall Study|Death|39|||
94571684|NCT02927301|323892021|FG000|Overall Study|Lost to Follow-up|8|||
94571685|NCT02927301|323892021|FG000|Overall Study|Physician Decision|2|||
94571686|NCT02927301|323892021|FG000|Overall Study|Withdrawal by Subject|12|||
94571687|NCT02927301|323892021|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
94571688|NCT01018030|323892026|FG000|Overall Study|Adverse Event|10|||
94571689|NCT01018030|323892027|FG001|Overall Study|Adverse Event|5|||
94571690|NCT01018030|323892028|FG002|Overall Study|Adverse Event|5|||
94571691|NCT01018030|323892026|FG000|Overall Study|Withdrawal by Subject|2|||
94571692|NCT01018030|323892027|FG001|Overall Study|Withdrawal by Subject|2|||
94571693|NCT01018030|323892028|FG002|Overall Study|Withdrawal by Subject|4|||
94571694|NCT01018030|323892026|FG000|Overall Study|Lost to Follow-up|2|||
94571695|NCT01018030|323892027|FG001|Overall Study|Lost to Follow-up|0|||
94451821|NCT00347009|323441856|FG000|Overall Study|Lost to Follow-up|4|||
94571696|NCT01018030|323892028|FG002|Overall Study|Lost to Follow-up|3|||
94571697|NCT01018030|323892026|FG000|Overall Study|Protocol Violation|2|||
94571698|NCT01018030|323892027|FG001|Overall Study|Protocol Violation|1|||
94451822|NCT00347009|323441856|FG000|Overall Study|Protocol Violation|2|||
94571699|NCT01018030|323892028|FG002|Overall Study|Protocol Violation|0|||
94571700|NCT01018030|323892026|FG000|Overall Study|Physician Decision|1|||
94571701|NCT01018030|323892027|FG001|Overall Study|Physician Decision|0|||
94571702|NCT01018030|323892028|FG002|Overall Study|Physician Decision|1|||
94571703|NCT01018030|323892026|FG000|Overall Study|Lack of Efficacy|1|||
94571704|NCT01018030|323892027|FG001|Overall Study|Lack of Efficacy|0|||
94571705|NCT01018030|323892028|FG002|Overall Study|Lack of Efficacy|0|||
94571706|NCT01018030|323892026|FG000|Overall Study|Did Not Receive Study Drug|1|||
94571707|NCT01018030|323892027|FG001|Overall Study|Did Not Receive Study Drug|3|||
94571708|NCT01018030|323892028|FG002|Overall Study|Did Not Receive Study Drug|0|||
94571709|NCT03452540|323892029|FG000|Overall Study|Adverse Event|1|||
94571710|NCT03452540|323892029|FG000|Overall Study|Withdrawal by Subject|1|||
94571711|NCT03452540|323892029|FG000|Overall Study|Other SAE and AE|2|||
94571712|NCT04664153|323892030|FG000|Overall Study|Lack of Efficacy|0|||
94571713|NCT04664153|323892031|FG001|Overall Study|Lack of Efficacy|0|||
94571714|NCT04664153|323892032|FG002|Overall Study|Lack of Efficacy|1|||
94571715|NCT04664153|323892033|FG003|Overall Study|Lack of Efficacy|0|||
94571716|NCT04664153|323892030|FG000|Overall Study|Physician Decision|0|||
94571717|NCT04664153|323892031|FG001|Overall Study|Physician Decision|0|||
94571718|NCT04664153|323892032|FG002|Overall Study|Physician Decision|1|||
94571719|NCT04664153|323892033|FG003|Overall Study|Physician Decision|0|||
94571720|NCT04664153|323892030|FG000|Overall Study|Withdrawal by Subject|3|||
94571721|NCT04664153|323892031|FG001|Overall Study|Withdrawal by Subject|2|||
94571722|NCT04664153|323892032|FG002|Overall Study|Withdrawal by Subject|1|||
94571723|NCT04664153|323892033|FG003|Overall Study|Withdrawal by Subject|2|||
94571724|NCT04664153|323892030|FG000|Overall Study|Other|0|||
94571725|NCT04664153|323892031|FG001|Overall Study|Other|1|||
94571726|NCT04664153|323892032|FG002|Overall Study|Other|0|||
94571727|NCT04664153|323892033|FG003|Overall Study|Other|0|||
94571728|NCT04664153|323892030|FG000|Overall Study|Adverse Event|4|||
94571729|NCT04664153|323892031|FG001|Overall Study|Adverse Event|0|||
94571730|NCT04664153|323892032|FG002|Overall Study|Adverse Event|1|||
94571731|NCT04664153|323892033|FG003|Overall Study|Adverse Event|0|||
94571732|NCT00667888|323892035|FG000|Overall Study|Death|1|||
94571733|NCT00667888|323892036|FG001|Overall Study|Death|1|||
94571734|NCT00667888|323892035|FG000|Overall Study|Withdrawal by Subject|6|||
94571735|NCT00667888|323892036|FG001|Overall Study|Withdrawal by Subject|3|||
94571736|NCT00667888|323892035|FG000|Overall Study|Proceed with other treatment|3|||
94571737|NCT00667888|323892036|FG001|Overall Study|Proceed with other treatment|3|||
94571738|NCT00667888|323892035|FG000|Overall Study|Ineligible after SIM|0|||
94571739|NCT00667888|323892036|FG001|Overall Study|Ineligible after SIM|2|||
94571740|NCT00499681|323892037|FG000|Overall Study|toxicity|0|||
94571741|NCT00499681|323892038|FG001|Overall Study|toxicity|1|||
94571742|NCT00499681|323892037|FG000|Overall Study|disease progression|0|||
94571743|NCT00499681|323892038|FG001|Overall Study|disease progression|1|||
94571744|NCT00333775|323892039|FG000|Overall Study|Death|144|||
94571745|NCT00333775|323892040|FG001|Overall Study|Death|149|||
94571746|NCT00333775|323892041|FG002|Overall Study|Death|143|||
94571747|NCT00333775|323892039|FG000|Overall Study|In Follow-up When Study Stopped|87|||
94571748|NCT00333775|323892040|FG001|Overall Study|In Follow-up When Study Stopped|92|||
94571749|NCT00333775|323892041|FG002|Overall Study|In Follow-up When Study Stopped|96|||
94571750|NCT00333775|323892039|FG000|Overall Study|Lost to Follow-up|10|||
94571751|NCT00333775|323892040|FG001|Overall Study|Lost to Follow-up|7|||
94571752|NCT00333775|323892041|FG002|Overall Study|Lost to Follow-up|8|||
94571753|NCT00739401|323892045|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
94571754|NCT00739401|323892045|FG000|Overall Study|Death|3|||
94571755|NCT00739401|323892045|FG000|Overall Study|Withdrawal by Subject|4|||
94571756|NCT03915717|323892048|FG000|Overall Study|EchoMark Not Implanted|6|||
94571757|NCT00702702|323892050|FG000|Overall Study|Study prematurely terminated|56|||
94571758|NCT04819945|323892051|FG000|Overall Study|Lost to Follow-up|1|||
94571759|NCT00475670|323892055|FG000|Overall Study|Death|0|||
94571760|NCT00475670|323892056|FG001|Overall Study|Death|1|||
94571761|NCT00475670|323892055|FG000|Overall Study|Lack of Efficacy|3|||
94571762|NCT00475670|323892056|FG001|Overall Study|Lack of Efficacy|34|||
94571763|NCT00475670|323892055|FG000|Overall Study|Refused treatment|0|||
94571764|NCT00475670|323892056|FG001|Overall Study|Refused treatment|2|||
94571765|NCT00475670|323892055|FG000|Overall Study|Failure to Return|0|||
94571766|NCT00475670|323892056|FG001|Overall Study|Failure to Return|1|||
94571767|NCT00475670|323892055|FG000|Overall Study|Other|0|||
94571768|NCT00475670|323892056|FG001|Overall Study|Other|3|||
94571769|NCT00703014|323892057|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
94571770|NCT00703014|323892058|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
94571771|NCT00703014|323892059|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
94571772|NCT00703014|323892060|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
94571773|NCT00703014|323892057|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
94571774|NCT00703014|323892058|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
94571775|NCT00703014|323892059|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
94571776|NCT00703014|323892060|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
94571777|NCT00730158|323892061|FG000|Overall Study|Withdrawal by Subject|1|||
94571778|NCT00730158|323892062|FG001|Overall Study|Withdrawal by Subject|1|||
94571779|NCT03740048|323892066|FG000|Overall Study|Withdrawal by Subject|1|||
94571780|NCT03740048|323892067|FG001|Overall Study|Withdrawal by Subject|1|||
94571781|NCT03740048|323892066|FG000|Overall Study|Death|1|||
94571782|NCT03740048|323892067|FG001|Overall Study|Death|6|||
94571783|NCT03740048|323892066|FG000|Overall Study|Switched to thrice-weekly HD|2|||
94571784|NCT03740048|323892067|FG001|Overall Study|Switched to thrice-weekly HD|0|||
94571785|NCT03740048|323892066|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
94571786|NCT03740048|323892067|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
94571787|NCT03740048|323892066|FG000|Overall Study|Lost to Follow-up|0|||
94571788|NCT03740048|323892067|FG001|Overall Study|Lost to Follow-up|1|||
94571789|NCT03740048|323892066|FG000|Overall Study|Non-compliance with HD|0|||
94571790|NCT03740048|323892067|FG001|Overall Study|Non-compliance with HD|1|||
94571791|NCT00292942|323892069|FG000|Overall Study|Withdrawal by Subject|0|||
94571792|NCT00292942|323892070|FG001|Overall Study|Withdrawal by Subject|0|||
94571793|NCT00292942|323892071|FG002|Overall Study|Withdrawal by Subject|1|||
94571794|NCT00292942|323892072|FG003|Overall Study|Withdrawal by Subject|0|||
94571795|NCT00292942|323892069|FG000|Overall Study|Adverse Event|0|||
94571796|NCT00292942|323892070|FG001|Overall Study|Adverse Event|0|||
94571797|NCT00292942|323892071|FG002|Overall Study|Adverse Event|0|||
94571798|NCT00292942|323892072|FG003|Overall Study|Adverse Event|1|||
94571799|NCT00644358|323892073|FG000|Overall Study|Adverse Event|124|||
94571800|NCT00644358|323892073|FG000|Overall Study|Lost to Follow-up|105|||
94571801|NCT00644358|323892073|FG000|Overall Study|Consent Withdrawal|64|||
94571802|NCT00644358|323892073|FG000|Overall Study|Lack of Effectiveness|39|||
94571803|NCT00644358|323892073|FG000|Overall Study|Protocol Violation|5|||
94571804|NCT00644358|323892073|FG000|Overall Study|Noncompliance|14|||
94571805|NCT00644358|323892073|FG000|Overall Study|Other Unspecified|11|||
94571806|NCT00625131|323892077|FG000|Overall Study|Lost to Follow-up|3|||
94571807|NCT00625131|323892078|FG001|Overall Study|Lost to Follow-up|2|||
94571808|NCT00625131|323892079|FG002|Overall Study|Lost to Follow-up|0|||
94571809|NCT00625131|323892077|FG000|Overall Study|Withdrawal by Subject|1|||
94571810|NCT00625131|323892078|FG001|Overall Study|Withdrawal by Subject|0|||
94571811|NCT00625131|323892079|FG002|Overall Study|Withdrawal by Subject|5|||
94571812|NCT00918281|323892080|FG000|Overall Study|Physician Decision|29|||
94571813|NCT02051764|323892082|FG000|Overall Study|Study terminated by sponsor|0|||
94571814|NCT02051764|323892083|FG001|Overall Study|Study terminated by sponsor|7|||
94571815|NCT00591006|323892084|FG000|Overall Study|Withdrawal by Subject|0|||
94571816|NCT00591006|323892085|FG001|Overall Study|Withdrawal by Subject|0|||
94571817|NCT00591006|323892086|FG002|Overall Study|Withdrawal by Subject|0|||
94571818|NCT00591006|323892087|FG003|Overall Study|Withdrawal by Subject|0|||
94571819|NCT00591006|323892088|FG004|Overall Study|Withdrawal by Subject|0|||
94571820|NCT00591006|323892089|FG005|Overall Study|Withdrawal by Subject|0|||
94571821|NCT00591006|323892090|FG006|Overall Study|Withdrawal by Subject|0|||
94571822|NCT00591006|323892091|FG007|Overall Study|Withdrawal by Subject|0|||
94571823|NCT00591006|323892092|FG008|Overall Study|Withdrawal by Subject|0|||
94571824|NCT00591006|323892093|FG009|Overall Study|Withdrawal by Subject|0|||
94571825|NCT00591006|323892094|FG010|Overall Study|Withdrawal by Subject|0|||
94571826|NCT00591006|323892095|FG011|Overall Study|Withdrawal by Subject|0|||
94571827|NCT00591006|323892096|FG012|Overall Study|Withdrawal by Subject|0|||
94571828|NCT00591006|323892097|FG013|Overall Study|Withdrawal by Subject|0|||
94571829|NCT00591006|323892098|FG014|Overall Study|Withdrawal by Subject|0|||
94571830|NCT00591006|323892099|FG015|Overall Study|Withdrawal by Subject|1|||
94571831|NCT00591006|323892100|FG016|Overall Study|Withdrawal by Subject|0|||
94571832|NCT00591006|323892101|FG017|Overall Study|Withdrawal by Subject|0|||
94571833|NCT00591006|323892102|FG018|Overall Study|Withdrawal by Subject|0|||
94571834|NCT00591006|323892103|FG019|Overall Study|Withdrawal by Subject|0|||
94571835|NCT00591006|323892104|FG020|Overall Study|Withdrawal by Subject|0|||
94571836|NCT00591006|323892105|FG021|Overall Study|Withdrawal by Subject|0|||
94571837|NCT00591006|323892106|FG022|Overall Study|Withdrawal by Subject|0|||
94571838|NCT00591006|323892107|FG023|Overall Study|Withdrawal by Subject|1|||
94571839|NCT00591006|323892084|FG000|Overall Study|Adverse Event|0|||
94571840|NCT00591006|323892085|FG001|Overall Study|Adverse Event|0|||
94571841|NCT00591006|323892086|FG002|Overall Study|Adverse Event|0|||
94571842|NCT00591006|323892087|FG003|Overall Study|Adverse Event|0|||
94571843|NCT00591006|323892088|FG004|Overall Study|Adverse Event|0|||
94571844|NCT00591006|323892089|FG005|Overall Study|Adverse Event|0|||
94571845|NCT00591006|323892090|FG006|Overall Study|Adverse Event|0|||
94571846|NCT00591006|323892091|FG007|Overall Study|Adverse Event|0|||
94571847|NCT00591006|323892092|FG008|Overall Study|Adverse Event|0|||
94238242|NCT03126110|322666606|FG009|Phase 1|Safety follow-up no longer necessary|0|||
94571848|NCT00591006|323892093|FG009|Overall Study|Adverse Event|0|||
94571849|NCT00591006|323892094|FG010|Overall Study|Adverse Event|0|||
94238243|NCT03126110|322666607|FG010|Phase 1|Safety follow-up no longer necessary|0|||
94238244|NCT03126110|322666608|FG011|Phase 1|Safety follow-up no longer necessary|0|||
94571850|NCT00591006|323892095|FG011|Overall Study|Adverse Event|0|||
94571851|NCT00591006|323892096|FG012|Overall Study|Adverse Event|0|||
94238245|NCT03126110|322666609|FG012|Phase 1|Safety follow-up no longer necessary|0|||
94238246|NCT03126110|322666610|FG013|Phase 1|Safety follow-up no longer necessary|0|||
94238247|NCT03126110|322666611|FG014|Phase 1|Safety follow-up no longer necessary|0|||
94571852|NCT00591006|323892097|FG013|Overall Study|Adverse Event|0|||
94571853|NCT00591006|323892098|FG014|Overall Study|Adverse Event|0|||
94571854|NCT00591006|323892099|FG015|Overall Study|Adverse Event|0|||
94571855|NCT00591006|323892100|FG016|Overall Study|Adverse Event|0|||
94571856|NCT00591006|323892101|FG017|Overall Study|Adverse Event|0|||
94571857|NCT00591006|323892102|FG018|Overall Study|Adverse Event|0|||
94571858|NCT00591006|323892103|FG019|Overall Study|Adverse Event|0|||
94571859|NCT00591006|323892104|FG020|Overall Study|Adverse Event|0|||
94238248|NCT03126110|322666612|FG015|Phase 1|Safety follow-up no longer necessary|0|||
94571860|NCT00591006|323892105|FG021|Overall Study|Adverse Event|0|||
94571861|NCT00591006|323892106|FG022|Overall Study|Adverse Event|1|||
94571862|NCT00591006|323892107|FG023|Overall Study|Adverse Event|0|||
94571863|NCT02657889|323892108|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
94571864|NCT02657889|323892109|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
94571865|NCT02657889|323892110|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
94571866|NCT02657889|323892111|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
94571867|NCT02657889|323892108|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
94571868|NCT02657889|323892109|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
94571869|NCT02657889|323892110|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
94571870|NCT02657889|323892111|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
94571871|NCT02657889|323892108|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
94571872|NCT02657889|323892109|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
94571873|NCT02657889|323892110|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
94571874|NCT02657889|323892111|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
94571875|NCT02657889|323892108|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
94571876|NCT02657889|323892109|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
94571877|NCT02657889|323892110|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
94571878|NCT02657889|323892111|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
94571879|NCT02657889|323892108|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
94571880|NCT02657889|323892109|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
94571881|NCT02657889|323892110|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
94571882|NCT02657889|323892111|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
94571883|NCT02657889|323892108|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
94571884|NCT02657889|323892109|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
94571885|NCT02657889|323892110|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
94571886|NCT02657889|323892111|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
94571887|NCT02657889|323892108|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
94571888|NCT02657889|323892109|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
94571889|NCT02657889|323892110|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
94571890|NCT02657889|323892111|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
94571891|NCT02657889|323892108|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
94571892|NCT02657889|323892109|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
94571893|NCT02657889|323892110|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
94571894|NCT02657889|323892111|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
94571895|NCT02657889|323892108|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
94571896|NCT02657889|323892109|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
94571897|NCT02657889|323892110|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
94571898|NCT02657889|323892111|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
94571899|NCT02657889|323892108|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
94571900|NCT02657889|323892109|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
94571901|NCT02657889|323892110|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
94571902|NCT02657889|323892111|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
94571903|NCT02657889|323892108|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
94571904|NCT02657889|323892109|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
94571905|NCT02657889|323892110|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
94571906|NCT02657889|323892111|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
94571907|NCT02657889|323892108|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
94571908|NCT02657889|323892109|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
94571909|NCT02657889|323892110|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
94571910|NCT02657889|323892111|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
94571911|NCT03353675|323892113|FG000|Overall Study|Adverse Event|4|||
94571912|NCT02741245|323892116|FG000|Overall Study|Adverse Event|0|||
94571913|NCT02741245|323892117|FG001|Overall Study|Adverse Event|0|||
94571914|NCT02741245|323892118|FG002|Overall Study|Adverse Event|0|||
94571915|NCT02741245|323892119|FG003|Overall Study|Adverse Event|2|||
94571916|NCT02741245|323892120|FG004|Overall Study|Adverse Event|2|||
94571917|NCT02741245|323892116|FG000|Overall Study|Protocol Violation|0|||
94571918|NCT02741245|323892117|FG001|Overall Study|Protocol Violation|1|||
94571919|NCT02741245|323892118|FG002|Overall Study|Protocol Violation|0|||
94571920|NCT02741245|323892119|FG003|Overall Study|Protocol Violation|1|||
94571921|NCT02741245|323892120|FG004|Overall Study|Protocol Violation|0|||
94571922|NCT02741245|323892116|FG000|Overall Study|Withdrawal by Subject|0|||
94571923|NCT02741245|323892117|FG001|Overall Study|Withdrawal by Subject|0|||
94571924|NCT02741245|323892118|FG002|Overall Study|Withdrawal by Subject|0|||
94571925|NCT02741245|323892119|FG003|Overall Study|Withdrawal by Subject|1|||
94238249|NCT03126110|322666613|FG016|Phase 1|Safety follow-up no longer necessary|0|||
94238250|NCT03126110|322666597|FG000|Phase 1|Survival follow-up no longer necessary|0|||
94238251|NCT03126110|322666598|FG001|Phase 1|Survival follow-up no longer necessary|0|||
94238252|NCT03126110|322666599|FG002|Phase 1|Survival follow-up no longer necessary|1|||
94238253|NCT03126110|322666600|FG003|Phase 1|Survival follow-up no longer necessary|0|||
94238254|NCT03126110|322666601|FG004|Phase 1|Survival follow-up no longer necessary|0|||
94571926|NCT02741245|323892120|FG004|Overall Study|Withdrawal by Subject|0|||
94571927|NCT02025179|323892121|FG000|Overall Study|Lost to Follow-up|0|||
94571928|NCT02025179|323892122|FG001|Overall Study|Lost to Follow-up|0|||
94571929|NCT02025179|323892123|FG002|Overall Study|Lost to Follow-up|1|||
94571930|NCT02362724|323892124|FG000|Overall Study|Withdrawal by Subject|3|||
94571931|NCT02362724|323892125|FG001|Overall Study|Withdrawal by Subject|1|||
94571932|NCT02362724|323892124|FG000|Overall Study|Adverse Event|3|||
94571933|NCT02362724|323892125|FG001|Overall Study|Adverse Event|0|||
94571934|NCT01927497|323892131|FG000|Overall Study|Death|0|||
94238255|NCT03126110|322666602|FG005|Phase 1|Survival follow-up no longer necessary|0|||
94571935|NCT01927497|323892132|FG001|Overall Study|Death|1|||
94571936|NCT01927497|323892131|FG000|Overall Study|Protocol Violation|2|||
94571937|NCT01927497|323892132|FG001|Overall Study|Protocol Violation|0|||
94571938|NCT01420861|323892133|FG000|Overall Study|Adverse Event|2|||
94571939|NCT01420861|323892133|FG000|Overall Study|Study terminated by Sponsor|7|||
94238256|NCT03126110|322666603|FG006|Phase 1|Survival follow-up no longer necessary|0|||
94238257|NCT03126110|322666604|FG007|Phase 1|Survival follow-up no longer necessary|0|||
94238258|NCT03126110|322666605|FG008|Phase 1|Survival follow-up no longer necessary|0|||
94238259|NCT03126110|322666606|FG009|Phase 1|Survival follow-up no longer necessary|0|||
94571940|NCT01420861|323892133|FG000|Overall Study|Screen failure|7|||
94571941|NCT01420861|323892133|FG000|Overall Study|Randomized not Treated|2|||
94571958|NCT01247324|323892138|FG000|Overall Study|Death|6|||
94238260|NCT03126110|322666607|FG010|Phase 1|Survival follow-up no longer necessary|0|||
94238261|NCT03126110|322666608|FG011|Phase 1|Survival follow-up no longer necessary|0|||
94571959|NCT01247324|323892139|FG001|Overall Study|Death|10|||
94571960|NCT01247324|323892138|FG000|Overall Study|Physician Decision|2|||
94571961|NCT01247324|323892139|FG001|Overall Study|Physician Decision|3|||
94571962|NCT01247324|323892138|FG000|Overall Study|Non-compliance with study drug|3|||
94571963|NCT01247324|323892139|FG001|Overall Study|Non-compliance with study drug|0|||
94571964|NCT01247324|323892138|FG000|Overall Study|Lack of Efficacy|24|||
94571965|NCT01247324|323892139|FG001|Overall Study|Lack of Efficacy|14|||
94571966|NCT01247324|323892138|FG000|Overall Study|Non-compliance|3|||
94571967|NCT01247324|323892139|FG001|Overall Study|Non-compliance|2|||
94571968|NCT01247324|323892138|FG000|Overall Study|Pregnancy|5|||
94571969|NCT01247324|323892139|FG001|Overall Study|Pregnancy|10|||
94571970|NCT01247324|323892138|FG000|Overall Study|Protocol Violation|1|||
94571971|NCT01247324|323892139|FG001|Overall Study|Protocol Violation|1|||
94571972|NCT01247324|323892138|FG000|Overall Study|Reason not specified|42|||
94571973|NCT01247324|323892139|FG001|Overall Study|Reason not specified|32|||
94571974|NCT01247324|323892138|FG000|Overall Study|Consent withdrawn by participant|41|||
94571975|NCT01247324|323892139|FG001|Overall Study|Consent withdrawn by participant|56|||
94571976|NCT01247324|323892138|FG000|Overall Study|Adverse Event|49|||
94571977|NCT01247324|323892139|FG001|Overall Study|Adverse Event|35|||
94571978|NCT01247324|323892138|FG000|Overall Study|Lost to Follow-up|3|||
94571979|NCT01247324|323892139|FG001|Overall Study|Lost to Follow-up|6|||
94571980|NCT01247324|323892138|FG000|Overall Study|Study Terminated by Sponsor|4|||
94571981|NCT01247324|323892139|FG001|Overall Study|Study Terminated by Sponsor|1|||
94571982|NCT01247324|323892138|FG000|Overall Study|Missing|2|||
94571983|NCT01247324|323892139|FG001|Overall Study|Missing|1|||
94571984|NCT01253291|323892140|FG000|Overall Study|Withdrawal by Subject|1|||
94571985|NCT01253291|323892141|FG001|Overall Study|Withdrawal by Subject|1|||
94571986|NCT01253291|323892142|FG002|Overall Study|Withdrawal by Subject|0|||
94571987|NCT01253291|323892143|FG003|Overall Study|Withdrawal by Subject|0|||
94571988|NCT01253291|323892144|FG004|Overall Study|Withdrawal by Subject|0|||
94571989|NCT01253291|323892140|FG000|Overall Study|Adverse Event|0|||
94571990|NCT01253291|323892141|FG001|Overall Study|Adverse Event|1|||
94571991|NCT01253291|323892142|FG002|Overall Study|Adverse Event|0|||
94571992|NCT01253291|323892143|FG003|Overall Study|Adverse Event|0|||
94571993|NCT01253291|323892144|FG004|Overall Study|Adverse Event|0|||
94571994|NCT01253291|323892140|FG000|Overall Study|Lack of Efficacy|1|||
94571995|NCT01253291|323892141|FG001|Overall Study|Lack of Efficacy|0|||
94571996|NCT01253291|323892142|FG002|Overall Study|Lack of Efficacy|0|||
94571997|NCT01253291|323892143|FG003|Overall Study|Lack of Efficacy|0|||
94571998|NCT01253291|323892144|FG004|Overall Study|Lack of Efficacy|0|||
94571999|NCT01253291|323892140|FG000|Overall Study|Physician Decision|2|||
94572000|NCT01253291|323892141|FG001|Overall Study|Physician Decision|0|||
94572001|NCT01253291|323892142|FG002|Overall Study|Physician Decision|0|||
94572002|NCT01253291|323892143|FG003|Overall Study|Physician Decision|0|||
94572003|NCT01253291|323892144|FG004|Overall Study|Physician Decision|2|||
94572004|NCT00506350|323892145|FG000|Overall Study|Serious Adverse Event|1|||
94572005|NCT00506350|323892146|FG001|Overall Study|Serious Adverse Event|0|||
94572006|NCT00506350|323892147|FG002|Overall Study|Serious Adverse Event|0|||
94572007|NCT00506350|323892148|FG003|Overall Study|Serious Adverse Event|0|||
94572008|NCT00506350|323892149|FG004|Overall Study|Serious Adverse Event|0|||
94572009|NCT00506350|323892150|FG005|Overall Study|Serious Adverse Event|0|||
94572010|NCT00506350|323892151|FG006|Overall Study|Serious Adverse Event|0|||
94572011|NCT00506350|323892152|FG007|Overall Study|Serious Adverse Event|0|||
94572012|NCT00506350|323892153|FG008|Overall Study|Serious Adverse Event|0|||
94572013|NCT00506350|323892145|FG000|Overall Study|Adverse Event|0|||
94572014|NCT00506350|323892146|FG001|Overall Study|Adverse Event|0|||
94572015|NCT00506350|323892147|FG002|Overall Study|Adverse Event|0|||
94572016|NCT00506350|323892148|FG003|Overall Study|Adverse Event|0|||
94238262|NCT03126110|322666609|FG012|Phase 1|Survival follow-up no longer necessary|0|||
94238263|NCT03126110|322666610|FG013|Phase 1|Survival follow-up no longer necessary|0|||
94238264|NCT03126110|322666611|FG014|Phase 1|Survival follow-up no longer necessary|0|||
94238265|NCT03126110|322666612|FG015|Phase 1|Survival follow-up no longer necessary|0|||
94238266|NCT03126110|322666613|FG016|Phase 1|Survival follow-up no longer necessary|0|||
94238267|NCT03126110|322666597|FG000|Phase 2|Study terminated by the sponsor|0|||
94238268|NCT03126110|322666598|FG001|Phase 2|Study terminated by the sponsor|0|||
94238269|NCT03126110|322666599|FG002|Phase 2|Study terminated by the sponsor|0|||
94238270|NCT03126110|322666600|FG003|Phase 2|Study terminated by the sponsor|0|||
94238271|NCT03126110|322666601|FG004|Phase 2|Study terminated by the sponsor|0|||
94451823|NCT00347009|323441856|FG000|Overall Study|Adverse Laboratory Experience|1|||
94451824|NCT00347009|323441856|FG000|Overall Study|Insufficient Viral Suppression|3|||
94572017|NCT00506350|323892149|FG004|Overall Study|Adverse Event|0|||
94238272|NCT03126110|322666602|FG005|Phase 2|Study terminated by the sponsor|0|||
94238273|NCT03126110|322666603|FG006|Phase 2|Study terminated by the sponsor|0|||
94238274|NCT03126110|322666604|FG007|Phase 2|Study terminated by the sponsor|0|||
94451825|NCT00347009|323441856|FG000|Overall Study|Increased ALT/HBV DNA|1|||
94572018|NCT00506350|323892150|FG005|Overall Study|Adverse Event|0|||
94572019|NCT00506350|323892151|FG006|Overall Study|Adverse Event|0|||
94572020|NCT00506350|323892152|FG007|Overall Study|Adverse Event|1|||
94572021|NCT00506350|323892153|FG008|Overall Study|Adverse Event|1|||
94572022|NCT00506350|323892145|FG000|Overall Study|Protocol Violation|0|||
94572023|NCT00506350|323892146|FG001|Overall Study|Protocol Violation|0|||
94572024|NCT00506350|323892147|FG002|Overall Study|Protocol Violation|1|||
94572025|NCT00506350|323892148|FG003|Overall Study|Protocol Violation|0|||
94572026|NCT00506350|323892149|FG004|Overall Study|Protocol Violation|0|||
94572027|NCT00506350|323892150|FG005|Overall Study|Protocol Violation|0|||
94572028|NCT00506350|323892151|FG006|Overall Study|Protocol Violation|1|||
94572029|NCT00506350|323892152|FG007|Overall Study|Protocol Violation|0|||
94572030|NCT00506350|323892153|FG008|Overall Study|Protocol Violation|0|||
94572031|NCT00506350|323892145|FG000|Overall Study|Withdrawal by Subject|0|||
94572032|NCT00506350|323892146|FG001|Overall Study|Withdrawal by Subject|1|||
94572033|NCT00506350|323892147|FG002|Overall Study|Withdrawal by Subject|1|||
94572034|NCT00506350|323892148|FG003|Overall Study|Withdrawal by Subject|1|||
94572035|NCT00506350|323892149|FG004|Overall Study|Withdrawal by Subject|4|||
94572036|NCT00506350|323892150|FG005|Overall Study|Withdrawal by Subject|1|||
94572037|NCT00506350|323892151|FG006|Overall Study|Withdrawal by Subject|1|||
94572038|NCT00506350|323892152|FG007|Overall Study|Withdrawal by Subject|2|||
94572039|NCT00506350|323892153|FG008|Overall Study|Withdrawal by Subject|0|||
94572040|NCT00506350|323892145|FG000|Overall Study|Lost to Follow-up|1|||
94572041|NCT00506350|323892146|FG001|Overall Study|Lost to Follow-up|1|||
94572042|NCT00506350|323892147|FG002|Overall Study|Lost to Follow-up|1|||
94572043|NCT00506350|323892148|FG003|Overall Study|Lost to Follow-up|1|||
94572044|NCT00506350|323892149|FG004|Overall Study|Lost to Follow-up|2|||
94572045|NCT00506350|323892150|FG005|Overall Study|Lost to Follow-up|1|||
94572046|NCT00506350|323892151|FG006|Overall Study|Lost to Follow-up|0|||
94572047|NCT00506350|323892152|FG007|Overall Study|Lost to Follow-up|0|||
94572048|NCT00506350|323892153|FG008|Overall Study|Lost to Follow-up|2|||
94572049|NCT00506350|323892145|FG000|Overall Study|Medical Reason|0|||
94572050|NCT00506350|323892146|FG001|Overall Study|Medical Reason|0|||
94572051|NCT00506350|323892147|FG002|Overall Study|Medical Reason|0|||
94572052|NCT00506350|323892148|FG003|Overall Study|Medical Reason|0|||
94572053|NCT00506350|323892149|FG004|Overall Study|Medical Reason|1|||
94572054|NCT00506350|323892150|FG005|Overall Study|Medical Reason|0|||
94572055|NCT00506350|323892151|FG006|Overall Study|Medical Reason|0|||
94572056|NCT00506350|323892152|FG007|Overall Study|Medical Reason|0|||
94572057|NCT00506350|323892153|FG008|Overall Study|Medical Reason|0|||
94572058|NCT00506350|323892145|FG000|Overall Study|Other|1|||
94572059|NCT00506350|323892146|FG001|Overall Study|Other|1|||
94572060|NCT00506350|323892147|FG002|Overall Study|Other|3|||
94572061|NCT00506350|323892148|FG003|Overall Study|Other|0|||
94572062|NCT00506350|323892149|FG004|Overall Study|Other|3|||
94572063|NCT00506350|323892150|FG005|Overall Study|Other|0|||
94572064|NCT00506350|323892151|FG006|Overall Study|Other|0|||
94572065|NCT00506350|323892152|FG007|Overall Study|Other|2|||
94572066|NCT00506350|323892153|FG008|Overall Study|Other|2|||
94572067|NCT04972786|323892154|FG000|First Intervention (1 Day)|Adverse Event|1|||
94572068|NCT04972786|323892155|FG001|First Intervention (1 Day)|Adverse Event|0|||
94572069|NCT01350999|323892156|FG000|Overall Study|Adverse Event|4|||
94572070|NCT01350999|323892157|FG001|Overall Study|Adverse Event|9|||
94572071|NCT01350999|323892158|FG002|Overall Study|Adverse Event|10|||
94572072|NCT01350999|323892156|FG000|Overall Study|Voluntary withdrawal|3|||
94572073|NCT01350999|323892157|FG001|Overall Study|Voluntary withdrawal|4|||
94572074|NCT01350999|323892158|FG002|Overall Study|Voluntary withdrawal|6|||
94572075|NCT01350999|323892156|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
94572076|NCT01350999|323892157|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
94572077|NCT01350999|323892158|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
94572078|NCT00948064|323893762|FG000|Phase I|No treatment received|1|||
94572079|NCT00948064|323893763|FG001|Phase I|No treatment received|0|||
94572080|NCT00948064|323893764|FG002|Phase I|No treatment received|0|||
94572081|NCT00948064|323893762|FG000|Phase II|Physician Decision|0|||
94572082|NCT00948064|323893763|FG001|Phase II|Physician Decision|0|||
94572083|NCT00948064|323893764|FG002|Phase II|Physician Decision|1|||
94572084|NCT00948064|323893762|FG000|Phase II|Withdrawal by Subject|0|||
94572085|NCT00948064|323893763|FG001|Phase II|Withdrawal by Subject|1|||
94572086|NCT00948064|323893764|FG002|Phase II|Withdrawal by Subject|0|||
94572087|NCT01131507|323893770|FG000|Overall Study|Adverse Event|1|||
94658802|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
94658803|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
94658804|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
94658805|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
94572088|NCT01131507|323893770|FG000|Overall Study|Lost to Follow-up|1|||
94572089|NCT01131507|323893770|FG000|Overall Study|Withdrawal by Subject|1|||
94572090|NCT01405768|323893771|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
94572091|NCT01405768|323893772|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
94572092|NCT01393158|323893775|FG000|Overall Study|Adverse Event|1|||
94572093|NCT01393158|323893776|FG001|Overall Study|Adverse Event|0|||
94572094|NCT02173769|323893779|FG000|Overall Study|Protocol Violation|4|||
94572095|NCT03224130|323893780|FG000|Overall Study|consent issue|0|||
94572096|NCT03224130|323893781|FG001|Overall Study|consent issue|1|||
94658806|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
94572097|NCT01474317|323893783|FG000|Overall Study|Adverse Event|1|||
94572098|NCT01474317|323893783|FG000|Overall Study|Subject ineligible for study|1|||
94572099|NCT05482308|323893787|FG000|Overall Study|Withdrawal by Subject|1|||
94572100|NCT05482308|323893788|FG001|Overall Study|Withdrawal by Subject|0|||
94572101|NCT05482308|323893787|FG000|Overall Study|No longer meets eligibility criteria|0|||
94572102|NCT05482308|323893788|FG001|Overall Study|No longer meets eligibility criteria|1|||
94572103|NCT04516746|323893794|FG000|Overall Study|Randomized but not Treated|51|||
94572104|NCT04516746|323893795|FG001|Overall Study|Randomized but not Treated|19|||
94572105|NCT04516746|323893794|FG000|Overall Study|Adverse Event|0|||
94572106|NCT04516746|323893795|FG001|Overall Study|Adverse Event|1|||
94572107|NCT04516746|323893794|FG000|Overall Study|Death|62|||
94572108|NCT04516746|323893795|FG001|Overall Study|Death|32|||
94572109|NCT04516746|323893794|FG000|Overall Study|Lost to Follow-up|3431|||
94572110|NCT04516746|323893795|FG001|Overall Study|Lost to Follow-up|1831|||
94572111|NCT04516746|323893794|FG000|Overall Study|Withdrawal by Subject|1946|||
94348441|NCT02140762|323056151|FG000|Overall Study|Withdrawal by Subject|6|||
94348442|NCT02140762|323056152|FG001|Overall Study|Withdrawal by Subject|4|||
94348443|NCT02140762|323056151|FG000|Overall Study|Other|0|||
94348444|NCT02140762|323056152|FG001|Overall Study|Other|1|||
94348445|NCT02709889|323056153|FG000|Overall Study|Withdrawal by Subject|11|||
94348446|NCT02709889|323056154|FG001|Overall Study|Withdrawal by Subject|10|||
94348447|NCT02709889|323056155|FG002|Overall Study|Withdrawal by Subject|2|||
94348448|NCT02709889|323056156|FG003|Overall Study|Withdrawal by Subject|12|||
94348449|NCT02709889|323056153|FG000|Overall Study|Death|25|||
94348450|NCT02709889|323056154|FG001|Overall Study|Death|38|||
94348451|NCT02709889|323056155|FG002|Overall Study|Death|4|||
94348452|NCT02709889|323056156|FG003|Overall Study|Death|44|||
94348453|NCT02709889|323056153|FG000|Overall Study|Physician Decision|1|||
94348454|NCT02709889|323056154|FG001|Overall Study|Physician Decision|2|||
94348455|NCT02709889|323056155|FG002|Overall Study|Physician Decision|3|||
94572112|NCT04516746|323893795|FG001|Overall Study|Withdrawal by Subject|1696|||
94572113|NCT04516746|323893794|FG000|Overall Study|Physician Decision|10|||
94572114|NCT04516746|323893795|FG001|Overall Study|Physician Decision|8|||
94572115|NCT04516746|323893794|FG000|Overall Study|Other|35|||
94572116|NCT04516746|323893795|FG001|Overall Study|Other|16|||
94572117|NCT00979901|323893796|FG000|Overall Study|Adverse Event|1|||
94572118|NCT00979901|323893797|FG001|Overall Study|Adverse Event|3|||
94572119|NCT00979901|323893798|FG002|Overall Study|Adverse Event|9|||
94572120|NCT00979901|323893799|FG003|Overall Study|Adverse Event|2|||
94572121|NCT00979901|323893796|FG000|Overall Study|Lack of Efficacy|8|||
94572122|NCT00979901|323893797|FG001|Overall Study|Lack of Efficacy|4|||
94572123|NCT00979901|323893798|FG002|Overall Study|Lack of Efficacy|9|||
94572124|NCT00979901|323893799|FG003|Overall Study|Lack of Efficacy|0|||
94572125|NCT00979901|323893796|FG000|Overall Study|Lost to Follow-up|1|||
94572126|NCT00979901|323893797|FG001|Overall Study|Lost to Follow-up|1|||
94348456|NCT02709889|323056156|FG003|Overall Study|Physician Decision|5|||
94348457|NCT02709889|323056153|FG000|Overall Study|Lost to Follow-up|2|||
94572127|NCT00979901|323893798|FG002|Overall Study|Lost to Follow-up|2|||
94572128|NCT00979901|323893799|FG003|Overall Study|Lost to Follow-up|0|||
94572129|NCT00979901|323893796|FG000|Overall Study|Protocol Violation|2|||
94572130|NCT00979901|323893797|FG001|Overall Study|Protocol Violation|2|||
94348458|NCT02709889|323056154|FG001|Overall Study|Lost to Follow-up|0|||
94572131|NCT00979901|323893798|FG002|Overall Study|Protocol Violation|7|||
94572132|NCT00979901|323893799|FG003|Overall Study|Protocol Violation|1|||
94572133|NCT00979901|323893796|FG000|Overall Study|Withdrawal by Subject|2|||
94572134|NCT00979901|323893797|FG001|Overall Study|Withdrawal by Subject|1|||
94572135|NCT00979901|323893798|FG002|Overall Study|Withdrawal by Subject|1|||
94572136|NCT00979901|323893799|FG003|Overall Study|Withdrawal by Subject|1|||
94572137|NCT00979901|323893796|FG000|Overall Study|Noncompliance|1|||
94572138|NCT00979901|323893797|FG001|Overall Study|Noncompliance|0|||
94238275|NCT03126110|322666605|FG008|Phase 2|Study terminated by the sponsor|0|||
94238276|NCT03126110|322666606|FG009|Phase 2|Study terminated by the sponsor|0|||
94238277|NCT03126110|322666607|FG010|Phase 2|Study terminated by the sponsor|0|||
94238278|NCT03126110|322666608|FG011|Phase 2|Study terminated by the sponsor|0|||
94238279|NCT03126110|322666609|FG012|Phase 2|Study terminated by the sponsor|0|||
94238280|NCT03126110|322666610|FG013|Phase 2|Study terminated by the sponsor|4|||
94238281|NCT03126110|322666611|FG014|Phase 2|Study terminated by the sponsor|0|||
94572139|NCT00979901|323893798|FG002|Overall Study|Noncompliance|0|||
94572140|NCT00979901|323893799|FG003|Overall Study|Noncompliance|0|||
94572141|NCT00979901|323893796|FG000|Overall Study|out-of-state|1|||
94572142|NCT00979901|323893797|FG001|Overall Study|out-of-state|0|||
94572143|NCT00979901|323893798|FG002|Overall Study|out-of-state|0|||
94572144|NCT00979901|323893799|FG003|Overall Study|out-of-state|0|||
94572145|NCT00979901|323893796|FG000|Overall Study|vacation|1|||
94572146|NCT00979901|323893797|FG001|Overall Study|vacation|0|||
94572147|NCT00979901|323893798|FG002|Overall Study|vacation|0|||
94572148|NCT00979901|323893799|FG003|Overall Study|vacation|0|||
94572149|NCT00979901|323893796|FG000|Overall Study|elevated lab values pre-randomization|1|||
94572150|NCT00979901|323893797|FG001|Overall Study|elevated lab values pre-randomization|0|||
94572151|NCT00979901|323893798|FG002|Overall Study|elevated lab values pre-randomization|0|||
94572152|NCT00979901|323893799|FG003|Overall Study|elevated lab values pre-randomization|0|||
94572153|NCT00979901|323893796|FG000|Overall Study|Discontinued in Error|0|||
94572154|NCT00979901|323893797|FG001|Overall Study|Discontinued in Error|1|||
94572155|NCT00979901|323893798|FG002|Overall Study|Discontinued in Error|0|||
94572156|NCT00979901|323893799|FG003|Overall Study|Discontinued in Error|0|||
94572157|NCT00979901|323893796|FG000|Overall Study|Left Country|0|||
94572158|NCT00979901|323893797|FG001|Overall Study|Left Country|0|||
94572159|NCT00979901|323893798|FG002|Overall Study|Left Country|1|||
94572160|NCT00979901|323893799|FG003|Overall Study|Left Country|0|||
94572161|NCT00979901|323893796|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
94572162|NCT00979901|323893797|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
94572163|NCT00979901|323893798|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
94572164|NCT00979901|323893799|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
94572165|NCT03284710|323893802|FG000|Overall Study|Withdrawal by Subject|1|||
94572166|NCT03284710|323893803|FG001|Overall Study|Withdrawal by Subject|0|||
94572167|NCT03284710|323893804|FG002|Overall Study|Withdrawal by Subject|1|||
94572168|NCT03284710|323893805|FG003|Overall Study|Withdrawal by Subject|6|||
94572169|NCT03284710|323893802|FG000|Overall Study|Lost to Follow-up|3|||
94572170|NCT03284710|323893803|FG001|Overall Study|Lost to Follow-up|3|||
94572171|NCT03284710|323893804|FG002|Overall Study|Lost to Follow-up|1|||
94572172|NCT03284710|323893805|FG003|Overall Study|Lost to Follow-up|0|||
94238282|NCT03126110|322666612|FG015|Phase 2|Study terminated by the sponsor|0|||
94238283|NCT03126110|322666613|FG016|Phase 2|Study terminated by the sponsor|0|||
94238284|NCT03126110|322666597|FG000|Phase 2|Withdrawal by Subject|0|||
94238285|NCT03126110|322666598|FG001|Phase 2|Withdrawal by Subject|0|||
94238286|NCT03126110|322666599|FG002|Phase 2|Withdrawal by Subject|0|||
94238287|NCT03126110|322666600|FG003|Phase 2|Withdrawal by Subject|0|||
94238288|NCT03126110|322666601|FG004|Phase 2|Withdrawal by Subject|0|||
94238289|NCT03126110|322666602|FG005|Phase 2|Withdrawal by Subject|0|||
94238290|NCT03126110|322666603|FG006|Phase 2|Withdrawal by Subject|0|||
94238291|NCT03126110|322666604|FG007|Phase 2|Withdrawal by Subject|0|||
94238292|NCT03126110|322666605|FG008|Phase 2|Withdrawal by Subject|0|||
94572173|NCT03284710|323893802|FG000|Overall Study|Physician Decision|1|||
94572174|NCT03284710|323893803|FG001|Overall Study|Physician Decision|0|||
94238293|NCT03126110|322666606|FG009|Phase 2|Withdrawal by Subject|0|||
94238294|NCT03126110|322666607|FG010|Phase 2|Withdrawal by Subject|0|||
94238295|NCT03126110|322666608|FG011|Phase 2|Withdrawal by Subject|1|||
94451826|NCT00347009|323441856|FG000|Overall Study|Serious Adverse Event|1|||
94451827|NCT00552396|323441859|FG000|Overall Study|protocol withdrawal criteria|3|||
94572175|NCT03284710|323893804|FG002|Overall Study|Physician Decision|0|||
94572176|NCT03284710|323893805|FG003|Overall Study|Physician Decision|0|||
94572177|NCT03284710|323893802|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
94572178|NCT03284710|323893803|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
94572179|NCT03284710|323893804|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
94572180|NCT03284710|323893805|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
94238296|NCT03126110|322666609|FG012|Phase 2|Withdrawal by Subject|3|||
94238297|NCT03126110|322666610|FG013|Phase 2|Withdrawal by Subject|3|||
94238298|NCT03126110|322666611|FG014|Phase 2|Withdrawal by Subject|2|||
94238299|NCT03126110|322666612|FG015|Phase 2|Withdrawal by Subject|1|||
94572181|NCT03284710|323893802|FG000|Overall Study|HIV Infection|0|||
94572182|NCT03284710|323893803|FG001|Overall Study|HIV Infection|2|||
94572183|NCT03284710|323893804|FG002|Overall Study|HIV Infection|2|||
94572184|NCT03284710|323893805|FG003|Overall Study|HIV Infection|1|||
94572185|NCT00141453|323893808|FG000|Overall Study|Protocol Violation|6|||
94572186|NCT00141453|323893809|FG001|Overall Study|Protocol Violation|5|||
94572187|NCT03040999|323893811|FG000|Overall Study|Lost to Follow-up|1|||
94572188|NCT03040999|323893812|FG001|Overall Study|Lost to Follow-up|0|||
94572189|NCT03040999|323893811|FG000|Overall Study|Withdrawal by Subject|7|||
94572190|NCT03040999|323893812|FG001|Overall Study|Withdrawal by Subject|12|||
94572191|NCT03040999|323893811|FG000|Overall Study|Death|128|||
94572192|NCT03040999|323893812|FG001|Overall Study|Death|138|||
94572193|NCT03040999|323893811|FG000|Overall Study|Participants Ongoing in Trial|266|||
94572194|NCT03040999|323893812|FG001|Overall Study|Participants Ongoing in Trial|252|||
94572195|NCT00764699|323893818|FG000|Overall Study|PI left and study terminated|3|||
94572196|NCT03661723|323893821|FG000|Overall Study|Disease Progression|4|||
94572197|NCT03661723|323893822|FG001|Overall Study|Disease Progression|24|||
94572198|NCT03661723|323893823|FG002|Overall Study|Disease Progression|4|||
94572199|NCT03661723|323893824|FG003|Overall Study|Disease Progression|19|||
94572200|NCT03661723|323893821|FG000|Overall Study|Withdrawal by Subject|1|||
94572201|NCT03661723|323893822|FG001|Overall Study|Withdrawal by Subject|0|||
94572202|NCT03661723|323893823|FG002|Overall Study|Withdrawal by Subject|2|||
94572203|NCT03661723|323893824|FG003|Overall Study|Withdrawal by Subject|4|||
94572204|NCT03661723|323893821|FG000|Overall Study|Physician Decision|1|||
94572205|NCT03661723|323893822|FG001|Overall Study|Physician Decision|0|||
94572206|NCT03661723|323893823|FG002|Overall Study|Physician Decision|0|||
94572207|NCT03661723|323893824|FG003|Overall Study|Physician Decision|0|||
94572208|NCT03661723|323893821|FG000|Overall Study|Clinical Deterioration|0|||
94572209|NCT03661723|323893822|FG001|Overall Study|Clinical Deterioration|0|||
94572210|NCT03661723|323893823|FG002|Overall Study|Clinical Deterioration|0|||
94572211|NCT03661723|323893824|FG003|Overall Study|Clinical Deterioration|1|||
94572212|NCT04244253|323893825|FG000|Overall Study|Adverse Event|2|||
94572213|NCT04244253|323893826|FG001|Overall Study|Adverse Event|2|||
94572214|NCT04244253|323893827|FG002|Overall Study|Adverse Event|4|||
94572215|NCT04244253|323893825|FG000|Overall Study|Protocol Violation|1|||
94572216|NCT04244253|323893826|FG001|Overall Study|Protocol Violation|2|||
94572217|NCT04244253|323893827|FG002|Overall Study|Protocol Violation|1|||
94572218|NCT04244253|323893825|FG000|Overall Study|Withdrawal by Subject|0|||
94572219|NCT04244253|323893826|FG001|Overall Study|Withdrawal by Subject|1|||
94572220|NCT04244253|323893827|FG002|Overall Study|Withdrawal by Subject|6|||
94572221|NCT04244253|323893825|FG000|Overall Study|Non-Compliance With Study Drug|0|||
94572222|NCT04244253|323893826|FG001|Overall Study|Non-Compliance With Study Drug|0|||
94572223|NCT04244253|323893827|FG002|Overall Study|Non-Compliance With Study Drug|1|||
94572224|NCT04663321|323893828|FG000|Overall Study|Study terminated by Sponsor|2|||
94572225|NCT04663321|323893829|FG001|Overall Study|Study terminated by Sponsor|1|||
94572226|NCT04663321|323893830|FG002|Overall Study|Study terminated by Sponsor|2|||
94572227|NCT04663321|323893828|FG000|Overall Study|Withdrawal by Subject|10|||
94572228|NCT04663321|323893829|FG001|Overall Study|Withdrawal by Subject|3|||
94572229|NCT04663321|323893830|FG002|Overall Study|Withdrawal by Subject|2|||
94572230|NCT04663321|323893828|FG000|Overall Study|Not provided|0|||
94572231|NCT04663321|323893829|FG001|Overall Study|Not provided|0|||
94572232|NCT04663321|323893830|FG002|Overall Study|Not provided|1|||
94572233|NCT04247347|323893833|FG000|Overall Study|Withdrawal by Subject|2|||
94572234|NCT04247347|323893834|FG001|Overall Study|Withdrawal by Subject|3|||
94572235|NCT04247347|323893835|FG002|Overall Study|Withdrawal by Subject|3|||
94572236|NCT04247347|323893833|FG000|Overall Study|Lost to Follow-up|1|||
94572237|NCT04247347|323893834|FG001|Overall Study|Lost to Follow-up|1|||
94572238|NCT04247347|323893835|FG002|Overall Study|Lost to Follow-up|1|||
94572239|NCT03562195|323893836|FG000|Overall Study|Adverse Event|0|||
94572240|NCT03562195|323893837|FG001|Overall Study|Adverse Event|6|||
94572241|NCT03562195|323893836|FG000|Overall Study|Lack of Efficacy|0|||
94572242|NCT03562195|323893837|FG001|Overall Study|Lack of Efficacy|5|||
94572243|NCT03562195|323893836|FG000|Overall Study|Protocol Violation|0|||
94572244|NCT03562195|323893837|FG001|Overall Study|Protocol Violation|1|||
94572245|NCT03562195|323893836|FG000|Overall Study|Lost to Follow-up|0|||
94572246|NCT03562195|323893837|FG001|Overall Study|Lost to Follow-up|1|||
94572247|NCT03562195|323893836|FG000|Overall Study|Physician Decision|1|||
94572248|NCT03562195|323893837|FG001|Overall Study|Physician Decision|0|||
94572249|NCT03562195|323893836|FG000|Overall Study|Withdrawal by Subject|3|||
94572250|NCT03562195|323893837|FG001|Overall Study|Withdrawal by Subject|0|||
94572251|NCT02529852|323893838|FG000|Overall Study|Withdrawal by Subject|2|||
94572252|NCT03532542|323893839|FG000|Overall Study|Death|1|||
94572253|NCT03532542|323893840|FG001|Overall Study|Death|0|||
94572254|NCT03532542|323893839|FG000|Overall Study|Study Terminated by Sponsor|41|||
94572255|NCT03532542|323893840|FG001|Overall Study|Study Terminated by Sponsor|65|||
94572256|NCT03532542|323893839|FG000|Overall Study|Withdrawal by Subject|6|||
94572257|NCT03532542|323893840|FG001|Overall Study|Withdrawal by Subject|5|||
94572258|NCT01488045|323893841|FG000|Overall Study|Withdrawal by Subject|6|||
94572259|NCT01488045|323893842|FG001|Overall Study|Withdrawal by Subject|11|||
94572260|NCT01488045|323893841|FG000|Overall Study|Failure to present for colonoscopy|3|||
94572261|NCT01488045|323893842|FG001|Overall Study|Failure to present for colonoscopy|6|||
94572262|NCT01488045|323893841|FG000|Overall Study|Failure to report exclusion criteria|0|||
94572263|NCT01488045|323893842|FG001|Overall Study|Failure to report exclusion criteria|1|||
94572264|NCT02201524|323893843|FG000|Overall Study|Adverse Event|0|||
94572265|NCT02201524|323893844|FG001|Overall Study|Adverse Event|2|||
94572266|NCT02201524|323893845|FG002|Overall Study|Adverse Event|1|||
94572267|NCT02201524|323893846|FG003|Overall Study|Adverse Event|0|||
94572268|NCT02201524|323893843|FG000|Overall Study|Insufficient clinical response|1|||
94572269|NCT02201524|323893844|FG001|Overall Study|Insufficient clinical response|0|||
94572270|NCT02201524|323893845|FG002|Overall Study|Insufficient clinical response|0|||
94572271|NCT02201524|323893846|FG003|Overall Study|Insufficient clinical response|0|||
94572272|NCT02201524|323893843|FG000|Overall Study|Lost to Follow-up|0|||
94572273|NCT02201524|323893844|FG001|Overall Study|Lost to Follow-up|0|||
94572274|NCT02201524|323893845|FG002|Overall Study|Lost to Follow-up|2|||
94572275|NCT02201524|323893846|FG003|Overall Study|Lost to Follow-up|0|||
94572276|NCT02201524|323893843|FG000|Overall Study|No longer meets eligibility criteria|0|||
94572277|NCT02201524|323893844|FG001|Overall Study|No longer meets eligibility criteria|0|||
94572278|NCT02201524|323893845|FG002|Overall Study|No longer meets eligibility criteria|0|||
94572279|NCT02201524|323893846|FG003|Overall Study|No longer meets eligibility criteria|2|||
94572280|NCT02201524|323893843|FG000|Overall Study|Protocol Violation|0|||
94572281|NCT02201524|323893844|FG001|Overall Study|Protocol Violation|0|||
94572282|NCT02201524|323893845|FG002|Overall Study|Protocol Violation|0|||
94572283|NCT02201524|323893846|FG003|Overall Study|Protocol Violation|1|||
94572284|NCT02201524|323893843|FG000|Overall Study|Withdrawal by Subject|0|||
94572285|NCT02201524|323893844|FG001|Overall Study|Withdrawal by Subject|0|||
94572286|NCT02201524|323893845|FG002|Overall Study|Withdrawal by Subject|1|||
94572287|NCT02201524|323893846|FG003|Overall Study|Withdrawal by Subject|1|||
94572288|NCT02201524|323893843|FG000|Overall Study|Other|1|||
94572289|NCT02201524|323893844|FG001|Overall Study|Other|1|||
94572290|NCT02201524|323893845|FG002|Overall Study|Other|0|||
94572291|NCT02201524|323893846|FG003|Overall Study|Other|0|||
94572292|NCT00001832|323893861|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
94572293|NCT00001832|323893862|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
94572294|NCT00001832|323893863|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
94572295|NCT00001832|323893864|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
94572296|NCT00001832|323893865|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
94572297|NCT00001832|323893866|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
94572298|NCT00001832|323893867|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
94572299|NCT00001832|323893868|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
94572300|NCT00001832|323893869|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
94572301|NCT00001832|323893870|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
94572302|NCT00001832|323893871|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
94572303|NCT00001832|323893872|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
94572304|NCT00001832|323893873|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
94572305|NCT00001832|323893874|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
94572306|NCT00001832|323893875|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
94572307|NCT00001832|323893861|FG000|Treatment Period|Death during treatment|0|||
94572308|NCT00001832|323893862|FG001|Treatment Period|Death during treatment|0|||
94572309|NCT00001832|323893863|FG002|Treatment Period|Death during treatment|0|||
94572310|NCT00001832|323893864|FG003|Treatment Period|Death during treatment|0|||
94572311|NCT00001832|323893865|FG004|Treatment Period|Death during treatment|0|||
94572312|NCT00001832|323893866|FG005|Treatment Period|Death during treatment|1|||
94572313|NCT00001832|323893867|FG006|Treatment Period|Death during treatment|0|||
94572314|NCT00001832|323893868|FG007|Treatment Period|Death during treatment|0|||
94572315|NCT00001832|323893869|FG008|Treatment Period|Death during treatment|0|||
94572316|NCT00001832|323893870|FG009|Treatment Period|Death during treatment|0|||
94572317|NCT00001832|323893871|FG010|Treatment Period|Death during treatment|0|||
94572318|NCT00001832|323893872|FG011|Treatment Period|Death during treatment|0|||
94572319|NCT00001832|323893873|FG012|Treatment Period|Death during treatment|0|||
94572320|NCT00001832|323893874|FG013|Treatment Period|Death during treatment|0|||
94238300|NCT03126110|322666613|FG016|Phase 2|Withdrawal by Subject|0|||
94572321|NCT00001832|323893875|FG014|Treatment Period|Death during treatment|0|||
94572322|NCT00001832|323893861|FG000|Treatment Period|Not treated|0|||
94572323|NCT00001832|323893862|FG001|Treatment Period|Not treated|0|||
94238301|NCT03126110|322666597|FG000|Phase 2|Lost to Follow-up|0|||
94572324|NCT00001832|323893863|FG002|Treatment Period|Not treated|0|||
94572325|NCT00001832|323893864|FG003|Treatment Period|Not treated|0|||
94572326|NCT00001832|323893865|FG004|Treatment Period|Not treated|0|||
94572327|NCT00001832|323893866|FG005|Treatment Period|Not treated|0|||
94572328|NCT00001832|323893867|FG006|Treatment Period|Not treated|0|||
94238302|NCT03126110|322666598|FG001|Phase 2|Lost to Follow-up|0|||
94572329|NCT00001832|323893868|FG007|Treatment Period|Not treated|1|||
94572330|NCT00001832|323893869|FG008|Treatment Period|Not treated|0|||
94572331|NCT00001832|323893870|FG009|Treatment Period|Not treated|0|||
94572332|NCT00001832|323893871|FG010|Treatment Period|Not treated|0|||
94572333|NCT00001832|323893872|FG011|Treatment Period|Not treated|0|||
94572334|NCT00001832|323893873|FG012|Treatment Period|Not treated|0|||
94572335|NCT00001832|323893874|FG013|Treatment Period|Not treated|0|||
94572336|NCT00001832|323893875|FG014|Treatment Period|Not treated|0|||
94572337|NCT01009060|323893876|FG000|Overall Study|Adverse Event|1|||
94572338|NCT01009060|323893877|FG001|Overall Study|Adverse Event|2|||
94572339|NCT01009060|323893876|FG000|Overall Study|Protocol Violation|0|||
94572340|NCT01009060|323893877|FG001|Overall Study|Protocol Violation|1|||
94572341|NCT01009060|323893876|FG000|Overall Study|Lost to Follow-up|1|||
94572342|NCT01009060|323893877|FG001|Overall Study|Lost to Follow-up|0|||
94572343|NCT01009060|323893876|FG000|Overall Study|Physician Decision|1|||
94572344|NCT01009060|323893877|FG001|Overall Study|Physician Decision|1|||
94572345|NCT01009060|323893876|FG000|Overall Study|Withdrawal by Subject|1|||
94572346|NCT01009060|323893877|FG001|Overall Study|Withdrawal by Subject|1|||
94572347|NCT03305666|323893878|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
94572348|NCT03305666|323893879|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
94572349|NCT02587221|323893884|FG000|Overall Study|Adverse Event|3|||
94572350|NCT02587221|323893885|FG001|Overall Study|Adverse Event|3|||
94572351|NCT02587221|323893884|FG000|Overall Study|Death|33|||
94572352|NCT02587221|323893885|FG001|Overall Study|Death|34|||
94572353|NCT02587221|323893884|FG000|Overall Study|Withdrawal by Subject|66|||
94572354|NCT02587221|323893885|FG001|Overall Study|Withdrawal by Subject|61|||
94572355|NCT02587221|323893884|FG000|Overall Study|Lost to Follow-up|21|||
94572356|NCT02587221|323893885|FG001|Overall Study|Lost to Follow-up|19|||
94572357|NCT02587221|323893884|FG000|Overall Study|Protocol Violation|6|||
94572358|NCT02587221|323893885|FG001|Overall Study|Protocol Violation|5|||
94572359|NCT02587221|323893884|FG000|Overall Study|Other Reason or Unspecified|2|||
94572360|NCT02587221|323893885|FG001|Overall Study|Other Reason or Unspecified|1|||
94572361|NCT02546609|323893886|FG000|Overall Study|Withdrawal by Subject|0|||
94572362|NCT02546609|323893887|FG001|Overall Study|Withdrawal by Subject|1|||
94572363|NCT02546609|323893888|FG002|Overall Study|Withdrawal by Subject|2|||
94572364|NCT02546609|323893886|FG000|Overall Study|Adverse Event|0|||
94572365|NCT02546609|323893887|FG001|Overall Study|Adverse Event|6|||
94572366|NCT02546609|323893888|FG002|Overall Study|Adverse Event|1|||
94572367|NCT02546609|323893886|FG000|Overall Study|Protocol Violation|0|||
94572368|NCT02546609|323893887|FG001|Overall Study|Protocol Violation|1|||
94572369|NCT02546609|323893888|FG002|Overall Study|Protocol Violation|1|||
94572370|NCT02546609|323893886|FG000|Overall Study|Lost to Follow-up|2|||
94572371|NCT02546609|323893887|FG001|Overall Study|Lost to Follow-up|3|||
94572372|NCT02546609|323893888|FG002|Overall Study|Lost to Follow-up|1|||
94572373|NCT02546609|323893886|FG000|Overall Study|travel or work schedule restriction|0|||
94572374|NCT02546609|323893887|FG001|Overall Study|travel or work schedule restriction|0|||
94572375|NCT02546609|323893888|FG002|Overall Study|travel or work schedule restriction|2|||
94572376|NCT00883779|323893889|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
94572377|NCT00883779|323893890|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
94572378|NCT00883779|323893889|FG000|Primary Study Treatment Phase|Disease progression|75|||
94572379|NCT00883779|323893890|FG001|Primary Study Treatment Phase|Disease progression|59|||
94572380|NCT00883779|323893889|FG000|Primary Study Treatment Phase|Adverse Event|16|||
94572381|NCT00883779|323893890|FG001|Primary Study Treatment Phase|Adverse Event|16|||
94572382|NCT00883779|323893889|FG000|Primary Study Treatment Phase|Death|2|||
94572383|NCT00883779|323893890|FG001|Primary Study Treatment Phase|Death|3|||
94572384|NCT00883779|323893889|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
94572385|NCT00883779|323893890|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
94572386|NCT00883779|323893889|FG000|Primary Study Treatment Phase|Other|3|||
94572387|NCT00883779|323893890|FG001|Primary Study Treatment Phase|Other|0|||
94572388|NCT00883779|323893889|FG000|Post-Study Treatment Phase|Adverse Event|2|||
94572389|NCT00883779|323893890|FG001|Post-Study Treatment Phase|Adverse Event|3|||
94572390|NCT00883779|323893889|FG000|Post-Study Treatment Phase|Death|1|||
94658807|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
94572391|NCT00883779|323893890|FG001|Post-Study Treatment Phase|Death|3|||
94572392|NCT00883779|323893889|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
94572393|NCT00883779|323893890|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
94572394|NCT00883779|323893889|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
94572395|NCT00883779|323893890|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
94572396|NCT00883779|323893889|FG000|Post-Study Treatment Phase|Disease progression|103|||
94572397|NCT00883779|323893890|FG001|Post-Study Treatment Phase|Disease progression|122|||
94572398|NCT00883779|323893889|FG000|Post-Study Treatment Phase|Other|3|||
94572399|NCT00883779|323893890|FG001|Post-Study Treatment Phase|Other|0|||
94572400|NCT00883779|323893889|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
94572401|NCT00883779|323893890|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
94238303|NCT03126110|322666599|FG002|Phase 2|Lost to Follow-up|0|||
94238304|NCT03126110|322666600|FG003|Phase 2|Lost to Follow-up|0|||
94238305|NCT03126110|322666601|FG004|Phase 2|Lost to Follow-up|0|||
94238306|NCT03126110|322666602|FG005|Phase 2|Lost to Follow-up|0|||
94238307|NCT03126110|322666603|FG006|Phase 2|Lost to Follow-up|0|||
94238308|NCT03126110|322666604|FG007|Phase 2|Lost to Follow-up|0|||
94238309|NCT03126110|322666605|FG008|Phase 2|Lost to Follow-up|0|||
94238310|NCT03126110|322666606|FG009|Phase 2|Lost to Follow-up|0|||
94238311|NCT03126110|322666607|FG010|Phase 2|Lost to Follow-up|0|||
94238312|NCT03126110|322666608|FG011|Phase 2|Lost to Follow-up|1|||
94238313|NCT03126110|322666609|FG012|Phase 2|Lost to Follow-up|1|||
94238314|NCT03126110|322666610|FG013|Phase 2|Lost to Follow-up|1|||
94238315|NCT03126110|322666611|FG014|Phase 2|Lost to Follow-up|2|||
94238316|NCT03126110|322666612|FG015|Phase 2|Lost to Follow-up|0|||
94572402|NCT00883779|323893889|FG000|Off-study Phase|Death|185|||
94572403|NCT00883779|323893890|FG001|Off-study Phase|Death|174|||
94572404|NCT00883779|323893889|FG000|Off-study Phase|Refused treatment|1|||
94572405|NCT00883779|323893890|FG001|Off-study Phase|Refused treatment|1|||
94238317|NCT03126110|322666613|FG016|Phase 2|Lost to Follow-up|0|||
94238318|NCT03126110|322666597|FG000|Phase 2|Death|0|||
94572406|NCT00883779|323893889|FG000|Off-study Phase|Failure to return|5|||
94572407|NCT00883779|323893890|FG001|Off-study Phase|Failure to return|6|||
94572408|NCT00883779|323893889|FG000|Off-study Phase|Other|18|||
94572409|NCT00883779|323893890|FG001|Off-study Phase|Other|21|||
94572410|NCT04913610|323893891|FG000|Randomized Participants|Did Not Receive Treatment|0|||
94572411|NCT04913610|323893892|FG001|Randomized Participants|Did Not Receive Treatment|0|||
94572412|NCT04913610|323893893|FG002|Randomized Participants|Did Not Receive Treatment|1|||
94572413|NCT04913610|323893894|FG003|Randomized Participants|Did Not Receive Treatment|1|||
94572414|NCT04913610|323893895|FG004|Randomized Participants|Did Not Receive Treatment|0|||
94572415|NCT04913610|323893891|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
94572416|NCT04913610|323893892|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
94572417|NCT04913610|323893893|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
94572418|NCT04913610|323893894|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
94572419|NCT04913610|323893895|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
94572420|NCT02174731|323893896|FG000|Overall Study|Participant decision|67|||
94572421|NCT02174731|323893897|FG001|Overall Study|Participant decision|64|||
94572422|NCT02174731|323893896|FG000|Overall Study|Incorrect enrolment before randomization|0|||
94572423|NCT02174731|323893897|FG001|Overall Study|Incorrect enrolment before randomization|1|||
94238319|NCT03126110|322666598|FG001|Phase 2|Death|0|||
94238320|NCT03126110|322666599|FG002|Phase 2|Death|0|||
94238321|NCT03126110|322666600|FG003|Phase 2|Death|0|||
94238322|NCT03126110|322666601|FG004|Phase 2|Death|0|||
94238323|NCT03126110|322666602|FG005|Phase 2|Death|0|||
94238324|NCT03126110|322666603|FG006|Phase 2|Death|0|||
94238325|NCT03126110|322666604|FG007|Phase 2|Death|0|||
94238326|NCT03126110|322666605|FG008|Phase 2|Death|0|||
94572424|NCT02174731|323893896|FG000|Overall Study|Missing|2|||
94572425|NCT02174731|323893897|FG001|Overall Study|Missing|0|||
94572426|NCT00659061|323893898|FG000|Overall Study|Migration due to political unrest|21|||
94572427|NCT00659061|323893899|FG001|Overall Study|Migration due to political unrest|15|||
94572428|NCT00079040|323893902|FG000|Overall Study|Withdrew before treatment|1|||
94572429|NCT00079040|323893902|FG000|Overall Study|Ineligible|1|||
94572430|NCT01277744|323893905|FG000|Overall Study|Physician Decision|2|||
94572431|NCT01664910|323893909|FG000|Overall Study|Adverse Event|0|||
94238327|NCT03126110|322666606|FG009|Phase 2|Death|0|||
94572432|NCT01664910|323893910|FG001|Overall Study|Adverse Event|0|||
94572433|NCT01664910|323893911|FG002|Overall Study|Adverse Event|1|||
94572434|NCT02004236|323893912|FG000|Overall Study|Lack of Efficacy|0|||
94572435|NCT02004236|323893913|FG001|Overall Study|Lack of Efficacy|0|||
94238328|NCT03126110|322666607|FG010|Phase 2|Death|0|||
94238329|NCT03126110|322666608|FG011|Phase 2|Death|6|||
94238330|NCT03126110|322666609|FG012|Phase 2|Death|12|||
94238331|NCT03126110|322666610|FG013|Phase 2|Death|25|||
94238332|NCT03126110|322666611|FG014|Phase 2|Death|11|||
94238333|NCT03126110|322666612|FG015|Phase 2|Death|3|||
94238334|NCT03126110|322666613|FG016|Phase 2|Death|2|||
94572436|NCT02004236|323893914|FG002|Overall Study|Lack of Efficacy|16|||
94572437|NCT00918385|323893915|FG000|Monotherapy|Adverse Event|1|||
94238335|NCT03126110|322666597|FG000|Phase 2|Progressive Disease|0|||
94238336|NCT03126110|322666598|FG001|Phase 2|Progressive Disease|0|||
94238337|NCT03126110|322666599|FG002|Phase 2|Progressive Disease|0|||
94238338|NCT03126110|322666600|FG003|Phase 2|Progressive Disease|0|||
94238339|NCT03126110|322666601|FG004|Phase 2|Progressive Disease|0|||
94238340|NCT03126110|322666602|FG005|Phase 2|Progressive Disease|0|||
94238341|NCT03126110|322666603|FG006|Phase 2|Progressive Disease|0|||
94238342|NCT03126110|322666604|FG007|Phase 2|Progressive Disease|0|||
94238343|NCT03126110|322666605|FG008|Phase 2|Progressive Disease|0|||
94572438|NCT00918385|323893916|FG001|Monotherapy|Adverse Event|6|||
94572439|NCT00918385|323893915|FG000|Monotherapy|Complicating illness|1|||
94572440|NCT00918385|323893916|FG001|Monotherapy|Complicating illness|0|||
94572441|NCT00918385|323893915|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
94572442|NCT00918385|323893916|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
94572443|NCT00918385|323893915|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
94572444|NCT00918385|323893916|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
94572445|NCT00918385|323893915|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
94572446|NCT00918385|323893916|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
94572447|NCT00918385|323893915|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
94572448|NCT00918385|323893916|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
94572449|NCT00771914|323893924|FG000|Overall Study|Physician Decision|0|||
94572450|NCT00771914|323893925|FG001|Overall Study|Physician Decision|0|||
94572451|NCT00771914|323893926|FG002|Overall Study|Physician Decision|0|||
94572452|NCT00771914|323893927|FG003|Overall Study|Physician Decision|1|||
94572453|NCT00771914|323893924|FG000|Overall Study|Lost to Follow-up|0|||
94572454|NCT00771914|323893925|FG001|Overall Study|Lost to Follow-up|0|||
94572455|NCT00771914|323893926|FG002|Overall Study|Lost to Follow-up|0|||
94572456|NCT00771914|323893927|FG003|Overall Study|Lost to Follow-up|1|||
94572457|NCT02978417|323893930|FG000|Overall Study|Lost to Follow-up|2|||
94572458|NCT02978417|323893931|FG001|Overall Study|Lost to Follow-up|2|||
94572459|NCT00317473|323893934|FG000|Overall Study|Withdrawal by Subject|2|||
94572460|NCT00317473|323893935|FG001|Overall Study|Withdrawal by Subject|1|||
94572461|NCT00317473|323893936|FG002|Overall Study|Withdrawal by Subject|2|||
94572462|NCT00317473|323893937|FG003|Overall Study|Withdrawal by Subject|1|||
94572463|NCT00317473|323893938|FG004|Overall Study|Withdrawal by Subject|3|||
94572464|NCT00317473|323893939|FG005|Overall Study|Withdrawal by Subject|1|||
94572465|NCT00317473|323893934|FG000|Overall Study|Relocation|1|||
94572466|NCT00317473|323893935|FG001|Overall Study|Relocation|0|||
94572467|NCT00317473|323893936|FG002|Overall Study|Relocation|1|||
94572468|NCT00317473|323893937|FG003|Overall Study|Relocation|1|||
94572469|NCT00317473|323893938|FG004|Overall Study|Relocation|5|||
94572470|NCT00317473|323893939|FG005|Overall Study|Relocation|2|||
94572471|NCT00317473|323893934|FG000|Overall Study|Death|1|||
94572472|NCT00317473|323893935|FG001|Overall Study|Death|0|||
94572473|NCT00317473|323893936|FG002|Overall Study|Death|0|||
94572474|NCT00317473|323893937|FG003|Overall Study|Death|0|||
94572475|NCT00317473|323893938|FG004|Overall Study|Death|0|||
94572476|NCT00317473|323893939|FG005|Overall Study|Death|0|||
94572477|NCT00317473|323893934|FG000|Overall Study|Other|0|||
94572478|NCT00317473|323893935|FG001|Overall Study|Other|2|||
94572479|NCT00317473|323893936|FG002|Overall Study|Other|0|||
94572480|NCT00317473|323893937|FG003|Overall Study|Other|0|||
94572481|NCT00317473|323893938|FG004|Overall Study|Other|0|||
94572482|NCT00317473|323893939|FG005|Overall Study|Other|0|||
94572483|NCT00556075|323893945|FG000|Overall Study|Lost to Follow-up|3|||
94572484|NCT00556075|323893946|FG001|Overall Study|Lost to Follow-up|0|||
94572485|NCT00556075|323893947|FG002|Overall Study|Lost to Follow-up|3|||
94572486|NCT00556075|323893945|FG000|Overall Study|Withdrawal by Subject|3|||
94572487|NCT00556075|323893946|FG001|Overall Study|Withdrawal by Subject|3|||
94572488|NCT00556075|323893947|FG002|Overall Study|Withdrawal by Subject|0|||
94572489|NCT00556075|323893945|FG000|Overall Study|Protocol Violation|1|||
94572490|NCT00556075|323893946|FG001|Overall Study|Protocol Violation|1|||
94572491|NCT00556075|323893947|FG002|Overall Study|Protocol Violation|3|||
94572492|NCT00556075|323893945|FG000|Overall Study|Not eligible|1|||
94572493|NCT00556075|323893946|FG001|Overall Study|Not eligible|1|||
94572494|NCT00556075|323893947|FG002|Overall Study|Not eligible|2|||
94572495|NCT00556075|323893945|FG000|Overall Study|Adverse Event|1|||
94572496|NCT00556075|323893946|FG001|Overall Study|Adverse Event|2|||
94572497|NCT00556075|323893947|FG002|Overall Study|Adverse Event|0|||
94572498|NCT00556075|323893945|FG000|Overall Study|Personal issues|4|||
94572499|NCT00556075|323893946|FG001|Overall Study|Personal issues|1|||
94572500|NCT00556075|323893947|FG002|Overall Study|Personal issues|0|||
94572501|NCT00556075|323893945|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
94572502|NCT00556075|323893946|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
94572503|NCT00556075|323893947|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
94572504|NCT00601835|323893948|FG000|Overall Study|Withdrawal by Subject|9|||
94572505|NCT00601835|323893949|FG001|Overall Study|Withdrawal by Subject|6|||
94572506|NCT00601835|323893948|FG000|Overall Study|Physician Decision|1|||
94572507|NCT00601835|323893949|FG001|Overall Study|Physician Decision|0|||
94572508|NCT00601835|323893948|FG000|Overall Study|Lost to Follow-up|37|||
94572509|NCT00601835|323893949|FG001|Overall Study|Lost to Follow-up|5|||
94572510|NCT00601835|323893948|FG000|Overall Study|Adverse Event|1|||
94572511|NCT00601835|323893949|FG001|Overall Study|Adverse Event|1|||
94572512|NCT00601835|323893948|FG000|Overall Study|Relocate|12|||
94572513|NCT00601835|323893949|FG001|Overall Study|Relocate|2|||
94238344|NCT03126110|322666606|FG009|Phase 2|Progressive Disease|0|||
94238345|NCT03126110|322666607|FG010|Phase 2|Progressive Disease|0|||
94238346|NCT03126110|322666608|FG011|Phase 2|Progressive Disease|0|||
94238347|NCT03126110|322666609|FG012|Phase 2|Progressive Disease|0|||
94238348|NCT03126110|322666610|FG013|Phase 2|Progressive Disease|1|||
94238349|NCT03126110|322666611|FG014|Phase 2|Progressive Disease|0|||
94238350|NCT03126110|322666612|FG015|Phase 2|Progressive Disease|0|||
94238351|NCT03126110|322666613|FG016|Phase 2|Progressive Disease|0|||
94238352|NCT03126110|322666597|FG000|Phase 2|Started new treatment|0|||
94348459|NCT02709889|323056155|FG002|Overall Study|Lost to Follow-up|0|||
94348460|NCT02709889|323056156|FG003|Overall Study|Lost to Follow-up|4|||
94348461|NCT02709889|323056153|FG000|Overall Study|Study Terminated by Sponsor|4|||
94348462|NCT02709889|323056154|FG001|Overall Study|Study Terminated by Sponsor|6|||
94348463|NCT02709889|323056155|FG002|Overall Study|Study Terminated by Sponsor|2|||
94348464|NCT02709889|323056156|FG003|Overall Study|Study Terminated by Sponsor|17|||
94348465|NCT02709889|323056153|FG000|Overall Study|Other, Not Specified|0|||
94348466|NCT02709889|323056154|FG001|Overall Study|Other, Not Specified|1|||
94348467|NCT02709889|323056155|FG002|Overall Study|Other, Not Specified|1|||
94348468|NCT02709889|323056156|FG003|Overall Study|Other, Not Specified|6|||
94348469|NCT01454531|323056157|FG000|Overall Study|Adverse Event|14|||
94348470|NCT01454531|323056157|FG000|Overall Study|Withdrawal by Subject|5|||
94348471|NCT01454531|323056157|FG000|Overall Study|Lost to Follow-up|1|||
94348472|NCT01454531|323056157|FG000|Overall Study|Physician Decision|1|||
94348473|NCT01454531|323056157|FG000|Overall Study|Delay in IMP administration|1|||
94348474|NCT01454531|323056157|FG000|Overall Study|Other|1|||
94348475|NCT00095836|323056159|FG000|Overall Study|Lost to Follow-up|1|||
94348476|NCT00095836|323056159|FG000|Overall Study|Adverse Event|1|||
94348477|NCT00095836|323056159|FG000|Overall Study|Death|2|||
94348478|NCT00989664|323056160|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
94348479|NCT00989664|323056160|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
94348480|NCT00989664|323056160|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
94348481|NCT00989664|323056160|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
94348482|NCT00989664|323056160|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
94348483|NCT00989664|323056160|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
94348484|NCT00989664|323056160|FG000|Long-Term Follow-Up|Death|3|||
94348485|NCT01066546|323056164|FG000|Overall Study|Study terminated by sponsor|5|||
94348486|NCT00252499|323056165|FG000|Overall Study|Lost to Follow-up|1|||
94348487|NCT00252499|323056166|FG001|Overall Study|Lost to Follow-up|0|||
94348488|NCT00252499|323056167|FG002|Overall Study|Lost to Follow-up|0|||
94348489|NCT02055976|323056172|FG000|Overall Study|Other|0|||
94348490|NCT02055976|323056173|FG001|Overall Study|Other|0|||
94348491|NCT02055976|323056174|FG002|Overall Study|Other|1|||
94348492|NCT02055976|323056175|FG003|Overall Study|Other|0|||
94348493|NCT02055976|323056176|FG004|Overall Study|Other|0|||
94348494|NCT02055976|323056177|FG005|Overall Study|Other|0|||
94348495|NCT02055976|323056178|FG006|Overall Study|Other|0|||
94348496|NCT02055976|323056179|FG007|Overall Study|Other|0|||
94348497|NCT02055976|323056180|FG008|Overall Study|Other|0|||
94348498|NCT02055976|323056172|FG000|Overall Study|Adverse Event|0|||
94348499|NCT02055976|323056173|FG001|Overall Study|Adverse Event|0|||
94348500|NCT02055976|323056174|FG002|Overall Study|Adverse Event|0|||
94348501|NCT02055976|323056175|FG003|Overall Study|Adverse Event|0|||
94348502|NCT02055976|323056176|FG004|Overall Study|Adverse Event|0|||
94348503|NCT02055976|323056177|FG005|Overall Study|Adverse Event|1|||
94348504|NCT02055976|323056178|FG006|Overall Study|Adverse Event|1|||
94348505|NCT02055976|323056179|FG007|Overall Study|Adverse Event|0|||
94348506|NCT02055976|323056180|FG008|Overall Study|Adverse Event|0|||
94348507|NCT02055976|323056172|FG000|Overall Study|Does not meet entrance criteria|0|||
94348508|NCT02055976|323056173|FG001|Overall Study|Does not meet entrance criteria|0|||
94348509|NCT02055976|323056174|FG002|Overall Study|Does not meet entrance criteria|0|||
94451828|NCT00552396|323441860|FG001|Overall Study|protocol withdrawal criteria|3|||
94451829|NCT00552396|323441861|FG002|Overall Study|protocol withdrawal criteria|3|||
94451830|NCT00552396|323441862|FG003|Overall Study|protocol withdrawal criteria|6|||
94451831|NCT00552396|323441863|FG004|Overall Study|protocol withdrawal criteria|3|||
94451832|NCT00552396|323441864|FG005|Overall Study|protocol withdrawal criteria|3|||
94451833|NCT00552396|323441865|FG006|Overall Study|protocol withdrawal criteria|9|||
94451834|NCT04537234|323441866|FG000|Overall Study|Withdrawal by Subject|2|||
94451835|NCT04537234|323441867|FG001|Overall Study|Withdrawal by Subject|0|||
94451836|NCT01726270|323441870|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
94451837|NCT01726270|323441870|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
94451838|NCT01726270|323441870|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
94451839|NCT01726270|323441870|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
94451840|NCT01726270|323441870|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
94451841|NCT01726270|323441870|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
94238353|NCT03126110|322666598|FG001|Phase 2|Started new treatment|0|||
94238354|NCT03126110|322666599|FG002|Phase 2|Started new treatment|0|||
94572514|NCT00152503|323893950|FG000|Overall Study|Adverse Event|4|||
94572515|NCT03914417|323893951|FG000|Overall Study|Withdrawal by Subject|2|||
94572516|NCT03361137|323893952|FG000|Overall Study|Reason not specified|1|||
94572517|NCT03361137|323893953|FG001|Overall Study|Reason not specified|0|||
94572518|NCT03361137|323893954|FG002|Overall Study|Reason not specified|0|||
94572519|NCT03361137|323893955|FG003|Overall Study|Reason not specified|0|||
94572520|NCT03361137|323893956|FG004|Overall Study|Reason not specified|0|||
94572521|NCT02587520|323896035|FG000|Overall Study|Protocol Violation|2|||
94572522|NCT02587520|323896036|FG001|Overall Study|Protocol Violation|0|||
94572523|NCT02587520|323896037|FG002|Overall Study|Protocol Violation|0|||
94572524|NCT02587520|323896038|FG003|Overall Study|Protocol Violation|2|||
94572525|NCT02587520|323896039|FG004|Overall Study|Protocol Violation|0|||
94572526|NCT02587520|323896040|FG005|Overall Study|Protocol Violation|1|||
94572527|NCT02587520|323896041|FG006|Overall Study|Protocol Violation|1|||
94572528|NCT02587520|323896042|FG007|Overall Study|Protocol Violation|1|||
94572529|NCT02587520|323896043|FG008|Overall Study|Protocol Violation|3|||
94572530|NCT02587520|323896044|FG009|Overall Study|Protocol Violation|3|||
94572531|NCT02587520|323896045|FG010|Overall Study|Protocol Violation|1|||
94572532|NCT02587520|323896046|FG011|Overall Study|Protocol Violation|2|||
94572533|NCT02587520|323896047|FG012|Overall Study|Protocol Violation|0|||
94572534|NCT02587520|323896048|FG013|Overall Study|Protocol Violation|0|||
94572535|NCT02587520|323896049|FG014|Overall Study|Protocol Violation|0|||
94572536|NCT02587520|323896050|FG015|Overall Study|Protocol Violation|0|||
94572537|NCT02587520|323896051|FG016|Overall Study|Protocol Violation|0|||
94572538|NCT02587520|323896052|FG017|Overall Study|Protocol Violation|0|||
94572539|NCT02587520|323896035|FG000|Overall Study|Adverse Event|0|||
94572540|NCT02587520|323896036|FG001|Overall Study|Adverse Event|0|||
94572541|NCT02587520|323896037|FG002|Overall Study|Adverse Event|0|||
94572542|NCT02587520|323896038|FG003|Overall Study|Adverse Event|0|||
94572543|NCT02587520|323896039|FG004|Overall Study|Adverse Event|0|||
94572544|NCT02587520|323896040|FG005|Overall Study|Adverse Event|0|||
94572545|NCT02587520|323896041|FG006|Overall Study|Adverse Event|0|||
94572546|NCT02587520|323896042|FG007|Overall Study|Adverse Event|0|||
94572547|NCT02587520|323896043|FG008|Overall Study|Adverse Event|0|||
94572548|NCT02587520|323896044|FG009|Overall Study|Adverse Event|0|||
94572549|NCT02587520|323896045|FG010|Overall Study|Adverse Event|0|||
94572550|NCT02587520|323896046|FG011|Overall Study|Adverse Event|1|||
94572551|NCT02587520|323896047|FG012|Overall Study|Adverse Event|0|||
94572552|NCT02587520|323896048|FG013|Overall Study|Adverse Event|0|||
94572553|NCT02587520|323896049|FG014|Overall Study|Adverse Event|0|||
94572554|NCT02587520|323896050|FG015|Overall Study|Adverse Event|0|||
94572555|NCT02587520|323896051|FG016|Overall Study|Adverse Event|0|||
94572556|NCT02587520|323896052|FG017|Overall Study|Adverse Event|0|||
94572557|NCT02587520|323896035|FG000|Overall Study|Withdrawal by Subject|0|||
94572558|NCT02587520|323896036|FG001|Overall Study|Withdrawal by Subject|0|||
94572559|NCT02587520|323896037|FG002|Overall Study|Withdrawal by Subject|1|||
94572560|NCT02587520|323896038|FG003|Overall Study|Withdrawal by Subject|1|||
94572561|NCT02587520|323896039|FG004|Overall Study|Withdrawal by Subject|0|||
94572562|NCT02587520|323896040|FG005|Overall Study|Withdrawal by Subject|1|||
94572563|NCT02587520|323896041|FG006|Overall Study|Withdrawal by Subject|1|||
94572564|NCT02587520|323896042|FG007|Overall Study|Withdrawal by Subject|0|||
94572565|NCT02587520|323896043|FG008|Overall Study|Withdrawal by Subject|0|||
94572566|NCT02587520|323896044|FG009|Overall Study|Withdrawal by Subject|0|||
94572567|NCT02587520|323896045|FG010|Overall Study|Withdrawal by Subject|0|||
94572568|NCT02587520|323896046|FG011|Overall Study|Withdrawal by Subject|0|||
94572569|NCT02587520|323896047|FG012|Overall Study|Withdrawal by Subject|0|||
94572570|NCT02587520|323896048|FG013|Overall Study|Withdrawal by Subject|1|||
94572571|NCT02587520|323896049|FG014|Overall Study|Withdrawal by Subject|0|||
94572572|NCT02587520|323896050|FG015|Overall Study|Withdrawal by Subject|0|||
94572573|NCT02587520|323896051|FG016|Overall Study|Withdrawal by Subject|0|||
94572574|NCT02587520|323896052|FG017|Overall Study|Withdrawal by Subject|0|||
94348510|NCT02055976|323056175|FG003|Overall Study|Does not meet entrance criteria|0|||
94348511|NCT02055976|323056176|FG004|Overall Study|Does not meet entrance criteria|0|||
94572575|NCT02587520|323896035|FG000|Overall Study|Lost to Follow-up|0|||
94572576|NCT02587520|323896036|FG001|Overall Study|Lost to Follow-up|2|||
94572577|NCT02587520|323896037|FG002|Overall Study|Lost to Follow-up|0|||
94572578|NCT02587520|323896038|FG003|Overall Study|Lost to Follow-up|2|||
94572579|NCT02587520|323896039|FG004|Overall Study|Lost to Follow-up|0|||
94572580|NCT02587520|323896040|FG005|Overall Study|Lost to Follow-up|1|||
94658808|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
94572581|NCT02587520|323896041|FG006|Overall Study|Lost to Follow-up|1|||
94572582|NCT02587520|323896042|FG007|Overall Study|Lost to Follow-up|1|||
94572583|NCT02587520|323896043|FG008|Overall Study|Lost to Follow-up|0|||
94572584|NCT02587520|323896044|FG009|Overall Study|Lost to Follow-up|2|||
94572585|NCT02587520|323896045|FG010|Overall Study|Lost to Follow-up|2|||
94572586|NCT02587520|323896046|FG011|Overall Study|Lost to Follow-up|1|||
94572587|NCT02587520|323896047|FG012|Overall Study|Lost to Follow-up|0|||
94572588|NCT02587520|323896048|FG013|Overall Study|Lost to Follow-up|0|||
94572589|NCT02587520|323896049|FG014|Overall Study|Lost to Follow-up|0|||
94572590|NCT02587520|323896050|FG015|Overall Study|Lost to Follow-up|0|||
94572591|NCT02587520|323896051|FG016|Overall Study|Lost to Follow-up|0|||
94572592|NCT02587520|323896052|FG017|Overall Study|Lost to Follow-up|0|||
94572593|NCT00672555|323896053|FG000|Overall Study|Lost to Follow-up|4|||
94572594|NCT00672555|323896053|FG000|Overall Study|Did not want to answer questionnaire|2|||
94572595|NCT03623243|323896054|FG000|Overall Study|Adverse Event|15|||
94572596|NCT03623243|323896054|FG000|Overall Study|Guardian Decision|1|||
94572597|NCT03623243|323896054|FG000|Overall Study|New Therapy for Study Indication|1|||
94572598|NCT03623243|323896054|FG000|Overall Study|Protocol Deviation|3|||
94572599|NCT03623243|323896054|FG000|Overall Study|Physician Decision|4|||
94572600|NCT03623243|323896054|FG000|Overall Study|Patient Decision|15|||
94572601|NCT03007966|323896055|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
94572602|NCT03007966|323896056|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
94572603|NCT01428258|323896057|FG000|Intervention 1|Withdrawal by Subject|2|||
94572604|NCT01428258|323896058|FG001|Intervention 1|Withdrawal by Subject|0|||
94572605|NCT00419393|323896059|FG000|Overall Study|Adverse Event|5|||
94572606|NCT00419393|323896059|FG000|Overall Study|Protocol Violation|5|||
94572607|NCT00419393|323896059|FG000|Overall Study|Withdrawal by Subject|7|||
94572608|NCT00419393|323896059|FG000|Overall Study|Other: Sponsor request|3|||
94572609|NCT00419393|323896059|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
94572610|NCT00419393|323896059|FG000|Overall Study|Other: Site closure|1|||
94572611|NCT00419393|323896059|FG000|Overall Study|Other: Other health problems|1|||
94572612|NCT00419393|323896059|FG000|Overall Study|Other: Investigator decision|1|||
94572613|NCT00416624|323896062|FG000|Overall Study|Withdrawal by Subject|1|||
94348512|NCT02055976|323056177|FG005|Overall Study|Does not meet entrance criteria|0|||
94348513|NCT02055976|323056178|FG006|Overall Study|Does not meet entrance criteria|1|||
94348514|NCT02055976|323056179|FG007|Overall Study|Does not meet entrance criteria|0|||
94572614|NCT00416624|323896063|FG001|Overall Study|Withdrawal by Subject|6|||
94572615|NCT00416624|323896064|FG002|Overall Study|Withdrawal by Subject|4|||
94572616|NCT00416624|323896065|FG003|Overall Study|Withdrawal by Subject|9|||
94572617|NCT00416624|323896062|FG000|Overall Study|Death|4|||
94572618|NCT00416624|323896063|FG001|Overall Study|Death|7|||
94572619|NCT00416624|323896064|FG002|Overall Study|Death|7|||
94572620|NCT00416624|323896065|FG003|Overall Study|Death|1|||
94572621|NCT00416624|323896062|FG000|Overall Study|Adverse Event|8|||
94348515|NCT02055976|323056180|FG008|Overall Study|Does not meet entrance criteria|0|||
94348516|NCT02055976|323056172|FG000|Overall Study|Lost to Follow-up|0|||
94348517|NCT02055976|323056173|FG001|Overall Study|Lost to Follow-up|0|||
94348518|NCT02055976|323056174|FG002|Overall Study|Lost to Follow-up|0|||
94348519|NCT02055976|323056175|FG003|Overall Study|Lost to Follow-up|1|||
94348520|NCT02055976|323056176|FG004|Overall Study|Lost to Follow-up|0|||
94348521|NCT02055976|323056177|FG005|Overall Study|Lost to Follow-up|0|||
94348522|NCT02055976|323056178|FG006|Overall Study|Lost to Follow-up|0|||
94348523|NCT02055976|323056179|FG007|Overall Study|Lost to Follow-up|0|||
94348524|NCT02055976|323056180|FG008|Overall Study|Lost to Follow-up|0|||
94348525|NCT01230827|323056186|FG000|Overall Study|Lost to Follow-up|0|||
94348526|NCT01230827|323056187|FG001|Overall Study|Lost to Follow-up|0|||
94348527|NCT01230827|323056188|FG002|Overall Study|Lost to Follow-up|1|||
94348528|NCT01230827|323056189|FG003|Overall Study|Lost to Follow-up|3|||
94348529|NCT01230827|323056186|FG000|Overall Study|Withdrawal by Subject|1|||
94348530|NCT01230827|323056187|FG001|Overall Study|Withdrawal by Subject|0|||
94348531|NCT01230827|323056188|FG002|Overall Study|Withdrawal by Subject|3|||
94348532|NCT01230827|323056189|FG003|Overall Study|Withdrawal by Subject|2|||
94348533|NCT01230827|323056186|FG000|Overall Study|Lack of Efficacy|14|||
94348534|NCT01230827|323056187|FG001|Overall Study|Lack of Efficacy|1|||
94348535|NCT01230827|323056188|FG002|Overall Study|Lack of Efficacy|2|||
94348536|NCT01230827|323056189|FG003|Overall Study|Lack of Efficacy|3|||
94348537|NCT01230827|323056186|FG000|Overall Study|Adverse Event|4|||
94348538|NCT01230827|323056187|FG001|Overall Study|Adverse Event|2|||
94348539|NCT01230827|323056188|FG002|Overall Study|Adverse Event|3|||
94348540|NCT01230827|323056189|FG003|Overall Study|Adverse Event|7|||
94348541|NCT01230827|323056186|FG000|Overall Study|Recovery|0|||
94348542|NCT01230827|323056187|FG001|Overall Study|Recovery|6|||
94348543|NCT01230827|323056188|FG002|Overall Study|Recovery|0|||
94348544|NCT01230827|323056189|FG003|Overall Study|Recovery|0|||
94348545|NCT01230827|323056186|FG000|Overall Study|Study terminated by Sponsor|0|||
94348546|NCT01230827|323056187|FG001|Overall Study|Study terminated by Sponsor|2|||
94348547|NCT01230827|323056188|FG002|Overall Study|Study terminated by Sponsor|56|||
94348548|NCT01230827|323056189|FG003|Overall Study|Study terminated by Sponsor|63|||
94348549|NCT02698176|323056190|FG000|Overall Study|Progressive disease|4|||
94348550|NCT02698176|323056191|FG001|Overall Study|Progressive disease|3|||
94348551|NCT02698176|323056192|FG002|Overall Study|Progressive disease|1|||
94348552|NCT02698176|323056193|FG003|Overall Study|Progressive disease|0|||
94348553|NCT02698176|323056190|FG000|Overall Study|Adverse Event|2|||
94348554|NCT02698176|323056191|FG001|Overall Study|Adverse Event|0|||
94348555|NCT02698176|323056192|FG002|Overall Study|Adverse Event|0|||
94348556|NCT02698176|323056193|FG003|Overall Study|Adverse Event|0|||
94348557|NCT02698176|323056190|FG000|Overall Study|Clinical progression|3|||
94348558|NCT02698176|323056191|FG001|Overall Study|Clinical progression|0|||
94348559|NCT02698176|323056192|FG002|Overall Study|Clinical progression|0|||
94348560|NCT02698176|323056193|FG003|Overall Study|Clinical progression|0|||
94348561|NCT02728804|323056200|FG000|Overall Study|Ineligible|3|||
94348562|NCT02728804|323056200|FG000|Overall Study|Did not complete baseline questionnaire|9|||
94348563|NCT02728804|323056200|FG000|Overall Study|Death|99|||
94348564|NCT01156012|323056202|FG000|Overall Study|Adverse Event|3|||
94348565|NCT01156012|323056203|FG001|Overall Study|Adverse Event|1|||
94348566|NCT01156012|323056202|FG000|Overall Study|Lost to Follow-up|1|||
94348567|NCT01156012|323056203|FG001|Overall Study|Lost to Follow-up|0|||
94348568|NCT01156012|323056202|FG000|Overall Study|Withdrawal by Subject|1|||
94348569|NCT01156012|323056203|FG001|Overall Study|Withdrawal by Subject|0|||
94348570|NCT01156012|323056202|FG000|Overall Study|use of commercial drug instead of study|0|||
94348571|NCT01156012|323056203|FG001|Overall Study|use of commercial drug instead of study|1|||
94348572|NCT01156012|323056202|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
94348573|NCT01156012|323056203|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
94348574|NCT02705755|323056204|FG000|Part A (6 Days)|Adverse Event|1|||
94348575|NCT02705755|323056205|FG001|Part A (6 Days)|Adverse Event|0|||
94348576|NCT02705755|323056206|FG002|Part A (6 Days)|Adverse Event|0|||
94348577|NCT02705755|323056207|FG003|Part A (6 Days)|Adverse Event|0|||
94348578|NCT02705755|323056204|FG000|Part A (6 Days)|Physician Decision|3|||
94348579|NCT02705755|323056205|FG001|Part A (6 Days)|Physician Decision|0|||
94348580|NCT02705755|323056206|FG002|Part A (6 Days)|Physician Decision|0|||
94348581|NCT02705755|323056207|FG003|Part A (6 Days)|Physician Decision|0|||
94348582|NCT02705755|323056204|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
94451842|NCT01464164|323441872|FG000|Overall Study|Screen failure|0|||
94348583|NCT02705755|323056205|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
94348584|NCT02705755|323056206|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
94348585|NCT02705755|323056207|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
94348586|NCT02705755|323056204|FG000|Part C (20 Weeks)|Physician Decision|0|||
94348587|NCT02705755|323056205|FG001|Part C (20 Weeks)|Physician Decision|0|||
94348588|NCT02705755|323056206|FG002|Part C (20 Weeks)|Physician Decision|0|||
94348589|NCT02705755|323056207|FG003|Part C (20 Weeks)|Physician Decision|2|||
94348590|NCT02705755|323056204|FG000|Part C (20 Weeks)|Adverse Event|0|||
94348591|NCT02705755|323056205|FG001|Part C (20 Weeks)|Adverse Event|0|||
94348592|NCT02705755|323056206|FG002|Part C (20 Weeks)|Adverse Event|0|||
94348593|NCT02705755|323056207|FG003|Part C (20 Weeks)|Adverse Event|6|||
94348594|NCT02705755|323056204|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
94348595|NCT02705755|323056205|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
94348596|NCT02705755|323056206|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
94348597|NCT02705755|323056207|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
94348598|NCT03053180|323058776|FG000|Overall Study|Failure to Return|1|||
94348599|NCT01855919|323058777|FG000|Overall Study|Adverse Event|16|||
94348600|NCT01855919|323058778|FG001|Overall Study|Adverse Event|8|||
94348601|NCT01855919|323058777|FG000|Overall Study|Lack of Efficacy|1|||
94348602|NCT01855919|323058778|FG001|Overall Study|Lack of Efficacy|3|||
94348603|NCT01855919|323058777|FG000|Overall Study|Withdrawal by Subject|4|||
94348604|NCT01855919|323058778|FG001|Overall Study|Withdrawal by Subject|10|||
94348605|NCT01855919|323058777|FG000|Overall Study|Entry Criteria Not Met|1|||
94348606|NCT01855919|323058778|FG001|Overall Study|Entry Criteria Not Met|1|||
94572622|NCT00416624|323896063|FG001|Overall Study|Adverse Event|3|||
94572623|NCT00416624|323896064|FG002|Overall Study|Adverse Event|2|||
94572624|NCT00416624|323896065|FG003|Overall Study|Adverse Event|2|||
94572625|NCT00416624|323896062|FG000|Overall Study|Other|8|||
94572626|NCT00416624|323896063|FG001|Overall Study|Other|11|||
94572627|NCT00416624|323896064|FG002|Overall Study|Other|5|||
94572628|NCT00416624|323896065|FG003|Overall Study|Other|5|||
94572629|NCT00416624|323896062|FG000|Overall Study|Cancel|1|||
94572630|NCT00416624|323896063|FG001|Overall Study|Cancel|0|||
94572631|NCT00416624|323896064|FG002|Overall Study|Cancel|0|||
94572632|NCT00416624|323896065|FG003|Overall Study|Cancel|0|||
94572633|NCT00443040|323896069|FG000|Overall Study|Withdrawal by Subject|1|||
94572634|NCT00443040|323896070|FG001|Overall Study|Withdrawal by Subject|0|||
94572635|NCT00443040|323896071|FG002|Overall Study|Withdrawal by Subject|0|||
94572636|NCT00443040|323896069|FG000|Overall Study|Converted to an open laparotomy|3|||
94572637|NCT00443040|323896070|FG001|Overall Study|Converted to an open laparotomy|0|||
94572638|NCT00443040|323896071|FG002|Overall Study|Converted to an open laparotomy|1|||
94572639|NCT02656017|323896072|FG000|Overall Study|Study burden|3|||
94572640|NCT02656017|323896073|FG001|Overall Study|Study burden|3|||
94572641|NCT02656017|323896072|FG000|Overall Study|Adverse Event|2|||
94572642|NCT02656017|323896073|FG001|Overall Study|Adverse Event|1|||
94572643|NCT02656017|323896072|FG000|Overall Study|Unable/unwilling to take study medication|2|||
94572644|NCT02656017|323896073|FG001|Overall Study|Unable/unwilling to take study medication|1|||
94572645|NCT02656017|323896072|FG000|Overall Study|Began Tolvaptan|1|||
94572646|NCT02656017|323896073|FG001|Overall Study|Began Tolvaptan|1|||
94572647|NCT02656017|323896072|FG000|Overall Study|Withdrawal by Subject|1|||
94572648|NCT02656017|323896073|FG001|Overall Study|Withdrawal by Subject|0|||
94572649|NCT03585660|323896074|FG000|Overall Study|operator error|1|||
94572650|NCT03585660|323896074|FG000|Overall Study|technical error|2|||
94572651|NCT03585660|323896074|FG000|Overall Study|hip prosthesis|2|||
94572652|NCT03585660|323896074|FG000|Overall Study|did not undergo biopsy|8|||
94572653|NCT03585660|323896074|FG000|Overall Study|scanner problem|2|||
94572654|NCT04245111|323896075|FG000|Overall Study|Lost to Follow-up|5|||
94572655|NCT04245111|323896076|FG001|Overall Study|Lost to Follow-up|1|||
94572656|NCT04245111|323896077|FG002|Overall Study|Lost to Follow-up|1|||
94572657|NCT00435409|323896078|FG000|Overall Study|Protocol Violation|1|||
94572658|NCT00435409|323896079|FG001|Overall Study|Protocol Violation|2|||
94572659|NCT00435409|323896080|FG002|Overall Study|Protocol Violation|0|||
94572660|NCT00435409|323896078|FG000|Overall Study|Lost to Follow-up|1|||
94572661|NCT00435409|323896079|FG001|Overall Study|Lost to Follow-up|2|||
94572662|NCT00435409|323896080|FG002|Overall Study|Lost to Follow-up|0|||
94572663|NCT00435409|323896078|FG000|Overall Study|Death|8|||
94572664|NCT00435409|323896079|FG001|Overall Study|Death|6|||
94572665|NCT00435409|323896080|FG002|Overall Study|Death|6|||
94572666|NCT00435409|323896078|FG000|Overall Study|Objective progression or relapse|158|||
94572667|NCT00435409|323896079|FG001|Overall Study|Objective progression or relapse|93|||
94572668|NCT00435409|323896080|FG002|Overall Study|Objective progression or relapse|58|||
94572669|NCT00435409|323896078|FG000|Overall Study|Global deterioration of health status|0|||
94572670|NCT00435409|323896079|FG001|Overall Study|Global deterioration of health status|0|||
94572671|NCT00435409|323896080|FG002|Overall Study|Global deterioration of health status|4|||
94572672|NCT00435409|323896078|FG000|Overall Study|Withdrawal by Subject|8|||
94572673|NCT00435409|323896079|FG001|Overall Study|Withdrawal by Subject|7|||
94572674|NCT00435409|323896080|FG002|Overall Study|Withdrawal by Subject|1|||
94572675|NCT00435409|323896078|FG000|Overall Study|Other|45|||
94572676|NCT00435409|323896079|FG001|Overall Study|Other|30|||
94572677|NCT00435409|323896080|FG002|Overall Study|Other|1|||
94572678|NCT00435409|323896078|FG000|Overall Study|Adverse Event|0|||
94572679|NCT00435409|323896079|FG001|Overall Study|Adverse Event|0|||
94572680|NCT00435409|323896080|FG002|Overall Study|Adverse Event|8|||
94572681|NCT00435409|323896078|FG000|Overall Study|Sponsor decision|0|||
94238355|NCT03126110|322666600|FG003|Phase 2|Started new treatment|0|||
94238356|NCT03126110|322666601|FG004|Phase 2|Started new treatment|0|||
94238357|NCT03126110|322666602|FG005|Phase 2|Started new treatment|0|||
94238358|NCT03126110|322666603|FG006|Phase 2|Started new treatment|0|||
94238359|NCT03126110|322666604|FG007|Phase 2|Started new treatment|0|||
94238360|NCT03126110|322666605|FG008|Phase 2|Started new treatment|0|||
94238361|NCT03126110|322666606|FG009|Phase 2|Started new treatment|0|||
94572682|NCT00435409|323896079|FG001|Overall Study|Sponsor decision|3|||
94572683|NCT00435409|323896080|FG002|Overall Study|Sponsor decision|0|||
94572684|NCT03760029|323896082|FG000|Overall Study|Death|1|||
94572685|NCT03760029|323896083|FG001|Overall Study|Death|0|||
94572686|NCT03760029|323896084|FG002|Overall Study|Death|0|||
94572687|NCT03760029|323896082|FG000|Overall Study|Lost to Follow-up|0|||
94572688|NCT03760029|323896083|FG001|Overall Study|Lost to Follow-up|2|||
94572689|NCT03760029|323896084|FG002|Overall Study|Lost to Follow-up|1|||
94572690|NCT03760029|323896082|FG000|Overall Study|Withdrawal by Subject|1|||
94238362|NCT03126110|322666607|FG010|Phase 2|Started new treatment|0|||
94572691|NCT03760029|323896083|FG001|Overall Study|Withdrawal by Subject|4|||
94238363|NCT03126110|322666608|FG011|Phase 2|Started new treatment|0|||
94572692|NCT03760029|323896084|FG002|Overall Study|Withdrawal by Subject|1|||
94572693|NCT03760029|323896082|FG000|Overall Study|Withdrawal by parent/guardian|4|||
94572694|NCT03760029|323896083|FG001|Overall Study|Withdrawal by parent/guardian|4|||
94572695|NCT03760029|323896084|FG002|Overall Study|Withdrawal by parent/guardian|1|||
94572696|NCT03760029|323896082|FG000|Overall Study|Other|2|||
94572697|NCT03760029|323896083|FG001|Overall Study|Other|1|||
94572698|NCT03760029|323896084|FG002|Overall Study|Other|0|||
94572699|NCT05196828|323896088|FG000|Overall Study|Withdrawal by Subject|2|||
94572700|NCT05196828|323896089|FG001|Overall Study|Withdrawal by Subject|0|||
94572701|NCT05196828|323896088|FG000|Overall Study|Lost to Follow-up|0|||
94572702|NCT05196828|323896089|FG001|Overall Study|Lost to Follow-up|4|||
94572703|NCT05196828|323896088|FG000|Overall Study|Adverse Event|1|||
94572704|NCT05196828|323896089|FG001|Overall Study|Adverse Event|0|||
94572705|NCT01600885|323896092|FG000|First Period|Adverse Event|1|||
94572706|NCT01600885|323896093|FG001|First Period|Adverse Event|1|||
94572707|NCT01600885|323896092|FG000|First Period|moved out of area|1|||
94572708|NCT01600885|323896093|FG001|First Period|moved out of area|0|||
94572709|NCT02399215|323896094|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
94572710|NCT02399215|323896094|FG000|Overall Study|Withdrawal by Subject|1|||
94572711|NCT00472108|323896095|FG000|Overall Study|Lost to Follow-up|0|||
94572712|NCT00472108|323896096|FG001|Overall Study|Lost to Follow-up|1|||
94572713|NCT01924845|323896097|FG000|Overall Study|Adverse Event|3|||
94572714|NCT01924845|323896097|FG000|Overall Study|Withdrawal by Subject|2|||
94572715|NCT01924845|323896097|FG000|Overall Study|Protocol Violation|1|||
94572716|NCT00713609|323896098|FG000|Overall Study|Adverse Event|2|||
94572717|NCT00713609|323896099|FG001|Overall Study|Adverse Event|0|||
94572718|NCT00713609|323896100|FG002|Overall Study|Adverse Event|2|||
94572719|NCT00713609|323896101|FG003|Overall Study|Adverse Event|2|||
94572720|NCT00713609|323896102|FG004|Overall Study|Adverse Event|3|||
94572721|NCT00713609|323896103|FG005|Overall Study|Adverse Event|1|||
94572722|NCT00713609|323896098|FG000|Overall Study|Lost to Follow-up|5|||
94572723|NCT00713609|323896099|FG001|Overall Study|Lost to Follow-up|7|||
94572724|NCT00713609|323896100|FG002|Overall Study|Lost to Follow-up|5|||
94572725|NCT00713609|323896101|FG003|Overall Study|Lost to Follow-up|5|||
94572726|NCT00713609|323896102|FG004|Overall Study|Lost to Follow-up|7|||
94572727|NCT00713609|323896103|FG005|Overall Study|Lost to Follow-up|0|||
94572728|NCT00713609|323896098|FG000|Overall Study|Lack of Efficacy|1|||
94572729|NCT00713609|323896099|FG001|Overall Study|Lack of Efficacy|3|||
94572730|NCT00713609|323896100|FG002|Overall Study|Lack of Efficacy|0|||
94572731|NCT00713609|323896101|FG003|Overall Study|Lack of Efficacy|0|||
94572732|NCT00713609|323896102|FG004|Overall Study|Lack of Efficacy|1|||
94572733|NCT00713609|323896103|FG005|Overall Study|Lack of Efficacy|0|||
94572734|NCT00713609|323896098|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
94572735|NCT00713609|323896099|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
94572736|NCT00713609|323896100|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
94238364|NCT03126110|322666609|FG012|Phase 2|Started new treatment|0|||
94238365|NCT03126110|322666610|FG013|Phase 2|Started new treatment|0|||
94238366|NCT03126110|322666611|FG014|Phase 2|Started new treatment|1|||
94238367|NCT03126110|322666612|FG015|Phase 2|Started new treatment|0|||
94238368|NCT03126110|322666613|FG016|Phase 2|Started new treatment|0|||
94238369|NCT01012947|322666614|FG000|Overall Study|Lost to Follow-up|131|||
94238370|NCT01012947|322666615|FG001|Overall Study|Lost to Follow-up|135|||
94238371|NCT01012947|322666616|FG002|Overall Study|Lost to Follow-up|130|||
94238372|NCT01012947|322666617|FG003|Overall Study|Lost to Follow-up|118|||
94238373|NCT01012947|322666618|FG004|Overall Study|Lost to Follow-up|142|||
94238374|NCT00422734|322666619|FG000|Overall Study|Physician Decision|1|||
94238375|NCT00422734|322666620|FG001|Overall Study|Physician Decision|1|||
94238376|NCT00422734|322666619|FG000|Overall Study|Protocol Violation|1|||
94238377|NCT00422734|322666620|FG001|Overall Study|Protocol Violation|6|||
94238378|NCT00422734|322666619|FG000|Overall Study|Withdrawal by Subject|12|||
94238379|NCT00422734|322666620|FG001|Overall Study|Withdrawal by Subject|8|||
94238380|NCT00422734|322666619|FG000|Overall Study|Adverse Event|0|||
94238381|NCT00422734|322666620|FG001|Overall Study|Adverse Event|3|||
94238382|NCT00422734|322666619|FG000|Overall Study|Partner Decision|0|||
94238383|NCT00422734|322666620|FG001|Overall Study|Partner Decision|3|||
94238384|NCT01441635|322666626|FG000|Overall Study|Adverse Event|4|||
94238385|NCT01441635|322666627|FG001|Overall Study|Adverse Event|3|||
94238386|NCT01441635|322666628|FG002|Overall Study|Adverse Event|1|||
94238387|NCT01441635|322666629|FG003|Overall Study|Adverse Event|5|||
94451843|NCT01464164|323441873|FG001|Overall Study|Screen failure|1|||
94451844|NCT01464164|323441874|FG002|Overall Study|Screen failure|2|||
94451845|NCT01464164|323441875|FG003|Overall Study|Screen failure|0|||
94451846|NCT01464164|323441876|FG004|Overall Study|Screen failure|0|||
94451847|NCT01464164|323441877|FG005|Overall Study|Screen failure|0|||
94451848|NCT01464164|323441878|FG006|Overall Study|Screen failure|0|||
94451849|NCT01464164|323441872|FG000|Overall Study|Physician Decision|0|||
94451850|NCT01464164|323441873|FG001|Overall Study|Physician Decision|1|||
94451851|NCT01464164|323441874|FG002|Overall Study|Physician Decision|0|||
94451852|NCT01464164|323441875|FG003|Overall Study|Physician Decision|0|||
94451853|NCT01464164|323441876|FG004|Overall Study|Physician Decision|0|||
94451854|NCT01464164|323441877|FG005|Overall Study|Physician Decision|0|||
94451855|NCT01464164|323441878|FG006|Overall Study|Physician Decision|2|||
94451856|NCT03682848|323441879|FG000|Overall Study|Withdrawal by Subject|2|||
94451857|NCT03682848|323441879|FG000|Overall Study|Site closed|5|||
94451858|NCT03682848|323441879|FG000|Overall Study|Protocol Deviation|1|||
94451859|NCT03682848|323441879|FG000|Overall Study|Adverse Event|1|||
94451860|NCT04013672|323441880|FG000|Overall Study|Withdrawal by Subject|3|||
94451861|NCT04013672|323441881|FG001|Overall Study|Withdrawal by Subject|0|||
94451862|NCT04013672|323441880|FG000|Overall Study|Death|1|||
94451863|NCT04013672|323441881|FG001|Overall Study|Death|0|||
94451864|NCT04013672|323441880|FG000|Overall Study|Physician Decision|5|||
94451865|NCT04013672|323441881|FG001|Overall Study|Physician Decision|0|||
94451866|NCT00454363|323441882|FG000|Overall Study|Adverse Event|1|||
94451867|NCT00454363|323441883|FG001|Overall Study|Adverse Event|2|||
94451868|NCT00454363|323441882|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
94451869|NCT00454363|323441883|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
94451870|NCT03478644|323441891|FG000|Phase 2|Withdrawal by Subject|2|||
94451871|NCT03478644|323441892|FG001|Phase 2|Withdrawal by Subject|1|||
94451872|NCT03478644|323441891|FG000|Phase 2|Lost to Follow-up|1|||
94451873|NCT03478644|323441892|FG001|Phase 2|Lost to Follow-up|0|||
94451874|NCT01029782|323441893|FG000|Overall Study|Lost to Follow-up|2|||
94451875|NCT01029782|323441894|FG001|Overall Study|Lost to Follow-up|2|||
94451876|NCT01029782|323441893|FG000|Overall Study|Diagnosis changed|1|||
94451877|NCT01029782|323441894|FG001|Overall Study|Diagnosis changed|1|||
94451878|NCT01029782|323441893|FG000|Overall Study|Adverse Event|0|||
94451879|NCT01029782|323441894|FG001|Overall Study|Adverse Event|1|||
94451880|NCT01029782|323441893|FG000|Overall Study|Physician Decision|0|||
94451881|NCT01029782|323441894|FG001|Overall Study|Physician Decision|1|||
94451882|NCT01029782|323441893|FG000|Overall Study|Protocol Violation|0|||
94238388|NCT01441635|322666630|FG004|Overall Study|Adverse Event|1|||
94238389|NCT01441635|322666631|FG005|Overall Study|Adverse Event|2|||
94238390|NCT01441635|322666632|FG006|Overall Study|Adverse Event|2|||
94451883|NCT01029782|323441894|FG001|Overall Study|Protocol Violation|2|||
94451884|NCT01029782|323441893|FG000|Overall Study|Withdrawal by Subject|0|||
94451885|NCT01029782|323441894|FG001|Overall Study|Withdrawal by Subject|1|||
94451886|NCT00757042|323441895|FG000|Overall Study|Lost to Follow-up|0|||
94451887|NCT00757042|323441896|FG001|Overall Study|Lost to Follow-up|0|||
94451888|NCT00757042|323441897|FG002|Overall Study|Lost to Follow-up|0|||
94451889|NCT00757042|323441898|FG003|Overall Study|Lost to Follow-up|0|||
94451890|NCT00757042|323441899|FG004|Overall Study|Lost to Follow-up|0|||
94451891|NCT00757042|323441900|FG005|Overall Study|Lost to Follow-up|0|||
94451892|NCT00757042|323441901|FG006|Overall Study|Lost to Follow-up|0|||
94451893|NCT00757042|323441902|FG007|Overall Study|Lost to Follow-up|0|||
94451894|NCT00757042|323441903|FG008|Overall Study|Lost to Follow-up|1|||
94238391|NCT01441635|322666633|FG007|Overall Study|Adverse Event|2|||
94238392|NCT01441635|322666634|FG008|Overall Study|Adverse Event|1|||
94238393|NCT01441635|322666635|FG009|Overall Study|Adverse Event|0|||
94238394|NCT01441635|322666626|FG000|Overall Study|Withdrawal by Subject|1|||
94238395|NCT01441635|322666627|FG001|Overall Study|Withdrawal by Subject|1|||
94238396|NCT01441635|322666628|FG002|Overall Study|Withdrawal by Subject|0|||
94238397|NCT01441635|322666629|FG003|Overall Study|Withdrawal by Subject|1|||
94238398|NCT01441635|322666630|FG004|Overall Study|Withdrawal by Subject|0|||
94238399|NCT01441635|322666631|FG005|Overall Study|Withdrawal by Subject|0|||
94238400|NCT01441635|322666632|FG006|Overall Study|Withdrawal by Subject|2|||
94238401|NCT01441635|322666633|FG007|Overall Study|Withdrawal by Subject|0|||
94238402|NCT01441635|322666634|FG008|Overall Study|Withdrawal by Subject|1|||
94238403|NCT01441635|322666635|FG009|Overall Study|Withdrawal by Subject|1|||
94238404|NCT01441635|322666626|FG000|Overall Study|Lost to Follow-up|0|||
94238405|NCT01441635|322666627|FG001|Overall Study|Lost to Follow-up|1|||
94238406|NCT01441635|322666628|FG002|Overall Study|Lost to Follow-up|1|||
94238407|NCT01441635|322666629|FG003|Overall Study|Lost to Follow-up|1|||
94238408|NCT01441635|322666630|FG004|Overall Study|Lost to Follow-up|1|||
94348607|NCT01855919|323058777|FG000|Overall Study|Protocol Violation|1|||
94348608|NCT01855919|323058778|FG001|Overall Study|Protocol Violation|4|||
94348609|NCT02785588|323058781|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
94572737|NCT00713609|323896101|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
94572738|NCT00713609|323896102|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
94572739|NCT00713609|323896103|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
94572740|NCT00713609|323896098|FG000|Overall Study|Withdrawal by Subject|6|||
94572741|NCT00713609|323896099|FG001|Overall Study|Withdrawal by Subject|1|||
94572742|NCT00713609|323896100|FG002|Overall Study|Withdrawal by Subject|5|||
94348610|NCT02785588|323058781|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
94348611|NCT03031327|323058782|FG000|Overall Study|Withdrawal by Subject|0|||
94348612|NCT03031327|323058783|FG001|Overall Study|Withdrawal by Subject|1|||
94348613|NCT03031327|323058784|FG002|Overall Study|Withdrawal by Subject|1|||
94348614|NCT01004861|323058785|FG000|Overall Study|Disease progression|3|||
94348615|NCT01004861|323058786|FG001|Overall Study|Disease progression|4|||
94348616|NCT01004861|323058787|FG002|Overall Study|Disease progression|5|||
94572743|NCT00713609|323896101|FG003|Overall Study|Withdrawal by Subject|1|||
94572744|NCT00713609|323896102|FG004|Overall Study|Withdrawal by Subject|5|||
94572745|NCT00713609|323896103|FG005|Overall Study|Withdrawal by Subject|7|||
94572746|NCT00713609|323896098|FG000|Overall Study|Protocol Violation|6|||
94572747|NCT00713609|323896099|FG001|Overall Study|Protocol Violation|3|||
94572748|NCT00713609|323896100|FG002|Overall Study|Protocol Violation|1|||
94572749|NCT00713609|323896101|FG003|Overall Study|Protocol Violation|1|||
94572750|NCT00713609|323896102|FG004|Overall Study|Protocol Violation|2|||
94572751|NCT00713609|323896103|FG005|Overall Study|Protocol Violation|0|||
94572752|NCT01001221|323896104|FG000|Overall Study|Adverse Event|1|||
94572753|NCT01001221|323896105|FG001|Overall Study|Adverse Event|2|||
94572754|NCT01001221|323896106|FG002|Overall Study|Adverse Event|0|||
94572755|NCT01001221|323896107|FG003|Overall Study|Adverse Event|2|||
94572756|NCT01001221|323896108|FG004|Overall Study|Adverse Event|0|||
94572757|NCT01001221|323896104|FG000|Overall Study|Disease progression|3|||
94572758|NCT01001221|323896105|FG001|Overall Study|Disease progression|2|||
94572759|NCT01001221|323896106|FG002|Overall Study|Disease progression|2|||
94572760|NCT01001221|323896107|FG003|Overall Study|Disease progression|4|||
94572761|NCT01001221|323896108|FG004|Overall Study|Disease progression|0|||
94572762|NCT01001221|323896104|FG000|Overall Study|Other|1|||
94572763|NCT01001221|323896105|FG001|Overall Study|Other|1|||
94572764|NCT01001221|323896106|FG002|Overall Study|Other|0|||
94572765|NCT01001221|323896107|FG003|Overall Study|Other|0|||
94572766|NCT01001221|323896108|FG004|Overall Study|Other|0|||
94572767|NCT01001221|323896104|FG000|Overall Study|Not treated; protocol exclusion|0|||
94572768|NCT01001221|323896105|FG001|Overall Study|Not treated; protocol exclusion|0|||
94572769|NCT01001221|323896106|FG002|Overall Study|Not treated; protocol exclusion|1|||
94572770|NCT01001221|323896107|FG003|Overall Study|Not treated; protocol exclusion|0|||
94238409|NCT01441635|322666631|FG005|Overall Study|Lost to Follow-up|3|||
94238410|NCT01441635|322666632|FG006|Overall Study|Lost to Follow-up|1|||
94238411|NCT01441635|322666633|FG007|Overall Study|Lost to Follow-up|1|||
94348617|NCT01004861|323058788|FG003|Overall Study|Disease progression|4|||
94348618|NCT01004861|323058789|FG004|Overall Study|Disease progression|4|||
94348619|NCT01004861|323058790|FG005|Overall Study|Disease progression|4|||
94348620|NCT01004861|323058791|FG006|Overall Study|Disease progression|5|||
94572771|NCT01001221|323896108|FG004|Overall Study|Not treated; protocol exclusion|0|||
94572772|NCT01945021|323896113|FG000|Overall Study|Adverse Event|1|||
94238412|NCT01441635|322666634|FG008|Overall Study|Lost to Follow-up|0|||
94238413|NCT01441635|322666635|FG009|Overall Study|Lost to Follow-up|1|||
94572773|NCT01945021|323896113|FG000|Overall Study|Withdrawal of consent|12|||
94572774|NCT01945021|323896113|FG000|Overall Study|Lost to Follow-up|5|||
94572775|NCT01945021|323896113|FG000|Overall Study|Death|65|||
94572776|NCT02163902|323896114|FG000|Overall Study|Subject's Request|3|||
94238414|NCT01441635|322666626|FG000|Overall Study|Noncompliance|0|||
94572777|NCT02163902|323896115|FG001|Overall Study|Subject's Request|4|||
94572778|NCT02163902|323896114|FG000|Overall Study|Lost to Follow-up|6|||
94572779|NCT02163902|323896115|FG001|Overall Study|Lost to Follow-up|7|||
94572780|NCT02163902|323896114|FG000|Overall Study|Administrative Decision|2|||
94572781|NCT02163902|323896115|FG001|Overall Study|Administrative Decision|2|||
94572782|NCT02140047|323896116|FG000|Overall Study|Withdrawal by parent/guardian|1|||
94572783|NCT02140047|323896117|FG001|Overall Study|Withdrawal by parent/guardian|1|||
94572784|NCT02140047|323896118|FG002|Overall Study|Withdrawal by parent/guardian|0|||
94572785|NCT04575155|323896120|FG000|2 Month|Withdrawal by Subject|1|||
94572786|NCT04575155|323896121|FG001|2 Month|Withdrawal by Subject|1|||
94572787|NCT04575155|323896120|FG000|2 Month|Lost to Follow-up|5|||
94572788|NCT04575155|323896121|FG001|2 Month|Lost to Follow-up|3|||
94572789|NCT04575155|323896120|FG000|2 Month|Ineligible|1|||
94572790|NCT04575155|323896121|FG001|2 Month|Ineligible|0|||
94572791|NCT04423718|323896122|FG000|Overall Study|Adverse Event|6|||
94572792|NCT04423718|323896123|FG001|Overall Study|Adverse Event|2|||
94572793|NCT04423718|323896124|FG002|Overall Study|Adverse Event|5|||
94572794|NCT04423718|323896122|FG000|Overall Study|Physician Decision|1|||
94572795|NCT04423718|323896123|FG001|Overall Study|Physician Decision|4|||
94572796|NCT04423718|323896124|FG002|Overall Study|Physician Decision|1|||
94572797|NCT04423718|323896122|FG000|Overall Study|Protocol Violation|0|||
94572798|NCT04423718|323896123|FG001|Overall Study|Protocol Violation|1|||
94572799|NCT04423718|323896124|FG002|Overall Study|Protocol Violation|1|||
94572800|NCT04423718|323896122|FG000|Overall Study|Lost to Follow-up|1|||
94572801|NCT04423718|323896123|FG001|Overall Study|Lost to Follow-up|1|||
94572802|NCT04423718|323896124|FG002|Overall Study|Lost to Follow-up|2|||
94572803|NCT04423718|323896122|FG000|Overall Study|Lack of Efficacy|2|||
94572804|NCT04423718|323896123|FG001|Overall Study|Lack of Efficacy|0|||
94572805|NCT04423718|323896124|FG002|Overall Study|Lack of Efficacy|0|||
94658809|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
94572806|NCT04423718|323896122|FG000|Overall Study|Withdrawal by Subject|6|||
94658810|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
94658811|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
94658812|NCT01172938|324206182|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
94658813|NCT01172938|324206183|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
94238415|NCT01441635|322666627|FG001|Overall Study|Noncompliance|1|||
94238416|NCT01441635|322666628|FG002|Overall Study|Noncompliance|0|||
94238417|NCT01441635|322666629|FG003|Overall Study|Noncompliance|0|||
94238418|NCT01441635|322666630|FG004|Overall Study|Noncompliance|0|||
94238419|NCT01441635|322666631|FG005|Overall Study|Noncompliance|0|||
94238420|NCT01441635|322666632|FG006|Overall Study|Noncompliance|1|||
94238421|NCT01441635|322666633|FG007|Overall Study|Noncompliance|0|||
94238422|NCT01441635|322666634|FG008|Overall Study|Noncompliance|0|||
94238423|NCT01441635|322666635|FG009|Overall Study|Noncompliance|0|||
94238424|NCT01441635|322666626|FG000|Overall Study|Surgery or Invasive Intervention|0|||
94238425|NCT01441635|322666627|FG001|Overall Study|Surgery or Invasive Intervention|0|||
94238426|NCT01441635|322666628|FG002|Overall Study|Surgery or Invasive Intervention|1|||
94238427|NCT01441635|322666629|FG003|Overall Study|Surgery or Invasive Intervention|0|||
94238428|NCT01441635|322666630|FG004|Overall Study|Surgery or Invasive Intervention|0|||
94238429|NCT01441635|322666631|FG005|Overall Study|Surgery or Invasive Intervention|0|||
94238430|NCT01441635|322666632|FG006|Overall Study|Surgery or Invasive Intervention|0|||
94238431|NCT01441635|322666633|FG007|Overall Study|Surgery or Invasive Intervention|0|||
94238432|NCT01441635|322666634|FG008|Overall Study|Surgery or Invasive Intervention|0|||
94238433|NCT01441635|322666635|FG009|Overall Study|Surgery or Invasive Intervention|0|||
94238434|NCT01441635|322666626|FG000|Overall Study|Received Exclusionary Medication|1|||
94238435|NCT01441635|322666627|FG001|Overall Study|Received Exclusionary Medication|0|||
94238436|NCT01441635|322666628|FG002|Overall Study|Received Exclusionary Medication|0|||
94238437|NCT01441635|322666629|FG003|Overall Study|Received Exclusionary Medication|0|||
94238438|NCT01441635|322666630|FG004|Overall Study|Received Exclusionary Medication|0|||
94238439|NCT01441635|322666631|FG005|Overall Study|Received Exclusionary Medication|0|||
94572807|NCT04423718|323896123|FG001|Overall Study|Withdrawal by Subject|8|||
94572808|NCT04423718|323896124|FG002|Overall Study|Withdrawal by Subject|14|||
94572809|NCT04423718|323896122|FG000|Overall Study|Death|5|||
94572810|NCT04423718|323896123|FG001|Overall Study|Death|3|||
94572811|NCT04423718|323896124|FG002|Overall Study|Death|2|||
94572812|NCT04423718|323896122|FG000|Overall Study|COVID-19 pandemic|2|||
94572813|NCT04423718|323896123|FG001|Overall Study|COVID-19 pandemic|2|||
94572814|NCT04423718|323896124|FG002|Overall Study|COVID-19 pandemic|2|||
94572815|NCT04423718|323896122|FG000|Overall Study|Other|6|||
94572816|NCT04423718|323896123|FG001|Overall Study|Other|2|||
94572817|NCT04423718|323896124|FG002|Overall Study|Other|2|||
94572818|NCT04423718|323896122|FG000|Overall Study|Unknown if completed study treatment until Week 60|3|||
94572819|NCT04423718|323896123|FG001|Overall Study|Unknown if completed study treatment until Week 60|3|||
94572820|NCT04423718|323896124|FG002|Overall Study|Unknown if completed study treatment until Week 60|1|||
94572821|NCT03748823|323896125|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
94572822|NCT03748823|323896126|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
94572823|NCT03748823|323896125|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
94572824|NCT03748823|323896126|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
94572825|NCT03748823|323896125|FG000|Extension Period|Withdrawal by Subject|9|||
94572826|NCT03748823|323896126|FG001|Extension Period|Withdrawal by Subject|12|||
94572827|NCT03748823|323896125|FG000|Extension Period|Death|2|||
94572828|NCT03748823|323896126|FG001|Extension Period|Death|2|||
94572829|NCT03748823|323896125|FG000|Extension Period|Other than Specified|0|||
94572830|NCT03748823|323896126|FG001|Extension Period|Other than Specified|1|||
94572831|NCT03748823|323896125|FG000|Extension Period|Protocol Violation|1|||
94572832|NCT03748823|323896126|FG001|Extension Period|Protocol Violation|0|||
94572833|NCT03748823|323896125|FG000|Extension Period|Lost to Follow-up|0|||
94572834|NCT03748823|323896126|FG001|Extension Period|Lost to Follow-up|1|||
94572835|NCT03748823|323896125|FG000|Extension Period|Lack of Efficacy|0|||
94572836|NCT03748823|323896126|FG001|Extension Period|Lack of Efficacy|1|||
94572837|NCT03748823|323896125|FG000|Extension Period|Physician Decision|1|||
94572838|NCT03748823|323896126|FG001|Extension Period|Physician Decision|2|||
94572839|NCT02734693|323896127|FG000|Overall Study|Adverse Event|1|||
94572840|NCT02734693|323896128|FG001|Overall Study|Adverse Event|3|||
94572841|NCT02734693|323896129|FG002|Overall Study|Adverse Event|3|||
94572842|NCT02734693|323896127|FG000|Overall Study|Lack of Efficacy|1|||
94572843|NCT02734693|323896128|FG001|Overall Study|Lack of Efficacy|0|||
94572844|NCT02734693|323896129|FG002|Overall Study|Lack of Efficacy|0|||
94572845|NCT02734693|323896127|FG000|Overall Study|Lost to Follow-up|2|||
94572846|NCT02734693|323896128|FG001|Overall Study|Lost to Follow-up|0|||
94572847|NCT02734693|323896129|FG002|Overall Study|Lost to Follow-up|0|||
94572848|NCT02734693|323896127|FG000|Overall Study|Protocol Violation|1|||
94572849|NCT02734693|323896128|FG001|Overall Study|Protocol Violation|0|||
94572850|NCT02734693|323896129|FG002|Overall Study|Protocol Violation|0|||
94572851|NCT02734693|323896127|FG000|Overall Study|Withdrawal by Subject|1|||
94572852|NCT02734693|323896128|FG001|Overall Study|Withdrawal by Subject|0|||
94572853|NCT02734693|323896129|FG002|Overall Study|Withdrawal by Subject|0|||
94572854|NCT01743469|323896130|FG000|Active Treatment Phase|Adverse Event|10|||
94572855|NCT01743469|323896131|FG001|Active Treatment Phase|Adverse Event|5|||
94572856|NCT01743469|323896132|FG002|Active Treatment Phase|Adverse Event|8|||
94572857|NCT01743469|323896133|FG003|Active Treatment Phase|Adverse Event|1|||
94572858|NCT01743469|323896130|FG000|Active Treatment Phase|Disease Progression|40|||
94572859|NCT01743469|323896131|FG001|Active Treatment Phase|Disease Progression|47|||
94572860|NCT01743469|323896132|FG002|Active Treatment Phase|Disease Progression|30|||
94572861|NCT01743469|323896133|FG003|Active Treatment Phase|Disease Progression|20|||
94572862|NCT01743469|323896130|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
94572863|NCT01743469|323896131|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
94572864|NCT01743469|323896132|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
94572865|NCT01743469|323896133|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
94572866|NCT01743469|323896130|FG000|Active Treatment Phase|Missing|1|||
94572867|NCT01743469|323896131|FG001|Active Treatment Phase|Missing|0|||
94572868|NCT01743469|323896132|FG002|Active Treatment Phase|Missing|0|||
94572869|NCT01743469|323896133|FG003|Active Treatment Phase|Missing|0|||
94348621|NCT01004861|323058792|FG007|Overall Study|Disease progression|1|||
94572870|NCT01743469|323896130|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
94572871|NCT01743469|323896131|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
94572872|NCT01743469|323896132|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
94572873|NCT01743469|323896133|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
94572874|NCT01743469|323896130|FG000|Follow-up Period - Post-Treatment|Death|43|||
94572875|NCT01743469|323896131|FG001|Follow-up Period - Post-Treatment|Death|47|||
94572876|NCT01743469|323896132|FG002|Follow-up Period - Post-Treatment|Death|22|||
94572877|NCT01743469|323896133|FG003|Follow-up Period - Post-Treatment|Death|16|||
94572878|NCT01743469|323896130|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
94572879|NCT01743469|323896131|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
94572880|NCT01743469|323896132|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
94572881|NCT01743469|323896133|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
94572882|NCT03624881|323896134|FG000|Overall Study|Screen Failure|14|||
94572883|NCT03624881|323896135|FG001|Overall Study|Screen Failure|0|||
94572884|NCT03624881|323896134|FG000|Overall Study|No Catheter Inserted|6|||
94572885|NCT03624881|323896135|FG001|Overall Study|No Catheter Inserted|1|||
94572886|NCT03624881|323896134|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
94572887|NCT03624881|323896135|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
94572888|NCT03624881|323896134|FG000|Overall Study|Death|2|||
94572889|NCT03624881|323896135|FG001|Overall Study|Death|0|||
94572890|NCT03624881|323896134|FG000|Overall Study|Lost to Follow-up|10|||
94572891|NCT03624881|323896135|FG001|Overall Study|Lost to Follow-up|4|||
94572892|NCT03624881|323896134|FG000|Overall Study|Withdrawal by Subject|12|||
94572893|NCT03624881|323896135|FG001|Overall Study|Withdrawal by Subject|1|||
94572894|NCT00388349|323896136|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
94572895|NCT00388349|323896137|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
94572896|NCT01339832|323896138|FG000|Overall Study|Lost to Follow-up|3|||
94572897|NCT01339832|323896138|FG000|Overall Study|Death|11|||
94572898|NCT03309020|323896141|FG000|Overall Study|Death|1|||
94572899|NCT03309020|323896142|FG001|Overall Study|Death|0|||
94572900|NCT03309020|323896141|FG000|Overall Study|Did not undergo surgery|2|||
94572901|NCT03309020|323896142|FG001|Overall Study|Did not undergo surgery|1|||
94572902|NCT02485691|323896143|FG000|Overall Study|Adverse Event|25|||
94572903|NCT02485691|323896144|FG001|Overall Study|Adverse Event|11|||
94572904|NCT02485691|323896143|FG000|Overall Study|Poor compliance to protocol|0|||
94572905|NCT02485691|323896144|FG001|Overall Study|Poor compliance to protocol|1|||
94572906|NCT02485691|323896143|FG000|Overall Study|Disease progression|57|||
94572907|NCT02485691|323896144|FG001|Overall Study|Disease progression|92|||
94572908|NCT02485691|323896143|FG000|Overall Study|Investigator's decision|23|||
94572909|NCT02485691|323896144|FG001|Overall Study|Investigator's decision|5|||
94572910|NCT02485691|323896143|FG000|Overall Study|Participant's request|13|||
94572911|NCT02485691|323896144|FG001|Overall Study|Participant's request|6|||
94572912|NCT02485691|323896143|FG000|Overall Study|Other reason|8|||
94572913|NCT02485691|323896144|FG001|Overall Study|Other reason|9|||
94572914|NCT02485691|323896143|FG000|Overall Study|Randomized and not treated|3|||
94572915|NCT02485691|323896144|FG001|Overall Study|Randomized and not treated|2|||
94572916|NCT04528641|323896145|FG000|Overall Study|Withdrawal by Subject|0|||
94572917|NCT04528641|323896146|FG001|Overall Study|Withdrawal by Subject|0|||
94572918|NCT04528641|323896147|FG002|Overall Study|Withdrawal by Subject|0|||
94572919|NCT04528641|323896148|FG003|Overall Study|Withdrawal by Subject|1|||
94572920|NCT04528641|323896149|FG004|Overall Study|Withdrawal by Subject|0|||
94572921|NCT04528641|323896150|FG005|Overall Study|Withdrawal by Subject|1|||
94572922|NCT03836625|323896151|FG000|Overall Study|Lost to Follow-up|9|||
94572923|NCT03836625|323896152|FG001|Overall Study|Lost to Follow-up|9|||
94572924|NCT03836625|323896151|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
94572925|NCT03836625|323896152|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
94572926|NCT03836625|323896151|FG000|Overall Study|Death|0|||
94572927|NCT03836625|323896152|FG001|Overall Study|Death|1|||
94572928|NCT03836625|323896151|FG000|Overall Study|Refused follow-up|0|||
94572929|NCT03836625|323896152|FG001|Overall Study|Refused follow-up|1|||
94572930|NCT03137992|323896156|FG000|Washout Period 1|Adverse Event|1|||
94572931|NCT03137992|323896157|FG001|Washout Period 1|Adverse Event|1|||
94572932|NCT03137992|323896158|FG002|Washout Period 1|Adverse Event|0|||
94572933|NCT03137992|323896159|FG003|Washout Period 1|Adverse Event|0|||
94572934|NCT03137992|323896160|FG004|Washout Period 1|Adverse Event|0|||
94572935|NCT03137992|323896161|FG005|Washout Period 1|Adverse Event|1|||
94572936|NCT03137992|323896156|FG000|Washout Period 1|Withdrawal by Subject|0|||
94572937|NCT03137992|323896157|FG001|Washout Period 1|Withdrawal by Subject|1|||
94572938|NCT03137992|323896158|FG002|Washout Period 1|Withdrawal by Subject|1|||
94572939|NCT03137992|323896159|FG003|Washout Period 1|Withdrawal by Subject|0|||
94572940|NCT03137992|323896160|FG004|Washout Period 1|Withdrawal by Subject|0|||
94572941|NCT03137992|323896161|FG005|Washout Period 1|Withdrawal by Subject|0|||
94572942|NCT03137992|323896156|FG000|Washout Period 1|Principal Investigator Discretion|0|||
94572943|NCT03137992|323896157|FG001|Washout Period 1|Principal Investigator Discretion|1|||
94572944|NCT03137992|323896158|FG002|Washout Period 1|Principal Investigator Discretion|0|||
94572945|NCT03137992|323896159|FG003|Washout Period 1|Principal Investigator Discretion|0|||
94572946|NCT03137992|323896160|FG004|Washout Period 1|Principal Investigator Discretion|0|||
94572947|NCT03137992|323896161|FG005|Washout Period 1|Principal Investigator Discretion|0|||
94451895|NCT00757042|323441904|FG009|Overall Study|Lost to Follow-up|0|||
94572948|NCT03137992|323896156|FG000|Washout Period 1|COPD Exacerbation|1|||
94572949|NCT03137992|323896157|FG001|Washout Period 1|COPD Exacerbation|1|||
94572950|NCT03137992|323896158|FG002|Washout Period 1|COPD Exacerbation|1|||
94572951|NCT03137992|323896159|FG003|Washout Period 1|COPD Exacerbation|0|||
94572952|NCT03137992|323896160|FG004|Washout Period 1|COPD Exacerbation|1|||
94572953|NCT03137992|323896161|FG005|Washout Period 1|COPD Exacerbation|1|||
94572954|NCT03137992|323896156|FG000|Washout Period 1|Subject Noncompliance|1|||
94572955|NCT03137992|323896157|FG001|Washout Period 1|Subject Noncompliance|0|||
94572956|NCT03137992|323896158|FG002|Washout Period 1|Subject Noncompliance|0|||
94572957|NCT03137992|323896159|FG003|Washout Period 1|Subject Noncompliance|0|||
94572958|NCT03137992|323896160|FG004|Washout Period 1|Subject Noncompliance|1|||
94572959|NCT03137992|323896161|FG005|Washout Period 1|Subject Noncompliance|0|||
94572960|NCT03137992|323896156|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
94572961|NCT03137992|323896157|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
94572962|NCT03137992|323896158|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
94572963|NCT03137992|323896159|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
94572964|NCT03137992|323896160|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
94572965|NCT03137992|323896161|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
94572966|NCT03137992|323896156|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
94572967|NCT03137992|323896157|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
94572968|NCT03137992|323896158|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
94572969|NCT03137992|323896159|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
94572970|NCT03137992|323896160|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
94572971|NCT03137992|323896161|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
94572972|NCT03137992|323896156|FG000|Period 2 (Visit 3)|Adverse Event|0|||
94572973|NCT03137992|323896157|FG001|Period 2 (Visit 3)|Adverse Event|1|||
94572974|NCT03137992|323896158|FG002|Period 2 (Visit 3)|Adverse Event|0|||
94572975|NCT03137992|323896159|FG003|Period 2 (Visit 3)|Adverse Event|0|||
94572976|NCT03137992|323896160|FG004|Period 2 (Visit 3)|Adverse Event|0|||
94572977|NCT03137992|323896161|FG005|Period 2 (Visit 3)|Adverse Event|0|||
94572978|NCT03137992|323896156|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
94572979|NCT03137992|323896157|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
94572980|NCT03137992|323896158|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
94572981|NCT03137992|323896159|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
94572982|NCT03137992|323896160|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
94572983|NCT03137992|323896161|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
94572984|NCT03137992|323896156|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
94572985|NCT03137992|323896157|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
94572986|NCT03137992|323896158|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
94572987|NCT03137992|323896159|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
94572988|NCT03137992|323896160|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
94572989|NCT03137992|323896161|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
94572990|NCT03137992|323896156|FG000|Washout Period 2|COPD Exacerbation|1|||
94572991|NCT03137992|323896157|FG001|Washout Period 2|COPD Exacerbation|1|||
94572992|NCT03137992|323896158|FG002|Washout Period 2|COPD Exacerbation|0|||
94572993|NCT03137992|323896159|FG003|Washout Period 2|COPD Exacerbation|0|||
94572994|NCT03137992|323896160|FG004|Washout Period 2|COPD Exacerbation|1|||
94572995|NCT03137992|323896161|FG005|Washout Period 2|COPD Exacerbation|0|||
94572996|NCT03137992|323896156|FG000|Washout Period 2|Subject Non-compliance|0|||
94572997|NCT03137992|323896157|FG001|Washout Period 2|Subject Non-compliance|1|||
94572998|NCT03137992|323896158|FG002|Washout Period 2|Subject Non-compliance|0|||
94572999|NCT03137992|323896159|FG003|Washout Period 2|Subject Non-compliance|0|||
94573000|NCT03137992|323896160|FG004|Washout Period 2|Subject Non-compliance|0|||
94573001|NCT03137992|323896161|FG005|Washout Period 2|Subject Non-compliance|0|||
94573002|NCT03137992|323896156|FG000|Washout Period 2|Adverse Event|0|||
94451896|NCT00757042|323441905|FG010|Overall Study|Lost to Follow-up|0|||
94451897|NCT00757042|323441895|FG000|Overall Study|Ineligibility Determined|0|||
94573003|NCT03137992|323896157|FG001|Washout Period 2|Adverse Event|0|||
94573004|NCT03137992|323896158|FG002|Washout Period 2|Adverse Event|0|||
94573005|NCT03137992|323896159|FG003|Washout Period 2|Adverse Event|1|||
94573006|NCT03137992|323896160|FG004|Washout Period 2|Adverse Event|1|||
94573007|NCT03137992|323896161|FG005|Washout Period 2|Adverse Event|0|||
94573008|NCT03137992|323896156|FG000|Washout Period 2|Withdrawal by Subject|1|||
94573009|NCT03137992|323896157|FG001|Washout Period 2|Withdrawal by Subject|0|||
94573010|NCT03137992|323896158|FG002|Washout Period 2|Withdrawal by Subject|0|||
94451898|NCT00757042|323441896|FG001|Overall Study|Ineligibility Determined|0|||
94451899|NCT00757042|323441897|FG002|Overall Study|Ineligibility Determined|0|||
94573011|NCT03137992|323896159|FG003|Washout Period 2|Withdrawal by Subject|0|||
94573012|NCT03137992|323896160|FG004|Washout Period 2|Withdrawal by Subject|1|||
94573013|NCT03137992|323896161|FG005|Washout Period 2|Withdrawal by Subject|0|||
94573014|NCT03137992|323896156|FG000|Washout Period 2|Sponsor Decision|0|||
94573015|NCT03137992|323896157|FG001|Washout Period 2|Sponsor Decision|0|||
94573016|NCT03137992|323896158|FG002|Washout Period 2|Sponsor Decision|0|||
94573017|NCT03137992|323896159|FG003|Washout Period 2|Sponsor Decision|0|||
94573018|NCT03137992|323896160|FG004|Washout Period 2|Sponsor Decision|0|||
94573019|NCT03137992|323896161|FG005|Washout Period 2|Sponsor Decision|1|||
94573020|NCT03137992|323896156|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
94573021|NCT03137992|323896157|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
94573022|NCT03137992|323896158|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
94573023|NCT03137992|323896159|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
94573024|NCT03137992|323896160|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
94573025|NCT03137992|323896161|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
94573026|NCT03137992|323896156|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
94573027|NCT03137992|323896157|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
94573028|NCT03137992|323896158|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
94573029|NCT03137992|323896159|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
94573030|NCT03137992|323896160|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
94573031|NCT03137992|323896161|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
94573032|NCT03137992|323896156|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
94573033|NCT03137992|323896157|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
94573034|NCT03137992|323896158|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
94573035|NCT03137992|323896159|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
94573036|NCT03137992|323896160|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
94573037|NCT03137992|323896161|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
94573038|NCT03137992|323896156|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
94573039|NCT03137992|323896157|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
94573040|NCT03137992|323896158|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
94573041|NCT03137992|323896159|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
94573042|NCT03137992|323896160|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
94573043|NCT03137992|323896161|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
94573044|NCT03137992|323896156|FG000|Part 2 (Open-label Extension)|Per study team|1|||
94573045|NCT03137992|323896157|FG001|Part 2 (Open-label Extension)|Per study team|0|||
94573046|NCT03137992|323896158|FG002|Part 2 (Open-label Extension)|Per study team|0|||
94573047|NCT03137992|323896159|FG003|Part 2 (Open-label Extension)|Per study team|0|||
94573048|NCT03137992|323896160|FG004|Part 2 (Open-label Extension)|Per study team|0|||
94573049|NCT03137992|323896161|FG005|Part 2 (Open-label Extension)|Per study team|0|||
94573050|NCT03137992|323896156|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
94573051|NCT03137992|323896157|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
94573052|NCT03137992|323896158|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
94573053|NCT03137992|323896159|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
94573054|NCT03137992|323896160|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
94573055|NCT03137992|323896161|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
94573056|NCT02532517|323896162|FG000|Overall Study|Did not complete 24-Month visit|4|||
94573057|NCT02532517|323896162|FG000|Overall Study|Failed Angiographic eligibility|1|||
94573058|NCT02532517|323896162|FG000|Overall Study|Lost to Follow-up|4|||
94573059|NCT02532517|323896162|FG000|Overall Study|Withdrawal by Subject|4|||
94573060|NCT02532517|323896162|FG000|Overall Study|Death|4|||
94573061|NCT01691794|323896163|FG000|Overall Study|Poor/Non-Compliance|1|||
94573062|NCT01691794|323896164|FG001|Overall Study|Poor/Non-Compliance|4|||
94573063|NCT01691794|323896165|FG002|Overall Study|Poor/Non-Compliance|1|||
94573064|NCT01691794|323896163|FG000|Overall Study|Death|0|||
94573065|NCT01691794|323896164|FG001|Overall Study|Death|0|||
94573066|NCT01691794|323896165|FG002|Overall Study|Death|1|||
94573067|NCT01691794|323896163|FG000|Overall Study|Lack of Efficacy|0|||
94573068|NCT01691794|323896164|FG001|Overall Study|Lack of Efficacy|7|||
94573069|NCT01691794|323896165|FG002|Overall Study|Lack of Efficacy|1|||
94573070|NCT01691794|323896163|FG000|Overall Study|Participant request to discontinue|0|||
94573071|NCT01691794|323896164|FG001|Overall Study|Participant request to discontinue|1|||
94238440|NCT01441635|322666632|FG006|Overall Study|Received Exclusionary Medication|0|||
94238441|NCT01441635|322666633|FG007|Overall Study|Received Exclusionary Medication|0|||
94238442|NCT01441635|322666634|FG008|Overall Study|Received Exclusionary Medication|0|||
94238443|NCT01441635|322666635|FG009|Overall Study|Received Exclusionary Medication|0|||
94573072|NCT01691794|323896165|FG002|Overall Study|Participant request to discontinue|0|||
94573073|NCT01691794|323896163|FG000|Overall Study|Adverse Event|0|||
94573074|NCT01691794|323896164|FG001|Overall Study|Adverse Event|1|||
94573075|NCT01691794|323896165|FG002|Overall Study|Adverse Event|1|||
94573076|NCT01691794|323896163|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
94573077|NCT01691794|323896164|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
94238444|NCT01441635|322666626|FG000|Overall Study|Other|0|||
94573078|NCT01691794|323896165|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
94573079|NCT01691794|323896163|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
94238445|NCT01441635|322666627|FG001|Overall Study|Other|0|||
94573080|NCT01691794|323896164|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
94573081|NCT01691794|323896165|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
94573082|NCT03905096|323896168|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
94573083|NCT03905096|323896169|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
94573084|NCT02016781|323896172|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
94573085|NCT02016781|323896173|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
94573086|NCT02016781|323896172|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
94573087|NCT02016781|323896173|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
94573088|NCT02016781|323896172|FG000|Final Database Lock|Withdrawal by Subject|2|||
94573089|NCT02016781|323896173|FG001|Final Database Lock|Withdrawal by Subject|1|||
94573090|NCT02016781|323896172|FG000|Final Database Lock|Lost to Follow-up|11|||
94573091|NCT02016781|323896173|FG001|Final Database Lock|Lost to Follow-up|4|||
94573092|NCT02016781|323896172|FG000|Final Database Lock|Missing data|0|||
94573093|NCT02016781|323896173|FG001|Final Database Lock|Missing data|3|||
94573094|NCT01400698|323896174|FG000|Overall Study|Lost to Follow-up|2|||
94573095|NCT01400698|323896175|FG001|Overall Study|Lost to Follow-up|5|||
94573096|NCT01400698|323896176|FG002|Overall Study|Lost to Follow-up|2|||
94573097|NCT01400698|323896177|FG003|Overall Study|Lost to Follow-up|1|||
94573098|NCT01400698|323896178|FG004|Overall Study|Lost to Follow-up|4|||
94573099|NCT01400698|323896179|FG005|Overall Study|Lost to Follow-up|3|||
94573100|NCT01400698|323896174|FG000|Overall Study|Withdrawal by Subject|8|||
94573101|NCT01400698|323896175|FG001|Overall Study|Withdrawal by Subject|2|||
94573102|NCT01400698|323896176|FG002|Overall Study|Withdrawal by Subject|0|||
94573103|NCT01400698|323896177|FG003|Overall Study|Withdrawal by Subject|4|||
94573104|NCT01400698|323896178|FG004|Overall Study|Withdrawal by Subject|1|||
94573105|NCT01400698|323896179|FG005|Overall Study|Withdrawal by Subject|3|||
94573106|NCT01400698|323896174|FG000|Overall Study|Protocol Violation|0|||
94573107|NCT01400698|323896175|FG001|Overall Study|Protocol Violation|1|||
94573108|NCT01400698|323896176|FG002|Overall Study|Protocol Violation|0|||
94573109|NCT01400698|323896177|FG003|Overall Study|Protocol Violation|0|||
94573110|NCT01400698|323896178|FG004|Overall Study|Protocol Violation|1|||
94573111|NCT01400698|323896179|FG005|Overall Study|Protocol Violation|0|||
94573112|NCT01400698|323896174|FG000|Overall Study|Non-compliance|0|||
94573113|NCT01400698|323896175|FG001|Overall Study|Non-compliance|1|||
94573114|NCT01400698|323896176|FG002|Overall Study|Non-compliance|0|||
94573115|NCT01400698|323896177|FG003|Overall Study|Non-compliance|1|||
94573116|NCT01400698|323896178|FG004|Overall Study|Non-compliance|0|||
94573117|NCT01400698|323896179|FG005|Overall Study|Non-compliance|0|||
94573118|NCT01400698|323896174|FG000|Overall Study|Adverse Event|1|||
94573119|NCT01400698|323896175|FG001|Overall Study|Adverse Event|0|||
94573120|NCT01400698|323896176|FG002|Overall Study|Adverse Event|0|||
94573121|NCT01400698|323896177|FG003|Overall Study|Adverse Event|0|||
94573122|NCT01400698|323896178|FG004|Overall Study|Adverse Event|0|||
94573123|NCT01400698|323896179|FG005|Overall Study|Adverse Event|0|||
94573124|NCT01400698|323896174|FG000|Overall Study|Other|4|||
94658814|NCT01172938|324206184|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
94573125|NCT01400698|323896175|FG001|Overall Study|Other|2|||
94573126|NCT01400698|323896176|FG002|Overall Study|Other|0|||
94573127|NCT01400698|323896177|FG003|Overall Study|Other|2|||
94573128|NCT01400698|323896178|FG004|Overall Study|Other|1|||
94573129|NCT01400698|323896179|FG005|Overall Study|Other|0|||
94573130|NCT04906499|323897607|FG000|Overall Study|Lack of time|1|||
94573131|NCT02412306|323897615|FG000|Overall Study|Lost to Follow-up|0|||
94573132|NCT02412306|323897616|FG001|Overall Study|Lost to Follow-up|1|||
94573133|NCT02412306|323897617|FG002|Overall Study|Lost to Follow-up|0|||
94573134|NCT02412306|323897618|FG003|Overall Study|Lost to Follow-up|0|||
94573135|NCT02412306|323897619|FG004|Overall Study|Lost to Follow-up|0|||
94573136|NCT02412306|323897615|FG000|Overall Study|Withdrawal by Subject|0|||
94573137|NCT02412306|323897616|FG001|Overall Study|Withdrawal by Subject|0|||
94573138|NCT02412306|323897617|FG002|Overall Study|Withdrawal by Subject|1|||
94573139|NCT02412306|323897618|FG003|Overall Study|Withdrawal by Subject|0|||
94573140|NCT02412306|323897619|FG004|Overall Study|Withdrawal by Subject|0|||
94573141|NCT02412306|323897615|FG000|Overall Study|Death|5|||
94573142|NCT02412306|323897616|FG001|Overall Study|Death|7|||
94573143|NCT02412306|323897617|FG002|Overall Study|Death|15|||
94238446|NCT01441635|322666628|FG002|Overall Study|Other|0|||
94573144|NCT02412306|323897618|FG003|Overall Study|Death|0|||
94348622|NCT01004861|323058793|FG008|Overall Study|Disease progression|4|||
94348623|NCT01004861|323058794|FG009|Overall Study|Disease progression|7|||
94348624|NCT01004861|323058795|FG010|Overall Study|Disease progression|6|||
94348625|NCT01004861|323058796|FG011|Overall Study|Disease progression|3|||
94348626|NCT01004861|323058797|FG012|Overall Study|Disease progression|8|||
94348627|NCT01004861|323058785|FG000|Overall Study|Physician Decision|0|||
94348628|NCT01004861|323058786|FG001|Overall Study|Physician Decision|2|||
94348629|NCT01004861|323058787|FG002|Overall Study|Physician Decision|1|||
94348630|NCT01004861|323058788|FG003|Overall Study|Physician Decision|1|||
94348631|NCT01004861|323058789|FG004|Overall Study|Physician Decision|1|||
94348632|NCT01004861|323058790|FG005|Overall Study|Physician Decision|0|||
94348633|NCT01004861|323058791|FG006|Overall Study|Physician Decision|0|||
94348634|NCT01004861|323058792|FG007|Overall Study|Physician Decision|1|||
94348635|NCT01004861|323058793|FG008|Overall Study|Physician Decision|0|||
94348636|NCT01004861|323058794|FG009|Overall Study|Physician Decision|0|||
94348637|NCT01004861|323058795|FG010|Overall Study|Physician Decision|0|||
94348638|NCT01004861|323058796|FG011|Overall Study|Physician Decision|0|||
94348639|NCT01004861|323058797|FG012|Overall Study|Physician Decision|3|||
94348640|NCT01004861|323058785|FG000|Overall Study|Adverse Event|0|||
94348641|NCT01004861|323058786|FG001|Overall Study|Adverse Event|0|||
94348642|NCT01004861|323058787|FG002|Overall Study|Adverse Event|0|||
94348643|NCT01004861|323058788|FG003|Overall Study|Adverse Event|1|||
94348644|NCT01004861|323058789|FG004|Overall Study|Adverse Event|0|||
94348645|NCT01004861|323058790|FG005|Overall Study|Adverse Event|2|||
94348646|NCT01004861|323058791|FG006|Overall Study|Adverse Event|1|||
94348647|NCT01004861|323058792|FG007|Overall Study|Adverse Event|1|||
94348648|NCT01004861|323058793|FG008|Overall Study|Adverse Event|13|||
94348649|NCT01004861|323058794|FG009|Overall Study|Adverse Event|1|||
94348650|NCT01004861|323058795|FG010|Overall Study|Adverse Event|1|||
94348651|NCT01004861|323058796|FG011|Overall Study|Adverse Event|0|||
94348652|NCT01004861|323058797|FG012|Overall Study|Adverse Event|2|||
94348653|NCT01004861|323058785|FG000|Overall Study|Protocol Violation|0|||
94348654|NCT01004861|323058786|FG001|Overall Study|Protocol Violation|0|||
94348655|NCT01004861|323058787|FG002|Overall Study|Protocol Violation|0|||
94348656|NCT01004861|323058788|FG003|Overall Study|Protocol Violation|0|||
94348657|NCT01004861|323058789|FG004|Overall Study|Protocol Violation|1|||
94348658|NCT01004861|323058790|FG005|Overall Study|Protocol Violation|0|||
94348659|NCT01004861|323058791|FG006|Overall Study|Protocol Violation|0|||
94348660|NCT01004861|323058792|FG007|Overall Study|Protocol Violation|0|||
94348661|NCT01004861|323058793|FG008|Overall Study|Protocol Violation|0|||
94348662|NCT01004861|323058794|FG009|Overall Study|Protocol Violation|0|||
94348663|NCT01004861|323058795|FG010|Overall Study|Protocol Violation|0|||
94348664|NCT01004861|323058796|FG011|Overall Study|Protocol Violation|0|||
94348665|NCT01004861|323058797|FG012|Overall Study|Protocol Violation|0|||
94348666|NCT01004861|323058785|FG000|Overall Study|Lost to Follow-up|0|||
94348667|NCT01004861|323058786|FG001|Overall Study|Lost to Follow-up|0|||
94348668|NCT01004861|323058787|FG002|Overall Study|Lost to Follow-up|0|||
94348669|NCT01004861|323058788|FG003|Overall Study|Lost to Follow-up|0|||
94348670|NCT01004861|323058789|FG004|Overall Study|Lost to Follow-up|0|||
94348671|NCT01004861|323058790|FG005|Overall Study|Lost to Follow-up|0|||
94348672|NCT01004861|323058791|FG006|Overall Study|Lost to Follow-up|0|||
94348673|NCT01004861|323058792|FG007|Overall Study|Lost to Follow-up|1|||
94348674|NCT01004861|323058793|FG008|Overall Study|Lost to Follow-up|3|||
94348675|NCT01004861|323058794|FG009|Overall Study|Lost to Follow-up|0|||
94348676|NCT01004861|323058795|FG010|Overall Study|Lost to Follow-up|0|||
94348677|NCT01004861|323058796|FG011|Overall Study|Lost to Follow-up|1|||
94348678|NCT01004861|323058797|FG012|Overall Study|Lost to Follow-up|0|||
94348679|NCT01004861|323058785|FG000|Overall Study|Non-compliance|0|||
94348680|NCT01004861|323058786|FG001|Overall Study|Non-compliance|0|||
94348681|NCT01004861|323058787|FG002|Overall Study|Non-compliance|0|||
94348682|NCT01004861|323058788|FG003|Overall Study|Non-compliance|0|||
94348683|NCT01004861|323058789|FG004|Overall Study|Non-compliance|0|||
94348684|NCT01004861|323058790|FG005|Overall Study|Non-compliance|0|||
94348685|NCT01004861|323058791|FG006|Overall Study|Non-compliance|0|||
94348686|NCT01004861|323058792|FG007|Overall Study|Non-compliance|0|||
94348687|NCT01004861|323058793|FG008|Overall Study|Non-compliance|5|||
94348688|NCT01004861|323058794|FG009|Overall Study|Non-compliance|0|||
94348689|NCT01004861|323058795|FG010|Overall Study|Non-compliance|0|||
94348690|NCT01004861|323058796|FG011|Overall Study|Non-compliance|0|||
94348691|NCT01004861|323058797|FG012|Overall Study|Non-compliance|1|||
94348692|NCT01004861|323058785|FG000|Overall Study|Other|0|||
94348693|NCT01004861|323058786|FG001|Overall Study|Other|0|||
94348694|NCT01004861|323058787|FG002|Overall Study|Other|0|||
94348695|NCT01004861|323058788|FG003|Overall Study|Other|0|||
94348696|NCT01004861|323058789|FG004|Overall Study|Other|0|||
94348697|NCT01004861|323058790|FG005|Overall Study|Other|0|||
94348698|NCT01004861|323058791|FG006|Overall Study|Other|0|||
94348699|NCT01004861|323058792|FG007|Overall Study|Other|0|||
94348700|NCT01004861|323058793|FG008|Overall Study|Other|0|||
94348701|NCT01004861|323058794|FG009|Overall Study|Other|2|||
94348702|NCT01004861|323058795|FG010|Overall Study|Other|1|||
94451900|NCT00757042|323441898|FG003|Overall Study|Ineligibility Determined|0|||
94451901|NCT00757042|323441899|FG004|Overall Study|Ineligibility Determined|0|||
94451902|NCT00757042|323441900|FG005|Overall Study|Ineligibility Determined|0|||
94451903|NCT00757042|323441901|FG006|Overall Study|Ineligibility Determined|0|||
94451904|NCT00757042|323441902|FG007|Overall Study|Ineligibility Determined|0|||
94451905|NCT00757042|323441903|FG008|Overall Study|Ineligibility Determined|0|||
94451906|NCT00757042|323441904|FG009|Overall Study|Ineligibility Determined|0|||
94451907|NCT00757042|323441905|FG010|Overall Study|Ineligibility Determined|1|||
94451908|NCT00757042|323441895|FG000|Overall Study|Withdrawal by Subject|0|||
94451909|NCT00757042|323441896|FG001|Overall Study|Withdrawal by Subject|0|||
94451910|NCT00757042|323441897|FG002|Overall Study|Withdrawal by Subject|0|||
94451911|NCT00757042|323441898|FG003|Overall Study|Withdrawal by Subject|0|||
94451912|NCT00757042|323441899|FG004|Overall Study|Withdrawal by Subject|0|||
94451913|NCT00757042|323441900|FG005|Overall Study|Withdrawal by Subject|0|||
94451914|NCT00757042|323441901|FG006|Overall Study|Withdrawal by Subject|0|||
94451915|NCT00757042|323441902|FG007|Overall Study|Withdrawal by Subject|0|||
94451916|NCT00757042|323441903|FG008|Overall Study|Withdrawal by Subject|0|||
94451917|NCT00757042|323441904|FG009|Overall Study|Withdrawal by Subject|1|||
94451918|NCT00757042|323441905|FG010|Overall Study|Withdrawal by Subject|0|||
94451919|NCT03887442|323441906|FG000|Overall Study|Adverse Event|1|||
94451920|NCT03887442|323441907|FG001|Overall Study|Adverse Event|0|||
94451921|NCT03319732|323441908|FG000|Overall Study|Adverse Event|40|||
94451922|NCT03319732|323441908|FG000|Overall Study|Withdrawal by Subject|50|||
94451923|NCT03319732|323441908|FG000|Overall Study|MS relapse|10|||
94451924|NCT03319732|323441908|FG000|Overall Study|reason not specified|5|||
94451925|NCT00789698|323441912|FG000|Overall Study|Lack of Efficacy|10|||
94451926|NCT00789698|323441913|FG001|Overall Study|Lack of Efficacy|4|||
94451927|NCT00789698|323441914|FG002|Overall Study|Lack of Efficacy|5|||
94451928|NCT00789698|323441915|FG003|Overall Study|Lack of Efficacy|18|||
94451929|NCT00789698|323441912|FG000|Overall Study|Adverse Event|5|||
94451930|NCT00789698|323441913|FG001|Overall Study|Adverse Event|5|||
94451931|NCT00789698|323441914|FG002|Overall Study|Adverse Event|3|||
94451932|NCT00789698|323441915|FG003|Overall Study|Adverse Event|4|||
94451933|NCT00789698|323441912|FG000|Overall Study|Lost to Follow-up|5|||
94451934|NCT00789698|323441913|FG001|Overall Study|Lost to Follow-up|5|||
94451935|NCT00789698|323441914|FG002|Overall Study|Lost to Follow-up|2|||
94451936|NCT00789698|323441915|FG003|Overall Study|Lost to Follow-up|9|||
94451937|NCT00789698|323441912|FG000|Overall Study|Protocol Violation|6|||
94451938|NCT00789698|323441913|FG001|Overall Study|Protocol Violation|1|||
94451939|NCT00789698|323441914|FG002|Overall Study|Protocol Violation|2|||
94451940|NCT00789698|323441915|FG003|Overall Study|Protocol Violation|1|||
94451941|NCT00789698|323441912|FG000|Overall Study|Withdrawal by Subject|14|||
94451942|NCT00789698|323441913|FG001|Overall Study|Withdrawal by Subject|15|||
94451943|NCT00789698|323441914|FG002|Overall Study|Withdrawal by Subject|12|||
94451944|NCT00789698|323441915|FG003|Overall Study|Withdrawal by Subject|19|||
94451945|NCT00789698|323441912|FG000|Overall Study|Administrative|0|||
94451946|NCT00789698|323441913|FG001|Overall Study|Administrative|3|||
94451947|NCT00789698|323441914|FG002|Overall Study|Administrative|3|||
94451948|NCT00789698|323441915|FG003|Overall Study|Administrative|1|||
94451949|NCT01500382|323441917|FG000|Washout Period|Study site went out of business|0|||
94451950|NCT01500382|323441918|FG001|Washout Period|Study site went out of business|0|||
94451951|NCT01500382|323441919|FG002|Washout Period|Study site went out of business|1|||
94451952|NCT01500382|323441920|FG003|Washout Period|Study site went out of business|0|||
94451953|NCT01483027|323441921|FG000|Overall Study|Administrative Reasons|2|||
94451954|NCT01483027|323441922|FG001|Overall Study|Administrative Reasons|1|||
94451955|NCT01483027|323441921|FG000|Overall Study|Withdrawal by Subject|21|||
94451956|NCT01483027|323441922|FG001|Overall Study|Withdrawal by Subject|32|||
94451957|NCT01483027|323441921|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
94451958|NCT01483027|323441922|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
94451959|NCT01483027|323441921|FG000|Overall Study|Lost to Follow-up|1|||
94451960|NCT01483027|323441922|FG001|Overall Study|Lost to Follow-up|1|||
94451961|NCT01483027|323441921|FG000|Overall Study|Adverse Event|0|||
94451962|NCT01483027|323441922|FG001|Overall Study|Adverse Event|1|||
94451963|NCT01483027|323441921|FG000|Overall Study|Withdrawal by Subject|0|||
94451964|NCT01483027|323441922|FG001|Overall Study|Withdrawal by Subject|1|||
94451965|NCT01870973|323441923|FG000|Overall Study|Lost to Follow-up|10|||
94451966|NCT01870973|323441924|FG001|Overall Study|Lost to Follow-up|3|||
94451967|NCT04463251|323441926|FG000|Overall Study|Death|1|||
94451968|NCT04463251|323441927|FG001|Overall Study|Death|0|||
94451969|NCT04463251|323441928|FG002|Overall Study|Death|1|||
94451970|NCT04463251|323441926|FG000|Overall Study|Adverse Event|0|||
94451971|NCT04463251|323441927|FG001|Overall Study|Adverse Event|1|||
94451972|NCT04463251|323441928|FG002|Overall Study|Adverse Event|0|||
94451973|NCT04463251|323441926|FG000|Overall Study|Lost to Follow-up|0|||
94451974|NCT04463251|323441927|FG001|Overall Study|Lost to Follow-up|1|||
94451975|NCT04463251|323441928|FG002|Overall Study|Lost to Follow-up|0|||
94573145|NCT02412306|323897619|FG004|Overall Study|Death|2|||
94238447|NCT01441635|322666629|FG003|Overall Study|Other|0|||
94573146|NCT03035032|323897624|FG000|Overall Study|Adverse Event|2|||
94573147|NCT03035032|323897624|FG000|Overall Study|Death|9|||
94573148|NCT03035032|323897624|FG000|Overall Study|Lost to Follow-up|1|||
94573149|NCT03035032|323897624|FG000|Overall Study|Progressive Disease|22|||
94573150|NCT03035032|323897624|FG000|Overall Study|Protocol Violation|2|||
94573151|NCT03035032|323897624|FG000|Overall Study|Withdrawal by Subject|2|||
94573152|NCT03035032|323897624|FG000|Overall Study|Physician Decision|5|||
94573153|NCT00836589|323897625|FG000|Overall Study|Lost to Follow-up|246|||
94573154|NCT00836589|323897625|FG000|Overall Study|Death|429|||
94573155|NCT00836589|323897625|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
94573156|NCT02914639|323897629|FG000|Overall Study|Withdrawal by Subject|0|||
94573157|NCT02914639|323897630|FG001|Overall Study|Withdrawal by Subject|2|||
94573158|NCT02269124|323897631|FG000|Overall Study|Lost to Follow-up|1|||
94573159|NCT02269124|323897632|FG001|Overall Study|Lost to Follow-up|0|||
94573160|NCT02269124|323897631|FG000|Overall Study|Withdrawal by Subject|0|||
94573161|NCT02269124|323897632|FG001|Overall Study|Withdrawal by Subject|2|||
94573162|NCT01045460|323897641|FG000|Overall Study|Physician Decision|3|||
94573163|NCT01045460|323897642|FG001|Overall Study|Physician Decision|2|||
94573164|NCT01045460|323897641|FG000|Overall Study|Lost to Follow-up|0|||
94573165|NCT01045460|323897642|FG001|Overall Study|Lost to Follow-up|1|||
94573166|NCT01045460|323897641|FG000|Overall Study|Lack of Efficacy|3|||
94573167|NCT01045460|323897642|FG001|Overall Study|Lack of Efficacy|0|||
94573168|NCT00436332|323897645|FG000|Overall Study|Adverse Event|9|||
94573169|NCT00436332|323897645|FG000|Overall Study|Withdrawal by Subject|2|||
94573170|NCT00436332|323897645|FG000|Overall Study|Progression|59|||
94573171|NCT00436332|323897645|FG000|Overall Study|Death|2|||
94573172|NCT00436332|323897645|FG000|Overall Study|Not Protocol Specified|6|||
94573173|NCT00436332|323897645|FG000|Overall Study|Ineligible|2|||
94573174|NCT00436332|323897645|FG000|Overall Study|Never Received Treatment|3|||
94573175|NCT03617172|323897648|FG000|Overall Study|Lost to Follow-up|1|||
94573176|NCT03617172|323897649|FG001|Overall Study|Lost to Follow-up|0|||
94573177|NCT00189540|323897650|FG000|Overall Study|Withdrawal by Subject|3|||
94573178|NCT00189540|323897651|FG001|Overall Study|Withdrawal by Subject|0|||
94573179|NCT00189540|323897650|FG000|Overall Study|Death|4|||
94573180|NCT00189540|323897651|FG001|Overall Study|Death|1|||
94573181|NCT00642356|323897652|FG000|Overall Study|Adverse Event|1|||
94573182|NCT00642356|323897653|FG001|Overall Study|Adverse Event|0|||
94573183|NCT00642356|323897652|FG000|Overall Study|Protocol Violation|0|||
94573184|NCT00642356|323897653|FG001|Overall Study|Protocol Violation|3|||
94573185|NCT00642356|323897652|FG000|Overall Study|Lack of Efficacy|1|||
94573186|NCT00642356|323897653|FG001|Overall Study|Lack of Efficacy|0|||
94573187|NCT01903356|323897654|FG000|Overall Study|Lost to Follow-up|7|||
94573188|NCT01903356|323897654|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
94573189|NCT01903356|323897654|FG000|Overall Study|Violated the dosage and administration|3|||
94573190|NCT04529083|323897655|FG000|Overall Study|Withdrawal by Subject|3|||
94573191|NCT00005906|323897660|FG000|Overall Study|Lack of Efficacy|3|||
94573192|NCT04196686|323897661|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
94573193|NCT04196686|323897662|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
94573194|NCT00914849|323897663|FG000|Overall Study|Withdrawal by Subject|1|||
94573195|NCT00914849|323897664|FG001|Overall Study|Withdrawal by Subject|0|||
94573196|NCT00914849|323897663|FG000|Overall Study|Not eligible|0|||
94573197|NCT00914849|323897664|FG001|Overall Study|Not eligible|1|||
94573198|NCT05106959|323897665|FG000|Overall Study|Lost to Follow-up|1|||
94573199|NCT04551989|323897666|FG000|Overall Study|Adverse Event|4|||
94573200|NCT04551989|323897666|FG000|Overall Study|Protocol Violation|3|||
94573201|NCT04551989|323897666|FG000|Overall Study|Lost to Follow-up|1|||
94573202|NCT04551989|323897666|FG000|Overall Study|Physician Decision|3|||
94573203|NCT00265564|323897667|FG000|Overall Study|Lost to Follow-up|5|||
94573204|NCT00265564|323897668|FG001|Overall Study|Lost to Follow-up|7|||
94573205|NCT00265564|323897667|FG000|Overall Study|met exclusion criteria|5|||
94573206|NCT00265564|323897668|FG001|Overall Study|met exclusion criteria|2|||
94573207|NCT01546857|323897672|FG000|Overall Study|Withdrawal by Subject|2|||
94573208|NCT01546857|323897673|FG001|Overall Study|Withdrawal by Subject|3|||
94573209|NCT01339689|323897674|FG000|Overall Study|Adverse Event|1|||
94573210|NCT01339689|323897675|FG001|Overall Study|Adverse Event|2|||
94573211|NCT01339689|323897674|FG000|Overall Study|Lost to Follow-up|9|||
94573212|NCT01339689|323897675|FG001|Overall Study|Lost to Follow-up|3|||
94573213|NCT01339689|323897674|FG000|Overall Study|Withdrawal by Subject|3|||
94573214|NCT01339689|323897675|FG001|Overall Study|Withdrawal by Subject|0|||
94573215|NCT01339689|323897674|FG000|Overall Study|Noncompliance|1|||
94573216|NCT01339689|323897675|FG001|Overall Study|Noncompliance|0|||
94573217|NCT01339689|323897674|FG000|Overall Study|Relocated out of area|0|||
94573218|NCT01339689|323897675|FG001|Overall Study|Relocated out of area|1|||
94573219|NCT01339689|323897674|FG000|Overall Study|Other|2|||
94573220|NCT01339689|323897675|FG001|Overall Study|Other|2|||
94573221|NCT01339689|323897674|FG000|Overall Study|multiple reasons|1|||
94573222|NCT01339689|323897675|FG001|Overall Study|multiple reasons|1|||
94573223|NCT01469221|323897676|FG000|Double Blind Phase|Protocol Violation|1|||
94573224|NCT01469221|323897677|FG001|Double Blind Phase|Protocol Violation|0|||
94573225|NCT01469221|323897678|FG002|Double Blind Phase|Protocol Violation|0|||
94573226|NCT01469221|323897676|FG000|Double Blind Phase|Physician Decision|1|||
94573227|NCT01469221|323897677|FG001|Double Blind Phase|Physician Decision|1|||
94573228|NCT01469221|323897678|FG002|Double Blind Phase|Physician Decision|0|||
94573229|NCT01469221|323897676|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
94573230|NCT01469221|323897677|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
94573231|NCT01469221|323897678|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
94573232|NCT04571944|323897679|FG000|Overall Study|Death|1|||
94573233|NCT04571944|323897680|FG001|Overall Study|Death|0|||
94573234|NCT04571944|323897679|FG000|Overall Study|Withdrawal by Subject|3|||
94573235|NCT04571944|323897680|FG001|Overall Study|Withdrawal by Subject|0|||
94573236|NCT04571944|323897679|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
94573237|NCT04571944|323897680|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
94573238|NCT02694744|323897681|FG000|Overall Study|Adverse Event|2|||
94573239|NCT02694744|323897682|FG001|Overall Study|Adverse Event|1|||
94573240|NCT02694744|323897681|FG000|Overall Study|Withdrawal by Subject|2|||
94573241|NCT02694744|323897682|FG001|Overall Study|Withdrawal by Subject|1|||
94573242|NCT02694744|323897681|FG000|Overall Study|Physician Decision|1|||
94573243|NCT02694744|323897682|FG001|Overall Study|Physician Decision|2|||
94573244|NCT02694744|323897681|FG000|Overall Study|Lost to Follow-up|1|||
94573245|NCT02694744|323897682|FG001|Overall Study|Lost to Follow-up|0|||
94573246|NCT02694744|323897681|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
94573247|NCT02694744|323897682|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
94573248|NCT00686777|323897683|FG000|Overall Study|Adverse Event|2|||
94573249|NCT00686777|323897683|FG000|Overall Study|Pregnancy|1|||
94573250|NCT00686777|323897683|FG000|Overall Study|Withdrawal by Subject|2|||
94238448|NCT01441635|322666630|FG004|Overall Study|Other|0|||
94238449|NCT01441635|322666631|FG005|Overall Study|Other|0|||
94238450|NCT01441635|322666632|FG006|Overall Study|Other|0|||
94238451|NCT01441635|322666633|FG007|Overall Study|Other|1|||
94238452|NCT01441635|322666634|FG008|Overall Study|Other|0|||
94238453|NCT01441635|322666635|FG009|Overall Study|Other|0|||
94238454|NCT02878603|322666636|FG000|Overall Study|Lost to Follow-up|4|||
94238455|NCT02878603|322666637|FG001|Overall Study|Lost to Follow-up|1|||
94238456|NCT02878603|322666636|FG000|Overall Study|Withdrawal by Subject|1|||
94238457|NCT02878603|322666637|FG001|Overall Study|Withdrawal by Subject|1|||
94238458|NCT02878603|322666636|FG000|Overall Study|Death|1|||
94238459|NCT02878603|322666637|FG001|Overall Study|Death|0|||
94238460|NCT02878603|322666636|FG000|Overall Study|Physician Decision|0|||
94238461|NCT02878603|322666637|FG001|Overall Study|Physician Decision|3|||
94238462|NCT04674189|322666638|FG000|Overall Study|Adverse Event|0|||
94238463|NCT04674189|322666639|FG001|Overall Study|Adverse Event|0|||
94238464|NCT04674189|322666640|FG002|Overall Study|Adverse Event|1|||
94238465|NCT04674189|322666638|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
94238466|NCT04674189|322666639|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
94238467|NCT04674189|322666640|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
94238468|NCT04674189|322666638|FG000|Overall Study|Physician Decision|1|||
94238469|NCT04674189|322666639|FG001|Overall Study|Physician Decision|0|||
94238470|NCT04674189|322666640|FG002|Overall Study|Physician Decision|0|||
94238471|NCT04674189|322666638|FG000|Overall Study|Withdrawal by Participant|83|||
94238472|NCT04674189|322666639|FG001|Overall Study|Withdrawal by Participant|71|||
94238473|NCT04674189|322666640|FG002|Overall Study|Withdrawal by Participant|142|||
94238474|NCT04674189|322666638|FG000|Overall Study|Lost to Follow-up|55|||
94238475|NCT04674189|322666639|FG001|Overall Study|Lost to Follow-up|53|||
94238476|NCT04674189|322666640|FG002|Overall Study|Lost to Follow-up|44|||
94238477|NCT04674189|322666638|FG000|Overall Study|Miscellaneous|27|||
94238478|NCT04674189|322666639|FG001|Overall Study|Miscellaneous|23|||
94238479|NCT04674189|322666640|FG002|Overall Study|Miscellaneous|207|||
94238480|NCT04674189|322666638|FG000|Overall Study|Did Not Receive Treatment|3|||
94238481|NCT04674189|322666639|FG001|Overall Study|Did Not Receive Treatment|1|||
94573251|NCT00686777|323897683|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
94573252|NCT00686777|323897683|FG000|Overall Study|No Visit|1|||
94573253|NCT03582215|323897684|FG000|Overall Study|Adverse Event|1|||
94573254|NCT03582215|323897685|FG001|Overall Study|Adverse Event|0|||
94573255|NCT03582215|323897686|FG002|Overall Study|Adverse Event|0|||
94573256|NCT03582215|323897687|FG003|Overall Study|Adverse Event|0|||
94573257|NCT03582215|323897688|FG004|Overall Study|Adverse Event|0|||
94573258|NCT03582215|323897689|FG005|Overall Study|Adverse Event|0|||
94573259|NCT03582215|323897690|FG006|Overall Study|Adverse Event|2|||
94573260|NCT03582215|323897691|FG007|Overall Study|Adverse Event|2|||
94573261|NCT03119259|323897696|FG000|Overall Study|Withdrawn as no longer eligible|1|||
94573262|NCT03119259|323897697|FG001|Overall Study|Withdrawn as no longer eligible|0|||
94573263|NCT03119259|323897696|FG000|Overall Study|Withdrawal by Subject|4|||
94573264|NCT03119259|323897697|FG001|Overall Study|Withdrawal by Subject|2|||
94573265|NCT03119259|323897696|FG000|Overall Study|Lost to Follow-up|0|||
94573266|NCT03119259|323897697|FG001|Overall Study|Lost to Follow-up|1|||
94573267|NCT03796728|323897699|FG000|Overall Study|Lost to Follow-up|8|||
94573268|NCT03796728|323897699|FG000|Overall Study|Reason not Specified|16|||
94573269|NCT01791244|323897700|FG000|Overall Study|Adverse Event|5|||
94573270|NCT01791244|323897701|FG001|Overall Study|Adverse Event|7|||
94573271|NCT01791244|323897700|FG000|Overall Study|Insufficient clinical response|10|||
94573272|NCT01791244|323897701|FG001|Overall Study|Insufficient clinical response|10|||
94573273|NCT01791244|323897700|FG000|Overall Study|Laboratory Abnormality|0|||
94573274|NCT01791244|323897701|FG001|Overall Study|Laboratory Abnormality|1|||
94573275|NCT01383928|323897702|FG000|Overall Study|Initiation of ASCT|2|||
94573276|NCT01383928|323897703|FG001|Overall Study|Initiation of ASCT|1|||
94573277|NCT01383928|323897704|FG002|Overall Study|Initiation of ASCT|18|||
94573278|NCT01383928|323897702|FG000|Overall Study|Adverse Event|1|||
94573279|NCT01383928|323897703|FG001|Overall Study|Adverse Event|2|||
94573280|NCT01383928|323897704|FG002|Overall Study|Adverse Event|8|||
94573281|NCT01383928|323897702|FG000|Overall Study|Other|1|||
94573282|NCT01383928|323897703|FG001|Overall Study|Other|3|||
94573283|NCT01383928|323897704|FG002|Overall Study|Other|4|||
94573284|NCT01383928|323897702|FG000|Overall Study|Progressive Disease|1|||
94573285|NCT01383928|323897703|FG001|Overall Study|Progressive Disease|1|||
94573286|NCT01383928|323897704|FG002|Overall Study|Progressive Disease|5|||
94573287|NCT01383928|323897702|FG000|Overall Study|Withdrawal by Subject|0|||
94573288|NCT01383928|323897703|FG001|Overall Study|Withdrawal by Subject|0|||
94573289|NCT01383928|323897704|FG002|Overall Study|Withdrawal by Subject|4|||
94573290|NCT01383928|323897702|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
94573291|NCT01383928|323897703|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
94573292|NCT01383928|323897704|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
94573293|NCT01149096|323897705|FG000|Overall Study|Lost to Follow-up|0|||
94573294|NCT01149096|323897706|FG001|Overall Study|Lost to Follow-up|1|||
94573295|NCT00325897|323897707|FG000|Overall Study|Lost to Follow-up|12|||
94573296|NCT00325897|323897708|FG001|Overall Study|Lost to Follow-up|13|||
94573297|NCT01346358|323897709|FG000|Overall Study|Withdrawal by Subject|1|||
94573298|NCT01346358|323897710|FG001|Overall Study|Withdrawal by Subject|0|||
94573299|NCT01346358|323897711|FG002|Overall Study|Withdrawal by Subject|1|||
94573300|NCT01346358|323897712|FG003|Overall Study|Withdrawal by Subject|1|||
94573301|NCT01346358|323897713|FG004|Overall Study|Withdrawal by Subject|0|||
94573302|NCT01346358|323897714|FG005|Overall Study|Withdrawal by Subject|2|||
94573303|NCT01346358|323897715|FG006|Overall Study|Withdrawal by Subject|1|||
94573304|NCT01346358|323897716|FG007|Overall Study|Withdrawal by Subject|1|||
94573305|NCT01346358|323897717|FG008|Overall Study|Withdrawal by Subject|1|||
94573306|NCT01346358|323897709|FG000|Overall Study|Adverse Event|1|||
94573307|NCT01346358|323897710|FG001|Overall Study|Adverse Event|0|||
94573308|NCT01346358|323897711|FG002|Overall Study|Adverse Event|0|||
94573309|NCT01346358|323897712|FG003|Overall Study|Adverse Event|0|||
94573310|NCT01346358|323897713|FG004|Overall Study|Adverse Event|1|||
94573311|NCT01346358|323897714|FG005|Overall Study|Adverse Event|0|||
94573312|NCT01346358|323897715|FG006|Overall Study|Adverse Event|0|||
94573313|NCT01346358|323897716|FG007|Overall Study|Adverse Event|0|||
94573314|NCT01346358|323897717|FG008|Overall Study|Adverse Event|1|||
94348703|NCT01004861|323058796|FG011|Overall Study|Other|2|||
94573315|NCT01346358|323897709|FG000|Overall Study|Non-Compliance|0|||
94573316|NCT01346358|323897710|FG001|Overall Study|Non-Compliance|0|||
94573317|NCT01346358|323897711|FG002|Overall Study|Non-Compliance|0|||
94573318|NCT01346358|323897712|FG003|Overall Study|Non-Compliance|0|||
94573319|NCT01346358|323897713|FG004|Overall Study|Non-Compliance|0|||
94573320|NCT01346358|323897714|FG005|Overall Study|Non-Compliance|0|||
94573321|NCT01346358|323897715|FG006|Overall Study|Non-Compliance|0|||
94573322|NCT01346358|323897716|FG007|Overall Study|Non-Compliance|2|||
94573323|NCT01346358|323897717|FG008|Overall Study|Non-Compliance|0|||
94573324|NCT01346358|323897709|FG000|Overall Study|Physician Decision|0|||
94573325|NCT01346358|323897710|FG001|Overall Study|Physician Decision|1|||
94573326|NCT01346358|323897711|FG002|Overall Study|Physician Decision|0|||
94573327|NCT01346358|323897712|FG003|Overall Study|Physician Decision|0|||
94573328|NCT01346358|323897713|FG004|Overall Study|Physician Decision|0|||
94573329|NCT01346358|323897714|FG005|Overall Study|Physician Decision|0|||
94573330|NCT01346358|323897715|FG006|Overall Study|Physician Decision|0|||
94573331|NCT01346358|323897716|FG007|Overall Study|Physician Decision|1|||
94573332|NCT01346358|323897717|FG008|Overall Study|Physician Decision|1|||
94573333|NCT02240485|323897718|FG000|3 Months Post-admission|Lost to Follow-up|1|||
94573334|NCT02240485|323897719|FG001|3 Months Post-admission|Lost to Follow-up|5|||
94573335|NCT02240485|323897718|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
94573336|NCT02240485|323897719|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
94573337|NCT02240485|323897718|FG000|9 Months Post-admission|Lost to Follow-up|3|||
94573338|NCT02240485|323897719|FG001|9 Months Post-admission|Lost to Follow-up|1|||
94573339|NCT02240485|323897718|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
94573340|NCT02240485|323897719|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
94573341|NCT02240485|323897718|FG000|18 Months Post-admission|Lost to Follow-up|1|||
94573342|NCT02240485|323897719|FG001|18 Months Post-admission|Lost to Follow-up|1|||
94573343|NCT02240485|323897718|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
94573344|NCT02240485|323897719|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
94573345|NCT00549640|323897720|FG000|Overall Study|Withdrawal by Subject|6|||
94573346|NCT00549640|323897721|FG001|Overall Study|Withdrawal by Subject|12|||
94573347|NCT00549640|323897720|FG000|Overall Study|Adverse Event|5|||
94573348|NCT00549640|323897721|FG001|Overall Study|Adverse Event|0|||
94573349|NCT00549640|323897720|FG000|Overall Study|Lost to Follow-up|7|||
94573350|NCT00549640|323897721|FG001|Overall Study|Lost to Follow-up|4|||
94573351|NCT03261336|323897722|FG000|Overall Study|Adverse Event|1|||
94573352|NCT00537394|323897723|FG000|First Year of Follow-up|Death|7|||
94573353|NCT00537394|323897724|FG001|First Year of Follow-up|Death|0|||
94573354|NCT00537394|323897725|FG002|First Year of Follow-up|Death|0|||
94573355|NCT00537394|323897723|FG000|First Year of Follow-up|Severe debilitation|1|||
94573356|NCT00537394|323897724|FG001|First Year of Follow-up|Severe debilitation|0|||
94573357|NCT00537394|323897725|FG002|First Year of Follow-up|Severe debilitation|1|||
94573358|NCT00537394|323897723|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
94573359|NCT00537394|323897724|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
94573360|NCT00537394|323897725|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
94573361|NCT00537394|323897723|FG000|First Year of Follow-up|Lost to Follow-up|1|||
94658815|NCT01172938|324206185|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
94348704|NCT01004861|323058797|FG012|Overall Study|Other|3|||
94348705|NCT01004861|323058785|FG000|Overall Study|Patient decision|0|||
94348706|NCT01004861|323058786|FG001|Overall Study|Patient decision|0|||
94348707|NCT01004861|323058787|FG002|Overall Study|Patient decision|0|||
94348708|NCT01004861|323058788|FG003|Overall Study|Patient decision|0|||
94348709|NCT01004861|323058789|FG004|Overall Study|Patient decision|1|||
94348710|NCT01004861|323058790|FG005|Overall Study|Patient decision|0|||
94348711|NCT01004861|323058791|FG006|Overall Study|Patient decision|1|||
94573362|NCT00537394|323897724|FG001|First Year of Follow-up|Lost to Follow-up|5|||
94573363|NCT00537394|323897725|FG002|First Year of Follow-up|Lost to Follow-up|1|||
94573364|NCT00537394|323897723|FG000|2nd Year of Follow-up|Death|4|||
94573365|NCT00537394|323897724|FG001|2nd Year of Follow-up|Death|1|||
94573366|NCT00537394|323897725|FG002|2nd Year of Follow-up|Death|2|||
94573367|NCT00537394|323897723|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
94573368|NCT00537394|323897724|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
94573369|NCT00537394|323897725|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
94573370|NCT00537394|323897723|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
94573371|NCT00537394|323897724|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
94573372|NCT00537394|323897725|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
94658816|NCT01172938|324206186|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
94348712|NCT01004861|323058792|FG007|Overall Study|Patient decision|0|||
94348713|NCT01004861|323058793|FG008|Overall Study|Patient decision|7|||
94348714|NCT01004861|323058794|FG009|Overall Study|Patient decision|1|||
94348715|NCT01004861|323058795|FG010|Overall Study|Patient decision|1|||
94348716|NCT01004861|323058796|FG011|Overall Study|Patient decision|2|||
94348717|NCT01004861|323058797|FG012|Overall Study|Patient decision|3|||
94348718|NCT01004861|323058785|FG000|Overall Study|Transitioned to Phase 4 study|0|||
94348719|NCT01004861|323058786|FG001|Overall Study|Transitioned to Phase 4 study|0|||
94573373|NCT00537394|323897723|FG000|2nd Year of Follow-up|Clinic site closure|1|||
94573374|NCT00537394|323897724|FG001|2nd Year of Follow-up|Clinic site closure|0|||
94573375|NCT00537394|323897725|FG002|2nd Year of Follow-up|Clinic site closure|0|||
94573376|NCT03341299|323897728|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
94573377|NCT03341299|323897729|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
94658817|NCT01172938|324206187|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
94573378|NCT03341299|323897730|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
94348720|NCT01004861|323058787|FG002|Overall Study|Transitioned to Phase 4 study|0|||
94348721|NCT01004861|323058788|FG003|Overall Study|Transitioned to Phase 4 study|0|||
94451976|NCT04463251|323441926|FG000|Overall Study|Withdrawal by Subject|0|||
94451977|NCT04463251|323441927|FG001|Overall Study|Withdrawal by Subject|2|||
94238482|NCT04674189|322666640|FG002|Overall Study|Did Not Receive Treatment|2|||
94238483|NCT01564277|322666641|FG000|Overall Study|Protocol Violation|0|||
94238484|NCT01564277|322666642|FG001|Overall Study|Protocol Violation|1|||
94238485|NCT01564277|322666641|FG000|Overall Study|Physician Decision|1|||
94238486|NCT01564277|322666642|FG001|Overall Study|Physician Decision|0|||
94238487|NCT00953615|322666643|FG000|Overall Study|Adverse Event|1|||
94238488|NCT00245960|322666644|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
94238489|NCT00245960|322666645|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
94238490|NCT00245960|322666644|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
94238491|NCT00245960|322666645|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
94238492|NCT00245960|322666644|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
94238493|NCT00245960|322666645|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
94238494|NCT00245960|322666644|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
94451978|NCT04463251|323441928|FG002|Overall Study|Withdrawal by Subject|2|||
94451979|NCT01266291|323441929|FG000|Overall Study|Adverse Event|1|||
94451980|NCT00072280|323441930|FG000|Treatment|Found ineligible|1|||
94451981|NCT00072280|323441931|FG001|Treatment|Found ineligible|2|||
94451982|NCT00072280|323441930|FG000|Follow-up|Early termination of study|2|||
94451983|NCT00072280|323441931|FG001|Follow-up|Early termination of study|2|||
94451984|NCT00550745|323441933|FG000|Overall Study|Death|20|||
94451985|NCT00550745|323441934|FG001|Overall Study|Death|16|||
94451986|NCT00550745|323441933|FG000|Overall Study|Lost to Follow-up|45|||
94451987|NCT00550745|323441934|FG001|Overall Study|Lost to Follow-up|30|||
94451988|NCT00550745|323441933|FG000|Overall Study|Physician Decision|0|||
94451989|NCT00550745|323441934|FG001|Overall Study|Physician Decision|2|||
94451990|NCT00550745|323441933|FG000|Overall Study|Protocol Violation|4|||
94451991|NCT00550745|323441934|FG001|Overall Study|Protocol Violation|2|||
94451992|NCT00550745|323441933|FG000|Overall Study|Withdrawal by Subject|17|||
94451993|NCT00550745|323441934|FG001|Overall Study|Withdrawal by Subject|10|||
94451994|NCT00550745|323441933|FG000|Overall Study|Screen failure|1|||
94451995|NCT00550745|323441934|FG001|Overall Study|Screen failure|0|||
94451996|NCT00596687|323443617|FG000|Overall Study|< 24 hours of insulin treatment|8|||
94451997|NCT00596687|323443618|FG001|Overall Study|< 24 hours of insulin treatment|6|||
94451998|NCT00596687|323443617|FG000|Overall Study|continuous insulin infusion during TPN|2|||
94451999|NCT00596687|323443618|FG001|Overall Study|continuous insulin infusion during TPN|1|||
94452000|NCT00596687|323443617|FG000|Overall Study|Withdrawal by Subject|3|||
94452001|NCT00596687|323443618|FG001|Overall Study|Withdrawal by Subject|1|||
94452002|NCT00596687|323443617|FG000|Overall Study|cancelled surgery|1|||
94452003|NCT00596687|323443618|FG001|Overall Study|cancelled surgery|1|||
94452004|NCT03625466|323443619|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
94452005|NCT03625466|323443620|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
94452006|NCT03625466|323443621|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
94452007|NCT03625466|323443619|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
94452008|NCT03625466|323443620|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
94452009|NCT03625466|323443621|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
94452010|NCT03625466|323443619|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
94452011|NCT03625466|323443620|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
94452012|NCT03625466|323443621|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
94452013|NCT03491462|323443629|FG000|Overall Study|Lost to Follow-up|2|||
94452014|NCT03491462|323443630|FG001|Overall Study|Lost to Follow-up|0|||
94452015|NCT03491462|323443629|FG000|Overall Study|Adverse Event|11|||
94452016|NCT03491462|323443630|FG001|Overall Study|Adverse Event|1|||
94452017|NCT03491462|323443629|FG000|Overall Study|Physician Decision|3|||
94452018|NCT03491462|323443630|FG001|Overall Study|Physician Decision|0|||
94452019|NCT03491462|323443629|FG000|Overall Study|Withdrawal by Subject|22|||
94452020|NCT03491462|323443630|FG001|Overall Study|Withdrawal by Subject|15|||
94452021|NCT03850496|323443635|FG000|Overall Study|Withdrawal by Subject|1|||
94452022|NCT03850496|323443636|FG001|Overall Study|Withdrawal by Subject|0|||
94452023|NCT03850496|323443637|FG002|Overall Study|Withdrawal by Subject|0|||
94238495|NCT00245960|322666645|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
94238496|NCT00245960|322666644|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
94238497|NCT00245960|322666645|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
94452024|NCT03850496|323443635|FG000|Overall Study|Lost to Follow-up|0|||
94238498|NCT00245960|322666644|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
94452025|NCT03850496|323443636|FG001|Overall Study|Lost to Follow-up|1|||
94452026|NCT03850496|323443637|FG002|Overall Study|Lost to Follow-up|4|||
94452027|NCT02875613|323443650|FG000|Overall Study|Withdrawal by Subject|1|||
94452028|NCT02875613|323443650|FG000|Overall Study|Screen Failure|1|||
94452029|NCT00758485|323443651|FG000|Overall Study|Lost to Follow-up|0|||
94452030|NCT00758485|323443652|FG001|Overall Study|Lost to Follow-up|1|||
94452031|NCT00758485|323443651|FG000|Overall Study|Not Treated|1|||
94452032|NCT00758485|323443652|FG001|Overall Study|Not Treated|2|||
94573379|NCT03341299|323897731|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
94573380|NCT03221556|323897733|FG000|Allocation|post-randomization exclusion|0|||
94573381|NCT03221556|323897734|FG001|Allocation|post-randomization exclusion|1|||
94573382|NCT03221556|323897733|FG000|Follow-Up|Withdrawal by Subject|0|||
94573383|NCT03221556|323897734|FG001|Follow-Up|Withdrawal by Subject|1|||
94573384|NCT05064735|323897735|FG000|Overall Study|Withdrawal by Subject|7|||
94573385|NCT05064735|323897736|FG001|Overall Study|Withdrawal by Subject|8|||
94573386|NCT05064735|323897735|FG000|Overall Study|Lost to Follow-up|7|||
94573387|NCT05064735|323897736|FG001|Overall Study|Lost to Follow-up|2|||
94573388|NCT05064735|323897735|FG000|Overall Study|Physician Decision|2|||
94573389|NCT05064735|323897736|FG001|Overall Study|Physician Decision|1|||
94573390|NCT05064735|323897735|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
94573391|NCT05064735|323897736|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
94573392|NCT05064735|323897735|FG000|Overall Study|Site Closure|7|||
94573393|NCT05064735|323897736|FG001|Overall Study|Site Closure|2|||
94573394|NCT02234843|323897738|FG000|Overall Study|Death|1|||
94573395|NCT02234843|323897739|FG001|Overall Study|Death|0|||
94573396|NCT02234843|323897740|FG002|Overall Study|Death|0|||
94573397|NCT02234843|323897741|FG003|Overall Study|Death|0|||
94573398|NCT02234843|323897742|FG004|Overall Study|Death|0|||
94573399|NCT02234843|323897743|FG005|Overall Study|Death|0|||
94573400|NCT02234843|323897744|FG006|Overall Study|Death|0|||
94573401|NCT02234843|323897745|FG007|Overall Study|Death|0|||
94573402|NCT02234843|323897746|FG008|Overall Study|Death|0|||
94573403|NCT02234843|323897747|FG009|Overall Study|Death|0|||
94573404|NCT02234843|323897738|FG000|Overall Study|Protocol Violation|1|||
94573405|NCT02234843|323897739|FG001|Overall Study|Protocol Violation|0|||
94573406|NCT02234843|323897740|FG002|Overall Study|Protocol Violation|1|||
94573407|NCT02234843|323897741|FG003|Overall Study|Protocol Violation|0|||
94573408|NCT02234843|323897742|FG004|Overall Study|Protocol Violation|0|||
94573409|NCT02234843|323897743|FG005|Overall Study|Protocol Violation|0|||
94573410|NCT02234843|323897744|FG006|Overall Study|Protocol Violation|0|||
94573411|NCT02234843|323897745|FG007|Overall Study|Protocol Violation|0|||
94573412|NCT02234843|323897746|FG008|Overall Study|Protocol Violation|0|||
94573413|NCT02234843|323897747|FG009|Overall Study|Protocol Violation|0|||
94573414|NCT02234843|323897738|FG000|Overall Study|Efficacy outcome reached|2|||
94573415|NCT02234843|323897739|FG001|Overall Study|Efficacy outcome reached|0|||
94573416|NCT02234843|323897740|FG002|Overall Study|Efficacy outcome reached|0|||
94573417|NCT02234843|323897741|FG003|Overall Study|Efficacy outcome reached|0|||
94573418|NCT02234843|323897742|FG004|Overall Study|Efficacy outcome reached|0|||
94573419|NCT02234843|323897743|FG005|Overall Study|Efficacy outcome reached|2|||
94573420|NCT02234843|323897744|FG006|Overall Study|Efficacy outcome reached|0|||
94573421|NCT02234843|323897745|FG007|Overall Study|Efficacy outcome reached|0|||
94573422|NCT02234843|323897746|FG008|Overall Study|Efficacy outcome reached|0|||
94573423|NCT02234843|323897747|FG009|Overall Study|Efficacy outcome reached|0|||
94573424|NCT02234843|323897738|FG000|Overall Study|Patient convenience|2|||
94573425|NCT02234843|323897739|FG001|Overall Study|Patient convenience|0|||
94573426|NCT02234843|323897740|FG002|Overall Study|Patient convenience|0|||
94573427|NCT02234843|323897741|FG003|Overall Study|Patient convenience|0|||
94573428|NCT02234843|323897742|FG004|Overall Study|Patient convenience|0|||
94573429|NCT02234843|323897743|FG005|Overall Study|Patient convenience|1|||
94573430|NCT02234843|323897744|FG006|Overall Study|Patient convenience|0|||
94573431|NCT02234843|323897745|FG007|Overall Study|Patient convenience|0|||
94573432|NCT02234843|323897746|FG008|Overall Study|Patient convenience|0|||
94573433|NCT02234843|323897747|FG009|Overall Study|Patient convenience|0|||
94573434|NCT02234843|323897738|FG000|Overall Study|Withdrawal by Subject|5|||
94348722|NCT01004861|323058789|FG004|Overall Study|Transitioned to Phase 4 study|0|||
94573435|NCT02234843|323897739|FG001|Overall Study|Withdrawal by Subject|1|||
94573436|NCT02234843|323897740|FG002|Overall Study|Withdrawal by Subject|1|||
94573437|NCT02234843|323897741|FG003|Overall Study|Withdrawal by Subject|0|||
94348723|NCT01004861|323058790|FG005|Overall Study|Transitioned to Phase 4 study|0|||
94348724|NCT01004861|323058791|FG006|Overall Study|Transitioned to Phase 4 study|0|||
94348725|NCT01004861|323058792|FG007|Overall Study|Transitioned to Phase 4 study|0|||
94348726|NCT01004861|323058793|FG008|Overall Study|Transitioned to Phase 4 study|2|||
94573438|NCT02234843|323897742|FG004|Overall Study|Withdrawal by Subject|0|||
94348727|NCT01004861|323058794|FG009|Overall Study|Transitioned to Phase 4 study|0|||
94348728|NCT01004861|323058795|FG010|Overall Study|Transitioned to Phase 4 study|0|||
94573439|NCT02234843|323897743|FG005|Overall Study|Withdrawal by Subject|7|||
94573440|NCT02234843|323897744|FG006|Overall Study|Withdrawal by Subject|0|||
94573441|NCT02234843|323897745|FG007|Overall Study|Withdrawal by Subject|0|||
94573442|NCT02234843|323897746|FG008|Overall Study|Withdrawal by Subject|0|||
94573443|NCT02234843|323897747|FG009|Overall Study|Withdrawal by Subject|0|||
94573444|NCT02234843|323897738|FG000|Overall Study|Recovery|1|||
94573445|NCT02234843|323897739|FG001|Overall Study|Recovery|0|||
94573446|NCT02234843|323897740|FG002|Overall Study|Recovery|0|||
94573447|NCT02234843|323897741|FG003|Overall Study|Recovery|0|||
94573448|NCT02234843|323897742|FG004|Overall Study|Recovery|0|||
94573449|NCT02234843|323897743|FG005|Overall Study|Recovery|0|||
94573450|NCT02234843|323897744|FG006|Overall Study|Recovery|0|||
94452033|NCT01136356|323443653|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
94452034|NCT01136356|323443654|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
94452035|NCT01136356|323443653|FG000|First 18-day Withdrawal|Physician Decision|1|||
94452036|NCT01136356|323443654|FG001|First 18-day Withdrawal|Physician Decision|0|||
94452037|NCT01136356|323443653|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
94452038|NCT01136356|323443654|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
94452039|NCT02564900|323443657|FG000|Dose Escalation|Progressive disease per RECIST|2|||
94452040|NCT02564900|323443658|FG001|Dose Escalation|Progressive disease per RECIST|3|||
94452041|NCT02564900|323443659|FG002|Dose Escalation|Progressive disease per RECIST|3|||
94452042|NCT02564900|323443660|FG003|Dose Escalation|Progressive disease per RECIST|3|||
94452043|NCT02564900|323443661|FG004|Dose Escalation|Progressive disease per RECIST|3|||
94452044|NCT02564900|323443662|FG005|Dose Escalation|Progressive disease per RECIST|1|||
94452045|NCT02564900|323443663|FG006|Dose Escalation|Progressive disease per RECIST|0|||
94452046|NCT02564900|323443664|FG007|Dose Escalation|Progressive disease per RECIST|0|||
94452047|NCT02564900|323443665|FG008|Dose Escalation|Progressive disease per RECIST|0|||
94452048|NCT02564900|323443666|FG009|Dose Escalation|Progressive disease per RECIST|0|||
94452049|NCT02564900|323443667|FG010|Dose Escalation|Progressive disease per RECIST|0|||
94452050|NCT02564900|323443668|FG011|Dose Escalation|Progressive disease per RECIST|0|||
94452051|NCT02564900|323443669|FG012|Dose Escalation|Progressive disease per RECIST|0|||
94452052|NCT02564900|323443670|FG013|Dose Escalation|Progressive disease per RECIST|0|||
94452053|NCT02564900|323443671|FG014|Dose Escalation|Progressive disease per RECIST|0|||
94452054|NCT02564900|323443657|FG000|Dose Escalation|Ongoing|1|||
94452055|NCT02564900|323443658|FG001|Dose Escalation|Ongoing|0|||
94452056|NCT02564900|323443659|FG002|Dose Escalation|Ongoing|0|||
94452057|NCT02564900|323443660|FG003|Dose Escalation|Ongoing|2|||
94452058|NCT02564900|323443661|FG004|Dose Escalation|Ongoing|2|||
94452059|NCT02564900|323443662|FG005|Dose Escalation|Ongoing|2|||
94452060|NCT02564900|323443663|FG006|Dose Escalation|Ongoing|0|||
94452061|NCT02564900|323443664|FG007|Dose Escalation|Ongoing|0|||
94452062|NCT02564900|323443665|FG008|Dose Escalation|Ongoing|0|||
94452063|NCT02564900|323443666|FG009|Dose Escalation|Ongoing|0|||
94452064|NCT02564900|323443667|FG010|Dose Escalation|Ongoing|0|||
94452065|NCT02564900|323443668|FG011|Dose Escalation|Ongoing|0|||
94452066|NCT02564900|323443669|FG012|Dose Escalation|Ongoing|0|||
94452067|NCT02564900|323443670|FG013|Dose Escalation|Ongoing|0|||
94452068|NCT02564900|323443671|FG014|Dose Escalation|Ongoing|0|||
94452069|NCT02564900|323443657|FG000|Dose Escalation|Adverse Event|0|||
94452070|NCT02564900|323443658|FG001|Dose Escalation|Adverse Event|0|||
94452071|NCT02564900|323443659|FG002|Dose Escalation|Adverse Event|0|||
94452072|NCT02564900|323443660|FG003|Dose Escalation|Adverse Event|1|||
94452073|NCT02564900|323443661|FG004|Dose Escalation|Adverse Event|1|||
94452074|NCT02564900|323443662|FG005|Dose Escalation|Adverse Event|3|||
94452075|NCT02564900|323443663|FG006|Dose Escalation|Adverse Event|0|||
94452076|NCT02564900|323443664|FG007|Dose Escalation|Adverse Event|0|||
94452077|NCT02564900|323443665|FG008|Dose Escalation|Adverse Event|0|||
94452078|NCT02564900|323443666|FG009|Dose Escalation|Adverse Event|0|||
94452079|NCT02564900|323443667|FG010|Dose Escalation|Adverse Event|0|||
94452080|NCT02564900|323443668|FG011|Dose Escalation|Adverse Event|0|||
94452081|NCT02564900|323443669|FG012|Dose Escalation|Adverse Event|0|||
94452082|NCT02564900|323443670|FG013|Dose Escalation|Adverse Event|0|||
94452083|NCT02564900|323443671|FG014|Dose Escalation|Adverse Event|0|||
94452084|NCT02564900|323443657|FG000|Dose Expansion|Progressive disease per RECIST|0|||
94452085|NCT02564900|323443658|FG001|Dose Expansion|Progressive disease per RECIST|0|||
94452086|NCT02564900|323443659|FG002|Dose Expansion|Progressive disease per RECIST|0|||
94452087|NCT02564900|323443660|FG003|Dose Expansion|Progressive disease per RECIST|0|||
94452088|NCT02564900|323443661|FG004|Dose Expansion|Progressive disease per RECIST|0|||
94452089|NCT02564900|323443662|FG005|Dose Expansion|Progressive disease per RECIST|0|||
94452090|NCT02564900|323443663|FG006|Dose Expansion|Progressive disease per RECIST|19|||
94452091|NCT02564900|323443664|FG007|Dose Expansion|Progressive disease per RECIST|17|||
94452092|NCT02564900|323443665|FG008|Dose Expansion|Progressive disease per RECIST|8|||
94452093|NCT02564900|323443666|FG009|Dose Expansion|Progressive disease per RECIST|16|||
94452094|NCT02564900|323443667|FG010|Dose Expansion|Progressive disease per RECIST|13|||
94452095|NCT02564900|323443668|FG011|Dose Expansion|Progressive disease per RECIST|19|||
94452096|NCT02564900|323443669|FG012|Dose Expansion|Progressive disease per RECIST|10|||
94452097|NCT02564900|323443670|FG013|Dose Expansion|Progressive disease per RECIST|13|||
94452098|NCT02564900|323443671|FG014|Dose Expansion|Progressive disease per RECIST|11|||
94452099|NCT02564900|323443657|FG000|Dose Expansion|Clinical progression|0|||
94452100|NCT02564900|323443658|FG001|Dose Expansion|Clinical progression|0|||
94452101|NCT02564900|323443659|FG002|Dose Expansion|Clinical progression|0|||
94452102|NCT02564900|323443660|FG003|Dose Expansion|Clinical progression|0|||
94573451|NCT02234843|323897745|FG007|Overall Study|Recovery|0|||
94573452|NCT02234843|323897746|FG008|Overall Study|Recovery|0|||
94573453|NCT02234843|323897747|FG009|Overall Study|Recovery|0|||
94573454|NCT02234843|323897738|FG000|Overall Study|Other|0|||
94573455|NCT02234843|323897739|FG001|Overall Study|Other|2|||
94573456|NCT02234843|323897740|FG002|Overall Study|Other|0|||
94573457|NCT02234843|323897741|FG003|Overall Study|Other|1|||
94573458|NCT02234843|323897742|FG004|Overall Study|Other|0|||
94573459|NCT02234843|323897743|FG005|Overall Study|Other|1|||
94573460|NCT02234843|323897744|FG006|Overall Study|Other|0|||
94573461|NCT02234843|323897745|FG007|Overall Study|Other|1|||
94573462|NCT02234843|323897746|FG008|Overall Study|Other|0|||
94573463|NCT02234843|323897747|FG009|Overall Study|Other|0|||
94573464|NCT02234843|323897738|FG000|Overall Study|Physician Decision|4|||
94573465|NCT02234843|323897739|FG001|Overall Study|Physician Decision|1|||
94573466|NCT02234843|323897740|FG002|Overall Study|Physician Decision|0|||
94573467|NCT02234843|323897741|FG003|Overall Study|Physician Decision|1|||
94573468|NCT02234843|323897742|FG004|Overall Study|Physician Decision|0|||
94573469|NCT02234843|323897743|FG005|Overall Study|Physician Decision|0|||
94573470|NCT02234843|323897744|FG006|Overall Study|Physician Decision|0|||
94573471|NCT02234843|323897745|FG007|Overall Study|Physician Decision|1|||
94348729|NCT01004861|323058796|FG011|Overall Study|Transitioned to Phase 4 study|0|||
94348730|NCT01004861|323058797|FG012|Overall Study|Transitioned to Phase 4 study|0|||
94348731|NCT01004861|323058785|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
94573472|NCT02234843|323897746|FG008|Overall Study|Physician Decision|0|||
94348732|NCT01004861|323058786|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
94348733|NCT01004861|323058787|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
94348734|NCT01004861|323058788|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
94348735|NCT01004861|323058789|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
94348736|NCT01004861|323058790|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
94348737|NCT01004861|323058791|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
94348738|NCT01004861|323058792|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
94348739|NCT01004861|323058793|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
94348740|NCT01004861|323058794|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
94348741|NCT01004861|323058795|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
94348742|NCT01004861|323058796|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
94348743|NCT01004861|323058797|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
94348744|NCT01004861|323058785|FG000|Overall Study|Patient withdrew|0|||
94348745|NCT01004861|323058786|FG001|Overall Study|Patient withdrew|0|||
94348746|NCT01004861|323058787|FG002|Overall Study|Patient withdrew|0|||
94348747|NCT01004861|323058788|FG003|Overall Study|Patient withdrew|0|||
94348748|NCT01004861|323058789|FG004|Overall Study|Patient withdrew|0|||
94348749|NCT01004861|323058790|FG005|Overall Study|Patient withdrew|0|||
94348750|NCT01004861|323058791|FG006|Overall Study|Patient withdrew|0|||
94348751|NCT01004861|323058792|FG007|Overall Study|Patient withdrew|0|||
94348752|NCT01004861|323058793|FG008|Overall Study|Patient withdrew|1|||
94348753|NCT01004861|323058794|FG009|Overall Study|Patient withdrew|0|||
94348754|NCT01004861|323058795|FG010|Overall Study|Patient withdrew|0|||
94348755|NCT01004861|323058796|FG011|Overall Study|Patient withdrew|0|||
94348756|NCT01004861|323058797|FG012|Overall Study|Patient withdrew|0|||
94348757|NCT01004861|323058785|FG000|Overall Study|Surgical resection|0|||
94348758|NCT01004861|323058786|FG001|Overall Study|Surgical resection|0|||
94348759|NCT01004861|323058787|FG002|Overall Study|Surgical resection|0|||
94348760|NCT01004861|323058788|FG003|Overall Study|Surgical resection|0|||
94348761|NCT01004861|323058789|FG004|Overall Study|Surgical resection|0|||
94348762|NCT01004861|323058790|FG005|Overall Study|Surgical resection|0|||
94348763|NCT01004861|323058791|FG006|Overall Study|Surgical resection|0|||
94348764|NCT01004861|323058792|FG007|Overall Study|Surgical resection|0|||
94348765|NCT01004861|323058793|FG008|Overall Study|Surgical resection|1|||
94348766|NCT01004861|323058794|FG009|Overall Study|Surgical resection|0|||
94348767|NCT01004861|323058795|FG010|Overall Study|Surgical resection|0|||
94348768|NCT01004861|323058796|FG011|Overall Study|Surgical resection|0|||
94348769|NCT01004861|323058797|FG012|Overall Study|Surgical resection|0|||
94348770|NCT01004861|323058785|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
94348771|NCT01004861|323058786|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
94348772|NCT01004861|323058787|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
94348773|NCT01004861|323058788|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
94348774|NCT01004861|323058789|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
94365656|NCT01788163|323124743|FG004|Overall Study|Withdrawal by Subject|0|||
94573473|NCT02234843|323897747|FG009|Overall Study|Physician Decision|0|||
94573474|NCT02234843|323897738|FG000|Overall Study|Adverse Event|5|||
94573475|NCT02234843|323897739|FG001|Overall Study|Adverse Event|1|||
94573476|NCT02234843|323897740|FG002|Overall Study|Adverse Event|1|||
94573477|NCT02234843|323897741|FG003|Overall Study|Adverse Event|3|||
94573478|NCT02234843|323897742|FG004|Overall Study|Adverse Event|2|||
94573479|NCT02234843|323897743|FG005|Overall Study|Adverse Event|1|||
94573480|NCT02234843|323897744|FG006|Overall Study|Adverse Event|0|||
94573481|NCT02234843|323897745|FG007|Overall Study|Adverse Event|0|||
94573482|NCT02234843|323897746|FG008|Overall Study|Adverse Event|1|||
94573483|NCT02234843|323897747|FG009|Overall Study|Adverse Event|0|||
94573484|NCT02234843|323897738|FG000|Overall Study|Non-compliance with study drug|1|||
94573485|NCT02234843|323897739|FG001|Overall Study|Non-compliance with study drug|0|||
94573486|NCT02234843|323897740|FG002|Overall Study|Non-compliance with study drug|0|||
94573487|NCT02234843|323897741|FG003|Overall Study|Non-compliance with study drug|0|||
94573488|NCT02234843|323897742|FG004|Overall Study|Non-compliance with study drug|0|||
94573489|NCT02234843|323897743|FG005|Overall Study|Non-compliance with study drug|1|||
94573490|NCT02234843|323897744|FG006|Overall Study|Non-compliance with study drug|1|||
94573491|NCT02234843|323897745|FG007|Overall Study|Non-compliance with study drug|0|||
94573492|NCT02234843|323897746|FG008|Overall Study|Non-compliance with study drug|0|||
94573493|NCT02234843|323897747|FG009|Overall Study|Non-compliance with study drug|0|||
94573494|NCT02234843|323897738|FG000|Overall Study|Lost to Follow-up|0|||
94573495|NCT02234843|323897739|FG001|Overall Study|Lost to Follow-up|1|||
94573496|NCT02234843|323897740|FG002|Overall Study|Lost to Follow-up|0|||
94573497|NCT02234843|323897741|FG003|Overall Study|Lost to Follow-up|0|||
94573498|NCT02234843|323897742|FG004|Overall Study|Lost to Follow-up|0|||
94573499|NCT02234843|323897743|FG005|Overall Study|Lost to Follow-up|0|||
94573500|NCT02234843|323897744|FG006|Overall Study|Lost to Follow-up|1|||
94573501|NCT02234843|323897745|FG007|Overall Study|Lost to Follow-up|0|||
94573502|NCT02234843|323897746|FG008|Overall Study|Lost to Follow-up|0|||
94573503|NCT02234843|323897747|FG009|Overall Study|Lost to Follow-up|0|||
94573504|NCT03919773|323897756|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
94573505|NCT03919773|323897757|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
94573506|NCT03919773|323897756|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
94573507|NCT03919773|323897757|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
94573508|NCT00668148|323897759|FG000|Overall Study|Adverse Event|5|||
94573509|NCT00668148|323897759|FG000|Overall Study|Subject Non-compliance|1|||
94573510|NCT00668148|323897759|FG000|Overall Study|Progressive Disease Before Treatment|2|||
94573511|NCT00668148|323897759|FG000|Overall Study|Withdrawal of Consent|2|||
94573512|NCT05472090|323897760|FG000|Overall Study|Adverse Event|2|||
94348775|NCT01004861|323058790|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
94573513|NCT05472090|323897761|FG001|Overall Study|Adverse Event|3|||
94573514|NCT05472090|323897760|FG000|Overall Study|Lack of Efficacy|1|||
94573515|NCT05472090|323897761|FG001|Overall Study|Lack of Efficacy|0|||
94573516|NCT05472090|323897760|FG000|Overall Study|Physician Decision|1|||
94573517|NCT05472090|323897761|FG001|Overall Study|Physician Decision|0|||
94573518|NCT05472090|323897760|FG000|Overall Study|Withdrawal by Subject|2|||
94573519|NCT05472090|323897761|FG001|Overall Study|Withdrawal by Subject|0|||
94573520|NCT05472090|323897760|FG000|Overall Study|Lost to Follow-up|0|||
94348776|NCT01004861|323058791|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
94348777|NCT01004861|323058792|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
94348778|NCT01004861|323058793|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
94348779|NCT01004861|323058794|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
94573521|NCT05472090|323897761|FG001|Overall Study|Lost to Follow-up|3|||
94573522|NCT03253393|323897762|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
94573523|NCT03253393|323897763|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
94573524|NCT03253393|323897764|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
94573525|NCT01602224|323899955|FG000|Overall Study|Adverse Event|0|||
94573526|NCT01602224|323899956|FG001|Overall Study|Adverse Event|1|||
94573527|NCT01602224|323899957|FG002|Overall Study|Adverse Event|0|||
94573528|NCT01602224|323899955|FG000|Overall Study|Investigator Decison|1|||
94573529|NCT01602224|323899956|FG001|Overall Study|Investigator Decison|0|||
94348780|NCT01004861|323058795|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
94348781|NCT01004861|323058796|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
94573530|NCT01602224|323899957|FG002|Overall Study|Investigator Decison|0|||
94573531|NCT01602224|323899955|FG000|Overall Study|Lost to Follow-up|0|||
94573532|NCT01602224|323899956|FG001|Overall Study|Lost to Follow-up|0|||
94573533|NCT01602224|323899957|FG002|Overall Study|Lost to Follow-up|1|||
94573534|NCT01602224|323899955|FG000|Overall Study|Protocol Violation|0|||
94573535|NCT01602224|323899956|FG001|Overall Study|Protocol Violation|1|||
94573536|NCT01602224|323899957|FG002|Overall Study|Protocol Violation|0|||
94573537|NCT01602224|323899955|FG000|Overall Study|Sponsor Decision|2|||
94573538|NCT01602224|323899956|FG001|Overall Study|Sponsor Decision|3|||
94573539|NCT01602224|323899957|FG002|Overall Study|Sponsor Decision|2|||
94573540|NCT01602224|323899955|FG000|Overall Study|Withdrawal by Subject|5|||
94573541|NCT01602224|323899956|FG001|Overall Study|Withdrawal by Subject|3|||
94573542|NCT01602224|323899957|FG002|Overall Study|Withdrawal by Subject|3|||
94573543|NCT01352117|323899958|FG000|Overall Study|Death|15|||
94573544|NCT01352117|323899959|FG001|Overall Study|Death|16|||
94573545|NCT01352117|323899958|FG000|Overall Study|Withdrawal by Subject|1|||
94573546|NCT01352117|323899959|FG001|Overall Study|Withdrawal by Subject|0|||
94573547|NCT01352117|323899958|FG000|Overall Study|Lost to Follow-up|2|||
94573548|NCT01352117|323899959|FG001|Overall Study|Lost to Follow-up|7|||
94573549|NCT01352117|323899958|FG000|Overall Study|Non-adherent to study requirements|1|||
94573550|NCT01352117|323899959|FG001|Overall Study|Non-adherent to study requirements|1|||
94573551|NCT01352117|323899958|FG000|Overall Study|Did not initiate study treatment|1|||
94573552|NCT01352117|323899959|FG001|Overall Study|Did not initiate study treatment|0|||
94573553|NCT01352117|323899958|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
94573554|NCT01352117|323899959|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
94573555|NCT00633477|323899960|FG000|Overall Study|Death|1|||
94573556|NCT00633477|323899961|FG001|Overall Study|Death|0|||
94573557|NCT00633477|323899960|FG000|Overall Study|Randomized but not treated|1|||
94573558|NCT00633477|323899961|FG001|Overall Study|Randomized but not treated|0|||
94573559|NCT01766050|323899962|FG000|Overall Study|Adverse Event|1|||
94573560|NCT01766050|323899962|FG000|Overall Study|Lost to Follow-up|1|||
94573561|NCT01766050|323899962|FG000|Overall Study|Withdrawal by Subject|2|||
94573562|NCT00179621|323899963|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
94573563|NCT00179621|323899964|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
94573564|NCT00179621|323899965|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
94573565|NCT00179621|323899966|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
94573566|NCT00179621|323899963|FG000|Double-Blind Period|Adverse Event|2|||
94573567|NCT00179621|323899964|FG001|Double-Blind Period|Adverse Event|7|||
94573568|NCT00179621|323899965|FG002|Double-Blind Period|Adverse Event|4|||
94573569|NCT00179621|323899966|FG003|Double-Blind Period|Adverse Event|0|||
94573570|NCT00179621|323899963|FG000|Double-Blind Period|Withdrawal by Subject|2|||
94573571|NCT00179621|323899964|FG001|Double-Blind Period|Withdrawal by Subject|1|||
94573572|NCT00179621|323899965|FG002|Double-Blind Period|Withdrawal by Subject|3|||
94573573|NCT00179621|323899966|FG003|Double-Blind Period|Withdrawal by Subject|0|||
94573574|NCT00179621|323899963|FG000|Double-Blind Period|Death|0|||
94573575|NCT00179621|323899964|FG001|Double-Blind Period|Death|1|||
94573576|NCT00179621|323899965|FG002|Double-Blind Period|Death|2|||
94573577|NCT00179621|323899966|FG003|Double-Blind Period|Death|0|||
94573578|NCT00179621|323899963|FG000|Double-Blind Period|Protocol Violation|1|||
94573579|NCT00179621|323899964|FG001|Double-Blind Period|Protocol Violation|0|||
94573580|NCT00179621|323899965|FG002|Double-Blind Period|Protocol Violation|0|||
94573581|NCT00179621|323899966|FG003|Double-Blind Period|Protocol Violation|0|||
94573582|NCT00179621|323899963|FG000|Double-Blind Period|Other|0|||
94573583|NCT00179621|323899964|FG001|Double-Blind Period|Other|2|||
94573584|NCT00179621|323899965|FG002|Double-Blind Period|Other|2|||
94573585|NCT00179621|323899966|FG003|Double-Blind Period|Other|0|||
94573586|NCT00179621|323899963|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
94573587|NCT00179621|323899964|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
94573588|NCT00179621|323899965|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
94573589|NCT00179621|323899966|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
94573590|NCT00179621|323899963|FG000|Open-Label Period|Adverse Event|0|||
94573591|NCT00179621|323899964|FG001|Open-Label Period|Adverse Event|6|||
94573592|NCT00179621|323899965|FG002|Open-Label Period|Adverse Event|5|||
94573593|NCT00179621|323899966|FG003|Open-Label Period|Adverse Event|6|||
94573594|NCT00179621|323899963|FG000|Open-Label Period|Withdrawal by Subject|0|||
94573595|NCT00179621|323899964|FG001|Open-Label Period|Withdrawal by Subject|2|||
94573596|NCT00179621|323899965|FG002|Open-Label Period|Withdrawal by Subject|2|||
94573597|NCT00179621|323899966|FG003|Open-Label Period|Withdrawal by Subject|2|||
94658818|NCT01172938|324206188|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
94238499|NCT00245960|322666645|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
94238500|NCT00245960|322666644|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
94238501|NCT00245960|322666645|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
94238502|NCT00245960|322666644|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
94238503|NCT00245960|322666645|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
94238504|NCT00245960|322666644|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
94238505|NCT00245960|322666645|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
94573598|NCT00179621|323899963|FG000|Open-Label Period|Death|0|||
94573599|NCT00179621|323899964|FG001|Open-Label Period|Death|0|||
94573600|NCT00179621|323899965|FG002|Open-Label Period|Death|1|||
94573601|NCT00179621|323899966|FG003|Open-Label Period|Death|2|||
94573602|NCT00179621|323899963|FG000|Open-Label Period|Other|0|||
94573603|NCT00179621|323899964|FG001|Open-Label Period|Other|1|||
94573604|NCT00179621|323899965|FG002|Open-Label Period|Other|1|||
94573605|NCT00179621|323899966|FG003|Open-Label Period|Other|2|||
94573606|NCT02426580|323899969|FG000|Overall Study|Death|2|||
94573607|NCT02426580|323899970|FG001|Overall Study|Death|2|||
94573608|NCT02426580|323899969|FG000|Overall Study|Lost to Follow-up|0|||
94573609|NCT02426580|323899970|FG001|Overall Study|Lost to Follow-up|9|||
94573610|NCT02426580|323899969|FG000|Overall Study|transfer to hemodialysis|5|||
94573611|NCT02426580|323899970|FG001|Overall Study|transfer to hemodialysis|5|||
94573612|NCT02426580|323899969|FG000|Overall Study|Kidney transplant|3|||
94573613|NCT02426580|323899970|FG001|Overall Study|Kidney transplant|0|||
94573614|NCT02426580|323899969|FG000|Overall Study|Allergic to egg white|1|||
94573615|NCT02426580|323899970|FG001|Overall Study|Allergic to egg white|0|||
94573616|NCT04235140|323899976|FG000|Overall Study|Adverse Event|2|||
94573617|NCT04235140|323899976|FG000|Overall Study|Lost to Follow-up|1|||
94573618|NCT04235140|323899976|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
94573619|NCT04235140|323899976|FG000|Overall Study|Commercial drug is available for participants|7|||
94573620|NCT04890652|323899984|FG000|Overall Study|Withdrawal by Subject|2|||
94573621|NCT02953652|323899985|FG000|Overall Study|Adverse Event|18|||
94573622|NCT02953652|323899985|FG000|Overall Study|Withdrawal by Subject|6|||
94573623|NCT02953652|323899985|FG000|Overall Study|Protocol Violation|1|||
94573624|NCT02953652|323899985|FG000|Overall Study|Disease Progression|27|||
94573625|NCT00074711|323899992|FG000|Overall Study|Withdrawal by Subject|1|||
94573626|NCT00074711|323899993|FG001|Overall Study|Withdrawal by Subject|1|||
94573627|NCT00074711|323899992|FG000|Overall Study|Lost to Follow-up|10|||
94573628|NCT00074711|323899993|FG001|Overall Study|Lost to Follow-up|8|||
94573629|NCT00074711|323899992|FG000|Overall Study|Participant stopped study drug|4|||
94573630|NCT00074711|323899993|FG001|Overall Study|Participant stopped study drug|6|||
94573631|NCT00614575|323899995|FG000|Overall Study|Adverse Event|106|||
94573632|NCT00614575|323899995|FG000|Overall Study|Lost to Follow-up|55|||
94238506|NCT00245960|322666644|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
94238507|NCT00245960|322666645|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
94238508|NCT00245960|322666644|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
94238509|NCT00245960|322666645|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
94238510|NCT00245960|322666644|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
94238511|NCT00245960|322666645|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
94238512|NCT00475228|322666646|FG000|Overall Study|Lost to Follow-up|17|||
94238513|NCT00475228|322666647|FG001|Overall Study|Lost to Follow-up|17|||
94348782|NCT01004861|323058797|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
94348783|NCT01004861|323058785|FG000|Overall Study|Study termination by Sponsor|0|||
94348784|NCT01004861|323058786|FG001|Overall Study|Study termination by Sponsor|0|||
94348785|NCT01004861|323058787|FG002|Overall Study|Study termination by Sponsor|0|||
94348786|NCT01004861|323058788|FG003|Overall Study|Study termination by Sponsor|0|||
94348787|NCT01004861|323058789|FG004|Overall Study|Study termination by Sponsor|0|||
94348788|NCT01004861|323058790|FG005|Overall Study|Study termination by Sponsor|0|||
94348789|NCT01004861|323058791|FG006|Overall Study|Study termination by Sponsor|0|||
94573633|NCT00614575|323899995|FG000|Overall Study|Lack of Efficacy|14|||
94573634|NCT00614575|323899995|FG000|Overall Study|Withdrawal by Subject|6|||
94573635|NCT00614575|323899995|FG000|Overall Study|Death|3|||
94573636|NCT00614575|323899995|FG000|Overall Study|Physician Decision|2|||
94573637|NCT00614575|323899995|FG000|Overall Study|No data were collected.|18|||
94573638|NCT00614575|323899995|FG000|Overall Study|Irregularly enrolled patients|23|||
94573639|NCT00614575|323899995|FG000|Overall Study|No treatment|1|||
94573640|NCT04949191|323900001|FG000|Overall Study|Non-compliance with Study Drug|1|||
94573641|NCT04949191|323900002|FG001|Overall Study|Non-compliance with Study Drug|0|||
94573642|NCT04949191|323900003|FG002|Overall Study|Non-compliance with Study Drug|0|||
94573643|NCT04949191|323900004|FG003|Overall Study|Non-compliance with Study Drug|0|||
94573644|NCT04949191|323900001|FG000|Overall Study|Progressive Disease|0|||
94573645|NCT04949191|323900002|FG001|Overall Study|Progressive Disease|1|||
94573646|NCT04949191|323900003|FG002|Overall Study|Progressive Disease|0|||
94573647|NCT04949191|323900004|FG003|Overall Study|Progressive Disease|0|||
94573648|NCT04949191|323900001|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
94573649|NCT04949191|323900002|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
94573650|NCT04949191|323900003|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
94573651|NCT04949191|323900004|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
94573652|NCT04949191|323900001|FG000|Overall Study|Sponsor Terminated Study|0|||
94573653|NCT04949191|323900002|FG001|Overall Study|Sponsor Terminated Study|0|||
94573654|NCT04949191|323900003|FG002|Overall Study|Sponsor Terminated Study|1|||
94573655|NCT04949191|323900004|FG003|Overall Study|Sponsor Terminated Study|1|||
94348790|NCT01004861|323058792|FG007|Overall Study|Study termination by Sponsor|0|||
94348791|NCT01004861|323058793|FG008|Overall Study|Study termination by Sponsor|1|||
94348792|NCT01004861|323058794|FG009|Overall Study|Study termination by Sponsor|0|||
94573656|NCT03259230|323900005|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
94573657|NCT03259230|323900006|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
94573658|NCT01033240|323900007|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
94573659|NCT01033240|323900008|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
94573660|NCT01033240|323900009|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
94573661|NCT01033240|323900007|FG000|Overall Study|Death|2|||
94573662|NCT01033240|323900008|FG001|Overall Study|Death|0|||
94573663|NCT01033240|323900009|FG002|Overall Study|Death|0|||
94238514|NCT00681668|322666648|FG000|Overall Study|Protocol Violation|1|||
94238515|NCT00681668|322666648|FG000|Overall Study|Withdrawal by Subject|1|||
94238516|NCT02548078|322666651|FG000|Overall Study|Serious adverse event/Adverse event|1|||
94238517|NCT02548078|322666652|FG001|Overall Study|Serious adverse event/Adverse event|0|||
94238518|NCT02548078|322666651|FG000|Overall Study|Moved from study area|3|||
94238519|NCT02548078|322666652|FG001|Overall Study|Moved from study area|3|||
94238520|NCT02548078|322666651|FG000|Overall Study|Lost to Follow-up|1|||
94238521|NCT02548078|322666652|FG001|Overall Study|Lost to Follow-up|3|||
94238522|NCT00490698|322666653|FG000|Overall Study|Withdrawal by Subject|1|||
94238523|NCT00490698|322666653|FG000|Overall Study|Disease Progression|7|||
94452103|NCT02564900|323443661|FG004|Dose Expansion|Clinical progression|0|||
94452104|NCT02564900|323443662|FG005|Dose Expansion|Clinical progression|0|||
94452105|NCT02564900|323443663|FG006|Dose Expansion|Clinical progression|5|||
94452106|NCT02564900|323443664|FG007|Dose Expansion|Clinical progression|12|||
94452107|NCT02564900|323443665|FG008|Dose Expansion|Clinical progression|0|||
94452108|NCT02564900|323443666|FG009|Dose Expansion|Clinical progression|3|||
94452109|NCT02564900|323443667|FG010|Dose Expansion|Clinical progression|2|||
94452110|NCT02564900|323443668|FG011|Dose Expansion|Clinical progression|0|||
94452111|NCT02564900|323443669|FG012|Dose Expansion|Clinical progression|1|||
94452112|NCT02564900|323443670|FG013|Dose Expansion|Clinical progression|3|||
94452113|NCT02564900|323443671|FG014|Dose Expansion|Clinical progression|1|||
94452114|NCT02564900|323443657|FG000|Dose Expansion|Adverse Event|0|||
94452115|NCT02564900|323443658|FG001|Dose Expansion|Adverse Event|0|||
94452116|NCT02564900|323443659|FG002|Dose Expansion|Adverse Event|0|||
94452117|NCT02564900|323443660|FG003|Dose Expansion|Adverse Event|0|||
94452118|NCT02564900|323443661|FG004|Dose Expansion|Adverse Event|0|||
94452119|NCT02564900|323443662|FG005|Dose Expansion|Adverse Event|0|||
94452120|NCT02564900|323443663|FG006|Dose Expansion|Adverse Event|9|||
94452121|NCT02564900|323443664|FG007|Dose Expansion|Adverse Event|22|||
94452122|NCT02564900|323443665|FG008|Dose Expansion|Adverse Event|0|||
94452123|NCT02564900|323443666|FG009|Dose Expansion|Adverse Event|11|||
94452124|NCT02564900|323443667|FG010|Dose Expansion|Adverse Event|0|||
94452125|NCT02564900|323443668|FG011|Dose Expansion|Adverse Event|5|||
94452126|NCT02564900|323443669|FG012|Dose Expansion|Adverse Event|2|||
94452127|NCT02564900|323443670|FG013|Dose Expansion|Adverse Event|2|||
94452128|NCT02564900|323443671|FG014|Dose Expansion|Adverse Event|1|||
94452129|NCT02564900|323443657|FG000|Dose Expansion|Ongoing|0|||
94452130|NCT02564900|323443658|FG001|Dose Expansion|Ongoing|0|||
94452131|NCT02564900|323443659|FG002|Dose Expansion|Ongoing|0|||
94452132|NCT02564900|323443660|FG003|Dose Expansion|Ongoing|0|||
94452133|NCT02564900|323443661|FG004|Dose Expansion|Ongoing|0|||
94452134|NCT02564900|323443662|FG005|Dose Expansion|Ongoing|0|||
94452135|NCT02564900|323443663|FG006|Dose Expansion|Ongoing|9|||
94452136|NCT02564900|323443664|FG007|Dose Expansion|Ongoing|10|||
94452137|NCT02564900|323443665|FG008|Dose Expansion|Ongoing|11|||
94452138|NCT02564900|323443666|FG009|Dose Expansion|Ongoing|3|||
94452139|NCT02564900|323443667|FG010|Dose Expansion|Ongoing|0|||
94452140|NCT02564900|323443668|FG011|Dose Expansion|Ongoing|0|||
94452141|NCT02564900|323443669|FG012|Dose Expansion|Ongoing|4|||
94452142|NCT02564900|323443670|FG013|Dose Expansion|Ongoing|0|||
94452143|NCT02564900|323443671|FG014|Dose Expansion|Ongoing|6|||
94452144|NCT02564900|323443657|FG000|Dose Expansion|Death|0|||
94452145|NCT02564900|323443658|FG001|Dose Expansion|Death|0|||
94452146|NCT02564900|323443659|FG002|Dose Expansion|Death|0|||
94452147|NCT02564900|323443660|FG003|Dose Expansion|Death|0|||
94452148|NCT02564900|323443661|FG004|Dose Expansion|Death|0|||
94452149|NCT02564900|323443662|FG005|Dose Expansion|Death|0|||
94452150|NCT02564900|323443663|FG006|Dose Expansion|Death|1|||
94452151|NCT02564900|323443664|FG007|Dose Expansion|Death|0|||
94452152|NCT02564900|323443665|FG008|Dose Expansion|Death|0|||
94452153|NCT02564900|323443666|FG009|Dose Expansion|Death|0|||
94452154|NCT02564900|323443667|FG010|Dose Expansion|Death|1|||
94452155|NCT02564900|323443668|FG011|Dose Expansion|Death|0|||
94452156|NCT02564900|323443669|FG012|Dose Expansion|Death|1|||
94238524|NCT00490698|322666653|FG000|Overall Study|Physician Decision|2|||
94452157|NCT02564900|323443670|FG013|Dose Expansion|Death|1|||
94452158|NCT02564900|323443671|FG014|Dose Expansion|Death|0|||
94452159|NCT02564900|323443657|FG000|Dose Expansion|Withdrawal by Subject|0|||
94452160|NCT02564900|323443658|FG001|Dose Expansion|Withdrawal by Subject|0|||
94238525|NCT02284009|322666662|FG000|Overall Study|Adverse Event|3|||
94452161|NCT02564900|323443659|FG002|Dose Expansion|Withdrawal by Subject|0|||
94452162|NCT02564900|323443660|FG003|Dose Expansion|Withdrawal by Subject|0|||
94452163|NCT02564900|323443661|FG004|Dose Expansion|Withdrawal by Subject|0|||
94452164|NCT02564900|323443662|FG005|Dose Expansion|Withdrawal by Subject|0|||
94452165|NCT02564900|323443663|FG006|Dose Expansion|Withdrawal by Subject|4|||
94452166|NCT02564900|323443664|FG007|Dose Expansion|Withdrawal by Subject|0|||
94452167|NCT02564900|323443665|FG008|Dose Expansion|Withdrawal by Subject|0|||
94452168|NCT02564900|323443666|FG009|Dose Expansion|Withdrawal by Subject|0|||
94238526|NCT02284009|322666663|FG001|Overall Study|Adverse Event|0|||
94452169|NCT02564900|323443667|FG010|Dose Expansion|Withdrawal by Subject|1|||
94452170|NCT02564900|323443668|FG011|Dose Expansion|Withdrawal by Subject|0|||
94573664|NCT01033240|323900007|FG000|Overall Study|Withdrew Consent|2|||
94573665|NCT01033240|323900008|FG001|Overall Study|Withdrew Consent|9|||
94573666|NCT01033240|323900009|FG002|Overall Study|Withdrew Consent|2|||
94573667|NCT01033240|323900007|FG000|Overall Study|Disease Progression|35|||
94573668|NCT01033240|323900008|FG001|Overall Study|Disease Progression|32|||
94573669|NCT01033240|323900009|FG002|Overall Study|Disease Progression|41|||
94573670|NCT01033240|323900007|FG000|Overall Study|Investigator Discretion|0|||
94573671|NCT01033240|323900008|FG001|Overall Study|Investigator Discretion|0|||
94573672|NCT01033240|323900009|FG002|Overall Study|Investigator Discretion|2|||
94573673|NCT01033240|323900007|FG000|Overall Study|Other|0|||
94573674|NCT01033240|323900008|FG001|Overall Study|Other|1|||
94658819|NCT01172938|324206189|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
94658820|NCT01172938|324206190|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
94658821|NCT00889421|324206193|FG000|Overall Study|Lack of Efficacy|3|||
94658822|NCT02571452|324206198|FG000|Overall Study Treatment|Protocol Violation|0|||
94658823|NCT02571452|324206199|FG001|Overall Study Treatment|Protocol Violation|1|||
94658824|NCT02571452|324206198|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
94238527|NCT02284009|322666662|FG000|Overall Study|Lost to Follow-up|1|||
94238528|NCT02284009|322666663|FG001|Overall Study|Lost to Follow-up|3|||
94238529|NCT02284009|322666662|FG000|Overall Study|Physician Decision|0|||
94238530|NCT02284009|322666663|FG001|Overall Study|Physician Decision|2|||
94238531|NCT02284009|322666662|FG000|Overall Study|Withdrawal by Subject|2|||
94238532|NCT02284009|322666663|FG001|Overall Study|Withdrawal by Subject|5|||
94238533|NCT04147195|322666664|FG000|Overall Study|Adverse Event|0|||
94238534|NCT04147195|322666665|FG001|Overall Study|Adverse Event|3|||
94238535|NCT04147195|322666664|FG000|Overall Study|Study Terminated by Sponsor|4|||
94238536|NCT04147195|322666665|FG001|Overall Study|Study Terminated by Sponsor|2|||
94238537|NCT04147195|322666664|FG000|Overall Study|Withdrawal by Subject|0|||
94238538|NCT04147195|322666665|FG001|Overall Study|Withdrawal by Subject|1|||
94238539|NCT02473965|322668490|FG000|Overall Study|Adverse Event|6|||
94238540|NCT02473965|322668491|FG001|Overall Study|Adverse Event|4|||
94238541|NCT02473965|322668490|FG000|Overall Study|MG worsening|4|||
94238542|NCT02473965|322668491|FG001|Overall Study|MG worsening|1|||
94238543|NCT02473965|322668490|FG000|Overall Study|Withdrawal by Subject|2|||
94238544|NCT02473965|322668491|FG001|Overall Study|Withdrawal by Subject|3|||
94238545|NCT02473965|322668490|FG000|Overall Study|Physician Decision|0|||
94238546|NCT02473965|322668491|FG001|Overall Study|Physician Decision|2|||
94238547|NCT02358668|322668492|FG000|Overall Study|Adverse Event|2|||
94238548|NCT02358668|322668493|FG001|Overall Study|Adverse Event|0|||
94238549|NCT02358668|322668494|FG002|Overall Study|Adverse Event|0|||
94238550|NCT02358668|322668492|FG000|Overall Study|Withdrawal by Subject|0|||
94238551|NCT02358668|322668493|FG001|Overall Study|Withdrawal by Subject|1|||
94238552|NCT02358668|322668494|FG002|Overall Study|Withdrawal by Subject|0|||
94238553|NCT01240551|322668495|FG000|Overall Study|Refused further treatment|3|||
94238554|NCT01240551|322668496|FG001|Overall Study|Refused further treatment|2|||
94238555|NCT01240551|322668495|FG000|Overall Study|Lost to Follow-up|1|||
94238556|NCT01240551|322668496|FG001|Overall Study|Lost to Follow-up|1|||
94238557|NCT01730950|322668497|FG000|Overall Study|Protocol Violation|6|||
94238558|NCT01730950|322668498|FG001|Overall Study|Protocol Violation|6|||
94238559|NCT01439867|322668505|FG000|Overall Study|Non-compliance|0|||
94238560|NCT01439867|322668506|FG001|Overall Study|Non-compliance|1|||
94238561|NCT01439867|322668505|FG000|Overall Study|Withdrawal by Subject|1|||
94238562|NCT01439867|322668506|FG001|Overall Study|Withdrawal by Subject|2|||
94238563|NCT01439867|322668505|FG000|Overall Study|Administrative Decision|4|||
94573675|NCT01033240|323900009|FG002|Overall Study|Other|2|||
94573676|NCT04716426|323900011|FG000|Overall Study|Vaccination|1|||
94238564|NCT01439867|322668506|FG001|Overall Study|Administrative Decision|5|||
94238565|NCT01439867|322668505|FG000|Overall Study|Protocol-specified Criteria|1|||
94238566|NCT01439867|322668506|FG001|Overall Study|Protocol-specified Criteria|0|||
94238567|NCT02037477|322668507|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
94238568|NCT02037477|322668508|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
94238569|NCT02037477|322668509|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
94238570|NCT02037477|322668510|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
94238571|NCT01483144|322668511|FG000|Overall Study|Adverse Event|9|||
94238572|NCT01483144|322668512|FG001|Overall Study|Adverse Event|4|||
94238573|NCT01483144|322668513|FG002|Overall Study|Adverse Event|6|||
94238574|NCT01483144|322668511|FG000|Overall Study|Withdrawal by Subject|0|||
94238575|NCT01483144|322668512|FG001|Overall Study|Withdrawal by Subject|2|||
94238576|NCT01483144|322668513|FG002|Overall Study|Withdrawal by Subject|5|||
94238577|NCT01483144|322668511|FG000|Overall Study|Physician Decision|1|||
94238578|NCT01483144|322668512|FG001|Overall Study|Physician Decision|0|||
94348793|NCT01004861|323058795|FG010|Overall Study|Study termination by Sponsor|0|||
94348794|NCT01004861|323058796|FG011|Overall Study|Study termination by Sponsor|0|||
94348795|NCT01004861|323058797|FG012|Overall Study|Study termination by Sponsor|0|||
94573677|NCT04716426|323900012|FG001|Overall Study|Vaccination|1|||
94573678|NCT04716426|323900011|FG000|Overall Study|Contamination|1|||
94573679|NCT04716426|323900012|FG001|Overall Study|Contamination|0|||
94348796|NCT01524900|323058798|FG000|Overall Study|Lost to Follow-up|3|||
94348797|NCT01524900|323058799|FG001|Overall Study|Lost to Follow-up|12|||
94573680|NCT00551759|323900013|FG000|Overall Study|Adverse Event|7|||
94573681|NCT00551759|323900013|FG000|Overall Study|Death|5|||
94573682|NCT00551759|323900013|FG000|Overall Study|Ineligible|1|||
94573683|NCT01650558|323900016|FG000|Overall Study|Migration out of study area|61|||
94573684|NCT01650558|323900017|FG001|Overall Study|Migration out of study area|71|||
94573685|NCT01650558|323900018|FG002|Overall Study|Migration out of study area|56|||
94573686|NCT01650558|323900016|FG000|Overall Study|Lost to Follow-up|10|||
94573687|NCT01650558|323900017|FG001|Overall Study|Lost to Follow-up|13|||
94573688|NCT01650558|323900018|FG002|Overall Study|Lost to Follow-up|6|||
94573689|NCT01650558|323900016|FG000|Overall Study|Death|10|||
94573690|NCT01650558|323900017|FG001|Overall Study|Death|6|||
94573691|NCT01650558|323900018|FG002|Overall Study|Death|8|||
94573692|NCT01650558|323900016|FG000|Overall Study|Withdrawal by Subject|1|||
94573693|NCT01650558|323900017|FG001|Overall Study|Withdrawal by Subject|1|||
94573694|NCT01650558|323900018|FG002|Overall Study|Withdrawal by Subject|3|||
94573695|NCT01650558|323900016|FG000|Overall Study|Non-compliant participant|1|||
94573696|NCT01650558|323900017|FG001|Overall Study|Non-compliant participant|0|||
94573697|NCT01650558|323900018|FG002|Overall Study|Non-compliant participant|2|||
94573698|NCT01650558|323900016|FG000|Overall Study|Physician Decision|0|||
94573699|NCT01650558|323900017|FG001|Overall Study|Physician Decision|1|||
94573700|NCT01650558|323900018|FG002|Overall Study|Physician Decision|0|||
94573701|NCT02960217|323900019|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
94573702|NCT02960217|323900020|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
94573703|NCT02960217|323900019|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
94573704|NCT02960217|323900020|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
94573705|NCT02960217|323900019|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
94573706|NCT02960217|323900020|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
94573707|NCT02960217|323900019|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
94573708|NCT02960217|323900020|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
94573709|NCT02960217|323900019|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
94573710|NCT02960217|323900020|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
94573711|NCT02960217|323900019|FG000|Open-Label Extension Phase|Adverse Event|1|||
94573712|NCT02960217|323900020|FG001|Open-Label Extension Phase|Adverse Event|0|||
94573713|NCT02960217|323900019|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
94573714|NCT02960217|323900020|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
94573715|NCT02960217|323900019|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
94573716|NCT02960217|323900020|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
94573717|NCT02960217|323900019|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
94573718|NCT02960217|323900020|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
94573719|NCT00083889|323900021|FG000|Overall Study|Adverse Event|76|||
94573720|NCT00083889|323900022|FG001|Overall Study|Adverse Event|86|||
94573721|NCT00083889|323900021|FG000|Overall Study|Protocol Violation|2|||
94573722|NCT00083889|323900022|FG001|Overall Study|Protocol Violation|2|||
94573723|NCT00083889|323900021|FG000|Overall Study|Withdrawal by Subject|22|||
94573724|NCT00083889|323900022|FG001|Overall Study|Withdrawal by Subject|24|||
94573725|NCT00083889|323900021|FG000|Overall Study|Lack of Efficacy|240|||
94573726|NCT00083889|323900022|FG001|Overall Study|Lack of Efficacy|219|||
94573727|NCT00083889|323900021|FG000|Overall Study|Decision of sponsor|32|||
94573728|NCT00083889|323900022|FG001|Overall Study|Decision of sponsor|4|||
94573729|NCT00083889|323900021|FG000|Overall Study|Randomized: did not take study drug|0|||
94573730|NCT00083889|323900022|FG001|Overall Study|Randomized: did not take study drug|15|||
94573731|NCT00083889|323900021|FG000|Overall Study|Completed on marketed sunitinub|3|||
94573732|NCT00083889|323900022|FG001|Overall Study|Completed on marketed sunitinub|0|||
94573733|NCT00083889|323900021|FG000|Overall Study|Crossover to SU011248|0|||
94573734|NCT00083889|323900022|FG001|Overall Study|Crossover to SU011248|25|||
94573735|NCT00168844|323900023|FG000|Overall Study|Adverse Event|31|||
94573736|NCT00168844|323900024|FG001|Overall Study|Adverse Event|32|||
94573737|NCT00168844|323900025|FG002|Overall Study|Adverse Event|48|||
94348798|NCT01524900|323058800|FG002|Overall Study|Lost to Follow-up|1|||
94348799|NCT01524900|323058801|FG003|Overall Study|Lost to Follow-up|0|||
94573738|NCT00168844|323900023|FG000|Overall Study|Lost to Follow-up|4|||
94348800|NCT01524900|323058802|FG004|Overall Study|Lost to Follow-up|0|||
94348801|NCT01524900|323058798|FG000|Overall Study|Other reason than stated above|1|||
94573739|NCT00168844|323900024|FG001|Overall Study|Lost to Follow-up|5|||
94573740|NCT00168844|323900025|FG002|Overall Study|Lost to Follow-up|11|||
94573741|NCT00168844|323900023|FG000|Overall Study|Withdrawal by Subject|12|||
94573742|NCT00168844|323900024|FG001|Overall Study|Withdrawal by Subject|9|||
94573743|NCT00168844|323900025|FG002|Overall Study|Withdrawal by Subject|19|||
94573744|NCT00168844|323900023|FG000|Overall Study|Protocol Violation|2|||
94348802|NCT01524900|323058799|FG001|Overall Study|Other reason than stated above|1|||
94573745|NCT00168844|323900024|FG001|Overall Study|Protocol Violation|2|||
94573746|NCT00168844|323900025|FG002|Overall Study|Protocol Violation|4|||
94573747|NCT00168844|323900023|FG000|Overall Study|Other|6|||
94573748|NCT00168844|323900024|FG001|Overall Study|Other|7|||
94573749|NCT00168844|323900025|FG002|Overall Study|Other|9|||
94573750|NCT04011540|323900030|FG000|Overall Study|Lost to Follow-up|9|||
94573751|NCT04011540|323900031|FG001|Overall Study|Lost to Follow-up|6|||
94573752|NCT03668873|323900036|FG000|Overall Study|Lost to Follow-up|6|||
94573753|NCT03668873|323900037|FG001|Overall Study|Lost to Follow-up|3|||
94573754|NCT03043313|323900046|FG000|Overall Study|Withdrawal by Subject|5|||
94573755|NCT03043313|323900047|FG001|Overall Study|Withdrawal by Subject|1|||
94573756|NCT03043313|323900048|FG002|Overall Study|Withdrawal by Subject|1|||
94573757|NCT03043313|323900046|FG000|Overall Study|Lost to Follow-up|1|||
94573758|NCT03043313|323900047|FG001|Overall Study|Lost to Follow-up|1|||
94573759|NCT03043313|323900048|FG002|Overall Study|Lost to Follow-up|0|||
94573760|NCT03043313|323900046|FG000|Overall Study|Death|28|||
94573761|NCT03043313|323900047|FG001|Overall Study|Death|26|||
94573762|NCT03043313|323900048|FG002|Overall Study|Death|17|||
94573763|NCT03043313|323900046|FG000|Overall Study|Participation terminated by sponsor|11|||
94573764|NCT03043313|323900047|FG001|Overall Study|Participation terminated by sponsor|13|||
94573765|NCT03043313|323900048|FG002|Overall Study|Participation terminated by sponsor|13|||
94573766|NCT00980954|323900049|FG000|Overall Study|Protocol Violation|9|||
94573767|NCT00980954|323900050|FG001|Overall Study|Protocol Violation|15|||
94573768|NCT01844765|323900051|FG000|Overall Study|Adverse Event|6|||
94573769|NCT01844765|323900052|FG001|Overall Study|Adverse Event|8|||
94573770|NCT01844765|323900051|FG000|Overall Study|Withdrawal by Subject|2|||
94573771|NCT01844765|323900052|FG001|Overall Study|Withdrawal by Subject|3|||
94573772|NCT01844765|323900051|FG000|Overall Study|Disease progression|1|||
94573773|NCT01844765|323900052|FG001|Overall Study|Disease progression|0|||
94573774|NCT01844765|323900051|FG000|Overall Study|Administrative problems|3|||
94573775|NCT01844765|323900052|FG001|Overall Study|Administrative problems|4|||
94573776|NCT01844765|323900051|FG000|Overall Study|Protocol deviation|2|||
94573777|NCT01844765|323900052|FG001|Overall Study|Protocol deviation|0|||
94573778|NCT01844765|323900051|FG000|Overall Study|Untreated|1|||
94573779|NCT01844765|323900052|FG001|Overall Study|Untreated|0|||
94573780|NCT00617734|323900053|FG000|Overall Study|Withdrew Consent|2|||
94573781|NCT00617734|323900054|FG001|Overall Study|Withdrew Consent|0|||
94573782|NCT00617734|323900053|FG000|Overall Study|Adverse Event|4|||
94573783|NCT00617734|323900054|FG001|Overall Study|Adverse Event|1|||
94573784|NCT00617734|323900053|FG000|Overall Study|Protocol Violation|1|||
94573785|NCT00617734|323900054|FG001|Overall Study|Protocol Violation|0|||
94573786|NCT00617734|323900053|FG000|Overall Study|Found Ineligible After Randomization|1|||
94573787|NCT00617734|323900054|FG001|Overall Study|Found Ineligible After Randomization|4|||
94573788|NCT00617734|323900053|FG000|Overall Study|Lost to Follow-up|0|||
94573789|NCT00617734|323900054|FG001|Overall Study|Lost to Follow-up|1|||
94573790|NCT00604565|323900056|FG000|Overall Study|Study terminated|0|||
94573791|NCT00604565|323900057|FG001|Overall Study|Study terminated|3|||
94573792|NCT02260934|323900061|FG000|Overall Study|Lost to Follow-up|2|||
94573793|NCT02260934|323900062|FG001|Overall Study|Lost to Follow-up|1|||
94573794|NCT02260934|323900061|FG000|Overall Study|Withdrawal by Subject|0|||
94573795|NCT02260934|323900062|FG001|Overall Study|Withdrawal by Subject|2|||
94573796|NCT02260934|323900061|FG000|Overall Study|Participant Relocated|1|||
94573797|NCT02260934|323900062|FG001|Overall Study|Participant Relocated|0|||
94573798|NCT02260934|323900061|FG000|Overall Study|Site error|0|||
94573799|NCT02260934|323900062|FG001|Overall Study|Site error|1|||
94573800|NCT04292535|323900063|FG000|Overall Study|Withdrawal by Subject|0|||
94573801|NCT04292535|323900064|FG001|Overall Study|Withdrawal by Subject|0|||
94573802|NCT04292535|323900065|FG002|Overall Study|Withdrawal by Subject|0|||
94573803|NCT04292535|323900066|FG003|Overall Study|Withdrawal by Subject|0|||
94573804|NCT04292535|323900067|FG004|Overall Study|Withdrawal by Subject|0|||
94573805|NCT04292535|323900068|FG005|Overall Study|Withdrawal by Subject|0|||
94573806|NCT04292535|323900069|FG006|Overall Study|Withdrawal by Subject|0|||
94573807|NCT04292535|323900070|FG007|Overall Study|Withdrawal by Subject|1|||
94573808|NCT04292535|323900071|FG008|Overall Study|Withdrawal by Subject|0|||
94573809|NCT04292535|323900072|FG009|Overall Study|Withdrawal by Subject|0|||
94573810|NCT04292535|323900073|FG010|Overall Study|Withdrawal by Subject|0|||
94573811|NCT04292535|323900074|FG011|Overall Study|Withdrawal by Subject|0|||
94573812|NCT04292535|323900075|FG012|Overall Study|Withdrawal by Subject|0|||
94573813|NCT04292535|323900076|FG013|Overall Study|Withdrawal by Subject|0|||
94238579|NCT01483144|322668513|FG002|Overall Study|Physician Decision|0|||
94452171|NCT02564900|323443669|FG012|Dose Expansion|Withdrawal by Subject|0|||
94573814|NCT04292535|323900063|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
94573815|NCT04292535|323900064|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
94573816|NCT04292535|323900065|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
94573817|NCT04292535|323900066|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
94573818|NCT04292535|323900067|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
94573819|NCT04292535|323900068|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
94573820|NCT04292535|323900069|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
94573821|NCT04292535|323900070|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
94573822|NCT04292535|323900071|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
94452172|NCT02564900|323443670|FG013|Dose Expansion|Withdrawal by Subject|1|||
94452173|NCT02564900|323443671|FG014|Dose Expansion|Withdrawal by Subject|1|||
94452174|NCT02564900|323443657|FG000|Dose Expansion|Other|0|||
94452175|NCT02564900|323443658|FG001|Dose Expansion|Other|0|||
94452176|NCT02564900|323443659|FG002|Dose Expansion|Other|0|||
94452177|NCT02564900|323443660|FG003|Dose Expansion|Other|0|||
94452178|NCT02564900|323443661|FG004|Dose Expansion|Other|0|||
94452179|NCT02564900|323443662|FG005|Dose Expansion|Other|0|||
94452180|NCT02564900|323443663|FG006|Dose Expansion|Other|1|||
94452181|NCT02564900|323443664|FG007|Dose Expansion|Other|0|||
94452182|NCT02564900|323443665|FG008|Dose Expansion|Other|1|||
94452183|NCT02564900|323443666|FG009|Dose Expansion|Other|0|||
94452184|NCT02564900|323443667|FG010|Dose Expansion|Other|0|||
94452185|NCT02564900|323443668|FG011|Dose Expansion|Other|0|||
94452186|NCT02564900|323443669|FG012|Dose Expansion|Other|0|||
94452187|NCT02564900|323443670|FG013|Dose Expansion|Other|0|||
94452188|NCT02564900|323443671|FG014|Dose Expansion|Other|1|||
94452189|NCT02564900|323443657|FG000|Dose Expansion|Did not receive treatment|0|||
94452190|NCT02564900|323443658|FG001|Dose Expansion|Did not receive treatment|0|||
94452191|NCT02564900|323443659|FG002|Dose Expansion|Did not receive treatment|0|||
94452192|NCT02564900|323443660|FG003|Dose Expansion|Did not receive treatment|0|||
94452193|NCT02564900|323443661|FG004|Dose Expansion|Did not receive treatment|0|||
94452194|NCT02564900|323443662|FG005|Dose Expansion|Did not receive treatment|0|||
94452195|NCT02564900|323443663|FG006|Dose Expansion|Did not receive treatment|1|||
94452196|NCT02564900|323443664|FG007|Dose Expansion|Did not receive treatment|1|||
94452197|NCT02564900|323443665|FG008|Dose Expansion|Did not receive treatment|0|||
94452198|NCT02564900|323443666|FG009|Dose Expansion|Did not receive treatment|0|||
94452199|NCT02564900|323443667|FG010|Dose Expansion|Did not receive treatment|0|||
94452200|NCT02564900|323443668|FG011|Dose Expansion|Did not receive treatment|0|||
94452201|NCT02564900|323443669|FG012|Dose Expansion|Did not receive treatment|0|||
94452202|NCT02564900|323443670|FG013|Dose Expansion|Did not receive treatment|0|||
94452203|NCT02564900|323443671|FG014|Dose Expansion|Did not receive treatment|1|||
94452204|NCT00892151|323443672|FG000|Overall Study|Protocol Violation|1|||
94452205|NCT00713258|323443676|FG000|Overall Study|Adverse Event|2|||
94452206|NCT00713258|323443677|FG001|Overall Study|Adverse Event|4|||
94452207|NCT00713258|323443676|FG000|Overall Study|Non-Compliance|2|||
94452208|NCT00713258|323443677|FG001|Overall Study|Non-Compliance|1|||
94452209|NCT00713258|323443676|FG000|Overall Study|Other|1|||
94452210|NCT00713258|323443677|FG001|Overall Study|Other|1|||
94452211|NCT00568061|323443680|FG000|Overall Study|Inclusion / exclusion criteria|5|||
94452212|NCT00568061|323443681|FG001|Overall Study|Inclusion / exclusion criteria|1|||
94452213|NCT00568061|323443680|FG000|Overall Study|Adverse Event|0|||
94452214|NCT00568061|323443681|FG001|Overall Study|Adverse Event|1|||
94452215|NCT02016105|323443683|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
94452216|NCT02016105|323443684|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
94452217|NCT02016105|323443685|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
94452218|NCT02016105|323443686|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
94452219|NCT02016105|323443687|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
94452220|NCT02016105|323443688|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
94452221|NCT02016105|323443683|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
94452222|NCT02016105|323443684|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
94452223|NCT02016105|323443685|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
94452224|NCT02016105|323443686|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
94452225|NCT02016105|323443687|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
94452226|NCT02016105|323443688|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
94452227|NCT02016105|323443683|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
94452228|NCT02016105|323443684|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
94452229|NCT02016105|323443685|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
94238580|NCT01483144|322668511|FG000|Overall Study|Lost to Follow-up|2|||
94238581|NCT01483144|322668512|FG001|Overall Study|Lost to Follow-up|4|||
94238582|NCT01483144|322668513|FG002|Overall Study|Lost to Follow-up|1|||
94238583|NCT01483144|322668511|FG000|Overall Study|Protocol Violation|3|||
94452230|NCT02016105|323443686|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
94452231|NCT02016105|323443687|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
94452232|NCT02016105|323443688|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
94452233|NCT02016105|323443683|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
94452234|NCT02016105|323443684|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
94452235|NCT02016105|323443685|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
94452236|NCT02016105|323443686|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
94238584|NCT01483144|322668512|FG001|Overall Study|Protocol Violation|3|||
94452237|NCT02016105|323443687|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
94452238|NCT02016105|323443688|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
94452239|NCT02016105|323443683|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
94452240|NCT02016105|323443684|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
94573823|NCT04292535|323900072|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
94452241|NCT02016105|323443685|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
94452242|NCT02016105|323443686|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
94452243|NCT02016105|323443687|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
94238585|NCT01483144|322668513|FG002|Overall Study|Protocol Violation|3|||
94348803|NCT01524900|323058800|FG002|Overall Study|Other reason than stated above|0|||
94573824|NCT04292535|323900073|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
94348804|NCT01524900|323058801|FG003|Overall Study|Other reason than stated above|0|||
94348805|NCT01524900|323058802|FG004|Overall Study|Other reason than stated above|0|||
94348806|NCT01524900|323058798|FG000|Overall Study|No reason documented|2|||
94348807|NCT01524900|323058799|FG001|Overall Study|No reason documented|1|||
94348808|NCT01524900|323058800|FG002|Overall Study|No reason documented|0|||
94348809|NCT01524900|323058801|FG003|Overall Study|No reason documented|1|||
94348810|NCT01524900|323058802|FG004|Overall Study|No reason documented|0|||
94348811|NCT05466240|323058803|FG000|Overall Study|Adverse Event|1|||
94348812|NCT05466240|323058804|FG001|Overall Study|Adverse Event|0|||
94348813|NCT05466240|323058803|FG000|Overall Study|Withdrawal by Subject|1|||
94348814|NCT05466240|323058804|FG001|Overall Study|Withdrawal by Subject|0|||
94348815|NCT00305773|323058806|FG000|Overall Study|Death|3|||
94348816|NCT00305773|323058807|FG001|Overall Study|Death|2|||
94348817|NCT00305773|323058806|FG000|Overall Study|Adverse Event|1|||
94348818|NCT00305773|323058807|FG001|Overall Study|Adverse Event|2|||
94348819|NCT00305773|323058806|FG000|Overall Study|Alternative Treatment|4|||
94348820|NCT00305773|323058807|FG001|Overall Study|Alternative Treatment|4|||
94348821|NCT00305773|323058806|FG000|Overall Study|Physician Decision|1|||
94348822|NCT00305773|323058807|FG001|Overall Study|Physician Decision|1|||
94348823|NCT00305773|323058806|FG000|Overall Study|Withdrawal by Subject|1|||
94348824|NCT00305773|323058807|FG001|Overall Study|Withdrawal by Subject|4|||
94348825|NCT00305773|323058806|FG000|Overall Study|Disease Progression|1|||
94348826|NCT00305773|323058807|FG001|Overall Study|Disease Progression|3|||
94348827|NCT00305773|323058806|FG000|Overall Study|All other reasons|3|||
94348828|NCT00305773|323058807|FG001|Overall Study|All other reasons|2|||
94348829|NCT02759939|323058808|FG000|Overall Study|Missing data on first outcome assessed|11|||
94348830|NCT02759939|323058809|FG001|Overall Study|Missing data on first outcome assessed|2|||
94348831|NCT02759939|323058810|FG002|Overall Study|Missing data on first outcome assessed|5|||
94348832|NCT02759939|323058811|FG003|Overall Study|Missing data on first outcome assessed|2|||
94348833|NCT02759939|323058808|FG000|Overall Study|Ineligible for T2 and T3|310|||
94348834|NCT02759939|323058809|FG001|Overall Study|Ineligible for T2 and T3|179|||
94348835|NCT02759939|323058810|FG002|Overall Study|Ineligible for T2 and T3|366|||
94348836|NCT02759939|323058811|FG003|Overall Study|Ineligible for T2 and T3|391|||
94348837|NCT02759939|323058808|FG000|Overall Study|Lost to Follow-up|735|||
94348838|NCT02759939|323058809|FG001|Overall Study|Lost to Follow-up|791|||
94348839|NCT02759939|323058810|FG002|Overall Study|Lost to Follow-up|783|||
94348840|NCT02759939|323058811|FG003|Overall Study|Lost to Follow-up|650|||
94348841|NCT02679222|323058812|FG000|Overall Study|No time for project|1|||
94348842|NCT04354870|323058814|FG000|Overall Study|Lost to Follow-up|32|||
94348843|NCT04354870|323058815|FG001|Overall Study|Lost to Follow-up|12|||
94348844|NCT04354870|323058814|FG000|Overall Study|Withdrawal by Subject|10|||
94348845|NCT04354870|323058815|FG001|Overall Study|Withdrawal by Subject|16|||
94348846|NCT04354870|323058814|FG000|Overall Study|Did not complete all study visits|6|||
94348847|NCT04354870|323058815|FG001|Overall Study|Did not complete all study visits|5|||
94348848|NCT04735432|323058816|FG000|Overall Study|Other - due to personal reason|1|||
94348849|NCT04735432|323058817|FG001|Overall Study|Other - due to personal reason|0|||
94348850|NCT04735432|323058816|FG000|Overall Study|Adverse Event|2|||
94348851|NCT04735432|323058817|FG001|Overall Study|Adverse Event|0|||
94348852|NCT00413231|323058818|FG000|0 to 30-day Post Treatment|Death|5|||
94348853|NCT00413231|323058818|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
94348854|NCT00413231|323058818|FG000|30-day to 365-day Post Treatment|Death|13|||
94348855|NCT00413231|323058818|FG000|365-day to 60-month Post Treatment|Death|36|||
94348856|NCT00413231|323058818|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
94348857|NCT00413231|323058818|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
94348858|NCT00413231|323058818|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
94348859|NCT00945945|323058823|FG000|Overall Study|Adverse Event|15|||
94348860|NCT00945945|323058824|FG001|Overall Study|Adverse Event|35|||
94348861|NCT00945945|323058823|FG000|Overall Study|Withdrawal by Subject|7|||
94348862|NCT00945945|323058824|FG001|Overall Study|Withdrawal by Subject|10|||
94348863|NCT00945945|323058823|FG000|Overall Study|Lost to Follow-up|4|||
94348864|NCT00945945|323058824|FG001|Overall Study|Lost to Follow-up|5|||
94573825|NCT04292535|323900074|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
94348865|NCT00945945|323058823|FG000|Overall Study|Lack of Efficacy|6|||
94348866|NCT00945945|323058824|FG001|Overall Study|Lack of Efficacy|2|||
94348867|NCT00945945|323058823|FG000|Overall Study|Protocol Violation|4|||
94348868|NCT00945945|323058824|FG001|Overall Study|Protocol Violation|2|||
94348869|NCT00945945|323058823|FG000|Overall Study|Entry Criteria Not Met|0|||
94348870|NCT00945945|323058824|FG001|Overall Study|Entry Criteria Not Met|1|||
94348871|NCT01370499|323058825|FG000|Overall Study|Adverse Event|38|||
94348872|NCT01370499|323058826|FG001|Overall Study|Adverse Event|12|||
94348873|NCT01370499|323058825|FG000|Overall Study|Lack of Efficacy|4|||
94348874|NCT01370499|323058826|FG001|Overall Study|Lack of Efficacy|2|||
94348875|NCT01370499|323058825|FG000|Overall Study|Lost to Follow-up|2|||
94573826|NCT04292535|323900075|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
94573827|NCT04292535|323900076|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
94573828|NCT04292535|323900063|FG000|Overall Study|Report of Dizziness|0|||
94573829|NCT04292535|323900064|FG001|Overall Study|Report of Dizziness|0|||
94573830|NCT04292535|323900065|FG002|Overall Study|Report of Dizziness|0|||
94573831|NCT04292535|323900066|FG003|Overall Study|Report of Dizziness|0|||
94573832|NCT04292535|323900067|FG004|Overall Study|Report of Dizziness|0|||
94573833|NCT04292535|323900068|FG005|Overall Study|Report of Dizziness|0|||
94573834|NCT04292535|323900069|FG006|Overall Study|Report of Dizziness|0|||
94573835|NCT04292535|323900070|FG007|Overall Study|Report of Dizziness|0|||
94573836|NCT04292535|323900071|FG008|Overall Study|Report of Dizziness|0|||
94573837|NCT04292535|323900072|FG009|Overall Study|Report of Dizziness|0|||
94573838|NCT04292535|323900073|FG010|Overall Study|Report of Dizziness|0|||
94573839|NCT04292535|323900074|FG011|Overall Study|Report of Dizziness|0|||
94573840|NCT04292535|323900075|FG012|Overall Study|Report of Dizziness|0|||
94573841|NCT04292535|323900076|FG013|Overall Study|Report of Dizziness|1|||
94573842|NCT04292535|323900063|FG000|Overall Study|Equipment Failure|0|||
94573843|NCT04292535|323900064|FG001|Overall Study|Equipment Failure|0|||
94573844|NCT04292535|323900065|FG002|Overall Study|Equipment Failure|0|||
94573845|NCT04292535|323900066|FG003|Overall Study|Equipment Failure|0|||
94573846|NCT04292535|323900067|FG004|Overall Study|Equipment Failure|0|||
94573847|NCT04292535|323900068|FG005|Overall Study|Equipment Failure|0|||
94573848|NCT04292535|323900069|FG006|Overall Study|Equipment Failure|0|||
94573849|NCT04292535|323900070|FG007|Overall Study|Equipment Failure|0|||
94573850|NCT04292535|323900071|FG008|Overall Study|Equipment Failure|0|||
94573851|NCT04292535|323900072|FG009|Overall Study|Equipment Failure|0|||
94573852|NCT04292535|323900073|FG010|Overall Study|Equipment Failure|0|||
94573853|NCT04292535|323900074|FG011|Overall Study|Equipment Failure|1|||
94573854|NCT04292535|323900075|FG012|Overall Study|Equipment Failure|0|||
94573855|NCT04292535|323900076|FG013|Overall Study|Equipment Failure|0|||
94238586|NCT00983749|322668517|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
94238587|NCT00983749|322668518|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
94238588|NCT02906020|322668519|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
94238589|NCT02906020|322668520|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
94573856|NCT00395746|323900077|FG000|Overall Study|Adverse Event|5|||
94573857|NCT00395746|323900078|FG001|Overall Study|Adverse Event|2|||
94573858|NCT00395746|323900079|FG002|Overall Study|Adverse Event|2|||
94573859|NCT00395746|323900077|FG000|Overall Study|Protocol Violation|0|||
94573860|NCT00395746|323900078|FG001|Overall Study|Protocol Violation|1|||
94573861|NCT00395746|323900079|FG002|Overall Study|Protocol Violation|0|||
94573862|NCT00395746|323900077|FG000|Overall Study|Lack of Efficacy|2|||
94573863|NCT00395746|323900078|FG001|Overall Study|Lack of Efficacy|0|||
94573864|NCT00395746|323900079|FG002|Overall Study|Lack of Efficacy|17|||
94348876|NCT01370499|323058826|FG001|Overall Study|Lost to Follow-up|1|||
94348877|NCT01370499|323058825|FG000|Overall Study|Physician Decision|3|||
94348878|NCT01370499|323058826|FG001|Overall Study|Physician Decision|3|||
94348879|NCT01370499|323058825|FG000|Overall Study|Protocol Violation|5|||
94348880|NCT01370499|323058826|FG001|Overall Study|Protocol Violation|4|||
94348881|NCT01370499|323058825|FG000|Overall Study|Withdrawal by Subject|18|||
94348882|NCT01370499|323058826|FG001|Overall Study|Withdrawal by Subject|7|||
94348883|NCT01370499|323058825|FG000|Overall Study|Sponsor Decision|41|||
94348884|NCT01370499|323058826|FG001|Overall Study|Sponsor Decision|15|||
94348885|NCT02185040|323058827|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
94348886|NCT02185040|323058828|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
94348887|NCT02185040|323058829|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
94348888|NCT02185040|323058830|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
94348889|NCT02185040|323058831|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
94348890|NCT02185040|323058832|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
94452244|NCT02016105|323443688|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
94452245|NCT02016105|323443683|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
94452246|NCT02016105|323443684|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
94452247|NCT02016105|323443685|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
94452248|NCT02016105|323443686|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
94452249|NCT02016105|323443687|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
94452250|NCT02016105|323443688|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
94452251|NCT02016105|323443683|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
94452252|NCT02016105|323443684|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
94452253|NCT02016105|323443685|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
94452254|NCT02016105|323443686|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
94452255|NCT02016105|323443687|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
94452256|NCT02016105|323443688|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
94452257|NCT02016105|323443683|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
94452258|NCT02016105|323443684|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
94452259|NCT02016105|323443685|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
94452260|NCT02016105|323443686|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
94452261|NCT02016105|323443687|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
94452262|NCT02016105|323443688|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
94452263|NCT02016105|323443683|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
94452264|NCT02016105|323443684|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
94452265|NCT02016105|323443685|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
94452266|NCT02016105|323443686|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
94452267|NCT02016105|323443687|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
94452268|NCT02016105|323443688|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
94452269|NCT02016105|323443683|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
94452270|NCT02016105|323443684|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
94452271|NCT02016105|323443685|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
94452272|NCT02016105|323443686|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
94452273|NCT02016105|323443687|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
94452274|NCT02016105|323443688|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
94452275|NCT02016105|323443683|FG000|TREATMENT PERIOD 2|Death|0|||
94452276|NCT02016105|323443684|FG001|TREATMENT PERIOD 2|Death|0|||
94452277|NCT02016105|323443685|FG002|TREATMENT PERIOD 2|Death|0|||
94452278|NCT02016105|323443686|FG003|TREATMENT PERIOD 2|Death|0|||
94452279|NCT02016105|323443687|FG004|TREATMENT PERIOD 2|Death|0|||
94452280|NCT02016105|323443688|FG005|TREATMENT PERIOD 2|Death|1|||
94452281|NCT02016105|323443683|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
94452282|NCT02016105|323443684|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
94452283|NCT02016105|323443685|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
94452284|NCT02016105|323443686|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
94452285|NCT02016105|323443687|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
94452286|NCT02016105|323443688|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
94452287|NCT02016105|323443683|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
94452288|NCT02016105|323443684|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
94452289|NCT02016105|323443685|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
94658825|NCT02571452|324206199|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
94348891|NCT02185040|323058833|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
94452290|NCT02016105|323443686|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
94452291|NCT02016105|323443687|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
94452292|NCT02016105|323443688|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
94452293|NCT02016105|323443683|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
94452294|NCT02016105|323443684|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
94452295|NCT02016105|323443685|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
94348892|NCT02185040|323058827|FG000|Part 1 Treatment Phase|Adverse Event|1|||
94452296|NCT02016105|323443686|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
94452297|NCT02016105|323443687|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
94452298|NCT02016105|323443688|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
94452299|NCT02016105|323443683|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
94348893|NCT02185040|323058828|FG001|Part 1 Treatment Phase|Adverse Event|0|||
94348894|NCT02185040|323058829|FG002|Part 1 Treatment Phase|Adverse Event|0|||
94573865|NCT00395746|323900077|FG000|Overall Study|Hypoglycaemia|2|||
94573866|NCT00395746|323900078|FG001|Overall Study|Hypoglycaemia|1|||
94573867|NCT00395746|323900079|FG002|Overall Study|Hypoglycaemia|0|||
94573868|NCT00395746|323900077|FG000|Overall Study|Subject decision|0|||
94573869|NCT00395746|323900078|FG001|Overall Study|Subject decision|0|||
94573870|NCT00395746|323900079|FG002|Overall Study|Subject decision|1|||
94573871|NCT00395746|323900077|FG000|Overall Study|Withdrawal of consent|0|||
94573872|NCT00395746|323900078|FG001|Overall Study|Withdrawal of consent|0|||
94573873|NCT00395746|323900079|FG002|Overall Study|Withdrawal of consent|1|||
94573874|NCT00395746|323900077|FG000|Overall Study|Difficultulty in use of device|0|||
94573875|NCT00395746|323900078|FG001|Overall Study|Difficultulty in use of device|0|||
94573876|NCT00395746|323900079|FG002|Overall Study|Difficultulty in use of device|1|||
94573877|NCT00395746|323900077|FG000|Overall Study|Unable to visit site on schedule|1|||
94573878|NCT00395746|323900078|FG001|Overall Study|Unable to visit site on schedule|0|||
94573879|NCT00395746|323900079|FG002|Overall Study|Unable to visit site on schedule|0|||
94573880|NCT03009058|323900082|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
94573881|NCT03497676|323900083|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
94573882|NCT03497676|323900084|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
94573883|NCT03497676|323900085|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
94573884|NCT03497676|323900086|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
94573885|NCT03497676|323900083|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
94573886|NCT03497676|323900084|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
94573887|NCT03497676|323900085|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
94573888|NCT03497676|323900086|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
94573889|NCT03497676|323900083|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
94573890|NCT03497676|323900084|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
94573891|NCT03497676|323900085|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
94573892|NCT03497676|323900086|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
94573893|NCT03497676|323900083|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
94573894|NCT03497676|323900084|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
94573895|NCT03497676|323900085|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
94573896|NCT03497676|323900086|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
94573897|NCT03497676|323900083|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
94573898|NCT03497676|323900084|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
94573899|NCT03497676|323900085|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
94573900|NCT03497676|323900086|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
94573901|NCT03497676|323900083|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
94573902|NCT03497676|323900084|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
94573903|NCT03497676|323900085|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
94573904|NCT03497676|323900086|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
94573905|NCT03497676|323900083|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
94573906|NCT03497676|323900084|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
94573907|NCT03497676|323900085|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
94573908|NCT03497676|323900086|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
94573909|NCT03497676|323900083|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
94573910|NCT03497676|323900084|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
94573911|NCT03497676|323900085|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
94573912|NCT03497676|323900086|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
94573913|NCT02783690|323900087|FG000|Overall Study|Withdrawal by Subject|3|||
94573914|NCT02783690|323900088|FG001|Overall Study|Withdrawal by Subject|3|||
94573915|NCT00844844|323900093|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
94573916|NCT00844844|323900093|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
94573917|NCT00844844|323900093|FG000|Extension Treatment Period|Adverse Event|2|||
94573918|NCT00844844|323900093|FG000|Post Treatment Period|Withdrawal by Subject|1|||
94573919|NCT05417438|323900096|FG000|Overall Study|Withdrawal by Subject|3|||
94573920|NCT03724942|323900097|FG000|Overall Study|Adverse Event|20|||
94573921|NCT03724942|323900098|FG001|Overall Study|Adverse Event|14|||
94573922|NCT03724942|323900097|FG000|Overall Study|Lack of Efficacy|0|||
94573923|NCT03724942|323900098|FG001|Overall Study|Lack of Efficacy|1|||
94573924|NCT03724942|323900097|FG000|Overall Study|Physician Decision|5|||
94573925|NCT03724942|323900098|FG001|Overall Study|Physician Decision|2|||
94573926|NCT03724942|323900097|FG000|Overall Study|Protocol Violation|1|||
94573927|NCT03724942|323900098|FG001|Overall Study|Protocol Violation|0|||
94573928|NCT03724942|323900097|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
94573929|NCT03724942|323900098|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
94573930|NCT03724942|323900097|FG000|Overall Study|Withdrawal by Legal Representative|3|||
94573931|NCT03724942|323900098|FG001|Overall Study|Withdrawal by Legal Representative|0|||
94348895|NCT02185040|323058830|FG003|Part 1 Treatment Phase|Adverse Event|2|||
94348896|NCT02185040|323058831|FG004|Part 1 Treatment Phase|Adverse Event|3|||
94348897|NCT02185040|323058832|FG005|Part 1 Treatment Phase|Adverse Event|0|||
94348898|NCT02185040|323058833|FG006|Part 1 Treatment Phase|Adverse Event|0|||
94348899|NCT02185040|323058827|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
94348900|NCT02185040|323058828|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
94573932|NCT03409796|323901673|FG000|Overall Study|Adverse Event|2|||
94573933|NCT03409796|323901674|FG001|Overall Study|Adverse Event|0|||
94573934|NCT03409796|323901673|FG000|Overall Study|Other|0|||
94573935|NCT03409796|323901674|FG001|Overall Study|Other|1|||
94573936|NCT00740220|323901675|FG000|Overall Study|screen failures (non-COPD patients)|9|||
94573937|NCT00770653|323901679|FG000|Overall Study|Adverse Event|13|||
94573938|NCT00770653|323901680|FG001|Overall Study|Adverse Event|5|||
94573939|NCT00770653|323901679|FG000|Overall Study|Protocol Violation|8|||
94573940|NCT00770653|323901680|FG001|Overall Study|Protocol Violation|6|||
94573941|NCT00770653|323901679|FG000|Overall Study|Withdrawal by Subject|4|||
94573942|NCT00770653|323901680|FG001|Overall Study|Withdrawal by Subject|7|||
94573943|NCT00770653|323901679|FG000|Overall Study|Lack of Compliance|1|||
94573944|NCT00770653|323901680|FG001|Overall Study|Lack of Compliance|4|||
94573945|NCT00770653|323901679|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
94238590|NCT02906020|322668521|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
94238591|NCT02906020|322668522|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
94238592|NCT02906020|322668523|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
94238593|NCT02906020|322668524|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
94238594|NCT02906020|322668525|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
94238595|NCT02906020|322668526|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
94238596|NCT02906020|322668527|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
94238597|NCT02906020|322668528|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
94238598|NCT02906020|322668529|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
94238599|NCT02906020|322668530|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
94238600|NCT02906020|322668531|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
94238601|NCT02906020|322668532|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
94238602|NCT02906020|322668533|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
94238603|NCT02906020|322668534|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
94238604|NCT02906020|322668519|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
94238605|NCT02906020|322668520|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
94238606|NCT02906020|322668521|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
94238607|NCT02906020|322668522|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
94238608|NCT02906020|322668523|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
94238609|NCT02906020|322668524|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
94238610|NCT02906020|322668525|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
94238611|NCT02906020|322668526|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
94238612|NCT02906020|322668527|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
94238613|NCT02906020|322668528|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
94238614|NCT02906020|322668529|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
94238615|NCT02906020|322668530|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
94238616|NCT02906020|322668531|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
94238617|NCT02906020|322668532|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
94348901|NCT02185040|323058829|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
94573946|NCT00770653|323901680|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
94573947|NCT00770653|323901679|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
94573948|NCT00770653|323901680|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
94573949|NCT00770653|323901679|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
94573950|NCT00770653|323901680|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
94573951|NCT00770653|323901679|FG000|Overall Study|Lost to Follow-up|1|||
94238618|NCT02906020|322668533|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
94238619|NCT02906020|322668534|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
94238620|NCT02906020|322668519|FG000|Part 2: Double-blind Treatment Period|Other|0|||
94238621|NCT02906020|322668520|FG001|Part 2: Double-blind Treatment Period|Other|0|||
94238622|NCT02906020|322668521|FG002|Part 2: Double-blind Treatment Period|Other|0|||
94348902|NCT02185040|323058830|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
94573952|NCT00770653|323901680|FG001|Overall Study|Lost to Follow-up|2|||
94658826|NCT02571452|324206198|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
94238623|NCT02906020|322668522|FG003|Part 2: Double-blind Treatment Period|Other|0|||
94348903|NCT02185040|323058831|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
94573953|NCT00770653|323901679|FG000|Overall Study|Physician Decision|1|||
94573954|NCT00770653|323901680|FG001|Overall Study|Physician Decision|0|||
94573955|NCT00644423|323901681|FG000|Overall Study|Lost to Follow-up|1|||
94573956|NCT00644423|323901682|FG001|Overall Study|Lost to Follow-up|1|||
94573957|NCT01908426|323901683|FG000|Overall Study|Adverse Event|98|||
94573958|NCT01908426|323901684|FG001|Overall Study|Adverse Event|11|||
94573959|NCT01908426|323901683|FG000|Overall Study|Clinical Deterioration|72|||
94238624|NCT02906020|322668523|FG004|Part 2: Double-blind Treatment Period|Other|0|||
94238625|NCT02906020|322668524|FG005|Part 2: Double-blind Treatment Period|Other|0|||
94238626|NCT02906020|322668525|FG006|Part 2: Double-blind Treatment Period|Other|0|||
94238627|NCT02906020|322668526|FG007|Part 2: Double-blind Treatment Period|Other|0|||
94238628|NCT02906020|322668527|FG008|Part 2: Double-blind Treatment Period|Other|6|||
94238629|NCT02906020|322668528|FG009|Part 2: Double-blind Treatment Period|Other|10|||
94238630|NCT02906020|322668529|FG010|Part 2: Double-blind Treatment Period|Other|0|||
94238631|NCT02906020|322668530|FG011|Part 2: Double-blind Treatment Period|Other|0|||
94238632|NCT02906020|322668531|FG012|Part 2: Double-blind Treatment Period|Other|0|||
94238633|NCT02906020|322668532|FG013|Part 2: Double-blind Treatment Period|Other|0|||
94238634|NCT02906020|322668533|FG014|Part 2: Double-blind Treatment Period|Other|0|||
94238635|NCT02906020|322668534|FG015|Part 2: Double-blind Treatment Period|Other|0|||
94238636|NCT02906020|322668519|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
94238637|NCT02906020|322668520|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
94238638|NCT02906020|322668521|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
94238639|NCT02906020|322668522|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
94238640|NCT02906020|322668523|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
94238641|NCT02906020|322668524|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
94238642|NCT02906020|322668525|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
94238643|NCT02906020|322668526|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
94238644|NCT02906020|322668527|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
94238645|NCT02906020|322668528|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
94238646|NCT02906020|322668529|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
94238647|NCT02906020|322668530|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
94238648|NCT02906020|322668531|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
94238649|NCT02906020|322668532|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
94238650|NCT02906020|322668533|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
94238651|NCT02906020|322668534|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
94238652|NCT02906020|322668519|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
94238653|NCT02906020|322668520|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
94238654|NCT02906020|322668521|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
94238655|NCT02906020|322668522|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
94238656|NCT02906020|322668523|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
94238657|NCT02906020|322668524|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
94238658|NCT02906020|322668525|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
94238659|NCT02906020|322668526|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
94238660|NCT02906020|322668527|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
94238661|NCT02906020|322668528|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
94238662|NCT02906020|322668529|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
94238663|NCT02906020|322668530|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
94452300|NCT02016105|323443684|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
94452301|NCT02016105|323443685|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
94452302|NCT02016105|323443686|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
94452303|NCT02016105|323443687|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
94452304|NCT02016105|323443688|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
94452305|NCT02016105|323443683|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
94452306|NCT02016105|323443684|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
94452307|NCT02016105|323443685|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
94452308|NCT02016105|323443686|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
94452309|NCT02016105|323443687|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
94452310|NCT02016105|323443688|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
94452311|NCT02016105|323443683|FG000|EXTENSION PERIOD|Adverse Event|0|||
94452312|NCT02016105|323443684|FG001|EXTENSION PERIOD|Adverse Event|0|||
94452313|NCT02016105|323443685|FG002|EXTENSION PERIOD|Adverse Event|2|||
94452314|NCT02016105|323443686|FG003|EXTENSION PERIOD|Adverse Event|0|||
94452315|NCT02016105|323443687|FG004|EXTENSION PERIOD|Adverse Event|1|||
94452316|NCT02016105|323443688|FG005|EXTENSION PERIOD|Adverse Event|0|||
94452317|NCT02016105|323443683|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
94452318|NCT02016105|323443684|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
94452319|NCT02016105|323443685|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
94452320|NCT02016105|323443686|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
94452321|NCT02016105|323443687|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
94452322|NCT02016105|323443688|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
94452323|NCT02016105|323443683|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
94452324|NCT02016105|323443684|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
94452325|NCT02016105|323443685|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
94452326|NCT02016105|323443686|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
94452327|NCT02016105|323443687|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
94452328|NCT02016105|323443688|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
94452329|NCT02016105|323443683|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
94452330|NCT02016105|323443684|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
94238664|NCT02906020|322668531|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
94573960|NCT01908426|323901684|FG001|Overall Study|Clinical Deterioration|38|||
94573961|NCT01908426|323901683|FG000|Overall Study|Lack of Efficacy|3|||
94573962|NCT01908426|323901684|FG001|Overall Study|Lack of Efficacy|0|||
94573963|NCT01908426|323901683|FG000|Overall Study|Lost to Follow-up|0|||
94573964|NCT01908426|323901684|FG001|Overall Study|Lost to Follow-up|1|||
94238665|NCT02906020|322668532|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
94238666|NCT02906020|322668533|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
94238667|NCT02906020|322668534|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
94238668|NCT02906020|322668519|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
94238669|NCT02906020|322668520|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
94238670|NCT02906020|322668521|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
94573965|NCT01908426|323901683|FG000|Overall Study|Physician Decision|3|||
94238671|NCT02906020|322668522|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
94238672|NCT02906020|322668523|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
94238673|NCT02906020|322668524|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
94238674|NCT02906020|322668525|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
94238675|NCT02906020|322668526|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
94238676|NCT02906020|322668527|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
94238677|NCT02906020|322668528|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
94238678|NCT02906020|322668529|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
94238679|NCT02906020|322668530|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
94348904|NCT02185040|323058832|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
94348905|NCT02185040|323058833|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
94452331|NCT02016105|323443685|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
94452332|NCT02016105|323443686|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
94452333|NCT02016105|323443687|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
94452334|NCT02016105|323443688|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
94452335|NCT01680861|323443689|FG000|Early Post-transplant Period|Protocol Violation|1|||
94452336|NCT01680861|323443690|FG001|Early Post-transplant Period|Protocol Violation|1|||
94452337|NCT00492648|323443694|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
94452338|NCT00492648|323443695|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
94452339|NCT03474731|323443699|FG000|Overall Study|Withdrawal by Subject|36|||
94452340|NCT03474731|323443700|FG001|Overall Study|Withdrawal by Subject|29|||
94452341|NCT03474731|323443701|FG002|Overall Study|Withdrawal by Subject|11|||
94452342|NCT03474731|323443702|FG003|Overall Study|Withdrawal by Subject|27|||
94452343|NCT03474731|323443699|FG000|Overall Study|COVID|0|||
94452344|NCT03474731|323443700|FG001|Overall Study|COVID|23|||
94452345|NCT03474731|323443701|FG002|Overall Study|COVID|0|||
94452346|NCT03474731|323443702|FG003|Overall Study|COVID|0|||
94452347|NCT03474731|323443699|FG000|Overall Study|Participant moved from area|1|||
94452348|NCT03474731|323443700|FG001|Overall Study|Participant moved from area|0|||
94452349|NCT03474731|323443701|FG002|Overall Study|Participant moved from area|0|||
94452350|NCT03474731|323443702|FG003|Overall Study|Participant moved from area|0|||
94452351|NCT03474731|323443699|FG000|Overall Study|Lost to Follow-up|11|||
94452352|NCT03474731|323443700|FG001|Overall Study|Lost to Follow-up|3|||
94452353|NCT03474731|323443701|FG002|Overall Study|Lost to Follow-up|18|||
94452354|NCT03474731|323443702|FG003|Overall Study|Lost to Follow-up|17|||
94452355|NCT03474731|323443699|FG000|Overall Study|Death|0|||
94452356|NCT03474731|323443700|FG001|Overall Study|Death|1|||
94452357|NCT03474731|323443701|FG002|Overall Study|Death|0|||
94452358|NCT03474731|323443702|FG003|Overall Study|Death|0|||
94452359|NCT03474731|323443699|FG000|Overall Study|Participant Removed|0|||
94452360|NCT03474731|323443700|FG001|Overall Study|Participant Removed|0|||
94452361|NCT03474731|323443701|FG002|Overall Study|Participant Removed|0|||
94452362|NCT03474731|323443702|FG003|Overall Study|Participant Removed|1|||
94452363|NCT02549287|323443703|FG000|Overall Study|Lost to Follow-up|65|||
94452364|NCT02549287|323443704|FG001|Overall Study|Lost to Follow-up|26|||
94452365|NCT02549287|323443703|FG000|Overall Study|Withdrawal by Subject|15|||
94452366|NCT02549287|323443704|FG001|Overall Study|Withdrawal by Subject|6|||
94452367|NCT00900159|323443705|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
94452368|NCT00900159|323443706|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
94452369|NCT00765336|323443707|FG000|Overall Study|Protocol Violation|4|||
94452370|NCT00765336|323443708|FG001|Overall Study|Protocol Violation|2|||
94452371|NCT00765336|323443707|FG000|Overall Study|Withdrawal by Subject|6|||
94452372|NCT00765336|323443708|FG001|Overall Study|Withdrawal by Subject|4|||
94452373|NCT00765336|323443707|FG000|Overall Study|Lost to Follow-up|7|||
94452374|NCT00765336|323443708|FG001|Overall Study|Lost to Follow-up|9|||
94452375|NCT00765336|323443707|FG000|Overall Study|Adverse Event|2|||
94452376|NCT00765336|323443708|FG001|Overall Study|Adverse Event|1|||
94452377|NCT00478777|323443709|FG000|Overall Study|Adverse Event|29|||
94452378|NCT00478777|323443709|FG000|Overall Study|Lack of Efficacy|23|||
94452379|NCT00478777|323443709|FG000|Overall Study|Withdrawal by Subject|4|||
94452380|NCT00478777|323443709|FG000|Overall Study|Death|3|||
94452381|NCT00478777|323443709|FG000|Overall Study|Protocol Violation|3|||
94348906|NCT02185040|323058827|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
94348907|NCT02185040|323058828|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
94348908|NCT02185040|323058829|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
94348909|NCT02185040|323058830|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
94348910|NCT02185040|323058831|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
94348911|NCT02185040|323058832|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
94348912|NCT02185040|323058833|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
94348913|NCT02185040|323058827|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
94348914|NCT02185040|323058828|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
94348915|NCT02185040|323058829|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
94348916|NCT02185040|323058830|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
94348917|NCT02185040|323058831|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
94348918|NCT02185040|323058832|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
94348919|NCT02185040|323058833|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
94348920|NCT02185040|323058827|FG000|Active Treatment Extension Phase|Adverse Event|0|||
94348921|NCT02185040|323058828|FG001|Active Treatment Extension Phase|Adverse Event|0|||
94348922|NCT02185040|323058829|FG002|Active Treatment Extension Phase|Adverse Event|0|||
94348923|NCT02185040|323058830|FG003|Active Treatment Extension Phase|Adverse Event|0|||
94348924|NCT02185040|323058831|FG004|Active Treatment Extension Phase|Adverse Event|0|||
94348925|NCT02185040|323058832|FG005|Active Treatment Extension Phase|Adverse Event|1|||
94348926|NCT02185040|323058833|FG006|Active Treatment Extension Phase|Adverse Event|4|||
94348927|NCT02185040|323058827|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
94348928|NCT02185040|323058828|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
94348929|NCT02185040|323058829|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
94348930|NCT02185040|323058830|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
94348931|NCT02185040|323058831|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
94348932|NCT02185040|323058832|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
94452382|NCT00478777|323443709|FG000|Overall Study|Lost to Follow-up|3|||
94452383|NCT00478777|323443709|FG000|Overall Study|Physician Decision|1|||
94452384|NCT00478777|323443709|FG000|Overall Study|Intolerance of therapy|1|||
94452385|NCT00478777|323443709|FG000|Overall Study|Lack of compliance|1|||
94452386|NCT00478777|323443709|FG000|Overall Study|Lymphocytes infusion|1|||
94452387|NCT00478777|323443709|FG000|Overall Study|End of therapy|2|||
94452388|NCT00478777|323443709|FG000|Overall Study|Not treated with lenalidomide|6|||
94452389|NCT02858583|323443710|FG000|Overall Study|Declined consent|1|||
94452390|NCT02858583|323443711|FG001|Overall Study|Declined consent|1|||
94452391|NCT01323387|323443714|FG000|Overall Study|Withdrawal by Subject|41|||
94452392|NCT01323387|323443714|FG000|Overall Study|Radiographic Data Unavailable|1|||
94452393|NCT01323387|323443714|FG000|Overall Study|Revision|14|||
94452394|NCT01323387|323443714|FG000|Overall Study|Protocol Violation|12|||
94452395|NCT01323387|323443714|FG000|Overall Study|Randomized but Never Treated|16|||
94452396|NCT02073929|323443723|FG000|Overall Study|Lost to Follow-up|2|||
94452397|NCT02073929|323443724|FG001|Overall Study|Lost to Follow-up|1|||
94452398|NCT02073929|323443723|FG000|Overall Study|Adverse Event|2|||
94452399|NCT02073929|323443724|FG001|Overall Study|Adverse Event|1|||
94452400|NCT02073929|323443723|FG000|Overall Study|Withdrawal by Subject|0|||
94452401|NCT02073929|323443724|FG001|Overall Study|Withdrawal by Subject|1|||
94452402|NCT01295827|323443725|FG000|Overall Study|Adverse Event|1|||
94452403|NCT01295827|323443726|FG001|Overall Study|Adverse Event|2|||
94452404|NCT01295827|323443727|FG002|Overall Study|Adverse Event|2|||
94452405|NCT01295827|323443728|FG003|Overall Study|Adverse Event|1|||
94452406|NCT01295827|323443729|FG004|Overall Study|Adverse Event|1|||
94452407|NCT01295827|323443730|FG005|Overall Study|Adverse Event|4|||
94452408|NCT01295827|323443731|FG006|Overall Study|Adverse Event|15|||
94452409|NCT01295827|323443732|FG007|Overall Study|Adverse Event|49|||
94452410|NCT01295827|323443733|FG008|Overall Study|Adverse Event|22|||
94452411|NCT01295827|323443734|FG009|Overall Study|Adverse Event|7|||
94452412|NCT01295827|323443735|FG010|Overall Study|Adverse Event|50|||
94452413|NCT01295827|323443736|FG011|Overall Study|Adverse Event|21|||
94452414|NCT01295827|323443737|FG012|Overall Study|Adverse Event|0|||
94452415|NCT01295827|323443738|FG013|Overall Study|Adverse Event|0|||
94452416|NCT01295827|323443739|FG014|Overall Study|Adverse Event|0|||
94348933|NCT02185040|323058833|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
94348934|NCT02185040|323058827|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
94452417|NCT01295827|323443725|FG000|Overall Study|Lost to Follow-up|0|||
94452418|NCT01295827|323443726|FG001|Overall Study|Lost to Follow-up|0|||
94452419|NCT01295827|323443727|FG002|Overall Study|Lost to Follow-up|3|||
94452420|NCT01295827|323443728|FG003|Overall Study|Lost to Follow-up|0|||
94348935|NCT02185040|323058828|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
94348936|NCT02185040|323058829|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
94452421|NCT01295827|323443729|FG004|Overall Study|Lost to Follow-up|1|||
94452422|NCT01295827|323443730|FG005|Overall Study|Lost to Follow-up|0|||
94452423|NCT01295827|323443731|FG006|Overall Study|Lost to Follow-up|4|||
94452424|NCT01295827|323443732|FG007|Overall Study|Lost to Follow-up|8|||
94452425|NCT01295827|323443733|FG008|Overall Study|Lost to Follow-up|7|||
94573966|NCT01908426|323901684|FG001|Overall Study|Physician Decision|3|||
94573967|NCT01908426|323901683|FG000|Overall Study|Withdrawal by Subject|11|||
94573968|NCT01908426|323901684|FG001|Overall Study|Withdrawal by Subject|6|||
94573969|NCT01908426|323901683|FG000|Overall Study|Progressive Disease|206|||
94573970|NCT01908426|323901684|FG001|Overall Study|Progressive Disease|152|||
94573971|NCT01908426|323901683|FG000|Overall Study|Protocol Violation|1|||
94573972|NCT01908426|323901684|FG001|Overall Study|Protocol Violation|0|||
94573973|NCT01908426|323901683|FG000|Overall Study|No Study Treatment Given|3|||
94573974|NCT01908426|323901684|FG001|Overall Study|No Study Treatment Given|0|||
94573975|NCT03525444|323901685|FG000|Overall Study|Adverse Event|0|||
94573976|NCT03525444|323901686|FG001|Overall Study|Adverse Event|1|||
94573977|NCT03525444|323901685|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
94573978|NCT03525444|323901686|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
94573979|NCT03525444|323901685|FG000|Overall Study|Other|0|||
94573980|NCT03525444|323901686|FG001|Overall Study|Other|1|||
94573981|NCT04456504|323901696|FG000|Overall Study|Lost to Follow-up|2|||
94573982|NCT01775501|323901706|FG000|Overall Study|Discontinued prior to treatment|1|||
94573983|NCT04515771|323901711|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
94573984|NCT04515771|323901712|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
94573985|NCT04515771|323901711|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
94573986|NCT04515771|323901712|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
94573987|NCT04515771|323901711|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
94573988|NCT04515771|323901712|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
94573989|NCT00948246|323901715|FG000|Overall Study|Lost to Follow-up|11|||
94573990|NCT00948246|323901715|FG000|Overall Study|Adverse Event|11|||
94573991|NCT00948246|323901715|FG000|Overall Study|Death|1|||
94573992|NCT00948246|323901715|FG000|Overall Study|Withdrawal by Subject|1|||
94573993|NCT03598036|323901718|FG000|Overall Study|Withdrawal by Subject|1|||
94573994|NCT03598036|323901719|FG001|Overall Study|Withdrawal by Subject|0|||
94573995|NCT02891174|323901720|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
94573996|NCT02891174|323901721|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
94573997|NCT02891174|323901720|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
94573998|NCT02891174|323901721|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
94573999|NCT02891174|323901720|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
94574000|NCT02891174|323901721|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
94574001|NCT02891174|323901720|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
94574002|NCT02891174|323901721|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
94574003|NCT02891174|323901720|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
94574004|NCT02891174|323901721|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
94574005|NCT02891174|323901720|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
94574006|NCT02891174|323901721|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
94574007|NCT02891174|323901720|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
94574008|NCT02891174|323901721|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
94574009|NCT04124939|323901722|FG000|Overall Study|Lost to Follow-up|1|||
94574010|NCT04124939|323901723|FG001|Overall Study|Lost to Follow-up|3|||
94574011|NCT04607668|323901727|FG000|Overall Study|Death|49|||
94574012|NCT04607668|323901728|FG001|Overall Study|Death|26|||
94574013|NCT04607668|323901727|FG000|Overall Study|Lost to Follow-up|3|||
94574014|NCT04607668|323901728|FG001|Overall Study|Lost to Follow-up|4|||
94574015|NCT04607668|323901727|FG000|Overall Study|Study terminated by Sponsor|92|||
94574016|NCT04607668|323901728|FG001|Overall Study|Study terminated by Sponsor|114|||
94574017|NCT04607668|323901727|FG000|Overall Study|Withdrawal by Subject|12|||
94574018|NCT04607668|323901728|FG001|Overall Study|Withdrawal by Subject|11|||
94574019|NCT04607668|323901727|FG000|Overall Study|Other, unspecified|8|||
94574020|NCT04607668|323901728|FG001|Overall Study|Other, unspecified|7|||
94574021|NCT03182374|323901730|FG000|Overall Study|Lost to Follow-up|3|||
94574022|NCT03182374|323901731|FG001|Overall Study|Lost to Follow-up|2|||
94574023|NCT03182374|323901730|FG000|Overall Study|Lack of Efficacy|8|||
94574024|NCT03182374|323901731|FG001|Overall Study|Lack of Efficacy|14|||
94574025|NCT03182374|323901730|FG000|Overall Study|Withdrawal by Subject|1|||
94238680|NCT02906020|322668531|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
94238681|NCT02906020|322668532|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
94238682|NCT02906020|322668533|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
94238683|NCT02906020|322668534|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
94238684|NCT02906020|322668519|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
94238685|NCT02906020|322668520|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
94238686|NCT02906020|322668521|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
94238687|NCT02906020|322668522|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
94238688|NCT02906020|322668523|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
94238689|NCT02906020|322668524|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
94238690|NCT02906020|322668525|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
94238691|NCT02906020|322668526|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
94238692|NCT02906020|322668527|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
94452426|NCT01295827|323443734|FG009|Overall Study|Lost to Follow-up|4|||
94452427|NCT01295827|323443735|FG010|Overall Study|Lost to Follow-up|7|||
94452428|NCT01295827|323443736|FG011|Overall Study|Lost to Follow-up|3|||
94452429|NCT01295827|323443737|FG012|Overall Study|Lost to Follow-up|0|||
94452430|NCT01295827|323443738|FG013|Overall Study|Lost to Follow-up|0|||
94452431|NCT01295827|323443739|FG014|Overall Study|Lost to Follow-up|0|||
94452432|NCT01295827|323443725|FG000|Overall Study|Not Reported|0|||
94452433|NCT01295827|323443726|FG001|Overall Study|Not Reported|0|||
94452434|NCT01295827|323443727|FG002|Overall Study|Not Reported|0|||
94452435|NCT01295827|323443728|FG003|Overall Study|Not Reported|1|||
94452436|NCT01295827|323443729|FG004|Overall Study|Not Reported|0|||
94452437|NCT01295827|323443730|FG005|Overall Study|Not Reported|0|||
94658827|NCT02571452|324206199|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
94238693|NCT02906020|322668528|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
94238694|NCT02906020|322668529|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
94238695|NCT02906020|322668530|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
94238696|NCT02906020|322668531|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
94238697|NCT02906020|322668532|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
94238698|NCT02906020|322668533|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
94238699|NCT02906020|322668534|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
94238700|NCT02906020|322668519|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
94238701|NCT02906020|322668520|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
94238702|NCT02906020|322668521|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
94238703|NCT02906020|322668522|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
94238704|NCT02906020|322668523|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
94238705|NCT02906020|322668524|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
94238706|NCT02906020|322668525|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
94238707|NCT02906020|322668526|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
94238708|NCT02906020|322668527|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
94238709|NCT02906020|322668528|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
94238710|NCT02906020|322668529|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
94238711|NCT02906020|322668530|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
94238712|NCT02906020|322668531|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
94238713|NCT02906020|322668532|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
94238714|NCT02906020|322668533|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
94452438|NCT01295827|323443731|FG006|Overall Study|Not Reported|24|||
94452439|NCT01295827|323443732|FG007|Overall Study|Not Reported|58|||
94452440|NCT01295827|323443733|FG008|Overall Study|Not Reported|41|||
94452441|NCT01295827|323443734|FG009|Overall Study|Not Reported|2|||
94574026|NCT03182374|323901731|FG001|Overall Study|Withdrawal by Subject|1|||
94574027|NCT03182374|323901730|FG000|Overall Study|exit for non-compliance|1|||
94574028|NCT03182374|323901731|FG001|Overall Study|exit for non-compliance|1|||
94574029|NCT03182374|323901730|FG000|Overall Study|one subject was randomized but not treated|1|||
94574030|NCT03182374|323901731|FG001|Overall Study|one subject was randomized but not treated|0|||
94574031|NCT03182374|323901730|FG000|Overall Study|Other reasons|0|||
94574032|NCT03182374|323901731|FG001|Overall Study|Other reasons|3|||
94574033|NCT04205812|323901738|FG000|Randomized Treatment Period|Ongoing|28|||
94574034|NCT04205812|323901739|FG001|Randomized Treatment Period|Ongoing|138|||
94574035|NCT04205812|323901738|FG000|Randomized Treatment Period|Death|94|||
94574036|NCT04205812|323901739|FG001|Randomized Treatment Period|Death|226|||
94574037|NCT04205812|323901738|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
94574038|NCT04205812|323901739|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
94574039|NCT04205812|323901738|FG000|Randomized Treatment Period|Physician Decision|1|||
94574040|NCT04205812|323901739|FG001|Randomized Treatment Period|Physician Decision|4|||
94574041|NCT04205812|323901738|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
94574042|NCT04205812|323901739|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
94574043|NCT04205812|323901738|FG000|Randomized Treatment Period|Progressive Disease|0|||
94574044|NCT04205812|323901739|FG001|Randomized Treatment Period|Progressive Disease|1|||
94574045|NCT04205812|323901738|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
94574046|NCT04205812|323901739|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
94574047|NCT04205812|323901738|FG000|Monotherapy Treatment Period|Ongoing|17|||
94574048|NCT04205812|323901739|FG001|Monotherapy Treatment Period|Ongoing|0|||
94574049|NCT04205812|323901738|FG000|Monotherapy Treatment Period|Death|39|||
94574050|NCT04205812|323901739|FG001|Monotherapy Treatment Period|Death|0|||
94574051|NCT04205812|323901738|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
94574052|NCT04205812|323901739|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
94574053|NCT04205812|323901738|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
94574054|NCT04205812|323901739|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
94574055|NCT05316597|323901742|FG000|First Session|Withdrawal by Subject|0|||
94574056|NCT05316597|323901743|FG001|First Session|Withdrawal by Subject|1|||
94574057|NCT05316597|323901742|FG000|Washout Period|Lost to Follow-up|1|||
94574058|NCT05316597|323901743|FG001|Washout Period|Lost to Follow-up|2|||
94574059|NCT05316597|323901742|FG000|Washout Period|Physician Decision|1|||
94574060|NCT05316597|323901743|FG001|Washout Period|Physician Decision|1|||
94574061|NCT05316597|323901742|FG000|Washout Period|Excluded before second session|1|||
94574062|NCT05316597|323901743|FG001|Washout Period|Excluded before second session|1|||
94574063|NCT05316597|323901742|FG000|Washout Period|Withdrawal by Subject|0|||
94574064|NCT05316597|323901743|FG001|Washout Period|Withdrawal by Subject|4|||
94574065|NCT05526716|323901744|FG000|Overall Study|Death|1|||
94574066|NCT05526716|323901745|FG001|Overall Study|Death|2|||
94574067|NCT05526716|323901744|FG000|Overall Study|Lost to Follow-up|17|||
94574068|NCT05526716|323901745|FG001|Overall Study|Lost to Follow-up|15|||
94574069|NCT05526716|323901744|FG000|Overall Study|Physician Decision|0|||
94574070|NCT05526716|323901745|FG001|Overall Study|Physician Decision|1|||
94574071|NCT05526716|323901744|FG000|Overall Study|Randomized by mistake without study treatment|0|||
94574072|NCT05526716|323901745|FG001|Overall Study|Randomized by mistake without study treatment|1|||
94574073|NCT05526716|323901744|FG000|Overall Study|Withdrawal by Subject|12|||
94574074|NCT05526716|323901745|FG001|Overall Study|Withdrawal by Subject|12|||
94574075|NCT05526716|323901744|FG000|Overall Study|Not reported|0|||
94574076|NCT05526716|323901745|FG001|Overall Study|Not reported|2|||
94574077|NCT04750824|323901746|FG000|Overall Study|Toxicity/intolerability|3|||
94574078|NCT04750824|323901747|FG001|Overall Study|Toxicity/intolerability|1|||
94574079|NCT04750824|323901746|FG000|Overall Study|Death|1|||
94574080|NCT04750824|323901747|FG001|Overall Study|Death|3|||
94574081|NCT04750824|323901746|FG000|Overall Study|Scheduled duration of therapy complete|1|||
94574082|NCT04750824|323901747|FG001|Overall Study|Scheduled duration of therapy complete|9|||
94574083|NCT04750824|323901746|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
94574084|NCT04750824|323901747|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
94574085|NCT00524485|323901752|FG000|Overall Study|Withdrawal by Subject|5|||
94574086|NCT01089504|323901753|FG000|Overall Study|Lost to Follow-up|1|||
94574087|NCT01089504|323901754|FG001|Overall Study|Lost to Follow-up|1|||
94574088|NCT01089504|323901753|FG000|Overall Study|Withdrawal by Subject|2|||
94574089|NCT01089504|323901754|FG001|Overall Study|Withdrawal by Subject|0|||
94574090|NCT00062439|323901755|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
94574091|NCT00062439|323901755|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
94574092|NCT00062439|323901755|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
94574093|NCT00062439|323901755|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
94574094|NCT00062439|323901755|FG000|Post Chemoradiation Assessment|Death|1|||
94574095|NCT00062439|323901755|FG000|Post Chemoradiation Assessment|Disease progression|2|||
94574096|NCT00062439|323901755|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
94574097|NCT00062439|323901755|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
94574098|NCT00062439|323901755|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
94348937|NCT02185040|323058830|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
94348938|NCT02185040|323058831|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
94348939|NCT02185040|323058832|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
94348940|NCT02185040|323058833|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
94348941|NCT02200510|323058834|FG000|Overall Study|Death|1|||
94348942|NCT02200510|323058835|FG001|Overall Study|Death|1|||
94348943|NCT02200510|323058834|FG000|Overall Study|Protocol Violation|0|||
94452442|NCT01295827|323443735|FG010|Overall Study|Not Reported|23|||
94452443|NCT01295827|323443736|FG011|Overall Study|Not Reported|13|||
94452444|NCT01295827|323443737|FG012|Overall Study|Not Reported|0|||
94452445|NCT01295827|323443738|FG013|Overall Study|Not Reported|0|||
94452446|NCT01295827|323443739|FG014|Overall Study|Not Reported|0|||
94452447|NCT01295827|323443725|FG000|Overall Study|Progressive Disease|2|||
94452448|NCT01295827|323443726|FG001|Overall Study|Progressive Disease|1|||
94452449|NCT01295827|323443727|FG002|Overall Study|Progressive Disease|5|||
94452450|NCT01295827|323443728|FG003|Overall Study|Progressive Disease|2|||
94452451|NCT01295827|323443729|FG004|Overall Study|Progressive Disease|0|||
94452452|NCT01295827|323443730|FG005|Overall Study|Progressive Disease|1|||
94452453|NCT01295827|323443731|FG006|Overall Study|Progressive Disease|87|||
94452454|NCT01295827|323443732|FG007|Overall Study|Progressive Disease|144|||
94452455|NCT01295827|323443733|FG008|Overall Study|Progressive Disease|85|||
94452456|NCT01295827|323443734|FG009|Overall Study|Progressive Disease|40|||
94452457|NCT01295827|323443735|FG010|Overall Study|Progressive Disease|175|||
94452458|NCT01295827|323443736|FG011|Overall Study|Progressive Disease|136|||
94452459|NCT01295827|323443737|FG012|Overall Study|Progressive Disease|0|||
94452460|NCT01295827|323443738|FG013|Overall Study|Progressive Disease|0|||
94452461|NCT01295827|323443739|FG014|Overall Study|Progressive Disease|0|||
94452462|NCT01295827|323443725|FG000|Overall Study|Screen Failure|0|||
94452463|NCT01295827|323443726|FG001|Overall Study|Screen Failure|0|||
94452464|NCT01295827|323443727|FG002|Overall Study|Screen Failure|0|||
94452465|NCT01295827|323443728|FG003|Overall Study|Screen Failure|0|||
94452466|NCT01295827|323443729|FG004|Overall Study|Screen Failure|0|||
94452467|NCT01295827|323443730|FG005|Overall Study|Screen Failure|0|||
94452468|NCT01295827|323443731|FG006|Overall Study|Screen Failure|2|||
94452469|NCT01295827|323443732|FG007|Overall Study|Screen Failure|2|||
94452470|NCT01295827|323443733|FG008|Overall Study|Screen Failure|2|||
94452471|NCT01295827|323443734|FG009|Overall Study|Screen Failure|0|||
94452472|NCT01295827|323443735|FG010|Overall Study|Screen Failure|1|||
94452473|NCT01295827|323443736|FG011|Overall Study|Screen Failure|0|||
94452474|NCT01295827|323443737|FG012|Overall Study|Screen Failure|0|||
94452475|NCT01295827|323443738|FG013|Overall Study|Screen Failure|0|||
94452476|NCT01295827|323443739|FG014|Overall Study|Screen Failure|0|||
94452477|NCT01295827|323443725|FG000|Overall Study|Withdrawal by Subject|1|||
94452478|NCT01295827|323443726|FG001|Overall Study|Withdrawal by Subject|0|||
94452479|NCT01295827|323443727|FG002|Overall Study|Withdrawal by Subject|2|||
94452480|NCT01295827|323443728|FG003|Overall Study|Withdrawal by Subject|0|||
94452481|NCT01295827|323443729|FG004|Overall Study|Withdrawal by Subject|0|||
94452482|NCT01295827|323443730|FG005|Overall Study|Withdrawal by Subject|1|||
94452483|NCT01295827|323443731|FG006|Overall Study|Withdrawal by Subject|13|||
94452484|NCT01295827|323443732|FG007|Overall Study|Withdrawal by Subject|35|||
94452485|NCT01295827|323443733|FG008|Overall Study|Withdrawal by Subject|11|||
94452486|NCT01295827|323443734|FG009|Overall Study|Withdrawal by Subject|2|||
94452487|NCT01295827|323443735|FG010|Overall Study|Withdrawal by Subject|18|||
94452488|NCT01295827|323443736|FG011|Overall Study|Withdrawal by Subject|13|||
94452489|NCT01295827|323443737|FG012|Overall Study|Withdrawal by Subject|0|||
94452490|NCT01295827|323443738|FG013|Overall Study|Withdrawal by Subject|0|||
94452491|NCT01295827|323443739|FG014|Overall Study|Withdrawal by Subject|0|||
94452492|NCT01295827|323443725|FG000|Overall Study|Other|0|||
94452493|NCT01295827|323443726|FG001|Overall Study|Other|0|||
94452494|NCT01295827|323443727|FG002|Overall Study|Other|0|||
94452495|NCT01295827|323443728|FG003|Overall Study|Other|0|||
94452496|NCT01295827|323443729|FG004|Overall Study|Other|0|||
94452497|NCT01295827|323443730|FG005|Overall Study|Other|0|||
94452498|NCT01295827|323443731|FG006|Overall Study|Other|1|||
94452499|NCT01295827|323443732|FG007|Overall Study|Other|1|||
94452500|NCT01295827|323443733|FG008|Overall Study|Other|1|||
94452501|NCT01295827|323443734|FG009|Overall Study|Other|0|||
94452502|NCT01295827|323443735|FG010|Overall Study|Other|2|||
94452503|NCT01295827|323443736|FG011|Overall Study|Other|0|||
94452504|NCT01295827|323443737|FG012|Overall Study|Other|0|||
94452505|NCT01295827|323443738|FG013|Overall Study|Other|0|||
94452506|NCT01295827|323443739|FG014|Overall Study|Other|0|||
94452507|NCT00101166|323443740|FG000|Overall Study|progressive disease|10|||
94452508|NCT05020665|323443741|FG000|Overall Study|Study terminated by Sponsor|5|||
94452509|NCT05020665|323443742|FG001|Overall Study|Study terminated by Sponsor|4|||
94452510|NCT05020665|323443741|FG000|Overall Study|Death|2|||
94348944|NCT02200510|323058835|FG001|Overall Study|Protocol Violation|1|||
94452511|NCT05020665|323443742|FG001|Overall Study|Death|1|||
94452512|NCT05020665|323443741|FG000|Overall Study|Physician Decision|0|||
94452513|NCT05020665|323443742|FG001|Overall Study|Physician Decision|1|||
94574099|NCT00062439|323901755|FG000|Surgery|Physician Decision|4|||
94574100|NCT00062439|323901755|FG000|Surgery|Death|1|||
94574101|NCT00062439|323901755|FG000|Surgery|Adverse Event|2|||
94574102|NCT00062439|323901755|FG000|Consolidation Chemotherapy|Adverse Event|2|||
94574103|NCT04038359|323901768|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
94574104|NCT04038359|323901769|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
94574105|NCT04038359|323901768|FG000|Overall Study|Death|8|||
94574106|NCT04038359|323901769|FG001|Overall Study|Death|7|||
94574107|NCT04038359|323901768|FG000|Overall Study|Lost to Follow-up|3|||
94574108|NCT04038359|323901769|FG001|Overall Study|Lost to Follow-up|0|||
94574109|NCT04038359|323901768|FG000|Overall Study|Participant Moved|1|||
94574110|NCT04038359|323901769|FG001|Overall Study|Participant Moved|0|||
94574111|NCT04038359|323901768|FG000|Overall Study|Withdrawal by Subject|4|||
94574112|NCT04038359|323901769|FG001|Overall Study|Withdrawal by Subject|3|||
94574113|NCT04038359|323901768|FG000|Overall Study|Physician Decision|3|||
94574114|NCT04038359|323901769|FG001|Overall Study|Physician Decision|2|||
94574115|NCT04038359|323901768|FG000|Overall Study|Adverse Event|0|||
94574116|NCT04038359|323901769|FG001|Overall Study|Adverse Event|2|||
94574117|NCT04038359|323901768|FG000|Overall Study|Progressive Disease|0|||
94574118|NCT04038359|323901769|FG001|Overall Study|Progressive Disease|1|||
94574119|NCT05121766|323901770|FG000|Overall Study|Covid reinfection|3|||
94574120|NCT05121766|323901771|FG001|Overall Study|Covid reinfection|0|||
94574121|NCT05121766|323901770|FG000|Overall Study|Withdrawal by Subject|3|||
94574122|NCT05121766|323901771|FG001|Overall Study|Withdrawal by Subject|1|||
94574123|NCT05121766|323901770|FG000|Overall Study|Adverse Event|2|||
94574124|NCT05121766|323901771|FG001|Overall Study|Adverse Event|4|||
94574125|NCT05121766|323901770|FG000|Overall Study|Lost to Follow-up|0|||
94574126|NCT05121766|323901771|FG001|Overall Study|Lost to Follow-up|1|||
94574127|NCT01643668|323901774|FG000|Overall Study|Death|1|||
94574128|NCT00322881|323901776|FG000|Overall Study|Death|2|||
94574129|NCT00322881|323901776|FG000|Overall Study|Adverse Event|1|||
94574130|NCT00322881|323901776|FG000|Overall Study|Disease Progression|2|||
94574131|NCT04842747|323901782|FG000|Overall Study|Withdrawal by Subject|6|||
94574132|NCT04842747|323901783|FG001|Overall Study|Withdrawal by Subject|2|||
94574133|NCT04842747|323901782|FG000|Overall Study|Lost to Follow-up|1|||
94574134|NCT04842747|323901783|FG001|Overall Study|Lost to Follow-up|2|||
94574135|NCT04842747|323901782|FG000|Overall Study|Physician Decision|1|||
94574136|NCT04842747|323901783|FG001|Overall Study|Physician Decision|0|||
94574137|NCT04842747|323901782|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
94574138|NCT04842747|323901783|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
94574139|NCT02285855|323901786|FG000|Overall Study|Withdrawal by Subject|2|||
94574140|NCT02285855|323901787|FG001|Overall Study|Withdrawal by Subject|1|||
94574141|NCT03253796|323901788|FG000|Period 1: Run-In|Adverse Event|4|||
94574142|NCT03253796|323901789|FG001|Period 1: Run-In|Adverse Event|0|||
94574143|NCT03253796|323901790|FG002|Period 1: Run-In|Adverse Event|0|||
94574144|NCT03253796|323901791|FG003|Period 1: Run-In|Adverse Event|0|||
94574145|NCT03253796|323901792|FG004|Period 1: Run-In|Adverse Event|0|||
94574146|NCT03253796|323901788|FG000|Period 1: Run-In|Lack of Efficacy|1|||
94574147|NCT03253796|323901789|FG001|Period 1: Run-In|Lack of Efficacy|0|||
94574148|NCT03253796|323901790|FG002|Period 1: Run-In|Lack of Efficacy|0|||
94574149|NCT03253796|323901791|FG003|Period 1: Run-In|Lack of Efficacy|0|||
94574150|NCT03253796|323901792|FG004|Period 1: Run-In|Lack of Efficacy|0|||
94574151|NCT03253796|323901788|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
94574152|NCT03253796|323901789|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
94574153|NCT03253796|323901790|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
94574154|NCT03253796|323901791|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
94574155|NCT03253796|323901792|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
94574156|NCT03253796|323901788|FG000|Period 1: Run-In|Protocol Violation|5|||
94574157|NCT03253796|323901789|FG001|Period 1: Run-In|Protocol Violation|0|||
94574158|NCT03253796|323901790|FG002|Period 1: Run-In|Protocol Violation|0|||
94574159|NCT03253796|323901791|FG003|Period 1: Run-In|Protocol Violation|0|||
94574160|NCT03253796|323901792|FG004|Period 1: Run-In|Protocol Violation|0|||
94574161|NCT03253796|323901788|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
94574162|NCT03253796|323901789|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
94574163|NCT03253796|323901790|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
94574164|NCT03253796|323901791|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
94574165|NCT03253796|323901792|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
94574166|NCT03253796|323901788|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
94574167|NCT03253796|323901789|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
94574168|NCT03253796|323901790|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
94574169|NCT03253796|323901791|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
94574170|NCT03253796|323901792|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
94574171|NCT03253796|323901788|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
94574172|NCT03253796|323901789|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
94574173|NCT03253796|323901790|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
94348945|NCT02200510|323058834|FG000|Overall Study|Lost to Follow-up|7|||
94348946|NCT02200510|323058835|FG001|Overall Study|Lost to Follow-up|1|||
94348947|NCT02200510|323058834|FG000|Overall Study|potential COI - joined study team|1|||
94348948|NCT02200510|323058835|FG001|Overall Study|potential COI - joined study team|0|||
94574174|NCT03253796|323901791|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
94574175|NCT03253796|323901792|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
94574176|NCT03253796|323901788|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
94574177|NCT03253796|323901789|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
94574178|NCT03253796|323901790|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
94574179|NCT03253796|323901791|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
94574180|NCT03253796|323901792|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
94574181|NCT03253796|323901788|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
94574182|NCT03253796|323901789|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
94574183|NCT03253796|323901790|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
94574184|NCT03253796|323901791|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
94574185|NCT03253796|323901792|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
94574186|NCT03253796|323901788|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
94574187|NCT03253796|323901789|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
94574188|NCT03253796|323901790|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
94574189|NCT03253796|323901791|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
94574190|NCT03253796|323901792|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
94574191|NCT03253796|323901788|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
94574192|NCT03253796|323901789|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
94574193|NCT03253796|323901790|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
94574194|NCT03253796|323901791|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
94574195|NCT03253796|323901792|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
94574196|NCT00528112|323901793|FG000|Treatment up to 3 Years|Adverse Event|313|||
94574197|NCT00528112|323901794|FG001|Treatment up to 3 Years|Adverse Event|278|||
94574198|NCT00528112|323901793|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
94574199|NCT00528112|323901794|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
94574200|NCT00528112|323901793|FG000|Treatment up to 3 Years|Protocol Violation|16|||
94574201|NCT00528112|323901794|FG001|Treatment up to 3 Years|Protocol Violation|16|||
94574202|NCT00528112|323901793|FG000|Treatment up to 3 Years|Death|0|||
94574203|NCT00528112|323901794|FG001|Treatment up to 3 Years|Death|1|||
94574204|NCT00528112|323901793|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
94574205|NCT00528112|323901794|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
94574206|NCT00528112|323901793|FG000|Treatment up to 3 Years|Pregnancy|9|||
94574207|NCT00528112|323901794|FG001|Treatment up to 3 Years|Pregnancy|10|||
94574208|NCT00528112|323901793|FG000|Treatment up to 3 Years|Other reasons|186|||
94574209|NCT00528112|323901794|FG001|Treatment up to 3 Years|Other reasons|186|||
94574210|NCT00528112|323901793|FG000|Extension Phase|Withdrawal by Subject|0|||
94574211|NCT00528112|323901794|FG001|Extension Phase|Withdrawal by Subject|3|||
94574212|NCT00528112|323901793|FG000|Extension Phase|Other reasons|0|||
94574213|NCT00528112|323901794|FG001|Extension Phase|Other reasons|100|||
94574214|NCT00528112|323901793|FG000|Extension Phase|Pregnancy|0|||
94574215|NCT00528112|323901794|FG001|Extension Phase|Pregnancy|3|||
94574216|NCT00528112|323901793|FG000|Extension Phase|Lost to Follow-up|0|||
94574217|NCT00528112|323901794|FG001|Extension Phase|Lost to Follow-up|12|||
94574218|NCT00528112|323901793|FG000|Extension Phase|Death|0|||
94574219|NCT00528112|323901794|FG001|Extension Phase|Death|1|||
94574220|NCT00528112|323901793|FG000|Extension Phase|Adverse Event|0|||
94348949|NCT02275052|323058836|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
94348950|NCT02275052|323058837|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
94574221|NCT00528112|323901794|FG001|Extension Phase|Adverse Event|36|||
94348951|NCT02275052|323058838|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
94348952|NCT02275052|323058839|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
94574222|NCT00528112|323901793|FG000|Extension Phase|Protocol Violation|0|||
94574223|NCT00528112|323901794|FG001|Extension Phase|Protocol Violation|2|||
94365657|NCT01788163|323124744|FG005|Overall Study|Withdrawal by Subject|0|||
94574224|NCT01451606|323901795|FG000|Overall Study|Withdrawal by Subject|4|||
94574225|NCT01451606|323901796|FG001|Overall Study|Withdrawal by Subject|3|||
94574226|NCT02559622|323901799|FG000|Overall Study|Progressive disease|0|||
94574227|NCT02559622|323901800|FG001|Overall Study|Progressive disease|1|||
94574228|NCT02559622|323901801|FG002|Overall Study|Progressive disease|0|||
94574229|NCT02559622|323901802|FG003|Overall Study|Progressive disease|0|||
94574230|NCT02559622|323901799|FG000|Overall Study|Adverse Event|0|||
94574231|NCT02559622|323901800|FG001|Overall Study|Adverse Event|2|||
94574232|NCT02559622|323901801|FG002|Overall Study|Adverse Event|2|||
94574233|NCT02559622|323901802|FG003|Overall Study|Adverse Event|2|||
94574234|NCT02559622|323901799|FG000|Overall Study|Patient/guardian decision|1|||
94574235|NCT02559622|323901800|FG001|Overall Study|Patient/guardian decision|2|||
94574236|NCT02559622|323901801|FG002|Overall Study|Patient/guardian decision|0|||
94574237|NCT02559622|323901802|FG003|Overall Study|Patient/guardian decision|1|||
94574238|NCT02163538|323901803|FG000|Overall Study|Protocol Violation|1|||
94574239|NCT02163538|323901804|FG001|Overall Study|Protocol Violation|0|||
94574240|NCT02163538|323901803|FG000|Overall Study|Physician Decision|0|||
94574241|NCT02163538|323901804|FG001|Overall Study|Physician Decision|1|||
94574242|NCT00894803|323901807|FG000|Overall Study|Death|20|||
94574243|NCT00894803|323901808|FG001|Overall Study|Death|4|||
94574244|NCT00894803|323901807|FG000|Overall Study|Lost to Follow-up|0|||
94574245|NCT00894803|323901808|FG001|Overall Study|Lost to Follow-up|1|||
94574246|NCT04484961|323901809|FG000|Overall Study|Lost to Follow-up|9|||
94574247|NCT04484961|323901810|FG001|Overall Study|Lost to Follow-up|9|||
94574248|NCT01667900|323901814|FG000|Part B|Death|0|||
94574249|NCT01667900|323901815|FG001|Part B|Death|0|||
94574250|NCT01667900|323901816|FG002|Part B|Death|0|||
94574251|NCT01667900|323901817|FG003|Part B|Death|0|||
94574252|NCT01667900|323901818|FG004|Part B|Death|0|||
94574253|NCT01667900|323901819|FG005|Part B|Death|0|||
94574254|NCT01667900|323901820|FG006|Part B|Death|0|||
94574255|NCT01667900|323901821|FG007|Part B|Death|0|||
94574256|NCT01667900|323901822|FG008|Part B|Death|0|||
94574257|NCT01667900|323901823|FG009|Part B|Death|0|||
94574258|NCT01667900|323901824|FG010|Part B|Death|0|||
94574259|NCT01667900|323901825|FG011|Part B|Death|0|||
94574260|NCT01667900|323901826|FG012|Part B|Death|0|||
94574261|NCT01667900|323901827|FG013|Part B|Death|0|||
94574262|NCT01667900|323901828|FG014|Part B|Death|0|||
94574263|NCT01667900|323901829|FG015|Part B|Death|0|||
94574264|NCT01667900|323901830|FG016|Part B|Death|1|||
94574265|NCT01667900|323901831|FG017|Part B|Death|0|||
94574266|NCT01667900|323901832|FG018|Part B|Death|0|||
94574267|NCT01667900|323901833|FG019|Part B|Death|0|||
94574268|NCT02138890|323901834|FG000|Overall Study|Adverse Event|1|||
94574269|NCT02138890|323901835|FG001|Overall Study|Adverse Event|0|||
94574270|NCT00849940|323901836|FG000|Overall Study|Physician Decision|4|||
94574271|NCT00878501|323903197|FG000|Overall Study|Adverse Event|11|||
94574272|NCT00878501|323903198|FG001|Overall Study|Adverse Event|3|||
94574273|NCT00878501|323903199|FG002|Overall Study|Adverse Event|3|||
94574274|NCT00878501|323903197|FG000|Overall Study|Lack of Efficacy|2|||
94574275|NCT00878501|323903198|FG001|Overall Study|Lack of Efficacy|1|||
94574276|NCT00878501|323903199|FG002|Overall Study|Lack of Efficacy|0|||
94574277|NCT00878501|323903197|FG000|Overall Study|Withdrawal by Subject|2|||
94452514|NCT05020665|323443741|FG000|Overall Study|Withdrawal by Subject|0|||
94452515|NCT05020665|323443742|FG001|Overall Study|Withdrawal by Subject|1|||
94574278|NCT00878501|323903198|FG001|Overall Study|Withdrawal by Subject|1|||
94574279|NCT00878501|323903199|FG002|Overall Study|Withdrawal by Subject|2|||
94574280|NCT00878501|323903197|FG000|Overall Study|Protocol Violation|0|||
94574281|NCT00878501|323903198|FG001|Overall Study|Protocol Violation|0|||
94574282|NCT00878501|323903199|FG002|Overall Study|Protocol Violation|1|||
94574283|NCT00878501|323903197|FG000|Overall Study|Incorrect enrolment|1|||
94574284|NCT00878501|323903198|FG001|Overall Study|Incorrect enrolment|2|||
94574285|NCT00878501|323903199|FG002|Overall Study|Incorrect enrolment|0|||
94574286|NCT00878501|323903197|FG000|Overall Study|Intake of prohibited concom. medication|0|||
94574287|NCT00878501|323903198|FG001|Overall Study|Intake of prohibited concom. medication|0|||
94574288|NCT00878501|323903199|FG002|Overall Study|Intake of prohibited concom. medication|1|||
94574289|NCT00878501|323903197|FG000|Overall Study|Mis-randomisation of patient|1|||
94574290|NCT00878501|323903198|FG001|Overall Study|Mis-randomisation of patient|0|||
94574291|NCT00878501|323903199|FG002|Overall Study|Mis-randomisation of patient|0|||
94574292|NCT00878501|323903197|FG000|Overall Study|Administrative|0|||
94574293|NCT00878501|323903198|FG001|Overall Study|Administrative|0|||
94574294|NCT00878501|323903199|FG002|Overall Study|Administrative|1|||
94574295|NCT01097668|323903200|FG000|Overall Study|Withdrawal by Subject|1|||
94574296|NCT01097668|323903201|FG001|Overall Study|Withdrawal by Subject|2|||
94574297|NCT01097668|323903200|FG000|Overall Study|Lost to Follow-up|1|||
94574298|NCT01097668|323903201|FG001|Overall Study|Lost to Follow-up|0|||
94574299|NCT00812708|323903206|FG000|Overall Study|Device could not be implanted|2|||
94238715|NCT02906020|322668534|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
94238716|NCT02906020|322668519|FG000|Part 2: Long-term Follow-up Period|Other|0|||
94238717|NCT02906020|322668520|FG001|Part 2: Long-term Follow-up Period|Other|0|||
94238718|NCT02906020|322668521|FG002|Part 2: Long-term Follow-up Period|Other|0|||
94238719|NCT02906020|322668522|FG003|Part 2: Long-term Follow-up Period|Other|0|||
94238720|NCT02906020|322668523|FG004|Part 2: Long-term Follow-up Period|Other|0|||
94238721|NCT02906020|322668524|FG005|Part 2: Long-term Follow-up Period|Other|0|||
94238722|NCT02906020|322668525|FG006|Part 2: Long-term Follow-up Period|Other|0|||
94238723|NCT02906020|322668526|FG007|Part 2: Long-term Follow-up Period|Other|0|||
94238724|NCT02906020|322668527|FG008|Part 2: Long-term Follow-up Period|Other|0|||
94238725|NCT02906020|322668528|FG009|Part 2: Long-term Follow-up Period|Other|0|||
94238726|NCT02906020|322668529|FG010|Part 2: Long-term Follow-up Period|Other|0|||
94574300|NCT00812708|323903206|FG000|Overall Study|Lack of medical insurance|1|||
94574301|NCT00812708|323903206|FG000|Overall Study|Switched to another study|1|||
94574302|NCT00812708|323903206|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
94574303|NCT00812708|323903206|FG000|Overall Study|Signed consent but later withdrew|3|||
94574304|NCT01959503|323903207|FG000|Overall Study|Death|2|||
94574305|NCT01959503|323903208|FG001|Overall Study|Death|1|||
94574306|NCT01959503|323903207|FG000|Overall Study|Randomized but not treated|1|||
94574307|NCT01959503|323903208|FG001|Overall Study|Randomized but not treated|1|||
94574308|NCT01600326|323903209|FG000|Overall Study|Lost to Follow-up|1|||
94574309|NCT01600326|323903210|FG001|Overall Study|Lost to Follow-up|1|||
94574310|NCT04199351|323903211|FG000|Overall Study|Decision by sponsor|0|||
94574311|NCT04199351|323903212|FG001|Overall Study|Decision by sponsor|0|||
94574312|NCT04199351|323903213|FG002|Overall Study|Decision by sponsor|0|||
94574313|NCT04199351|323903214|FG003|Overall Study|Decision by sponsor|2|||
94574314|NCT04199351|323903215|FG004|Overall Study|Decision by sponsor|0|||
94574315|NCT04199351|323903216|FG005|Overall Study|Decision by sponsor|0|||
94574316|NCT04199351|323903217|FG006|Overall Study|Decision by sponsor|0|||
94574317|NCT04199351|323903218|FG007|Overall Study|Decision by sponsor|0|||
94574318|NCT04199351|323903219|FG008|Overall Study|Decision by sponsor|0|||
94574319|NCT04199351|323903220|FG009|Overall Study|Decision by sponsor|6|||
94574320|NCT04199351|323903211|FG000|Overall Study|Lost to Follow-up|0|||
94574321|NCT04199351|323903212|FG001|Overall Study|Lost to Follow-up|0|||
94574322|NCT04199351|323903213|FG002|Overall Study|Lost to Follow-up|1|||
94574323|NCT04199351|323903214|FG003|Overall Study|Lost to Follow-up|0|||
94574324|NCT04199351|323903215|FG004|Overall Study|Lost to Follow-up|0|||
94574325|NCT04199351|323903216|FG005|Overall Study|Lost to Follow-up|1|||
94574326|NCT04199351|323903217|FG006|Overall Study|Lost to Follow-up|0|||
94574327|NCT04199351|323903218|FG007|Overall Study|Lost to Follow-up|0|||
94574328|NCT04199351|323903219|FG008|Overall Study|Lost to Follow-up|0|||
94574329|NCT04199351|323903220|FG009|Overall Study|Lost to Follow-up|0|||
94574330|NCT04199351|323903211|FG000|Overall Study|Withdrawal by Subject|0|||
94574331|NCT04199351|323903212|FG001|Overall Study|Withdrawal by Subject|1|||
94574332|NCT04199351|323903213|FG002|Overall Study|Withdrawal by Subject|0|||
94574333|NCT04199351|323903214|FG003|Overall Study|Withdrawal by Subject|0|||
94574334|NCT04199351|323903215|FG004|Overall Study|Withdrawal by Subject|1|||
94574335|NCT04199351|323903216|FG005|Overall Study|Withdrawal by Subject|4|||
94238727|NCT02906020|322668530|FG011|Part 2: Long-term Follow-up Period|Other|0|||
94238728|NCT02906020|322668531|FG012|Part 2: Long-term Follow-up Period|Other|13|||
94238729|NCT02906020|322668532|FG013|Part 2: Long-term Follow-up Period|Other|8|||
94238730|NCT02906020|322668533|FG014|Part 2: Long-term Follow-up Period|Other|3|||
94238731|NCT02906020|322668534|FG015|Part 2: Long-term Follow-up Period|Other|2|||
94238732|NCT01810939|322668535|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
94574336|NCT04199351|323903217|FG006|Overall Study|Withdrawal by Subject|2|||
94574337|NCT04199351|323903218|FG007|Overall Study|Withdrawal by Subject|0|||
94574338|NCT04199351|323903219|FG008|Overall Study|Withdrawal by Subject|3|||
94574339|NCT04199351|323903220|FG009|Overall Study|Withdrawal by Subject|0|||
94238733|NCT01810939|322668536|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
94238734|NCT01810939|322668537|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
94238735|NCT01810939|322668535|FG000|Part A Treatment Period|Protocol Violation|2|||
94238736|NCT01810939|322668536|FG001|Part A Treatment Period|Protocol Violation|0|||
94574340|NCT00248625|323903221|FG000|Overall Study|Withdrawal by Subject|0|||
94574341|NCT00248625|323903222|FG001|Overall Study|Withdrawal by Subject|2|||
94574342|NCT02182895|323903225|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
94574343|NCT02182895|323903226|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
94574344|NCT03547518|323903227|FG000|Overall Study|Lost to Follow-up|2|||
94574345|NCT03547518|323903228|FG001|Overall Study|Lost to Follow-up|0|||
94574346|NCT03103542|323903230|FG000|Overall Study|Physician Decision|2|||
94574347|NCT03103542|323903230|FG000|Overall Study|Adverse Event|2|||
94574348|NCT03103542|323903230|FG000|Overall Study|Other|2|||
94574349|NCT03103542|323903230|FG000|Overall Study|Withdrawal by Subject|1|||
94574350|NCT05137041|323903232|FG000|Overall Study|Lost to Follow-up|1|||
94574351|NCT05137041|323903233|FG001|Overall Study|Lost to Follow-up|1|||
94574352|NCT05137041|323903232|FG000|Overall Study|Withdrawal by Subject|0|||
94574353|NCT05137041|323903233|FG001|Overall Study|Withdrawal by Subject|2|||
94574354|NCT05137041|323903232|FG000|Overall Study|Reason not Specified|0|||
94574355|NCT05137041|323903233|FG001|Overall Study|Reason not Specified|1|||
94574356|NCT02384551|323903234|FG000|Overall Study|Lost to Follow-up|13|||
94574357|NCT02384551|323903235|FG001|Overall Study|Lost to Follow-up|14|||
94574358|NCT02384551|323903236|FG002|Overall Study|Lost to Follow-up|14|||
94574359|NCT02384551|323903237|FG003|Overall Study|Lost to Follow-up|14|||
94574360|NCT04613362|323903238|FG000|3 Month Follow-up|Lost to Follow-up|1|||
94574361|NCT04613362|323903239|FG001|3 Month Follow-up|Lost to Follow-up|2|||
94574362|NCT04613362|323903238|FG000|6 Month Follow-up|Lost to Follow-up|0|||
94574363|NCT04613362|323903239|FG001|6 Month Follow-up|Lost to Follow-up|1|||
94574364|NCT04742556|323903240|FG000|Overall Study|Withdrawal by Subject|0|||
94574365|NCT04742556|323903241|FG001|Overall Study|Withdrawal by Subject|1|||
94574366|NCT04742556|323903242|FG002|Overall Study|Withdrawal by Subject|0|||
94574367|NCT04742556|323903240|FG000|Overall Study|Adverse Event|0|||
94574368|NCT04742556|323903241|FG001|Overall Study|Adverse Event|0|||
94574369|NCT04742556|323903242|FG002|Overall Study|Adverse Event|2|||
94574370|NCT04742556|323903240|FG000|Overall Study|Clinical disease progression|0|||
94574371|NCT04742556|323903241|FG001|Overall Study|Clinical disease progression|1|||
94574372|NCT04742556|323903242|FG002|Overall Study|Clinical disease progression|2|||
94574373|NCT04742556|323903240|FG000|Overall Study|Objective disease progression|3|||
94574374|NCT04742556|323903241|FG001|Overall Study|Objective disease progression|2|||
94574375|NCT04742556|323903242|FG002|Overall Study|Objective disease progression|4|||
94574376|NCT00656513|323903254|FG000|Overall Study|Protocol Violation|1|||
94574377|NCT00656513|323903255|FG001|Overall Study|Protocol Violation|0|||
94574378|NCT00656513|323903256|FG002|Overall Study|Protocol Violation|2|||
94574379|NCT00656513|323903254|FG000|Overall Study|Withdrawal by Subject|0|||
94574380|NCT00656513|323903255|FG001|Overall Study|Withdrawal by Subject|11|||
94574381|NCT00656513|323903256|FG002|Overall Study|Withdrawal by Subject|4|||
94574382|NCT00656513|323903254|FG000|Overall Study|Death|0|||
94574383|NCT00656513|323903255|FG001|Overall Study|Death|0|||
94574384|NCT00656513|323903256|FG002|Overall Study|Death|1|||
94574385|NCT00656513|323903254|FG000|Overall Study|Missing data|0|||
94574386|NCT00656513|323903255|FG001|Overall Study|Missing data|11|||
94574387|NCT00656513|323903256|FG002|Overall Study|Missing data|9|||
94574388|NCT00656513|323903254|FG000|Overall Study|Incomplete treatment|3|||
94574389|NCT00656513|323903255|FG001|Overall Study|Incomplete treatment|0|||
94574390|NCT00656513|323903256|FG002|Overall Study|Incomplete treatment|0|||
94574391|NCT00656513|323903254|FG000|Overall Study|Treatment completed outside of timeframe|0|||
94574392|NCT00656513|323903255|FG001|Overall Study|Treatment completed outside of timeframe|3|||
94574393|NCT00656513|323903256|FG002|Overall Study|Treatment completed outside of timeframe|1|||
94574394|NCT00656513|323903254|FG000|Overall Study|Missing baseline form|0|||
94574395|NCT00656513|323903255|FG001|Overall Study|Missing baseline form|5|||
94574396|NCT00656513|323903256|FG002|Overall Study|Missing baseline form|5|||
94574397|NCT03780452|323903257|FG000|Overall Study|Screening failure|2|||
94574398|NCT00087152|323903258|FG000|Overall Study|Ineligible|6|||
94574399|NCT03199976|323903260|FG000|Overall Study|Lack of Efficacy|3|||
94574400|NCT03199976|323903261|FG001|Overall Study|Lack of Efficacy|6|||
94574401|NCT03199976|323903262|FG002|Overall Study|Lack of Efficacy|13|||
94574402|NCT03199976|323903260|FG000|Overall Study|Withdrawal by Subject|1|||
94574403|NCT03199976|323903261|FG001|Overall Study|Withdrawal by Subject|0|||
94574404|NCT03199976|323903262|FG002|Overall Study|Withdrawal by Subject|0|||
94574405|NCT03199976|323903260|FG000|Overall Study|Lost to Follow-up|0|||
94574406|NCT03199976|323903261|FG001|Overall Study|Lost to Follow-up|1|||
94574407|NCT03199976|323903262|FG002|Overall Study|Lost to Follow-up|1|||
94348953|NCT02275052|323058836|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
94348954|NCT02275052|323058837|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
94348955|NCT02275052|323058838|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
94348956|NCT02275052|323058839|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
94348957|NCT02275052|323058836|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
94574408|NCT04602390|323903263|FG000|Overall Study|Withdrawal by Subject|0|||
94574409|NCT04602390|323903264|FG001|Overall Study|Withdrawal by Subject|0|||
94574410|NCT04602390|323903265|FG002|Overall Study|Withdrawal by Subject|0|||
94574411|NCT04602390|323903266|FG003|Overall Study|Withdrawal by Subject|0|||
94574412|NCT04602390|323903267|FG004|Overall Study|Withdrawal by Subject|1|||
94574413|NCT04602390|323903268|FG005|Overall Study|Withdrawal by Subject|0|||
94574414|NCT04602390|323903263|FG000|Overall Study|Adverse Event|0|||
94574415|NCT04602390|323903264|FG001|Overall Study|Adverse Event|0|||
94574416|NCT04602390|323903265|FG002|Overall Study|Adverse Event|0|||
94574417|NCT04602390|323903266|FG003|Overall Study|Adverse Event|0|||
94658828|NCT02667912|324206200|FG000|Overall Study|Death|3|||
94574418|NCT04602390|323903267|FG004|Overall Study|Adverse Event|0|||
94574419|NCT04602390|323903268|FG005|Overall Study|Adverse Event|1|||
94574420|NCT03988400|323903269|FG000|Overall Study|Adverse Event|1|||
94574421|NCT03988400|323903270|FG001|Overall Study|Adverse Event|0|||
94574422|NCT03988400|323903269|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
94574423|NCT03988400|323903270|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
94574424|NCT03988400|323903269|FG000|Overall Study|Lost to Follow-up|0|||
94574425|NCT03988400|323903270|FG001|Overall Study|Lost to Follow-up|1|||
94574426|NCT03186209|323903277|FG000|Overall Study|Withdrawal by Subject|11|||
94574427|NCT03186209|323903278|FG001|Overall Study|Withdrawal by Subject|22|||
94574428|NCT03186209|323903277|FG000|Overall Study|Pregnancy|1|||
94574429|NCT03186209|323903278|FG001|Overall Study|Pregnancy|0|||
94574430|NCT03186209|323903277|FG000|Overall Study|Adverse Event|4|||
94574431|NCT03186209|323903278|FG001|Overall Study|Adverse Event|0|||
94574432|NCT03186209|323903277|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
94574433|NCT03186209|323903278|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
94574434|NCT03186209|323903277|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
94574435|NCT03186209|323903278|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
94574436|NCT03186209|323903277|FG000|Overall Study|Fail to meet randomization criteria|0|||
94574437|NCT03186209|323903278|FG001|Overall Study|Fail to meet randomization criteria|1|||
94574438|NCT03186209|323903277|FG000|Overall Study|Lost to Follow-up|0|||
94574439|NCT03186209|323903278|FG001|Overall Study|Lost to Follow-up|1|||
94574440|NCT04079296|323903290|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
94574441|NCT04079296|323903291|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
94574442|NCT04079296|323903292|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
94574443|NCT04079296|323903293|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
94574444|NCT04079296|323903294|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
94574445|NCT04079296|323903290|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
94574446|NCT04079296|323903291|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
94574447|NCT04079296|323903292|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
94574448|NCT04079296|323903293|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
94658829|NCT02667912|324206201|FG001|Overall Study|Death|1|||
94658830|NCT02667912|324206200|FG000|Overall Study|Withdrawal by Subject|1|||
94658831|NCT02667912|324206201|FG001|Overall Study|Withdrawal by Subject|2|||
94658832|NCT02667912|324206200|FG000|Overall Study|Withdrawal by Subject|1|||
94658833|NCT02667912|324206201|FG001|Overall Study|Withdrawal by Subject|0|||
94658834|NCT00346034|324206202|FG000|Overall Study|Adverse Event|34|||
94658835|NCT00346034|324206202|FG000|Overall Study|Lack of Efficacy|8|||
94658836|NCT00346034|324206202|FG000|Overall Study|Withdrawal by Subject|13|||
94658837|NCT00346034|324206202|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
94658838|NCT00346034|324206202|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
94658839|NCT02464969|324206207|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
94658840|NCT02464969|324206208|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
94658841|NCT02464969|324206207|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
94658842|NCT02464969|324206208|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
94658843|NCT02464969|324206207|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
94658844|NCT02464969|324206208|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
94658845|NCT02464969|324206207|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
94574449|NCT04079296|323903294|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
94574450|NCT04079296|323903290|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
94658846|NCT02464969|324206208|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
94658847|NCT02464969|324206207|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
94658848|NCT02464969|324206208|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
94348958|NCT02275052|323058837|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
94348959|NCT02275052|323058838|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
94348960|NCT02275052|323058839|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
94348961|NCT02275052|323058836|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
94348962|NCT02275052|323058837|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
94348963|NCT02275052|323058838|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
94348964|NCT02275052|323058839|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
94348965|NCT02275052|323058836|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
94348966|NCT02275052|323058837|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
94348967|NCT02275052|323058838|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
94348968|NCT02275052|323058839|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
94348969|NCT02275052|323058836|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
94348970|NCT02275052|323058837|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
94348971|NCT02275052|323058838|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
94348972|NCT02275052|323058839|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
94348973|NCT02275052|323058836|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
94348974|NCT02275052|323058837|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
94348975|NCT02275052|323058838|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
94348976|NCT02275052|323058839|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
94348977|NCT02275052|323058836|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
94348978|NCT02275052|323058837|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
94348979|NCT02275052|323058838|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
94348980|NCT02275052|323058839|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
94348981|NCT02275052|323058836|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
94348982|NCT02275052|323058837|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
94348983|NCT02275052|323058838|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
94348984|NCT02275052|323058839|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
94348985|NCT02275052|323058836|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
94348986|NCT02275052|323058837|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
94348987|NCT02275052|323058838|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
94348988|NCT02275052|323058839|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
94348989|NCT02275052|323058836|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
94574451|NCT04079296|323903291|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
94574452|NCT04079296|323903292|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
94574453|NCT04079296|323903293|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
94574454|NCT04079296|323903294|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
94574455|NCT04079296|323903290|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
94574456|NCT04079296|323903291|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
94574457|NCT04079296|323903292|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
94574458|NCT04079296|323903293|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
94574459|NCT04079296|323903294|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
94574460|NCT04079296|323903290|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
94574461|NCT04079296|323903291|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
94574462|NCT04079296|323903292|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
94574463|NCT04079296|323903293|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
94574464|NCT04079296|323903294|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
94574465|NCT04079296|323903290|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
94574466|NCT04079296|323903291|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
94574467|NCT04079296|323903292|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
94574468|NCT04079296|323903293|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
94574469|NCT04079296|323903294|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
94574470|NCT04079296|323903290|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
94574471|NCT04079296|323903291|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
94574472|NCT04079296|323903292|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
94574473|NCT04079296|323903293|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
94574474|NCT04079296|323903294|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
94574475|NCT04079296|323903290|FG000|Dose Expansion Phase (168 Days)|Death|0|||
94574476|NCT04079296|323903291|FG001|Dose Expansion Phase (168 Days)|Death|0|||
94574477|NCT04079296|323903292|FG002|Dose Expansion Phase (168 Days)|Death|0|||
94574478|NCT04079296|323903293|FG003|Dose Expansion Phase (168 Days)|Death|1|||
94574479|NCT04079296|323903294|FG004|Dose Expansion Phase (168 Days)|Death|0|||
94574480|NCT00758771|323903295|FG000|Overall Study|Withdrawal by Subject|1|||
94574481|NCT00758771|323903296|FG001|Overall Study|Withdrawal by Subject|1|||
94574482|NCT00758771|323903295|FG000|Overall Study|Did not meet eligibility criteria|2|||
94574483|NCT00758771|323903296|FG001|Overall Study|Did not meet eligibility criteria|4|||
94574484|NCT00449696|323903299|FG000|Overall Study|Other Treatment Required|6|||
94574485|NCT00449696|323903300|FG001|Overall Study|Other Treatment Required|1|||
94574486|NCT00449696|323903299|FG000|Overall Study|Withdrawal by Subject|5|||
94574487|NCT00449696|323903300|FG001|Overall Study|Withdrawal by Subject|5|||
94574488|NCT00449696|323903299|FG000|Overall Study|Lost to Follow-up|2|||
94574489|NCT00449696|323903300|FG001|Overall Study|Lost to Follow-up|3|||
94574490|NCT00449696|323903299|FG000|Overall Study|Others|7|||
94574491|NCT00449696|323903300|FG001|Overall Study|Others|0|||
94574492|NCT01903460|323903304|FG000|Overall Study|Adverse Event|0|||
94574493|NCT01903460|323903305|FG001|Overall Study|Adverse Event|0|||
94574494|NCT01903460|323903306|FG002|Overall Study|Adverse Event|0|||
94574495|NCT01903460|323903307|FG003|Overall Study|Adverse Event|1|||
94574496|NCT04576988|323903308|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
94574497|NCT04576988|323903309|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
94574498|NCT04576988|323903308|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
94574499|NCT04576988|323903309|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
94574500|NCT04576988|323903308|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
94574501|NCT04576988|323903309|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
94574502|NCT04576988|323903308|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
94574503|NCT04576988|323903309|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
94574504|NCT04576988|323903308|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
94574505|NCT04576988|323903309|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
94574506|NCT04576988|323903308|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
94574507|NCT04576988|323903309|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
94574508|NCT04576988|323903308|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
94574509|NCT04576988|323903309|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
94574510|NCT04576988|323903308|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
94574511|NCT04576988|323903309|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
94574512|NCT04576988|323903308|FG000|Long Term Double Blind (LTDB)|Death|2|||
94574513|NCT04576988|323903309|FG001|Long Term Double Blind (LTDB)|Death|1|||
94574514|NCT04576988|323903308|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
94574515|NCT04576988|323903309|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
94574516|NCT00517296|323903312|FG000|Overall Study|Withdrawal by Subject|1|||
94574517|NCT00517296|323903313|FG001|Overall Study|Withdrawal by Subject|0|||
94574518|NCT04366349|323903314|FG000|Overall Study|Withdrawal by Subject|1|||
94574519|NCT04366349|323903315|FG001|Overall Study|Withdrawal by Subject|0|||
94574520|NCT04366349|323903316|FG002|Overall Study|Withdrawal by Subject|0|||
94574521|NCT04366349|323903317|FG003|Overall Study|Withdrawal by Subject|0|||
94574522|NCT04366349|323903318|FG004|Overall Study|Withdrawal by Subject|0|||
94574523|NCT04366349|323903319|FG005|Overall Study|Withdrawal by Subject|0|||
94574524|NCT03413891|323903325|FG000|Overall Study|Lost to Follow-up|2|||
94574525|NCT03413891|323903326|FG001|Overall Study|Lost to Follow-up|1|||
94574526|NCT03413891|323903325|FG000|Overall Study|Protocol Violation|0|||
94574527|NCT03413891|323903326|FG001|Overall Study|Protocol Violation|1|||
94574528|NCT03474588|323903327|FG000|Overall Study|Withdrawal by Subject|4|||
94574529|NCT03474588|323903328|FG001|Overall Study|Withdrawal by Subject|3|||
94574530|NCT03474588|323903327|FG000|Overall Study|Death|0|||
94574531|NCT03474588|323903328|FG001|Overall Study|Death|1|||
94574532|NCT05546476|323904784|FG000|Period 1: Part A|Adverse Event|2|||
94574533|NCT05546476|323904785|FG001|Period 1: Part A|Adverse Event|0|||
94574534|NCT05546476|323904786|FG002|Period 1: Part A|Adverse Event|0|||
94574535|NCT05546476|323904787|FG003|Period 1: Part A|Adverse Event|1|||
94574536|NCT05546476|323904784|FG000|Period 1: Part A|Death|4|||
94574537|NCT05546476|323904785|FG001|Period 1: Part A|Death|4|||
94574538|NCT05546476|323904786|FG002|Period 1: Part A|Death|5|||
94574539|NCT05546476|323904787|FG003|Period 1: Part A|Death|6|||
94574540|NCT05546476|323904784|FG000|Period 1: Part A|Lack of Efficacy|0|||
94238737|NCT01810939|322668537|FG002|Part A Treatment Period|Protocol Violation|0|||
94238738|NCT01810939|322668535|FG000|Part A Treatment Period|Adverse Event|10|||
94238739|NCT01810939|322668536|FG001|Part A Treatment Period|Adverse Event|0|||
94238740|NCT01810939|322668537|FG002|Part A Treatment Period|Adverse Event|0|||
94238741|NCT01810939|322668535|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
94238742|NCT01810939|322668536|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
94238743|NCT01810939|322668537|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
94238744|NCT01810939|322668535|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
94238745|NCT01810939|322668536|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
94238746|NCT01810939|322668537|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
94238747|NCT01810939|322668535|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
94238748|NCT01810939|322668536|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
94574541|NCT05546476|323904785|FG001|Period 1: Part A|Lack of Efficacy|0|||
94574542|NCT05546476|323904786|FG002|Period 1: Part A|Lack of Efficacy|0|||
94574543|NCT05546476|323904787|FG003|Period 1: Part A|Lack of Efficacy|1|||
94574544|NCT05546476|323904784|FG000|Period 1: Part A|Lost to Follow-up|0|||
94574545|NCT05546476|323904785|FG001|Period 1: Part A|Lost to Follow-up|0|||
94574546|NCT05546476|323904786|FG002|Period 1: Part A|Lost to Follow-up|0|||
94574547|NCT05546476|323904787|FG003|Period 1: Part A|Lost to Follow-up|1|||
94574548|NCT05546476|323904784|FG000|Period 1: Part A|Physician Decision|1|||
94574549|NCT05546476|323904785|FG001|Period 1: Part A|Physician Decision|0|||
94574550|NCT05546476|323904786|FG002|Period 1: Part A|Physician Decision|0|||
94574551|NCT05546476|323904787|FG003|Period 1: Part A|Physician Decision|0|||
94574552|NCT05546476|323904784|FG000|Period 1: Part A|Progressive disease|3|||
94574553|NCT05546476|323904785|FG001|Period 1: Part A|Progressive disease|5|||
94574554|NCT05546476|323904786|FG002|Period 1: Part A|Progressive disease|0|||
94574555|NCT05546476|323904787|FG003|Period 1: Part A|Progressive disease|1|||
94574556|NCT05546476|323904784|FG000|Period 1: Part A|Withdrawal by Subject|1|||
94574557|NCT05546476|323904785|FG001|Period 1: Part A|Withdrawal by Subject|1|||
94574558|NCT05546476|323904786|FG002|Period 1: Part A|Withdrawal by Subject|1|||
94574559|NCT05546476|323904787|FG003|Period 1: Part A|Withdrawal by Subject|2|||
94574560|NCT05546476|323904784|FG000|Period 1: Part A|Global deterioration of health status|2|||
94574561|NCT05546476|323904785|FG001|Period 1: Part A|Global deterioration of health status|2|||
94574562|NCT05546476|323904786|FG002|Period 1: Part A|Global deterioration of health status|1|||
94574563|NCT05546476|323904787|FG003|Period 1: Part A|Global deterioration of health status|4|||
94574564|NCT05546476|323904784|FG000|Period 1: Part A|Other: Unspecified|0|||
94574565|NCT05546476|323904785|FG001|Period 1: Part A|Other: Unspecified|2|||
94574566|NCT05546476|323904786|FG002|Period 1: Part A|Other: Unspecified|0|||
94574567|NCT05546476|323904787|FG003|Period 1: Part A|Other: Unspecified|0|||
94574568|NCT05546476|323904784|FG000|Period 2: Part B|Ongoing|26|||
94574569|NCT05546476|323904785|FG001|Period 2: Part B|Ongoing|27|||
94574570|NCT05546476|323904786|FG002|Period 2: Part B|Ongoing|35|||
94574571|NCT05546476|323904787|FG003|Period 2: Part B|Ongoing|29|||
94574572|NCT01473134|323904795|FG000|Overall Study|Lost to Follow-up|21|||
94574573|NCT01473134|323904796|FG001|Overall Study|Lost to Follow-up|13|||
94574574|NCT01473134|323904795|FG000|Overall Study|Protocol Violation|32|||
94574575|NCT01473134|323904796|FG001|Overall Study|Protocol Violation|19|||
94574576|NCT01473134|323904795|FG000|Overall Study|Withdrawal by Subject|1|||
94574577|NCT01473134|323904796|FG001|Overall Study|Withdrawal by Subject|2|||
94574578|NCT01473134|323904795|FG000|Overall Study|Death|0|||
94574579|NCT01473134|323904796|FG001|Overall Study|Death|1|||
94574580|NCT01473134|323904795|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
94574581|NCT01473134|323904796|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
94574582|NCT02814916|323904797|FG000|Overall Study|Withdrawal of consent|0|||
94574583|NCT02814916|323904798|FG001|Overall Study|Withdrawal of consent|2|||
94574584|NCT02814916|323904799|FG002|Overall Study|Withdrawal of consent|0|||
94574585|NCT02814916|323904797|FG000|Overall Study|Lost to Follow-up|0|||
94574586|NCT02814916|323904798|FG001|Overall Study|Lost to Follow-up|1|||
94574587|NCT02814916|323904799|FG002|Overall Study|Lost to Follow-up|0|||
94574588|NCT02814916|323904797|FG000|Overall Study|Other, not specified|0|||
94574589|NCT02814916|323904798|FG001|Overall Study|Other, not specified|1|||
94574590|NCT02814916|323904799|FG002|Overall Study|Other, not specified|0|||
94574591|NCT05635461|323904803|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
94574592|NCT05635461|323904804|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
94574593|NCT05635461|323904805|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
94574594|NCT05635461|323904806|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
94574595|NCT05635461|323904807|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
94574596|NCT05635461|323904808|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
94574597|NCT05635461|323904803|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
94574598|NCT05635461|323904804|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
94574599|NCT05635461|323904805|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
94574600|NCT05635461|323904806|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
94574601|NCT05635461|323904807|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
94574602|NCT05635461|323904808|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
94348990|NCT02275052|323058837|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
94348991|NCT02275052|323058838|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
94348992|NCT02275052|323058839|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
94348993|NCT01542632|323058842|FG000|Overall Study|Withdrawal of Consent|0|||
94348994|NCT01542632|323058843|FG001|Overall Study|Withdrawal of Consent|0|||
94348995|NCT01542632|323058844|FG002|Overall Study|Withdrawal of Consent|0|||
94348996|NCT01542632|323058845|FG003|Overall Study|Withdrawal of Consent|2|||
94348997|NCT01542632|323058846|FG004|Overall Study|Withdrawal of Consent|3|||
94348998|NCT01542632|323058847|FG005|Overall Study|Withdrawal of Consent|0|||
94348999|NCT01542632|323058842|FG000|Overall Study|Adverse Event|0|||
94349000|NCT01542632|323058843|FG001|Overall Study|Adverse Event|0|||
94349001|NCT01542632|323058844|FG002|Overall Study|Adverse Event|1|||
94349002|NCT01542632|323058845|FG003|Overall Study|Adverse Event|0|||
94349003|NCT01542632|323058846|FG004|Overall Study|Adverse Event|0|||
94349004|NCT01542632|323058847|FG005|Overall Study|Adverse Event|0|||
94349005|NCT01542632|323058842|FG000|Overall Study|Lost to Follow-up|0|||
94349006|NCT01542632|323058843|FG001|Overall Study|Lost to Follow-up|1|||
94349007|NCT01542632|323058844|FG002|Overall Study|Lost to Follow-up|0|||
94349008|NCT01542632|323058845|FG003|Overall Study|Lost to Follow-up|0|||
94349009|NCT01542632|323058846|FG004|Overall Study|Lost to Follow-up|0|||
94349010|NCT01542632|323058847|FG005|Overall Study|Lost to Follow-up|0|||
94349011|NCT01542632|323058842|FG000|Overall Study|Sponsor/Investigator Decision|0|||
94349012|NCT01542632|323058843|FG001|Overall Study|Sponsor/Investigator Decision|0|||
94349013|NCT01542632|323058844|FG002|Overall Study|Sponsor/Investigator Decision|0|||
94349014|NCT01542632|323058845|FG003|Overall Study|Sponsor/Investigator Decision|0|||
94349015|NCT01542632|323058846|FG004|Overall Study|Sponsor/Investigator Decision|1|||
94349016|NCT01542632|323058847|FG005|Overall Study|Sponsor/Investigator Decision|0|||
94349017|NCT00033514|323058848|FG000|Overall Study|Lost to Follow-up|1|||
94349018|NCT00033514|323058849|FG001|Overall Study|Lost to Follow-up|1|||
94349019|NCT00033514|323058848|FG000|Overall Study|Withdrawal by Subject|0|||
94349020|NCT00033514|323058849|FG001|Overall Study|Withdrawal by Subject|3|||
94349021|NCT03228836|323058850|FG000|Overall Study|Adverse Event|3|||
94349022|NCT03228836|323058850|FG000|Overall Study|Withdrawal by Subject|1|||
94349023|NCT03228836|323058850|FG000|Overall Study|Death|1|||
94349024|NCT03228836|323058850|FG000|Overall Study|Physician Decision|1|||
94574603|NCT05635461|323904803|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
94574604|NCT05635461|323904804|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
94574605|NCT05635461|323904805|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
94574606|NCT05635461|323904806|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
94238749|NCT01810939|322668537|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
94238750|NCT01810939|322668535|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
94238751|NCT01810939|322668536|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
94238752|NCT01810939|322668537|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
94238753|NCT01810939|322668535|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
94238754|NCT01810939|322668536|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
94349025|NCT03228836|323058850|FG000|Overall Study|Disease Progression|7|||
94349026|NCT03228836|323058850|FG000|Overall Study|Other|4|||
94349027|NCT00948389|323058854|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
94349028|NCT00948389|323058855|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
94349029|NCT00948389|323058856|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
94349030|NCT00948389|323058857|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
94349031|NCT00948389|323058858|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
94349032|NCT00948389|323058854|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
94349033|NCT00948389|323058855|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
94349034|NCT00948389|323058856|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
94349035|NCT00948389|323058857|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
94349036|NCT00948389|323058858|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
94452516|NCT05020665|323443741|FG000|Overall Study|Reason not specified|1|||
94349037|NCT00948389|323058854|FG000|Overall Study|Both Progression and Toxicity|1|||
94349038|NCT00948389|323058855|FG001|Overall Study|Both Progression and Toxicity|0|||
94349039|NCT00948389|323058856|FG002|Overall Study|Both Progression and Toxicity|0|||
94349040|NCT00948389|323058857|FG003|Overall Study|Both Progression and Toxicity|0|||
94349041|NCT00948389|323058858|FG004|Overall Study|Both Progression and Toxicity|0|||
94349042|NCT00348686|323058865|FG000|Overall Study|Withdrawal by Subject|45|||
94349043|NCT00348686|323058865|FG000|Overall Study|Adverse Event|5|||
94349044|NCT00348686|323058865|FG000|Overall Study|Protocol Violation|6|||
94349045|NCT00348686|323058865|FG000|Overall Study|Lost to Follow-up|2|||
94349046|NCT00348686|323058865|FG000|Overall Study|Multiple Reasons|8|||
94349047|NCT00508001|323058874|FG000|Overall Study|Adverse Event|2|||
94349048|NCT00508001|323058875|FG001|Overall Study|Adverse Event|0|||
94349049|NCT00508001|323058876|FG002|Overall Study|Adverse Event|4|||
94349050|NCT00508001|323058874|FG000|Overall Study|condition under investigation worsened|13|||
94349051|NCT00508001|323058875|FG001|Overall Study|condition under investigation worsened|7|||
94349052|NCT00508001|323058876|FG002|Overall Study|condition under investigation worsened|1|||
94349053|NCT00508001|323058874|FG000|Overall Study|Death|0|||
94349054|NCT00508001|323058875|FG001|Overall Study|Death|1|||
94349055|NCT00508001|323058876|FG002|Overall Study|Death|1|||
94349056|NCT00508001|323058874|FG000|Overall Study|Withdrawal by Subject|4|||
94349057|NCT00508001|323058875|FG001|Overall Study|Withdrawal by Subject|4|||
94349058|NCT00508001|323058876|FG002|Overall Study|Withdrawal by Subject|1|||
94349059|NCT02967562|323058879|FG000|Overall Study|Consent not obtained|1|||
94349060|NCT02967562|323058880|FG001|Overall Study|Consent not obtained|0|||
94349061|NCT02967562|323058879|FG000|Overall Study|High leak precluding analysis|1|||
94349062|NCT02967562|323058880|FG001|Overall Study|High leak precluding analysis|1|||
94349063|NCT00732199|323058885|FG000|Overall Study|Withdrawal by Subject|25|||
94349064|NCT00732199|323058886|FG001|Overall Study|Withdrawal by Subject|18|||
94349065|NCT00732199|323058885|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
94349066|NCT00732199|323058886|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
94349067|NCT02243306|323058892|FG000|Overall Study|Adverse Event|0|||
94349068|NCT02243306|323058893|FG001|Overall Study|Adverse Event|1|||
94349069|NCT02243306|323058892|FG000|Overall Study|Other: Reached stopping criteria|0|||
94452517|NCT05020665|323443742|FG001|Overall Study|Reason not specified|0|||
94574607|NCT05635461|323904807|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
94574608|NCT05635461|323904808|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
94574609|NCT01680341|323904811|FG000|Overall Study|Adverse Event|3|||
94574610|NCT01680341|323904812|FG001|Overall Study|Adverse Event|2|||
94574611|NCT01680341|323904811|FG000|Overall Study|Unclassified|18|||
94574612|NCT01680341|323904812|FG001|Overall Study|Unclassified|15|||
94574613|NCT00499486|323904813|FG000|Overall Study|Withdrawal by Subject|16|||
94574614|NCT02388269|323904814|FG000|Overall Study|Adverse Event|2|||
94574615|NCT02388269|323904815|FG001|Overall Study|Adverse Event|0|||
94574616|NCT02388269|323904816|FG002|Overall Study|Adverse Event|0|||
94574617|NCT02388269|323904814|FG000|Overall Study|Withdrawal by Subject|1|||
94574618|NCT02388269|323904815|FG001|Overall Study|Withdrawal by Subject|2|||
94574619|NCT02388269|323904816|FG002|Overall Study|Withdrawal by Subject|0|||
94574620|NCT02388269|323904814|FG000|Overall Study|less than 50% stimulations|1|||
94574621|NCT02388269|323904815|FG001|Overall Study|less than 50% stimulations|0|||
94574622|NCT02388269|323904816|FG002|Overall Study|less than 50% stimulations|0|||
94574623|NCT02388269|323904814|FG000|Overall Study|no diary data|3|||
94574624|NCT02388269|323904815|FG001|Overall Study|no diary data|0|||
94574625|NCT02388269|323904816|FG002|Overall Study|no diary data|0|||
94574626|NCT02388269|323904814|FG000|Overall Study|Protocol Violation|2|||
94574627|NCT02388269|323904815|FG001|Overall Study|Protocol Violation|0|||
94574628|NCT02388269|323904816|FG002|Overall Study|Protocol Violation|0|||
94574629|NCT02388269|323904814|FG000|Overall Study|Screen Failure|0|||
94574630|NCT02388269|323904815|FG001|Overall Study|Screen Failure|0|||
94574631|NCT02388269|323904816|FG002|Overall Study|Screen Failure|10|||
94574632|NCT03379818|323904817|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
94574633|NCT03379818|323904818|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
94574634|NCT03379818|323904817|FG000|Overall Study|Withdrawal by Subject|2|||
94574635|NCT03379818|323904818|FG001|Overall Study|Withdrawal by Subject|3|||
94574636|NCT03379818|323904817|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
94574637|NCT03379818|323904818|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
94574638|NCT03882021|323904819|FG000|Enrollment|Procedure aborted/cancelled|2|||
94574639|NCT03882021|323904819|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
94574640|NCT03882021|323904819|FG000|Enrollment to 3-Month|Death|1|||
94574641|NCT03882021|323904819|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
94574642|NCT03882021|323904819|FG000|Enrollment to 3-Month|Missed Visit|4|||
94574643|NCT03882021|323904819|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
94574644|NCT03882021|323904819|FG000|6-Month to 12-Month Visit|Death|1|||
94574645|NCT03882021|323904819|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
94574646|NCT04201431|323904820|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
94574647|NCT04201431|323904821|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
94574648|NCT04201431|323904822|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
94574649|NCT04629508|323904823|FG000|Overall Study|Adverse Event|1|||
94574650|NCT04629508|323904823|FG000|Overall Study|Death|2|||
94574651|NCT04629508|323904823|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
94574652|NCT05236270|323904830|FG000|Overall Study|Lost to Follow-up|3|||
94574653|NCT05236270|323904831|FG001|Overall Study|Lost to Follow-up|2|||
94574654|NCT05236270|323904832|FG002|Overall Study|Lost to Follow-up|0|||
94574655|NCT05236270|323904833|FG003|Overall Study|Lost to Follow-up|0|||
94574656|NCT05236270|323904834|FG004|Overall Study|Lost to Follow-up|2|||
94574657|NCT05236270|323904835|FG005|Overall Study|Lost to Follow-up|0|||
94349070|NCT02243306|323058893|FG001|Overall Study|Other: Reached stopping criteria|1|||
94574658|NCT05236270|323904836|FG006|Overall Study|Lost to Follow-up|1|||
94574659|NCT05236270|323904837|FG007|Overall Study|Lost to Follow-up|3|||
94574660|NCT02358473|323904839|FG000|Overall Study|Disease Progession|6|||
94574661|NCT02358473|323904839|FG000|Overall Study|Adverse Event|3|||
94574662|NCT02358473|323904839|FG000|Overall Study|Withdrawal by Subject|2|||
94574663|NCT02358473|323904839|FG000|Overall Study|Physician Decision|2|||
94574664|NCT04852302|323904840|FG000|Overall Study|Withdrawal by Subject|2|||
94574665|NCT04852302|323904840|FG000|Overall Study|Did not complete CALM therapy.|2|||
94349071|NCT02243306|323058892|FG000|Overall Study|Physician Decision|0|||
94349072|NCT02243306|323058893|FG001|Overall Study|Physician Decision|1|||
94574666|NCT01263769|323904841|FG000|Overall Study|Non-Compliant with treatment|1|||
94574667|NCT03267277|323904842|FG000|Overall Study|Withdrawal by Subject|1|||
94574668|NCT05468814|323904843|FG000|Overall Study|Lost to Follow-up|5|||
94574669|NCT05468814|323904844|FG001|Overall Study|Lost to Follow-up|6|||
94574670|NCT00561652|323904845|FG000|Overall Study|Withdrawal by Subject|0|||
94574671|NCT00561652|323904846|FG001|Overall Study|Withdrawal by Subject|1|||
94574672|NCT02718898|323904847|FG000|Blinded Treatment Period|Adverse Event|5|||
94574673|NCT02718898|323904848|FG001|Blinded Treatment Period|Adverse Event|1|||
94349073|NCT02381795|323058894|FG000|Overall Study|Withdrawal by Subject|1|||
94349074|NCT02381795|323058894|FG000|Overall Study|Study Terminated|2|||
94349075|NCT00829010|323058899|FG000|Overall Study|Adverse Event|1|||
94349076|NCT00829010|323058900|FG001|Overall Study|Adverse Event|0|||
94574674|NCT02718898|323904849|FG002|Blinded Treatment Period|Adverse Event|0|||
94574675|NCT02718898|323904850|FG003|Blinded Treatment Period|Adverse Event|0|||
94574676|NCT02718898|323904851|FG004|Blinded Treatment Period|Adverse Event|0|||
94574677|NCT02718898|323904852|FG005|Blinded Treatment Period|Adverse Event|0|||
94574678|NCT02718898|323904853|FG006|Blinded Treatment Period|Adverse Event|0|||
94574679|NCT02718898|323904847|FG000|Blinded Treatment Period|Physician Decision|1|||
94574680|NCT02718898|323904848|FG001|Blinded Treatment Period|Physician Decision|0|||
94574681|NCT02718898|323904849|FG002|Blinded Treatment Period|Physician Decision|0|||
94574682|NCT02718898|323904850|FG003|Blinded Treatment Period|Physician Decision|0|||
94574683|NCT02718898|323904851|FG004|Blinded Treatment Period|Physician Decision|0|||
94574684|NCT02718898|323904852|FG005|Blinded Treatment Period|Physician Decision|0|||
94574685|NCT02718898|323904853|FG006|Blinded Treatment Period|Physician Decision|0|||
94574686|NCT02718898|323904847|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
94574687|NCT02718898|323904848|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
94574688|NCT02718898|323904849|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
94349077|NCT00829010|323058901|FG002|Overall Study|Adverse Event|0|||
94574689|NCT02718898|323904850|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
94574690|NCT02718898|323904851|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
94574691|NCT02718898|323904852|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
94574692|NCT02718898|323904853|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
94574693|NCT02718898|323904847|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
94574694|NCT02718898|323904848|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
94574695|NCT02718898|323904849|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
94574696|NCT02718898|323904850|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
94574697|NCT02718898|323904851|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
94574698|NCT02718898|323904852|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
94574699|NCT02718898|323904853|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
94574700|NCT02718898|323904847|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
94574701|NCT02718898|323904848|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
94574702|NCT02718898|323904849|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
94574703|NCT02718898|323904850|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
94574704|NCT02718898|323904851|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
94574705|NCT02718898|323904852|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
94349078|NCT00829010|323058902|FG003|Overall Study|Adverse Event|0|||
94574706|NCT02718898|323904853|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
94349079|NCT00829010|323058903|FG004|Overall Study|Adverse Event|0|||
94349080|NCT00829010|323058899|FG000|Overall Study|Withdrawal by Subject|0|||
94349081|NCT00829010|323058900|FG001|Overall Study|Withdrawal by Subject|1|||
94574707|NCT02718898|323904847|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
94574708|NCT02718898|323904848|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
94574709|NCT02718898|323904849|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
94574710|NCT02718898|323904850|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
94574711|NCT02718898|323904851|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
94574712|NCT02718898|323904852|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
94574713|NCT02718898|323904853|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
94574714|NCT02718898|323904847|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
94574715|NCT02718898|323904848|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
94574716|NCT02718898|323904849|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
94574717|NCT02718898|323904850|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
94574718|NCT02718898|323904851|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
94574719|NCT02718898|323904852|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
94574720|NCT02718898|323904853|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
94574721|NCT02718898|323904847|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
94574722|NCT02718898|323904848|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
94574723|NCT02718898|323904849|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
94574724|NCT02718898|323904850|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
94574725|NCT02718898|323904851|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
94574726|NCT02718898|323904852|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
94349082|NCT00829010|323058901|FG002|Overall Study|Withdrawal by Subject|1|||
94349083|NCT00829010|323058902|FG003|Overall Study|Withdrawal by Subject|0|||
94349084|NCT00829010|323058903|FG004|Overall Study|Withdrawal by Subject|2|||
94349085|NCT00829010|323058899|FG000|Overall Study|Lost to Follow-up|1|||
94349086|NCT00829010|323058900|FG001|Overall Study|Lost to Follow-up|0|||
94349087|NCT00829010|323058901|FG002|Overall Study|Lost to Follow-up|2|||
94349088|NCT00829010|323058902|FG003|Overall Study|Lost to Follow-up|0|||
94349089|NCT00829010|323058903|FG004|Overall Study|Lost to Follow-up|0|||
94349090|NCT00829010|323058899|FG000|Overall Study|Fatality|5|||
94349091|NCT00829010|323058900|FG001|Overall Study|Fatality|4|||
94349092|NCT00829010|323058901|FG002|Overall Study|Fatality|0|||
94349093|NCT00829010|323058902|FG003|Overall Study|Fatality|3|||
94574727|NCT02718898|323904853|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
94574728|NCT02718898|323904847|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
94574729|NCT02718898|323904848|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
94574730|NCT02718898|323904849|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
94574731|NCT02718898|323904850|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
94574732|NCT02718898|323904851|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
94574733|NCT02718898|323904852|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
94349094|NCT00829010|323058903|FG004|Overall Study|Fatality|0|||
94349095|NCT00829010|323058899|FG000|Overall Study|Migrated/Moved from study area|3|||
94349096|NCT00829010|323058900|FG001|Overall Study|Migrated/Moved from study area|4|||
94349097|NCT00829010|323058901|FG002|Overall Study|Migrated/Moved from study area|0|||
94349098|NCT00829010|323058902|FG003|Overall Study|Migrated/Moved from study area|5|||
94349099|NCT00829010|323058903|FG004|Overall Study|Migrated/Moved from study area|0|||
94349100|NCT02908841|323058904|FG000|Overall Study|Physician Decision|4|||
94574734|NCT02718898|323904853|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
94574735|NCT02718898|323904847|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
94574736|NCT02718898|323904848|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
94574737|NCT02718898|323904849|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
94574738|NCT02718898|323904850|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
94574739|NCT02718898|323904851|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
94574740|NCT02718898|323904852|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
94574741|NCT02718898|323904853|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
94574742|NCT02718898|323904847|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
94574743|NCT02718898|323904848|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
94574744|NCT02718898|323904849|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
94574745|NCT02718898|323904850|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
94452518|NCT01628198|323443745|FG000|Overall Study|Lost to Follow-up|7|||
94574746|NCT02718898|323904851|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
94574747|NCT02718898|323904852|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
94574748|NCT02718898|323904853|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
94574749|NCT02718898|323904847|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
94574750|NCT02718898|323904848|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
94574751|NCT02718898|323904849|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
94574752|NCT02718898|323904850|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
94452519|NCT01628198|323443745|FG000|Overall Study|Withdrawal by Subject|10|||
94349101|NCT02908841|323058905|FG001|Overall Study|Physician Decision|0|||
94349102|NCT01227252|323058923|FG000|Overall Study|Sponsor Decision|0|||
94349103|NCT01227252|323058924|FG001|Overall Study|Sponsor Decision|1|||
94238755|NCT01810939|322668537|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
94238756|NCT01810939|322668535|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
94238757|NCT01810939|322668536|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
94238758|NCT01810939|322668537|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
94238759|NCT01810939|322668535|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
94238760|NCT01810939|322668536|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
94238761|NCT01810939|322668537|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
94238762|NCT01810939|322668535|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
94238763|NCT01810939|322668536|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
94238764|NCT01810939|322668537|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
94238765|NCT01810939|322668535|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
94238766|NCT01810939|322668536|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
94238767|NCT01810939|322668537|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
94238768|NCT01810939|322668535|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
94238769|NCT01810939|322668536|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
94238770|NCT01810939|322668537|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
94238771|NCT01810939|322668535|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
94238772|NCT01810939|322668536|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
94238773|NCT01810939|322668537|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
94238774|NCT01810939|322668535|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
94574753|NCT02718898|323904851|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
94574754|NCT02718898|323904852|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
94574755|NCT02718898|323904853|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
94574756|NCT02718898|323904847|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
94574757|NCT02718898|323904848|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
94574758|NCT02718898|323904849|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
94574759|NCT02718898|323904850|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
94574760|NCT02718898|323904851|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
94574761|NCT02718898|323904852|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
94574762|NCT02718898|323904853|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
94574763|NCT01345240|323904856|FG000|Overall Study|Adverse Event|3|||
94574764|NCT01345240|323904857|FG001|Overall Study|Adverse Event|5|||
94574765|NCT01345240|323904858|FG002|Overall Study|Adverse Event|4|||
94574766|NCT01345240|323904859|FG003|Overall Study|Adverse Event|2|||
94238775|NCT01810939|322668536|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
94238776|NCT01810939|322668537|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
94238777|NCT01810939|322668535|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
94238778|NCT01810939|322668536|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
94238779|NCT01810939|322668537|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
94238780|NCT01810939|322668535|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
94238781|NCT01810939|322668536|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
94238782|NCT01810939|322668537|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
94238783|NCT01174446|322668540|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
94238784|NCT01174446|322668541|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
94238785|NCT01174446|322668542|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
94238786|NCT01174446|322668543|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
94238787|NCT01174446|322668540|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
94238788|NCT01174446|322668541|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
94238789|NCT01174446|322668542|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
94238790|NCT01174446|322668543|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
94238791|NCT01174446|322668540|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
94238792|NCT01174446|322668541|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
94238793|NCT01174446|322668542|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
94238794|NCT01174446|322668543|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
94238795|NCT01174446|322668540|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
94238796|NCT01174446|322668541|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
94238797|NCT01174446|322668542|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
94238798|NCT01174446|322668543|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
94238799|NCT04829747|322668544|FG000|Overall Study|Protocol Violation|1|||
94238800|NCT02615509|322668545|FG000|Overall Study|Lost to Follow-up|134|||
94238801|NCT02615509|322668545|FG000|Overall Study|Death|4|||
94238802|NCT02615509|322668545|FG000|Overall Study|Withdrawal by Subject|8|||
94238803|NCT01077128|322668550|FG000|Overall Study|Adverse Event|8|||
94238804|NCT01077128|322668550|FG000|Overall Study|Lack of Efficacy|1|||
94238805|NCT01077128|322668550|FG000|Overall Study|Disease exacerbation|1|||
94574767|NCT01345240|323904860|FG004|Overall Study|Adverse Event|1|||
94349104|NCT01227252|323058925|FG002|Overall Study|Sponsor Decision|0|||
94349105|NCT01227252|323058926|FG003|Overall Study|Sponsor Decision|0|||
94349106|NCT01227252|323058923|FG000|Overall Study|Lost to Follow-up|0|||
94349107|NCT01227252|323058924|FG001|Overall Study|Lost to Follow-up|1|||
94349108|NCT01227252|323058925|FG002|Overall Study|Lost to Follow-up|0|||
94349109|NCT01227252|323058926|FG003|Overall Study|Lost to Follow-up|0|||
94349110|NCT01227252|323058923|FG000|Overall Study|Withdrawal by Subject|0|||
94349111|NCT01227252|323058924|FG001|Overall Study|Withdrawal by Subject|1|||
94349112|NCT01227252|323058925|FG002|Overall Study|Withdrawal by Subject|0|||
94349113|NCT01227252|323058926|FG003|Overall Study|Withdrawal by Subject|0|||
94349114|NCT00545740|323058933|FG000|Overall Study|Lack of Efficacy|34|||
94349115|NCT00545740|323058934|FG001|Overall Study|Lack of Efficacy|35|||
94574768|NCT01345240|323904856|FG000|Overall Study|Lost to Follow-up|8|||
94574769|NCT01345240|323904857|FG001|Overall Study|Lost to Follow-up|9|||
94574770|NCT01345240|323904858|FG002|Overall Study|Lost to Follow-up|14|||
94574771|NCT01345240|323904859|FG003|Overall Study|Lost to Follow-up|7|||
94574772|NCT01345240|323904860|FG004|Overall Study|Lost to Follow-up|9|||
94574773|NCT04298697|323904861|FG000|Overall Study|Lost to Follow-up|5|||
94574774|NCT04298697|323904862|FG001|Overall Study|Lost to Follow-up|5|||
94574775|NCT04298697|323904863|FG002|Overall Study|Lost to Follow-up|1|||
94574776|NCT04298697|323904864|FG003|Overall Study|Lost to Follow-up|0|||
94574777|NCT04298697|323904861|FG000|Overall Study|Withdrawal by Subject|0|||
94574778|NCT04298697|323904862|FG001|Overall Study|Withdrawal by Subject|3|||
94349116|NCT00545740|323058935|FG002|Overall Study|Lack of Efficacy|47|||
94349117|NCT00545740|323058936|FG003|Overall Study|Lack of Efficacy|36|||
94349118|NCT00545740|323058933|FG000|Overall Study|Withdrawal by Subject|17|||
94349119|NCT00545740|323058934|FG001|Overall Study|Withdrawal by Subject|15|||
94349120|NCT00545740|323058935|FG002|Overall Study|Withdrawal by Subject|16|||
94349121|NCT00545740|323058936|FG003|Overall Study|Withdrawal by Subject|18|||
94349122|NCT00545740|323058933|FG000|Overall Study|Adverse Event|10|||
94349123|NCT00545740|323058934|FG001|Overall Study|Adverse Event|18|||
94349124|NCT00545740|323058935|FG002|Overall Study|Adverse Event|19|||
94349125|NCT00545740|323058936|FG003|Overall Study|Adverse Event|9|||
94349126|NCT00545740|323058933|FG000|Overall Study|Lost to Follow-up|7|||
94349127|NCT00545740|323058934|FG001|Overall Study|Lost to Follow-up|5|||
94349128|NCT00545740|323058935|FG002|Overall Study|Lost to Follow-up|5|||
94349129|NCT00545740|323058936|FG003|Overall Study|Lost to Follow-up|6|||
94349130|NCT00545740|323058933|FG000|Overall Study|Protocol Violation|1|||
94349131|NCT00545740|323058934|FG001|Overall Study|Protocol Violation|3|||
94349132|NCT00545740|323058935|FG002|Overall Study|Protocol Violation|1|||
94349133|NCT00545740|323058936|FG003|Overall Study|Protocol Violation|0|||
94349134|NCT00545740|323058933|FG000|Overall Study|Non-compliance|0|||
94349135|NCT00545740|323058934|FG001|Overall Study|Non-compliance|2|||
94349136|NCT00545740|323058935|FG002|Overall Study|Non-compliance|1|||
94349137|NCT00545740|323058936|FG003|Overall Study|Non-compliance|0|||
94349138|NCT00545740|323058933|FG000|Overall Study|Moved|2|||
94349139|NCT00545740|323058934|FG001|Overall Study|Moved|0|||
94349140|NCT00545740|323058935|FG002|Overall Study|Moved|1|||
94349141|NCT00545740|323058936|FG003|Overall Study|Moved|0|||
94349142|NCT00545740|323058933|FG000|Overall Study|Diverticulitis attack|0|||
94349143|NCT00545740|323058934|FG001|Overall Study|Diverticulitis attack|0|||
94349144|NCT00545740|323058935|FG002|Overall Study|Diverticulitis attack|1|||
94349145|NCT00545740|323058936|FG003|Overall Study|Diverticulitis attack|1|||
94349146|NCT00545740|323058933|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
94349147|NCT00545740|323058934|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
94349148|NCT00545740|323058935|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
94574779|NCT04298697|323904863|FG002|Overall Study|Withdrawal by Subject|2|||
94574780|NCT04298697|323904864|FG003|Overall Study|Withdrawal by Subject|3|||
94574781|NCT01446159|323904866|FG000|Overall Study|Withdrawal by Subject|1|||
94574782|NCT01446159|323904867|FG001|Overall Study|Withdrawal by Subject|0|||
94349149|NCT00545740|323058936|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
94349150|NCT00545740|323058933|FG000|Overall Study|Site closure|1|||
94349151|NCT00545740|323058934|FG001|Overall Study|Site closure|0|||
94349152|NCT00545740|323058935|FG002|Overall Study|Site closure|0|||
94349153|NCT00545740|323058936|FG003|Overall Study|Site closure|0|||
94349154|NCT00545740|323058933|FG000|Overall Study|Missed visit|1|||
94349155|NCT00545740|323058934|FG001|Overall Study|Missed visit|0|||
94349156|NCT00545740|323058935|FG002|Overall Study|Missed visit|0|||
94349157|NCT00545740|323058936|FG003|Overall Study|Missed visit|0|||
94349158|NCT00545740|323058933|FG000|Overall Study|Physician Decision|0|||
94349159|NCT00545740|323058934|FG001|Overall Study|Physician Decision|0|||
94574783|NCT01446159|323904868|FG002|Overall Study|Withdrawal by Subject|14|||
94349160|NCT00545740|323058935|FG002|Overall Study|Physician Decision|3|||
94349161|NCT00545740|323058936|FG003|Overall Study|Physician Decision|0|||
94349162|NCT00545740|323058933|FG000|Overall Study|Accepted only monthly telephone calls|1|||
94349163|NCT00545740|323058934|FG001|Overall Study|Accepted only monthly telephone calls|0|||
94349164|NCT00545740|323058935|FG002|Overall Study|Accepted only monthly telephone calls|0|||
94349165|NCT00545740|323058936|FG003|Overall Study|Accepted only monthly telephone calls|0|||
94349166|NCT00545740|323058933|FG000|Overall Study|Sponsor decision|0|||
94349167|NCT00545740|323058934|FG001|Overall Study|Sponsor decision|1|||
94349168|NCT00545740|323058935|FG002|Overall Study|Sponsor decision|0|||
94349169|NCT00545740|323058936|FG003|Overall Study|Sponsor decision|0|||
94349170|NCT00545740|323058933|FG000|Overall Study|Lack of time|0|||
94349171|NCT00545740|323058934|FG001|Overall Study|Lack of time|1|||
94349172|NCT00545740|323058935|FG002|Overall Study|Lack of time|0|||
94349173|NCT00545740|323058936|FG003|Overall Study|Lack of time|0|||
94349174|NCT00545740|323058933|FG000|Overall Study|Non-adherence to visits|0|||
94349175|NCT00545740|323058934|FG001|Overall Study|Non-adherence to visits|1|||
94349176|NCT00545740|323058935|FG002|Overall Study|Non-adherence to visits|0|||
94349177|NCT00545740|323058936|FG003|Overall Study|Non-adherence to visits|0|||
94349178|NCT00545740|323058933|FG000|Overall Study|Patient difficulties|0|||
94349179|NCT00545740|323058934|FG001|Overall Study|Patient difficulties|1|||
94349180|NCT00545740|323058935|FG002|Overall Study|Patient difficulties|0|||
94349181|NCT00545740|323058936|FG003|Overall Study|Patient difficulties|0|||
94349182|NCT00545740|323058933|FG000|Overall Study|Husband against study|0|||
94349183|NCT00545740|323058934|FG001|Overall Study|Husband against study|0|||
94349184|NCT00545740|323058935|FG002|Overall Study|Husband against study|1|||
94349185|NCT00545740|323058936|FG003|Overall Study|Husband against study|0|||
94349186|NCT03018340|323058937|FG000|Overall Study|Adverse Event|1|||
94349187|NCT03018340|323058938|FG001|Overall Study|Adverse Event|2|||
94349188|NCT03018340|323058937|FG000|Overall Study|Withdrawal by Subject|0|||
94349189|NCT03018340|323058938|FG001|Overall Study|Withdrawal by Subject|8|||
94349190|NCT03018340|323058937|FG000|Overall Study|Lack of Efficacy|0|||
94349191|NCT03018340|323058938|FG001|Overall Study|Lack of Efficacy|1|||
94349192|NCT03018340|323058937|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
94349193|NCT03018340|323058938|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
94349194|NCT03018340|323058937|FG000|Overall Study|Lost to Follow-up|1|||
94349195|NCT03018340|323058938|FG001|Overall Study|Lost to Follow-up|7|||
94238806|NCT01077128|322668550|FG000|Overall Study|Adverse event and consent withdrawal|1|||
94238807|NCT01077128|322668550|FG000|Overall Study|Adverse event and disease exacerbation|1|||
94238808|NCT01077128|322668550|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
94238809|NCT01077128|322668550|FG000|Overall Study|Other|54|||
94238810|NCT00340704|322668551|FG000|PK Study|Adverse Event|0|||
94238811|NCT00340704|322668552|FG001|PK Study|Adverse Event|1|||
94238812|NCT00340704|322668553|FG002|PK Study|Adverse Event|0|||
94238813|NCT00340704|322668554|FG003|PK Study|Adverse Event|0|||
94349196|NCT03018340|323058937|FG000|Overall Study|Protocol Violation|3|||
94349197|NCT03018340|323058938|FG001|Overall Study|Protocol Violation|7|||
94349198|NCT03018340|323058937|FG000|Overall Study|Not further specified|0|||
94349199|NCT03018340|323058938|FG001|Overall Study|Not further specified|1|||
94574784|NCT01446159|323904869|FG003|Overall Study|Withdrawal by Subject|11|||
94574785|NCT01446159|323904866|FG000|Overall Study|Lost to Follow-up|0|||
94574786|NCT01446159|323904867|FG001|Overall Study|Lost to Follow-up|0|||
94349200|NCT00579527|323058939|FG000|Overall Study|Death|4|||
94349201|NCT01195636|323058940|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
94349202|NCT01195636|323058941|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
94349203|NCT01195636|323058940|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
94349204|NCT01195636|323058941|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
94349205|NCT01195636|323058940|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
94349206|NCT01195636|323058941|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
94349207|NCT01195636|323058940|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
94349208|NCT01195636|323058941|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
94349209|NCT01195636|323058940|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
94349210|NCT01195636|323058941|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
94574787|NCT01446159|323904868|FG002|Overall Study|Lost to Follow-up|1|||
94574788|NCT01446159|323904869|FG003|Overall Study|Lost to Follow-up|2|||
94574789|NCT01446159|323904866|FG000|Overall Study|Death|2|||
94574790|NCT01446159|323904867|FG001|Overall Study|Death|3|||
94574791|NCT01446159|323904868|FG002|Overall Study|Death|43|||
94349211|NCT01195636|323058940|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
94349212|NCT01195636|323058941|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
94349213|NCT01195636|323058940|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
94349214|NCT01195636|323058941|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
94349215|NCT01195636|323058940|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
94349216|NCT01195636|323058941|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
94349217|NCT03644173|323058942|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
94349218|NCT03644173|323058942|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
94349219|NCT03644173|323058942|FG000|Participants at the 1-month Follow up|Death|2|||
94349220|NCT03644173|323058942|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
94349221|NCT00381706|323058945|FG000|Overall Study|Never treated|7|||
94349222|NCT00381706|323058946|FG001|Overall Study|Never treated|2|||
94349223|NCT00381706|323058947|FG002|Overall Study|Never treated|1|||
94349224|NCT00082628|323058948|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
94349225|NCT00082628|323058949|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
94349226|NCT00082628|323058950|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
94238814|NCT00340704|322668555|FG004|PK Study|Adverse Event|0|||
94238815|NCT00340704|322668556|FG005|PK Study|Adverse Event|0|||
94238816|NCT00340704|322668557|FG006|PK Study|Adverse Event|0|||
94238817|NCT00340704|322668558|FG007|PK Study|Adverse Event|0|||
94349227|NCT00082628|323058951|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
94349228|NCT00082628|323058952|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
94349229|NCT00082628|323058948|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
94238818|NCT00340704|322668559|FG008|PK Study|Adverse Event|0|||
94238819|NCT00340704|322668551|FG000|PK Study|Not treated|0|||
94238820|NCT00340704|322668552|FG001|PK Study|Not treated|0|||
94238821|NCT00340704|322668553|FG002|PK Study|Not treated|1|||
94349230|NCT00082628|323058949|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
94238822|NCT00340704|322668554|FG003|PK Study|Not treated|0|||
94238823|NCT00340704|322668555|FG004|PK Study|Not treated|0|||
94349231|NCT00082628|323058950|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
94349232|NCT00082628|323058951|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
94349233|NCT00082628|323058952|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
94452520|NCT01628198|323443745|FG000|Overall Study|Screen failure|1|||
94452521|NCT00022698|323443746|FG000|Overall Study|Adverse Event|5|||
94452522|NCT00022698|323443747|FG001|Overall Study|Adverse Event|9|||
94452523|NCT00022698|323443746|FG000|Overall Study|Death|0|||
94452524|NCT00022698|323443747|FG001|Overall Study|Death|2|||
94452525|NCT00022698|323443746|FG000|Overall Study|Failure to return|0|||
94452526|NCT00022698|323443747|FG001|Overall Study|Failure to return|1|||
94452527|NCT00022698|323443746|FG000|Overall Study|Refused treatment|0|||
94452528|NCT00022698|323443747|FG001|Overall Study|Refused treatment|2|||
94452529|NCT00022698|323443746|FG000|Overall Study|Insufficient therapeutic response|2|||
94452530|NCT00022698|323443747|FG001|Overall Study|Insufficient therapeutic response|14|||
94452531|NCT00022698|323443746|FG000|Overall Study|Administrative /other|1|||
94452532|NCT00022698|323443747|FG001|Overall Study|Administrative /other|7|||
94452533|NCT03226769|323443751|FG000|Overall Study|Withdrawal by Subject|0|||
94452534|NCT03226769|323443752|FG001|Overall Study|Withdrawal by Subject|1|||
94452535|NCT01732640|323443753|FG000|Overall Study|Adverse Event|0|||
94452536|NCT01732640|323443754|FG001|Overall Study|Adverse Event|1|||
94452537|NCT01732640|323443753|FG000|Overall Study|Death|0|||
94452538|NCT01732640|323443754|FG001|Overall Study|Death|1|||
94452539|NCT00712543|323443763|FG000|Day 8-14|Lost to Follow-up|0|||
94452540|NCT00712543|323443764|FG001|Day 8-14|Lost to Follow-up|2|||
94452541|NCT01441765|323443767|FG000|Overall Study|Death|1|||
94452542|NCT01441765|323443768|FG001|Overall Study|Death|0|||
94452543|NCT05119595|323445352|FG000|Overall Study|Death|1|||
94452544|NCT05119595|323445352|FG000|Overall Study|Lost to Follow-up|7|||
94452545|NCT03503370|323445353|FG000|Overall Study|Death|3|||
94452546|NCT03503370|323445354|FG001|Overall Study|Death|1|||
94452547|NCT02609607|323445359|FG000|Overall Study|Lost to Follow-up|0|||
94452548|NCT02609607|323445360|FG001|Overall Study|Lost to Follow-up|1|||
94452549|NCT02453334|323445362|FG000|Overall Study|Death|15|||
94452550|NCT02453334|323445363|FG001|Overall Study|Death|13|||
94452551|NCT02453334|323445362|FG000|Overall Study|Adverse Event|2|||
94452552|NCT02453334|323445363|FG001|Overall Study|Adverse Event|1|||
94452553|NCT02453334|323445362|FG000|Overall Study|Lost to Follow-up|5|||
94452554|NCT02453334|323445363|FG001|Overall Study|Lost to Follow-up|9|||
94452555|NCT02453334|323445362|FG000|Overall Study|Physician Decision|1|||
94452556|NCT02453334|323445363|FG001|Overall Study|Physician Decision|0|||
94452557|NCT02453334|323445362|FG000|Overall Study|Withdrawal by Subject|17|||
94452558|NCT02453334|323445363|FG001|Overall Study|Withdrawal by Subject|13|||
94452559|NCT02453334|323445362|FG000|Overall Study|Other reason|1|||
94452560|NCT02453334|323445363|FG001|Overall Study|Other reason|4|||
94452561|NCT03981926|323445370|FG000|Overall Study|Lost to Follow-up|5|||
94452562|NCT03981926|323445371|FG001|Overall Study|Lost to Follow-up|9|||
94238824|NCT00340704|322668556|FG005|PK Study|Not treated|0|||
94452563|NCT00610155|323445372|FG000|Period 1|Withdrawal by Subject|0|||
94452564|NCT00610155|323445373|FG001|Period 1|Withdrawal by Subject|0|||
94452565|NCT00610155|323445374|FG002|Period 1|Withdrawal by Subject|1|||
94452566|NCT00610155|323445375|FG003|Period 1|Withdrawal by Subject|0|||
94238825|NCT00340704|322668557|FG006|PK Study|Not treated|0|||
94238826|NCT00340704|322668558|FG007|PK Study|Not treated|0|||
94452567|NCT00610155|323445376|FG004|Period 1|Withdrawal by Subject|0|||
94452568|NCT00610155|323445377|FG005|Period 1|Withdrawal by Subject|0|||
94574792|NCT01446159|323904869|FG003|Overall Study|Death|36|||
94574793|NCT01446159|323904866|FG000|Overall Study|Other|0|||
94574794|NCT01446159|323904867|FG001|Overall Study|Other|0|||
94574795|NCT01446159|323904868|FG002|Overall Study|Other|13|||
94574796|NCT01446159|323904869|FG003|Overall Study|Other|13|||
94574797|NCT00627393|323904872|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
94574798|NCT00627393|323904873|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
94574799|NCT00627393|323904872|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
94574800|NCT00627393|323904873|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
94574801|NCT00627393|323904872|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
94574802|NCT00627393|323904873|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
94574803|NCT00627393|323904872|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
94574804|NCT00627393|323904873|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
94574805|NCT00784563|323904875|FG000|Years 1 & 2|Withdrawal by Subject|3|||
94238827|NCT00340704|322668559|FG008|PK Study|Not treated|0|||
94238828|NCT00340704|322668551|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
94238829|NCT00340704|322668552|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
94238830|NCT00340704|322668553|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
94238831|NCT00340704|322668554|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
94238832|NCT00340704|322668555|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
94238833|NCT00340704|322668556|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
94238834|NCT00340704|322668557|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
94238835|NCT00340704|322668558|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
94238836|NCT00340704|322668559|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
94238837|NCT00340704|322668551|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
94238838|NCT00340704|322668552|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
94238839|NCT00340704|322668553|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
94238840|NCT00340704|322668554|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
94238841|NCT00340704|322668555|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
94238842|NCT00340704|322668556|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
94238843|NCT00340704|322668557|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
94238844|NCT00340704|322668558|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
94238845|NCT00340704|322668559|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
94238846|NCT00340704|322668551|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
94238847|NCT00340704|322668552|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
94238848|NCT00340704|322668553|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
94238849|NCT00340704|322668554|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
94238850|NCT00340704|322668555|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
94238851|NCT00340704|322668556|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
94238852|NCT00340704|322668557|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
94238853|NCT00340704|322668558|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
94238854|NCT00340704|322668559|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
94452569|NCT00610155|323445372|FG000|Period 3|Adverse Event|1|||
94574806|NCT00784563|323904876|FG001|Years 1 & 2|Withdrawal by Subject|2|||
94349234|NCT00082628|323058948|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
94349235|NCT00082628|323058949|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
94349236|NCT00082628|323058950|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
94349237|NCT00082628|323058951|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
94349238|NCT00082628|323058952|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
94349239|NCT00082628|323058948|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
94349240|NCT00082628|323058949|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
94349241|NCT00082628|323058950|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
94349242|NCT00082628|323058951|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
94349243|NCT00082628|323058952|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
94349244|NCT00082628|323058948|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
94349245|NCT00082628|323058949|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
94349246|NCT00082628|323058950|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
94349247|NCT00082628|323058951|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
94349248|NCT00082628|323058952|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
94349249|NCT00082628|323058948|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
94349250|NCT00082628|323058949|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
94349251|NCT00082628|323058950|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
94349252|NCT00082628|323058951|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
94349253|NCT00082628|323058952|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
94349254|NCT00082628|323058948|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
94349255|NCT00082628|323058949|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
94349256|NCT00082628|323058950|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
94349257|NCT00082628|323058951|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
94349258|NCT00082628|323058952|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
94349259|NCT02555722|323058953|FG000|Week 2|Adverse Event|0|||
94349260|NCT02555722|323058954|FG001|Week 2|Adverse Event|1|||
94349261|NCT02555722|323058953|FG000|Week 2|Withdrawal by Subject|1|||
94349262|NCT02555722|323058954|FG001|Week 2|Withdrawal by Subject|0|||
94349263|NCT02555722|323058953|FG000|Month 1|Lens Discomfort|1|||
94349264|NCT02555722|323058954|FG001|Month 1|Lens Discomfort|0|||
94349265|NCT02555722|323058953|FG000|Month 2|Withdrawal by Subject|3|||
94349266|NCT02555722|323058954|FG001|Month 2|Withdrawal by Subject|0|||
94349267|NCT02555722|323058953|FG000|Month 2|Lost to Follow-up|1|||
94349268|NCT02555722|323058954|FG001|Month 2|Lost to Follow-up|0|||
94349269|NCT00887913|323058959|FG000|Overall Study|Withdrawal by Subject|6|||
94349270|NCT01711359|323058960|FG000|Treatment Period|Withdrawal by Subject|18|||
94349271|NCT01711359|323058961|FG001|Treatment Period|Withdrawal by Subject|7|||
94349272|NCT01711359|323058962|FG002|Treatment Period|Withdrawal by Subject|13|||
94349273|NCT01711359|323058960|FG000|Treatment Period|Lack of Efficacy|13|||
94349274|NCT01711359|323058961|FG001|Treatment Period|Lack of Efficacy|2|||
94349275|NCT01711359|323058962|FG002|Treatment Period|Lack of Efficacy|2|||
94349276|NCT01711359|323058960|FG000|Treatment Period|Adverse Event|8|||
94349277|NCT01711359|323058961|FG001|Treatment Period|Adverse Event|10|||
94349278|NCT01711359|323058962|FG002|Treatment Period|Adverse Event|24|||
94452570|NCT00610155|323445373|FG001|Period 3|Adverse Event|0|||
94452571|NCT00610155|323445374|FG002|Period 3|Adverse Event|0|||
94452572|NCT00610155|323445375|FG003|Period 3|Adverse Event|0|||
94452573|NCT00610155|323445376|FG004|Period 3|Adverse Event|0|||
94452574|NCT00610155|323445377|FG005|Period 3|Adverse Event|0|||
94452575|NCT02035202|323445389|FG000|Overall Study|Lost to Follow-up|8|||
94452576|NCT02035202|323445390|FG001|Overall Study|Lost to Follow-up|16|||
94452577|NCT02035202|323445391|FG002|Overall Study|Lost to Follow-up|2|||
94452578|NCT00685399|323445393|FG000|Treatment Period 1|Withdrawal by Subject|2|||
94452579|NCT00685399|323445394|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94349279|NCT01711359|323058960|FG000|Treatment Period|Physician Decision|4|||
94349280|NCT01711359|323058961|FG001|Treatment Period|Physician Decision|3|||
94349281|NCT01711359|323058962|FG002|Treatment Period|Physician Decision|2|||
94349282|NCT01711359|323058960|FG000|Treatment Period|Death|3|||
94452580|NCT00685399|323445395|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94452581|NCT00685399|323445396|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94452582|NCT00685399|323445397|FG004|Treatment Period 1|Withdrawal by Subject|0|||
94452583|NCT00685399|323445398|FG005|Treatment Period 1|Withdrawal by Subject|0|||
94452584|NCT00685399|323445399|FG006|Treatment Period 1|Withdrawal by Subject|0|||
94452585|NCT00685399|323445400|FG007|Treatment Period 1|Withdrawal by Subject|0|||
94452586|NCT00685399|323445393|FG000|Treatment Period 1|Protocol Violation|1|||
94452587|NCT00685399|323445394|FG001|Treatment Period 1|Protocol Violation|0|||
94452588|NCT00685399|323445395|FG002|Treatment Period 1|Protocol Violation|0|||
94452589|NCT00685399|323445396|FG003|Treatment Period 1|Protocol Violation|0|||
94349283|NCT01711359|323058961|FG001|Treatment Period|Death|0|||
94452590|NCT00685399|323445397|FG004|Treatment Period 1|Protocol Violation|0|||
94349284|NCT01711359|323058962|FG002|Treatment Period|Death|0|||
94349285|NCT01711359|323058960|FG000|Treatment Period|Entry Criteria Not Met|1|||
94349286|NCT01711359|323058961|FG001|Treatment Period|Entry Criteria Not Met|0|||
94349287|NCT01711359|323058962|FG002|Treatment Period|Entry Criteria Not Met|0|||
94349288|NCT01711359|323058960|FG000|Treatment Period|Sponsor Decision|1|||
94349289|NCT01711359|323058961|FG001|Treatment Period|Sponsor Decision|0|||
94349290|NCT01711359|323058962|FG002|Treatment Period|Sponsor Decision|0|||
94349291|NCT01711359|323058960|FG000|Treatment Period|Lost to Follow-up|1|||
94349292|NCT01711359|323058961|FG001|Treatment Period|Lost to Follow-up|1|||
94349293|NCT01711359|323058962|FG002|Treatment Period|Lost to Follow-up|1|||
94349294|NCT01711359|323058960|FG000|Treatment Period|Randomized, Not Treated|3|||
94349295|NCT01711359|323058961|FG001|Treatment Period|Randomized, Not Treated|1|||
94349296|NCT01711359|323058962|FG002|Treatment Period|Randomized, Not Treated|0|||
94349297|NCT01070381|323058963|FG000|Period 2, 1 Week of Wear|Handling|0|||
94349298|NCT01070381|323058964|FG001|Period 2, 1 Week of Wear|Handling|1|||
94349299|NCT01070381|323058963|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
94349300|NCT01070381|323058964|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
94349301|NCT00554840|323058965|FG000|Overall Study|Physician Decision|0|||
94349302|NCT00554840|323058966|FG001|Overall Study|Physician Decision|1|||
94349303|NCT00983827|323058967|FG000|Overall Study|Withdrawal by Subject|1|||
94349304|NCT01521494|323058968|FG000|Overall Study|Adverse Event|1|||
94349305|NCT01521494|323058969|FG001|Overall Study|Adverse Event|2|||
94349306|NCT01521494|323058970|FG002|Overall Study|Adverse Event|9|||
94349307|NCT01521494|323058971|FG003|Overall Study|Adverse Event|6|||
94349308|NCT01521494|323058972|FG004|Overall Study|Adverse Event|2|||
94349309|NCT01521494|323058968|FG000|Overall Study|Lack of Efficacy|0|||
94349310|NCT01521494|323058969|FG001|Overall Study|Lack of Efficacy|0|||
94349311|NCT01521494|323058970|FG002|Overall Study|Lack of Efficacy|0|||
94349312|NCT01521494|323058971|FG003|Overall Study|Lack of Efficacy|0|||
94349313|NCT01521494|323058972|FG004|Overall Study|Lack of Efficacy|2|||
94349314|NCT01521494|323058968|FG000|Overall Study|Withdrawal by Subject|1|||
94349315|NCT01521494|323058969|FG001|Overall Study|Withdrawal by Subject|1|||
94349316|NCT01521494|323058970|FG002|Overall Study|Withdrawal by Subject|0|||
94349317|NCT01521494|323058971|FG003|Overall Study|Withdrawal by Subject|2|||
94349318|NCT01521494|323058972|FG004|Overall Study|Withdrawal by Subject|0|||
94349319|NCT01521494|323058968|FG000|Overall Study|Decrease in serum phosphate|0|||
94349320|NCT01521494|323058969|FG001|Overall Study|Decrease in serum phosphate|2|||
94349321|NCT01521494|323058970|FG002|Overall Study|Decrease in serum phosphate|3|||
94349322|NCT01521494|323058971|FG003|Overall Study|Decrease in serum phosphate|12|||
94349323|NCT01521494|323058972|FG004|Overall Study|Decrease in serum phosphate|0|||
94349324|NCT01521494|323058968|FG000|Overall Study|Decrease in serum calcium|0|||
94349325|NCT01521494|323058969|FG001|Overall Study|Decrease in serum calcium|0|||
94349326|NCT01521494|323058970|FG002|Overall Study|Decrease in serum calcium|0|||
94349327|NCT01521494|323058971|FG003|Overall Study|Decrease in serum calcium|1|||
94349328|NCT01521494|323058972|FG004|Overall Study|Decrease in serum calcium|1|||
94349329|NCT01521494|323058968|FG000|Overall Study|Physician Decision|0|||
94574807|NCT00784563|323904877|FG002|Years 1 & 2|Withdrawal by Subject|0|||
94574808|NCT00784563|323904875|FG000|Years 1 & 2|Adverse Event|0|||
94574809|NCT00784563|323904876|FG001|Years 1 & 2|Adverse Event|3|||
94574810|NCT00784563|323904877|FG002|Years 1 & 2|Adverse Event|0|||
94574811|NCT00784563|323904875|FG000|Year 3|Withdrawal by Subject|0|||
94574812|NCT00784563|323904876|FG001|Year 3|Withdrawal by Subject|0|||
94574813|NCT00784563|323904877|FG002|Year 3|Withdrawal by Subject|2|||
94574814|NCT00784563|323904875|FG000|Year 3|Adverse Event|0|||
94349330|NCT01521494|323058969|FG001|Overall Study|Physician Decision|0|||
94349331|NCT01521494|323058970|FG002|Overall Study|Physician Decision|0|||
94349332|NCT01521494|323058971|FG003|Overall Study|Physician Decision|0|||
94349333|NCT01521494|323058972|FG004|Overall Study|Physician Decision|2|||
94349334|NCT00925522|323058975|FG000|Overall Study|study closed -- business decision|20|||
94349335|NCT01854918|323058976|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
94349336|NCT01854918|323058977|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
94349337|NCT01854918|323058976|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
94349338|NCT01854918|323058977|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
94349339|NCT01854918|323058976|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
94349340|NCT01854918|323058977|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
94349341|NCT01854918|323058976|FG000|SOC-controlled Period (Year 1)|Death|5|||
94349342|NCT01854918|323058977|FG001|SOC-controlled Period (Year 1)|Death|5|||
94349343|NCT01854918|323058976|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
94349344|NCT01854918|323058977|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
94574815|NCT00784563|323904876|FG001|Year 3|Adverse Event|0|||
94574816|NCT00784563|323904877|FG002|Year 3|Adverse Event|1|||
94574817|NCT05498649|323904878|FG000|Overall Study|Lost to Follow-up|1|||
94349345|NCT01854918|323058976|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
94349346|NCT01854918|323058977|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
94349347|NCT01854918|323058976|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
94349348|NCT01854918|323058977|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
94574818|NCT03050801|323904881|FG000|Experiment 1|Lost to Follow-up|0|||
94574819|NCT03050801|323904882|FG001|Experiment 1|Lost to Follow-up|1|||
94574820|NCT03050801|323904883|FG002|Experiment 1|Lost to Follow-up|0|||
94574821|NCT03050801|323904884|FG003|Experiment 1|Lost to Follow-up|0|||
94574822|NCT03050801|323904885|FG004|Experiment 1|Lost to Follow-up|0|||
94574823|NCT03050801|323904886|FG005|Experiment 1|Lost to Follow-up|0|||
94574824|NCT03050801|323904881|FG000|Experiment 1|Physician Decision|0|||
94574825|NCT03050801|323904882|FG001|Experiment 1|Physician Decision|3|||
94574826|NCT03050801|323904883|FG002|Experiment 1|Physician Decision|0|||
94574827|NCT03050801|323904884|FG003|Experiment 1|Physician Decision|0|||
94574828|NCT03050801|323904885|FG004|Experiment 1|Physician Decision|0|||
94574829|NCT03050801|323904886|FG005|Experiment 1|Physician Decision|0|||
94574830|NCT03050801|323904881|FG000|Experiment 1|Change of experimental design|0|||
94574831|NCT03050801|323904882|FG001|Experiment 1|Change of experimental design|3|||
94574832|NCT03050801|323904883|FG002|Experiment 1|Change of experimental design|0|||
94574833|NCT03050801|323904884|FG003|Experiment 1|Change of experimental design|0|||
94574834|NCT03050801|323904885|FG004|Experiment 1|Change of experimental design|0|||
94574835|NCT03050801|323904886|FG005|Experiment 1|Change of experimental design|0|||
94574836|NCT03050801|323904881|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
94574837|NCT03050801|323904882|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
94574838|NCT03050801|323904883|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
94574839|NCT03050801|323904884|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
94574840|NCT03050801|323904885|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
94574841|NCT03050801|323904886|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
94574842|NCT03050801|323904881|FG000|Experiment 2|Lost to Follow-up|0|||
94574843|NCT03050801|323904882|FG001|Experiment 2|Lost to Follow-up|0|||
94574844|NCT03050801|323904883|FG002|Experiment 2|Lost to Follow-up|0|||
94574845|NCT03050801|323904884|FG003|Experiment 2|Lost to Follow-up|1|||
94349349|NCT01854918|323058976|FG000|All-IP Period (Years 2 and 3)|Death|5|||
94349350|NCT01854918|323058977|FG001|All-IP Period (Years 2 and 3)|Death|16|||
94349351|NCT01920061|323058980|FG000|Overall Study|Death|1|||
94349352|NCT01920061|323058981|FG001|Overall Study|Death|1|||
94349353|NCT01920061|323058982|FG002|Overall Study|Death|0|||
94349354|NCT01920061|323058983|FG003|Overall Study|Death|1|||
94349355|NCT01920061|323058984|FG004|Overall Study|Death|1|||
94349356|NCT01920061|323058985|FG005|Overall Study|Death|0|||
94349357|NCT01920061|323058986|FG006|Overall Study|Death|0|||
94349358|NCT01920061|323058987|FG007|Overall Study|Death|1|||
94349359|NCT01920061|323058988|FG008|Overall Study|Death|0|||
94349360|NCT01920061|323058989|FG009|Overall Study|Death|1|||
94349361|NCT01920061|323058990|FG010|Overall Study|Death|0|||
94349362|NCT01920061|323058991|FG011|Overall Study|Death|1|||
94349363|NCT01920061|323058992|FG012|Overall Study|Death|0|||
94349364|NCT01920061|323058993|FG013|Overall Study|Death|2|||
94349365|NCT01920061|323058994|FG014|Overall Study|Death|0|||
94349366|NCT01920061|323058995|FG015|Overall Study|Death|0|||
94349367|NCT01920061|323058996|FG016|Overall Study|Death|0|||
94349368|NCT01920061|323058997|FG017|Overall Study|Death|0|||
94349369|NCT01920061|323058998|FG018|Overall Study|Death|1|||
94349370|NCT01920061|323058999|FG019|Overall Study|Death|0|||
94349371|NCT01920061|323058980|FG000|Overall Study|Lost to Follow-up|0|||
94349372|NCT01920061|323058981|FG001|Overall Study|Lost to Follow-up|2|||
94349373|NCT01920061|323058982|FG002|Overall Study|Lost to Follow-up|0|||
94349374|NCT01920061|323058983|FG003|Overall Study|Lost to Follow-up|0|||
94658849|NCT02464969|324206207|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
94349375|NCT01920061|323058984|FG004|Overall Study|Lost to Follow-up|0|||
94349376|NCT01920061|323058985|FG005|Overall Study|Lost to Follow-up|0|||
94238855|NCT00340704|322668551|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
94349377|NCT01920061|323058986|FG006|Overall Study|Lost to Follow-up|1|||
94349378|NCT01920061|323058987|FG007|Overall Study|Lost to Follow-up|0|||
94349379|NCT01920061|323058988|FG008|Overall Study|Lost to Follow-up|0|||
94349380|NCT01920061|323058989|FG009|Overall Study|Lost to Follow-up|0|||
94349381|NCT01920061|323058990|FG010|Overall Study|Lost to Follow-up|3|||
94349382|NCT01920061|323058991|FG011|Overall Study|Lost to Follow-up|0|||
94349383|NCT01920061|323058992|FG012|Overall Study|Lost to Follow-up|0|||
94574846|NCT03050801|323904885|FG004|Experiment 2|Lost to Follow-up|1|||
94574847|NCT03050801|323904886|FG005|Experiment 2|Lost to Follow-up|0|||
94574848|NCT03050801|323904881|FG000|Experiment 2|Physician Decision|0|||
94349384|NCT01920061|323058993|FG013|Overall Study|Lost to Follow-up|0|||
94349385|NCT01920061|323058994|FG014|Overall Study|Lost to Follow-up|0|||
94349386|NCT01920061|323058995|FG015|Overall Study|Lost to Follow-up|0|||
94349387|NCT01920061|323058996|FG016|Overall Study|Lost to Follow-up|0|||
94349388|NCT01920061|323058997|FG017|Overall Study|Lost to Follow-up|1|||
94349389|NCT01920061|323058998|FG018|Overall Study|Lost to Follow-up|4|||
94349390|NCT01920061|323058999|FG019|Overall Study|Lost to Follow-up|3|||
94349391|NCT01920061|323058980|FG000|Overall Study|Other|1|||
94349392|NCT01920061|323058981|FG001|Overall Study|Other|1|||
94349393|NCT01920061|323058982|FG002|Overall Study|Other|2|||
94349394|NCT01920061|323058983|FG003|Overall Study|Other|1|||
94349395|NCT01920061|323058984|FG004|Overall Study|Other|0|||
94349396|NCT01920061|323058985|FG005|Overall Study|Other|1|||
94349397|NCT01920061|323058986|FG006|Overall Study|Other|0|||
94349398|NCT01920061|323058987|FG007|Overall Study|Other|0|||
94349399|NCT01920061|323058988|FG008|Overall Study|Other|0|||
94349400|NCT01920061|323058989|FG009|Overall Study|Other|1|||
94349401|NCT01920061|323058990|FG010|Overall Study|Other|1|||
94349402|NCT01920061|323058991|FG011|Overall Study|Other|2|||
94349403|NCT01920061|323058992|FG012|Overall Study|Other|1|||
94349404|NCT01920061|323058993|FG013|Overall Study|Other|4|||
94349405|NCT01920061|323058994|FG014|Overall Study|Other|0|||
94349406|NCT01920061|323058995|FG015|Overall Study|Other|1|||
94349407|NCT01920061|323058996|FG016|Overall Study|Other|1|||
94349408|NCT01920061|323058997|FG017|Overall Study|Other|0|||
94349409|NCT01920061|323058998|FG018|Overall Study|Other|1|||
94349410|NCT01920061|323058999|FG019|Overall Study|Other|1|||
94349411|NCT01920061|323058980|FG000|Overall Study|Participant refused further follow-up|0|||
94349412|NCT01920061|323058981|FG001|Overall Study|Participant refused further follow-up|0|||
94349413|NCT01920061|323058982|FG002|Overall Study|Participant refused further follow-up|0|||
94349414|NCT01920061|323058983|FG003|Overall Study|Participant refused further follow-up|0|||
94349415|NCT01920061|323058984|FG004|Overall Study|Participant refused further follow-up|1|||
94349416|NCT01920061|323058985|FG005|Overall Study|Participant refused further follow-up|1|||
94349417|NCT01920061|323058986|FG006|Overall Study|Participant refused further follow-up|0|||
94349418|NCT01920061|323058987|FG007|Overall Study|Participant refused further follow-up|0|||
94349419|NCT01920061|323058988|FG008|Overall Study|Participant refused further follow-up|1|||
94349420|NCT01920061|323058989|FG009|Overall Study|Participant refused further follow-up|0|||
94349421|NCT01920061|323058990|FG010|Overall Study|Participant refused further follow-up|1|||
94349422|NCT01920061|323058991|FG011|Overall Study|Participant refused further follow-up|0|||
94349423|NCT01920061|323058992|FG012|Overall Study|Participant refused further follow-up|1|||
94349424|NCT01920061|323058993|FG013|Overall Study|Participant refused further follow-up|0|||
94349425|NCT01920061|323058994|FG014|Overall Study|Participant refused further follow-up|1|||
94349426|NCT01920061|323058995|FG015|Overall Study|Participant refused further follow-up|2|||
94349427|NCT01920061|323058996|FG016|Overall Study|Participant refused further follow-up|1|||
94349428|NCT01920061|323058997|FG017|Overall Study|Participant refused further follow-up|1|||
94349429|NCT01920061|323058998|FG018|Overall Study|Participant refused further follow-up|0|||
94349430|NCT01920061|323058999|FG019|Overall Study|Participant refused further follow-up|0|||
94349431|NCT00554229|323059000|FG000|Overall Study|Lost to Follow-up|3|||
94349432|NCT00554229|323059001|FG001|Overall Study|Lost to Follow-up|6|||
94349433|NCT00554229|323059000|FG000|Overall Study|Withdrawal by Subject|29|||
94349434|NCT00554229|323059001|FG001|Overall Study|Withdrawal by Subject|37|||
94349435|NCT00554229|323059000|FG000|Overall Study|Adverse Event|71|||
94349436|NCT00554229|323059001|FG001|Overall Study|Adverse Event|39|||
94349437|NCT00554229|323059000|FG000|Overall Study|Protocol Violation|3|||
94349438|NCT00554229|323059001|FG001|Overall Study|Protocol Violation|3|||
94452591|NCT00685399|323445398|FG005|Treatment Period 1|Protocol Violation|0|||
94452592|NCT00685399|323445399|FG006|Treatment Period 1|Protocol Violation|0|||
94452593|NCT00685399|323445400|FG007|Treatment Period 1|Protocol Violation|0|||
94452594|NCT00685399|323445393|FG000|Treatment Period 1|Administrative|2|||
94452595|NCT00685399|323445394|FG001|Treatment Period 1|Administrative|0|||
94452596|NCT00685399|323445395|FG002|Treatment Period 1|Administrative|0|||
94452597|NCT00685399|323445396|FG003|Treatment Period 1|Administrative|0|||
94452598|NCT00685399|323445397|FG004|Treatment Period 1|Administrative|0|||
94452599|NCT00685399|323445398|FG005|Treatment Period 1|Administrative|0|||
94574849|NCT03050801|323904882|FG001|Experiment 2|Physician Decision|0|||
94349439|NCT00554229|323059000|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
94452600|NCT00685399|323445399|FG006|Treatment Period 1|Administrative|0|||
94349440|NCT00554229|323059001|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
94349441|NCT00554229|323059000|FG000|Overall Study|Randomised but no treatment received|1|||
94452601|NCT00685399|323445400|FG007|Treatment Period 1|Administrative|0|||
94349442|NCT00554229|323059001|FG001|Overall Study|Randomised but no treatment received|0|||
94349443|NCT01140646|323059002|FG000|Overall Study|Adverse Event|4|||
94349444|NCT01140646|323059002|FG000|Overall Study|Refused Further Treatment|5|||
94349445|NCT02146352|323059005|FG000|Overall Study|Death|1|||
94349446|NCT02146352|323059005|FG000|Overall Study|Patient entered hospice care|1|||
94349447|NCT02561572|323059010|FG000|Overall Study|Inadequate time before surgery|2|||
94349448|NCT02561572|323059011|FG001|Overall Study|Inadequate time before surgery|1|||
94349449|NCT02561572|323059010|FG000|Overall Study|Protocol Violation|0|||
94349450|NCT02561572|323059011|FG001|Overall Study|Protocol Violation|1|||
94349451|NCT02918006|323059012|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
94349452|NCT02918006|323059013|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
94349453|NCT02918006|323059014|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
94349454|NCT02918006|323059012|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
94349455|NCT02918006|323059013|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
94349456|NCT02918006|323059014|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
94349457|NCT02918006|323059012|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
94349458|NCT02918006|323059013|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
94349459|NCT02918006|323059014|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
94349460|NCT02918006|323059012|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
94349461|NCT02918006|323059013|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
94349462|NCT02918006|323059014|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
94349463|NCT02918006|323059012|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
94349464|NCT02918006|323059013|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
94349465|NCT02918006|323059014|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
94349466|NCT02918006|323059012|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
94349467|NCT02918006|323059013|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
94349468|NCT02918006|323059014|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
94349469|NCT02918006|323059012|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
94349470|NCT02918006|323059013|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
94349471|NCT02918006|323059014|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
94349472|NCT02918006|323059012|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
94349473|NCT02918006|323059013|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
94349474|NCT02918006|323059014|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
94349475|NCT02918006|323059012|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
94349476|NCT02918006|323059013|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
94349477|NCT02918006|323059014|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
94349478|NCT00795717|323059015|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
94349479|NCT00795717|323059016|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
94349480|NCT00795717|323059015|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
94349481|NCT00795717|323059016|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
94349482|NCT00795717|323059015|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
94349483|NCT00795717|323059016|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
94349484|NCT00795717|323059015|FG000|Phase II|too busy|0|||
94349485|NCT00795717|323059016|FG001|Phase II|too busy|1|||
94349486|NCT00805142|323059017|FG000|Titration Period|Adverse Event|3|||
94349487|NCT00805142|323059018|FG001|Titration Period|Adverse Event|3|||
94574850|NCT03050801|323904883|FG002|Experiment 2|Physician Decision|0|||
94574851|NCT03050801|323904884|FG003|Experiment 2|Physician Decision|0|||
94574852|NCT03050801|323904885|FG004|Experiment 2|Physician Decision|1|||
94574853|NCT03050801|323904886|FG005|Experiment 2|Physician Decision|0|||
94574854|NCT03050801|323904881|FG000|Experiment 2|Pregnancy|0|||
94574855|NCT03050801|323904882|FG001|Experiment 2|Pregnancy|0|||
94574856|NCT03050801|323904883|FG002|Experiment 2|Pregnancy|0|||
94349488|NCT00805142|323059017|FG000|Titration Period|Lack of Efficacy|1|||
94349489|NCT00805142|323059018|FG001|Titration Period|Lack of Efficacy|1|||
94349490|NCT00805142|323059017|FG000|Titration Period|Lost to Follow-up|0|||
94349491|NCT00805142|323059018|FG001|Titration Period|Lost to Follow-up|1|||
94349492|NCT00805142|323059017|FG000|Titration Period|Disease Progression|2|||
94349493|NCT00805142|323059018|FG001|Titration Period|Disease Progression|1|||
94349494|NCT00805142|323059017|FG000|Titration Period|Withdrawal of consent|0|||
94349495|NCT00805142|323059018|FG001|Titration Period|Withdrawal of consent|1|||
94349496|NCT00805142|323059017|FG000|Titration Period|Other|0|||
94349497|NCT00805142|323059018|FG001|Titration Period|Other|3|||
94349498|NCT00805142|323059017|FG000|Maintenance Period|Adverse Event|0|||
94349499|NCT00805142|323059018|FG001|Maintenance Period|Adverse Event|1|||
94349500|NCT00805142|323059017|FG000|Maintenance Period|Other|0|||
94349501|NCT00805142|323059018|FG001|Maintenance Period|Other|1|||
94349502|NCT00960323|323060831|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
94349503|NCT00027027|323060836|FG000|Overall Study|Adverse Event|0|||
94349504|NCT00027027|323060837|FG001|Overall Study|Adverse Event|0|||
94349505|NCT00027027|323060838|FG002|Overall Study|Adverse Event|1|||
94349506|NCT00027027|323060839|FG003|Overall Study|Adverse Event|0|||
94574857|NCT03050801|323904884|FG003|Experiment 2|Pregnancy|0|||
94574858|NCT03050801|323904885|FG004|Experiment 2|Pregnancy|1|||
94574859|NCT03050801|323904886|FG005|Experiment 2|Pregnancy|0|||
94574860|NCT03050801|323904881|FG000|Experiment 2|Withdrawal by Subject|0|||
94574861|NCT03050801|323904882|FG001|Experiment 2|Withdrawal by Subject|0|||
94574862|NCT03050801|323904883|FG002|Experiment 2|Withdrawal by Subject|0|||
94574863|NCT03050801|323904884|FG003|Experiment 2|Withdrawal by Subject|1|||
94574864|NCT03050801|323904885|FG004|Experiment 2|Withdrawal by Subject|0|||
94574865|NCT03050801|323904886|FG005|Experiment 2|Withdrawal by Subject|0|||
94574866|NCT03050801|323904881|FG000|Experiment 2|Poor data quality|0|||
94574867|NCT03050801|323904882|FG001|Experiment 2|Poor data quality|0|||
94574868|NCT03050801|323904883|FG002|Experiment 2|Poor data quality|0|||
94574869|NCT03050801|323904884|FG003|Experiment 2|Poor data quality|4|||
94574870|NCT03050801|323904885|FG004|Experiment 2|Poor data quality|1|||
94574871|NCT03050801|323904886|FG005|Experiment 2|Poor data quality|0|||
94574872|NCT03050801|323904881|FG000|Experiment 2|Discomfort during stimulation|0|||
94574873|NCT03050801|323904882|FG001|Experiment 2|Discomfort during stimulation|0|||
94574874|NCT03050801|323904883|FG002|Experiment 2|Discomfort during stimulation|0|||
94574875|NCT03050801|323904884|FG003|Experiment 2|Discomfort during stimulation|0|||
94574876|NCT03050801|323904885|FG004|Experiment 2|Discomfort during stimulation|0|||
94574877|NCT03050801|323904886|FG005|Experiment 2|Discomfort during stimulation|2|||
94574878|NCT01576341|323904888|FG000|Overall Study|Withdrawal by Subject|24|||
94574879|NCT01576341|323904888|FG000|Overall Study|Adverse Event|10|||
94349507|NCT00027027|323060840|FG004|Overall Study|Adverse Event|1|||
94574880|NCT01576341|323904888|FG000|Overall Study|Death|21|||
94574881|NCT01576341|323904888|FG000|Overall Study|Physician Decision|2|||
94574882|NCT01576341|323904888|FG000|Overall Study|Lost to Follow-up|2|||
94574883|NCT01576341|323904888|FG000|Overall Study|Kidney transplantation|10|||
94574884|NCT01576341|323904888|FG000|Overall Study|Protocol Violation|12|||
94574885|NCT01576341|323904888|FG000|Overall Study|Other|12|||
94574886|NCT03605667|323904891|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
94349508|NCT00027027|323060836|FG000|Overall Study|Admitted for Signs of PD|0|||
94349509|NCT00027027|323060837|FG001|Overall Study|Admitted for Signs of PD|0|||
94349510|NCT00027027|323060838|FG002|Overall Study|Admitted for Signs of PD|0|||
94349511|NCT00027027|323060839|FG003|Overall Study|Admitted for Signs of PD|0|||
94349512|NCT00027027|323060840|FG004|Overall Study|Admitted for Signs of PD|1|||
94349513|NCT00027027|323060836|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
94349514|NCT00027027|323060837|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
94349515|NCT00027027|323060838|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
94349516|NCT00027027|323060839|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
94349517|NCT00027027|323060840|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
94349518|NCT00027027|323060836|FG000|Overall Study|PD Requiring Surgery|0|||
94349519|NCT00027027|323060837|FG001|Overall Study|PD Requiring Surgery|0|||
94349520|NCT00027027|323060838|FG002|Overall Study|PD Requiring Surgery|1|||
94349521|NCT00027027|323060839|FG003|Overall Study|PD Requiring Surgery|0|||
94349522|NCT00027027|323060840|FG004|Overall Study|PD Requiring Surgery|0|||
94349523|NCT00027027|323060836|FG000|Overall Study|Physician Decision Due To PD|2|||
94349524|NCT00027027|323060837|FG001|Overall Study|Physician Decision Due To PD|3|||
94349525|NCT00027027|323060838|FG002|Overall Study|Physician Decision Due To PD|2|||
94349526|NCT00027027|323060839|FG003|Overall Study|Physician Decision Due To PD|3|||
94349527|NCT00027027|323060840|FG004|Overall Study|Physician Decision Due To PD|5|||
94349528|NCT00027027|323060836|FG000|Overall Study|Withdrawal by Subject|0|||
94349529|NCT00027027|323060837|FG001|Overall Study|Withdrawal by Subject|0|||
94349530|NCT00027027|323060838|FG002|Overall Study|Withdrawal by Subject|0|||
94349531|NCT00027027|323060839|FG003|Overall Study|Withdrawal by Subject|0|||
94349532|NCT00027027|323060840|FG004|Overall Study|Withdrawal by Subject|1|||
94349533|NCT00724243|323060843|FG000|Overall Study|Lack of Efficacy|10|||
94349534|NCT00724243|323060843|FG000|Overall Study|Adverse Event|5|||
94349535|NCT01640353|323060854|FG000|Overall Study|Withdrew prior to treatment|10|||
94349536|NCT01640353|323060854|FG000|Overall Study|Withdrawn from analysis at term site|12|||
94349537|NCT01640353|323060854|FG000|Overall Study|Withdrawal by Subject|5|||
94349538|NCT01640353|323060854|FG000|Overall Study|Death|2|||
94349539|NCT01640353|323060854|FG000|Overall Study|Early site termination|3|||
94349540|NCT01640353|323060854|FG000|Overall Study|Lost to Follow-up|12|||
94349541|NCT01640353|323060854|FG000|Overall Study|Physician Decision|1|||
94349542|NCT03758612|323060855|FG000|Washout Period|Withdrawal by Subject|0|||
94349543|NCT03758612|323060856|FG001|Washout Period|Withdrawal by Subject|0|||
94349544|NCT03758612|323060857|FG002|Washout Period|Withdrawal by Subject|2|||
94349545|NCT03758612|323060858|FG003|Washout Period|Withdrawal by Subject|0|||
94349546|NCT03758612|323060859|FG004|Washout Period|Withdrawal by Subject|0|||
94349547|NCT03758612|323060860|FG005|Washout Period|Withdrawal by Subject|0|||
94349548|NCT03758612|323060861|FG006|Washout Period|Withdrawal by Subject|0|||
94349549|NCT03758612|323060862|FG007|Washout Period|Withdrawal by Subject|0|||
94349550|NCT03758612|323060863|FG008|Washout Period|Withdrawal by Subject|0|||
94349551|NCT03758612|323060864|FG009|Washout Period|Withdrawal by Subject|0|||
94349552|NCT03758612|323060865|FG010|Washout Period|Withdrawal by Subject|0|||
94349553|NCT03758612|323060866|FG011|Washout Period|Withdrawal by Subject|0|||
94349554|NCT03758612|323060855|FG000|Period 2|Protocol Violation|0|||
94349555|NCT03758612|323060856|FG001|Period 2|Protocol Violation|0|||
94349556|NCT03758612|323060857|FG002|Period 2|Protocol Violation|0|||
94349557|NCT03758612|323060858|FG003|Period 2|Protocol Violation|0|||
94349558|NCT03758612|323060859|FG004|Period 2|Protocol Violation|1|||
94349559|NCT03758612|323060860|FG005|Period 2|Protocol Violation|0|||
94349560|NCT03758612|323060861|FG006|Period 2|Protocol Violation|0|||
94349561|NCT03758612|323060862|FG007|Period 2|Protocol Violation|0|||
94349562|NCT03758612|323060863|FG008|Period 2|Protocol Violation|0|||
94349563|NCT03758612|323060864|FG009|Period 2|Protocol Violation|0|||
94349564|NCT03758612|323060865|FG010|Period 2|Protocol Violation|0|||
94349565|NCT03758612|323060866|FG011|Period 2|Protocol Violation|0|||
94349566|NCT00532441|323060867|FG000|Overall Study|Death|1|||
94349567|NCT00532441|323060868|FG001|Overall Study|Death|0|||
94349568|NCT01967134|323060869|FG000|Overall Study|Lost to Follow-up|0|||
94349569|NCT01967134|323060870|FG001|Overall Study|Lost to Follow-up|1|||
94349570|NCT01967134|323060871|FG002|Overall Study|Lost to Follow-up|0|||
94349571|NCT03419741|323060872|FG000|Overall Study|Adverse Event|1|||
94349572|NCT03419741|323060873|FG001|Overall Study|Adverse Event|0|||
94349573|NCT03419741|323060872|FG000|Overall Study|Withdrawal by Subject|1|||
94349574|NCT03419741|323060873|FG001|Overall Study|Withdrawal by Subject|2|||
94349575|NCT03824704|323060878|FG000|Overall Study|Study Terminated by Sponsor|1|||
94349576|NCT01904760|323060885|FG000|Overall Study|Protocol Violation|1|||
94349577|NCT01904760|323060886|FG001|Overall Study|Protocol Violation|0|||
94349578|NCT01051856|323060888|FG000|Overall Study|Withdrawal by Subject|1|||
94349579|NCT01051856|323060889|FG001|Overall Study|Withdrawal by Subject|0|||
94349580|NCT01488994|323060890|FG000|Overall Study|Withdrawal by Subject|0|||
94349581|NCT01488994|323060891|FG001|Overall Study|Withdrawal by Subject|1|||
94349582|NCT02519777|323060892|FG000|Overall Study|Death|1|||
94349583|NCT02519777|323060893|FG001|Overall Study|Death|0|||
94349584|NCT02519777|323060894|FG002|Overall Study|Death|0|||
94349585|NCT02519777|323060892|FG000|Overall Study|Lost to Follow-up|0|||
94349586|NCT02519777|323060893|FG001|Overall Study|Lost to Follow-up|4|||
94349587|NCT02519777|323060894|FG002|Overall Study|Lost to Follow-up|2|||
94349588|NCT02519777|323060892|FG000|Overall Study|Withdrawal by Subject|3|||
94349589|NCT02519777|323060893|FG001|Overall Study|Withdrawal by Subject|1|||
94349590|NCT02519777|323060894|FG002|Overall Study|Withdrawal by Subject|0|||
94349591|NCT02519777|323060892|FG000|Overall Study|Severe Debilitation|1|||
94349592|NCT02519777|323060893|FG001|Overall Study|Severe Debilitation|1|||
94349593|NCT02519777|323060894|FG002|Overall Study|Severe Debilitation|1|||
94349594|NCT02519777|323060892|FG000|Overall Study|Not able to get to clinic|1|||
94349595|NCT02519777|323060893|FG001|Overall Study|Not able to get to clinic|2|||
94349596|NCT02519777|323060894|FG002|Overall Study|Not able to get to clinic|1|||
94349597|NCT01947127|323060895|FG000|Overall Study|Protocol Violation|18|||
94349598|NCT01947127|323060896|FG001|Overall Study|Protocol Violation|38|||
94349599|NCT01947127|323060895|FG000|Overall Study|Withdrawal by Subject|1|||
94349600|NCT01947127|323060896|FG001|Overall Study|Withdrawal by Subject|1|||
94349601|NCT01947127|323060895|FG000|Overall Study|Data loss|4|||
94349602|NCT01947127|323060896|FG001|Overall Study|Data loss|4|||
94349603|NCT01969565|323060900|FG000|Overall Study|Withdrawal by Subject|1|||
94349604|NCT00203294|323060904|FG000|Overall Study|Withdrawal by Subject|8|||
94349605|NCT00203294|323060905|FG001|Overall Study|Withdrawal by Subject|13|||
94349606|NCT01796106|323060909|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
94349607|NCT01796106|323060910|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
94349608|NCT00994890|323060911|FG000|Overall Study|Adverse Event|13|||
94349609|NCT00994890|323060912|FG001|Overall Study|Adverse Event|9|||
94349610|NCT00994890|323060913|FG002|Overall Study|Adverse Event|11|||
94349611|NCT00994890|323060911|FG000|Overall Study|Lack of Efficacy|0|||
94349612|NCT00994890|323060912|FG001|Overall Study|Lack of Efficacy|0|||
94574887|NCT03605667|323904892|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
94574888|NCT03605667|323904891|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
94574889|NCT03605667|323904892|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
94574890|NCT03605667|323904891|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
94349613|NCT00994890|323060913|FG002|Overall Study|Lack of Efficacy|1|||
94349614|NCT00994890|323060911|FG000|Overall Study|Lost to Follow-up|6|||
94349615|NCT00994890|323060912|FG001|Overall Study|Lost to Follow-up|1|||
94349616|NCT00994890|323060913|FG002|Overall Study|Lost to Follow-up|3|||
94349617|NCT00994890|323060911|FG000|Overall Study|No longer willing to participate|8|||
94349618|NCT00994890|323060912|FG001|Overall Study|No longer willing to participate|5|||
94349619|NCT00994890|323060913|FG002|Overall Study|No longer willing to participate|13|||
94349620|NCT00994890|323060911|FG000|Overall Study|Protocol Violation|2|||
94349621|NCT00994890|323060912|FG001|Overall Study|Protocol Violation|4|||
94349622|NCT00994890|323060913|FG002|Overall Study|Protocol Violation|0|||
94349623|NCT00994890|323060911|FG000|Overall Study|Study terminated by sponsor|199|||
94349624|NCT00994890|323060912|FG001|Overall Study|Study terminated by sponsor|201|||
94349625|NCT00994890|323060913|FG002|Overall Study|Study terminated by sponsor|197|||
94349626|NCT00994890|323060911|FG000|Overall Study|Randomized, but not treated|1|||
94349627|NCT00994890|323060912|FG001|Overall Study|Randomized, but not treated|0|||
94349628|NCT00994890|323060913|FG002|Overall Study|Randomized, but not treated|0|||
94349629|NCT00994890|323060911|FG000|Overall Study|Other|2|||
94349630|NCT00994890|323060912|FG001|Overall Study|Other|2|||
94349631|NCT00994890|323060913|FG002|Overall Study|Other|1|||
94349632|NCT01371721|323060921|FG000|Overall Study|Adverse Event|5|||
94349633|NCT01371721|323060922|FG001|Overall Study|Adverse Event|4|||
94349634|NCT01371721|323060923|FG002|Overall Study|Adverse Event|5|||
94349635|NCT01371721|323060921|FG000|Overall Study|Protocol Violation|6|||
94349636|NCT01371721|323060922|FG001|Overall Study|Protocol Violation|4|||
94349637|NCT01371721|323060923|FG002|Overall Study|Protocol Violation|5|||
94574891|NCT03605667|323904892|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
94574892|NCT03605667|323904891|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
94349638|NCT01371721|323060921|FG000|Overall Study|Lost to Follow-up|8|||
94349639|NCT01371721|323060922|FG001|Overall Study|Lost to Follow-up|2|||
94349640|NCT01371721|323060923|FG002|Overall Study|Lost to Follow-up|6|||
94349641|NCT01371721|323060921|FG000|Overall Study|Withdrawal by Subject|5|||
94349642|NCT01371721|323060922|FG001|Overall Study|Withdrawal by Subject|7|||
94349643|NCT01371721|323060923|FG002|Overall Study|Withdrawal by Subject|11|||
94349644|NCT01371721|323060921|FG000|Overall Study|Other|2|||
94349645|NCT01371721|323060922|FG001|Overall Study|Other|3|||
94238856|NCT00340704|322668552|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
94238857|NCT00340704|322668553|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
94238858|NCT00340704|322668554|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
94238859|NCT00340704|322668555|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
94238860|NCT00340704|322668556|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
94238861|NCT00340704|322668557|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
94238862|NCT00340704|322668558|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
94238863|NCT00340704|322668559|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
94238864|NCT01732549|322668560|FG000|Overall Study|Adverse Event|13|||
94238865|NCT01732549|322668561|FG001|Overall Study|Adverse Event|3|||
94238866|NCT01732549|322668560|FG000|Overall Study|Consent withdrawn|13|||
94238867|NCT01732549|322668561|FG001|Overall Study|Consent withdrawn|6|||
94238868|NCT01732549|322668560|FG000|Overall Study|Disease progression|37|||
94238869|NCT01732549|322668561|FG001|Overall Study|Disease progression|50|||
94238870|NCT01732549|322668560|FG000|Overall Study|Other|8|||
94238871|NCT01732549|322668561|FG001|Overall Study|Other|14|||
94238872|NCT01661205|322668562|FG000|Overall Study|Physician Decision|2|||
94238873|NCT01736540|322668563|FG000|Overall Study|Did not complete scan within 45 days|2|||
94238874|NCT01736540|322668563|FG000|Overall Study|Death|1|||
94238875|NCT01736540|322668563|FG000|Overall Study|Abnormal test procedure|1|||
94238876|NCT01736540|322668563|FG000|Overall Study|Withdrawal by Subject|5|||
94238877|NCT01736540|322668563|FG000|Overall Study|Protocol Violation|1|||
94238878|NCT01736540|322668563|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
94238879|NCT01736540|322668563|FG000|Overall Study|No show for MRI appointment|1|||
94238880|NCT01736540|322668563|FG000|Overall Study|Unable to make MRI appointment|3|||
94238881|NCT02224703|322668565|FG000|Overall Study|Adverse Event|0|||
94238882|NCT02224703|322668566|FG001|Overall Study|Adverse Event|5|||
94238883|NCT02224703|322668567|FG002|Overall Study|Adverse Event|0|||
94238884|NCT02224703|322668565|FG000|Overall Study|Withdrawn by investigator|1|||
94238885|NCT02224703|322668566|FG001|Overall Study|Withdrawn by investigator|0|||
94238886|NCT02224703|322668567|FG002|Overall Study|Withdrawn by investigator|0|||
94238887|NCT02224703|322668565|FG000|Overall Study|Advised by medical monitor|1|||
94238888|NCT02224703|322668566|FG001|Overall Study|Advised by medical monitor|0|||
94238889|NCT02224703|322668567|FG002|Overall Study|Advised by medical monitor|0|||
94238890|NCT02224703|322668565|FG000|Overall Study|Withdrawn by parent/guardian|0|||
94238891|NCT02224703|322668566|FG001|Overall Study|Withdrawn by parent/guardian|1|||
94238892|NCT02224703|322668567|FG002|Overall Study|Withdrawn by parent/guardian|0|||
94238893|NCT02224703|322668565|FG000|Overall Study|Lack of Efficacy|1|||
94238894|NCT02224703|322668566|FG001|Overall Study|Lack of Efficacy|0|||
94238895|NCT02224703|322668567|FG002|Overall Study|Lack of Efficacy|0|||
94238896|NCT01023958|322668570|FG000|Overall Study|Progressive disease|48|||
94238897|NCT01023958|322668570|FG000|Overall Study|Other adverse event|1|||
94238898|NCT01023958|322668570|FG000|Overall Study|Refused to continue medication|1|||
94238899|NCT02159040|322668571|FG000|Overall Study|Death|1|||
94238900|NCT00742326|322668572|FG000|Overall Study|Physician Decision|0|||
94238901|NCT00742326|322668573|FG001|Overall Study|Physician Decision|1|||
94238902|NCT00790205|322668574|FG000|Overall Study|Lost to Follow-up|61|||
94238903|NCT00790205|322668575|FG001|Overall Study|Lost to Follow-up|71|||
94238904|NCT00790205|322668574|FG000|Overall Study|Withdrawal by Subject|299|||
94238905|NCT00790205|322668575|FG001|Overall Study|Withdrawal by Subject|363|||
94238906|NCT01080326|322668576|FG000|Overall Study|Patient deterioration prior to procedure|3|||
94238907|NCT01080326|322668576|FG000|Overall Study|Surgeon decision|1|||
94238908|NCT01304498|322668577|FG000|Overall Study|Adverse Event|1|||
94238909|NCT01304498|322668578|FG001|Overall Study|Adverse Event|1|||
94238910|NCT01304498|322668577|FG000|Overall Study|Withdrawal by Subject|2|||
94238911|NCT01304498|322668578|FG001|Overall Study|Withdrawal by Subject|3|||
94238912|NCT01304498|322668577|FG000|Overall Study|Protocol Violation|1|||
94238913|NCT01304498|322668578|FG001|Overall Study|Protocol Violation|0|||
94238914|NCT01304498|322668577|FG000|Overall Study|Lost to Follow-up|2|||
94238915|NCT01304498|322668578|FG001|Overall Study|Lost to Follow-up|1|||
94238916|NCT03933462|322668579|FG000|Overall Study|Adverse Event|2|||
94238917|NCT03933462|322668580|FG001|Overall Study|Adverse Event|0|||
94238918|NCT00967005|322668584|FG000|Overall Study|Lost to Follow-up|7|||
94238919|NCT00967005|322668585|FG001|Overall Study|Lost to Follow-up|10|||
94238920|NCT01436305|322668587|FG000|Overall Study|Death|1|||
94238921|NCT01436305|322668588|FG001|Overall Study|Death|0|||
94238922|NCT01436305|322668589|FG002|Overall Study|Death|0|||
94238923|NCT01436305|322668587|FG000|Overall Study|Lost to Follow-up|0|||
94238924|NCT01436305|322668588|FG001|Overall Study|Lost to Follow-up|1|||
94238925|NCT01436305|322668589|FG002|Overall Study|Lost to Follow-up|0|||
94238926|NCT01436305|322668587|FG000|Overall Study|Withdrawal by Subject|1|||
94238927|NCT01436305|322668588|FG001|Overall Study|Withdrawal by Subject|3|||
94238928|NCT01436305|322668589|FG002|Overall Study|Withdrawal by Subject|0|||
94238929|NCT01485120|322668593|FG000|Overall Study|Withdrawal by Subject|2|||
94238930|NCT04148651|322668598|FG000|Overall Study|Lost to Follow-up|2|||
94238931|NCT00895895|322668599|FG000|Period 1|Adverse Event|7|||
94349646|NCT01371721|323060923|FG002|Overall Study|Other|0|||
94349647|NCT01371721|323060921|FG000|Overall Study|Lack of Efficacy|2|||
94349648|NCT01371721|323060922|FG001|Overall Study|Lack of Efficacy|4|||
94349649|NCT01371721|323060923|FG002|Overall Study|Lack of Efficacy|3|||
94349650|NCT01371721|323060921|FG000|Overall Study|Randomized but not treated|1|||
94349651|NCT01371721|323060922|FG001|Overall Study|Randomized but not treated|0|||
94349652|NCT01371721|323060923|FG002|Overall Study|Randomized but not treated|0|||
94349653|NCT01200758|323060924|FG000|Stage I|Death|0|||
94349654|NCT01200758|323060925|FG001|Stage I|Death|1|||
94349655|NCT01200758|323060926|FG002|Stage I|Death|0|||
94349656|NCT01200758|323060927|FG003|Stage I|Death|0|||
94349657|NCT01200758|323060924|FG000|Stage I|Physician Decision|1|||
94349658|NCT01200758|323060925|FG001|Stage I|Physician Decision|1|||
94349659|NCT01200758|323060926|FG002|Stage I|Physician Decision|0|||
94349660|NCT01200758|323060927|FG003|Stage I|Physician Decision|0|||
94349661|NCT01200758|323060924|FG000|Stage I|Lack of Efficacy|2|||
94349662|NCT01200758|323060925|FG001|Stage I|Lack of Efficacy|1|||
94349663|NCT01200758|323060926|FG002|Stage I|Lack of Efficacy|0|||
94349664|NCT01200758|323060927|FG003|Stage I|Lack of Efficacy|0|||
94349665|NCT01200758|323060924|FG000|Stage I|Adverse Event|5|||
94349666|NCT01200758|323060925|FG001|Stage I|Adverse Event|5|||
94349667|NCT01200758|323060926|FG002|Stage I|Adverse Event|0|||
94349668|NCT01200758|323060927|FG003|Stage I|Adverse Event|0|||
94349669|NCT01200758|323060924|FG000|Stage I|Withdrawal by Subject|1|||
94349670|NCT01200758|323060925|FG001|Stage I|Withdrawal by Subject|2|||
94349671|NCT01200758|323060926|FG002|Stage I|Withdrawal by Subject|0|||
94349672|NCT01200758|323060927|FG003|Stage I|Withdrawal by Subject|0|||
94349673|NCT01200758|323060924|FG000|Stage I|Disease Progression|9|||
94349674|NCT01200758|323060925|FG001|Stage I|Disease Progression|7|||
94349675|NCT01200758|323060926|FG002|Stage I|Disease Progression|0|||
94349676|NCT01200758|323060927|FG003|Stage I|Disease Progression|0|||
94349677|NCT01200758|323060924|FG000|Stage 2|Disease Progression|0|||
94349678|NCT01200758|323060925|FG001|Stage 2|Disease Progression|0|||
94349679|NCT01200758|323060926|FG002|Stage 2|Disease Progression|16|||
94349680|NCT01200758|323060927|FG003|Stage 2|Disease Progression|21|||
94574893|NCT03605667|323904892|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
94574894|NCT03605667|323904891|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
94238932|NCT00895895|322668600|FG001|Period 1|Adverse Event|6|||
94238933|NCT00895895|322668601|FG002|Period 1|Adverse Event|4|||
94238934|NCT00895895|322668602|FG003|Period 1|Adverse Event|6|||
94238935|NCT00895895|322668603|FG004|Period 1|Adverse Event|7|||
94238936|NCT00895895|322668599|FG000|Period 1|Death|0|||
94238937|NCT00895895|322668600|FG001|Period 1|Death|0|||
94238938|NCT00895895|322668601|FG002|Period 1|Death|0|||
94238939|NCT00895895|322668602|FG003|Period 1|Death|0|||
94238940|NCT00895895|322668603|FG004|Period 1|Death|1|||
94238941|NCT00895895|322668599|FG000|Period 1|discontinued by sponsor|2|||
94238942|NCT00895895|322668600|FG001|Period 1|discontinued by sponsor|1|||
94238943|NCT00895895|322668601|FG002|Period 1|discontinued by sponsor|2|||
94238944|NCT00895895|322668602|FG003|Period 1|discontinued by sponsor|1|||
94238945|NCT00895895|322668603|FG004|Period 1|discontinued by sponsor|1|||
94238946|NCT00895895|322668599|FG000|Period 1|failed to return|0|||
94349681|NCT01200758|323060924|FG000|Stage 2|Lack of Efficacy|0|||
94349682|NCT01200758|323060925|FG001|Stage 2|Lack of Efficacy|0|||
94349683|NCT01200758|323060926|FG002|Stage 2|Lack of Efficacy|4|||
94349684|NCT01200758|323060927|FG003|Stage 2|Lack of Efficacy|2|||
94349685|NCT01200758|323060924|FG000|Stage 2|Physician Decision|0|||
94349686|NCT01200758|323060925|FG001|Stage 2|Physician Decision|0|||
94349687|NCT01200758|323060926|FG002|Stage 2|Physician Decision|5|||
94349688|NCT01200758|323060927|FG003|Stage 2|Physician Decision|7|||
94349689|NCT01200758|323060924|FG000|Stage 2|Adverse Event|0|||
94238947|NCT00895895|322668600|FG001|Period 1|failed to return|0|||
94349690|NCT01200758|323060925|FG001|Stage 2|Adverse Event|0|||
94349691|NCT01200758|323060926|FG002|Stage 2|Adverse Event|5|||
94349692|NCT01200758|323060927|FG003|Stage 2|Adverse Event|9|||
94349693|NCT01200758|323060924|FG000|Stage 2|Withdrawal by Subject|0|||
94349694|NCT01200758|323060925|FG001|Stage 2|Withdrawal by Subject|0|||
94574895|NCT03605667|323904892|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
94574896|NCT03605667|323904891|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
94574897|NCT03605667|323904892|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
94574898|NCT03605667|323904891|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
94574899|NCT03605667|323904892|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
94574900|NCT03605667|323904891|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
94574901|NCT03605667|323904892|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
94574902|NCT03605667|323904891|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
94574903|NCT03605667|323904892|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
94574904|NCT03605667|323904891|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
94574905|NCT03605667|323904892|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
94574906|NCT03605667|323904891|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
94574907|NCT03605667|323904892|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
94574908|NCT03605667|323904891|FG000|OLE Phase (48 Weeks)|Other|6|||
94574909|NCT03605667|323904892|FG001|OLE Phase (48 Weeks)|Other|8|||
94574910|NCT03605667|323904891|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
94574911|NCT03605667|323904892|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
94574912|NCT03605667|323904891|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
94574913|NCT03605667|323904892|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
94574914|NCT03605667|323904891|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
94574915|NCT03605667|323904892|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
94574916|NCT03605667|323904891|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
94574917|NCT03605667|323904892|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
94574918|NCT03605667|323904891|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
94574919|NCT03605667|323904892|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
94574920|NCT03605667|323904891|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
94574921|NCT03605667|323904892|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
94574922|NCT03605667|323904891|FG000|OLE Phase (48 Weeks)|Death|0|||
94574923|NCT03605667|323904892|FG001|OLE Phase (48 Weeks)|Death|2|||
94238948|NCT00895895|322668601|FG002|Period 1|failed to return|1|||
94238949|NCT00895895|322668602|FG003|Period 1|failed to return|0|||
94238950|NCT00895895|322668603|FG004|Period 1|failed to return|1|||
94238951|NCT00895895|322668599|FG000|Period 1|investigator request|0|||
94238952|NCT00895895|322668600|FG001|Period 1|investigator request|1|||
94238953|NCT00895895|322668601|FG002|Period 1|investigator request|0|||
94238954|NCT00895895|322668602|FG003|Period 1|investigator request|0|||
94238955|NCT00895895|322668603|FG004|Period 1|investigator request|0|||
94238956|NCT00895895|322668599|FG000|Period 1|Lost to Follow-up|2|||
94238957|NCT00895895|322668600|FG001|Period 1|Lost to Follow-up|1|||
94238958|NCT00895895|322668601|FG002|Period 1|Lost to Follow-up|3|||
94238959|NCT00895895|322668602|FG003|Period 1|Lost to Follow-up|2|||
94238960|NCT00895895|322668603|FG004|Period 1|Lost to Follow-up|3|||
94238961|NCT00895895|322668599|FG000|Period 1|Other|1|||
94238962|NCT00895895|322668600|FG001|Period 1|Other|2|||
94238963|NCT00895895|322668601|FG002|Period 1|Other|1|||
94238964|NCT00895895|322668602|FG003|Period 1|Other|1|||
94238965|NCT00895895|322668603|FG004|Period 1|Other|1|||
94238966|NCT00895895|322668599|FG000|Period 1|Protocol Violation|0|||
94238967|NCT00895895|322668600|FG001|Period 1|Protocol Violation|1|||
94238968|NCT00895895|322668601|FG002|Period 1|Protocol Violation|0|||
94574924|NCT03605667|323904891|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
94238969|NCT00895895|322668602|FG003|Period 1|Protocol Violation|0|||
94238970|NCT00895895|322668603|FG004|Period 1|Protocol Violation|0|||
94574925|NCT03605667|323904892|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
94574926|NCT04764162|323904893|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
94574927|NCT04764162|323904894|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
94574928|NCT05556265|323904896|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
94574929|NCT05556265|323904897|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
94574930|NCT05556265|323904898|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
94574931|NCT05556265|323904899|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
94574932|NCT05556265|323904900|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
94574933|NCT05556265|323904896|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
94574934|NCT05556265|323904897|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
94574935|NCT05556265|323904898|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
94574936|NCT05556265|323904899|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
94574937|NCT05556265|323904900|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
94574938|NCT05556265|323904896|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
94574939|NCT05556265|323904897|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
94574940|NCT05556265|323904898|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
94574941|NCT05556265|323904899|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
94574942|NCT05556265|323904900|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
94574943|NCT05556265|323904896|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
94349695|NCT01200758|323060926|FG002|Stage 2|Withdrawal by Subject|4|||
94349696|NCT01200758|323060927|FG003|Stage 2|Withdrawal by Subject|1|||
94349697|NCT01200758|323060924|FG000|Stage 2|Lost to Follow-up|0|||
94349698|NCT01200758|323060925|FG001|Stage 2|Lost to Follow-up|0|||
94349699|NCT01200758|323060926|FG002|Stage 2|Lost to Follow-up|3|||
94349700|NCT01200758|323060927|FG003|Stage 2|Lost to Follow-up|1|||
94349701|NCT01200758|323060924|FG000|Stage 2|Protocol Violation|0|||
94349702|NCT01200758|323060925|FG001|Stage 2|Protocol Violation|0|||
94349703|NCT01200758|323060926|FG002|Stage 2|Protocol Violation|1|||
94349704|NCT01200758|323060927|FG003|Stage 2|Protocol Violation|4|||
94349705|NCT01200758|323060924|FG000|Stage 2|Death|0|||
94349706|NCT01200758|323060925|FG001|Stage 2|Death|0|||
94574944|NCT05556265|323904897|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
94574945|NCT05556265|323904898|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
94574946|NCT05556265|323904899|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
94574947|NCT05556265|323904900|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
94574948|NCT05556265|323904896|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
94574949|NCT05556265|323904897|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
94574950|NCT05556265|323904898|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
94574951|NCT05556265|323904899|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
94574952|NCT05556265|323904900|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
94349707|NCT01200758|323060926|FG002|Stage 2|Death|3|||
94349708|NCT01200758|323060927|FG003|Stage 2|Death|5|||
94349709|NCT04491591|323060928|FG000|Overall Study|Accidently randomized|3|||
94349710|NCT04491591|323060929|FG001|Overall Study|Accidently randomized|1|||
94349711|NCT04491591|323060930|FG002|Overall Study|Accidently randomized|0|||
94349712|NCT04491591|323060928|FG000|Overall Study|Did not complete survey|28|||
94349713|NCT04491591|323060929|FG001|Overall Study|Did not complete survey|20|||
94349714|NCT04491591|323060930|FG002|Overall Study|Did not complete survey|3|||
94349715|NCT03525613|323060931|FG000|Overall Study|Adverse Event|11|||
94349716|NCT03525613|323060932|FG001|Overall Study|Adverse Event|8|||
94349717|NCT03525613|323060933|FG002|Overall Study|Adverse Event|3|||
94349718|NCT03525613|323060934|FG003|Overall Study|Adverse Event|3|||
94349719|NCT03525613|323060931|FG000|Overall Study|Lost to Follow-up|4|||
94349720|NCT03525613|323060932|FG001|Overall Study|Lost to Follow-up|5|||
94349721|NCT03525613|323060933|FG002|Overall Study|Lost to Follow-up|3|||
94349722|NCT03525613|323060934|FG003|Overall Study|Lost to Follow-up|2|||
94349723|NCT03525613|323060931|FG000|Overall Study|Physician Decision|0|||
94349724|NCT03525613|323060932|FG001|Overall Study|Physician Decision|1|||
94349725|NCT03525613|323060933|FG002|Overall Study|Physician Decision|0|||
94349726|NCT03525613|323060934|FG003|Overall Study|Physician Decision|1|||
94349727|NCT03525613|323060931|FG000|Overall Study|Consent Withdrawal|25|||
94349728|NCT03525613|323060932|FG001|Overall Study|Consent Withdrawal|16|||
94349729|NCT03525613|323060933|FG002|Overall Study|Consent Withdrawal|12|||
94349730|NCT03525613|323060934|FG003|Overall Study|Consent Withdrawal|9|||
94349731|NCT03525613|323060931|FG000|Overall Study|Death|20|||
94349732|NCT03525613|323060932|FG001|Overall Study|Death|9|||
94349733|NCT03525613|323060933|FG002|Overall Study|Death|7|||
94349734|NCT03525613|323060934|FG003|Overall Study|Death|1|||
94349735|NCT03525613|323060931|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
94349736|NCT03525613|323060932|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
94349737|NCT03525613|323060933|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
94349738|NCT03525613|323060934|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
94349739|NCT03480360|323060935|FG000|Overall Study|Death|2|||
94349740|NCT00374452|323060938|FG000|Overall Study|Left clinic before intervention started|4|||
94349741|NCT00374452|323060939|FG001|Overall Study|Left clinic before intervention started|1|||
94349742|NCT00374452|323060938|FG000|Overall Study|Change in job role before intervention|0|||
94349743|NCT00374452|323060939|FG001|Overall Study|Change in job role before intervention|1|||
94349744|NCT00374452|323060938|FG000|Overall Study|Left clinic after intervention started|1|||
94349745|NCT00374452|323060939|FG001|Overall Study|Left clinic after intervention started|1|||
94349746|NCT00374452|323060938|FG000|Overall Study|Withdrawal by Subject|0|||
94349747|NCT00374452|323060939|FG001|Overall Study|Withdrawal by Subject|2|||
94349748|NCT00523744|323060940|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
94349749|NCT00523744|323060940|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
94349750|NCT00523744|323060940|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
94349751|NCT00523744|323060940|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
94349752|NCT00523744|323060940|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
94349753|NCT00523744|323060940|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
94349754|NCT03370133|323060944|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
94349755|NCT03370133|323060945|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
94349756|NCT03370133|323060946|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
94349757|NCT03370133|323060947|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
94349758|NCT03370133|323060948|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
94349759|NCT03370133|323060949|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
94349760|NCT03370133|323060944|FG000|Initial Treatment Period (WK 16)|Death|1|||
94349761|NCT03370133|323060945|FG001|Initial Treatment Period (WK 16)|Death|1|||
94349762|NCT03370133|323060946|FG002|Initial Treatment Period (WK 16)|Death|1|||
94349763|NCT03370133|323060947|FG003|Initial Treatment Period (WK 16)|Death|0|||
94349764|NCT03370133|323060948|FG004|Initial Treatment Period (WK 16)|Death|0|||
94349765|NCT03370133|323060949|FG005|Initial Treatment Period (WK 16)|Death|0|||
94349766|NCT03370133|323060944|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
94574953|NCT05556265|323904896|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
94574954|NCT05556265|323904897|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
94574955|NCT05556265|323904898|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
94574956|NCT05556265|323904899|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
94574957|NCT05556265|323904900|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
94574958|NCT05556265|323904896|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
94574959|NCT05556265|323904897|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
94574960|NCT05556265|323904898|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
94574961|NCT05556265|323904899|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
94574962|NCT05556265|323904900|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
94574963|NCT05556265|323904896|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
94574964|NCT05556265|323904897|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
94574965|NCT05556265|323904898|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
94574966|NCT05556265|323904899|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
94574967|NCT05556265|323904900|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
94574968|NCT05556265|323904896|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
94574969|NCT05556265|323904897|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
94574970|NCT05556265|323904898|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
94574971|NCT05556265|323904899|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
94574972|NCT05556265|323904900|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
94574973|NCT04609319|323904901|FG000|Overall Study|Death|64|||
94574974|NCT04609319|323904902|FG001|Overall Study|Death|49|||
94574975|NCT04609319|323904903|FG002|Overall Study|Death|1|||
94574976|NCT04609319|323904901|FG000|Overall Study|Withdrawal of consent|15|||
94574977|NCT04609319|323904902|FG001|Overall Study|Withdrawal of consent|3|||
94574978|NCT04609319|323904903|FG002|Overall Study|Withdrawal of consent|0|||
94574979|NCT04609319|323904901|FG000|Overall Study|Lost to Follow-up|20|||
94574980|NCT04609319|323904902|FG001|Overall Study|Lost to Follow-up|33|||
94574981|NCT04609319|323904903|FG002|Overall Study|Lost to Follow-up|0|||
94574982|NCT04609319|323904901|FG000|Overall Study|Alive until end of follow-up|60|||
94574983|NCT04609319|323904902|FG001|Overall Study|Alive until end of follow-up|53|||
94574984|NCT04609319|323904903|FG002|Overall Study|Alive until end of follow-up|1|||
94574985|NCT01838395|323904908|FG000|Overall Study|Withdrawal by Subject|0|||
94574986|NCT01838395|323904909|FG001|Overall Study|Withdrawal by Subject|0|||
94574987|NCT01838395|323904910|FG002|Overall Study|Withdrawal by Subject|0|||
94574988|NCT01838395|323904911|FG003|Overall Study|Withdrawal by Subject|0|||
94574989|NCT01838395|323904912|FG004|Overall Study|Withdrawal by Subject|1|||
94574990|NCT01838395|323904913|FG005|Overall Study|Withdrawal by Subject|0|||
94574991|NCT01838395|323904908|FG000|Overall Study|Death|0|||
94574992|NCT01838395|323904909|FG001|Overall Study|Death|0|||
94574993|NCT01838395|323904910|FG002|Overall Study|Death|1|||
94574994|NCT01838395|323904911|FG003|Overall Study|Death|0|||
94574995|NCT01838395|323904912|FG004|Overall Study|Death|0|||
94574996|NCT01838395|323904913|FG005|Overall Study|Death|0|||
94574997|NCT01838395|323904908|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
94574998|NCT01838395|323904909|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
94574999|NCT01838395|323904910|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
94575000|NCT01838395|323904911|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
94575001|NCT01838395|323904912|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
94575002|NCT01838395|323904913|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
94575003|NCT03157830|323904917|FG000|Overall Study|Lost to Follow-up|1|||
94575004|NCT03157830|323904917|FG000|Overall Study|Withdrawal by Subject|1|||
94349767|NCT03370133|323060945|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
94575005|NCT01607957|323904918|FG000|Overall Study|Not treated|1|||
94575006|NCT01607957|323904919|FG001|Overall Study|Not treated|1|||
94575007|NCT01607957|323904918|FG000|Overall Study|Death|367|||
94575008|NCT01607957|323904919|FG001|Overall Study|Death|211|||
94349768|NCT03370133|323060946|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
94575009|NCT01607957|323904918|FG000|Overall Study|Lost to Follow-up|3|||
94575010|NCT01607957|323904919|FG001|Overall Study|Lost to Follow-up|3|||
94575011|NCT01607957|323904918|FG000|Overall Study|Participant refusal|1|||
94575012|NCT01607957|323904919|FG001|Overall Study|Participant refusal|0|||
94575013|NCT00945009|323904923|FG000|Overall Study|Lack of Efficacy|10|||
94575014|NCT00945009|323904924|FG001|Overall Study|Lack of Efficacy|0|||
94575015|NCT00945009|323904925|FG002|Overall Study|Lack of Efficacy|0|||
94575016|NCT00945009|323904923|FG000|Overall Study|Physician Decision|21|||
94575017|NCT00945009|323904924|FG001|Overall Study|Physician Decision|4|||
94575018|NCT00945009|323904925|FG002|Overall Study|Physician Decision|3|||
94575019|NCT00945009|323904923|FG000|Overall Study|Protocol Violation|6|||
94575020|NCT00945009|323904924|FG001|Overall Study|Protocol Violation|1|||
94575021|NCT00945009|323904925|FG002|Overall Study|Protocol Violation|0|||
94575022|NCT00945009|323904923|FG000|Overall Study|Withdrawal by Subject|1|||
94575023|NCT00945009|323904924|FG001|Overall Study|Withdrawal by Subject|0|||
94575024|NCT00945009|323904925|FG002|Overall Study|Withdrawal by Subject|0|||
94575025|NCT00945009|323904923|FG000|Overall Study|Ineligible|6|||
94575026|NCT00945009|323904924|FG001|Overall Study|Ineligible|1|||
94575027|NCT00945009|323904925|FG002|Overall Study|Ineligible|0|||
94575028|NCT00945009|323904923|FG000|Overall Study|Inevaluable|0|||
94575029|NCT00945009|323904924|FG001|Overall Study|Inevaluable|1|||
94575030|NCT00945009|323904925|FG002|Overall Study|Inevaluable|0|||
94575031|NCT00945009|323904923|FG000|Overall Study|Refusal of further protocol|1|||
94575032|NCT00945009|323904924|FG001|Overall Study|Refusal of further protocol|0|||
94575033|NCT00945009|323904925|FG002|Overall Study|Refusal of further protocol|0|||
94575034|NCT04659044|323904926|FG000|Induction|Physician Decision|1|||
94575035|NCT04659044|323904926|FG000|Induction|Adverse Event|2|||
94575036|NCT02331134|323904928|FG000|Overall Study|Withdrawal by Subject|1|||
94575037|NCT04966013|323904929|FG000|Overall Study|Withdrawal by Subject|0|||
94575038|NCT04966013|323904930|FG001|Overall Study|Withdrawal by Subject|2|||
94575039|NCT04966013|323904931|FG002|Overall Study|Withdrawal by Subject|1|||
94575040|NCT04966013|323904929|FG000|Overall Study|Adverse Event|2|||
94575041|NCT04966013|323904930|FG001|Overall Study|Adverse Event|1|||
94575042|NCT04966013|323904931|FG002|Overall Study|Adverse Event|1|||
94575043|NCT04825574|323904932|FG000|Overall Study|Commercial treatment became available|1|||
94575044|NCT04825574|323904932|FG000|Overall Study|Disease progression|1|||
94575045|NCT05752487|323904933|FG000|Overall Study|Randomized, not treated|9|||
94575046|NCT05752487|323904933|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
94575047|NCT05752487|323904933|FG000|Overall Study|Withdrawal by Subject|2|||
94575048|NCT05752487|323904933|FG000|Overall Study|Ongoing|137|||
94575049|NCT03518086|323904934|FG000|Overall Study|Adverse Event|23|||
94575050|NCT03518086|323904935|FG001|Overall Study|Adverse Event|15|||
94575051|NCT03518086|323904936|FG002|Overall Study|Adverse Event|3|||
94575052|NCT03518086|323904937|FG003|Overall Study|Adverse Event|2|||
94575053|NCT03518086|323904934|FG000|Overall Study|Withdrawal by Subject|8|||
94575054|NCT03518086|323904935|FG001|Overall Study|Withdrawal by Subject|5|||
94575055|NCT03518086|323904936|FG002|Overall Study|Withdrawal by Subject|1|||
94575056|NCT03518086|323904937|FG003|Overall Study|Withdrawal by Subject|0|||
94575057|NCT03518086|323904934|FG000|Overall Study|Lack of Efficacy|5|||
94575058|NCT03518086|323904935|FG001|Overall Study|Lack of Efficacy|5|||
94575059|NCT03518086|323904936|FG002|Overall Study|Lack of Efficacy|0|||
94575060|NCT03518086|323904937|FG003|Overall Study|Lack of Efficacy|2|||
94575061|NCT03518086|323904934|FG000|Overall Study|Protocol Violation|1|||
94575062|NCT03518086|323904935|FG001|Overall Study|Protocol Violation|5|||
94575063|NCT03518086|323904936|FG002|Overall Study|Protocol Violation|1|||
94575064|NCT03518086|323904937|FG003|Overall Study|Protocol Violation|3|||
94575065|NCT03518086|323904934|FG000|Overall Study|Lost to Follow-up|0|||
94575066|NCT03518086|323904935|FG001|Overall Study|Lost to Follow-up|3|||
94575067|NCT03518086|323904936|FG002|Overall Study|Lost to Follow-up|0|||
94575068|NCT03518086|323904937|FG003|Overall Study|Lost to Follow-up|0|||
94575069|NCT03518086|323904934|FG000|Overall Study|Insufficient Diary Data|0|||
94575070|NCT03518086|323904935|FG001|Overall Study|Insufficient Diary Data|2|||
94575071|NCT03518086|323904936|FG002|Overall Study|Insufficient Diary Data|0|||
94575072|NCT03518086|323904937|FG003|Overall Study|Insufficient Diary Data|0|||
94238971|NCT00895895|322668599|FG000|Period 1|Withdrawal by Subject|6|||
94238972|NCT00895895|322668600|FG001|Period 1|Withdrawal by Subject|6|||
94575073|NCT03518086|323904934|FG000|Overall Study|Non- compliance to Protocol|0|||
94575074|NCT03518086|323904935|FG001|Overall Study|Non- compliance to Protocol|1|||
94238973|NCT00895895|322668601|FG002|Period 1|Withdrawal by Subject|8|||
94238974|NCT00895895|322668602|FG003|Period 1|Withdrawal by Subject|2|||
94575075|NCT03518086|323904936|FG002|Overall Study|Non- compliance to Protocol|0|||
94575076|NCT03518086|323904937|FG003|Overall Study|Non- compliance to Protocol|0|||
94575077|NCT03518086|323904934|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
94575078|NCT03518086|323904935|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
94575079|NCT03518086|323904936|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
94575080|NCT03518086|323904937|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
94575081|NCT03518086|323904934|FG000|Overall Study|Site Terminated by Sponsor|0|||
94575082|NCT03518086|323904935|FG001|Overall Study|Site Terminated by Sponsor|1|||
94575083|NCT03518086|323904936|FG002|Overall Study|Site Terminated by Sponsor|0|||
94575084|NCT03518086|323904937|FG003|Overall Study|Site Terminated by Sponsor|0|||
94575085|NCT03518086|323904934|FG000|Overall Study|Pregnancy|0|||
94575086|NCT03518086|323904935|FG001|Overall Study|Pregnancy|0|||
94575087|NCT03518086|323904936|FG002|Overall Study|Pregnancy|0|||
94575088|NCT03518086|323904937|FG003|Overall Study|Pregnancy|2|||
94575089|NCT02336282|323904938|FG000|Overall Study|Unrelated illness|1|||
94575090|NCT02336282|323904938|FG000|Overall Study|Uncomfortable with technology|1|||
94575091|NCT02336282|323904938|FG000|Overall Study|Lost to Follow-up|1|||
94575092|NCT02336282|323904938|FG000|Overall Study|Not enough time to complete sessions|2|||
94575093|NCT00781768|323906724|FG000|Overall Study|Not transplanted.|0|||
94575094|NCT00781768|323906725|FG001|Overall Study|Not transplanted.|2|||
94575095|NCT02458313|323906726|FG000|Overall Study|Withdrawal by Subject|6|||
94575096|NCT02458313|323906727|FG001|Overall Study|Withdrawal by Subject|8|||
94575097|NCT02458313|323906726|FG000|Overall Study|Excluded for motion during MRI|1|||
94575098|NCT02458313|323906727|FG001|Overall Study|Excluded for motion during MRI|2|||
94575099|NCT02177695|323906730|FG000|ITT Analysis|Ineligible|5|||
94575100|NCT02177695|323906731|FG001|ITT Analysis|Ineligible|5|||
94575101|NCT02177695|323906730|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
94575102|NCT02177695|323906731|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
94575103|NCT02177695|323906730|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
94575104|NCT02177695|323906731|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
94575105|NCT02177695|323906730|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
94575106|NCT02177695|323906731|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
94575107|NCT02153086|323906732|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
94575108|NCT02153086|323906732|FG000|Overall Study|Other|2|||
94575109|NCT00446849|323906733|FG000|Acute Phase|Lack of Efficacy|64|||
94575110|NCT00446849|323906733|FG000|Acute Phase|Protocol Violation|10|||
94575111|NCT00446849|323906733|FG000|Acute Phase|Consent withdrawn|4|||
94575112|NCT00446849|323906733|FG000|Acute Phase|Lost to Follow-up|2|||
94575113|NCT00446849|323906733|FG000|Acute Phase|Physician Decision|1|||
94575114|NCT00446849|323906733|FG000|Acute Phase|noncompliance|1|||
94575115|NCT00446849|323906733|FG000|Maintenance Phase|Lack of Efficacy|40|||
94575116|NCT00446849|323906733|FG000|Maintenance Phase|Protocol Violation|7|||
94575117|NCT00446849|323906733|FG000|Maintenance Phase|Adverse Event|6|||
94575118|NCT00446849|323906733|FG000|Maintenance Phase|Consent withdrawn|5|||
94575119|NCT00446849|323906733|FG000|Maintenance Phase|Lost to Follow-up|3|||
94575120|NCT00446849|323906733|FG000|Maintenance Phase|Pregnancy|1|||
94575121|NCT00446849|323906733|FG000|Maintenance Phase|noncompliance|2|||
94575122|NCT00446849|323906733|FG000|Maintenance Phase|prohibited medication use|2|||
94575123|NCT00446849|323906733|FG000|Maintenance Phase|antibiotic use|1|||
94575124|NCT00446849|323906733|FG000|Maintenance Phase|study closure|1|||
94575125|NCT00446849|323906733|FG000|Maintenance Phase|hydrocodone use|1|||
94575126|NCT00446849|323906733|FG000|Maintenance Phase|concomitant medication use|1|||
94575127|NCT03085095|323906734|FG000|Overall Study|Adverse Event|23|||
94575128|NCT03085095|323906735|FG001|Overall Study|Adverse Event|8|||
94575129|NCT03085095|323906734|FG000|Overall Study|Protocol Violation|0|||
94575130|NCT03085095|323906735|FG001|Overall Study|Protocol Violation|1|||
94575131|NCT03085095|323906734|FG000|Overall Study|Lost to Follow-up|2|||
94575132|NCT03085095|323906735|FG001|Overall Study|Lost to Follow-up|1|||
94575133|NCT03085095|323906734|FG000|Overall Study|Withdrawal by Subject|17|||
94575134|NCT03085095|323906735|FG001|Overall Study|Withdrawal by Subject|6|||
94575135|NCT03085095|323906734|FG000|Overall Study|Physician Decision|9|||
94575136|NCT03085095|323906735|FG001|Overall Study|Physician Decision|3|||
94575137|NCT03085095|323906734|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
94575138|NCT03085095|323906735|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
94575139|NCT03085095|323906734|FG000|Overall Study|Did not Receive Study Drug|2|||
94575140|NCT03085095|323906735|FG001|Overall Study|Did not Receive Study Drug|2|||
94575141|NCT03085095|323906734|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
94575142|NCT03085095|323906735|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
94575143|NCT02218372|323906739|FG000|Overall Study|Adverse Event|1|||
94575144|NCT02218372|323906740|FG001|Overall Study|Adverse Event|1|||
94575145|NCT02218372|323906739|FG000|Overall Study|Miscellaneous|2|||
94575146|NCT02218372|323906740|FG001|Overall Study|Miscellaneous|1|||
94575147|NCT02218372|323906739|FG000|Overall Study|Randomized but did not receive treatment|2|||
94575148|NCT02218372|323906740|FG001|Overall Study|Randomized but did not receive treatment|3|||
94575149|NCT02218372|323906739|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94575150|NCT02218372|323906740|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
94575151|NCT03466658|323906741|FG000|Overall Study|Withdrawal by Subject|3|||
94575152|NCT02230410|323906742|FG000|Overall Study|Screen Failure|3|||
94575153|NCT03962491|323906745|FG000|Overall Study|Lost to Follow-up|4|||
94575154|NCT03962491|323906746|FG001|Overall Study|Lost to Follow-up|5|||
94575155|NCT04849364|323906750|FG000|Overall Study|Eligibility criteria not meet|0|||
94575156|NCT04849364|323906751|FG001|Overall Study|Eligibility criteria not meet|1|||
94575157|NCT04849364|323906752|FG002|Overall Study|Eligibility criteria not meet|0|||
94575158|NCT00231816|323906764|FG000|Overall Study|Adverse Event|1|||
94575159|NCT00231816|323906765|FG001|Overall Study|Adverse Event|0|||
94575160|NCT00231816|323906764|FG000|Overall Study|Lost to Follow-up|8|||
94575161|NCT00231816|323906765|FG001|Overall Study|Lost to Follow-up|5|||
94575162|NCT00231816|323906764|FG000|Overall Study|Protocol Violation|2|||
94575163|NCT00231816|323906765|FG001|Overall Study|Protocol Violation|3|||
94575164|NCT00231816|323906764|FG000|Overall Study|Withdrawal by Subject|3|||
94575165|NCT00231816|323906765|FG001|Overall Study|Withdrawal by Subject|3|||
94575166|NCT00231816|323906764|FG000|Overall Study|Other|2|||
94575167|NCT00231816|323906765|FG001|Overall Study|Other|1|||
94575168|NCT01126749|323906770|FG000|Phase 1b|Other|0|||
94575169|NCT01126749|323906771|FG001|Phase 1b|Other|1|||
94575170|NCT01126749|323906772|FG002|Phase 1b|Other|0|||
94575171|NCT01126749|323906773|FG003|Phase 1b|Other|0|||
94575172|NCT01126749|323906770|FG000|Phase 1b|Withdrawal by Subject|0|||
94575173|NCT01126749|323906771|FG001|Phase 1b|Withdrawal by Subject|1|||
94575174|NCT01126749|323906772|FG002|Phase 1b|Withdrawal by Subject|0|||
94575175|NCT01126749|323906773|FG003|Phase 1b|Withdrawal by Subject|0|||
94575176|NCT01126749|323906770|FG000|Phase 1b|Death|3|||
94575177|NCT01126749|323906771|FG001|Phase 1b|Death|4|||
94575178|NCT01126749|323906772|FG002|Phase 1b|Death|0|||
94575179|NCT01126749|323906773|FG003|Phase 1b|Death|0|||
94575180|NCT01126749|323906770|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
94575181|NCT01126749|323906771|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
94575182|NCT01126749|323906772|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
94575183|NCT01126749|323906773|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
94575184|NCT01126749|323906770|FG000|Phase 2|Study Termination by Sponsor|0|||
94575185|NCT01126749|323906771|FG001|Phase 2|Study Termination by Sponsor|0|||
94575186|NCT01126749|323906772|FG002|Phase 2|Study Termination by Sponsor|12|||
94575187|NCT01126749|323906773|FG003|Phase 2|Study Termination by Sponsor|6|||
94575188|NCT01126749|323906770|FG000|Phase 2|Other|0|||
94575189|NCT01126749|323906771|FG001|Phase 2|Other|0|||
94575190|NCT01126749|323906772|FG002|Phase 2|Other|4|||
94575191|NCT01126749|323906773|FG003|Phase 2|Other|2|||
94575192|NCT01126749|323906770|FG000|Phase 2|Withdrawal by Subject|0|||
94575193|NCT01126749|323906771|FG001|Phase 2|Withdrawal by Subject|0|||
94575194|NCT01126749|323906772|FG002|Phase 2|Withdrawal by Subject|0|||
94575195|NCT01126749|323906773|FG003|Phase 2|Withdrawal by Subject|2|||
94575196|NCT01126749|323906770|FG000|Phase 2|Lost to Follow-up|0|||
94575197|NCT01126749|323906771|FG001|Phase 2|Lost to Follow-up|0|||
94575198|NCT01126749|323906772|FG002|Phase 2|Lost to Follow-up|0|||
94575199|NCT01126749|323906773|FG003|Phase 2|Lost to Follow-up|1|||
94575200|NCT01126749|323906770|FG000|Phase 2|Death|0|||
94575201|NCT01126749|323906771|FG001|Phase 2|Death|0|||
94575202|NCT01126749|323906772|FG002|Phase 2|Death|22|||
94575203|NCT01126749|323906773|FG003|Phase 2|Death|22|||
94575204|NCT01126749|323906770|FG000|Phase 2|Adverse Event|0|||
94575205|NCT01126749|323906771|FG001|Phase 2|Adverse Event|0|||
94575206|NCT01126749|323906772|FG002|Phase 2|Adverse Event|0|||
94575207|NCT01126749|323906773|FG003|Phase 2|Adverse Event|1|||
94575208|NCT01283139|323906774|FG000|Overall Study|Lost to Follow-up|5|||
94575209|NCT01283139|323906775|FG001|Overall Study|Lost to Follow-up|2|||
94575210|NCT01283139|323906776|FG002|Overall Study|Lost to Follow-up|3|||
94575211|NCT01283139|323906777|FG003|Overall Study|Lost to Follow-up|1|||
94575212|NCT01283139|323906774|FG000|Overall Study|Withdrawal by Subject|8|||
94575213|NCT01283139|323906775|FG001|Overall Study|Withdrawal by Subject|8|||
94575214|NCT01283139|323906776|FG002|Overall Study|Withdrawal by Subject|6|||
94575215|NCT01283139|323906777|FG003|Overall Study|Withdrawal by Subject|8|||
94575216|NCT01283139|323906774|FG000|Overall Study|Death|2|||
94575217|NCT01283139|323906775|FG001|Overall Study|Death|0|||
94575218|NCT01283139|323906776|FG002|Overall Study|Death|2|||
94575219|NCT01283139|323906777|FG003|Overall Study|Death|2|||
94575220|NCT01283139|323906774|FG000|Overall Study|Lack of Efficacy|1|||
94575221|NCT01283139|323906775|FG001|Overall Study|Lack of Efficacy|2|||
94575222|NCT01283139|323906776|FG002|Overall Study|Lack of Efficacy|2|||
94575223|NCT01283139|323906777|FG003|Overall Study|Lack of Efficacy|1|||
94575224|NCT01283139|323906774|FG000|Overall Study|Early termination due to AE/SAE|1|||
94575225|NCT01283139|323906775|FG001|Overall Study|Early termination due to AE/SAE|1|||
94575226|NCT01283139|323906776|FG002|Overall Study|Early termination due to AE/SAE|0|||
94575227|NCT01283139|323906777|FG003|Overall Study|Early termination due to AE/SAE|0|||
94575228|NCT01283139|323906774|FG000|Overall Study|Participant's refusal to continue|0|||
94575229|NCT01283139|323906775|FG001|Overall Study|Participant's refusal to continue|3|||
94575230|NCT01283139|323906776|FG002|Overall Study|Participant's refusal to continue|1|||
94575231|NCT01283139|323906777|FG003|Overall Study|Participant's refusal to continue|1|||
94575232|NCT01283139|323906774|FG000|Overall Study|Pregnancy|0|||
94575233|NCT01283139|323906775|FG001|Overall Study|Pregnancy|1|||
94575234|NCT01283139|323906776|FG002|Overall Study|Pregnancy|1|||
94575235|NCT01283139|323906777|FG003|Overall Study|Pregnancy|0|||
94575236|NCT01283139|323906774|FG000|Overall Study|Missed follow-up visit|0|||
94575237|NCT01283139|323906775|FG001|Overall Study|Missed follow-up visit|1|||
94575238|NCT01283139|323906776|FG002|Overall Study|Missed follow-up visit|2|||
94575239|NCT01283139|323906777|FG003|Overall Study|Missed follow-up visit|2|||
94575240|NCT01283139|323906774|FG000|Overall Study|Participant randomized in error|0|||
94575241|NCT01283139|323906775|FG001|Overall Study|Participant randomized in error|0|||
94575242|NCT01283139|323906776|FG002|Overall Study|Participant randomized in error|1|||
94575243|NCT01283139|323906777|FG003|Overall Study|Participant randomized in error|0|||
94575244|NCT01075243|323906780|FG000|Overall Study|Lost to Follow-up|5|||
94575245|NCT01075243|323906781|FG001|Overall Study|Lost to Follow-up|2|||
94575246|NCT01075243|323906782|FG002|Overall Study|Lost to Follow-up|0|||
94575247|NCT01075243|323906780|FG000|Overall Study|Withdrawal by Subject|1|||
94575248|NCT01075243|323906781|FG001|Overall Study|Withdrawal by Subject|1|||
94575249|NCT01075243|323906782|FG002|Overall Study|Withdrawal by Subject|0|||
94575250|NCT02183675|323906783|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
94575251|NCT02183675|323906784|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
94575252|NCT02183675|323906785|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
94575253|NCT02183675|323906786|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
94575254|NCT02183675|323906787|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
94575255|NCT02183675|323906788|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
94575256|NCT01521117|323906789|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
94575257|NCT01521117|323906790|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
94575258|NCT01521117|323906789|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
94575259|NCT01521117|323906790|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
94575260|NCT01521117|323906789|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
94575261|NCT01521117|323906790|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
94575262|NCT00004563|323906793|FG000|Overall Study|Withdrawal by Subject|20|||
94575263|NCT00004563|323906794|FG001|Overall Study|Withdrawal by Subject|16|||
94575264|NCT00004563|323906793|FG000|Overall Study|Lack of Efficacy|3|||
94575265|NCT00004563|323906794|FG001|Overall Study|Lack of Efficacy|5|||
94575266|NCT00004563|323906793|FG000|Overall Study|Death|2|||
94575267|NCT00004563|323906794|FG001|Overall Study|Death|3|||
94575268|NCT03337308|323906795|FG000|Overall Study|Adverse Event|2|||
94575269|NCT03337308|323906796|FG001|Overall Study|Adverse Event|3|||
94575270|NCT03337308|323906797|FG002|Overall Study|Adverse Event|3|||
94575271|NCT03337308|323906798|FG003|Overall Study|Adverse Event|1|||
94575272|NCT03337308|323906795|FG000|Overall Study|Lost to Follow-up|1|||
94575273|NCT03337308|323906796|FG001|Overall Study|Lost to Follow-up|2|||
94575274|NCT03337308|323906797|FG002|Overall Study|Lost to Follow-up|0|||
94575275|NCT03337308|323906798|FG003|Overall Study|Lost to Follow-up|0|||
94575276|NCT03337308|323906795|FG000|Overall Study|Withdrawal by Subject|2|||
94575277|NCT03337308|323906796|FG001|Overall Study|Withdrawal by Subject|1|||
94575278|NCT03337308|323906797|FG002|Overall Study|Withdrawal by Subject|2|||
94575279|NCT03337308|323906798|FG003|Overall Study|Withdrawal by Subject|1|||
94575280|NCT03337308|323906795|FG000|Overall Study|Protocol Violation|0|||
94575281|NCT03337308|323906796|FG001|Overall Study|Protocol Violation|1|||
94575282|NCT03337308|323906797|FG002|Overall Study|Protocol Violation|0|||
94575283|NCT03337308|323906798|FG003|Overall Study|Protocol Violation|0|||
94575284|NCT01056822|323906799|FG000|Overall Study|Adverse Event|0|||
94575285|NCT01056822|323906800|FG001|Overall Study|Adverse Event|1|||
94575286|NCT01056822|323906799|FG000|Overall Study|Protocol Violation|6|||
94575287|NCT01056822|323906800|FG001|Overall Study|Protocol Violation|5|||
94575288|NCT01056822|323906799|FG000|Overall Study|Withdrawal by Subject|1|||
94658850|NCT02464969|324206208|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
94658851|NCT02464969|324206207|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
94658852|NCT02464969|324206208|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
94658853|NCT02464969|324206207|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
94658854|NCT02464969|324206208|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
94575289|NCT01056822|323906800|FG001|Overall Study|Withdrawal by Subject|1|||
94575290|NCT01056822|323906799|FG000|Overall Study|Lost to Follow-up|1|||
94575291|NCT01056822|323906800|FG001|Overall Study|Lost to Follow-up|0|||
94575292|NCT00005780|323906808|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
94575293|NCT03600909|323906809|FG000|Overall Study|Not treated|0|||
94575294|NCT03600909|323906810|FG001|Overall Study|Not treated|3|||
94575295|NCT03600909|323906811|FG002|Overall Study|Not treated|0|||
94575296|NCT00521079|323906812|FG000|Overall Study|Adverse Event|7|||
94575297|NCT00521079|323906813|FG001|Overall Study|Adverse Event|1|||
94575298|NCT00521079|323906812|FG000|Overall Study|Lost to Follow-up|2|||
94575299|NCT00521079|323906813|FG001|Overall Study|Lost to Follow-up|1|||
94575300|NCT00521079|323906812|FG000|Overall Study|Withdrawal by Subject|5|||
94575301|NCT00521079|323906813|FG001|Overall Study|Withdrawal by Subject|3|||
94575302|NCT00374140|323906814|FG000|Overall Study|Lost to Follow-up|1|||
94575303|NCT00374140|323906814|FG000|Overall Study|Protocol Violation|1|||
94575304|NCT02018562|323906816|FG000|Overall Study|Withdrawal by Subject|2|||
94575305|NCT02018562|323906817|FG001|Overall Study|Withdrawal by Subject|0|||
94575306|NCT02018562|323906816|FG000|Overall Study|Discharged prior to study completion|1|||
94575307|NCT02018562|323906817|FG001|Overall Study|Discharged prior to study completion|0|||
94658855|NCT02464969|324206207|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
94575308|NCT05194124|323906818|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
94575309|NCT05194124|323906819|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
94575310|NCT05194124|323906820|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
94575311|NCT05194124|323906821|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
94575312|NCT05194124|323906822|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
94575313|NCT05194124|323906823|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
94575314|NCT05194124|323906824|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
94575315|NCT05194124|323906825|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
94575316|NCT05194124|323906826|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
94575317|NCT05194124|323906827|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
94575318|NCT05194124|323906818|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
94575319|NCT05194124|323906819|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
94575320|NCT05194124|323906820|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
94575321|NCT05194124|323906821|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
94575322|NCT05194124|323906822|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
94575323|NCT05194124|323906823|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
94575324|NCT05194124|323906824|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
94575325|NCT05194124|323906825|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
94575326|NCT05194124|323906826|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
94575327|NCT05194124|323906827|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
94575328|NCT04583618|323906828|FG000|Overall Study|Adverse Event|0|||
94575329|NCT04583618|323906829|FG001|Overall Study|Adverse Event|0|||
94575330|NCT04583618|323906830|FG002|Overall Study|Adverse Event|1|||
94575331|NCT04583618|323906831|FG003|Overall Study|Adverse Event|0|||
94575332|NCT04583618|323906832|FG004|Overall Study|Adverse Event|0|||
94575333|NCT04583618|323906828|FG000|Overall Study|Protocol deviation|1|||
94575334|NCT04583618|323906829|FG001|Overall Study|Protocol deviation|1|||
94575335|NCT04583618|323906830|FG002|Overall Study|Protocol deviation|1|||
94575336|NCT04583618|323906831|FG003|Overall Study|Protocol deviation|0|||
94575337|NCT04583618|323906832|FG004|Overall Study|Protocol deviation|0|||
94575338|NCT04583618|323906828|FG000|Overall Study|Withdrawal by Subject|2|||
94575339|NCT04583618|323906829|FG001|Overall Study|Withdrawal by Subject|1|||
94575340|NCT04583618|323906830|FG002|Overall Study|Withdrawal by Subject|3|||
94575341|NCT04583618|323906831|FG003|Overall Study|Withdrawal by Subject|1|||
94575342|NCT04583618|323906832|FG004|Overall Study|Withdrawal by Subject|1|||
94575343|NCT04583618|323906828|FG000|Overall Study|Lost to Follow-up|0|||
94575344|NCT04583618|323906829|FG001|Overall Study|Lost to Follow-up|1|||
94575345|NCT04583618|323906830|FG002|Overall Study|Lost to Follow-up|3|||
94575346|NCT04583618|323906831|FG003|Overall Study|Lost to Follow-up|1|||
94575347|NCT04583618|323906832|FG004|Overall Study|Lost to Follow-up|1|||
94575348|NCT03642873|323906833|FG000|Third Intervention (1 Day)|Screen failure|0|||
94575349|NCT03642873|323906834|FG001|Third Intervention (1 Day)|Screen failure|0|||
94575350|NCT03642873|323906835|FG002|Third Intervention (1 Day)|Screen failure|0|||
94575351|NCT03642873|323906836|FG003|Third Intervention (1 Day)|Screen failure|0|||
94575352|NCT03642873|323906837|FG004|Third Intervention (1 Day)|Screen failure|1|||
94575353|NCT03642873|323906838|FG005|Third Intervention (1 Day)|Screen failure|0|||
94575354|NCT00651742|323906840|FG000|Overall Study|Objective Disease Progression|22|||
94575355|NCT00651742|323906840|FG000|Overall Study|Toxicity|3|||
94575356|NCT00651742|323906840|FG000|Overall Study|Investigator Judgment|1|||
94575357|NCT00651742|323906840|FG000|Overall Study|Withdrawal of Consent|1|||
94575358|NCT00651742|323906840|FG000|Overall Study|Enrolled but not treated|1|||
94575359|NCT01535040|323906841|FG000|Overall Study|Physician Decision|0|||
94575360|NCT01535040|323906842|FG001|Overall Study|Physician Decision|1|||
94575361|NCT01535040|323906841|FG000|Overall Study|Withdrawal by Subject|13|||
94575362|NCT01535040|323906842|FG001|Overall Study|Withdrawal by Subject|10|||
94575363|NCT01535040|323906841|FG000|Overall Study|Never Started|9|||
94575364|NCT01535040|323906842|FG001|Overall Study|Never Started|4|||
94575365|NCT01535040|323906841|FG000|Overall Study|Toxicity|7|||
94349769|NCT03370133|323060947|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
94575366|NCT01535040|323906842|FG001|Overall Study|Toxicity|5|||
94575367|NCT01535040|323906841|FG000|Overall Study|Multiple Reasons|1|||
94575368|NCT01535040|323906842|FG001|Overall Study|Multiple Reasons|1|||
94349770|NCT03370133|323060948|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
94575369|NCT05430854|323906843|FG000|Overall Study|Trial terminated by Sponsor|39|||
94575370|NCT05430854|323906844|FG001|Overall Study|Trial terminated by Sponsor|50|||
94575371|NCT05430854|323906845|FG002|Overall Study|Trial terminated by Sponsor|46|||
94575372|NCT05430854|323906843|FG000|Overall Study|Withdrawal by Subject|0|||
94575373|NCT05430854|323906844|FG001|Overall Study|Withdrawal by Subject|3|||
94575374|NCT05430854|323906845|FG002|Overall Study|Withdrawal by Subject|0|||
94575375|NCT01652235|323906853|FG000|Overall Study|Death|9|||
94349771|NCT03370133|323060949|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
94349772|NCT03370133|323060944|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
94349773|NCT03370133|323060945|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
94349774|NCT03370133|323060946|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
94575376|NCT01652235|323906853|FG000|Overall Study|Lost to Follow-up|5|||
94349775|NCT03370133|323060947|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
94349776|NCT03370133|323060948|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
94349777|NCT03370133|323060949|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
94349778|NCT03370133|323060944|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
94349779|NCT03370133|323060945|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
94575377|NCT01652235|323906853|FG000|Overall Study|Withdrawal by Subject|2|||
94575378|NCT05138653|323906854|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
94575379|NCT05138653|323906855|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
94575380|NCT05138653|323906856|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
94575381|NCT05138653|323906857|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
94575382|NCT05138653|323906858|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
94575383|NCT05138653|323906859|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
94575384|NCT05138653|323906860|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
94575385|NCT05138653|323906861|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
94575386|NCT05138653|323906862|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
94575387|NCT05138653|323906863|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
94575388|NCT05138653|323906864|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
94575389|NCT05138653|323906865|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
94575390|NCT05138653|323906866|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
94575391|NCT05138653|323906867|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
94575392|NCT05138653|323906868|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
94575393|NCT05138653|323906869|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
94575394|NCT05138653|323906854|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
94575395|NCT05138653|323906855|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
94575396|NCT05138653|323906856|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
94575397|NCT05138653|323906857|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
94575398|NCT05138653|323906858|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
94575399|NCT05138653|323906859|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
94575400|NCT05138653|323906860|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
94575401|NCT05138653|323906861|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
94575402|NCT05138653|323906862|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
94575403|NCT05138653|323906863|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
94575404|NCT05138653|323906864|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
94575405|NCT05138653|323906865|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
94575406|NCT05138653|323906866|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
94575407|NCT05138653|323906867|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
94575408|NCT05138653|323906868|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
94575409|NCT05138653|323906869|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
94575410|NCT05138653|323906854|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
94575411|NCT05138653|323906855|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
94575412|NCT05138653|323906856|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
94575413|NCT05138653|323906857|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
94575414|NCT05138653|323906858|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
94575415|NCT05138653|323906859|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
94575416|NCT05138653|323906860|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
94575417|NCT05138653|323906861|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
94575418|NCT05138653|323906862|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
94575419|NCT05138653|323906863|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
94575420|NCT05138653|323906864|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
94575421|NCT05138653|323906865|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
94575422|NCT05138653|323906866|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
94575423|NCT05138653|323906867|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
94575424|NCT05138653|323906868|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
94575425|NCT05138653|323906869|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
94349780|NCT03370133|323060946|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
94452602|NCT00685399|323445393|FG000|Treatment Period 1|Lack of Efficacy|1|||
94575426|NCT05138653|323906854|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
94349781|NCT03370133|323060947|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
94349782|NCT03370133|323060948|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
94575427|NCT05138653|323906855|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
94575428|NCT05138653|323906856|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
94575429|NCT05138653|323906857|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
94575430|NCT05138653|323906858|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
94575431|NCT05138653|323906859|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
94575432|NCT05138653|323906860|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
94575433|NCT05138653|323906861|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
94575434|NCT05138653|323906862|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
94575435|NCT05138653|323906863|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
94575436|NCT05138653|323906864|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
94575437|NCT05138653|323906865|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
94575438|NCT05138653|323906866|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
94575439|NCT05138653|323906867|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
94575440|NCT05138653|323906868|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
94575441|NCT05138653|323906869|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
94575442|NCT05138653|323906854|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
94575443|NCT05138653|323906855|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
94575444|NCT05138653|323906856|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
94575445|NCT05138653|323906857|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
94575446|NCT05138653|323906858|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
94575447|NCT05138653|323906859|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
94575448|NCT05138653|323906860|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
94575449|NCT05138653|323906861|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
94575450|NCT05138653|323906862|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
94575451|NCT05138653|323906863|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
94575452|NCT05138653|323906864|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
94575453|NCT05138653|323906865|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
94575454|NCT05138653|323906866|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
94575455|NCT05138653|323906867|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
94575456|NCT05138653|323906868|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
94575457|NCT05138653|323906869|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
94575458|NCT05138653|323906854|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
94575459|NCT05138653|323906855|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
94575460|NCT05138653|323906856|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
94575461|NCT05138653|323906857|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
94575462|NCT05138653|323906858|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
94575463|NCT05138653|323906859|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
94575464|NCT05138653|323906860|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
94575465|NCT05138653|323906861|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
94575466|NCT05138653|323906862|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
94575467|NCT05138653|323906863|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
94575468|NCT05138653|323906864|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
94575469|NCT05138653|323906865|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
94575470|NCT05138653|323906866|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
94575471|NCT05138653|323906867|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
94575472|NCT05138653|323906868|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
94575473|NCT05138653|323906869|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
94575474|NCT05138653|323906854|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
94575475|NCT05138653|323906855|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
94575476|NCT05138653|323906856|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
94575477|NCT05138653|323906857|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
94575478|NCT05138653|323906858|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
94575479|NCT05138653|323906859|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
94575480|NCT05138653|323906860|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
94575481|NCT05138653|323906861|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
94575482|NCT05138653|323906862|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
94575483|NCT05138653|323906863|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
94575484|NCT05138653|323906864|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
94575485|NCT05138653|323906865|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
94575486|NCT05138653|323906866|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
94575487|NCT05138653|323906867|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
94575488|NCT05138653|323906868|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
94575489|NCT05138653|323906869|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
94238975|NCT00895895|322668603|FG004|Period 1|Withdrawal by Subject|4|||
94575490|NCT04607005|323906870|FG000|Overall Study|Adverse Event|0|||
94575491|NCT04607005|323906871|FG001|Overall Study|Adverse Event|1|||
94575492|NCT04607005|323906870|FG000|Overall Study|Lack of Efficacy|1|||
94575493|NCT04607005|323906871|FG001|Overall Study|Lack of Efficacy|6|||
94575494|NCT04607005|323906870|FG000|Overall Study|Withdrawal by Subject|4|||
94575495|NCT04607005|323906871|FG001|Overall Study|Withdrawal by Subject|9|||
94575496|NCT04607005|323906870|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
94575497|NCT04607005|323906871|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
94575498|NCT04886154|323906872|FG000|Overall Study|Adverse Event|0|||
94575499|NCT04886154|323906873|FG001|Overall Study|Adverse Event|0|||
94575500|NCT04886154|323906874|FG002|Overall Study|Adverse Event|0|||
94575501|NCT04886154|323906875|FG003|Overall Study|Adverse Event|0|||
94575502|NCT04886154|323906876|FG004|Overall Study|Adverse Event|1|||
94575503|NCT04886154|323906877|FG005|Overall Study|Adverse Event|0|||
94575504|NCT04886154|323906878|FG006|Overall Study|Adverse Event|0|||
94575505|NCT04886154|323906879|FG007|Overall Study|Adverse Event|1|||
94575506|NCT04886154|323906880|FG008|Overall Study|Adverse Event|1|||
94575507|NCT04886154|323906881|FG009|Overall Study|Adverse Event|0|||
94575508|NCT04886154|323906882|FG010|Overall Study|Adverse Event|0|||
94575509|NCT04886154|323906883|FG011|Overall Study|Adverse Event|1|||
94575510|NCT04886154|323906884|FG012|Overall Study|Adverse Event|0|||
94575511|NCT04886154|323906885|FG013|Overall Study|Adverse Event|0|||
94575512|NCT04886154|323906886|FG014|Overall Study|Adverse Event|3|||
94575513|NCT04886154|323906872|FG000|Overall Study|Lost to Follow-up|1|||
94575514|NCT04886154|323906873|FG001|Overall Study|Lost to Follow-up|0|||
94575515|NCT04886154|323906874|FG002|Overall Study|Lost to Follow-up|2|||
94575516|NCT04886154|323906875|FG003|Overall Study|Lost to Follow-up|0|||
94575517|NCT04886154|323906876|FG004|Overall Study|Lost to Follow-up|17|||
94575518|NCT04886154|323906877|FG005|Overall Study|Lost to Follow-up|7|||
94575519|NCT04886154|323906878|FG006|Overall Study|Lost to Follow-up|8|||
94575520|NCT04886154|323906879|FG007|Overall Study|Lost to Follow-up|7|||
94575521|NCT04886154|323906880|FG008|Overall Study|Lost to Follow-up|8|||
94575522|NCT04886154|323906881|FG009|Overall Study|Lost to Follow-up|0|||
94575523|NCT04886154|323906882|FG010|Overall Study|Lost to Follow-up|2|||
94575524|NCT04886154|323906883|FG011|Overall Study|Lost to Follow-up|0|||
94575525|NCT04886154|323906884|FG012|Overall Study|Lost to Follow-up|0|||
94575526|NCT04886154|323906885|FG013|Overall Study|Lost to Follow-up|0|||
94575527|NCT04886154|323906886|FG014|Overall Study|Lost to Follow-up|0|||
94575528|NCT04886154|323906872|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
94575529|NCT04886154|323906873|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
94575530|NCT04886154|323906874|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
94575531|NCT04886154|323906875|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
94575532|NCT04886154|323906876|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
94575533|NCT04886154|323906877|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
94575534|NCT04886154|323906878|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
94575535|NCT04886154|323906879|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
94575536|NCT04886154|323906880|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
94575537|NCT04886154|323906881|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
94575538|NCT04886154|323906882|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
94575539|NCT04886154|323906883|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
94575540|NCT04886154|323906884|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
94575541|NCT04886154|323906885|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
94575542|NCT04886154|323906886|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
94575543|NCT04886154|323906872|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94575544|NCT04886154|323906873|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94575545|NCT04886154|323906874|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94575546|NCT04886154|323906875|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94575547|NCT04886154|323906876|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
94575548|NCT04886154|323906877|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94575549|NCT04886154|323906878|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
94575550|NCT04886154|323906879|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
94575551|NCT04886154|323906880|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94575552|NCT04886154|323906881|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94575553|NCT04886154|323906882|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94575554|NCT04886154|323906883|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94575555|NCT04886154|323906884|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94575556|NCT04886154|323906885|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94575557|NCT04886154|323906886|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
94575558|NCT04886154|323906872|FG000|Overall Study|Other, Not Specified|0|||
94575559|NCT04886154|323906873|FG001|Overall Study|Other, Not Specified|0|||
94575560|NCT04886154|323906874|FG002|Overall Study|Other, Not Specified|0|||
94238976|NCT00895895|322668599|FG000|Period 1|unsatisfactory response-efficacy|2|||
94575561|NCT04886154|323906875|FG003|Overall Study|Other, Not Specified|0|||
94575562|NCT04886154|323906876|FG004|Overall Study|Other, Not Specified|11|||
94575563|NCT04886154|323906877|FG005|Overall Study|Other, Not Specified|8|||
94575564|NCT04886154|323906878|FG006|Overall Study|Other, Not Specified|9|||
94575565|NCT04886154|323906879|FG007|Overall Study|Other, Not Specified|10|||
94575566|NCT04886154|323906880|FG008|Overall Study|Other, Not Specified|6|||
94575567|NCT04886154|323906881|FG009|Overall Study|Other, Not Specified|1|||
94575568|NCT04886154|323906882|FG010|Overall Study|Other, Not Specified|1|||
94575569|NCT04886154|323906883|FG011|Overall Study|Other, Not Specified|2|||
94575570|NCT04886154|323906884|FG012|Overall Study|Other, Not Specified|1|||
94575571|NCT04886154|323906885|FG013|Overall Study|Other, Not Specified|2|||
94575572|NCT04886154|323906886|FG014|Overall Study|Other, Not Specified|3|||
94575573|NCT05177354|323906889|FG000|Implant to 30-day Visit|Physician Decision|1|||
94575574|NCT05177354|323906889|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
94575575|NCT05177354|323906889|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
94575576|NCT05177354|323906889|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
94575577|NCT03589859|323906890|FG000|Overall Study|Withdrawal by Subject|0|||
94575578|NCT03589859|323906891|FG001|Overall Study|Withdrawal by Subject|6|||
94575579|NCT05967260|323906896|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
94575580|NCT05967260|323906897|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
94575581|NCT00089297|323908431|FG000|Overall Study|Adverse Event|9|||
94575582|NCT00089297|323908431|FG000|Overall Study|Death|1|||
94575583|NCT00089297|323908431|FG000|Overall Study|Withdrawal by Subject|12|||
94575584|NCT00089297|323908431|FG000|Overall Study|Disease progression|2|||
94575585|NCT00089297|323908431|FG000|Overall Study|Ineligible|11|||
94575586|NCT00089297|323908431|FG000|Overall Study|Secondary malignancy|1|||
94575587|NCT00089297|323908431|FG000|Overall Study|IRB approval not ready|1|||
94575588|NCT00089297|323908431|FG000|Overall Study|Non-compliance|1|||
94575589|NCT00904969|323908432|FG000|Overall Study|Lost to Follow-up|4|||
94575590|NCT00904969|323908432|FG000|Overall Study|Withdrawal by Subject|3|||
94575591|NCT00904969|323908432|FG000|Overall Study|Additional Treatments|11|||
94575592|NCT00904969|323908432|FG000|Overall Study|Case Aborted; Subject Exited|1|||
94575593|NCT00199381|323908433|FG000|Overall Study|Withdrawal by Subject|38|||
94575594|NCT00199381|323908433|FG000|Overall Study|Adverse Event|73|||
94575595|NCT00199381|323908433|FG000|Overall Study|Protocol Violation|6|||
94575596|NCT00199381|323908433|FG000|Overall Study|Lack of Efficacy|27|||
94575597|NCT00199381|323908433|FG000|Overall Study|Not including due to early termination|37|||
94575598|NCT00199381|323908433|FG000|Overall Study|Study termination by Sponsor|323|||
94575599|NCT00385671|323908436|FG000|Overall Study|Adverse Event|14|||
94575600|NCT00385671|323908437|FG001|Overall Study|Adverse Event|27|||
94575601|NCT00385671|323908438|FG002|Overall Study|Adverse Event|18|||
94575602|NCT00385671|323908436|FG000|Overall Study|Lack of Efficacy|5|||
94575603|NCT00385671|323908437|FG001|Overall Study|Lack of Efficacy|9|||
94575604|NCT00385671|323908438|FG002|Overall Study|Lack of Efficacy|5|||
94575605|NCT00385671|323908436|FG000|Overall Study|Lost to Follow-up|6|||
94575606|NCT00385671|323908437|FG001|Overall Study|Lost to Follow-up|6|||
94575607|NCT00385671|323908438|FG002|Overall Study|Lost to Follow-up|5|||
94575608|NCT00385671|323908436|FG000|Overall Study|Physician Decision|2|||
94575609|NCT00385671|323908437|FG001|Overall Study|Physician Decision|1|||
94575610|NCT00385671|323908438|FG002|Overall Study|Physician Decision|2|||
94575611|NCT00385671|323908436|FG000|Overall Study|Protocol Violation|5|||
94575612|NCT00385671|323908437|FG001|Overall Study|Protocol Violation|2|||
94575613|NCT00385671|323908438|FG002|Overall Study|Protocol Violation|1|||
94575614|NCT00385671|323908436|FG000|Overall Study|Sponsor Decision|2|||
94575615|NCT00385671|323908437|FG001|Overall Study|Sponsor Decision|2|||
94575616|NCT00385671|323908438|FG002|Overall Study|Sponsor Decision|1|||
94575617|NCT00385671|323908436|FG000|Overall Study|Withdrawal by Subject|4|||
94575618|NCT00385671|323908437|FG001|Overall Study|Withdrawal by Subject|4|||
94575619|NCT00385671|323908438|FG002|Overall Study|Withdrawal by Subject|4|||
94575620|NCT01910298|323908440|FG000|Overall Study|Adverse Event|1|||
94575621|NCT01910298|323908441|FG001|Overall Study|Adverse Event|0|||
94575622|NCT01910298|323908440|FG000|Overall Study|Withdrawal by Subject|2|||
94575623|NCT01910298|323908441|FG001|Overall Study|Withdrawal by Subject|7|||
94575624|NCT01910298|323908440|FG000|Overall Study|Protocol Deviation|0|||
94575625|NCT01910298|323908441|FG001|Overall Study|Protocol Deviation|5|||
94575626|NCT01910298|323908440|FG000|Overall Study|Lost to Follow-up|1|||
94575627|NCT01910298|323908441|FG001|Overall Study|Lost to Follow-up|1|||
94238977|NCT00895895|322668600|FG001|Period 1|unsatisfactory response-efficacy|0|||
94238978|NCT00895895|322668601|FG002|Period 1|unsatisfactory response-efficacy|0|||
94575628|NCT01910298|323908440|FG000|Overall Study|Study Terminated by Sponsor|1|||
94575629|NCT01910298|323908441|FG001|Overall Study|Study Terminated by Sponsor|17|||
94238979|NCT00895895|322668602|FG003|Period 1|unsatisfactory response-efficacy|0|||
94238980|NCT00895895|322668603|FG004|Period 1|unsatisfactory response-efficacy|0|||
94575630|NCT01910298|323908440|FG000|Overall Study|Other Miscellaneous Reasons|0|||
94575631|NCT01910298|323908441|FG001|Overall Study|Other Miscellaneous Reasons|2|||
94452603|NCT00685399|323445394|FG001|Treatment Period 1|Lack of Efficacy|0|||
94452604|NCT00685399|323445395|FG002|Treatment Period 1|Lack of Efficacy|0|||
94452605|NCT00685399|323445396|FG003|Treatment Period 1|Lack of Efficacy|0|||
94452606|NCT00685399|323445397|FG004|Treatment Period 1|Lack of Efficacy|0|||
94452607|NCT00685399|323445398|FG005|Treatment Period 1|Lack of Efficacy|0|||
94452608|NCT00685399|323445399|FG006|Treatment Period 1|Lack of Efficacy|0|||
94452609|NCT00685399|323445400|FG007|Treatment Period 1|Lack of Efficacy|0|||
94238981|NCT00895895|322668599|FG000|Period 1|randomized and not treated|1|||
94238982|NCT00895895|322668600|FG001|Period 1|randomized and not treated|3|||
94238983|NCT00895895|322668601|FG002|Period 1|randomized and not treated|1|||
94238984|NCT00895895|322668602|FG003|Period 1|randomized and not treated|1|||
94238985|NCT00895895|322668603|FG004|Period 1|randomized and not treated|2|||
94238986|NCT00895895|322668599|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
94452610|NCT00685399|323445393|FG000|Treatment Period 2|Administrative Problems|0|||
94452611|NCT00685399|323445394|FG001|Treatment Period 2|Administrative Problems|2|||
94452612|NCT00685399|323445395|FG002|Treatment Period 2|Administrative Problems|1|||
94452613|NCT00685399|323445396|FG003|Treatment Period 2|Administrative Problems|0|||
94452614|NCT00685399|323445397|FG004|Treatment Period 2|Administrative Problems|0|||
94452615|NCT00685399|323445398|FG005|Treatment Period 2|Administrative Problems|0|||
94452616|NCT00685399|323445399|FG006|Treatment Period 2|Administrative Problems|0|||
94452617|NCT00685399|323445400|FG007|Treatment Period 2|Administrative Problems|0|||
94452618|NCT00685399|323445393|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94452619|NCT00685399|323445394|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94452620|NCT00685399|323445395|FG002|Treatment Period 2|Withdrawal by Subject|0|||
94452621|NCT00685399|323445396|FG003|Treatment Period 2|Withdrawal by Subject|0|||
94452622|NCT00685399|323445397|FG004|Treatment Period 2|Withdrawal by Subject|0|||
94452623|NCT00685399|323445398|FG005|Treatment Period 2|Withdrawal by Subject|0|||
94452624|NCT00685399|323445399|FG006|Treatment Period 2|Withdrawal by Subject|0|||
94452625|NCT00685399|323445400|FG007|Treatment Period 2|Withdrawal by Subject|2|||
94452626|NCT00685399|323445393|FG000|Treatment Period 2|Adverse Event|0|||
94452627|NCT00685399|323445394|FG001|Treatment Period 2|Adverse Event|0|||
94452628|NCT00685399|323445395|FG002|Treatment Period 2|Adverse Event|0|||
94452629|NCT00685399|323445396|FG003|Treatment Period 2|Adverse Event|0|||
94452630|NCT00685399|323445397|FG004|Treatment Period 2|Adverse Event|0|||
94452631|NCT00685399|323445398|FG005|Treatment Period 2|Adverse Event|1|||
94452632|NCT00685399|323445399|FG006|Treatment Period 2|Adverse Event|0|||
94452633|NCT00685399|323445400|FG007|Treatment Period 2|Adverse Event|0|||
94452634|NCT00685399|323445393|FG000|Treatment Period 2|Lack of Efficacy|0|||
94452635|NCT00685399|323445394|FG001|Treatment Period 2|Lack of Efficacy|10|||
94452636|NCT00685399|323445395|FG002|Treatment Period 2|Lack of Efficacy|2|||
94452637|NCT00685399|323445396|FG003|Treatment Period 2|Lack of Efficacy|0|||
94452638|NCT00685399|323445397|FG004|Treatment Period 2|Lack of Efficacy|0|||
94452639|NCT00685399|323445398|FG005|Treatment Period 2|Lack of Efficacy|1|||
94452640|NCT00685399|323445399|FG006|Treatment Period 2|Lack of Efficacy|0|||
94452641|NCT00685399|323445400|FG007|Treatment Period 2|Lack of Efficacy|0|||
94452642|NCT00685399|323445393|FG000|Extension|Administrative Issues|0|||
94452643|NCT00685399|323445394|FG001|Extension|Administrative Issues|0|||
94452644|NCT00685399|323445395|FG002|Extension|Administrative Issues|0|||
94238987|NCT00895895|322668600|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
94238988|NCT00895895|322668601|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
94238989|NCT00895895|322668602|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
94238990|NCT00895895|322668603|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
94238991|NCT00895895|322668599|FG000|After Period 1, Prior to Period 2|Other|0|||
94452645|NCT00685399|323445396|FG003|Extension|Administrative Issues|1|||
94452646|NCT00685399|323445397|FG004|Extension|Administrative Issues|0|||
94452647|NCT00685399|323445398|FG005|Extension|Administrative Issues|0|||
94238992|NCT00895895|322668600|FG001|After Period 1, Prior to Period 2|Other|0|||
94452648|NCT00685399|323445399|FG006|Extension|Administrative Issues|0|||
94452649|NCT00685399|323445400|FG007|Extension|Administrative Issues|0|||
94238993|NCT00895895|322668601|FG002|After Period 1, Prior to Period 2|Other|1|||
94238994|NCT00895895|322668602|FG003|After Period 1, Prior to Period 2|Other|0|||
94238995|NCT00895895|322668603|FG004|After Period 1, Prior to Period 2|Other|0|||
94452650|NCT00685399|323445393|FG000|Extension|Withdrawal by Subject|0|||
94575632|NCT03037385|323908442|FG000|Overall Study|Adverse Event|0|||
94575633|NCT03037385|323908443|FG001|Overall Study|Adverse Event|0|||
94575634|NCT03037385|323908444|FG002|Overall Study|Adverse Event|1|||
94238996|NCT00895895|322668599|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
94452651|NCT00685399|323445394|FG001|Extension|Withdrawal by Subject|0|||
94452652|NCT00685399|323445395|FG002|Extension|Withdrawal by Subject|0|||
94452653|NCT00685399|323445396|FG003|Extension|Withdrawal by Subject|1|||
94452654|NCT00685399|323445397|FG004|Extension|Withdrawal by Subject|0|||
94452655|NCT00685399|323445398|FG005|Extension|Withdrawal by Subject|0|||
94452656|NCT00685399|323445399|FG006|Extension|Withdrawal by Subject|0|||
94452657|NCT00685399|323445400|FG007|Extension|Withdrawal by Subject|0|||
94452658|NCT00685399|323445393|FG000|Extension|Protocol Violation|0|||
94452659|NCT00685399|323445394|FG001|Extension|Protocol Violation|0|||
94452660|NCT00685399|323445395|FG002|Extension|Protocol Violation|0|||
94452661|NCT00685399|323445396|FG003|Extension|Protocol Violation|1|||
94452662|NCT00685399|323445397|FG004|Extension|Protocol Violation|0|||
94452663|NCT00685399|323445398|FG005|Extension|Protocol Violation|0|||
94452664|NCT00685399|323445399|FG006|Extension|Protocol Violation|0|||
94452665|NCT00685399|323445400|FG007|Extension|Protocol Violation|0|||
94452666|NCT00685399|323445393|FG000|Extension|Lack of Efficacy|0|||
94452667|NCT00685399|323445394|FG001|Extension|Lack of Efficacy|0|||
94452668|NCT00685399|323445395|FG002|Extension|Lack of Efficacy|0|||
94452669|NCT00685399|323445396|FG003|Extension|Lack of Efficacy|2|||
94452670|NCT00685399|323445397|FG004|Extension|Lack of Efficacy|0|||
94452671|NCT00685399|323445398|FG005|Extension|Lack of Efficacy|0|||
94452672|NCT00685399|323445399|FG006|Extension|Lack of Efficacy|0|||
94452673|NCT00685399|323445400|FG007|Extension|Lack of Efficacy|0|||
94452674|NCT00685399|323445393|FG000|Extension|Adverse Event|0|||
94452675|NCT00685399|323445394|FG001|Extension|Adverse Event|0|||
94452676|NCT00685399|323445395|FG002|Extension|Adverse Event|0|||
94452677|NCT00685399|323445396|FG003|Extension|Adverse Event|2|||
94452678|NCT00685399|323445397|FG004|Extension|Adverse Event|0|||
94452679|NCT00685399|323445398|FG005|Extension|Adverse Event|0|||
94452680|NCT00685399|323445399|FG006|Extension|Adverse Event|0|||
94452681|NCT00685399|323445400|FG007|Extension|Adverse Event|0|||
94452682|NCT00178685|323445402|FG000|Overall Study|Death|3|||
94452683|NCT00178685|323445403|FG001|Overall Study|Death|3|||
94452684|NCT00178685|323445404|FG002|Overall Study|Death|6|||
94452685|NCT00178685|323445402|FG000|Overall Study|Lost to Follow-up|100|||
94452686|NCT00178685|323445403|FG001|Overall Study|Lost to Follow-up|187|||
94452687|NCT00178685|323445404|FG002|Overall Study|Lost to Follow-up|183|||
94452688|NCT00178685|323445402|FG000|Overall Study|Withdrawal by Subject|8|||
94452689|NCT00178685|323445403|FG001|Overall Study|Withdrawal by Subject|14|||
94452690|NCT00178685|323445404|FG002|Overall Study|Withdrawal by Subject|7|||
94452691|NCT02589626|323445407|FG000|Overall Study|Other than the reason specified|1|||
94452692|NCT02589626|323445408|FG001|Overall Study|Other than the reason specified|0|||
94452693|NCT02589626|323445407|FG000|Overall Study|Withdrawal by Subject|1|||
94452694|NCT02589626|323445408|FG001|Overall Study|Withdrawal by Subject|1|||
94452695|NCT02589626|323445407|FG000|Overall Study|Adverse Event|1|||
94452696|NCT02589626|323445408|FG001|Overall Study|Adverse Event|1|||
94452697|NCT04075682|323445412|FG000|Overall Study|Lost to Follow-up|5|||
94452698|NCT04075682|323445413|FG001|Overall Study|Lost to Follow-up|5|||
94452699|NCT04075682|323445414|FG002|Overall Study|Lost to Follow-up|2|||
94452700|NCT04075682|323445415|FG003|Overall Study|Lost to Follow-up|2|||
94452701|NCT04075682|323445412|FG000|Overall Study|Withdrawal by Subject|1|||
94452702|NCT04075682|323445413|FG001|Overall Study|Withdrawal by Subject|0|||
94452703|NCT04075682|323445414|FG002|Overall Study|Withdrawal by Subject|1|||
94452704|NCT04075682|323445415|FG003|Overall Study|Withdrawal by Subject|0|||
94452705|NCT04075682|323445412|FG000|Overall Study|Protocol Violation|0|||
94452706|NCT04075682|323445413|FG001|Overall Study|Protocol Violation|1|||
94452707|NCT04075682|323445414|FG002|Overall Study|Protocol Violation|1|||
94452708|NCT04075682|323445415|FG003|Overall Study|Protocol Violation|0|||
94452709|NCT04075682|323445412|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
94452710|NCT04075682|323445413|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
94452711|NCT04075682|323445414|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
94452712|NCT04075682|323445415|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
94452713|NCT04075682|323445412|FG000|Overall Study|Lost study phone the first day of study participation|0|||
94452714|NCT04075682|323445413|FG001|Overall Study|Lost study phone the first day of study participation|1|||
94452715|NCT04075682|323445414|FG002|Overall Study|Lost study phone the first day of study participation|0|||
94452716|NCT04075682|323445415|FG003|Overall Study|Lost study phone the first day of study participation|0|||
94452717|NCT01289639|323445418|FG000|Overall Study|Lost to Follow-up|1|||
94452718|NCT01289639|323445419|FG001|Overall Study|Lost to Follow-up|0|||
94452719|NCT01289639|323445420|FG002|Overall Study|Lost to Follow-up|0|||
94452720|NCT02780713|323445421|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
94452721|NCT02780713|323445422|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
94452722|NCT02780713|323445423|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
94452723|NCT02780713|323445424|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
94575635|NCT03037385|323908445|FG003|Overall Study|Adverse Event|0|||
94452724|NCT02780713|323445425|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
94452725|NCT01931475|323445426|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
94452726|NCT01931475|323445427|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
94452727|NCT01931475|323445426|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
94575636|NCT03037385|323908446|FG004|Overall Study|Adverse Event|0|||
94452728|NCT01931475|323445427|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
94452729|NCT01931475|323445426|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
94452730|NCT01931475|323445427|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
94452731|NCT01931475|323445426|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
94452732|NCT01931475|323445427|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
94452733|NCT01931475|323445426|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
94452734|NCT01931475|323445427|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
94452735|NCT01931475|323445426|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
94452736|NCT01931475|323445427|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
94452737|NCT01931475|323445426|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
94452738|NCT01931475|323445427|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
94452739|NCT01931475|323445426|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
94452740|NCT01931475|323445427|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
94452741|NCT01931475|323445426|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
94452742|NCT01931475|323445427|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
94452743|NCT01931475|323445426|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
94452744|NCT01931475|323445427|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
94452745|NCT01931475|323445426|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
94452746|NCT01931475|323445427|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
94452747|NCT01091662|323445428|FG000|Overall Study|Adverse Event|1|||
94452748|NCT01091662|323445429|FG001|Overall Study|Adverse Event|9|||
94452749|NCT01091662|323445428|FG000|Overall Study|Physician Decision|1|||
94452750|NCT01091662|323445429|FG001|Overall Study|Physician Decision|1|||
94452751|NCT01091662|323445428|FG000|Overall Study|Withdrawal by Subject|7|||
94452752|NCT01091662|323445429|FG001|Overall Study|Withdrawal by Subject|6|||
94452753|NCT01091662|323445428|FG000|Overall Study|met exit criteria|7|||
94452754|NCT01091662|323445429|FG001|Overall Study|met exit criteria|13|||
94452755|NCT01091662|323445428|FG000|Overall Study|met exclusion criteria|1|||
94452756|NCT01091662|323445429|FG001|Overall Study|met exclusion criteria|0|||
94452757|NCT01091662|323445428|FG000|Overall Study|Lost to Follow-up|0|||
94452758|NCT01091662|323445429|FG001|Overall Study|Lost to Follow-up|1|||
94452759|NCT01091662|323445428|FG000|Overall Study|Pregnancy|0|||
94452760|NCT01091662|323445429|FG001|Overall Study|Pregnancy|1|||
94452761|NCT01091662|323445428|FG000|Overall Study|Protocol Violation|0|||
94452762|NCT01091662|323445429|FG001|Overall Study|Protocol Violation|2|||
94452763|NCT01091662|323445428|FG000|Overall Study|unable to swallow capsule|0|||
94452764|NCT01091662|323445429|FG001|Overall Study|unable to swallow capsule|1|||
94452765|NCT01222520|323445430|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
94452766|NCT01222520|323445431|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
94452767|NCT01222520|323445430|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
94452768|NCT01222520|323445431|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
94452769|NCT01222520|323445430|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
94452770|NCT01222520|323445431|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
94452771|NCT01222520|323445430|FG000|Double-blind Period|Adverse Event|0|||
94452772|NCT01222520|323445431|FG001|Double-blind Period|Adverse Event|1|||
94452773|NCT01222520|323445430|FG000|Double-blind Period|Lack of Efficacy|0|||
94452774|NCT01222520|323445431|FG001|Double-blind Period|Lack of Efficacy|1|||
94452775|NCT01222520|323445430|FG000|Double-blind Period|Study medication stolen|1|||
94452776|NCT01222520|323445431|FG001|Double-blind Period|Study medication stolen|0|||
94452777|NCT00596817|323445432|FG000|Open-label Period|Adverse Event|0|||
94452778|NCT00596817|323445433|FG001|Open-label Period|Adverse Event|49|||
94452779|NCT00596817|323445432|FG000|Open-label Period|Lack of Efficacy|0|||
94452780|NCT00596817|323445433|FG001|Open-label Period|Lack of Efficacy|33|||
94452781|NCT00596817|323445432|FG000|Open-label Period|Other Reasons|0|||
94452782|NCT00596817|323445433|FG001|Open-label Period|Other Reasons|65|||
94452783|NCT00596817|323445432|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
94452784|NCT00596817|323445433|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
94452785|NCT00596817|323445432|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
94575637|NCT03037385|323908447|FG005|Overall Study|Adverse Event|0|||
94238997|NCT00895895|322668600|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
94238998|NCT00895895|322668601|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
94238999|NCT00895895|322668602|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
94239000|NCT00895895|322668603|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
94239001|NCT00895895|322668599|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
94239002|NCT00895895|322668600|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
94239003|NCT00895895|322668601|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
94239004|NCT00895895|322668602|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
94239005|NCT00895895|322668603|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
94239006|NCT00895895|322668599|FG000|Period 2|Adverse Event|3|||
94239007|NCT00895895|322668600|FG001|Period 2|Adverse Event|3|||
94452786|NCT00596817|323445433|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
94452787|NCT00596817|323445432|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
94452788|NCT00596817|323445433|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
94452789|NCT00596817|323445432|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
94452790|NCT00596817|323445433|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
94452791|NCT00596817|323445432|FG000|Double-blind Period|Adverse Event|5|||
94452792|NCT00596817|323445433|FG001|Double-blind Period|Adverse Event|16|||
94452793|NCT00596817|323445432|FG000|Double-blind Period|Lack of Efficacy|52|||
94452794|NCT00596817|323445433|FG001|Double-blind Period|Lack of Efficacy|28|||
94452795|NCT00596817|323445432|FG000|Double-blind Period|Non-compliance With Study Product|3|||
94452796|NCT00596817|323445433|FG001|Double-blind Period|Non-compliance With Study Product|4|||
94452797|NCT00596817|323445432|FG000|Double-blind Period|Protocol Violation|11|||
94452798|NCT00596817|323445433|FG001|Double-blind Period|Protocol Violation|8|||
94452799|NCT00596817|323445432|FG000|Double-blind Period|Withdrawal of Consent|7|||
94452800|NCT00596817|323445433|FG001|Double-blind Period|Withdrawal of Consent|3|||
94452801|NCT00596817|323445432|FG000|Double-blind Period|Lost to Follow-up|0|||
94452802|NCT00596817|323445433|FG001|Double-blind Period|Lost to Follow-up|2|||
94452803|NCT00596817|323445432|FG000|Double-blind Period|Other Reasons|10|||
94452804|NCT00596817|323445433|FG001|Double-blind Period|Other Reasons|18|||
94452805|NCT01089608|323445436|FG000|Overall Study|Adverse Event|0|||
94452806|NCT01089608|323445437|FG001|Overall Study|Adverse Event|4|||
94452807|NCT01089608|323445436|FG000|Overall Study|Lost to Follow-up|0|||
94452808|NCT01089608|323445437|FG001|Overall Study|Lost to Follow-up|2|||
94452809|NCT02097238|323445440|FG000|Overall Study|Death|1|||
94452810|NCT02097238|323445440|FG000|Overall Study|Physician Decision|1|||
94452811|NCT02097238|323445440|FG000|Overall Study|Progressive Disease|17|||
94452812|NCT02049814|323445441|FG000|Overall Study|Reason not Specified|4|||
94452813|NCT02049814|323445442|FG001|Overall Study|Reason not Specified|3|||
94452814|NCT02049814|323445441|FG000|Overall Study|Pregnancy|1|||
94452815|NCT02049814|323445442|FG001|Overall Study|Pregnancy|0|||
94452816|NCT02049814|323445441|FG000|Overall Study|Lost to Follow-up|2|||
94452817|NCT02049814|323445442|FG001|Overall Study|Lost to Follow-up|3|||
94452818|NCT02049814|323445441|FG000|Overall Study|Serious Protocol Violation|5|||
94452819|NCT02049814|323445442|FG001|Overall Study|Serious Protocol Violation|7|||
94452820|NCT02049814|323445441|FG000|Overall Study|Study Termination|0|||
94452821|NCT02049814|323445442|FG001|Overall Study|Study Termination|1|||
94452822|NCT02049814|323445441|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
94452823|NCT02049814|323445442|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
94452824|NCT02049814|323445441|FG000|Overall Study|Voluntary withdrawal|9|||
94452825|NCT02049814|323445442|FG001|Overall Study|Voluntary withdrawal|8|||
94452826|NCT01282372|323445444|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
94452827|NCT01282372|323445444|FG000|Overall Study|Lost to Follow-up|23|||
94452828|NCT01282372|323445444|FG000|Overall Study|Withdrawal by Subject|11|||
94452829|NCT01282372|323445444|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
94452830|NCT01282372|323445444|FG000|Overall Study|Death|1|||
94452831|NCT01282372|323445444|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
94452832|NCT01282372|323445444|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
94452833|NCT01282372|323445444|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
94452834|NCT01282372|323445444|FG000|Overall Study|Adverse Event|12|||
94452835|NCT02714595|323445446|FG000|Overall Study|Lost to Follow-up|1|||
94452836|NCT02714595|323445447|FG001|Overall Study|Lost to Follow-up|0|||
94452837|NCT02714595|323445446|FG000|Overall Study|Withdrawal by Subject|1|||
94452838|NCT02714595|323445447|FG001|Overall Study|Withdrawal by Subject|2|||
94452839|NCT02714595|323445446|FG000|Overall Study|Lack of Efficacy|0|||
94452840|NCT02714595|323445447|FG001|Overall Study|Lack of Efficacy|1|||
94452841|NCT02714595|323445446|FG000|Overall Study|Death|30|||
94452842|NCT02714595|323445447|FG001|Overall Study|Death|9|||
94452843|NCT02714595|323445446|FG000|Overall Study|Other-Miscellaneous|0|||
94452844|NCT02714595|323445447|FG001|Overall Study|Other-Miscellaneous|1|||
94452845|NCT03124407|323445458|FG000|Overall Study|Lost to Follow-up|1|||
94452846|NCT03124407|323445459|FG001|Overall Study|Lost to Follow-up|0|||
94452847|NCT03124407|323445460|FG002|Overall Study|Lost to Follow-up|0|||
94452848|NCT03124407|323445461|FG003|Overall Study|Lost to Follow-up|0|||
94452849|NCT03124407|323445458|FG000|Overall Study|Adverse Event|0|||
94452850|NCT03124407|323445459|FG001|Overall Study|Adverse Event|0|||
94452851|NCT03124407|323445460|FG002|Overall Study|Adverse Event|1|||
94452852|NCT03124407|323445461|FG003|Overall Study|Adverse Event|0|||
94452853|NCT02977572|323445464|FG000|Overall Study|Exclusion criterion|2|||
94452854|NCT02977572|323445465|FG001|Overall Study|Exclusion criterion|2|||
94452855|NCT00427921|323445468|FG000|Overall Study|Adverse Event|26|||
94452856|NCT00427921|323445468|FG000|Overall Study|Withdrawal by Subject|4|||
94452857|NCT00427921|323445468|FG000|Overall Study|Lost to Follow-up|2|||
94452858|NCT00427921|323445468|FG000|Overall Study|Other reason not specified|10|||
94452859|NCT00427921|323445468|FG000|Overall Study|Adverse Event + Hospitalization|1|||
94452860|NCT00427921|323445468|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
94452861|NCT00427921|323445468|FG000|Overall Study|Adverse Event + No Response|1|||
94452862|NCT00427921|323445468|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
94452863|NCT00427921|323445468|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
94452864|NCT00427921|323445468|FG000|Overall Study|Adverse Event + Lost Response|1|||
94452865|NCT00427921|323445468|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
94452866|NCT00427921|323445468|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
94452867|NCT02887248|323445469|FG000|Overall Study|Withdrawal by Subject|1|||
94452868|NCT02887248|323445469|FG000|Overall Study|Adverse Event|1|||
94452869|NCT02887248|323445469|FG000|Overall Study|Progressive Disease|1|||
94452870|NCT02294396|323445470|FG000|Overall Study|Adverse Event|26|||
94349783|NCT03370133|323060949|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
94349784|NCT03370133|323060944|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
94349785|NCT03370133|323060945|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
94349786|NCT03370133|323060946|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
94349787|NCT03370133|323060947|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
94349788|NCT03370133|323060948|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
94349789|NCT03370133|323060949|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
94349790|NCT03370133|323060944|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
94349791|NCT03370133|323060945|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
94349792|NCT03370133|323060946|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
94349793|NCT03370133|323060947|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
94349794|NCT03370133|323060948|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
94349795|NCT03370133|323060949|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
94349796|NCT03370133|323060944|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
94349797|NCT03370133|323060945|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
94349798|NCT03370133|323060946|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
94349799|NCT03370133|323060947|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
94349800|NCT03370133|323060948|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
94349801|NCT03370133|323060949|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
94349802|NCT03370133|323060944|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
94349803|NCT03370133|323060945|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
94349804|NCT03370133|323060946|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
94349805|NCT03370133|323060947|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
94349806|NCT03370133|323060948|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
94349807|NCT03370133|323060949|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
94349808|NCT03370133|323060944|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
94349809|NCT03370133|323060945|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
94349810|NCT03370133|323060946|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
94349811|NCT03370133|323060947|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
94349812|NCT03370133|323060948|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
94349813|NCT03370133|323060949|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
94349814|NCT03370133|323060944|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
94349815|NCT03370133|323060945|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
94349816|NCT03370133|323060946|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
94349817|NCT03370133|323060947|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
94349818|NCT03370133|323060948|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
94349819|NCT03370133|323060949|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
94349820|NCT03370133|323060944|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
94349821|NCT03370133|323060945|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
94349822|NCT03370133|323060946|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
94349823|NCT03370133|323060947|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
94349824|NCT03370133|323060948|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
94349825|NCT03370133|323060949|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
94349826|NCT03370133|323060944|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
94349827|NCT03370133|323060945|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
94349828|NCT03370133|323060946|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
94349829|NCT03370133|323060947|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
94349830|NCT03370133|323060948|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
94349831|NCT03370133|323060949|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
94349832|NCT03370133|323060944|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
94349833|NCT03370133|323060945|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
94349834|NCT03370133|323060946|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
94349835|NCT03370133|323060947|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
94349836|NCT03370133|323060948|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
94349837|NCT03370133|323060949|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
94349838|NCT03370133|323060944|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
94349839|NCT03370133|323060945|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
94349840|NCT03370133|323060946|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
94349841|NCT03370133|323060947|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
94452871|NCT02294396|323445471|FG001|Overall Study|Adverse Event|25|||
94452872|NCT02294396|323445472|FG002|Overall Study|Adverse Event|21|||
94349842|NCT03370133|323060948|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
94452873|NCT02294396|323445473|FG003|Overall Study|Adverse Event|24|||
94452874|NCT02294396|323445470|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
94452875|NCT02294396|323445471|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
94239008|NCT00895895|322668601|FG002|Period 2|Adverse Event|5|||
94239009|NCT00895895|322668602|FG003|Period 2|Adverse Event|2|||
94239010|NCT00895895|322668603|FG004|Period 2|Adverse Event|5|||
94239011|NCT00895895|322668599|FG000|Period 2|Death|0|||
94239012|NCT00895895|322668600|FG001|Period 2|Death|0|||
94239013|NCT00895895|322668601|FG002|Period 2|Death|1|||
94239014|NCT00895895|322668602|FG003|Period 2|Death|0|||
94239015|NCT00895895|322668603|FG004|Period 2|Death|0|||
94239016|NCT00895895|322668599|FG000|Period 2|discontinued by sponsor|44|||
94239017|NCT00895895|322668600|FG001|Period 2|discontinued by sponsor|44|||
94239018|NCT00895895|322668601|FG002|Period 2|discontinued by sponsor|38|||
94239019|NCT00895895|322668602|FG003|Period 2|discontinued by sponsor|46|||
94239020|NCT00895895|322668603|FG004|Period 2|discontinued by sponsor|37|||
94239021|NCT00895895|322668599|FG000|Period 2|failed to return|2|||
94239022|NCT00895895|322668600|FG001|Period 2|failed to return|0|||
94239023|NCT00895895|322668601|FG002|Period 2|failed to return|0|||
94239024|NCT00895895|322668602|FG003|Period 2|failed to return|0|||
94239025|NCT00895895|322668603|FG004|Period 2|failed to return|0|||
94239026|NCT00895895|322668599|FG000|Period 2|investigator request|2|||
94239027|NCT00895895|322668600|FG001|Period 2|investigator request|0|||
94239028|NCT00895895|322668601|FG002|Period 2|investigator request|0|||
94239029|NCT00895895|322668602|FG003|Period 2|investigator request|0|||
94239030|NCT00895895|322668603|FG004|Period 2|investigator request|0|||
94349843|NCT03370133|323060949|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
94349844|NCT00866606|323060950|FG000|Overall Study|Lost to Follow-up|3|||
94349845|NCT00866606|323060950|FG000|Overall Study|Adverse Event|1|||
94349846|NCT02269709|323060952|FG000|Time of Enrollment|Withdrawal by Subject|3|||
94349847|NCT02269709|323060952|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
94349848|NCT02269709|323060952|FG000|Six Month Follow-up|Lost to Follow-up|12|||
94349849|NCT00440232|323060953|FG000|Overall Study|Lost to Follow-up|1|||
94349850|NCT00440232|323060954|FG001|Overall Study|Lost to Follow-up|1|||
94349851|NCT00440232|323060953|FG000|Overall Study|Unable to treat within allowed time|0|||
94349852|NCT00440232|323060954|FG001|Overall Study|Unable to treat within allowed time|1|||
94349853|NCT00440232|323060953|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
94349854|NCT00440232|323060954|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
94349855|NCT01535638|323060955|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
94349856|NCT01535638|323060956|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
94349857|NCT01535638|323060957|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
94349858|NCT01535638|323060958|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
94349859|NCT01535638|323060959|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
94349860|NCT01535638|323060960|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
94239031|NCT00895895|322668599|FG000|Period 2|Lost to Follow-up|1|||
94239032|NCT00895895|322668600|FG001|Period 2|Lost to Follow-up|2|||
94239033|NCT00895895|322668601|FG002|Period 2|Lost to Follow-up|1|||
94239034|NCT00895895|322668602|FG003|Period 2|Lost to Follow-up|1|||
94239035|NCT00895895|322668603|FG004|Period 2|Lost to Follow-up|0|||
94239036|NCT00895895|322668599|FG000|Period 2|Other|1|||
94239037|NCT00895895|322668600|FG001|Period 2|Other|1|||
94239038|NCT00895895|322668601|FG002|Period 2|Other|3|||
94239039|NCT00895895|322668602|FG003|Period 2|Other|1|||
94239040|NCT00895895|322668603|FG004|Period 2|Other|1|||
94239041|NCT00895895|322668599|FG000|Period 2|Protocol Violation|1|||
94239042|NCT00895895|322668600|FG001|Period 2|Protocol Violation|0|||
94239043|NCT00895895|322668601|FG002|Period 2|Protocol Violation|1|||
94239044|NCT00895895|322668602|FG003|Period 2|Protocol Violation|1|||
94239045|NCT00895895|322668603|FG004|Period 2|Protocol Violation|1|||
94239046|NCT00895895|322668599|FG000|Period 2|Withdrawal by Subject|0|||
94239047|NCT00895895|322668600|FG001|Period 2|Withdrawal by Subject|2|||
94239048|NCT00895895|322668601|FG002|Period 2|Withdrawal by Subject|0|||
94349861|NCT01535638|323060955|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
94349862|NCT01535638|323060956|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
94349863|NCT01535638|323060957|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
94349864|NCT01535638|323060958|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
94349865|NCT01535638|323060959|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
94349866|NCT01535638|323060960|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
94349867|NCT01365468|323060961|FG000|Overall Study|Physician Decision|1|||
94349868|NCT01365468|323060962|FG001|Overall Study|Physician Decision|0|||
94349869|NCT01365468|323060961|FG000|Overall Study|Disease progression|1|||
94349870|NCT01365468|323060962|FG001|Overall Study|Disease progression|0|||
94349871|NCT01365468|323060961|FG000|Overall Study|Lost to Follow-up|2|||
94349872|NCT01365468|323060962|FG001|Overall Study|Lost to Follow-up|0|||
94239049|NCT00895895|322668602|FG003|Period 2|Withdrawal by Subject|3|||
94239050|NCT00895895|322668603|FG004|Period 2|Withdrawal by Subject|5|||
94239051|NCT00895895|322668599|FG000|Period 2|unsatisfactory response-efficacy|2|||
94239052|NCT00895895|322668600|FG001|Period 2|unsatisfactory response-efficacy|1|||
94239053|NCT00895895|322668601|FG002|Period 2|unsatisfactory response-efficacy|0|||
94239054|NCT00895895|322668602|FG003|Period 2|unsatisfactory response-efficacy|0|||
94239055|NCT00895895|322668603|FG004|Period 2|unsatisfactory response-efficacy|0|||
94239056|NCT01261000|322668604|FG000|Overall Study|Screen failure|1|||
94452876|NCT02294396|323445472|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
94452877|NCT02294396|323445473|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
94452878|NCT02294396|323445470|FG000|Overall Study|Withdrawal by Subject|8|||
94452879|NCT02294396|323445471|FG001|Overall Study|Withdrawal by Subject|6|||
94452880|NCT02294396|323445472|FG002|Overall Study|Withdrawal by Subject|6|||
94452881|NCT02294396|323445473|FG003|Overall Study|Withdrawal by Subject|8|||
94452882|NCT02294396|323445470|FG000|Overall Study|Lost to Follow-up|0|||
94452883|NCT02294396|323445471|FG001|Overall Study|Lost to Follow-up|0|||
94452884|NCT02294396|323445472|FG002|Overall Study|Lost to Follow-up|1|||
94452885|NCT02294396|323445473|FG003|Overall Study|Lost to Follow-up|1|||
94452886|NCT02294396|323445470|FG000|Overall Study|Protocol Deviation|3|||
94452887|NCT02294396|323445471|FG001|Overall Study|Protocol Deviation|2|||
94452888|NCT02294396|323445472|FG002|Overall Study|Protocol Deviation|2|||
94452889|NCT02294396|323445473|FG003|Overall Study|Protocol Deviation|1|||
94452890|NCT02294396|323445470|FG000|Overall Study|Miscellaneous|2|||
94452891|NCT02294396|323445471|FG001|Overall Study|Miscellaneous|0|||
94452892|NCT02294396|323445472|FG002|Overall Study|Miscellaneous|5|||
94452893|NCT02294396|323445473|FG003|Overall Study|Miscellaneous|2|||
94452894|NCT05107492|323445474|FG000|Overall Study|Lost to Follow-up|1|||
94452895|NCT05107492|323445475|FG001|Overall Study|Lost to Follow-up|0|||
94452896|NCT00520533|323445476|FG000|Overall Study|Death|1|||
94452897|NCT00520533|323445476|FG000|Overall Study|Suspension of the study for safety reasons|1|||
94452898|NCT00520533|323445476|FG000|Overall Study|Withdrawal by Subject|1|||
94452899|NCT00520533|323445476|FG000|Overall Study|Physician Decision|1|||
94452900|NCT01166438|323445479|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
94452901|NCT01166438|323445480|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
94452902|NCT01166438|323445479|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
94452903|NCT01166438|323445480|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
94452904|NCT01166438|323445479|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
94452905|NCT01166438|323445480|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
94452906|NCT01166438|323445479|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
94452907|NCT01166438|323445480|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
94452908|NCT01166438|323445479|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
94452909|NCT01166438|323445480|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
94452910|NCT01166438|323445479|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
94452911|NCT01166438|323445480|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
94452912|NCT02438826|323445481|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
94452913|NCT02438826|323445482|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
94452914|NCT02438826|323445483|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
94452915|NCT02438826|323445484|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
94452916|NCT02438826|323445481|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
94452917|NCT02438826|323445482|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
94452918|NCT02438826|323445483|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
94452919|NCT02438826|323445484|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
94452920|NCT02438826|323445481|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
94452921|NCT02438826|323445482|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
94452922|NCT02438826|323445483|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
94452923|NCT02438826|323445484|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
94452924|NCT02438826|323445481|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
94452925|NCT02438826|323445482|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
94452926|NCT02438826|323445483|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
94452927|NCT02438826|323445484|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
94452928|NCT02438826|323445481|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
94452929|NCT02438826|323445482|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
94452930|NCT02438826|323445483|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
94452931|NCT02438826|323445484|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
94452932|NCT02438826|323445481|FG000|Open-Label Treatment Phase|Adverse Event|11|||
94452933|NCT02438826|323445482|FG001|Open-Label Treatment Phase|Adverse Event|6|||
94452934|NCT02438826|323445483|FG002|Open-Label Treatment Phase|Adverse Event|0|||
94452935|NCT02438826|323445484|FG003|Open-Label Treatment Phase|Adverse Event|0|||
94452936|NCT02438826|323445481|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
94452937|NCT02438826|323445482|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
94452938|NCT02438826|323445483|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
94452939|NCT02438826|323445484|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
94575638|NCT03037385|323908448|FG006|Overall Study|Adverse Event|0|||
94452940|NCT02438826|323445481|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
94452941|NCT02438826|323445482|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
94452942|NCT02438826|323445483|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
94452943|NCT02438826|323445484|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
94452944|NCT02438826|323445481|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
94452945|NCT02438826|323445482|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
94452946|NCT02438826|323445483|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
94349873|NCT00827112|323060963|FG000|Overall Study|Adverse Event|2|||
94349874|NCT00827112|323060964|FG001|Overall Study|Adverse Event|0|||
94349875|NCT00827112|323060963|FG000|Overall Study|Lack of Efficacy|2|||
94349876|NCT00827112|323060964|FG001|Overall Study|Lack of Efficacy|0|||
94349877|NCT00827112|323060963|FG000|Overall Study|Lost to Follow-up|3|||
94349878|NCT00827112|323060964|FG001|Overall Study|Lost to Follow-up|2|||
94349879|NCT00827112|323060963|FG000|Overall Study|Pregnancy|0|||
94349880|NCT00827112|323060964|FG001|Overall Study|Pregnancy|1|||
94349881|NCT00827112|323060963|FG000|Overall Study|Protocol Violation|0|||
94349882|NCT00827112|323060964|FG001|Overall Study|Protocol Violation|2|||
94349883|NCT00827112|323060963|FG000|Overall Study|Withdrawal by Subject|2|||
94349884|NCT00827112|323060964|FG001|Overall Study|Withdrawal by Subject|1|||
94349885|NCT00827112|323060963|FG000|Overall Study|Randomized but not treated|5|||
94349886|NCT00827112|323060964|FG001|Overall Study|Randomized but not treated|3|||
94349887|NCT00827112|323060963|FG000|Overall Study|Other|1|||
94349888|NCT00827112|323060964|FG001|Overall Study|Other|3|||
94349889|NCT00620815|323060965|FG000|Overall Study|Adverse Event|1|||
94349890|NCT00620815|323060966|FG001|Overall Study|Adverse Event|1|||
94349891|NCT00620815|323060967|FG002|Overall Study|Adverse Event|2|||
94349892|NCT00620815|323060965|FG000|Overall Study|Withdrawal by Subject|1|||
94349893|NCT00620815|323060966|FG001|Overall Study|Withdrawal by Subject|2|||
94349894|NCT00620815|323060967|FG002|Overall Study|Withdrawal by Subject|0|||
94349895|NCT00620815|323060965|FG000|Overall Study|Lost to Follow-up|1|||
94349896|NCT00620815|323060966|FG001|Overall Study|Lost to Follow-up|6|||
94575639|NCT03037385|323908449|FG007|Overall Study|Adverse Event|0|||
94349897|NCT00620815|323060967|FG002|Overall Study|Lost to Follow-up|3|||
94349898|NCT00620815|323060965|FG000|Overall Study|Inappropriate enrolment|0|||
94349899|NCT00620815|323060966|FG001|Overall Study|Inappropriate enrolment|0|||
94349900|NCT00620815|323060967|FG002|Overall Study|Inappropriate enrolment|1|||
94349901|NCT00620815|323060965|FG000|Overall Study|Protocol Violation|1|||
94349902|NCT00620815|323060966|FG001|Overall Study|Protocol Violation|2|||
94349903|NCT00620815|323060967|FG002|Overall Study|Protocol Violation|1|||
94349904|NCT01636076|323060968|FG000|Overall Study|Terminated by sponsor|1|||
94349905|NCT01636076|323060969|FG001|Overall Study|Terminated by sponsor|1|||
94349906|NCT01636076|323060968|FG000|Overall Study|Lack of Efficacy|0|||
94349907|NCT01636076|323060969|FG001|Overall Study|Lack of Efficacy|1|||
94349908|NCT01636076|323060968|FG000|Overall Study|Lost to Follow-up|1|||
94349909|NCT01636076|323060969|FG001|Overall Study|Lost to Follow-up|0|||
94349910|NCT01636076|323060968|FG000|Overall Study|Physician Decision|1|||
94349911|NCT01636076|323060969|FG001|Overall Study|Physician Decision|1|||
94349912|NCT01636076|323060968|FG000|Overall Study|Non-compliance with study treatment|1|||
94452947|NCT02438826|323445484|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
94452948|NCT02438826|323445481|FG000|Post-Treatment Phase|Adverse Event|3|||
94452949|NCT02438826|323445482|FG001|Post-Treatment Phase|Adverse Event|0|||
94452950|NCT02438826|323445483|FG002|Post-Treatment Phase|Adverse Event|0|||
94452951|NCT02438826|323445484|FG003|Post-Treatment Phase|Adverse Event|0|||
94452952|NCT02438826|323445481|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
94452953|NCT02438826|323445482|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
94452954|NCT02438826|323445483|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
94452955|NCT02438826|323445484|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
94452956|NCT02438826|323445481|FG000|Post-Treatment Phase|Physician Decision|1|||
94452957|NCT02438826|323445482|FG001|Post-Treatment Phase|Physician Decision|0|||
94452958|NCT02438826|323445483|FG002|Post-Treatment Phase|Physician Decision|0|||
94452959|NCT02438826|323445484|FG003|Post-Treatment Phase|Physician Decision|0|||
94452960|NCT02438826|323445481|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
94452961|NCT02438826|323445482|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
94452962|NCT02438826|323445483|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
94452963|NCT02438826|323445484|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
94452964|NCT01075256|323445485|FG000|Overall Study|Withdrawal by Subject|1|||
94452965|NCT01075256|323445486|FG001|Overall Study|Withdrawal by Subject|0|||
94452966|NCT01075256|323445487|FG002|Overall Study|Withdrawal by Subject|0|||
94452967|NCT03502070|323445489|FG000|Overall Study|Withdrawal by Subject|1|||
94452968|NCT03502070|323445489|FG000|Overall Study|Screen Failure|1|||
94452969|NCT04105218|323445490|FG000|Overall Study|Withdrawal by Subject|3|||
94239057|NCT00401258|322668610|FG000|Overall Study|Adverse Event|7|||
94239058|NCT03995316|322668611|FG000|Overall Study|Lost to Follow-up|10|||
94349913|NCT01636076|323060969|FG001|Overall Study|Non-compliance with study treatment|1|||
94349914|NCT01636076|323060968|FG000|Overall Study|Adverse Event|6|||
94349915|NCT01636076|323060969|FG001|Overall Study|Adverse Event|11|||
94349916|NCT01636076|323060968|FG000|Overall Study|Withdrawal by Subject|7|||
94349917|NCT01636076|323060969|FG001|Overall Study|Withdrawal by Subject|10|||
94349918|NCT01021423|323060971|FG000|Overall Study|Study terminated|4|||
94349919|NCT01021423|323060972|FG001|Overall Study|Study terminated|5|||
94349920|NCT00695318|323060974|FG000|Overall Study|Lost to Follow-up|1|||
94349921|NCT00695318|323060975|FG001|Overall Study|Lost to Follow-up|0|||
94349922|NCT00695318|323060974|FG000|Overall Study|Withdrawal by Subject|2|||
94349923|NCT00695318|323060975|FG001|Overall Study|Withdrawal by Subject|0|||
94349924|NCT00695318|323060974|FG000|Overall Study|Death|1|||
94349925|NCT00695318|323060975|FG001|Overall Study|Death|1|||
94349926|NCT00695318|323060974|FG000|Overall Study|Study Terminated|1|||
94452970|NCT04105218|323445491|FG001|Overall Study|Withdrawal by Subject|2|||
94452971|NCT04105218|323445490|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
94452972|NCT04105218|323445491|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
94452973|NCT04105218|323445490|FG000|Overall Study|Failed screening tests|2|||
94239059|NCT03995316|322668612|FG001|Overall Study|Lost to Follow-up|3|||
94239060|NCT00856245|322668613|FG000|Overall Study|Was not transplanted|5|||
94239061|NCT01443923|322668614|FG000|Overall Study|Adverse Event|1|||
94239062|NCT01443923|322668615|FG001|Overall Study|Adverse Event|0|||
94239063|NCT00570908|322668619|FG000|Overall Study|Adverse Event|5|||
94239064|NCT00570908|322668619|FG000|Overall Study|Withdrawal by Subject|2|||
94239065|NCT00486252|322668632|FG000|Overall Study|Adverse Event|7|||
94239066|NCT00486252|322668632|FG000|Overall Study|Lack of Efficacy|9|||
94239067|NCT00486252|322668632|FG000|Overall Study|Lost to Follow-up|24|||
94239068|NCT00486252|322668632|FG000|Overall Study|Other|18|||
94239069|NCT01183390|322670510|FG000|First Intervention|Adverse Event|0|||
94239070|NCT01183390|322670511|FG001|First Intervention|Adverse Event|1|||
94239071|NCT03816761|322670512|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
94239072|NCT03816761|322670513|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
94239073|NCT03816761|322670514|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
94575640|NCT03037385|323908450|FG008|Overall Study|Adverse Event|0|||
94575641|NCT03037385|323908451|FG009|Overall Study|Adverse Event|6|||
94575642|NCT03037385|323908442|FG000|Overall Study|Death|1|||
94575643|NCT03037385|323908443|FG001|Overall Study|Death|4|||
94575644|NCT03037385|323908444|FG002|Overall Study|Death|2|||
94575645|NCT03037385|323908445|FG003|Overall Study|Death|2|||
94239074|NCT03816761|322670515|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
94349927|NCT00695318|323060975|FG001|Overall Study|Study Terminated|0|||
94349928|NCT03395704|323060976|FG000|Overall Study|Adverse Event|2|||
94349929|NCT03395704|323060977|FG001|Overall Study|Adverse Event|1|||
94349930|NCT03395704|323060976|FG000|Overall Study|Withdrawal by Subject|2|||
94452974|NCT04105218|323445491|FG001|Overall Study|Failed screening tests|1|||
94452975|NCT01167881|323445492|FG000|Overall Study|Adverse Event|47|||
94239075|NCT03816761|322670516|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
94239076|NCT03816761|322670517|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
94239077|NCT03816761|322670512|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
94239078|NCT03816761|322670513|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
94239079|NCT03816761|322670514|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
94239080|NCT03816761|322670515|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
94239081|NCT03816761|322670516|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
94239082|NCT03816761|322670517|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
94239083|NCT02419417|322670518|FG000|Overall Study|Disease progression|5|||
94239084|NCT02419417|322670519|FG001|Overall Study|Disease progression|4|||
94239085|NCT02419417|322670520|FG002|Overall Study|Disease progression|13|||
94239086|NCT02419417|322670521|FG003|Overall Study|Disease progression|10|||
94239087|NCT02419417|322670522|FG004|Overall Study|Disease progression|10|||
94239088|NCT02419417|322670523|FG005|Overall Study|Disease progression|3|||
94239089|NCT02419417|322670524|FG006|Overall Study|Disease progression|4|||
94239090|NCT02419417|322670525|FG007|Overall Study|Disease progression|5|||
94239091|NCT02419417|322670526|FG008|Overall Study|Disease progression|13|||
94239092|NCT02419417|322670527|FG009|Overall Study|Disease progression|9|||
94239093|NCT02419417|322670528|FG010|Overall Study|Disease progression|0|||
94239094|NCT02419417|322670518|FG000|Overall Study|Study drug toxicity|0|||
94239095|NCT02419417|322670519|FG001|Overall Study|Study drug toxicity|0|||
94239096|NCT02419417|322670520|FG002|Overall Study|Study drug toxicity|0|||
94239097|NCT02419417|322670521|FG003|Overall Study|Study drug toxicity|0|||
94239098|NCT02419417|322670522|FG004|Overall Study|Study drug toxicity|1|||
94239099|NCT02419417|322670523|FG005|Overall Study|Study drug toxicity|0|||
94239100|NCT02419417|322670524|FG006|Overall Study|Study drug toxicity|0|||
94239101|NCT02419417|322670525|FG007|Overall Study|Study drug toxicity|0|||
94239102|NCT02419417|322670526|FG008|Overall Study|Study drug toxicity|0|||
94239103|NCT02419417|322670527|FG009|Overall Study|Study drug toxicity|0|||
94239104|NCT02419417|322670528|FG010|Overall Study|Study drug toxicity|0|||
94239105|NCT02419417|322670518|FG000|Overall Study|Adverse event unrelated to study drug|0|||
94239106|NCT02419417|322670519|FG001|Overall Study|Adverse event unrelated to study drug|0|||
94239107|NCT02419417|322670520|FG002|Overall Study|Adverse event unrelated to study drug|0|||
94239108|NCT02419417|322670521|FG003|Overall Study|Adverse event unrelated to study drug|0|||
94239109|NCT02419417|322670522|FG004|Overall Study|Adverse event unrelated to study drug|2|||
94239110|NCT02419417|322670523|FG005|Overall Study|Adverse event unrelated to study drug|1|||
94239111|NCT02419417|322670524|FG006|Overall Study|Adverse event unrelated to study drug|0|||
94239112|NCT02419417|322670525|FG007|Overall Study|Adverse event unrelated to study drug|1|||
94239113|NCT02419417|322670526|FG008|Overall Study|Adverse event unrelated to study drug|0|||
94239114|NCT02419417|322670527|FG009|Overall Study|Adverse event unrelated to study drug|0|||
94239115|NCT02419417|322670528|FG010|Overall Study|Adverse event unrelated to study drug|0|||
94239116|NCT02419417|322670518|FG000|Overall Study|Participant request to discontinue|0|||
94239117|NCT02419417|322670519|FG001|Overall Study|Participant request to discontinue|0|||
94239118|NCT02419417|322670520|FG002|Overall Study|Participant request to discontinue|0|||
94239119|NCT02419417|322670521|FG003|Overall Study|Participant request to discontinue|0|||
94239120|NCT02419417|322670522|FG004|Overall Study|Participant request to discontinue|0|||
94239121|NCT02419417|322670523|FG005|Overall Study|Participant request to discontinue|0|||
94239122|NCT02419417|322670524|FG006|Overall Study|Participant request to discontinue|0|||
94239123|NCT02419417|322670525|FG007|Overall Study|Participant request to discontinue|0|||
94239124|NCT02419417|322670526|FG008|Overall Study|Participant request to discontinue|0|||
94239125|NCT02419417|322670527|FG009|Overall Study|Participant request to discontinue|1|||
94239126|NCT02419417|322670528|FG010|Overall Study|Participant request to discontinue|0|||
94239127|NCT02419417|322670518|FG000|Overall Study|Withdrawal by Subject|0|||
94239128|NCT02419417|322670519|FG001|Overall Study|Withdrawal by Subject|0|||
94239129|NCT02419417|322670520|FG002|Overall Study|Withdrawal by Subject|0|||
94239130|NCT02419417|322670521|FG003|Overall Study|Withdrawal by Subject|0|||
94239131|NCT02419417|322670522|FG004|Overall Study|Withdrawal by Subject|0|||
94239132|NCT02419417|322670523|FG005|Overall Study|Withdrawal by Subject|0|||
94239133|NCT02419417|322670524|FG006|Overall Study|Withdrawal by Subject|0|||
94239134|NCT02419417|322670525|FG007|Overall Study|Withdrawal by Subject|0|||
94239135|NCT02419417|322670526|FG008|Overall Study|Withdrawal by Subject|0|||
94239136|NCT02419417|322670527|FG009|Overall Study|Withdrawal by Subject|0|||
94239137|NCT02419417|322670528|FG010|Overall Study|Withdrawal by Subject|1|||
94239138|NCT01200342|322670531|FG000|Overall Study|Disease Progression|1|||
94239139|NCT02056626|322670537|FG000|Overall Study|patient did not follow directions|3|||
94239140|NCT02056626|322670538|FG001|Overall Study|patient did not follow directions|1|||
94239141|NCT02056626|322670539|FG002|Overall Study|patient did not follow directions|0|||
94239142|NCT02056626|322670540|FG003|Overall Study|patient did not follow directions|0|||
94239143|NCT00790400|322670541|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
94239144|NCT00790400|322670542|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
94452976|NCT01167881|323445493|FG001|Overall Study|Adverse Event|51|||
94239145|NCT00790400|322670541|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
94349931|NCT03395704|323060977|FG001|Overall Study|Withdrawal by Subject|1|||
94349932|NCT03395704|323060976|FG000|Overall Study|Physician Decision|0|||
94349933|NCT03395704|323060977|FG001|Overall Study|Physician Decision|1|||
94349934|NCT02475564|323060978|FG000|Overall Study|Withdrawal by Subject|1|||
94349935|NCT02475564|323060979|FG001|Overall Study|Withdrawal by Subject|0|||
94349936|NCT02475564|323060978|FG000|Overall Study|Lost to Follow-up|2|||
94349937|NCT02475564|323060979|FG001|Overall Study|Lost to Follow-up|1|||
94349938|NCT02475564|323060978|FG000|Overall Study|Intense Menstrual bleeding|1|||
94349939|NCT02475564|323060979|FG001|Overall Study|Intense Menstrual bleeding|0|||
94349940|NCT02408016|323063277|FG000|Overall Study|Death|6|||
94349941|NCT02408016|323063278|FG001|Overall Study|Death|1|||
94349942|NCT02408016|323063279|FG002|Overall Study|Death|0|||
94349943|NCT02408016|323063277|FG000|Overall Study|Physician Decision|0|||
94239146|NCT00790400|322670542|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
94239147|NCT00790400|322670541|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
94239148|NCT00790400|322670542|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
94239149|NCT00790400|322670541|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
94239150|NCT00790400|322670542|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
94239151|NCT00790400|322670541|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
94239152|NCT00790400|322670542|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
94349944|NCT02408016|323063278|FG001|Overall Study|Physician Decision|2|||
94239153|NCT00790400|322670541|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
94349945|NCT02408016|323063279|FG002|Overall Study|Physician Decision|0|||
94349946|NCT00805194|323063280|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
94349947|NCT00805194|323063281|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
94349948|NCT00805194|323063280|FG000|Overall Study|Worsening or AE of underlying disease|64|||
94349949|NCT00805194|323063281|FG001|Overall Study|Worsening or AE of underlying disease|70|||
94349950|NCT00805194|323063280|FG000|Overall Study|Other AE|84|||
94349951|NCT00805194|323063281|FG001|Overall Study|Other AE|73|||
94349952|NCT00805194|323063280|FG000|Overall Study|Protocol Violation|9|||
94349953|NCT00805194|323063281|FG001|Overall Study|Protocol Violation|9|||
94349954|NCT00805194|323063280|FG000|Overall Study|Lost to Follow-up|5|||
94349955|NCT00805194|323063281|FG001|Overall Study|Lost to Follow-up|5|||
94349956|NCT00805194|323063280|FG000|Overall Study|Withdrawal by Subject|60|||
94349957|NCT00805194|323063281|FG001|Overall Study|Withdrawal by Subject|42|||
94349958|NCT00805194|323063280|FG000|Overall Study|Not treated|3|||
94349959|NCT00805194|323063281|FG001|Overall Study|Not treated|4|||
94349960|NCT00805194|323063280|FG000|Overall Study|Reasons other than stated above|20|||
94349961|NCT00805194|323063281|FG001|Overall Study|Reasons other than stated above|16|||
94349962|NCT00298766|323063282|FG000|Overall Study|Adverse Event|18|||
94349963|NCT00298766|323063282|FG000|Overall Study|Death|2|||
94349964|NCT00298766|323063282|FG000|Overall Study|Withdrawal by Subject|9|||
94349965|NCT00298766|323063282|FG000|Overall Study|Treatment ongoing|4|||
94349966|NCT00298766|323063282|FG000|Overall Study|Progression of amyloid markers|4|||
94349967|NCT00298766|323063282|FG000|Overall Study|Deterioration in KPS and organ function|1|||
94349968|NCT00298766|323063282|FG000|Overall Study|Subjects overall condition deterioration|4|||
94349969|NCT00298766|323063282|FG000|Overall Study|Other|4|||
94349970|NCT02500901|323063289|FG000|Overall Study|Disease ProgressionDD|2|||
94349971|NCT02505945|323063290|FG000|Overall Study|Withdrawal by Subject|13|||
94349972|NCT02505945|323063291|FG001|Overall Study|Withdrawal by Subject|2|||
94349973|NCT02505945|323063290|FG000|Overall Study|Adverse Event|1|||
94349974|NCT02505945|323063291|FG001|Overall Study|Adverse Event|0|||
94349975|NCT02505945|323063290|FG000|Overall Study|Physician Decision|2|||
94349976|NCT02505945|323063291|FG001|Overall Study|Physician Decision|1|||
94349977|NCT02505945|323063290|FG000|Overall Study|Lost to Follow-up|6|||
94349978|NCT02505945|323063291|FG001|Overall Study|Lost to Follow-up|1|||
94349979|NCT00661362|323063295|FG000|Overall Study|Adverse Event|5|||
94349980|NCT00661362|323063296|FG001|Overall Study|Adverse Event|4|||
94349981|NCT00661362|323063295|FG000|Overall Study|Incorrect enrollment|2|||
94349982|NCT00661362|323063296|FG001|Overall Study|Incorrect enrollment|0|||
94349983|NCT00661362|323063295|FG000|Overall Study|Study specific discontinuation criteria|4|||
94349984|NCT00661362|323063296|FG001|Overall Study|Study specific discontinuation criteria|11|||
94349985|NCT00661362|323063295|FG000|Overall Study|Withdrawal by Subject|13|||
94349986|NCT00661362|323063296|FG001|Overall Study|Withdrawal by Subject|23|||
94349987|NCT00661362|323063295|FG000|Overall Study|Lost to Follow-up|3|||
94349988|NCT00661362|323063296|FG001|Overall Study|Lost to Follow-up|1|||
94349989|NCT00661362|323063295|FG000|Overall Study|Severe non-compliance to protocol|0|||
94349990|NCT00661362|323063296|FG001|Overall Study|Severe non-compliance to protocol|1|||
94349991|NCT00661362|323063295|FG000|Overall Study|Safety reasons|1|||
94349992|NCT00661362|323063296|FG001|Overall Study|Safety reasons|0|||
94349993|NCT00661362|323063295|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
94349994|NCT00661362|323063296|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
94349995|NCT00104299|323063297|FG000|Overall Study|Adverse Event|3|||
94349996|NCT00104299|323063298|FG001|Overall Study|Adverse Event|1|||
94349997|NCT00104299|323063297|FG000|Overall Study|Death|2|||
94349998|NCT00104299|323063298|FG001|Overall Study|Death|2|||
94349999|NCT00104299|323063297|FG000|Overall Study|Withdrawal by Subject|2|||
94350000|NCT00104299|323063298|FG001|Overall Study|Withdrawal by Subject|6|||
94350001|NCT00104299|323063297|FG000|Overall Study|Physician Decision|1|||
94350002|NCT00104299|323063298|FG001|Overall Study|Physician Decision|1|||
94350003|NCT00104299|323063297|FG000|Overall Study|To have renal transplant|1|||
94350004|NCT00104299|323063298|FG001|Overall Study|To have renal transplant|0|||
94350005|NCT02906644|323063299|FG000|First 2 Weeks|Withdrawal by Subject|0|||
94350006|NCT02906644|323063300|FG001|First 2 Weeks|Withdrawal by Subject|2|||
94350007|NCT02906644|323063299|FG000|First 2 Weeks|Physician Decision|1|||
94350008|NCT02906644|323063300|FG001|First 2 Weeks|Physician Decision|1|||
94350009|NCT02906644|323063299|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
94350010|NCT02906644|323063300|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
94350011|NCT02906644|323063299|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
94350012|NCT02906644|323063300|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
94350013|NCT00689611|323063302|FG000|Overall Study|Death|6|||
94350014|NCT00689611|323063303|FG001|Overall Study|Death|9|||
94350015|NCT00689611|323063302|FG000|Overall Study|Withdrawal by Subject|8|||
94350016|NCT00689611|323063303|FG001|Overall Study|Withdrawal by Subject|9|||
94350017|NCT00689611|323063302|FG000|Overall Study|Lost to Follow-up|27|||
94350018|NCT00689611|323063303|FG001|Overall Study|Lost to Follow-up|28|||
94350019|NCT00568399|323063304|FG000|Overall Study|Death|2|||
94350020|NCT00568399|323063304|FG000|Overall Study|Adverse Event|5|||
94239154|NCT00790400|322670542|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
94239155|NCT00790400|322670541|FG000|Double-blind Period (Core Phase)|Death|1|||
94239156|NCT00790400|322670542|FG001|Double-blind Period (Core Phase)|Death|0|||
94239157|NCT00790400|322670541|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
94239158|NCT00790400|322670542|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
94239159|NCT00790400|322670541|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
94239160|NCT00790400|322670542|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
94239161|NCT00790400|322670541|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
94239162|NCT00790400|322670542|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
94239163|NCT00790400|322670541|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
94239164|NCT00790400|322670542|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
94239165|NCT00790400|322670541|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
94239166|NCT00790400|322670542|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
94239167|NCT00790400|322670541|FG000|Everolimus Period (Core or Extension)|Death|1|||
94239168|NCT00790400|322670542|FG001|Everolimus Period (Core or Extension)|Death|0|||
94239169|NCT00790400|322670541|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
94239170|NCT00790400|322670542|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
94239171|NCT00790400|322670541|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
94239172|NCT00790400|322670542|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
94239173|NCT00790400|322670541|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
94239174|NCT00790400|322670542|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
94239175|NCT02460575|322670543|FG000|Overall Study|Lost to Follow-up|1|||
94239176|NCT02460575|322670544|FG001|Overall Study|Lost to Follow-up|0|||
94239177|NCT01107899|322670549|FG000|Overall Study|Physician Decision|5|||
94239178|NCT01107899|322670550|FG001|Overall Study|Physician Decision|0|||
94239179|NCT01107899|322670551|FG002|Overall Study|Physician Decision|3|||
94239180|NCT01107899|322670549|FG000|Overall Study|Withdrawal by Subject|0|||
94239181|NCT01107899|322670550|FG001|Overall Study|Withdrawal by Subject|0|||
94239182|NCT01107899|322670551|FG002|Overall Study|Withdrawal by Subject|1|||
94239183|NCT00974259|322670552|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
94239184|NCT00974259|322670553|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
94239185|NCT02963090|322670554|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
94239186|NCT02963090|322670555|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
94239187|NCT02870972|322670558|FG000|Overall Study|Adverse Event|1|||
94239188|NCT02870972|322670559|FG001|Overall Study|Adverse Event|0|||
94239189|NCT02870972|322670560|FG002|Overall Study|Adverse Event|0|||
94239190|NCT02870972|322670561|FG003|Overall Study|Adverse Event|0|||
94350021|NCT00568399|323063304|FG000|Overall Study|Withdrawal by Subject|8|||
94350022|NCT01220024|323063306|FG000|Overall Study|Lost to Follow-up|1|||
94350023|NCT01220024|323063307|FG001|Overall Study|Lost to Follow-up|1|||
94350024|NCT00490815|323063310|FG000|Overall Study|Adverse Event|2|||
94350025|NCT00490815|323063311|FG001|Overall Study|Adverse Event|3|||
94239191|NCT02870972|322670562|FG004|Overall Study|Adverse Event|0|||
94350026|NCT00490815|323063310|FG000|Overall Study|Withdrawal by Subject|4|||
94350027|NCT00490815|323063311|FG001|Overall Study|Withdrawal by Subject|0|||
94350028|NCT00490815|323063310|FG000|Overall Study|Lost to Follow-up|1|||
94575646|NCT03037385|323908446|FG004|Overall Study|Death|5|||
94575647|NCT03037385|323908447|FG005|Overall Study|Death|2|||
94350029|NCT00490815|323063311|FG001|Overall Study|Lost to Follow-up|3|||
94350030|NCT00490815|323063310|FG000|Overall Study|Death|1|||
94350031|NCT00490815|323063311|FG001|Overall Study|Death|3|||
94350032|NCT04047472|323063324|FG000|Overall Study|Adverse Event|3|||
94350033|NCT04047472|323063325|FG001|Overall Study|Adverse Event|3|||
94350034|NCT04047472|323063324|FG000|Overall Study|Death|0|||
94350035|NCT04047472|323063325|FG001|Overall Study|Death|1|||
94350036|NCT04047472|323063324|FG000|Overall Study|Lost to Follow-up|1|||
94350037|NCT04047472|323063325|FG001|Overall Study|Lost to Follow-up|0|||
94350038|NCT04047472|323063324|FG000|Overall Study|Physician Decision|1|||
94350039|NCT04047472|323063325|FG001|Overall Study|Physician Decision|2|||
94350040|NCT04047472|323063324|FG000|Overall Study|Protocol Violation|1|||
94350041|NCT04047472|323063325|FG001|Overall Study|Protocol Violation|0|||
94350042|NCT04047472|323063324|FG000|Overall Study|Withdrawal by Subject|10|||
94350043|NCT04047472|323063325|FG001|Overall Study|Withdrawal by Subject|10|||
94350044|NCT02195531|323063327|FG000|Overall Study|Withdrawal by Subject|1|||
94350045|NCT02195531|323063328|FG001|Overall Study|Withdrawal by Subject|1|||
94350046|NCT02195531|323063329|FG002|Overall Study|Withdrawal by Subject|1|||
94350047|NCT02543801|323063330|FG000|Overall Study|Protocol Violation|1|||
94350048|NCT02543801|323063331|FG001|Overall Study|Protocol Violation|2|||
94350049|NCT02543801|323063332|FG002|Overall Study|Protocol Violation|0|||
94350050|NCT02543801|323063333|FG003|Overall Study|Protocol Violation|0|||
94350051|NCT01038635|323063334|FG000|Overall Study|Disease Progression|2|||
94350052|NCT01038635|323063335|FG001|Overall Study|Disease Progression|0|||
94350053|NCT01038635|323063336|FG002|Overall Study|Disease Progression|0|||
94350054|NCT01038635|323063337|FG003|Overall Study|Disease Progression|0|||
94350055|NCT01038635|323063338|FG004|Overall Study|Disease Progression|0|||
94350056|NCT01038635|323063339|FG005|Overall Study|Disease Progression|0|||
94350057|NCT01038635|323063340|FG006|Overall Study|Disease Progression|1|||
94350058|NCT01038635|323063341|FG007|Overall Study|Disease Progression|4|||
94350059|NCT01038635|323063342|FG008|Overall Study|Disease Progression|0|||
94350060|NCT01038635|323063334|FG000|Overall Study|Death|0|||
94350061|NCT01038635|323063335|FG001|Overall Study|Death|0|||
94350062|NCT01038635|323063336|FG002|Overall Study|Death|0|||
94350063|NCT01038635|323063337|FG003|Overall Study|Death|0|||
94350064|NCT01038635|323063338|FG004|Overall Study|Death|1|||
94350065|NCT01038635|323063339|FG005|Overall Study|Death|0|||
94350066|NCT01038635|323063340|FG006|Overall Study|Death|1|||
94350067|NCT01038635|323063341|FG007|Overall Study|Death|1|||
94350068|NCT01038635|323063342|FG008|Overall Study|Death|2|||
94350069|NCT01034709|323063343|FG000|Overall Study|Protocol Violation|9|||
94350070|NCT01034709|323063344|FG001|Overall Study|Protocol Violation|16|||
94575648|NCT03037385|323908448|FG006|Overall Study|Death|1|||
94350071|NCT01562327|323063345|FG000|Overall Study|Adverse Event|2|||
94350072|NCT01562327|323063345|FG000|Overall Study|Lack of Efficacy|1|||
94350073|NCT01562327|323063345|FG000|Overall Study|Participant drop-out|1|||
94350074|NCT01562327|323063345|FG000|Overall Study|Infusion not received at 6 month window|4|||
94350075|NCT01836549|323063346|FG000|Overall Study|Did not receive study drug|0|||
94350076|NCT01836549|323063347|FG001|Overall Study|Did not receive study drug|0|||
94350077|NCT01836549|323063348|FG002|Overall Study|Did not receive study drug|1|||
94350078|NCT01836549|323063349|FG003|Overall Study|Did not receive study drug|0|||
94239192|NCT00847626|322670568|FG000|Overall Study|Adverse Event|10|||
94239193|NCT00847626|322670569|FG001|Overall Study|Adverse Event|10|||
94350079|NCT01836549|323063350|FG004|Overall Study|Did not receive study drug|0|||
94350080|NCT01836549|323063351|FG005|Overall Study|Did not receive study drug|0|||
94350081|NCT01836549|323063352|FG006|Overall Study|Did not receive study drug|0|||
94350082|NCT01836549|323063346|FG000|Overall Study|Patient declared ineligible|0|||
94350083|NCT01836549|323063347|FG001|Overall Study|Patient declared ineligible|0|||
94350084|NCT01836549|323063348|FG002|Overall Study|Patient declared ineligible|0|||
94350085|NCT01836549|323063349|FG003|Overall Study|Patient declared ineligible|1|||
94350086|NCT01836549|323063350|FG004|Overall Study|Patient declared ineligible|0|||
94350087|NCT01836549|323063351|FG005|Overall Study|Patient declared ineligible|0|||
94350088|NCT01836549|323063352|FG006|Overall Study|Patient declared ineligible|0|||
94350089|NCT01836549|323063346|FG000|Overall Study|Patient inevaluable to start therapy|0|||
94350090|NCT01836549|323063347|FG001|Overall Study|Patient inevaluable to start therapy|0|||
94350091|NCT01836549|323063348|FG002|Overall Study|Patient inevaluable to start therapy|0|||
94350092|NCT01836549|323063349|FG003|Overall Study|Patient inevaluable to start therapy|0|||
94350093|NCT01836549|323063350|FG004|Overall Study|Patient inevaluable to start therapy|0|||
94350094|NCT01836549|323063351|FG005|Overall Study|Patient inevaluable to start therapy|0|||
94350095|NCT01836549|323063352|FG006|Overall Study|Patient inevaluable to start therapy|1|||
94350096|NCT01683058|323063353|FG000|Overall Study|Lost to Follow-up|9|||
94350097|NCT01683058|323063353|FG000|Overall Study|Adverse Event|6|||
94350098|NCT01683058|323063353|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
94350099|NCT01683058|323063353|FG000|Overall Study|Withdrawal by Subject|7|||
94350100|NCT01683058|323063353|FG000|Overall Study|Lack of Efficacy|2|||
94350101|NCT01957111|323063354|FG000|Overall Study|Withdrawal by Subject|1|||
94350102|NCT01957111|323063355|FG001|Overall Study|Withdrawal by Subject|1|||
94350103|NCT00808132|323063365|FG000|Overall Study|Adverse Event|34|||
94350104|NCT00808132|323063366|FG001|Overall Study|Adverse Event|33|||
94350105|NCT00808132|323063367|FG002|Overall Study|Adverse Event|16|||
94350106|NCT00808132|323063368|FG003|Overall Study|Adverse Event|31|||
94350107|NCT00808132|323063369|FG004|Overall Study|Adverse Event|33|||
94350108|NCT00808132|323063365|FG000|Overall Study|Death|0|||
94350109|NCT00808132|323063366|FG001|Overall Study|Death|0|||
94350110|NCT00808132|323063367|FG002|Overall Study|Death|0|||
94239194|NCT00847626|322670570|FG002|Overall Study|Adverse Event|6|||
94239195|NCT00847626|322670571|FG003|Overall Study|Adverse Event|19|||
94239196|NCT00847626|322670572|FG004|Overall Study|Adverse Event|11|||
94239197|NCT00847626|322670573|FG005|Overall Study|Adverse Event|22|||
94239198|NCT00847626|322670574|FG006|Overall Study|Adverse Event|4|||
94239199|NCT00847626|322670575|FG007|Overall Study|Adverse Event|6|||
94239200|NCT00847626|322670576|FG008|Overall Study|Adverse Event|3|||
94239201|NCT00847626|322670577|FG009|Overall Study|Adverse Event|6|||
94239202|NCT00847626|322670578|FG010|Overall Study|Adverse Event|6|||
94239203|NCT00847626|322670568|FG000|Overall Study|Protocol Violation|2|||
94239204|NCT00847626|322670569|FG001|Overall Study|Protocol Violation|1|||
94239205|NCT00847626|322670570|FG002|Overall Study|Protocol Violation|2|||
94239206|NCT00847626|322670571|FG003|Overall Study|Protocol Violation|1|||
94239207|NCT00847626|322670572|FG004|Overall Study|Protocol Violation|1|||
94239208|NCT00847626|322670573|FG005|Overall Study|Protocol Violation|1|||
94239209|NCT00847626|322670574|FG006|Overall Study|Protocol Violation|1|||
94350111|NCT00808132|323063368|FG003|Overall Study|Death|0|||
94350112|NCT00808132|323063369|FG004|Overall Study|Death|1|||
94350113|NCT00808132|323063365|FG000|Overall Study|Physician Decision|0|||
94350114|NCT00808132|323063366|FG001|Overall Study|Physician Decision|1|||
94350115|NCT00808132|323063367|FG002|Overall Study|Physician Decision|0|||
94350116|NCT00808132|323063368|FG003|Overall Study|Physician Decision|0|||
94350117|NCT00808132|323063369|FG004|Overall Study|Physician Decision|0|||
94350118|NCT00808132|323063365|FG000|Overall Study|Lost to Follow-up|8|||
94350119|NCT00808132|323063366|FG001|Overall Study|Lost to Follow-up|10|||
94350120|NCT00808132|323063367|FG002|Overall Study|Lost to Follow-up|11|||
94350121|NCT00808132|323063368|FG003|Overall Study|Lost to Follow-up|8|||
94350122|NCT00808132|323063369|FG004|Overall Study|Lost to Follow-up|9|||
94350123|NCT00808132|323063365|FG000|Overall Study|Protocol Violation|8|||
94350124|NCT00808132|323063366|FG001|Overall Study|Protocol Violation|9|||
94350125|NCT00808132|323063367|FG002|Overall Study|Protocol Violation|4|||
94350126|NCT00808132|323063368|FG003|Overall Study|Protocol Violation|9|||
94350127|NCT00808132|323063369|FG004|Overall Study|Protocol Violation|5|||
94350128|NCT00808132|323063365|FG000|Overall Study|Withdrawal by Subject|27|||
94350129|NCT00808132|323063366|FG001|Overall Study|Withdrawal by Subject|18|||
94350130|NCT00808132|323063367|FG002|Overall Study|Withdrawal by Subject|2|||
94350131|NCT00808132|323063368|FG003|Overall Study|Withdrawal by Subject|7|||
94350132|NCT00808132|323063369|FG004|Overall Study|Withdrawal by Subject|16|||
94350133|NCT00808132|323063365|FG000|Overall Study|Other|6|||
94452977|NCT01167881|323445492|FG000|Overall Study|Lack of Efficacy|4|||
94239210|NCT00847626|322670575|FG007|Overall Study|Protocol Violation|1|||
94350134|NCT00808132|323063366|FG001|Overall Study|Other|4|||
94350135|NCT00808132|323063367|FG002|Overall Study|Other|6|||
94350136|NCT00808132|323063368|FG003|Overall Study|Other|2|||
94350137|NCT00808132|323063369|FG004|Overall Study|Other|15|||
94350138|NCT00808132|323063365|FG000|Overall Study|Randomized, but not treated|10|||
94350139|NCT00808132|323063366|FG001|Overall Study|Randomized, but not treated|7|||
94350140|NCT00808132|323063367|FG002|Overall Study|Randomized, but not treated|9|||
94239211|NCT00847626|322670576|FG008|Overall Study|Protocol Violation|0|||
94239212|NCT00847626|322670577|FG009|Overall Study|Protocol Violation|1|||
94350141|NCT00808132|323063368|FG003|Overall Study|Randomized, but not treated|8|||
94350142|NCT00808132|323063369|FG004|Overall Study|Randomized, but not treated|9|||
94350143|NCT00808132|323063365|FG000|Overall Study|Unsatisfactory response|5|||
94350144|NCT00808132|323063366|FG001|Overall Study|Unsatisfactory response|6|||
94350145|NCT00808132|323063367|FG002|Overall Study|Unsatisfactory response|6|||
94350146|NCT00808132|323063368|FG003|Overall Study|Unsatisfactory response|4|||
94575649|NCT03037385|323908449|FG007|Overall Study|Death|4|||
94575650|NCT03037385|323908450|FG008|Overall Study|Death|3|||
94575651|NCT03037385|323908451|FG009|Overall Study|Death|240|||
94452978|NCT01167881|323445493|FG001|Overall Study|Lack of Efficacy|7|||
94452979|NCT01167881|323445492|FG000|Overall Study|Non compliant with protocol|9|||
94452980|NCT01167881|323445493|FG001|Overall Study|Non compliant with protocol|18|||
94452981|NCT01167881|323445492|FG000|Overall Study|Lost to Follow-up|19|||
94452982|NCT01167881|323445493|FG001|Overall Study|Lost to Follow-up|20|||
94452983|NCT01167881|323445492|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
94452984|NCT01167881|323445493|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
94452985|NCT01167881|323445492|FG000|Overall Study|Not treated|4|||
94452986|NCT01167881|323445493|FG001|Overall Study|Not treated|0|||
94452987|NCT01167881|323445492|FG000|Overall Study|Other not defined above|31|||
94452988|NCT01167881|323445493|FG001|Overall Study|Other not defined above|55|||
94452989|NCT04152837|323445494|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
94452990|NCT04152837|323445494|FG000|Maintenance Period|Adverse Event|1|||
94452991|NCT04152837|323445494|FG000|Maintenance Period|Withdrawal by Subject|1|||
94452992|NCT04152837|323445494|FG000|Maintenance Period|Sponsor Termination of Study|2|||
94452993|NCT03483961|323447274|FG000|Overall Study|Lost to Follow-up|7|||
94452994|NCT03483961|323447275|FG001|Overall Study|Lost to Follow-up|6|||
94452995|NCT03483961|323447276|FG002|Overall Study|Lost to Follow-up|6|||
94239213|NCT00847626|322670578|FG010|Overall Study|Protocol Violation|1|||
94239214|NCT00847626|322670568|FG000|Overall Study|Lost to Follow-up|0|||
94239215|NCT00847626|322670569|FG001|Overall Study|Lost to Follow-up|1|||
94239216|NCT00847626|322670570|FG002|Overall Study|Lost to Follow-up|1|||
94239217|NCT00847626|322670571|FG003|Overall Study|Lost to Follow-up|1|||
94239218|NCT00847626|322670572|FG004|Overall Study|Lost to Follow-up|0|||
94239219|NCT00847626|322670573|FG005|Overall Study|Lost to Follow-up|3|||
94239220|NCT00847626|322670574|FG006|Overall Study|Lost to Follow-up|1|||
94239221|NCT00847626|322670575|FG007|Overall Study|Lost to Follow-up|3|||
94239222|NCT00847626|322670576|FG008|Overall Study|Lost to Follow-up|1|||
94239223|NCT00847626|322670577|FG009|Overall Study|Lost to Follow-up|0|||
94239224|NCT00847626|322670578|FG010|Overall Study|Lost to Follow-up|1|||
94239225|NCT00847626|322670568|FG000|Overall Study|Withdrawal by Subject|5|||
94452996|NCT03483961|323447277|FG003|Overall Study|Lost to Follow-up|6|||
94452997|NCT03483961|323447278|FG004|Overall Study|Lost to Follow-up|6|||
94452998|NCT03483961|323447279|FG005|Overall Study|Lost to Follow-up|4|||
94239226|NCT00847626|322670569|FG001|Overall Study|Withdrawal by Subject|5|||
94452999|NCT03483961|323447280|FG006|Overall Study|Lost to Follow-up|4|||
94453000|NCT03483961|323447281|FG007|Overall Study|Lost to Follow-up|11|||
94453001|NCT03483961|323447282|FG008|Overall Study|Lost to Follow-up|1|||
94453002|NCT03483961|323447283|FG009|Overall Study|Lost to Follow-up|0|||
94350147|NCT00808132|323063369|FG004|Overall Study|Unsatisfactory response|12|||
94350148|NCT01351415|323063370|FG000|Overall Study|Withdrawal by Subject|15|||
94350149|NCT01351415|323063371|FG001|Overall Study|Withdrawal by Subject|17|||
94350150|NCT01351415|323063370|FG000|Overall Study|Trial termination by the Sponsor|28|||
94350151|NCT01351415|323063371|FG001|Overall Study|Trial termination by the Sponsor|19|||
94350152|NCT01351415|323063370|FG000|Overall Study|Lost to Follow-up|5|||
94350153|NCT01351415|323063371|FG001|Overall Study|Lost to Follow-up|7|||
94350154|NCT01351415|323063370|FG000|Overall Study|Death|190|||
94350155|NCT01351415|323063371|FG001|Overall Study|Death|187|||
94350156|NCT01351415|323063370|FG000|Overall Study|Physician Decision|2|||
94350157|NCT01351415|323063371|FG001|Overall Study|Physician Decision|3|||
94350158|NCT01351415|323063370|FG000|Overall Study|Reason unknown|0|||
94350159|NCT01351415|323063371|FG001|Overall Study|Reason unknown|2|||
94350160|NCT01351415|323063370|FG000|Overall Study|Never Started|5|||
94350161|NCT01351415|323063371|FG001|Overall Study|Never Started|5|||
94350162|NCT02405091|323063372|FG000|Overall Study|Adverse Event|16|||
94350163|NCT02405091|323063373|FG001|Overall Study|Adverse Event|10|||
94350164|NCT02405091|323063374|FG002|Overall Study|Adverse Event|0|||
94350165|NCT02405091|323063372|FG000|Overall Study|Protocol Violation|1|||
94350166|NCT02405091|323063373|FG001|Overall Study|Protocol Violation|0|||
94350167|NCT02405091|323063374|FG002|Overall Study|Protocol Violation|0|||
94350168|NCT02405091|323063372|FG000|Overall Study|Noncompliance|1|||
94350169|NCT02405091|323063373|FG001|Overall Study|Noncompliance|6|||
94350170|NCT02405091|323063374|FG002|Overall Study|Noncompliance|2|||
94350171|NCT02405091|323063372|FG000|Overall Study|Withdrawal by Subject|4|||
94350172|NCT02405091|323063373|FG001|Overall Study|Withdrawal by Subject|8|||
94350173|NCT02405091|323063374|FG002|Overall Study|Withdrawal by Subject|0|||
94350174|NCT02405091|323063372|FG000|Overall Study|Death|0|||
94350175|NCT02405091|323063373|FG001|Overall Study|Death|1|||
94350176|NCT02405091|323063374|FG002|Overall Study|Death|0|||
94350177|NCT02405091|323063372|FG000|Overall Study|Lost to Follow-up|5|||
94350178|NCT02405091|323063373|FG001|Overall Study|Lost to Follow-up|6|||
94350179|NCT02405091|323063374|FG002|Overall Study|Lost to Follow-up|0|||
94350180|NCT02405091|323063372|FG000|Overall Study|Physician Decision|2|||
94350181|NCT02405091|323063373|FG001|Overall Study|Physician Decision|2|||
94350182|NCT02405091|323063374|FG002|Overall Study|Physician Decision|0|||
94350183|NCT01234337|323063375|FG000|Overall Study|Adverse Event|58|||
94350184|NCT01234337|323063376|FG001|Overall Study|Adverse Event|21|||
94350185|NCT01234337|323063375|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
94350186|NCT01234337|323063376|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
94350187|NCT01234337|323063375|FG000|Overall Study|Investi. decision not protocol driven|5|||
94350188|NCT01234337|323063376|FG001|Overall Study|Investi. decision not protocol driven|6|||
94350189|NCT01234337|323063375|FG000|Overall Study|Non-compliant with study medication|3|||
94350190|NCT01234337|323063376|FG001|Overall Study|Non-compliant with study medication|2|||
94350191|NCT01234337|323063375|FG000|Overall Study|Randomized but not treated|6|||
94350192|NCT01234337|323063376|FG001|Overall Study|Randomized but not treated|4|||
94350193|NCT01234337|323063375|FG000|Overall Study|Lost to Follow-up|0|||
94350194|NCT01234337|323063376|FG001|Overall Study|Lost to Follow-up|1|||
94239227|NCT00847626|322670570|FG002|Overall Study|Withdrawal by Subject|3|||
94239228|NCT00847626|322670571|FG003|Overall Study|Withdrawal by Subject|8|||
94239229|NCT00847626|322670572|FG004|Overall Study|Withdrawal by Subject|12|||
94239230|NCT00847626|322670573|FG005|Overall Study|Withdrawal by Subject|9|||
94239231|NCT00847626|322670574|FG006|Overall Study|Withdrawal by Subject|8|||
94239232|NCT00847626|322670575|FG007|Overall Study|Withdrawal by Subject|4|||
94239233|NCT00847626|322670576|FG008|Overall Study|Withdrawal by Subject|4|||
94239234|NCT00847626|322670577|FG009|Overall Study|Withdrawal by Subject|5|||
94239235|NCT00847626|322670578|FG010|Overall Study|Withdrawal by Subject|2|||
94239236|NCT00847626|322670568|FG000|Overall Study|Lack of Efficacy|3|||
94239237|NCT00847626|322670569|FG001|Overall Study|Lack of Efficacy|1|||
94239238|NCT00847626|322670570|FG002|Overall Study|Lack of Efficacy|0|||
94239239|NCT00847626|322670571|FG003|Overall Study|Lack of Efficacy|1|||
94239240|NCT00847626|322670572|FG004|Overall Study|Lack of Efficacy|2|||
94239241|NCT00847626|322670573|FG005|Overall Study|Lack of Efficacy|0|||
94350195|NCT01234337|323063375|FG000|Overall Study|Protocol Violation|2|||
94350196|NCT01234337|323063376|FG001|Overall Study|Protocol Violation|3|||
94350197|NCT01234337|323063375|FG000|Overall Study|Withdrawal by Subject|11|||
94350198|NCT01234337|323063376|FG001|Overall Study|Withdrawal by Subject|9|||
94350199|NCT01234337|323063375|FG000|Overall Study|Death|0|||
94350200|NCT01234337|323063376|FG001|Overall Study|Death|1|||
94350201|NCT01234337|323063375|FG000|Overall Study|Switch to commercial drug|0|||
94239242|NCT00847626|322670574|FG006|Overall Study|Lack of Efficacy|6|||
94350202|NCT01234337|323063376|FG001|Overall Study|Switch to commercial drug|1|||
94350203|NCT00247962|323063387|FG000|Overall Study|Adverse Event|15|||
94350204|NCT00247962|323063388|FG001|Overall Study|Adverse Event|12|||
94350205|NCT00247962|323063387|FG000|Overall Study|Lost to Follow-up|3|||
94350206|NCT00247962|323063388|FG001|Overall Study|Lost to Follow-up|1|||
94350207|NCT00247962|323063387|FG000|Overall Study|Physician Decision|0|||
94350208|NCT00247962|323063388|FG001|Overall Study|Physician Decision|1|||
94350209|NCT00247962|323063387|FG000|Overall Study|Protocol Violation|1|||
94350210|NCT00247962|323063388|FG001|Overall Study|Protocol Violation|1|||
94350211|NCT00247962|323063387|FG000|Overall Study|Withdrawal by Subject|3|||
94350212|NCT00247962|323063388|FG001|Overall Study|Withdrawal by Subject|2|||
94350213|NCT00247962|323063387|FG000|Overall Study|Lack of Efficacy|4|||
94350214|NCT00247962|323063388|FG001|Overall Study|Lack of Efficacy|2|||
94350215|NCT01849289|323063389|FG000|Overall Study|Adverse Event|3|||
94350216|NCT01849289|323063390|FG001|Overall Study|Adverse Event|3|||
94350217|NCT01849289|323063389|FG000|Overall Study|Protocol Violation|3|||
94350218|NCT01849289|323063390|FG001|Overall Study|Protocol Violation|3|||
94350219|NCT01849289|323063389|FG000|Overall Study|Withdrawal criteria|1|||
94350220|NCT01849289|323063390|FG001|Overall Study|Withdrawal criteria|0|||
94350221|NCT01849289|323063389|FG000|Overall Study|Unclassified|25|||
94350222|NCT01849289|323063390|FG001|Overall Study|Unclassified|18|||
94350223|NCT00702949|323063391|FG000|Overall Study|Refusal|3|||
94350224|NCT00702949|323063392|FG001|Overall Study|Refusal|2|||
94350225|NCT00702949|323063393|FG002|Overall Study|Refusal|2|||
94350226|NCT00702949|323063391|FG000|Overall Study|Adverse Event|1|||
94350227|NCT00702949|323063392|FG001|Overall Study|Adverse Event|6|||
94350228|NCT00702949|323063393|FG002|Overall Study|Adverse Event|3|||
94350229|NCT00702949|323063391|FG000|Overall Study|Other Medical Reason/unknown|1|||
94350230|NCT00702949|323063392|FG001|Overall Study|Other Medical Reason/unknown|1|||
94350231|NCT00702949|323063393|FG002|Overall Study|Other Medical Reason/unknown|3|||
94350232|NCT01469637|323063394|FG000|First Intervention|Unacceptable behavior|0|||
94350233|NCT01469637|323063395|FG001|First Intervention|Unacceptable behavior|1|||
94350234|NCT01469637|323063394|FG000|Second Intervention|Incarcerated|1|||
94350235|NCT01469637|323063395|FG001|Second Intervention|Incarcerated|0|||
94350236|NCT00962780|323063410|FG000|Overall Study|Death|0|||
94350237|NCT00962780|323063411|FG001|Overall Study|Death|1|||
94350238|NCT00962780|323063410|FG000|Overall Study|Protocol Violation|9|||
94350239|NCT00962780|323063411|FG001|Overall Study|Protocol Violation|4|||
94350240|NCT00962780|323063410|FG000|Overall Study|Withdrawal by Subject|1|||
94350241|NCT00962780|323063411|FG001|Overall Study|Withdrawal by Subject|8|||
94350242|NCT00962780|323063410|FG000|Overall Study|Other|0|||
94453003|NCT03483961|323447274|FG000|Overall Study|Withdrawal by Subject|3|||
94453004|NCT03483961|323447275|FG001|Overall Study|Withdrawal by Subject|4|||
94453005|NCT03483961|323447276|FG002|Overall Study|Withdrawal by Subject|5|||
94453006|NCT03483961|323447277|FG003|Overall Study|Withdrawal by Subject|3|||
94453007|NCT03483961|323447278|FG004|Overall Study|Withdrawal by Subject|4|||
94453008|NCT03483961|323447279|FG005|Overall Study|Withdrawal by Subject|2|||
94453009|NCT03483961|323447280|FG006|Overall Study|Withdrawal by Subject|1|||
94453010|NCT03483961|323447281|FG007|Overall Study|Withdrawal by Subject|2|||
94453011|NCT03483961|323447282|FG008|Overall Study|Withdrawal by Subject|1|||
94453012|NCT03483961|323447283|FG009|Overall Study|Withdrawal by Subject|0|||
94453013|NCT03483961|323447274|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
94350243|NCT00962780|323063411|FG001|Overall Study|Other|1|||
94350244|NCT01775995|323063414|FG000|Overall Study|Lost to Follow-up|1|||
94350245|NCT01775995|323063415|FG001|Overall Study|Lost to Follow-up|1|||
94350246|NCT02909504|323063416|FG000|Overall Study|Adverse Event|2|||
94350247|NCT02909504|323063416|FG000|Overall Study|Lack of Efficacy|3|||
94350248|NCT02909504|323063416|FG000|Overall Study|Withdrawal by Subject|4|||
94350249|NCT02909504|323063416|FG000|Overall Study|Pregnancy|1|||
94350250|NCT02909504|323063416|FG000|Overall Study|Subject moved|1|||
94350251|NCT02909504|323063416|FG000|Overall Study|Lost to Follow-up|1|||
94350252|NCT04411472|323063417|FG000|Overall Study|Adverse Event|5|||
94350253|NCT04411472|323063418|FG001|Overall Study|Adverse Event|10|||
94350254|NCT04411472|323063419|FG002|Overall Study|Adverse Event|1|||
94350255|NCT04411472|323063420|FG003|Overall Study|Adverse Event|0|||
94350256|NCT04411472|323063421|FG004|Overall Study|Adverse Event|0|||
94350257|NCT04411472|323063422|FG005|Overall Study|Adverse Event|0|||
94350258|NCT04411472|323063417|FG000|Overall Study|Protocol Violation|1|||
94350259|NCT04411472|323063418|FG001|Overall Study|Protocol Violation|0|||
94350260|NCT04411472|323063419|FG002|Overall Study|Protocol Violation|0|||
94350261|NCT04411472|323063420|FG003|Overall Study|Protocol Violation|0|||
94350262|NCT04411472|323063421|FG004|Overall Study|Protocol Violation|0|||
94350263|NCT04411472|323063422|FG005|Overall Study|Protocol Violation|0|||
94453014|NCT03483961|323447275|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
94350264|NCT04411472|323063417|FG000|Overall Study|Withdrawal by Subject|0|||
94350265|NCT04411472|323063418|FG001|Overall Study|Withdrawal by Subject|1|||
94350266|NCT04411472|323063419|FG002|Overall Study|Withdrawal by Subject|0|||
94350267|NCT04411472|323063420|FG003|Overall Study|Withdrawal by Subject|1|||
94350268|NCT04411472|323063421|FG004|Overall Study|Withdrawal by Subject|0|||
94350269|NCT04411472|323063422|FG005|Overall Study|Withdrawal by Subject|0|||
94350270|NCT04411472|323063417|FG000|Overall Study|Physician Decision|1|||
94350271|NCT04411472|323063418|FG001|Overall Study|Physician Decision|0|||
94350272|NCT04411472|323063419|FG002|Overall Study|Physician Decision|0|||
94350273|NCT04411472|323063420|FG003|Overall Study|Physician Decision|0|||
94239243|NCT00847626|322670575|FG007|Overall Study|Lack of Efficacy|2|||
94239244|NCT00847626|322670576|FG008|Overall Study|Lack of Efficacy|5|||
94239245|NCT00847626|322670577|FG009|Overall Study|Lack of Efficacy|1|||
94239246|NCT00847626|322670578|FG010|Overall Study|Lack of Efficacy|7|||
94239247|NCT00847626|322670568|FG000|Overall Study|Other|1|||
94239248|NCT00847626|322670569|FG001|Overall Study|Other|5|||
94239249|NCT00847626|322670570|FG002|Overall Study|Other|4|||
94239250|NCT00847626|322670571|FG003|Overall Study|Other|1|||
94239251|NCT00847626|322670572|FG004|Overall Study|Other|2|||
94239252|NCT00847626|322670573|FG005|Overall Study|Other|2|||
94239253|NCT00847626|322670574|FG006|Overall Study|Other|2|||
94239254|NCT00847626|322670575|FG007|Overall Study|Other|3|||
94239255|NCT00847626|322670576|FG008|Overall Study|Other|1|||
94350274|NCT04411472|323063421|FG004|Overall Study|Physician Decision|0|||
94350275|NCT04411472|323063422|FG005|Overall Study|Physician Decision|0|||
94239256|NCT00847626|322670577|FG009|Overall Study|Other|1|||
94239257|NCT00847626|322670578|FG010|Overall Study|Other|3|||
94239258|NCT03274453|322670579|FG000|Overall Study|Lost to Follow-up|2|||
94239259|NCT03274453|322670580|FG001|Overall Study|Lost to Follow-up|5|||
94239260|NCT03274453|322670581|FG002|Overall Study|Lost to Follow-up|4|||
94239261|NCT03274453|322670582|FG003|Overall Study|Lost to Follow-up|1|||
94239262|NCT03274453|322670579|FG000|Overall Study|Physician Decision|2|||
94239263|NCT03274453|322670580|FG001|Overall Study|Physician Decision|0|||
94239264|NCT03274453|322670581|FG002|Overall Study|Physician Decision|0|||
94239265|NCT03274453|322670582|FG003|Overall Study|Physician Decision|3|||
94239266|NCT03274453|322670579|FG000|Overall Study|Surgery Cancelled|0|||
94239267|NCT03274453|322670580|FG001|Overall Study|Surgery Cancelled|1|||
94239268|NCT03274453|322670581|FG002|Overall Study|Surgery Cancelled|0|||
94239269|NCT03274453|322670582|FG003|Overall Study|Surgery Cancelled|0|||
94239270|NCT02088957|322670583|FG000|Overall Study|Lack of Efficacy|1|||
94239271|NCT02088957|322670584|FG001|Overall Study|Lack of Efficacy|0|||
94239272|NCT01327612|322670585|FG000|Overall Study|Withdrawal by Subject|0|||
94239273|NCT01327612|322670586|FG001|Overall Study|Withdrawal by Subject|0|||
94239274|NCT01327612|322670587|FG002|Overall Study|Withdrawal by Subject|0|||
94239275|NCT01327612|322670588|FG003|Overall Study|Withdrawal by Subject|0|||
94239276|NCT01327612|322670589|FG004|Overall Study|Withdrawal by Subject|0|||
94239277|NCT01327612|322670590|FG005|Overall Study|Withdrawal by Subject|1|||
94239278|NCT01327612|322670591|FG006|Overall Study|Withdrawal by Subject|0|||
94239279|NCT01327612|322670585|FG000|Overall Study|Disease Progression|1|||
94239280|NCT01327612|322670586|FG001|Overall Study|Disease Progression|1|||
94239281|NCT01327612|322670587|FG002|Overall Study|Disease Progression|1|||
94239282|NCT01327612|322670588|FG003|Overall Study|Disease Progression|0|||
94239283|NCT01327612|322670589|FG004|Overall Study|Disease Progression|1|||
94239284|NCT01327612|322670590|FG005|Overall Study|Disease Progression|2|||
94239285|NCT01327612|322670591|FG006|Overall Study|Disease Progression|2|||
94239286|NCT01327612|322670585|FG000|Overall Study|Administrative Decision|0|||
94350276|NCT04411472|323063417|FG000|Overall Study|Study terminated by sponsor|17|||
94239287|NCT01327612|322670586|FG001|Overall Study|Administrative Decision|0|||
94239288|NCT01327612|322670587|FG002|Overall Study|Administrative Decision|0|||
94239289|NCT01327612|322670588|FG003|Overall Study|Administrative Decision|1|||
94239290|NCT01327612|322670589|FG004|Overall Study|Administrative Decision|0|||
94239291|NCT01327612|322670590|FG005|Overall Study|Administrative Decision|0|||
94239292|NCT01327612|322670591|FG006|Overall Study|Administrative Decision|0|||
94239293|NCT01327612|322670585|FG000|Overall Study|Death|0|||
94239294|NCT01327612|322670586|FG001|Overall Study|Death|0|||
94239295|NCT01327612|322670587|FG002|Overall Study|Death|0|||
94239296|NCT01327612|322670588|FG003|Overall Study|Death|0|||
94239297|NCT01327612|322670589|FG004|Overall Study|Death|1|||
94239298|NCT01327612|322670590|FG005|Overall Study|Death|0|||
94239299|NCT01327612|322670591|FG006|Overall Study|Death|0|||
94239300|NCT00678301|322670594|FG000|Overall Study|Non-compliance with study procedures|0|||
94239301|NCT00678301|322670595|FG001|Overall Study|Non-compliance with study procedures|1|||
94239302|NCT00678301|322670594|FG000|Overall Study|Adverse Event|1|||
94239303|NCT00678301|322670595|FG001|Overall Study|Adverse Event|0|||
94239304|NCT00678301|322670594|FG000|Overall Study|Withdrawal by Subject|4|||
94239305|NCT00678301|322670595|FG001|Overall Study|Withdrawal by Subject|0|||
94239306|NCT00678301|322670594|FG000|Overall Study|Lost to Follow-up|3|||
94239307|NCT00678301|322670595|FG001|Overall Study|Lost to Follow-up|1|||
94239308|NCT00504075|322670597|FG000|Overall Study|Adverse Event|1|||
94239309|NCT00504075|322670597|FG000|Overall Study|Lost to Follow-up|5|||
94239310|NCT00504075|322670597|FG000|Overall Study|Withdrawal by Subject|1|||
94239311|NCT00504075|322670597|FG000|Overall Study|Required other therapeutic intervention|1|||
94239312|NCT02127125|322670602|FG000|Overall Study|Lost to Follow-up|0|||
94239313|NCT02127125|322670603|FG001|Overall Study|Lost to Follow-up|0|||
94239314|NCT02127125|322670604|FG002|Overall Study|Lost to Follow-up|0|||
94239315|NCT02127125|322670605|FG003|Overall Study|Lost to Follow-up|0|||
94239316|NCT02127125|322670606|FG004|Overall Study|Lost to Follow-up|2|||
94239317|NCT02127125|322670607|FG005|Overall Study|Lost to Follow-up|1|||
94239318|NCT02127125|322670608|FG006|Overall Study|Lost to Follow-up|0|||
94239319|NCT02127125|322670609|FG007|Overall Study|Lost to Follow-up|0|||
94239320|NCT02127125|322670610|FG008|Overall Study|Lost to Follow-up|0|||
94239321|NCT02127125|322670602|FG000|Overall Study|Withdrawal by Subject|0|||
94239322|NCT02127125|322670603|FG001|Overall Study|Withdrawal by Subject|0|||
94239323|NCT02127125|322670604|FG002|Overall Study|Withdrawal by Subject|0|||
94239324|NCT02127125|322670605|FG003|Overall Study|Withdrawal by Subject|1|||
94239325|NCT02127125|322670606|FG004|Overall Study|Withdrawal by Subject|0|||
94239326|NCT02127125|322670607|FG005|Overall Study|Withdrawal by Subject|0|||
94239327|NCT02127125|322670608|FG006|Overall Study|Withdrawal by Subject|0|||
94239328|NCT02127125|322670609|FG007|Overall Study|Withdrawal by Subject|0|||
94239329|NCT02127125|322670610|FG008|Overall Study|Withdrawal by Subject|0|||
94239330|NCT02127125|322670602|FG000|Overall Study|Physician Decision|0|||
94239331|NCT02127125|322670603|FG001|Overall Study|Physician Decision|0|||
94239332|NCT02127125|322670604|FG002|Overall Study|Physician Decision|1|||
94239333|NCT02127125|322670605|FG003|Overall Study|Physician Decision|0|||
94239334|NCT02127125|322670606|FG004|Overall Study|Physician Decision|1|||
94239335|NCT02127125|322670607|FG005|Overall Study|Physician Decision|2|||
94239336|NCT02127125|322670608|FG006|Overall Study|Physician Decision|0|||
94239337|NCT02127125|322670609|FG007|Overall Study|Physician Decision|0|||
94239338|NCT02127125|322670610|FG008|Overall Study|Physician Decision|0|||
94239339|NCT03690427|322670616|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
94239340|NCT03690427|322670617|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
94239341|NCT03519204|322670618|FG000|Overall Study|Lost to Follow-up|3|||
94239342|NCT03519204|322670619|FG001|Overall Study|Lost to Follow-up|8|||
94239343|NCT03519204|322670618|FG000|Overall Study|Withdrawal by Subject|9|||
94239344|NCT03519204|322670619|FG001|Overall Study|Withdrawal by Subject|7|||
94239345|NCT03519204|322670618|FG000|Overall Study|Other Miscellaneous Reasons|1|||
94239346|NCT03519204|322670619|FG001|Overall Study|Other Miscellaneous Reasons|0|||
94239347|NCT02609672|322670620|FG000|Overall Study|Lost to Follow-up|3|||
94239348|NCT02609672|322670621|FG001|Overall Study|Lost to Follow-up|1|||
94239349|NCT01154140|322670622|FG000|Overall Study|Death|71|||
94239350|NCT01154140|322670623|FG001|Overall Study|Death|81|||
94239351|NCT01154140|322670622|FG000|Overall Study|Lost to Follow-up|4|||
94239352|NCT01154140|322670623|FG001|Overall Study|Lost to Follow-up|5|||
94239353|NCT01154140|322670622|FG000|Overall Study|Withdrawal by Subject|12|||
94239354|NCT01154140|322670623|FG001|Overall Study|Withdrawal by Subject|13|||
94239355|NCT01154140|322670622|FG000|Overall Study|Other|3|||
94239356|NCT01154140|322670623|FG001|Overall Study|Other|1|||
94239357|NCT01154140|322670622|FG000|Overall Study|Randomized but not treated|1|||
94239358|NCT01154140|322670623|FG001|Overall Study|Randomized but not treated|2|||
94239359|NCT00368875|322670624|FG000|Overall Study|Adverse Event|0|||
94239360|NCT00368875|322670625|FG001|Overall Study|Adverse Event|12|||
94239361|NCT00368875|322670624|FG000|Overall Study|Progressive disease|3|||
94239362|NCT00368875|322670625|FG001|Overall Study|Progressive disease|27|||
94239363|NCT00368875|322670624|FG000|Overall Study|Withdrawal by Subject|2|||
94239364|NCT00368875|322670625|FG001|Overall Study|Withdrawal by Subject|6|||
94239365|NCT00368875|322670624|FG000|Overall Study|Other Reason|0|||
94239366|NCT00368875|322670625|FG001|Overall Study|Other Reason|2|||
94239367|NCT00368875|322670624|FG000|Overall Study|Alternative Therapy|1|||
94239368|NCT00368875|322670625|FG001|Overall Study|Alternative Therapy|1|||
94350277|NCT04411472|323063418|FG001|Overall Study|Study terminated by sponsor|20|||
94350278|NCT04411472|323063419|FG002|Overall Study|Study terminated by sponsor|3|||
94350279|NCT04411472|323063420|FG003|Overall Study|Study terminated by sponsor|0|||
94350280|NCT04411472|323063421|FG004|Overall Study|Study terminated by sponsor|0|||
94350281|NCT04411472|323063422|FG005|Overall Study|Study terminated by sponsor|0|||
94350282|NCT05060003|323063423|FG000|Overall Study|ctDNA negative|7|||
94350283|NCT01747655|323063424|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
94350284|NCT01747655|323063425|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
94350285|NCT01747655|323063424|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
94350286|NCT01747655|323063425|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
94350287|NCT01747655|323063424|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
94350288|NCT01747655|323063425|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
94350289|NCT03524664|323063428|FG000|Overall Study|Withdrawal by Subject|1|||
94350290|NCT03524664|323063429|FG001|Overall Study|Withdrawal by Subject|2|||
94350291|NCT03524664|323063428|FG000|Overall Study|Lost to Follow-up|4|||
94350292|NCT03524664|323063429|FG001|Overall Study|Lost to Follow-up|13|||
94350293|NCT00982111|323063430|FG000|Overall Study|Adverse Event|1|||
94350294|NCT00982111|323063431|FG001|Overall Study|Adverse Event|1|||
94350295|NCT00982111|323063430|FG000|Overall Study|Progressive Disease|46|||
94350296|NCT00982111|323063431|FG001|Overall Study|Progressive Disease|39|||
94350297|NCT00982111|323063430|FG000|Overall Study|Lost to Follow-up|9|||
94350298|NCT00982111|323063431|FG001|Overall Study|Lost to Follow-up|6|||
94350299|NCT00982111|323063430|FG000|Overall Study|New Anti-Cancer Therapy|5|||
94350300|NCT00982111|323063431|FG001|Overall Study|New Anti-Cancer Therapy|5|||
94350301|NCT00982111|323063430|FG000|Overall Study|Medical Decision|1|||
94350302|NCT00982111|323063431|FG001|Overall Study|Medical Decision|0|||
94350303|NCT00982111|323063430|FG000|Overall Study|Withdrawal by Subject|17|||
94350304|NCT00982111|323063431|FG001|Overall Study|Withdrawal by Subject|19|||
94350305|NCT00982111|323063430|FG000|Overall Study|Global Study End|0|||
94350306|NCT00982111|323063431|FG001|Overall Study|Global Study End|1|||
94350307|NCT00982111|323063430|FG000|Overall Study|Sponsor's Decision|0|||
94350308|NCT00982111|323063431|FG001|Overall Study|Sponsor's Decision|1|||
94350309|NCT03769753|323063432|FG000|Overall Study|Not Treated|6|||
94350310|NCT03769753|323063432|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
94350311|NCT02694562|323063433|FG000|Overall Study|Death|8|||
94239369|NCT01818531|322670626|FG000|Overall Study|Withdrawn for case delay after block|1|||
94239370|NCT01818531|322670627|FG001|Overall Study|Withdrawn for case delay after block|0|||
94239371|NCT01818531|322670626|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
94239372|NCT01818531|322670627|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
94239373|NCT01818531|322670626|FG000|Overall Study|Withdrawn for failure to place block|0|||
94350312|NCT02694562|323063433|FG000|Overall Study|Protocol Violation|4|||
94350313|NCT02694562|323063433|FG000|Overall Study|Lost to Follow-up|3|||
94350314|NCT02694562|323063433|FG000|Overall Study|Screen Failure|2|||
94350315|NCT02694562|323063433|FG000|Overall Study|Physician Decision|1|||
94239374|NCT01818531|322670627|FG001|Overall Study|Withdrawn for failure to place block|1|||
94239375|NCT03274895|322670628|FG000|Overall Study|Lack of Efficacy|1|||
94239376|NCT03274895|322670629|FG001|Overall Study|Lack of Efficacy|0|||
94239377|NCT03274895|322670628|FG000|Overall Study|Adverse Event|8|||
94239378|NCT03274895|322670629|FG001|Overall Study|Adverse Event|7|||
94239379|NCT03274895|322670628|FG000|Overall Study|Lost to Follow-up|1|||
94239380|NCT03274895|322670629|FG001|Overall Study|Lost to Follow-up|0|||
94239381|NCT03274895|322670628|FG000|Overall Study|Diagnosis not confirmed|3|||
94239382|NCT03274895|322670629|FG001|Overall Study|Diagnosis not confirmed|4|||
94239383|NCT00477490|322670630|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
94239384|NCT00477490|322670631|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
94239385|NCT00477490|322670632|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
94239386|NCT00477490|322670633|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
94239387|NCT00477490|322670634|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
94239388|NCT00477490|322670635|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
94350316|NCT00423267|323063434|FG000|Period A|Withdrawal by Subject|0|||
94350317|NCT00423267|323063435|FG001|Period A|Withdrawal by Subject|1|||
94350318|NCT00423267|323063434|FG000|Period A|Non-compliance with protocol|1|||
94350319|NCT00423267|323063435|FG001|Period A|Non-compliance with protocol|0|||
94350320|NCT00423267|323063434|FG000|Period A|Administrative|1|||
94350321|NCT00423267|323063435|FG001|Period A|Administrative|0|||
94239389|NCT00477490|322670636|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
94350322|NCT03702166|323063436|FG000|Overall Study|Lost to Follow-up|1|||
94350323|NCT03702166|323063436|FG000|Overall Study|Withdrawal by Subject|1|||
94350324|NCT00684073|323063437|FG000|Selection|Selection/non-selection criteria|3|||
94350325|NCT00684073|323063437|FG000|Selection|Death|1|||
94350326|NCT00684073|323063437|FG000|Selection|noncompliance|1|||
94350327|NCT00684073|323063437|FG000|Selection|Lost to Follow-up|1|||
94350328|NCT00684073|323063437|FG000|Selection|request of the sponsor|1|||
94350329|NCT00684073|323063437|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
94575652|NCT03037385|323908442|FG000|Overall Study|Initiation of Another Therapy|1|||
94575653|NCT03037385|323908443|FG001|Overall Study|Initiation of Another Therapy|0|||
94350330|NCT01657903|323063438|FG000|Overall Study|Lost to Follow-up|1|||
94350331|NCT01657903|323063438|FG000|Overall Study|Withdrawal by Subject|1|||
94350332|NCT01259388|323063439|FG000|Overall Study|Adverse Event|3|||
94350333|NCT01259388|323063440|FG001|Overall Study|Adverse Event|0|||
94350334|NCT01259388|323063439|FG000|Overall Study|Withdrawal by Subject|1|||
94350335|NCT01259388|323063440|FG001|Overall Study|Withdrawal by Subject|1|||
94350336|NCT01259388|323063439|FG000|Overall Study|Physician Decision|1|||
94350337|NCT01259388|323063440|FG001|Overall Study|Physician Decision|0|||
94350338|NCT03512028|323063441|FG000|Overall Study|Withdrawal by Subject|2|||
94350339|NCT03512028|323063442|FG001|Overall Study|Withdrawal by Subject|0|||
94350340|NCT03512028|323063441|FG000|Overall Study|Protocol Violation|2|||
94350341|NCT03512028|323063442|FG001|Overall Study|Protocol Violation|0|||
94350342|NCT01385098|323063443|FG000|Overall Study|Adverse Event|10|||
94350343|NCT01385098|323063443|FG000|Overall Study|Lost to Follow-up|4|||
94350344|NCT02743494|323063444|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
94350345|NCT02743494|323063445|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
94350346|NCT02743494|323063444|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
94350347|NCT02743494|323063445|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
94350348|NCT02743494|323063444|FG000|Treatment Period|Completed treatment|229|||
94350349|NCT02743494|323063445|FG001|Treatment Period|Completed treatment|99|||
94350350|NCT02743494|323063444|FG000|Treatment Period|Disease recurrence|149|||
94350351|NCT02743494|323063445|FG001|Treatment Period|Disease recurrence|113|||
94350352|NCT02743494|323063444|FG000|Treatment Period|Study drug toxicity|57|||
94350353|NCT02743494|323063445|FG001|Treatment Period|Study drug toxicity|8|||
94350354|NCT02743494|323063444|FG000|Treatment Period|Death|1|||
94350355|NCT02743494|323063445|FG001|Treatment Period|Death|0|||
94350356|NCT02743494|323063444|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
94350357|NCT02743494|323063445|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
94350358|NCT02743494|323063444|FG000|Treatment Period|Participant request to discontinue treatment|30|||
94350359|NCT02743494|323063445|FG001|Treatment Period|Participant request to discontinue treatment|5|||
94350360|NCT02743494|323063444|FG000|Treatment Period|Participant withdrew consent|12|||
94350361|NCT02743494|323063445|FG001|Treatment Period|Participant withdrew consent|4|||
94350362|NCT02743494|323063444|FG000|Treatment Period|Lost to Follow-up|0|||
94350363|NCT02743494|323063445|FG001|Treatment Period|Lost to Follow-up|1|||
94350364|NCT02743494|323063444|FG000|Treatment Period|Poor/Non-compliance|1|||
94350365|NCT02743494|323063445|FG001|Treatment Period|Poor/Non-compliance|0|||
94350366|NCT02743494|323063444|FG000|Treatment Period|Other reasons|7|||
94350367|NCT02743494|323063445|FG001|Treatment Period|Other reasons|2|||
94350368|NCT03529162|323063448|FG000|Overall Study|Lost to Follow-up|2|||
94350369|NCT03529162|323063449|FG001|Overall Study|Lost to Follow-up|2|||
94350370|NCT00591786|323063453|FG000|Overall Study|Withdrawal of Informed Consent|0|||
94350371|NCT00591786|323063454|FG001|Overall Study|Withdrawal of Informed Consent|0|||
94350372|NCT00591786|323063455|FG002|Overall Study|Withdrawal of Informed Consent|1|||
94350373|NCT00591786|323063456|FG003|Overall Study|Withdrawal of Informed Consent|0|||
94350374|NCT00591786|323063457|FG004|Overall Study|Withdrawal of Informed Consent|0|||
94350375|NCT00591786|323063458|FG005|Overall Study|Withdrawal of Informed Consent|0|||
94350376|NCT00591786|323063459|FG006|Overall Study|Withdrawal of Informed Consent|0|||
94350377|NCT00591786|323063460|FG007|Overall Study|Withdrawal of Informed Consent|0|||
94350378|NCT00591786|323063461|FG008|Overall Study|Withdrawal of Informed Consent|0|||
94350379|NCT00591786|323063462|FG009|Overall Study|Withdrawal of Informed Consent|0|||
94350380|NCT01906489|323063463|FG000|Overall Study|Adverse Event|10|||
94350381|NCT01906489|323063464|FG001|Overall Study|Adverse Event|3|||
94350382|NCT01906489|323063463|FG000|Overall Study|Worsening of CKD|6|||
94350383|NCT01906489|323063464|FG001|Overall Study|Worsening of CKD|4|||
94350384|NCT01906489|323063463|FG000|Overall Study|Withdrawal by Subject|5|||
94350385|NCT01906489|323063464|FG001|Overall Study|Withdrawal by Subject|0|||
94350386|NCT01906489|323063463|FG000|Overall Study|Worsening of Anemia|1|||
94350387|NCT01906489|323063464|FG001|Overall Study|Worsening of Anemia|0|||
94350388|NCT01906489|323063463|FG000|Overall Study|Protocol Violation|0|||
94350389|NCT01906489|323063464|FG001|Overall Study|Protocol Violation|1|||
94350390|NCT01906489|323063463|FG000|Overall Study|Non- Compliance|1|||
94350391|NCT01906489|323063464|FG001|Overall Study|Non- Compliance|0|||
94350392|NCT01906489|323063463|FG000|Overall Study|Sponsor Decision|1|||
94350393|NCT01906489|323063464|FG001|Overall Study|Sponsor Decision|0|||
94350394|NCT01906489|323063463|FG000|Overall Study|Lost to Follow-up|1|||
94350395|NCT01906489|323063464|FG001|Overall Study|Lost to Follow-up|1|||
94350396|NCT01906489|323063463|FG000|Overall Study|Other|1|||
94350397|NCT01906489|323063464|FG001|Overall Study|Other|0|||
94350398|NCT00877929|323063465|FG000|Overall Study|Adverse Event|11|||
94350399|NCT00877929|323063466|FG001|Overall Study|Adverse Event|20|||
94350400|NCT00877929|323063465|FG000|Overall Study|Protocol Violation|3|||
94350401|NCT00877929|323063466|FG001|Overall Study|Protocol Violation|3|||
94350402|NCT00877929|323063465|FG000|Overall Study|Lost to Follow-up|0|||
94350403|NCT00877929|323063466|FG001|Overall Study|Lost to Follow-up|1|||
94350404|NCT00877929|323063465|FG000|Overall Study|Withdrawal by Subject|4|||
94350405|NCT00877929|323063466|FG001|Overall Study|Withdrawal by Subject|4|||
94350406|NCT00877929|323063465|FG000|Overall Study|Lack of Efficacy|0|||
94350407|NCT00877929|323063466|FG001|Overall Study|Lack of Efficacy|1|||
94350408|NCT00877929|323063465|FG000|Overall Study|Other reason (not specified)|2|||
94350409|NCT00877929|323063466|FG001|Overall Study|Other reason (not specified)|6|||
94350410|NCT00689728|323063467|FG000|Double-Blind Treatment|Adverse Event|1|||
94350411|NCT00689728|323063468|FG001|Double-Blind Treatment|Adverse Event|0|||
94350412|NCT00689728|323063469|FG002|Double-Blind Treatment|Adverse Event|0|||
94350413|NCT00689728|323063467|FG000|Double-Blind Treatment|Protocol Violation|0|||
94350414|NCT00689728|323063468|FG001|Double-Blind Treatment|Protocol Violation|0|||
94350415|NCT00689728|323063469|FG002|Double-Blind Treatment|Protocol Violation|1|||
94350416|NCT00689728|323063467|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
94350417|NCT00689728|323063468|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
94350418|NCT00689728|323063469|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
94350419|NCT00689728|323063467|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
94350420|NCT00689728|323063468|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
94350421|NCT00689728|323063469|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
94350422|NCT00689728|323063467|FG000|Rescue|Adverse Event|0|||
94350423|NCT00689728|323063468|FG001|Rescue|Adverse Event|1|||
94350424|NCT00689728|323063469|FG002|Rescue|Adverse Event|0|||
94350425|NCT00689728|323063467|FG000|Rescue|Withdrawal by Subject|1|||
94453015|NCT03483961|323447276|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
94453016|NCT03483961|323447277|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
94453017|NCT03483961|323447278|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
94453018|NCT03483961|323447279|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
94453019|NCT03483961|323447280|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
94453020|NCT03483961|323447281|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
94453021|NCT03483961|323447282|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
94350426|NCT00689728|323063468|FG001|Rescue|Withdrawal by Subject|1|||
94350427|NCT00689728|323063469|FG002|Rescue|Withdrawal by Subject|1|||
94350428|NCT00689728|323063467|FG000|Optional Follow-Up|Adverse Event|1|||
94350429|NCT00689728|323063468|FG001|Optional Follow-Up|Adverse Event|0|||
94350430|NCT00689728|323063469|FG002|Optional Follow-Up|Adverse Event|0|||
94350431|NCT00689728|323063467|FG000|Optional Follow-Up|Lack of Efficacy|0|||
94350432|NCT00689728|323063468|FG001|Optional Follow-Up|Lack of Efficacy|1|||
94350433|NCT00689728|323063469|FG002|Optional Follow-Up|Lack of Efficacy|1|||
94350434|NCT00689728|323063467|FG000|Optional Follow-Up|Lost to Follow-up|0|||
94350435|NCT00689728|323063468|FG001|Optional Follow-Up|Lost to Follow-up|1|||
94350436|NCT00689728|323063469|FG002|Optional Follow-Up|Lost to Follow-up|1|||
94350437|NCT00689728|323063467|FG000|Optional Follow-Up|Protocol Violation|0|||
94350438|NCT00689728|323063468|FG001|Optional Follow-Up|Protocol Violation|0|||
94350439|NCT00689728|323063469|FG002|Optional Follow-Up|Protocol Violation|1|||
94350440|NCT00689728|323063467|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
94453022|NCT03483961|323447283|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
94453023|NCT03483961|323447274|FG000|Overall Study|Adverse Event|0|||
94453024|NCT03483961|323447275|FG001|Overall Study|Adverse Event|0|||
94453025|NCT03483961|323447276|FG002|Overall Study|Adverse Event|1|||
94453026|NCT03483961|323447277|FG003|Overall Study|Adverse Event|0|||
94453027|NCT03483961|323447278|FG004|Overall Study|Adverse Event|0|||
94453028|NCT03483961|323447279|FG005|Overall Study|Adverse Event|0|||
94453029|NCT03483961|323447280|FG006|Overall Study|Adverse Event|0|||
94350441|NCT00689728|323063468|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
94350442|NCT00689728|323063469|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
94350443|NCT00784836|323063470|FG000|Overall Study|Early Study Termination|3|||
94350444|NCT04557189|323063472|FG000|Overall Study|Adverse Event|0|||
94350445|NCT04557189|323063473|FG001|Overall Study|Adverse Event|1|||
94350446|NCT04557189|323063472|FG000|Overall Study|Lost to Follow-up|1|||
94350447|NCT04557189|323063473|FG001|Overall Study|Lost to Follow-up|1|||
94350448|NCT04557189|323063472|FG000|Overall Study|Withdrawal by Subject|2|||
94350449|NCT04557189|323063473|FG001|Overall Study|Withdrawal by Subject|1|||
94350450|NCT04557189|323063472|FG000|Overall Study|Reason not Specified|3|||
94350451|NCT04557189|323063473|FG001|Overall Study|Reason not Specified|6|||
94350452|NCT00660829|323063474|FG000|Overall Study|Adverse Event|3|||
94350453|NCT00660829|323063475|FG001|Overall Study|Adverse Event|4|||
94350454|NCT00660829|323063474|FG000|Overall Study|Lack of Efficacy|2|||
94350455|NCT00660829|323063475|FG001|Overall Study|Lack of Efficacy|3|||
94350456|NCT00660829|323063474|FG000|Overall Study|Non-Compliance|0|||
94350457|NCT00660829|323063475|FG001|Overall Study|Non-Compliance|4|||
94350458|NCT00660829|323063474|FG000|Overall Study|Withdrawal by Subject|1|||
94350459|NCT00660829|323063475|FG001|Overall Study|Withdrawal by Subject|2|||
94350460|NCT00660829|323063474|FG000|Overall Study|Lost to Follow-up|3|||
94350461|NCT00660829|323063475|FG001|Overall Study|Lost to Follow-up|2|||
94350462|NCT00660829|323063474|FG000|Overall Study|Other|9|||
94350463|NCT00660829|323063475|FG001|Overall Study|Other|4|||
94350464|NCT00517634|323063476|FG000|Second Treatment Period|Withdrawal by Subject|0|||
94350465|NCT00517634|323063477|FG001|Second Treatment Period|Withdrawal by Subject|0|||
94350466|NCT00517634|323063478|FG002|Second Treatment Period|Withdrawal by Subject|0|||
94350467|NCT00517634|323063479|FG003|Second Treatment Period|Withdrawal by Subject|0|||
94350468|NCT00517634|323063480|FG004|Second Treatment Period|Withdrawal by Subject|1|||
94350469|NCT00517634|323063481|FG005|Second Treatment Period|Withdrawal by Subject|0|||
94350470|NCT03091920|323063483|FG000|Overall Study|Adverse Event|0|||
94350471|NCT03091920|323063484|FG001|Overall Study|Adverse Event|1|||
94350472|NCT03091920|323063485|FG002|Overall Study|Adverse Event|0|||
94350473|NCT03143855|323063486|FG000|Overall Study|Withdrawal by Subject|4|||
94350474|NCT03143855|323063487|FG001|Overall Study|Withdrawal by Subject|3|||
94350475|NCT03143855|323063486|FG000|Overall Study|Protocol Violation|1|||
94350476|NCT03143855|323063487|FG001|Overall Study|Protocol Violation|0|||
94350477|NCT03143855|323063486|FG000|Overall Study|Participant experienced withdrawal|0|||
94350478|NCT03143855|323063487|FG001|Overall Study|Participant experienced withdrawal|1|||
94350479|NCT01681004|323063492|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
94350480|NCT01681004|323063493|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
94350481|NCT01681004|323063492|FG000|Study Completion|Lost to Follow-up|8|||
94350482|NCT01681004|323063493|FG001|Study Completion|Lost to Follow-up|3|||
94350483|NCT01681004|323063492|FG000|Study Completion|Physician Decision|1|||
94350484|NCT01681004|323063493|FG001|Study Completion|Physician Decision|3|||
94350485|NCT01681004|323063492|FG000|Study Completion|Site Termination|2|||
94350486|NCT01681004|323063493|FG001|Study Completion|Site Termination|1|||
94350487|NCT01681004|323063492|FG000|Study Completion|Death|1|||
94350488|NCT01681004|323063493|FG001|Study Completion|Death|1|||
94350489|NCT00424463|323063494|FG000|Overall Study|Adverse Event|2|||
94350490|NCT00424463|323063495|FG001|Overall Study|Adverse Event|3|||
94350491|NCT00424463|323063496|FG002|Overall Study|Adverse Event|2|||
94350492|NCT00424463|323063494|FG000|Overall Study|Physician Decision|0|||
94453030|NCT03483961|323447281|FG007|Overall Study|Adverse Event|0|||
94453031|NCT03483961|323447282|FG008|Overall Study|Adverse Event|0|||
94453032|NCT03483961|323447283|FG009|Overall Study|Adverse Event|0|||
94575654|NCT03037385|323908444|FG002|Overall Study|Initiation of Another Therapy|0|||
94350493|NCT00424463|323063495|FG001|Overall Study|Physician Decision|2|||
94350494|NCT00424463|323063496|FG002|Overall Study|Physician Decision|2|||
94350495|NCT00424463|323063494|FG000|Overall Study|Withdrawal by Subject|4|||
94350496|NCT00424463|323063495|FG001|Overall Study|Withdrawal by Subject|2|||
94350497|NCT00424463|323063496|FG002|Overall Study|Withdrawal by Subject|5|||
94350498|NCT00424463|323063494|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
94350499|NCT00424463|323063495|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
94350500|NCT00424463|323063496|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
94453033|NCT03192306|323447285|FG000|Overall Study|Did not treat cold sore during study|149|||
94453034|NCT03192306|323447286|FG001|Overall Study|Did not treat cold sore during study|143|||
94350501|NCT00424463|323063494|FG000|Overall Study|Patient's convenience|0|||
94350502|NCT00424463|323063495|FG001|Overall Study|Patient's convenience|0|||
94350503|NCT00424463|323063496|FG002|Overall Study|Patient's convenience|1|||
94350504|NCT00508820|323063505|FG000|Overall Study|Adverse Event|6|||
94350505|NCT00508820|323063506|FG001|Overall Study|Adverse Event|10|||
94350506|NCT00508820|323063505|FG000|Overall Study|Death|6|||
94350507|NCT00508820|323063506|FG001|Overall Study|Death|8|||
94350508|NCT00508820|323063505|FG000|Overall Study|Lost to Follow-up|1|||
94350509|NCT00508820|323063506|FG001|Overall Study|Lost to Follow-up|1|||
94350510|NCT00508820|323063505|FG000|Overall Study|Physician Decision|8|||
94350511|NCT00508820|323063506|FG001|Overall Study|Physician Decision|2|||
94350512|NCT00508820|323063505|FG000|Overall Study|Pregnancy|0|||
94350513|NCT00508820|323063506|FG001|Overall Study|Pregnancy|2|||
94350514|NCT00508820|323063505|FG000|Overall Study|Protocol Violation|2|||
94350515|NCT00508820|323063506|FG001|Overall Study|Protocol Violation|0|||
94350516|NCT00508820|323063505|FG000|Overall Study|Withdrawal by Subject|10|||
94350517|NCT00508820|323063506|FG001|Overall Study|Withdrawal by Subject|12|||
94350518|NCT00508820|323063505|FG000|Overall Study|Other|11|||
94350519|NCT00508820|323063506|FG001|Overall Study|Other|2|||
94350520|NCT00508820|323063505|FG000|Overall Study|Noncompliance|1|||
94350521|NCT00508820|323063506|FG001|Overall Study|Noncompliance|0|||
94350522|NCT00508820|323063505|FG000|Overall Study|Requirement for alternative therapy|7|||
94350523|NCT00508820|323063506|FG001|Overall Study|Requirement for alternative therapy|15|||
94350524|NCT00508820|323063505|FG000|Overall Study|Protocol-specified Criteria|3|||
94350525|NCT00508820|323063506|FG001|Overall Study|Protocol-specified Criteria|12|||
94350526|NCT02390167|323065388|FG000|Overall Study|Lost to Follow-up|1|||
94350527|NCT01084096|323065389|FG000|Overall Study|Lost to Follow-up|1501|||
94350528|NCT01084096|323065390|FG001|Overall Study|Lost to Follow-up|1833|||
94350529|NCT01084096|323065389|FG000|Overall Study|Withdrawal by Subject|3|||
94350530|NCT01084096|323065390|FG001|Overall Study|Withdrawal by Subject|0|||
94350531|NCT01084096|323065389|FG000|Overall Study|Woman had a miscarriage|21|||
94350532|NCT01084096|323065390|FG001|Overall Study|Woman had a miscarriage|17|||
94350533|NCT00027846|323065391|FG000|Overall Study|Lost to Follow-up|0|||
94350534|NCT00027846|323065392|FG001|Overall Study|Lost to Follow-up|41|||
94350535|NCT00027846|323065393|FG002|Overall Study|Lost to Follow-up|9|||
94350536|NCT00027846|323065391|FG000|Overall Study|Withdrawal by Subject|0|||
94350537|NCT00027846|323065392|FG001|Overall Study|Withdrawal by Subject|14|||
94350538|NCT00027846|323065393|FG002|Overall Study|Withdrawal by Subject|7|||
94350539|NCT00027846|323065391|FG000|Overall Study|Ineligible for study|2|||
94350540|NCT00027846|323065392|FG001|Overall Study|Ineligible for study|6|||
94350541|NCT00027846|323065393|FG002|Overall Study|Ineligible for study|14|||
94350542|NCT00027846|323065391|FG000|Overall Study|Entry into another COG therapeutic study|0|||
94350543|NCT00027846|323065392|FG001|Overall Study|Entry into another COG therapeutic study|5|||
94350544|NCT00027846|323065393|FG002|Overall Study|Entry into another COG therapeutic study|2|||
94350545|NCT00027846|323065391|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
94350546|NCT00027846|323065392|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
94575655|NCT03037385|323908445|FG003|Overall Study|Initiation of Another Therapy|0|||
94350547|NCT00027846|323065393|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
94350548|NCT02033369|323065394|FG000|Overall Study|Physician Decision|1|||
94350549|NCT02033369|323065395|FG001|Overall Study|Physician Decision|2|||
94350550|NCT02033369|323065394|FG000|Overall Study|Not a good demographic match|0|||
94350551|NCT02033369|323065395|FG001|Overall Study|Not a good demographic match|2|||
94350552|NCT02033369|323065394|FG000|Overall Study|Withdrawal by Subject|1|||
94575656|NCT03037385|323908446|FG004|Overall Study|Initiation of Another Therapy|0|||
94575657|NCT03037385|323908447|FG005|Overall Study|Initiation of Another Therapy|0|||
94575658|NCT03037385|323908448|FG006|Overall Study|Initiation of Another Therapy|0|||
94350553|NCT02033369|323065395|FG001|Overall Study|Withdrawal by Subject|1|||
94350554|NCT02033369|323065394|FG000|Overall Study|Lost to Follow-up|1|||
94350555|NCT02033369|323065395|FG001|Overall Study|Lost to Follow-up|0|||
94350556|NCT02033369|323065394|FG000|Overall Study|Protocol Violation|2|||
94350557|NCT02033369|323065395|FG001|Overall Study|Protocol Violation|0|||
94350558|NCT02194699|323065396|FG000|Randomised|Did not receive treatment|1|||
94350559|NCT02194699|323065397|FG001|Randomised|Did not receive treatment|5|||
94350560|NCT02194699|323065396|FG000|Randomised|Without potential for 52 weeks of IP|5|||
94350561|NCT02194699|323065397|FG001|Randomised|Without potential for 52 weeks of IP|5|||
94350562|NCT02194699|323065396|FG000|Randomised|Duplicate patient|2|||
94350563|NCT02194699|323065397|FG001|Randomised|Duplicate patient|1|||
94350564|NCT02194699|323065396|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
94350565|NCT02194699|323065397|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
94350566|NCT02194699|323065396|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
94350567|NCT02194699|323065397|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
94453035|NCT03192306|323447285|FG000|Overall Study|Withdrawal by Subject|1|||
94453036|NCT03192306|323447286|FG001|Overall Study|Withdrawal by Subject|1|||
94453037|NCT03192306|323447285|FG000|Overall Study|Lost to Follow-up|1|||
94453038|NCT03192306|323447286|FG001|Overall Study|Lost to Follow-up|0|||
94453039|NCT03192306|323447285|FG000|Overall Study|Protocol Violation|1|||
94350568|NCT02194699|323065396|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
94350569|NCT02194699|323065397|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
94350570|NCT02194699|323065396|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
94350571|NCT02194699|323065397|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
94350572|NCT02194699|323065396|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
94350573|NCT02194699|323065397|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
94350574|NCT02194699|323065396|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
94350575|NCT02194699|323065397|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
94350576|NCT00386152|323065398|FG000|Overall Study|Adverse Event|6|||
94350577|NCT00386152|323065399|FG001|Overall Study|Adverse Event|5|||
94350578|NCT00386152|323065400|FG002|Overall Study|Adverse Event|4|||
94350579|NCT00386152|323065398|FG000|Overall Study|Chang from original chemo stratification|4|||
94350580|NCT00386152|323065399|FG001|Overall Study|Chang from original chemo stratification|5|||
94350581|NCT00386152|323065400|FG002|Overall Study|Chang from original chemo stratification|6|||
94350582|NCT00386152|323065398|FG000|Overall Study|Death|3|||
94350583|NCT00386152|323065399|FG001|Overall Study|Death|0|||
94350584|NCT00386152|323065400|FG002|Overall Study|Death|1|||
94350585|NCT00386152|323065398|FG000|Overall Study|Disease progression|7|||
94453040|NCT03192306|323447286|FG001|Overall Study|Protocol Violation|1|||
94453041|NCT00441129|323447287|FG000|Overall Study|Withdrawal by Subject|6|||
94453042|NCT00441129|323447288|FG001|Overall Study|Withdrawal by Subject|14|||
94453043|NCT00379080|323447298|FG000|Overall Study|Withdrawal by Subject|0|||
94453044|NCT00379080|323447299|FG001|Overall Study|Withdrawal by Subject|4|||
94453045|NCT00379080|323447300|FG002|Overall Study|Withdrawal by Subject|0|||
94453046|NCT00857896|323447303|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
94453047|NCT04606394|323447306|FG000|Overall Study|Withdrawal by Subject|3|||
94350586|NCT00386152|323065399|FG001|Overall Study|Disease progression|4|||
94350587|NCT00386152|323065400|FG002|Overall Study|Disease progression|5|||
94350588|NCT00386152|323065398|FG000|Overall Study|Physician Decision|13|||
94350589|NCT00386152|323065399|FG001|Overall Study|Physician Decision|10|||
94350590|NCT00386152|323065400|FG002|Overall Study|Physician Decision|4|||
94350591|NCT00386152|323065398|FG000|Overall Study|Lost to Follow-up|1|||
94350592|NCT00386152|323065399|FG001|Overall Study|Lost to Follow-up|0|||
94350593|NCT00386152|323065400|FG002|Overall Study|Lost to Follow-up|0|||
94350594|NCT00386152|323065398|FG000|Overall Study|Completed chemotherapy|4|||
94350595|NCT00386152|323065399|FG001|Overall Study|Completed chemotherapy|5|||
94350596|NCT00386152|323065400|FG002|Overall Study|Completed chemotherapy|1|||
94350597|NCT00386152|323065398|FG000|Overall Study|Protocol Violation|3|||
94350598|NCT00386152|323065399|FG001|Overall Study|Protocol Violation|5|||
94350599|NCT00386152|323065400|FG002|Overall Study|Protocol Violation|2|||
94350600|NCT00386152|323065398|FG000|Overall Study|Withdrawal by Subject|3|||
94350601|NCT00386152|323065399|FG001|Overall Study|Withdrawal by Subject|6|||
94350602|NCT00386152|323065400|FG002|Overall Study|Withdrawal by Subject|10|||
94453048|NCT04606394|323447306|FG000|Overall Study|Exclusion criteria screen failure|12|||
94453049|NCT00955955|323447307|FG000|Overall Study|Lost to Follow-up|2|||
94453050|NCT00955955|323447308|FG001|Overall Study|Lost to Follow-up|0|||
94453051|NCT00955955|323447309|FG002|Overall Study|Lost to Follow-up|0|||
94453052|NCT03423173|323447312|FG000|Overall Study|Randomized but not vaccinated|1|||
94453053|NCT03423173|323447313|FG001|Overall Study|Randomized but not vaccinated|0|||
94575659|NCT03037385|323908449|FG007|Overall Study|Initiation of Another Therapy|1|||
94575660|NCT03037385|323908450|FG008|Overall Study|Initiation of Another Therapy|0|||
94575661|NCT03037385|323908451|FG009|Overall Study|Initiation of Another Therapy|2|||
94350603|NCT00577382|323065409|FG000|Overall Study|Adverse Event|0|||
94350604|NCT00577382|323065410|FG001|Overall Study|Adverse Event|6|||
94350605|NCT00577382|323065409|FG000|Overall Study|Withdrawal by Subject|0|||
94350606|NCT00577382|323065410|FG001|Overall Study|Withdrawal by Subject|1|||
94350607|NCT00577382|323065409|FG000|Overall Study|Progressive Disease|17|||
94350608|NCT00577382|323065410|FG001|Overall Study|Progressive Disease|19|||
94350609|NCT00577382|323065409|FG000|Overall Study|Intercurrent Illness|1|||
94350610|NCT00577382|323065410|FG001|Overall Study|Intercurrent Illness|2|||
94350611|NCT00577382|323065409|FG000|Overall Study|Death|1|||
94350612|NCT00577382|323065410|FG001|Overall Study|Death|1|||
94350613|NCT00577382|323065409|FG000|Overall Study|Lost to Follow-up|2|||
94350614|NCT00577382|323065410|FG001|Overall Study|Lost to Follow-up|2|||
94350615|NCT02839330|323065411|FG000|Overall Study|Adverse Event|0|||
94350616|NCT02839330|323065412|FG001|Overall Study|Adverse Event|1|||
94350617|NCT02839330|323065413|FG002|Overall Study|Adverse Event|2|||
94350618|NCT02839330|323065414|FG003|Overall Study|Adverse Event|2|||
94350619|NCT02839330|323065411|FG000|Overall Study|Death|4|||
94350620|NCT02839330|323065412|FG001|Overall Study|Death|6|||
94350621|NCT02839330|323065413|FG002|Overall Study|Death|1|||
94350622|NCT02839330|323065414|FG003|Overall Study|Death|1|||
94350623|NCT02839330|323065411|FG000|Overall Study|Withdrawal by Subject|27|||
94350624|NCT02839330|323065412|FG001|Overall Study|Withdrawal by Subject|19|||
94350625|NCT02839330|323065413|FG002|Overall Study|Withdrawal by Subject|11|||
94350626|NCT02839330|323065414|FG003|Overall Study|Withdrawal by Subject|13|||
94350627|NCT02839330|323065411|FG000|Overall Study|Lost to Follow-up|22|||
94350628|NCT02839330|323065412|FG001|Overall Study|Lost to Follow-up|27|||
94350629|NCT02839330|323065413|FG002|Overall Study|Lost to Follow-up|29|||
94350630|NCT02839330|323065414|FG003|Overall Study|Lost to Follow-up|25|||
94350631|NCT02839330|323065411|FG000|Overall Study|Administrative Reason|0|||
94350632|NCT02839330|323065412|FG001|Overall Study|Administrative Reason|0|||
94350633|NCT02839330|323065413|FG002|Overall Study|Administrative Reason|0|||
94350634|NCT02839330|323065414|FG003|Overall Study|Administrative Reason|1|||
94350635|NCT02839330|323065411|FG000|Overall Study|Protocol Violation|1|||
94350636|NCT02839330|323065412|FG001|Overall Study|Protocol Violation|2|||
94350637|NCT02839330|323065413|FG002|Overall Study|Protocol Violation|2|||
94350638|NCT02839330|323065414|FG003|Overall Study|Protocol Violation|3|||
94350639|NCT02839330|323065411|FG000|Overall Study|Other reason, not specified|4|||
94350640|NCT02839330|323065412|FG001|Overall Study|Other reason, not specified|3|||
94350641|NCT02839330|323065413|FG002|Overall Study|Other reason, not specified|3|||
94350642|NCT02839330|323065414|FG003|Overall Study|Other reason, not specified|6|||
94350643|NCT02127970|323065415|FG000|Overall Study|Adverse Event|2|||
94350644|NCT02127970|323065416|FG001|Overall Study|Adverse Event|1|||
94350645|NCT02127970|323065415|FG000|Overall Study|Death|1|||
94350646|NCT02127970|323065416|FG001|Overall Study|Death|1|||
94350647|NCT02127970|323065415|FG000|Overall Study|Lost to Follow-up|14|||
94350648|NCT02127970|323065416|FG001|Overall Study|Lost to Follow-up|14|||
94350649|NCT02127970|323065415|FG000|Overall Study|Reason not Specified|4|||
94350650|NCT02127970|323065416|FG001|Overall Study|Reason not Specified|7|||
94350651|NCT02127970|323065415|FG000|Overall Study|Pregnancy|0|||
94350652|NCT02127970|323065416|FG001|Overall Study|Pregnancy|1|||
94350653|NCT02127970|323065415|FG000|Overall Study|Subject Withdrew Consent|5|||
94350654|NCT02127970|323065416|FG001|Overall Study|Subject Withdrew Consent|3|||
94350655|NCT00718887|323065417|FG000|Overall Study|Withdrawal by Subject|3|||
94350656|NCT00718887|323065418|FG001|Overall Study|Withdrawal by Subject|2|||
94350657|NCT00718887|323065417|FG000|Overall Study|Not identified|2|||
94350658|NCT00718887|323065418|FG001|Overall Study|Not identified|7|||
94350659|NCT00775138|323065419|FG000|Overall Study|Withdrawal by Subject|0|||
94350660|NCT00775138|323065420|FG001|Overall Study|Withdrawal by Subject|0|||
94350661|NCT00775138|323065421|FG002|Overall Study|Withdrawal by Subject|2|||
94350662|NCT00775138|323065422|FG003|Overall Study|Withdrawal by Subject|2|||
94350663|NCT00775138|323065419|FG000|Overall Study|Adverse Event|0|||
94350664|NCT00775138|323065420|FG001|Overall Study|Adverse Event|0|||
94350665|NCT00775138|323065421|FG002|Overall Study|Adverse Event|1|||
94350666|NCT00775138|323065422|FG003|Overall Study|Adverse Event|0|||
94350667|NCT02452034|323065427|FG000|Overall Study|Adverse Event|0|||
94350668|NCT02452034|323065428|FG001|Overall Study|Adverse Event|0|||
94350669|NCT02452034|323065429|FG002|Overall Study|Adverse Event|0|||
94350670|NCT02452034|323065430|FG003|Overall Study|Adverse Event|0|||
94350671|NCT02452034|323065431|FG004|Overall Study|Adverse Event|0|||
94350672|NCT02452034|323065432|FG005|Overall Study|Adverse Event|1|||
94350673|NCT02452034|323065427|FG000|Overall Study|Death|0|||
94350674|NCT02452034|323065428|FG001|Overall Study|Death|0|||
94350675|NCT02452034|323065429|FG002|Overall Study|Death|0|||
94350676|NCT02452034|323065430|FG003|Overall Study|Death|0|||
94350677|NCT02452034|323065431|FG004|Overall Study|Death|1|||
94350678|NCT02452034|323065432|FG005|Overall Study|Death|1|||
94350679|NCT02452034|323065427|FG000|Overall Study|Physician Decision|0|||
94350680|NCT02452034|323065428|FG001|Overall Study|Physician Decision|1|||
94350681|NCT02452034|323065429|FG002|Overall Study|Physician Decision|1|||
94350682|NCT02452034|323065430|FG003|Overall Study|Physician Decision|0|||
94453054|NCT03423173|323447314|FG002|Overall Study|Randomized but not vaccinated|2|||
94350683|NCT02452034|323065431|FG004|Overall Study|Physician Decision|0|||
94350684|NCT02452034|323065432|FG005|Overall Study|Physician Decision|0|||
94350685|NCT02452034|323065427|FG000|Overall Study|Protocol Violation|0|||
94350686|NCT02452034|323065428|FG001|Overall Study|Protocol Violation|0|||
94350687|NCT02452034|323065429|FG002|Overall Study|Protocol Violation|0|||
94350688|NCT02452034|323065430|FG003|Overall Study|Protocol Violation|0|||
94350689|NCT02452034|323065431|FG004|Overall Study|Protocol Violation|0|||
94350690|NCT02452034|323065432|FG005|Overall Study|Protocol Violation|1|||
94350691|NCT02452034|323065427|FG000|Overall Study|Screen Failure|1|||
94350692|NCT02452034|323065428|FG001|Overall Study|Screen Failure|0|||
94350693|NCT02452034|323065429|FG002|Overall Study|Screen Failure|0|||
94350694|NCT02452034|323065430|FG003|Overall Study|Screen Failure|1|||
94350695|NCT02452034|323065431|FG004|Overall Study|Screen Failure|0|||
94350696|NCT02452034|323065432|FG005|Overall Study|Screen Failure|0|||
94350697|NCT02452034|323065427|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
94350698|NCT02452034|323065428|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
94350699|NCT02452034|323065429|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
94350700|NCT02452034|323065430|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
94350701|NCT02452034|323065431|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
94350702|NCT02452034|323065432|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
94350703|NCT03055806|323065433|FG000|Overall Study|Adverse Event|0|||
94350704|NCT03055806|323065434|FG001|Overall Study|Adverse Event|0|||
94350705|NCT03055806|323065435|FG002|Overall Study|Adverse Event|1|||
94350706|NCT03055806|323065436|FG003|Overall Study|Adverse Event|1|||
94350707|NCT03055806|323065433|FG000|Overall Study|Lost to Follow-up|0|||
94350708|NCT03055806|323065434|FG001|Overall Study|Lost to Follow-up|3|||
94350709|NCT03055806|323065435|FG002|Overall Study|Lost to Follow-up|6|||
94350710|NCT03055806|323065436|FG003|Overall Study|Lost to Follow-up|7|||
94350711|NCT03055806|323065433|FG000|Overall Study|Physician Decision|1|||
94350712|NCT03055806|323065434|FG001|Overall Study|Physician Decision|0|||
94350713|NCT03055806|323065435|FG002|Overall Study|Physician Decision|0|||
94350714|NCT03055806|323065436|FG003|Overall Study|Physician Decision|1|||
94350715|NCT03055806|323065433|FG000|Overall Study|Protocol Violation|1|||
94350716|NCT03055806|323065434|FG001|Overall Study|Protocol Violation|0|||
94350717|NCT03055806|323065435|FG002|Overall Study|Protocol Violation|0|||
94350718|NCT03055806|323065436|FG003|Overall Study|Protocol Violation|0|||
94350719|NCT03055806|323065433|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
94350720|NCT03055806|323065434|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
94350721|NCT03055806|323065435|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
94350722|NCT03055806|323065436|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
94350723|NCT03055806|323065433|FG000|Overall Study|Withdrawal of consent to continue study|2|||
94350724|NCT03055806|323065434|FG001|Overall Study|Withdrawal of consent to continue study|3|||
94350725|NCT03055806|323065435|FG002|Overall Study|Withdrawal of consent to continue study|4|||
94350726|NCT03055806|323065436|FG003|Overall Study|Withdrawal of consent to continue study|6|||
94350727|NCT03055806|323065433|FG000|Overall Study|Partner not willing to try intercourse|1|||
94350728|NCT03055806|323065434|FG001|Overall Study|Partner not willing to try intercourse|0|||
94453055|NCT03423173|323447315|FG003|Overall Study|Randomized but not vaccinated|1|||
94239390|NCT00477490|322670637|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
94239391|NCT00477490|322670638|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
94239392|NCT00477490|322670630|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
94239393|NCT00477490|322670631|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
94239394|NCT00477490|322670632|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
94239395|NCT00477490|322670633|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
94239396|NCT00477490|322670634|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
94239397|NCT00477490|322670635|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
94239398|NCT00477490|322670636|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
94239399|NCT00477490|322670637|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
94239400|NCT00477490|322670638|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
94239401|NCT00477490|322670630|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
94239402|NCT00477490|322670631|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
94239403|NCT00477490|322670632|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
94239404|NCT00477490|322670633|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
94239405|NCT00477490|322670634|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
94239406|NCT00477490|322670635|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
94239407|NCT00477490|322670636|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
94239408|NCT00477490|322670637|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
94239409|NCT00477490|322670638|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
94239410|NCT00477490|322670630|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
94239411|NCT00477490|322670631|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
94350729|NCT03055806|323065435|FG002|Overall Study|Partner not willing to try intercourse|0|||
94350730|NCT03055806|323065436|FG003|Overall Study|Partner not willing to try intercourse|0|||
94350731|NCT04601194|323065437|FG000|Overall Study|Lost to Follow-up|7|||
94350732|NCT00125138|323065438|FG000|Overall Study|Adverse Event|1|||
94350733|NCT00125138|323065439|FG001|Overall Study|Adverse Event|0|||
94350734|NCT00125138|323065440|FG002|Overall Study|Adverse Event|3|||
94453056|NCT03423173|323447312|FG000|Overall Study|Adverse Event|1|||
94453057|NCT03423173|323447313|FG001|Overall Study|Adverse Event|1|||
94239412|NCT00477490|322670632|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
94239413|NCT00477490|322670633|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
94239414|NCT00477490|322670634|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
94239415|NCT00477490|322670635|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
94239416|NCT00477490|322670636|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
94239417|NCT00477490|322670637|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
94239418|NCT00477490|322670638|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
94239419|NCT00477490|322670630|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
94239420|NCT00477490|322670631|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
94239421|NCT00477490|322670632|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
94239422|NCT00477490|322670633|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
94239423|NCT00477490|322670634|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
94239424|NCT00477490|322670635|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
94239425|NCT00477490|322670636|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
94239426|NCT00477490|322670637|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
94239427|NCT00477490|322670638|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
94239428|NCT00477490|322670630|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
94239429|NCT00477490|322670631|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
94239430|NCT00477490|322670632|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
94239431|NCT00477490|322670633|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
94239432|NCT00477490|322670634|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
94239433|NCT00477490|322670635|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
94239434|NCT00477490|322670636|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
94239435|NCT00477490|322670637|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
94239436|NCT00477490|322670638|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
94239437|NCT00477490|322670630|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
94239438|NCT00477490|322670631|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
94239439|NCT00477490|322670632|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
94239440|NCT00477490|322670633|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
94239441|NCT00477490|322670634|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
94239442|NCT00477490|322670635|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
94239443|NCT00477490|322670636|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
94239444|NCT00477490|322670637|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
94239445|NCT00477490|322670638|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
94239446|NCT00477490|322670630|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
94239447|NCT00477490|322670631|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
94239448|NCT00477490|322670632|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
94239449|NCT00477490|322670633|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
94239450|NCT00477490|322670634|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
94239451|NCT00477490|322670635|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
94239452|NCT00477490|322670636|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
94239453|NCT00477490|322670637|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
94239454|NCT00477490|322670638|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
94239455|NCT00477490|322670630|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
94239456|NCT00477490|322670631|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
94239457|NCT00477490|322670632|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
94239458|NCT00477490|322670633|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
94239459|NCT00477490|322670634|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
94239460|NCT00477490|322670635|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
94239461|NCT00477490|322670636|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
94239462|NCT00477490|322670637|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
94239463|NCT00477490|322670638|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
94239464|NCT00477490|322670630|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
94239465|NCT00477490|322670631|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
94239466|NCT00477490|322670632|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
94239467|NCT00477490|322670633|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
94239468|NCT00477490|322670634|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
94239469|NCT00477490|322670635|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
94239470|NCT00477490|322670636|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
94239471|NCT00477490|322670637|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
94239472|NCT00477490|322670638|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
94239473|NCT00477490|322670630|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
94239474|NCT00477490|322670631|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
94239475|NCT00477490|322670632|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
94239476|NCT00477490|322670633|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
94239477|NCT00477490|322670634|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
94239478|NCT00477490|322670635|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
94575662|NCT03037385|323908442|FG000|Overall Study|Lost to Follow-up|0|||
94575663|NCT03037385|323908443|FG001|Overall Study|Lost to Follow-up|0|||
94453058|NCT03423173|323447314|FG002|Overall Study|Adverse Event|1|||
94453059|NCT03423173|323447315|FG003|Overall Study|Adverse Event|1|||
94239479|NCT00477490|322670636|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
94239480|NCT00477490|322670637|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
94350735|NCT00125138|323065441|FG003|Overall Study|Adverse Event|2|||
94350736|NCT00125138|323065438|FG000|Overall Study|Withdrawal by Subject|2|||
94350737|NCT00125138|323065439|FG001|Overall Study|Withdrawal by Subject|3|||
94350738|NCT00125138|323065440|FG002|Overall Study|Withdrawal by Subject|1|||
94350739|NCT00125138|323065441|FG003|Overall Study|Withdrawal by Subject|1|||
94350740|NCT00125138|323065438|FG000|Overall Study|Lack of Efficacy|0|||
94350741|NCT00125138|323065439|FG001|Overall Study|Lack of Efficacy|0|||
94350742|NCT00125138|323065440|FG002|Overall Study|Lack of Efficacy|0|||
94350743|NCT00125138|323065441|FG003|Overall Study|Lack of Efficacy|1|||
94350744|NCT00125138|323065438|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
94350745|NCT00125138|323065439|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
94350746|NCT00125138|323065440|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
94350747|NCT00125138|323065441|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
94350748|NCT04905563|323065442|FG000|Overall Study|Withdrawal by Subject|1|||
94350749|NCT04905563|323065443|FG001|Overall Study|Withdrawal by Subject|0|||
94350750|NCT04905563|323065442|FG000|Overall Study|Standard of care orders entered by resident|1|||
94350751|NCT04905563|323065443|FG001|Overall Study|Standard of care orders entered by resident|0|||
94350752|NCT04905563|323065442|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
94350753|NCT04905563|323065443|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
94350754|NCT04905563|323065442|FG000|Overall Study|Withdrawal by Subject|0|||
94350755|NCT04905563|323065443|FG001|Overall Study|Withdrawal by Subject|1|||
94350756|NCT02074059|323065445|FG000|Overall Study|Death|0|||
94350757|NCT02074059|323065446|FG001|Overall Study|Death|0|||
94350758|NCT02074059|323065447|FG002|Overall Study|Death|0|||
94350759|NCT02074059|323065448|FG003|Overall Study|Death|0|||
94350760|NCT02074059|323065449|FG004|Overall Study|Death|1|||
94350761|NCT02074059|323065450|FG005|Overall Study|Death|1|||
94350762|NCT02773849|323065451|FG000|Overall Study|Lost to Follow-up|11|||
94350763|NCT02773849|323065451|FG000|Overall Study|Death|26|||
94350764|NCT02773849|323065451|FG000|Overall Study|Withdrawal by Subject|5|||
94350765|NCT02773849|323065451|FG000|Overall Study|Withdrawal of Consent|9|||
94350766|NCT02773849|323065451|FG000|Overall Study|Other: not due to lack of tolerability|11|||
94350767|NCT00917553|323065452|FG000|Overall Study|Lost to Follow-up|2|||
94350768|NCT00917553|323065453|FG001|Overall Study|Lost to Follow-up|1|||
94350769|NCT01258738|323065459|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
94350770|NCT01258738|323065460|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
94350771|NCT01258738|323065459|FG000|Double-blind Period|Withdrawal by Subject|2|||
94350772|NCT01258738|323065460|FG001|Double-blind Period|Withdrawal by Subject|2|||
94350773|NCT01258738|323065459|FG000|Double-blind Period|Protocol Violation|1|||
94350774|NCT01258738|323065460|FG001|Double-blind Period|Protocol Violation|1|||
94350775|NCT01258738|323065459|FG000|Double-blind Period|Adverse Event|3|||
94350776|NCT01258738|323065460|FG001|Double-blind Period|Adverse Event|1|||
94350777|NCT01258738|323065459|FG000|Open-label Period|Did not meet inclusion criteria|0|||
94350778|NCT01258738|323065460|FG001|Open-label Period|Did not meet inclusion criteria|1|||
94350779|NCT01258738|323065459|FG000|Open-label Period|Insufficient clinical response|5|||
94350780|NCT01258738|323065460|FG001|Open-label Period|Insufficient clinical response|3|||
94350781|NCT01258738|323065459|FG000|Open-label Period|Lost to Follow-up|0|||
94350782|NCT01258738|323065460|FG001|Open-label Period|Lost to Follow-up|2|||
94350783|NCT01258738|323065459|FG000|Open-label Period|Withdrawal by Subject|5|||
94350784|NCT01258738|323065460|FG001|Open-label Period|Withdrawal by Subject|6|||
94350785|NCT01258738|323065459|FG000|Open-label Period|Protocol Violation|2|||
94350786|NCT01258738|323065460|FG001|Open-label Period|Protocol Violation|2|||
94575664|NCT03037385|323908444|FG002|Overall Study|Lost to Follow-up|0|||
94575665|NCT03037385|323908445|FG003|Overall Study|Lost to Follow-up|0|||
94350787|NCT01258738|323065459|FG000|Open-label Period|Adverse Event|4|||
94350788|NCT01258738|323065460|FG001|Open-label Period|Adverse Event|5|||
94453060|NCT03423173|323447312|FG000|Overall Study|Lost to Follow-up|10|||
94350789|NCT01258738|323065459|FG000|Open-label Period|Other Reasons|0|||
94350790|NCT01258738|323065460|FG001|Open-label Period|Other Reasons|1|||
94350791|NCT01258738|323065459|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
94575666|NCT03037385|323908446|FG004|Overall Study|Lost to Follow-up|0|||
94239481|NCT00477490|322670638|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
94239482|NCT00477490|322670630|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
94239483|NCT00477490|322670631|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
94239484|NCT00477490|322670632|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
94239485|NCT00477490|322670633|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
94239486|NCT00477490|322670634|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
94239487|NCT00477490|322670635|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
94239488|NCT00477490|322670636|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
94239489|NCT00477490|322670637|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
94239490|NCT00477490|322670638|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
94239491|NCT00477490|322670630|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
94239492|NCT00477490|322670631|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
94239493|NCT00477490|322670632|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
94239494|NCT00477490|322670633|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
94239495|NCT00477490|322670634|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
94239496|NCT00477490|322670635|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
94239497|NCT00477490|322670636|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
94239498|NCT00477490|322670637|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
94239499|NCT00477490|322670638|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
94239500|NCT00477490|322670630|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
94239501|NCT00477490|322670631|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
94239502|NCT00477490|322670632|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
94239503|NCT00477490|322670633|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
94239504|NCT00477490|322670634|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
94239505|NCT00477490|322670635|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
94239506|NCT00477490|322670636|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
94239507|NCT00477490|322670637|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
94239508|NCT00477490|322670638|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
94239509|NCT01465763|322670639|FG000|Overall Study|Withdrawal by Subject|4|||
94239510|NCT01465763|322670640|FG001|Overall Study|Withdrawal by Subject|0|||
94239511|NCT01465763|322670641|FG002|Overall Study|Withdrawal by Subject|1|||
94239512|NCT01465763|322670639|FG000|Overall Study|Insufficient Clinical Response|11|||
94239513|NCT01465763|322670640|FG001|Overall Study|Insufficient Clinical Response|0|||
94239514|NCT01465763|322670641|FG002|Overall Study|Insufficient Clinical Response|1|||
94239515|NCT01465763|322670639|FG000|Overall Study|Adverse Event|9|||
94239516|NCT01465763|322670640|FG001|Overall Study|Adverse Event|0|||
94239517|NCT01465763|322670641|FG002|Overall Study|Adverse Event|1|||
94239518|NCT01465763|322670639|FG000|Overall Study|Other|2|||
94239519|NCT01465763|322670640|FG001|Overall Study|Other|0|||
94239520|NCT01465763|322670641|FG002|Overall Study|Other|0|||
94239521|NCT01465763|322670639|FG000|Overall Study|Protocol Violation|4|||
94350792|NCT01258738|323065460|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
94350793|NCT02418000|323065461|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
94350794|NCT02418000|323065462|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
94350795|NCT02418000|323065463|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
94350796|NCT02418000|323065464|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
94350797|NCT02418000|323065465|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
94350798|NCT02418000|323065461|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
94350799|NCT02418000|323065462|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
94350800|NCT02418000|323065463|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
94350801|NCT02418000|323065464|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
94350802|NCT02418000|323065465|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
94350803|NCT02418000|323065461|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
94350804|NCT02418000|323065462|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
94350805|NCT02418000|323065463|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
94350806|NCT02418000|323065464|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
94350807|NCT02418000|323065465|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
94350808|NCT02418000|323065461|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
94350809|NCT02418000|323065462|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
94350810|NCT02418000|323065463|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
94350811|NCT02418000|323065464|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
94350812|NCT02418000|323065465|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
94350813|NCT02418000|323065461|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
94239522|NCT01465763|322670640|FG001|Overall Study|Protocol Violation|1|||
94239523|NCT01465763|322670641|FG002|Overall Study|Protocol Violation|1|||
94239524|NCT01465763|322670639|FG000|Overall Study|Death|1|||
94239525|NCT01465763|322670640|FG001|Overall Study|Death|0|||
94453061|NCT03423173|323447313|FG001|Overall Study|Lost to Follow-up|19|||
94239526|NCT01465763|322670641|FG002|Overall Study|Death|0|||
94239527|NCT01038427|322670644|FG000|Overall Study|Lost to follow up|1|||
94239528|NCT01038427|322670645|FG001|Overall Study|Lost to follow up|1|||
94239529|NCT01038427|322670646|FG002|Overall Study|Lost to follow up|0|||
94239530|NCT01038427|322670644|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
94239531|NCT01038427|322670645|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
94239532|NCT01038427|322670646|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
94239533|NCT01038427|322670644|FG000|Overall Study|Withdrew consent|0|||
94239534|NCT01038427|322670645|FG001|Overall Study|Withdrew consent|0|||
94239535|NCT01038427|322670646|FG002|Overall Study|Withdrew consent|1|||
94239536|NCT01038427|322670644|FG000|Overall Study|Adverse Event|2|||
94239537|NCT01038427|322670645|FG001|Overall Study|Adverse Event|2|||
94239538|NCT01038427|322670646|FG002|Overall Study|Adverse Event|1|||
94239539|NCT01038427|322670644|FG000|Overall Study|Enrolled in error|0|||
94239540|NCT01038427|322670645|FG001|Overall Study|Enrolled in error|1|||
94239541|NCT01038427|322670646|FG002|Overall Study|Enrolled in error|1|||
94239542|NCT01038427|322670644|FG000|Overall Study|Other|0|||
94239543|NCT01038427|322670645|FG001|Overall Study|Other|2|||
94239544|NCT01038427|322670646|FG002|Overall Study|Other|0|||
94239545|NCT01827046|322670648|FG000|Overall Study|Lost to Follow-up|1|||
94239546|NCT01827046|322670649|FG001|Overall Study|Lost to Follow-up|5|||
94239547|NCT01827046|322670648|FG000|Overall Study|Withdrawal by Subject|0|||
94239548|NCT01827046|322670649|FG001|Overall Study|Withdrawal by Subject|4|||
94239549|NCT01430468|322670657|FG000|Overall Study|Physician Decision|2|||
94239550|NCT01430468|322670658|FG001|Overall Study|Physician Decision|1|||
94239551|NCT01430468|322670657|FG000|Overall Study|Withdrawal by Subject|5|||
94239552|NCT01430468|322670658|FG001|Overall Study|Withdrawal by Subject|5|||
94239553|NCT02202785|322670659|FG000|Overall Study|Study Terminated by Sponsor|1|||
94239554|NCT02202785|322670660|FG001|Overall Study|Study Terminated by Sponsor|6|||
94239555|NCT02202785|322670661|FG002|Overall Study|Study Terminated by Sponsor|4|||
94239556|NCT02202785|322670659|FG000|Overall Study|Withdrawal by Subject|0|||
94239557|NCT02202785|322670660|FG001|Overall Study|Withdrawal by Subject|1|||
94239558|NCT02202785|322670661|FG002|Overall Study|Withdrawal by Subject|0|||
94239559|NCT02202785|322670659|FG000|Overall Study|Lost to Follow-up|0|||
94239560|NCT02202785|322670660|FG001|Overall Study|Lost to Follow-up|1|||
94239561|NCT02202785|322670661|FG002|Overall Study|Lost to Follow-up|0|||
94239562|NCT02202785|322670659|FG000|Overall Study|Reason not Specified|10|||
94239563|NCT02202785|322670660|FG001|Overall Study|Reason not Specified|7|||
94239564|NCT02202785|322670661|FG002|Overall Study|Reason not Specified|13|||
94239565|NCT01281839|322670662|FG000|Overall Study|Lost to Follow-up|6|||
94239566|NCT01281839|322670663|FG001|Overall Study|Lost to Follow-up|3|||
94239567|NCT01281839|322670662|FG000|Overall Study|Withdrawal by Subject|4|||
94239568|NCT01281839|322670663|FG001|Overall Study|Withdrawal by Subject|10|||
94239569|NCT01281839|322670662|FG000|Overall Study|Reason not specified|0|||
94239570|NCT01281839|322670663|FG001|Overall Study|Reason not specified|1|||
94239571|NCT01294436|322670664|FG000|Overall Study|Adverse Event|10|||
94239572|NCT01294436|322670665|FG001|Overall Study|Adverse Event|17|||
94239573|NCT01294436|322670664|FG000|Overall Study|Withdrawal by Subject|11|||
94239574|NCT01294436|322670665|FG001|Overall Study|Withdrawal by Subject|28|||
94453062|NCT03423173|323447314|FG002|Overall Study|Lost to Follow-up|17|||
94453063|NCT03423173|323447315|FG003|Overall Study|Lost to Follow-up|22|||
94239575|NCT01294436|322670664|FG000|Overall Study|subject no longer meets study criteria|5|||
94239576|NCT01294436|322670665|FG001|Overall Study|subject no longer meets study criteria|20|||
94239577|NCT01294436|322670664|FG000|Overall Study|poor/non-compliance|2|||
94239578|NCT01294436|322670665|FG001|Overall Study|poor/non-compliance|5|||
94239579|NCT03041792|322670666|FG000|Overall Study|Adverse Event|4|||
94239580|NCT03041792|322670667|FG001|Overall Study|Adverse Event|0|||
94239581|NCT03041792|322670666|FG000|Overall Study|Death in the family|0|||
94239582|NCT03041792|322670667|FG001|Overall Study|Death in the family|2|||
94239583|NCT03041792|322670666|FG000|Overall Study|Randomized but not treated|0|||
94239584|NCT03041792|322670667|FG001|Overall Study|Randomized but not treated|1|||
94239585|NCT00839956|322670668|FG000|Overall Study|Adverse Event|2|||
94239586|NCT00839956|322670668|FG000|Overall Study|Lack of Efficacy|6|||
94239587|NCT00839956|322670668|FG000|Overall Study|Physician Decision|1|||
94239588|NCT00839956|322670668|FG000|Overall Study|Withdrawal by Subject|3|||
94239589|NCT02227992|322670669|FG000|Overall Study|Lost to Follow-up|1|||
94239590|NCT02227992|322670670|FG001|Overall Study|Lost to Follow-up|1|||
94239591|NCT00862836|322670681|FG000|Overall Study|Withdrawal by Subject|1|||
94239592|NCT04949802|322672565|FG000|Overall Study|Lost to Follow-up|3|||
94239593|NCT03192462|322672566|FG000|Overall Study|Death|13|||
94239594|NCT03192462|322672567|FG001|Overall Study|Death|11|||
94453064|NCT03423173|323447312|FG000|Overall Study|Withdrawal of consent|4|||
94239595|NCT03192462|322672568|FG002|Overall Study|Death|9|||
94239596|NCT03192462|322672566|FG000|Overall Study|Lost to Follow-up|0|||
94239597|NCT03192462|322672567|FG001|Overall Study|Lost to Follow-up|1|||
94239598|NCT03192462|322672568|FG002|Overall Study|Lost to Follow-up|0|||
94239599|NCT03192462|322672566|FG000|Overall Study|On follow up|0|||
94453065|NCT03423173|323447313|FG001|Overall Study|Withdrawal of consent|10|||
94350814|NCT02418000|323065462|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
94350815|NCT02418000|323065463|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
94350816|NCT02418000|323065464|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
94350817|NCT02418000|323065465|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
94350818|NCT02418000|323065461|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
94350819|NCT02418000|323065462|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
94350820|NCT02418000|323065463|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
94350821|NCT02418000|323065464|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
94350822|NCT02418000|323065465|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
94350823|NCT02418000|323065461|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
94350824|NCT02418000|323065462|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
94350825|NCT02418000|323065463|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
94350826|NCT02418000|323065464|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
94350827|NCT02418000|323065465|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
94350828|NCT02418000|323065461|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
94350829|NCT02418000|323065462|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
94350830|NCT02418000|323065463|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
94350831|NCT02418000|323065464|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
94350832|NCT02418000|323065465|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
94350833|NCT02418000|323065461|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
94350834|NCT02418000|323065462|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
94350835|NCT02418000|323065463|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
94350836|NCT02418000|323065464|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
94350837|NCT02418000|323065465|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
94350838|NCT00750867|323065467|FG000|Overall Study|Adverse Event|2|||
94350839|NCT03018028|323065468|FG000|Overall Study|Withdrawal by Subject|3|||
94350840|NCT03018028|323065469|FG001|Overall Study|Withdrawal by Subject|0|||
94350841|NCT03018028|323065470|FG002|Overall Study|Withdrawal by Subject|1|||
94350842|NCT03018028|323065471|FG003|Overall Study|Withdrawal by Subject|2|||
94350843|NCT03018028|323065472|FG004|Overall Study|Withdrawal by Subject|0|||
94350844|NCT01060150|323065473|FG000|Overall Study|Adverse Event|6|||
94350845|NCT01060150|323065473|FG000|Overall Study|Lost to Follow-up|1|||
94350846|NCT01060150|323065473|FG000|Overall Study|Protocol Violation|6|||
94239600|NCT03192462|322672567|FG001|Overall Study|On follow up|0|||
94350847|NCT01060150|323065473|FG000|Overall Study|Withdrawal by Subject|8|||
94350848|NCT01060150|323065473|FG000|Overall Study|Enrolled, but not treated|2|||
94350849|NCT00660816|323065478|FG000|Overall Study|Adverse Event|1|||
94350850|NCT00660816|323065479|FG001|Overall Study|Adverse Event|2|||
94350851|NCT00660816|323065478|FG000|Overall Study|Withdrawal by Subject|1|||
94350852|NCT00660816|323065479|FG001|Overall Study|Withdrawal by Subject|0|||
94350853|NCT00660816|323065478|FG000|Overall Study|Death|0|||
94350854|NCT00660816|323065479|FG001|Overall Study|Death|2|||
94350855|NCT00660816|323065478|FG000|Overall Study|Lack of Efficacy|1|||
94239601|NCT03192462|322672568|FG002|Overall Study|On follow up|3|||
94239602|NCT01443403|322672569|FG000|Overall Study|Adverse Event|1|||
94239603|NCT01443403|322672570|FG001|Overall Study|Adverse Event|1|||
94239604|NCT01443403|322672571|FG002|Overall Study|Adverse Event|4|||
94239605|NCT01443403|322672572|FG003|Overall Study|Adverse Event|5|||
94239606|NCT01443403|322672569|FG000|Overall Study|Withdrawal by Subject|0|||
94239607|NCT01443403|322672570|FG001|Overall Study|Withdrawal by Subject|1|||
94239608|NCT01443403|322672571|FG002|Overall Study|Withdrawal by Subject|2|||
94350856|NCT00660816|323065479|FG001|Overall Study|Lack of Efficacy|0|||
94350857|NCT00660816|323065478|FG000|Overall Study|Physician Decision|0|||
94350858|NCT00660816|323065479|FG001|Overall Study|Physician Decision|2|||
94350859|NCT00660816|323065478|FG000|Overall Study|Protocol Violation|1|||
94350860|NCT00660816|323065479|FG001|Overall Study|Protocol Violation|0|||
94350861|NCT00660816|323065478|FG000|Overall Study|Disease Progression|16|||
94350862|NCT00660816|323065479|FG001|Overall Study|Disease Progression|12|||
94350863|NCT00660816|323065478|FG000|Overall Study|Complicating Disease|0|||
94350864|NCT00660816|323065479|FG001|Overall Study|Complicating Disease|1|||
94453066|NCT03423173|323447314|FG002|Overall Study|Withdrawal of consent|4|||
94453067|NCT03423173|323447315|FG003|Overall Study|Withdrawal of consent|5|||
94453068|NCT03423173|323447312|FG000|Overall Study|Death|1|||
94350865|NCT04212221|323065480|FG000|Overall Study|Remained on Treatment|0|||
94350866|NCT04212221|323065481|FG001|Overall Study|Remained on Treatment|0|||
94350867|NCT04212221|323065482|FG002|Overall Study|Remained on Treatment|0|||
94350868|NCT04212221|323065483|FG003|Overall Study|Remained on Treatment|1|||
94350869|NCT04212221|323065484|FG004|Overall Study|Remained on Treatment|0|||
94350870|NCT04212221|323065485|FG005|Overall Study|Remained on Treatment|0|||
94350871|NCT04212221|323065486|FG006|Overall Study|Remained on Treatment|3|||
94453069|NCT03423173|323447313|FG001|Overall Study|Death|0|||
94453070|NCT03423173|323447314|FG002|Overall Study|Death|0|||
94453071|NCT03423173|323447315|FG003|Overall Study|Death|0|||
94453072|NCT03423173|323447312|FG000|Overall Study|Reason not Specified|2|||
94453073|NCT03423173|323447313|FG001|Overall Study|Reason not Specified|5|||
94453074|NCT03423173|323447314|FG002|Overall Study|Reason not Specified|3|||
94453075|NCT03423173|323447315|FG003|Overall Study|Reason not Specified|1|||
94453076|NCT03348930|323447316|FG000|Washout (1 Week)|Lost to Follow-up|1|||
94453077|NCT03348930|323447317|FG001|Washout (1 Week)|Lost to Follow-up|1|||
94453078|NCT02920008|323447318|FG000|Overall Study|Death|117|||
94453079|NCT02920008|323447319|FG001|Overall Study|Death|127|||
94239609|NCT01443403|322672572|FG003|Overall Study|Withdrawal by Subject|1|||
94239610|NCT01443403|322672569|FG000|Overall Study|Lost to Follow-up|0|||
94239611|NCT01443403|322672570|FG001|Overall Study|Lost to Follow-up|0|||
94239612|NCT01443403|322672571|FG002|Overall Study|Lost to Follow-up|0|||
94239613|NCT01443403|322672572|FG003|Overall Study|Lost to Follow-up|1|||
94239614|NCT01443403|322672569|FG000|Overall Study|Protocol Violation|2|||
94239615|NCT01443403|322672570|FG001|Overall Study|Protocol Violation|1|||
94239616|NCT01443403|322672571|FG002|Overall Study|Protocol Violation|1|||
94239617|NCT01443403|322672572|FG003|Overall Study|Protocol Violation|1|||
94239618|NCT01443403|322672569|FG000|Overall Study|Use of Prohibited Treatment|2|||
94239619|NCT01443403|322672570|FG001|Overall Study|Use of Prohibited Treatment|3|||
94239620|NCT01443403|322672571|FG002|Overall Study|Use of Prohibited Treatment|0|||
94239621|NCT01443403|322672572|FG003|Overall Study|Use of Prohibited Treatment|0|||
94239622|NCT01443403|322672569|FG000|Overall Study|Other - Miscellaneous|1|||
94239623|NCT01443403|322672570|FG001|Overall Study|Other - Miscellaneous|0|||
94239624|NCT01443403|322672571|FG002|Overall Study|Other - Miscellaneous|0|||
94239625|NCT01443403|322672572|FG003|Overall Study|Other - Miscellaneous|1|||
94239626|NCT00474526|322672573|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
94239627|NCT00474526|322672574|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
94239628|NCT00474526|322672575|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
94239629|NCT00474526|322672576|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
94239630|NCT00474526|322672577|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
94239631|NCT00474526|322672578|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
94239632|NCT00474526|322672579|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
94239633|NCT00474526|322672580|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
94239634|NCT00474526|322672581|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
94239635|NCT00474526|322672582|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
94350872|NCT04212221|323065487|FG007|Overall Study|Remained on Treatment|9|||
94575667|NCT03037385|323908447|FG005|Overall Study|Lost to Follow-up|1|||
94575668|NCT03037385|323908448|FG006|Overall Study|Lost to Follow-up|0|||
94575669|NCT03037385|323908449|FG007|Overall Study|Lost to Follow-up|0|||
94239636|NCT00474526|322672583|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
94350873|NCT04212221|323065480|FG000|Overall Study|Adverse Event|0|||
94453080|NCT02920008|323447318|FG000|Overall Study|Withdrawal by Subject|3|||
94239637|NCT00474526|322672584|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
94350874|NCT04212221|323065481|FG001|Overall Study|Adverse Event|0|||
94453081|NCT02920008|323447319|FG001|Overall Study|Withdrawal by Subject|6|||
94453082|NCT02920008|323447318|FG000|Overall Study|Lost to Follow-up|0|||
94350875|NCT04212221|323065482|FG002|Overall Study|Adverse Event|0|||
94453083|NCT02920008|323447319|FG001|Overall Study|Lost to Follow-up|1|||
94453084|NCT01053663|323447320|FG000|Overall Study|Death|2|||
94453085|NCT01053663|323447320|FG000|Overall Study|Lost to Follow-up|1|||
94453086|NCT01053663|323447320|FG000|Overall Study|Poor IV Access|1|||
94453087|NCT01053663|323447320|FG000|Overall Study|Transferred to Another Hospital|1|||
94453088|NCT01053663|323447320|FG000|Overall Study|Negative Influenza Diagnosis|1|||
94350876|NCT04212221|323065483|FG003|Overall Study|Adverse Event|0|||
94350877|NCT04212221|323065484|FG004|Overall Study|Adverse Event|0|||
94350878|NCT04212221|323065485|FG005|Overall Study|Adverse Event|0|||
94350879|NCT04212221|323065486|FG006|Overall Study|Adverse Event|2|||
94350880|NCT04212221|323065487|FG007|Overall Study|Adverse Event|3|||
94350881|NCT04212221|323065480|FG000|Overall Study|Death|0|||
94350882|NCT04212221|323065481|FG001|Overall Study|Death|0|||
94453089|NCT00582608|323447321|FG000|Overall Study|Not Treated|7|||
94453090|NCT00582608|323447321|FG000|Overall Study|Patient Ineligible|1|||
94453091|NCT00582608|323447321|FG000|Overall Study|Lack of accrual|4|||
94453092|NCT00708214|323447322|FG000|Overall Study|Other Adverse Event|3|||
94453093|NCT00708214|323447323|FG001|Overall Study|Other Adverse Event|6|||
94453094|NCT00708214|323447324|FG002|Overall Study|Other Adverse Event|2|||
94453095|NCT00708214|323447322|FG000|Overall Study|Other|0|||
94350883|NCT04212221|323065482|FG002|Overall Study|Death|0|||
94350884|NCT04212221|323065483|FG003|Overall Study|Death|0|||
94453096|NCT00708214|323447323|FG001|Overall Study|Other|1|||
94453097|NCT00708214|323447324|FG002|Overall Study|Other|1|||
94453098|NCT00708214|323447322|FG000|Overall Study|Progressive Disease|4|||
94453099|NCT00708214|323447323|FG001|Overall Study|Progressive Disease|6|||
94453100|NCT00708214|323447324|FG002|Overall Study|Progressive Disease|5|||
94453101|NCT03169881|323447325|FG000|Overall Study|Incomplete Follow-up|10|||
94453102|NCT03169881|323447326|FG001|Overall Study|Incomplete Follow-up|15|||
94453103|NCT03169881|323447325|FG000|Overall Study|Lost to Follow-up|18|||
94453104|NCT03169881|323447326|FG001|Overall Study|Lost to Follow-up|20|||
94453105|NCT03169881|323447325|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
94453106|NCT03169881|323447326|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
94453107|NCT01862250|323447327|FG000|Overall Study|Adverse Event|4|||
94453108|NCT02411396|323447330|FG000|Overall Study|Lost to Follow-up|31|||
94453109|NCT02411396|323447330|FG000|Overall Study|Death|10|||
94453110|NCT01250873|323447337|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
94453111|NCT01250873|323447337|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
94453112|NCT02278939|323447338|FG000|Overall Study|lack of time|1|||
94453113|NCT02278939|323447339|FG001|Overall Study|lack of time|0|||
94453114|NCT02278939|323447338|FG000|Overall Study|Lost to Follow-up|1|||
94453115|NCT02278939|323447339|FG001|Overall Study|Lost to Follow-up|1|||
94453116|NCT02278939|323447338|FG000|Overall Study|death in family|1|||
94453117|NCT02278939|323447339|FG001|Overall Study|death in family|0|||
94453118|NCT02278939|323447338|FG000|Overall Study|family emergency unable to commit|2|||
94453119|NCT02278939|323447339|FG001|Overall Study|family emergency unable to commit|0|||
94453120|NCT02423343|323447340|FG000|Overall Study|Withdrawal by Subject|0|||
94453121|NCT02423343|323447341|FG001|Overall Study|Withdrawal by Subject|1|||
94453122|NCT02423343|323447342|FG002|Overall Study|Withdrawal by Subject|0|||
94453123|NCT02423343|323447343|FG003|Overall Study|Withdrawal by Subject|0|||
94453124|NCT02423343|323447344|FG004|Overall Study|Withdrawal by Subject|0|||
94453125|NCT02423343|323447345|FG005|Overall Study|Withdrawal by Subject|0|||
94453126|NCT02423343|323447340|FG000|Overall Study|Progressive Disease|0|||
94453127|NCT02423343|323447341|FG001|Overall Study|Progressive Disease|0|||
94453128|NCT02423343|323447342|FG002|Overall Study|Progressive Disease|0|||
94453129|NCT02423343|323447343|FG003|Overall Study|Progressive Disease|0|||
94453130|NCT02423343|323447344|FG004|Overall Study|Progressive Disease|2|||
94453131|NCT02423343|323447345|FG005|Overall Study|Progressive Disease|0|||
94453132|NCT02423343|323447340|FG000|Overall Study|Adverse Event|0|||
94350885|NCT04212221|323065484|FG004|Overall Study|Death|0|||
94350886|NCT04212221|323065485|FG005|Overall Study|Death|0|||
94350887|NCT04212221|323065486|FG006|Overall Study|Death|0|||
94350888|NCT04212221|323065487|FG007|Overall Study|Death|2|||
94350889|NCT04212221|323065480|FG000|Overall Study|Disease progression according to irRECIST|1|||
94350890|NCT04212221|323065481|FG001|Overall Study|Disease progression according to irRECIST|2|||
94350891|NCT04212221|323065482|FG002|Overall Study|Disease progression according to irRECIST|3|||
94453133|NCT02423343|323447341|FG001|Overall Study|Adverse Event|0|||
94453134|NCT02423343|323447342|FG002|Overall Study|Adverse Event|0|||
94453135|NCT02423343|323447343|FG003|Overall Study|Adverse Event|0|||
94453136|NCT02423343|323447344|FG004|Overall Study|Adverse Event|2|||
94453137|NCT02423343|323447345|FG005|Overall Study|Adverse Event|0|||
94453138|NCT02423343|323447340|FG000|Overall Study|Death|0|||
94453139|NCT02423343|323447341|FG001|Overall Study|Death|0|||
94453140|NCT02423343|323447342|FG002|Overall Study|Death|0|||
94575670|NCT03037385|323908450|FG008|Overall Study|Lost to Follow-up|0|||
94575671|NCT03037385|323908451|FG009|Overall Study|Lost to Follow-up|16|||
94575672|NCT03037385|323908442|FG000|Overall Study|Physician Decision|0|||
94350892|NCT04212221|323065483|FG003|Overall Study|Disease progression according to irRECIST|3|||
94453141|NCT02423343|323447343|FG003|Overall Study|Death|0|||
94453142|NCT02423343|323447344|FG004|Overall Study|Death|1|||
94575673|NCT03037385|323908443|FG001|Overall Study|Physician Decision|0|||
94453143|NCT02423343|323447345|FG005|Overall Study|Death|0|||
94453144|NCT00090493|323447346|FG000|Overall Study|Physician Decision|2|||
94453145|NCT02111577|323447347|FG000|Overall Study|Protocol Violation|2|||
94453146|NCT02111577|323447348|FG001|Overall Study|Protocol Violation|0|||
94453147|NCT02111577|323447347|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
94453148|NCT02111577|323447348|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
94453149|NCT02111577|323447347|FG000|Overall Study|Failure to produce study treatment|6|||
94453150|NCT02111577|323447348|FG001|Overall Study|Failure to produce study treatment|0|||
94453151|NCT02111577|323447347|FG000|Overall Study|Death|518|||
94453152|NCT02111577|323447348|FG001|Overall Study|Death|254|||
94453153|NCT02111577|323447347|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
94453154|NCT02111577|323447348|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
94453155|NCT02111577|323447347|FG000|Overall Study|Adverse Event|1|||
94453156|NCT02111577|323447348|FG001|Overall Study|Adverse Event|1|||
94453157|NCT02111577|323447347|FG000|Overall Study|Withdrawal by Subject|51|||
94453158|NCT02111577|323447348|FG001|Overall Study|Withdrawal by Subject|23|||
94453159|NCT02111577|323447347|FG000|Overall Study|Disease progression|0|||
94453160|NCT02111577|323447348|FG001|Overall Study|Disease progression|1|||
94453161|NCT02111577|323447347|FG000|Overall Study|Lost to Follow-up|19|||
94453162|NCT02111577|323447348|FG001|Overall Study|Lost to Follow-up|10|||
94453163|NCT01908829|323447351|FG000|Overall Study|Adverse Event|13|||
94453164|NCT01908829|323447352|FG001|Overall Study|Adverse Event|11|||
94453165|NCT01908829|323447353|FG002|Overall Study|Adverse Event|13|||
94453166|NCT01908829|323447351|FG000|Overall Study|Lost to Follow-up|4|||
94453167|NCT01908829|323447352|FG001|Overall Study|Lost to Follow-up|2|||
94453168|NCT01908829|323447353|FG002|Overall Study|Lost to Follow-up|1|||
94453169|NCT01908829|323447351|FG000|Overall Study|Randomized no double-blind drug received|1|||
94453170|NCT01908829|323447352|FG001|Overall Study|Randomized no double-blind drug received|0|||
94453171|NCT01908829|323447353|FG002|Overall Study|Randomized no double-blind drug received|1|||
94453172|NCT01908829|323447351|FG000|Overall Study|Discontinued (no EoT page)|2|||
94453173|NCT01908829|323447352|FG001|Overall Study|Discontinued (no EoT page)|0|||
94453174|NCT01908829|323447353|FG002|Overall Study|Discontinued (no EoT page)|0|||
94453175|NCT01908829|323447351|FG000|Overall Study|Miscellaneous|0|||
94453176|NCT01908829|323447352|FG001|Overall Study|Miscellaneous|2|||
94453177|NCT01908829|323447353|FG002|Overall Study|Miscellaneous|0|||
94453178|NCT01908829|323447351|FG000|Overall Study|Protocol Violation|2|||
94453179|NCT01908829|323447352|FG001|Overall Study|Protocol Violation|2|||
94453180|NCT01908829|323447353|FG002|Overall Study|Protocol Violation|0|||
94453181|NCT01908829|323447351|FG000|Overall Study|Lack of Efficacy|1|||
94453182|NCT01908829|323447352|FG001|Overall Study|Lack of Efficacy|3|||
94453183|NCT01908829|323447353|FG002|Overall Study|Lack of Efficacy|2|||
94453184|NCT01908829|323447351|FG000|Overall Study|Withdrawal by Subject|26|||
94453185|NCT01908829|323447352|FG001|Overall Study|Withdrawal by Subject|29|||
94453186|NCT01908829|323447353|FG002|Overall Study|Withdrawal by Subject|22|||
94453187|NCT01895270|323447354|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
94453188|NCT01895270|323447355|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
94453189|NCT01895270|323447354|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
94453190|NCT01895270|323447355|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
94453191|NCT01895270|323447354|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
94453192|NCT01895270|323447355|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
94453193|NCT01895270|323447354|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
94453194|NCT01895270|323447355|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
94453195|NCT01895270|323447354|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
94453196|NCT01895270|323447355|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
94239638|NCT00474526|322672585|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
94453197|NCT01895270|323447354|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
94453198|NCT01895270|323447355|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
94453199|NCT01895270|323447354|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
94453200|NCT01895270|323447355|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
94453201|NCT04967885|323447356|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
94453202|NCT04967885|323447357|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
94453203|NCT04967885|323447356|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
94453204|NCT04967885|323447357|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
94453205|NCT04967885|323447356|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
94453206|NCT04967885|323447357|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
94453207|NCT04967885|323447356|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
94453208|NCT04967885|323447357|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
94453209|NCT04967885|323447356|FG000|EMI-II Intervention|Lost to Follow-up|14|||
94453210|NCT04967885|323447357|FG001|EMI-II Intervention|Lost to Follow-up|10|||
94453211|NCT02792192|323447358|FG000|Overall Study|Death|1|||
94453212|NCT02792192|323447359|FG001|Overall Study|Death|0|||
94453213|NCT02792192|323447360|FG002|Overall Study|Death|0|||
94453214|NCT02792192|323447361|FG003|Overall Study|Death|0|||
94453215|NCT02792192|323447358|FG000|Overall Study|Informed Consent Withdrawn|4|||
94453216|NCT02792192|323447359|FG001|Overall Study|Informed Consent Withdrawn|0|||
94453217|NCT02792192|323447360|FG002|Overall Study|Informed Consent Withdrawn|0|||
94453218|NCT02792192|323447361|FG003|Overall Study|Informed Consent Withdrawn|0|||
94453219|NCT02792192|323447358|FG000|Overall Study|Physician Decision|1|||
94453220|NCT02792192|323447359|FG001|Overall Study|Physician Decision|0|||
94453221|NCT02792192|323447360|FG002|Overall Study|Physician Decision|0|||
94350893|NCT04212221|323065484|FG004|Overall Study|Disease progression according to irRECIST|2|||
94350894|NCT04212221|323065485|FG005|Overall Study|Disease progression according to irRECIST|2|||
94350895|NCT04212221|323065486|FG006|Overall Study|Disease progression according to irRECIST|21|||
94350896|NCT04212221|323065487|FG007|Overall Study|Disease progression according to irRECIST|17|||
94350897|NCT04212221|323065480|FG000|Overall Study|Global Deterioration of Health Status|0|||
94350898|NCT04212221|323065481|FG001|Overall Study|Global Deterioration of Health Status|0|||
94350899|NCT04212221|323065482|FG002|Overall Study|Global Deterioration of Health Status|0|||
94350900|NCT04212221|323065483|FG003|Overall Study|Global Deterioration of Health Status|0|||
94350901|NCT04212221|323065484|FG004|Overall Study|Global Deterioration of Health Status|0|||
94350902|NCT04212221|323065485|FG005|Overall Study|Global Deterioration of Health Status|0|||
94350903|NCT04212221|323065486|FG006|Overall Study|Global Deterioration of Health Status|0|||
94350904|NCT04212221|323065487|FG007|Overall Study|Global Deterioration of Health Status|2|||
94350905|NCT04212221|323065480|FG000|Overall Study|Investigator's Decision|0|||
94350906|NCT04212221|323065481|FG001|Overall Study|Investigator's Decision|0|||
94350907|NCT04212221|323065482|FG002|Overall Study|Investigator's Decision|0|||
94350908|NCT04212221|323065483|FG003|Overall Study|Investigator's Decision|1|||
94350909|NCT04212221|323065484|FG004|Overall Study|Investigator's Decision|0|||
94350910|NCT04212221|323065485|FG005|Overall Study|Investigator's Decision|0|||
94350911|NCT04212221|323065486|FG006|Overall Study|Investigator's Decision|3|||
94350912|NCT04212221|323065487|FG007|Overall Study|Investigator's Decision|0|||
94350913|NCT04212221|323065480|FG000|Overall Study|Participant refused to continue treatment|0|||
94350914|NCT04212221|323065481|FG001|Overall Study|Participant refused to continue treatment|1|||
94350915|NCT04212221|323065482|FG002|Overall Study|Participant refused to continue treatment|0|||
94350916|NCT04212221|323065483|FG003|Overall Study|Participant refused to continue treatment|1|||
94350917|NCT04212221|323065484|FG004|Overall Study|Participant refused to continue treatment|1|||
94350918|NCT04212221|323065485|FG005|Overall Study|Participant refused to continue treatment|2|||
94350919|NCT04212221|323065486|FG006|Overall Study|Participant refused to continue treatment|4|||
94350920|NCT04212221|323065487|FG007|Overall Study|Participant refused to continue treatment|2|||
94350921|NCT04212221|323065480|FG000|Overall Study|Protocol Violation|0|||
94350922|NCT04212221|323065481|FG001|Overall Study|Protocol Violation|0|||
94350923|NCT04212221|323065482|FG002|Overall Study|Protocol Violation|0|||
94350924|NCT04212221|323065483|FG003|Overall Study|Protocol Violation|0|||
94350925|NCT04212221|323065484|FG004|Overall Study|Protocol Violation|0|||
94350926|NCT04212221|323065485|FG005|Overall Study|Protocol Violation|0|||
94350927|NCT04212221|323065486|FG006|Overall Study|Protocol Violation|0|||
94350928|NCT04212221|323065487|FG007|Overall Study|Protocol Violation|1|||
94350929|NCT04129242|323065494|FG000|Overall Study|Physician Decision|1|||
94350930|NCT04129242|323065495|FG001|Overall Study|Physician Decision|1|||
94350931|NCT04129242|323065494|FG000|Overall Study|Protocol Violation|0|||
94350932|NCT04129242|323065495|FG001|Overall Study|Protocol Violation|1|||
94350933|NCT00392210|323065499|FG000|First Voiding Trial|Physician Decision|2|||
94350934|NCT00392210|323065500|FG001|First Voiding Trial|Physician Decision|2|||
94350935|NCT00266695|323065501|FG000|Overall Study|Adverse Event|1|||
94350936|NCT00266695|323065501|FG000|Overall Study|Death|9|||
94350937|NCT00266695|323065501|FG000|Overall Study|Physician Decision|1|||
94350938|NCT00266695|323065501|FG000|Overall Study|Lost to Follow-up|3|||
94350939|NCT00266695|323065501|FG000|Overall Study|Withdrawal by Subject|15|||
94350940|NCT03480841|323065502|FG000|Overall Study|Lost to Follow-up|2|||
94350941|NCT02610231|323065504|FG000|Overall Study|Withdrawal by Subject|27|||
94350942|NCT02610231|323065504|FG000|Overall Study|Adverse Event|20|||
94350943|NCT02610231|323065504|FG000|Overall Study|Death|5|||
94350944|NCT02610231|323065504|FG000|Overall Study|Surgery|2|||
94453222|NCT02792192|323447361|FG003|Overall Study|Physician Decision|0|||
94453223|NCT02792192|323447358|FG000|Overall Study|Progressive Disease|0|||
94453224|NCT02792192|323447359|FG001|Overall Study|Progressive Disease|1|||
94453225|NCT02792192|323447360|FG002|Overall Study|Progressive Disease|0|||
94453226|NCT02792192|323447361|FG003|Overall Study|Progressive Disease|0|||
94453227|NCT02792192|323447358|FG000|Overall Study|Study Terminated By Sponsor|6|||
94453228|NCT02792192|323447359|FG001|Overall Study|Study Terminated By Sponsor|10|||
94453229|NCT02792192|323447360|FG002|Overall Study|Study Terminated By Sponsor|0|||
94453230|NCT02792192|323447361|FG003|Overall Study|Study Terminated By Sponsor|0|||
94453231|NCT01339923|323447365|FG000|Overall Study|Adverse Event|1|||
94453232|NCT01339923|323447366|FG001|Overall Study|Adverse Event|1|||
94453233|NCT01339923|323447367|FG002|Overall Study|Adverse Event|1|||
94453234|NCT01339923|323447368|FG003|Overall Study|Adverse Event|0|||
94453235|NCT01339923|323447369|FG004|Overall Study|Adverse Event|0|||
94453236|NCT01339923|323447370|FG005|Overall Study|Adverse Event|0|||
94453237|NCT01339923|323447371|FG006|Overall Study|Adverse Event|1|||
94453238|NCT01339923|323447365|FG000|Overall Study|Inappropriate Enrollment|1|||
94453239|NCT01339923|323447366|FG001|Overall Study|Inappropriate Enrollment|0|||
94453240|NCT01339923|323447367|FG002|Overall Study|Inappropriate Enrollment|0|||
94453241|NCT01339923|323447368|FG003|Overall Study|Inappropriate Enrollment|0|||
94453242|NCT01339923|323447369|FG004|Overall Study|Inappropriate Enrollment|0|||
94453243|NCT01339923|323447370|FG005|Overall Study|Inappropriate Enrollment|1|||
94453244|NCT01339923|323447371|FG006|Overall Study|Inappropriate Enrollment|0|||
94453245|NCT01339923|323447365|FG000|Overall Study|Lost to Follow-up|4|||
94453246|NCT01339923|323447366|FG001|Overall Study|Lost to Follow-up|4|||
94453247|NCT01339923|323447367|FG002|Overall Study|Lost to Follow-up|0|||
94453248|NCT01339923|323447368|FG003|Overall Study|Lost to Follow-up|3|||
94453249|NCT01339923|323447369|FG004|Overall Study|Lost to Follow-up|1|||
94453250|NCT01339923|323447370|FG005|Overall Study|Lost to Follow-up|1|||
94453251|NCT01339923|323447371|FG006|Overall Study|Lost to Follow-up|5|||
94453252|NCT01339923|323447365|FG000|Overall Study|Protocol Violation|0|||
94453253|NCT01339923|323447366|FG001|Overall Study|Protocol Violation|0|||
94453254|NCT01339923|323447367|FG002|Overall Study|Protocol Violation|0|||
94453255|NCT01339923|323447368|FG003|Overall Study|Protocol Violation|0|||
94453256|NCT01339923|323447369|FG004|Overall Study|Protocol Violation|0|||
94453257|NCT01339923|323447370|FG005|Overall Study|Protocol Violation|3|||
94453258|NCT01339923|323447371|FG006|Overall Study|Protocol Violation|1|||
94453259|NCT01339923|323447365|FG000|Overall Study|Unable to Classify|1|||
94453260|NCT01339923|323447366|FG001|Overall Study|Unable to Classify|0|||
94453261|NCT01339923|323447367|FG002|Overall Study|Unable to Classify|1|||
94453262|NCT01339923|323447368|FG003|Overall Study|Unable to Classify|0|||
94453263|NCT01339923|323447369|FG004|Overall Study|Unable to Classify|0|||
94453264|NCT01339923|323447370|FG005|Overall Study|Unable to Classify|1|||
94453265|NCT01339923|323447371|FG006|Overall Study|Unable to Classify|5|||
94453266|NCT01339923|323447365|FG000|Overall Study|Withdrawal by Subject|7|||
94453267|NCT01339923|323447366|FG001|Overall Study|Withdrawal by Subject|11|||
94453268|NCT01339923|323447367|FG002|Overall Study|Withdrawal by Subject|6|||
94453269|NCT01339923|323447368|FG003|Overall Study|Withdrawal by Subject|1|||
94453270|NCT01339923|323447369|FG004|Overall Study|Withdrawal by Subject|4|||
94453271|NCT01339923|323447370|FG005|Overall Study|Withdrawal by Subject|3|||
94453272|NCT01339923|323447371|FG006|Overall Study|Withdrawal by Subject|2|||
94453273|NCT01014988|323447372|FG000|Overall Study|Adverse Event|20|||
94453274|NCT01014988|323447373|FG001|Overall Study|Adverse Event|0|||
94453275|NCT01014988|323447374|FG002|Overall Study|Adverse Event|1|||
94453276|NCT01014988|323447375|FG003|Overall Study|Adverse Event|0|||
94453277|NCT01014988|323447376|FG004|Overall Study|Adverse Event|1|||
94453278|NCT01014988|323447377|FG005|Overall Study|Adverse Event|3|||
94453279|NCT01014988|323447372|FG000|Overall Study|Lost to Follow-up|1|||
94453280|NCT01014988|323447373|FG001|Overall Study|Lost to Follow-up|0|||
94453281|NCT01014988|323447374|FG002|Overall Study|Lost to Follow-up|1|||
94453282|NCT01014988|323447375|FG003|Overall Study|Lost to Follow-up|0|||
94453283|NCT01014988|323447376|FG004|Overall Study|Lost to Follow-up|0|||
94453284|NCT01014988|323447377|FG005|Overall Study|Lost to Follow-up|0|||
94453285|NCT01014988|323447372|FG000|Overall Study|Physician Decision|1|||
94453286|NCT01014988|323447373|FG001|Overall Study|Physician Decision|0|||
94575674|NCT03037385|323908444|FG002|Overall Study|Physician Decision|0|||
94453287|NCT01014988|323447374|FG002|Overall Study|Physician Decision|0|||
94453288|NCT01014988|323447375|FG003|Overall Study|Physician Decision|0|||
94453289|NCT01014988|323447376|FG004|Overall Study|Physician Decision|0|||
94453290|NCT01014988|323447377|FG005|Overall Study|Physician Decision|0|||
94453291|NCT01014988|323447372|FG000|Overall Study|Withdrawal by Subject|1|||
94453292|NCT01014988|323447373|FG001|Overall Study|Withdrawal by Subject|0|||
94453293|NCT01014988|323447374|FG002|Overall Study|Withdrawal by Subject|0|||
94453294|NCT01014988|323447375|FG003|Overall Study|Withdrawal by Subject|0|||
94453295|NCT01014988|323447376|FG004|Overall Study|Withdrawal by Subject|0|||
94453296|NCT01014988|323447377|FG005|Overall Study|Withdrawal by Subject|0|||
94453297|NCT00729157|323447379|FG000|Overall Study|Withdrawal by Subject|1|||
94453298|NCT02217410|323447380|FG000|Overall Study|Graft Loss|0|||
94350945|NCT02610231|323065504|FG000|Overall Study|Physician Decision|1|||
94350946|NCT02610231|323065504|FG000|Overall Study|Non Compliance|2|||
94350947|NCT02610231|323065504|FG000|Overall Study|Other|3|||
94350948|NCT02850276|323065507|FG000|Overall Study|screen failure|43|||
94350949|NCT02850276|323065507|FG000|Overall Study|Withdrawal by Subject|14|||
94350950|NCT02850276|323065507|FG000|Overall Study|Physician Decision|2|||
94350951|NCT02850276|323065507|FG000|Overall Study|Lost to Follow-up|2|||
94350952|NCT00434876|323065508|FG000|Overall Study|Lost to Follow-up|1|||
94350953|NCT00434876|323065509|FG001|Overall Study|Lost to Follow-up|1|||
94350954|NCT01899729|323065512|FG000|Overall Study|Adverse Event|1|||
94350955|NCT01899729|323065513|FG001|Overall Study|Adverse Event|0|||
94350956|NCT01899729|323065514|FG002|Overall Study|Adverse Event|0|||
94350957|NCT01899729|323065515|FG003|Overall Study|Adverse Event|0|||
94350958|NCT01899729|323065516|FG004|Overall Study|Adverse Event|1|||
94350959|NCT01899729|323065512|FG000|Overall Study|Withdrawal by Subject|1|||
94350960|NCT01899729|323065513|FG001|Overall Study|Withdrawal by Subject|2|||
94350961|NCT01899729|323065514|FG002|Overall Study|Withdrawal by Subject|0|||
94350962|NCT01899729|323065515|FG003|Overall Study|Withdrawal by Subject|0|||
94350963|NCT01899729|323065516|FG004|Overall Study|Withdrawal by Subject|0|||
94350964|NCT01899729|323065512|FG000|Overall Study|Lack of Efficacy|0|||
94350965|NCT01899729|323065513|FG001|Overall Study|Lack of Efficacy|0|||
94350966|NCT01899729|323065514|FG002|Overall Study|Lack of Efficacy|2|||
94350967|NCT01899729|323065515|FG003|Overall Study|Lack of Efficacy|0|||
94350968|NCT01899729|323065516|FG004|Overall Study|Lack of Efficacy|1|||
94350969|NCT04490499|323065527|FG000|Overall Study|Withdrawal by Subject|2|||
94350970|NCT02646332|323065528|FG000|Overall Study|Lost to Follow-up|0|||
94350971|NCT02646332|323065529|FG001|Overall Study|Lost to Follow-up|3|||
94350972|NCT01882439|323065530|FG000|Overall Study|Adverse event related to study drug|3|||
94350973|NCT01882439|323065531|FG001|Overall Study|Adverse event related to study drug|8|||
94350974|NCT01882439|323065532|FG002|Overall Study|Adverse event related to study drug|1|||
94350975|NCT01882439|323065533|FG003|Overall Study|Adverse event related to study drug|2|||
94350976|NCT01882439|323065530|FG000|Overall Study|Pregnancy|0|||
94350977|NCT01882439|323065531|FG001|Overall Study|Pregnancy|1|||
94350978|NCT01882439|323065532|FG002|Overall Study|Pregnancy|0|||
94350979|NCT01882439|323065533|FG003|Overall Study|Pregnancy|0|||
94350980|NCT01882439|323065530|FG000|Overall Study|Protocol Violation|2|||
94350981|NCT01882439|323065531|FG001|Overall Study|Protocol Violation|2|||
94350982|NCT01882439|323065532|FG002|Overall Study|Protocol Violation|0|||
94350983|NCT01882439|323065533|FG003|Overall Study|Protocol Violation|1|||
94350984|NCT01882439|323065530|FG000|Overall Study|No longer willing to participate|1|||
94350985|NCT01882439|323065531|FG001|Overall Study|No longer willing to participate|4|||
94350986|NCT01882439|323065532|FG002|Overall Study|No longer willing to participate|2|||
94350987|NCT01882439|323065533|FG003|Overall Study|No longer willing to participate|3|||
94350988|NCT01882439|323065530|FG000|Overall Study|Medication error with no associated AE|0|||
94350989|NCT01882439|323065531|FG001|Overall Study|Medication error with no associated AE|0|||
94350990|NCT01882439|323065532|FG002|Overall Study|Medication error with no associated AE|2|||
94350991|NCT01882439|323065533|FG003|Overall Study|Medication error with no associated AE|0|||
94350992|NCT01882439|323065530|FG000|Overall Study|Insufficient clinical response|1|||
94350993|NCT01882439|323065531|FG001|Overall Study|Insufficient clinical response|4|||
94350994|NCT01882439|323065532|FG002|Overall Study|Insufficient clinical response|4|||
94350995|NCT01882439|323065533|FG003|Overall Study|Insufficient clinical response|2|||
94350996|NCT01882439|323065530|FG000|Overall Study|Adverse event unrelated to study drug|2|||
94350997|NCT01882439|323065531|FG001|Overall Study|Adverse event unrelated to study drug|2|||
94350998|NCT01882439|323065532|FG002|Overall Study|Adverse event unrelated to study drug|1|||
94350999|NCT01882439|323065533|FG003|Overall Study|Adverse event unrelated to study drug|1|||
94351000|NCT03125902|323065534|FG000|Overall Study|Adverse Event|0|||
94351001|NCT03125902|323065535|FG001|Overall Study|Adverse Event|1|||
94351002|NCT03125902|323065534|FG000|Overall Study|Death|119|||
94351003|NCT03125902|323065535|FG001|Overall Study|Death|229|||
94351004|NCT03125902|323065534|FG000|Overall Study|Lost to Follow-up|4|||
94351005|NCT03125902|323065535|FG001|Overall Study|Lost to Follow-up|13|||
94351006|NCT03125902|323065534|FG000|Overall Study|Other|0|||
94351007|NCT03125902|323065535|FG001|Overall Study|Other|4|||
94351008|NCT03125902|323065534|FG000|Overall Study|Physician Decision|2|||
94351009|NCT03125902|323065535|FG001|Overall Study|Physician Decision|1|||
94351010|NCT03125902|323065534|FG000|Overall Study|Progressive Disease|0|||
94351011|NCT03125902|323065535|FG001|Overall Study|Progressive Disease|3|||
94351012|NCT03125902|323065534|FG000|Overall Study|Study Terminated By Sponsor|74|||
94351013|NCT03125902|323065535|FG001|Overall Study|Study Terminated By Sponsor|143|||
94351014|NCT03125902|323065534|FG000|Overall Study|Withdrawal by Subject|21|||
94351015|NCT03125902|323065535|FG001|Overall Study|Withdrawal by Subject|37|||
94351016|NCT01888367|323065544|FG000|Overall Study|Physician Decision|3|||
94351017|NCT01888367|323065545|FG001|Overall Study|Physician Decision|4|||
94351018|NCT01888367|323065546|FG002|Overall Study|Physician Decision|2|||
94453299|NCT02217410|323447381|FG001|Overall Study|Graft Loss|0|||
94453300|NCT02217410|323447382|FG002|Overall Study|Graft Loss|2|||
94453301|NCT02217410|323447380|FG000|Overall Study|Withdrawal by Subject|0|||
94453302|NCT02217410|323447381|FG001|Overall Study|Withdrawal by Subject|0|||
94453303|NCT02217410|323447382|FG002|Overall Study|Withdrawal by Subject|2|||
94453304|NCT02217410|323447380|FG000|Overall Study|Lost to Follow-up|0|||
94453305|NCT02217410|323447381|FG001|Overall Study|Lost to Follow-up|0|||
94453306|NCT02217410|323447382|FG002|Overall Study|Lost to Follow-up|1|||
94453307|NCT02217410|323447380|FG000|Overall Study|Lack of Efficacy|0|||
94453308|NCT02217410|323447381|FG001|Overall Study|Lack of Efficacy|1|||
94453309|NCT02217410|323447382|FG002|Overall Study|Lack of Efficacy|0|||
94453310|NCT02217410|323447380|FG000|Overall Study|Physician Decision|1|||
94453311|NCT02217410|323447381|FG001|Overall Study|Physician Decision|3|||
94453312|NCT02217410|323447382|FG002|Overall Study|Physician Decision|0|||
94453313|NCT01940887|323447383|FG000|Year 1|Protocol Violation|0|||
94453314|NCT01940887|323447384|FG001|Year 1|Protocol Violation|1|||
94453315|NCT01940887|323447383|FG000|Year 1|Physician Decision|7|||
94453316|NCT01940887|323447384|FG001|Year 1|Physician Decision|3|||
94453317|NCT01940887|323447383|FG000|Year 1|Death|5|||
94453318|NCT01940887|323447384|FG001|Year 1|Death|3|||
94453319|NCT01940887|323447383|FG000|Year 1|Adverse Event|7|||
94453320|NCT01940887|323447384|FG001|Year 1|Adverse Event|6|||
94453321|NCT01940887|323447383|FG000|Year 1|Withdrawal by Subject|18|||
94453322|NCT01940887|323447384|FG001|Year 1|Withdrawal by Subject|9|||
94453323|NCT01940887|323447383|FG000|Year 1|Lost to Follow-up|2|||
94453324|NCT01940887|323447384|FG001|Year 1|Lost to Follow-up|1|||
94453325|NCT01940887|323447383|FG000|Year 2|Physician Decision|8|||
94453326|NCT01940887|323447384|FG001|Year 2|Physician Decision|1|||
94453327|NCT01940887|323447383|FG000|Year 2|Death|0|||
94453328|NCT01940887|323447384|FG001|Year 2|Death|2|||
94453329|NCT01940887|323447383|FG000|Year 2|Sponsor Decision, early termination|192|||
94453330|NCT01940887|323447384|FG001|Year 2|Sponsor Decision, early termination|203|||
94453331|NCT01940887|323447383|FG000|Year 2|Adverse Event|8|||
94453332|NCT01940887|323447384|FG001|Year 2|Adverse Event|2|||
94453333|NCT01940887|323447383|FG000|Year 2|Withdrawal by Subject|8|||
94453334|NCT01940887|323447384|FG001|Year 2|Withdrawal by Subject|8|||
94453335|NCT01940887|323447383|FG000|Year 2|Lost to Follow-up|1|||
94453336|NCT01940887|323447384|FG001|Year 2|Lost to Follow-up|6|||
94453337|NCT00766636|323447386|FG000|Overall Study|Withdrawal by Subject|1|||
94453338|NCT00766636|323447387|FG001|Overall Study|Withdrawal by Subject|1|||
94453339|NCT00766636|323447386|FG000|Overall Study|Incomplete Treatment|0|||
94453340|NCT00766636|323447387|FG001|Overall Study|Incomplete Treatment|1|||
94453341|NCT00766636|323447386|FG000|Overall Study|Adverse Event|1|||
94453342|NCT00766636|323447387|FG001|Overall Study|Adverse Event|0|||
94453343|NCT00766636|323447386|FG000|Overall Study|Disease Progression|1|||
94453344|NCT00766636|323447387|FG001|Overall Study|Disease Progression|0|||
94453345|NCT04657198|323447392|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
94453346|NCT04657198|323447393|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
94453347|NCT04657198|323447394|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
94453348|NCT00767455|323447420|FG000|Overall Study|Investigator error|19|||
94453349|NCT00430573|323447421|FG000|Overall Study|Withdrawal by Subject|5|||
94239639|NCT00474526|322672586|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
94239640|NCT00474526|322672587|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
94239641|NCT00474526|322672588|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
94453350|NCT03386994|323447425|FG000|Overall Study|Lung transplant|1|||
94453351|NCT03386994|323447425|FG000|Overall Study|Adverse Event|14|||
94453352|NCT03386994|323447425|FG000|Overall Study|Lost to Follow-up|4|||
94453353|NCT03386994|323447425|FG000|Overall Study|Withdrawal by Subject|3|||
94453354|NCT03386994|323447425|FG000|Overall Study|Death|16|||
94453355|NCT02640677|323447432|FG000|Overall Study|Lost to Follow-up|1|||
94453356|NCT02640677|323447432|FG000|Overall Study|Withdrawal by Subject|1|||
94575675|NCT03037385|323908445|FG003|Overall Study|Physician Decision|0|||
94575676|NCT03037385|323908446|FG004|Overall Study|Physician Decision|0|||
94575677|NCT03037385|323908447|FG005|Overall Study|Physician Decision|0|||
94453357|NCT02729051|323447435|FG000|Overall Study|Adverse Event|21|||
94453358|NCT02729051|323447436|FG001|Overall Study|Adverse Event|11|||
94453359|NCT02729051|323447435|FG000|Overall Study|Lack of Efficacy|1|||
94453360|NCT02729051|323447436|FG001|Overall Study|Lack of Efficacy|1|||
94453361|NCT02729051|323447435|FG000|Overall Study|Lost to Follow-up|1|||
94453362|NCT02729051|323447436|FG001|Overall Study|Lost to Follow-up|2|||
94453363|NCT02729051|323447435|FG000|Overall Study|Physician Decision|1|||
94453364|NCT02729051|323447436|FG001|Overall Study|Physician Decision|1|||
94453365|NCT02729051|323447435|FG000|Overall Study|Withdrawal by Subject|6|||
94453366|NCT02729051|323447436|FG001|Overall Study|Withdrawal by Subject|17|||
94453367|NCT00940823|323447437|FG000|Overall Study|Death|8|||
94453368|NCT00940823|323447438|FG001|Overall Study|Death|12|||
94453369|NCT00940823|323447437|FG000|Overall Study|Lost to Follow-up|27|||
94453370|NCT00940823|323447438|FG001|Overall Study|Lost to Follow-up|20|||
94453371|NCT04520997|323447439|FG000|Overall Study|Lost to Follow-up|1|||
94453372|NCT04520997|323447440|FG001|Overall Study|Lost to Follow-up|1|||
94453373|NCT04520997|323447439|FG000|Overall Study|Withdrawal by Subject|1|||
94453374|NCT04520997|323447440|FG001|Overall Study|Withdrawal by Subject|0|||
94453375|NCT04520997|323447439|FG000|Overall Study|Not Treated|0|||
94453376|NCT04520997|323447440|FG001|Overall Study|Not Treated|1|||
94453377|NCT02122887|323447446|FG000|Overall Study|Withdrawal by Subject|20|||
94453378|NCT02122887|323447447|FG001|Overall Study|Withdrawal by Subject|2|||
94453379|NCT01314872|323447448|FG000|Treatment Period 1|Protocol Violation|2|||
94453380|NCT01314872|323447449|FG001|Treatment Period 1|Protocol Violation|1|||
94453381|NCT01314872|323447450|FG002|Treatment Period 1|Protocol Violation|1|||
94453382|NCT01314872|323447451|FG003|Treatment Period 1|Protocol Violation|0|||
94453383|NCT01314872|323447452|FG004|Treatment Period 1|Protocol Violation|1|||
94453384|NCT01314872|323447453|FG005|Treatment Period 1|Protocol Violation|0|||
94453385|NCT01314872|323447454|FG006|Treatment Period 1|Protocol Violation|0|||
94453386|NCT01314872|323447455|FG007|Treatment Period 1|Protocol Violation|0|||
94453387|NCT01314872|323447456|FG008|Treatment Period 1|Protocol Violation|0|||
94453388|NCT01314872|323447457|FG009|Treatment Period 1|Protocol Violation|1|||
94453389|NCT01314872|323447458|FG010|Treatment Period 1|Protocol Violation|1|||
94453390|NCT01314872|323447459|FG011|Treatment Period 1|Protocol Violation|0|||
94453391|NCT01314872|323447460|FG012|Treatment Period 1|Protocol Violation|0|||
94453392|NCT01314872|323447461|FG013|Treatment Period 1|Protocol Violation|0|||
94453393|NCT01314872|323447462|FG014|Treatment Period 1|Protocol Violation|0|||
94453394|NCT01314872|323447448|FG000|Treatment Period 1|Physician Decision|0|||
94453395|NCT01314872|323447449|FG001|Treatment Period 1|Physician Decision|1|||
94453396|NCT01314872|323447450|FG002|Treatment Period 1|Physician Decision|0|||
94453397|NCT01314872|323447451|FG003|Treatment Period 1|Physician Decision|1|||
94453398|NCT01314872|323447452|FG004|Treatment Period 1|Physician Decision|0|||
94453399|NCT01314872|323447453|FG005|Treatment Period 1|Physician Decision|0|||
94453400|NCT01314872|323447454|FG006|Treatment Period 1|Physician Decision|0|||
94453401|NCT01314872|323447455|FG007|Treatment Period 1|Physician Decision|0|||
94453402|NCT01314872|323447456|FG008|Treatment Period 1|Physician Decision|0|||
94453403|NCT01314872|323447457|FG009|Treatment Period 1|Physician Decision|1|||
94453404|NCT01314872|323447458|FG010|Treatment Period 1|Physician Decision|0|||
94453405|NCT01314872|323447459|FG011|Treatment Period 1|Physician Decision|0|||
94453406|NCT01314872|323447460|FG012|Treatment Period 1|Physician Decision|0|||
94453407|NCT01314872|323447461|FG013|Treatment Period 1|Physician Decision|0|||
94453408|NCT01314872|323447462|FG014|Treatment Period 1|Physician Decision|0|||
94453409|NCT01314872|323447448|FG000|Treatment Period 1|Lack of Efficacy|1|||
94453410|NCT01314872|323447449|FG001|Treatment Period 1|Lack of Efficacy|0|||
94453411|NCT01314872|323447450|FG002|Treatment Period 1|Lack of Efficacy|0|||
94453412|NCT01314872|323447451|FG003|Treatment Period 1|Lack of Efficacy|0|||
94453413|NCT01314872|323447452|FG004|Treatment Period 1|Lack of Efficacy|0|||
94453414|NCT01314872|323447453|FG005|Treatment Period 1|Lack of Efficacy|1|||
94453415|NCT01314872|323447454|FG006|Treatment Period 1|Lack of Efficacy|0|||
94453416|NCT01314872|323447455|FG007|Treatment Period 1|Lack of Efficacy|2|||
94453417|NCT01314872|323447456|FG008|Treatment Period 1|Lack of Efficacy|0|||
94453418|NCT01314872|323447457|FG009|Treatment Period 1|Lack of Efficacy|0|||
94453419|NCT01314872|323447458|FG010|Treatment Period 1|Lack of Efficacy|0|||
94453420|NCT01314872|323447459|FG011|Treatment Period 1|Lack of Efficacy|0|||
94453421|NCT01314872|323447460|FG012|Treatment Period 1|Lack of Efficacy|0|||
94453422|NCT01314872|323447461|FG013|Treatment Period 1|Lack of Efficacy|0|||
94453423|NCT01314872|323447462|FG014|Treatment Period 1|Lack of Efficacy|0|||
94453424|NCT01314872|323447448|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
94453425|NCT01314872|323447449|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
94453426|NCT01314872|323447450|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
94453427|NCT01314872|323447451|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
94453428|NCT01314872|323447452|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
94453429|NCT01314872|323447453|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
94453430|NCT01314872|323447454|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
94453431|NCT01314872|323447455|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
94453432|NCT01314872|323447456|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
94453433|NCT01314872|323447457|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
94453434|NCT01314872|323447458|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
94453435|NCT01314872|323447459|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
94453436|NCT01314872|323447460|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
94453437|NCT01314872|323447461|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
94453438|NCT01314872|323447462|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
94453439|NCT01314872|323447448|FG000|Treatment Period 1|Withdrawal by Subject|3|||
94453440|NCT01314872|323447449|FG001|Treatment Period 1|Withdrawal by Subject|1|||
94453441|NCT01314872|323447450|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94453442|NCT01314872|323447451|FG003|Treatment Period 1|Withdrawal by Subject|2|||
94453443|NCT01314872|323447452|FG004|Treatment Period 1|Withdrawal by Subject|3|||
94453444|NCT01314872|323447453|FG005|Treatment Period 1|Withdrawal by Subject|1|||
94453445|NCT01314872|323447454|FG006|Treatment Period 1|Withdrawal by Subject|3|||
94453446|NCT01314872|323447455|FG007|Treatment Period 1|Withdrawal by Subject|2|||
94453447|NCT01314872|323447456|FG008|Treatment Period 1|Withdrawal by Subject|2|||
94453448|NCT01314872|323447457|FG009|Treatment Period 1|Withdrawal by Subject|2|||
94453449|NCT01314872|323447458|FG010|Treatment Period 1|Withdrawal by Subject|1|||
94453450|NCT01314872|323447459|FG011|Treatment Period 1|Withdrawal by Subject|0|||
94453451|NCT01314872|323447460|FG012|Treatment Period 1|Withdrawal by Subject|0|||
94453452|NCT01314872|323447461|FG013|Treatment Period 1|Withdrawal by Subject|0|||
94453453|NCT01314872|323447462|FG014|Treatment Period 1|Withdrawal by Subject|0|||
94239642|NCT00474526|322672589|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
94239643|NCT00474526|322672573|FG000|Overall Study|Adverse Event|2|||
94239644|NCT00474526|322672574|FG001|Overall Study|Adverse Event|0|||
94239645|NCT00474526|322672575|FG002|Overall Study|Adverse Event|2|||
94239646|NCT00474526|322672576|FG003|Overall Study|Adverse Event|4|||
94239647|NCT00474526|322672577|FG004|Overall Study|Adverse Event|2|||
94239648|NCT00474526|322672578|FG005|Overall Study|Adverse Event|1|||
94239649|NCT00474526|322672579|FG006|Overall Study|Adverse Event|1|||
94239650|NCT00474526|322672580|FG007|Overall Study|Adverse Event|0|||
94239651|NCT00474526|322672581|FG008|Overall Study|Adverse Event|0|||
94351019|NCT01888367|323065544|FG000|Overall Study|Death|2|||
94351020|NCT01888367|323065545|FG001|Overall Study|Death|0|||
94351021|NCT01888367|323065546|FG002|Overall Study|Death|1|||
94351022|NCT01888367|323065544|FG000|Overall Study|Withdrawal by Subject|1|||
94351023|NCT01888367|323065545|FG001|Overall Study|Withdrawal by Subject|0|||
94351024|NCT01888367|323065546|FG002|Overall Study|Withdrawal by Subject|1|||
94351025|NCT01888367|323065544|FG000|Overall Study|Lost to Follow-up|1|||
94351026|NCT01888367|323065545|FG001|Overall Study|Lost to Follow-up|1|||
94351027|NCT01888367|323065546|FG002|Overall Study|Lost to Follow-up|0|||
94351028|NCT01888367|323065544|FG000|Overall Study|Protocol Violation|0|||
94351029|NCT01888367|323065545|FG001|Overall Study|Protocol Violation|0|||
94351030|NCT01888367|323065546|FG002|Overall Study|Protocol Violation|1|||
94351031|NCT01888367|323065544|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
94351032|NCT01888367|323065545|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
94351033|NCT01888367|323065546|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
94351034|NCT01354964|323067306|FG000|Overall Study|Lost to Follow-up|2|||
94351035|NCT01354964|323067307|FG001|Overall Study|Lost to Follow-up|0|||
94351036|NCT01354964|323067306|FG000|Overall Study|IV access issues|1|||
94351037|NCT01354964|323067307|FG001|Overall Study|IV access issues|1|||
94351038|NCT01354964|323067306|FG000|Overall Study|Physician Decision|1|||
94351039|NCT01354964|323067307|FG001|Overall Study|Physician Decision|0|||
94351040|NCT04823494|323067308|FG000|Overall Study|Programming software malfunction.|1|||
94351041|NCT04823494|323067309|FG001|Overall Study|Programming software malfunction.|0|||
94351042|NCT04823494|323067308|FG000|Overall Study|Withdrawal by Subject|1|||
94351043|NCT04823494|323067309|FG001|Overall Study|Withdrawal by Subject|0|||
94351044|NCT04823494|323067308|FG000|Overall Study|Devices lost|0|||
94351045|NCT04823494|323067309|FG001|Overall Study|Devices lost|1|||
94351046|NCT01265719|323067313|FG000|Overall Study|Does not meet entrance criteria|0|||
94351047|NCT01265719|323067314|FG001|Overall Study|Does not meet entrance criteria|3|||
94351048|NCT01265719|323067313|FG000|Overall Study|Other reasons|2|||
94351049|NCT01265719|323067314|FG001|Overall Study|Other reasons|0|||
94351050|NCT01265719|323067313|FG000|Overall Study|Withdrawal by Subject|8|||
94351051|NCT01265719|323067314|FG001|Overall Study|Withdrawal by Subject|3|||
94351052|NCT01265719|323067313|FG000|Overall Study|Lost to Follow-up|2|||
94351053|NCT01265719|323067314|FG001|Overall Study|Lost to Follow-up|7|||
94453454|NCT01314872|323447448|FG000|Treatment Period 1|Lost to Follow-up|0|||
94453455|NCT01314872|323447449|FG001|Treatment Period 1|Lost to Follow-up|1|||
94239652|NCT00474526|322672582|FG009|Overall Study|Adverse Event|0|||
94351054|NCT01265719|323067313|FG000|Overall Study|Adverse Event|2|||
94351055|NCT01265719|323067314|FG001|Overall Study|Adverse Event|0|||
94453456|NCT01314872|323447450|FG002|Treatment Period 1|Lost to Follow-up|2|||
94453457|NCT01314872|323447451|FG003|Treatment Period 1|Lost to Follow-up|2|||
94575678|NCT03037385|323908448|FG006|Overall Study|Physician Decision|0|||
94351056|NCT05604781|323067323|FG000|Overall Study|Lost to Follow-up|3|||
94239653|NCT00474526|322672583|FG010|Overall Study|Adverse Event|0|||
94239654|NCT00474526|322672584|FG011|Overall Study|Adverse Event|0|||
94239655|NCT00474526|322672585|FG012|Overall Study|Adverse Event|0|||
94239656|NCT00474526|322672586|FG013|Overall Study|Adverse Event|0|||
94239657|NCT00474526|322672587|FG014|Overall Study|Adverse Event|1|||
94453458|NCT01314872|323447452|FG004|Treatment Period 1|Lost to Follow-up|1|||
94453459|NCT01314872|323447453|FG005|Treatment Period 1|Lost to Follow-up|1|||
94453460|NCT01314872|323447454|FG006|Treatment Period 1|Lost to Follow-up|1|||
94453461|NCT01314872|323447455|FG007|Treatment Period 1|Lost to Follow-up|1|||
94453462|NCT01314872|323447456|FG008|Treatment Period 1|Lost to Follow-up|1|||
94453463|NCT01314872|323447457|FG009|Treatment Period 1|Lost to Follow-up|0|||
94453464|NCT01314872|323447458|FG010|Treatment Period 1|Lost to Follow-up|0|||
94453465|NCT01314872|323447459|FG011|Treatment Period 1|Lost to Follow-up|0|||
94453466|NCT01314872|323447460|FG012|Treatment Period 1|Lost to Follow-up|0|||
94453467|NCT01314872|323447461|FG013|Treatment Period 1|Lost to Follow-up|0|||
94453468|NCT01314872|323447462|FG014|Treatment Period 1|Lost to Follow-up|0|||
94453469|NCT01314872|323447448|FG000|Period 2|Protocol Violation|0|||
94453470|NCT01314872|323447449|FG001|Period 2|Protocol Violation|0|||
94239658|NCT00474526|322672588|FG015|Overall Study|Adverse Event|1|||
94239659|NCT00474526|322672589|FG016|Overall Study|Adverse Event|0|||
94239660|NCT00474526|322672573|FG000|Overall Study|Death|0|||
94239661|NCT00474526|322672574|FG001|Overall Study|Death|0|||
94239662|NCT00474526|322672575|FG002|Overall Study|Death|0|||
94239663|NCT00474526|322672576|FG003|Overall Study|Death|0|||
94239664|NCT00474526|322672577|FG004|Overall Study|Death|0|||
94239665|NCT00474526|322672578|FG005|Overall Study|Death|0|||
94239666|NCT00474526|322672579|FG006|Overall Study|Death|0|||
94239667|NCT00474526|322672580|FG007|Overall Study|Death|0|||
94239668|NCT00474526|322672581|FG008|Overall Study|Death|0|||
94239669|NCT00474526|322672582|FG009|Overall Study|Death|0|||
94239670|NCT00474526|322672583|FG010|Overall Study|Death|0|||
94239671|NCT00474526|322672584|FG011|Overall Study|Death|0|||
94239672|NCT00474526|322672585|FG012|Overall Study|Death|0|||
94239673|NCT00474526|322672586|FG013|Overall Study|Death|3|||
94239674|NCT00474526|322672587|FG014|Overall Study|Death|0|||
94239675|NCT00474526|322672588|FG015|Overall Study|Death|0|||
94239676|NCT00474526|322672589|FG016|Overall Study|Death|0|||
94239677|NCT00474526|322672573|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
94239678|NCT00474526|322672574|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
94239679|NCT00474526|322672575|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
94239680|NCT00474526|322672576|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
94239681|NCT00474526|322672577|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
94239682|NCT00474526|322672578|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
94239683|NCT00474526|322672579|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
94239684|NCT00474526|322672580|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
94239685|NCT00474526|322672581|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
94239686|NCT00474526|322672582|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
94239687|NCT00474526|322672583|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
94453471|NCT01314872|323447450|FG002|Period 2|Protocol Violation|0|||
94453472|NCT01314872|323447451|FG003|Period 2|Protocol Violation|0|||
94453473|NCT01314872|323447452|FG004|Period 2|Protocol Violation|0|||
94453474|NCT01314872|323447453|FG005|Period 2|Protocol Violation|0|||
94453475|NCT01314872|323447454|FG006|Period 2|Protocol Violation|0|||
94453476|NCT01314872|323447455|FG007|Period 2|Protocol Violation|0|||
94453477|NCT01314872|323447456|FG008|Period 2|Protocol Violation|0|||
94453478|NCT01314872|323447457|FG009|Period 2|Protocol Violation|0|||
94453479|NCT01314872|323447458|FG010|Period 2|Protocol Violation|0|||
94453480|NCT01314872|323447459|FG011|Period 2|Protocol Violation|3|||
94453481|NCT01314872|323447460|FG012|Period 2|Protocol Violation|3|||
94453482|NCT01314872|323447461|FG013|Period 2|Protocol Violation|2|||
94453483|NCT01314872|323447462|FG014|Period 2|Protocol Violation|0|||
94453484|NCT01314872|323447448|FG000|Period 2|Non-compliance with study drug|0|||
94239688|NCT00474526|322672584|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
94239689|NCT00474526|322672585|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
94453485|NCT01314872|323447449|FG001|Period 2|Non-compliance with study drug|0|||
94575679|NCT03037385|323908449|FG007|Overall Study|Physician Decision|0|||
94575680|NCT03037385|323908450|FG008|Overall Study|Physician Decision|0|||
94239690|NCT00474526|322672586|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
94239691|NCT00474526|322672587|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
94239692|NCT00474526|322672588|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
94239693|NCT00474526|322672589|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
94239694|NCT00474526|322672573|FG000|Overall Study|Lost to Follow-up|8|||
94239695|NCT00474526|322672574|FG001|Overall Study|Lost to Follow-up|6|||
94453486|NCT01314872|323447450|FG002|Period 2|Non-compliance with study drug|0|||
94453487|NCT01314872|323447451|FG003|Period 2|Non-compliance with study drug|0|||
94453488|NCT01314872|323447452|FG004|Period 2|Non-compliance with study drug|0|||
94453489|NCT01314872|323447453|FG005|Period 2|Non-compliance with study drug|0|||
94453490|NCT01314872|323447454|FG006|Period 2|Non-compliance with study drug|0|||
94453491|NCT01314872|323447455|FG007|Period 2|Non-compliance with study drug|0|||
94575681|NCT03037385|323908451|FG009|Overall Study|Physician Decision|1|||
94453492|NCT01314872|323447456|FG008|Period 2|Non-compliance with study drug|0|||
94453493|NCT01314872|323447457|FG009|Period 2|Non-compliance with study drug|0|||
94453494|NCT01314872|323447458|FG010|Period 2|Non-compliance with study drug|0|||
94453495|NCT01314872|323447459|FG011|Period 2|Non-compliance with study drug|3|||
94453496|NCT01314872|323447460|FG012|Period 2|Non-compliance with study drug|3|||
94453497|NCT01314872|323447461|FG013|Period 2|Non-compliance with study drug|1|||
94453498|NCT01314872|323447462|FG014|Period 2|Non-compliance with study drug|2|||
94453499|NCT01314872|323447448|FG000|Period 2|Lack of Efficacy|0|||
94453500|NCT01314872|323447449|FG001|Period 2|Lack of Efficacy|0|||
94453501|NCT01314872|323447450|FG002|Period 2|Lack of Efficacy|0|||
94453502|NCT01314872|323447451|FG003|Period 2|Lack of Efficacy|0|||
94453503|NCT01314872|323447452|FG004|Period 2|Lack of Efficacy|0|||
94453504|NCT01314872|323447453|FG005|Period 2|Lack of Efficacy|0|||
94453505|NCT01314872|323447454|FG006|Period 2|Lack of Efficacy|0|||
94453506|NCT01314872|323447455|FG007|Period 2|Lack of Efficacy|0|||
94453507|NCT01314872|323447456|FG008|Period 2|Lack of Efficacy|0|||
94575682|NCT03037385|323908442|FG000|Overall Study|Progressive Disease|0|||
94453508|NCT01314872|323447457|FG009|Period 2|Lack of Efficacy|0|||
94453509|NCT01314872|323447458|FG010|Period 2|Lack of Efficacy|0|||
94453510|NCT01314872|323447459|FG011|Period 2|Lack of Efficacy|7|||
94453511|NCT01314872|323447460|FG012|Period 2|Lack of Efficacy|12|||
94453512|NCT01314872|323447461|FG013|Period 2|Lack of Efficacy|9|||
94453513|NCT01314872|323447462|FG014|Period 2|Lack of Efficacy|2|||
94453514|NCT01314872|323447448|FG000|Period 2|Pregnancy|0|||
94453515|NCT01314872|323447449|FG001|Period 2|Pregnancy|0|||
94453516|NCT01314872|323447450|FG002|Period 2|Pregnancy|0|||
94453517|NCT01314872|323447451|FG003|Period 2|Pregnancy|0|||
94453518|NCT01314872|323447452|FG004|Period 2|Pregnancy|0|||
94453519|NCT01314872|323447453|FG005|Period 2|Pregnancy|0|||
94453520|NCT01314872|323447454|FG006|Period 2|Pregnancy|0|||
94453521|NCT01314872|323447455|FG007|Period 2|Pregnancy|0|||
94453522|NCT01314872|323447456|FG008|Period 2|Pregnancy|0|||
94453523|NCT01314872|323447457|FG009|Period 2|Pregnancy|0|||
94453524|NCT01314872|323447458|FG010|Period 2|Pregnancy|0|||
94453525|NCT01314872|323447459|FG011|Period 2|Pregnancy|0|||
94453526|NCT01314872|323447460|FG012|Period 2|Pregnancy|0|||
94453527|NCT01314872|323447461|FG013|Period 2|Pregnancy|0|||
94453528|NCT01314872|323447462|FG014|Period 2|Pregnancy|1|||
94453529|NCT01314872|323447448|FG000|Period 2|Study terminated by Sponsor|0|||
94453530|NCT01314872|323447449|FG001|Period 2|Study terminated by Sponsor|0|||
94453531|NCT01314872|323447450|FG002|Period 2|Study terminated by Sponsor|0|||
94453532|NCT01314872|323447451|FG003|Period 2|Study terminated by Sponsor|0|||
94453533|NCT01314872|323447452|FG004|Period 2|Study terminated by Sponsor|0|||
94453534|NCT01314872|323447453|FG005|Period 2|Study terminated by Sponsor|0|||
94453535|NCT01314872|323447454|FG006|Period 2|Study terminated by Sponsor|0|||
94453536|NCT01314872|323447455|FG007|Period 2|Study terminated by Sponsor|0|||
94453537|NCT01314872|323447456|FG008|Period 2|Study terminated by Sponsor|0|||
94453538|NCT01314872|323447457|FG009|Period 2|Study terminated by Sponsor|0|||
94453539|NCT01314872|323447458|FG010|Period 2|Study terminated by Sponsor|0|||
94453540|NCT01314872|323447459|FG011|Period 2|Study terminated by Sponsor|2|||
94453541|NCT01314872|323447460|FG012|Period 2|Study terminated by Sponsor|2|||
94453542|NCT01314872|323447461|FG013|Period 2|Study terminated by Sponsor|3|||
94453543|NCT01314872|323447462|FG014|Period 2|Study terminated by Sponsor|0|||
94453544|NCT01314872|323447448|FG000|Period 2|Adverse event, non-fatal|0|||
94453545|NCT01314872|323447449|FG001|Period 2|Adverse event, non-fatal|0|||
94453546|NCT01314872|323447450|FG002|Period 2|Adverse event, non-fatal|0|||
94453547|NCT01314872|323447451|FG003|Period 2|Adverse event, non-fatal|0|||
94351057|NCT05604781|323067323|FG000|Overall Study|Adverse Event|1|||
94351058|NCT01005966|323067324|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
94351059|NCT01005966|323067325|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
94351060|NCT01005966|323067326|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
94351061|NCT01005966|323067327|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
94351062|NCT01005966|323067328|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
94351063|NCT01005966|323067324|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
94351064|NCT01005966|323067325|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
94351065|NCT01005966|323067326|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
94351066|NCT01005966|323067327|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
94351067|NCT01005966|323067328|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
94351068|NCT01005966|323067324|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
94351069|NCT01005966|323067325|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
94351070|NCT01005966|323067326|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
94351071|NCT01005966|323067327|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
94351072|NCT01005966|323067328|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
94351073|NCT01005966|323067324|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
94351074|NCT01005966|323067325|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
94351075|NCT01005966|323067326|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
94351076|NCT01005966|323067327|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
94351077|NCT01005966|323067328|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
94351078|NCT01005966|323067324|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
94351079|NCT01005966|323067325|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
94351080|NCT01005966|323067326|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
94351081|NCT01005966|323067327|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
94351082|NCT01005966|323067328|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
94351083|NCT01005966|323067324|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
94351084|NCT01005966|323067325|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
94453548|NCT01314872|323447452|FG004|Period 2|Adverse event, non-fatal|0|||
94453549|NCT01314872|323447453|FG005|Period 2|Adverse event, non-fatal|0|||
94453550|NCT01314872|323447454|FG006|Period 2|Adverse event, non-fatal|0|||
94575683|NCT03037385|323908443|FG001|Overall Study|Progressive Disease|1|||
94575684|NCT03037385|323908444|FG002|Overall Study|Progressive Disease|1|||
94453551|NCT01314872|323447455|FG007|Period 2|Adverse event, non-fatal|0|||
94453552|NCT01314872|323447456|FG008|Period 2|Adverse event, non-fatal|0|||
94453553|NCT01314872|323447457|FG009|Period 2|Adverse event, non-fatal|0|||
94453554|NCT01314872|323447458|FG010|Period 2|Adverse event, non-fatal|0|||
94453555|NCT01314872|323447459|FG011|Period 2|Adverse event, non-fatal|13|||
94453556|NCT01314872|323447460|FG012|Period 2|Adverse event, non-fatal|16|||
94453557|NCT01314872|323447461|FG013|Period 2|Adverse event, non-fatal|24|||
94453558|NCT01314872|323447462|FG014|Period 2|Adverse event, non-fatal|9|||
94453559|NCT01314872|323447448|FG000|Period 2|Withdrawal by Subject|0|||
94453560|NCT01314872|323447449|FG001|Period 2|Withdrawal by Subject|0|||
94453561|NCT01314872|323447450|FG002|Period 2|Withdrawal by Subject|0|||
94453562|NCT01314872|323447451|FG003|Period 2|Withdrawal by Subject|0|||
94453563|NCT01314872|323447452|FG004|Period 2|Withdrawal by Subject|0|||
94453564|NCT01314872|323447453|FG005|Period 2|Withdrawal by Subject|0|||
94453565|NCT01314872|323447454|FG006|Period 2|Withdrawal by Subject|0|||
94453566|NCT01314872|323447455|FG007|Period 2|Withdrawal by Subject|0|||
94453567|NCT01314872|323447456|FG008|Period 2|Withdrawal by Subject|0|||
94453568|NCT01314872|323447457|FG009|Period 2|Withdrawal by Subject|0|||
94453569|NCT01314872|323447458|FG010|Period 2|Withdrawal by Subject|0|||
94453570|NCT01314872|323447459|FG011|Period 2|Withdrawal by Subject|14|||
94453571|NCT01314872|323447460|FG012|Period 2|Withdrawal by Subject|17|||
94453572|NCT01314872|323447461|FG013|Period 2|Withdrawal by Subject|12|||
94453573|NCT01314872|323447462|FG014|Period 2|Withdrawal by Subject|4|||
94453574|NCT01314872|323447448|FG000|Period 2|Lost to Follow-up|0|||
94453575|NCT01314872|323447449|FG001|Period 2|Lost to Follow-up|0|||
94453576|NCT01314872|323447450|FG002|Period 2|Lost to Follow-up|0|||
94453577|NCT01314872|323447451|FG003|Period 2|Lost to Follow-up|0|||
94453578|NCT01314872|323447452|FG004|Period 2|Lost to Follow-up|0|||
94453579|NCT01314872|323447453|FG005|Period 2|Lost to Follow-up|0|||
94453580|NCT01314872|323447454|FG006|Period 2|Lost to Follow-up|0|||
94453581|NCT01314872|323447455|FG007|Period 2|Lost to Follow-up|0|||
94453582|NCT01314872|323447456|FG008|Period 2|Lost to Follow-up|0|||
94453583|NCT01314872|323447457|FG009|Period 2|Lost to Follow-up|0|||
94453584|NCT01314872|323447458|FG010|Period 2|Lost to Follow-up|0|||
94453585|NCT01314872|323447459|FG011|Period 2|Lost to Follow-up|6|||
94453586|NCT01314872|323447460|FG012|Period 2|Lost to Follow-up|7|||
94453587|NCT01314872|323447461|FG013|Period 2|Lost to Follow-up|2|||
94453588|NCT01314872|323447462|FG014|Period 2|Lost to Follow-up|6|||
94453589|NCT03274687|323448920|FG000|Overall Study|Protocol Violation|1|||
94453590|NCT03274687|323448921|FG001|Overall Study|Protocol Violation|1|||
94453591|NCT04925557|323448922|FG000|Overall Study|Study closed|5|||
94453592|NCT04925557|323448923|FG001|Overall Study|Study closed|3|||
94453593|NCT05488470|323448924|FG000|Overall Study|Physician Decision|2|||
94453594|NCT05488470|323448924|FG000|Overall Study|Withdrawal by Subject|1|||
94453595|NCT05488470|323448924|FG000|Overall Study|Death|1|||
94453596|NCT00068393|323448925|FG000|Overall Study|Adverse Event|2|||
94453597|NCT00068393|323448925|FG000|Overall Study|Death|3|||
94453598|NCT00068393|323448925|FG000|Overall Study|Withdrawal by Subject|3|||
94453599|NCT00068393|323448925|FG000|Overall Study|Alternative treatment|1|||
94453600|NCT00068393|323448925|FG000|Overall Study|Quality of life worsening|1|||
94453601|NCT04390503|323448937|FG000|Overall Study|Physician Decision|2|||
94453602|NCT04390503|323448938|FG001|Overall Study|Physician Decision|1|||
94453603|NCT04390503|323448937|FG000|Overall Study|Adverse Event|1|||
94453604|NCT04390503|323448938|FG001|Overall Study|Adverse Event|0|||
94453605|NCT01515865|323448940|FG000|Part A (Open-label)|Other|3|||
94453606|NCT01515865|323448941|FG001|Part A (Open-label)|Other|0|||
94453607|NCT01515865|323448942|FG002|Part A (Open-label)|Other|0|||
94453608|NCT01515865|323448940|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
94453609|NCT01515865|323448941|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
94453610|NCT01515865|323448942|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
94453611|NCT01515865|323448940|FG000|Part B (Open-label)|Other|1|||
94453612|NCT01515865|323448941|FG001|Part B (Open-label)|Other|0|||
94351085|NCT01005966|323067326|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
94351086|NCT01005966|323067327|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
94351087|NCT01005966|323067328|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
94351088|NCT01005966|323067324|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
94351089|NCT01005966|323067325|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
94351090|NCT01005966|323067326|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
94351091|NCT01005966|323067327|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
94453613|NCT01515865|323448942|FG002|Part B (Open-label)|Other|0|||
94453614|NCT00459290|323448943|FG000|Overall Study|Adverse Event|3|||
94453615|NCT00459290|323448943|FG000|Overall Study|Ineligible|2|||
94453616|NCT00594100|323448944|FG000|Procedure|Technical Failure|9|||
94453617|NCT00594100|323448944|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
94453618|NCT00594100|323448944|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
94575685|NCT03037385|323908445|FG003|Overall Study|Progressive Disease|5|||
94351092|NCT01005966|323067328|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
94351093|NCT01005966|323067324|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
94453619|NCT00594100|323448944|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
94453620|NCT05483686|323448945|FG000|Overall Study|Lost to Follow-up|5|||
94453621|NCT05483686|323448946|FG001|Overall Study|Lost to Follow-up|7|||
94453622|NCT00956592|323448947|FG000|Overall Study|Protocol Violation|1|||
94453623|NCT00956592|323448948|FG001|Overall Study|Protocol Violation|3|||
94453624|NCT02448537|323448949|FG000|Overall Study|Withdrawal by Subject|1|||
94453625|NCT02448537|323448950|FG001|Overall Study|Withdrawal by Subject|1|||
94239696|NCT00474526|322672575|FG002|Overall Study|Lost to Follow-up|13|||
94239697|NCT00474526|322672576|FG003|Overall Study|Lost to Follow-up|29|||
94239698|NCT00474526|322672577|FG004|Overall Study|Lost to Follow-up|11|||
94239699|NCT00474526|322672578|FG005|Overall Study|Lost to Follow-up|5|||
94239700|NCT00474526|322672579|FG006|Overall Study|Lost to Follow-up|8|||
94239701|NCT00474526|322672580|FG007|Overall Study|Lost to Follow-up|1|||
94351094|NCT01005966|323067325|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
94351095|NCT01005966|323067326|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
94351096|NCT01005966|323067327|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
94351097|NCT01005966|323067328|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
94351098|NCT01005966|323067324|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
94351099|NCT01005966|323067325|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
94351100|NCT01005966|323067326|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
94351101|NCT01005966|323067327|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
94351102|NCT01005966|323067328|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
94351103|NCT01249404|323067331|FG000|Overall Study|Study treatment not received|0|||
94351104|NCT01249404|323067332|FG001|Overall Study|Study treatment not received|1|||
94351105|NCT01249404|323067333|FG002|Overall Study|Study treatment not received|2|||
94351106|NCT01249404|323067331|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
94351107|NCT01249404|323067332|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
94351108|NCT01249404|323067333|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
94351109|NCT01249404|323067331|FG000|Overall Study|Adverse Event|2|||
94351110|NCT01249404|323067332|FG001|Overall Study|Adverse Event|2|||
94351111|NCT01249404|323067333|FG002|Overall Study|Adverse Event|2|||
94351112|NCT01249404|323067331|FG000|Overall Study|Withdrawal by Subject|2|||
94351113|NCT01249404|323067332|FG001|Overall Study|Withdrawal by Subject|2|||
94351114|NCT01249404|323067333|FG002|Overall Study|Withdrawal by Subject|0|||
94351115|NCT01249404|323067331|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
94351116|NCT01249404|323067332|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
94351117|NCT01249404|323067333|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
94351118|NCT01249404|323067331|FG000|Overall Study|Non compliance to visit schedule|0|||
94351119|NCT01249404|323067332|FG001|Overall Study|Non compliance to visit schedule|1|||
94351120|NCT01249404|323067333|FG002|Overall Study|Non compliance to visit schedule|0|||
94351121|NCT02927990|323067334|FG000|Overall Study|Protocol Violation|4|||
94351122|NCT02927990|323067334|FG000|Overall Study|Physician Decision|9|||
94351123|NCT02927990|323067334|FG000|Overall Study|Room switched and therefore no study device available|15|||
94351124|NCT02927990|323067334|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
94351125|NCT04450394|323067343|FG000|Overall Study|Adverse Event|2|||
94351126|NCT04450394|323067344|FG001|Overall Study|Adverse Event|0|||
94351127|NCT04450394|323067345|FG002|Overall Study|Adverse Event|0|||
94351128|NCT04450394|323067343|FG000|Overall Study|Death|0|||
94351129|NCT04450394|323067344|FG001|Overall Study|Death|1|||
94351130|NCT04450394|323067345|FG002|Overall Study|Death|0|||
94351131|NCT04450394|323067343|FG000|Overall Study|Lost to Follow-up|0|||
94351132|NCT04450394|323067344|FG001|Overall Study|Lost to Follow-up|3|||
94351133|NCT04450394|323067345|FG002|Overall Study|Lost to Follow-up|0|||
94351134|NCT04450394|323067343|FG000|Overall Study|Physician Decision|0|||
94351135|NCT04450394|323067344|FG001|Overall Study|Physician Decision|1|||
94351136|NCT04450394|323067345|FG002|Overall Study|Physician Decision|0|||
94351137|NCT04450394|323067343|FG000|Overall Study|Protocol Violation|2|||
94351138|NCT04450394|323067344|FG001|Overall Study|Protocol Violation|0|||
94351139|NCT04450394|323067345|FG002|Overall Study|Protocol Violation|0|||
94351140|NCT04450394|323067343|FG000|Overall Study|Withdrawal by Subject|6|||
94351141|NCT04450394|323067344|FG001|Overall Study|Withdrawal by Subject|9|||
94351142|NCT04450394|323067345|FG002|Overall Study|Withdrawal by Subject|0|||
94351143|NCT01066819|323067350|FG000|Overall Study|Adverse Event|18|||
94351144|NCT01066819|323067351|FG001|Overall Study|Adverse Event|1|||
94351145|NCT01066819|323067352|FG002|Overall Study|Adverse Event|6|||
94351146|NCT01066819|323067353|FG003|Overall Study|Adverse Event|0|||
94351147|NCT01066819|323067354|FG004|Overall Study|Adverse Event|0|||
94351148|NCT01066819|323067355|FG005|Overall Study|Adverse Event|0|||
94351149|NCT01066819|323067350|FG000|Overall Study|Death|5|||
94351150|NCT01066819|323067351|FG001|Overall Study|Death|0|||
94351151|NCT01066819|323067352|FG002|Overall Study|Death|1|||
94351152|NCT01066819|323067353|FG003|Overall Study|Death|0|||
94351153|NCT01066819|323067354|FG004|Overall Study|Death|0|||
94351154|NCT01066819|323067355|FG005|Overall Study|Death|0|||
94351155|NCT01066819|323067350|FG000|Overall Study|Lack of Efficacy|22|||
94351156|NCT01066819|323067351|FG001|Overall Study|Lack of Efficacy|1|||
94351157|NCT01066819|323067352|FG002|Overall Study|Lack of Efficacy|2|||
94351158|NCT01066819|323067353|FG003|Overall Study|Lack of Efficacy|1|||
94351159|NCT01066819|323067354|FG004|Overall Study|Lack of Efficacy|0|||
94351160|NCT01066819|323067355|FG005|Overall Study|Lack of Efficacy|0|||
94351161|NCT01066819|323067350|FG000|Overall Study|Physician Decision|6|||
94351162|NCT01066819|323067351|FG001|Overall Study|Physician Decision|2|||
94239702|NCT00474526|322672581|FG008|Overall Study|Lost to Follow-up|0|||
94239703|NCT00474526|322672582|FG009|Overall Study|Lost to Follow-up|6|||
94239704|NCT00474526|322672583|FG010|Overall Study|Lost to Follow-up|2|||
94453626|NCT02448537|323448951|FG002|Overall Study|Withdrawal by Subject|1|||
94453627|NCT01270464|323448952|FG000|Overall Study|Protocol Violation|4|||
94453628|NCT01270464|323448953|FG001|Overall Study|Protocol Violation|3|||
94453629|NCT01270464|323448954|FG002|Overall Study|Protocol Violation|2|||
94453630|NCT01270464|323448952|FG000|Overall Study|Lack of Efficacy|2|||
94453631|NCT01270464|323448953|FG001|Overall Study|Lack of Efficacy|3|||
94453632|NCT01270464|323448954|FG002|Overall Study|Lack of Efficacy|1|||
94453633|NCT01270464|323448952|FG000|Overall Study|Adverse Event|9|||
94453634|NCT01270464|323448953|FG001|Overall Study|Adverse Event|1|||
94453635|NCT01270464|323448954|FG002|Overall Study|Adverse Event|7|||
94239705|NCT00474526|322672584|FG011|Overall Study|Lost to Follow-up|4|||
94239706|NCT00474526|322672585|FG012|Overall Study|Lost to Follow-up|6|||
94453636|NCT01270464|323448952|FG000|Overall Study|Withdrawal by Subject|2|||
94239707|NCT00474526|322672586|FG013|Overall Study|Lost to Follow-up|74|||
94239708|NCT00474526|322672587|FG014|Overall Study|Lost to Follow-up|29|||
94239709|NCT00474526|322672588|FG015|Overall Study|Lost to Follow-up|4|||
94239710|NCT00474526|322672589|FG016|Overall Study|Lost to Follow-up|5|||
94239711|NCT00474526|322672573|FG000|Overall Study|Protocol Violation|2|||
94239712|NCT00474526|322672574|FG001|Overall Study|Protocol Violation|6|||
94239713|NCT00474526|322672575|FG002|Overall Study|Protocol Violation|4|||
94239714|NCT00474526|322672576|FG003|Overall Study|Protocol Violation|12|||
94239715|NCT00474526|322672577|FG004|Overall Study|Protocol Violation|3|||
94239716|NCT00474526|322672578|FG005|Overall Study|Protocol Violation|1|||
94239717|NCT00474526|322672579|FG006|Overall Study|Protocol Violation|3|||
94239718|NCT00474526|322672580|FG007|Overall Study|Protocol Violation|0|||
94239719|NCT00474526|322672581|FG008|Overall Study|Protocol Violation|0|||
94239720|NCT00474526|322672582|FG009|Overall Study|Protocol Violation|4|||
94239721|NCT00474526|322672583|FG010|Overall Study|Protocol Violation|2|||
94239722|NCT00474526|322672584|FG011|Overall Study|Protocol Violation|2|||
94239723|NCT00474526|322672585|FG012|Overall Study|Protocol Violation|4|||
94239724|NCT00474526|322672586|FG013|Overall Study|Protocol Violation|19|||
94239725|NCT00474526|322672587|FG014|Overall Study|Protocol Violation|9|||
94239726|NCT00474526|322672588|FG015|Overall Study|Protocol Violation|6|||
94239727|NCT00474526|322672589|FG016|Overall Study|Protocol Violation|2|||
94239728|NCT00474526|322672573|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
94239729|NCT00474526|322672574|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
94239730|NCT00474526|322672575|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
94239731|NCT00474526|322672576|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
94239732|NCT00474526|322672577|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
94239733|NCT00474526|322672578|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
94239734|NCT00474526|322672579|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
94239735|NCT00474526|322672580|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
94239736|NCT00474526|322672581|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
94239737|NCT00474526|322672582|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
94239738|NCT00474526|322672583|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
94239739|NCT00474526|322672584|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
94239740|NCT00474526|322672585|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
94239741|NCT00474526|322672586|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
94239742|NCT00474526|322672587|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
94239743|NCT00474526|322672588|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
94239744|NCT00474526|322672589|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
94239745|NCT00474526|322672573|FG000|Overall Study|Withdrawal by Subject|9|||
94239746|NCT00474526|322672574|FG001|Overall Study|Withdrawal by Subject|24|||
94239747|NCT00474526|322672575|FG002|Overall Study|Withdrawal by Subject|21|||
94239748|NCT00474526|322672576|FG003|Overall Study|Withdrawal by Subject|52|||
94239749|NCT00474526|322672577|FG004|Overall Study|Withdrawal by Subject|38|||
94239750|NCT00474526|322672578|FG005|Overall Study|Withdrawal by Subject|6|||
94453637|NCT01270464|323448953|FG001|Overall Study|Withdrawal by Subject|1|||
94453638|NCT01270464|323448954|FG002|Overall Study|Withdrawal by Subject|4|||
94453639|NCT01270464|323448952|FG000|Overall Study|Lost to Follow-up|2|||
94453640|NCT01270464|323448953|FG001|Overall Study|Lost to Follow-up|3|||
94575686|NCT03037385|323908446|FG004|Overall Study|Progressive Disease|2|||
94239751|NCT00474526|322672579|FG006|Overall Study|Withdrawal by Subject|12|||
94239752|NCT00474526|322672580|FG007|Overall Study|Withdrawal by Subject|4|||
94239753|NCT00474526|322672581|FG008|Overall Study|Withdrawal by Subject|4|||
94239754|NCT00474526|322672582|FG009|Overall Study|Withdrawal by Subject|13|||
94239755|NCT00474526|322672583|FG010|Overall Study|Withdrawal by Subject|5|||
94453641|NCT01270464|323448954|FG002|Overall Study|Lost to Follow-up|1|||
94239756|NCT00474526|322672584|FG011|Overall Study|Withdrawal by Subject|4|||
94239757|NCT00474526|322672585|FG012|Overall Study|Withdrawal by Subject|4|||
94239758|NCT00474526|322672586|FG013|Overall Study|Withdrawal by Subject|37|||
94239759|NCT00474526|322672587|FG014|Overall Study|Withdrawal by Subject|22|||
94239760|NCT00474526|322672588|FG015|Overall Study|Withdrawal by Subject|1|||
94453642|NCT01270464|323448952|FG000|Overall Study|Other|1|||
94453643|NCT01270464|323448953|FG001|Overall Study|Other|1|||
94453644|NCT01270464|323448954|FG002|Overall Study|Other|3|||
94453645|NCT01057810|323448964|FG000|Overall Study|Disease progression|156|||
94239761|NCT00474526|322672589|FG016|Overall Study|Withdrawal by Subject|1|||
94453646|NCT01057810|323448965|FG001|Overall Study|Disease progression|197|||
94453647|NCT01057810|323448964|FG000|Overall Study|Study drug toxicity|5|||
94453648|NCT01057810|323448965|FG001|Overall Study|Study drug toxicity|114|||
94453649|NCT01057810|323448964|FG000|Overall Study|Adverse event unrelated to study drug|13|||
94453650|NCT01057810|323448965|FG001|Overall Study|Adverse event unrelated to study drug|29|||
94453651|NCT01057810|323448964|FG000|Overall Study|Withdrawal by Subject|10|||
94453652|NCT01057810|323448965|FG001|Overall Study|Withdrawal by Subject|25|||
94453653|NCT01057810|323448964|FG000|Overall Study|Death|2|||
94453654|NCT01057810|323448965|FG001|Overall Study|Death|12|||
94453655|NCT01057810|323448964|FG000|Overall Study|Maximum clinical benefit|5|||
94453656|NCT01057810|323448965|FG001|Overall Study|Maximum clinical benefit|5|||
94453657|NCT01057810|323448964|FG000|Overall Study|Poor/non-compliance|0|||
94453658|NCT01057810|323448965|FG001|Overall Study|Poor/non-compliance|1|||
94453659|NCT01057810|323448964|FG000|Overall Study|No longer met study criteria|0|||
94453660|NCT01057810|323448965|FG001|Overall Study|No longer met study criteria|1|||
94453661|NCT01057810|323448964|FG000|Overall Study|Other|7|||
94351163|NCT01066819|323067352|FG002|Overall Study|Physician Decision|3|||
94351164|NCT01066819|323067353|FG003|Overall Study|Physician Decision|0|||
94351165|NCT01066819|323067354|FG004|Overall Study|Physician Decision|0|||
94351166|NCT01066819|323067355|FG005|Overall Study|Physician Decision|0|||
94351167|NCT01066819|323067350|FG000|Overall Study|Protocol Violation|12|||
94351168|NCT01066819|323067351|FG001|Overall Study|Protocol Violation|6|||
94351169|NCT01066819|323067352|FG002|Overall Study|Protocol Violation|0|||
94351170|NCT01066819|323067353|FG003|Overall Study|Protocol Violation|0|||
94351171|NCT01066819|323067354|FG004|Overall Study|Protocol Violation|0|||
94351172|NCT01066819|323067355|FG005|Overall Study|Protocol Violation|0|||
94351173|NCT01066819|323067350|FG000|Overall Study|Withdrawal by Subject|29|||
94351174|NCT01066819|323067351|FG001|Overall Study|Withdrawal by Subject|11|||
94351175|NCT01066819|323067352|FG002|Overall Study|Withdrawal by Subject|6|||
94351176|NCT01066819|323067353|FG003|Overall Study|Withdrawal by Subject|0|||
94351177|NCT01066819|323067354|FG004|Overall Study|Withdrawal by Subject|0|||
94351178|NCT01066819|323067355|FG005|Overall Study|Withdrawal by Subject|0|||
94351179|NCT01066819|323067350|FG000|Overall Study|Administrative|6|||
94351180|NCT01066819|323067351|FG001|Overall Study|Administrative|4|||
94351181|NCT01066819|323067352|FG002|Overall Study|Administrative|2|||
94351182|NCT01066819|323067353|FG003|Overall Study|Administrative|0|||
94351183|NCT01066819|323067354|FG004|Overall Study|Administrative|0|||
94351184|NCT01066819|323067355|FG005|Overall Study|Administrative|0|||
94351185|NCT01066819|323067350|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
94351186|NCT01066819|323067351|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
94351187|NCT01066819|323067352|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
94351188|NCT01066819|323067353|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
94351189|NCT01066819|323067354|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
94351190|NCT01066819|323067355|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
94351191|NCT01066819|323067350|FG000|Overall Study|Early termination|2|||
94351192|NCT01066819|323067351|FG001|Overall Study|Early termination|0|||
94351193|NCT01066819|323067352|FG002|Overall Study|Early termination|0|||
94351194|NCT01066819|323067353|FG003|Overall Study|Early termination|0|||
94351195|NCT01066819|323067354|FG004|Overall Study|Early termination|0|||
94351196|NCT01066819|323067355|FG005|Overall Study|Early termination|0|||
94351197|NCT01066819|323067350|FG000|Overall Study|Failed to return|298|||
94351198|NCT01066819|323067351|FG001|Overall Study|Failed to return|107|||
94351199|NCT01066819|323067352|FG002|Overall Study|Failed to return|68|||
94351200|NCT01066819|323067353|FG003|Overall Study|Failed to return|7|||
94351201|NCT01066819|323067354|FG004|Overall Study|Failed to return|2|||
94351202|NCT01066819|323067355|FG005|Overall Study|Failed to return|3|||
94351203|NCT01066819|323067350|FG000|Overall Study|Lab test not done|9|||
94351204|NCT01066819|323067351|FG001|Overall Study|Lab test not done|0|||
94351205|NCT01066819|323067352|FG002|Overall Study|Lab test not done|2|||
94351206|NCT01066819|323067353|FG003|Overall Study|Lab test not done|1|||
94351207|NCT01066819|323067354|FG004|Overall Study|Lab test not done|0|||
94351208|NCT01066819|323067355|FG005|Overall Study|Lab test not done|0|||
94351209|NCT01066819|323067350|FG000|Overall Study|Miscellaneous|28|||
94453662|NCT01057810|323448965|FG001|Overall Study|Other|14|||
94453663|NCT02737930|323448971|FG000|Overall Study|Withdrawal by Subject|0|||
94453664|NCT02737930|323448972|FG001|Overall Study|Withdrawal by Subject|1|||
94351210|NCT01066819|323067351|FG001|Overall Study|Miscellaneous|10|||
94351211|NCT01066819|323067352|FG002|Overall Study|Miscellaneous|18|||
94351212|NCT01066819|323067353|FG003|Overall Study|Miscellaneous|1|||
94351213|NCT01066819|323067354|FG004|Overall Study|Miscellaneous|0|||
94453665|NCT03533114|323448973|FG000|Overall|Adverse Event|16|||
94453666|NCT03533114|323448974|FG001|Overall|Adverse Event|11|||
94453667|NCT03533114|323448973|FG000|Overall|Consent Withdrawal by Participant|7|||
94453668|NCT03533114|323448974|FG001|Overall|Consent Withdrawal by Participant|6|||
94453669|NCT03533114|323448973|FG000|Overall|Lack of Efficacy|5|||
94453670|NCT03533114|323448974|FG001|Overall|Lack of Efficacy|3|||
94453671|NCT03533114|323448973|FG000|Overall|Lost to Follow-up|1|||
94453672|NCT03533114|323448974|FG001|Overall|Lost to Follow-up|1|||
94453673|NCT03533114|323448973|FG000|Overall|Physician Decision|0|||
94453674|NCT03533114|323448974|FG001|Overall|Physician Decision|2|||
94453675|NCT03533114|323448973|FG000|Overall|Protocol deviation|1|||
94453676|NCT03533114|323448974|FG001|Overall|Protocol deviation|1|||
94453677|NCT03533114|323448973|FG000|Overall|Failure to meet randomization criteria|1|||
94453678|NCT03533114|323448974|FG001|Overall|Failure to meet randomization criteria|2|||
94453679|NCT03533114|323448973|FG000|Overall|Non-Compliance with study drug|0|||
94453680|NCT03533114|323448974|FG001|Overall|Non-Compliance with study drug|1|||
94453681|NCT03533114|323448973|FG000|Overall|Other|0|||
94453682|NCT03533114|323448974|FG001|Overall|Other|1|||
94453683|NCT03533114|323448973|FG000|Open Label Titration and Optimization|Adverse Event|11|||
94453684|NCT03533114|323448974|FG001|Open Label Titration and Optimization|Adverse Event|8|||
94453685|NCT03533114|323448973|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
94453686|NCT03533114|323448974|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
94453687|NCT03533114|323448973|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
94453688|NCT03533114|323448974|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
94453689|NCT03533114|323448973|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
94453690|NCT03533114|323448974|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
94453691|NCT03533114|323448973|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
94453692|NCT03533114|323448974|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
94453693|NCT03533114|323448973|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
94453694|NCT03533114|323448974|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
94453695|NCT03533114|323448973|FG000|Stable Dose|Adverse Event|0|||
94453696|NCT03533114|323448974|FG001|Stable Dose|Adverse Event|2|||
94453697|NCT03533114|323448973|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
94453698|NCT03533114|323448974|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
94453699|NCT03533114|323448973|FG000|Stable Dose|Lack of Efficacy|1|||
94453700|NCT03533114|323448974|FG001|Stable Dose|Lack of Efficacy|0|||
94453701|NCT03533114|323448973|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
94453702|NCT03533114|323448974|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
94453703|NCT03533114|323448973|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
94453704|NCT03533114|323448974|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
94453705|NCT03533114|323448973|FG000|Open-Label Safety Extension|Adverse Event|3|||
94453706|NCT03533114|323448974|FG001|Open-Label Safety Extension|Adverse Event|0|||
94453707|NCT03533114|323448973|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
94453708|NCT03533114|323448974|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
94453709|NCT03533114|323448973|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
94453710|NCT03533114|323448974|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
94453711|NCT03533114|323448973|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
94453712|NCT03533114|323448974|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
94453713|NCT03533114|323448973|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
94453714|NCT03533114|323448974|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
94453715|NCT05338502|323448975|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
94453716|NCT05338502|323448976|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
94453717|NCT05338502|323448977|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
94453718|NCT05338502|323448975|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
94453719|NCT05338502|323448976|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
94453720|NCT05338502|323448977|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
94453721|NCT01683266|323448983|FG000|Overall Study|Adverse Event|5|||
94453722|NCT01683266|323448984|FG001|Overall Study|Adverse Event|4|||
94453723|NCT01683266|323448983|FG000|Overall Study|Lack of Efficacy|5|||
94453724|NCT01683266|323448984|FG001|Overall Study|Lack of Efficacy|2|||
94453725|NCT01683266|323448983|FG000|Overall Study|Protocol Violation|13|||
94453726|NCT01683266|323448984|FG001|Overall Study|Protocol Violation|6|||
94453727|NCT01683266|323448983|FG000|Overall Study|Personal Reason|17|||
94453728|NCT01683266|323448984|FG001|Overall Study|Personal Reason|25|||
94453729|NCT01683266|323448983|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
94453730|NCT01683266|323448984|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
94453731|NCT01683266|323448983|FG000|Overall Study|Lost to Follow-up|5|||
94575687|NCT03037385|323908447|FG005|Overall Study|Progressive Disease|0|||
94575688|NCT03037385|323908448|FG006|Overall Study|Progressive Disease|1|||
94575689|NCT03037385|323908449|FG007|Overall Study|Progressive Disease|0|||
94351214|NCT01066819|323067355|FG005|Overall Study|Miscellaneous|0|||
94351215|NCT01066819|323067350|FG000|Overall Study|Non responders|123|||
94351216|NCT01066819|323067351|FG001|Overall Study|Non responders|2|||
94351217|NCT01066819|323067352|FG002|Overall Study|Non responders|7|||
94351218|NCT01066819|323067353|FG003|Overall Study|Non responders|2|||
94351219|NCT01066819|323067354|FG004|Overall Study|Non responders|0|||
94351220|NCT01066819|323067355|FG005|Overall Study|Non responders|1|||
94351221|NCT01066819|323067350|FG000|Overall Study|Not categorised|9|||
94351222|NCT01066819|323067351|FG001|Overall Study|Not categorised|2|||
94351223|NCT01066819|323067352|FG002|Overall Study|Not categorised|6|||
94351224|NCT01066819|323067353|FG003|Overall Study|Not categorised|1|||
94351225|NCT01066819|323067354|FG004|Overall Study|Not categorised|0|||
94351226|NCT01066819|323067355|FG005|Overall Study|Not categorised|0|||
94351227|NCT01066819|323067350|FG000|Overall Study|Relapse|16|||
94351228|NCT01066819|323067351|FG001|Overall Study|Relapse|4|||
94351229|NCT01066819|323067352|FG002|Overall Study|Relapse|3|||
94351230|NCT01066819|323067353|FG003|Overall Study|Relapse|0|||
94351231|NCT01066819|323067354|FG004|Overall Study|Relapse|0|||
94351232|NCT01066819|323067355|FG005|Overall Study|Relapse|0|||
94351233|NCT01066819|323067350|FG000|Overall Study|Results not available|1|||
94351234|NCT01066819|323067351|FG001|Overall Study|Results not available|0|||
94351235|NCT01066819|323067352|FG002|Overall Study|Results not available|0|||
94351236|NCT01066819|323067353|FG003|Overall Study|Results not available|0|||
94351237|NCT01066819|323067354|FG004|Overall Study|Results not available|0|||
94351238|NCT01066819|323067355|FG005|Overall Study|Results not available|0|||
94351239|NCT01066819|323067350|FG000|Overall Study|Screen failure|1|||
94351240|NCT01066819|323067351|FG001|Overall Study|Screen failure|0|||
94351241|NCT01066819|323067352|FG002|Overall Study|Screen failure|0|||
94351242|NCT01066819|323067353|FG003|Overall Study|Screen failure|0|||
94351243|NCT01066819|323067354|FG004|Overall Study|Screen failure|0|||
94351244|NCT01066819|323067355|FG005|Overall Study|Screen failure|0|||
94351245|NCT01066819|323067350|FG000|Overall Study|Spontaneous cure|1|||
94351246|NCT01066819|323067351|FG001|Overall Study|Spontaneous cure|0|||
94351247|NCT01066819|323067352|FG002|Overall Study|Spontaneous cure|0|||
94351248|NCT01066819|323067353|FG003|Overall Study|Spontaneous cure|0|||
94351249|NCT01066819|323067354|FG004|Overall Study|Spontaneous cure|0|||
94351250|NCT01066819|323067355|FG005|Overall Study|Spontaneous cure|0|||
94351251|NCT01066819|323067350|FG000|Overall Study|Treatment never started|85|||
94351252|NCT01066819|323067351|FG001|Overall Study|Treatment never started|19|||
94351253|NCT01066819|323067352|FG002|Overall Study|Treatment never started|19|||
94351254|NCT01066819|323067353|FG003|Overall Study|Treatment never started|3|||
94351255|NCT01066819|323067354|FG004|Overall Study|Treatment never started|2|||
94351256|NCT01066819|323067355|FG005|Overall Study|Treatment never started|2|||
94351257|NCT01066819|323067350|FG000|Overall Study|Treatment stopped|12|||
94351258|NCT01066819|323067351|FG001|Overall Study|Treatment stopped|1|||
94351259|NCT01066819|323067352|FG002|Overall Study|Treatment stopped|2|||
94351260|NCT01066819|323067353|FG003|Overall Study|Treatment stopped|1|||
94351261|NCT01066819|323067354|FG004|Overall Study|Treatment stopped|0|||
94351262|NCT01066819|323067355|FG005|Overall Study|Treatment stopped|0|||
94351263|NCT01066819|323067350|FG000|Overall Study|Other|5|||
94351264|NCT01066819|323067351|FG001|Overall Study|Other|1|||
94351265|NCT01066819|323067352|FG002|Overall Study|Other|1|||
94351266|NCT01066819|323067353|FG003|Overall Study|Other|0|||
94351267|NCT01066819|323067354|FG004|Overall Study|Other|0|||
94351268|NCT01066819|323067355|FG005|Overall Study|Other|0|||
94351269|NCT03322540|323067356|FG000|Overall Study|Death|21|||
94351270|NCT03322540|323067357|FG001|Overall Study|Death|28|||
94351271|NCT03322540|323067356|FG000|Overall Study|Lost to Follow-up|0|||
94351272|NCT03322540|323067357|FG001|Overall Study|Lost to Follow-up|1|||
94351273|NCT03322540|323067356|FG000|Overall Study|Physician Decision|7|||
94351274|NCT03322540|323067357|FG001|Overall Study|Physician Decision|6|||
94351275|NCT03322540|323067356|FG000|Overall Study|Withdrawal by Subject|3|||
94351276|NCT03322540|323067357|FG001|Overall Study|Withdrawal by Subject|1|||
94351277|NCT03322540|323067356|FG000|Overall Study|Study terminated by sponsor|0|||
94351278|NCT03322540|323067357|FG001|Overall Study|Study terminated by sponsor|1|||
94351279|NCT03287960|323067359|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
94351280|NCT03287960|323067359|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
94351281|NCT01641952|323067360|FG000|Overall Study|Lost to Follow-up|28|||
94351282|NCT01641952|323067360|FG000|Overall Study|Adverse Event|6|||
94351283|NCT02643420|323067362|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
94351284|NCT02643420|323067363|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
94351285|NCT02643420|323067362|FG000|Overall Study|Withdrawal by Subject|25|||
94351286|NCT02643420|323067363|FG001|Overall Study|Withdrawal by Subject|19|||
94351287|NCT02643420|323067362|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
94351288|NCT02643420|323067363|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
94351289|NCT02643420|323067362|FG000|Overall Study|Lost to Follow-up|6|||
94351290|NCT02643420|323067363|FG001|Overall Study|Lost to Follow-up|10|||
94351291|NCT02643420|323067362|FG000|Overall Study|Investigator Decision|2|||
94351292|NCT02643420|323067363|FG001|Overall Study|Investigator Decision|4|||
94351293|NCT02643420|323067362|FG000|Overall Study|Sponsor decision|1|||
94351294|NCT02643420|323067363|FG001|Overall Study|Sponsor decision|1|||
94351295|NCT02643420|323067362|FG000|Overall Study|Death|0|||
94351296|NCT02643420|323067363|FG001|Overall Study|Death|2|||
94351297|NCT02643420|323067362|FG000|Overall Study|Reason not Specified|8|||
94351298|NCT02643420|323067363|FG001|Overall Study|Reason not Specified|7|||
94351299|NCT03432819|323067364|FG000|Overall Study|Lost to Follow-up|2|||
94351300|NCT03432819|323067365|FG001|Overall Study|Lost to Follow-up|2|||
94351301|NCT03432819|323067364|FG000|Overall Study|Withdrawal by Subject|5|||
94351302|NCT03432819|323067365|FG001|Overall Study|Withdrawal by Subject|3|||
94351303|NCT04419558|323067366|FG000|DB Period (48 Weeks)|Adverse Event|6|||
94351304|NCT04419558|323067367|FG001|DB Period (48 Weeks)|Adverse Event|6|||
94351305|NCT04419558|323067366|FG000|DB Period (48 Weeks)|Death|14|||
94351306|NCT04419558|323067367|FG001|DB Period (48 Weeks)|Death|11|||
94351307|NCT04419558|323067366|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
94351308|NCT04419558|323067367|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
94351309|NCT04419558|323067366|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
94351310|NCT04419558|323067367|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
94351311|NCT04419558|323067366|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
94351312|NCT04419558|323067367|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
94351313|NCT04419558|323067366|FG000|DB Period (48 Weeks)|Disease Progression|1|||
94351314|NCT04419558|323067367|FG001|DB Period (48 Weeks)|Disease Progression|0|||
94351315|NCT04419558|323067366|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
94351316|NCT04419558|323067367|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
94351317|NCT04419558|323067366|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
94351318|NCT04419558|323067367|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
94351319|NCT04419558|323067366|FG000|DB Period (48 Weeks)|Participant Decision|4|||
94351320|NCT04419558|323067367|FG001|DB Period (48 Weeks)|Participant Decision|3|||
94351321|NCT04419558|323067366|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
94351322|NCT04419558|323067367|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
94351323|NCT04419558|323067366|FG000|OLE Period (48 Weeks)|Death|4|||
94351324|NCT04419558|323067367|FG001|OLE Period (48 Weeks)|Death|6|||
94351325|NCT04419558|323067366|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
94351326|NCT04419558|323067367|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
94351327|NCT04419558|323067366|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
94351328|NCT04419558|323067367|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
94351329|NCT03319160|323067368|FG000|Overall Study|Data not available.|7|||
94351330|NCT04738123|323067369|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
94351331|NCT04738123|323067370|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
94351332|NCT04738123|323067369|FG000|Overall Study|Progressive Disease|0|||
94351333|NCT04738123|323067370|FG001|Overall Study|Progressive Disease|4|||
94351334|NCT04738123|323067369|FG000|Overall Study|Adverse Event|8|||
94351335|NCT04738123|323067370|FG001|Overall Study|Adverse Event|7|||
94351336|NCT04738123|323067369|FG000|Overall Study|Other Reasons|0|||
94351337|NCT04738123|323067370|FG001|Overall Study|Other Reasons|1|||
94351338|NCT04738123|323067369|FG000|Overall Study|Suicidal or assaultive behavior|0|||
94239762|NCT04497389|322672590|FG000|Overall Study|Withdrawal by Subject|1|||
94239763|NCT04497389|322672591|FG001|Overall Study|Withdrawal by Subject|0|||
94239764|NCT02179177|322672592|FG000|Overall Study|Lost to Follow-up|1|||
94239765|NCT02179177|322672593|FG001|Overall Study|Lost to Follow-up|1|||
94239766|NCT02179177|322672592|FG000|Overall Study|Withdrawal by Subject|1|||
94239767|NCT02179177|322672593|FG001|Overall Study|Withdrawal by Subject|1|||
94239768|NCT04400487|322672594|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
94239769|NCT04400487|322672594|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
94239770|NCT04400487|322672594|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
94239771|NCT01516749|322672597|FG000|Active Therapy|Lost to Follow-up|1|||
94239772|NCT01516749|322672597|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
94239773|NCT00731133|322672600|FG000|Overall Study|Withdrawal by Subject|10|||
94239774|NCT01706705|322672601|FG000|Overall Study|Death|1|||
94239775|NCT01706705|322672601|FG000|Overall Study|Lack of Efficacy|13|||
94239776|NCT01706705|322672601|FG000|Overall Study|Non-clinical|6|||
94239777|NCT00968526|322672602|FG000|Overall Study|Adverse Event|2|||
94239778|NCT00968526|322672603|FG001|Overall Study|Adverse Event|0|||
94239779|NCT00968526|322672602|FG000|Overall Study|Migrated/moved from study area|1|||
94239780|NCT00968526|322672603|FG001|Overall Study|Migrated/moved from study area|0|||
94239781|NCT00685698|322672604|FG000|Overall Study|Withdrawal by Subject|1|||
94239782|NCT00685698|322672604|FG000|Overall Study|Protocol Violation|6|||
94239783|NCT00685698|322672604|FG000|Overall Study|Adverse Event|3|||
94239784|NCT00685698|322672604|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
94239785|NCT00685698|322672604|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
94239786|NCT00685698|322672604|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
94239787|NCT02030002|322672607|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
94239788|NCT02030002|322672607|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
94239789|NCT02030002|322672607|FG000|Follow-up|Lost to Follow-up|2|||
94239790|NCT01681992|322672610|FG000|Overall Study|Adverse Event|3|||
94239791|NCT01681992|322672611|FG001|Overall Study|Adverse Event|2|||
94239792|NCT01681992|322672612|FG002|Overall Study|Adverse Event|3|||
94239793|NCT01681992|322672610|FG000|Overall Study|Lost to Follow-up|36|||
94239794|NCT01681992|322672611|FG001|Overall Study|Lost to Follow-up|38|||
94239795|NCT01681992|322672612|FG002|Overall Study|Lost to Follow-up|53|||
94239796|NCT01681992|322672610|FG000|Overall Study|As Per Sponsor Decision|0|||
94239797|NCT01681992|322672611|FG001|Overall Study|As Per Sponsor Decision|0|||
94239798|NCT01681992|322672612|FG002|Overall Study|As Per Sponsor Decision|1|||
94239799|NCT01681992|322672610|FG000|Overall Study|Protocol Violation|0|||
94239800|NCT01681992|322672611|FG001|Overall Study|Protocol Violation|0|||
94239801|NCT01681992|322672612|FG002|Overall Study|Protocol Violation|1|||
94239802|NCT01681992|322672610|FG000|Overall Study|Withdrawal by Subject|27|||
94239803|NCT01681992|322672611|FG001|Overall Study|Withdrawal by Subject|30|||
94239804|NCT01681992|322672612|FG002|Overall Study|Withdrawal by Subject|25|||
94239805|NCT01199068|322672619|FG000|Overall Study|Unacceptable toxicity|0|||
94239806|NCT01199068|322672620|FG001|Overall Study|Unacceptable toxicity|0|||
94239807|NCT01199068|322672621|FG002|Overall Study|Unacceptable toxicity|2|||
94239808|NCT01199068|322672619|FG000|Overall Study|Progressive disease|3|||
94239809|NCT01199068|322672620|FG001|Overall Study|Progressive disease|3|||
94239810|NCT01199068|322672621|FG002|Overall Study|Progressive disease|6|||
94239811|NCT01199068|322672619|FG000|Overall Study|Withdrawal by Subject|0|||
94239812|NCT01199068|322672620|FG001|Overall Study|Withdrawal by Subject|0|||
94239813|NCT01199068|322672621|FG002|Overall Study|Withdrawal by Subject|1|||
94239814|NCT00447590|322672622|FG000|Overall Study|Withdrawal by Subject|26|||
94239815|NCT00447590|322672622|FG000|Overall Study|Lost to Follow-up|24|||
94239816|NCT00447590|322672622|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
94239817|NCT01294397|322672623|FG000|Overall Study|Withdrawal by Subject|1|||
94239818|NCT01294397|322672623|FG000|Overall Study|Administrative Decision|1|||
94239819|NCT01967069|322672624|FG000|Overall Study|Adverse Event|2|||
94239820|NCT01967069|322672625|FG001|Overall Study|Adverse Event|2|||
94239821|NCT01967069|322672624|FG000|Overall Study|Lost to Follow-up|5|||
94239822|NCT01967069|322672625|FG001|Overall Study|Lost to Follow-up|2|||
94239823|NCT01967069|322672624|FG000|Overall Study|Withdrawal by Subject|1|||
94453732|NCT01683266|323448984|FG001|Overall Study|Lost to Follow-up|0|||
94351339|NCT04738123|323067370|FG001|Overall Study|Suicidal or assaultive behavior|2|||
94351340|NCT04738123|323067369|FG000|Overall Study|Protocol Violation|2|||
94351341|NCT04738123|323067370|FG001|Overall Study|Protocol Violation|2|||
94351342|NCT04738123|323067369|FG000|Overall Study|Consent Withdrawn|35|||
94351343|NCT04738123|323067370|FG001|Overall Study|Consent Withdrawn|22|||
94351344|NCT00851721|323067371|FG000|Overall Study|planned surgery|1|||
94351345|NCT00851721|323067372|FG001|Overall Study|planned surgery|0|||
94351346|NCT00851721|323067371|FG000|Overall Study|Death|1|||
94351347|NCT00851721|323067372|FG001|Overall Study|Death|0|||
94351348|NCT00851721|323067371|FG000|Overall Study|Adverse Event|0|||
94351349|NCT00851721|323067372|FG001|Overall Study|Adverse Event|1|||
94351350|NCT00665002|323067373|FG000|Overall Study|Progression/relapse during treatment|11|||
94351351|NCT00665002|323067373|FG000|Overall Study|Cytogenetic resistance|1|||
94351352|NCT00405756|323067374|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
94351353|NCT00405756|323067375|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
94351354|NCT00405756|323067376|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
94351355|NCT00405756|323067374|FG000|Double-blind Treatment|Adverse Event|31|||
94351356|NCT00405756|323067375|FG001|Double-blind Treatment|Adverse Event|27|||
94351357|NCT00405756|323067376|FG002|Double-blind Treatment|Adverse Event|12|||
94351358|NCT00405756|323067374|FG000|Double-blind Treatment|Disease Progression|47|||
94351359|NCT00405756|323067375|FG001|Double-blind Treatment|Disease Progression|81|||
94351360|NCT00405756|323067376|FG002|Double-blind Treatment|Disease Progression|102|||
94351361|NCT00405756|323067374|FG000|Double-blind Treatment|Lack of Efficacy|1|||
94351362|NCT00405756|323067375|FG001|Double-blind Treatment|Lack of Efficacy|4|||
94351363|NCT00405756|323067376|FG002|Double-blind Treatment|Lack of Efficacy|2|||
94351364|NCT00405756|323067374|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
94351365|NCT00405756|323067375|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
94351366|NCT00405756|323067376|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
94351367|NCT00405756|323067374|FG000|Double-blind Treatment|Lost to Follow-up|1|||
94351368|NCT00405756|323067375|FG001|Double-blind Treatment|Lost to Follow-up|0|||
94351369|NCT00405756|323067376|FG002|Double-blind Treatment|Lost to Follow-up|0|||
94351370|NCT00405756|323067374|FG000|Double-blind Treatment|Death|4|||
94351371|NCT00405756|323067375|FG001|Double-blind Treatment|Death|4|||
94351372|NCT00405756|323067376|FG002|Double-blind Treatment|Death|4|||
94351373|NCT00405756|323067374|FG000|Double-blind Treatment|Protocol Violation|1|||
94351374|NCT00405756|323067375|FG001|Double-blind Treatment|Protocol Violation|0|||
94351375|NCT00405756|323067376|FG002|Double-blind Treatment|Protocol Violation|2|||
94351376|NCT00405756|323067374|FG000|Double-blind Treatment|Other|7|||
94351377|NCT00405756|323067375|FG001|Double-blind Treatment|Other|4|||
94351378|NCT00405756|323067376|FG002|Double-blind Treatment|Other|4|||
94351379|NCT00405756|323067374|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
94351380|NCT00405756|323067375|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
94351381|NCT00405756|323067376|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
94351382|NCT00405756|323067374|FG000|Open-label Extension|Adverse Event|1|||
94351383|NCT00405756|323067375|FG001|Open-label Extension|Adverse Event|3|||
94351384|NCT00405756|323067376|FG002|Open-label Extension|Adverse Event|7|||
94351385|NCT00405756|323067374|FG000|Open-label Extension|Disease Progression|8|||
94351386|NCT00405756|323067375|FG001|Open-label Extension|Disease Progression|23|||
94351387|NCT00405756|323067376|FG002|Open-label Extension|Disease Progression|26|||
94351388|NCT00405756|323067374|FG000|Open-label Extension|Withdrawal by Subject|2|||
94351389|NCT00405756|323067375|FG001|Open-label Extension|Withdrawal by Subject|3|||
94351390|NCT00405756|323067376|FG002|Open-label Extension|Withdrawal by Subject|3|||
94351391|NCT00405756|323067374|FG000|Open-label Extension|Death|1|||
94351392|NCT00405756|323067375|FG001|Open-label Extension|Death|2|||
94351393|NCT00405756|323067376|FG002|Open-label Extension|Death|4|||
94351394|NCT00405756|323067374|FG000|Open-label Extension|Other|0|||
94351395|NCT00405756|323067375|FG001|Open-label Extension|Other|1|||
94351396|NCT00405756|323067376|FG002|Open-label Extension|Other|7|||
94351397|NCT00405756|323067374|FG000|Follow-up|Ongoing in Follow-up Period|52|||
94351398|NCT00405756|323067375|FG001|Follow-up|Ongoing in Follow-up Period|51|||
94351399|NCT00405756|323067376|FG002|Follow-up|Ongoing in Follow-up Period|60|||
94351400|NCT00405756|323067374|FG000|Follow-up|Death|21|||
94351401|NCT00405756|323067375|FG001|Follow-up|Death|31|||
94351402|NCT00405756|323067376|FG002|Follow-up|Death|24|||
94351403|NCT00405756|323067374|FG000|Follow-up|Lost to Follow-up|2|||
94351404|NCT00405756|323067375|FG001|Follow-up|Lost to Follow-up|8|||
94351405|NCT00405756|323067376|FG002|Follow-up|Lost to Follow-up|4|||
94351406|NCT03604159|323067379|FG000|Overall Study|Lost to Follow-up|6|||
94351407|NCT03604159|323067380|FG001|Overall Study|Lost to Follow-up|7|||
94351408|NCT03137433|323067383|FG000|Overall Study|Withdrawal by Subject|11|||
94351409|NCT03137433|323067384|FG001|Overall Study|Withdrawal by Subject|11|||
94351410|NCT03137433|323067383|FG000|Overall Study|Lost to Follow-up|5|||
94351411|NCT03137433|323067384|FG001|Overall Study|Lost to Follow-up|6|||
94351412|NCT03137433|323067383|FG000|Overall Study|Physician Decision|2|||
94351413|NCT03137433|323067384|FG001|Overall Study|Physician Decision|0|||
94351414|NCT03137433|323067383|FG000|Overall Study|Moved out of study area|1|||
94453733|NCT01683266|323448983|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
94453734|NCT01683266|323448984|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
94453735|NCT01683266|323448983|FG000|Overall Study|Nonserious Hypoglycemia|0|||
94453736|NCT01683266|323448984|FG001|Overall Study|Nonserious Hypoglycemia|3|||
94453737|NCT01683266|323448983|FG000|Overall Study|Perceived Lack of Efficacy|1|||
94453738|NCT01683266|323448984|FG001|Overall Study|Perceived Lack of Efficacy|1|||
94453739|NCT01683266|323448983|FG000|Overall Study|Possibly Hypoglycemia|1|||
94453740|NCT01683266|323448984|FG001|Overall Study|Possibly Hypoglycemia|0|||
94453741|NCT01683266|323448983|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
94453742|NCT01683266|323448984|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
94453743|NCT03793842|323448990|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
94453744|NCT03793842|323448991|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
94453745|NCT03793842|323448990|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
94453746|NCT03793842|323448991|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
94453747|NCT01094301|323449000|FG000|Trial Stage|Withdrawal by Subject|1|||
94453748|NCT01094301|323449000|FG000|Implant Stage|Adverse Event|1|||
94453749|NCT01094301|323449000|FG000|Implant Stage|Protocol Violation|1|||
94453750|NCT01094301|323449000|FG000|Implant Stage|Withdrawal by Subject|2|||
94453751|NCT01094301|323449000|FG000|Implant Stage|No return of pain|4|||
94453752|NCT01186692|323449001|FG000|Overall Study|Not Catheterized|11|||
94453753|NCT01186692|323449001|FG000|Overall Study|Futher testing contraindicated implant|19|||
94453754|NCT01186692|323449001|FG000|Overall Study|Adverse Event|2|||
94453755|NCT01668173|323449013|FG000|Overall Study|Adverse Event|3|||
94453756|NCT01668173|323449013|FG000|Overall Study|Trial suspension|4|||
94453757|NCT01868022|323449016|FG000|Overall Study|Withdrawal by Subject|0|||
94453758|NCT01868022|323449017|FG001|Overall Study|Withdrawal by Subject|0|||
94453759|NCT01868022|323449018|FG002|Overall Study|Withdrawal by Subject|1|||
94453760|NCT01868022|323449019|FG003|Overall Study|Withdrawal by Subject|1|||
94453761|NCT01868022|323449020|FG004|Overall Study|Withdrawal by Subject|0|||
94453762|NCT01868022|323449021|FG005|Overall Study|Withdrawal by Subject|0|||
94453763|NCT01868022|323449022|FG006|Overall Study|Withdrawal by Subject|0|||
94453764|NCT01868022|323449023|FG007|Overall Study|Withdrawal by Subject|1|||
94453765|NCT01868022|323449024|FG008|Overall Study|Withdrawal by Subject|0|||
94453766|NCT01868022|323449016|FG000|Overall Study|Adverse Event|0|||
94453767|NCT01868022|323449017|FG001|Overall Study|Adverse Event|0|||
94453768|NCT01868022|323449018|FG002|Overall Study|Adverse Event|0|||
94453769|NCT01868022|323449019|FG003|Overall Study|Adverse Event|0|||
94453770|NCT01868022|323449020|FG004|Overall Study|Adverse Event|2|||
94453771|NCT01868022|323449021|FG005|Overall Study|Adverse Event|0|||
94453772|NCT01868022|323449022|FG006|Overall Study|Adverse Event|0|||
94453773|NCT01868022|323449023|FG007|Overall Study|Adverse Event|2|||
94453774|NCT01868022|323449024|FG008|Overall Study|Adverse Event|2|||
94453775|NCT01868022|323449016|FG000|Overall Study|Physician Decision|0|||
94453776|NCT01868022|323449017|FG001|Overall Study|Physician Decision|0|||
94453777|NCT01868022|323449018|FG002|Overall Study|Physician Decision|0|||
94453778|NCT01868022|323449019|FG003|Overall Study|Physician Decision|0|||
94453779|NCT01868022|323449020|FG004|Overall Study|Physician Decision|0|||
94453780|NCT01868022|323449021|FG005|Overall Study|Physician Decision|1|||
94453781|NCT01868022|323449022|FG006|Overall Study|Physician Decision|0|||
94453782|NCT01868022|323449023|FG007|Overall Study|Physician Decision|2|||
94453783|NCT01868022|323449024|FG008|Overall Study|Physician Decision|0|||
94453784|NCT01868022|323449016|FG000|Overall Study|Study closed/terminated|0|||
94453785|NCT01868022|323449017|FG001|Overall Study|Study closed/terminated|0|||
94453786|NCT01868022|323449018|FG002|Overall Study|Study closed/terminated|0|||
94453787|NCT01868022|323449019|FG003|Overall Study|Study closed/terminated|0|||
94453788|NCT01868022|323449020|FG004|Overall Study|Study closed/terminated|0|||
94453789|NCT01868022|323449021|FG005|Overall Study|Study closed/terminated|0|||
94453790|NCT01868022|323449022|FG006|Overall Study|Study closed/terminated|0|||
94453791|NCT01868022|323449023|FG007|Overall Study|Study closed/terminated|1|||
94453792|NCT01868022|323449024|FG008|Overall Study|Study closed/terminated|0|||
94453793|NCT01868022|323449016|FG000|Overall Study|Ongoing|0|||
94453794|NCT01868022|323449017|FG001|Overall Study|Ongoing|0|||
94453795|NCT01868022|323449018|FG002|Overall Study|Ongoing|0|||
94453796|NCT01868022|323449019|FG003|Overall Study|Ongoing|0|||
94453797|NCT01868022|323449020|FG004|Overall Study|Ongoing|0|||
94453798|NCT01868022|323449021|FG005|Overall Study|Ongoing|0|||
94658856|NCT02464969|324206208|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
94453799|NCT01868022|323449022|FG006|Overall Study|Ongoing|0|||
94453800|NCT01868022|323449023|FG007|Overall Study|Ongoing|3|||
94453801|NCT01868022|323449024|FG008|Overall Study|Ongoing|0|||
94453802|NCT02504827|323449025|FG000|Overall Study|Could not produce sputum|1|||
94453803|NCT00877487|323449028|FG000|Open-label Treatment Phase|Adverse Event|1|||
94453804|NCT00877487|323449029|FG001|Open-label Treatment Phase|Adverse Event|0|||
94575690|NCT03037385|323908450|FG008|Overall Study|Progressive Disease|0|||
94575691|NCT03037385|323908451|FG009|Overall Study|Progressive Disease|30|||
94575692|NCT03037385|323908442|FG000|Overall Study|Withdrawal by Subject|0|||
94575693|NCT03037385|323908443|FG001|Overall Study|Withdrawal by Subject|0|||
94575694|NCT03037385|323908444|FG002|Overall Study|Withdrawal by Subject|1|||
94575695|NCT03037385|323908445|FG003|Overall Study|Withdrawal by Subject|2|||
94575696|NCT03037385|323908446|FG004|Overall Study|Withdrawal by Subject|1|||
94575697|NCT03037385|323908447|FG005|Overall Study|Withdrawal by Subject|3|||
94575698|NCT03037385|323908448|FG006|Overall Study|Withdrawal by Subject|0|||
94575699|NCT03037385|323908449|FG007|Overall Study|Withdrawal by Subject|0|||
94575700|NCT03037385|323908450|FG008|Overall Study|Withdrawal by Subject|0|||
94575701|NCT03037385|323908451|FG009|Overall Study|Withdrawal by Subject|52|||
94575702|NCT03037385|323908442|FG000|Overall Study|Reason Not Specified|0|||
94575703|NCT03037385|323908443|FG001|Overall Study|Reason Not Specified|1|||
94575704|NCT03037385|323908444|FG002|Overall Study|Reason Not Specified|0|||
94575705|NCT03037385|323908445|FG003|Overall Study|Reason Not Specified|4|||
94575706|NCT03037385|323908446|FG004|Overall Study|Reason Not Specified|3|||
94575707|NCT03037385|323908447|FG005|Overall Study|Reason Not Specified|6|||
94575708|NCT03037385|323908448|FG006|Overall Study|Reason Not Specified|2|||
94575709|NCT03037385|323908449|FG007|Overall Study|Reason Not Specified|0|||
94575710|NCT03037385|323908450|FG008|Overall Study|Reason Not Specified|1|||
94575711|NCT03037385|323908451|FG009|Overall Study|Reason Not Specified|181|||
94575712|NCT05050318|323908453|FG000|Overall Study|Protocol Deviation|1|||
94575713|NCT05050318|323908454|FG001|Overall Study|Protocol Deviation|0|||
94575714|NCT05050318|323908455|FG002|Overall Study|Protocol Deviation|0|||
94575715|NCT00474487|323908457|FG000|Overall Study|Withdrawal by Subject|6|||
94239824|NCT01967069|322672625|FG001|Overall Study|Withdrawal by Subject|3|||
94239825|NCT01967069|322672624|FG000|Overall Study|Lack of Efficacy|0|||
94239826|NCT01967069|322672625|FG001|Overall Study|Lack of Efficacy|1|||
94239827|NCT01250925|322672626|FG000|Overall Study|Lost to Follow-up|1|||
94239828|NCT01250925|322672627|FG001|Overall Study|Lost to Follow-up|1|||
94239829|NCT01250925|322672628|FG002|Overall Study|Lost to Follow-up|0|||
94239830|NCT01250925|322672626|FG000|Overall Study|Withdrawal by Subject|2|||
94239831|NCT01250925|322672627|FG001|Overall Study|Withdrawal by Subject|0|||
94239832|NCT01250925|322672628|FG002|Overall Study|Withdrawal by Subject|0|||
94239833|NCT01250925|322672626|FG000|Overall Study|Protocol Violation|2|||
94239834|NCT01250925|322672627|FG001|Overall Study|Protocol Violation|0|||
94239835|NCT01250925|322672628|FG002|Overall Study|Protocol Violation|0|||
94239836|NCT01250925|322672626|FG000|Overall Study|Physician Decision|0|||
94239837|NCT01250925|322672627|FG001|Overall Study|Physician Decision|2|||
94575716|NCT00474487|323908458|FG001|Overall Study|Withdrawal by Subject|0|||
94575717|NCT00474487|323908459|FG002|Overall Study|Withdrawal by Subject|0|||
94575718|NCT00474487|323908460|FG003|Overall Study|Withdrawal by Subject|0|||
94575719|NCT00474487|323908457|FG000|Overall Study|Lost to Follow-up|20|||
94575720|NCT00474487|323908458|FG001|Overall Study|Lost to Follow-up|1|||
94575721|NCT00474487|323908459|FG002|Overall Study|Lost to Follow-up|7|||
94575722|NCT00474487|323908460|FG003|Overall Study|Lost to Follow-up|0|||
94575723|NCT00474487|323908457|FG000|Overall Study|Inappropriate enrollment|4|||
94575724|NCT00474487|323908458|FG001|Overall Study|Inappropriate enrollment|0|||
94575725|NCT00474487|323908459|FG002|Overall Study|Inappropriate enrollment|7|||
94575726|NCT00474487|323908460|FG003|Overall Study|Inappropriate enrollment|0|||
94575727|NCT00474487|323908457|FG000|Overall Study|Death|0|||
94575728|NCT00474487|323908458|FG001|Overall Study|Death|1|||
94575729|NCT00474487|323908459|FG002|Overall Study|Death|0|||
94575730|NCT00474487|323908460|FG003|Overall Study|Death|0|||
94575731|NCT02443688|323908461|FG000|Overall Study|Adverse Event|2|||
94575732|NCT02443688|323908462|FG001|Overall Study|Adverse Event|3|||
94575733|NCT02443688|323908463|FG002|Overall Study|Adverse Event|2|||
94575734|NCT02443688|323908461|FG000|Overall Study|Lost to Follow-up|1|||
94575735|NCT02443688|323908462|FG001|Overall Study|Lost to Follow-up|0|||
94575736|NCT02443688|323908463|FG002|Overall Study|Lost to Follow-up|0|||
94658857|NCT02464969|324206207|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
94658858|NCT02464969|324206208|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
94239838|NCT01250925|322672628|FG002|Overall Study|Physician Decision|1|||
94239839|NCT01250925|322672626|FG000|Overall Study|Adverse Event|0|||
94239840|NCT01250925|322672627|FG001|Overall Study|Adverse Event|0|||
94239841|NCT01250925|322672628|FG002|Overall Study|Adverse Event|1|||
94239842|NCT00426127|322672629|FG000|Overall Study|Adverse Event|1|||
94351415|NCT03137433|323067384|FG001|Overall Study|Moved out of study area|0|||
94351416|NCT03137433|323067383|FG000|Overall Study|Too far out of window due to COVID|0|||
94351417|NCT03137433|323067384|FG001|Overall Study|Too far out of window due to COVID|1|||
94351418|NCT00083616|323067385|FG000|Overall Study|Disease Progression|16|||
94351419|NCT00083616|323067385|FG000|Overall Study|Lost to Follow-up|1|||
94575737|NCT02443688|323908461|FG000|Overall Study|Physician Decision|3|||
94575738|NCT02443688|323908462|FG001|Overall Study|Physician Decision|0|||
94575739|NCT02443688|323908463|FG002|Overall Study|Physician Decision|1|||
94575740|NCT02443688|323908461|FG000|Overall Study|Pregnancy|0|||
94575741|NCT02443688|323908462|FG001|Overall Study|Pregnancy|0|||
94575742|NCT02443688|323908463|FG002|Overall Study|Pregnancy|1|||
94575743|NCT02443688|323908461|FG000|Overall Study|Withdrawal by Subject|3|||
94575744|NCT02443688|323908462|FG001|Overall Study|Withdrawal by Subject|3|||
94575745|NCT02443688|323908463|FG002|Overall Study|Withdrawal by Subject|4|||
94575746|NCT02443688|323908461|FG000|Overall Study|Non-compliance with study drug|1|||
94575747|NCT02443688|323908462|FG001|Overall Study|Non-compliance with study drug|2|||
94575748|NCT02443688|323908463|FG002|Overall Study|Non-compliance with study drug|4|||
94575749|NCT02443688|323908461|FG000|Overall Study|Sponsor Request|2|||
94575750|NCT02443688|323908462|FG001|Overall Study|Sponsor Request|1|||
94575751|NCT02443688|323908463|FG002|Overall Study|Sponsor Request|0|||
94575752|NCT01317472|323908466|FG000|Overall Study|Withdrawal by Subject|1|||
94575753|NCT01317472|323908467|FG001|Overall Study|Withdrawal by Subject|0|||
94575754|NCT01317472|323908466|FG000|Overall Study|Unrelated hospitalization|1|||
94575755|NCT01317472|323908467|FG001|Overall Study|Unrelated hospitalization|0|||
94575756|NCT01815918|323908468|FG000|Overall Study|Patient samples not analyzable|3|||
94575757|NCT01815918|323908469|FG001|Overall Study|Patient samples not analyzable|4|||
94575758|NCT01815918|323908468|FG000|Overall Study|Lack of Efficacy|15|||
94575759|NCT01815918|323908469|FG001|Overall Study|Lack of Efficacy|15|||
94575760|NCT05176314|323908474|FG000|Overall Study|Lost to Follow-up|2|||
94575761|NCT05176314|323908474|FG000|Overall Study|Physician Decision|1|||
94575762|NCT05176314|323908474|FG000|Overall Study|Adverse Event|1|||
94575763|NCT05543265|323908475|FG000|Overall Study|Lost to Follow-up|3|||
94575764|NCT05543265|323908476|FG001|Overall Study|Lost to Follow-up|3|||
94575765|NCT05543265|323908475|FG000|Overall Study|Withdrawal by Subject|0|||
94575766|NCT05543265|323908476|FG001|Overall Study|Withdrawal by Subject|1|||
94575767|NCT06271993|323908480|FG000|Overall Study|Not reactive to histamine|5|||
94575768|NCT06271993|323908481|FG001|Overall Study|Not reactive to histamine|5|||
94575769|NCT06271993|323908482|FG002|Overall Study|Not reactive to histamine|5|||
94575770|NCT00286468|323908483|FG000|Overall Study|Hyperglycemic Rescue|28|||
94575771|NCT00286468|323908484|FG001|Overall Study|Hyperglycemic Rescue|30|||
94575772|NCT00286468|323908485|FG002|Overall Study|Hyperglycemic Rescue|31|||
94575773|NCT00286468|323908483|FG000|Overall Study|Adverse Event|2|||
94575774|NCT00286468|323908484|FG001|Overall Study|Adverse Event|6|||
94575775|NCT00286468|323908485|FG002|Overall Study|Adverse Event|4|||
94575776|NCT00286468|323908483|FG000|Overall Study|Protocol Violation|0|||
94575777|NCT00286468|323908484|FG001|Overall Study|Protocol Violation|3|||
94575778|NCT00286468|323908485|FG002|Overall Study|Protocol Violation|1|||
94575779|NCT00286468|323908483|FG000|Overall Study|Lost to Follow-up|1|||
94575780|NCT00286468|323908484|FG001|Overall Study|Lost to Follow-up|1|||
94575781|NCT00286468|323908485|FG002|Overall Study|Lost to Follow-up|2|||
94575782|NCT00286468|323908483|FG000|Overall Study|Withdrawal by Subject|3|||
94575783|NCT00286468|323908484|FG001|Overall Study|Withdrawal by Subject|8|||
94575784|NCT00286468|323908485|FG002|Overall Study|Withdrawal by Subject|11|||
94575785|NCT00286468|323908483|FG000|Overall Study|Physician Decision|3|||
94575786|NCT00286468|323908484|FG001|Overall Study|Physician Decision|2|||
94351420|NCT00083616|323067385|FG000|Overall Study|Physician Decision|2|||
94575787|NCT00286468|323908485|FG002|Overall Study|Physician Decision|1|||
94575788|NCT03566511|323908486|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
94575789|NCT03566511|323908487|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
94575790|NCT00981656|323908491|FG000|Overall Study|Protocol Violation|1|||
94575791|NCT00981656|323908491|FG000|Overall Study|Did not start protocol treatment|2|||
94575792|NCT05365217|323908497|FG000|Treatment Period 1|Withdrawal by Subject|1|||
94575793|NCT05365217|323908498|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94575794|NCT03041038|323908500|FG000|Overall Study|Withdrawal by Subject|4|||
94575795|NCT03041038|323908501|FG001|Overall Study|Withdrawal by Subject|0|||
94575796|NCT03041038|323908500|FG000|Overall Study|Lost to Follow-up|1|||
94575797|NCT03041038|323908501|FG001|Overall Study|Lost to Follow-up|1|||
94575798|NCT03041038|323908500|FG000|Overall Study|Protocol Violation|1|||
94575799|NCT03041038|323908501|FG001|Overall Study|Protocol Violation|1|||
94575800|NCT01553084|323908504|FG000|Overall Study|Withdrawal by Subject|15|||
94575801|NCT01553084|323908505|FG001|Overall Study|Withdrawal by Subject|13|||
94575802|NCT01553084|323908506|FG002|Overall Study|Withdrawal by Subject|35|||
94575803|NCT03486912|323908507|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
94575804|NCT03486912|323908508|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
94575805|NCT03486912|323908509|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
94575806|NCT03486912|323908510|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
94575807|NCT03486912|323908507|FG000|Treatment Period|Withdrawal by Subject|3|||
94575808|NCT03486912|323908508|FG001|Treatment Period|Withdrawal by Subject|3|||
94575809|NCT03486912|323908509|FG002|Treatment Period|Withdrawal by Subject|3|||
94575810|NCT03486912|323908510|FG003|Treatment Period|Withdrawal by Subject|2|||
94575811|NCT03486912|323908507|FG000|Treatment Period|Other Reasons|0|||
94575812|NCT03486912|323908508|FG001|Treatment Period|Other Reasons|2|||
94575813|NCT03486912|323908509|FG002|Treatment Period|Other Reasons|1|||
94575814|NCT03486912|323908510|FG003|Treatment Period|Other Reasons|1|||
94575815|NCT03486912|323908507|FG000|Treatment Period|Adverse Event|0|||
94575816|NCT03486912|323908508|FG001|Treatment Period|Adverse Event|1|||
94575817|NCT03486912|323908509|FG002|Treatment Period|Adverse Event|1|||
94575818|NCT03486912|323908510|FG003|Treatment Period|Adverse Event|0|||
94575819|NCT03486912|323908507|FG000|Treatment Period|Lost to Follow-up|1|||
94575820|NCT03486912|323908508|FG001|Treatment Period|Lost to Follow-up|0|||
94239843|NCT00426127|322672629|FG000|Overall Study|Removed due to disease progression|1|||
94239844|NCT01939353|322672630|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
94239845|NCT01939353|322672630|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
94239846|NCT01939353|322672630|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
94239847|NCT01939353|322672630|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
94239848|NCT01939353|322672630|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
94239849|NCT01689857|322672632|FG000|Overall Study|Lost to Follow-up|5|||
94239850|NCT01689857|322672633|FG001|Overall Study|Lost to Follow-up|2|||
94239851|NCT01730378|322672634|FG000|Overall Study|Lost to Follow-up|1|||
94239852|NCT01730378|322672635|FG001|Overall Study|Lost to Follow-up|0|||
94239853|NCT00955708|322672637|FG000|Overall Study|Death|269|||
94239854|NCT00955708|322672637|FG000|Overall Study|Lost to Follow-up|72|||
94239855|NCT00955708|322672637|FG000|Overall Study|Physician Decision|36|||
94239856|NCT00955708|322672637|FG000|Overall Study|Protocol Violation|134|||
94239857|NCT00955708|322672637|FG000|Overall Study|Registry Conclusion|186|||
94239858|NCT00955708|322672637|FG000|Overall Study|Product removed from service|94|||
94239859|NCT00955708|322672637|FG000|Overall Study|Patient Refused to participate further|116|||
94239860|NCT00955708|322672637|FG000|Overall Study|Closure of study location|60|||
94239861|NCT00955708|322672637|FG000|Overall Study|Patient changed care provider/moved|91|||
94351421|NCT00083616|323067385|FG000|Overall Study|Withdrawal by Subject|3|||
94351422|NCT00083616|323067385|FG000|Overall Study|Ineligibility determined|2|||
94575821|NCT03486912|323908509|FG002|Treatment Period|Lost to Follow-up|0|||
94575822|NCT03486912|323908510|FG003|Treatment Period|Lost to Follow-up|2|||
94575823|NCT03651765|323908511|FG000|Overall Study|Adverse Event|6|||
94575824|NCT03651765|323908511|FG000|Overall Study|Lack of Efficacy|18|||
94575825|NCT03651765|323908511|FG000|Overall Study|Lost to Follow-up|5|||
94575826|NCT03651765|323908511|FG000|Overall Study|Non-Compliance with Study Drug|4|||
94575827|NCT03651765|323908511|FG000|Overall Study|Physician Decision|6|||
94575828|NCT03651765|323908511|FG000|Overall Study|Pregnancy|1|||
94575829|NCT03651765|323908511|FG000|Overall Study|Discontinued by Sponsor|40|||
94351423|NCT00083616|323067385|FG000|Overall Study|Non-compliance|1|||
94351424|NCT00083616|323067385|FG000|Overall Study|Other|6|||
94351425|NCT01611558|323067386|FG000|Induction Phase|Study drug toxicity|15|||
94351426|NCT01611558|323067386|FG000|Induction Phase|Disease progression|18|||
94575830|NCT03651765|323908511|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
94575831|NCT03651765|323908511|FG000|Overall Study|Withdrawal by Subject|24|||
94575832|NCT03651765|323908511|FG000|Overall Study|Miscellaneous|6|||
94239862|NCT01725126|322672638|FG000|Overall Study|Protocol Violation|0|||
94351427|NCT01611558|323067386|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
94575833|NCT04531176|323908512|FG000|Overall Study|Study was stopped early|24|||
94575834|NCT04531176|323908513|FG001|Overall Study|Study was stopped early|26|||
94575835|NCT04531176|323908514|FG002|Overall Study|Study was stopped early|24|||
94658859|NCT02464969|324206207|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
94239863|NCT01725126|322672639|FG001|Overall Study|Protocol Violation|1|||
94239864|NCT01725126|322672640|FG002|Overall Study|Protocol Violation|0|||
94239865|NCT01725126|322672641|FG003|Overall Study|Protocol Violation|0|||
94575836|NCT03773978|323908517|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
94575837|NCT03773978|323908518|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
94575838|NCT03773978|323908517|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
94575839|NCT03773978|323908518|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
94575840|NCT03773978|323908517|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
94575841|NCT03773978|323908518|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
94575842|NCT03773978|323908517|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
94575843|NCT03773978|323908518|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
94575844|NCT03773978|323908517|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
94575845|NCT03773978|323908518|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
94575846|NCT03773978|323908517|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
94575847|NCT03773978|323908518|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
94575848|NCT03773978|323908517|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
94575849|NCT03773978|323908518|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
94575850|NCT03773978|323908517|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
94575851|NCT03773978|323908518|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
94575852|NCT03773978|323908517|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
94575853|NCT03773978|323908518|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
94575854|NCT03773978|323908517|FG000|DBW Period|Adverse Event|2|||
94575855|NCT03773978|323908518|FG001|DBW Period|Adverse Event|2|||
94575856|NCT03773978|323908517|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
94575857|NCT03773978|323908518|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
94575858|NCT03773978|323908517|FG000|DBW Period|Withdrawal by Subject|2|||
94575859|NCT03773978|323908518|FG001|DBW Period|Withdrawal by Subject|1|||
94575860|NCT03773978|323908517|FG000|DBW Period|Due to epidemic or pandemic|5|||
94575861|NCT03773978|323908518|FG001|DBW Period|Due to epidemic or pandemic|6|||
94575862|NCT03773978|323908517|FG000|DBW Period|Study team decision|1|||
94575863|NCT03773978|323908518|FG001|DBW Period|Study team decision|0|||
94575864|NCT04189952|323908521|FG000|Follow-up Period|Death|1|||
94575865|NCT04189952|323908521|FG000|Follow-up Period|Withdrawal by Subject|1|||
94575866|NCT00976274|323908531|FG000|Overall Study|Lost to Follow-up|5|||
94575867|NCT00976274|323908532|FG001|Overall Study|Lost to Follow-up|5|||
94575868|NCT00976274|323908531|FG000|Overall Study|Withdrawal by Subject|1|||
94575869|NCT00976274|323908532|FG001|Overall Study|Withdrawal by Subject|1|||
94575870|NCT00976274|323908531|FG000|Overall Study|Physician Decision|1|||
94575871|NCT00976274|323908532|FG001|Overall Study|Physician Decision|2|||
94575872|NCT01614249|323908534|FG000|Overall Study|Lost to Follow-up|11|||
94575873|NCT01614249|323908535|FG001|Overall Study|Lost to Follow-up|23|||
94575874|NCT02946580|323908536|FG000|Overall Study|Withdrawal by Subject|1|||
94575875|NCT02946580|323908537|FG001|Overall Study|Withdrawal by Subject|2|||
94575876|NCT02946580|323908536|FG000|Overall Study|Adverse Event|0|||
94575877|NCT02946580|323908537|FG001|Overall Study|Adverse Event|2|||
94351428|NCT01611558|323067386|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
94351429|NCT01611558|323067386|FG000|Induction Phase|Death|1|||
94351430|NCT01611558|323067386|FG000|Maintenance Phase|Withdrawal by Subject|1|||
94351431|NCT01611558|323067386|FG000|Maintenance Phase|Elevated Uric acid|1|||
94351432|NCT02030067|323067389|FG000|Overall Study|Disease Progression|1|||
94351433|NCT02030067|323067390|FG001|Overall Study|Disease Progression|1|||
94351434|NCT02030067|323067391|FG002|Overall Study|Disease Progression|2|||
94351435|NCT02030067|323067392|FG003|Overall Study|Disease Progression|2|||
94575878|NCT02946580|323908536|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
94575879|NCT02946580|323908537|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
94575880|NCT03094416|323908538|FG000|Run-in|Screening failure|8|||
94575881|NCT03094416|323908538|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
94351436|NCT02030067|323067393|FG004|Overall Study|Disease Progression|3|||
94575882|NCT03094416|323908538|FG000|Run-in|Withdrawal by Subject|3|||
94575883|NCT03094416|323908538|FG000|Treatment Period|Withdrawal by Subject|2|||
94575884|NCT03104868|323908539|FG000|6 Week Follow up|Lost to Follow-up|5|||
94575885|NCT03104868|323908540|FG001|6 Week Follow up|Lost to Follow-up|8|||
94351437|NCT02030067|323067394|FG005|Overall Study|Disease Progression|2|||
94239866|NCT01725126|322672642|FG004|Overall Study|Protocol Violation|0|||
94239867|NCT01725126|322672643|FG005|Overall Study|Protocol Violation|0|||
94239868|NCT01725126|322672638|FG000|Overall Study|Withdrawal by Subject|0|||
94239869|NCT01725126|322672639|FG001|Overall Study|Withdrawal by Subject|0|||
94239870|NCT01725126|322672640|FG002|Overall Study|Withdrawal by Subject|0|||
94453805|NCT00877487|323449028|FG000|Open-label Treatment Phase|Protocol Violation|3|||
94453806|NCT00877487|323449029|FG001|Open-label Treatment Phase|Protocol Violation|0|||
94453807|NCT00877487|323449028|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
94453808|NCT00877487|323449029|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
94453809|NCT00877487|323449028|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
94453810|NCT00877487|323449029|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
94453811|NCT00877487|323449028|FG000|Open-label Treatment Phase|Out of country for business|1|||
94453812|NCT00877487|323449029|FG001|Open-label Treatment Phase|Out of country for business|0|||
94453813|NCT00877487|323449028|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
94453814|NCT00877487|323449029|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
94453815|NCT00877487|323449028|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
94453816|NCT00877487|323449029|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
94453817|NCT00877487|323449028|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
94453818|NCT00877487|323449029|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
94453819|NCT00877487|323449028|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
94453820|NCT00877487|323449029|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
94453821|NCT04740827|323449030|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
94453822|NCT04740827|323449031|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
94453823|NCT04740827|323449030|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
94453824|NCT04740827|323449031|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
94453825|NCT04740827|323449030|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
94453826|NCT04740827|323449031|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
94453827|NCT04740827|323449030|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
94453828|NCT04740827|323449031|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
94453829|NCT04740827|323449030|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
94453830|NCT04740827|323449031|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
94453831|NCT04740827|323449030|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
94453832|NCT04740827|323449031|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
94453833|NCT04445714|323449032|FG000|Overall Study|Discontinuation of the study|14|||
94453834|NCT04445714|323449032|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
94453835|NCT04445714|323449032|FG000|Overall Study|Withdrawal of Informed Consent|8|||
94453836|NCT00833482|323449033|FG000|Days 11-20|Adverse Event|0|||
94453837|NCT00833482|323449034|FG001|Days 11-20|Adverse Event|2|||
94453838|NCT00833482|323449035|FG002|Days 11-20|Adverse Event|0|||
94453839|NCT00833482|323449036|FG003|Days 11-20|Adverse Event|0|||
94453840|NCT00833482|323449037|FG004|Days 11-20|Adverse Event|0|||
94453841|NCT00833482|323449038|FG005|Days 11-20|Adverse Event|0|||
94453842|NCT00833482|323449033|FG000|Days 11-20|Withdrawal by Subject|0|||
94453843|NCT00833482|323449034|FG001|Days 11-20|Withdrawal by Subject|1|||
94453844|NCT00833482|323449035|FG002|Days 11-20|Withdrawal by Subject|0|||
94453845|NCT00833482|323449036|FG003|Days 11-20|Withdrawal by Subject|0|||
94453846|NCT00833482|323449037|FG004|Days 11-20|Withdrawal by Subject|0|||
94453847|NCT00833482|323449038|FG005|Days 11-20|Withdrawal by Subject|0|||
94453848|NCT00833482|323449033|FG000|Days 21-30|Adverse Event|0|||
94453849|NCT00833482|323449034|FG001|Days 21-30|Adverse Event|0|||
94453850|NCT00833482|323449035|FG002|Days 21-30|Adverse Event|1|||
94453851|NCT00833482|323449036|FG003|Days 21-30|Adverse Event|0|||
94453852|NCT00833482|323449037|FG004|Days 21-30|Adverse Event|0|||
94453853|NCT00833482|323449038|FG005|Days 21-30|Adverse Event|0|||
94453854|NCT00833482|323449033|FG000|Days 21-30|Withdrawal by Subject|0|||
94453855|NCT00833482|323449034|FG001|Days 21-30|Withdrawal by Subject|0|||
94453856|NCT00833482|323449035|FG002|Days 21-30|Withdrawal by Subject|0|||
94453857|NCT00833482|323449036|FG003|Days 21-30|Withdrawal by Subject|0|||
94453858|NCT00833482|323449037|FG004|Days 21-30|Withdrawal by Subject|1|||
94453859|NCT00833482|323449038|FG005|Days 21-30|Withdrawal by Subject|0|||
94453860|NCT00915876|323449039|FG000|Overall Study|Adverse Event|0|||
94453861|NCT00915876|323449040|FG001|Overall Study|Adverse Event|1|||
94453862|NCT00356135|323449041|FG000|Overall Study|Protocol Violation|1|||
94453863|NCT00356135|323449042|FG001|Overall Study|Protocol Violation|0|||
94453864|NCT00356135|323449043|FG002|Overall Study|Protocol Violation|0|||
94453865|NCT00356135|323449041|FG000|Overall Study|Adverse Event|1|||
94453866|NCT00356135|323449042|FG001|Overall Study|Adverse Event|0|||
94453867|NCT00356135|323449043|FG002|Overall Study|Adverse Event|0|||
94453868|NCT00356135|323449041|FG000|Overall Study|Lost to Follow-up|0|||
94239871|NCT01725126|322672641|FG003|Overall Study|Withdrawal by Subject|1|||
94453869|NCT00356135|323449042|FG001|Overall Study|Lost to Follow-up|0|||
94453870|NCT00356135|323449043|FG002|Overall Study|Lost to Follow-up|1|||
94453871|NCT00356135|323449041|FG000|Overall Study|Physician Decision|1|||
94453872|NCT00356135|323449042|FG001|Overall Study|Physician Decision|1|||
94575886|NCT03104868|323908539|FG000|6 Week Follow up|Death|1|||
94575887|NCT03104868|323908540|FG001|6 Week Follow up|Death|1|||
94575888|NCT03104868|323908539|FG000|6 Week Follow up|Withdrawal by Subject|7|||
94575889|NCT03104868|323908540|FG001|6 Week Follow up|Withdrawal by Subject|6|||
94575890|NCT03104868|323908539|FG000|6 Week Follow up|Completed Later Timepoint|24|||
94575891|NCT03104868|323908540|FG001|6 Week Follow up|Completed Later Timepoint|22|||
94575892|NCT03104868|323908539|FG000|6 Month Follow up|Lost to Follow-up|2|||
94575893|NCT03104868|323908540|FG001|6 Month Follow up|Lost to Follow-up|2|||
94575894|NCT03104868|323908539|FG000|6 Month Follow up|Death|0|||
94575895|NCT03104868|323908540|FG001|6 Month Follow up|Death|1|||
94575896|NCT03104868|323908539|FG000|6 Month Follow up|Completed Later Timepoint|22|||
94575897|NCT03104868|323908540|FG001|6 Month Follow up|Completed Later Timepoint|32|||
94575898|NCT03104868|323908539|FG000|12 Month Follow up|Lost to Follow-up|1|||
94575899|NCT03104868|323908540|FG001|12 Month Follow up|Lost to Follow-up|2|||
94575900|NCT03104868|323908539|FG000|12 Month Follow up|Death|0|||
94575901|NCT03104868|323908540|FG001|12 Month Follow up|Death|1|||
94575902|NCT03104868|323908539|FG000|12 Month Follow up|Withdrawal by Subject|0|||
94575903|NCT03104868|323908540|FG001|12 Month Follow up|Withdrawal by Subject|3|||
94575904|NCT03104868|323908539|FG000|12 Month Follow up|Completed Later Timepoint|32|||
94658860|NCT02464969|324206208|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
94575905|NCT03104868|323908540|FG001|12 Month Follow up|Completed Later Timepoint|29|||
94575906|NCT03104868|323908539|FG000|18 Month Follow up|Lost to Follow-up|7|||
94575907|NCT03104868|323908540|FG001|18 Month Follow up|Lost to Follow-up|11|||
94575908|NCT03104868|323908539|FG000|18 Month Follow up|Death|2|||
94575909|NCT03104868|323908540|FG001|18 Month Follow up|Death|1|||
94575910|NCT03104868|323908539|FG000|18 Month Follow up|Withdrawal by Subject|1|||
94575911|NCT03104868|323908540|FG001|18 Month Follow up|Withdrawal by Subject|2|||
94575912|NCT03104868|323908539|FG000|18 Month Follow up|Graft Loss|1|||
94575913|NCT03104868|323908540|FG001|18 Month Follow up|Graft Loss|1|||
94575914|NCT03104868|323908539|FG000|18 Month Follow up|Completed Later Timepoint|19|||
94575915|NCT03104868|323908540|FG001|18 Month Follow up|Completed Later Timepoint|20|||
94575916|NCT03104868|323908539|FG000|24 Month Follow up|Lost to Follow-up|15|||
94575917|NCT03104868|323908540|FG001|24 Month Follow up|Lost to Follow-up|16|||
94575918|NCT03104868|323908539|FG000|24 Month Follow up|Death|3|||
94575919|NCT03104868|323908540|FG001|24 Month Follow up|Death|2|||
94575920|NCT03104868|323908539|FG000|24 Month Follow up|Withdrawal by Subject|1|||
94575921|NCT03104868|323908540|FG001|24 Month Follow up|Withdrawal by Subject|0|||
94575922|NCT03104868|323908539|FG000|24 Month Follow up|Graft Loss|2|||
94575923|NCT03104868|323908540|FG001|24 Month Follow up|Graft Loss|0|||
94575924|NCT02246530|323908541|FG000|Overall Study|Lost to Follow-up|4|||
94575925|NCT02246530|323908542|FG001|Overall Study|Lost to Follow-up|0|||
94575926|NCT00107653|323908551|FG000|Overall Study|Adverse Event|24|||
94575927|NCT00107653|323908552|FG001|Overall Study|Adverse Event|43|||
94575928|NCT00107653|323908551|FG000|Overall Study|Insufficient Therapeutic Response|25|||
94575929|NCT00107653|323908552|FG001|Overall Study|Insufficient Therapeutic Response|11|||
94575930|NCT00107653|323908551|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
94575931|NCT00107653|323908552|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
94575932|NCT00107653|323908551|FG000|Overall Study|Protocol Violation|1|||
94575933|NCT00107653|323908552|FG001|Overall Study|Protocol Violation|0|||
94575934|NCT00107653|323908551|FG000|Overall Study|Withdrawal by Subject|12|||
94575935|NCT00107653|323908552|FG001|Overall Study|Withdrawal by Subject|13|||
94575936|NCT00107653|323908551|FG000|Overall Study|Lost to Follow-up|13|||
94575937|NCT00107653|323908552|FG001|Overall Study|Lost to Follow-up|5|||
94658861|NCT01255358|324206209|FG000|Overall Study|Adverse Event|2|||
94239872|NCT01725126|322672642|FG004|Overall Study|Withdrawal by Subject|0|||
94575938|NCT00107653|323908551|FG000|Overall Study|Administrative Reasons|3|||
94575939|NCT00107653|323908552|FG001|Overall Study|Administrative Reasons|3|||
94575940|NCT04905134|323908553|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
94575941|NCT04905134|323908553|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
94575942|NCT04875975|323908556|FG000|Overall Study|Adverse Event|1|||
94575943|NCT04875975|323908557|FG001|Overall Study|Adverse Event|2|||
94575944|NCT04875975|323908556|FG000|Overall Study|Lack of Efficacy|2|||
94575945|NCT04875975|323908557|FG001|Overall Study|Lack of Efficacy|2|||
94575946|NCT04875975|323908556|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
94575947|NCT04875975|323908557|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
94575948|NCT04875975|323908556|FG000|Overall Study|Relapse With Insults|0|||
94239873|NCT01725126|322672643|FG005|Overall Study|Withdrawal by Subject|0|||
94239874|NCT00479882|322672644|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
94575949|NCT04875975|323908557|FG001|Overall Study|Relapse With Insults|1|||
94575950|NCT04875975|323908556|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
94575951|NCT04875975|323908557|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
94239875|NCT00479882|322672645|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
94239876|NCT00479882|322672646|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
94239877|NCT00479882|322672647|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
94239878|NCT00479882|322672644|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
94239879|NCT00479882|322672645|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
94239880|NCT00479882|322672646|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
94575952|NCT04586205|323908560|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
94575953|NCT04586205|323908561|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
94575954|NCT02994108|323909989|FG000|Intervention Messages|Withdrawal by Subject|2|||
94575955|NCT02994108|323909990|FG001|Intervention Messages|Withdrawal by Subject|0|||
94239881|NCT00479882|322672647|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
94239882|NCT00479882|322672644|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
94239883|NCT00479882|322672645|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
94239884|NCT00479882|322672646|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
94239885|NCT00479882|322672647|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
94239886|NCT00479882|322672644|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
94239887|NCT00479882|322672645|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
94575956|NCT02994108|323909989|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
94575957|NCT02994108|323909990|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
94575958|NCT02994108|323909989|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
94575959|NCT02994108|323909990|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
94575960|NCT02994108|323909989|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
94575961|NCT02994108|323909990|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
94575962|NCT00079417|323909999|FG000|Overall Study|Physician Decision|2|||
94575963|NCT00079417|323909999|FG000|Overall Study|Ineligible|7|||
94575964|NCT02151058|323910002|FG000|Overall Study|Withdrawal by Subject|1|||
94575965|NCT02151058|323910003|FG001|Overall Study|Withdrawal by Subject|1|||
94575966|NCT02151058|323910004|FG002|Overall Study|Withdrawal by Subject|3|||
94575967|NCT02151058|323910002|FG000|Overall Study|Lost to Follow-up|1|||
94575968|NCT02151058|323910003|FG001|Overall Study|Lost to Follow-up|0|||
94575969|NCT02151058|323910004|FG002|Overall Study|Lost to Follow-up|2|||
94575970|NCT04026113|323910009|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
94575971|NCT04026113|323910010|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
94575972|NCT04026113|323910011|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
94575973|NCT04026113|323910012|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
94575974|NCT04026113|323910009|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
94575975|NCT04026113|323910010|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
94575976|NCT04026113|323910011|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
94575977|NCT04026113|323910012|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
94575978|NCT04026113|323910009|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
94575979|NCT04026113|323910010|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
94575980|NCT04026113|323910011|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
94575981|NCT04026113|323910012|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
94575982|NCT04026113|323910009|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
94575983|NCT04026113|323910010|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
94575984|NCT04026113|323910011|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
94239888|NCT00479882|322672646|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
94239889|NCT00479882|322672647|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
94239890|NCT00479882|322672644|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
94239891|NCT00479882|322672645|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
94239892|NCT00479882|322672646|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
94239893|NCT00479882|322672647|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
94239894|NCT00479882|322672644|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
94239895|NCT00479882|322672645|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
94239896|NCT00479882|322672646|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
94239897|NCT00479882|322672647|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
94351438|NCT02030067|323067395|FG006|Overall Study|Disease Progression|3|||
94351439|NCT02030067|323067396|FG007|Overall Study|Disease Progression|3|||
94575985|NCT04026113|323910012|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
94575986|NCT04026113|323910009|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
94575987|NCT04026113|323910010|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
94575988|NCT04026113|323910011|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
94575989|NCT04026113|323910012|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
94575990|NCT04026113|323910009|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
94575991|NCT04026113|323910010|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
94575992|NCT04026113|323910011|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
94575993|NCT04026113|323910012|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
94575994|NCT04026113|323910009|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
94575995|NCT04026113|323910010|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
94575996|NCT04026113|323910011|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
94575997|NCT04026113|323910012|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
94575998|NCT04026113|323910009|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
94575999|NCT04026113|323910010|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
94576000|NCT04026113|323910011|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
94576001|NCT04026113|323910012|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
94576002|NCT04026113|323910009|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
94576003|NCT04026113|323910010|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
94576004|NCT04026113|323910011|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
94576005|NCT04026113|323910012|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
94576006|NCT00687596|323910013|FG000|Overall Study|Adverse Event (AE)|10|||
94576007|NCT00687596|323910014|FG001|Overall Study|Adverse Event (AE)|3|||
94576008|NCT00687596|323910013|FG000|Overall Study|Radiological Disease Progression|6|||
94576009|NCT00687596|323910014|FG001|Overall Study|Radiological Disease Progression|2|||
94576010|NCT00687596|323910013|FG000|Overall Study|Clinical Disease Progression|1|||
94576011|NCT00687596|323910014|FG001|Overall Study|Clinical Disease Progression|3|||
94576012|NCT00687596|323910013|FG000|Overall Study|Investigator Discretion|3|||
94576013|NCT00687596|323910014|FG001|Overall Study|Investigator Discretion|1|||
94576014|NCT00687596|323910013|FG000|Overall Study|Sponsor Terminated Study|6|||
94576015|NCT00687596|323910014|FG001|Overall Study|Sponsor Terminated Study|17|||
94576016|NCT00837434|323910017|FG000|Overall Study|Physician Decision|3|||
94576017|NCT00837434|323910018|FG001|Overall Study|Physician Decision|0|||
94576018|NCT00837434|323910017|FG000|Overall Study|Lost to Follow-up|1|||
94576019|NCT00837434|323910018|FG001|Overall Study|Lost to Follow-up|1|||
94576020|NCT00837434|323910017|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
94576021|NCT00837434|323910018|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
94576022|NCT00837434|323910017|FG000|Overall Study|Noncompliant|2|||
94576023|NCT00837434|323910018|FG001|Overall Study|Noncompliant|0|||
94576024|NCT00837434|323910017|FG000|Overall Study|Baseline assessments not done in time|1|||
94576025|NCT00837434|323910018|FG001|Overall Study|Baseline assessments not done in time|0|||
94576026|NCT00837434|323910017|FG000|Overall Study|Unable to obtain study drug|1|||
94576027|NCT00837434|323910018|FG001|Overall Study|Unable to obtain study drug|0|||
94576028|NCT00671658|323910019|FG000|Overall Study|Physician Decision|5|||
94576029|NCT01921205|323910020|FG000|Overall Study|Adverse Event|12|||
94576030|NCT01921205|323910021|FG001|Overall Study|Adverse Event|7|||
94576031|NCT01921205|323910020|FG000|Overall Study|Lack of Efficacy|1|||
94576032|NCT01921205|323910021|FG001|Overall Study|Lack of Efficacy|0|||
94576033|NCT01921205|323910020|FG000|Overall Study|Protocol Violation|1|||
94576034|NCT01921205|323910021|FG001|Overall Study|Protocol Violation|3|||
94576035|NCT01921205|323910020|FG000|Overall Study|Lost to Follow-up|1|||
94576036|NCT01921205|323910021|FG001|Overall Study|Lost to Follow-up|1|||
94576037|NCT01921205|323910020|FG000|Overall Study|Withdrawal by Subject|6|||
94576038|NCT01921205|323910021|FG001|Overall Study|Withdrawal by Subject|5|||
94576039|NCT01921205|323910020|FG000|Overall Study|Use Of Prohibited Medication|0|||
94576040|NCT01921205|323910021|FG001|Overall Study|Use Of Prohibited Medication|1|||
94576041|NCT01921205|323910020|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
94576042|NCT01921205|323910021|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
94239898|NCT00479882|322672644|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
94576043|NCT01921205|323910020|FG000|Overall Study|Non Compliance Of The Parent|0|||
94576044|NCT01921205|323910021|FG001|Overall Study|Non Compliance Of The Parent|1|||
94576045|NCT01921205|323910020|FG000|Overall Study|Non Compliance Of Child|0|||
94576046|NCT01921205|323910021|FG001|Overall Study|Non Compliance Of Child|1|||
94576047|NCT00772538|323910022|FG000|Overall Study|Adverse Event|6|||
94576048|NCT00772538|323910023|FG001|Overall Study|Adverse Event|6|||
94576049|NCT00772538|323910022|FG000|Overall Study|Protocol Violation|3|||
94576050|NCT00772538|323910023|FG001|Overall Study|Protocol Violation|3|||
94576051|NCT00772538|323910022|FG000|Overall Study|Lost to Follow-up|1|||
94576052|NCT00772538|323910023|FG001|Overall Study|Lost to Follow-up|1|||
94576053|NCT00772538|323910022|FG000|Overall Study|Withdrawal by Subject|3|||
94576054|NCT00772538|323910023|FG001|Overall Study|Withdrawal by Subject|8|||
94576055|NCT00772538|323910022|FG000|Overall Study|Lack of Efficacy|0|||
94239899|NCT00479882|322672645|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
94351440|NCT02030067|323067397|FG008|Overall Study|Disease Progression|4|||
94576056|NCT00772538|323910023|FG001|Overall Study|Lack of Efficacy|1|||
94576057|NCT00772538|323910022|FG000|Overall Study|Other|7|||
94576058|NCT00772538|323910023|FG001|Overall Study|Other|7|||
94576059|NCT02558894|323910043|FG000|Overall Study|Death; any cause, entire study duration|28|||
94576060|NCT02558894|323910044|FG001|Overall Study|Death; any cause, entire study duration|31|||
94576061|NCT02558894|323910043|FG000|Overall Study|Withdrawal by Subject|2|||
94576062|NCT02558894|323910044|FG001|Overall Study|Withdrawal by Subject|1|||
94576063|NCT02558894|323910043|FG000|Overall Study|Closure of Part A|2|||
94576064|NCT02558894|323910044|FG001|Overall Study|Closure of Part A|1|||
94576065|NCT02006472|323910048|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
94576066|NCT02006472|323910049|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
94576067|NCT02006472|323910050|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
94576068|NCT02006472|323910051|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
94576069|NCT02006472|323910052|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
94576070|NCT02006472|323910048|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
94576071|NCT02006472|323910049|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
94576072|NCT02006472|323910050|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
94576073|NCT02006472|323910051|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
94576074|NCT02006472|323910052|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
94576075|NCT02006472|323910048|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
94576076|NCT02006472|323910049|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
94576077|NCT02006472|323910050|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
94576078|NCT02006472|323910051|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
94576079|NCT02006472|323910052|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
94576080|NCT02006472|323910048|FG000|Period 1 (Through Week 26)|Other|1|||
94576081|NCT02006472|323910049|FG001|Period 1 (Through Week 26)|Other|5|||
94576082|NCT02006472|323910050|FG002|Period 1 (Through Week 26)|Other|0|||
94576083|NCT02006472|323910051|FG003|Period 1 (Through Week 26)|Other|2|||
94576084|NCT02006472|323910052|FG004|Period 1 (Through Week 26)|Other|3|||
94576085|NCT02006472|323910048|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
94576086|NCT02006472|323910049|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
94576087|NCT02006472|323910050|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
94576088|NCT02006472|323910051|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
94576089|NCT02006472|323910052|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
94576090|NCT02006472|323910048|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
94576091|NCT02006472|323910049|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
94576092|NCT02006472|323910050|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
94576093|NCT02006472|323910051|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
94576094|NCT02006472|323910052|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
94576095|NCT02006472|323910048|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
94576096|NCT02006472|323910049|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
94576097|NCT02006472|323910050|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
94576098|NCT02006472|323910051|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
94576099|NCT02006472|323910052|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
94576100|NCT02006472|323910048|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
94576101|NCT02006472|323910049|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
94576102|NCT02006472|323910050|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
94576103|NCT02006472|323910051|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
94576104|NCT02006472|323910052|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
94576105|NCT02006472|323910048|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
94576106|NCT02006472|323910049|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
94576107|NCT02006472|323910050|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
94576108|NCT02006472|323910051|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
94576109|NCT02006472|323910052|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
94576110|NCT02006472|323910048|FG000|Period 2 (Through Week 52)|Other|0|||
94576111|NCT02006472|323910049|FG001|Period 2 (Through Week 52)|Other|1|||
94576112|NCT02006472|323910050|FG002|Period 2 (Through Week 52)|Other|0|||
94576113|NCT02006472|323910051|FG003|Period 2 (Through Week 52)|Other|1|||
94576114|NCT02006472|323910052|FG004|Period 2 (Through Week 52)|Other|0|||
94576115|NCT02006472|323910048|FG000|Period 2 (Through Week 52)|Not treated|0|||
94576116|NCT02006472|323910049|FG001|Period 2 (Through Week 52)|Not treated|0|||
94576117|NCT02006472|323910050|FG002|Period 2 (Through Week 52)|Not treated|2|||
94576118|NCT02006472|323910051|FG003|Period 2 (Through Week 52)|Not treated|0|||
94576119|NCT02006472|323910052|FG004|Period 2 (Through Week 52)|Not treated|0|||
94576120|NCT02006472|323910048|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
94576121|NCT02006472|323910049|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
94576122|NCT02006472|323910050|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
94576123|NCT02006472|323910051|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
94576124|NCT02006472|323910052|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
94576125|NCT02006472|323910048|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
94239900|NCT00479882|322672646|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
94239901|NCT00479882|322672647|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
94239902|NCT00479882|322672644|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
94239903|NCT00479882|322672645|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
94239904|NCT00479882|322672646|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
94239905|NCT00479882|322672647|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
94239906|NCT00479882|322672644|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
94576126|NCT02006472|323910049|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
94576127|NCT02006472|323910050|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
94576128|NCT02006472|323910051|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
94658862|NCT01255358|324206209|FG000|Overall Study|Protocol Violation|2|||
94576129|NCT02006472|323910052|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
94576130|NCT01292486|323910055|FG000|Overall Study|Protocol Violation|2|||
94576131|NCT01292486|323910055|FG000|Overall Study|Did not meet screening criteria|2|||
94239907|NCT00479882|322672645|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
94239908|NCT00479882|322672646|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
94239909|NCT00479882|322672647|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
94453873|NCT00356135|323449043|FG002|Overall Study|Physician Decision|1|||
94453874|NCT00356135|323449041|FG000|Overall Study|Subject non-compliance|1|||
94453875|NCT00356135|323449042|FG001|Overall Study|Subject non-compliance|1|||
94453876|NCT00356135|323449043|FG002|Overall Study|Subject non-compliance|3|||
94453877|NCT03617770|323449044|FG000|Overall Study|Lost to Follow-up|1|||
94453878|NCT03617770|323449045|FG001|Overall Study|Lost to Follow-up|0|||
94453879|NCT04999163|323449055|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
94453880|NCT04999163|323449056|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
94453881|NCT04999163|323449055|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
94453882|NCT04999163|323449056|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
94453883|NCT04999163|323449055|FG000|Overall Study|Withdrawal by Subject|1|||
94453884|NCT04999163|323449056|FG001|Overall Study|Withdrawal by Subject|0|||
94453893|NCT00083759|323450193|FG000|Overall Study|Adverse Event|5|||
94453894|NCT00083759|323450194|FG001|Overall Study|Adverse Event|3|||
94453895|NCT00083759|323450193|FG000|Overall Study|Lost to Follow-up|1|||
94453896|NCT00083759|323450194|FG001|Overall Study|Lost to Follow-up|0|||
94453897|NCT00083759|323450193|FG000|Overall Study|Death|1|||
94453898|NCT00083759|323450194|FG001|Overall Study|Death|1|||
94453899|NCT00083759|323450193|FG000|Overall Study|Inadequate Therapeutic Response|32|||
94453900|NCT00083759|323450194|FG001|Overall Study|Inadequate Therapeutic Response|35|||
94453901|NCT00083759|323450193|FG000|Overall Study|Subject Withdrew Consent|2|||
94453902|NCT00083759|323450194|FG001|Overall Study|Subject Withdrew Consent|2|||
94453903|NCT00083759|323450193|FG000|Overall Study|Non-Compliance|1|||
94453904|NCT00083759|323450194|FG001|Overall Study|Non-Compliance|0|||
94453905|NCT00083759|323450193|FG000|Overall Study|Sponsor's Discretion|28|||
94453906|NCT00083759|323450194|FG001|Overall Study|Sponsor's Discretion|29|||
94453907|NCT00083759|323450193|FG000|Overall Study|Other|14|||
94453908|NCT00083759|323450194|FG001|Overall Study|Other|13|||
94453909|NCT00280397|323450198|FG000|Overall Study|Adverse Event|1|||
94453910|NCT03852264|323450199|FG000|Third Research Visit|Lost to Follow-up|1|||
94453911|NCT03852264|323450200|FG001|Third Research Visit|Lost to Follow-up|0|||
94453912|NCT01028014|323450201|FG000|Overall Study|Lost to Follow-up|1|||
94453913|NCT01028014|323450202|FG001|Overall Study|Lost to Follow-up|2|||
94453914|NCT01028014|323450203|FG002|Overall Study|Lost to Follow-up|0|||
94453915|NCT01028014|323450204|FG003|Overall Study|Lost to Follow-up|1|||
94453916|NCT01028014|323450205|FG004|Overall Study|Lost to Follow-up|1|||
94453917|NCT01028014|323450206|FG005|Overall Study|Lost to Follow-up|2|||
94453918|NCT03728426|323450207|FG000|Overall Study|Death|3|||
94453919|NCT02320058|323450213|FG000|Overall Study|Death|25|||
94453920|NCT02320058|323450214|FG001|Overall Study|Death|10|||
94453921|NCT02320058|323450213|FG000|Overall Study|Lost to Follow-up|4|||
94453922|NCT02320058|323450214|FG001|Overall Study|Lost to Follow-up|0|||
94453923|NCT02320058|323450213|FG000|Overall Study|Other reasons|4|||
94453924|NCT02320058|323450214|FG001|Overall Study|Other reasons|1|||
94576132|NCT01292486|323910055|FG000|Overall Study|Adverse Event|1|||
94576133|NCT01292486|323910055|FG000|Overall Study|Physician Decision|1|||
94576134|NCT03405792|323910061|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
94453925|NCT02320058|323450213|FG000|Overall Study|Withdrawal by Subject|8|||
94453926|NCT02320058|323450214|FG001|Overall Study|Withdrawal by Subject|2|||
94453927|NCT02320058|323450213|FG000|Overall Study|Not reported|1|||
94576135|NCT03405792|323910062|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
94576136|NCT03405792|323910061|FG000|Overall Study|o Did not receive pembrolizumab|1|||
94576137|NCT03405792|323910062|FG001|Overall Study|o Did not receive pembrolizumab|0|||
94576138|NCT02476617|323910063|FG000|Overall Study|Adverse Event|1|||
94453928|NCT02320058|323450214|FG001|Overall Study|Not reported|0|||
94453929|NCT05835011|323450215|FG000|Overall Study|Study Terminated by the Sponsor|1|||
94453930|NCT05835011|323450215|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
94453931|NCT01471340|323450219|FG000|Overall Study|Death|5|||
94453932|NCT01471340|323450220|FG001|Overall Study|Death|4|||
94576139|NCT02476617|323910063|FG000|Overall Study|Lost to Follow-up|1|||
94239910|NCT00479882|322672644|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
94453933|NCT01471340|323450219|FG000|Overall Study|Lost to Follow-up|0|||
94453934|NCT01471340|323450220|FG001|Overall Study|Lost to Follow-up|1|||
94453935|NCT01471340|323450219|FG000|Overall Study|Investigational site closure|0|||
94576140|NCT02738801|323910079|FG000|Overall Study|Adverse Event|1|||
94576141|NCT02738801|323910080|FG001|Overall Study|Adverse Event|1|||
94576142|NCT02738801|323910079|FG000|Overall Study|Withdrawal by Subject|0|||
94576143|NCT02738801|323910080|FG001|Overall Study|Withdrawal by Subject|1|||
94576144|NCT01668784|323910102|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
94576145|NCT01668784|323910103|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
94576146|NCT01668784|323910102|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
94576147|NCT01668784|323910103|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
94576148|NCT01668784|323910102|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
94576149|NCT01668784|323910103|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
94576150|NCT01668784|323910102|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
94576151|NCT01668784|323910103|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
94576152|NCT01668784|323910102|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
94576153|NCT01668784|323910103|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
94576154|NCT01668784|323910102|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
94576155|NCT01668784|323910103|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
94576156|NCT01668784|323910102|FG000|Treatment Period|Disease Progression|316|||
94576157|NCT01668784|323910103|FG001|Treatment Period|Disease Progression|293|||
94576158|NCT01668784|323910102|FG000|Treatment Period|Study Drug Toxicity|46|||
94576159|NCT01668784|323910103|FG001|Treatment Period|Study Drug Toxicity|53|||
94576160|NCT01668784|323910102|FG000|Treatment Period|Death|1|||
94576161|NCT01668784|323910103|FG001|Treatment Period|Death|1|||
94576162|NCT01668784|323910102|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
94576163|NCT01668784|323910103|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
94576164|NCT01668784|323910102|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
94576165|NCT01668784|323910103|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
94576166|NCT01668784|323910102|FG000|Treatment Period|Withdrawal by Subject|5|||
94576167|NCT01668784|323910103|FG001|Treatment Period|Withdrawal by Subject|3|||
94576168|NCT01668784|323910102|FG000|Treatment Period|Maximal Clinical Benefit|3|||
94576169|NCT01668784|323910103|FG001|Treatment Period|Maximal Clinical Benefit|3|||
94576170|NCT01668784|323910102|FG000|Treatment Period|Other|2|||
94576171|NCT01668784|323910103|FG001|Treatment Period|Other|8|||
94576172|NCT01668784|323910102|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
94576173|NCT01668784|323910103|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
94576174|NCT02761330|323910104|FG000|Treatment Week 1|Withdrawal by Subject|0|||
94576175|NCT02761330|323910105|FG001|Treatment Week 1|Withdrawal by Subject|0|||
94576176|NCT02761330|323910106|FG002|Treatment Week 1|Withdrawal by Subject|0|||
94576177|NCT02761330|323910107|FG003|Treatment Week 1|Withdrawal by Subject|1|||
94576178|NCT02761330|323910108|FG004|Treatment Week 1|Withdrawal by Subject|0|||
94576179|NCT02761330|323910109|FG005|Treatment Week 1|Withdrawal by Subject|1|||
94576180|NCT05712460|323910110|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
94576181|NCT05712460|323910111|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
94576182|NCT05712460|323910112|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
94576183|NCT05712460|323910113|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
94576184|NCT05712460|323910114|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
94576185|NCT05712460|323910115|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
94576186|NCT05712460|323910116|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
94576187|NCT05712460|323910117|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
94576188|NCT05712460|323910118|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
94576189|NCT05712460|323910119|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
94576190|NCT05712460|323910120|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
94576191|NCT05712460|323910121|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
94576192|NCT00829426|323910122|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
94576193|NCT00829426|323910123|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
94576194|NCT05720897|323910125|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
94576195|NCT05720897|323910126|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
94576196|NCT01844986|323910129|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
94576197|NCT01844986|323910130|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
94576198|NCT01844986|323910129|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
94576199|NCT01844986|323910130|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
94576200|NCT01844986|323910129|FG000|Overall Study (Global Cohort)|Death|55|||
94576201|NCT01844986|323910130|FG001|Overall Study (Global Cohort)|Death|26|||
94576202|NCT01844986|323910129|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
94576203|NCT01844986|323910130|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
94576204|NCT01844986|323910129|FG000|Overall Study (China Cohort)|Death|10|||
94576205|NCT01844986|323910130|FG001|Overall Study (China Cohort)|Death|6|||
94351441|NCT02030067|323067398|FG009|Overall Study|Disease Progression|3|||
94576206|NCT00489307|323910135|FG000|Overall Study|Death|1|||
94576207|NCT00489307|323910136|FG001|Overall Study|Death|1|||
94576208|NCT00489307|323910135|FG000|Overall Study|Lost to Follow-up|2|||
94239911|NCT00479882|322672645|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
94239912|NCT00479882|322672646|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
94239913|NCT00479882|322672647|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
94239914|NCT00479882|322672644|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
94239915|NCT00479882|322672645|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
94576209|NCT00489307|323910136|FG001|Overall Study|Lost to Follow-up|2|||
94576210|NCT00489307|323910135|FG000|Overall Study|Physician Decision|1|||
94576211|NCT00489307|323910136|FG001|Overall Study|Physician Decision|0|||
94576212|NCT00489307|323910135|FG000|Overall Study|Withdrawal by Subject|2|||
94576213|NCT00489307|323910136|FG001|Overall Study|Withdrawal by Subject|4|||
94576214|NCT00489307|323910135|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
94576215|NCT00489307|323910136|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
94576216|NCT00489307|323910135|FG000|Overall Study|Surgery after assignment|1|||
94576217|NCT00489307|323910136|FG001|Overall Study|Surgery after assignment|0|||
94576218|NCT00489307|323910135|FG000|Overall Study|Did not fill up the forms|2|||
94576219|NCT00489307|323910136|FG001|Overall Study|Did not fill up the forms|1|||
94576220|NCT00489307|323910135|FG000|Overall Study|Patient or family refusal|5|||
94576221|NCT00489307|323910136|FG001|Overall Study|Patient or family refusal|9|||
94576222|NCT00092417|323911719|FG000|Overall Study|Lost to Follow-up|2|||
94576223|NCT00092417|323911720|FG001|Overall Study|Lost to Follow-up|0|||
94576224|NCT00092417|323911719|FG000|Overall Study|Withdrawal by Subject|2|||
94576225|NCT00092417|323911720|FG001|Overall Study|Withdrawal by Subject|1|||
94576226|NCT00092417|323911719|FG000|Overall Study|Other|1|||
94576227|NCT00092417|323911720|FG001|Overall Study|Other|0|||
94576228|NCT00751296|323911721|FG000|Overall Study|Adverse Event|2|||
94576229|NCT01972217|323911722|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
94576230|NCT01972217|323911723|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
94576231|NCT01972217|323911724|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
94576232|NCT01972217|323911725|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
94576233|NCT01972217|323911722|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
94576234|NCT01972217|323911723|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
94576235|NCT01972217|323911724|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
94576236|NCT01972217|323911725|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
94576237|NCT01972217|323911722|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
94576238|NCT01972217|323911723|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
94576239|NCT01972217|323911724|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
94576240|NCT01972217|323911725|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
94576241|NCT01972217|323911722|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
94576242|NCT01972217|323911723|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
94576243|NCT01972217|323911724|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
94576244|NCT01972217|323911725|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
94576245|NCT01972217|323911722|FG000|Part B Double-blind, Randomised Period|Death|0|||
94576246|NCT01972217|323911723|FG001|Part B Double-blind, Randomised Period|Death|0|||
94576247|NCT01972217|323911724|FG002|Part B Double-blind, Randomised Period|Death|43|||
94576248|NCT01972217|323911725|FG003|Part B Double-blind, Randomised Period|Death|44|||
94576249|NCT01972217|323911722|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
94576250|NCT01972217|323911723|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
94576251|NCT01972217|323911724|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
94576252|NCT01972217|323911725|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
94576253|NCT01972217|323911722|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
94576254|NCT01972217|323911723|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
94576255|NCT01972217|323911724|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
94576256|NCT01972217|323911725|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
94576257|NCT01972217|323911722|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
94576258|NCT01972217|323911723|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
94576259|NCT01972217|323911724|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
94576260|NCT01972217|323911725|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
94576261|NCT01972217|323911722|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
94576262|NCT01972217|323911723|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
94239916|NCT00479882|322672646|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
94576263|NCT01972217|323911724|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
94576264|NCT01972217|323911725|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
94576265|NCT01702311|323911726|FG000|Overall Study|Withdrawal by Subject|3|||
94576266|NCT01702311|323911727|FG001|Overall Study|Withdrawal by Subject|2|||
94576267|NCT01702311|323911726|FG000|Overall Study|Discharge less than 24 hours|10|||
94239917|NCT00479882|322672647|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
94239918|NCT00479882|322672644|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
94351442|NCT02030067|323067399|FG010|Overall Study|Disease Progression|7|||
94576268|NCT01702311|323911727|FG001|Overall Study|Discharge less than 24 hours|7|||
94576269|NCT01702311|323911726|FG000|Overall Study|Physician Decision|3|||
94576270|NCT01702311|323911727|FG001|Overall Study|Physician Decision|4|||
94576271|NCT03175367|323911735|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
94576272|NCT03175367|323911736|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
94576273|NCT03175367|323911737|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
94576274|NCT03175367|323911738|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
94576275|NCT03175367|323911739|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
94576276|NCT03175367|323911740|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
94576277|NCT03175367|323911741|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
94576278|NCT03175367|323911735|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
94576279|NCT03175367|323911736|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
94576280|NCT03175367|323911737|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
94576281|NCT03175367|323911738|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
94576282|NCT03175367|323911739|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
94576283|NCT03175367|323911740|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
94576284|NCT03175367|323911741|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
94576285|NCT03175367|323911735|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
94576286|NCT03175367|323911736|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
94576287|NCT03175367|323911737|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
94576288|NCT03175367|323911738|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
94576289|NCT03175367|323911739|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
94576290|NCT03175367|323911740|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
94576291|NCT03175367|323911741|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
94576292|NCT03175367|323911735|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
94576293|NCT03175367|323911736|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
94576294|NCT03175367|323911737|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
94576295|NCT03175367|323911738|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
94576296|NCT03175367|323911739|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
94576297|NCT03175367|323911740|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
94576298|NCT03175367|323911741|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
94576299|NCT03175367|323911735|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
94576300|NCT03175367|323911736|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
94576301|NCT03175367|323911737|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
94576302|NCT03175367|323911738|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
94576303|NCT03175367|323911739|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
94576304|NCT03175367|323911740|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
94576305|NCT03175367|323911741|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
94576306|NCT03175367|323911735|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
94576307|NCT03175367|323911736|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
94576308|NCT03175367|323911737|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
94576309|NCT03175367|323911738|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
94576310|NCT03175367|323911739|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
94576311|NCT03175367|323911740|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
94576312|NCT03175367|323911741|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
94576313|NCT03175367|323911735|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
94576314|NCT03175367|323911736|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
94576315|NCT03175367|323911737|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
94576316|NCT03175367|323911738|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
94576317|NCT03175367|323911739|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
94576318|NCT03175367|323911740|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
94576319|NCT03175367|323911741|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
94576320|NCT03304626|323911746|FG000|Overall Study|Adverse Event|1|||
94576321|NCT03304626|323911747|FG001|Overall Study|Adverse Event|0|||
94576322|NCT03304626|323911746|FG000|Overall Study|Lack of Efficacy|1|||
94576323|NCT03304626|323911747|FG001|Overall Study|Lack of Efficacy|1|||
94576324|NCT01074502|323911748|FG000|Overall Study|Withdrawal by Subject|1|||
94576325|NCT02220920|323911749|FG000|Overall Study|Adverse Event|1|||
94576326|NCT02220920|323911750|FG001|Overall Study|Adverse Event|0|||
94576327|NCT02220920|323911749|FG000|Overall Study|Lack of Efficacy|0|||
94576328|NCT02220920|323911750|FG001|Overall Study|Lack of Efficacy|1|||
94576329|NCT02220920|323911749|FG000|Overall Study|Withdrawal by Subject|1|||
94576330|NCT02220920|323911750|FG001|Overall Study|Withdrawal by Subject|0|||
94576331|NCT02220920|323911749|FG000|Overall Study|Conflict with the stopping criteria|1|||
94576332|NCT02220920|323911750|FG001|Overall Study|Conflict with the stopping criteria|2|||
94576333|NCT03198715|323911751|FG000|Overall Study|Death|0|||
94576334|NCT03198715|323911752|FG001|Overall Study|Death|0|||
94576335|NCT03198715|323911753|FG002|Overall Study|Death|1|||
94576336|NCT03198715|323911754|FG003|Overall Study|Death|0|||
94576337|NCT03198715|323911755|FG004|Overall Study|Death|2|||
94576338|NCT03198715|323911751|FG000|Overall Study|Other|0|||
94576339|NCT03198715|323911752|FG001|Overall Study|Other|1|||
94576340|NCT03198715|323911753|FG002|Overall Study|Other|1|||
94576341|NCT03198715|323911754|FG003|Overall Study|Other|0|||
94576342|NCT03198715|323911755|FG004|Overall Study|Other|0|||
94576343|NCT00853307|323911756|FG000|Overall Study|Adverse Event|1|||
94576344|NCT00853307|323911757|FG001|Overall Study|Adverse Event|2|||
94576345|NCT00853307|323911756|FG000|Overall Study|Withdrawal by Subject|1|||
94576346|NCT00853307|323911757|FG001|Overall Study|Withdrawal by Subject|2|||
94576347|NCT00853307|323911756|FG000|Overall Study|Reason Not Specified|0|||
94576348|NCT00853307|323911757|FG001|Overall Study|Reason Not Specified|1|||
94576349|NCT00473564|323911758|FG000|Overall Study|robot surgery aborted in OR|23|||
94576350|NCT00674817|323911759|FG000|Period 1|Withdrawal by Subject|2|||
94576351|NCT00674817|323911759|FG000|Period 1|Protocol Violation|1|||
94576352|NCT00674817|323911759|FG000|Period 3|Adverse Event|1|||
94576353|NCT00674817|323911759|FG000|Period 3|Protocol Violation|1|||
94576354|NCT00674817|323911759|FG000|Period 4|Adverse Event|1|||
94576355|NCT01527149|323911765|FG000|Overall Study|Death|2|||
94576356|NCT00481832|323911767|FG000|Enrollment|Physician Decision|8|||
94576357|NCT00481832|323911767|FG000|Enrollment|Unable to collect enough stem cells|2|||
94576358|NCT00481832|323911767|FG000|Inter-transplant Period|Adverse Event|4|||
94576359|NCT00481832|323911767|FG000|Inter-transplant Period|Death|3|||
94576360|NCT00481832|323911767|FG000|Inter-transplant Period|Physician Decision|4|||
94576361|NCT00481832|323911767|FG000|Inter-transplant Period|Disease relapse|11|||
94351443|NCT02030067|323067400|FG011|Overall Study|Disease Progression|2|||
94351444|NCT02030067|323067401|FG012|Overall Study|Disease Progression|59|||
94351445|NCT02030067|323067389|FG000|Overall Study|Withdrawal by Subject|0|||
94351446|NCT02030067|323067390|FG001|Overall Study|Withdrawal by Subject|0|||
94351447|NCT02030067|323067391|FG002|Overall Study|Withdrawal by Subject|0|||
94351448|NCT02030067|323067392|FG003|Overall Study|Withdrawal by Subject|1|||
94351449|NCT02030067|323067393|FG004|Overall Study|Withdrawal by Subject|0|||
94351450|NCT02030067|323067394|FG005|Overall Study|Withdrawal by Subject|0|||
94351451|NCT02030067|323067395|FG006|Overall Study|Withdrawal by Subject|0|||
94351452|NCT02030067|323067396|FG007|Overall Study|Withdrawal by Subject|1|||
94351453|NCT02030067|323067397|FG008|Overall Study|Withdrawal by Subject|0|||
94351454|NCT02030067|323067398|FG009|Overall Study|Withdrawal by Subject|0|||
94351455|NCT02030067|323067399|FG010|Overall Study|Withdrawal by Subject|3|||
94351456|NCT02030067|323067400|FG011|Overall Study|Withdrawal by Subject|0|||
94351457|NCT02030067|323067401|FG012|Overall Study|Withdrawal by Subject|6|||
94351458|NCT02030067|323067389|FG000|Overall Study|Physician Decision|0|||
94351459|NCT02030067|323067390|FG001|Overall Study|Physician Decision|0|||
94351460|NCT02030067|323067391|FG002|Overall Study|Physician Decision|0|||
94351461|NCT02030067|323067392|FG003|Overall Study|Physician Decision|0|||
94351462|NCT02030067|323067393|FG004|Overall Study|Physician Decision|0|||
94351463|NCT02030067|323067394|FG005|Overall Study|Physician Decision|0|||
94351464|NCT02030067|323067395|FG006|Overall Study|Physician Decision|0|||
94351465|NCT02030067|323067396|FG007|Overall Study|Physician Decision|0|||
94351466|NCT02030067|323067397|FG008|Overall Study|Physician Decision|0|||
94351467|NCT02030067|323067398|FG009|Overall Study|Physician Decision|0|||
94351468|NCT02030067|323067399|FG010|Overall Study|Physician Decision|1|||
94351469|NCT02030067|323067400|FG011|Overall Study|Physician Decision|0|||
94351470|NCT02030067|323067401|FG012|Overall Study|Physician Decision|3|||
94351471|NCT02030067|323067389|FG000|Overall Study|other reasons|0|||
94351472|NCT02030067|323067390|FG001|Overall Study|other reasons|0|||
94351473|NCT02030067|323067391|FG002|Overall Study|other reasons|0|||
94351474|NCT02030067|323067392|FG003|Overall Study|other reasons|0|||
94351475|NCT02030067|323067393|FG004|Overall Study|other reasons|0|||
94351476|NCT02030067|323067394|FG005|Overall Study|other reasons|1|||
94576362|NCT00481832|323911767|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
94576363|NCT00456846|323911768|FG000|Overall Study|Adverse Event|2|||
94576364|NCT00456846|323911769|FG001|Overall Study|Adverse Event|15|||
94351477|NCT02030067|323067395|FG006|Overall Study|other reasons|0|||
94351478|NCT02030067|323067396|FG007|Overall Study|other reasons|0|||
94351479|NCT02030067|323067397|FG008|Overall Study|other reasons|2|||
94351480|NCT02030067|323067398|FG009|Overall Study|other reasons|0|||
94576365|NCT00456846|323911768|FG000|Overall Study|Physician Decision|11|||
94576366|NCT00456846|323911769|FG001|Overall Study|Physician Decision|6|||
94576367|NCT00456846|323911768|FG000|Overall Study|Protocol Deviation|2|||
94576368|NCT00456846|323911769|FG001|Overall Study|Protocol Deviation|0|||
94351481|NCT02030067|323067399|FG010|Overall Study|other reasons|0|||
94351482|NCT02030067|323067400|FG011|Overall Study|other reasons|0|||
94351483|NCT02030067|323067401|FG012|Overall Study|other reasons|4|||
94351484|NCT02030067|323067389|FG000|Overall Study|Adverse Event|0|||
94351485|NCT02030067|323067390|FG001|Overall Study|Adverse Event|0|||
94576369|NCT00456846|323911768|FG000|Overall Study|Participant Discretion|1|||
94576370|NCT00456846|323911769|FG001|Overall Study|Participant Discretion|5|||
94576371|NCT00456846|323911768|FG000|Overall Study|Other|0|||
94576372|NCT00456846|323911769|FG001|Overall Study|Other|2|||
94576373|NCT01310777|323911775|FG000|Overall Study|Adverse Event|23|||
94576374|NCT01310777|323911776|FG001|Overall Study|Adverse Event|1|||
94576375|NCT01310777|323911777|FG002|Overall Study|Adverse Event|15|||
94239919|NCT00479882|322672645|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
94239920|NCT00479882|322672646|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
94239921|NCT00479882|322672647|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
94239922|NCT00479882|322672644|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
94239923|NCT00479882|322672645|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
94239924|NCT00479882|322672646|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
94576376|NCT01310777|323911775|FG000|Overall Study|Lost to Follow-up|0|||
94576377|NCT01310777|323911776|FG001|Overall Study|Lost to Follow-up|4|||
94576378|NCT01310777|323911777|FG002|Overall Study|Lost to Follow-up|1|||
94576379|NCT01310777|323911775|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
94576380|NCT01310777|323911776|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
94576381|NCT01310777|323911777|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
94239925|NCT00479882|322672647|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
94576382|NCT01310777|323911775|FG000|Overall Study|Inadequate Control of IOP|5|||
94576383|NCT01310777|323911776|FG001|Overall Study|Inadequate Control of IOP|7|||
94576384|NCT01310777|323911777|FG002|Overall Study|Inadequate Control of IOP|10|||
94576385|NCT01310777|323911775|FG000|Overall Study|Other|4|||
94576386|NCT01310777|323911776|FG001|Overall Study|Other|1|||
94576387|NCT01310777|323911777|FG002|Overall Study|Other|2|||
94576388|NCT02491684|323911778|FG000|Treatment Phase|Adverse Event|2|||
94576389|NCT02491684|323911779|FG001|Treatment Phase|Adverse Event|2|||
94576390|NCT02491684|323911778|FG000|Treatment Phase|Incorrect randomisation|1|||
94576391|NCT02491684|323911779|FG001|Treatment Phase|Incorrect randomisation|0|||
94576392|NCT02491684|323911778|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
94576393|NCT02491684|323911779|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
94576394|NCT02383576|323911781|FG000|Overall Study|Death|53|||
94576395|NCT02383576|323911782|FG001|Overall Study|Death|33|||
94576396|NCT02383576|323911781|FG000|Overall Study|Lost to Follow-up|7|||
94576397|NCT02383576|323911782|FG001|Overall Study|Lost to Follow-up|1|||
94576398|NCT02383576|323911781|FG000|Overall Study|Withdrew Consent|1|||
94576399|NCT02383576|323911782|FG001|Overall Study|Withdrew Consent|6|||
94576400|NCT02383576|323911781|FG000|Overall Study|Investigator's Decision|0|||
94576401|NCT02383576|323911782|FG001|Overall Study|Investigator's Decision|1|||
94576402|NCT02383576|323911781|FG000|Overall Study|Administrative/Other|2|||
94576403|NCT02383576|323911782|FG001|Overall Study|Administrative/Other|4|||
94576404|NCT04914364|323911785|FG000|Overall Study|No longer eligible for study|1|||
94576405|NCT04914364|323911785|FG000|Overall Study|Lost to Follow-up|2|||
94576406|NCT02435212|323911786|FG000|Core Phase|Adverse Event|8|||
94576407|NCT02435212|323911787|FG001|Core Phase|Adverse Event|5|||
94576408|NCT02435212|323911786|FG000|Core Phase|Withdrawal by Subject|3|||
94576409|NCT02435212|323911787|FG001|Core Phase|Withdrawal by Subject|0|||
94576410|NCT02435212|323911786|FG000|Core Phase|Withdrawal by parent/guardian|9|||
94576411|NCT02435212|323911787|FG001|Core Phase|Withdrawal by parent/guardian|4|||
94576412|NCT02435212|323911786|FG000|Core Phase|Protocol Violation|1|||
94576413|NCT02435212|323911787|FG001|Core Phase|Protocol Violation|2|||
94576414|NCT02435212|323911786|FG000|Core Phase|Physician Decision|3|||
94576415|NCT02435212|323911787|FG001|Core Phase|Physician Decision|0|||
94576416|NCT02435212|323911786|FG000|Core Phase|Lost to Follow-up|0|||
94576417|NCT02435212|323911787|FG001|Core Phase|Lost to Follow-up|1|||
94576418|NCT02435212|323911786|FG000|Core Phase|Lack of Efficacy|0|||
94576419|NCT02435212|323911787|FG001|Core Phase|Lack of Efficacy|1|||
94576420|NCT02435212|323911786|FG000|Core Phase|Recovery|1|||
94576421|NCT02435212|323911787|FG001|Core Phase|Recovery|0|||
94576422|NCT02435212|323911786|FG000|Optional Extension Phase|Adverse Event|3|||
94576423|NCT02435212|323911787|FG001|Optional Extension Phase|Adverse Event|9|||
94576424|NCT02435212|323911786|FG000|Optional Extension Phase|Physician Decision|6|||
94576425|NCT02435212|323911787|FG001|Optional Extension Phase|Physician Decision|8|||
94576426|NCT02435212|323911786|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
94576427|NCT02435212|323911787|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
94576428|NCT02435212|323911786|FG000|Optional Extension Phase|Lack of Efficacy|2|||
94576429|NCT02435212|323911787|FG001|Optional Extension Phase|Lack of Efficacy|3|||
94576430|NCT02435212|323911786|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
94576431|NCT02435212|323911787|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
94453936|NCT01471340|323450220|FG001|Overall Study|Investigational site closure|1|||
94453937|NCT01471340|323450219|FG000|Overall Study|Invalid informed consent|1|||
94453938|NCT01471340|323450220|FG001|Overall Study|Invalid informed consent|0|||
94576432|NCT02435212|323911786|FG000|Optional Extension Phase|Protocol Violation|0|||
94576433|NCT02435212|323911787|FG001|Optional Extension Phase|Protocol Violation|1|||
94576434|NCT02435212|323911786|FG000|Optional Extension Phase|Recovery|1|||
94576435|NCT02435212|323911787|FG001|Optional Extension Phase|Recovery|1|||
94576436|NCT02435212|323911786|FG000|Optional Extension Phase|Death|1|||
94576437|NCT02435212|323911787|FG001|Optional Extension Phase|Death|0|||
94576438|NCT02435212|323911786|FG000|Optional Extension Phase|Technical problems|2|||
94576439|NCT02435212|323911787|FG001|Optional Extension Phase|Technical problems|0|||
94576440|NCT00107198|323911788|FG000|Overall Study|Lack of Efficacy|28|||
94576441|NCT00107198|323911788|FG000|Overall Study|Lost to Follow-up|12|||
94239926|NCT00479882|322672644|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
94239927|NCT00479882|322672645|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
94239928|NCT00479882|322672646|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
94239929|NCT00479882|322672647|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
94239930|NCT03738475|322672648|FG000|Overall Study|Participant Non-Compliance|1|||
94239931|NCT03738475|322672649|FG001|Overall Study|Participant Non-Compliance|0|||
94239932|NCT01132820|322672650|FG000|Overall Study|Ineligible: wrong cell type|1|||
94239933|NCT01132820|322672650|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
94239934|NCT01132820|322672650|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
94239935|NCT01132820|322672650|FG000|Overall Study|Never treated|1|||
94239936|NCT01132820|322672650|FG000|Overall Study|Inadequate data|1|||
94239937|NCT00677534|322672651|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
94239938|NCT00677534|322672651|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
94239939|NCT00677534|322672651|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
94239940|NCT00581477|322672654|FG000|Overall Study|Physician Decision|2|||
94239941|NCT03106753|322672655|FG000|Overall Study|Withdrawal by Subject|0|||
94239942|NCT03106753|322672656|FG001|Overall Study|Withdrawal by Subject|1|||
94239943|NCT02522728|322672659|FG000|Overall Study|Withdrawal by Subject|6|||
94239944|NCT02522728|322672660|FG001|Overall Study|Withdrawal by Subject|6|||
94239945|NCT02522728|322672659|FG000|Overall Study|Death|4|||
94239946|NCT02522728|322672660|FG001|Overall Study|Death|3|||
94239947|NCT02522728|322672659|FG000|Overall Study|Adverse Event|2|||
94239948|NCT02522728|322672660|FG001|Overall Study|Adverse Event|1|||
94239949|NCT02522728|322672659|FG000|Overall Study|Did not receive randomized study device|0|||
94239950|NCT02522728|322672660|FG001|Overall Study|Did not receive randomized study device|1|||
94239951|NCT01081886|322672661|FG000|Overall Study|Study termination|11|||
94239952|NCT01081886|322672662|FG001|Overall Study|Study termination|13|||
94239953|NCT02975102|322672664|FG000|Overall Study|Adverse Event|2|||
94239954|NCT02975102|322672665|FG001|Overall Study|Adverse Event|1|||
94239955|NCT01371825|322672668|FG000|Overall Study|Death|4|||
94239956|NCT03392168|322672669|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
94239957|NCT03392168|322672670|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
94239958|NCT03392168|322672671|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
94239959|NCT03392168|322672672|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
94239960|NCT03392168|322672669|FG000|Period 2: Cohort 2|Other|0|||
94239961|NCT03392168|322672670|FG001|Period 2: Cohort 2|Other|1|||
94239962|NCT03392168|322672671|FG002|Period 2: Cohort 2|Other|0|||
94239963|NCT03392168|322672672|FG003|Period 2: Cohort 2|Other|0|||
94239964|NCT02597712|322672675|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
94239965|NCT02597712|322672676|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
94239966|NCT02597712|322672675|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
94239967|NCT02597712|322672676|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
94239968|NCT02597712|322672675|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
94239969|NCT02597712|322672676|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
94239970|NCT00504777|322672677|FG000|Overall Study|Adverse Event|1|||
94239971|NCT01572740|322672681|FG000|Overall Study|Adverse Event|1|||
94239972|NCT01572740|322672682|FG001|Overall Study|Adverse Event|1|||
94239973|NCT01572740|322672681|FG000|Overall Study|Withdrawal by Subject|1|||
94239974|NCT01572740|322672682|FG001|Overall Study|Withdrawal by Subject|1|||
94239975|NCT01572740|322672681|FG000|Overall Study|unclassified|4|||
94239976|NCT01572740|322672682|FG001|Overall Study|unclassified|3|||
94239977|NCT01305239|322672689|FG000|Overall Study|Adverse Event|22|||
94239978|NCT01305239|322672689|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
94239979|NCT04160988|322672691|FG000|Overall Study|poor image quality|28|||
94239980|NCT01228175|322672692|FG000|Overall Study|Lost to Follow-up|64|||
94239981|NCT01228175|322672693|FG001|Overall Study|Lost to Follow-up|50|||
94239982|NCT01228175|322672692|FG000|Overall Study|Withdrawal by Subject|1|||
94239983|NCT01228175|322672693|FG001|Overall Study|Withdrawal by Subject|2|||
94239984|NCT01228175|322672692|FG000|Overall Study|Physician Decision|1|||
94351486|NCT02030067|323067391|FG002|Overall Study|Adverse Event|0|||
94351487|NCT02030067|323067392|FG003|Overall Study|Adverse Event|0|||
94351488|NCT02030067|323067393|FG004|Overall Study|Adverse Event|0|||
94351489|NCT02030067|323067394|FG005|Overall Study|Adverse Event|0|||
94351490|NCT02030067|323067395|FG006|Overall Study|Adverse Event|0|||
94351491|NCT02030067|323067396|FG007|Overall Study|Adverse Event|0|||
94351492|NCT02030067|323067397|FG008|Overall Study|Adverse Event|0|||
94351493|NCT02030067|323067398|FG009|Overall Study|Adverse Event|0|||
94351494|NCT02030067|323067399|FG010|Overall Study|Adverse Event|0|||
94351495|NCT02030067|323067400|FG011|Overall Study|Adverse Event|1|||
94351496|NCT02030067|323067401|FG012|Overall Study|Adverse Event|8|||
94351497|NCT00496782|323067405|FG000|Overall Study|Protocol Violation|1|||
94239985|NCT01228175|322672693|FG001|Overall Study|Physician Decision|1|||
94239986|NCT02807883|322672696|FG000|Overall Study|Withdrawal by Subject|2|||
94351498|NCT00496782|323067406|FG001|Overall Study|Protocol Violation|2|||
94351499|NCT01474993|323067407|FG000|Overall Study|Lost to Follow-up|1|||
94351500|NCT01474993|323067408|FG001|Overall Study|Lost to Follow-up|2|||
94576442|NCT00107198|323911788|FG000|Overall Study|Protocol Violation|1|||
94576443|NCT00107198|323911788|FG000|Overall Study|Withdrawal by Subject|6|||
94576444|NCT00107198|323911788|FG000|Overall Study|Ineligible|5|||
94576445|NCT05058365|323911792|FG000|Overall Study|Migration|1|||
94576446|NCT05058365|323911793|FG001|Overall Study|Migration|1|||
94576447|NCT00001959|323911794|FG000|Overall Study|newly diagnosed colon cancer|1|||
94576448|NCT00001959|323911794|FG000|Overall Study|disabling sedation|1|||
94576449|NCT00001959|323911794|FG000|Overall Study|non-compliance|1|||
94576450|NCT01710345|323911795|FG000|Overall Study|Adverse Event|0|||
94576451|NCT01710345|323911796|FG001|Overall Study|Adverse Event|2|||
94576452|NCT01710345|323911797|FG002|Overall Study|Adverse Event|0|||
94576453|NCT01710345|323911795|FG000|Overall Study|Lack of Efficacy|2|||
94576454|NCT01710345|323911796|FG001|Overall Study|Lack of Efficacy|3|||
94576455|NCT01710345|323911797|FG002|Overall Study|Lack of Efficacy|1|||
94576456|NCT01710345|323911795|FG000|Overall Study|Drug Dosing Error|1|||
94576457|NCT01710345|323911796|FG001|Overall Study|Drug Dosing Error|0|||
94576458|NCT01710345|323911797|FG002|Overall Study|Drug Dosing Error|0|||
94576459|NCT03019406|323911798|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
94576460|NCT03019406|323911799|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
94576461|NCT03019406|323911800|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
94576462|NCT03019406|323911801|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
94576463|NCT00468169|323911802|FG000|Overall Study|Withdrawal by Subject|1|||
94576464|NCT00468169|323911803|FG001|Overall Study|Withdrawal by Subject|0|||
94576465|NCT00774046|323911804|FG000|Screening|Not eligible|56|||
94576466|NCT00774046|323911804|FG000|Enrollment|Desired other therapy/refused|28|||
94576467|NCT00774046|323911804|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
94576468|NCT00762164|323911805|FG000|Overall Study|Lost to Follow-up|1|||
94576469|NCT00762164|323911806|FG001|Overall Study|Lost to Follow-up|1|||
94576470|NCT00762164|323911805|FG000|Overall Study|Discontinued medication|2|||
94576471|NCT00762164|323911806|FG001|Overall Study|Discontinued medication|0|||
94576472|NCT00762164|323911805|FG000|Overall Study|Withdrawal by Subject|0|||
94576473|NCT00762164|323911806|FG001|Overall Study|Withdrawal by Subject|1|||
94576474|NCT02954536|323911807|FG000|Overall Study|Adverse Event|2|||
94576475|NCT02954536|323911807|FG000|Overall Study|Death|12|||
94576476|NCT04408989|323911808|FG000|Overall Study|Lost to Follow-up|0|||
94576477|NCT04408989|323911809|FG001|Overall Study|Lost to Follow-up|0|||
94576478|NCT04408989|323911810|FG002|Overall Study|Lost to Follow-up|1|||
94576479|NCT04408989|323911808|FG000|Overall Study|Withdrawal by Subject|0|||
94576480|NCT04408989|323911809|FG001|Overall Study|Withdrawal by Subject|0|||
94576481|NCT04408989|323911810|FG002|Overall Study|Withdrawal by Subject|2|||
94576482|NCT03312231|323911819|FG000|Overall Study|Lost to Follow-up|2|||
94576483|NCT03312231|323911820|FG001|Overall Study|Lost to Follow-up|6|||
94576484|NCT03312231|323911821|FG002|Overall Study|Lost to Follow-up|1|||
94576485|NCT03312231|323911822|FG003|Overall Study|Lost to Follow-up|3|||
94576486|NCT03312231|323911823|FG004|Overall Study|Lost to Follow-up|1|||
94576487|NCT03312231|323911819|FG000|Overall Study|Withdrawal by Subject|0|||
94576488|NCT03312231|323911820|FG001|Overall Study|Withdrawal by Subject|3|||
94576489|NCT03312231|323911821|FG002|Overall Study|Withdrawal by Subject|1|||
94576490|NCT03312231|323911822|FG003|Overall Study|Withdrawal by Subject|0|||
94576491|NCT03312231|323911823|FG004|Overall Study|Withdrawal by Subject|0|||
94576492|NCT03312231|323911819|FG000|Overall Study|Death|0|||
94576493|NCT03312231|323911820|FG001|Overall Study|Death|1|||
94576494|NCT03312231|323911821|FG002|Overall Study|Death|1|||
94576495|NCT03312231|323911822|FG003|Overall Study|Death|0|||
94576496|NCT03312231|323911823|FG004|Overall Study|Death|0|||
94576497|NCT03312231|323911819|FG000|Overall Study|Study Vaccination not Received|1|||
94576498|NCT03312231|323911820|FG001|Overall Study|Study Vaccination not Received|1|||
94576499|NCT03312231|323911821|FG002|Overall Study|Study Vaccination not Received|1|||
94576500|NCT03312231|323911822|FG003|Overall Study|Study Vaccination not Received|0|||
94576501|NCT03312231|323911823|FG004|Overall Study|Study Vaccination not Received|0|||
94576502|NCT03694353|323911827|FG000|Overall Study|Withdrawal by Subject|1|||
94576503|NCT03694353|323911827|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
94576504|NCT03804528|323911828|FG000|Overall Study|Time Commitment|18|||
94576505|NCT03804528|323911828|FG000|Overall Study|Health Reasons|5|||
94453939|NCT01430403|323450224|FG000|Overall Study|Lost to Follow-up|5|||
94453940|NCT01430403|323450225|FG001|Overall Study|Lost to Follow-up|5|||
94576506|NCT00400179|323911829|FG000|Overall Study|Adverse Event|2|||
94576507|NCT00400179|323911830|FG001|Overall Study|Adverse Event|2|||
94576508|NCT00400179|323911829|FG000|Overall Study|Death|1|||
94576509|NCT00400179|323911830|FG001|Overall Study|Death|2|||
94576510|NCT00400179|323911829|FG000|Overall Study|Withdrew Consent|1|||
94576511|NCT00400179|323911830|FG001|Overall Study|Withdrew Consent|5|||
94576512|NCT00400179|323911829|FG000|Overall Study|Disease progression|1|||
94576513|NCT00400179|323911830|FG001|Overall Study|Disease progression|1|||
94576514|NCT00400179|323911829|FG000|Overall Study|Intercurrent illness|0|||
94576515|NCT00400179|323911830|FG001|Overall Study|Intercurrent illness|1|||
94576516|NCT00400179|323911829|FG000|Overall Study|Investigator judgment|0|||
94576517|NCT00400179|323911830|FG001|Overall Study|Investigator judgment|1|||
94576518|NCT00400179|323911829|FG000|Overall Study|Randomization error/patient ineligible|1|||
94576519|NCT00400179|323911830|FG001|Overall Study|Randomization error/patient ineligible|6|||
94576520|NCT00626106|323911831|FG000|Overall Study|Withdrawal by Subject|2|||
94576521|NCT00626106|323911832|FG001|Overall Study|Withdrawal by Subject|1|||
94576522|NCT00626106|323911831|FG000|Overall Study|Lost to Follow-up|1|||
94576523|NCT00626106|323911832|FG001|Overall Study|Lost to Follow-up|4|||
94576524|NCT00626106|323911831|FG000|Overall Study|Death|64|||
94576525|NCT00626106|323911832|FG001|Overall Study|Death|19|||
94576526|NCT04272242|323911833|FG000|Overall Study|Withdrawal by Subject|3|||
94576527|NCT04272242|323911833|FG000|Overall Study|Lost to Follow-up|1|||
94576528|NCT04272242|323911833|FG000|Overall Study|Adverse Event|1|||
94576529|NCT02702492|323911836|FG000|Overall Study|Disease progression|3|||
94576530|NCT02702492|323911837|FG001|Overall Study|Disease progression|3|||
94576531|NCT02702492|323911838|FG002|Overall Study|Disease progression|2|||
94576532|NCT02702492|323911839|FG003|Overall Study|Disease progression|4|||
94576533|NCT02702492|323911840|FG004|Overall Study|Disease progression|4|||
94576534|NCT02702492|323911841|FG005|Overall Study|Disease progression|1|||
94576535|NCT02702492|323911842|FG006|Overall Study|Disease progression|2|||
94576536|NCT02702492|323911843|FG007|Overall Study|Disease progression|8|||
94576537|NCT02702492|323911844|FG008|Overall Study|Disease progression|5|||
94576538|NCT02702492|323911845|FG009|Overall Study|Disease progression|1|||
94576539|NCT02702492|323911846|FG010|Overall Study|Disease progression|0|||
94576540|NCT02702492|323911847|FG011|Overall Study|Disease progression|3|||
94576541|NCT02702492|323911848|FG012|Overall Study|Disease progression|2|||
94576542|NCT02702492|323911836|FG000|Overall Study|Clinical progression|0|||
94576543|NCT02702492|323911837|FG001|Overall Study|Clinical progression|0|||
94576544|NCT02702492|323911838|FG002|Overall Study|Clinical progression|2|||
94576545|NCT02702492|323911839|FG003|Overall Study|Clinical progression|1|||
94576546|NCT02702492|323911840|FG004|Overall Study|Clinical progression|0|||
94576547|NCT02702492|323911841|FG005|Overall Study|Clinical progression|2|||
94576548|NCT02702492|323911842|FG006|Overall Study|Clinical progression|1|||
94576549|NCT02702492|323911843|FG007|Overall Study|Clinical progression|4|||
94576550|NCT02702492|323911844|FG008|Overall Study|Clinical progression|0|||
94576551|NCT02702492|323911845|FG009|Overall Study|Clinical progression|0|||
94576552|NCT02702492|323911846|FG010|Overall Study|Clinical progression|1|||
94576553|NCT02702492|323911847|FG011|Overall Study|Clinical progression|2|||
94576554|NCT02702492|323911848|FG012|Overall Study|Clinical progression|0|||
94576555|NCT02702492|323911836|FG000|Overall Study|Adverse Event|0|||
94576556|NCT02702492|323911837|FG001|Overall Study|Adverse Event|0|||
94576557|NCT02702492|323911838|FG002|Overall Study|Adverse Event|1|||
94576558|NCT02702492|323911839|FG003|Overall Study|Adverse Event|2|||
94576559|NCT02702492|323911840|FG004|Overall Study|Adverse Event|1|||
94576560|NCT02702492|323911841|FG005|Overall Study|Adverse Event|0|||
94576561|NCT02702492|323911842|FG006|Overall Study|Adverse Event|1|||
94576562|NCT02702492|323911843|FG007|Overall Study|Adverse Event|0|||
94576563|NCT02702492|323911844|FG008|Overall Study|Adverse Event|2|||
94576564|NCT02702492|323911845|FG009|Overall Study|Adverse Event|0|||
94576565|NCT02702492|323911846|FG010|Overall Study|Adverse Event|0|||
94576566|NCT02702492|323911847|FG011|Overall Study|Adverse Event|0|||
94576567|NCT02702492|323911848|FG012|Overall Study|Adverse Event|1|||
94576568|NCT02702492|323911836|FG000|Overall Study|Other|0|||
94576569|NCT02702492|323911837|FG001|Overall Study|Other|0|||
94576570|NCT02702492|323911838|FG002|Overall Study|Other|0|||
94576571|NCT02702492|323911839|FG003|Overall Study|Other|0|||
94576572|NCT02702492|323911840|FG004|Overall Study|Other|0|||
94576573|NCT02702492|323911841|FG005|Overall Study|Other|0|||
94576574|NCT02702492|323911842|FG006|Overall Study|Other|0|||
94576575|NCT02702492|323911843|FG007|Overall Study|Other|0|||
94576576|NCT02702492|323911844|FG008|Overall Study|Other|0|||
94576577|NCT02702492|323911845|FG009|Overall Study|Other|0|||
94576578|NCT02702492|323911846|FG010|Overall Study|Other|0|||
94576579|NCT02702492|323911847|FG011|Overall Study|Other|0|||
94576580|NCT02702492|323911848|FG012|Overall Study|Other|1|||
94453941|NCT01430403|323450226|FG002|Overall Study|Lost to Follow-up|3|||
94576581|NCT01824836|323911849|FG000|Overall Study|Adverse Event|48|||
94576582|NCT01824836|323911849|FG000|Overall Study|Withdrawal by Subject|63|||
94576583|NCT01824836|323911849|FG000|Overall Study|Other complicating disease|116|||
94576584|NCT01824836|323911849|FG000|Overall Study|Disease progression|5|||
94576585|NCT01824836|323911849|FG000|Overall Study|Alternative therapy|2|||
94576586|NCT01824836|323911849|FG000|Overall Study|Depression|1|||
94576587|NCT01824836|323911849|FG000|Overall Study|Non-compliance|3|||
94576588|NCT01824836|323911849|FG000|Overall Study|Patient regained ovarian function|3|||
94576589|NCT01824836|323911849|FG000|Overall Study|Lost to Follow-up|8|||
94576590|NCT01824836|323911849|FG000|Overall Study|Physician Decision|2|||
94576591|NCT01824836|323911849|FG000|Overall Study|Research office was closed|3|||
94576592|NCT01824836|323911849|FG000|Overall Study|Relocation|3|||
94576593|NCT01824836|323911849|FG000|Overall Study|Insurance-related issue|1|||
94576594|NCT01824836|323911849|FG000|Overall Study|Transportation issue|1|||
94576595|NCT01824836|323911849|FG000|Overall Study|Patient transferred care|1|||
94576596|NCT01824836|323911849|FG000|Overall Study|Unknown reasons|4|||
94576597|NCT01824836|323911849|FG000|Overall Study|Never started treatment|16|||
94576598|NCT00726063|323913430|FG000|Overall Study|Adverse Event|9|||
94576599|NCT00726063|323913431|FG001|Overall Study|Adverse Event|7|||
94576600|NCT02118584|323913432|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
94576601|NCT02118584|323913433|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
94576602|NCT02118584|323913434|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
94576603|NCT02118584|323913432|FG000|Part 1: Open Label Extension Period|Death|9|||
94576604|NCT02118584|323913433|FG001|Part 1: Open Label Extension Period|Death|0|||
94576605|NCT02118584|323913434|FG002|Part 1: Open Label Extension Period|Death|0|||
94576606|NCT02118584|323913432|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
94576607|NCT02118584|323913433|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
94576608|NCT02118584|323913434|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
94576609|NCT02118584|323913432|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
94576610|NCT02118584|323913433|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
94576611|NCT02118584|323913434|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
94576612|NCT02118584|323913432|FG000|Part 1: Open Label Extension Period|Other|135|||
94576613|NCT02118584|323913433|FG001|Part 1: Open Label Extension Period|Other|0|||
94576614|NCT02118584|323913434|FG002|Part 1: Open Label Extension Period|Other|0|||
94576615|NCT02118584|323913432|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
94576616|NCT02118584|323913433|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
94576617|NCT02118584|323913434|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
94576618|NCT02118584|323913432|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
94576619|NCT02118584|323913433|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
94576620|NCT02118584|323913434|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
94576621|NCT02118584|323913432|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
94576622|NCT02118584|323913433|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
94576623|NCT02118584|323913434|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
94576624|NCT02118584|323913432|FG000|Part 1: Open Label Extension Period|Other|3|||
94576625|NCT02118584|323913433|FG001|Part 1: Open Label Extension Period|Other|0|||
94576626|NCT02118584|323913434|FG002|Part 1: Open Label Extension Period|Other|0|||
94576627|NCT02118584|323913432|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
94576628|NCT02118584|323913433|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
94576629|NCT02118584|323913434|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
94576630|NCT02118584|323913432|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
94576631|NCT02118584|323913433|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
94576632|NCT02118584|323913434|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
94576633|NCT02118584|323913432|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
94576634|NCT02118584|323913433|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
94576635|NCT02118584|323913434|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
94576636|NCT02118584|323913432|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
94576637|NCT02118584|323913433|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
94576638|NCT02118584|323913434|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
94576639|NCT02118584|323913432|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
94576640|NCT02118584|323913433|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
94576641|NCT02118584|323913434|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
94576642|NCT02118584|323913432|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
94576643|NCT02118584|323913433|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
94239987|NCT01509547|322672697|FG000|Overall Study|Lost to Follow-up|24|||
94351501|NCT01474993|323067407|FG000|Overall Study|Adverse Event|0|||
94351502|NCT01474993|323067408|FG001|Overall Study|Adverse Event|1|||
94351503|NCT01412333|323067409|FG000|Overall Study|Adverse Event|40|||
94576644|NCT02118584|323913434|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
94576645|NCT02118584|323913432|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
94576646|NCT02118584|323913433|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
94576647|NCT02118584|323913434|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
94576648|NCT02118584|323913432|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
94576649|NCT02118584|323913433|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
94576650|NCT02118584|323913434|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
94576651|NCT02118584|323913432|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
94576652|NCT02118584|323913433|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
94576653|NCT02118584|323913434|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
94576654|NCT01231984|323913435|FG000|Study Period 1|Withdrawal by Subject|0|||
94576655|NCT01231984|323913436|FG001|Study Period 1|Withdrawal by Subject|0|||
94576656|NCT01231984|323913437|FG002|Study Period 1|Withdrawal by Subject|0|||
94576657|NCT01231984|323913438|FG003|Study Period 1|Withdrawal by Subject|1|||
94576658|NCT01231984|323913435|FG000|Study Period 1|Lost to Follow-up|1|||
94576659|NCT01231984|323913436|FG001|Study Period 1|Lost to Follow-up|1|||
94576660|NCT01231984|323913437|FG002|Study Period 1|Lost to Follow-up|1|||
94576661|NCT01231984|323913438|FG003|Study Period 1|Lost to Follow-up|0|||
94576662|NCT01231984|323913435|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
94576663|NCT01231984|323913436|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
94576664|NCT01231984|323913437|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
94576665|NCT01231984|323913438|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
94576666|NCT01231984|323913435|FG000|Study Period 1|Screen Failure|0|||
94576667|NCT01231984|323913436|FG001|Study Period 1|Screen Failure|0|||
94576668|NCT01231984|323913437|FG002|Study Period 1|Screen Failure|0|||
94576669|NCT01231984|323913438|FG003|Study Period 1|Screen Failure|1|||
94576670|NCT01231984|323913435|FG000|Study Period 1|Non-compliance with study requirements|5|||
94576671|NCT01231984|323913436|FG001|Study Period 1|Non-compliance with study requirements|0|||
94576672|NCT01231984|323913437|FG002|Study Period 1|Non-compliance with study requirements|2|||
94576673|NCT01231984|323913438|FG003|Study Period 1|Non-compliance with study requirements|1|||
94576674|NCT01231984|323913435|FG000|Study Period 1|Protocol Violation|3|||
94576675|NCT01231984|323913436|FG001|Study Period 1|Protocol Violation|4|||
94576676|NCT01231984|323913437|FG002|Study Period 1|Protocol Violation|2|||
94576677|NCT01231984|323913438|FG003|Study Period 1|Protocol Violation|3|||
94576678|NCT01231984|323913435|FG000|Study Period 1|Adverse Event|1|||
94576679|NCT01231984|323913436|FG001|Study Period 1|Adverse Event|0|||
94576680|NCT01231984|323913437|FG002|Study Period 1|Adverse Event|0|||
94576681|NCT01231984|323913438|FG003|Study Period 1|Adverse Event|0|||
94576682|NCT01231984|323913435|FG000|Study Period 1|Other|0|||
94576683|NCT01231984|323913436|FG001|Study Period 1|Other|0|||
94576684|NCT01231984|323913437|FG002|Study Period 1|Other|0|||
94576685|NCT01231984|323913438|FG003|Study Period 1|Other|1|||
94576686|NCT01231984|323913435|FG000|Study Period 2|Withdrawal by Subject|1|||
94576687|NCT01231984|323913436|FG001|Study Period 2|Withdrawal by Subject|1|||
94576688|NCT01231984|323913437|FG002|Study Period 2|Withdrawal by Subject|0|||
94576689|NCT01231984|323913438|FG003|Study Period 2|Withdrawal by Subject|0|||
94576690|NCT01231984|323913435|FG000|Study Period 2|Lost to Follow-up|1|||
94576691|NCT01231984|323913436|FG001|Study Period 2|Lost to Follow-up|0|||
94576692|NCT01231984|323913437|FG002|Study Period 2|Lost to Follow-up|0|||
94576693|NCT01231984|323913438|FG003|Study Period 2|Lost to Follow-up|3|||
94576694|NCT01231984|323913435|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
94576695|NCT01231984|323913436|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
94576696|NCT01231984|323913437|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
94576697|NCT01231984|323913438|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
94576698|NCT00807911|323913439|FG000|Overall Study|Withdrawal by Subject|12|||
94576699|NCT00807911|323913440|FG001|Overall Study|Withdrawal by Subject|10|||
94576700|NCT00807911|323913439|FG000|Overall Study|Ineligible|0|||
94576701|NCT00807911|323913440|FG001|Overall Study|Ineligible|4|||
94576702|NCT03363841|323913441|FG000|Overall Study|Adverse Event|1|||
94576703|NCT03363841|323913441|FG000|Overall Study|Withdrawal by Subject|1|||
94576704|NCT03363841|323913441|FG000|Overall Study|Death|7|||
94576705|NCT03363841|323913441|FG000|Overall Study|Physician Decision|1|||
94576706|NCT02085460|323913449|FG000|Overall Study|Adverse Event|2|||
94576707|NCT02085460|323913450|FG001|Overall Study|Adverse Event|2|||
94351504|NCT01412333|323067410|FG001|Overall Study|Adverse Event|42|||
94576708|NCT02085460|323913451|FG002|Overall Study|Adverse Event|1|||
94576709|NCT02085460|323913449|FG000|Overall Study|Physician Decision|1|||
94576710|NCT02085460|323913450|FG001|Overall Study|Physician Decision|1|||
94576711|NCT02085460|323913451|FG002|Overall Study|Physician Decision|2|||
94576712|NCT02085460|323913449|FG000|Overall Study|Withdrawal by Subject|11|||
94576713|NCT02085460|323913450|FG001|Overall Study|Withdrawal by Subject|5|||
94576714|NCT02085460|323913451|FG002|Overall Study|Withdrawal by Subject|7|||
94576715|NCT00360230|323913452|FG000|Overall Study|Withdrawal by Subject|1|||
94576716|NCT00360230|323913453|FG001|Overall Study|Withdrawal by Subject|1|||
94576717|NCT00360230|323913454|FG002|Overall Study|Withdrawal by Subject|0|||
94576718|NCT00360230|323913455|FG003|Overall Study|Withdrawal by Subject|1|||
94576719|NCT00360230|323913456|FG004|Overall Study|Withdrawal by Subject|1|||
94576720|NCT00360230|323913457|FG005|Overall Study|Withdrawal by Subject|1|||
94576721|NCT00360230|323913458|FG006|Overall Study|Withdrawal by Subject|0|||
94576722|NCT00360230|323913452|FG000|Overall Study|Migrated|4|||
94576723|NCT00360230|323913453|FG001|Overall Study|Migrated|1|||
94576724|NCT00360230|323913454|FG002|Overall Study|Migrated|3|||
94576725|NCT00360230|323913455|FG003|Overall Study|Migrated|1|||
94576726|NCT00360230|323913456|FG004|Overall Study|Migrated|4|||
94576727|NCT00360230|323913457|FG005|Overall Study|Migrated|1|||
94576728|NCT00360230|323913458|FG006|Overall Study|Migrated|1|||
94576729|NCT00360230|323913452|FG000|Overall Study|Other|1|||
94576730|NCT00360230|323913453|FG001|Overall Study|Other|0|||
94576731|NCT00360230|323913454|FG002|Overall Study|Other|0|||
94576732|NCT00360230|323913455|FG003|Overall Study|Other|0|||
94576733|NCT00360230|323913456|FG004|Overall Study|Other|0|||
94576734|NCT00360230|323913457|FG005|Overall Study|Other|0|||
94576735|NCT00360230|323913458|FG006|Overall Study|Other|0|||
94576736|NCT00360230|323913452|FG000|Overall Study|Protocol Violation|0|||
94576737|NCT00360230|323913453|FG001|Overall Study|Protocol Violation|0|||
94576738|NCT00360230|323913454|FG002|Overall Study|Protocol Violation|0|||
94576739|NCT00360230|323913455|FG003|Overall Study|Protocol Violation|0|||
94576740|NCT00360230|323913456|FG004|Overall Study|Protocol Violation|0|||
94576741|NCT00360230|323913457|FG005|Overall Study|Protocol Violation|1|||
94576742|NCT00360230|323913458|FG006|Overall Study|Protocol Violation|0|||
94576743|NCT00360230|323913452|FG000|Overall Study|Death|0|||
94576744|NCT00360230|323913453|FG001|Overall Study|Death|1|||
94576745|NCT00360230|323913454|FG002|Overall Study|Death|0|||
94576746|NCT00360230|323913455|FG003|Overall Study|Death|0|||
94576747|NCT00360230|323913456|FG004|Overall Study|Death|0|||
94576748|NCT00360230|323913457|FG005|Overall Study|Death|1|||
94576749|NCT00360230|323913458|FG006|Overall Study|Death|1|||
94576750|NCT04558125|323913459|FG000|Overall Study|Death|1|||
94576751|NCT04218240|323913465|FG000|Overall Study|Withdrawal by Subject|6|||
94576752|NCT04218240|323913466|FG001|Overall Study|Withdrawal by Subject|0|||
94576753|NCT04218240|323913465|FG000|Overall Study|Lack of Efficacy|24|||
94576754|NCT04218240|323913466|FG001|Overall Study|Lack of Efficacy|19|||
94576755|NCT04218240|323913465|FG000|Overall Study|Physician Decision|0|||
94576756|NCT04218240|323913466|FG001|Overall Study|Physician Decision|1|||
94576757|NCT04218240|323913465|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
94576758|NCT04218240|323913466|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
94576759|NCT04711850|323913467|FG000|Overall Study|Graft loss|2|||
94576760|NCT04711850|323913468|FG001|Overall Study|Graft loss|1|||
94576761|NCT04711850|323913467|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
94576762|NCT04711850|323913468|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
94576763|NCT04711850|323913467|FG000|Overall Study|Study terminated by sponsor|5|||
94576764|NCT04711850|323913468|FG001|Overall Study|Study terminated by sponsor|3|||
94576765|NCT04711850|323913467|FG000|Overall Study|Sponsor decision|0|||
94576766|NCT04711850|323913468|FG001|Overall Study|Sponsor decision|2|||
94576767|NCT05249582|323913469|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
94576768|NCT05249582|323913470|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
94576769|NCT05249582|323913469|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
94576770|NCT05249582|323913470|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
94576771|NCT05249582|323913469|FG000|Overall Study|Declined to use virtual reality headset|1|||
94576772|NCT05249582|323913470|FG001|Overall Study|Declined to use virtual reality headset|0|||
94576773|NCT03675126|323913471|FG000|Overall Study|Study Terminated by Sponsor|9|||
94576774|NCT03675126|323913471|FG000|Overall Study|Death|2|||
94576775|NCT03675126|323913471|FG000|Overall Study|Withdrawal by Subject|4|||
94576776|NCT02242942|323913486|FG000|Overall Study|Death|17|||
94576777|NCT02242942|323913487|FG001|Overall Study|Death|20|||
94576778|NCT02242942|323913488|FG002|Overall Study|Death|2|||
94576779|NCT02242942|323913486|FG000|Overall Study|Physician Decision|1|||
94576780|NCT02242942|323913487|FG001|Overall Study|Physician Decision|0|||
94576781|NCT02242942|323913488|FG002|Overall Study|Physician Decision|0|||
94576782|NCT02242942|323913486|FG000|Overall Study|Withdrawal by Subject|8|||
94576783|NCT02242942|323913487|FG001|Overall Study|Withdrawal by Subject|10|||
94576784|NCT02242942|323913488|FG002|Overall Study|Withdrawal by Subject|0|||
94576785|NCT02242942|323913486|FG000|Overall Study|On-going in Study|190|||
94576786|NCT02242942|323913487|FG001|Overall Study|On-going in Study|186|||
94576787|NCT02242942|323913488|FG002|Overall Study|On-going in Study|11|||
94576788|NCT03279081|323913489|FG000|Overall Study|Withdrawal by Subject|12|||
94576789|NCT03279081|323913490|FG001|Overall Study|Withdrawal by Subject|20|||
94576790|NCT03279081|323913489|FG000|Overall Study|Physician Decision|4|||
94576791|NCT03279081|323913490|FG001|Overall Study|Physician Decision|1|||
94576792|NCT03279081|323913489|FG000|Overall Study|Lost to Follow-up|8|||
94576793|NCT03279081|323913490|FG001|Overall Study|Lost to Follow-up|8|||
94576794|NCT03279081|323913489|FG000|Overall Study|Death|0|||
94576795|NCT03279081|323913490|FG001|Overall Study|Death|1|||
94576796|NCT03279081|323913489|FG000|Overall Study|Adverse Event|1|||
94576797|NCT03279081|323913490|FG001|Overall Study|Adverse Event|0|||
94576798|NCT03279081|323913489|FG000|Overall Study|Reason not Specified|14|||
94576799|NCT03279081|323913490|FG001|Overall Study|Reason not Specified|4|||
94576800|NCT00283296|323913496|FG000|Overall Study|in-home trial not completed|5|||
94576801|NCT02589938|323913497|FG000|Overall Study|Withdrawal by Subject|11|||
94576802|NCT02589938|323913498|FG001|Overall Study|Withdrawal by Subject|5|||
94576803|NCT02589938|323913499|FG002|Overall Study|Withdrawal by Subject|6|||
94576804|NCT02589938|323913497|FG000|Overall Study|Lost to Follow-up|3|||
94576805|NCT02589938|323913498|FG001|Overall Study|Lost to Follow-up|3|||
94576806|NCT02589938|323913499|FG002|Overall Study|Lost to Follow-up|3|||
94576807|NCT02589938|323913497|FG000|Overall Study|Death|1|||
94576808|NCT02589938|323913498|FG001|Overall Study|Death|0|||
94576809|NCT02589938|323913499|FG002|Overall Study|Death|1|||
94576810|NCT02589938|323913497|FG000|Overall Study|Protocol Violation|6|||
94576811|NCT02589938|323913498|FG001|Overall Study|Protocol Violation|2|||
94576812|NCT02589938|323913499|FG002|Overall Study|Protocol Violation|3|||
94576813|NCT02589938|323913497|FG000|Overall Study|Physician Decision|1|||
94576814|NCT02589938|323913498|FG001|Overall Study|Physician Decision|0|||
94576815|NCT02589938|323913499|FG002|Overall Study|Physician Decision|0|||
94576816|NCT02589938|323913497|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
94576817|NCT02589938|323913498|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
94576818|NCT02589938|323913499|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
94576819|NCT04973449|323913504|FG000|Overall Study|Withdrawal by Subject|3|||
94576820|NCT04973449|323913505|FG001|Overall Study|Withdrawal by Subject|3|||
94576821|NCT04973449|323913506|FG002|Overall Study|Withdrawal by Subject|2|||
94576822|NCT04973449|323913507|FG003|Overall Study|Withdrawal by Subject|5|||
94576823|NCT04973449|323913508|FG004|Overall Study|Withdrawal by Subject|5|||
94576824|NCT04973449|323913509|FG005|Overall Study|Withdrawal by Subject|4|||
94576825|NCT04973449|323913510|FG006|Overall Study|Withdrawal by Subject|7|||
94576826|NCT04973449|323913511|FG007|Overall Study|Withdrawal by Subject|5|||
94576827|NCT04973449|323913504|FG000|Overall Study|Lost to Follow-up|15|||
94576828|NCT04973449|323913505|FG001|Overall Study|Lost to Follow-up|16|||
94576829|NCT04973449|323913506|FG002|Overall Study|Lost to Follow-up|16|||
94576830|NCT04973449|323913507|FG003|Overall Study|Lost to Follow-up|13|||
94576831|NCT04973449|323913508|FG004|Overall Study|Lost to Follow-up|5|||
94576832|NCT04973449|323913509|FG005|Overall Study|Lost to Follow-up|6|||
94576833|NCT04973449|323913510|FG006|Overall Study|Lost to Follow-up|10|||
94576834|NCT04973449|323913511|FG007|Overall Study|Lost to Follow-up|6|||
94576835|NCT04973449|323913504|FG000|Overall Study|Death|1|||
94576836|NCT04973449|323913505|FG001|Overall Study|Death|0|||
94576837|NCT04973449|323913506|FG002|Overall Study|Death|0|||
94576838|NCT04973449|323913507|FG003|Overall Study|Death|0|||
94576839|NCT04973449|323913508|FG004|Overall Study|Death|0|||
94576840|NCT04973449|323913509|FG005|Overall Study|Death|1|||
94576841|NCT04973449|323913510|FG006|Overall Study|Death|0|||
94576842|NCT04973449|323913511|FG007|Overall Study|Death|0|||
94576843|NCT04973449|323913504|FG000|Overall Study|Other|1|||
94576844|NCT04973449|323913505|FG001|Overall Study|Other|1|||
94576845|NCT04973449|323913506|FG002|Overall Study|Other|2|||
94576846|NCT04973449|323913507|FG003|Overall Study|Other|1|||
94576847|NCT04973449|323913508|FG004|Overall Study|Other|4|||
94576848|NCT04973449|323913509|FG005|Overall Study|Other|0|||
94576849|NCT04973449|323913510|FG006|Overall Study|Other|2|||
94576850|NCT04973449|323913511|FG007|Overall Study|Other|2|||
94576851|NCT01506596|323913512|FG000|Overall Study|ineligible pathology|1|||
94576852|NCT00771758|323913513|FG000|Overall Study|Adverse Event|2|||
94576853|NCT00771758|323913514|FG001|Overall Study|Adverse Event|8|||
94576854|NCT00771758|323913515|FG002|Overall Study|Adverse Event|1|||
94576855|NCT00771758|323913513|FG000|Overall Study|Lack of Efficacy|0|||
94576856|NCT00771758|323913514|FG001|Overall Study|Lack of Efficacy|2|||
94576857|NCT00771758|323913515|FG002|Overall Study|Lack of Efficacy|1|||
94576858|NCT00771758|323913513|FG000|Overall Study|Lost to Follow-up|1|||
94239988|NCT01509547|322672698|FG001|Overall Study|Lost to Follow-up|14|||
94576859|NCT00771758|323913514|FG001|Overall Study|Lost to Follow-up|0|||
94576860|NCT00771758|323913515|FG002|Overall Study|Lost to Follow-up|0|||
94576861|NCT00771758|323913513|FG000|Overall Study|Protocol Violation|1|||
94576862|NCT00771758|323913514|FG001|Overall Study|Protocol Violation|0|||
94576863|NCT00771758|323913515|FG002|Overall Study|Protocol Violation|0|||
94576864|NCT00771758|323913513|FG000|Overall Study|Withdrawal by Subject|1|||
94576865|NCT00771758|323913514|FG001|Overall Study|Withdrawal by Subject|0|||
94576866|NCT00771758|323913515|FG002|Overall Study|Withdrawal by Subject|0|||
94576867|NCT00771758|323913513|FG000|Overall Study|Other|3|||
94576868|NCT00771758|323913514|FG001|Overall Study|Other|2|||
94576869|NCT00771758|323913515|FG002|Overall Study|Other|0|||
94576870|NCT03597347|323913524|FG000|Overall Study|Withdrawal by Subject|1|||
94576871|NCT03597347|323913525|FG001|Overall Study|Withdrawal by Subject|1|||
94576872|NCT03597347|323913526|FG002|Overall Study|Withdrawal by Subject|0|||
94576873|NCT03597347|323913524|FG000|Overall Study|Withdrawal due to Covid-19|3|||
94576874|NCT03597347|323913525|FG001|Overall Study|Withdrawal due to Covid-19|0|||
94576875|NCT03597347|323913526|FG002|Overall Study|Withdrawal due to Covid-19|0|||
94576876|NCT03597347|323913524|FG000|Overall Study|Sponsor decision to terminate study|3|||
94576877|NCT03597347|323913525|FG001|Overall Study|Sponsor decision to terminate study|2|||
94576878|NCT03597347|323913526|FG002|Overall Study|Sponsor decision to terminate study|4|||
94576879|NCT04825678|323913527|FG000|Overall Study|Decision by Sponsor|2|||
94576880|NCT04825678|323913528|FG001|Overall Study|Decision by Sponsor|3|||
94576881|NCT04825678|323913527|FG000|Overall Study|Withdrawal of Consent From Study|7|||
94576882|NCT04825678|323913528|FG001|Overall Study|Withdrawal of Consent From Study|9|||
94576883|NCT04825678|323913527|FG000|Overall Study|Lost to Follow-up|3|||
94576884|NCT04825678|323913528|FG001|Overall Study|Lost to Follow-up|4|||
94576885|NCT04825678|323913527|FG000|Overall Study|Never Received Investigational Product|1|||
94576886|NCT04825678|323913528|FG001|Overall Study|Never Received Investigational Product|1|||
94576887|NCT04780061|323913529|FG000|Overall Study|Withdrawal by Subject|5|||
94576888|NCT04780061|323913530|FG001|Overall Study|Withdrawal by Subject|8|||
94576889|NCT04780061|323913529|FG000|Overall Study|Adverse Event|2|||
94576890|NCT04780061|323913530|FG001|Overall Study|Adverse Event|2|||
94576891|NCT04780061|323913529|FG000|Overall Study|Lost to Follow-up|1|||
94576892|NCT04780061|323913530|FG001|Overall Study|Lost to Follow-up|5|||
94576893|NCT04050553|323913532|FG000|Period 1|Physician Decision|2|||
94576894|NCT04050553|323913533|FG001|Period 1|Physician Decision|2|||
94576895|NCT04050553|323913532|FG000|Period 1|Adverse Event|1|||
94576896|NCT04050553|323913533|FG001|Period 1|Adverse Event|1|||
94576897|NCT04050553|323913532|FG000|Period 1|Withdrawal by Subject|0|||
94576898|NCT04050553|323913533|FG001|Period 1|Withdrawal by Subject|1|||
94576899|NCT04050553|323913532|FG000|Wash-out|Adverse Event|0|||
94576900|NCT04050553|323913533|FG001|Wash-out|Adverse Event|1|||
94576901|NCT04050553|323913532|FG000|Wash-out|Withdrawal by Subject|0|||
94576902|NCT04050553|323913533|FG001|Wash-out|Withdrawal by Subject|1|||
94576903|NCT00734149|323913534|FG000|Overall Study|Withdrawal by Subject|1|||
94576904|NCT02023086|323913535|FG000|Overall Study|Withdrawal by Subject|2|||
94576905|NCT02023086|323913536|FG001|Overall Study|Withdrawal by Subject|0|||
94576906|NCT03472885|323913538|FG000|24-Week Treatment Period|Adverse Event|1|||
94576907|NCT05523089|323913539|FG000|Overall Study|Withdrawal by Subject|1|||
94576908|NCT05523089|323913540|FG001|Overall Study|Withdrawal by Subject|0|||
94576909|NCT05523089|323913541|FG002|Overall Study|Withdrawal by Subject|0|||
94576910|NCT05523089|323913539|FG000|Overall Study|Lost to Follow-up|1|||
94576911|NCT05523089|323913540|FG001|Overall Study|Lost to Follow-up|0|||
94576912|NCT05523089|323913541|FG002|Overall Study|Lost to Follow-up|0|||
94576913|NCT01899040|323913542|FG000|Overall Study|Randomized in error|0|||
94576914|NCT01899040|323913543|FG001|Overall Study|Randomized in error|1|||
94576915|NCT01899040|323913544|FG002|Overall Study|Randomized in error|1|||
94576916|NCT01899040|323913542|FG000|Overall Study|Adverse Event|3|||
94576917|NCT01899040|323913543|FG001|Overall Study|Adverse Event|1|||
94576918|NCT01899040|323913544|FG002|Overall Study|Adverse Event|2|||
94576919|NCT01899040|323913542|FG000|Overall Study|Unspecified reasons|4|||
94576920|NCT01899040|323913543|FG001|Overall Study|Unspecified reasons|4|||
94576921|NCT01899040|323913544|FG002|Overall Study|Unspecified reasons|0|||
94576922|NCT01899040|323913542|FG000|Overall Study|Compliance issues|1|||
94576923|NCT01899040|323913543|FG001|Overall Study|Compliance issues|2|||
94576924|NCT01899040|323913544|FG002|Overall Study|Compliance issues|0|||
94576925|NCT03204188|323913547|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
94576926|NCT03204188|323913547|FG000|Immunotherapy Phase (1 Year)|Death|1|||
94576927|NCT03204188|323913547|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
94576928|NCT03204188|323913547|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
94651347|NCT02460224|324179728|FG013|Overall Study|Subject/guardian decision|0|||
94651348|NCT02460224|324179729|FG014|Overall Study|Subject/guardian decision|0|||
94651349|NCT02460224|324179730|FG015|Overall Study|Subject/guardian decision|1|||
94651350|NCT02460224|324179731|FG016|Overall Study|Subject/guardian decision|0|||
94651351|NCT02460224|324179732|FG017|Overall Study|Subject/guardian decision|1|||
94651352|NCT02460224|324179733|FG018|Overall Study|Subject/guardian decision|2|||
94651353|NCT02460224|324179734|FG019|Overall Study|Subject/guardian decision|0|||
94651354|NCT02460224|324179735|FG020|Overall Study|Subject/guardian decision|0|||
94651355|NCT02460224|324179736|FG021|Overall Study|Subject/guardian decision|1|||
94651356|NCT02460224|324179737|FG022|Overall Study|Subject/guardian decision|0|||
94453942|NCT01430403|323450224|FG000|Overall Study|Physician Decision|1|||
94651357|NCT02460224|324179738|FG023|Overall Study|Subject/guardian decision|0|||
94651358|NCT02460224|324179739|FG024|Overall Study|Subject/guardian decision|0|||
94651359|NCT02460224|324179740|FG025|Overall Study|Subject/guardian decision|0|||
94651360|NCT02460224|324179741|FG026|Overall Study|Subject/guardian decision|6|||
94651361|NCT02460224|324179742|FG027|Overall Study|Subject/guardian decision|2|||
94651362|NCT02460224|324179743|FG028|Overall Study|Subject/guardian decision|3|||
94651363|NCT04055116|324179746|FG000|First Intervention|Physician Decision|2|||
94651364|NCT04055116|324179747|FG001|First Intervention|Physician Decision|7|||
94651365|NCT02553421|324179752|FG000|Overall Study|Lost to Follow-up|21|||
94651366|NCT02553421|324179753|FG001|Overall Study|Lost to Follow-up|1|||
94651367|NCT02553421|324179752|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
94651368|NCT02553421|324179753|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
94651369|NCT02553421|324179752|FG000|Overall Study|Improper Device Placement|3|||
94576929|NCT05291520|323914943|FG000|Overall Study|Lost to Follow-up|0|||
94576930|NCT05291520|323914944|FG001|Overall Study|Lost to Follow-up|0|||
94576931|NCT05291520|323914945|FG002|Overall Study|Lost to Follow-up|1|||
94576932|NCT03780244|323914950|FG000|Overall Study|Lost to Follow-up|1|||
94576933|NCT03780244|323914951|FG001|Overall Study|Lost to Follow-up|0|||
94576934|NCT01280903|323914952|FG000|Overall Study|Lost to Follow-up|23|||
94576935|NCT01280903|323914953|FG001|Overall Study|Lost to Follow-up|16|||
94576936|NCT03453164|323914954|FG000|Overall Study|Lack of Efficacy|16|||
94576937|NCT03453164|323914954|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
94576938|NCT01942837|323914955|FG000|Overall Study|Death|1|||
94576939|NCT01942837|323914955|FG000|Overall Study|Symptomatic or radiographic progression|49|||
94576940|NCT01942837|323914955|FG000|Overall Study|Adverse Event|6|||
94576941|NCT01942837|323914955|FG000|Overall Study|Physician Decision|3|||
94576942|NCT01942837|323914955|FG000|Overall Study|Withdrawal by Subject|2|||
94576943|NCT01942837|323914955|FG000|Overall Study|Intercurrent Illness|1|||
94576944|NCT01942837|323914955|FG000|Overall Study|On treatment|3|||
94576945|NCT01942837|323914955|FG000|Overall Study|Never initiate the treatment|2|||
94576946|NCT00124943|323914958|FG000|Phase II|Adverse Event|0|||
94576947|NCT00124943|323914959|FG001|Phase II|Adverse Event|2|||
94576948|NCT00124943|323914960|FG002|Phase II|Adverse Event|0|||
94576949|NCT00124943|323914961|FG003|Phase II|Adverse Event|1|||
94576950|NCT00124943|323914958|FG000|Phase II|Protocol Violation|0|||
94576951|NCT00124943|323914959|FG001|Phase II|Protocol Violation|0|||
94576952|NCT00124943|323914960|FG002|Phase II|Protocol Violation|0|||
94576953|NCT00124943|323914961|FG003|Phase II|Protocol Violation|1|||
94576954|NCT00124943|323914958|FG000|Phase II|Lost to Follow-up|0|||
94576955|NCT00124943|323914959|FG001|Phase II|Lost to Follow-up|0|||
94576956|NCT00124943|323914960|FG002|Phase II|Lost to Follow-up|0|||
94576957|NCT00124943|323914961|FG003|Phase II|Lost to Follow-up|1|||
94576958|NCT00124943|323914958|FG000|Phase II|Withdrawal by Subject|0|||
94576959|NCT00124943|323914959|FG001|Phase II|Withdrawal by Subject|0|||
94576960|NCT00124943|323914960|FG002|Phase II|Withdrawal by Subject|0|||
94576961|NCT00124943|323914961|FG003|Phase II|Withdrawal by Subject|2|||
94576962|NCT03459079|323914962|FG000|Overall Study|Adverse Event|4|||
94576963|NCT03459079|323914963|FG001|Overall Study|Adverse Event|2|||
94576964|NCT03459079|323914964|FG002|Overall Study|Adverse Event|0|||
94576965|NCT03459079|323914962|FG000|Overall Study|Withdrawal by Subject|2|||
94576966|NCT03459079|323914963|FG001|Overall Study|Withdrawal by Subject|2|||
94576967|NCT03459079|323914964|FG002|Overall Study|Withdrawal by Subject|0|||
94576968|NCT02177123|323914966|FG000|Overall Study|Lost to Follow-up|6|||
94576969|NCT02177123|323914966|FG000|Overall Study|Withdrawal by Subject|4|||
94576970|NCT02177123|323914966|FG000|Overall Study|Adverse Event|4|||
94576971|NCT02177123|323914966|FG000|Overall Study|Physician Decision|3|||
94576972|NCT02177123|323914966|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
94576973|NCT02177123|323914966|FG000|Overall Study|Excluded for medical reasons|2|||
94576974|NCT02177123|323914966|FG000|Overall Study|Death|1|||
94576975|NCT02177123|323914966|FG000|Overall Study|Other|1|||
94576976|NCT02177123|323914966|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
94576977|NCT04945733|323914967|FG000|Overall Study|Physician Decision|1|||
94576978|NCT04945733|323914968|FG001|Overall Study|Physician Decision|3|||
94576979|NCT04945733|323914969|FG002|Overall Study|Physician Decision|0|||
94576980|NCT04945733|323914967|FG000|Overall Study|Withdrawal by Subject|3|||
94576981|NCT04945733|323914968|FG001|Overall Study|Withdrawal by Subject|3|||
94576982|NCT04945733|323914969|FG002|Overall Study|Withdrawal by Subject|0|||
94576983|NCT02007096|323914970|FG000|Overall Study|medication not available|2|||
94576984|NCT02007096|323914971|FG001|Overall Study|medication not available|0|||
94576985|NCT02007096|323914970|FG000|Overall Study|did not inject saline|0|||
94576986|NCT02007096|323914971|FG001|Overall Study|did not inject saline|3|||
94576987|NCT02007096|323914970|FG000|Overall Study|did not follow postoperative protocol|8|||
94576988|NCT02007096|323914971|FG001|Overall Study|did not follow postoperative protocol|11|||
94576989|NCT02007096|323914970|FG000|Overall Study|converted to open surgery|1|||
94576990|NCT02007096|323914971|FG001|Overall Study|converted to open surgery|1|||
94576991|NCT02007096|323914970|FG000|Overall Study|no mesh placed|0|||
94576992|NCT02007096|323914971|FG001|Overall Study|no mesh placed|1|||
94351505|NCT01412333|323067409|FG000|Overall Study|Death|5|||
94576993|NCT04385277|323914973|FG000|Overall Study|Physician Decision|2|||
94576994|NCT04385277|323914973|FG000|Overall Study|Ineligible|1|||
94576995|NCT04385277|323914973|FG000|Overall Study|Patient/Parent Refusal|2|||
94576996|NCT02766023|323914976|FG000|Overall Study|Lost to Follow-up|23|||
94576997|NCT02766023|323914977|FG001|Overall Study|Lost to Follow-up|11|||
94576998|NCT02766023|323914976|FG000|Overall Study|Pregnancy|1|||
94576999|NCT02766023|323914977|FG001|Overall Study|Pregnancy|0|||
94577000|NCT02766023|323914976|FG000|Overall Study|Adverse Event|1|||
94577001|NCT02766023|323914977|FG001|Overall Study|Adverse Event|0|||
94577002|NCT02766023|323914976|FG000|Overall Study|Withdrawal by Subject|4|||
94577003|NCT02766023|323914977|FG001|Overall Study|Withdrawal by Subject|5|||
94577004|NCT02766023|323914976|FG000|Overall Study|Physician Decision|1|||
94577005|NCT02766023|323914977|FG001|Overall Study|Physician Decision|0|||
94577006|NCT02766023|323914976|FG000|Overall Study|Not Eligible at Enrollment|0|||
94577007|NCT02766023|323914977|FG001|Overall Study|Not Eligible at Enrollment|1|||
94577008|NCT02903771|323914978|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
94577009|NCT02903771|323914979|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
94577010|NCT02903771|323914980|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
94577011|NCT02903771|323914981|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
94577012|NCT02903771|323914982|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
94577013|NCT02903771|323914983|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
94577014|NCT02903771|323914984|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
94577015|NCT02903771|323914978|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
94577016|NCT02903771|323914979|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
94577017|NCT02903771|323914980|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
94577018|NCT02903771|323914981|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
94577019|NCT02903771|323914982|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
94577020|NCT02903771|323914983|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
94577021|NCT02903771|323914984|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
94577022|NCT02903771|323914978|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
94577023|NCT02903771|323914979|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
94577024|NCT02903771|323914980|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
94577025|NCT02903771|323914981|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
94577026|NCT02903771|323914982|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
94577027|NCT02903771|323914983|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
94577028|NCT02903771|323914984|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
94577029|NCT02903771|323914978|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
94577030|NCT02903771|323914979|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
94577031|NCT02903771|323914980|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
94577032|NCT02903771|323914981|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
94577033|NCT02903771|323914982|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
94577034|NCT02903771|323914983|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
94577035|NCT02903771|323914984|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
94577036|NCT02903771|323914978|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
94577037|NCT02903771|323914979|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
94577038|NCT02903771|323914980|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
94577039|NCT02903771|323914981|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
94577040|NCT02903771|323914982|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
94577041|NCT02903771|323914983|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
94577042|NCT02903771|323914984|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
94577043|NCT02903771|323914978|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
94577044|NCT02903771|323914979|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
94577045|NCT02903771|323914980|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
94577046|NCT02903771|323914981|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
94577047|NCT02903771|323914982|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
94577048|NCT02903771|323914983|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
94577049|NCT02903771|323914984|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
94577050|NCT02903771|323914978|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
94577051|NCT02903771|323914979|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
94577052|NCT02903771|323914980|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
94577053|NCT02903771|323914981|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
94577054|NCT02903771|323914982|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
94577055|NCT02903771|323914983|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
94577056|NCT02903771|323914984|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
94577057|NCT02903771|323914978|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
94577058|NCT02903771|323914979|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
94577059|NCT02903771|323914980|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
94577060|NCT02903771|323914981|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
94577061|NCT02903771|323914982|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
94577062|NCT02903771|323914983|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
94577063|NCT02903771|323914984|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
94577064|NCT02903771|323914978|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
94577065|NCT02903771|323914979|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
94577066|NCT02903771|323914980|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
94577067|NCT02903771|323914981|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
94453943|NCT01430403|323450225|FG001|Overall Study|Physician Decision|0|||
94577068|NCT02903771|323914982|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
94577069|NCT02903771|323914983|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
94577070|NCT02903771|323914984|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
94577071|NCT02903771|323914978|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
94577072|NCT02903771|323914979|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
94351506|NCT01412333|323067410|FG001|Overall Study|Death|6|||
94351507|NCT01412333|323067409|FG000|Overall Study|Lack of Efficacy|22|||
94351508|NCT01412333|323067410|FG001|Overall Study|Lack of Efficacy|10|||
94351509|NCT01412333|323067409|FG000|Overall Study|Lost to Follow-up|15|||
94351510|NCT01412333|323067410|FG001|Overall Study|Lost to Follow-up|12|||
94351511|NCT01412333|323067409|FG000|Overall Study|Non-Compliance|3|||
94351512|NCT01412333|323067410|FG001|Overall Study|Non-Compliance|7|||
94351513|NCT01412333|323067409|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94351514|NCT01412333|323067410|FG001|Overall Study|Non-Compliance With Study Drug|1|||
94351515|NCT01412333|323067409|FG000|Overall Study|Other|30|||
94351516|NCT01412333|323067410|FG001|Overall Study|Other|33|||
94351517|NCT01412333|323067409|FG000|Overall Study|Physician Decision|11|||
94351518|NCT01412333|323067410|FG001|Overall Study|Physician Decision|16|||
94351519|NCT01412333|323067409|FG000|Overall Study|Pregnancy|6|||
94351520|NCT01412333|323067410|FG001|Overall Study|Pregnancy|4|||
94351521|NCT01412333|323067409|FG000|Overall Study|Protocol Violation|1|||
94577073|NCT02903771|323914980|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
94577074|NCT02903771|323914981|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
94577075|NCT02903771|323914982|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
94577076|NCT02903771|323914983|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
94577077|NCT02903771|323914984|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
94577078|NCT02903771|323914978|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
94577079|NCT02903771|323914979|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
94577080|NCT02903771|323914980|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
94577081|NCT02903771|323914981|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
94577082|NCT02903771|323914982|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
94577083|NCT02903771|323914983|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
94577084|NCT02903771|323914984|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
94577085|NCT03331315|323914987|FG000|Overall Study|Physician Decision|18|||
94577086|NCT03331315|323914988|FG001|Overall Study|Physician Decision|14|||
94577087|NCT01527370|323914989|FG000|Overall Study|Withdrawal by Subject|4|||
94577088|NCT01527370|323914989|FG000|Overall Study|Physician Decision|1|||
94577089|NCT01527370|323914989|FG000|Overall Study|Death|1|||
94577090|NCT01435382|323914990|FG000|Overall Study|Lost to Follow-up|1|||
94577091|NCT01435382|323914991|FG001|Overall Study|Lost to Follow-up|0|||
94577092|NCT01435382|323914992|FG002|Overall Study|Lost to Follow-up|1|||
94577093|NCT01435382|323914993|FG003|Overall Study|Lost to Follow-up|0|||
94577094|NCT01435382|323914990|FG000|Overall Study|Withdrawal by Subject|0|||
94577095|NCT01435382|323914991|FG001|Overall Study|Withdrawal by Subject|2|||
94577096|NCT01435382|323914992|FG002|Overall Study|Withdrawal by Subject|0|||
94577097|NCT01435382|323914993|FG003|Overall Study|Withdrawal by Subject|1|||
94577098|NCT03125395|323914994|FG000|Overall Study|Adverse Event|2|||
94577099|NCT03125395|323914994|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
94577100|NCT03125395|323914994|FG000|Overall Study|Physician Decision|2|||
94577101|NCT03125395|323914994|FG000|Overall Study|Commercial drug is available|5|||
94577102|NCT00871975|323914995|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
94577103|NCT00871975|323914995|FG000|Overall Study|Catheters could not be inserted|1|||
94577104|NCT00871975|323914995|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
94577105|NCT00871975|323914995|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
94577106|NCT03694678|323914996|FG000|Overall Study|Withdrawal by Subject|2|||
94577107|NCT03694678|323914997|FG001|Overall Study|Withdrawal by Subject|0|||
94577108|NCT03694678|323914996|FG000|Overall Study|Lost to Follow-up|2|||
94577109|NCT03694678|323914997|FG001|Overall Study|Lost to Follow-up|3|||
94577110|NCT02340026|323915000|FG000|Treatment Phase|Withdrawal by Subject|2|||
94577111|NCT02340026|323915001|FG001|Treatment Phase|Withdrawal by Subject|2|||
94577112|NCT02340026|323915000|FG000|Follow-up Phase|Lost to Follow-up|1|||
94577113|NCT02340026|323915001|FG001|Follow-up Phase|Lost to Follow-up|0|||
94577114|NCT01436149|323915002|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
94577115|NCT01436149|323915003|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
94577116|NCT01436149|323915004|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
94577117|NCT01436149|323915002|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
94577118|NCT01436149|323915003|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
94577119|NCT01436149|323915004|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
94577120|NCT01436149|323915002|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
94577121|NCT01436149|323915003|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
94577122|NCT01436149|323915004|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
94577123|NCT01436149|323915002|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
94577124|NCT01436149|323915003|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
94577125|NCT01436149|323915004|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
94577126|NCT01436149|323915002|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
94577127|NCT01436149|323915003|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
94577128|NCT01436149|323915004|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
94577129|NCT01436149|323915002|FG000|Antidepressant Lead-in Phase|Other|119|||
94577130|NCT01436149|323915003|FG001|Antidepressant Lead-in Phase|Other|0|||
94577131|NCT01436149|323915004|FG002|Antidepressant Lead-in Phase|Other|0|||
94577132|NCT01436149|323915002|FG000|Randomized Phase|Adverse Event|9|||
94577133|NCT01436149|323915003|FG001|Randomized Phase|Adverse Event|10|||
94577134|NCT01436149|323915004|FG002|Randomized Phase|Adverse Event|11|||
94577135|NCT01436149|323915002|FG000|Randomized Phase|Protocol Violation|4|||
94577136|NCT01436149|323915003|FG001|Randomized Phase|Protocol Violation|5|||
94577137|NCT01436149|323915004|FG002|Randomized Phase|Protocol Violation|0|||
94577138|NCT01436149|323915002|FG000|Randomized Phase|Withdrawal by Subject|16|||
94577139|NCT01436149|323915003|FG001|Randomized Phase|Withdrawal by Subject|10|||
94577140|NCT01436149|323915004|FG002|Randomized Phase|Withdrawal by Subject|10|||
94577141|NCT01436149|323915002|FG000|Randomized Phase|Lost to Follow-up|34|||
94577142|NCT01436149|323915003|FG001|Randomized Phase|Lost to Follow-up|5|||
94577143|NCT01436149|323915004|FG002|Randomized Phase|Lost to Follow-up|6|||
94577144|NCT01436149|323915002|FG000|Randomized Phase|Lack of Efficacy|0|||
94577145|NCT01436149|323915003|FG001|Randomized Phase|Lack of Efficacy|0|||
94577146|NCT01436149|323915004|FG002|Randomized Phase|Lack of Efficacy|1|||
94577147|NCT01436149|323915002|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
94577148|NCT01436149|323915003|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
94577149|NCT01436149|323915004|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
94577150|NCT01436149|323915002|FG000|Randomized Phase|Other|12|||
94577151|NCT01436149|323915003|FG001|Randomized Phase|Other|5|||
94577152|NCT01436149|323915004|FG002|Randomized Phase|Other|11|||
94577153|NCT01502293|323915022|FG000|Overall Study|Progressive Disease|20|||
94577154|NCT01502293|323915023|FG001|Overall Study|Progressive Disease|12|||
94577155|NCT01502293|323915024|FG002|Overall Study|Progressive Disease|2|||
94577156|NCT01502293|323915022|FG000|Overall Study|Withdrawal by Subject|3|||
94577157|NCT01502293|323915023|FG001|Overall Study|Withdrawal by Subject|3|||
94577158|NCT01502293|323915024|FG002|Overall Study|Withdrawal by Subject|1|||
94577159|NCT01502293|323915022|FG000|Overall Study|Adverse Event|0|||
94577160|NCT01502293|323915023|FG001|Overall Study|Adverse Event|2|||
94577161|NCT01502293|323915024|FG002|Overall Study|Adverse Event|0|||
94577162|NCT01502293|323915022|FG000|Overall Study|Reason Not Specified|2|||
94577163|NCT01502293|323915023|FG001|Overall Study|Reason Not Specified|0|||
94577164|NCT01502293|323915024|FG002|Overall Study|Reason Not Specified|0|||
94577165|NCT01502293|323915022|FG000|Overall Study|Physician Decision|0|||
94577166|NCT01502293|323915023|FG001|Overall Study|Physician Decision|0|||
94577167|NCT01502293|323915024|FG002|Overall Study|Physician Decision|1|||
94577168|NCT01318915|323915027|FG000|Overall Study|Lost to Follow-up|1|||
94577169|NCT02195518|323915031|FG000|Overall Study|Adverse Event|1|||
94577170|NCT02195518|323915031|FG000|Overall Study|Protocol Violation|4|||
94577171|NCT02195518|323915031|FG000|Overall Study|Pregnancy|2|||
94577172|NCT02195518|323915031|FG000|Overall Study|Withdrawal by Subject|1|||
94577173|NCT02195518|323915031|FG000|Overall Study|Lost to Follow-up|1|||
94577174|NCT01074970|323915032|FG000|Overall Study|Never Treated|0|||
94577175|NCT01074970|323915033|FG001|Overall Study|Never Treated|0|||
94577176|NCT01074970|323915034|FG002|Overall Study|Never Treated|8|||
94577177|NCT01074970|323915035|FG003|Overall Study|Never Treated|1|||
94577178|NCT01074970|323915032|FG000|Overall Study|Adverse Event|1|||
94577179|NCT01074970|323915033|FG001|Overall Study|Adverse Event|0|||
94577180|NCT01074970|323915034|FG002|Overall Study|Adverse Event|4|||
94577181|NCT01074970|323915035|FG003|Overall Study|Adverse Event|3|||
94577182|NCT01074970|323915032|FG000|Overall Study|Disease progression during treatment|3|||
94577183|NCT01074970|323915033|FG001|Overall Study|Disease progression during treatment|1|||
94577184|NCT01074970|323915034|FG002|Overall Study|Disease progression during treatment|2|||
94577185|NCT01074970|323915035|FG003|Overall Study|Disease progression during treatment|9|||
94577186|NCT01074970|323915032|FG000|Overall Study|Lost to Follow-up|0|||
94577187|NCT01074970|323915033|FG001|Overall Study|Lost to Follow-up|0|||
94577188|NCT01074970|323915034|FG002|Overall Study|Lost to Follow-up|1|||
94577189|NCT01074970|323915035|FG003|Overall Study|Lost to Follow-up|0|||
94577190|NCT01074970|323915032|FG000|Overall Study|Withdrawal by Subject|0|||
94577191|NCT01074970|323915033|FG001|Overall Study|Withdrawal by Subject|0|||
94577192|NCT01074970|323915034|FG002|Overall Study|Withdrawal by Subject|6|||
94577193|NCT01074970|323915035|FG003|Overall Study|Withdrawal by Subject|4|||
94577194|NCT04314284|323915037|FG000|Overall Study|Withdrawal by Subject|4|||
94577195|NCT04314284|323915038|FG001|Overall Study|Withdrawal by Subject|7|||
94577196|NCT04314284|323915037|FG000|Overall Study|Consented but did not complete survey|0|||
94577197|NCT04314284|323915038|FG001|Overall Study|Consented but did not complete survey|6|||
94577198|NCT04467905|323915046|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
94577199|NCT04467905|323915047|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
94577200|NCT04467905|323915048|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
94577201|NCT04467905|323915046|FG000|Overall Study|Conversion to SR|0|||
94577202|NCT04467905|323915047|FG001|Overall Study|Conversion to SR|0|||
94577203|NCT04467905|323915048|FG002|Overall Study|Conversion to SR|3|||
94577204|NCT04467905|323915046|FG000|Overall Study|Technical issue with Holter ECG|0|||
94577205|NCT04467905|323915047|FG001|Overall Study|Technical issue with Holter ECG|0|||
94577206|NCT04467905|323915048|FG002|Overall Study|Technical issue with Holter ECG|3|||
94577207|NCT04467905|323915046|FG000|Overall Study|Hemodynamic instability|0|||
94577208|NCT04467905|323915047|FG001|Overall Study|Hemodynamic instability|0|||
94577209|NCT04467905|323915048|FG002|Overall Study|Hemodynamic instability|1|||
94577210|NCT04467905|323915046|FG000|Overall Study|Site misinterpretation of protocol|0|||
94577211|NCT04467905|323915047|FG001|Overall Study|Site misinterpretation of protocol|0|||
94577212|NCT04467905|323915048|FG002|Overall Study|Site misinterpretation of protocol|1|||
94577213|NCT02201953|323915051|FG000|Overall Study|Randomized but Never Treated|1|||
94577214|NCT02201953|323915052|FG001|Overall Study|Randomized but Never Treated|5|||
94577215|NCT02201953|323915051|FG000|Overall Study|Lack of Efficacy|9|||
94577216|NCT02201953|323915052|FG001|Overall Study|Lack of Efficacy|30|||
94577217|NCT02201953|323915051|FG000|Overall Study|Lost to Follow-up|8|||
94577218|NCT02201953|323915052|FG001|Overall Study|Lost to Follow-up|8|||
94577219|NCT02201953|323915051|FG000|Overall Study|Withdrew Consent|2|||
94577220|NCT02201953|323915052|FG001|Overall Study|Withdrew Consent|5|||
94577221|NCT02201953|323915051|FG000|Overall Study|Adverse Event|0|||
94577222|NCT02201953|323915052|FG001|Overall Study|Adverse Event|5|||
94577223|NCT02201953|323915051|FG000|Overall Study|Death|0|||
94577224|NCT02201953|323915052|FG001|Overall Study|Death|3|||
94577225|NCT02484391|323915053|FG000|Overall Study|Lack of Efficacy|15|||
94577226|NCT02484391|323915054|FG001|Overall Study|Lack of Efficacy|14|||
94577227|NCT02484391|323915055|FG002|Overall Study|Lack of Efficacy|3|||
94577228|NCT02484391|323915053|FG000|Overall Study|Lost to Follow-up|0|||
94577229|NCT02484391|323915054|FG001|Overall Study|Lost to Follow-up|0|||
94577230|NCT02484391|323915055|FG002|Overall Study|Lost to Follow-up|2|||
94577231|NCT02484391|323915053|FG000|Overall Study|Physician Decision|1|||
94577232|NCT02484391|323915054|FG001|Overall Study|Physician Decision|3|||
94577233|NCT02484391|323915055|FG002|Overall Study|Physician Decision|0|||
94577234|NCT02484391|323915053|FG000|Overall Study|Went to Transplant|5|||
94577235|NCT02484391|323915054|FG001|Overall Study|Went to Transplant|3|||
94577236|NCT02484391|323915055|FG002|Overall Study|Went to Transplant|2|||
94577237|NCT02083354|323917120|FG000|Overall Study|Withdrawal by Subject|9|||
94577238|NCT02083354|323917120|FG000|Overall Study|Lost to Follow-up|1|||
94577239|NCT02083354|323917120|FG000|Overall Study|Adverse Event|3|||
94577240|NCT02083354|323917120|FG000|Overall Study|Disease progression|46|||
94577241|NCT02083354|323917120|FG000|Overall Study|Study closed/terminated|5|||
94577242|NCT00906204|323917121|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
94577243|NCT00906204|323917122|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
94577244|NCT00906204|323917121|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
94577245|NCT00906204|323917122|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
94577246|NCT00906204|323917121|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
94577247|NCT00906204|323917122|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
94577248|NCT00906204|323917121|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
94577249|NCT00906204|323917122|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
94577250|NCT00906204|323917121|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
94577251|NCT00906204|323917122|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
94577252|NCT01456039|323917123|FG000|Phase 1 (First Step)|Disease Progression|1|||
94351522|NCT01412333|323067410|FG001|Overall Study|Protocol Violation|2|||
94351523|NCT01412333|323067409|FG000|Overall Study|Study Terminated By Sponsor|3|||
94577253|NCT01456039|323917124|FG001|Phase 1 (First Step)|Disease Progression|1|||
94577254|NCT01456039|323917125|FG002|Phase 1 (First Step)|Disease Progression|0|||
94577255|NCT01456039|323917123|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
94577256|NCT01456039|323917124|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
94577257|NCT01456039|323917125|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
94577258|NCT01456039|323917123|FG000|Phase 1 (First Step)|Adverse Event|0|||
94577259|NCT01456039|323917124|FG001|Phase 1 (First Step)|Adverse Event|3|||
94577260|NCT01456039|323917125|FG002|Phase 1 (First Step)|Adverse Event|0|||
94577261|NCT01456039|323917123|FG000|Phase 1 (First Step)|Other|0|||
94577262|NCT01456039|323917124|FG001|Phase 1 (First Step)|Other|1|||
94577263|NCT01456039|323917125|FG002|Phase 1 (First Step)|Other|0|||
94577264|NCT01456039|323917123|FG000|Phase 2 (Second Step)|Disease Progression|0|||
94577265|NCT01456039|323917124|FG001|Phase 2 (Second Step)|Disease Progression|0|||
94577266|NCT01456039|323917125|FG002|Phase 2 (Second Step)|Disease Progression|17|||
94577267|NCT01456039|323917123|FG000|Phase 2 (Second Step)|Adverse Event|0|||
94577268|NCT01456039|323917124|FG001|Phase 2 (Second Step)|Adverse Event|0|||
94577269|NCT01456039|323917125|FG002|Phase 2 (Second Step)|Adverse Event|10|||
94577270|NCT01456039|323917123|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
94577271|NCT01456039|323917124|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
94577272|NCT01456039|323917125|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
94577273|NCT01456039|323917123|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
94577274|NCT01456039|323917124|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
94577275|NCT01456039|323917125|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
94577276|NCT01456039|323917123|FG000|Phase 2 (Second Step)|Other|0|||
94577277|NCT01456039|323917124|FG001|Phase 2 (Second Step)|Other|0|||
94577278|NCT01456039|323917125|FG002|Phase 2 (Second Step)|Other|1|||
94577279|NCT01021020|323917128|FG000|Period I|Protocol Violation|1|||
94577280|NCT01021020|323917128|FG000|Period I|Withdrawal by Subject|1|||
94577281|NCT01021020|323917128|FG000|14 Day Washout Period A|Physician Decision|1|||
94577282|NCT00992108|323917137|FG000|Overall Study|Lost to Follow-up|0|||
94577283|NCT00992108|323917138|FG001|Overall Study|Lost to Follow-up|1|||
94577284|NCT04106557|323917140|FG000|Overall Study|Physician Decision|0|||
94577285|NCT04106557|323917141|FG001|Overall Study|Physician Decision|1|||
94577286|NCT04106557|323917142|FG002|Overall Study|Physician Decision|0|||
94577287|NCT04106557|323917140|FG000|Overall Study|Protocol Violation|0|||
94577288|NCT04106557|323917141|FG001|Overall Study|Protocol Violation|1|||
94577289|NCT04106557|323917142|FG002|Overall Study|Protocol Violation|0|||
94577290|NCT00129402|323917143|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
94577291|NCT00129402|323917144|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
94577292|NCT00129402|323917145|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
94577293|NCT00129402|323917146|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
94577294|NCT00129402|323917147|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
94577295|NCT00129402|323917148|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
94577296|NCT00129402|323917149|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
94577297|NCT00129402|323917143|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
94577298|NCT00129402|323917144|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
94577299|NCT00129402|323917145|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
94577300|NCT00129402|323917146|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
94577301|NCT00129402|323917147|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
94577302|NCT00129402|323917148|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
94577303|NCT00129402|323917149|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
94577304|NCT00129402|323917143|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
94577305|NCT00129402|323917144|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
94577306|NCT00129402|323917145|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
94577307|NCT00129402|323917146|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
94577308|NCT00129402|323917147|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
94577309|NCT00129402|323917148|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
94577310|NCT00129402|323917149|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
94577311|NCT00129402|323917143|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
94577312|NCT00129402|323917144|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
94577313|NCT00129402|323917145|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
94577314|NCT00129402|323917146|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
94577315|NCT00129402|323917147|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
94453944|NCT01430403|323450226|FG002|Overall Study|Physician Decision|0|||
94577316|NCT00129402|323917148|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
94577317|NCT00129402|323917149|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
94577318|NCT00129402|323917143|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
94577319|NCT00129402|323917144|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
94577320|NCT00129402|323917145|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
94577321|NCT00129402|323917146|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
94577322|NCT00129402|323917147|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
94577323|NCT00129402|323917148|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
94577324|NCT00129402|323917149|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
94577325|NCT00129402|323917143|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
94577326|NCT00129402|323917144|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
94577327|NCT00129402|323917145|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
94577328|NCT00129402|323917146|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
94577329|NCT00129402|323917147|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
94577330|NCT00129402|323917148|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
94577331|NCT00129402|323917149|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
94577332|NCT00129402|323917143|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
94577333|NCT00129402|323917144|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
94577334|NCT00129402|323917145|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
94239989|NCT01509547|322672697|FG000|Overall Study|Withdrawal by Subject|11|||
94239990|NCT01509547|322672698|FG001|Overall Study|Withdrawal by Subject|24|||
94239991|NCT01509547|322672697|FG000|Overall Study|Physician Decision|0|||
94239992|NCT01509547|322672698|FG001|Overall Study|Physician Decision|1|||
94239993|NCT01607476|322672707|FG000|Overall Study|Withdrawal by Subject|1|||
94239994|NCT01607476|322672708|FG001|Overall Study|Withdrawal by Subject|0|||
94239995|NCT01607476|322672709|FG002|Overall Study|Withdrawal by Subject|1|||
94239996|NCT01607476|322672707|FG000|Overall Study|Lost to Follow-up|0|||
94239997|NCT01607476|322672708|FG001|Overall Study|Lost to Follow-up|0|||
94239998|NCT01607476|322672709|FG002|Overall Study|Lost to Follow-up|2|||
94239999|NCT01217437|322672712|FG000|Overall Study|Adverse Event|0|||
94240000|NCT01217437|322672713|FG001|Overall Study|Adverse Event|8|||
94240001|NCT01217437|322672712|FG000|Overall Study|Death|5|||
94240002|NCT01217437|322672713|FG001|Overall Study|Death|0|||
94240003|NCT01217437|322672712|FG000|Overall Study|Lack of Efficacy|29|||
94240004|NCT01217437|322672713|FG001|Overall Study|Lack of Efficacy|25|||
94240005|NCT01217437|322672712|FG000|Overall Study|Physician Decision|8|||
94240006|NCT01217437|322672713|FG001|Overall Study|Physician Decision|5|||
94240007|NCT01217437|322672712|FG000|Overall Study|Withdrawal by Subject|0|||
94240008|NCT01217437|322672713|FG001|Overall Study|Withdrawal by Subject|2|||
94240009|NCT01217437|322672712|FG000|Overall Study|Ineligible|1|||
94240010|NCT01217437|322672713|FG001|Overall Study|Ineligible|1|||
94240011|NCT03548220|322672723|FG000|Overall Study|Lost to Follow-up|1|||
94240012|NCT03548220|322672724|FG001|Overall Study|Lost to Follow-up|0|||
94240013|NCT03548220|322672725|FG002|Overall Study|Lost to Follow-up|0|||
94240014|NCT03548220|322672726|FG003|Overall Study|Lost to Follow-up|0|||
94240015|NCT01607879|322674485|FG000|Overall Study|Death|1|||
94240016|NCT01607879|322674486|FG001|Overall Study|Death|0|||
94240017|NCT00737477|322674491|FG000|Overall Study|Adverse Event|9|||
94240018|NCT00737477|322674491|FG000|Overall Study|Death|9|||
94240019|NCT00737477|322674491|FG000|Overall Study|Treatment Refusal|1|||
94240020|NCT00737477|322674491|FG000|Overall Study|Withdrawal by Subject|1|||
94240021|NCT00737477|322674491|FG000|Overall Study|Renal Transplantation|10|||
94240022|NCT00737477|322674491|FG000|Overall Study|Other|4|||
94240023|NCT03325777|322674497|FG000|Overall Study|Lost to Follow-up|9|||
94240024|NCT03325777|322674498|FG001|Overall Study|Lost to Follow-up|12|||
94577335|NCT00129402|323917146|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
94577336|NCT00129402|323917147|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
94577337|NCT00129402|323917148|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
94577338|NCT00129402|323917149|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
94577339|NCT00129402|323917143|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
94577340|NCT00129402|323917144|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
94577341|NCT00129402|323917145|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
94577342|NCT00129402|323917146|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
94577343|NCT00129402|323917147|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
94240025|NCT02567708|322674505|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
94240026|NCT02567708|322674506|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
94240027|NCT02567708|322674505|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
94240028|NCT02567708|322674506|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
94240029|NCT02567708|322674505|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
94240030|NCT02567708|322674506|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
94240031|NCT02567708|322674505|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
94240032|NCT02567708|322674506|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
94577344|NCT00129402|323917148|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
94577345|NCT00129402|323917149|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
94577346|NCT00129402|323917143|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
94577347|NCT00129402|323917144|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
94577348|NCT00129402|323917145|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
94577349|NCT00129402|323917146|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
94577350|NCT00129402|323917147|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
94577351|NCT00129402|323917148|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
94577352|NCT00129402|323917149|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
94577353|NCT00129402|323917143|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
94577354|NCT00129402|323917144|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
94577355|NCT00129402|323917145|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
94577356|NCT00129402|323917146|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
94577357|NCT00129402|323917147|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
94577358|NCT00129402|323917148|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
94577359|NCT00129402|323917149|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
94577360|NCT00129402|323917143|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
94577361|NCT00129402|323917144|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
94577362|NCT00129402|323917145|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
94577363|NCT00129402|323917146|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
94577364|NCT00129402|323917147|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
94577365|NCT00129402|323917148|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
94577366|NCT00129402|323917149|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
94577367|NCT00129402|323917143|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
94577368|NCT00129402|323917144|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
94577369|NCT00129402|323917145|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
94577370|NCT00129402|323917146|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
94577371|NCT00129402|323917147|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
94577372|NCT00129402|323917148|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
94577373|NCT00129402|323917149|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
94577374|NCT00129402|323917143|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
94577375|NCT00129402|323917144|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
94577376|NCT00129402|323917145|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
94577377|NCT00129402|323917146|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
94577378|NCT00129402|323917147|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
94577379|NCT00129402|323917148|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
94577380|NCT00129402|323917149|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
94577381|NCT01709721|323917150|FG000|Open Label Phase|Withdrawal by Subject|0|||
94577382|NCT01709721|323917151|FG001|Open Label Phase|Withdrawal by Subject|0|||
94577383|NCT01709721|323917152|FG002|Open Label Phase|Withdrawal by Subject|5|||
94577384|NCT01709721|323917150|FG000|Open Label Phase|Adverse Event|0|||
94577385|NCT01709721|323917151|FG001|Open Label Phase|Adverse Event|0|||
94577386|NCT01709721|323917152|FG002|Open Label Phase|Adverse Event|8|||
94577387|NCT01709721|323917150|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
94577388|NCT01709721|323917151|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
94577389|NCT01709721|323917152|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
94577390|NCT01709721|323917150|FG000|Open Label Phase|Investigator Decision|0|||
94577391|NCT01709721|323917151|FG001|Open Label Phase|Investigator Decision|0|||
94577392|NCT01709721|323917152|FG002|Open Label Phase|Investigator Decision|1|||
94577393|NCT01709721|323917150|FG000|Open Label Phase|Sponsor Decision|0|||
94577394|NCT01709721|323917151|FG001|Open Label Phase|Sponsor Decision|0|||
94577395|NCT01709721|323917152|FG002|Open Label Phase|Sponsor Decision|2|||
94577396|NCT01709721|323917150|FG000|Open Label Phase|Protocol Violation|0|||
94577397|NCT01709721|323917151|FG001|Open Label Phase|Protocol Violation|0|||
94577398|NCT01709721|323917152|FG002|Open Label Phase|Protocol Violation|1|||
94577399|NCT01709721|323917150|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
94577400|NCT01709721|323917151|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
94577401|NCT01709721|323917152|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
94577402|NCT01709721|323917150|FG000|Open Label Phase|Inadequate Pain Control|0|||
94577403|NCT01709721|323917151|FG001|Open Label Phase|Inadequate Pain Control|0|||
94577404|NCT01709721|323917152|FG002|Open Label Phase|Inadequate Pain Control|37|||
94577405|NCT01709721|323917150|FG000|Open Label Phase|Other, Specify in text field in database|0|||
94577406|NCT01709721|323917151|FG001|Open Label Phase|Other, Specify in text field in database|0|||
94577407|NCT01709721|323917152|FG002|Open Label Phase|Other, Specify in text field in database|14|||
94577408|NCT01709721|323917150|FG000|Randomized Phase|Adverse Event|0|||
94577409|NCT01709721|323917151|FG001|Randomized Phase|Adverse Event|1|||
94577410|NCT01709721|323917152|FG002|Randomized Phase|Adverse Event|0|||
94577411|NCT01709721|323917150|FG000|Randomized Phase|Lost to Follow-up|1|||
94577412|NCT01709721|323917151|FG001|Randomized Phase|Lost to Follow-up|0|||
94577413|NCT01709721|323917152|FG002|Randomized Phase|Lost to Follow-up|0|||
94577414|NCT01709721|323917150|FG000|Randomized Phase|Inadequate Pain Control|1|||
94577415|NCT01709721|323917151|FG001|Randomized Phase|Inadequate Pain Control|2|||
94577416|NCT01709721|323917152|FG002|Randomized Phase|Inadequate Pain Control|0|||
94577417|NCT01709721|323917150|FG000|Randomized Phase|Other, Specify text field in database|1|||
94577418|NCT01709721|323917151|FG001|Randomized Phase|Other, Specify text field in database|3|||
94577419|NCT01709721|323917152|FG002|Randomized Phase|Other, Specify text field in database|0|||
94577420|NCT01614886|323917153|FG000|Overall Study|Adverse Event|15|||
94577421|NCT01614886|323917154|FG001|Overall Study|Adverse Event|20|||
94577422|NCT01614886|323917153|FG000|Overall Study|Withdrawal by Subject|4|||
94577423|NCT01614886|323917154|FG001|Overall Study|Withdrawal by Subject|4|||
94577424|NCT01614886|323917153|FG000|Overall Study|Death|1|||
94577425|NCT01614886|323917154|FG001|Overall Study|Death|0|||
94577426|NCT01614886|323917153|FG000|Overall Study|Protocol deviation|0|||
94577427|NCT01614886|323917154|FG001|Overall Study|Protocol deviation|2|||
94577428|NCT01207414|323917155|FG000|Overall Study|Adverse Event|25|||
94577429|NCT01207414|323917156|FG001|Overall Study|Adverse Event|39|||
94577430|NCT01207414|323917155|FG000|Overall Study|Abnormal test procedure results|0|||
94577431|NCT01207414|323917156|FG001|Overall Study|Abnormal test procedure results|1|||
94577432|NCT01207414|323917155|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
94577433|NCT01207414|323917156|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
94577434|NCT01207414|323917155|FG000|Overall Study|Patient withdrew consent|14|||
94577435|NCT01207414|323917156|FG001|Overall Study|Patient withdrew consent|11|||
94577436|NCT01207414|323917155|FG000|Overall Study|Lost to Follow-up|15|||
94577437|NCT01207414|323917156|FG001|Overall Study|Lost to Follow-up|17|||
94577438|NCT01207414|323917155|FG000|Overall Study|Administrative problems|1|||
94577439|NCT01207414|323917156|FG001|Overall Study|Administrative problems|1|||
94577440|NCT01207414|323917155|FG000|Overall Study|Protocol deviation|12|||
94577441|NCT01207414|323917156|FG001|Overall Study|Protocol deviation|9|||
94577442|NCT01207414|323917155|FG000|Overall Study|Randomized in error|1|||
94577443|NCT01207414|323917156|FG001|Overall Study|Randomized in error|0|||
94577444|NCT03448406|323917157|FG000|Overall Study|Noncompliance of scheduled visits|1|||
94577445|NCT03448406|323917158|FG001|Overall Study|Noncompliance of scheduled visits|2|||
94577446|NCT03448406|323917157|FG000|Overall Study|Withdrawal by Subject|1|||
94577447|NCT03448406|323917158|FG001|Overall Study|Withdrawal by Subject|2|||
94577448|NCT03448406|323917157|FG000|Overall Study|Protocol Violation|1|||
94577449|NCT03448406|323917158|FG001|Overall Study|Protocol Violation|0|||
94577450|NCT03448406|323917157|FG000|Overall Study|Adverse Event|8|||
94577451|NCT03448406|323917158|FG001|Overall Study|Adverse Event|9|||
94577452|NCT00910650|323917163|FG000|Overall Study|Death|2|||
94577453|NCT03367793|323917164|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
94577454|NCT03367793|323917165|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
94577455|NCT03367793|323917166|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
94577456|NCT03367793|323917167|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
94577457|NCT03367793|323917168|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
94577458|NCT03367793|323917169|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
94577459|NCT02435992|323917170|FG000|Overall Study|non compliance with protocol|2|||
94577460|NCT02435992|323917171|FG001|Overall Study|non compliance with protocol|0|||
94577461|NCT02435992|323917172|FG002|Overall Study|non compliance with protocol|1|||
94577462|NCT02435992|323917173|FG003|Overall Study|non compliance with protocol|0|||
94577463|NCT02435992|323917174|FG004|Overall Study|non compliance with protocol|0|||
94577464|NCT02435992|323917170|FG000|Overall Study|Adverse Event|11|||
94577465|NCT02435992|323917171|FG001|Overall Study|Adverse Event|6|||
94577466|NCT02435992|323917172|FG002|Overall Study|Adverse Event|12|||
94577467|NCT02435992|323917173|FG003|Overall Study|Adverse Event|0|||
94577468|NCT02435992|323917174|FG004|Overall Study|Adverse Event|0|||
94577469|NCT02435992|323917170|FG000|Overall Study|Lack of Efficacy|4|||
94577470|NCT02435992|323917171|FG001|Overall Study|Lack of Efficacy|10|||
94577471|NCT02435992|323917172|FG002|Overall Study|Lack of Efficacy|9|||
94577472|NCT02435992|323917173|FG003|Overall Study|Lack of Efficacy|0|||
94577473|NCT02435992|323917174|FG004|Overall Study|Lack of Efficacy|0|||
94577474|NCT02435992|323917170|FG000|Overall Study|Withdrawal by Subject|10|||
94577475|NCT02435992|323917171|FG001|Overall Study|Withdrawal by Subject|8|||
94577476|NCT02435992|323917172|FG002|Overall Study|Withdrawal by Subject|20|||
94577477|NCT02435992|323917173|FG003|Overall Study|Withdrawal by Subject|0|||
94577478|NCT02435992|323917174|FG004|Overall Study|Withdrawal by Subject|0|||
94577479|NCT02435992|323917170|FG000|Overall Study|Other Reason|1|||
94577480|NCT02435992|323917171|FG001|Overall Study|Other Reason|0|||
94453945|NCT01430403|323450224|FG000|Overall Study|Protocol Violation|2|||
94453946|NCT01430403|323450225|FG001|Overall Study|Protocol Violation|3|||
94453947|NCT01430403|323450226|FG002|Overall Study|Protocol Violation|2|||
94453948|NCT01430403|323450224|FG000|Overall Study|Withdrawal by Subject|9|||
94453949|NCT01430403|323450225|FG001|Overall Study|Withdrawal by Subject|1|||
94453950|NCT01430403|323450226|FG002|Overall Study|Withdrawal by Subject|3|||
94453951|NCT01981954|323450227|FG000|Titration Period|Protocol Deviation|1|||
94453952|NCT01981954|323450227|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
94453953|NCT02218736|323450228|FG000|Overall Study|Withdrawal by Subject|10|||
94453954|NCT02218736|323450229|FG001|Overall Study|Withdrawal by Subject|9|||
94453955|NCT02218736|323450228|FG000|Overall Study|Protocol Violation|2|||
94453956|NCT02218736|323450229|FG001|Overall Study|Protocol Violation|0|||
94453957|NCT01860040|323450230|FG000|Overall Study|Withdrawal by Subject|1|||
94453958|NCT01860040|323450231|FG001|Overall Study|Withdrawal by Subject|0|||
94453959|NCT03315286|323450232|FG000|Overall Study|Lost to Follow-up|0|||
94453960|NCT03315286|323450233|FG001|Overall Study|Lost to Follow-up|3|||
94453961|NCT03315286|323450232|FG000|Overall Study|Withdrawal by Subject|1|||
94453962|NCT03315286|323450233|FG001|Overall Study|Withdrawal by Subject|0|||
94453963|NCT03315286|323450232|FG000|Overall Study|Protocol Violation|0|||
94453964|NCT03315286|323450233|FG001|Overall Study|Protocol Violation|1|||
94453965|NCT04087720|323450234|FG000|Overall Study|Withdrawal by Subject|2|||
94453966|NCT04087720|323450234|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
94453967|NCT03706430|323450235|FG000|Overall Study|No A-Line placed|5|||
94453968|NCT03706430|323450235|FG000|Overall Study|Subject had gel nail polish|1|||
94453969|NCT03706430|323450235|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
94453970|NCT03706430|323450235|FG000|Overall Study|Cancelled Case|6|||
94453971|NCT03706430|323450235|FG000|Overall Study|Physician Decision|2|||
94453972|NCT02120833|323450236|FG000|Overall Study|Adverse Event|1|||
94453973|NCT02120833|323450237|FG001|Overall Study|Adverse Event|0|||
94453974|NCT02120833|323450236|FG000|Overall Study|Withdrawal by Subject|2|||
94453975|NCT02120833|323450237|FG001|Overall Study|Withdrawal by Subject|0|||
94453976|NCT02120833|323450236|FG000|Overall Study|Lost to Follow-up|1|||
94453977|NCT02120833|323450237|FG001|Overall Study|Lost to Follow-up|1|||
94453978|NCT00746564|323450242|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
94453979|NCT01743560|323450243|FG000|Overall Study|Disease progression|26|||
94453980|NCT01743560|323450243|FG000|Overall Study|Adverse Event|8|||
94453981|NCT01743560|323450243|FG000|Overall Study|Death|3|||
94453982|NCT01743560|323450243|FG000|Overall Study|Withdrawal by Subject|2|||
94453983|NCT01743560|323450243|FG000|Overall Study|Protocol Violation|1|||
94453984|NCT01743560|323450243|FG000|Overall Study|>1 dose of study drug|3|||
94453985|NCT01827267|323450244|FG000|Overall Study|Did not receive study drug|1|||
94453986|NCT01827267|323450245|FG001|Overall Study|Did not receive study drug|1|||
94453987|NCT01827267|323450244|FG000|Overall Study|Physician Decision|1|||
94453988|NCT01827267|323450245|FG001|Overall Study|Physician Decision|0|||
94453989|NCT01827267|323450244|FG000|Overall Study|Disease Progression|1|||
94453990|NCT01827267|323450245|FG001|Overall Study|Disease Progression|1|||
94453991|NCT01827267|323450244|FG000|Overall Study|Sponsor Discontinued Study|2|||
94453992|NCT01827267|323450245|FG001|Overall Study|Sponsor Discontinued Study|8|||
94453993|NCT01827267|323450244|FG000|Overall Study|Still on study|0|||
94453994|NCT01827267|323450245|FG001|Overall Study|Still on study|2|||
94453995|NCT03070002|323450248|FG000|Follow up for 2 Years|Death|1|||
94453996|NCT01684943|323450251|FG000|Overall Study|Inadequate Venous Access|3|||
94453997|NCT01684943|323450252|FG001|Overall Study|Inadequate Venous Access|0|||
94453998|NCT01684943|323450253|FG002|Overall Study|Inadequate Venous Access|0|||
94453999|NCT01684943|323450251|FG000|Overall Study|Principal Investigator Determination|1|||
94454000|NCT01684943|323450252|FG001|Overall Study|Principal Investigator Determination|0|||
94454001|NCT01684943|323450253|FG002|Overall Study|Principal Investigator Determination|0|||
94454002|NCT01684943|323450251|FG000|Overall Study|Excluded from Analysis|1|||
94454003|NCT01684943|323450252|FG001|Overall Study|Excluded from Analysis|1|||
94454004|NCT01684943|323450253|FG002|Overall Study|Excluded from Analysis|1|||
94454005|NCT01684943|323450251|FG000|Overall Study|Lost to Follow-up|3|||
94454006|NCT01684943|323450252|FG001|Overall Study|Lost to Follow-up|0|||
94454007|NCT01684943|323450253|FG002|Overall Study|Lost to Follow-up|0|||
94454008|NCT01684943|323450251|FG000|Overall Study|Planning Pregnancy|1|||
94454009|NCT01684943|323450252|FG001|Overall Study|Planning Pregnancy|0|||
94454010|NCT01684943|323450253|FG002|Overall Study|Planning Pregnancy|0|||
94454011|NCT01516008|323450254|FG000|Overall Study|Adverse Event|0|||
94454012|NCT01516008|323450255|FG001|Overall Study|Adverse Event|2|||
94454013|NCT01516008|323450256|FG002|Overall Study|Adverse Event|7|||
94454014|NCT01516008|323450254|FG000|Overall Study|Lack of Efficacy|44|||
94454015|NCT01516008|323450255|FG001|Overall Study|Lack of Efficacy|14|||
94454016|NCT01516008|323450256|FG002|Overall Study|Lack of Efficacy|10|||
94454017|NCT01516008|323450254|FG000|Overall Study|Protocol Violation|1|||
94454018|NCT01516008|323450255|FG001|Overall Study|Protocol Violation|0|||
94454019|NCT01516008|323450256|FG002|Overall Study|Protocol Violation|0|||
94454020|NCT01516008|323450254|FG000|Overall Study|Reason not specified|0|||
94454021|NCT01516008|323450255|FG001|Overall Study|Reason not specified|0|||
94577481|NCT02435992|323917172|FG002|Overall Study|Other Reason|0|||
94577482|NCT02435992|323917173|FG003|Overall Study|Other Reason|0|||
94577483|NCT02435992|323917174|FG004|Overall Study|Other Reason|0|||
94577484|NCT02435992|323917170|FG000|Overall Study|Physician Decision|0|||
94577485|NCT02435992|323917171|FG001|Overall Study|Physician Decision|0|||
94577486|NCT02435992|323917172|FG002|Overall Study|Physician Decision|1|||
94577487|NCT02435992|323917173|FG003|Overall Study|Physician Decision|0|||
94577488|NCT02435992|323917174|FG004|Overall Study|Physician Decision|0|||
94577489|NCT00423579|323917175|FG000|Overall Study|Lost to Follow-up|3|||
94577490|NCT00423579|323917176|FG001|Overall Study|Lost to Follow-up|0|||
94577491|NCT00423579|323917175|FG000|Overall Study|Protocol Violation|1|||
94577492|NCT00423579|323917176|FG001|Overall Study|Protocol Violation|3|||
94577493|NCT00423579|323917175|FG000|Overall Study|Diagnosis of diabetes|0|||
94577494|NCT00423579|323917176|FG001|Overall Study|Diagnosis of diabetes|1|||
94577495|NCT00260533|323917177|FG000|Overall Study|Other|3|||
94577496|NCT00260533|323917178|FG001|Overall Study|Other|3|||
94577497|NCT01761877|323917179|FG000|Overall Study|Adverse Event|7|||
94577498|NCT01761877|323917180|FG001|Overall Study|Adverse Event|0|||
94577499|NCT01761877|323917179|FG000|Overall Study|Withdrawal by Subject|6|||
94577500|NCT01761877|323917180|FG001|Overall Study|Withdrawal by Subject|4|||
94577501|NCT01761877|323917179|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
94577502|NCT01761877|323917180|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
94577503|NCT01761877|323917179|FG000|Overall Study|Death|0|||
94577504|NCT01761877|323917180|FG001|Overall Study|Death|1|||
94577505|NCT01761877|323917179|FG000|Overall Study|MRI intolerant|1|||
94577506|NCT01761877|323917180|FG001|Overall Study|MRI intolerant|6|||
94577507|NCT03879772|323917181|FG000|Overall Study|Adverse Event|2|||
94577508|NCT03879772|323917182|FG001|Overall Study|Adverse Event|2|||
94577509|NCT03879772|323917183|FG002|Overall Study|Adverse Event|3|||
94577510|NCT03879772|323917184|FG003|Overall Study|Adverse Event|4|||
94577511|NCT03879772|323917185|FG004|Overall Study|Adverse Event|3|||
94577512|NCT03879772|323917181|FG000|Overall Study|Treatment Failure|1|||
94577513|NCT03879772|323917182|FG001|Overall Study|Treatment Failure|0|||
94577514|NCT03879772|323917183|FG002|Overall Study|Treatment Failure|0|||
94577515|NCT03879772|323917184|FG003|Overall Study|Treatment Failure|2|||
94577516|NCT03879772|323917185|FG004|Overall Study|Treatment Failure|1|||
94577517|NCT03879772|323917181|FG000|Overall Study|Lost to Follow-up|0|||
94577518|NCT03879772|323917182|FG001|Overall Study|Lost to Follow-up|0|||
94577519|NCT03879772|323917183|FG002|Overall Study|Lost to Follow-up|0|||
94577520|NCT03879772|323917184|FG003|Overall Study|Lost to Follow-up|0|||
94577521|NCT03879772|323917185|FG004|Overall Study|Lost to Follow-up|1|||
94577522|NCT03879772|323917181|FG000|Overall Study|Withdrawal by Subject|0|||
94577523|NCT03879772|323917182|FG001|Overall Study|Withdrawal by Subject|1|||
94577524|NCT03879772|323917183|FG002|Overall Study|Withdrawal by Subject|3|||
94577525|NCT03879772|323917184|FG003|Overall Study|Withdrawal by Subject|1|||
94577526|NCT03879772|323917185|FG004|Overall Study|Withdrawal by Subject|1|||
94577527|NCT03879772|323917181|FG000|Overall Study|Protocol Violation|0|||
94577528|NCT03879772|323917182|FG001|Overall Study|Protocol Violation|0|||
94577529|NCT03879772|323917183|FG002|Overall Study|Protocol Violation|3|||
94577530|NCT03879772|323917184|FG003|Overall Study|Protocol Violation|1|||
94577531|NCT03879772|323917185|FG004|Overall Study|Protocol Violation|2|||
94577532|NCT03879772|323917181|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
94577533|NCT03879772|323917182|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
94577534|NCT03879772|323917183|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
94577535|NCT03879772|323917184|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
94577536|NCT03879772|323917185|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
94577537|NCT03697252|323917187|FG000|Overall Study|Adverse Event|3|||
94577538|NCT03697252|323917188|FG001|Overall Study|Adverse Event|2|||
94577539|NCT03697252|323917187|FG000|Overall Study|Withdrawal by Subject|14|||
94577540|NCT03697252|323917188|FG001|Overall Study|Withdrawal by Subject|14|||
94577541|NCT03697252|323917187|FG000|Overall Study|Lost to Follow-up|0|||
94577542|NCT03697252|323917188|FG001|Overall Study|Lost to Follow-up|1|||
94577543|NCT03697252|323917187|FG000|Overall Study|Physician Decision|1|||
94577544|NCT03697252|323917188|FG001|Overall Study|Physician Decision|1|||
94577545|NCT03697252|323917187|FG000|Overall Study|Other|0|||
94577546|NCT03697252|323917188|FG001|Overall Study|Other|1|||
94577547|NCT01780506|323917189|FG000|Double-Blind Phase|Randomized but not Treated|3|||
94577548|NCT01780506|323917190|FG001|Double-Blind Phase|Randomized but not Treated|2|||
94577549|NCT01780506|323917189|FG000|Double-Blind Phase|Adverse Event|4|||
94577550|NCT01780506|323917190|FG001|Double-Blind Phase|Adverse Event|14|||
94577551|NCT01780506|323917189|FG000|Double-Blind Phase|Death|1|||
94577552|NCT01780506|323917190|FG001|Double-Blind Phase|Death|2|||
94577553|NCT01780506|323917189|FG000|Double-Blind Phase|Pregnancy|2|||
94577554|NCT01780506|323917190|FG001|Double-Blind Phase|Pregnancy|1|||
94577555|NCT01780506|323917189|FG000|Double-Blind Phase|Lack of Efficacy|1|||
94577556|NCT01780506|323917190|FG001|Double-Blind Phase|Lack of Efficacy|1|||
94577557|NCT01780506|323917189|FG000|Double-Blind Phase|Investigator's Discretion|5|||
94577558|NCT01780506|323917190|FG001|Double-Blind Phase|Investigator's Discretion|2|||
94577559|NCT01780506|323917189|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
94577560|NCT01780506|323917190|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
94577561|NCT01780506|323917189|FG000|Double-Blind Phase|Protocol Violation|4|||
94577562|NCT01780506|323917190|FG001|Double-Blind Phase|Protocol Violation|3|||
94577563|NCT01780506|323917189|FG000|Double-Blind Phase|Withdrew Consent|23|||
94577564|NCT01780506|323917190|FG001|Double-Blind Phase|Withdrew Consent|24|||
94577565|NCT01780506|323917189|FG000|Double-Blind Phase|Lost to Follow-up|23|||
94577566|NCT01780506|323917190|FG001|Double-Blind Phase|Lost to Follow-up|26|||
94577567|NCT01780506|323917189|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
94577568|NCT01780506|323917190|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
94577569|NCT02461758|323917192|FG000|Overall Study|Lost to Follow-up|0|||
94577570|NCT02461758|323917193|FG001|Overall Study|Lost to Follow-up|1|||
94577571|NCT02461758|323917194|FG002|Overall Study|Lost to Follow-up|1|||
94577572|NCT02461758|323917195|FG003|Overall Study|Lost to Follow-up|0|||
94577573|NCT04030143|323917196|FG000|Overall Study|Adverse Event|5|||
94577574|NCT04030143|323917197|FG001|Overall Study|Adverse Event|10|||
94577575|NCT04030143|323917196|FG000|Overall Study|Lost to Follow-up|3|||
94577576|NCT04030143|323917197|FG001|Overall Study|Lost to Follow-up|7|||
94577577|NCT04030143|323917196|FG000|Overall Study|Protocol Deviation|2|||
94577578|NCT04030143|323917197|FG001|Overall Study|Protocol Deviation|2|||
94577579|NCT04030143|323917196|FG000|Overall Study|Withdrawal by Subject|16|||
94577580|NCT04030143|323917197|FG001|Overall Study|Withdrawal by Subject|18|||
94577581|NCT04030143|323917196|FG000|Overall Study|Physician Decision|1|||
94577582|NCT04030143|323917197|FG001|Overall Study|Physician Decision|1|||
94577583|NCT04030143|323917196|FG000|Overall Study|Due to Covid-19|2|||
94577584|NCT04030143|323917197|FG001|Overall Study|Due to Covid-19|3|||
94577585|NCT04030143|323917196|FG000|Overall Study|Not Due to Covid-19|1|||
94577586|NCT04030143|323917197|FG001|Overall Study|Not Due to Covid-19|1|||
94577587|NCT00412984|323917198|FG000|Overall Study|Death|331|||
94577588|NCT00412984|323917199|FG001|Overall Study|Death|349|||
94577589|NCT00412984|323917198|FG000|Overall Study|Adverse Event|679|||
94577590|NCT00412984|323917199|FG001|Overall Study|Adverse Event|738|||
94577591|NCT00412984|323917198|FG000|Overall Study|Withdrawal by Subject|921|||
94577592|NCT00412984|323917199|FG001|Overall Study|Withdrawal by Subject|989|||
94577593|NCT00412984|323917198|FG000|Overall Study|Lost to Follow-up|51|||
94577594|NCT00412984|323917199|FG001|Overall Study|Lost to Follow-up|39|||
94577595|NCT00412984|323917198|FG000|Overall Study|Poor/Noncompliance|57|||
94577596|NCT00412984|323917199|FG001|Overall Study|Poor/Noncompliance|77|||
94577597|NCT00412984|323917198|FG000|Overall Study|Pregnancy|1|||
94577598|NCT00412984|323917199|FG001|Overall Study|Pregnancy|0|||
94577599|NCT00412984|323917198|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
94577600|NCT00412984|323917199|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
94577601|NCT00412984|323917198|FG000|Overall Study|Administrative Reason by Sponsor|11|||
94577602|NCT00412984|323917199|FG001|Overall Study|Administrative Reason by Sponsor|8|||
94577603|NCT00412984|323917198|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
94577604|NCT00412984|323917199|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
94577605|NCT00412984|323917198|FG000|Overall Study|Other Reason|80|||
94577606|NCT00412984|323917199|FG001|Overall Study|Other Reason|92|||
94658863|NCT02504866|324206210|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
94658864|NCT02504866|324206211|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
94658865|NCT02504866|324206212|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
94658866|NCT05101252|324206213|FG000|Overall Study|Unsatisfactory Test Article|1|||
94658867|NCT05101252|324206214|FG001|Overall Study|Unsatisfactory Test Article|0|||
94658868|NCT05101252|324206213|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
94658869|NCT05101252|324206214|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
94658870|NCT05101252|324206213|FG000|Overall Study|Withdrew Consent during study|0|||
94658871|NCT05101252|324206214|FG001|Overall Study|Withdrew Consent during study|1|||
94658872|NCT05101252|324206213|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
94658873|NCT05101252|324206214|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
94658874|NCT03231371|324206215|FG000|Overall Study|Withdrawal by Subject|1|||
94658875|NCT03231371|324206215|FG000|Overall Study|chose or were ineligible to have MRI|12|||
94658876|NCT04111497|324206221|FG000|Overall Study|relapse of primary disease|1|||
94454022|NCT01516008|323450256|FG002|Overall Study|Reason not specified|1|||
94577607|NCT00412984|323917198|FG000|Overall Study|Not Reported|11|||
94577608|NCT00412984|323917199|FG001|Overall Study|Not Reported|12|||
94577609|NCT01499940|323917200|FG000|Overall Study|Study was withdrawn before completion.|9|||
94577610|NCT05966142|323917201|FG000|Overall Study|Death|3|||
94577611|NCT05966142|323917202|FG001|Overall Study|Death|3|||
94577612|NCT05966142|323917201|FG000|Overall Study|Lost to Follow-up|55|||
94577613|NCT05966142|323917202|FG001|Overall Study|Lost to Follow-up|52|||
94577614|NCT05966142|323917201|FG000|Overall Study|Physician Decision|1|||
94658877|NCT04111497|324206221|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
94658878|NCT03321019|324206222|FG000|Overall Study|Withdrawal by Subject|0|||
94658879|NCT03321019|324206223|FG001|Overall Study|Withdrawal by Subject|6|||
94658880|NCT03321019|324206222|FG000|Overall Study|Lost to Follow-up|0|||
94658881|NCT03321019|324206223|FG001|Overall Study|Lost to Follow-up|22|||
94658882|NCT02056301|324206225|FG000|Overall Study|Protocol Violation|1|||
94577615|NCT05966142|323917202|FG001|Overall Study|Physician Decision|0|||
94577616|NCT05966142|323917201|FG000|Overall Study|Withdrawal by Subject|9|||
94577617|NCT05966142|323917202|FG001|Overall Study|Withdrawal by Subject|8|||
94577618|NCT05966142|323917201|FG000|Overall Study|Duplicate Enrollment|1|||
94577619|NCT05966142|323917202|FG001|Overall Study|Duplicate Enrollment|0|||
94577620|NCT05966142|323917201|FG000|Overall Study|Study Logistical Reason|1|||
94577621|NCT05966142|323917202|FG001|Overall Study|Study Logistical Reason|0|||
94577622|NCT05966142|323917201|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
94577623|NCT05966142|323917202|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
94577624|NCT01210313|323917203|FG000|Overall Study|Withdrawal by Subject|3|||
94577625|NCT01210313|323917203|FG000|Overall Study|Adverse Event|2|||
94577626|NCT01210313|323917203|FG000|Overall Study|Distant recurrence|4|||
94577627|NCT01210313|323917203|FG000|Overall Study|Non-compliance|7|||
94577628|NCT01353898|323917206|FG000|Overall Study|Study site terminated|0|||
94577629|NCT01353898|323917207|FG001|Overall Study|Study site terminated|0|||
94577630|NCT01353898|323917208|FG002|Overall Study|Study site terminated|0|||
94577631|NCT01353898|323917209|FG003|Overall Study|Study site terminated|0|||
94577632|NCT01353898|323917210|FG004|Overall Study|Study site terminated|0|||
94577633|NCT01353898|323917211|FG005|Overall Study|Study site terminated|1|||
94577634|NCT00453206|323917214|FG000|Overall Study|Death|1|||
94577635|NCT00632229|323917215|FG000|Overall Study|Adverse Event|6|||
94577636|NCT00632229|323917216|FG001|Overall Study|Adverse Event|0|||
94577637|NCT00632229|323917215|FG000|Overall Study|Lost to Follow-up|0|||
94577638|NCT00632229|323917216|FG001|Overall Study|Lost to Follow-up|3|||
94577639|NCT00632229|323917215|FG000|Overall Study|Lack of Efficacy|0|||
94577640|NCT00632229|323917216|FG001|Overall Study|Lack of Efficacy|2|||
94577641|NCT00632229|323917215|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
94577642|NCT00632229|323917216|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
94577643|NCT00888134|323917220|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
94577644|NCT00888134|323917220|FG000|Follow-up|being followed for long-term survival|1|||
94577645|NCT03224819|323917221|FG000|Overall Study|Withdrawal by Subject|0|||
94577646|NCT03224819|323917222|FG001|Overall Study|Withdrawal by Subject|0|||
94577647|NCT03224819|323917223|FG002|Overall Study|Withdrawal by Subject|0|||
94577648|NCT03224819|323917224|FG003|Overall Study|Withdrawal by Subject|0|||
94577649|NCT03224819|323917225|FG004|Overall Study|Withdrawal by Subject|0|||
94577650|NCT03224819|323917226|FG005|Overall Study|Withdrawal by Subject|0|||
94577651|NCT03224819|323917227|FG006|Overall Study|Withdrawal by Subject|0|||
94577652|NCT03224819|323917228|FG007|Overall Study|Withdrawal by Subject|0|||
94577653|NCT03224819|323917229|FG008|Overall Study|Withdrawal by Subject|0|||
94577654|NCT03224819|323917230|FG009|Overall Study|Withdrawal by Subject|0|||
94577655|NCT03224819|323917231|FG010|Overall Study|Withdrawal by Subject|0|||
94577656|NCT03224819|323917232|FG011|Overall Study|Withdrawal by Subject|0|||
94577657|NCT03224819|323917233|FG012|Overall Study|Withdrawal by Subject|1|||
94577658|NCT03224819|323917234|FG013|Overall Study|Withdrawal by Subject|0|||
94577659|NCT03224819|323917221|FG000|Overall Study|Sponsor Decision|0|||
94577660|NCT03224819|323917222|FG001|Overall Study|Sponsor Decision|0|||
94577661|NCT03224819|323917223|FG002|Overall Study|Sponsor Decision|0|||
94577662|NCT03224819|323917224|FG003|Overall Study|Sponsor Decision|1|||
94577663|NCT03224819|323917225|FG004|Overall Study|Sponsor Decision|1|||
94577664|NCT03224819|323917226|FG005|Overall Study|Sponsor Decision|2|||
94577665|NCT03224819|323917227|FG006|Overall Study|Sponsor Decision|1|||
94577666|NCT03224819|323917228|FG007|Overall Study|Sponsor Decision|1|||
94577667|NCT03224819|323917229|FG008|Overall Study|Sponsor Decision|1|||
94577668|NCT03224819|323917230|FG009|Overall Study|Sponsor Decision|2|||
94577669|NCT03224819|323917231|FG010|Overall Study|Sponsor Decision|1|||
94577670|NCT03224819|323917232|FG011|Overall Study|Sponsor Decision|1|||
94577671|NCT03224819|323917233|FG012|Overall Study|Sponsor Decision|1|||
94577672|NCT03224819|323917234|FG013|Overall Study|Sponsor Decision|0|||
94577673|NCT03224819|323917221|FG000|Overall Study|Lost to Follow-up|0|||
94577674|NCT03224819|323917222|FG001|Overall Study|Lost to Follow-up|0|||
94577675|NCT03224819|323917223|FG002|Overall Study|Lost to Follow-up|0|||
94577676|NCT03224819|323917224|FG003|Overall Study|Lost to Follow-up|0|||
94577677|NCT03224819|323917225|FG004|Overall Study|Lost to Follow-up|0|||
94577678|NCT03224819|323917226|FG005|Overall Study|Lost to Follow-up|0|||
94577679|NCT03224819|323917227|FG006|Overall Study|Lost to Follow-up|0|||
94658883|NCT02056301|324206226|FG001|Overall Study|Protocol Violation|2|||
94577680|NCT03224819|323917228|FG007|Overall Study|Lost to Follow-up|0|||
94351524|NCT01412333|323067410|FG001|Overall Study|Study Terminated By Sponsor|2|||
94577681|NCT03224819|323917229|FG008|Overall Study|Lost to Follow-up|1|||
94577682|NCT03224819|323917230|FG009|Overall Study|Lost to Follow-up|0|||
94577683|NCT03224819|323917231|FG010|Overall Study|Lost to Follow-up|0|||
94577684|NCT03224819|323917232|FG011|Overall Study|Lost to Follow-up|0|||
94577685|NCT03224819|323917233|FG012|Overall Study|Lost to Follow-up|0|||
94577686|NCT03224819|323917234|FG013|Overall Study|Lost to Follow-up|0|||
94577687|NCT03224819|323917221|FG000|Overall Study|Death|0|||
94577688|NCT03224819|323917222|FG001|Overall Study|Death|1|||
94577689|NCT03224819|323917223|FG002|Overall Study|Death|0|||
94351525|NCT01412333|323067409|FG000|Overall Study|Withdrawal by Subject|51|||
94577690|NCT03224819|323917224|FG003|Overall Study|Death|0|||
94577691|NCT03224819|323917225|FG004|Overall Study|Death|0|||
94577692|NCT03224819|323917226|FG005|Overall Study|Death|0|||
94240033|NCT01195623|322674507|FG000|Overall Study|Lost to Follow-up|35|||
94240034|NCT01195623|322674508|FG001|Overall Study|Lost to Follow-up|37|||
94240035|NCT00416195|322674509|FG000|Overall Study|Adverse Event|1|||
94240036|NCT00416195|322674510|FG001|Overall Study|Adverse Event|2|||
94240037|NCT00416195|322674509|FG000|Overall Study|Protocol Violation|1|||
94240038|NCT00416195|322674510|FG001|Overall Study|Protocol Violation|1|||
94240039|NCT00416195|322674509|FG000|Overall Study|Other|0|||
94240040|NCT00416195|322674510|FG001|Overall Study|Other|1|||
94240041|NCT02233803|322674513|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
94240042|NCT02233803|322674514|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
94240043|NCT02233803|322674513|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
94240044|NCT02233803|322674514|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
94240045|NCT02233803|322674513|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
94240046|NCT02233803|322674514|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
94240047|NCT02233803|322674513|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
94240048|NCT02233803|322674514|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
94240049|NCT02233803|322674513|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
94240050|NCT02233803|322674514|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
94240051|NCT02233803|322674513|FG000|Washout Period (4-Wks)|Physician Decision|1|||
94240052|NCT02233803|322674514|FG001|Washout Period (4-Wks)|Physician Decision|0|||
94240053|NCT02233803|322674513|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
94240054|NCT02233803|322674514|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
94240055|NCT02233803|322674513|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
94240056|NCT02233803|322674514|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
94240057|NCT02233803|322674513|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
94240058|NCT02233803|322674514|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
94240059|NCT01110408|322674515|FG000|Overall Study|Protocol Violation|1|||
94240060|NCT01110408|322674516|FG001|Overall Study|Protocol Violation|0|||
94240061|NCT01068665|322674517|FG000|Overall Study|Adverse Event|5|||
94240062|NCT01068665|322674518|FG001|Overall Study|Adverse Event|4|||
94240063|NCT01068665|322674517|FG000|Overall Study|Lack of Efficacy|0|||
94240064|NCT01068665|322674518|FG001|Overall Study|Lack of Efficacy|2|||
94240065|NCT01068665|322674517|FG000|Overall Study|Protocol Violation|5|||
94240066|NCT01068665|322674518|FG001|Overall Study|Protocol Violation|2|||
94240067|NCT01068665|322674517|FG000|Overall Study|Withdrawal Criteria|3|||
94240068|NCT01068665|322674518|FG001|Overall Study|Withdrawal Criteria|9|||
94240069|NCT01068665|322674517|FG000|Overall Study|Other|17|||
94240070|NCT01068665|322674518|FG001|Overall Study|Other|12|||
94240071|NCT00757627|322674519|FG000|Overall Study|Adverse Event|15|||
94240072|NCT00757627|322674519|FG000|Overall Study|Lack of Efficacy|10|||
94240073|NCT00757627|322674519|FG000|Overall Study|Lost to Follow-up|28|||
94240074|NCT00757627|322674519|FG000|Overall Study|Withdrawal by Subject|27|||
94240075|NCT00757627|322674519|FG000|Overall Study|Other|1|||
94240076|NCT00468143|322674521|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
94240077|NCT00468143|322674522|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
94240078|NCT00468143|322674521|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
94240079|NCT00468143|322674522|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
94240080|NCT01427725|322674523|FG000|Overall Study|Lost to Follow-up|17|||
94240081|NCT01427725|322674523|FG000|Overall Study|Protocol Violation|1|||
94240082|NCT01427725|322674523|FG000|Overall Study|Drug not administered|1|||
94240083|NCT01427725|322674523|FG000|Overall Study|Failure to visit|7|||
94240084|NCT01427725|322674523|FG000|Overall Study|Adverse Event|46|||
94240085|NCT01427725|322674523|FG000|Overall Study|Failure to visit after administration|40|||
94240086|NCT01427725|322674523|FG000|Overall Study|Patient's rejection|27|||
94240087|NCT01427725|322674523|FG000|Overall Study|Transfer to a different hospital|17|||
94577693|NCT03224819|323917227|FG006|Overall Study|Death|0|||
94577694|NCT03224819|323917228|FG007|Overall Study|Death|1|||
94577695|NCT03224819|323917229|FG008|Overall Study|Death|0|||
94577696|NCT03224819|323917230|FG009|Overall Study|Death|0|||
94240088|NCT01427725|322674523|FG000|Overall Study|Lack of Efficacy|8|||
94240089|NCT01427725|322674523|FG000|Overall Study|Death|7|||
94240090|NCT01427725|322674523|FG000|Overall Study|Symptom improvement|6|||
94240091|NCT01427725|322674523|FG000|Overall Study|AE and Patient's rejection|5|||
94240092|NCT01427725|322674523|FG000|Overall Study|Physician Decision|5|||
94240093|NCT01427725|322674523|FG000|Overall Study|Exacerbation of underlying disease|5|||
94240094|NCT01427725|322674523|FG000|Overall Study|Oral feeding difficulty|5|||
94240095|NCT01427725|322674523|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
94240096|NCT01427725|322674523|FG000|Overall Study|Forgetting prescription|1|||
94240097|NCT01427725|322674523|FG000|Overall Study|Other|2|||
94240098|NCT04276051|322674524|FG000|Overall Study|Lost to Follow-up|0|||
94240099|NCT04276051|322674525|FG001|Overall Study|Lost to Follow-up|1|||
94240100|NCT04276051|322674524|FG000|Overall Study|Physician Decision|0|||
94577697|NCT03224819|323917231|FG010|Overall Study|Death|0|||
94577698|NCT03224819|323917232|FG011|Overall Study|Death|1|||
94577699|NCT03224819|323917233|FG012|Overall Study|Death|0|||
94577700|NCT03224819|323917234|FG013|Overall Study|Death|0|||
94577701|NCT03674411|323917235|FG000|Overall Study|Non-treatment|4|||
94577702|NCT01488890|323917237|FG000|Overall Study|Serious adverse event|2|||
94577703|NCT01488890|323917238|FG001|Overall Study|Serious adverse event|0|||
94577704|NCT01488890|323917239|FG002|Overall Study|Serious adverse event|0|||
94577705|NCT01488890|323917240|FG003|Overall Study|Serious adverse event|0|||
94577706|NCT01488890|323917237|FG000|Overall Study|Protocol Violation|3|||
94577707|NCT01488890|323917238|FG001|Overall Study|Protocol Violation|0|||
94577708|NCT01488890|323917239|FG002|Overall Study|Protocol Violation|4|||
94577709|NCT01488890|323917240|FG003|Overall Study|Protocol Violation|0|||
94577710|NCT01488890|323917237|FG000|Overall Study|Lost to Follow-up|13|||
94577711|NCT01488890|323917238|FG001|Overall Study|Lost to Follow-up|10|||
94577712|NCT01488890|323917239|FG002|Overall Study|Lost to Follow-up|20|||
94577713|NCT01488890|323917240|FG003|Overall Study|Lost to Follow-up|3|||
94577714|NCT01488890|323917237|FG000|Overall Study|Withdrawal by Subject|14|||
94577715|NCT01488890|323917238|FG001|Overall Study|Withdrawal by Subject|10|||
94577716|NCT01488890|323917239|FG002|Overall Study|Withdrawal by Subject|11|||
94577717|NCT01488890|323917240|FG003|Overall Study|Withdrawal by Subject|2|||
94577718|NCT02694185|323917241|FG000|Overall Study|Withdrawal by Subject|45|||
94577719|NCT02694185|323917242|FG001|Overall Study|Withdrawal by Subject|0|||
94577720|NCT05082857|323917243|FG000|Overall Study|participants relocated and could not continue|2|||
94577721|NCT05082857|323917244|FG001|Overall Study|participants relocated and could not continue|1|||
94577722|NCT05082857|323917243|FG000|Overall Study|Lost to Follow-up|1|||
94577723|NCT05082857|323917244|FG001|Overall Study|Lost to Follow-up|3|||
94577724|NCT04672239|323917245|FG000|Week 2 Survey|Failed survey check items|1|||
94577725|NCT04672239|323917246|FG001|Week 2 Survey|Failed survey check items|2|||
94577726|NCT04672239|323917247|FG002|Week 2 Survey|Failed survey check items|3|||
94577727|NCT04672239|323917245|FG000|Week 2 Survey|Partially completed survey|7|||
94577728|NCT04672239|323917246|FG001|Week 2 Survey|Partially completed survey|1|||
94577729|NCT04672239|323917247|FG002|Week 2 Survey|Partially completed survey|4|||
94577730|NCT04672239|323917245|FG000|Week 2 Survey|Withdrawal by Subject|0|||
94577731|NCT04672239|323917246|FG001|Week 2 Survey|Withdrawal by Subject|1|||
94577732|NCT04672239|323917247|FG002|Week 2 Survey|Withdrawal by Subject|0|||
94577733|NCT04672239|323917245|FG000|Week 2 Survey|Lost to Follow-up|3|||
94577734|NCT04672239|323917246|FG001|Week 2 Survey|Lost to Follow-up|2|||
94577735|NCT04672239|323917247|FG002|Week 2 Survey|Lost to Follow-up|5|||
94577736|NCT04672239|323917245|FG000|Week 6 Survey|Failed survey check items|2|||
94577737|NCT04672239|323917246|FG001|Week 6 Survey|Failed survey check items|2|||
94577738|NCT04672239|323917247|FG002|Week 6 Survey|Failed survey check items|2|||
94577739|NCT04672239|323917245|FG000|Week 6 Survey|Partially completed survey|3|||
94240101|NCT04276051|322674525|FG001|Overall Study|Physician Decision|1|||
94577740|NCT04672239|323917246|FG001|Week 6 Survey|Partially completed survey|3|||
94577741|NCT04672239|323917247|FG002|Week 6 Survey|Partially completed survey|2|||
94577742|NCT04672239|323917245|FG000|Week 6 Survey|Withdrawal by Subject|1|||
94577743|NCT04672239|323917246|FG001|Week 6 Survey|Withdrawal by Subject|1|||
94577744|NCT04672239|323917247|FG002|Week 6 Survey|Withdrawal by Subject|1|||
94577745|NCT04672239|323917245|FG000|Week 6 Survey|Withdrawn by PI|0|||
94577746|NCT04672239|323917246|FG001|Week 6 Survey|Withdrawn by PI|1|||
94577747|NCT04672239|323917247|FG002|Week 6 Survey|Withdrawn by PI|0|||
94577748|NCT04672239|323917245|FG000|Week 6 Survey|Lost to Follow-up|12|||
94577749|NCT04672239|323917246|FG001|Week 6 Survey|Lost to Follow-up|2|||
94577750|NCT04672239|323917247|FG002|Week 6 Survey|Lost to Follow-up|5|||
94577751|NCT04672239|323917245|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
94577752|NCT04672239|323917246|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
94577753|NCT04672239|323917247|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
94577754|NCT04672239|323917245|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
94577755|NCT04672239|323917246|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
94577756|NCT04672239|323917247|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
94240102|NCT04276051|322674524|FG000|Overall Study|Withdrawal by Subject|1|||
94240103|NCT04276051|322674525|FG001|Overall Study|Withdrawal by Subject|1|||
94240104|NCT00392925|322674526|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
94240105|NCT00392925|322674527|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
94240106|NCT00392925|322674528|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
94454023|NCT04553471|323450257|FG000|Overall Study|Did not start treatment on protocol|3|||
94454024|NCT04553471|323450257|FG000|Overall Study|Death|1|||
94577757|NCT04672239|323917245|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
94577758|NCT04672239|323917246|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
94577759|NCT04672239|323917247|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
94577760|NCT04672239|323917245|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
94577761|NCT04672239|323917246|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
94577762|NCT04672239|323917247|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
94577763|NCT04672239|323917245|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
94577764|NCT04672239|323917246|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
94454025|NCT02147158|323450258|FG000|Treatment Course 1|Adverse Event|1|||
94240107|NCT00392925|322674529|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
94240108|NCT00392925|322674526|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
94240109|NCT00392925|322674527|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
94240110|NCT00392925|322674528|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
94240111|NCT00392925|322674529|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
94240112|NCT00392925|322674526|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
94240113|NCT00392925|322674527|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
94240114|NCT00392925|322674528|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
94240115|NCT00392925|322674529|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
94240116|NCT00392925|322674526|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
94240117|NCT00392925|322674527|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
94240118|NCT00392925|322674528|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
94240119|NCT00392925|322674529|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
94240120|NCT00392925|322674526|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
94240121|NCT00392925|322674527|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
94240122|NCT00392925|322674528|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
94240123|NCT00392925|322674529|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
94240124|NCT00392925|322674526|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
94240125|NCT00392925|322674527|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
94240126|NCT00392925|322674528|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
94240127|NCT00392925|322674529|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
94240128|NCT00392925|322674526|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
94240129|NCT00392925|322674527|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
94240130|NCT00392925|322674528|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
94240131|NCT00392925|322674529|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
94240132|NCT00392925|322674526|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
94240133|NCT00392925|322674527|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
94240134|NCT00392925|322674528|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
94240135|NCT00392925|322674529|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
94240136|NCT00392925|322674526|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
94240137|NCT00392925|322674527|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
94240138|NCT00392925|322674528|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
94240139|NCT00392925|322674529|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
94240140|NCT01912404|322674530|FG000|Overall Study|Due to personal reasons|1|||
94240141|NCT01912404|322674531|FG001|Overall Study|Due to personal reasons|0|||
94240142|NCT02269423|322674532|FG000|Overall Study|Discontinued due to change in residence|0|||
94240143|NCT02269423|322674533|FG001|Overall Study|Discontinued due to change in residence|1|||
94240144|NCT02269423|322674534|FG002|Overall Study|Discontinued due to change in residence|0|||
94240145|NCT02269423|322674535|FG003|Overall Study|Discontinued due to change in residence|1|||
94240146|NCT00820170|322674536|FG000|Overall Study|Adverse Event|0|||
94240147|NCT00820170|322674537|FG001|Overall Study|Adverse Event|0|||
94240148|NCT00820170|322674538|FG002|Overall Study|Adverse Event|0|||
94240149|NCT00820170|322674539|FG003|Overall Study|Adverse Event|0|||
94240150|NCT00820170|322674540|FG004|Overall Study|Adverse Event|2|||
94240151|NCT00820170|322674536|FG000|Overall Study|Progressive Disease|0|||
94240152|NCT00820170|322674537|FG001|Overall Study|Progressive Disease|0|||
94240153|NCT00820170|322674538|FG002|Overall Study|Progressive Disease|0|||
94240154|NCT00820170|322674539|FG003|Overall Study|Progressive Disease|0|||
94240155|NCT00820170|322674540|FG004|Overall Study|Progressive Disease|2|||
94240156|NCT03192475|322674541|FG000|Overall Study|Death|0|||
94240157|NCT03192475|322674542|FG001|Overall Study|Death|1|||
94577765|NCT04672239|323917247|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
94577766|NCT04672239|323917245|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
94577767|NCT04672239|323917246|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
94577768|NCT04672239|323917247|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
94577769|NCT04672239|323917245|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
94577770|NCT04672239|323917246|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
94577771|NCT04672239|323917247|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
94240158|NCT03192475|322674541|FG000|Overall Study|Lost to Follow-up|13|||
94240159|NCT03192475|322674542|FG001|Overall Study|Lost to Follow-up|8|||
94240160|NCT03552523|322674545|FG000|Overall Study|Withdrawal by Subject|1|||
94577772|NCT04606134|323917250|FG000|Overall Study|Adverse Event|0|||
94577773|NCT04606134|323917251|FG001|Overall Study|Adverse Event|1|||
94577774|NCT01099267|323917253|FG000|MDS-003 Study|Adverse Event|37|||
94577775|NCT01099267|323917253|FG000|MDS-003 Study|Lack of Efficacy|52|||
94577776|NCT01099267|323917253|FG000|MDS-003 Study|Withdrawal by Subject|8|||
94577777|NCT01099267|323917253|FG000|MDS-003 Study|Lost to Follow-up|1|||
94577778|NCT01099267|323917253|FG000|MDS-003 Study|Death|11|||
94577779|NCT01099267|323917253|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
94577780|NCT01099267|323917253|FG000|MDS-003 Study|Disease Progression|7|||
94577781|NCT01099267|323917253|FG000|MDS-003 Study|Investigator Decision|2|||
94577782|NCT01099267|323917253|FG000|MDS-003 Study|Non-Compliance|2|||
94577783|NCT01099267|323917253|FG000|MDS-003 Study|Loss of Response|1|||
94577784|NCT01099267|323917253|FG000|MDS-003 Study|Secondary Malign Disease|1|||
94577785|NCT05408429|323917266|FG000|Overall Study|Lost to Follow-up|1|||
94577786|NCT05408429|323917267|FG001|Overall Study|Lost to Follow-up|1|||
94577787|NCT05408429|323917268|FG002|Overall Study|Lost to Follow-up|0|||
94577788|NCT05408429|323917266|FG000|Overall Study|Withdrawal by Subject|5|||
94577789|NCT05408429|323917267|FG001|Overall Study|Withdrawal by Subject|0|||
94577790|NCT05408429|323917268|FG002|Overall Study|Withdrawal by Subject|1|||
94577791|NCT05477108|323917270|FG000|Overall Study|Participants randomized, not treated|1|||
94577792|NCT05477108|323917271|FG001|Overall Study|Participants randomized, not treated|1|||
94577793|NCT05477108|323917272|FG002|Overall Study|Participants randomized, not treated|1|||
94577794|NCT05477108|323917270|FG000|Overall Study|Physician Decision|0|||
94577795|NCT05477108|323917271|FG001|Overall Study|Physician Decision|0|||
94577796|NCT05477108|323917272|FG002|Overall Study|Physician Decision|1|||
94577797|NCT05477108|323917270|FG000|Overall Study|withdrawn from study|0|||
94577798|NCT05477108|323917271|FG001|Overall Study|withdrawn from study|0|||
94577799|NCT05477108|323917272|FG002|Overall Study|withdrawn from study|1|||
94577800|NCT05972993|323917274|FG000|Overall Study|Lost to Follow-up|2|||
94577801|NCT05972993|323917275|FG001|Overall Study|Lost to Follow-up|0|||
94577802|NCT05972993|323917276|FG002|Overall Study|Lost to Follow-up|1|||
94577803|NCT05972993|323917277|FG003|Overall Study|Lost to Follow-up|0|||
94577804|NCT05972993|323917278|FG004|Overall Study|Lost to Follow-up|0|||
94577805|NCT05972993|323917279|FG005|Overall Study|Lost to Follow-up|0|||
94577806|NCT05972993|323917280|FG006|Overall Study|Lost to Follow-up|0|||
94577807|NCT05972993|323917281|FG007|Overall Study|Lost to Follow-up|2|||
94577808|NCT05972993|323917282|FG008|Overall Study|Lost to Follow-up|0|||
94577809|NCT03866577|323917289|FG000|Overall Study|Protocol Violation|0|||
94577810|NCT03866577|323917290|FG001|Overall Study|Protocol Violation|0|||
94577811|NCT03866577|323917291|FG002|Overall Study|Protocol Violation|0|||
94577812|NCT03866577|323917292|FG003|Overall Study|Protocol Violation|0|||
94577813|NCT03866577|323917293|FG004|Overall Study|Protocol Violation|0|||
94577814|NCT03866577|323917294|FG005|Overall Study|Protocol Violation|0|||
94577815|NCT03866577|323917295|FG006|Overall Study|Protocol Violation|0|||
94577816|NCT03866577|323917296|FG007|Overall Study|Protocol Violation|0|||
94577817|NCT03866577|323917297|FG008|Overall Study|Protocol Violation|0|||
94577818|NCT03866577|323917298|FG009|Overall Study|Protocol Violation|0|||
94577819|NCT03866577|323917299|FG010|Overall Study|Protocol Violation|0|||
94577820|NCT03866577|323917300|FG011|Overall Study|Protocol Violation|1|||
94577821|NCT03866577|323917301|FG012|Overall Study|Protocol Violation|0|||
94577822|NCT03866577|323917289|FG000|Overall Study|Withdrawal by Subject|0|||
94577823|NCT03866577|323917290|FG001|Overall Study|Withdrawal by Subject|0|||
94577824|NCT03866577|323917291|FG002|Overall Study|Withdrawal by Subject|0|||
94577825|NCT03866577|323917292|FG003|Overall Study|Withdrawal by Subject|0|||
94577826|NCT03866577|323917293|FG004|Overall Study|Withdrawal by Subject|0|||
94577827|NCT03866577|323917294|FG005|Overall Study|Withdrawal by Subject|0|||
94577828|NCT03866577|323917295|FG006|Overall Study|Withdrawal by Subject|0|||
94577829|NCT03866577|323917296|FG007|Overall Study|Withdrawal by Subject|0|||
94577830|NCT03866577|323917297|FG008|Overall Study|Withdrawal by Subject|1|||
94577831|NCT03866577|323917298|FG009|Overall Study|Withdrawal by Subject|1|||
94577832|NCT03866577|323917299|FG010|Overall Study|Withdrawal by Subject|0|||
94577833|NCT03866577|323917300|FG011|Overall Study|Withdrawal by Subject|0|||
94577834|NCT03866577|323917301|FG012|Overall Study|Withdrawal by Subject|0|||
94577835|NCT03866577|323917289|FG000|Overall Study|Not qualified for IVIg infusion|0|||
94577836|NCT03866577|323917290|FG001|Overall Study|Not qualified for IVIg infusion|0|||
94577837|NCT03866577|323917291|FG002|Overall Study|Not qualified for IVIg infusion|0|||
94577838|NCT03866577|323917292|FG003|Overall Study|Not qualified for IVIg infusion|0|||
94577839|NCT03866577|323917293|FG004|Overall Study|Not qualified for IVIg infusion|0|||
94577840|NCT03866577|323917294|FG005|Overall Study|Not qualified for IVIg infusion|0|||
94577841|NCT03866577|323917295|FG006|Overall Study|Not qualified for IVIg infusion|0|||
94454026|NCT02147158|323450259|FG001|Treatment Course 1|Adverse Event|4|||
94454027|NCT02147158|323450260|FG002|Treatment Course 1|Adverse Event|3|||
94577842|NCT03866577|323917296|FG007|Overall Study|Not qualified for IVIg infusion|0|||
94577843|NCT03866577|323917297|FG008|Overall Study|Not qualified for IVIg infusion|0|||
94577844|NCT03866577|323917298|FG009|Overall Study|Not qualified for IVIg infusion|1|||
94577845|NCT03866577|323917299|FG010|Overall Study|Not qualified for IVIg infusion|0|||
94577846|NCT03866577|323917300|FG011|Overall Study|Not qualified for IVIg infusion|0|||
94577847|NCT03866577|323917301|FG012|Overall Study|Not qualified for IVIg infusion|0|||
94577848|NCT05530252|323917302|FG000|Overall Study|Lost to Follow-up|1|||
94577849|NCT05530252|323917303|FG001|Overall Study|Lost to Follow-up|1|||
94454028|NCT02147158|323450261|FG003|Treatment Course 1|Adverse Event|4|||
94577850|NCT05530252|323917304|FG002|Overall Study|Lost to Follow-up|1|||
94577851|NCT03818256|323917305|FG000|Overall Study|Withdrawal by Subject|2|||
94577852|NCT03818256|323917306|FG001|Overall Study|Withdrawal by Subject|2|||
94577853|NCT03818256|323917305|FG000|Overall Study|Adverse Event|3|||
94577854|NCT03818256|323917306|FG001|Overall Study|Adverse Event|1|||
94577855|NCT03818256|323917305|FG000|Overall Study|Lost to Follow-up|0|||
94577856|NCT03818256|323917306|FG001|Overall Study|Lost to Follow-up|5|||
94577857|NCT03818256|323917305|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
94577858|NCT03818256|323917306|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
94577859|NCT03818256|323917305|FG000|Overall Study|Not reporting for scheduled visits|1|||
94577860|NCT03818256|323917306|FG001|Overall Study|Not reporting for scheduled visits|0|||
94577861|NCT03818256|323917305|FG000|Overall Study|Non-compliant with investigational product|1|||
94577862|NCT03818256|323917306|FG001|Overall Study|Non-compliant with investigational product|0|||
94577863|NCT05615922|323917312|FG000|Overall Study|Lost to Follow-up|1|||
94577864|NCT04482647|323917317|FG000|Overall Study|Time constraints|2|||
94577865|NCT04482647|323917317|FG000|Overall Study|Health issues|1|||
94577866|NCT04482647|323917317|FG000|Overall Study|Death in the family|1|||
94577867|NCT04482647|323917317|FG000|Overall Study|Disliked the intervention|1|||
94577868|NCT04482647|323917317|FG000|Overall Study|No reasons specified|7|||
94577869|NCT02514083|323917324|FG000|Overall Study|Adverse Event|1|||
94577870|NCT01615939|323918472|FG000|Overall Study|Lost to Follow-up|5|||
94577871|NCT01615939|323918473|FG001|Overall Study|Lost to Follow-up|0|||
94577872|NCT01295814|323918474|FG000|Overall Study|Lack of Efficacy|0|||
94577873|NCT01295814|323918475|FG001|Overall Study|Lack of Efficacy|2|||
94577874|NCT01295814|323918474|FG000|Overall Study|Withdrawal by Subject|2|||
94577875|NCT01295814|323918475|FG001|Overall Study|Withdrawal by Subject|0|||
94577876|NCT00303069|323918476|FG000|Overall Study|Lost to Follow-up|1|||
94577877|NCT00303069|323918477|FG001|Overall Study|Lost to Follow-up|0|||
94577878|NCT00303069|323918478|FG002|Overall Study|Lost to Follow-up|0|||
94577879|NCT00303069|323918479|FG003|Overall Study|Lost to Follow-up|2|||
94577880|NCT00303069|323918476|FG000|Overall Study|subject moved|1|||
94577881|NCT00303069|323918477|FG001|Overall Study|subject moved|0|||
94577882|NCT00303069|323918478|FG002|Overall Study|subject moved|0|||
94577883|NCT00303069|323918479|FG003|Overall Study|subject moved|0|||
94577884|NCT00303069|323918476|FG000|Overall Study|Recruitment into Army Reserves|0|||
94577885|NCT00303069|323918477|FG001|Overall Study|Recruitment into Army Reserves|0|||
94577886|NCT00303069|323918478|FG002|Overall Study|Recruitment into Army Reserves|1|||
94577887|NCT00303069|323918479|FG003|Overall Study|Recruitment into Army Reserves|0|||
94577888|NCT01084655|323918483|FG000|Overall Study|Radiographic disease progression|3|||
94577889|NCT01084655|323918484|FG001|Overall Study|Radiographic disease progression|2|||
94577890|NCT01084655|323918485|FG002|Overall Study|Radiographic disease progression|8|||
94577891|NCT01084655|323918483|FG000|Overall Study|Withdrawal by Subject|1|||
94577892|NCT01084655|323918484|FG001|Overall Study|Withdrawal by Subject|0|||
94577893|NCT01084655|323918485|FG002|Overall Study|Withdrawal by Subject|4|||
94577894|NCT01084655|323918483|FG000|Overall Study|Adverse Event|2|||
94577895|NCT01084655|323918484|FG001|Overall Study|Adverse Event|1|||
94577896|NCT01084655|323918485|FG002|Overall Study|Adverse Event|2|||
94577897|NCT01084655|323918483|FG000|Overall Study|Other|0|||
94577898|NCT01084655|323918484|FG001|Overall Study|Other|3|||
94577899|NCT01084655|323918485|FG002|Overall Study|Other|2|||
94577900|NCT01084655|323918483|FG000|Overall Study|Symptomatic deterioration|0|||
94577901|NCT01084655|323918484|FG001|Overall Study|Symptomatic deterioration|0|||
94577902|NCT01084655|323918485|FG002|Overall Study|Symptomatic deterioration|2|||
94577903|NCT01084655|323918483|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
94577904|NCT01084655|323918484|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
94577905|NCT01084655|323918485|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
94577906|NCT03312634|323918488|FG000|Overall Study|Adverse Event|11|||
94351526|NCT01412333|323067410|FG001|Overall Study|Withdrawal by Subject|54|||
94577907|NCT03312634|323918489|FG001|Overall Study|Adverse Event|0|||
94577908|NCT03312634|323918488|FG000|Overall Study|Sponsor request|2|||
94577909|NCT03312634|323918489|FG001|Overall Study|Sponsor request|0|||
94577910|NCT03312634|323918488|FG000|Overall Study|Withdrawal by Subject|31|||
94577911|NCT03312634|323918489|FG001|Overall Study|Withdrawal by Subject|9|||
94577912|NCT03312634|323918488|FG000|Overall Study|Enrolled in an interventional study|0|||
94240161|NCT03552523|322674546|FG001|Overall Study|Withdrawal by Subject|1|||
94240162|NCT00604708|322674547|FG000|Overall Study|Withdrawal by Subject|9|||
94240163|NCT00604708|322674548|FG001|Overall Study|Withdrawal by Subject|10|||
94240164|NCT00604708|322674547|FG000|Overall Study|Protocol Violation|2|||
94240165|NCT00604708|322674548|FG001|Overall Study|Protocol Violation|8|||
94240166|NCT00604708|322674547|FG000|Overall Study|Lost to Follow-up|5|||
94240167|NCT00604708|322674548|FG001|Overall Study|Lost to Follow-up|5|||
94240168|NCT00604708|322674547|FG000|Overall Study|administrative reasons|9|||
94240169|NCT00604708|322674548|FG001|Overall Study|administrative reasons|11|||
94240170|NCT00604708|322674547|FG000|Overall Study|Adverse Event|6|||
94240171|NCT00604708|322674548|FG001|Overall Study|Adverse Event|6|||
94240172|NCT00780559|322674551|FG000|Overall Study|Lost to Follow-up|2|||
94240173|NCT00780559|322674552|FG001|Overall Study|Lost to Follow-up|7|||
94240174|NCT00780559|322674551|FG000|Overall Study|Death|1|||
94240175|NCT00780559|322674552|FG001|Overall Study|Death|0|||
94240176|NCT01896726|322674553|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
94240177|NCT01896726|322674553|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
94240178|NCT01754753|322674554|FG000|Overall Study|Study close|43|||
94240179|NCT01754753|322674555|FG001|Overall Study|Study close|44|||
94240180|NCT01754753|322674554|FG000|Overall Study|Lost to Follow-up|9|||
94240181|NCT01754753|322674555|FG001|Overall Study|Lost to Follow-up|5|||
94240182|NCT01111240|322674557|FG000|Overall Study|Adverse Event|190|||
94240183|NCT01111240|322674557|FG000|Overall Study|Lack of Efficacy|545|||
94577913|NCT03312634|323918489|FG001|Overall Study|Enrolled in an interventional study|52|||
94577914|NCT03312634|323918488|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
94577915|NCT03312634|323918489|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
94577916|NCT03312634|323918488|FG000|Overall Study|Death|0|||
94577917|NCT03312634|323918489|FG001|Overall Study|Death|1|||
94577918|NCT03312634|323918488|FG000|Overall Study|Non-compliance|0|||
94577919|NCT03312634|323918489|FG001|Overall Study|Non-compliance|2|||
94577920|NCT03312634|323918488|FG000|Overall Study|Lost to Follow-up|0|||
94577921|NCT03312634|323918489|FG001|Overall Study|Lost to Follow-up|1|||
94577922|NCT03312634|323918488|FG000|Overall Study|Enrolled into non-interventional study|0|||
94577923|NCT03312634|323918489|FG001|Overall Study|Enrolled into non-interventional study|5|||
94577924|NCT03312634|323918488|FG000|Overall Study|Worsening clinical condition|0|||
94577925|NCT03312634|323918489|FG001|Overall Study|Worsening clinical condition|1|||
94577926|NCT03312634|323918488|FG000|Overall Study|Participant did not want to travel|0|||
94577927|NCT03312634|323918489|FG001|Overall Study|Participant did not want to travel|1|||
94577928|NCT03312634|323918488|FG000|Overall Study|Physician Decision|1|||
94577929|NCT03312634|323918489|FG001|Overall Study|Physician Decision|0|||
94577930|NCT03312634|323918488|FG000|Overall Study|Other|13|||
94577931|NCT03312634|323918489|FG001|Overall Study|Other|0|||
94577932|NCT01112917|323918490|FG000|Overall Study|Death|2|||
94577933|NCT01112917|323918491|FG001|Overall Study|Death|11|||
94577934|NCT01112917|323918490|FG000|Overall Study|Lost to Follow-up|1|||
94240184|NCT01111240|322674557|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
94351527|NCT01412333|323067409|FG000|Overall Study|Missing|1|||
94577935|NCT01112917|323918491|FG001|Overall Study|Lost to Follow-up|1|||
94577936|NCT01112917|323918490|FG000|Overall Study|Withdrawal by Subject|1|||
94577937|NCT01112917|323918491|FG001|Overall Study|Withdrawal by Subject|3|||
94240185|NCT01111240|322674557|FG000|Overall Study|Other|312|||
94577938|NCT01112917|323918490|FG000|Overall Study|Unable to Convert Filter|3|||
94577939|NCT01112917|323918491|FG001|Overall Study|Unable to Convert Filter|0|||
94577940|NCT03131219|323918492|FG000|Initial Evaluation Period|Adverse Event|2|||
94240186|NCT00208325|322674558|FG000|Overall Study|Death|18|||
94240187|NCT00208325|322674559|FG001|Overall Study|Death|19|||
94240188|NCT00208325|322674560|FG002|Overall Study|Death|7|||
94240189|NCT00208325|322674561|FG003|Overall Study|Death|5|||
94240190|NCT00208325|322674558|FG000|Overall Study|Withdrawal by Subject|0|||
94577941|NCT03131219|323918493|FG001|Initial Evaluation Period|Adverse Event|0|||
94577942|NCT03131219|323918492|FG000|Initial Evaluation Period|Protocol Violation|1|||
94577943|NCT03131219|323918493|FG001|Initial Evaluation Period|Protocol Violation|0|||
94577944|NCT03131219|323918492|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
94577945|NCT03131219|323918493|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
94577946|NCT03131219|323918492|FG000|Initial Evaluation Period|Physician Decision|1|||
94577947|NCT03131219|323918493|FG001|Initial Evaluation Period|Physician Decision|0|||
94577948|NCT03131219|323918492|FG000|Extension Period|Physician Decision|1|||
94577949|NCT03131219|323918493|FG001|Extension Period|Physician Decision|0|||
94577950|NCT00616759|323918494|FG000|Overall Study|Physician Decision|2|||
94577951|NCT00616759|323918495|FG001|Overall Study|Physician Decision|0|||
94577952|NCT00616759|323918494|FG000|Overall Study|Withdrawal by Subject|1|||
94577953|NCT00616759|323918495|FG001|Overall Study|Withdrawal by Subject|2|||
94577954|NCT02923726|323918501|FG000|Overall Study|Death|196|||
94577955|NCT02923726|323918502|FG001|Overall Study|Death|175|||
94577956|NCT02923726|323918501|FG000|Overall Study|Withdrawal by Subject|337|||
94577957|NCT02923726|323918502|FG001|Overall Study|Withdrawal by Subject|307|||
94577958|NCT02992288|323918506|FG000|Overall Study|Adverse Event|8|||
94577959|NCT02992288|323918507|FG001|Overall Study|Adverse Event|2|||
94577960|NCT02992288|323918508|FG002|Overall Study|Adverse Event|2|||
94577961|NCT02992288|323918509|FG003|Overall Study|Adverse Event|2|||
94577962|NCT02992288|323918510|FG004|Overall Study|Adverse Event|2|||
94577963|NCT02992288|323918511|FG005|Overall Study|Adverse Event|7|||
94577964|NCT02992288|323918506|FG000|Overall Study|Non-compliance with study drug|0|||
94577965|NCT02992288|323918507|FG001|Overall Study|Non-compliance with study drug|1|||
94240191|NCT00208325|322674559|FG001|Overall Study|Withdrawal by Subject|1|||
94240192|NCT00208325|322674560|FG002|Overall Study|Withdrawal by Subject|0|||
94577966|NCT02992288|323918508|FG002|Overall Study|Non-compliance with study drug|1|||
94240193|NCT00208325|322674561|FG003|Overall Study|Withdrawal by Subject|0|||
94577967|NCT02992288|323918509|FG003|Overall Study|Non-compliance with study drug|0|||
94577968|NCT02992288|323918510|FG004|Overall Study|Non-compliance with study drug|1|||
94577969|NCT02992288|323918511|FG005|Overall Study|Non-compliance with study drug|0|||
94577970|NCT02992288|323918506|FG000|Overall Study|Physician Decision|3|||
94577971|NCT02992288|323918507|FG001|Overall Study|Physician Decision|0|||
94577972|NCT02992288|323918508|FG002|Overall Study|Physician Decision|1|||
94577973|NCT02992288|323918509|FG003|Overall Study|Physician Decision|0|||
94577974|NCT02992288|323918510|FG004|Overall Study|Physician Decision|0|||
94240194|NCT00208325|322674558|FG000|Overall Study|Revision|4|||
94240195|NCT00208325|322674559|FG001|Overall Study|Revision|1|||
94240196|NCT00208325|322674560|FG002|Overall Study|Revision|0|||
94240197|NCT00208325|322674561|FG003|Overall Study|Revision|4|||
94454029|NCT02147158|323450262|FG004|Treatment Course 1|Adverse Event|1|||
94454030|NCT02147158|323450263|FG005|Treatment Course 1|Adverse Event|2|||
94454031|NCT02147158|323450258|FG000|Treatment Course 1|Lost to Follow-up|2|||
94454032|NCT02147158|323450259|FG001|Treatment Course 1|Lost to Follow-up|4|||
94454033|NCT02147158|323450260|FG002|Treatment Course 1|Lost to Follow-up|3|||
94454034|NCT02147158|323450261|FG003|Treatment Course 1|Lost to Follow-up|3|||
94454035|NCT02147158|323450262|FG004|Treatment Course 1|Lost to Follow-up|2|||
94454036|NCT02147158|323450263|FG005|Treatment Course 1|Lost to Follow-up|4|||
94454037|NCT02147158|323450258|FG000|Treatment Course 1|Protocol Violation|0|||
94454038|NCT02147158|323450259|FG001|Treatment Course 1|Protocol Violation|0|||
94454039|NCT02147158|323450260|FG002|Treatment Course 1|Protocol Violation|1|||
94454040|NCT02147158|323450261|FG003|Treatment Course 1|Protocol Violation|1|||
94454041|NCT02147158|323450262|FG004|Treatment Course 1|Protocol Violation|0|||
94454042|NCT02147158|323450263|FG005|Treatment Course 1|Protocol Violation|0|||
94454043|NCT02147158|323450258|FG000|Treatment Course 1|Withdrawal of Consent|1|||
94454044|NCT02147158|323450259|FG001|Treatment Course 1|Withdrawal of Consent|1|||
94454045|NCT02147158|323450260|FG002|Treatment Course 1|Withdrawal of Consent|1|||
94454046|NCT02147158|323450261|FG003|Treatment Course 1|Withdrawal of Consent|5|||
94577975|NCT02992288|323918511|FG005|Overall Study|Physician Decision|1|||
94577976|NCT02992288|323918506|FG000|Overall Study|Death|2|||
94577977|NCT02992288|323918507|FG001|Overall Study|Death|0|||
94577978|NCT02992288|323918508|FG002|Overall Study|Death|2|||
94577979|NCT02992288|323918509|FG003|Overall Study|Death|1|||
94577980|NCT02992288|323918510|FG004|Overall Study|Death|2|||
94577981|NCT02992288|323918511|FG005|Overall Study|Death|0|||
94577982|NCT02992288|323918506|FG000|Overall Study|Lost to Follow-up|0|||
94454047|NCT02147158|323450262|FG004|Treatment Course 1|Withdrawal of Consent|3|||
94454048|NCT02147158|323450263|FG005|Treatment Course 1|Withdrawal of Consent|2|||
94454049|NCT02147158|323450258|FG000|Off-Treatment Interval 1|Adverse Event|1|||
94577983|NCT02992288|323918507|FG001|Overall Study|Lost to Follow-up|0|||
94577984|NCT02992288|323918508|FG002|Overall Study|Lost to Follow-up|0|||
94577985|NCT02992288|323918509|FG003|Overall Study|Lost to Follow-up|1|||
94577986|NCT02992288|323918510|FG004|Overall Study|Lost to Follow-up|0|||
94240198|NCT00208325|322674558|FG000|Overall Study|Lost to Follow-up|1|||
94240199|NCT00208325|322674559|FG001|Overall Study|Lost to Follow-up|0|||
94577987|NCT02992288|323918511|FG005|Overall Study|Lost to Follow-up|0|||
94577988|NCT02992288|323918506|FG000|Overall Study|Protocol Violation|0|||
94577989|NCT02992288|323918507|FG001|Overall Study|Protocol Violation|0|||
94577990|NCT02992288|323918508|FG002|Overall Study|Protocol Violation|0|||
94577991|NCT02992288|323918509|FG003|Overall Study|Protocol Violation|0|||
94577992|NCT02992288|323918510|FG004|Overall Study|Protocol Violation|0|||
94577993|NCT02992288|323918511|FG005|Overall Study|Protocol Violation|1|||
94577994|NCT02992288|323918506|FG000|Overall Study|Withdrawal by Subject|4|||
94577995|NCT02992288|323918507|FG001|Overall Study|Withdrawal by Subject|2|||
94577996|NCT02992288|323918508|FG002|Overall Study|Withdrawal by Subject|1|||
94577997|NCT02992288|323918509|FG003|Overall Study|Withdrawal by Subject|5|||
94577998|NCT02992288|323918510|FG004|Overall Study|Withdrawal by Subject|3|||
94577999|NCT02992288|323918511|FG005|Overall Study|Withdrawal by Subject|4|||
94578000|NCT00581308|323918512|FG000|Pre Discharge|Lost to Follow-up|1|||
94578001|NCT00581308|323918512|FG000|Pre Discharge|Device Removed|1|||
94578002|NCT00581308|323918512|FG000|Month 1|Lost to Follow-up|3|||
94578003|NCT00581308|323918512|FG000|Month 1|Withdrawal by Subject|2|||
94578004|NCT00581308|323918512|FG000|Month 1|Device Removed|2|||
94578005|NCT00581308|323918512|FG000|Month 1|Uknown|1|||
94578006|NCT00581308|323918512|FG000|Month 6|Lost to Follow-up|1|||
94578007|NCT00581308|323918512|FG000|Month 6|Withdrawal by Subject|2|||
94578008|NCT00581308|323918512|FG000|Month 12|Death|1|||
94578009|NCT00581308|323918512|FG000|Month 12|Lost to Follow-up|14|||
94578010|NCT00581308|323918512|FG000|Month 12|Withdrawal by Subject|3|||
94578011|NCT00581308|323918512|FG000|Month 12|Device Removed|1|||
94578012|NCT00581308|323918512|FG000|Month 12|Other|1|||
94578013|NCT00886379|323918513|FG000|Overall Study|Transferred Schools|0|||
94578014|NCT00886379|323918514|FG001|Overall Study|Transferred Schools|0|||
94578015|NCT00886379|323918515|FG002|Overall Study|Transferred Schools|2|||
94578016|NCT00886379|323918516|FG003|Overall Study|Transferred Schools|1|||
94578017|NCT00886379|323918517|FG004|Overall Study|Transferred Schools|1|||
94578018|NCT00886379|323918513|FG000|Overall Study|Final blood draw not obtained|3|||
94578019|NCT00886379|323918514|FG001|Overall Study|Final blood draw not obtained|3|||
94578020|NCT00886379|323918515|FG002|Overall Study|Final blood draw not obtained|4|||
94578021|NCT00886379|323918516|FG003|Overall Study|Final blood draw not obtained|2|||
94578022|NCT00886379|323918517|FG004|Overall Study|Final blood draw not obtained|2|||
94578023|NCT03137381|323918518|FG000|Overall Study|Adverse Event|3|||
94578024|NCT03137381|323918519|FG001|Overall Study|Adverse Event|0|||
94578025|NCT03137381|323918520|FG002|Overall Study|Adverse Event|2|||
94578026|NCT03137381|323918521|FG003|Overall Study|Adverse Event|0|||
94578027|NCT03137381|323918518|FG000|Overall Study|Lost to Follow-up|2|||
94578028|NCT03137381|323918519|FG001|Overall Study|Lost to Follow-up|1|||
94578029|NCT03137381|323918520|FG002|Overall Study|Lost to Follow-up|1|||
94578030|NCT03137381|323918521|FG003|Overall Study|Lost to Follow-up|0|||
94578031|NCT03137381|323918518|FG000|Overall Study|Protocol deviation|1|||
94578032|NCT03137381|323918519|FG001|Overall Study|Protocol deviation|1|||
94578033|NCT03137381|323918520|FG002|Overall Study|Protocol deviation|0|||
94578034|NCT03137381|323918521|FG003|Overall Study|Protocol deviation|1|||
94578035|NCT03137381|323918518|FG000|Overall Study|Withdrawal by Investigator|0|||
94578036|NCT03137381|323918519|FG001|Overall Study|Withdrawal by Investigator|1|||
94578037|NCT03137381|323918520|FG002|Overall Study|Withdrawal by Investigator|1|||
94578038|NCT03137381|323918521|FG003|Overall Study|Withdrawal by Investigator|0|||
94578039|NCT03137381|323918518|FG000|Overall Study|Withdrawal by Subject|3|||
94578040|NCT03137381|323918519|FG001|Overall Study|Withdrawal by Subject|4|||
94578041|NCT03137381|323918520|FG002|Overall Study|Withdrawal by Subject|3|||
94578042|NCT03137381|323918521|FG003|Overall Study|Withdrawal by Subject|0|||
94578043|NCT03137381|323918518|FG000|Overall Study|Pregnancy|0|||
94578044|NCT03137381|323918519|FG001|Overall Study|Pregnancy|0|||
94578045|NCT03137381|323918520|FG002|Overall Study|Pregnancy|1|||
94578046|NCT03137381|323918521|FG003|Overall Study|Pregnancy|0|||
94658884|NCT02056301|324206225|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
94658885|NCT02056301|324206226|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
94658886|NCT02056301|324206225|FG000|Overall Study|Withdrawal by Subject|0|||
94658887|NCT02056301|324206226|FG001|Overall Study|Withdrawal by Subject|1|||
94658888|NCT02056301|324206225|FG000|Overall Study|Issues with epidural|0|||
94578047|NCT00459316|323918522|FG000|Steps 1 & 2|Other eligibility failure|1|||
94578048|NCT00459316|323918523|FG001|Steps 1 & 2|Other eligibility failure|1|||
94578049|NCT00459316|323918524|FG002|Steps 1 & 2|Other eligibility failure|0|||
94578050|NCT00459316|323918522|FG000|Steps 1 & 2|Death|1|||
94578051|NCT00459316|323918523|FG001|Steps 1 & 2|Death|1|||
94578052|NCT00459316|323918524|FG002|Steps 1 & 2|Death|0|||
94578053|NCT00459316|323918522|FG000|Steps 1 & 2|Not able to get to clinic|7|||
94578054|NCT00459316|323918523|FG001|Steps 1 & 2|Not able to get to clinic|4|||
94658889|NCT02056301|324206226|FG001|Overall Study|Issues with epidural|3|||
94578055|NCT00459316|323918524|FG002|Steps 1 & 2|Not able to get to clinic|0|||
94578056|NCT00459316|323918522|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
94578057|NCT00459316|323918523|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
94578058|NCT00459316|323918524|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
94578059|NCT00459316|323918522|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
94578060|NCT00459316|323918523|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
94578061|NCT00459316|323918524|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
94578062|NCT00459316|323918522|FG000|Steps 1 & 2|Lost to Follow-up|5|||
94578063|NCT00459316|323918523|FG001|Steps 1 & 2|Lost to Follow-up|0|||
94578064|NCT00459316|323918524|FG002|Steps 1 & 2|Lost to Follow-up|2|||
94578065|NCT00459316|323918522|FG000|Step 3|Withdrawal by Subject|3|||
94578066|NCT00459316|323918523|FG001|Step 3|Withdrawal by Subject|0|||
94578067|NCT00459316|323918524|FG002|Step 3|Withdrawal by Subject|1|||
94578068|NCT01748292|323918527|FG000|Overall Study|Adverse Event|2|||
94578069|NCT01748292|323918528|FG001|Overall Study|Adverse Event|4|||
94578070|NCT01748292|323918527|FG000|Overall Study|Lost to Follow-up|0|||
94578071|NCT01748292|323918528|FG001|Overall Study|Lost to Follow-up|3|||
94578072|NCT01748292|323918527|FG000|Overall Study|Death|0|||
94578073|NCT01748292|323918528|FG001|Overall Study|Death|3|||
94578074|NCT01748292|323918527|FG000|Overall Study|Withdrawal by Subject|0|||
94578075|NCT01748292|323918528|FG001|Overall Study|Withdrawal by Subject|2|||
94578076|NCT04097678|323918530|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
94578077|NCT04097678|323918531|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
94578078|NCT03592186|323918532|FG000|Overall Study|Withdrawal by Subject|1|||
94578079|NCT03592186|323918533|FG001|Overall Study|Withdrawal by Subject|0|||
94578080|NCT03592186|323918532|FG000|Overall Study|Lost to Follow-up|16|||
94578081|NCT03592186|323918533|FG001|Overall Study|Lost to Follow-up|11|||
94578082|NCT01052493|323918534|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
94578083|NCT01052493|323918535|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
94578084|NCT01052493|323918536|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
94578085|NCT00474812|323918539|FG000|Overall Study|Withdrawal by Subject|5|||
94578086|NCT00474812|323918539|FG000|Overall Study|No Initiation of treatment|2|||
94578087|NCT00888173|323918540|FG000|Overall Study|Wrong Primary|1|||
94578088|NCT00888173|323918540|FG000|Overall Study|Ineligible: required test not done|1|||
94578089|NCT00935584|323918541|FG000|Overall Study|Withdrawal by Subject|9|||
94578090|NCT00935584|323918542|FG001|Overall Study|Withdrawal by Subject|0|||
94578091|NCT00935584|323918541|FG000|Overall Study|Death|3|||
94578092|NCT00935584|323918542|FG001|Overall Study|Death|0|||
94578093|NCT00935584|323918541|FG000|Overall Study|Lost to Follow-up|8|||
94578094|NCT00935584|323918542|FG001|Overall Study|Lost to Follow-up|0|||
94578095|NCT00935584|323918541|FG000|Overall Study|No show|9|||
94578096|NCT00935584|323918542|FG001|Overall Study|No show|0|||
94578097|NCT00935584|323918541|FG000|Overall Study|Relocated|3|||
94578098|NCT00935584|323918542|FG001|Overall Study|Relocated|0|||
94578099|NCT00935584|323918541|FG000|Overall Study|Patient changed provider|3|||
94578100|NCT00935584|323918542|FG001|Overall Study|Patient changed provider|0|||
94578101|NCT00935584|323918541|FG000|Overall Study|Provider dropped out of study|14|||
94240200|NCT00208325|322674560|FG002|Overall Study|Lost to Follow-up|2|||
94454050|NCT02147158|323450259|FG001|Off-Treatment Interval 1|Adverse Event|0|||
94578102|NCT00935584|323918542|FG001|Overall Study|Provider dropped out of study|4|||
94240201|NCT00208325|322674561|FG003|Overall Study|Lost to Follow-up|0|||
94240202|NCT00208325|322674558|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
94578103|NCT01394016|323918543|FG000|Overall Study|Progressive Disease|2|||
94578104|NCT01394016|323918544|FG001|Overall Study|Progressive Disease|0|||
94578105|NCT01394016|323918545|FG002|Overall Study|Progressive Disease|0|||
94578106|NCT01394016|323918546|FG003|Overall Study|Progressive Disease|0|||
94578107|NCT01394016|323918547|FG004|Overall Study|Progressive Disease|0|||
94578108|NCT01394016|323918548|FG005|Overall Study|Progressive Disease|0|||
94578109|NCT01394016|323918549|FG006|Overall Study|Progressive Disease|0|||
94578110|NCT01394016|323918550|FG007|Overall Study|Progressive Disease|0|||
94578111|NCT01394016|323918551|FG008|Overall Study|Progressive Disease|0|||
94578112|NCT01394016|323918552|FG009|Overall Study|Progressive Disease|0|||
94578113|NCT01394016|323918553|FG010|Overall Study|Progressive Disease|0|||
94578114|NCT01394016|323918554|FG011|Overall Study|Progressive Disease|0|||
94578115|NCT01394016|323918555|FG012|Overall Study|Progressive Disease|0|||
94578116|NCT01394016|323918556|FG013|Overall Study|Progressive Disease|0|||
94578117|NCT01394016|323918557|FG014|Overall Study|Progressive Disease|0|||
94578118|NCT01394016|323918558|FG015|Overall Study|Progressive Disease|0|||
94578119|NCT01394016|323918559|FG016|Overall Study|Progressive Disease|0|||
94578120|NCT01394016|323918560|FG017|Overall Study|Progressive Disease|0|||
94578121|NCT01394016|323918561|FG018|Overall Study|Progressive Disease|0|||
94578122|NCT01394016|323918543|FG000|Overall Study|Withdrawal by Subject|0|||
94578123|NCT01394016|323918544|FG001|Overall Study|Withdrawal by Subject|0|||
94578124|NCT01394016|323918545|FG002|Overall Study|Withdrawal by Subject|0|||
94578125|NCT01394016|323918546|FG003|Overall Study|Withdrawal by Subject|0|||
94578126|NCT01394016|323918547|FG004|Overall Study|Withdrawal by Subject|0|||
94578127|NCT01394016|323918548|FG005|Overall Study|Withdrawal by Subject|0|||
94578128|NCT01394016|323918549|FG006|Overall Study|Withdrawal by Subject|0|||
94578129|NCT01394016|323918550|FG007|Overall Study|Withdrawal by Subject|1|||
94578130|NCT01394016|323918551|FG008|Overall Study|Withdrawal by Subject|1|||
94578131|NCT01394016|323918552|FG009|Overall Study|Withdrawal by Subject|1|||
94578132|NCT01394016|323918553|FG010|Overall Study|Withdrawal by Subject|4|||
94578133|NCT01394016|323918554|FG011|Overall Study|Withdrawal by Subject|0|||
94578134|NCT01394016|323918555|FG012|Overall Study|Withdrawal by Subject|0|||
94578135|NCT01394016|323918556|FG013|Overall Study|Withdrawal by Subject|3|||
94578136|NCT01394016|323918557|FG014|Overall Study|Withdrawal by Subject|1|||
94578137|NCT01394016|323918558|FG015|Overall Study|Withdrawal by Subject|3|||
94578138|NCT01394016|323918559|FG016|Overall Study|Withdrawal by Subject|1|||
94578139|NCT01394016|323918560|FG017|Overall Study|Withdrawal by Subject|1|||
94578140|NCT01394016|323918561|FG018|Overall Study|Withdrawal by Subject|2|||
94578141|NCT01394016|323918543|FG000|Overall Study|Adverse Event|0|||
94578142|NCT01394016|323918544|FG001|Overall Study|Adverse Event|0|||
94578143|NCT01394016|323918545|FG002|Overall Study|Adverse Event|0|||
94578144|NCT01394016|323918546|FG003|Overall Study|Adverse Event|0|||
94578145|NCT01394016|323918547|FG004|Overall Study|Adverse Event|0|||
94578146|NCT01394016|323918548|FG005|Overall Study|Adverse Event|0|||
94578147|NCT01394016|323918549|FG006|Overall Study|Adverse Event|0|||
94578148|NCT01394016|323918550|FG007|Overall Study|Adverse Event|0|||
94578149|NCT01394016|323918551|FG008|Overall Study|Adverse Event|0|||
94578150|NCT01394016|323918552|FG009|Overall Study|Adverse Event|1|||
94578151|NCT01394016|323918553|FG010|Overall Study|Adverse Event|0|||
94578152|NCT01394016|323918554|FG011|Overall Study|Adverse Event|0|||
94578153|NCT01394016|323918555|FG012|Overall Study|Adverse Event|0|||
94578154|NCT01394016|323918556|FG013|Overall Study|Adverse Event|0|||
94578155|NCT01394016|323918557|FG014|Overall Study|Adverse Event|0|||
94578156|NCT01394016|323918558|FG015|Overall Study|Adverse Event|0|||
94578157|NCT01394016|323918559|FG016|Overall Study|Adverse Event|1|||
94578158|NCT01394016|323918560|FG017|Overall Study|Adverse Event|1|||
94578159|NCT01394016|323918561|FG018|Overall Study|Adverse Event|0|||
94578160|NCT01394016|323918543|FG000|Overall Study|Sponsor Decision|0|||
94578161|NCT01394016|323918544|FG001|Overall Study|Sponsor Decision|0|||
94578162|NCT01394016|323918545|FG002|Overall Study|Sponsor Decision|0|||
94578163|NCT01394016|323918546|FG003|Overall Study|Sponsor Decision|0|||
94578164|NCT01394016|323918547|FG004|Overall Study|Sponsor Decision|0|||
94578165|NCT01394016|323918548|FG005|Overall Study|Sponsor Decision|0|||
94578166|NCT01394016|323918549|FG006|Overall Study|Sponsor Decision|0|||
94578167|NCT01394016|323918550|FG007|Overall Study|Sponsor Decision|0|||
94578168|NCT01394016|323918551|FG008|Overall Study|Sponsor Decision|0|||
94578169|NCT01394016|323918552|FG009|Overall Study|Sponsor Decision|0|||
94578170|NCT01394016|323918553|FG010|Overall Study|Sponsor Decision|0|||
94578171|NCT01394016|323918554|FG011|Overall Study|Sponsor Decision|0|||
94578172|NCT01394016|323918555|FG012|Overall Study|Sponsor Decision|1|||
94578173|NCT01394016|323918556|FG013|Overall Study|Sponsor Decision|0|||
94578174|NCT01394016|323918557|FG014|Overall Study|Sponsor Decision|0|||
94578175|NCT01394016|323918558|FG015|Overall Study|Sponsor Decision|0|||
94578176|NCT01394016|323918559|FG016|Overall Study|Sponsor Decision|0|||
94578177|NCT01394016|323918560|FG017|Overall Study|Sponsor Decision|0|||
94578178|NCT01394016|323918561|FG018|Overall Study|Sponsor Decision|0|||
94578179|NCT01394016|323918543|FG000|Overall Study|Lost to Follow-up|0|||
94578180|NCT01394016|323918544|FG001|Overall Study|Lost to Follow-up|0|||
94578181|NCT01394016|323918545|FG002|Overall Study|Lost to Follow-up|0|||
94578182|NCT01394016|323918546|FG003|Overall Study|Lost to Follow-up|0|||
94578183|NCT01394016|323918547|FG004|Overall Study|Lost to Follow-up|0|||
94578184|NCT01394016|323918548|FG005|Overall Study|Lost to Follow-up|0|||
94578185|NCT01394016|323918549|FG006|Overall Study|Lost to Follow-up|0|||
94578186|NCT01394016|323918550|FG007|Overall Study|Lost to Follow-up|0|||
94578187|NCT01394016|323918551|FG008|Overall Study|Lost to Follow-up|0|||
94240203|NCT00208325|322674559|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
94240204|NCT00208325|322674560|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
94240205|NCT00208325|322674561|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
94240206|NCT00208325|322674558|FG000|Overall Study|Does not wish to Continue in Study|5|||
94240207|NCT00208325|322674559|FG001|Overall Study|Does not wish to Continue in Study|8|||
94240208|NCT00208325|322674560|FG002|Overall Study|Does not wish to Continue in Study|3|||
94240209|NCT00208325|322674561|FG003|Overall Study|Does not wish to Continue in Study|2|||
94240210|NCT00208325|322674558|FG000|Overall Study|Other|2|||
94240211|NCT00208325|322674559|FG001|Overall Study|Other|1|||
94240212|NCT00208325|322674560|FG002|Overall Study|Other|1|||
94240213|NCT00208325|322674561|FG003|Overall Study|Other|0|||
94240214|NCT00208325|322674558|FG000|Overall Study|Mis-Randomized|17|||
94240215|NCT00208325|322674559|FG001|Overall Study|Mis-Randomized|20|||
94240216|NCT00208325|322674560|FG002|Overall Study|Mis-Randomized|0|||
94240217|NCT00208325|322674561|FG003|Overall Study|Mis-Randomized|0|||
94240218|NCT01011868|322674569|FG000|After Week 18 Follow-up|Adverse Event|8|||
94240219|NCT01011868|322674570|FG001|After Week 18 Follow-up|Adverse Event|6|||
94240220|NCT01011868|322674571|FG002|After Week 18 Follow-up|Adverse Event|13|||
94240221|NCT01011868|322674569|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
94454051|NCT02147158|323450260|FG002|Off-Treatment Interval 1|Adverse Event|0|||
94454052|NCT02147158|323450261|FG003|Off-Treatment Interval 1|Adverse Event|1|||
94454053|NCT02147158|323450262|FG004|Off-Treatment Interval 1|Adverse Event|0|||
94454054|NCT02147158|323450263|FG005|Off-Treatment Interval 1|Adverse Event|0|||
94454055|NCT02147158|323450258|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
94454056|NCT02147158|323450259|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
94454057|NCT02147158|323450260|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
94454058|NCT02147158|323450261|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
94454059|NCT02147158|323450262|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
94454060|NCT02147158|323450263|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
94454061|NCT02147158|323450258|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
94454062|NCT02147158|323450259|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
94454063|NCT02147158|323450260|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
94454064|NCT02147158|323450261|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
94454065|NCT02147158|323450262|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
94454066|NCT02147158|323450263|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
94454067|NCT02147158|323450258|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
94454068|NCT02147158|323450259|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
94454069|NCT02147158|323450260|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
94454070|NCT02147158|323450261|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
94454071|NCT02147158|323450262|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
94454072|NCT02147158|323450263|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
94454073|NCT02147158|323450258|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
94454074|NCT02147158|323450259|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
94454075|NCT02147158|323450260|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
94454076|NCT02147158|323450261|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
94454077|NCT02147158|323450262|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
94454078|NCT02147158|323450263|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
94454079|NCT02147158|323450258|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
94454080|NCT02147158|323450259|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
94454081|NCT02147158|323450260|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
94454082|NCT02147158|323450261|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
94454083|NCT02147158|323450262|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
94454084|NCT02147158|323450263|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
94454085|NCT02147158|323450258|FG000|Treatment Course 2|Adverse Event|0|||
94454086|NCT02147158|323450259|FG001|Treatment Course 2|Adverse Event|4|||
94454087|NCT02147158|323450260|FG002|Treatment Course 2|Adverse Event|2|||
94454088|NCT02147158|323450261|FG003|Treatment Course 2|Adverse Event|1|||
94454089|NCT02147158|323450262|FG004|Treatment Course 2|Adverse Event|0|||
94454090|NCT02147158|323450263|FG005|Treatment Course 2|Adverse Event|1|||
94454091|NCT02147158|323450258|FG000|Treatment Course 2|Withdrawal of Consent|0|||
94454092|NCT02147158|323450259|FG001|Treatment Course 2|Withdrawal of Consent|1|||
94454093|NCT02147158|323450260|FG002|Treatment Course 2|Withdrawal of Consent|2|||
94454094|NCT02147158|323450261|FG003|Treatment Course 2|Withdrawal of Consent|3|||
94454095|NCT02147158|323450262|FG004|Treatment Course 2|Withdrawal of Consent|0|||
94454096|NCT02147158|323450263|FG005|Treatment Course 2|Withdrawal of Consent|0|||
94454097|NCT02147158|323450258|FG000|Treatment Course 2|Lost to Follow-up|1|||
94454098|NCT02147158|323450259|FG001|Treatment Course 2|Lost to Follow-up|0|||
94454099|NCT02147158|323450260|FG002|Treatment Course 2|Lost to Follow-up|1|||
94240222|NCT01011868|322674570|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
94240223|NCT01011868|322674571|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
94240224|NCT01011868|322674569|FG000|After Week 18 Follow-up|Protocol Violation|1|||
94240225|NCT01011868|322674570|FG001|After Week 18 Follow-up|Protocol Violation|1|||
94240226|NCT01011868|322674571|FG002|After Week 18 Follow-up|Protocol Violation|1|||
94578188|NCT01394016|323918552|FG009|Overall Study|Lost to Follow-up|0|||
94578189|NCT01394016|323918553|FG010|Overall Study|Lost to Follow-up|0|||
94578190|NCT01394016|323918554|FG011|Overall Study|Lost to Follow-up|0|||
94578191|NCT01394016|323918555|FG012|Overall Study|Lost to Follow-up|0|||
94578192|NCT01394016|323918556|FG013|Overall Study|Lost to Follow-up|0|||
94578193|NCT01394016|323918557|FG014|Overall Study|Lost to Follow-up|0|||
94578194|NCT01394016|323918558|FG015|Overall Study|Lost to Follow-up|0|||
94578195|NCT01394016|323918559|FG016|Overall Study|Lost to Follow-up|0|||
94578196|NCT01394016|323918560|FG017|Overall Study|Lost to Follow-up|0|||
94578197|NCT01394016|323918561|FG018|Overall Study|Lost to Follow-up|1|||
94578198|NCT03534804|323918562|FG000|Overall Study|Withdrawal by Subject|1|||
94578199|NCT05135767|323918565|FG000|Baseline|Lost to Follow-up|1|||
94578200|NCT05135767|323918566|FG001|Baseline|Lost to Follow-up|1|||
94578201|NCT05135767|323918565|FG000|Baseline|Withdrawal by Subject|0|||
94578202|NCT05135767|323918566|FG001|Baseline|Withdrawal by Subject|2|||
94578203|NCT05135767|323918565|FG000|Active Study Phase|Lost to Follow-up|2|||
94578204|NCT05135767|323918566|FG001|Active Study Phase|Lost to Follow-up|0|||
94578205|NCT04363320|323918567|FG000|Overall Study|Lost to Follow-up|43|||
94578206|NCT04363320|323918568|FG001|Overall Study|Lost to Follow-up|42|||
94578207|NCT04363320|323918569|FG002|Overall Study|Lost to Follow-up|24|||
94578208|NCT04363320|323918570|FG003|Overall Study|Lost to Follow-up|29|||
94578209|NCT04363320|323918567|FG000|Overall Study|Death|0|||
94578210|NCT04363320|323918568|FG001|Overall Study|Death|0|||
94578211|NCT04363320|323918569|FG002|Overall Study|Death|1|||
94578212|NCT04363320|323918570|FG003|Overall Study|Death|0|||
94578213|NCT02002598|323918574|FG000|Dose Level 1|Withdrawal by Subject|1|||
94578214|NCT02002598|323918575|FG001|Dose Level 1|Withdrawal by Subject|0|||
94578215|NCT02002598|323918576|FG002|Dose Level 1|Withdrawal by Subject|0|||
94578216|NCT02002598|323918577|FG003|Dose Level 1|Withdrawal by Subject|0|||
94578217|NCT02002598|323918578|FG004|Dose Level 1|Withdrawal by Subject|0|||
94578218|NCT00630838|323918581|FG000|Overall Study|Death|0|||
94578219|NCT00630838|323918582|FG001|Overall Study|Death|1|||
94578220|NCT00630838|323918581|FG000|Overall Study|Lost to Follow-up|0|||
94578221|NCT00630838|323918582|FG001|Overall Study|Lost to Follow-up|1|||
94578222|NCT00791934|323918583|FG000|Overall Study|Withdrawal by Subject|2|||
94578223|NCT00791934|323918583|FG000|Overall Study|Did not consent for extended follow-up|13|||
94578224|NCT04081103|323918586|FG000|Overall Study|Adverse Event|1|||
94578225|NCT04081103|323918587|FG001|Overall Study|Adverse Event|1|||
94578226|NCT04081103|323918588|FG002|Overall Study|Adverse Event|1|||
94578227|NCT04081103|323918586|FG000|Overall Study|Physician Decision|0|||
94578228|NCT04081103|323918587|FG001|Overall Study|Physician Decision|0|||
94578229|NCT04081103|323918588|FG002|Overall Study|Physician Decision|1|||
94578230|NCT05565742|323918593|FG000|Overall Study|Withdrawal by Subject|0|||
94578231|NCT05565742|323918594|FG001|Overall Study|Withdrawal by Subject|0|||
94578232|NCT05565742|323918595|FG002|Overall Study|Withdrawal by Subject|2|||
94578233|NCT05565742|323918596|FG003|Overall Study|Withdrawal by Subject|2|||
94578234|NCT05565742|323918597|FG004|Overall Study|Withdrawal by Subject|2|||
94578235|NCT05565742|323918593|FG000|Overall Study|Death|1|||
94578236|NCT05565742|323918594|FG001|Overall Study|Death|0|||
94578237|NCT05565742|323918595|FG002|Overall Study|Death|0|||
94578238|NCT05565742|323918596|FG003|Overall Study|Death|0|||
94578239|NCT05565742|323918597|FG004|Overall Study|Death|0|||
94578240|NCT05565742|323918593|FG000|Overall Study|Participant Travelled Abroad|0|||
94578241|NCT05565742|323918594|FG001|Overall Study|Participant Travelled Abroad|0|||
94578242|NCT05565742|323918595|FG002|Overall Study|Participant Travelled Abroad|0|||
94578243|NCT05565742|323918596|FG003|Overall Study|Participant Travelled Abroad|0|||
94578244|NCT05565742|323918597|FG004|Overall Study|Participant Travelled Abroad|1|||
94578245|NCT02855125|323918598|FG000|Overall Study|Withdrawal by Subject|2|||
94578246|NCT02855125|323918599|FG001|Overall Study|Withdrawal by Subject|2|||
94578247|NCT02855125|323918598|FG000|Overall Study|Clinical Disease Progression|5|||
94578248|NCT02855125|323918599|FG001|Overall Study|Clinical Disease Progression|4|||
94578249|NCT02855125|323918598|FG000|Overall Study|Radiologic Disease Progression|36|||
94578250|NCT02855125|323918599|FG001|Overall Study|Radiologic Disease Progression|39|||
94578251|NCT02855125|323918598|FG000|Overall Study|Adverse Event|11|||
94578252|NCT02855125|323918599|FG001|Overall Study|Adverse Event|7|||
94578253|NCT02855125|323918598|FG000|Overall Study|Physician Decision|1|||
94578254|NCT02855125|323918599|FG001|Overall Study|Physician Decision|0|||
94578255|NCT02855125|323918598|FG000|Overall Study|On Treatment|9|||
94578256|NCT02855125|323918599|FG001|Overall Study|On Treatment|11|||
94578257|NCT02855125|323918598|FG000|Overall Study|Randomized but not treated|0|||
94578258|NCT02855125|323918599|FG001|Overall Study|Randomized but not treated|1|||
94578259|NCT02681523|323918600|FG000|Overall Study|Adverse Event|1|||
94578260|NCT02681523|323918600|FG000|Overall Study|Patient Non-compliance|1|||
94578261|NCT04721977|323918601|FG000|Overall Study|Death|15|||
94578262|NCT04721977|323918601|FG000|Overall Study|Ongoing|51|||
94578263|NCT02864394|323918603|FG000|Overall Study|Death|184|||
94578264|NCT02864394|323918604|FG001|Overall Study|Death|189|||
94578265|NCT02864394|323918603|FG000|Overall Study|Lost to Follow-up|0|||
94578266|NCT02864394|323918604|FG001|Overall Study|Lost to Follow-up|2|||
94578267|NCT02864394|323918603|FG000|Overall Study|Sponsor Decision|26|||
94578268|NCT02864394|323918604|FG001|Overall Study|Sponsor Decision|11|||
94578269|NCT02864394|323918603|FG000|Overall Study|Withdrawal by Subject|3|||
94578270|NCT02864394|323918604|FG001|Overall Study|Withdrawal by Subject|10|||
94578271|NCT02638220|323918610|FG000|Overall Study|Lost to Follow-up|6|||
94578272|NCT02638220|323918610|FG000|Overall Study|Withdrawal by Subject|3|||
94578273|NCT02638220|323918610|FG000|Overall Study|Physician Decision|1|||
94578274|NCT02638220|323918610|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
94578275|NCT02318706|323919586|FG000|Double-blind Phase|Adverse Event|7|||
94578276|NCT02318706|323919587|FG001|Double-blind Phase|Adverse Event|4|||
94578277|NCT02318706|323919588|FG002|Double-blind Phase|Adverse Event|3|||
94578278|NCT02318706|323919589|FG003|Double-blind Phase|Adverse Event|10|||
94578279|NCT02318706|323919590|FG004|Double-blind Phase|Adverse Event|0|||
94578280|NCT02318706|323919586|FG000|Double-blind Phase|Lost to Follow-up|1|||
94578281|NCT02318706|323919587|FG001|Double-blind Phase|Lost to Follow-up|0|||
94578282|NCT02318706|323919588|FG002|Double-blind Phase|Lost to Follow-up|0|||
94578283|NCT02318706|323919589|FG003|Double-blind Phase|Lost to Follow-up|0|||
94578284|NCT02318706|323919590|FG004|Double-blind Phase|Lost to Follow-up|0|||
94578285|NCT02318706|323919586|FG000|Double-blind Phase|Protocol Violation|4|||
94578286|NCT02318706|323919587|FG001|Double-blind Phase|Protocol Violation|2|||
94578287|NCT02318706|323919588|FG002|Double-blind Phase|Protocol Violation|4|||
94578288|NCT02318706|323919589|FG003|Double-blind Phase|Protocol Violation|3|||
94578289|NCT02318706|323919590|FG004|Double-blind Phase|Protocol Violation|0|||
94578290|NCT02318706|323919586|FG000|Double-blind Phase|Withdrawal by Subject|9|||
94578291|NCT02318706|323919587|FG001|Double-blind Phase|Withdrawal by Subject|5|||
94578292|NCT02318706|323919588|FG002|Double-blind Phase|Withdrawal by Subject|7|||
94578293|NCT02318706|323919589|FG003|Double-blind Phase|Withdrawal by Subject|10|||
94578294|NCT02318706|323919590|FG004|Double-blind Phase|Withdrawal by Subject|0|||
94578295|NCT02318706|323919586|FG000|Double-blind Phase|Other|4|||
94578296|NCT02318706|323919587|FG001|Double-blind Phase|Other|1|||
94578297|NCT02318706|323919588|FG002|Double-blind Phase|Other|2|||
94578298|NCT02318706|323919589|FG003|Double-blind Phase|Other|1|||
94578299|NCT02318706|323919590|FG004|Double-blind Phase|Other|0|||
94578300|NCT02318706|323919586|FG000|Double-blind Phase|Death|0|||
94578301|NCT02318706|323919587|FG001|Double-blind Phase|Death|0|||
94578302|NCT02318706|323919588|FG002|Double-blind Phase|Death|2|||
94578303|NCT02318706|323919589|FG003|Double-blind Phase|Death|0|||
94578304|NCT02318706|323919590|FG004|Double-blind Phase|Death|0|||
94578305|NCT02318706|323919586|FG000|Open-label Extension Phase|Adverse Event|0|||
94578306|NCT02318706|323919587|FG001|Open-label Extension Phase|Adverse Event|0|||
94578307|NCT02318706|323919588|FG002|Open-label Extension Phase|Adverse Event|0|||
94578308|NCT02318706|323919589|FG003|Open-label Extension Phase|Adverse Event|0|||
94578309|NCT02318706|323919590|FG004|Open-label Extension Phase|Adverse Event|21|||
94578310|NCT02318706|323919586|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
94578311|NCT02318706|323919587|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
94578312|NCT02318706|323919588|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
94578313|NCT02318706|323919589|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
94578314|NCT02318706|323919590|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
94578315|NCT02318706|323919586|FG000|Open-label Extension Phase|Death|0|||
94578316|NCT02318706|323919587|FG001|Open-label Extension Phase|Death|0|||
94578317|NCT02318706|323919588|FG002|Open-label Extension Phase|Death|0|||
94578318|NCT02318706|323919589|FG003|Open-label Extension Phase|Death|0|||
94578319|NCT02318706|323919590|FG004|Open-label Extension Phase|Death|1|||
94578320|NCT02318706|323919586|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
94578321|NCT02318706|323919587|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
94578322|NCT02318706|323919588|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
94578323|NCT02318706|323919589|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
94578324|NCT02318706|323919590|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
94578325|NCT01347112|323919591|FG000|Overall Study|Withdrawal by Subject|1|||
94578326|NCT01347112|323919592|FG001|Overall Study|Withdrawal by Subject|7|||
94578327|NCT01347112|323919591|FG000|Overall Study|Lost to Follow-up|3|||
94578328|NCT01347112|323919592|FG001|Overall Study|Lost to Follow-up|5|||
94578329|NCT00696072|323919593|FG000|Overall Study|continuing active treatment|10|||
94578330|NCT00696072|323919594|FG001|Overall Study|continuing active treatment|13|||
94578331|NCT00696072|323919593|FG000|Overall Study|Adverse Event|10|||
94578332|NCT00696072|323919594|FG001|Overall Study|Adverse Event|6|||
94578333|NCT00696072|323919593|FG000|Overall Study|Patient Request|3|||
94578334|NCT00696072|323919594|FG001|Overall Study|Patient Request|7|||
94578335|NCT00696072|323919593|FG000|Overall Study|Investigator Request|1|||
94578336|NCT00696072|323919594|FG001|Overall Study|Investigator Request|4|||
94578337|NCT00696072|323919593|FG000|Overall Study|Sponsor Request|0|||
94578338|NCT00696072|323919594|FG001|Overall Study|Sponsor Request|1|||
94578339|NCT00696072|323919593|FG000|Overall Study|Disease Progression|32|||
94578340|NCT00696072|323919594|FG001|Overall Study|Disease Progression|30|||
94578341|NCT00696072|323919593|FG000|Overall Study|Non-specified|1|||
94578342|NCT00696072|323919594|FG001|Overall Study|Non-specified|2|||
94578343|NCT04639245|323919600|FG000|Overall Study|Death|1|||
94578344|NCT03038100|323919609|FG000|Overall Study|Death|289|||
94578345|NCT03038100|323919610|FG001|Overall Study|Death|272|||
94578346|NCT03038100|323919609|FG000|Overall Study|Lost to Follow-up|9|||
94578347|NCT03038100|323919610|FG001|Overall Study|Lost to Follow-up|10|||
94578348|NCT03038100|323919609|FG000|Overall Study|Protocol Deviation|1|||
94578349|NCT03038100|323919610|FG001|Overall Study|Protocol Deviation|4|||
94578350|NCT03038100|323919609|FG000|Overall Study|Withdrawal by Subject|45|||
94578351|NCT03038100|323919610|FG001|Overall Study|Withdrawal by Subject|51|||
94578352|NCT03038100|323919609|FG000|Overall Study|Study Terminated By Sponsor|305|||
94578353|NCT03038100|323919610|FG001|Overall Study|Study Terminated By Sponsor|311|||
94578354|NCT03038100|323919609|FG000|Overall Study|Physician Decision|1|||
94578355|NCT03038100|323919610|FG001|Overall Study|Physician Decision|3|||
94578356|NCT01213472|323919615|FG000|Overall Study|Recurrence/Progressive disease|25|||
94578357|NCT01213472|323919615|FG000|Overall Study|Withdrawal by Subject|1|||
94578358|NCT01213472|323919615|FG000|Overall Study|Physician Decision|1|||
94578359|NCT03406780|323919616|FG000|Overall Study|Withdrawal by Subject|1|||
94578360|NCT03406780|323919617|FG001|Overall Study|Withdrawal by Subject|1|||
94578361|NCT03406780|323919616|FG000|Overall Study|Other|0|||
94240227|NCT01011868|322674569|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
94240228|NCT01011868|322674570|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
94578362|NCT03406780|323919617|FG001|Overall Study|Other|2|||
94578363|NCT01498068|323919618|FG000|Overall Study|Withdrawal by Subject|1|||
94578364|NCT01498068|323919619|FG001|Overall Study|Withdrawal by Subject|1|||
94578365|NCT02667119|323919629|FG000|Overall Study|Lost to Follow-up|3|||
94578366|NCT02667119|323919630|FG001|Overall Study|Lost to Follow-up|0|||
94578367|NCT02651675|323919631|FG000|Overall Study|Death|0|||
94240229|NCT01011868|322674571|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
94578368|NCT02651675|323919632|FG001|Overall Study|Death|0|||
94578369|NCT02651675|323919633|FG002|Overall Study|Death|1|||
94578370|NCT03326713|323919634|FG000|Overall Study|Death|2|||
94578371|NCT03326713|323919635|FG001|Overall Study|Death|1|||
94578372|NCT03326713|323919636|FG002|Overall Study|Death|0|||
94578373|NCT03326713|323919634|FG000|Overall Study|Lost to Follow-up|20|||
94578374|NCT03326713|323919635|FG001|Overall Study|Lost to Follow-up|21|||
94578375|NCT03326713|323919636|FG002|Overall Study|Lost to Follow-up|33|||
94578376|NCT03326713|323919634|FG000|Overall Study|Withdrawal by Subject|1|||
94578377|NCT03326713|323919635|FG001|Overall Study|Withdrawal by Subject|2|||
94578378|NCT03326713|323919636|FG002|Overall Study|Withdrawal by Subject|11|||
94578379|NCT03326713|323919634|FG000|Overall Study|Found Ineligible|11|||
94578380|NCT03326713|323919635|FG001|Overall Study|Found Ineligible|11|||
94578381|NCT03326713|323919636|FG002|Overall Study|Found Ineligible|8|||
94578382|NCT02059278|323919637|FG000|Overall Study|Adverse Event|1|||
94578383|NCT02059278|323919638|FG001|Overall Study|Adverse Event|1|||
94578384|NCT02059278|323919637|FG000|Overall Study|Lost to Follow-up|1|||
94578385|NCT02059278|323919638|FG001|Overall Study|Lost to Follow-up|0|||
94578386|NCT02059278|323919637|FG000|Overall Study|Withdrawal by Subject|0|||
94578387|NCT02059278|323919638|FG001|Overall Study|Withdrawal by Subject|3|||
94578388|NCT02059278|323919637|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
94578389|NCT02059278|323919638|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
94578390|NCT01285557|323919649|FG000|Overall Study|Death|173|||
94578391|NCT01285557|323919650|FG001|Overall Study|Death|90|||
94578392|NCT01285557|323919649|FG000|Overall Study|Lost to Follow-up|6|||
94578393|NCT01285557|323919650|FG001|Overall Study|Lost to Follow-up|2|||
94578394|NCT01285557|323919649|FG000|Overall Study|Withdrew Consent|6|||
94578395|NCT01285557|323919650|FG001|Overall Study|Withdrew Consent|1|||
94578396|NCT01285557|323919649|FG000|Overall Study|Sponsor Study Termination|23|||
94578397|NCT01285557|323919650|FG001|Overall Study|Sponsor Study Termination|13|||
94578398|NCT01285557|323919649|FG000|Overall Study|Randomized but not treated|1|||
94578399|NCT01285557|323919650|FG001|Overall Study|Randomized but not treated|1|||
94578400|NCT01285557|323919649|FG000|Overall Study|Study follow-up ongoing|28|||
94578401|NCT01285557|323919650|FG001|Overall Study|Study follow-up ongoing|14|||
94578402|NCT01285557|323919649|FG000|Overall Study|Sponsor Decision|2|||
94578403|NCT01285557|323919650|FG001|Overall Study|Sponsor Decision|1|||
94578404|NCT01648751|323919651|FG000|Overall Study|Withdrawal by Subject|2|||
94578405|NCT01648751|323919652|FG001|Overall Study|Withdrawal by Subject|3|||
94578406|NCT01588522|323919653|FG000|Overall Study|Withdrawal by Subject|1|||
94578407|NCT01588522|323919654|FG001|Overall Study|Withdrawal by Subject|5|||
94578408|NCT01588522|323919655|FG002|Overall Study|Withdrawal by Subject|3|||
94578409|NCT01588522|323919656|FG003|Overall Study|Withdrawal by Subject|1|||
94578410|NCT01588522|323919657|FG004|Overall Study|Withdrawal by Subject|2|||
94578411|NCT01588522|323919658|FG005|Overall Study|Withdrawal by Subject|0|||
94578412|NCT01588522|323919653|FG000|Overall Study|Lack of Efficacy|0|||
94578413|NCT01588522|323919654|FG001|Overall Study|Lack of Efficacy|0|||
94578414|NCT01588522|323919655|FG002|Overall Study|Lack of Efficacy|0|||
94578415|NCT01588522|323919656|FG003|Overall Study|Lack of Efficacy|0|||
94578416|NCT01588522|323919657|FG004|Overall Study|Lack of Efficacy|1|||
94578417|NCT01588522|323919658|FG005|Overall Study|Lack of Efficacy|0|||
94578418|NCT01588522|323919653|FG000|Overall Study|Adverse Event|0|||
94578419|NCT01588522|323919654|FG001|Overall Study|Adverse Event|0|||
94578420|NCT01588522|323919655|FG002|Overall Study|Adverse Event|0|||
94578421|NCT01588522|323919656|FG003|Overall Study|Adverse Event|1|||
94578422|NCT01588522|323919657|FG004|Overall Study|Adverse Event|0|||
94578423|NCT01588522|323919658|FG005|Overall Study|Adverse Event|0|||
94578424|NCT01588522|323919653|FG000|Overall Study|Grade 2 alopecia|1|||
94578425|NCT01588522|323919654|FG001|Overall Study|Grade 2 alopecia|0|||
94578426|NCT01588522|323919655|FG002|Overall Study|Grade 2 alopecia|0|||
94578427|NCT01588522|323919656|FG003|Overall Study|Grade 2 alopecia|0|||
94578428|NCT01588522|323919657|FG004|Overall Study|Grade 2 alopecia|0|||
94578429|NCT01588522|323919658|FG005|Overall Study|Grade 2 alopecia|0|||
94578430|NCT01588522|323919653|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
94578431|NCT01588522|323919654|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
94578432|NCT01588522|323919655|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
94578433|NCT01588522|323919656|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
94578434|NCT01588522|323919657|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
94578435|NCT01588522|323919658|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
94578436|NCT01588522|323919653|FG000|Overall Study|Taken off taxane-based regimen|0|||
94578437|NCT01588522|323919654|FG001|Overall Study|Taken off taxane-based regimen|0|||
94578438|NCT01588522|323919655|FG002|Overall Study|Taken off taxane-based regimen|0|||
94578439|NCT01588522|323919656|FG003|Overall Study|Taken off taxane-based regimen|1|||
94578440|NCT01588522|323919657|FG004|Overall Study|Taken off taxane-based regimen|0|||
94578441|NCT01588522|323919658|FG005|Overall Study|Taken off taxane-based regimen|0|||
94578442|NCT01588522|323919653|FG000|Overall Study|Did not initiate chemotherapy|0|||
94578443|NCT01588522|323919654|FG001|Overall Study|Did not initiate chemotherapy|0|||
94578444|NCT01588522|323919655|FG002|Overall Study|Did not initiate chemotherapy|0|||
94578445|NCT01588522|323919656|FG003|Overall Study|Did not initiate chemotherapy|0|||
94578446|NCT01588522|323919657|FG004|Overall Study|Did not initiate chemotherapy|1|||
94578447|NCT01588522|323919658|FG005|Overall Study|Did not initiate chemotherapy|0|||
94578448|NCT02991768|323919659|FG000|Overall Study|Physician Decision|4|||
94578449|NCT03467750|323919660|FG000|Overall Study|Surgery canceled|1|||
94578450|NCT03467750|323919661|FG001|Overall Study|Surgery canceled|0|||
94578451|NCT03467750|323919660|FG000|Overall Study|Protocol Violation|1|||
94578452|NCT03467750|323919661|FG001|Overall Study|Protocol Violation|1|||
94578453|NCT03467750|323919660|FG000|Overall Study|Withdrawal by Subject|0|||
94578454|NCT03467750|323919661|FG001|Overall Study|Withdrawal by Subject|1|||
94578455|NCT01231906|323919662|FG000|Overall Study|Lack of Efficacy|75|||
94578456|NCT01231906|323919663|FG001|Overall Study|Lack of Efficacy|68|||
94578457|NCT01231906|323919662|FG000|Overall Study|Lost to Follow-up|1|||
94578458|NCT01231906|323919663|FG001|Overall Study|Lost to Follow-up|0|||
94578459|NCT01231906|323919662|FG000|Overall Study|Physician Decision|34|||
94578460|NCT01231906|323919663|FG001|Overall Study|Physician Decision|24|||
94578461|NCT01231906|323919662|FG000|Overall Study|Withdrawal by Subject|0|||
94578462|NCT01231906|323919663|FG001|Overall Study|Withdrawal by Subject|4|||
94578463|NCT01231906|323919662|FG000|Overall Study|Ineligible|10|||
94578464|NCT01231906|323919663|FG001|Overall Study|Ineligible|3|||
94578465|NCT01231906|323919662|FG000|Overall Study|No treatment|1|||
94578466|NCT01231906|323919663|FG001|Overall Study|No treatment|2|||
94578467|NCT04163341|323919664|FG000|Overall Study|Withdrawal by Subject|2|||
94578468|NCT04163341|323919665|FG001|Overall Study|Withdrawal by Subject|0|||
94578469|NCT04163341|323919664|FG000|Overall Study|Lost to Follow-up|3|||
94578470|NCT04163341|323919665|FG001|Overall Study|Lost to Follow-up|4|||
94578471|NCT04949490|323919667|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
94578472|NCT04949490|323919668|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
94578473|NCT04949490|323919669|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
94578474|NCT04949490|323919670|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
94578475|NCT04949490|323919671|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
94578476|NCT04949490|323919672|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
94578477|NCT04949490|323919667|FG000|Group A and Group B|Withdrawal by Subject|0|||
94578478|NCT04949490|323919668|FG001|Group A and Group B|Withdrawal by Subject|0|||
94578479|NCT04949490|323919669|FG002|Group A and Group B|Withdrawal by Subject|1|||
94578480|NCT04949490|323919670|FG003|Group A and Group B|Withdrawal by Subject|0|||
94578481|NCT04949490|323919671|FG004|Group A and Group B|Withdrawal by Subject|0|||
94578482|NCT04949490|323919672|FG005|Group A and Group B|Withdrawal by Subject|0|||
94578483|NCT04949490|323919667|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
94578484|NCT04949490|323919668|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
94578485|NCT04949490|323919669|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
94578486|NCT04949490|323919670|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
94578487|NCT04949490|323919671|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
94578488|NCT04949490|323919672|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
94578489|NCT04949490|323919667|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
94578490|NCT04949490|323919668|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
94578491|NCT04949490|323919669|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
94578492|NCT04949490|323919670|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
94578493|NCT04949490|323919671|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
94578494|NCT04949490|323919672|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
94578495|NCT04988477|323919673|FG000|Overall Study|Death|1|||
94578496|NCT04988477|323919674|FG001|Overall Study|Death|0|||
94578497|NCT04988477|323919675|FG002|Overall Study|Death|0|||
94578498|NCT04988477|323919673|FG000|Overall Study|Lost to Follow-up|5|||
94578499|NCT04988477|323919674|FG001|Overall Study|Lost to Follow-up|2|||
94578500|NCT04988477|323919675|FG002|Overall Study|Lost to Follow-up|0|||
94578501|NCT04988477|323919673|FG000|Overall Study|Withdrawal by Subject|2|||
94578502|NCT04988477|323919674|FG001|Overall Study|Withdrawal by Subject|0|||
94578503|NCT04988477|323919675|FG002|Overall Study|Withdrawal by Subject|0|||
94578504|NCT04730804|323919676|FG000|Overall Study|Physician Decision|0|||
94578505|NCT04730804|323919677|FG001|Overall Study|Physician Decision|0|||
94578506|NCT04730804|323919678|FG002|Overall Study|Physician Decision|0|||
94578507|NCT04730804|323919679|FG003|Overall Study|Physician Decision|0|||
94578508|NCT04730804|323919680|FG004|Overall Study|Physician Decision|0|||
94578509|NCT04730804|323919681|FG005|Overall Study|Physician Decision|1|||
94578510|NCT04730804|323919676|FG000|Overall Study|Withdrawal by Subject|0|||
94578511|NCT04730804|323919677|FG001|Overall Study|Withdrawal by Subject|0|||
94578512|NCT04730804|323919678|FG002|Overall Study|Withdrawal by Subject|0|||
94578513|NCT04730804|323919679|FG003|Overall Study|Withdrawal by Subject|0|||
94578514|NCT04730804|323919680|FG004|Overall Study|Withdrawal by Subject|1|||
94578515|NCT04730804|323919681|FG005|Overall Study|Withdrawal by Subject|2|||
94578516|NCT01256788|323920734|FG000|Overall Study|Lost to Follow-up|5|||
94578517|NCT01256788|323920735|FG001|Overall Study|Lost to Follow-up|8|||
94578518|NCT01256788|323920736|FG002|Overall Study|Lost to Follow-up|3|||
94578519|NCT05366738|323920737|FG000|Overall Study|Adverse Event|0|||
94578520|NCT05366738|323920738|FG001|Overall Study|Adverse Event|1|||
94578521|NCT05366738|323920739|FG002|Overall Study|Adverse Event|0|||
94578522|NCT04328077|323920742|FG000|Overall Study|Lost to Follow-up|0|||
94578523|NCT04328077|323920743|FG001|Overall Study|Lost to Follow-up|1|||
94578524|NCT04328077|323920744|FG002|Overall Study|Lost to Follow-up|0|||
94578525|NCT04328077|323920745|FG003|Overall Study|Lost to Follow-up|0|||
94578526|NCT04328077|323920742|FG000|Overall Study|Withdrawal by Subject|0|||
94578527|NCT04328077|323920743|FG001|Overall Study|Withdrawal by Subject|1|||
94578528|NCT04328077|323920744|FG002|Overall Study|Withdrawal by Subject|1|||
94578529|NCT04328077|323920745|FG003|Overall Study|Withdrawal by Subject|3|||
94578530|NCT00148317|323920758|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
94578531|NCT00148317|323920758|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
94578532|NCT00148317|323920758|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
94578533|NCT05024032|323920759|FG000|Overall Study|Withdrawal by Subject|0|||
94578534|NCT05024032|323920760|FG001|Overall Study|Withdrawal by Subject|3|||
94578535|NCT05024032|323920761|FG002|Overall Study|Withdrawal by Subject|4|||
94578536|NCT05024032|323920759|FG000|Overall Study|Adverse Event|0|||
94578537|NCT05024032|323920760|FG001|Overall Study|Adverse Event|1|||
94578538|NCT05024032|323920761|FG002|Overall Study|Adverse Event|0|||
94578539|NCT05024032|323920759|FG000|Overall Study|Protocol Deviation|1|||
94578540|NCT05024032|323920760|FG001|Overall Study|Protocol Deviation|0|||
94578541|NCT05024032|323920761|FG002|Overall Study|Protocol Deviation|0|||
94578542|NCT00313014|323920762|FG000|Overall Study|Withdrawal by Subject|11|||
94578543|NCT00313014|323920763|FG001|Overall Study|Withdrawal by Subject|7|||
94578544|NCT00313014|323920764|FG002|Overall Study|Withdrawal by Subject|5|||
94578545|NCT00313014|323920762|FG000|Overall Study|Adverse Event|14|||
94240230|NCT01011868|322674569|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
94240231|NCT01011868|322674570|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
94578546|NCT00313014|323920763|FG001|Overall Study|Adverse Event|29|||
94578547|NCT00313014|323920764|FG002|Overall Study|Adverse Event|16|||
94578548|NCT00313014|323920762|FG000|Overall Study|Lost to Follow-up|7|||
94578549|NCT00313014|323920763|FG001|Overall Study|Lost to Follow-up|6|||
94240232|NCT01011868|322674571|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
94454100|NCT02147158|323450261|FG003|Treatment Course 2|Lost to Follow-up|1|||
94578550|NCT00313014|323920764|FG002|Overall Study|Lost to Follow-up|10|||
94578551|NCT00313014|323920762|FG000|Overall Study|Administrative|9|||
94578552|NCT00313014|323920763|FG001|Overall Study|Administrative|6|||
94578553|NCT00313014|323920764|FG002|Overall Study|Administrative|14|||
94578554|NCT00313014|323920762|FG000|Overall Study|Lack of Efficacy|52|||
94454101|NCT02147158|323450262|FG004|Treatment Course 2|Lost to Follow-up|0|||
94454102|NCT02147158|323450263|FG005|Treatment Course 2|Lost to Follow-up|1|||
94240233|NCT01011868|322674569|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
94240234|NCT01011868|322674570|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
94240235|NCT01011868|322674571|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
94240236|NCT01011868|322674569|FG000|After Week 78 Follow-up|Adverse Event|14|||
94240237|NCT01011868|322674570|FG001|After Week 78 Follow-up|Adverse Event|18|||
94240238|NCT01011868|322674571|FG002|After Week 78 Follow-up|Adverse Event|21|||
94240239|NCT01011868|322674569|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
94454103|NCT02147158|323450258|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
94454104|NCT02147158|323450259|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
94658890|NCT04102501|324206230|FG000|Overall Study|Withdrawal by Subject|7|||
94658891|NCT04102501|324206231|FG001|Overall Study|Withdrawal by Subject|9|||
94454105|NCT02147158|323450260|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
94454106|NCT02147158|323450261|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
94454107|NCT02147158|323450262|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
94454108|NCT02147158|323450263|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
94454109|NCT02147158|323450258|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
94454110|NCT02147158|323450259|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
94454111|NCT02147158|323450260|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
94454112|NCT02147158|323450261|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
94454113|NCT02147158|323450262|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
94454114|NCT02147158|323450263|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
94454115|NCT02147158|323450258|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
94454116|NCT02147158|323450259|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
94454117|NCT02147158|323450260|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
94454118|NCT02147158|323450261|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
94454119|NCT02147158|323450262|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
94454120|NCT02147158|323450263|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
94454121|NCT02147158|323450258|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
94454122|NCT02147158|323450259|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
94454123|NCT02147158|323450260|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
94454124|NCT02147158|323450261|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
94454125|NCT02147158|323450262|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
94454126|NCT02147158|323450263|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
94454127|NCT02147158|323450258|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
94454128|NCT02147158|323450259|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
94454129|NCT02147158|323450260|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
94454130|NCT02147158|323450261|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
94454131|NCT02147158|323450262|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
94454132|NCT02147158|323450263|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
94454133|NCT03033602|323450264|FG000|Overall Study|Withdrawal by Subject|11|||
94454134|NCT03033602|323450265|FG001|Overall Study|Withdrawal by Subject|21|||
94454135|NCT03033602|323450264|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
94454136|NCT03033602|323450265|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
94454137|NCT03425396|323450266|FG000|Overall Study|Lost to Follow-up|2|||
94454138|NCT03425396|323450267|FG001|Overall Study|Lost to Follow-up|5|||
94454139|NCT03425396|323450268|FG002|Overall Study|Lost to Follow-up|2|||
94454140|NCT03425396|323450269|FG003|Overall Study|Lost to Follow-up|0|||
94454141|NCT03425396|323450270|FG004|Overall Study|Lost to Follow-up|0|||
94454142|NCT03425396|323450266|FG000|Overall Study|Withdrawal by Subject|0|||
94454143|NCT03425396|323450267|FG001|Overall Study|Withdrawal by Subject|1|||
94454144|NCT03425396|323450268|FG002|Overall Study|Withdrawal by Subject|0|||
94454145|NCT03425396|323450269|FG003|Overall Study|Withdrawal by Subject|1|||
94454146|NCT03425396|323450270|FG004|Overall Study|Withdrawal by Subject|0|||
94454147|NCT03425396|323450266|FG000|Overall Study|Other|0|||
94454148|NCT03425396|323450267|FG001|Overall Study|Other|1|||
94454149|NCT03425396|323450268|FG002|Overall Study|Other|1|||
94454150|NCT03425396|323450269|FG003|Overall Study|Other|0|||
94454151|NCT03425396|323450270|FG004|Overall Study|Other|1|||
94454152|NCT02981082|323450271|FG000|Overall Study|Withdrawal by Subject|2|||
94454153|NCT02981082|323450272|FG001|Overall Study|Withdrawal by Subject|0|||
94454154|NCT02981082|323450271|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
94454155|NCT02981082|323450272|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
94454156|NCT02981082|323450271|FG000|Overall Study|Adverse Event|0|||
94454157|NCT02981082|323450272|FG001|Overall Study|Adverse Event|1|||
94454158|NCT03689374|323450273|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
94454159|NCT03689374|323450274|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
94454160|NCT03689374|323450275|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
94658892|NCT04102501|324206230|FG000|Overall Study|Adverse Event|1|||
94454161|NCT03689374|323450273|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
94454162|NCT03689374|323450274|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
94454163|NCT03689374|323450275|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
94454164|NCT03689374|323450273|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
94240240|NCT01011868|322674570|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
94578555|NCT00313014|323920763|FG001|Overall Study|Lack of Efficacy|25|||
94578556|NCT00313014|323920764|FG002|Overall Study|Lack of Efficacy|16|||
94578557|NCT00804908|323920768|FG000|Overall Study|Other|115|||
94578558|NCT00804908|323920769|FG001|Overall Study|Other|116|||
94578559|NCT00804908|323920770|FG002|Overall Study|Other|114|||
94578560|NCT01421719|323920771|FG000|Overall Study|Withdrawal by Subject|4|||
94578561|NCT01803607|323920776|FG000|Overall Study|Adverse Event|5|||
94578562|NCT01803607|323920777|FG001|Overall Study|Adverse Event|3|||
94578563|NCT01803607|323920776|FG000|Overall Study|Lack of Efficacy|0|||
94578564|NCT01803607|323920777|FG001|Overall Study|Lack of Efficacy|1|||
94578565|NCT01803607|323920776|FG000|Overall Study|Protocol Violation|3|||
94578566|NCT01803607|323920777|FG001|Overall Study|Protocol Violation|2|||
94578567|NCT01803607|323920776|FG000|Overall Study|Study terminated by sponsor|54|||
94578568|NCT01803607|323920777|FG001|Overall Study|Study terminated by sponsor|56|||
94578569|NCT01803607|323920776|FG000|Overall Study|Withdrawal by Subject|6|||
94578570|NCT01803607|323920777|FG001|Overall Study|Withdrawal by Subject|5|||
94578571|NCT00321620|323920778|FG000|Overall Study|Death|269|||
94578572|NCT00321620|323920779|FG001|Overall Study|Death|294|||
94578573|NCT00321620|323920778|FG000|Overall Study|Withdrawal by Subject|164|||
94578574|NCT00321620|323920779|FG001|Overall Study|Withdrawal by Subject|147|||
94578575|NCT00321620|323920778|FG000|Overall Study|Disease progression|113|||
94578576|NCT00321620|323920779|FG001|Overall Study|Disease progression|117|||
94578577|NCT00321620|323920778|FG000|Overall Study|Adverse Event|43|||
94578578|NCT00321620|323920779|FG001|Overall Study|Adverse Event|56|||
94578579|NCT00321620|323920778|FG000|Overall Study|Lost to Follow-up|13|||
94578580|NCT00321620|323920779|FG001|Overall Study|Lost to Follow-up|9|||
94578581|NCT00321620|323920778|FG000|Overall Study|Physician Decision|4|||
94578582|NCT00321620|323920779|FG001|Overall Study|Physician Decision|1|||
94578583|NCT00321620|323920778|FG000|Overall Study|Noncompliance|14|||
94578584|NCT00321620|323920779|FG001|Overall Study|Noncompliance|7|||
94578585|NCT00321620|323920778|FG000|Overall Study|Protocol deviation|4|||
94578586|NCT00321620|323920779|FG001|Overall Study|Protocol deviation|3|||
94578587|NCT00321620|323920778|FG000|Overall Study|Ineligibility determined|2|||
94578588|NCT00321620|323920779|FG001|Overall Study|Ineligibility determined|3|||
94578589|NCT00321620|323920778|FG000|Overall Study|Participant request|75|||
94578590|NCT00321620|323920779|FG001|Overall Study|Participant request|52|||
94578591|NCT00321620|323920778|FG000|Overall Study|Other|42|||
94578592|NCT00321620|323920779|FG001|Overall Study|Other|33|||
94578593|NCT03337477|323920780|FG000|Overall Study|not categorized into the listed ones|11|||
94578594|NCT03337477|323920781|FG001|Overall Study|not categorized into the listed ones|9|||
94578595|NCT03337477|323920780|FG000|Overall Study|Withdrawal by Subject|0|||
94578596|NCT03337477|323920781|FG001|Overall Study|Withdrawal by Subject|1|||
94578597|NCT03337477|323920780|FG000|Overall Study|Death|0|||
94578598|NCT03337477|323920781|FG001|Overall Study|Death|1|||
94578599|NCT03337477|323920780|FG000|Overall Study|Lost to Follow-up|0|||
94578600|NCT03337477|323920781|FG001|Overall Study|Lost to Follow-up|2|||
94578601|NCT03250273|323920784|FG000|Overall Study|Disease Progression|2|||
94578602|NCT03250273|323920785|FG001|Overall Study|Disease Progression|11|||
94578603|NCT03250273|323920784|FG000|Overall Study|Death|0|||
94578604|NCT03250273|323920785|FG001|Overall Study|Death|1|||
94578605|NCT01600716|323920787|FG000|Overall Study|Other Reasons|3|||
94578606|NCT01600716|323920788|FG001|Overall Study|Other Reasons|1|||
94578607|NCT01600716|323920787|FG000|Overall Study|Personal Reasons|0|||
94578608|NCT01600716|323920788|FG001|Overall Study|Personal Reasons|2|||
94578609|NCT01600716|323920787|FG000|Overall Study|Lost to Follow-up|0|||
94578610|NCT01600716|323920788|FG001|Overall Study|Lost to Follow-up|2|||
94578611|NCT01600716|323920787|FG000|Overall Study|Pregnancy|1|||
94578612|NCT01600716|323920788|FG001|Overall Study|Pregnancy|0|||
94578613|NCT01600716|323920787|FG000|Overall Study|Lack of Efficacy|2|||
94578614|NCT01600716|323920788|FG001|Overall Study|Lack of Efficacy|1|||
94578615|NCT01600716|323920787|FG000|Overall Study|Adverse Event|1|||
94578616|NCT01600716|323920788|FG001|Overall Study|Adverse Event|1|||
94578617|NCT02939287|323920797|FG000|Overall Study|met exclusion criteria|1|||
94578618|NCT02939287|323920798|FG001|Overall Study|met exclusion criteria|1|||
94578619|NCT02939287|323920799|FG002|Overall Study|met exclusion criteria|1|||
94578620|NCT02939287|323920797|FG000|Overall Study|Did not complete survey|2|||
94578621|NCT02939287|323920798|FG001|Overall Study|Did not complete survey|2|||
94578622|NCT02939287|323920799|FG002|Overall Study|Did not complete survey|0|||
94578623|NCT02939287|323920797|FG000|Overall Study|Withdrawal by Subject|1|||
94578624|NCT02939287|323920798|FG001|Overall Study|Withdrawal by Subject|1|||
94578625|NCT02939287|323920799|FG002|Overall Study|Withdrawal by Subject|0|||
94578626|NCT01285323|323920802|FG000|Overall Study|Adverse Event|9|||
94578627|NCT01285323|323920803|FG001|Overall Study|Adverse Event|8|||
94578628|NCT01285323|323920802|FG000|Overall Study|Lack of Efficacy|4|||
94578629|NCT01285323|323920803|FG001|Overall Study|Lack of Efficacy|2|||
94578630|NCT01285323|323920802|FG000|Overall Study|Withdrawal by Subject|15|||
94578631|NCT01285323|323920803|FG001|Overall Study|Withdrawal by Subject|11|||
94578632|NCT01285323|323920802|FG000|Overall Study|Protocol Violation|1|||
94578633|NCT01285323|323920803|FG001|Overall Study|Protocol Violation|2|||
94578634|NCT01285323|323920802|FG000|Overall Study|Non-compliance with study procedures|2|||
94578635|NCT01285323|323920803|FG001|Overall Study|Non-compliance with study procedures|3|||
94578636|NCT01285323|323920802|FG000|Overall Study|Lost to Follow-up|1|||
94578637|NCT01285323|323920803|FG001|Overall Study|Lost to Follow-up|1|||
94578638|NCT01285323|323920802|FG000|Overall Study|Other|1|||
94578639|NCT01285323|323920803|FG001|Overall Study|Other|3|||
94578640|NCT02351817|323920804|FG000|Period 1|Adverse Event|1|||
94578641|NCT02351817|323920805|FG001|Period 1|Adverse Event|2|||
94578642|NCT02351817|323920804|FG000|Period 1|Lack of Efficacy|0|||
94578643|NCT02351817|323920805|FG001|Period 1|Lack of Efficacy|1|||
94578644|NCT02351817|323920804|FG000|Period 2|Adverse Event|0|||
94578645|NCT02351817|323920805|FG001|Period 2|Adverse Event|2|||
94578646|NCT02351817|323920804|FG000|Period 2|Protocol Violation|1|||
94578647|NCT02351817|323920805|FG001|Period 2|Protocol Violation|0|||
94578648|NCT03219723|323920806|FG000|Overall Study|Case Report Forms Uncollected|6|||
94578649|NCT03219723|323920806|FG000|Overall Study|Protocol Deviation|4|||
94578650|NCT01550003|323920807|FG000|Overall Study|Adverse Event|0|||
94578651|NCT01550003|323920808|FG001|Overall Study|Adverse Event|9|||
94578652|NCT01550003|323920809|FG002|Overall Study|Adverse Event|15|||
94578653|NCT01550003|323920807|FG000|Overall Study|Lack of Efficacy|4|||
94578654|NCT01550003|323920808|FG001|Overall Study|Lack of Efficacy|11|||
94578655|NCT01550003|323920809|FG002|Overall Study|Lack of Efficacy|15|||
94578656|NCT01550003|323920807|FG000|Overall Study|Protocol Violation|0|||
94578657|NCT01550003|323920808|FG001|Overall Study|Protocol Violation|3|||
94578658|NCT01550003|323920809|FG002|Overall Study|Protocol Violation|2|||
94578659|NCT01550003|323920807|FG000|Overall Study|Lost to Follow-up|1|||
94578660|NCT01550003|323920808|FG001|Overall Study|Lost to Follow-up|4|||
94578661|NCT01550003|323920809|FG002|Overall Study|Lost to Follow-up|8|||
94578662|NCT01550003|323920807|FG000|Overall Study|Consent withdrawn|2|||
94578663|NCT01550003|323920808|FG001|Overall Study|Consent withdrawn|11|||
94578664|NCT01550003|323920809|FG002|Overall Study|Consent withdrawn|23|||
94578665|NCT01550003|323920807|FG000|Overall Study|Missing|1|||
94578666|NCT01550003|323920808|FG001|Overall Study|Missing|0|||
94578667|NCT01550003|323920809|FG002|Overall Study|Missing|2|||
94578668|NCT01550003|323920807|FG000|Overall Study|Study closure as announced by sponsor|7|||
94578669|NCT01550003|323920808|FG001|Overall Study|Study closure as announced by sponsor|6|||
94578670|NCT01550003|323920809|FG002|Overall Study|Study closure as announced by sponsor|24|||
94578671|NCT01550003|323920807|FG000|Overall Study|Protocol Noncompliance|1|||
94578672|NCT01550003|323920808|FG001|Overall Study|Protocol Noncompliance|0|||
94578673|NCT01550003|323920809|FG002|Overall Study|Protocol Noncompliance|0|||
94578674|NCT01550003|323920807|FG000|Overall Study|Study closure|0|||
94578675|NCT01550003|323920808|FG001|Overall Study|Study closure|1|||
94578676|NCT01550003|323920809|FG002|Overall Study|Study closure|1|||
94578677|NCT01550003|323920807|FG000|Overall Study|Patient reached adulthood|0|||
94578678|NCT01550003|323920808|FG001|Overall Study|Patient reached adulthood|1|||
94578679|NCT01550003|323920809|FG002|Overall Study|Patient reached adulthood|0|||
94578680|NCT01550003|323920807|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
94578681|NCT01550003|323920808|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
94578682|NCT01550003|323920809|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
94578683|NCT01550003|323920807|FG000|Overall Study|Sponsor's order|0|||
94578684|NCT01550003|323920808|FG001|Overall Study|Sponsor's order|3|||
94578685|NCT01550003|323920809|FG002|Overall Study|Sponsor's order|3|||
94578686|NCT01550003|323920807|FG000|Overall Study|Sponsor's decision|1|||
94578687|NCT01550003|323920808|FG001|Overall Study|Sponsor's decision|5|||
94578688|NCT01550003|323920809|FG002|Overall Study|Sponsor's decision|4|||
94578689|NCT01550003|323920807|FG000|Overall Study|Subject mother passed away|0|||
94578690|NCT01550003|323920808|FG001|Overall Study|Subject mother passed away|1|||
94578691|NCT01550003|323920809|FG002|Overall Study|Subject mother passed away|0|||
94578692|NCT01550003|323920807|FG000|Overall Study|Discontinuation|0|||
94578693|NCT01550003|323920808|FG001|Overall Study|Discontinuation|1|||
94578694|NCT01550003|323920809|FG002|Overall Study|Discontinuation|0|||
94578695|NCT01550003|323920807|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
94578696|NCT01550003|323920808|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
94578697|NCT01550003|323920809|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
94578698|NCT01550003|323920807|FG000|Overall Study|Site closure|0|||
94578699|NCT01550003|323920808|FG001|Overall Study|Site closure|2|||
94578700|NCT01550003|323920809|FG002|Overall Study|Site closure|0|||
94578701|NCT01550003|323920807|FG000|Overall Study|Pregnancy|0|||
94578702|NCT01550003|323920808|FG001|Overall Study|Pregnancy|1|||
94578703|NCT01550003|323920809|FG002|Overall Study|Pregnancy|0|||
94578704|NCT01550003|323920807|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
94578705|NCT01550003|323920808|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
94578706|NCT01550003|323920809|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
94578707|NCT01550003|323920807|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
94578708|NCT01550003|323920808|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
94578709|NCT01550003|323920809|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
94578710|NCT01550003|323920807|FG000|Overall Study|Switching to adult rheumatologist|0|||
94578711|NCT01550003|323920808|FG001|Overall Study|Switching to adult rheumatologist|0|||
94578712|NCT01550003|323920809|FG002|Overall Study|Switching to adult rheumatologist|1|||
94578713|NCT01550003|323920807|FG000|Overall Study|Patient transition to adult care|0|||
94578714|NCT01550003|323920808|FG001|Overall Study|Patient transition to adult care|0|||
94578715|NCT01550003|323920809|FG002|Overall Study|Patient transition to adult care|1|||
94578716|NCT01550003|323920807|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
94578717|NCT01550003|323920808|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
94578718|NCT01550003|323920809|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
94578719|NCT01550003|323920807|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
94578720|NCT01550003|323920808|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
94578721|NCT01550003|323920809|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
94578722|NCT01550003|323920807|FG000|Overall Study|Per Sponsor request|1|||
94578723|NCT01550003|323920808|FG001|Overall Study|Per Sponsor request|0|||
94578724|NCT01550003|323920809|FG002|Overall Study|Per Sponsor request|1|||
94578725|NCT01550003|323920807|FG000|Overall Study|Patient not compliance|0|||
94578726|NCT01550003|323920808|FG001|Overall Study|Patient not compliance|0|||
94578727|NCT01550003|323920809|FG002|Overall Study|Patient not compliance|1|||
94578728|NCT01550003|323920807|FG000|Overall Study|Non-compliance|0|||
94578729|NCT01550003|323920808|FG001|Overall Study|Non-compliance|0|||
94578730|NCT01550003|323920809|FG002|Overall Study|Non-compliance|1|||
94578731|NCT01550003|323920807|FG000|Overall Study|Study closed|0|||
94578732|NCT01550003|323920808|FG001|Overall Study|Study closed|1|||
94578733|NCT01550003|323920809|FG002|Overall Study|Study closed|0|||
94578734|NCT01550003|323920807|FG000|Overall Study|Transitioned to adult rheumatology|0|||
94578735|NCT01550003|323920808|FG001|Overall Study|Transitioned to adult rheumatology|0|||
94578736|NCT01550003|323920809|FG002|Overall Study|Transitioned to adult rheumatology|1|||
94578737|NCT03521570|323920814|FG000|Overall Study|Not eligible|11|||
94578738|NCT03995368|323920815|FG000|Overall Study|Lost to Follow-up|1|||
94578739|NCT03995368|323920816|FG001|Overall Study|Lost to Follow-up|4|||
94578740|NCT03995368|323920817|FG002|Overall Study|Lost to Follow-up|1|||
94578741|NCT03995368|323920815|FG000|Overall Study|Did not meet inclusion criteria|1|||
94578742|NCT03995368|323920816|FG001|Overall Study|Did not meet inclusion criteria|6|||
94578743|NCT03995368|323920817|FG002|Overall Study|Did not meet inclusion criteria|3|||
94578744|NCT03995368|323920815|FG000|Overall Study|Withdrawal by Subject|0|||
94578745|NCT03995368|323920816|FG001|Overall Study|Withdrawal by Subject|1|||
94578746|NCT03995368|323920817|FG002|Overall Study|Withdrawal by Subject|1|||
94578747|NCT01033019|323920818|FG000|Overall Study|Withdrawal by Subject|1|||
94578748|NCT01033019|323920819|FG001|Overall Study|Withdrawal by Subject|0|||
94578749|NCT00904982|323920821|FG000|Overall Study|Withdrawal by Subject|2|||
94578750|NCT00904982|323920822|FG001|Overall Study|Withdrawal by Subject|0|||
94578751|NCT00904982|323920823|FG002|Overall Study|Withdrawal by Subject|0|||
94578752|NCT00904982|323920824|FG003|Overall Study|Withdrawal by Subject|0|||
94578753|NCT03011099|323920825|FG000|Overall Study|Withdrawal by Subject|0|||
94578754|NCT03011099|323920826|FG001|Overall Study|Withdrawal by Subject|2|||
94578755|NCT02158442|323920827|FG000|Overall Study|Withdrawal by Subject|1|||
94578756|NCT02158442|323920828|FG001|Overall Study|Withdrawal by Subject|0|||
94578757|NCT02158442|323920827|FG000|Overall Study|Perfusion staff not available|1|||
94578758|NCT02158442|323920828|FG001|Overall Study|Perfusion staff not available|0|||
94578759|NCT03987503|323920829|FG000|Overall Study|Lost to Follow-up|20|||
94578760|NCT03987503|323920829|FG000|Overall Study|Withdrawal by Subject|2|||
94578761|NCT00926237|323920830|FG000|Overall Study|Withdrawal by Subject|2|||
94578762|NCT00926237|323920831|FG001|Overall Study|Withdrawal by Subject|1|||
94578763|NCT05673876|323920844|FG000|Overall Study|Death|3|||
94578764|NCT05673876|323920845|FG001|Overall Study|Death|1|||
94578765|NCT05673876|323920844|FG000|Overall Study|Study Terminated by Sponsor|0|||
94578766|NCT05673876|323920845|FG001|Overall Study|Study Terminated by Sponsor|1|||
94658893|NCT04102501|324206231|FG001|Overall Study|Adverse Event|3|||
94658894|NCT01427712|324206232|FG000|Overall Study|Transfer to a different hospital|2|||
94658895|NCT01427712|324206232|FG000|Overall Study|Lost to Follow-up|1|||
94658896|NCT01427712|324206232|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
94658897|NCT01427712|324206232|FG000|Overall Study|Failure to visit|1|||
94658898|NCT00968617|324206234|FG000|Overall Study|Study terminated by sponsor|6|||
94578767|NCT05673876|323920844|FG000|Overall Study|Physician Decision|0|||
94578768|NCT05673876|323920845|FG001|Overall Study|Physician Decision|1|||
94578769|NCT04500158|323920849|FG000|Overall Study|Physician Decision|17|||
94578770|NCT04500158|323920850|FG001|Overall Study|Physician Decision|11|||
94578771|NCT03205423|323920851|FG000|Overall Study|Personal|1|||
94578772|NCT03205423|323920852|FG001|Overall Study|Personal|1|||
94578773|NCT03205423|323920851|FG000|Overall Study|Physician Decision|0|||
94578774|NCT03205423|323920852|FG001|Overall Study|Physician Decision|2|||
94578775|NCT02419001|323922324|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
94578776|NCT02419001|323922325|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
94578777|NCT02851615|323922328|FG000|Overall Study|Cognitive Issue|1|||
94578778|NCT02851615|323922329|FG001|Overall Study|Cognitive Issue|0|||
94578779|NCT02851615|323922328|FG000|Overall Study|Lost to Follow-up|0|||
94578780|NCT02851615|323922329|FG001|Overall Study|Lost to Follow-up|4|||
94578781|NCT00371150|323922335|FG000|Overall Study|Lost to Follow-up|3|||
94578782|NCT00371150|323922336|FG001|Overall Study|Lost to Follow-up|2|||
94578783|NCT02345070|323922338|FG000|Overall Study|Adverse Event|12|||
94578784|NCT02345070|323922339|FG001|Overall Study|Adverse Event|8|||
94578785|NCT02345070|323922340|FG002|Overall Study|Adverse Event|16|||
94578786|NCT02345070|323922338|FG000|Overall Study|Poor compliance to protocol|2|||
94578787|NCT02345070|323922339|FG001|Overall Study|Poor compliance to protocol|0|||
94578788|NCT02345070|323922340|FG002|Overall Study|Poor compliance to protocol|0|||
94578789|NCT02345070|323922338|FG000|Overall Study|Other than specified above|6|||
94578790|NCT02345070|323922339|FG001|Overall Study|Other than specified above|3|||
94578791|NCT02345070|323922340|FG002|Overall Study|Other than specified above|7|||
94578792|NCT01710501|323922341|FG000|Overall Study|Lost to Follow-up|2|||
94578793|NCT01710501|323922342|FG001|Overall Study|Lost to Follow-up|0|||
94240241|NCT01011868|322674571|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
94240242|NCT01011868|322674569|FG000|After Week 78 Follow-up|Protocol Violation|9|||
94240243|NCT01011868|322674570|FG001|After Week 78 Follow-up|Protocol Violation|1|||
94240244|NCT01011868|322674571|FG002|After Week 78 Follow-up|Protocol Violation|2|||
94240245|NCT01011868|322674569|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
94240246|NCT01011868|322674570|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
94578794|NCT01710501|323922343|FG002|Overall Study|Lost to Follow-up|0|||
94578795|NCT02536976|323922344|FG000|Overall Study|Physician Decision|0|||
94578796|NCT02536976|323922345|FG001|Overall Study|Physician Decision|1|||
94578797|NCT01198795|323922357|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
94578798|NCT01198795|323922357|FG000|Overall Study|Withdrawal by Subject|17|||
94578799|NCT01198795|323922357|FG000|Overall Study|Lost to Follow-up|15|||
94578800|NCT01198795|323922357|FG000|Overall Study|Adverse Event|9|||
94578801|NCT01198795|323922357|FG000|Overall Study|Lack of Efficacy|5|||
94578802|NCT01198795|323922357|FG000|Overall Study|Protocol Violation|2|||
94578803|NCT01198795|323922357|FG000|Overall Study|Other Reason|4|||
94578804|NCT00744497|323922358|FG000|Overall Study|Withdrawal by Subject|21|||
94578805|NCT00744497|323922359|FG001|Overall Study|Withdrawal by Subject|18|||
94578806|NCT00744497|323922358|FG000|Overall Study|Death|11|||
94578807|NCT00744497|323922359|FG001|Overall Study|Death|9|||
94578808|NCT00744497|323922358|FG000|Overall Study|Lost to Follow-up|4|||
94578809|NCT00744497|323922359|FG001|Overall Study|Lost to Follow-up|2|||
94578810|NCT00744497|323922358|FG000|Overall Study|Poor compliance/noncompliance|9|||
94578811|NCT00744497|323922359|FG001|Overall Study|Poor compliance/noncompliance|5|||
94578812|NCT00744497|323922358|FG000|Overall Study|No longer meets study criteria|7|||
94578813|NCT00744497|323922359|FG001|Overall Study|No longer meets study criteria|3|||
94578814|NCT00744497|323922358|FG000|Overall Study|Administrative Reason By Sponsor|25|||
94578815|NCT00744497|323922359|FG001|Overall Study|Administrative Reason By Sponsor|8|||
94578816|NCT00744497|323922358|FG000|Overall Study|Disease progression|312|||
94578817|NCT00744497|323922359|FG001|Overall Study|Disease progression|219|||
94578818|NCT00744497|323922358|FG000|Overall Study|Study drug toxicity|68|||
94578819|NCT00744497|323922359|FG001|Overall Study|Study drug toxicity|141|||
94578820|NCT00744497|323922358|FG000|Overall Study|Adverse event unrelated to study drug|78|||
94578821|NCT00744497|323922359|FG001|Overall Study|Adverse event unrelated to study drug|122|||
94578822|NCT00744497|323922358|FG000|Overall Study|Patient requested to stop study drug|65|||
94578823|NCT00744497|323922359|FG001|Overall Study|Patient requested to stop study drug|80|||
94240247|NCT01011868|322674571|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
94578824|NCT00744497|323922358|FG000|Overall Study|Maximum clinical benefit|141|||
94578825|NCT00744497|323922359|FG001|Overall Study|Maximum clinical benefit|142|||
94578826|NCT00744497|323922358|FG000|Overall Study|Not defined|19|||
94578827|NCT00744497|323922359|FG001|Overall Study|Not defined|13|||
94578828|NCT05101122|323922363|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
94578829|NCT05101122|323922363|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
94578830|NCT05101122|323922363|FG000|AD313 80/5|Withdrawal by Subject|1|||
94578831|NCT05101122|323922363|FG000|AD313 80/10|Physician Decision|1|||
94240248|NCT01011868|322674569|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
94351528|NCT01412333|323067410|FG001|Overall Study|Missing|3|||
94578832|NCT02703597|323922370|FG000|Assignment to Baseline|Lost to Follow-up|17|||
94578833|NCT02703597|323922371|FG001|Assignment to Baseline|Lost to Follow-up|16|||
94578834|NCT02703597|323922370|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
94578835|NCT02703597|323922371|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
94578836|NCT02703597|323922370|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
94578837|NCT02703597|323922371|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
94578838|NCT02703597|323922370|FG000|First Post-test to First Follow-up|Site drop out|0|||
94578839|NCT02703597|323922371|FG001|First Post-test to First Follow-up|Site drop out|58|||
94578840|NCT02703597|323922370|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
94578841|NCT02703597|323922371|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
94578842|NCT02703597|323922370|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
94578843|NCT02703597|323922371|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
94578844|NCT02703597|323922370|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
94578845|NCT02703597|323922371|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
94578846|NCT02606643|323922372|FG000|Overall Study|did not meet inclusion criteria|1|||
94578847|NCT02606643|323922373|FG001|Overall Study|did not meet inclusion criteria|3|||
94578848|NCT02796170|323922375|FG000|Overall Study|Lost to Follow-up|3|||
94578849|NCT02796170|323922376|FG001|Overall Study|Lost to Follow-up|0|||
94578850|NCT01980017|323922377|FG000|Overall Study|Lost to Follow-up|30|||
94578851|NCT01980017|323922378|FG001|Overall Study|Lost to Follow-up|21|||
94578852|NCT01980017|323922377|FG000|Overall Study|Death|0|||
94578853|NCT01980017|323922378|FG001|Overall Study|Death|1|||
94578854|NCT03044106|323922379|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
94578855|NCT03044106|323922380|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
94578856|NCT02057250|323922381|FG000|AID Assessment Phase|Adverse Event|3|||
94578857|NCT02057250|323922382|FG001|AID Assessment Phase|Adverse Event|2|||
94578858|NCT02057250|323922383|FG002|AID Assessment Phase|Adverse Event|6|||
94578859|NCT02057250|323922384|FG003|AID Assessment Phase|Adverse Event|1|||
94578860|NCT02057250|323922385|FG004|AID Assessment Phase|Adverse Event|0|||
94578861|NCT02057250|323922381|FG000|AID Assessment Phase|Other than specified above|1|||
94578862|NCT02057250|323922382|FG001|AID Assessment Phase|Other than specified above|1|||
94578863|NCT02057250|323922383|FG002|AID Assessment Phase|Other than specified above|1|||
94578864|NCT02057250|323922384|FG003|AID Assessment Phase|Other than specified above|1|||
94578865|NCT02057250|323922385|FG004|AID Assessment Phase|Other than specified above|0|||
94578866|NCT02057250|323922381|FG000|Extension Phase|Adverse Event|0|||
94578867|NCT02057250|323922382|FG001|Extension Phase|Adverse Event|0|||
94578868|NCT02057250|323922383|FG002|Extension Phase|Adverse Event|0|||
94578869|NCT02057250|323922384|FG003|Extension Phase|Adverse Event|0|||
94578870|NCT02057250|323922385|FG004|Extension Phase|Adverse Event|15|||
94578871|NCT02057250|323922381|FG000|Extension Phase|Lack of Efficacy|0|||
94578872|NCT02057250|323922382|FG001|Extension Phase|Lack of Efficacy|0|||
94578873|NCT02057250|323922383|FG002|Extension Phase|Lack of Efficacy|0|||
94578874|NCT02057250|323922384|FG003|Extension Phase|Lack of Efficacy|0|||
94578875|NCT02057250|323922385|FG004|Extension Phase|Lack of Efficacy|10|||
94578876|NCT02057250|323922381|FG000|Extension Phase|Entered in this period but not treated|0|||
94578877|NCT02057250|323922382|FG001|Extension Phase|Entered in this period but not treated|0|||
94578878|NCT02057250|323922383|FG002|Extension Phase|Entered in this period but not treated|0|||
94578879|NCT02057250|323922384|FG003|Extension Phase|Entered in this period but not treated|0|||
94578880|NCT02057250|323922385|FG004|Extension Phase|Entered in this period but not treated|4|||
94578881|NCT02057250|323922381|FG000|Extension Phase|Other than specified above|0|||
94578882|NCT02057250|323922382|FG001|Extension Phase|Other than specified above|0|||
94578883|NCT02057250|323922383|FG002|Extension Phase|Other than specified above|0|||
94351529|NCT04815291|323067417|FG000|Overall Study|Lost to Follow-up|1|||
94578884|NCT02057250|323922384|FG003|Extension Phase|Other than specified above|0|||
94578885|NCT02057250|323922385|FG004|Extension Phase|Other than specified above|7|||
94578886|NCT04798196|323922390|FG000|Overall Study|Lost to Follow-up|3|||
94578887|NCT04798196|323922391|FG001|Overall Study|Lost to Follow-up|1|||
94578888|NCT04798196|323922392|FG002|Overall Study|Lost to Follow-up|3|||
94578889|NCT01249261|323922393|FG000|Overall Study|Withdrawal by Subject|1|||
94578890|NCT01249261|323922394|FG001|Overall Study|Withdrawal by Subject|0|||
94578891|NCT02224560|323922399|FG000|Overall Study|Protocol Deviation|1|||
94578892|NCT02224560|323922400|FG001|Overall Study|Protocol Deviation|0|||
94578893|NCT02224560|323922401|FG002|Overall Study|Protocol Deviation|0|||
94578894|NCT02224560|323922399|FG000|Overall Study|Withdrawal by Subject|2|||
94578895|NCT02224560|323922400|FG001|Overall Study|Withdrawal by Subject|0|||
94578896|NCT02224560|323922401|FG002|Overall Study|Withdrawal by Subject|1|||
94578897|NCT02224560|323922399|FG000|Overall Study|Met Withdrawal Criteria|1|||
94578898|NCT02224560|323922400|FG001|Overall Study|Met Withdrawal Criteria|0|||
94578899|NCT02224560|323922401|FG002|Overall Study|Met Withdrawal Criteria|0|||
94578900|NCT02224560|323922399|FG000|Overall Study|Adverse Event|4|||
94578901|NCT02224560|323922400|FG001|Overall Study|Adverse Event|1|||
94578902|NCT02224560|323922401|FG002|Overall Study|Adverse Event|1|||
94578903|NCT02224560|323922399|FG000|Overall Study|Withdrawn by Investigator|1|||
94578904|NCT02224560|323922400|FG001|Overall Study|Withdrawn by Investigator|1|||
94578905|NCT02224560|323922401|FG002|Overall Study|Withdrawn by Investigator|0|||
94578906|NCT00389610|323922404|FG000|Overall Study|Disease Progression|0|||
94578907|NCT00389610|323922405|FG001|Overall Study|Disease Progression|19|||
94578908|NCT00389610|323922404|FG000|Overall Study|Death|0|||
94578909|NCT00389610|323922405|FG001|Overall Study|Death|1|||
94578910|NCT00389610|323922404|FG000|Overall Study|Physician Decision|0|||
94578911|NCT00389610|323922405|FG001|Overall Study|Physician Decision|1|||
94578912|NCT00389610|323922404|FG000|Overall Study|Withdrawal by Subject|0|||
94578913|NCT00389610|323922405|FG001|Overall Study|Withdrawal by Subject|1|||
94578914|NCT00887809|323922406|FG000|Overall Study|Patient Not Treated|3|||
94578915|NCT00887809|323922407|FG001|Overall Study|Patient Not Treated|0|||
94578916|NCT00887809|323922406|FG000|Overall Study|Death|1|||
94578917|NCT00887809|323922407|FG001|Overall Study|Death|0|||
94578918|NCT04596267|323922408|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
94578919|NCT04596267|323922409|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
94578920|NCT04596267|323922408|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
94578921|NCT04596267|323922409|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
94578922|NCT00071058|323922410|FG000|Overall Study|brain tumor-removed from study|1|||
94578923|NCT03755934|323922413|FG000|Overall Study|Adverse Event|4|||
94578924|NCT03755934|323922414|FG001|Overall Study|Adverse Event|1|||
94578925|NCT03755934|323922415|FG002|Overall Study|Adverse Event|1|||
94578926|NCT03755934|323922416|FG003|Overall Study|Adverse Event|3|||
94578927|NCT03755934|323922413|FG000|Overall Study|Physician Decision|2|||
94578928|NCT03755934|323922414|FG001|Overall Study|Physician Decision|0|||
94578929|NCT03755934|323922415|FG002|Overall Study|Physician Decision|0|||
94578930|NCT03755934|323922416|FG003|Overall Study|Physician Decision|1|||
94578931|NCT03755934|323922413|FG000|Overall Study|Withdrawal by Subject|5|||
94578932|NCT03755934|323922414|FG001|Overall Study|Withdrawal by Subject|0|||
94578933|NCT03755934|323922415|FG002|Overall Study|Withdrawal by Subject|0|||
94578934|NCT03755934|323922416|FG003|Overall Study|Withdrawal by Subject|1|||
94578935|NCT03755934|323922413|FG000|Overall Study|Other|3|||
94578936|NCT03755934|323922414|FG001|Overall Study|Other|1|||
94578937|NCT03755934|323922415|FG002|Overall Study|Other|3|||
94578938|NCT03755934|323922416|FG003|Overall Study|Other|1|||
94578939|NCT00307801|323922419|FG000|Overall Study|Adverse Event|12|||
94578940|NCT00307801|323922420|FG001|Overall Study|Adverse Event|4|||
94578941|NCT00307801|323922419|FG000|Overall Study|Withdrawal by Subject|9|||
94578942|NCT00307801|323922420|FG001|Overall Study|Withdrawal by Subject|4|||
94578943|NCT00307801|323922419|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
94578944|NCT00307801|323922420|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
94578945|NCT00307801|323922419|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
94578946|NCT00307801|323922420|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
94578947|NCT00307801|323922419|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
94578948|NCT00307801|323922420|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
94578949|NCT00307801|323922419|FG000|Overall Study|Wrong Randomization|1|||
94578950|NCT00307801|323922420|FG001|Overall Study|Wrong Randomization|0|||
94578951|NCT00307801|323922419|FG000|Overall Study|Lack of Efficacy|0|||
94578952|NCT00307801|323922420|FG001|Overall Study|Lack of Efficacy|2|||
94578953|NCT00307801|323922419|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
94578954|NCT00307801|323922420|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
94578955|NCT00307801|323922419|FG000|Overall Study|Frustration with e-diary|1|||
94578956|NCT00307801|323922420|FG001|Overall Study|Frustration with e-diary|0|||
94578957|NCT00307801|323922419|FG000|Overall Study|Protocol Violation|3|||
94578958|NCT00307801|323922420|FG001|Overall Study|Protocol Violation|2|||
94578959|NCT00307801|323922419|FG000|Overall Study|No reason specified|2|||
94578960|NCT00307801|323922420|FG001|Overall Study|No reason specified|0|||
94578961|NCT00307801|323922419|FG000|Overall Study|Pregnancy|0|||
94578962|NCT00307801|323922420|FG001|Overall Study|Pregnancy|1|||
94578963|NCT02072668|323922427|FG000|Second Intervention|Lost to Follow-up|1|||
94578964|NCT02072668|323922428|FG001|Second Intervention|Lost to Follow-up|0|||
94578965|NCT05386329|323922434|FG000|Overall Study|Lost to Follow-up|3|||
94578966|NCT03041181|323922441|FG000|Overall Study|Disease Progression|1|||
94578967|NCT03041181|323922442|FG001|Overall Study|Disease Progression|2|||
94578968|NCT03783078|323922445|FG000|Overall Study|Death|31|||
94578969|NCT03783078|323922445|FG000|Overall Study|Sponsor Decision|23|||
94578970|NCT03783078|323922445|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
94578971|NCT03815929|323922446|FG000|Overall Study|Lost to Follow-up|2|||
94578972|NCT03815929|323922447|FG001|Overall Study|Lost to Follow-up|1|||
94578973|NCT03815929|323922448|FG002|Overall Study|Lost to Follow-up|0|||
94578974|NCT03815929|323922446|FG000|Overall Study|Physician Decision|2|||
94578975|NCT03815929|323922447|FG001|Overall Study|Physician Decision|2|||
94578976|NCT03815929|323922448|FG002|Overall Study|Physician Decision|0|||
94578977|NCT03815929|323922446|FG000|Overall Study|Withdrawal by Subject|0|||
94578978|NCT03815929|323922447|FG001|Overall Study|Withdrawal by Subject|0|||
94578979|NCT03815929|323922448|FG002|Overall Study|Withdrawal by Subject|1|||
94578980|NCT02760498|323922449|FG000|Overall Study|Adverse Event|3|||
94578981|NCT02760498|323922450|FG001|Overall Study|Adverse Event|3|||
94578982|NCT02760498|323922451|FG002|Overall Study|Adverse Event|1|||
94578983|NCT02760498|323922452|FG003|Overall Study|Adverse Event|1|||
94578984|NCT02760498|323922453|FG004|Overall Study|Adverse Event|0|||
94578985|NCT02760498|323922454|FG005|Overall Study|Adverse Event|6|||
94578986|NCT02760498|323922449|FG000|Overall Study|Death|7|||
94578987|NCT02760498|323922450|FG001|Overall Study|Death|5|||
94578988|NCT02760498|323922451|FG002|Overall Study|Death|5|||
94578989|NCT02760498|323922452|FG003|Overall Study|Death|7|||
94578990|NCT02760498|323922453|FG004|Overall Study|Death|0|||
94454165|NCT03689374|323450274|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
94578991|NCT02760498|323922454|FG005|Overall Study|Death|23|||
94578992|NCT02760498|323922449|FG000|Overall Study|Lost to Follow-up|0|||
94578993|NCT02760498|323922450|FG001|Overall Study|Lost to Follow-up|0|||
94578994|NCT02760498|323922451|FG002|Overall Study|Lost to Follow-up|0|||
94578995|NCT02760498|323922452|FG003|Overall Study|Lost to Follow-up|0|||
94578996|NCT02760498|323922453|FG004|Overall Study|Lost to Follow-up|0|||
94578997|NCT02760498|323922454|FG005|Overall Study|Lost to Follow-up|3|||
94578998|NCT02760498|323922449|FG000|Overall Study|Non-compliance with study drug|0|||
94454166|NCT03689374|323450275|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
94578999|NCT02760498|323922450|FG001|Overall Study|Non-compliance with study drug|2|||
94579000|NCT02760498|323922451|FG002|Overall Study|Non-compliance with study drug|0|||
94579001|NCT02760498|323922452|FG003|Overall Study|Non-compliance with study drug|0|||
94579002|NCT02760498|323922453|FG004|Overall Study|Non-compliance with study drug|0|||
94579003|NCT02760498|323922454|FG005|Overall Study|Non-compliance with study drug|0|||
94579004|NCT02760498|323922449|FG000|Overall Study|Participant decision|1|||
94579005|NCT02760498|323922450|FG001|Overall Study|Participant decision|4|||
94579006|NCT02760498|323922451|FG002|Overall Study|Participant decision|2|||
94579007|NCT02760498|323922452|FG003|Overall Study|Participant decision|2|||
94579008|NCT02760498|323922453|FG004|Overall Study|Participant decision|1|||
94579009|NCT02760498|323922454|FG005|Overall Study|Participant decision|6|||
94579010|NCT02760498|323922449|FG000|Overall Study|Sponsor decision|0|||
94579011|NCT02760498|323922450|FG001|Overall Study|Sponsor decision|0|||
94579012|NCT02760498|323922451|FG002|Overall Study|Sponsor decision|0|||
94579013|NCT02760498|323922452|FG003|Overall Study|Sponsor decision|3|||
94579014|NCT02760498|323922453|FG004|Overall Study|Sponsor decision|0|||
94579015|NCT02760498|323922454|FG005|Overall Study|Sponsor decision|0|||
94579016|NCT02760498|323922449|FG000|Overall Study|Physician Decision|3|||
94579017|NCT02760498|323922450|FG001|Overall Study|Physician Decision|4|||
94579018|NCT02760498|323922451|FG002|Overall Study|Physician Decision|1|||
94579019|NCT02760498|323922452|FG003|Overall Study|Physician Decision|4|||
94579020|NCT02760498|323922453|FG004|Overall Study|Physician Decision|0|||
94579021|NCT02760498|323922454|FG005|Overall Study|Physician Decision|2|||
94579022|NCT02760498|323922449|FG000|Overall Study|Disease progression|21|||
94579023|NCT02760498|323922450|FG001|Overall Study|Disease progression|19|||
94579024|NCT02760498|323922451|FG002|Overall Study|Disease progression|20|||
94579025|NCT02760498|323922452|FG003|Overall Study|Disease progression|18|||
94579026|NCT02760498|323922453|FG004|Overall Study|Disease progression|4|||
94579027|NCT02760498|323922454|FG005|Overall Study|Disease progression|55|||
94579028|NCT02760498|323922449|FG000|Overall Study|Withdrawal by Subject|4|||
94579029|NCT02760498|323922450|FG001|Overall Study|Withdrawal by Subject|7|||
94579030|NCT02760498|323922451|FG002|Overall Study|Withdrawal by Subject|5|||
94579031|NCT02760498|323922452|FG003|Overall Study|Withdrawal by Subject|1|||
94579032|NCT02760498|323922453|FG004|Overall Study|Withdrawal by Subject|0|||
94579033|NCT02760498|323922454|FG005|Overall Study|Withdrawal by Subject|6|||
94579034|NCT02760498|323922449|FG000|Overall Study|Other than specified|1|||
94579035|NCT02760498|323922450|FG001|Overall Study|Other than specified|6|||
94579036|NCT02760498|323922451|FG002|Overall Study|Other than specified|0|||
94579037|NCT02760498|323922452|FG003|Overall Study|Other than specified|3|||
94579038|NCT02760498|323922453|FG004|Overall Study|Other than specified|1|||
94579039|NCT02760498|323922454|FG005|Overall Study|Other than specified|0|||
94579040|NCT02760498|323922449|FG000|Overall Study|Not treated|0|||
94579041|NCT02760498|323922450|FG001|Overall Study|Not treated|0|||
94579042|NCT02760498|323922451|FG002|Overall Study|Not treated|0|||
94579043|NCT02760498|323922452|FG003|Overall Study|Not treated|0|||
94579044|NCT02760498|323922453|FG004|Overall Study|Not treated|0|||
94579045|NCT02760498|323922454|FG005|Overall Study|Not treated|2|||
94579046|NCT02205736|323922455|FG000|Overall Study|Lost to Follow-up|106|||
94579047|NCT01467960|323922456|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
94579048|NCT01467960|323922457|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
94579049|NCT01467960|323922458|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
94579050|NCT01467960|323922459|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
94579051|NCT01467960|323922460|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
94579052|NCT01467960|323922461|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
94579053|NCT03955146|323922464|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
94579054|NCT03955146|323922465|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
94579055|NCT03955146|323922466|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
94579056|NCT03955146|323922467|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
94579057|NCT03955146|323922464|FG000|DB Period (48 Weeks)|Adverse Event|2|||
94579058|NCT03955146|323922465|FG001|DB Period (48 Weeks)|Adverse Event|5|||
94579059|NCT03955146|323922466|FG002|DB Period (48 Weeks)|Adverse Event|1|||
94579060|NCT03955146|323922467|FG003|DB Period (48 Weeks)|Adverse Event|2|||
94579061|NCT03955146|323922464|FG000|DB Period (48 Weeks)|Death|13|||
94579062|NCT03955146|323922465|FG001|DB Period (48 Weeks)|Death|17|||
94579063|NCT03955146|323922466|FG002|DB Period (48 Weeks)|Death|1|||
94579064|NCT03955146|323922467|FG003|DB Period (48 Weeks)|Death|0|||
94579065|NCT03955146|323922464|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
94579066|NCT03955146|323922465|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
94579067|NCT03955146|323922466|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
94579068|NCT03955146|323922467|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
94579069|NCT03955146|323922464|FG000|DB Period (48 Weeks)|Disease Progression|2|||
94579070|NCT03955146|323922465|FG001|DB Period (48 Weeks)|Disease Progression|0|||
94579071|NCT03955146|323922466|FG002|DB Period (48 Weeks)|Disease Progression|0|||
94579072|NCT03955146|323922467|FG003|DB Period (48 Weeks)|Disease Progression|0|||
94579073|NCT03955146|323922464|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
94579074|NCT03955146|323922465|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
94579075|NCT03955146|323922466|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
94579076|NCT03955146|323922467|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
94579077|NCT03955146|323922464|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
94579078|NCT03955146|323922465|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
94579079|NCT03955146|323922466|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
94579080|NCT03955146|323922467|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
94579081|NCT03955146|323922464|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
94579082|NCT03955146|323922465|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
94579083|NCT03955146|323922466|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
94579084|NCT03955146|323922467|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
94579085|NCT03955146|323922464|FG000|DB Period (48 Weeks)|Participant Decision|9|||
94579086|NCT03955146|323922465|FG001|DB Period (48 Weeks)|Participant Decision|12|||
94579087|NCT03955146|323922466|FG002|DB Period (48 Weeks)|Participant Decision|1|||
94579088|NCT03955146|323922467|FG003|DB Period (48 Weeks)|Participant Decision|1|||
94579089|NCT03955146|323922464|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
94579090|NCT03955146|323922465|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
94579091|NCT03955146|323922466|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
94579092|NCT03955146|323922467|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
94579093|NCT03955146|323922464|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
94579094|NCT03955146|323922465|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
94579095|NCT03955146|323922466|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
94579096|NCT03955146|323922467|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
94579097|NCT03955146|323922464|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
94579098|NCT03955146|323922465|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
94579099|NCT03955146|323922466|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
94579100|NCT03955146|323922467|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
94579101|NCT03955146|323922464|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
94579102|NCT03955146|323922465|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
94579103|NCT03955146|323922466|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
94579104|NCT03955146|323922467|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
94579105|NCT03955146|323922464|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
94240249|NCT01011868|322674570|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
94579106|NCT03955146|323922465|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
94579107|NCT03955146|323922466|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
94579108|NCT03955146|323922467|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
94579109|NCT03955146|323922464|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
94579110|NCT03955146|323922465|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
94579111|NCT03955146|323922466|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
94579112|NCT03955146|323922467|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
94579113|NCT03955146|323922464|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
94579114|NCT03955146|323922465|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
94240250|NCT01011868|322674571|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
94240251|NCT01011868|322674569|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
94240252|NCT01011868|322674570|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
94579115|NCT03955146|323922466|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
94579116|NCT03955146|323922467|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
94240253|NCT01011868|322674571|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
94579117|NCT03955146|323922464|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
94240254|NCT00664534|322674573|FG000|Overall Study|Adverse Event|2|||
94240255|NCT00664534|322674574|FG001|Overall Study|Adverse Event|3|||
94579118|NCT03955146|323922465|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
94579119|NCT03955146|323922466|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
94579120|NCT03955146|323922467|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
94579121|NCT03955146|323922464|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
94579122|NCT03955146|323922465|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
94579123|NCT03955146|323922466|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
94579124|NCT03955146|323922467|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
94579125|NCT03955146|323922464|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
94579126|NCT03955146|323922465|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
94579127|NCT03955146|323922466|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
94579128|NCT03955146|323922467|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
94579129|NCT03955146|323922464|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
94579130|NCT03955146|323922465|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
94579131|NCT03955146|323922466|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
94579132|NCT03955146|323922467|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
94579133|NCT05632211|323922468|FG000|Overall Study|Withdrawal by Subject|2|||
94579134|NCT05632211|323922469|FG001|Overall Study|Withdrawal by Subject|0|||
94579135|NCT05632211|323922470|FG002|Overall Study|Withdrawal by Subject|2|||
94579136|NCT05632211|323922468|FG000|Overall Study|Other reasons|1|||
94579137|NCT05632211|323922469|FG001|Overall Study|Other reasons|1|||
94579138|NCT05632211|323922470|FG002|Overall Study|Other reasons|1|||
94579139|NCT03043794|323922474|FG000|Overall Study|Lost to Follow-up|1|||
94579140|NCT04390763|323922475|FG000|Safety run-in Part|Adverse Event|4|||
94579141|NCT04390763|323922476|FG001|Safety run-in Part|Adverse Event|0|||
94579142|NCT04390763|323922477|FG002|Safety run-in Part|Adverse Event|0|||
94579143|NCT04390763|323922478|FG003|Safety run-in Part|Adverse Event|0|||
94579144|NCT04390763|323922475|FG000|Safety run-in Part|Physician Decision|1|||
94579145|NCT04390763|323922476|FG001|Safety run-in Part|Physician Decision|0|||
94579146|NCT04390763|323922477|FG002|Safety run-in Part|Physician Decision|0|||
94579147|NCT04390763|323922478|FG003|Safety run-in Part|Physician Decision|0|||
94579148|NCT04390763|323922475|FG000|Safety run-in Part|Progressive Disease|6|||
94579149|NCT04390763|323922476|FG001|Safety run-in Part|Progressive Disease|0|||
94579150|NCT04390763|323922477|FG002|Safety run-in Part|Progressive Disease|0|||
94579151|NCT04390763|323922478|FG003|Safety run-in Part|Progressive Disease|0|||
94579152|NCT04390763|323922475|FG000|Randomized Part|Adverse Event|0|||
94579153|NCT04390763|323922476|FG001|Randomized Part|Adverse Event|11|||
94579154|NCT04390763|323922477|FG002|Randomized Part|Adverse Event|5|||
94579155|NCT04390763|323922478|FG003|Randomized Part|Adverse Event|5|||
94240256|NCT00664534|322674573|FG000|Overall Study|Lost to Follow-up|6|||
94240257|NCT00664534|322674574|FG001|Overall Study|Lost to Follow-up|10|||
94579156|NCT04390763|323922475|FG000|Randomized Part|Death|0|||
94579157|NCT04390763|323922476|FG001|Randomized Part|Death|3|||
94579158|NCT04390763|323922477|FG002|Randomized Part|Death|4|||
94579159|NCT04390763|323922478|FG003|Randomized Part|Death|2|||
94579160|NCT04390763|323922475|FG000|Randomized Part|Physician Decision|0|||
94579161|NCT04390763|323922476|FG001|Randomized Part|Physician Decision|2|||
94579162|NCT04390763|323922477|FG002|Randomized Part|Physician Decision|2|||
94579163|NCT04390763|323922478|FG003|Randomized Part|Physician Decision|9|||
94579164|NCT04390763|323922475|FG000|Randomized Part|Progressive Disease|0|||
94579165|NCT04390763|323922476|FG001|Randomized Part|Progressive Disease|24|||
94579166|NCT04390763|323922477|FG002|Randomized Part|Progressive Disease|31|||
94579167|NCT04390763|323922478|FG003|Randomized Part|Progressive Disease|23|||
94579168|NCT04390763|323922475|FG000|Randomized Part|Study terminated by sponsor|0|||
94579169|NCT04390763|323922476|FG001|Randomized Part|Study terminated by sponsor|1|||
94579170|NCT04390763|323922477|FG002|Randomized Part|Study terminated by sponsor|0|||
94579171|NCT04390763|323922478|FG003|Randomized Part|Study terminated by sponsor|0|||
94579172|NCT04390763|323922475|FG000|Randomized Part|Participant Decision|0|||
94579173|NCT04390763|323922476|FG001|Randomized Part|Participant Decision|5|||
94579174|NCT04390763|323922477|FG002|Randomized Part|Participant Decision|7|||
94579175|NCT04390763|323922478|FG003|Randomized Part|Participant Decision|6|||
94579176|NCT04390763|323922475|FG000|Randomized Part|Not treated|0|||
94579177|NCT04390763|323922476|FG001|Randomized Part|Not treated|4|||
94579178|NCT04390763|323922477|FG002|Randomized Part|Not treated|2|||
94579179|NCT04390763|323922478|FG003|Randomized Part|Not treated|7|||
94579180|NCT02081677|323924393|FG000|Overall Study|Adverse Event|0|||
94579181|NCT02081677|323924394|FG001|Overall Study|Adverse Event|0|||
94579182|NCT02081677|323924395|FG002|Overall Study|Adverse Event|1|||
94579183|NCT02081677|323924396|FG003|Overall Study|Adverse Event|0|||
94579184|NCT02081677|323924393|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
94579185|NCT02081677|323924394|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
94579186|NCT02081677|323924395|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
94579187|NCT02081677|323924396|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
94579188|NCT02081677|323924393|FG000|Overall Study|Not comfortable with lens care system|1|||
94240258|NCT00664534|322674573|FG000|Overall Study|Protocol Violation|10|||
94240259|NCT00664534|322674574|FG001|Overall Study|Protocol Violation|8|||
94240260|NCT00664534|322674573|FG000|Overall Study|Withdrawal by Subject|7|||
94454167|NCT03689374|323450273|FG000|Treatment Period (Week 0 to 52)|Death|0|||
94454168|NCT03689374|323450274|FG001|Treatment Period (Week 0 to 52)|Death|11|||
94454169|NCT03689374|323450275|FG002|Treatment Period (Week 0 to 52)|Death|1|||
94454170|NCT00986921|323450280|FG000|Overall Study|Physician Decision|1|||
94454171|NCT00986921|323450281|FG001|Overall Study|Physician Decision|0|||
94454172|NCT00813813|323450282|FG000|Overall Study|Withdrawal by Subject|1|||
94454173|NCT00813813|323450283|FG001|Overall Study|Withdrawal by Subject|1|||
94454174|NCT00813813|323450282|FG000|Overall Study|Lost to Follow-up|2|||
94454175|NCT00813813|323450283|FG001|Overall Study|Lost to Follow-up|7|||
94454176|NCT00813813|323450282|FG000|Overall Study|Other|0|||
94454177|NCT00813813|323450283|FG001|Overall Study|Other|1|||
94454178|NCT02805660|323450284|FG000|Overall Study|Death|5|||
94454179|NCT02805660|323450285|FG001|Overall Study|Death|2|||
94454180|NCT02805660|323450286|FG002|Overall Study|Death|9|||
94454181|NCT02805660|323450287|FG003|Overall Study|Death|5|||
94454182|NCT02805660|323450288|FG004|Overall Study|Death|0|||
94454183|NCT02805660|323450289|FG005|Overall Study|Death|14|||
94454184|NCT02805660|323450290|FG006|Overall Study|Death|12|||
94454185|NCT02805660|323450284|FG000|Overall Study|Lost to Follow-up|0|||
94454186|NCT02805660|323450285|FG001|Overall Study|Lost to Follow-up|1|||
94454187|NCT02805660|323450286|FG002|Overall Study|Lost to Follow-up|1|||
94454188|NCT02805660|323450287|FG003|Overall Study|Lost to Follow-up|2|||
94454189|NCT02805660|323450288|FG004|Overall Study|Lost to Follow-up|0|||
94454190|NCT02805660|323450289|FG005|Overall Study|Lost to Follow-up|0|||
94454191|NCT02805660|323450290|FG006|Overall Study|Lost to Follow-up|0|||
94454192|NCT02805660|323450284|FG000|Overall Study|Withdrawal by Subject|0|||
94454193|NCT02805660|323450285|FG001|Overall Study|Withdrawal by Subject|0|||
94454194|NCT02805660|323450286|FG002|Overall Study|Withdrawal by Subject|0|||
94454195|NCT02805660|323450287|FG003|Overall Study|Withdrawal by Subject|3|||
94454196|NCT02805660|323450288|FG004|Overall Study|Withdrawal by Subject|1|||
94454197|NCT02805660|323450289|FG005|Overall Study|Withdrawal by Subject|0|||
94454198|NCT02805660|323450290|FG006|Overall Study|Withdrawal by Subject|2|||
94454199|NCT02805660|323450284|FG000|Overall Study|Study terminated by Sponsor|0|||
94454200|NCT02805660|323450285|FG001|Overall Study|Study terminated by Sponsor|0|||
94454201|NCT02805660|323450286|FG002|Overall Study|Study terminated by Sponsor|1|||
94454202|NCT02805660|323450287|FG003|Overall Study|Study terminated by Sponsor|4|||
94454203|NCT02805660|323450288|FG004|Overall Study|Study terminated by Sponsor|2|||
94454204|NCT02805660|323450289|FG005|Overall Study|Study terminated by Sponsor|3|||
94454205|NCT02805660|323450290|FG006|Overall Study|Study terminated by Sponsor|1|||
94454206|NCT02805660|323450284|FG000|Overall Study|Miscellaneous|0|||
94454207|NCT02805660|323450285|FG001|Overall Study|Miscellaneous|1|||
94454208|NCT02805660|323450286|FG002|Overall Study|Miscellaneous|0|||
94454209|NCT02805660|323450287|FG003|Overall Study|Miscellaneous|4|||
94454210|NCT02805660|323450288|FG004|Overall Study|Miscellaneous|0|||
94240261|NCT00664534|322674574|FG001|Overall Study|Withdrawal by Subject|6|||
94454211|NCT02805660|323450289|FG005|Overall Study|Miscellaneous|6|||
94454212|NCT02805660|323450290|FG006|Overall Study|Miscellaneous|4|||
94454213|NCT05270395|323450291|FG000|Overall Study|Lost to Follow-up|2|||
94579189|NCT02081677|323924394|FG001|Overall Study|Not comfortable with lens care system|0|||
94579190|NCT02081677|323924395|FG002|Overall Study|Not comfortable with lens care system|0|||
94579191|NCT02081677|323924396|FG003|Overall Study|Not comfortable with lens care system|0|||
94579192|NCT02081677|323924393|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
94579193|NCT02081677|323924394|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
94579194|NCT02081677|323924395|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
94579195|NCT02081677|323924396|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
94579196|NCT02892344|323924397|FG000|Overall Study|Protocol deviation|3|||
94579197|NCT02892344|323924398|FG001|Overall Study|Protocol deviation|4|||
94579198|NCT02892344|323924397|FG000|Overall Study|Adverse Event|1|||
94579199|NCT02892344|323924398|FG001|Overall Study|Adverse Event|8|||
94579200|NCT02892344|323924397|FG000|Overall Study|Lost to Follow-up|0|||
94579201|NCT02892344|323924398|FG001|Overall Study|Lost to Follow-up|1|||
94579202|NCT02892344|323924397|FG000|Overall Study|Non-compliance with study treatment|0|||
94579203|NCT02892344|323924398|FG001|Overall Study|Non-compliance with study treatment|1|||
94579204|NCT02892344|323924397|FG000|Overall Study|Physician Decision|0|||
94579205|NCT02892344|323924398|FG001|Overall Study|Physician Decision|2|||
94579206|NCT02892344|323924397|FG000|Overall Study|Subject/guardian decision|0|||
94579207|NCT02892344|323924398|FG001|Overall Study|Subject/guardian decision|4|||
94579208|NCT02892344|323924397|FG000|Overall Study|Technical problems|0|||
94579209|NCT02892344|323924398|FG001|Overall Study|Technical problems|1|||
94579210|NCT01586364|323924399|FG000|Overall Study|Withdrawal by Subject|40|||
94579211|NCT01586364|323924399|FG000|Overall Study|Adverse Event|37|||
94579212|NCT01586364|323924399|FG000|Overall Study|Lost to Follow-up|17|||
94579213|NCT01586364|323924399|FG000|Overall Study|Protocol Violation|16|||
94579214|NCT01586364|323924399|FG000|Overall Study|Lack of Efficacy|1|||
94579215|NCT01586364|323924399|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
94579216|NCT01586364|323924399|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
94579217|NCT01586364|323924399|FG000|Overall Study|Other-Site closure due to PI illness|1|||
94579218|NCT01586364|323924399|FG000|Overall Study|Other-PI discretion, site closing|2|||
94579219|NCT01586364|323924399|FG000|Overall Study|Other-Not specified|1|||
94579220|NCT02121535|323924400|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
94579221|NCT02121535|323924401|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
94579222|NCT02121535|323924400|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
94579223|NCT02121535|323924401|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
94579224|NCT04944992|323924402|FG000|Overall Study|Lost to Follow-up|1|||
94579225|NCT04944992|323924403|FG001|Overall Study|Lost to Follow-up|1|||
94579226|NCT04944992|323924402|FG000|Overall Study|Physician Decision|1|||
94579227|NCT04944992|323924403|FG001|Overall Study|Physician Decision|0|||
94579228|NCT04944992|323924402|FG000|Overall Study|Withdrawal by Subject|6|||
94579229|NCT04944992|323924403|FG001|Overall Study|Withdrawal by Subject|1|||
94579230|NCT00091949|323924404|FG000|Overall Study|Withdrawal by Subject|117|||
94579231|NCT00091949|323924405|FG001|Overall Study|Withdrawal by Subject|110|||
94579232|NCT00091949|323924404|FG000|Overall Study|Lost to Follow-up|58|||
94579233|NCT00091949|323924405|FG001|Overall Study|Lost to Follow-up|41|||
94579234|NCT03414983|323924406|FG000|Pre-Treatment|Other reasons|1|||
94579235|NCT03414983|323924407|FG001|Pre-Treatment|Other reasons|0|||
94579236|NCT03414983|323924406|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
94579237|NCT03414983|323924407|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
94579238|NCT03414983|323924406|FG000|Pre-Treatment|Participant withdrew consent|1|||
94579239|NCT03414983|323924407|FG001|Pre-Treatment|Participant withdrew consent|3|||
94579240|NCT03414983|323924406|FG000|Treatment|Participant withdrew consent|4|||
94579241|NCT03414983|323924407|FG001|Treatment|Participant withdrew consent|3|||
94579242|NCT03414983|323924406|FG000|Treatment|Participant request to discontinue study treatment|8|||
94579243|NCT03414983|323924407|FG001|Treatment|Participant request to discontinue study treatment|10|||
94579244|NCT03414983|323924406|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
94579245|NCT03414983|323924407|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
94579246|NCT03414983|323924406|FG000|Treatment|Death|0|||
94579247|NCT03414983|323924407|FG001|Treatment|Death|1|||
94579248|NCT03414983|323924406|FG000|Treatment|Study Drug Toxicity|10|||
94579249|NCT03414983|323924407|FG001|Treatment|Study Drug Toxicity|5|||
94579250|NCT03414983|323924406|FG000|Treatment|Disease Progression|75|||
94579251|NCT03414983|323924407|FG001|Treatment|Disease Progression|29|||
94579252|NCT03414983|323924406|FG000|Treatment|Not reported|1|||
94579253|NCT03414983|323924407|FG001|Treatment|Not reported|0|||
94579254|NCT03414983|323924406|FG000|Treatment|Other reasons|3|||
94579255|NCT03414983|323924407|FG001|Treatment|Other reasons|2|||
94579256|NCT03414983|323924406|FG000|Treatment|Poor/non-compliance|2|||
94579257|NCT03414983|323924407|FG001|Treatment|Poor/non-compliance|0|||
94579258|NCT03414983|323924406|FG000|Treatment|Maximum clinical benefit|5|||
94579259|NCT03414983|323924407|FG001|Treatment|Maximum clinical benefit|9|||
94579260|NCT03414983|323924406|FG000|Treatment|Lost to Follow-up|0|||
94579261|NCT03414983|323924407|FG001|Treatment|Lost to Follow-up|1|||
94579262|NCT03414983|323924406|FG000|Treatment|Administrative reasons by sponsor|1|||
94579263|NCT03414983|323924407|FG001|Treatment|Administrative reasons by sponsor|0|||
94579264|NCT02608684|323924408|FG000|Overall Study|Physician Decision|2|||
94579265|NCT02608684|323924408|FG000|Overall Study|Withdrawal by Subject|1|||
94579266|NCT01520506|323924409|FG000|Overall Study|Missed Visit|4|||
94579267|NCT01520506|323924409|FG000|Overall Study|Lost to Follow-up|1|||
94579268|NCT01520506|323924409|FG000|Overall Study|Withdrawal by Subject|1|||
94579269|NCT00425269|323924410|FG000|Overall Study|Pregnancy|5|||
94579270|NCT00425269|323924411|FG001|Overall Study|Pregnancy|7|||
94579271|NCT00425269|323924410|FG000|Overall Study|Lost to Follow-up|9|||
94579272|NCT00425269|323924411|FG001|Overall Study|Lost to Follow-up|9|||
94579273|NCT00425269|323924410|FG000|Overall Study|moved or medical reason|5|||
94579274|NCT00425269|323924411|FG001|Overall Study|moved or medical reason|4|||
94579275|NCT01597596|323924414|FG000|Overall Study|Study terminated by sponsor|1|||
94579276|NCT01597596|323924415|FG001|Overall Study|Study terminated by sponsor|0|||
94579277|NCT01597596|323924414|FG000|Overall Study|Physician Decision|0|||
94579278|NCT01597596|323924415|FG001|Overall Study|Physician Decision|1|||
94579279|NCT00755183|323924416|FG000|Overall Study|Adverse Event|5|||
94579280|NCT00755183|323924417|FG001|Overall Study|Adverse Event|2|||
94579281|NCT00755183|323924416|FG000|Overall Study|Protocol Violation|0|||
94579282|NCT00755183|323924417|FG001|Overall Study|Protocol Violation|1|||
94579283|NCT00755183|323924416|FG000|Overall Study|Withdrawal by Subject|0|||
94579284|NCT00755183|323924417|FG001|Overall Study|Withdrawal by Subject|2|||
94579285|NCT00755183|323924416|FG000|Overall Study|Administrative|2|||
94579286|NCT00755183|323924417|FG001|Overall Study|Administrative|1|||
94579287|NCT00335777|323924418|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
94579288|NCT00335777|323924418|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
94579289|NCT00335777|323924418|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
94579290|NCT00335777|323924418|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
94579291|NCT00335777|323924418|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
94579292|NCT02326155|323924420|FG000|Overall Study|Adverse Event|21|||
94579293|NCT02326155|323924421|FG001|Overall Study|Adverse Event|5|||
94579294|NCT02326155|323924420|FG000|Overall Study|Death|3|||
94579295|NCT02326155|323924421|FG001|Overall Study|Death|0|||
94579296|NCT02326155|323924420|FG000|Overall Study|Lack of Efficacy|49|||
94579297|NCT02326155|323924421|FG001|Overall Study|Lack of Efficacy|5|||
94579298|NCT02326155|323924420|FG000|Overall Study|Lost to Follow-up|14|||
94579299|NCT02326155|323924421|FG001|Overall Study|Lost to Follow-up|3|||
94579300|NCT02326155|323924420|FG000|Overall Study|Protocol Violation|2|||
94579301|NCT02326155|323924421|FG001|Overall Study|Protocol Violation|0|||
94579302|NCT02326155|323924420|FG000|Overall Study|Withdrawal by Subject|34|||
94579303|NCT02326155|323924421|FG001|Overall Study|Withdrawal by Subject|11|||
94579304|NCT02326155|323924420|FG000|Overall Study|Disease progression|37|||
94579305|NCT02326155|323924421|FG001|Overall Study|Disease progression|4|||
94579306|NCT02326155|323924420|FG000|Overall Study|Study close|188|||
94579307|NCT02326155|323924421|FG001|Overall Study|Study close|21|||
94579308|NCT02326155|323924420|FG000|Overall Study|except for study close|46|||
94579309|NCT02326155|323924421|FG001|Overall Study|except for study close|13|||
94579310|NCT01209689|323924422|FG000|Overall Study|Insufficient Therapeutic Response|7|||
94579311|NCT01209689|323924423|FG001|Overall Study|Insufficient Therapeutic Response|2|||
94579312|NCT01209689|323924422|FG000|Overall Study|Refused Treatment|8|||
94579313|NCT01209689|323924423|FG001|Overall Study|Refused Treatment|3|||
94579314|NCT01209689|323924422|FG000|Overall Study|Adverse Event|4|||
94351530|NCT04815291|323067417|FG000|Overall Study|Physician Decision|4|||
94579315|NCT01209689|323924423|FG001|Overall Study|Adverse Event|0|||
94579316|NCT01209689|323924422|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
94579317|NCT01209689|323924423|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
94579318|NCT01209689|323924422|FG000|Overall Study|Failure to Return|3|||
94579319|NCT01209689|323924423|FG001|Overall Study|Failure to Return|0|||
94579320|NCT01209689|323924422|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
94579321|NCT01209689|323924423|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
94579322|NCT03591406|323924426|FG000|Overall Study|Adverse Event|5|||
94579323|NCT03591406|323924427|FG001|Overall Study|Adverse Event|3|||
94579324|NCT03591406|323924426|FG000|Overall Study|Protocol Violation|2|||
94579325|NCT03591406|323924427|FG001|Overall Study|Protocol Violation|1|||
94579326|NCT03591406|323924426|FG000|Overall Study|Withdrawal by Subject|0|||
94579327|NCT03591406|323924427|FG001|Overall Study|Withdrawal by Subject|5|||
94579328|NCT02066181|323924428|FG000|Overall Study|Withdrawal by Subject|1|||
94579329|NCT02066181|323924429|FG001|Overall Study|Withdrawal by Subject|1|||
94579330|NCT01083771|323924430|FG000|Overall Study|non-compliant|2|||
94579331|NCT01083771|323924430|FG000|Overall Study|Withdrawal by Subject|3|||
94579332|NCT02141295|323924433|FG000|Overall Study|Adverse Event|1|||
94579333|NCT02141295|323924434|FG001|Overall Study|Adverse Event|18|||
94351531|NCT04815291|323067417|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
94579334|NCT02141295|323924435|FG002|Overall Study|Adverse Event|11|||
94579335|NCT02141295|323924433|FG000|Overall Study|Physician Decision|2|||
94579336|NCT02141295|323924434|FG001|Overall Study|Physician Decision|19|||
94579337|NCT02141295|323924435|FG002|Overall Study|Physician Decision|14|||
94579338|NCT02141295|323924433|FG000|Overall Study|Study terminated by sponsor|0|||
94579339|NCT02141295|323924434|FG001|Overall Study|Study terminated by sponsor|6|||
94579340|NCT02141295|323924435|FG002|Overall Study|Study terminated by sponsor|6|||
94579341|NCT02141295|323924433|FG000|Overall Study|Non-compliance|0|||
94579342|NCT02141295|323924434|FG001|Overall Study|Non-compliance|1|||
94579343|NCT02141295|323924435|FG002|Overall Study|Non-compliance|0|||
94579344|NCT02141295|323924433|FG000|Overall Study|Progressive disease|3|||
94579345|NCT02141295|323924434|FG001|Overall Study|Progressive disease|32|||
94579346|NCT02141295|323924435|FG002|Overall Study|Progressive disease|50|||
94579347|NCT02141295|323924433|FG000|Overall Study|Reason not specified|0|||
94579348|NCT02141295|323924434|FG001|Overall Study|Reason not specified|9|||
94579349|NCT02141295|323924435|FG002|Overall Study|Reason not specified|10|||
94579350|NCT02141295|323924433|FG000|Overall Study|Withdrawal by Subject|0|||
94579351|NCT02141295|323924434|FG001|Overall Study|Withdrawal by Subject|9|||
94579352|NCT02141295|323924435|FG002|Overall Study|Withdrawal by Subject|4|||
94579353|NCT01389596|323924436|FG000|Overall Study|Protocol Violation|3|||
94579354|NCT01389596|323924437|FG001|Overall Study|Protocol Violation|4|||
94579355|NCT01389596|323924438|FG002|Overall Study|Protocol Violation|3|||
94579356|NCT01389596|323924436|FG000|Overall Study|Withdrawal by Subject|1|||
94579357|NCT01389596|323924437|FG001|Overall Study|Withdrawal by Subject|2|||
94579358|NCT01389596|323924438|FG002|Overall Study|Withdrawal by Subject|2|||
94579359|NCT01389596|323924436|FG000|Overall Study|Insufficient Clinical Response|3|||
94579360|NCT01389596|323924437|FG001|Overall Study|Insufficient Clinical Response|4|||
94579361|NCT01389596|323924438|FG002|Overall Study|Insufficient Clinical Response|5|||
94579362|NCT01389596|323924436|FG000|Overall Study|Adverse Event|1|||
94579363|NCT01389596|323924437|FG001|Overall Study|Adverse Event|4|||
94579364|NCT01389596|323924438|FG002|Overall Study|Adverse Event|0|||
94579365|NCT01389596|323924436|FG000|Overall Study|Death|0|||
94579366|NCT01389596|323924437|FG001|Overall Study|Death|1|||
94579367|NCT01389596|323924438|FG002|Overall Study|Death|0|||
94579368|NCT01389596|323924436|FG000|Overall Study|Other Unspecified|2|||
94579369|NCT01389596|323924437|FG001|Overall Study|Other Unspecified|1|||
94579370|NCT01389596|323924438|FG002|Overall Study|Other Unspecified|0|||
94579371|NCT01709084|323924439|FG000|Overall Study|Lost to Follow-up|4|||
94579372|NCT01709084|323924440|FG001|Overall Study|Lost to Follow-up|7|||
94579373|NCT01709084|323924439|FG000|Overall Study|Withdrawal by Subject|2|||
94579374|NCT01709084|323924440|FG001|Overall Study|Withdrawal by Subject|2|||
94579375|NCT01709084|323924439|FG000|Overall Study|Adverse Event|5|||
94579376|NCT01709084|323924440|FG001|Overall Study|Adverse Event|0|||
94579377|NCT01709084|323924439|FG000|Overall Study|Other|5|||
94579378|NCT01709084|323924440|FG001|Overall Study|Other|3|||
94579379|NCT01709084|323924439|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
94579380|NCT01709084|323924440|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
94579381|NCT01709084|323924439|FG000|Overall Study|Not Treated|0|||
94579382|NCT01709084|323924440|FG001|Overall Study|Not Treated|2|||
94579383|NCT02144610|323924441|FG000|Overall Study|Physician Decision|1|||
94579384|NCT02144610|323924442|FG001|Overall Study|Physician Decision|0|||
94579385|NCT02144610|323924441|FG000|Overall Study|Withdrawal by Subject|1|||
94579386|NCT02144610|323924442|FG001|Overall Study|Withdrawal by Subject|5|||
94579387|NCT02144610|323924441|FG000|Overall Study|Death|2|||
94579388|NCT02144610|323924442|FG001|Overall Study|Death|2|||
94579389|NCT02144610|323924441|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
94579390|NCT02144610|323924442|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
94579391|NCT02144610|323924441|FG000|Overall Study|Other|0|||
94579392|NCT02144610|323924442|FG001|Overall Study|Other|1|||
94579393|NCT01054885|323924443|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
94579394|NCT01054885|323924444|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
94579395|NCT01054885|323924445|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
94579396|NCT01054885|323924446|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
94579397|NCT01054885|323924447|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
94579398|NCT01054885|323924448|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
94579399|NCT01054885|323924449|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
94579400|NCT01054885|323924443|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
94579401|NCT01054885|323924444|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
94579402|NCT01054885|323924445|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
94579403|NCT01054885|323924446|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
94579404|NCT01054885|323924447|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
94579405|NCT01054885|323924448|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
94579406|NCT01054885|323924449|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
94579407|NCT01054885|323924443|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
94579408|NCT01054885|323924444|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
94579409|NCT01054885|323924445|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
94579410|NCT01054885|323924446|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
94579411|NCT01054885|323924447|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
94579412|NCT01054885|323924448|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
94579413|NCT01054885|323924449|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
94579414|NCT01054885|323924443|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
94579415|NCT01054885|323924444|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
94579416|NCT01054885|323924445|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
94579417|NCT01054885|323924446|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
94579418|NCT01054885|323924447|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
94579419|NCT01054885|323924448|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
94579420|NCT01054885|323924449|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
94579421|NCT01054885|323924443|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
94579422|NCT01054885|323924444|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
94579423|NCT01054885|323924445|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
94579424|NCT01054885|323924446|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
94579425|NCT01054885|323924447|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
94579426|NCT01054885|323924448|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
94579427|NCT01054885|323924449|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
94579428|NCT01054885|323924443|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
94579429|NCT01054885|323924444|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
94579430|NCT01054885|323924445|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
94579431|NCT01054885|323924446|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
94579432|NCT01054885|323924447|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
94579433|NCT01054885|323924448|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
94579434|NCT01054885|323924449|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
94579435|NCT01054885|323924443|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
94579436|NCT01054885|323924444|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
94579437|NCT01054885|323924445|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
94579438|NCT01054885|323924446|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
94579439|NCT01054885|323924447|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
94579440|NCT01054885|323924448|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
94579441|NCT01054885|323924449|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
94579442|NCT01054885|323924443|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
94579443|NCT01054885|323924444|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
94579444|NCT01054885|323924445|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
94579445|NCT01054885|323924446|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
94579446|NCT01054885|323924447|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
94579447|NCT01054885|323924448|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
94579448|NCT01054885|323924449|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
94579449|NCT01054885|323924443|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
94579450|NCT01054885|323924444|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
94579451|NCT01054885|323924445|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
94579452|NCT01054885|323924446|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
94579453|NCT01054885|323924447|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
94579454|NCT01054885|323924448|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
94579455|NCT01054885|323924449|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
94579456|NCT01054885|323924443|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
94579457|NCT01054885|323924444|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
94579458|NCT01054885|323924445|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
94579459|NCT01054885|323924446|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
94579460|NCT01054885|323924447|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
94579461|NCT01054885|323924448|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
94579462|NCT01054885|323924449|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
94579463|NCT01054885|323924443|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
94579464|NCT01054885|323924444|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
94579465|NCT01054885|323924445|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
94579466|NCT01054885|323924446|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
94579467|NCT01054885|323924447|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
94579468|NCT01054885|323924448|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
94579469|NCT01054885|323924449|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
94579470|NCT01054885|323924443|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
94579471|NCT01054885|323924444|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
94579472|NCT01054885|323924445|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
94579473|NCT01054885|323924446|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
94579474|NCT01054885|323924447|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
94579475|NCT01054885|323924448|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
94579476|NCT01054885|323924449|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
94579477|NCT01054885|323924443|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
94579478|NCT01054885|323924444|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
94579479|NCT01054885|323924445|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
94579480|NCT01054885|323924446|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
94579481|NCT01054885|323924447|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
94579482|NCT01054885|323924448|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
94579483|NCT01054885|323924449|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
94579484|NCT01054885|323924443|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
94579485|NCT01054885|323924444|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
94579486|NCT01054885|323924445|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
94579487|NCT01054885|323924446|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
94579488|NCT01054885|323924447|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
94579489|NCT01054885|323924448|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
94579490|NCT01054885|323924449|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
94579491|NCT01054885|323924443|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
94579492|NCT01054885|323924444|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
94579493|NCT01054885|323924445|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
94579494|NCT01054885|323924446|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
94579495|NCT01054885|323924447|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
94579496|NCT01054885|323924448|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
94579497|NCT01054885|323924449|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
94579498|NCT00918255|323924452|FG000|Overall Study|Adverse Event|1|||
94579499|NCT00918255|323924453|FG001|Overall Study|Adverse Event|0|||
94579500|NCT00918255|323924454|FG002|Overall Study|Adverse Event|0|||
94579501|NCT00918255|323924452|FG000|Overall Study|Withdrawal by Subject|1|||
94579502|NCT00918255|323924453|FG001|Overall Study|Withdrawal by Subject|0|||
94579503|NCT00918255|323924454|FG002|Overall Study|Withdrawal by Subject|2|||
94579504|NCT00918255|323924452|FG000|Overall Study|Lack of Efficacy|1|||
94579505|NCT00918255|323924453|FG001|Overall Study|Lack of Efficacy|0|||
94579506|NCT00918255|323924454|FG002|Overall Study|Lack of Efficacy|0|||
94579507|NCT00918255|323924452|FG000|Overall Study|Lost to Follow-up|1|||
94579508|NCT00918255|323924453|FG001|Overall Study|Lost to Follow-up|0|||
94579509|NCT00918255|323924454|FG002|Overall Study|Lost to Follow-up|2|||
94579510|NCT00918255|323924452|FG000|Overall Study|Exceeded allowed number of interventions|0|||
94579511|NCT00918255|323924453|FG001|Overall Study|Exceeded allowed number of interventions|0|||
94579512|NCT00918255|323924454|FG002|Overall Study|Exceeded allowed number of interventions|1|||
94579513|NCT00918255|323924452|FG000|Overall Study|Non-compliance|1|||
94579514|NCT00918255|323924453|FG001|Overall Study|Non-compliance|0|||
94579515|NCT00918255|323924454|FG002|Overall Study|Non-compliance|0|||
94579516|NCT00918255|323924452|FG000|Overall Study|Investigator discretion|1|||
94579517|NCT00918255|323924453|FG001|Overall Study|Investigator discretion|0|||
94579518|NCT00918255|323924454|FG002|Overall Study|Investigator discretion|0|||
94579519|NCT04154904|323924456|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
94579520|NCT04154904|323924457|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
94579521|NCT04154904|323924458|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
94579522|NCT02392624|323924459|FG000|Overall Study|Withdrawal by Subject|15|||
94579523|NCT02392624|323924460|FG001|Overall Study|Withdrawal by Subject|12|||
94579524|NCT02392624|323924461|FG002|Overall Study|Withdrawal by Subject|9|||
94579525|NCT02392624|323924459|FG000|Overall Study|Adverse Event|4|||
94579526|NCT02392624|323924460|FG001|Overall Study|Adverse Event|1|||
94579527|NCT02392624|323924461|FG002|Overall Study|Adverse Event|2|||
94579528|NCT02392624|323924459|FG000|Overall Study|Pregnancy|1|||
94579529|NCT02392624|323924460|FG001|Overall Study|Pregnancy|0|||
94579530|NCT02392624|323924461|FG002|Overall Study|Pregnancy|0|||
94579531|NCT02392624|323924459|FG000|Overall Study|Protocol Violation|0|||
94579532|NCT02392624|323924460|FG001|Overall Study|Protocol Violation|0|||
94579533|NCT02392624|323924461|FG002|Overall Study|Protocol Violation|1|||
94579534|NCT02392624|323924459|FG000|Overall Study|Sponsor/Investigator Decision|2|||
94579535|NCT02392624|323924460|FG001|Overall Study|Sponsor/Investigator Decision|1|||
94579536|NCT02392624|323924461|FG002|Overall Study|Sponsor/Investigator Decision|0|||
94579537|NCT02392624|323924459|FG000|Overall Study|Other|49|||
94579538|NCT02392624|323924460|FG001|Overall Study|Other|1|||
94579539|NCT02392624|323924461|FG002|Overall Study|Other|1|||
94579540|NCT00936715|323924462|FG000|Overall Study|Investigators Discretion|1|||
94579541|NCT00936715|323924462|FG000|Overall Study|Protocol Violation|1|||
94579542|NCT00936715|323924462|FG000|Overall Study|Safety or Tolerability Reasons|4|||
94579543|NCT03819114|323924464|FG000|Overall Study|Protocol Violation|0|||
94579544|NCT03819114|323924465|FG001|Overall Study|Protocol Violation|1|||
94579545|NCT03819114|323924466|FG002|Overall Study|Protocol Violation|1|||
94579546|NCT03819114|323924467|FG003|Overall Study|Protocol Violation|0|||
94351532|NCT00362297|323067418|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
94351533|NCT00362297|323067419|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
94579547|NCT03819114|323924464|FG000|Overall Study|Lost to Follow-up|0|||
94240262|NCT00664534|322674573|FG000|Overall Study|Physician Decision|8|||
94240263|NCT00664534|322674574|FG001|Overall Study|Physician Decision|0|||
94240264|NCT00664534|322674573|FG000|Overall Study|Sponsor decision|8|||
94240265|NCT00664534|322674574|FG001|Overall Study|Sponsor decision|6|||
94240266|NCT01245374|322674575|FG000|Overall Study|Protocol Violation|1|||
94240267|NCT01245374|322674575|FG000|Overall Study|Withdrawal by Subject|3|||
94240268|NCT04343976|322674576|FG000|Overall Study|Withdrawal by Subject|0|||
94240269|NCT04343976|322674577|FG001|Overall Study|Withdrawal by Subject|1|||
94240270|NCT01371708|322674578|FG000|Overall Study|Insufficient clinical response|3|||
94240271|NCT01371708|322674579|FG001|Overall Study|Insufficient clinical response|2|||
94240272|NCT01371708|322674580|FG002|Overall Study|Insufficient clinical response|0|||
94240273|NCT01371708|322674578|FG000|Overall Study|Lost to Follow-up|5|||
94240274|NCT01371708|322674579|FG001|Overall Study|Lost to Follow-up|9|||
94240275|NCT01371708|322674580|FG002|Overall Study|Lost to Follow-up|7|||
94240276|NCT01371708|322674578|FG000|Overall Study|Protocol Violation|2|||
94240277|NCT01371708|322674579|FG001|Overall Study|Protocol Violation|1|||
94240278|NCT01371708|322674580|FG002|Overall Study|Protocol Violation|2|||
94240279|NCT01371708|322674578|FG000|Overall Study|No longer willing to participate|7|||
94240280|NCT01371708|322674579|FG001|Overall Study|No longer willing to participate|7|||
94240281|NCT01371708|322674580|FG002|Overall Study|No longer willing to participate|13|||
94454214|NCT05270395|323450292|FG001|Overall Study|Lost to Follow-up|2|||
94454215|NCT05270395|323450291|FG000|Overall Study|Death|1|||
94454216|NCT05270395|323450292|FG001|Overall Study|Death|2|||
94454217|NCT05270395|323450291|FG000|Overall Study|Study Team Withdrew|1|||
94454218|NCT05270395|323450292|FG001|Overall Study|Study Team Withdrew|0|||
94454219|NCT03725761|323450293|FG000|Overall Study|still on study|1|||
94454220|NCT03232931|323451526|FG000|Overall Study|Physician Decision|1|||
94454221|NCT03232931|323451527|FG001|Overall Study|Physician Decision|1|||
94454222|NCT03232931|323451526|FG000|Overall Study|Withdrawal by Subject|6|||
94454223|NCT03232931|323451527|FG001|Overall Study|Withdrawal by Subject|0|||
94454224|NCT03232931|323451526|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
94454225|NCT03232931|323451527|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
94454226|NCT03232931|323451526|FG000|Overall Study|Parent did not record voice|1|||
94454227|NCT03232931|323451527|FG001|Overall Study|Parent did not record voice|2|||
94454228|NCT03232931|323451526|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
94454229|NCT03232931|323451527|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
94454230|NCT04432831|323451539|FG000|Overall Study|Withdrawal by Subject|24|||
94454231|NCT04432831|323451540|FG001|Overall Study|Withdrawal by Subject|28|||
94454232|NCT04432831|323451541|FG002|Overall Study|Withdrawal by Subject|21|||
94454233|NCT04432831|323451539|FG000|Overall Study|Death|23|||
94454234|NCT04432831|323451540|FG001|Overall Study|Death|23|||
94454235|NCT04432831|323451541|FG002|Overall Study|Death|17|||
94454236|NCT04432831|323451539|FG000|Overall Study|Lost to Follow-up|15|||
94454237|NCT04432831|323451540|FG001|Overall Study|Lost to Follow-up|15|||
94454238|NCT04432831|323451541|FG002|Overall Study|Lost to Follow-up|12|||
94454239|NCT04432831|323451539|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
94454240|NCT04432831|323451540|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
94454241|NCT04432831|323451541|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
94454242|NCT04432831|323451539|FG000|Overall Study|Reason Not Specified|7|||
94454243|NCT04432831|323451540|FG001|Overall Study|Reason Not Specified|11|||
94454244|NCT04432831|323451541|FG002|Overall Study|Reason Not Specified|9|||
94454245|NCT04432831|323451539|FG000|Overall Study|Adverse Event|7|||
94454246|NCT04432831|323451540|FG001|Overall Study|Adverse Event|7|||
94454247|NCT04432831|323451541|FG002|Overall Study|Adverse Event|7|||
94454248|NCT04432831|323451539|FG000|Overall Study|Physician Decision|1|||
94454249|NCT04432831|323451540|FG001|Overall Study|Physician Decision|3|||
94454250|NCT04432831|323451541|FG002|Overall Study|Physician Decision|6|||
94454251|NCT04432831|323451539|FG000|Overall Study|Protocol Violation|1|||
94454252|NCT04432831|323451540|FG001|Overall Study|Protocol Violation|0|||
94454253|NCT04432831|323451541|FG002|Overall Study|Protocol Violation|2|||
94454254|NCT04432831|323451539|FG000|Overall Study|Pregnancy|0|||
94454255|NCT04432831|323451540|FG001|Overall Study|Pregnancy|1|||
94454256|NCT04432831|323451541|FG002|Overall Study|Pregnancy|0|||
94454257|NCT04432831|323451539|FG000|Overall Study|Lack of Efficacy|0|||
94454258|NCT04432831|323451540|FG001|Overall Study|Lack of Efficacy|0|||
94454259|NCT04432831|323451541|FG002|Overall Study|Lack of Efficacy|2|||
94454260|NCT03300505|323451543|FG000|Overall Study|Death|0|||
94454261|NCT03300505|323451544|FG001|Overall Study|Death|1|||
94454262|NCT03300505|323451545|FG002|Overall Study|Death|0|||
94454263|NCT03300505|323451543|FG000|Overall Study|Withdrawal by Subject|0|||
94240282|NCT01371708|322674578|FG000|Overall Study|Medication error/not related to AE|0|||
94240283|NCT01371708|322674579|FG001|Overall Study|Medication error/not related to AE|1|||
94240284|NCT01371708|322674580|FG002|Overall Study|Medication error/not related to AE|0|||
94454264|NCT03300505|323451544|FG001|Overall Study|Withdrawal by Subject|1|||
94454265|NCT03300505|323451545|FG002|Overall Study|Withdrawal by Subject|1|||
94454266|NCT03300505|323451543|FG000|Overall Study|Sponsor Termination|0|||
94240285|NCT01371708|322674578|FG000|Overall Study|Other|3|||
94240286|NCT01371708|322674579|FG001|Overall Study|Other|2|||
94240287|NCT01371708|322674580|FG002|Overall Study|Other|4|||
94240288|NCT01371708|322674578|FG000|Overall Study|Adverse Event|5|||
94240289|NCT01371708|322674579|FG001|Overall Study|Adverse Event|8|||
94240290|NCT01371708|322674580|FG002|Overall Study|Adverse Event|12|||
94240291|NCT01371708|322674578|FG000|Overall Study|Started but did not receive treatment|1|||
94240292|NCT01371708|322674579|FG001|Overall Study|Started but did not receive treatment|0|||
94240293|NCT01371708|322674580|FG002|Overall Study|Started but did not receive treatment|1|||
94240294|NCT00694109|322674581|FG000|Overall Study|Physician Decision|3|||
94240295|NCT00694109|322674581|FG000|Overall Study|Adverse Event|74|||
94579548|NCT03819114|323924465|FG001|Overall Study|Lost to Follow-up|0|||
94579549|NCT03819114|323924466|FG002|Overall Study|Lost to Follow-up|1|||
94579550|NCT03819114|323924467|FG003|Overall Study|Lost to Follow-up|0|||
94579551|NCT00408317|323924468|FG000|First Intervention Period|Adverse Event|0|||
94579552|NCT00408317|323924469|FG001|First Intervention Period|Adverse Event|1|||
94579553|NCT00408317|323924468|FG000|Second Intervention Period|Adverse Event|2|||
94240296|NCT00694109|322674581|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
94240297|NCT00694109|322674581|FG000|Overall Study|Lack of Efficacy|2|||
94240298|NCT00694109|322674581|FG000|Overall Study|Withdrawal by Subject|13|||
94240299|NCT00694109|322674581|FG000|Overall Study|Pregnancy|1|||
94240300|NCT00694109|322674581|FG000|Overall Study|Enrolled but not treated|1|||
94240301|NCT00694109|322674581|FG000|Overall Study|Other|2|||
94240302|NCT00694109|322674581|FG000|Overall Study|Consented but no additional treatment|3|||
94240303|NCT02514551|322674582|FG000|Overall Study|Lost to Follow-up|0|||
94240304|NCT02514551|322674583|FG001|Overall Study|Lost to Follow-up|1|||
94351534|NCT01482598|323067420|FG000|Overall Study|Death|7|||
94579554|NCT00408317|323924469|FG001|Second Intervention Period|Adverse Event|0|||
94579555|NCT00408317|323924468|FG000|Second Intervention Period|Protocol Violation|0|||
94579556|NCT00408317|323924469|FG001|Second Intervention Period|Protocol Violation|1|||
94579557|NCT00408317|323924468|FG000|Second Intervention Period|Withdrawal of consent|0|||
94579558|NCT00408317|323924469|FG001|Second Intervention Period|Withdrawal of consent|1|||
94579559|NCT03877510|323924470|FG000|Overall Study|Death|6|||
94579560|NCT03877510|323924470|FG000|Overall Study|Lost to Follow-up|2|||
94579561|NCT03877510|323924470|FG000|Overall Study|Non-compliance with study drug|2|||
94579562|NCT03877510|323924470|FG000|Overall Study|Lack of Efficacy|14|||
94579563|NCT03877510|323924470|FG000|Overall Study|Adverse Event|20|||
94579564|NCT03877510|323924470|FG000|Overall Study|Withdrawal by Subject|22|||
94579565|NCT03877510|323924470|FG000|Overall Study|Miscellaneous|1|||
94579566|NCT02113982|323924471|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
94579567|NCT02113982|323924472|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
94579568|NCT02113982|323924473|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
94579569|NCT02113982|323924474|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
94579570|NCT02113982|323924475|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
94579571|NCT02113982|323924476|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
94579572|NCT02113982|323924477|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
94579573|NCT02113982|323924478|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
94579574|NCT02113982|323924479|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
94579575|NCT02113982|323924480|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
94579576|NCT02113982|323924481|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
94579577|NCT02113982|323924482|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
94579578|NCT02113982|323924483|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
94579579|NCT02113982|323924484|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
94579580|NCT02113982|323924471|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
94579581|NCT02113982|323924472|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
94579582|NCT02113982|323924473|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
94240305|NCT02514551|322674582|FG000|Overall Study|Participant Never Treated|0|||
94240306|NCT02514551|322674583|FG001|Overall Study|Participant Never Treated|2|||
94240307|NCT00402051|322674584|FG000|Overall Study|Progressive Disease|13|||
94579583|NCT02113982|323924474|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
94658899|NCT02371369|324206239|FG000|Part 1|Physician Decision|0|||
94240308|NCT00402051|322674585|FG001|Overall Study|Progressive Disease|20|||
94351535|NCT01482598|323067421|FG001|Overall Study|Death|10|||
94240309|NCT00402051|322674584|FG000|Overall Study|Adverse Event|11|||
94240310|NCT00402051|322674585|FG001|Overall Study|Adverse Event|4|||
94240311|NCT00402051|322674584|FG000|Overall Study|Physician Decision|7|||
94240312|NCT00402051|322674585|FG001|Overall Study|Physician Decision|3|||
94240313|NCT00402051|322674584|FG000|Overall Study|Withdrawal by Subject|3|||
94240314|NCT00402051|322674585|FG001|Overall Study|Withdrawal by Subject|3|||
94240315|NCT00402051|322674584|FG000|Overall Study|Death - Related to Study Drug|1|||
94240316|NCT00402051|322674585|FG001|Overall Study|Death - Related to Study Drug|2|||
94240317|NCT00402051|322674584|FG000|Overall Study|Death Due to Study Disease|2|||
94240318|NCT00402051|322674585|FG001|Overall Study|Death Due to Study Disease|1|||
94240319|NCT00402051|322674584|FG000|Overall Study|Death Due to Adverse Event|0|||
94240320|NCT00402051|322674585|FG001|Overall Study|Death Due to Adverse Event|2|||
94240321|NCT00402051|322674584|FG000|Overall Study|Lost to Follow-up|1|||
94240322|NCT00402051|322674585|FG001|Overall Study|Lost to Follow-up|0|||
94240323|NCT01254747|322674588|FG000|Overall Study|Unacceptable subjective vision|0|||
94240324|NCT01254747|322674589|FG001|Overall Study|Unacceptable subjective vision|0|||
94240325|NCT01254747|322674590|FG002|Overall Study|Unacceptable subjective vision|0|||
94240326|NCT01254747|322674591|FG003|Overall Study|Unacceptable subjective vision|2|||
94240327|NCT01254747|322674588|FG000|Overall Study|Difficult removal handling|0|||
94240328|NCT01254747|322674589|FG001|Overall Study|Difficult removal handling|0|||
94240329|NCT01254747|322674590|FG002|Overall Study|Difficult removal handling|1|||
94240330|NCT01254747|322674591|FG003|Overall Study|Difficult removal handling|0|||
94240331|NCT01254747|322674588|FG000|Overall Study|Symptoms and problems|0|||
94240332|NCT01254747|322674589|FG001|Overall Study|Symptoms and problems|2|||
94240333|NCT01254747|322674590|FG002|Overall Study|Symptoms and problems|1|||
94240334|NCT01254747|322674591|FG003|Overall Study|Symptoms and problems|0|||
94240335|NCT01254747|322674588|FG000|Overall Study|Lost to Follow-up|0|||
94240336|NCT01254747|322674589|FG001|Overall Study|Lost to Follow-up|0|||
94240337|NCT01254747|322674590|FG002|Overall Study|Lost to Follow-up|1|||
94579584|NCT02113982|323924475|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
94240338|NCT01254747|322674591|FG003|Overall Study|Lost to Follow-up|0|||
94240339|NCT01254747|322674588|FG000|Overall Study|Biomicroscopy|0|||
94240340|NCT01254747|322674589|FG001|Overall Study|Biomicroscopy|0|||
94240341|NCT01254747|322674590|FG002|Overall Study|Biomicroscopy|1|||
94240342|NCT01254747|322674591|FG003|Overall Study|Biomicroscopy|0|||
94240343|NCT01254747|322674588|FG000|Overall Study|Discomfort|0|||
94240344|NCT01254747|322674589|FG001|Overall Study|Discomfort|4|||
94240345|NCT01254747|322674590|FG002|Overall Study|Discomfort|0|||
94240346|NCT01254747|322674591|FG003|Overall Study|Discomfort|0|||
94240347|NCT01399918|322674592|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
94240348|NCT01067846|322674593|FG000|Overall Study|Lost to Follow-up|17|||
94240349|NCT01067846|322674594|FG001|Overall Study|Lost to Follow-up|19|||
94579585|NCT02113982|323924476|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
94579586|NCT02113982|323924477|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
94579587|NCT02113982|323924478|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
94579588|NCT02113982|323924479|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
94579589|NCT02113982|323924480|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
94240350|NCT01067846|322674593|FG000|Overall Study|Withdrawal by Subject|1|||
94240351|NCT01067846|322674594|FG001|Overall Study|Withdrawal by Subject|0|||
94579590|NCT02113982|323924481|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
94579591|NCT02113982|323924482|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
94579592|NCT02113982|323924483|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
94579593|NCT02113982|323924484|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
94579594|NCT02113982|323924471|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
94579595|NCT02113982|323924472|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
94579596|NCT02113982|323924473|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
94579597|NCT02113982|323924474|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
94579598|NCT02113982|323924475|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
94579599|NCT02113982|323924476|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
94240352|NCT01067846|322674593|FG000|Overall Study|participation in other tx study|1|||
94240353|NCT01067846|322674594|FG001|Overall Study|participation in other tx study|0|||
94240354|NCT00972322|322674598|FG000|Overall Study|Adverse Event|2|||
94240355|NCT00972322|322674599|FG001|Overall Study|Adverse Event|1|||
94240356|NCT00972322|322674598|FG000|Overall Study|Positive drug screen|0|||
94579600|NCT02113982|323924477|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
94579601|NCT02113982|323924478|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
94579602|NCT02113982|323924479|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
94579603|NCT02113982|323924480|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
94579604|NCT02113982|323924481|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
94240357|NCT00972322|322674599|FG001|Overall Study|Positive drug screen|1|||
94240358|NCT00972322|322674598|FG000|Overall Study|Lost to Follow-up|0|||
94240359|NCT00972322|322674599|FG001|Overall Study|Lost to Follow-up|1|||
94240360|NCT00972322|322674598|FG000|Overall Study|Consistently high glucose values|1|||
94240361|NCT00972322|322674599|FG001|Overall Study|Consistently high glucose values|0|||
94240362|NCT01495598|322674600|FG000|Overall Study|Death during follow up period|2|||
94579605|NCT02113982|323924482|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
94579606|NCT02113982|323924483|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
94579607|NCT02113982|323924484|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
94579608|NCT02113982|323924471|FG000|Stage 1: Dose Escalation|Transplant|0|||
94579609|NCT02113982|323924472|FG001|Stage 1: Dose Escalation|Transplant|1|||
94579610|NCT02113982|323924473|FG002|Stage 1: Dose Escalation|Transplant|0|||
94579611|NCT02113982|323924474|FG003|Stage 1: Dose Escalation|Transplant|0|||
94579612|NCT02113982|323924475|FG004|Stage 1: Dose Escalation|Transplant|0|||
94579613|NCT02113982|323924476|FG005|Stage 1: Dose Escalation|Transplant|1|||
94579614|NCT02113982|323924477|FG006|Stage 1: Dose Escalation|Transplant|0|||
94579615|NCT02113982|323924478|FG007|Stage 1: Dose Escalation|Transplant|0|||
94579616|NCT02113982|323924479|FG008|Stage 1: Dose Escalation|Transplant|0|||
94579617|NCT02113982|323924480|FG009|Stage 1: Dose Escalation|Transplant|0|||
94579618|NCT02113982|323924481|FG010|Stage 1: Dose Escalation|Transplant|0|||
94579619|NCT02113982|323924482|FG011|Stage 1: Dose Escalation|Transplant|0|||
94579620|NCT02113982|323924483|FG012|Stage 1: Dose Escalation|Transplant|0|||
94579621|NCT02113982|323924484|FG013|Stage 1: Dose Escalation|Transplant|0|||
94579622|NCT02113982|323924471|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
94579623|NCT02113982|323924472|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
94579624|NCT02113982|323924473|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
94579625|NCT02113982|323924474|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
94579626|NCT02113982|323924475|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
94579627|NCT02113982|323924476|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
94579628|NCT02113982|323924477|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
94579629|NCT02113982|323924478|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
94579630|NCT02113982|323924479|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
94579631|NCT02113982|323924480|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
94579632|NCT02113982|323924481|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
94579633|NCT02113982|323924482|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
94579634|NCT02113982|323924483|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
94579635|NCT02113982|323924484|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
94579636|NCT02113982|323924471|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
94579637|NCT02113982|323924472|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
94579638|NCT02113982|323924473|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
94579639|NCT02113982|323924474|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
94579640|NCT02113982|323924475|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
94579641|NCT02113982|323924476|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
94579642|NCT02113982|323924477|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
94579643|NCT02113982|323924478|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
94579644|NCT02113982|323924479|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
94579645|NCT02113982|323924480|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
94579646|NCT02113982|323924481|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
94579647|NCT02113982|323924482|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
94579648|NCT02113982|323924483|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
94579649|NCT02113982|323924484|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
94579650|NCT02113982|323924471|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
94579651|NCT02113982|323924472|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
94579652|NCT02113982|323924473|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
94579653|NCT02113982|323924474|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
94579654|NCT02113982|323924475|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
94579655|NCT02113982|323924476|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
94240363|NCT01495598|322674600|FG000|Overall Study|Death on study|1|||
94240364|NCT01495598|322674600|FG000|Overall Study|Lost to Follow-up|3|||
94240365|NCT01495598|322674600|FG000|Overall Study|Physician Decision|8|||
94240366|NCT02671500|322674603|FG000|Overall Study|Lack of Efficacy|12|||
94240367|NCT02671500|322674603|FG000|Overall Study|Lost to Follow-up|2|||
94240368|NCT02108964|322674605|FG000|Overall Study|Progressive disease|15|||
94240369|NCT02108964|322674606|FG001|Overall Study|Progressive disease|31|||
94240370|NCT02108964|322674607|FG002|Overall Study|Progressive disease|54|||
94240371|NCT02108964|322674608|FG003|Overall Study|Progressive disease|7|||
94240372|NCT02108964|322674609|FG004|Overall Study|Progressive disease|20|||
94240373|NCT02108964|322674610|FG005|Overall Study|Progressive disease|4|||
94240374|NCT02108964|322674611|FG006|Overall Study|Progressive disease|6|||
94240375|NCT02108964|322674612|FG007|Overall Study|Progressive disease|33|||
94240376|NCT02108964|322674605|FG000|Overall Study|Physician Decision|1|||
94240377|NCT02108964|322674606|FG001|Overall Study|Physician Decision|5|||
94240378|NCT02108964|322674607|FG002|Overall Study|Physician Decision|7|||
94240379|NCT02108964|322674608|FG003|Overall Study|Physician Decision|1|||
94240380|NCT02108964|322674609|FG004|Overall Study|Physician Decision|2|||
94240381|NCT02108964|322674610|FG005|Overall Study|Physician Decision|1|||
94240382|NCT02108964|322674611|FG006|Overall Study|Physician Decision|1|||
94240383|NCT02108964|322674612|FG007|Overall Study|Physician Decision|3|||
94240384|NCT02108964|322674605|FG000|Overall Study|Adverse Event|0|||
94240385|NCT02108964|322674606|FG001|Overall Study|Adverse Event|0|||
94240386|NCT02108964|322674607|FG002|Overall Study|Adverse Event|4|||
94240387|NCT02108964|322674608|FG003|Overall Study|Adverse Event|0|||
94240388|NCT02108964|322674609|FG004|Overall Study|Adverse Event|1|||
94240389|NCT02108964|322674610|FG005|Overall Study|Adverse Event|0|||
94454267|NCT03300505|323451544|FG001|Overall Study|Sponsor Termination|1|||
94454268|NCT03300505|323451545|FG002|Overall Study|Sponsor Termination|0|||
94454269|NCT03300505|323451543|FG000|Overall Study|Adverse Event|0|||
94454270|NCT03300505|323451544|FG001|Overall Study|Adverse Event|0|||
94454271|NCT03300505|323451545|FG002|Overall Study|Adverse Event|2|||
94454272|NCT01108341|323451546|FG000|Overall Study|Death|2|||
94454273|NCT01108341|323451546|FG000|Overall Study|Withdrawal by Subject|1|||
94454274|NCT01108341|323451546|FG000|Overall Study|Lost to Follow-up|1|||
94454275|NCT01108341|323451546|FG000|Overall Study|Other|1|||
94454276|NCT00504725|323451548|FG000|Overall Study|Protocol Violation|1|||
94454277|NCT00504725|323451549|FG001|Overall Study|Protocol Violation|0|||
94454278|NCT04981470|323451554|FG000|Overall Study|Device failure in all 4 patients|4|||
94454279|NCT04402138|323451555|FG000|Overall Study|Progressive Disease|2|||
94454280|NCT04402138|323451555|FG000|Overall Study|Adverse Event|1|||
94454281|NCT00468481|323451556|FG000|Overall Study|Adverse Event|13|||
94454282|NCT00468481|323451557|FG001|Overall Study|Adverse Event|3|||
94454283|NCT00468481|323451556|FG000|Overall Study|Lost to Follow-up|25|||
94454284|NCT00468481|323451557|FG001|Overall Study|Lost to Follow-up|8|||
94454285|NCT00468481|323451556|FG000|Overall Study|Pregnancy|2|||
94454286|NCT00468481|323451557|FG001|Overall Study|Pregnancy|0|||
94454287|NCT00468481|323451556|FG000|Overall Study|Protocol Violation|18|||
94454288|NCT00468481|323451557|FG001|Overall Study|Protocol Violation|8|||
94454289|NCT00468481|323451556|FG000|Overall Study|Withdrawal by Subject|12|||
94454290|NCT00468481|323451557|FG001|Overall Study|Withdrawal by Subject|3|||
94454291|NCT00468481|323451556|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
94454292|NCT00468481|323451557|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
94454293|NCT00468481|323451556|FG000|Overall Study|Prohibited Medication|1|||
94454294|NCT00468481|323451557|FG001|Overall Study|Prohibited Medication|1|||
94454295|NCT00468481|323451556|FG000|Overall Study|Egg Donor|1|||
94454296|NCT00468481|323451557|FG001|Overall Study|Egg Donor|0|||
94454297|NCT00468481|323451556|FG000|Overall Study|Moved out of area|4|||
94454298|NCT00468481|323451557|FG001|Overall Study|Moved out of area|1|||
94454299|NCT00468481|323451556|FG000|Overall Study|Non-Compliance|5|||
94454300|NCT00468481|323451557|FG001|Overall Study|Non-Compliance|0|||
94454301|NCT00468481|323451556|FG000|Overall Study|Other|6|||
94454302|NCT00468481|323451557|FG001|Overall Study|Other|0|||
94454303|NCT03806933|323451558|FG000|Main Period|Physician Decision|0|||
94454304|NCT03806933|323451559|FG001|Main Period|Physician Decision|0|||
94454305|NCT03806933|323451560|FG002|Main Period|Physician Decision|0|||
94454306|NCT03806933|323451561|FG003|Main Period|Physician Decision|1|||
94579656|NCT02113982|323924477|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
94579657|NCT02113982|323924478|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
94240390|NCT02108964|322674611|FG006|Overall Study|Adverse Event|3|||
94240391|NCT02108964|322674612|FG007|Overall Study|Adverse Event|2|||
94240392|NCT02108964|322674605|FG000|Overall Study|Death|1|||
94240393|NCT02108964|322674606|FG001|Overall Study|Death|1|||
94240394|NCT02108964|322674607|FG002|Overall Study|Death|4|||
94240395|NCT02108964|322674608|FG003|Overall Study|Death|0|||
94240396|NCT02108964|322674609|FG004|Overall Study|Death|3|||
94454307|NCT03806933|323451558|FG000|Main Period|Pregnancy|0|||
94454308|NCT03806933|323451559|FG001|Main Period|Pregnancy|0|||
94454309|NCT03806933|323451560|FG002|Main Period|Pregnancy|1|||
94454310|NCT03806933|323451561|FG003|Main Period|Pregnancy|0|||
94454311|NCT03806933|323451558|FG000|Main Period|Withdrawal by Subject|2|||
94579658|NCT02113982|323924479|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
94579659|NCT02113982|323924480|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
94579660|NCT02113982|323924481|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
94579661|NCT02113982|323924482|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
94579662|NCT02113982|323924483|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
94579663|NCT02113982|323924484|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
94579664|NCT02113982|323924471|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
94579665|NCT02113982|323924472|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
94579666|NCT02113982|323924473|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
94579667|NCT02113982|323924474|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
94579668|NCT02113982|323924475|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
94579669|NCT02113982|323924476|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
94579670|NCT02113982|323924477|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
94579671|NCT02113982|323924478|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
94579672|NCT02113982|323924479|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
94579673|NCT02113982|323924480|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
94579674|NCT02113982|323924481|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
94579675|NCT02113982|323924482|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
94579676|NCT02113982|323924483|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
94579677|NCT02113982|323924484|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
94579678|NCT02113982|323924471|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
94579679|NCT02113982|323924472|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
94579680|NCT02113982|323924473|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
94579681|NCT02113982|323924474|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
94579682|NCT02113982|323924475|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
94579683|NCT02113982|323924476|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
94579684|NCT02113982|323924477|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
94579685|NCT02113982|323924478|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
94579686|NCT02113982|323924479|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
94579687|NCT02113982|323924480|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
94579688|NCT02113982|323924481|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
94579689|NCT02113982|323924482|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
94579690|NCT02113982|323924483|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
94579691|NCT02113982|323924484|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
94579692|NCT02113982|323924471|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
94579693|NCT02113982|323924472|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
94579694|NCT02113982|323924473|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
94579695|NCT02113982|323924474|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
94579696|NCT02113982|323924475|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
94579697|NCT02113982|323924476|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
94579698|NCT02113982|323924477|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
94579699|NCT02113982|323924478|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
94579700|NCT02113982|323924479|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
94579701|NCT02113982|323924480|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
94579702|NCT02113982|323924481|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
94579703|NCT02113982|323924482|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
94579704|NCT02113982|323924483|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
94579705|NCT02113982|323924484|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
94579706|NCT02113982|323924471|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
94579707|NCT02113982|323924472|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
94579708|NCT02113982|323924473|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
94579709|NCT02113982|323924474|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
94579710|NCT02113982|323924475|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
94579711|NCT02113982|323924476|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
94579712|NCT02113982|323924477|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
94579713|NCT02113982|323924478|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
94579714|NCT02113982|323924479|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
94579715|NCT02113982|323924480|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
94579716|NCT02113982|323924481|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
94579717|NCT02113982|323924482|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
94579718|NCT02113982|323924483|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
94579719|NCT02113982|323924484|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
94579720|NCT02113982|323924471|FG000|Stage 2: Cohort Expansion|Transplant|0|||
94579721|NCT02113982|323924472|FG001|Stage 2: Cohort Expansion|Transplant|0|||
94579722|NCT02113982|323924473|FG002|Stage 2: Cohort Expansion|Transplant|0|||
94579723|NCT02113982|323924474|FG003|Stage 2: Cohort Expansion|Transplant|0|||
94579724|NCT02113982|323924475|FG004|Stage 2: Cohort Expansion|Transplant|0|||
94579725|NCT02113982|323924476|FG005|Stage 2: Cohort Expansion|Transplant|0|||
94579726|NCT02113982|323924477|FG006|Stage 2: Cohort Expansion|Transplant|0|||
94579727|NCT02113982|323924478|FG007|Stage 2: Cohort Expansion|Transplant|0|||
94579728|NCT02113982|323924479|FG008|Stage 2: Cohort Expansion|Transplant|0|||
94579729|NCT02113982|323924480|FG009|Stage 2: Cohort Expansion|Transplant|4|||
94579730|NCT02113982|323924481|FG010|Stage 2: Cohort Expansion|Transplant|2|||
94579731|NCT02113982|323924482|FG011|Stage 2: Cohort Expansion|Transplant|0|||
94579732|NCT02113982|323924483|FG012|Stage 2: Cohort Expansion|Transplant|0|||
94579733|NCT02113982|323924484|FG013|Stage 2: Cohort Expansion|Transplant|0|||
94579734|NCT02113982|323924471|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
94579735|NCT02113982|323924472|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
94579736|NCT02113982|323924473|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
94579737|NCT02113982|323924474|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
94579738|NCT02113982|323924475|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
94579739|NCT02113982|323924476|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
94579740|NCT02113982|323924477|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
94579741|NCT02113982|323924478|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
94579742|NCT02113982|323924479|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
94579743|NCT02113982|323924480|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
94579744|NCT02113982|323924481|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
94579745|NCT02113982|323924482|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
94579746|NCT02113982|323924483|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
94579747|NCT02113982|323924484|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
94579748|NCT02113982|323924471|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
94579749|NCT02113982|323924472|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
94579750|NCT02113982|323924473|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
94579751|NCT02113982|323924474|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
94579752|NCT02113982|323924475|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
94579753|NCT02113982|323924476|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
94579754|NCT02113982|323924477|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
94579755|NCT02113982|323924478|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
94579756|NCT02113982|323924479|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
94579757|NCT02113982|323924480|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
94579758|NCT02113982|323924481|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
94579759|NCT02113982|323924482|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
94579760|NCT02113982|323924483|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
94579761|NCT02113982|323924484|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
94579762|NCT02113982|323924471|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
94579763|NCT02113982|323924472|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
94579764|NCT02113982|323924473|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
94579765|NCT02113982|323924474|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
94579766|NCT02113982|323924475|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
94579767|NCT02113982|323924476|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
94579768|NCT02113982|323924477|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
94579769|NCT02113982|323924478|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
94579770|NCT02113982|323924479|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
94579771|NCT02113982|323924480|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
94579772|NCT02113982|323924481|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
94579773|NCT02113982|323924482|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
94579774|NCT02113982|323924483|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
94579775|NCT02113982|323924484|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
94579776|NCT02113982|323924471|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
94579777|NCT02113982|323924472|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
94579778|NCT02113982|323924473|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
94579779|NCT02113982|323924474|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
94579780|NCT02113982|323924475|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
94579781|NCT02113982|323924476|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
94579782|NCT02113982|323924477|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
94579783|NCT02113982|323924478|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
94579784|NCT02113982|323924479|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
94579785|NCT02113982|323924480|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
94579786|NCT02113982|323924481|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
94579787|NCT02113982|323924482|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
94579788|NCT02113982|323924483|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
94579789|NCT02113982|323924484|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
94579790|NCT02113982|323924471|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
94579791|NCT02113982|323924472|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
94579792|NCT02113982|323924473|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
94579793|NCT02113982|323924474|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
94579794|NCT02113982|323924475|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
94579795|NCT02113982|323924476|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
94579796|NCT02113982|323924477|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
94579797|NCT02113982|323924478|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
94579798|NCT02113982|323924479|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
94579799|NCT02113982|323924480|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
94579800|NCT02113982|323924481|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
94240397|NCT02108964|322674610|FG005|Overall Study|Death|0|||
94240398|NCT02108964|322674611|FG006|Overall Study|Death|0|||
94240399|NCT02108964|322674612|FG007|Overall Study|Death|2|||
94240400|NCT02108964|322674605|FG000|Overall Study|Subject/Guardian decision|0|||
94240401|NCT02108964|322674606|FG001|Overall Study|Subject/Guardian decision|1|||
94240402|NCT02108964|322674607|FG002|Overall Study|Subject/Guardian decision|4|||
94240403|NCT02108964|322674608|FG003|Overall Study|Subject/Guardian decision|0|||
94240404|NCT02108964|322674609|FG004|Overall Study|Subject/Guardian decision|2|||
94240405|NCT02108964|322674610|FG005|Overall Study|Subject/Guardian decision|0|||
94240406|NCT02108964|322674611|FG006|Overall Study|Subject/Guardian decision|1|||
94240407|NCT02108964|322674612|FG007|Overall Study|Subject/Guardian decision|2|||
94240408|NCT02108964|322674605|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
94579801|NCT02113982|323924482|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
94579802|NCT02113982|323924483|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
94579803|NCT02113982|323924484|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
94579804|NCT02113982|323924471|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
94240409|NCT02108964|322674606|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
94240410|NCT02108964|322674607|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
94579805|NCT02113982|323924472|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
94579806|NCT02113982|323924473|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
94579807|NCT02113982|323924474|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
94579808|NCT02113982|323924475|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
94579809|NCT02113982|323924476|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
94579810|NCT02113982|323924477|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
94579811|NCT02113982|323924478|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
94579812|NCT02113982|323924479|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
94579813|NCT02113982|323924480|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
94579814|NCT02113982|323924481|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
94579815|NCT02113982|323924482|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
94579816|NCT02113982|323924483|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
94579817|NCT02113982|323924484|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
94579818|NCT02113982|323924471|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
94579819|NCT02113982|323924472|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
94579820|NCT02113982|323924473|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
94579821|NCT02113982|323924474|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
94579822|NCT02113982|323924475|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
94579823|NCT02113982|323924476|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
94579824|NCT02113982|323924477|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
94579825|NCT02113982|323924478|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
94579826|NCT02113982|323924479|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
94579827|NCT02113982|323924480|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
94579828|NCT02113982|323924481|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
94579829|NCT02113982|323924482|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
94579830|NCT02113982|323924483|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
94579831|NCT02113982|323924484|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
94579832|NCT02113982|323924471|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
94579833|NCT02113982|323924472|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
94579834|NCT02113982|323924473|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
94579835|NCT02113982|323924474|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
94579836|NCT02113982|323924475|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
94579837|NCT02113982|323924476|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
94579838|NCT02113982|323924477|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
94579839|NCT02113982|323924478|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
94579840|NCT02113982|323924479|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
94579841|NCT02113982|323924480|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
94579842|NCT02113982|323924481|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
94579843|NCT02113982|323924482|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
94579844|NCT02113982|323924483|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
94579845|NCT02113982|323924484|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
94579846|NCT02113982|323924471|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
94579847|NCT02113982|323924472|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
94240411|NCT02108964|322674608|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
94240412|NCT02108964|322674609|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
94579848|NCT02113982|323924473|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
94579849|NCT02113982|323924474|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
94579850|NCT02113982|323924475|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
94579851|NCT02113982|323924476|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
94579852|NCT02113982|323924477|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
94579853|NCT02113982|323924478|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
94579854|NCT02113982|323924479|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
94579855|NCT02113982|323924480|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
94579856|NCT02113982|323924481|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
94579857|NCT02113982|323924482|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
94579858|NCT02113982|323924483|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
94579859|NCT02113982|323924484|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
94579860|NCT02113982|323924471|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
94579861|NCT02113982|323924472|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
94579862|NCT02113982|323924473|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
94579863|NCT02113982|323924474|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
94579864|NCT02113982|323924475|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
94579865|NCT02113982|323924476|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
94579866|NCT02113982|323924477|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
94579867|NCT02113982|323924478|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
94579868|NCT02113982|323924479|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
94579869|NCT02113982|323924480|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
94579870|NCT02113982|323924481|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
94579871|NCT02113982|323924482|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
94579872|NCT02113982|323924483|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
94579873|NCT02113982|323924484|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
94579874|NCT02113982|323924471|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
94579875|NCT02113982|323924472|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
94579876|NCT02113982|323924473|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
94579877|NCT02113982|323924474|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
94579878|NCT02113982|323924475|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
94579879|NCT02113982|323924476|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
94579880|NCT02113982|323924477|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
94579881|NCT02113982|323924478|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
94579882|NCT02113982|323924479|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
94579883|NCT02113982|323924480|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
94579884|NCT02113982|323924481|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
94579885|NCT02113982|323924482|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
94579886|NCT02113982|323924483|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
94579887|NCT02113982|323924484|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
94579888|NCT02113982|323924471|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
94579889|NCT02113982|323924472|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
94579890|NCT02113982|323924473|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
94579891|NCT02113982|323924474|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
94579892|NCT02113982|323924475|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
94579893|NCT02113982|323924476|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
94579894|NCT02113982|323924477|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
94579895|NCT02113982|323924478|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
94579896|NCT02113982|323924479|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
94579897|NCT02113982|323924480|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
94579898|NCT02113982|323924481|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
94579899|NCT02113982|323924482|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
94454312|NCT03806933|323451559|FG001|Main Period|Withdrawal by Subject|1|||
94454313|NCT03806933|323451560|FG002|Main Period|Withdrawal by Subject|1|||
94454314|NCT03806933|323451561|FG003|Main Period|Withdrawal by Subject|2|||
94454315|NCT03806933|323451558|FG000|Main Period|Lost to Follow-up|2|||
94454316|NCT03806933|323451559|FG001|Main Period|Lost to Follow-up|2|||
94454317|NCT03806933|323451560|FG002|Main Period|Lost to Follow-up|0|||
94454318|NCT03806933|323451561|FG003|Main Period|Lost to Follow-up|0|||
94454319|NCT03806933|323451558|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
94454320|NCT03806933|323451559|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
94454321|NCT03806933|323451560|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
94454322|NCT03806933|323451561|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
94454323|NCT03831113|323451562|FG000|Overall Study|Withdrawal by Subject|0|||
94454324|NCT03831113|323451563|FG001|Overall Study|Withdrawal by Subject|2|||
94454325|NCT03831113|323451562|FG000|Overall Study|Protocol Violation|0|||
94454326|NCT03831113|323451563|FG001|Overall Study|Protocol Violation|9|||
94579900|NCT02113982|323924483|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
94579901|NCT02113982|323924484|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
94579902|NCT02113982|323924471|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
94579903|NCT02113982|323924472|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
94579904|NCT02113982|323924473|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
94579905|NCT02113982|323924474|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
94579906|NCT02113982|323924475|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
94579907|NCT02113982|323924476|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
94579908|NCT02113982|323924477|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
94579909|NCT02113982|323924478|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
94579910|NCT02113982|323924479|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
94579911|NCT02113982|323924480|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
94579912|NCT02113982|323924481|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
94579913|NCT02113982|323924482|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
94579914|NCT02113982|323924483|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
94579915|NCT02113982|323924484|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
94579916|NCT01747876|323924485|FG000|Overall Study|Adverse Event|1|||
94579917|NCT01747876|323924486|FG001|Overall Study|Adverse Event|0|||
94579918|NCT01747876|323924487|FG002|Overall Study|Adverse Event|2|||
94579919|NCT01747876|323924485|FG000|Overall Study|Withdrawal by Subject|0|||
94579920|NCT01747876|323924486|FG001|Overall Study|Withdrawal by Subject|1|||
94579921|NCT01747876|323924487|FG002|Overall Study|Withdrawal by Subject|1|||
94579922|NCT01747876|323924485|FG000|Overall Study|Disease progression|4|||
94579923|NCT01747876|323924486|FG001|Overall Study|Disease progression|13|||
94579924|NCT01747876|323924487|FG002|Overall Study|Disease progression|8|||
94579925|NCT01747876|323924485|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
94579926|NCT01747876|323924486|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
94579927|NCT01747876|323924487|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
94579928|NCT03822117|323924488|FG000|Overall Study|Death|18|||
94579929|NCT03822117|323924489|FG001|Overall Study|Death|17|||
94579930|NCT03822117|323924490|FG002|Overall Study|Death|12|||
94579931|NCT03822117|323924491|FG003|Overall Study|Death|4|||
94579932|NCT03822117|323924488|FG000|Overall Study|Lost to Follow-up|1|||
94579933|NCT03822117|323924489|FG001|Overall Study|Lost to Follow-up|2|||
94579934|NCT03822117|323924490|FG002|Overall Study|Lost to Follow-up|3|||
94579935|NCT03822117|323924491|FG003|Overall Study|Lost to Follow-up|0|||
94579936|NCT03822117|323924488|FG000|Overall Study|Study Terminated by Sponsor|25|||
94579937|NCT03822117|323924489|FG001|Overall Study|Study Terminated by Sponsor|11|||
94579938|NCT03822117|323924490|FG002|Overall Study|Study Terminated by Sponsor|6|||
94579939|NCT03822117|323924491|FG003|Overall Study|Study Terminated by Sponsor|0|||
94579940|NCT03822117|323924488|FG000|Overall Study|Withdrawal by Subject|4|||
94579941|NCT03822117|323924489|FG001|Overall Study|Withdrawal by Subject|0|||
94579942|NCT03822117|323924490|FG002|Overall Study|Withdrawal by Subject|3|||
94579943|NCT03822117|323924491|FG003|Overall Study|Withdrawal by Subject|0|||
94579944|NCT03822117|323924488|FG000|Overall Study|Disease Progression|1|||
94579945|NCT03822117|323924489|FG001|Overall Study|Disease Progression|2|||
94579946|NCT03822117|323924490|FG002|Overall Study|Disease Progression|1|||
94579947|NCT03822117|323924491|FG003|Overall Study|Disease Progression|0|||
94579948|NCT03822117|323924488|FG000|Overall Study|Never Returned to Hospital|0|||
94579949|NCT03822117|323924489|FG001|Overall Study|Never Returned to Hospital|0|||
94579950|NCT03822117|323924490|FG002|Overall Study|Never Returned to Hospital|1|||
94579951|NCT03822117|323924491|FG003|Overall Study|Never Returned to Hospital|0|||
94579952|NCT02379728|323924496|FG000|Overall Study|Lost to Follow-up|1|||
94579953|NCT02379728|323924497|FG001|Overall Study|Lost to Follow-up|0|||
94579954|NCT02379728|323924498|FG002|Overall Study|Lost to Follow-up|3|||
94579955|NCT02379728|323924499|FG003|Overall Study|Lost to Follow-up|0|||
94579956|NCT02379728|323924496|FG000|Overall Study|Withdrawal by Subject|5|||
94579957|NCT02379728|323924497|FG001|Overall Study|Withdrawal by Subject|0|||
94579958|NCT02379728|323924498|FG002|Overall Study|Withdrawal by Subject|5|||
94579959|NCT02379728|323924499|FG003|Overall Study|Withdrawal by Subject|3|||
94579960|NCT02379728|323924496|FG000|Overall Study|Protocol Violation|0|||
94579961|NCT02379728|323924497|FG001|Overall Study|Protocol Violation|0|||
94579962|NCT02379728|323924498|FG002|Overall Study|Protocol Violation|2|||
94579963|NCT02379728|323924499|FG003|Overall Study|Protocol Violation|0|||
94579964|NCT02131259|323924500|FG000|Overall Study|Progressive disease|751|||
94579965|NCT02131259|323924500|FG000|Overall Study|Adverse Event|341|||
94579966|NCT02131259|323924500|FG000|Overall Study|Lost to Follow-up|7|||
94579967|NCT02131259|323924500|FG000|Overall Study|Relocation|32|||
94579968|NCT02131259|323924500|FG000|Overall Study|Other|63|||
94579969|NCT02131259|323924500|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
94579970|NCT02131259|323924500|FG000|Overall Study|Progressive disease/relocation|1|||
94579971|NCT02131259|323924500|FG000|Overall Study|Progressive disease/other|2|||
94579972|NCT02131259|323924500|FG000|Overall Study|AE/lost to follow-up|1|||
94579973|NCT02131259|323924500|FG000|Overall Study|AE/other|1|||
94579974|NCT02131259|323924500|FG000|Overall Study|Progressive disease/AE/other|1|||
94579975|NCT02131259|323924500|FG000|Overall Study|Missing|3|||
94579976|NCT02488915|323924501|FG000|Overall Study|Death|21|||
94579977|NCT02488915|323924501|FG000|Overall Study|Lost to Follow-up|4|||
94579978|NCT02488915|323924501|FG000|Overall Study|Withdrawal by Subject|1|||
94579979|NCT00684021|323924503|FG000|Overall Study|MRI Contraindicated|1|||
94579980|NCT00684021|323924504|FG001|Overall Study|MRI Contraindicated|1|||
94579981|NCT00684021|323924505|FG002|Overall Study|MRI Contraindicated|1|||
94579982|NCT00684021|323924506|FG003|Overall Study|MRI Contraindicated|0|||
94579983|NCT00684021|323924503|FG000|Overall Study|MRI not performed|0|||
94579984|NCT00684021|323924504|FG001|Overall Study|MRI not performed|1|||
94579985|NCT00684021|323924505|FG002|Overall Study|MRI not performed|1|||
94579986|NCT00684021|323924506|FG003|Overall Study|MRI not performed|2|||
94579987|NCT00684021|323924503|FG000|Overall Study|Death|1|||
94579988|NCT00684021|323924504|FG001|Overall Study|Death|0|||
94579989|NCT00684021|323924505|FG002|Overall Study|Death|0|||
94579990|NCT00684021|323924506|FG003|Overall Study|Death|0|||
94579991|NCT00891904|323924507|FG000|Overall Study|Death|1|||
94579992|NCT00891904|323924507|FG000|Overall Study|Adverse Event|1|||
94579993|NCT00927953|323924508|FG000|Overall Study|Death|2|||
94579994|NCT00927953|323924509|FG001|Overall Study|Death|1|||
94579995|NCT00907335|323924510|FG000|Overall Study|Withdrawal by Subject|2|||
94579996|NCT00907335|323924511|FG001|Overall Study|Withdrawal by Subject|0|||
94579997|NCT00907335|323924510|FG000|Overall Study|Adverse Event|4|||
94579998|NCT00907335|323924511|FG001|Overall Study|Adverse Event|1|||
94579999|NCT00907335|323924510|FG000|Overall Study|Lost to Follow-up|2|||
94580000|NCT00907335|323924511|FG001|Overall Study|Lost to Follow-up|0|||
94580001|NCT03818321|323924514|FG000|Overall Study|Withdrawal by Subject|1|||
94580002|NCT03818321|323924515|FG001|Overall Study|Withdrawal by Subject|2|||
94580003|NCT03345784|323924516|FG000|Overall Study|Withdrawal by Subject|2|||
94580004|NCT03345784|323924517|FG001|Overall Study|Withdrawal by Subject|1|||
94580005|NCT00728689|323924522|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
94580006|NCT00728689|323924523|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
94580007|NCT03216226|323924530|FG000|Overall Study|Adverse Event|3|||
94580008|NCT03216226|323924531|FG001|Overall Study|Adverse Event|0|||
94580009|NCT03216226|323924530|FG000|Overall Study|Protocol Violation|1|||
94580010|NCT03216226|323924531|FG001|Overall Study|Protocol Violation|3|||
94580011|NCT03216226|323924530|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
94580012|NCT03216226|323924531|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
94580013|NCT03216226|323924530|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
94580014|NCT03216226|323924531|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
94580015|NCT03216226|323924530|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
94580016|NCT03216226|323924531|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
94580017|NCT00538902|323924532|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
94580018|NCT00538902|323924533|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
94580019|NCT00538902|323924534|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
94580020|NCT00538902|323924532|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
94580021|NCT00538902|323924533|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
94580022|NCT00538902|323924534|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
94580023|NCT00538902|323924532|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
94580024|NCT00538902|323924533|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
94580025|NCT00538902|323924534|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
94580026|NCT00538902|323924532|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
94580027|NCT00538902|323924533|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
94580028|NCT00538902|323924534|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
94580029|NCT00538902|323924532|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
94580030|NCT00538902|323924533|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
94580031|NCT00538902|323924534|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
94580032|NCT00538902|323924532|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
94580033|NCT00538902|323924533|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
94580034|NCT00538902|323924534|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
94580035|NCT00538902|323924532|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
94580036|NCT00538902|323924533|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
94580037|NCT00538902|323924534|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
94580038|NCT00538902|323924532|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
94580039|NCT00538902|323924533|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
94580040|NCT00538902|323924534|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
94580041|NCT02000440|323924539|FG000|Overall Study|Adverse Event|3|||
94580042|NCT02000440|323924539|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
94580043|NCT01188343|323924540|FG000|Overall Study|Not vaccinated|0|||
94580044|NCT01188343|323924541|FG001|Overall Study|Not vaccinated|2|||
94580045|NCT01188343|323924542|FG002|Overall Study|Not vaccinated|1|||
94580046|NCT01188343|323924540|FG000|Overall Study|Withdrawal by Subject|1|||
94580047|NCT01188343|323924541|FG001|Overall Study|Withdrawal by Subject|24|||
94580048|NCT01188343|323924542|FG002|Overall Study|Withdrawal by Subject|0|||
94580049|NCT04109547|323924543|FG000|Overall Study|Withdrawal by Subject|3|||
94580050|NCT04109547|323924544|FG001|Overall Study|Withdrawal by Subject|2|||
94580051|NCT04109547|323924545|FG002|Overall Study|Withdrawal by Subject|6|||
94658900|NCT02371369|324206240|FG001|Part 1|Physician Decision|3|||
94240413|NCT02108964|322674610|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
94240414|NCT02108964|322674611|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
94240415|NCT02108964|322674612|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
94240416|NCT02626455|322674613|FG000|Overall Study|Other|1|||
94240417|NCT02626455|322674614|FG001|Overall Study|Other|1|||
94240418|NCT02626455|322674615|FG002|Overall Study|Other|0|||
94240419|NCT02626455|322674616|FG003|Overall Study|Other|0|||
94240420|NCT02626455|322674617|FG004|Overall Study|Other|0|||
94240421|NCT02626455|322674618|FG005|Overall Study|Other|17|||
94240422|NCT02626455|322674619|FG006|Overall Study|Other|23|||
94240423|NCT02626455|322674613|FG000|Overall Study|Withdrawal by Subject|1|||
94240424|NCT02626455|322674614|FG001|Overall Study|Withdrawal by Subject|0|||
94240425|NCT02626455|322674615|FG002|Overall Study|Withdrawal by Subject|0|||
94240426|NCT02626455|322674616|FG003|Overall Study|Withdrawal by Subject|0|||
94240427|NCT02626455|322674617|FG004|Overall Study|Withdrawal by Subject|0|||
94240428|NCT02626455|322674618|FG005|Overall Study|Withdrawal by Subject|10|||
94240429|NCT02626455|322674619|FG006|Overall Study|Withdrawal by Subject|6|||
94240430|NCT02626455|322674613|FG000|Overall Study|Physician Decision|0|||
94240431|NCT02626455|322674614|FG001|Overall Study|Physician Decision|2|||
94240432|NCT02626455|322674615|FG002|Overall Study|Physician Decision|2|||
94240433|NCT02626455|322674616|FG003|Overall Study|Physician Decision|2|||
94240434|NCT02626455|322674617|FG004|Overall Study|Physician Decision|1|||
94240435|NCT02626455|322674618|FG005|Overall Study|Physician Decision|10|||
94240436|NCT02626455|322674619|FG006|Overall Study|Physician Decision|3|||
94240437|NCT02626455|322674613|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
94240438|NCT02626455|322674614|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
94240439|NCT02626455|322674615|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
94240440|NCT02626455|322674616|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
94240441|NCT02626455|322674617|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
94240442|NCT02626455|322674618|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
94240443|NCT02626455|322674619|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
94240444|NCT02626455|322674613|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
94240445|NCT02626455|322674614|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
94454327|NCT00809471|323451565|FG000|Overall Study|Protocol non-compliance|15|||
94454328|NCT00809471|323451566|FG001|Overall Study|Protocol non-compliance|15|||
94454329|NCT00809471|323451567|FG002|Overall Study|Protocol non-compliance|6|||
94454330|NCT00809471|323451565|FG000|Overall Study|Lost to Follow-up|4|||
94454331|NCT00809471|323451566|FG001|Overall Study|Lost to Follow-up|2|||
94454332|NCT00809471|323451567|FG002|Overall Study|Lost to Follow-up|9|||
94454333|NCT00809471|323451565|FG000|Overall Study|Adverse Event|0|||
94454334|NCT00809471|323451566|FG001|Overall Study|Adverse Event|2|||
94454335|NCT00809471|323451567|FG002|Overall Study|Adverse Event|2|||
94454336|NCT00809471|323451565|FG000|Overall Study|Requirement for restricted medication|1|||
94454337|NCT00809471|323451566|FG001|Overall Study|Requirement for restricted medication|1|||
94454338|NCT00809471|323451567|FG002|Overall Study|Requirement for restricted medication|0|||
94454339|NCT00831311|323451568|FG000|Overall Study|Definitive Contraindication|3|||
94454340|NCT00831311|323451569|FG001|Overall Study|Definitive Contraindication|3|||
94454341|NCT00831311|323451568|FG000|Overall Study|Lost to Follow-up|3|||
94454342|NCT00831311|323451569|FG001|Overall Study|Lost to Follow-up|0|||
94454343|NCT00831311|323451568|FG000|Overall Study|Physician Decision|0|||
94454344|NCT00831311|323451569|FG001|Overall Study|Physician Decision|1|||
94454345|NCT00831311|323451568|FG000|Overall Study|Withdrawal by Subject|6|||
94454346|NCT00831311|323451569|FG001|Overall Study|Withdrawal by Subject|4|||
94454347|NCT01736397|323451570|FG000|Overall Study|Lack of Efficacy|1|||
94454348|NCT01736397|323451571|FG001|Overall Study|Lack of Efficacy|11|||
94454349|NCT01736397|323451570|FG000|Overall Study|Withdrawal by Subject|6|||
94454350|NCT01736397|323451571|FG001|Overall Study|Withdrawal by Subject|5|||
94454351|NCT01736397|323451570|FG000|Overall Study|Lost to Follow-up|0|||
94454352|NCT01736397|323451571|FG001|Overall Study|Lost to Follow-up|1|||
94454353|NCT01736397|323451570|FG000|Overall Study|Adverse Event|6|||
94454354|NCT01736397|323451571|FG001|Overall Study|Adverse Event|3|||
94454355|NCT01736397|323451570|FG000|Overall Study|Not stated|1|||
94454356|NCT01736397|323451571|FG001|Overall Study|Not stated|4|||
94454357|NCT02693106|323451572|FG000|Overall Study|No time|3|||
94454358|NCT00160706|323451573|FG000|Overall Study|Adverse Event|53|||
94454359|NCT00160706|323451573|FG000|Overall Study|Adverse Event and Other Reason|105|||
94240446|NCT02626455|322674615|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
94240447|NCT02626455|322674616|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
94240448|NCT02626455|322674617|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
94240449|NCT02626455|322674618|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
94454360|NCT00160706|323451573|FG000|Overall Study|Protocol Violation|3|||
94454361|NCT00160706|323451573|FG000|Overall Study|Withdrawal by Subject|41|||
94454362|NCT00160706|323451573|FG000|Overall Study|Withdrawal by Subject and Other|12|||
94454363|NCT00160706|323451573|FG000|Overall Study|Physician Decision|10|||
94580052|NCT04109547|323924546|FG003|Overall Study|Withdrawal by Subject|6|||
94580053|NCT04109547|323924543|FG000|Overall Study|Lost to Follow-up|0|||
94580054|NCT04109547|323924544|FG001|Overall Study|Lost to Follow-up|0|||
94580055|NCT04109547|323924545|FG002|Overall Study|Lost to Follow-up|0|||
94580056|NCT04109547|323924546|FG003|Overall Study|Lost to Follow-up|1|||
94580057|NCT04109547|323924543|FG000|Overall Study|Physician Decision|1|||
94580058|NCT04109547|323924544|FG001|Overall Study|Physician Decision|2|||
94580059|NCT04109547|323924545|FG002|Overall Study|Physician Decision|0|||
94580060|NCT04109547|323924546|FG003|Overall Study|Physician Decision|0|||
94580061|NCT01690143|323924549|FG000|Overall Study|Withdrawal by Subject|1|||
94580062|NCT03777982|323924550|FG000|Overall Study|Physician Decision|0|||
94580063|NCT03777982|323924551|FG001|Overall Study|Physician Decision|1|||
94580064|NCT02668653|323924555|FG000|Overall Study|Refractory disease|41|||
94580065|NCT02668653|323924556|FG001|Overall Study|Refractory disease|70|||
94580066|NCT02668653|323924555|FG000|Overall Study|Relapse|44|||
94580067|NCT02668653|323924556|FG001|Overall Study|Relapse|65|||
94580068|NCT02668653|323924555|FG000|Overall Study|Adverse Event|58|||
94580069|NCT02668653|323924556|FG001|Overall Study|Adverse Event|23|||
94580070|NCT02668653|323924555|FG000|Overall Study|Subject decision to stop study drug|25|||
94580071|NCT02668653|323924556|FG001|Overall Study|Subject decision to stop study drug|23|||
94580072|NCT02668653|323924555|FG000|Overall Study|Other reasons not specified|16|||
94580073|NCT02668653|323924556|FG001|Overall Study|Other reasons not specified|11|||
94580074|NCT02668653|323924555|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
94580075|NCT02668653|323924556|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
94580076|NCT02668653|323924555|FG000|Overall Study|Investigator decision|10|||
94580077|NCT02668653|323924556|FG001|Overall Study|Investigator decision|7|||
94580078|NCT02668653|323924555|FG000|Overall Study|Failure to meet continuation criteria|5|||
94580079|NCT02668653|323924556|FG001|Overall Study|Failure to meet continuation criteria|12|||
94580080|NCT02668653|323924555|FG000|Overall Study|Lost to Follow-up|1|||
94580081|NCT02668653|323924556|FG001|Overall Study|Lost to Follow-up|0|||
94580082|NCT02668653|323924555|FG000|Overall Study|Pregnancy|0|||
94580083|NCT02668653|323924556|FG001|Overall Study|Pregnancy|1|||
94580084|NCT02668653|323924555|FG000|Overall Study|Death|0|||
94580085|NCT02668653|323924556|FG001|Overall Study|Death|1|||
94580086|NCT03558737|323924557|FG000|Overall Study|Death|1|||
94580087|NCT03558737|323924558|FG001|Overall Study|Death|1|||
94580088|NCT02420821|323924559|FG000|Overall Study|Lost to Follow-up|6|||
94580089|NCT02420821|323924560|FG001|Overall Study|Lost to Follow-up|6|||
94580090|NCT02420821|323924559|FG000|Overall Study|Non-compliance|0|||
94580091|NCT02420821|323924560|FG001|Overall Study|Non-compliance|2|||
94580092|NCT02420821|323924559|FG000|Overall Study|Physician Decision|6|||
94580093|NCT02420821|323924560|FG001|Overall Study|Physician Decision|2|||
94580094|NCT02420821|323924559|FG000|Overall Study|Withdrawal by Subject|32|||
94580095|NCT02420821|323924560|FG001|Overall Study|Withdrawal by Subject|25|||
94580096|NCT02420821|323924559|FG000|Overall Study|Death|270|||
94580097|NCT02420821|323924560|FG001|Overall Study|Death|263|||
94454364|NCT00160706|323451573|FG000|Overall Study|Physician Decision and Other|3|||
94580098|NCT02420821|323924559|FG000|Overall Study|Study Terminated By Sponsor|145|||
94580099|NCT02420821|323924560|FG001|Overall Study|Study Terminated By Sponsor|149|||
94580100|NCT02420821|323924559|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
94580101|NCT02420821|323924560|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
94580102|NCT02420821|323924559|FG000|Overall Study|Adverse Event|0|||
94580103|NCT02420821|323924560|FG001|Overall Study|Adverse Event|1|||
94580104|NCT02420821|323924559|FG000|Overall Study|Protinuria|0|||
94580105|NCT02420821|323924560|FG001|Overall Study|Protinuria|1|||
94580106|NCT02420821|323924559|FG000|Overall Study|Progressive Disease|1|||
94580107|NCT02420821|323924560|FG001|Overall Study|Progressive Disease|1|||
94580108|NCT02420821|323924559|FG000|Overall Study|Disease Progression|0|||
94580109|NCT02420821|323924560|FG001|Overall Study|Disease Progression|1|||
94580110|NCT02420821|323924559|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
94580111|NCT02420821|323924560|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
94580112|NCT00577889|323924568|FG000|Overall Study|Withdrawal by Subject|1|||
94580113|NCT00577889|323924569|FG001|Overall Study|Withdrawal by Subject|0|||
94580114|NCT00577889|323924570|FG002|Overall Study|Withdrawal by Subject|0|||
94580115|NCT02202759|323926580|FG000|Overall Study|Study Terminated by Sponsor|3|||
94580116|NCT02202759|323926581|FG001|Overall Study|Study Terminated by Sponsor|3|||
94580117|NCT02202759|323926582|FG002|Overall Study|Study Terminated by Sponsor|3|||
94580118|NCT02202759|323926580|FG000|Overall Study|Withdrawal by Subject|2|||
94580119|NCT02202759|323926581|FG001|Overall Study|Withdrawal by Subject|1|||
94580120|NCT02202759|323926582|FG002|Overall Study|Withdrawal by Subject|1|||
94580121|NCT02202759|323926580|FG000|Overall Study|Reason not Specified|4|||
94580122|NCT02202759|323926581|FG001|Overall Study|Reason not Specified|11|||
94580123|NCT02202759|323926582|FG002|Overall Study|Reason not Specified|10|||
94580124|NCT00535496|323926590|FG000|Overall Study|Lost to Follow-up|0|||
94580125|NCT00535496|323926591|FG001|Overall Study|Lost to Follow-up|1|||
94580126|NCT00535496|323926592|FG002|Overall Study|Lost to Follow-up|0|||
94580127|NCT00535496|323926593|FG003|Overall Study|Lost to Follow-up|0|||
94580128|NCT00535496|323926590|FG000|Overall Study|Not treated with sugammadex|0|||
94580129|NCT00535496|323926591|FG001|Overall Study|Not treated with sugammadex|1|||
94580130|NCT00535496|323926592|FG002|Overall Study|Not treated with sugammadex|0|||
94580131|NCT00535496|323926593|FG003|Overall Study|Not treated with sugammadex|0|||
94580132|NCT01298648|323926600|FG000|Overall Study|Withdrawal by Subject|2|||
94580133|NCT01298648|323926600|FG000|Overall Study|Lost to Follow-up|21|||
94580134|NCT03829228|323926605|FG000|Overall Study|Protocol Violation|1|||
94580135|NCT03181932|323926612|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
94580136|NCT03181932|323926613|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
94580137|NCT03181932|323926612|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
94580138|NCT03181932|323926613|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
94580139|NCT03181932|323926612|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
94580140|NCT03181932|323926613|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
94580141|NCT03181932|323926612|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
94580142|NCT03181932|323926613|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
94580143|NCT03181932|323926612|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
94580144|NCT03181932|323926613|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
94580145|NCT03181932|323926612|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
94580146|NCT03181932|323926613|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
94580147|NCT03181932|323926612|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
94580148|NCT03181932|323926613|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
94580149|NCT03181932|323926612|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
94580150|NCT03181932|323926613|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
94580151|NCT03181932|323926612|FG000|Period 2 (Open-label Period)|Reason missing|2|||
94580152|NCT03181932|323926613|FG001|Period 2 (Open-label Period)|Reason missing|0|||
94580153|NCT01281124|323926614|FG000|Overall Study|Death|1|||
94580154|NCT04226742|323926615|FG000|Overall Study|Lost to Follow-up|16|||
94580155|NCT04226742|323926616|FG001|Overall Study|Lost to Follow-up|13|||
94580156|NCT04226742|323926615|FG000|Overall Study|Withdrawal by Subject|5|||
94580157|NCT04226742|323926616|FG001|Overall Study|Withdrawal by Subject|3|||
94580158|NCT01462370|323926617|FG000|Overall Study|Lack of Qualifying Event|1|||
94580159|NCT01462370|323926618|FG001|Overall Study|Lack of Qualifying Event|1|||
94580160|NCT01462370|323926617|FG000|Overall Study|Physician Decision|0|||
94580161|NCT01462370|323926618|FG001|Overall Study|Physician Decision|1|||
94580162|NCT01462370|323926617|FG000|Overall Study|Withdrawal by Subject|0|||
94580163|NCT01462370|323926618|FG001|Overall Study|Withdrawal by Subject|3|||
94580164|NCT01337960|323926619|FG000|Overall Study|Lost to Follow-up|1|||
94580165|NCT01337960|323926620|FG001|Overall Study|Lost to Follow-up|0|||
94580166|NCT01337960|323926621|FG002|Overall Study|Lost to Follow-up|0|||
94580167|NCT01337960|323926619|FG000|Overall Study|Withdrawal by Subject|1|||
94580168|NCT01337960|323926620|FG001|Overall Study|Withdrawal by Subject|0|||
94580169|NCT01337960|323926621|FG002|Overall Study|Withdrawal by Subject|0|||
94580170|NCT02085161|323926623|FG000|Overall Study|Not Treated|1|||
94580171|NCT02085161|323926624|FG001|Overall Study|Not Treated|0|||
94580172|NCT02085161|323926625|FG002|Overall Study|Not Treated|0|||
94580173|NCT02085161|323926626|FG003|Overall Study|Not Treated|0|||
94580174|NCT02085161|323926623|FG000|Overall Study|Adverse Event|8|||
94580175|NCT02085161|323926624|FG001|Overall Study|Adverse Event|5|||
94580176|NCT02085161|323926625|FG002|Overall Study|Adverse Event|4|||
94580177|NCT02085161|323926626|FG003|Overall Study|Adverse Event|5|||
94580178|NCT02085161|323926623|FG000|Overall Study|Protocol Violation|0|||
94580179|NCT02085161|323926624|FG001|Overall Study|Protocol Violation|1|||
94580180|NCT02085161|323926625|FG002|Overall Study|Protocol Violation|0|||
94580181|NCT02085161|323926626|FG003|Overall Study|Protocol Violation|1|||
94580182|NCT02085161|323926623|FG000|Overall Study|Withdrawal by Subject|2|||
94580183|NCT02085161|323926624|FG001|Overall Study|Withdrawal by Subject|4|||
94580184|NCT02085161|323926625|FG002|Overall Study|Withdrawal by Subject|0|||
94580185|NCT02085161|323926626|FG003|Overall Study|Withdrawal by Subject|3|||
94580186|NCT02085161|323926623|FG000|Overall Study|Other Reason|1|||
94580187|NCT02085161|323926624|FG001|Overall Study|Other Reason|0|||
94580188|NCT02085161|323926625|FG002|Overall Study|Other Reason|1|||
94580189|NCT02085161|323926626|FG003|Overall Study|Other Reason|1|||
94580190|NCT01774721|323926627|FG000|Overall Study|Death|133|||
94580191|NCT01774721|323926628|FG001|Overall Study|Death|152|||
94580192|NCT01774721|323926627|FG000|Overall Study|Withdrawal by Subject|20|||
94580193|NCT01774721|323926628|FG001|Overall Study|Withdrawal by Subject|14|||
94580194|NCT01774721|323926627|FG000|Overall Study|Lost to Follow-up|6|||
94580195|NCT01774721|323926628|FG001|Overall Study|Lost to Follow-up|7|||
94580196|NCT01774721|323926627|FG000|Overall Study|Did not meet eligibility criteria|0|||
94580197|NCT01774721|323926628|FG001|Overall Study|Did not meet eligibility criteria|3|||
94580198|NCT01774721|323926627|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
94580199|NCT01774721|323926628|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
94580200|NCT01774721|323926627|FG000|Overall Study|Study terminated by sponsor|5|||
94580201|NCT01774721|323926628|FG001|Overall Study|Study terminated by sponsor|0|||
94580202|NCT01774721|323926627|FG000|Overall Study|Disease progression|5|||
94580203|NCT01774721|323926628|FG001|Overall Study|Disease progression|0|||
94580204|NCT02156076|323926630|FG000|Treatment Period|no longer meets study criteria|0|||
94580205|NCT02156076|323926631|FG001|Treatment Period|no longer meets study criteria|0|||
94580206|NCT02156076|323926632|FG002|Treatment Period|no longer meets study criteria|1|||
94580207|NCT02156076|323926633|FG003|Treatment Period|no longer meets study criteria|0|||
94580208|NCT02156076|323926630|FG000|Treatment Period|Poor/non-compliance|0|||
94580209|NCT02156076|323926631|FG001|Treatment Period|Poor/non-compliance|1|||
94580210|NCT02156076|323926632|FG002|Treatment Period|Poor/non-compliance|0|||
94580211|NCT02156076|323926633|FG003|Treatment Period|Poor/non-compliance|0|||
94580212|NCT02156076|323926630|FG000|Treatment Period|Lost to Follow-up|0|||
94580213|NCT02156076|323926631|FG001|Treatment Period|Lost to Follow-up|0|||
94580214|NCT02156076|323926632|FG002|Treatment Period|Lost to Follow-up|0|||
94580215|NCT02156076|323926633|FG003|Treatment Period|Lost to Follow-up|1|||
94580216|NCT02156076|323926630|FG000|Treatment Period|Withdrawal by Subject|0|||
94580217|NCT02156076|323926631|FG001|Treatment Period|Withdrawal by Subject|0|||
94580218|NCT02156076|323926632|FG002|Treatment Period|Withdrawal by Subject|1|||
94580219|NCT02156076|323926633|FG003|Treatment Period|Withdrawal by Subject|0|||
94580220|NCT02156076|323926630|FG000|Treatment Period|Subject request to discontinue treatment|0|||
94580221|NCT02156076|323926631|FG001|Treatment Period|Subject request to discontinue treatment|1|||
94580222|NCT02156076|323926632|FG002|Treatment Period|Subject request to discontinue treatment|0|||
94580223|NCT02156076|323926633|FG003|Treatment Period|Subject request to discontinue treatment|0|||
94580224|NCT02156076|323926630|FG000|Treatment Period|Adverse Event|0|||
94580225|NCT02156076|323926631|FG001|Treatment Period|Adverse Event|0|||
94580226|NCT02156076|323926632|FG002|Treatment Period|Adverse Event|0|||
94580227|NCT02156076|323926633|FG003|Treatment Period|Adverse Event|1|||
94580228|NCT02156076|323926630|FG000|Follow-up Period|Withdrawal by Subject|1|||
94580229|NCT02156076|323926631|FG001|Follow-up Period|Withdrawal by Subject|0|||
94580230|NCT02156076|323926632|FG002|Follow-up Period|Withdrawal by Subject|0|||
94580231|NCT02156076|323926633|FG003|Follow-up Period|Withdrawal by Subject|0|||
94658901|NCT02371369|324206239|FG000|Part 1|Adverse Event|8|||
94580232|NCT00561925|323926637|FG000|14 Day Lead-In Period|Adverse Event|38|||
94580233|NCT00561925|323926638|FG001|14 Day Lead-In Period|Adverse Event|0|||
94580234|NCT00561925|323926639|FG002|14 Day Lead-In Period|Adverse Event|0|||
94580235|NCT00561925|323926640|FG003|14 Day Lead-In Period|Adverse Event|0|||
94580236|NCT00561925|323926641|FG004|14 Day Lead-In Period|Adverse Event|0|||
94580237|NCT00561925|323926637|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
94580238|NCT00561925|323926638|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
94580239|NCT00561925|323926639|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
94580240|NCT00561925|323926640|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
94580241|NCT00561925|323926641|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
94580242|NCT00561925|323926637|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
94580243|NCT00561925|323926638|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
94580244|NCT00561925|323926639|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
94580245|NCT00561925|323926640|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
94580246|NCT00561925|323926641|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
94580247|NCT00561925|323926637|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
94580248|NCT00561925|323926638|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
94580249|NCT00561925|323926639|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
94580250|NCT00561925|323926640|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
94580251|NCT00561925|323926641|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
94580252|NCT00561925|323926637|FG000|14 Day Lead-In Period|Other|5|||
94580253|NCT00561925|323926638|FG001|14 Day Lead-In Period|Other|0|||
94580254|NCT00561925|323926639|FG002|14 Day Lead-In Period|Other|0|||
94580255|NCT00561925|323926640|FG003|14 Day Lead-In Period|Other|0|||
94580256|NCT00561925|323926641|FG004|14 Day Lead-In Period|Other|0|||
94580257|NCT00561925|323926637|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
94580258|NCT00561925|323926638|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
94580259|NCT00561925|323926639|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
94580260|NCT00561925|323926640|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
94580261|NCT00561925|323926641|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
94580262|NCT00561925|323926637|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
94580263|NCT00561925|323926638|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
94580264|NCT00561925|323926639|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
94580265|NCT00561925|323926640|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
94580266|NCT00561925|323926641|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
94580267|NCT00561925|323926637|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
94580268|NCT00561925|323926638|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
94580269|NCT00561925|323926639|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
94580270|NCT00561925|323926640|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
94580271|NCT00561925|323926641|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
94580272|NCT00561925|323926637|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
94580273|NCT00561925|323926638|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
94580274|NCT00561925|323926639|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
94580275|NCT00561925|323926640|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
94580276|NCT00561925|323926641|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
94580277|NCT00561925|323926637|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
94580278|NCT00561925|323926638|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
94580279|NCT00561925|323926639|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
94580280|NCT00561925|323926640|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
94580281|NCT00561925|323926641|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
94351536|NCT01482598|323067420|FG000|Overall Study|Physician Decision|0|||
94580282|NCT00561925|323926637|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
94580283|NCT00561925|323926638|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
94580284|NCT00561925|323926639|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
94658902|NCT02371369|324206240|FG001|Part 1|Adverse Event|0|||
94351537|NCT01482598|323067421|FG001|Overall Study|Physician Decision|3|||
94351538|NCT01482598|323067420|FG000|Overall Study|Withdrawal by Subject|4|||
94351539|NCT01482598|323067421|FG001|Overall Study|Withdrawal by Subject|5|||
94351540|NCT01482598|323067420|FG000|Overall Study|Lost to Follow-up|5|||
94351541|NCT01482598|323067421|FG001|Overall Study|Lost to Follow-up|4|||
94351542|NCT01333865|323067422|FG000|Overall Study|Adverse Event|2|||
94351543|NCT01475214|323067427|FG000|Overall Study|Lost to Follow-up|1|||
94351544|NCT01475214|323067428|FG001|Overall Study|Lost to Follow-up|0|||
94351545|NCT01475214|323067429|FG002|Overall Study|Lost to Follow-up|1|||
94351546|NCT01475214|323067427|FG000|Overall Study|Physician Decision|2|||
94351547|NCT01475214|323067428|FG001|Overall Study|Physician Decision|0|||
94351548|NCT01475214|323067429|FG002|Overall Study|Physician Decision|0|||
94351549|NCT01475214|323067427|FG000|Overall Study|Withdrawal by Subject|2|||
94351550|NCT01475214|323067428|FG001|Overall Study|Withdrawal by Subject|4|||
94351551|NCT01475214|323067429|FG002|Overall Study|Withdrawal by Subject|1|||
94351552|NCT00453349|323067432|FG000|Randomized|Adverse Event|12|||
94351553|NCT00453349|323067433|FG001|Randomized|Adverse Event|11|||
94351554|NCT00453349|323067432|FG000|Randomized|Lack of Efficacy|2|||
94351555|NCT00453349|323067433|FG001|Randomized|Lack of Efficacy|1|||
94351556|NCT00453349|323067432|FG000|Randomized|Lost to Follow-up|7|||
94351557|NCT00453349|323067433|FG001|Randomized|Lost to Follow-up|5|||
94351558|NCT00453349|323067432|FG000|Randomized|Protocol Violation|1|||
94351559|NCT00453349|323067433|FG001|Randomized|Protocol Violation|1|||
94351560|NCT00453349|323067432|FG000|Randomized|Withdrawal by Subject|3|||
94351561|NCT00453349|323067433|FG001|Randomized|Withdrawal by Subject|5|||
94351562|NCT00453349|323067432|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
94351563|NCT00453349|323067433|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
94351564|NCT00453349|323067432|FG000|Completed Study|Adverse Event|12|||
94351565|NCT00453349|323067433|FG001|Completed Study|Adverse Event|11|||
94351566|NCT00453349|323067432|FG000|Completed Study|Lack of Efficacy|2|||
94351567|NCT00453349|323067433|FG001|Completed Study|Lack of Efficacy|1|||
94351568|NCT00453349|323067432|FG000|Completed Study|Lost to Follow-up|7|||
94351569|NCT00453349|323067433|FG001|Completed Study|Lost to Follow-up|5|||
94351570|NCT00453349|323067432|FG000|Completed Study|Protocol Violation|1|||
94351571|NCT00453349|323067433|FG001|Completed Study|Protocol Violation|1|||
94351572|NCT00453349|323067432|FG000|Completed Study|Withdrawal by Subject|3|||
94351573|NCT00453349|323067433|FG001|Completed Study|Withdrawal by Subject|5|||
94351574|NCT00453349|323067432|FG000|Completed Study|Lost to follow up after study treatment|2|||
94351575|NCT00453349|323067433|FG001|Completed Study|Lost to follow up after study treatment|11|||
94351576|NCT04369742|323067434|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
94351577|NCT04369742|323067435|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
94351578|NCT04369742|323067434|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
94351579|NCT04369742|323067435|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
94351580|NCT00951912|323067438|FG000|Overall Study|Lack of Efficacy|1|||
94351581|NCT00951912|323067439|FG001|Overall Study|Lack of Efficacy|0|||
94351582|NCT00951912|323067440|FG002|Overall Study|Lack of Efficacy|0|||
94351583|NCT00951912|323067438|FG000|Overall Study|Adverse Event|0|||
94351584|NCT00951912|323067439|FG001|Overall Study|Adverse Event|1|||
94351585|NCT00951912|323067440|FG002|Overall Study|Adverse Event|1|||
94351586|NCT00951912|323067438|FG000|Overall Study|Lost to Follow-up|2|||
94351587|NCT00951912|323067439|FG001|Overall Study|Lost to Follow-up|2|||
94351588|NCT00951912|323067440|FG002|Overall Study|Lost to Follow-up|0|||
94351589|NCT00951912|323067438|FG000|Overall Study|Physician Decision|1|||
94351590|NCT00951912|323067439|FG001|Overall Study|Physician Decision|0|||
94351591|NCT00951912|323067440|FG002|Overall Study|Physician Decision|1|||
94351592|NCT00951912|323067438|FG000|Overall Study|Withdrawal by Subject|1|||
94351593|NCT00951912|323067439|FG001|Overall Study|Withdrawal by Subject|1|||
94351594|NCT00951912|323067440|FG002|Overall Study|Withdrawal by Subject|0|||
94351595|NCT00951912|323067438|FG000|Overall Study|Other:Depression|1|||
94351596|NCT00951912|323067439|FG001|Overall Study|Other:Depression|0|||
94351597|NCT00951912|323067440|FG002|Overall Study|Other:Depression|0|||
94351598|NCT00951912|323067438|FG000|Overall Study|Other: Colon cancer|1|||
94351599|NCT00951912|323067439|FG001|Overall Study|Other: Colon cancer|0|||
94351600|NCT00951912|323067440|FG002|Overall Study|Other: Colon cancer|0|||
94351601|NCT00951912|323067438|FG000|Overall Study|Other: Stroke|0|||
94580285|NCT00561925|323926640|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
94351602|NCT00951912|323067439|FG001|Overall Study|Other: Stroke|1|||
94351603|NCT00951912|323067440|FG002|Overall Study|Other: Stroke|0|||
94351604|NCT03417999|323067441|FG000|Overall Study|Withdrawal by Subject|1|||
94351605|NCT03417999|323067442|FG001|Overall Study|Withdrawal by Subject|0|||
94351606|NCT03417999|323067443|FG002|Overall Study|Withdrawal by Subject|0|||
94351607|NCT03417999|323067441|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
94351608|NCT03417999|323067442|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
94580286|NCT00561925|323926641|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
94351609|NCT03417999|323067443|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
94351610|NCT03417999|323067441|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
94351611|NCT03417999|323067442|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
94658903|NCT02371369|324206239|FG000|Part 1|Withdrawal by Subject|1|||
94658904|NCT02371369|324206240|FG001|Part 1|Withdrawal by Subject|6|||
94351612|NCT03417999|323067443|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
94351613|NCT03417999|323067441|FG000|Overall Study|Inadequate study staff available to process samples|0|||
94351614|NCT03417999|323067442|FG001|Overall Study|Inadequate study staff available to process samples|0|||
94351615|NCT03417999|323067443|FG002|Overall Study|Inadequate study staff available to process samples|1|||
94351616|NCT03039699|323067454|FG000|Overall Study|Incorrect inclusion|5|||
94351617|NCT03039699|323067455|FG001|Overall Study|Incorrect inclusion|4|||
94351618|NCT03039699|323067454|FG000|Overall Study|Lack of data to assess study endpoint|5|||
94351619|NCT03039699|323067455|FG001|Overall Study|Lack of data to assess study endpoint|3|||
94351620|NCT03039699|323067454|FG000|Overall Study|Bacterial infection|12|||
94351621|NCT03039699|323067455|FG001|Overall Study|Bacterial infection|28|||
94351622|NCT02539160|323067458|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
94351623|NCT02539160|323067459|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
94351624|NCT02539160|323067460|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
94351625|NCT02539160|323067461|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
94351626|NCT02539160|323067458|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
94351627|NCT02539160|323067459|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
94351628|NCT02539160|323067460|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
94351629|NCT02539160|323067461|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
94351630|NCT02539160|323067458|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
94351631|NCT02539160|323067459|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
94351632|NCT02539160|323067460|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
94351633|NCT02539160|323067461|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
94351634|NCT00967343|323067465|FG000|Overall Study|Study termination by sponsor|12|||
94351635|NCT00967343|323067465|FG000|Overall Study|Death|24|||
94351636|NCT00967343|323067465|FG000|Overall Study|Relapse|1|||
94351637|NCT00967343|323067465|FG000|Overall Study|Lost to Follow-up|1|||
94351638|NCT00758394|323067466|FG000|2nd Intervention Order|Lost to Follow-up|0|||
94351639|NCT00758394|323067467|FG001|2nd Intervention Order|Lost to Follow-up|1|||
94351640|NCT00758394|323067468|FG002|2nd Intervention Order|Lost to Follow-up|0|||
94351641|NCT00758394|323067469|FG003|2nd Intervention Order|Lost to Follow-up|0|||
94351642|NCT00758394|323067466|FG000|3rd Intervention|Lost to Follow-up|1|||
94351643|NCT00758394|323067467|FG001|3rd Intervention|Lost to Follow-up|0|||
94351644|NCT00758394|323067468|FG002|3rd Intervention|Lost to Follow-up|0|||
94351645|NCT00758394|323067469|FG003|3rd Intervention|Lost to Follow-up|1|||
94351646|NCT00950755|323067472|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
94351647|NCT00950755|323067472|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
94351648|NCT00950755|323067472|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
94351649|NCT00950755|323067472|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
94351650|NCT00950755|323067472|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
94351651|NCT00950755|323067472|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
94351652|NCT00950755|323067472|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
94351653|NCT00950755|323067472|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
94351654|NCT00950755|323067472|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
94351655|NCT00950755|323067472|FG000|Long-Term Follow-Up|Death|8|||
94351656|NCT01078389|323069292|FG000|Overall Study|Adverse Event|10|||
94351657|NCT01078389|323069293|FG001|Overall Study|Adverse Event|6|||
94351658|NCT01078389|323069292|FG000|Overall Study|Major Protocol Deviation|2|||
94351659|NCT01078389|323069293|FG001|Overall Study|Major Protocol Deviation|0|||
94351660|NCT01078389|323069292|FG000|Overall Study|Lost to Follow-up|23|||
94351661|NCT01078389|323069293|FG001|Overall Study|Lost to Follow-up|23|||
94351662|NCT01078389|323069292|FG000|Overall Study|Voluntary Withdrawal|20|||
94351663|NCT01078389|323069293|FG001|Overall Study|Voluntary Withdrawal|36|||
94351664|NCT01078389|323069292|FG000|Overall Study|Other|9|||
94351665|NCT01078389|323069293|FG001|Overall Study|Other|2|||
94351666|NCT01002573|323069294|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
94351667|NCT01002573|323069295|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
94351668|NCT00663208|323069296|FG000|Treatment Period|Lost to Follow-up|0|||
94351669|NCT00663208|323069297|FG001|Treatment Period|Lost to Follow-up|1|||
94351670|NCT00663208|323069298|FG002|Treatment Period|Lost to Follow-up|0|||
94351671|NCT00663208|323069299|FG003|Treatment Period|Lost to Follow-up|0|||
94351672|NCT00663208|323069300|FG004|Treatment Period|Lost to Follow-up|0|||
94351673|NCT00663208|323069301|FG005|Treatment Period|Lost to Follow-up|0|||
94351674|NCT00663208|323069302|FG006|Treatment Period|Lost to Follow-up|0|||
94351675|NCT00663208|323069296|FG000|Follow-up Period|Lost to Follow-up|2|||
94351676|NCT00663208|323069297|FG001|Follow-up Period|Lost to Follow-up|0|||
94351677|NCT00663208|323069298|FG002|Follow-up Period|Lost to Follow-up|3|||
94351678|NCT00663208|323069299|FG003|Follow-up Period|Lost to Follow-up|2|||
94351679|NCT00663208|323069300|FG004|Follow-up Period|Lost to Follow-up|0|||
94351680|NCT00663208|323069301|FG005|Follow-up Period|Lost to Follow-up|0|||
94351681|NCT00663208|323069302|FG006|Follow-up Period|Lost to Follow-up|0|||
94454365|NCT00160706|323451573|FG000|Overall Study|Lost to Follow-up|4|||
94580287|NCT00561925|323926637|FG000|144-week Double-blind, Double-dummy|Death|0|||
94580288|NCT00561925|323926638|FG001|144-week Double-blind, Double-dummy|Death|6|||
94580289|NCT00561925|323926639|FG002|144-week Double-blind, Double-dummy|Death|3|||
94580290|NCT00561925|323926640|FG003|144-week Double-blind, Double-dummy|Death|0|||
94580291|NCT00561925|323926641|FG004|144-week Double-blind, Double-dummy|Death|0|||
94580292|NCT00561925|323926637|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
94580293|NCT00561925|323926638|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
94580294|NCT00561925|323926639|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
94580295|NCT00561925|323926640|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
94580296|NCT00561925|323926641|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
94580297|NCT00561925|323926637|FG000|144-week Double-blind, Double-dummy|Other|0|||
94580298|NCT00561925|323926638|FG001|144-week Double-blind, Double-dummy|Other|8|||
94580299|NCT00561925|323926639|FG002|144-week Double-blind, Double-dummy|Other|11|||
94580300|NCT00561925|323926640|FG003|144-week Double-blind, Double-dummy|Other|0|||
94580301|NCT00561925|323926641|FG004|144-week Double-blind, Double-dummy|Other|0|||
94580302|NCT00561925|323926637|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
94580303|NCT00561925|323926638|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
94580304|NCT00561925|323926639|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
94580305|NCT00561925|323926640|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
94580306|NCT00561925|323926641|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
94580307|NCT04313244|323926642|FG000|Overall Study|Withdrawal of Consent|3|||
94580308|NCT04313244|323926643|FG001|Overall Study|Withdrawal of Consent|3|||
94580309|NCT04313244|323926642|FG000|Overall Study|Met Exclusion Criteria|1|||
94580310|NCT04313244|323926643|FG001|Overall Study|Met Exclusion Criteria|0|||
94580311|NCT04313244|323926642|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
94580312|NCT04313244|323926643|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
94580313|NCT02976038|323926646|FG000|Overall Study|Physician Decision|22|||
94580314|NCT02976038|323926646|FG000|Overall Study|Withdrawal by Subject|3|||
94580315|NCT02976038|323926646|FG000|Overall Study|Lost to Follow-up|2|||
94580316|NCT02976038|323926646|FG000|Overall Study|Adverse Event|1|||
94580317|NCT03096288|323926651|FG000|Overall Study|Withdrawal by Subject|0|||
94580318|NCT03096288|323926652|FG001|Overall Study|Withdrawal by Subject|1|||
94580319|NCT03096288|323926653|FG002|Overall Study|Withdrawal by Subject|0|||
94580320|NCT03096288|323926654|FG003|Overall Study|Withdrawal by Subject|1|||
94580321|NCT02004093|323926658|FG000|Overall Study|Death|2|||
94580322|NCT02004093|323926659|FG001|Overall Study|Death|1|||
94580323|NCT02004093|323926658|FG000|Overall Study|Lack of Efficacy|66|||
94580324|NCT02004093|323926659|FG001|Overall Study|Lack of Efficacy|62|||
94580325|NCT02004093|323926658|FG000|Overall Study|Protocol Violation|0|||
94580326|NCT02004093|323926659|FG001|Overall Study|Protocol Violation|1|||
94580327|NCT02004093|323926658|FG000|Overall Study|Lost to Follow-up|0|||
94580328|NCT02004093|323926659|FG001|Overall Study|Lost to Follow-up|1|||
94580329|NCT02004093|323926658|FG000|Overall Study|Withdrawal by Subject|3|||
94580330|NCT02004093|323926659|FG001|Overall Study|Withdrawal by Subject|7|||
94580331|NCT02004093|323926658|FG000|Overall Study|Other|3|||
94580332|NCT02004093|323926659|FG001|Overall Study|Other|1|||
94580333|NCT02531802|323926660|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
94580334|NCT02531802|323926661|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
94580335|NCT02531802|323926662|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
94580336|NCT02531802|323926663|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
94580337|NCT02531802|323926664|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
94580338|NCT02531802|323926665|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
94658905|NCT02371369|324206239|FG000|Part 1|Disease progression|0|||
94658906|NCT02371369|324206240|FG001|Part 1|Disease progression|1|||
94658907|NCT02371369|324206239|FG000|Part 1|Protocol Violation|0|||
94658908|NCT02371369|324206240|FG001|Part 1|Protocol Violation|1|||
94658909|NCT02371369|324206239|FG000|Part 2|Adverse Event|6|||
94658910|NCT02371369|324206240|FG001|Part 2|Adverse Event|5|||
94658911|NCT02371369|324206239|FG000|Part 2|Withdrawal by Subject|16|||
94658912|NCT02371369|324206240|FG001|Part 2|Withdrawal by Subject|6|||
94658913|NCT02371369|324206239|FG000|Part 2|Investigator decision|1|||
94658914|NCT02371369|324206240|FG001|Part 2|Investigator decision|2|||
94658915|NCT02371369|324206239|FG000|Part 2|Death|0|||
94580339|NCT02531802|323926666|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
94580340|NCT02531802|323926667|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
94580341|NCT02531802|323926668|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
94658916|NCT02371369|324206240|FG001|Part 2|Death|1|||
94658917|NCT02371369|324206239|FG000|Part 2|Disease progression|1|||
94658918|NCT02371369|324206240|FG001|Part 2|Disease progression|0|||
94658919|NCT02371369|324206239|FG000|Part 2|Subject Noncompliance|1|||
94580342|NCT02531802|323926669|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
94658920|NCT02371369|324206240|FG001|Part 2|Subject Noncompliance|0|||
94658921|NCT02371369|324206239|FG000|Part 2|Lost to Follow-up|1|||
94658922|NCT02371369|324206240|FG001|Part 2|Lost to Follow-up|1|||
94658923|NCT02371369|324206239|FG000|Part 2|Subject transitioned to commercial supply|6|||
94658924|NCT02371369|324206240|FG001|Part 2|Subject transitioned to commercial supply|4|||
94658925|NCT02371369|324206239|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
94658926|NCT02371369|324206240|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
94658927|NCT02371369|324206239|FG000|Part 2|Surgical resection of tumor|1|||
94454366|NCT00160706|323451573|FG000|Overall Study|Lost to Follow-up and Other|1|||
94454367|NCT00160706|323451573|FG000|Overall Study|Lack of Efficacy|42|||
94454368|NCT00160706|323451573|FG000|Overall Study|Lack of Efficacy and Other|1|||
94454369|NCT00160706|323451573|FG000|Overall Study|Other Reason|11|||
94454370|NCT02162719|323451574|FG000|Overall Study|Death|41|||
94454371|NCT02162719|323451575|FG001|Overall Study|Death|46|||
94454372|NCT02162719|323451574|FG000|Overall Study|Lost to Follow-up|1|||
94454373|NCT02162719|323451575|FG001|Overall Study|Lost to Follow-up|3|||
94454374|NCT02162719|323451574|FG000|Overall Study|Disease Progression|2|||
94454375|NCT02162719|323451575|FG001|Overall Study|Disease Progression|1|||
94454376|NCT02162719|323451574|FG000|Overall Study|Withdrawal by Subject|8|||
94454377|NCT02162719|323451575|FG001|Overall Study|Withdrawal by Subject|2|||
94454378|NCT02162719|323451574|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
94454379|NCT02162719|323451575|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
94454380|NCT03063086|323451583|FG000|Overall Study|technical problems|1|||
94454381|NCT03063086|323451584|FG001|Overall Study|technical problems|0|||
94454382|NCT03063086|323451585|FG002|Overall Study|technical problems|0|||
94454383|NCT03063086|323451586|FG003|Overall Study|technical problems|0|||
94454384|NCT03063086|323451587|FG004|Overall Study|technical problems|0|||
94454385|NCT03063086|323451588|FG005|Overall Study|technical problems|0|||
94454386|NCT03063086|323451583|FG000|Overall Study|Adverse Event|1|||
94454387|NCT03063086|323451584|FG001|Overall Study|Adverse Event|1|||
94454388|NCT03063086|323451585|FG002|Overall Study|Adverse Event|1|||
94454389|NCT03063086|323451586|FG003|Overall Study|Adverse Event|1|||
94454390|NCT03063086|323451587|FG004|Overall Study|Adverse Event|0|||
94454391|NCT03063086|323451588|FG005|Overall Study|Adverse Event|0|||
94454392|NCT03063086|323451583|FG000|Overall Study|subject/guardian decision|1|||
94454393|NCT03063086|323451584|FG001|Overall Study|subject/guardian decision|0|||
94454394|NCT03063086|323451585|FG002|Overall Study|subject/guardian decision|0|||
94454395|NCT03063086|323451586|FG003|Overall Study|subject/guardian decision|0|||
94454396|NCT03063086|323451587|FG004|Overall Study|subject/guardian decision|0|||
94454397|NCT03063086|323451588|FG005|Overall Study|subject/guardian decision|0|||
94454398|NCT03063086|323451583|FG000|Overall Study|Non-compliance with study treatment|0|||
94454399|NCT03063086|323451584|FG001|Overall Study|Non-compliance with study treatment|0|||
94454400|NCT03063086|323451585|FG002|Overall Study|Non-compliance with study treatment|0|||
94454401|NCT03063086|323451586|FG003|Overall Study|Non-compliance with study treatment|1|||
94454402|NCT03063086|323451587|FG004|Overall Study|Non-compliance with study treatment|0|||
94454403|NCT03063086|323451588|FG005|Overall Study|Non-compliance with study treatment|1|||
94454404|NCT03063086|323451583|FG000|Overall Study|Physician Decision|0|||
94454405|NCT03063086|323451584|FG001|Overall Study|Physician Decision|0|||
94454406|NCT03063086|323451585|FG002|Overall Study|Physician Decision|0|||
94454407|NCT03063086|323451586|FG003|Overall Study|Physician Decision|1|||
94454408|NCT03063086|323451587|FG004|Overall Study|Physician Decision|0|||
94454409|NCT03063086|323451588|FG005|Overall Study|Physician Decision|0|||
94454410|NCT01893281|323451589|FG000|Overall Study|Adverse Event|1|||
94454411|NCT01893281|323451589|FG000|Overall Study|Protocol Violation|1|||
94454412|NCT01893281|323451589|FG000|Overall Study|Withdrawal by Subject|1|||
94454413|NCT00562302|323451590|FG000|Overall Study|Lost to Follow-up|3|||
94454414|NCT00562302|323451591|FG001|Overall Study|Lost to Follow-up|3|||
94454415|NCT00562302|323451590|FG000|Overall Study|Adverse Event|0|||
94454416|NCT00562302|323451591|FG001|Overall Study|Adverse Event|6|||
94454417|NCT00562302|323451590|FG000|Overall Study|Non-compliance|1|||
94454418|NCT00562302|323451591|FG001|Overall Study|Non-compliance|2|||
94454419|NCT00562302|323451590|FG000|Overall Study|Withdrawal by Subject|7|||
94454420|NCT00562302|323451591|FG001|Overall Study|Withdrawal by Subject|8|||
94454421|NCT00562302|323451590|FG000|Overall Study|Death|1|||
94454422|NCT00562302|323451591|FG001|Overall Study|Death|2|||
94454423|NCT00562302|323451590|FG000|Overall Study|Lung resection prior to study completion|7|||
94454424|NCT00562302|323451591|FG001|Overall Study|Lung resection prior to study completion|7|||
94454425|NCT00562302|323451590|FG000|Overall Study|Not stated|1|||
94658928|NCT02371369|324206240|FG001|Part 2|Surgical resection of tumor|1|||
94658929|NCT02371369|324206239|FG000|Part 2|Other|0|||
94658930|NCT02371369|324206240|FG001|Part 2|Other|1|||
94658931|NCT01272934|324206243|FG000|Overall Study|Adverse Event|0|||
94454426|NCT00562302|323451591|FG001|Overall Study|Not stated|4|||
94454427|NCT04603482|323451594|FG000|Overall Study|Lost to Follow-up|15|||
94454428|NCT04603482|323451595|FG001|Overall Study|Lost to Follow-up|15|||
94454429|NCT04603482|323451596|FG002|Overall Study|Lost to Follow-up|15|||
94454430|NCT01355575|323451598|FG000|Overall Study|Withdrawal by Subject|2|||
94454431|NCT03382834|323451599|FG000|Step 1|Lost to Follow-up|0|||
94454432|NCT03382834|323451600|FG001|Step 1|Lost to Follow-up|1|||
94454433|NCT03382834|323451599|FG000|Step 2|Death|1|||
94454434|NCT03382834|323451600|FG001|Step 2|Death|0|||
94580343|NCT02531802|323926670|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
94580344|NCT02531802|323926671|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
94580345|NCT02531802|323926672|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
94580346|NCT02531802|323926673|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
94580347|NCT02531802|323926674|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
94580348|NCT02531802|323926675|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
94580349|NCT02531802|323926676|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
94580350|NCT02531802|323926677|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
94580351|NCT02531802|323926678|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
94580352|NCT02531802|323926679|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
94580353|NCT02531802|323926680|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
94580354|NCT02531802|323926660|FG000|Received Vaccination 2|Physician Decision|0|||
94580355|NCT02531802|323926661|FG001|Received Vaccination 2|Physician Decision|0|||
94580356|NCT02531802|323926662|FG002|Received Vaccination 2|Physician Decision|0|||
94580357|NCT02531802|323926663|FG003|Received Vaccination 2|Physician Decision|0|||
94580358|NCT02531802|323926664|FG004|Received Vaccination 2|Physician Decision|0|||
94580359|NCT02531802|323926665|FG005|Received Vaccination 2|Physician Decision|1|||
94580360|NCT02531802|323926666|FG006|Received Vaccination 2|Physician Decision|0|||
94580361|NCT02531802|323926667|FG007|Received Vaccination 2|Physician Decision|0|||
94580362|NCT02531802|323926668|FG008|Received Vaccination 2|Physician Decision|0|||
94580363|NCT02531802|323926669|FG009|Received Vaccination 2|Physician Decision|2|||
94580364|NCT02531802|323926670|FG010|Received Vaccination 2|Physician Decision|0|||
94580365|NCT02531802|323926671|FG011|Received Vaccination 2|Physician Decision|0|||
94580366|NCT02531802|323926672|FG012|Received Vaccination 2|Physician Decision|0|||
94580367|NCT02531802|323926673|FG013|Received Vaccination 2|Physician Decision|1|||
94580368|NCT02531802|323926674|FG014|Received Vaccination 2|Physician Decision|0|||
94580369|NCT02531802|323926675|FG015|Received Vaccination 2|Physician Decision|0|||
94580370|NCT02531802|323926676|FG016|Received Vaccination 2|Physician Decision|0|||
94580371|NCT02531802|323926677|FG017|Received Vaccination 2|Physician Decision|1|||
94580372|NCT02531802|323926678|FG018|Received Vaccination 2|Physician Decision|0|||
94580373|NCT02531802|323926679|FG019|Received Vaccination 2|Physician Decision|0|||
94580374|NCT02531802|323926680|FG020|Received Vaccination 2|Physician Decision|0|||
94580375|NCT02531802|323926660|FG000|Received Vaccination 2|Adverse Event|0|||
94580376|NCT02531802|323926661|FG001|Received Vaccination 2|Adverse Event|0|||
94580377|NCT02531802|323926662|FG002|Received Vaccination 2|Adverse Event|0|||
94580378|NCT02531802|323926663|FG003|Received Vaccination 2|Adverse Event|0|||
94580379|NCT02531802|323926664|FG004|Received Vaccination 2|Adverse Event|0|||
94580380|NCT02531802|323926665|FG005|Received Vaccination 2|Adverse Event|2|||
94580381|NCT02531802|323926666|FG006|Received Vaccination 2|Adverse Event|0|||
94580382|NCT02531802|323926667|FG007|Received Vaccination 2|Adverse Event|0|||
94580383|NCT02531802|323926668|FG008|Received Vaccination 2|Adverse Event|0|||
94658932|NCT01272934|324206244|FG001|Overall Study|Adverse Event|1|||
94658933|NCT01272934|324206243|FG000|Overall Study|Abnormal Laboratory Value|0|||
94658934|NCT01272934|324206244|FG001|Overall Study|Abnormal Laboratory Value|1|||
94658935|NCT03588572|324206252|FG000|Visitation 1|Lack of Efficacy|1|||
94658936|NCT03588572|324206253|FG001|Visitation 1|Lack of Efficacy|1|||
94658937|NCT03588572|324206252|FG000|Visitation 2|Lost to Follow-up|1|||
94658938|NCT03588572|324206253|FG001|Visitation 2|Lost to Follow-up|1|||
94658939|NCT03588572|324206252|FG000|Visitation 2|Lack of Efficacy|0|||
94658940|NCT03588572|324206253|FG001|Visitation 2|Lack of Efficacy|1|||
94658941|NCT03588572|324206252|FG000|Visitation 2|Withdrawal by Subject|1|||
94658942|NCT03588572|324206253|FG001|Visitation 2|Withdrawal by Subject|0|||
94658943|NCT03588572|324206252|FG000|Visitation 3|Lost to Follow-up|1|||
94240450|NCT02626455|322674619|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
94240451|NCT02626455|322674613|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
94240452|NCT02626455|322674614|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
94240453|NCT02626455|322674615|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
94240454|NCT02626455|322674616|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
94240455|NCT02626455|322674617|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
94240456|NCT02626455|322674618|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
94240457|NCT02626455|322674619|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
94240458|NCT02626455|322674613|FG000|Overall Study|Patient decision|0|||
94240459|NCT02626455|322674614|FG001|Overall Study|Patient decision|1|||
94658944|NCT03588572|324206253|FG001|Visitation 3|Lost to Follow-up|1|||
94658945|NCT03588572|324206252|FG000|Visitation 3|Physician Decision|1|||
94240460|NCT02626455|322674615|FG002|Overall Study|Patient decision|0|||
94580384|NCT02531802|323926669|FG009|Received Vaccination 2|Adverse Event|0|||
94580385|NCT02531802|323926670|FG010|Received Vaccination 2|Adverse Event|0|||
94580386|NCT02531802|323926671|FG011|Received Vaccination 2|Adverse Event|0|||
94580387|NCT02531802|323926672|FG012|Received Vaccination 2|Adverse Event|0|||
94580388|NCT02531802|323926673|FG013|Received Vaccination 2|Adverse Event|0|||
94658946|NCT03588572|324206253|FG001|Visitation 3|Physician Decision|1|||
94580389|NCT02531802|323926674|FG014|Received Vaccination 2|Adverse Event|0|||
94580390|NCT02531802|323926675|FG015|Received Vaccination 2|Adverse Event|0|||
94580391|NCT02531802|323926676|FG016|Received Vaccination 2|Adverse Event|0|||
94580392|NCT02531802|323926677|FG017|Received Vaccination 2|Adverse Event|2|||
94580393|NCT02531802|323926678|FG018|Received Vaccination 2|Adverse Event|1|||
94580394|NCT02531802|323926679|FG019|Received Vaccination 2|Adverse Event|0|||
94580395|NCT02531802|323926680|FG020|Received Vaccination 2|Adverse Event|1|||
94580396|NCT02531802|323926660|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
94580397|NCT02531802|323926661|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
94580398|NCT02531802|323926662|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
94580399|NCT02531802|323926663|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
94580400|NCT02531802|323926664|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
94580401|NCT02531802|323926665|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
94580402|NCT02531802|323926666|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
94580403|NCT02531802|323926667|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
94580404|NCT02531802|323926668|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
94580405|NCT02531802|323926669|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
94580406|NCT02531802|323926670|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
94580407|NCT02531802|323926671|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
94580408|NCT02531802|323926672|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
94580409|NCT02531802|323926673|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
94580410|NCT02531802|323926674|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
94580411|NCT02531802|323926675|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
94580412|NCT02531802|323926676|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
94580413|NCT02531802|323926677|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
94580414|NCT02531802|323926678|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
94580415|NCT02531802|323926679|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
94580416|NCT02531802|323926680|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
94580417|NCT02731638|323926683|FG000|Overall Study|Lost to Follow-up|6|||
94580418|NCT02731638|323926684|FG001|Overall Study|Lost to Follow-up|9|||
94580419|NCT02839200|323926686|FG000|Overall Study|Withdrawal by Subject|2|||
94580420|NCT02839200|323926687|FG001|Overall Study|Withdrawal by Subject|0|||
94580421|NCT02839200|323926688|FG002|Overall Study|Withdrawal by Subject|1|||
94580422|NCT02839200|323926689|FG003|Overall Study|Withdrawal by Subject|0|||
94580423|NCT02839200|323926690|FG004|Overall Study|Withdrawal by Subject|0|||
94580424|NCT02839200|323926691|FG005|Overall Study|Withdrawal by Subject|1|||
94580425|NCT02839200|323926686|FG000|Overall Study|Lost to Follow-up|2|||
94580426|NCT02839200|323926687|FG001|Overall Study|Lost to Follow-up|0|||
94580427|NCT02839200|323926688|FG002|Overall Study|Lost to Follow-up|0|||
94580428|NCT02839200|323926689|FG003|Overall Study|Lost to Follow-up|0|||
94580429|NCT02839200|323926690|FG004|Overall Study|Lost to Follow-up|1|||
94580430|NCT02839200|323926691|FG005|Overall Study|Lost to Follow-up|0|||
94580431|NCT02839200|323926686|FG000|Overall Study|Adverse Event|0|||
94580432|NCT02839200|323926687|FG001|Overall Study|Adverse Event|0|||
94580433|NCT02839200|323926688|FG002|Overall Study|Adverse Event|0|||
94580434|NCT02839200|323926689|FG003|Overall Study|Adverse Event|0|||
94580435|NCT02839200|323926690|FG004|Overall Study|Adverse Event|1|||
94580436|NCT02839200|323926691|FG005|Overall Study|Adverse Event|0|||
94580437|NCT02839200|323926686|FG000|Overall Study|Randomized in error|0|||
94580438|NCT02839200|323926687|FG001|Overall Study|Randomized in error|1|||
94580439|NCT02839200|323926688|FG002|Overall Study|Randomized in error|0|||
94580440|NCT02839200|323926689|FG003|Overall Study|Randomized in error|0|||
94580441|NCT02839200|323926690|FG004|Overall Study|Randomized in error|0|||
94580442|NCT02839200|323926691|FG005|Overall Study|Randomized in error|0|||
94580443|NCT03486834|323926692|FG000|Overall Study|Withdrawal by Subject|46|||
94580444|NCT03486834|323926693|FG001|Overall Study|Withdrawal by Subject|46|||
94580445|NCT03486834|323926694|FG002|Overall Study|Withdrawal by Subject|52|||
94580446|NCT03486834|323926692|FG000|Overall Study|Adverse Event|8|||
94580447|NCT03486834|323926693|FG001|Overall Study|Adverse Event|7|||
94580448|NCT03486834|323926694|FG002|Overall Study|Adverse Event|0|||
94580449|NCT03486834|323926692|FG000|Overall Study|Lost to Follow-up|41|||
94580450|NCT03486834|323926693|FG001|Overall Study|Lost to Follow-up|24|||
94580451|NCT03486834|323926694|FG002|Overall Study|Lost to Follow-up|39|||
94240461|NCT02626455|322674616|FG003|Overall Study|Patient decision|0|||
94580452|NCT03486834|323926692|FG000|Overall Study|Non-compliance with Study Drug|2|||
94580453|NCT03486834|323926693|FG001|Overall Study|Non-compliance with Study Drug|2|||
94580454|NCT03486834|323926694|FG002|Overall Study|Non-compliance with Study Drug|0|||
94580455|NCT03486834|323926692|FG000|Overall Study|Physician Decision|5|||
94580456|NCT03486834|323926693|FG001|Overall Study|Physician Decision|2|||
94580457|NCT03486834|323926694|FG002|Overall Study|Physician Decision|3|||
94580458|NCT03486834|323926692|FG000|Overall Study|Pregnancy|10|||
94580459|NCT03486834|323926693|FG001|Overall Study|Pregnancy|12|||
94580460|NCT03486834|323926694|FG002|Overall Study|Pregnancy|12|||
94580461|NCT03486834|323926692|FG000|Overall Study|Protocol Deviation|2|||
94580462|NCT03486834|323926693|FG001|Overall Study|Protocol Deviation|3|||
94580463|NCT03486834|323926694|FG002|Overall Study|Protocol Deviation|3|||
94580464|NCT03486834|323926692|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
94580465|NCT03486834|323926693|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
94580466|NCT03486834|323926694|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
94580467|NCT03486834|323926692|FG000|Overall Study|Randomized but not treated|4|||
94580468|NCT03486834|323926693|FG001|Overall Study|Randomized but not treated|4|||
94580469|NCT03486834|323926694|FG002|Overall Study|Randomized but not treated|1|||
94580470|NCT04476797|323926695|FG000|Overall Study|Withdrawal by Subject|1|||
94580471|NCT04476797|323926696|FG001|Overall Study|Withdrawal by Subject|0|||
94580472|NCT04476797|323926697|FG002|Overall Study|Withdrawal by Subject|0|||
94580473|NCT04476797|323926695|FG000|Overall Study|Death|0|||
94580474|NCT04476797|323926696|FG001|Overall Study|Death|1|||
94580475|NCT04476797|323926697|FG002|Overall Study|Death|2|||
94580476|NCT04476797|323926695|FG000|Overall Study|Sponsor Terminated Study|0|||
94580477|NCT04476797|323926696|FG001|Overall Study|Sponsor Terminated Study|18|||
94580478|NCT04476797|323926697|FG002|Overall Study|Sponsor Terminated Study|17|||
94580479|NCT03863080|323926701|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
94580480|NCT03863080|323926702|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
94580481|NCT03863080|323926703|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
94580482|NCT03863080|323926704|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
94580483|NCT03863080|323926701|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
94580484|NCT03863080|323926702|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
94580485|NCT03863080|323926703|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
94580486|NCT03863080|323926704|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
94580487|NCT03863080|323926701|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
94580488|NCT03863080|323926702|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
94580489|NCT03863080|323926703|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
94580490|NCT03863080|323926704|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
94580491|NCT01342211|323926705|FG000|Overall Study|Lost to Follow-up|0|||
94580492|NCT01342211|323926706|FG001|Overall Study|Lost to Follow-up|0|||
94580493|NCT01342211|323926707|FG002|Overall Study|Lost to Follow-up|0|||
94580494|NCT01342211|323926708|FG003|Overall Study|Lost to Follow-up|1|||
94580495|NCT01342211|323926709|FG004|Overall Study|Lost to Follow-up|0|||
94580496|NCT01342211|323926705|FG000|Overall Study|Adverse Event|0|||
94580497|NCT01342211|323926706|FG001|Overall Study|Adverse Event|0|||
94580498|NCT01342211|323926707|FG002|Overall Study|Adverse Event|0|||
94580499|NCT01342211|323926708|FG003|Overall Study|Adverse Event|0|||
94580500|NCT01342211|323926709|FG004|Overall Study|Adverse Event|1|||
94580501|NCT01342211|323926705|FG000|Overall Study|Withdrawal by Subject|0|||
94580502|NCT01342211|323926706|FG001|Overall Study|Withdrawal by Subject|0|||
94580503|NCT01342211|323926707|FG002|Overall Study|Withdrawal by Subject|0|||
94580504|NCT01342211|323926708|FG003|Overall Study|Withdrawal by Subject|1|||
94580505|NCT01342211|323926709|FG004|Overall Study|Withdrawal by Subject|0|||
94580506|NCT01342211|323926705|FG000|Overall Study|Randomized, but not Treated|0|||
94580507|NCT01342211|323926706|FG001|Overall Study|Randomized, but not Treated|2|||
94580508|NCT01342211|323926707|FG002|Overall Study|Randomized, but not Treated|0|||
94580509|NCT01342211|323926708|FG003|Overall Study|Randomized, but not Treated|0|||
94580510|NCT01342211|323926709|FG004|Overall Study|Randomized, but not Treated|1|||
94580511|NCT03173248|323926710|FG000|Overall Study|Death|28|||
94580512|NCT03173248|323926711|FG001|Overall Study|Death|46|||
94580513|NCT03173248|323926710|FG000|Overall Study|Lost to Follow-up|0|||
94580514|NCT03173248|323926711|FG001|Overall Study|Lost to Follow-up|1|||
94580515|NCT03173248|323926710|FG000|Overall Study|Withdrawal by Subject|6|||
94580516|NCT03173248|323926711|FG001|Overall Study|Withdrawal by Subject|4|||
94580517|NCT03173248|323926710|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
94580518|NCT03173248|323926711|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
94580519|NCT05786651|323926715|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
94580520|NCT00911170|323926720|FG000|Treatment Period|Randomized in error|1|||
94580521|NCT00911170|323926721|FG001|Treatment Period|Randomized in error|1|||
94580522|NCT00911170|323926720|FG000|Treatment Period|Ineligibility determined|1|||
94580523|NCT00911170|323926721|FG001|Treatment Period|Ineligibility determined|3|||
94580524|NCT00911170|323926720|FG000|Treatment Period|Protocol deviation|1|||
94580525|NCT00911170|323926721|FG001|Treatment Period|Protocol deviation|2|||
94580526|NCT00911170|323926720|FG000|Treatment Period|Adverse Event|9|||
94580527|NCT00911170|323926721|FG001|Treatment Period|Adverse Event|10|||
94580528|NCT00911170|323926720|FG000|Treatment Period|Withdrawal by Subject|4|||
94580529|NCT00911170|323926721|FG001|Treatment Period|Withdrawal by Subject|4|||
94580530|NCT00911170|323926720|FG000|Treatment Period|Disease progression|0|||
94580531|NCT00911170|323926721|FG001|Treatment Period|Disease progression|2|||
94580532|NCT00911170|323926720|FG000|Treatment Period|Physician Decision|5|||
94580533|NCT00911170|323926721|FG001|Treatment Period|Physician Decision|5|||
94580534|NCT00911170|323926720|FG000|Treatment Period|Lost to Follow-up|0|||
94580535|NCT00911170|323926721|FG001|Treatment Period|Lost to Follow-up|1|||
94580536|NCT00911170|323926720|FG000|Treatment Period|Death|6|||
94580537|NCT00911170|323926721|FG001|Treatment Period|Death|9|||
94580538|NCT00911170|323926720|FG000|Long Term Follow-Up|Continuing in study|274|||
94580539|NCT00911170|323926721|FG001|Long Term Follow-Up|Continuing in study|269|||
94580540|NCT00911170|323926720|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
94580541|NCT00911170|323926721|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
94580542|NCT00911170|323926720|FG000|Long Term Follow-Up|Physician Decision|5|||
94580543|NCT00911170|323926721|FG001|Long Term Follow-Up|Physician Decision|4|||
94580544|NCT00911170|323926720|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
94580545|NCT00911170|323926721|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
94580546|NCT00911170|323926720|FG000|Long Term Follow-Up|Death|116|||
94580547|NCT00911170|323926721|FG001|Long Term Follow-Up|Death|121|||
94580548|NCT02807402|323926722|FG000|Overall Study|Failure to Return|1|||
94580549|NCT02807402|323926722|FG000|Overall Study|Death|3|||
94580550|NCT02807402|323926722|FG000|Overall Study|Other|2|||
94580551|NCT03278249|323926729|FG000|Overall Study|Withdrawal by Subject|2|||
94580552|NCT03278249|323926729|FG000|Overall Study|Lost to Follow-up|1|||
94580553|NCT02017405|323926730|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
94580554|NCT02017405|323926731|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
94580555|NCT02017405|323926732|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
94580556|NCT02017405|323926733|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
94580557|NCT02017405|323926734|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
94580558|NCT02017405|323926735|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
94580559|NCT02017405|323926730|FG000|Open-label Phase|Adverse Event|1|||
94580560|NCT02017405|323926731|FG001|Open-label Phase|Adverse Event|1|||
94580561|NCT02017405|323926732|FG002|Open-label Phase|Adverse Event|0|||
94580562|NCT02017405|323926733|FG003|Open-label Phase|Adverse Event|0|||
94580563|NCT02017405|323926734|FG004|Open-label Phase|Adverse Event|0|||
94580564|NCT02017405|323926735|FG005|Open-label Phase|Adverse Event|0|||
94580565|NCT02374450|323926736|FG000|Overall Study|Protocol Violation|0|||
94580566|NCT02374450|323926737|FG001|Overall Study|Protocol Violation|1|||
94580567|NCT02374450|323926738|FG002|Overall Study|Protocol Violation|0|||
94580568|NCT02374450|323926736|FG000|Overall Study|Withdrawal by Subject|91|||
94580569|NCT02374450|323926737|FG001|Overall Study|Withdrawal by Subject|110|||
94580570|NCT02374450|323926738|FG002|Overall Study|Withdrawal by Subject|4|||
94580571|NCT02374450|323926736|FG000|Overall Study|Lost to Follow-up|168|||
94580572|NCT02374450|323926737|FG001|Overall Study|Lost to Follow-up|194|||
94580573|NCT02374450|323926738|FG002|Overall Study|Lost to Follow-up|138|||
94580574|NCT02374450|323926736|FG000|Overall Study|Death|173|||
94580575|NCT02374450|323926737|FG001|Overall Study|Death|185|||
94580576|NCT02374450|323926738|FG002|Overall Study|Death|81|||
94580577|NCT02374450|323926736|FG000|Overall Study|Migrated from the study area|538|||
94580578|NCT02374450|323926737|FG001|Overall Study|Migrated from the study area|648|||
94580579|NCT02374450|323926738|FG002|Overall Study|Migrated from the study area|181|||
94580580|NCT02374450|323926736|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
94580581|NCT02374450|323926737|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
94580582|NCT02374450|323926738|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
94580583|NCT02374450|323926736|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
94580584|NCT02374450|323926737|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
94580585|NCT02374450|323926738|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
94658947|NCT03588572|324206252|FG000|Visitation 3|Withdrawal by Subject|1|||
94658948|NCT03588572|324206253|FG001|Visitation 3|Withdrawal by Subject|0|||
94580586|NCT02374450|323926736|FG000|Overall Study|Other|0|||
94580587|NCT02374450|323926737|FG001|Overall Study|Other|21|||
94580588|NCT02374450|323926738|FG002|Overall Study|Other|79|||
94580589|NCT00905164|323926740|FG000|Period 1|Protocol Violation|0|||
94580590|NCT00905164|323926741|FG001|Period 1|Protocol Violation|1|||
94580591|NCT03525678|323926744|FG000|Overall Study|Withdrawal by Subject|8|||
94580592|NCT03525678|323926745|FG001|Overall Study|Withdrawal by Subject|2|||
94580593|NCT03525678|323926746|FG002|Overall Study|Withdrawal by Subject|2|||
94580594|NCT03525678|323926744|FG000|Overall Study|Physician Decision|2|||
94580595|NCT03525678|323926745|FG001|Overall Study|Physician Decision|4|||
94580596|NCT03525678|323926746|FG002|Overall Study|Physician Decision|0|||
94580597|NCT03525678|323926744|FG000|Overall Study|Lost to Follow-up|2|||
94580598|NCT03525678|323926745|FG001|Overall Study|Lost to Follow-up|1|||
94580599|NCT03525678|323926746|FG002|Overall Study|Lost to Follow-up|2|||
94580600|NCT03525678|323926744|FG000|Overall Study|Death|70|||
94580601|NCT03525678|323926745|FG001|Overall Study|Death|80|||
94580602|NCT03525678|323926746|FG002|Overall Study|Death|16|||
94580603|NCT03525678|323926744|FG000|Overall Study|other reasons|14|||
94580604|NCT03525678|323926745|FG001|Overall Study|other reasons|10|||
94580605|NCT03525678|323926746|FG002|Overall Study|other reasons|5|||
94580606|NCT03525678|323926744|FG000|Overall Study|ongoing at the time of analysis|1|||
94580607|NCT03525678|323926745|FG001|Overall Study|ongoing at the time of analysis|2|||
94580608|NCT03525678|323926746|FG002|Overall Study|ongoing at the time of analysis|0|||
94580609|NCT01772316|323929148|FG000|Overall Study|Serious adverse event|1|||
94580610|NCT01772316|323929148|FG000|Overall Study|Inform consent withdrawn|1|||
94580611|NCT01772316|323929148|FG000|Overall Study|Withdrawn by sponsor decision|5|||
94580612|NCT01936870|323929152|FG000|Overall Study|No Visit After Treatment|176|||
94580613|NCT01936870|323929152|FG000|Overall Study|Protocol Violation|12|||
94580614|NCT01936870|323929152|FG000|Overall Study|No Drug Administration|1|||
94580615|NCT03557034|323929157|FG000|Overall Study|Withdrawal by Subject|1|||
94580616|NCT03557034|323929158|FG001|Overall Study|Withdrawal by Subject|0|||
94580617|NCT00914316|323929160|FG000|Phase 1|Physician Decision|4|||
94580618|NCT00914316|323929161|FG001|Phase 1|Physician Decision|0|||
94580619|NCT00914316|323929162|FG002|Phase 1|Physician Decision|1|||
94580620|NCT00914316|323929163|FG003|Phase 1|Physician Decision|2|||
94580621|NCT00914316|323929160|FG000|Phase 1|Withdrawal by Subject|0|||
94580622|NCT00914316|323929161|FG001|Phase 1|Withdrawal by Subject|2|||
94580623|NCT00914316|323929162|FG002|Phase 1|Withdrawal by Subject|4|||
94580624|NCT00914316|323929163|FG003|Phase 1|Withdrawal by Subject|0|||
94580625|NCT00914316|323929160|FG000|Phase 1|Adverse Event|1|||
94580626|NCT00914316|323929161|FG001|Phase 1|Adverse Event|0|||
94580627|NCT00914316|323929162|FG002|Phase 1|Adverse Event|0|||
94580628|NCT00914316|323929163|FG003|Phase 1|Adverse Event|0|||
94580629|NCT00914316|323929160|FG000|Phase 2|Withdrawal by Subject|1|||
94580630|NCT00914316|323929161|FG001|Phase 2|Withdrawal by Subject|0|||
94580631|NCT00914316|323929162|FG002|Phase 2|Withdrawal by Subject|1|||
94580632|NCT00914316|323929163|FG003|Phase 2|Withdrawal by Subject|0|||
94580633|NCT01383356|323929164|FG000|Period 1|Adverse Event|5|||
94580634|NCT01383356|323929165|FG001|Period 1|Adverse Event|3|||
94580635|NCT01383356|323929164|FG000|Period 1|Non-compliance|3|||
94580636|NCT01383356|323929165|FG001|Period 1|Non-compliance|0|||
94580637|NCT01383356|323929164|FG000|Period 1|Out of Range Mid-study-Test|0|||
94580638|NCT01383356|323929165|FG001|Period 1|Out of Range Mid-study-Test|1|||
94580639|NCT01383356|323929164|FG000|Period 1|Personal|0|||
94580640|NCT01383356|323929165|FG001|Period 1|Personal|2|||
94580641|NCT00716417|323929167|FG000|Overall Study|Adverse Event|0|||
94580642|NCT00716417|323929168|FG001|Overall Study|Adverse Event|0|||
94580643|NCT00716417|323929169|FG002|Overall Study|Adverse Event|2|||
94580644|NCT00716417|323929170|FG003|Overall Study|Adverse Event|1|||
94580645|NCT00716417|323929171|FG004|Overall Study|Adverse Event|0|||
94580646|NCT00716417|323929172|FG005|Overall Study|Adverse Event|0|||
94580647|NCT00716417|323929173|FG006|Overall Study|Adverse Event|3|||
94580648|NCT00716417|323929174|FG007|Overall Study|Adverse Event|1|||
94580649|NCT00716417|323929175|FG008|Overall Study|Adverse Event|0|||
94580650|NCT00716417|323929176|FG009|Overall Study|Adverse Event|3|||
94580651|NCT00716417|323929167|FG000|Overall Study|Withdrawal by Subject|0|||
94580652|NCT00716417|323929168|FG001|Overall Study|Withdrawal by Subject|1|||
94580653|NCT00716417|323929169|FG002|Overall Study|Withdrawal by Subject|0|||
94580654|NCT00716417|323929170|FG003|Overall Study|Withdrawal by Subject|2|||
94580655|NCT00716417|323929171|FG004|Overall Study|Withdrawal by Subject|0|||
94580656|NCT00716417|323929172|FG005|Overall Study|Withdrawal by Subject|0|||
94580657|NCT00716417|323929173|FG006|Overall Study|Withdrawal by Subject|1|||
94580658|NCT00716417|323929174|FG007|Overall Study|Withdrawal by Subject|0|||
94580659|NCT00716417|323929175|FG008|Overall Study|Withdrawal by Subject|0|||
94580660|NCT00716417|323929176|FG009|Overall Study|Withdrawal by Subject|0|||
94580661|NCT00716417|323929167|FG000|Overall Study|Progressive disease|3|||
94580662|NCT00716417|323929168|FG001|Overall Study|Progressive disease|5|||
94580663|NCT00716417|323929169|FG002|Overall Study|Progressive disease|3|||
94580664|NCT00716417|323929170|FG003|Overall Study|Progressive disease|8|||
94580665|NCT00716417|323929171|FG004|Overall Study|Progressive disease|0|||
94580666|NCT00716417|323929172|FG005|Overall Study|Progressive disease|3|||
94580667|NCT00716417|323929173|FG006|Overall Study|Progressive disease|3|||
94580668|NCT00716417|323929174|FG007|Overall Study|Progressive disease|1|||
94580669|NCT00716417|323929175|FG008|Overall Study|Progressive disease|5|||
94580670|NCT00716417|323929176|FG009|Overall Study|Progressive disease|0|||
94580671|NCT00716417|323929167|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
94580672|NCT00716417|323929168|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
94580673|NCT00716417|323929169|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
94580674|NCT00716417|323929170|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
94580675|NCT00716417|323929171|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
94580676|NCT00716417|323929172|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
94580677|NCT00716417|323929173|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
94580678|NCT00716417|323929174|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
94580679|NCT00716417|323929175|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
94580680|NCT00716417|323929176|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
94580681|NCT00716417|323929167|FG000|Overall Study|On patient request due to toxicities|0|||
94580682|NCT00716417|323929168|FG001|Overall Study|On patient request due to toxicities|0|||
94580683|NCT00716417|323929169|FG002|Overall Study|On patient request due to toxicities|0|||
94580684|NCT00716417|323929170|FG003|Overall Study|On patient request due to toxicities|0|||
94580685|NCT00716417|323929171|FG004|Overall Study|On patient request due to toxicities|0|||
94580686|NCT00716417|323929172|FG005|Overall Study|On patient request due to toxicities|0|||
94580687|NCT00716417|323929173|FG006|Overall Study|On patient request due to toxicities|0|||
94580688|NCT00716417|323929174|FG007|Overall Study|On patient request due to toxicities|1|||
94580689|NCT00716417|323929175|FG008|Overall Study|On patient request due to toxicities|0|||
94580690|NCT00716417|323929176|FG009|Overall Study|On patient request due to toxicities|0|||
94580691|NCT03809104|323929177|FG000|Overall Study|Withdrawal by Subject|3|||
94580692|NCT00790842|323929178|FG000|Dose Level 1|Adverse Event|1|||
94580693|NCT00790842|323929179|FG001|Dose Level 1|Adverse Event|0|||
94580694|NCT00790842|323929180|FG002|Dose Level 1|Adverse Event|0|||
94580695|NCT00790842|323929181|FG003|Dose Level 1|Adverse Event|2|||
94580696|NCT00790842|323929182|FG004|Dose Level 1|Adverse Event|0|||
94580697|NCT00790842|323929183|FG005|Dose Level 1|Adverse Event|0|||
94580698|NCT00790842|323929184|FG006|Dose Level 1|Adverse Event|0|||
94580699|NCT00790842|323929185|FG007|Dose Level 1|Adverse Event|1|||
94580700|NCT00790842|323929186|FG008|Dose Level 1|Adverse Event|0|||
94580701|NCT00790842|323929187|FG009|Dose Level 1|Adverse Event|0|||
94580702|NCT00790842|323929188|FG010|Dose Level 1|Adverse Event|0|||
94580703|NCT00790842|323929178|FG000|Dose Level 1|Physician Decision|1|||
94580704|NCT00790842|323929179|FG001|Dose Level 1|Physician Decision|0|||
94580705|NCT00790842|323929180|FG002|Dose Level 1|Physician Decision|0|||
94580706|NCT00790842|323929181|FG003|Dose Level 1|Physician Decision|0|||
94580707|NCT00790842|323929182|FG004|Dose Level 1|Physician Decision|0|||
94580708|NCT00790842|323929183|FG005|Dose Level 1|Physician Decision|0|||
94580709|NCT00790842|323929184|FG006|Dose Level 1|Physician Decision|0|||
94580710|NCT00790842|323929185|FG007|Dose Level 1|Physician Decision|1|||
94580711|NCT00790842|323929186|FG008|Dose Level 1|Physician Decision|0|||
94580712|NCT00790842|323929187|FG009|Dose Level 1|Physician Decision|0|||
94580713|NCT00790842|323929188|FG010|Dose Level 1|Physician Decision|0|||
94580714|NCT00790842|323929178|FG000|Dose Level 1|Withdrawal by Subject|1|||
94580715|NCT00790842|323929179|FG001|Dose Level 1|Withdrawal by Subject|0|||
94580716|NCT00790842|323929180|FG002|Dose Level 1|Withdrawal by Subject|0|||
94580717|NCT00790842|323929181|FG003|Dose Level 1|Withdrawal by Subject|0|||
94580718|NCT00790842|323929182|FG004|Dose Level 1|Withdrawal by Subject|0|||
94580719|NCT00790842|323929183|FG005|Dose Level 1|Withdrawal by Subject|0|||
94580720|NCT00790842|323929184|FG006|Dose Level 1|Withdrawal by Subject|0|||
94580721|NCT00790842|323929185|FG007|Dose Level 1|Withdrawal by Subject|0|||
94580722|NCT00790842|323929186|FG008|Dose Level 1|Withdrawal by Subject|0|||
94580723|NCT00790842|323929187|FG009|Dose Level 1|Withdrawal by Subject|0|||
94580724|NCT00790842|323929188|FG010|Dose Level 1|Withdrawal by Subject|0|||
94580725|NCT00790842|323929178|FG000|Dose Level 2|Death|0|||
94580726|NCT00790842|323929179|FG001|Dose Level 2|Death|1|||
94580727|NCT00790842|323929180|FG002|Dose Level 2|Death|0|||
94580728|NCT00790842|323929181|FG003|Dose Level 2|Death|0|||
94580729|NCT00790842|323929182|FG004|Dose Level 2|Death|1|||
94580730|NCT00790842|323929183|FG005|Dose Level 2|Death|0|||
94580731|NCT00790842|323929184|FG006|Dose Level 2|Death|0|||
94580732|NCT00790842|323929185|FG007|Dose Level 2|Death|0|||
94580733|NCT00790842|323929186|FG008|Dose Level 2|Death|0|||
94351682|NCT00663208|323069296|FG000|Follow-up Period|Other reason|1|||
94580734|NCT00790842|323929187|FG009|Dose Level 2|Death|0|||
94351683|NCT00663208|323069297|FG001|Follow-up Period|Other reason|0|||
94580735|NCT00790842|323929188|FG010|Dose Level 2|Death|0|||
94580736|NCT00790842|323929178|FG000|Dose Level 2|Physician Decision|0|||
94580737|NCT00790842|323929179|FG001|Dose Level 2|Physician Decision|1|||
94580738|NCT00790842|323929180|FG002|Dose Level 2|Physician Decision|0|||
94580739|NCT00790842|323929181|FG003|Dose Level 2|Physician Decision|0|||
94580740|NCT00790842|323929182|FG004|Dose Level 2|Physician Decision|0|||
94580741|NCT00790842|323929183|FG005|Dose Level 2|Physician Decision|0|||
94580742|NCT00790842|323929184|FG006|Dose Level 2|Physician Decision|0|||
94580743|NCT00790842|323929185|FG007|Dose Level 2|Physician Decision|0|||
94580744|NCT00790842|323929186|FG008|Dose Level 2|Physician Decision|0|||
94580745|NCT00790842|323929187|FG009|Dose Level 2|Physician Decision|0|||
94580746|NCT00790842|323929188|FG010|Dose Level 2|Physician Decision|0|||
94580747|NCT00790842|323929178|FG000|Dose Level 2|Withdrawal by Subject|0|||
94580748|NCT00790842|323929179|FG001|Dose Level 2|Withdrawal by Subject|1|||
94580749|NCT00790842|323929180|FG002|Dose Level 2|Withdrawal by Subject|0|||
94580750|NCT00790842|323929181|FG003|Dose Level 2|Withdrawal by Subject|0|||
94580751|NCT00790842|323929182|FG004|Dose Level 2|Withdrawal by Subject|0|||
94580752|NCT00790842|323929183|FG005|Dose Level 2|Withdrawal by Subject|0|||
94580753|NCT00790842|323929184|FG006|Dose Level 2|Withdrawal by Subject|0|||
94580754|NCT00790842|323929185|FG007|Dose Level 2|Withdrawal by Subject|0|||
94580755|NCT00790842|323929186|FG008|Dose Level 2|Withdrawal by Subject|0|||
94580756|NCT00790842|323929187|FG009|Dose Level 2|Withdrawal by Subject|0|||
94580757|NCT00790842|323929188|FG010|Dose Level 2|Withdrawal by Subject|0|||
94580758|NCT00790842|323929178|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
94580759|NCT00790842|323929179|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
94580760|NCT00790842|323929180|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
94580761|NCT00790842|323929181|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
94580762|NCT00790842|323929182|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
94580763|NCT00790842|323929183|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
94580764|NCT00790842|323929184|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
94580765|NCT00790842|323929185|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
94580766|NCT00790842|323929186|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
94580767|NCT00790842|323929187|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
94580768|NCT00790842|323929188|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
94580769|NCT00790842|323929178|FG000|Dose Level 3|Adverse Event|0|||
94580770|NCT00790842|323929179|FG001|Dose Level 3|Adverse Event|0|||
94580771|NCT00790842|323929180|FG002|Dose Level 3|Adverse Event|1|||
94580772|NCT00790842|323929181|FG003|Dose Level 3|Adverse Event|0|||
94580773|NCT00790842|323929182|FG004|Dose Level 3|Adverse Event|0|||
94580774|NCT00790842|323929183|FG005|Dose Level 3|Adverse Event|0|||
94580775|NCT00790842|323929184|FG006|Dose Level 3|Adverse Event|0|||
94580776|NCT00790842|323929185|FG007|Dose Level 3|Adverse Event|0|||
94580777|NCT00790842|323929186|FG008|Dose Level 3|Adverse Event|0|||
94580778|NCT00790842|323929187|FG009|Dose Level 3|Adverse Event|0|||
94580779|NCT00790842|323929188|FG010|Dose Level 3|Adverse Event|0|||
94580780|NCT00790842|323929178|FG000|Dose Level 3|Withdrawal by Subject|0|||
94580781|NCT00790842|323929179|FG001|Dose Level 3|Withdrawal by Subject|0|||
94580782|NCT00790842|323929180|FG002|Dose Level 3|Withdrawal by Subject|3|||
94580783|NCT00790842|323929181|FG003|Dose Level 3|Withdrawal by Subject|0|||
94580784|NCT00790842|323929182|FG004|Dose Level 3|Withdrawal by Subject|0|||
94580785|NCT00790842|323929183|FG005|Dose Level 3|Withdrawal by Subject|0|||
94580786|NCT00790842|323929184|FG006|Dose Level 3|Withdrawal by Subject|0|||
94580787|NCT00790842|323929185|FG007|Dose Level 3|Withdrawal by Subject|0|||
94580788|NCT00790842|323929186|FG008|Dose Level 3|Withdrawal by Subject|0|||
94580789|NCT00790842|323929187|FG009|Dose Level 3|Withdrawal by Subject|2|||
94580790|NCT00790842|323929188|FG010|Dose Level 3|Withdrawal by Subject|0|||
94580791|NCT00790842|323929178|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
94580792|NCT00790842|323929179|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
94580793|NCT00790842|323929180|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
94580794|NCT00790842|323929181|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
94580795|NCT00790842|323929182|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
94580796|NCT00790842|323929183|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
94580797|NCT00790842|323929184|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
94580798|NCT00790842|323929185|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
94580799|NCT00790842|323929186|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
94580800|NCT00790842|323929187|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
94580801|NCT00790842|323929188|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
94580802|NCT00790842|323929178|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
94580803|NCT00790842|323929179|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
94580804|NCT00790842|323929180|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
94580805|NCT00790842|323929181|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
94580806|NCT00790842|323929182|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
94580807|NCT00790842|323929183|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
94658949|NCT00898677|324206258|FG000|Overall Study|Adverse Event|0|||
94658950|NCT00898677|324206259|FG001|Overall Study|Adverse Event|0|||
94658951|NCT00898677|324206260|FG002|Overall Study|Adverse Event|1|||
94580808|NCT00790842|323929184|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
94580809|NCT00790842|323929185|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
94580810|NCT00790842|323929186|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
94580811|NCT00790842|323929187|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
94580812|NCT00790842|323929188|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
94658952|NCT00898677|324206261|FG003|Overall Study|Adverse Event|0|||
94658953|NCT00898677|324206258|FG000|Overall Study|Lost to Follow-up|0|||
94580813|NCT00790842|323929178|FG000|Dose Level 4|Adverse Event|0|||
94580814|NCT00790842|323929179|FG001|Dose Level 4|Adverse Event|0|||
94580815|NCT00790842|323929180|FG002|Dose Level 4|Adverse Event|0|||
94580816|NCT00790842|323929181|FG003|Dose Level 4|Adverse Event|0|||
94580817|NCT00790842|323929182|FG004|Dose Level 4|Adverse Event|0|||
94580818|NCT00790842|323929183|FG005|Dose Level 4|Adverse Event|0|||
94580819|NCT00790842|323929184|FG006|Dose Level 4|Adverse Event|1|||
94580820|NCT00790842|323929185|FG007|Dose Level 4|Adverse Event|0|||
94580821|NCT00790842|323929186|FG008|Dose Level 4|Adverse Event|0|||
94580822|NCT00790842|323929187|FG009|Dose Level 4|Adverse Event|0|||
94580823|NCT00790842|323929188|FG010|Dose Level 4|Adverse Event|0|||
94580824|NCT00790842|323929178|FG000|Dose Level 4|Physician Decision|0|||
94580825|NCT00790842|323929179|FG001|Dose Level 4|Physician Decision|0|||
94580826|NCT00790842|323929180|FG002|Dose Level 4|Physician Decision|0|||
94580827|NCT00790842|323929181|FG003|Dose Level 4|Physician Decision|0|||
94580828|NCT00790842|323929182|FG004|Dose Level 4|Physician Decision|0|||
94580829|NCT00790842|323929183|FG005|Dose Level 4|Physician Decision|0|||
94580830|NCT00790842|323929184|FG006|Dose Level 4|Physician Decision|1|||
94580831|NCT00790842|323929185|FG007|Dose Level 4|Physician Decision|0|||
94580832|NCT00790842|323929186|FG008|Dose Level 4|Physician Decision|0|||
94580833|NCT00790842|323929187|FG009|Dose Level 4|Physician Decision|0|||
94580834|NCT00790842|323929188|FG010|Dose Level 4|Physician Decision|1|||
94580835|NCT00790842|323929178|FG000|Dose Level 4|Withdrawal by Subject|0|||
94580836|NCT00790842|323929179|FG001|Dose Level 4|Withdrawal by Subject|0|||
94580837|NCT00790842|323929180|FG002|Dose Level 4|Withdrawal by Subject|0|||
94580838|NCT00790842|323929181|FG003|Dose Level 4|Withdrawal by Subject|0|||
94580839|NCT00790842|323929182|FG004|Dose Level 4|Withdrawal by Subject|0|||
94580840|NCT00790842|323929183|FG005|Dose Level 4|Withdrawal by Subject|0|||
94580841|NCT00790842|323929184|FG006|Dose Level 4|Withdrawal by Subject|0|||
94580842|NCT00790842|323929185|FG007|Dose Level 4|Withdrawal by Subject|0|||
94580843|NCT00790842|323929186|FG008|Dose Level 4|Withdrawal by Subject|0|||
94580844|NCT00790842|323929187|FG009|Dose Level 4|Withdrawal by Subject|0|||
94580845|NCT00790842|323929188|FG010|Dose Level 4|Withdrawal by Subject|1|||
94580846|NCT00790842|323929178|FG000|Expansion Cohort|Adverse Event|0|||
94580847|NCT00790842|323929179|FG001|Expansion Cohort|Adverse Event|0|||
94580848|NCT00790842|323929180|FG002|Expansion Cohort|Adverse Event|0|||
94580849|NCT00790842|323929181|FG003|Expansion Cohort|Adverse Event|0|||
94580850|NCT00790842|323929182|FG004|Expansion Cohort|Adverse Event|0|||
94580851|NCT00790842|323929183|FG005|Expansion Cohort|Adverse Event|0|||
94580852|NCT00790842|323929184|FG006|Expansion Cohort|Adverse Event|1|||
94580853|NCT00790842|323929185|FG007|Expansion Cohort|Adverse Event|0|||
94580854|NCT00790842|323929186|FG008|Expansion Cohort|Adverse Event|0|||
94580855|NCT00790842|323929187|FG009|Expansion Cohort|Adverse Event|0|||
94580856|NCT00790842|323929188|FG010|Expansion Cohort|Adverse Event|0|||
94580857|NCT00790842|323929178|FG000|Expansion Cohort|Death|0|||
94580858|NCT00790842|323929179|FG001|Expansion Cohort|Death|0|||
94580859|NCT00790842|323929180|FG002|Expansion Cohort|Death|2|||
94580860|NCT00790842|323929181|FG003|Expansion Cohort|Death|0|||
94580861|NCT00790842|323929182|FG004|Expansion Cohort|Death|0|||
94580862|NCT00790842|323929183|FG005|Expansion Cohort|Death|0|||
94580863|NCT00790842|323929184|FG006|Expansion Cohort|Death|0|||
94580864|NCT00790842|323929185|FG007|Expansion Cohort|Death|0|||
94580865|NCT00790842|323929186|FG008|Expansion Cohort|Death|0|||
94580866|NCT00790842|323929187|FG009|Expansion Cohort|Death|0|||
94580867|NCT00790842|323929188|FG010|Expansion Cohort|Death|0|||
94580868|NCT00790842|323929178|FG000|Expansion Cohort|Physician Decision|0|||
94580869|NCT00790842|323929179|FG001|Expansion Cohort|Physician Decision|0|||
94580870|NCT00790842|323929180|FG002|Expansion Cohort|Physician Decision|1|||
94580871|NCT00790842|323929181|FG003|Expansion Cohort|Physician Decision|0|||
94580872|NCT00790842|323929182|FG004|Expansion Cohort|Physician Decision|0|||
94580873|NCT00790842|323929183|FG005|Expansion Cohort|Physician Decision|0|||
94580874|NCT00790842|323929184|FG006|Expansion Cohort|Physician Decision|0|||
94580875|NCT00790842|323929185|FG007|Expansion Cohort|Physician Decision|0|||
94580876|NCT00790842|323929186|FG008|Expansion Cohort|Physician Decision|0|||
94580877|NCT00790842|323929187|FG009|Expansion Cohort|Physician Decision|0|||
94580878|NCT00790842|323929188|FG010|Expansion Cohort|Physician Decision|0|||
94580879|NCT00790842|323929178|FG000|Expansion Cohort|Withdrawal by Subject|0|||
94580880|NCT00790842|323929179|FG001|Expansion Cohort|Withdrawal by Subject|0|||
94580881|NCT00790842|323929180|FG002|Expansion Cohort|Withdrawal by Subject|3|||
94580882|NCT00790842|323929181|FG003|Expansion Cohort|Withdrawal by Subject|0|||
94580883|NCT00790842|323929182|FG004|Expansion Cohort|Withdrawal by Subject|0|||
94580884|NCT00790842|323929183|FG005|Expansion Cohort|Withdrawal by Subject|0|||
94580885|NCT00790842|323929184|FG006|Expansion Cohort|Withdrawal by Subject|0|||
94580886|NCT00790842|323929185|FG007|Expansion Cohort|Withdrawal by Subject|0|||
94580887|NCT00790842|323929186|FG008|Expansion Cohort|Withdrawal by Subject|0|||
94580888|NCT00790842|323929187|FG009|Expansion Cohort|Withdrawal by Subject|0|||
94580889|NCT00790842|323929188|FG010|Expansion Cohort|Withdrawal by Subject|0|||
94580890|NCT00790842|323929178|FG000|Expansion Cohort|Study Closure|0|||
94580891|NCT00790842|323929179|FG001|Expansion Cohort|Study Closure|0|||
94580892|NCT00790842|323929180|FG002|Expansion Cohort|Study Closure|1|||
94580893|NCT00790842|323929181|FG003|Expansion Cohort|Study Closure|0|||
94580894|NCT00790842|323929182|FG004|Expansion Cohort|Study Closure|0|||
94580895|NCT00790842|323929183|FG005|Expansion Cohort|Study Closure|0|||
94580896|NCT00790842|323929184|FG006|Expansion Cohort|Study Closure|0|||
94580897|NCT00790842|323929185|FG007|Expansion Cohort|Study Closure|0|||
94580898|NCT00790842|323929186|FG008|Expansion Cohort|Study Closure|0|||
94580899|NCT00790842|323929187|FG009|Expansion Cohort|Study Closure|0|||
94580900|NCT00790842|323929188|FG010|Expansion Cohort|Study Closure|0|||
94580901|NCT04225897|323929189|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
94580902|NCT04225897|323929190|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
94580903|NCT04225897|323929191|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
94580904|NCT04225897|323929192|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
94580905|NCT04225897|323929193|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
94580906|NCT04225897|323929194|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
94580907|NCT04225897|323929195|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
94580908|NCT04225897|323929196|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
94580909|NCT04225897|323929197|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
94580910|NCT04225897|323929198|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
94580911|NCT04225897|323929199|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
94580912|NCT04225897|323929200|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
94580913|NCT04225897|323929189|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
94580914|NCT04225897|323929190|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
94580915|NCT04225897|323929191|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
94580916|NCT04225897|323929192|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
94580917|NCT04225897|323929193|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
94580918|NCT04225897|323929194|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
94580919|NCT04225897|323929195|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
94580920|NCT04225897|323929196|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
94580921|NCT04225897|323929197|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
94580922|NCT04225897|323929198|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
94580923|NCT04225897|323929199|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
94580924|NCT04225897|323929200|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
94580925|NCT04225897|323929189|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
94580926|NCT04225897|323929190|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
94580927|NCT04225897|323929191|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
94580928|NCT04225897|323929192|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
94580929|NCT04225897|323929193|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
94580930|NCT04225897|323929194|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
94580931|NCT04225897|323929195|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
94580932|NCT04225897|323929196|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
94580933|NCT04225897|323929197|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
94580934|NCT04225897|323929198|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
94580935|NCT04225897|323929199|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
94580936|NCT04225897|323929200|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
94580937|NCT04225897|323929189|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
94580938|NCT04225897|323929190|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
94580939|NCT04225897|323929191|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
94580940|NCT04225897|323929192|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
94580941|NCT04225897|323929193|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
94580942|NCT04225897|323929194|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
94580943|NCT04225897|323929195|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
94580944|NCT04225897|323929196|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
94580945|NCT04225897|323929197|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
94580946|NCT04225897|323929198|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
94580947|NCT04225897|323929199|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
94580948|NCT04225897|323929200|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
94580949|NCT01472289|323929207|FG000|Overall Study|Death|2|||
94580950|NCT01046396|323929208|FG000|Overall Study|Withdrawal by Subject|5|||
94580951|NCT01208207|323929209|FG000|Part I|Adverse Event|19|||
94580952|NCT01208207|323929210|FG001|Part I|Adverse Event|2|||
94580953|NCT01208207|323929211|FG002|Part I|Adverse Event|6|||
94580954|NCT01208207|323929212|FG003|Part I|Adverse Event|0|||
94580955|NCT01208207|323929213|FG004|Part I|Adverse Event|0|||
94580956|NCT01208207|323929214|FG005|Part I|Adverse Event|0|||
94580957|NCT01208207|323929215|FG006|Part I|Adverse Event|0|||
94580958|NCT01208207|323929209|FG000|Part I|Lack of Efficacy|21|||
94658954|NCT00898677|324206259|FG001|Overall Study|Lost to Follow-up|0|||
94351684|NCT00663208|323069298|FG002|Follow-up Period|Other reason|0|||
94580959|NCT01208207|323929210|FG001|Part I|Lack of Efficacy|3|||
94580960|NCT01208207|323929211|FG002|Part I|Lack of Efficacy|2|||
94580961|NCT01208207|323929212|FG003|Part I|Lack of Efficacy|0|||
94580962|NCT01208207|323929213|FG004|Part I|Lack of Efficacy|0|||
94580963|NCT01208207|323929214|FG005|Part I|Lack of Efficacy|0|||
94580964|NCT01208207|323929215|FG006|Part I|Lack of Efficacy|0|||
94580965|NCT01208207|323929209|FG000|Part I|Lost to Follow-up|6|||
94580966|NCT01208207|323929210|FG001|Part I|Lost to Follow-up|1|||
94580967|NCT01208207|323929211|FG002|Part I|Lost to Follow-up|0|||
94580968|NCT01208207|323929212|FG003|Part I|Lost to Follow-up|0|||
94580969|NCT01208207|323929213|FG004|Part I|Lost to Follow-up|0|||
94580970|NCT01208207|323929214|FG005|Part I|Lost to Follow-up|0|||
94580971|NCT01208207|323929215|FG006|Part I|Lost to Follow-up|0|||
94580972|NCT01208207|323929209|FG000|Part I|Non-Compliance With Study Drug|1|||
94580973|NCT01208207|323929210|FG001|Part I|Non-Compliance With Study Drug|0|||
94580974|NCT01208207|323929211|FG002|Part I|Non-Compliance With Study Drug|1|||
94580975|NCT01208207|323929212|FG003|Part I|Non-Compliance With Study Drug|0|||
94580976|NCT01208207|323929213|FG004|Part I|Non-Compliance With Study Drug|0|||
94580977|NCT01208207|323929214|FG005|Part I|Non-Compliance With Study Drug|0|||
94580978|NCT01208207|323929215|FG006|Part I|Non-Compliance With Study Drug|0|||
94580979|NCT01208207|323929209|FG000|Part I|Physician Decision|0|||
94580980|NCT01208207|323929210|FG001|Part I|Physician Decision|1|||
94580981|NCT01208207|323929211|FG002|Part I|Physician Decision|0|||
94580982|NCT01208207|323929212|FG003|Part I|Physician Decision|0|||
94580983|NCT01208207|323929213|FG004|Part I|Physician Decision|0|||
94580984|NCT01208207|323929214|FG005|Part I|Physician Decision|0|||
94580985|NCT01208207|323929215|FG006|Part I|Physician Decision|0|||
94580986|NCT01208207|323929209|FG000|Part I|Progressive Disease|1|||
94580987|NCT01208207|323929210|FG001|Part I|Progressive Disease|0|||
94580988|NCT01208207|323929211|FG002|Part I|Progressive Disease|0|||
94580989|NCT01208207|323929212|FG003|Part I|Progressive Disease|0|||
94580990|NCT01208207|323929213|FG004|Part I|Progressive Disease|0|||
94580991|NCT01208207|323929214|FG005|Part I|Progressive Disease|0|||
94580992|NCT01208207|323929215|FG006|Part I|Progressive Disease|0|||
94580993|NCT01208207|323929209|FG000|Part I|Protocol Violation|8|||
94580994|NCT01208207|323929210|FG001|Part I|Protocol Violation|0|||
94580995|NCT01208207|323929211|FG002|Part I|Protocol Violation|2|||
94580996|NCT01208207|323929212|FG003|Part I|Protocol Violation|0|||
94580997|NCT01208207|323929213|FG004|Part I|Protocol Violation|0|||
94580998|NCT01208207|323929214|FG005|Part I|Protocol Violation|0|||
94580999|NCT01208207|323929215|FG006|Part I|Protocol Violation|0|||
94581000|NCT01208207|323929209|FG000|Part I|Withdrawal by Subject|14|||
94581001|NCT01208207|323929210|FG001|Part I|Withdrawal by Subject|4|||
94581002|NCT01208207|323929211|FG002|Part I|Withdrawal by Subject|4|||
94581003|NCT01208207|323929212|FG003|Part I|Withdrawal by Subject|0|||
94581004|NCT01208207|323929213|FG004|Part I|Withdrawal by Subject|0|||
94581005|NCT01208207|323929214|FG005|Part I|Withdrawal by Subject|0|||
94581006|NCT01208207|323929215|FG006|Part I|Withdrawal by Subject|0|||
94581007|NCT01208207|323929209|FG000|Part II|Withdrawal by Subject|0|||
94581008|NCT01208207|323929210|FG001|Part II|Withdrawal by Subject|0|||
94581009|NCT01208207|323929211|FG002|Part II|Withdrawal by Subject|0|||
94581010|NCT01208207|323929212|FG003|Part II|Withdrawal by Subject|10|||
94581011|NCT01208207|323929213|FG004|Part II|Withdrawal by Subject|9|||
94581012|NCT01208207|323929214|FG005|Part II|Withdrawal by Subject|3|||
94581013|NCT01208207|323929215|FG006|Part II|Withdrawal by Subject|5|||
94581014|NCT01208207|323929209|FG000|Part II|Adverse Event|0|||
94581015|NCT01208207|323929210|FG001|Part II|Adverse Event|0|||
94581016|NCT01208207|323929211|FG002|Part II|Adverse Event|0|||
94581017|NCT01208207|323929212|FG003|Part II|Adverse Event|5|||
94581018|NCT01208207|323929213|FG004|Part II|Adverse Event|9|||
94581019|NCT01208207|323929214|FG005|Part II|Adverse Event|4|||
94581020|NCT01208207|323929215|FG006|Part II|Adverse Event|2|||
94581021|NCT01208207|323929209|FG000|Part II|Lack of Efficacy|0|||
94581022|NCT01208207|323929210|FG001|Part II|Lack of Efficacy|0|||
94581023|NCT01208207|323929211|FG002|Part II|Lack of Efficacy|0|||
94581024|NCT01208207|323929212|FG003|Part II|Lack of Efficacy|6|||
94581025|NCT01208207|323929213|FG004|Part II|Lack of Efficacy|4|||
94581026|NCT01208207|323929214|FG005|Part II|Lack of Efficacy|3|||
94581027|NCT01208207|323929215|FG006|Part II|Lack of Efficacy|3|||
94581028|NCT01208207|323929209|FG000|Part II|Lost to Follow-up|0|||
94581029|NCT01208207|323929210|FG001|Part II|Lost to Follow-up|0|||
94581030|NCT01208207|323929211|FG002|Part II|Lost to Follow-up|0|||
94581031|NCT01208207|323929212|FG003|Part II|Lost to Follow-up|4|||
94581032|NCT01208207|323929213|FG004|Part II|Lost to Follow-up|0|||
94581033|NCT01208207|323929214|FG005|Part II|Lost to Follow-up|2|||
94581034|NCT01208207|323929215|FG006|Part II|Lost to Follow-up|1|||
94581035|NCT01208207|323929209|FG000|Part II|Non-Compliance With Study Drug|0|||
94581036|NCT01208207|323929210|FG001|Part II|Non-Compliance With Study Drug|0|||
94581037|NCT01208207|323929211|FG002|Part II|Non-Compliance With Study Drug|0|||
94581038|NCT01208207|323929212|FG003|Part II|Non-Compliance With Study Drug|4|||
94581039|NCT01208207|323929213|FG004|Part II|Non-Compliance With Study Drug|1|||
94581040|NCT01208207|323929214|FG005|Part II|Non-Compliance With Study Drug|1|||
94581041|NCT01208207|323929215|FG006|Part II|Non-Compliance With Study Drug|0|||
94581042|NCT01208207|323929209|FG000|Part II|Physician Decision|0|||
94581043|NCT01208207|323929210|FG001|Part II|Physician Decision|0|||
94581044|NCT01208207|323929211|FG002|Part II|Physician Decision|0|||
94581045|NCT01208207|323929212|FG003|Part II|Physician Decision|1|||
94581046|NCT01208207|323929213|FG004|Part II|Physician Decision|0|||
94581047|NCT01208207|323929214|FG005|Part II|Physician Decision|2|||
94581048|NCT01208207|323929215|FG006|Part II|Physician Decision|0|||
94581049|NCT01208207|323929209|FG000|Part II|Protocol Violation|0|||
94581050|NCT01208207|323929210|FG001|Part II|Protocol Violation|0|||
94581051|NCT01208207|323929211|FG002|Part II|Protocol Violation|0|||
94581052|NCT01208207|323929212|FG003|Part II|Protocol Violation|1|||
94581053|NCT01208207|323929213|FG004|Part II|Protocol Violation|0|||
94581054|NCT01208207|323929214|FG005|Part II|Protocol Violation|0|||
94581055|NCT01208207|323929215|FG006|Part II|Protocol Violation|0|||
94581056|NCT01208207|323929209|FG000|Part II|Technical Problems|0|||
94581057|NCT01208207|323929210|FG001|Part II|Technical Problems|0|||
94581058|NCT01208207|323929211|FG002|Part II|Technical Problems|0|||
94581059|NCT01208207|323929212|FG003|Part II|Technical Problems|1|||
94581060|NCT01208207|323929213|FG004|Part II|Technical Problems|0|||
94581061|NCT01208207|323929214|FG005|Part II|Technical Problems|1|||
94581062|NCT01208207|323929215|FG006|Part II|Technical Problems|0|||
94581063|NCT02177032|323929218|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
94581064|NCT02177032|323929219|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
94581065|NCT02177032|323929220|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
94581066|NCT02177032|323929221|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
94581067|NCT02177032|323929218|FG000|Overall Study|Lost to Follow-up|0|||
94581068|NCT02177032|323929219|FG001|Overall Study|Lost to Follow-up|2|||
94581069|NCT02177032|323929220|FG002|Overall Study|Lost to Follow-up|0|||
94581070|NCT02177032|323929221|FG003|Overall Study|Lost to Follow-up|0|||
94581071|NCT02177032|323929218|FG000|Overall Study|OTHER|2|||
94581072|NCT02177032|323929219|FG001|Overall Study|OTHER|0|||
94581073|NCT02177032|323929220|FG002|Overall Study|OTHER|1|||
94581074|NCT02177032|323929221|FG003|Overall Study|OTHER|0|||
94581075|NCT02177032|323929218|FG000|Overall Study|Withdrawal by Subject|1|||
94581076|NCT02177032|323929219|FG001|Overall Study|Withdrawal by Subject|0|||
94581077|NCT02177032|323929220|FG002|Overall Study|Withdrawal by Subject|1|||
94581078|NCT02177032|323929221|FG003|Overall Study|Withdrawal by Subject|0|||
94581079|NCT00930046|323929222|FG000|Overall Study|Wound catheter malfunctioned|1|||
94581080|NCT00930046|323929223|FG001|Overall Study|Wound catheter malfunctioned|2|||
94581081|NCT02161016|323929225|FG000|Overall Study|withdrawn by IRB|1|||
94581082|NCT00414596|323929226|FG000|Overall Study|Protocol Violation|2|||
94581083|NCT00912808|323929227|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
94581084|NCT00912808|323929228|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
94581085|NCT00912808|323929227|FG000|Washout|Withdrawal by Subject|0|||
94581086|NCT00912808|323929228|FG001|Washout|Withdrawal by Subject|1|||
94581087|NCT00912808|323929227|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
94581088|NCT00912808|323929228|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
94581089|NCT00912808|323929227|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
94581090|NCT00912808|323929228|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
94581091|NCT03873116|323929229|FG000|Part 1|Study drug discontinuation due to rash|0|||
94581092|NCT03873116|323929230|FG001|Part 1|Study drug discontinuation due to rash|0|||
94581093|NCT03873116|323929231|FG002|Part 1|Study drug discontinuation due to rash|0|||
94581094|NCT03873116|323929232|FG003|Part 1|Study drug discontinuation due to rash|0|||
94581095|NCT03873116|323929233|FG004|Part 1|Study drug discontinuation due to rash|0|||
94240462|NCT02626455|322674617|FG004|Overall Study|Patient decision|1|||
94581096|NCT03873116|323929234|FG005|Part 1|Study drug discontinuation due to rash|1|||
94581097|NCT03873116|323929229|FG000|Part 2|Withdrawal by Subject|0|||
94581098|NCT03873116|323929230|FG001|Part 2|Withdrawal by Subject|0|||
94581099|NCT03873116|323929231|FG002|Part 2|Withdrawal by Subject|1|||
94581100|NCT03873116|323929232|FG003|Part 2|Withdrawal by Subject|0|||
94581101|NCT03873116|323929233|FG004|Part 2|Withdrawal by Subject|0|||
94581102|NCT03873116|323929234|FG005|Part 2|Withdrawal by Subject|0|||
94581103|NCT03873116|323929229|FG000|Part 2|Lab abnormality or AE|0|||
94581104|NCT03873116|323929230|FG001|Part 2|Lab abnormality or AE|0|||
94240463|NCT02626455|322674618|FG005|Overall Study|Patient decision|36|||
94240464|NCT02626455|322674619|FG006|Overall Study|Patient decision|22|||
94240465|NCT02626455|322674613|FG000|Overall Study|Protocol Violation|0|||
94240466|NCT02626455|322674614|FG001|Overall Study|Protocol Violation|0|||
94240467|NCT02626455|322674615|FG002|Overall Study|Protocol Violation|0|||
94240468|NCT02626455|322674616|FG003|Overall Study|Protocol Violation|0|||
94240469|NCT02626455|322674617|FG004|Overall Study|Protocol Violation|0|||
94240470|NCT02626455|322674618|FG005|Overall Study|Protocol Violation|0|||
94581105|NCT03873116|323929231|FG002|Part 2|Lab abnormality or AE|0|||
94581106|NCT03873116|323929232|FG003|Part 2|Lab abnormality or AE|0|||
94581107|NCT03873116|323929233|FG004|Part 2|Lab abnormality or AE|1|||
94581108|NCT03873116|323929234|FG005|Part 2|Lab abnormality or AE|0|||
94240471|NCT02626455|322674619|FG006|Overall Study|Protocol Violation|1|||
94581109|NCT03873116|323929229|FG000|Part 3|Withdrawal by Subject|0|||
94581110|NCT03873116|323929230|FG001|Part 3|Withdrawal by Subject|0|||
94581111|NCT03873116|323929231|FG002|Part 3|Withdrawal by Subject|0|||
94581112|NCT03873116|323929232|FG003|Part 3|Withdrawal by Subject|0|||
94581113|NCT03873116|323929233|FG004|Part 3|Withdrawal by Subject|1|||
94581114|NCT03873116|323929234|FG005|Part 3|Withdrawal by Subject|0|||
94581115|NCT00003475|323929235|FG000|Overall Study|Not evaluable|13|||
94581116|NCT04682366|323929236|FG000|Overall Study|Lost to Follow-up|1|||
94351685|NCT00663208|323069299|FG003|Follow-up Period|Other reason|0|||
94351686|NCT00663208|323069300|FG004|Follow-up Period|Other reason|0|||
94351687|NCT00663208|323069301|FG005|Follow-up Period|Other reason|0|||
94351688|NCT00663208|323069302|FG006|Follow-up Period|Other reason|1|||
94351689|NCT03890731|323069303|FG000|Overall Study|Progressive disease|1|||
94351690|NCT03890731|323069303|FG000|Overall Study|Patient's decision|1|||
94351691|NCT03890731|323069303|FG000|Overall Study|Adverse Event|4|||
94351692|NCT04144140|323069304|FG000|Overall Study|Other|0|||
94351693|NCT04144140|323069305|FG001|Overall Study|Other|0|||
94351694|NCT04144140|323069306|FG002|Overall Study|Other|0|||
94351695|NCT04144140|323069307|FG003|Overall Study|Other|0|||
94351696|NCT04144140|323069308|FG004|Overall Study|Other|0|||
94351697|NCT04144140|323069309|FG005|Overall Study|Other|1|||
94351698|NCT04144140|323069310|FG006|Overall Study|Other|0|||
94351699|NCT01465958|323069311|FG000|Run-in Phase|Protocol Violation|1|||
94351700|NCT01465958|323069312|FG001|Run-in Phase|Protocol Violation|0|||
94581117|NCT04682366|323929237|FG001|Overall Study|Lost to Follow-up|1|||
94581118|NCT02556177|323929238|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
94351701|NCT01465958|323069311|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
94351702|NCT01465958|323069312|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
94351703|NCT02146274|323069313|FG000|Overall Study|Protocol Violation|73|||
94351704|NCT02039687|323069319|FG000|Overall Study|Adverse Event|0|||
94351705|NCT02039687|323069320|FG001|Overall Study|Adverse Event|0|||
94351706|NCT02039687|323069321|FG002|Overall Study|Adverse Event|1|||
94351707|NCT02039687|323069322|FG003|Overall Study|Adverse Event|0|||
94351708|NCT02039687|323069319|FG000|Overall Study|Withdrawal by Subject|0|||
94351709|NCT02039687|323069320|FG001|Overall Study|Withdrawal by Subject|1|||
94351710|NCT02039687|323069321|FG002|Overall Study|Withdrawal by Subject|0|||
94581119|NCT02556177|323929239|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
94581120|NCT00702221|323929240|FG000|Overall Study|Adverse Event|4|||
94581121|NCT00702221|323929241|FG001|Overall Study|Adverse Event|3|||
94581122|NCT00658359|323929242|FG000|Overall Study|Death|3|||
94581123|NCT00658359|323929243|FG001|Overall Study|Death|1|||
94581124|NCT00658359|323929244|FG002|Overall Study|Death|2|||
94351711|NCT02039687|323069322|FG003|Overall Study|Withdrawal by Subject|0|||
94351712|NCT02039687|323069319|FG000|Overall Study|treatment assignment could not be confir|0|||
94581125|NCT00658359|323929242|FG000|Overall Study|Adverse Event|13|||
94581126|NCT00658359|323929243|FG001|Overall Study|Adverse Event|6|||
94581127|NCT00658359|323929244|FG002|Overall Study|Adverse Event|9|||
94581128|NCT00658359|323929242|FG000|Overall Study|Protocol Violation|1|||
94581129|NCT00658359|323929243|FG001|Overall Study|Protocol Violation|0|||
94581130|NCT00658359|323929244|FG002|Overall Study|Protocol Violation|0|||
94351713|NCT02039687|323069320|FG001|Overall Study|treatment assignment could not be confir|0|||
94351714|NCT02039687|323069321|FG002|Overall Study|treatment assignment could not be confir|2|||
94351715|NCT02039687|323069322|FG003|Overall Study|treatment assignment could not be confir|0|||
94351716|NCT02155660|323069331|FG000|Overall Study|Other Reason|8|||
94351717|NCT02155660|323069332|FG001|Overall Study|Other Reason|6|||
94351718|NCT02155660|323069333|FG002|Overall Study|Other Reason|10|||
94581131|NCT00658359|323929242|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
94581132|NCT00658359|323929243|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
94581133|NCT00658359|323929244|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
94581134|NCT00658359|323929242|FG000|Overall Study|Withdrawal by Subject|7|||
94581135|NCT00658359|323929243|FG001|Overall Study|Withdrawal by Subject|4|||
94351719|NCT02155660|323069334|FG003|Overall Study|Other Reason|10|||
94351720|NCT02155660|323069331|FG000|Overall Study|Study-specific withdrawal criteria|0|||
94351721|NCT02155660|323069332|FG001|Overall Study|Study-specific withdrawal criteria|1|||
94351722|NCT02155660|323069333|FG002|Overall Study|Study-specific withdrawal criteria|1|||
94351723|NCT02155660|323069334|FG003|Overall Study|Study-specific withdrawal criteria|1|||
94454435|NCT03382834|323451599|FG000|Step 2|Lost to Follow-up|2|||
94581136|NCT00658359|323929244|FG002|Overall Study|Withdrawal by Subject|2|||
94581137|NCT00658359|323929242|FG000|Overall Study|Lost to Follow-up|2|||
94581138|NCT00658359|323929243|FG001|Overall Study|Lost to Follow-up|2|||
94581139|NCT00658359|323929244|FG002|Overall Study|Lost to Follow-up|4|||
94581140|NCT00658359|323929242|FG000|Overall Study|Lack of Efficacy|0|||
94581141|NCT00658359|323929243|FG001|Overall Study|Lack of Efficacy|1|||
94581142|NCT00658359|323929244|FG002|Overall Study|Lack of Efficacy|0|||
94351724|NCT02155660|323069331|FG000|Overall Study|Severe non-compliance|0|||
94351725|NCT02155660|323069332|FG001|Overall Study|Severe non-compliance|4|||
94351726|NCT02155660|323069333|FG002|Overall Study|Severe non-compliance|0|||
94351727|NCT02155660|323069334|FG003|Overall Study|Severe non-compliance|1|||
94351728|NCT02155660|323069331|FG000|Overall Study|Adverse Event|2|||
94581143|NCT02900378|323929247|FG000|Randomization (Visit 2)|Adverse Event|14|||
94581144|NCT02900378|323929248|FG001|Randomization (Visit 2)|Adverse Event|11|||
94581145|NCT02900378|323929247|FG000|Randomization (Visit 2)|Death|1|||
94581146|NCT02900378|323929248|FG001|Randomization (Visit 2)|Death|4|||
94240472|NCT02626455|322674613|FG000|Overall Study|Progressive disease - radiological progression|0|||
94240473|NCT02626455|322674614|FG001|Overall Study|Progressive disease - radiological progression|0|||
94581147|NCT02900378|323929247|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
94581148|NCT02900378|323929248|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
94581149|NCT02900378|323929247|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
94581150|NCT02900378|323929248|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
94581151|NCT02900378|323929247|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
94581152|NCT02900378|323929248|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
94581153|NCT02900378|323929247|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
94581154|NCT02900378|323929248|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
94581155|NCT02900378|323929247|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
94581156|NCT02900378|323929248|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
94581157|NCT00297258|323929250|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
94581158|NCT00297258|323929250|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
94581159|NCT00297258|323929250|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
94581160|NCT00297258|323929250|FG000|Overall Study|Intercurrent Illness|3|||
94581161|NCT00297258|323929250|FG000|Overall Study|Intercurrent Death|2|||
94581162|NCT00297258|323929250|FG000|Overall Study|Deteriorization of General Condition|1|||
94581163|NCT00297258|323929250|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
94581164|NCT00297258|323929250|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
94581165|NCT00297258|323929250|FG000|Overall Study|Switch to Commercial Treatment|1|||
94581166|NCT00297258|323929250|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
94581167|NCT01263197|323929255|FG000|First Intervention (Period 1)|Adverse Event|0|||
94581168|NCT01263197|323929256|FG001|First Intervention (Period 1)|Adverse Event|0|||
94581169|NCT01263197|323929257|FG002|First Intervention (Period 1)|Adverse Event|0|||
94581170|NCT01263197|323929258|FG003|First Intervention (Period 1)|Adverse Event|0|||
94581171|NCT01263197|323929259|FG004|First Intervention (Period 1)|Adverse Event|0|||
94581172|NCT01263197|323929260|FG005|First Intervention (Period 1)|Adverse Event|1|||
94581173|NCT01263197|323929255|FG000|Washout Period 1|Protocol Violation|0|||
94581174|NCT01263197|323929256|FG001|Washout Period 1|Protocol Violation|0|||
94581175|NCT01263197|323929257|FG002|Washout Period 1|Protocol Violation|0|||
94581176|NCT01263197|323929258|FG003|Washout Period 1|Protocol Violation|0|||
94581177|NCT01263197|323929259|FG004|Washout Period 1|Protocol Violation|1|||
94581178|NCT01263197|323929260|FG005|Washout Period 1|Protocol Violation|0|||
94581179|NCT01263197|323929255|FG000|Washout Period 2|Physician Decision|0|||
94581180|NCT01263197|323929256|FG001|Washout Period 2|Physician Decision|0|||
94581181|NCT01263197|323929257|FG002|Washout Period 2|Physician Decision|0|||
94581182|NCT01263197|323929258|FG003|Washout Period 2|Physician Decision|0|||
94581183|NCT01263197|323929259|FG004|Washout Period 2|Physician Decision|0|||
94581184|NCT01263197|323929260|FG005|Washout Period 2|Physician Decision|1|||
94581185|NCT01263197|323929255|FG000|Washout Period 2|Protocol Violation|0|||
94581186|NCT01263197|323929256|FG001|Washout Period 2|Protocol Violation|0|||
94581187|NCT01263197|323929257|FG002|Washout Period 2|Protocol Violation|0|||
94581188|NCT01263197|323929258|FG003|Washout Period 2|Protocol Violation|1|||
94581189|NCT01263197|323929259|FG004|Washout Period 2|Protocol Violation|0|||
94581190|NCT01263197|323929260|FG005|Washout Period 2|Protocol Violation|0|||
94581191|NCT01263197|323929255|FG000|Third Intervention (Period 3)|Adverse Event|0|||
94581192|NCT01263197|323929256|FG001|Third Intervention (Period 3)|Adverse Event|1|||
94581193|NCT01263197|323929257|FG002|Third Intervention (Period 3)|Adverse Event|0|||
94581194|NCT01263197|323929258|FG003|Third Intervention (Period 3)|Adverse Event|0|||
94581195|NCT01263197|323929259|FG004|Third Intervention (Period 3)|Adverse Event|0|||
94581196|NCT01263197|323929260|FG005|Third Intervention (Period 3)|Adverse Event|0|||
94581197|NCT01189032|323929261|FG000|Overall Study|Adverse Event|1|||
94581198|NCT01189032|323929262|FG001|Overall Study|Adverse Event|3|||
94240474|NCT02626455|322674615|FG002|Overall Study|Progressive disease - radiological progression|0|||
94240475|NCT02626455|322674616|FG003|Overall Study|Progressive disease - radiological progression|0|||
94240476|NCT02626455|322674617|FG004|Overall Study|Progressive disease - radiological progression|0|||
94240477|NCT02626455|322674618|FG005|Overall Study|Progressive disease - radiological progression|11|||
94581199|NCT01189032|323929263|FG002|Overall Study|Adverse Event|4|||
94581200|NCT01189032|323929261|FG000|Overall Study|Lack of Efficacy|2|||
94581201|NCT01189032|323929262|FG001|Overall Study|Lack of Efficacy|3|||
94581202|NCT01189032|323929263|FG002|Overall Study|Lack of Efficacy|0|||
94581203|NCT01189032|323929261|FG000|Overall Study|Withdrawal by Subject|1|||
94581204|NCT01189032|323929262|FG001|Overall Study|Withdrawal by Subject|0|||
94581205|NCT01189032|323929263|FG002|Overall Study|Withdrawal by Subject|1|||
94581206|NCT01189032|323929261|FG000|Overall Study|Protocol Violation|1|||
94581207|NCT01189032|323929262|FG001|Overall Study|Protocol Violation|1|||
94581208|NCT01189032|323929263|FG002|Overall Study|Protocol Violation|1|||
94658955|NCT00898677|324206260|FG002|Overall Study|Lost to Follow-up|2|||
94658956|NCT00898677|324206261|FG003|Overall Study|Lost to Follow-up|0|||
94658957|NCT00898677|324206258|FG000|Overall Study|Protocol Violation|1|||
94658958|NCT00898677|324206259|FG001|Overall Study|Protocol Violation|1|||
94658959|NCT00898677|324206260|FG002|Overall Study|Protocol Violation|2|||
94658960|NCT00898677|324206261|FG003|Overall Study|Protocol Violation|0|||
94658961|NCT00898677|324206258|FG000|Overall Study|Withdrawal by Subject|0|||
94581209|NCT00106704|323929264|FG000|Overall Study|Adverse Event|10|||
94581210|NCT00106704|323929265|FG001|Overall Study|Adverse Event|7|||
94581211|NCT00106704|323929264|FG000|Overall Study|Death|2|||
94581212|NCT00106704|323929265|FG001|Overall Study|Death|1|||
94581213|NCT00106704|323929264|FG000|Overall Study|Lack of Efficacy|67|||
94581214|NCT00106704|323929265|FG001|Overall Study|Lack of Efficacy|69|||
94581215|NCT00106704|323929264|FG000|Overall Study|Lost to Follow-up|7|||
94581216|NCT00106704|323929265|FG001|Overall Study|Lost to Follow-up|3|||
94581217|NCT00106704|323929264|FG000|Overall Study|Pregnancy|1|||
94581218|NCT00106704|323929265|FG001|Overall Study|Pregnancy|0|||
94581219|NCT00106704|323929264|FG000|Overall Study|Protocol Violation|4|||
94581220|NCT00106704|323929265|FG001|Overall Study|Protocol Violation|7|||
94581221|NCT00106704|323929264|FG000|Overall Study|Withdrawal by Subject|14|||
94581222|NCT00106704|323929265|FG001|Overall Study|Withdrawal by Subject|21|||
94581223|NCT00106704|323929264|FG000|Overall Study|Patient moved|1|||
94581224|NCT00106704|323929265|FG001|Overall Study|Patient moved|0|||
94581225|NCT00106704|323929264|FG000|Overall Study|Site terminated|0|||
94581226|NCT00106704|323929265|FG001|Overall Study|Site terminated|1|||
94581227|NCT00106704|323929264|FG000|Overall Study|Planned major surgery|1|||
94581228|NCT00106704|323929265|FG001|Overall Study|Planned major surgery|0|||
94581229|NCT00106704|323929264|FG000|Overall Study|Patient Received Glycemic Medication|22|||
94581230|NCT00106704|323929265|FG001|Overall Study|Patient Received Glycemic Medication|41|||
94581231|NCT00106704|323929264|FG000|Overall Study|Unable to re-enter US|1|||
94581232|NCT00106704|323929265|FG001|Overall Study|Unable to re-enter US|0|||
94581233|NCT00106704|323929264|FG000|Overall Study|Laboratory test|1|||
94581234|NCT00106704|323929265|FG001|Overall Study|Laboratory test|1|||
94581235|NCT00346697|323929275|FG000|Overall Study|Lost to Follow-up|0|||
94581236|NCT00346697|323929276|FG001|Overall Study|Lost to Follow-up|1|||
94581237|NCT00870740|323929277|FG000|Overall Study|Adverse Event|2|||
94581238|NCT00870740|323929278|FG001|Overall Study|Adverse Event|1|||
94581239|NCT00870740|323929279|FG002|Overall Study|Adverse Event|3|||
94581240|NCT00870740|323929280|FG003|Overall Study|Adverse Event|2|||
94581241|NCT00870740|323929281|FG004|Overall Study|Adverse Event|1|||
94581242|NCT00870740|323929282|FG005|Overall Study|Adverse Event|6|||
94581243|NCT00870740|323929277|FG000|Overall Study|Consent Withdrawn|6|||
94581244|NCT00870740|323929278|FG001|Overall Study|Consent Withdrawn|3|||
94581245|NCT00870740|323929279|FG002|Overall Study|Consent Withdrawn|4|||
94581246|NCT00870740|323929280|FG003|Overall Study|Consent Withdrawn|6|||
94581247|NCT00870740|323929281|FG004|Overall Study|Consent Withdrawn|6|||
94581248|NCT00870740|323929282|FG005|Overall Study|Consent Withdrawn|5|||
94581249|NCT00870740|323929277|FG000|Overall Study|Investigator Decision|2|||
94581250|NCT00870740|323929278|FG001|Overall Study|Investigator Decision|0|||
94581251|NCT00870740|323929279|FG002|Overall Study|Investigator Decision|1|||
94581252|NCT00870740|323929280|FG003|Overall Study|Investigator Decision|0|||
94581253|NCT00870740|323929281|FG004|Overall Study|Investigator Decision|0|||
94581254|NCT00870740|323929282|FG005|Overall Study|Investigator Decision|0|||
94581255|NCT00870740|323929277|FG000|Overall Study|Subject Non-compliance|0|||
94581256|NCT00870740|323929278|FG001|Overall Study|Subject Non-compliance|0|||
94581257|NCT00870740|323929279|FG002|Overall Study|Subject Non-compliance|0|||
94581258|NCT00870740|323929280|FG003|Overall Study|Subject Non-compliance|0|||
94581259|NCT00870740|323929281|FG004|Overall Study|Subject Non-compliance|0|||
94581260|NCT00870740|323929282|FG005|Overall Study|Subject Non-compliance|1|||
94581261|NCT00870740|323929277|FG000|Overall Study|Death|0|||
94581262|NCT00870740|323929278|FG001|Overall Study|Death|0|||
94581263|NCT00870740|323929279|FG002|Overall Study|Death|0|||
94581264|NCT00870740|323929280|FG003|Overall Study|Death|0|||
94581265|NCT00870740|323929281|FG004|Overall Study|Death|1|||
94581266|NCT00870740|323929282|FG005|Overall Study|Death|0|||
94581267|NCT00870740|323929277|FG000|Overall Study|Other|2|||
94581268|NCT00870740|323929278|FG001|Overall Study|Other|5|||
94581269|NCT00870740|323929279|FG002|Overall Study|Other|2|||
94658962|NCT00898677|324206259|FG001|Overall Study|Withdrawal by Subject|0|||
94658963|NCT00898677|324206260|FG002|Overall Study|Withdrawal by Subject|0|||
94581270|NCT00870740|323929280|FG003|Overall Study|Other|4|||
94581271|NCT00870740|323929281|FG004|Overall Study|Other|3|||
94581272|NCT00870740|323929282|FG005|Overall Study|Other|5|||
94658964|NCT00898677|324206261|FG003|Overall Study|Withdrawal by Subject|1|||
94581273|NCT01409707|323929284|FG000|Overall Study|Withdrawal by Subject|5|||
94581274|NCT01409707|323929285|FG001|Overall Study|Withdrawal by Subject|17|||
94581275|NCT01409707|323929286|FG002|Overall Study|Withdrawal by Subject|16|||
94240478|NCT02626455|322674619|FG006|Overall Study|Progressive disease - radiological progression|22|||
94240479|NCT02626455|322674613|FG000|Overall Study|Progressive disease - clinical progression|0|||
94240480|NCT02626455|322674614|FG001|Overall Study|Progressive disease - clinical progression|0|||
94240481|NCT02626455|322674615|FG002|Overall Study|Progressive disease - clinical progression|0|||
94240482|NCT02626455|322674616|FG003|Overall Study|Progressive disease - clinical progression|0|||
94240483|NCT02626455|322674617|FG004|Overall Study|Progressive disease - clinical progression|0|||
94240484|NCT02626455|322674618|FG005|Overall Study|Progressive disease - clinical progression|1|||
94240485|NCT02626455|322674619|FG006|Overall Study|Progressive disease - clinical progression|2|||
94581276|NCT01294553|323929287|FG000|Overall Study|Duplicated Participants|1|||
94581277|NCT01294553|323929287|FG000|Overall Study|Protocol Violation|268|||
94581278|NCT02952820|323929288|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
94581279|NCT02952820|323929289|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
94581280|NCT02952820|323929290|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
94581281|NCT02952820|323929288|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
94581282|NCT02952820|323929289|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
94581283|NCT02952820|323929290|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
94581284|NCT02952820|323929288|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
94581285|NCT02952820|323929289|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
94581286|NCT02952820|323929290|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
94581287|NCT02952820|323929288|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
94581288|NCT02952820|323929289|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
94581289|NCT02952820|323929290|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
94581290|NCT02952820|323929288|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
94581291|NCT02952820|323929289|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
94581292|NCT02952820|323929290|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
94581293|NCT02952820|323929288|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
94581294|NCT02952820|323929289|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
94581295|NCT02952820|323929290|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
94581296|NCT02952820|323929288|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
94581297|NCT02952820|323929289|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
94581298|NCT02952820|323929290|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
94581299|NCT02952820|323929288|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
94581300|NCT02952820|323929289|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
94581301|NCT02952820|323929290|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
94581302|NCT02952820|323929288|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
94581303|NCT02952820|323929289|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
94581304|NCT02952820|323929290|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
94581305|NCT02952820|323929288|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
94581306|NCT02952820|323929289|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
94581307|NCT02952820|323929290|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
94581308|NCT02952820|323929288|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
94581309|NCT02952820|323929289|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
94581310|NCT02952820|323929290|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
94581311|NCT02952820|323929288|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
94581312|NCT02952820|323929289|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
94581313|NCT02952820|323929290|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
94581314|NCT02952820|323929288|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
94581315|NCT02952820|323929289|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
94581316|NCT02952820|323929290|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
94581317|NCT02952820|323929288|FG000|Active Treatment Period (6 Months)|Not treated|0|||
94581318|NCT02952820|323929289|FG001|Active Treatment Period (6 Months)|Not treated|0|||
94581319|NCT02952820|323929290|FG002|Active Treatment Period (6 Months)|Not treated|1|||
94581320|NCT01929317|323929291|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
94581321|NCT01929317|323929292|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
94581322|NCT01929317|323929291|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
94581323|NCT01929317|323929292|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
94581324|NCT01929317|323929291|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
94581325|NCT01929317|323929292|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
94581326|NCT01929317|323929291|FG000|Long-term Phase|Adverse Event|5|||
94581327|NCT01929317|323929292|FG001|Long-term Phase|Adverse Event|1|||
94581328|NCT01929317|323929291|FG000|Long-term Phase|Physician Decision|3|||
94581329|NCT01929317|323929292|FG001|Long-term Phase|Physician Decision|0|||
94581330|NCT01929317|323929291|FG000|Long-term Phase|Withdrawal by Subject|4|||
94581331|NCT01929317|323929292|FG001|Long-term Phase|Withdrawal by Subject|0|||
94581332|NCT01929317|323929291|FG000|Long-term Phase|Protocol Violation|1|||
94581333|NCT01929317|323929292|FG001|Long-term Phase|Protocol Violation|0|||
94581334|NCT01929317|323929291|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
94581335|NCT01929317|323929292|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
94581336|NCT01929317|323929291|FG000|Long-term Phase|Study Closed/Terminated|5|||
94581337|NCT01929317|323929292|FG001|Long-term Phase|Study Closed/Terminated|3|||
94581338|NCT04322526|323929294|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
94581339|NCT04322526|323929295|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
94581340|NCT04322526|323929294|FG000|Washout (1 Week)|Lost to Follow-up|1|||
94581341|NCT04322526|323929295|FG001|Washout (1 Week)|Lost to Follow-up|2|||
94581342|NCT02628873|323929297|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
94581343|NCT02628873|323929298|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
94581344|NCT02628873|323929297|FG000|Second Test (1 Hour)|Physician Decision|1|||
94581345|NCT02628873|323929298|FG001|Second Test (1 Hour)|Physician Decision|0|||
94581346|NCT00541658|323929299|FG000|Overall Study|Adverse Event|28|||
94581347|NCT00541658|323929300|FG001|Overall Study|Adverse Event|37|||
94581348|NCT00541658|323929301|FG002|Overall Study|Adverse Event|25|||
94581349|NCT00541658|323929299|FG000|Overall Study|Physician Decision|0|||
94581350|NCT00541658|323929300|FG001|Overall Study|Physician Decision|0|||
94581351|NCT00541658|323929301|FG002|Overall Study|Physician Decision|4|||
94581352|NCT00541658|323929299|FG000|Overall Study|Lost to Follow-up|3|||
94581353|NCT00541658|323929300|FG001|Overall Study|Lost to Follow-up|3|||
94581354|NCT00541658|323929301|FG002|Overall Study|Lost to Follow-up|6|||
94581355|NCT00541658|323929299|FG000|Overall Study|Protocol Violation|0|||
94581356|NCT00541658|323929300|FG001|Overall Study|Protocol Violation|1|||
94581357|NCT00541658|323929301|FG002|Overall Study|Protocol Violation|1|||
94581358|NCT00541658|323929299|FG000|Overall Study|Withdrawal by Subject|28|||
94581359|NCT00541658|323929300|FG001|Overall Study|Withdrawal by Subject|32|||
94581360|NCT00541658|323929301|FG002|Overall Study|Withdrawal by Subject|32|||
94581361|NCT00541658|323929299|FG000|Overall Study|Took No Study Drug|1|||
94581362|NCT00541658|323929300|FG001|Overall Study|Took No Study Drug|0|||
94581363|NCT00541658|323929301|FG002|Overall Study|Took No Study Drug|0|||
94581364|NCT00787644|323929302|FG000|Overall Study|Lost to Follow-up|1|||
94581365|NCT00787644|323929303|FG001|Overall Study|Lost to Follow-up|1|||
94581366|NCT00787644|323929302|FG000|Overall Study|Withdrawal by Subject|1|||
94581367|NCT00787644|323929303|FG001|Overall Study|Withdrawal by Subject|1|||
94581368|NCT00174187|323929304|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
94581369|NCT00174187|323929305|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
94581370|NCT00174187|323929306|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
94581371|NCT00174187|323929304|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
94581372|NCT00174187|323929305|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
94581373|NCT00174187|323929306|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
94581374|NCT00174187|323929304|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
94581375|NCT00174187|323929305|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
94581376|NCT00174187|323929306|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
94581377|NCT00174187|323929304|FG000|Period 1 (up to 3 Years)|Other|0|||
94581378|NCT00174187|323929305|FG001|Period 1 (up to 3 Years)|Other|1|||
94581379|NCT00174187|323929306|FG002|Period 1 (up to 3 Years)|Other|0|||
94581380|NCT00174187|323929304|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
94581381|NCT00174187|323929305|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
94581382|NCT00174187|323929306|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
94581383|NCT00174187|323929304|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
94581384|NCT00174187|323929305|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
94581385|NCT00174187|323929306|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
94454436|NCT03382834|323451600|FG001|Step 2|Lost to Follow-up|2|||
94581386|NCT00174187|323929304|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
94581387|NCT00174187|323929305|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
94581388|NCT00174187|323929306|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
94581389|NCT00174187|323929304|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
94581390|NCT00174187|323929305|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
94581391|NCT00174187|323929306|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
94581392|NCT00174187|323929304|FG000|Period 2 (After 3 Years)|Other|0|||
94581393|NCT00174187|323929305|FG001|Period 2 (After 3 Years)|Other|0|||
94581394|NCT00174187|323929306|FG002|Period 2 (After 3 Years)|Other|5|||
94581395|NCT04123470|323929309|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
94581396|NCT04123470|323929310|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
94581397|NCT04123470|323929309|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
94581398|NCT04123470|323929310|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
94581399|NCT04123470|323929309|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
94581400|NCT04123470|323929310|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
94581401|NCT04123470|323929309|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
94581402|NCT04123470|323929310|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
94581403|NCT03435211|323929311|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
94581404|NCT00759941|323929312|FG000|Overall Study|Use of medication|1|||
94581405|NCT00759941|323929313|FG001|Overall Study|Use of medication|0|||
94581406|NCT00759941|323929312|FG000|Overall Study|Adverse Event|1|||
94581407|NCT00759941|323929313|FG001|Overall Study|Adverse Event|0|||
94581408|NCT00759941|323929312|FG000|Overall Study|Exited in error by site|1|||
94581409|NCT00759941|323929313|FG001|Overall Study|Exited in error by site|1|||
94581410|NCT01198977|323929314|FG000|Overall Study|Lost to Follow-up|1|||
94581411|NCT01198977|323929315|FG001|Overall Study|Lost to Follow-up|0|||
94581412|NCT02749422|323929318|FG000|Overall Study|Lost to Follow-up|0|||
94581413|NCT02749422|323929319|FG001|Overall Study|Lost to Follow-up|2|||
94581414|NCT02749422|323929318|FG000|Overall Study|Ineligible|0|||
94581415|NCT02749422|323929319|FG001|Overall Study|Ineligible|1|||
94581416|NCT02594124|323929320|FG000|Overall Study|Adverse Event|0|||
94581417|NCT02594124|323929321|FG001|Overall Study|Adverse Event|5|||
94581418|NCT02594124|323929322|FG002|Overall Study|Adverse Event|8|||
94581419|NCT02594124|323929323|FG003|Overall Study|Adverse Event|1|||
94581420|NCT02594124|323929324|FG004|Overall Study|Adverse Event|0|||
94581421|NCT02594124|323929325|FG005|Overall Study|Adverse Event|0|||
94581422|NCT02594124|323929326|FG006|Overall Study|Adverse Event|2|||
94581423|NCT02594124|323929327|FG007|Overall Study|Adverse Event|2|||
94581424|NCT02594124|323929328|FG008|Overall Study|Adverse Event|0|||
94581425|NCT02594124|323929320|FG000|Overall Study|Withdrawal by Subject|2|||
94581426|NCT02594124|323929321|FG001|Overall Study|Withdrawal by Subject|3|||
94581427|NCT02594124|323929322|FG002|Overall Study|Withdrawal by Subject|5|||
94581428|NCT02594124|323929323|FG003|Overall Study|Withdrawal by Subject|1|||
94581429|NCT02594124|323929324|FG004|Overall Study|Withdrawal by Subject|8|||
94581430|NCT02594124|323929325|FG005|Overall Study|Withdrawal by Subject|4|||
94581431|NCT02594124|323929326|FG006|Overall Study|Withdrawal by Subject|13|||
94581432|NCT02594124|323929327|FG007|Overall Study|Withdrawal by Subject|19|||
94581433|NCT02594124|323929328|FG008|Overall Study|Withdrawal by Subject|0|||
94581434|NCT02594124|323929320|FG000|Overall Study|Physician Decision|0|||
94581435|NCT02594124|323929321|FG001|Overall Study|Physician Decision|2|||
94581436|NCT02594124|323929322|FG002|Overall Study|Physician Decision|0|||
94581437|NCT02594124|323929323|FG003|Overall Study|Physician Decision|0|||
94581438|NCT02594124|323929324|FG004|Overall Study|Physician Decision|0|||
94581439|NCT02594124|323929325|FG005|Overall Study|Physician Decision|0|||
94581440|NCT02594124|323929326|FG006|Overall Study|Physician Decision|0|||
94581441|NCT02594124|323929327|FG007|Overall Study|Physician Decision|1|||
94581442|NCT02594124|323929328|FG008|Overall Study|Physician Decision|0|||
94581443|NCT02594124|323929320|FG000|Overall Study|Commercial drug|0|||
94581444|NCT02594124|323929321|FG001|Overall Study|Commercial drug|1|||
94581445|NCT02594124|323929322|FG002|Overall Study|Commercial drug|6|||
94581446|NCT02594124|323929323|FG003|Overall Study|Commercial drug|3|||
94581447|NCT02594124|323929324|FG004|Overall Study|Commercial drug|0|||
94581448|NCT02594124|323929325|FG005|Overall Study|Commercial drug|0|||
94581449|NCT02594124|323929326|FG006|Overall Study|Commercial drug|7|||
94581450|NCT02594124|323929327|FG007|Overall Study|Commercial drug|11|||
94581451|NCT02594124|323929328|FG008|Overall Study|Commercial drug|2|||
94658965|NCT00898677|324206258|FG000|Overall Study|Not Treated: Adverse Event|0|||
94581452|NCT02594124|323929320|FG000|Overall Study|Reason Not Specified|1|||
94581453|NCT02594124|323929321|FG001|Overall Study|Reason Not Specified|3|||
94581454|NCT02594124|323929322|FG002|Overall Study|Reason Not Specified|4|||
94581455|NCT02594124|323929323|FG003|Overall Study|Reason Not Specified|0|||
94581456|NCT02594124|323929324|FG004|Overall Study|Reason Not Specified|0|||
94581457|NCT02594124|323929325|FG005|Overall Study|Reason Not Specified|1|||
94581458|NCT02594124|323929326|FG006|Overall Study|Reason Not Specified|1|||
94581459|NCT02594124|323929327|FG007|Overall Study|Reason Not Specified|6|||
94581460|NCT02594124|323929328|FG008|Overall Study|Reason Not Specified|1|||
94581461|NCT03493464|323929329|FG000|Overall Study|Surgery not performed|1|||
94581462|NCT04774094|323929330|FG000|Overall Study|Other|2|||
94581463|NCT04774094|323929330|FG000|Overall Study|Withdrawal by Subject|9|||
94581464|NCT04774094|323929330|FG000|Overall Study|Lost to Follow-up|7|||
94581465|NCT04774094|323929330|FG000|Overall Study|Lack of Efficacy|5|||
94581466|NCT04774094|323929330|FG000|Overall Study|Death|17|||
94581467|NCT04774094|323929330|FG000|Overall Study|Adverse Event|4|||
94581468|NCT05232682|323929331|FG000|Overall Study|Lost to Follow-up|2|||
94581469|NCT04323124|323929332|FG000|Overall Study|Adverse Event|0|||
94581470|NCT04323124|323929333|FG001|Overall Study|Adverse Event|0|||
94581471|NCT04323124|323929334|FG002|Overall Study|Adverse Event|0|||
94581472|NCT04323124|323929335|FG003|Overall Study|Adverse Event|0|||
94581473|NCT04323124|323929336|FG004|Overall Study|Adverse Event|0|||
94581474|NCT04323124|323929337|FG005|Overall Study|Adverse Event|1|||
94581475|NCT04323124|323929338|FG006|Overall Study|Adverse Event|0|||
94581476|NCT04323124|323929339|FG007|Overall Study|Adverse Event|1|||
94581477|NCT04323124|323929340|FG008|Overall Study|Adverse Event|1|||
94581478|NCT04323124|323929341|FG009|Overall Study|Adverse Event|0|||
94581479|NCT04323124|323929342|FG010|Overall Study|Adverse Event|0|||
94581480|NCT04323124|323929343|FG011|Overall Study|Adverse Event|0|||
94581481|NCT04323124|323929344|FG012|Overall Study|Adverse Event|0|||
94581482|NCT04323124|323929345|FG013|Overall Study|Adverse Event|0|||
94581483|NCT04323124|323929346|FG014|Overall Study|Adverse Event|0|||
94581484|NCT04323124|323929332|FG000|Overall Study|Other|0|||
94581485|NCT04323124|323929333|FG001|Overall Study|Other|0|||
94581486|NCT04323124|323929334|FG002|Overall Study|Other|0|||
94581487|NCT04323124|323929335|FG003|Overall Study|Other|0|||
94581488|NCT04323124|323929336|FG004|Overall Study|Other|1|||
94581489|NCT04323124|323929337|FG005|Overall Study|Other|0|||
94581490|NCT04323124|323929338|FG006|Overall Study|Other|0|||
94581491|NCT04323124|323929339|FG007|Overall Study|Other|0|||
94581492|NCT04323124|323929340|FG008|Overall Study|Other|1|||
94581493|NCT04323124|323929341|FG009|Overall Study|Other|0|||
94581494|NCT04323124|323929342|FG010|Overall Study|Other|0|||
94581495|NCT04323124|323929343|FG011|Overall Study|Other|0|||
94581496|NCT04323124|323929344|FG012|Overall Study|Other|0|||
94581497|NCT04323124|323929345|FG013|Overall Study|Other|0|||
94581498|NCT04323124|323929346|FG014|Overall Study|Other|0|||
94581499|NCT04323124|323929332|FG000|Overall Study|Coming from a red zone (COVID)|0|||
94581500|NCT04323124|323929333|FG001|Overall Study|Coming from a red zone (COVID)|0|||
94581501|NCT04323124|323929334|FG002|Overall Study|Coming from a red zone (COVID)|0|||
94581502|NCT04323124|323929335|FG003|Overall Study|Coming from a red zone (COVID)|0|||
94581503|NCT04323124|323929336|FG004|Overall Study|Coming from a red zone (COVID)|1|||
94581504|NCT04323124|323929337|FG005|Overall Study|Coming from a red zone (COVID)|1|||
94581505|NCT04323124|323929338|FG006|Overall Study|Coming from a red zone (COVID)|0|||
94581506|NCT04323124|323929339|FG007|Overall Study|Coming from a red zone (COVID)|0|||
94581507|NCT04323124|323929340|FG008|Overall Study|Coming from a red zone (COVID)|0|||
94581508|NCT04323124|323929341|FG009|Overall Study|Coming from a red zone (COVID)|0|||
94581509|NCT04323124|323929342|FG010|Overall Study|Coming from a red zone (COVID)|0|||
94581510|NCT04323124|323929343|FG011|Overall Study|Coming from a red zone (COVID)|0|||
94581511|NCT04323124|323929344|FG012|Overall Study|Coming from a red zone (COVID)|0|||
94581512|NCT04323124|323929345|FG013|Overall Study|Coming from a red zone (COVID)|0|||
94581513|NCT04323124|323929346|FG014|Overall Study|Coming from a red zone (COVID)|0|||
94581514|NCT04323124|323929332|FG000|Overall Study|No longer meets eligibility criteria|0|||
94581515|NCT04323124|323929333|FG001|Overall Study|No longer meets eligibility criteria|0|||
94581516|NCT04323124|323929334|FG002|Overall Study|No longer meets eligibility criteria|0|||
94581517|NCT04323124|323929335|FG003|Overall Study|No longer meets eligibility criteria|0|||
94581518|NCT04323124|323929336|FG004|Overall Study|No longer meets eligibility criteria|0|||
94581519|NCT04323124|323929337|FG005|Overall Study|No longer meets eligibility criteria|0|||
94581520|NCT04323124|323929338|FG006|Overall Study|No longer meets eligibility criteria|0|||
94581521|NCT04323124|323929339|FG007|Overall Study|No longer meets eligibility criteria|1|||
94581522|NCT04323124|323929340|FG008|Overall Study|No longer meets eligibility criteria|0|||
94581523|NCT04323124|323929341|FG009|Overall Study|No longer meets eligibility criteria|0|||
94581524|NCT04323124|323929342|FG010|Overall Study|No longer meets eligibility criteria|0|||
94581525|NCT04323124|323929343|FG011|Overall Study|No longer meets eligibility criteria|0|||
94581526|NCT04323124|323929344|FG012|Overall Study|No longer meets eligibility criteria|0|||
94581527|NCT04323124|323929345|FG013|Overall Study|No longer meets eligibility criteria|1|||
94581528|NCT04323124|323929346|FG014|Overall Study|No longer meets eligibility criteria|1|||
94581529|NCT04323124|323929332|FG000|Overall Study|Study terminated by sponsor|0|||
94581530|NCT04323124|323929333|FG001|Overall Study|Study terminated by sponsor|0|||
94581531|NCT04323124|323929334|FG002|Overall Study|Study terminated by sponsor|0|||
94581532|NCT04323124|323929335|FG003|Overall Study|Study terminated by sponsor|0|||
94581533|NCT04323124|323929336|FG004|Overall Study|Study terminated by sponsor|0|||
94581534|NCT04323124|323929337|FG005|Overall Study|Study terminated by sponsor|0|||
94581535|NCT04323124|323929338|FG006|Overall Study|Study terminated by sponsor|0|||
94581536|NCT04323124|323929339|FG007|Overall Study|Study terminated by sponsor|0|||
94581537|NCT04323124|323929340|FG008|Overall Study|Study terminated by sponsor|0|||
94581538|NCT04323124|323929341|FG009|Overall Study|Study terminated by sponsor|0|||
94581539|NCT04323124|323929342|FG010|Overall Study|Study terminated by sponsor|0|||
94581540|NCT04323124|323929343|FG011|Overall Study|Study terminated by sponsor|2|||
94581541|NCT04323124|323929344|FG012|Overall Study|Study terminated by sponsor|1|||
94581542|NCT04323124|323929345|FG013|Overall Study|Study terminated by sponsor|0|||
94581543|NCT04323124|323929346|FG014|Overall Study|Study terminated by sponsor|0|||
94581544|NCT03714672|323931614|FG000|Overall Study|Adverse Event|0|||
94581545|NCT03714672|323931615|FG001|Overall Study|Adverse Event|0|||
94581546|NCT03714672|323931616|FG002|Overall Study|Adverse Event|3|||
94581547|NCT03714672|323931617|FG003|Overall Study|Adverse Event|0|||
94581548|NCT03714672|323931614|FG000|Overall Study|Physician Decision|0|||
94581549|NCT03714672|323931615|FG001|Overall Study|Physician Decision|1|||
94581550|NCT03714672|323931616|FG002|Overall Study|Physician Decision|0|||
94581551|NCT03714672|323931617|FG003|Overall Study|Physician Decision|0|||
94581552|NCT03714672|323931614|FG000|Overall Study|Other Reason|1|||
94581553|NCT03714672|323931615|FG001|Overall Study|Other Reason|2|||
94581554|NCT03714672|323931616|FG002|Overall Study|Other Reason|1|||
94581555|NCT03714672|323931617|FG003|Overall Study|Other Reason|1|||
94581556|NCT03714672|323931614|FG000|Overall Study|Lost to Follow-up|1|||
94581557|NCT03714672|323931615|FG001|Overall Study|Lost to Follow-up|1|||
94581558|NCT03714672|323931616|FG002|Overall Study|Lost to Follow-up|0|||
94581559|NCT03714672|323931617|FG003|Overall Study|Lost to Follow-up|0|||
94581560|NCT02266888|323931619|FG000|Overall Study|Death|2|||
94581561|NCT02266888|323931620|FG001|Overall Study|Death|2|||
94581562|NCT02266888|323931621|FG002|Overall Study|Death|4|||
94581563|NCT02266888|323931622|FG003|Overall Study|Death|2|||
94581564|NCT02266888|323931619|FG000|Overall Study|Physician Decision|0|||
94581565|NCT02266888|323931620|FG001|Overall Study|Physician Decision|1|||
94581566|NCT02266888|323931621|FG002|Overall Study|Physician Decision|2|||
94581567|NCT02266888|323931622|FG003|Overall Study|Physician Decision|2|||
94581568|NCT02266888|323931619|FG000|Overall Study|Study Terminated|5|||
94581569|NCT02266888|323931620|FG001|Overall Study|Study Terminated|1|||
94581570|NCT02266888|323931621|FG002|Overall Study|Study Terminated|0|||
94581571|NCT02266888|323931622|FG003|Overall Study|Study Terminated|0|||
94581572|NCT02266888|323931619|FG000|Overall Study|No Longer Eligible|0|||
94581573|NCT02266888|323931620|FG001|Overall Study|No Longer Eligible|0|||
94581574|NCT02266888|323931621|FG002|Overall Study|No Longer Eligible|0|||
94581575|NCT02266888|323931622|FG003|Overall Study|No Longer Eligible|2|||
94581576|NCT02266888|323931619|FG000|Overall Study|Randomization Closed|0|||
94581577|NCT02266888|323931620|FG001|Overall Study|Randomization Closed|0|||
94581578|NCT02266888|323931621|FG002|Overall Study|Randomization Closed|4|||
94581579|NCT02266888|323931622|FG003|Overall Study|Randomization Closed|0|||
94581580|NCT02266888|323931619|FG000|Overall Study|Personnel unavailable at transplant|0|||
94581581|NCT02266888|323931620|FG001|Overall Study|Personnel unavailable at transplant|0|||
94581582|NCT02266888|323931621|FG002|Overall Study|Personnel unavailable at transplant|0|||
94581583|NCT02266888|323931622|FG003|Overall Study|Personnel unavailable at transplant|1|||
94581584|NCT02266888|323931619|FG000|Overall Study|Transfer of care|0|||
94581585|NCT02266888|323931620|FG001|Overall Study|Transfer of care|0|||
94581586|NCT02266888|323931621|FG002|Overall Study|Transfer of care|1|||
94581587|NCT02266888|323931622|FG003|Overall Study|Transfer of care|0|||
94581588|NCT02038933|323931655|FG000|Overall Study|Disease progression|104|||
94581589|NCT02038933|323931655|FG000|Overall Study|Study drug toxicity|6|||
94581590|NCT02038933|323931655|FG000|Overall Study|Adverse event unrelated to study drug|6|||
94581591|NCT02038933|323931655|FG000|Overall Study|Participant request to discontinue treatment|2|||
94581592|NCT02038933|323931655|FG000|Overall Study|Lost to Follow-up|1|||
94581593|NCT02038933|323931655|FG000|Overall Study|Other reasons|2|||
94581594|NCT02492763|323931658|FG000|Overall Study|Withdrawal by Subject|0|||
94581595|NCT02492763|323931659|FG001|Overall Study|Withdrawal by Subject|2|||
94581596|NCT02492763|323931660|FG002|Overall Study|Withdrawal by Subject|1|||
94581597|NCT02492763|323931661|FG003|Overall Study|Withdrawal by Subject|0|||
94581598|NCT02492763|323931658|FG000|Overall Study|Adverse Event|3|||
94581599|NCT02492763|323931659|FG001|Overall Study|Adverse Event|1|||
94581600|NCT02492763|323931660|FG002|Overall Study|Adverse Event|1|||
94454437|NCT03382834|323451599|FG000|Step 2|Site Terminated by Sponsor|1|||
94581601|NCT02492763|323931661|FG003|Overall Study|Adverse Event|2|||
94581602|NCT02492763|323931658|FG000|Overall Study|Death|0|||
94581603|NCT02492763|323931659|FG001|Overall Study|Death|0|||
94581604|NCT02492763|323931660|FG002|Overall Study|Death|1|||
94581605|NCT02492763|323931661|FG003|Overall Study|Death|0|||
94581606|NCT02492763|323931658|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
94581607|NCT02492763|323931659|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
94581608|NCT02492763|323931660|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
94581609|NCT02492763|323931661|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
94581610|NCT02492763|323931658|FG000|Overall Study|Lost to Follow-up|0|||
94581611|NCT02492763|323931659|FG001|Overall Study|Lost to Follow-up|0|||
94581612|NCT02492763|323931660|FG002|Overall Study|Lost to Follow-up|1|||
94581613|NCT02492763|323931661|FG003|Overall Study|Lost to Follow-up|0|||
94454438|NCT03382834|323451600|FG001|Step 2|Site Terminated by Sponsor|0|||
94454439|NCT02949843|323451601|FG000|Overall Study|Withdrawal by Subject|0|||
94454440|NCT02949843|323451602|FG001|Overall Study|Withdrawal by Subject|1|||
94454441|NCT02949843|323451603|FG002|Overall Study|Withdrawal by Subject|1|||
94454442|NCT01680159|323451604|FG000|Screening Period|Not meet criteria for dose-up period|7|||
94454443|NCT01680159|323451604|FG000|Increased Dose Period|Adverse Event|6|||
94454444|NCT01680159|323451604|FG000|Increased Dose Period|Withdrawal by Subject|2|||
94454445|NCT01046903|323451609|FG000|Overall Study|Lost to Follow-up|16|||
94454446|NCT01046903|323451609|FG000|Overall Study|Adverse Event|4|||
94454447|NCT01046903|323451609|FG000|Overall Study|Withdrawal by Subject|3|||
94454448|NCT01046903|323451609|FG000|Overall Study|Other|5|||
94454449|NCT00977314|323451610|FG000|Overall Study|Withdrawal by Subject|1|||
94454450|NCT00977314|323451611|FG001|Overall Study|Withdrawal by Subject|0|||
94454451|NCT00977314|323451610|FG000|Overall Study|Physician Decision|1|||
94454452|NCT00977314|323451611|FG001|Overall Study|Physician Decision|0|||
94454453|NCT01894100|323451614|FG000|Overall Study|Lost to Follow-up|0|||
94454454|NCT01894100|323451615|FG001|Overall Study|Lost to Follow-up|1|||
94454455|NCT01894100|323451614|FG000|Overall Study|Withdrawal by Subject|3|||
94454456|NCT01894100|323451615|FG001|Overall Study|Withdrawal by Subject|0|||
94454457|NCT02553499|323451616|FG000|Overall Study|Adverse Event|0|||
94454458|NCT02553499|323451617|FG001|Overall Study|Adverse Event|0|||
94454459|NCT02553499|323451618|FG002|Overall Study|Adverse Event|0|||
94454460|NCT02553499|323451619|FG003|Overall Study|Adverse Event|0|||
94454461|NCT02553499|323451620|FG004|Overall Study|Adverse Event|0|||
94454462|NCT02553499|323451621|FG005|Overall Study|Adverse Event|0|||
94454463|NCT02553499|323451622|FG006|Overall Study|Adverse Event|1|||
94454464|NCT02553499|323451623|FG007|Overall Study|Adverse Event|1|||
94454465|NCT02553499|323451624|FG008|Overall Study|Adverse Event|0|||
94454466|NCT02553499|323451625|FG009|Overall Study|Adverse Event|0|||
94454467|NCT02553499|323451626|FG010|Overall Study|Adverse Event|0|||
94454468|NCT02553499|323451627|FG011|Overall Study|Adverse Event|0|||
94454469|NCT02553499|323451628|FG012|Overall Study|Adverse Event|0|||
94454470|NCT02553499|323451629|FG013|Overall Study|Adverse Event|1|||
94454471|NCT02553499|323451616|FG000|Overall Study|Death|0|||
94454472|NCT02553499|323451617|FG001|Overall Study|Death|1|||
94454473|NCT02553499|323451618|FG002|Overall Study|Death|1|||
94454474|NCT02553499|323451619|FG003|Overall Study|Death|0|||
94454475|NCT02553499|323451620|FG004|Overall Study|Death|1|||
94454476|NCT02553499|323451621|FG005|Overall Study|Death|2|||
94454477|NCT02553499|323451622|FG006|Overall Study|Death|0|||
94454478|NCT02553499|323451623|FG007|Overall Study|Death|0|||
94454479|NCT02553499|323451624|FG008|Overall Study|Death|0|||
94454480|NCT02553499|323451625|FG009|Overall Study|Death|0|||
94454481|NCT02553499|323451626|FG010|Overall Study|Death|1|||
94454482|NCT02553499|323451627|FG011|Overall Study|Death|0|||
94454483|NCT02553499|323451628|FG012|Overall Study|Death|0|||
94454484|NCT02553499|323451629|FG013|Overall Study|Death|0|||
94454485|NCT02553499|323451616|FG000|Overall Study|Lost to Follow-up|0|||
94454486|NCT02553499|323451617|FG001|Overall Study|Lost to Follow-up|0|||
94454487|NCT02553499|323451618|FG002|Overall Study|Lost to Follow-up|0|||
94454488|NCT02553499|323451619|FG003|Overall Study|Lost to Follow-up|0|||
94454489|NCT02553499|323451620|FG004|Overall Study|Lost to Follow-up|0|||
94454490|NCT02553499|323451621|FG005|Overall Study|Lost to Follow-up|0|||
94454491|NCT02553499|323451622|FG006|Overall Study|Lost to Follow-up|1|||
94454492|NCT02553499|323451623|FG007|Overall Study|Lost to Follow-up|0|||
94454493|NCT02553499|323451624|FG008|Overall Study|Lost to Follow-up|0|||
94454494|NCT02553499|323451625|FG009|Overall Study|Lost to Follow-up|0|||
94454495|NCT02553499|323451626|FG010|Overall Study|Lost to Follow-up|0|||
94454496|NCT02553499|323451627|FG011|Overall Study|Lost to Follow-up|0|||
94454497|NCT02553499|323451628|FG012|Overall Study|Lost to Follow-up|0|||
94658966|NCT00898677|324206259|FG001|Overall Study|Not Treated: Adverse Event|2|||
94454498|NCT02553499|323451629|FG013|Overall Study|Lost to Follow-up|0|||
94454499|NCT02553499|323451616|FG000|Overall Study|Physician Decision|0|||
94658967|NCT00898677|324206260|FG002|Overall Study|Not Treated: Adverse Event|1|||
94454500|NCT02553499|323451617|FG001|Overall Study|Physician Decision|1|||
94454501|NCT02553499|323451618|FG002|Overall Study|Physician Decision|1|||
94454502|NCT02553499|323451619|FG003|Overall Study|Physician Decision|0|||
94454503|NCT02553499|323451620|FG004|Overall Study|Physician Decision|1|||
94454504|NCT02553499|323451621|FG005|Overall Study|Physician Decision|0|||
94454505|NCT02553499|323451622|FG006|Overall Study|Physician Decision|0|||
94454506|NCT02553499|323451623|FG007|Overall Study|Physician Decision|1|||
94454507|NCT02553499|323451624|FG008|Overall Study|Physician Decision|1|||
94454508|NCT02553499|323451625|FG009|Overall Study|Physician Decision|2|||
94454509|NCT02553499|323451626|FG010|Overall Study|Physician Decision|1|||
94454510|NCT02553499|323451627|FG011|Overall Study|Physician Decision|3|||
94454511|NCT02553499|323451628|FG012|Overall Study|Physician Decision|1|||
94454512|NCT02553499|323451629|FG013|Overall Study|Physician Decision|0|||
94454513|NCT02553499|323451616|FG000|Overall Study|Progressive Disease|0|||
94454514|NCT02553499|323451617|FG001|Overall Study|Progressive Disease|0|||
94454515|NCT02553499|323451618|FG002|Overall Study|Progressive Disease|0|||
94454516|NCT02553499|323451619|FG003|Overall Study|Progressive Disease|2|||
94581614|NCT02492763|323931658|FG000|Overall Study|Non-Compliance With Study Drug|0|||
94581615|NCT02492763|323931659|FG001|Overall Study|Non-Compliance With Study Drug|1|||
94581616|NCT02492763|323931660|FG002|Overall Study|Non-Compliance With Study Drug|0|||
94581617|NCT02492763|323931661|FG003|Overall Study|Non-Compliance With Study Drug|0|||
94581618|NCT02492763|323931658|FG000|Overall Study|Screen Failure|0|||
94581619|NCT02492763|323931659|FG001|Overall Study|Screen Failure|0|||
94581620|NCT02492763|323931660|FG002|Overall Study|Screen Failure|0|||
94581621|NCT02492763|323931661|FG003|Overall Study|Screen Failure|1|||
94581622|NCT02492763|323931658|FG000|Overall Study|Study Terminated by Sponsor|13|||
94581623|NCT02492763|323931659|FG001|Overall Study|Study Terminated by Sponsor|10|||
94581624|NCT02492763|323931660|FG002|Overall Study|Study Terminated by Sponsor|6|||
94581625|NCT02492763|323931661|FG003|Overall Study|Study Terminated by Sponsor|10|||
94581626|NCT01524796|323931662|FG000|Overall Study|Adverse Event|13|||
94581627|NCT01524796|323931662|FG000|Overall Study|Lack of Efficacy|3|||
94581628|NCT01524796|323931662|FG000|Overall Study|Lost to Follow-up|1|||
94581629|NCT01524796|323931662|FG000|Overall Study|The price|1|||
94581630|NCT01524796|323931662|FG000|Overall Study|Withdrawal by Subject|4|||
94581631|NCT01524796|323931662|FG000|Overall Study|Move|1|||
94581632|NCT01524796|323931662|FG000|Overall Study|Deterioration of pains|1|||
94581633|NCT01524796|323931662|FG000|Overall Study|Gall stone surgery|1|||
94581634|NCT01524796|323931662|FG000|Overall Study|Nervous about confidentiality|1|||
94581635|NCT01524796|323931662|FG000|Overall Study|Switch to carbamazapine|1|||
94581636|NCT01524796|323931662|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
94581637|NCT01002339|323931665|FG000|Overall Study|Withdrawal by Subject|0|||
94581638|NCT01002339|323931666|FG001|Overall Study|Withdrawal by Subject|1|||
94581639|NCT01002339|323931667|FG002|Overall Study|Withdrawal by Subject|0|||
94581640|NCT01002339|323931665|FG000|Overall Study|Incorrect treatment assignment|0|||
94581641|NCT01002339|323931666|FG001|Overall Study|Incorrect treatment assignment|0|||
94581642|NCT01002339|323931667|FG002|Overall Study|Incorrect treatment assignment|1|||
94581643|NCT01002339|323931665|FG000|Overall Study|Protocol Violation|0|||
94581644|NCT01002339|323931666|FG001|Overall Study|Protocol Violation|0|||
94581645|NCT01002339|323931667|FG002|Overall Study|Protocol Violation|2|||
94581646|NCT01002339|323931665|FG000|Overall Study|Lung cancer detected before transplant|0|||
94581647|NCT01002339|323931666|FG001|Overall Study|Lung cancer detected before transplant|0|||
94581648|NCT01002339|323931667|FG002|Overall Study|Lung cancer detected before transplant|1|||
94581649|NCT01002339|323931665|FG000|Overall Study|Randomized. Not transplanted|0|||
94581650|NCT01002339|323931666|FG001|Overall Study|Randomized. Not transplanted|0|||
94581651|NCT01002339|323931667|FG002|Overall Study|Randomized. Not transplanted|1|||
94581652|NCT01907854|323931668|FG000|Overall Study|Protocol Violation|1|||
94581653|NCT01907854|323931669|FG001|Overall Study|Protocol Violation|1|||
94581654|NCT01907854|323931668|FG000|Overall Study|Withdrawal by Subject|9|||
94581655|NCT01907854|323931669|FG001|Overall Study|Withdrawal by Subject|7|||
94581656|NCT01907854|323931668|FG000|Overall Study|Lost to Follow-up|2|||
94581657|NCT01907854|323931669|FG001|Overall Study|Lost to Follow-up|2|||
94581658|NCT01907854|323931668|FG000|Overall Study|Unclassified|4|||
94581659|NCT01907854|323931669|FG001|Overall Study|Unclassified|3|||
94581660|NCT02633306|323931672|FG000|Overall Study|Withdrawal by Subject|3|||
94581661|NCT01744977|323931673|FG000|Overall Study|Withdrawal by Subject|1|||
94581662|NCT01744977|323931674|FG001|Overall Study|Withdrawal by Subject|2|||
94581663|NCT01744977|323931673|FG000|Overall Study|Death|2|||
94581664|NCT01744977|323931674|FG001|Overall Study|Death|3|||
94581665|NCT01744977|323931673|FG000|Overall Study|Lost to Follow-up|2|||
94581666|NCT01744977|323931674|FG001|Overall Study|Lost to Follow-up|0|||
94581667|NCT01744977|323931673|FG000|Overall Study|No longer meets inclusion|6|||
94581668|NCT01744977|323931674|FG001|Overall Study|No longer meets inclusion|0|||
94581669|NCT03774576|323931675|FG000|Period 2|Adverse Event|1|||
94581670|NCT01746901|323931676|FG000|Naloxone Challenge Phase|Adverse Event|2|||
94581671|NCT01746901|323931677|FG001|Naloxone Challenge Phase|Adverse Event|0|||
94581672|NCT01746901|323931678|FG002|Naloxone Challenge Phase|Adverse Event|0|||
94581673|NCT01746901|323931679|FG003|Naloxone Challenge Phase|Adverse Event|0|||
94581674|NCT01746901|323931680|FG004|Naloxone Challenge Phase|Adverse Event|0|||
94581675|NCT01746901|323931681|FG005|Naloxone Challenge Phase|Adverse Event|0|||
94581676|NCT01746901|323931682|FG006|Naloxone Challenge Phase|Adverse Event|0|||
94581677|NCT01746901|323931683|FG007|Naloxone Challenge Phase|Adverse Event|0|||
94581678|NCT01746901|323931684|FG008|Naloxone Challenge Phase|Adverse Event|0|||
94581679|NCT01746901|323931676|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
94581680|NCT01746901|323931677|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
94581681|NCT01746901|323931678|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
94581682|NCT01746901|323931679|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
94658968|NCT00898677|324206261|FG003|Overall Study|Not Treated: Adverse Event|0|||
94658969|NCT00898677|324206258|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
94658970|NCT00898677|324206259|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
94581683|NCT01746901|323931680|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
94581684|NCT01746901|323931681|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
94581685|NCT01746901|323931682|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
94581686|NCT01746901|323931683|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
94581687|NCT01746901|323931684|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
94581688|NCT01746901|323931676|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
94581689|NCT01746901|323931677|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
94581690|NCT01746901|323931678|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
94581691|NCT01746901|323931679|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
94581692|NCT01746901|323931680|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
94581693|NCT01746901|323931681|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
94581694|NCT01746901|323931682|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
94581695|NCT01746901|323931683|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
94581696|NCT01746901|323931684|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
94581697|NCT01746901|323931676|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
94581698|NCT01746901|323931677|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
94581699|NCT01746901|323931678|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
94581700|NCT01746901|323931679|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
94581701|NCT01746901|323931680|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
94581702|NCT01746901|323931681|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
94581703|NCT01746901|323931682|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
94581704|NCT01746901|323931683|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
94581705|NCT01746901|323931684|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
94581706|NCT01746901|323931676|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
94581707|NCT01746901|323931677|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
94581708|NCT01746901|323931678|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
94581709|NCT01746901|323931679|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
94581710|NCT01746901|323931680|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
94581711|NCT01746901|323931681|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
94581712|NCT01746901|323931682|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
94581713|NCT01746901|323931683|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
94581714|NCT01746901|323931684|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
94581715|NCT01746901|323931676|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
94581716|NCT01746901|323931677|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
94581717|NCT01746901|323931678|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
94581718|NCT01746901|323931679|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
94581719|NCT01746901|323931680|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
94581720|NCT01746901|323931681|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
94581721|NCT01746901|323931682|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
94581722|NCT01746901|323931683|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
94581723|NCT01746901|323931684|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
94581724|NCT01746901|323931676|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
94581725|NCT01746901|323931677|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
94581726|NCT01746901|323931678|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
94581727|NCT01746901|323931679|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
94581728|NCT01746901|323931680|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
94581729|NCT01746901|323931681|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
94581730|NCT01746901|323931682|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
94581731|NCT01746901|323931683|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
94581732|NCT01746901|323931684|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
94581733|NCT01746901|323931676|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
94581734|NCT01746901|323931677|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
94581735|NCT01746901|323931678|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
94581736|NCT01746901|323931679|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
94581737|NCT01746901|323931680|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
94581738|NCT01746901|323931681|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
94581739|NCT01746901|323931682|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
94581740|NCT01746901|323931683|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
94581741|NCT01746901|323931684|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
94581742|NCT01746901|323931676|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
94581743|NCT01746901|323931677|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
94581744|NCT01746901|323931678|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
94240486|NCT02626455|322674613|FG000|Overall Study|Lost to Follow-up|0|||
94454517|NCT02553499|323451620|FG004|Overall Study|Progressive Disease|1|||
94454518|NCT02553499|323451621|FG005|Overall Study|Progressive Disease|1|||
94454519|NCT02553499|323451622|FG006|Overall Study|Progressive Disease|1|||
94454520|NCT02553499|323451623|FG007|Overall Study|Progressive Disease|0|||
94454521|NCT02553499|323451624|FG008|Overall Study|Progressive Disease|0|||
94454522|NCT02553499|323451625|FG009|Overall Study|Progressive Disease|1|||
94454523|NCT02553499|323451626|FG010|Overall Study|Progressive Disease|0|||
94454524|NCT02553499|323451627|FG011|Overall Study|Progressive Disease|0|||
94454525|NCT02553499|323451628|FG012|Overall Study|Progressive Disease|2|||
94454526|NCT02553499|323451629|FG013|Overall Study|Progressive Disease|1|||
94454527|NCT02553499|323451616|FG000|Overall Study|Study Terminated by Sponsor|0|||
94454528|NCT02553499|323451617|FG001|Overall Study|Study Terminated by Sponsor|0|||
94454529|NCT02553499|323451618|FG002|Overall Study|Study Terminated by Sponsor|0|||
94454530|NCT02553499|323451619|FG003|Overall Study|Study Terminated by Sponsor|0|||
94454531|NCT02553499|323451620|FG004|Overall Study|Study Terminated by Sponsor|0|||
94454532|NCT02553499|323451621|FG005|Overall Study|Study Terminated by Sponsor|0|||
94454533|NCT02553499|323451622|FG006|Overall Study|Study Terminated by Sponsor|0|||
94454534|NCT02553499|323451623|FG007|Overall Study|Study Terminated by Sponsor|0|||
94454535|NCT02553499|323451624|FG008|Overall Study|Study Terminated by Sponsor|1|||
94454536|NCT02553499|323451625|FG009|Overall Study|Study Terminated by Sponsor|0|||
94454537|NCT02553499|323451626|FG010|Overall Study|Study Terminated by Sponsor|0|||
94454538|NCT02553499|323451627|FG011|Overall Study|Study Terminated by Sponsor|0|||
94454539|NCT02553499|323451628|FG012|Overall Study|Study Terminated by Sponsor|0|||
94454540|NCT02553499|323451629|FG013|Overall Study|Study Terminated by Sponsor|0|||
94454541|NCT02553499|323451616|FG000|Overall Study|Withdrawal by Subject|2|||
94454542|NCT02553499|323451617|FG001|Overall Study|Withdrawal by Subject|0|||
94454543|NCT02553499|323451618|FG002|Overall Study|Withdrawal by Subject|0|||
94454544|NCT02553499|323451619|FG003|Overall Study|Withdrawal by Subject|0|||
94454545|NCT02553499|323451620|FG004|Overall Study|Withdrawal by Subject|0|||
94454546|NCT02553499|323451621|FG005|Overall Study|Withdrawal by Subject|0|||
94454547|NCT02553499|323451622|FG006|Overall Study|Withdrawal by Subject|0|||
94454548|NCT02553499|323451623|FG007|Overall Study|Withdrawal by Subject|1|||
94454549|NCT02553499|323451624|FG008|Overall Study|Withdrawal by Subject|1|||
94454550|NCT02553499|323451625|FG009|Overall Study|Withdrawal by Subject|0|||
94454551|NCT02553499|323451626|FG010|Overall Study|Withdrawal by Subject|1|||
94454552|NCT02553499|323451627|FG011|Overall Study|Withdrawal by Subject|0|||
94454553|NCT02553499|323451628|FG012|Overall Study|Withdrawal by Subject|0|||
94454554|NCT02553499|323451629|FG013|Overall Study|Withdrawal by Subject|0|||
94454555|NCT04439214|323451630|FG000|Overall Study|Adverse Event|13|||
94454556|NCT04439214|323451630|FG000|Overall Study|Disease progression|16|||
94454557|NCT04439214|323451630|FG000|Overall Study|Death|1|||
94454558|NCT04439214|323451630|FG000|Overall Study|Withdrawal by Subject|2|||
94454559|NCT04439214|323451630|FG000|Overall Study|Declining health|1|||
94454560|NCT04439214|323451630|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
94454561|NCT04439214|323451630|FG000|Overall Study|Ineligible|5|||
94454562|NCT00556933|323451631|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
94454563|NCT00556933|323451632|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
94454564|NCT00556933|323451633|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
94454565|NCT00556933|323451634|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
94454566|NCT00556933|323451631|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
94454567|NCT00556933|323451632|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
94454568|NCT00556933|323451633|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
94454569|NCT00556933|323451634|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
94454570|NCT00556933|323451631|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
94581745|NCT01746901|323931679|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
94581746|NCT01746901|323931680|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
94581747|NCT01746901|323931681|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
94581748|NCT01746901|323931682|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
94581749|NCT01746901|323931683|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
94581750|NCT01746901|323931684|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
94581751|NCT01746901|323931676|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
94581752|NCT01746901|323931677|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
94581753|NCT01746901|323931678|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
94581754|NCT01746901|323931679|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
94581755|NCT01746901|323931680|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
94581756|NCT01746901|323931681|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
94581757|NCT01746901|323931682|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
94581758|NCT01746901|323931683|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
94581759|NCT01746901|323931684|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
94581760|NCT01746901|323931676|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
94581761|NCT01746901|323931677|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
94581762|NCT01746901|323931678|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
94581763|NCT01746901|323931679|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
94581764|NCT01746901|323931680|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
94581765|NCT01746901|323931681|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
94581766|NCT01746901|323931682|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
94581767|NCT01746901|323931683|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
94581768|NCT01746901|323931684|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
94581769|NCT01746901|323931676|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
94581770|NCT01746901|323931677|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
94581771|NCT01746901|323931678|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
94581772|NCT01746901|323931679|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
94581773|NCT01746901|323931680|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
94581774|NCT01746901|323931681|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
94581775|NCT01746901|323931682|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
94581776|NCT01746901|323931683|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
94581777|NCT01746901|323931684|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
94581778|NCT00763035|323931685|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
94581779|NCT00763035|323931686|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
94581780|NCT00763035|323931685|FG000|First Intervention|Adverse Event|0|||
94581781|NCT00763035|323931686|FG001|First Intervention|Adverse Event|1|||
94581782|NCT00763035|323931685|FG000|Second Intervention|Adverse Event|1|||
94581783|NCT00763035|323931686|FG001|Second Intervention|Adverse Event|0|||
94581784|NCT00763035|323931685|FG000|Second Intervention|Physician Decision|2|||
94581785|NCT00763035|323931686|FG001|Second Intervention|Physician Decision|0|||
94581786|NCT03112603|323931687|FG000|End of Randomization Period|Lost to Follow-up|3|||
94581787|NCT03112603|323931688|FG001|End of Randomization Period|Lost to Follow-up|0|||
94581788|NCT03112603|323931689|FG002|End of Randomization Period|Lost to Follow-up|0|||
94581789|NCT03112603|323931687|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
94581790|NCT03112603|323931688|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
94658971|NCT00898677|324206260|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
94240487|NCT02626455|322674614|FG001|Overall Study|Lost to Follow-up|0|||
94581791|NCT03112603|323931689|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
94581792|NCT03112603|323931687|FG000|End of Randomization Period|Physician Decision|43|||
94581793|NCT03112603|323931688|FG001|End of Randomization Period|Physician Decision|18|||
94581794|NCT03112603|323931689|FG002|End of Randomization Period|Physician Decision|0|||
94581795|NCT03112603|323931687|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
94581796|NCT03112603|323931688|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
94581797|NCT03112603|323931689|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
94581798|NCT03112603|323931687|FG000|End of Randomization Period|Death|10|||
94581799|NCT03112603|323931688|FG001|End of Randomization Period|Death|7|||
94581800|NCT03112603|323931689|FG002|End of Randomization Period|Death|0|||
94581801|NCT03112603|323931687|FG000|End of Randomization Period|Disease Relapse|12|||
94581802|NCT03112603|323931688|FG001|End of Randomization Period|Disease Relapse|7|||
94581803|NCT03112603|323931689|FG002|End of Randomization Period|Disease Relapse|0|||
94581804|NCT03112603|323931687|FG000|End of Randomization Period|Lack of Efficacy|25|||
94581805|NCT03112603|323931688|FG001|End of Randomization Period|Lack of Efficacy|77|||
94581806|NCT03112603|323931689|FG002|End of Randomization Period|Lack of Efficacy|0|||
94581807|NCT03112603|323931687|FG000|End of Randomization Period|Adverse Event|32|||
94581808|NCT03112603|323931688|FG001|End of Randomization Period|Adverse Event|12|||
94581809|NCT03112603|323931689|FG002|End of Randomization Period|Adverse Event|0|||
94581810|NCT03112603|323931687|FG000|End of Cross Over Period|Death|0|||
94581811|NCT03112603|323931688|FG001|End of Cross Over Period|Death|0|||
94581812|NCT03112603|323931689|FG002|End of Cross Over Period|Death|2|||
94581813|NCT03112603|323931687|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
94581814|NCT03112603|323931688|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
94581815|NCT03112603|323931689|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
94581816|NCT03112603|323931687|FG000|End of Cross Over Period|Physician Decision|0|||
94581817|NCT03112603|323931688|FG001|End of Cross Over Period|Physician Decision|0|||
94581818|NCT03112603|323931689|FG002|End of Cross Over Period|Physician Decision|29|||
94581819|NCT03112603|323931687|FG000|End of Cross Over Period|Lack of Efficacy|0|||
94581820|NCT03112603|323931688|FG001|End of Cross Over Period|Lack of Efficacy|0|||
94581821|NCT03112603|323931689|FG002|End of Cross Over Period|Lack of Efficacy|8|||
94581822|NCT03112603|323931687|FG000|End of Cross Over Period|Adverse Event|0|||
94581823|NCT03112603|323931688|FG001|End of Cross Over Period|Adverse Event|0|||
94581824|NCT03112603|323931689|FG002|End of Cross Over Period|Adverse Event|6|||
94581825|NCT03112603|323931687|FG000|End of Cross Over Period|Disease Relapse|0|||
94581826|NCT03112603|323931688|FG001|End of Cross Over Period|Disease Relapse|0|||
94581827|NCT03112603|323931689|FG002|End of Cross Over Period|Disease Relapse|2|||
94581828|NCT05021978|323931690|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
94581829|NCT05021978|323931691|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
94581830|NCT05021978|323931692|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
94581831|NCT05021978|323931693|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
94581832|NCT05021978|323931690|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
94581833|NCT05021978|323931691|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
94581834|NCT05021978|323931692|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
94581835|NCT05021978|323931693|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
94581836|NCT00665652|323931694|FG000|Overall Study|Adverse Event|4|||
94581837|NCT00665652|323931694|FG000|Overall Study|Death|1|||
94581838|NCT00665652|323931694|FG000|Overall Study|No longer met inclusion criteria.|1|||
94581839|NCT01411891|323931697|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
94581840|NCT01411891|323931698|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
94581841|NCT04004988|323931699|FG000|Period 1|Physician Decision|2|||
94581842|NCT04004988|323931700|FG001|Period 1|Physician Decision|0|||
94581843|NCT04004988|323931699|FG000|Period 1|Withdrawal by Subject|0|||
94581844|NCT04004988|323931700|FG001|Period 1|Withdrawal by Subject|1|||
94581845|NCT04004988|323931699|FG000|Period 1|Adverse Event|1|||
94581846|NCT04004988|323931700|FG001|Period 1|Adverse Event|2|||
94581847|NCT01598532|323931701|FG000|Overall Study|Lost to Follow-up|3|||
94581848|NCT01598532|323931701|FG000|Overall Study|Did not meet inclusion criteria|8|||
94581849|NCT02919995|323931707|FG000|Overall Study|Adverse Event|0|||
94240488|NCT02626455|322674615|FG002|Overall Study|Lost to Follow-up|0|||
94581850|NCT02919995|323931708|FG001|Overall Study|Adverse Event|0|||
94581851|NCT02919995|323931709|FG002|Overall Study|Adverse Event|0|||
94581852|NCT02919995|323931710|FG003|Overall Study|Adverse Event|0|||
94581853|NCT02919995|323931711|FG004|Overall Study|Adverse Event|0|||
94581854|NCT02919995|323931712|FG005|Overall Study|Adverse Event|1|||
94581855|NCT01166282|323931716|FG000|Open-label Period|Adverse Event|0|||
94581856|NCT01166282|323931717|FG001|Open-label Period|Adverse Event|0|||
94581857|NCT01166282|323931718|FG002|Open-label Period|Adverse Event|6|||
94581858|NCT01166282|323931716|FG000|Open-label Period|Withdrawal by Subject|0|||
94581859|NCT01166282|323931717|FG001|Open-label Period|Withdrawal by Subject|0|||
94581860|NCT01166282|323931718|FG002|Open-label Period|Withdrawal by Subject|4|||
94581861|NCT01166282|323931716|FG000|Open-label Period|Lack of Efficacy|0|||
94581862|NCT01166282|323931717|FG001|Open-label Period|Lack of Efficacy|0|||
94581863|NCT01166282|323931718|FG002|Open-label Period|Lack of Efficacy|2|||
94581864|NCT01166282|323931716|FG000|Open-label Period|Remission|0|||
94581865|NCT01166282|323931717|FG001|Open-label Period|Remission|0|||
94581866|NCT01166282|323931718|FG002|Open-label Period|Remission|4|||
94581867|NCT01166282|323931716|FG000|Open-label Period|Irregular Compliance|0|||
94581868|NCT01166282|323931717|FG001|Open-label Period|Irregular Compliance|0|||
94581869|NCT01166282|323931718|FG002|Open-label Period|Irregular Compliance|1|||
94581870|NCT01995838|323931719|FG000|Overall Study|Lost to Follow-up|0|||
94581871|NCT01995838|323931720|FG001|Overall Study|Lost to Follow-up|1|||
94581872|NCT01995838|323931721|FG002|Overall Study|Lost to Follow-up|0|||
94581873|NCT01995838|323931722|FG003|Overall Study|Lost to Follow-up|0|||
94581874|NCT01995838|323931723|FG004|Overall Study|Lost to Follow-up|0|||
94581875|NCT01995838|323931724|FG005|Overall Study|Lost to Follow-up|0|||
94581876|NCT01995838|323931725|FG006|Overall Study|Lost to Follow-up|1|||
94581877|NCT01995838|323931719|FG000|Overall Study|Participant choice|2|||
94581878|NCT01995838|323931720|FG001|Overall Study|Participant choice|0|||
94581879|NCT01995838|323931721|FG002|Overall Study|Participant choice|0|||
94581880|NCT01995838|323931722|FG003|Overall Study|Participant choice|0|||
94581881|NCT01995838|323931723|FG004|Overall Study|Participant choice|0|||
94581882|NCT01995838|323931724|FG005|Overall Study|Participant choice|1|||
94581883|NCT01995838|323931725|FG006|Overall Study|Participant choice|1|||
94581884|NCT01995838|323931719|FG000|Overall Study|Adverse Event|0|||
94581885|NCT01995838|323931720|FG001|Overall Study|Adverse Event|0|||
94581886|NCT01995838|323931721|FG002|Overall Study|Adverse Event|0|||
94581887|NCT01995838|323931722|FG003|Overall Study|Adverse Event|0|||
94581888|NCT01995838|323931723|FG004|Overall Study|Adverse Event|0|||
94581889|NCT01995838|323931724|FG005|Overall Study|Adverse Event|0|||
94581890|NCT01995838|323931725|FG006|Overall Study|Adverse Event|1|||
94581891|NCT01995838|323931719|FG000|Overall Study|Withdrawal by Subject|0|||
94581892|NCT01995838|323931720|FG001|Overall Study|Withdrawal by Subject|0|||
94581893|NCT01995838|323931721|FG002|Overall Study|Withdrawal by Subject|0|||
94581894|NCT01995838|323931722|FG003|Overall Study|Withdrawal by Subject|0|||
94581895|NCT01995838|323931723|FG004|Overall Study|Withdrawal by Subject|1|||
94581896|NCT01995838|323931724|FG005|Overall Study|Withdrawal by Subject|0|||
94581897|NCT01995838|323931725|FG006|Overall Study|Withdrawal by Subject|0|||
94581898|NCT01995838|323931719|FG000|Overall Study|Other|3|||
94581899|NCT01995838|323931720|FG001|Overall Study|Other|1|||
94581900|NCT01995838|323931721|FG002|Overall Study|Other|0|||
94581901|NCT01995838|323931722|FG003|Overall Study|Other|2|||
94581902|NCT01995838|323931723|FG004|Overall Study|Other|1|||
94581903|NCT01995838|323931724|FG005|Overall Study|Other|1|||
94581904|NCT01995838|323931725|FG006|Overall Study|Other|2|||
94581905|NCT01867671|323931727|FG000|Overall Study|Adverse Event|5|||
94581906|NCT01867671|323931728|FG001|Overall Study|Adverse Event|3|||
94581907|NCT01867671|323931727|FG000|Overall Study|Anaphylaxis|0|||
94581908|NCT01867671|323931728|FG001|Overall Study|Anaphylaxis|1|||
94581909|NCT01867671|323931727|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
94581910|NCT01867671|323931728|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
94581911|NCT01867671|323931727|FG000|Overall Study|Lost to Follow-up|0|||
94581912|NCT01867671|323931728|FG001|Overall Study|Lost to Follow-up|1|||
94581913|NCT01867671|323931727|FG000|Overall Study|Non-compliance with Study Drug|1|||
94581914|NCT01867671|323931728|FG001|Overall Study|Non-compliance with Study Drug|2|||
94581915|NCT01867671|323931727|FG000|Overall Study|Withdrawal by Subject|21|||
94581916|NCT01867671|323931728|FG001|Overall Study|Withdrawal by Subject|21|||
94581917|NCT04885998|323931729|FG000|Overall Study|Ongoing in study|3|||
94581918|NCT04885998|323931730|FG001|Overall Study|Ongoing in study|2|||
94581919|NCT04885998|323931731|FG002|Overall Study|Ongoing in study|2|||
94581920|NCT04885998|323931732|FG003|Overall Study|Ongoing in study|6|||
94581921|NCT04885998|323931729|FG000|Overall Study|Withdrawal by Subject|0|||
94581922|NCT04885998|323931730|FG001|Overall Study|Withdrawal by Subject|2|||
94581923|NCT04885998|323931731|FG002|Overall Study|Withdrawal by Subject|1|||
94581924|NCT04885998|323931732|FG003|Overall Study|Withdrawal by Subject|1|||
94581925|NCT04885998|323931729|FG000|Overall Study|Lost to Follow-up|1|||
94581926|NCT04885998|323931730|FG001|Overall Study|Lost to Follow-up|0|||
94581927|NCT04885998|323931731|FG002|Overall Study|Lost to Follow-up|0|||
94581928|NCT04885998|323931732|FG003|Overall Study|Lost to Follow-up|0|||
94581929|NCT04885998|323931729|FG000|Overall Study|Death|2|||
94581930|NCT04885998|323931730|FG001|Overall Study|Death|1|||
94581931|NCT04885998|323931731|FG002|Overall Study|Death|1|||
94581932|NCT04885998|323931732|FG003|Overall Study|Death|0|||
94581933|NCT01055197|323931733|FG000|Overall Study|Protocol Violation|7|||
94581934|NCT01055197|323931734|FG001|Overall Study|Protocol Violation|2|||
94581935|NCT01055197|323931733|FG000|Overall Study|Withdrawal by Subject|2|||
94581936|NCT01055197|323931734|FG001|Overall Study|Withdrawal by Subject|0|||
94581937|NCT00734539|323931735|FG000|Main Study|Death|33|||
94581938|NCT00734539|323931736|FG001|Main Study|Death|32|||
94581939|NCT00734539|323931735|FG000|Main Study|Physician Decision|2|||
94581940|NCT00734539|323931736|FG001|Main Study|Physician Decision|0|||
94581941|NCT00734539|323931735|FG000|Main Study|Withdrawal by Subject|1|||
94581942|NCT00734539|323931736|FG001|Main Study|Withdrawal by Subject|3|||
94581943|NCT00734539|323931735|FG000|Main Study|Enrolled in error; ineligible|1|||
94581944|NCT00734539|323931736|FG001|Main Study|Enrolled in error; ineligible|0|||
94581945|NCT02691507|323931737|FG000|Overall Study|Missed Visit 3|0|||
94581946|NCT02691507|323931738|FG001|Overall Study|Missed Visit 3|1|||
94581947|NCT03131570|323931743|FG000|Overall Study|Adverse Event|1|||
94581948|NCT03131570|323931744|FG001|Overall Study|Adverse Event|0|||
94581949|NCT02592798|323931745|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
94581950|NCT02592798|323931746|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
94581951|NCT02592798|323931745|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
94581952|NCT02592798|323931746|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
94581953|NCT02592798|323931745|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
94581954|NCT02592798|323931746|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
94581955|NCT02592798|323931745|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
94581956|NCT02592798|323931746|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
94581957|NCT02592798|323931745|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
94581958|NCT02592798|323931746|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
94581959|NCT02592798|323931745|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
94581960|NCT02592798|323931746|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
94581961|NCT02592798|323931745|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
94581962|NCT02592798|323931746|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
94581963|NCT02592798|323931745|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
94581964|NCT02592798|323931746|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
94581965|NCT02592798|323931745|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
94581966|NCT02592798|323931746|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
94581967|NCT02592798|323931745|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
94581968|NCT02592798|323931746|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
94581969|NCT02592798|323931745|FG000|Transition From DB2 to OLE|Other reasons|1|||
94581970|NCT02592798|323931746|FG001|Transition From DB2 to OLE|Other reasons|0|||
94581971|NCT02592798|323931745|FG000|Open Label Period (OLE)|Other reasons|0|||
94581972|NCT02592798|323931746|FG001|Open Label Period (OLE)|Other reasons|2|||
94581973|NCT02592798|323931745|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
94581974|NCT02592798|323931746|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
94581975|NCT02592798|323931745|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
94581976|NCT02592798|323931746|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
94581977|NCT02592798|323931745|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
94581978|NCT02592798|323931746|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
94581979|NCT02592798|323931745|FG000|Open Label Period (OLE)|Adverse Event|0|||
94581980|NCT02592798|323931746|FG001|Open Label Period (OLE)|Adverse Event|1|||
94581981|NCT01967940|323931747|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
94581982|NCT01967940|323931748|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
94581983|NCT01967940|323931749|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
94581984|NCT01967940|323931750|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
94581985|NCT01967940|323931747|FG000|Part 2|Adverse Event|0|||
94581986|NCT01967940|323931748|FG001|Part 2|Adverse Event|0|||
94581987|NCT01967940|323931749|FG002|Part 2|Adverse Event|0|||
94581988|NCT01967940|323931750|FG003|Part 2|Adverse Event|1|||
94581989|NCT01967940|323931747|FG000|Part 2|Unknown Reason|0|||
94581990|NCT01967940|323931748|FG001|Part 2|Unknown Reason|0|||
94581991|NCT01967940|323931749|FG002|Part 2|Unknown Reason|0|||
94581992|NCT01967940|323931750|FG003|Part 2|Unknown Reason|1|||
94581993|NCT00942604|323931752|FG000|Overall Study|Protocol Violation|1|||
94581994|NCT00942604|323931753|FG001|Overall Study|Protocol Violation|1|||
94581995|NCT00942604|323931752|FG000|Overall Study|Adverse Event|0|||
94581996|NCT00942604|323931753|FG001|Overall Study|Adverse Event|1|||
94581997|NCT00942604|323931752|FG000|Overall Study|Withdrawal by Subject|0|||
94581998|NCT00942604|323931753|FG001|Overall Study|Withdrawal by Subject|1|||
94581999|NCT00942604|323931752|FG000|Overall Study|Patient relocation|1|||
94582000|NCT00942604|323931753|FG001|Overall Study|Patient relocation|1|||
94582001|NCT01663103|323931754|FG000|Overall Study|Withdrawal by Subject|1|||
94582002|NCT01663103|323931755|FG001|Overall Study|Withdrawal by Subject|2|||
94582003|NCT01663103|323931754|FG000|Overall Study|Adverse Event|1|||
94582004|NCT01663103|323931755|FG001|Overall Study|Adverse Event|0|||
94582005|NCT01663103|323931754|FG000|Overall Study|dog bite|1|||
94582006|NCT01663103|323931755|FG001|Overall Study|dog bite|0|||
94582007|NCT01656408|323931756|FG000|Overall Study|Adverse Event|0|||
94582008|NCT01656408|323931757|FG001|Overall Study|Adverse Event|0|||
94582009|NCT01656408|323931758|FG002|Overall Study|Adverse Event|1|||
94582010|NCT01656408|323931759|FG003|Overall Study|Adverse Event|0|||
94582011|NCT01656408|323931760|FG004|Overall Study|Adverse Event|0|||
94582012|NCT01656408|323931761|FG005|Overall Study|Adverse Event|1|||
94582013|NCT01656408|323931762|FG006|Overall Study|Adverse Event|1|||
94582014|NCT01656408|323931763|FG007|Overall Study|Adverse Event|0|||
94582015|NCT01656408|323931764|FG008|Overall Study|Adverse Event|1|||
94582016|NCT01656408|323931765|FG009|Overall Study|Adverse Event|0|||
94582017|NCT01656408|323931756|FG000|Overall Study|Physician Decision|1|||
94582018|NCT01656408|323931757|FG001|Overall Study|Physician Decision|0|||
94582019|NCT01656408|323931758|FG002|Overall Study|Physician Decision|1|||
94582020|NCT01656408|323931759|FG003|Overall Study|Physician Decision|0|||
94582021|NCT01656408|323931760|FG004|Overall Study|Physician Decision|1|||
94582022|NCT01656408|323931761|FG005|Overall Study|Physician Decision|1|||
94582023|NCT01656408|323931762|FG006|Overall Study|Physician Decision|0|||
94582024|NCT01656408|323931763|FG007|Overall Study|Physician Decision|1|||
94582025|NCT01656408|323931764|FG008|Overall Study|Physician Decision|1|||
94582026|NCT01656408|323931765|FG009|Overall Study|Physician Decision|3|||
94582027|NCT05567783|323931766|FG000|Overall Study|Death|2|||
94582028|NCT05567783|323931767|FG001|Overall Study|Death|3|||
94582029|NCT05567783|323931768|FG002|Overall Study|Death|0|||
94582030|NCT05567783|323931766|FG000|Overall Study|Lost to Follow-up|25|||
94582031|NCT05567783|323931767|FG001|Overall Study|Lost to Follow-up|19|||
94582032|NCT05567783|323931768|FG002|Overall Study|Lost to Follow-up|17|||
94582033|NCT05567783|323931766|FG000|Overall Study|Physician Decision|10|||
94582034|NCT05567783|323931767|FG001|Overall Study|Physician Decision|7|||
94582035|NCT05567783|323931768|FG002|Overall Study|Physician Decision|9|||
94582036|NCT05567783|323931766|FG000|Overall Study|Study Terminated by Sponsor|924|||
94582037|NCT05567783|323931767|FG001|Overall Study|Study Terminated by Sponsor|937|||
94582038|NCT05567783|323931768|FG002|Overall Study|Study Terminated by Sponsor|941|||
94582039|NCT05567783|323931766|FG000|Overall Study|Withdrawal by Subject|23|||
94582040|NCT05567783|323931767|FG001|Overall Study|Withdrawal by Subject|27|||
94582041|NCT05567783|323931768|FG002|Overall Study|Withdrawal by Subject|24|||
94582042|NCT05567783|323931766|FG000|Overall Study|Incarcerated|1|||
94582043|NCT05567783|323931767|FG001|Overall Study|Incarcerated|0|||
94582044|NCT05567783|323931768|FG002|Overall Study|Incarcerated|0|||
94582045|NCT05567783|323931766|FG000|Overall Study|Participant randomized in error|4|||
94582046|NCT05567783|323931767|FG001|Overall Study|Participant randomized in error|2|||
94582047|NCT05567783|323931768|FG002|Overall Study|Participant randomized in error|2|||
94582048|NCT03944577|323931771|FG000|Overall Study|Adverse Event|3|||
94582049|NCT00551642|323931772|FG000|Treatment Period|Protocol Deviation|6|||
94582050|NCT00551642|323931773|FG001|Treatment Period|Protocol Deviation|11|||
94582051|NCT00551642|323931772|FG000|Treatment Period|Delivery device failure|1|||
94582052|NCT00551642|323931773|FG001|Treatment Period|Delivery device failure|3|||
94582053|NCT00551642|323931772|FG000|Treatment Period|Physician Decision|0|||
94351729|NCT02155660|323069332|FG001|Overall Study|Adverse Event|6|||
94351730|NCT02155660|323069333|FG002|Overall Study|Adverse Event|3|||
94351731|NCT02155660|323069334|FG003|Overall Study|Adverse Event|1|||
94351732|NCT02155660|323069331|FG000|Overall Study|Lost to Follow-up|3|||
94351733|NCT02155660|323069332|FG001|Overall Study|Lost to Follow-up|6|||
94351734|NCT02155660|323069333|FG002|Overall Study|Lost to Follow-up|5|||
94351735|NCT02155660|323069334|FG003|Overall Study|Lost to Follow-up|8|||
94351736|NCT02155660|323069331|FG000|Overall Study|Death|17|||
94351737|NCT02155660|323069332|FG001|Overall Study|Death|19|||
94351738|NCT02155660|323069333|FG002|Overall Study|Death|17|||
94351739|NCT02155660|323069334|FG003|Overall Study|Death|19|||
94351740|NCT02155660|323069331|FG000|Overall Study|Withdrawal by Subject|28|||
94582054|NCT00551642|323931773|FG001|Treatment Period|Physician Decision|1|||
94582055|NCT00551642|323931772|FG000|Treatment Period|Death|33|||
94582056|NCT00551642|323931773|FG001|Treatment Period|Death|31|||
94582057|NCT00551642|323931772|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
94582058|NCT00551642|323931773|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
94582059|NCT00551642|323931772|FG000|Treatment Period|Adverse Event|15|||
94351741|NCT02155660|323069332|FG001|Overall Study|Withdrawal by Subject|31|||
94351742|NCT02155660|323069333|FG002|Overall Study|Withdrawal by Subject|24|||
94582060|NCT00551642|323931773|FG001|Treatment Period|Adverse Event|12|||
94351743|NCT02155660|323069334|FG003|Overall Study|Withdrawal by Subject|21|||
94351744|NCT03633461|323069340|FG000|Overall Study|Lost to Follow-up|0|||
94351745|NCT03633461|323069341|FG001|Overall Study|Lost to Follow-up|1|||
94351746|NCT00561912|323069342|FG000|Overall Study|ineligible|1|||
94351747|NCT02406586|323069345|FG000|Overall Study|Lost to Follow-up|0|||
94351748|NCT02406586|323069346|FG001|Overall Study|Lost to Follow-up|4|||
94351749|NCT02406586|323069347|FG002|Overall Study|Lost to Follow-up|2|||
94351750|NCT02406586|323069345|FG000|Overall Study|Withdrawal by Subject|1|||
94351751|NCT02406586|323069346|FG001|Overall Study|Withdrawal by Subject|0|||
94351752|NCT02406586|323069347|FG002|Overall Study|Withdrawal by Subject|0|||
94351753|NCT02577107|323069348|FG000|Overall Study|Protocol deviation|0|||
94351754|NCT02577107|323069349|FG001|Overall Study|Protocol deviation|1|||
94351755|NCT02516605|323069350|FG000|Overall Study|Protocol Violation|0|||
94351756|NCT02516605|323069351|FG001|Overall Study|Protocol Violation|0|||
94351757|NCT02516605|323069352|FG002|Overall Study|Protocol Violation|0|||
94582061|NCT00551642|323931772|FG000|Treatment Period|Withdrawal by Subject|2|||
94582062|NCT00551642|323931773|FG001|Treatment Period|Withdrawal by Subject|1|||
94582063|NCT00391586|323931774|FG000|Overall Study|Progressive disease|13|||
94582064|NCT00391586|323931774|FG000|Overall Study|Adverse Event|5|||
94582065|NCT00391586|323931774|FG000|Overall Study|Physician Decision|2|||
94582066|NCT00391586|323931774|FG000|Overall Study|Death|4|||
94351758|NCT02516605|323069353|FG003|Overall Study|Protocol Violation|0|||
94351759|NCT02516605|323069354|FG004|Overall Study|Protocol Violation|1|||
94351760|NCT02516605|323069350|FG000|Overall Study|Withdrawal by Subject|0|||
94351761|NCT02516605|323069351|FG001|Overall Study|Withdrawal by Subject|0|||
94351762|NCT02516605|323069352|FG002|Overall Study|Withdrawal by Subject|0|||
94351763|NCT02516605|323069353|FG003|Overall Study|Withdrawal by Subject|1|||
94351764|NCT02516605|323069354|FG004|Overall Study|Withdrawal by Subject|0|||
94351765|NCT00682539|323069355|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
94351766|NCT00682539|323069356|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
94582067|NCT00198822|323931775|FG000|Overall Study|Lost to Follow-up|14|||
94582068|NCT00198822|323931776|FG001|Overall Study|Lost to Follow-up|20|||
94582069|NCT00198822|323931777|FG002|Overall Study|Lost to Follow-up|21|||
94658972|NCT00898677|324206261|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
94351767|NCT00682539|323069357|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
94351768|NCT00682539|323069355|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
94351769|NCT00682539|323069356|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
94351770|NCT00682539|323069357|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
94351771|NCT04052425|323069358|FG000|24-Week Double-blind Period|Adverse Event|0|||
94351772|NCT04052425|323069359|FG001|24-Week Double-blind Period|Adverse Event|1|||
94351773|NCT04052425|323069360|FG002|24-Week Double-blind Period|Adverse Event|0|||
94351774|NCT04052425|323069361|FG003|24-Week Double-blind Period|Adverse Event|0|||
94351775|NCT04052425|323069358|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
94351776|NCT04052425|323069359|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
94351777|NCT04052425|323069360|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
94351778|NCT04052425|323069361|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
94351779|NCT04052425|323069358|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
94351780|NCT04052425|323069359|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
94351781|NCT04052425|323069360|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
94351782|NCT04052425|323069361|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
94351783|NCT04052425|323069358|FG000|24-Week Double-blind Period|Physician Decision|1|||
94351784|NCT04052425|323069359|FG001|24-Week Double-blind Period|Physician Decision|0|||
94351785|NCT04052425|323069360|FG002|24-Week Double-blind Period|Physician Decision|0|||
94351786|NCT04052425|323069361|FG003|24-Week Double-blind Period|Physician Decision|0|||
94351787|NCT04052425|323069358|FG000|24-Week Double-blind Period|Protocol Violation|1|||
94351788|NCT04052425|323069359|FG001|24-Week Double-blind Period|Protocol Violation|0|||
94351789|NCT04052425|323069360|FG002|24-Week Double-blind Period|Protocol Violation|0|||
94351790|NCT04052425|323069361|FG003|24-Week Double-blind Period|Protocol Violation|0|||
94351791|NCT04052425|323069358|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
94351792|NCT04052425|323069359|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
94351793|NCT04052425|323069360|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
94351794|NCT04052425|323069361|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
94351795|NCT04052425|323069358|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
94351796|NCT04052425|323069359|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
94351797|NCT04052425|323069360|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
94351798|NCT04052425|323069361|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
94351799|NCT04052425|323069358|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
94351800|NCT04052425|323069359|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
94658973|NCT00898677|324206258|FG000|Overall Study|Not Treated: Pregnancy|0|||
94351801|NCT04052425|323069360|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
94582070|NCT01457703|323931786|FG000|Overall Study|Screen Failure|5|||
94582071|NCT01457703|323931787|FG001|Overall Study|Screen Failure|7|||
94658974|NCT00898677|324206259|FG001|Overall Study|Not Treated: Pregnancy|0|||
94240489|NCT02626455|322674616|FG003|Overall Study|Lost to Follow-up|0|||
94351802|NCT04052425|323069361|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
94351803|NCT04052425|323069358|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
94351804|NCT04052425|323069359|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
94351805|NCT04052425|323069360|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
94351806|NCT04052425|323069361|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
94351807|NCT04052425|323069358|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
94351808|NCT04052425|323069359|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
94351809|NCT04052425|323069360|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
94351810|NCT04052425|323069361|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
94351811|NCT04052425|323069358|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
94240490|NCT02626455|322674617|FG004|Overall Study|Lost to Follow-up|0|||
94240491|NCT02626455|322674618|FG005|Overall Study|Lost to Follow-up|1|||
94240492|NCT02626455|322674619|FG006|Overall Study|Lost to Follow-up|0|||
94240493|NCT02626455|322674613|FG000|Overall Study|AE not associated with clinical disease progression|1|||
94240494|NCT02626455|322674614|FG001|Overall Study|AE not associated with clinical disease progression|1|||
94240495|NCT02626455|322674615|FG002|Overall Study|AE not associated with clinical disease progression|0|||
94240496|NCT02626455|322674616|FG003|Overall Study|AE not associated with clinical disease progression|2|||
94240497|NCT02626455|322674617|FG004|Overall Study|AE not associated with clinical disease progression|1|||
94240498|NCT02626455|322674618|FG005|Overall Study|AE not associated with clinical disease progression|65|||
94240499|NCT02626455|322674619|FG006|Overall Study|AE not associated with clinical disease progression|21|||
94240500|NCT02626455|322674613|FG000|Overall Study|AE associated with clinical disease progression|0|||
94240501|NCT02626455|322674614|FG001|Overall Study|AE associated with clinical disease progression|0|||
94240502|NCT02626455|322674615|FG002|Overall Study|AE associated with clinical disease progression|0|||
94240503|NCT02626455|322674616|FG003|Overall Study|AE associated with clinical disease progression|0|||
94240504|NCT02626455|322674617|FG004|Overall Study|AE associated with clinical disease progression|0|||
94240505|NCT02626455|322674618|FG005|Overall Study|AE associated with clinical disease progression|1|||
94240506|NCT02626455|322674619|FG006|Overall Study|AE associated with clinical disease progression|2|||
94240507|NCT02626455|322674613|FG000|Overall Study|Study intervention never administered|0|||
94351812|NCT04052425|323069359|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
94351813|NCT04052425|323069360|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
94351814|NCT04052425|323069361|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
94351815|NCT04052425|323069358|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
94351816|NCT04052425|323069359|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
94351817|NCT04052425|323069360|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
94351818|NCT04052425|323069361|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
94351819|NCT04052425|323069358|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
94351820|NCT04052425|323069359|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
94351821|NCT04052425|323069360|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
94351822|NCT04052425|323069361|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
94351823|NCT04052425|323069358|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
94351824|NCT04052425|323069359|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
94351825|NCT04052425|323069360|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
94351826|NCT04052425|323069361|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
94351827|NCT01731951|323069365|FG000|Overall Study|Documented Disease Progression|1|||
94582072|NCT01457703|323931786|FG000|Overall Study|Withdrawal by Subject|1|||
94582073|NCT01457703|323931787|FG001|Overall Study|Withdrawal by Subject|4|||
94582074|NCT01658436|323931788|FG000|Overall Study|Adverse Event|6|||
94582075|NCT01658436|323931789|FG001|Overall Study|Adverse Event|5|||
94582076|NCT01658436|323931788|FG000|Overall Study|Physician Decision|1|||
94582077|NCT01658436|323931789|FG001|Overall Study|Physician Decision|0|||
94582078|NCT01658436|323931788|FG000|Overall Study|Progressive disease|12|||
94582079|NCT01658436|323931789|FG001|Overall Study|Progressive disease|4|||
94582080|NCT01658436|323931788|FG000|Overall Study|Study terminated by sponsor|0|||
94582081|NCT01658436|323931789|FG001|Overall Study|Study terminated by sponsor|1|||
94582082|NCT01658436|323931788|FG000|Overall Study|Subject/guardian decision|0|||
94582083|NCT01658436|323931789|FG001|Overall Study|Subject/guardian decision|1|||
94582084|NCT01658436|323931788|FG000|Overall Study|Death|1|||
94582085|NCT01658436|323931789|FG001|Overall Study|Death|0|||
94582086|NCT00686712|323931790|FG000|Overall Study|Protocol Violation|8|||
94582087|NCT00686712|323931791|FG001|Overall Study|Protocol Violation|8|||
94582088|NCT00686712|323931792|FG002|Overall Study|Protocol Violation|10|||
94582089|NCT00686712|323931790|FG000|Overall Study|Lost to Follow-up|1|||
94240508|NCT02626455|322674614|FG001|Overall Study|Study intervention never administered|0|||
94240509|NCT02626455|322674615|FG002|Overall Study|Study intervention never administered|0|||
94582090|NCT00686712|323931791|FG001|Overall Study|Lost to Follow-up|2|||
94582091|NCT00686712|323931792|FG002|Overall Study|Lost to Follow-up|3|||
94582092|NCT00686712|323931790|FG000|Overall Study|Adverse Event|1|||
94582093|NCT00686712|323931791|FG001|Overall Study|Adverse Event|1|||
94582094|NCT00686712|323931792|FG002|Overall Study|Adverse Event|0|||
94582095|NCT01217229|323931793|FG000|Overall Study|Adverse Event|1|||
94582096|NCT01217229|323931793|FG000|Overall Study|Disease progression, deterioration|2|||
94582097|NCT01217229|323931793|FG000|Overall Study|Disease progression, Cheson criteria|14|||
94582098|NCT01217229|323931793|FG000|Overall Study|Protocol Violation|1|||
94582099|NCT01217229|323931793|FG000|Overall Study|Disease progression not confirmed|2|||
94582100|NCT00949702|323931794|FG000|Overall Study|Death|40|||
94582101|NCT00949702|323931794|FG000|Overall Study|Disease progression|7|||
94582102|NCT00949702|323931794|FG000|Overall Study|Withdrawal of consent|1|||
94582103|NCT01654302|323931795|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
94582104|NCT01654302|323931796|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
94582105|NCT04119414|323931797|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
94582106|NCT01352793|323931799|FG000|Overall Study|Lost to Follow-up|289|||
94582107|NCT01352793|323931800|FG001|Overall Study|Lost to Follow-up|125|||
94582108|NCT01352793|323931799|FG000|Overall Study|Withdrawal by Subject|120|||
94582109|NCT01352793|323931800|FG001|Overall Study|Withdrawal by Subject|55|||
94582110|NCT01352793|323931799|FG000|Overall Study|Protocol Violation|44|||
94582111|NCT01352793|323931800|FG001|Overall Study|Protocol Violation|23|||
94582112|NCT01352793|323931799|FG000|Overall Study|Adverse Event|44|||
94582113|NCT01352793|323931800|FG001|Overall Study|Adverse Event|10|||
94582114|NCT01352793|323931799|FG000|Overall Study|Physician Decision|1|||
94582115|NCT01352793|323931800|FG001|Overall Study|Physician Decision|0|||
94582116|NCT01352793|323931799|FG000|Overall Study|Pregnancy|26|||
94582117|NCT01352793|323931800|FG001|Overall Study|Pregnancy|8|||
94582118|NCT01352793|323931799|FG000|Overall Study|Other|25|||
94582119|NCT01352793|323931800|FG001|Overall Study|Other|7|||
94240510|NCT02626455|322674616|FG003|Overall Study|Study intervention never administered|0|||
94240511|NCT02626455|322674617|FG004|Overall Study|Study intervention never administered|0|||
94240512|NCT02626455|322674618|FG005|Overall Study|Study intervention never administered|1|||
94240513|NCT02626455|322674619|FG006|Overall Study|Study intervention never administered|3|||
94240514|NCT00798434|322674620|FG000|Double-Blind|Adverse Event|22|||
94240515|NCT00798434|322674621|FG001|Double-Blind|Adverse Event|46|||
94240516|NCT00798434|322674620|FG000|Double-Blind|Death|0|||
94240517|NCT00798434|322674621|FG001|Double-Blind|Death|1|||
94240518|NCT00798434|322674620|FG000|Double-Blind|Lost to Follow-up|1|||
94240519|NCT00798434|322674621|FG001|Double-Blind|Lost to Follow-up|0|||
94240520|NCT00798434|322674620|FG000|Double-Blind|Lack of Efficacy|8|||
94240521|NCT00798434|322674621|FG001|Double-Blind|Lack of Efficacy|12|||
94240522|NCT00798434|322674620|FG000|Double-Blind|Withdrawal by Subject|17|||
94240523|NCT00798434|322674621|FG001|Double-Blind|Withdrawal by Subject|14|||
94240524|NCT00798434|322674620|FG000|Double-Blind|Protocol Violation|1|||
94240525|NCT00798434|322674621|FG001|Double-Blind|Protocol Violation|4|||
94240526|NCT00798434|322674620|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
94240527|NCT00798434|322674621|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
94240528|NCT00798434|322674620|FG000|Double-Blind|Other|1|||
94240529|NCT00798434|322674621|FG001|Double-Blind|Other|0|||
94240530|NCT00798434|322674620|FG000|Double-Blind|Not Treated|3|||
94240531|NCT00798434|322674621|FG001|Double-Blind|Not Treated|6|||
94240532|NCT00798434|322674620|FG000|Open-Label|Adverse Event|33|||
94240533|NCT00798434|322674621|FG001|Open-Label|Adverse Event|11|||
94240534|NCT00798434|322674620|FG000|Open-Label|Lack of Efficacy|5|||
94240535|NCT00798434|322674621|FG001|Open-Label|Lack of Efficacy|11|||
94240536|NCT00798434|322674620|FG000|Open-Label|Withdrawal by Subject|2|||
94240537|NCT00798434|322674621|FG001|Open-Label|Withdrawal by Subject|7|||
94240538|NCT00798434|322674620|FG000|Open-Label|Protocol Violation|1|||
94240539|NCT00798434|322674621|FG001|Open-Label|Protocol Violation|0|||
94240540|NCT00798434|322674620|FG000|Open-Label|Other|1|||
94240541|NCT00798434|322674621|FG001|Open-Label|Other|2|||
94240542|NCT00798434|322674620|FG000|Open-Label|Not Treated|0|||
94240543|NCT00798434|322674621|FG001|Open-Label|Not Treated|1|||
94240544|NCT01447576|322674622|FG000|Overall Study|Lost to Follow-up|52|||
94240545|NCT01447576|322674622|FG000|Overall Study|Adverse Event|127|||
94240546|NCT01447576|322674622|FG000|Overall Study|Participant met withdrawal criteria|40|||
94240547|NCT01447576|322674622|FG000|Overall Study|Withdrawal by Subject|100|||
94240548|NCT01447576|322674622|FG000|Overall Study|Protocol deviation|83|||
94240549|NCT01447576|322674622|FG000|Overall Study|Lack of Efficacy|68|||
94240550|NCT01447576|322674622|FG000|Overall Study|Physician Decision|6|||
94240551|NCT01040169|322674626|FG000|Overall Study|Lost to Follow-up|3|||
94240552|NCT01040169|322674627|FG001|Overall Study|Lost to Follow-up|8|||
94240553|NCT02579772|322674628|FG000|Overall Study|Withdrawal by Subject|0|||
94240554|NCT02579772|322674629|FG001|Overall Study|Withdrawal by Subject|1|||
94240555|NCT02579772|322674628|FG000|Overall Study|Usage of additional antioxidants|1|||
94240556|NCT02579772|322674629|FG001|Overall Study|Usage of additional antioxidants|0|||
94240557|NCT02579772|322674628|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
94240558|NCT02579772|322674629|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
94240559|NCT00350727|322674630|FG000|Phase I: Dose Escalation|Adverse Event|4|||
94582120|NCT01352793|323931799|FG000|Overall Study|Medication error|2|||
94240560|NCT00350727|322674631|FG001|Phase I: Dose Escalation|Adverse Event|0|||
94351828|NCT01731951|323069366|FG001|Overall Study|Documented Disease Progression|0|||
94351829|NCT01731951|323069367|FG002|Overall Study|Documented Disease Progression|0|||
94351830|NCT01731951|323069368|FG003|Overall Study|Documented Disease Progression|0|||
94351831|NCT01731951|323069369|FG004|Overall Study|Documented Disease Progression|0|||
94351832|NCT01731951|323069370|FG005|Overall Study|Documented Disease Progression|0|||
94351833|NCT01731951|323069365|FG000|Overall Study|Lost to Follow-up|2|||
94351834|NCT01731951|323069366|FG001|Overall Study|Lost to Follow-up|0|||
94351835|NCT01731951|323069367|FG002|Overall Study|Lost to Follow-up|0|||
94351836|NCT01731951|323069368|FG003|Overall Study|Lost to Follow-up|1|||
94351837|NCT01731951|323069369|FG004|Overall Study|Lost to Follow-up|3|||
94351838|NCT01731951|323069370|FG005|Overall Study|Lost to Follow-up|1|||
94351839|NCT01731951|323069365|FG000|Overall Study|Withdrawal of Consent|1|||
94351840|NCT01731951|323069366|FG001|Overall Study|Withdrawal of Consent|0|||
94351841|NCT01731951|323069367|FG002|Overall Study|Withdrawal of Consent|0|||
94351842|NCT01731951|323069368|FG003|Overall Study|Withdrawal of Consent|0|||
94351843|NCT01731951|323069369|FG004|Overall Study|Withdrawal of Consent|0|||
94351844|NCT01731951|323069370|FG005|Overall Study|Withdrawal of Consent|2|||
94351845|NCT01731951|323069365|FG000|Overall Study|Death|13|||
94582121|NCT01352793|323931800|FG001|Overall Study|Medication error|2|||
94582122|NCT01352793|323931799|FG000|Overall Study|Death|1|||
94582123|NCT01352793|323931800|FG001|Overall Study|Death|0|||
94582124|NCT01352793|323931799|FG000|Overall Study|Randomized but not vaccinated|8|||
94582125|NCT01352793|323931800|FG001|Overall Study|Randomized but not vaccinated|0|||
94582126|NCT01352793|323931799|FG000|Overall Study|No longer meets eligibility criteria|25|||
94582127|NCT01352793|323931800|FG001|Overall Study|No longer meets eligibility criteria|15|||
94582128|NCT01094119|323931803|FG000|Overall Study|Lack of Efficacy|2|||
94582129|NCT01094119|323931804|FG001|Overall Study|Lack of Efficacy|4|||
94582130|NCT00834093|323931806|FG000|Overall Study|Progressive Disease|3|||
94351846|NCT01731951|323069366|FG001|Overall Study|Death|15|||
94351847|NCT01731951|323069367|FG002|Overall Study|Death|9|||
94351848|NCT01731951|323069368|FG003|Overall Study|Death|8|||
94351849|NCT01731951|323069369|FG004|Overall Study|Death|9|||
94351850|NCT01731951|323069370|FG005|Overall Study|Death|6|||
94351851|NCT04880642|323069371|FG000|Randomization|Withdrawal by Subject|2|||
94351852|NCT04880642|323069372|FG001|Randomization|Withdrawal by Subject|3|||
94351853|NCT04880642|323069371|FG000|Treatment Period|Adverse Event|0|||
94351854|NCT04880642|323069372|FG001|Treatment Period|Adverse Event|1|||
94351855|NCT04880642|323069371|FG000|Treatment Period|Death|6|||
94351856|NCT04880642|323069372|FG001|Treatment Period|Death|6|||
94351857|NCT04880642|323069371|FG000|Treatment Period|Lost to Follow-up|1|||
94351858|NCT04880642|323069372|FG001|Treatment Period|Lost to Follow-up|0|||
94351859|NCT04880642|323069371|FG000|Treatment Period|Protocol Violation|0|||
94351860|NCT04880642|323069372|FG001|Treatment Period|Protocol Violation|1|||
94351861|NCT04880642|323069371|FG000|Treatment Period|Withdrawal by Subject|5|||
94351862|NCT04880642|323069372|FG001|Treatment Period|Withdrawal by Subject|3|||
94351863|NCT04880642|323069371|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
94351864|NCT04880642|323069372|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
94351865|NCT04880642|323069371|FG000|Follow-up|Death|4|||
94351866|NCT04880642|323069372|FG001|Follow-up|Death|3|||
94351867|NCT04880642|323069371|FG000|Follow-up|Withdrawal by Subject|1|||
94351868|NCT04880642|323069372|FG001|Follow-up|Withdrawal by Subject|0|||
94351869|NCT01716585|323069375|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
94351870|NCT01716585|323069376|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
94351871|NCT01716585|323069375|FG000|Double-blind Treatment|Adverse Event|2|||
94351872|NCT01716585|323069376|FG001|Double-blind Treatment|Adverse Event|1|||
94351873|NCT01716585|323069375|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
94582131|NCT00834093|323931806|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
94582132|NCT01523756|323931807|FG000|Baseline Period|Adverse Event|0|||
94582133|NCT01523756|323931808|FG001|Baseline Period|Adverse Event|1|||
94582134|NCT01523756|323931807|FG000|Test Period 1|Adverse Event|1|||
94582135|NCT01523756|323931808|FG001|Test Period 1|Adverse Event|0|||
94582136|NCT01523756|323931807|FG000|Test Period 2|Withdrawal by Subject|0|||
94582137|NCT01523756|323931808|FG001|Test Period 2|Withdrawal by Subject|1|||
94582138|NCT02141204|323931811|FG000|Overall Study|Lost to Follow-up|2|||
94582139|NCT02141204|323931812|FG001|Overall Study|Lost to Follow-up|1|||
94582140|NCT02141204|323931811|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
94582141|NCT02141204|323931812|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
94582142|NCT02141204|323931811|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
94582143|NCT02141204|323931812|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
94582144|NCT02141204|323931811|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
94582145|NCT02141204|323931812|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
94582146|NCT02379091|323931813|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
94582147|NCT02379091|323931814|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
94582148|NCT02379091|323931815|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
94582149|NCT02379091|323931816|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
94582150|NCT02379091|323931813|FG000|Overall Study|Principal Investigator Discretion|0|||
94582151|NCT02379091|323931814|FG001|Overall Study|Principal Investigator Discretion|1|||
94582152|NCT02379091|323931815|FG002|Overall Study|Principal Investigator Discretion|0|||
94582153|NCT02379091|323931816|FG003|Overall Study|Principal Investigator Discretion|0|||
94582154|NCT02379091|323931813|FG000|Overall Study|Lost to Follow-up|0|||
94582155|NCT02379091|323931814|FG001|Overall Study|Lost to Follow-up|0|||
94582156|NCT02379091|323931815|FG002|Overall Study|Lost to Follow-up|0|||
94582157|NCT02379091|323931816|FG003|Overall Study|Lost to Follow-up|1|||
94582158|NCT02379091|323931813|FG000|Overall Study|Voluntary Withdrawal|2|||
94582159|NCT02379091|323931814|FG001|Overall Study|Voluntary Withdrawal|5|||
94582160|NCT02379091|323931815|FG002|Overall Study|Voluntary Withdrawal|2|||
94240561|NCT00350727|322674632|FG002|Phase I: Dose Escalation|Adverse Event|0|||
94240562|NCT00350727|322674630|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
94240563|NCT00350727|322674631|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
94582161|NCT02379091|323931816|FG003|Overall Study|Voluntary Withdrawal|4|||
94582162|NCT02379091|323931813|FG000|Overall Study|Study Termination|7|||
94582163|NCT02379091|323931814|FG001|Overall Study|Study Termination|2|||
94582164|NCT02379091|323931815|FG002|Overall Study|Study Termination|5|||
94454571|NCT00556933|323451632|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
94454572|NCT00556933|323451633|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
94454573|NCT00556933|323451634|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
94454574|NCT00556933|323451631|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
94454575|NCT00556933|323451632|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
94454576|NCT00556933|323451633|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
94454577|NCT00556933|323451634|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
94454578|NCT00556933|323451631|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
94454579|NCT00556933|323451632|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
94454580|NCT00556933|323451633|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
94454581|NCT00556933|323451634|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
94454582|NCT00556933|323451631|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
94582165|NCT02379091|323931816|FG003|Overall Study|Study Termination|8|||
94582166|NCT02379091|323931813|FG000|Overall Study|Lack of Efficacy|3|||
94582167|NCT02379091|323931814|FG001|Overall Study|Lack of Efficacy|0|||
94582168|NCT02379091|323931815|FG002|Overall Study|Lack of Efficacy|0|||
94582169|NCT02379091|323931816|FG003|Overall Study|Lack of Efficacy|0|||
94240564|NCT00350727|322674632|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
94240565|NCT00350727|322674630|FG000|Phase I: Dose Escalation|Death|1|||
94240566|NCT00350727|322674631|FG001|Phase I: Dose Escalation|Death|0|||
94240567|NCT00350727|322674632|FG002|Phase I: Dose Escalation|Death|0|||
94240568|NCT00350727|322674630|FG000|Phase I: Dose Escalation|Physician Decision|1|||
94240569|NCT00350727|322674631|FG001|Phase I: Dose Escalation|Physician Decision|0|||
94240570|NCT00350727|322674632|FG002|Phase I: Dose Escalation|Physician Decision|0|||
94240571|NCT00350727|322674630|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
94240572|NCT00350727|322674631|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
94240573|NCT00350727|322674632|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
94240574|NCT00350727|322674630|FG000|Phase II|Disease Progression|0|||
94240575|NCT00350727|322674631|FG001|Phase II|Disease Progression|15|||
94240576|NCT00350727|322674632|FG002|Phase II|Disease Progression|16|||
94240577|NCT00350727|322674630|FG000|Phase II|Clinical Deterioration|0|||
94240578|NCT00350727|322674631|FG001|Phase II|Clinical Deterioration|1|||
94240579|NCT00350727|322674632|FG002|Phase II|Clinical Deterioration|0|||
94240580|NCT00350727|322674630|FG000|Phase II|Withdrawal by Subject|0|||
94240581|NCT00350727|322674631|FG001|Phase II|Withdrawal by Subject|2|||
94240582|NCT00350727|322674632|FG002|Phase II|Withdrawal by Subject|1|||
94240583|NCT00350727|322674630|FG000|Phase II|Adverse Event|0|||
94240584|NCT00350727|322674631|FG001|Phase II|Adverse Event|1|||
94240585|NCT00350727|322674632|FG002|Phase II|Adverse Event|1|||
94240586|NCT00350727|322674630|FG000|Phase II|Death|0|||
94240587|NCT00350727|322674631|FG001|Phase II|Death|0|||
94240588|NCT00350727|322674632|FG002|Phase II|Death|2|||
94240589|NCT00350727|322674630|FG000|Phase II|Sponsor Terminated Study|0|||
94240590|NCT00350727|322674631|FG001|Phase II|Sponsor Terminated Study|0|||
94240591|NCT00350727|322674632|FG002|Phase II|Sponsor Terminated Study|1|||
94240592|NCT00350727|322674630|FG000|Phase II|Enrolled in Rollover Study|0|||
94240593|NCT00350727|322674631|FG001|Phase II|Enrolled in Rollover Study|0|||
94240594|NCT00350727|322674632|FG002|Phase II|Enrolled in Rollover Study|1|||
94240595|NCT03682185|322674633|FG000|Overall Study|Lost to Follow-up|4|||
94240596|NCT03682185|322674634|FG001|Overall Study|Lost to Follow-up|7|||
94240597|NCT03682185|322674635|FG002|Overall Study|Lost to Follow-up|4|||
94240598|NCT03682185|322674636|FG003|Overall Study|Lost to Follow-up|7|||
94240599|NCT03682185|322674637|FG004|Overall Study|Lost to Follow-up|1|||
94240600|NCT03682185|322674633|FG000|Overall Study|Withdrawal by Subject|7|||
94240601|NCT03682185|322674634|FG001|Overall Study|Withdrawal by Subject|3|||
94240602|NCT03682185|322674635|FG002|Overall Study|Withdrawal by Subject|7|||
94240603|NCT03682185|322674636|FG003|Overall Study|Withdrawal by Subject|3|||
94240604|NCT03682185|322674637|FG004|Overall Study|Withdrawal by Subject|0|||
94240605|NCT03238963|322674641|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
94240606|NCT03238963|322674642|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
94240607|NCT03238963|322674641|FG000|Overall Study|Withdrawal by Subject|1|||
94240608|NCT03238963|322674642|FG001|Overall Study|Withdrawal by Subject|1|||
94240609|NCT03238963|322674641|FG000|Overall Study|Lost to Follow-up|1|||
94240610|NCT03238963|322674642|FG001|Overall Study|Lost to Follow-up|0|||
94240611|NCT03238963|322674641|FG000|Overall Study|Protocol Violation|1|||
94240612|NCT03238963|322674642|FG001|Overall Study|Protocol Violation|1|||
94240613|NCT03238963|322674641|FG000|Overall Study|Adverse Event|1|||
94240614|NCT03238963|322674642|FG001|Overall Study|Adverse Event|0|||
94240615|NCT01424813|322674643|FG000|Overall Study|Withdrawal by Subject|3|||
94240616|NCT01424813|322674644|FG001|Overall Study|Withdrawal by Subject|0|||
94240617|NCT01424813|322674643|FG000|Overall Study|Protocol Violation|1|||
94240618|NCT01424813|322674644|FG001|Overall Study|Protocol Violation|0|||
94240619|NCT01424813|322674643|FG000|Overall Study|Other|1|||
94240620|NCT01424813|322674644|FG001|Overall Study|Other|2|||
94240621|NCT04546217|322676658|FG000|Overall Study|Withdrawal by Subject|2|||
94582170|NCT01958164|323931817|FG000|Overall Study|Adverse Event|0|||
94454583|NCT00556933|323451632|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
94454584|NCT00556933|323451633|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
94454585|NCT00556933|323451634|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
94454586|NCT00556933|323451631|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
94454587|NCT00556933|323451632|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
94454588|NCT00556933|323451633|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
94454589|NCT00556933|323451634|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
94454590|NCT00556933|323451631|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
94454591|NCT00556933|323451632|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
94454592|NCT00556933|323451633|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
94454593|NCT00556933|323451634|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
94454594|NCT00556933|323451631|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
94454595|NCT00556933|323451632|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
94454596|NCT00556933|323451633|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
94454597|NCT00556933|323451634|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
94454598|NCT00556933|323451631|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
94454599|NCT00556933|323451632|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
94454600|NCT00556933|323451633|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
94454601|NCT00556933|323451634|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
94454602|NCT00556933|323451631|FG000|CNI Withdrawal vs. Minimization|Death|0|||
94454603|NCT00556933|323451632|FG001|CNI Withdrawal vs. Minimization|Death|0|||
94454604|NCT00556933|323451633|FG002|CNI Withdrawal vs. Minimization|Death|0|||
94454605|NCT00556933|323451634|FG003|CNI Withdrawal vs. Minimization|Death|1|||
94454606|NCT00686829|323451635|FG000|Overall Study|Adverse Event|5|||
94454607|NCT00686829|323451635|FG000|Overall Study|Lack of Efficacy|6|||
94454608|NCT00686829|323451635|FG000|Overall Study|Lost to Follow-up|4|||
94454609|NCT00686829|323451635|FG000|Overall Study|Withdrawal by Subject|14|||
94454610|NCT00686829|323451635|FG000|Overall Study|Protocol Violation|3|||
94454611|NCT00686829|323451635|FG000|Overall Study|Sponsor discontinued VCV|47|||
94454612|NCT02537431|323451645|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
94454613|NCT02727777|323451648|FG000|Overall Study|Screen Failure|2|||
94454614|NCT02727777|323451649|FG001|Overall Study|Screen Failure|0|||
94454615|NCT02727777|323451650|FG002|Overall Study|Screen Failure|0|||
94454616|NCT02727777|323451648|FG000|Overall Study|Progressive disease|2|||
94454617|NCT02727777|323451649|FG001|Overall Study|Progressive disease|0|||
94454618|NCT02727777|323451650|FG002|Overall Study|Progressive disease|0|||
94454619|NCT01868438|323453134|FG000|First Intervention|Withdrawal by Subject|5|||
94454620|NCT01868438|323453135|FG001|First Intervention|Withdrawal by Subject|1|||
94454621|NCT01868438|323453134|FG000|First Intervention|Lost to Follow-up|2|||
94454622|NCT01868438|323453135|FG001|First Intervention|Lost to Follow-up|3|||
94454623|NCT01868438|323453134|FG000|First Intervention|Meeting the non-redosing criteria|0|||
94454624|NCT01868438|323453135|FG001|First Intervention|Meeting the non-redosing criteria|1|||
94454625|NCT01868438|323453134|FG000|Second Intervention|Adverse Event|3|||
94454626|NCT01868438|323453135|FG001|Second Intervention|Adverse Event|3|||
94454627|NCT03555565|323453144|FG000|Overall Study|Case Report Forms Uncollected|2|||
94454628|NCT03555565|323453144|FG000|Overall Study|Protocol Deviation|13|||
94454629|NCT04696055|323453145|FG000|Overall Study|Adverse Event|10|||
94454630|NCT04696055|323453146|FG001|Overall Study|Adverse Event|2|||
94454631|NCT04696055|323453145|FG000|Overall Study|Death|4|||
94454632|NCT04696055|323453146|FG001|Overall Study|Death|0|||
94454633|NCT04696055|323453145|FG000|Overall Study|Other|7|||
94454634|NCT04696055|323453146|FG001|Overall Study|Other|2|||
94454635|NCT04696055|323453145|FG000|Overall Study|Physician Decision|3|||
94454636|NCT04696055|323453146|FG001|Overall Study|Physician Decision|0|||
94454637|NCT04696055|323453145|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
94454638|NCT04696055|323453146|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
94454639|NCT04696055|323453145|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
94454640|NCT04696055|323453146|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
94454641|NCT04696055|323453145|FG000|Overall Study|Subject Decision|1|||
94454642|NCT04696055|323453146|FG001|Overall Study|Subject Decision|2|||
94454643|NCT03969901|323453147|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94454644|NCT03969901|323453148|FG001|Overall Study|Withdrawal by parent/guardian|0|||
94454645|NCT03969901|323453149|FG002|Overall Study|Withdrawal by parent/guardian|0|||
94454646|NCT03969901|323453150|FG003|Overall Study|Withdrawal by parent/guardian|0|||
94454647|NCT03969901|323453151|FG004|Overall Study|Withdrawal by parent/guardian|1|||
94454648|NCT03969901|323453152|FG005|Overall Study|Withdrawal by parent/guardian|0|||
94454649|NCT03969901|323453153|FG006|Overall Study|Withdrawal by parent/guardian|0|||
94454650|NCT03969901|323453154|FG007|Overall Study|Withdrawal by parent/guardian|1|||
94582171|NCT01958164|323931818|FG001|Overall Study|Adverse Event|2|||
94582172|NCT01958164|323931817|FG000|Overall Study|Lost to Follow-up|2|||
94582173|NCT01958164|323931818|FG001|Overall Study|Lost to Follow-up|3|||
94582174|NCT00687193|323931819|FG000|Overall Study|Adverse Event|0|||
94582175|NCT00687193|323931820|FG001|Overall Study|Adverse Event|1|||
94454651|NCT03969901|323453155|FG008|Overall Study|Withdrawal by parent/guardian|1|||
94351874|NCT01716585|323069376|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
94351875|NCT01716585|323069375|FG000|Double-blind Treatment|Lost to Follow-up|2|||
94351876|NCT01716585|323069376|FG001|Double-blind Treatment|Lost to Follow-up|0|||
94351877|NCT01716585|323069375|FG000|Double-blind Treatment|Subject Noncompliant|1|||
94351878|NCT01716585|323069376|FG001|Double-blind Treatment|Subject Noncompliant|0|||
94351879|NCT01716585|323069375|FG000|Double-blind Treatment|Other|1|||
94351880|NCT01716585|323069376|FG001|Double-blind Treatment|Other|0|||
94351881|NCT01716585|323069375|FG000|Open-label Treatment|Adverse Event|0|||
94351882|NCT01716585|323069376|FG001|Open-label Treatment|Adverse Event|2|||
94351883|NCT01716585|323069375|FG000|Open-label Treatment|Virologic Failure|0|||
94351884|NCT01716585|323069376|FG001|Open-label Treatment|Virologic Failure|2|||
94351885|NCT01716585|323069375|FG000|Open-label Treatment|Withdrawal by Subject|0|||
94351886|NCT01716585|323069376|FG001|Open-label Treatment|Withdrawal by Subject|3|||
94351887|NCT00561795|323069377|FG000|Overall Study|Adverse Event|3|||
94351888|NCT00561795|323069378|FG001|Overall Study|Adverse Event|3|||
94351889|NCT00561795|323069379|FG002|Overall Study|Adverse Event|0|||
94351890|NCT00561795|323069380|FG003|Overall Study|Adverse Event|0|||
94351891|NCT00561795|323069377|FG000|Overall Study|Study Closed/Terminated|0|||
94351892|NCT00561795|323069378|FG001|Overall Study|Study Closed/Terminated|3|||
94351893|NCT00561795|323069379|FG002|Overall Study|Study Closed/Terminated|0|||
94351894|NCT00561795|323069380|FG003|Overall Study|Study Closed/Terminated|0|||
94351895|NCT00561795|323069377|FG000|Overall Study|Physician Decision|1|||
94351896|NCT00561795|323069378|FG001|Overall Study|Physician Decision|0|||
94351897|NCT00561795|323069379|FG002|Overall Study|Physician Decision|0|||
94454652|NCT03969901|323453156|FG009|Overall Study|Withdrawal by parent/guardian|0|||
94454653|NCT03991299|323453157|FG000|Overall Study|Study closed, sponsor decision|3|||
94454654|NCT03991299|323453157|FG000|Overall Study|Withdrawal by Subject|1|||
94454655|NCT04304235|323453158|FG000|Overall Study|incomplete triage data|0|||
94454656|NCT04304235|323453159|FG001|Overall Study|incomplete triage data|69|||
94454657|NCT04304235|323453160|FG002|Overall Study|incomplete triage data|0|||
94454658|NCT04304235|323453161|FG003|Overall Study|incomplete triage data|0|||
94454659|NCT04304235|323453162|FG004|Overall Study|incomplete triage data|289|||
94454660|NCT04304235|323453163|FG005|Overall Study|incomplete triage data|123|||
94454661|NCT04304235|323453164|FG006|Overall Study|incomplete triage data|65|||
94351898|NCT00561795|323069380|FG003|Overall Study|Physician Decision|0|||
94351899|NCT03802331|323069382|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
94351900|NCT03802331|323069383|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
94351901|NCT04382066|323069386|FG000|Overall Study|Adverse Event|1|||
94351902|NCT04382066|323069387|FG001|Overall Study|Adverse Event|0|||
94351903|NCT04382066|323069388|FG002|Overall Study|Adverse Event|0|||
94351904|NCT04382066|323069386|FG000|Overall Study|Death|1|||
94454662|NCT00930774|323453169|FG000|Overall Study|Withdrawal by Subject|1|||
94454663|NCT00930774|323453170|FG001|Overall Study|Withdrawal by Subject|9|||
94454664|NCT00930774|323453171|FG002|Overall Study|Withdrawal by Subject|2|||
94454665|NCT00930774|323453172|FG003|Overall Study|Withdrawal by Subject|0|||
94454666|NCT03436693|323453173|FG000|Overall Study|Adverse Event|22|||
94454667|NCT03436693|323453174|FG001|Overall Study|Adverse Event|10|||
94454668|NCT03436693|323453173|FG000|Overall Study|Physician Decision|3|||
94454669|NCT03436693|323453174|FG001|Overall Study|Physician Decision|3|||
94454670|NCT03436693|323453173|FG000|Overall Study|Withdrawal by Subject|4|||
94454671|NCT03436693|323453174|FG001|Overall Study|Withdrawal by Subject|13|||
94454672|NCT03436693|323453173|FG000|Overall Study|Progressive Disease|1|||
94454673|NCT03436693|323453174|FG001|Overall Study|Progressive Disease|1|||
94454674|NCT02071706|323453175|FG000|Overall Study|Adverse Event|1|||
94454675|NCT02071706|323453175|FG000|Overall Study|Withdrawal by Subject|2|||
94454676|NCT02005692|323453176|FG000|Overall Study|Protocol Violation|1|||
94454677|NCT02005692|323453176|FG000|Overall Study|Withdrawal by Subject|1|||
94454678|NCT02005692|323453176|FG000|Overall Study|Discharged earlier than anticipated|5|||
94454679|NCT02247440|323453182|FG000|Overall Study|Withdrawal by Subject|1|||
94454680|NCT02247440|323453182|FG000|Overall Study|Lack of Efficacy|3|||
94454681|NCT00661609|323453186|FG000|Overall Study|Adverse Event|4|||
94454682|NCT00661609|323453186|FG000|Overall Study|Death|20|||
94454683|NCT00661609|323453186|FG000|Overall Study|Withdrawal by Subject|2|||
94454684|NCT00661609|323453186|FG000|Overall Study|PI Decision|1|||
94454685|NCT00661609|323453186|FG000|Overall Study|Survival follow up stage discontinued|11|||
94454686|NCT00661609|323453186|FG000|Overall Study|Disease progression|3|||
94658975|NCT00898677|324206260|FG002|Overall Study|Not Treated: Pregnancy|1|||
94658976|NCT00898677|324206261|FG003|Overall Study|Not Treated: Pregnancy|0|||
94351905|NCT04382066|323069387|FG001|Overall Study|Death|0|||
94351906|NCT04382066|323069388|FG002|Overall Study|Death|1|||
94351907|NCT00579059|323069389|FG000|Overall Study|Study Canceled at 1 Year|21|||
94351908|NCT00579059|323069390|FG001|Overall Study|Study Canceled at 1 Year|10|||
94351909|NCT00779506|323069393|FG000|Overall Study|Screening Failed|2|||
94351910|NCT00779506|323069393|FG000|Overall Study|Adverse Event|4|||
94454687|NCT02475265|323453187|FG000|Overall Study|Physician Decision|1|||
94454688|NCT02475265|323453187|FG000|Overall Study|Withdrawal by Subject|2|||
94454689|NCT00839527|323453193|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
94454690|NCT00839527|323453194|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
94454691|NCT00839527|323453195|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
94454692|NCT00839527|323453193|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
94454693|NCT00839527|323453194|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
94454694|NCT00839527|323453195|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
94454695|NCT00839527|323453193|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
94454696|NCT00839527|323453194|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
94454697|NCT00839527|323453195|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
94454698|NCT00839527|323453193|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
94454699|NCT00839527|323453194|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
94454700|NCT00839527|323453195|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
94454701|NCT00839527|323453193|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
94454702|NCT00839527|323453194|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
94454703|NCT00839527|323453195|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
94454704|NCT00839527|323453193|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
94454705|NCT00839527|323453194|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
94454706|NCT00839527|323453195|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
94454707|NCT00839527|323453193|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
94454708|NCT00839527|323453194|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
94454709|NCT00839527|323453195|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
94454710|NCT00839527|323453193|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
94454711|NCT00839527|323453194|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
94454712|NCT00839527|323453195|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
94454713|NCT00839527|323453193|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
94454714|NCT00839527|323453194|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
94454715|NCT00839527|323453195|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
94454716|NCT00839527|323453193|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
94454717|NCT00839527|323453194|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
94454718|NCT00839527|323453195|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
94454719|NCT00839527|323453193|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
94454720|NCT00839527|323453194|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
94454721|NCT00839527|323453195|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
94454722|NCT00839527|323453193|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
94454723|NCT00839527|323453194|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
94454724|NCT00839527|323453195|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
94351911|NCT00779506|323069393|FG000|Overall Study|Lack of Efficacy|11|||
94351912|NCT00779506|323069393|FG000|Overall Study|Protocol Violation|5|||
94351913|NCT00779506|323069393|FG000|Overall Study|Withdrawal by Subject|6|||
94351914|NCT00779506|323069393|FG000|Overall Study|Lost to Follow-up|1|||
94351915|NCT00697255|323069394|FG000|Stage 1a|Insufficient ovarian response|1|||
94351916|NCT00697255|323069395|FG001|Stage 1a|Insufficient ovarian response|0|||
94351917|NCT00697255|323069394|FG000|Stage 1a|Multifollicular growth|1|||
94351918|NCT00697255|323069395|FG001|Stage 1a|Multifollicular growth|0|||
94351919|NCT00697255|323069394|FG000|Stage 1a|Not growing of dominant follicle|1|||
94351920|NCT00697255|323069395|FG001|Stage 1a|Not growing of dominant follicle|0|||
94351921|NCT00697255|323069394|FG000|Stage 1b|Not growing of dominant follicle|0|||
94351922|NCT00697255|323069395|FG001|Stage 1b|Not growing of dominant follicle|1|||
94351923|NCT00697255|323069394|FG000|Stage 1b|Insufficient ovarian response|0|||
94351924|NCT00697255|323069395|FG001|Stage 1b|Insufficient ovarian response|1|||
94454725|NCT00839527|323453193|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
94454726|NCT00839527|323453194|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
94454727|NCT00839527|323453195|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
94454728|NCT00839527|323453193|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
94454729|NCT00839527|323453194|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
94454730|NCT00839527|323453195|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
94454731|NCT00839527|323453193|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
94454732|NCT00839527|323453194|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
94454733|NCT00839527|323453195|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
94454734|NCT00839527|323453193|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
94454735|NCT00839527|323453194|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
94454736|NCT00839527|323453195|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
94454737|NCT00839527|323453193|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
94454738|NCT00839527|323453194|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
94454739|NCT00839527|323453195|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
94351925|NCT01218477|323069396|FG000|Overall Study|Disease progression|2|||
94454740|NCT00839527|323453193|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
94454741|NCT00839527|323453194|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
94454742|NCT00839527|323453195|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
94454743|NCT00839527|323453193|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
94454744|NCT00839527|323453194|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
94454745|NCT00839527|323453195|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
94454746|NCT00839527|323453193|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
94454747|NCT00839527|323453194|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
94454748|NCT00839527|323453195|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
94454749|NCT00839527|323453193|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
94351926|NCT01218477|323069397|FG001|Overall Study|Disease progression|3|||
94351927|NCT01218477|323069398|FG002|Overall Study|Disease progression|6|||
94351928|NCT01218477|323069399|FG003|Overall Study|Disease progression|2|||
94454750|NCT00839527|323453194|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
94454751|NCT00839527|323453195|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
94454752|NCT00839527|323453193|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
94454753|NCT00839527|323453194|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
94454754|NCT00839527|323453195|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
94454755|NCT00839527|323453193|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
94454756|NCT00839527|323453194|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
94454757|NCT00839527|323453195|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
94351929|NCT01218477|323069396|FG000|Overall Study|Study drug toxicity|0|||
94351930|NCT01218477|323069397|FG001|Overall Study|Study drug toxicity|2|||
94351931|NCT01218477|323069398|FG002|Overall Study|Study drug toxicity|5|||
94351932|NCT01218477|323069399|FG003|Overall Study|Study drug toxicity|0|||
94351933|NCT01218477|323069396|FG000|Overall Study|No longer meets study criteria|1|||
94351934|NCT01218477|323069397|FG001|Overall Study|No longer meets study criteria|0|||
94351935|NCT01218477|323069398|FG002|Overall Study|No longer meets study criteria|0|||
94351936|NCT01218477|323069399|FG003|Overall Study|No longer meets study criteria|0|||
94454758|NCT00839527|323453193|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
94454759|NCT00839527|323453194|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
94454760|NCT00839527|323453195|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
94454761|NCT02751450|323453196|FG000|Overall Study|Adverse Event|1|||
94454762|NCT02751450|323453197|FG001|Overall Study|Adverse Event|0|||
94454763|NCT01290679|323453198|FG000|Overall Study|Adverse Event|2|||
94454764|NCT01290679|323453199|FG001|Overall Study|Adverse Event|0|||
94454765|NCT01290679|323453198|FG000|Overall Study|Lost to Follow-up|8|||
94454766|NCT01290679|323453199|FG001|Overall Study|Lost to Follow-up|10|||
94454767|NCT01290679|323453198|FG000|Overall Study|Protocol Violation|0|||
94351937|NCT01218477|323069396|FG000|Overall Study|Withdrawal by Subject|0|||
94351938|NCT01218477|323069397|FG001|Overall Study|Withdrawal by Subject|0|||
94351939|NCT01218477|323069398|FG002|Overall Study|Withdrawal by Subject|1|||
94351940|NCT01218477|323069399|FG003|Overall Study|Withdrawal by Subject|0|||
94351941|NCT01218477|323069396|FG000|Overall Study|Prepared for cell transplantation|0|||
94351942|NCT01218477|323069397|FG001|Overall Study|Prepared for cell transplantation|1|||
94351943|NCT01218477|323069398|FG002|Overall Study|Prepared for cell transplantation|1|||
94351944|NCT01218477|323069399|FG003|Overall Study|Prepared for cell transplantation|0|||
94351945|NCT01218477|323069396|FG000|Overall Study|Administrative reason by sponsor|0|||
94351946|NCT01218477|323069397|FG001|Overall Study|Administrative reason by sponsor|0|||
94351947|NCT01218477|323069398|FG002|Overall Study|Administrative reason by sponsor|1|||
94351948|NCT01218477|323069399|FG003|Overall Study|Administrative reason by sponsor|0|||
94351949|NCT01218477|323069396|FG000|Overall Study|Maximum clinical benefit|0|||
94351950|NCT01218477|323069397|FG001|Overall Study|Maximum clinical benefit|2|||
94351951|NCT01218477|323069398|FG002|Overall Study|Maximum clinical benefit|0|||
94351952|NCT01218477|323069399|FG003|Overall Study|Maximum clinical benefit|0|||
94351953|NCT02135848|323069400|FG000|Overall Study|Adverse Event|2|||
94351954|NCT02135848|323069401|FG001|Overall Study|Adverse Event|0|||
94454768|NCT01290679|323453199|FG001|Overall Study|Protocol Violation|1|||
94454769|NCT01290679|323453198|FG000|Overall Study|Withdrawal by Subject|6|||
94454770|NCT01290679|323453199|FG001|Overall Study|Withdrawal by Subject|5|||
94454771|NCT01290679|323453198|FG000|Overall Study|Subject Entered Another Trial|0|||
94454772|NCT01290679|323453199|FG001|Overall Study|Subject Entered Another Trial|5|||
94454773|NCT01598090|323453200|FG000|Treatment Period|Poor/non-compliance|0|||
94454774|NCT01598090|323453201|FG001|Treatment Period|Poor/non-compliance|2|||
94454775|NCT01598090|323453202|FG002|Treatment Period|Poor/non-compliance|0|||
94454776|NCT01598090|323453200|FG000|Treatment Period|No longer meet study criteria|0|||
94454777|NCT01598090|323453201|FG001|Treatment Period|No longer meet study criteria|1|||
94658977|NCT00898677|324206258|FG000|Overall Study|Not Treated: Protocol Violation|2|||
94351955|NCT02135848|323069400|FG000|Overall Study|Withdrawal by Subject|1|||
94351956|NCT02135848|323069401|FG001|Overall Study|Withdrawal by Subject|1|||
94351957|NCT00265382|323069406|FG000|Overall Study|Adverse Event|21|||
94351958|NCT00265382|323069406|FG000|Overall Study|Laboratory Abnormality|1|||
94351959|NCT00265382|323069406|FG000|Overall Study|Lost to Follow-up|3|||
94454778|NCT01598090|323453202|FG002|Treatment Period|No longer meet study criteria|0|||
94454779|NCT01598090|323453200|FG000|Treatment Period|Lack of Efficacy|5|||
94454780|NCT01598090|323453201|FG001|Treatment Period|Lack of Efficacy|14|||
94454781|NCT01598090|323453202|FG002|Treatment Period|Lack of Efficacy|6|||
94454782|NCT01598090|323453200|FG000|Treatment Period|Adverse Event|2|||
94454783|NCT01598090|323453201|FG001|Treatment Period|Adverse Event|33|||
94454784|NCT01598090|323453202|FG002|Treatment Period|Adverse Event|17|||
94454785|NCT01598090|323453200|FG000|Treatment Period|Other reasons|0|||
94454786|NCT01598090|323453201|FG001|Treatment Period|Other reasons|4|||
94454787|NCT01598090|323453202|FG002|Treatment Period|Other reasons|1|||
94454788|NCT01598090|323453200|FG000|Treatment Period|Withdrawal by Subject|3|||
94454789|NCT01598090|323453201|FG001|Treatment Period|Withdrawal by Subject|13|||
94454790|NCT01598090|323453202|FG002|Treatment Period|Withdrawal by Subject|10|||
94454791|NCT01598090|323453200|FG000|Treatment Period|Lost to Follow-up|1|||
94454792|NCT01598090|323453201|FG001|Treatment Period|Lost to Follow-up|5|||
94454793|NCT01598090|323453202|FG002|Treatment Period|Lost to Follow-up|1|||
94454794|NCT01598090|323453200|FG000|Follow-up Period|Death|0|||
94454795|NCT01598090|323453201|FG001|Follow-up Period|Death|1|||
94454796|NCT01598090|323453202|FG002|Follow-up Period|Death|0|||
94454797|NCT01598090|323453200|FG000|Follow-up Period|No longer required per protocol|1|||
94454798|NCT01598090|323453201|FG001|Follow-up Period|No longer required per protocol|3|||
94454799|NCT01598090|323453202|FG002|Follow-up Period|No longer required per protocol|2|||
94454800|NCT01598090|323453200|FG000|Follow-up Period|Not reported|0|||
94454801|NCT01598090|323453201|FG001|Follow-up Period|Not reported|10|||
94454802|NCT01598090|323453202|FG002|Follow-up Period|Not reported|4|||
94454803|NCT01598090|323453200|FG000|Follow-up Period|Withdrawal by Subject|0|||
94454804|NCT01598090|323453201|FG001|Follow-up Period|Withdrawal by Subject|3|||
94454805|NCT01598090|323453202|FG002|Follow-up Period|Withdrawal by Subject|2|||
94454806|NCT01598090|323453200|FG000|Follow-up Period|Other reasons|2|||
94454807|NCT01598090|323453201|FG001|Follow-up Period|Other reasons|8|||
94454808|NCT01598090|323453202|FG002|Follow-up Period|Other reasons|8|||
94454809|NCT01598090|323453200|FG000|Follow-up Period|Lost to Follow-up|2|||
94454810|NCT01598090|323453201|FG001|Follow-up Period|Lost to Follow-up|10|||
94454811|NCT01598090|323453202|FG002|Follow-up Period|Lost to Follow-up|12|||
94454812|NCT01855243|323453203|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
94454813|NCT01855243|323453204|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
94454814|NCT01855243|323453205|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
94454815|NCT03615144|323453206|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
94454816|NCT03615144|323453207|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
94454817|NCT02587598|323453212|FG000|Overall Study|Death|4|||
94454818|NCT02587598|323453213|FG001|Overall Study|Death|8|||
94351960|NCT00265382|323069406|FG000|Overall Study|Lack of Efficacy|6|||
94351961|NCT00265382|323069406|FG000|Overall Study|Miscellaneous|6|||
94351962|NCT00265382|323069406|FG000|Overall Study|Withdrawal by Subject|13|||
94351963|NCT00265382|323069406|FG000|Overall Study|Study terminated by sponsor|94|||
94351964|NCT00265382|323069406|FG000|Overall Study|Death|1|||
94351965|NCT00537810|323069407|FG000|Overall Study|Withdrawal by Subject|4|||
94351966|NCT00537810|323069408|FG001|Overall Study|Withdrawal by Subject|11|||
94351967|NCT00537810|323069409|FG002|Overall Study|Withdrawal by Subject|4|||
94351968|NCT00537810|323069410|FG003|Overall Study|Withdrawal by Subject|3|||
94351969|NCT00537810|323069407|FG000|Overall Study|Medically withdrawn|2|||
94351970|NCT00537810|323069408|FG001|Overall Study|Medically withdrawn|2|||
94351971|NCT00537810|323069409|FG002|Overall Study|Medically withdrawn|0|||
94351972|NCT00537810|323069410|FG003|Overall Study|Medically withdrawn|1|||
94351973|NCT01997333|323069411|FG000|Randomization and Treatment|Disease Progression|70|||
94351974|NCT01997333|323069412|FG001|Randomization and Treatment|Disease Progression|159|||
94454819|NCT02587598|323453214|FG002|Overall Study|Death|4|||
94454820|NCT02587598|323453215|FG003|Overall Study|Death|16|||
94454821|NCT02587598|323453216|FG004|Overall Study|Death|9|||
94454822|NCT02587598|323453217|FG005|Overall Study|Death|4|||
94454823|NCT02587598|323453218|FG006|Overall Study|Death|6|||
94454824|NCT02587598|323453219|FG007|Overall Study|Death|7|||
94582176|NCT00687193|323931821|FG002|Overall Study|Adverse Event|2|||
94582177|NCT00687193|323931822|FG003|Overall Study|Adverse Event|3|||
94582178|NCT00687193|323931823|FG004|Overall Study|Adverse Event|0|||
94582179|NCT00687193|323931824|FG005|Overall Study|Adverse Event|2|||
94582180|NCT00687193|323931819|FG000|Overall Study|Lack of Efficacy|1|||
94582181|NCT00687193|323931820|FG001|Overall Study|Lack of Efficacy|1|||
94582182|NCT00687193|323931821|FG002|Overall Study|Lack of Efficacy|0|||
94351975|NCT01997333|323069411|FG000|Randomization and Treatment|Adverse Event|10|||
94582183|NCT00687193|323931822|FG003|Overall Study|Lack of Efficacy|0|||
94351976|NCT01997333|323069412|FG001|Randomization and Treatment|Adverse Event|32|||
94351977|NCT01997333|323069411|FG000|Randomization and Treatment|Physician Decision|0|||
94351978|NCT01997333|323069412|FG001|Randomization and Treatment|Physician Decision|4|||
94351979|NCT01997333|323069411|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
94351980|NCT01997333|323069412|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
94351981|NCT01997333|323069411|FG000|Randomization and Treatment|Did not receive treatment|17|||
94351982|NCT01997333|323069412|FG001|Randomization and Treatment|Did not receive treatment|5|||
94351983|NCT01997333|323069411|FG000|Survival Follow up|Withdrawal by Subject|15|||
94351984|NCT01997333|323069412|FG001|Survival Follow up|Withdrawal by Subject|6|||
94351985|NCT01997333|323069411|FG000|Survival Follow up|Lost to Follow-up|0|||
94351986|NCT01997333|323069412|FG001|Survival Follow up|Lost to Follow-up|6|||
94351987|NCT01997333|323069411|FG000|Survival Follow up|Various|1|||
94351988|NCT01997333|323069412|FG001|Survival Follow up|Various|2|||
94351989|NCT03137173|323069413|FG000|Overall Study|Withdrawal by Subject|8|||
94351990|NCT03137173|323069414|FG001|Overall Study|Withdrawal by Subject|13|||
94351991|NCT03137173|323069413|FG000|Overall Study|Death|1|||
94351992|NCT03137173|323069414|FG001|Overall Study|Death|3|||
94351993|NCT03137173|323069413|FG000|Overall Study|Physician Decision|1|||
94351994|NCT03137173|323069414|FG001|Overall Study|Physician Decision|0|||
94351995|NCT03137173|323069413|FG000|Overall Study|Lost to Follow-up|13|||
94351996|NCT03137173|323069414|FG001|Overall Study|Lost to Follow-up|18|||
94351997|NCT03137173|323069413|FG000|Overall Study|Other reasons|3|||
94351998|NCT03137173|323069414|FG001|Overall Study|Other reasons|2|||
94351999|NCT00426842|323069415|FG000|Overall Study|Lost to Follow-up|1|||
94352000|NCT00819052|323069416|FG000|Overall Study|Adverse Event|0|||
94352001|NCT00819052|323069417|FG001|Overall Study|Adverse Event|5|||
94352002|NCT00819052|323069416|FG000|Overall Study|Protocol Violation|1|||
94352003|NCT00819052|323069417|FG001|Overall Study|Protocol Violation|2|||
94352004|NCT00819052|323069416|FG000|Overall Study|Lost to Follow-up|1|||
94352005|NCT00819052|323069417|FG001|Overall Study|Lost to Follow-up|2|||
94352006|NCT00819052|323069416|FG000|Overall Study|Withdrawal by Subject|1|||
94352007|NCT00819052|323069417|FG001|Overall Study|Withdrawal by Subject|2|||
94352008|NCT00819052|323069416|FG000|Overall Study|Lack of Efficacy|1|||
94352009|NCT00819052|323069417|FG001|Overall Study|Lack of Efficacy|1|||
94352010|NCT00819052|323069416|FG000|Overall Study|Pregnancy|1|||
94352011|NCT00819052|323069417|FG001|Overall Study|Pregnancy|2|||
94352012|NCT00819052|323069416|FG000|Overall Study|Death or events leading to death|1|||
94352013|NCT00819052|323069417|FG001|Overall Study|Death or events leading to death|0|||
94352014|NCT00643851|323069420|FG000|Overall Study|Death|0|||
94352015|NCT00643851|323069421|FG001|Overall Study|Death|1|||
94352016|NCT00643851|323069422|FG002|Overall Study|Death|0|||
94352017|NCT00643851|323069420|FG000|Overall Study|Lack of Efficacy|0|||
94352018|NCT00643851|323069421|FG001|Overall Study|Lack of Efficacy|1|||
94352019|NCT00643851|323069422|FG002|Overall Study|Lack of Efficacy|0|||
94352020|NCT00643851|323069420|FG000|Overall Study|Adverse Event|2|||
94352021|NCT00643851|323069421|FG001|Overall Study|Adverse Event|6|||
94352022|NCT00643851|323069422|FG002|Overall Study|Adverse Event|6|||
94352023|NCT00643851|323069420|FG000|Overall Study|Lost to Follow-up|4|||
94352024|NCT00643851|323069421|FG001|Overall Study|Lost to Follow-up|6|||
94352025|NCT00643851|323069422|FG002|Overall Study|Lost to Follow-up|9|||
94352026|NCT00643851|323069420|FG000|Overall Study|Withdrawal by Subject|8|||
94352027|NCT00643851|323069421|FG001|Overall Study|Withdrawal by Subject|15|||
94352028|NCT00643851|323069422|FG002|Overall Study|Withdrawal by Subject|9|||
94352029|NCT00643851|323069420|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
94352030|NCT00643851|323069421|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
94352031|NCT00643851|323069422|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
94352032|NCT00842829|323069427|FG000|Dose Titration Period|Adverse Event|11|||
94352033|NCT00842829|323069428|FG001|Dose Titration Period|Adverse Event|10|||
94352034|NCT00842829|323069429|FG002|Dose Titration Period|Adverse Event|0|||
94352035|NCT00842829|323069427|FG000|Dose Titration Period|Lack of Efficacy|4|||
94352036|NCT00842829|323069428|FG001|Dose Titration Period|Lack of Efficacy|1|||
94352037|NCT00842829|323069429|FG002|Dose Titration Period|Lack of Efficacy|0|||
94352038|NCT00842829|323069427|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
94352039|NCT00842829|323069428|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
94352040|NCT00842829|323069429|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
94352041|NCT00842829|323069427|FG000|Dose Titration Period|Withdrawal by Subject|2|||
94352042|NCT00842829|323069428|FG001|Dose Titration Period|Withdrawal by Subject|6|||
94352043|NCT00842829|323069429|FG002|Dose Titration Period|Withdrawal by Subject|0|||
94352044|NCT00842829|323069427|FG000|Dose Titration Period|Other|5|||
94352045|NCT00842829|323069428|FG001|Dose Titration Period|Other|4|||
94352046|NCT00842829|323069429|FG002|Dose Titration Period|Other|0|||
94352047|NCT00842829|323069427|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
94352048|NCT00842829|323069428|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
94352049|NCT00842829|323069429|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
94454825|NCT02587598|323453220|FG008|Overall Study|Death|9|||
94454826|NCT02587598|323453221|FG009|Overall Study|Death|1|||
94454827|NCT02587598|323453222|FG010|Overall Study|Death|3|||
94454828|NCT02587598|323453212|FG000|Overall Study|Study Terminated by the Sponsor|0|||
94454829|NCT02587598|323453213|FG001|Overall Study|Study Terminated by the Sponsor|1|||
94454830|NCT02587598|323453214|FG002|Overall Study|Study Terminated by the Sponsor|0|||
94454831|NCT02587598|323453215|FG003|Overall Study|Study Terminated by the Sponsor|3|||
94454832|NCT02587598|323453216|FG004|Overall Study|Study Terminated by the Sponsor|0|||
94454833|NCT02587598|323453217|FG005|Overall Study|Study Terminated by the Sponsor|1|||
94352050|NCT00842829|323069427|FG000|Dose Titration Period|Non-compliance to study drug|2|||
94352051|NCT00842829|323069428|FG001|Dose Titration Period|Non-compliance to study drug|1|||
94352052|NCT00842829|323069429|FG002|Dose Titration Period|Non-compliance to study drug|0|||
94352053|NCT00842829|323069427|FG000|Treatment Period|Adverse Event|0|||
94352054|NCT00842829|323069428|FG001|Treatment Period|Adverse Event|0|||
94352055|NCT00842829|323069429|FG002|Treatment Period|Adverse Event|15|||
94352056|NCT00842829|323069427|FG000|Treatment Period|Lack of Efficacy|0|||
94352057|NCT00842829|323069428|FG001|Treatment Period|Lack of Efficacy|0|||
94352058|NCT00842829|323069429|FG002|Treatment Period|Lack of Efficacy|6|||
94352059|NCT00842829|323069427|FG000|Treatment Period|Unstable persistent cancer pain|0|||
94352060|NCT00842829|323069428|FG001|Treatment Period|Unstable persistent cancer pain|0|||
94352061|NCT00842829|323069429|FG002|Treatment Period|Unstable persistent cancer pain|5|||
94352062|NCT00842829|323069427|FG000|Treatment Period|Withdrawal by Subject|0|||
94352063|NCT00842829|323069428|FG001|Treatment Period|Withdrawal by Subject|0|||
94454834|NCT02587598|323453218|FG006|Overall Study|Study Terminated by the Sponsor|0|||
94454835|NCT02587598|323453219|FG007|Overall Study|Study Terminated by the Sponsor|0|||
94454836|NCT02587598|323453220|FG008|Overall Study|Study Terminated by the Sponsor|0|||
94454837|NCT02587598|323453221|FG009|Overall Study|Study Terminated by the Sponsor|1|||
94454838|NCT02587598|323453222|FG010|Overall Study|Study Terminated by the Sponsor|6|||
94352064|NCT00842829|323069429|FG002|Treatment Period|Withdrawal by Subject|11|||
94352065|NCT00842829|323069427|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
94454839|NCT02587598|323453212|FG000|Overall Study|Reason for study withdrawal not specified|0|||
94454840|NCT02587598|323453213|FG001|Overall Study|Reason for study withdrawal not specified|1|||
94454841|NCT02587598|323453214|FG002|Overall Study|Reason for study withdrawal not specified|0|||
94454842|NCT02587598|323453215|FG003|Overall Study|Reason for study withdrawal not specified|0|||
94454843|NCT02587598|323453216|FG004|Overall Study|Reason for study withdrawal not specified|0|||
94454844|NCT02587598|323453217|FG005|Overall Study|Reason for study withdrawal not specified|0|||
94454845|NCT02587598|323453218|FG006|Overall Study|Reason for study withdrawal not specified|0|||
94454846|NCT02587598|323453219|FG007|Overall Study|Reason for study withdrawal not specified|0|||
94454847|NCT02587598|323453220|FG008|Overall Study|Reason for study withdrawal not specified|0|||
94454848|NCT02587598|323453221|FG009|Overall Study|Reason for study withdrawal not specified|0|||
94454849|NCT02587598|323453222|FG010|Overall Study|Reason for study withdrawal not specified|0|||
94454850|NCT02587598|323453212|FG000|Overall Study|Withdrawal by Subject|0|||
94454851|NCT02587598|323453213|FG001|Overall Study|Withdrawal by Subject|1|||
94454852|NCT02587598|323453214|FG002|Overall Study|Withdrawal by Subject|0|||
94454853|NCT02587598|323453215|FG003|Overall Study|Withdrawal by Subject|2|||
94454854|NCT02587598|323453216|FG004|Overall Study|Withdrawal by Subject|3|||
94454855|NCT02587598|323453217|FG005|Overall Study|Withdrawal by Subject|1|||
94454856|NCT02587598|323453218|FG006|Overall Study|Withdrawal by Subject|0|||
94454857|NCT02587598|323453219|FG007|Overall Study|Withdrawal by Subject|0|||
94454858|NCT02587598|323453220|FG008|Overall Study|Withdrawal by Subject|0|||
94454859|NCT02587598|323453221|FG009|Overall Study|Withdrawal by Subject|1|||
94454860|NCT02587598|323453222|FG010|Overall Study|Withdrawal by Subject|2|||
94454861|NCT02587598|323453212|FG000|Overall Study|Physician Decision|0|||
94454862|NCT02587598|323453213|FG001|Overall Study|Physician Decision|0|||
94454863|NCT02587598|323453214|FG002|Overall Study|Physician Decision|0|||
94454864|NCT02587598|323453215|FG003|Overall Study|Physician Decision|0|||
94454865|NCT02587598|323453216|FG004|Overall Study|Physician Decision|0|||
94454866|NCT02587598|323453217|FG005|Overall Study|Physician Decision|0|||
94454867|NCT02587598|323453218|FG006|Overall Study|Physician Decision|0|||
94454868|NCT02587598|323453219|FG007|Overall Study|Physician Decision|0|||
94454869|NCT02587598|323453220|FG008|Overall Study|Physician Decision|0|||
94454870|NCT02587598|323453221|FG009|Overall Study|Physician Decision|0|||
94352066|NCT00842829|323069428|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
94352067|NCT00842829|323069429|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
94352068|NCT00842829|323069427|FG000|Treatment Period|Protocol Violation|0|||
94454871|NCT02587598|323453222|FG010|Overall Study|Physician Decision|3|||
94454872|NCT01704651|323453225|FG000|Overall Study|Pre-op withdrawal by subject|1|||
94454873|NCT01704651|323453226|FG001|Overall Study|Pre-op withdrawal by subject|1|||
94454874|NCT01704651|323453225|FG000|Overall Study|Pre-op change in treatment plan|1|||
94454875|NCT01704651|323453226|FG001|Overall Study|Pre-op change in treatment plan|4|||
94454876|NCT01704651|323453225|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
94454877|NCT01704651|323453226|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
94454878|NCT01704651|323453225|FG000|Overall Study|Post-op did not have laparotomy|2|||
94352069|NCT00842829|323069428|FG001|Treatment Period|Protocol Violation|0|||
94454879|NCT01704651|323453226|FG001|Overall Study|Post-op did not have laparotomy|1|||
94454880|NCT03514485|323453231|FG000|Overall Study|Lost to Follow-up|5|||
94454881|NCT03514485|323453232|FG001|Overall Study|Lost to Follow-up|3|||
94454882|NCT03514485|323453233|FG002|Overall Study|Lost to Follow-up|2|||
94454883|NCT03514485|323453234|FG003|Overall Study|Lost to Follow-up|0|||
94454884|NCT03514485|323453235|FG004|Overall Study|Lost to Follow-up|1|||
94454885|NCT03514485|323453236|FG005|Overall Study|Lost to Follow-up|4|||
94454886|NCT03514485|323453231|FG000|Overall Study|Withdrawal by Subject|0|||
94352070|NCT00842829|323069429|FG002|Treatment Period|Protocol Violation|2|||
94454887|NCT03514485|323453232|FG001|Overall Study|Withdrawal by Subject|1|||
94454888|NCT03514485|323453233|FG002|Overall Study|Withdrawal by Subject|3|||
94454889|NCT03514485|323453234|FG003|Overall Study|Withdrawal by Subject|1|||
94454890|NCT03514485|323453235|FG004|Overall Study|Withdrawal by Subject|2|||
94454891|NCT03514485|323453236|FG005|Overall Study|Withdrawal by Subject|1|||
94454892|NCT03075891|323453244|FG000|Overall Study|Withdrawal by Subject|3|||
94454893|NCT03075891|323453245|FG001|Overall Study|Withdrawal by Subject|6|||
94454894|NCT03075891|323453244|FG000|Overall Study|Lost to Follow-up|1|||
94454895|NCT03075891|323453245|FG001|Overall Study|Lost to Follow-up|0|||
94454896|NCT03075891|323453244|FG000|Overall Study|Pregnancy|3|||
94454897|NCT03075891|323453245|FG001|Overall Study|Pregnancy|1|||
94454898|NCT03075891|323453244|FG000|Overall Study|visits not performed (no time)|1|||
94454899|NCT03075891|323453245|FG001|Overall Study|visits not performed (no time)|0|||
94454900|NCT03075891|323453244|FG000|Overall Study|Drug abuse relapse issue|0|||
94454901|NCT03075891|323453245|FG001|Overall Study|Drug abuse relapse issue|1|||
94454902|NCT03075891|323453244|FG000|Overall Study|Participant requiring study withdrawal|0|||
94454903|NCT03075891|323453245|FG001|Overall Study|Participant requiring study withdrawal|1|||
94454904|NCT03075891|323453244|FG000|Overall Study|Adverse event, non-fatal|1|||
94454905|NCT03075891|323453245|FG001|Overall Study|Adverse event, non-fatal|4|||
94454906|NCT00791661|323453246|FG000|7 Day Wash-out|Adverse Event|0|||
94454907|NCT00791661|323453247|FG001|7 Day Wash-out|Adverse Event|0|||
94454908|NCT00791661|323453248|FG002|7 Day Wash-out|Adverse Event|1|||
94454909|NCT00791661|323453246|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
94454910|NCT00791661|323453247|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
94454911|NCT00791661|323453248|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
94454912|NCT01878084|323453249|FG000|Overall Study|Physician Decision|2|||
94454913|NCT04143594|323453250|FG000|Overall Study|Withdrew consent|3|||
94454914|NCT04143594|323453251|FG001|Overall Study|Withdrew consent|10|||
94454915|NCT04143594|323453252|FG002|Overall Study|Withdrew consent|3|||
94454916|NCT04143594|323453253|FG003|Overall Study|Withdrew consent|1|||
94454917|NCT04143594|323453250|FG000|Overall Study|Lost to Follow-up|3|||
94454918|NCT04143594|323453251|FG001|Overall Study|Lost to Follow-up|5|||
94454919|NCT04143594|323453252|FG002|Overall Study|Lost to Follow-up|11|||
94454920|NCT04143594|323453253|FG003|Overall Study|Lost to Follow-up|0|||
94454921|NCT04143594|323453250|FG000|Overall Study|Investigator's discretion|2|||
94454922|NCT04143594|323453251|FG001|Overall Study|Investigator's discretion|2|||
94454923|NCT04143594|323453252|FG002|Overall Study|Investigator's discretion|0|||
94454924|NCT04143594|323453253|FG003|Overall Study|Investigator's discretion|0|||
94454925|NCT04143594|323453250|FG000|Overall Study|Randomized but never treated|0|||
94454926|NCT04143594|323453251|FG001|Overall Study|Randomized but never treated|0|||
94454927|NCT04143594|323453252|FG002|Overall Study|Randomized but never treated|0|||
94454928|NCT04143594|323453253|FG003|Overall Study|Randomized but never treated|1|||
94454929|NCT04143594|323453250|FG000|Overall Study|Death|1|||
94454930|NCT04143594|323453251|FG001|Overall Study|Death|0|||
94454931|NCT04143594|323453252|FG002|Overall Study|Death|1|||
94454932|NCT04143594|323453253|FG003|Overall Study|Death|0|||
94454933|NCT04143594|323453250|FG000|Overall Study|Adverse Event|1|||
94352071|NCT00842829|323069427|FG000|Treatment Period|Other|0|||
94352072|NCT00842829|323069428|FG001|Treatment Period|Other|0|||
94352073|NCT00842829|323069429|FG002|Treatment Period|Other|18|||
94352074|NCT00842829|323069427|FG000|Treatment Period|Non-compliance to study procedures|0|||
94352075|NCT00842829|323069428|FG001|Treatment Period|Non-compliance to study procedures|0|||
94352076|NCT00842829|323069429|FG002|Treatment Period|Non-compliance to study procedures|4|||
94352077|NCT00842829|323069427|FG000|Treatment Period|Unclear completion status|0|||
94454934|NCT04143594|323453251|FG001|Overall Study|Adverse Event|0|||
94454935|NCT04143594|323453252|FG002|Overall Study|Adverse Event|0|||
94454936|NCT04143594|323453253|FG003|Overall Study|Adverse Event|0|||
94454937|NCT04143594|323453250|FG000|Overall Study|Pregnancy|0|||
94454938|NCT04143594|323453251|FG001|Overall Study|Pregnancy|0|||
94454939|NCT04143594|323453252|FG002|Overall Study|Pregnancy|1|||
94454940|NCT04143594|323453253|FG003|Overall Study|Pregnancy|0|||
94454941|NCT04143594|323453250|FG000|Overall Study|Lack of Efficacy|1|||
94352078|NCT00842829|323069428|FG001|Treatment Period|Unclear completion status|0|||
94454942|NCT04143594|323453251|FG001|Overall Study|Lack of Efficacy|1|||
94454943|NCT04143594|323453252|FG002|Overall Study|Lack of Efficacy|0|||
94454944|NCT04143594|323453253|FG003|Overall Study|Lack of Efficacy|0|||
94454945|NCT02387957|323453256|FG000|Overall Study|The study was discontinued|21|||
94454946|NCT02387957|323453257|FG001|Overall Study|The study was discontinued|21|||
94454947|NCT02387957|323453258|FG002|Overall Study|The study was discontinued|20|||
94454948|NCT00675428|323453261|FG000|Overall Study|Disease Progression|2|||
94454949|NCT00675428|323453262|FG001|Overall Study|Disease Progression|2|||
94454950|NCT00675428|323453261|FG000|Overall Study|No Disease Response After Cycle 6|0|||
94454951|NCT00675428|323453262|FG001|Overall Study|No Disease Response After Cycle 6|1|||
94454952|NCT00675428|323453261|FG000|Overall Study|Physician Decision|1|||
94454953|NCT00675428|323453262|FG001|Overall Study|Physician Decision|0|||
94454954|NCT02107859|323453267|FG000|Overall Study|Withdrawal by Subject|14|||
94454955|NCT02107859|323453267|FG000|Overall Study|Adverse Event|3|||
94454956|NCT02107859|323453267|FG000|Overall Study|Study closure|41|||
94454957|NCT02107859|323453267|FG000|Overall Study|Other than specified|3|||
94454958|NCT00135512|323453268|FG000|Overall Study|Adverse Event|56|||
94454959|NCT00135512|323453268|FG000|Overall Study|Lack of Efficacy|25|||
94454960|NCT00135512|323453268|FG000|Overall Study|Other|42|||
94454961|NCT00586820|323453269|FG000|Overall Study|Unsuccessful PCI|1|||
94454962|NCT00586820|323453270|FG001|Overall Study|Unsuccessful PCI|0|||
94454963|NCT02702388|323453271|FG000|Overall Study|Disease Progression|18|||
94454964|NCT02702388|323453272|FG001|Overall Study|Disease Progression|25|||
94454965|NCT02702388|323453271|FG000|Overall Study|Withdrawal by Subject|9|||
94454966|NCT02702388|323453272|FG001|Overall Study|Withdrawal by Subject|7|||
94454967|NCT02702388|323453271|FG000|Overall Study|Adverse Event|11|||
94454968|NCT02702388|323453272|FG001|Overall Study|Adverse Event|15|||
94454969|NCT02702388|323453271|FG000|Overall Study|Other|2|||
94454970|NCT02702388|323453272|FG001|Overall Study|Other|4|||
94454971|NCT05367973|323453277|FG000|Overall Study|Adverse Event|0|||
94454972|NCT05367973|323453278|FG001|Overall Study|Adverse Event|2|||
94454973|NCT04687072|323453279|FG000|Overall Study|Adverse Event|2|||
94454974|NCT04687072|323453280|FG001|Overall Study|Adverse Event|0|||
94454975|NCT04687072|323453279|FG000|Overall Study|Death|1|||
94454976|NCT04687072|323453280|FG001|Overall Study|Death|0|||
94454977|NCT04687072|323453279|FG000|Overall Study|Lack of Efficacy|2|||
94454978|NCT04687072|323453280|FG001|Overall Study|Lack of Efficacy|1|||
94454979|NCT04687072|323453279|FG000|Overall Study|Physician Decision|1|||
94454980|NCT04687072|323453280|FG001|Overall Study|Physician Decision|0|||
94454981|NCT04687072|323453279|FG000|Overall Study|Pregnancy|1|||
94454982|NCT04687072|323453280|FG001|Overall Study|Pregnancy|0|||
94454983|NCT04687072|323453279|FG000|Overall Study|Requires Prohibited Medication|2|||
94454984|NCT04687072|323453280|FG001|Overall Study|Requires Prohibited Medication|0|||
94454985|NCT04687072|323453279|FG000|Overall Study|Withdrawal of Consent|11|||
94454986|NCT04687072|323453280|FG001|Overall Study|Withdrawal of Consent|6|||
94454987|NCT04687072|323453279|FG000|Overall Study|Miscellaneous|4|||
94454988|NCT04687072|323453280|FG001|Overall Study|Miscellaneous|1|||
94454989|NCT01672710|323453281|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
94454990|NCT01672710|323453282|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
94454991|NCT01672710|323453281|FG000|3 Month Follow up|Lost to Follow-up|2|||
94454992|NCT01672710|323453282|FG001|3 Month Follow up|Lost to Follow-up|3|||
94454993|NCT01672710|323453281|FG000|3 Month Follow up|follow up due after termination date|4|||
94454994|NCT01672710|323453282|FG001|3 Month Follow up|follow up due after termination date|1|||
94454995|NCT01294696|323453284|FG000|Overall Study|Screening failures|7|||
94454996|NCT01294696|323453284|FG000|Overall Study|Protocol Violation|8|||
94454997|NCT01294696|323453284|FG000|Overall Study|Missing BPI Response|7|||
94454998|NCT01294696|323453284|FG000|Overall Study|Site closure|52|||
94658978|NCT00898677|324206259|FG001|Overall Study|Not Treated: Protocol Violation|0|||
94658979|NCT00898677|324206260|FG002|Overall Study|Not Treated: Protocol Violation|2|||
94454999|NCT00378508|323454648|FG000|Overall Study|Withdrawal by Subject|1|||
94658980|NCT00898677|324206261|FG003|Overall Study|Not Treated: Protocol Violation|0|||
94658981|NCT00898677|324206258|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
94455000|NCT00378508|323454649|FG001|Overall Study|Withdrawal by Subject|3|||
94455001|NCT00378508|323454648|FG000|Overall Study|Lost to Follow-up|1|||
94455002|NCT00378508|323454649|FG001|Overall Study|Lost to Follow-up|0|||
94455003|NCT00734162|323454650|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
94455004|NCT00734162|323454651|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
94455005|NCT00734162|323454652|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
94455006|NCT00734162|323454653|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
94455007|NCT00734162|323454650|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
94455008|NCT00734162|323454651|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
94455009|NCT00734162|323454652|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
94455010|NCT00734162|323454653|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
94455011|NCT00734162|323454650|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
94455012|NCT00734162|323454651|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
94455013|NCT00734162|323454652|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
94455014|NCT00734162|323454653|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
94455015|NCT00734162|323454650|FG000|Open-Label Phase|Withdrew Consent|1|||
94455016|NCT00734162|323454651|FG001|Open-Label Phase|Withdrew Consent|0|||
94455017|NCT00734162|323454652|FG002|Open-Label Phase|Withdrew Consent|1|||
94455018|NCT00734162|323454653|FG003|Open-Label Phase|Withdrew Consent|1|||
94455019|NCT00734162|323454650|FG000|Open-Label Phase|Lost to Follow-up|1|||
94455020|NCT00734162|323454651|FG001|Open-Label Phase|Lost to Follow-up|2|||
94455021|NCT00734162|323454652|FG002|Open-Label Phase|Lost to Follow-up|0|||
94455022|NCT00734162|323454653|FG003|Open-Label Phase|Lost to Follow-up|1|||
94455023|NCT00734162|323454650|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
94455024|NCT00734162|323454651|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
94455025|NCT00734162|323454652|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
94455026|NCT00734162|323454653|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
94455027|NCT01841762|323454655|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
94455028|NCT01841762|323454655|FG000|Treatment Period|Adverse Event|16|||
94455029|NCT01841762|323454655|FG000|Treatment Period|Death|1|||
94455030|NCT01841762|323454655|FG000|Treatment Period|Withdrawal by Subject|7|||
94455031|NCT01841762|323454655|FG000|Treatment Period|Lost to Follow-up|1|||
94455032|NCT01841762|323454655|FG000|Treatment Period|Physician Decision|2|||
94455033|NCT01841762|323454655|FG000|Treatment Period|Other, including non-compliance|5|||
94455034|NCT01841762|323454655|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
94455035|NCT01841762|323454655|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
94455036|NCT01841762|323454655|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
94455037|NCT01841762|323454655|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
94455038|NCT03981900|323454659|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
94455039|NCT03981900|323454659|FG000|Overall Study|Adverse Event|5|||
94455040|NCT03981900|323454659|FG000|Overall Study|Protocol Violation|1|||
94455041|NCT03981900|323454659|FG000|Overall Study|Withdrawal by Subject|7|||
94455042|NCT03981900|323454659|FG000|Overall Study|Lost to Follow-up|46|||
94455043|NCT03981900|323454659|FG000|Overall Study|Decision of the researcher|3|||
94455044|NCT03981900|323454659|FG000|Overall Study|Death|3|||
94455045|NCT03981900|323454659|FG000|Overall Study|Other|5|||
94455046|NCT02028767|323454667|FG000|Treatment Period 2|Non compliant with protocol|1|||
94455047|NCT02028767|323454668|FG001|Treatment Period 2|Non compliant with protocol|0|||
94455048|NCT02028767|323454667|FG000|Treatment Period 2|Reason other than those specified above|1|||
94455049|NCT02028767|323454668|FG001|Treatment Period 2|Reason other than those specified above|0|||
94455050|NCT04292912|323454675|FG000|Overall Study|Physician Decision|1|||
94352079|NCT00842829|323069429|FG002|Treatment Period|Unclear completion status|1|||
94352080|NCT00842829|323069427|FG000|Continuation Period|Adverse Event|0|||
94352081|NCT00842829|323069428|FG001|Continuation Period|Adverse Event|0|||
94352082|NCT00842829|323069429|FG002|Continuation Period|Adverse Event|32|||
94352083|NCT00842829|323069427|FG000|Continuation Period|Lack of Efficacy|0|||
94352084|NCT00842829|323069428|FG001|Continuation Period|Lack of Efficacy|0|||
94352085|NCT00842829|323069429|FG002|Continuation Period|Lack of Efficacy|6|||
94352086|NCT00842829|323069427|FG000|Continuation Period|Unstable persistent cancer pain|0|||
94352087|NCT00842829|323069428|FG001|Continuation Period|Unstable persistent cancer pain|0|||
94352088|NCT00842829|323069429|FG002|Continuation Period|Unstable persistent cancer pain|3|||
94352089|NCT00842829|323069427|FG000|Continuation Period|Withdrawal by Subject|0|||
94352090|NCT00842829|323069428|FG001|Continuation Period|Withdrawal by Subject|0|||
94455051|NCT04292912|323454675|FG000|Overall Study|Protocol Violation|6|||
94455052|NCT00231114|323454683|FG000|Randomized|Withdrawal by Subject|6|||
94455053|NCT00231114|323454684|FG001|Randomized|Withdrawal by Subject|3|||
94455054|NCT00231114|323454683|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
94455055|NCT00231114|323454684|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
94455056|NCT00231114|323454683|FG000|Post-Treatment Period|Lost to Follow-up|6|||
94455057|NCT00231114|323454684|FG001|Post-Treatment Period|Lost to Follow-up|1|||
94455058|NCT00231114|323454683|FG000|Post-Treatment Period|Physician Decision|1|||
94455059|NCT00231114|323454684|FG001|Post-Treatment Period|Physician Decision|0|||
94455060|NCT00231114|323454683|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
94352091|NCT00842829|323069429|FG002|Continuation Period|Withdrawal by Subject|10|||
94352092|NCT00842829|323069427|FG000|Continuation Period|Other|0|||
94455061|NCT00231114|323454684|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
94455062|NCT02703272|323454686|FG000|Overall Study|Death|4|||
94455063|NCT02703272|323454687|FG001|Overall Study|Death|9|||
94455064|NCT02703272|323454688|FG002|Overall Study|Death|19|||
94455065|NCT02703272|323454689|FG003|Overall Study|Death|10|||
94455066|NCT02703272|323454686|FG000|Overall Study|Withdrawal by Subject|0|||
94455067|NCT02703272|323454687|FG001|Overall Study|Withdrawal by Subject|0|||
94455068|NCT02703272|323454688|FG002|Overall Study|Withdrawal by Subject|4|||
94455069|NCT02703272|323454689|FG003|Overall Study|Withdrawal by Subject|2|||
94352093|NCT00842829|323069428|FG001|Continuation Period|Other|0|||
94352094|NCT00842829|323069429|FG002|Continuation Period|Other|7|||
94455070|NCT02703272|323454686|FG000|Overall Study|Study Terminated by Sponsor|6|||
94455071|NCT02703272|323454687|FG001|Overall Study|Study Terminated by Sponsor|1|||
94455072|NCT02703272|323454688|FG002|Overall Study|Study Terminated by Sponsor|12|||
94455073|NCT02703272|323454689|FG003|Overall Study|Study Terminated by Sponsor|4|||
94455074|NCT02703272|323454686|FG000|Overall Study|Other|1|||
94455075|NCT02703272|323454687|FG001|Overall Study|Other|0|||
94455076|NCT02703272|323454688|FG002|Overall Study|Other|0|||
94455077|NCT02703272|323454689|FG003|Overall Study|Other|0|||
94455078|NCT00712881|323454691|FG000|Overall Study|Adverse Event|3|||
94455079|NCT00712881|323454692|FG001|Overall Study|Adverse Event|3|||
94455080|NCT00712881|323454691|FG000|Overall Study|Withdrawal by Subject|1|||
94455081|NCT00712881|323454692|FG001|Overall Study|Withdrawal by Subject|1|||
94455082|NCT00712881|323454691|FG000|Overall Study|Disease Progression|2|||
94455083|NCT00712881|323454692|FG001|Overall Study|Disease Progression|1|||
94455084|NCT00712881|323454691|FG000|Overall Study|Lost to Follow-up|1|||
94455085|NCT00712881|323454692|FG001|Overall Study|Lost to Follow-up|1|||
94455086|NCT00712881|323454691|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
94455087|NCT00712881|323454692|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
94455088|NCT00712881|323454691|FG000|Overall Study|Protocol Violation|1|||
94455089|NCT00712881|323454692|FG001|Overall Study|Protocol Violation|1|||
94455090|NCT00712881|323454691|FG000|Overall Study|Randomized but not treated|1|||
94455091|NCT00712881|323454692|FG001|Overall Study|Randomized but not treated|0|||
94455092|NCT03200704|323454693|FG000|Overall Study|Withdrawal by Subject|1|||
94455093|NCT01194999|323454694|FG000|Overall Study|Lost to Follow-up|17|||
94455094|NCT00654875|323454695|FG000|Overall Study|Adverse Event|5|||
94455095|NCT00654875|323454696|FG001|Overall Study|Adverse Event|5|||
94455096|NCT00654875|323454695|FG000|Overall Study|Withdrawal by Subject|4|||
94455097|NCT00654875|323454696|FG001|Overall Study|Withdrawal by Subject|4|||
94455098|NCT00654875|323454695|FG000|Overall Study|Protocol Violation|3|||
94455099|NCT00654875|323454696|FG001|Overall Study|Protocol Violation|3|||
94352095|NCT00842829|323069427|FG000|Continuation Period|Non-compliance to study procedures|0|||
94352096|NCT00842829|323069428|FG001|Continuation Period|Non-compliance to study procedures|0|||
94352097|NCT00842829|323069429|FG002|Continuation Period|Non-compliance to study procedures|2|||
94352098|NCT00842829|323069427|FG000|Continuation Period|Non-compliance to study drug|0|||
94352099|NCT00842829|323069428|FG001|Continuation Period|Non-compliance to study drug|0|||
94352100|NCT00842829|323069429|FG002|Continuation Period|Non-compliance to study drug|1|||
94352101|NCT03590613|323069438|FG000|Period 2, 4 Days|Physician Decision|0|||
94352102|NCT03590613|323069439|FG001|Period 2, 4 Days|Physician Decision|0|||
94352103|NCT03590613|323069440|FG002|Period 2, 4 Days|Physician Decision|0|||
94352104|NCT03590613|323069441|FG003|Period 2, 4 Days|Physician Decision|1|||
94352105|NCT00280059|323069444|FG000|Efficacy Assessment Phase|Death|2|||
94352106|NCT00280059|323069445|FG001|Efficacy Assessment Phase|Death|0|||
94352107|NCT00280059|323069444|FG000|Efficacy Assessment Phase|Adverse Event|33|||
94352108|NCT00280059|323069445|FG001|Efficacy Assessment Phase|Adverse Event|31|||
94352109|NCT00280059|323069444|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
94455100|NCT00654875|323454695|FG000|Overall Study|Lack of Efficacy|2|||
94455101|NCT00654875|323454696|FG001|Overall Study|Lack of Efficacy|2|||
94455102|NCT00654875|323454695|FG000|Overall Study|Lost to Follow-up|1|||
94455103|NCT00654875|323454696|FG001|Overall Study|Lost to Follow-up|3|||
94455104|NCT00654875|323454695|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
94455105|NCT00654875|323454696|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
94455106|NCT00654875|323454695|FG000|Overall Study|Administrative Problems|1|||
94455107|NCT00654875|323454696|FG001|Overall Study|Administrative Problems|0|||
94455108|NCT01011465|323454697|FG000|Overall Study|Withdrawal by Subject|2|||
94455109|NCT01011465|323454698|FG001|Overall Study|Withdrawal by Subject|1|||
94455110|NCT01011465|323454699|FG002|Overall Study|Withdrawal by Subject|0|||
94455111|NCT01011465|323454700|FG003|Overall Study|Withdrawal by Subject|0|||
94455112|NCT01011465|323454701|FG004|Overall Study|Withdrawal by Subject|1|||
94455113|NCT01011465|323454702|FG005|Overall Study|Withdrawal by Subject|0|||
94455114|NCT01011465|323454703|FG006|Overall Study|Withdrawal by Subject|1|||
94455115|NCT01011465|323454704|FG007|Overall Study|Withdrawal by Subject|0|||
94455116|NCT00626821|323454706|FG000|Overall Study|Adverse Event|44|||
94455117|NCT00626821|323454706|FG000|Overall Study|Protocol Violation|33|||
94455118|NCT00626821|323454706|FG000|Overall Study|Withdrawal by Subject|10|||
94455119|NCT00626821|323454706|FG000|Overall Study|Physician Decision|9|||
94455120|NCT00626821|323454706|FG000|Overall Study|Product dysfunction|21|||
94455121|NCT00626821|323454706|FG000|Overall Study|other/unknown reason|104|||
94455122|NCT04720911|323454707|FG000|Overall Study|Withdrawal by Subject|0|||
94455123|NCT04720911|323454708|FG001|Overall Study|Withdrawal by Subject|1|||
94455124|NCT04720911|323454709|FG002|Overall Study|Withdrawal by Subject|0|||
94455125|NCT02632409|323454710|FG000|Randomized|AE unrelated to study Drug|0|||
94455126|NCT02632409|323454711|FG001|Randomized|AE unrelated to study Drug|1|||
94582184|NCT00687193|323931823|FG004|Overall Study|Lack of Efficacy|0|||
94352110|NCT00280059|323069445|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
94352111|NCT00280059|323069444|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
94455127|NCT02632409|323454710|FG000|Randomized|Participant withdrew consent|2|||
94658982|NCT00898677|324206259|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
94658983|NCT00898677|324206260|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
94658984|NCT00898677|324206261|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
94658985|NCT00898677|324206258|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
94658986|NCT00898677|324206259|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
94658987|NCT00898677|324206260|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
94658988|NCT00898677|324206261|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
94658989|NCT00898677|324206258|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
94658990|NCT00898677|324206259|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
94658991|NCT00898677|324206260|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
94658992|NCT00898677|324206261|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
94658993|NCT00898677|324206258|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
94658994|NCT00898677|324206259|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
94658995|NCT00898677|324206260|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
94658996|NCT00898677|324206261|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
94658997|NCT00898677|324206258|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
94658998|NCT00898677|324206259|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
94658999|NCT00898677|324206260|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
94659000|NCT00898677|324206261|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
94659001|NCT00898677|324206258|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
94659002|NCT00898677|324206259|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
94659003|NCT00898677|324206260|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
94659004|NCT00898677|324206261|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
94659005|NCT00898677|324206258|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
94659006|NCT00898677|324206259|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
94659007|NCT00898677|324206260|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
94659008|NCT00898677|324206261|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
94659009|NCT02663817|324206271|FG000|Overall Study|Screen failure|2|||
94659010|NCT03136068|324207942|FG000|Overall Study|Lost to Follow-up|1|||
94659011|NCT03136068|324207943|FG001|Overall Study|Lost to Follow-up|1|||
94659012|NCT03136068|324207942|FG000|Overall Study|Protocol Violation|1|||
94659013|NCT03136068|324207943|FG001|Overall Study|Protocol Violation|0|||
94659014|NCT00432380|324207949|FG000|Overall Study|Migrated/moved from study area|3|||
94659015|NCT00432380|324207950|FG001|Overall Study|Migrated/moved from study area|4|||
94659016|NCT00432380|324207951|FG002|Overall Study|Migrated/moved from study area|1|||
94659017|NCT00432380|324207949|FG000|Overall Study|Adverse Event|1|||
94659018|NCT00432380|324207950|FG001|Overall Study|Adverse Event|0|||
94659019|NCT00432380|324207951|FG002|Overall Study|Adverse Event|0|||
94352112|NCT00280059|323069445|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
94352113|NCT00280059|323069444|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
94352114|NCT00280059|323069445|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
94352115|NCT00280059|323069444|FG000|Efficacy Assessment Phase|Other|7|||
94352116|NCT00280059|323069445|FG001|Efficacy Assessment Phase|Other|8|||
94352117|NCT00280059|323069444|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
94352118|NCT00280059|323069445|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
94352119|NCT04335929|323071239|FG000|Overall Study|Lost to Follow-up|10|||
94352120|NCT02534324|323071240|FG000|Overall Study|Protocol Violation|4|||
94352121|NCT02534324|323071241|FG001|Overall Study|Protocol Violation|1|||
94352122|NCT02534324|323071240|FG000|Overall Study|Lost to Follow-up|20|||
94352123|NCT02534324|323071241|FG001|Overall Study|Lost to Follow-up|7|||
94352124|NCT02534324|323071240|FG000|Overall Study|Adverse Event|1|||
94352125|NCT02534324|323071241|FG001|Overall Study|Adverse Event|0|||
94352126|NCT02889861|323071254|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
94352127|NCT02491463|323071255|FG000|Overall Study|Withdrawal by Subject|1|||
94352128|NCT02491463|323071256|FG001|Overall Study|Withdrawal by Subject|2|||
94352129|NCT02491463|323071257|FG002|Overall Study|Withdrawal by Subject|0|||
94352130|NCT02491463|323071258|FG003|Overall Study|Withdrawal by Subject|0|||
94352131|NCT02491463|323071255|FG000|Overall Study|Migrated/moved from study area|1|||
94352132|NCT02491463|323071256|FG001|Overall Study|Migrated/moved from study area|5|||
94352133|NCT02491463|323071257|FG002|Overall Study|Migrated/moved from study area|1|||
94352134|NCT02491463|323071258|FG003|Overall Study|Migrated/moved from study area|1|||
94352135|NCT02491463|323071255|FG000|Overall Study|Lost to Follow-up|0|||
94352136|NCT02491463|323071256|FG001|Overall Study|Lost to Follow-up|3|||
94352137|NCT02491463|323071257|FG002|Overall Study|Lost to Follow-up|3|||
94352138|NCT02491463|323071258|FG003|Overall Study|Lost to Follow-up|0|||
94352139|NCT01864746|323071259|FG000|Overall Study|Disease recurrence|25|||
94659020|NCT01071395|324207959|FG000|Overall Study|Withdrawal by Subject|2|||
94659021|NCT01071395|324207960|FG001|Overall Study|Withdrawal by Subject|1|||
94352140|NCT01864746|323071260|FG001|Overall Study|Disease recurrence|40|||
94352141|NCT01864746|323071259|FG000|Overall Study|Second primary invasive nonbreast|2|||
94352142|NCT01864746|323071260|FG001|Overall Study|Second primary invasive nonbreast|3|||
94352143|NCT01864746|323071259|FG000|Overall Study|Death|2|||
94352144|NCT01864746|323071260|FG001|Overall Study|Death|1|||
94352145|NCT01864746|323071259|FG000|Overall Study|Adverse Event|33|||
94352146|NCT01864746|323071260|FG001|Overall Study|Adverse Event|5|||
94352147|NCT01864746|323071259|FG000|Overall Study|Withdrawal by Subject|56|||
94352148|NCT01864746|323071260|FG001|Overall Study|Withdrawal by Subject|41|||
94352149|NCT01864746|323071259|FG000|Overall Study|Physician Decision|5|||
94352150|NCT01864746|323071260|FG001|Overall Study|Physician Decision|6|||
94352151|NCT01097057|323071265|FG000|Overall Study|Physician Decision|3|||
94352152|NCT01425268|323071268|FG000|Overall Study|Withdrawal by Subject|2|||
94352153|NCT01425268|323071269|FG001|Overall Study|Withdrawal by Subject|0|||
94352154|NCT01425268|323071268|FG000|Overall Study|Sponsor Decision|5|||
94352155|NCT01425268|323071269|FG001|Overall Study|Sponsor Decision|0|||
94352156|NCT01425268|323071268|FG000|Overall Study|Physician Decision|1|||
94352157|NCT01425268|323071269|FG001|Overall Study|Physician Decision|0|||
94352158|NCT01101321|323071270|FG000|Period 1|Withdrawal by Subject|1|||
94352159|NCT01101321|323071271|FG001|Period 1|Withdrawal by Subject|1|||
94352160|NCT01101321|323071270|FG000|Period 1|Adverse Event|3|||
94352161|NCT01101321|323071271|FG001|Period 1|Adverse Event|3|||
94352162|NCT00719706|323071272|FG000|Overall Study|Adverse Event|5|||
94352163|NCT00719706|323071273|FG001|Overall Study|Adverse Event|4|||
94352164|NCT00719706|323071272|FG000|Overall Study|Withdrawal by Subject|1|||
94352165|NCT00719706|323071273|FG001|Overall Study|Withdrawal by Subject|2|||
94352166|NCT00719706|323071272|FG000|Overall Study|Protocol Violation|3|||
94352167|NCT00719706|323071273|FG001|Overall Study|Protocol Violation|0|||
94352168|NCT04225026|323071277|FG000|Overall Study|Withdrawal by Subject|4|||
94352169|NCT04225026|323071277|FG000|Overall Study|Adverse Event|1|||
94352170|NCT04225026|323071277|FG000|Overall Study|Other|1|||
94352171|NCT04225026|323071277|FG000|Overall Study|Death|11|||
94352172|NCT04225026|323071277|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
94352173|NCT00334893|323071278|FG000|Overall Study|Not Treated|1|||
94352174|NCT00334893|323071279|FG001|Overall Study|Not Treated|0|||
94352175|NCT00760994|323071282|FG000|Overall Study|Lost to Follow-up|4|||
94352176|NCT00760994|323071283|FG001|Overall Study|Lost to Follow-up|4|||
94352177|NCT00760994|323071284|FG002|Overall Study|Lost to Follow-up|3|||
94352178|NCT02452892|323071285|FG000|Week 1 Initial Randommization|Adverse Event|1|||
94352179|NCT02452892|323071286|FG001|Week 1 Initial Randommization|Adverse Event|0|||
94352180|NCT02452892|323071287|FG002|Week 1 Initial Randommization|Adverse Event|0|||
94352181|NCT02452892|323071288|FG003|Week 1 Initial Randommization|Adverse Event|0|||
94352182|NCT02452892|323071285|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
94352183|NCT02452892|323071286|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
94352184|NCT02452892|323071287|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
94352185|NCT02452892|323071288|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
94352186|NCT02452892|323071285|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
94352187|NCT02452892|323071286|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
94352188|NCT02452892|323071287|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
94352189|NCT02452892|323071288|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
94352190|NCT02452892|323071285|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
94352191|NCT02452892|323071286|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
94352192|NCT02452892|323071287|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
94352193|NCT02452892|323071288|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
94352194|NCT02452892|323071285|FG000|Follow-up|Withdrawal by Subject|0|||
94352195|NCT02452892|323071286|FG001|Follow-up|Withdrawal by Subject|0|||
94352196|NCT02452892|323071287|FG002|Follow-up|Withdrawal by Subject|0|||
94352197|NCT02452892|323071288|FG003|Follow-up|Withdrawal by Subject|1|||
94352198|NCT02452892|323071285|FG000|Follow-up|Subject left town on Day 42|1|||
94352199|NCT02452892|323071286|FG001|Follow-up|Subject left town on Day 42|0|||
94352200|NCT02452892|323071287|FG002|Follow-up|Subject left town on Day 42|0|||
94352201|NCT02452892|323071288|FG003|Follow-up|Subject left town on Day 42|0|||
94352202|NCT00955682|323071289|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
94352203|NCT00955682|323071290|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
94352204|NCT02041533|323071294|FG000|Pre-Treatment Period|Disease Progression|1|||
94352205|NCT02041533|323071295|FG001|Pre-Treatment Period|Disease Progression|1|||
94352206|NCT02041533|323071294|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
94352207|NCT02041533|323071295|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
94352208|NCT02041533|323071294|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
94352209|NCT02041533|323071295|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
94352210|NCT02041533|323071294|FG000|Treatment Period|Disease progression|189|||
94352211|NCT02041533|323071295|FG001|Treatment Period|Disease progression|146|||
94352212|NCT02041533|323071294|FG000|Treatment Period|Study drug toxicity|30|||
94352213|NCT02041533|323071295|FG001|Treatment Period|Study drug toxicity|34|||
94352214|NCT02041533|323071294|FG000|Treatment Period|Death|1|||
94352215|NCT02041533|323071295|FG001|Treatment Period|Death|0|||
94352216|NCT02041533|323071294|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
94352217|NCT02041533|323071295|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
94582185|NCT00687193|323931824|FG005|Overall Study|Lack of Efficacy|2|||
94455128|NCT02632409|323454711|FG001|Randomized|Participant withdrew consent|1|||
94455129|NCT02632409|323454710|FG000|Randomized|No Longer meets study criteria|5|||
94352218|NCT02041533|323071294|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
94352219|NCT02041533|323071295|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
94455130|NCT02632409|323454711|FG001|Randomized|No Longer meets study criteria|0|||
94455131|NCT02632409|323454710|FG000|Randomized|other reasons|1|||
94582186|NCT00687193|323931819|FG000|Overall Study|Protocol Violation|1|||
94352220|NCT02041533|323071294|FG000|Treatment Period|Participant withdrew consent|2|||
94352221|NCT02041533|323071295|FG001|Treatment Period|Participant withdrew consent|2|||
94352222|NCT02041533|323071294|FG000|Treatment Period|Maximum clinical benefit|0|||
94352223|NCT02041533|323071295|FG001|Treatment Period|Maximum clinical benefit|18|||
94352224|NCT02041533|323071294|FG000|Treatment Period|Poor/Non-compliance|1|||
94352225|NCT02041533|323071295|FG001|Treatment Period|Poor/Non-compliance|0|||
94352226|NCT02041533|323071294|FG000|Treatment Period|Administrative reason by sponsor|1|||
94352227|NCT02041533|323071295|FG001|Treatment Period|Administrative reason by sponsor|0|||
94352228|NCT02041533|323071294|FG000|Treatment Period|Other reasons|9|||
94352229|NCT02041533|323071295|FG001|Treatment Period|Other reasons|2|||
94352230|NCT02041533|323071294|FG000|Treatment Period|Not Reported|0|||
94352231|NCT02041533|323071295|FG001|Treatment Period|Not Reported|1|||
94352232|NCT01756846|323071296|FG000|Overall Study|Lost to Follow-up|5|||
94352233|NCT01756846|323071297|FG001|Overall Study|Lost to Follow-up|10|||
94352234|NCT01756846|323071296|FG000|Overall Study|Withdrawal by Subject|1|||
94352235|NCT01756846|323071297|FG001|Overall Study|Withdrawal by Subject|2|||
94352236|NCT01284127|323071300|FG000|Overall Study|Adverse Event|2|||
94352237|NCT01284127|323071300|FG000|Overall Study|Withdrawal by Subject|4|||
94352238|NCT01284127|323071300|FG000|Overall Study|Physician Decision|1|||
94352239|NCT00565721|323071301|FG000|Overall Study|Screen Failure|2|||
94352240|NCT00565721|323071301|FG000|Overall Study|Lost to Follow-up|6|||
94352241|NCT00565721|323071301|FG000|Overall Study|Technical Problems|1|||
94352242|NCT00565721|323071301|FG000|Overall Study|Physician Decision|2|||
94352243|NCT00565721|323071301|FG000|Overall Study|Other reasons|6|||
94352244|NCT02813681|323071304|FG000|Overall Study|Physician Decision|5|||
94352245|NCT02813681|323071305|FG001|Overall Study|Physician Decision|5|||
94352246|NCT02813681|323071306|FG002|Overall Study|Physician Decision|0|||
94352247|NCT02813681|323071304|FG000|Overall Study|Lost to Follow-up|0|||
94352248|NCT02813681|323071305|FG001|Overall Study|Lost to Follow-up|1|||
94352249|NCT02813681|323071306|FG002|Overall Study|Lost to Follow-up|0|||
94352250|NCT00529152|323071307|FG000|Overall Study|Adverse Event|2|||
94352251|NCT00529152|323071307|FG000|Overall Study|Withdrawal by Subject|2|||
94352252|NCT00529152|323071307|FG000|Overall Study|Lost to Follow-up|1|||
94352253|NCT02500706|323071308|FG000|Overall Study|Adverse Event|0|||
94352254|NCT02500706|323071309|FG001|Overall Study|Adverse Event|0|||
94352255|NCT02500706|323071310|FG002|Overall Study|Adverse Event|1|||
94352256|NCT02500706|323071308|FG000|Overall Study|Lost to Follow-up|0|||
94352257|NCT02500706|323071309|FG001|Overall Study|Lost to Follow-up|1|||
94352258|NCT02500706|323071310|FG002|Overall Study|Lost to Follow-up|1|||
94352259|NCT02500706|323071308|FG000|Overall Study|Withdrawal by Subject|4|||
94352260|NCT02500706|323071309|FG001|Overall Study|Withdrawal by Subject|6|||
94352261|NCT02500706|323071310|FG002|Overall Study|Withdrawal by Subject|4|||
94352262|NCT02500706|323071308|FG000|Overall Study|Unclassified|0|||
94582187|NCT00687193|323931820|FG001|Overall Study|Protocol Violation|2|||
94582188|NCT00687193|323931821|FG002|Overall Study|Protocol Violation|0|||
94582189|NCT00687193|323931822|FG003|Overall Study|Protocol Violation|1|||
94582190|NCT00687193|323931823|FG004|Overall Study|Protocol Violation|2|||
94582191|NCT00687193|323931824|FG005|Overall Study|Protocol Violation|0|||
94582192|NCT01724346|323931825|FG000|Overall Study|Death|42|||
94582193|NCT01724346|323931826|FG001|Overall Study|Death|42|||
94582194|NCT01724346|323931825|FG000|Overall Study|Lost to Follow-up|5|||
94582195|NCT01724346|323931826|FG001|Overall Study|Lost to Follow-up|1|||
94582196|NCT01724346|323931825|FG000|Overall Study|Withdrawal by Subject|27|||
94582197|NCT01724346|323931826|FG001|Overall Study|Withdrawal by Subject|19|||
94582198|NCT01724346|323931825|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
94582199|NCT01724346|323931826|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
94582200|NCT00737672|323931827|FG000|Overall Study|Graft Abandonment|48|||
94582201|NCT00737672|323931828|FG001|Overall Study|Graft Abandonment|56|||
94352263|NCT02500706|323071309|FG001|Overall Study|Unclassified|0|||
94455132|NCT02632409|323454711|FG001|Randomized|other reasons|0|||
94582202|NCT00737672|323931827|FG000|Overall Study|Death|23|||
94582203|NCT00737672|323931828|FG001|Overall Study|Death|22|||
94582204|NCT00737672|323931827|FG000|Overall Study|Withdrawal by Subject|1|||
94582205|NCT00737672|323931828|FG001|Overall Study|Withdrawal by Subject|2|||
94582206|NCT00737672|323931827|FG000|Overall Study|Lost to Follow-up|1|||
94352264|NCT02500706|323071310|FG002|Overall Study|Unclassified|1|||
94352265|NCT01326481|323071313|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
94352266|NCT05047601|323071317|FG000|Overall Study|Lost to Follow-up|9|||
94352267|NCT05047601|323071318|FG001|Overall Study|Lost to Follow-up|11|||
94352268|NCT05047601|323071319|FG002|Overall Study|Lost to Follow-up|7|||
94352269|NCT05047601|323071317|FG000|Overall Study|Withdrawal by Subject|25|||
94352270|NCT05047601|323071318|FG001|Overall Study|Withdrawal by Subject|36|||
94352271|NCT05047601|323071319|FG002|Overall Study|Withdrawal by Subject|23|||
94352272|NCT05047601|323071317|FG000|Overall Study|Other|10|||
94352273|NCT05047601|323071318|FG001|Overall Study|Other|6|||
94352274|NCT05047601|323071319|FG002|Overall Study|Other|5|||
94352275|NCT00699582|323071325|FG000|Overall Study|Adverse Event|4|||
94352276|NCT00699582|323071326|FG001|Overall Study|Adverse Event|11|||
94352277|NCT00699582|323071327|FG002|Overall Study|Adverse Event|23|||
94352278|NCT00699582|323071325|FG000|Overall Study|Withdrawal by Subject|6|||
94352279|NCT00699582|323071326|FG001|Overall Study|Withdrawal by Subject|7|||
94352280|NCT00699582|323071327|FG002|Overall Study|Withdrawal by Subject|4|||
94352281|NCT00699582|323071325|FG000|Overall Study|Lack of Efficacy|1|||
94352282|NCT00699582|323071326|FG001|Overall Study|Lack of Efficacy|0|||
94352283|NCT00699582|323071327|FG002|Overall Study|Lack of Efficacy|1|||
94352284|NCT00699582|323071325|FG000|Overall Study|Progressive Disease|1|||
94352285|NCT00699582|323071326|FG001|Overall Study|Progressive Disease|0|||
94352286|NCT00699582|323071327|FG002|Overall Study|Progressive Disease|0|||
94352287|NCT00699582|323071325|FG000|Overall Study|Administrative/Other|4|||
94352288|NCT00699582|323071326|FG001|Overall Study|Administrative/Other|3|||
94352289|NCT00699582|323071327|FG002|Overall Study|Administrative/Other|0|||
94352290|NCT00699582|323071325|FG000|Overall Study|Randomized, Not Treated|2|||
94352291|NCT00699582|323071326|FG001|Overall Study|Randomized, Not Treated|1|||
94352292|NCT00699582|323071327|FG002|Overall Study|Randomized, Not Treated|0|||
94352293|NCT00598585|323071329|FG000|Overall Study|Lost to Follow-up|1|||
94352294|NCT00598585|323071330|FG001|Overall Study|Lost to Follow-up|0|||
94352295|NCT00135694|323071331|FG000|Overall Study|Adverse Event|17|||
94352296|NCT00135694|323071332|FG001|Overall Study|Adverse Event|4|||
94352297|NCT00135694|323071333|FG002|Overall Study|Adverse Event|0|||
94352298|NCT00135694|323071331|FG000|Overall Study|Death|14|||
94352299|NCT00135694|323071332|FG001|Overall Study|Death|1|||
94352300|NCT00135694|323071333|FG002|Overall Study|Death|2|||
94352301|NCT00135694|323071331|FG000|Overall Study|Lost to Follow-up|8|||
94352302|NCT00135694|323071332|FG001|Overall Study|Lost to Follow-up|7|||
94352303|NCT00135694|323071333|FG002|Overall Study|Lost to Follow-up|1|||
94582207|NCT00737672|323931828|FG001|Overall Study|Lost to Follow-up|0|||
94582208|NCT00737672|323931827|FG000|Overall Study|Miscellaneous|7|||
94582209|NCT00737672|323931828|FG001|Overall Study|Miscellaneous|1|||
94582210|NCT00737672|323931827|FG000|Overall Study|Physician Decision|0|||
94582211|NCT00737672|323931828|FG001|Overall Study|Physician Decision|2|||
94582212|NCT01076361|323931829|FG000|Overall Study|22 leads were excluded from analysis|21|||
94582213|NCT04986904|323931833|FG000|Overall Study|Lost to Follow-up|11|||
94582214|NCT04986904|323931833|FG000|Overall Study|Withdrawal by Subject|1|||
94582215|NCT00536744|323931834|FG000|Overall Study|Adverse Event|13|||
94582216|NCT00536744|323931835|FG001|Overall Study|Adverse Event|10|||
94582217|NCT00536744|323931834|FG000|Overall Study|Death|2|||
94582218|NCT00536744|323931835|FG001|Overall Study|Death|1|||
94582219|NCT00536744|323931834|FG000|Overall Study|Physician Decision|3|||
94582220|NCT00536744|323931835|FG001|Overall Study|Physician Decision|1|||
94582221|NCT00536744|323931834|FG000|Overall Study|Lost to Follow-up|3|||
94582222|NCT00536744|323931835|FG001|Overall Study|Lost to Follow-up|5|||
94582223|NCT00536744|323931834|FG000|Overall Study|Withdrawal by Subject|7|||
94582224|NCT00536744|323931835|FG001|Overall Study|Withdrawal by Subject|8|||
94582225|NCT00536744|323931834|FG000|Overall Study|PI tried alternative treatment|1|||
94582226|NCT00536744|323931835|FG001|Overall Study|PI tried alternative treatment|3|||
94582227|NCT01967238|323931836|FG000|Overall Study|Adverse Event|1|||
94582228|NCT01967238|323931837|FG001|Overall Study|Adverse Event|1|||
94582229|NCT01967238|323931838|FG002|Overall Study|Adverse Event|0|||
94582230|NCT01967238|323931836|FG000|Overall Study|Lost to Follow-up|1|||
94582231|NCT01967238|323931837|FG001|Overall Study|Lost to Follow-up|0|||
94582232|NCT01967238|323931838|FG002|Overall Study|Lost to Follow-up|1|||
94582233|NCT01967238|323931836|FG000|Overall Study|Withdrawal by Subject|0|||
94582234|NCT01967238|323931837|FG001|Overall Study|Withdrawal by Subject|0|||
94582235|NCT01967238|323931838|FG002|Overall Study|Withdrawal by Subject|1|||
94582236|NCT02079246|323933366|FG000|OLEX|Withdrawal before treatment|1|||
94582237|NCT02079246|323933367|FG001|OLEX|Withdrawal before treatment|0|||
94582238|NCT02079246|323933366|FG000|OLEX|Death|11|||
94582239|NCT02079246|323933367|FG001|OLEX|Death|0|||
94582240|NCT02079246|323933366|FG000|OLEX|Adverse Event|66|||
94582241|NCT02079246|323933367|FG001|OLEX|Adverse Event|0|||
94582242|NCT02079246|323933366|FG000|OLEX|Withdrawal by Subject|60|||
94582243|NCT02079246|323933367|FG001|OLEX|Withdrawal by Subject|0|||
94582244|NCT02079246|323933366|FG000|OLEX|Lost to Follow-up|6|||
94582245|NCT02079246|323933367|FG001|OLEX|Lost to Follow-up|0|||
94582246|NCT02079246|323933366|FG000|OLEX|Protocol Violation|6|||
94352304|NCT00135694|323071331|FG000|Overall Study|Withdrawal by Subject|41|||
94352305|NCT00135694|323071332|FG001|Overall Study|Withdrawal by Subject|7|||
94352306|NCT00135694|323071333|FG002|Overall Study|Withdrawal by Subject|4|||
94352307|NCT00135694|323071331|FG000|Overall Study|Protocol Violation|19|||
94582247|NCT02079246|323933367|FG001|OLEX|Protocol Violation|0|||
94582248|NCT02079246|323933366|FG000|OLEX|Lack of Efficacy|3|||
94582249|NCT02079246|323933367|FG001|OLEX|Lack of Efficacy|0|||
94582250|NCT02079246|323933366|FG000|OLEX|Results of the lead-in studies|58|||
94582251|NCT02079246|323933367|FG001|OLEX|Results of the lead-in studies|0|||
94582252|NCT02079246|323933366|FG000|OLEX|Other: Disallowed medication|8|||
94582253|NCT02079246|323933367|FG001|OLEX|Other: Disallowed medication|0|||
94582254|NCT02079246|323933366|FG000|OLEX|Other: Insufficient compliance|2|||
94582255|NCT02079246|323933367|FG001|OLEX|Other: Insufficient compliance|0|||
94582256|NCT02079246|323933366|FG000|OLEX|Other: Caregiver unavailable|3|||
94582257|NCT02079246|323933367|FG001|OLEX|Other: Caregiver unavailable|0|||
94582258|NCT02079246|323933366|FG000|OLEX|Other: Coordinator decision|1|||
94582259|NCT02079246|323933367|FG001|OLEX|Other: Coordinator decision|0|||
94582260|NCT02079246|323933366|FG000|OLEX|Other: Worsening of condition|1|||
94582261|NCT02079246|323933367|FG001|OLEX|Other: Worsening of condition|0|||
94352308|NCT00135694|323071332|FG001|Overall Study|Protocol Violation|1|||
94352309|NCT00135694|323071333|FG002|Overall Study|Protocol Violation|0|||
94352310|NCT00135694|323071331|FG000|Overall Study|Hepatitis C related reasons|39|||
94352311|NCT00135694|323071332|FG001|Overall Study|Hepatitis C related reasons|1|||
94352312|NCT00135694|323071333|FG002|Overall Study|Hepatitis C related reasons|0|||
94352313|NCT00135694|323071331|FG000|Overall Study|Ineligible for Random assignment|42|||
94352314|NCT00135694|323071332|FG001|Overall Study|Ineligible for Random assignment|0|||
94352315|NCT00135694|323071333|FG002|Overall Study|Ineligible for Random assignment|0|||
94352316|NCT02309372|323071336|FG000|Overall Study|Lost to Follow-up|3|||
94352317|NCT02309372|323071337|FG001|Overall Study|Lost to Follow-up|2|||
94352318|NCT01590810|323071342|FG000|Overall Study|Physician Decision|0|||
94352319|NCT01590810|323071343|FG001|Overall Study|Physician Decision|1|||
94582262|NCT02079246|323933366|FG000|OLEX|Other: Moved to nursing home|1|||
94352320|NCT01590810|323071344|FG002|Overall Study|Physician Decision|1|||
94352321|NCT01590810|323071345|FG003|Overall Study|Physician Decision|0|||
94352322|NCT01590810|323071346|FG004|Overall Study|Physician Decision|0|||
94352323|NCT01277666|323071349|FG000|Overall Study|Adverse Event|26|||
94352324|NCT01277666|323071350|FG001|Overall Study|Adverse Event|25|||
94352325|NCT01277666|323071351|FG002|Overall Study|Adverse Event|20|||
94352326|NCT01277666|323071349|FG000|Overall Study|Lack of Efficacy|8|||
94352327|NCT01277666|323071350|FG001|Overall Study|Lack of Efficacy|20|||
94352328|NCT01277666|323071351|FG002|Overall Study|Lack of Efficacy|12|||
94352329|NCT01277666|323071349|FG000|Overall Study|Protocol Violation|2|||
94352330|NCT01277666|323071350|FG001|Overall Study|Protocol Violation|3|||
94352331|NCT01277666|323071351|FG002|Overall Study|Protocol Violation|2|||
94352332|NCT01277666|323071349|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
94352333|NCT01277666|323071350|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
94352334|NCT01277666|323071351|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
94352335|NCT01277666|323071349|FG000|Overall Study|Lost to Follow-up|1|||
94352336|NCT01277666|323071350|FG001|Overall Study|Lost to Follow-up|1|||
94352337|NCT01277666|323071351|FG002|Overall Study|Lost to Follow-up|2|||
94352338|NCT01277666|323071349|FG000|Overall Study|Withdrawal by Subject|7|||
94352339|NCT01277666|323071350|FG001|Overall Study|Withdrawal by Subject|8|||
94352340|NCT01277666|323071351|FG002|Overall Study|Withdrawal by Subject|6|||
94352341|NCT01277666|323071349|FG000|Overall Study|Death|0|||
94582263|NCT02079246|323933367|FG001|OLEX|Other: Moved to nursing home|0|||
94582264|NCT02079246|323933366|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
94352342|NCT01277666|323071350|FG001|Overall Study|Death|0|||
94352343|NCT01277666|323071351|FG002|Overall Study|Death|1|||
94352344|NCT01815099|323071352|FG000|Overall Study|Lack of Efficacy|1|||
94352345|NCT01815099|323071352|FG000|Overall Study|unable to attend study visits|1|||
94352346|NCT04604015|323071353|FG000|Overall Study|Incomplete Data Collection|33|||
94352347|NCT01373294|323071354|FG000|Overall Study|Adverse Event|1|||
94352348|NCT01373294|323071355|FG001|Overall Study|Adverse Event|0|||
94352349|NCT01731600|323071358|FG000|Overall Study|Adverse Event|2|||
94582265|NCT02079246|323933367|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
94582266|NCT02079246|323933366|FG000|OLEX-MEM|Adverse Event|0|||
94455133|NCT02632409|323454710|FG000|Treatment Period|Ongoing Treatment|20|||
94455134|NCT02632409|323454711|FG001|Treatment Period|Ongoing Treatment|21|||
94352350|NCT01731600|323071359|FG001|Overall Study|Adverse Event|0|||
94352351|NCT01731600|323071358|FG000|Overall Study|Withdrawal criteria|1|||
94352352|NCT01731600|323071359|FG001|Overall Study|Withdrawal criteria|0|||
94352353|NCT01731600|323071358|FG000|Overall Study|Other reasons|3|||
94352354|NCT01731600|323071359|FG001|Overall Study|Other reasons|0|||
94352355|NCT02828982|323071360|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
94352356|NCT02828982|323071361|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
94352357|NCT00372905|323071362|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
94352358|NCT00372905|323071363|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
94352359|NCT00372905|323071364|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
94352360|NCT00372905|323071365|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
94352361|NCT00372905|323071362|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
94352362|NCT00372905|323071363|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
94352363|NCT00372905|323071364|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
94352364|NCT00372905|323071365|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
94352365|NCT00372905|323071362|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
94352366|NCT00372905|323071363|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
94352367|NCT00372905|323071364|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
94352368|NCT00372905|323071365|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
94352369|NCT00372905|323071362|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
94352370|NCT00372905|323071363|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
94352371|NCT00372905|323071364|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
94352372|NCT00372905|323071365|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
94352373|NCT00372905|323071362|FG000|Follow up Until Relapse or Progression|Study closed|0|||
94352374|NCT00372905|323071363|FG001|Follow up Until Relapse or Progression|Study closed|0|||
94352375|NCT00372905|323071364|FG002|Follow up Until Relapse or Progression|Study closed|0|||
94352376|NCT00372905|323071365|FG003|Follow up Until Relapse or Progression|Study closed|3|||
94352377|NCT00372905|323071362|FG000|Follow up Until Relapse or Progression|Other|0|||
94352378|NCT00372905|323071363|FG001|Follow up Until Relapse or Progression|Other|1|||
94352379|NCT00372905|323071364|FG002|Follow up Until Relapse or Progression|Other|0|||
94352380|NCT00372905|323071365|FG003|Follow up Until Relapse or Progression|Other|0|||
94352381|NCT02312934|323071366|FG000|Overall Study|Lost to Follow-up|1|||
94352382|NCT02312934|323071367|FG001|Overall Study|Lost to Follow-up|0|||
94352383|NCT02312934|323071366|FG000|Overall Study|Physician Decision|1|||
94352384|NCT02312934|323071367|FG001|Overall Study|Physician Decision|0|||
94352385|NCT00689299|323071380|FG000|Overall Study|Adverse Event|2|||
94352386|NCT00689299|323071381|FG001|Overall Study|Adverse Event|1|||
94455135|NCT02632409|323454710|FG000|Treatment Period|Disease Recurrence|147|||
94455136|NCT02632409|323454711|FG001|Treatment Period|Disease Recurrence|90|||
94455137|NCT02632409|323454710|FG000|Treatment Period|Study Drug Toxicity|8|||
94455138|NCT02632409|323454711|FG001|Treatment Period|Study Drug Toxicity|49|||
94455139|NCT02632409|323454710|FG000|Treatment Period|Death|1|||
94455140|NCT02632409|323454711|FG001|Treatment Period|Death|0|||
94455141|NCT02632409|323454710|FG000|Treatment Period|AE unrelated to study drug|15|||
94455142|NCT02632409|323454711|FG001|Treatment Period|AE unrelated to study drug|16|||
94455143|NCT02632409|323454710|FG000|Treatment Period|Request to discontinue treatment|4|||
94455144|NCT02632409|323454711|FG001|Treatment Period|Request to discontinue treatment|19|||
94455145|NCT02632409|323454710|FG000|Treatment Period|Participant withdrew consent|7|||
94455146|NCT02632409|323454711|FG001|Treatment Period|Participant withdrew consent|5|||
94455147|NCT02632409|323454710|FG000|Treatment Period|Lost to Follow-up|0|||
94455148|NCT02632409|323454711|FG001|Treatment Period|Lost to Follow-up|1|||
94455149|NCT02632409|323454710|FG000|Treatment Period|Maximum clinical benefit|1|||
94455150|NCT02632409|323454711|FG001|Treatment Period|Maximum clinical benefit|0|||
94455151|NCT02632409|323454710|FG000|Treatment Period|No longer meets study criteria|3|||
94455152|NCT02632409|323454711|FG001|Treatment Period|No longer meets study criteria|0|||
94455153|NCT02632409|323454710|FG000|Treatment Period|Administrative Reason by sponsor|0|||
94455154|NCT02632409|323454711|FG001|Treatment Period|Administrative Reason by sponsor|1|||
94455155|NCT02632409|323454710|FG000|Treatment Period|Other Reasons|10|||
94455156|NCT02632409|323454711|FG001|Treatment Period|Other Reasons|6|||
94455157|NCT02429778|323454712|FG000|Overall Study|Lost to Follow-up|2|||
94455158|NCT02429778|323454713|FG001|Overall Study|Lost to Follow-up|0|||
94455159|NCT02429778|323454712|FG000|Overall Study|Withdrawal by Subject|5|||
94455160|NCT02429778|323454713|FG001|Overall Study|Withdrawal by Subject|0|||
94352387|NCT00689299|323071382|FG002|Overall Study|Adverse Event|1|||
94352388|NCT00689299|323071380|FG000|Overall Study|Lost to Follow-up|0|||
94352389|NCT00689299|323071381|FG001|Overall Study|Lost to Follow-up|1|||
94352390|NCT00689299|323071382|FG002|Overall Study|Lost to Follow-up|1|||
94352391|NCT00689299|323071380|FG000|Overall Study|Withdrawal by Subject|4|||
94352392|NCT00689299|323071381|FG001|Overall Study|Withdrawal by Subject|1|||
94240622|NCT04546217|322676659|FG001|Overall Study|Withdrawal by Subject|0|||
94455161|NCT01082211|323454718|FG000|Overall Study|Protocol Violation|4|||
94582267|NCT02079246|323933367|FG001|OLEX-MEM|Adverse Event|6|||
94352393|NCT00689299|323071382|FG002|Overall Study|Withdrawal by Subject|3|||
94352394|NCT00689299|323071380|FG000|Overall Study|Protocol Violation|1|||
94352395|NCT00689299|323071381|FG001|Overall Study|Protocol Violation|0|||
94352396|NCT00689299|323071382|FG002|Overall Study|Protocol Violation|0|||
94352397|NCT02613910|323071383|FG000|Overall Study|Termination of study|1|||
94352398|NCT02993731|323071384|FG000|Overall Study|Study Termination|101|||
94352399|NCT02993731|323071385|FG001|Overall Study|Study Termination|105|||
94352400|NCT00526227|323071386|FG000|Overall Study|Device not implanted|1|||
94352401|NCT00526227|323071386|FG000|Overall Study|Death|1|||
94352402|NCT03044730|323071387|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
94352403|NCT03044730|323071387|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
94352404|NCT03044730|323071387|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
94352405|NCT03044730|323071387|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
94352406|NCT03044730|323071387|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
94352407|NCT03044730|323071387|FG000|Cycles 4 and Beyond|Adverse Event|1|||
94352408|NCT03044730|323071387|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
94352409|NCT03044730|323071387|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
94352410|NCT03044730|323071387|FG000|On Follow-up for 2 Years|Death|17|||
94352411|NCT04524663|323073468|FG000|Overall Study|Withdrawal by Subject|0|||
94352412|NCT04524663|323073469|FG001|Overall Study|Withdrawal by Subject|2|||
94352413|NCT00690612|323073470|FG000|Overall Study|Adverse Event|1|||
94352414|NCT00690612|323073470|FG000|Overall Study|Withdrawal by Subject|2|||
94352415|NCT02361307|323073471|FG000|Overall Study|Unstable medical condition.|0|||
94352416|NCT02361307|323073472|FG001|Overall Study|Unstable medical condition.|1|||
94352417|NCT00711009|323073473|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
94352418|NCT00711009|323073474|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
94352419|NCT00711009|323073473|FG000|Overall Study|Withdrawal by Subject|4|||
94352420|NCT00711009|323073474|FG001|Overall Study|Withdrawal by Subject|2|||
94352421|NCT00711009|323073473|FG000|Overall Study|Lost to Follow-up|3|||
94352422|NCT00711009|323073474|FG001|Overall Study|Lost to Follow-up|9|||
94352423|NCT00711009|323073473|FG000|Overall Study|Participant Noncompliant|0|||
94352424|NCT00711009|323073474|FG001|Overall Study|Participant Noncompliant|1|||
94352425|NCT00711009|323073473|FG000|Overall Study|Virologic Failure|2|||
94352426|NCT00711009|323073474|FG001|Overall Study|Virologic Failure|1|||
94352427|NCT00711009|323073473|FG000|Overall Study|Pregnancy|1|||
94352428|NCT00711009|323073474|FG001|Overall Study|Pregnancy|0|||
94352429|NCT00711009|323073473|FG000|Overall Study|Site closing|0|||
94352430|NCT00711009|323073474|FG001|Overall Study|Site closing|1|||
94352431|NCT00711009|323073473|FG000|Overall Study|Dose adjustment|1|||
94352432|NCT00711009|323073474|FG001|Overall Study|Dose adjustment|0|||
94352433|NCT01189201|323073475|FG000|Overall Study|Adverse Event|1|||
94352434|NCT01682876|323073476|FG000|Overall Study|Administrative reason|4|||
94352435|NCT01682876|323073477|FG001|Overall Study|Administrative reason|4|||
94352436|NCT01682876|323073478|FG002|Overall Study|Administrative reason|0|||
94352437|NCT01682876|323073479|FG003|Overall Study|Administrative reason|3|||
94352438|NCT01682876|323073476|FG000|Overall Study|Adverse Event|0|||
94352439|NCT01682876|323073477|FG001|Overall Study|Adverse Event|0|||
94352440|NCT01682876|323073478|FG002|Overall Study|Adverse Event|0|||
94352441|NCT01682876|323073479|FG003|Overall Study|Adverse Event|1|||
94352442|NCT01682876|323073476|FG000|Overall Study|Lost to Follow-up|11|||
94352443|NCT01682876|323073477|FG001|Overall Study|Lost to Follow-up|15|||
94352444|NCT01682876|323073478|FG002|Overall Study|Lost to Follow-up|9|||
94352445|NCT01682876|323073479|FG003|Overall Study|Lost to Follow-up|11|||
94352446|NCT01682876|323073476|FG000|Overall Study|Protocol Violation|1|||
94352447|NCT01682876|323073477|FG001|Overall Study|Protocol Violation|1|||
94352448|NCT01682876|323073478|FG002|Overall Study|Protocol Violation|1|||
94352449|NCT01682876|323073479|FG003|Overall Study|Protocol Violation|1|||
94352450|NCT01682876|323073476|FG000|Overall Study|Withdrawal by Subject|4|||
94352451|NCT01682876|323073477|FG001|Overall Study|Withdrawal by Subject|0|||
94352452|NCT01682876|323073478|FG002|Overall Study|Withdrawal by Subject|0|||
94352453|NCT01682876|323073479|FG003|Overall Study|Withdrawal by Subject|2|||
94352454|NCT01682876|323073476|FG000|Overall Study|Other|1|||
94352455|NCT01682876|323073477|FG001|Overall Study|Other|0|||
94352456|NCT01682876|323073478|FG002|Overall Study|Other|1|||
94352457|NCT01682876|323073479|FG003|Overall Study|Other|1|||
94352458|NCT01277757|323073480|FG000|Overall Study|Disease Progression|1|||
94352459|NCT01277757|323073480|FG000|Overall Study|Withdrawal by Subject|1|||
94352460|NCT01459016|323073481|FG000|Overall Study|Withdrawal by Subject|11|||
94352461|NCT01459016|323073481|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
94352462|NCT00303602|323073485|FG000|Overall Study|Adverse Event|2|||
94352463|NCT00303602|323073486|FG001|Overall Study|Adverse Event|2|||
94352464|NCT00303602|323073485|FG000|Overall Study|Withdrawal by Subject|5|||
94352465|NCT00303602|323073486|FG001|Overall Study|Withdrawal by Subject|6|||
94352466|NCT00303602|323073485|FG000|Overall Study|Lost to Follow-up|5|||
94352467|NCT00303602|323073486|FG001|Overall Study|Lost to Follow-up|2|||
94352468|NCT00303602|323073485|FG000|Overall Study|Protocol entry criteria not met|2|||
94352469|NCT00303602|323073486|FG001|Overall Study|Protocol entry criteria not met|2|||
94352470|NCT00303602|323073485|FG000|Overall Study|Physician Decision|2|||
94352471|NCT00303602|323073486|FG001|Overall Study|Physician Decision|1|||
94352472|NCT00303602|323073485|FG000|Overall Study|Noncompliance|2|||
94352473|NCT00303602|323073486|FG001|Overall Study|Noncompliance|2|||
94352474|NCT00303602|323073485|FG000|Overall Study|Protocol Violation|1|||
94352475|NCT00303602|323073486|FG001|Overall Study|Protocol Violation|0|||
94352476|NCT00911508|323073487|FG000|Overall Study|Lost to Follow-up|27|||
94352477|NCT00911508|323073488|FG001|Overall Study|Lost to Follow-up|18|||
94352478|NCT00911508|323073487|FG000|Overall Study|Withdrawal by Subject|79|||
94352479|NCT00911508|323073488|FG001|Overall Study|Withdrawal by Subject|112|||
94352480|NCT00240331|323073491|FG000|Overall Study|Withdrawal by Subject|125|||
94352481|NCT00240331|323073492|FG001|Overall Study|Withdrawal by Subject|132|||
94352482|NCT00240331|323073491|FG000|Overall Study|Option selected by investigator|1|||
94352483|NCT00240331|323073492|FG001|Overall Study|Option selected by investigator|2|||
94352484|NCT00313716|323073493|FG000|Overall Study|Death|3|||
94352485|NCT00313716|323073494|FG001|Overall Study|Death|2|||
94352486|NCT00313716|323073495|FG002|Overall Study|Death|9|||
94352487|NCT00313716|323073496|FG003|Overall Study|Death|3|||
94352488|NCT00313716|323073497|FG004|Overall Study|Death|5|||
94352489|NCT00313716|323073498|FG005|Overall Study|Death|9|||
94352490|NCT00313716|323073493|FG000|Overall Study|Lost to Follow-up|2|||
94352491|NCT00313716|323073494|FG001|Overall Study|Lost to Follow-up|5|||
94352492|NCT00313716|323073495|FG002|Overall Study|Lost to Follow-up|2|||
94352493|NCT00313716|323073496|FG003|Overall Study|Lost to Follow-up|1|||
94352494|NCT00313716|323073497|FG004|Overall Study|Lost to Follow-up|0|||
94352495|NCT00313716|323073498|FG005|Overall Study|Lost to Follow-up|4|||
94352496|NCT00313716|323073493|FG000|Overall Study|Withdrawal by Subject|0|||
94352497|NCT00313716|323073494|FG001|Overall Study|Withdrawal by Subject|1|||
94352498|NCT00313716|323073495|FG002|Overall Study|Withdrawal by Subject|1|||
94352499|NCT00313716|323073496|FG003|Overall Study|Withdrawal by Subject|0|||
94352500|NCT00313716|323073497|FG004|Overall Study|Withdrawal by Subject|1|||
94352501|NCT00313716|323073498|FG005|Overall Study|Withdrawal by Subject|0|||
94352502|NCT01491802|323073499|FG000|Overall Study|Adverse Event|1|||
94352503|NCT01491802|323073500|FG001|Overall Study|Adverse Event|1|||
94352504|NCT01491802|323073499|FG000|Overall Study|Withdrawal by Subject|0|||
94352505|NCT01491802|323073500|FG001|Overall Study|Withdrawal by Subject|1|||
94352506|NCT01451203|323073503|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
94352507|NCT01451203|323073504|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
94352508|NCT01451203|323073503|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
94352509|NCT01451203|323073504|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
94352510|NCT01451203|323073503|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
94352511|NCT01451203|323073504|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
94352512|NCT01451203|323073503|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
94352513|NCT01451203|323073504|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
94352514|NCT01451203|323073503|FG000|Double-blind Treatment Period|Adverse Event|6|||
94352515|NCT01451203|323073504|FG001|Double-blind Treatment Period|Adverse Event|9|||
94352516|NCT01451203|323073503|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
94352517|NCT01451203|323073504|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
94352518|NCT01451203|323073503|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
94352519|NCT01451203|323073504|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
94352520|NCT01451203|323073503|FG000|Double-blind Treatment Period|Investigator decision|2|||
94352521|NCT01451203|323073504|FG001|Double-blind Treatment Period|Investigator decision|0|||
94352522|NCT01451203|323073503|FG000|Post-treatment Period|Consent withdrawn|2|||
94352523|NCT01451203|323073504|FG001|Post-treatment Period|Consent withdrawn|4|||
94352524|NCT01451203|323073503|FG000|Post-treatment Period|Lack of Efficacy|12|||
94352525|NCT01451203|323073504|FG001|Post-treatment Period|Lack of Efficacy|28|||
94352526|NCT01451203|323073503|FG000|Post-treatment Period|Adverse Event|0|||
94352527|NCT01451203|323073504|FG001|Post-treatment Period|Adverse Event|1|||
94352528|NCT01451203|323073503|FG000|Post-treatment Period|Investigator decision|0|||
94352529|NCT01451203|323073504|FG001|Post-treatment Period|Investigator decision|1|||
94352530|NCT03812224|323073506|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
94352531|NCT03812224|323073507|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
94352532|NCT03812224|323073506|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
94352533|NCT03812224|323073507|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
94352534|NCT03812224|323073506|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
94352535|NCT03812224|323073507|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
94352536|NCT03812224|323073506|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
94352537|NCT03812224|323073507|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
94352538|NCT00303719|323073515|FG000|Overall Study|Not evaluable, prior therapies|0|||
94352539|NCT00303719|323073516|FG001|Overall Study|Not evaluable, prior therapies|30|||
94352540|NCT00303719|323073515|FG000|Overall Study|Lost to Follow-up|0|||
94352541|NCT00303719|323073516|FG001|Overall Study|Lost to Follow-up|7|||
94352542|NCT01710709|323073525|FG000|Overall Study|Lost to Follow-up|29|||
94352543|NCT01710709|323073525|FG000|Overall Study|Adverse Event|48|||
94352544|NCT01710709|323073525|FG000|Overall Study|Participant met withdrawal criteria|33|||
94352545|NCT01710709|323073525|FG000|Overall Study|Participant withdrawn by investigator|2|||
94352546|NCT01710709|323073525|FG000|Overall Study|Withdrawal by Subject|53|||
94352547|NCT01710709|323073525|FG000|Overall Study|Protocol Violation|5|||
94352548|NCT01710709|323073525|FG000|Overall Study|Lack of Efficacy|3|||
94352549|NCT01398176|323073526|FG000|Overall Study|Lost to Follow-up|1|||
94352550|NCT01398176|323073527|FG001|Overall Study|Lost to Follow-up|3|||
94240623|NCT04546217|322676658|FG000|Overall Study|Uncontrolled hypertension|1|||
94240624|NCT04546217|322676659|FG001|Overall Study|Uncontrolled hypertension|0|||
94352551|NCT01398176|323073526|FG000|Overall Study|Physician Decision|2|||
94240625|NCT01901419|322676660|FG000|Overall Study|Protocol Violation|2|||
94240626|NCT01901419|322676661|FG001|Overall Study|Protocol Violation|6|||
94240627|NCT01901419|322676660|FG000|Overall Study|unavailable researchers|6|||
94240628|NCT01901419|322676661|FG001|Overall Study|unavailable researchers|3|||
94240629|NCT01228318|322676668|FG000|Overall Study|Clinic no show to receive intervention|1|||
94352552|NCT01398176|323073527|FG001|Overall Study|Physician Decision|3|||
94352553|NCT03007472|323073528|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
94352554|NCT03007472|323073528|FG000|Overall Study|Death|2|||
94352555|NCT03007472|323073528|FG000|Overall Study|Loss to Follow Up|1|||
94352556|NCT00883896|323073529|FG000|Overall Study|Lost to Follow-up|0|||
94352557|NCT00883896|323073530|FG001|Overall Study|Lost to Follow-up|0|||
94352558|NCT00883896|323073531|FG002|Overall Study|Lost to Follow-up|0|||
94352559|NCT00883896|323073532|FG003|Overall Study|Lost to Follow-up|2|||
94352560|NCT00883896|323073529|FG000|Overall Study|Withdrawal by Subject|5|||
94352561|NCT00883896|323073530|FG001|Overall Study|Withdrawal by Subject|0|||
94352562|NCT00883896|323073531|FG002|Overall Study|Withdrawal by Subject|1|||
94352563|NCT00883896|323073532|FG003|Overall Study|Withdrawal by Subject|3|||
94352564|NCT00883896|323073529|FG000|Overall Study|Lack of Efficacy|0|||
94352565|NCT00883896|323073530|FG001|Overall Study|Lack of Efficacy|0|||
94352566|NCT00883896|323073531|FG002|Overall Study|Lack of Efficacy|0|||
94352567|NCT00883896|323073532|FG003|Overall Study|Lack of Efficacy|2|||
94352568|NCT00883896|323073529|FG000|Overall Study|Other|1|||
94352569|NCT00883896|323073530|FG001|Overall Study|Other|0|||
94352570|NCT00883896|323073531|FG002|Overall Study|Other|0|||
94352571|NCT00883896|323073532|FG003|Overall Study|Other|0|||
94240630|NCT01228318|322676669|FG001|Overall Study|Clinic no show to receive intervention|0|||
94352572|NCT02988115|323073535|FG000|Overall Study|Adverse Event|6|||
94352573|NCT02988115|323073536|FG001|Overall Study|Adverse Event|1|||
94352574|NCT02988115|323073535|FG000|Overall Study|Sponsor Decision|5|||
94352575|NCT02988115|323073536|FG001|Overall Study|Sponsor Decision|2|||
94352576|NCT02988115|323073535|FG000|Overall Study|Withdrawal by Subject|1|||
94352577|NCT02988115|323073536|FG001|Overall Study|Withdrawal by Subject|1|||
94352578|NCT02988115|323073535|FG000|Overall Study|Withdrawn by Mistake|1|||
94352579|NCT02988115|323073536|FG001|Overall Study|Withdrawn by Mistake|0|||
94352580|NCT02988115|323073535|FG000|Overall Study|Lost to Follow-up|1|||
94352581|NCT02988115|323073536|FG001|Overall Study|Lost to Follow-up|0|||
94352582|NCT00253747|323073537|FG000|Overall Study|Lost to Follow-up|13|||
94352583|NCT00253747|323073538|FG001|Overall Study|Lost to Follow-up|14|||
94352584|NCT00253747|323073537|FG000|Overall Study|Withdrawal by Subject|10|||
94352585|NCT00253747|323073538|FG001|Overall Study|Withdrawal by Subject|11|||
94352586|NCT00253747|323073537|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
94352587|NCT00253747|323073538|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
94352588|NCT01977651|323073539|FG000|4 Month Treatment Period|Adverse Event|34|||
94352589|NCT01977651|323073539|FG000|4 Month Treatment Period|Death|3|||
94352590|NCT01977651|323073539|FG000|4 Month Treatment Period|Progressive Disease|43|||
94352591|NCT01977651|323073539|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
94352592|NCT01977651|323073539|FG000|4 Month Treatment Period|Physician Decision|4|||
94352593|NCT01977651|323073539|FG000|1 Year Extension Period|Adverse Event|14|||
94240631|NCT01228318|322676668|FG000|Overall Study|Unable to contact|2|||
94240632|NCT01228318|322676669|FG001|Overall Study|Unable to contact|5|||
94352594|NCT01977651|323073539|FG000|1 Year Extension Period|Death|10|||
94352595|NCT01977651|323073539|FG000|1 Year Extension Period|Lost to Follow-up|2|||
94352596|NCT01977651|323073539|FG000|1 Year Extension Period|Progressive Disease|86|||
94352597|NCT01977651|323073539|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
94352598|NCT01977651|323073539|FG000|1 Year Extension Period|Physician Decision|6|||
94352599|NCT01977651|323073539|FG000|1 Year Extension Period|Miscellaneous|1|||
94352600|NCT01977651|323073539|FG000|Post 1 Year Extension Period|Adverse Event|5|||
94352601|NCT01977651|323073539|FG000|Post 1 Year Extension Period|Death|13|||
94352602|NCT01977651|323073539|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
94352603|NCT01977651|323073539|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
94352604|NCT01977651|323073539|FG000|Post 1 Year Extension Period|Physician Decision|4|||
94352605|NCT01977651|323073539|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
94352606|NCT01399619|323073540|FG000|Overall Study|Adverse Event|10|||
94352607|NCT01399619|323073541|FG001|Overall Study|Adverse Event|0|||
94352608|NCT01399619|323073542|FG002|Overall Study|Adverse Event|4|||
94352609|NCT01399619|323073543|FG003|Overall Study|Adverse Event|10|||
94352610|NCT01399619|323073540|FG000|Overall Study|Lack of Efficacy|9|||
94352611|NCT01399619|323073541|FG001|Overall Study|Lack of Efficacy|0|||
94352612|NCT01399619|323073542|FG002|Overall Study|Lack of Efficacy|5|||
94352613|NCT01399619|323073543|FG003|Overall Study|Lack of Efficacy|0|||
94352614|NCT01399619|323073540|FG000|Overall Study|Withdrawal by Subject|6|||
94352615|NCT01399619|323073541|FG001|Overall Study|Withdrawal by Subject|0|||
94352616|NCT01399619|323073542|FG002|Overall Study|Withdrawal by Subject|3|||
94352617|NCT01399619|323073543|FG003|Overall Study|Withdrawal by Subject|4|||
94352618|NCT01399619|323073540|FG000|Overall Study|Protocol Violation|0|||
94352619|NCT01399619|323073541|FG001|Overall Study|Protocol Violation|0|||
94352620|NCT01399619|323073542|FG002|Overall Study|Protocol Violation|0|||
94352621|NCT01399619|323073543|FG003|Overall Study|Protocol Violation|1|||
94352622|NCT01399619|323073540|FG000|Overall Study|Not treated|0|||
94352623|NCT01399619|323073541|FG001|Overall Study|Not treated|0|||
94352624|NCT01399619|323073542|FG002|Overall Study|Not treated|0|||
94352625|NCT01399619|323073543|FG003|Overall Study|Not treated|2|||
94352626|NCT01856920|323073544|FG000|Overall Study|Disease Progression On Study|3|||
94352627|NCT01856920|323073545|FG001|Overall Study|Disease Progression On Study|4|||
94352628|NCT01856920|323073544|FG000|Overall Study|Disease Progression before Treatment|1|||
94352629|NCT01856920|323073545|FG001|Overall Study|Disease Progression before Treatment|0|||
94352630|NCT01856920|323073544|FG000|Overall Study|Ineligible|0|||
94352631|NCT01856920|323073545|FG001|Overall Study|Ineligible|1|||
94352632|NCT01856920|323073544|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
94352633|NCT01856920|323073545|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
94352634|NCT01856920|323073544|FG000|Overall Study|Refused further Treatment|5|||
94352635|NCT01856920|323073545|FG001|Overall Study|Refused further Treatment|1|||
94352636|NCT01856920|323073544|FG000|Overall Study|Other Reasons|0|||
94352637|NCT01856920|323073545|FG001|Overall Study|Other Reasons|1|||
94352638|NCT01856920|323073544|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
94352639|NCT01856920|323073545|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
94352640|NCT03672006|323073546|FG000|Overall Study|exclusion criteria met|0|||
94352641|NCT03672006|323073547|FG001|Overall Study|exclusion criteria met|1|||
94352642|NCT05102734|323073548|FG000|Overall Study|Did not require vasopressors|1|||
94352643|NCT05102734|323073549|FG001|Overall Study|Did not require vasopressors|0|||
94352644|NCT05102734|323073548|FG000|Overall Study|Did not have functioning PA catheter|1|||
94352645|NCT05102734|323073549|FG001|Overall Study|Did not have functioning PA catheter|0|||
94352646|NCT05102734|323073548|FG000|Overall Study|Inadequate video quality|2|||
94352647|NCT05102734|323073549|FG001|Overall Study|Inadequate video quality|0|||
94352648|NCT04235959|323073550|FG000|Overall Study|Protocol Violation|0|||
94352649|NCT04235959|323073551|FG001|Overall Study|Protocol Violation|1|||
94352650|NCT04235959|323073552|FG002|Overall Study|Protocol Violation|0|||
94352651|NCT04235959|323073550|FG000|Overall Study|Adverse Event|1|||
94352652|NCT04235959|323073551|FG001|Overall Study|Adverse Event|0|||
94352653|NCT04235959|323073552|FG002|Overall Study|Adverse Event|0|||
94352654|NCT00608426|323073553|FG000|Overall Study|Death|32|||
94352655|NCT00608426|323073554|FG001|Overall Study|Death|36|||
94352656|NCT00608426|323073553|FG000|Overall Study|Lost to Follow-up|485|||
94352657|NCT00608426|323073554|FG001|Overall Study|Lost to Follow-up|521|||
94352658|NCT00608426|323073553|FG000|Overall Study|refused, health issues, wrong address|319|||
94352659|NCT00608426|323073554|FG001|Overall Study|refused, health issues, wrong address|348|||
94352660|NCT00761891|323073558|FG000|Overall Study|Withdrawal by Subject|10|||
94352661|NCT01707667|323073559|FG000|Period 1|expulsion of colonic sensor catheter|1|||
94352662|NCT01707667|323073560|FG001|Period 1|expulsion of colonic sensor catheter|0|||
94352663|NCT02898662|323073562|FG000|Overall Study|Adverse Event|1|||
94352664|NCT02898662|323073563|FG001|Overall Study|Adverse Event|0|||
94352665|NCT02898662|323073562|FG000|Overall Study|Loss of asthma control|23|||
94352666|NCT02898662|323073563|FG001|Overall Study|Loss of asthma control|24|||
94352667|NCT02898662|323073562|FG000|Overall Study|Withdrawal by Subject|4|||
94352668|NCT02898662|323073563|FG001|Overall Study|Withdrawal by Subject|1|||
94352669|NCT02898662|323073562|FG000|Overall Study|Technical issue|0|||
94352670|NCT02898662|323073563|FG001|Overall Study|Technical issue|1|||
94352671|NCT02898662|323073562|FG000|Overall Study|Randomized in error|0|||
94352672|NCT02898662|323073563|FG001|Overall Study|Randomized in error|1|||
94352673|NCT02898662|323073562|FG000|Overall Study|Subject decision|1|||
94352674|NCT02898662|323073563|FG001|Overall Study|Subject decision|0|||
94352675|NCT02898662|323073562|FG000|Overall Study|Other|0|||
94352676|NCT02898662|323073563|FG001|Overall Study|Other|1|||
94352677|NCT00267202|323073564|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
94352678|NCT00267202|323073565|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
94352679|NCT00267202|323073564|FG000|Overall Study|Withdrawal by Subject|12|||
94352680|NCT00267202|323073565|FG001|Overall Study|Withdrawal by Subject|15|||
94352681|NCT00267202|323073564|FG000|Overall Study|Adverse Event|13|||
94352682|NCT00267202|323073565|FG001|Overall Study|Adverse Event|7|||
94352683|NCT00267202|323073564|FG000|Overall Study|Protocol Violation|2|||
94352684|NCT00267202|323073565|FG001|Overall Study|Protocol Violation|3|||
94352685|NCT00267202|323073564|FG000|Overall Study|Administrative problems|2|||
94352686|NCT00267202|323073565|FG001|Overall Study|Administrative problems|1|||
94352687|NCT00267202|323073564|FG000|Overall Study|Lost to Follow-up|3|||
94352688|NCT00267202|323073565|FG001|Overall Study|Lost to Follow-up|0|||
94352689|NCT01014442|323073566|FG000|Overall Study|Adverse Event|0|||
94352690|NCT01014442|323073567|FG001|Overall Study|Adverse Event|8|||
94352691|NCT01014442|323073566|FG000|Overall Study|Withdrawal by Subject|4|||
94352692|NCT01014442|323073567|FG001|Overall Study|Withdrawal by Subject|4|||
94352693|NCT01014442|323073566|FG000|Overall Study|Protocol Violation|2|||
94352694|NCT01014442|323073567|FG001|Overall Study|Protocol Violation|5|||
94352695|NCT01014442|323073566|FG000|Overall Study|Lack of Compliance|0|||
94352696|NCT01014442|323073567|FG001|Overall Study|Lack of Compliance|1|||
94352697|NCT01014442|323073566|FG000|Overall Study|Unspecified Reason|1|||
94352698|NCT01014442|323073567|FG001|Overall Study|Unspecified Reason|1|||
94352699|NCT01632345|323073573|FG000|Treatment: Part I|Adverse Event|1|||
94352700|NCT01632345|323073574|FG001|Treatment: Part I|Adverse Event|4|||
94352701|NCT01632345|323073575|FG002|Treatment: Part I|Adverse Event|2|||
94352702|NCT01632345|323073576|FG003|Treatment: Part I|Adverse Event|1|||
94352703|NCT01632345|323073577|FG004|Treatment: Part I|Adverse Event|3|||
94352704|NCT01632345|323073578|FG005|Treatment: Part I|Adverse Event|0|||
94352705|NCT01632345|323073579|FG006|Treatment: Part I|Adverse Event|0|||
94352706|NCT01632345|323073573|FG000|Treatment: Part I|Lack of Efficacy|0|||
94352707|NCT01632345|323073574|FG001|Treatment: Part I|Lack of Efficacy|1|||
94352708|NCT01632345|323073575|FG002|Treatment: Part I|Lack of Efficacy|0|||
94352709|NCT01632345|323073576|FG003|Treatment: Part I|Lack of Efficacy|1|||
94352710|NCT01632345|323073577|FG004|Treatment: Part I|Lack of Efficacy|1|||
94352711|NCT01632345|323073578|FG005|Treatment: Part I|Lack of Efficacy|0|||
94352712|NCT01632345|323073579|FG006|Treatment: Part I|Lack of Efficacy|0|||
94352713|NCT01632345|323073573|FG000|Treatment: Part I|Lost to Follow-up|3|||
94352714|NCT01632345|323073574|FG001|Treatment: Part I|Lost to Follow-up|2|||
94352715|NCT01632345|323073575|FG002|Treatment: Part I|Lost to Follow-up|1|||
94352716|NCT01632345|323073576|FG003|Treatment: Part I|Lost to Follow-up|3|||
94352717|NCT01632345|323073577|FG004|Treatment: Part I|Lost to Follow-up|4|||
94352718|NCT01632345|323073578|FG005|Treatment: Part I|Lost to Follow-up|0|||
94352719|NCT01632345|323073579|FG006|Treatment: Part I|Lost to Follow-up|0|||
94352720|NCT01632345|323073573|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
94352721|NCT01632345|323073574|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
94352722|NCT01632345|323073575|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
94352723|NCT01632345|323073576|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
94352724|NCT01632345|323073577|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
94455162|NCT01082211|323454718|FG000|Overall Study|No protocol treatment received|3|||
94352725|NCT01632345|323073578|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
94352726|NCT01632345|323073579|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
94352727|NCT01632345|323073573|FG000|Treatment: Part I|Physician Decision|2|||
94352728|NCT01632345|323073574|FG001|Treatment: Part I|Physician Decision|1|||
94352729|NCT01632345|323073575|FG002|Treatment: Part I|Physician Decision|0|||
94352730|NCT01632345|323073576|FG003|Treatment: Part I|Physician Decision|0|||
94352731|NCT01632345|323073577|FG004|Treatment: Part I|Physician Decision|1|||
94352732|NCT01632345|323073578|FG005|Treatment: Part I|Physician Decision|0|||
94352733|NCT01632345|323073579|FG006|Treatment: Part I|Physician Decision|0|||
94352734|NCT01632345|323073573|FG000|Treatment: Part I|Pregnancy|0|||
94582268|NCT02079246|323933366|FG000|OLEX-MEM|Withdrawal by Subject|0|||
94582269|NCT02079246|323933367|FG001|OLEX-MEM|Withdrawal by Subject|7|||
94582270|NCT02079246|323933366|FG000|OLEX-MEM|Protocol Violation|0|||
94582271|NCT02079246|323933367|FG001|OLEX-MEM|Protocol Violation|2|||
94582272|NCT02079246|323933366|FG000|OLEX-MEM|Lost to Follow-up|0|||
94582273|NCT02079246|323933367|FG001|OLEX-MEM|Lost to Follow-up|1|||
94582274|NCT02079246|323933366|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
94240633|NCT01228318|322676668|FG000|Overall Study|Moved|0|||
94352735|NCT01632345|323073574|FG001|Treatment: Part I|Pregnancy|1|||
94352736|NCT01632345|323073575|FG002|Treatment: Part I|Pregnancy|0|||
94352737|NCT01632345|323073576|FG003|Treatment: Part I|Pregnancy|0|||
94352738|NCT01632345|323073577|FG004|Treatment: Part I|Pregnancy|0|||
94352739|NCT01632345|323073578|FG005|Treatment: Part I|Pregnancy|0|||
94352740|NCT01632345|323073579|FG006|Treatment: Part I|Pregnancy|0|||
94352741|NCT01632345|323073573|FG000|Treatment: Part I|Protocol Deviation|0|||
94352742|NCT01632345|323073574|FG001|Treatment: Part I|Protocol Deviation|0|||
94352743|NCT01632345|323073575|FG002|Treatment: Part I|Protocol Deviation|1|||
94352744|NCT01632345|323073576|FG003|Treatment: Part I|Protocol Deviation|1|||
94352745|NCT01632345|323073577|FG004|Treatment: Part I|Protocol Deviation|0|||
94352746|NCT01632345|323073578|FG005|Treatment: Part I|Protocol Deviation|0|||
94352747|NCT01632345|323073579|FG006|Treatment: Part I|Protocol Deviation|0|||
94352748|NCT01632345|323073573|FG000|Treatment: Part I|Withdrawal by Subject|3|||
94352749|NCT01632345|323073574|FG001|Treatment: Part I|Withdrawal by Subject|4|||
94352750|NCT01632345|323073575|FG002|Treatment: Part I|Withdrawal by Subject|4|||
94352751|NCT01632345|323073576|FG003|Treatment: Part I|Withdrawal by Subject|1|||
94455163|NCT04791319|323454721|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
94582275|NCT02079246|323933367|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
94455164|NCT04791319|323454722|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
94455165|NCT04791319|323454723|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
94455166|NCT04791319|323454724|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
94455167|NCT04791319|323454725|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
94455168|NCT04791319|323454726|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
94455169|NCT04791319|323454727|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
94455170|NCT04791319|323454728|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
94455171|NCT04791319|323454729|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
94455172|NCT04791319|323454730|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
94455173|NCT04791319|323454731|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
94455174|NCT04791319|323454721|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
94455175|NCT04791319|323454722|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
94455176|NCT04791319|323454723|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
94455177|NCT04791319|323454724|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
94455178|NCT04791319|323454725|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
94455179|NCT04791319|323454726|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
94455180|NCT04791319|323454727|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
94455181|NCT04791319|323454728|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
94659022|NCT01071395|324207959|FG000|Overall Study|Adverse Event|3|||
94352752|NCT01632345|323073577|FG004|Treatment: Part I|Withdrawal by Subject|4|||
94352753|NCT01632345|323073578|FG005|Treatment: Part I|Withdrawal by Subject|0|||
94352754|NCT01632345|323073579|FG006|Treatment: Part I|Withdrawal by Subject|0|||
94352755|NCT01632345|323073573|FG000|Treatment: Part II|Adverse Event|0|||
94352756|NCT01632345|323073574|FG001|Treatment: Part II|Adverse Event|0|||
94352757|NCT01632345|323073575|FG002|Treatment: Part II|Adverse Event|0|||
94352758|NCT01632345|323073576|FG003|Treatment: Part II|Adverse Event|0|||
94352759|NCT01632345|323073577|FG004|Treatment: Part II|Adverse Event|0|||
94352760|NCT01632345|323073578|FG005|Treatment: Part II|Adverse Event|3|||
94352761|NCT01632345|323073579|FG006|Treatment: Part II|Adverse Event|8|||
94352762|NCT01632345|323073573|FG000|Treatment: Part II|Lost to Follow-up|0|||
94352763|NCT01632345|323073574|FG001|Treatment: Part II|Lost to Follow-up|0|||
94352764|NCT01632345|323073575|FG002|Treatment: Part II|Lost to Follow-up|0|||
94352765|NCT01632345|323073576|FG003|Treatment: Part II|Lost to Follow-up|0|||
94352766|NCT01632345|323073577|FG004|Treatment: Part II|Lost to Follow-up|0|||
94352767|NCT01632345|323073578|FG005|Treatment: Part II|Lost to Follow-up|3|||
94352768|NCT01632345|323073579|FG006|Treatment: Part II|Lost to Follow-up|1|||
94352769|NCT01632345|323073573|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
94352770|NCT01632345|323073574|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
94352771|NCT01632345|323073575|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
94352772|NCT01632345|323073576|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
94352773|NCT01632345|323073577|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
94352774|NCT01632345|323073578|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
94352775|NCT01632345|323073579|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
94352776|NCT01632345|323073573|FG000|Treatment: Part II|Withdrawal by Subject|0|||
94352777|NCT01632345|323073574|FG001|Treatment: Part II|Withdrawal by Subject|0|||
94352778|NCT01632345|323073575|FG002|Treatment: Part II|Withdrawal by Subject|0|||
94352779|NCT01632345|323073576|FG003|Treatment: Part II|Withdrawal by Subject|0|||
94352780|NCT01632345|323073577|FG004|Treatment: Part II|Withdrawal by Subject|0|||
94352781|NCT01632345|323073578|FG005|Treatment: Part II|Withdrawal by Subject|2|||
94352782|NCT01632345|323073579|FG006|Treatment: Part II|Withdrawal by Subject|2|||
94352783|NCT03451630|323073580|FG000|Overall Study|Death|15|||
94352784|NCT03451630|323073581|FG001|Overall Study|Death|16|||
94352785|NCT03451630|323073582|FG002|Overall Study|Death|11|||
94352786|NCT03451630|323073580|FG000|Overall Study|Lost to Follow-up|9|||
94352787|NCT03451630|323073581|FG001|Overall Study|Lost to Follow-up|0|||
94352788|NCT03451630|323073582|FG002|Overall Study|Lost to Follow-up|4|||
94352789|NCT03451630|323073580|FG000|Overall Study|Withdrawal by Subject|0|||
94352790|NCT03451630|323073581|FG001|Overall Study|Withdrawal by Subject|3|||
94352791|NCT03451630|323073582|FG002|Overall Study|Withdrawal by Subject|0|||
94352792|NCT03451630|323073580|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
94352793|NCT03451630|323073581|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
94352794|NCT03451630|323073582|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
94352795|NCT00307736|323073589|FG000|Overall Study|Adverse Event|0|||
94352796|NCT00307736|323073590|FG001|Overall Study|Adverse Event|0|||
94352797|NCT00307736|323073591|FG002|Overall Study|Adverse Event|1|||
94352798|NCT00307736|323073592|FG003|Overall Study|Adverse Event|3|||
94352799|NCT00307736|323073589|FG000|Overall Study|Withdrawal by Subject|0|||
94352800|NCT00307736|323073590|FG001|Overall Study|Withdrawal by Subject|0|||
94352801|NCT00307736|323073591|FG002|Overall Study|Withdrawal by Subject|2|||
94352802|NCT00307736|323073592|FG003|Overall Study|Withdrawal by Subject|0|||
94352803|NCT01005875|323073593|FG000|Overall Study|Death|3|||
94352804|NCT02924129|323073598|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
94352805|NCT02924129|323073599|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
94582276|NCT00939393|323933368|FG000|Overall Study|Withdrawal by Subject|1|||
94582277|NCT00939393|323933369|FG001|Overall Study|Withdrawal by Subject|0|||
94582278|NCT00939393|323933368|FG000|Overall Study|Lost to Follow-up|3|||
94582279|NCT00939393|323933369|FG001|Overall Study|Lost to Follow-up|0|||
94582280|NCT01193244|323933373|FG000|Overall Study|Withdrawal by Subject|79|||
94582281|NCT01193244|323933374|FG001|Overall Study|Withdrawal by Subject|97|||
94582282|NCT01193244|323933373|FG000|Overall Study|Other|303|||
94582283|NCT01193244|323933374|FG001|Overall Study|Other|278|||
94582284|NCT01193244|323933373|FG000|Overall Study|Lost to Follow-up|6|||
94582285|NCT01193244|323933374|FG001|Overall Study|Lost to Follow-up|15|||
94582286|NCT03040336|323933383|FG000|Overall Study|Death|1|||
94582287|NCT03040336|323933384|FG001|Overall Study|Death|0|||
94582288|NCT03040336|323933383|FG000|Overall Study|Withdrawal by Subject|2|||
94582289|NCT03040336|323933384|FG001|Overall Study|Withdrawal by Subject|3|||
94582290|NCT03387085|323933389|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
94582291|NCT03848832|323933390|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
94582292|NCT03848832|323933391|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
94582293|NCT03848832|323933392|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
94582294|NCT03848832|323933390|FG000|Overall Study|Withdrawal by Subject|0|||
94582295|NCT03848832|323933391|FG001|Overall Study|Withdrawal by Subject|0|||
94582296|NCT03848832|323933392|FG002|Overall Study|Withdrawal by Subject|1|||
94582297|NCT03848832|323933390|FG000|Overall Study|Withdrawal (Covid-19)|0|||
94582298|NCT03848832|323933391|FG001|Overall Study|Withdrawal (Covid-19)|2|||
94582299|NCT03848832|323933392|FG002|Overall Study|Withdrawal (Covid-19)|0|||
94582300|NCT03848832|323933390|FG000|Overall Study|Physician Decision|2|||
94582301|NCT03848832|323933391|FG001|Overall Study|Physician Decision|1|||
94352806|NCT02924129|323073598|FG000|Overall Study|Withdrawal by Subject|2|||
94582302|NCT03848832|323933392|FG002|Overall Study|Physician Decision|3|||
94582303|NCT03848832|323933390|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
94582304|NCT03848832|323933391|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
94582305|NCT03848832|323933392|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
94582306|NCT03848832|323933390|FG000|Overall Study|Adverse Event|1|||
94582307|NCT03848832|323933391|FG001|Overall Study|Adverse Event|0|||
94352807|NCT02924129|323073599|FG001|Overall Study|Withdrawal by Subject|2|||
94352808|NCT02924129|323073598|FG000|Overall Study|Physician Decision|1|||
94352809|NCT02924129|323073599|FG001|Overall Study|Physician Decision|0|||
94352810|NCT02924129|323073598|FG000|Overall Study|Missed Visit|0|||
94352811|NCT02924129|323073599|FG001|Overall Study|Missed Visit|1|||
94352812|NCT01955005|323073601|FG000|Overall Study|Withdrawal by Subject|3|||
94352813|NCT01955005|323073602|FG001|Overall Study|Withdrawal by Subject|5|||
94352814|NCT04118127|323073606|FG000|Overall Study|Trial terminated by sponsor|0|||
94352815|NCT04118127|323073607|FG001|Overall Study|Trial terminated by sponsor|12|||
94352816|NCT04118127|323073606|FG000|Overall Study|Adverse Event|1|||
94352817|NCT04118127|323073607|FG001|Overall Study|Adverse Event|2|||
94352818|NCT04118127|323073606|FG000|Overall Study|Physician Decision|0|||
94352819|NCT04118127|323073607|FG001|Overall Study|Physician Decision|1|||
94352820|NCT04118127|323073606|FG000|Overall Study|Withdrawal by Subject|2|||
94352821|NCT04118127|323073607|FG001|Overall Study|Withdrawal by Subject|1|||
94352822|NCT01411917|323073608|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
94352823|NCT01411917|323073609|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
94352824|NCT00283062|323073610|FG000|Overall Study|Did not receive any study medication|5|||
94352825|NCT00283062|323073611|FG001|Overall Study|Did not receive any study medication|4|||
94352826|NCT00283062|323073612|FG002|Overall Study|Did not receive any study medication|36|||
94352827|NCT00283062|323073613|FG003|Overall Study|Did not receive any study medication|45|||
94240634|NCT01228318|322676669|FG001|Overall Study|Moved|2|||
94352828|NCT00283062|323073610|FG000|Overall Study|Adverse Event|2|||
94352829|NCT00283062|323073611|FG001|Overall Study|Adverse Event|0|||
94352830|NCT00283062|323073612|FG002|Overall Study|Adverse Event|1|||
94352831|NCT00283062|323073613|FG003|Overall Study|Adverse Event|0|||
94352832|NCT00283062|323073610|FG000|Overall Study|Lost to Follow-up|1|||
94582308|NCT03848832|323933392|FG002|Overall Study|Adverse Event|0|||
94582309|NCT01759446|323933393|FG000|Overall Study|Protocol Violation|1|||
94582310|NCT01759446|323933394|FG001|Overall Study|Protocol Violation|0|||
94582311|NCT01759446|323933395|FG002|Overall Study|Protocol Violation|1|||
94582312|NCT01759446|323933396|FG003|Overall Study|Protocol Violation|0|||
94582313|NCT01759446|323933397|FG004|Overall Study|Protocol Violation|0|||
94582314|NCT01759446|323933393|FG000|Overall Study|Withdrawal by Subject|0|||
94582315|NCT01759446|323933394|FG001|Overall Study|Withdrawal by Subject|1|||
94582316|NCT01759446|323933395|FG002|Overall Study|Withdrawal by Subject|0|||
94582317|NCT01759446|323933396|FG003|Overall Study|Withdrawal by Subject|1|||
94582318|NCT01759446|323933397|FG004|Overall Study|Withdrawal by Subject|0|||
94582319|NCT01244893|323933398|FG000|Baseline|Protocol Violation|0|||
94582320|NCT01244893|323933399|FG001|Baseline|Protocol Violation|1|||
94582321|NCT01244893|323933398|FG000|1-Week Follow Up|Lost to Follow-up|1|||
94582322|NCT01244893|323933399|FG001|1-Week Follow Up|Lost to Follow-up|0|||
94582323|NCT02819804|323933411|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
94582324|NCT00482053|323933415|FG000|Inter-treatment Period|Disease progression|1|||
94582325|NCT02892448|323933416|FG000|Overall Study|Screening failure|2|||
94582326|NCT02892448|323933417|FG001|Overall Study|Screening failure|2|||
94582327|NCT02892448|323933418|FG002|Overall Study|Screening failure|1|||
94582328|NCT00439517|323933419|FG000|Overall Study|Subject on treatment|1|||
94582329|NCT00439517|323933420|FG001|Overall Study|Subject on treatment|0|||
94582330|NCT00439517|323933419|FG000|Overall Study|Subject in survival follow-up|1|||
94582331|NCT00439517|323933420|FG001|Overall Study|Subject in survival follow-up|0|||
94582332|NCT01523366|323933423|FG000|Treatment Period 1|Withdrawal by Subject|1|||
94582333|NCT01523366|323933424|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94582334|NCT01523366|323933423|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
94582335|NCT01523366|323933424|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
94582336|NCT04543279|323933425|FG000|Overall Study|Withdrawal by Subject|1|||
94582337|NCT04543279|323933426|FG001|Overall Study|Withdrawal by Subject|0|||
94582338|NCT04543279|323933425|FG000|Overall Study|Adverse Event|1|||
94582339|NCT04543279|323933426|FG001|Overall Study|Adverse Event|0|||
94582340|NCT04543279|323933425|FG000|Overall Study|Physician Decision|1|||
94582341|NCT04543279|323933426|FG001|Overall Study|Physician Decision|0|||
94582342|NCT02504151|323933431|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
94582343|NCT02504151|323933432|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
94582344|NCT02504151|323933431|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
94582345|NCT02504151|323933432|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
94582346|NCT02504151|323933431|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
94582347|NCT02504151|323933432|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
94582348|NCT02504151|323933431|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
94582349|NCT02504151|323933432|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
94582350|NCT00929695|323933433|FG000|Overall Study|Death|2|||
94582351|NCT00929695|323933434|FG001|Overall Study|Death|1|||
94582352|NCT00929695|323933433|FG000|Overall Study|Withdrawal by Subject|0|||
94582353|NCT00929695|323933434|FG001|Overall Study|Withdrawal by Subject|2|||
94582354|NCT00929695|323933433|FG000|Overall Study|discharge home|4|||
94582355|NCT00929695|323933434|FG001|Overall Study|discharge home|3|||
94582356|NCT00929695|323933433|FG000|Overall Study|incorrect stratification|2|||
94582357|NCT00929695|323933434|FG001|Overall Study|incorrect stratification|0|||
94582358|NCT05038982|323933435|FG000|Overall Study|Withdrawal by Subject|0|||
94582359|NCT05038982|323933436|FG001|Overall Study|Withdrawal by Subject|2|||
94582360|NCT02557139|323933439|FG000|Overall Study|Significant liver elevation|1|||
94352833|NCT00283062|323073611|FG001|Overall Study|Lost to Follow-up|0|||
94582361|NCT02557139|323933440|FG001|Overall Study|Significant liver elevation|0|||
94352834|NCT00283062|323073612|FG002|Overall Study|Lost to Follow-up|1|||
94352835|NCT00283062|323073613|FG003|Overall Study|Lost to Follow-up|0|||
94582362|NCT02557139|323933441|FG002|Overall Study|Significant liver elevation|1|||
94582363|NCT02557139|323933439|FG000|Overall Study|Withdrawal by Subject|1|||
94582364|NCT02557139|323933440|FG001|Overall Study|Withdrawal by Subject|0|||
94582365|NCT02557139|323933441|FG002|Overall Study|Withdrawal by Subject|0|||
94582366|NCT02557139|323933439|FG000|Overall Study|Illness of prohibited medication|0|||
94582367|NCT02557139|323933440|FG001|Overall Study|Illness of prohibited medication|0|||
94582368|NCT02557139|323933441|FG002|Overall Study|Illness of prohibited medication|1|||
94582369|NCT01782378|323933442|FG000|First Series|Lost to Follow-up|7|||
94582370|NCT01782378|323933443|FG001|First Series|Lost to Follow-up|8|||
94582371|NCT01782378|323933442|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
94582372|NCT01782378|323933443|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
94582373|NCT01782378|323933442|FG000|Second Series|Lost to Follow-up|8|||
94582374|NCT01782378|323933443|FG001|Second Series|Lost to Follow-up|7|||
94582375|NCT01782378|323933442|FG000|Second Series|Did not choose to complete S2 Optional|18|||
94582376|NCT01782378|323933443|FG001|Second Series|Did not choose to complete S2 Optional|0|||
94582377|NCT03058146|323933445|FG000|Overall Study|Withdrawal by Subject|4|||
94582378|NCT03058146|323933446|FG001|Overall Study|Withdrawal by Subject|1|||
94582379|NCT03058146|323933445|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
94582380|NCT03058146|323933446|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
94582381|NCT03133793|323933449|FG000|Overall Study|Withdrawal by Subject|0|||
94582382|NCT03133793|323933450|FG001|Overall Study|Withdrawal by Subject|4|||
94582383|NCT03133793|323933451|FG002|Overall Study|Withdrawal by Subject|2|||
94582384|NCT03133793|323933452|FG003|Overall Study|Withdrawal by Subject|4|||
94582385|NCT03133793|323933449|FG000|Overall Study|Lost to Follow-up|1|||
94582386|NCT03133793|323933450|FG001|Overall Study|Lost to Follow-up|0|||
94582387|NCT03133793|323933451|FG002|Overall Study|Lost to Follow-up|2|||
94582388|NCT03133793|323933452|FG003|Overall Study|Lost to Follow-up|0|||
94455182|NCT04791319|323454729|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
94455183|NCT04791319|323454730|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
94582389|NCT03133793|323933449|FG000|Overall Study|Death|0|||
94582390|NCT03133793|323933450|FG001|Overall Study|Death|0|||
94582391|NCT03133793|323933451|FG002|Overall Study|Death|0|||
94455184|NCT04791319|323454731|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
94455185|NCT04791319|323454721|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
94455186|NCT04791319|323454722|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
94455187|NCT04791319|323454723|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
94455188|NCT04791319|323454724|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
94455189|NCT04791319|323454725|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
94455190|NCT04791319|323454726|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
94455191|NCT04791319|323454727|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
94455192|NCT04791319|323454728|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
94455193|NCT04791319|323454729|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
94455194|NCT04791319|323454730|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
94455195|NCT04791319|323454731|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
94455196|NCT04791319|323454721|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
94455197|NCT04791319|323454722|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
94455198|NCT04791319|323454723|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
94455199|NCT04791319|323454724|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
94455200|NCT04791319|323454725|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
94455201|NCT04791319|323454726|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
94455202|NCT04791319|323454727|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
94455203|NCT04791319|323454728|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
94455204|NCT04791319|323454729|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
94455205|NCT04791319|323454730|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
94455206|NCT04791319|323454731|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
94582392|NCT03133793|323933452|FG003|Overall Study|Death|1|||
94582393|NCT01599637|323933453|FG000|Overall Study|administrative problems|0|||
94582394|NCT01599637|323933454|FG001|Overall Study|administrative problems|2|||
94582395|NCT01599637|323933455|FG002|Overall Study|administrative problems|0|||
94582396|NCT01599637|323933453|FG000|Overall Study|Adverse Event|1|||
94582397|NCT01599637|323933454|FG001|Overall Study|Adverse Event|0|||
94582398|NCT01599637|323933455|FG002|Overall Study|Adverse Event|0|||
94582399|NCT01716234|323933472|FG000|Overall Study|Protocol Violation|0|||
94582400|NCT01716234|323933473|FG001|Overall Study|Protocol Violation|0|||
94582401|NCT01716234|323933474|FG002|Overall Study|Protocol Violation|0|||
94582402|NCT01716234|323933475|FG003|Overall Study|Protocol Violation|1|||
94582403|NCT01716234|323933476|FG004|Overall Study|Protocol Violation|1|||
94582404|NCT01716234|323933477|FG005|Overall Study|Protocol Violation|1|||
94582405|NCT01716234|323933478|FG006|Overall Study|Protocol Violation|0|||
94582406|NCT01716234|323933472|FG000|Overall Study|Lack of Efficacy|0|||
94582407|NCT01716234|323933473|FG001|Overall Study|Lack of Efficacy|0|||
94582408|NCT01716234|323933474|FG002|Overall Study|Lack of Efficacy|0|||
94582409|NCT01716234|323933475|FG003|Overall Study|Lack of Efficacy|1|||
94582410|NCT01716234|323933476|FG004|Overall Study|Lack of Efficacy|0|||
94582411|NCT01716234|323933477|FG005|Overall Study|Lack of Efficacy|0|||
94582412|NCT01716234|323933478|FG006|Overall Study|Lack of Efficacy|0|||
94582413|NCT01716234|323933472|FG000|Overall Study|Did not meet protocol eligibility|0|||
94582414|NCT01716234|323933473|FG001|Overall Study|Did not meet protocol eligibility|0|||
94582415|NCT01716234|323933474|FG002|Overall Study|Did not meet protocol eligibility|1|||
94582416|NCT01716234|323933475|FG003|Overall Study|Did not meet protocol eligibility|0|||
94582417|NCT01716234|323933476|FG004|Overall Study|Did not meet protocol eligibility|0|||
94582418|NCT01716234|323933477|FG005|Overall Study|Did not meet protocol eligibility|4|||
94582419|NCT01716234|323933478|FG006|Overall Study|Did not meet protocol eligibility|0|||
94582420|NCT01716234|323933472|FG000|Overall Study|Adverse Event|7|||
94582421|NCT01716234|323933473|FG001|Overall Study|Adverse Event|10|||
94582422|NCT01716234|323933474|FG002|Overall Study|Adverse Event|2|||
94582423|NCT01716234|323933475|FG003|Overall Study|Adverse Event|8|||
94582424|NCT01716234|323933476|FG004|Overall Study|Adverse Event|3|||
94582425|NCT01716234|323933477|FG005|Overall Study|Adverse Event|6|||
94582426|NCT01716234|323933478|FG006|Overall Study|Adverse Event|0|||
94582427|NCT01716234|323933472|FG000|Overall Study|Withdrawal by Subject|3|||
94582428|NCT01716234|323933473|FG001|Overall Study|Withdrawal by Subject|0|||
94582429|NCT01716234|323933474|FG002|Overall Study|Withdrawal by Subject|2|||
94582430|NCT01716234|323933475|FG003|Overall Study|Withdrawal by Subject|2|||
94582431|NCT01716234|323933476|FG004|Overall Study|Withdrawal by Subject|1|||
94582432|NCT01716234|323933477|FG005|Overall Study|Withdrawal by Subject|3|||
94582433|NCT01716234|323933478|FG006|Overall Study|Withdrawal by Subject|0|||
94582434|NCT02157883|323933479|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
94582435|NCT02157883|323933479|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
94582436|NCT02157883|323933479|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
94582437|NCT02157883|323933479|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
94582438|NCT02157883|323933479|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
94582439|NCT00960999|323933480|FG000|Overall Study|Withdrawal by Subject|1|||
94582440|NCT00960999|323933481|FG001|Overall Study|Withdrawal by Subject|0|||
94582441|NCT00960999|323933480|FG000|Overall Study|Protocol Violation|5|||
94582442|NCT00960999|323933481|FG001|Overall Study|Protocol Violation|2|||
94582443|NCT00960999|323933480|FG000|Overall Study|RT dose constraints not met|2|||
94582444|NCT00960999|323933481|FG001|Overall Study|RT dose constraints not met|0|||
94582445|NCT02963506|323933487|FG000|Double-Blind Period|Adverse Event|0|||
94582446|NCT02963506|323933488|FG001|Double-Blind Period|Adverse Event|0|||
94582447|NCT02963506|323933489|FG002|Double-Blind Period|Adverse Event|1|||
94582448|NCT02963506|323933490|FG003|Double-Blind Period|Adverse Event|0|||
94582449|NCT02963506|323933491|FG004|Double-Blind Period|Adverse Event|0|||
94582450|NCT02963506|323933492|FG005|Double-Blind Period|Adverse Event|0|||
94582451|NCT02963506|323933493|FG006|Double-Blind Period|Adverse Event|0|||
94582452|NCT02963506|323933494|FG007|Double-Blind Period|Adverse Event|0|||
94582453|NCT02963506|323933495|FG008|Double-Blind Period|Adverse Event|0|||
94582454|NCT02963506|323933496|FG009|Double-Blind Period|Adverse Event|0|||
94582455|NCT02963506|323933497|FG010|Double-Blind Period|Adverse Event|0|||
94582456|NCT02963506|323933498|FG011|Double-Blind Period|Adverse Event|0|||
94582457|NCT02963506|323933499|FG012|Double-Blind Period|Adverse Event|0|||
94582458|NCT02963506|323933487|FG000|Double-Blind Period|Death|0|||
94582459|NCT02963506|323933488|FG001|Double-Blind Period|Death|0|||
94582460|NCT02963506|323933489|FG002|Double-Blind Period|Death|0|||
94582461|NCT02963506|323933490|FG003|Double-Blind Period|Death|1|||
94582462|NCT02963506|323933491|FG004|Double-Blind Period|Death|0|||
94582463|NCT02963506|323933492|FG005|Double-Blind Period|Death|0|||
94582464|NCT02963506|323933493|FG006|Double-Blind Period|Death|0|||
94582465|NCT02963506|323933494|FG007|Double-Blind Period|Death|0|||
94582466|NCT02963506|323933495|FG008|Double-Blind Period|Death|0|||
94582467|NCT02963506|323933496|FG009|Double-Blind Period|Death|0|||
94582468|NCT02963506|323933497|FG010|Double-Blind Period|Death|0|||
94582469|NCT02963506|323933498|FG011|Double-Blind Period|Death|0|||
94582470|NCT02963506|323933499|FG012|Double-Blind Period|Death|0|||
94582471|NCT02963506|323933487|FG000|Double-Blind Period|Lost to Follow-up|0|||
94582472|NCT02963506|323933488|FG001|Double-Blind Period|Lost to Follow-up|1|||
94582473|NCT02963506|323933489|FG002|Double-Blind Period|Lost to Follow-up|0|||
94582474|NCT02963506|323933490|FG003|Double-Blind Period|Lost to Follow-up|0|||
94582475|NCT02963506|323933491|FG004|Double-Blind Period|Lost to Follow-up|0|||
94582476|NCT02963506|323933492|FG005|Double-Blind Period|Lost to Follow-up|0|||
94582477|NCT02963506|323933493|FG006|Double-Blind Period|Lost to Follow-up|0|||
94582478|NCT02963506|323933494|FG007|Double-Blind Period|Lost to Follow-up|0|||
94582479|NCT02963506|323933495|FG008|Double-Blind Period|Lost to Follow-up|0|||
94582480|NCT02963506|323933496|FG009|Double-Blind Period|Lost to Follow-up|0|||
94582481|NCT02963506|323933497|FG010|Double-Blind Period|Lost to Follow-up|0|||
94582482|NCT02963506|323933498|FG011|Double-Blind Period|Lost to Follow-up|0|||
94582483|NCT02963506|323933499|FG012|Double-Blind Period|Lost to Follow-up|0|||
94582484|NCT02963506|323933487|FG000|Double-Blind Period|Withdrawal by Subject|0|||
94582485|NCT02963506|323933488|FG001|Double-Blind Period|Withdrawal by Subject|0|||
94582486|NCT02963506|323933489|FG002|Double-Blind Period|Withdrawal by Subject|1|||
94582487|NCT02963506|323933490|FG003|Double-Blind Period|Withdrawal by Subject|1|||
94582488|NCT02963506|323933491|FG004|Double-Blind Period|Withdrawal by Subject|0|||
94582489|NCT02963506|323933492|FG005|Double-Blind Period|Withdrawal by Subject|0|||
94582490|NCT02963506|323933493|FG006|Double-Blind Period|Withdrawal by Subject|0|||
94582491|NCT02963506|323933494|FG007|Double-Blind Period|Withdrawal by Subject|0|||
94582492|NCT02963506|323933495|FG008|Double-Blind Period|Withdrawal by Subject|0|||
94582493|NCT02963506|323933496|FG009|Double-Blind Period|Withdrawal by Subject|0|||
94582494|NCT02963506|323933497|FG010|Double-Blind Period|Withdrawal by Subject|0|||
94582495|NCT02963506|323933498|FG011|Double-Blind Period|Withdrawal by Subject|0|||
94582496|NCT02963506|323933499|FG012|Double-Blind Period|Withdrawal by Subject|0|||
94582497|NCT02963506|323933487|FG000|Double-Blind Period|No compliance|0|||
94582498|NCT02963506|323933488|FG001|Double-Blind Period|No compliance|1|||
94582499|NCT02963506|323933489|FG002|Double-Blind Period|No compliance|0|||
94582500|NCT02963506|323933490|FG003|Double-Blind Period|No compliance|0|||
94582501|NCT02963506|323933491|FG004|Double-Blind Period|No compliance|0|||
94582502|NCT02963506|323933492|FG005|Double-Blind Period|No compliance|0|||
94582503|NCT02963506|323933493|FG006|Double-Blind Period|No compliance|0|||
94582504|NCT02963506|323933494|FG007|Double-Blind Period|No compliance|0|||
94582505|NCT02963506|323933495|FG008|Double-Blind Period|No compliance|0|||
94582506|NCT02963506|323933496|FG009|Double-Blind Period|No compliance|0|||
94582507|NCT02963506|323933497|FG010|Double-Blind Period|No compliance|0|||
94582508|NCT02963506|323933498|FG011|Double-Blind Period|No compliance|0|||
94582509|NCT02963506|323933499|FG012|Double-Blind Period|No compliance|0|||
94582510|NCT02963506|323933487|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
94582511|NCT02963506|323933488|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
94582512|NCT02963506|323933489|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
94582513|NCT02963506|323933490|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
94582514|NCT02963506|323933491|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
94582515|NCT02963506|323933492|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
94582516|NCT02963506|323933493|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
94582517|NCT02963506|323933494|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
94582518|NCT02963506|323933495|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
94582519|NCT02963506|323933496|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
94582520|NCT02963506|323933497|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
94582521|NCT02963506|323933498|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
94582522|NCT02963506|323933499|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
94582523|NCT02963506|323933487|FG000|Dose-Blind Period|Adverse Event|0|||
94582524|NCT02963506|323933488|FG001|Dose-Blind Period|Adverse Event|0|||
94582525|NCT02963506|323933489|FG002|Dose-Blind Period|Adverse Event|0|||
94582526|NCT02963506|323933490|FG003|Dose-Blind Period|Adverse Event|0|||
94582527|NCT02963506|323933491|FG004|Dose-Blind Period|Adverse Event|0|||
94582528|NCT02963506|323933492|FG005|Dose-Blind Period|Adverse Event|1|||
94582529|NCT02963506|323933493|FG006|Dose-Blind Period|Adverse Event|3|||
94582530|NCT02963506|323933494|FG007|Dose-Blind Period|Adverse Event|2|||
94582531|NCT02963506|323933495|FG008|Dose-Blind Period|Adverse Event|2|||
94582532|NCT02963506|323933496|FG009|Dose-Blind Period|Adverse Event|2|||
94582533|NCT02963506|323933497|FG010|Dose-Blind Period|Adverse Event|1|||
94582534|NCT02963506|323933498|FG011|Dose-Blind Period|Adverse Event|1|||
94582535|NCT02963506|323933499|FG012|Dose-Blind Period|Adverse Event|6|||
94582536|NCT02963506|323933487|FG000|Dose-Blind Period|Lack of Efficacy|0|||
94582537|NCT02963506|323933488|FG001|Dose-Blind Period|Lack of Efficacy|0|||
94582538|NCT02963506|323933489|FG002|Dose-Blind Period|Lack of Efficacy|0|||
94582539|NCT02963506|323933490|FG003|Dose-Blind Period|Lack of Efficacy|0|||
94582540|NCT02963506|323933491|FG004|Dose-Blind Period|Lack of Efficacy|0|||
94582541|NCT02963506|323933492|FG005|Dose-Blind Period|Lack of Efficacy|0|||
94582542|NCT02963506|323933493|FG006|Dose-Blind Period|Lack of Efficacy|0|||
94455207|NCT04791319|323454721|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
94455208|NCT04791319|323454722|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
94455209|NCT04791319|323454723|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
94582543|NCT02963506|323933494|FG007|Dose-Blind Period|Lack of Efficacy|1|||
94582544|NCT02963506|323933495|FG008|Dose-Blind Period|Lack of Efficacy|0|||
94582545|NCT02963506|323933496|FG009|Dose-Blind Period|Lack of Efficacy|1|||
94582546|NCT02963506|323933497|FG010|Dose-Blind Period|Lack of Efficacy|0|||
94582547|NCT02963506|323933498|FG011|Dose-Blind Period|Lack of Efficacy|0|||
94582548|NCT02963506|323933499|FG012|Dose-Blind Period|Lack of Efficacy|0|||
94582549|NCT02963506|323933487|FG000|Dose-Blind Period|Lost to Follow-up|0|||
94582550|NCT02963506|323933488|FG001|Dose-Blind Period|Lost to Follow-up|0|||
94582551|NCT02963506|323933489|FG002|Dose-Blind Period|Lost to Follow-up|0|||
94582552|NCT02963506|323933490|FG003|Dose-Blind Period|Lost to Follow-up|0|||
94582553|NCT02963506|323933491|FG004|Dose-Blind Period|Lost to Follow-up|0|||
94582554|NCT02963506|323933492|FG005|Dose-Blind Period|Lost to Follow-up|1|||
94582555|NCT02963506|323933493|FG006|Dose-Blind Period|Lost to Follow-up|0|||
94582556|NCT02963506|323933494|FG007|Dose-Blind Period|Lost to Follow-up|0|||
94582557|NCT02963506|323933495|FG008|Dose-Blind Period|Lost to Follow-up|1|||
94582558|NCT02963506|323933496|FG009|Dose-Blind Period|Lost to Follow-up|0|||
94582559|NCT02963506|323933497|FG010|Dose-Blind Period|Lost to Follow-up|0|||
94582560|NCT02963506|323933498|FG011|Dose-Blind Period|Lost to Follow-up|1|||
94582561|NCT02963506|323933499|FG012|Dose-Blind Period|Lost to Follow-up|0|||
94582562|NCT02963506|323933487|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
94582563|NCT02963506|323933488|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
94582564|NCT02963506|323933489|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
94582565|NCT02963506|323933490|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
94582566|NCT02963506|323933491|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
94582567|NCT02963506|323933492|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
94582568|NCT02963506|323933493|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
94582569|NCT02963506|323933494|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
94582570|NCT02963506|323933495|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
94582571|NCT02963506|323933496|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
94582572|NCT02963506|323933497|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
94582573|NCT02963506|323933498|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
94582574|NCT02963506|323933499|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
94582575|NCT02963506|323933487|FG000|Dose-Blind Period|Sponsor decision|0|||
94582576|NCT02963506|323933488|FG001|Dose-Blind Period|Sponsor decision|0|||
94582577|NCT02963506|323933489|FG002|Dose-Blind Period|Sponsor decision|0|||
94582578|NCT02963506|323933490|FG003|Dose-Blind Period|Sponsor decision|0|||
94582579|NCT02963506|323933491|FG004|Dose-Blind Period|Sponsor decision|0|||
94582580|NCT02963506|323933492|FG005|Dose-Blind Period|Sponsor decision|1|||
94582581|NCT02963506|323933493|FG006|Dose-Blind Period|Sponsor decision|0|||
94582582|NCT02963506|323933494|FG007|Dose-Blind Period|Sponsor decision|0|||
94582583|NCT02963506|323933495|FG008|Dose-Blind Period|Sponsor decision|0|||
94582584|NCT02963506|323933496|FG009|Dose-Blind Period|Sponsor decision|0|||
94582585|NCT02963506|323933497|FG010|Dose-Blind Period|Sponsor decision|0|||
94582586|NCT02963506|323933498|FG011|Dose-Blind Period|Sponsor decision|0|||
94582587|NCT02963506|323933499|FG012|Dose-Blind Period|Sponsor decision|0|||
94582588|NCT02963506|323933487|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
94582589|NCT02963506|323933488|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
94582590|NCT02963506|323933489|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
94582591|NCT02963506|323933490|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
94582592|NCT02963506|323933491|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
94582593|NCT02963506|323933492|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
94582594|NCT02963506|323933493|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
94582595|NCT02963506|323933494|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
94582596|NCT02963506|323933495|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
94582597|NCT02963506|323933496|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
94582598|NCT02963506|323933497|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
94582599|NCT02963506|323933498|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
94582600|NCT02963506|323933499|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
94582601|NCT02129699|323933500|FG000|Overall Study|Did not start treatment|3|||
94582602|NCT02129699|323933501|FG001|Overall Study|Did not start treatment|2|||
94582603|NCT01780974|323933502|FG000|Overall Study|Death|1|||
94582604|NCT01780974|323933503|FG001|Overall Study|Death|0|||
94582605|NCT01780974|323933502|FG000|Overall Study|Adverse Event|1|||
94240635|NCT01228318|322676668|FG000|Overall Study|Incarcerated|1|||
94240636|NCT01228318|322676669|FG001|Overall Study|Incarcerated|0|||
94240637|NCT02815579|322676670|FG000|Overall Study|Non-payment of loan down-payment|16|||
94240638|NCT02815579|322676671|FG001|Overall Study|Non-payment of loan down-payment|0|||
94240639|NCT02815579|322676670|FG000|Overall Study|Withdrawal by Subject|7|||
94240640|NCT02815579|322676671|FG001|Overall Study|Withdrawal by Subject|1|||
94240641|NCT02815579|322676670|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
94582606|NCT01780974|323933503|FG001|Overall Study|Adverse Event|3|||
94240642|NCT02815579|322676671|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
94582607|NCT04498832|323933509|FG000|Overall Study|Adverse Event|1|||
94582608|NCT04498832|323933510|FG001|Overall Study|Adverse Event|3|||
94582609|NCT04498832|323933509|FG000|Overall Study|Withdrawal by Subject|0|||
94582610|NCT04498832|323933510|FG001|Overall Study|Withdrawal by Subject|1|||
94582611|NCT04161157|323933511|FG000|Overall Study|Lost to Follow-up|4|||
94582612|NCT04161157|323933511|FG000|Overall Study|Death|3|||
94582613|NCT04161157|323933511|FG000|Overall Study|Ineligible|2|||
94240643|NCT02815579|322676670|FG000|Overall Study|Lost to Follow-up|7|||
94240644|NCT02815579|322676671|FG001|Overall Study|Lost to Follow-up|4|||
94240645|NCT02815579|322676670|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
94582614|NCT04161157|323933511|FG000|Overall Study|Withdrawal by Subject|4|||
94582615|NCT02581410|323933512|FG000|Vaccination Phase|Adverse Event|2|||
94582616|NCT02581410|323933513|FG001|Vaccination Phase|Adverse Event|1|||
94659023|NCT01071395|324207960|FG001|Overall Study|Adverse Event|1|||
94582617|NCT02581410|323933512|FG000|Vaccination Phase|Withdrawal by Subject|0|||
94582618|NCT02581410|323933513|FG001|Vaccination Phase|Withdrawal by Subject|1|||
94582619|NCT02581410|323933512|FG000|Vaccination Phase|Migrated/moved from study area|0|||
94582620|NCT02581410|323933513|FG001|Vaccination Phase|Migrated/moved from study area|1|||
94582621|NCT02581410|323933512|FG000|End of Study Phase|Adverse Event|4|||
94582622|NCT02581410|323933513|FG001|End of Study Phase|Adverse Event|3|||
94582623|NCT02581410|323933512|FG000|End of Study Phase|Withdrawal by Subject|1|||
94582624|NCT02581410|323933513|FG001|End of Study Phase|Withdrawal by Subject|2|||
94582625|NCT02581410|323933512|FG000|End of Study Phase|Migrated/moved from study area|0|||
94582626|NCT02581410|323933513|FG001|End of Study Phase|Migrated/moved from study area|3|||
94582627|NCT02581410|323933512|FG000|End of Study Phase|Lost to Follow-up|0|||
94582628|NCT02581410|323933513|FG001|End of Study Phase|Lost to Follow-up|2|||
94582629|NCT02581410|323933512|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
94582630|NCT02581410|323933513|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
94582631|NCT00670748|323933518|FG000|Overall Study|Death during treatment|1|||
94582632|NCT00670748|323933519|FG001|Overall Study|Death during treatment|1|||
94582633|NCT00670748|323933520|FG002|Overall Study|Death during treatment|1|||
94582634|NCT00670748|323933521|FG003|Overall Study|Death during treatment|0|||
94582635|NCT00670748|323933518|FG000|Overall Study|Not off study|2|||
94582636|NCT00670748|323933519|FG001|Overall Study|Not off study|1|||
94582637|NCT00670748|323933520|FG002|Overall Study|Not off study|1|||
94582638|NCT00670748|323933521|FG003|Overall Study|Not off study|1|||
94582639|NCT00494676|323933527|FG000|Allocation|Withdrawal by Subject|2|||
94582640|NCT00494676|323933528|FG001|Allocation|Withdrawal by Subject|4|||
94582641|NCT00494676|323933527|FG000|First Intervention|Withdrawal by Subject|1|||
94582642|NCT00494676|323933528|FG001|First Intervention|Withdrawal by Subject|3|||
94582643|NCT00494676|323933527|FG000|Second Intervention|Withdrawal by Subject|1|||
94582644|NCT00494676|323933528|FG001|Second Intervention|Withdrawal by Subject|1|||
94582645|NCT04434937|323933529|FG000|Overall Study|Death|4|||
94582646|NCT04434937|323933529|FG000|Overall Study|Withdrawal by Subject|1|||
94582647|NCT04434937|323933529|FG000|Overall Study|Transitioned to Rollover Study|19|||
94582648|NCT04434937|323933529|FG000|Overall Study|Progressive Disease|18|||
94582649|NCT05767749|323933530|FG000|Overall Study|Withdrawal by Subject|0|||
94582650|NCT05767749|323933531|FG001|Overall Study|Withdrawal by Subject|0|||
94582651|NCT05767749|323933532|FG002|Overall Study|Withdrawal by Subject|2|||
94582652|NCT05767749|323933533|FG003|Overall Study|Withdrawal by Subject|2|||
94582653|NCT05767749|323933534|FG004|Overall Study|Withdrawal by Subject|2|||
94582654|NCT05767749|323933535|FG005|Overall Study|Withdrawal by Subject|2|||
94582655|NCT03299166|323933540|FG000|Overall Study|Adverse Event|9|||
94582656|NCT03299166|323933541|FG001|Overall Study|Adverse Event|4|||
94582657|NCT03299166|323933540|FG000|Overall Study|Withdrawal by Subject|6|||
94582658|NCT03299166|323933541|FG001|Overall Study|Withdrawal by Subject|5|||
94582659|NCT03299166|323933540|FG000|Overall Study|Physician Decision|1|||
94582660|NCT03299166|323933541|FG001|Overall Study|Physician Decision|1|||
94582661|NCT03299166|323933540|FG000|Overall Study|Sponsor Decision|3|||
94582662|NCT03299166|323933541|FG001|Overall Study|Sponsor Decision|0|||
94582663|NCT03299166|323933540|FG000|Overall Study|Lost to Follow-up|2|||
94582664|NCT03299166|323933541|FG001|Overall Study|Lost to Follow-up|4|||
94582665|NCT03299166|323933540|FG000|Overall Study|Randomization Error|0|||
94582666|NCT03299166|323933541|FG001|Overall Study|Randomization Error|1|||
94582667|NCT03299166|323933540|FG000|Overall Study|Subject unable to return due to COVID|1|||
94582668|NCT03299166|323933541|FG001|Overall Study|Subject unable to return due to COVID|0|||
94582669|NCT03299166|323933540|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
94582670|NCT03299166|323933541|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
94582671|NCT00775190|323934901|FG000|Overall Study|Lost to Follow-up|2|||
94582672|NCT00775190|323934902|FG001|Overall Study|Lost to Follow-up|3|||
94582673|NCT00775190|323934901|FG000|Overall Study|Withdrawal by Subject|1|||
94582674|NCT00775190|323934902|FG001|Overall Study|Withdrawal by Subject|2|||
94582675|NCT00775190|323934901|FG000|Overall Study|Protocol Violation|1|||
94582676|NCT00775190|323934902|FG001|Overall Study|Protocol Violation|0|||
94582677|NCT01671319|323934903|FG000|Overall Study|Withdrawal by Subject|1|||
94582678|NCT01712399|323934907|FG000|Overall Study|Lost to Follow-up|1|||
94582679|NCT01712399|323934907|FG000|Overall Study|Withdrawal by Subject|39|||
94582680|NCT01712399|323934907|FG000|Overall Study|Death|1|||
94582681|NCT01712399|323934907|FG000|Overall Study|Adverse Event|11|||
94582682|NCT01712399|323934907|FG000|Overall Study|Study closure|345|||
94582683|NCT01458392|323934914|FG000|Overall Study|Death|2|||
94582684|NCT01458392|323934915|FG001|Overall Study|Death|11|||
94582685|NCT01458392|323934916|FG002|Overall Study|Death|22|||
94582686|NCT01458392|323934914|FG000|Overall Study|At the discretion of the sponsor|0|||
94582687|NCT01458392|323934915|FG001|Overall Study|At the discretion of the sponsor|2|||
94352836|NCT00283062|323073610|FG000|Overall Study|Progressive disease|0|||
94582688|NCT01458392|323934916|FG002|Overall Study|At the discretion of the sponsor|7|||
94582689|NCT01458392|323934914|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
94582690|NCT01458392|323934915|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
94582691|NCT01458392|323934916|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
94582692|NCT00706238|323934919|FG000|Overall Study|Disease progression|4|||
94582693|NCT00706238|323934919|FG000|Overall Study|Other|1|||
94582694|NCT00753506|323934920|FG000|Overall Study|Withdrawal by Subject|4|||
94582695|NCT00753506|323934921|FG001|Overall Study|Withdrawal by Subject|1|||
94582696|NCT00753506|323934920|FG000|Overall Study|Lost to Follow-up|2|||
94582697|NCT00753506|323934921|FG001|Overall Study|Lost to Follow-up|0|||
94582698|NCT00753506|323934920|FG000|Overall Study|Other reason|1|||
94582699|NCT00753506|323934921|FG001|Overall Study|Other reason|1|||
94582700|NCT03841604|323934922|FG000|Overall Study|Withdrawal by Subject|3|||
94582701|NCT03841604|323934923|FG001|Overall Study|Withdrawal by Subject|1|||
94582702|NCT03841604|323934922|FG000|Overall Study|Adverse Event|4|||
94582703|NCT03841604|323934923|FG001|Overall Study|Adverse Event|2|||
94582704|NCT03841604|323934922|FG000|Overall Study|Physician Decision|1|||
94582705|NCT03841604|323934923|FG001|Overall Study|Physician Decision|0|||
94582706|NCT01417377|323934924|FG000|Overall Study|Lost to Follow-up|12|||
94582707|NCT01417377|323934924|FG000|Overall Study|Enrolled, but not treated|1|||
94582708|NCT03763877|323934925|FG000|Overall Study|Withdrawal by Subject|3|||
94582709|NCT03763877|323934926|FG001|Overall Study|Withdrawal by Subject|1|||
94582710|NCT03763877|323934927|FG002|Overall Study|Withdrawal by Subject|3|||
94582711|NCT03763877|323934928|FG003|Overall Study|Withdrawal by Subject|4|||
94582712|NCT03763877|323934925|FG000|Overall Study|Adverse Event|1|||
94582713|NCT03763877|323934926|FG001|Overall Study|Adverse Event|1|||
94582714|NCT03763877|323934927|FG002|Overall Study|Adverse Event|3|||
94582715|NCT03763877|323934928|FG003|Overall Study|Adverse Event|1|||
94582716|NCT03763877|323934925|FG000|Overall Study|Protocol Violation|1|||
94582717|NCT03763877|323934926|FG001|Overall Study|Protocol Violation|1|||
94582718|NCT03763877|323934927|FG002|Overall Study|Protocol Violation|0|||
94582719|NCT03763877|323934928|FG003|Overall Study|Protocol Violation|0|||
94582720|NCT03763877|323934925|FG000|Overall Study|Lost to Follow-up|0|||
94582721|NCT03763877|323934926|FG001|Overall Study|Lost to Follow-up|1|||
94582722|NCT03763877|323934927|FG002|Overall Study|Lost to Follow-up|1|||
94582723|NCT03763877|323934928|FG003|Overall Study|Lost to Follow-up|0|||
94582724|NCT00068692|323934929|FG000|Step 1: Registration|Disese progression/relapse|5|||
94582725|NCT00068692|323934930|FG001|Step 1: Registration|Disese progression/relapse|0|||
94582726|NCT00068692|323934931|FG002|Step 1: Registration|Disese progression/relapse|0|||
94582727|NCT00068692|323934932|FG003|Step 1: Registration|Disese progression/relapse|0|||
94582728|NCT00068692|323934933|FG004|Step 1: Registration|Disese progression/relapse|0|||
94582729|NCT00068692|323934934|FG005|Step 1: Registration|Disese progression/relapse|0|||
94582730|NCT00068692|323934935|FG006|Step 1: Registration|Disese progression/relapse|0|||
94582731|NCT00068692|323934936|FG007|Step 1: Registration|Disese progression/relapse|0|||
94582732|NCT00068692|323934929|FG000|Step 1: Registration|Adverse Event|7|||
94582733|NCT00068692|323934930|FG001|Step 1: Registration|Adverse Event|0|||
94582734|NCT00068692|323934931|FG002|Step 1: Registration|Adverse Event|0|||
94582735|NCT00068692|323934932|FG003|Step 1: Registration|Adverse Event|0|||
94582736|NCT00068692|323934933|FG004|Step 1: Registration|Adverse Event|0|||
94582737|NCT00068692|323934934|FG005|Step 1: Registration|Adverse Event|0|||
94582738|NCT00068692|323934935|FG006|Step 1: Registration|Adverse Event|0|||
94582739|NCT00068692|323934936|FG007|Step 1: Registration|Adverse Event|0|||
94582740|NCT00068692|323934929|FG000|Step 1: Registration|Death|1|||
94582741|NCT00068692|323934930|FG001|Step 1: Registration|Death|0|||
94582742|NCT00068692|323934931|FG002|Step 1: Registration|Death|0|||
94582743|NCT00068692|323934932|FG003|Step 1: Registration|Death|0|||
94582744|NCT00068692|323934933|FG004|Step 1: Registration|Death|0|||
94582745|NCT00068692|323934934|FG005|Step 1: Registration|Death|0|||
94582746|NCT00068692|323934935|FG006|Step 1: Registration|Death|0|||
94582747|NCT00068692|323934936|FG007|Step 1: Registration|Death|0|||
94582748|NCT00068692|323934929|FG000|Step 1: Registration|Withdrawal by Subject|11|||
94582749|NCT00068692|323934930|FG001|Step 1: Registration|Withdrawal by Subject|0|||
94582750|NCT00068692|323934931|FG002|Step 1: Registration|Withdrawal by Subject|0|||
94582751|NCT00068692|323934932|FG003|Step 1: Registration|Withdrawal by Subject|0|||
94582752|NCT00068692|323934933|FG004|Step 1: Registration|Withdrawal by Subject|0|||
94582753|NCT00068692|323934934|FG005|Step 1: Registration|Withdrawal by Subject|0|||
94582754|NCT00068692|323934935|FG006|Step 1: Registration|Withdrawal by Subject|0|||
94582755|NCT00068692|323934936|FG007|Step 1: Registration|Withdrawal by Subject|0|||
94582756|NCT00068692|323934929|FG000|Step 1: Registration|Alternative therapy|2|||
94582757|NCT00068692|323934930|FG001|Step 1: Registration|Alternative therapy|0|||
94582758|NCT00068692|323934931|FG002|Step 1: Registration|Alternative therapy|0|||
94582759|NCT00068692|323934932|FG003|Step 1: Registration|Alternative therapy|0|||
94582760|NCT00068692|323934933|FG004|Step 1: Registration|Alternative therapy|0|||
94582761|NCT00068692|323934934|FG005|Step 1: Registration|Alternative therapy|0|||
94582762|NCT00068692|323934935|FG006|Step 1: Registration|Alternative therapy|0|||
94582763|NCT00068692|323934936|FG007|Step 1: Registration|Alternative therapy|0|||
94582764|NCT00068692|323934929|FG000|Step 1: Registration|Complicating disease|2|||
94582765|NCT00068692|323934930|FG001|Step 1: Registration|Complicating disease|0|||
94582766|NCT00068692|323934931|FG002|Step 1: Registration|Complicating disease|0|||
94582767|NCT00068692|323934932|FG003|Step 1: Registration|Complicating disease|0|||
94582768|NCT00068692|323934933|FG004|Step 1: Registration|Complicating disease|0|||
94352837|NCT00283062|323073611|FG001|Overall Study|Progressive disease|0|||
94582769|NCT00068692|323934934|FG005|Step 1: Registration|Complicating disease|0|||
94582770|NCT00068692|323934935|FG006|Step 1: Registration|Complicating disease|0|||
94582771|NCT00068692|323934936|FG007|Step 1: Registration|Complicating disease|0|||
94582772|NCT00068692|323934929|FG000|Step 1: Registration|Protocol Violation|1|||
94582773|NCT00068692|323934930|FG001|Step 1: Registration|Protocol Violation|0|||
94582774|NCT00068692|323934931|FG002|Step 1: Registration|Protocol Violation|0|||
94582775|NCT00068692|323934932|FG003|Step 1: Registration|Protocol Violation|0|||
94582776|NCT00068692|323934933|FG004|Step 1: Registration|Protocol Violation|0|||
94582777|NCT00068692|323934934|FG005|Step 1: Registration|Protocol Violation|0|||
94582778|NCT00068692|323934935|FG006|Step 1: Registration|Protocol Violation|0|||
94582779|NCT00068692|323934936|FG007|Step 1: Registration|Protocol Violation|0|||
94659024|NCT01539291|324207961|FG000|Study GS-US-312-0116|Adverse Event|9|||
94352838|NCT00283062|323073612|FG002|Overall Study|Progressive disease|1|||
94352839|NCT00283062|323073613|FG003|Overall Study|Progressive disease|0|||
94352840|NCT00283062|323073610|FG000|Overall Study|Participant did not wish to continue|3|||
94352841|NCT00283062|323073611|FG001|Overall Study|Participant did not wish to continue|2|||
94352842|NCT00283062|323073612|FG002|Overall Study|Participant did not wish to continue|1|||
94352843|NCT00283062|323073613|FG003|Overall Study|Participant did not wish to continue|0|||
94352844|NCT00283062|323073610|FG000|Overall Study|Undefined|0|||
94352845|NCT00283062|323073611|FG001|Overall Study|Undefined|1|||
94352846|NCT00283062|323073612|FG002|Overall Study|Undefined|1|||
94352847|NCT00283062|323073613|FG003|Overall Study|Undefined|4|||
94352848|NCT00283062|323073610|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
94352849|NCT00283062|323073611|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
94352850|NCT00283062|323073612|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
94352851|NCT00283062|323073613|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
94352852|NCT01990339|323073614|FG000|Overall Study|Data Not Available|49|||
94352853|NCT01990339|323073614|FG000|Overall Study|Voluntary Withdrawal|1402|||
94352854|NCT01990339|323073614|FG000|Overall Study|Lost to Follow-up|861|||
94352855|NCT00242658|323073615|FG000|Overall Study|Lost to Follow-up|22|||
94352856|NCT00242658|323073616|FG001|Overall Study|Lost to Follow-up|19|||
94352857|NCT02811640|323073618|FG000|Overall Study|Technology malfunction|2|||
94352858|NCT02127931|323073621|FG000|Overall Study|Glitch in Game|1|||
94352859|NCT01130831|323073622|FG000|Overall Study|Withdrawal by Subject|7|||
94352860|NCT01130831|323073622|FG000|Overall Study|Death|4|||
94352861|NCT01130831|323073622|FG000|Overall Study|Information was missing|3|||
94352862|NCT00489216|323073623|FG000|Overall Study|Adverse Event|1|||
94352863|NCT00422942|323073624|FG000|Overall Study|Study terminated by Sponsor|3|||
94352864|NCT02612194|323073625|FG000|Overall Study|Death|5|||
94352865|NCT02612194|323073626|FG001|Overall Study|Death|0|||
94352866|NCT02612194|323073627|FG002|Overall Study|Death|2|||
94352867|NCT02612194|323073625|FG000|Overall Study|Early Study Termination|1|||
94352868|NCT02612194|323073626|FG001|Overall Study|Early Study Termination|0|||
94352869|NCT02612194|323073627|FG002|Overall Study|Early Study Termination|0|||
94352870|NCT00540228|323073628|FG000|Overall Study|Adverse Event|2|||
94352871|NCT00540228|323073629|FG001|Overall Study|Adverse Event|0|||
94352872|NCT00540228|323073630|FG002|Overall Study|Adverse Event|0|||
94352873|NCT00540228|323073631|FG003|Overall Study|Adverse Event|0|||
94352874|NCT00540228|323073632|FG004|Overall Study|Adverse Event|0|||
94352875|NCT00540228|323073628|FG000|Overall Study|Lost to Follow-up|1|||
94352876|NCT00540228|323073629|FG001|Overall Study|Lost to Follow-up|1|||
94352877|NCT00540228|323073630|FG002|Overall Study|Lost to Follow-up|0|||
94352878|NCT00540228|323073631|FG003|Overall Study|Lost to Follow-up|0|||
94352879|NCT00540228|323073632|FG004|Overall Study|Lost to Follow-up|0|||
94352880|NCT02173158|323073634|FG000|Efficacy Phase|Adverse Event|1|||
94352881|NCT01349816|323073635|FG000|Overall Study|Withdrawal by Subject|4|||
94352882|NCT01349816|323073635|FG000|Overall Study|Physician Decision|1|||
94352883|NCT01349816|323073635|FG000|Overall Study|Adverse Event|14|||
94352884|NCT01349816|323073635|FG000|Overall Study|Lost to Follow-up|2|||
94352885|NCT01349816|323073635|FG000|Overall Study|Protocol Violation|1|||
94352886|NCT01349816|323073635|FG000|Overall Study|Protocol-specified criteria|8|||
94352887|NCT01728454|323073636|FG000|Stage 1 and 2|Pregnancy|1|||
94352888|NCT01728454|323073637|FG001|Stage 1 and 2|Pregnancy|0|||
94352889|NCT01728454|323073638|FG002|Stage 1 and 2|Pregnancy|0|||
94352890|NCT01728454|323073636|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
94352891|NCT01728454|323073637|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
94352892|NCT01728454|323073638|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
94352893|NCT01728454|323073636|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
94352894|NCT01728454|323073637|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
94352895|NCT01728454|323073638|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
94352896|NCT01728454|323073636|FG000|Stage 1 and 2|Lost to Follow-up|1|||
94352897|NCT01728454|323073637|FG001|Stage 1 and 2|Lost to Follow-up|1|||
94352898|NCT01728454|323073638|FG002|Stage 1 and 2|Lost to Follow-up|0|||
94352899|NCT01728454|323073636|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
94352900|NCT01728454|323073637|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
94352901|NCT01728454|323073638|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
94352902|NCT01728454|323073636|FG000|Stage 3|Reason Missing|0|||
94352903|NCT01728454|323073637|FG001|Stage 3|Reason Missing|0|||
94352904|NCT01728454|323073638|FG002|Stage 3|Reason Missing|1|||
94352905|NCT01728454|323073636|FG000|Stage 3|Subject Required Other Treatment|0|||
94352906|NCT01728454|323073637|FG001|Stage 3|Subject Required Other Treatment|1|||
94352907|NCT01728454|323073638|FG002|Stage 3|Subject Required Other Treatment|0|||
94352908|NCT01728454|323073636|FG000|Stage 3|Pregnancy|1|||
94582780|NCT00068692|323934929|FG000|Step 1: Registration|Not eligible|6|||
94582781|NCT00068692|323934930|FG001|Step 1: Registration|Not eligible|0|||
94582782|NCT00068692|323934931|FG002|Step 1: Registration|Not eligible|0|||
94582783|NCT00068692|323934932|FG003|Step 1: Registration|Not eligible|0|||
94582784|NCT00068692|323934933|FG004|Step 1: Registration|Not eligible|0|||
94582785|NCT00068692|323934934|FG005|Step 1: Registration|Not eligible|0|||
94582786|NCT00068692|323934935|FG006|Step 1: Registration|Not eligible|0|||
94582787|NCT00068692|323934936|FG007|Step 1: Registration|Not eligible|0|||
94582788|NCT00068692|323934929|FG000|Step 1: Registration|Other|2|||
94582789|NCT00068692|323934930|FG001|Step 1: Registration|Other|0|||
94582790|NCT00068692|323934931|FG002|Step 1: Registration|Other|0|||
94582791|NCT00068692|323934932|FG003|Step 1: Registration|Other|0|||
94582792|NCT00068692|323934933|FG004|Step 1: Registration|Other|0|||
94582793|NCT00068692|323934934|FG005|Step 1: Registration|Other|0|||
94582794|NCT00068692|323934935|FG006|Step 1: Registration|Other|0|||
94582795|NCT00068692|323934936|FG007|Step 1: Registration|Other|0|||
94582796|NCT00068692|323934929|FG000|Step 1: Registration|Not start protocol therapy|3|||
94582797|NCT00068692|323934930|FG001|Step 1: Registration|Not start protocol therapy|0|||
94582798|NCT00068692|323934931|FG002|Step 1: Registration|Not start protocol therapy|0|||
94582799|NCT00068692|323934932|FG003|Step 1: Registration|Not start protocol therapy|0|||
94582800|NCT00068692|323934933|FG004|Step 1: Registration|Not start protocol therapy|0|||
94582801|NCT00068692|323934934|FG005|Step 1: Registration|Not start protocol therapy|0|||
94582802|NCT00068692|323934935|FG006|Step 1: Registration|Not start protocol therapy|0|||
94582803|NCT00068692|323934936|FG007|Step 1: Registration|Not start protocol therapy|0|||
94582804|NCT00068692|323934929|FG000|Step 1: Registration|Registered but not randomized|0|||
94582805|NCT00068692|323934930|FG001|Step 1: Registration|Registered but not randomized|1|||
94582806|NCT00068692|323934931|FG002|Step 1: Registration|Registered but not randomized|0|||
94582807|NCT00068692|323934932|FG003|Step 1: Registration|Registered but not randomized|0|||
94582808|NCT00068692|323934933|FG004|Step 1: Registration|Registered but not randomized|0|||
94582809|NCT00068692|323934934|FG005|Step 1: Registration|Registered but not randomized|0|||
94582810|NCT00068692|323934935|FG006|Step 1: Registration|Registered but not randomized|0|||
94582811|NCT00068692|323934936|FG007|Step 1: Registration|Registered but not randomized|0|||
94582812|NCT00068692|323934929|FG000|Step 2: Randomization|Disesae progression/replase|0|||
94582813|NCT00068692|323934930|FG001|Step 2: Randomization|Disesae progression/replase|0|||
94582814|NCT00068692|323934931|FG002|Step 2: Randomization|Disesae progression/replase|1|||
94582815|NCT00068692|323934932|FG003|Step 2: Randomization|Disesae progression/replase|1|||
94582816|NCT00068692|323934933|FG004|Step 2: Randomization|Disesae progression/replase|0|||
94582817|NCT00068692|323934934|FG005|Step 2: Randomization|Disesae progression/replase|0|||
94582818|NCT00068692|323934935|FG006|Step 2: Randomization|Disesae progression/replase|0|||
94582819|NCT00068692|323934936|FG007|Step 2: Randomization|Disesae progression/replase|0|||
94582820|NCT00068692|323934929|FG000|Step 2: Randomization|Adverse Event|0|||
94582821|NCT00068692|323934930|FG001|Step 2: Randomization|Adverse Event|0|||
94582822|NCT00068692|323934931|FG002|Step 2: Randomization|Adverse Event|4|||
94582823|NCT00068692|323934932|FG003|Step 2: Randomization|Adverse Event|2|||
94582824|NCT00068692|323934933|FG004|Step 2: Randomization|Adverse Event|2|||
94582825|NCT00068692|323934934|FG005|Step 2: Randomization|Adverse Event|3|||
94582826|NCT00068692|323934935|FG006|Step 2: Randomization|Adverse Event|4|||
94582827|NCT00068692|323934936|FG007|Step 2: Randomization|Adverse Event|4|||
94582828|NCT00068692|323934929|FG000|Step 2: Randomization|Death|0|||
94582829|NCT00068692|323934930|FG001|Step 2: Randomization|Death|0|||
94582830|NCT00068692|323934931|FG002|Step 2: Randomization|Death|0|||
94582831|NCT00068692|323934932|FG003|Step 2: Randomization|Death|0|||
94582832|NCT00068692|323934933|FG004|Step 2: Randomization|Death|1|||
94582833|NCT00068692|323934934|FG005|Step 2: Randomization|Death|0|||
94582834|NCT00068692|323934935|FG006|Step 2: Randomization|Death|0|||
94582835|NCT00068692|323934936|FG007|Step 2: Randomization|Death|1|||
94582836|NCT00068692|323934929|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
94582837|NCT00068692|323934930|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
94582838|NCT00068692|323934931|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
94582839|NCT00068692|323934932|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
94582840|NCT00068692|323934933|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
94582841|NCT00068692|323934934|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
94582842|NCT00068692|323934935|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
94582843|NCT00068692|323934936|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
94582844|NCT00068692|323934929|FG000|Step 2: Randomization|alternative therapy|0|||
94582845|NCT00068692|323934930|FG001|Step 2: Randomization|alternative therapy|0|||
94582846|NCT00068692|323934931|FG002|Step 2: Randomization|alternative therapy|0|||
94582847|NCT00068692|323934932|FG003|Step 2: Randomization|alternative therapy|1|||
94582848|NCT00068692|323934933|FG004|Step 2: Randomization|alternative therapy|1|||
94582849|NCT00068692|323934934|FG005|Step 2: Randomization|alternative therapy|0|||
94582850|NCT00068692|323934935|FG006|Step 2: Randomization|alternative therapy|0|||
94582851|NCT00068692|323934936|FG007|Step 2: Randomization|alternative therapy|0|||
94582852|NCT00068692|323934929|FG000|Step 2: Randomization|Physician Decision|0|||
94582853|NCT00068692|323934930|FG001|Step 2: Randomization|Physician Decision|0|||
94582854|NCT00068692|323934931|FG002|Step 2: Randomization|Physician Decision|0|||
94582855|NCT00068692|323934932|FG003|Step 2: Randomization|Physician Decision|1|||
94455210|NCT04791319|323454724|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
94455211|NCT04791319|323454725|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
94455212|NCT04791319|323454726|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
94455213|NCT04791319|323454727|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
94455214|NCT04791319|323454728|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
94455215|NCT04791319|323454729|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
94455216|NCT04791319|323454730|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
94455217|NCT04791319|323454731|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
94455218|NCT04791319|323454721|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
94455219|NCT04791319|323454722|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
94455220|NCT04791319|323454723|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
94455221|NCT04791319|323454724|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
94455222|NCT04791319|323454725|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
94455223|NCT04791319|323454726|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
94455224|NCT04791319|323454727|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
94455225|NCT04791319|323454728|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
94455226|NCT04791319|323454729|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
94455227|NCT04791319|323454730|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
94455228|NCT04791319|323454731|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
94455229|NCT04791319|323454721|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
94455230|NCT04791319|323454722|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
94455231|NCT04791319|323454723|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
94455232|NCT04791319|323454724|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
94455233|NCT04791319|323454725|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
94455234|NCT04791319|323454726|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
94455235|NCT04791319|323454727|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
94455236|NCT04791319|323454728|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
94455237|NCT04791319|323454729|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
94455238|NCT04791319|323454730|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
94455239|NCT04791319|323454731|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
94455240|NCT04791319|323454721|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
94455241|NCT04791319|323454722|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
94455242|NCT04791319|323454723|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
94455243|NCT04791319|323454724|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
94455244|NCT04791319|323454725|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
94455245|NCT04791319|323454726|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
94455246|NCT04791319|323454727|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
94455247|NCT04791319|323454728|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
94455248|NCT04791319|323454729|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
94455249|NCT04791319|323454730|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
94455250|NCT04791319|323454731|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
94455251|NCT04791319|323454721|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
94455252|NCT04791319|323454722|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
94455253|NCT04791319|323454723|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
94455254|NCT04791319|323454724|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
94455255|NCT04791319|323454725|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
94455256|NCT04791319|323454726|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
94455257|NCT04791319|323454727|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
94455258|NCT04791319|323454728|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
94455259|NCT04791319|323454729|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
94455260|NCT04791319|323454730|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
94455261|NCT04791319|323454731|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
94582856|NCT00068692|323934933|FG004|Step 2: Randomization|Physician Decision|1|||
94455262|NCT01931995|323454734|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
94455263|NCT01931995|323454735|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
94455264|NCT01931995|323454734|FG000|First Intervention (1 Day)|Physician Decision|1|||
94455265|NCT01931995|323454735|FG001|First Intervention (1 Day)|Physician Decision|1|||
94582857|NCT00068692|323934934|FG005|Step 2: Randomization|Physician Decision|0|||
94582858|NCT00068692|323934935|FG006|Step 2: Randomization|Physician Decision|0|||
94582859|NCT00068692|323934936|FG007|Step 2: Randomization|Physician Decision|0|||
94582860|NCT00068692|323934929|FG000|Step 2: Randomization|Other|0|||
94582861|NCT00068692|323934930|FG001|Step 2: Randomization|Other|0|||
94582862|NCT00068692|323934931|FG002|Step 2: Randomization|Other|0|||
94582863|NCT00068692|323934932|FG003|Step 2: Randomization|Other|1|||
94582864|NCT00068692|323934933|FG004|Step 2: Randomization|Other|0|||
94582865|NCT00068692|323934934|FG005|Step 2: Randomization|Other|1|||
94582866|NCT00068692|323934935|FG006|Step 2: Randomization|Other|0|||
94582867|NCT00068692|323934936|FG007|Step 2: Randomization|Other|0|||
94582868|NCT00068692|323934929|FG000|Step 2: Randomization|never start protocol therapy|0|||
94582869|NCT00068692|323934930|FG001|Step 2: Randomization|never start protocol therapy|0|||
94582870|NCT00068692|323934931|FG002|Step 2: Randomization|never start protocol therapy|1|||
94582871|NCT00068692|323934932|FG003|Step 2: Randomization|never start protocol therapy|0|||
94582872|NCT00068692|323934933|FG004|Step 2: Randomization|never start protocol therapy|1|||
94582873|NCT00068692|323934934|FG005|Step 2: Randomization|never start protocol therapy|0|||
94582874|NCT00068692|323934935|FG006|Step 2: Randomization|never start protocol therapy|0|||
94582875|NCT00068692|323934936|FG007|Step 2: Randomization|never start protocol therapy|0|||
94582876|NCT01177397|323934949|FG000|Overall Study|Protocol Violation|0|||
94582877|NCT01177397|323934950|FG001|Overall Study|Protocol Violation|0|||
94582878|NCT01177397|323934951|FG002|Overall Study|Protocol Violation|0|||
94582879|NCT01177397|323934952|FG003|Overall Study|Protocol Violation|0|||
94582880|NCT01177397|323934953|FG004|Overall Study|Protocol Violation|0|||
94582881|NCT01177397|323934954|FG005|Overall Study|Protocol Violation|1|||
94582882|NCT01177397|323934955|FG006|Overall Study|Protocol Violation|0|||
94582883|NCT01177397|323934956|FG007|Overall Study|Protocol Violation|0|||
94582884|NCT01177397|323934957|FG008|Overall Study|Protocol Violation|0|||
94582885|NCT01177397|323934958|FG009|Overall Study|Protocol Violation|0|||
94582886|NCT01177397|323934959|FG010|Overall Study|Protocol Violation|0|||
94582887|NCT01177397|323934960|FG011|Overall Study|Protocol Violation|0|||
94582888|NCT01177397|323934949|FG000|Overall Study|Lost to Follow-up|0|||
94582889|NCT01177397|323934950|FG001|Overall Study|Lost to Follow-up|0|||
94582890|NCT01177397|323934951|FG002|Overall Study|Lost to Follow-up|0|||
94582891|NCT01177397|323934952|FG003|Overall Study|Lost to Follow-up|0|||
94582892|NCT01177397|323934953|FG004|Overall Study|Lost to Follow-up|1|||
94582893|NCT01177397|323934954|FG005|Overall Study|Lost to Follow-up|0|||
94582894|NCT01177397|323934955|FG006|Overall Study|Lost to Follow-up|0|||
94582895|NCT01177397|323934956|FG007|Overall Study|Lost to Follow-up|2|||
94582896|NCT01177397|323934957|FG008|Overall Study|Lost to Follow-up|0|||
94582897|NCT01177397|323934958|FG009|Overall Study|Lost to Follow-up|0|||
94582898|NCT01177397|323934959|FG010|Overall Study|Lost to Follow-up|0|||
94582899|NCT01177397|323934960|FG011|Overall Study|Lost to Follow-up|0|||
94582900|NCT01177397|323934949|FG000|Overall Study|Death|0|||
94582901|NCT01177397|323934950|FG001|Overall Study|Death|0|||
94582902|NCT01177397|323934951|FG002|Overall Study|Death|1|||
94582903|NCT01177397|323934952|FG003|Overall Study|Death|1|||
94582904|NCT01177397|323934953|FG004|Overall Study|Death|0|||
94582905|NCT01177397|323934954|FG005|Overall Study|Death|0|||
94582906|NCT01177397|323934955|FG006|Overall Study|Death|0|||
94582907|NCT01177397|323934956|FG007|Overall Study|Death|5|||
94582908|NCT01177397|323934957|FG008|Overall Study|Death|2|||
94582909|NCT01177397|323934958|FG009|Overall Study|Death|1|||
94582910|NCT01177397|323934959|FG010|Overall Study|Death|0|||
94582911|NCT01177397|323934960|FG011|Overall Study|Death|0|||
94582912|NCT01177397|323934949|FG000|Overall Study|Withdrawal by Subject|0|||
94582913|NCT01177397|323934950|FG001|Overall Study|Withdrawal by Subject|0|||
94582914|NCT01177397|323934951|FG002|Overall Study|Withdrawal by Subject|1|||
94582915|NCT01177397|323934952|FG003|Overall Study|Withdrawal by Subject|1|||
94582916|NCT01177397|323934953|FG004|Overall Study|Withdrawal by Subject|1|||
94582917|NCT01177397|323934954|FG005|Overall Study|Withdrawal by Subject|2|||
94582918|NCT01177397|323934955|FG006|Overall Study|Withdrawal by Subject|0|||
94582919|NCT01177397|323934956|FG007|Overall Study|Withdrawal by Subject|5|||
94582920|NCT01177397|323934957|FG008|Overall Study|Withdrawal by Subject|9|||
94582921|NCT01177397|323934958|FG009|Overall Study|Withdrawal by Subject|1|||
94582922|NCT01177397|323934959|FG010|Overall Study|Withdrawal by Subject|1|||
94582923|NCT01177397|323934960|FG011|Overall Study|Withdrawal by Subject|0|||
94582924|NCT01177397|323934949|FG000|Overall Study|Adverse Event|0|||
94582925|NCT01177397|323934950|FG001|Overall Study|Adverse Event|0|||
94582926|NCT01177397|323934951|FG002|Overall Study|Adverse Event|1|||
94582927|NCT01177397|323934952|FG003|Overall Study|Adverse Event|2|||
94582928|NCT01177397|323934953|FG004|Overall Study|Adverse Event|0|||
94582929|NCT01177397|323934954|FG005|Overall Study|Adverse Event|12|||
94582930|NCT01177397|323934955|FG006|Overall Study|Adverse Event|1|||
94582931|NCT01177397|323934956|FG007|Overall Study|Adverse Event|14|||
94582932|NCT01177397|323934957|FG008|Overall Study|Adverse Event|8|||
94582933|NCT01177397|323934958|FG009|Overall Study|Adverse Event|6|||
94582934|NCT01177397|323934959|FG010|Overall Study|Adverse Event|3|||
94582935|NCT01177397|323934960|FG011|Overall Study|Adverse Event|7|||
94582936|NCT01177397|323934949|FG000|Overall Study|Disease progression|1|||
94582937|NCT01177397|323934950|FG001|Overall Study|Disease progression|2|||
94582938|NCT01177397|323934951|FG002|Overall Study|Disease progression|5|||
94582939|NCT01177397|323934952|FG003|Overall Study|Disease progression|5|||
94582940|NCT01177397|323934953|FG004|Overall Study|Disease progression|4|||
94582941|NCT01177397|323934954|FG005|Overall Study|Disease progression|10|||
94582942|NCT01177397|323934955|FG006|Overall Study|Disease progression|10|||
94582943|NCT01177397|323934956|FG007|Overall Study|Disease progression|21|||
94582944|NCT01177397|323934957|FG008|Overall Study|Disease progression|18|||
94582945|NCT01177397|323934958|FG009|Overall Study|Disease progression|12|||
94582946|NCT01177397|323934959|FG010|Overall Study|Disease progression|10|||
94582947|NCT01177397|323934960|FG011|Overall Study|Disease progression|8|||
94582948|NCT01177397|323934949|FG000|Overall Study|Other reasons|0|||
94582949|NCT01177397|323934950|FG001|Overall Study|Other reasons|0|||
94582950|NCT01177397|323934951|FG002|Overall Study|Other reasons|1|||
94582951|NCT01177397|323934952|FG003|Overall Study|Other reasons|0|||
94582952|NCT01177397|323934953|FG004|Overall Study|Other reasons|1|||
94582953|NCT01177397|323934954|FG005|Overall Study|Other reasons|1|||
94582954|NCT01177397|323934955|FG006|Overall Study|Other reasons|2|||
94582955|NCT01177397|323934956|FG007|Overall Study|Other reasons|6|||
94582956|NCT01177397|323934957|FG008|Overall Study|Other reasons|10|||
94582957|NCT01177397|323934958|FG009|Overall Study|Other reasons|8|||
94582958|NCT01177397|323934959|FG010|Overall Study|Other reasons|0|||
94582959|NCT01177397|323934960|FG011|Overall Study|Other reasons|2|||
94582960|NCT00865566|323934962|FG000|Overall Study|Death|1|||
94582961|NCT00865566|323934963|FG001|Overall Study|Death|11|||
94582962|NCT00865566|323934962|FG000|Overall Study|Lost to Follow-up|314|||
94582963|NCT00865566|323934963|FG001|Overall Study|Lost to Follow-up|315|||
94582964|NCT00865566|323934962|FG000|Overall Study|Withdrawal by Subject|45|||
94582965|NCT00865566|323934963|FG001|Overall Study|Withdrawal by Subject|65|||
94582966|NCT00865566|323934962|FG000|Overall Study|Physician Decision|0|||
94582967|NCT00865566|323934963|FG001|Overall Study|Physician Decision|1|||
94582968|NCT00865566|323934962|FG000|Overall Study|Participant relocated|78|||
94582969|NCT00865566|323934963|FG001|Overall Study|Participant relocated|107|||
94582970|NCT00865566|323934962|FG000|Overall Study|Participant unable to adhere|27|||
94582971|NCT00865566|323934963|FG001|Overall Study|Participant unable to adhere|42|||
94582972|NCT00865566|323934962|FG000|Overall Study|Other; N=245 due to early study closure|154|||
94582973|NCT00865566|323934963|FG001|Overall Study|Other; N=245 due to early study closure|139|||
94352909|NCT01728454|323073637|FG001|Stage 3|Pregnancy|0|||
94352910|NCT01728454|323073638|FG002|Stage 3|Pregnancy|0|||
94352911|NCT01728454|323073636|FG000|Stage 3|Withdrew Consent|1|||
94352912|NCT01728454|323073637|FG001|Stage 3|Withdrew Consent|0|||
94352913|NCT01728454|323073638|FG002|Stage 3|Withdrew Consent|1|||
94352914|NCT01728454|323073636|FG000|Stage 3|Non-compliance with Protocol|0|||
94352915|NCT01728454|323073637|FG001|Stage 3|Non-compliance with Protocol|0|||
94352916|NCT01728454|323073638|FG002|Stage 3|Non-compliance with Protocol|1|||
94352917|NCT01728454|323073636|FG000|Stage 3|Lost to Follow-up|0|||
94352918|NCT01728454|323073637|FG001|Stage 3|Lost to Follow-up|3|||
94352919|NCT01728454|323073638|FG002|Stage 3|Lost to Follow-up|1|||
94352920|NCT01728454|323073636|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
94352921|NCT01728454|323073637|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
94352922|NCT01728454|323073638|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
94352923|NCT00701064|323073639|FG000|Overall Study|Protocol Violation|1|||
94352924|NCT00701064|323073640|FG001|Overall Study|Protocol Violation|1|||
94352925|NCT00701064|323073639|FG000|Overall Study|Withdrawal by Subject|1|||
94352926|NCT00701064|323073640|FG001|Overall Study|Withdrawal by Subject|1|||
94352927|NCT00701064|323073639|FG000|Overall Study|initiated other PTSD treatment|2|||
94582974|NCT00865566|323934962|FG000|Overall Study|HIV infection|5|||
94582975|NCT00865566|323934963|FG001|Overall Study|HIV infection|7|||
94582976|NCT00719472|323934968|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
94582977|NCT00719472|323934968|FG000|Enrolled in Study|Subject decision to withdraw|8|||
94582978|NCT00719472|323934968|FG000|Enrolled in Study|Various Reasons|17|||
94582979|NCT00719472|323934968|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
94582980|NCT00719472|323934968|FG000|Received Cycle 1 Treatment|Death|5|||
94582981|NCT00719472|323934968|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
94352928|NCT00701064|323073640|FG001|Overall Study|initiated other PTSD treatment|2|||
94240646|NCT02815579|322676671|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
94240647|NCT02815579|322676670|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
94240648|NCT02815579|322676671|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
94240649|NCT02815579|322676670|FG000|Overall Study|Death|5|||
94582982|NCT00719472|323934968|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
94582983|NCT00719472|323934968|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
94582984|NCT00719472|323934968|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
94582985|NCT00719472|323934968|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
94582986|NCT00719472|323934968|FG000|Received Cycle 2 Treatment|Death|6|||
94582987|NCT00719472|323934968|FG000|Received Cycle 2 Treatment|Disease progression|3|||
94582988|NCT00719472|323934968|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
94582989|NCT00719472|323934968|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
94582990|NCT00719472|323934968|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
94582991|NCT00719472|323934968|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
94582992|NCT00815659|323934969|FG000|Overall Study|Adverse Event|9|||
94582993|NCT00815659|323934969|FG000|Overall Study|Withdrawal by Subject|9|||
94582994|NCT00815659|323934969|FG000|Overall Study|Lost to Follow-up|4|||
94582995|NCT00815659|323934969|FG000|Overall Study|Protocol Violation|1|||
94582996|NCT03847896|323934970|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
94582997|NCT03847896|323934971|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
94582998|NCT03847896|323934972|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
94582999|NCT03847896|323934973|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
94583000|NCT03847896|323934974|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
94583001|NCT03847896|323934970|FG000|Overall Study|Withdrawal by Subject|2|||
94583002|NCT03847896|323934971|FG001|Overall Study|Withdrawal by Subject|10|||
94583003|NCT03847896|323934972|FG002|Overall Study|Withdrawal by Subject|5|||
94583004|NCT03847896|323934973|FG003|Overall Study|Withdrawal by Subject|9|||
94583005|NCT03847896|323934974|FG004|Overall Study|Withdrawal by Subject|8|||
94583006|NCT03847896|323934970|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94583007|NCT03847896|323934971|FG001|Overall Study|Withdrawal by parent/guardian|0|||
94583008|NCT03847896|323934972|FG002|Overall Study|Withdrawal by parent/guardian|1|||
94583009|NCT03847896|323934973|FG003|Overall Study|Withdrawal by parent/guardian|0|||
94583010|NCT03847896|323934974|FG004|Overall Study|Withdrawal by parent/guardian|0|||
94583011|NCT03847896|323934970|FG000|Overall Study|Adverse Event|2|||
94583012|NCT03847896|323934971|FG001|Overall Study|Adverse Event|1|||
94583013|NCT03847896|323934972|FG002|Overall Study|Adverse Event|3|||
94240650|NCT02815579|322676671|FG001|Overall Study|Death|4|||
94240651|NCT02815579|322676670|FG000|Overall Study|Imprisoned|0|||
94240652|NCT02815579|322676671|FG001|Overall Study|Imprisoned|2|||
94240653|NCT02815579|322676670|FG000|Overall Study|Did not meet enrollment criteria|0|||
94240654|NCT02815579|322676671|FG001|Overall Study|Did not meet enrollment criteria|1|||
94240655|NCT04307940|322676672|FG000|Overall Study|Adverse Event|1|||
94240656|NCT04307940|322676673|FG001|Overall Study|Adverse Event|0|||
94240657|NCT04307940|322676674|FG002|Overall Study|Adverse Event|0|||
94240658|NCT04307940|322676672|FG000|Overall Study|Withdrawal by Subject|2|||
94240659|NCT04307940|322676673|FG001|Overall Study|Withdrawal by Subject|3|||
94240660|NCT04307940|322676674|FG002|Overall Study|Withdrawal by Subject|1|||
94240661|NCT04307940|322676672|FG000|Overall Study|Lost to Follow-up|2|||
94240662|NCT04307940|322676673|FG001|Overall Study|Lost to Follow-up|0|||
94240663|NCT04307940|322676674|FG002|Overall Study|Lost to Follow-up|1|||
94240664|NCT03057847|322676675|FG000|Overall Study|Lost to Follow-up|16|||
94240665|NCT03301155|322676676|FG000|Overall Study|Сompliance with exclusion criteria|8|||
94240666|NCT03301155|322676677|FG001|Overall Study|Сompliance with exclusion criteria|7|||
94240667|NCT03809039|322676678|FG000|Part 1|Withdrawal by Subject|1|||
94240668|NCT03809039|322676679|FG001|Part 1|Withdrawal by Subject|0|||
94240669|NCT03809039|322676680|FG002|Part 1|Withdrawal by Subject|0|||
94240670|NCT03809039|322676681|FG003|Part 1|Withdrawal by Subject|1|||
94240671|NCT03809039|322676682|FG004|Part 1|Withdrawal by Subject|0|||
94240672|NCT03809039|322676683|FG005|Part 1|Withdrawal by Subject|0|||
94240673|NCT03809039|322676684|FG006|Part 1|Withdrawal by Subject|0|||
94240674|NCT03809039|322676685|FG007|Part 1|Withdrawal by Subject|0|||
94240675|NCT03809039|322676686|FG008|Part 1|Withdrawal by Subject|0|||
94240676|NCT03809039|322676678|FG000|Part 3|Withdrawn by study termination|0|||
94240677|NCT03809039|322676679|FG001|Part 3|Withdrawn by study termination|0|||
94240678|NCT03809039|322676680|FG002|Part 3|Withdrawn by study termination|0|||
94240679|NCT03809039|322676681|FG003|Part 3|Withdrawn by study termination|0|||
94240680|NCT03809039|322676682|FG004|Part 3|Withdrawn by study termination|0|||
94240681|NCT03809039|322676683|FG005|Part 3|Withdrawn by study termination|0|||
94240682|NCT03809039|322676684|FG006|Part 3|Withdrawn by study termination|0|||
94583014|NCT03847896|323934973|FG003|Overall Study|Adverse Event|2|||
94583015|NCT03847896|323934974|FG004|Overall Study|Adverse Event|4|||
94583016|NCT03847896|323934970|FG000|Overall Study|A severe exacerbation event|0|||
94240683|NCT03809039|322676685|FG007|Part 3|Withdrawn by study termination|2|||
94583017|NCT03847896|323934971|FG001|Overall Study|A severe exacerbation event|0|||
94583018|NCT03847896|323934972|FG002|Overall Study|A severe exacerbation event|0|||
94583019|NCT03847896|323934973|FG003|Overall Study|A severe exacerbation event|0|||
94583020|NCT03847896|323934974|FG004|Overall Study|A severe exacerbation event|3|||
94583021|NCT03847896|323934970|FG000|Overall Study|Protocol Violation|0|||
94583022|NCT03847896|323934971|FG001|Overall Study|Protocol Violation|2|||
94583023|NCT03847896|323934972|FG002|Overall Study|Protocol Violation|1|||
94583024|NCT03847896|323934973|FG003|Overall Study|Protocol Violation|0|||
94583025|NCT03847896|323934974|FG004|Overall Study|Protocol Violation|2|||
94583026|NCT03847896|323934970|FG000|Overall Study|Lost to Follow-up|0|||
94583027|NCT03847896|323934971|FG001|Overall Study|Lost to Follow-up|0|||
94583028|NCT03847896|323934972|FG002|Overall Study|Lost to Follow-up|0|||
94583029|NCT03847896|323934973|FG003|Overall Study|Lost to Follow-up|1|||
94583030|NCT03847896|323934974|FG004|Overall Study|Lost to Follow-up|0|||
94583031|NCT03847896|323934970|FG000|Overall Study|Condition under investigation worsened|0|||
94583032|NCT03847896|323934971|FG001|Overall Study|Condition under investigation worsened|0|||
94583033|NCT03847896|323934972|FG002|Overall Study|Condition under investigation worsened|0|||
94583034|NCT03847896|323934973|FG003|Overall Study|Condition under investigation worsened|1|||
94583035|NCT03847896|323934974|FG004|Overall Study|Condition under investigation worsened|1|||
94583036|NCT03847896|323934970|FG000|Overall Study|Lack of Efficacy|0|||
94583037|NCT03847896|323934971|FG001|Overall Study|Lack of Efficacy|0|||
94583038|NCT03847896|323934972|FG002|Overall Study|Lack of Efficacy|0|||
94583039|NCT03847896|323934973|FG003|Overall Study|Lack of Efficacy|2|||
94583040|NCT03847896|323934974|FG004|Overall Study|Lack of Efficacy|2|||
94583041|NCT03847896|323934970|FG000|Overall Study|Other reasons|3|||
94583042|NCT03847896|323934971|FG001|Overall Study|Other reasons|3|||
94583043|NCT03847896|323934972|FG002|Overall Study|Other reasons|1|||
94583044|NCT03847896|323934973|FG003|Overall Study|Other reasons|2|||
94583045|NCT03847896|323934974|FG004|Overall Study|Other reasons|1|||
94583046|NCT00118417|323934975|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
94583047|NCT00118417|323934976|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
94583048|NCT00118417|323934975|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
94583049|NCT00118417|323934976|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
94583050|NCT00118417|323934975|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
94583051|NCT00118417|323934976|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
94583052|NCT00118417|323934975|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
94583053|NCT00118417|323934976|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
94583054|NCT00118417|323934975|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
94583055|NCT00118417|323934976|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
94583056|NCT01391546|323934979|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
94583057|NCT01391546|323934980|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
94583058|NCT03938259|323934982|FG000|Overall Study|unable to establish baseline for ventilation|1|||
94583059|NCT03938259|323934983|FG001|Overall Study|unable to establish baseline for ventilation|1|||
94583060|NCT00836693|323934984|FG000|Overall Study|Adverse Event|4|||
94583061|NCT00836693|323934985|FG001|Overall Study|Adverse Event|1|||
94583062|NCT00836693|323934984|FG000|Overall Study|Sponsor Decision|0|||
94583063|NCT00836693|323934985|FG001|Overall Study|Sponsor Decision|1|||
94583064|NCT00836693|323934984|FG000|Overall Study|Physician Decision|2|||
94583065|NCT00836693|323934985|FG001|Overall Study|Physician Decision|0|||
94583066|NCT00836693|323934984|FG000|Overall Study|Withdrawal by Subject|9|||
94583067|NCT00836693|323934985|FG001|Overall Study|Withdrawal by Subject|4|||
94583068|NCT00836693|323934984|FG000|Overall Study|Protocol Violation|1|||
94583069|NCT00836693|323934985|FG001|Overall Study|Protocol Violation|0|||
94583070|NCT00836693|323934984|FG000|Overall Study|Lost to Follow-up|1|||
94583071|NCT00836693|323934985|FG001|Overall Study|Lost to Follow-up|0|||
94583072|NCT05660577|323934988|FG000|Overall Study|Discontinued|9|||
94583073|NCT02215252|323934989|FG000|Overall Study|Adverse Event|1|||
94583074|NCT02215252|323934990|FG001|Overall Study|Adverse Event|5|||
94583075|NCT02215252|323934991|FG002|Overall Study|Adverse Event|2|||
94583076|NCT02215252|323934989|FG000|Overall Study|Lost to Follow-up|0|||
94659025|NCT01539291|324207962|FG001|Study GS-US-312-0116|Adverse Event|0|||
94659026|NCT01539291|324207963|FG002|Study GS-US-312-0116|Adverse Event|0|||
94659027|NCT01539291|324207964|FG003|Study GS-US-312-0116|Adverse Event|0|||
94352929|NCT01791543|323073641|FG000|Overall Study|Lost to Follow-up|1|||
94583077|NCT02215252|323934990|FG001|Overall Study|Lost to Follow-up|0|||
94583078|NCT02215252|323934991|FG002|Overall Study|Lost to Follow-up|1|||
94583079|NCT02215252|323934989|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
94583080|NCT02215252|323934990|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
94583081|NCT02215252|323934991|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
94583082|NCT02215252|323934989|FG000|Overall Study|Protocol Violation|0|||
94583083|NCT02215252|323934990|FG001|Overall Study|Protocol Violation|1|||
94583084|NCT02215252|323934991|FG002|Overall Study|Protocol Violation|0|||
94583085|NCT02215252|323934989|FG000|Overall Study|Withdrawal by Subject|1|||
94583086|NCT02215252|323934990|FG001|Overall Study|Withdrawal by Subject|0|||
94583087|NCT02215252|323934991|FG002|Overall Study|Withdrawal by Subject|0|||
94583088|NCT02215252|323934989|FG000|Overall Study|Other|0|||
94583089|NCT02215252|323934990|FG001|Overall Study|Other|1|||
94583090|NCT02215252|323934991|FG002|Overall Study|Other|1|||
94583091|NCT02118961|323934992|FG000|Overall Study|Withdrawal by Subject|1|||
94583092|NCT02118961|323934993|FG001|Overall Study|Withdrawal by Subject|0|||
94583093|NCT00998296|323934996|FG000|Overall Study|Progressive disease|0|||
94583094|NCT00998296|323934997|FG001|Overall Study|Progressive disease|1|||
94583095|NCT00998296|323934998|FG002|Overall Study|Progressive disease|0|||
94583096|NCT00998296|323934999|FG003|Overall Study|Progressive disease|0|||
94583097|NCT00998296|323935000|FG004|Overall Study|Progressive disease|0|||
94583098|NCT00998296|323935001|FG005|Overall Study|Progressive disease|0|||
94583099|NCT00998296|323935002|FG006|Overall Study|Progressive disease|1|||
94583100|NCT00998296|323935003|FG007|Overall Study|Progressive disease|0|||
94583101|NCT00998296|323935004|FG008|Overall Study|Progressive disease|0|||
94583102|NCT00998296|323935005|FG009|Overall Study|Progressive disease|14|||
94583103|NCT00998296|323935006|FG010|Overall Study|Progressive disease|5|||
94583104|NCT00998296|323934996|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
94583105|NCT00998296|323934997|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
94583106|NCT00998296|323934998|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
94583107|NCT00998296|323934999|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
94583108|NCT00998296|323935000|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
94583109|NCT00998296|323935001|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
94583110|NCT00998296|323935002|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
94583111|NCT00998296|323935003|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
94583112|NCT00998296|323935004|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
94583113|NCT00998296|323935005|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
94583114|NCT00998296|323935006|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
94583115|NCT00998296|323934996|FG000|Overall Study|Other adverse event|0|||
94583116|NCT00998296|323934997|FG001|Overall Study|Other adverse event|0|||
94583117|NCT00998296|323934998|FG002|Overall Study|Other adverse event|0|||
94583118|NCT00998296|323934999|FG003|Overall Study|Other adverse event|0|||
94583119|NCT00998296|323935000|FG004|Overall Study|Other adverse event|1|||
94583120|NCT00998296|323935001|FG005|Overall Study|Other adverse event|0|||
94583121|NCT00998296|323935002|FG006|Overall Study|Other adverse event|0|||
94583122|NCT00998296|323935003|FG007|Overall Study|Other adverse event|0|||
94583123|NCT00998296|323935004|FG008|Overall Study|Other adverse event|0|||
94583124|NCT00998296|323935005|FG009|Overall Study|Other adverse event|1|||
94583125|NCT00998296|323935006|FG010|Overall Study|Other adverse event|2|||
94583126|NCT00998296|323934996|FG000|Overall Study|Refused to continue taking trial med.|0|||
94583127|NCT00998296|323934997|FG001|Overall Study|Refused to continue taking trial med.|0|||
94583128|NCT00998296|323934998|FG002|Overall Study|Refused to continue taking trial med.|0|||
94583129|NCT00998296|323934999|FG003|Overall Study|Refused to continue taking trial med.|0|||
94583130|NCT00998296|323935000|FG004|Overall Study|Refused to continue taking trial med.|0|||
94583131|NCT00998296|323935001|FG005|Overall Study|Refused to continue taking trial med.|0|||
94583132|NCT00998296|323935002|FG006|Overall Study|Refused to continue taking trial med.|0|||
94583133|NCT00998296|323935003|FG007|Overall Study|Refused to continue taking trial med.|0|||
94583134|NCT00998296|323935004|FG008|Overall Study|Refused to continue taking trial med.|0|||
94583135|NCT00998296|323935005|FG009|Overall Study|Refused to continue taking trial med.|2|||
94583136|NCT00998296|323935006|FG010|Overall Study|Refused to continue taking trial med.|0|||
94583137|NCT00998296|323934996|FG000|Overall Study|Reason other than those specified above|0|||
94583138|NCT00998296|323934997|FG001|Overall Study|Reason other than those specified above|0|||
94583139|NCT00998296|323934998|FG002|Overall Study|Reason other than those specified above|0|||
94583140|NCT00998296|323934999|FG003|Overall Study|Reason other than those specified above|0|||
94583141|NCT00998296|323935000|FG004|Overall Study|Reason other than those specified above|0|||
94583142|NCT00998296|323935001|FG005|Overall Study|Reason other than those specified above|0|||
94583143|NCT00998296|323935002|FG006|Overall Study|Reason other than those specified above|0|||
94583144|NCT00998296|323935003|FG007|Overall Study|Reason other than those specified above|0|||
94583145|NCT00998296|323935004|FG008|Overall Study|Reason other than those specified above|0|||
94583146|NCT00998296|323935005|FG009|Overall Study|Reason other than those specified above|1|||
94583147|NCT00998296|323935006|FG010|Overall Study|Reason other than those specified above|0|||
94455266|NCT01931995|323454734|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
94455267|NCT01931995|323454735|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
94583148|NCT00830440|323935007|FG000|Overall Study|Protocol Violation|1|||
94583149|NCT00830440|323935008|FG001|Overall Study|Protocol Violation|0|||
94583150|NCT00830440|323935007|FG000|Overall Study|Withdrawal by Subject|1|||
94583151|NCT00830440|323935008|FG001|Overall Study|Withdrawal by Subject|0|||
94583152|NCT00830440|323935007|FG000|Overall Study|unsuccessful procedure|4|||
94583153|NCT00830440|323935008|FG001|Overall Study|unsuccessful procedure|0|||
94583154|NCT00830440|323935007|FG000|Overall Study|Adverse Event|2|||
94583155|NCT00830440|323935008|FG001|Overall Study|Adverse Event|0|||
94583156|NCT03023397|323935009|FG000|Run-In|Failed screening allergen challenge|1|||
94583157|NCT03023397|323935010|FG001|Run-In|Failed screening allergen challenge|0|||
94583158|NCT03023397|323935011|FG002|Run-In|Failed screening allergen challenge|0|||
94659028|NCT01539291|324207961|FG000|Study GS-US-312-0116|Physician Decision|1|||
94659029|NCT01539291|324207962|FG001|Study GS-US-312-0116|Physician Decision|0|||
94455268|NCT02353442|323454736|FG000|Overall Study|Withdrawal by Subject|3|||
94455269|NCT02353442|323454737|FG001|Overall Study|Withdrawal by Subject|4|||
94455270|NCT06586788|323454738|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
94455271|NCT01876784|323454742|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
94455272|NCT01876784|323454743|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
94455273|NCT01876784|323454742|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
94455274|NCT01876784|323454743|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
94455275|NCT01876784|323454742|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
94455276|NCT01876784|323454743|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
94455277|NCT01876784|323454742|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
94455278|NCT01876784|323454743|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
94455279|NCT01876784|323454742|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
94455280|NCT01876784|323454743|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
94455281|NCT01876784|323454742|FG000|Randomized Treatment Period (40 Months)|Death|1|||
94455282|NCT01876784|323454743|FG001|Randomized Treatment Period (40 Months)|Death|0|||
94455283|NCT01876784|323454742|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
94455284|NCT01876784|323454743|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
94455285|NCT01876784|323454742|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
94455286|NCT01876784|323454743|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
94455287|NCT01876784|323454742|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
94455288|NCT01876784|323454743|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
94455289|NCT01876784|323454742|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
94455290|NCT01876784|323454743|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
94455291|NCT01876784|323454742|FG000|Open-label Period (31 Months)|Adverse Event|2|||
94455292|NCT01876784|323454743|FG001|Open-label Period (31 Months)|Adverse Event|6|||
94455293|NCT01876784|323454742|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
94455294|NCT01876784|323454743|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
94455295|NCT01876784|323454742|FG000|Open-label Period (31 Months)|Progressive disease|4|||
94455296|NCT01876784|323454743|FG001|Open-label Period (31 Months)|Progressive disease|35|||
94455297|NCT01876784|323454742|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
94455298|NCT01876784|323454743|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
94455299|NCT01876784|323454742|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
94455300|NCT01876784|323454743|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
94455301|NCT01876784|323454742|FG000|Open-label Period (31 Months)|Death|0|||
94455302|NCT01876784|323454743|FG001|Open-label Period (31 Months)|Death|1|||
94455303|NCT01876784|323454742|FG000|Open-label Period (31 Months)|Other than specified above|9|||
94455304|NCT01876784|323454743|FG001|Open-label Period (31 Months)|Other than specified above|18|||
94455305|NCT01194531|323454745|FG000|Overall Study|Withdrawal by Subject|1|||
94455306|NCT01194531|323454746|FG001|Overall Study|Withdrawal by Subject|0|||
94455307|NCT01194531|323454745|FG000|Overall Study|Protocol Violation|4|||
94455308|NCT01194531|323454746|FG001|Overall Study|Protocol Violation|1|||
94455309|NCT01194531|323454745|FG000|Overall Study|Physician Decision|0|||
94455310|NCT01194531|323454746|FG001|Overall Study|Physician Decision|2|||
94455311|NCT03891862|323454747|FG000|Open-label Period|Adverse Event|2|||
94455312|NCT03891862|323454748|FG001|Open-label Period|Adverse Event|0|||
94455313|NCT03891862|323454749|FG002|Open-label Period|Adverse Event|0|||
94455314|NCT03891862|323454747|FG000|Open-label Period|Protocol Violation|5|||
94455315|NCT03891862|323454748|FG001|Open-label Period|Protocol Violation|0|||
94455316|NCT03891862|323454749|FG002|Open-label Period|Protocol Violation|0|||
94455317|NCT03891862|323454747|FG000|Open-label Period|Withdrawal by Subject|6|||
94455318|NCT03891862|323454748|FG001|Open-label Period|Withdrawal by Subject|0|||
94455319|NCT03891862|323454749|FG002|Open-label Period|Withdrawal by Subject|0|||
94455320|NCT03891862|323454747|FG000|Open-label Period|Death|1|||
94455321|NCT03891862|323454748|FG001|Open-label Period|Death|0|||
94455322|NCT03891862|323454749|FG002|Open-label Period|Death|0|||
94455323|NCT03891862|323454747|FG000|Open-label Period|Lost to Follow-up|2|||
94455324|NCT03891862|323454748|FG001|Open-label Period|Lost to Follow-up|0|||
94455325|NCT03891862|323454749|FG002|Open-label Period|Lost to Follow-up|0|||
94455326|NCT03891862|323454747|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
94455327|NCT03891862|323454748|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
94455328|NCT03891862|323454749|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
94455329|NCT03891862|323454747|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
94455330|NCT03891862|323454748|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
94455331|NCT03891862|323454749|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
94455332|NCT03891862|323454747|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
94659030|NCT01539291|324207963|FG002|Study GS-US-312-0116|Physician Decision|0|||
94352930|NCT01791543|323073641|FG000|Overall Study|Adverse Event|1|||
94352931|NCT01190839|323073642|FG000|Overall Study|Adverse Event|32|||
94352932|NCT01190839|323073643|FG001|Overall Study|Adverse Event|41|||
94352933|NCT01190839|323073642|FG000|Overall Study|Protocol Violation|2|||
94352934|NCT01190839|323073643|FG001|Overall Study|Protocol Violation|2|||
94352935|NCT01190839|323073642|FG000|Overall Study|Lost to Follow-up|7|||
94352936|NCT01190839|323073643|FG001|Overall Study|Lost to Follow-up|1|||
94352937|NCT01190839|323073642|FG000|Overall Study|Death|1|||
94352938|NCT01190839|323073643|FG001|Overall Study|Death|0|||
94352939|NCT01190839|323073642|FG000|Overall Study|Trial stopped by Sponsor|71|||
94352940|NCT01190839|323073643|FG001|Overall Study|Trial stopped by Sponsor|68|||
94352941|NCT01190839|323073642|FG000|Overall Study|Undefined|35|||
94352942|NCT01190839|323073643|FG001|Overall Study|Undefined|31|||
94352943|NCT01190839|323073642|FG000|Overall Study|Randomized but not treated|2|||
94352944|NCT01190839|323073643|FG001|Overall Study|Randomized but not treated|4|||
94352945|NCT00323479|323073648|FG000|Overall Study|Adverse Event|2|||
94352946|NCT00323479|323073648|FG000|Overall Study|Withdrawal by Subject|2|||
94352947|NCT00323479|323073648|FG000|Overall Study|Protocol Violation|3|||
94352948|NCT00323479|323073648|FG000|Overall Study|house moving|1|||
94352949|NCT02545504|323073649|FG000|Overall Study|Death|174|||
94352950|NCT02545504|323073650|FG001|Overall Study|Death|168|||
94352951|NCT02545504|323073649|FG000|Overall Study|Unknown reason|30|||
94352952|NCT02545504|323073650|FG001|Overall Study|Unknown reason|32|||
94352953|NCT02545504|323073649|FG000|Overall Study|Withdrew consent|9|||
94352954|NCT02545504|323073650|FG001|Overall Study|Withdrew consent|11|||
94352955|NCT02545504|323073649|FG000|Overall Study|Investigator's discretion|3|||
94352956|NCT02545504|323073650|FG001|Overall Study|Investigator's discretion|1|||
94352957|NCT02545504|323073649|FG000|Overall Study|Lost to Follow-up|2|||
94352958|NCT02545504|323073650|FG001|Overall Study|Lost to Follow-up|2|||
94352959|NCT02198040|323074871|FG000|Overall Study|Work reasons|0|||
94352960|NCT02198040|323074872|FG001|Overall Study|Work reasons|1|||
94352961|NCT02198040|323074873|FG002|Overall Study|Work reasons|0|||
94352962|NCT02198040|323074871|FG000|Overall Study|Withdrawal by Subject|0|||
94352963|NCT02198040|323074872|FG001|Overall Study|Withdrawal by Subject|0|||
94352964|NCT02198040|323074873|FG002|Overall Study|Withdrawal by Subject|1|||
94352965|NCT03359811|323074874|FG000|Overall Study|Protocol Violation|2|||
94352966|NCT03359811|323074875|FG001|Overall Study|Protocol Violation|0|||
94352967|NCT01409382|323074880|FG000|Overall Study|Lost to Follow-up|1|||
94352968|NCT01409382|323074881|FG001|Overall Study|Lost to Follow-up|1|||
94352969|NCT01409382|323074880|FG000|Overall Study|Protocol Violation|0|||
94352970|NCT01409382|323074881|FG001|Overall Study|Protocol Violation|3|||
94352971|NCT01409382|323074880|FG000|Overall Study|Multiple pregnancy|2|||
94352972|NCT01409382|323074881|FG001|Overall Study|Multiple pregnancy|4|||
94352973|NCT01409382|323074880|FG000|Overall Study|Still pregnant when study ended|13|||
94352974|NCT01409382|323074881|FG001|Overall Study|Still pregnant when study ended|2|||
94352975|NCT01409382|323074880|FG000|Overall Study|Did not manage to get pregnant|64|||
94352976|NCT01409382|323074881|FG001|Overall Study|Did not manage to get pregnant|70|||
94352977|NCT01409382|323074880|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
94352978|NCT01409382|323074881|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
94352979|NCT02551874|323074888|FG000|Overall Study|Lost to Follow-up|0|||
94352980|NCT02551874|323074889|FG001|Overall Study|Lost to Follow-up|2|||
94352981|NCT02551874|323074888|FG000|Overall Study|Pregnancy|0|||
94352982|NCT02551874|323074889|FG001|Overall Study|Pregnancy|1|||
94352983|NCT02551874|323074888|FG000|Overall Study|Reason not reported|10|||
94352984|NCT02551874|323074889|FG001|Overall Study|Reason not reported|4|||
94352985|NCT02551874|323074888|FG000|Overall Study|Did not receive randomized treatment|0|||
94352986|NCT02551874|323074889|FG001|Overall Study|Did not receive randomized treatment|7|||
94352987|NCT02551874|323074888|FG000|Overall Study|Did not enter long-term study|18|||
94352988|NCT02551874|323074889|FG001|Overall Study|Did not enter long-term study|25|||
94352989|NCT00039377|323074891|FG000|Initial Registration|Adverse Event|2|||
94352990|NCT00039377|323074892|FG001|Initial Registration|Adverse Event|0|||
94352991|NCT00039377|323074893|FG002|Initial Registration|Adverse Event|0|||
94352992|NCT00039377|323074894|FG003|Initial Registration|Adverse Event|0|||
94352993|NCT00039377|323074891|FG000|Initial Registration|Relapsed|6|||
94352994|NCT00039377|323074892|FG001|Initial Registration|Relapsed|0|||
94352995|NCT00039377|323074893|FG002|Initial Registration|Relapsed|0|||
94352996|NCT00039377|323074894|FG003|Initial Registration|Relapsed|0|||
94352997|NCT00039377|323074891|FG000|Initial Registration|Received non-protocol therapy|11|||
94352998|NCT00039377|323074892|FG001|Initial Registration|Received non-protocol therapy|0|||
94352999|NCT00039377|323074893|FG002|Initial Registration|Received non-protocol therapy|0|||
94353000|NCT00039377|323074894|FG003|Initial Registration|Received non-protocol therapy|0|||
94353001|NCT00039377|323074891|FG000|Initial Registration|Withdrawal by Subject|3|||
94353002|NCT00039377|323074892|FG001|Initial Registration|Withdrawal by Subject|0|||
94353003|NCT00039377|323074893|FG002|Initial Registration|Withdrawal by Subject|0|||
94353004|NCT00039377|323074894|FG003|Initial Registration|Withdrawal by Subject|0|||
94353005|NCT01858701|323074898|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
94353006|NCT01858701|323074899|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
94583159|NCT03023397|323935009|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
94583160|NCT03023397|323935010|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
94583161|NCT03023397|323935011|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
94583162|NCT01143246|323935019|FG000|Overall Study|Adverse Event|24|||
94583163|NCT01143246|323935020|FG001|Overall Study|Adverse Event|28|||
94583164|NCT01143246|323935019|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
94583165|NCT01143246|323935020|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
94583166|NCT01143246|323935019|FG000|Overall Study|Lost to Follow-up|0|||
94583167|NCT01143246|323935020|FG001|Overall Study|Lost to Follow-up|1|||
94583168|NCT01143246|323935019|FG000|Overall Study|Death|16|||
94583169|NCT01143246|323935020|FG001|Overall Study|Death|15|||
94583170|NCT01143246|323935019|FG000|Overall Study|Reason not Specified|3|||
94583171|NCT01143246|323935020|FG001|Overall Study|Reason not Specified|5|||
94583172|NCT00361296|323935026|FG000|Overall Study|Physician Decision|1|||
94583173|NCT00361296|323935026|FG000|Overall Study|Lack of Efficacy|2|||
94583174|NCT03155841|323935027|FG000|Overall Study|Protocol Violation|3|||
94583175|NCT03155841|323935028|FG001|Overall Study|Protocol Violation|4|||
94583176|NCT04032093|323935031|FG000|Overall Study|Lost to Follow-up|7|||
94583177|NCT04032093|323935032|FG001|Overall Study|Lost to Follow-up|7|||
94583178|NCT04032093|323935033|FG002|Overall Study|Lost to Follow-up|6|||
94583179|NCT04032093|323935034|FG003|Overall Study|Lost to Follow-up|10|||
94583180|NCT04032093|323935035|FG004|Overall Study|Lost to Follow-up|13|||
94583181|NCT04032093|323935036|FG005|Overall Study|Lost to Follow-up|7|||
94583182|NCT04032093|323935037|FG006|Overall Study|Lost to Follow-up|7|||
94583183|NCT04032093|323935038|FG007|Overall Study|Lost to Follow-up|5|||
94583184|NCT04032093|323935039|FG008|Overall Study|Lost to Follow-up|9|||
94583185|NCT04032093|323935040|FG009|Overall Study|Lost to Follow-up|12|||
94583186|NCT04032093|323935031|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
94583187|NCT04032093|323935032|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
94583188|NCT04032093|323935033|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
94583189|NCT04032093|323935034|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
94583190|NCT04032093|323935035|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
94583191|NCT04032093|323935036|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
94583192|NCT04032093|323935037|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
94583193|NCT04032093|323935038|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
94583194|NCT04032093|323935039|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
94583195|NCT04032093|323935040|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
94583196|NCT04032093|323935031|FG000|Overall Study|Other|1|||
94583197|NCT04032093|323935032|FG001|Overall Study|Other|0|||
94583198|NCT04032093|323935033|FG002|Overall Study|Other|0|||
94583199|NCT04032093|323935034|FG003|Overall Study|Other|1|||
94583200|NCT04032093|323935035|FG004|Overall Study|Other|1|||
94583201|NCT04032093|323935036|FG005|Overall Study|Other|0|||
94583202|NCT04032093|323935037|FG006|Overall Study|Other|0|||
94583203|NCT04032093|323935038|FG007|Overall Study|Other|0|||
94583204|NCT04032093|323935039|FG008|Overall Study|Other|0|||
94583205|NCT04032093|323935040|FG009|Overall Study|Other|1|||
94583206|NCT04032093|323935031|FG000|Overall Study|Withdrawal by Subject|1|||
94583207|NCT04032093|323935032|FG001|Overall Study|Withdrawal by Subject|3|||
94583208|NCT04032093|323935033|FG002|Overall Study|Withdrawal by Subject|2|||
94583209|NCT04032093|323935034|FG003|Overall Study|Withdrawal by Subject|2|||
94583210|NCT04032093|323935035|FG004|Overall Study|Withdrawal by Subject|3|||
94583211|NCT04032093|323935036|FG005|Overall Study|Withdrawal by Subject|0|||
94583212|NCT04032093|323935037|FG006|Overall Study|Withdrawal by Subject|0|||
94583213|NCT04032093|323935038|FG007|Overall Study|Withdrawal by Subject|0|||
94583214|NCT04032093|323935039|FG008|Overall Study|Withdrawal by Subject|0|||
94583215|NCT04032093|323935040|FG009|Overall Study|Withdrawal by Subject|0|||
94583216|NCT04032093|323935031|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94583217|NCT04032093|323935032|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94583218|NCT04032093|323935033|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
94583219|NCT04032093|323935034|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
94583220|NCT04032093|323935035|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
94583221|NCT04032093|323935036|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
94583222|NCT04032093|323935037|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
94583223|NCT04032093|323935038|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
94583224|NCT04032093|323935039|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
94583225|NCT04032093|323935040|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
94583226|NCT04032093|323935031|FG000|Overall Study|Adverse Event|0|||
94583227|NCT04032093|323935032|FG001|Overall Study|Adverse Event|0|||
94583228|NCT04032093|323935033|FG002|Overall Study|Adverse Event|0|||
94583229|NCT04032093|323935034|FG003|Overall Study|Adverse Event|0|||
94583230|NCT04032093|323935035|FG004|Overall Study|Adverse Event|0|||
94583231|NCT04032093|323935036|FG005|Overall Study|Adverse Event|0|||
94583232|NCT04032093|323935037|FG006|Overall Study|Adverse Event|0|||
94583233|NCT04032093|323935038|FG007|Overall Study|Adverse Event|0|||
94583234|NCT04032093|323935039|FG008|Overall Study|Adverse Event|0|||
94583235|NCT04032093|323935040|FG009|Overall Study|Adverse Event|1|||
94583236|NCT04032093|323935031|FG000|Overall Study|Physician Decision|0|||
94583237|NCT04032093|323935032|FG001|Overall Study|Physician Decision|0|||
94583238|NCT04032093|323935033|FG002|Overall Study|Physician Decision|0|||
94583239|NCT04032093|323935034|FG003|Overall Study|Physician Decision|0|||
94583240|NCT04032093|323935035|FG004|Overall Study|Physician Decision|0|||
94583241|NCT04032093|323935036|FG005|Overall Study|Physician Decision|1|||
94583242|NCT04032093|323935037|FG006|Overall Study|Physician Decision|0|||
94583243|NCT04032093|323935038|FG007|Overall Study|Physician Decision|0|||
94583244|NCT04032093|323935039|FG008|Overall Study|Physician Decision|0|||
94583245|NCT04032093|323935040|FG009|Overall Study|Physician Decision|0|||
94583246|NCT04139018|323935041|FG000|Overall Study|Screen fail|1|||
94583247|NCT04139018|323935042|FG001|Overall Study|Screen fail|0|||
94583248|NCT04139018|323935041|FG000|Overall Study|Withdrawal by Subject|2|||
94583249|NCT04139018|323935042|FG001|Overall Study|Withdrawal by Subject|0|||
94583250|NCT04139018|323935041|FG000|Overall Study|Lost to Follow-up|0|||
94583251|NCT04139018|323935042|FG001|Overall Study|Lost to Follow-up|1|||
94583252|NCT01147874|323935045|FG000|Overall Study|Adverse Event|5|||
94583253|NCT01147874|323935045|FG000|Overall Study|Investigator's Request|1|||
94583254|NCT01147874|323935045|FG000|Overall Study|Lost to Follow-up|25|||
94583255|NCT01147874|323935045|FG000|Overall Study|Other|5|||
94583256|NCT01147874|323935045|FG000|Overall Study|Protocol Violation|5|||
94583257|NCT01147874|323935045|FG000|Overall Study|Sponsor's Decision|2|||
94583258|NCT01147874|323935045|FG000|Overall Study|Withdrawal by Subject|24|||
94583259|NCT02745119|323935048|FG000|Overall Study|Adverse Event|1|||
94583260|NCT02745119|323935049|FG001|Overall Study|Adverse Event|0|||
94583261|NCT02745119|323935050|FG002|Overall Study|Adverse Event|1|||
94583262|NCT02745119|323935051|FG003|Overall Study|Adverse Event|3|||
94583263|NCT02745119|323935048|FG000|Overall Study|Death|3|||
94583264|NCT02745119|323935049|FG001|Overall Study|Death|3|||
94583265|NCT02745119|323935050|FG002|Overall Study|Death|0|||
94583266|NCT02745119|323935051|FG003|Overall Study|Death|4|||
94583267|NCT02745119|323935048|FG000|Overall Study|Lost to Follow-up|0|||
94583268|NCT02745119|323935049|FG001|Overall Study|Lost to Follow-up|0|||
94583269|NCT02745119|323935050|FG002|Overall Study|Lost to Follow-up|0|||
94583270|NCT02745119|323935051|FG003|Overall Study|Lost to Follow-up|1|||
94583271|NCT02745119|323935048|FG000|Overall Study|Protocol Deviation|0|||
94583272|NCT02745119|323935049|FG001|Overall Study|Protocol Deviation|0|||
94583273|NCT02745119|323935050|FG002|Overall Study|Protocol Deviation|0|||
94583274|NCT02745119|323935051|FG003|Overall Study|Protocol Deviation|1|||
94583275|NCT02745119|323935048|FG000|Overall Study|Withdrawal by Subject|7|||
94583276|NCT02745119|323935049|FG001|Overall Study|Withdrawal by Subject|15|||
94583277|NCT02745119|323935050|FG002|Overall Study|Withdrawal by Subject|8|||
94583278|NCT02745119|323935051|FG003|Overall Study|Withdrawal by Subject|14|||
94583279|NCT02745119|323935048|FG000|Overall Study|Study Terminated by Sponsor|134|||
94583280|NCT02745119|323935049|FG001|Overall Study|Study Terminated by Sponsor|252|||
94583281|NCT02745119|323935050|FG002|Overall Study|Study Terminated by Sponsor|135|||
94583282|NCT02745119|323935051|FG003|Overall Study|Study Terminated by Sponsor|251|||
94583283|NCT02745119|323935048|FG000|Overall Study|Physician Decision|0|||
94583284|NCT02745119|323935049|FG001|Overall Study|Physician Decision|2|||
94583285|NCT02745119|323935050|FG002|Overall Study|Physician Decision|2|||
94583286|NCT02745119|323935051|FG003|Overall Study|Physician Decision|2|||
94583287|NCT02745119|323935048|FG000|Overall Study|Reason Not Specified|0|||
94583288|NCT02745119|323935049|FG001|Overall Study|Reason Not Specified|2|||
94583289|NCT02745119|323935050|FG002|Overall Study|Reason Not Specified|0|||
94583290|NCT02745119|323935051|FG003|Overall Study|Reason Not Specified|1|||
94583291|NCT00993967|323935052|FG000|Overall Study|Adverse Event|8|||
94583292|NCT00993967|323935052|FG000|Overall Study|Death|1|||
94583293|NCT00993967|323935052|FG000|Overall Study|Lost to Follow-up|14|||
94583294|NCT00993967|323935052|FG000|Overall Study|Withdrawal by Subject|36|||
94583295|NCT00993967|323935052|FG000|Overall Study|Protocol Violation|2|||
94583296|NCT00432172|323935053|FG000|Overall Study|Physician Decision|0|||
94583297|NCT00432172|323935054|FG001|Overall Study|Physician Decision|0|||
94583298|NCT00432172|323935055|FG002|Overall Study|Physician Decision|2|||
94583299|NCT00432172|323935056|FG003|Overall Study|Physician Decision|0|||
94583300|NCT00432172|323935053|FG000|Overall Study|Adverse Event|4|||
94583301|NCT00432172|323935054|FG001|Overall Study|Adverse Event|2|||
94583302|NCT00432172|323935055|FG002|Overall Study|Adverse Event|4|||
94583303|NCT00432172|323935056|FG003|Overall Study|Adverse Event|3|||
94583304|NCT00432172|323935053|FG000|Overall Study|Disease progression|0|||
94583305|NCT00432172|323935054|FG001|Overall Study|Disease progression|2|||
94583306|NCT00432172|323935055|FG002|Overall Study|Disease progression|5|||
94583307|NCT00432172|323935056|FG003|Overall Study|Disease progression|1|||
94583308|NCT00432172|323935053|FG000|Overall Study|Withdrawal by Subject|0|||
94583309|NCT00432172|323935054|FG001|Overall Study|Withdrawal by Subject|1|||
94583310|NCT00432172|323935055|FG002|Overall Study|Withdrawal by Subject|0|||
94583311|NCT00432172|323935056|FG003|Overall Study|Withdrawal by Subject|2|||
94583312|NCT00432172|323935053|FG000|Overall Study|No treatment received|2|||
94583313|NCT00432172|323935054|FG001|Overall Study|No treatment received|2|||
94583314|NCT00432172|323935055|FG002|Overall Study|No treatment received|0|||
94583315|NCT00432172|323935056|FG003|Overall Study|No treatment received|1|||
94583316|NCT00888940|323935057|FG000|Overall Study|Adverse Event|12|||
94583317|NCT00888940|323935058|FG001|Overall Study|Adverse Event|3|||
94583318|NCT00888940|323935057|FG000|Overall Study|Lost to Follow-up|5|||
94583319|NCT00888940|323935058|FG001|Overall Study|Lost to Follow-up|5|||
94583320|NCT00888940|323935057|FG000|Overall Study|Randomized Not Treated|11|||
94583321|NCT00888940|323935058|FG001|Overall Study|Randomized Not Treated|13|||
94583322|NCT01106248|323935060|FG000|Overall Study|Adverse Event|1|||
94583323|NCT01106248|323935060|FG000|Overall Study|Administrative|2|||
94583324|NCT00515619|323935063|FG000|Overall Study|Adverse Event|34|||
94583325|NCT00515619|323935063|FG000|Overall Study|Lack of Efficacy|92|||
94583326|NCT00515619|323935063|FG000|Overall Study|Withdrawal by Subject|66|||
94583327|NCT00515619|323935063|FG000|Overall Study|Protocol Violation|3|||
94583328|NCT00515619|323935063|FG000|Overall Study|Lost to Follow-up|4|||
94583329|NCT00515619|323935063|FG000|Overall Study|Unsatisfactory compliance|6|||
94583330|NCT00515619|323935063|FG000|Overall Study|Other: Site discontinuing trials|2|||
94583331|NCT00515619|323935063|FG000|Overall Study|Other: Subject cannot attend visits|2|||
94583332|NCT00515619|323935063|FG000|Overall Study|Other: Subject required surgery|1|||
94583333|NCT00515619|323935063|FG000|Overall Study|Other: Subject moved to another country|1|||
94583334|NCT00515619|323935063|FG000|Overall Study|Other: Investigator decision|1|||
94583335|NCT00515619|323935063|FG000|Overall Study|Other: Subject became pregnant|1|||
94583336|NCT00515619|323935063|FG000|Overall Study|Other: Request from sponsor|1|||
94583337|NCT00515619|323935063|FG000|Overall Study|Other: Drug available on license|1|||
94583338|NCT00515619|323935063|FG000|Overall Study|Other: Subject interested in other AED|1|||
94583339|NCT02170077|323935066|FG000|Overall Study|Withdrawal by Subject|3|||
94583340|NCT02170077|323935067|FG001|Overall Study|Withdrawal by Subject|4|||
94583341|NCT02170077|323935068|FG002|Overall Study|Withdrawal by Subject|2|||
94583342|NCT02170077|323935066|FG000|Overall Study|Adverse Event|4|||
94583343|NCT02170077|323935067|FG001|Overall Study|Adverse Event|4|||
94583344|NCT02170077|323935068|FG002|Overall Study|Adverse Event|4|||
94583345|NCT02170077|323935066|FG000|Overall Study|Lost to Follow-up|0|||
94583346|NCT02170077|323935067|FG001|Overall Study|Lost to Follow-up|1|||
94583347|NCT02170077|323935068|FG002|Overall Study|Lost to Follow-up|0|||
94583348|NCT02170077|323935066|FG000|Overall Study|Exclusion criteria|2|||
94583349|NCT02170077|323935067|FG001|Overall Study|Exclusion criteria|2|||
94583350|NCT02170077|323935068|FG002|Overall Study|Exclusion criteria|5|||
94583351|NCT02170077|323935066|FG000|Overall Study|Exacerbation of seizures|0|||
94583352|NCT02170077|323935067|FG001|Overall Study|Exacerbation of seizures|2|||
94583353|NCT02170077|323935068|FG002|Overall Study|Exacerbation of seizures|1|||
94583354|NCT00214201|323936703|FG000|Overall Study|Withdrawal by Subject|2|||
94583355|NCT00214201|323936704|FG001|Overall Study|Withdrawal by Subject|0|||
94583356|NCT00214201|323936703|FG000|Overall Study|Death|0|||
94583357|NCT00214201|323936704|FG001|Overall Study|Death|2|||
94583358|NCT01399372|323936705|FG000|Overall Study|Protocol Violation|3|||
94583359|NCT01399372|323936706|FG001|Overall Study|Protocol Violation|1|||
94583360|NCT00463567|323936707|FG000|Overall Study|Adverse Event|29|||
94583361|NCT00463567|323936708|FG001|Overall Study|Adverse Event|26|||
94583362|NCT00463567|323936709|FG002|Overall Study|Adverse Event|17|||
94583363|NCT00463567|323936710|FG003|Overall Study|Adverse Event|46|||
94583364|NCT00463567|323936711|FG004|Overall Study|Adverse Event|10|||
94583365|NCT00463567|323936712|FG005|Overall Study|Adverse Event|10|||
94583366|NCT00463567|323936713|FG006|Overall Study|Adverse Event|4|||
94583367|NCT00463567|323936707|FG000|Overall Study|Withdrawal by Subject|29|||
94583368|NCT00463567|323936708|FG001|Overall Study|Withdrawal by Subject|22|||
94583369|NCT00463567|323936709|FG002|Overall Study|Withdrawal by Subject|20|||
94583370|NCT00463567|323936710|FG003|Overall Study|Withdrawal by Subject|37|||
94583371|NCT00463567|323936711|FG004|Overall Study|Withdrawal by Subject|6|||
94583372|NCT00463567|323936712|FG005|Overall Study|Withdrawal by Subject|5|||
94583373|NCT00463567|323936713|FG006|Overall Study|Withdrawal by Subject|1|||
94583374|NCT00463567|323936707|FG000|Overall Study|Protocol Deviation|13|||
94583375|NCT00463567|323936708|FG001|Overall Study|Protocol Deviation|9|||
94583376|NCT00463567|323936709|FG002|Overall Study|Protocol Deviation|14|||
94583377|NCT00463567|323936710|FG003|Overall Study|Protocol Deviation|11|||
94583378|NCT00463567|323936711|FG004|Overall Study|Protocol Deviation|1|||
94583379|NCT00463567|323936712|FG005|Overall Study|Protocol Deviation|1|||
94583380|NCT00463567|323936713|FG006|Overall Study|Protocol Deviation|2|||
94583381|NCT00463567|323936707|FG000|Overall Study|Lost to Follow-up|12|||
94583382|NCT00463567|323936708|FG001|Overall Study|Lost to Follow-up|6|||
94583383|NCT00463567|323936709|FG002|Overall Study|Lost to Follow-up|13|||
94583384|NCT00463567|323936710|FG003|Overall Study|Lost to Follow-up|8|||
94583385|NCT00463567|323936711|FG004|Overall Study|Lost to Follow-up|1|||
94583386|NCT00463567|323936712|FG005|Overall Study|Lost to Follow-up|1|||
94583387|NCT00463567|323936713|FG006|Overall Study|Lost to Follow-up|1|||
94583388|NCT00463567|323936707|FG000|Overall Study|Administrative problems|5|||
94583389|NCT00463567|323936708|FG001|Overall Study|Administrative problems|3|||
94583390|NCT00463567|323936709|FG002|Overall Study|Administrative problems|6|||
94583391|NCT00463567|323936710|FG003|Overall Study|Administrative problems|9|||
94583392|NCT00463567|323936711|FG004|Overall Study|Administrative problems|3|||
94583393|NCT00463567|323936712|FG005|Overall Study|Administrative problems|2|||
94583394|NCT00463567|323936713|FG006|Overall Study|Administrative problems|2|||
94583395|NCT00463567|323936707|FG000|Overall Study|Lack of Efficacy|4|||
94583396|NCT00463567|323936708|FG001|Overall Study|Lack of Efficacy|9|||
94583397|NCT00463567|323936709|FG002|Overall Study|Lack of Efficacy|9|||
94583398|NCT00463567|323936710|FG003|Overall Study|Lack of Efficacy|17|||
94583399|NCT00463567|323936711|FG004|Overall Study|Lack of Efficacy|1|||
94583400|NCT00463567|323936712|FG005|Overall Study|Lack of Efficacy|0|||
94583401|NCT00463567|323936713|FG006|Overall Study|Lack of Efficacy|1|||
94583402|NCT00463567|323936707|FG000|Overall Study|Abnormal lab value(s)|1|||
94583403|NCT00463567|323936708|FG001|Overall Study|Abnormal lab value(s)|1|||
94583404|NCT00463567|323936709|FG002|Overall Study|Abnormal lab value(s)|2|||
94583405|NCT00463567|323936710|FG003|Overall Study|Abnormal lab value(s)|1|||
94583406|NCT00463567|323936711|FG004|Overall Study|Abnormal lab value(s)|1|||
94583407|NCT00463567|323936712|FG005|Overall Study|Abnormal lab value(s)|0|||
94583408|NCT00463567|323936713|FG006|Overall Study|Abnormal lab value(s)|0|||
94583409|NCT00463567|323936707|FG000|Overall Study|Abnormal test procedure result(s)|1|||
94583410|NCT00463567|323936708|FG001|Overall Study|Abnormal test procedure result(s)|1|||
94583411|NCT00463567|323936709|FG002|Overall Study|Abnormal test procedure result(s)|6|||
94583412|NCT00463567|323936710|FG003|Overall Study|Abnormal test procedure result(s)|2|||
94583413|NCT00463567|323936711|FG004|Overall Study|Abnormal test procedure result(s)|0|||
94583414|NCT00463567|323936712|FG005|Overall Study|Abnormal test procedure result(s)|2|||
94583415|NCT00463567|323936713|FG006|Overall Study|Abnormal test procedure result(s)|0|||
94583416|NCT00463567|323936707|FG000|Overall Study|Death|1|||
94583417|NCT00463567|323936708|FG001|Overall Study|Death|0|||
94583418|NCT00463567|323936709|FG002|Overall Study|Death|2|||
94583419|NCT00463567|323936710|FG003|Overall Study|Death|0|||
94583420|NCT00463567|323936711|FG004|Overall Study|Death|0|||
94583421|NCT00463567|323936712|FG005|Overall Study|Death|0|||
94583422|NCT00463567|323936713|FG006|Overall Study|Death|0|||
94583423|NCT01432730|323936714|FG000|Period 1|Adverse Event|2|||
94583424|NCT01432730|323936715|FG001|Period 1|Adverse Event|0|||
94583425|NCT01432730|323936714|FG000|Period 2|Adverse Event|0|||
94583426|NCT01432730|323936715|FG001|Period 2|Adverse Event|4|||
94583427|NCT01124006|323936718|FG000|Overall Study|Withdrawal by Subject|2|||
94583428|NCT01124006|323936719|FG001|Overall Study|Withdrawal by Subject|2|||
94583429|NCT01124006|323936720|FG002|Overall Study|Withdrawal by Subject|0|||
94583430|NCT01124006|323936718|FG000|Overall Study|Lost to Follow-up|1|||
94583431|NCT01124006|323936719|FG001|Overall Study|Lost to Follow-up|0|||
94583432|NCT01124006|323936720|FG002|Overall Study|Lost to Follow-up|1|||
94583433|NCT01124006|323936718|FG000|Overall Study|Other|0|||
94583434|NCT01124006|323936719|FG001|Overall Study|Other|0|||
94583435|NCT01124006|323936720|FG002|Overall Study|Other|1|||
94583436|NCT03077412|323936722|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
94583437|NCT03077412|323936723|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
94583438|NCT03077412|323936724|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
94583439|NCT03077412|323936722|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
94583440|NCT03077412|323936723|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
94583441|NCT03077412|323936724|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
94583442|NCT03077412|323936722|FG000|Overall Study|Adverse Event|1|||
94583443|NCT03077412|323936723|FG001|Overall Study|Adverse Event|2|||
94583444|NCT03077412|323936724|FG002|Overall Study|Adverse Event|2|||
94583445|NCT03077412|323936722|FG000|Overall Study|Investigator's Discretion|0|||
94583446|NCT03077412|323936723|FG001|Overall Study|Investigator's Discretion|1|||
94583447|NCT03077412|323936724|FG002|Overall Study|Investigator's Discretion|1|||
94583448|NCT03077412|323936722|FG000|Overall Study|Withdrew Consent|0|||
94583449|NCT03077412|323936723|FG001|Overall Study|Withdrew Consent|2|||
94583450|NCT03077412|323936724|FG002|Overall Study|Withdrew Consent|0|||
94583451|NCT00248040|323936727|FG000|Overall Study|transplantectomy|2|||
94583452|NCT00248040|323936728|FG001|Overall Study|transplantectomy|1|||
94583453|NCT00248040|323936729|FG002|Overall Study|transplantectomy|3|||
94583454|NCT00248040|323936727|FG000|Overall Study|transplant cancelled post treat start|1|||
94583455|NCT00248040|323936728|FG001|Overall Study|transplant cancelled post treat start|0|||
94583456|NCT00248040|323936729|FG002|Overall Study|transplant cancelled post treat start|0|||
94583457|NCT00248040|323936727|FG000|Overall Study|Death|0|||
94583458|NCT00248040|323936728|FG001|Overall Study|Death|0|||
94583459|NCT00248040|323936729|FG002|Overall Study|Death|1|||
94353007|NCT01858701|323074898|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
94353008|NCT01858701|323074899|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
94583460|NCT00628108|323936730|FG000|Overall Study|Adverse Event|0|||
94583461|NCT00628108|323936731|FG001|Overall Study|Adverse Event|3|||
94353009|NCT01858701|323074898|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
94353010|NCT01858701|323074899|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
94353011|NCT01858701|323074898|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
94353012|NCT01858701|323074899|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
94353013|NCT02528643|323074900|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
94353014|NCT02528643|323074901|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
94353015|NCT02528643|323074900|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
94353016|NCT02528643|323074901|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
94353017|NCT02528643|323074900|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
94353018|NCT02528643|323074901|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
94353019|NCT02528643|323074900|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
94353020|NCT02528643|323074901|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
94353021|NCT02528643|323074900|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
94353022|NCT02528643|323074901|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
94353023|NCT02528643|323074900|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
94353024|NCT02528643|323074901|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
94353025|NCT02528643|323074900|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
94353026|NCT02528643|323074901|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
94353027|NCT02501642|323074902|FG000|Overall Study|Lost to Follow-up|7|||
94353028|NCT02501642|323074903|FG001|Overall Study|Lost to Follow-up|11|||
94353029|NCT00134563|323074910|FG000|Overall Study|Not treated due to protocol violation|0|||
94353030|NCT00134563|323074911|FG001|Overall Study|Not treated due to protocol violation|1|||
94583462|NCT00628108|323936730|FG000|Overall Study|Withdrawal by Subject|1|||
94583463|NCT00628108|323936731|FG001|Overall Study|Withdrawal by Subject|0|||
94583464|NCT01760733|323936732|FG000|Waiting List|Death|18|||
94583465|NCT01760733|323936732|FG000|Waiting List|Removed from waiting list|41|||
94583466|NCT01760733|323936732|FG000|Waiting List|Not received a transplant yet|13|||
94353031|NCT00134563|323074912|FG002|Overall Study|Not treated due to protocol violation|1|||
94353032|NCT00134563|323074910|FG000|Overall Study|Adverse Event|29|||
94583467|NCT01760733|323936732|FG000|Transplanted|Not reached 10 years post transplant|184|||
94583468|NCT01760733|323936732|FG000|Transplanted|Death|26|||
94353033|NCT00134563|323074911|FG001|Overall Study|Adverse Event|37|||
94353034|NCT00134563|323074912|FG002|Overall Study|Adverse Event|38|||
94353035|NCT00134563|323074910|FG000|Overall Study|Lack of Efficacy|24|||
94353036|NCT00134563|323074911|FG001|Overall Study|Lack of Efficacy|14|||
94353037|NCT00134563|323074912|FG002|Overall Study|Lack of Efficacy|17|||
94353038|NCT00134563|323074910|FG000|Overall Study|Protocol Violation|3|||
94353039|NCT00134563|323074911|FG001|Overall Study|Protocol Violation|2|||
94353040|NCT00134563|323074912|FG002|Overall Study|Protocol Violation|5|||
94353041|NCT00134563|323074910|FG000|Overall Study|Lost to Follow-up|4|||
94583469|NCT01760733|323936732|FG000|Transplanted|Graft loss|7|||
94583470|NCT02395471|323936733|FG000|Overall Study|Lost to Follow-up|2|||
94583471|NCT02395471|323936734|FG001|Overall Study|Lost to Follow-up|0|||
94583472|NCT02395471|323936733|FG000|Overall Study|Withdrawal by Subject|2|||
94583473|NCT02395471|323936734|FG001|Overall Study|Withdrawal by Subject|1|||
94583474|NCT02395471|323936733|FG000|Overall Study|Physician Decision|1|||
94583475|NCT02395471|323936734|FG001|Overall Study|Physician Decision|0|||
94583476|NCT02395471|323936733|FG000|Overall Study|Protocol Violation|0|||
94583477|NCT02395471|323936734|FG001|Overall Study|Protocol Violation|1|||
94583478|NCT02395471|323936733|FG000|Overall Study|Failure to swollow sponge twice|1|||
94583479|NCT02395471|323936734|FG001|Overall Study|Failure to swollow sponge twice|0|||
94583480|NCT02395471|323936733|FG000|Overall Study|Patient did not return for procedure|0|||
94583481|NCT02395471|323936734|FG001|Overall Study|Patient did not return for procedure|1|||
94583482|NCT02395471|323936733|FG000|Overall Study|Subject not eligible|1|||
94583483|NCT02395471|323936734|FG001|Overall Study|Subject not eligible|0|||
94583484|NCT00882557|323936735|FG000|Overall Study|Withdrawal by Subject|1|||
94583485|NCT00882557|323936736|FG001|Overall Study|Withdrawal by Subject|0|||
94583486|NCT00882557|323936735|FG000|Overall Study|Trouble with Vein Access|1|||
94583487|NCT00882557|323936736|FG001|Overall Study|Trouble with Vein Access|0|||
94583488|NCT00882557|323936735|FG000|Overall Study|Randomized Not Treated|0|||
94583489|NCT00882557|323936736|FG001|Overall Study|Randomized Not Treated|1|||
94583490|NCT02282605|323936737|FG000|Overall Study|negative SA result on Day -1|3|||
94353042|NCT00134563|323074911|FG001|Overall Study|Lost to Follow-up|0|||
94353043|NCT00134563|323074912|FG002|Overall Study|Lost to Follow-up|2|||
94353044|NCT00134563|323074910|FG000|Overall Study|progressive disease|11|||
94353045|NCT00134563|323074911|FG001|Overall Study|progressive disease|4|||
94583491|NCT02282605|323936738|FG001|Overall Study|negative SA result on Day -1|0|||
94455333|NCT03891862|323454748|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
94455334|NCT03891862|323454749|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
94455335|NCT03891862|323454747|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
94455336|NCT03891862|323454748|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
94455337|NCT03891862|323454749|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
94455338|NCT00179673|323454751|FG000|Overall Study|Adverse Event|7|||
94583492|NCT02282605|323936739|FG002|Overall Study|negative SA result on Day -1|0|||
94583493|NCT02399163|323936740|FG000|Overall Study|Adverse Event|2|||
94583494|NCT02399163|323936740|FG000|Overall Study|Protocol Deviation|2|||
94353046|NCT00134563|323074912|FG002|Overall Study|progressive disease|2|||
94353047|NCT00134563|323074910|FG000|Overall Study|did not wish to continue|33|||
94353048|NCT00134563|323074911|FG001|Overall Study|did not wish to continue|32|||
94353049|NCT00134563|323074912|FG002|Overall Study|did not wish to continue|26|||
94353050|NCT00134563|323074910|FG000|Overall Study|Reason other than above|0|||
94353051|NCT00134563|323074911|FG001|Overall Study|Reason other than above|2|||
94353052|NCT00134563|323074912|FG002|Overall Study|Reason other than above|5|||
94583495|NCT02399163|323936740|FG000|Overall Study|Withdrawal by Participant|5|||
94583496|NCT03584789|323936743|FG000|Overall Study|refused EHR permission|19|||
94583497|NCT03584789|323936744|FG001|Overall Study|refused EHR permission|28|||
94583498|NCT03584789|323936745|FG002|Overall Study|refused EHR permission|23|||
94583499|NCT03584789|323936743|FG000|Overall Study|patients tied to a provider who retired|0|||
94583500|NCT03584789|323936744|FG001|Overall Study|patients tied to a provider who retired|0|||
94583501|NCT03584789|323936745|FG002|Overall Study|patients tied to a provider who retired|3|||
94583502|NCT04646044|323936746|FG000|Overall Study|Lost to Follow-up|0|||
94583503|NCT04646044|323936747|FG001|Overall Study|Lost to Follow-up|0|||
94583504|NCT04646044|323936748|FG002|Overall Study|Lost to Follow-up|1|||
94583505|NCT04646044|323936749|FG003|Overall Study|Lost to Follow-up|0|||
94583506|NCT04646044|323936746|FG000|Overall Study|Withdrawal by Subject|0|||
94583507|NCT04646044|323936747|FG001|Overall Study|Withdrawal by Subject|1|||
94583508|NCT04646044|323936748|FG002|Overall Study|Withdrawal by Subject|0|||
94583509|NCT04646044|323936749|FG003|Overall Study|Withdrawal by Subject|0|||
94583510|NCT00602472|323936752|FG000|Overall Study|Adverse Event|5|||
94583511|NCT00602472|323936753|FG001|Overall Study|Adverse Event|23|||
94583512|NCT00602472|323936752|FG000|Overall Study|Protocol Violation|4|||
94583513|NCT00602472|323936753|FG001|Overall Study|Protocol Violation|19|||
94583514|NCT00602472|323936752|FG000|Overall Study|Withdrawal by Subject|8|||
94583515|NCT00602472|323936753|FG001|Overall Study|Withdrawal by Subject|14|||
94583516|NCT00602472|323936752|FG000|Overall Study|Other incl. lack of efficacy|4|||
94583517|NCT00602472|323936753|FG001|Overall Study|Other incl. lack of efficacy|2|||
94583518|NCT01938716|323936754|FG000|Overall Study|Physician Decision|2|||
94583519|NCT01938716|323936754|FG000|Overall Study|Withdrawal by Subject|2|||
94583520|NCT01908803|323936756|FG000|Overall Study|Adverse Event|1|||
94583521|NCT01908803|323936757|FG001|Overall Study|Adverse Event|0|||
94583522|NCT01908803|323936756|FG000|Overall Study|Physician Decision|0|||
94583523|NCT01908803|323936757|FG001|Overall Study|Physician Decision|1|||
94583524|NCT01908803|323936756|FG000|Overall Study|Withdrawal by Subject|1|||
94583525|NCT01908803|323936757|FG001|Overall Study|Withdrawal by Subject|0|||
94583526|NCT01908803|323936756|FG000|Overall Study|Randomization Error|1|||
94583527|NCT01908803|323936757|FG001|Overall Study|Randomization Error|0|||
94583528|NCT01908803|323936756|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
94583529|NCT01908803|323936757|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
94583530|NCT02404025|323936758|FG000|Overall Study|Adverse Event|1|||
94583531|NCT02404025|323936758|FG000|Overall Study|Lack of Efficacy|3|||
94583532|NCT02612779|323936759|FG000|Overall Study|Administrative reason by sponsor|4|||
94583533|NCT02612779|323936760|FG001|Overall Study|Administrative reason by sponsor|1|||
94353053|NCT00508872|323074914|FG000|Overall Study|Lost to Follow-up|1|||
94583534|NCT02612779|323936759|FG000|Overall Study|No longer meet study criteria|0|||
94583535|NCT02612779|323936760|FG001|Overall Study|No longer meet study criteria|1|||
94583536|NCT02612779|323936759|FG000|Overall Study|Disease progression|29|||
94583537|NCT02612779|323936760|FG001|Overall Study|Disease progression|2|||
94583538|NCT02612779|323936759|FG000|Overall Study|Study drug toxicity|10|||
94583539|NCT02612779|323936760|FG001|Overall Study|Study drug toxicity|1|||
94353054|NCT00508872|323074914|FG000|Overall Study|Physician Decision|1|||
94353055|NCT00542321|323074915|FG000|Overall Study|Death|0|||
94583540|NCT02612779|323936759|FG000|Overall Study|Death|1|||
94353056|NCT00542321|323074916|FG001|Overall Study|Death|1|||
94353057|NCT01871870|323074917|FG000|Overall Study|Hardware issues|7|||
94353058|NCT01871870|323074917|FG000|Overall Study|hyperglycemia|2|||
94353059|NCT01161173|323074918|FG000|Overall Study|Protocol Violation|13|||
94583541|NCT02612779|323936760|FG001|Overall Study|Death|0|||
94583542|NCT02612779|323936759|FG000|Overall Study|Adverse event unrelated to study drug|5|||
94583543|NCT02612779|323936760|FG001|Overall Study|Adverse event unrelated to study drug|0|||
94583544|NCT02612779|323936759|FG000|Overall Study|Participant withdrew consent|4|||
94583545|NCT02612779|323936760|FG001|Overall Study|Participant withdrew consent|0|||
94583546|NCT02612779|323936759|FG000|Overall Study|Lost to Follow-up|1|||
94583547|NCT02612779|323936760|FG001|Overall Study|Lost to Follow-up|0|||
94583548|NCT02612779|323936759|FG000|Overall Study|Maximum clinical benefit|10|||
94583549|NCT02612779|323936760|FG001|Overall Study|Maximum clinical benefit|1|||
94583550|NCT02612779|323936759|FG000|Overall Study|Other reasons|4|||
94583551|NCT02612779|323936760|FG001|Overall Study|Other reasons|0|||
94583552|NCT03910244|323936762|FG000|Overall Study|Adverse Event|14|||
94583553|NCT03910244|323936763|FG001|Overall Study|Adverse Event|0|||
94583554|NCT03910244|323936762|FG000|Overall Study|Death|1|||
94583555|NCT03910244|323936763|FG001|Overall Study|Death|0|||
94583556|NCT03910244|323936762|FG000|Overall Study|Lost to Follow-up|0|||
94583557|NCT03910244|323936763|FG001|Overall Study|Lost to Follow-up|2|||
94583558|NCT03910244|323936762|FG000|Overall Study|Joint withdrawal decision|1|||
94583559|NCT03910244|323936763|FG001|Overall Study|Joint withdrawal decision|0|||
94583560|NCT03910244|323936762|FG000|Overall Study|Study Terminated by Sponsor|7|||
94583561|NCT03910244|323936763|FG001|Overall Study|Study Terminated by Sponsor|4|||
94583562|NCT03910244|323936762|FG000|Overall Study|Physician Decision|1|||
94583563|NCT03910244|323936763|FG001|Overall Study|Physician Decision|0|||
94583564|NCT03910244|323936762|FG000|Overall Study|Protocol Violation|1|||
94583565|NCT03910244|323936763|FG001|Overall Study|Protocol Violation|0|||
94583566|NCT03910244|323936762|FG000|Overall Study|Withdrawal by Subject|7|||
94583567|NCT03910244|323936763|FG001|Overall Study|Withdrawal by Subject|2|||
94583568|NCT02636595|323936764|FG000|Overall Study|Lost to Follow-up|1|||
94583569|NCT02636595|323936764|FG000|Overall Study|Other|1|||
94583570|NCT02015637|323936768|FG000|Overall Study|Lost to Follow-up|3|||
94583571|NCT02015637|323936769|FG001|Overall Study|Lost to Follow-up|5|||
94583572|NCT02015637|323936768|FG000|Overall Study|Adverse Event|3|||
94583573|NCT02015637|323936769|FG001|Overall Study|Adverse Event|0|||
94583574|NCT02015637|323936768|FG000|Overall Study|Did not take study drug|2|||
94583575|NCT02015637|323936769|FG001|Overall Study|Did not take study drug|0|||
94583576|NCT02106390|323936770|FG000|Overall Study|Withdrawal by Subject|15|||
94583577|NCT02106390|323936771|FG001|Overall Study|Withdrawal by Subject|16|||
94583578|NCT02106390|323936772|FG002|Overall Study|Withdrawal by Subject|15|||
94583579|NCT02106390|323936770|FG000|Overall Study|Lost to Follow-up|25|||
94583580|NCT02106390|323936771|FG001|Overall Study|Lost to Follow-up|20|||
94583581|NCT02106390|323936772|FG002|Overall Study|Lost to Follow-up|13|||
94583582|NCT02106390|323936770|FG000|Overall Study|Other: Administrative Reason|8|||
94583583|NCT02106390|323936771|FG001|Overall Study|Other: Administrative Reason|5|||
94583584|NCT02106390|323936772|FG002|Overall Study|Other: Administrative Reason|12|||
94583585|NCT02106390|323936770|FG000|Overall Study|Other: Unspecified|1|||
94583586|NCT02106390|323936771|FG001|Overall Study|Other: Unspecified|4|||
94583587|NCT02106390|323936772|FG002|Overall Study|Other: Unspecified|2|||
94583588|NCT02106390|323936770|FG000|Overall Study|Adverse Event|0|||
94583589|NCT02106390|323936771|FG001|Overall Study|Adverse Event|2|||
94583590|NCT02106390|323936772|FG002|Overall Study|Adverse Event|1|||
94583591|NCT02106390|323936770|FG000|Overall Study|Protocol Violation|0|||
94583592|NCT02106390|323936771|FG001|Overall Study|Protocol Violation|1|||
94659031|NCT01539291|324207964|FG003|Study GS-US-312-0116|Physician Decision|0|||
94659032|NCT01539291|324207961|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
94659033|NCT01539291|324207962|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
94659034|NCT01539291|324207963|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
94659035|NCT01539291|324207964|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
94659036|NCT01539291|324207961|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
94659037|NCT01539291|324207962|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
94659038|NCT01539291|324207963|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
94353060|NCT01161173|323074918|FG000|Overall Study|Lost to Follow-up|7|||
94353061|NCT01161173|323074918|FG000|Overall Study|Progressive Disease|82|||
94353062|NCT01161173|323074918|FG000|Overall Study|Withdrawal of Consent|5|||
94353063|NCT01161173|323074918|FG000|Overall Study|Unacceptable Toxicity|21|||
94353064|NCT01161173|323074918|FG000|Overall Study|Death|194|||
94353065|NCT01161173|323074918|FG000|Overall Study|End of Study|2|||
94353066|NCT01161173|323074918|FG000|Overall Study|Reasons Not Specified|23|||
94353067|NCT05602818|323074919|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
94583593|NCT02106390|323936772|FG002|Overall Study|Protocol Violation|0|||
94583594|NCT03126591|323936776|FG000|Overall Study|Death|6|||
94583595|NCT03126591|323936777|FG001|Overall Study|Death|3|||
94583596|NCT03126591|323936778|FG002|Overall Study|Death|17|||
94583597|NCT03126591|323936776|FG000|Overall Study|Progressive Disease|0|||
94583598|NCT03126591|323936777|FG001|Overall Study|Progressive Disease|1|||
94583599|NCT03126591|323936778|FG002|Overall Study|Progressive Disease|2|||
94583600|NCT03126591|323936776|FG000|Overall Study|Terminated by Sponsor|0|||
94583601|NCT03126591|323936777|FG001|Overall Study|Terminated by Sponsor|1|||
94583602|NCT03126591|323936778|FG002|Overall Study|Terminated by Sponsor|4|||
94583603|NCT03126591|323936776|FG000|Overall Study|Withdrawal by Subject|1|||
94583604|NCT03126591|323936777|FG001|Overall Study|Withdrawal by Subject|1|||
94659039|NCT01539291|324207964|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
94583605|NCT03126591|323936778|FG002|Overall Study|Withdrawal by Subject|4|||
94583606|NCT03722238|323936781|FG000|Overall Study|Protocol Violation|1|||
94583607|NCT03722238|323936782|FG001|Overall Study|Protocol Violation|0|||
94583608|NCT03722238|323936781|FG000|Overall Study|Physician Decision|1|||
94583609|NCT03722238|323936782|FG001|Overall Study|Physician Decision|0|||
94583610|NCT03722238|323936781|FG000|Overall Study|Death|1|||
94583611|NCT03722238|323936782|FG001|Overall Study|Death|0|||
94583612|NCT03722238|323936781|FG000|Overall Study|Lost to Follow-up|6|||
94583613|NCT03722238|323936782|FG001|Overall Study|Lost to Follow-up|0|||
94583614|NCT03722238|323936781|FG000|Overall Study|Partial missing data|44|||
94583615|NCT03722238|323936782|FG001|Overall Study|Partial missing data|1|||
94583616|NCT03722238|323936781|FG000|Overall Study|Withdrawal by Subject|2|||
94583617|NCT03722238|323936782|FG001|Overall Study|Withdrawal by Subject|0|||
94583618|NCT03722238|323936781|FG000|Overall Study|Other|4|||
94583619|NCT03722238|323936782|FG001|Overall Study|Other|0|||
94583620|NCT03722238|323936781|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
94583621|NCT03722238|323936782|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
94583622|NCT03722238|323936781|FG000|Overall Study|Did not meet risk classification group criteria|90|||
94583623|NCT03722238|323936782|FG001|Overall Study|Did not meet risk classification group criteria|0|||
94583624|NCT03722238|323936781|FG000|Overall Study|Did not sign consent|17|||
94583625|NCT03722238|323936782|FG001|Overall Study|Did not sign consent|0|||
94583626|NCT03722238|323936781|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
94583627|NCT03722238|323936782|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
94583628|NCT03722238|323936781|FG000|Overall Study|Not willing to purchase study medication|142|||
94583629|NCT03722238|323936782|FG001|Overall Study|Not willing to purchase study medication|0|||
94583630|NCT03722238|323936781|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
94583631|NCT03722238|323936782|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
94583632|NCT02158546|323936789|FG000|Overall Study|Physician Decision|0|||
94583633|NCT02158546|323936790|FG001|Overall Study|Physician Decision|1|||
94583634|NCT02158546|323936791|FG002|Overall Study|Physician Decision|0|||
94583635|NCT02158546|323936792|FG003|Overall Study|Physician Decision|0|||
94583636|NCT02158546|323936789|FG000|Overall Study|Non-compliance|0|||
94583637|NCT02158546|323936790|FG001|Overall Study|Non-compliance|1|||
94583638|NCT02158546|323936791|FG002|Overall Study|Non-compliance|0|||
94583639|NCT02158546|323936792|FG003|Overall Study|Non-compliance|1|||
94583640|NCT02158546|323936789|FG000|Overall Study|Failure to meet eligibility criteria|0|||
94583641|NCT02158546|323936790|FG001|Overall Study|Failure to meet eligibility criteria|1|||
94583642|NCT02158546|323936791|FG002|Overall Study|Failure to meet eligibility criteria|0|||
94583643|NCT02158546|323936792|FG003|Overall Study|Failure to meet eligibility criteria|0|||
94583644|NCT02158546|323936789|FG000|Overall Study|Lack of Efficacy|1|||
94583645|NCT02158546|323936790|FG001|Overall Study|Lack of Efficacy|1|||
94583646|NCT02158546|323936791|FG002|Overall Study|Lack of Efficacy|0|||
94583647|NCT02158546|323936792|FG003|Overall Study|Lack of Efficacy|0|||
94583648|NCT02158546|323936789|FG000|Overall Study|Adverse Event|2|||
94583649|NCT02158546|323936790|FG001|Overall Study|Adverse Event|2|||
94583650|NCT02158546|323936791|FG002|Overall Study|Adverse Event|0|||
94583651|NCT02158546|323936792|FG003|Overall Study|Adverse Event|0|||
94583652|NCT02158546|323936789|FG000|Overall Study|Withdrawal by Subject|6|||
94583653|NCT02158546|323936790|FG001|Overall Study|Withdrawal by Subject|2|||
94583654|NCT02158546|323936791|FG002|Overall Study|Withdrawal by Subject|1|||
94583655|NCT02158546|323936792|FG003|Overall Study|Withdrawal by Subject|0|||
94583656|NCT02158546|323936789|FG000|Overall Study|Lost to Follow-up|5|||
94583657|NCT02158546|323936790|FG001|Overall Study|Lost to Follow-up|4|||
94583658|NCT02158546|323936791|FG002|Overall Study|Lost to Follow-up|0|||
94455339|NCT00179673|323454751|FG000|Overall Study|Lack of Efficacy|15|||
94455340|NCT00179673|323454751|FG000|Overall Study|Withdrawal by Subject|3|||
94455341|NCT00179673|323454751|FG000|Overall Study|Death|4|||
94455342|NCT00179673|323454751|FG000|Overall Study|Other Observations and options|14|||
94455343|NCT01892722|323454755|FG000|Overall Study|Protocol deviation|0|||
94455344|NCT01892722|323454756|FG001|Overall Study|Protocol deviation|1|||
94455345|NCT01892722|323454755|FG000|Overall Study|Administrative problems|0|||
94583659|NCT02158546|323936792|FG003|Overall Study|Lost to Follow-up|1|||
94583660|NCT02158546|323936789|FG000|Overall Study|Site Excluded|5|||
94583661|NCT02158546|323936790|FG001|Overall Study|Site Excluded|5|||
94583662|NCT02158546|323936791|FG002|Overall Study|Site Excluded|3|||
94583663|NCT02158546|323936792|FG003|Overall Study|Site Excluded|4|||
94583664|NCT00803569|323936793|FG000|Overall Study|Progressive Disease|3|||
94583665|NCT00803569|323936793|FG000|Overall Study|Noncompliance|1|||
94583666|NCT03771664|323936794|FG000|Overall Study|Adverse Event|1|||
94455346|NCT01892722|323454756|FG001|Overall Study|Administrative problems|1|||
94455347|NCT01892722|323454755|FG000|Overall Study|Patient/guardian decision|0|||
94583667|NCT03771664|323936795|FG001|Overall Study|Adverse Event|0|||
94583668|NCT03771664|323936794|FG000|Overall Study|Lost to Follow-up|1|||
94583669|NCT03771664|323936795|FG001|Overall Study|Lost to Follow-up|0|||
94583670|NCT03771664|323936794|FG000|Overall Study|Withdrawal by Participant|1|||
94583671|NCT03771664|323936795|FG001|Overall Study|Withdrawal by Participant|4|||
94583672|NCT03771664|323936794|FG000|Overall Study|Randomized but not Treated|0|||
94583673|NCT03771664|323936795|FG001|Overall Study|Randomized but not Treated|1|||
94583674|NCT02120898|323936796|FG000|Overall Study|Withdrawal by Subject|4|||
94583675|NCT02120898|323936797|FG001|Overall Study|Withdrawal by Subject|2|||
94583676|NCT02120898|323936798|FG002|Overall Study|Withdrawal by Subject|2|||
94583677|NCT02120898|323936796|FG000|Overall Study|Non-compliance with study drug|3|||
94583678|NCT02120898|323936797|FG001|Overall Study|Non-compliance with study drug|0|||
94583679|NCT02120898|323936798|FG002|Overall Study|Non-compliance with study drug|0|||
94583680|NCT02120898|323936796|FG000|Overall Study|Adverse Event|1|||
94583681|NCT02120898|323936797|FG001|Overall Study|Adverse Event|2|||
94583682|NCT02120898|323936798|FG002|Overall Study|Adverse Event|1|||
94583683|NCT02120898|323936796|FG000|Overall Study|Protocol Violation|1|||
94583684|NCT02120898|323936797|FG001|Overall Study|Protocol Violation|2|||
94583685|NCT02120898|323936798|FG002|Overall Study|Protocol Violation|0|||
94583686|NCT02120898|323936796|FG000|Overall Study|Lost to Follow-up|0|||
94583687|NCT02120898|323936797|FG001|Overall Study|Lost to Follow-up|0|||
94583688|NCT02120898|323936798|FG002|Overall Study|Lost to Follow-up|1|||
94583689|NCT00831181|323936799|FG000|Overall Study|Adverse Event|12|||
94583690|NCT01662102|323936800|FG000|Overall Study|Sponsor's decision|1|||
94583691|NCT01662102|323936801|FG001|Overall Study|Sponsor's decision|0|||
94583692|NCT02863419|323936802|FG000|Overall Study|Lost to Follow-up|0|||
94583693|NCT02863419|323936803|FG001|Overall Study|Lost to Follow-up|1|||
94583694|NCT02863419|323936804|FG002|Overall Study|Lost to Follow-up|4|||
94583695|NCT02863419|323936802|FG000|Overall Study|Withdrawal by Subject|5|||
94583696|NCT02863419|323936803|FG001|Overall Study|Withdrawal by Subject|5|||
94583697|NCT02863419|323936804|FG002|Overall Study|Withdrawal by Subject|3|||
94583698|NCT02863419|323936802|FG000|Overall Study|Died|3|||
94583699|NCT02863419|323936803|FG001|Overall Study|Died|4|||
94583700|NCT02863419|323936804|FG002|Overall Study|Died|1|||
94583701|NCT00724698|323936805|FG000|Overall Study|Adverse Event|9|||
94583702|NCT00724698|323936805|FG000|Overall Study|Failure of Therapy|4|||
94583703|NCT00724698|323936805|FG000|Overall Study|Poor Compliance|16|||
94583704|NCT00724698|323936805|FG000|Overall Study|Lost to Follow-up|36|||
94583705|NCT00724698|323936805|FG000|Overall Study|No Info|25|||
94583706|NCT00043979|323936806|FG000|Period 1|recipient with progressive disease|7|||
94583707|NCT00043979|323936807|FG001|Period 1|recipient with progressive disease|4|||
94583708|NCT00043979|323936808|FG002|Period 1|recipient with progressive disease|3|||
94583709|NCT04041414|323936809|FG000|Overall Study|Lost to Follow-up|1|||
94583710|NCT04041414|323936810|FG001|Overall Study|Lost to Follow-up|2|||
94583711|NCT04639258|323936814|FG000|Overall Study|Screen failure|5|||
94583712|NCT04639258|323936814|FG000|Overall Study|Physician Decision|2|||
94583713|NCT04639258|323936814|FG000|Overall Study|Early study termination|3|||
94583714|NCT04639258|323936814|FG000|Overall Study|Withdrawal by Subject|1|||
94583715|NCT00499083|323936815|FG000|Overall Study|Not evaluable|3|||
94583716|NCT01012440|323936816|FG000|Overall Study|Withdrawal by Subject|2|||
94583717|NCT01254422|323936817|FG000|Overall Study|Protocol Violation|1|||
94583718|NCT01254422|323936818|FG001|Overall Study|Protocol Violation|0|||
94583719|NCT01254422|323936817|FG000|Overall Study|Adverse Event|1|||
94583720|NCT01254422|323936818|FG001|Overall Study|Adverse Event|0|||
94583721|NCT01254422|323936817|FG000|Overall Study|Serious adverse event|0|||
94583722|NCT01254422|323936818|FG001|Overall Study|Serious adverse event|1|||
94583723|NCT01254422|323936817|FG000|Overall Study|Lost to Follow-up|1|||
94583724|NCT01254422|323936818|FG001|Overall Study|Lost to Follow-up|0|||
94583725|NCT00705016|323936820|FG000|Overall Study|Adverse Event|6|||
94583726|NCT00705016|323936821|FG001|Overall Study|Adverse Event|11|||
94583727|NCT00705016|323936822|FG002|Overall Study|Adverse Event|10|||
94583728|NCT00705016|323936820|FG000|Overall Study|Death|5|||
94583729|NCT00705016|323936821|FG001|Overall Study|Death|7|||
94583730|NCT00705016|323936822|FG002|Overall Study|Death|5|||
94583731|NCT00705016|323936820|FG000|Overall Study|Protocol Violation|0|||
94583732|NCT00705016|323936821|FG001|Overall Study|Protocol Violation|1|||
94583733|NCT00705016|323936822|FG002|Overall Study|Protocol Violation|1|||
94583734|NCT00705016|323936820|FG000|Overall Study|Withdrawal by Subject|4|||
94583735|NCT00705016|323936821|FG001|Overall Study|Withdrawal by Subject|3|||
94583736|NCT00705016|323936822|FG002|Overall Study|Withdrawal by Subject|2|||
94583737|NCT00705016|323936820|FG000|Overall Study|Progressive Disease|33|||
94583738|NCT00705016|323936821|FG001|Overall Study|Progressive Disease|29|||
94583739|NCT00705016|323936822|FG002|Overall Study|Progressive Disease|33|||
94583740|NCT00705016|323936820|FG000|Overall Study|Symptomatic Deterioration|3|||
94583741|NCT00705016|323936821|FG001|Overall Study|Symptomatic Deterioration|1|||
94583742|NCT00705016|323936822|FG002|Overall Study|Symptomatic Deterioration|1|||
94583743|NCT00705016|323936820|FG000|Overall Study|Other|9|||
94583744|NCT00705016|323936821|FG001|Overall Study|Other|6|||
94583745|NCT00705016|323936822|FG002|Overall Study|Other|6|||
94583746|NCT01918306|323936825|FG000|Overall Study|progresive disease|4|||
94583747|NCT01918306|323936826|FG001|Overall Study|progresive disease|0|||
94583748|NCT01918306|323936827|FG002|Overall Study|progresive disease|1|||
94583749|NCT01918306|323936828|FG003|Overall Study|progresive disease|1|||
94583750|NCT01918306|323936825|FG000|Overall Study|Withdrawal by Subject|0|||
94583751|NCT01918306|323936826|FG001|Overall Study|Withdrawal by Subject|0|||
94583752|NCT01918306|323936827|FG002|Overall Study|Withdrawal by Subject|0|||
94583753|NCT01918306|323936828|FG003|Overall Study|Withdrawal by Subject|2|||
94583754|NCT01918306|323936825|FG000|Overall Study|neutropenia|1|||
94583755|NCT01918306|323936826|FG001|Overall Study|neutropenia|0|||
94583756|NCT01918306|323936827|FG002|Overall Study|neutropenia|0|||
94583757|NCT01918306|323936828|FG003|Overall Study|neutropenia|0|||
94583758|NCT01918306|323936825|FG000|Overall Study|Lack of Efficacy|1|||
94583759|NCT01918306|323936826|FG001|Overall Study|Lack of Efficacy|0|||
94583760|NCT01918306|323936827|FG002|Overall Study|Lack of Efficacy|0|||
94583761|NCT01918306|323936828|FG003|Overall Study|Lack of Efficacy|0|||
94583762|NCT01918306|323936825|FG000|Overall Study|progress disease, crossover|0|||
94583763|NCT01918306|323936826|FG001|Overall Study|progress disease, crossover|0|||
94583764|NCT01918306|323936827|FG002|Overall Study|progress disease, crossover|1|||
94583765|NCT01918306|323936828|FG003|Overall Study|progress disease, crossover|0|||
94583766|NCT02506244|323936829|FG000|Overall Study|Did not undergo active monitoring|458|||
94583767|NCT02506244|323936830|FG001|Overall Study|Did not undergo active monitoring|459|||
94583768|NCT02506244|323936831|FG002|Overall Study|Did not undergo active monitoring|0|||
94583769|NCT03067077|323936832|FG000|Overall Study|Did not receive surgery|4|||
94583770|NCT03067077|323936833|FG001|Overall Study|Did not receive surgery|5|||
94583771|NCT03067077|323936832|FG000|Overall Study|Lost to Follow-up|3|||
94583772|NCT03067077|323936833|FG001|Overall Study|Lost to Follow-up|2|||
94583773|NCT00525161|323936837|FG000|Overall Study|Adverse Event|1|||
94583774|NCT03848728|323936840|FG000|Overall Study|Death|16|||
94583775|NCT03848728|323936841|FG001|Overall Study|Death|13|||
94583776|NCT03848728|323936840|FG000|Overall Study|Outmigrated to non-study community|98|||
94583777|NCT03848728|323936841|FG001|Overall Study|Outmigrated to non-study community|106|||
94583778|NCT03848728|323936840|FG000|Overall Study|Transfered to non-study clinic|32|||
94583779|NCT03848728|323936841|FG001|Overall Study|Transfered to non-study clinic|48|||
94583780|NCT03848728|323936840|FG000|Overall Study|Withdrawal by Subject|1|||
94583781|NCT03848728|323936841|FG001|Overall Study|Withdrawal by Subject|0|||
94583782|NCT01108185|323936842|FG000|Overall Study|Non-compliance|15|||
94583783|NCT01108185|323936842|FG000|Overall Study|Lost to Follow-up|12|||
94583784|NCT00554216|323938318|FG000|Overall Study|Lost to Follow-up|92|||
94583785|NCT00554216|323938319|FG001|Overall Study|Lost to Follow-up|31|||
94583786|NCT00554216|323938320|FG002|Overall Study|Lost to Follow-up|63|||
94583787|NCT00554216|323938318|FG000|Overall Study|Adverse Event|16|||
94583788|NCT00554216|323938319|FG001|Overall Study|Adverse Event|16|||
94583789|NCT00554216|323938320|FG002|Overall Study|Adverse Event|36|||
94583790|NCT00554216|323938318|FG000|Overall Study|Withdrawal by Subject|92|||
94583791|NCT00554216|323938319|FG001|Overall Study|Withdrawal by Subject|31|||
94583792|NCT00554216|323938320|FG002|Overall Study|Withdrawal by Subject|43|||
94583793|NCT00554216|323938318|FG000|Overall Study|Non compliance|10|||
94583794|NCT00554216|323938319|FG001|Overall Study|Non compliance|4|||
94583795|NCT00554216|323938320|FG002|Overall Study|Non compliance|5|||
94583796|NCT00554216|323938318|FG000|Overall Study|Pregnancy|2|||
94583797|NCT00554216|323938319|FG001|Overall Study|Pregnancy|1|||
94583798|NCT00554216|323938320|FG002|Overall Study|Pregnancy|14|||
94583799|NCT00554216|323938318|FG000|Overall Study|Restricted med|3|||
94583800|NCT00554216|323938319|FG001|Overall Study|Restricted med|1|||
94583801|NCT00554216|323938320|FG002|Overall Study|Restricted med|1|||
94583802|NCT00554216|323938318|FG000|Overall Study|Other|12|||
94583803|NCT00554216|323938319|FG001|Overall Study|Other|7|||
94583804|NCT00554216|323938320|FG002|Overall Study|Other|10|||
94583805|NCT00554216|323938318|FG000|Overall Study|Lack of Efficacy|15|||
94583806|NCT00554216|323938319|FG001|Overall Study|Lack of Efficacy|3|||
94583807|NCT00554216|323938320|FG002|Overall Study|Lack of Efficacy|0|||
94583808|NCT04610281|323938327|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
94583809|NCT04610281|323938328|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
94583810|NCT01491607|323938330|FG000|Overall Study|Lost to Follow-up|7|||
94583811|NCT01491607|323938330|FG000|Overall Study|Withdrawal by Subject|3|||
94583812|NCT01635153|323938334|FG000|Overall Study|Lost to Follow-up|40|||
94583813|NCT01635153|323938335|FG001|Overall Study|Lost to Follow-up|43|||
94583814|NCT02754440|323938336|FG000|Overall Study|Protocol Violation|3|||
94240684|NCT03809039|322676686|FG008|Part 3|Withdrawn by study termination|6|||
94240685|NCT00945672|322676688|FG000|Overall Study|Withdrawal by Subject|0|||
94240686|NCT00945672|322676689|FG001|Overall Study|Withdrawal by Subject|0|||
94240687|NCT00945672|322676690|FG002|Overall Study|Withdrawal by Subject|0|||
94240688|NCT00945672|322676691|FG003|Overall Study|Withdrawal by Subject|1|||
94240689|NCT03510455|322676692|FG000|Overall Study|Physician Decision|1|||
94240690|NCT02493062|322676694|FG000|Overall Study|Physician Decision|12|||
94240691|NCT02383940|322676695|FG000|Overall Study|Adverse Event|1|||
94240692|NCT02383940|322676696|FG001|Overall Study|Adverse Event|0|||
94240693|NCT02383940|322676695|FG000|Overall Study|Lost to Follow-up|2|||
94240694|NCT02383940|322676696|FG001|Overall Study|Lost to Follow-up|2|||
94240695|NCT02383940|322676695|FG000|Overall Study|Physician Decision|2|||
94240696|NCT02383940|322676696|FG001|Overall Study|Physician Decision|0|||
94240697|NCT02383940|322676695|FG000|Overall Study|Withdrawal by Subject|1|||
94240698|NCT02383940|322676696|FG001|Overall Study|Withdrawal by Subject|1|||
94240699|NCT02383940|322676695|FG000|Overall Study|Randomized but not treated|2|||
94240700|NCT02383940|322676696|FG001|Overall Study|Randomized but not treated|0|||
94240701|NCT02383940|322676695|FG000|Overall Study|Other than specified above|1|||
94240702|NCT02383940|322676696|FG001|Overall Study|Other than specified above|0|||
94240703|NCT03845140|322676697|FG000|Overall Study|Participant travelled outside study area|0|||
94240704|NCT03845140|322676698|FG001|Overall Study|Participant travelled outside study area|1|||
94240705|NCT03845140|322676699|FG002|Overall Study|Participant travelled outside study area|0|||
94240706|NCT03845140|322676700|FG003|Overall Study|Participant travelled outside study area|0|||
94240707|NCT03845140|322676701|FG004|Overall Study|Participant travelled outside study area|0|||
94240708|NCT03845140|322676702|FG005|Overall Study|Participant travelled outside study area|0|||
94240709|NCT03926195|322676704|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
94240710|NCT03926195|322676705|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
94240711|NCT03926195|322676704|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
94240712|NCT03926195|322676705|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
94240713|NCT03926195|322676704|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
94240714|NCT03926195|322676705|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
94240715|NCT03926195|322676704|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
94583815|NCT02754440|323938337|FG001|Overall Study|Protocol Violation|2|||
94583816|NCT02754440|323938338|FG002|Overall Study|Protocol Violation|2|||
94583817|NCT02754440|323938339|FG003|Overall Study|Protocol Violation|6|||
94583818|NCT02754440|323938336|FG000|Overall Study|Adverse Event|3|||
94583819|NCT02754440|323938337|FG001|Overall Study|Adverse Event|1|||
94583820|NCT02754440|323938338|FG002|Overall Study|Adverse Event|0|||
94583821|NCT02754440|323938339|FG003|Overall Study|Adverse Event|9|||
94583822|NCT02754440|323938336|FG000|Overall Study|Withdrawal by Subject|0|||
94583823|NCT02754440|323938337|FG001|Overall Study|Withdrawal by Subject|0|||
94583824|NCT02754440|323938338|FG002|Overall Study|Withdrawal by Subject|0|||
94583825|NCT02754440|323938339|FG003|Overall Study|Withdrawal by Subject|1|||
94583826|NCT02754440|323938336|FG000|Overall Study|Equipment failure|0|||
94583827|NCT02754440|323938337|FG001|Overall Study|Equipment failure|5|||
94583828|NCT02754440|323938338|FG002|Overall Study|Equipment failure|5|||
94583829|NCT02754440|323938339|FG003|Overall Study|Equipment failure|7|||
94583830|NCT02754440|323938336|FG000|Overall Study|Subject issues not resulting in AE|0|||
94583831|NCT02754440|323938337|FG001|Overall Study|Subject issues not resulting in AE|0|||
94583832|NCT02754440|323938338|FG002|Overall Study|Subject issues not resulting in AE|0|||
94583833|NCT02754440|323938339|FG003|Overall Study|Subject issues not resulting in AE|12|||
94583834|NCT02558296|323938340|FG000|Completed the Study Through Week 24|Adverse Event|9|||
94583835|NCT02558296|323938341|FG001|Completed the Study Through Week 24|Adverse Event|3|||
94583836|NCT02558296|323938340|FG000|Completed the Study Through Week 24|Death|7|||
94583837|NCT02558296|323938341|FG001|Completed the Study Through Week 24|Death|7|||
94583838|NCT02558296|323938340|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
94583839|NCT02558296|323938341|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
94583840|NCT02558296|323938340|FG000|Completed the Study Through Week 24|Physician Decision|1|||
94583841|NCT02558296|323938341|FG001|Completed the Study Through Week 24|Physician Decision|0|||
94583842|NCT02558296|323938340|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
94240716|NCT03926195|322676705|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
94240717|NCT03926195|322676704|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
94240718|NCT03926195|322676705|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
94240719|NCT03926195|322676704|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
94240720|NCT03926195|322676705|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
94240721|NCT00874731|322676713|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
94353068|NCT05602818|323074920|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
94353069|NCT05602818|323074921|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
94353070|NCT05602818|323074922|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
94353071|NCT05602818|323074923|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
94353072|NCT05602818|323074924|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
94583843|NCT02558296|323938341|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
94583844|NCT02558296|323938340|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
94583845|NCT02558296|323938341|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
94583846|NCT02558296|323938340|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
94583847|NCT02558296|323938341|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
94583848|NCT02558296|323938340|FG000|Completed the Study|Adverse Event|14|||
94583849|NCT02558296|323938341|FG001|Completed the Study|Adverse Event|5|||
94583850|NCT02558296|323938340|FG000|Completed the Study|Death|39|||
94583851|NCT02558296|323938341|FG001|Completed the Study|Death|25|||
94583852|NCT02558296|323938340|FG000|Completed the Study|Lost to Follow-up|31|||
94583853|NCT02558296|323938341|FG001|Completed the Study|Lost to Follow-up|23|||
94583854|NCT02558296|323938340|FG000|Completed the Study|Physician Decision|6|||
94583855|NCT02558296|323938341|FG001|Completed the Study|Physician Decision|0|||
94583856|NCT02558296|323938340|FG000|Completed the Study|Protocol Violation|2|||
94583857|NCT02558296|323938341|FG001|Completed the Study|Protocol Violation|1|||
94583858|NCT02558296|323938340|FG000|Completed the Study|Withdrawal by Subject|53|||
94583859|NCT02558296|323938341|FG001|Completed the Study|Withdrawal by Subject|31|||
94583860|NCT02558296|323938340|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
94583861|NCT02558296|323938341|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
94583862|NCT02454517|323938342|FG000|Overall Study|Withdrawal by Subject|3|||
94583863|NCT02454517|323938343|FG001|Overall Study|Withdrawal by Subject|0|||
94583864|NCT02454517|323938342|FG000|Overall Study|Lost to Follow-up|4|||
94583865|NCT02454517|323938343|FG001|Overall Study|Lost to Follow-up|7|||
94583866|NCT02454517|323938342|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
94583867|NCT02454517|323938343|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
94583868|NCT01470326|323938344|FG000|Overall Study|Protocol Violation|32|||
94583869|NCT01470326|323938344|FG000|Overall Study|No Drug Administration Information|2|||
94583870|NCT01470326|323938344|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
94583871|NCT04154189|323938345|FG000|Overall Study|Withdrawal by Subject|4|||
94583872|NCT04154189|323938346|FG001|Overall Study|Withdrawal by Subject|6|||
94583873|NCT04154189|323938345|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
94583874|NCT04154189|323938346|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
94583875|NCT04154189|323938345|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
94583876|NCT04154189|323938346|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
94583877|NCT04154189|323938345|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
94583878|NCT04154189|323938346|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
94583879|NCT04154189|323938345|FG000|Overall Study|Death|25|||
94583880|NCT04154189|323938346|FG001|Overall Study|Death|25|||
94583881|NCT03599089|323938347|FG000|Overall Study|Lost to Follow-up|1|||
94583882|NCT03599089|323938348|FG001|Overall Study|Lost to Follow-up|0|||
94583883|NCT03599089|323938349|FG002|Overall Study|Lost to Follow-up|0|||
94583884|NCT03599089|323938350|FG003|Overall Study|Lost to Follow-up|0|||
94583885|NCT03599089|323938347|FG000|Overall Study|Withdrawal by Subject|2|||
94583886|NCT03599089|323938348|FG001|Overall Study|Withdrawal by Subject|1|||
94583887|NCT03599089|323938349|FG002|Overall Study|Withdrawal by Subject|0|||
94583888|NCT03599089|323938350|FG003|Overall Study|Withdrawal by Subject|0|||
94583889|NCT03599089|323938347|FG000|Overall Study|Lack of Efficacy|0|||
94583890|NCT03599089|323938348|FG001|Overall Study|Lack of Efficacy|0|||
94583891|NCT03599089|323938349|FG002|Overall Study|Lack of Efficacy|1|||
94583892|NCT03599089|323938350|FG003|Overall Study|Lack of Efficacy|2|||
94583893|NCT03214666|323938351|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
94583894|NCT03214666|323938352|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
94583895|NCT03214666|323938353|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
94583896|NCT03214666|323938354|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
94583897|NCT03214666|323938355|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
94583898|NCT03214666|323938356|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
94583899|NCT00131248|323938357|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
94583900|NCT00131248|323938358|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
94583901|NCT00477386|323938364|FG000|Overall Study|Adverse Event|4|||
94583902|NCT00477386|323938365|FG001|Overall Study|Adverse Event|8|||
94583903|NCT00477386|323938364|FG000|Overall Study|Disease progression, relapse|3|||
94583904|NCT00477386|323938365|FG001|Overall Study|Disease progression, relapse|4|||
94240722|NCT00874731|322676714|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
94353073|NCT05602818|323074925|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
94353074|NCT05602818|323074926|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
94353075|NCT05602818|323074927|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
94583905|NCT00477386|323938364|FG000|Overall Study|Disease progression, refractory|1|||
94583906|NCT00477386|323938365|FG001|Overall Study|Disease progression, refractory|3|||
94583907|NCT00477386|323938364|FG000|Overall Study|Other|1|||
94583908|NCT00477386|323938365|FG001|Overall Study|Other|2|||
94583909|NCT00477386|323938364|FG000|Overall Study|Physician Decision|1|||
94583910|NCT00477386|323938365|FG001|Overall Study|Physician Decision|0|||
94353076|NCT05602818|323074928|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
94353077|NCT05602818|323074929|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
94353078|NCT05602818|323074930|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
94353079|NCT05602818|323074919|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
94353080|NCT05602818|323074920|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
94353081|NCT05602818|323074921|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
94353082|NCT05602818|323074922|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
94353083|NCT05602818|323074923|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
94353084|NCT05602818|323074924|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
94353085|NCT05602818|323074925|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
94455348|NCT01892722|323454756|FG001|Overall Study|Patient/guardian decision|2|||
94455349|NCT01892722|323454755|FG000|Overall Study|Physician Decision|1|||
94455350|NCT01892722|323454756|FG001|Overall Study|Physician Decision|2|||
94583911|NCT00477386|323938364|FG000|Overall Study|Withdrawal by Subject|1|||
94583912|NCT00477386|323938365|FG001|Overall Study|Withdrawal by Subject|0|||
94583913|NCT02207088|323938366|FG000|Overall Study|Adverse Event|2|||
94583914|NCT03739203|323938371|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
94583915|NCT03739203|323938372|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
94583916|NCT03739203|323938373|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
94583917|NCT03739203|323938371|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
94583918|NCT03739203|323938372|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
94583919|NCT03739203|323938373|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
94583920|NCT03739203|323938371|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
94583921|NCT03739203|323938372|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
94583922|NCT03739203|323938373|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
94583923|NCT03739203|323938371|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
94583924|NCT03739203|323938372|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
94583925|NCT03739203|323938373|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
94583926|NCT03739203|323938371|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
94583927|NCT03739203|323938372|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
94583928|NCT03739203|323938373|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
94583929|NCT03739203|323938371|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
94583930|NCT03739203|323938372|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
94583931|NCT03739203|323938373|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
94583932|NCT03739203|323938371|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
94583933|NCT03739203|323938372|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
94583934|NCT03739203|323938373|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
94583935|NCT03739203|323938371|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
94583936|NCT03739203|323938372|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
94455351|NCT01892722|323454755|FG000|Overall Study|Adverse Event|3|||
94583937|NCT03739203|323938373|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
94583938|NCT03739203|323938371|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
94583939|NCT03739203|323938372|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
94583940|NCT03739203|323938373|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
94583941|NCT03739203|323938371|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
94583942|NCT03739203|323938372|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
94583943|NCT03739203|323938373|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
94583944|NCT03739203|323938371|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
94583945|NCT03739203|323938372|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
94583946|NCT03739203|323938373|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
94583947|NCT01352715|323938376|FG000|Overall Study|Death|3|||
94583948|NCT01352715|323938377|FG001|Overall Study|Death|3|||
94583949|NCT01352715|323938376|FG000|Overall Study|Lost to Follow-up|5|||
94583950|NCT01352715|323938377|FG001|Overall Study|Lost to Follow-up|7|||
94583951|NCT01352715|323938376|FG000|Overall Study|Withdrawal by Subject|4|||
94583952|NCT01352715|323938377|FG001|Overall Study|Withdrawal by Subject|8|||
94583953|NCT01352715|323938376|FG000|Overall Study|site closure|16|||
94583954|NCT01352715|323938377|FG001|Overall Study|site closure|15|||
94583955|NCT01352715|323938376|FG000|Overall Study|no final visit in closeout period|15|||
94583956|NCT01352715|323938377|FG001|Overall Study|no final visit in closeout period|12|||
94455352|NCT01892722|323454756|FG001|Overall Study|Adverse Event|2|||
94583957|NCT01352715|323938376|FG000|Overall Study|major ineligibility|2|||
94583958|NCT01352715|323938377|FG001|Overall Study|major ineligibility|1|||
94583959|NCT01519921|323938378|FG000|Overall Study|Adverse Event|10|||
94583960|NCT01519921|323938379|FG001|Overall Study|Adverse Event|9|||
94240723|NCT00874731|322676715|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
94583961|NCT01519921|323938378|FG000|Overall Study|Lack of Efficacy|4|||
94583962|NCT01519921|323938379|FG001|Overall Study|Lack of Efficacy|3|||
94455353|NCT01892722|323454755|FG000|Overall Study|Lack of Efficacy|0|||
94583963|NCT01519921|323938378|FG000|Overall Study|Withdrawal by Subject|3|||
94583964|NCT01519921|323938379|FG001|Overall Study|Withdrawal by Subject|0|||
94353086|NCT05602818|323074926|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
94353087|NCT05602818|323074927|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
94353088|NCT05602818|323074928|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
94353089|NCT05602818|323074929|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
94353090|NCT05602818|323074930|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
94353091|NCT05602818|323074919|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
94455354|NCT01892722|323454756|FG001|Overall Study|Lack of Efficacy|7|||
94455355|NCT01892722|323454755|FG000|Overall Study|Withdrawal by Subject|3|||
94583965|NCT01519921|323938378|FG000|Overall Study|Lost to Follow-up|2|||
94583966|NCT01519921|323938379|FG001|Overall Study|Lost to Follow-up|1|||
94583967|NCT01519921|323938378|FG000|Overall Study|Treatment refusal|2|||
94583968|NCT01519921|323938379|FG001|Overall Study|Treatment refusal|1|||
94583969|NCT01519921|323938378|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
94583970|NCT01519921|323938379|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
94583971|NCT02284243|323938382|FG000|Overall Study|Lack of Efficacy|3|||
94583972|NCT02284243|323938383|FG001|Overall Study|Lack of Efficacy|3|||
94583973|NCT02284243|323938382|FG000|Overall Study|Adverse Event|1|||
94583974|NCT02284243|323938383|FG001|Overall Study|Adverse Event|0|||
94583975|NCT01216189|323938384|FG000|Overall Study|Lost to Follow-up|21|||
94583976|NCT01216189|323938385|FG001|Overall Study|Lost to Follow-up|3|||
94583977|NCT01216189|323938384|FG000|Overall Study|Death|4|||
94583978|NCT01216189|323938385|FG001|Overall Study|Death|2|||
94583979|NCT01146795|323938387|FG000|Overall Study|Withdrawal by Subject|4|||
94583980|NCT01146795|323938387|FG000|Overall Study|Adverse Event|6|||
94583981|NCT01146795|323938387|FG000|Overall Study|Still in treatment at study closure|10|||
94353092|NCT05602818|323074920|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
94353093|NCT05602818|323074921|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
94353094|NCT05602818|323074922|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
94353095|NCT05602818|323074923|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
94353096|NCT05602818|323074924|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
94353097|NCT05602818|323074925|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
94353098|NCT05602818|323074926|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
94353099|NCT05602818|323074927|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
94353100|NCT05602818|323074928|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
94353101|NCT05602818|323074929|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
94353102|NCT05602818|323074930|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
94353103|NCT05602818|323074919|FG000|Qualification Phase (3 Days)|Other|1|||
94353104|NCT05602818|323074920|FG001|Qualification Phase (3 Days)|Other|0|||
94455356|NCT01892722|323454756|FG001|Overall Study|Withdrawal by Subject|5|||
94455357|NCT02496091|323454757|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
94455358|NCT02778074|323454758|FG000|Overall Study|Lost to Follow-up|7|||
94583982|NCT05375760|323938388|FG000|Overall Study|Adverse Event|1|||
94583983|NCT05375760|323938389|FG001|Overall Study|Adverse Event|0|||
94583984|NCT05375760|323938388|FG000|Overall Study|Death|0|||
94583985|NCT05375760|323938389|FG001|Overall Study|Death|1|||
94583986|NCT05375760|323938388|FG000|Overall Study|Lost to Follow-up|6|||
94583987|NCT05375760|323938389|FG001|Overall Study|Lost to Follow-up|6|||
94583988|NCT05375760|323938388|FG000|Overall Study|Withdrawal by Subject|17|||
94455359|NCT02778074|323454759|FG001|Overall Study|Lost to Follow-up|10|||
94455360|NCT03395184|323454760|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
94455361|NCT03395184|323454761|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
94455362|NCT03395184|323454762|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
94455363|NCT03395184|323454763|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
94455364|NCT03395184|323454764|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
94455365|NCT03395184|323454765|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
94455366|NCT03395184|323454766|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
94455367|NCT03395184|323454760|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
94455368|NCT03395184|323454761|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
94455369|NCT03395184|323454762|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
94583989|NCT05375760|323938389|FG001|Overall Study|Withdrawal by Subject|19|||
94583990|NCT05375760|323938388|FG000|Overall Study|Dosing halted by FDA|96|||
94583991|NCT05375760|323938389|FG001|Overall Study|Dosing halted by FDA|100|||
94583992|NCT05375760|323938388|FG000|Overall Study|Not compliant with study visit|2|||
94583993|NCT05375760|323938389|FG001|Overall Study|Not compliant with study visit|0|||
94583994|NCT05375760|323938388|FG000|Overall Study|Physician Decision|1|||
94583995|NCT05375760|323938389|FG001|Overall Study|Physician Decision|0|||
94583996|NCT05375760|323938388|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
94659040|NCT01539291|324207961|FG000|Study GS-US-312-0116|Other|1|||
94583997|NCT05375760|323938389|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
94583998|NCT05375760|323938388|FG000|Overall Study|Participant moved|1|||
94583999|NCT05375760|323938389|FG001|Overall Study|Participant moved|0|||
94584000|NCT03636893|323938390|FG000|Overall Study|Death|0|||
94584001|NCT03636893|323938391|FG001|Overall Study|Death|1|||
94584002|NCT03636893|323938390|FG000|Overall Study|Protocol Violation|0|||
94584003|NCT03636893|323938391|FG001|Overall Study|Protocol Violation|3|||
94584004|NCT03636893|323938390|FG000|Overall Study|Withdrawal by Subject|1|||
94584005|NCT03636893|323938391|FG001|Overall Study|Withdrawal by Subject|2|||
94584006|NCT03636893|323938390|FG000|Overall Study|Refusal to surgery|4|||
94584007|NCT03636893|323938391|FG001|Overall Study|Refusal to surgery|3|||
94584008|NCT03636893|323938390|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
94584009|NCT03636893|323938391|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
94584010|NCT03636893|323938390|FG000|Overall Study|Adverse Event|1|||
94584011|NCT03636893|323938391|FG001|Overall Study|Adverse Event|1|||
94353105|NCT05602818|323074921|FG002|Qualification Phase (3 Days)|Other|0|||
94353106|NCT05602818|323074922|FG003|Qualification Phase (3 Days)|Other|0|||
94353107|NCT05602818|323074923|FG004|Qualification Phase (3 Days)|Other|0|||
94353108|NCT05602818|323074924|FG005|Qualification Phase (3 Days)|Other|0|||
94353109|NCT05602818|323074925|FG006|Qualification Phase (3 Days)|Other|0|||
94353110|NCT05602818|323074926|FG007|Qualification Phase (3 Days)|Other|0|||
94584012|NCT00996333|323938392|FG000|Overall Study|Screen failure|1|||
94584013|NCT00996333|323938392|FG000|Overall Study|Withdrawal by Subject|1|||
94584014|NCT00996333|323938392|FG000|Overall Study|Death|4|||
94353111|NCT05602818|323074927|FG008|Qualification Phase (3 Days)|Other|0|||
94584015|NCT00996333|323938392|FG000|Overall Study|Adverse Event|1|||
94584016|NCT00996333|323938392|FG000|Overall Study|Physician Decision|1|||
94455370|NCT03395184|323454763|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
94455371|NCT03395184|323454764|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
94584017|NCT00996333|323938392|FG000|Overall Study|Other|5|||
94455372|NCT03395184|323454765|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
94455373|NCT03395184|323454766|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
94455374|NCT03395184|323454760|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
94455375|NCT03395184|323454761|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
94455376|NCT03395184|323454762|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
94455377|NCT03395184|323454763|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
94455378|NCT03395184|323454764|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
94584018|NCT01327482|323938393|FG000|Overall Study|Adverse Event|1|||
94584019|NCT00363480|323938394|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
94584020|NCT00363480|323938394|FG000|Overall Study|Adverse Event|4|||
94584021|NCT00363480|323938394|FG000|Overall Study|Lost to Follow-up|5|||
94353112|NCT05602818|323074928|FG009|Qualification Phase (3 Days)|Other|0|||
94353113|NCT05602818|323074929|FG010|Qualification Phase (3 Days)|Other|0|||
94353114|NCT05602818|323074930|FG011|Qualification Phase (3 Days)|Other|0|||
94353115|NCT05602818|323074919|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
94353116|NCT05602818|323074920|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
94353117|NCT05602818|323074921|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
94353118|NCT05602818|323074922|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
94353119|NCT05602818|323074923|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
94353120|NCT05602818|323074924|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
94353121|NCT05602818|323074925|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
94353122|NCT05602818|323074926|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
94353123|NCT05602818|323074927|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
94353124|NCT05602818|323074928|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
94353125|NCT05602818|323074929|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
94353126|NCT05602818|323074930|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
94353127|NCT05602818|323074919|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
94353128|NCT05602818|323074920|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
94353129|NCT05602818|323074921|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
94353130|NCT05602818|323074922|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
94353131|NCT05602818|323074923|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
94353132|NCT05602818|323074924|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
94353133|NCT05602818|323074925|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
94353134|NCT05602818|323074926|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
94353135|NCT05602818|323074927|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
94353136|NCT05602818|323074928|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
94353137|NCT05602818|323074929|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
94353138|NCT05602818|323074930|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
94353139|NCT05602818|323074919|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
94353140|NCT05602818|323074920|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
94353141|NCT05602818|323074921|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
94353142|NCT05602818|323074922|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
94353143|NCT05602818|323074923|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
94353144|NCT05602818|323074924|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
94353145|NCT05602818|323074925|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
94455379|NCT03395184|323454765|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
94455380|NCT03395184|323454766|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
94455381|NCT03395184|323454760|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
94455382|NCT03395184|323454761|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
94584022|NCT00363480|323938394|FG000|Overall Study|Withdrawal by Subject|5|||
94584023|NCT00363480|323938394|FG000|Overall Study|Non-compliance of subject|1|||
94584024|NCT00363480|323938394|FG000|Overall Study|Participant discontinued on its own|1|||
94584025|NCT01301027|323938395|FG000|Overall Study|Physician Decision|2|||
94584026|NCT01301027|323938396|FG001|Overall Study|Physician Decision|0|||
94584027|NCT01301027|323938395|FG000|Overall Study|Withdrawal by Subject|2|||
94584028|NCT01301027|323938396|FG001|Overall Study|Withdrawal by Subject|3|||
94584029|NCT01301027|323938395|FG000|Overall Study|Adverse Event|0|||
94584030|NCT01301027|323938396|FG001|Overall Study|Adverse Event|2|||
94584031|NCT01301027|323938395|FG000|Overall Study|Fracture|1|||
94584032|NCT01301027|323938396|FG001|Overall Study|Fracture|3|||
94584033|NCT01301027|323938395|FG000|Overall Study|Transplant|0|||
94584034|NCT01301027|323938396|FG001|Overall Study|Transplant|2|||
94584035|NCT01301027|323938395|FG000|Overall Study|Volume Overload|3|||
94584036|NCT01301027|323938396|FG001|Overall Study|Volume Overload|0|||
94353146|NCT05602818|323074926|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
94584037|NCT00541385|323938397|FG000|Overall Study|Adverse Event|6|||
94584038|NCT00541385|323938398|FG001|Overall Study|Adverse Event|3|||
94584039|NCT00541385|323938397|FG000|Overall Study|Withdrawal by Subject|2|||
94584040|NCT00541385|323938398|FG001|Overall Study|Withdrawal by Subject|2|||
94584041|NCT00541385|323938397|FG000|Overall Study|Lost to Follow-up|6|||
94584042|NCT00541385|323938398|FG001|Overall Study|Lost to Follow-up|1|||
94584043|NCT00541385|323938397|FG000|Overall Study|Parasite reappearance/malaria|67|||
94584044|NCT00541385|323938398|FG001|Overall Study|Parasite reappearance/malaria|32|||
94584045|NCT01469377|323938399|FG000|Overall Study|Protocol Deviation|7|||
94584046|NCT01469377|323938400|FG001|Overall Study|Protocol Deviation|10|||
94353147|NCT05602818|323074927|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
94353148|NCT05602818|323074928|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
94353149|NCT05602818|323074929|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
94353150|NCT05602818|323074930|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
94353151|NCT05602818|323074919|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
94353152|NCT05602818|323074920|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
94353153|NCT05602818|323074921|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
94353154|NCT05602818|323074922|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
94353155|NCT05602818|323074923|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
94353156|NCT05602818|323074924|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
94353157|NCT05602818|323074925|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
94353158|NCT05602818|323074926|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
94584047|NCT01469377|323938401|FG002|Overall Study|Protocol Deviation|10|||
94584048|NCT01469377|323938399|FG000|Overall Study|Lost to Follow-up|3|||
94240724|NCT00874731|322676713|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
94240725|NCT00874731|322676714|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
94240726|NCT00874731|322676715|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
94240727|NCT00874731|322676713|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
94240728|NCT00874731|322676714|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
94353159|NCT05602818|323074927|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
94353160|NCT05602818|323074928|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
94240729|NCT00874731|322676715|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
94240730|NCT03812029|322676718|FG000|Overall Study|Protocol Violation|1|||
94240731|NCT03812029|322676719|FG001|Overall Study|Protocol Violation|0|||
94240732|NCT03812029|322676720|FG002|Overall Study|Protocol Violation|0|||
94240733|NCT03812029|322676721|FG003|Overall Study|Protocol Violation|1|||
94240734|NCT03812029|322676722|FG004|Overall Study|Protocol Violation|0|||
94240735|NCT03812029|322676718|FG000|Overall Study|Withdrawal by Subject|1|||
94240736|NCT03812029|322676719|FG001|Overall Study|Withdrawal by Subject|0|||
94240737|NCT03812029|322676720|FG002|Overall Study|Withdrawal by Subject|0|||
94240738|NCT03812029|322676721|FG003|Overall Study|Withdrawal by Subject|2|||
94353161|NCT05602818|323074929|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
94353162|NCT05602818|323074930|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
94584049|NCT01469377|323938400|FG001|Overall Study|Lost to Follow-up|2|||
94584050|NCT01469377|323938401|FG002|Overall Study|Lost to Follow-up|5|||
94584051|NCT01469377|323938399|FG000|Overall Study|Withdrawal of Consent|12|||
94240739|NCT03812029|322676722|FG004|Overall Study|Withdrawal by Subject|2|||
94240740|NCT03812029|322676718|FG000|Overall Study|Stopping rules|0|||
94240741|NCT03812029|322676719|FG001|Overall Study|Stopping rules|1|||
94240742|NCT03812029|322676720|FG002|Overall Study|Stopping rules|0|||
94240743|NCT03812029|322676721|FG003|Overall Study|Stopping rules|0|||
94240744|NCT03812029|322676722|FG004|Overall Study|Stopping rules|0|||
94240745|NCT03812029|322676718|FG000|Overall Study|Adverse Event|0|||
94240746|NCT03812029|322676719|FG001|Overall Study|Adverse Event|9|||
94240747|NCT03812029|322676720|FG002|Overall Study|Adverse Event|0|||
94240748|NCT03812029|322676721|FG003|Overall Study|Adverse Event|3|||
94240749|NCT03812029|322676722|FG004|Overall Study|Adverse Event|5|||
94240750|NCT03812029|322676718|FG000|Overall Study|Lost to Follow-up|0|||
94240751|NCT03812029|322676719|FG001|Overall Study|Lost to Follow-up|0|||
94353163|NCT00679354|323074933|FG000|Overall Study|Death|3|||
94584052|NCT01469377|323938400|FG001|Overall Study|Withdrawal of Consent|14|||
94353164|NCT00679354|323074933|FG000|Overall Study|Lack of Efficacy|22|||
94353165|NCT00679354|323074933|FG000|Overall Study|Physician Decision|4|||
94353166|NCT00679354|323074933|FG000|Overall Study|Ineligible|1|||
94353167|NCT03764813|323074934|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
94353168|NCT03764813|323074935|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
94353169|NCT03764813|323074936|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
94353170|NCT03764813|323074937|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
94353171|NCT00408408|323074938|FG000|Overall Study|No follow up data|2|||
94353172|NCT00408408|323074939|FG001|Overall Study|No follow up data|3|||
94353173|NCT00408408|323074940|FG002|Overall Study|No follow up data|0|||
94353174|NCT00408408|323074941|FG003|Overall Study|No follow up data|7|||
94353175|NCT00408408|323074942|FG004|Overall Study|No follow up data|5|||
94353176|NCT00408408|323074943|FG005|Overall Study|No follow up data|3|||
94353177|NCT01616173|323074946|FG000|Overall Study|Lost to Follow-up|0|||
94353178|NCT01616173|323074947|FG001|Overall Study|Lost to Follow-up|2|||
94353179|NCT01616173|323074948|FG002|Overall Study|Lost to Follow-up|0|||
94353180|NCT03172026|323074952|FG000|Overall Study|Withdrawal by Subject|1|||
94353181|NCT03172026|323074953|FG001|Overall Study|Withdrawal by Subject|0|||
94353182|NCT03172026|323074952|FG000|Overall Study|COVID restrictions|1|||
94353183|NCT03172026|323074953|FG001|Overall Study|COVID restrictions|0|||
94353184|NCT00808665|323074954|FG000|Overall Study|Withdrawal by Subject|1|||
94353185|NCT00808665|323074955|FG001|Overall Study|Withdrawal by Subject|0|||
94353186|NCT00808665|323074954|FG000|Overall Study|only required minimally invasive surgery|1|||
94353187|NCT00808665|323074955|FG001|Overall Study|only required minimally invasive surgery|0|||
94353188|NCT00808665|323074954|FG000|Overall Study|surgery cancelled|1|||
94353189|NCT00808665|323074955|FG001|Overall Study|surgery cancelled|0|||
94353190|NCT00808665|323074954|FG000|Overall Study|required an additional procedure|0|||
94353191|NCT00808665|323074955|FG001|Overall Study|required an additional procedure|1|||
94353192|NCT00808665|323074954|FG000|Overall Study|Physician Decision|3|||
94353193|NCT00808665|323074955|FG001|Overall Study|Physician Decision|1|||
94353194|NCT00808665|323074954|FG000|Overall Study|Medication stopped by resident|0|||
94353195|NCT00808665|323074955|FG001|Overall Study|Medication stopped by resident|1|||
94353196|NCT02764229|323074957|FG000|Overall Study|Withdrawal by Subject|15|||
94353197|NCT02764229|323074957|FG000|Overall Study|Adverse Event|9|||
94353198|NCT02764229|323074957|FG000|Overall Study|Physician Decision|5|||
94353199|NCT02764229|323074957|FG000|Overall Study|Lost to Follow-up|3|||
94353200|NCT02764229|323074957|FG000|Overall Study|Lack of Efficacy|1|||
94353201|NCT02764229|323074957|FG000|Overall Study|Study Stopped by Sponsor|69|||
94353202|NCT00779142|323074958|FG000|Overall Study|Screen Failures|3|||
94353203|NCT01552408|323074962|FG000|Overall Study|Lost to Follow-up|2|||
94353204|NCT01552408|323074963|FG001|Overall Study|Lost to Follow-up|0|||
94353205|NCT01552408|323074962|FG000|Overall Study|Relocation|0|||
94353206|NCT01552408|323074963|FG001|Overall Study|Relocation|1|||
94353207|NCT01552408|323074962|FG000|Overall Study|Withdrawal by Subject|2|||
94353208|NCT01552408|323074963|FG001|Overall Study|Withdrawal by Subject|1|||
94353209|NCT03982069|323074967|FG000|Overall Study|Lost to Follow-up|5|||
94353210|NCT03982069|323074968|FG001|Overall Study|Lost to Follow-up|5|||
94353211|NCT03982069|323074969|FG002|Overall Study|Lost to Follow-up|3|||
94353212|NCT03982069|323074970|FG003|Overall Study|Lost to Follow-up|5|||
94353213|NCT03982069|323074967|FG000|Overall Study|Physician Decision|0|||
94353214|NCT03982069|323074968|FG001|Overall Study|Physician Decision|1|||
94353215|NCT03982069|323074969|FG002|Overall Study|Physician Decision|0|||
94353216|NCT03982069|323074970|FG003|Overall Study|Physician Decision|0|||
94353217|NCT03982069|323074967|FG000|Overall Study|Withdrawal by Subject|2|||
94353218|NCT03982069|323074968|FG001|Overall Study|Withdrawal by Subject|1|||
94353219|NCT03982069|323074969|FG002|Overall Study|Withdrawal by Subject|5|||
94353220|NCT03982069|323074970|FG003|Overall Study|Withdrawal by Subject|2|||
94584053|NCT01469377|323938401|FG002|Overall Study|Withdrawal of Consent|15|||
94584054|NCT01469377|323938399|FG000|Overall Study|Adverse Event|8|||
94584055|NCT01469377|323938400|FG001|Overall Study|Adverse Event|18|||
94240752|NCT03812029|322676720|FG002|Overall Study|Lost to Follow-up|0|||
94455383|NCT03395184|323454762|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
94584056|NCT01469377|323938401|FG002|Overall Study|Adverse Event|36|||
94659041|NCT01539291|324207962|FG001|Study GS-US-312-0116|Other|0|||
94353221|NCT03982069|323074967|FG000|Overall Study|Specimen loss|3|||
94353222|NCT03982069|323074968|FG001|Overall Study|Specimen loss|3|||
94353223|NCT03982069|323074969|FG002|Overall Study|Specimen loss|1|||
94353224|NCT03982069|323074970|FG003|Overall Study|Specimen loss|1|||
94353225|NCT01853397|323074988|FG000|Overall Study|Withdrawal by Subject|0|||
94353226|NCT01853397|323074989|FG001|Overall Study|Withdrawal by Subject|0|||
94353227|NCT01853397|323074990|FG002|Overall Study|Withdrawal by Subject|0|||
94353228|NCT01853397|323074991|FG003|Overall Study|Withdrawal by Subject|1|||
94353229|NCT01853397|323074988|FG000|Overall Study|Subject Noncompliance|0|||
94353230|NCT01853397|323074989|FG001|Overall Study|Subject Noncompliance|0|||
94353231|NCT01853397|323074990|FG002|Overall Study|Subject Noncompliance|0|||
94353232|NCT01853397|323074991|FG003|Overall Study|Subject Noncompliance|1|||
94584057|NCT01469377|323938399|FG000|Overall Study|Insufficient Therapeutic Response|3|||
94584058|NCT01469377|323938400|FG001|Overall Study|Insufficient Therapeutic Response|4|||
94584059|NCT01469377|323938401|FG002|Overall Study|Insufficient Therapeutic Response|0|||
94584060|NCT01469377|323938399|FG000|Overall Study|Other Miscellaneous Reasons|2|||
94584061|NCT01469377|323938400|FG001|Overall Study|Other Miscellaneous Reasons|0|||
94584062|NCT01469377|323938401|FG002|Overall Study|Other Miscellaneous Reasons|0|||
94584063|NCT00074490|323938402|FG000|Overall Study|Progressive malignancy|0|||
94584064|NCT00074490|323938403|FG001|Overall Study|Progressive malignancy|7|||
94584065|NCT00074490|323938404|FG002|Overall Study|Progressive malignancy|0|||
94584066|NCT00074490|323938405|FG003|Overall Study|Progressive malignancy|0|||
94584067|NCT00074490|323938406|FG004|Overall Study|Progressive malignancy|3|||
94584068|NCT00074490|323938407|FG005|Overall Study|Progressive malignancy|0|||
94584069|NCT03566485|323938408|FG000|Overall Study|Disease progression|5|||
94584070|NCT03566485|323938409|FG001|Overall Study|Disease progression|4|||
94584071|NCT03566485|323938408|FG000|Overall Study|Clinical progression|0|||
94584072|NCT03566485|323938409|FG001|Overall Study|Clinical progression|1|||
94584073|NCT03566485|323938408|FG000|Overall Study|Toxicity|0|||
94584074|NCT03566485|323938409|FG001|Overall Study|Toxicity|2|||
94584075|NCT01721044|323938410|FG000|Treatment Period|Adverse Event|7|||
94584076|NCT01721044|323938411|FG001|Treatment Period|Adverse Event|7|||
94240753|NCT03812029|322676721|FG003|Overall Study|Lost to Follow-up|0|||
94240754|NCT03812029|322676722|FG004|Overall Study|Lost to Follow-up|3|||
94240755|NCT01370655|322676728|FG000|Period 1|Adverse Event|2|||
94240756|NCT01370655|322676729|FG001|Period 1|Adverse Event|0|||
94240757|NCT01370655|322676730|FG002|Period 1|Adverse Event|0|||
94240758|NCT01370655|322676731|FG003|Period 1|Adverse Event|0|||
94240759|NCT01370655|322676732|FG004|Period 1|Adverse Event|0|||
94240760|NCT01370655|322676733|FG005|Period 1|Adverse Event|0|||
94240761|NCT01370655|322676734|FG006|Period 1|Adverse Event|1|||
94240762|NCT01370655|322676735|FG007|Period 1|Adverse Event|0|||
94240763|NCT01370655|322676736|FG008|Period 1|Adverse Event|0|||
94240764|NCT01370655|322676737|FG009|Period 1|Adverse Event|0|||
94240765|NCT01370655|322676738|FG010|Period 1|Adverse Event|0|||
94240766|NCT01370655|322676739|FG011|Period 1|Adverse Event|0|||
94240767|NCT01370655|322676728|FG000|Period 2|Adverse Event|0|||
94240768|NCT01370655|322676729|FG001|Period 2|Adverse Event|0|||
94240769|NCT01370655|322676730|FG002|Period 2|Adverse Event|1|||
94240770|NCT01370655|322676731|FG003|Period 2|Adverse Event|0|||
94240771|NCT01370655|322676732|FG004|Period 2|Adverse Event|1|||
94240772|NCT01370655|322676733|FG005|Period 2|Adverse Event|0|||
94240773|NCT01370655|322676734|FG006|Period 2|Adverse Event|0|||
94240774|NCT01370655|322676735|FG007|Period 2|Adverse Event|1|||
94240775|NCT01370655|322676736|FG008|Period 2|Adverse Event|0|||
94240776|NCT01370655|322676737|FG009|Period 2|Adverse Event|0|||
94240777|NCT01370655|322676738|FG010|Period 2|Adverse Event|0|||
94240778|NCT01370655|322676739|FG011|Period 2|Adverse Event|0|||
94240779|NCT01370655|322676728|FG000|Period 2|met protocol specified stopping criteria|0|||
94240780|NCT01370655|322676729|FG001|Period 2|met protocol specified stopping criteria|0|||
94240781|NCT01370655|322676730|FG002|Period 2|met protocol specified stopping criteria|1|||
94240782|NCT01370655|322676731|FG003|Period 2|met protocol specified stopping criteria|0|||
94240783|NCT01370655|322676732|FG004|Period 2|met protocol specified stopping criteria|0|||
94240784|NCT01370655|322676733|FG005|Period 2|met protocol specified stopping criteria|0|||
94240785|NCT01370655|322676734|FG006|Period 2|met protocol specified stopping criteria|1|||
94240786|NCT01370655|322676735|FG007|Period 2|met protocol specified stopping criteria|0|||
94240787|NCT01370655|322676736|FG008|Period 2|met protocol specified stopping criteria|1|||
94240788|NCT01370655|322676737|FG009|Period 2|met protocol specified stopping criteria|0|||
94240789|NCT01370655|322676738|FG010|Period 2|met protocol specified stopping criteria|1|||
94240790|NCT01370655|322676739|FG011|Period 2|met protocol specified stopping criteria|0|||
94240791|NCT01370655|322676728|FG000|Period 2|Withdrawal by Subject|0|||
94240792|NCT01370655|322676729|FG001|Period 2|Withdrawal by Subject|0|||
94240793|NCT01370655|322676730|FG002|Period 2|Withdrawal by Subject|0|||
94240794|NCT01370655|322676731|FG003|Period 2|Withdrawal by Subject|0|||
94240795|NCT01370655|322676732|FG004|Period 2|Withdrawal by Subject|0|||
94240796|NCT01370655|322676733|FG005|Period 2|Withdrawal by Subject|0|||
94240797|NCT01370655|322676734|FG006|Period 2|Withdrawal by Subject|0|||
94240798|NCT01370655|322676735|FG007|Period 2|Withdrawal by Subject|0|||
94240799|NCT01370655|322676736|FG008|Period 2|Withdrawal by Subject|1|||
94240800|NCT01370655|322676737|FG009|Period 2|Withdrawal by Subject|0|||
94240801|NCT01370655|322676738|FG010|Period 2|Withdrawal by Subject|0|||
94584077|NCT01721044|323938412|FG002|Treatment Period|Adverse Event|10|||
94240802|NCT01370655|322676739|FG011|Period 2|Withdrawal by Subject|0|||
94240803|NCT02687035|322676740|FG000|Overall Study|Withdrawal by Subject|1|||
94240804|NCT02687035|322676740|FG000|Overall Study|Death|87|||
94240805|NCT02687035|322676740|FG000|Overall Study|Lost to Follow-up|1|||
94240806|NCT02687035|322676740|FG000|Overall Study|Missed Visit|87|||
94584078|NCT01721044|323938410|FG000|Treatment Period|Death|0|||
94584079|NCT01721044|323938411|FG001|Treatment Period|Death|0|||
94240807|NCT02687035|322676740|FG000|Overall Study|Did not receive Study Device|8|||
94240808|NCT03149042|322676742|FG000|Overall Study|Invasive FFR not performed|21|||
94240809|NCT03149042|322676742|FG000|Overall Study|Poor CT Image Quality|1|||
94353233|NCT02132312|323074992|FG000|Overall Study|Adverse Event|2|||
94353234|NCT02132312|323074993|FG001|Overall Study|Adverse Event|0|||
94353235|NCT02132312|323074992|FG000|Overall Study|Physician Decision|1|||
94353236|NCT02132312|323074993|FG001|Overall Study|Physician Decision|1|||
94353237|NCT02132312|323074992|FG000|Overall Study|Protocol Violation|0|||
94353238|NCT02132312|323074993|FG001|Overall Study|Protocol Violation|1|||
94353239|NCT02132312|323074992|FG000|Overall Study|Withdrawal by Subject|1|||
94353240|NCT02132312|323074993|FG001|Overall Study|Withdrawal by Subject|0|||
94353241|NCT02132312|323074992|FG000|Overall Study|Lost to Follow-up|2|||
94353242|NCT02132312|323074993|FG001|Overall Study|Lost to Follow-up|1|||
94353243|NCT02242305|323074996|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
94353244|NCT02242305|323074997|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
94353245|NCT02242305|323074996|FG000|Overall Study|Adverse Event|1|||
94353246|NCT02242305|323074997|FG001|Overall Study|Adverse Event|0|||
94353247|NCT02242305|323074996|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
94353248|NCT02242305|323074997|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
94455384|NCT03395184|323454763|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
94455385|NCT03395184|323454764|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
94455386|NCT03395184|323454765|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
94455387|NCT03395184|323454766|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
94455388|NCT03395184|323454760|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
94584080|NCT01721044|323938412|FG002|Treatment Period|Death|1|||
94455389|NCT03395184|323454761|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
94455390|NCT03395184|323454762|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
94455391|NCT03395184|323454763|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
94455392|NCT03395184|323454764|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
94455393|NCT03395184|323454765|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
94455394|NCT03395184|323454766|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
94455395|NCT03395184|323454760|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
94455396|NCT03395184|323454761|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
94455397|NCT03395184|323454762|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
94455398|NCT03395184|323454763|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
94455399|NCT03395184|323454764|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
94455400|NCT03395184|323454765|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
94455401|NCT03395184|323454766|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
94455402|NCT03395184|323454760|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
94455403|NCT03395184|323454761|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
94455404|NCT03395184|323454762|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
94455405|NCT03395184|323454763|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
94455406|NCT03395184|323454764|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
94455407|NCT03395184|323454765|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
94455408|NCT03395184|323454766|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
94455409|NCT03395184|323454760|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
94455410|NCT03395184|323454761|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
94455411|NCT03395184|323454762|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
94455412|NCT03395184|323454763|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
94455413|NCT03395184|323454764|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
94455414|NCT03395184|323454765|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
94455415|NCT03395184|323454766|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
94455416|NCT03395184|323454760|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
94455417|NCT03395184|323454761|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
94455418|NCT03395184|323454762|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
94455419|NCT03395184|323454763|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
94455420|NCT03395184|323454764|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
94455421|NCT03395184|323454765|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
94455422|NCT03395184|323454766|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
94455423|NCT03395184|323454760|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
94455424|NCT03395184|323454761|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
94455425|NCT03395184|323454762|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
94455426|NCT03395184|323454763|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
94455427|NCT03395184|323454764|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
94455428|NCT03395184|323454765|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
94455429|NCT03395184|323454766|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
94455430|NCT03395184|323454760|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
94584081|NCT01721044|323938410|FG000|Treatment Period|Lack of Efficacy|16|||
94584082|NCT01721044|323938411|FG001|Treatment Period|Lack of Efficacy|4|||
94584083|NCT01721044|323938412|FG002|Treatment Period|Lack of Efficacy|4|||
94353249|NCT02242305|323074996|FG000|Overall Study|Subject withdraws inform consent|0|||
94353250|NCT02242305|323074997|FG001|Overall Study|Subject withdraws inform consent|4|||
94353251|NCT02242305|323074996|FG000|Overall Study|Lost to Follow-up|2|||
94353252|NCT02242305|323074997|FG001|Overall Study|Lost to Follow-up|0|||
94353253|NCT02431559|323074998|FG000|Overall Study|Adverse Event|0|||
94353254|NCT02431559|323074999|FG001|Overall Study|Adverse Event|1|||
94455431|NCT03395184|323454761|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
94455432|NCT03395184|323454762|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
94455433|NCT03395184|323454763|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
94455434|NCT03395184|323454764|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
94455435|NCT03395184|323454765|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
94455436|NCT03395184|323454766|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
94455437|NCT03395184|323454760|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
94455438|NCT03395184|323454761|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
94455439|NCT03395184|323454762|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
94455440|NCT03395184|323454763|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
94455441|NCT03395184|323454764|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
94455442|NCT03395184|323454765|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
94455443|NCT03395184|323454766|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
94455444|NCT05685732|323454772|FG000|Overall Study|Withdrawal by Subject|2|||
94455445|NCT05685732|323454773|FG001|Overall Study|Withdrawal by Subject|0|||
94455446|NCT05685732|323454774|FG002|Overall Study|Withdrawal by Subject|2|||
94240810|NCT03149042|322676742|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
94240811|NCT01240915|322676745|FG000|Overall Study|Adverse Event|0|||
94240812|NCT01240915|322676746|FG001|Overall Study|Adverse Event|0|||
94455447|NCT05685732|323454775|FG003|Overall Study|Withdrawal by Subject|3|||
94455448|NCT05685732|323454772|FG000|Overall Study|Protocol Violation|1|||
94455449|NCT05685732|323454773|FG001|Overall Study|Protocol Violation|2|||
94455450|NCT05685732|323454774|FG002|Overall Study|Protocol Violation|4|||
94455451|NCT05685732|323454775|FG003|Overall Study|Protocol Violation|1|||
94455452|NCT05685732|323454772|FG000|Overall Study|Lost to Follow-up|5|||
94455453|NCT05685732|323454773|FG001|Overall Study|Lost to Follow-up|1|||
94240813|NCT01240915|322676747|FG002|Overall Study|Adverse Event|0|||
94240814|NCT01240915|322676748|FG003|Overall Study|Adverse Event|1|||
94455454|NCT05685732|323454774|FG002|Overall Study|Lost to Follow-up|3|||
94584084|NCT01721044|323938410|FG000|Treatment Period|Lost to Follow-up|0|||
94584085|NCT01721044|323938411|FG001|Treatment Period|Lost to Follow-up|0|||
94584086|NCT01721044|323938412|FG002|Treatment Period|Lost to Follow-up|1|||
94584087|NCT01721044|323938410|FG000|Treatment Period|Physician Decision|1|||
94240815|NCT01240915|322676749|FG004|Overall Study|Adverse Event|0|||
94455455|NCT05685732|323454775|FG003|Overall Study|Lost to Follow-up|1|||
94455456|NCT05685732|323454772|FG000|Overall Study|Adverse Event|2|||
94455457|NCT05685732|323454773|FG001|Overall Study|Adverse Event|1|||
94455458|NCT05685732|323454774|FG002|Overall Study|Adverse Event|0|||
94455459|NCT05685732|323454775|FG003|Overall Study|Adverse Event|0|||
94455460|NCT05685732|323454772|FG000|Overall Study|Physician Decision|1|||
94455461|NCT05685732|323454773|FG001|Overall Study|Physician Decision|0|||
94455462|NCT05685732|323454774|FG002|Overall Study|Physician Decision|0|||
94240816|NCT01240915|322676750|FG005|Overall Study|Adverse Event|2|||
94240817|NCT01240915|322676751|FG006|Overall Study|Adverse Event|0|||
94240818|NCT01240915|322676752|FG007|Overall Study|Adverse Event|0|||
94455463|NCT05685732|323454775|FG003|Overall Study|Physician Decision|0|||
94240819|NCT01240915|322676753|FG008|Overall Study|Adverse Event|1|||
94240820|NCT01240915|322676745|FG000|Overall Study|Lost to Follow-up|0|||
94240821|NCT01240915|322676746|FG001|Overall Study|Lost to Follow-up|0|||
94455464|NCT03963232|323454776|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
94455465|NCT03963232|323454777|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
94584088|NCT01721044|323938411|FG001|Treatment Period|Physician Decision|0|||
94584089|NCT01721044|323938412|FG002|Treatment Period|Physician Decision|2|||
94584090|NCT01721044|323938410|FG000|Treatment Period|Protocol Violation|1|||
94240822|NCT01240915|322676747|FG002|Overall Study|Lost to Follow-up|0|||
94455466|NCT03963232|323454776|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
94240823|NCT01240915|322676748|FG003|Overall Study|Lost to Follow-up|0|||
94240824|NCT01240915|322676749|FG004|Overall Study|Lost to Follow-up|1|||
94240825|NCT01240915|322676750|FG005|Overall Study|Lost to Follow-up|1|||
94240826|NCT01240915|322676751|FG006|Overall Study|Lost to Follow-up|0|||
94240827|NCT01240915|322676752|FG007|Overall Study|Lost to Follow-up|1|||
94240828|NCT01240915|322676753|FG008|Overall Study|Lost to Follow-up|1|||
94240829|NCT01240915|322676745|FG000|Overall Study|Withdrawal by Subject|2|||
94240830|NCT01240915|322676746|FG001|Overall Study|Withdrawal by Subject|1|||
94240831|NCT01240915|322676747|FG002|Overall Study|Withdrawal by Subject|0|||
94240832|NCT01240915|322676748|FG003|Overall Study|Withdrawal by Subject|2|||
94240833|NCT01240915|322676749|FG004|Overall Study|Withdrawal by Subject|0|||
94240834|NCT01240915|322676750|FG005|Overall Study|Withdrawal by Subject|4|||
94240835|NCT01240915|322676751|FG006|Overall Study|Withdrawal by Subject|2|||
94240836|NCT01240915|322676752|FG007|Overall Study|Withdrawal by Subject|3|||
94240837|NCT01240915|322676753|FG008|Overall Study|Withdrawal by Subject|3|||
94240838|NCT01240915|322676745|FG000|Overall Study|Other|0|||
94240839|NCT01240915|322676746|FG001|Overall Study|Other|0|||
94240840|NCT01240915|322676747|FG002|Overall Study|Other|0|||
94240841|NCT01240915|322676748|FG003|Overall Study|Other|0|||
94240842|NCT01240915|322676749|FG004|Overall Study|Other|2|||
94240843|NCT01240915|322676750|FG005|Overall Study|Other|0|||
94240844|NCT01240915|322676751|FG006|Overall Study|Other|0|||
94240845|NCT01240915|322676752|FG007|Overall Study|Other|0|||
94240846|NCT01240915|322676753|FG008|Overall Study|Other|0|||
94240847|NCT01240915|322676745|FG000|Overall Study|Insufficient Clinical Response|0|||
94240848|NCT01240915|322676746|FG001|Overall Study|Insufficient Clinical Response|0|||
94240849|NCT01240915|322676747|FG002|Overall Study|Insufficient Clinical Response|0|||
94240850|NCT01240915|322676748|FG003|Overall Study|Insufficient Clinical Response|0|||
94240851|NCT01240915|322676749|FG004|Overall Study|Insufficient Clinical Response|1|||
94240852|NCT01240915|322676750|FG005|Overall Study|Insufficient Clinical Response|3|||
94240853|NCT01240915|322676751|FG006|Overall Study|Insufficient Clinical Response|6|||
94240854|NCT01240915|322676752|FG007|Overall Study|Insufficient Clinical Response|0|||
94240855|NCT01240915|322676753|FG008|Overall Study|Insufficient Clinical Response|3|||
94240856|NCT01886287|322676761|FG000|Overall Study|Radiographic disease progression|1|||
94240857|NCT01886287|322676761|FG000|Overall Study|Clinical progression due to disease|1|||
94240858|NCT04936685|322676763|FG000|Overall Study|Protocol Violation|1|||
94240859|NCT04936685|322676764|FG001|Overall Study|Protocol Violation|0|||
94240860|NCT00879775|322676765|FG000|Overall Study|Lost to Follow-up|2|||
94240861|NCT00879775|322676766|FG001|Overall Study|Lost to Follow-up|1|||
94240862|NCT02614183|322676767|FG000|Double Blind Treatment Phase|Adverse Event|10|||
94240863|NCT02614183|322676768|FG001|Double Blind Treatment Phase|Adverse Event|9|||
94240864|NCT02614183|322676769|FG002|Double Blind Treatment Phase|Adverse Event|7|||
94240865|NCT02614183|322676767|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
94240866|NCT02614183|322676768|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
94240867|NCT02614183|322676769|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
94240868|NCT02614183|322676767|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
94240869|NCT02614183|322676768|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
94240870|NCT02614183|322676769|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
94240871|NCT02614183|322676767|FG000|Double Blind Treatment Phase|Physician Decision|7|||
94240872|NCT02614183|322676768|FG001|Double Blind Treatment Phase|Physician Decision|3|||
94240873|NCT02614183|322676769|FG002|Double Blind Treatment Phase|Physician Decision|2|||
94240874|NCT02614183|322676767|FG000|Double Blind Treatment Phase|Pregnancy|2|||
94240875|NCT02614183|322676768|FG001|Double Blind Treatment Phase|Pregnancy|1|||
94240876|NCT02614183|322676769|FG002|Double Blind Treatment Phase|Pregnancy|3|||
94240877|NCT02614183|322676767|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
94240878|NCT02614183|322676768|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
94240879|NCT02614183|322676769|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
94240880|NCT02614183|322676767|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
94240881|NCT02614183|322676768|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
94240882|NCT02614183|322676769|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
94240883|NCT02614183|322676767|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
94240884|NCT02614183|322676768|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
94240885|NCT02614183|322676769|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
94240886|NCT02614183|322676767|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
94240887|NCT02614183|322676768|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
94240888|NCT02614183|322676769|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
94240889|NCT02614183|322676767|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
94240890|NCT02614183|322676768|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
94240891|NCT02614183|322676769|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
94240892|NCT02614183|322676767|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
94240893|NCT02614183|322676768|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
94240894|NCT02614183|322676769|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
94240895|NCT02614183|322676767|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
94659042|NCT01539291|324207963|FG002|Study GS-US-312-0116|Other|0|||
94240896|NCT02614183|322676768|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
94240897|NCT02614183|322676769|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
94240898|NCT05262751|322676770|FG000|Washout Period 2|Adverse Event|1|||
94240899|NCT05262751|322676771|FG001|Washout Period 2|Adverse Event|0|||
94240900|NCT05262751|322676772|FG002|Washout Period 2|Adverse Event|0|||
94240901|NCT05262751|322676773|FG003|Washout Period 2|Adverse Event|0|||
94240902|NCT05262751|322676774|FG004|Washout Period 2|Adverse Event|0|||
94240903|NCT05262751|322676775|FG005|Washout Period 2|Adverse Event|0|||
94240904|NCT05262751|322676770|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
94240905|NCT05262751|322676771|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
94240906|NCT05262751|322676772|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
94240907|NCT05262751|322676773|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
94240908|NCT05262751|322676774|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
94240909|NCT05262751|322676775|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
94240910|NCT03819634|322676776|FG000|Overall Study|Physician Decision|2|||
94240911|NCT03019640|322676777|FG000|Overall Study|Screen Failures|4|||
94240912|NCT03019640|322676777|FG000|Overall Study|Adverse Event|3|||
94240913|NCT03019640|322676777|FG000|Overall Study|Participant Relapsed|1|||
94240914|NCT02683785|322676778|FG000|Overall Study|Withdrawal by Subject|1|||
94240915|NCT02683785|322676779|FG001|Overall Study|Withdrawal by Subject|1|||
94240916|NCT02683785|322676778|FG000|Overall Study|Lost to Follow-up|0|||
94240917|NCT02683785|322676779|FG001|Overall Study|Lost to Follow-up|1|||
94240918|NCT02683785|322676778|FG000|Overall Study|Adverse Event|0|||
94240919|NCT02683785|322676779|FG001|Overall Study|Adverse Event|2|||
94240920|NCT03846453|322676780|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
94240921|NCT03846453|322676781|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
94240922|NCT03846453|322676782|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
94240923|NCT03846453|322676780|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
94240924|NCT03846453|322676781|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
94240925|NCT03846453|322676782|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
94240926|NCT03846453|322676780|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
94240927|NCT03846453|322676781|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
94240928|NCT03846453|322676782|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
94240929|NCT03846453|322676780|FG000|Placebo Run-in (14 Days)|Other|2|||
94240930|NCT03846453|322676781|FG001|Placebo Run-in (14 Days)|Other|0|||
94240931|NCT03846453|322676782|FG002|Placebo Run-in (14 Days)|Other|0|||
94240932|NCT03846453|322676780|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
94240933|NCT03846453|322676781|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
94240934|NCT03846453|322676782|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
94240935|NCT03846453|322676780|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
94240936|NCT03846453|322676781|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
94240937|NCT03846453|322676782|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
94240938|NCT03846453|322676780|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
94240939|NCT03846453|322676781|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
94240940|NCT03846453|322676782|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
94240941|NCT03846453|322676780|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
94240942|NCT03846453|322676781|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
94240943|NCT03846453|322676782|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
94240944|NCT03846453|322676780|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
94240945|NCT03846453|322676781|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
94240946|NCT03846453|322676782|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
94240947|NCT01711853|322676786|FG000|Overall Study|Not treated|3|||
94240948|NCT01162863|322676789|FG000|Overall Study|Lack of Efficacy|1|||
94240949|NCT01162863|322676790|FG001|Overall Study|Lack of Efficacy|0|||
94240950|NCT01162863|322676791|FG002|Overall Study|Lack of Efficacy|0|||
94240951|NCT01162863|322676789|FG000|Overall Study|Adverse Event|0|||
94240952|NCT01162863|322676790|FG001|Overall Study|Adverse Event|1|||
94240953|NCT01162863|322676791|FG002|Overall Study|Adverse Event|0|||
94240954|NCT02992691|322676792|FG000|Overall Study|Adverse Event|2|||
94240955|NCT02992691|322676792|FG000|Overall Study|Withdrawal by Subject|1|||
94240956|NCT00588692|322676793|FG000|Overall Study|Withdrawal by Subject|4|||
94240957|NCT00588692|322676794|FG001|Overall Study|Withdrawal by Subject|2|||
94240958|NCT00588692|322676793|FG000|Overall Study|Hip Surgery|0|||
94240959|NCT00588692|322676794|FG001|Overall Study|Hip Surgery|1|||
94240960|NCT00588692|322676793|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
94240961|NCT00588692|322676794|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
94240962|NCT00588692|322676793|FG000|Overall Study|Cancer|1|||
94584091|NCT01721044|323938411|FG001|Treatment Period|Protocol Violation|0|||
94584092|NCT01721044|323938412|FG002|Treatment Period|Protocol Violation|0|||
94584093|NCT01721044|323938410|FG000|Treatment Period|Withdrawal by Subject|7|||
94584094|NCT01721044|323938411|FG001|Treatment Period|Withdrawal by Subject|6|||
94584095|NCT01721044|323938412|FG002|Treatment Period|Withdrawal by Subject|1|||
94240963|NCT00588692|322676794|FG001|Overall Study|Cancer|0|||
94240964|NCT00588692|322676793|FG000|Overall Study|Death|1|||
94240965|NCT00588692|322676794|FG001|Overall Study|Death|0|||
94240966|NCT03538938|322676799|FG000|Overall Study|Death|0|||
94240967|NCT03538938|322676800|FG001|Overall Study|Death|0|||
94240968|NCT03538938|322676801|FG002|Overall Study|Death|2|||
94240969|NCT03538938|322676802|FG003|Overall Study|Death|0|||
94240970|NCT03538938|322676803|FG004|Overall Study|Death|0|||
94240971|NCT03538938|322676804|FG005|Overall Study|Death|1|||
94240972|NCT03538938|322676805|FG006|Overall Study|Death|0|||
94240973|NCT03538938|322676806|FG007|Overall Study|Death|1|||
94240974|NCT03538938|322676807|FG008|Overall Study|Death|1|||
94240975|NCT03538938|322676808|FG009|Overall Study|Death|1|||
94240976|NCT03538938|322676809|FG010|Overall Study|Death|0|||
94240977|NCT03538938|322676810|FG011|Overall Study|Death|0|||
94240978|NCT03538938|322676811|FG012|Overall Study|Death|1|||
94240979|NCT03538938|322676812|FG013|Overall Study|Death|1|||
94240980|NCT03538938|322676813|FG014|Overall Study|Death|0|||
94240981|NCT03538938|322676814|FG015|Overall Study|Death|1|||
94240982|NCT03538938|322676799|FG000|Overall Study|Withdrawal by Subject|4|||
94240983|NCT03538938|322676800|FG001|Overall Study|Withdrawal by Subject|6|||
94240984|NCT03538938|322676801|FG002|Overall Study|Withdrawal by Subject|5|||
94240985|NCT03538938|322676802|FG003|Overall Study|Withdrawal by Subject|3|||
94240986|NCT03538938|322676803|FG004|Overall Study|Withdrawal by Subject|0|||
94240987|NCT03538938|322676804|FG005|Overall Study|Withdrawal by Subject|0|||
94240988|NCT03538938|322676805|FG006|Overall Study|Withdrawal by Subject|3|||
94240989|NCT03538938|322676806|FG007|Overall Study|Withdrawal by Subject|1|||
94240990|NCT03538938|322676807|FG008|Overall Study|Withdrawal by Subject|5|||
94240991|NCT03538938|322676808|FG009|Overall Study|Withdrawal by Subject|1|||
94240992|NCT03538938|322676809|FG010|Overall Study|Withdrawal by Subject|2|||
94240993|NCT03538938|322676810|FG011|Overall Study|Withdrawal by Subject|1|||
94240994|NCT03538938|322676811|FG012|Overall Study|Withdrawal by Subject|3|||
94240995|NCT03538938|322676812|FG013|Overall Study|Withdrawal by Subject|0|||
94240996|NCT03538938|322676813|FG014|Overall Study|Withdrawal by Subject|2|||
94240997|NCT03538938|322676814|FG015|Overall Study|Withdrawal by Subject|4|||
94240998|NCT03538938|322676799|FG000|Overall Study|Incarcerated|0|||
94240999|NCT03538938|322676800|FG001|Overall Study|Incarcerated|0|||
94241000|NCT03538938|322676801|FG002|Overall Study|Incarcerated|0|||
94241001|NCT03538938|322676802|FG003|Overall Study|Incarcerated|0|||
94241002|NCT03538938|322676803|FG004|Overall Study|Incarcerated|0|||
94241003|NCT03538938|322676804|FG005|Overall Study|Incarcerated|0|||
94241004|NCT03538938|322676805|FG006|Overall Study|Incarcerated|0|||
94241005|NCT03538938|322676806|FG007|Overall Study|Incarcerated|0|||
94241006|NCT03538938|322676807|FG008|Overall Study|Incarcerated|0|||
94241007|NCT03538938|322676808|FG009|Overall Study|Incarcerated|0|||
94241008|NCT03538938|322676809|FG010|Overall Study|Incarcerated|0|||
94241009|NCT03538938|322676810|FG011|Overall Study|Incarcerated|1|||
94241010|NCT03538938|322676811|FG012|Overall Study|Incarcerated|0|||
94241011|NCT03538938|322676812|FG013|Overall Study|Incarcerated|0|||
94241012|NCT03538938|322676813|FG014|Overall Study|Incarcerated|0|||
94241013|NCT03538938|322676814|FG015|Overall Study|Incarcerated|0|||
94241014|NCT00755105|322676815|FG000|Overall Study|Withdrawal by Subject|9|||
94241015|NCT00755105|322676816|FG001|Overall Study|Withdrawal by Subject|11|||
94241016|NCT00755105|322676817|FG002|Overall Study|Withdrawal by Subject|4|||
94241017|NCT01361594|322676819|FG000|Overall Study|Withdrawal by Subject|1|||
94241018|NCT01361594|322676820|FG001|Overall Study|Withdrawal by Subject|2|||
94241019|NCT01277887|322676821|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
94241020|NCT01277887|322676822|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
94241021|NCT01277887|322676821|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
94241022|NCT01277887|322676822|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
94241023|NCT01277887|322676821|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
94241024|NCT01277887|322676822|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
94455467|NCT03963232|323454777|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
94455468|NCT03963232|323454776|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
94455469|NCT03963232|323454777|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
94455470|NCT03963232|323454776|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
94241025|NCT00415051|322676823|FG000|Overall Study|Protocol Violation|1|||
94241026|NCT01518153|322676824|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
94241027|NCT01518153|322676825|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
94241028|NCT01518153|322676826|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
94241029|NCT01518153|322676824|FG000|Stem Cell Transplant|Death|2|||
94241030|NCT01518153|322676825|FG001|Stem Cell Transplant|Death|0|||
94241031|NCT01518153|322676826|FG002|Stem Cell Transplant|Death|0|||
94241032|NCT01518153|322676824|FG000|Stem Cell Transplant|Secondary graft failure|1|||
94241033|NCT01518153|322676825|FG001|Stem Cell Transplant|Secondary graft failure|0|||
94241034|NCT01518153|322676826|FG002|Stem Cell Transplant|Secondary graft failure|0|||
94241035|NCT01518153|322676824|FG000|Stem Cell Transplant|Adverse Event|1|||
94659043|NCT01539291|324207964|FG003|Study GS-US-312-0116|Other|0|||
94584096|NCT04308291|323938413|FG000|Run-In Phase|Withdrawal by Subject|4|||
94584097|NCT04308291|323938413|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
94353255|NCT02431559|323075000|FG002|Overall Study|Adverse Event|0|||
94353256|NCT02431559|323075001|FG003|Overall Study|Adverse Event|4|||
94353257|NCT02431559|323074998|FG000|Overall Study|Progressive disease|2|||
94353258|NCT02431559|323074999|FG001|Overall Study|Progressive disease|1|||
94353259|NCT02431559|323075000|FG002|Overall Study|Progressive disease|4|||
94353260|NCT02431559|323075001|FG003|Overall Study|Progressive disease|22|||
94353261|NCT02431559|323074998|FG000|Overall Study|Withdrawal by Subject|0|||
94353262|NCT02431559|323074999|FG001|Overall Study|Withdrawal by Subject|1|||
94353263|NCT02431559|323075000|FG002|Overall Study|Withdrawal by Subject|0|||
94353264|NCT02431559|323075001|FG003|Overall Study|Withdrawal by Subject|4|||
94353265|NCT02431559|323074998|FG000|Overall Study|Physician Decision|0|||
94353266|NCT02431559|323074999|FG001|Overall Study|Physician Decision|0|||
94353267|NCT02431559|323075000|FG002|Overall Study|Physician Decision|0|||
94353268|NCT02431559|323075001|FG003|Overall Study|Physician Decision|1|||
94353269|NCT00486720|323075002|FG000|Overall Study|Adverse Event|1|||
94353270|NCT00486720|323075003|FG001|Overall Study|Adverse Event|2|||
94584098|NCT04308291|323938413|FG000|Study Phase 6-M|Physician Decision|2|||
94353271|NCT00486720|323075002|FG000|Overall Study|Lack of Efficacy|4|||
94353272|NCT00486720|323075003|FG001|Overall Study|Lack of Efficacy|6|||
94353273|NCT00486720|323075002|FG000|Overall Study|Physician Decision|1|||
94353274|NCT00486720|323075003|FG001|Overall Study|Physician Decision|2|||
94353275|NCT00486720|323075002|FG000|Overall Study|Protocol Violation|1|||
94353276|NCT00486720|323075003|FG001|Overall Study|Protocol Violation|0|||
94353277|NCT00486720|323075002|FG000|Overall Study|Withdrawal by Subject|3|||
94353278|NCT00486720|323075003|FG001|Overall Study|Withdrawal by Subject|1|||
94455471|NCT03963232|323454777|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
94455472|NCT03963232|323454776|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
94455473|NCT03963232|323454777|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
94455474|NCT03963232|323454776|FG000|Open-Label Treatment Phase|Adverse Event|1|||
94455475|NCT03963232|323454777|FG001|Open-Label Treatment Phase|Adverse Event|2|||
94455476|NCT03963232|323454776|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
94455477|NCT03963232|323454777|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
94455478|NCT03963232|323454776|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
94584099|NCT04308291|323938413|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
94584100|NCT04308291|323938413|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
94455479|NCT03963232|323454777|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
94455480|NCT03963232|323454776|FG000|Open-Label Treatment Phase|Pregnancy|1|||
94584101|NCT04308291|323938413|FG000|Study Phase 12-M|Physician Decision|2|||
94584102|NCT04308291|323938413|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
94584103|NCT01526733|323938414|FG000|Phase 1|Protocol Violation|1|||
94584104|NCT01526733|323938415|FG001|Phase 1|Protocol Violation|0|||
94584105|NCT01526733|323938414|FG000|Phase 1|Withdrawal by Subject|1|||
94584106|NCT01526733|323938415|FG001|Phase 1|Withdrawal by Subject|1|||
94584107|NCT00369265|323938422|FG000|Overall Study|Study terminated|4|||
94584108|NCT00369265|323938423|FG001|Overall Study|Study terminated|7|||
94584109|NCT00714870|323938424|FG000|Overall Study|Lost to Follow-up|22|||
94584110|NCT00714870|323938425|FG001|Overall Study|Lost to Follow-up|5|||
94584111|NCT00714870|323938424|FG000|Overall Study|patient unable to come b/c back pain|1|||
94584112|NCT00714870|323938425|FG001|Overall Study|patient unable to come b/c back pain|0|||
94584113|NCT00714870|323938424|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
94584114|NCT00714870|323938425|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
94584115|NCT03399552|323938426|FG000|Overall Study|No evidence of disease|1|||
94584116|NCT03399552|323938426|FG000|Overall Study|Unevaluable|1|||
94584117|NCT02699749|323938429|FG000|Overall Study|Other|0|||
94584118|NCT02699749|323938430|FG001|Overall Study|Other|0|||
94584119|NCT02699749|323938431|FG002|Overall Study|Other|2|||
94584120|NCT02699749|323938432|FG003|Overall Study|Other|0|||
94584121|NCT02699749|323938433|FG004|Overall Study|Other|0|||
94584122|NCT02699749|323938434|FG005|Overall Study|Other|1|||
94584123|NCT02699749|323938435|FG006|Overall Study|Other|1|||
94584124|NCT02699749|323938436|FG007|Overall Study|Other|0|||
94584125|NCT02699749|323938437|FG008|Overall Study|Other|0|||
94584126|NCT02699749|323938438|FG009|Overall Study|Other|0|||
94584127|NCT02699749|323938439|FG010|Overall Study|Other|1|||
94584128|NCT02699749|323938440|FG011|Overall Study|Other|0|||
94584129|NCT02699749|323938441|FG012|Overall Study|Other|0|||
94584130|NCT02699749|323938442|FG013|Overall Study|Other|0|||
94584131|NCT02699749|323938429|FG000|Overall Study|Progressive Disease|3|||
94584132|NCT02699749|323938430|FG001|Overall Study|Progressive Disease|3|||
94584133|NCT02699749|323938431|FG002|Overall Study|Progressive Disease|14|||
94584134|NCT02699749|323938432|FG003|Overall Study|Progressive Disease|3|||
94584135|NCT02699749|323938433|FG004|Overall Study|Progressive Disease|3|||
94584136|NCT02699749|323938434|FG005|Overall Study|Progressive Disease|7|||
94584137|NCT02699749|323938435|FG006|Overall Study|Progressive Disease|5|||
94584138|NCT02699749|323938436|FG007|Overall Study|Progressive Disease|5|||
94584139|NCT02699749|323938437|FG008|Overall Study|Progressive Disease|6|||
94584140|NCT02699749|323938438|FG009|Overall Study|Progressive Disease|6|||
94584141|NCT02699749|323938439|FG010|Overall Study|Progressive Disease|5|||
94584142|NCT02699749|323938440|FG011|Overall Study|Progressive Disease|4|||
94584143|NCT02699749|323938441|FG012|Overall Study|Progressive Disease|3|||
94241036|NCT01518153|322676825|FG001|Stem Cell Transplant|Adverse Event|0|||
94241037|NCT01518153|322676826|FG002|Stem Cell Transplant|Adverse Event|0|||
94241038|NCT01518153|322676824|FG000|Donor Lymphocyte Infusion|Death|0|||
94241039|NCT01518153|322676825|FG001|Donor Lymphocyte Infusion|Death|2|||
94241040|NCT01518153|322676826|FG002|Donor Lymphocyte Infusion|Death|1|||
94241041|NCT01128114|322676827|FG000|Overall Study|Treatment Withdrawn|6|||
94241042|NCT01128114|322676827|FG000|Overall Study|Screening Failed|2|||
94241043|NCT01327846|322676830|FG000|Core Phase|Subject decision (vital status: missing)|1|||
94241044|NCT01327846|322676831|FG001|Core Phase|Subject decision (vital status: missing)|2|||
94241045|NCT01327846|322676832|FG002|Core Phase|Subject decision (vital status: missing)|2|||
94241046|NCT01327846|322676833|FG003|Core Phase|Subject decision (vital status: missing)|1|||
94241047|NCT01327846|322676830|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
94241048|NCT01327846|322676831|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
94241049|NCT01327846|322676832|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
94241050|NCT01327846|322676833|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
94241051|NCT01327846|322676830|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
94241052|NCT01327846|322676831|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
94241053|NCT01327846|322676832|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
94241054|NCT01327846|322676833|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
94241055|NCT01327846|322676830|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
94241056|NCT01327846|322676831|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
94241057|NCT01327846|322676832|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
94241058|NCT01327846|322676833|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
94241059|NCT01327846|322676830|FG000|Core Phase|Lost to Follow-up|3|||
94241060|NCT01327846|322676831|FG001|Core Phase|Lost to Follow-up|3|||
94241061|NCT01327846|322676832|FG002|Core Phase|Lost to Follow-up|4|||
94241062|NCT01327846|322676833|FG003|Core Phase|Lost to Follow-up|5|||
94241063|NCT01327846|322676830|FG000|Extension Phase|Study terminated by sponsor|1073|||
94241064|NCT01327846|322676831|FG001|Extension Phase|Study terminated by sponsor|1124|||
94241065|NCT01327846|322676832|FG002|Extension Phase|Study terminated by sponsor|1067|||
94241066|NCT01327846|322676833|FG003|Extension Phase|Study terminated by sponsor|1660|||
94241067|NCT01327846|322676830|FG000|Extension Phase|Withdrawal by Subject|20|||
94241068|NCT01327846|322676831|FG001|Extension Phase|Withdrawal by Subject|13|||
94241069|NCT01327846|322676832|FG002|Extension Phase|Withdrawal by Subject|19|||
94241070|NCT01327846|322676833|FG003|Extension Phase|Withdrawal by Subject|37|||
94241071|NCT01327846|322676830|FG000|Extension Phase|Lost to Follow-up|4|||
94455481|NCT03963232|323454777|FG001|Open-Label Treatment Phase|Pregnancy|0|||
94455482|NCT03963232|323454776|FG000|Follow-up Phase|Withdrawal by Subject|7|||
94455483|NCT03963232|323454777|FG001|Follow-up Phase|Withdrawal by Subject|5|||
94455484|NCT03963232|323454776|FG000|Follow-up Phase|Protocol Violation|0|||
94455485|NCT03963232|323454777|FG001|Follow-up Phase|Protocol Violation|2|||
94455486|NCT03963232|323454776|FG000|Follow-up Phase|Adverse Event|0|||
94455487|NCT03963232|323454777|FG001|Follow-up Phase|Adverse Event|1|||
94455488|NCT03963232|323454776|FG000|Follow-up Phase|Lost to Follow-up|0|||
94455489|NCT03963232|323454777|FG001|Follow-up Phase|Lost to Follow-up|1|||
94455490|NCT03512210|323454779|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
94455491|NCT03512210|323454779|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
94455492|NCT03512210|323454779|FG000|Step 2:Post-MINMON|Death|2|||
94455493|NCT03512210|323454779|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
94455494|NCT03512210|323454779|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
94455495|NCT00652626|323456354|FG000|Initial Treatment Phase|Adverse Event|0|||
94455496|NCT00652626|323456355|FG001|Initial Treatment Phase|Adverse Event|0|||
94455497|NCT00652626|323456356|FG002|Initial Treatment Phase|Adverse Event|0|||
94455498|NCT00652626|323456357|FG003|Initial Treatment Phase|Adverse Event|0|||
94455499|NCT00652626|323456358|FG004|Initial Treatment Phase|Adverse Event|1|||
94455500|NCT00652626|323456359|FG005|Initial Treatment Phase|Adverse Event|0|||
94455501|NCT00652626|323456360|FG006|Initial Treatment Phase|Adverse Event|0|||
94455502|NCT00652626|323456354|FG000|Initial Treatment Phase|Protocol Violation|0|||
94455503|NCT00652626|323456355|FG001|Initial Treatment Phase|Protocol Violation|0|||
94455504|NCT00652626|323456356|FG002|Initial Treatment Phase|Protocol Violation|0|||
94241072|NCT01327846|322676831|FG001|Extension Phase|Lost to Follow-up|3|||
94241073|NCT01327846|322676832|FG002|Extension Phase|Lost to Follow-up|4|||
94455505|NCT00652626|323456357|FG003|Initial Treatment Phase|Protocol Violation|1|||
94455506|NCT00652626|323456358|FG004|Initial Treatment Phase|Protocol Violation|0|||
94455507|NCT00652626|323456359|FG005|Initial Treatment Phase|Protocol Violation|0|||
94584144|NCT02699749|323938442|FG013|Overall Study|Progressive Disease|5|||
94241074|NCT01327846|322676833|FG003|Extension Phase|Lost to Follow-up|7|||
94241075|NCT01327846|322676830|FG000|Extension Phase|Technical Problems|2|||
94455508|NCT00652626|323456360|FG006|Initial Treatment Phase|Protocol Violation|0|||
94584145|NCT02699749|323938429|FG000|Overall Study|Death|0|||
94584146|NCT02699749|323938430|FG001|Overall Study|Death|0|||
94584147|NCT02699749|323938431|FG002|Overall Study|Death|0|||
94241076|NCT01327846|322676831|FG001|Extension Phase|Technical Problems|4|||
94241077|NCT01327846|322676832|FG002|Extension Phase|Technical Problems|2|||
94241078|NCT01327846|322676833|FG003|Extension Phase|Technical Problems|2|||
94241079|NCT01250509|322676836|FG000|Overall Study|Lost to Follow-up|5|||
94241080|NCT01250509|322676837|FG001|Overall Study|Lost to Follow-up|2|||
94241081|NCT00203268|322676841|FG000|Early Treatment|only treated one headache|2|||
94241082|NCT00203268|322676841|FG000|Early Treatment|Lost to Follow-up|1|||
94241083|NCT00203268|322676841|FG000|Early Treatment|Withdrawal by Subject|1|||
94241084|NCT02206061|322676842|FG000|Overall Study|Withdrawal by Subject|4|||
94241085|NCT02206061|322676843|FG001|Overall Study|Withdrawal by Subject|7|||
94241086|NCT02206061|322676844|FG002|Overall Study|Withdrawal by Subject|1|||
94241087|NCT02206061|322676842|FG000|Overall Study|Lost to Follow-up|14|||
94241088|NCT02206061|322676843|FG001|Overall Study|Lost to Follow-up|7|||
94241089|NCT02206061|322676844|FG002|Overall Study|Lost to Follow-up|20|||
94241090|NCT00846807|322676845|FG000|Overall Study|Adverse Event|270|||
94241091|NCT00846807|322676845|FG000|Overall Study|Lost to Follow-up|94|||
94241092|NCT00846807|322676845|FG000|Overall Study|Withdrawal by Subject|56|||
94241093|NCT00846807|322676845|FG000|Overall Study|Non compliant with European label|7|||
94241094|NCT00846807|322676845|FG000|Overall Study|Switch to other anticoagulants|89|||
94241095|NCT00846807|322676845|FG000|Overall Study|No prescription after hospital discharge|56|||
94241096|NCT00846807|322676845|FG000|Overall Study|Other|60|||
94241097|NCT02406677|322676846|FG000|Overall Study|Death|16|||
94241098|NCT02406677|322676847|FG001|Overall Study|Death|8|||
94241099|NCT02406677|322676846|FG000|Overall Study|Discharged without P2Y12|1|||
94241100|NCT02406677|322676847|FG001|Overall Study|Discharged without P2Y12|3|||
94241101|NCT02406677|322676846|FG000|Overall Study|Discharged on prasugrel|283|||
94241102|NCT02406677|322676847|FG001|Overall Study|Discharged on prasugrel|587|||
94241103|NCT02406677|322676846|FG000|Overall Study|Withdrawal by Subject|1|||
94241104|NCT02406677|322676847|FG001|Overall Study|Withdrawal by Subject|0|||
94241105|NCT01920477|322678215|FG000|Overall Study|Adverse Event|0|||
94241106|NCT01920477|322678216|FG001|Overall Study|Adverse Event|1|||
94241107|NCT01920477|322678215|FG000|Overall Study|Lack of Efficacy|1|||
94241108|NCT01920477|322678216|FG001|Overall Study|Lack of Efficacy|0|||
94241109|NCT01920477|322678215|FG000|Overall Study|Study closed/terminated|14|||
94241110|NCT01920477|322678216|FG001|Overall Study|Study closed/terminated|15|||
94241111|NCT01920477|322678215|FG000|Overall Study|Withdrawal by Subject|0|||
94241112|NCT01920477|322678216|FG001|Overall Study|Withdrawal by Subject|1|||
94241113|NCT01681277|322678217|FG000|Overall Study|Adverse Event|1|||
94241114|NCT01681277|322678218|FG001|Overall Study|Adverse Event|0|||
94241115|NCT01681277|322678219|FG002|Overall Study|Adverse Event|0|||
94241116|NCT01681277|322678220|FG003|Overall Study|Adverse Event|0|||
94241117|NCT01681277|322678221|FG004|Overall Study|Adverse Event|0|||
94241118|NCT04942366|322678222|FG000|Overall Study|Withdrawal by Subject|5|||
94241119|NCT04942366|322678223|FG001|Overall Study|Withdrawal by Subject|5|||
94241120|NCT01484431|322678228|FG000|Period 1: High Dose|Physician Decision|0|||
94241121|NCT01484431|322678229|FG001|Period 1: High Dose|Physician Decision|1|||
94241122|NCT01484431|322678230|FG002|Period 1: High Dose|Physician Decision|0|||
94241123|NCT01484431|322678228|FG000|Period 2|Death|0|||
94241124|NCT01484431|322678229|FG001|Period 2|Death|1|||
94241125|NCT01484431|322678230|FG002|Period 2|Death|1|||
94241126|NCT01484431|322678228|FG000|Period 2|Physician Decision|0|||
94241127|NCT01484431|322678229|FG001|Period 2|Physician Decision|0|||
94241128|NCT01484431|322678230|FG002|Period 2|Physician Decision|1|||
94241129|NCT01484431|322678228|FG000|Period 2|Non-Compliance with Study Drug|1|||
94241130|NCT01484431|322678229|FG001|Period 2|Non-Compliance with Study Drug|0|||
94241131|NCT01484431|322678230|FG002|Period 2|Non-Compliance with Study Drug|0|||
94241132|NCT03838731|322678231|FG000|Overall Study|Pregnancy|0|||
94241133|NCT03838731|322678232|FG001|Overall Study|Pregnancy|1|||
94241134|NCT03838731|322678231|FG000|Overall Study|Withdrawal of consent|1|||
94241135|NCT03838731|322678232|FG001|Overall Study|Withdrawal of consent|0|||
94241136|NCT04491877|322678233|FG000|Overall Study|Protocol Deviation|1|||
94241137|NCT04491877|322678234|FG001|Overall Study|Protocol Deviation|0|||
94241138|NCT04491877|322678235|FG002|Overall Study|Protocol Deviation|2|||
94241139|NCT04491877|322678236|FG003|Overall Study|Protocol Deviation|0|||
94241140|NCT04491877|322678237|FG004|Overall Study|Protocol Deviation|0|||
94455509|NCT00652626|323456354|FG000|Initial Treatment Phase|Physician Decision|0|||
94455510|NCT00652626|323456355|FG001|Initial Treatment Phase|Physician Decision|0|||
94455511|NCT00652626|323456356|FG002|Initial Treatment Phase|Physician Decision|0|||
94455512|NCT00652626|323456357|FG003|Initial Treatment Phase|Physician Decision|0|||
94241141|NCT04491877|322678238|FG005|Overall Study|Protocol Deviation|0|||
94241142|NCT04491877|322678239|FG006|Overall Study|Protocol Deviation|1|||
94241143|NCT04491877|322678240|FG007|Overall Study|Protocol Deviation|1|||
94241144|NCT04491877|322678241|FG008|Overall Study|Protocol Deviation|0|||
94455513|NCT00652626|323456358|FG004|Initial Treatment Phase|Physician Decision|1|||
94584148|NCT02699749|323938432|FG003|Overall Study|Death|0|||
94241145|NCT04491877|322678233|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94241146|NCT04491877|322678234|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94241147|NCT04491877|322678235|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
94241148|NCT04491877|322678236|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
94241149|NCT04491877|322678237|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
94241150|NCT04491877|322678238|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
94241151|NCT04491877|322678239|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
94241152|NCT04491877|322678240|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
94353279|NCT00486720|323075002|FG000|Overall Study|Progressive Disease|0|||
94353280|NCT00486720|323075003|FG001|Overall Study|Progressive Disease|1|||
94241153|NCT04491877|322678241|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
94241154|NCT04491877|322678233|FG000|Overall Study|Lost to Follow-up|0|||
94241155|NCT04491877|322678234|FG001|Overall Study|Lost to Follow-up|2|||
94241156|NCT04491877|322678235|FG002|Overall Study|Lost to Follow-up|0|||
94241157|NCT04491877|322678236|FG003|Overall Study|Lost to Follow-up|0|||
94241158|NCT04491877|322678237|FG004|Overall Study|Lost to Follow-up|0|||
94241159|NCT04491877|322678238|FG005|Overall Study|Lost to Follow-up|0|||
94241160|NCT04491877|322678239|FG006|Overall Study|Lost to Follow-up|2|||
94353281|NCT01078974|323075015|FG000|Overall Study|Adverse Event|3|||
94353282|NCT01159665|323075021|FG000|Overall Study|Withdrawal by Subject|0|||
94353283|NCT01159665|323075022|FG001|Overall Study|Withdrawal by Subject|1|||
94353284|NCT01159665|323075023|FG002|Overall Study|Withdrawal by Subject|0|||
94353285|NCT01159665|323075024|FG003|Overall Study|Withdrawal by Subject|0|||
94353286|NCT01159665|323075025|FG004|Overall Study|Withdrawal by Subject|0|||
94353287|NCT01159665|323075026|FG005|Overall Study|Withdrawal by Subject|0|||
94353288|NCT01513460|323075027|FG000|Overall Study|Death|0|||
94353289|NCT01513460|323075028|FG001|Overall Study|Death|0|||
94353290|NCT01513460|323075029|FG002|Overall Study|Death|1|||
94455514|NCT00652626|323456359|FG005|Initial Treatment Phase|Physician Decision|0|||
94455515|NCT00652626|323456360|FG006|Initial Treatment Phase|Physician Decision|0|||
94455516|NCT00652626|323456354|FG000|Initial Treatment Phase|Sponsor Request|0|||
94455517|NCT00652626|323456355|FG001|Initial Treatment Phase|Sponsor Request|0|||
94455518|NCT00652626|323456356|FG002|Initial Treatment Phase|Sponsor Request|1|||
94455519|NCT00652626|323456357|FG003|Initial Treatment Phase|Sponsor Request|0|||
94455520|NCT00652626|323456358|FG004|Initial Treatment Phase|Sponsor Request|0|||
94455521|NCT00652626|323456359|FG005|Initial Treatment Phase|Sponsor Request|0|||
94455522|NCT00652626|323456360|FG006|Initial Treatment Phase|Sponsor Request|0|||
94455523|NCT00652626|323456354|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
94241161|NCT04491877|322678240|FG007|Overall Study|Lost to Follow-up|1|||
94241162|NCT04491877|322678241|FG008|Overall Study|Lost to Follow-up|1|||
94241163|NCT00699153|322678243|FG000|Overall Study|Lost to Follow-up|1|||
94241164|NCT00699153|322678244|FG001|Overall Study|Lost to Follow-up|0|||
94353291|NCT01513460|323075027|FG000|Overall Study|Lost to Follow-up|0|||
94353292|NCT01513460|323075028|FG001|Overall Study|Lost to Follow-up|0|||
94455524|NCT00652626|323456355|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
94455525|NCT00652626|323456356|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
94455526|NCT00652626|323456357|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
94455527|NCT00652626|323456358|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
94455528|NCT00652626|323456359|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
94455529|NCT00652626|323456360|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
94455530|NCT00652626|323456354|FG000|Extension Phase|Withdrawal by Subject|0|||
94455531|NCT00652626|323456355|FG001|Extension Phase|Withdrawal by Subject|0|||
94455532|NCT00652626|323456356|FG002|Extension Phase|Withdrawal by Subject|0|||
94455533|NCT00652626|323456357|FG003|Extension Phase|Withdrawal by Subject|0|||
94455534|NCT00652626|323456358|FG004|Extension Phase|Withdrawal by Subject|0|||
94455535|NCT00652626|323456359|FG005|Extension Phase|Withdrawal by Subject|2|||
94455536|NCT00652626|323456360|FG006|Extension Phase|Withdrawal by Subject|0|||
94455537|NCT00652626|323456354|FG000|Extension Phase|Adverse Event|0|||
94455538|NCT00652626|323456355|FG001|Extension Phase|Adverse Event|0|||
94455539|NCT00652626|323456356|FG002|Extension Phase|Adverse Event|0|||
94455540|NCT00652626|323456357|FG003|Extension Phase|Adverse Event|0|||
94455541|NCT00652626|323456358|FG004|Extension Phase|Adverse Event|0|||
94455542|NCT00652626|323456359|FG005|Extension Phase|Adverse Event|2|||
94455543|NCT00652626|323456360|FG006|Extension Phase|Adverse Event|1|||
94455544|NCT00652626|323456354|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
94455545|NCT00652626|323456355|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
94455546|NCT00652626|323456356|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
94455547|NCT00652626|323456357|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
94455548|NCT00652626|323456358|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
94455549|NCT00652626|323456359|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
94455550|NCT00652626|323456360|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
94455551|NCT00652626|323456354|FG000|Extension Phase|Physician Decision|0|||
94455552|NCT00652626|323456355|FG001|Extension Phase|Physician Decision|0|||
94455553|NCT00652626|323456356|FG002|Extension Phase|Physician Decision|0|||
94241165|NCT00699153|322678243|FG000|Overall Study|Adverse Event|0|||
94353293|NCT01513460|323075029|FG002|Overall Study|Lost to Follow-up|2|||
94241166|NCT00699153|322678244|FG001|Overall Study|Adverse Event|2|||
94241167|NCT00699153|322678243|FG000|Overall Study|Protocol Violation|1|||
94353294|NCT01513460|323075027|FG000|Overall Study|Abnormal laboratory value|1|||
94353295|NCT01513460|323075028|FG001|Overall Study|Abnormal laboratory value|0|||
94353296|NCT01513460|323075029|FG002|Overall Study|Abnormal laboratory value|1|||
94353297|NCT01513460|323075027|FG000|Overall Study|Lack of Efficacy|1|||
94241168|NCT00699153|322678244|FG001|Overall Study|Protocol Violation|0|||
94241169|NCT00699153|322678243|FG000|Overall Study|Travel Problem|1|||
94241170|NCT00699153|322678244|FG001|Overall Study|Travel Problem|0|||
94241171|NCT02412735|322678247|FG000|Overall Study|Adverse Event|0|||
94241172|NCT02412735|322678248|FG001|Overall Study|Adverse Event|1|||
94241173|NCT02412735|322678249|FG002|Overall Study|Adverse Event|2|||
94241174|NCT02412735|322678247|FG000|Overall Study|Withdrawal by Subject|23|||
94241175|NCT02412735|322678248|FG001|Overall Study|Withdrawal by Subject|27|||
94241176|NCT02412735|322678249|FG002|Overall Study|Withdrawal by Subject|22|||
94241177|NCT02412735|322678247|FG000|Overall Study|Investigator Decision|3|||
94241178|NCT02412735|322678248|FG001|Overall Study|Investigator Decision|3|||
94241179|NCT02412735|322678249|FG002|Overall Study|Investigator Decision|2|||
94241180|NCT02412735|322678247|FG000|Overall Study|Lost to Follow-up|17|||
94241181|NCT02412735|322678248|FG001|Overall Study|Lost to Follow-up|11|||
94241182|NCT02412735|322678249|FG002|Overall Study|Lost to Follow-up|18|||
94241183|NCT02412735|322678247|FG000|Overall Study|Reason not Specified|3|||
94241184|NCT02412735|322678248|FG001|Overall Study|Reason not Specified|2|||
94241185|NCT02412735|322678249|FG002|Overall Study|Reason not Specified|2|||
94241186|NCT05602727|322678250|FG000|Overall Study|Physician Decision|0|||
94241187|NCT05602727|322678251|FG001|Overall Study|Physician Decision|1|||
94241188|NCT05602727|322678252|FG002|Overall Study|Physician Decision|0|||
94241189|NCT05602727|322678250|FG000|Overall Study|Randomized by mistake without study medication|1|||
94241190|NCT05602727|322678251|FG001|Overall Study|Randomized by mistake without study medication|0|||
94241191|NCT05602727|322678252|FG002|Overall Study|Randomized by mistake without study medication|0|||
94241192|NCT05602727|322678250|FG000|Overall Study|Study termination by Sponsor|18|||
94241193|NCT05602727|322678251|FG001|Overall Study|Study termination by Sponsor|15|||
94241194|NCT05602727|322678252|FG002|Overall Study|Study termination by Sponsor|19|||
94241195|NCT05602727|322678250|FG000|Overall Study|Withdrawal by Subject|2|||
94241196|NCT05602727|322678251|FG001|Overall Study|Withdrawal by Subject|1|||
94353298|NCT01513460|323075028|FG001|Overall Study|Lack of Efficacy|2|||
94353299|NCT01513460|323075029|FG002|Overall Study|Lack of Efficacy|5|||
94353300|NCT01513460|323075027|FG000|Overall Study|Protocol deviations|3|||
94353301|NCT01513460|323075028|FG001|Overall Study|Protocol deviations|4|||
94353302|NCT01513460|323075029|FG002|Overall Study|Protocol deviations|3|||
94353303|NCT01513460|323075027|FG000|Overall Study|Withdrawal by Subject|7|||
94353304|NCT01513460|323075028|FG001|Overall Study|Withdrawal by Subject|8|||
94353305|NCT01513460|323075029|FG002|Overall Study|Withdrawal by Subject|21|||
94353306|NCT01513460|323075027|FG000|Overall Study|Adverse Event|16|||
94353307|NCT01513460|323075028|FG001|Overall Study|Adverse Event|18|||
94353308|NCT01513460|323075029|FG002|Overall Study|Adverse Event|23|||
94353309|NCT01513460|323075027|FG000|Overall Study|Abnormal test procedure|1|||
94353310|NCT01513460|323075028|FG001|Overall Study|Abnormal test procedure|0|||
94353311|NCT01513460|323075029|FG002|Overall Study|Abnormal test procedure|0|||
94353312|NCT01230489|323075030|FG000|Overall Study|Death|2|||
94353313|NCT01230489|323075030|FG000|Overall Study|Adverse Event|2|||
94353314|NCT01230489|323075030|FG000|Overall Study|Treatment modality changed|1|||
94353315|NCT03077646|323075031|FG000|Overall Study|Lost to Follow-up|29|||
94659044|NCT01539291|324207961|FG000|Study GS-US-312-0117|Adverse Event|22|||
94659045|NCT01539291|324207962|FG001|Study GS-US-312-0117|Adverse Event|1|||
94659046|NCT01539291|324207963|FG002|Study GS-US-312-0117|Adverse Event|9|||
94659047|NCT01539291|324207964|FG003|Study GS-US-312-0117|Adverse Event|12|||
94659048|NCT01539291|324207961|FG000|Study GS-US-312-0117|Physician Decision|9|||
94659049|NCT01539291|324207962|FG001|Study GS-US-312-0117|Physician Decision|0|||
94659050|NCT01539291|324207963|FG002|Study GS-US-312-0117|Physician Decision|6|||
94659051|NCT01539291|324207964|FG003|Study GS-US-312-0117|Physician Decision|4|||
94659052|NCT01539291|324207961|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
94659053|NCT01539291|324207962|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
94659054|NCT01539291|324207963|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
94659055|NCT01539291|324207964|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
94659056|NCT01539291|324207961|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
94659057|NCT01539291|324207962|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
94659058|NCT01539291|324207963|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
94241197|NCT05602727|322678252|FG002|Overall Study|Withdrawal by Subject|1|||
94353316|NCT03077646|323075032|FG001|Overall Study|Lost to Follow-up|30|||
94353317|NCT03077646|323075033|FG002|Overall Study|Lost to Follow-up|31|||
94353318|NCT01362062|323075034|FG000|Overall Study|Adverse Event|1|||
94353319|NCT01362062|323075035|FG001|Overall Study|Adverse Event|0|||
94353320|NCT01362062|323075034|FG000|Overall Study|Lost to Follow-up|11|||
94353321|NCT01362062|323075035|FG001|Overall Study|Lost to Follow-up|0|||
94659059|NCT01539291|324207964|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
94455554|NCT00652626|323456357|FG003|Extension Phase|Physician Decision|0|||
94241198|NCT05602727|322678250|FG000|Overall Study|Various reasons|1|||
94241199|NCT05602727|322678251|FG001|Overall Study|Various reasons|6|||
94241200|NCT05602727|322678252|FG002|Overall Study|Various reasons|1|||
94241201|NCT04020185|322678253|FG000|Overall Study|Death|0|||
94241202|NCT04020185|322678254|FG001|Overall Study|Death|0|||
94241203|NCT04020185|322678255|FG002|Overall Study|Death|1|||
94241204|NCT04020185|322678256|FG003|Overall Study|Death|2|||
94241205|NCT04020185|322678257|FG004|Overall Study|Death|1|||
94241206|NCT04020185|322678258|FG005|Overall Study|Death|0|||
94241207|NCT04020185|322678259|FG006|Overall Study|Death|1|||
94241208|NCT04020185|322678260|FG007|Overall Study|Death|0|||
94241209|NCT04020185|322678253|FG000|Overall Study|Consent withdrawn|1|||
94241210|NCT04020185|322678254|FG001|Overall Study|Consent withdrawn|0|||
94241211|NCT04020185|322678255|FG002|Overall Study|Consent withdrawn|0|||
94241212|NCT04020185|322678256|FG003|Overall Study|Consent withdrawn|0|||
94241213|NCT04020185|322678257|FG004|Overall Study|Consent withdrawn|2|||
94241214|NCT04020185|322678258|FG005|Overall Study|Consent withdrawn|0|||
94241215|NCT04020185|322678259|FG006|Overall Study|Consent withdrawn|1|||
94241216|NCT04020185|322678260|FG007|Overall Study|Consent withdrawn|1|||
94241217|NCT04020185|322678253|FG000|Overall Study|Patient in hospice|0|||
94241218|NCT04020185|322678254|FG001|Overall Study|Patient in hospice|1|||
94241219|NCT04020185|322678255|FG002|Overall Study|Patient in hospice|0|||
94241220|NCT04020185|322678256|FG003|Overall Study|Patient in hospice|0|||
94241221|NCT04020185|322678257|FG004|Overall Study|Patient in hospice|0|||
94241222|NCT04020185|322678258|FG005|Overall Study|Patient in hospice|0|||
94241223|NCT04020185|322678259|FG006|Overall Study|Patient in hospice|0|||
94241224|NCT04020185|322678260|FG007|Overall Study|Patient in hospice|0|||
94241225|NCT04020185|322678253|FG000|Overall Study|Continuing on expanded access|0|||
94241226|NCT04020185|322678254|FG001|Overall Study|Continuing on expanded access|0|||
94241227|NCT04020185|322678255|FG002|Overall Study|Continuing on expanded access|0|||
94241228|NCT04020185|322678256|FG003|Overall Study|Continuing on expanded access|0|||
94241229|NCT04020185|322678257|FG004|Overall Study|Continuing on expanded access|0|||
94241230|NCT04020185|322678258|FG005|Overall Study|Continuing on expanded access|0|||
94455555|NCT00652626|323456358|FG004|Extension Phase|Physician Decision|0|||
94455556|NCT00652626|323456359|FG005|Extension Phase|Physician Decision|1|||
94455557|NCT00652626|323456360|FG006|Extension Phase|Physician Decision|1|||
94455558|NCT00652626|323456354|FG000|Extension Phase|Death|0|||
94455559|NCT00652626|323456355|FG001|Extension Phase|Death|0|||
94455560|NCT00652626|323456356|FG002|Extension Phase|Death|0|||
94455561|NCT00652626|323456357|FG003|Extension Phase|Death|0|||
94455562|NCT00652626|323456358|FG004|Extension Phase|Death|0|||
94455563|NCT00652626|323456359|FG005|Extension Phase|Death|1|||
94241231|NCT04020185|322678259|FG006|Overall Study|Continuing on expanded access|1|||
94241232|NCT04020185|322678260|FG007|Overall Study|Continuing on expanded access|1|||
94241233|NCT03433677|322678261|FG000|Period 1|Protocol Violation|1|||
94241234|NCT03433677|322678262|FG001|Period 1|Protocol Violation|0|||
94241235|NCT03433677|322678261|FG000|Period 2|Withdrawal by Subject|1|||
94241236|NCT03433677|322678262|FG001|Period 2|Withdrawal by Subject|1|||
94241237|NCT00709228|322678263|FG000|Overall Study|Not treated|14|||
94455564|NCT00652626|323456360|FG006|Extension Phase|Death|1|||
94241238|NCT00709228|322678263|FG000|Overall Study|Eligibility criteria not met|281|||
94455565|NCT01435018|323456361|FG000|Overall Study|Death|37|||
94455566|NCT01435018|323456362|FG001|Overall Study|Death|18|||
94455567|NCT01435018|323456363|FG002|Overall Study|Death|25|||
94455568|NCT01435018|323456361|FG000|Overall Study|Site is closing|4|||
94584149|NCT02699749|323938433|FG004|Overall Study|Death|0|||
94584150|NCT02699749|323938434|FG005|Overall Study|Death|0|||
94584151|NCT02699749|323938435|FG006|Overall Study|Death|0|||
94584152|NCT02699749|323938436|FG007|Overall Study|Death|0|||
94584153|NCT02699749|323938437|FG008|Overall Study|Death|0|||
94584154|NCT02699749|323938438|FG009|Overall Study|Death|0|||
94584155|NCT02699749|323938439|FG010|Overall Study|Death|0|||
94584156|NCT02699749|323938440|FG011|Overall Study|Death|0|||
94584157|NCT02699749|323938441|FG012|Overall Study|Death|0|||
94584158|NCT02699749|323938442|FG013|Overall Study|Death|1|||
94584159|NCT02699749|323938429|FG000|Overall Study|Lost to Follow-up|0|||
94584160|NCT02699749|323938430|FG001|Overall Study|Lost to Follow-up|0|||
94584161|NCT02699749|323938431|FG002|Overall Study|Lost to Follow-up|0|||
94584162|NCT02699749|323938432|FG003|Overall Study|Lost to Follow-up|0|||
94584163|NCT02699749|323938433|FG004|Overall Study|Lost to Follow-up|0|||
94353322|NCT01362062|323075034|FG000|Overall Study|Withdrawal by Subject|2|||
94353323|NCT01362062|323075035|FG001|Overall Study|Withdrawal by Subject|0|||
94353324|NCT01362062|323075034|FG000|Overall Study|Non-compliant participant|2|||
94353325|NCT01362062|323075035|FG001|Overall Study|Non-compliant participant|0|||
94353326|NCT01362062|323075034|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
94353327|NCT01362062|323075035|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
94353328|NCT01362062|323075034|FG000|Overall Study|Had significant improvement|9|||
94353329|NCT01362062|323075035|FG001|Overall Study|Had significant improvement|0|||
94353330|NCT00157157|323075037|FG000|Overall Study|Withdrawal by Subject|6|||
94353331|NCT00157157|323075037|FG000|Overall Study|Physician Decision|1|||
94353332|NCT00157157|323075037|FG000|Overall Study|Lost to Follow-up|1|||
94353333|NCT00157157|323075037|FG000|Overall Study|Enrolled in another study|1|||
94353334|NCT00157157|323075037|FG000|Overall Study|Met exclusion criteria|1|||
94353335|NCT00157157|323075037|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
94353336|NCT01503229|323077027|FG000|Overall Study|Withdrew consent|1|||
94353337|NCT03726320|323077028|FG000|Overall Study|Lost to Follow-up|2|||
94353338|NCT03726320|323077029|FG001|Overall Study|Lost to Follow-up|4|||
94353339|NCT03726320|323077030|FG002|Overall Study|Lost to Follow-up|0|||
94353340|NCT03726320|323077028|FG000|Overall Study|Time Constraints|4|||
94353341|NCT03726320|323077029|FG001|Overall Study|Time Constraints|1|||
94353342|NCT03726320|323077030|FG002|Overall Study|Time Constraints|0|||
94353343|NCT03726320|323077028|FG000|Overall Study|Ineligible after enrollment|3|||
94353344|NCT03726320|323077029|FG001|Overall Study|Ineligible after enrollment|3|||
94353345|NCT03726320|323077030|FG002|Overall Study|Ineligible after enrollment|0|||
94353346|NCT03726320|323077028|FG000|Overall Study|Clinic / insurance issue|2|||
94353347|NCT03726320|323077029|FG001|Overall Study|Clinic / insurance issue|0|||
94353348|NCT03726320|323077030|FG002|Overall Study|Clinic / insurance issue|0|||
94353349|NCT03726320|323077028|FG000|Overall Study|Language barrier|1|||
94584164|NCT02699749|323938434|FG005|Overall Study|Lost to Follow-up|1|||
94584165|NCT02699749|323938435|FG006|Overall Study|Lost to Follow-up|0|||
94584166|NCT02699749|323938436|FG007|Overall Study|Lost to Follow-up|1|||
94455569|NCT01435018|323456362|FG001|Overall Study|Site is closing|9|||
94455570|NCT01435018|323456363|FG002|Overall Study|Site is closing|7|||
94455571|NCT01435018|323456361|FG000|Overall Study|Withdrew consent|0|||
94455572|NCT01435018|323456362|FG001|Overall Study|Withdrew consent|3|||
94455573|NCT01435018|323456363|FG002|Overall Study|Withdrew consent|1|||
94455574|NCT01435018|323456361|FG000|Overall Study|Not willing to adhere to requirements|0|||
94455575|NCT01435018|323456362|FG001|Overall Study|Not willing to adhere to requirements|2|||
94455576|NCT01435018|323456363|FG002|Overall Study|Not willing to adhere to requirements|3|||
94455577|NCT01435018|323456361|FG000|Overall Study|Not able to get to clinic|2|||
94455578|NCT01435018|323456362|FG001|Overall Study|Not able to get to clinic|0|||
94241239|NCT00709228|322678263|FG000|Overall Study|Adverse events|2|||
94241240|NCT00709228|322678263|FG000|Overall Study|Discontinued treatment|14|||
94241241|NCT00709228|322678263|FG000|Overall Study|Did not enter follow-up|4|||
94241242|NCT00709228|322678263|FG000|Overall Study|Discontinued follow-up|5|||
94455579|NCT01435018|323456363|FG002|Overall Study|Not able to get to clinic|2|||
94455580|NCT01435018|323456361|FG000|Overall Study|Severe debilitation, unable to continue|0|||
94455581|NCT01435018|323456362|FG001|Overall Study|Severe debilitation, unable to continue|0|||
94455582|NCT01435018|323456363|FG002|Overall Study|Severe debilitation, unable to continue|1|||
94455583|NCT01435018|323456361|FG000|Overall Study|Unable to contact participant/parent|1|||
94455584|NCT01435018|323456362|FG001|Overall Study|Unable to contact participant/parent|1|||
94241243|NCT00709228|322678263|FG000|Overall Study|Disease progression|1|||
94241244|NCT00709228|322678263|FG000|Overall Study|Lost to Follow-up|6|||
94241245|NCT00709228|322678263|FG000|Overall Study|Non-compliance|5|||
94241246|NCT03853551|322678266|FG000|Overall Study|Death|2|||
94241247|NCT03853551|322678266|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
94241248|NCT02476175|322678267|FG000|Overall Study|Adverse Event|2|||
94241249|NCT01252355|322678268|FG000|Overall Study|Adverse Event|9|||
94241250|NCT01252355|322678269|FG001|Overall Study|Adverse Event|17|||
94241251|NCT01252355|322678270|FG002|Overall Study|Adverse Event|22|||
94241252|NCT01252355|322678268|FG000|Overall Study|Lack of Efficacy|6|||
94241253|NCT01252355|322678269|FG001|Overall Study|Lack of Efficacy|4|||
94241254|NCT01252355|322678270|FG002|Overall Study|Lack of Efficacy|2|||
94241255|NCT01252355|322678268|FG000|Overall Study|Lost to Follow-up|0|||
94241256|NCT01252355|322678269|FG001|Overall Study|Lost to Follow-up|0|||
94241257|NCT01252355|322678270|FG002|Overall Study|Lost to Follow-up|1|||
94241258|NCT01252355|322678268|FG000|Overall Study|Poor Compliance to Protocol|1|||
94241259|NCT01252355|322678269|FG001|Overall Study|Poor Compliance to Protocol|1|||
94241260|NCT01252355|322678270|FG002|Overall Study|Poor Compliance to Protocol|1|||
94241261|NCT01252355|322678268|FG000|Overall Study|Progressive Disease|2|||
94241262|NCT01252355|322678269|FG001|Overall Study|Progressive Disease|0|||
94241263|NCT01252355|322678270|FG002|Overall Study|Progressive Disease|0|||
94241264|NCT01252355|322678268|FG000|Overall Study|Sponsor Early Termination of Study|149|||
94241265|NCT01252355|322678269|FG001|Overall Study|Sponsor Early Termination of Study|149|||
94241266|NCT01252355|322678270|FG002|Overall Study|Sponsor Early Termination of Study|146|||
94241267|NCT01252355|322678268|FG000|Overall Study|Randomized but not Treated|2|||
94241268|NCT01252355|322678269|FG001|Overall Study|Randomized but not Treated|0|||
94241269|NCT01252355|322678270|FG002|Overall Study|Randomized but not Treated|0|||
94241270|NCT01252355|322678268|FG000|Overall Study|Other Than Above|8|||
94241271|NCT01252355|322678269|FG001|Overall Study|Other Than Above|7|||
94241272|NCT01252355|322678270|FG002|Overall Study|Other Than Above|7|||
94241273|NCT01016262|322678273|FG000|Double-blind Phase|Adverse Event|0|||
94241274|NCT01016262|322678274|FG001|Double-blind Phase|Adverse Event|0|||
94455585|NCT01435018|323456363|FG002|Overall Study|Unable to contact participant/parent|1|||
94241275|NCT01016262|322678275|FG002|Double-blind Phase|Adverse Event|1|||
94241276|NCT01016262|322678276|FG003|Double-blind Phase|Adverse Event|0|||
94455586|NCT01435018|323456361|FG000|Overall Study|Enrollment Violation|0|||
94241277|NCT01016262|322678277|FG004|Double-blind Phase|Adverse Event|0|||
94241278|NCT01016262|322678278|FG005|Double-blind Phase|Adverse Event|0|||
94241279|NCT01016262|322678273|FG000|Double-blind Phase|Lack of Efficacy|1|||
94241280|NCT01016262|322678274|FG001|Double-blind Phase|Lack of Efficacy|0|||
94241281|NCT01016262|322678275|FG002|Double-blind Phase|Lack of Efficacy|5|||
94241282|NCT01016262|322678276|FG003|Double-blind Phase|Lack of Efficacy|0|||
94241283|NCT01016262|322678277|FG004|Double-blind Phase|Lack of Efficacy|0|||
94455587|NCT01435018|323456362|FG001|Overall Study|Enrollment Violation|1|||
94455588|NCT01435018|323456363|FG002|Overall Study|Enrollment Violation|0|||
94241284|NCT01016262|322678278|FG005|Double-blind Phase|Lack of Efficacy|0|||
94241285|NCT01016262|322678273|FG000|Double-blind Phase|Disease Progression|0|||
94241286|NCT01016262|322678274|FG001|Double-blind Phase|Disease Progression|1|||
94241287|NCT01016262|322678275|FG002|Double-blind Phase|Disease Progression|2|||
94241288|NCT01016262|322678276|FG003|Double-blind Phase|Disease Progression|0|||
94241289|NCT01016262|322678277|FG004|Double-blind Phase|Disease Progression|0|||
94241290|NCT01016262|322678278|FG005|Double-blind Phase|Disease Progression|0|||
94241291|NCT01016262|322678273|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
94241292|NCT01016262|322678274|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
94241293|NCT01016262|322678275|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
94241294|NCT01016262|322678276|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
94241295|NCT01016262|322678277|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
94241296|NCT01016262|322678278|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
94241297|NCT01016262|322678273|FG000|Open-Label Phase|Adverse Event|0|||
94241298|NCT01016262|322678274|FG001|Open-Label Phase|Adverse Event|0|||
94241299|NCT01016262|322678275|FG002|Open-Label Phase|Adverse Event|0|||
94241300|NCT01016262|322678276|FG003|Open-Label Phase|Adverse Event|1|||
94241301|NCT01016262|322678277|FG004|Open-Label Phase|Adverse Event|0|||
94241302|NCT01016262|322678278|FG005|Open-Label Phase|Adverse Event|0|||
94241303|NCT01016262|322678273|FG000|Open-Label Phase|Lost to Follow-up|0|||
94241304|NCT01016262|322678274|FG001|Open-Label Phase|Lost to Follow-up|0|||
94241305|NCT01016262|322678275|FG002|Open-Label Phase|Lost to Follow-up|0|||
94241306|NCT01016262|322678276|FG003|Open-Label Phase|Lost to Follow-up|0|||
94241307|NCT01016262|322678277|FG004|Open-Label Phase|Lost to Follow-up|1|||
94241308|NCT01016262|322678278|FG005|Open-Label Phase|Lost to Follow-up|0|||
94241309|NCT01016262|322678273|FG000|Open-Label Phase|Lack of Efficacy|0|||
94241310|NCT01016262|322678274|FG001|Open-Label Phase|Lack of Efficacy|0|||
94241311|NCT01016262|322678275|FG002|Open-Label Phase|Lack of Efficacy|0|||
94241312|NCT01016262|322678276|FG003|Open-Label Phase|Lack of Efficacy|1|||
94241313|NCT01016262|322678277|FG004|Open-Label Phase|Lack of Efficacy|0|||
94241314|NCT01016262|322678278|FG005|Open-Label Phase|Lack of Efficacy|0|||
94241315|NCT01016262|322678273|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
94241316|NCT01016262|322678274|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
94241317|NCT01016262|322678275|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
94241318|NCT01016262|322678276|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
94241319|NCT01016262|322678277|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
94241320|NCT01016262|322678278|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
94241321|NCT00335140|322678281|FG000|Overall Study|Ineligible|1|||
94241322|NCT00667394|322678282|FG000|Overall Study|Adverse Event|3|||
94241323|NCT00667394|322678283|FG001|Overall Study|Adverse Event|0|||
94241324|NCT00667394|322678282|FG000|Overall Study|Progressive disease|1|||
94241325|NCT00667394|322678283|FG001|Overall Study|Progressive disease|0|||
94241326|NCT00332462|322678285|FG000|Overall Study|Adverse Event|5|||
94241327|NCT00332462|322678285|FG000|Overall Study|Abnormal Lab Value|1|||
94241328|NCT00332462|322678285|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
94241329|NCT00332462|322678285|FG000|Overall Study|no longer requires study drug|1|||
94241330|NCT00332462|322678285|FG000|Overall Study|Death|3|||
94241331|NCT00332462|322678285|FG000|Overall Study|Graft Loss|2|||
94241332|NCT01643044|322678286|FG000|Overall Study|Lost to Follow-up|1|||
94241333|NCT01643044|322678287|FG001|Overall Study|Lost to Follow-up|1|||
94241334|NCT01643044|322678286|FG000|Overall Study|Miscarried baby|2|||
94241335|NCT01643044|322678287|FG001|Overall Study|Miscarried baby|2|||
94241336|NCT01643044|322678286|FG000|Overall Study|Delivered outside of hospital|1|||
94241337|NCT01643044|322678287|FG001|Overall Study|Delivered outside of hospital|2|||
94241338|NCT01399697|322678288|FG000|Overall Study|Adverse Event|13|||
94241339|NCT01399697|322678289|FG001|Overall Study|Adverse Event|3|||
94455589|NCT01435018|323456361|FG000|Overall Study|Never started chemotherapy|3|||
94241340|NCT01399697|322678290|FG002|Overall Study|Adverse Event|1|||
94241341|NCT01399697|322678288|FG000|Overall Study|Lost to Follow-up|2|||
94584167|NCT02699749|323938437|FG008|Overall Study|Lost to Follow-up|0|||
94241342|NCT01399697|322678289|FG001|Overall Study|Lost to Follow-up|0|||
94241343|NCT01399697|322678290|FG002|Overall Study|Lost to Follow-up|0|||
94241344|NCT01399697|322678288|FG000|Overall Study|Withdrawal by Subject|8|||
94241345|NCT01399697|322678289|FG001|Overall Study|Withdrawal by Subject|0|||
94241346|NCT01399697|322678290|FG002|Overall Study|Withdrawal by Subject|0|||
94241347|NCT01399697|322678288|FG000|Overall Study|Investigator Decisión|1|||
94241348|NCT01399697|322678289|FG001|Overall Study|Investigator Decisión|0|||
94455590|NCT01435018|323456362|FG001|Overall Study|Never started chemotherapy|0|||
94584168|NCT02699749|323938438|FG009|Overall Study|Lost to Follow-up|0|||
94584169|NCT02699749|323938439|FG010|Overall Study|Lost to Follow-up|0|||
94584170|NCT02699749|323938440|FG011|Overall Study|Lost to Follow-up|0|||
94584171|NCT02699749|323938441|FG012|Overall Study|Lost to Follow-up|0|||
94241349|NCT01399697|322678290|FG002|Overall Study|Investigator Decisión|2|||
94241350|NCT01399697|322678288|FG000|Overall Study|Lack of Efficacy|9|||
94241351|NCT01399697|322678289|FG001|Overall Study|Lack of Efficacy|0|||
94241352|NCT01399697|322678290|FG002|Overall Study|Lack of Efficacy|1|||
94241353|NCT01399697|322678288|FG000|Overall Study|Protocol Violation|2|||
94241354|NCT01399697|322678289|FG001|Overall Study|Protocol Violation|0|||
94241355|NCT01399697|322678290|FG002|Overall Study|Protocol Violation|0|||
94241356|NCT01399697|322678288|FG000|Overall Study|Non-Compliant|1|||
94241357|NCT01399697|322678289|FG001|Overall Study|Non-Compliant|0|||
94241358|NCT01399697|322678290|FG002|Overall Study|Non-Compliant|0|||
94241359|NCT01399697|322678288|FG000|Overall Study|Inclusion Error|2|||
94241360|NCT01399697|322678289|FG001|Overall Study|Inclusion Error|0|||
94241361|NCT01399697|322678290|FG002|Overall Study|Inclusion Error|0|||
94241362|NCT01399697|322678288|FG000|Overall Study|Positive result for hepatitis B|1|||
94241363|NCT01399697|322678289|FG001|Overall Study|Positive result for hepatitis B|0|||
94241364|NCT01399697|322678290|FG002|Overall Study|Positive result for hepatitis B|0|||
94241365|NCT01399697|322678288|FG000|Overall Study|Clinical RA remission|1|||
94241366|NCT01399697|322678289|FG001|Overall Study|Clinical RA remission|0|||
94241367|NCT01399697|322678290|FG002|Overall Study|Clinical RA remission|0|||
94241368|NCT01399697|322678288|FG000|Overall Study|Sponsor Decision|1|||
94241369|NCT01399697|322678289|FG001|Overall Study|Sponsor Decision|0|||
94241370|NCT01399697|322678290|FG002|Overall Study|Sponsor Decision|0|||
94584172|NCT02699749|323938442|FG013|Overall Study|Lost to Follow-up|0|||
94584173|NCT02377817|323938443|FG000|Overall Study|Transportation/childcare barriers.|2|||
94584174|NCT02377817|323938444|FG001|Overall Study|Transportation/childcare barriers.|0|||
94241371|NCT01031628|322678293|FG000|Overall Study|Study terminated early|0|||
94241372|NCT01031628|322678294|FG001|Overall Study|Study terminated early|1|||
94241373|NCT01031628|322678295|FG002|Overall Study|Study terminated early|3|||
94241374|NCT01031628|322678296|FG003|Overall Study|Study terminated early|0|||
94584175|NCT02377817|323938443|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
94353350|NCT03726320|323077029|FG001|Overall Study|Language barrier|0|||
94353351|NCT03726320|323077030|FG002|Overall Study|Language barrier|0|||
94353352|NCT03726320|323077028|FG000|Overall Study|Provider left the clinic|0|||
94353353|NCT03726320|323077029|FG001|Overall Study|Provider left the clinic|0|||
94353354|NCT03726320|323077030|FG002|Overall Study|Provider left the clinic|1|||
94353355|NCT02028182|323077031|FG000|Overall Study|Protocol Violation|2|||
94353356|NCT00337935|323077032|FG000|Overall Study|Adverse Event|2|||
94353357|NCT00337935|323077033|FG001|Overall Study|Adverse Event|5|||
94353358|NCT00337935|323077032|FG000|Overall Study|Death|2|||
94353359|NCT00337935|323077033|FG001|Overall Study|Death|8|||
94353360|NCT00337935|323077032|FG000|Overall Study|Physician Decision|1|||
94353361|NCT00337935|323077033|FG001|Overall Study|Physician Decision|1|||
94353362|NCT00337935|323077032|FG000|Overall Study|Lost to Follow-up|0|||
94353363|NCT00337935|323077033|FG001|Overall Study|Lost to Follow-up|1|||
94659060|NCT01539291|324207961|FG000|Study GS-US-312-0117|Other|2|||
94241375|NCT00643617|322678297|FG000|Overall Study|Death|6|||
94241376|NCT00643617|322678298|FG001|Overall Study|Death|9|||
94241377|NCT00643617|322678297|FG000|Overall Study|Lost to Follow-up|42|||
94241378|NCT00643617|322678298|FG001|Overall Study|Lost to Follow-up|51|||
94353364|NCT00337935|323077032|FG000|Overall Study|Protocol Violation|4|||
94353365|NCT00337935|323077033|FG001|Overall Study|Protocol Violation|3|||
94353366|NCT00337935|323077032|FG000|Overall Study|Withdrawal by Subject|1|||
94241379|NCT01931098|322678299|FG000|Overall Study|Withdrawal by Subject|0|||
94241380|NCT01931098|322678300|FG001|Overall Study|Withdrawal by Subject|1|||
94241381|NCT01931098|322678299|FG000|Overall Study|Enrolled in different protocol|0|||
94241382|NCT01931098|322678300|FG001|Overall Study|Enrolled in different protocol|1|||
94241383|NCT01931098|322678299|FG000|Overall Study|Unable to begin trmt:active infection|0|||
94241384|NCT01931098|322678300|FG001|Overall Study|Unable to begin trmt:active infection|1|||
94241385|NCT01931098|322678299|FG000|Overall Study|Refused further treatment|0|||
94241386|NCT01931098|322678300|FG001|Overall Study|Refused further treatment|1|||
94241387|NCT01712061|322678301|FG000|Overall Study|Adverse Event|4|||
94241388|NCT01712061|322678302|FG001|Overall Study|Adverse Event|9|||
94241389|NCT01712061|322678303|FG002|Overall Study|Adverse Event|5|||
94241390|NCT01712061|322678301|FG000|Overall Study|Death|0|||
94241391|NCT01712061|322678302|FG001|Overall Study|Death|0|||
94241392|NCT01712061|322678303|FG002|Overall Study|Death|1|||
94241393|NCT01712061|322678301|FG000|Overall Study|Lost to Follow-up|1|||
94241394|NCT01712061|322678302|FG001|Overall Study|Lost to Follow-up|0|||
94241395|NCT01712061|322678303|FG002|Overall Study|Lost to Follow-up|1|||
94241396|NCT01712061|322678301|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
94241397|NCT01712061|322678302|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
94241398|NCT01712061|322678303|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
94241399|NCT01712061|322678301|FG000|Overall Study|Medication Error Without Associated AE|0|||
94241400|NCT01712061|322678302|FG001|Overall Study|Medication Error Without Associated AE|1|||
94241401|NCT01712061|322678303|FG002|Overall Study|Medication Error Without Associated AE|0|||
94241402|NCT01712061|322678301|FG000|Overall Study|Withdrawal by Subject|1|||
94241403|NCT01712061|322678302|FG001|Overall Study|Withdrawal by Subject|7|||
94241404|NCT01712061|322678303|FG002|Overall Study|Withdrawal by Subject|1|||
94241405|NCT01712061|322678301|FG000|Overall Study|Other|0|||
94241406|NCT01712061|322678302|FG001|Overall Study|Other|3|||
94241407|NCT01712061|322678303|FG002|Overall Study|Other|0|||
94241408|NCT02797080|322678304|FG000|Overall Study|Lost to Follow-up|1|||
94241409|NCT02797080|322678304|FG000|Overall Study|Withdrawal by Subject|1|||
94241410|NCT01417104|322678309|FG000|Overall Study|Withdrawal by Subject|5|||
94241411|NCT01417104|322678310|FG001|Overall Study|Withdrawal by Subject|1|||
94241412|NCT01417104|322678309|FG000|Overall Study|Failure to make contact|0|||
94241413|NCT01417104|322678310|FG001|Overall Study|Failure to make contact|1|||
94241414|NCT01417104|322678309|FG000|Overall Study|Adverse Event|1|||
94241415|NCT01417104|322678310|FG001|Overall Study|Adverse Event|0|||
94241416|NCT02440425|322678313|FG000|Overall Study|Death likely due to disease progression|1|||
94241417|NCT02440425|322678313|FG000|Overall Study|Withdrawal by Subject|2|||
94241418|NCT02440425|322678313|FG000|Overall Study|Adverse Event|1|||
94241419|NCT02440425|322678313|FG000|Overall Study|Adverse Event/Ineligible|1|||
94241420|NCT02920970|322678318|FG000|First Intervention|Protocol Violation|0|||
94241421|NCT02920970|322678319|FG001|First Intervention|Protocol Violation|1|||
94241422|NCT02920970|322678318|FG000|First Intervention|Adverse Event|0|||
94241423|NCT02920970|322678319|FG001|First Intervention|Adverse Event|1|||
94241424|NCT02920970|322678318|FG000|Second Intervention|Poor Lens Fit|1|||
94241425|NCT02920970|322678319|FG001|Second Intervention|Poor Lens Fit|0|||
94241426|NCT01374568|322678321|FG000|Overall Study|Lab unable to analyze BTM|0|||
94241427|NCT01374568|322678322|FG001|Overall Study|Lab unable to analyze BTM|2|||
94241428|NCT00368927|322678323|FG000|Overall Study|Lost to Follow-up|2|||
94241429|NCT00368927|322678324|FG001|Overall Study|Lost to Follow-up|0|||
94241430|NCT00368927|322678323|FG000|Overall Study|Adverse Event|1|||
94241431|NCT00368927|322678324|FG001|Overall Study|Adverse Event|1|||
94241432|NCT00368927|322678323|FG000|Overall Study|Withdrawal by Subject|1|||
94241433|NCT00368927|322678324|FG001|Overall Study|Withdrawal by Subject|2|||
94241434|NCT00368927|322678323|FG000|Overall Study|Physician Decision|1|||
94241435|NCT00368927|322678324|FG001|Overall Study|Physician Decision|0|||
94241436|NCT00818779|322678327|FG000|Overall Study|Protocol Violation|1|||
94241437|NCT00818779|322678328|FG001|Overall Study|Protocol Violation|0|||
94241438|NCT00818779|322678327|FG000|Overall Study|Lost to Follow-up|1|||
94241439|NCT00818779|322678328|FG001|Overall Study|Lost to Follow-up|0|||
94241440|NCT00818779|322678327|FG000|Overall Study|Adverse Event|4|||
94241441|NCT00818779|322678328|FG001|Overall Study|Adverse Event|1|||
94241442|NCT01989169|322678329|FG000|Period 2|Adverse Event|0|||
94241443|NCT01989169|322678330|FG001|Period 2|Adverse Event|1|||
94241444|NCT00594880|322678331|FG000|Overall Study|Withdrawal by Subject|1|||
94241445|NCT00594880|322678332|FG001|Overall Study|Withdrawal by Subject|1|||
94241446|NCT00594880|322678331|FG000|Overall Study|Lost to Follow-up|1|||
94241447|NCT00594880|322678332|FG001|Overall Study|Lost to Follow-up|0|||
94241448|NCT01413503|322678333|FG000|Overall Study|Lost to Follow-up|1|||
94241449|NCT01114880|322678334|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
94241450|NCT01114880|322678335|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
94241451|NCT01114880|322678334|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
94241452|NCT01114880|322678335|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
94241453|NCT01114880|322678334|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
94241454|NCT01114880|322678335|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
94659061|NCT01539291|324207962|FG001|Study GS-US-312-0117|Other|1|||
94241455|NCT01114880|322678334|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
94241456|NCT01114880|322678335|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
94241457|NCT01114880|322678334|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
94241458|NCT01114880|322678335|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
94241459|NCT01114880|322678334|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
94241460|NCT01114880|322678335|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
94241461|NCT02817906|322678336|FG000|Overall Study|Adverse Event|3|||
94241462|NCT02817906|322678337|FG001|Overall Study|Adverse Event|0|||
94241463|NCT02817906|322678336|FG000|Overall Study|Lack of Efficacy|1|||
94241464|NCT02817906|322678337|FG001|Overall Study|Lack of Efficacy|0|||
94241465|NCT02817906|322678336|FG000|Overall Study|Protocol Violation|1|||
94241466|NCT02817906|322678337|FG001|Overall Study|Protocol Violation|1|||
94241467|NCT02817906|322678336|FG000|Overall Study|Study Terminated by Sponsor|2|||
94241468|NCT02817906|322678337|FG001|Overall Study|Study Terminated by Sponsor|2|||
94241469|NCT02817906|322678336|FG000|Overall Study|Withdrawal by Subject|7|||
94241470|NCT02817906|322678337|FG001|Overall Study|Withdrawal by Subject|0|||
94241471|NCT02817906|322678336|FG000|Overall Study|Other|2|||
94241472|NCT02817906|322678337|FG001|Overall Study|Other|2|||
94241473|NCT03686423|322678339|FG000|Overall Study|Withdrawal by Subject|9|||
94241474|NCT03686423|322678339|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
94241475|NCT04608773|322678340|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
94241476|NCT04608773|322678341|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
94241477|NCT04608773|322678340|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
94241478|NCT04608773|322678341|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
94241479|NCT04608773|322678340|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
94241480|NCT04608773|322678341|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
94241481|NCT04608773|322678340|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
94241482|NCT04608773|322678341|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
94241483|NCT04608773|322678340|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
94241484|NCT04608773|322678341|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
94241485|NCT02833077|322678342|FG000|Overall Study|Adverse Event|1|||
94241486|NCT02833077|322678343|FG001|Overall Study|Adverse Event|2|||
94241487|NCT02833077|322678342|FG000|Overall Study|Lost to Follow-up|10|||
94241488|NCT02833077|322678343|FG001|Overall Study|Lost to Follow-up|1|||
94241489|NCT02833077|322678342|FG000|Overall Study|Personal Reasons|6|||
94241490|NCT02833077|322678343|FG001|Overall Study|Personal Reasons|4|||
94241491|NCT02833077|322678342|FG000|Overall Study|Protocol Deviation|0|||
94241492|NCT02833077|322678343|FG001|Overall Study|Protocol Deviation|1|||
94455591|NCT01435018|323456363|FG002|Overall Study|Never started chemotherapy|1|||
94455592|NCT02282631|323456367|FG000|Overall Study|Lost to Follow-up|2|||
94455593|NCT02282631|323456368|FG001|Overall Study|Lost to Follow-up|0|||
94455594|NCT05088603|323456371|FG000|Overall Study|Protocol Violation|6|||
94455595|NCT05088603|323456372|FG001|Overall Study|Protocol Violation|1|||
94455596|NCT03260244|323456373|FG000|Overall Study|Death|19|||
94455597|NCT03260244|323456373|FG000|Overall Study|Lost to Follow-up|60|||
94455598|NCT03260244|323456373|FG000|Overall Study|Withdrawal by Subject|48|||
94659062|NCT01539291|324207963|FG002|Study GS-US-312-0117|Other|1|||
94659063|NCT01539291|324207964|FG003|Study GS-US-312-0117|Other|1|||
94659064|NCT01076400|324207965|FG000|Overall Study|Adverse Event|2|||
94659065|NCT01076400|324207966|FG001|Overall Study|Adverse Event|0|||
94659066|NCT01076400|324207967|FG002|Overall Study|Adverse Event|0|||
94659067|NCT01076400|324207965|FG000|Overall Study|Progressive Disease|5|||
94455599|NCT03260244|323456373|FG000|Overall Study|Procedure Not Performed|21|||
94455600|NCT03260244|323456373|FG000|Overall Study|Enrollment Criteria Not Met|31|||
94455601|NCT03260244|323456373|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
94455602|NCT03260244|323456373|FG000|Overall Study|Subject Noncompliance|6|||
94659068|NCT01076400|324207966|FG001|Overall Study|Progressive Disease|0|||
94659069|NCT01076400|324207967|FG002|Overall Study|Progressive Disease|0|||
94659070|NCT03794089|324207975|FG000|Overall Study|Lost to Follow-up|4|||
94659071|NCT03794089|324207976|FG001|Overall Study|Lost to Follow-up|1|||
94659072|NCT03794089|324207975|FG000|Overall Study|Withdrawal by Subject|2|||
94241493|NCT00316017|322678350|FG000|Overall Study|Protocol Violation|11|||
94241494|NCT00316017|322678351|FG001|Overall Study|Protocol Violation|13|||
94241495|NCT00316017|322678352|FG002|Overall Study|Protocol Violation|19|||
94659073|NCT03794089|324207976|FG001|Overall Study|Withdrawal by Subject|0|||
94659074|NCT00566228|324207983|FG000|Overall Study|Withdrawal by Subject|1|||
94241496|NCT00384397|322678356|FG000|Overall Study|Adverse Event|0|||
94241497|NCT00384397|322678357|FG001|Overall Study|Adverse Event|1|||
94241498|NCT00384397|322678358|FG002|Overall Study|Adverse Event|2|||
94241499|NCT00384397|322678356|FG000|Overall Study|Protocol Violation|7|||
94455603|NCT03260244|323456373|FG000|Overall Study|No inducible Arrhythmia|2|||
94659075|NCT00566228|324207984|FG001|Overall Study|Withdrawal by Subject|0|||
94659076|NCT00566228|324207983|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
94241500|NCT00384397|322678357|FG001|Overall Study|Protocol Violation|15|||
94241501|NCT00384397|322678358|FG002|Overall Study|Protocol Violation|13|||
94241502|NCT00384397|322678356|FG000|Overall Study|Lost to Follow-up|11|||
94241503|NCT00384397|322678357|FG001|Overall Study|Lost to Follow-up|13|||
94241504|NCT00384397|322678358|FG002|Overall Study|Lost to Follow-up|3|||
94241505|NCT00384397|322678356|FG000|Overall Study|Withdrawal by Subject|14|||
94241506|NCT00384397|322678357|FG001|Overall Study|Withdrawal by Subject|17|||
94241507|NCT00384397|322678358|FG002|Overall Study|Withdrawal by Subject|15|||
94241508|NCT01825798|322678359|FG000|Overall Study|Adverse Event|1|||
94241509|NCT01825798|322678360|FG001|Overall Study|Adverse Event|5|||
94241510|NCT01825798|322678359|FG000|Overall Study|Lost to Follow-up|1|||
94241511|NCT01825798|322678360|FG001|Overall Study|Lost to Follow-up|0|||
94241512|NCT01214642|322678361|FG000|Overall Study|Progressive Disease|3|||
94241513|NCT01214642|322678362|FG001|Overall Study|Progressive Disease|2|||
94241514|NCT01214642|322678363|FG002|Overall Study|Progressive Disease|3|||
94241515|NCT01214642|322678364|FG003|Overall Study|Progressive Disease|5|||
94241516|NCT01214642|322678365|FG004|Overall Study|Progressive Disease|5|||
94241517|NCT01214642|322678366|FG005|Overall Study|Progressive Disease|3|||
94241518|NCT01214642|322678367|FG006|Overall Study|Progressive Disease|5|||
94241519|NCT01214642|322678368|FG007|Overall Study|Progressive Disease|3|||
94241520|NCT01214642|322678369|FG008|Overall Study|Progressive Disease|10|||
94241521|NCT01214642|322678370|FG009|Overall Study|Progressive Disease|2|||
94241522|NCT01214642|322678371|FG010|Overall Study|Progressive Disease|1|||
94241523|NCT01214642|322678372|FG011|Overall Study|Progressive Disease|4|||
94241524|NCT01214642|322678361|FG000|Overall Study|Adverse Event|0|||
94241525|NCT01214642|322678362|FG001|Overall Study|Adverse Event|1|||
94241526|NCT01214642|322678363|FG002|Overall Study|Adverse Event|0|||
94241527|NCT01214642|322678364|FG003|Overall Study|Adverse Event|0|||
94241528|NCT01214642|322678365|FG004|Overall Study|Adverse Event|0|||
94241529|NCT01214642|322678366|FG005|Overall Study|Adverse Event|0|||
94241530|NCT01214642|322678367|FG006|Overall Study|Adverse Event|1|||
94241531|NCT01214642|322678368|FG007|Overall Study|Adverse Event|0|||
94241532|NCT01214642|322678369|FG008|Overall Study|Adverse Event|0|||
94241533|NCT01214642|322678370|FG009|Overall Study|Adverse Event|1|||
94241534|NCT01214642|322678371|FG010|Overall Study|Adverse Event|1|||
94241535|NCT01214642|322678372|FG011|Overall Study|Adverse Event|0|||
94241536|NCT01214642|322678361|FG000|Overall Study|Death|0|||
94241537|NCT01214642|322678362|FG001|Overall Study|Death|0|||
94241538|NCT01214642|322678363|FG002|Overall Study|Death|1|||
94241539|NCT01214642|322678364|FG003|Overall Study|Death|0|||
94241540|NCT01214642|322678365|FG004|Overall Study|Death|0|||
94241541|NCT01214642|322678366|FG005|Overall Study|Death|0|||
94241542|NCT01214642|322678367|FG006|Overall Study|Death|0|||
94241543|NCT01214642|322678368|FG007|Overall Study|Death|0|||
94241544|NCT01214642|322678369|FG008|Overall Study|Death|0|||
94241545|NCT01214642|322678370|FG009|Overall Study|Death|0|||
94241546|NCT01214642|322678371|FG010|Overall Study|Death|1|||
94241547|NCT01214642|322678372|FG011|Overall Study|Death|0|||
94241548|NCT01214642|322678361|FG000|Overall Study|Withdrawal by Subject|0|||
94241549|NCT01214642|322678362|FG001|Overall Study|Withdrawal by Subject|0|||
94241550|NCT01214642|322678363|FG002|Overall Study|Withdrawal by Subject|1|||
94241551|NCT01214642|322678364|FG003|Overall Study|Withdrawal by Subject|0|||
94241552|NCT01214642|322678365|FG004|Overall Study|Withdrawal by Subject|0|||
94241553|NCT01214642|322678366|FG005|Overall Study|Withdrawal by Subject|0|||
94241554|NCT01214642|322678367|FG006|Overall Study|Withdrawal by Subject|0|||
94241555|NCT01214642|322678368|FG007|Overall Study|Withdrawal by Subject|0|||
94241556|NCT01214642|322678369|FG008|Overall Study|Withdrawal by Subject|3|||
94241557|NCT01214642|322678370|FG009|Overall Study|Withdrawal by Subject|1|||
94241558|NCT01214642|322678371|FG010|Overall Study|Withdrawal by Subject|1|||
94241559|NCT01214642|322678372|FG011|Overall Study|Withdrawal by Subject|0|||
94241560|NCT01214642|322678361|FG000|Overall Study|Physician Decision|0|||
94241561|NCT01214642|322678362|FG001|Overall Study|Physician Decision|0|||
94241562|NCT01214642|322678363|FG002|Overall Study|Physician Decision|1|||
94241563|NCT01214642|322678364|FG003|Overall Study|Physician Decision|1|||
94241564|NCT01214642|322678365|FG004|Overall Study|Physician Decision|1|||
94241565|NCT01214642|322678366|FG005|Overall Study|Physician Decision|0|||
94241566|NCT01214642|322678367|FG006|Overall Study|Physician Decision|0|||
94241567|NCT01214642|322678368|FG007|Overall Study|Physician Decision|0|||
94455604|NCT03260244|323456373|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
94241568|NCT01214642|322678369|FG008|Overall Study|Physician Decision|0|||
94455605|NCT03260244|323456373|FG000|Overall Study|Screen Failure|2|||
94455606|NCT03260244|323456373|FG000|Overall Study|Treated Off Label|69|||
94455607|NCT03260244|323456373|FG000|Overall Study|No Radiofrequency Ablation|14|||
94455608|NCT01177293|323456374|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
94241569|NCT01214642|322678370|FG009|Overall Study|Physician Decision|0|||
94241570|NCT01214642|322678371|FG010|Overall Study|Physician Decision|0|||
94241571|NCT01214642|322678372|FG011|Overall Study|Physician Decision|2|||
94241572|NCT02592876|322678377|FG000|Overall Study|Withdrawal by Subject|3|||
94241573|NCT02592876|322678378|FG001|Overall Study|Withdrawal by Subject|3|||
94241574|NCT02592876|322678377|FG000|Overall Study|Study Termination by Sponsor|32|||
94241575|NCT02592876|322678378|FG001|Overall Study|Study Termination by Sponsor|27|||
94241576|NCT02592876|322678377|FG000|Overall Study|Lost to Follow-up|0|||
94241577|NCT02592876|322678378|FG001|Overall Study|Lost to Follow-up|1|||
94241578|NCT02592876|322678377|FG000|Overall Study|Death|6|||
94241579|NCT02592876|322678378|FG001|Overall Study|Death|9|||
94241580|NCT02218606|322680270|FG000|Overall Study|Adverse Event|1|||
94241581|NCT02218606|322680271|FG001|Overall Study|Adverse Event|1|||
94241582|NCT02218606|322680270|FG000|Overall Study|Death|15|||
94241583|NCT02218606|322680271|FG001|Overall Study|Death|28|||
94455609|NCT01177293|323456375|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
94455610|NCT03528369|323456379|FG000|Overall Study|Withdrawal by Subject|2|||
94584176|NCT02377817|323938444|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
94241584|NCT02218606|322680270|FG000|Overall Study|Physician Decision|0|||
94584177|NCT03895840|323938445|FG000|Overall Study|Withdrawal by Subject|21|||
94584178|NCT02565108|323938446|FG000|Overall Study|Adverse Event|1|||
94584179|NCT02565108|323938447|FG001|Overall Study|Adverse Event|0|||
94584180|NCT02565108|323938446|FG000|Overall Study|Withdrew Consent|1|||
94584181|NCT02565108|323938447|FG001|Overall Study|Withdrew Consent|0|||
94241585|NCT02218606|322680271|FG001|Overall Study|Physician Decision|1|||
94241586|NCT02218606|322680270|FG000|Overall Study|Withdrawal by Subject|4|||
94353367|NCT00337935|323077033|FG001|Overall Study|Withdrawal by Subject|7|||
94353368|NCT00337935|323077032|FG000|Overall Study|Other|0|||
94353369|NCT00337935|323077033|FG001|Overall Study|Other|1|||
94353370|NCT00337935|323077032|FG000|Overall Study|Lack of Efficacy|0|||
94455611|NCT03528369|323456380|FG001|Overall Study|Withdrawal by Subject|0|||
94455612|NCT03528369|323456381|FG002|Overall Study|Withdrawal by Subject|0|||
94455613|NCT03528369|323456379|FG000|Overall Study|Lost to Follow-up|1|||
94455614|NCT03528369|323456380|FG001|Overall Study|Lost to Follow-up|0|||
94455615|NCT03528369|323456381|FG002|Overall Study|Lost to Follow-up|0|||
94455616|NCT03528369|323456379|FG000|Overall Study|Adverse Event|0|||
94455617|NCT03528369|323456380|FG001|Overall Study|Adverse Event|1|||
94455618|NCT03528369|323456381|FG002|Overall Study|Adverse Event|0|||
94455619|NCT02752165|323456382|FG000|Overall Study|Withdrawal by Subject|6|||
94455620|NCT02752165|323456383|FG001|Overall Study|Withdrawal by Subject|6|||
94455621|NCT02752165|323456382|FG000|Overall Study|Protocol Violation|6|||
94455622|NCT02752165|323456383|FG001|Overall Study|Protocol Violation|5|||
94455623|NCT02752165|323456382|FG000|Overall Study|Lost to Follow-up|33|||
94455624|NCT02752165|323456383|FG001|Overall Study|Lost to Follow-up|38|||
94455625|NCT00394836|323456384|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
94455626|NCT00394836|323456385|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
94455627|NCT00394836|323456384|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
94241587|NCT02218606|322680271|FG001|Overall Study|Withdrawal by Subject|0|||
94241588|NCT02218606|322680270|FG000|Overall Study|Noncompliance|1|||
94241589|NCT02218606|322680271|FG001|Overall Study|Noncompliance|0|||
94455628|NCT00394836|323456385|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
94455629|NCT00394836|323456384|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
94455630|NCT00394836|323456385|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
94455631|NCT00394836|323456384|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
94455632|NCT00394836|323456385|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
94455633|NCT00394836|323456384|FG000|Teatment or Follow-up Phase|Death|0|||
94241590|NCT02218606|322680270|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
94241591|NCT02218606|322680271|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
94241592|NCT02218606|322680270|FG000|Overall Study|Other|2|||
94241593|NCT02218606|322680271|FG001|Overall Study|Other|1|||
94241594|NCT02218606|322680270|FG000|Overall Study|Never started treatment|0|||
94241595|NCT02218606|322680271|FG001|Overall Study|Never started treatment|1|||
94241596|NCT03203473|322680272|FG000|Induction Phase|Never started primary treatment|2|||
94241597|NCT03203473|322680273|FG001|Induction Phase|Never started primary treatment|0|||
94241598|NCT03203473|322680274|FG002|Induction Phase|Never started primary treatment|0|||
94241599|NCT03203473|322680272|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
94241600|NCT03203473|322680273|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
94241601|NCT03203473|322680274|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
94241602|NCT03203473|322680272|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
94241603|NCT03203473|322680273|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
94241604|NCT03203473|322680274|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
94241605|NCT03203473|322680272|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
94241606|NCT03203473|322680273|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
94241607|NCT03203473|322680274|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
94353371|NCT00337935|323077033|FG001|Overall Study|Lack of Efficacy|1|||
94353372|NCT01884675|323077034|FG000|Overall Study|Study closed/terminated|3|||
94353373|NCT01884675|323077035|FG001|Overall Study|Study closed/terminated|2|||
94353374|NCT04563845|323077036|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
94353375|NCT04563845|323077037|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
94353376|NCT04563845|323077038|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
94353377|NCT04563845|323077039|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
94353378|NCT04563845|323077040|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
94353379|NCT04563845|323077041|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
94353380|NCT04563845|323077042|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
94353381|NCT04563845|323077043|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
94353382|NCT04563845|323077044|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
94353383|NCT04563845|323077045|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
94353384|NCT04563845|323077046|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
94353385|NCT04563845|323077047|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
94353386|NCT04563845|323077048|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
94353387|NCT04563845|323077049|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
94353388|NCT04563845|323077036|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
94353389|NCT04563845|323077037|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
94353390|NCT04563845|323077038|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
94353391|NCT04563845|323077039|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
94455634|NCT00394836|323456385|FG001|Teatment or Follow-up Phase|Death|1|||
94455635|NCT00394836|323456384|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
94241608|NCT03203473|322680272|FG000|Arm Allocation Phase|started salvage therapy|0|||
94241609|NCT03203473|322680273|FG001|Arm Allocation Phase|started salvage therapy|5|||
94455636|NCT00394836|323456385|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
94455637|NCT00394836|323456384|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
94455638|NCT00394836|323456385|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
94455639|NCT00394836|323456384|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
94455640|NCT00394836|323456385|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
94455641|NCT00394836|323456384|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
94455642|NCT00394836|323456385|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
94455643|NCT00394836|323456384|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
94455644|NCT00394836|323456385|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
94455645|NCT00394836|323456384|FG000|Teatment or Follow-up Phase|Non compliance|0|||
94455646|NCT00394836|323456385|FG001|Teatment or Follow-up Phase|Non compliance|1|||
94455647|NCT00394836|323456384|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
94455648|NCT00394836|323456385|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
94455649|NCT00394836|323456384|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
94455650|NCT00394836|323456385|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
94455651|NCT00394836|323456384|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
94455652|NCT00394836|323456385|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
94455653|NCT00394836|323456384|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
94455654|NCT00394836|323456385|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
94455655|NCT01424514|323456386|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
94455656|NCT01424514|323456387|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
94455657|NCT01424514|323456386|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
94455658|NCT01424514|323456387|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
94455659|NCT02653170|323456388|FG000|Overall Study|Withdrawal by Subject|3|||
94455660|NCT02653170|323456389|FG001|Overall Study|Withdrawal by Subject|8|||
94455661|NCT02653170|323456390|FG002|Overall Study|Withdrawal by Subject|3|||
94455662|NCT02653170|323456388|FG000|Overall Study|withdrawn by study team|2|||
94455663|NCT02653170|323456389|FG001|Overall Study|withdrawn by study team|4|||
94455664|NCT02653170|323456390|FG002|Overall Study|withdrawn by study team|5|||
94455665|NCT02653170|323456388|FG000|Overall Study|Lost to Follow-up|12|||
94455666|NCT02653170|323456389|FG001|Overall Study|Lost to Follow-up|4|||
94455667|NCT02653170|323456390|FG002|Overall Study|Lost to Follow-up|10|||
94455668|NCT01942486|323456397|FG000|Overall Study|Lost to Follow-up|27|||
94455669|NCT04429555|323456398|FG000|Overall Study|Death|0|||
94455670|NCT04429555|323456399|FG001|Overall Study|Death|2|||
94455671|NCT04429555|323456398|FG000|Overall Study|Other|2|||
94584182|NCT03614156|323938448|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
94584183|NCT03614156|323938449|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
94584184|NCT03614156|323938450|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
94584185|NCT03614156|323938451|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
94584186|NCT03614156|323938448|FG000|Open-Label Treatment Period|Adverse Event|7|||
94584187|NCT03614156|323938449|FG001|Open-Label Treatment Period|Adverse Event|0|||
94584188|NCT03614156|323938450|FG002|Open-Label Treatment Period|Adverse Event|0|||
94584189|NCT03614156|323938451|FG003|Open-Label Treatment Period|Adverse Event|0|||
94584190|NCT03614156|323938448|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
94584191|NCT03614156|323938449|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
94584192|NCT03614156|323938450|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
94584193|NCT03614156|323938451|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
94584194|NCT03614156|323938448|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
94584195|NCT03614156|323938449|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
94584196|NCT03614156|323938450|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
94584197|NCT03614156|323938451|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
94584198|NCT03614156|323938448|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
94584199|NCT03614156|323938449|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
94584200|NCT03614156|323938450|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
94584201|NCT03614156|323938451|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
94584202|NCT03614156|323938448|FG000|Open-Label Treatment Period|Protocol Violation|2|||
94584203|NCT03614156|323938449|FG001|Open-Label Treatment Period|Protocol Violation|0|||
94584204|NCT03614156|323938450|FG002|Open-Label Treatment Period|Protocol Violation|0|||
94584205|NCT03614156|323938451|FG003|Open-Label Treatment Period|Protocol Violation|0|||
94584206|NCT03614156|323938448|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
94584207|NCT03614156|323938449|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
94584208|NCT03614156|323938450|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
94584209|NCT03614156|323938451|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
94455672|NCT04429555|323456399|FG001|Overall Study|Other|0|||
94659077|NCT00566228|324207984|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
94455673|NCT04470544|323456400|FG000|Overall Study|Withdrawal by Subject|4|||
94455674|NCT04470544|323456401|FG001|Overall Study|Withdrawal by Subject|6|||
94455675|NCT02042950|323456402|FG000|Overall Study|Progressive Disease|4|||
94455676|NCT05217641|323456405|FG000|Overall Study|Lost to Follow-up|1|||
94584210|NCT03614156|323938448|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
94584211|NCT03614156|323938449|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
94584212|NCT03614156|323938450|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
94584213|NCT03614156|323938451|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
94584214|NCT03614156|323938448|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
94584215|NCT03614156|323938449|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
94353392|NCT04563845|323077040|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
94353393|NCT04563845|323077041|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
94584216|NCT03614156|323938450|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
94584217|NCT03614156|323938451|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
94584218|NCT03614156|323938448|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
94584219|NCT03614156|323938449|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
94584220|NCT03614156|323938450|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
94584221|NCT03614156|323938451|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
94584222|NCT03614156|323938448|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
94584223|NCT03614156|323938449|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
94584224|NCT03614156|323938450|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
94584225|NCT03614156|323938451|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
94584226|NCT03614156|323938448|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
94584227|NCT03614156|323938449|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
94584228|NCT03614156|323938450|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
94584229|NCT03614156|323938451|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
94584230|NCT03614156|323938448|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
94584231|NCT03614156|323938449|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
94584232|NCT03614156|323938450|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
94584233|NCT03614156|323938451|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
94584234|NCT03614156|323938448|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
94584235|NCT03614156|323938449|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
94584236|NCT03614156|323938450|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
94353394|NCT04563845|323077042|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
94353395|NCT04563845|323077043|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
94353396|NCT04563845|323077044|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
94353397|NCT04563845|323077045|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
94353398|NCT04563845|323077046|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
94353399|NCT04563845|323077047|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
94353400|NCT04563845|323077048|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
94353401|NCT04563845|323077049|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
94353402|NCT01801475|323077050|FG000|Overall Study|Withdrawal by Subject|0|||
94353403|NCT01801475|323077051|FG001|Overall Study|Withdrawal by Subject|0|||
94353404|NCT01801475|323077052|FG002|Overall Study|Withdrawal by Subject|0|||
94353405|NCT01801475|323077053|FG003|Overall Study|Withdrawal by Subject|0|||
94353406|NCT01801475|323077054|FG004|Overall Study|Withdrawal by Subject|1|||
94353407|NCT05056311|323077055|FG000|Overall Study|Lost to Follow-up|14|||
94353408|NCT05056311|323077055|FG000|Overall Study|Withdrawal by Subject|1|||
94353409|NCT05056311|323077055|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
94353410|NCT02985541|323077057|FG000|Overall Study|Withdrawal by Subject|33|||
94353411|NCT02985541|323077057|FG000|Overall Study|Lost to Follow-up|26|||
94353412|NCT02985541|323077057|FG000|Overall Study|Adverse Event|27|||
94353413|NCT02985541|323077057|FG000|Overall Study|Physician Decision|2|||
94353414|NCT02985541|323077057|FG000|Overall Study|Pregnancy|2|||
94353415|NCT02985541|323077057|FG000|Overall Study|Wish for pregnancy|44|||
94353416|NCT02985541|323077057|FG000|Overall Study|Other reason|5|||
94584237|NCT03614156|323938451|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
94584238|NCT03614156|323938448|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
94584239|NCT03614156|323938449|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
94584240|NCT03614156|323938450|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
94584241|NCT03614156|323938451|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
94584242|NCT03614156|323938448|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
94584243|NCT03614156|323938449|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
94584244|NCT03614156|323938450|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
94584245|NCT03614156|323938451|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
94584246|NCT03614156|323938448|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
94584247|NCT03614156|323938449|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
94584248|NCT03614156|323938450|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
94584249|NCT03614156|323938451|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
94584250|NCT01310075|323938452|FG000|Overall Study|Lost to Follow-up|1|||
94584251|NCT01310075|323938453|FG001|Overall Study|Lost to Follow-up|0|||
94584252|NCT01310075|323938452|FG000|Overall Study|Physician Decision|10|||
94584253|NCT01310075|323938453|FG001|Overall Study|Physician Decision|7|||
94584254|NCT01310075|323938452|FG000|Overall Study|Protocol Violation|2|||
94584255|NCT01310075|323938453|FG001|Overall Study|Protocol Violation|2|||
94584256|NCT01310075|323938452|FG000|Overall Study|Withdrawal by Subject|1|||
94584257|NCT01310075|323938453|FG001|Overall Study|Withdrawal by Subject|1|||
94584258|NCT02395081|323938455|FG000|Overall Study|Withdrawal by Subject|1|||
94584259|NCT02395081|323938456|FG001|Overall Study|Withdrawal by Subject|1|||
94584260|NCT02395081|323938457|FG002|Overall Study|Withdrawal by Subject|0|||
94584261|NCT02395081|323938455|FG000|Overall Study|Moved where blood couldn't be collected|4|||
94584262|NCT02395081|323938456|FG001|Overall Study|Moved where blood couldn't be collected|1|||
94584263|NCT02395081|323938457|FG002|Overall Study|Moved where blood couldn't be collected|3|||
94584264|NCT02395081|323938455|FG000|Overall Study|Fetal Loss|2|||
94584265|NCT02395081|323938456|FG001|Overall Study|Fetal Loss|3|||
94241610|NCT03203473|322680274|FG002|Arm Allocation Phase|started salvage therapy|0|||
94241611|NCT03203473|322680272|FG000|Arm Allocation Phase|Disease progression|0|||
94241612|NCT03203473|322680273|FG001|Arm Allocation Phase|Disease progression|0|||
94241613|NCT03203473|322680274|FG002|Arm Allocation Phase|Disease progression|37|||
94241614|NCT03203473|322680272|FG000|Arm Allocation Phase|Adverse Event|0|||
94241615|NCT03203473|322680273|FG001|Arm Allocation Phase|Adverse Event|0|||
94241616|NCT03203473|322680274|FG002|Arm Allocation Phase|Adverse Event|11|||
94241617|NCT03203473|322680272|FG000|Arm Allocation Phase|Physician Decision|0|||
94241618|NCT03203473|322680273|FG001|Arm Allocation Phase|Physician Decision|0|||
94241619|NCT03203473|322680274|FG002|Arm Allocation Phase|Physician Decision|3|||
94241620|NCT03203473|322680272|FG000|Arm Allocation Phase|Death|0|||
94241621|NCT03203473|322680273|FG001|Arm Allocation Phase|Death|0|||
94241622|NCT03203473|322680274|FG002|Arm Allocation Phase|Death|1|||
94241623|NCT03203473|322680272|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
94241624|NCT03203473|322680273|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
94241625|NCT03203473|322680274|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
94241626|NCT03203473|322680272|FG000|Arm Allocation Phase|Intercurrent illness|0|||
94241627|NCT03203473|322680273|FG001|Arm Allocation Phase|Intercurrent illness|0|||
94241628|NCT03203473|322680274|FG002|Arm Allocation Phase|Intercurrent illness|1|||
94241629|NCT03203473|322680272|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
94241630|NCT03203473|322680273|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
94241631|NCT03203473|322680274|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
94241632|NCT02550938|322680275|FG000|Overall Study|Lost to Follow-up|8|||
94241633|NCT02550938|322680276|FG001|Overall Study|Lost to Follow-up|7|||
94241634|NCT02550938|322680277|FG002|Overall Study|Lost to Follow-up|12|||
94241635|NCT02550938|322680278|FG003|Overall Study|Lost to Follow-up|11|||
94241636|NCT01251770|322680279|FG000|Overall Study|Protocol Violation|13|||
94241637|NCT01251770|322680280|FG001|Overall Study|Protocol Violation|7|||
94241638|NCT03554629|322680281|FG000|Overall Study|Inadequate data|6|||
94241639|NCT00918879|322680292|FG000|Overall Study|Withdrawal by Subject|4|||
94241640|NCT00918879|322680293|FG001|Overall Study|Withdrawal by Subject|4|||
94241641|NCT00918879|322680292|FG000|Overall Study|Lost to Follow-up|1|||
94241642|NCT00918879|322680293|FG001|Overall Study|Lost to Follow-up|1|||
94241643|NCT00918879|322680292|FG000|Overall Study|Severe non-compliance to protocol|1|||
94241644|NCT00918879|322680293|FG001|Overall Study|Severe non-compliance to protocol|1|||
94241645|NCT01020877|322680299|FG000|Second Intervention|Withdrawal by Subject|1|||
94241646|NCT01020877|322680300|FG001|Second Intervention|Withdrawal by Subject|0|||
94241647|NCT01182441|322680307|FG000|Overall Study|Patient Still in Follow-up|152|||
94241648|NCT01182441|322680308|FG001|Overall Study|Patient Still in Follow-up|72|||
94241649|NCT01182441|322680307|FG000|Overall Study|Death|37|||
94241650|NCT01182441|322680308|FG001|Overall Study|Death|25|||
94241651|NCT01182441|322680307|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
94241652|NCT01182441|322680308|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
94241653|NCT01182441|322680307|FG000|Overall Study|Lost to Follow-up|5|||
94241654|NCT01182441|322680308|FG001|Overall Study|Lost to Follow-up|8|||
94241655|NCT01182441|322680307|FG000|Overall Study|Withdrawal by Subject|6|||
94241656|NCT01182441|322680308|FG001|Overall Study|Withdrawal by Subject|13|||
94241657|NCT01182441|322680307|FG000|Overall Study|Implant Not Attempted|4|||
94241658|NCT01182441|322680308|FG001|Overall Study|Implant Not Attempted|0|||
94241659|NCT01182441|322680307|FG000|Overall Study|Adverse Event|2|||
94241660|NCT01182441|322680308|FG001|Overall Study|Adverse Event|0|||
94241661|NCT01182441|322680307|FG000|Overall Study|Physician Decision|1|||
94241662|NCT01182441|322680308|FG001|Overall Study|Physician Decision|1|||
94241663|NCT00515671|322680309|FG000|Overall Study|Lost to Follow-up|13|||
94241664|NCT00515671|322680310|FG001|Overall Study|Lost to Follow-up|10|||
94241665|NCT00515671|322680309|FG000|Overall Study|Withdrawal by Subject|3|||
94241666|NCT00515671|322680310|FG001|Overall Study|Withdrawal by Subject|5|||
94241667|NCT00515671|322680309|FG000|Overall Study|incarcerated|1|||
94241668|NCT00515671|322680310|FG001|Overall Study|incarcerated|2|||
94241669|NCT00603525|322680311|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
94241670|NCT00603525|322680312|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
94241671|NCT00603525|322680313|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
94353417|NCT02985541|323077057|FG000|Overall Study|Not valid for analysis|2|||
94353418|NCT02719028|323077061|FG000|Overall Study|Adverse Event|2|||
94353419|NCT02719028|323077062|FG001|Overall Study|Adverse Event|1|||
94241672|NCT00603525|322680311|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
94353420|NCT02719028|323077063|FG002|Overall Study|Adverse Event|4|||
94241673|NCT00603525|322680312|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
94241674|NCT00603525|322680313|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
94241675|NCT00603525|322680311|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
94241676|NCT00603525|322680312|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
94241677|NCT00603525|322680313|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
94241678|NCT00603525|322680311|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
94241679|NCT00603525|322680312|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
94241680|NCT00603525|322680313|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94353421|NCT02719028|323077064|FG003|Overall Study|Adverse Event|8|||
94241681|NCT00603525|322680311|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
94241682|NCT00603525|322680312|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
94241683|NCT00603525|322680313|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94241684|NCT00603525|322680311|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
94241685|NCT00603525|322680312|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
94241686|NCT00603525|322680313|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
94241687|NCT00603525|322680311|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
94241688|NCT00603525|322680312|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
94241689|NCT00603525|322680313|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
94241690|NCT00603525|322680311|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
94241691|NCT00603525|322680312|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
94241692|NCT00603525|322680313|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
94241693|NCT00603525|322680311|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
94241694|NCT00603525|322680312|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
94241695|NCT00603525|322680313|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
94241696|NCT00603525|322680311|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
94241697|NCT00603525|322680312|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
94241698|NCT00603525|322680313|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
94241699|NCT00603525|322680311|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
94241700|NCT00603525|322680312|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
94241701|NCT00603525|322680313|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
94241702|NCT00603525|322680311|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
94241703|NCT00603525|322680312|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
94241704|NCT00603525|322680313|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
94241705|NCT00603525|322680311|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
94241706|NCT00603525|322680312|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
94241707|NCT00603525|322680313|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
94241708|NCT00603525|322680311|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
94241709|NCT00603525|322680312|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
94241710|NCT00603525|322680313|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
94241711|NCT00603525|322680311|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
94241712|NCT00603525|322680312|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
94241713|NCT00603525|322680313|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
94241714|NCT04043143|322680316|FG000|Overall Study|Lost to Follow-up|5|||
94241715|NCT04043143|322680317|FG001|Overall Study|Lost to Follow-up|5|||
94241716|NCT04043143|322680316|FG000|Overall Study|screen failure|1|||
94241717|NCT04043143|322680317|FG001|Overall Study|screen failure|0|||
94241718|NCT03480932|322680318|FG000|Overall Study|Death|1|||
94241719|NCT03480932|322680319|FG001|Overall Study|Death|1|||
94241720|NCT03480932|322680320|FG002|Overall Study|Death|0|||
94241721|NCT03480932|322680318|FG000|Overall Study|Lost to Follow-up|0|||
94241722|NCT03480932|322680319|FG001|Overall Study|Lost to Follow-up|2|||
94241723|NCT03480932|322680320|FG002|Overall Study|Lost to Follow-up|3|||
94241724|NCT03480932|322680318|FG000|Overall Study|Incarcerated|2|||
94241725|NCT03480932|322680319|FG001|Overall Study|Incarcerated|2|||
94241726|NCT03480932|322680320|FG002|Overall Study|Incarcerated|2|||
94241727|NCT01008553|322680321|FG000|Period 1 (Titration Period)|Physician Decision|2|||
94241728|NCT01008553|322680322|FG001|Period 1 (Titration Period)|Physician Decision|0|||
94241729|NCT01008553|322680323|FG002|Period 1 (Titration Period)|Physician Decision|0|||
94241730|NCT01008553|322680321|FG000|Period 1 (Titration Period)|Adverse Event|33|||
94241731|NCT01008553|322680322|FG001|Period 1 (Titration Period)|Adverse Event|0|||
94241732|NCT01008553|322680323|FG002|Period 1 (Titration Period)|Adverse Event|0|||
94241733|NCT01008553|322680321|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
94241734|NCT01008553|322680322|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
94241735|NCT01008553|322680323|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
94241736|NCT01008553|322680321|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
94241737|NCT01008553|322680322|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
94241738|NCT01008553|322680323|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
94241739|NCT01008553|322680321|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
94241740|NCT01008553|322680322|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
94241741|NCT01008553|322680323|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
94241742|NCT01008553|322680321|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
94241743|NCT01008553|322680322|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
94241744|NCT01008553|322680323|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
94241745|NCT01008553|322680321|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
94241746|NCT01008553|322680322|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
94241747|NCT01008553|322680323|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
94241748|NCT01008553|322680321|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
94241749|NCT01008553|322680322|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
94241750|NCT01008553|322680323|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
94241751|NCT01008553|322680321|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
94241752|NCT01008553|322680322|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
94241753|NCT01008553|322680323|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
94241754|NCT01008553|322680321|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
94241755|NCT01008553|322680322|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
94241756|NCT01008553|322680323|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
94241757|NCT01008553|322680321|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
94241758|NCT01008553|322680322|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
94455677|NCT05217641|323456406|FG001|Overall Study|Lost to Follow-up|1|||
94455678|NCT05217641|323456407|FG002|Overall Study|Lost to Follow-up|0|||
94455679|NCT05217641|323456408|FG003|Overall Study|Lost to Follow-up|1|||
94584266|NCT02395081|323938457|FG002|Overall Study|Fetal Loss|1|||
94584267|NCT02991040|323938459|FG000|Overall Study|Withdrawal by Subject|2|||
94241759|NCT01008553|322680323|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
94241760|NCT01008553|322680321|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
94241761|NCT01008553|322680322|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
94241762|NCT01008553|322680323|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
94241763|NCT01008553|322680321|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
94241764|NCT01008553|322680322|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
94241765|NCT01008553|322680323|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
94241766|NCT01008553|322680321|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
94241767|NCT01008553|322680322|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
94241768|NCT01008553|322680323|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
94241769|NCT01008410|322680324|FG000|Overall Study|Adverse Event|13|||
94241770|NCT01008410|322680325|FG001|Overall Study|Adverse Event|7|||
94241771|NCT01008410|322680324|FG000|Overall Study|Withdrawal by Subject|6|||
94241772|NCT01008410|322680325|FG001|Overall Study|Withdrawal by Subject|2|||
94241773|NCT01008410|322680324|FG000|Overall Study|Lost to Follow-up|1|||
94241774|NCT01008410|322680325|FG001|Overall Study|Lost to Follow-up|0|||
94241775|NCT01008410|322680324|FG000|Overall Study|Noncompliance|1|||
94241776|NCT01008410|322680325|FG001|Overall Study|Noncompliance|0|||
94241777|NCT01008410|322680324|FG000|Overall Study|Low Cortisol|2|||
94241778|NCT01008410|322680325|FG001|Overall Study|Low Cortisol|0|||
94241779|NCT01008410|322680324|FG000|Overall Study|Lack of Efficacy|2|||
94241780|NCT01008410|322680325|FG001|Overall Study|Lack of Efficacy|6|||
94241781|NCT01008410|322680324|FG000|Overall Study|Met Exclusion Criterion|0|||
94241782|NCT01008410|322680325|FG001|Overall Study|Met Exclusion Criterion|1|||
94241783|NCT01977677|322680329|FG000|Overall Study|Unrelated Adverse Event|0|||
94241784|NCT01977677|322680330|FG001|Overall Study|Unrelated Adverse Event|0|||
94241785|NCT01977677|322680331|FG002|Overall Study|Unrelated Adverse Event|1|||
94241786|NCT00667225|322680332|FG000|Overall Study|Subject had no more lesions to treat.|1|||
94241787|NCT00667225|322680333|FG001|Overall Study|Subject had no more lesions to treat.|0|||
94241788|NCT00667225|322680332|FG000|Overall Study|Lost to Follow-up|0|||
94241789|NCT00667225|322680333|FG001|Overall Study|Lost to Follow-up|1|||
94241790|NCT00953771|322680336|FG000|Overall Study|Death|1|||
94241791|NCT00953771|322680337|FG001|Overall Study|Death|0|||
94241792|NCT03330405|322680342|FG000|Overall Study|Other|1|||
94241793|NCT03330405|322680343|FG001|Overall Study|Other|3|||
94241794|NCT03330405|322680344|FG002|Overall Study|Other|1|||
94241795|NCT03330405|322680345|FG003|Overall Study|Other|0|||
94241796|NCT03330405|322680346|FG004|Overall Study|Other|2|||
94241797|NCT03330405|322680347|FG005|Overall Study|Other|0|||
94241798|NCT03330405|322680348|FG006|Overall Study|Other|1|||
94241799|NCT03330405|322680349|FG007|Overall Study|Other|0|||
94241800|NCT03330405|322680350|FG008|Overall Study|Other|0|||
94241801|NCT03330405|322680351|FG009|Overall Study|Other|0|||
94241802|NCT03330405|322680352|FG010|Overall Study|Other|0|||
94241803|NCT03330405|322680342|FG000|Overall Study|Progressive disease|8|||
94241804|NCT03330405|322680343|FG001|Overall Study|Progressive disease|27|||
94241805|NCT03330405|322680344|FG002|Overall Study|Progressive disease|4|||
94241806|NCT03330405|322680345|FG003|Overall Study|Progressive disease|18|||
94241807|NCT03330405|322680346|FG004|Overall Study|Progressive disease|16|||
94241808|NCT03330405|322680347|FG005|Overall Study|Progressive disease|14|||
94241809|NCT03330405|322680348|FG006|Overall Study|Progressive disease|7|||
94241810|NCT03330405|322680349|FG007|Overall Study|Progressive disease|29|||
94241811|NCT03330405|322680350|FG008|Overall Study|Progressive disease|9|||
94241812|NCT03330405|322680351|FG009|Overall Study|Progressive disease|11|||
94241813|NCT03330405|322680352|FG010|Overall Study|Progressive disease|5|||
94241814|NCT03330405|322680342|FG000|Overall Study|Withdrawal by Subject|1|||
94241815|NCT03330405|322680343|FG001|Overall Study|Withdrawal by Subject|4|||
94241816|NCT03330405|322680344|FG002|Overall Study|Withdrawal by Subject|0|||
94455680|NCT05217641|323456409|FG004|Overall Study|Lost to Follow-up|1|||
94241817|NCT03330405|322680345|FG003|Overall Study|Withdrawal by Subject|1|||
94241818|NCT03330405|322680346|FG004|Overall Study|Withdrawal by Subject|1|||
94241819|NCT03330405|322680347|FG005|Overall Study|Withdrawal by Subject|1|||
94241820|NCT03330405|322680348|FG006|Overall Study|Withdrawal by Subject|0|||
94241821|NCT03330405|322680349|FG007|Overall Study|Withdrawal by Subject|2|||
94241822|NCT03330405|322680350|FG008|Overall Study|Withdrawal by Subject|2|||
94241823|NCT03330405|322680351|FG009|Overall Study|Withdrawal by Subject|1|||
94241824|NCT03330405|322680352|FG010|Overall Study|Withdrawal by Subject|1|||
94241825|NCT03330405|322680342|FG000|Overall Study|Global deterioration of health status|2|||
94241826|NCT03330405|322680343|FG001|Overall Study|Global deterioration of health status|3|||
94241827|NCT03330405|322680344|FG002|Overall Study|Global deterioration of health status|0|||
94241828|NCT03330405|322680345|FG003|Overall Study|Global deterioration of health status|2|||
94241829|NCT03330405|322680346|FG004|Overall Study|Global deterioration of health status|3|||
94241830|NCT03330405|322680347|FG005|Overall Study|Global deterioration of health status|3|||
94241831|NCT03330405|322680348|FG006|Overall Study|Global deterioration of health status|0|||
94241832|NCT03330405|322680349|FG007|Overall Study|Global deterioration of health status|2|||
94241833|NCT03330405|322680350|FG008|Overall Study|Global deterioration of health status|8|||
94241834|NCT03330405|322680351|FG009|Overall Study|Global deterioration of health status|4|||
94241835|NCT03330405|322680352|FG010|Overall Study|Global deterioration of health status|1|||
94241836|NCT03330405|322680342|FG000|Overall Study|Adverse Event|0|||
94241837|NCT03330405|322680343|FG001|Overall Study|Adverse Event|1|||
94241838|NCT03330405|322680344|FG002|Overall Study|Adverse Event|0|||
94241839|NCT03330405|322680345|FG003|Overall Study|Adverse Event|1|||
94241840|NCT03330405|322680346|FG004|Overall Study|Adverse Event|1|||
94241841|NCT03330405|322680347|FG005|Overall Study|Adverse Event|1|||
94241842|NCT03330405|322680348|FG006|Overall Study|Adverse Event|3|||
94241843|NCT03330405|322680349|FG007|Overall Study|Adverse Event|4|||
94241844|NCT03330405|322680350|FG008|Overall Study|Adverse Event|2|||
94241845|NCT03330405|322680351|FG009|Overall Study|Adverse Event|2|||
94241846|NCT03330405|322680352|FG010|Overall Study|Adverse Event|2|||
94241847|NCT03330405|322680342|FG000|Overall Study|Death|0|||
94241848|NCT03330405|322680343|FG001|Overall Study|Death|4|||
94241849|NCT03330405|322680344|FG002|Overall Study|Death|0|||
94241850|NCT03330405|322680345|FG003|Overall Study|Death|0|||
94241851|NCT03330405|322680346|FG004|Overall Study|Death|0|||
94241852|NCT03330405|322680347|FG005|Overall Study|Death|1|||
94241853|NCT03330405|322680348|FG006|Overall Study|Death|0|||
94241854|NCT03330405|322680349|FG007|Overall Study|Death|2|||
94241855|NCT03330405|322680350|FG008|Overall Study|Death|0|||
94241856|NCT03330405|322680351|FG009|Overall Study|Death|0|||
94241857|NCT03330405|322680352|FG010|Overall Study|Death|0|||
94241858|NCT03330405|322680342|FG000|Overall Study|Physician Decision|0|||
94241859|NCT03330405|322680343|FG001|Overall Study|Physician Decision|0|||
94241860|NCT03330405|322680344|FG002|Overall Study|Physician Decision|0|||
94241861|NCT03330405|322680345|FG003|Overall Study|Physician Decision|0|||
94241862|NCT03330405|322680346|FG004|Overall Study|Physician Decision|0|||
94241863|NCT03330405|322680347|FG005|Overall Study|Physician Decision|0|||
94241864|NCT03330405|322680348|FG006|Overall Study|Physician Decision|0|||
94241865|NCT03330405|322680349|FG007|Overall Study|Physician Decision|1|||
94241866|NCT03330405|322680350|FG008|Overall Study|Physician Decision|0|||
94241867|NCT03330405|322680351|FG009|Overall Study|Physician Decision|0|||
94241868|NCT03330405|322680352|FG010|Overall Study|Physician Decision|0|||
94241869|NCT00789360|322680353|FG000|Overall Study|Protocol Violation|3|||
94241870|NCT00789360|322680354|FG001|Overall Study|Protocol Violation|1|||
94241871|NCT03139604|322680355|FG000|Overall Study|Other|7|||
94241872|NCT03139604|322680356|FG001|Overall Study|Other|3|||
94241873|NCT03139604|322680355|FG000|Overall Study|Withdrawal by Subject|16|||
94241874|NCT03139604|322680356|FG001|Overall Study|Withdrawal by Subject|17|||
94241875|NCT03139604|322680355|FG000|Overall Study|Physician Decision|1|||
94241876|NCT03139604|322680356|FG001|Overall Study|Physician Decision|2|||
94241877|NCT03139604|322680355|FG000|Overall Study|Lost to Follow-up|3|||
94455681|NCT05217641|323456410|FG005|Overall Study|Lost to Follow-up|0|||
94455682|NCT05217641|323456405|FG000|Overall Study|Withdrawal by Subject|0|||
94455683|NCT05217641|323456406|FG001|Overall Study|Withdrawal by Subject|0|||
94455684|NCT05217641|323456407|FG002|Overall Study|Withdrawal by Subject|0|||
94241878|NCT03139604|322680356|FG001|Overall Study|Lost to Follow-up|1|||
94241879|NCT03139604|322680355|FG000|Overall Study|Death|65|||
94241880|NCT03139604|322680356|FG001|Overall Study|Death|67|||
94455685|NCT05217641|323456408|FG003|Overall Study|Withdrawal by Subject|3|||
94241881|NCT03139604|322680355|FG000|Overall Study|Study Terminated by Sponsor|122|||
94241882|NCT03139604|322680356|FG001|Overall Study|Study Terminated by Sponsor|127|||
94241883|NCT03139604|322680355|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
94241884|NCT03139604|322680356|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
94241885|NCT00626197|322680359|FG000|Overall Study|Did not cooperate|2|||
94659078|NCT00566228|324207983|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
94241886|NCT00626197|322680360|FG001|Overall Study|Did not cooperate|6|||
94455686|NCT05217641|323456409|FG004|Overall Study|Withdrawal by Subject|1|||
94241887|NCT00626197|322680361|FG002|Overall Study|Did not cooperate|1|||
94241888|NCT00626197|322680359|FG000|Overall Study|Failure to return|6|||
94241889|NCT00626197|322680360|FG001|Overall Study|Failure to return|5|||
94241890|NCT00626197|322680361|FG002|Overall Study|Failure to return|6|||
94241891|NCT00626197|322680359|FG000|Overall Study|Adverse event, serious fatal|3|||
94241892|NCT00626197|322680360|FG001|Overall Study|Adverse event, serious fatal|6|||
94241893|NCT00626197|322680361|FG002|Overall Study|Adverse event, serious fatal|6|||
94241894|NCT00626197|322680359|FG000|Overall Study|Adverse Event|1|||
94241895|NCT00626197|322680360|FG001|Overall Study|Adverse Event|1|||
94241896|NCT00626197|322680361|FG002|Overall Study|Adverse Event|2|||
94241897|NCT00626197|322680359|FG000|Overall Study|Withdrawal by Subject|17|||
94241898|NCT00626197|322680360|FG001|Overall Study|Withdrawal by Subject|17|||
94241899|NCT00626197|322680361|FG002|Overall Study|Withdrawal by Subject|7|||
94241900|NCT00626197|322680359|FG000|Overall Study|Administrative reasons|15|||
94241901|NCT00626197|322680360|FG001|Overall Study|Administrative reasons|19|||
94241902|NCT00626197|322680361|FG002|Overall Study|Administrative reasons|55|||
94241903|NCT01757197|322680362|FG000|Overall Study|Death|2|||
94241904|NCT01736189|322680363|FG000|Overall Study|Violation of registration criteria|41|||
94241905|NCT01736189|322680363|FG000|Overall Study|Protocol Violation|4|||
94241906|NCT01736189|322680363|FG000|Overall Study|Criteria and protocol violations|1|||
94241907|NCT03338296|322680369|FG000|Overall Study|Adverse Event|0|||
94241908|NCT03338296|322680370|FG001|Overall Study|Adverse Event|1|||
94241909|NCT03338296|322680369|FG000|Overall Study|Withdrawal by Subject|14|||
94241910|NCT03338296|322680370|FG001|Overall Study|Withdrawal by Subject|13|||
94241911|NCT03338296|322680369|FG000|Overall Study|Lost to Follow-up|10|||
94241912|NCT03338296|322680370|FG001|Overall Study|Lost to Follow-up|10|||
94241913|NCT03338296|322680369|FG000|Overall Study|Study Terminated by Sponsor|77|||
94241914|NCT03338296|322680370|FG001|Overall Study|Study Terminated by Sponsor|76|||
94241915|NCT03338296|322680369|FG000|Overall Study|Other|2|||
94241916|NCT03338296|322680370|FG001|Overall Study|Other|7|||
94241917|NCT03338296|322680369|FG000|Overall Study|Missing|0|||
94241918|NCT03338296|322680370|FG001|Overall Study|Missing|1|||
94241919|NCT04076943|322680371|FG000|Overall Study|Withdrawal by Subject|12|||
94241920|NCT04076943|322680371|FG000|Overall Study|Adverse Event|1|||
94241921|NCT04076943|322680371|FG000|Overall Study|Progressive Disease|2|||
94241922|NCT04076943|322680371|FG000|Overall Study|Death|13|||
94241923|NCT04076943|322680371|FG000|Overall Study|Other than specified|6|||
94241924|NCT00863681|322680372|FG000|Overall Study|Other|2|||
94241925|NCT00863681|322680373|FG001|Overall Study|Other|0|||
94241926|NCT00863681|322680374|FG002|Overall Study|Other|0|||
94241927|NCT00863681|322680372|FG000|Overall Study|Missing|1|||
94241928|NCT00863681|322680373|FG001|Overall Study|Missing|0|||
94241929|NCT00863681|322680374|FG002|Overall Study|Missing|0|||
94241930|NCT00863681|322680372|FG000|Overall Study|Death|40|||
94241931|NCT00863681|322680373|FG001|Overall Study|Death|23|||
94241932|NCT00863681|322680374|FG002|Overall Study|Death|6|||
94241933|NCT00863681|322680372|FG000|Overall Study|Withdrawal by Subject|12|||
94241934|NCT00863681|322680373|FG001|Overall Study|Withdrawal by Subject|5|||
94241935|NCT00863681|322680374|FG002|Overall Study|Withdrawal by Subject|2|||
94241936|NCT00863681|322680372|FG000|Overall Study|Protocol Violation|2|||
94241937|NCT00863681|322680373|FG001|Overall Study|Protocol Violation|0|||
94241938|NCT00863681|322680374|FG002|Overall Study|Protocol Violation|0|||
94241939|NCT00863681|322680372|FG000|Overall Study|Lost to Follow-up|3|||
94241940|NCT00863681|322680373|FG001|Overall Study|Lost to Follow-up|0|||
94241941|NCT00863681|322680374|FG002|Overall Study|Lost to Follow-up|3|||
94241942|NCT00863681|322680372|FG000|Overall Study|Adverse Event|28|||
94353422|NCT02719028|323077061|FG000|Overall Study|Physician Decision|0|||
94353423|NCT02719028|323077062|FG001|Overall Study|Physician Decision|1|||
94353424|NCT02719028|323077063|FG002|Overall Study|Physician Decision|1|||
94353425|NCT02719028|323077064|FG003|Overall Study|Physician Decision|1|||
94584268|NCT02991040|323938459|FG000|Overall Study|Lost to Follow-up|2|||
94584269|NCT04287517|323938460|FG000|Overall Study|Withdrawal by Subject|1|||
94584270|NCT04287517|323938461|FG001|Overall Study|Withdrawal by Subject|1|||
94584271|NCT02721966|323938462|FG000|Overall Study|Protocol Violation|1|||
94584272|NCT02721966|323938463|FG001|Overall Study|Protocol Violation|0|||
94584273|NCT02721966|323938464|FG002|Overall Study|Protocol Violation|0|||
94584274|NCT02721966|323938465|FG003|Overall Study|Protocol Violation|0|||
94584275|NCT02721966|323938466|FG004|Overall Study|Protocol Violation|0|||
94584276|NCT02721966|323938462|FG000|Overall Study|Withdrawal by Subject|9|||
94241943|NCT00863681|322680373|FG001|Overall Study|Adverse Event|10|||
94241944|NCT00863681|322680374|FG002|Overall Study|Adverse Event|6|||
94241945|NCT00863681|322680372|FG000|Overall Study|Lack of Efficacy|2|||
94241946|NCT00863681|322680373|FG001|Overall Study|Lack of Efficacy|2|||
94241947|NCT00863681|322680374|FG002|Overall Study|Lack of Efficacy|1|||
94241948|NCT00863681|322680372|FG000|Overall Study|Non-compliance with study drug|1|||
94241949|NCT00863681|322680373|FG001|Overall Study|Non-compliance with study drug|3|||
94241950|NCT00863681|322680374|FG002|Overall Study|Non-compliance with study drug|0|||
94241951|NCT03868787|322680377|FG000|Overall Study|Withdrawal by Subject|2|||
94353426|NCT02719028|323077061|FG000|Overall Study|Use of prohibited medication|0|||
94241952|NCT03868787|322680378|FG001|Overall Study|Withdrawal by Subject|1|||
94241953|NCT01685229|322680379|FG000|Overall Study|Subjects missing Study Exit form|3|||
94241954|NCT01685229|322680380|FG001|Overall Study|Subjects missing Study Exit form|1|||
94241955|NCT01685229|322680379|FG000|Overall Study|Lost to Follow-up|16|||
94241956|NCT01685229|322680380|FG001|Overall Study|Lost to Follow-up|10|||
94241957|NCT01685229|322680379|FG000|Overall Study|Withdrawal by Subject|6|||
94241958|NCT01685229|322680380|FG001|Overall Study|Withdrawal by Subject|5|||
94241959|NCT01685229|322680379|FG000|Overall Study|Death|1|||
94241960|NCT01685229|322680380|FG001|Overall Study|Death|0|||
94241961|NCT01598662|322680381|FG000|Overall Study|Lost to Follow-up|10|||
94241962|NCT01598662|322680382|FG001|Overall Study|Lost to Follow-up|17|||
94241963|NCT01598662|322680381|FG000|Overall Study|Physician Decision|1|||
94241964|NCT01598662|322680382|FG001|Overall Study|Physician Decision|2|||
94241965|NCT01598662|322680381|FG000|Overall Study|IUD expelled before month 6|0|||
94241966|NCT01598662|322680382|FG001|Overall Study|IUD expelled before month 6|2|||
94241967|NCT01853475|322680385|FG000|Overall Study|Withdrawal by Subject|0|||
94241968|NCT01853475|322680386|FG001|Overall Study|Withdrawal by Subject|1|||
94241969|NCT01853475|322680387|FG002|Overall Study|Withdrawal by Subject|0|||
94241970|NCT04313608|322680388|FG000|Overall Study|Death|12|||
94241971|NCT04313608|322680389|FG001|Overall Study|Death|3|||
94241972|NCT02510040|322680390|FG000|Overall Study|Deemed no longer eligible|18|||
94241973|NCT02510040|322680391|FG001|Overall Study|Deemed no longer eligible|3|||
94241974|NCT02510040|322680392|FG002|Overall Study|Deemed no longer eligible|1|||
94241975|NCT03174431|322680393|FG000|Overall Study|Withdrawal by Subject|14|||
94241976|NCT03174431|322680394|FG001|Overall Study|Withdrawal by Subject|11|||
94241977|NCT03174431|322680393|FG000|Overall Study|alternative treatment|2|||
94241978|NCT03174431|322680394|FG001|Overall Study|alternative treatment|0|||
94241979|NCT03174431|322680393|FG000|Overall Study|Lost to Follow-up|1|||
94241980|NCT03174431|322680394|FG001|Overall Study|Lost to Follow-up|5|||
94241981|NCT02593123|322680399|FG000|Overall Study|Physician Decision|2|||
94241982|NCT02593123|322680400|FG001|Overall Study|Physician Decision|1|||
94241983|NCT02593123|322680399|FG000|Overall Study|Relapse|1|||
94241984|NCT02593123|322680400|FG001|Overall Study|Relapse|1|||
94241985|NCT00299494|322680402|FG000|Overall Study|Withdrawal by Subject|0|||
94241986|NCT00299494|322680403|FG001|Overall Study|Withdrawal by Subject|0|||
94241987|NCT00299494|322680404|FG002|Overall Study|Withdrawal by Subject|0|||
94241988|NCT00299494|322680405|FG003|Overall Study|Withdrawal by Subject|3|||
94241989|NCT00299494|322680406|FG004|Overall Study|Withdrawal by Subject|1|||
94241990|NCT00299494|322680407|FG005|Overall Study|Withdrawal by Subject|4|||
94241991|NCT00299494|322680402|FG000|Overall Study|Physician Decision|0|||
94241992|NCT00299494|322680403|FG001|Overall Study|Physician Decision|0|||
94241993|NCT00299494|322680404|FG002|Overall Study|Physician Decision|0|||
94241994|NCT00299494|322680405|FG003|Overall Study|Physician Decision|0|||
94241995|NCT00299494|322680406|FG004|Overall Study|Physician Decision|1|||
94241996|NCT00299494|322680407|FG005|Overall Study|Physician Decision|0|||
94241997|NCT00299494|322680402|FG000|Overall Study|Death|3|||
94241998|NCT00299494|322680403|FG001|Overall Study|Death|1|||
94241999|NCT00299494|322680404|FG002|Overall Study|Death|4|||
94242000|NCT00299494|322680405|FG003|Overall Study|Death|6|||
94242001|NCT00299494|322680406|FG004|Overall Study|Death|18|||
94242002|NCT00299494|322680407|FG005|Overall Study|Death|19|||
94242003|NCT00299494|322680402|FG000|Overall Study|Lost to Follow-up|0|||
94242004|NCT00299494|322680403|FG001|Overall Study|Lost to Follow-up|0|||
94242005|NCT00299494|322680404|FG002|Overall Study|Lost to Follow-up|0|||
94242006|NCT00299494|322680405|FG003|Overall Study|Lost to Follow-up|0|||
94242007|NCT00299494|322680406|FG004|Overall Study|Lost to Follow-up|3|||
94242008|NCT00299494|322680407|FG005|Overall Study|Lost to Follow-up|1|||
94242009|NCT00299494|322680402|FG000|Overall Study|Other - Unspecified|0|||
94242010|NCT00299494|322680403|FG001|Overall Study|Other - Unspecified|0|||
94242011|NCT00299494|322680404|FG002|Overall Study|Other - Unspecified|0|||
94353427|NCT02719028|323077062|FG001|Overall Study|Use of prohibited medication|0|||
94353428|NCT02719028|323077063|FG002|Overall Study|Use of prohibited medication|1|||
94584277|NCT02721966|323938463|FG001|Overall Study|Withdrawal by Subject|2|||
94242012|NCT00299494|322680405|FG003|Overall Study|Other - Unspecified|0|||
94242013|NCT00299494|322680406|FG004|Overall Study|Other - Unspecified|3|||
94242014|NCT00299494|322680407|FG005|Overall Study|Other - Unspecified|1|||
94242015|NCT00299494|322680402|FG000|Overall Study|Other - site closure|0|||
94242016|NCT00299494|322680403|FG001|Overall Study|Other - site closure|0|||
94242017|NCT00299494|322680404|FG002|Overall Study|Other - site closure|0|||
94242018|NCT00299494|322680405|FG003|Overall Study|Other - site closure|1|||
94242019|NCT00299494|322680406|FG004|Overall Study|Other - site closure|1|||
94242020|NCT00299494|322680407|FG005|Overall Study|Other - site closure|1|||
94242021|NCT00534495|322680410|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
94242022|NCT00534495|322680411|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
94242023|NCT00534495|322680412|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
94242024|NCT00534495|322680410|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
94242025|NCT00534495|322680411|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
94242026|NCT00534495|322680412|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
94242027|NCT00534495|322680410|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
94242028|NCT00534495|322680411|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
94242029|NCT00534495|322680412|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
94242030|NCT00534495|322680410|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
94242031|NCT00534495|322680411|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
94242032|NCT00534495|322680412|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
94242033|NCT00534495|322680410|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
94242034|NCT00534495|322680411|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
94242035|NCT00534495|322680412|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
94242036|NCT00534495|322680410|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
94242037|NCT00534495|322680411|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
94242038|NCT00534495|322680412|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
94242039|NCT00534495|322680410|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
94242040|NCT00534495|322680411|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
94242041|NCT00534495|322680412|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
94242042|NCT00534495|322680410|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
94242043|NCT00534495|322680411|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
94242044|NCT00534495|322680412|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
94242045|NCT00534495|322680410|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
94242046|NCT00534495|322680411|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
94242047|NCT00534495|322680412|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
94242048|NCT01305408|322680414|FG000|Overall Study|Adverse Event|10|||
94242049|NCT01305408|322680415|FG001|Overall Study|Adverse Event|7|||
94242050|NCT01305408|322680414|FG000|Overall Study|Lack of Efficacy|3|||
94242051|NCT01305408|322680415|FG001|Overall Study|Lack of Efficacy|4|||
94242052|NCT01305408|322680414|FG000|Overall Study|Withdrawal by Subject|9|||
94242053|NCT01305408|322680415|FG001|Overall Study|Withdrawal by Subject|9|||
94242054|NCT01305408|322680414|FG000|Overall Study|Protocol Violation|4|||
94242055|NCT01305408|322680415|FG001|Overall Study|Protocol Violation|6|||
94242056|NCT01305408|322680414|FG000|Overall Study|Lost to Follow-up|5|||
94242057|NCT01305408|322680415|FG001|Overall Study|Lost to Follow-up|3|||
94242058|NCT01305408|322680414|FG000|Overall Study|Noncompliance with study medication|0|||
94242059|NCT01305408|322680415|FG001|Overall Study|Noncompliance with study medication|1|||
94242060|NCT01305408|322680414|FG000|Overall Study|Noncompliance with study procedures|0|||
94242061|NCT01305408|322680415|FG001|Overall Study|Noncompliance with study procedures|1|||
94242062|NCT01305408|322680414|FG000|Overall Study|Other|1|||
94242063|NCT01305408|322680415|FG001|Overall Study|Other|0|||
94242064|NCT03101462|322680416|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
94242065|NCT03101462|322680417|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
94242066|NCT00635661|322680420|FG000|Overall Study|Withdrawal by Subject|4|||
94242067|NCT03551691|322680428|FG000|Overall Study|Withdrawal by Subject|3|||
94242068|NCT03551691|322680429|FG001|Overall Study|Withdrawal by Subject|3|||
94242069|NCT00611975|322680434|FG000|Overall Study|Withdrawal by Subject|3|||
94242070|NCT00611975|322680435|FG001|Overall Study|Withdrawal by Subject|7|||
94242071|NCT00611975|322680434|FG000|Overall Study|Pregnancy|2|||
94242072|NCT00611975|322680435|FG001|Overall Study|Pregnancy|1|||
94242073|NCT04707664|322682645|FG000|Overall Study|Adverse Event|2|||
94242074|NCT04707664|322682646|FG001|Overall Study|Adverse Event|0|||
94242075|NCT04707664|322682645|FG000|Overall Study|Death|1|||
94242076|NCT04707664|322682646|FG001|Overall Study|Death|2|||
94242077|NCT04707664|322682645|FG000|Overall Study|Withdrawal by Subject|13|||
94242078|NCT04707664|322682646|FG001|Overall Study|Withdrawal by Subject|21|||
94242079|NCT04707664|322682645|FG000|Overall Study|Lost to Follow-up|11|||
94242080|NCT04707664|322682646|FG001|Overall Study|Lost to Follow-up|13|||
94242081|NCT04707664|322682645|FG000|Overall Study|Not treated|2|||
94242082|NCT04707664|322682646|FG001|Overall Study|Not treated|0|||
94242083|NCT02706405|322682651|FG000|Overall Study|Death|3|||
94242084|NCT02706405|322682652|FG001|Overall Study|Death|2|||
94242085|NCT02706405|322682653|FG002|Overall Study|Death|0|||
94242086|NCT02706405|322682654|FG003|Overall Study|Death|1|||
94242087|NCT02706405|322682655|FG004|Overall Study|Death|0|||
94242088|NCT02706405|322682656|FG005|Overall Study|Death|0|||
94242089|NCT02706405|322682657|FG006|Overall Study|Death|3|||
94242090|NCT02706405|322682658|FG007|Overall Study|Death|4|||
94242091|NCT02706405|322682651|FG000|Overall Study|Disease progression|0|||
94455687|NCT05217641|323456410|FG005|Overall Study|Withdrawal by Subject|0|||
94455688|NCT05217641|323456405|FG000|Overall Study|Other: participant did not specify reason|0|||
94455689|NCT05217641|323456406|FG001|Overall Study|Other: participant did not specify reason|0|||
94455690|NCT05217641|323456407|FG002|Overall Study|Other: participant did not specify reason|0|||
94455691|NCT05217641|323456408|FG003|Overall Study|Other: participant did not specify reason|0|||
94242092|NCT02706405|322682652|FG001|Overall Study|Disease progression|0|||
94242093|NCT02706405|322682653|FG002|Overall Study|Disease progression|0|||
94242094|NCT02706405|322682654|FG003|Overall Study|Disease progression|0|||
94242095|NCT02706405|322682655|FG004|Overall Study|Disease progression|0|||
94242096|NCT02706405|322682656|FG005|Overall Study|Disease progression|0|||
94242097|NCT02706405|322682657|FG006|Overall Study|Disease progression|0|||
94242098|NCT02706405|322682658|FG007|Overall Study|Disease progression|1|||
94242099|NCT02706405|322682651|FG000|Overall Study|Pt moved to new therapy|0|||
94242100|NCT02706405|322682652|FG001|Overall Study|Pt moved to new therapy|0|||
94242101|NCT02706405|322682653|FG002|Overall Study|Pt moved to new therapy|0|||
94242102|NCT02706405|322682654|FG003|Overall Study|Pt moved to new therapy|0|||
94242103|NCT02706405|322682655|FG004|Overall Study|Pt moved to new therapy|0|||
94242104|NCT02706405|322682656|FG005|Overall Study|Pt moved to new therapy|1|||
94242105|NCT02706405|322682657|FG006|Overall Study|Pt moved to new therapy|0|||
94242106|NCT02706405|322682658|FG007|Overall Study|Pt moved to new therapy|1|||
94242107|NCT02706405|322682651|FG000|Overall Study|Physician Decision|1|||
94242108|NCT02706405|322682652|FG001|Overall Study|Physician Decision|0|||
94242109|NCT02706405|322682653|FG002|Overall Study|Physician Decision|0|||
94242110|NCT02706405|322682654|FG003|Overall Study|Physician Decision|0|||
94242111|NCT02706405|322682655|FG004|Overall Study|Physician Decision|0|||
94242112|NCT02706405|322682656|FG005|Overall Study|Physician Decision|0|||
94242113|NCT02706405|322682657|FG006|Overall Study|Physician Decision|0|||
94242114|NCT02706405|322682658|FG007|Overall Study|Physician Decision|0|||
94242115|NCT01195948|322682659|FG000|Overall Study|Lost to Follow-up|0|||
94242116|NCT01195948|322682660|FG001|Overall Study|Lost to Follow-up|1|||
94242117|NCT01195948|322682661|FG002|Overall Study|Lost to Follow-up|2|||
94242118|NCT00527787|322682662|FG000|Overall Study|Adverse Event|14|||
94242119|NCT00527787|322682663|FG001|Overall Study|Adverse Event|24|||
94242120|NCT00527787|322682662|FG000|Overall Study|Withdrawal by Subject|13|||
94242121|NCT00527787|322682663|FG001|Overall Study|Withdrawal by Subject|25|||
94242122|NCT00527787|322682662|FG000|Overall Study|Lost to Follow-up|5|||
94242123|NCT00527787|322682663|FG001|Overall Study|Lost to Follow-up|2|||
94242124|NCT00527787|322682662|FG000|Overall Study|Duodenal Ulcer|1|||
94242125|NCT00527787|322682663|FG001|Overall Study|Duodenal Ulcer|10|||
94242126|NCT00527787|322682662|FG000|Overall Study|misc|5|||
94242127|NCT00527787|322682663|FG001|Overall Study|misc|2|||
94242128|NCT03559062|322682664|FG000|Overall Study|Other|0|||
94242129|NCT03559062|322682665|FG001|Overall Study|Other|1|||
94242130|NCT03559062|322682666|FG002|Overall Study|Other|0|||
94242131|NCT00022659|322682667|FG000|Overall Study|Ineligible: wrong primary|1|||
94242132|NCT00022659|322682667|FG000|Overall Study|Never treated|1|||
94242133|NCT04939701|322682671|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
94242134|NCT04939701|322682672|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
94242135|NCT04939701|322682673|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
94242136|NCT04939701|322682671|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
94242137|NCT04939701|322682672|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
94242138|NCT04939701|322682673|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
94242139|NCT04939701|322682671|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
94242140|NCT04939701|322682672|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
94242141|NCT04939701|322682673|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
94242142|NCT04939701|322682671|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
94242143|NCT04939701|322682672|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
94242144|NCT04939701|322682673|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
94242145|NCT04939701|322682671|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
94242146|NCT04939701|322682672|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
94242147|NCT04939701|322682673|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
94242148|NCT04939701|322682671|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
94242149|NCT04939701|322682672|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
94242150|NCT04939701|322682673|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
94242151|NCT04939701|322682671|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
94242152|NCT04939701|322682672|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
94242153|NCT04939701|322682673|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
94242154|NCT00384189|322682678|FG000|Overall Study|Reason Not Specified|50|||
94242155|NCT00384189|322682679|FG001|Overall Study|Reason Not Specified|57|||
94242156|NCT00384189|322682680|FG002|Overall Study|Reason Not Specified|58|||
94455692|NCT05217641|323456409|FG004|Overall Study|Other: participant did not specify reason|1|||
94455693|NCT05217641|323456410|FG005|Overall Study|Other: participant did not specify reason|0|||
94242157|NCT00384189|322682681|FG003|Overall Study|Reason Not Specified|40|||
94242158|NCT02672852|322682683|FG000|Part A1|Disease Worsening|1|||
94242159|NCT02672852|322682684|FG001|Part A1|Disease Worsening|0|||
94242160|NCT02672852|322682685|FG002|Part A1|Disease Worsening|0|||
94242161|NCT02672852|322682686|FG003|Part A1|Disease Worsening|0|||
94584278|NCT02721966|323938464|FG002|Overall Study|Withdrawal by Subject|3|||
94242162|NCT02672852|322682687|FG004|Part A1|Disease Worsening|0|||
94242163|NCT02672852|322682688|FG005|Part A1|Disease Worsening|0|||
94242164|NCT02672852|322682689|FG006|Part A1|Disease Worsening|0|||
94242165|NCT02672852|322682683|FG000|Part A1|Adverse Event|0|||
94242166|NCT02672852|322682684|FG001|Part A1|Adverse Event|1|||
94242167|NCT02672852|322682685|FG002|Part A1|Adverse Event|0|||
94242168|NCT02672852|322682686|FG003|Part A1|Adverse Event|0|||
94242169|NCT02672852|322682687|FG004|Part A1|Adverse Event|0|||
94242170|NCT02672852|322682688|FG005|Part A1|Adverse Event|0|||
94242171|NCT02672852|322682689|FG006|Part A1|Adverse Event|0|||
94242172|NCT02672852|322682683|FG000|Part A1|Lost to Follow-up|1|||
94242173|NCT02672852|322682684|FG001|Part A1|Lost to Follow-up|2|||
94242174|NCT02672852|322682685|FG002|Part A1|Lost to Follow-up|0|||
94242175|NCT02672852|322682686|FG003|Part A1|Lost to Follow-up|0|||
94242176|NCT02672852|322682687|FG004|Part A1|Lost to Follow-up|0|||
94242177|NCT02672852|322682688|FG005|Part A1|Lost to Follow-up|0|||
94242178|NCT02672852|322682689|FG006|Part A1|Lost to Follow-up|0|||
94242179|NCT02672852|322682683|FG000|Part A1|Withdrawal by Subject|1|||
94242180|NCT02672852|322682684|FG001|Part A1|Withdrawal by Subject|1|||
94242181|NCT02672852|322682685|FG002|Part A1|Withdrawal by Subject|0|||
94242182|NCT02672852|322682686|FG003|Part A1|Withdrawal by Subject|0|||
94242183|NCT02672852|322682687|FG004|Part A1|Withdrawal by Subject|0|||
94242184|NCT02672852|322682688|FG005|Part A1|Withdrawal by Subject|0|||
94242185|NCT02672852|322682689|FG006|Part A1|Withdrawal by Subject|0|||
94242186|NCT02672852|322682683|FG000|Part A2|Disease worsening|0|||
94242187|NCT02672852|322682684|FG001|Part A2|Disease worsening|0|||
94242188|NCT02672852|322682685|FG002|Part A2|Disease worsening|1|||
94242189|NCT02672852|322682686|FG003|Part A2|Disease worsening|0|||
94242190|NCT02672852|322682687|FG004|Part A2|Disease worsening|0|||
94242191|NCT02672852|322682688|FG005|Part A2|Disease worsening|0|||
94242192|NCT02672852|322682689|FG006|Part A2|Disease worsening|0|||
94242193|NCT02672852|322682683|FG000|Part A2|Adverse Event|0|||
94242194|NCT02672852|322682684|FG001|Part A2|Adverse Event|0|||
94242195|NCT02672852|322682685|FG002|Part A2|Adverse Event|3|||
94242196|NCT02672852|322682686|FG003|Part A2|Adverse Event|0|||
94242197|NCT02672852|322682687|FG004|Part A2|Adverse Event|0|||
94242198|NCT02672852|322682688|FG005|Part A2|Adverse Event|0|||
94242199|NCT02672852|322682689|FG006|Part A2|Adverse Event|0|||
94242200|NCT02672852|322682683|FG000|Part A2|Lost to Follow-up|0|||
94242201|NCT02672852|322682684|FG001|Part A2|Lost to Follow-up|0|||
94242202|NCT02672852|322682685|FG002|Part A2|Lost to Follow-up|2|||
94242203|NCT02672852|322682686|FG003|Part A2|Lost to Follow-up|0|||
94242204|NCT02672852|322682687|FG004|Part A2|Lost to Follow-up|0|||
94242205|NCT02672852|322682688|FG005|Part A2|Lost to Follow-up|0|||
94242206|NCT02672852|322682689|FG006|Part A2|Lost to Follow-up|0|||
94242207|NCT02672852|322682683|FG000|Part A2|Withdrawal by Subject|0|||
94242208|NCT02672852|322682684|FG001|Part A2|Withdrawal by Subject|0|||
94242209|NCT02672852|322682685|FG002|Part A2|Withdrawal by Subject|1|||
94242210|NCT02672852|322682686|FG003|Part A2|Withdrawal by Subject|0|||
94242211|NCT02672852|322682687|FG004|Part A2|Withdrawal by Subject|0|||
94242212|NCT02672852|322682688|FG005|Part A2|Withdrawal by Subject|0|||
94242213|NCT02672852|322682689|FG006|Part A2|Withdrawal by Subject|0|||
94242214|NCT02672852|322682683|FG000|Part A2|Other|0|||
94242215|NCT02672852|322682684|FG001|Part A2|Other|0|||
94242216|NCT02672852|322682685|FG002|Part A2|Other|3|||
94242217|NCT02672852|322682686|FG003|Part A2|Other|0|||
94242218|NCT02672852|322682687|FG004|Part A2|Other|0|||
94242219|NCT02672852|322682688|FG005|Part A2|Other|0|||
94242220|NCT02672852|322682689|FG006|Part A2|Other|0|||
94242221|NCT02672852|322682683|FG000|Part A2|Not entered in Part B|0|||
94242222|NCT02672852|322682684|FG001|Part A2|Not entered in Part B|0|||
94242223|NCT02672852|322682685|FG002|Part A2|Not entered in Part B|0|||
94242224|NCT02672852|322682686|FG003|Part A2|Not entered in Part B|4|||
94242225|NCT02672852|322682687|FG004|Part A2|Not entered in Part B|0|||
94242226|NCT02672852|322682688|FG005|Part A2|Not entered in Part B|0|||
94242227|NCT02672852|322682689|FG006|Part A2|Not entered in Part B|0|||
94242228|NCT02672852|322682683|FG000|Part B|Disease worsening|0|||
94242229|NCT02672852|322682684|FG001|Part B|Disease worsening|0|||
94242230|NCT02672852|322682685|FG002|Part B|Disease worsening|0|||
94242231|NCT02672852|322682686|FG003|Part B|Disease worsening|0|||
94242232|NCT02672852|322682687|FG004|Part B|Disease worsening|1|||
94242233|NCT02672852|322682688|FG005|Part B|Disease worsening|0|||
94242234|NCT02672852|322682689|FG006|Part B|Disease worsening|1|||
94242235|NCT02672852|322682683|FG000|Part B|Worsening pre-existing condition|0|||
94242236|NCT02672852|322682684|FG001|Part B|Worsening pre-existing condition|0|||
94242237|NCT02672852|322682685|FG002|Part B|Worsening pre-existing condition|0|||
94242238|NCT02672852|322682686|FG003|Part B|Worsening pre-existing condition|0|||
94242239|NCT02672852|322682687|FG004|Part B|Worsening pre-existing condition|0|||
94242240|NCT02672852|322682688|FG005|Part B|Worsening pre-existing condition|1|||
94242241|NCT02672852|322682689|FG006|Part B|Worsening pre-existing condition|0|||
94242242|NCT02672852|322682683|FG000|Part B|Other adverse event|0|||
94242243|NCT02672852|322682684|FG001|Part B|Other adverse event|0|||
94242244|NCT02672852|322682685|FG002|Part B|Other adverse event|0|||
94242245|NCT02672852|322682686|FG003|Part B|Other adverse event|0|||
94584279|NCT02721966|323938465|FG003|Overall Study|Withdrawal by Subject|7|||
94584280|NCT02721966|323938466|FG004|Overall Study|Withdrawal by Subject|0|||
94242246|NCT02672852|322682687|FG004|Part B|Other adverse event|3|||
94242247|NCT02672852|322682688|FG005|Part B|Other adverse event|5|||
94242248|NCT02672852|322682689|FG006|Part B|Other adverse event|1|||
94242249|NCT02672852|322682683|FG000|Part B|Lost to Follow-up|0|||
94242250|NCT02672852|322682684|FG001|Part B|Lost to Follow-up|0|||
94242251|NCT02672852|322682685|FG002|Part B|Lost to Follow-up|0|||
94242252|NCT02672852|322682686|FG003|Part B|Lost to Follow-up|0|||
94242253|NCT02672852|322682687|FG004|Part B|Lost to Follow-up|3|||
94242254|NCT02672852|322682688|FG005|Part B|Lost to Follow-up|4|||
94242255|NCT02672852|322682689|FG006|Part B|Lost to Follow-up|1|||
94242256|NCT02672852|322682683|FG000|Part B|Withdrawal by Subject|0|||
94242257|NCT02672852|322682684|FG001|Part B|Withdrawal by Subject|0|||
94242258|NCT02672852|322682685|FG002|Part B|Withdrawal by Subject|0|||
94242259|NCT02672852|322682686|FG003|Part B|Withdrawal by Subject|0|||
94242260|NCT02672852|322682687|FG004|Part B|Withdrawal by Subject|5|||
94242261|NCT02672852|322682688|FG005|Part B|Withdrawal by Subject|0|||
94242262|NCT02672852|322682689|FG006|Part B|Withdrawal by Subject|7|||
94242263|NCT02672852|322682683|FG000|Part B|Other|0|||
94242264|NCT02672852|322682684|FG001|Part B|Other|0|||
94242265|NCT02672852|322682685|FG002|Part B|Other|0|||
94242266|NCT02672852|322682686|FG003|Part B|Other|0|||
94242267|NCT02672852|322682687|FG004|Part B|Other|4|||
94242268|NCT02672852|322682688|FG005|Part B|Other|1|||
94242269|NCT02672852|322682689|FG006|Part B|Other|2|||
94242270|NCT04958642|322682690|FG000|Overall Study|Transferred to OLEX program|3|||
94242271|NCT04958642|322682691|FG001|Overall Study|Transferred to OLEX program|0|||
94242272|NCT04958642|322682692|FG002|Overall Study|Transferred to OLEX program|5|||
94242273|NCT04958642|322682690|FG000|Overall Study|Death|0|||
94242274|NCT04958642|322682691|FG001|Overall Study|Death|0|||
94242275|NCT04958642|322682692|FG002|Overall Study|Death|1|||
94242276|NCT04958642|322682690|FG000|Overall Study|Withdrawal by Subject|4|||
94242277|NCT04958642|322682691|FG001|Overall Study|Withdrawal by Subject|9|||
94242278|NCT04958642|322682692|FG002|Overall Study|Withdrawal by Subject|13|||
94242279|NCT04958642|322682690|FG000|Overall Study|Investigator's Decision|0|||
94242280|NCT04958642|322682691|FG001|Overall Study|Investigator's Decision|0|||
94242281|NCT04958642|322682692|FG002|Overall Study|Investigator's Decision|1|||
94242282|NCT04958642|322682690|FG000|Overall Study|Adverse Event|1|||
94242283|NCT04958642|322682691|FG001|Overall Study|Adverse Event|0|||
94242284|NCT04958642|322682692|FG002|Overall Study|Adverse Event|1|||
94242285|NCT04958642|322682690|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
94242286|NCT04958642|322682691|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
94242287|NCT04958642|322682692|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
94242288|NCT04958642|322682690|FG000|Overall Study|Lost to Follow-up|1|||
94242289|NCT04958642|322682691|FG001|Overall Study|Lost to Follow-up|0|||
94242290|NCT04958642|322682692|FG002|Overall Study|Lost to Follow-up|0|||
94242291|NCT04958642|322682690|FG000|Overall Study|Transferred to EAP following study termination|0|||
94242292|NCT04958642|322682691|FG001|Overall Study|Transferred to EAP following study termination|0|||
94242293|NCT04958642|322682692|FG002|Overall Study|Transferred to EAP following study termination|1|||
94242294|NCT04958642|322682690|FG000|Overall Study|Transferred to Expanded Access Program|1|||
94242295|NCT04958642|322682691|FG001|Overall Study|Transferred to Expanded Access Program|0|||
94242296|NCT04958642|322682692|FG002|Overall Study|Transferred to Expanded Access Program|0|||
94242297|NCT02138786|322682693|FG000|Overall Study|Adverse Event|0|||
94242298|NCT02138786|322682694|FG001|Overall Study|Adverse Event|2|||
94242299|NCT02138786|322682695|FG002|Overall Study|Adverse Event|1|||
94242300|NCT02138786|322682693|FG000|Overall Study|Death|1|||
94242301|NCT02138786|322682694|FG001|Overall Study|Death|7|||
94242302|NCT02138786|322682695|FG002|Overall Study|Death|2|||
94242303|NCT02138786|322682693|FG000|Overall Study|Disease Progression|1|||
94242304|NCT02138786|322682694|FG001|Overall Study|Disease Progression|1|||
94242305|NCT02138786|322682695|FG002|Overall Study|Disease Progression|3|||
94242306|NCT02138786|322682693|FG000|Overall Study|Withdrawal by Subject|1|||
94242307|NCT02138786|322682694|FG001|Overall Study|Withdrawal by Subject|2|||
94242308|NCT02138786|322682695|FG002|Overall Study|Withdrawal by Subject|0|||
94242309|NCT02138786|322682693|FG000|Overall Study|Patient's Wish|0|||
94242310|NCT02138786|322682694|FG001|Overall Study|Patient's Wish|2|||
94242311|NCT02138786|322682695|FG002|Overall Study|Patient's Wish|0|||
94242312|NCT02138786|322682693|FG000|Overall Study|Sponsor Terminated Study|0|||
94242313|NCT02138786|322682694|FG001|Overall Study|Sponsor Terminated Study|1|||
94242314|NCT02138786|322682695|FG002|Overall Study|Sponsor Terminated Study|1|||
94242315|NCT02138786|322682693|FG000|Overall Study|Non-Compliance|0|||
94242316|NCT02138786|322682694|FG001|Overall Study|Non-Compliance|0|||
94242317|NCT02138786|322682695|FG002|Overall Study|Non-Compliance|1|||
94242318|NCT00608868|322682696|FG000|Overall Study|Withdrawal by Subject|7|||
94242319|NCT00608868|322682696|FG000|Overall Study|Protocol Violation|3|||
94242320|NCT00608868|322682696|FG000|Overall Study|Lost to Follow-up|2|||
94242321|NCT00608868|322682696|FG000|Overall Study|Adverse Event|1|||
94242322|NCT00608868|322682696|FG000|Overall Study|Physician Decision|2|||
94242323|NCT02922023|322682699|FG000|Overall Study|Lost to Follow-up|2|||
94242324|NCT02922023|322682700|FG001|Overall Study|Lost to Follow-up|0|||
94242325|NCT03031496|322682701|FG000|Period 1|Adverse Event|2|||
94242326|NCT03031496|322682702|FG001|Period 1|Adverse Event|0|||
94242327|NCT03031496|322682701|FG000|Period 1|Withdrawal by Subject|0|||
94242328|NCT03031496|322682702|FG001|Period 1|Withdrawal by Subject|2|||
94242329|NCT05032872|322682703|FG000|Overall Study|Adverse Event|1|||
94242330|NCT05032872|322682704|FG001|Overall Study|Adverse Event|0|||
94242331|NCT05032872|322682703|FG000|Overall Study|Lost to Follow-up|2|||
94659079|NCT00566228|324207984|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
94242332|NCT05032872|322682704|FG001|Overall Study|Lost to Follow-up|4|||
94242333|NCT05032872|322682703|FG000|Overall Study|Withdrawal by Subject|4|||
94242334|NCT05032872|322682704|FG001|Overall Study|Withdrawal by Subject|3|||
94242335|NCT01125046|322682705|FG000|First 6 Months of Treatment|Death|1|||
94242336|NCT01125046|322682705|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
94242337|NCT01125046|322682705|FG000|First 6 Months of Treatment|Non-compliance|1|||
94242338|NCT01125046|322682705|FG000|First 6 Months of Treatment|Surgery|1|||
94242339|NCT01125046|322682705|FG000|First 6 Months of Treatment|Progressive Disease|7|||
94242340|NCT01125046|322682705|FG000|First 6 Months of Treatment|Adverse Event|2|||
94242341|NCT01125046|322682705|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
94242342|NCT01125046|322682705|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
94242343|NCT01125046|322682705|FG000|Follow-up/Data Cut Off Point|Death|29|||
94242344|NCT01125046|322682705|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
94242345|NCT03733314|322682706|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
94242346|NCT03733314|322682707|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
94242347|NCT03733314|322682706|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
94242348|NCT03733314|322682707|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
94242349|NCT03733314|322682706|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
94242350|NCT03733314|322682707|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
94242351|NCT03733314|322682706|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
94242352|NCT03733314|322682707|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
94242353|NCT03733314|322682706|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
94242354|NCT03733314|322682707|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
94242355|NCT03733314|322682706|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
94242356|NCT03733314|322682707|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
94242357|NCT02766777|322682711|FG000|Overall Study|Adverse Event|12|||
94242358|NCT02766777|322682711|FG000|Overall Study|Lost to Follow-up|16|||
94242359|NCT02766777|322682711|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94242360|NCT02766777|322682711|FG000|Overall Study|Protocol Violation|1|||
94242361|NCT02766777|322682711|FG000|Overall Study|Withdrawal by Subject|4|||
94242362|NCT02964325|322682712|FG000|Overall Study|Lost to Follow-up|3|||
94242363|NCT02964325|322682713|FG001|Overall Study|Lost to Follow-up|3|||
94242364|NCT02964325|322682712|FG000|Overall Study|Physician Decision|5|||
94242365|NCT02964325|322682713|FG001|Overall Study|Physician Decision|4|||
94242366|NCT02964325|322682712|FG000|Overall Study|Death|1|||
94242367|NCT02964325|322682713|FG001|Overall Study|Death|3|||
94242368|NCT02964325|322682712|FG000|Overall Study|Withdrawal by Subject|2|||
94242369|NCT02964325|322682713|FG001|Overall Study|Withdrawal by Subject|1|||
94242370|NCT02964325|322682712|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
94242371|NCT02964325|322682713|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
94242372|NCT01401153|322682714|FG000|First Test Day|Learning disabilities; illness|1|||
94242373|NCT01401153|322682715|FG001|First Test Day|Learning disabilities; illness|10|||
94242374|NCT01401153|322682714|FG000|Second Test Day|illness|0|||
94242375|NCT01401153|322682715|FG001|Second Test Day|illness|5|||
94242376|NCT00214019|322682716|FG000|Overall Study|Lost to Follow-up|11|||
94242377|NCT00214019|322682716|FG000|Overall Study|Withdrawal by Subject|2|||
94242378|NCT00214019|322682716|FG000|Overall Study|Screen Failed prior to randomization|17|||
94242379|NCT02530970|322682717|FG000|Overall Study|Adverse Event|8|||
94242380|NCT02530970|322682717|FG000|Overall Study|Lost to Follow-up|88|||
94242381|NCT02530970|322682717|FG000|Overall Study|Physician Decision|5|||
94242382|NCT02530970|322682717|FG000|Overall Study|Withdrawal by Subject|14|||
94242383|NCT02530970|322682717|FG000|Overall Study|Death|6|||
94242384|NCT02530970|322682717|FG000|Overall Study|Hospitalization|1|||
94242385|NCT02530970|322682717|FG000|Overall Study|Insurance|2|||
94242386|NCT02530970|322682717|FG000|Overall Study|Explant|2|||
94242387|NCT02530970|322682717|FG000|Overall Study|Change in Provider|5|||
94242388|NCT02530970|322682717|FG000|Overall Study|Relocation|3|||
94242389|NCT00842244|322682718|FG000|Overall Study|Death|3|||
94242390|NCT00842244|322682718|FG000|Overall Study|Withdrawal by Subject|1|||
94242391|NCT00842244|322682718|FG000|Overall Study|Other|17|||
94242392|NCT00669877|322682721|FG000|Overall Study|Disease Progression/Death|4|||
94242393|NCT03635099|322682722|FG000|Period 1|Adverse Event|1|||
94242394|NCT03635099|322682723|FG001|Period 1|Adverse Event|0|||
94242395|NCT03635099|322682724|FG002|Period 1|Adverse Event|0|||
94242396|NCT03635099|322682725|FG003|Period 1|Adverse Event|1|||
94242397|NCT03635099|322682726|FG004|Period 1|Adverse Event|0|||
94242398|NCT03635099|322682727|FG005|Period 1|Adverse Event|0|||
94242399|NCT03635099|322682728|FG006|Period 1|Adverse Event|0|||
94242400|NCT03635099|322682729|FG007|Period 1|Adverse Event|0|||
94242401|NCT03635099|322682722|FG000|Period 1|Protocol Violation|0|||
94242402|NCT03635099|322682723|FG001|Period 1|Protocol Violation|0|||
94455694|NCT05217641|323456405|FG000|Overall Study|Extended Follow up|1|||
94242403|NCT03635099|322682724|FG002|Period 1|Protocol Violation|1|||
94242404|NCT03635099|322682725|FG003|Period 1|Protocol Violation|0|||
94242405|NCT03635099|322682726|FG004|Period 1|Protocol Violation|0|||
94242406|NCT03635099|322682727|FG005|Period 1|Protocol Violation|0|||
94242407|NCT03635099|322682728|FG006|Period 1|Protocol Violation|0|||
94242408|NCT03635099|322682729|FG007|Period 1|Protocol Violation|0|||
94242409|NCT03635099|322682722|FG000|Period 1|Lost to Follow-up|0|||
94242410|NCT03635099|322682723|FG001|Period 1|Lost to Follow-up|0|||
94242411|NCT03635099|322682724|FG002|Period 1|Lost to Follow-up|1|||
94242412|NCT03635099|322682725|FG003|Period 1|Lost to Follow-up|2|||
94242413|NCT03635099|322682726|FG004|Period 1|Lost to Follow-up|1|||
94242414|NCT03635099|322682727|FG005|Period 1|Lost to Follow-up|0|||
94242415|NCT03635099|322682728|FG006|Period 1|Lost to Follow-up|1|||
94659080|NCT00566228|324207983|FG000|Overall Study|progressed before infusion could occur|0|||
94659081|NCT00566228|324207984|FG001|Overall Study|progressed before infusion could occur|1|||
94659082|NCT01627249|324207985|FG000|Overall Study|Death|3|||
94659083|NCT01627249|324207986|FG001|Overall Study|Death|5|||
94659084|NCT01627249|324207987|FG002|Overall Study|Death|3|||
94659085|NCT01627249|324207985|FG000|Overall Study|Withdrawal by Subject|12|||
94659086|NCT01627249|324207986|FG001|Overall Study|Withdrawal by Subject|6|||
94659087|NCT01627249|324207987|FG002|Overall Study|Withdrawal by Subject|9|||
94659088|NCT01627249|324207985|FG000|Overall Study|Missed Visit|1|||
94659089|NCT01627249|324207986|FG001|Overall Study|Missed Visit|1|||
94659090|NCT01627249|324207987|FG002|Overall Study|Missed Visit|0|||
94659091|NCT01760954|324207988|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
94659092|NCT01760954|324207989|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
94659093|NCT01760954|324207990|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
94659094|NCT01760954|324207991|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
94659095|NCT01760954|324207988|FG000|Treatment Period (6 Months)|Adverse Event|5|||
94659096|NCT01760954|324207989|FG001|Treatment Period (6 Months)|Adverse Event|3|||
94659097|NCT01760954|324207990|FG002|Treatment Period (6 Months)|Adverse Event|4|||
94659098|NCT01760954|324207991|FG003|Treatment Period (6 Months)|Adverse Event|10|||
94659099|NCT01760954|324207988|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
94659100|NCT01760954|324207989|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
94659101|NCT01760954|324207990|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
94659102|NCT01760954|324207991|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
94659103|NCT01760954|324207988|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
94659104|NCT01760954|324207989|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
94242416|NCT03635099|322682729|FG007|Period 1|Lost to Follow-up|2|||
94242417|NCT03635099|322682722|FG000|Period 1|Withdrawal by Subject|3|||
94242418|NCT03635099|322682723|FG001|Period 1|Withdrawal by Subject|3|||
94242419|NCT03635099|322682724|FG002|Period 1|Withdrawal by Subject|5|||
94659105|NCT01760954|324207990|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
94659106|NCT01760954|324207991|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
94659107|NCT01760954|324207988|FG000|Treatment Period (6 Months)|Pregnancy|5|||
94659108|NCT01760954|324207989|FG001|Treatment Period (6 Months)|Pregnancy|0|||
94659109|NCT01760954|324207990|FG002|Treatment Period (6 Months)|Pregnancy|3|||
94659110|NCT01760954|324207991|FG003|Treatment Period (6 Months)|Pregnancy|2|||
94659111|NCT01760954|324207988|FG000|Treatment Period (6 Months)|Non-compliance|1|||
94659112|NCT01760954|324207989|FG001|Treatment Period (6 Months)|Non-compliance|4|||
94659113|NCT01760954|324207990|FG002|Treatment Period (6 Months)|Non-compliance|0|||
94659114|NCT01760954|324207991|FG003|Treatment Period (6 Months)|Non-compliance|3|||
94659115|NCT01760954|324207988|FG000|Treatment Period (6 Months)|Other|0|||
94659116|NCT01760954|324207989|FG001|Treatment Period (6 Months)|Other|3|||
94659117|NCT01760954|324207990|FG002|Treatment Period (6 Months)|Other|3|||
94659118|NCT01760954|324207991|FG003|Treatment Period (6 Months)|Other|1|||
94659119|NCT01760954|324207988|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
94659120|NCT01760954|324207989|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
94659121|NCT01760954|324207990|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
94659122|NCT01760954|324207991|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
94659123|NCT01760954|324207988|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
94659124|NCT01760954|324207989|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
94659125|NCT01760954|324207990|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
94659126|NCT01760954|324207991|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
94659127|NCT01760954|324207988|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
94659128|NCT01760954|324207989|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
94242420|NCT03635099|322682725|FG003|Period 1|Withdrawal by Subject|2|||
94242421|NCT03635099|322682726|FG004|Period 1|Withdrawal by Subject|2|||
94242422|NCT03635099|322682727|FG005|Period 1|Withdrawal by Subject|0|||
94659129|NCT01760954|324207990|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
94659130|NCT01760954|324207991|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
94659131|NCT01760954|324207988|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
94242423|NCT03635099|322682728|FG006|Period 1|Withdrawal by Subject|3|||
94242424|NCT03635099|322682729|FG007|Period 1|Withdrawal by Subject|0|||
94242425|NCT03635099|322682722|FG000|Period 1|History of suicidal ideation|0|||
94242426|NCT03635099|322682723|FG001|Period 1|History of suicidal ideation|0|||
94584281|NCT02721966|323938462|FG000|Overall Study|Adverse Event|4|||
94584282|NCT02721966|323938463|FG001|Overall Study|Adverse Event|4|||
94584283|NCT02721966|323938464|FG002|Overall Study|Adverse Event|3|||
94584284|NCT02721966|323938465|FG003|Overall Study|Adverse Event|0|||
94584285|NCT02721966|323938466|FG004|Overall Study|Adverse Event|0|||
94584286|NCT02721966|323938462|FG000|Overall Study|Death|1|||
94584287|NCT02721966|323938463|FG001|Overall Study|Death|0|||
94584288|NCT02721966|323938464|FG002|Overall Study|Death|0|||
94584289|NCT02721966|323938465|FG003|Overall Study|Death|0|||
94584290|NCT02721966|323938466|FG004|Overall Study|Death|0|||
94584291|NCT02721966|323938462|FG000|Overall Study|Lack of Efficacy|7|||
94659132|NCT01760954|324207989|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
94659133|NCT01760954|324207990|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
94659134|NCT01760954|324207991|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
94659135|NCT01760954|324207988|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
94659136|NCT01760954|324207989|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
94242427|NCT03635099|322682724|FG002|Period 1|History of suicidal ideation|1|||
94353429|NCT02719028|323077064|FG003|Overall Study|Use of prohibited medication|0|||
94584292|NCT02721966|323938463|FG001|Overall Study|Lack of Efficacy|4|||
94584293|NCT02721966|323938464|FG002|Overall Study|Lack of Efficacy|0|||
94584294|NCT02721966|323938465|FG003|Overall Study|Lack of Efficacy|0|||
94584295|NCT02721966|323938466|FG004|Overall Study|Lack of Efficacy|0|||
94659137|NCT01760954|324207990|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
94659138|NCT01760954|324207991|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
94242428|NCT03635099|322682725|FG003|Period 1|History of suicidal ideation|0|||
94242429|NCT03635099|322682726|FG004|Period 1|History of suicidal ideation|0|||
94242430|NCT03635099|322682727|FG005|Period 1|History of suicidal ideation|0|||
94242431|NCT03635099|322682728|FG006|Period 1|History of suicidal ideation|0|||
94242432|NCT03635099|322682729|FG007|Period 1|History of suicidal ideation|0|||
94242433|NCT03635099|322682722|FG000|Period 1|pursue other treatment options|0|||
94242434|NCT03635099|322682723|FG001|Period 1|pursue other treatment options|0|||
94242435|NCT03635099|322682724|FG002|Period 1|pursue other treatment options|0|||
94242436|NCT03635099|322682725|FG003|Period 1|pursue other treatment options|0|||
94242437|NCT03635099|322682726|FG004|Period 1|pursue other treatment options|0|||
94242438|NCT03635099|322682727|FG005|Period 1|pursue other treatment options|1|||
94242439|NCT03635099|322682728|FG006|Period 1|pursue other treatment options|0|||
94242440|NCT03635099|322682729|FG007|Period 1|pursue other treatment options|0|||
94242441|NCT03635099|322682722|FG000|Not Eligible for Period 2|Pregnancy|0|||
94242442|NCT03635099|322682723|FG001|Not Eligible for Period 2|Pregnancy|0|||
94242443|NCT03635099|322682724|FG002|Not Eligible for Period 2|Pregnancy|0|||
94242444|NCT03635099|322682725|FG003|Not Eligible for Period 2|Pregnancy|1|||
94242445|NCT03635099|322682726|FG004|Not Eligible for Period 2|Pregnancy|0|||
94242446|NCT03635099|322682727|FG005|Not Eligible for Period 2|Pregnancy|0|||
94242447|NCT03635099|322682728|FG006|Not Eligible for Period 2|Pregnancy|0|||
94242448|NCT03635099|322682729|FG007|Not Eligible for Period 2|Pregnancy|0|||
94242449|NCT03635099|322682722|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
94242450|NCT03635099|322682723|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
94242451|NCT03635099|322682724|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
94242452|NCT03635099|322682725|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
94242453|NCT03635099|322682726|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
94242454|NCT03635099|322682727|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
94353430|NCT02719028|323077061|FG000|Overall Study|Protocol Violation|0|||
94353431|NCT02719028|323077062|FG001|Overall Study|Protocol Violation|0|||
94353432|NCT02719028|323077063|FG002|Overall Study|Protocol Violation|0|||
94242455|NCT03635099|322682728|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
94242456|NCT03635099|322682729|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
94242457|NCT03635099|322682722|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
94242458|NCT03635099|322682723|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
94242459|NCT03635099|322682724|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
94242460|NCT03635099|322682725|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
94242461|NCT03635099|322682726|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
94242462|NCT03635099|322682727|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
94353433|NCT02719028|323077064|FG003|Overall Study|Protocol Violation|1|||
94353434|NCT01539720|323077066|FG000|Overall Study|Screen Fail|15|||
94584296|NCT02721966|323938462|FG000|Overall Study|Lost to Follow-up|0|||
94584297|NCT02721966|323938463|FG001|Overall Study|Lost to Follow-up|0|||
94659139|NCT01760954|324207988|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
94242463|NCT03635099|322682728|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
94353435|NCT01539720|323077067|FG001|Overall Study|Screen Fail|3|||
94584298|NCT02721966|323938464|FG002|Overall Study|Lost to Follow-up|3|||
94584299|NCT02721966|323938465|FG003|Overall Study|Lost to Follow-up|0|||
94584300|NCT02721966|323938466|FG004|Overall Study|Lost to Follow-up|0|||
94584301|NCT02721966|323938462|FG000|Overall Study|Physician Decision|1|||
94659140|NCT01760954|324207989|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
94688605|NCT00390455|324315526|FG000|Overall Study|Other Medical Reasons|7|||
94455695|NCT05217641|323456406|FG001|Overall Study|Extended Follow up|1|||
94455696|NCT05217641|323456407|FG002|Overall Study|Extended Follow up|0|||
94455697|NCT05217641|323456408|FG003|Overall Study|Extended Follow up|0|||
94455698|NCT05217641|323456409|FG004|Overall Study|Extended Follow up|1|||
94455699|NCT05217641|323456410|FG005|Overall Study|Extended Follow up|0|||
94455700|NCT03452488|323456415|FG000|Overall Study|Adverse Event|4|||
94455701|NCT03452488|323456416|FG001|Overall Study|Adverse Event|6|||
94455702|NCT03452488|323456417|FG002|Overall Study|Adverse Event|1|||
94455703|NCT03452488|323456415|FG000|Overall Study|Death|0|||
94455704|NCT03452488|323456416|FG001|Overall Study|Death|0|||
94455705|NCT03452488|323456417|FG002|Overall Study|Death|1|||
94455706|NCT03452488|323456415|FG000|Overall Study|Lost to Follow-up|1|||
94455707|NCT03452488|323456416|FG001|Overall Study|Lost to Follow-up|2|||
94455708|NCT03452488|323456417|FG002|Overall Study|Lost to Follow-up|0|||
94455709|NCT03452488|323456415|FG000|Overall Study|PI Decision|1|||
94455710|NCT03452488|323456416|FG001|Overall Study|PI Decision|0|||
94455711|NCT03452488|323456417|FG002|Overall Study|PI Decision|0|||
94455712|NCT03452488|323456415|FG000|Overall Study|Withdrew consent|4|||
94455713|NCT03452488|323456416|FG001|Overall Study|Withdrew consent|2|||
94455714|NCT03452488|323456417|FG002|Overall Study|Withdrew consent|2|||
94455715|NCT03452488|323456415|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
94455716|NCT03452488|323456416|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
94455717|NCT03452488|323456417|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
94455718|NCT03452488|323456415|FG000|Overall Study|Other|0|||
94455719|NCT03452488|323456416|FG001|Overall Study|Other|2|||
94455720|NCT03452488|323456417|FG002|Overall Study|Other|2|||
94455721|NCT05481125|323456418|FG000|Overall Study|Adverse Event|1|||
94455722|NCT05481125|323456419|FG001|Overall Study|Adverse Event|0|||
94455723|NCT05481125|323456418|FG000|Overall Study|Lost to Follow-up|0|||
94455724|NCT05481125|323456419|FG001|Overall Study|Lost to Follow-up|1|||
94455725|NCT05481125|323456418|FG000|Overall Study|Withdrawal by Subject|0|||
94455726|NCT05481125|323456419|FG001|Overall Study|Withdrawal by Subject|1|||
94455727|NCT03702010|323456420|FG000|Follow-up (30days)|Lack of Efficacy|2|||
94455728|NCT03702010|323456421|FG001|Follow-up (30days)|Lack of Efficacy|2|||
94455729|NCT01769508|323456422|FG000|Overall Study|Death|3|||
94455730|NCT01769508|323456422|FG000|Overall Study|Withdrawal by Subject|1|||
94455731|NCT01769508|323456422|FG000|Overall Study|Adverse Event|1|||
94455732|NCT01769508|323456422|FG000|Overall Study|Lost to Follow-up|1|||
94455733|NCT00637000|323456427|FG000|Overall Study|Withdrawal by Subject|4|||
94455734|NCT00637000|323456428|FG001|Overall Study|Withdrawal by Subject|3|||
94455735|NCT04016779|323456429|FG000|Overall Study|Adverse Event|9|||
94455736|NCT04016779|323456430|FG001|Overall Study|Adverse Event|17|||
94455737|NCT04016779|323456429|FG000|Overall Study|Lack of Efficacy|4|||
94455738|NCT04016779|323456430|FG001|Overall Study|Lack of Efficacy|1|||
94455739|NCT04016779|323456429|FG000|Overall Study|Lost to Follow-up|5|||
94455740|NCT04016779|323456430|FG001|Overall Study|Lost to Follow-up|14|||
94455741|NCT04016779|323456429|FG000|Overall Study|Physician Decision|1|||
94455742|NCT04016779|323456430|FG001|Overall Study|Physician Decision|3|||
94455743|NCT04016779|323456429|FG000|Overall Study|Withdrawal by Subject|6|||
94455744|NCT04016779|323456430|FG001|Overall Study|Withdrawal by Subject|8|||
94455745|NCT04016779|323456429|FG000|Overall Study|Non-compliance with Study Drug|2|||
94455746|NCT04016779|323456430|FG001|Overall Study|Non-compliance with Study Drug|3|||
94455747|NCT04016779|323456429|FG000|Overall Study|Other, Multiple categories|17|||
94455748|NCT04016779|323456430|FG001|Overall Study|Other, Multiple categories|17|||
94455749|NCT02295020|323456434|FG000|Overall Study|Adverse Event|0|||
94455750|NCT02295020|323456435|FG001|Overall Study|Adverse Event|1|||
94455751|NCT02295020|323456434|FG000|Overall Study|Withdrawal by Subject|3|||
94455752|NCT02295020|323456435|FG001|Overall Study|Withdrawal by Subject|2|||
94455753|NCT04481789|323456436|FG000|Period 1|Withdrawal by Subject|1|||
94455754|NCT04481789|323456437|FG001|Period 1|Withdrawal by Subject|0|||
94455755|NCT04481789|323456438|FG002|Period 1|Withdrawal by Subject|0|||
94455756|NCT04481789|323456439|FG003|Period 1|Withdrawal by Subject|0|||
94455757|NCT04481789|323456440|FG004|Period 1|Withdrawal by Subject|0|||
94455758|NCT04481789|323456441|FG005|Period 1|Withdrawal by Subject|0|||
94455759|NCT01475851|323456447|FG000|Overall Study|Protocol defined stopping criteria|1|||
94455760|NCT01475851|323456448|FG001|Overall Study|Protocol defined stopping criteria|0|||
94455761|NCT01054196|323456449|FG000|Overall Study|Physician Decision|0|||
94455762|NCT01054196|323456450|FG001|Overall Study|Physician Decision|0|||
94455763|NCT01054196|323456451|FG002|Overall Study|Physician Decision|0|||
94455764|NCT01054196|323456452|FG003|Overall Study|Physician Decision|1|||
94455765|NCT01054196|323456453|FG004|Overall Study|Physician Decision|0|||
94455766|NCT01054196|323456454|FG005|Overall Study|Physician Decision|0|||
94455767|NCT01054196|323456455|FG006|Overall Study|Physician Decision|1|||
94455768|NCT03613649|323456459|FG000|Second Treatment|Lost to Follow-up|0|||
94455769|NCT03613649|323456460|FG001|Second Treatment|Lost to Follow-up|0|||
94455770|NCT03613649|323456461|FG002|Second Treatment|Lost to Follow-up|1|||
94455771|NCT03613649|323456462|FG003|Second Treatment|Lost to Follow-up|0|||
94455772|NCT03613649|323456463|FG004|Second Treatment|Lost to Follow-up|0|||
94455773|NCT03613649|323456464|FG005|Second Treatment|Lost to Follow-up|0|||
94455774|NCT03613649|323456465|FG006|Second Treatment|Lost to Follow-up|0|||
94455775|NCT03613649|323456466|FG007|Second Treatment|Lost to Follow-up|0|||
94455776|NCT03613649|323456467|FG008|Second Treatment|Lost to Follow-up|0|||
94455777|NCT03613649|323456468|FG009|Second Treatment|Lost to Follow-up|0|||
94455778|NCT03613649|323456469|FG010|Second Treatment|Lost to Follow-up|0|||
94455779|NCT03613649|323456470|FG011|Second Treatment|Lost to Follow-up|0|||
94455780|NCT03613649|323456459|FG000|Second Treatment|Withdrawal by Subject|0|||
94455781|NCT03613649|323456460|FG001|Second Treatment|Withdrawal by Subject|0|||
94455782|NCT03613649|323456461|FG002|Second Treatment|Withdrawal by Subject|0|||
94455783|NCT03613649|323456462|FG003|Second Treatment|Withdrawal by Subject|0|||
94455784|NCT03613649|323456463|FG004|Second Treatment|Withdrawal by Subject|1|||
94455785|NCT03613649|323456464|FG005|Second Treatment|Withdrawal by Subject|0|||
94455786|NCT03613649|323456465|FG006|Second Treatment|Withdrawal by Subject|0|||
94455787|NCT03613649|323456466|FG007|Second Treatment|Withdrawal by Subject|0|||
94455788|NCT03613649|323456467|FG008|Second Treatment|Withdrawal by Subject|0|||
94455789|NCT03613649|323456468|FG009|Second Treatment|Withdrawal by Subject|0|||
94455790|NCT03613649|323456469|FG010|Second Treatment|Withdrawal by Subject|0|||
94455791|NCT03613649|323456470|FG011|Second Treatment|Withdrawal by Subject|0|||
94455792|NCT03613649|323456459|FG000|Third Treatment|Lost to Follow-up|0|||
94455793|NCT03613649|323456460|FG001|Third Treatment|Lost to Follow-up|0|||
94455794|NCT03613649|323456461|FG002|Third Treatment|Lost to Follow-up|0|||
94455795|NCT03613649|323456462|FG003|Third Treatment|Lost to Follow-up|0|||
94455796|NCT03613649|323456463|FG004|Third Treatment|Lost to Follow-up|1|||
94455797|NCT03613649|323456464|FG005|Third Treatment|Lost to Follow-up|0|||
94455798|NCT03613649|323456465|FG006|Third Treatment|Lost to Follow-up|0|||
94455799|NCT03613649|323456466|FG007|Third Treatment|Lost to Follow-up|0|||
94455800|NCT03613649|323456467|FG008|Third Treatment|Lost to Follow-up|0|||
94455801|NCT03613649|323456468|FG009|Third Treatment|Lost to Follow-up|0|||
94455802|NCT03613649|323456469|FG010|Third Treatment|Lost to Follow-up|0|||
94455803|NCT03613649|323456470|FG011|Third Treatment|Lost to Follow-up|1|||
94455804|NCT03613649|323456459|FG000|Third Treatment|Protocol Violation|0|||
94455805|NCT03613649|323456460|FG001|Third Treatment|Protocol Violation|0|||
94455806|NCT03613649|323456461|FG002|Third Treatment|Protocol Violation|0|||
94455807|NCT03613649|323456462|FG003|Third Treatment|Protocol Violation|0|||
94455808|NCT03613649|323456463|FG004|Third Treatment|Protocol Violation|0|||
94455809|NCT03613649|323456464|FG005|Third Treatment|Protocol Violation|0|||
94455810|NCT03613649|323456465|FG006|Third Treatment|Protocol Violation|1|||
94455811|NCT03613649|323456466|FG007|Third Treatment|Protocol Violation|0|||
94455812|NCT03613649|323456467|FG008|Third Treatment|Protocol Violation|0|||
94584302|NCT02721966|323938463|FG001|Overall Study|Physician Decision|1|||
94584303|NCT02721966|323938464|FG002|Overall Study|Physician Decision|0|||
94584304|NCT02721966|323938465|FG003|Overall Study|Physician Decision|0|||
94584305|NCT02721966|323938466|FG004|Overall Study|Physician Decision|0|||
94584306|NCT02721966|323938462|FG000|Overall Study|Pregnancy|1|||
94584307|NCT02721966|323938463|FG001|Overall Study|Pregnancy|0|||
94584308|NCT02721966|323938464|FG002|Overall Study|Pregnancy|0|||
94584309|NCT02721966|323938465|FG003|Overall Study|Pregnancy|0|||
94584310|NCT02721966|323938466|FG004|Overall Study|Pregnancy|0|||
94584311|NCT02721966|323938462|FG000|Overall Study|Did not continue to period 2|5|||
94584312|NCT02721966|323938463|FG001|Overall Study|Did not continue to period 2|12|||
94584313|NCT02721966|323938464|FG002|Overall Study|Did not continue to period 2|0|||
94584314|NCT02721966|323938465|FG003|Overall Study|Did not continue to period 2|0|||
94584315|NCT02721966|323938466|FG004|Overall Study|Did not continue to period 2|5|||
94584316|NCT00750438|323938472|FG000|Overall Study|Protocol Violation|4|||
94584317|NCT00750438|323938473|FG001|Overall Study|Protocol Violation|1|||
94584318|NCT00750438|323938472|FG000|Overall Study|Physician Decision|2|||
94584319|NCT00750438|323938473|FG001|Overall Study|Physician Decision|2|||
94584320|NCT00750438|323938472|FG000|Overall Study|Withdrawal by Subject|1|||
94584321|NCT00750438|323938473|FG001|Overall Study|Withdrawal by Subject|1|||
94584322|NCT00256997|323938474|FG000|Overall Study|Protocol Violation|1|||
94584323|NCT00256997|323938475|FG001|Overall Study|Protocol Violation|4|||
94584324|NCT00256997|323938474|FG000|Overall Study|Lack of Efficacy|1|||
94584325|NCT00256997|323938475|FG001|Overall Study|Lack of Efficacy|4|||
94455813|NCT03613649|323456468|FG009|Third Treatment|Protocol Violation|0|||
94584326|NCT00256997|323938474|FG000|Overall Study|Death|2|||
94584327|NCT00256997|323938475|FG001|Overall Study|Death|0|||
94584328|NCT00256997|323938474|FG000|Overall Study|Adverse Event|4|||
94455814|NCT03613649|323456469|FG010|Third Treatment|Protocol Violation|0|||
94455815|NCT03613649|323456470|FG011|Third Treatment|Protocol Violation|1|||
94455816|NCT03613649|323456459|FG000|Fourth Treatment|Protocol Violation|1|||
94455817|NCT03613649|323456460|FG001|Fourth Treatment|Protocol Violation|0|||
94455818|NCT03613649|323456461|FG002|Fourth Treatment|Protocol Violation|0|||
94584329|NCT00256997|323938475|FG001|Overall Study|Adverse Event|0|||
94455819|NCT03613649|323456462|FG003|Fourth Treatment|Protocol Violation|0|||
94584330|NCT00256997|323938474|FG000|Overall Study|Lost to Follow-up|3|||
94584331|NCT00256997|323938475|FG001|Overall Study|Lost to Follow-up|5|||
94584332|NCT00256997|323938474|FG000|Overall Study|Withdrawal by Subject|13|||
94584333|NCT00256997|323938475|FG001|Overall Study|Withdrawal by Subject|3|||
94584334|NCT00256997|323938474|FG000|Overall Study|Started but not treated|2|||
94584335|NCT00256997|323938475|FG001|Overall Study|Started but not treated|0|||
94584336|NCT00256997|323938474|FG000|Overall Study|Other|5|||
94353436|NCT01539720|323077066|FG000|Overall Study|Lost to Follow-up|14|||
94353437|NCT01539720|323077067|FG001|Overall Study|Lost to Follow-up|7|||
94584337|NCT00256997|323938475|FG001|Overall Study|Other|8|||
94584338|NCT00256997|323938474|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
94584339|NCT00256997|323938475|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
94584340|NCT00256997|323938474|FG000|Overall Study|Participant Non-compliant|3|||
94584341|NCT00256997|323938475|FG001|Overall Study|Participant Non-compliant|6|||
94584342|NCT00256997|323938474|FG000|Overall Study|Investigator Withdrew Participant|2|||
94584343|NCT00256997|323938475|FG001|Overall Study|Investigator Withdrew Participant|1|||
94584344|NCT02904954|323940445|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
94584345|NCT02904954|323940446|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
94584346|NCT02904954|323940445|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
94584347|NCT02904954|323940446|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
94584348|NCT02904954|323940445|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
94353438|NCT03938857|323077069|FG000|Overall Study|Physician Decision|1|||
94353439|NCT03938857|323077070|FG001|Overall Study|Physician Decision|0|||
94353440|NCT03938857|323077071|FG002|Overall Study|Physician Decision|0|||
94353441|NCT03938857|323077072|FG003|Overall Study|Physician Decision|0|||
94353442|NCT03198559|323077073|FG000|Overall Study|Adverse Event|2|||
94353443|NCT01072175|323077074|FG000|Part A (Drug-Drug Interaction)|Death|1|||
94353444|NCT01072175|323077075|FG001|Part A (Drug-Drug Interaction)|Death|0|||
94353445|NCT01072175|323077076|FG002|Part A (Drug-Drug Interaction)|Death|0|||
94353446|NCT01072175|323077077|FG003|Part A (Drug-Drug Interaction)|Death|0|||
94353447|NCT01072175|323077078|FG004|Part A (Drug-Drug Interaction)|Death|0|||
94353448|NCT01072175|323077079|FG005|Part A (Drug-Drug Interaction)|Death|0|||
94353449|NCT01072175|323077080|FG006|Part A (Drug-Drug Interaction)|Death|0|||
94353450|NCT01072175|323077081|FG007|Part A (Drug-Drug Interaction)|Death|0|||
94353451|NCT01072175|323077082|FG008|Part A (Drug-Drug Interaction)|Death|0|||
94353452|NCT01072175|323077083|FG009|Part A (Drug-Drug Interaction)|Death|0|||
94353453|NCT01072175|323077084|FG010|Part A (Drug-Drug Interaction)|Death|0|||
94353454|NCT01072175|323077085|FG011|Part A (Drug-Drug Interaction)|Death|0|||
94353455|NCT01072175|323077086|FG012|Part A (Drug-Drug Interaction)|Death|0|||
94353456|NCT01072175|323077074|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
94353457|NCT01072175|323077075|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
94353458|NCT01072175|323077076|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
94353459|NCT01072175|323077077|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
94353460|NCT01072175|323077078|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
94353461|NCT01072175|323077079|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
94353462|NCT01072175|323077080|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
94353463|NCT01072175|323077081|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
94353464|NCT01072175|323077082|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
94353465|NCT01072175|323077083|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
94353466|NCT01072175|323077084|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
94353467|NCT01072175|323077085|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
94353468|NCT01072175|323077086|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
94353469|NCT01072175|323077074|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
94353470|NCT01072175|323077075|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
94353471|NCT01072175|323077076|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
94353472|NCT01072175|323077077|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
94353473|NCT01072175|323077078|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
94353474|NCT01072175|323077079|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
94353475|NCT01072175|323077080|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
94353476|NCT01072175|323077081|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
94353477|NCT01072175|323077082|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
94584349|NCT02904954|323940446|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
94584350|NCT02904954|323940445|FG000|Adjuvant Durvalumab|Recurrence|2|||
94584351|NCT02904954|323940446|FG001|Adjuvant Durvalumab|Recurrence|0|||
94584352|NCT02904954|323940445|FG000|Adjuvant Durvalumab|Adverse Event|2|||
94584353|NCT02904954|323940446|FG001|Adjuvant Durvalumab|Adverse Event|6|||
94584354|NCT02904954|323940445|FG000|Adjuvant Durvalumab|Participant wishes|12|||
94584355|NCT02904954|323940446|FG001|Adjuvant Durvalumab|Participant wishes|7|||
94584356|NCT02904954|323940445|FG000|Adjuvant Durvalumab|Physician Decision|2|||
94584357|NCT02904954|323940446|FG001|Adjuvant Durvalumab|Physician Decision|1|||
94584358|NCT02904954|323940445|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
94353478|NCT01072175|323077083|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
94584359|NCT02904954|323940446|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
94455820|NCT03613649|323456463|FG004|Fourth Treatment|Protocol Violation|1|||
94455821|NCT03613649|323456464|FG005|Fourth Treatment|Protocol Violation|0|||
94455822|NCT03613649|323456465|FG006|Fourth Treatment|Protocol Violation|0|||
94584360|NCT02904954|323940445|FG000|Adjuvant Durvalumab|Death|0|||
94584361|NCT02904954|323940446|FG001|Adjuvant Durvalumab|Death|1|||
94584362|NCT02904954|323940445|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
94584363|NCT02904954|323940446|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
94584364|NCT05097963|323940449|FG000|Overall Study|Protocol Violation|13|||
94242464|NCT03635099|322682729|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
94242465|NCT03635099|322682722|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
94584365|NCT05097963|323940449|FG000|Overall Study|Withdrawal by Subject|21|||
94584366|NCT01413204|323940459|FG000|Overall Study|Adverse Event|1|||
94584367|NCT01413204|323940460|FG001|Overall Study|Adverse Event|2|||
94584368|NCT01413204|323940461|FG002|Overall Study|Adverse Event|2|||
94584369|NCT01413204|323940459|FG000|Overall Study|Physician Decision|3|||
94584370|NCT01413204|323940460|FG001|Overall Study|Physician Decision|0|||
94584371|NCT01413204|323940461|FG002|Overall Study|Physician Decision|2|||
94584372|NCT01413204|323940459|FG000|Overall Study|Withdrawal by Subject|1|||
94584373|NCT01413204|323940460|FG001|Overall Study|Withdrawal by Subject|4|||
94584374|NCT01413204|323940461|FG002|Overall Study|Withdrawal by Subject|4|||
94584375|NCT01413204|323940459|FG000|Overall Study|Clearly not eligible for the study|0|||
94584376|NCT01413204|323940460|FG001|Overall Study|Clearly not eligible for the study|0|||
94455823|NCT03613649|323456466|FG007|Fourth Treatment|Protocol Violation|0|||
94455824|NCT03613649|323456467|FG008|Fourth Treatment|Protocol Violation|0|||
94455825|NCT03613649|323456468|FG009|Fourth Treatment|Protocol Violation|0|||
94455826|NCT03613649|323456469|FG010|Fourth Treatment|Protocol Violation|0|||
94455827|NCT03613649|323456470|FG011|Fourth Treatment|Protocol Violation|0|||
94455828|NCT03613649|323456459|FG000|Fourth Treatment|Physician Decision|0|||
94455829|NCT03613649|323456460|FG001|Fourth Treatment|Physician Decision|0|||
94455830|NCT03613649|323456461|FG002|Fourth Treatment|Physician Decision|0|||
94242466|NCT03635099|322682723|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
94242467|NCT03635099|322682724|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
94455831|NCT03613649|323456462|FG003|Fourth Treatment|Physician Decision|0|||
94455832|NCT03613649|323456463|FG004|Fourth Treatment|Physician Decision|0|||
94242468|NCT03635099|322682725|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
94242469|NCT03635099|322682726|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
94242470|NCT03635099|322682727|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
94242471|NCT03635099|322682728|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
94242472|NCT03635099|322682729|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
94455833|NCT03613649|323456464|FG005|Fourth Treatment|Physician Decision|0|||
94455834|NCT03613649|323456465|FG006|Fourth Treatment|Physician Decision|1|||
94455835|NCT03613649|323456466|FG007|Fourth Treatment|Physician Decision|0|||
94455836|NCT03613649|323456467|FG008|Fourth Treatment|Physician Decision|0|||
94455837|NCT03613649|323456468|FG009|Fourth Treatment|Physician Decision|0|||
94455838|NCT03613649|323456469|FG010|Fourth Treatment|Physician Decision|0|||
94584377|NCT01413204|323940461|FG002|Overall Study|Clearly not eligible for the study|1|||
94584378|NCT01413204|323940459|FG000|Overall Study|Fasting plasma glucose level increased|1|||
94584379|NCT01413204|323940460|FG001|Overall Study|Fasting plasma glucose level increased|0|||
94584380|NCT01413204|323940461|FG002|Overall Study|Fasting plasma glucose level increased|10|||
94584381|NCT01039376|323940462|FG000|Overall Study|Lost to Follow-up|5|||
94584382|NCT01039376|323940463|FG001|Overall Study|Lost to Follow-up|12|||
94584383|NCT01039376|323940462|FG000|Overall Study|Physician Decision|15|||
94659141|NCT01760954|324207990|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
94659142|NCT01760954|324207991|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
94242473|NCT03635099|322682722|FG000|Period 2|Adverse Event|0|||
94455839|NCT03613649|323456470|FG011|Fourth Treatment|Physician Decision|0|||
94455840|NCT01217476|323456481|FG000|Overall Study|Adverse Event|6|||
94455841|NCT01217476|323456482|FG001|Overall Study|Adverse Event|1|||
94455842|NCT01217476|323456481|FG000|Overall Study|Physician Decision|0|||
94455843|NCT01217476|323456482|FG001|Overall Study|Physician Decision|1|||
94455844|NCT01217476|323456481|FG000|Overall Study|Withdrawal by Subject|3|||
94455845|NCT01217476|323456482|FG001|Overall Study|Withdrawal by Subject|3|||
94584384|NCT01039376|323940463|FG001|Overall Study|Physician Decision|10|||
94242474|NCT03635099|322682723|FG001|Period 2|Adverse Event|0|||
94242475|NCT03635099|322682724|FG002|Period 2|Adverse Event|1|||
94242476|NCT03635099|322682725|FG003|Period 2|Adverse Event|0|||
94455846|NCT01217476|323456481|FG000|Overall Study|Surgery on the Target Limb|0|||
94455847|NCT01217476|323456482|FG001|Overall Study|Surgery on the Target Limb|2|||
94584385|NCT01039376|323940462|FG000|Overall Study|Withdrawal by Subject|20|||
94584386|NCT01039376|323940463|FG001|Overall Study|Withdrawal by Subject|32|||
94455848|NCT01217476|323456481|FG000|Overall Study|Protocol Deviation|1|||
94455849|NCT01217476|323456482|FG001|Overall Study|Protocol Deviation|0|||
94455850|NCT01217476|323456481|FG000|Overall Study|Other|2|||
94455851|NCT01217476|323456482|FG001|Overall Study|Other|0|||
94455852|NCT05033262|323456486|FG000|Overall Study|Lost to Follow-up|1|||
94353479|NCT01072175|323077084|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
94353480|NCT01072175|323077085|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
94353481|NCT01072175|323077086|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
94353482|NCT01072175|323077074|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
94353483|NCT01072175|323077075|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
94353484|NCT01072175|323077076|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
94353485|NCT01072175|323077077|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
94353486|NCT01072175|323077078|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
94353487|NCT01072175|323077079|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
94353488|NCT01072175|323077080|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
94353489|NCT01072175|323077081|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
94353490|NCT01072175|323077082|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
94353491|NCT01072175|323077083|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
94353492|NCT01072175|323077084|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
94353493|NCT01072175|323077085|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
94353494|NCT01072175|323077086|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
94353495|NCT01072175|323077074|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
94353496|NCT01072175|323077075|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
94353497|NCT01072175|323077076|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
94353498|NCT01072175|323077077|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
94353499|NCT01072175|323077078|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
94353500|NCT01072175|323077079|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
94353501|NCT01072175|323077080|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
94353502|NCT01072175|323077081|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
94353503|NCT01072175|323077082|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
94353504|NCT01072175|323077083|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
94353505|NCT01072175|323077084|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
94353506|NCT01072175|323077085|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
94353507|NCT01072175|323077086|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
94353508|NCT01072175|323077074|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
94353509|NCT01072175|323077075|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
94353510|NCT01072175|323077076|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
94353511|NCT01072175|323077077|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
94353512|NCT01072175|323077078|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
94353513|NCT01072175|323077079|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
94353514|NCT01072175|323077080|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
94353515|NCT01072175|323077081|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
94353516|NCT01072175|323077082|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
94353517|NCT01072175|323077083|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
94353518|NCT01072175|323077084|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
94353519|NCT01072175|323077085|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
94353520|NCT01072175|323077086|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
94353521|NCT01072175|323077074|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
94353522|NCT01072175|323077075|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
94353523|NCT01072175|323077076|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
94353524|NCT01072175|323077077|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
94353525|NCT01072175|323077078|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
94353526|NCT01072175|323077079|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
94353527|NCT01072175|323077080|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
94353528|NCT01072175|323077081|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
94353529|NCT01072175|323077082|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
94455853|NCT05033262|323456487|FG001|Overall Study|Lost to Follow-up|0|||
94455854|NCT05033262|323456488|FG002|Overall Study|Lost to Follow-up|0|||
94455855|NCT05033262|323456489|FG003|Overall Study|Lost to Follow-up|1|||
94455856|NCT03214380|323458110|FG000|Lead-in|Adverse Event|3|||
94455857|NCT03214380|323458111|FG001|Lead-in|Adverse Event|0|||
94455858|NCT03214380|323458112|FG002|Lead-in|Adverse Event|0|||
94455859|NCT03214380|323458113|FG003|Lead-in|Adverse Event|1|||
94353530|NCT01072175|323077083|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
94353531|NCT01072175|323077084|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
94353532|NCT01072175|323077085|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
94353533|NCT01072175|323077086|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
94353534|NCT01072175|323077074|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
94353535|NCT01072175|323077075|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
94455860|NCT03214380|323458114|FG004|Lead-in|Adverse Event|0|||
94455861|NCT03214380|323458115|FG005|Lead-in|Adverse Event|0|||
94455862|NCT03214380|323458110|FG000|Lead-in|Lost to Follow-up|4|||
94455863|NCT03214380|323458111|FG001|Lead-in|Lost to Follow-up|0|||
94455864|NCT03214380|323458112|FG002|Lead-in|Lost to Follow-up|0|||
94455865|NCT03214380|323458113|FG003|Lead-in|Lost to Follow-up|1|||
94455866|NCT03214380|323458114|FG004|Lead-in|Lost to Follow-up|0|||
94455867|NCT03214380|323458115|FG005|Lead-in|Lost to Follow-up|0|||
94584387|NCT01039376|323940462|FG000|Overall Study|Study terminated by Sponsor|90|||
94584388|NCT01039376|323940463|FG001|Overall Study|Study terminated by Sponsor|72|||
94584389|NCT02978781|323940464|FG000|Part A|Adverse Event|1|||
94584390|NCT02978781|323940465|FG001|Part A|Adverse Event|1|||
94584391|NCT02978781|323940466|FG002|Part A|Adverse Event|0|||
94584392|NCT02978781|323940467|FG003|Part A|Adverse Event|0|||
94584393|NCT02978781|323940468|FG004|Part A|Adverse Event|0|||
94584394|NCT02978781|323940464|FG000|Part A|Withdrawal by Subject|0|||
94584395|NCT02978781|323940465|FG001|Part A|Withdrawal by Subject|1|||
94584396|NCT02978781|323940466|FG002|Part A|Withdrawal by Subject|0|||
94584397|NCT02978781|323940467|FG003|Part A|Withdrawal by Subject|0|||
94584398|NCT02978781|323940468|FG004|Part A|Withdrawal by Subject|0|||
94455868|NCT03214380|323458110|FG000|Lead-in|Eligibility Criteria|3|||
94455869|NCT03214380|323458111|FG001|Lead-in|Eligibility Criteria|0|||
94455870|NCT03214380|323458112|FG002|Lead-in|Eligibility Criteria|0|||
94584399|NCT02978781|323940464|FG000|Part B|Withdrawal by Subject|0|||
94584400|NCT02978781|323940465|FG001|Part B|Withdrawal by Subject|0|||
94584401|NCT02978781|323940466|FG002|Part B|Withdrawal by Subject|0|||
94584402|NCT02978781|323940467|FG003|Part B|Withdrawal by Subject|1|||
94584403|NCT02978781|323940468|FG004|Part B|Withdrawal by Subject|0|||
94584404|NCT02978781|323940464|FG000|Part C|Adverse Event|0|||
94584405|NCT02978781|323940465|FG001|Part C|Adverse Event|0|||
94584406|NCT02978781|323940466|FG002|Part C|Adverse Event|0|||
94584407|NCT02978781|323940467|FG003|Part C|Adverse Event|0|||
94584408|NCT02978781|323940468|FG004|Part C|Adverse Event|2|||
94584409|NCT02978781|323940464|FG000|Part C|Withdrawal by Subject|0|||
94584410|NCT02978781|323940465|FG001|Part C|Withdrawal by Subject|0|||
94584411|NCT02978781|323940466|FG002|Part C|Withdrawal by Subject|0|||
94353536|NCT01072175|323077076|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
94353537|NCT01072175|323077077|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
94353538|NCT01072175|323077078|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
94353539|NCT01072175|323077079|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
94353540|NCT01072175|323077080|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
94353541|NCT01072175|323077081|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
94353542|NCT01072175|323077082|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
94353543|NCT01072175|323077083|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
94455871|NCT03214380|323458113|FG003|Lead-in|Eligibility Criteria|0|||
94455872|NCT03214380|323458114|FG004|Lead-in|Eligibility Criteria|0|||
94455873|NCT03214380|323458115|FG005|Lead-in|Eligibility Criteria|0|||
94455874|NCT03214380|323458110|FG000|Lead-in|Physician Decision|6|||
94455875|NCT03214380|323458111|FG001|Lead-in|Physician Decision|0|||
94584412|NCT02978781|323940467|FG003|Part C|Withdrawal by Subject|0|||
94584413|NCT02978781|323940468|FG004|Part C|Withdrawal by Subject|1|||
94584414|NCT02978781|323940464|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
94455876|NCT03214380|323458112|FG002|Lead-in|Physician Decision|0|||
94455877|NCT03214380|323458113|FG003|Lead-in|Physician Decision|0|||
94584415|NCT02978781|323940465|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
94584416|NCT02978781|323940466|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
94584417|NCT02978781|323940467|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
94584418|NCT02978781|323940468|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
94584419|NCT00753649|323940469|FG000|Overall Study|Migrated/moved from study area|1|||
94584420|NCT00753649|323940470|FG001|Overall Study|Migrated/moved from study area|0|||
94584421|NCT00753649|323940469|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
94584422|NCT00753649|323940470|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
94584423|NCT00753649|323940469|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
94584424|NCT00753649|323940470|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
94584425|NCT00753649|323940469|FG000|Overall Study|Protocol Violation|2|||
94584426|NCT00753649|323940470|FG001|Overall Study|Protocol Violation|0|||
94584427|NCT03252925|323940471|FG000|Overall Study|Withdrawal by Subject|1|||
94584428|NCT03252925|323940472|FG001|Overall Study|Withdrawal by Subject|0|||
94584429|NCT03252925|323940471|FG000|Overall Study|Protocol Violation|6|||
94584430|NCT03252925|323940472|FG001|Overall Study|Protocol Violation|0|||
94584431|NCT03252925|323940471|FG000|Overall Study|Adverse Event|1|||
94584432|NCT03252925|323940472|FG001|Overall Study|Adverse Event|0|||
94455878|NCT03214380|323458114|FG004|Lead-in|Physician Decision|0|||
94455879|NCT03214380|323458115|FG005|Lead-in|Physician Decision|0|||
94455880|NCT03214380|323458110|FG000|Lead-in|Protocol Deviation|7|||
94455881|NCT03214380|323458111|FG001|Lead-in|Protocol Deviation|0|||
94584433|NCT03252925|323940471|FG000|Overall Study|Lost to Follow-up|6|||
94584434|NCT03252925|323940472|FG001|Overall Study|Lost to Follow-up|6|||
94584435|NCT00357552|323940473|FG000|Screening|Did not meet eligibility criteria|84|||
94584436|NCT00357552|323940473|FG000|Weeks 0 to 24|Death|1|||
94584437|NCT00357552|323940473|FG000|Weeks 24 to 104|Death|3|||
94584438|NCT00357552|323940473|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
94584439|NCT00521404|323940476|FG000|Overall Study|Adverse Event|13|||
94584440|NCT00521404|323940476|FG000|Overall Study|Disease Progression|33|||
94584441|NCT00521404|323940476|FG000|Overall Study|Investigator decision|5|||
94584442|NCT00521404|323940476|FG000|Overall Study|Withdrawal of consent|3|||
94584443|NCT00521404|323940476|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
94584444|NCT00521404|323940476|FG000|Overall Study|Other|7|||
94584445|NCT01528969|323940478|FG000|Overall Study|absent from the school at baseline|2|||
94584446|NCT01528969|323940479|FG001|Overall Study|absent from the school at baseline|0|||
94584447|NCT00711191|323940485|FG000|Overall Study|Adverse Event|1|||
94584448|NCT00711191|323940486|FG001|Overall Study|Adverse Event|1|||
94584449|NCT00711191|323940487|FG002|Overall Study|Adverse Event|2|||
94584450|NCT00711191|323940485|FG000|Overall Study|Objective progression or relapse|2|||
94584451|NCT00711191|323940486|FG001|Overall Study|Objective progression or relapse|3|||
94584452|NCT00711191|323940487|FG002|Overall Study|Objective progression or relapse|7|||
94584453|NCT00711191|323940485|FG000|Overall Study|Withdrawal by Subject|0|||
94584454|NCT00711191|323940486|FG001|Overall Study|Withdrawal by Subject|1|||
94584455|NCT00711191|323940487|FG002|Overall Study|Withdrawal by Subject|3|||
94584456|NCT02560558|323940491|FG000|Overall Study|Adverse Event|1|||
94584457|NCT02560558|323940492|FG001|Overall Study|Adverse Event|0|||
94584458|NCT02560558|323940491|FG000|Overall Study|Death|0|||
94584459|NCT02560558|323940492|FG001|Overall Study|Death|2|||
94584460|NCT02560558|323940491|FG000|Overall Study|Lost to Follow-up|0|||
94584461|NCT02560558|323940492|FG001|Overall Study|Lost to Follow-up|4|||
94584462|NCT02560558|323940491|FG000|Overall Study|Protocol Violation|3|||
94584463|NCT02560558|323940492|FG001|Overall Study|Protocol Violation|0|||
94584464|NCT02560558|323940491|FG000|Overall Study|Withdrawal by Subject|3|||
94584465|NCT02560558|323940492|FG001|Overall Study|Withdrawal by Subject|0|||
94584466|NCT01134055|323940503|FG000|Overall Study|Adverse Event|5|||
94584467|NCT01134055|323940504|FG001|Overall Study|Adverse Event|2|||
94584468|NCT01134055|323940505|FG002|Overall Study|Adverse Event|2|||
94584469|NCT01134055|323940506|FG003|Overall Study|Adverse Event|2|||
94584470|NCT01134055|323940507|FG004|Overall Study|Adverse Event|5|||
94455882|NCT03214380|323458112|FG002|Lead-in|Protocol Deviation|0|||
94584471|NCT01134055|323940508|FG005|Overall Study|Adverse Event|7|||
94584472|NCT01134055|323940509|FG006|Overall Study|Adverse Event|2|||
94455883|NCT03214380|323458113|FG003|Lead-in|Protocol Deviation|3|||
94584473|NCT01134055|323940503|FG000|Overall Study|Lost to Follow-up|0|||
94584474|NCT01134055|323940504|FG001|Overall Study|Lost to Follow-up|1|||
94584475|NCT01134055|323940505|FG002|Overall Study|Lost to Follow-up|0|||
94584476|NCT01134055|323940506|FG003|Overall Study|Lost to Follow-up|1|||
94584477|NCT01134055|323940507|FG004|Overall Study|Lost to Follow-up|0|||
94584478|NCT01134055|323940508|FG005|Overall Study|Lost to Follow-up|0|||
94584479|NCT01134055|323940509|FG006|Overall Study|Lost to Follow-up|0|||
94584480|NCT01134055|323940503|FG000|Overall Study|Withdrawal by Subject|3|||
94584481|NCT01134055|323940504|FG001|Overall Study|Withdrawal by Subject|3|||
94584482|NCT01134055|323940505|FG002|Overall Study|Withdrawal by Subject|1|||
94584483|NCT01134055|323940506|FG003|Overall Study|Withdrawal by Subject|2|||
94584484|NCT01134055|323940507|FG004|Overall Study|Withdrawal by Subject|0|||
94584485|NCT01134055|323940508|FG005|Overall Study|Withdrawal by Subject|0|||
94584486|NCT01134055|323940509|FG006|Overall Study|Withdrawal by Subject|8|||
94584487|NCT01134055|323940503|FG000|Overall Study|Protocol Violation|0|||
94584488|NCT01134055|323940504|FG001|Overall Study|Protocol Violation|0|||
94584489|NCT01134055|323940505|FG002|Overall Study|Protocol Violation|0|||
94584490|NCT01134055|323940506|FG003|Overall Study|Protocol Violation|1|||
94584491|NCT01134055|323940507|FG004|Overall Study|Protocol Violation|1|||
94584492|NCT01134055|323940508|FG005|Overall Study|Protocol Violation|0|||
94584493|NCT01134055|323940509|FG006|Overall Study|Protocol Violation|0|||
94584494|NCT01134055|323940503|FG000|Overall Study|Physician Decision|0|||
94584495|NCT01134055|323940504|FG001|Overall Study|Physician Decision|0|||
94584496|NCT01134055|323940505|FG002|Overall Study|Physician Decision|0|||
94584497|NCT01134055|323940506|FG003|Overall Study|Physician Decision|0|||
94584498|NCT01134055|323940507|FG004|Overall Study|Physician Decision|0|||
94584499|NCT01134055|323940508|FG005|Overall Study|Physician Decision|0|||
94584500|NCT01134055|323940509|FG006|Overall Study|Physician Decision|1|||
94584501|NCT02577718|323940510|FG000|Overall Study|Death|6|||
94584502|NCT02577718|323940510|FG000|Overall Study|Withdrawal by Subject|2|||
94584503|NCT00275509|323940515|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
94584504|NCT00275509|323940516|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
94584505|NCT01967576|323940517|FG000|Overall Study|Withdrawal by Subject|3|||
94584506|NCT01967576|323940517|FG000|Overall Study|Progressed/Removed from treatment|1|||
94584507|NCT01967576|323940517|FG000|Overall Study|Study closing at site|1|||
94584508|NCT01967576|323940517|FG000|Overall Study|Adverse Event|1|||
94584509|NCT01967576|323940517|FG000|Overall Study|Refused further treatment|1|||
94584510|NCT00811018|323940518|FG000|Overall Study|Additional Chronic Treatment|31|||
94584511|NCT00811018|323940518|FG000|Overall Study|Adverse Event|79|||
94584512|NCT00811018|323940518|FG000|Overall Study|Death|147|||
94584513|NCT00811018|323940518|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
94584514|NCT00811018|323940518|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
94584515|NCT00811018|323940518|FG000|Overall Study|Investigator Decision|57|||
94584516|NCT00811018|323940518|FG000|Overall Study|Lost to Follow-up|19|||
94584517|NCT00811018|323940518|FG000|Overall Study|Pregnancy|6|||
94584518|NCT00811018|323940518|FG000|Overall Study|Sponsor Decision|450|||
94584519|NCT00811018|323940518|FG000|Overall Study|Withdrawal by Subject|70|||
94584520|NCT00811018|323940518|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
94584521|NCT00811018|323940518|FG000|Overall Study|Other|26|||
94584522|NCT03967444|323940523|FG000|Overall Study|Lost to Follow-up|1|||
94584523|NCT03967444|323940524|FG001|Overall Study|Lost to Follow-up|2|||
94584524|NCT01605799|323940534|FG000|Overall Study|Withdrawal by Subject|2|||
94584525|NCT01605799|323940535|FG001|Overall Study|Withdrawal by Subject|1|||
94584526|NCT00392769|323940536|FG000|Overall Study|Clinical Deterioration|9|||
94584527|NCT00392769|323940536|FG000|Overall Study|Adverse Event|1|||
94584528|NCT00345358|323940543|FG000|Primary Vaccination Phase|Other|0|||
94659143|NCT01760954|324207988|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
94659144|NCT01760954|324207989|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
94659145|NCT01760954|324207990|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
94584529|NCT00345358|323940544|FG001|Primary Vaccination Phase|Other|1|||
94584530|NCT00345358|323940545|FG002|Primary Vaccination Phase|Other|1|||
94584531|NCT00345358|323940546|FG003|Primary Vaccination Phase|Other|0|||
94584532|NCT00345358|323940543|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
94584533|NCT00345358|323940544|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
94584534|NCT00345358|323940545|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
94584535|NCT00345358|323940546|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
94584536|NCT00345358|323940543|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
94584537|NCT00345358|323940544|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
94584538|NCT00345358|323940545|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
94584539|NCT00345358|323940546|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
94584540|NCT00345358|323940543|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
94584541|NCT00345358|323940544|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
94584542|NCT00345358|323940545|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
94584543|NCT00345358|323940546|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
94584544|NCT00345358|323940543|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
94584545|NCT00345358|323940544|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
94584546|NCT00345358|323940545|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
94584547|NCT00345358|323940546|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
94584548|NCT00345358|323940543|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
94584549|NCT00345358|323940544|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
94584550|NCT00345358|323940545|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
94584551|NCT00345358|323940546|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
94584552|NCT00686686|323940547|FG000|Overall Study|Non-compliance|1|||
94584553|NCT00686686|323940547|FG000|Overall Study|Adverse Event|2|||
94584554|NCT00686686|323940547|FG000|Overall Study|Lost to Follow-up|3|||
94584555|NCT02304367|323940548|FG000|Overall Study|Lack of Response to Bruosumab|1|||
94584556|NCT02304367|323940548|FG000|Overall Study|Sponsor Decision|3|||
94584557|NCT02304367|323940548|FG000|Overall Study|Death|2|||
94584558|NCT02304367|323940548|FG000|Overall Study|Physician Decision|1|||
94584559|NCT02304367|323940548|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
94584560|NCT00594815|323940549|FG000|Overall Study|Never Treated|3|||
94584561|NCT00594815|323940549|FG000|Overall Study|Withdrawal by Subject|2|||
94584562|NCT00594815|323940549|FG000|Overall Study|Toxicity|4|||
94584563|NCT00643162|323940552|FG000|Overall Study|Withdrawal by Subject|1|||
94584564|NCT00643162|323940553|FG001|Overall Study|Withdrawal by Subject|1|||
94584565|NCT01454102|323940554|FG000|Overall Study|Continuing in the treatment period|0|||
94584566|NCT01454102|323940555|FG001|Overall Study|Continuing in the treatment period|0|||
94584567|NCT01454102|323940556|FG002|Overall Study|Continuing in the treatment period|0|||
94584568|NCT01454102|323940557|FG003|Overall Study|Continuing in the treatment period|0|||
94584569|NCT01454102|323940558|FG004|Overall Study|Continuing in the treatment period|3|||
94584570|NCT01454102|323940559|FG005|Overall Study|Continuing in the treatment period|3|||
94584571|NCT01454102|323940560|FG006|Overall Study|Continuing in the treatment period|2|||
94584572|NCT01454102|323940561|FG007|Overall Study|Continuing in the treatment period|0|||
94584573|NCT01454102|323940562|FG008|Overall Study|Continuing in the treatment period|1|||
94584574|NCT01454102|323940563|FG009|Overall Study|Continuing in the treatment period|0|||
94584575|NCT01454102|323940564|FG010|Overall Study|Continuing in the treatment period|0|||
94584576|NCT01454102|323940565|FG011|Overall Study|Continuing in the treatment period|4|||
94584577|NCT01454102|323940566|FG012|Overall Study|Continuing in the treatment period|7|||
94584578|NCT01454102|323940567|FG013|Overall Study|Continuing in the treatment period|4|||
94584579|NCT01454102|323940568|FG014|Overall Study|Continuing in the treatment period|3|||
94584580|NCT01454102|323940569|FG015|Overall Study|Continuing in the treatment period|1|||
94659146|NCT01760954|324207991|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
94659147|NCT01760954|324207988|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
94584581|NCT03857867|323940571|FG000|Overall Study|Physician Decision|1|||
94584582|NCT03070964|323940572|FG000|Overall Study|Progressive disease|8|||
94584583|NCT03070964|323940572|FG000|Overall Study|Treatment-unrelated adverse event|2|||
94584584|NCT03070964|323940572|FG000|Overall Study|Never treated|1|||
94584585|NCT03070964|323940572|FG000|Overall Study|Physician Decision|1|||
94584586|NCT03070964|323940572|FG000|Overall Study|Withdrawal by Subject|1|||
94584587|NCT03070964|323940572|FG000|Overall Study|Adverse Event|1|||
94584588|NCT01869764|323940573|FG000|Overall Study|Withdrawal by Subject|0|||
94584589|NCT01869764|323940574|FG001|Overall Study|Withdrawal by Subject|2|||
94584590|NCT02175030|323940575|FG000|Overall Study|Failed screen after consent|7|||
94584591|NCT02175030|323940576|FG001|Overall Study|Failed screen after consent|6|||
94584592|NCT02175030|323940575|FG000|Overall Study|Failed IUD Insertion|20|||
94584593|NCT02175030|323940576|FG001|Overall Study|Failed IUD Insertion|21|||
94584594|NCT02175030|323940575|FG000|Overall Study|Physician Decision|1|||
94659148|NCT01760954|324207989|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
94659149|NCT01760954|324207990|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
94659150|NCT01760954|324207991|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
94659151|NCT02318329|324207994|FG000|Overall Study|Progressive Disease|2|||
94659152|NCT02318329|324207995|FG001|Overall Study|Progressive Disease|3|||
94659153|NCT02318329|324207996|FG002|Overall Study|Progressive Disease|2|||
94659154|NCT02318329|324207997|FG003|Overall Study|Progressive Disease|3|||
94659155|NCT02318329|324207998|FG004|Overall Study|Progressive Disease|3|||
94659156|NCT02318329|324207999|FG005|Overall Study|Progressive Disease|3|||
94659157|NCT02318329|324208000|FG006|Overall Study|Progressive Disease|1|||
94659158|NCT02318329|324208001|FG007|Overall Study|Progressive Disease|1|||
94659159|NCT02318329|324208002|FG008|Overall Study|Progressive Disease|5|||
94659160|NCT02318329|324208003|FG009|Overall Study|Progressive Disease|39|||
94659161|NCT02318329|324207994|FG000|Overall Study|Death|0|||
94659162|NCT02318329|324207995|FG001|Overall Study|Death|0|||
94659163|NCT02318329|324207996|FG002|Overall Study|Death|0|||
94659164|NCT02318329|324207997|FG003|Overall Study|Death|0|||
94659165|NCT02318329|324207998|FG004|Overall Study|Death|0|||
94659166|NCT02318329|324207999|FG005|Overall Study|Death|0|||
94659167|NCT02318329|324208000|FG006|Overall Study|Death|0|||
94584595|NCT02175030|323940576|FG001|Overall Study|Physician Decision|1|||
94584596|NCT02175030|323940575|FG000|Overall Study|Lost to Follow-up|6|||
94659168|NCT02318329|324208001|FG007|Overall Study|Death|0|||
94659169|NCT02318329|324208002|FG008|Overall Study|Death|0|||
94242477|NCT03635099|322682726|FG004|Period 2|Adverse Event|1|||
94659170|NCT02318329|324208003|FG009|Overall Study|Death|5|||
94584597|NCT02175030|323940576|FG001|Overall Study|Lost to Follow-up|6|||
94584598|NCT02175030|323940575|FG000|Overall Study|Withdrawal by Subject|1|||
94659171|NCT02318329|324207994|FG000|Overall Study|Lost to Follow-up|0|||
94659172|NCT02318329|324207995|FG001|Overall Study|Lost to Follow-up|0|||
94659173|NCT02318329|324207996|FG002|Overall Study|Lost to Follow-up|0|||
94584599|NCT02175030|323940576|FG001|Overall Study|Withdrawal by Subject|4|||
94584600|NCT01286480|323940577|FG000|Overall Study|Withdrawal by Subject|5|||
94584601|NCT01286480|323940578|FG001|Overall Study|Withdrawal by Subject|3|||
94584602|NCT01587924|323940580|FG000|Overall Study|Adverse Event|0|||
94584603|NCT01587924|323940581|FG001|Overall Study|Adverse Event|2|||
94584604|NCT01587924|323940582|FG002|Overall Study|Adverse Event|0|||
94584605|NCT01587924|323940583|FG003|Overall Study|Adverse Event|0|||
94584606|NCT01587924|323940580|FG000|Overall Study|Protocol Violation|2|||
94584607|NCT01587924|323940581|FG001|Overall Study|Protocol Violation|1|||
94584608|NCT01587924|323940582|FG002|Overall Study|Protocol Violation|2|||
94584609|NCT01587924|323940583|FG003|Overall Study|Protocol Violation|1|||
94584610|NCT01587924|323940580|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
94584611|NCT01587924|323940581|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
94584612|NCT01587924|323940582|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
94584613|NCT01587924|323940583|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
94584614|NCT01587924|323940580|FG000|Overall Study|Withdrawal by Subject|0|||
94584615|NCT01587924|323940581|FG001|Overall Study|Withdrawal by Subject|1|||
94584616|NCT01587924|323940582|FG002|Overall Study|Withdrawal by Subject|1|||
94584617|NCT01587924|323940583|FG003|Overall Study|Withdrawal by Subject|0|||
94584618|NCT01696188|323940585|FG000|Overall Study|Protocol Violation|1|||
94584619|NCT01696188|323940586|FG001|Overall Study|Protocol Violation|1|||
94584620|NCT01578486|323940587|FG000|Overall Study|Physician Decision|3|||
94584621|NCT01578486|323940587|FG000|Overall Study|Withdrawal by Subject|2|||
94584622|NCT04292899|323940589|FG000|Overall Study|Death|21|||
94584623|NCT04292899|323940590|FG001|Overall Study|Death|28|||
94584624|NCT04292899|323940591|FG002|Overall Study|Death|188|||
94584625|NCT04292899|323940592|FG003|Overall Study|Death|371|||
94584626|NCT04292899|323940589|FG000|Overall Study|Lost to Follow-up|8|||
94584627|NCT04292899|323940590|FG001|Overall Study|Lost to Follow-up|4|||
94584628|NCT04292899|323940591|FG002|Overall Study|Lost to Follow-up|22|||
94584629|NCT04292899|323940592|FG003|Overall Study|Lost to Follow-up|235|||
94584630|NCT04292899|323940589|FG000|Overall Study|Withdrew consent|1|||
94584631|NCT04292899|323940590|FG001|Overall Study|Withdrew consent|0|||
94584632|NCT04292899|323940591|FG002|Overall Study|Withdrew consent|11|||
94584633|NCT04292899|323940592|FG003|Overall Study|Withdrew consent|32|||
94584634|NCT04292899|323940589|FG000|Overall Study|Adverse Event|2|||
94584635|NCT04292899|323940590|FG001|Overall Study|Adverse Event|1|||
94584636|NCT04292899|323940591|FG002|Overall Study|Adverse Event|2|||
94584637|NCT04292899|323940592|FG003|Overall Study|Adverse Event|2|||
94584638|NCT04292899|323940589|FG000|Overall Study|Investigator's Discretion|0|||
94584639|NCT04292899|323940590|FG001|Overall Study|Investigator's Discretion|0|||
94584640|NCT04292899|323940591|FG002|Overall Study|Investigator's Discretion|0|||
94584641|NCT04292899|323940592|FG003|Overall Study|Investigator's Discretion|3|||
94584642|NCT04292899|323940589|FG000|Overall Study|Non-compliance With Study Drug|0|||
94584643|NCT04292899|323940590|FG001|Overall Study|Non-compliance With Study Drug|0|||
94584644|NCT04292899|323940591|FG002|Overall Study|Non-compliance With Study Drug|0|||
94584645|NCT04292899|323940592|FG003|Overall Study|Non-compliance With Study Drug|1|||
94584646|NCT04292899|323940589|FG000|Overall Study|Protocol Violation|0|||
94584647|NCT04292899|323940590|FG001|Overall Study|Protocol Violation|0|||
94584648|NCT04292899|323940591|FG002|Overall Study|Protocol Violation|0|||
94584649|NCT04292899|323940592|FG003|Overall Study|Protocol Violation|1|||
94584650|NCT02536963|323940593|FG000|Overall Study|Withdrawal by Subject|18|||
94584651|NCT00357903|323940595|FG000|Overall Study|Adverse Event|87|||
94584652|NCT00357903|323940596|FG001|Overall Study|Adverse Event|4|||
94584653|NCT00357903|323940595|FG000|Overall Study|Death|33|||
94584654|NCT00357903|323940596|FG001|Overall Study|Death|0|||
94584655|NCT00357903|323940595|FG000|Overall Study|Lost to Follow-up|23|||
94584656|NCT00357903|323940596|FG001|Overall Study|Lost to Follow-up|4|||
94584657|NCT00357903|323940595|FG000|Overall Study|Physician Decision|39|||
94584658|NCT00357903|323940596|FG001|Overall Study|Physician Decision|5|||
94584659|NCT00357903|323940595|FG000|Overall Study|Withdrawal by Subject|57|||
94584660|NCT00357903|323940596|FG001|Overall Study|Withdrawal by Subject|7|||
94584661|NCT00357903|323940595|FG000|Overall Study|Completed month 12 only|0|||
94584662|NCT00357903|323940596|FG001|Overall Study|Completed month 12 only|1|||
94584663|NCT00357903|323940595|FG000|Overall Study|Protocol issues|14|||
94584664|NCT00357903|323940596|FG001|Overall Study|Protocol issues|3|||
94584665|NCT00357903|323940595|FG000|Overall Study|Response status|61|||
94584666|NCT00357903|323940596|FG001|Overall Study|Response status|9|||
94584667|NCT00357903|323940595|FG000|Overall Study|Other|49|||
94584668|NCT00357903|323940596|FG001|Overall Study|Other|10|||
94584669|NCT02668393|323940597|FG000|Overall Study|Progressive disease|6|||
94584670|NCT02668393|323940598|FG001|Overall Study|Progressive disease|3|||
94584671|NCT02668393|323940597|FG000|Overall Study|Adverse Event|0|||
94584672|NCT02668393|323940598|FG001|Overall Study|Adverse Event|2|||
94584673|NCT02668393|323940597|FG000|Overall Study|Withdrawal from the trial|0|||
94584674|NCT02668393|323940598|FG001|Overall Study|Withdrawal from the trial|1|||
94584675|NCT02668393|323940597|FG000|Overall Study|Lack of benefit and side effects|1|||
94584676|NCT02668393|323940598|FG001|Overall Study|Lack of benefit and side effects|0|||
94584677|NCT00606593|323940599|FG000|Overall Study|Adverse Event|0|||
94584678|NCT00606593|323940600|FG001|Overall Study|Adverse Event|0|||
94584679|NCT00606593|323940601|FG002|Overall Study|Adverse Event|0|||
94584680|NCT00606593|323940602|FG003|Overall Study|Adverse Event|1|||
94584681|NCT00606593|323940603|FG004|Overall Study|Adverse Event|1|||
94584682|NCT00606593|323940604|FG005|Overall Study|Adverse Event|0|||
94584683|NCT00606593|323940605|FG006|Overall Study|Adverse Event|1|||
94584684|NCT00606593|323940606|FG007|Overall Study|Adverse Event|2|||
94584685|NCT00606593|323940607|FG008|Overall Study|Adverse Event|1|||
94584686|NCT00606593|323940608|FG009|Overall Study|Adverse Event|0|||
94584687|NCT00606593|323940599|FG000|Overall Study|Withdrawal of consent|1|||
94584688|NCT00606593|323940600|FG001|Overall Study|Withdrawal of consent|0|||
94584689|NCT00606593|323940601|FG002|Overall Study|Withdrawal of consent|1|||
94584690|NCT00606593|323940602|FG003|Overall Study|Withdrawal of consent|0|||
94584691|NCT00606593|323940603|FG004|Overall Study|Withdrawal of consent|0|||
94584692|NCT00606593|323940604|FG005|Overall Study|Withdrawal of consent|0|||
94584693|NCT00606593|323940605|FG006|Overall Study|Withdrawal of consent|0|||
94584694|NCT00606593|323940606|FG007|Overall Study|Withdrawal of consent|0|||
94584695|NCT00606593|323940607|FG008|Overall Study|Withdrawal of consent|0|||
94584696|NCT00606593|323940608|FG009|Overall Study|Withdrawal of consent|0|||
94584697|NCT00606593|323940599|FG000|Overall Study|Administrative/Other|0|||
94584698|NCT00606593|323940600|FG001|Overall Study|Administrative/Other|0|||
94584699|NCT00606593|323940601|FG002|Overall Study|Administrative/Other|1|||
94584700|NCT00606593|323940602|FG003|Overall Study|Administrative/Other|0|||
94584701|NCT00606593|323940603|FG004|Overall Study|Administrative/Other|0|||
94584702|NCT00606593|323940604|FG005|Overall Study|Administrative/Other|0|||
94584703|NCT00606593|323940605|FG006|Overall Study|Administrative/Other|0|||
94584704|NCT00606593|323940606|FG007|Overall Study|Administrative/Other|0|||
94584705|NCT00606593|323940607|FG008|Overall Study|Administrative/Other|0|||
94584706|NCT00606593|323940608|FG009|Overall Study|Administrative/Other|0|||
94584707|NCT03695367|323940609|FG000|Overall Study|Missed the Day 28 visit.|1|||
94584708|NCT03695367|323940610|FG001|Overall Study|Missed the Day 28 visit.|0|||
94584709|NCT03695367|323940609|FG000|Overall Study|Lost to Follow-up|0|||
94584710|NCT03695367|323940610|FG001|Overall Study|Lost to Follow-up|1|||
94584711|NCT03695367|323940609|FG000|Overall Study|Withdrawal by Subject|0|||
94584712|NCT03695367|323940610|FG001|Overall Study|Withdrawal by Subject|1|||
94242478|NCT03635099|322682727|FG005|Period 2|Adverse Event|0|||
94584713|NCT03695367|323940609|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
94584714|NCT03695367|323940610|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
94584715|NCT03313037|323940611|FG000|Overall Study|Protocol Violation|4|||
94584716|NCT03313037|323940612|FG001|Overall Study|Protocol Violation|1|||
94584717|NCT03313037|323940611|FG000|Overall Study|Other|1|||
94584718|NCT03313037|323940612|FG001|Overall Study|Other|1|||
94584719|NCT03313037|323940611|FG000|Overall Study|Withdrawal by Subject|4|||
94584720|NCT03313037|323940612|FG001|Overall Study|Withdrawal by Subject|3|||
94584721|NCT03313037|323940611|FG000|Overall Study|No longer meets eligibility criteria|1|||
94242479|NCT03635099|322682728|FG006|Period 2|Adverse Event|0|||
94455884|NCT03214380|323458114|FG004|Lead-in|Protocol Deviation|0|||
94455885|NCT03214380|323458115|FG005|Lead-in|Protocol Deviation|0|||
94455886|NCT03214380|323458110|FG000|Lead-in|Withdrawal by Subject|41|||
94455887|NCT03214380|323458111|FG001|Lead-in|Withdrawal by Subject|0|||
94455888|NCT03214380|323458112|FG002|Lead-in|Withdrawal by Subject|0|||
94455889|NCT03214380|323458113|FG003|Lead-in|Withdrawal by Subject|14|||
94455890|NCT03214380|323458114|FG004|Lead-in|Withdrawal by Subject|0|||
94455891|NCT03214380|323458115|FG005|Lead-in|Withdrawal by Subject|0|||
94455892|NCT03214380|323458110|FG000|Lead-in|Family Emergency|1|||
94455893|NCT03214380|323458111|FG001|Lead-in|Family Emergency|0|||
94455894|NCT03214380|323458112|FG002|Lead-in|Family Emergency|0|||
94455895|NCT03214380|323458113|FG003|Lead-in|Family Emergency|0|||
94455896|NCT03214380|323458114|FG004|Lead-in|Family Emergency|0|||
94455897|NCT03214380|323458115|FG005|Lead-in|Family Emergency|0|||
94455898|NCT03214380|323458110|FG000|Lead-in|Natural Disaster|9|||
94455899|NCT03214380|323458111|FG001|Lead-in|Natural Disaster|0|||
94455900|NCT03214380|323458112|FG002|Lead-in|Natural Disaster|0|||
94455901|NCT03214380|323458113|FG003|Lead-in|Natural Disaster|0|||
94455902|NCT03214380|323458114|FG004|Lead-in|Natural Disaster|0|||
94455903|NCT03214380|323458115|FG005|Lead-in|Natural Disaster|0|||
94455904|NCT03214380|323458110|FG000|Lead-in|Non Compliance|1|||
94455905|NCT03214380|323458111|FG001|Lead-in|Non Compliance|0|||
94455906|NCT03214380|323458112|FG002|Lead-in|Non Compliance|0|||
94455907|NCT03214380|323458113|FG003|Lead-in|Non Compliance|0|||
94455908|NCT03214380|323458114|FG004|Lead-in|Non Compliance|0|||
94455909|NCT03214380|323458115|FG005|Lead-in|Non Compliance|0|||
94455910|NCT03214380|323458110|FG000|Lead-in|Participant Schedule|2|||
94455911|NCT03214380|323458111|FG001|Lead-in|Participant Schedule|0|||
94455912|NCT03214380|323458112|FG002|Lead-in|Participant Schedule|0|||
94455913|NCT03214380|323458113|FG003|Lead-in|Participant Schedule|0|||
94455914|NCT03214380|323458114|FG004|Lead-in|Participant Schedule|0|||
94455915|NCT03214380|323458115|FG005|Lead-in|Participant Schedule|0|||
94455916|NCT03214380|323458110|FG000|Treatment Period|Adverse Event|0|||
94455917|NCT03214380|323458111|FG001|Treatment Period|Adverse Event|1|||
94455918|NCT03214380|323458112|FG002|Treatment Period|Adverse Event|1|||
94455919|NCT03214380|323458113|FG003|Treatment Period|Adverse Event|0|||
94455920|NCT03214380|323458114|FG004|Treatment Period|Adverse Event|1|||
94455921|NCT03214380|323458115|FG005|Treatment Period|Adverse Event|0|||
94455922|NCT03214380|323458110|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
94455923|NCT03214380|323458111|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
94455924|NCT03214380|323458112|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
94455925|NCT03214380|323458113|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
94455926|NCT03214380|323458114|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
94455927|NCT03214380|323458115|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
94455928|NCT03214380|323458110|FG000|Treatment Period|Withdrawal by Subject|0|||
94455929|NCT03214380|323458111|FG001|Treatment Period|Withdrawal by Subject|10|||
94455930|NCT03214380|323458112|FG002|Treatment Period|Withdrawal by Subject|8|||
94584722|NCT03313037|323940612|FG001|Overall Study|No longer meets eligibility criteria|7|||
94455931|NCT03214380|323458113|FG003|Treatment Period|Withdrawal by Subject|0|||
94455932|NCT03214380|323458114|FG004|Treatment Period|Withdrawal by Subject|7|||
94455933|NCT03214380|323458115|FG005|Treatment Period|Withdrawal by Subject|11|||
94455934|NCT03214380|323458110|FG000|Treatment Period|Death|0|||
94455935|NCT03214380|323458111|FG001|Treatment Period|Death|1|||
94455936|NCT03214380|323458112|FG002|Treatment Period|Death|2|||
94455937|NCT03214380|323458113|FG003|Treatment Period|Death|0|||
94455938|NCT03214380|323458114|FG004|Treatment Period|Death|0|||
94455939|NCT03214380|323458115|FG005|Treatment Period|Death|0|||
94584723|NCT03313037|323940611|FG000|Overall Study|Lost to Follow-up|9|||
94584724|NCT03313037|323940612|FG001|Overall Study|Lost to Follow-up|8|||
94584725|NCT03313037|323940611|FG000|Overall Study|Randomized but not treated|1|||
94584726|NCT03313037|323940612|FG001|Overall Study|Randomized but not treated|0|||
94584727|NCT00092443|323940613|FG000|Overall Study|Adverse Event|9|||
94584728|NCT00092443|323940614|FG001|Overall Study|Adverse Event|13|||
94584729|NCT00092443|323940613|FG000|Overall Study|Lost to Follow-up|7|||
94584730|NCT00092443|323940614|FG001|Overall Study|Lost to Follow-up|3|||
94584731|NCT00092443|323940613|FG000|Overall Study|Protocol Violation|11|||
94584732|NCT00092443|323940614|FG001|Overall Study|Protocol Violation|9|||
94584733|NCT00092443|323940613|FG000|Overall Study|Withdrawal by Subject|9|||
94584734|NCT00092443|323940614|FG001|Overall Study|Withdrawal by Subject|11|||
94584735|NCT00092443|323940613|FG000|Overall Study|Moved|5|||
94584736|NCT00092443|323940614|FG001|Overall Study|Moved|5|||
94584737|NCT00092443|323940613|FG000|Overall Study|Other|17|||
94584738|NCT00092443|323940614|FG001|Overall Study|Other|13|||
94584739|NCT03532451|323940615|FG000|Overall Study|Withdrawal by Subject|0|||
94584740|NCT03532451|323940616|FG001|Overall Study|Withdrawal by Subject|1|||
94584741|NCT03532451|323940615|FG000|Overall Study|Did not undergo surgery|1|||
94584742|NCT03532451|323940616|FG001|Overall Study|Did not undergo surgery|1|||
94584743|NCT00828204|323940617|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
94584744|NCT00828204|323940618|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
94584745|NCT00828204|323940617|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
94584746|NCT00828204|323940618|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
94584747|NCT00828204|323940617|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
94584748|NCT00828204|323940618|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
94584749|NCT00828204|323940617|FG000|Main Study: After Study Restart|Adverse Event|0|||
94584750|NCT00828204|323940618|FG001|Main Study: After Study Restart|Adverse Event|2|||
94584751|NCT00828204|323940617|FG000|Main Study: After Study Restart|Noncompliance|0|||
94584752|NCT00828204|323940618|FG001|Main Study: After Study Restart|Noncompliance|1|||
94584753|NCT00828204|323940617|FG000|Extension Study|Lost to Follow-up|0|||
94584754|NCT00828204|323940618|FG001|Extension Study|Lost to Follow-up|1|||
94584755|NCT00828204|323940617|FG000|Extension Study|Physician Decision|0|||
94584756|NCT00828204|323940618|FG001|Extension Study|Physician Decision|2|||
94584757|NCT04237116|323940623|FG000|Overall Study|Adverse Event|0|||
94584758|NCT04237116|323940624|FG001|Overall Study|Adverse Event|1|||
94584759|NCT04237116|323940623|FG000|Overall Study|Study terminated by Sponsor|4|||
94584760|NCT04237116|323940624|FG001|Overall Study|Study terminated by Sponsor|1|||
94584761|NCT02840461|323940625|FG000|Overall Study|Adverse Event|1|||
94584762|NCT02840461|323940626|FG001|Overall Study|Adverse Event|5|||
94584763|NCT02840461|323940627|FG002|Overall Study|Adverse Event|3|||
94584764|NCT02840461|323940625|FG000|Overall Study|Lost to Follow-up|10|||
94584765|NCT02840461|323940626|FG001|Overall Study|Lost to Follow-up|7|||
94584766|NCT02840461|323940627|FG002|Overall Study|Lost to Follow-up|6|||
94584767|NCT02840461|323940625|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
94584768|NCT02840461|323940626|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
94584769|NCT02840461|323940627|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
94584770|NCT02840461|323940625|FG000|Overall Study|Protocol Violation|2|||
94584771|NCT02840461|323940626|FG001|Overall Study|Protocol Violation|3|||
94584772|NCT02840461|323940627|FG002|Overall Study|Protocol Violation|1|||
94584773|NCT02840461|323940625|FG000|Overall Study|Withdrawal by Subject|10|||
94584774|NCT02840461|323940626|FG001|Overall Study|Withdrawal by Subject|6|||
94584775|NCT02840461|323940627|FG002|Overall Study|Withdrawal by Subject|2|||
94584776|NCT02840461|323940625|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
94584777|NCT02840461|323940626|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
94584778|NCT02840461|323940627|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
94584779|NCT00114517|323940628|FG000|Overall Study|Adverse Event|6|||
94584780|NCT00114517|323940629|FG001|Overall Study|Adverse Event|1|||
94659174|NCT02318329|324207997|FG003|Overall Study|Lost to Follow-up|0|||
94659175|NCT02318329|324207998|FG004|Overall Study|Lost to Follow-up|0|||
94659176|NCT02318329|324207999|FG005|Overall Study|Lost to Follow-up|0|||
94659177|NCT02318329|324208000|FG006|Overall Study|Lost to Follow-up|0|||
94659178|NCT02318329|324208001|FG007|Overall Study|Lost to Follow-up|0|||
94584781|NCT00114517|323940630|FG002|Overall Study|Adverse Event|6|||
94659179|NCT02318329|324208002|FG008|Overall Study|Lost to Follow-up|0|||
94659180|NCT02318329|324208003|FG009|Overall Study|Lost to Follow-up|1|||
94584782|NCT00114517|323940631|FG003|Overall Study|Adverse Event|3|||
94584783|NCT00114517|323940628|FG000|Overall Study|Lost to Follow-up|2|||
94584784|NCT00114517|323940629|FG001|Overall Study|Lost to Follow-up|2|||
94584785|NCT00114517|323940630|FG002|Overall Study|Lost to Follow-up|2|||
94584786|NCT00114517|323940631|FG003|Overall Study|Lost to Follow-up|1|||
94584787|NCT00114517|323940628|FG000|Overall Study|Too busy|3|||
94584788|NCT00114517|323940629|FG001|Overall Study|Too busy|1|||
94584789|NCT00114517|323940630|FG002|Overall Study|Too busy|1|||
94584790|NCT00114517|323940631|FG003|Overall Study|Too busy|2|||
94584791|NCT00114517|323940628|FG000|Overall Study|Moved from area|0|||
94659181|NCT02318329|324207994|FG000|Overall Study|Withdrawal by Subject|0|||
94659182|NCT02318329|324207995|FG001|Overall Study|Withdrawal by Subject|0|||
94659183|NCT02318329|324207996|FG002|Overall Study|Withdrawal by Subject|0|||
94659184|NCT02318329|324207997|FG003|Overall Study|Withdrawal by Subject|0|||
94659185|NCT02318329|324207998|FG004|Overall Study|Withdrawal by Subject|0|||
94659186|NCT02318329|324207999|FG005|Overall Study|Withdrawal by Subject|0|||
94659187|NCT02318329|324208000|FG006|Overall Study|Withdrawal by Subject|0|||
94659188|NCT02318329|324208001|FG007|Overall Study|Withdrawal by Subject|0|||
94659189|NCT02318329|324208002|FG008|Overall Study|Withdrawal by Subject|0|||
94659190|NCT02318329|324208003|FG009|Overall Study|Withdrawal by Subject|6|||
94659191|NCT02318329|324207994|FG000|Overall Study|Other|1|||
94659192|NCT02318329|324207995|FG001|Overall Study|Other|1|||
94659193|NCT02318329|324207996|FG002|Overall Study|Other|1|||
94659194|NCT02318329|324207997|FG003|Overall Study|Other|0|||
94659195|NCT02318329|324207998|FG004|Overall Study|Other|0|||
94659196|NCT02318329|324207999|FG005|Overall Study|Other|0|||
94659197|NCT02318329|324208000|FG006|Overall Study|Other|0|||
94659198|NCT02318329|324208001|FG007|Overall Study|Other|0|||
94659199|NCT02318329|324208002|FG008|Overall Study|Other|1|||
94659200|NCT02318329|324208003|FG009|Overall Study|Other|1|||
94659201|NCT02039505|324208004|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
94659202|NCT02039505|324208005|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
94659203|NCT02039505|324208006|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
94659204|NCT02039505|324208007|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
94659205|NCT02039505|324208008|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
94659206|NCT02039505|324208009|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
94659207|NCT02039505|324208010|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
94659208|NCT02039505|324208004|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
94659209|NCT02039505|324208005|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
94659210|NCT02039505|324208006|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
94659211|NCT02039505|324208007|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
94659212|NCT02039505|324208008|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
94659213|NCT02039505|324208009|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
94659214|NCT02039505|324208010|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
94659215|NCT02039505|324208004|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
94659216|NCT02039505|324208005|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
94659217|NCT02039505|324208006|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
94659218|NCT02039505|324208007|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
94659219|NCT02039505|324208008|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
94659220|NCT02039505|324208009|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
94659221|NCT02039505|324208010|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
94659222|NCT02039505|324208004|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
94659223|NCT02039505|324208005|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
94659224|NCT02039505|324208006|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
94659225|NCT02039505|324208007|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
94659226|NCT02039505|324208008|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
94659227|NCT02039505|324208009|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
94659228|NCT02039505|324208010|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
94659229|NCT02039505|324208004|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
94659230|NCT02039505|324208005|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
94659231|NCT02039505|324208006|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
94455940|NCT03214380|323458110|FG000|Treatment Period|Lost to Follow-up|0|||
94455941|NCT03214380|323458111|FG001|Treatment Period|Lost to Follow-up|6|||
94455942|NCT03214380|323458112|FG002|Treatment Period|Lost to Follow-up|3|||
94455943|NCT03214380|323458113|FG003|Treatment Period|Lost to Follow-up|0|||
94455944|NCT03214380|323458114|FG004|Treatment Period|Lost to Follow-up|0|||
94455945|NCT03214380|323458115|FG005|Treatment Period|Lost to Follow-up|0|||
94455946|NCT03214380|323458110|FG000|Treatment Period|Participant schedule|0|||
94455947|NCT03214380|323458111|FG001|Treatment Period|Participant schedule|0|||
94455948|NCT03214380|323458112|FG002|Treatment Period|Participant schedule|1|||
94455949|NCT03214380|323458113|FG003|Treatment Period|Participant schedule|0|||
94584792|NCT00114517|323940629|FG001|Overall Study|Moved from area|3|||
94584793|NCT00114517|323940630|FG002|Overall Study|Moved from area|2|||
94584794|NCT00114517|323940631|FG003|Overall Study|Moved from area|1|||
94584795|NCT00114517|323940628|FG000|Overall Study|Did not want estradiol|1|||
94584796|NCT00114517|323940629|FG001|Overall Study|Did not want estradiol|1|||
94584797|NCT00114517|323940630|FG002|Overall Study|Did not want estradiol|0|||
94584798|NCT00114517|323940631|FG003|Overall Study|Did not want estradiol|0|||
94584799|NCT00114517|323940628|FG000|Overall Study|Armed-services duty|0|||
94584800|NCT00114517|323940629|FG001|Overall Study|Armed-services duty|1|||
94584801|NCT00114517|323940630|FG002|Overall Study|Armed-services duty|0|||
94584802|NCT00114517|323940631|FG003|Overall Study|Armed-services duty|1|||
94584803|NCT00114517|323940628|FG000|Overall Study|Competing family issue|0|||
94584804|NCT00114517|323940629|FG001|Overall Study|Competing family issue|1|||
94584805|NCT00114517|323940630|FG002|Overall Study|Competing family issue|0|||
94584806|NCT00114517|323940631|FG003|Overall Study|Competing family issue|1|||
94584807|NCT00114517|323940628|FG000|Overall Study|Physician Decision|0|||
94584808|NCT00114517|323940629|FG001|Overall Study|Physician Decision|1|||
94584809|NCT00114517|323940630|FG002|Overall Study|Physician Decision|0|||
94584810|NCT00114517|323940631|FG003|Overall Study|Physician Decision|0|||
94584811|NCT00114517|323940628|FG000|Overall Study|Lost interest|0|||
94584812|NCT00114517|323940629|FG001|Overall Study|Lost interest|0|||
94584813|NCT00114517|323940630|FG002|Overall Study|Lost interest|1|||
94584814|NCT00114517|323940631|FG003|Overall Study|Lost interest|0|||
94584815|NCT00114517|323940628|FG000|Overall Study|Weight increase|0|||
94584816|NCT00114517|323940629|FG001|Overall Study|Weight increase|0|||
94584817|NCT00114517|323940630|FG002|Overall Study|Weight increase|1|||
94584818|NCT00114517|323940631|FG003|Overall Study|Weight increase|0|||
94584819|NCT00114517|323940628|FG000|Overall Study|Concern about blood clots|0|||
94584820|NCT00114517|323940629|FG001|Overall Study|Concern about blood clots|0|||
94584821|NCT00114517|323940630|FG002|Overall Study|Concern about blood clots|1|||
94584822|NCT00114517|323940631|FG003|Overall Study|Concern about blood clots|0|||
94584823|NCT00114517|323940628|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
94584824|NCT00114517|323940629|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
94584825|NCT00114517|323940630|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
94584826|NCT00114517|323940631|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
94584827|NCT00488683|323940632|FG000|Overall Study|Withdrawal by Subject|1|||
94584828|NCT00488683|323940633|FG001|Overall Study|Withdrawal by Subject|2|||
94584829|NCT00488683|323940634|FG002|Overall Study|Withdrawal by Subject|2|||
94584830|NCT00488683|323940632|FG000|Overall Study|Lost to Follow-up|5|||
94584831|NCT00488683|323940633|FG001|Overall Study|Lost to Follow-up|3|||
94584832|NCT00488683|323940634|FG002|Overall Study|Lost to Follow-up|0|||
94584833|NCT00488683|323940632|FG000|Overall Study|Protocol Violation|5|||
94584834|NCT00488683|323940633|FG001|Overall Study|Protocol Violation|1|||
94584835|NCT00488683|323940634|FG002|Overall Study|Protocol Violation|0|||
94584836|NCT00488683|323940632|FG000|Overall Study|Unable to Classify|1|||
94584837|NCT00488683|323940633|FG001|Overall Study|Unable to Classify|0|||
94584838|NCT00488683|323940634|FG002|Overall Study|Unable to Classify|0|||
94584839|NCT01442103|323942644|FG000|Overall Study|Lost to Follow-up|2|||
94584840|NCT03349034|323942645|FG000|Overall Study|catheters dislodged during transport|2|||
94584841|NCT03349034|323942646|FG001|Overall Study|catheters dislodged during transport|0|||
94584842|NCT03349034|323942645|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
94584843|NCT03349034|323942646|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
94584844|NCT03349034|323942645|FG000|Overall Study|soft tissue flap used|1|||
94584845|NCT03349034|323942646|FG001|Overall Study|soft tissue flap used|0|||
94584846|NCT03349034|323942645|FG000|Overall Study|Other|0|||
94584847|NCT03349034|323942646|FG001|Overall Study|Other|1|||
94584848|NCT03436082|323942647|FG000|Overall Study|Did not undergo procedure|1|||
94584849|NCT03436082|323942648|FG001|Overall Study|Did not undergo procedure|0|||
94584850|NCT02035267|323942649|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
94584851|NCT02035267|323942650|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
94584852|NCT02035267|323942651|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
94584853|NCT02035267|323942652|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
94584854|NCT02035267|323942649|FG000|Overall Study|Adverse Event|0|||
94584855|NCT02035267|323942650|FG001|Overall Study|Adverse Event|0|||
94584856|NCT02035267|323942651|FG002|Overall Study|Adverse Event|1|||
94584857|NCT02035267|323942652|FG003|Overall Study|Adverse Event|0|||
94584858|NCT02035267|323942649|FG000|Overall Study|Lost to Follow-up|0|||
94584859|NCT02035267|323942650|FG001|Overall Study|Lost to Follow-up|0|||
94584860|NCT02035267|323942651|FG002|Overall Study|Lost to Follow-up|0|||
94584861|NCT02035267|323942652|FG003|Overall Study|Lost to Follow-up|1|||
94584862|NCT02035267|323942649|FG000|Overall Study|Other unspecified|0|||
94584863|NCT02035267|323942650|FG001|Overall Study|Other unspecified|1|||
94584864|NCT02035267|323942651|FG002|Overall Study|Other unspecified|0|||
94584865|NCT02035267|323942652|FG003|Overall Study|Other unspecified|0|||
94584866|NCT03038880|323942653|FG000|Overall Study|Death|1|||
94584867|NCT03038880|323942654|FG001|Overall Study|Death|2|||
94584868|NCT03038880|323942655|FG002|Overall Study|Death|0|||
94584869|NCT03038880|323942653|FG000|Overall Study|Physician Decision|2|||
94584870|NCT03038880|323942654|FG001|Overall Study|Physician Decision|1|||
94584871|NCT03038880|323942655|FG002|Overall Study|Physician Decision|0|||
94584872|NCT02803580|323942658|FG000|Overall Study|Death|13|||
94584873|NCT02803580|323942658|FG000|Overall Study|Lost to Follow-up|19|||
94584874|NCT02803580|323942658|FG000|Overall Study|Withdrawal by Subject|3|||
94584875|NCT02803580|323942658|FG000|Overall Study|Inclusion in clinical trial|1|||
94584876|NCT00823615|323942663|FG000|Period 2|Lost to Follow-up|2|||
94584877|NCT00823615|323942664|FG001|Period 2|Lost to Follow-up|0|||
94584878|NCT00823615|323942663|FG000|Period 2|Time/Job Conflict|1|||
94584879|NCT00823615|323942664|FG001|Period 2|Time/Job Conflict|2|||
94584880|NCT00098813|323942669|FG000|Overall Study|Death|8|||
94584881|NCT00098813|323942669|FG000|Overall Study|Protocol Violation|1|||
94584882|NCT00098813|323942669|FG000|Overall Study|Withdrawal by Subject|7|||
94584883|NCT00098813|323942669|FG000|Overall Study|Progression of Disease|1|||
94584884|NCT00098813|323942669|FG000|Overall Study|Other complicating disease|1|||
94584885|NCT00098813|323942669|FG000|Overall Study|Reversal of RAI resistance|1|||
94584886|NCT01864603|323942670|FG000|Stage 2|DSMB design modification|86056|||
94584887|NCT01864603|323942671|FG001|Stage 2|DSMB design modification|92558|||
94584888|NCT02446899|323942673|FG000|Overall Study|Adverse Event|4|||
94584889|NCT02446899|323942674|FG001|Overall Study|Adverse Event|7|||
94584890|NCT02446899|323942673|FG000|Overall Study|Condition Under Investigation Worsened|1|||
94584891|NCT02446899|323942674|FG001|Overall Study|Condition Under Investigation Worsened|4|||
94242480|NCT03635099|322682729|FG007|Period 2|Adverse Event|0|||
94242481|NCT03635099|322682722|FG000|Period 2|Lost to Follow-up|0|||
94242482|NCT03635099|322682723|FG001|Period 2|Lost to Follow-up|0|||
94242483|NCT03635099|322682724|FG002|Period 2|Lost to Follow-up|1|||
94242484|NCT03635099|322682725|FG003|Period 2|Lost to Follow-up|0|||
94242485|NCT03635099|322682726|FG004|Period 2|Lost to Follow-up|4|||
94584892|NCT02446899|323942673|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
94584893|NCT02446899|323942674|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
94584894|NCT02446899|323942673|FG000|Overall Study|Lack of Efficacy|2|||
94584895|NCT02446899|323942674|FG001|Overall Study|Lack of Efficacy|8|||
94584896|NCT02446899|323942673|FG000|Overall Study|Lost to Follow-up|1|||
94584897|NCT02446899|323942674|FG001|Overall Study|Lost to Follow-up|3|||
94584898|NCT02446899|323942673|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
94584899|NCT02446899|323942674|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
94584900|NCT02446899|323942673|FG000|Overall Study|Withdrawal by Subject|11|||
94584901|NCT02446899|323942674|FG001|Overall Study|Withdrawal by Subject|19|||
94584902|NCT02446899|323942673|FG000|Overall Study|Miscellaneous|5|||
94584903|NCT02446899|323942674|FG001|Overall Study|Miscellaneous|4|||
94584904|NCT02446899|323942673|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
94584905|NCT02446899|323942674|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
94584906|NCT01750229|323942675|FG000|Randomized Crossover Phase|Adverse Event|1|||
94584907|NCT01750229|323942675|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
94584908|NCT01750229|323942675|FG000|Long-term Follow-up Phase|Adverse Event|2|||
94584909|NCT01750229|323942675|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
94584910|NCT02346721|323942676|FG000|Overall Study|Withdrew Consent|3|||
94584911|NCT02346721|323942676|FG000|Overall Study|Lack of Efficacy|1|||
94584912|NCT04396639|323942679|FG000|Overall Study|Withdrawal by Subject|1|||
94584913|NCT04396639|323942679|FG000|Overall Study|Other|1|||
94584914|NCT01544335|323942682|FG000|Overall Study|Lost to Follow-up|27|||
94584915|NCT01544335|323942682|FG000|Overall Study|Death|4|||
94584916|NCT01544335|323942682|FG000|Overall Study|Disease progression|3|||
94584917|NCT01544335|323942682|FG000|Overall Study|Baseline Measurements not Available|19|||
94584918|NCT00419952|323942685|FG000|Overall Study|Adverse Event|8|||
94584919|NCT00419952|323942686|FG001|Overall Study|Adverse Event|10|||
94584920|NCT00419952|323942685|FG000|Overall Study|Withdrawal by Subject|44|||
94584921|NCT00419952|323942686|FG001|Overall Study|Withdrawal by Subject|43|||
94584922|NCT00419952|323942685|FG000|Overall Study|Lost to Follow-up|43|||
94584923|NCT00419952|323942686|FG001|Overall Study|Lost to Follow-up|34|||
94584924|NCT00419952|323942685|FG000|Overall Study|Protocol Violation|32|||
94584925|NCT00419952|323942686|FG001|Overall Study|Protocol Violation|24|||
94584926|NCT00419952|323942685|FG000|Overall Study|Pregnancy|4|||
94584927|NCT00419952|323942686|FG001|Overall Study|Pregnancy|2|||
94584928|NCT00419952|323942685|FG000|Overall Study|Physician Decision|1|||
94584929|NCT00419952|323942686|FG001|Overall Study|Physician Decision|3|||
94584930|NCT00419952|323942685|FG000|Overall Study|Incorrectly enrolled|10|||
94584931|NCT00419952|323942686|FG001|Overall Study|Incorrectly enrolled|3|||
94584932|NCT00419952|323942685|FG000|Overall Study|Intake of prohibited medication|2|||
94584933|NCT00419952|323942686|FG001|Overall Study|Intake of prohibited medication|2|||
94584934|NCT00419952|323942685|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
94584935|NCT00419952|323942686|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
94584936|NCT00419952|323942685|FG000|Overall Study|Diary or medication non-compliance|2|||
94584937|NCT00419952|323942686|FG001|Overall Study|Diary or medication non-compliance|4|||
94584938|NCT00419952|323942685|FG000|Overall Study|Abnormal ECG|1|||
94584939|NCT00419952|323942686|FG001|Overall Study|Abnormal ECG|0|||
94584940|NCT01532986|323942687|FG000|Overall Study|Death|9|||
94584941|NCT01532986|323942688|FG001|Overall Study|Death|9|||
94584942|NCT01532986|323942687|FG000|Overall Study|Withdrawal by Subject|7|||
94584943|NCT01532986|323942688|FG001|Overall Study|Withdrawal by Subject|10|||
94584944|NCT01532986|323942687|FG000|Overall Study|Physician Decision|7|||
94584945|NCT01532986|323942688|FG001|Overall Study|Physician Decision|5|||
94584946|NCT00885170|323942691|FG000|Overall Study|Adverse Event|12|||
94584947|NCT00885170|323942692|FG001|Overall Study|Adverse Event|4|||
94584948|NCT00885170|323942691|FG000|Overall Study|Excessive bone loss|6|||
94584949|NCT00885170|323942692|FG001|Overall Study|Excessive bone loss|3|||
94584950|NCT00885170|323942691|FG000|Overall Study|Lost to Follow-up|2|||
94584951|NCT00885170|323942692|FG001|Overall Study|Lost to Follow-up|1|||
94584952|NCT00885170|323942691|FG000|Overall Study|Physician Decision|2|||
94584953|NCT00885170|323942692|FG001|Overall Study|Physician Decision|1|||
94584954|NCT00885170|323942691|FG000|Overall Study|Protocol Violation|3|||
94584955|NCT00885170|323942692|FG001|Overall Study|Protocol Violation|1|||
94584956|NCT00885170|323942691|FG000|Overall Study|Withdrawal by Subject|13|||
94584957|NCT00885170|323942692|FG001|Overall Study|Withdrawal by Subject|13|||
94584958|NCT04085289|323942693|FG000|Overall Study|Withdrawal by Subject|0|||
94584959|NCT04085289|323942694|FG001|Overall Study|Withdrawal by Subject|0|||
94584960|NCT04085289|323942695|FG002|Overall Study|Withdrawal by Subject|1|||
94584961|NCT04960202|323942696|FG000|Overall Study|Other|12|||
94584962|NCT04960202|323942697|FG001|Overall Study|Other|10|||
94584963|NCT04960202|323942696|FG000|Overall Study|Withdrawal by Subject|43|||
94584964|NCT04960202|323942697|FG001|Overall Study|Withdrawal by Subject|45|||
94584965|NCT04960202|323942696|FG000|Overall Study|Lost to Follow-up|20|||
94584966|NCT04960202|323942697|FG001|Overall Study|Lost to Follow-up|17|||
94584967|NCT04960202|323942696|FG000|Overall Study|Death|0|||
94584968|NCT04960202|323942697|FG001|Overall Study|Death|15|||
94584969|NCT02999672|323942699|FG000|Overall Study|Death|0|||
94584970|NCT02999672|323942700|FG001|Overall Study|Death|1|||
94584971|NCT02999672|323942699|FG000|Overall Study|Study Terminated by Sponsor|0|||
94584972|NCT02999672|323942700|FG001|Overall Study|Study Terminated by Sponsor|1|||
94584973|NCT02999672|323942699|FG000|Overall Study|Progressive Disease|9|||
94584974|NCT02999672|323942700|FG001|Overall Study|Progressive Disease|5|||
94584975|NCT02999672|323942699|FG000|Overall Study|Adverse Event|4|||
94584976|NCT02999672|323942700|FG001|Overall Study|Adverse Event|0|||
94584977|NCT03527732|323942701|FG000|Overall Study|Lost to Follow-up|21|||
94584978|NCT03527732|323942702|FG001|Overall Study|Lost to Follow-up|23|||
94584979|NCT03527732|323942703|FG002|Overall Study|Lost to Follow-up|80|||
94584980|NCT03527732|323942704|FG003|Overall Study|Lost to Follow-up|62|||
94584981|NCT03527732|323942705|FG004|Overall Study|Lost to Follow-up|12|||
94584982|NCT03527732|323942706|FG005|Overall Study|Lost to Follow-up|20|||
94584983|NCT00470275|323942707|FG000|Overall Study|Death|1|||
94584984|NCT00470275|323942707|FG000|Overall Study|Lack of Efficacy|7|||
94584985|NCT00470275|323942707|FG000|Overall Study|Withdrawal by Subject|2|||
94584986|NCT03048578|323942708|FG000|Overall Study|Withdrawal by Subject|5|||
94584987|NCT03048578|323942709|FG001|Overall Study|Withdrawal by Subject|6|||
94584988|NCT03048578|323942708|FG000|Overall Study|Lost to Follow-up|22|||
94584989|NCT03048578|323942709|FG001|Overall Study|Lost to Follow-up|10|||
94584990|NCT03048578|323942708|FG000|Overall Study|Adverse Event|1|||
94584991|NCT03048578|323942709|FG001|Overall Study|Adverse Event|2|||
94584992|NCT03048578|323942708|FG000|Overall Study|Terminated|3|||
94584993|NCT03048578|323942709|FG001|Overall Study|Terminated|2|||
94584994|NCT02500797|323942714|FG000|Overall Study|Cancel (rapid disease progression)|0|||
94584995|NCT02500797|323942715|FG001|Overall Study|Cancel (rapid disease progression)|0|||
94584996|NCT02500797|323942716|FG002|Overall Study|Cancel (rapid disease progression)|0|||
94584997|NCT02500797|323942717|FG003|Overall Study|Cancel (rapid disease progression)|0|||
94584998|NCT02500797|323942718|FG004|Overall Study|Cancel (rapid disease progression)|1|||
94584999|NCT02500797|323942719|FG005|Overall Study|Cancel (rapid disease progression)|1|||
94585000|NCT02500797|323942720|FG006|Overall Study|Cancel (rapid disease progression)|0|||
94585001|NCT02500797|323942721|FG007|Overall Study|Cancel (rapid disease progression)|0|||
94585002|NCT02500797|323942714|FG000|Overall Study|Withdrawal by Subject|1|||
94585003|NCT02500797|323942715|FG001|Overall Study|Withdrawal by Subject|0|||
94585004|NCT02500797|323942716|FG002|Overall Study|Withdrawal by Subject|0|||
94585005|NCT02500797|323942717|FG003|Overall Study|Withdrawal by Subject|0|||
94585006|NCT02500797|323942718|FG004|Overall Study|Withdrawal by Subject|0|||
94585007|NCT02500797|323942719|FG005|Overall Study|Withdrawal by Subject|0|||
94585008|NCT02500797|323942720|FG006|Overall Study|Withdrawal by Subject|0|||
94585009|NCT02500797|323942721|FG007|Overall Study|Withdrawal by Subject|0|||
94585010|NCT03710161|323942722|FG000|Overall Study|Study halted due to COVID pandemic|3|||
94585011|NCT03710161|323942723|FG001|Overall Study|Study halted due to COVID pandemic|2|||
94585012|NCT04269889|323942726|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
94585013|NCT01499355|323942727|FG000|Run-In Period|Study Termination|15|||
94585014|NCT01499355|323942728|FG001|Run-In Period|Study Termination|0|||
94585015|NCT01499355|323942729|FG002|Run-In Period|Study Termination|0|||
94585016|NCT01499355|323942730|FG003|Run-In Period|Study Termination|0|||
94585017|NCT01499355|323942727|FG000|Run-In Period|Other|3|||
94585018|NCT01499355|323942728|FG001|Run-In Period|Other|0|||
94585019|NCT01499355|323942729|FG002|Run-In Period|Other|0|||
94585020|NCT01499355|323942730|FG003|Run-In Period|Other|0|||
94585021|NCT01499355|323942727|FG000|Run-In Period|Death|2|||
94585022|NCT01499355|323942728|FG001|Run-In Period|Death|0|||
94585023|NCT01499355|323942729|FG002|Run-In Period|Death|0|||
94585024|NCT01499355|323942730|FG003|Run-In Period|Death|0|||
94585025|NCT01499355|323942727|FG000|Run-In Period|Investigator Decision|2|||
94585026|NCT01499355|323942728|FG001|Run-In Period|Investigator Decision|0|||
94585027|NCT01499355|323942729|FG002|Run-In Period|Investigator Decision|0|||
94585028|NCT01499355|323942730|FG003|Run-In Period|Investigator Decision|0|||
94585029|NCT01499355|323942727|FG000|Run-In Period|Consent Withdrawn|1|||
94585030|NCT01499355|323942728|FG001|Run-In Period|Consent Withdrawn|0|||
94585031|NCT01499355|323942729|FG002|Run-In Period|Consent Withdrawn|0|||
94585032|NCT01499355|323942730|FG003|Run-In Period|Consent Withdrawn|0|||
94585033|NCT01499355|323942727|FG000|Run-In Period|Adverse Event|8|||
94585034|NCT01499355|323942728|FG001|Run-In Period|Adverse Event|0|||
94585035|NCT01499355|323942729|FG002|Run-In Period|Adverse Event|0|||
94585036|NCT01499355|323942730|FG003|Run-In Period|Adverse Event|0|||
94585037|NCT01499355|323942727|FG000|Double-Blind Period|Adverse Event|0|||
94585038|NCT01499355|323942728|FG001|Double-Blind Period|Adverse Event|2|||
94585039|NCT01499355|323942729|FG002|Double-Blind Period|Adverse Event|3|||
94585040|NCT01499355|323942730|FG003|Double-Blind Period|Adverse Event|2|||
94585041|NCT01499355|323942727|FG000|Double-Blind Period|Study Termination|0|||
94585042|NCT01499355|323942728|FG001|Double-Blind Period|Study Termination|18|||
94585043|NCT01499355|323942729|FG002|Double-Blind Period|Study Termination|16|||
94585044|NCT01499355|323942730|FG003|Double-Blind Period|Study Termination|14|||
94585045|NCT01499355|323942727|FG000|Double-Blind Period|Other|0|||
94585046|NCT01499355|323942728|FG001|Double-Blind Period|Other|1|||
94585047|NCT01499355|323942729|FG002|Double-Blind Period|Other|2|||
94585048|NCT01499355|323942730|FG003|Double-Blind Period|Other|2|||
94585049|NCT01499355|323942727|FG000|Double-Blind Period|Death|0|||
94585050|NCT01499355|323942728|FG001|Double-Blind Period|Death|1|||
94585051|NCT01499355|323942729|FG002|Double-Blind Period|Death|0|||
94585052|NCT01499355|323942730|FG003|Double-Blind Period|Death|0|||
94585053|NCT01499355|323942727|FG000|Double-Blind Period|Investigator Decision|0|||
94585054|NCT01499355|323942728|FG001|Double-Blind Period|Investigator Decision|0|||
94585055|NCT01499355|323942729|FG002|Double-Blind Period|Investigator Decision|3|||
94585056|NCT01499355|323942730|FG003|Double-Blind Period|Investigator Decision|3|||
94585057|NCT01499355|323942727|FG000|Double-Blind Period|Consent Withdrawn|0|||
94585058|NCT01499355|323942728|FG001|Double-Blind Period|Consent Withdrawn|0|||
94585059|NCT01499355|323942729|FG002|Double-Blind Period|Consent Withdrawn|1|||
94585060|NCT01499355|323942730|FG003|Double-Blind Period|Consent Withdrawn|2|||
94585061|NCT01499355|323942727|FG000|Double-Blind Period|Lost to Follow-up|0|||
94585062|NCT01499355|323942728|FG001|Double-Blind Period|Lost to Follow-up|1|||
94585063|NCT01499355|323942729|FG002|Double-Blind Period|Lost to Follow-up|0|||
94585064|NCT01499355|323942730|FG003|Double-Blind Period|Lost to Follow-up|0|||
94585065|NCT01354314|323942731|FG000|Overall Study|Lost to Follow-up|1|||
94585066|NCT01354314|323942732|FG001|Overall Study|Lost to Follow-up|0|||
94585067|NCT01354314|323942733|FG002|Overall Study|Lost to Follow-up|1|||
94585068|NCT01354314|323942734|FG003|Overall Study|Lost to Follow-up|1|||
94585069|NCT01354314|323942731|FG000|Overall Study|Withdrawal by Subject|0|||
94585070|NCT01354314|323942732|FG001|Overall Study|Withdrawal by Subject|0|||
94585071|NCT01354314|323942733|FG002|Overall Study|Withdrawal by Subject|1|||
94585072|NCT01354314|323942734|FG003|Overall Study|Withdrawal by Subject|0|||
94585073|NCT01354314|323942731|FG000|Overall Study|Adverse Event|0|||
94585074|NCT01354314|323942732|FG001|Overall Study|Adverse Event|0|||
94585075|NCT01354314|323942733|FG002|Overall Study|Adverse Event|0|||
94585076|NCT01354314|323942734|FG003|Overall Study|Adverse Event|1|||
94585077|NCT01354314|323942731|FG000|Overall Study|Protocol Violation|1|||
94585078|NCT01354314|323942732|FG001|Overall Study|Protocol Violation|1|||
94585079|NCT01354314|323942733|FG002|Overall Study|Protocol Violation|0|||
94585080|NCT01354314|323942734|FG003|Overall Study|Protocol Violation|0|||
94585081|NCT01354314|323942731|FG000|Overall Study|Less than 90% Adherence|4|||
94585082|NCT01354314|323942732|FG001|Overall Study|Less than 90% Adherence|2|||
94585083|NCT01354314|323942733|FG002|Overall Study|Less than 90% Adherence|6|||
94585084|NCT01354314|323942734|FG003|Overall Study|Less than 90% Adherence|4|||
94585085|NCT02453711|323942735|FG000|Overall Study|Withdrawal by Subject|5|||
94585086|NCT02453711|323942736|FG001|Overall Study|Withdrawal by Subject|4|||
94585087|NCT02453711|323942737|FG002|Overall Study|Withdrawal by Subject|6|||
94585088|NCT02453711|323942738|FG003|Overall Study|Withdrawal by Subject|4|||
94585089|NCT02453711|323942739|FG004|Overall Study|Withdrawal by Subject|1|||
94585090|NCT02453711|323942740|FG005|Overall Study|Withdrawal by Subject|1|||
94585091|NCT02453711|323942741|FG006|Overall Study|Withdrawal by Subject|0|||
94585092|NCT02453711|323942742|FG007|Overall Study|Withdrawal by Subject|1|||
94585093|NCT02453711|323942743|FG008|Overall Study|Withdrawal by Subject|7|||
94585094|NCT02453711|323942735|FG000|Overall Study|Lost to Follow-up|5|||
94585095|NCT02453711|323942736|FG001|Overall Study|Lost to Follow-up|3|||
94585096|NCT02453711|323942737|FG002|Overall Study|Lost to Follow-up|2|||
94585097|NCT02453711|323942738|FG003|Overall Study|Lost to Follow-up|3|||
94585098|NCT02453711|323942739|FG004|Overall Study|Lost to Follow-up|1|||
94585099|NCT02453711|323942740|FG005|Overall Study|Lost to Follow-up|5|||
94585100|NCT02453711|323942741|FG006|Overall Study|Lost to Follow-up|2|||
94585101|NCT02453711|323942742|FG007|Overall Study|Lost to Follow-up|6|||
94585102|NCT02453711|323942743|FG008|Overall Study|Lost to Follow-up|6|||
94585103|NCT02453711|323942735|FG000|Overall Study|Death|0|||
94585104|NCT02453711|323942736|FG001|Overall Study|Death|0|||
94585105|NCT02453711|323942737|FG002|Overall Study|Death|0|||
94585106|NCT02453711|323942738|FG003|Overall Study|Death|0|||
94585107|NCT02453711|323942739|FG004|Overall Study|Death|0|||
94585108|NCT02453711|323942740|FG005|Overall Study|Death|0|||
94585109|NCT02453711|323942741|FG006|Overall Study|Death|1|||
94585110|NCT02453711|323942742|FG007|Overall Study|Death|0|||
94585111|NCT02453711|323942743|FG008|Overall Study|Death|0|||
94585112|NCT02453711|323942735|FG000|Overall Study|Unclassified|1|||
94585113|NCT02453711|323942736|FG001|Overall Study|Unclassified|0|||
94585114|NCT02453711|323942737|FG002|Overall Study|Unclassified|1|||
94585115|NCT02453711|323942738|FG003|Overall Study|Unclassified|0|||
94585116|NCT02453711|323942739|FG004|Overall Study|Unclassified|0|||
94585117|NCT02453711|323942740|FG005|Overall Study|Unclassified|0|||
94455950|NCT03214380|323458114|FG004|Treatment Period|Participant schedule|0|||
94585118|NCT02453711|323942741|FG006|Overall Study|Unclassified|0|||
94585119|NCT02453711|323942742|FG007|Overall Study|Unclassified|0|||
94585120|NCT02453711|323942743|FG008|Overall Study|Unclassified|0|||
94585121|NCT02425943|323942744|FG000|Overall Study|Adverse Event|3|||
94585122|NCT02425943|323942745|FG001|Overall Study|Adverse Event|1|||
94585123|NCT02425943|323942744|FG000|Overall Study|Lost to Follow-up|59|||
94585124|NCT02425943|323942745|FG001|Overall Study|Lost to Follow-up|37|||
94585125|NCT02425943|323942744|FG000|Overall Study|Protocol Violation|4|||
94585126|NCT02425943|323942745|FG001|Overall Study|Protocol Violation|1|||
94585127|NCT02425943|323942744|FG000|Overall Study|Withdrawal by Subject|64|||
94585128|NCT02425943|323942745|FG001|Overall Study|Withdrawal by Subject|31|||
94585129|NCT02425943|323942744|FG000|Overall Study|Other|6|||
94585130|NCT02425943|323942745|FG001|Overall Study|Other|0|||
94585131|NCT00607373|323942753|FG000|Treatment Period|Adverse Event|0|||
94585132|NCT00607373|323942754|FG001|Treatment Period|Adverse Event|4|||
94585133|NCT00607373|323942753|FG000|Treatment Period|Physician Decision|0|||
94585134|NCT00607373|323942754|FG001|Treatment Period|Physician Decision|1|||
94585135|NCT00607373|323942753|FG000|Treatment Period|Withdrawal by Subject|0|||
94585136|NCT00607373|323942754|FG001|Treatment Period|Withdrawal by Subject|1|||
94585137|NCT00607373|323942753|FG000|Follow-up Period|Other|0|||
94585138|NCT00607373|323942754|FG001|Follow-up Period|Other|1|||
94585139|NCT00607373|323942753|FG000|Follow-up Period|Protocol Violation|0|||
94585140|NCT00607373|323942754|FG001|Follow-up Period|Protocol Violation|1|||
94242486|NCT03635099|322682727|FG005|Period 2|Lost to Follow-up|0|||
94585141|NCT00607373|323942753|FG000|Follow-up Period|Withdrawal by Subject|1|||
94585142|NCT00607373|323942754|FG001|Follow-up Period|Withdrawal by Subject|3|||
94585143|NCT02116205|323942759|FG000|Overall Study|Withdrawal by Subject|2|||
94585144|NCT02116205|323942760|FG001|Overall Study|Withdrawal by Subject|4|||
94585145|NCT02116205|323942761|FG002|Overall Study|Withdrawal by Subject|1|||
94585146|NCT02116205|323942762|FG003|Overall Study|Withdrawal by Subject|3|||
94585147|NCT02116205|323942759|FG000|Overall Study|Lost to Follow-up|0|||
94585148|NCT02116205|323942760|FG001|Overall Study|Lost to Follow-up|2|||
94585149|NCT02116205|323942761|FG002|Overall Study|Lost to Follow-up|1|||
94585150|NCT02116205|323942762|FG003|Overall Study|Lost to Follow-up|2|||
94585151|NCT02116205|323942759|FG000|Overall Study|Physician Decision|0|||
94585152|NCT02116205|323942760|FG001|Overall Study|Physician Decision|1|||
94585153|NCT02116205|323942761|FG002|Overall Study|Physician Decision|1|||
94585154|NCT02116205|323942762|FG003|Overall Study|Physician Decision|1|||
94585155|NCT02116205|323942759|FG000|Overall Study|Exclusion criteria|0|||
94585156|NCT02116205|323942760|FG001|Overall Study|Exclusion criteria|0|||
94585157|NCT02116205|323942761|FG002|Overall Study|Exclusion criteria|1|||
94585158|NCT02116205|323942762|FG003|Overall Study|Exclusion criteria|0|||
94585159|NCT00928408|323942763|FG000|Overall Study|Other|2|||
94585160|NCT00928408|323942763|FG000|Overall Study|Withdrawal by Subject|4|||
94585161|NCT00928408|323942763|FG000|Overall Study|Death|5|||
94585162|NCT00928408|323942763|FG000|Overall Study|Lost to Follow-up|12|||
94585163|NCT04393454|323942764|FG000|Overall Study|Death|1|||
94585164|NCT04393454|323942764|FG000|Overall Study|Lost to Follow-up|1|||
94585165|NCT01642589|323942773|FG000|Overall Study|Withdrawal by Subject|1|||
94585166|NCT01642589|323942774|FG001|Overall Study|Withdrawal by Subject|1|||
94585167|NCT01704599|323942781|FG000|Overall Study|Adverse Event|1|||
94585168|NCT00472030|323942782|FG000|Overall Study|Physician Decision|1|||
94585169|NCT00472030|323942783|FG001|Overall Study|Physician Decision|0|||
94585170|NCT00599339|323942784|FG000|Overall Study|Adverse Event|79|||
94585171|NCT00599339|323942784|FG000|Overall Study|Withdrawal by Subject|137|||
94585172|NCT00599339|323942784|FG000|Overall Study|Other Reason|179|||
94585173|NCT00599339|323942784|FG000|Overall Study|Lost to Follow-up|221|||
94585174|NCT00599339|323942784|FG000|Overall Study|No valid data consent|36|||
94585175|NCT00599339|323942784|FG000|Overall Study|Study Termination Status Unknown|12|||
94585176|NCT00354432|323942785|FG000|Overall Study|Adverse Event|3|||
94585177|NCT00354432|323942786|FG001|Overall Study|Adverse Event|1|||
94585178|NCT00354432|323942787|FG002|Overall Study|Adverse Event|5|||
94585179|NCT00354432|323942788|FG003|Overall Study|Adverse Event|5|||
94585180|NCT00354432|323942785|FG000|Overall Study|Off/Toxicity|3|||
94585181|NCT00354432|323942786|FG001|Overall Study|Off/Toxicity|7|||
94585182|NCT00354432|323942787|FG002|Overall Study|Off/Toxicity|5|||
94585183|NCT00354432|323942788|FG003|Overall Study|Off/Toxicity|5|||
94585184|NCT02736578|323942789|FG000|Overall Study|Adverse Event|1|||
94585185|NCT02736578|323942790|FG001|Overall Study|Adverse Event|0|||
94585186|NCT00912197|323942792|FG000|Overall Study|Withdrawal by Subject|3|||
94585187|NCT00912197|323942793|FG001|Overall Study|Withdrawal by Subject|3|||
94585188|NCT04163016|323942798|FG000|Enrollment|Adverse Event|1|||
94585189|NCT04163016|323942799|FG001|Enrollment|Adverse Event|0|||
94585190|NCT04163016|323942800|FG002|Enrollment|Adverse Event|0|||
94585191|NCT04163016|323942801|FG003|Enrollment|Adverse Event|0|||
94585192|NCT04163016|323942798|FG000|Treatment|Adverse Event|0|||
94585193|NCT04163016|323942799|FG001|Treatment|Adverse Event|1|||
94585194|NCT04163016|323942800|FG002|Treatment|Adverse Event|0|||
94455951|NCT03214380|323458115|FG005|Treatment Period|Participant schedule|0|||
94455952|NCT03214380|323458110|FG000|Treatment Period|Treatment Interruption|0|||
94585195|NCT04163016|323942801|FG003|Treatment|Adverse Event|0|||
94585196|NCT04163016|323942798|FG000|Treatment|Withdrawal by Subject|0|||
94585197|NCT04163016|323942799|FG001|Treatment|Withdrawal by Subject|2|||
94585198|NCT04163016|323942800|FG002|Treatment|Withdrawal by Subject|0|||
94585199|NCT04163016|323942801|FG003|Treatment|Withdrawal by Subject|0|||
94585200|NCT04163016|323942798|FG000|Treatment|Indeterminate TB-test|0|||
94585201|NCT04163016|323942799|FG001|Treatment|Indeterminate TB-test|0|||
94585202|NCT04163016|323942800|FG002|Treatment|Indeterminate TB-test|0|||
94659232|NCT02039505|324208007|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
94659233|NCT02039505|324208008|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
94585203|NCT04163016|323942801|FG003|Treatment|Indeterminate TB-test|1|||
94585204|NCT04163016|323942798|FG000|Treatment|Participant did not want to continue in study|0|||
94585205|NCT04163016|323942799|FG001|Treatment|Participant did not want to continue in study|0|||
94585206|NCT04163016|323942800|FG002|Treatment|Participant did not want to continue in study|0|||
94585207|NCT04163016|323942801|FG003|Treatment|Participant did not want to continue in study|1|||
94585208|NCT00560352|323942804|FG000|Overall Study|Adverse event unrelated to study drug|2|||
94585209|NCT00560352|323942805|FG001|Overall Study|Adverse event unrelated to study drug|1|||
94585210|NCT00560352|323942806|FG002|Overall Study|Adverse event unrelated to study drug|1|||
94585211|NCT00560352|323942804|FG000|Overall Study|Study drug toxicity|3|||
94585212|NCT00560352|323942805|FG001|Overall Study|Study drug toxicity|0|||
94585213|NCT00560352|323942806|FG002|Overall Study|Study drug toxicity|1|||
94585214|NCT00560352|323942804|FG000|Overall Study|Disease progression|0|||
94585215|NCT00560352|323942805|FG001|Overall Study|Disease progression|1|||
94585216|NCT00560352|323942806|FG002|Overall Study|Disease progression|1|||
94585217|NCT00560352|323942804|FG000|Overall Study|Withdrawal by Subject|1|||
94585218|NCT00560352|323942805|FG001|Overall Study|Withdrawal by Subject|1|||
94585219|NCT00560352|323942806|FG002|Overall Study|Withdrawal by Subject|1|||
94585220|NCT00560352|323942804|FG000|Overall Study|Maximum clinical benefit|1|||
94585221|NCT00560352|323942805|FG001|Overall Study|Maximum clinical benefit|0|||
94585222|NCT00560352|323942806|FG002|Overall Study|Maximum clinical benefit|0|||
94585223|NCT01077050|323944173|FG000|Overall Study|Subjects signed ICF could not be located|1|||
94585224|NCT01077050|323944173|FG000|Overall Study|Screen failure|8|||
94585225|NCT01987453|323944174|FG000|Overall Study|Death|0|||
94585226|NCT01987453|323944175|FG001|Overall Study|Death|0|||
94585227|NCT01987453|323944176|FG002|Overall Study|Death|1|||
94585228|NCT01987453|323944174|FG000|Overall Study|Lack of Efficacy|1|||
94585229|NCT01987453|323944175|FG001|Overall Study|Lack of Efficacy|12|||
94585230|NCT01987453|323944176|FG002|Overall Study|Lack of Efficacy|0|||
94585231|NCT01590888|323944178|FG000|Overall Study|Adverse Event|3|||
94585232|NCT01590888|323944179|FG001|Overall Study|Adverse Event|0|||
94585233|NCT01590888|323944180|FG002|Overall Study|Adverse Event|1|||
94585234|NCT01590888|323944178|FG000|Overall Study|Lost to Follow-up|1|||
94585235|NCT01590888|323944179|FG001|Overall Study|Lost to Follow-up|0|||
94585236|NCT01590888|323944180|FG002|Overall Study|Lost to Follow-up|0|||
94585237|NCT04953728|323944189|FG000|Overall Study|Withdrawal by Subject|3|||
94585238|NCT04953728|323944189|FG000|Overall Study|Physician Decision|1|||
94585239|NCT01148979|323944190|FG000|Overall Study|Lost to Follow-up|0|||
94585240|NCT01148979|323944191|FG001|Overall Study|Lost to Follow-up|1|||
94585241|NCT00777153|323944192|FG000|Overall Study|Lost to Follow-up|1|||
94585242|NCT00777153|323944193|FG001|Overall Study|Lost to Follow-up|1|||
94585243|NCT00777153|323944194|FG002|Overall Study|Lost to Follow-up|0|||
94585244|NCT00777153|323944192|FG000|Overall Study|Death|85|||
94585245|NCT00777153|323944193|FG001|Overall Study|Death|73|||
94585246|NCT00777153|323944194|FG002|Overall Study|Death|33|||
94585247|NCT00777153|323944192|FG000|Overall Study|Withdrawal by Subject|3|||
94585248|NCT00777153|323944193|FG001|Overall Study|Withdrawal by Subject|4|||
94585249|NCT00777153|323944194|FG002|Overall Study|Withdrawal by Subject|3|||
94585250|NCT00777153|323944192|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
94585251|NCT00777153|323944193|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
94585252|NCT00777153|323944194|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
94585253|NCT01646125|323944197|FG000|Overall Study|Untreated|2|||
94585254|NCT01646125|323944198|FG001|Overall Study|Untreated|5|||
94585255|NCT01646125|323944197|FG000|Overall Study|Adverse Event|2|||
94585256|NCT01646125|323944198|FG001|Overall Study|Adverse Event|1|||
94585257|NCT01646125|323944197|FG000|Overall Study|Death|1|||
94585258|NCT01646125|323944198|FG001|Overall Study|Death|1|||
94585259|NCT01646125|323944197|FG000|Overall Study|Physician Decision|1|||
94688606|NCT00390455|324315527|FG001|Overall Study|Other Medical Reasons|11|||
94585260|NCT01646125|323944198|FG001|Overall Study|Physician Decision|3|||
94585261|NCT01646125|323944197|FG000|Overall Study|Progressive disease|22|||
94585262|NCT01646125|323944198|FG001|Overall Study|Progressive disease|16|||
94585263|NCT01646125|323944197|FG000|Overall Study|Study terminated by sponsor|2|||
94585264|NCT01646125|323944198|FG001|Overall Study|Study terminated by sponsor|1|||
94585265|NCT01646125|323944197|FG000|Overall Study|Subject/Guardian decision|1|||
94585266|NCT01646125|323944198|FG001|Overall Study|Subject/Guardian decision|1|||
94585267|NCT01376804|323944200|FG000|Treatment Period|Withdrawal by Subject|1|||
94585268|NCT01376804|323944200|FG000|Treatment Period|Adverse Event|6|||
94585269|NCT01376804|323944200|FG000|Treatment Period|Patient did not receive study drug|1|||
94585270|NCT00641667|323944203|FG000|Overall Study|Withdrawal by Subject|1|||
94585271|NCT00641667|323944203|FG000|Overall Study|Adverse Event|1|||
94585272|NCT00641667|323944203|FG000|Overall Study|Physician Decision|1|||
94585273|NCT00641667|323944203|FG000|Overall Study|Worsening of underlying disease|3|||
94585274|NCT01705509|323944211|FG000|Inclusion CPET|Screen Failure|5|||
94585275|NCT01705509|323944211|FG000|Inclusion CPET|Withdrawal by Subject|2|||
94585276|NCT01705509|323944211|FG000|CPET w/ Ranexa|Screen Failure|2|||
94585277|NCT01227018|323944212|FG000|Overall Study|Disease progression|9|||
94585278|NCT01227018|323944212|FG000|Overall Study|Toxicity|2|||
94585279|NCT01227018|323944212|FG000|Overall Study|Withdrew after beginning treatment|4|||
94585280|NCT02351856|323944213|FG000|Overall Study|Adverse Event|2|||
94585281|NCT02351856|323944213|FG000|Overall Study|Physician Decision|5|||
94585282|NCT02351856|323944213|FG000|Overall Study|Study terminated by sponsor|1|||
94585283|NCT01621802|323944214|FG000|Overall Study|Protocol Violation|0|||
94585284|NCT01621802|323944215|FG001|Overall Study|Protocol Violation|0|||
94585285|NCT01621802|323944216|FG002|Overall Study|Protocol Violation|0|||
94585286|NCT01621802|323944217|FG003|Overall Study|Protocol Violation|0|||
94585287|NCT01621802|323944218|FG004|Overall Study|Protocol Violation|0|||
94585288|NCT01621802|323944219|FG005|Overall Study|Protocol Violation|1|||
94585289|NCT01621802|323944214|FG000|Overall Study|Withdrawal by Subject|8|||
94585290|NCT01621802|323944215|FG001|Overall Study|Withdrawal by Subject|4|||
94585291|NCT01621802|323944216|FG002|Overall Study|Withdrawal by Subject|4|||
94585292|NCT01621802|323944217|FG003|Overall Study|Withdrawal by Subject|2|||
94585293|NCT01621802|323944218|FG004|Overall Study|Withdrawal by Subject|2|||
94585294|NCT01621802|323944219|FG005|Overall Study|Withdrawal by Subject|0|||
94585295|NCT01621802|323944214|FG000|Overall Study|Migrated/moved from study area|0|||
94585296|NCT01621802|323944215|FG001|Overall Study|Migrated/moved from study area|0|||
94585297|NCT01621802|323944216|FG002|Overall Study|Migrated/moved from study area|2|||
94585298|NCT01621802|323944217|FG003|Overall Study|Migrated/moved from study area|0|||
94585299|NCT01621802|323944218|FG004|Overall Study|Migrated/moved from study area|1|||
94585300|NCT01621802|323944219|FG005|Overall Study|Migrated/moved from study area|0|||
94585301|NCT01621802|323944214|FG000|Overall Study|Others|3|||
94585302|NCT01621802|323944215|FG001|Overall Study|Others|3|||
94585303|NCT01621802|323944216|FG002|Overall Study|Others|3|||
94585304|NCT01621802|323944217|FG003|Overall Study|Others|2|||
94585305|NCT01621802|323944218|FG004|Overall Study|Others|1|||
94585306|NCT01621802|323944219|FG005|Overall Study|Others|0|||
94585307|NCT01621802|323944214|FG000|Overall Study|Lost to Follow-up|36|||
94585308|NCT01621802|323944215|FG001|Overall Study|Lost to Follow-up|16|||
94585309|NCT01621802|323944216|FG002|Overall Study|Lost to Follow-up|24|||
94585310|NCT01621802|323944217|FG003|Overall Study|Lost to Follow-up|7|||
94585311|NCT01621802|323944218|FG004|Overall Study|Lost to Follow-up|31|||
94585312|NCT01621802|323944219|FG005|Overall Study|Lost to Follow-up|11|||
94585313|NCT02873702|323944220|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
94585314|NCT02873702|323944221|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
94585315|NCT02873702|323944222|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
94585316|NCT02873702|323944223|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
94585317|NCT02873702|323944220|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
94585318|NCT02873702|323944221|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
94585319|NCT02873702|323944222|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
94585320|NCT02873702|323944223|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
94585321|NCT02873702|323944220|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
94585322|NCT02873702|323944221|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
94585323|NCT02873702|323944222|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
94585324|NCT02873702|323944223|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
94585325|NCT02873702|323944220|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
94585326|NCT02873702|323944221|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
94585327|NCT02873702|323944222|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
94585328|NCT02873702|323944223|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
94585329|NCT02873702|323944220|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
94585330|NCT02873702|323944221|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
94585331|NCT02873702|323944222|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
94585332|NCT02873702|323944223|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
94585333|NCT00785785|323944224|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
94585334|NCT00785785|323944225|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
94585335|NCT00785785|323944224|FG000|Core Phase up to 36 Months|Adverse Event|31|||
94585336|NCT00785785|323944225|FG001|Core Phase up to 36 Months|Adverse Event|21|||
94659234|NCT02039505|324208009|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
94585337|NCT00785785|323944224|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
94585338|NCT00785785|323944225|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
94585339|NCT00785785|323944224|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
94585340|NCT00785785|323944225|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
94585341|NCT00785785|323944224|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
94585342|NCT00785785|323944225|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
94585343|NCT00785785|323944224|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
94585344|NCT00785785|323944225|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
94585345|NCT00785785|323944224|FG000|Core Phase up to 36 Months|Administrative problems|3|||
94585346|NCT00785785|323944225|FG001|Core Phase up to 36 Months|Administrative problems|3|||
94585347|NCT00785785|323944224|FG000|Core Phase up to 36 Months|Death|5|||
94585348|NCT00785785|323944225|FG001|Core Phase up to 36 Months|Death|8|||
94585349|NCT00785785|323944224|FG000|Core Phase up to 36 Months|Disease progression|139|||
94585350|NCT00785785|323944225|FG001|Core Phase up to 36 Months|Disease progression|119|||
94585351|NCT00785785|323944224|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
94585352|NCT00785785|323944225|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
94585353|NCT00785785|323944224|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
94585354|NCT00785785|323944225|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
94585355|NCT00785785|323944224|FG000|Optional Extension Phase|Adverse Event|4|||
94585356|NCT00785785|323944225|FG001|Optional Extension Phase|Adverse Event|5|||
94585357|NCT00785785|323944224|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
94585358|NCT00785785|323944225|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
94585359|NCT00785785|323944224|FG000|Optional Extension Phase|Lost to Follow-up|1|||
94585360|NCT00785785|323944225|FG001|Optional Extension Phase|Lost to Follow-up|0|||
94585361|NCT00785785|323944224|FG000|Optional Extension Phase|Administrative problems|2|||
94585362|NCT00785785|323944225|FG001|Optional Extension Phase|Administrative problems|0|||
94585363|NCT00785785|323944224|FG000|Optional Extension Phase|Death|1|||
94585364|NCT00785785|323944225|FG001|Optional Extension Phase|Death|5|||
94585365|NCT00785785|323944224|FG000|Optional Extension Phase|Disease progression|22|||
94585366|NCT00785785|323944225|FG001|Optional Extension Phase|Disease progression|70|||
94585367|NCT00785785|323944224|FG000|Optional Extension Phase|Protocol deviation|0|||
94585368|NCT00785785|323944225|FG001|Optional Extension Phase|Protocol deviation|2|||
94585369|NCT00785785|323944224|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
94585370|NCT00785785|323944225|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
94585371|NCT02453321|323944226|FG000|Overall Study|Weakness|1|||
94585372|NCT02453321|323944227|FG001|Overall Study|Weakness|1|||
94585373|NCT02453321|323944228|FG002|Overall Study|Weakness|2|||
94585374|NCT02453321|323944226|FG000|Overall Study|Deep Venous Thrombosis|0|||
94585375|NCT02453321|323944227|FG001|Overall Study|Deep Venous Thrombosis|1|||
94585376|NCT02453321|323944228|FG002|Overall Study|Deep Venous Thrombosis|0|||
94585377|NCT00499616|323944229|FG000|Overall Study|Death|1|||
94585378|NCT00499616|323944230|FG001|Overall Study|Death|5|||
94585379|NCT00499616|323944231|FG002|Overall Study|Death|3|||
94585380|NCT00499616|323944232|FG003|Overall Study|Death|1|||
94585381|NCT00499616|323944229|FG000|Overall Study|Lack of Efficacy|5|||
94585382|NCT00499616|323944230|FG001|Overall Study|Lack of Efficacy|0|||
94585383|NCT00499616|323944231|FG002|Overall Study|Lack of Efficacy|19|||
94585384|NCT00499616|323944232|FG003|Overall Study|Lack of Efficacy|0|||
94585385|NCT00499616|323944229|FG000|Overall Study|Lost to Follow-up|0|||
94585386|NCT00499616|323944230|FG001|Overall Study|Lost to Follow-up|0|||
94585387|NCT00499616|323944231|FG002|Overall Study|Lost to Follow-up|1|||
94585388|NCT00499616|323944232|FG003|Overall Study|Lost to Follow-up|0|||
94585389|NCT00499616|323944229|FG000|Overall Study|Physician Decision|6|||
94585390|NCT00499616|323944230|FG001|Overall Study|Physician Decision|16|||
94585391|NCT00499616|323944231|FG002|Overall Study|Physician Decision|9|||
94585392|NCT00499616|323944232|FG003|Overall Study|Physician Decision|0|||
94585393|NCT00499616|323944229|FG000|Overall Study|Withdrawal by Subject|1|||
94585394|NCT00499616|323944230|FG001|Overall Study|Withdrawal by Subject|0|||
94585395|NCT00499616|323944231|FG002|Overall Study|Withdrawal by Subject|1|||
94585396|NCT00499616|323944232|FG003|Overall Study|Withdrawal by Subject|0|||
94585397|NCT00499616|323944229|FG000|Overall Study|Ineligible|1|||
94585398|NCT00499616|323944230|FG001|Overall Study|Ineligible|2|||
94585399|NCT00499616|323944231|FG002|Overall Study|Ineligible|0|||
94585400|NCT00499616|323944232|FG003|Overall Study|Ineligible|15|||
94585401|NCT00499616|323944229|FG000|Overall Study|Not evaluable|0|||
94585402|NCT00499616|323944230|FG001|Overall Study|Not evaluable|0|||
94585403|NCT00499616|323944231|FG002|Overall Study|Not evaluable|0|||
94585404|NCT00499616|323944232|FG003|Overall Study|Not evaluable|41|||
94585405|NCT00499616|323944229|FG000|Overall Study|Patient/Parent Refusal|1|||
94585406|NCT00499616|323944230|FG001|Overall Study|Patient/Parent Refusal|5|||
94585407|NCT00499616|323944231|FG002|Overall Study|Patient/Parent Refusal|3|||
94585408|NCT00499616|323944232|FG003|Overall Study|Patient/Parent Refusal|0|||
94585409|NCT02563067|323944235|FG000|Overall Study|Subject/guardian decision|14|||
94585410|NCT02563067|323944236|FG001|Overall Study|Subject/guardian decision|20|||
94585411|NCT02563067|323944237|FG002|Overall Study|Subject/guardian decision|16|||
94585412|NCT02563067|323944235|FG000|Overall Study|Physician Decision|0|||
94585413|NCT02563067|323944236|FG001|Overall Study|Physician Decision|1|||
94585414|NCT02563067|323944237|FG002|Overall Study|Physician Decision|3|||
94585415|NCT02563067|323944235|FG000|Overall Study|Lost to Follow-up|1|||
94585416|NCT02563067|323944236|FG001|Overall Study|Lost to Follow-up|2|||
94585417|NCT02563067|323944237|FG002|Overall Study|Lost to Follow-up|0|||
94585418|NCT02563067|323944235|FG000|Overall Study|Technical problems|0|||
94585419|NCT02563067|323944236|FG001|Overall Study|Technical problems|1|||
94585420|NCT02563067|323944237|FG002|Overall Study|Technical problems|0|||
94585421|NCT02563067|323944235|FG000|Overall Study|Lack of Efficacy|1|||
94585422|NCT02563067|323944236|FG001|Overall Study|Lack of Efficacy|0|||
94585423|NCT02563067|323944237|FG002|Overall Study|Lack of Efficacy|0|||
94585424|NCT02563067|323944235|FG000|Overall Study|Death|0|||
94585425|NCT02563067|323944236|FG001|Overall Study|Death|1|||
94585426|NCT02563067|323944237|FG002|Overall Study|Death|1|||
94585427|NCT02563067|323944235|FG000|Overall Study|Adverse Event|2|||
94585428|NCT02563067|323944236|FG001|Overall Study|Adverse Event|1|||
94585429|NCT02563067|323944237|FG002|Overall Study|Adverse Event|0|||
94585430|NCT02563067|323944235|FG000|Overall Study|Death post Treatment/safety period|1|||
94585431|NCT02563067|323944236|FG001|Overall Study|Death post Treatment/safety period|0|||
94585432|NCT02563067|323944237|FG002|Overall Study|Death post Treatment/safety period|0|||
94585433|NCT04816669|323944240|FG000|Part 1|Adverse Event|1|||
94585434|NCT04816669|323944241|FG001|Part 1|Adverse Event|1|||
94585435|NCT04816669|323944242|FG002|Part 1|Adverse Event|0|||
94585436|NCT04816669|323944243|FG003|Part 1|Adverse Event|0|||
94585437|NCT04816669|323944240|FG000|Part 1|Lost to Follow-up|2|||
94585438|NCT04816669|323944241|FG001|Part 1|Lost to Follow-up|2|||
94585439|NCT04816669|323944242|FG002|Part 1|Lost to Follow-up|0|||
94585440|NCT04816669|323944243|FG003|Part 1|Lost to Follow-up|0|||
94585441|NCT04816669|323944240|FG000|Part 1|Protocol Violation|0|||
94585442|NCT04816669|323944241|FG001|Part 1|Protocol Violation|1|||
94585443|NCT04816669|323944242|FG002|Part 1|Protocol Violation|0|||
94585444|NCT04816669|323944243|FG003|Part 1|Protocol Violation|0|||
94242487|NCT03635099|322682728|FG006|Period 2|Lost to Follow-up|0|||
94585445|NCT04816669|323944240|FG000|Part 1|Withdrawal by Subject|1|||
94585446|NCT04816669|323944241|FG001|Part 1|Withdrawal by Subject|2|||
94585447|NCT04816669|323944242|FG002|Part 1|Withdrawal by Subject|0|||
94585448|NCT04816669|323944243|FG003|Part 1|Withdrawal by Subject|0|||
94585449|NCT04816669|323944240|FG000|Part 2|Other|0|||
94585450|NCT04816669|323944241|FG001|Part 2|Other|0|||
94585451|NCT04816669|323944242|FG002|Part 2|Other|1|||
94585452|NCT04816669|323944243|FG003|Part 2|Other|0|||
94585453|NCT04816669|323944240|FG000|Part 2|Withdrawal by Subject|0|||
94585454|NCT04816669|323944241|FG001|Part 2|Withdrawal by Subject|0|||
94585455|NCT04816669|323944242|FG002|Part 2|Withdrawal by Subject|0|||
94585456|NCT04816669|323944243|FG003|Part 2|Withdrawal by Subject|1|||
94585457|NCT04816669|323944240|FG000|Part 2|Lost to Follow-up|0|||
94585458|NCT04816669|323944241|FG001|Part 2|Lost to Follow-up|0|||
94585459|NCT04816669|323944242|FG002|Part 2|Lost to Follow-up|1|||
94585460|NCT04816669|323944243|FG003|Part 2|Lost to Follow-up|0|||
94585461|NCT00084136|323944248|FG000|PI Comparison|Death|10|||
94585462|NCT00084136|323944249|FG001|PI Comparison|Death|9|||
94585463|NCT00084136|323944250|FG002|PI Comparison|Death|0|||
94585464|NCT00084136|323944248|FG000|PI Comparison|Lost to Follow-up|11|||
94585465|NCT00084136|323944249|FG001|PI Comparison|Lost to Follow-up|8|||
94585466|NCT00084136|323944250|FG002|PI Comparison|Lost to Follow-up|0|||
94585467|NCT00084136|323944248|FG000|PI Comparison|Withdrawal by Subject|33|||
94585468|NCT00084136|323944249|FG001|PI Comparison|Withdrawal by Subject|30|||
94585469|NCT00084136|323944250|FG002|PI Comparison|Withdrawal by Subject|0|||
94242488|NCT03635099|322682729|FG007|Period 2|Lost to Follow-up|0|||
94242489|NCT03635099|322682722|FG000|Period 2|Withdrawal by Subject|0|||
94242490|NCT03635099|322682723|FG001|Period 2|Withdrawal by Subject|0|||
94242491|NCT03635099|322682724|FG002|Period 2|Withdrawal by Subject|7|||
94242492|NCT03635099|322682725|FG003|Period 2|Withdrawal by Subject|4|||
94242493|NCT03635099|322682726|FG004|Period 2|Withdrawal by Subject|7|||
94242494|NCT03635099|322682727|FG005|Period 2|Withdrawal by Subject|0|||
94585470|NCT00084136|323944248|FG000|PI Comparison|Clinic site closed|1|||
94585471|NCT00084136|323944249|FG001|PI Comparison|Clinic site closed|0|||
94585472|NCT00084136|323944250|FG002|PI Comparison|Clinic site closed|0|||
94585473|NCT00084136|323944248|FG000|NRTI Comparison|Death|20|||
94585474|NCT00084136|323944249|FG001|NRTI Comparison|Death|0|||
94585475|NCT00084136|323944250|FG002|NRTI Comparison|Death|18|||
94242495|NCT03635099|322682728|FG006|Period 2|Withdrawal by Subject|0|||
94585476|NCT00084136|323944248|FG000|NRTI Comparison|Lost to Follow-up|14|||
94585477|NCT00084136|323944249|FG001|NRTI Comparison|Lost to Follow-up|0|||
94585478|NCT00084136|323944250|FG002|NRTI Comparison|Lost to Follow-up|12|||
94585479|NCT00084136|323944248|FG000|NRTI Comparison|Withdrawal by Subject|54|||
94585480|NCT00084136|323944249|FG001|NRTI Comparison|Withdrawal by Subject|0|||
94585481|NCT00084136|323944250|FG002|NRTI Comparison|Withdrawal by Subject|38|||
94585482|NCT00084136|323944248|FG000|NRTI Comparison|Clinic site closed|12|||
94585483|NCT00084136|323944249|FG001|NRTI Comparison|Clinic site closed|0|||
94585484|NCT00084136|323944250|FG002|NRTI Comparison|Clinic site closed|14|||
94585485|NCT00084136|323944248|FG000|NRTI Comparison|Not reason above|1|||
94585486|NCT00084136|323944249|FG001|NRTI Comparison|Not reason above|0|||
94585487|NCT00084136|323944250|FG002|NRTI Comparison|Not reason above|0|||
94585488|NCT00001213|323944251|FG000|Overall Study|Death|18|||
94585489|NCT02230670|323944252|FG000|Overall Study|Adverse Event|1|||
94585490|NCT02230670|323944253|FG001|Overall Study|Adverse Event|2|||
94585491|NCT02230670|323944252|FG000|Overall Study|Withdrawal by Subject|2|||
94585492|NCT02230670|323944253|FG001|Overall Study|Withdrawal by Subject|2|||
94585493|NCT02230670|323944252|FG000|Overall Study|Physician Decision|0|||
94585494|NCT02230670|323944253|FG001|Overall Study|Physician Decision|1|||
94585495|NCT02230670|323944252|FG000|Overall Study|Protocol Violation|0|||
94585496|NCT02230670|323944253|FG001|Overall Study|Protocol Violation|1|||
94585497|NCT02230670|323944252|FG000|Overall Study|Progression to Child-Pugh C|1|||
94585498|NCT02230670|323944253|FG001|Overall Study|Progression to Child-Pugh C|2|||
94585499|NCT01554241|323944254|FG000|Overall Study|Death|3|||
94585500|NCT01554241|323944255|FG001|Overall Study|Death|1|||
94585501|NCT01554241|323944256|FG002|Overall Study|Death|1|||
94585502|NCT01554241|323944257|FG003|Overall Study|Death|0|||
94585503|NCT01554241|323944254|FG000|Overall Study|protocol specified renal stone|0|||
94585504|NCT01554241|323944255|FG001|Overall Study|protocol specified renal stone|0|||
94585505|NCT01554241|323944256|FG002|Overall Study|protocol specified renal stone|0|||
94585506|NCT01554241|323944257|FG003|Overall Study|protocol specified renal stone|1|||
94585507|NCT01554241|323944254|FG000|Overall Study|protocol specified change in eGFR|0|||
94585508|NCT01554241|323944255|FG001|Overall Study|protocol specified change in eGFR|0|||
94585509|NCT01554241|323944256|FG002|Overall Study|protocol specified change in eGFR|1|||
94585510|NCT01554241|323944257|FG003|Overall Study|protocol specified change in eGFR|0|||
94585511|NCT01554241|323944254|FG000|Overall Study|Withdrawal by Subject|0|||
94585512|NCT01554241|323944255|FG001|Overall Study|Withdrawal by Subject|0|||
94585513|NCT01554241|323944256|FG002|Overall Study|Withdrawal by Subject|2|||
94585514|NCT01554241|323944257|FG003|Overall Study|Withdrawal by Subject|0|||
94585515|NCT00892099|323944258|FG000|Overall Study|Death|1|||
94585516|NCT00892099|323944259|FG001|Overall Study|Death|0|||
94585517|NCT00892099|323944260|FG002|Overall Study|Death|1|||
94585518|NCT00892099|323944258|FG000|Overall Study|Adverse Event|1|||
94585519|NCT00892099|323944259|FG001|Overall Study|Adverse Event|0|||
94585520|NCT00892099|323944260|FG002|Overall Study|Adverse Event|0|||
94585521|NCT00892099|323944258|FG000|Overall Study|replocated|1|||
94585522|NCT00892099|323944259|FG001|Overall Study|replocated|0|||
94585523|NCT00892099|323944260|FG002|Overall Study|replocated|2|||
94585524|NCT00892099|323944258|FG000|Overall Study|Prolonged hospitalization|1|||
94585525|NCT00892099|323944259|FG001|Overall Study|Prolonged hospitalization|0|||
94585526|NCT00892099|323944260|FG002|Overall Study|Prolonged hospitalization|1|||
94585527|NCT00892099|323944258|FG000|Overall Study|no further details|1|||
94585528|NCT00892099|323944259|FG001|Overall Study|no further details|0|||
94585529|NCT00892099|323944260|FG002|Overall Study|no further details|1|||
94585530|NCT00892099|323944258|FG000|Overall Study|kidney function recovered|0|||
94585531|NCT00892099|323944259|FG001|Overall Study|kidney function recovered|1|||
94585532|NCT00892099|323944260|FG002|Overall Study|kidney function recovered|0|||
94585533|NCT00892099|323944258|FG000|Overall Study|investigator decision|0|||
94585534|NCT00892099|323944259|FG001|Overall Study|investigator decision|0|||
94242496|NCT03635099|322682729|FG007|Period 2|Withdrawal by Subject|0|||
94242497|NCT01646177|322682730|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
94242498|NCT01646177|322682731|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
94242499|NCT01646177|322682732|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
94242500|NCT01646177|322682733|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
94242501|NCT01646177|322682734|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
94242502|NCT01646177|322682735|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
94242503|NCT01646177|322682736|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
94242504|NCT01646177|322682737|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
94242505|NCT01646177|322682738|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
94242506|NCT01646177|322682739|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
94242507|NCT01646177|322682740|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
94242508|NCT01646177|322682741|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
94242509|NCT01646177|322682730|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
94585535|NCT00892099|323944260|FG002|Overall Study|investigator decision|1|||
94585536|NCT00892099|323944258|FG000|Overall Study|Lost to Follow-up|0|||
94585537|NCT00892099|323944259|FG001|Overall Study|Lost to Follow-up|0|||
94585538|NCT00892099|323944260|FG002|Overall Study|Lost to Follow-up|1|||
94585539|NCT00372593|323944261|FG000|Overall Study|Adverse Event|43|||
94585540|NCT00372593|323944262|FG001|Overall Study|Adverse Event|45|||
94585541|NCT00372593|323944263|FG002|Overall Study|Adverse Event|0|||
94585542|NCT00372593|323944261|FG000|Overall Study|Death|16|||
94585543|NCT00372593|323944262|FG001|Overall Study|Death|20|||
94585544|NCT00372593|323944263|FG002|Overall Study|Death|1|||
94585545|NCT00372593|323944261|FG000|Overall Study|Lack of Efficacy|82|||
94585546|NCT00372593|323944262|FG001|Overall Study|Lack of Efficacy|71|||
94585547|NCT00372593|323944263|FG002|Overall Study|Lack of Efficacy|2|||
94585548|NCT00372593|323944261|FG000|Overall Study|Lost to Follow-up|1|||
94585549|NCT00372593|323944262|FG001|Overall Study|Lost to Follow-up|0|||
94585550|NCT00372593|323944263|FG002|Overall Study|Lost to Follow-up|0|||
94242510|NCT01646177|322682731|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
94242511|NCT01646177|322682732|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
94242512|NCT01646177|322682733|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
94242513|NCT01646177|322682734|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
94242514|NCT01646177|322682735|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
94242515|NCT01646177|322682736|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
94242516|NCT01646177|322682737|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
94242517|NCT01646177|322682738|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
94585551|NCT00372593|323944261|FG000|Overall Study|Physician Decision|42|||
94585552|NCT00372593|323944262|FG001|Overall Study|Physician Decision|41|||
94585553|NCT00372593|323944263|FG002|Overall Study|Physician Decision|0|||
94585554|NCT00372593|323944261|FG000|Overall Study|Ineligible|20|||
94585555|NCT00372593|323944262|FG001|Overall Study|Ineligible|21|||
94585556|NCT00372593|323944263|FG002|Overall Study|Ineligible|1|||
94585557|NCT00433004|323944264|FG000|Overall Study|Lost to Follow-up|5|||
94242518|NCT01646177|322682739|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
94242519|NCT01646177|322682740|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
94242520|NCT01646177|322682741|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
94242521|NCT01646177|322682730|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
94242522|NCT01646177|322682731|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
94585558|NCT00433004|323944265|FG001|Overall Study|Lost to Follow-up|7|||
94585559|NCT00790088|323944266|FG000|Overall Study|Protocol Violation|11|||
94585560|NCT00790088|323944266|FG000|Overall Study|Withdrawal by Subject|17|||
94585561|NCT00790088|323944266|FG000|Overall Study|Lost to Follow-up|7|||
94585562|NCT00790088|323944266|FG000|Overall Study|Physician Decision|4|||
94585563|NCT01106690|323944268|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
94585564|NCT01106690|323944269|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
94585565|NCT01106690|323944270|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
94585566|NCT01106690|323944268|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
94585567|NCT01106690|323944269|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
94242523|NCT01646177|322682732|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
94242524|NCT01646177|322682733|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
94242525|NCT01646177|322682734|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
94242526|NCT01646177|322682735|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
94242527|NCT01646177|322682736|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
94242528|NCT01646177|322682737|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
94242529|NCT01646177|322682738|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
94585568|NCT01106690|323944270|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
94585569|NCT01106690|323944268|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
94585570|NCT01106690|323944269|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
94242530|NCT01646177|322682739|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
94242531|NCT01646177|322682740|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
94242532|NCT01646177|322682741|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
94242533|NCT01646177|322682730|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
94242534|NCT01646177|322682731|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
94242535|NCT01646177|322682732|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
94242536|NCT01646177|322682733|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
94242537|NCT01646177|322682734|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
94242538|NCT01646177|322682735|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
94242539|NCT01646177|322682736|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
94242540|NCT01646177|322682737|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
94242541|NCT01646177|322682738|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
94585571|NCT01106690|323944270|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
94585572|NCT01106690|323944268|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
94585573|NCT01106690|323944269|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
94585574|NCT01106690|323944270|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
94585575|NCT01106690|323944268|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
94585576|NCT01106690|323944269|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
94585577|NCT01106690|323944270|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
94585578|NCT01106690|323944268|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
94585579|NCT01106690|323944269|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
94585580|NCT01106690|323944270|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
94585581|NCT01106690|323944268|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
94585582|NCT01106690|323944269|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
94585583|NCT01106690|323944270|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
94242542|NCT01646177|322682739|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
94585584|NCT01106690|323944268|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
94585585|NCT01106690|323944269|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
94585586|NCT01106690|323944270|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
94585587|NCT01106690|323944268|FG000|Core Period: Baseline to Week 26|Other|10|||
94585588|NCT01106690|323944269|FG001|Core Period: Baseline to Week 26|Other|2|||
94585589|NCT01106690|323944270|FG002|Core Period: Baseline to Week 26|Other|6|||
94585590|NCT01106690|323944268|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
94585591|NCT01106690|323944269|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
94585592|NCT01106690|323944270|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
94585593|NCT01106690|323944268|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
94585594|NCT01106690|323944269|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
94585595|NCT01106690|323944270|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
94585596|NCT01106690|323944268|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
94585597|NCT01106690|323944269|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
94585598|NCT01106690|323944270|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
94585599|NCT01106690|323944268|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
94585600|NCT01106690|323944269|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
94585601|NCT01106690|323944270|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
94585602|NCT01106690|323944268|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
94585603|NCT01106690|323944269|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
94585604|NCT01106690|323944270|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
94585605|NCT01106690|323944268|FG000|Extension Period: Week 26 to Week 52|Other|8|||
94585606|NCT01106690|323944269|FG001|Extension Period: Week 26 to Week 52|Other|3|||
94585607|NCT01106690|323944270|FG002|Extension Period: Week 26 to Week 52|Other|4|||
94585608|NCT01106690|323944268|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
94585609|NCT01106690|323944269|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
94585610|NCT01106690|323944270|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
94585611|NCT00196313|323944276|FG000|Overall Study|Protocol Violation|2|||
94585612|NCT00196313|323944277|FG001|Overall Study|Protocol Violation|3|||
94585613|NCT00196313|323944276|FG000|Overall Study|Withdrawal by Subject|3|||
94585614|NCT00196313|323944277|FG001|Overall Study|Withdrawal by Subject|1|||
94585615|NCT00196313|323944276|FG000|Overall Study|Adverse Event|3|||
94585616|NCT00196313|323944277|FG001|Overall Study|Adverse Event|1|||
94585617|NCT00196313|323944276|FG000|Overall Study|Subject Pregnant|1|||
94585618|NCT00196313|323944277|FG001|Overall Study|Subject Pregnant|1|||
94585619|NCT00196313|323944276|FG000|Overall Study|Lost to Follow-up|2|||
94585620|NCT00196313|323944277|FG001|Overall Study|Lost to Follow-up|2|||
94585621|NCT00473382|323944280|FG000|Core Study|Adverse Event|3|||
94585622|NCT00473382|323944281|FG001|Core Study|Adverse Event|1|||
94585623|NCT00473382|323944282|FG002|Core Study|Adverse Event|1|||
94585624|NCT00473382|323944280|FG000|Core Study|Death|3|||
94585625|NCT00473382|323944281|FG001|Core Study|Death|5|||
94585626|NCT00473382|323944282|FG002|Core Study|Death|10|||
94585627|NCT00473382|323944280|FG000|Core Study|Lost to Follow-up|3|||
94585628|NCT00473382|323944281|FG001|Core Study|Lost to Follow-up|3|||
94585629|NCT00473382|323944282|FG002|Core Study|Lost to Follow-up|3|||
94585630|NCT00473382|323944280|FG000|Core Study|Physician Decision|1|||
94585631|NCT00473382|323944281|FG001|Core Study|Physician Decision|2|||
94585632|NCT00473382|323944282|FG002|Core Study|Physician Decision|2|||
94585633|NCT00473382|323944280|FG000|Core Study|Subject non-compliance|5|||
94585634|NCT00473382|323944281|FG001|Core Study|Subject non-compliance|2|||
94585635|NCT00473382|323944282|FG002|Core Study|Subject non-compliance|1|||
94585636|NCT00473382|323944280|FG000|Core Study|Subject needed other treatment|1|||
94585637|NCT00473382|323944281|FG001|Core Study|Subject needed other treatment|3|||
94585638|NCT00473382|323944282|FG002|Core Study|Subject needed other treatment|2|||
94585639|NCT00473382|323944280|FG000|Core Study|Subject's decision|12|||
94585640|NCT00473382|323944281|FG001|Core Study|Subject's decision|11|||
94585641|NCT00473382|323944282|FG002|Core Study|Subject's decision|10|||
94585642|NCT00473382|323944280|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
94585643|NCT00473382|323944281|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
94585644|NCT00473382|323944282|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
94585645|NCT00473382|323944280|FG000|Open-label Extension Through Month 48|Death|1|||
94585646|NCT00473382|323944281|FG001|Open-label Extension Through Month 48|Death|3|||
94585647|NCT00473382|323944282|FG002|Open-label Extension Through Month 48|Death|3|||
94585648|NCT00473382|323944280|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
94585649|NCT00473382|323944281|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
94585650|NCT00473382|323944282|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
94585651|NCT00473382|323944280|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
94585652|NCT00473382|323944281|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
94585653|NCT00473382|323944282|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
94585654|NCT00473382|323944280|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
94585655|NCT00473382|323944281|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
94585656|NCT00473382|323944282|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
94585657|NCT00473382|323944280|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
94585658|NCT00473382|323944281|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
94585659|NCT00473382|323944282|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
94585660|NCT00473382|323944280|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
94585661|NCT00473382|323944281|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
94585662|NCT00473382|323944282|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
94585663|NCT00473382|323944280|FG000|Open-label Extension Through Month 60|Death|1|||
94585664|NCT00473382|323944281|FG001|Open-label Extension Through Month 60|Death|7|||
94585665|NCT00473382|323944282|FG002|Open-label Extension Through Month 60|Death|4|||
94585666|NCT00473382|323944280|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
94585667|NCT00473382|323944281|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
94585668|NCT00473382|323944282|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
94585669|NCT00473382|323944280|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
94585670|NCT00473382|323944281|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
94585671|NCT00473382|323944282|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
94585672|NCT00473382|323944280|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
94585673|NCT00473382|323944281|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
94585674|NCT00473382|323944282|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
94585675|NCT00473382|323944280|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
94585676|NCT00473382|323944281|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
94585677|NCT00473382|323944282|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
94585678|NCT03388164|323944285|FG000|Overall Study|Withdrawal by Subject|3|||
94585679|NCT03388164|323944286|FG001|Overall Study|Withdrawal by Subject|1|||
94585680|NCT00934362|323944287|FG000|Overall Study|Adverse Event|1|||
94585681|NCT00934362|323944288|FG001|Overall Study|Adverse Event|0|||
94585682|NCT01821118|323944289|FG000|Overall Study|Death|0|||
94585683|NCT01821118|323944290|FG001|Overall Study|Death|1|||
94585684|NCT00318643|323944295|FG000|Overall Study|Adverse Event|0|||
94585685|NCT00318643|323944296|FG001|Overall Study|Adverse Event|0|||
94585686|NCT00318643|323944297|FG002|Overall Study|Adverse Event|0|||
94585687|NCT00318643|323944298|FG003|Overall Study|Adverse Event|0|||
94585688|NCT00318643|323944299|FG004|Overall Study|Adverse Event|1|||
94585689|NCT00318643|323944295|FG000|Overall Study|Participant's Decision|0|||
94585690|NCT00318643|323944296|FG001|Overall Study|Participant's Decision|0|||
94585691|NCT00318643|323944297|FG002|Overall Study|Participant's Decision|0|||
94585692|NCT00318643|323944298|FG003|Overall Study|Participant's Decision|0|||
94659235|NCT02039505|324208010|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
94585693|NCT00318643|323944299|FG004|Overall Study|Participant's Decision|1|||
94585694|NCT00318643|323944295|FG000|Overall Study|Investigator's Decision|0|||
94242543|NCT01646177|322682740|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
94242544|NCT01646177|322682741|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
94242545|NCT01646177|322682730|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
94585695|NCT00318643|323944296|FG001|Overall Study|Investigator's Decision|0|||
94585696|NCT00318643|323944297|FG002|Overall Study|Investigator's Decision|0|||
94585697|NCT00318643|323944298|FG003|Overall Study|Investigator's Decision|0|||
94585698|NCT00318643|323944299|FG004|Overall Study|Investigator's Decision|1|||
94585699|NCT01812252|323944300|FG000|Overall Study|Persistent Disease|1|||
94585700|NCT01812252|323944301|FG001|Overall Study|Persistent Disease|0|||
94585701|NCT01812252|323944300|FG000|Overall Study|Not transplanted|11|||
94585702|NCT01812252|323944301|FG001|Overall Study|Not transplanted|11|||
94585703|NCT01812252|323944300|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
94585704|NCT01812252|323944301|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
94585705|NCT01812252|323944300|FG000|Overall Study|Withdrawal by Subject|1|||
94585706|NCT01812252|323944301|FG001|Overall Study|Withdrawal by Subject|1|||
94585707|NCT01812252|323944300|FG000|Overall Study|Screen Failure|1|||
94242546|NCT01646177|322682731|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
94585708|NCT01812252|323944301|FG001|Overall Study|Screen Failure|0|||
94585709|NCT00357006|323944302|FG000|Overall Study|Lost to Follow-up|1|||
94585710|NCT00357006|323944303|FG001|Overall Study|Lost to Follow-up|2|||
94585711|NCT00357006|323944304|FG002|Overall Study|Lost to Follow-up|1|||
94585712|NCT00357006|323944302|FG000|Overall Study|Withdrawal by Subject|1|||
94585713|NCT00357006|323944303|FG001|Overall Study|Withdrawal by Subject|3|||
94585714|NCT00357006|323944304|FG002|Overall Study|Withdrawal by Subject|2|||
94585715|NCT00125164|323944306|FG000|Overall Study|Adverse Event|0|||
94585716|NCT00125164|323944307|FG001|Overall Study|Adverse Event|0|||
94585717|NCT00125164|323944308|FG002|Overall Study|Adverse Event|2|||
94585718|NCT00125164|323944309|FG003|Overall Study|Adverse Event|4|||
94585719|NCT00125164|323944306|FG000|Overall Study|Lost to Follow-up|0|||
94585720|NCT00125164|323944307|FG001|Overall Study|Lost to Follow-up|0|||
94585721|NCT00125164|323944308|FG002|Overall Study|Lost to Follow-up|1|||
94585722|NCT00125164|323944309|FG003|Overall Study|Lost to Follow-up|1|||
94585723|NCT00125164|323944306|FG000|Overall Study|Withdrawal by Subject|2|||
94585724|NCT00125164|323944307|FG001|Overall Study|Withdrawal by Subject|0|||
94585725|NCT00125164|323944308|FG002|Overall Study|Withdrawal by Subject|1|||
94242547|NCT01646177|322682732|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
94242548|NCT01646177|322682733|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
94242549|NCT01646177|322682734|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
94242550|NCT01646177|322682735|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
94242551|NCT01646177|322682736|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
94242552|NCT01646177|322682737|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
94242553|NCT01646177|322682738|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
94242554|NCT01646177|322682739|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
94242555|NCT01646177|322682740|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
94242556|NCT01646177|322682741|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
94242557|NCT01646177|322682730|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
94242558|NCT01646177|322682731|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
94242559|NCT01646177|322682732|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
94242560|NCT01646177|322682733|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
94242561|NCT01646177|322682734|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
94242562|NCT01646177|322682735|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
94242563|NCT01646177|322682736|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
94242564|NCT01646177|322682737|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
94242565|NCT01646177|322682738|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
94242566|NCT01646177|322682739|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
94242567|NCT01646177|322682740|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
94242568|NCT01646177|322682741|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
94242569|NCT01646177|322682730|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
94242570|NCT01646177|322682731|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
94585726|NCT00125164|323944309|FG003|Overall Study|Withdrawal by Subject|1|||
94585727|NCT03610269|323944312|FG000|Overall Study|Physician Decision|10|||
94585728|NCT03610269|323944312|FG000|Overall Study|Protocol Violation|1|||
94585729|NCT03610269|323944312|FG000|Overall Study|Unable to draw blood|1|||
94585730|NCT03610269|323944312|FG000|Overall Study|Screen fail|4|||
94585731|NCT00067002|323944313|FG000|Overall Study|Early Death|1|||
94585732|NCT00067002|323944314|FG001|Overall Study|Early Death|2|||
94585733|NCT00067002|323944313|FG000|Overall Study|Delayed|1|||
94585734|NCT00067002|323944314|FG001|Overall Study|Delayed|1|||
94585735|NCT00067002|323944313|FG000|Overall Study|Graft Failure|5|||
94585736|NCT00067002|323944314|FG001|Overall Study|Graft Failure|6|||
94585737|NCT03350672|323944315|FG000|Overall Study|Withdrawal by Subject|7|||
94585738|NCT03350672|323944316|FG001|Overall Study|Withdrawal by Subject|0|||
94585739|NCT03350672|323944317|FG002|Overall Study|Withdrawal by Subject|0|||
94585740|NCT00760617|323944319|FG000|Overall Study|Adverse Event|5|||
94585741|NCT00760617|323944320|FG001|Overall Study|Adverse Event|2|||
94585742|NCT00760617|323944321|FG002|Overall Study|Adverse Event|0|||
94585743|NCT00760617|323944319|FG000|Overall Study|Lost to Follow-up|0|||
94585744|NCT00760617|323944320|FG001|Overall Study|Lost to Follow-up|0|||
94585745|NCT00760617|323944321|FG002|Overall Study|Lost to Follow-up|5|||
94585746|NCT00467753|323944322|FG000|Overall Study|Lost to Follow-up|1|||
94585747|NCT00467753|323944323|FG001|Overall Study|Lost to Follow-up|2|||
94585748|NCT00467753|323944322|FG000|Overall Study|Adverse Event|2|||
94585749|NCT00467753|323944323|FG001|Overall Study|Adverse Event|0|||
94585750|NCT03530124|323944324|FG000|Overall Study|Withdrawal by Subject|0|||
94585751|NCT03530124|323944325|FG001|Overall Study|Withdrawal by Subject|1|||
94585752|NCT03530124|323944324|FG000|Overall Study|Protocol Violation|1|||
94585753|NCT03530124|323944325|FG001|Overall Study|Protocol Violation|0|||
94585754|NCT03530124|323944324|FG000|Overall Study|Discharged prior to study completion|1|||
94585755|NCT03530124|323944325|FG001|Overall Study|Discharged prior to study completion|0|||
94585756|NCT01626872|323944326|FG000|Overall Study|Physician Decision|13|||
94585757|NCT01626872|323944327|FG001|Overall Study|Physician Decision|9|||
94585758|NCT01626872|323944328|FG002|Overall Study|Physician Decision|6|||
94585759|NCT01626872|323944326|FG000|Overall Study|Withdrawal by Subject|19|||
94585760|NCT01626872|323944327|FG001|Overall Study|Withdrawal by Subject|27|||
94585761|NCT01626872|323944328|FG002|Overall Study|Withdrawal by Subject|8|||
94585762|NCT01626872|323944326|FG000|Overall Study|Adverse Event (including Death)|20|||
94585763|NCT01626872|323944327|FG001|Overall Study|Adverse Event (including Death)|28|||
94585764|NCT01626872|323944328|FG002|Overall Study|Adverse Event (including Death)|8|||
94585765|NCT01626872|323944326|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
94585766|NCT01626872|323944327|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
94585767|NCT01626872|323944328|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
94585768|NCT01657019|323945873|FG000|Overall Study|Withdrawal by Subject|65|||
94585769|NCT01657019|323945873|FG000|Overall Study|Adverse Event|55|||
94585770|NCT01657019|323945873|FG000|Overall Study|Lost to Follow-up|48|||
94585771|NCT01657019|323945873|FG000|Overall Study|Protocol Violation|6|||
94585772|NCT01657019|323945873|FG000|Overall Study|Lack of Efficacy|3|||
94585773|NCT01657019|323945873|FG000|Overall Study|Other|58|||
94585774|NCT02578706|323945878|FG000|Overall Study|Withdrawal by Subject|1|||
94585775|NCT02578706|323945879|FG001|Overall Study|Withdrawal by Subject|0|||
94585776|NCT02578706|323945880|FG002|Overall Study|Withdrawal by Subject|0|||
94585777|NCT02578706|323945878|FG000|Overall Study|Lost to Follow-up|0|||
94585778|NCT02578706|323945879|FG001|Overall Study|Lost to Follow-up|4|||
94585779|NCT02578706|323945880|FG002|Overall Study|Lost to Follow-up|0|||
94585780|NCT02578706|323945878|FG000|Overall Study|Physician Decision|0|||
94585781|NCT02578706|323945879|FG001|Overall Study|Physician Decision|1|||
94585782|NCT02578706|323945880|FG002|Overall Study|Physician Decision|0|||
94585783|NCT03219528|323945881|FG000|Overall Study|Lost to Follow-up|5|||
94585784|NCT03219528|323945882|FG001|Overall Study|Lost to Follow-up|4|||
94585785|NCT03219528|323945881|FG000|Overall Study|Withdrawal by Subject|4|||
94585786|NCT03219528|323945882|FG001|Overall Study|Withdrawal by Subject|4|||
94585787|NCT03682770|323945888|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
94585788|NCT03682770|323945889|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
94585789|NCT03682770|323945890|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
94585790|NCT03682770|323945891|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
94585791|NCT03682770|323945892|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
94585792|NCT03682770|323945893|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
94585793|NCT03682770|323945894|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
94585794|NCT03682770|323945888|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
94585795|NCT03682770|323945889|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
94585796|NCT03682770|323945890|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
94585797|NCT03682770|323945891|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
94585798|NCT03682770|323945892|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
94585799|NCT03682770|323945893|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
94585800|NCT03682770|323945894|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
94585801|NCT03682770|323945888|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
94242571|NCT01646177|322682732|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
94242572|NCT01646177|322682733|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
94242573|NCT01646177|322682734|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
94242574|NCT01646177|322682735|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
94242575|NCT01646177|322682736|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
94242576|NCT01646177|322682737|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
94242577|NCT01646177|322682738|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
94585802|NCT03682770|323945889|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
94585803|NCT03682770|323945890|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
94585804|NCT03682770|323945891|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
94585805|NCT03682770|323945892|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
94585806|NCT03682770|323945893|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
94585807|NCT03682770|323945894|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
94585808|NCT03682770|323945888|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
94585809|NCT03682770|323945889|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
94585810|NCT03682770|323945890|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
94585811|NCT03682770|323945891|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
94585812|NCT03682770|323945892|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
94585813|NCT03682770|323945893|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
94585814|NCT03682770|323945894|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
94585815|NCT03682770|323945888|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
94585816|NCT03682770|323945889|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
94585817|NCT03682770|323945890|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
94585818|NCT03682770|323945891|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
94585819|NCT03682770|323945892|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
94585820|NCT03682770|323945893|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
94585821|NCT03682770|323945894|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
94585822|NCT03682770|323945888|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
94585823|NCT03682770|323945889|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
94585824|NCT03682770|323945890|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
94585825|NCT03682770|323945891|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
94585826|NCT03682770|323945892|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
94585827|NCT03682770|323945893|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
94585828|NCT03682770|323945894|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
94585829|NCT03682770|323945888|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
94585830|NCT03682770|323945889|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
94585831|NCT03682770|323945890|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
94585832|NCT03682770|323945891|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
94585833|NCT03682770|323945892|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
94585834|NCT03682770|323945893|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
94585835|NCT03682770|323945894|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
94585836|NCT03682770|323945888|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
94585837|NCT03682770|323945889|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
94585838|NCT03682770|323945890|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
94585839|NCT03682770|323945891|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
94585840|NCT03682770|323945892|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
94585841|NCT03682770|323945893|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
94585842|NCT03682770|323945894|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
94585843|NCT03682770|323945888|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
94585844|NCT03682770|323945889|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
94585845|NCT03682770|323945890|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
94585846|NCT03682770|323945891|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
94585847|NCT03682770|323945892|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
94585848|NCT03682770|323945893|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
94585849|NCT03682770|323945894|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
94585850|NCT03682770|323945888|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
94585851|NCT03682770|323945889|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
94585852|NCT03682770|323945890|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
94585853|NCT03682770|323945891|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
94585854|NCT03682770|323945892|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
94585855|NCT03682770|323945893|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
94585856|NCT03682770|323945894|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
94585857|NCT03682770|323945888|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
94585858|NCT03682770|323945889|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
94585859|NCT03682770|323945890|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
94585860|NCT03682770|323945891|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
94585861|NCT03682770|323945892|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
94585862|NCT03682770|323945893|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
94585863|NCT03682770|323945894|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
94688607|NCT04076020|324315528|FG000|Overall Study|Death|4|||
94242578|NCT01646177|322682739|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
94242579|NCT01646177|322682740|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
94242580|NCT01646177|322682741|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
94242581|NCT01646177|322682730|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
94242582|NCT01646177|322682731|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
94585864|NCT03682770|323945888|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
94242583|NCT01646177|322682732|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
94242584|NCT01646177|322682733|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
94242585|NCT01646177|322682734|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
94242586|NCT01646177|322682735|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
94242587|NCT01646177|322682736|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
94242588|NCT01646177|322682737|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
94242589|NCT01646177|322682738|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
94242590|NCT01646177|322682739|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
94242591|NCT01646177|322682740|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
94242592|NCT01646177|322682741|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
94242593|NCT01646177|322682730|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
94242594|NCT01646177|322682731|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
94242595|NCT01646177|322682732|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
94242596|NCT01646177|322682733|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
94242597|NCT01646177|322682734|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
94585865|NCT03682770|323945889|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
94585866|NCT03682770|323945890|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
94585867|NCT03682770|323945891|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
94585868|NCT03682770|323945892|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
94585869|NCT03682770|323945893|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
94585870|NCT03682770|323945894|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
94585871|NCT02362282|323945895|FG000|Overall Study|Withdrawal by Subject|1|||
94585872|NCT02362282|323945896|FG001|Overall Study|Withdrawal by Subject|0|||
94585873|NCT00774566|323945897|FG000|Overall Study|Protocol Violation|18|||
94585874|NCT00774566|323945898|FG001|Overall Study|Protocol Violation|15|||
94585875|NCT00526071|323945905|FG000|Overall Study|Adverse Event|1|||
94585876|NCT00526071|323945905|FG000|Overall Study|Withdrawal by Subject|1|||
94585877|NCT00526071|323945905|FG000|Overall Study|Lack of Response to Study Drug|4|||
94585878|NCT00126490|323945908|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
94585879|NCT00975780|323945909|FG000|Follow Up|Death|88|||
94585880|NCT00975780|323945910|FG001|Follow Up|Death|122|||
94585881|NCT00975780|323945909|FG000|Follow Up|Facility Withdrawal|7|||
94585882|NCT00975780|323945910|FG001|Follow Up|Facility Withdrawal|23|||
94585883|NCT00975780|323945909|FG000|Follow Up|Discharged from Facility|7|||
94585884|NCT00975780|323945910|FG001|Follow Up|Discharged from Facility|12|||
94585885|NCT02625909|323945911|FG000|Overall Study|Death|2|||
94585886|NCT02625909|323945912|FG001|Overall Study|Death|0|||
94585887|NCT02625909|323945911|FG000|Overall Study|Lost to Follow-up|3|||
94585888|NCT02625909|323945912|FG001|Overall Study|Lost to Follow-up|5|||
94585889|NCT02625909|323945911|FG000|Overall Study|Lack of Efficacy|9|||
94585890|NCT02625909|323945912|FG001|Overall Study|Lack of Efficacy|2|||
94585891|NCT02625909|323945911|FG000|Overall Study|Reinfection|3|||
94585892|NCT02625909|323945912|FG001|Overall Study|Reinfection|2|||
94585893|NCT03051178|323945913|FG000|Overall Study|Withdrawal by Subject|5|||
94585894|NCT00953056|323945914|FG000|Overall Study|Withdrew Consent|0|||
94585895|NCT00953056|323945915|FG001|Overall Study|Withdrew Consent|0|||
94585896|NCT00953056|323945916|FG002|Overall Study|Withdrew Consent|0|||
94585897|NCT00953056|323945917|FG003|Overall Study|Withdrew Consent|0|||
94242598|NCT01646177|322682735|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
94242599|NCT01646177|322682736|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
94242600|NCT01646177|322682737|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
94242601|NCT01646177|322682738|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
94242602|NCT01646177|322682739|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
94242603|NCT01646177|322682740|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
94353544|NCT01072175|323077084|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
94585898|NCT00953056|323945918|FG004|Overall Study|Withdrew Consent|2|||
94585899|NCT00953056|323945919|FG005|Overall Study|Withdrew Consent|3|||
94585900|NCT00953056|323945914|FG000|Overall Study|Serious Adverse Event|0|||
94585901|NCT00953056|323945915|FG001|Overall Study|Serious Adverse Event|0|||
94585902|NCT00953056|323945916|FG002|Overall Study|Serious Adverse Event|0|||
94585903|NCT00953056|323945917|FG003|Overall Study|Serious Adverse Event|0|||
94585904|NCT00953056|323945918|FG004|Overall Study|Serious Adverse Event|0|||
94585905|NCT00953056|323945919|FG005|Overall Study|Serious Adverse Event|1|||
94585906|NCT01339052|323945924|FG000|Overall Study|Disease progression|13|||
94585907|NCT01339052|323945925|FG001|Overall Study|Disease progression|46|||
94585908|NCT01339052|323945924|FG000|Overall Study|Adverse Event|1|||
94585909|NCT01339052|323945925|FG001|Overall Study|Adverse Event|1|||
94585910|NCT01339052|323945924|FG000|Overall Study|Withdrawal by Subject|0|||
94585911|NCT01339052|323945925|FG001|Overall Study|Withdrawal by Subject|3|||
94585912|NCT01339052|323945924|FG000|Overall Study|Physician Decision|1|||
94585913|NCT01339052|323945925|FG001|Overall Study|Physician Decision|0|||
94585914|NCT02164461|323945927|FG000|Overall Study|Adverse Event|0|||
94585915|NCT02164461|323945928|FG001|Overall Study|Adverse Event|0|||
94585916|NCT02164461|323945929|FG002|Overall Study|Adverse Event|1|||
94585917|NCT02164461|323945927|FG000|Overall Study|Disease Progression|1|||
94585918|NCT02164461|323945928|FG001|Overall Study|Disease Progression|3|||
94585919|NCT02164461|323945929|FG002|Overall Study|Disease Progression|4|||
94585920|NCT02164461|323945927|FG000|Overall Study|Withdrawal by Subject|0|||
94585921|NCT02164461|323945928|FG001|Overall Study|Withdrawal by Subject|3|||
94585922|NCT02164461|323945929|FG002|Overall Study|Withdrawal by Subject|0|||
94585923|NCT03904693|323945931|FG000|Overall Study|Death|0|||
94585924|NCT03904693|323945932|FG001|Overall Study|Death|0|||
94585925|NCT03904693|323945933|FG002|Overall Study|Death|3|||
94585926|NCT03904693|323945931|FG000|Overall Study|Physician Decision|0|||
94585927|NCT03904693|323945932|FG001|Overall Study|Physician Decision|0|||
94585928|NCT03904693|323945933|FG002|Overall Study|Physician Decision|2|||
94585929|NCT03904693|323945931|FG000|Overall Study|Withdrawal by Subject|0|||
94585930|NCT03904693|323945932|FG001|Overall Study|Withdrawal by Subject|1|||
94585931|NCT03904693|323945933|FG002|Overall Study|Withdrawal by Subject|4|||
94585932|NCT02100696|323945934|FG000|Induction Phase|Adverse Event|0|||
94585933|NCT02100696|323945935|FG001|Induction Phase|Adverse Event|0|||
94585934|NCT02100696|323945936|FG002|Induction Phase|Adverse Event|1|||
94585935|NCT02100696|323945937|FG003|Induction Phase|Adverse Event|0|||
94585936|NCT02100696|323945938|FG004|Induction Phase|Adverse Event|0|||
94585937|NCT02100696|323945939|FG005|Induction Phase|Adverse Event|0|||
94585938|NCT02100696|323945934|FG000|Induction Phase|Lost to Follow-up|1|||
94585939|NCT02100696|323945935|FG001|Induction Phase|Lost to Follow-up|0|||
94585940|NCT02100696|323945936|FG002|Induction Phase|Lost to Follow-up|1|||
94585941|NCT02100696|323945937|FG003|Induction Phase|Lost to Follow-up|0|||
94585942|NCT02100696|323945938|FG004|Induction Phase|Lost to Follow-up|0|||
94585943|NCT02100696|323945939|FG005|Induction Phase|Lost to Follow-up|0|||
94585944|NCT02100696|323945934|FG000|Induction Phase|Protocol Violation|0|||
94585945|NCT02100696|323945935|FG001|Induction Phase|Protocol Violation|1|||
94585946|NCT02100696|323945936|FG002|Induction Phase|Protocol Violation|1|||
94585947|NCT02100696|323945937|FG003|Induction Phase|Protocol Violation|0|||
94585948|NCT02100696|323945938|FG004|Induction Phase|Protocol Violation|0|||
94585949|NCT02100696|323945939|FG005|Induction Phase|Protocol Violation|0|||
94585950|NCT02100696|323945934|FG000|Induction Phase|Withdrawal by Subject|8|||
94585951|NCT02100696|323945935|FG001|Induction Phase|Withdrawal by Subject|2|||
94585952|NCT02100696|323945936|FG002|Induction Phase|Withdrawal by Subject|13|||
94585953|NCT02100696|323945937|FG003|Induction Phase|Withdrawal by Subject|0|||
94585954|NCT02100696|323945938|FG004|Induction Phase|Withdrawal by Subject|0|||
94585955|NCT02100696|323945939|FG005|Induction Phase|Withdrawal by Subject|0|||
94585956|NCT02100696|323945934|FG000|Induction Phase|Physician Decision|1|||
94585957|NCT02100696|323945935|FG001|Induction Phase|Physician Decision|0|||
94585958|NCT02100696|323945936|FG002|Induction Phase|Physician Decision|2|||
94585959|NCT02100696|323945937|FG003|Induction Phase|Physician Decision|0|||
94585960|NCT02100696|323945938|FG004|Induction Phase|Physician Decision|0|||
94585961|NCT02100696|323945939|FG005|Induction Phase|Physician Decision|0|||
94585962|NCT02100696|323945934|FG000|Induction Phase|Multiple Reasons|5|||
94585963|NCT02100696|323945935|FG001|Induction Phase|Multiple Reasons|2|||
94585964|NCT02100696|323945936|FG002|Induction Phase|Multiple Reasons|8|||
94585965|NCT02100696|323945937|FG003|Induction Phase|Multiple Reasons|0|||
94585966|NCT02100696|323945938|FG004|Induction Phase|Multiple Reasons|0|||
94585967|NCT02100696|323945939|FG005|Induction Phase|Multiple Reasons|0|||
94585968|NCT02100696|323945934|FG000|Maintenance Phase|Adverse Event|0|||
94585969|NCT02100696|323945935|FG001|Maintenance Phase|Adverse Event|0|||
94585970|NCT02100696|323945936|FG002|Maintenance Phase|Adverse Event|0|||
94585971|NCT02100696|323945937|FG003|Maintenance Phase|Adverse Event|0|||
94585972|NCT02100696|323945938|FG004|Maintenance Phase|Adverse Event|0|||
94585973|NCT02100696|323945939|FG005|Maintenance Phase|Adverse Event|2|||
94585974|NCT02100696|323945934|FG000|Maintenance Phase|Lost to Follow-up|0|||
94585975|NCT02100696|323945935|FG001|Maintenance Phase|Lost to Follow-up|0|||
94585976|NCT02100696|323945936|FG002|Maintenance Phase|Lost to Follow-up|0|||
94585977|NCT02100696|323945937|FG003|Maintenance Phase|Lost to Follow-up|0|||
94585978|NCT02100696|323945938|FG004|Maintenance Phase|Lost to Follow-up|1|||
94585979|NCT02100696|323945939|FG005|Maintenance Phase|Lost to Follow-up|0|||
94585980|NCT02100696|323945934|FG000|Maintenance Phase|Protocol Violation|0|||
94585981|NCT02100696|323945935|FG001|Maintenance Phase|Protocol Violation|0|||
94585982|NCT02100696|323945936|FG002|Maintenance Phase|Protocol Violation|0|||
94585983|NCT02100696|323945937|FG003|Maintenance Phase|Protocol Violation|0|||
94688608|NCT04076020|324315529|FG001|Overall Study|Death|6|||
94659236|NCT02039505|324208004|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
94659237|NCT02039505|324208005|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
94659238|NCT02039505|324208006|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
94659239|NCT02039505|324208007|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
94455953|NCT03214380|323458111|FG001|Treatment Period|Treatment Interruption|0|||
94455954|NCT03214380|323458112|FG002|Treatment Period|Treatment Interruption|1|||
94455955|NCT03214380|323458113|FG003|Treatment Period|Treatment Interruption|0|||
94455956|NCT03214380|323458114|FG004|Treatment Period|Treatment Interruption|0|||
94455957|NCT03214380|323458115|FG005|Treatment Period|Treatment Interruption|0|||
94455958|NCT01905553|323458121|FG000|Period 2|Adverse Event|1|||
94455959|NCT01905553|323458122|FG001|Period 2|Adverse Event|0|||
94455960|NCT02759055|323458123|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
94455961|NCT02759055|323458124|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
94455962|NCT03962790|323458125|FG000|Period 1|Adverse Event|0|||
94455963|NCT03962790|323458126|FG001|Period 1|Adverse Event|1|||
94455964|NCT03962790|323458125|FG000|Period 1|Failed to meet all eligibility criteria|1|||
94455965|NCT03962790|323458126|FG001|Period 1|Failed to meet all eligibility criteria|1|||
94455966|NCT03962790|323458125|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
94455967|NCT03962790|323458126|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
94455968|NCT03962790|323458125|FG000|Period 1|Withdrawal by Subject|1|||
94455969|NCT03962790|323458126|FG001|Period 1|Withdrawal by Subject|0|||
94455970|NCT02656290|323458129|FG000|Overall Study|Lost to Follow-up|1|||
94455971|NCT02656290|323458129|FG000|Overall Study|Reintervention|3|||
94455972|NCT04725812|323458132|FG000|Overall Study|Withdrawal by Subject|1|||
94455973|NCT02002533|323458136|FG000|Overall Study|Withdrawal by Subject|6|||
94455974|NCT02002533|323458137|FG001|Overall Study|Withdrawal by Subject|13|||
94455975|NCT02002533|323458136|FG000|Overall Study|Protocol Violation|0|||
94455976|NCT02002533|323458137|FG001|Overall Study|Protocol Violation|1|||
94455977|NCT02002533|323458136|FG000|Overall Study|Adverse Event|0|||
94455978|NCT02002533|323458137|FG001|Overall Study|Adverse Event|3|||
94455979|NCT02002533|323458136|FG000|Overall Study|Lost to Follow-up|0|||
94455980|NCT02002533|323458137|FG001|Overall Study|Lost to Follow-up|1|||
94455981|NCT03575793|323458142|FG000|Overall Study|Withdrawal by Subject|0|||
94455982|NCT03575793|323458143|FG001|Overall Study|Withdrawal by Subject|1|||
94455983|NCT03575793|323458142|FG000|Overall Study|Never Treated|0|||
94455984|NCT03575793|323458143|FG001|Overall Study|Never Treated|2|||
94455985|NCT02048826|323458144|FG000|Overall Study|Withdrawal by Subject|1|||
94455986|NCT02048826|323458145|FG001|Overall Study|Withdrawal by Subject|0|||
94353545|NCT01072175|323077085|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
94353546|NCT01072175|323077086|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
94353547|NCT01072175|323077074|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
94353548|NCT01072175|323077075|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
94353549|NCT01072175|323077076|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
94353550|NCT01072175|323077077|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
94353551|NCT01072175|323077078|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
94353552|NCT01072175|323077079|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
94353553|NCT01072175|323077080|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
94353554|NCT01072175|323077081|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
94353555|NCT01072175|323077082|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
94353556|NCT01072175|323077083|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
94353557|NCT01072175|323077084|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
94353558|NCT01072175|323077085|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
94353559|NCT01072175|323077086|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
94353560|NCT01072175|323077074|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
94353561|NCT01072175|323077075|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
94353562|NCT01072175|323077076|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
94353563|NCT01072175|323077077|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
94353564|NCT01072175|323077078|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
94353565|NCT01072175|323077079|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
94353566|NCT01072175|323077080|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
94353567|NCT01072175|323077081|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
94353568|NCT01072175|323077082|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
94353569|NCT01072175|323077083|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
94353570|NCT01072175|323077084|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
94353571|NCT01072175|323077085|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
94353572|NCT01072175|323077086|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
94353573|NCT01072175|323077074|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
94353574|NCT01072175|323077075|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
94455987|NCT02682823|323458148|FG000|Overall Study|Withdrawal by Subject|0|||
94455988|NCT02682823|323458149|FG001|Overall Study|Withdrawal by Subject|0|||
94242604|NCT01646177|322682741|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
94242605|NCT01646177|322682730|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
94242606|NCT01646177|322682731|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
94242607|NCT01646177|322682732|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
94242608|NCT01646177|322682733|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
94242609|NCT01646177|322682734|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
94242610|NCT01646177|322682735|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
94242611|NCT01646177|322682736|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
94242612|NCT01646177|322682737|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
94242613|NCT01646177|322682738|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
94242614|NCT01646177|322682739|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
94242615|NCT01646177|322682740|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
94242616|NCT01646177|322682741|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
94242617|NCT01646177|322682730|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
94242618|NCT01646177|322682731|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
94242619|NCT01646177|322682732|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
94242620|NCT01646177|322682733|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
94242621|NCT01646177|322682734|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
94242622|NCT01646177|322682735|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
94242623|NCT01646177|322682736|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
94242624|NCT01646177|322682737|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
94242625|NCT01646177|322682738|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
94242626|NCT01646177|322682739|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
94242627|NCT01646177|322682740|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
94242628|NCT01646177|322682741|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
94242629|NCT01646177|322682730|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
94242630|NCT01646177|322682731|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
94242631|NCT01646177|322682732|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
94242632|NCT01646177|322682733|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
94242633|NCT01646177|322682734|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
94242634|NCT01646177|322682735|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
94242635|NCT01646177|322682736|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
94242636|NCT01646177|322682737|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
94353575|NCT01072175|323077076|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
94353576|NCT01072175|323077077|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
94353577|NCT01072175|323077078|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
94353578|NCT01072175|323077079|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
94353579|NCT01072175|323077080|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
94353580|NCT01072175|323077081|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
94353581|NCT01072175|323077082|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
94353582|NCT01072175|323077083|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
94353583|NCT01072175|323077084|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
94353584|NCT01072175|323077085|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
94353585|NCT01072175|323077086|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
94353586|NCT01072175|323077074|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
94353587|NCT01072175|323077075|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
94353588|NCT01072175|323077076|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
94353589|NCT01072175|323077077|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
94353590|NCT01072175|323077078|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
94353591|NCT01072175|323077079|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
94353592|NCT01072175|323077080|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
94455989|NCT02682823|323458150|FG002|Overall Study|Withdrawal by Subject|1|||
94455990|NCT02682823|323458151|FG003|Overall Study|Withdrawal by Subject|0|||
94455991|NCT02682823|323458152|FG004|Overall Study|Withdrawal by Subject|1|||
94659240|NCT02039505|324208008|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
94242637|NCT01646177|322682738|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
94242638|NCT01646177|322682739|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
94242639|NCT01646177|322682740|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
94242640|NCT01646177|322682741|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
94242641|NCT01646177|322682730|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
94242642|NCT01646177|322682731|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
94242643|NCT01646177|322682732|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
94242644|NCT01646177|322682733|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
94585984|NCT02100696|323945938|FG004|Maintenance Phase|Protocol Violation|1|||
94585985|NCT02100696|323945939|FG005|Maintenance Phase|Protocol Violation|0|||
94585986|NCT02100696|323945934|FG000|Maintenance Phase|Withdrawal by Subject|0|||
94585987|NCT02100696|323945935|FG001|Maintenance Phase|Withdrawal by Subject|0|||
94585988|NCT02100696|323945936|FG002|Maintenance Phase|Withdrawal by Subject|0|||
94585989|NCT02100696|323945937|FG003|Maintenance Phase|Withdrawal by Subject|1|||
94585990|NCT02100696|323945938|FG004|Maintenance Phase|Withdrawal by Subject|4|||
94585991|NCT02100696|323945939|FG005|Maintenance Phase|Withdrawal by Subject|2|||
94585992|NCT02100696|323945934|FG000|Maintenance Phase|Physician Decision|0|||
94585993|NCT02100696|323945935|FG001|Maintenance Phase|Physician Decision|0|||
94585994|NCT02100696|323945936|FG002|Maintenance Phase|Physician Decision|0|||
94585995|NCT02100696|323945937|FG003|Maintenance Phase|Physician Decision|0|||
94585996|NCT02100696|323945938|FG004|Maintenance Phase|Physician Decision|1|||
94585997|NCT02100696|323945939|FG005|Maintenance Phase|Physician Decision|0|||
94585998|NCT02100696|323945934|FG000|Maintenance Phase|Multiple Reasons|0|||
94585999|NCT02100696|323945935|FG001|Maintenance Phase|Multiple Reasons|0|||
94586000|NCT02100696|323945936|FG002|Maintenance Phase|Multiple Reasons|0|||
94586001|NCT02100696|323945937|FG003|Maintenance Phase|Multiple Reasons|0|||
94586002|NCT02100696|323945938|FG004|Maintenance Phase|Multiple Reasons|2|||
94586003|NCT02100696|323945939|FG005|Maintenance Phase|Multiple Reasons|1|||
94586004|NCT02722499|323945940|FG000|Overall Study|Lost to Follow-up|2|||
94586005|NCT02722499|323945941|FG001|Overall Study|Lost to Follow-up|0|||
94586006|NCT02722499|323945942|FG002|Overall Study|Lost to Follow-up|1|||
94586007|NCT04634253|323945954|FG000|Overall Study|Adverse Event|1|||
94586008|NCT04634253|323945955|FG001|Overall Study|Adverse Event|1|||
94586009|NCT04634253|323945956|FG002|Overall Study|Adverse Event|0|||
94586010|NCT04634253|323945954|FG000|Overall Study|Physician Decision|0|||
94586011|NCT04634253|323945955|FG001|Overall Study|Physician Decision|1|||
94586012|NCT04634253|323945956|FG002|Overall Study|Physician Decision|0|||
94586013|NCT04634253|323945954|FG000|Overall Study|Withdrawal by Subject|1|||
94586014|NCT04634253|323945955|FG001|Overall Study|Withdrawal by Subject|0|||
94586015|NCT04634253|323945956|FG002|Overall Study|Withdrawal by Subject|3|||
94586016|NCT04411667|323945958|FG000|Overall Study|Physician Decision|1|||
94586017|NCT04411667|323945959|FG001|Overall Study|Physician Decision|0|||
94586018|NCT03181529|323945974|FG000|Overall Study|Withdrawal by Subject|1|||
94586019|NCT03181529|323945975|FG001|Overall Study|Withdrawal by Subject|1|||
94586020|NCT03181529|323945974|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
94586021|NCT03181529|323945975|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
94586022|NCT05334212|323945984|FG000|Overall Study|Study terminated prematurely|7|||
94586023|NCT01209325|323945985|FG000|Overall Study|Lost to Follow-up|24|||
94586024|NCT01209325|323945985|FG000|Overall Study|Adverse Event|1|||
94586025|NCT01209325|323945985|FG000|Overall Study|Relocated|3|||
94586026|NCT01209325|323945985|FG000|Overall Study|Refusal after starting therapy|8|||
94586027|NCT01209325|323945985|FG000|Overall Study|Protocol Violation|4|||
94586028|NCT01209325|323945985|FG000|Overall Study|Refusal prior to therapy|1|||
94586029|NCT01209325|323945985|FG000|Overall Study|Incarceration|2|||
94586030|NCT04200352|323945991|FG000|Overall Study|Death|1|||
94586031|NCT04200352|323945991|FG000|Overall Study|Adverse Event|6|||
94586032|NCT04200352|323945991|FG000|Overall Study|Withdrawal by parent/guardian|6|||
94659241|NCT02039505|324208009|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
94659242|NCT02039505|324208010|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
94659243|NCT02039505|324208004|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
94659244|NCT02039505|324208005|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
94242645|NCT01646177|322682734|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
94242646|NCT01646177|322682735|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
94242647|NCT01646177|322682736|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
94242648|NCT01646177|322682737|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
94242649|NCT01646177|322682738|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
94242650|NCT01646177|322682739|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
94242651|NCT01646177|322682740|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
94242652|NCT01646177|322682741|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
94242653|NCT01646177|322682730|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
94242654|NCT01646177|322682731|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
94242655|NCT01646177|322682732|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
94242656|NCT01646177|322682733|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
94242657|NCT01646177|322682734|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
94242658|NCT01646177|322682735|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
94242659|NCT01646177|322682736|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
94242660|NCT01646177|322682737|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
94242661|NCT01646177|322682738|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
94586033|NCT04200352|323945991|FG000|Overall Study|Lack of Efficacy|1|||
94242662|NCT01646177|322682739|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
94242663|NCT01646177|322682740|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
94586034|NCT04200352|323945991|FG000|Overall Study|Other than specified|6|||
94586035|NCT02447003|323945992|FG000|Overall Study|Other|0|||
94586036|NCT02447003|323945993|FG001|Overall Study|Other|4|||
94586037|NCT02447003|323945992|FG000|Overall Study|Site discontinued|0|||
94586038|NCT02447003|323945993|FG001|Overall Study|Site discontinued|2|||
94586039|NCT02447003|323945992|FG000|Overall Study|Physician Decision|0|||
94586040|NCT02447003|323945993|FG001|Overall Study|Physician Decision|1|||
94586041|NCT02447003|323945992|FG000|Overall Study|Withdrawal by Subject|4|||
94586042|NCT02447003|323945993|FG001|Overall Study|Withdrawal by Subject|3|||
94586043|NCT02447003|323945992|FG000|Overall Study|Sponsor Decision|6|||
94586044|NCT02447003|323945993|FG001|Overall Study|Sponsor Decision|11|||
94586045|NCT02447003|323945992|FG000|Overall Study|Progressive Disease|1|||
94586046|NCT02447003|323945993|FG001|Overall Study|Progressive Disease|0|||
94586047|NCT02447003|323945992|FG000|Overall Study|Lost to Follow-up|5|||
94586048|NCT02447003|323945993|FG001|Overall Study|Lost to Follow-up|0|||
94586049|NCT02447003|323945992|FG000|Overall Study|Death|154|||
94586050|NCT02447003|323945993|FG001|Overall Study|Death|63|||
94586051|NCT00233064|323945994|FG000|Overall Study|Lost to Follow-up|7|||
94586052|NCT00233064|323945995|FG001|Overall Study|Lost to Follow-up|7|||
94586053|NCT00233064|323945994|FG000|Overall Study|Withdrawal by Subject|5|||
94586054|NCT00233064|323945995|FG001|Overall Study|Withdrawal by Subject|3|||
94586055|NCT00233064|323945994|FG000|Overall Study|Death|0|||
94586056|NCT00233064|323945995|FG001|Overall Study|Death|1|||
94586057|NCT00233064|323945994|FG000|Overall Study|Relocation|0|||
94586058|NCT00233064|323945995|FG001|Overall Study|Relocation|1|||
94586059|NCT00233064|323945994|FG000|Overall Study|Protocol Violation|1|||
94586060|NCT00233064|323945995|FG001|Overall Study|Protocol Violation|0|||
94586061|NCT00233064|323945994|FG000|Overall Study|Moved to Dom. Republic|1|||
94586062|NCT00233064|323945995|FG001|Overall Study|Moved to Dom. Republic|0|||
94586063|NCT01120964|323945996|FG000|Overall Study|Did not receive full treatment|1|||
94586064|NCT01120964|323945997|FG001|Overall Study|Did not receive full treatment|0|||
94586065|NCT03212144|323946000|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
94586066|NCT03212144|323946001|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
94586067|NCT03212144|323946000|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
94586068|NCT03212144|323946001|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
94586069|NCT01185080|323946002|FG000|Overall Study|Adverse Event|1|||
94586070|NCT01185080|323946003|FG001|Overall Study|Adverse Event|1|||
94586071|NCT01185080|323946004|FG002|Overall Study|Adverse Event|0|||
94586072|NCT01185080|323946002|FG000|Overall Study|Personal reasons|0|||
94586073|NCT01185080|323946003|FG001|Overall Study|Personal reasons|0|||
94586074|NCT01185080|323946004|FG002|Overall Study|Personal reasons|1|||
94586075|NCT02876601|323946005|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
94586076|NCT02876601|323946006|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
94586077|NCT02876601|323946007|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
94586078|NCT02876601|323946008|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
94586079|NCT04421027|323946011|FG000|Treatment Period|Adverse Event|5|||
94586080|NCT04421027|323946012|FG001|Treatment Period|Adverse Event|3|||
94586081|NCT04421027|323946013|FG002|Treatment Period|Adverse Event|0|||
94586082|NCT04421027|323946014|FG003|Treatment Period|Adverse Event|0|||
94586083|NCT04421027|323946011|FG000|Treatment Period|Death|98|||
94586084|NCT04421027|323946012|FG001|Treatment Period|Death|61|||
94586085|NCT04421027|323946013|FG002|Treatment Period|Death|0|||
94586086|NCT04421027|323946014|FG003|Treatment Period|Death|0|||
94586087|NCT04421027|323946011|FG000|Treatment Period|Lost to Follow-up|22|||
94586088|NCT04421027|323946012|FG001|Treatment Period|Lost to Follow-up|20|||
94586089|NCT04421027|323946013|FG002|Treatment Period|Lost to Follow-up|0|||
94586090|NCT04421027|323946014|FG003|Treatment Period|Lost to Follow-up|0|||
94586091|NCT04421027|323946011|FG000|Treatment Period|Other-Unknown|15|||
94586092|NCT04421027|323946012|FG001|Treatment Period|Other-Unknown|9|||
94586093|NCT04421027|323946013|FG002|Treatment Period|Other-Unknown|0|||
94586094|NCT04421027|323946014|FG003|Treatment Period|Other-Unknown|0|||
94455992|NCT02682823|323458148|FG000|Overall Study|Protocol Deviation|0|||
94586095|NCT04421027|323946011|FG000|Treatment Period|Physician Decision|1|||
94586096|NCT04421027|323946012|FG001|Treatment Period|Physician Decision|1|||
94586097|NCT04421027|323946013|FG002|Treatment Period|Physician Decision|0|||
94586098|NCT04421027|323946014|FG003|Treatment Period|Physician Decision|0|||
94586099|NCT04421027|323946011|FG000|Treatment Period|Withdrawal by Subject|7|||
94586100|NCT04421027|323946012|FG001|Treatment Period|Withdrawal by Subject|12|||
94586101|NCT04421027|323946013|FG002|Treatment Period|Withdrawal by Subject|0|||
94586102|NCT04421027|323946014|FG003|Treatment Period|Withdrawal by Subject|0|||
94586103|NCT04421027|323946011|FG000|Treatment Period|Randomized Not Dosed|9|||
94659245|NCT02039505|324208006|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
94455993|NCT02682823|323458149|FG001|Overall Study|Protocol Deviation|1|||
94586104|NCT04421027|323946012|FG001|Treatment Period|Randomized Not Dosed|14|||
94586105|NCT04421027|323946013|FG002|Treatment Period|Randomized Not Dosed|0|||
94586106|NCT04421027|323946014|FG003|Treatment Period|Randomized Not Dosed|0|||
94586107|NCT04421027|323946011|FG000|Follow-Up Period|Adverse Event|0|||
94586108|NCT04421027|323946012|FG001|Follow-Up Period|Adverse Event|0|||
94586109|NCT04421027|323946013|FG002|Follow-Up Period|Adverse Event|0|||
94586110|NCT04421027|323946014|FG003|Follow-Up Period|Adverse Event|3|||
94586111|NCT04421027|323946011|FG000|Follow-Up Period|Death|0|||
94586112|NCT04421027|323946012|FG001|Follow-Up Period|Death|0|||
94586113|NCT04421027|323946013|FG002|Follow-Up Period|Death|16|||
94586114|NCT04421027|323946014|FG003|Follow-Up Period|Death|17|||
94586115|NCT04421027|323946011|FG000|Follow-Up Period|Lost to Follow-up|0|||
94586116|NCT04421027|323946012|FG001|Follow-Up Period|Lost to Follow-up|0|||
94586117|NCT04421027|323946013|FG002|Follow-Up Period|Lost to Follow-up|7|||
94586118|NCT04421027|323946014|FG003|Follow-Up Period|Lost to Follow-up|7|||
94586119|NCT04421027|323946011|FG000|Follow-Up Period|Protocol Deviation|0|||
94586120|NCT04421027|323946012|FG001|Follow-Up Period|Protocol Deviation|0|||
94586121|NCT04421027|323946013|FG002|Follow-Up Period|Protocol Deviation|1|||
94586122|NCT04421027|323946014|FG003|Follow-Up Period|Protocol Deviation|0|||
94586123|NCT04421027|323946011|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
94586124|NCT04421027|323946012|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
94586125|NCT04421027|323946013|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
94586126|NCT04421027|323946014|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
94586127|NCT04421027|323946011|FG000|Follow-Up Period|Left message, participant did not call back|0|||
94586128|NCT04421027|323946012|FG001|Follow-Up Period|Left message, participant did not call back|0|||
94586129|NCT04421027|323946013|FG002|Follow-Up Period|Left message, participant did not call back|0|||
94586130|NCT04421027|323946014|FG003|Follow-Up Period|Left message, participant did not call back|1|||
94586131|NCT04421027|323946011|FG000|Follow-Up Period|Participant died|0|||
94586132|NCT04421027|323946012|FG001|Follow-Up Period|Participant died|0|||
94586133|NCT04421027|323946013|FG002|Follow-Up Period|Participant died|0|||
94586134|NCT04421027|323946014|FG003|Follow-Up Period|Participant died|1|||
94586135|NCT04421027|323946011|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
94586136|NCT04421027|323946012|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
94586137|NCT04421027|323946013|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
94586138|NCT04421027|323946014|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
94586139|NCT00802945|323946015|FG000|Overall Study|Death|27|||
94586140|NCT00802945|323946016|FG001|Overall Study|Death|23|||
94586141|NCT00802945|323946015|FG000|Overall Study|Terminated by sponsor|8|||
94586142|NCT00802945|323946016|FG001|Overall Study|Terminated by sponsor|12|||
94586143|NCT00721968|323946017|FG000|Overall Study|Lost to Follow-up|2|||
94586144|NCT00721968|323946018|FG001|Overall Study|Lost to Follow-up|0|||
94586145|NCT01064947|323946020|FG000|Overall Study|negative culture|41|||
94586146|NCT02930018|323946021|FG000|Overall Study|Lost to Follow-up|1|||
94586147|NCT02930018|323946022|FG001|Overall Study|Lost to Follow-up|1|||
94586148|NCT02930018|323946021|FG000|Overall Study|Withdrawal by Subject|5|||
94586149|NCT02930018|323946022|FG001|Overall Study|Withdrawal by Subject|2|||
94586150|NCT01104311|323946023|FG000|Overall Study|Withdrawal by Subject|6|||
94586151|NCT01104311|323946024|FG001|Overall Study|Withdrawal by Subject|6|||
94586152|NCT01104311|323946023|FG000|Overall Study|Protocol Violation|0|||
94586153|NCT01104311|323946024|FG001|Overall Study|Protocol Violation|1|||
94586154|NCT01104311|323946023|FG000|Overall Study|Physician Decision|2|||
94586155|NCT01104311|323946024|FG001|Overall Study|Physician Decision|2|||
94586156|NCT01104311|323946023|FG000|Overall Study|low compliance|1|||
94586157|NCT01104311|323946024|FG001|Overall Study|low compliance|1|||
94586158|NCT01104311|323946023|FG000|Overall Study|Adverse Event|1|||
94586159|NCT01104311|323946024|FG001|Overall Study|Adverse Event|2|||
94586160|NCT02105662|323947987|FG000|Overall Study|Lost to Follow-up|5|||
94586161|NCT02105662|323947987|FG000|Overall Study|Withdrawal by Subject|1|||
94586162|NCT05462756|323947990|FG000|Treatment Period|Adverse Event|3|||
94586163|NCT05462756|323947991|FG001|Treatment Period|Adverse Event|0|||
94586164|NCT05462756|323947990|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
94586165|NCT05462756|323947991|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
94586166|NCT05462756|323947990|FG000|Treatment Period|Death|0|||
94586167|NCT05462756|323947991|FG001|Treatment Period|Death|1|||
94586168|NCT05462756|323947990|FG000|Treatment Period|Lost to Follow-up|2|||
94586169|NCT05462756|323947991|FG001|Treatment Period|Lost to Follow-up|1|||
94586170|NCT05462756|323947990|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
94586171|NCT05462756|323947991|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
94586172|NCT05462756|323947990|FG000|Treatment Period|Physician Decision|2|||
94586173|NCT05462756|323947991|FG001|Treatment Period|Physician Decision|0|||
94586174|NCT05462756|323947990|FG000|Treatment Period|Protocol Violation|0|||
94659246|NCT02039505|324208007|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
94659247|NCT02039505|324208008|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
94659248|NCT02039505|324208009|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
94659249|NCT02039505|324208010|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
94659250|NCT02039505|324208004|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
94586175|NCT05462756|323947991|FG001|Treatment Period|Protocol Violation|1|||
94586176|NCT05462756|323947990|FG000|Treatment Period|Withdrawal by Subject|5|||
94586177|NCT05462756|323947991|FG001|Treatment Period|Withdrawal by Subject|12|||
94586178|NCT05462756|323947990|FG000|Follow-Up Period|Adverse Event|1|||
94586179|NCT05462756|323947991|FG001|Follow-Up Period|Adverse Event|0|||
94586180|NCT05462756|323947990|FG000|Follow-Up Period|Death|1|||
94586181|NCT05462756|323947991|FG001|Follow-Up Period|Death|0|||
94659251|NCT02039505|324208005|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
94659252|NCT02039505|324208006|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
94586182|NCT05462756|323947990|FG000|Follow-Up Period|Lost to Follow-up|3|||
94586183|NCT05462756|323947991|FG001|Follow-Up Period|Lost to Follow-up|1|||
94586184|NCT05462756|323947990|FG000|Follow-Up Period|Withdrawal by Subject|0|||
94586185|NCT05462756|323947991|FG001|Follow-Up Period|Withdrawal by Subject|4|||
94586186|NCT00990704|323947993|FG000|Overall Study|Adverse Event|1|||
94586187|NCT00990704|323947994|FG001|Overall Study|Adverse Event|1|||
94586188|NCT00990704|323947993|FG000|Overall Study|Physician Decision|0|||
94586189|NCT00990704|323947994|FG001|Overall Study|Physician Decision|1|||
94586190|NCT03894813|323947995|FG000|Overall Study|Adverse Event|1|||
94586191|NCT03894813|323947996|FG001|Overall Study|Adverse Event|1|||
94586192|NCT03894813|323947995|FG000|Overall Study|Lack of Efficacy|3|||
94586193|NCT03894813|323947996|FG001|Overall Study|Lack of Efficacy|3|||
94586194|NCT03894813|323947995|FG000|Overall Study|Lost to Follow-up|1|||
94586195|NCT03894813|323947996|FG001|Overall Study|Lost to Follow-up|0|||
94586196|NCT03894813|323947995|FG000|Overall Study|Pregnancy|2|||
94586197|NCT03894813|323947996|FG001|Overall Study|Pregnancy|1|||
94586198|NCT03894813|323947995|FG000|Overall Study|Protocol Violation|3|||
94659253|NCT02039505|324208007|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
94659254|NCT02039505|324208008|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
94659255|NCT02039505|324208009|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
94659256|NCT02039505|324208010|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
94659257|NCT02039505|324208004|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
94659258|NCT02039505|324208005|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
94353593|NCT01072175|323077081|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
94586199|NCT03894813|323947996|FG001|Overall Study|Protocol Violation|7|||
94586200|NCT03894813|323947995|FG000|Overall Study|Withdrawal by Subject|1|||
94586201|NCT03894813|323947996|FG001|Overall Study|Withdrawal by Subject|3|||
94586202|NCT03894813|323947995|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
94688609|NCT04076020|324315528|FG000|Overall Study|Withdrawal by Subject|12|||
94586203|NCT03894813|323947996|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
94586204|NCT03083873|323947997|FG000|Overall Study|Death|6|||
94586205|NCT03083873|323947998|FG001|Overall Study|Death|15|||
94586206|NCT03083873|323947999|FG002|Overall Study|Death|13|||
94586207|NCT03083873|323948000|FG003|Overall Study|Death|9|||
94586208|NCT03083873|323948001|FG004|Overall Study|Death|0|||
94586209|NCT03083873|323947997|FG000|Overall Study|Sponsor Terminated Study|0|||
94586210|NCT03083873|323947998|FG001|Overall Study|Sponsor Terminated Study|1|||
94586211|NCT03083873|323947999|FG002|Overall Study|Sponsor Terminated Study|2|||
94586212|NCT03083873|323948000|FG003|Overall Study|Sponsor Terminated Study|3|||
94586213|NCT03083873|323948001|FG004|Overall Study|Sponsor Terminated Study|0|||
94586214|NCT03083873|323947997|FG000|Overall Study|Lost to Follow-up|0|||
94586215|NCT03083873|323947998|FG001|Overall Study|Lost to Follow-up|1|||
94586216|NCT03083873|323947999|FG002|Overall Study|Lost to Follow-up|1|||
94586217|NCT03083873|323948000|FG003|Overall Study|Lost to Follow-up|0|||
94586218|NCT03083873|323948001|FG004|Overall Study|Lost to Follow-up|0|||
94586219|NCT03083873|323947997|FG000|Overall Study|Withdrawal by Subject|2|||
94586220|NCT03083873|323947998|FG001|Overall Study|Withdrawal by Subject|0|||
94586221|NCT03083873|323947999|FG002|Overall Study|Withdrawal by Subject|0|||
94586222|NCT03083873|323948000|FG003|Overall Study|Withdrawal by Subject|0|||
94586223|NCT03083873|323948001|FG004|Overall Study|Withdrawal by Subject|0|||
94586224|NCT03083873|323947997|FG000|Overall Study|Did Not Receive TIL|2|||
94586225|NCT03083873|323947998|FG001|Overall Study|Did Not Receive TIL|5|||
94586226|NCT03083873|323947999|FG002|Overall Study|Did Not Receive TIL|3|||
94586227|NCT03083873|323948000|FG003|Overall Study|Did Not Receive TIL|1|||
94586228|NCT03083873|323948001|FG004|Overall Study|Did Not Receive TIL|0|||
94586229|NCT00807001|323948005|FG000|Overall Study|Non-compliance|0|||
94586230|NCT00807001|323948006|FG001|Overall Study|Non-compliance|1|||
94586231|NCT00807001|323948007|FG002|Overall Study|Non-compliance|0|||
94586232|NCT00807001|323948008|FG003|Overall Study|Non-compliance|0|||
94586233|NCT00807001|323948009|FG004|Overall Study|Non-compliance|0|||
94586234|NCT02656693|323948023|FG000|Overall Study|Pregnancy|1|||
94586235|NCT02656693|323948024|FG001|Overall Study|Pregnancy|1|||
94586236|NCT02656693|323948025|FG002|Overall Study|Pregnancy|1|||
94586237|NCT02656693|323948023|FG000|Overall Study|Bariatric surgery|0|||
94586238|NCT02656693|323948024|FG001|Overall Study|Bariatric surgery|1|||
94586239|NCT02656693|323948025|FG002|Overall Study|Bariatric surgery|2|||
94586240|NCT00539864|323948028|FG000|Overall Study|Lost to Follow-up|0|||
94586241|NCT00539864|323948029|FG001|Overall Study|Lost to Follow-up|1|||
94586242|NCT00539864|323948028|FG000|Overall Study|Withdrawal by Subject|1|||
94586243|NCT00539864|323948029|FG001|Overall Study|Withdrawal by Subject|1|||
94586244|NCT02840799|323948030|FG000|Phase 1|Physician Decision|1|||
94586245|NCT02840799|323948031|FG001|Phase 1|Physician Decision|3|||
94586246|NCT02840799|323948030|FG000|Phase 1|Withdrawal by Subject|4|||
94586247|NCT02840799|323948031|FG001|Phase 1|Withdrawal by Subject|0|||
94586248|NCT02840799|323948030|FG000|Phase 2 (Crossover)|Adverse Event|0|||
94586249|NCT02840799|323948031|FG001|Phase 2 (Crossover)|Adverse Event|1|||
94586250|NCT02840799|323948030|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
94586251|NCT02840799|323948031|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
94586252|NCT00145158|323948033|FG000|Overall Study|premature withdrawal|2|||
94586253|NCT00145158|323948034|FG001|Overall Study|premature withdrawal|3|||
94586254|NCT03887702|323948035|FG000|Overall Study|Study terminated|0|||
94586255|NCT03887702|323948036|FG001|Overall Study|Study terminated|0|||
94586256|NCT03887702|323948037|FG002|Overall Study|Study terminated|2|||
94586257|NCT03887702|323948038|FG003|Overall Study|Study terminated|2|||
94586258|NCT04896086|323948044|FG000|Overall Study|Lost to Follow-up|0|||
94586259|NCT04896086|323948045|FG001|Overall Study|Lost to Follow-up|2|||
94586260|NCT04896086|323948046|FG002|Overall Study|Lost to Follow-up|1|||
94586261|NCT04896086|323948047|FG003|Overall Study|Lost to Follow-up|0|||
94586262|NCT04896086|323948048|FG004|Overall Study|Lost to Follow-up|0|||
94586263|NCT04896086|323948044|FG000|Overall Study|Physician Decision|0|||
94586264|NCT04896086|323948045|FG001|Overall Study|Physician Decision|1|||
94586265|NCT04896086|323948046|FG002|Overall Study|Physician Decision|0|||
94586266|NCT04896086|323948047|FG003|Overall Study|Physician Decision|0|||
94586267|NCT04896086|323948048|FG004|Overall Study|Physician Decision|0|||
94586268|NCT04896086|323948044|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
94586269|NCT04896086|323948045|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
94586270|NCT04896086|323948046|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
94586271|NCT04896086|323948047|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
94586272|NCT04896086|323948048|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
94586273|NCT04896086|323948044|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
94586274|NCT04896086|323948045|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
94586275|NCT04896086|323948046|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
94586276|NCT04896086|323948047|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
94586277|NCT04896086|323948048|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
94586278|NCT00123422|323948049|FG000|Overall Study|Physician Decision|2|||
94586279|NCT00123422|323948050|FG001|Overall Study|Physician Decision|2|||
94586280|NCT00123422|323948051|FG002|Overall Study|Physician Decision|6|||
94586281|NCT00123422|323948049|FG000|Overall Study|Withdrawal by Subject|1|||
94586282|NCT00123422|323948050|FG001|Overall Study|Withdrawal by Subject|2|||
94586283|NCT00123422|323948051|FG002|Overall Study|Withdrawal by Subject|2|||
94586284|NCT00123422|323948049|FG000|Overall Study|Lost to Follow-up|1|||
94586285|NCT00123422|323948050|FG001|Overall Study|Lost to Follow-up|2|||
94586286|NCT00123422|323948051|FG002|Overall Study|Lost to Follow-up|2|||
94586287|NCT04555616|323948056|FG000|Overall Study|Death|1|||
94586288|NCT04555616|323948057|FG001|Overall Study|Death|0|||
94586289|NCT04555616|323948058|FG002|Overall Study|Death|1|||
94586290|NCT04555616|323948056|FG000|Overall Study|Withdrawal by Subject|2|||
94586291|NCT04555616|323948057|FG001|Overall Study|Withdrawal by Subject|1|||
94586292|NCT04555616|323948058|FG002|Overall Study|Withdrawal by Subject|0|||
94586293|NCT03544333|323948068|FG000|Overall Study|Withdrawal by Subject|1|||
94586294|NCT03544333|323948069|FG001|Overall Study|Withdrawal by Subject|0|||
94586295|NCT01039519|323948070|FG000|Treatment|Progressive disease|20|||
94586296|NCT01039519|323948070|FG000|Treatment|Treatment failure|2|||
94586297|NCT01039519|323948070|FG000|Treatment|Adverse Event|3|||
94586298|NCT01039519|323948070|FG000|Treatment|Physician Decision|2|||
94586299|NCT01039519|323948070|FG000|Survival Follow-up|Death|23|||
94586300|NCT01039519|323948070|FG000|Survival Follow-up|Sponsor decision|4|||
94586301|NCT01255436|323948078|FG000|Overall Study|Lost to Follow-up|178|||
94586302|NCT01255436|323948079|FG001|Overall Study|Lost to Follow-up|191|||
94586303|NCT01255436|323948078|FG000|Overall Study|Death, stroke, or MI|4|||
94586304|NCT01255436|323948079|FG001|Overall Study|Death, stroke, or MI|3|||
94586305|NCT01229267|323948080|FG000|Overall Study|Adverse Event|4|||
94586306|NCT01229267|323948081|FG001|Overall Study|Adverse Event|6|||
94586307|NCT01229267|323948082|FG002|Overall Study|Adverse Event|3|||
94586308|NCT01229267|323948083|FG003|Overall Study|Adverse Event|2|||
94586309|NCT01229267|323948084|FG004|Overall Study|Adverse Event|10|||
94586310|NCT01229267|323948080|FG000|Overall Study|Death|40|||
94586311|NCT01229267|323948081|FG001|Overall Study|Death|37|||
94586312|NCT01229267|323948082|FG002|Overall Study|Death|35|||
94586313|NCT01229267|323948083|FG003|Overall Study|Death|13|||
94353594|NCT01072175|323077082|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
94353595|NCT01072175|323077083|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
94353596|NCT01072175|323077084|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
94353597|NCT01072175|323077085|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
94353598|NCT01072175|323077086|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
94586314|NCT01229267|323948084|FG004|Overall Study|Death|103|||
94586315|NCT01229267|323948080|FG000|Overall Study|Withdrawal by Subject|23|||
94586316|NCT01229267|323948081|FG001|Overall Study|Withdrawal by Subject|22|||
94586317|NCT01229267|323948082|FG002|Overall Study|Withdrawal by Subject|32|||
94586318|NCT01229267|323948083|FG003|Overall Study|Withdrawal by Subject|14|||
94586319|NCT01229267|323948084|FG004|Overall Study|Withdrawal by Subject|59|||
94586320|NCT01229267|323948080|FG000|Overall Study|Protocol Violation|0|||
94586321|NCT01229267|323948081|FG001|Overall Study|Protocol Violation|1|||
94586322|NCT01229267|323948082|FG002|Overall Study|Protocol Violation|0|||
94586323|NCT01229267|323948083|FG003|Overall Study|Protocol Violation|0|||
94586324|NCT01229267|323948084|FG004|Overall Study|Protocol Violation|0|||
94586325|NCT01229267|323948080|FG000|Overall Study|Progressive disease|0|||
94586326|NCT01229267|323948081|FG001|Overall Study|Progressive disease|0|||
94586327|NCT01229267|323948082|FG002|Overall Study|Progressive disease|0|||
94586328|NCT01229267|323948083|FG003|Overall Study|Progressive disease|0|||
94586329|NCT01229267|323948084|FG004|Overall Study|Progressive disease|1|||
94586330|NCT01229267|323948080|FG000|Overall Study|Physician Decision|8|||
94586331|NCT01229267|323948081|FG001|Overall Study|Physician Decision|11|||
94586332|NCT01229267|323948082|FG002|Overall Study|Physician Decision|8|||
94586333|NCT01229267|323948083|FG003|Overall Study|Physician Decision|3|||
94586334|NCT01229267|323948084|FG004|Overall Study|Physician Decision|25|||
94586335|NCT01229267|323948080|FG000|Overall Study|Lost to Follow-up|6|||
94586336|NCT01229267|323948081|FG001|Overall Study|Lost to Follow-up|5|||
94586337|NCT01229267|323948082|FG002|Overall Study|Lost to Follow-up|8|||
94586338|NCT01229267|323948083|FG003|Overall Study|Lost to Follow-up|3|||
94586339|NCT01229267|323948084|FG004|Overall Study|Lost to Follow-up|22|||
94586340|NCT00808080|323948090|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
94586341|NCT02054104|323948091|FG000|Overall Study|Did not want to continue due to college classes|1|||
94586342|NCT02054104|323948092|FG001|Overall Study|Did not want to continue due to college classes|0|||
94586343|NCT02054104|323948091|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
94586344|NCT02054104|323948092|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
94586345|NCT02054104|323948091|FG000|Overall Study|No evidence of immunologic response|2|||
94586346|NCT02054104|323948092|FG001|Overall Study|No evidence of immunologic response|2|||
94586347|NCT02054104|323948091|FG000|Overall Study|Disease Progression On Study|4|||
94586348|NCT02054104|323948092|FG001|Overall Study|Disease Progression On Study|5|||
94586349|NCT02054104|323948091|FG000|Overall Study|Diagnosis of lymphoma|0|||
94586350|NCT02054104|323948092|FG001|Overall Study|Diagnosis of lymphoma|1|||
94586351|NCT02054104|323948091|FG000|Overall Study|Inconclusive response|0|||
94586352|NCT02054104|323948092|FG001|Overall Study|Inconclusive response|1|||
94586353|NCT01075685|323948099|FG000|Overall Study|Protocol Violation|9|||
94586354|NCT01075685|323948100|FG001|Overall Study|Protocol Violation|1|||
94586355|NCT01075685|323948099|FG000|Overall Study|Withdrawal by Subject|20|||
94586356|NCT01075685|323948100|FG001|Overall Study|Withdrawal by Subject|5|||
94586357|NCT01075685|323948099|FG000|Overall Study|Lost to Follow-up|563|||
94586358|NCT01075685|323948100|FG001|Overall Study|Lost to Follow-up|220|||
94586359|NCT03196349|323948101|FG000|Overall Study|Did not receive study drug|0|||
94586360|NCT03196349|323948102|FG001|Overall Study|Did not receive study drug|1|||
94586361|NCT03196349|323948103|FG002|Overall Study|Did not receive study drug|2|||
94586362|NCT03196349|323948101|FG000|Overall Study|No data entered|2|||
94586363|NCT03196349|323948102|FG001|Overall Study|No data entered|4|||
94586364|NCT03196349|323948103|FG002|Overall Study|No data entered|0|||
94586365|NCT03196349|323948101|FG000|Overall Study|Study Terminated early|15|||
94586366|NCT03196349|323948102|FG001|Overall Study|Study Terminated early|9|||
94586367|NCT03196349|323948103|FG002|Overall Study|Study Terminated early|11|||
94586368|NCT02858362|323948104|FG000|Overall Study|Protocol Violation|0|||
94586369|NCT02858362|323948105|FG001|Overall Study|Protocol Violation|1|||
94586370|NCT02858362|323948106|FG002|Overall Study|Protocol Violation|0|||
94586371|NCT02858362|323948104|FG000|Overall Study|Withdrawal by Subject|1|||
94586372|NCT02858362|323948105|FG001|Overall Study|Withdrawal by Subject|0|||
94586373|NCT02858362|323948106|FG002|Overall Study|Withdrawal by Subject|0|||
94586374|NCT02858362|323948104|FG000|Overall Study|Early Study Termination|0|||
94586375|NCT02858362|323948105|FG001|Overall Study|Early Study Termination|0|||
94659259|NCT02039505|324208006|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
94659260|NCT02039505|324208007|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
94586376|NCT02858362|323948106|FG002|Overall Study|Early Study Termination|3|||
94586377|NCT02858362|323948104|FG000|Overall Study|Lost to Follow-up|1|||
94586378|NCT02858362|323948105|FG001|Overall Study|Lost to Follow-up|0|||
94586379|NCT02858362|323948106|FG002|Overall Study|Lost to Follow-up|0|||
94586380|NCT02474069|323948107|FG000|Selection Phase (SP)|Adverse Event|8|||
94586381|NCT02474069|323948108|FG001|Selection Phase (SP)|Adverse Event|0|||
94586382|NCT02474069|323948109|FG002|Selection Phase (SP)|Adverse Event|0|||
94586383|NCT02474069|323948107|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
94586384|NCT02474069|323948108|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
94586385|NCT02474069|323948109|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
94242664|NCT01646177|322682741|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
94586386|NCT02474069|323948107|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
94586387|NCT02474069|323948108|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
94586388|NCT02474069|323948109|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
94586389|NCT02474069|323948107|FG000|Selection Phase (SP)|Physician Decision|1|||
94586390|NCT02474069|323948108|FG001|Selection Phase (SP)|Physician Decision|0|||
94586391|NCT02474069|323948109|FG002|Selection Phase (SP)|Physician Decision|0|||
94586392|NCT02474069|323948107|FG000|Selection Phase (SP)|Protocol Violation|1|||
94586393|NCT02474069|323948108|FG001|Selection Phase (SP)|Protocol Violation|0|||
94586394|NCT02474069|323948109|FG002|Selection Phase (SP)|Protocol Violation|0|||
94586395|NCT02474069|323948107|FG000|Selection Phase (SP)|No longer requires treatment|1|||
94586396|NCT02474069|323948108|FG001|Selection Phase (SP)|No longer requires treatment|0|||
94586397|NCT02474069|323948109|FG002|Selection Phase (SP)|No longer requires treatment|0|||
94586398|NCT02474069|323948107|FG000|Selection Phase (SP)|Technical Problem|1|||
94586399|NCT02474069|323948108|FG001|Selection Phase (SP)|Technical Problem|0|||
94586400|NCT02474069|323948109|FG002|Selection Phase (SP)|Technical Problem|0|||
94586401|NCT02474069|323948107|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
94586402|NCT02474069|323948108|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
94586403|NCT02474069|323948109|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
94586404|NCT02474069|323948107|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
94586405|NCT02474069|323948108|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
94586406|NCT02474069|323948109|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
94586407|NCT02474069|323948107|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
94586408|NCT02474069|323948108|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
94586409|NCT02474069|323948109|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
94586410|NCT02474069|323948107|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
94586411|NCT02474069|323948108|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
94586412|NCT02474069|323948109|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
94586413|NCT02474069|323948107|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
94586414|NCT02474069|323948108|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
94586415|NCT02474069|323948109|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
94586416|NCT02474069|323948107|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
94586417|NCT02474069|323948108|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
94586418|NCT02474069|323948109|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
94586419|NCT01623050|323948110|FG000|Overall Study|Lost to Follow-up|9|||
94586420|NCT01191762|323948111|FG000|Overall Study|Adverse Event|1|||
94586421|NCT01191762|323948112|FG001|Overall Study|Adverse Event|0|||
94586422|NCT01598506|323948114|FG000|Overall Study|Withdrawal by Subject|2|||
94586423|NCT01976741|323948115|FG000|Overall Study|Withdrawal by Subject|1|||
94586424|NCT01976741|323948116|FG001|Overall Study|Withdrawal by Subject|0|||
94586425|NCT01976741|323948117|FG002|Overall Study|Withdrawal by Subject|1|||
94586426|NCT01976741|323948118|FG003|Overall Study|Withdrawal by Subject|1|||
94586427|NCT01976741|323948119|FG004|Overall Study|Withdrawal by Subject|0|||
94586428|NCT01976741|323948120|FG005|Overall Study|Withdrawal by Subject|0|||
94586429|NCT01976741|323948121|FG006|Overall Study|Withdrawal by Subject|1|||
94586430|NCT01976741|323948122|FG007|Overall Study|Withdrawal by Subject|4|||
94586431|NCT01976741|323948123|FG008|Overall Study|Withdrawal by Subject|0|||
94586432|NCT01976741|323948124|FG009|Overall Study|Withdrawal by Subject|0|||
94586433|NCT01976741|323948115|FG000|Overall Study|Adverse Event|0|||
94586434|NCT01976741|323948116|FG001|Overall Study|Adverse Event|0|||
94586435|NCT01976741|323948117|FG002|Overall Study|Adverse Event|2|||
94586436|NCT01976741|323948118|FG003|Overall Study|Adverse Event|0|||
94586437|NCT01976741|323948119|FG004|Overall Study|Adverse Event|0|||
94586438|NCT01976741|323948120|FG005|Overall Study|Adverse Event|0|||
94586439|NCT01976741|323948121|FG006|Overall Study|Adverse Event|3|||
94586440|NCT01976741|323948122|FG007|Overall Study|Adverse Event|8|||
94586441|NCT01976741|323948123|FG008|Overall Study|Adverse Event|1|||
94586442|NCT01976741|323948124|FG009|Overall Study|Adverse Event|4|||
94586443|NCT00060840|323948125|FG000|Overall Study|Change in surgical plan|2|||
94586444|NCT00060840|323948126|FG001|Overall Study|Change in surgical plan|6|||
94586445|NCT00060840|323948125|FG000|Overall Study|Death|0|||
94586446|NCT00060840|323948126|FG001|Overall Study|Death|1|||
94242665|NCT01646177|322682730|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
94242666|NCT01646177|322682731|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
94455994|NCT02682823|323458150|FG002|Overall Study|Protocol Deviation|0|||
94586447|NCT00060840|323948125|FG000|Overall Study|Withdrawal by Subject|0|||
94586448|NCT00060840|323948126|FG001|Overall Study|Withdrawal by Subject|1|||
94586449|NCT00060840|323948125|FG000|Overall Study|Subinvestigator unavailable|0|||
94586450|NCT00060840|323948126|FG001|Overall Study|Subinvestigator unavailable|1|||
94586451|NCT00060840|323948125|FG000|Overall Study|Physician Decision|1|||
94586452|NCT00060840|323948126|FG001|Overall Study|Physician Decision|0|||
94586453|NCT00060840|323948125|FG000|Overall Study|Other|1|||
94586454|NCT00060840|323948126|FG001|Overall Study|Other|0|||
94586455|NCT00976560|323948133|FG000|Overall Study|Adverse Event|5|||
94586456|NCT00976560|323948134|FG001|Overall Study|Adverse Event|5|||
94586457|NCT00976560|323948133|FG000|Overall Study|Lack of Efficacy|3|||
94586458|NCT00976560|323948134|FG001|Overall Study|Lack of Efficacy|5|||
94586459|NCT00976560|323948133|FG000|Overall Study|Protocol Violation|1|||
94586460|NCT00976560|323948134|FG001|Overall Study|Protocol Violation|0|||
94586461|NCT00976560|323948133|FG000|Overall Study|Lost to Follow-up|1|||
94586462|NCT00976560|323948134|FG001|Overall Study|Lost to Follow-up|0|||
94586463|NCT00976560|323948133|FG000|Overall Study|Physician Decision|2|||
94586464|NCT00976560|323948134|FG001|Overall Study|Physician Decision|0|||
94586465|NCT00976560|323948133|FG000|Overall Study|Withdrawal by Subject|2|||
94586466|NCT00976560|323948134|FG001|Overall Study|Withdrawal by Subject|3|||
94586467|NCT00775593|323948135|FG000|Overall Study|Unmet eligibility criteria|6|||
94586468|NCT00775593|323948135|FG000|Overall Study|Death|1|||
94586469|NCT02023697|323948136|FG000|Treatment Period|Radiological progression|13|||
94586470|NCT02023697|323948137|FG001|Treatment Period|Radiological progression|17|||
94586471|NCT02023697|323948138|FG002|Treatment Period|Radiological progression|26|||
94586472|NCT02023697|323948136|FG000|Treatment Period|Never Treated|5|||
94586473|NCT02023697|323948137|FG001|Treatment Period|Never Treated|6|||
94586474|NCT02023697|323948138|FG002|Treatment Period|Never Treated|10|||
94586475|NCT02023697|323948136|FG000|Treatment Period|Adverse Event|13|||
94586476|NCT02023697|323948137|FG001|Treatment Period|Adverse Event|25|||
94659261|NCT02039505|324208008|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
94659262|NCT02039505|324208009|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
94586477|NCT02023697|323948138|FG002|Treatment Period|Adverse Event|23|||
94659263|NCT02039505|324208010|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
94659264|NCT02039505|324208004|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
94659265|NCT02039505|324208005|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
94659266|NCT02039505|324208006|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
94659267|NCT02039505|324208007|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
94659268|NCT02039505|324208008|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
94659269|NCT02039505|324208009|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
94659270|NCT02039505|324208010|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
94659271|NCT02039505|324208004|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
94659272|NCT02039505|324208005|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
94659273|NCT02039505|324208006|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
94659274|NCT02039505|324208007|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
94586478|NCT02023697|323948136|FG000|Treatment Period|Logistical difficulties|1|||
94586479|NCT02023697|323948137|FG001|Treatment Period|Logistical difficulties|1|||
94586480|NCT02023697|323948138|FG002|Treatment Period|Logistical difficulties|1|||
94586481|NCT02023697|323948136|FG000|Treatment Period|Clinical progression|10|||
94586482|NCT02023697|323948137|FG001|Treatment Period|Clinical progression|8|||
94586483|NCT02023697|323948138|FG002|Treatment Period|Clinical progression|28|||
94586484|NCT02023697|323948136|FG000|Treatment Period|Withdrawal by Subject|4|||
94586485|NCT02023697|323948137|FG001|Treatment Period|Withdrawal by Subject|5|||
94586486|NCT02023697|323948138|FG002|Treatment Period|Withdrawal by Subject|13|||
94586487|NCT02023697|323948136|FG000|Treatment Period|Safety outcome reached|0|||
94586488|NCT02023697|323948137|FG001|Treatment Period|Safety outcome reached|1|||
94586489|NCT02023697|323948138|FG002|Treatment Period|Safety outcome reached|0|||
94586490|NCT02023697|323948136|FG000|Treatment Period|Physician Decision|0|||
94586491|NCT02023697|323948137|FG001|Treatment Period|Physician Decision|0|||
94586492|NCT02023697|323948138|FG002|Treatment Period|Physician Decision|1|||
94586493|NCT02023697|323948136|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
94586494|NCT02023697|323948137|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
94586495|NCT02023697|323948138|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
94586496|NCT02023697|323948136|FG000|Active Follow-up Period|Lost to Follow-up|1|||
94586497|NCT02023697|323948137|FG001|Active Follow-up Period|Lost to Follow-up|1|||
94659275|NCT02039505|324208008|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
94659276|NCT02039505|324208009|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
94586498|NCT02023697|323948138|FG002|Active Follow-up Period|Lost to Follow-up|1|||
94586499|NCT02023697|323948136|FG000|Active Follow-up Period|Deterioration of general condition|1|||
94586500|NCT02023697|323948137|FG001|Active Follow-up Period|Deterioration of general condition|1|||
94586501|NCT02023697|323948138|FG002|Active Follow-up Period|Deterioration of general condition|1|||
94586502|NCT02023697|323948136|FG000|Active Follow-up Period|Other unspecified|2|||
94586503|NCT02023697|323948137|FG001|Active Follow-up Period|Other unspecified|0|||
94586504|NCT02023697|323948138|FG002|Active Follow-up Period|Other unspecified|1|||
94586505|NCT02023697|323948136|FG000|Active Follow-up Period|Clinical progression|0|||
94586506|NCT02023697|323948137|FG001|Active Follow-up Period|Clinical progression|2|||
94586507|NCT02023697|323948138|FG002|Active Follow-up Period|Clinical progression|1|||
94586508|NCT02023697|323948136|FG000|Active Follow-up Period|Radiological progression|0|||
94586509|NCT02023697|323948137|FG001|Active Follow-up Period|Radiological progression|0|||
94586510|NCT02023697|323948138|FG002|Active Follow-up Period|Radiological progression|1|||
94586511|NCT02023697|323948136|FG000|Active Follow-up Period|Death|83|||
94586512|NCT02023697|323948137|FG001|Active Follow-up Period|Death|82|||
94586513|NCT02023697|323948138|FG002|Active Follow-up Period|Death|87|||
94586514|NCT02023697|323948136|FG000|Long-term Follow-up Period|Death|9|||
94586515|NCT02023697|323948137|FG001|Long-term Follow-up Period|Death|6|||
94586516|NCT02023697|323948138|FG002|Long-term Follow-up Period|Death|4|||
94586517|NCT02023697|323948136|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
94586518|NCT02023697|323948137|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
94586519|NCT02023697|323948138|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
94586520|NCT02023697|323948136|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
94586521|NCT02023697|323948137|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
94586522|NCT02023697|323948138|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
94586523|NCT02023697|323948136|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
94586524|NCT02023697|323948137|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
94586525|NCT02023697|323948138|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
94586526|NCT02023697|323948136|FG000|Long-term Follow-up Period|Technical problems|0|||
94586527|NCT02023697|323948137|FG001|Long-term Follow-up Period|Technical problems|0|||
94586528|NCT02023697|323948138|FG002|Long-term Follow-up Period|Technical problems|1|||
94586529|NCT02023697|323948136|FG000|Long-term Follow-up Period|Other unspecified|6|||
94586530|NCT02023697|323948137|FG001|Long-term Follow-up Period|Other unspecified|3|||
94586531|NCT02023697|323948138|FG002|Long-term Follow-up Period|Other unspecified|5|||
94586532|NCT01733680|323948139|FG000|Overall Study|Withdrawal by Subject|0|||
94586533|NCT01733680|323948140|FG001|Overall Study|Withdrawal by Subject|1|||
94586534|NCT00476229|323948141|FG000|Overall Study|Progressive shortness of breath|1|||
94586535|NCT00845897|323948142|FG000|Overall Study|Lost to Follow-up|1|||
94586536|NCT00845897|323948143|FG001|Overall Study|Lost to Follow-up|1|||
94586537|NCT00845897|323948144|FG002|Overall Study|Lost to Follow-up|0|||
94586538|NCT00845897|323948142|FG000|Overall Study|Withdrawal by Subject|0|||
94586539|NCT00845897|323948143|FG001|Overall Study|Withdrawal by Subject|3|||
94586540|NCT00845897|323948144|FG002|Overall Study|Withdrawal by Subject|2|||
94586541|NCT00845897|323948142|FG000|Overall Study|Ulcer did not heal|1|||
94586542|NCT00845897|323948143|FG001|Overall Study|Ulcer did not heal|0|||
94586543|NCT00845897|323948144|FG002|Overall Study|Ulcer did not heal|1|||
94586544|NCT00845897|323948142|FG000|Overall Study|Too ill to participate|0|||
94586545|NCT00845897|323948143|FG001|Overall Study|Too ill to participate|1|||
94586546|NCT00845897|323948144|FG002|Overall Study|Too ill to participate|0|||
94586547|NCT03865381|323948145|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
94586548|NCT03865381|323948145|FG000|Overall Study|Withdrawal by Subject|2|||
94586549|NCT04139798|323948146|FG000|Overall Study|Withdrawal by Subject|6|||
94586550|NCT04139798|323948147|FG001|Overall Study|Withdrawal by Subject|5|||
94586551|NCT04139798|323948146|FG000|Overall Study|Lost to Follow-up|2|||
94586552|NCT04139798|323948147|FG001|Overall Study|Lost to Follow-up|5|||
94586553|NCT04139798|323948146|FG000|Overall Study|Discontinued|4|||
94586554|NCT04139798|323948147|FG001|Overall Study|Discontinued|2|||
94586555|NCT04139798|323948146|FG000|Overall Study|Adverse Event|1|||
94586556|NCT04139798|323948147|FG001|Overall Study|Adverse Event|3|||
94586557|NCT04139798|323948146|FG000|Overall Study|Protocol Violation|1|||
94586558|NCT04139798|323948147|FG001|Overall Study|Protocol Violation|0|||
94586559|NCT00611026|323948148|FG000|Randomized to Double-blind Treatment|Not treated|2|||
94586560|NCT00611026|323948149|FG001|Randomized to Double-blind Treatment|Not treated|1|||
94586561|NCT00611026|323948150|FG002|Randomized to Double-blind Treatment|Not treated|3|||
94586562|NCT00611026|323948148|FG000|Double-blind Treatment Period|Death|1|||
94586563|NCT00611026|323948149|FG001|Double-blind Treatment Period|Death|0|||
94586564|NCT00611026|323948150|FG002|Double-blind Treatment Period|Death|0|||
94586565|NCT00611026|323948148|FG000|Double-blind Treatment Period|Adverse Event|9|||
94586566|NCT00611026|323948149|FG001|Double-blind Treatment Period|Adverse Event|28|||
94586567|NCT00611026|323948150|FG002|Double-blind Treatment Period|Adverse Event|46|||
94586568|NCT00611026|323948148|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
94586569|NCT00611026|323948149|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
94586570|NCT00611026|323948150|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
94586571|NCT00611026|323948148|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
94586572|NCT00611026|323948149|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
94586573|NCT00611026|323948150|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
94586574|NCT00611026|323948148|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
94455995|NCT02682823|323458151|FG003|Overall Study|Protocol Deviation|0|||
94586575|NCT00611026|323948149|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
94586576|NCT00611026|323948150|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
94586577|NCT00611026|323948148|FG000|Double-blind Treatment Period|Other|13|||
94586578|NCT00611026|323948149|FG001|Double-blind Treatment Period|Other|20|||
94586579|NCT00611026|323948150|FG002|Double-blind Treatment Period|Other|18|||
94586580|NCT02873377|323948151|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
94586581|NCT02873377|323948152|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
94586582|NCT02873377|323948151|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
94586583|NCT02873377|323948152|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
94586584|NCT01583296|323948156|FG000|Overall Study|Withdrawal by Subject|11|||
94586585|NCT01583296|323948157|FG001|Overall Study|Withdrawal by Subject|10|||
94586586|NCT03179319|323948158|FG000|Overall Study|Lost to Follow-up|6|||
94586587|NCT03179319|323948159|FG001|Overall Study|Lost to Follow-up|0|||
94586588|NCT02533453|323948160|FG000|Overall Study|Adverse Event|6|||
94586589|NCT02533453|323948160|FG000|Overall Study|Protocol Violation|1|||
94586590|NCT02533453|323948160|FG000|Overall Study|Withdrawal by Subject|2|||
94586591|NCT02527421|323948162|FG000|Overall Study|Withdrawal by Subject|1|||
94586592|NCT02527421|323948163|FG001|Overall Study|Withdrawal by Subject|0|||
94586593|NCT00806819|323948169|FG000|Overall Study|progressive disease (modified RECIST )|217|||
94586594|NCT00806819|323948170|FG001|Overall Study|progressive disease (modified RECIST )|216|||
94586595|NCT00806819|323948169|FG000|Overall Study|Worsening or AE of underlying disease|18|||
94586596|NCT00806819|323948170|FG001|Overall Study|Worsening or AE of underlying disease|25|||
94586597|NCT00806819|323948169|FG000|Overall Study|Other AE|38|||
94586598|NCT00806819|323948170|FG001|Overall Study|Other AE|40|||
94586599|NCT00806819|323948169|FG000|Overall Study|Protocol Violation|9|||
94586600|NCT00806819|323948170|FG001|Overall Study|Protocol Violation|4|||
94586601|NCT00806819|323948169|FG000|Overall Study|Lost to Follow-up|1|||
94586602|NCT00806819|323948170|FG001|Overall Study|Lost to Follow-up|0|||
94586603|NCT00806819|323948169|FG000|Overall Study|Withdrawal by Subject|32|||
94586604|NCT00806819|323948170|FG001|Overall Study|Withdrawal by Subject|29|||
94586605|NCT00806819|323948169|FG000|Overall Study|Not treated|6|||
94586606|NCT00806819|323948170|FG001|Overall Study|Not treated|3|||
94586607|NCT00806819|323948169|FG000|Overall Study|Reasons other than stated above|25|||
94586608|NCT00806819|323948170|FG001|Overall Study|Reasons other than stated above|41|||
94586609|NCT00829504|323948173|FG000|First Intervention|Adverse Event|1|||
94586610|NCT00829504|323948174|FG001|First Intervention|Adverse Event|0|||
94586611|NCT00829504|323948173|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
94586612|NCT00829504|323948174|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
94586613|NCT00829504|323948173|FG000|Second Intervention|Physician Decision|1|||
94586614|NCT00829504|323948174|FG001|Second Intervention|Physician Decision|0|||
94586615|NCT00899431|323948175|FG000|Overall Study|Physician Decision|1|||
94586616|NCT00899431|323948176|FG001|Overall Study|Physician Decision|0|||
94586617|NCT00899431|323948177|FG002|Overall Study|Physician Decision|0|||
94586618|NCT00904033|323950273|FG000|Overall Study|Withdrawal by Subject|1|||
94586619|NCT00904033|323950274|FG001|Overall Study|Withdrawal by Subject|1|||
94586620|NCT00904033|323950275|FG002|Overall Study|Withdrawal by Subject|0|||
94586621|NCT00904033|323950276|FG003|Overall Study|Withdrawal by Subject|0|||
94586622|NCT00904033|323950273|FG000|Overall Study|Physician Decision|0|||
94586623|NCT00904033|323950274|FG001|Overall Study|Physician Decision|0|||
94586624|NCT00904033|323950275|FG002|Overall Study|Physician Decision|1|||
94586625|NCT00904033|323950276|FG003|Overall Study|Physician Decision|0|||
94586626|NCT00904033|323950273|FG000|Overall Study|Unable to obtain final blood draw|0|||
94586627|NCT00904033|323950274|FG001|Overall Study|Unable to obtain final blood draw|0|||
94586628|NCT00904033|323950275|FG002|Overall Study|Unable to obtain final blood draw|0|||
94586629|NCT00904033|323950276|FG003|Overall Study|Unable to obtain final blood draw|2|||
94659277|NCT02039505|324208010|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
94659278|NCT01722331|324208011|FG000|Part 1|Adverse Event|5|||
94659279|NCT01722331|324208012|FG001|Part 1|Adverse Event|0|||
94659280|NCT01722331|324208013|FG002|Part 1|Adverse Event|0|||
94659281|NCT01722331|324208014|FG003|Part 1|Adverse Event|0|||
94659282|NCT01722331|324208015|FG004|Part 1|Adverse Event|0|||
94659283|NCT01722331|324208016|FG005|Part 1|Adverse Event|0|||
94659284|NCT01722331|324208017|FG006|Part 1|Adverse Event|0|||
94659285|NCT01722331|324208011|FG000|Part 1|Lack of Efficacy|0|||
94353599|NCT01072175|323077074|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
94353600|NCT01072175|323077075|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
94586630|NCT01168219|323950277|FG000|Overall Study|off study before starting treatment|2|||
94586631|NCT01168219|323950277|FG000|Overall Study|withdrew before transplant|1|||
94586632|NCT01168219|323950277|FG000|Overall Study|ineligible due to CML|2|||
94586633|NCT01357850|323950278|FG000|Overall Study|Lost to Follow-up|1|||
94586634|NCT01357850|323950279|FG001|Overall Study|Lost to Follow-up|0|||
94586635|NCT01357850|323950280|FG002|Overall Study|Lost to Follow-up|0|||
94659286|NCT01722331|324208012|FG001|Part 1|Lack of Efficacy|0|||
94659287|NCT01722331|324208013|FG002|Part 1|Lack of Efficacy|1|||
94659288|NCT01722331|324208014|FG003|Part 1|Lack of Efficacy|0|||
94586636|NCT01357850|323950281|FG003|Overall Study|Lost to Follow-up|0|||
94586637|NCT02600819|323950282|FG000|GEN Phase|Adverse Event|2|||
94586638|NCT02600819|323950283|FG001|GEN Phase|Adverse Event|0|||
94586639|NCT02600819|323950282|FG000|GEN Phase|Death|2|||
94586640|NCT02600819|323950283|FG001|GEN Phase|Death|0|||
94586641|NCT02600819|323950282|FG000|GEN Phase|Investigator's Discretion|4|||
94586642|NCT02600819|323950283|FG001|GEN Phase|Investigator's Discretion|0|||
94586643|NCT02600819|323950282|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
94586644|NCT02600819|323950283|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
94586645|NCT02600819|323950282|FG000|GEN Phase|Withdrew Consent|5|||
94586646|NCT02600819|323950283|FG001|GEN Phase|Withdrew Consent|0|||
94586647|NCT02600819|323950282|FG000|GEN Phase|Lost to Follow-up|2|||
94586648|NCT02600819|323950283|FG001|GEN Phase|Lost to Follow-up|0|||
94586649|NCT02561832|323950285|FG000|Overall Study|Withdrawal by Subject|1|||
94586650|NCT02561832|323950286|FG001|Overall Study|Withdrawal by Subject|1|||
94586651|NCT02561832|323950285|FG000|Overall Study|Adverse Event|3|||
94586652|NCT02561832|323950286|FG001|Overall Study|Adverse Event|0|||
94586653|NCT02561832|323950285|FG000|Overall Study|Disease progression|3|||
94586654|NCT02561832|323950286|FG001|Overall Study|Disease progression|3|||
94586655|NCT02283762|323950287|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
94586656|NCT02283762|323950288|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
94586657|NCT02283762|323950287|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
94586658|NCT02283762|323950288|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
94586659|NCT02283762|323950287|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
94586660|NCT02283762|323950288|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
94586661|NCT02283762|323950287|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
94586662|NCT02283762|323950288|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
94586663|NCT02283762|323950287|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
94586664|NCT02283762|323950288|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
94586665|NCT02283762|323950287|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
94586666|NCT02283762|323950288|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
94586667|NCT02283762|323950287|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
94586668|NCT02283762|323950288|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
94586669|NCT02283762|323950287|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
94586670|NCT02283762|323950288|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
94586671|NCT02283762|323950287|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
94586672|NCT02283762|323950288|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
94586673|NCT02283762|323950287|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
94586674|NCT02283762|323950288|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
94586675|NCT02283762|323950287|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
94586676|NCT02283762|323950288|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
94586677|NCT02283762|323950287|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
94586678|NCT02283762|323950288|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
94586679|NCT00202878|323950289|FG000|Overall Study|Death|964|||
94586680|NCT00202878|323950290|FG001|Overall Study|Death|968|||
94586681|NCT00202878|323950289|FG000|Overall Study|Only Vital Status Known|357|||
94586682|NCT00202878|323950290|FG001|Overall Study|Only Vital Status Known|356|||
94586683|NCT00202878|323950289|FG000|Overall Study|Lost to Follow-up|44|||
94586684|NCT00202878|323950290|FG001|Overall Study|Lost to Follow-up|49|||
94586685|NCT00202878|323950289|FG000|Overall Study|Site Closure|39|||
94586686|NCT00202878|323950290|FG001|Overall Study|Site Closure|36|||
94586687|NCT00202878|323950289|FG000|Overall Study|Withdrawal by Subject|795|||
94586688|NCT00202878|323950290|FG001|Overall Study|Withdrawal by Subject|808|||
94586689|NCT01409811|323950291|FG000|Overall Study|Insurance denial|1|||
94586690|NCT00441064|323950294|FG000|Overall Study|Adverse Event|1|||
94586691|NCT00441064|323950295|FG001|Overall Study|Adverse Event|0|||
94586692|NCT00441064|323950294|FG000|Overall Study|Abnormal laboratory values|0|||
94586693|NCT00441064|323950295|FG001|Overall Study|Abnormal laboratory values|2|||
94586694|NCT00441064|323950294|FG000|Overall Study|Abnormal test procedure results|0|||
94586695|NCT00441064|323950295|FG001|Overall Study|Abnormal test procedure results|1|||
94586696|NCT00441064|323950294|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94586697|NCT00441064|323950295|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94586698|NCT00441064|323950294|FG000|Overall Study|Protocol Deviation|3|||
94586699|NCT00441064|323950295|FG001|Overall Study|Protocol Deviation|2|||
94586700|NCT00441064|323950294|FG000|Overall Study|Patient withdrew consent|5|||
94659289|NCT01722331|324208015|FG004|Part 1|Lack of Efficacy|2|||
94586701|NCT00441064|323950295|FG001|Overall Study|Patient withdrew consent|2|||
94586702|NCT00035932|323950298|FG000|Overall Study|Adverse Event|10|||
94586703|NCT00035932|323950299|FG001|Overall Study|Adverse Event|9|||
94586704|NCT00035932|323950300|FG002|Overall Study|Adverse Event|9|||
94586705|NCT00035932|323950298|FG000|Overall Study|Death|0|||
94586706|NCT00035932|323950299|FG001|Overall Study|Death|0|||
94586707|NCT00035932|323950300|FG002|Overall Study|Death|1|||
94586708|NCT00035932|323950298|FG000|Overall Study|Disease Progression / Relapse|1|||
94586709|NCT00035932|323950299|FG001|Overall Study|Disease Progression / Relapse|1|||
94659290|NCT01722331|324208016|FG005|Part 1|Lack of Efficacy|0|||
94586710|NCT00035932|323950300|FG002|Overall Study|Disease Progression / Relapse|0|||
94586711|NCT00035932|323950298|FG000|Overall Study|Lost to Follow-up|4|||
94586712|NCT00035932|323950299|FG001|Overall Study|Lost to Follow-up|4|||
94586713|NCT00035932|323950300|FG002|Overall Study|Lost to Follow-up|3|||
94586714|NCT00035932|323950298|FG000|Overall Study|Noncompliance|6|||
94586715|NCT00035932|323950299|FG001|Overall Study|Noncompliance|7|||
94586716|NCT00035932|323950300|FG002|Overall Study|Noncompliance|6|||
94586717|NCT00035932|323950298|FG000|Overall Study|Protocol Violation While on Study|0|||
94586718|NCT00035932|323950299|FG001|Overall Study|Protocol Violation While on Study|1|||
94586719|NCT00035932|323950300|FG002|Overall Study|Protocol Violation While on Study|2|||
94586720|NCT00035932|323950298|FG000|Overall Study|Withdrawal by Subject|1|||
94586721|NCT00035932|323950299|FG001|Overall Study|Withdrawal by Subject|5|||
94586722|NCT00035932|323950300|FG002|Overall Study|Withdrawal by Subject|0|||
94586723|NCT00035932|323950298|FG000|Overall Study|Study Termination by Sponsor|1|||
94586724|NCT00035932|323950299|FG001|Overall Study|Study Termination by Sponsor|0|||
94586725|NCT00035932|323950300|FG002|Overall Study|Study Termination by Sponsor|0|||
94586726|NCT00035932|323950298|FG000|Overall Study|Lack of Efficacy|33|||
94586727|NCT00035932|323950299|FG001|Overall Study|Lack of Efficacy|33|||
94586728|NCT00035932|323950300|FG002|Overall Study|Lack of Efficacy|28|||
94586729|NCT01388335|323950301|FG000|Period 1|Progressive Disease|1|||
94586730|NCT01388335|323950301|FG000|Period 2|Progressive Disease|2|||
94586731|NCT01388335|323950301|FG000|Period 2|Sponsor Decision|1|||
94586732|NCT01388335|323950301|FG000|Safety Extension|Progressive Disease|7|||
94586733|NCT00670306|323950302|FG000|Overall Study|Adverse Event|8|||
94586734|NCT00670306|323950302|FG000|Overall Study|Lack of Efficacy|10|||
94586735|NCT00670306|323950302|FG000|Overall Study|Withdrawal by Subject|9|||
94586736|NCT00670306|323950302|FG000|Overall Study|Physician Decision|1|||
94586737|NCT00670306|323950302|FG000|Overall Study|Lost to Follow-up|8|||
94586738|NCT00670306|323950302|FG000|Overall Study|incl/excl criterias did not meet|19|||
94586739|NCT01932437|323950303|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
94586740|NCT01932437|323950304|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
94586741|NCT01932437|323950305|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
94586742|NCT01932437|323950306|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
94586743|NCT01932437|323950307|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
94586744|NCT01932437|323950308|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
94586745|NCT00478023|323950312|FG000|Overall Study|Adverse Event|11|||
94586746|NCT00478023|323950313|FG001|Overall Study|Adverse Event|7|||
94586747|NCT00478023|323950314|FG002|Overall Study|Adverse Event|8|||
94586748|NCT00478023|323950315|FG003|Overall Study|Adverse Event|14|||
94586749|NCT00478023|323950316|FG004|Overall Study|Adverse Event|6|||
94586750|NCT00478023|323950312|FG000|Overall Study|Death|1|||
94586751|NCT00478023|323950313|FG001|Overall Study|Death|0|||
94586752|NCT00478023|323950314|FG002|Overall Study|Death|0|||
94586753|NCT00478023|323950315|FG003|Overall Study|Death|0|||
94586754|NCT00478023|323950316|FG004|Overall Study|Death|0|||
94586755|NCT00478023|323950312|FG000|Overall Study|Lack of Efficacy|11|||
94586756|NCT00478023|323950313|FG001|Overall Study|Lack of Efficacy|10|||
94586757|NCT00478023|323950314|FG002|Overall Study|Lack of Efficacy|4|||
94586758|NCT00478023|323950315|FG003|Overall Study|Lack of Efficacy|5|||
94586759|NCT00478023|323950316|FG004|Overall Study|Lack of Efficacy|41|||
94586760|NCT00478023|323950312|FG000|Overall Study|Lost to Follow-up|3|||
94586761|NCT00478023|323950313|FG001|Overall Study|Lost to Follow-up|1|||
94586762|NCT00478023|323950314|FG002|Overall Study|Lost to Follow-up|1|||
94586763|NCT00478023|323950315|FG003|Overall Study|Lost to Follow-up|1|||
94586764|NCT00478023|323950316|FG004|Overall Study|Lost to Follow-up|0|||
94586765|NCT00478023|323950312|FG000|Overall Study|Withdrawal by Subject|2|||
94586766|NCT00478023|323950313|FG001|Overall Study|Withdrawal by Subject|3|||
94586767|NCT00478023|323950314|FG002|Overall Study|Withdrawal by Subject|2|||
94586768|NCT00478023|323950315|FG003|Overall Study|Withdrawal by Subject|4|||
94586769|NCT00478023|323950316|FG004|Overall Study|Withdrawal by Subject|5|||
94586770|NCT00478023|323950312|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
94586771|NCT00478023|323950313|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
94586772|NCT00478023|323950314|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
94586773|NCT00478023|323950315|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
94586774|NCT00478023|323950316|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
94586775|NCT02357368|323950319|FG000|Overall Study|Lost to Follow-up|0|||
94586776|NCT02357368|323950320|FG001|Overall Study|Lost to Follow-up|0|||
94586777|NCT02357368|323950321|FG002|Overall Study|Lost to Follow-up|0|||
94586778|NCT02357368|323950322|FG003|Overall Study|Lost to Follow-up|1|||
94586779|NCT02357368|323950319|FG000|Overall Study|Pregnancy|3|||
94586780|NCT02357368|323950320|FG001|Overall Study|Pregnancy|2|||
94586781|NCT02357368|323950321|FG002|Overall Study|Pregnancy|0|||
94586782|NCT02357368|323950322|FG003|Overall Study|Pregnancy|0|||
94586783|NCT02357368|323950319|FG000|Overall Study|Withdrawal by Subject|3|||
94586784|NCT02357368|323950320|FG001|Overall Study|Withdrawal by Subject|1|||
94586785|NCT02357368|323950321|FG002|Overall Study|Withdrawal by Subject|1|||
94586786|NCT02357368|323950322|FG003|Overall Study|Withdrawal by Subject|2|||
94586787|NCT01931566|323950325|FG000|Overall Study|Randomized But Not Treated|6|||
94586788|NCT01931566|323950326|FG001|Overall Study|Randomized But Not Treated|9|||
94586789|NCT01931566|323950327|FG002|Overall Study|Randomized But Not Treated|14|||
94586790|NCT01931566|323950325|FG000|Overall Study|Adverse Event|37|||
94586791|NCT01931566|323950326|FG001|Overall Study|Adverse Event|167|||
94586792|NCT01931566|323950327|FG002|Overall Study|Adverse Event|132|||
94586793|NCT01931566|323950325|FG000|Overall Study|Major Protocol Deviation|5|||
94586794|NCT01931566|323950326|FG001|Overall Study|Major Protocol Deviation|14|||
94586795|NCT01931566|323950327|FG002|Overall Study|Major Protocol Deviation|21|||
94586796|NCT01931566|323950325|FG000|Overall Study|Lost to Follow-up|3|||
94586797|NCT01931566|323950326|FG001|Overall Study|Lost to Follow-up|26|||
94586798|NCT01931566|323950327|FG002|Overall Study|Lost to Follow-up|23|||
94586799|NCT01931566|323950325|FG000|Overall Study|Voluntary Withdrawal|78|||
94586800|NCT01931566|323950326|FG001|Overall Study|Voluntary Withdrawal|245|||
94586801|NCT01931566|323950327|FG002|Overall Study|Voluntary Withdrawal|225|||
94586802|NCT01931566|323950325|FG000|Overall Study|Study Termination|289|||
94586803|NCT01931566|323950326|FG001|Overall Study|Study Termination|968|||
94586804|NCT01931566|323950327|FG002|Overall Study|Study Termination|1037|||
94586805|NCT01931566|323950325|FG000|Overall Study|Reason Not Specified|11|||
94586806|NCT01931566|323950326|FG001|Overall Study|Reason Not Specified|47|||
94586807|NCT01931566|323950327|FG002|Overall Study|Reason Not Specified|53|||
94586808|NCT01931566|323950325|FG000|Overall Study|Missing|0|||
94586809|NCT01931566|323950326|FG001|Overall Study|Missing|0|||
94586810|NCT01931566|323950327|FG002|Overall Study|Missing|1|||
94586811|NCT02817464|323950332|FG000|Overall Study|Lost to Follow-up|1|||
94586812|NCT02817464|323950333|FG001|Overall Study|Lost to Follow-up|0|||
94586813|NCT02817464|323950332|FG000|Overall Study|Discontinued early due to personal decision|1|||
94586814|NCT02817464|323950333|FG001|Overall Study|Discontinued early due to personal decision|1|||
94586815|NCT00885534|323950334|FG000|Overall Study|Patient deemed ineligible|1|||
94586816|NCT01273519|323950335|FG000|Overall Study|Adverse Event|3|||
94586817|NCT01273519|323950336|FG001|Overall Study|Adverse Event|0|||
94586818|NCT01273519|323950337|FG002|Overall Study|Adverse Event|0|||
94586819|NCT01273519|323950335|FG000|Overall Study|Lost to Follow-up|2|||
94586820|NCT01273519|323950336|FG001|Overall Study|Lost to Follow-up|1|||
94586821|NCT01273519|323950337|FG002|Overall Study|Lost to Follow-up|3|||
94586822|NCT01273519|323950335|FG000|Overall Study|Lack of Efficacy|8|||
94586823|NCT01273519|323950336|FG001|Overall Study|Lack of Efficacy|3|||
94586824|NCT01273519|323950337|FG002|Overall Study|Lack of Efficacy|4|||
94586825|NCT01273519|323950335|FG000|Overall Study|Other|6|||
94586826|NCT01273519|323950336|FG001|Overall Study|Other|1|||
94586827|NCT01273519|323950337|FG002|Overall Study|Other|1|||
94586828|NCT01262820|323950340|FG000|Overall Study|Adverse Event|5|||
94586829|NCT01262820|323950340|FG000|Overall Study|Lack of Efficacy|9|||
94586830|NCT01262820|323950340|FG000|Overall Study|Drug held for 21+ days|1|||
94586831|NCT00068419|323950342|FG000|Overall Study|Adverse Event|3|||
94586832|NCT00068419|323950342|FG000|Overall Study|Lack of Efficacy|24|||
94586833|NCT00068419|323950342|FG000|Overall Study|Lost to Follow-up|1|||
94586834|NCT00068419|323950342|FG000|Overall Study|Physician Decision|7|||
94586835|NCT00068419|323950342|FG000|Overall Study|Withdrawal by Subject|14|||
94586836|NCT00068419|323950342|FG000|Overall Study|Ineligible|11|||
94586837|NCT02447302|323950343|FG000|Overall Study|Physician Decision|1|||
94586838|NCT02447302|323950344|FG001|Overall Study|Physician Decision|0|||
94586839|NCT02447302|323950345|FG002|Overall Study|Physician Decision|0|||
94586840|NCT02447302|323950343|FG000|Overall Study|Adverse Event|4|||
94586841|NCT02447302|323950344|FG001|Overall Study|Adverse Event|3|||
94586842|NCT02447302|323950345|FG002|Overall Study|Adverse Event|0|||
94586843|NCT02447302|323950343|FG000|Overall Study|Withdrawal by Subject|0|||
94586844|NCT02447302|323950344|FG001|Overall Study|Withdrawal by Subject|1|||
94586845|NCT02447302|323950345|FG002|Overall Study|Withdrawal by Subject|5|||
94586846|NCT02447302|323950343|FG000|Overall Study|Sponsor Decision|0|||
94586847|NCT02447302|323950344|FG001|Overall Study|Sponsor Decision|0|||
94586848|NCT02447302|323950345|FG002|Overall Study|Sponsor Decision|1|||
94353601|NCT01072175|323077076|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
94455996|NCT02682823|323458152|FG004|Overall Study|Protocol Deviation|0|||
94586849|NCT00396253|323950359|FG000|Overall Study|Protocol Violation|1|||
94586850|NCT00396253|323950359|FG000|Overall Study|Withdrawal by Subject|7|||
94586851|NCT00396253|323950359|FG000|Overall Study|Death|3|||
94586852|NCT00396253|323950359|FG000|Overall Study|Physician Decision|1|||
94586853|NCT00396253|323950359|FG000|Overall Study|Change in eligibility status|1|||
94586854|NCT00314795|323950367|FG000|Overall Study|Adverse Event|8|||
94586855|NCT00314795|323950367|FG000|Overall Study|Death|4|||
94586856|NCT00314795|323950367|FG000|Overall Study|Reason not Specified|3|||
94586857|NCT00314795|323950367|FG000|Overall Study|Renal Transplant|3|||
94586858|NCT00314795|323950367|FG000|Overall Study|Participants Withdrew Consent|2|||
94586859|NCT01742286|323950368|FG000|Escalation Phase|Administrative problems|1|||
94586860|NCT01742286|323950369|FG001|Escalation Phase|Administrative problems|1|||
94586861|NCT01742286|323950370|FG002|Escalation Phase|Administrative problems|0|||
94586862|NCT01742286|323950371|FG003|Escalation Phase|Administrative problems|0|||
94586863|NCT01742286|323950372|FG004|Escalation Phase|Administrative problems|0|||
94586864|NCT01742286|323950373|FG005|Escalation Phase|Administrative problems|0|||
94586865|NCT01742286|323950374|FG006|Escalation Phase|Administrative problems|2|||
94586866|NCT01742286|323950368|FG000|Escalation Phase|Adverse Event|0|||
94586867|NCT01742286|323950369|FG001|Escalation Phase|Adverse Event|1|||
94586868|NCT01742286|323950370|FG002|Escalation Phase|Adverse Event|2|||
94586869|NCT01742286|323950371|FG003|Escalation Phase|Adverse Event|0|||
94586870|NCT01742286|323950372|FG004|Escalation Phase|Adverse Event|0|||
94586871|NCT01742286|323950373|FG005|Escalation Phase|Adverse Event|1|||
94586872|NCT01742286|323950374|FG006|Escalation Phase|Adverse Event|0|||
94586873|NCT01742286|323950368|FG000|Escalation Phase|Disease progression|3|||
94586874|NCT01742286|323950369|FG001|Escalation Phase|Disease progression|7|||
94586875|NCT01742286|323950370|FG002|Escalation Phase|Disease progression|4|||
94586876|NCT01742286|323950371|FG003|Escalation Phase|Disease progression|1|||
94586877|NCT01742286|323950372|FG004|Escalation Phase|Disease progression|4|||
94586878|NCT01742286|323950373|FG005|Escalation Phase|Disease progression|3|||
94586879|NCT01742286|323950374|FG006|Escalation Phase|Disease progression|2|||
94586880|NCT01742286|323950368|FG000|Escalation Phase|Death|0|||
94586881|NCT01742286|323950369|FG001|Escalation Phase|Death|0|||
94586882|NCT01742286|323950370|FG002|Escalation Phase|Death|0|||
94586883|NCT01742286|323950371|FG003|Escalation Phase|Death|0|||
94586884|NCT01742286|323950372|FG004|Escalation Phase|Death|0|||
94586885|NCT01742286|323950373|FG005|Escalation Phase|Death|1|||
94586886|NCT01742286|323950374|FG006|Escalation Phase|Death|0|||
94586887|NCT01742286|323950368|FG000|Escalation Phase|Physician Decision|0|||
94586888|NCT01742286|323950369|FG001|Escalation Phase|Physician Decision|3|||
94586889|NCT01742286|323950370|FG002|Escalation Phase|Physician Decision|0|||
94586890|NCT01742286|323950371|FG003|Escalation Phase|Physician Decision|1|||
94586891|NCT01742286|323950372|FG004|Escalation Phase|Physician Decision|0|||
94586892|NCT01742286|323950373|FG005|Escalation Phase|Physician Decision|0|||
94586893|NCT01742286|323950374|FG006|Escalation Phase|Physician Decision|2|||
94586894|NCT01742286|323950368|FG000|Escalation Phase|Subject/guardian decision|1|||
94586895|NCT01742286|323950369|FG001|Escalation Phase|Subject/guardian decision|0|||
94586896|NCT01742286|323950370|FG002|Escalation Phase|Subject/guardian decision|0|||
94586897|NCT01742286|323950371|FG003|Escalation Phase|Subject/guardian decision|0|||
94353602|NCT01072175|323077077|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
94353603|NCT01072175|323077078|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
94586898|NCT01742286|323950372|FG004|Escalation Phase|Subject/guardian decision|0|||
94455997|NCT02682823|323458148|FG000|Overall Study|Adverse Event|0|||
94586899|NCT01742286|323950373|FG005|Escalation Phase|Subject/guardian decision|0|||
94586900|NCT01742286|323950374|FG006|Escalation Phase|Subject/guardian decision|0|||
94586901|NCT01742286|323950368|FG000|Expansion Phase|Administrative problems|0|||
94586902|NCT01742286|323950369|FG001|Expansion Phase|Administrative problems|0|||
94586903|NCT01742286|323950370|FG002|Expansion Phase|Administrative problems|0|||
94586904|NCT01742286|323950371|FG003|Expansion Phase|Administrative problems|0|||
94586905|NCT01742286|323950372|FG004|Expansion Phase|Administrative problems|0|||
94586906|NCT01742286|323950373|FG005|Expansion Phase|Administrative problems|0|||
94586907|NCT01742286|323950374|FG006|Expansion Phase|Administrative problems|5|||
94586908|NCT01742286|323950368|FG000|Expansion Phase|Physician Decision|0|||
94586909|NCT01742286|323950369|FG001|Expansion Phase|Physician Decision|0|||
94586910|NCT01742286|323950370|FG002|Expansion Phase|Physician Decision|4|||
94586911|NCT01742286|323950371|FG003|Expansion Phase|Physician Decision|0|||
94586912|NCT01742286|323950372|FG004|Expansion Phase|Physician Decision|0|||
94586913|NCT01742286|323950373|FG005|Expansion Phase|Physician Decision|0|||
94586914|NCT01742286|323950374|FG006|Expansion Phase|Physician Decision|9|||
94586915|NCT01742286|323950368|FG000|Expansion Phase|Adverse Event|0|||
94586916|NCT01742286|323950369|FG001|Expansion Phase|Adverse Event|0|||
94586917|NCT01742286|323950370|FG002|Expansion Phase|Adverse Event|0|||
94586918|NCT01742286|323950371|FG003|Expansion Phase|Adverse Event|0|||
94586919|NCT01742286|323950372|FG004|Expansion Phase|Adverse Event|0|||
94586920|NCT01742286|323950373|FG005|Expansion Phase|Adverse Event|0|||
94586921|NCT01742286|323950374|FG006|Expansion Phase|Adverse Event|6|||
94586922|NCT01742286|323950368|FG000|Expansion Phase|Disease progression|0|||
94586923|NCT01742286|323950369|FG001|Expansion Phase|Disease progression|0|||
94586924|NCT01742286|323950370|FG002|Expansion Phase|Disease progression|3|||
94586925|NCT01742286|323950371|FG003|Expansion Phase|Disease progression|0|||
94586926|NCT01742286|323950372|FG004|Expansion Phase|Disease progression|0|||
94586927|NCT01742286|323950373|FG005|Expansion Phase|Disease progression|0|||
94586928|NCT01742286|323950374|FG006|Expansion Phase|Disease progression|15|||
94586929|NCT01742286|323950368|FG000|Expansion Phase|Withdrawal by Subject|0|||
94586930|NCT01742286|323950369|FG001|Expansion Phase|Withdrawal by Subject|0|||
94586931|NCT01742286|323950370|FG002|Expansion Phase|Withdrawal by Subject|0|||
94586932|NCT01742286|323950371|FG003|Expansion Phase|Withdrawal by Subject|0|||
94586933|NCT01742286|323950372|FG004|Expansion Phase|Withdrawal by Subject|0|||
94586934|NCT01742286|323950373|FG005|Expansion Phase|Withdrawal by Subject|0|||
94586935|NCT01742286|323950374|FG006|Expansion Phase|Withdrawal by Subject|1|||
94586936|NCT04717336|323950376|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
94586937|NCT04717336|323950377|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
94586938|NCT04717336|323950376|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
94586939|NCT04717336|323950377|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
94586940|NCT01324401|323950381|FG000|Overall Study|Withdrawn before any treatment|0|||
94586941|NCT01324401|323950382|FG001|Overall Study|Withdrawn before any treatment|3|||
94586942|NCT01324401|323950381|FG000|Overall Study|Adverse Event|1|||
94586943|NCT01324401|323950382|FG001|Overall Study|Adverse Event|3|||
94586944|NCT02624986|323950383|FG000|Overall Study|Death|0|||
94586945|NCT02624986|323950384|FG001|Overall Study|Death|1|||
94586946|NCT02624986|323950385|FG002|Overall Study|Death|2|||
94586947|NCT02624986|323950386|FG003|Overall Study|Death|2|||
94586948|NCT02624986|323950387|FG004|Overall Study|Death|2|||
94586949|NCT02624986|323950388|FG005|Overall Study|Death|0|||
94586950|NCT02624986|323950389|FG006|Overall Study|Death|0|||
94586951|NCT02624986|323950390|FG007|Overall Study|Death|1|||
94586952|NCT02624986|323950383|FG000|Overall Study|Study Terminated by Sponsor|1|||
94586953|NCT02624986|323950384|FG001|Overall Study|Study Terminated by Sponsor|1|||
94586954|NCT02624986|323950385|FG002|Overall Study|Study Terminated by Sponsor|0|||
94586955|NCT02624986|323950386|FG003|Overall Study|Study Terminated by Sponsor|1|||
94586956|NCT02624986|323950387|FG004|Overall Study|Study Terminated by Sponsor|2|||
94586957|NCT02624986|323950388|FG005|Overall Study|Study Terminated by Sponsor|2|||
94586958|NCT02624986|323950389|FG006|Overall Study|Study Terminated by Sponsor|4|||
94586959|NCT02624986|323950390|FG007|Overall Study|Study Terminated by Sponsor|3|||
94586960|NCT02624986|323950383|FG000|Overall Study|Progressive Disease|0|||
94586961|NCT02624986|323950384|FG001|Overall Study|Progressive Disease|1|||
94586962|NCT02624986|323950385|FG002|Overall Study|Progressive Disease|0|||
94586963|NCT02624986|323950386|FG003|Overall Study|Progressive Disease|0|||
94586964|NCT02624986|323950387|FG004|Overall Study|Progressive Disease|0|||
94586965|NCT02624986|323950388|FG005|Overall Study|Progressive Disease|0|||
94586966|NCT02624986|323950389|FG006|Overall Study|Progressive Disease|0|||
94586967|NCT02624986|323950390|FG007|Overall Study|Progressive Disease|0|||
94586968|NCT02624986|323950383|FG000|Overall Study|Protocol Violation|1|||
94586969|NCT02624986|323950384|FG001|Overall Study|Protocol Violation|0|||
94586970|NCT02624986|323950385|FG002|Overall Study|Protocol Violation|0|||
94586971|NCT02624986|323950386|FG003|Overall Study|Protocol Violation|0|||
94586972|NCT02624986|323950387|FG004|Overall Study|Protocol Violation|0|||
94586973|NCT02624986|323950388|FG005|Overall Study|Protocol Violation|0|||
94586974|NCT02624986|323950389|FG006|Overall Study|Protocol Violation|0|||
94586975|NCT02624986|323950390|FG007|Overall Study|Protocol Violation|0|||
94586976|NCT02624986|323950383|FG000|Overall Study|Withdrawal by Subject|0|||
94586977|NCT02624986|323950384|FG001|Overall Study|Withdrawal by Subject|0|||
94586978|NCT02624986|323950385|FG002|Overall Study|Withdrawal by Subject|0|||
94586979|NCT02624986|323950386|FG003|Overall Study|Withdrawal by Subject|0|||
94586980|NCT02624986|323950387|FG004|Overall Study|Withdrawal by Subject|0|||
94586981|NCT02624986|323950388|FG005|Overall Study|Withdrawal by Subject|0|||
94586982|NCT02624986|323950389|FG006|Overall Study|Withdrawal by Subject|0|||
94586983|NCT02624986|323950390|FG007|Overall Study|Withdrawal by Subject|1|||
94586984|NCT00740857|323950392|FG000|Overall Study|Withdrawal by Subject|1|||
94586985|NCT00740857|323950393|FG001|Overall Study|Withdrawal by Subject|0|||
94586986|NCT00740857|323950394|FG002|Overall Study|Withdrawal by Subject|0|||
94586987|NCT02633020|323950395|FG000|Overall Study|Adverse Event|1|||
94586988|NCT02633020|323950396|FG001|Overall Study|Adverse Event|0|||
94586989|NCT00530816|323950400|FG000|Overall Study|Progressive Disease|16|||
94586990|NCT00530816|323950401|FG001|Overall Study|Progressive Disease|24|||
94586991|NCT00530816|323950402|FG002|Overall Study|Progressive Disease|24|||
94586992|NCT00530816|323950400|FG000|Overall Study|Adverse Event|6|||
94586993|NCT00530816|323950401|FG001|Overall Study|Adverse Event|13|||
94586994|NCT00530816|323950402|FG002|Overall Study|Adverse Event|7|||
94586995|NCT00530816|323950400|FG000|Overall Study|Other|3|||
94586996|NCT00530816|323950401|FG001|Overall Study|Other|3|||
94586997|NCT00530816|323950402|FG002|Overall Study|Other|4|||
94586998|NCT00530816|323950400|FG000|Overall Study|Withdrawal by Subject|1|||
94586999|NCT00530816|323950401|FG001|Overall Study|Withdrawal by Subject|2|||
94587000|NCT00530816|323950402|FG002|Overall Study|Withdrawal by Subject|6|||
94587001|NCT01519167|323950405|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
94587002|NCT01519167|323950406|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
94587003|NCT01519167|323950405|FG000|Overall Study|Adverse Event|0|||
94587004|NCT01519167|323950406|FG001|Overall Study|Adverse Event|1|||
94587005|NCT01519167|323950405|FG000|Overall Study|Lack of Efficacy|0|||
94587006|NCT01519167|323950406|FG001|Overall Study|Lack of Efficacy|1|||
94587007|NCT01519167|323950405|FG000|Overall Study|Medical condition changes&deep sedation|0|||
94587008|NCT01519167|323950406|FG001|Overall Study|Medical condition changes&deep sedation|2|||
94587009|NCT01519167|323950405|FG000|Overall Study|Physician Decision|0|||
94587010|NCT01519167|323950406|FG001|Overall Study|Physician Decision|1|||
94587011|NCT02541604|323950409|FG000|Overall Study|Death|6|||
94587012|NCT02541604|323950410|FG001|Overall Study|Death|5|||
94587013|NCT02541604|323950411|FG002|Overall Study|Death|7|||
94587014|NCT02541604|323950412|FG003|Overall Study|Death|2|||
94587015|NCT02541604|323950413|FG004|Overall Study|Death|9|||
94587016|NCT02541604|323950414|FG005|Overall Study|Death|8|||
94587017|NCT02541604|323950415|FG006|Overall Study|Death|9|||
94587018|NCT02541604|323950416|FG007|Overall Study|Death|9|||
94587019|NCT02541604|323950417|FG008|Overall Study|Death|3|||
94587020|NCT02541604|323950418|FG009|Overall Study|Death|4|||
94587021|NCT02541604|323950419|FG010|Overall Study|Death|2|||
94587022|NCT02541604|323950420|FG011|Overall Study|Death|3|||
94587023|NCT02541604|323950409|FG000|Overall Study|Lost to Follow-up|2|||
94587024|NCT02541604|323950410|FG001|Overall Study|Lost to Follow-up|0|||
94587025|NCT02541604|323950411|FG002|Overall Study|Lost to Follow-up|1|||
94587026|NCT02541604|323950412|FG003|Overall Study|Lost to Follow-up|0|||
94587027|NCT02541604|323950413|FG004|Overall Study|Lost to Follow-up|0|||
94587028|NCT02541604|323950414|FG005|Overall Study|Lost to Follow-up|1|||
94587029|NCT02541604|323950415|FG006|Overall Study|Lost to Follow-up|1|||
94587030|NCT02541604|323950416|FG007|Overall Study|Lost to Follow-up|0|||
94587031|NCT02541604|323950417|FG008|Overall Study|Lost to Follow-up|0|||
94587032|NCT02541604|323950418|FG009|Overall Study|Lost to Follow-up|0|||
94587033|NCT02541604|323950419|FG010|Overall Study|Lost to Follow-up|0|||
94587034|NCT02541604|323950420|FG011|Overall Study|Lost to Follow-up|0|||
94587035|NCT02541604|323950409|FG000|Overall Study|Withdrawal by Subject|2|||
94587036|NCT02541604|323950410|FG001|Overall Study|Withdrawal by Subject|0|||
94587037|NCT02541604|323950411|FG002|Overall Study|Withdrawal by Subject|1|||
94587038|NCT02541604|323950412|FG003|Overall Study|Withdrawal by Subject|0|||
94587039|NCT02541604|323950413|FG004|Overall Study|Withdrawal by Subject|1|||
94587040|NCT02541604|323950414|FG005|Overall Study|Withdrawal by Subject|1|||
94587041|NCT02541604|323950415|FG006|Overall Study|Withdrawal by Subject|0|||
94587042|NCT02541604|323950416|FG007|Overall Study|Withdrawal by Subject|0|||
94587043|NCT02541604|323950417|FG008|Overall Study|Withdrawal by Subject|1|||
94587044|NCT02541604|323950418|FG009|Overall Study|Withdrawal by Subject|0|||
94587045|NCT02541604|323950419|FG010|Overall Study|Withdrawal by Subject|0|||
94587046|NCT02541604|323950420|FG011|Overall Study|Withdrawal by Subject|0|||
94587047|NCT02541604|323950409|FG000|Overall Study|Study Terminated by Sponsor|1|||
94587048|NCT02541604|323950410|FG001|Overall Study|Study Terminated by Sponsor|4|||
94587049|NCT02541604|323950411|FG002|Overall Study|Study Terminated by Sponsor|2|||
94587050|NCT02541604|323950412|FG003|Overall Study|Study Terminated by Sponsor|1|||
94587051|NCT02541604|323950413|FG004|Overall Study|Study Terminated by Sponsor|0|||
94587052|NCT02541604|323950414|FG005|Overall Study|Study Terminated by Sponsor|0|||
94587053|NCT02541604|323950415|FG006|Overall Study|Study Terminated by Sponsor|0|||
94587054|NCT02541604|323950416|FG007|Overall Study|Study Terminated by Sponsor|0|||
94587055|NCT02541604|323950417|FG008|Overall Study|Study Terminated by Sponsor|0|||
94587056|NCT02541604|323950418|FG009|Overall Study|Study Terminated by Sponsor|0|||
94587057|NCT02541604|323950419|FG010|Overall Study|Study Terminated by Sponsor|0|||
94587058|NCT02541604|323950420|FG011|Overall Study|Study Terminated by Sponsor|0|||
94587059|NCT02541604|323950409|FG000|Overall Study|Medical condition may jeopardize safety|0|||
94587060|NCT02541604|323950410|FG001|Overall Study|Medical condition may jeopardize safety|0|||
94587061|NCT02541604|323950411|FG002|Overall Study|Medical condition may jeopardize safety|0|||
94587062|NCT02541604|323950412|FG003|Overall Study|Medical condition may jeopardize safety|0|||
94587063|NCT02541604|323950413|FG004|Overall Study|Medical condition may jeopardize safety|0|||
94587064|NCT02541604|323950414|FG005|Overall Study|Medical condition may jeopardize safety|0|||
94587065|NCT02541604|323950415|FG006|Overall Study|Medical condition may jeopardize safety|0|||
94587066|NCT02541604|323950416|FG007|Overall Study|Medical condition may jeopardize safety|1|||
94587067|NCT02541604|323950417|FG008|Overall Study|Medical condition may jeopardize safety|0|||
94587068|NCT02541604|323950418|FG009|Overall Study|Medical condition may jeopardize safety|0|||
94587069|NCT02541604|323950419|FG010|Overall Study|Medical condition may jeopardize safety|0|||
94587070|NCT02541604|323950420|FG011|Overall Study|Medical condition may jeopardize safety|0|||
94587071|NCT00993148|323950421|FG000|Overall Study|Lost to Follow-up|2|||
94587072|NCT00993148|323950421|FG000|Overall Study|never initiated treatment|1|||
94587073|NCT02302339|323950424|FG000|Overall Study|Lost to Follow-up|1|||
94587074|NCT02302339|323950425|FG001|Overall Study|Lost to Follow-up|0|||
94587075|NCT02302339|323950426|FG002|Overall Study|Lost to Follow-up|0|||
94587076|NCT02302339|323950427|FG003|Overall Study|Lost to Follow-up|0|||
94587077|NCT02302339|323950424|FG000|Overall Study|Withdrawal by Subject|0|||
94587078|NCT02302339|323950425|FG001|Overall Study|Withdrawal by Subject|2|||
94587079|NCT02302339|323950426|FG002|Overall Study|Withdrawal by Subject|1|||
94587080|NCT02302339|323950427|FG003|Overall Study|Withdrawal by Subject|0|||
94587081|NCT00334113|323950433|FG000|Overall Study|Lost to Follow-up|2|||
94587082|NCT00334113|323950434|FG001|Overall Study|Lost to Follow-up|2|||
94587083|NCT00334113|323950433|FG000|Overall Study|Withdrawal by Subject|0|||
94587084|NCT00334113|323950434|FG001|Overall Study|Withdrawal by Subject|1|||
94587085|NCT01615029|323950436|FG000|Overall Study|Adverse Event|0|||
94587086|NCT01615029|323950437|FG001|Overall Study|Adverse Event|0|||
94587087|NCT01615029|323950438|FG002|Overall Study|Adverse Event|0|||
94587088|NCT01615029|323950439|FG003|Overall Study|Adverse Event|0|||
94587089|NCT01615029|323950440|FG004|Overall Study|Adverse Event|1|||
94587090|NCT01615029|323950436|FG000|Overall Study|Death|0|||
94587091|NCT01615029|323950437|FG001|Overall Study|Death|0|||
94587092|NCT01615029|323950438|FG002|Overall Study|Death|0|||
94587093|NCT01615029|323950439|FG003|Overall Study|Death|0|||
94587094|NCT01615029|323950440|FG004|Overall Study|Death|1|||
94587095|NCT01615029|323950436|FG000|Overall Study|Lost to Follow-up|0|||
94587096|NCT01615029|323950437|FG001|Overall Study|Lost to Follow-up|0|||
94587097|NCT01615029|323950438|FG002|Overall Study|Lost to Follow-up|0|||
94587098|NCT01615029|323950439|FG003|Overall Study|Lost to Follow-up|0|||
94587099|NCT01615029|323950440|FG004|Overall Study|Lost to Follow-up|1|||
94587100|NCT01615029|323950436|FG000|Overall Study|Progressive disease|2|||
94587101|NCT01615029|323950437|FG001|Overall Study|Progressive disease|1|||
94587102|NCT01615029|323950438|FG002|Overall Study|Progressive disease|1|||
94455998|NCT02682823|323458149|FG001|Overall Study|Adverse Event|0|||
94455999|NCT02682823|323458150|FG002|Overall Study|Adverse Event|0|||
94456000|NCT02682823|323458151|FG003|Overall Study|Adverse Event|1|||
94456001|NCT02682823|323458152|FG004|Overall Study|Adverse Event|0|||
94456002|NCT00723008|323458153|FG000|Enrollment|Lost to Follow-up|1|||
94456003|NCT00723008|323458154|FG001|Enrollment|Lost to Follow-up|0|||
94456004|NCT00723008|323458153|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
94456005|NCT00723008|323458154|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
94456006|NCT00723008|323458153|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
94456007|NCT00723008|323458154|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
94456008|NCT00723008|323458153|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
94456009|NCT00723008|323458154|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
94456010|NCT00723008|323458153|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
94456011|NCT00723008|323458154|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
94587103|NCT01615029|323950439|FG003|Overall Study|Progressive disease|1|||
94587104|NCT01615029|323950440|FG004|Overall Study|Progressive disease|5|||
94587105|NCT01615029|323950436|FG000|Overall Study|Physician Decision|0|||
94587106|NCT01615029|323950437|FG001|Overall Study|Physician Decision|0|||
94456012|NCT00723008|323458153|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
94456013|NCT00723008|323458154|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
94587107|NCT01615029|323950438|FG002|Overall Study|Physician Decision|0|||
94587108|NCT01615029|323950439|FG003|Overall Study|Physician Decision|0|||
94587109|NCT01615029|323950440|FG004|Overall Study|Physician Decision|1|||
94587110|NCT01615029|323950436|FG000|Overall Study|Ongoing|1|||
94587111|NCT01615029|323950437|FG001|Overall Study|Ongoing|2|||
94587112|NCT01615029|323950438|FG002|Overall Study|Ongoing|3|||
94587113|NCT01615029|323950439|FG003|Overall Study|Ongoing|2|||
94587114|NCT01615029|323950440|FG004|Overall Study|Ongoing|23|||
94587115|NCT01326104|323950441|FG000|Overall Study|progressed prior to vaccine|0|||
94587116|NCT01326104|323950442|FG001|Overall Study|progressed prior to vaccine|2|||
94587117|NCT01326104|323950441|FG000|Overall Study|unable to make vaccine|0|||
94587118|NCT01326104|323950442|FG001|Overall Study|unable to make vaccine|2|||
94587119|NCT01287741|323950443|FG000|Overall Study|Withdrawal by Subject|35|||
94587120|NCT01287741|323950444|FG001|Overall Study|Withdrawal by Subject|38|||
94587121|NCT01287741|323950443|FG000|Overall Study|Protocol Violation|2|||
94587122|NCT01287741|323950444|FG001|Overall Study|Protocol Violation|0|||
94587123|NCT01287741|323950443|FG000|Overall Study|Physician Decision|15|||
94587124|NCT01287741|323950444|FG001|Overall Study|Physician Decision|23|||
94587125|NCT01287741|323950443|FG000|Overall Study|Non-compliance|8|||
94587126|NCT01287741|323950444|FG001|Overall Study|Non-compliance|6|||
94587127|NCT01287741|323950443|FG000|Overall Study|Lost to Follow-up|10|||
94587128|NCT01287741|323950444|FG001|Overall Study|Lost to Follow-up|8|||
94587129|NCT01287741|323950443|FG000|Overall Study|Death|32|||
94587130|NCT01287741|323950444|FG001|Overall Study|Death|44|||
94587131|NCT01287741|323950443|FG000|Overall Study|Adverse Event|4|||
94587132|NCT01287741|323950444|FG001|Overall Study|Adverse Event|6|||
94587133|NCT01287741|323950443|FG000|Overall Study|Study terminated by Sponsor|307|||
94587134|NCT01287741|323950444|FG001|Overall Study|Study terminated by Sponsor|315|||
94587135|NCT01287741|323950443|FG000|Overall Study|Progressive disease|190|||
94587136|NCT01287741|323950444|FG001|Overall Study|Progressive disease|166|||
94587137|NCT01287741|323950443|FG000|Overall Study|Reason not specified|23|||
94587138|NCT01287741|323950444|FG001|Overall Study|Reason not specified|9|||
94587139|NCT05307692|323950447|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
94587140|NCT05307692|323950448|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
94587141|NCT05307692|323950449|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
94587142|NCT05307692|323950450|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
94587143|NCT05307692|323950447|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
94587144|NCT05307692|323950448|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
94587145|NCT05307692|323950449|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
94587146|NCT05307692|323950450|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
94587147|NCT05307692|323950447|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
94587148|NCT05307692|323950448|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
94587149|NCT05307692|323950449|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
94587150|NCT05307692|323950450|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
94587151|NCT05307692|323950447|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
94587152|NCT05307692|323950448|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
94587153|NCT05307692|323950449|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
94587154|NCT05307692|323950450|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
94587155|NCT05307692|323950447|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
94587156|NCT05307692|323950448|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
94587157|NCT05307692|323950449|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
94587158|NCT05307692|323950450|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
94587159|NCT05307692|323950447|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
94587160|NCT05307692|323950448|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
94587161|NCT05307692|323950449|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
94587162|NCT05307692|323950450|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
94587163|NCT05307692|323950447|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
94587164|NCT05307692|323950448|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
94587165|NCT05307692|323950449|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
94587166|NCT05307692|323950450|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
94587167|NCT05307692|323950447|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
94587168|NCT05307692|323950448|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
94587169|NCT05307692|323950449|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
94587170|NCT05307692|323950450|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
94587171|NCT05601544|323950451|FG000|Phase 2 Period 1|Adverse Event|0|||
94587172|NCT05601544|323950452|FG001|Phase 2 Period 1|Adverse Event|1|||
94587173|NCT05601544|323950453|FG002|Phase 2 Period 1|Adverse Event|0|||
94587174|NCT05601544|323950454|FG003|Phase 2 Period 1|Adverse Event|0|||
94587175|NCT05601544|323950455|FG004|Phase 2 Period 1|Adverse Event|0|||
94587176|NCT05601544|323950456|FG005|Phase 2 Period 1|Adverse Event|0|||
94587177|NCT02970942|323950457|FG000|Overall Study|Death|0|||
94587178|NCT02970942|323950458|FG001|Overall Study|Death|1|||
94587179|NCT02970942|323950459|FG002|Overall Study|Death|0|||
94587180|NCT02970942|323950460|FG003|Overall Study|Death|0|||
94587181|NCT02970942|323950457|FG000|Overall Study|Lost to Follow-up|1|||
94587182|NCT02970942|323950458|FG001|Overall Study|Lost to Follow-up|0|||
94587183|NCT02970942|323950459|FG002|Overall Study|Lost to Follow-up|2|||
94587184|NCT02970942|323950460|FG003|Overall Study|Lost to Follow-up|1|||
94587185|NCT02970942|323950457|FG000|Overall Study|Withdrawal by Subject|3|||
94587186|NCT02970942|323950458|FG001|Overall Study|Withdrawal by Subject|5|||
94587187|NCT02970942|323950459|FG002|Overall Study|Withdrawal by Subject|3|||
94659291|NCT01722331|324208017|FG006|Part 1|Lack of Efficacy|0|||
94659292|NCT01722331|324208011|FG000|Part 1|Lost to Follow-up|1|||
94659293|NCT01722331|324208012|FG001|Part 1|Lost to Follow-up|0|||
94659294|NCT01722331|324208013|FG002|Part 1|Lost to Follow-up|2|||
94659295|NCT01722331|324208014|FG003|Part 1|Lost to Follow-up|0|||
94659296|NCT01722331|324208015|FG004|Part 1|Lost to Follow-up|1|||
94587188|NCT02970942|323950460|FG003|Overall Study|Withdrawal by Subject|2|||
94587189|NCT00702715|323952100|FG000|Overall Study|Lost to Follow-up|1|||
94587190|NCT00702715|323952101|FG001|Overall Study|Lost to Follow-up|0|||
94587191|NCT04040933|323952102|FG000|Overall Study|Protocol Violation|1|||
94587192|NCT04040933|323952102|FG000|Overall Study|Withdrawal by Subject|2|||
94587193|NCT01677377|323952111|FG000|Overall Study|Protocol Violation|1|||
94587194|NCT01677377|323952112|FG001|Overall Study|Protocol Violation|0|||
94587195|NCT01677377|323952113|FG002|Overall Study|Protocol Violation|0|||
94587196|NCT01677377|323952111|FG000|Overall Study|Lost to Follow-up|0|||
94587197|NCT01677377|323952112|FG001|Overall Study|Lost to Follow-up|1|||
94587198|NCT01677377|323952113|FG002|Overall Study|Lost to Follow-up|1|||
94587199|NCT01677377|323952111|FG000|Overall Study|Withdrawal by Subject|0|||
94587200|NCT01677377|323952112|FG001|Overall Study|Withdrawal by Subject|0|||
94587201|NCT01677377|323952113|FG002|Overall Study|Withdrawal by Subject|3|||
94587202|NCT01677377|323952111|FG000|Overall Study|Lack of Efficacy|0|||
94587203|NCT01677377|323952112|FG001|Overall Study|Lack of Efficacy|0|||
94587204|NCT01677377|323952113|FG002|Overall Study|Lack of Efficacy|1|||
94587205|NCT01677377|323952111|FG000|Overall Study|Pregnancy|0|||
94587206|NCT01677377|323952112|FG001|Overall Study|Pregnancy|0|||
94587207|NCT01677377|323952113|FG002|Overall Study|Pregnancy|1|||
94587208|NCT01354899|323952114|FG000|Overall Study|discharge from the hospital|2|||
94587209|NCT01354899|323952114|FG000|Overall Study|Protocol Violation|1|||
94587210|NCT01071798|323952115|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
94587211|NCT01071798|323952115|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
94587212|NCT01071798|323952115|FG000|Participants Who Received One Cycle|Patient requirement|20|||
94587213|NCT01071798|323952115|FG000|Participants Who Received One Cycle|Death|5|||
94587214|NCT01071798|323952115|FG000|Participants Who Received One Cycle|Change of therapy|6|||
94587215|NCT01071798|323952115|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
94587216|NCT01071798|323952115|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
94587217|NCT01071798|323952115|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
94587218|NCT01071798|323952115|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
94587219|NCT01071798|323952115|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
94587220|NCT00796419|323952117|FG000|Overall Study|Death|0|||
94587221|NCT00796419|323952118|FG001|Overall Study|Death|1|||
94587222|NCT03180840|323952119|FG000|Overall Study|Withdrawal by Subject|1|||
94587223|NCT00950859|323952123|FG000|Overall Study|Adverse Event|3|||
94587224|NCT00950859|323952124|FG001|Overall Study|Adverse Event|3|||
94659297|NCT01722331|324208016|FG005|Part 1|Lost to Follow-up|0|||
94659298|NCT01722331|324208017|FG006|Part 1|Lost to Follow-up|0|||
94659299|NCT01722331|324208011|FG000|Part 1|Physician Decision|0|||
94659300|NCT01722331|324208012|FG001|Part 1|Physician Decision|0|||
94587225|NCT00950859|323952123|FG000|Overall Study|Insufficient Viral Load Response|12|||
94587226|NCT00950859|323952124|FG001|Overall Study|Insufficient Viral Load Response|3|||
94659301|NCT01722331|324208013|FG002|Part 1|Physician Decision|3|||
94659302|NCT01722331|324208014|FG003|Part 1|Physician Decision|0|||
94659303|NCT01722331|324208015|FG004|Part 1|Physician Decision|1|||
94659304|NCT01722331|324208016|FG005|Part 1|Physician Decision|0|||
94587227|NCT00950859|323952123|FG000|Overall Study|Protocol Violation|1|||
94587228|NCT00950859|323952124|FG001|Overall Study|Protocol Violation|1|||
94587229|NCT00950859|323952123|FG000|Overall Study|Lost to Follow-up|0|||
94587230|NCT00950859|323952124|FG001|Overall Study|Lost to Follow-up|3|||
94587231|NCT00423917|323952129|FG000|Overall Study|Cancel|2|||
94587232|NCT00423917|323952129|FG000|Overall Study|Ineligible|1|||
94587233|NCT01358721|323952130|FG000|Overall Study|Withdrawal by Subject|0|||
94587234|NCT01358721|323952131|FG001|Overall Study|Withdrawal by Subject|0|||
94659305|NCT01722331|324208017|FG006|Part 1|Physician Decision|0|||
94659306|NCT01722331|324208011|FG000|Part 1|Pregnancy|1|||
94659307|NCT01722331|324208012|FG001|Part 1|Pregnancy|0|||
94659308|NCT01722331|324208013|FG002|Part 1|Pregnancy|0|||
94659309|NCT01722331|324208014|FG003|Part 1|Pregnancy|0|||
94659310|NCT01722331|324208015|FG004|Part 1|Pregnancy|0|||
94659311|NCT01722331|324208016|FG005|Part 1|Pregnancy|0|||
94659312|NCT01722331|324208017|FG006|Part 1|Pregnancy|0|||
94659313|NCT01722331|324208011|FG000|Part 1|Progressive Disease|0|||
94587235|NCT01358721|323952132|FG002|Overall Study|Withdrawal by Subject|0|||
94587236|NCT01358721|323952133|FG003|Overall Study|Withdrawal by Subject|1|||
94587237|NCT01358721|323952130|FG000|Overall Study|Death|0|||
94587238|NCT01358721|323952131|FG001|Overall Study|Death|2|||
94587239|NCT01358721|323952132|FG002|Overall Study|Death|0|||
94587240|NCT01358721|323952133|FG003|Overall Study|Death|0|||
94587241|NCT01358721|323952130|FG000|Overall Study|Study Drug Toxicity|1|||
94587242|NCT01358721|323952131|FG001|Overall Study|Study Drug Toxicity|3|||
94587243|NCT01358721|323952132|FG002|Overall Study|Study Drug Toxicity|4|||
94587244|NCT01358721|323952133|FG003|Overall Study|Study Drug Toxicity|5|||
94587245|NCT01358721|323952130|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
94587246|NCT01358721|323952131|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
94587247|NCT01358721|323952132|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
94587248|NCT01358721|323952133|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
94587249|NCT01358721|323952130|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
94587250|NCT01358721|323952131|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
94587251|NCT01358721|323952132|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
94587252|NCT01358721|323952133|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
94587253|NCT01358721|323952130|FG000|Overall Study|Adverse Event related to study drug|1|||
94587254|NCT01358721|323952131|FG001|Overall Study|Adverse Event related to study drug|0|||
94587255|NCT01358721|323952132|FG002|Overall Study|Adverse Event related to study drug|0|||
94587256|NCT01358721|323952133|FG003|Overall Study|Adverse Event related to study drug|1|||
94587257|NCT01358721|323952130|FG000|Overall Study|Disease Progression|19|||
94587258|NCT01358721|323952131|FG001|Overall Study|Disease Progression|15|||
94587259|NCT01358721|323952132|FG002|Overall Study|Disease Progression|17|||
94587260|NCT01358721|323952133|FG003|Overall Study|Disease Progression|15|||
94587261|NCT01358721|323952130|FG000|Overall Study|Out of State/Unmet Criteria|0|||
94587262|NCT01358721|323952131|FG001|Overall Study|Out of State/Unmet Criteria|0|||
94587263|NCT01358721|323952132|FG002|Overall Study|Out of State/Unmet Criteria|1|||
94587264|NCT01358721|323952133|FG003|Overall Study|Out of State/Unmet Criteria|0|||
94587265|NCT00485134|323952136|FG000|Overall Study|Lost to Follow-up|1|||
94587266|NCT00485134|323952137|FG001|Overall Study|Lost to Follow-up|0|||
94587267|NCT00485134|323952138|FG002|Overall Study|Lost to Follow-up|0|||
94587268|NCT00485134|323952139|FG003|Overall Study|Lost to Follow-up|0|||
94587269|NCT00485134|323952140|FG004|Overall Study|Lost to Follow-up|0|||
94587270|NCT00485134|323952141|FG005|Overall Study|Lost to Follow-up|0|||
94587271|NCT00485134|323952142|FG006|Overall Study|Lost to Follow-up|0|||
94587272|NCT00485134|323952143|FG007|Overall Study|Lost to Follow-up|0|||
94587273|NCT00485134|323952136|FG000|Overall Study|Withdrawal by Subject|0|||
94587274|NCT00485134|323952137|FG001|Overall Study|Withdrawal by Subject|1|||
94587275|NCT00485134|323952138|FG002|Overall Study|Withdrawal by Subject|0|||
94587276|NCT00485134|323952139|FG003|Overall Study|Withdrawal by Subject|0|||
94587277|NCT00485134|323952140|FG004|Overall Study|Withdrawal by Subject|0|||
94587278|NCT00485134|323952141|FG005|Overall Study|Withdrawal by Subject|0|||
94587279|NCT00485134|323952142|FG006|Overall Study|Withdrawal by Subject|0|||
94587280|NCT00485134|323952143|FG007|Overall Study|Withdrawal by Subject|0|||
94587281|NCT00485134|323952136|FG000|Overall Study|Change in health status|0|||
94587282|NCT00485134|323952137|FG001|Overall Study|Change in health status|1|||
94587283|NCT00485134|323952138|FG002|Overall Study|Change in health status|2|||
94587284|NCT00485134|323952139|FG003|Overall Study|Change in health status|1|||
94456014|NCT00886743|323458157|FG000|Overall Study|Adverse Event|3|||
94587285|NCT00485134|323952140|FG004|Overall Study|Change in health status|0|||
94587286|NCT00485134|323952141|FG005|Overall Study|Change in health status|1|||
94587287|NCT00485134|323952142|FG006|Overall Study|Change in health status|0|||
94587288|NCT00485134|323952143|FG007|Overall Study|Change in health status|0|||
94587289|NCT00485134|323952136|FG000|Overall Study|Withdrew for adverse event|0|||
94587290|NCT00485134|323952137|FG001|Overall Study|Withdrew for adverse event|0|||
94587291|NCT00485134|323952138|FG002|Overall Study|Withdrew for adverse event|1|||
94587292|NCT00485134|323952139|FG003|Overall Study|Withdrew for adverse event|0|||
94587293|NCT00485134|323952140|FG004|Overall Study|Withdrew for adverse event|0|||
94587294|NCT00485134|323952141|FG005|Overall Study|Withdrew for adverse event|0|||
94587295|NCT00485134|323952142|FG006|Overall Study|Withdrew for adverse event|0|||
94587296|NCT00485134|323952143|FG007|Overall Study|Withdrew for adverse event|0|||
94587297|NCT00485134|323952136|FG000|Overall Study|Positive drug test|0|||
94587298|NCT00485134|323952137|FG001|Overall Study|Positive drug test|0|||
94587299|NCT00485134|323952138|FG002|Overall Study|Positive drug test|0|||
94587300|NCT00485134|323952139|FG003|Overall Study|Positive drug test|0|||
94587301|NCT00485134|323952140|FG004|Overall Study|Positive drug test|2|||
94587302|NCT00485134|323952141|FG005|Overall Study|Positive drug test|1|||
94587303|NCT00485134|323952142|FG006|Overall Study|Positive drug test|0|||
94587304|NCT00485134|323952143|FG007|Overall Study|Positive drug test|0|||
94587305|NCT00485134|323952136|FG000|Overall Study|Non-compliance|0|||
94587306|NCT00485134|323952137|FG001|Overall Study|Non-compliance|0|||
94587307|NCT00485134|323952138|FG002|Overall Study|Non-compliance|0|||
94587308|NCT00485134|323952139|FG003|Overall Study|Non-compliance|0|||
94587309|NCT00485134|323952140|FG004|Overall Study|Non-compliance|1|||
94587310|NCT00485134|323952141|FG005|Overall Study|Non-compliance|2|||
94587311|NCT00485134|323952142|FG006|Overall Study|Non-compliance|2|||
94587312|NCT00485134|323952143|FG007|Overall Study|Non-compliance|0|||
94587313|NCT00485134|323952136|FG000|Overall Study|Unable to comply with study schedule|0|||
94587314|NCT00485134|323952137|FG001|Overall Study|Unable to comply with study schedule|0|||
94587315|NCT00485134|323952138|FG002|Overall Study|Unable to comply with study schedule|0|||
94587316|NCT00485134|323952139|FG003|Overall Study|Unable to comply with study schedule|0|||
94587317|NCT00485134|323952140|FG004|Overall Study|Unable to comply with study schedule|0|||
94587318|NCT00485134|323952141|FG005|Overall Study|Unable to comply with study schedule|0|||
94587319|NCT00485134|323952142|FG006|Overall Study|Unable to comply with study schedule|0|||
94587320|NCT00485134|323952143|FG007|Overall Study|Unable to comply with study schedule|1|||
94587321|NCT00485134|323952136|FG000|Overall Study|Pregnancy|0|||
94587322|NCT00485134|323952137|FG001|Overall Study|Pregnancy|0|||
94587323|NCT00485134|323952138|FG002|Overall Study|Pregnancy|0|||
94587324|NCT00485134|323952139|FG003|Overall Study|Pregnancy|0|||
94587325|NCT00485134|323952140|FG004|Overall Study|Pregnancy|0|||
94587326|NCT00485134|323952141|FG005|Overall Study|Pregnancy|0|||
94587327|NCT00485134|323952142|FG006|Overall Study|Pregnancy|1|||
94587328|NCT00485134|323952143|FG007|Overall Study|Pregnancy|0|||
94587329|NCT04455815|323952145|FG000|Randomisation Phase|Adverse Event|1|||
94587330|NCT04455815|323952146|FG001|Randomisation Phase|Adverse Event|0|||
94587331|NCT04455815|323952145|FG000|Treatment Phase|Adverse Event|0|||
94587332|NCT04455815|323952146|FG001|Treatment Phase|Adverse Event|1|||
94587333|NCT04455815|323952145|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
94587334|NCT04455815|323952146|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
94587335|NCT04455815|323952145|FG000|Treatment Phase|Withdrawal by Subject|1|||
94587336|NCT04455815|323952146|FG001|Treatment Phase|Withdrawal by Subject|1|||
94587337|NCT00241839|323952147|FG000|Overall Study|Withdrawal by Subject|18|||
94587338|NCT00241839|323952148|FG001|Overall Study|Withdrawal by Subject|17|||
94587339|NCT00241839|323952147|FG000|Overall Study|Adverse Event|1|||
94587340|NCT00241839|323952148|FG001|Overall Study|Adverse Event|1|||
94587341|NCT03860259|323952153|FG000|Overall Study|Lost to Follow-up|5|||
94587342|NCT03860259|323952154|FG001|Overall Study|Lost to Follow-up|5|||
94587343|NCT03860259|323952153|FG000|Overall Study|Protocol Violation|1|||
94587344|NCT03860259|323952154|FG001|Overall Study|Protocol Violation|0|||
94587345|NCT00380367|323952155|FG000|Overall Study|Lost to Follow-up|1|||
94587346|NCT00380367|323952155|FG000|Overall Study|Withdrawal by Subject|1|||
94587347|NCT01262989|323952158|FG000|Period 1|Lost to Follow-up|1|||
94587348|NCT01262989|323952159|FG001|Period 1|Lost to Follow-up|1|||
94587349|NCT01262989|323952158|FG000|Period 1|Intercurrent disease|0|||
94587350|NCT01262989|323952159|FG001|Period 1|Intercurrent disease|1|||
94587351|NCT01262989|323952158|FG000|Period 1|Positive answer for exclusion criteria|0|||
94587352|NCT01262989|323952159|FG001|Period 1|Positive answer for exclusion criteria|1|||
94587353|NCT01262989|323952158|FG000|Period 2|Intercurrent disease|0|||
94587354|NCT01262989|323952159|FG001|Period 2|Intercurrent disease|1|||
94587355|NCT03710083|323952160|FG000|Overall Study|Withdrawal by Subject|2|||
94587356|NCT03710083|323952160|FG000|Overall Study|Unsuccessful Procedure|1|||
94587357|NCT05300763|323952161|FG000|Overall Study|Adverse Event|0|||
94587358|NCT05300763|323952162|FG001|Overall Study|Adverse Event|1|||
94587359|NCT05300763|323952161|FG000|Overall Study|Major Protocol Deviation|1|||
94587360|NCT05300763|323952162|FG001|Overall Study|Major Protocol Deviation|0|||
94587361|NCT05300763|323952161|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
94587362|NCT05300763|323952162|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
94587363|NCT03962504|323952163|FG000|Overall Study|Other|11|||
94587364|NCT03962504|323952164|FG001|Overall Study|Other|32|||
94587365|NCT02813577|323952165|FG000|Overall Study|Study terminated|4|||
94587366|NCT02367833|323952166|FG000|Overall Study|Withdrawal by Subject|1|||
94587367|NCT02367833|323952167|FG001|Overall Study|Withdrawal by Subject|1|||
94587368|NCT02367833|323952168|FG002|Overall Study|Withdrawal by Subject|0|||
94587369|NCT01077076|323952169|FG000|First Intervention|Withdrawal by Subject|1|||
94587370|NCT01077076|323952170|FG001|First Intervention|Withdrawal by Subject|0|||
94587371|NCT01077076|323952171|FG002|First Intervention|Withdrawal by Subject|0|||
94587372|NCT01077076|323952172|FG003|First Intervention|Withdrawal by Subject|0|||
94587373|NCT01077076|323952173|FG004|First Intervention|Withdrawal by Subject|0|||
94587374|NCT01077076|323952174|FG005|First Intervention|Withdrawal by Subject|0|||
94587375|NCT01077076|323952169|FG000|Third Intervention|Death in the participant's family|0|||
94587376|NCT01077076|323952170|FG001|Third Intervention|Death in the participant's family|0|||
94587377|NCT01077076|323952171|FG002|Third Intervention|Death in the participant's family|0|||
94587378|NCT01077076|323952172|FG003|Third Intervention|Death in the participant's family|0|||
94587379|NCT01077076|323952173|FG004|Third Intervention|Death in the participant's family|0|||
94587380|NCT01077076|323952174|FG005|Third Intervention|Death in the participant's family|1|||
94587381|NCT00889720|323952179|FG000|Overall Study|Withdrawal by Subject|4|||
94587382|NCT00889720|323952179|FG000|Overall Study|Other|4|||
94587383|NCT01459497|323952181|FG000|Overall Study|Inability to meet trial constraints.|1|||
94587384|NCT01459497|323952182|FG001|Overall Study|Inability to meet trial constraints.|0|||
94587385|NCT01459497|323952181|FG000|Overall Study|Physician Decision|1|||
94587386|NCT01459497|323952182|FG001|Overall Study|Physician Decision|1|||
94587387|NCT01459497|323952181|FG000|Overall Study|Hospitalization.|0|||
94587388|NCT01459497|323952182|FG001|Overall Study|Hospitalization.|3|||
94587389|NCT01459497|323952181|FG000|Overall Study|Disease progression.|0|||
94587390|NCT01459497|323952182|FG001|Overall Study|Disease progression.|1|||
94587391|NCT00048074|323952183|FG000|Overall Study|Adverse Event|46|||
94587392|NCT00048074|323952184|FG001|Overall Study|Adverse Event|41|||
94587393|NCT00048074|323952185|FG002|Overall Study|Adverse Event|53|||
94587394|NCT00048074|323952183|FG000|Overall Study|Death|3|||
94587395|NCT00048074|323952184|FG001|Overall Study|Death|3|||
94587396|NCT00048074|323952185|FG002|Overall Study|Death|2|||
94587397|NCT00048074|323952183|FG000|Overall Study|Lost to Follow-up|2|||
94587398|NCT00048074|323952184|FG001|Overall Study|Lost to Follow-up|6|||
94587399|NCT00048074|323952185|FG002|Overall Study|Lost to Follow-up|6|||
94587400|NCT00048074|323952183|FG000|Overall Study|Withdrawal by Subject|28|||
94587401|NCT00048074|323952184|FG001|Overall Study|Withdrawal by Subject|30|||
94587402|NCT00048074|323952185|FG002|Overall Study|Withdrawal by Subject|35|||
94587403|NCT00048074|323952183|FG000|Overall Study|Protocol Violation|1|||
94587404|NCT00048074|323952184|FG001|Overall Study|Protocol Violation|3|||
94587405|NCT00048074|323952185|FG002|Overall Study|Protocol Violation|0|||
94587406|NCT00048074|323952183|FG000|Overall Study|Study participation was terminated|0|||
94587407|NCT00048074|323952184|FG001|Overall Study|Study participation was terminated|1|||
94587408|NCT00048074|323952185|FG002|Overall Study|Study participation was terminated|0|||
94587409|NCT00048074|323952183|FG000|Overall Study|Husband ill|0|||
94587410|NCT00048074|323952184|FG001|Overall Study|Husband ill|1|||
94587411|NCT00048074|323952185|FG002|Overall Study|Husband ill|0|||
94587412|NCT00048074|323952183|FG000|Overall Study|Poor compliance|0|||
94456015|NCT00886743|323458157|FG000|Overall Study|Other|1|||
94456016|NCT01062113|323458160|FG000|Overall Study|Adverse Event|1|||
94587413|NCT00048074|323952184|FG001|Overall Study|Poor compliance|1|||
94587414|NCT00048074|323952185|FG002|Overall Study|Poor compliance|0|||
94587415|NCT00048074|323952183|FG000|Overall Study|Out of station|0|||
94587416|NCT00048074|323952184|FG001|Overall Study|Out of station|1|||
94456017|NCT01062113|323458161|FG001|Overall Study|Adverse Event|0|||
94456018|NCT01062113|323458162|FG002|Overall Study|Adverse Event|0|||
94587417|NCT00048074|323952185|FG002|Overall Study|Out of station|1|||
94587418|NCT00048074|323952183|FG000|Overall Study|Social reasons|1|||
94587419|NCT00048074|323952184|FG001|Overall Study|Social reasons|0|||
94587420|NCT00048074|323952185|FG002|Overall Study|Social reasons|0|||
94587421|NCT01708902|323952186|FG000|Overall Study|Adverse Event|3|||
94587422|NCT01708902|323952187|FG001|Overall Study|Adverse Event|4|||
94587423|NCT01708902|323952188|FG002|Overall Study|Adverse Event|9|||
94587424|NCT01708902|323952189|FG003|Overall Study|Adverse Event|2|||
94587425|NCT01708902|323952190|FG004|Overall Study|Adverse Event|7|||
94587426|NCT01708902|323952191|FG005|Overall Study|Adverse Event|3|||
94587427|NCT01708902|323952192|FG006|Overall Study|Adverse Event|5|||
94587428|NCT01708902|323952186|FG000|Overall Study|Lack of Efficacy|3|||
94587429|NCT01708902|323952187|FG001|Overall Study|Lack of Efficacy|1|||
94587430|NCT01708902|323952188|FG002|Overall Study|Lack of Efficacy|0|||
94587431|NCT01708902|323952189|FG003|Overall Study|Lack of Efficacy|0|||
94587432|NCT01708902|323952190|FG004|Overall Study|Lack of Efficacy|0|||
94587433|NCT01708902|323952191|FG005|Overall Study|Lack of Efficacy|1|||
94587434|NCT01708902|323952192|FG006|Overall Study|Lack of Efficacy|0|||
94587435|NCT01708902|323952186|FG000|Overall Study|Non compliance with protocol|0|||
94587436|NCT01708902|323952187|FG001|Overall Study|Non compliance with protocol|2|||
94587437|NCT01708902|323952188|FG002|Overall Study|Non compliance with protocol|1|||
94587438|NCT01708902|323952189|FG003|Overall Study|Non compliance with protocol|3|||
94659314|NCT01722331|324208012|FG001|Part 1|Progressive Disease|0|||
94659315|NCT01722331|324208013|FG002|Part 1|Progressive Disease|0|||
94659316|NCT01722331|324208014|FG003|Part 1|Progressive Disease|0|||
94659317|NCT01722331|324208015|FG004|Part 1|Progressive Disease|1|||
94659318|NCT01722331|324208016|FG005|Part 1|Progressive Disease|0|||
94659319|NCT01722331|324208017|FG006|Part 1|Progressive Disease|0|||
94659320|NCT01722331|324208011|FG000|Part 1|Protocol Violation|1|||
94659321|NCT01722331|324208012|FG001|Part 1|Protocol Violation|0|||
94659322|NCT01722331|324208013|FG002|Part 1|Protocol Violation|0|||
94659323|NCT01722331|324208014|FG003|Part 1|Protocol Violation|0|||
94587439|NCT01708902|323952190|FG004|Overall Study|Non compliance with protocol|0|||
94587440|NCT01708902|323952191|FG005|Overall Study|Non compliance with protocol|0|||
94587441|NCT01708902|323952192|FG006|Overall Study|Non compliance with protocol|0|||
94587442|NCT01708902|323952186|FG000|Overall Study|Lost to Follow-up|2|||
94587443|NCT01708902|323952187|FG001|Overall Study|Lost to Follow-up|1|||
94587444|NCT01708902|323952188|FG002|Overall Study|Lost to Follow-up|2|||
94587445|NCT01708902|323952189|FG003|Overall Study|Lost to Follow-up|2|||
94587446|NCT01708902|323952190|FG004|Overall Study|Lost to Follow-up|0|||
94587447|NCT01708902|323952191|FG005|Overall Study|Lost to Follow-up|0|||
94587448|NCT01708902|323952192|FG006|Overall Study|Lost to Follow-up|1|||
94587449|NCT01708902|323952186|FG000|Overall Study|Refused to continue trial medication|8|||
94587450|NCT01708902|323952187|FG001|Overall Study|Refused to continue trial medication|0|||
94587451|NCT01708902|323952188|FG002|Overall Study|Refused to continue trial medication|4|||
94587452|NCT01708902|323952189|FG003|Overall Study|Refused to continue trial medication|2|||
94587453|NCT01708902|323952190|FG004|Overall Study|Refused to continue trial medication|8|||
94587454|NCT01708902|323952191|FG005|Overall Study|Refused to continue trial medication|1|||
94587455|NCT01708902|323952192|FG006|Overall Study|Refused to continue trial medication|1|||
94587456|NCT01708902|323952186|FG000|Overall Study|Other Reason|1|||
94587457|NCT01708902|323952187|FG001|Overall Study|Other Reason|0|||
94587458|NCT01708902|323952188|FG002|Overall Study|Other Reason|1|||
94587459|NCT01708902|323952189|FG003|Overall Study|Other Reason|1|||
94587460|NCT01708902|323952190|FG004|Overall Study|Other Reason|1|||
94587461|NCT01708902|323952191|FG005|Overall Study|Other Reason|2|||
94587462|NCT01708902|323952192|FG006|Overall Study|Other Reason|0|||
94587463|NCT01500720|323952193|FG000|Overall Study|Randomized But Not Treated|1|||
94587464|NCT01500720|323952194|FG001|Overall Study|Randomized But Not Treated|1|||
94587465|NCT01500720|323952193|FG000|Overall Study|Other|4|||
94587466|NCT01500720|323952194|FG001|Overall Study|Other|8|||
94587467|NCT02281383|323952195|FG000|Overall Study|Progressive Disease|1|||
94587468|NCT02281383|323952195|FG000|Overall Study|Withdrawal by Subject|6|||
94659324|NCT01722331|324208015|FG004|Part 1|Protocol Violation|1|||
94659325|NCT01722331|324208016|FG005|Part 1|Protocol Violation|0|||
94587469|NCT02281383|323952195|FG000|Overall Study|Protocol Violation|2|||
94587470|NCT02281383|323952195|FG000|Overall Study|Death|1|||
94587471|NCT02281383|323952195|FG000|Overall Study|Adverse Event|2|||
94587472|NCT02252939|323952196|FG000|Overall Study|Lost to Follow-up|3|||
94587473|NCT04198714|323952200|FG000|Overall Study|Physician Decision|0|||
94587474|NCT04198714|323952201|FG001|Overall Study|Physician Decision|1|||
94659326|NCT01722331|324208017|FG006|Part 1|Protocol Violation|0|||
94659327|NCT01722331|324208011|FG000|Part 1|Withdrawal by Subject|2|||
94659328|NCT01722331|324208012|FG001|Part 1|Withdrawal by Subject|0|||
94587475|NCT02499328|323952204|FG000|Overall Study|Withdrawal by Subject|1|||
94587476|NCT02499328|323952205|FG001|Overall Study|Withdrawal by Subject|1|||
94587477|NCT02499328|323952206|FG002|Overall Study|Withdrawal by Subject|5|||
94587478|NCT02499328|323952207|FG003|Overall Study|Withdrawal by Subject|3|||
94587479|NCT02499328|323952208|FG004|Overall Study|Withdrawal by Subject|5|||
94587480|NCT02499328|323952209|FG005|Overall Study|Withdrawal by Subject|0|||
94587481|NCT02499328|323952210|FG006|Overall Study|Withdrawal by Subject|0|||
94587482|NCT02499328|323952211|FG007|Overall Study|Withdrawal by Subject|0|||
94587483|NCT02499328|323952212|FG008|Overall Study|Withdrawal by Subject|2|||
94587484|NCT02499328|323952213|FG009|Overall Study|Withdrawal by Subject|2|||
94587485|NCT02499328|323952214|FG010|Overall Study|Withdrawal by Subject|0|||
94587486|NCT02499328|323952215|FG011|Overall Study|Withdrawal by Subject|3|||
94587487|NCT02499328|323952216|FG012|Overall Study|Withdrawal by Subject|7|||
94587488|NCT02499328|323952217|FG013|Overall Study|Withdrawal by Subject|3|||
94587489|NCT02499328|323952218|FG014|Overall Study|Withdrawal by Subject|1|||
94587490|NCT02499328|323952219|FG015|Overall Study|Withdrawal by Subject|0|||
94587491|NCT02499328|323952220|FG016|Overall Study|Withdrawal by Subject|0|||
94587492|NCT02499328|323952221|FG017|Overall Study|Withdrawal by Subject|3|||
94587493|NCT02499328|323952222|FG018|Overall Study|Withdrawal by Subject|0|||
94587494|NCT02499328|323952204|FG000|Overall Study|Lost to Follow-up|0|||
94587495|NCT02499328|323952205|FG001|Overall Study|Lost to Follow-up|1|||
94587496|NCT02499328|323952206|FG002|Overall Study|Lost to Follow-up|1|||
94587497|NCT02499328|323952207|FG003|Overall Study|Lost to Follow-up|2|||
94587498|NCT02499328|323952208|FG004|Overall Study|Lost to Follow-up|0|||
94587499|NCT02499328|323952209|FG005|Overall Study|Lost to Follow-up|0|||
94587500|NCT02499328|323952210|FG006|Overall Study|Lost to Follow-up|0|||
94587501|NCT02499328|323952211|FG007|Overall Study|Lost to Follow-up|2|||
94587502|NCT02499328|323952212|FG008|Overall Study|Lost to Follow-up|3|||
94587503|NCT02499328|323952213|FG009|Overall Study|Lost to Follow-up|0|||
94587504|NCT02499328|323952214|FG010|Overall Study|Lost to Follow-up|0|||
94587505|NCT02499328|323952215|FG011|Overall Study|Lost to Follow-up|0|||
94587506|NCT02499328|323952216|FG012|Overall Study|Lost to Follow-up|0|||
94587507|NCT02499328|323952217|FG013|Overall Study|Lost to Follow-up|0|||
94587508|NCT02499328|323952218|FG014|Overall Study|Lost to Follow-up|0|||
94587509|NCT02499328|323952219|FG015|Overall Study|Lost to Follow-up|0|||
94587510|NCT02499328|323952220|FG016|Overall Study|Lost to Follow-up|0|||
94587511|NCT02499328|323952221|FG017|Overall Study|Lost to Follow-up|0|||
94587512|NCT02499328|323952222|FG018|Overall Study|Lost to Follow-up|1|||
94587513|NCT02499328|323952204|FG000|Overall Study|Death|0|||
94587514|NCT02499328|323952205|FG001|Overall Study|Death|3|||
94587515|NCT02499328|323952206|FG002|Overall Study|Death|3|||
94587516|NCT02499328|323952207|FG003|Overall Study|Death|2|||
94456019|NCT01062113|323458160|FG000|Overall Study|Lack of Efficacy|38|||
94587517|NCT02499328|323952208|FG004|Overall Study|Death|4|||
94587518|NCT02499328|323952209|FG005|Overall Study|Death|7|||
94587519|NCT02499328|323952210|FG006|Overall Study|Death|3|||
94587520|NCT02499328|323952211|FG007|Overall Study|Death|0|||
94587521|NCT02499328|323952212|FG008|Overall Study|Death|2|||
94587522|NCT02499328|323952213|FG009|Overall Study|Death|6|||
94587523|NCT02499328|323952214|FG010|Overall Study|Death|6|||
94587524|NCT02499328|323952215|FG011|Overall Study|Death|20|||
94587525|NCT02499328|323952216|FG012|Overall Study|Death|9|||
94587526|NCT02499328|323952217|FG013|Overall Study|Death|7|||
94587527|NCT02499328|323952218|FG014|Overall Study|Death|3|||
94587528|NCT02499328|323952219|FG015|Overall Study|Death|1|||
94587529|NCT02499328|323952220|FG016|Overall Study|Death|1|||
94587530|NCT02499328|323952221|FG017|Overall Study|Death|16|||
94587531|NCT02499328|323952222|FG018|Overall Study|Death|5|||
94587532|NCT02499328|323952204|FG000|Overall Study|"Other"|2|||
94587533|NCT02499328|323952205|FG001|Overall Study|"Other"|2|||
94587534|NCT02499328|323952206|FG002|Overall Study|"Other"|1|||
94587535|NCT02499328|323952207|FG003|Overall Study|"Other"|3|||
94587536|NCT02499328|323952208|FG004|Overall Study|"Other"|6|||
94587537|NCT02499328|323952209|FG005|Overall Study|"Other"|2|||
94587538|NCT02499328|323952210|FG006|Overall Study|"Other"|3|||
94587539|NCT02499328|323952211|FG007|Overall Study|"Other"|4|||
94587540|NCT02499328|323952212|FG008|Overall Study|"Other"|6|||
94587541|NCT02499328|323952213|FG009|Overall Study|"Other"|16|||
94587542|NCT02499328|323952214|FG010|Overall Study|"Other"|13|||
94587543|NCT02499328|323952215|FG011|Overall Study|"Other"|31|||
94587544|NCT02499328|323952216|FG012|Overall Study|"Other"|8|||
94587545|NCT02499328|323952217|FG013|Overall Study|"Other"|7|||
94587546|NCT02499328|323952218|FG014|Overall Study|"Other"|6|||
94587547|NCT02499328|323952219|FG015|Overall Study|"Other"|0|||
94587548|NCT02499328|323952220|FG016|Overall Study|"Other"|0|||
94587549|NCT02499328|323952221|FG017|Overall Study|"Other"|34|||
94587550|NCT02499328|323952222|FG018|Overall Study|"Other"|43|||
94587551|NCT02499328|323952204|FG000|Overall Study|Disease Progression|0|||
94587552|NCT02499328|323952205|FG001|Overall Study|Disease Progression|0|||
94587553|NCT02499328|323952206|FG002|Overall Study|Disease Progression|0|||
94587554|NCT02499328|323952207|FG003|Overall Study|Disease Progression|0|||
94587555|NCT02499328|323952208|FG004|Overall Study|Disease Progression|0|||
94587556|NCT02499328|323952209|FG005|Overall Study|Disease Progression|0|||
94587557|NCT02499328|323952210|FG006|Overall Study|Disease Progression|1|||
94587558|NCT02499328|323952211|FG007|Overall Study|Disease Progression|0|||
94587559|NCT02499328|323952212|FG008|Overall Study|Disease Progression|1|||
94587560|NCT02499328|323952213|FG009|Overall Study|Disease Progression|0|||
94587561|NCT02499328|323952214|FG010|Overall Study|Disease Progression|1|||
94587562|NCT02499328|323952215|FG011|Overall Study|Disease Progression|0|||
94587563|NCT02499328|323952216|FG012|Overall Study|Disease Progression|0|||
94587564|NCT02499328|323952217|FG013|Overall Study|Disease Progression|0|||
94587565|NCT02499328|323952218|FG014|Overall Study|Disease Progression|0|||
94587566|NCT02499328|323952219|FG015|Overall Study|Disease Progression|0|||
94587567|NCT02499328|323952220|FG016|Overall Study|Disease Progression|0|||
94587568|NCT02499328|323952221|FG017|Overall Study|Disease Progression|2|||
94587569|NCT02499328|323952222|FG018|Overall Study|Disease Progression|0|||
94587570|NCT02499328|323952204|FG000|Overall Study|Adverse Event|1|||
94587571|NCT02499328|323952205|FG001|Overall Study|Adverse Event|0|||
94587572|NCT02499328|323952206|FG002|Overall Study|Adverse Event|0|||
94587573|NCT02499328|323952207|FG003|Overall Study|Adverse Event|1|||
94587574|NCT02499328|323952208|FG004|Overall Study|Adverse Event|0|||
94587575|NCT02499328|323952209|FG005|Overall Study|Adverse Event|0|||
94587576|NCT02499328|323952210|FG006|Overall Study|Adverse Event|0|||
94587577|NCT02499328|323952211|FG007|Overall Study|Adverse Event|0|||
94587578|NCT02499328|323952212|FG008|Overall Study|Adverse Event|0|||
94587579|NCT02499328|323952213|FG009|Overall Study|Adverse Event|0|||
94587580|NCT02499328|323952214|FG010|Overall Study|Adverse Event|0|||
94587581|NCT02499328|323952215|FG011|Overall Study|Adverse Event|0|||
94587582|NCT02499328|323952216|FG012|Overall Study|Adverse Event|1|||
94587583|NCT02499328|323952217|FG013|Overall Study|Adverse Event|0|||
94587584|NCT02499328|323952218|FG014|Overall Study|Adverse Event|0|||
94587585|NCT02499328|323952219|FG015|Overall Study|Adverse Event|0|||
94587586|NCT02499328|323952220|FG016|Overall Study|Adverse Event|0|||
94587587|NCT02499328|323952221|FG017|Overall Study|Adverse Event|0|||
94587588|NCT02499328|323952222|FG018|Overall Study|Adverse Event|0|||
94587589|NCT03207763|323954019|FG000|Overall Study|Lost to Follow-up|1|||
94587590|NCT03207763|323954020|FG001|Overall Study|Lost to Follow-up|0|||
94587591|NCT00854113|323954021|FG000|Overall Study|Adverse Event|0|||
94587592|NCT00854113|323954022|FG001|Overall Study|Adverse Event|0|||
94587593|NCT00854113|323954023|FG002|Overall Study|Adverse Event|0|||
94587594|NCT00854113|323954024|FG003|Overall Study|Adverse Event|0|||
94587595|NCT00854113|323954025|FG004|Overall Study|Adverse Event|0|||
94587596|NCT00854113|323954026|FG005|Overall Study|Adverse Event|0|||
94587597|NCT00854113|323954027|FG006|Overall Study|Adverse Event|0|||
94587598|NCT00854113|323954028|FG007|Overall Study|Adverse Event|2|||
94587599|NCT00854113|323954029|FG008|Overall Study|Adverse Event|0|||
94587600|NCT00854113|323954030|FG009|Overall Study|Adverse Event|0|||
94587601|NCT00854113|323954031|FG010|Overall Study|Adverse Event|0|||
94587602|NCT00854113|323954021|FG000|Overall Study|Withdrawal by Subject|0|||
94587603|NCT00854113|323954022|FG001|Overall Study|Withdrawal by Subject|0|||
94587604|NCT00854113|323954023|FG002|Overall Study|Withdrawal by Subject|0|||
94587605|NCT00854113|323954024|FG003|Overall Study|Withdrawal by Subject|0|||
94587606|NCT00854113|323954025|FG004|Overall Study|Withdrawal by Subject|0|||
94587607|NCT00854113|323954026|FG005|Overall Study|Withdrawal by Subject|0|||
94587608|NCT00854113|323954027|FG006|Overall Study|Withdrawal by Subject|0|||
94587609|NCT00854113|323954028|FG007|Overall Study|Withdrawal by Subject|1|||
94587610|NCT00854113|323954029|FG008|Overall Study|Withdrawal by Subject|1|||
94587611|NCT00854113|323954030|FG009|Overall Study|Withdrawal by Subject|0|||
94587612|NCT00854113|323954031|FG010|Overall Study|Withdrawal by Subject|0|||
94587613|NCT03052400|323954032|FG000|Overall Study|Lost to Follow-up|1|||
94587614|NCT03052400|323954033|FG001|Overall Study|Lost to Follow-up|0|||
94587615|NCT03052400|323954032|FG000|Overall Study|Withdrawal by Subject|0|||
94587616|NCT03052400|323954033|FG001|Overall Study|Withdrawal by Subject|1|||
94587617|NCT00867815|323954034|FG000|Overall Study|Lost to Follow-up|1|||
94587618|NCT04294680|323954036|FG000|Overall Study|Withdrawal by Subject|2|||
94587619|NCT04294680|323954037|FG001|Overall Study|Withdrawal by Subject|1|||
94587620|NCT04294680|323954036|FG000|Overall Study|Follow-up visits completed outside of window|1|||
94587621|NCT04294680|323954037|FG001|Overall Study|Follow-up visits completed outside of window|0|||
94242667|NCT01646177|322682732|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
94242668|NCT01646177|322682733|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
94587622|NCT01499277|323954041|FG000|Overall Study|Adverse Event|3|||
94242669|NCT01646177|322682734|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
94587623|NCT01499277|323954042|FG001|Overall Study|Adverse Event|6|||
94587624|NCT01499277|323954041|FG000|Overall Study|Death|3|||
94587625|NCT01499277|323954042|FG001|Overall Study|Death|2|||
94587626|NCT01499277|323954041|FG000|Overall Study|Lost to Follow-up|15|||
94587627|NCT01499277|323954042|FG001|Overall Study|Lost to Follow-up|8|||
94587628|NCT01499277|323954041|FG000|Overall Study|Protocol Violation|2|||
94587629|NCT01499277|323954042|FG001|Overall Study|Protocol Violation|3|||
94587630|NCT01499277|323954041|FG000|Overall Study|Withdrawal by Subject|16|||
94587631|NCT01499277|323954042|FG001|Overall Study|Withdrawal by Subject|6|||
94659329|NCT01722331|324208013|FG002|Part 1|Withdrawal by Subject|3|||
94587632|NCT01499277|323954041|FG000|Overall Study|Lack of therapeutic response and other|8|||
94587633|NCT01499277|323954042|FG001|Overall Study|Lack of therapeutic response and other|7|||
94587634|NCT02974543|323954045|FG000|Overall Study|Withdrawal by Subject|1|||
94587635|NCT02974543|323954046|FG001|Overall Study|Withdrawal by Subject|0|||
94587636|NCT00742235|323954047|FG000|Overall Study|Lost to Follow-up|0|||
94587637|NCT00742235|323954048|FG001|Overall Study|Lost to Follow-up|31|||
94587638|NCT00330967|323954049|FG000|Overall Study|Withdrawal by Subject|0|||
94587639|NCT00330967|323954050|FG001|Overall Study|Withdrawal by Subject|5|||
94587640|NCT00330967|323954049|FG000|Overall Study|Physician Decision|0|||
94587641|NCT00330967|323954050|FG001|Overall Study|Physician Decision|9|||
94587642|NCT01237899|323954051|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
94587643|NCT01237899|323954052|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
94587644|NCT01237899|323954053|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
94587645|NCT01237899|323954054|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
94587646|NCT01237899|323954055|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
94587647|NCT01237899|323954056|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
94587648|NCT01237899|323954057|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
94587649|NCT01237899|323954058|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
94587650|NCT01237899|323954059|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
94587651|NCT01237899|323954060|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
94587652|NCT01237899|323954061|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
94587653|NCT00337675|323954062|FG000|Overall Study|Adverse Event|10|||
94587654|NCT00337675|323954063|FG001|Overall Study|Adverse Event|9|||
94587655|NCT00337675|323954064|FG002|Overall Study|Adverse Event|19|||
94587656|NCT00337675|323954062|FG000|Overall Study|Lack of Efficacy|10|||
94587657|NCT00337675|323954063|FG001|Overall Study|Lack of Efficacy|7|||
94587658|NCT00337675|323954064|FG002|Overall Study|Lack of Efficacy|9|||
94587659|NCT00337675|323954062|FG000|Overall Study|Lost to Follow-up|22|||
94587660|NCT00337675|323954063|FG001|Overall Study|Lost to Follow-up|19|||
94587661|NCT00337675|323954064|FG002|Overall Study|Lost to Follow-up|17|||
94587662|NCT00337675|323954062|FG000|Overall Study|Physician Decision|9|||
94587663|NCT00337675|323954063|FG001|Overall Study|Physician Decision|17|||
94587664|NCT00337675|323954064|FG002|Overall Study|Physician Decision|14|||
94587665|NCT00337675|323954062|FG000|Overall Study|Protocol Violation|21|||
94587666|NCT00337675|323954063|FG001|Overall Study|Protocol Violation|24|||
94587667|NCT00337675|323954064|FG002|Overall Study|Protocol Violation|19|||
94587668|NCT00337675|323954062|FG000|Overall Study|Withdrawal by Subject|25|||
94587669|NCT00337675|323954063|FG001|Overall Study|Withdrawal by Subject|25|||
94587670|NCT00337675|323954064|FG002|Overall Study|Withdrawal by Subject|19|||
94587671|NCT00337675|323954062|FG000|Overall Study|Progressive Disease|0|||
94587672|NCT00337675|323954063|FG001|Overall Study|Progressive Disease|2|||
94587673|NCT00337675|323954064|FG002|Overall Study|Progressive Disease|0|||
94587674|NCT00337675|323954062|FG000|Overall Study|Trial Terminated|0|||
94587675|NCT00337675|323954063|FG001|Overall Study|Trial Terminated|0|||
94587676|NCT00337675|323954064|FG002|Overall Study|Trial Terminated|2|||
94587677|NCT04023396|323954065|FG000|Overall Study|Adverse Event|16|||
94587678|NCT04023396|323954065|FG000|Overall Study|Death|1|||
94587679|NCT04023396|323954065|FG000|Overall Study|Lost to Follow-up|1|||
94587680|NCT04023396|323954065|FG000|Overall Study|Withdrawal by Subject|14|||
94587681|NCT04023396|323954065|FG000|Overall Study|Pregnancy|4|||
94587682|NCT04023396|323954065|FG000|Overall Study|Lack of Efficacy|3|||
94587683|NCT04023396|323954065|FG000|Overall Study|Physician Decision|4|||
94587684|NCT04023396|323954065|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
94587685|NCT04730271|323954066|FG000|Overall Study|Adverse Event|0|||
94587686|NCT04730271|323954067|FG001|Overall Study|Adverse Event|2|||
94587687|NCT04730271|323954066|FG000|Overall Study|Withdrawal by Subject|1|||
94587688|NCT04730271|323954067|FG001|Overall Study|Withdrawal by Subject|1|||
94587689|NCT04730271|323954066|FG000|Overall Study|Protocol Violation|7|||
94587690|NCT04730271|323954067|FG001|Overall Study|Protocol Violation|13|||
94587691|NCT04730271|323954066|FG000|Overall Study|Lost to Follow-up|3|||
94587692|NCT04730271|323954067|FG001|Overall Study|Lost to Follow-up|3|||
94587693|NCT04730271|323954066|FG000|Overall Study|Death|1|||
94587694|NCT04730271|323954067|FG001|Overall Study|Death|0|||
94587695|NCT03198507|323954068|FG000|Overall Study|Withdrawal by Subject|1|||
94587696|NCT03198507|323954069|FG001|Overall Study|Withdrawal by Subject|0|||
94587697|NCT01349959|323954076|FG000|Overall Study|Adverse Event|7|||
94587698|NCT01317277|323954078|FG000|Overall Study|Lost to Follow-up|3|||
94587699|NCT01317277|323954079|FG001|Overall Study|Lost to Follow-up|1|||
94587700|NCT01317277|323954078|FG000|Overall Study|Lost MEMS|1|||
94587701|NCT01317277|323954079|FG001|Overall Study|Lost MEMS|1|||
94587702|NCT01317277|323954078|FG000|Overall Study|Unable to comply with intervention|1|||
94587703|NCT01317277|323954079|FG001|Overall Study|Unable to comply with intervention|0|||
94587704|NCT01317277|323954078|FG000|Overall Study|Withdrawal by Subject|1|||
94587705|NCT01317277|323954079|FG001|Overall Study|Withdrawal by Subject|0|||
94587706|NCT01317277|323954078|FG000|Overall Study|Adverse Event|1|||
94587707|NCT01317277|323954079|FG001|Overall Study|Adverse Event|0|||
94587708|NCT03565497|323954083|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
94587709|NCT03565497|323954084|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
94587710|NCT03565497|323954085|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
94587711|NCT03565497|323954083|FG000|Overall Study|Lost to Follow-up|1|||
94587712|NCT03565497|323954084|FG001|Overall Study|Lost to Follow-up|1|||
94587713|NCT03565497|323954085|FG002|Overall Study|Lost to Follow-up|2|||
94587714|NCT03565497|323954083|FG000|Overall Study|Withdrawal by Subject|1|||
94587715|NCT03565497|323954084|FG001|Overall Study|Withdrawal by Subject|1|||
94587716|NCT03565497|323954085|FG002|Overall Study|Withdrawal by Subject|1|||
94587717|NCT02194985|323954089|FG000|Overall Study|Adverse Event|1|||
94587718|NCT02194985|323954089|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
94587719|NCT02194985|323954089|FG000|Overall Study|Physician Decision|4|||
94587720|NCT02194985|323954089|FG000|Overall Study|Lost to Follow-up|1|||
94587721|NCT02194985|323954089|FG000|Overall Study|Withdrawal by Subject|2|||
94587722|NCT02280408|323954090|FG000|Overall Study|Lost to Follow-up|0|||
94587723|NCT02280408|323954091|FG001|Overall Study|Lost to Follow-up|2|||
94587724|NCT02280408|323954092|FG002|Overall Study|Lost to Follow-up|0|||
94587725|NCT02280408|323954093|FG003|Overall Study|Lost to Follow-up|0|||
94587726|NCT03801031|323954095|FG000|Overall Study|Lost to Follow-up|1|||
94587727|NCT03801031|323954096|FG001|Overall Study|Lost to Follow-up|0|||
94587728|NCT03801031|323954095|FG000|Overall Study|Unable to comply|1|||
94587729|NCT03801031|323954096|FG001|Overall Study|Unable to comply|0|||
94587730|NCT03801031|323954095|FG000|Overall Study|Withdrawal by Subject|0|||
94587731|NCT03801031|323954096|FG001|Overall Study|Withdrawal by Subject|1|||
94587732|NCT01942733|323954097|FG000|Overall Study|Lost to Follow-up|1|||
94587733|NCT01942733|323954097|FG000|Overall Study|Non-compliance with IMP|1|||
94587734|NCT01942733|323954097|FG000|Overall Study|Administrative|1|||
94587735|NCT00486291|323954101|FG000|Overall Study|Adverse Event|3|||
94587736|NCT00486291|323954102|FG001|Overall Study|Adverse Event|4|||
94587737|NCT00486291|323954101|FG000|Overall Study|Lost to Follow-up|3|||
94587738|NCT00486291|323954102|FG001|Overall Study|Lost to Follow-up|7|||
94587739|NCT00486291|323954101|FG000|Overall Study|protocol non-compliance|10|||
94587740|NCT00486291|323954102|FG001|Overall Study|protocol non-compliance|15|||
94587741|NCT00486291|323954101|FG000|Overall Study|requirement for restricted medication|0|||
94587742|NCT00486291|323954102|FG001|Overall Study|requirement for restricted medication|3|||
94587743|NCT04080167|323954105|FG000|Overall Study|Lost to Follow-up-Patients|7|||
94587744|NCT04080167|323954106|FG001|Overall Study|Lost to Follow-up-Patients|14|||
94587745|NCT04080167|323954107|FG002|Overall Study|Lost to Follow-up-Patients|0|||
94587746|NCT04080167|323954105|FG000|Overall Study|Lost to Follow-up-Providers|2|||
94587747|NCT04080167|323954106|FG001|Overall Study|Lost to Follow-up-Providers|2|||
94587748|NCT04080167|323954107|FG002|Overall Study|Lost to Follow-up-Providers|0|||
94587749|NCT04080167|323954105|FG000|Overall Study|Withdrawal by Subject|1|||
94587750|NCT04080167|323954106|FG001|Overall Study|Withdrawal by Subject|2|||
94587751|NCT04080167|323954107|FG002|Overall Study|Withdrawal by Subject|0|||
94587752|NCT04080167|323954105|FG000|Overall Study|Withdrawal by Provider|0|||
94587753|NCT04080167|323954106|FG001|Overall Study|Withdrawal by Provider|0|||
94587754|NCT04080167|323954107|FG002|Overall Study|Withdrawal by Provider|4|||
94587755|NCT04080167|323954105|FG000|Overall Study|Death-Patient|2|||
94587756|NCT04080167|323954106|FG001|Overall Study|Death-Patient|1|||
94587757|NCT04080167|323954107|FG002|Overall Study|Death-Patient|0|||
94587758|NCT04080167|323954105|FG000|Overall Study|Hydroxyurea New Starts|0|||
94587759|NCT04080167|323954106|FG001|Overall Study|Hydroxyurea New Starts|0|||
94587760|NCT04080167|323954107|FG002|Overall Study|Hydroxyurea New Starts|1|||
94587761|NCT04080167|323954105|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
94587762|NCT04080167|323954106|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
94587763|NCT04080167|323954107|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
94587764|NCT02637037|323954111|FG000|Overall Study|Positive drug screen at admission|1|||
94587765|NCT02637037|323954112|FG001|Overall Study|Positive drug screen at admission|0|||
94587766|NCT02637037|323954111|FG000|Overall Study|Withdrawal by Subject|2|||
94587767|NCT02637037|323954112|FG001|Overall Study|Withdrawal by Subject|1|||
94587768|NCT02637037|323954111|FG000|Overall Study|Adverse Event|1|||
94587769|NCT02637037|323954112|FG001|Overall Study|Adverse Event|0|||
94587770|NCT03339219|323954113|FG000|Overall Study|Death|12|||
94587771|NCT03339219|323954113|FG000|Overall Study|Site Terminated by Sponsor|22|||
94587772|NCT03339219|323954113|FG000|Overall Study|Withdrawal by Subject|1|||
94587773|NCT02167139|323954114|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
94587774|NCT02167139|323954115|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
94587775|NCT02167139|323954116|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
94587776|NCT02167139|323954117|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
94659330|NCT01722331|324208014|FG003|Part 1|Withdrawal by Subject|0|||
94659331|NCT01722331|324208015|FG004|Part 1|Withdrawal by Subject|3|||
94659332|NCT01722331|324208016|FG005|Part 1|Withdrawal by Subject|0|||
94659333|NCT01722331|324208017|FG006|Part 1|Withdrawal by Subject|0|||
94659334|NCT01722331|324208011|FG000|Part 2|Adverse Event|3|||
94659335|NCT01722331|324208012|FG001|Part 2|Adverse Event|0|||
94659336|NCT01722331|324208013|FG002|Part 2|Adverse Event|0|||
94659337|NCT01722331|324208014|FG003|Part 2|Adverse Event|0|||
94659338|NCT01722331|324208015|FG004|Part 2|Adverse Event|0|||
94659339|NCT01722331|324208016|FG005|Part 2|Adverse Event|1|||
94659340|NCT01722331|324208017|FG006|Part 2|Adverse Event|0|||
94587777|NCT02167139|323954114|FG000|Randomised, Double-blind|Adverse Event|2|||
94587778|NCT02167139|323954115|FG001|Randomised, Double-blind|Adverse Event|9|||
94587779|NCT02167139|323954116|FG002|Randomised, Double-blind|Adverse Event|0|||
94587780|NCT02167139|323954117|FG003|Randomised, Double-blind|Adverse Event|0|||
94587781|NCT02167139|323954114|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
94587782|NCT02167139|323954115|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
94587783|NCT02167139|323954116|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
94587784|NCT02167139|323954117|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
94587785|NCT02167139|323954114|FG000|Randomised, Double-blind|Other|3|||
94587786|NCT02167139|323954115|FG001|Randomised, Double-blind|Other|0|||
94587787|NCT02167139|323954116|FG002|Randomised, Double-blind|Other|0|||
94587788|NCT02167139|323954117|FG003|Randomised, Double-blind|Other|0|||
94587789|NCT02167139|323954114|FG000|Transition-extension|Adverse Event|2|||
94587790|NCT02167139|323954115|FG001|Transition-extension|Adverse Event|0|||
94587791|NCT02167139|323954116|FG002|Transition-extension|Adverse Event|2|||
94587792|NCT02167139|323954117|FG003|Transition-extension|Adverse Event|3|||
94587793|NCT02167139|323954114|FG000|Transition-extension|Withdrawal by Subject|2|||
94587794|NCT02167139|323954115|FG001|Transition-extension|Withdrawal by Subject|0|||
94587795|NCT02167139|323954116|FG002|Transition-extension|Withdrawal by Subject|4|||
94587796|NCT02167139|323954117|FG003|Transition-extension|Withdrawal by Subject|1|||
94587797|NCT02167139|323954114|FG000|Transition-extension|Lack of Efficacy|0|||
94587798|NCT02167139|323954115|FG001|Transition-extension|Lack of Efficacy|0|||
94587799|NCT02167139|323954116|FG002|Transition-extension|Lack of Efficacy|1|||
94587800|NCT02167139|323954117|FG003|Transition-extension|Lack of Efficacy|1|||
94587801|NCT02167139|323954114|FG000|Transition-extension|Other|1|||
94587802|NCT02167139|323954115|FG001|Transition-extension|Other|0|||
94587803|NCT02167139|323954116|FG002|Transition-extension|Other|1|||
94587804|NCT02167139|323954117|FG003|Transition-extension|Other|0|||
94587805|NCT02167139|323954114|FG000|Transition-extension|Lost to Follow-up|1|||
94587806|NCT02167139|323954115|FG001|Transition-extension|Lost to Follow-up|0|||
94587807|NCT02167139|323954116|FG002|Transition-extension|Lost to Follow-up|0|||
94587808|NCT02167139|323954117|FG003|Transition-extension|Lost to Follow-up|0|||
94587809|NCT02067676|323954118|FG000|Overall Study|Withdrawal by Subject|1|||
94587810|NCT02067676|323954119|FG001|Overall Study|Withdrawal by Subject|0|||
94587811|NCT02067676|323954120|FG002|Overall Study|Withdrawal by Subject|0|||
94587812|NCT02067676|323954121|FG003|Overall Study|Withdrawal by Subject|0|||
94587813|NCT02067676|323954122|FG004|Overall Study|Withdrawal by Subject|0|||
94587814|NCT02067676|323954123|FG005|Overall Study|Withdrawal by Subject|0|||
94587815|NCT00312195|323954126|FG000|Overall Study|Adverse Event|4|||
94587816|NCT00312195|323954127|FG001|Overall Study|Adverse Event|6|||
94587817|NCT00312195|323954126|FG000|Overall Study|Lost to Follow-up|1|||
94587818|NCT00312195|323954127|FG001|Overall Study|Lost to Follow-up|0|||
94587819|NCT00312195|323954126|FG000|Overall Study|Protocol Violation|1|||
94587820|NCT00312195|323954127|FG001|Overall Study|Protocol Violation|0|||
94659341|NCT01722331|324208011|FG000|Part 2|Lack of Efficacy|3|||
94659342|NCT01722331|324208012|FG001|Part 2|Lack of Efficacy|0|||
94659343|NCT01722331|324208013|FG002|Part 2|Lack of Efficacy|11|||
94659344|NCT01722331|324208014|FG003|Part 2|Lack of Efficacy|0|||
94659345|NCT01722331|324208015|FG004|Part 2|Lack of Efficacy|0|||
94659346|NCT01722331|324208016|FG005|Part 2|Lack of Efficacy|3|||
94659347|NCT01722331|324208017|FG006|Part 2|Lack of Efficacy|3|||
94587821|NCT04973436|323954132|FG000|Overall Study|Lost to Follow-up|3|||
94587822|NCT04973436|323954132|FG000|Overall Study|Withdrawal by Subject|1|||
94587823|NCT04973436|323954132|FG000|Overall Study|Death|2|||
94587824|NCT00711477|323954133|FG000|Overall Study|Adverse Event|3|||
94587825|NCT00711477|323954134|FG001|Overall Study|Adverse Event|1|||
94587826|NCT00711477|323954133|FG000|Overall Study|Lost to Follow-up|0|||
94587827|NCT00711477|323954134|FG001|Overall Study|Lost to Follow-up|1|||
94587828|NCT00711477|323954133|FG000|Overall Study|Noncompliance|0|||
94587829|NCT00711477|323954134|FG001|Overall Study|Noncompliance|1|||
94587830|NCT01561313|323954140|FG000|Overall Study|Withdrawal by Subject|1|||
94587831|NCT01561313|323954141|FG001|Overall Study|Withdrawal by Subject|0|||
94587832|NCT01561313|323954140|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
94659348|NCT01722331|324208011|FG000|Part 2|Lost to Follow-up|0|||
94659349|NCT01722331|324208012|FG001|Part 2|Lost to Follow-up|0|||
94659350|NCT01722331|324208013|FG002|Part 2|Lost to Follow-up|3|||
94659351|NCT01722331|324208014|FG003|Part 2|Lost to Follow-up|0|||
94587833|NCT01561313|323954141|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
94587834|NCT04254913|323954142|FG000|Overall Study|Adverse Event|1|||
94587835|NCT00916929|323954145|FG000|Overall Study|Lost to Follow-up|1|||
94587836|NCT00916929|323954146|FG001|Overall Study|Lost to Follow-up|3|||
94587837|NCT00916929|323954145|FG000|Overall Study|Death|5|||
94587838|NCT00916929|323954146|FG001|Overall Study|Death|10|||
94587839|NCT00916929|323954145|FG000|Overall Study|Withdrawal by Subject|1|||
94587840|NCT00916929|323954146|FG001|Overall Study|Withdrawal by Subject|5|||
94587841|NCT00916929|323954145|FG000|Overall Study|Left ventricular epicardial lead|1|||
94587842|NCT00916929|323954146|FG001|Overall Study|Left ventricular epicardial lead|2|||
94587843|NCT00916929|323954145|FG000|Overall Study|Transferred to hospice care|1|||
94587844|NCT00916929|323954146|FG001|Overall Study|Transferred to hospice care|1|||
94587845|NCT00916929|323954145|FG000|Overall Study|System explant|1|||
94587846|NCT00916929|323954146|FG001|Overall Study|System explant|0|||
94587847|NCT00916929|323954145|FG000|Overall Study|Moved to another state|0|||
94587848|NCT00916929|323954146|FG001|Overall Study|Moved to another state|1|||
94587849|NCT00916929|323954145|FG000|Overall Study|Device unable to process impedance data|0|||
94587850|NCT00916929|323954146|FG001|Overall Study|Device unable to process impedance data|7|||
94587851|NCT01032889|323954147|FG000|Overall Study|Adverse Event|2|||
94587852|NCT01032889|323954148|FG001|Overall Study|Adverse Event|2|||
94587853|NCT01032889|323954149|FG002|Overall Study|Adverse Event|0|||
94587854|NCT01032889|323954147|FG000|Overall Study|Withdrawal of Consent|1|||
94587855|NCT01032889|323954148|FG001|Overall Study|Withdrawal of Consent|2|||
94587856|NCT01032889|323954149|FG002|Overall Study|Withdrawal of Consent|1|||
94587857|NCT01032889|323954147|FG000|Overall Study|Patient Request|0|||
94587858|NCT01032889|323954148|FG001|Overall Study|Patient Request|1|||
94587859|NCT01032889|323954149|FG002|Overall Study|Patient Request|0|||
94587860|NCT01032889|323954147|FG000|Overall Study|Lost to Follow-up|1|||
94587861|NCT01032889|323954148|FG001|Overall Study|Lost to Follow-up|1|||
94587862|NCT01032889|323954149|FG002|Overall Study|Lost to Follow-up|0|||
94587863|NCT01032889|323954147|FG000|Overall Study|Lack of Submental Fat|2|||
94587864|NCT01032889|323954148|FG001|Overall Study|Lack of Submental Fat|8|||
94587865|NCT01032889|323954149|FG002|Overall Study|Lack of Submental Fat|1|||
94587866|NCT01032889|323954147|FG000|Overall Study|Miscellaneous Reasons|2|||
94587867|NCT01032889|323954148|FG001|Overall Study|Miscellaneous Reasons|1|||
94587868|NCT01032889|323954149|FG002|Overall Study|Miscellaneous Reasons|1|||
94587869|NCT01160822|323954152|FG000|Overall Study|Adverse Event|0|||
94587870|NCT01160822|323954153|FG001|Overall Study|Adverse Event|0|||
94587871|NCT01160822|323954154|FG002|Overall Study|Adverse Event|0|||
94587872|NCT01160822|323954155|FG003|Overall Study|Adverse Event|0|||
94587873|NCT01160822|323954156|FG004|Overall Study|Adverse Event|1|||
94587874|NCT01160822|323954157|FG005|Overall Study|Adverse Event|2|||
94587875|NCT01160822|323954158|FG006|Overall Study|Adverse Event|5|||
94587876|NCT01160822|323954152|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94587877|NCT01160822|323954153|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94587878|NCT01160822|323954154|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
94587879|NCT01160822|323954155|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
94587880|NCT01160822|323954156|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
94587881|NCT01160822|323954157|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
94587882|NCT01160822|323954158|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
94587883|NCT01160822|323954152|FG000|Overall Study|Withdrawal by Subject|0|||
94587884|NCT01160822|323954153|FG001|Overall Study|Withdrawal by Subject|0|||
94587885|NCT01160822|323954154|FG002|Overall Study|Withdrawal by Subject|0|||
94587886|NCT01160822|323954155|FG003|Overall Study|Withdrawal by Subject|0|||
94587887|NCT01160822|323954156|FG004|Overall Study|Withdrawal by Subject|0|||
94587888|NCT01160822|323954157|FG005|Overall Study|Withdrawal by Subject|0|||
94587889|NCT01160822|323954158|FG006|Overall Study|Withdrawal by Subject|1|||
94587890|NCT01160822|323954152|FG000|Overall Study|Lost to Follow-up|0|||
94587891|NCT01160822|323954153|FG001|Overall Study|Lost to Follow-up|0|||
94587892|NCT01160822|323954154|FG002|Overall Study|Lost to Follow-up|0|||
94587893|NCT01160822|323954155|FG003|Overall Study|Lost to Follow-up|0|||
94587894|NCT01160822|323954156|FG004|Overall Study|Lost to Follow-up|1|||
94587895|NCT01160822|323954157|FG005|Overall Study|Lost to Follow-up|0|||
94587896|NCT01160822|323954158|FG006|Overall Study|Lost to Follow-up|0|||
94587897|NCT01160822|323954152|FG000|Overall Study|Administrative problems|0|||
94587898|NCT01160822|323954153|FG001|Overall Study|Administrative problems|0|||
94587899|NCT01160822|323954154|FG002|Overall Study|Administrative problems|0|||
94587900|NCT01160822|323954155|FG003|Overall Study|Administrative problems|0|||
94587901|NCT01160822|323954156|FG004|Overall Study|Administrative problems|1|||
94587902|NCT01160822|323954157|FG005|Overall Study|Administrative problems|0|||
94587903|NCT01160822|323954158|FG006|Overall Study|Administrative problems|0|||
94587904|NCT01160822|323954152|FG000|Overall Study|Protocol deviation|0|||
94587905|NCT01160822|323954153|FG001|Overall Study|Protocol deviation|0|||
94587906|NCT01160822|323954154|FG002|Overall Study|Protocol deviation|0|||
94587907|NCT01160822|323954155|FG003|Overall Study|Protocol deviation|0|||
94587908|NCT01160822|323954156|FG004|Overall Study|Protocol deviation|2|||
94587909|NCT01160822|323954157|FG005|Overall Study|Protocol deviation|0|||
94587910|NCT01160822|323954158|FG006|Overall Study|Protocol deviation|0|||
94587911|NCT02036853|323954159|FG000|Overall Study|Adverse Event|0|||
94587912|NCT02036853|323954160|FG001|Overall Study|Adverse Event|2|||
94587913|NCT02036853|323954159|FG000|Overall Study|Lack of Efficacy|0|||
94587914|NCT02036853|323954160|FG001|Overall Study|Lack of Efficacy|2|||
94587915|NCT02036853|323954159|FG000|Overall Study|Physician Decision|0|||
94587916|NCT02036853|323954160|FG001|Overall Study|Physician Decision|1|||
94587917|NCT02036853|323954159|FG000|Overall Study|Withdrawal by Subject|0|||
94587918|NCT02036853|323954160|FG001|Overall Study|Withdrawal by Subject|1|||
94587919|NCT02087423|323954161|FG000|Overall Study|Withdrawal by Subject|20|||
94659352|NCT01722331|324208015|FG004|Part 2|Lost to Follow-up|0|||
94659353|NCT01722331|324208016|FG005|Part 2|Lost to Follow-up|1|||
94659354|NCT01722331|324208017|FG006|Part 2|Lost to Follow-up|1|||
94659355|NCT01722331|324208011|FG000|Part 2|Non-Compliance with Study Drug|1|||
94659356|NCT01722331|324208012|FG001|Part 2|Non-Compliance with Study Drug|0|||
94587920|NCT02087423|323954162|FG001|Overall Study|Withdrawal by Subject|20|||
94587921|NCT02087423|323954163|FG002|Overall Study|Withdrawal by Subject|3|||
94587922|NCT02087423|323954161|FG000|Overall Study|Death|68|||
94587923|NCT02087423|323954162|FG001|Overall Study|Death|207|||
94587924|NCT02087423|323954163|FG002|Overall Study|Death|40|||
94587925|NCT02087423|323954161|FG000|Overall Study|Lost to Follow-up|0|||
94587926|NCT02087423|323954162|FG001|Overall Study|Lost to Follow-up|2|||
94587927|NCT02087423|323954163|FG002|Overall Study|Lost to Follow-up|0|||
94587928|NCT02087423|323954161|FG000|Overall Study|Terminated from study at final DCO|23|||
94587929|NCT02087423|323954162|FG001|Overall Study|Terminated from study at final DCO|36|||
94587930|NCT02087423|323954163|FG002|Overall Study|Terminated from study at final DCO|25|||
94587931|NCT01010867|323954164|FG000|Overall Study|< 50% adherence to probiotic|1|||
94659357|NCT01722331|324208013|FG002|Part 2|Non-Compliance with Study Drug|1|||
94659358|NCT01722331|324208014|FG003|Part 2|Non-Compliance with Study Drug|0|||
94659359|NCT01722331|324208015|FG004|Part 2|Non-Compliance with Study Drug|0|||
94587932|NCT02039843|323954167|FG000|Randomization and Observation Period|Adverse Event|2|||
94587933|NCT02039843|323954168|FG001|Randomization and Observation Period|Adverse Event|0|||
94587934|NCT02039843|323954167|FG000|Randomization and Observation Period|Death|1|||
94587935|NCT02039843|323954168|FG001|Randomization and Observation Period|Death|0|||
94587936|NCT02039843|323954167|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
94587937|NCT02039843|323954168|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
94587938|NCT02039843|323954167|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
94587939|NCT02039843|323954168|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
94587940|NCT02039843|323954167|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
94587941|NCT02039843|323954168|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
94587942|NCT02039843|323954167|FG000|Pairing With a Study Dog|Death|1|||
94587943|NCT02039843|323954168|FG001|Pairing With a Study Dog|Death|0|||
94587944|NCT02039843|323954167|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
94587945|NCT02039843|323954168|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
94587946|NCT02039843|323954167|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
94587947|NCT02039843|323954168|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
94587948|NCT02039843|323954167|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
94587949|NCT02039843|323954168|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
94587950|NCT00884741|323954169|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
94587951|NCT00884741|323954170|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
94587952|NCT00884741|323954171|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
94587953|NCT00884741|323954172|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
94587954|NCT00884741|323954169|FG000|Step 1 Registration: Tissue Screening|Death|3|||
94587955|NCT00884741|323954170|FG001|Step 1 Registration: Tissue Screening|Death|0|||
94587956|NCT00884741|323954171|FG002|Step 1 Registration: Tissue Screening|Death|0|||
94587957|NCT00884741|323954172|FG003|Step 1 Registration: Tissue Screening|Death|0|||
94587958|NCT00884741|323954169|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
94587959|NCT00884741|323954170|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
94587960|NCT00884741|323954171|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
94587961|NCT00884741|323954172|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
94659360|NCT01722331|324208016|FG005|Part 2|Non-Compliance with Study Drug|0|||
94659361|NCT01722331|324208017|FG006|Part 2|Non-Compliance with Study Drug|0|||
94659362|NCT01722331|324208011|FG000|Part 2|Physician Decision|0|||
94659363|NCT01722331|324208012|FG001|Part 2|Physician Decision|0|||
94353604|NCT01072175|323077079|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
94353605|NCT01072175|323077080|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
94353606|NCT01072175|323077081|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
94587962|NCT00884741|323954169|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
94587963|NCT00884741|323954170|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
94659364|NCT01722331|324208013|FG002|Part 2|Physician Decision|2|||
94587964|NCT00884741|323954171|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
94587965|NCT00884741|323954172|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
94587966|NCT00884741|323954169|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
94587967|NCT00884741|323954170|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
94587968|NCT00884741|323954171|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
94587969|NCT00884741|323954172|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
94587970|NCT00884741|323954169|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
94587971|NCT00884741|323954170|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
94587972|NCT00884741|323954171|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
94587973|NCT00884741|323954172|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
94587974|NCT00884741|323954169|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
94587975|NCT00884741|323954170|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
94587976|NCT00884741|323954171|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
94587977|NCT00884741|323954172|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
94587978|NCT00884741|323954169|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
94587979|NCT00884741|323954170|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
94587980|NCT00884741|323954171|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
94587981|NCT00884741|323954172|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
94587982|NCT00884741|323954169|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
94587983|NCT00884741|323954170|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
94587984|NCT00884741|323954171|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
94587985|NCT00884741|323954172|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
94587986|NCT00884741|323954169|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
94587987|NCT00884741|323954170|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
94587988|NCT00884741|323954171|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
94587989|NCT00884741|323954172|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
94587990|NCT00884741|323954169|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
94587991|NCT00884741|323954170|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
94587992|NCT00884741|323954171|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
94587993|NCT00884741|323954172|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
94587994|NCT00884741|323954169|FG000|Randomization|Protocol Violation|0|||
94587995|NCT00884741|323954170|FG001|Randomization|Protocol Violation|0|||
94587996|NCT00884741|323954171|FG002|Randomization|Protocol Violation|8|||
94587997|NCT00884741|323954172|FG003|Randomization|Protocol Violation|8|||
94587998|NCT03500224|323954173|FG000|Overall Study|Withdrawal by Subject|2|||
94587999|NCT01668589|323954175|FG000|Overall Study|Lost to Follow-up|29|||
94588000|NCT01668589|323954176|FG001|Overall Study|Lost to Follow-up|37|||
94588001|NCT01668589|323954177|FG002|Overall Study|Lost to Follow-up|15|||
94588002|NCT01668589|323954178|FG003|Overall Study|Lost to Follow-up|5|||
94588003|NCT01668589|323954175|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
94588004|NCT01668589|323954176|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
94588005|NCT01668589|323954177|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
94588006|NCT01668589|323954178|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
94588007|NCT01668589|323954175|FG000|Overall Study|Death|12|||
94588008|NCT01668589|323954176|FG001|Overall Study|Death|3|||
94588009|NCT01668589|323954177|FG002|Overall Study|Death|2|||
94588010|NCT01668589|323954178|FG003|Overall Study|Death|11|||
94588011|NCT01668589|323954175|FG000|Overall Study|Other|44|||
94588012|NCT01668589|323954176|FG001|Overall Study|Other|10|||
94588013|NCT01668589|323954177|FG002|Overall Study|Other|7|||
94588014|NCT01668589|323954178|FG003|Overall Study|Other|15|||
94588015|NCT04002908|323954179|FG000|Overall Study|Death|41|||
94588016|NCT04002908|323954180|FG001|Overall Study|Death|0|||
94588017|NCT04002908|323954181|FG002|Overall Study|Death|0|||
94588018|NCT04002908|323954182|FG003|Overall Study|Death|0|||
94588019|NCT04002908|323954179|FG000|Overall Study|Withdrawal by Subject|112|||
94588020|NCT04002908|323954180|FG001|Overall Study|Withdrawal by Subject|0|||
94588021|NCT04002908|323954181|FG002|Overall Study|Withdrawal by Subject|0|||
94588022|NCT04002908|323954182|FG003|Overall Study|Withdrawal by Subject|0|||
94588023|NCT04002908|323954179|FG000|Overall Study|Lost to Follow-up|72|||
94588024|NCT04002908|323954180|FG001|Overall Study|Lost to Follow-up|0|||
94588025|NCT04002908|323954181|FG002|Overall Study|Lost to Follow-up|0|||
94456020|NCT01062113|323458161|FG001|Overall Study|Lack of Efficacy|22|||
94456021|NCT01062113|323458162|FG002|Overall Study|Lack of Efficacy|31|||
94588026|NCT04002908|323954182|FG003|Overall Study|Lost to Follow-up|0|||
94588027|NCT04002908|323954179|FG000|Overall Study|Infant died, so mother withdrawn|34|||
94588028|NCT04002908|323954180|FG001|Overall Study|Infant died, so mother withdrawn|0|||
94588029|NCT04002908|323954181|FG002|Overall Study|Infant died, so mother withdrawn|0|||
94588030|NCT04002908|323954182|FG003|Overall Study|Infant died, so mother withdrawn|0|||
94588031|NCT04189224|323954183|FG000|Period 2|Adverse Event|0|||
94588032|NCT04189224|323954184|FG001|Period 2|Adverse Event|1|||
94588033|NCT02529553|323954188|FG000|Overall Study|Progressive Disease|1|||
94588034|NCT02529553|323954189|FG001|Overall Study|Progressive Disease|0|||
94588035|NCT02529553|323954190|FG002|Overall Study|Progressive Disease|1|||
94588036|NCT02529553|323954191|FG003|Overall Study|Progressive Disease|3|||
94588037|NCT02529553|323954192|FG004|Overall Study|Progressive Disease|2|||
94588038|NCT02529553|323954193|FG005|Overall Study|Progressive Disease|3|||
94588039|NCT02529553|323954194|FG006|Overall Study|Progressive Disease|3|||
94588040|NCT02529553|323954195|FG007|Overall Study|Progressive Disease|5|||
94588041|NCT02529553|323954196|FG008|Overall Study|Progressive Disease|3|||
94588042|NCT02529553|323954188|FG000|Overall Study|Physician Decision|0|||
94588043|NCT02529553|323954189|FG001|Overall Study|Physician Decision|1|||
94588044|NCT02529553|323954190|FG002|Overall Study|Physician Decision|0|||
94588045|NCT02529553|323954191|FG003|Overall Study|Physician Decision|0|||
94588046|NCT02529553|323954192|FG004|Overall Study|Physician Decision|1|||
94588047|NCT02529553|323954193|FG005|Overall Study|Physician Decision|0|||
94588048|NCT02529553|323954194|FG006|Overall Study|Physician Decision|0|||
94588049|NCT02529553|323954195|FG007|Overall Study|Physician Decision|0|||
94588050|NCT02529553|323954196|FG008|Overall Study|Physician Decision|0|||
94588051|NCT02529553|323954188|FG000|Overall Study|Withdrawal by Subject|0|||
94588052|NCT02529553|323954189|FG001|Overall Study|Withdrawal by Subject|0|||
94588053|NCT02529553|323954190|FG002|Overall Study|Withdrawal by Subject|0|||
94588054|NCT02529553|323954191|FG003|Overall Study|Withdrawal by Subject|0|||
94588055|NCT02529553|323954192|FG004|Overall Study|Withdrawal by Subject|0|||
94588056|NCT02529553|323954193|FG005|Overall Study|Withdrawal by Subject|1|||
94588057|NCT02529553|323954194|FG006|Overall Study|Withdrawal by Subject|0|||
94588058|NCT02529553|323954195|FG007|Overall Study|Withdrawal by Subject|1|||
94588059|NCT02529553|323954196|FG008|Overall Study|Withdrawal by Subject|0|||
94588060|NCT03818035|323954203|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
94588061|NCT03818035|323954204|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
94588062|NCT03818035|323954205|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
94588063|NCT03818035|323954206|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
94588064|NCT03818035|323954203|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
94588065|NCT03818035|323954204|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
94588066|NCT03818035|323954205|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
94588067|NCT03818035|323954206|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
94588068|NCT03818035|323954203|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
94588069|NCT03818035|323954204|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
94588070|NCT03818035|323954205|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
94588071|NCT03818035|323954206|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
94588072|NCT03818035|323954203|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
94588073|NCT03818035|323954204|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
94588074|NCT03818035|323954205|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
94588075|NCT03818035|323954206|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
94588076|NCT03818035|323954203|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
94588077|NCT03818035|323954204|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
94588078|NCT03818035|323954205|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
94588079|NCT03818035|323954206|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
94588080|NCT03818035|323954203|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
94588081|NCT03818035|323954204|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
94588082|NCT03818035|323954205|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
94588083|NCT03818035|323954206|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
94588084|NCT03818035|323954203|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
94588085|NCT03818035|323954204|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
94588086|NCT03818035|323954205|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
94588087|NCT03818035|323954206|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
94588088|NCT03818035|323954203|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
94588089|NCT03818035|323954204|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
94588090|NCT03818035|323954205|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
94588091|NCT03818035|323954206|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
94588092|NCT03818035|323954203|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
94588093|NCT03818035|323954204|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
94588094|NCT03818035|323954205|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
94588095|NCT03818035|323954206|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
94588096|NCT03818035|323954203|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
94588097|NCT03818035|323954204|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
94588098|NCT03818035|323954205|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
94588099|NCT03818035|323954206|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
94588100|NCT03818035|323954203|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
94588101|NCT03818035|323954204|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
94588102|NCT03818035|323954205|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
94588103|NCT03818035|323954206|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
94588104|NCT03818035|323954203|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
94588105|NCT03818035|323954204|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
94588106|NCT03818035|323954205|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
94588107|NCT03818035|323954206|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
94588108|NCT03818035|323954203|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
94588109|NCT03818035|323954204|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
94588110|NCT03818035|323954205|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
94588111|NCT03818035|323954206|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
94588112|NCT03818035|323954203|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
94588113|NCT03818035|323954204|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
94588114|NCT03818035|323954205|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
94588115|NCT03818035|323954206|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
94588116|NCT03818035|323954203|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
94588117|NCT03818035|323954204|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
94588118|NCT03818035|323954205|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
94588119|NCT03818035|323954206|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
94588120|NCT03374202|323954207|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
94588121|NCT03374202|323954208|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
94588122|NCT03374202|323954209|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
94588123|NCT03374202|323954207|FG000|Five Year Long Term Follow Up|Death|0|||
94588124|NCT03374202|323954208|FG001|Five Year Long Term Follow Up|Death|1|||
94588125|NCT03374202|323954209|FG002|Five Year Long Term Follow Up|Death|0|||
94588126|NCT05141448|323954210|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
94588127|NCT05141448|323954211|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
94588128|NCT05141448|323954212|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
94588129|NCT05141448|323954213|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
94588130|NCT05141448|323954214|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
94588131|NCT05141448|323954215|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
94588132|NCT05141448|323954210|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
94588133|NCT05141448|323954211|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
94588134|NCT05141448|323954212|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
94588135|NCT05141448|323954213|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
94588136|NCT05141448|323954214|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
94588137|NCT05141448|323954215|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
94588138|NCT05141448|323954210|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
94588139|NCT05141448|323954211|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
94588140|NCT05141448|323954212|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
94588141|NCT05141448|323954213|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
94588142|NCT05141448|323954214|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
94588143|NCT05141448|323954215|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
94588144|NCT05141448|323954210|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
94588145|NCT05141448|323954211|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
94588146|NCT05141448|323954212|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
94588147|NCT05141448|323954213|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
94588148|NCT05141448|323954214|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
94588149|NCT05141448|323954215|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
94588150|NCT05141448|323954210|FG000|Period 2|COVID-19 Related|0|||
94588151|NCT05141448|323954211|FG001|Period 2|COVID-19 Related|0|||
94588152|NCT05141448|323954212|FG002|Period 2|COVID-19 Related|0|||
94588153|NCT05141448|323954213|FG003|Period 2|COVID-19 Related|1|||
94588154|NCT05141448|323954214|FG004|Period 2|COVID-19 Related|0|||
94588155|NCT05141448|323954215|FG005|Period 2|COVID-19 Related|1|||
94588156|NCT05141448|323954210|FG000|3|Covid-19 related|2|||
94588157|NCT05141448|323954211|FG001|3|Covid-19 related|0|||
94588158|NCT05141448|323954212|FG002|3|Covid-19 related|0|||
94588159|NCT05141448|323954213|FG003|3|Covid-19 related|0|||
94588160|NCT05141448|323954214|FG004|3|Covid-19 related|0|||
94588161|NCT05141448|323954215|FG005|3|Covid-19 related|1|||
94588162|NCT05141448|323954210|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
94588163|NCT05141448|323954211|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
94588164|NCT05141448|323954212|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
94588165|NCT05141448|323954213|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
94588166|NCT05141448|323954214|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
94588167|NCT05141448|323954215|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
94588168|NCT02605122|323955746|FG000|Overall Study|Withdrawal by Subject|4|||
94242670|NCT01646177|322682735|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
94588169|NCT02605122|323955747|FG001|Overall Study|Withdrawal by Subject|1|||
94588170|NCT02605122|323955746|FG000|Overall Study|Lost to Follow-up|1|||
94588171|NCT02605122|323955747|FG001|Overall Study|Lost to Follow-up|1|||
94588172|NCT02331277|323955748|FG000|Overall Study|Withdrawal by Subject|1|||
94588173|NCT02331277|323955749|FG001|Overall Study|Withdrawal by Subject|0|||
94588174|NCT02604160|323955752|FG000|Overall Study|Protocol Violation|0|||
94588175|NCT02604160|323955753|FG001|Overall Study|Protocol Violation|1|||
94588176|NCT02604160|323955752|FG000|Overall Study|Physician Decision|0|||
94588177|NCT02604160|323955753|FG001|Overall Study|Physician Decision|1|||
94588178|NCT01069900|323955756|FG000|Overall Study|Technical problems|0|||
94588179|NCT01069900|323955757|FG001|Overall Study|Technical problems|1|||
94588180|NCT01069900|323955756|FG000|Overall Study|Lost to Follow-up|7|||
94588181|NCT01069900|323955757|FG001|Overall Study|Lost to Follow-up|1|||
94588182|NCT01069900|323955756|FG000|Overall Study|Withdrawal by Subject|6|||
94588183|NCT01069900|323955757|FG001|Overall Study|Withdrawal by Subject|1|||
94588184|NCT01069900|323955756|FG000|Overall Study|Protocol Violation|4|||
94588185|NCT01069900|323955757|FG001|Overall Study|Protocol Violation|1|||
94588186|NCT01069900|323955756|FG000|Overall Study|Insufficient Therapeutic effect|1|||
94659365|NCT01722331|324208014|FG003|Part 2|Physician Decision|0|||
94659366|NCT01722331|324208015|FG004|Part 2|Physician Decision|0|||
94659367|NCT01722331|324208016|FG005|Part 2|Physician Decision|0|||
94659368|NCT01722331|324208017|FG006|Part 2|Physician Decision|0|||
94659369|NCT01722331|324208011|FG000|Part 2|Pregnancy|0|||
94659370|NCT01722331|324208012|FG001|Part 2|Pregnancy|0|||
94659371|NCT01722331|324208013|FG002|Part 2|Pregnancy|0|||
94659372|NCT01722331|324208014|FG003|Part 2|Pregnancy|0|||
94659373|NCT01722331|324208015|FG004|Part 2|Pregnancy|0|||
94659374|NCT01722331|324208016|FG005|Part 2|Pregnancy|1|||
94588187|NCT01069900|323955757|FG001|Overall Study|Insufficient Therapeutic effect|0|||
94588188|NCT02687191|323955758|FG000|Overall Study|Death|0|||
94588189|NCT02687191|323955759|FG001|Overall Study|Death|1|||
94659375|NCT01722331|324208017|FG006|Part 2|Pregnancy|0|||
94659376|NCT01722331|324208011|FG000|Part 2|Progressive Disease|0|||
94659377|NCT01722331|324208012|FG001|Part 2|Progressive Disease|0|||
94659378|NCT01722331|324208013|FG002|Part 2|Progressive Disease|1|||
94588190|NCT02687191|323955760|FG002|Overall Study|Death|1|||
94588191|NCT02687191|323955761|FG003|Overall Study|Death|0|||
94588192|NCT02687191|323955762|FG004|Overall Study|Death|1|||
94588193|NCT02687191|323955763|FG005|Overall Study|Death|1|||
94588194|NCT02687191|323955758|FG000|Overall Study|Withdrawal by Subject|0|||
94588195|NCT02687191|323955759|FG001|Overall Study|Withdrawal by Subject|0|||
94588196|NCT02687191|323955760|FG002|Overall Study|Withdrawal by Subject|0|||
94588197|NCT02687191|323955761|FG003|Overall Study|Withdrawal by Subject|1|||
94588198|NCT02687191|323955762|FG004|Overall Study|Withdrawal by Subject|0|||
94588199|NCT02687191|323955763|FG005|Overall Study|Withdrawal by Subject|0|||
94588200|NCT01754727|323955766|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
94588201|NCT02948634|323955767|FG000|Overall Study|Lack of efficacy and study suspended|10|||
94588202|NCT02948634|323955768|FG001|Overall Study|Lack of efficacy and study suspended|2|||
94588203|NCT03790696|323955769|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
94588204|NCT03790696|323955770|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
94588205|NCT01149148|323955771|FG000|Overall Study|Lost to Follow-up|1|||
94588206|NCT01149148|323955772|FG001|Overall Study|Lost to Follow-up|2|||
94588207|NCT01149148|323955771|FG000|Overall Study|Death|1|||
94588208|NCT01149148|323955772|FG001|Overall Study|Death|0|||
94588209|NCT02249832|323955773|FG000|Overall Study|Withdrawal by Subject|3|||
94588210|NCT02249832|323955773|FG000|Overall Study|Lost to Follow-up|10|||
94588211|NCT00243269|323955779|FG000|Overall Study|Protocol Violation|2|||
94588212|NCT00243269|323955780|FG001|Overall Study|Protocol Violation|1|||
94588213|NCT00243269|323955781|FG002|Overall Study|Protocol Violation|0|||
94588214|NCT00243269|323955782|FG003|Overall Study|Protocol Violation|1|||
94588215|NCT00243269|323955779|FG000|Overall Study|Lost to Follow-up|1|||
94659379|NCT01722331|324208014|FG003|Part 2|Progressive Disease|0|||
94659380|NCT01722331|324208015|FG004|Part 2|Progressive Disease|0|||
94659381|NCT01722331|324208016|FG005|Part 2|Progressive Disease|0|||
94659382|NCT01722331|324208017|FG006|Part 2|Progressive Disease|0|||
94659383|NCT01722331|324208011|FG000|Part 2|Protocol Violation|1|||
94659384|NCT01722331|324208012|FG001|Part 2|Protocol Violation|0|||
94659385|NCT01722331|324208013|FG002|Part 2|Protocol Violation|0|||
94659386|NCT01722331|324208014|FG003|Part 2|Protocol Violation|0|||
94659387|NCT01722331|324208015|FG004|Part 2|Protocol Violation|0|||
94588216|NCT00243269|323955780|FG001|Overall Study|Lost to Follow-up|0|||
94659388|NCT01722331|324208016|FG005|Part 2|Protocol Violation|0|||
94659389|NCT01722331|324208017|FG006|Part 2|Protocol Violation|0|||
94588217|NCT00243269|323955781|FG002|Overall Study|Lost to Follow-up|1|||
94588218|NCT00243269|323955782|FG003|Overall Study|Lost to Follow-up|3|||
94659390|NCT01722331|324208011|FG000|Part 2|Withdrawal by Subject|5|||
94659391|NCT01722331|324208012|FG001|Part 2|Withdrawal by Subject|0|||
94659392|NCT01722331|324208013|FG002|Part 2|Withdrawal by Subject|3|||
94659393|NCT01722331|324208014|FG003|Part 2|Withdrawal by Subject|0|||
94659394|NCT01722331|324208015|FG004|Part 2|Withdrawal by Subject|0|||
94659395|NCT01722331|324208016|FG005|Part 2|Withdrawal by Subject|2|||
94588219|NCT03085797|323955784|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
94588220|NCT03085797|323955785|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
94588221|NCT03085797|323955784|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
94588222|NCT03085797|323955785|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
94588223|NCT03085797|323955784|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
94588224|NCT03085797|323955785|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
94588225|NCT01716052|323955786|FG000|Overall Study|Withdrawal of funding|1|||
94588226|NCT01716052|323955787|FG001|Overall Study|Withdrawal of funding|1|||
94588227|NCT03534180|323955788|FG000|Overall Study|Withdrawal by Subject|1|||
94588228|NCT00220636|323955789|FG000|Overall Study|Withdrawal by Subject|4|||
94588229|NCT00859456|323955791|FG000|Overall Study|Adverse Event|3|||
94588230|NCT00859456|323955791|FG000|Overall Study|Progressive disease|2|||
94588231|NCT00859456|323955791|FG000|Overall Study|Non-compliance|3|||
94588232|NCT04881942|323955792|FG000|Overall Study|Adverse Event|0|||
94588233|NCT04881942|323955793|FG001|Overall Study|Adverse Event|0|||
94588234|NCT04881942|323955794|FG002|Overall Study|Adverse Event|0|||
94588235|NCT04881942|323955795|FG003|Overall Study|Adverse Event|0|||
94588236|NCT04881942|323955796|FG004|Overall Study|Adverse Event|1|||
94588237|NCT04881942|323955792|FG000|Overall Study|Alternates|0|||
94588238|NCT04881942|323955793|FG001|Overall Study|Alternates|0|||
94588239|NCT04881942|323955794|FG002|Overall Study|Alternates|0|||
94588240|NCT04881942|323955795|FG003|Overall Study|Alternates|0|||
94588241|NCT04881942|323955796|FG004|Overall Study|Alternates|2|||
94588242|NCT04693234|323955797|FG000|Overall Study|Death|79|||
94588243|NCT04693234|323955798|FG001|Overall Study|Death|19|||
94588244|NCT04693234|323955797|FG000|Overall Study|Sponsor Ended Study|47|||
94588245|NCT04693234|323955798|FG001|Overall Study|Sponsor Ended Study|18|||
94588246|NCT04693234|323955797|FG000|Overall Study|Withdrawal by Subject|10|||
94588247|NCT04693234|323955798|FG001|Overall Study|Withdrawal by Subject|2|||
94588248|NCT04693234|323955797|FG000|Overall Study|Lost to Follow-up|2|||
94588249|NCT04693234|323955798|FG001|Overall Study|Lost to Follow-up|1|||
94588250|NCT01092546|323955799|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
94588251|NCT02779556|323955800|FG000|Baseline|Partial baseline interview completed|1|||
94588252|NCT02779556|323955801|FG001|Baseline|Partial baseline interview completed|0|||
94588253|NCT02779556|323955800|FG000|3 Months|Lost to Follow-up|40|||
94588254|NCT02779556|323955801|FG001|3 Months|Lost to Follow-up|29|||
94588255|NCT02779556|323955800|FG000|3 Months|Missed 3 month clinic visit|27|||
94588256|NCT02779556|323955801|FG001|3 Months|Missed 3 month clinic visit|19|||
94588257|NCT02779556|323955800|FG000|6 Month|Lost to Follow-up|33|||
94588258|NCT02779556|323955801|FG001|6 Month|Lost to Follow-up|39|||
94588259|NCT02779556|323955800|FG000|6 Month HbA1c|No value collected during window|69|||
94588260|NCT02779556|323955801|FG001|6 Month HbA1c|No value collected during window|50|||
94588261|NCT02779556|323955800|FG000|12 Month HbA1c|No value collected during window|138|||
94588262|NCT02779556|323955801|FG001|12 Month HbA1c|No value collected during window|102|||
94588263|NCT00622440|323955802|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
94588264|NCT00622440|323955803|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
94588265|NCT00622440|323955802|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
94588266|NCT00622440|323955803|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
94588267|NCT00622440|323955802|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
94588268|NCT00622440|323955803|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
94588269|NCT00622440|323955802|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
94588270|NCT00622440|323955803|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
94588271|NCT02223858|323955806|FG000|Overall Study|Death|1|||
94588272|NCT02223858|323955807|FG001|Overall Study|Death|1|||
94588273|NCT02223858|323955806|FG000|Overall Study|Lost to Follow-up|6|||
94588274|NCT02223858|323955807|FG001|Overall Study|Lost to Follow-up|11|||
94588275|NCT02223858|323955806|FG000|Overall Study|Withdrawal by Subject|8|||
94588276|NCT02223858|323955807|FG001|Overall Study|Withdrawal by Subject|5|||
94588277|NCT02223858|323955806|FG000|Overall Study|Refused|9|||
94588278|NCT02223858|323955807|FG001|Overall Study|Refused|9|||
94588279|NCT03110770|323955808|FG000|Overall Study|Death|1|||
94588280|NCT03110770|323955809|FG001|Overall Study|Death|0|||
94588281|NCT03110770|323955810|FG002|Overall Study|Death|0|||
94588282|NCT03110770|323955811|FG003|Overall Study|Death|1|||
94588283|NCT03110770|323955812|FG004|Overall Study|Death|0|||
94659396|NCT01722331|324208017|FG006|Part 2|Withdrawal by Subject|2|||
94588284|NCT03110770|323955808|FG000|Overall Study|Enrolled but did not receive product|0|||
94588285|NCT03110770|323955809|FG001|Overall Study|Enrolled but did not receive product|0|||
94588286|NCT03110770|323955810|FG002|Overall Study|Enrolled but did not receive product|0|||
94588287|NCT03110770|323955811|FG003|Overall Study|Enrolled but did not receive product|8|||
94588288|NCT03110770|323955812|FG004|Overall Study|Enrolled but did not receive product|7|||
94588289|NCT03110770|323955808|FG000|Overall Study|Lost to Follow-up|0|||
94588290|NCT03110770|323955809|FG001|Overall Study|Lost to Follow-up|0|||
94588291|NCT03110770|323955810|FG002|Overall Study|Lost to Follow-up|0|||
94588292|NCT03110770|323955811|FG003|Overall Study|Lost to Follow-up|53|||
94588293|NCT03110770|323955812|FG004|Overall Study|Lost to Follow-up|45|||
94588294|NCT03110770|323955808|FG000|Overall Study|Investigator Decision|0|||
94588295|NCT03110770|323955809|FG001|Overall Study|Investigator Decision|0|||
94588296|NCT03110770|323955810|FG002|Overall Study|Investigator Decision|0|||
94588297|NCT03110770|323955811|FG003|Overall Study|Investigator Decision|5|||
94588298|NCT03110770|323955812|FG004|Overall Study|Investigator Decision|3|||
94588299|NCT03110770|323955808|FG000|Overall Study|Withdrawal by Subject|0|||
94588300|NCT03110770|323955809|FG001|Overall Study|Withdrawal by Subject|0|||
94588301|NCT03110770|323955810|FG002|Overall Study|Withdrawal by Subject|0|||
94588302|NCT03110770|323955811|FG003|Overall Study|Withdrawal by Subject|24|||
94588303|NCT03110770|323955812|FG004|Overall Study|Withdrawal by Subject|24|||
94588304|NCT03110770|323955808|FG000|Overall Study|Moved from area|5|||
94588305|NCT03110770|323955809|FG001|Overall Study|Moved from area|0|||
94588306|NCT03110770|323955810|FG002|Overall Study|Moved from area|2|||
94588307|NCT03110770|323955811|FG003|Overall Study|Moved from area|42|||
94588308|NCT03110770|323955812|FG004|Overall Study|Moved from area|43|||
94588309|NCT03110770|323955808|FG000|Overall Study|Illness/Injury unrelated to product|0|||
94588310|NCT03110770|323955809|FG001|Overall Study|Illness/Injury unrelated to product|0|||
94588311|NCT03110770|323955810|FG002|Overall Study|Illness/Injury unrelated to product|0|||
94588312|NCT03110770|323955811|FG003|Overall Study|Illness/Injury unrelated to product|0|||
94588313|NCT03110770|323955812|FG004|Overall Study|Illness/Injury unrelated to product|1|||
94588314|NCT00771953|323955813|FG000|Overall Study|Adverse Event|5|||
94588315|NCT00771953|323955814|FG001|Overall Study|Adverse Event|3|||
94588316|NCT00771953|323955813|FG000|Overall Study|Death|2|||
94588317|NCT00771953|323955814|FG001|Overall Study|Death|2|||
94588318|NCT00771953|323955813|FG000|Overall Study|Progression before active Tx|1|||
94588319|NCT00771953|323955814|FG001|Overall Study|Progression before active Tx|2|||
94588320|NCT00771953|323955813|FG000|Overall Study|Sponsor decision|1|||
94588321|NCT00771953|323955814|FG001|Overall Study|Sponsor decision|0|||
94353607|NCT01072175|323077082|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
94588322|NCT00771953|323955813|FG000|Overall Study|Other complicating disease|1|||
94588323|NCT00771953|323955814|FG001|Overall Study|Other complicating disease|0|||
94588324|NCT00771953|323955813|FG000|Overall Study|Withdrawal by Subject|0|||
94588325|NCT00771953|323955814|FG001|Overall Study|Withdrawal by Subject|3|||
94588326|NCT00856518|323955815|FG000|Overall Study|Lost to Follow-up|4|||
94588327|NCT00856518|323955816|FG001|Overall Study|Lost to Follow-up|2|||
94588328|NCT04849559|323955817|FG000|Overall Study|Withdrawal by Subject|2|||
94588329|NCT04849559|323955818|FG001|Overall Study|Withdrawal by Subject|1|||
94588330|NCT00947193|323955819|FG000|Overall Study|Lost to Follow-up|1|||
94588331|NCT00947193|323955820|FG001|Overall Study|Lost to Follow-up|0|||
94588332|NCT00947193|323955819|FG000|Overall Study|Withdrawal by Subject|1|||
94353608|NCT01072175|323077083|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
94588333|NCT00947193|323955820|FG001|Overall Study|Withdrawal by Subject|0|||
94353609|NCT01072175|323077084|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
94588334|NCT00947193|323955819|FG000|Overall Study|Factor VIII >1%|1|||
94588335|NCT00947193|323955820|FG001|Overall Study|Factor VIII >1%|0|||
94588336|NCT00926029|323955821|FG000|Overall Study|Lost to Follow-up|2|||
94588337|NCT00926029|323955822|FG001|Overall Study|Lost to Follow-up|1|||
94588338|NCT00926029|323955823|FG002|Overall Study|Lost to Follow-up|1|||
94588339|NCT02675634|323955824|FG000|Test Period 1|Adverse Event|0|||
94588340|NCT02675634|323955825|FG001|Test Period 1|Adverse Event|1|||
94588341|NCT02675634|323955826|FG002|Test Period 1|Adverse Event|0|||
94588342|NCT02675634|323955827|FG003|Test Period 1|Adverse Event|1|||
94588343|NCT02675634|323955828|FG004|Test Period 1|Adverse Event|0|||
94588344|NCT02675634|323955829|FG005|Test Period 1|Adverse Event|0|||
94588345|NCT02675634|323955824|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
94588346|NCT02675634|323955825|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
94588347|NCT02675634|323955826|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
94588348|NCT02675634|323955827|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
94588349|NCT02675634|323955828|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
94588350|NCT02675634|323955829|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
94659397|NCT01722331|324208011|FG000|Part 2|Other Protocol Specified Criteria|6|||
94659398|NCT01722331|324208012|FG001|Part 2|Other Protocol Specified Criteria|0|||
94659399|NCT01722331|324208013|FG002|Part 2|Other Protocol Specified Criteria|10|||
94659400|NCT01722331|324208014|FG003|Part 2|Other Protocol Specified Criteria|0|||
94242671|NCT01646177|322682736|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
94242672|NCT01646177|322682737|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
94242673|NCT01646177|322682738|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
94242674|NCT01646177|322682739|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
94242675|NCT01646177|322682740|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
94242676|NCT01646177|322682741|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
94242677|NCT01646177|322682730|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
94242678|NCT01646177|322682731|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
94353610|NCT01072175|323077085|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
94659401|NCT01722331|324208015|FG004|Part 2|Other Protocol Specified Criteria|0|||
94659402|NCT01722331|324208016|FG005|Part 2|Other Protocol Specified Criteria|2|||
94659403|NCT01722331|324208017|FG006|Part 2|Other Protocol Specified Criteria|1|||
94659404|NCT01722331|324208011|FG000|Part 3|Adverse Event|2|||
94659405|NCT01722331|324208012|FG001|Part 3|Adverse Event|2|||
94659406|NCT01722331|324208013|FG002|Part 3|Adverse Event|0|||
94659407|NCT01722331|324208014|FG003|Part 3|Adverse Event|1|||
94659408|NCT01722331|324208015|FG004|Part 3|Adverse Event|0|||
94659409|NCT01722331|324208016|FG005|Part 3|Adverse Event|0|||
94659410|NCT01722331|324208017|FG006|Part 3|Adverse Event|0|||
94659411|NCT01722331|324208011|FG000|Part 3|Death|1|||
94659412|NCT01722331|324208012|FG001|Part 3|Death|0|||
94659413|NCT01722331|324208013|FG002|Part 3|Death|0|||
94659414|NCT01722331|324208014|FG003|Part 3|Death|0|||
94659415|NCT01722331|324208015|FG004|Part 3|Death|0|||
94659416|NCT01722331|324208016|FG005|Part 3|Death|0|||
94659417|NCT01722331|324208017|FG006|Part 3|Death|0|||
94659418|NCT01722331|324208011|FG000|Part 3|Lack of Efficacy|1|||
94659419|NCT01722331|324208012|FG001|Part 3|Lack of Efficacy|0|||
94659420|NCT01722331|324208013|FG002|Part 3|Lack of Efficacy|0|||
94659421|NCT01722331|324208014|FG003|Part 3|Lack of Efficacy|0|||
94659422|NCT01722331|324208015|FG004|Part 3|Lack of Efficacy|0|||
94659423|NCT01722331|324208016|FG005|Part 3|Lack of Efficacy|0|||
94659424|NCT01722331|324208017|FG006|Part 3|Lack of Efficacy|0|||
94659425|NCT01722331|324208011|FG000|Part 3|Lost to Follow-up|3|||
94659426|NCT01722331|324208012|FG001|Part 3|Lost to Follow-up|4|||
94659427|NCT01722331|324208013|FG002|Part 3|Lost to Follow-up|0|||
94659428|NCT01722331|324208014|FG003|Part 3|Lost to Follow-up|0|||
94659429|NCT01722331|324208015|FG004|Part 3|Lost to Follow-up|0|||
94659430|NCT01722331|324208016|FG005|Part 3|Lost to Follow-up|1|||
94659431|NCT01722331|324208017|FG006|Part 3|Lost to Follow-up|0|||
94659432|NCT01722331|324208011|FG000|Part 3|Non-Compliance with Study Drug|0|||
94659433|NCT01722331|324208012|FG001|Part 3|Non-Compliance with Study Drug|1|||
94659434|NCT01722331|324208013|FG002|Part 3|Non-Compliance with Study Drug|0|||
94659435|NCT01722331|324208014|FG003|Part 3|Non-Compliance with Study Drug|0|||
94659436|NCT01722331|324208015|FG004|Part 3|Non-Compliance with Study Drug|0|||
94659437|NCT01722331|324208016|FG005|Part 3|Non-Compliance with Study Drug|0|||
94659438|NCT01722331|324208017|FG006|Part 3|Non-Compliance with Study Drug|0|||
94659439|NCT01722331|324208011|FG000|Part 3|Physician Decision|1|||
94659440|NCT01722331|324208012|FG001|Part 3|Physician Decision|1|||
94659441|NCT01722331|324208013|FG002|Part 3|Physician Decision|0|||
94659442|NCT01722331|324208014|FG003|Part 3|Physician Decision|0|||
94659443|NCT01722331|324208015|FG004|Part 3|Physician Decision|0|||
94659444|NCT01722331|324208016|FG005|Part 3|Physician Decision|0|||
94588351|NCT02675634|323955824|FG000|Test Period 2|Lack of Efficacy|1|||
94588352|NCT02675634|323955825|FG001|Test Period 2|Lack of Efficacy|0|||
94659445|NCT01722331|324208017|FG006|Part 3|Physician Decision|1|||
94659446|NCT01722331|324208011|FG000|Part 3|Protocol Violation|2|||
94659447|NCT01722331|324208012|FG001|Part 3|Protocol Violation|1|||
94659448|NCT01722331|324208013|FG002|Part 3|Protocol Violation|0|||
94659449|NCT01722331|324208014|FG003|Part 3|Protocol Violation|0|||
94659450|NCT01722331|324208015|FG004|Part 3|Protocol Violation|0|||
94659451|NCT01722331|324208016|FG005|Part 3|Protocol Violation|0|||
94659452|NCT01722331|324208017|FG006|Part 3|Protocol Violation|0|||
94659453|NCT01722331|324208011|FG000|Part 3|Withdrawal by Subject|4|||
94456022|NCT01062113|323458160|FG000|Overall Study|Withdrawal by Subject|1|||
94456023|NCT01062113|323458161|FG001|Overall Study|Withdrawal by Subject|0|||
94242679|NCT01646177|322682732|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
94242680|NCT01646177|322682733|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
94242681|NCT01646177|322682734|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
94242682|NCT01646177|322682735|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
94242683|NCT01646177|322682736|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
94242684|NCT01646177|322682737|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
94456024|NCT01062113|323458162|FG002|Overall Study|Withdrawal by Subject|0|||
94456025|NCT03521115|323458165|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
94456026|NCT03521115|323458166|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
94588353|NCT02675634|323955826|FG002|Test Period 2|Lack of Efficacy|0|||
94588354|NCT02675634|323955827|FG003|Test Period 2|Lack of Efficacy|0|||
94588355|NCT02675634|323955828|FG004|Test Period 2|Lack of Efficacy|0|||
94588356|NCT02675634|323955829|FG005|Test Period 2|Lack of Efficacy|0|||
94588357|NCT02675634|323955824|FG000|Test Period 2|Adverse Event|0|||
94588358|NCT02675634|323955825|FG001|Test Period 2|Adverse Event|0|||
94588359|NCT02675634|323955826|FG002|Test Period 2|Adverse Event|0|||
94588360|NCT02675634|323955827|FG003|Test Period 2|Adverse Event|0|||
94588361|NCT02675634|323955828|FG004|Test Period 2|Adverse Event|0|||
94588362|NCT02675634|323955829|FG005|Test Period 2|Adverse Event|1|||
94588363|NCT01652534|323955830|FG000|Overall Study|Lack of Efficacy|1|||
94588364|NCT01652534|323955831|FG001|Overall Study|Lack of Efficacy|0|||
94588365|NCT02105961|323955832|FG000|Overall Study|Adverse Event|18|||
94588366|NCT02105961|323955833|FG001|Overall Study|Adverse Event|7|||
94588367|NCT02105961|323955834|FG002|Overall Study|Adverse Event|13|||
94588368|NCT02105961|323955832|FG000|Overall Study|Lack of Efficacy|3|||
94588369|NCT02105961|323955833|FG001|Overall Study|Lack of Efficacy|0|||
94588370|NCT02105961|323955834|FG002|Overall Study|Lack of Efficacy|3|||
94588371|NCT02105961|323955832|FG000|Overall Study|Lost to Follow-up|2|||
94588372|NCT02105961|323955833|FG001|Overall Study|Lost to Follow-up|0|||
94588373|NCT02105961|323955834|FG002|Overall Study|Lost to Follow-up|1|||
94588374|NCT02105961|323955832|FG000|Overall Study|Physician Decision|3|||
94588375|NCT02105961|323955833|FG001|Overall Study|Physician Decision|3|||
94588376|NCT02105961|323955834|FG002|Overall Study|Physician Decision|2|||
94588377|NCT02105961|323955832|FG000|Overall Study|Withdrawal by Subject|15|||
94588378|NCT02105961|323955833|FG001|Overall Study|Withdrawal by Subject|7|||
94588379|NCT02105961|323955834|FG002|Overall Study|Withdrawal by Subject|11|||
94588380|NCT01092117|323955835|FG000|Index Procedure to 1 Month|Death|1|||
94588381|NCT01092117|323955835|FG000|1 Month|Death|1|||
94588382|NCT01092117|323955835|FG000|1 Month|Withdrawal by Subject|1|||
94588383|NCT01092117|323955835|FG000|1 Month|Lost to Follow-up|1|||
94588384|NCT01092117|323955835|FG000|6 Months|Death|2|||
94588385|NCT01092117|323955835|FG000|6 Months|Withdrawal by Subject|3|||
94588386|NCT01092117|323955835|FG000|12 Month|Death|11|||
94588387|NCT01092117|323955835|FG000|12 Month|Withdrawal by Subject|2|||
94588388|NCT01092117|323955835|FG000|12 Month|Lost to Follow-up|1|||
94588389|NCT01092117|323955835|FG000|Year 2|Death|5|||
94588390|NCT01092117|323955835|FG000|Year 2|Withdrawal by Subject|4|||
94588391|NCT01092117|323955835|FG000|Year 2|Lost to Follow-up|1|||
94588392|NCT01092117|323955835|FG000|Year 3|Death|7|||
94588393|NCT01092117|323955835|FG000|Year 3|Withdrawal by Subject|9|||
94588394|NCT01092117|323955835|FG000|Year 3|Lost to Follow-up|3|||
94588395|NCT01092117|323955835|FG000|Year 4|Death|8|||
94588396|NCT01092117|323955835|FG000|Year 4|Withdrawal by Subject|4|||
94588397|NCT01092117|323955835|FG000|Year 4|Lost to Follow-up|4|||
94588398|NCT04380519|323955836|FG000|Overall Study|Withdrawal by Subject|4|||
94588399|NCT04380519|323955837|FG001|Overall Study|Withdrawal by Subject|0|||
94588400|NCT04380519|323955838|FG002|Overall Study|Withdrawal by Subject|1|||
94588401|NCT04380519|323955836|FG000|Overall Study|Death|14|||
94588402|NCT04380519|323955837|FG001|Overall Study|Death|9|||
94588403|NCT04380519|323955838|FG002|Overall Study|Death|6|||
94588404|NCT04380519|323955836|FG000|Overall Study|Adverse Event|0|||
94588405|NCT04380519|323955837|FG001|Overall Study|Adverse Event|1|||
94588406|NCT04380519|323955838|FG002|Overall Study|Adverse Event|0|||
94588407|NCT04380519|323955836|FG000|Overall Study|relatives' decision|0|||
94588408|NCT04380519|323955837|FG001|Overall Study|relatives' decision|1|||
94588409|NCT04380519|323955838|FG002|Overall Study|relatives' decision|0|||
94588410|NCT01068600|323955839|FG000|Overall Study|Withdrawal by Subject|5|||
94588411|NCT01068600|323955840|FG001|Overall Study|Withdrawal by Subject|6|||
94588412|NCT01068600|323955839|FG000|Overall Study|Adverse Event|3|||
94588413|NCT01068600|323955840|FG001|Overall Study|Adverse Event|3|||
94588414|NCT01068600|323955839|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94588415|NCT01068600|323955840|FG001|Overall Study|Abnormal laboratory value(s)|0|||
94588416|NCT01068600|323955839|FG000|Overall Study|Lost to Follow-up|1|||
94588417|NCT01068600|323955840|FG001|Overall Study|Lost to Follow-up|2|||
94588418|NCT01068600|323955839|FG000|Overall Study|Protocol deviation|1|||
94588419|NCT01068600|323955840|FG001|Overall Study|Protocol deviation|1|||
94588420|NCT01068600|323955839|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94588421|NCT01068600|323955840|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
94588422|NCT01068600|323955839|FG000|Overall Study|Administrative problems|0|||
94588423|NCT01068600|323955840|FG001|Overall Study|Administrative problems|1|||
94588424|NCT02644109|323955841|FG000|Overall Study|Adverse Event|0|||
94588425|NCT02644109|323955842|FG001|Overall Study|Adverse Event|4|||
94588426|NCT02147561|323955843|FG000|Overall Study|Lost to Follow-up|3|||
94588427|NCT02147561|323955843|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
94588428|NCT00838513|323955847|FG000|Screening Period|Screen Failure|3|||
94588429|NCT00838513|323955847|FG000|Extension Treatment Period|Death|1|||
94588430|NCT00838513|323955847|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
94588431|NCT00139477|323955848|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
94588432|NCT00139477|323955849|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
94588433|NCT00139477|323955848|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
94588434|NCT00139477|323955849|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
94588435|NCT00139477|323955848|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
94588436|NCT00139477|323955849|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
94588437|NCT00139477|323955848|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
94588438|NCT00139477|323955849|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
94588439|NCT00139477|323955848|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
94588440|NCT00139477|323955849|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
94588441|NCT00139477|323955848|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
94588442|NCT00139477|323955849|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
94588443|NCT00139477|323955848|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
94242685|NCT01646177|322682738|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
94242686|NCT01646177|322682739|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
94242687|NCT01646177|322682740|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
94242688|NCT01646177|322682741|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
94242689|NCT01646177|322682730|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
94242690|NCT01646177|322682731|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
94242691|NCT01646177|322682732|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
94242692|NCT01646177|322682733|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
94242693|NCT01646177|322682734|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
94242694|NCT01646177|322682735|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
94242695|NCT01646177|322682736|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
94242696|NCT01646177|322682737|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
94242697|NCT01646177|322682738|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
94242698|NCT01646177|322682739|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
94242699|NCT01646177|322682740|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
94242700|NCT01646177|322682741|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
94242701|NCT01646177|322682730|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
94242702|NCT01646177|322682731|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
94242703|NCT01646177|322682732|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
94242704|NCT01646177|322682733|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
94242705|NCT01646177|322682734|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
94242706|NCT01646177|322682735|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
94242707|NCT01646177|322682736|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
94242708|NCT01646177|322682737|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
94242709|NCT01646177|322682738|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
94242710|NCT01646177|322682739|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
94242711|NCT01646177|322682740|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
94242712|NCT01646177|322682741|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
94242713|NCT01646177|322682730|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
94242714|NCT01646177|322682731|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
94242715|NCT01646177|322682732|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
94242716|NCT01646177|322682733|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
94242717|NCT01646177|322682734|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
94242718|NCT01646177|322682735|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
94242719|NCT01646177|322682736|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
94242720|NCT01646177|322682737|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
94588444|NCT00139477|323955849|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
94588445|NCT01297491|323955856|FG000|Overall Study|Adverse Event|11|||
94588446|NCT01297491|323955857|FG001|Overall Study|Adverse Event|6|||
94353611|NCT01072175|323077086|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
94353612|NCT01072175|323077074|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
94353613|NCT01072175|323077075|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
94353614|NCT01072175|323077076|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
94353615|NCT01072175|323077077|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
94353616|NCT01072175|323077078|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
94353617|NCT01072175|323077079|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
94353618|NCT01072175|323077080|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
94353619|NCT01072175|323077081|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
94353620|NCT01072175|323077082|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
94353621|NCT01072175|323077083|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
94353622|NCT01072175|323077084|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
94353623|NCT01072175|323077085|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
94353624|NCT01072175|323077086|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
94353625|NCT01072175|323077074|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
94353626|NCT01072175|323077075|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
94353627|NCT01072175|323077076|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
94353628|NCT01072175|323077077|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
94353629|NCT01072175|323077078|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
94353630|NCT01072175|323077079|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
94353631|NCT01072175|323077080|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
94353632|NCT01072175|323077081|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
94353633|NCT01072175|323077082|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
94353634|NCT01072175|323077083|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
94353635|NCT01072175|323077084|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
94353636|NCT01072175|323077085|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
94353637|NCT01072175|323077086|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
94353638|NCT01072175|323077074|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
94353639|NCT01072175|323077075|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
94353640|NCT01072175|323077076|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
94353641|NCT01072175|323077077|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
94353642|NCT01072175|323077078|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
94353643|NCT01072175|323077079|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
94353644|NCT01072175|323077080|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
94353645|NCT01072175|323077081|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
94353646|NCT01072175|323077082|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
94353647|NCT01072175|323077083|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
94353648|NCT01072175|323077084|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
94353649|NCT01072175|323077085|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
94353650|NCT01072175|323077086|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
94353651|NCT01072175|323077074|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
94353652|NCT01072175|323077075|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
94353653|NCT01072175|323077076|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
94353654|NCT01072175|323077077|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
94353655|NCT01072175|323077078|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
94353656|NCT01072175|323077079|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
94353657|NCT01072175|323077080|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
94353658|NCT01072175|323077081|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
94353659|NCT01072175|323077082|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
94353660|NCT01072175|323077083|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
94353661|NCT01072175|323077084|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
94353662|NCT01072175|323077085|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
94353663|NCT01072175|323077086|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
94456027|NCT03521115|323458165|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
94456028|NCT03521115|323458166|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
94456029|NCT00526669|323458167|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
94456030|NCT00526669|323458168|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
94456031|NCT00526669|323458167|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
94456032|NCT00526669|323458168|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
94456033|NCT00526669|323458167|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
94456034|NCT00526669|323458168|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
94456035|NCT00526669|323458167|FG000|Combined Treatment Phase|Death|0|||
94456036|NCT00526669|323458168|FG001|Combined Treatment Phase|Death|2|||
94456037|NCT03499899|323458169|FG000|Overall Study|Adverse Event|2|||
94456038|NCT03499899|323458170|FG001|Overall Study|Adverse Event|3|||
94456039|NCT03499899|323458171|FG002|Overall Study|Adverse Event|3|||
94456040|NCT03499899|323458169|FG000|Overall Study|Death|0|||
94456041|NCT03499899|323458170|FG001|Overall Study|Death|0|||
94456042|NCT03499899|323458171|FG002|Overall Study|Death|1|||
94456043|NCT03499899|323458169|FG000|Overall Study|Physician Decision|3|||
94456044|NCT03499899|323458170|FG001|Overall Study|Physician Decision|6|||
94242721|NCT01646177|322682738|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
94242722|NCT01646177|322682739|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
94242723|NCT01646177|322682740|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
94242724|NCT01646177|322682741|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
94242725|NCT01646177|322682730|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
94242726|NCT01646177|322682731|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
94242727|NCT01646177|322682732|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
94242728|NCT01646177|322682733|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
94242729|NCT01646177|322682734|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
94242730|NCT01646177|322682735|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
94242731|NCT01646177|322682736|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
94242732|NCT01646177|322682737|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
94242733|NCT01646177|322682738|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
94242734|NCT01646177|322682739|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
94242735|NCT01646177|322682740|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
94242736|NCT01646177|322682741|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
94242737|NCT01646177|322682730|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
94242738|NCT01646177|322682731|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
94242739|NCT01646177|322682732|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
94242740|NCT01646177|322682733|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
94242741|NCT01646177|322682734|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
94242742|NCT01646177|322682735|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
94242743|NCT01646177|322682736|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
94242744|NCT01646177|322682737|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
94242745|NCT01646177|322682738|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
94242746|NCT01646177|322682739|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
94242747|NCT01646177|322682740|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
94242748|NCT01646177|322682741|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
94242749|NCT01646177|322682730|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
94242750|NCT01646177|322682731|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
94242751|NCT01646177|322682732|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
94242752|NCT01646177|322682733|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
94242753|NCT01646177|322682734|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
94242754|NCT01646177|322682735|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
94242755|NCT01646177|322682736|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
94242756|NCT01646177|322682737|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
94242757|NCT01646177|322682738|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
94242758|NCT01646177|322682739|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
94242759|NCT01646177|322682740|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
94242760|NCT01646177|322682741|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
94242761|NCT01646177|322682730|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
94242762|NCT01646177|322682731|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
94242763|NCT01646177|322682732|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
94242764|NCT01646177|322682733|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
94242765|NCT01646177|322682734|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
94242766|NCT01646177|322682735|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
94242767|NCT01646177|322682736|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
94242768|NCT01646177|322682737|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
94242769|NCT01646177|322682738|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
94242770|NCT01646177|322682739|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
94242771|NCT01646177|322682740|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
94242772|NCT01646177|322682741|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
94456045|NCT03499899|323458171|FG002|Overall Study|Physician Decision|6|||
94456046|NCT03499899|323458169|FG000|Overall Study|Progressive disease|15|||
94588447|NCT01297491|323955856|FG000|Overall Study|Physician Decision|3|||
94588448|NCT01297491|323955857|FG001|Overall Study|Physician Decision|2|||
94242773|NCT01646177|322682730|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
94456047|NCT03499899|323458170|FG001|Overall Study|Progressive disease|23|||
94456048|NCT03499899|323458171|FG002|Overall Study|Progressive disease|23|||
94588449|NCT01297491|323955856|FG000|Overall Study|Progressive disease|11|||
94588450|NCT01297491|323955857|FG001|Overall Study|Progressive disease|20|||
94588451|NCT01297491|323955856|FG000|Overall Study|Patient/Guardian decision|3|||
94353664|NCT01072175|323077074|FG000|Part D (HPMC Capsules)|Death|0|||
94353665|NCT01072175|323077075|FG001|Part D (HPMC Capsules)|Death|0|||
94353666|NCT01072175|323077076|FG002|Part D (HPMC Capsules)|Death|0|||
94353667|NCT01072175|323077077|FG003|Part D (HPMC Capsules)|Death|0|||
94353668|NCT01072175|323077078|FG004|Part D (HPMC Capsules)|Death|0|||
94353669|NCT01072175|323077079|FG005|Part D (HPMC Capsules)|Death|0|||
94353670|NCT01072175|323077080|FG006|Part D (HPMC Capsules)|Death|0|||
94353671|NCT01072175|323077081|FG007|Part D (HPMC Capsules)|Death|0|||
94353672|NCT01072175|323077082|FG008|Part D (HPMC Capsules)|Death|0|||
94353673|NCT01072175|323077083|FG009|Part D (HPMC Capsules)|Death|10|||
94353674|NCT01072175|323077084|FG010|Part D (HPMC Capsules)|Death|12|||
94353675|NCT01072175|323077085|FG011|Part D (HPMC Capsules)|Death|28|||
94353676|NCT01072175|323077086|FG012|Part D (HPMC Capsules)|Death|26|||
94353677|NCT01072175|323077074|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
94353678|NCT01072175|323077075|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
94353679|NCT01072175|323077076|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
94353680|NCT01072175|323077077|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
94353681|NCT01072175|323077078|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
94353682|NCT01072175|323077079|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
94353683|NCT01072175|323077080|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
94353684|NCT01072175|323077081|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
94353685|NCT01072175|323077082|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
94353686|NCT01072175|323077083|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
94353687|NCT01072175|323077084|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
94353688|NCT01072175|323077085|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
94353689|NCT01072175|323077086|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
94353690|NCT01072175|323077074|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
94353691|NCT01072175|323077075|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
94353692|NCT01072175|323077076|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
94353693|NCT01072175|323077077|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
94353694|NCT01072175|323077078|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
94353695|NCT01072175|323077079|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
94353696|NCT01072175|323077080|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
94353697|NCT01072175|323077081|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
94353698|NCT01072175|323077082|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
94353699|NCT01072175|323077083|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
94353700|NCT01072175|323077084|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
94353701|NCT01072175|323077085|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
94353702|NCT01072175|323077086|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
94353703|NCT01072175|323077074|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
94353704|NCT01072175|323077075|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
94353705|NCT01072175|323077076|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
94353706|NCT01072175|323077077|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
94353707|NCT01072175|323077078|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
94353708|NCT01072175|323077079|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
94353709|NCT01072175|323077080|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
94353710|NCT01072175|323077081|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
94353711|NCT01072175|323077082|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
94353712|NCT01072175|323077083|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
94353713|NCT01072175|323077084|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
94353714|NCT01072175|323077085|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
94353715|NCT01072175|323077086|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
94353716|NCT01072175|323077074|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
94353717|NCT01072175|323077075|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
94353718|NCT01072175|323077076|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
94353719|NCT01072175|323077077|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
94353720|NCT01072175|323077078|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
94353721|NCT01072175|323077079|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
94353722|NCT01072175|323077080|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
94353723|NCT01072175|323077081|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
94353724|NCT01072175|323077082|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
94353725|NCT01072175|323077083|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
94353726|NCT01072175|323077084|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
94353727|NCT01072175|323077085|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
94353728|NCT01072175|323077086|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
94353729|NCT01345162|323077087|FG000|Overall Study|Protocol Violation|2|||
94353730|NCT01345162|323077088|FG001|Overall Study|Protocol Violation|4|||
94353731|NCT00310440|323077090|FG000|Overall Study|Lost to Follow-up|17|||
94353732|NCT00310440|323077091|FG001|Overall Study|Lost to Follow-up|8|||
94353733|NCT00310440|323077090|FG000|Overall Study|Withdrawal by Subject|2|||
94353734|NCT00310440|323077091|FG001|Overall Study|Withdrawal by Subject|1|||
94353735|NCT00310440|323077090|FG000|Overall Study|Missed 12 Month Visit|7|||
94353736|NCT00310440|323077091|FG001|Overall Study|Missed 12 Month Visit|4|||
94353737|NCT00148109|323077094|FG000|Overall Study|Lack of Efficacy|10|||
94353738|NCT00148109|323077095|FG001|Overall Study|Lack of Efficacy|18|||
94353739|NCT00148109|323077094|FG000|Overall Study|Adverse Event|0|||
94353740|NCT00148109|323077095|FG001|Overall Study|Adverse Event|2|||
94353741|NCT00148109|323077094|FG000|Overall Study|Withdrawal by Subject|2|||
94353742|NCT00148109|323077095|FG001|Overall Study|Withdrawal by Subject|0|||
94353743|NCT00525499|323077096|FG000|Overall Study|Lost to Follow-up|2|||
94353744|NCT00525499|323077097|FG001|Overall Study|Lost to Follow-up|4|||
94353745|NCT00525499|323077098|FG002|Overall Study|Lost to Follow-up|1|||
94353746|NCT00525499|323077099|FG003|Overall Study|Lost to Follow-up|4|||
94353747|NCT00525499|323077096|FG000|Overall Study|Adverse Event|0|||
94353748|NCT00525499|323077097|FG001|Overall Study|Adverse Event|1|||
94353749|NCT00525499|323077098|FG002|Overall Study|Adverse Event|0|||
94353750|NCT00525499|323077099|FG003|Overall Study|Adverse Event|1|||
94353751|NCT00525499|323077096|FG000|Overall Study|Withdrawal by Subject|5|||
94353752|NCT00525499|323077097|FG001|Overall Study|Withdrawal by Subject|1|||
94353753|NCT00525499|323077098|FG002|Overall Study|Withdrawal by Subject|5|||
94353754|NCT00525499|323077099|FG003|Overall Study|Withdrawal by Subject|2|||
94353755|NCT00525499|323077096|FG000|Overall Study|Protocol Violation|0|||
94353756|NCT00525499|323077097|FG001|Overall Study|Protocol Violation|1|||
94353757|NCT00525499|323077098|FG002|Overall Study|Protocol Violation|1|||
94353758|NCT00525499|323077099|FG003|Overall Study|Protocol Violation|0|||
94353759|NCT00438815|323077100|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
94353760|NCT00438815|323077100|FG000|Overall Study|3-month follow-up no longer required|12|||
94353761|NCT00438815|323077100|FG000|Overall Study|Noncompliance with protocol requirements|9|||
94353762|NCT00438815|323077100|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
94353763|NCT00438815|323077100|FG000|Overall Study|Lost to Follow-up|6|||
94353764|NCT00438815|323077100|FG000|Overall Study|Withdrawal by Subject|6|||
94353765|NCT00438815|323077100|FG000|Overall Study|Death|1|||
94353766|NCT01733758|323077101|FG000|Overall Study|Adverse Event|5|||
94353767|NCT01733758|323077102|FG001|Overall Study|Adverse Event|7|||
94353768|NCT01733758|323077103|FG002|Overall Study|Adverse Event|8|||
94353769|NCT01733758|323077104|FG003|Overall Study|Adverse Event|1|||
94353770|NCT01733758|323077101|FG000|Overall Study|Withdrawal by Subject|1|||
94353771|NCT01733758|323077102|FG001|Overall Study|Withdrawal by Subject|1|||
94353772|NCT01733758|323077103|FG002|Overall Study|Withdrawal by Subject|5|||
94353773|NCT01733758|323077104|FG003|Overall Study|Withdrawal by Subject|3|||
94353774|NCT01733758|323077101|FG000|Overall Study|Persistent Hyperglycemia|3|||
94353775|NCT01733758|323077102|FG001|Overall Study|Persistent Hyperglycemia|2|||
94353776|NCT01733758|323077103|FG002|Overall Study|Persistent Hyperglycemia|0|||
94353777|NCT01733758|323077104|FG003|Overall Study|Persistent Hyperglycemia|0|||
94353778|NCT01733758|323077101|FG000|Overall Study|Protocol Violation|0|||
94353779|NCT01733758|323077102|FG001|Overall Study|Protocol Violation|1|||
94353780|NCT01733758|323077103|FG002|Overall Study|Protocol Violation|2|||
94353781|NCT01733758|323077104|FG003|Overall Study|Protocol Violation|2|||
94353782|NCT01733758|323077101|FG000|Overall Study|Non-compliance|1|||
94353783|NCT01733758|323077102|FG001|Overall Study|Non-compliance|0|||
94353784|NCT01733758|323077103|FG002|Overall Study|Non-compliance|0|||
94353785|NCT01733758|323077104|FG003|Overall Study|Non-compliance|0|||
94353786|NCT01733758|323077101|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
94353787|NCT01733758|323077102|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
94353788|NCT01733758|323077103|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
94353789|NCT01733758|323077104|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
94353790|NCT01733758|323077101|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
94353791|NCT01733758|323077102|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
94353792|NCT01733758|323077103|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
94353793|NCT01733758|323077104|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
94353794|NCT02557308|323077109|FG000|Overall Study|Withdrawal by Subject|11|||
94353795|NCT02557308|323077110|FG001|Overall Study|Withdrawal by Subject|3|||
94353796|NCT02557308|323077111|FG002|Overall Study|Withdrawal by Subject|2|||
94353797|NCT02557308|323077112|FG003|Overall Study|Withdrawal by Subject|0|||
94353798|NCT02557308|323077113|FG004|Overall Study|Withdrawal by Subject|1|||
94353799|NCT02557308|323077114|FG005|Overall Study|Withdrawal by Subject|0|||
94353800|NCT02557308|323077115|FG006|Overall Study|Withdrawal by Subject|10|||
94353801|NCT02557308|323077116|FG007|Overall Study|Withdrawal by Subject|1|||
94588452|NCT01297491|323955857|FG001|Overall Study|Patient/Guardian decision|4|||
94588453|NCT01297491|323955856|FG000|Overall Study|Death|2|||
94588454|NCT01297491|323955857|FG001|Overall Study|Death|1|||
94588455|NCT04413617|323955863|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
94353802|NCT02557308|323077109|FG000|Overall Study|Disease Progression|0|||
94353803|NCT02557308|323077110|FG001|Overall Study|Disease Progression|1|||
94353804|NCT02557308|323077111|FG002|Overall Study|Disease Progression|0|||
94353805|NCT02557308|323077112|FG003|Overall Study|Disease Progression|0|||
94456049|NCT03499899|323458169|FG000|Overall Study|Patient decision|0|||
94588456|NCT04413617|323955864|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
94588457|NCT04413617|323955865|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
94353806|NCT02557308|323077113|FG004|Overall Study|Disease Progression|0|||
94353807|NCT02557308|323077114|FG005|Overall Study|Disease Progression|0|||
94659454|NCT01722331|324208012|FG001|Part 3|Withdrawal by Subject|7|||
94659455|NCT01722331|324208013|FG002|Part 3|Withdrawal by Subject|0|||
94659456|NCT01722331|324208014|FG003|Part 3|Withdrawal by Subject|0|||
94659457|NCT01722331|324208015|FG004|Part 3|Withdrawal by Subject|0|||
94659458|NCT01722331|324208016|FG005|Part 3|Withdrawal by Subject|2|||
94242774|NCT01646177|322682731|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
94242775|NCT01646177|322682732|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
94242776|NCT01646177|322682733|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
94242777|NCT01646177|322682734|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
94242778|NCT01646177|322682735|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
94242779|NCT01646177|322682736|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
94242780|NCT01646177|322682737|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
94242781|NCT01646177|322682738|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
94242782|NCT01646177|322682739|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
94242783|NCT01646177|322682740|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
94242784|NCT01646177|322682741|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
94242785|NCT01646177|322682730|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
94242786|NCT01646177|322682731|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
94242787|NCT01646177|322682732|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
94242788|NCT01646177|322682733|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
94242789|NCT01646177|322682734|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
94242790|NCT01646177|322682735|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
94242791|NCT01646177|322682736|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
94242792|NCT01646177|322682737|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
94242793|NCT01646177|322682738|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
94242794|NCT01646177|322682739|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
94242795|NCT01646177|322682740|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
94242796|NCT01646177|322682741|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
94242797|NCT01646177|322682730|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
94242798|NCT01646177|322682731|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
94242799|NCT01646177|322682732|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
94242800|NCT01646177|322682733|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
94242801|NCT01646177|322682734|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
94242802|NCT01646177|322682735|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
94242803|NCT01646177|322682736|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
94242804|NCT01646177|322682737|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
94242805|NCT01646177|322682738|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
94242806|NCT01646177|322682739|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
94242807|NCT01646177|322682740|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
94242808|NCT01646177|322682741|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
94242809|NCT01646177|322682730|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
94242810|NCT01646177|322682731|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
94456050|NCT03499899|323458170|FG001|Overall Study|Patient decision|1|||
94588458|NCT04413617|323955866|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
94588459|NCT04413617|323955867|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
94588460|NCT04413617|323955863|FG000|Overall Study|Protocol Violation|0|||
94588461|NCT04413617|323955864|FG001|Overall Study|Protocol Violation|1|||
94588462|NCT04413617|323955865|FG002|Overall Study|Protocol Violation|0|||
94588463|NCT04413617|323955866|FG003|Overall Study|Protocol Violation|0|||
94588464|NCT04413617|323955867|FG004|Overall Study|Protocol Violation|1|||
94588465|NCT04413617|323955863|FG000|Overall Study|Lack of Efficacy|2|||
94588466|NCT04413617|323955864|FG001|Overall Study|Lack of Efficacy|0|||
94588467|NCT04413617|323955865|FG002|Overall Study|Lack of Efficacy|2|||
94588468|NCT04413617|323955866|FG003|Overall Study|Lack of Efficacy|1|||
94588469|NCT04413617|323955867|FG004|Overall Study|Lack of Efficacy|0|||
94588470|NCT04413617|323955863|FG000|Overall Study|Withdrawal by Subject|3|||
94588471|NCT04413617|323955864|FG001|Overall Study|Withdrawal by Subject|4|||
94588472|NCT04413617|323955865|FG002|Overall Study|Withdrawal by Subject|2|||
94588473|NCT04413617|323955866|FG003|Overall Study|Withdrawal by Subject|5|||
94588474|NCT04413617|323955867|FG004|Overall Study|Withdrawal by Subject|3|||
94588475|NCT04413617|323955863|FG000|Overall Study|Death|1|||
94659459|NCT01722331|324208017|FG006|Part 3|Withdrawal by Subject|1|||
94659460|NCT01722331|324208011|FG000|Part 3|Other Protocol Specified Criteria|1|||
94659461|NCT01722331|324208012|FG001|Part 3|Other Protocol Specified Criteria|1|||
94242811|NCT01646177|322682732|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
94242812|NCT01646177|322682733|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
94242813|NCT01646177|322682734|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
94588476|NCT04413617|323955864|FG001|Overall Study|Death|0|||
94588477|NCT04413617|323955865|FG002|Overall Study|Death|0|||
94588478|NCT04413617|323955866|FG003|Overall Study|Death|0|||
94588479|NCT04413617|323955867|FG004|Overall Study|Death|0|||
94242814|NCT01646177|322682735|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
94242815|NCT01646177|322682736|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
94242816|NCT01646177|322682737|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
94242817|NCT01646177|322682738|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
94242818|NCT01646177|322682739|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
94242819|NCT01646177|322682740|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
94242820|NCT01646177|322682741|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
94242821|NCT02807272|322682744|FG000|Overall Study|Death|9|||
94242822|NCT02807272|322682745|FG001|Overall Study|Death|5|||
94242823|NCT02807272|322682746|FG002|Overall Study|Death|2|||
94242824|NCT02807272|322682747|FG003|Overall Study|Death|0|||
94242825|NCT02807272|322682748|FG004|Overall Study|Death|1|||
94242826|NCT02807272|322682744|FG000|Overall Study|Lost to Follow-up|1|||
94242827|NCT02807272|322682745|FG001|Overall Study|Lost to Follow-up|0|||
94242828|NCT02807272|322682746|FG002|Overall Study|Lost to Follow-up|0|||
94242829|NCT02807272|322682747|FG003|Overall Study|Lost to Follow-up|0|||
94242830|NCT02807272|322682748|FG004|Overall Study|Lost to Follow-up|0|||
94242831|NCT02807272|322682744|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
94242832|NCT02807272|322682745|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
94242833|NCT02807272|322682746|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
94242834|NCT02807272|322682747|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
94242835|NCT02807272|322682748|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
94242836|NCT02807272|322682744|FG000|Overall Study|Protocol-defined Disease Progression|0|||
94242837|NCT02807272|322682745|FG001|Overall Study|Protocol-defined Disease Progression|1|||
94242838|NCT02807272|322682746|FG002|Overall Study|Protocol-defined Disease Progression|0|||
94242839|NCT02807272|322682747|FG003|Overall Study|Protocol-defined Disease Progression|0|||
94242840|NCT02807272|322682748|FG004|Overall Study|Protocol-defined Disease Progression|1|||
94242841|NCT02807272|322682744|FG000|Overall Study|Study Terminated by Sponsor|1|||
94242842|NCT02807272|322682745|FG001|Overall Study|Study Terminated by Sponsor|0|||
94242843|NCT02807272|322682746|FG002|Overall Study|Study Terminated by Sponsor|0|||
94242844|NCT02807272|322682747|FG003|Overall Study|Study Terminated by Sponsor|1|||
94242845|NCT02807272|322682748|FG004|Overall Study|Study Terminated by Sponsor|0|||
94242846|NCT02807272|322682744|FG000|Overall Study|Other|1|||
94242847|NCT02807272|322682745|FG001|Overall Study|Other|0|||
94242848|NCT02807272|322682746|FG002|Overall Study|Other|0|||
94242849|NCT02807272|322682747|FG003|Overall Study|Other|0|||
94242850|NCT02807272|322682748|FG004|Overall Study|Other|1|||
94242851|NCT01606670|322682749|FG000|Overall Study|Adverse Event|6|||
94242852|NCT01606670|322682749|FG000|Overall Study|Lack of Efficacy|2|||
94242853|NCT01606670|322682749|FG000|Overall Study|Lost to Follow-up|3|||
94242854|NCT01606670|322682749|FG000|Overall Study|Withdrawal by Subject|3|||
94242855|NCT01606670|322682749|FG000|Overall Study|Other Reason|2|||
94242856|NCT02636725|322682751|FG000|Overall Study|Adverse Event|1|||
94242857|NCT02180243|322682752|FG000|Overall Study|Withdrawal by Subject|12|||
94242858|NCT02180243|322682753|FG001|Overall Study|Withdrawal by Subject|12|||
94242859|NCT02180243|322682752|FG000|Overall Study|Lost to Follow-up|12|||
94242860|NCT02180243|322682753|FG001|Overall Study|Lost to Follow-up|2|||
94242861|NCT00573859|322682756|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
94242862|NCT00573859|322682756|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
94242863|NCT01152814|322682757|FG000|Overall Study|Lost to Follow-up|2|||
94242864|NCT02229851|322682767|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
94242865|NCT02229851|322682768|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
94242866|NCT02229851|322682769|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
94242867|NCT02229851|322682770|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
94242868|NCT02229851|322682771|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
94242869|NCT02229851|322682772|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
94242870|NCT02229851|322682773|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
94242871|NCT02229851|322682767|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
94242872|NCT02229851|322682768|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
94242873|NCT02229851|322682769|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
94242874|NCT02229851|322682770|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
94242875|NCT02229851|322682771|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
94242876|NCT02229851|322682772|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
94242877|NCT02229851|322682773|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
94242878|NCT02229851|322682767|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
94242879|NCT02229851|322682768|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
94242880|NCT02229851|322682769|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
94242881|NCT02229851|322682770|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
94242882|NCT02229851|322682771|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
94242883|NCT02229851|322682772|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
94242884|NCT02229851|322682773|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
94242885|NCT02229851|322682767|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
94353808|NCT02557308|323077115|FG006|Overall Study|Disease Progression|0|||
94353809|NCT02557308|323077116|FG007|Overall Study|Disease Progression|0|||
94353810|NCT02557308|323077109|FG000|Overall Study|Lack of Efficacy|3|||
94353811|NCT02557308|323077110|FG001|Overall Study|Lack of Efficacy|0|||
94353812|NCT02557308|323077111|FG002|Overall Study|Lack of Efficacy|0|||
94353813|NCT02557308|323077112|FG003|Overall Study|Lack of Efficacy|0|||
94353814|NCT02557308|323077113|FG004|Overall Study|Lack of Efficacy|0|||
94353815|NCT02557308|323077114|FG005|Overall Study|Lack of Efficacy|0|||
94353816|NCT02557308|323077115|FG006|Overall Study|Lack of Efficacy|1|||
94353817|NCT02557308|323077116|FG007|Overall Study|Lack of Efficacy|0|||
94353818|NCT02557308|323077109|FG000|Overall Study|Adverse Event|4|||
94353819|NCT02557308|323077110|FG001|Overall Study|Adverse Event|1|||
94353820|NCT02557308|323077111|FG002|Overall Study|Adverse Event|2|||
94353821|NCT02557308|323077112|FG003|Overall Study|Adverse Event|0|||
94353822|NCT02557308|323077113|FG004|Overall Study|Adverse Event|0|||
94353823|NCT02557308|323077114|FG005|Overall Study|Adverse Event|0|||
94353824|NCT02557308|323077115|FG006|Overall Study|Adverse Event|4|||
94353825|NCT02557308|323077116|FG007|Overall Study|Adverse Event|1|||
94353826|NCT02557308|323077109|FG000|Overall Study|Lost to Follow-up|2|||
94353827|NCT02557308|323077110|FG001|Overall Study|Lost to Follow-up|0|||
94588480|NCT04413617|323955863|FG000|Overall Study|Adverse Event|1|||
94588481|NCT04413617|323955864|FG001|Overall Study|Adverse Event|0|||
94588482|NCT04413617|323955865|FG002|Overall Study|Adverse Event|0|||
94588483|NCT04413617|323955866|FG003|Overall Study|Adverse Event|1|||
94588484|NCT04413617|323955867|FG004|Overall Study|Adverse Event|1|||
94353828|NCT02557308|323077111|FG002|Overall Study|Lost to Follow-up|1|||
94353829|NCT02557308|323077112|FG003|Overall Study|Lost to Follow-up|0|||
94353830|NCT02557308|323077113|FG004|Overall Study|Lost to Follow-up|0|||
94353831|NCT02557308|323077114|FG005|Overall Study|Lost to Follow-up|0|||
94353832|NCT02557308|323077115|FG006|Overall Study|Lost to Follow-up|2|||
94353833|NCT02557308|323077116|FG007|Overall Study|Lost to Follow-up|0|||
94353834|NCT02557308|323077109|FG000|Overall Study|Death|1|||
94353835|NCT02557308|323077110|FG001|Overall Study|Death|0|||
94353836|NCT02557308|323077111|FG002|Overall Study|Death|0|||
94353837|NCT02557308|323077112|FG003|Overall Study|Death|0|||
94353838|NCT02557308|323077113|FG004|Overall Study|Death|0|||
94353839|NCT02557308|323077114|FG005|Overall Study|Death|0|||
94353840|NCT02557308|323077115|FG006|Overall Study|Death|0|||
94353841|NCT02557308|323077116|FG007|Overall Study|Death|0|||
94353842|NCT02557308|323077109|FG000|Overall Study|Study Close|98|||
94353843|NCT02557308|323077110|FG001|Overall Study|Study Close|18|||
94353844|NCT02557308|323077111|FG002|Overall Study|Study Close|5|||
94353845|NCT02557308|323077112|FG003|Overall Study|Study Close|3|||
94353846|NCT02557308|323077113|FG004|Overall Study|Study Close|1|||
94353847|NCT02557308|323077114|FG005|Overall Study|Study Close|0|||
94353848|NCT02557308|323077115|FG006|Overall Study|Study Close|123|||
94353849|NCT02557308|323077116|FG007|Overall Study|Study Close|5|||
94353850|NCT02557308|323077109|FG000|Overall Study|Except for study close|5|||
94353851|NCT02557308|323077110|FG001|Overall Study|Except for study close|0|||
94353852|NCT02557308|323077111|FG002|Overall Study|Except for study close|0|||
94353853|NCT02557308|323077112|FG003|Overall Study|Except for study close|0|||
94353854|NCT02557308|323077113|FG004|Overall Study|Except for study close|3|||
94353855|NCT02557308|323077114|FG005|Overall Study|Except for study close|0|||
94353856|NCT02557308|323077115|FG006|Overall Study|Except for study close|6|||
94353857|NCT02557308|323077116|FG007|Overall Study|Except for study close|10|||
94353858|NCT03287089|323077120|FG000|Overall Study|Lost to Follow-up|0|||
94353859|NCT03287089|323077121|FG001|Overall Study|Lost to Follow-up|2|||
94353860|NCT03287089|323077120|FG000|Overall Study|Physician Decision|0|||
94353861|NCT03287089|323077121|FG001|Overall Study|Physician Decision|2|||
94353862|NCT03287089|323077120|FG000|Overall Study|Withdrawal by Subject|0|||
94353863|NCT03287089|323077121|FG001|Overall Study|Withdrawal by Subject|2|||
94353864|NCT05664672|323077133|FG000|Overall Study|Adverse Event|0|||
94353865|NCT05664672|323077134|FG001|Overall Study|Adverse Event|0|||
94353866|NCT05664672|323077135|FG002|Overall Study|Adverse Event|0|||
94353867|NCT05664672|323077136|FG003|Overall Study|Adverse Event|0|||
94353868|NCT05664672|323077137|FG004|Overall Study|Adverse Event|0|||
94353869|NCT05664672|323077138|FG005|Overall Study|Adverse Event|1|||
94353870|NCT05664672|323077133|FG000|Overall Study|Withdrawal by Subject|0|||
94353871|NCT05664672|323077134|FG001|Overall Study|Withdrawal by Subject|1|||
94353872|NCT05664672|323077135|FG002|Overall Study|Withdrawal by Subject|3|||
94353873|NCT05664672|323077136|FG003|Overall Study|Withdrawal by Subject|0|||
94353874|NCT05664672|323077137|FG004|Overall Study|Withdrawal by Subject|5|||
94353875|NCT05664672|323077138|FG005|Overall Study|Withdrawal by Subject|6|||
94353876|NCT05664672|323077133|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
94353877|NCT05664672|323077134|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
94353878|NCT05664672|323077135|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
94588485|NCT04413617|323955863|FG000|Overall Study|COVID-19|0|||
94588486|NCT04413617|323955864|FG001|Overall Study|COVID-19|1|||
94588487|NCT04413617|323955865|FG002|Overall Study|COVID-19|0|||
94353879|NCT05664672|323077136|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
94353880|NCT05664672|323077137|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
94242886|NCT02229851|322682768|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
94242887|NCT02229851|322682769|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
94242888|NCT02229851|322682770|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
94242889|NCT02229851|322682771|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
94242890|NCT02229851|322682772|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
94242891|NCT02229851|322682773|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
94242892|NCT02229851|322682767|FG000|Main Phase (Double-blind Phase)|Death|1|||
94242893|NCT02229851|322682768|FG001|Main Phase (Double-blind Phase)|Death|1|||
94242894|NCT02229851|322682769|FG002|Main Phase (Double-blind Phase)|Death|0|||
94242895|NCT02229851|322682770|FG003|Main Phase (Double-blind Phase)|Death|0|||
94242896|NCT02229851|322682771|FG004|Main Phase (Double-blind Phase)|Death|0|||
94242897|NCT02229851|322682772|FG005|Main Phase (Double-blind Phase)|Death|0|||
94242898|NCT02229851|322682773|FG006|Main Phase (Double-blind Phase)|Death|0|||
94242899|NCT02229851|322682767|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
94242900|NCT02229851|322682768|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
94242901|NCT02229851|322682769|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
94242902|NCT02229851|322682770|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
94242903|NCT02229851|322682771|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
94242904|NCT02229851|322682772|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
94242905|NCT02229851|322682773|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
94242906|NCT02229851|322682767|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
94242907|NCT02229851|322682768|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
94242908|NCT02229851|322682769|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
94242909|NCT02229851|322682770|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
94242910|NCT02229851|322682771|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
94242911|NCT02229851|322682772|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
94242912|NCT02229851|322682773|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
94242913|NCT02229851|322682767|FG000|Extension Phase (Open-label Phase)|Death|0|||
94242914|NCT02229851|322682768|FG001|Extension Phase (Open-label Phase)|Death|0|||
94242915|NCT02229851|322682769|FG002|Extension Phase (Open-label Phase)|Death|0|||
94242916|NCT02229851|322682770|FG003|Extension Phase (Open-label Phase)|Death|1|||
94242917|NCT02229851|322682771|FG004|Extension Phase (Open-label Phase)|Death|0|||
94242918|NCT02229851|322682772|FG005|Extension Phase (Open-label Phase)|Death|1|||
94242919|NCT02229851|322682773|FG006|Extension Phase (Open-label Phase)|Death|1|||
94242920|NCT03541200|322682774|FG000|Overall Study|Adverse Event|19|||
94242921|NCT03541200|322682774|FG000|Overall Study|Death|1|||
94242922|NCT03541200|322682774|FG000|Overall Study|Lost to Follow-up|10|||
94242923|NCT03541200|322682774|FG000|Overall Study|Physician Decision|1|||
94242924|NCT03541200|322682774|FG000|Overall Study|Protocol Violation|51|||
94242925|NCT03541200|322682774|FG000|Overall Study|Withdrawal by Subject|23|||
94242926|NCT03541200|322682774|FG000|Overall Study|other|8|||
94242927|NCT03682302|322682775|FG000|Overall Study|Lost to Follow-up|1|||
94242928|NCT03682302|322682776|FG001|Overall Study|Lost to Follow-up|2|||
94242929|NCT03682302|322682777|FG002|Overall Study|Lost to Follow-up|0|||
94242930|NCT03682302|322682778|FG003|Overall Study|Lost to Follow-up|1|||
94242931|NCT03682302|322682775|FG000|Overall Study|Study drug was not administered|0|||
94242932|NCT03682302|322682776|FG001|Overall Study|Study drug was not administered|0|||
94242933|NCT03682302|322682777|FG002|Overall Study|Study drug was not administered|1|||
94242934|NCT03682302|322682778|FG003|Overall Study|Study drug was not administered|1|||
94242935|NCT02045875|322682779|FG000|Overall Study|Lost to Follow-up|3|||
94242936|NCT02045875|322682780|FG001|Overall Study|Lost to Follow-up|0|||
94242937|NCT02045875|322682779|FG000|Overall Study|Withdrawal by Subject|4|||
94242938|NCT02045875|322682780|FG001|Overall Study|Withdrawal by Subject|3|||
94242939|NCT05132127|322682781|FG000|Overall Study|Adverse Event|1|||
94242940|NCT01036438|322682782|FG000|Overall Study|Adverse Event|7|||
94242941|NCT01036438|322682783|FG001|Overall Study|Adverse Event|8|||
94242942|NCT01036438|322682782|FG000|Overall Study|Death|0|||
94242943|NCT01036438|322682783|FG001|Overall Study|Death|1|||
94353881|NCT05664672|323077138|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
94588488|NCT04413617|323955866|FG003|Overall Study|COVID-19|0|||
94588489|NCT04413617|323955867|FG004|Overall Study|COVID-19|0|||
94242944|NCT01036438|322682782|FG000|Overall Study|No effect of study treatment|3|||
94242945|NCT01036438|322682783|FG001|Overall Study|No effect of study treatment|1|||
94242946|NCT00864253|322682784|FG000|Overall Study|Adverse Event|56|||
94242947|NCT00864253|322682785|FG001|Overall Study|Adverse Event|11|||
94242948|NCT00864253|322682784|FG000|Overall Study|Unrelated Adverse Event|3|||
94242949|NCT00864253|322682785|FG001|Overall Study|Unrelated Adverse Event|1|||
94242950|NCT00864253|322682784|FG000|Overall Study|Physician Decision|11|||
94242951|NCT00864253|322682785|FG001|Overall Study|Physician Decision|15|||
94242952|NCT00864253|322682784|FG000|Overall Study|Protocol Violation|0|||
94242953|NCT00864253|322682785|FG001|Overall Study|Protocol Violation|2|||
94242954|NCT00864253|322682784|FG000|Overall Study|Lost to Follow-up|1|||
94588490|NCT00104520|323955879|FG000|Overall Study|Unrelated adverse event|34|||
94588491|NCT00104520|323955880|FG001|Overall Study|Unrelated adverse event|47|||
94242955|NCT00864253|322682785|FG001|Overall Study|Lost to Follow-up|1|||
94242956|NCT00864253|322682784|FG000|Overall Study|Withdrawal by Subject|18|||
94242957|NCT00864253|322682785|FG001|Overall Study|Withdrawal by Subject|18|||
94242958|NCT00864253|322682784|FG000|Overall Study|Death|1|||
94242959|NCT00864253|322682785|FG001|Overall Study|Death|0|||
94242960|NCT00864253|322682784|FG000|Overall Study|Ongoing|2|||
94242961|NCT00864253|322682785|FG001|Overall Study|Ongoing|3|||
94242962|NCT00864253|322682784|FG000|Overall Study|Untreated|7|||
94242963|NCT00864253|322682785|FG001|Overall Study|Untreated|7|||
94242964|NCT04958200|322682789|FG000|Overall Study|Withdrawal by Subject|0|||
94242965|NCT04958200|322682790|FG001|Overall Study|Withdrawal by Subject|2|||
94242966|NCT04958200|322682789|FG000|Overall Study|Lost to Follow-up|3|||
94242967|NCT04958200|322682790|FG001|Overall Study|Lost to Follow-up|2|||
94242968|NCT04531098|322682794|FG000|Stage I|Adverse Event|0|||
94242969|NCT04531098|322682795|FG001|Stage I|Adverse Event|0|||
94242970|NCT04531098|322682796|FG002|Stage I|Adverse Event|3|||
94242971|NCT04531098|322682794|FG000|Stage I|Protocol Violation|0|||
94242972|NCT04531098|322682795|FG001|Stage I|Protocol Violation|0|||
94242973|NCT04531098|322682796|FG002|Stage I|Protocol Violation|5|||
94242974|NCT04531098|322682794|FG000|Stage I|Withdrawal by Subject|0|||
94242975|NCT04531098|322682795|FG001|Stage I|Withdrawal by Subject|5|||
94242976|NCT04531098|322682796|FG002|Stage I|Withdrawal by Subject|10|||
94242977|NCT04531098|322682794|FG000|Stage II|Adverse Event|1|||
94242978|NCT04531098|322682795|FG001|Stage II|Adverse Event|2|||
94242979|NCT04531098|322682796|FG002|Stage II|Adverse Event|0|||
94242980|NCT04531098|322682794|FG000|Stage II|Protocol Violation|1|||
94242981|NCT04531098|322682795|FG001|Stage II|Protocol Violation|2|||
94242982|NCT04531098|322682796|FG002|Stage II|Protocol Violation|0|||
94242983|NCT04531098|322682794|FG000|Stage II|Withdrawal by Subject|3|||
94242984|NCT04531098|322682795|FG001|Stage II|Withdrawal by Subject|1|||
94242985|NCT04531098|322682796|FG002|Stage II|Withdrawal by Subject|0|||
94242986|NCT04531098|322682794|FG000|Stage II|Moved from study area|8|||
94242987|NCT04531098|322682795|FG001|Stage II|Moved from study area|5|||
94242988|NCT04531098|322682796|FG002|Stage II|Moved from study area|0|||
94242989|NCT01436253|322682797|FG000|Overall Study|Lost to Follow-up|182|||
94242990|NCT01436253|322682797|FG000|Overall Study|Not meeting all eligibility criteria|117|||
94242991|NCT01803282|322682813|FG000|Overall Study|Progressive Disease|4|||
94242992|NCT01803282|322682814|FG001|Overall Study|Progressive Disease|3|||
94242993|NCT01803282|322682815|FG002|Overall Study|Progressive Disease|6|||
94242994|NCT01803282|322682816|FG003|Overall Study|Progressive Disease|22|||
94242995|NCT01803282|322682817|FG004|Overall Study|Progressive Disease|5|||
94242996|NCT01803282|322682818|FG005|Overall Study|Progressive Disease|8|||
94242997|NCT01803282|322682819|FG006|Overall Study|Progressive Disease|23|||
94242998|NCT01803282|322682820|FG007|Overall Study|Progressive Disease|24|||
94242999|NCT01803282|322682821|FG008|Overall Study|Progressive Disease|3|||
94243000|NCT01803282|322682822|FG009|Overall Study|Progressive Disease|29|||
94243001|NCT01803282|322682823|FG010|Overall Study|Progressive Disease|6|||
94243002|NCT01803282|322682824|FG011|Overall Study|Progressive Disease|11|||
94243003|NCT01803282|322682813|FG000|Overall Study|Death|0|||
94243004|NCT01803282|322682814|FG001|Overall Study|Death|0|||
94243005|NCT01803282|322682815|FG002|Overall Study|Death|0|||
94243006|NCT01803282|322682816|FG003|Overall Study|Death|0|||
94243007|NCT01803282|322682817|FG004|Overall Study|Death|2|||
94243008|NCT01803282|322682818|FG005|Overall Study|Death|1|||
94243009|NCT01803282|322682819|FG006|Overall Study|Death|1|||
94243010|NCT01803282|322682820|FG007|Overall Study|Death|5|||
94243011|NCT01803282|322682821|FG008|Overall Study|Death|1|||
94243012|NCT01803282|322682822|FG009|Overall Study|Death|1|||
94243013|NCT01803282|322682823|FG010|Overall Study|Death|0|||
94243014|NCT01803282|322682824|FG011|Overall Study|Death|0|||
94243015|NCT01803282|322682813|FG000|Overall Study|Withdrew Consent|0|||
94243016|NCT01803282|322682814|FG001|Overall Study|Withdrew Consent|0|||
94243017|NCT01803282|322682815|FG002|Overall Study|Withdrew Consent|0|||
94243018|NCT01803282|322682816|FG003|Overall Study|Withdrew Consent|6|||
94243019|NCT01803282|322682817|FG004|Overall Study|Withdrew Consent|1|||
94243020|NCT01803282|322682818|FG005|Overall Study|Withdrew Consent|0|||
94243021|NCT01803282|322682819|FG006|Overall Study|Withdrew Consent|8|||
94243022|NCT01803282|322682820|FG007|Overall Study|Withdrew Consent|3|||
94243023|NCT01803282|322682821|FG008|Overall Study|Withdrew Consent|1|||
94243024|NCT01803282|322682822|FG009|Overall Study|Withdrew Consent|5|||
94243025|NCT01803282|322682823|FG010|Overall Study|Withdrew Consent|0|||
94243026|NCT01803282|322682824|FG011|Overall Study|Withdrew Consent|1|||
94243027|NCT01803282|322682813|FG000|Overall Study|Investigator's Discretion|0|||
94243028|NCT01803282|322682814|FG001|Overall Study|Investigator's Discretion|0|||
94243029|NCT01803282|322682815|FG002|Overall Study|Investigator's Discretion|0|||
94243030|NCT01803282|322682816|FG003|Overall Study|Investigator's Discretion|7|||
94243031|NCT01803282|322682817|FG004|Overall Study|Investigator's Discretion|2|||
94243032|NCT01803282|322682818|FG005|Overall Study|Investigator's Discretion|1|||
94243033|NCT01803282|322682819|FG006|Overall Study|Investigator's Discretion|7|||
94243034|NCT01803282|322682820|FG007|Overall Study|Investigator's Discretion|10|||
94243035|NCT01803282|322682821|FG008|Overall Study|Investigator's Discretion|6|||
94243036|NCT01803282|322682822|FG009|Overall Study|Investigator's Discretion|7|||
94353882|NCT05664672|323077133|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
94353883|NCT05664672|323077134|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
94353884|NCT05664672|323077135|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
94353885|NCT05664672|323077136|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
94353886|NCT05664672|323077137|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
94353887|NCT05664672|323077138|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
94353888|NCT02543918|323077139|FG000|Overall Study|Never treated|0|||
94353889|NCT02543918|323077140|FG001|Overall Study|Never treated|1|||
94353890|NCT02543918|323077139|FG000|Overall Study|Lost to Follow-up|1|||
94353891|NCT02543918|323077140|FG001|Overall Study|Lost to Follow-up|1|||
94353892|NCT02543918|323077139|FG000|Overall Study|Withdrawal by Subject|1|||
94353893|NCT02543918|323077140|FG001|Overall Study|Withdrawal by Subject|1|||
94353894|NCT02543918|323077139|FG000|Overall Study|Adverse Event|1|||
94353895|NCT02543918|323077140|FG001|Overall Study|Adverse Event|1|||
94353896|NCT03205605|323077141|FG000|Overall Study|Withdrawal by Subject|1|||
94353897|NCT03328325|323077143|FG000|Overall Study|Lost to Follow-up|4|||
94353898|NCT03328325|323077143|FG000|Overall Study|Physician Decision|1|||
94353899|NCT03328325|323077143|FG000|Overall Study|Withdrawal by Subject|3|||
94353900|NCT03328325|323077143|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
94353901|NCT02117024|323077144|FG000|Overall Study|Progressive Disease|26|||
94353902|NCT02117024|323077145|FG001|Overall Study|Progressive Disease|9|||
94353903|NCT02117024|323077144|FG000|Overall Study|Significant Clinical Progression|7|||
94353904|NCT02117024|323077145|FG001|Overall Study|Significant Clinical Progression|4|||
94353905|NCT02117024|323077144|FG000|Overall Study|Death|5|||
94353906|NCT02117024|323077145|FG001|Overall Study|Death|0|||
94353907|NCT02117024|323077144|FG000|Overall Study|Withdrawal by Subject|3|||
94353908|NCT02117024|323077145|FG001|Overall Study|Withdrawal by Subject|1|||
94353909|NCT02117024|323077144|FG000|Overall Study|Protocol Violation|1|||
94353910|NCT02117024|323077145|FG001|Overall Study|Protocol Violation|0|||
94353911|NCT02117024|323077144|FG000|Overall Study|Adverse Event|1|||
94353912|NCT02117024|323077145|FG001|Overall Study|Adverse Event|2|||
94353913|NCT02117024|323077144|FG000|Overall Study|Randomized in Error|1|||
94353914|NCT02117024|323077145|FG001|Overall Study|Randomized in Error|0|||
94353915|NCT02117024|323077144|FG000|Overall Study|Patient returned to primary oncologist|0|||
94353916|NCT02117024|323077145|FG001|Overall Study|Patient returned to primary oncologist|1|||
94353917|NCT02117024|323077144|FG000|Overall Study|Patient took treatment break|0|||
94353918|NCT02117024|323077145|FG001|Overall Study|Patient took treatment break|1|||
94353919|NCT02117024|323077144|FG000|Overall Study|Physician Decision|0|||
94353920|NCT02117024|323077145|FG001|Overall Study|Physician Decision|2|||
94353921|NCT01497899|323077152|FG000|Double-Blind Phase|Randomized but not Treated|1|||
94353922|NCT01497899|323077153|FG001|Double-Blind Phase|Randomized but not Treated|0|||
94588492|NCT00104520|323955879|FG000|Overall Study|Study drug intolerance|0|||
94588493|NCT00104520|323955880|FG001|Overall Study|Study drug intolerance|1|||
94588494|NCT00104520|323955879|FG000|Overall Study|Related adverse event|13|||
94588495|NCT00104520|323955880|FG001|Overall Study|Related adverse event|15|||
94588496|NCT00104520|323955879|FG000|Overall Study|Lost to Follow-up|1|||
94588497|NCT00104520|323955880|FG001|Overall Study|Lost to Follow-up|0|||
94588498|NCT00104520|323955879|FG000|Overall Study|Noncompliance|0|||
94588499|NCT00104520|323955880|FG001|Overall Study|Noncompliance|2|||
94588500|NCT00104520|323955879|FG000|Overall Study|Personal/administrative|1|||
94588501|NCT00104520|323955880|FG001|Overall Study|Personal/administrative|1|||
94588502|NCT00104520|323955879|FG000|Overall Study|Other|1|||
94588503|NCT00104520|323955880|FG001|Overall Study|Other|5|||
94588504|NCT05188053|323955882|FG000|Overall Study|Lost to Follow-up|23|||
94588505|NCT05188053|323955883|FG001|Overall Study|Lost to Follow-up|30|||
94588506|NCT05188053|323955882|FG000|Overall Study|Protocol Violation|16|||
94588507|NCT05188053|323955883|FG001|Overall Study|Protocol Violation|16|||
94588508|NCT05188053|323955882|FG000|Overall Study|Physician Decision|3|||
94588509|NCT05188053|323955883|FG001|Overall Study|Physician Decision|0|||
94588510|NCT05188053|323955882|FG000|Overall Study|Withdrawal by Subject|0|||
94588511|NCT05188053|323955883|FG001|Overall Study|Withdrawal by Subject|1|||
94588512|NCT04535453|323955890|FG000|Overall Study|Death|0|||
94588513|NCT04535453|323955891|FG001|Overall Study|Death|1|||
94588514|NCT04535453|323955892|FG002|Overall Study|Death|0|||
94588515|NCT04535453|323955893|FG003|Overall Study|Death|0|||
94588516|NCT04535453|323955894|FG004|Overall Study|Death|0|||
94588517|NCT04535453|323955895|FG005|Overall Study|Death|0|||
94588518|NCT04535453|323955896|FG006|Overall Study|Death|0|||
94588519|NCT04535453|323955897|FG007|Overall Study|Death|0|||
94353923|NCT01497899|323077154|FG002|Double-Blind Phase|Randomized but not Treated|0|||
94353924|NCT01497899|323077155|FG003|Double-Blind Phase|Randomized but not Treated|0|||
94353925|NCT01497899|323077152|FG000|Double-Blind Phase|Adverse Event|1|||
94353926|NCT01497899|323077153|FG001|Double-Blind Phase|Adverse Event|0|||
94588520|NCT04535453|323955898|FG008|Overall Study|Death|0|||
94588521|NCT04535453|323955899|FG009|Overall Study|Death|0|||
94588522|NCT04535453|323955900|FG010|Overall Study|Death|0|||
94588523|NCT04535453|323955901|FG011|Overall Study|Death|0|||
94588524|NCT04535453|323955890|FG000|Overall Study|Lost to Follow-up|1|||
94353927|NCT01497899|323077154|FG002|Double-Blind Phase|Adverse Event|0|||
94353928|NCT01497899|323077155|FG003|Double-Blind Phase|Adverse Event|0|||
94353929|NCT01497899|323077152|FG000|Double-Blind Phase|Lack of Efficacy|0|||
94353930|NCT01497899|323077153|FG001|Double-Blind Phase|Lack of Efficacy|1|||
94353931|NCT01497899|323077154|FG002|Double-Blind Phase|Lack of Efficacy|0|||
94353932|NCT01497899|323077155|FG003|Double-Blind Phase|Lack of Efficacy|0|||
94353933|NCT01497899|323077152|FG000|Double-Blind Phase|Investigator's Discretion|1|||
94353934|NCT01497899|323077153|FG001|Double-Blind Phase|Investigator's Discretion|0|||
94353935|NCT01497899|323077154|FG002|Double-Blind Phase|Investigator's Discretion|0|||
94353936|NCT01497899|323077155|FG003|Double-Blind Phase|Investigator's Discretion|0|||
94353937|NCT01497899|323077152|FG000|Double-Blind Phase|Withdrew Consent|0|||
94353938|NCT01497899|323077153|FG001|Double-Blind Phase|Withdrew Consent|1|||
94353939|NCT01497899|323077154|FG002|Double-Blind Phase|Withdrew Consent|0|||
94353940|NCT01497899|323077155|FG003|Double-Blind Phase|Withdrew Consent|0|||
94353941|NCT01497899|323077152|FG000|Double-Blind Phase|Lost to Follow-up|3|||
94353942|NCT01497899|323077153|FG001|Double-Blind Phase|Lost to Follow-up|2|||
94353943|NCT01497899|323077154|FG002|Double-Blind Phase|Lost to Follow-up|0|||
94353944|NCT01497899|323077155|FG003|Double-Blind Phase|Lost to Follow-up|0|||
94353945|NCT01497899|323077152|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
94353946|NCT01497899|323077153|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
94353947|NCT01497899|323077154|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
94353948|NCT01497899|323077155|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
94353949|NCT01497899|323077152|FG000|Open-Label Extension Phase|Adverse Event|1|||
94353950|NCT01497899|323077153|FG001|Open-Label Extension Phase|Adverse Event|0|||
94353951|NCT01497899|323077154|FG002|Open-Label Extension Phase|Adverse Event|0|||
94353952|NCT01497899|323077155|FG003|Open-Label Extension Phase|Adverse Event|0|||
94353953|NCT01497899|323077152|FG000|Open-Label Extension Phase|Death|1|||
94353954|NCT01497899|323077153|FG001|Open-Label Extension Phase|Death|0|||
94353955|NCT01497899|323077154|FG002|Open-Label Extension Phase|Death|0|||
94353956|NCT01497899|323077155|FG003|Open-Label Extension Phase|Death|0|||
94353957|NCT01497899|323077152|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
94353958|NCT01497899|323077153|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
94353959|NCT01497899|323077154|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
94353960|NCT01497899|323077155|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
94353961|NCT01497899|323077152|FG000|Open-Label Extension Phase|Pregnancy|0|||
94353962|NCT01497899|323077153|FG001|Open-Label Extension Phase|Pregnancy|1|||
94353963|NCT01497899|323077154|FG002|Open-Label Extension Phase|Pregnancy|1|||
94353964|NCT01497899|323077155|FG003|Open-Label Extension Phase|Pregnancy|0|||
94353965|NCT01497899|323077152|FG000|Open-Label Extension Phase|Protocol Violation|0|||
94353966|NCT01497899|323077153|FG001|Open-Label Extension Phase|Protocol Violation|0|||
94353967|NCT01497899|323077154|FG002|Open-Label Extension Phase|Protocol Violation|1|||
94353968|NCT01497899|323077155|FG003|Open-Label Extension Phase|Protocol Violation|0|||
94353969|NCT01497899|323077152|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
94353970|NCT01497899|323077153|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
94353971|NCT01497899|323077154|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
94353972|NCT01497899|323077155|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
94353973|NCT00606931|323077158|FG000|Overall Study|Withdrawal by Subject|3|||
94353974|NCT00286234|323077159|FG000|Overall Study|Protocol Violation|1|||
94353975|NCT00286234|323077160|FG001|Overall Study|Protocol Violation|2|||
94353976|NCT00286234|323077161|FG002|Overall Study|Protocol Violation|0|||
94353977|NCT00286234|323077162|FG003|Overall Study|Protocol Violation|1|||
94353978|NCT00286234|323077159|FG000|Overall Study|Physician Decision|1|||
94353979|NCT00286234|323077160|FG001|Overall Study|Physician Decision|0|||
94353980|NCT00286234|323077161|FG002|Overall Study|Physician Decision|0|||
94353981|NCT00286234|323077162|FG003|Overall Study|Physician Decision|1|||
94353982|NCT00286234|323077159|FG000|Overall Study|Adverse Event|0|||
94353983|NCT00286234|323077160|FG001|Overall Study|Adverse Event|0|||
94353984|NCT00286234|323077161|FG002|Overall Study|Adverse Event|0|||
94353985|NCT00286234|323077162|FG003|Overall Study|Adverse Event|1|||
94353986|NCT00286234|323077159|FG000|Overall Study|Adverse Event|0|||
94353987|NCT00286234|323077160|FG001|Overall Study|Adverse Event|0|||
94353988|NCT00286234|323077161|FG002|Overall Study|Adverse Event|0|||
94659462|NCT01722331|324208013|FG002|Part 3|Other Protocol Specified Criteria|0|||
94353989|NCT00286234|323077162|FG003|Overall Study|Adverse Event|1|||
94353990|NCT04246996|323077168|FG000|Overall Study|Physician Decision|1|||
94353991|NCT04246996|323077169|FG001|Overall Study|Physician Decision|1|||
94353992|NCT04246996|323077168|FG000|Overall Study|Did not meet eligibility criteria|1|||
94353993|NCT04246996|323077169|FG001|Overall Study|Did not meet eligibility criteria|4|||
94659463|NCT01722331|324208014|FG003|Part 3|Other Protocol Specified Criteria|0|||
94353994|NCT01348828|323077170|FG000|Overall Study|Death|20|||
94353995|NCT01348828|323077170|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
94353996|NCT01348828|323077170|FG000|Overall Study|Conversion|2|||
94353997|NCT01348828|323077170|FG000|Overall Study|missed visit|1|||
94353998|NCT01365182|323077172|FG000|Overall Study|Withdrawal by Subject|10|||
94659464|NCT01722331|324208015|FG004|Part 3|Other Protocol Specified Criteria|0|||
94353999|NCT01365182|323077173|FG001|Overall Study|Withdrawal by Subject|13|||
94354000|NCT01365182|323077174|FG002|Overall Study|Withdrawal by Subject|12|||
94354001|NCT01874288|323077175|FG000|Overall Study|Withdrawal by Subject|1|||
94354002|NCT01874288|323077176|FG001|Overall Study|Withdrawal by Subject|0|||
94354003|NCT01874288|323077177|FG002|Overall Study|Withdrawal by Subject|2|||
94354004|NCT01874288|323077178|FG003|Overall Study|Withdrawal by Subject|1|||
94354005|NCT01874288|323077179|FG004|Overall Study|Withdrawal by Subject|1|||
94354006|NCT01874288|323077175|FG000|Overall Study|Physician Decision|0|||
94354007|NCT01874288|323077176|FG001|Overall Study|Physician Decision|0|||
94354008|NCT01874288|323077177|FG002|Overall Study|Physician Decision|0|||
94354009|NCT01874288|323077178|FG003|Overall Study|Physician Decision|1|||
94354010|NCT01874288|323077179|FG004|Overall Study|Physician Decision|0|||
94354011|NCT01874288|323077175|FG000|Overall Study|Progressive disease|2|||
94354012|NCT01874288|323077176|FG001|Overall Study|Progressive disease|0|||
94354013|NCT01874288|323077177|FG002|Overall Study|Progressive disease|3|||
94354014|NCT01874288|323077178|FG003|Overall Study|Progressive disease|5|||
94354015|NCT01874288|323077179|FG004|Overall Study|Progressive disease|1|||
94354016|NCT04806334|323077185|FG000|Overall Study|Withdrawal by Subject|1|||
94354017|NCT03969589|323077189|FG000|Overall Study|Lost to Follow-up|3|||
94354018|NCT03969589|323077190|FG001|Overall Study|Lost to Follow-up|2|||
94354019|NCT03969589|323077189|FG000|Overall Study|Declined Follow-Up|0|||
94354020|NCT03969589|323077190|FG001|Overall Study|Declined Follow-Up|1|||
94354021|NCT02441517|323077191|FG000|Overall Study|Lost to Follow-up|1|||
94354022|NCT02441517|323077191|FG000|Overall Study|Withdrawal by Subject|2|||
94354023|NCT02441517|323077191|FG000|Overall Study|Study Terminated by Sponsor|1|||
94354024|NCT02260804|323077193|FG000|Induction Study Period|Protocol Violation|2|||
94354025|NCT02260804|323077194|FG001|Induction Study Period|Protocol Violation|0|||
94354026|NCT02260804|323077193|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
94354027|NCT02260804|323077194|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
94354028|NCT02260804|323077193|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
94354029|NCT02260804|323077194|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
94354030|NCT02260804|323077193|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
94354031|NCT02260804|323077194|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
94354032|NCT02260804|323077193|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
94354033|NCT02260804|323077194|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
94354034|NCT02260804|323077193|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
94354035|NCT02260804|323077194|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
94354036|NCT02260804|323077193|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
94354037|NCT02260804|323077194|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
94354038|NCT02260804|323077193|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
94354039|NCT02260804|323077194|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
94354040|NCT02260804|323077193|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
94354041|NCT02260804|323077194|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
94354042|NCT02260804|323077193|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
94354043|NCT02260804|323077194|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
94354044|NCT02260804|323077193|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
94354045|NCT02260804|323077194|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
94354046|NCT02207413|323077195|FG000|Overall Study|Withdrawal by Subject|1|||
94354047|NCT02207413|323077196|FG001|Overall Study|Withdrawal by Subject|0|||
94354048|NCT02207413|323077197|FG002|Overall Study|Withdrawal by Subject|0|||
94354049|NCT02207413|323077198|FG003|Overall Study|Withdrawal by Subject|0|||
94354050|NCT02207413|323077199|FG004|Overall Study|Withdrawal by Subject|3|||
94354051|NCT02207413|323077200|FG005|Overall Study|Withdrawal by Subject|7|||
94354052|NCT02207413|323077195|FG000|Overall Study|Lost to Follow-up|0|||
94354053|NCT02207413|323077196|FG001|Overall Study|Lost to Follow-up|0|||
94354054|NCT02207413|323077197|FG002|Overall Study|Lost to Follow-up|0|||
94354055|NCT02207413|323077198|FG003|Overall Study|Lost to Follow-up|1|||
94354056|NCT02207413|323077199|FG004|Overall Study|Lost to Follow-up|1|||
94354057|NCT02207413|323077200|FG005|Overall Study|Lost to Follow-up|5|||
94354058|NCT02207413|323077195|FG000|Overall Study|Adverse Event|0|||
94354059|NCT02207413|323077196|FG001|Overall Study|Adverse Event|0|||
94354060|NCT02207413|323077197|FG002|Overall Study|Adverse Event|0|||
94456051|NCT03499899|323458171|FG002|Overall Study|Patient decision|1|||
94354061|NCT02207413|323077198|FG003|Overall Study|Adverse Event|0|||
94465950|NCT04769739|323494959|FG000|Overall Study|Poor bowel preparation|0|||
94354062|NCT02207413|323077199|FG004|Overall Study|Adverse Event|2|||
94354063|NCT02207413|323077200|FG005|Overall Study|Adverse Event|1|||
94588525|NCT04535453|323955891|FG001|Overall Study|Lost to Follow-up|1|||
94588526|NCT04535453|323955892|FG002|Overall Study|Lost to Follow-up|1|||
94588527|NCT04535453|323955893|FG003|Overall Study|Lost to Follow-up|0|||
94588528|NCT04535453|323955894|FG004|Overall Study|Lost to Follow-up|3|||
94588529|NCT04535453|323955895|FG005|Overall Study|Lost to Follow-up|1|||
94588530|NCT04535453|323955896|FG006|Overall Study|Lost to Follow-up|0|||
94588531|NCT04535453|323955897|FG007|Overall Study|Lost to Follow-up|0|||
94588532|NCT04535453|323955898|FG008|Overall Study|Lost to Follow-up|1|||
94588533|NCT04535453|323955899|FG009|Overall Study|Lost to Follow-up|1|||
94588534|NCT04535453|323955900|FG010|Overall Study|Lost to Follow-up|0|||
94588535|NCT04535453|323955901|FG011|Overall Study|Lost to Follow-up|0|||
94588536|NCT04535453|323955890|FG000|Overall Study|Physician Decision|0|||
94588537|NCT04535453|323955891|FG001|Overall Study|Physician Decision|0|||
94588538|NCT04535453|323955892|FG002|Overall Study|Physician Decision|0|||
94588539|NCT04535453|323955893|FG003|Overall Study|Physician Decision|1|||
94588540|NCT04535453|323955894|FG004|Overall Study|Physician Decision|0|||
94588541|NCT04535453|323955895|FG005|Overall Study|Physician Decision|0|||
94588542|NCT04535453|323955896|FG006|Overall Study|Physician Decision|0|||
94588543|NCT04535453|323955897|FG007|Overall Study|Physician Decision|0|||
94588544|NCT04535453|323955898|FG008|Overall Study|Physician Decision|0|||
94588545|NCT04535453|323955899|FG009|Overall Study|Physician Decision|0|||
94588546|NCT04535453|323955900|FG010|Overall Study|Physician Decision|0|||
94588547|NCT04535453|323955901|FG011|Overall Study|Physician Decision|0|||
94588548|NCT04535453|323955890|FG000|Overall Study|Withdrawal by Subject|3|||
94588549|NCT04535453|323955891|FG001|Overall Study|Withdrawal by Subject|6|||
94588550|NCT04535453|323955892|FG002|Overall Study|Withdrawal by Subject|3|||
94588551|NCT04535453|323955893|FG003|Overall Study|Withdrawal by Subject|3|||
94588552|NCT04535453|323955894|FG004|Overall Study|Withdrawal by Subject|2|||
94588553|NCT04535453|323955895|FG005|Overall Study|Withdrawal by Subject|1|||
94588554|NCT04535453|323955896|FG006|Overall Study|Withdrawal by Subject|1|||
94588555|NCT04535453|323955897|FG007|Overall Study|Withdrawal by Subject|1|||
94588556|NCT04535453|323955898|FG008|Overall Study|Withdrawal by Subject|1|||
94588557|NCT04535453|323955899|FG009|Overall Study|Withdrawal by Subject|1|||
94588558|NCT04535453|323955900|FG010|Overall Study|Withdrawal by Subject|0|||
94588559|NCT04535453|323955901|FG011|Overall Study|Withdrawal by Subject|1|||
94588560|NCT04535453|323955890|FG000|Overall Study|Other|0|||
94588561|NCT04535453|323955891|FG001|Overall Study|Other|0|||
94588562|NCT04535453|323955892|FG002|Overall Study|Other|1|||
94588563|NCT04535453|323955893|FG003|Overall Study|Other|0|||
94588564|NCT04535453|323955894|FG004|Overall Study|Other|1|||
94588565|NCT04535453|323955895|FG005|Overall Study|Other|0|||
94588566|NCT04535453|323955896|FG006|Overall Study|Other|1|||
94588567|NCT04535453|323955897|FG007|Overall Study|Other|1|||
94588568|NCT04535453|323955898|FG008|Overall Study|Other|1|||
94588569|NCT04535453|323955899|FG009|Overall Study|Other|0|||
94588570|NCT04535453|323955900|FG010|Overall Study|Other|0|||
94588571|NCT04535453|323955901|FG011|Overall Study|Other|0|||
94588572|NCT02626624|323955902|FG000|Overall Study|Adverse Event|1|||
94588573|NCT02626624|323955902|FG000|Overall Study|Lost to Follow-up|3|||
94588574|NCT02626624|323955902|FG000|Overall Study|Protocol Violation|4|||
94588575|NCT02626624|323955902|FG000|Overall Study|Death|2|||
94588576|NCT00684060|323957428|FG000|Overall Study|Lost to Follow-up|1|||
94588577|NCT00684060|323957429|FG001|Overall Study|Lost to Follow-up|0|||
94588578|NCT00684060|323957428|FG000|Overall Study|New stenosis identified|1|||
94588579|NCT00684060|323957429|FG001|Overall Study|New stenosis identified|0|||
94588580|NCT00684060|323957428|FG000|Overall Study|Unable to collect MRI|1|||
94588581|NCT00684060|323957429|FG001|Overall Study|Unable to collect MRI|2|||
94588582|NCT00684060|323957428|FG000|Overall Study|Death|0|||
94588583|NCT00684060|323957429|FG001|Overall Study|Death|1|||
94588584|NCT01250145|323957431|FG000|Overall Study|Adverse Event|2|||
94588585|NCT01250145|323957432|FG001|Overall Study|Adverse Event|1|||
94588586|NCT01250145|323957431|FG000|Overall Study|Withdrawal by Subject|0|||
94588587|NCT01250145|323957432|FG001|Overall Study|Withdrawal by Subject|4|||
94588588|NCT02565784|323957433|FG000|First Treatment|Adverse Event|1|||
94588589|NCT02565784|323957433|FG000|First Treatment|Withdrawal by Subject|1|||
94588590|NCT02565784|323957433|FG000|Second Treatment|Withdrawal by Subject|2|||
94588591|NCT03983317|323957436|FG000|Overall Study|Physician Decision|5|||
94588592|NCT01596062|323957437|FG000|Overall Study|Adverse Event|1|||
94588593|NCT01596062|323957438|FG001|Overall Study|Adverse Event|0|||
94588594|NCT01596062|323957439|FG002|Overall Study|Adverse Event|2|||
94588595|NCT01596062|323957437|FG000|Overall Study|Lack of Efficacy|0|||
94588596|NCT01596062|323957438|FG001|Overall Study|Lack of Efficacy|0|||
94588597|NCT01596062|323957439|FG002|Overall Study|Lack of Efficacy|1|||
94588598|NCT02741518|323957444|FG000|Overall Study|Withdrawal by Subject|1|||
94588599|NCT02741518|323957445|FG001|Overall Study|Withdrawal by Subject|1|||
94588600|NCT00943072|323957446|FG000|Overall Study|Adverse Event|0|||
94588601|NCT00943072|323957447|FG001|Overall Study|Adverse Event|3|||
94588602|NCT00943072|323957446|FG000|Overall Study|Death|0|||
94588603|NCT00943072|323957447|FG001|Overall Study|Death|2|||
94588604|NCT00943072|323957446|FG000|Overall Study|Withdrawal by Subject|3|||
94588605|NCT00943072|323957447|FG001|Overall Study|Withdrawal by Subject|1|||
94588606|NCT00943072|323957446|FG000|Overall Study|Protocol Violation|0|||
94588607|NCT00943072|323957447|FG001|Overall Study|Protocol Violation|1|||
94588608|NCT00943072|323957446|FG000|Overall Study|Lost to Follow-up|1|||
94588609|NCT00943072|323957447|FG001|Overall Study|Lost to Follow-up|2|||
94588610|NCT00943072|323957446|FG000|Overall Study|Lack of Efficacy|0|||
94588611|NCT00943072|323957447|FG001|Overall Study|Lack of Efficacy|4|||
94588612|NCT00943072|323957446|FG000|Overall Study|Other|1|||
94588613|NCT00943072|323957447|FG001|Overall Study|Other|1|||
94588614|NCT00552188|323957451|FG000|Overall Study|Adverse Event|0|||
94588615|NCT00552188|323957452|FG001|Overall Study|Adverse Event|2|||
94588616|NCT00552188|323957451|FG000|Overall Study|Lost to Follow-up|2|||
94588617|NCT00552188|323957452|FG001|Overall Study|Lost to Follow-up|1|||
94588618|NCT00552188|323957451|FG000|Overall Study|Withdrawal of consent|0|||
94588619|NCT00552188|323957452|FG001|Overall Study|Withdrawal of consent|1|||
94588620|NCT00552188|323957451|FG000|Overall Study|Subject returned to home country|0|||
94588621|NCT00552188|323957452|FG001|Overall Study|Subject returned to home country|1|||
94588622|NCT01788358|323957455|FG000|Overall Study|Other|11|||
94588623|NCT01788358|323957455|FG000|Overall Study|Logistical difficulties|1|||
94588624|NCT01788358|323957455|FG000|Overall Study|Lost to Follow-up|5|||
94588625|NCT01788358|323957455|FG000|Overall Study|Protocol Violation|3|||
94588626|NCT01788358|323957455|FG000|Overall Study|Withdrawal by Subject|26|||
94588627|NCT01788358|323957455|FG000|Overall Study|Lack of Efficacy|1|||
94588628|NCT01788358|323957455|FG000|Overall Study|Adverse Event|51|||
94588629|NCT00375609|323957456|FG000|Overall Study|Did not receive treatment|1|||
94588630|NCT00375609|323957457|FG001|Overall Study|Did not receive treatment|0|||
94588631|NCT00375609|323957458|FG002|Overall Study|Did not receive treatment|0|||
94588632|NCT00375609|323957456|FG000|Overall Study|Adverse Event|0|||
94588633|NCT00375609|323957457|FG001|Overall Study|Adverse Event|3|||
94588634|NCT00375609|323957458|FG002|Overall Study|Adverse Event|0|||
94588635|NCT00375609|323957456|FG000|Overall Study|Lost to Follow-up|1|||
94588636|NCT00375609|323957457|FG001|Overall Study|Lost to Follow-up|0|||
94588637|NCT00375609|323957458|FG002|Overall Study|Lost to Follow-up|0|||
94588638|NCT00375609|323957456|FG000|Overall Study|Physician Decision|0|||
94588639|NCT00375609|323957457|FG001|Overall Study|Physician Decision|0|||
94588640|NCT00375609|323957458|FG002|Overall Study|Physician Decision|1|||
94588641|NCT00375609|323957456|FG000|Overall Study|Withdrawal by Subject|1|||
94588642|NCT00375609|323957457|FG001|Overall Study|Withdrawal by Subject|4|||
94588643|NCT00375609|323957458|FG002|Overall Study|Withdrawal by Subject|0|||
94588644|NCT00375609|323957456|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
94588645|NCT00375609|323957457|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
94456052|NCT03499899|323458169|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
94588646|NCT00375609|323957458|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
94588647|NCT00792571|323957459|FG000|Overall Study|Death|1|||
94588648|NCT00792571|323957459|FG000|Overall Study|Adverse Event|4|||
94588649|NCT00792571|323957459|FG000|Overall Study|Withdrawal by Subject|1|||
94588650|NCT00792571|323957459|FG000|Overall Study|Other|4|||
94588651|NCT00505778|323957460|FG000|Overall Study|Adverse Event|2|||
94588652|NCT00505778|323957461|FG001|Overall Study|Adverse Event|7|||
94588653|NCT00505778|323957460|FG000|Overall Study|Physician Decision|8|||
94588654|NCT00505778|323957461|FG001|Overall Study|Physician Decision|14|||
94588655|NCT00505778|323957460|FG000|Overall Study|Lost to Follow-up|17|||
94456053|NCT03499899|323458170|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
94456054|NCT03499899|323458171|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
94456055|NCT03655470|323458183|FG000|Overall Study|Lost to Follow-up|6|||
94456056|NCT03655470|323458184|FG001|Overall Study|Lost to Follow-up|7|||
94588656|NCT00505778|323957461|FG001|Overall Study|Lost to Follow-up|23|||
94588657|NCT00505778|323957460|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
94354064|NCT02207413|323077195|FG000|Overall Study|Migrated/moved from study area|0|||
94354065|NCT02207413|323077196|FG001|Overall Study|Migrated/moved from study area|0|||
94354066|NCT02207413|323077197|FG002|Overall Study|Migrated/moved from study area|0|||
94354067|NCT02207413|323077198|FG003|Overall Study|Migrated/moved from study area|0|||
94354068|NCT02207413|323077199|FG004|Overall Study|Migrated/moved from study area|1|||
94354069|NCT02207413|323077200|FG005|Overall Study|Migrated/moved from study area|0|||
94354070|NCT01347931|323078405|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
94354071|NCT04308668|323078406|FG000|Overall Study|Lost to Follow-up|32|||
94354072|NCT04308668|323078407|FG001|Overall Study|Lost to Follow-up|38|||
94354073|NCT04308668|323078406|FG000|Overall Study|Withdrawal by Subject|4|||
94354074|NCT04308668|323078407|FG001|Overall Study|Withdrawal by Subject|4|||
94354075|NCT01020812|323078408|FG000|Overall Study|Physician Decision|1|||
94354076|NCT01020812|323078408|FG000|Overall Study|Withdrawal by Subject|1|||
94354077|NCT01020812|323078408|FG000|Overall Study|Protocol Violation|1|||
94354078|NCT02087085|323078414|FG000|Overall Study|Adverse Event|10|||
94354079|NCT02087085|323078415|FG001|Overall Study|Adverse Event|14|||
94354080|NCT02087085|323078414|FG000|Overall Study|Lack of Efficacy|4|||
94354081|NCT02087085|323078415|FG001|Overall Study|Lack of Efficacy|3|||
94354082|NCT02087085|323078414|FG000|Overall Study|Lost to Follow-up|6|||
94354083|NCT02087085|323078415|FG001|Overall Study|Lost to Follow-up|4|||
94354084|NCT02087085|323078414|FG000|Overall Study|Withdrawal by Subject|9|||
94354085|NCT02087085|323078415|FG001|Overall Study|Withdrawal by Subject|11|||
94354086|NCT02087085|323078414|FG000|Overall Study|Protocol Violation|1|||
94354087|NCT02087085|323078415|FG001|Overall Study|Protocol Violation|0|||
94354088|NCT02087085|323078414|FG000|Overall Study|Study Terminated by Sponsor|87|||
94354089|NCT02087085|323078415|FG001|Overall Study|Study Terminated by Sponsor|80|||
94354090|NCT02087085|323078414|FG000|Overall Study|Other Miscellaneous Reasons|3|||
94354091|NCT02087085|323078415|FG001|Overall Study|Other Miscellaneous Reasons|4|||
94354092|NCT01928758|323078422|FG000|Overall Study|Lost to Follow-up|14|||
94354093|NCT01928758|323078423|FG001|Overall Study|Lost to Follow-up|9|||
94354094|NCT01928758|323078422|FG000|Overall Study|Withdrawal by Subject|5|||
94354095|NCT01928758|323078423|FG001|Overall Study|Withdrawal by Subject|2|||
94354096|NCT01928758|323078422|FG000|Overall Study|Adverse Event|3|||
94354097|NCT01928758|323078423|FG001|Overall Study|Adverse Event|5|||
94354098|NCT01928758|323078422|FG000|Overall Study|Protocol Violation|3|||
94354099|NCT01928758|323078423|FG001|Overall Study|Protocol Violation|4|||
94354100|NCT01667731|323078424|FG000|Overall Study|Enrolled but not treated|0|||
94354101|NCT01667731|323078425|FG001|Overall Study|Enrolled but not treated|0|||
94588658|NCT00505778|323957461|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
94588659|NCT00505778|323957460|FG000|Overall Study|Protocol Violation|7|||
94588660|NCT00505778|323957461|FG001|Overall Study|Protocol Violation|9|||
94588661|NCT00505778|323957460|FG000|Overall Study|Withdrawal by Subject|29|||
94588662|NCT00505778|323957461|FG001|Overall Study|Withdrawal by Subject|14|||
94588663|NCT00505778|323957460|FG000|Overall Study|Relapse|65|||
94588664|NCT00505778|323957461|FG001|Overall Study|Relapse|65|||
94588665|NCT00505778|323957460|FG000|Overall Study|Took No Study Drug|2|||
94588666|NCT00505778|323957461|FG001|Overall Study|Took No Study Drug|2|||
94354102|NCT01667731|323078426|FG002|Overall Study|Enrolled but not treated|0|||
94354103|NCT01667731|323078427|FG003|Overall Study|Enrolled but not treated|0|||
94354104|NCT01667731|323078428|FG004|Overall Study|Enrolled but not treated|1|||
94354105|NCT01667731|323078424|FG000|Overall Study|Efficacy Failure|1|||
94354106|NCT01667731|323078425|FG001|Overall Study|Efficacy Failure|12|||
94354107|NCT01667731|323078426|FG002|Overall Study|Efficacy Failure|0|||
94354108|NCT01667731|323078427|FG003|Overall Study|Efficacy Failure|1|||
94354109|NCT01667731|323078428|FG004|Overall Study|Efficacy Failure|24|||
94354110|NCT01667731|323078424|FG000|Overall Study|Lost to Follow-up|2|||
94354111|NCT01667731|323078425|FG001|Overall Study|Lost to Follow-up|3|||
94354112|NCT01667731|323078426|FG002|Overall Study|Lost to Follow-up|1|||
94354113|NCT01667731|323078427|FG003|Overall Study|Lost to Follow-up|1|||
94354114|NCT01667731|323078428|FG004|Overall Study|Lost to Follow-up|2|||
94354115|NCT01667731|323078424|FG000|Overall Study|Subject Withdrew Consent|2|||
94354116|NCT01667731|323078425|FG001|Overall Study|Subject Withdrew Consent|0|||
94588667|NCT03275350|323957462|FG000|Overall Study|Lost to Follow-up|4|||
94354117|NCT01667731|323078426|FG002|Overall Study|Subject Withdrew Consent|1|||
94354118|NCT01667731|323078427|FG003|Overall Study|Subject Withdrew Consent|0|||
94354119|NCT01667731|323078428|FG004|Overall Study|Subject Withdrew Consent|1|||
94354120|NCT01667731|323078424|FG000|Overall Study|Death|0|||
94588668|NCT03275350|323957463|FG001|Overall Study|Lost to Follow-up|6|||
94354121|NCT01667731|323078425|FG001|Overall Study|Death|1|||
94354122|NCT01667731|323078426|FG002|Overall Study|Death|0|||
94354123|NCT01667731|323078427|FG003|Overall Study|Death|0|||
94456057|NCT04590586|323458185|FG000|Overall Study|Death|7|||
94354124|NCT01667731|323078428|FG004|Overall Study|Death|0|||
94354125|NCT02718131|323078429|FG000|Overall Study|Withdrawal by Subject|1|||
94354126|NCT02718131|323078430|FG001|Overall Study|Withdrawal by Subject|0|||
94588669|NCT03275350|323957462|FG000|Overall Study|Death|2|||
94354127|NCT02718131|323078429|FG000|Overall Study|Adverse Event|1|||
94354128|NCT02718131|323078430|FG001|Overall Study|Adverse Event|0|||
94354129|NCT02718131|323078429|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
94354130|NCT02718131|323078430|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
94354131|NCT02545270|323078436|FG000|Overall Study|technical difficulties|0|||
94354132|NCT02545270|323078437|FG001|Overall Study|technical difficulties|1|||
94354133|NCT02545270|323078438|FG002|Overall Study|technical difficulties|0|||
94354134|NCT02545270|323078436|FG000|Overall Study|Videos being too similar to other|0|||
94354135|NCT02545270|323078437|FG001|Overall Study|Videos being too similar to other|0|||
94354136|NCT02545270|323078438|FG002|Overall Study|Videos being too similar to other|2|||
94354137|NCT03380091|323078441|FG000|Overall Study|Withdrawal by Subject|2|||
94354138|NCT03380091|323078442|FG001|Overall Study|Withdrawal by Subject|1|||
94354139|NCT03907072|323078446|FG000|Overall Study|Study Terminated by Sponsor|2|||
94354140|NCT03907072|323078447|FG001|Overall Study|Study Terminated by Sponsor|2|||
94354141|NCT03907072|323078448|FG002|Overall Study|Study Terminated by Sponsor|2|||
94354142|NCT00612456|323078449|FG000|Overall Study|Adverse Event|1|||
94354143|NCT00612456|323078450|FG001|Overall Study|Adverse Event|0|||
94354144|NCT00612456|323078451|FG002|Overall Study|Adverse Event|0|||
94354145|NCT00612456|323078449|FG000|Overall Study|Lack of Efficacy|1|||
94354146|NCT00612456|323078450|FG001|Overall Study|Lack of Efficacy|1|||
94354147|NCT00612456|323078451|FG002|Overall Study|Lack of Efficacy|0|||
94354148|NCT00612456|323078449|FG000|Overall Study|Withdrawal by Subject|0|||
94588670|NCT03275350|323957463|FG001|Overall Study|Death|1|||
94588671|NCT03275350|323957462|FG000|Overall Study|Physician Decision|1|||
94588672|NCT03275350|323957463|FG001|Overall Study|Physician Decision|0|||
94588673|NCT03275350|323957462|FG000|Overall Study|Incarcerated|1|||
94588674|NCT03275350|323957463|FG001|Overall Study|Incarcerated|1|||
94588675|NCT04661579|323957467|FG000|Overall Study|Lost to Follow-up|19|||
94588676|NCT04661579|323957468|FG001|Overall Study|Lost to Follow-up|10|||
94588677|NCT04661579|323957469|FG002|Overall Study|Lost to Follow-up|2|||
94588678|NCT04661579|323957470|FG003|Overall Study|Lost to Follow-up|7|||
94588679|NCT04661579|323957471|FG004|Overall Study|Lost to Follow-up|11|||
94588680|NCT04661579|323957467|FG000|Overall Study|Physician Decision|2|||
94588681|NCT04661579|323957468|FG001|Overall Study|Physician Decision|0|||
94588682|NCT04661579|323957469|FG002|Overall Study|Physician Decision|0|||
94588683|NCT04661579|323957470|FG003|Overall Study|Physician Decision|1|||
94588684|NCT04661579|323957471|FG004|Overall Study|Physician Decision|0|||
94588685|NCT04661579|323957467|FG000|Overall Study|Withdrawal by Subject|1|||
94588686|NCT04661579|323957468|FG001|Overall Study|Withdrawal by Subject|4|||
94588687|NCT04661579|323957469|FG002|Overall Study|Withdrawal by Subject|0|||
94588688|NCT04661579|323957470|FG003|Overall Study|Withdrawal by Subject|2|||
94588689|NCT04661579|323957471|FG004|Overall Study|Withdrawal by Subject|0|||
94588690|NCT04661579|323957467|FG000|Overall Study|Death|1|||
94588691|NCT04661579|323957468|FG001|Overall Study|Death|0|||
94588692|NCT04661579|323957469|FG002|Overall Study|Death|0|||
94354149|NCT00612456|323078450|FG001|Overall Study|Withdrawal by Subject|1|||
94354150|NCT00612456|323078451|FG002|Overall Study|Withdrawal by Subject|0|||
94588693|NCT04661579|323957470|FG003|Overall Study|Death|0|||
94354151|NCT00265109|323078452|FG000|Overall Study|Withdrawal by Subject|5|||
94354152|NCT00265109|323078452|FG000|Overall Study|Adverse Event|1|||
94354153|NCT00504595|323078453|FG000|Overall Study|Lack of Efficacy|1|||
94354154|NCT00504595|323078454|FG001|Overall Study|Lack of Efficacy|0|||
94588694|NCT04661579|323957471|FG004|Overall Study|Death|0|||
94588695|NCT04661579|323957467|FG000|Overall Study|Other|1|||
94354155|NCT00504595|323078455|FG002|Overall Study|Lack of Efficacy|0|||
94354156|NCT00504595|323078456|FG003|Overall Study|Lack of Efficacy|0|||
94354157|NCT00504595|323078453|FG000|Overall Study|Other|0|||
94354158|NCT00504595|323078454|FG001|Overall Study|Other|0|||
94354159|NCT00504595|323078455|FG002|Overall Study|Other|2|||
94243037|NCT01803282|322682823|FG010|Overall Study|Investigator's Discretion|1|||
94243038|NCT01803282|322682824|FG011|Overall Study|Investigator's Discretion|0|||
94243039|NCT01803282|322682813|FG000|Overall Study|Adverse Event|0|||
94243040|NCT01803282|322682814|FG001|Overall Study|Adverse Event|0|||
94243041|NCT01803282|322682815|FG002|Overall Study|Adverse Event|0|||
94243042|NCT01803282|322682816|FG003|Overall Study|Adverse Event|0|||
94354160|NCT00504595|323078456|FG003|Overall Study|Other|0|||
94354161|NCT03326323|323078457|FG000|Overall Study|Unable to receive ANH protocol|3|||
94354162|NCT00174460|323078458|FG000|Overall Study|Withdrawal by Subject|0|||
94354163|NCT00174460|323078459|FG001|Overall Study|Withdrawal by Subject|1|||
94354164|NCT04533204|323078462|FG000|Overall Study|Unable to understand training instructions|1|||
94354165|NCT04533204|323078463|FG001|Overall Study|Unable to understand training instructions|1|||
94243043|NCT01803282|322682817|FG004|Overall Study|Adverse Event|0|||
94243044|NCT01803282|322682818|FG005|Overall Study|Adverse Event|0|||
94243045|NCT01803282|322682819|FG006|Overall Study|Adverse Event|1|||
94243046|NCT01803282|322682820|FG007|Overall Study|Adverse Event|2|||
94243047|NCT01803282|322682821|FG008|Overall Study|Adverse Event|0|||
94243048|NCT01803282|322682822|FG009|Overall Study|Adverse Event|1|||
94243049|NCT01803282|322682823|FG010|Overall Study|Adverse Event|0|||
94243050|NCT01803282|322682824|FG011|Overall Study|Adverse Event|3|||
94243051|NCT01803282|322682813|FG000|Overall Study|Non-Compliance with Study Drug|0|||
94243052|NCT01803282|322682814|FG001|Overall Study|Non-Compliance with Study Drug|0|||
94243053|NCT01803282|322682815|FG002|Overall Study|Non-Compliance with Study Drug|0|||
94243054|NCT01803282|322682816|FG003|Overall Study|Non-Compliance with Study Drug|1|||
94243055|NCT01803282|322682817|FG004|Overall Study|Non-Compliance with Study Drug|0|||
94243056|NCT01803282|322682818|FG005|Overall Study|Non-Compliance with Study Drug|0|||
94243057|NCT01803282|322682819|FG006|Overall Study|Non-Compliance with Study Drug|0|||
94243058|NCT01803282|322682820|FG007|Overall Study|Non-Compliance with Study Drug|0|||
94243059|NCT01803282|322682821|FG008|Overall Study|Non-Compliance with Study Drug|0|||
94243060|NCT01803282|322682822|FG009|Overall Study|Non-Compliance with Study Drug|0|||
94243061|NCT01803282|322682823|FG010|Overall Study|Non-Compliance with Study Drug|0|||
94243062|NCT01803282|322682824|FG011|Overall Study|Non-Compliance with Study Drug|0|||
94354166|NCT00764465|323078464|FG000|Overall Study|Adverse Event|2|||
94456058|NCT04590586|323458186|FG001|Overall Study|Death|1|||
94456059|NCT04590586|323458187|FG002|Overall Study|Death|37|||
94456060|NCT04590586|323458188|FG003|Overall Study|Death|34|||
94456061|NCT04590586|323458189|FG004|Overall Study|Death|19|||
94456062|NCT04590586|323458190|FG005|Overall Study|Death|3|||
94456063|NCT04590586|323458185|FG000|Overall Study|Lost to Follow-up|3|||
94456064|NCT04590586|323458186|FG001|Overall Study|Lost to Follow-up|0|||
94456065|NCT04590586|323458187|FG002|Overall Study|Lost to Follow-up|11|||
94456066|NCT04590586|323458188|FG003|Overall Study|Lost to Follow-up|11|||
94456067|NCT04590586|323458189|FG004|Overall Study|Lost to Follow-up|6|||
94456068|NCT04590586|323458190|FG005|Overall Study|Lost to Follow-up|0|||
94456069|NCT04590586|323458185|FG000|Overall Study|Withdrawal by Subject|0|||
94456070|NCT04590586|323458186|FG001|Overall Study|Withdrawal by Subject|0|||
94456071|NCT04590586|323458187|FG002|Overall Study|Withdrawal by Subject|6|||
94456072|NCT04590586|323458188|FG003|Overall Study|Withdrawal by Subject|0|||
94456073|NCT04590586|323458189|FG004|Overall Study|Withdrawal by Subject|3|||
94456074|NCT04590586|323458190|FG005|Overall Study|Withdrawal by Subject|0|||
94456075|NCT04590586|323458185|FG000|Overall Study|Other|3|||
94456076|NCT04590586|323458186|FG001|Overall Study|Other|0|||
94456077|NCT04590586|323458187|FG002|Overall Study|Other|1|||
94456078|NCT04590586|323458188|FG003|Overall Study|Other|1|||
94456079|NCT04590586|323458189|FG004|Overall Study|Other|2|||
94456080|NCT04590586|323458190|FG005|Overall Study|Other|1|||
94456081|NCT01609543|323458191|FG000|Overall Study|Disease Progression|28|||
94456082|NCT01609543|323458191|FG000|Overall Study|Adverse Event|5|||
94456083|NCT01609543|323458191|FG000|Overall Study|Withdrawal by Subject|1|||
94588696|NCT04661579|323957468|FG001|Overall Study|Other|2|||
94243063|NCT01803282|322682813|FG000|Overall Study|Unknown Reason|0|||
94456084|NCT01609543|323458191|FG000|Overall Study|Protocol Violation|1|||
94456085|NCT01609543|323458191|FG000|Overall Study|Death|7|||
94243064|NCT01803282|322682814|FG001|Overall Study|Unknown Reason|0|||
94243065|NCT01803282|322682815|FG002|Overall Study|Unknown Reason|0|||
94354167|NCT00764465|323078465|FG001|Overall Study|Adverse Event|0|||
94354168|NCT00764465|323078466|FG002|Overall Study|Adverse Event|0|||
94456086|NCT00507819|323458193|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
94456087|NCT00507819|323458194|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
94243066|NCT01803282|322682816|FG003|Overall Study|Unknown Reason|0|||
94243067|NCT01803282|322682817|FG004|Overall Study|Unknown Reason|0|||
94354169|NCT00764465|323078467|FG003|Overall Study|Adverse Event|1|||
94354170|NCT00764465|323078468|FG004|Overall Study|Adverse Event|1|||
94456088|NCT02244463|323458197|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
94243068|NCT01803282|322682818|FG005|Overall Study|Unknown Reason|0|||
94243069|NCT01803282|322682819|FG006|Overall Study|Unknown Reason|0|||
94243070|NCT01803282|322682820|FG007|Overall Study|Unknown Reason|1|||
94243071|NCT01803282|322682821|FG008|Overall Study|Unknown Reason|0|||
94588697|NCT04661579|323957469|FG002|Overall Study|Other|1|||
94588698|NCT04661579|323957470|FG003|Overall Study|Other|1|||
94588699|NCT04661579|323957471|FG004|Overall Study|Other|1|||
94588700|NCT04661579|323957467|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
94588701|NCT04661579|323957468|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
94588702|NCT04661579|323957469|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
94588703|NCT04661579|323957470|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
94588704|NCT04661579|323957471|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
94588705|NCT01396447|323957472|FG000|Overall Study|Did Not Receive Treatment|3|||
94588706|NCT01396447|323957473|FG001|Overall Study|Did Not Receive Treatment|2|||
94588707|NCT01396447|323957474|FG002|Overall Study|Did Not Receive Treatment|1|||
94588708|NCT01396447|323957475|FG003|Overall Study|Did Not Receive Treatment|0|||
94588709|NCT01396447|323957472|FG000|Overall Study|Adverse Event|15|||
94588710|NCT01396447|323957473|FG001|Overall Study|Adverse Event|12|||
94588711|NCT01396447|323957474|FG002|Overall Study|Adverse Event|12|||
94588712|NCT01396447|323957475|FG003|Overall Study|Adverse Event|17|||
94588713|NCT01396447|323957472|FG000|Overall Study|Insufficient Therapeutic Response|5|||
94588714|NCT01396447|323957473|FG001|Overall Study|Insufficient Therapeutic Response|5|||
94588715|NCT01396447|323957474|FG002|Overall Study|Insufficient Therapeutic Response|2|||
94588716|NCT01396447|323957475|FG003|Overall Study|Insufficient Therapeutic Response|4|||
94588717|NCT01396447|323957472|FG000|Overall Study|Protocol Violation|5|||
94588718|NCT01396447|323957473|FG001|Overall Study|Protocol Violation|2|||
94588719|NCT01396447|323957474|FG002|Overall Study|Protocol Violation|3|||
94588720|NCT01396447|323957475|FG003|Overall Study|Protocol Violation|7|||
94588721|NCT01396447|323957472|FG000|Overall Study|Withdrawal of Consent|11|||
94588722|NCT01396447|323957473|FG001|Overall Study|Withdrawal of Consent|9|||
94588723|NCT01396447|323957474|FG002|Overall Study|Withdrawal of Consent|4|||
94588724|NCT01396447|323957475|FG003|Overall Study|Withdrawal of Consent|15|||
94588725|NCT01396447|323957472|FG000|Overall Study|Lost to Follow-up|4|||
94588726|NCT01396447|323957473|FG001|Overall Study|Lost to Follow-up|8|||
94588727|NCT01396447|323957474|FG002|Overall Study|Lost to Follow-up|7|||
94588728|NCT01396447|323957475|FG003|Overall Study|Lost to Follow-up|9|||
94588729|NCT01396447|323957472|FG000|Overall Study|Other Miscellaneous Reasons|0|||
94588730|NCT01396447|323957473|FG001|Overall Study|Other Miscellaneous Reasons|2|||
94588731|NCT01396447|323957474|FG002|Overall Study|Other Miscellaneous Reasons|1|||
94588732|NCT01396447|323957475|FG003|Overall Study|Other Miscellaneous Reasons|0|||
94588733|NCT01536067|323957479|FG000|Overall Study|Disease Progression|1|||
94588734|NCT02597478|323957480|FG000|Overall Study|Withdrawal by Subject|2|||
94588735|NCT02597478|323957481|FG001|Overall Study|Withdrawal by Subject|0|||
94588736|NCT02597478|323957480|FG000|Overall Study|Change of opioid dose|1|||
94588737|NCT02597478|323957481|FG001|Overall Study|Change of opioid dose|0|||
94588738|NCT02597478|323957480|FG000|Overall Study|Insufficient exertional dyspnea|0|||
94588739|NCT02597478|323957481|FG001|Overall Study|Insufficient exertional dyspnea|1|||
94588740|NCT01652469|323957482|FG000|Overall Study|Withdrawal by Subject|1|||
94588741|NCT01652469|323957483|FG001|Overall Study|Withdrawal by Subject|4|||
94588742|NCT01652469|323957482|FG000|Overall Study|Lost to Follow-up|0|||
94588743|NCT01652469|323957483|FG001|Overall Study|Lost to Follow-up|2|||
94588744|NCT01402102|323957484|FG000|Overall Study|Protocol Violation|1|||
94588745|NCT01402102|323957485|FG001|Overall Study|Protocol Violation|0|||
94588746|NCT01402102|323957484|FG000|Overall Study|Insufficiency of compliance|1|||
94588747|NCT01402102|323957485|FG001|Overall Study|Insufficiency of compliance|1|||
94588748|NCT01402102|323957484|FG000|Overall Study|Withdrawal by Subject|0|||
94588749|NCT01402102|323957485|FG001|Overall Study|Withdrawal by Subject|2|||
94588750|NCT01305577|323957487|FG000|Overall Study|Adverse Event|2|||
94588751|NCT01305577|323957488|FG001|Overall Study|Adverse Event|2|||
94588752|NCT01305577|323957489|FG002|Overall Study|Adverse Event|1|||
94588753|NCT01305577|323957487|FG000|Overall Study|Withdrawal by Subject|7|||
94588754|NCT01305577|323957488|FG001|Overall Study|Withdrawal by Subject|5|||
94588755|NCT01305577|323957489|FG002|Overall Study|Withdrawal by Subject|6|||
94588756|NCT01305577|323957487|FG000|Overall Study|Lost to Follow-up|4|||
94588757|NCT01305577|323957488|FG001|Overall Study|Lost to Follow-up|3|||
94243072|NCT01803282|322682822|FG009|Overall Study|Unknown Reason|0|||
94588758|NCT01305577|323957489|FG002|Overall Study|Lost to Follow-up|2|||
94588759|NCT01305577|323957487|FG000|Overall Study|Protocol Deviation|0|||
94588760|NCT01305577|323957488|FG001|Overall Study|Protocol Deviation|1|||
94243073|NCT01803282|322682823|FG010|Overall Study|Unknown Reason|0|||
94588761|NCT01305577|323957489|FG002|Overall Study|Protocol Deviation|1|||
94588762|NCT02888119|323957494|FG000|Overall Study|Lost to Follow-up|5|||
94588763|NCT02888119|323957495|FG001|Overall Study|Lost to Follow-up|4|||
94243074|NCT01803282|322682824|FG011|Overall Study|Unknown Reason|0|||
94243075|NCT01803282|322682813|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
94588764|NCT02888119|323957496|FG002|Overall Study|Lost to Follow-up|0|||
94588765|NCT01667419|323957497|FG000|Overall Study|Reason Not Specified|1|||
94588766|NCT01667419|323957498|FG001|Overall Study|Reason Not Specified|0|||
94588767|NCT01667419|323957499|FG002|Overall Study|Reason Not Specified|0|||
94588768|NCT01667419|323957500|FG003|Overall Study|Reason Not Specified|0|||
94588769|NCT01667419|323957497|FG000|Overall Study|Withdrawal by Subject|16|||
94588770|NCT01667419|323957498|FG001|Overall Study|Withdrawal by Subject|8|||
94588771|NCT01667419|323957499|FG002|Overall Study|Withdrawal by Subject|9|||
94588772|NCT01667419|323957500|FG003|Overall Study|Withdrawal by Subject|8|||
94588773|NCT01667419|323957497|FG000|Overall Study|Non-compliance|0|||
94588774|NCT01667419|323957498|FG001|Overall Study|Non-compliance|0|||
94243076|NCT01803282|322682814|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
94243077|NCT01803282|322682815|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
94243078|NCT01803282|322682816|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
94243079|NCT01803282|322682817|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
94243080|NCT01803282|322682818|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
94243081|NCT01803282|322682819|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
94243082|NCT01803282|322682820|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
94243083|NCT01803282|322682821|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
94243084|NCT01803282|322682822|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
94243085|NCT01803282|322682823|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
94243086|NCT01803282|322682824|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
94588775|NCT01667419|323957499|FG002|Overall Study|Non-compliance|0|||
94588776|NCT01667419|323957500|FG003|Overall Study|Non-compliance|1|||
94588777|NCT01667419|323957497|FG000|Overall Study|Protocol Violation|1|||
94588778|NCT01667419|323957498|FG001|Overall Study|Protocol Violation|0|||
94588779|NCT01667419|323957499|FG002|Overall Study|Protocol Violation|0|||
94588780|NCT01667419|323957500|FG003|Overall Study|Protocol Violation|0|||
94588781|NCT01667419|323957497|FG000|Overall Study|Lost to Follow-up|7|||
94588782|NCT01667419|323957498|FG001|Overall Study|Lost to Follow-up|6|||
94588783|NCT01667419|323957499|FG002|Overall Study|Lost to Follow-up|2|||
94588784|NCT01667419|323957500|FG003|Overall Study|Lost to Follow-up|4|||
94243087|NCT01803282|322682813|FG000|Overall Study|Enrolled but Never Treated|0|||
94243088|NCT01803282|322682814|FG001|Overall Study|Enrolled but Never Treated|0|||
94243089|NCT01803282|322682815|FG002|Overall Study|Enrolled but Never Treated|0|||
94243090|NCT01803282|322682816|FG003|Overall Study|Enrolled but Never Treated|0|||
94243091|NCT01803282|322682817|FG004|Overall Study|Enrolled but Never Treated|1|||
94243092|NCT01803282|322682818|FG005|Overall Study|Enrolled but Never Treated|0|||
94243093|NCT01803282|322682819|FG006|Overall Study|Enrolled but Never Treated|1|||
94243094|NCT01803282|322682820|FG007|Overall Study|Enrolled but Never Treated|1|||
94243095|NCT01803282|322682821|FG008|Overall Study|Enrolled but Never Treated|0|||
94243096|NCT01803282|322682822|FG009|Overall Study|Enrolled but Never Treated|1|||
94243097|NCT01803282|322682823|FG010|Overall Study|Enrolled but Never Treated|0|||
94243098|NCT01803282|322682824|FG011|Overall Study|Enrolled but Never Treated|0|||
94243099|NCT01743989|322682825|FG000|Treatment Phase|Unstable MR4.0|0|||
94243100|NCT01743989|322682826|FG001|Treatment Phase|Unstable MR4.0|6|||
94243101|NCT01743989|322682827|FG002|Treatment Phase|Unstable MR4.0|263|||
94243102|NCT01743989|322682825|FG000|Treatment Phase|Adverse Event|0|||
94243103|NCT01743989|322682826|FG001|Treatment Phase|Adverse Event|4|||
94243104|NCT01743989|322682827|FG002|Treatment Phase|Adverse Event|67|||
94243105|NCT01743989|322682825|FG000|Treatment Phase|Withdrawal by Subject|1|||
94243106|NCT01743989|322682826|FG001|Treatment Phase|Withdrawal by Subject|3|||
94243107|NCT01743989|322682827|FG002|Treatment Phase|Withdrawal by Subject|28|||
94243108|NCT01743989|322682825|FG000|Treatment Phase|Death|0|||
94243109|NCT01743989|322682826|FG001|Treatment Phase|Death|1|||
94243110|NCT01743989|322682827|FG002|Treatment Phase|Death|3|||
94243111|NCT01743989|322682825|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
94243112|NCT01743989|322682826|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
94243113|NCT01743989|322682827|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
94243114|NCT01743989|322682825|FG000|Treatment Phase|Protocol deviation|0|||
94243115|NCT01743989|322682826|FG001|Treatment Phase|Protocol deviation|0|||
94243116|NCT01743989|322682827|FG002|Treatment Phase|Protocol deviation|3|||
94243117|NCT01743989|322682825|FG000|Treatment Phase|Pregnancy|0|||
94243118|NCT01743989|322682826|FG001|Treatment Phase|Pregnancy|0|||
94243119|NCT01743989|322682827|FG002|Treatment Phase|Pregnancy|2|||
94243120|NCT01743989|322682825|FG000|Treatment Phase|Lost to Follow-up|0|||
94243121|NCT01743989|322682826|FG001|Treatment Phase|Lost to Follow-up|0|||
94243122|NCT01743989|322682827|FG002|Treatment Phase|Lost to Follow-up|2|||
94243123|NCT01743989|322682825|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
94243124|NCT01743989|322682826|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
94243125|NCT01743989|322682827|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
94243126|NCT01743989|322682825|FG000|Treatment Phase|Administrative problems|0|||
94243127|NCT01743989|322682826|FG001|Treatment Phase|Administrative problems|0|||
94243128|NCT01743989|322682827|FG002|Treatment Phase|Administrative problems|1|||
94243129|NCT01743989|322682825|FG000|Treatment Phase|New cancer (CML) therapy|0|||
94243130|NCT01743989|322682826|FG001|Treatment Phase|New cancer (CML) therapy|1|||
94243131|NCT01743989|322682827|FG002|Treatment Phase|New cancer (CML) therapy|0|||
94243132|NCT01743989|322682825|FG000|Treatment Phase|Physician Decision|0|||
94243133|NCT01743989|322682826|FG001|Treatment Phase|Physician Decision|0|||
94588785|NCT01667419|323957497|FG000|Overall Study|Death|18|||
94588786|NCT01667419|323957498|FG001|Overall Study|Death|33|||
94243134|NCT01743989|322682827|FG002|Treatment Phase|Physician Decision|3|||
94243135|NCT01743989|322682825|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
94243136|NCT01743989|322682826|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
94243137|NCT01743989|322682827|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
94588787|NCT01667419|323957499|FG002|Overall Study|Death|25|||
94588788|NCT01667419|323957500|FG003|Overall Study|Death|26|||
94354171|NCT00764465|323078469|FG005|Overall Study|Adverse Event|1|||
94354172|NCT00764465|323078464|FG000|Overall Study|Withdrawal by Subject|0|||
94354173|NCT00764465|323078465|FG001|Overall Study|Withdrawal by Subject|1|||
94354174|NCT00764465|323078466|FG002|Overall Study|Withdrawal by Subject|1|||
94354175|NCT00764465|323078467|FG003|Overall Study|Withdrawal by Subject|0|||
94354176|NCT00764465|323078468|FG004|Overall Study|Withdrawal by Subject|0|||
94354177|NCT00764465|323078469|FG005|Overall Study|Withdrawal by Subject|0|||
94354178|NCT00914940|323078470|FG000|D0 to D100 Post-transplant|Death|2|||
94354179|NCT00914940|323078470|FG000|D101 to 2 Years Post-transplant|Death|8|||
94354180|NCT00914940|323078470|FG000|2 Years to 5 Years Post-transplant|Death|3|||
94354181|NCT02221882|323078471|FG000|Overall Study|Withdrawal by Subject|0|||
94354182|NCT02221882|323078472|FG001|Overall Study|Withdrawal by Subject|0|||
94354183|NCT02221882|323078473|FG002|Overall Study|Withdrawal by Subject|4|||
94354184|NCT02221882|323078474|FG003|Overall Study|Withdrawal by Subject|2|||
94354185|NCT02221882|323078475|FG004|Overall Study|Withdrawal by Subject|2|||
94354186|NCT02221882|323078476|FG005|Overall Study|Withdrawal by Subject|2|||
94354187|NCT02221882|323078471|FG000|Overall Study|Death|0|||
94354188|NCT02221882|323078472|FG001|Overall Study|Death|1|||
94354189|NCT02221882|323078473|FG002|Overall Study|Death|0|||
94354190|NCT02221882|323078474|FG003|Overall Study|Death|0|||
94354191|NCT02221882|323078475|FG004|Overall Study|Death|0|||
94354192|NCT02221882|323078476|FG005|Overall Study|Death|0|||
94354193|NCT01724021|323078479|FG000|Overall Study|Adverse Event|11|||
94354194|NCT01724021|323078480|FG001|Overall Study|Adverse Event|6|||
94354195|NCT01724021|323078479|FG000|Overall Study|Death|46|||
94354196|NCT01724021|323078480|FG001|Overall Study|Death|58|||
94354197|NCT01724021|323078479|FG000|Overall Study|Participant request/ Withdrew consent|18|||
94354198|NCT01724021|323078480|FG001|Overall Study|Participant request/ Withdrew consent|14|||
94354199|NCT01724021|323078479|FG000|Overall Study|Lost to Follow-up|15|||
94354200|NCT01724021|323078480|FG001|Overall Study|Lost to Follow-up|15|||
94354201|NCT01724021|323078479|FG000|Overall Study|Reason Not Specified|36|||
94354202|NCT01724021|323078480|FG001|Overall Study|Reason Not Specified|39|||
94354203|NCT01724021|323078479|FG000|Overall Study|Missing|1|||
94354204|NCT01724021|323078480|FG001|Overall Study|Missing|1|||
94354205|NCT00302731|323078490|FG000|Overall Study|Lost to Follow-up|1|||
94354206|NCT00302731|323078491|FG001|Overall Study|Lost to Follow-up|2|||
94354207|NCT00302731|323078492|FG002|Overall Study|Lost to Follow-up|0|||
94354208|NCT00302731|323078493|FG003|Overall Study|Lost to Follow-up|0|||
94354209|NCT00302731|323078490|FG000|Overall Study|Adverse Event|0|||
94354210|NCT00302731|323078491|FG001|Overall Study|Adverse Event|2|||
94354211|NCT00302731|323078492|FG002|Overall Study|Adverse Event|2|||
94354212|NCT00302731|323078493|FG003|Overall Study|Adverse Event|0|||
94354213|NCT00302731|323078490|FG000|Overall Study|Withdrawal by Subject|1|||
94354214|NCT00302731|323078491|FG001|Overall Study|Withdrawal by Subject|1|||
94354215|NCT00302731|323078492|FG002|Overall Study|Withdrawal by Subject|0|||
94354216|NCT00302731|323078493|FG003|Overall Study|Withdrawal by Subject|0|||
94354217|NCT00302731|323078490|FG000|Overall Study|Protocol Violation|1|||
94354218|NCT00302731|323078491|FG001|Overall Study|Protocol Violation|0|||
94354219|NCT00302731|323078492|FG002|Overall Study|Protocol Violation|0|||
94354220|NCT00302731|323078493|FG003|Overall Study|Protocol Violation|0|||
94354221|NCT00302731|323078490|FG000|Overall Study|cancer unrelated to study discovered|1|||
94354222|NCT00302731|323078491|FG001|Overall Study|cancer unrelated to study discovered|0|||
94354223|NCT00302731|323078492|FG002|Overall Study|cancer unrelated to study discovered|1|||
94354224|NCT00302731|323078493|FG003|Overall Study|cancer unrelated to study discovered|0|||
94354225|NCT02354599|323078495|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
94354226|NCT02354599|323078496|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
94354227|NCT02354599|323078497|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
94354228|NCT02354599|323078498|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
94354229|NCT02354599|323078499|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
94354230|NCT02354599|323078500|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
94456089|NCT02244463|323458198|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
94456090|NCT02244463|323458199|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
94354231|NCT02354599|323078495|FG000|Overall Study|Withdrawal by Subject|1|||
94354232|NCT02354599|323078496|FG001|Overall Study|Withdrawal by Subject|1|||
94354233|NCT02354599|323078497|FG002|Overall Study|Withdrawal by Subject|0|||
94354234|NCT02354599|323078498|FG003|Overall Study|Withdrawal by Subject|0|||
94354235|NCT02354599|323078499|FG004|Overall Study|Withdrawal by Subject|0|||
94354236|NCT02354599|323078500|FG005|Overall Study|Withdrawal by Subject|0|||
94354237|NCT00553319|323078503|FG000|Overall Study|Lost to Follow-up|10|||
94354238|NCT00553319|323078504|FG001|Overall Study|Lost to Follow-up|9|||
94354239|NCT00553319|323078505|FG002|Overall Study|Lost to Follow-up|5|||
94354240|NCT00553319|323078503|FG000|Overall Study|wanted treatment elsewhere|2|||
94588789|NCT04364984|323957502|FG000|Overall Study|Death|2|||
94354241|NCT00553319|323078504|FG001|Overall Study|wanted treatment elsewhere|1|||
94354242|NCT00553319|323078505|FG002|Overall Study|wanted treatment elsewhere|1|||
94354243|NCT00553319|323078503|FG000|Overall Study|non-compliance|0|||
94354244|NCT00553319|323078504|FG001|Overall Study|non-compliance|0|||
94243138|NCT01743989|322682825|FG000|Treatment Phase|Not randomized by mistake|0|||
94243139|NCT01743989|322682826|FG001|Treatment Phase|Not randomized by mistake|0|||
94243140|NCT01743989|322682827|FG002|Treatment Phase|Not randomized by mistake|1|||
94243141|NCT01743989|322682825|FG000|Treatment Phase|Included by mistake|0|||
94243142|NCT01743989|322682826|FG001|Treatment Phase|Included by mistake|0|||
94243143|NCT01743989|322682827|FG002|Treatment Phase|Included by mistake|1|||
94243144|NCT01743989|322682825|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
94588790|NCT04364984|323957503|FG001|Overall Study|Death|2|||
94588791|NCT04364984|323957504|FG002|Overall Study|Death|0|||
94588792|NCT01941186|323957505|FG000|Follow-up|Lost to Follow-up|1|||
94588793|NCT01941186|323957506|FG001|Follow-up|Lost to Follow-up|0|||
94588794|NCT04173494|323957507|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
94588795|NCT04173494|323957508|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
94588796|NCT04173494|323957507|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
94588797|NCT04173494|323957508|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
94588798|NCT04173494|323957507|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
94588799|NCT04173494|323957508|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
94588800|NCT04173494|323957507|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
94588801|NCT04173494|323957508|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
94588802|NCT04173494|323957507|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
94588803|NCT04173494|323957508|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
94588804|NCT04173494|323957507|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
94588805|NCT04173494|323957508|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
94588806|NCT04173494|323957507|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
94588807|NCT04173494|323957508|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
94588808|NCT04173494|323957507|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
94588809|NCT04173494|323957508|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
94588810|NCT04173494|323957507|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
94588811|NCT04173494|323957508|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
94588812|NCT04173494|323957507|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
94588813|NCT04173494|323957508|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
94659465|NCT01722331|324208016|FG005|Part 3|Other Protocol Specified Criteria|0|||
94659466|NCT01722331|324208017|FG006|Part 3|Other Protocol Specified Criteria|0|||
94588814|NCT04173494|323957507|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
94588815|NCT04173494|323957508|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
94588816|NCT04173494|323957507|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
94588817|NCT04173494|323957508|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
94588818|NCT04173494|323957507|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
94588819|NCT04173494|323957508|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
94588820|NCT04173494|323957507|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
94588821|NCT04173494|323957508|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
94588822|NCT04173494|323957507|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
94588823|NCT04173494|323957508|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
94588824|NCT04173494|323957507|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
94588825|NCT04173494|323957508|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
94588826|NCT03735667|323957514|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
94588827|NCT03735667|323957515|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
94588828|NCT03735667|323957516|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
94588829|NCT03735667|323957514|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
94588830|NCT03735667|323957515|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
94588831|NCT03735667|323957516|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
94588832|NCT03735667|323957514|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
94588833|NCT03735667|323957515|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
94588834|NCT03735667|323957516|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
94588835|NCT03735667|323957514|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
94588836|NCT03735667|323957515|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
94588837|NCT03735667|323957516|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
94588838|NCT03735667|323957514|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
94588839|NCT03735667|323957515|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
94588840|NCT03735667|323957516|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
94588841|NCT03735667|323957514|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
94588842|NCT03735667|323957515|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
94588843|NCT03735667|323957516|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
94588844|NCT03735667|323957514|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
94588845|NCT03735667|323957515|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
94588846|NCT03735667|323957516|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
94588847|NCT03735667|323957514|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
94588848|NCT03735667|323957515|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
94588849|NCT03735667|323957516|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
94588850|NCT03735667|323957514|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
94588851|NCT03735667|323957515|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
94588852|NCT03735667|323957516|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
94588853|NCT03735667|323957514|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
94588854|NCT03735667|323957515|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
94588855|NCT03735667|323957516|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
94588856|NCT03735667|323957514|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
94588857|NCT03735667|323957515|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
94588858|NCT03735667|323957516|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
94588859|NCT03735667|323957514|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
94588860|NCT03735667|323957515|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
94588861|NCT03735667|323957516|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
94588862|NCT02872935|323957520|FG000|Overall Study|Other|0|||
94588863|NCT02872935|323957521|FG001|Overall Study|Other|1|||
94588864|NCT01192191|323957526|FG000|Overall Study|Adverse Event|7|||
94588865|NCT01192191|323957527|FG001|Overall Study|Adverse Event|12|||
94588866|NCT01192191|323957526|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
94588867|NCT01192191|323957527|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
94588868|NCT01192191|323957526|FG000|Overall Study|Lost to Follow-up|0|||
94588869|NCT01192191|323957527|FG001|Overall Study|Lost to Follow-up|1|||
94588870|NCT01192191|323957526|FG000|Overall Study|Withdrawal by Subject|1|||
94588871|NCT01192191|323957527|FG001|Overall Study|Withdrawal by Subject|6|||
94588872|NCT01047553|323957529|FG000|Overall Study|Adverse Event|10|||
94354245|NCT00553319|323078505|FG002|Overall Study|non-compliance|2|||
94354246|NCT00553319|323078503|FG000|Overall Study|incarceration|1|||
94354247|NCT00553319|323078504|FG001|Overall Study|incarceration|0|||
94354248|NCT00553319|323078505|FG002|Overall Study|incarceration|0|||
94354249|NCT00553319|323078503|FG000|Overall Study|moved|1|||
94588873|NCT01047553|323957530|FG001|Overall Study|Adverse Event|5|||
94588874|NCT01047553|323957529|FG000|Overall Study|Withdrawal by Subject|4|||
94588875|NCT01047553|323957530|FG001|Overall Study|Withdrawal by Subject|2|||
94588876|NCT01047553|323957529|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
94588877|NCT01047553|323957530|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
94588878|NCT01047553|323957529|FG000|Overall Study|Lost to Follow-up|1|||
94588879|NCT01047553|323957530|FG001|Overall Study|Lost to Follow-up|0|||
94588880|NCT01047553|323957529|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
94588881|NCT01047553|323957530|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
94588882|NCT01047553|323957529|FG000|Overall Study|PI's decision|0|||
94588883|NCT01047553|323957530|FG001|Overall Study|PI's decision|1|||
94588884|NCT01063283|323957531|FG000|Cycle 1|Adverse Event|2|||
94588885|NCT01063283|323957532|FG001|Cycle 1|Adverse Event|0|||
94588886|NCT01063283|323957533|FG002|Cycle 1|Adverse Event|0|||
94588887|NCT01063283|323957531|FG000|Cycle 1|Technical failure in data collection|1|||
94588888|NCT01063283|323957532|FG001|Cycle 1|Technical failure in data collection|0|||
94588889|NCT01063283|323957533|FG002|Cycle 1|Technical failure in data collection|0|||
94588890|NCT01276054|323957534|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
94588891|NCT01276054|323957535|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
94588892|NCT01120717|323957536|FG000|Overall Study|Withdrawal by Subject|11|||
94588893|NCT01120717|323957537|FG001|Overall Study|Withdrawal by Subject|6|||
94588894|NCT01120717|323957536|FG000|Overall Study|Adverse Event|10|||
94588895|NCT01120717|323957537|FG001|Overall Study|Adverse Event|6|||
94588896|NCT01120717|323957536|FG000|Overall Study|Protocol Deviation|2|||
94588897|NCT01120717|323957537|FG001|Overall Study|Protocol Deviation|5|||
94588898|NCT01120717|323957536|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
94588899|NCT01120717|323957537|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
94588900|NCT01120717|323957536|FG000|Overall Study|Lost to Follow-up|2|||
94588901|NCT01120717|323957537|FG001|Overall Study|Lost to Follow-up|3|||
94588902|NCT01120717|323957536|FG000|Overall Study|Death|3|||
94588903|NCT01120717|323957537|FG001|Overall Study|Death|1|||
94588904|NCT01120717|323957536|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
94588905|NCT01120717|323957537|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
94588906|NCT05343624|323957538|FG000|Overall Study|Chart review not completed|1|||
94588907|NCT02504216|323957545|FG000|Overall Study|Lost to Follow-up|3|||
94588908|NCT02504216|323957546|FG001|Overall Study|Lost to Follow-up|3|||
94588909|NCT02504216|323957545|FG000|Overall Study|Withdrawal by Subject|8|||
94588910|NCT02504216|323957546|FG001|Overall Study|Withdrawal by Subject|12|||
94588911|NCT00862082|323957547|FG000|Overall Study|Sponsor decision to terminate the study|5|||
94588912|NCT00862082|323957548|FG001|Overall Study|Sponsor decision to terminate the study|0|||
94588913|NCT00862082|323957547|FG000|Overall Study|Withdrawal by Subject|0|||
94588914|NCT00862082|323957548|FG001|Overall Study|Withdrawal by Subject|1|||
94588915|NCT00223080|323957549|FG000|Overall Study|Withdrawal by Subject|253|||
94588916|NCT00223080|323957550|FG001|Overall Study|Withdrawal by Subject|232|||
94588917|NCT00223080|323957549|FG000|Overall Study|Required contraindicated med|0|||
94588918|NCT00223080|323957550|FG001|Overall Study|Required contraindicated med|1|||
94588919|NCT00223080|323957549|FG000|Overall Study|Non-compliant|7|||
94588920|NCT00223080|323957550|FG001|Overall Study|Non-compliant|7|||
94588921|NCT00223080|323957549|FG000|Overall Study|Moved from study area|37|||
94588922|NCT00223080|323957550|FG001|Overall Study|Moved from study area|47|||
94588923|NCT00223080|323957549|FG000|Overall Study|Lost to Follow-up|259|||
94588924|NCT00223080|323957550|FG001|Overall Study|Lost to Follow-up|284|||
94588925|NCT00223080|323957549|FG000|Overall Study|Death|85|||
94588926|NCT00223080|323957550|FG001|Overall Study|Death|74|||
94588927|NCT00223080|323957549|FG000|Overall Study|Other|14|||
94588928|NCT00223080|323957550|FG001|Overall Study|Other|11|||
94588929|NCT00223080|323957549|FG000|Overall Study|Reason not provided|141|||
94588930|NCT00223080|323957550|FG001|Overall Study|Reason not provided|140|||
94588931|NCT00223080|323957549|FG000|Overall Study|Adverse Event|0|||
94588932|NCT00223080|323957550|FG001|Overall Study|Adverse Event|1|||
94588933|NCT00787267|323957551|FG000|Overall Study|Screen failure/Ineligible|10|||
94588934|NCT00787267|323957551|FG000|Overall Study|No Reason Provided|1|||
94588935|NCT00787267|323957551|FG000|Overall Study|Withdrawal by Subject|1|||
94243145|NCT01743989|322682826|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
94588936|NCT02598583|323957552|FG000|Extension Period|Withdrawal by Subject|1|||
94588937|NCT02598583|323957553|FG001|Extension Period|Withdrawal by Subject|0|||
94354250|NCT00553319|323078504|FG001|Overall Study|moved|0|||
94588938|NCT03237286|323957554|FG000|Overall Study|Withdrawal by Subject|1|||
94354251|NCT00553319|323078505|FG002|Overall Study|moved|1|||
94588939|NCT03237286|323957555|FG001|Overall Study|Withdrawal by Subject|0|||
94588940|NCT03237286|323957556|FG002|Overall Study|Withdrawal by Subject|2|||
94588941|NCT03237286|323957554|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
94588942|NCT03237286|323957555|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
94588943|NCT03237286|323957556|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
94588944|NCT00948441|323957557|FG000|Overall Study|no longer meet inclusion criteria|1|||
94588945|NCT00948441|323957558|FG001|Overall Study|no longer meet inclusion criteria|4|||
94588946|NCT02792829|323957559|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
94588947|NCT02792829|323957560|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
94588948|NCT02792829|323957561|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
94588949|NCT02792829|323957562|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
94243146|NCT01743989|322682827|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
94243147|NCT01743989|322682825|FG000|TFR Phase|Adverse Event|0|||
94243148|NCT01743989|322682826|FG001|TFR Phase|Adverse Event|1|||
94243149|NCT01743989|322682827|FG002|TFR Phase|Adverse Event|0|||
94243150|NCT01743989|322682825|FG000|TFR Phase|Lost to Follow-up|0|||
94243151|NCT01743989|322682826|FG001|TFR Phase|Lost to Follow-up|2|||
94243152|NCT01743989|322682827|FG002|TFR Phase|Lost to Follow-up|0|||
94243153|NCT01743989|322682825|FG000|TFR Phase|Physician Decision|0|||
94243154|NCT01743989|322682826|FG001|TFR Phase|Physician Decision|1|||
94243155|NCT01743989|322682827|FG002|TFR Phase|Physician Decision|0|||
94243156|NCT01743989|322682825|FG000|TFR Phase|Logistical problems|0|||
94243157|NCT01743989|322682826|FG001|TFR Phase|Logistical problems|2|||
94243158|NCT01743989|322682827|FG002|TFR Phase|Logistical problems|0|||
94588950|NCT02792829|323957563|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
94243159|NCT01743989|322682825|FG000|TFR Phase|Protocol deviation|0|||
94243160|NCT01743989|322682826|FG001|TFR Phase|Protocol deviation|1|||
94243161|NCT01743989|322682827|FG002|TFR Phase|Protocol deviation|0|||
94243162|NCT01743989|322682825|FG000|TFR Phase|Withdrawal by Subject|0|||
94243163|NCT01743989|322682826|FG001|TFR Phase|Withdrawal by Subject|2|||
94243164|NCT01743989|322682827|FG002|TFR Phase|Withdrawal by Subject|0|||
94243165|NCT01743989|322682825|FG000|Re-treatment Phase|Adverse Event|8|||
94243166|NCT01743989|322682826|FG001|Re-treatment Phase|Adverse Event|4|||
94243167|NCT01743989|322682827|FG002|Re-treatment Phase|Adverse Event|0|||
94243168|NCT01743989|322682825|FG000|Re-treatment Phase|Death|1|||
94243169|NCT01743989|322682826|FG001|Re-treatment Phase|Death|1|||
94243170|NCT01743989|322682827|FG002|Re-treatment Phase|Death|0|||
94243171|NCT01743989|322682825|FG000|Re-treatment Phase|Administrative problems|1|||
94243172|NCT01743989|322682826|FG001|Re-treatment Phase|Administrative problems|1|||
94243173|NCT01743989|322682827|FG002|Re-treatment Phase|Administrative problems|0|||
94243174|NCT01743989|322682825|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
94243175|NCT01743989|322682826|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
94243176|NCT01743989|322682827|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
94243177|NCT01743989|322682825|FG000|Re-treatment Phase|Unstable MR|1|||
94243178|NCT01743989|322682826|FG001|Re-treatment Phase|Unstable MR|0|||
94243179|NCT01743989|322682827|FG002|Re-treatment Phase|Unstable MR|0|||
94243180|NCT01743989|322682825|FG000|Re-treatment Phase|Physician Decision|0|||
94243181|NCT01743989|322682826|FG001|Re-treatment Phase|Physician Decision|1|||
94243182|NCT01743989|322682827|FG002|Re-treatment Phase|Physician Decision|0|||
94243183|NCT01743989|322682825|FG000|Re-treatment Phase|Lost to Follow-up|0|||
94243184|NCT01743989|322682826|FG001|Re-treatment Phase|Lost to Follow-up|1|||
94243185|NCT01743989|322682827|FG002|Re-treatment Phase|Lost to Follow-up|0|||
94243186|NCT02235311|322682834|FG000|Overall Study|Lost to Follow-up|0|||
94243187|NCT02235311|322682835|FG001|Overall Study|Lost to Follow-up|1|||
94588951|NCT02792829|323957564|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
94588952|NCT02792829|323957565|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
94588953|NCT02792829|323957566|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
94588954|NCT02792829|323957559|FG000|Treatment Period 2|Adverse Event|0|||
94243188|NCT02235311|322682834|FG000|Overall Study|Protocol Violation|0|||
94243189|NCT02235311|322682835|FG001|Overall Study|Protocol Violation|1|||
94243190|NCT04655027|322682836|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
94243191|NCT04655027|322682837|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
94243192|NCT02336451|322682838|FG000|Overall Study|Adverse Event|1|||
94243193|NCT02336451|322682839|FG001|Overall Study|Adverse Event|2|||
94243194|NCT02336451|322682840|FG002|Overall Study|Adverse Event|0|||
94243195|NCT02336451|322682841|FG003|Overall Study|Adverse Event|6|||
94243196|NCT02336451|322682842|FG004|Overall Study|Adverse Event|4|||
94243197|NCT02336451|322682838|FG000|Overall Study|Death|6|||
94243198|NCT02336451|322682839|FG001|Overall Study|Death|2|||
94243199|NCT02336451|322682840|FG002|Overall Study|Death|3|||
94243200|NCT02336451|322682841|FG003|Overall Study|Death|6|||
94243201|NCT02336451|322682842|FG004|Overall Study|Death|6|||
94243202|NCT02336451|322682838|FG000|Overall Study|Physician Decision|9|||
94243203|NCT02336451|322682839|FG001|Overall Study|Physician Decision|6|||
94243204|NCT02336451|322682840|FG002|Overall Study|Physician Decision|7|||
94243205|NCT02336451|322682841|FG003|Overall Study|Physician Decision|16|||
94243206|NCT02336451|322682842|FG004|Overall Study|Physician Decision|3|||
94243207|NCT02336451|322682838|FG000|Overall Study|Progressive disease|23|||
94243208|NCT02336451|322682839|FG001|Overall Study|Progressive disease|26|||
94243209|NCT02336451|322682840|FG002|Overall Study|Progressive disease|2|||
94243210|NCT02336451|322682841|FG003|Overall Study|Progressive disease|14|||
94243211|NCT02336451|322682842|FG004|Overall Study|Progressive disease|4|||
94243212|NCT02336451|322682838|FG000|Overall Study|Protocol Violation|1|||
94243213|NCT02336451|322682839|FG001|Overall Study|Protocol Violation|0|||
94243214|NCT02336451|322682840|FG002|Overall Study|Protocol Violation|0|||
94243215|NCT02336451|322682841|FG003|Overall Study|Protocol Violation|0|||
94243216|NCT02336451|322682842|FG004|Overall Study|Protocol Violation|0|||
94588955|NCT02792829|323957560|FG001|Treatment Period 2|Adverse Event|0|||
94588956|NCT02792829|323957561|FG002|Treatment Period 2|Adverse Event|0|||
94588957|NCT02792829|323957562|FG003|Treatment Period 2|Adverse Event|0|||
94243217|NCT02336451|322682838|FG000|Overall Study|Patient/guardian decision|2|||
94243218|NCT02336451|322682839|FG001|Overall Study|Patient/guardian decision|4|||
94243219|NCT02336451|322682840|FG002|Overall Study|Patient/guardian decision|0|||
94243220|NCT02336451|322682841|FG003|Overall Study|Patient/guardian decision|2|||
94588958|NCT02792829|323957563|FG004|Treatment Period 2|Adverse Event|1|||
94243221|NCT02336451|322682842|FG004|Overall Study|Patient/guardian decision|1|||
94243222|NCT01123070|322684391|FG000|Part B Double Blind Period|Protocol Violation|0|||
94243223|NCT01123070|322684392|FG001|Part B Double Blind Period|Protocol Violation|0|||
94243224|NCT01123070|322684393|FG002|Part B Double Blind Period|Protocol Violation|0|||
94588959|NCT02792829|323957564|FG005|Treatment Period 2|Adverse Event|0|||
94243225|NCT01123070|322684394|FG003|Part B Double Blind Period|Protocol Violation|1|||
94243226|NCT01123070|322684391|FG000|Part B Double Blind Period|Adverse Event|0|||
94243227|NCT01123070|322684392|FG001|Part B Double Blind Period|Adverse Event|0|||
94243228|NCT01123070|322684393|FG002|Part B Double Blind Period|Adverse Event|2|||
94588960|NCT02792829|323957565|FG006|Treatment Period 2|Adverse Event|1|||
94243229|NCT01123070|322684394|FG003|Part B Double Blind Period|Adverse Event|0|||
94243230|NCT01123070|322684391|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
94588961|NCT02792829|323957566|FG007|Treatment Period 2|Adverse Event|1|||
94588962|NCT02792829|323957559|FG000|Treatment Period 2|Use of proscribed medications|0|||
94588963|NCT02792829|323957560|FG001|Treatment Period 2|Use of proscribed medications|0|||
94588964|NCT02792829|323957561|FG002|Treatment Period 2|Use of proscribed medications|0|||
94588965|NCT02792829|323957562|FG003|Treatment Period 2|Use of proscribed medications|0|||
94588966|NCT02792829|323957563|FG004|Treatment Period 2|Use of proscribed medications|0|||
94588967|NCT02792829|323957564|FG005|Treatment Period 2|Use of proscribed medications|0|||
94588968|NCT02792829|323957565|FG006|Treatment Period 2|Use of proscribed medications|0|||
94588969|NCT02792829|323957566|FG007|Treatment Period 2|Use of proscribed medications|1|||
94588970|NCT00947882|323957567|FG000|Overall Study|Adverse Event|0|||
94588971|NCT00947882|323957568|FG001|Overall Study|Adverse Event|1|||
94588972|NCT00947882|323957569|FG002|Overall Study|Adverse Event|4|||
94588973|NCT00947882|323957570|FG003|Overall Study|Adverse Event|4|||
94588974|NCT00947882|323957567|FG000|Overall Study|Withdrawal by Subject|2|||
94588975|NCT00947882|323957568|FG001|Overall Study|Withdrawal by Subject|0|||
94588976|NCT00947882|323957569|FG002|Overall Study|Withdrawal by Subject|8|||
94588977|NCT00947882|323957570|FG003|Overall Study|Withdrawal by Subject|2|||
94588978|NCT00947882|323957567|FG000|Overall Study|Protocol Violation|0|||
94588979|NCT00947882|323957568|FG001|Overall Study|Protocol Violation|0|||
94588980|NCT00947882|323957569|FG002|Overall Study|Protocol Violation|1|||
94588981|NCT00947882|323957570|FG003|Overall Study|Protocol Violation|0|||
94588982|NCT00947882|323957567|FG000|Overall Study|Lost to Follow-up|0|||
94588983|NCT00947882|323957568|FG001|Overall Study|Lost to Follow-up|2|||
94588984|NCT00947882|323957569|FG002|Overall Study|Lost to Follow-up|1|||
94588985|NCT00947882|323957570|FG003|Overall Study|Lost to Follow-up|0|||
94588986|NCT00947882|323957567|FG000|Overall Study|Other/Unknown|10|||
94588987|NCT00947882|323957568|FG001|Overall Study|Other/Unknown|13|||
94588988|NCT00947882|323957569|FG002|Overall Study|Other/Unknown|3|||
94588989|NCT00947882|323957570|FG003|Overall Study|Other/Unknown|6|||
94588990|NCT00947882|323957567|FG000|Overall Study|Trial Terminated by Sponsor|62|||
94588991|NCT00947882|323957568|FG001|Overall Study|Trial Terminated by Sponsor|61|||
94588992|NCT00947882|323957569|FG002|Overall Study|Trial Terminated by Sponsor|62|||
94588993|NCT00947882|323957570|FG003|Overall Study|Trial Terminated by Sponsor|70|||
94588994|NCT01026324|323957571|FG000|Follow up/Survival|Withdrawal by Subject|1|||
94588995|NCT01026324|323957572|FG001|Follow up/Survival|Withdrawal by Subject|0|||
94588996|NCT01026324|323957573|FG002|Follow up/Survival|Withdrawal by Subject|0|||
94588997|NCT00635999|323957575|FG000|Overall Study|Withdrawal by Subject|4|||
94588998|NCT00635999|323957576|FG001|Overall Study|Withdrawal by Subject|2|||
94588999|NCT00635999|323957577|FG002|Overall Study|Withdrawal by Subject|1|||
94589000|NCT02695420|323957578|FG000|Overall Study|Death|0|||
94589001|NCT02695420|323957579|FG001|Overall Study|Death|1|||
94589002|NCT02695420|323957580|FG002|Overall Study|Death|0|||
94589003|NCT02695420|323957581|FG003|Overall Study|Death|0|||
94589004|NCT01253577|323957582|FG000|Overall Study|Lost to Follow-up|3|||
94589005|NCT05148234|323957583|FG000|Phase I|Ineligible|0|||
94589006|NCT05148234|323957584|FG001|Phase I|Ineligible|0|||
94589007|NCT05148234|323957585|FG002|Phase I|Ineligible|0|||
94589008|NCT05148234|323957586|FG003|Phase I|Ineligible|0|||
94456091|NCT02244463|323458200|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
94589009|NCT05148234|323957587|FG004|Phase I|Ineligible|0|||
94589010|NCT05148234|323957588|FG005|Phase I|Ineligible|0|||
94589011|NCT05148234|323957589|FG006|Phase I|Ineligible|0|||
94354252|NCT00465894|323078506|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
94354253|NCT00465894|323078507|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
94354254|NCT00465894|323078506|FG000|Treatment For 12 Weeks|Family Issues|1|||
94354255|NCT00465894|323078507|FG001|Treatment For 12 Weeks|Family Issues|1|||
94354256|NCT00465894|323078506|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
94589012|NCT05148234|323957590|FG007|Phase I|Ineligible|1|||
94589013|NCT05148234|323957583|FG000|Phase I|Company closed the trial.|0|||
94589014|NCT05148234|323957584|FG001|Phase I|Company closed the trial.|1|||
94589015|NCT05148234|323957585|FG002|Phase I|Company closed the trial.|0|||
94589016|NCT05148234|323957586|FG003|Phase I|Company closed the trial.|0|||
94589017|NCT05148234|323957587|FG004|Phase I|Company closed the trial.|0|||
94589018|NCT05148234|323957588|FG005|Phase I|Company closed the trial.|0|||
94589019|NCT05148234|323957589|FG006|Phase I|Company closed the trial.|0|||
94589020|NCT05148234|323957590|FG007|Phase I|Company closed the trial.|0|||
94589021|NCT02102204|323959266|FG000|Overall Study|Withdrawal by Subject|137|||
94354257|NCT00465894|323078507|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
94354258|NCT01377194|323078509|FG000|Overall Study|Adverse Event|3|||
94354259|NCT01377194|323078510|FG001|Overall Study|Adverse Event|12|||
94354260|NCT01377194|323078511|FG002|Overall Study|Adverse Event|19|||
94354261|NCT01377194|323078509|FG000|Overall Study|Lack of Efficacy|3|||
94354262|NCT01377194|323078510|FG001|Overall Study|Lack of Efficacy|3|||
94354263|NCT01377194|323078511|FG002|Overall Study|Lack of Efficacy|3|||
94354264|NCT01377194|323078509|FG000|Overall Study|Protocol Violation|4|||
94354265|NCT01377194|323078510|FG001|Overall Study|Protocol Violation|10|||
94354266|NCT01377194|323078511|FG002|Overall Study|Protocol Violation|6|||
94354267|NCT01377194|323078509|FG000|Overall Study|Withdrawal by Subject|8|||
94354268|NCT01377194|323078510|FG001|Overall Study|Withdrawal by Subject|10|||
94354269|NCT01377194|323078511|FG002|Overall Study|Withdrawal by Subject|7|||
94354270|NCT01377194|323078509|FG000|Overall Study|Lost to Follow-up|14|||
94354271|NCT01377194|323078510|FG001|Overall Study|Lost to Follow-up|8|||
94354272|NCT01377194|323078511|FG002|Overall Study|Lost to Follow-up|11|||
94354273|NCT02911285|323078512|FG000|Overall Study|Lost to Follow-up|8|||
94354274|NCT02911285|323078513|FG001|Overall Study|Lost to Follow-up|5|||
94354275|NCT02911285|323078512|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
94354276|NCT02911285|323078513|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
94354277|NCT01397409|323078514|FG000|Stage 2|Adverse Event|0|||
94354278|NCT01397409|323078515|FG001|Stage 2|Adverse Event|0|||
94354279|NCT01397409|323078516|FG002|Stage 2|Adverse Event|0|||
94354280|NCT01397409|323078517|FG003|Stage 2|Adverse Event|0|||
94354281|NCT01397409|323078518|FG004|Stage 2|Adverse Event|6|||
94354282|NCT01397409|323078519|FG005|Stage 2|Adverse Event|3|||
94354283|NCT01397409|323078520|FG006|Stage 2|Adverse Event|0|||
94354284|NCT01397409|323078521|FG007|Stage 2|Adverse Event|0|||
94354285|NCT01397409|323078522|FG008|Stage 2|Adverse Event|0|||
94354286|NCT01397409|323078523|FG009|Stage 2|Adverse Event|0|||
94354287|NCT01397409|323078514|FG000|Stage 2|Personal Reasons|0|||
94354288|NCT01397409|323078515|FG001|Stage 2|Personal Reasons|0|||
94354289|NCT01397409|323078516|FG002|Stage 2|Personal Reasons|0|||
94354290|NCT01397409|323078517|FG003|Stage 2|Personal Reasons|0|||
94354291|NCT01397409|323078518|FG004|Stage 2|Personal Reasons|1|||
94354292|NCT01397409|323078519|FG005|Stage 2|Personal Reasons|0|||
94354293|NCT01397409|323078520|FG006|Stage 2|Personal Reasons|0|||
94354294|NCT01397409|323078521|FG007|Stage 2|Personal Reasons|0|||
94354295|NCT01397409|323078522|FG008|Stage 2|Personal Reasons|0|||
94354296|NCT01397409|323078523|FG009|Stage 2|Personal Reasons|0|||
94354297|NCT01397409|323078514|FG000|Stage 2|Other Miscellaneous Reasons|0|||
94354298|NCT01397409|323078515|FG001|Stage 2|Other Miscellaneous Reasons|0|||
94354299|NCT01397409|323078516|FG002|Stage 2|Other Miscellaneous Reasons|0|||
94354300|NCT01397409|323078517|FG003|Stage 2|Other Miscellaneous Reasons|0|||
94354301|NCT01397409|323078518|FG004|Stage 2|Other Miscellaneous Reasons|1|||
94354302|NCT01397409|323078519|FG005|Stage 2|Other Miscellaneous Reasons|1|||
94354303|NCT01397409|323078520|FG006|Stage 2|Other Miscellaneous Reasons|0|||
94354304|NCT01397409|323078521|FG007|Stage 2|Other Miscellaneous Reasons|0|||
94354305|NCT01397409|323078522|FG008|Stage 2|Other Miscellaneous Reasons|0|||
94354306|NCT01397409|323078523|FG009|Stage 2|Other Miscellaneous Reasons|0|||
94354307|NCT01397409|323078514|FG000|Stage 3|Adverse Event|0|||
94589022|NCT02102204|323959266|FG000|Overall Study|Death|92|||
94589023|NCT02102204|323959266|FG000|Overall Study|Lost to Follow-up|65|||
94589024|NCT02102204|323959266|FG000|Overall Study|Sponsor Decision|5|||
94589025|NCT02102204|323959266|FG000|Overall Study|Ongoing|5|||
94354308|NCT01397409|323078515|FG001|Stage 3|Adverse Event|0|||
94354309|NCT01397409|323078516|FG002|Stage 3|Adverse Event|0|||
94354310|NCT01397409|323078517|FG003|Stage 3|Adverse Event|0|||
94456092|NCT02244463|323458201|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
94456093|NCT02244463|323458202|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
94589026|NCT03079102|323959271|FG000|Overall Study|Physician Decision|0|||
94354311|NCT01397409|323078518|FG004|Stage 3|Adverse Event|0|||
94354312|NCT01397409|323078519|FG005|Stage 3|Adverse Event|0|||
94354313|NCT01397409|323078520|FG006|Stage 3|Adverse Event|0|||
94589027|NCT03079102|323959272|FG001|Overall Study|Physician Decision|1|||
94589028|NCT02269267|323959275|FG000|Overall Study|Death|5|||
94589029|NCT03773796|323959276|FG000|Overall Study|Adverse Event|1|||
94589030|NCT03773796|323959276|FG000|Overall Study|Withdrawal by Subject|1|||
94589031|NCT03773796|323959276|FG000|Overall Study|Lack of Efficacy|1|||
94589032|NCT00122980|323959283|FG000|Overall Study|Death|0|||
94589033|NCT00122980|323959284|FG001|Overall Study|Death|1|||
94589034|NCT00122980|323959283|FG000|Overall Study|Physician Decision|2|||
94589035|NCT00122980|323959284|FG001|Overall Study|Physician Decision|0|||
94589036|NCT00122980|323959283|FG000|Overall Study|Protocol Violation|5|||
94589037|NCT00122980|323959284|FG001|Overall Study|Protocol Violation|1|||
94589038|NCT00122980|323959283|FG000|Overall Study|Withdrawal by Subject|2|||
94589039|NCT00122980|323959284|FG001|Overall Study|Withdrawal by Subject|3|||
94589040|NCT00122980|323959283|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
94589041|NCT00122980|323959284|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
94589042|NCT00122980|323959283|FG000|Overall Study|Study termination|27|||
94589043|NCT00122980|323959284|FG001|Overall Study|Study termination|35|||
94456094|NCT02244463|323458197|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
94456095|NCT02244463|323458198|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
94456096|NCT02244463|323458199|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
94589044|NCT02175199|323959285|FG000|Overall Study|Withdrawal by Subject|1|||
94589045|NCT02175199|323959286|FG001|Overall Study|Withdrawal by Subject|5|||
94589046|NCT02175199|323959285|FG000|Overall Study|Randomized in Error|1|||
94589047|NCT02175199|323959286|FG001|Overall Study|Randomized in Error|0|||
94589048|NCT02175199|323959285|FG000|Overall Study|Sponsor Decision|1|||
94589049|NCT02175199|323959286|FG001|Overall Study|Sponsor Decision|0|||
94589050|NCT01235741|323959289|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
94589051|NCT01235741|323959290|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
94589052|NCT01235741|323959291|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
94589053|NCT01235741|323959289|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
94589054|NCT01235741|323959290|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
94589055|NCT01235741|323959291|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
94589056|NCT01235741|323959289|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
94589057|NCT01235741|323959290|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
94589058|NCT01235741|323959291|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
94589059|NCT01235741|323959289|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
94659467|NCT00512135|324208018|FG000|Overall Study|Not Treated|5|||
94456097|NCT02244463|323458200|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
94589060|NCT01235741|323959290|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
94589061|NCT01235741|323959291|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
94589062|NCT01235741|323959289|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
94659468|NCT00512135|324208018|FG000|Overall Study|Lack of Efficacy|2|||
94659469|NCT00512135|324208018|FG000|Overall Study|Adverse Event|6|||
94659470|NCT00512135|324208018|FG000|Overall Study|Withdrawal by Subject|22|||
94659471|NCT00512135|324208018|FG000|Overall Study|Lost to Follow-up|27|||
94659472|NCT00512135|324208018|FG000|Overall Study|Other|22|||
94659473|NCT01854554|324208022|FG000|Overall Study|Denial of Insurance Coverage|12|||
94354314|NCT01397409|323078521|FG007|Stage 3|Adverse Event|1|||
94354315|NCT01397409|323078522|FG008|Stage 3|Adverse Event|0|||
94659474|NCT01854554|324208023|FG001|Overall Study|Denial of Insurance Coverage|0|||
94659475|NCT01854554|324208022|FG000|Overall Study|Decided to get treatment locally|1|||
94659476|NCT01854554|324208023|FG001|Overall Study|Decided to get treatment locally|5|||
94659477|NCT01854554|324208022|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
94659478|NCT01854554|324208023|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
94659479|NCT01854554|324208022|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
94659480|NCT01854554|324208023|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
94659481|NCT01854554|324208022|FG000|Overall Study|Progression|0|||
94659482|NCT01854554|324208023|FG001|Overall Study|Progression|1|||
94659483|NCT01854554|324208022|FG000|Overall Study|Lost to Follow-up|0|||
94659484|NCT01854554|324208023|FG001|Overall Study|Lost to Follow-up|1|||
94659485|NCT00359762|324208024|FG000|Period II|Adverse Event|17|||
94659486|NCT00359762|324208025|FG001|Period II|Adverse Event|0|||
94659487|NCT00359762|324208026|FG002|Period II|Adverse Event|0|||
94659488|NCT00359762|324208027|FG003|Period II|Adverse Event|0|||
94659489|NCT00359762|324208028|FG004|Period II|Adverse Event|49|||
94659490|NCT00359762|324208024|FG000|Period II|Protocol Violation|18|||
94659491|NCT00359762|324208025|FG001|Period II|Protocol Violation|0|||
94659492|NCT00359762|324208026|FG002|Period II|Protocol Violation|0|||
94659493|NCT00359762|324208027|FG003|Period II|Protocol Violation|0|||
94659494|NCT00359762|324208028|FG004|Period II|Protocol Violation|11|||
94659495|NCT00359762|324208024|FG000|Period II|Physician Decision|17|||
94659496|NCT00359762|324208025|FG001|Period II|Physician Decision|0|||
94659497|NCT00359762|324208026|FG002|Period II|Physician Decision|0|||
94659498|NCT00359762|324208027|FG003|Period II|Physician Decision|0|||
94659499|NCT00359762|324208028|FG004|Period II|Physician Decision|23|||
94659500|NCT00359762|324208024|FG000|Period II|Death|2|||
94659501|NCT00359762|324208025|FG001|Period II|Death|0|||
94354316|NCT01397409|323078523|FG009|Stage 3|Adverse Event|0|||
94354317|NCT01397409|323078514|FG000|Stage 3|Other Miscellaneous Reasons|0|||
94589063|NCT01235741|323959290|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
94589064|NCT01235741|323959291|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
94589065|NCT01235741|323959289|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
94589066|NCT01235741|323959290|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
94589067|NCT01235741|323959291|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
94589068|NCT01235741|323959289|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
94589069|NCT01235741|323959290|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
94589070|NCT01235741|323959291|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
94589071|NCT01235741|323959289|FG000|Randomized to Treatment|Adverse Event|0|||
94589072|NCT01235741|323959290|FG001|Randomized to Treatment|Adverse Event|1|||
94589073|NCT01235741|323959291|FG002|Randomized to Treatment|Adverse Event|1|||
94589074|NCT01235741|323959289|FG000|Randomized to Treatment|Sponsor terminated study|0|||
94589075|NCT01235741|323959290|FG001|Randomized to Treatment|Sponsor terminated study|35|||
94589076|NCT01235741|323959291|FG002|Randomized to Treatment|Sponsor terminated study|34|||
94589077|NCT01235741|323959289|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
94589078|NCT01235741|323959290|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
94589079|NCT01235741|323959291|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
94589080|NCT01235741|323959289|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
94589081|NCT01235741|323959290|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
94589082|NCT01235741|323959291|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
94589083|NCT01235741|323959289|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
94589084|NCT01235741|323959290|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
94589085|NCT01235741|323959291|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
94589086|NCT03805659|323959292|FG000|Overall Study|Withdrawal by Subject|0|||
94659502|NCT00359762|324208026|FG002|Period II|Death|0|||
94354318|NCT01397409|323078515|FG001|Stage 3|Other Miscellaneous Reasons|0|||
94589087|NCT03805659|323959293|FG001|Overall Study|Withdrawal by Subject|1|||
94659503|NCT00359762|324208027|FG003|Period II|Death|0|||
94659504|NCT00359762|324208028|FG004|Period II|Death|4|||
94659505|NCT00359762|324208024|FG000|Period II|Lack of Efficacy|11|||
94659506|NCT00359762|324208025|FG001|Period II|Lack of Efficacy|0|||
94659507|NCT00359762|324208026|FG002|Period II|Lack of Efficacy|0|||
94659508|NCT00359762|324208027|FG003|Period II|Lack of Efficacy|0|||
94659509|NCT00359762|324208028|FG004|Period II|Lack of Efficacy|8|||
94659510|NCT00359762|324208024|FG000|Period II|Lost to follow up|5|||
94659511|NCT00359762|324208025|FG001|Period II|Lost to follow up|0|||
94659512|NCT00359762|324208026|FG002|Period II|Lost to follow up|0|||
94659513|NCT00359762|324208027|FG003|Period II|Lost to follow up|0|||
94354319|NCT01397409|323078516|FG002|Stage 3|Other Miscellaneous Reasons|0|||
94354320|NCT01397409|323078517|FG003|Stage 3|Other Miscellaneous Reasons|0|||
94354321|NCT01397409|323078518|FG004|Stage 3|Other Miscellaneous Reasons|0|||
94354322|NCT01397409|323078519|FG005|Stage 3|Other Miscellaneous Reasons|0|||
94354323|NCT01397409|323078520|FG006|Stage 3|Other Miscellaneous Reasons|0|||
94354324|NCT01397409|323078521|FG007|Stage 3|Other Miscellaneous Reasons|1|||
94354325|NCT01397409|323078522|FG008|Stage 3|Other Miscellaneous Reasons|0|||
94354326|NCT01397409|323078523|FG009|Stage 3|Other Miscellaneous Reasons|0|||
94354327|NCT01207427|323078524|FG000|Double-blind Treatment Period|Adverse Event|0|||
94354328|NCT01207427|323078525|FG001|Double-blind Treatment Period|Adverse Event|1|||
94354329|NCT01207427|323078526|FG002|Double-blind Treatment Period|Adverse Event|0|||
94354330|NCT01207427|323078524|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
94354331|NCT01207427|323078525|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
94354332|NCT01207427|323078526|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
94354333|NCT01207427|323078524|FG000|Double-blind Treatment Period|Protocol Violation|2|||
94354334|NCT01207427|323078525|FG001|Double-blind Treatment Period|Protocol Violation|1|||
94354335|NCT01207427|323078526|FG002|Double-blind Treatment Period|Protocol Violation|1|||
94354336|NCT01207427|323078524|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
94354337|NCT01207427|323078525|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
94354338|NCT01207427|323078526|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
94354339|NCT01977573|323078531|FG000|Overall Study|Adverse Event|7|||
94354340|NCT01977573|323078532|FG001|Overall Study|Adverse Event|0|||
94354341|NCT01977573|323078533|FG002|Overall Study|Adverse Event|2|||
94354342|NCT01977573|323078534|FG003|Overall Study|Adverse Event|1|||
94354343|NCT01977573|323078531|FG000|Overall Study|Lost to Follow-up|1|||
94354344|NCT01977573|323078532|FG001|Overall Study|Lost to Follow-up|0|||
94354345|NCT01977573|323078533|FG002|Overall Study|Lost to Follow-up|0|||
94354346|NCT01977573|323078534|FG003|Overall Study|Lost to Follow-up|1|||
94354347|NCT01977573|323078531|FG000|Overall Study|Physician Decision|1|||
94354348|NCT01977573|323078532|FG001|Overall Study|Physician Decision|0|||
94354349|NCT01977573|323078533|FG002|Overall Study|Physician Decision|0|||
94354350|NCT01977573|323078534|FG003|Overall Study|Physician Decision|0|||
94354351|NCT01977573|323078531|FG000|Overall Study|Protocol Violation|3|||
94354352|NCT01977573|323078532|FG001|Overall Study|Protocol Violation|1|||
94354353|NCT01977573|323078533|FG002|Overall Study|Protocol Violation|0|||
94354354|NCT01977573|323078534|FG003|Overall Study|Protocol Violation|0|||
94354355|NCT01977573|323078531|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
94243231|NCT01123070|322684392|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
94243232|NCT01123070|322684393|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
94243233|NCT01123070|322684394|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
94243234|NCT02113124|322684395|FG000|Overall Study|Unable to retrieve blood sample|1|||
94243235|NCT02113124|322684396|FG001|Overall Study|Unable to retrieve blood sample|1|||
94243236|NCT02514239|322684397|FG000|Overall Study|Refused to continue trial medication|0|||
94243237|NCT02514239|322684398|FG001|Overall Study|Refused to continue trial medication|0|||
94243238|NCT02514239|322684399|FG002|Overall Study|Refused to continue trial medication|0|||
94243239|NCT02514239|322684400|FG003|Overall Study|Refused to continue trial medication|0|||
94243240|NCT02514239|322684401|FG004|Overall Study|Refused to continue trial medication|0|||
94243241|NCT02514239|322684402|FG005|Overall Study|Refused to continue trial medication|0|||
94243242|NCT02514239|322684403|FG006|Overall Study|Refused to continue trial medication|0|||
94243243|NCT02514239|322684404|FG007|Overall Study|Refused to continue trial medication|0|||
94243244|NCT02514239|322684405|FG008|Overall Study|Refused to continue trial medication|0|||
94243245|NCT02514239|322684406|FG009|Overall Study|Refused to continue trial medication|1|||
94243246|NCT02514239|322684397|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
94243247|NCT02514239|322684398|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
94243248|NCT02514239|322684399|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
94243249|NCT02514239|322684400|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
94243250|NCT02514239|322684401|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
94243251|NCT02514239|322684402|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
94243252|NCT02514239|322684403|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
94243253|NCT02514239|322684404|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
94243254|NCT02514239|322684405|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
94243255|NCT02514239|322684406|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
94243256|NCT02514239|322684397|FG000|Overall Study|Not treated|0|||
94243257|NCT02514239|322684398|FG001|Overall Study|Not treated|1|||
94243258|NCT02514239|322684399|FG002|Overall Study|Not treated|0|||
94243259|NCT02514239|322684400|FG003|Overall Study|Not treated|0|||
94243260|NCT02514239|322684401|FG004|Overall Study|Not treated|0|||
94243261|NCT02514239|322684402|FG005|Overall Study|Not treated|0|||
94243262|NCT02514239|322684403|FG006|Overall Study|Not treated|0|||
94243263|NCT02514239|322684404|FG007|Overall Study|Not treated|0|||
94243264|NCT02514239|322684405|FG008|Overall Study|Not treated|0|||
94354356|NCT01977573|323078532|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
94354357|NCT01977573|323078533|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
94354358|NCT01977573|323078534|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
94354359|NCT01977573|323078531|FG000|Overall Study|Withdrawal by Subject|6|||
94354360|NCT01977573|323078532|FG001|Overall Study|Withdrawal by Subject|1|||
94354361|NCT01977573|323078533|FG002|Overall Study|Withdrawal by Subject|1|||
94354362|NCT01977573|323078534|FG003|Overall Study|Withdrawal by Subject|1|||
94354363|NCT02058966|323078538|FG000|Open-Label Methamphetamine|Adverse Event|1|||
94354364|NCT02058966|323078538|FG000|First Intervention|Withdrawal by Subject|1|||
94354365|NCT01265511|323078539|FG000|Overall Study|Lack of Efficacy|2|||
94354366|NCT01265511|323078540|FG001|Overall Study|Lack of Efficacy|1|||
94354367|NCT01265511|323078539|FG000|Overall Study|Met stopping rules|0|||
94354368|NCT01265511|323078540|FG001|Overall Study|Met stopping rules|2|||
94354369|NCT01790633|323078541|FG000|Overall Study|Protocol Violation|1|||
94354370|NCT01790633|323078542|FG001|Overall Study|Protocol Violation|2|||
94354371|NCT01790633|323078541|FG000|Overall Study|Did not have serology performed|47|||
94354372|NCT01790633|323078542|FG001|Overall Study|Did not have serology performed|0|||
94354373|NCT01790633|323078541|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
94354374|NCT01790633|323078542|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
94354375|NCT01396434|323078545|FG000|Overall Study|Lost to Follow-up|1|||
94354376|NCT01396434|323078546|FG001|Overall Study|Lost to Follow-up|0|||
94354377|NCT01396434|323078547|FG002|Overall Study|Lost to Follow-up|0|||
94354378|NCT01396434|323078545|FG000|Overall Study|Other|10|||
94354379|NCT01396434|323078546|FG001|Overall Study|Other|0|||
94354380|NCT01396434|323078547|FG002|Overall Study|Other|0|||
94354381|NCT03691831|323080218|FG000|Overall Study|Lost to Follow-up|16|||
94354382|NCT03691831|323080219|FG001|Overall Study|Lost to Follow-up|12|||
94354383|NCT03691831|323080218|FG000|Overall Study|Withdrawal by Subject|9|||
94354384|NCT03691831|323080219|FG001|Overall Study|Withdrawal by Subject|17|||
94354385|NCT03691831|323080218|FG000|Overall Study|Investigator Decision|2|||
94354386|NCT03691831|323080219|FG001|Overall Study|Investigator Decision|2|||
94354387|NCT04067310|323080222|FG000|Overall Study|Physician Decision|2|||
94354388|NCT04067310|323080223|FG001|Overall Study|Physician Decision|6|||
94354389|NCT04067310|323080222|FG000|Overall Study|Lost to Follow-up|0|||
94354390|NCT04067310|323080223|FG001|Overall Study|Lost to Follow-up|1|||
94354391|NCT04067310|323080222|FG000|Overall Study|Withdrawal by Subject|3|||
94354392|NCT04067310|323080223|FG001|Overall Study|Withdrawal by Subject|0|||
94354393|NCT02713490|323080224|FG000|Overall Study|Withdrawal by Subject|2|||
94354394|NCT02713490|323080225|FG001|Overall Study|Withdrawal by Subject|1|||
94354395|NCT02713490|323080224|FG000|Overall Study|Did not receive study drug|1|||
94354396|NCT02713490|323080225|FG001|Overall Study|Did not receive study drug|0|||
94354397|NCT02713490|323080224|FG000|Overall Study|Met exclusion criteria|0|||
94354398|NCT02713490|323080225|FG001|Overall Study|Met exclusion criteria|1|||
94354399|NCT00960869|323080227|FG000|Overall Study|Adverse Event|17|||
94354400|NCT00960869|323080228|FG001|Overall Study|Adverse Event|26|||
94354401|NCT00960869|323080227|FG000|Overall Study|Withdrawal by Subject|16|||
94354402|NCT00960869|323080228|FG001|Overall Study|Withdrawal by Subject|14|||
94354403|NCT00960869|323080227|FG000|Overall Study|Lost to Follow-up|1|||
94354404|NCT00960869|323080228|FG001|Overall Study|Lost to Follow-up|4|||
94354405|NCT00960869|323080227|FG000|Overall Study|Misc|19|||
94354406|NCT00960869|323080228|FG001|Overall Study|Misc|18|||
94354407|NCT01096017|323080229|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
94354408|NCT01096017|323080230|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
94354409|NCT00594958|323080231|FG000|Overall Study|Withdrawal by Subject|1|||
94354410|NCT00594958|323080232|FG001|Overall Study|Withdrawal by Subject|0|||
94589088|NCT02273596|323959294|FG000|24-Week Treatment Period|Adverse Event|3|||
94589089|NCT02273596|323959294|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
94589090|NCT02273596|323959294|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
94589091|NCT02273596|323959294|FG000|24-Week Treatment Period|Physician Decision|1|||
94589092|NCT02273596|323959294|FG000|24-Week Treatment Period|Protocol Deviation|1|||
94589093|NCT02273596|323959294|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
94589094|NCT02273596|323959294|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
94589095|NCT02273596|323959294|FG000|Extension Period|Lost to Follow-up|1|||
94589096|NCT02273596|323959294|FG000|Extension Period|Protocol Deviation|1|||
94589097|NCT01330108|323959295|FG000|Overall Study|Withdrawal by Subject|4|||
94589098|NCT04195893|323959300|FG000|Second Intervention|Withdrawal by Subject|1|||
94589099|NCT04195893|323959301|FG001|Second Intervention|Withdrawal by Subject|0|||
94589100|NCT03023813|323959304|FG000|Overall Study|Lost to Follow-up|1|||
94589101|NCT03023813|323959305|FG001|Overall Study|Lost to Follow-up|2|||
94589102|NCT03023813|323959306|FG002|Overall Study|Lost to Follow-up|0|||
94589103|NCT01802073|323959309|FG000|Overall Study|Lost to Follow-up|0|||
94354411|NCT00594958|323080233|FG002|Overall Study|Withdrawal by Subject|1|||
94354412|NCT00594958|323080231|FG000|Overall Study|Adverse Event|4|||
94589104|NCT01802073|323959310|FG001|Overall Study|Lost to Follow-up|1|||
94589105|NCT01802073|323959309|FG000|Overall Study|Non-compliant|4|||
94354413|NCT00594958|323080232|FG001|Overall Study|Adverse Event|1|||
94354414|NCT00594958|323080233|FG002|Overall Study|Adverse Event|2|||
94354415|NCT00594958|323080231|FG000|Overall Study|Pregnancy|0|||
94589106|NCT01802073|323959310|FG001|Overall Study|Non-compliant|2|||
94659514|NCT00359762|324208028|FG004|Period II|Lost to follow up|5|||
94354416|NCT00594958|323080232|FG001|Overall Study|Pregnancy|2|||
94354417|NCT00594958|323080233|FG002|Overall Study|Pregnancy|0|||
94354418|NCT00594958|323080231|FG000|Overall Study|Protocol Violation|1|||
94354419|NCT00594958|323080232|FG001|Overall Study|Protocol Violation|0|||
94354420|NCT00594958|323080233|FG002|Overall Study|Protocol Violation|2|||
94354421|NCT00594958|323080231|FG000|Overall Study|Lost to Follow-up|5|||
94354422|NCT00594958|323080232|FG001|Overall Study|Lost to Follow-up|0|||
94354423|NCT00594958|323080233|FG002|Overall Study|Lost to Follow-up|3|||
94354424|NCT00594958|323080231|FG000|Overall Study|administrative|3|||
94354425|NCT00594958|323080232|FG001|Overall Study|administrative|0|||
94354426|NCT00594958|323080233|FG002|Overall Study|administrative|2|||
94354427|NCT02079077|323080234|FG000|Overall Study|Lost to Follow-up|5|||
94354428|NCT02079077|323080235|FG001|Overall Study|Lost to Follow-up|7|||
94354429|NCT02079077|323080234|FG000|Overall Study|Became STIs Positive|1|||
94354430|NCT02079077|323080235|FG001|Overall Study|Became STIs Positive|2|||
94354431|NCT03730987|323080236|FG000|Overall Study|Lost to Follow-up|2|||
94354432|NCT03730987|323080237|FG001|Overall Study|Lost to Follow-up|0|||
94354433|NCT03730987|323080238|FG002|Overall Study|Lost to Follow-up|2|||
94354434|NCT03730987|323080239|FG003|Overall Study|Lost to Follow-up|0|||
94354435|NCT00656136|323080240|FG000|Overall Study|Progressive disease|177|||
94354436|NCT00656136|323080241|FG001|Overall Study|Progressive disease|322|||
94354437|NCT00656136|323080240|FG000|Overall Study|Other Adverse Event|5|||
94354438|NCT00656136|323080241|FG001|Overall Study|Other Adverse Event|51|||
94354439|NCT00656136|323080240|FG000|Overall Study|Protocol Violation|2|||
94354440|NCT00656136|323080241|FG001|Overall Study|Protocol Violation|3|||
94354441|NCT00656136|323080240|FG000|Overall Study|Patient refused to take study medication|7|||
94354442|NCT00656136|323080241|FG001|Overall Study|Patient refused to take study medication|10|||
94354443|NCT00656136|323080240|FG000|Overall Study|Unknown and others|4|||
94589107|NCT01802073|323959309|FG000|Overall Study|Withdrawal by Subject|1|||
94589108|NCT01802073|323959310|FG001|Overall Study|Withdrawal by Subject|1|||
94589109|NCT01802073|323959309|FG000|Overall Study|Physician Decision|0|||
94589110|NCT01802073|323959310|FG001|Overall Study|Physician Decision|7|||
94589111|NCT04075734|323959311|FG000|Overall Study|Lost to Follow-up|1|||
94589112|NCT04075734|323959312|FG001|Overall Study|Lost to Follow-up|1|||
94589113|NCT04075734|323959313|FG002|Overall Study|Lost to Follow-up|0|||
94589114|NCT04075734|323959311|FG000|Overall Study|Withdrawal by Subject|3|||
94589115|NCT04075734|323959312|FG001|Overall Study|Withdrawal by Subject|0|||
94589116|NCT04075734|323959313|FG002|Overall Study|Withdrawal by Subject|0|||
94589117|NCT00393861|323959314|FG000|Overall Study|Adverse Event|2|||
94589118|NCT00393861|323959314|FG000|Overall Study|Disease Progression|24|||
94243265|NCT02514239|322684406|FG009|Overall Study|Not treated|0|||
94243266|NCT02514239|322684397|FG000|Overall Study|Other Adverse Events|2|||
94243267|NCT02514239|322684398|FG001|Overall Study|Other Adverse Events|0|||
94243268|NCT02514239|322684399|FG002|Overall Study|Other Adverse Events|0|||
94243269|NCT02514239|322684400|FG003|Overall Study|Other Adverse Events|1|||
94243270|NCT02514239|322684401|FG004|Overall Study|Other Adverse Events|0|||
94243271|NCT02514239|322684402|FG005|Overall Study|Other Adverse Events|1|||
94243272|NCT02514239|322684403|FG006|Overall Study|Other Adverse Events|0|||
94243273|NCT02514239|322684404|FG007|Overall Study|Other Adverse Events|1|||
94243274|NCT02514239|322684405|FG008|Overall Study|Other Adverse Events|2|||
94243275|NCT02514239|322684406|FG009|Overall Study|Other Adverse Events|0|||
94243276|NCT02514239|322684397|FG000|Overall Study|Progressive disease|3|||
94243277|NCT02514239|322684398|FG001|Overall Study|Progressive disease|3|||
94243278|NCT02514239|322684399|FG002|Overall Study|Progressive disease|2|||
94243279|NCT02514239|322684400|FG003|Overall Study|Progressive disease|2|||
94243280|NCT02514239|322684401|FG004|Overall Study|Progressive disease|3|||
94243281|NCT02514239|322684402|FG005|Overall Study|Progressive disease|3|||
94243282|NCT02514239|322684403|FG006|Overall Study|Progressive disease|4|||
94243283|NCT02514239|322684404|FG007|Overall Study|Progressive disease|2|||
94243284|NCT02514239|322684405|FG008|Overall Study|Progressive disease|5|||
94243285|NCT02514239|322684406|FG009|Overall Study|Progressive disease|0|||
94243286|NCT01088984|322684407|FG000|Phase 1|Death|2|||
94354444|NCT00656136|323080241|FG001|Overall Study|Unknown and others|4|||
94589119|NCT01485172|323959315|FG000|Overall Study|Adverse Event|2|||
94589120|NCT01485172|323959316|FG001|Overall Study|Adverse Event|1|||
94589121|NCT01485172|323959317|FG002|Overall Study|Adverse Event|2|||
94589122|NCT01485172|323959318|FG003|Overall Study|Adverse Event|2|||
94243287|NCT01088984|322684408|FG001|Phase 1|Death|1|||
94243288|NCT01088984|322684407|FG000|Phase 1|Disease Progression|2|||
94243289|NCT01088984|322684408|FG001|Phase 1|Disease Progression|4|||
94354445|NCT01191190|323080242|FG000|Overall Study|Withdrawal by Subject|1|||
94354446|NCT02681094|323080243|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
94354447|NCT02681094|323080244|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
94589123|NCT01485172|323959319|FG004|Overall Study|Adverse Event|1|||
94243290|NCT01088984|322684407|FG000|Phase 1|Other|1|||
94243291|NCT01088984|322684408|FG001|Phase 1|Other|1|||
94243292|NCT01088984|322684407|FG000|Phase 2|Death|0|||
94354448|NCT02681094|323080245|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
94243293|NCT01088984|322684408|FG001|Phase 2|Death|5|||
94589124|NCT01485172|323959320|FG005|Overall Study|Adverse Event|2|||
94659515|NCT00359762|324208024|FG000|Period II|Entry Criteria Not Met|8|||
94659516|NCT00359762|324208025|FG001|Period II|Entry Criteria Not Met|0|||
94659517|NCT00359762|324208026|FG002|Period II|Entry Criteria Not Met|0|||
94659518|NCT00359762|324208027|FG003|Period II|Entry Criteria Not Met|0|||
94659519|NCT00359762|324208028|FG004|Period II|Entry Criteria Not Met|4|||
94659520|NCT00359762|324208024|FG000|Period II|Subject Decision|50|||
94659521|NCT00359762|324208025|FG001|Period II|Subject Decision|0|||
94659522|NCT00359762|324208026|FG002|Period II|Subject Decision|0|||
94659523|NCT00359762|324208027|FG003|Period II|Subject Decision|0|||
94659524|NCT00359762|324208028|FG004|Period II|Subject Decision|70|||
94659525|NCT00359762|324208024|FG000|Period III|Protocol Violation|0|||
94659526|NCT00359762|324208025|FG001|Period III|Protocol Violation|5|||
94659527|NCT00359762|324208026|FG002|Period III|Protocol Violation|3|||
94659528|NCT00359762|324208027|FG003|Period III|Protocol Violation|8|||
94659529|NCT00359762|324208028|FG004|Period III|Protocol Violation|0|||
94659530|NCT00359762|324208024|FG000|Period III|Adverse Event|0|||
94659531|NCT00359762|324208025|FG001|Period III|Adverse Event|3|||
94659532|NCT00359762|324208026|FG002|Period III|Adverse Event|4|||
94659533|NCT00359762|324208027|FG003|Period III|Adverse Event|10|||
94659534|NCT00359762|324208028|FG004|Period III|Adverse Event|0|||
94659535|NCT00359762|324208024|FG000|Period III|Physician Decision|0|||
94659536|NCT00359762|324208025|FG001|Period III|Physician Decision|5|||
94659537|NCT00359762|324208026|FG002|Period III|Physician Decision|9|||
94659538|NCT00359762|324208027|FG003|Period III|Physician Decision|15|||
94659539|NCT00359762|324208028|FG004|Period III|Physician Decision|0|||
94659540|NCT00359762|324208024|FG000|Period III|Lack of Efficacy|0|||
94659541|NCT00359762|324208025|FG001|Period III|Lack of Efficacy|7|||
94659542|NCT00359762|324208026|FG002|Period III|Lack of Efficacy|5|||
94659543|NCT00359762|324208027|FG003|Period III|Lack of Efficacy|9|||
94659544|NCT00359762|324208028|FG004|Period III|Lack of Efficacy|0|||
94659545|NCT00359762|324208024|FG000|Period III|Lost to follow up|0|||
94659546|NCT00359762|324208025|FG001|Period III|Lost to follow up|1|||
94243294|NCT01088984|322684407|FG000|Phase 2|Withdrawal by Subject|0|||
94243295|NCT01088984|322684408|FG001|Phase 2|Withdrawal by Subject|1|||
94243296|NCT01088984|322684407|FG000|Phase 2|DIsease Progression|0|||
94243297|NCT01088984|322684408|FG001|Phase 2|DIsease Progression|25|||
94243298|NCT01088984|322684407|FG000|Phase 2|Other|0|||
94243299|NCT01088984|322684408|FG001|Phase 2|Other|1|||
94243300|NCT01006980|322684409|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
94243301|NCT01006980|322684410|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
94243302|NCT01006980|322684409|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
94243303|NCT01006980|322684410|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
94243304|NCT01006980|322684409|FG000|Vemurafenib and Dacarbazine|Death|13|||
94243305|NCT01006980|322684410|FG001|Vemurafenib and Dacarbazine|Death|12|||
94243306|NCT01006980|322684409|FG000|Vemurafenib and Dacarbazine|Progression|257|||
94243307|NCT01006980|322684410|FG001|Vemurafenib and Dacarbazine|Progression|218|||
94243308|NCT01006980|322684409|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
94243309|NCT01006980|322684410|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
94243310|NCT01006980|322684409|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
94243311|NCT01006980|322684410|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
94243312|NCT01006980|322684409|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
94243313|NCT01006980|322684410|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
94243314|NCT01006980|322684409|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
94243315|NCT01006980|322684410|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
94243316|NCT01006980|322684409|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
94243317|NCT01006980|322684410|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
94243318|NCT01006980|322684409|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
94243319|NCT01006980|322684410|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
94243320|NCT01006980|322684409|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
94243321|NCT01006980|322684410|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
94243322|NCT01006980|322684409|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
94243323|NCT01006980|322684410|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
94243324|NCT01006980|322684409|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
94243325|NCT01006980|322684410|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
94243326|NCT02993406|322684430|FG000|Overall Study|Withdrawal by Subject|170|||
94243327|NCT02993406|322684431|FG001|Overall Study|Withdrawal by Subject|196|||
94243328|NCT02993406|322684430|FG000|Overall Study|Physician Decision|3|||
94243329|NCT02993406|322684431|FG001|Overall Study|Physician Decision|5|||
94243330|NCT02993406|322684430|FG000|Overall Study|Lost to Follow-up|12|||
94243331|NCT02993406|322684431|FG001|Overall Study|Lost to Follow-up|13|||
94243332|NCT02993406|322684430|FG000|Overall Study|Unclassifiable Response|105|||
94243333|NCT02993406|322684431|FG001|Overall Study|Unclassifiable Response|139|||
94243334|NCT02993406|322684430|FG000|Overall Study|Administrative decision|1|||
94243335|NCT02993406|322684431|FG001|Overall Study|Administrative decision|0|||
94659547|NCT00359762|324208026|FG002|Period III|Lost to follow up|1|||
94659548|NCT00359762|324208027|FG003|Period III|Lost to follow up|2|||
94659549|NCT00359762|324208028|FG004|Period III|Lost to follow up|0|||
94354449|NCT02681094|323080243|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
94354450|NCT02681094|323080244|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
94354451|NCT02681094|323080245|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
94354452|NCT02681094|323080243|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
94354453|NCT02681094|323080244|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
94354454|NCT02681094|323080245|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
94354455|NCT02681094|323080243|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
94354456|NCT02681094|323080244|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
94354457|NCT02681094|323080245|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
94354458|NCT02681094|323080243|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
94589125|NCT01485172|323959315|FG000|Overall Study|Lack of Efficacy|2|||
94589126|NCT01485172|323959316|FG001|Overall Study|Lack of Efficacy|0|||
94589127|NCT01485172|323959317|FG002|Overall Study|Lack of Efficacy|0|||
94589128|NCT01485172|323959318|FG003|Overall Study|Lack of Efficacy|0|||
94589129|NCT01485172|323959319|FG004|Overall Study|Lack of Efficacy|0|||
94589130|NCT01485172|323959320|FG005|Overall Study|Lack of Efficacy|0|||
94589131|NCT01485172|323959315|FG000|Overall Study|Protocol Violation|0|||
94589132|NCT01485172|323959316|FG001|Overall Study|Protocol Violation|0|||
94589133|NCT01485172|323959317|FG002|Overall Study|Protocol Violation|4|||
94589134|NCT01485172|323959318|FG003|Overall Study|Protocol Violation|5|||
94589135|NCT01485172|323959319|FG004|Overall Study|Protocol Violation|1|||
94589136|NCT01485172|323959320|FG005|Overall Study|Protocol Violation|0|||
94589137|NCT01485172|323959315|FG000|Overall Study|Protocol defined stopping criteria|1|||
94589138|NCT01485172|323959316|FG001|Overall Study|Protocol defined stopping criteria|0|||
94589139|NCT01485172|323959317|FG002|Overall Study|Protocol defined stopping criteria|0|||
94589140|NCT01485172|323959318|FG003|Overall Study|Protocol defined stopping criteria|0|||
94589141|NCT01485172|323959319|FG004|Overall Study|Protocol defined stopping criteria|1|||
94589142|NCT01485172|323959320|FG005|Overall Study|Protocol defined stopping criteria|0|||
94589143|NCT01485172|323959315|FG000|Overall Study|Lost to Follow-up|0|||
94589144|NCT01485172|323959316|FG001|Overall Study|Lost to Follow-up|0|||
94589145|NCT01485172|323959317|FG002|Overall Study|Lost to Follow-up|1|||
94589146|NCT01485172|323959318|FG003|Overall Study|Lost to Follow-up|0|||
94589147|NCT01485172|323959319|FG004|Overall Study|Lost to Follow-up|0|||
94589148|NCT01485172|323959320|FG005|Overall Study|Lost to Follow-up|1|||
94589149|NCT01485172|323959315|FG000|Overall Study|Physician Decision|0|||
94589150|NCT01485172|323959316|FG001|Overall Study|Physician Decision|0|||
94589151|NCT01485172|323959317|FG002|Overall Study|Physician Decision|0|||
94589152|NCT01485172|323959318|FG003|Overall Study|Physician Decision|0|||
94589153|NCT01485172|323959319|FG004|Overall Study|Physician Decision|1|||
94589154|NCT01485172|323959320|FG005|Overall Study|Physician Decision|0|||
94589155|NCT01485172|323959315|FG000|Overall Study|Withdrawal by Subject|2|||
94589156|NCT01485172|323959316|FG001|Overall Study|Withdrawal by Subject|0|||
94589157|NCT01485172|323959317|FG002|Overall Study|Withdrawal by Subject|0|||
94589158|NCT01485172|323959318|FG003|Overall Study|Withdrawal by Subject|1|||
94589159|NCT01485172|323959319|FG004|Overall Study|Withdrawal by Subject|1|||
94589160|NCT01485172|323959320|FG005|Overall Study|Withdrawal by Subject|1|||
94589161|NCT02920242|323959324|FG000|Overall Study|Withdrawal by Subject|1|||
94589162|NCT02920242|323959325|FG001|Overall Study|Withdrawal by Subject|0|||
94589163|NCT02920242|323959326|FG002|Overall Study|Withdrawal by Subject|1|||
94589164|NCT02920242|323959324|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
94589165|NCT02920242|323959325|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
94589166|NCT02920242|323959326|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
94589167|NCT01474018|323959328|FG000|Overall Study|Lost to Follow-up|0|||
94589168|NCT01474018|323959329|FG001|Overall Study|Lost to Follow-up|1|||
94589169|NCT01474018|323959328|FG000|Overall Study|Withdrawal by Subject|0|||
94589170|NCT01474018|323959329|FG001|Overall Study|Withdrawal by Subject|2|||
94589171|NCT01587014|323959330|FG000|Overall Study|Death|2|||
94589172|NCT02948088|323959331|FG000|Overall Study|Lost to Follow-up|8|||
94589173|NCT02948088|323959331|FG000|Overall Study|Death|1|||
94589174|NCT02948088|323959331|FG000|Overall Study|Withdrawal by Subject|4|||
94589175|NCT02948088|323959331|FG000|Overall Study|Other|2|||
94589176|NCT00634101|323959332|FG000|Overall Study|Study Terminated|3|||
94589177|NCT00634101|323959333|FG001|Overall Study|Study Terminated|3|||
94589178|NCT00634101|323959332|FG000|Overall Study|Lost to Follow-up|2|||
94589179|NCT00634101|323959333|FG001|Overall Study|Lost to Follow-up|0|||
94589180|NCT04145219|323959334|FG000|Overall Study|Adverse Event|18|||
94589181|NCT04145219|323959335|FG001|Overall Study|Adverse Event|6|||
94589182|NCT04145219|323959334|FG000|Overall Study|Lost to Follow-up|2|||
94589183|NCT04145219|323959335|FG001|Overall Study|Lost to Follow-up|3|||
94589184|NCT04145219|323959334|FG000|Overall Study|Physician Decision|0|||
94589185|NCT04145219|323959335|FG001|Overall Study|Physician Decision|2|||
94589186|NCT04145219|323959334|FG000|Overall Study|Withdrawal by Subject|12|||
94589187|NCT04145219|323959335|FG001|Overall Study|Withdrawal by Subject|8|||
94659550|NCT00359762|324208024|FG000|Period III|Entry Criteria Not Met|0|||
94659551|NCT00359762|324208025|FG001|Period III|Entry Criteria Not Met|1|||
94659552|NCT00359762|324208026|FG002|Period III|Entry Criteria Not Met|0|||
94659553|NCT00359762|324208027|FG003|Period III|Entry Criteria Not Met|1|||
94659554|NCT00359762|324208028|FG004|Period III|Entry Criteria Not Met|0|||
94659555|NCT00359762|324208024|FG000|Period III|Subject Decision|0|||
94659556|NCT00359762|324208025|FG001|Period III|Subject Decision|7|||
94659557|NCT00359762|324208026|FG002|Period III|Subject Decision|8|||
94659558|NCT00359762|324208027|FG003|Period III|Subject Decision|20|||
94659559|NCT00359762|324208028|FG004|Period III|Subject Decision|0|||
94659560|NCT00530023|324208029|FG000|Overall Study|Withdrawal by Subject|0|||
94659561|NCT00530023|324208030|FG001|Overall Study|Withdrawal by Subject|1|||
94659562|NCT00003498|324208031|FG000|Overall Study|Not evaluable.|4|||
94659563|NCT00765245|324208032|FG000|Overall Study|disease progression|3|||
94659564|NCT00765245|324208033|FG001|Overall Study|disease progression|2|||
94659565|NCT00765245|324208032|FG000|Overall Study|Withdrawal by Subject|3|||
94659566|NCT00765245|324208033|FG001|Overall Study|Withdrawal by Subject|0|||
94659567|NCT00765245|324208032|FG000|Overall Study|Adverse Event|5|||
94659568|NCT00765245|324208033|FG001|Overall Study|Adverse Event|0|||
94659569|NCT00765245|324208032|FG000|Overall Study|Physician Decision|1|||
94659570|NCT00765245|324208033|FG001|Overall Study|Physician Decision|0|||
94659571|NCT00765245|324208032|FG000|Overall Study|Death|1|||
94659572|NCT00765245|324208033|FG001|Overall Study|Death|0|||
94659573|NCT04321460|324208036|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
94659574|NCT04321460|324208037|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
94659575|NCT02162810|324208038|FG000|Overall Study|Protocol Violation|1|||
94659576|NCT02162810|324208039|FG001|Overall Study|Protocol Violation|0|||
94659577|NCT02162810|324208038|FG000|Overall Study|patients did not report compliance|4|||
94659578|NCT02162810|324208039|FG001|Overall Study|patients did not report compliance|1|||
94659579|NCT02546544|324208040|FG000|Overall Study|Disease Progression|14|||
94659580|NCT02546544|324208040|FG000|Overall Study|Adverse Event|1|||
94659581|NCT02546544|324208040|FG000|Overall Study|Withdrawal by Subject|1|||
94659582|NCT01921348|324208041|FG000|Overall Study|Withdrawal by Subject|1|||
94659583|NCT01921348|324208042|FG001|Overall Study|Withdrawal by Subject|0|||
94659584|NCT01921348|324208041|FG000|Overall Study|Lost to Follow-up|0|||
94659585|NCT01921348|324208042|FG001|Overall Study|Lost to Follow-up|2|||
94659586|NCT01114646|324208046|FG000|Overall Study|Withdrawal by Subject|3|||
94659587|NCT01114646|324208047|FG001|Overall Study|Withdrawal by Subject|2|||
94659588|NCT02806986|324208053|FG000|Treatment Stage 1|Adverse Event|1|||
94659589|NCT02806986|324208053|FG000|Treatment Stage 2|Adverse Event|3|||
94659590|NCT02806986|324208053|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
94659591|NCT00462384|324208054|FG000|Overall Study|Adverse Event|2|||
94659592|NCT00462384|324208054|FG000|Overall Study|Death|2|||
94659593|NCT00462384|324208054|FG000|Overall Study|Withdrawal by Subject|1|||
94659594|NCT00462384|324208054|FG000|Overall Study|Other|4|||
94659595|NCT04079933|324208057|FG000|Overall Study|Withdrawal by Subject|3|||
94659596|NCT04079933|324208058|FG001|Overall Study|Withdrawal by Subject|4|||
94659597|NCT04079933|324208057|FG000|Overall Study|Lost to Follow-up|0|||
94659598|NCT04079933|324208058|FG001|Overall Study|Lost to Follow-up|1|||
94659599|NCT00781326|324208059|FG000|Phase I|Adverse Event|1|||
94659600|NCT00781326|324208059|FG000|Phase I|Withdrawal by Subject|1|||
94659601|NCT00781326|324208059|FG000|Phase I|Physician Decision|2|||
94659602|NCT00345579|324208060|FG000|Overall Study|Adverse Event|9|||
94659603|NCT00345579|324208061|FG001|Overall Study|Adverse Event|6|||
94659604|NCT00345579|324208060|FG000|Overall Study|Protocol Violation|14|||
94659605|NCT00345579|324208061|FG001|Overall Study|Protocol Violation|5|||
94659606|NCT00345579|324208060|FG000|Overall Study|Withdrawal by Subject|50|||
94659607|NCT00345579|324208061|FG001|Overall Study|Withdrawal by Subject|17|||
94659608|NCT00345579|324208060|FG000|Overall Study|Lost to Follow-up|82|||
94659609|NCT00345579|324208061|FG001|Overall Study|Lost to Follow-up|36|||
94659610|NCT00345579|324208060|FG000|Overall Study|Other|9|||
94659611|NCT00345579|324208061|FG001|Overall Study|Other|1|||
94659612|NCT00403546|324208062|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
94659613|NCT00403546|324208063|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
94456098|NCT02244463|323458201|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
94659614|NCT00403546|324208064|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
94659615|NCT00403546|324208062|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
94659616|NCT00403546|324208063|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
94659617|NCT00403546|324208064|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
94659618|NCT00403546|324208062|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
94659619|NCT00403546|324208063|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
94659620|NCT00403546|324208064|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
94659621|NCT00403546|324208062|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
94659622|NCT00403546|324208063|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
94589188|NCT04145219|323959334|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
94589189|NCT04145219|323959335|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
94589190|NCT01640314|323959336|FG000|Overall Study|Protocol Violation|0|||
94589191|NCT01640314|323959337|FG001|Overall Study|Protocol Violation|1|||
94589192|NCT02657408|323959338|FG000|Overall Study|Adverse Event|3|||
94589193|NCT02657408|323959339|FG001|Overall Study|Adverse Event|7|||
94589194|NCT04450381|323959341|FG000|Overall Study|Protocol Violation|4|||
94589195|NCT04450381|323959341|FG000|Overall Study|Wrong device setting|2|||
94589196|NCT02424578|323959342|FG000|Overall Study|Withdrawal by Subject|0|||
94589197|NCT02424578|323959343|FG001|Overall Study|Withdrawal by Subject|1|||
94589198|NCT00324961|323959344|FG000|Overall Study|Adverse Event|5|||
94589199|NCT00324961|323959344|FG000|Overall Study|Consent Withdrawn|11|||
94243336|NCT02993406|322684430|FG000|Overall Study|Sponsor decision|4|||
94243337|NCT02993406|322684431|FG001|Overall Study|Sponsor decision|5|||
94243338|NCT03046121|322684450|FG000|Overall Study|Death|32|||
94243339|NCT03046121|322684451|FG001|Overall Study|Death|60|||
94243340|NCT03046121|322684450|FG000|Overall Study|Withdrawal by Subject|14|||
94243341|NCT03046121|322684451|FG001|Overall Study|Withdrawal by Subject|12|||
94243342|NCT00821587|322684459|FG000|Overall Study|Physician Decision|0|||
94243343|NCT00821587|322684460|FG001|Overall Study|Physician Decision|1|||
94243344|NCT03596762|322684463|FG000|Overall Study|Protocol Violation|0|||
94243345|NCT03596762|322684464|FG001|Overall Study|Protocol Violation|0|||
94243346|NCT03596762|322684465|FG002|Overall Study|Protocol Violation|0|||
94243347|NCT03596762|322684466|FG003|Overall Study|Protocol Violation|0|||
94243348|NCT03596762|322684467|FG004|Overall Study|Protocol Violation|1|||
94243349|NCT03596762|322684463|FG000|Overall Study|Adverse Event|2|||
94243350|NCT03596762|322684464|FG001|Overall Study|Adverse Event|0|||
94243351|NCT03596762|322684465|FG002|Overall Study|Adverse Event|1|||
94243352|NCT03596762|322684466|FG003|Overall Study|Adverse Event|0|||
94243353|NCT03596762|322684467|FG004|Overall Study|Adverse Event|5|||
94243354|NCT03596762|322684463|FG000|Overall Study|Withdrawal by Subject|2|||
94243355|NCT03596762|322684464|FG001|Overall Study|Withdrawal by Subject|1|||
94243356|NCT03596762|322684465|FG002|Overall Study|Withdrawal by Subject|0|||
94243357|NCT03596762|322684466|FG003|Overall Study|Withdrawal by Subject|1|||
94243358|NCT03596762|322684467|FG004|Overall Study|Withdrawal by Subject|1|||
94243359|NCT02781090|322684468|FG000|3-Month Follow-Up|Missed Visit|20|||
94243360|NCT02781090|322684469|FG001|3-Month Follow-Up|Missed Visit|20|||
94243361|NCT02781090|322684468|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
94243362|NCT02781090|322684469|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
94243363|NCT02781090|322684468|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
94243364|NCT02781090|322684469|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
94243365|NCT02781090|322684468|FG000|3-Month Follow-Up|Death|1|||
94243366|NCT02781090|322684469|FG001|3-Month Follow-Up|Death|0|||
94243367|NCT02781090|322684468|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
94243368|NCT02781090|322684469|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
94243369|NCT02781090|322684468|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
94243370|NCT02781090|322684469|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
94243371|NCT02781090|322684468|FG000|6-Month Follow-Up|Death|0|||
94243372|NCT02781090|322684469|FG001|6-Month Follow-Up|Death|1|||
94243373|NCT01677767|322684471|FG000|Overall Study|Adverse Event|1|||
94243374|NCT01677767|322684471|FG000|Overall Study|Death|4|||
94243375|NCT01677767|322684471|FG000|Overall Study|Protocol Violation|4|||
94243376|NCT01677767|322684471|FG000|Overall Study|Withdrawal by Subject|10|||
94243377|NCT01677767|322684471|FG000|Overall Study|Non-compliance by the participants|3|||
94243378|NCT04230122|322684476|FG000|Overall Study|Lost to Follow-up|1|||
94243379|NCT04230122|322684477|FG001|Overall Study|Lost to Follow-up|0|||
94243380|NCT01696955|322684479|FG000|Main Study|Protocol Violation|1|||
94243381|NCT01696955|322684480|FG001|Main Study|Protocol Violation|0|||
94243382|NCT01696955|322684479|FG000|Main Study|Withdrawal by Subject|1|||
94243383|NCT01696955|322684480|FG001|Main Study|Withdrawal by Subject|1|||
94243384|NCT01641159|322684487|FG000|Overall Study|Lost to Follow-up|2|||
94243385|NCT01641159|322684488|FG001|Overall Study|Lost to Follow-up|1|||
94243386|NCT01641159|322684487|FG000|Overall Study|Withdrawal by Subject|0|||
94243387|NCT01641159|322684488|FG001|Overall Study|Withdrawal by Subject|1|||
94243388|NCT03752970|322684492|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
94243389|NCT03752970|322684493|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
94243390|NCT03752970|322684494|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
94243391|NCT03752970|322684492|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
94354459|NCT02681094|323080244|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
94589200|NCT00324961|323959344|FG000|Overall Study|Lost to Follow-up|22|||
94589201|NCT00324961|323959344|FG000|Overall Study|Protocol Violation|3|||
94589202|NCT00324961|323959344|FG000|Overall Study|Other|2|||
94243392|NCT03752970|322684493|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
94243393|NCT03752970|322684494|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
94243394|NCT03752970|322684492|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
94243395|NCT03752970|322684493|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
94589203|NCT03241368|323959349|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
94589204|NCT03241368|323959349|FG000|Overall Study|Lost to Follow-up|1|||
94589205|NCT03241368|323959349|FG000|Overall Study|Physician Decision|6|||
94589206|NCT03241368|323959349|FG000|Overall Study|Withdrawal by Subject|6|||
94589207|NCT03241368|323959349|FG000|Overall Study|Protocol Violation|1|||
94589208|NCT06351371|323959350|FG000|Overall Study|Mutation Status Not Confirmed|9|||
94589209|NCT06351371|323959350|FG000|Overall Study|Ineligible|1|||
94589210|NCT06351371|323959350|FG000|Overall Study|Adverse Event|4|||
94589211|NCT06351371|323959350|FG000|Overall Study|Death|1|||
94589212|NCT06351371|323959350|FG000|Overall Study|Disease progression|14|||
94589213|NCT06351371|323959350|FG000|Overall Study|Withdrawal by Subject|3|||
94589214|NCT06351371|323959350|FG000|Overall Study|Physician Decision|3|||
94589215|NCT00566696|323959351|FG000|Overall Study|Met Exclusion Criteria|2|||
94589216|NCT00566696|323959351|FG000|Overall Study|Muromonab not available|1|||
94589217|NCT00566696|323959351|FG000|Overall Study|Health Status Change|1|||
94589218|NCT00566696|323959351|FG000|Overall Study|Physician Decision|1|||
94589219|NCT00566696|323959351|FG000|Overall Study|Non-Patient Donors|37|||
94589220|NCT00329797|323959352|FG000|Overall Study|Protocol Violation|1|||
94589221|NCT00329797|323959353|FG001|Overall Study|Protocol Violation|0|||
94589222|NCT00329797|323959352|FG000|Overall Study|Withdrawal by Subject|6|||
94589223|NCT00329797|323959353|FG001|Overall Study|Withdrawal by Subject|6|||
94589224|NCT00776919|323959354|FG000|Overall Study|Withdrawal by Subject|16|||
94589225|NCT00776919|323959355|FG001|Overall Study|Withdrawal by Subject|14|||
94589226|NCT00776919|323959356|FG002|Overall Study|Withdrawal by Subject|15|||
94589227|NCT00776919|323959357|FG003|Overall Study|Withdrawal by Subject|26|||
94589228|NCT00776919|323959354|FG000|Overall Study|Lost to Follow-up|8|||
94589229|NCT00776919|323959355|FG001|Overall Study|Lost to Follow-up|12|||
94589230|NCT00776919|323959356|FG002|Overall Study|Lost to Follow-up|11|||
94589231|NCT00776919|323959357|FG003|Overall Study|Lost to Follow-up|8|||
94589232|NCT00776919|323959354|FG000|Overall Study|Adverse Event|1|||
94589233|NCT00776919|323959355|FG001|Overall Study|Adverse Event|0|||
94589234|NCT00776919|323959356|FG002|Overall Study|Adverse Event|2|||
94589235|NCT00776919|323959357|FG003|Overall Study|Adverse Event|2|||
94589236|NCT00776919|323959354|FG000|Overall Study|Protocol Violation|1|||
94589237|NCT00776919|323959355|FG001|Overall Study|Protocol Violation|2|||
94589238|NCT00776919|323959356|FG002|Overall Study|Protocol Violation|0|||
94589239|NCT00776919|323959357|FG003|Overall Study|Protocol Violation|1|||
94589240|NCT00776919|323959354|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
94589241|NCT00776919|323959355|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
94589242|NCT00776919|323959356|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
94589243|NCT00776919|323959357|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
94589244|NCT01396070|323959360|FG000|Overall Study|Withdrawal by Subject|2|||
94589245|NCT01396070|323959360|FG000|Overall Study|Death|2|||
94589246|NCT01396070|323959360|FG000|Overall Study|Adverse Event|8|||
94589247|NCT01396070|323959360|FG000|Overall Study|Physician Decision|3|||
94589248|NCT01396070|323959360|FG000|Overall Study|Lack of Efficacy|4|||
94589249|NCT03037580|323959361|FG000|Overall Study|Withdrawal by Subject|3|||
94589250|NCT03037580|323959362|FG001|Overall Study|Withdrawal by Subject|0|||
94589251|NCT03037580|323959361|FG000|Overall Study|Adverse Event|1|||
94589252|NCT03037580|323959362|FG001|Overall Study|Adverse Event|0|||
94589253|NCT03037580|323959361|FG000|Overall Study|Study Terminated by Sponsor|12|||
94589254|NCT03037580|323959362|FG001|Overall Study|Study Terminated by Sponsor|15|||
94589255|NCT03037580|323959361|FG000|Overall Study|Death|0|||
94589256|NCT03037580|323959362|FG001|Overall Study|Death|1|||
94589257|NCT02442804|323959363|FG000|Overall Study|Withdrawal by Subject|0|||
94589258|NCT02442804|323959364|FG001|Overall Study|Withdrawal by Subject|1|||
94589259|NCT02442804|323959363|FG000|Overall Study|Adverse Event|1|||
94589260|NCT02442804|323959364|FG001|Overall Study|Adverse Event|0|||
94589261|NCT02878798|323959365|FG000|Overall Study|Withdrawal by Subject|5|||
94589262|NCT02878798|323959366|FG001|Overall Study|Withdrawal by Subject|4|||
94589263|NCT02878798|323959365|FG000|Overall Study|Lost to Follow-up|2|||
94589264|NCT02878798|323959366|FG001|Overall Study|Lost to Follow-up|2|||
94589265|NCT02878798|323959365|FG000|Overall Study|Protocol Violation|0|||
94589266|NCT02878798|323959366|FG001|Overall Study|Protocol Violation|1|||
94589267|NCT01233232|323959367|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
94589268|NCT01233232|323959368|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
94589269|NCT01233232|323959369|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
94589270|NCT00101452|323959374|FG000|Overall Study|Adverse Event|2|||
94589271|NCT00101452|323959375|FG001|Overall Study|Adverse Event|0|||
94589272|NCT00101452|323959376|FG002|Overall Study|Adverse Event|1|||
94589273|NCT00101452|323959374|FG000|Overall Study|Lost to Follow-up|13|||
94589274|NCT00101452|323959375|FG001|Overall Study|Lost to Follow-up|8|||
94589275|NCT00101452|323959376|FG002|Overall Study|Lost to Follow-up|14|||
94589276|NCT00101452|323959374|FG000|Overall Study|Withdrawal by Subject|10|||
94589277|NCT00101452|323959375|FG001|Overall Study|Withdrawal by Subject|14|||
94589278|NCT00101452|323959376|FG002|Overall Study|Withdrawal by Subject|9|||
94589279|NCT00101452|323959374|FG000|Overall Study|Baseline Fail|2|||
94589280|NCT00101452|323959375|FG001|Overall Study|Baseline Fail|1|||
94589281|NCT00101452|323959376|FG002|Overall Study|Baseline Fail|2|||
94589282|NCT00101452|323959374|FG000|Overall Study|Physician Decision|0|||
94589283|NCT00101452|323959375|FG001|Overall Study|Physician Decision|3|||
94589284|NCT00101452|323959376|FG002|Overall Study|Physician Decision|2|||
94589285|NCT00101452|323959374|FG000|Overall Study|Protocol Violation|2|||
94589286|NCT00101452|323959375|FG001|Overall Study|Protocol Violation|1|||
94589287|NCT00101452|323959376|FG002|Overall Study|Protocol Violation|3|||
94589288|NCT00101452|323959374|FG000|Overall Study|Other|15|||
94589289|NCT00101452|323959375|FG001|Overall Study|Other|16|||
94589290|NCT00101452|323959376|FG002|Overall Study|Other|12|||
94589291|NCT00335764|323959377|FG000|Overall Study|wrong histology|1|||
94589292|NCT00335764|323959378|FG001|Overall Study|wrong histology|0|||
94589293|NCT00335764|323959379|FG002|Overall Study|wrong histology|0|||
94589294|NCT00335764|323959380|FG003|Overall Study|wrong histology|0|||
94589295|NCT00335764|323959381|FG004|Overall Study|wrong histology|1|||
94589296|NCT00499590|323959382|FG000|Overall Study|Study Terminated|112|||
94589297|NCT00499590|323959383|FG001|Overall Study|Study Terminated|112|||
94243396|NCT03752970|322684494|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
94243397|NCT03752970|322684492|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
94243398|NCT03752970|322684493|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
94243399|NCT03752970|322684494|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
94243400|NCT03752970|322684492|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
94243401|NCT03752970|322684493|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
94243402|NCT03752970|322684494|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
94243403|NCT01137578|322684495|FG000|Overall Study|Participant requested to Discontinue|3|||
94243404|NCT01137578|322684496|FG001|Overall Study|Participant requested to Discontinue|0|||
94243405|NCT01137578|322684497|FG002|Overall Study|Participant requested to Discontinue|0|||
94243406|NCT01137578|322684495|FG000|Overall Study|Withdrawal by Subject|1|||
94243407|NCT01137578|322684496|FG001|Overall Study|Withdrawal by Subject|0|||
94243408|NCT01137578|322684497|FG002|Overall Study|Withdrawal by Subject|0|||
94243409|NCT01137578|322684495|FG000|Overall Study|Other|12|||
94243410|NCT01137578|322684496|FG001|Overall Study|Other|2|||
94243411|NCT01137578|322684497|FG002|Overall Study|Other|6|||
94243412|NCT01696045|322684498|FG000|Overall Study|Study drug toxicity|1|||
94243413|NCT01696045|322684499|FG001|Overall Study|Study drug toxicity|5|||
94243414|NCT01696045|322684498|FG000|Overall Study|Disease progression|2|||
94243415|NCT01696045|322684499|FG001|Overall Study|Disease progression|2|||
94243416|NCT00886795|322684502|FG000|Overall Study|Lack of Efficacy|1|||
94243417|NCT03449901|322684503|FG000|Overall Study|Progression|57|||
94243418|NCT03449901|322684504|FG001|Overall Study|Progression|12|||
94243419|NCT03449901|322684503|FG000|Overall Study|Adverse Event|3|||
94243420|NCT03449901|322684504|FG001|Overall Study|Adverse Event|0|||
94243421|NCT03449901|322684503|FG000|Overall Study|Death|6|||
94243422|NCT03449901|322684504|FG001|Overall Study|Death|2|||
94243423|NCT03449901|322684503|FG000|Overall Study|Withdrawal by Subject|12|||
94243424|NCT03449901|322684504|FG001|Overall Study|Withdrawal by Subject|1|||
94243425|NCT03449901|322684503|FG000|Overall Study|Physician Decision|1|||
94243426|NCT03449901|322684504|FG001|Overall Study|Physician Decision|0|||
94243427|NCT03449901|322684503|FG000|Overall Study|Patient elected for surgical intervention|1|||
94243428|NCT03449901|322684504|FG001|Overall Study|Patient elected for surgical intervention|0|||
94243429|NCT03449901|322684503|FG000|Overall Study|Patient off for other complicating disease|1|||
94243430|NCT03449901|322684504|FG001|Overall Study|Patient off for other complicating disease|0|||
94243431|NCT00743431|322684508|FG000|Overall Study|Toxicity|6|||
94243432|NCT00743431|322684508|FG000|Overall Study|Tumor progression|56|||
94243433|NCT00743431|322684508|FG000|Overall Study|Withdrawal by Subject|13|||
94243434|NCT00743431|322684508|FG000|Overall Study|Death|9|||
94243435|NCT00743431|322684508|FG000|Overall Study|Reason for discontinuation not specified|29|||
94243436|NCT00743431|322684508|FG000|Overall Study|No documentation available|13|||
94243437|NCT02628028|322684514|FG000|Dosing Period|Withdrawal by Subject|0|||
94243438|NCT02628028|322684515|FG001|Dosing Period|Withdrawal by Subject|0|||
94243439|NCT02628028|322684516|FG002|Dosing Period|Withdrawal by Subject|1|||
94243440|NCT02628028|322684517|FG003|Dosing Period|Withdrawal by Subject|0|||
94243441|NCT02628028|322684518|FG004|Dosing Period|Withdrawal by Subject|2|||
94243442|NCT02628028|322684519|FG005|Dosing Period|Withdrawal by Subject|4|||
94243443|NCT02628028|322684520|FG006|Dosing Period|Withdrawal by Subject|1|||
94243444|NCT02628028|322684521|FG007|Dosing Period|Withdrawal by Subject|1|||
94243445|NCT02628028|322684514|FG000|Dosing Period|Adverse Event|0|||
94589298|NCT00499590|323959384|FG002|Overall Study|Study Terminated|112|||
94589299|NCT00499590|323959382|FG000|Overall Study|Not treated|1|||
94243446|NCT02628028|322684515|FG001|Dosing Period|Adverse Event|0|||
94243447|NCT02628028|322684516|FG002|Dosing Period|Adverse Event|0|||
94243448|NCT02628028|322684517|FG003|Dosing Period|Adverse Event|0|||
94589300|NCT00499590|323959383|FG001|Overall Study|Not treated|0|||
94589301|NCT00499590|323959384|FG002|Overall Study|Not treated|1|||
94589302|NCT01057589|323959385|FG000|Overall Study|Disease Progression|35|||
94589303|NCT01057589|323959385|FG000|Overall Study|Adverse Event|10|||
94589304|NCT01057589|323959385|FG000|Overall Study|Physician Decision|8|||
94659623|NCT00403546|324208064|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
94659624|NCT00403546|324208062|FG000|Screening Phase|Screening Failure|22|||
94659625|NCT00403546|324208063|FG001|Screening Phase|Screening Failure|0|||
94659626|NCT00403546|324208064|FG002|Screening Phase|Screening Failure|0|||
94659627|NCT00403546|324208062|FG000|Screening Phase|Adverse Event|1|||
94659628|NCT00403546|324208063|FG001|Screening Phase|Adverse Event|0|||
94659629|NCT00403546|324208064|FG002|Screening Phase|Adverse Event|0|||
94659630|NCT00403546|324208062|FG000|Screening Phase|Terminated Prior to Randomization|5|||
94659631|NCT00403546|324208063|FG001|Screening Phase|Terminated Prior to Randomization|0|||
94659632|NCT00403546|324208064|FG002|Screening Phase|Terminated Prior to Randomization|0|||
94659633|NCT00403546|324208062|FG000|Randomized Trial|Early Terminations|0|||
94659634|NCT00403546|324208063|FG001|Randomized Trial|Early Terminations|17|||
94659635|NCT00403546|324208064|FG002|Randomized Trial|Early Terminations|16|||
94659636|NCT00793910|324208065|FG000|Overall Study|discarded study pills|0|||
94659637|NCT00793910|324208066|FG001|Overall Study|discarded study pills|1|||
94659638|NCT00793910|324208065|FG000|Overall Study|did not pick up medications|1|||
94659639|NCT00793910|324208066|FG001|Overall Study|did not pick up medications|1|||
94659640|NCT00793910|324208065|FG000|Overall Study|ineligible based on entry criteria|2|||
94659641|NCT00793910|324208066|FG001|Overall Study|ineligible based on entry criteria|3|||
94659642|NCT00793910|324208065|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
94659643|NCT00793910|324208066|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
94659644|NCT00793910|324208065|FG000|Overall Study|Withdrawal by Subject|0|||
94659645|NCT00793910|324208066|FG001|Overall Study|Withdrawal by Subject|1|||
94659646|NCT01700946|324208067|FG000|Overall Study|Lost to Follow-up|1|||
94659647|NCT01700946|324208068|FG001|Overall Study|Lost to Follow-up|0|||
94659648|NCT01700946|324208067|FG000|Overall Study|Physician Decision|7|||
94659649|NCT01700946|324208068|FG001|Overall Study|Physician Decision|12|||
94659650|NCT01700946|324208067|FG000|Overall Study|Withdrawal by Subject|0|||
94659651|NCT01700946|324208068|FG001|Overall Study|Withdrawal by Subject|2|||
94659652|NCT01700946|324208067|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
94659653|NCT01700946|324208068|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
94659654|NCT01700946|324208067|FG000|Overall Study|Relapse|2|||
94659655|NCT01700946|324208068|FG001|Overall Study|Relapse|1|||
94659656|NCT01700946|324208067|FG000|Overall Study|Unacceptable toxicity|1|||
94659657|NCT01700946|324208068|FG001|Overall Study|Unacceptable toxicity|0|||
94243449|NCT02628028|322684518|FG004|Dosing Period|Adverse Event|2|||
94243450|NCT02628028|322684519|FG005|Dosing Period|Adverse Event|1|||
94243451|NCT02628028|322684520|FG006|Dosing Period|Adverse Event|3|||
94243452|NCT02628028|322684521|FG007|Dosing Period|Adverse Event|2|||
94659658|NCT04389840|324208074|FG000|Overall Study|Adverse Event|0|||
94659659|NCT04389840|324208075|FG001|Overall Study|Adverse Event|0|||
94659660|NCT04389840|324208076|FG002|Overall Study|Adverse Event|0|||
94659661|NCT04389840|324208077|FG003|Overall Study|Adverse Event|1|||
94659662|NCT04389840|324208078|FG004|Overall Study|Adverse Event|0|||
94659663|NCT04389840|324208079|FG005|Overall Study|Adverse Event|0|||
94659664|NCT04389840|324208074|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
94659665|NCT04389840|324208075|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
94659666|NCT04389840|324208076|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
94659667|NCT04389840|324208077|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
94659668|NCT04389840|324208078|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
94659669|NCT04389840|324208079|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
94659670|NCT04389840|324208074|FG000|Overall Study|Death|0|||
94659671|NCT04389840|324208075|FG001|Overall Study|Death|1|||
94659672|NCT04389840|324208076|FG002|Overall Study|Death|0|||
94243453|NCT02628028|322684514|FG000|Dosing Period|Death|0|||
94243454|NCT02628028|322684515|FG001|Dosing Period|Death|0|||
94243455|NCT02628028|322684516|FG002|Dosing Period|Death|0|||
94243456|NCT02628028|322684517|FG003|Dosing Period|Death|0|||
94243457|NCT02628028|322684518|FG004|Dosing Period|Death|0|||
94243458|NCT02628028|322684519|FG005|Dosing Period|Death|0|||
94659673|NCT04389840|324208077|FG003|Overall Study|Death|0|||
94659674|NCT04389840|324208078|FG004|Overall Study|Death|0|||
94659675|NCT04389840|324208079|FG005|Overall Study|Death|0|||
94243459|NCT02628028|322684520|FG006|Dosing Period|Death|0|||
94659676|NCT05799495|324208089|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
94659677|NCT05799495|324208090|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
94243460|NCT02628028|322684521|FG007|Dosing Period|Death|1|||
94243461|NCT02628028|322684514|FG000|Dosing Period|Lack of Efficacy|0|||
94243462|NCT02628028|322684515|FG001|Dosing Period|Lack of Efficacy|0|||
94659678|NCT05799495|324208091|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
94659679|NCT05799495|324208092|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
94659680|NCT05799495|324208089|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
94243463|NCT02628028|322684516|FG002|Dosing Period|Lack of Efficacy|0|||
94243464|NCT02628028|322684517|FG003|Dosing Period|Lack of Efficacy|0|||
94243465|NCT02628028|322684518|FG004|Dosing Period|Lack of Efficacy|3|||
94243466|NCT02628028|322684519|FG005|Dosing Period|Lack of Efficacy|0|||
94589305|NCT01057589|323959385|FG000|Overall Study|Withdrawal by Subject|3|||
94589306|NCT01057589|323959385|FG000|Overall Study|Sponsor Decision|1|||
94589307|NCT01057589|323959385|FG000|Overall Study|Death|8|||
94589308|NCT01057589|323959385|FG000|Overall Study|Lost to Follow-up|1|||
94589309|NCT00853567|323959388|FG000|Overall Study|Study prematurely terminated|71|||
94589310|NCT00782834|323959389|FG000|Treatment Phase|fibrous tumor not GIST|1|||
94589311|NCT02055118|323959390|FG000|Overall Study|Withdrawal by Subject|0|||
94589312|NCT02055118|323959391|FG001|Overall Study|Withdrawal by Subject|2|||
94589313|NCT02055118|323959392|FG002|Overall Study|Withdrawal by Subject|0|||
94589314|NCT04629066|323959393|FG000|Overall Study|Lost to Follow-up|3|||
94589315|NCT04629066|323959394|FG001|Overall Study|Lost to Follow-up|2|||
94589316|NCT02745080|323959402|FG000|Overall Study|Adverse Event|13|||
94589317|NCT02745080|323959403|FG001|Overall Study|Adverse Event|21|||
94243467|NCT02628028|322684520|FG006|Dosing Period|Lack of Efficacy|1|||
94243468|NCT02628028|322684521|FG007|Dosing Period|Lack of Efficacy|0|||
94243469|NCT02628028|322684514|FG000|Dosing Period|Study Terminated by Sponsor|0|||
94659681|NCT05799495|324208090|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
94659682|NCT05799495|324208091|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
94659683|NCT05799495|324208092|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
94659684|NCT05799495|324208089|FG000|Treatment (Up to 5 Days)|Other|0|||
94659685|NCT05799495|324208090|FG001|Treatment (Up to 5 Days)|Other|1|||
94659686|NCT05799495|324208091|FG002|Treatment (Up to 5 Days)|Other|0|||
94659687|NCT05799495|324208092|FG003|Treatment (Up to 5 Days)|Other|0|||
94659688|NCT05799495|324208089|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
94659689|NCT05799495|324208090|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
94659690|NCT05799495|324208091|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
94659691|NCT05799495|324208092|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
94659692|NCT05799495|324208089|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
94659693|NCT05799495|324208090|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
94659694|NCT05799495|324208091|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
94659695|NCT05799495|324208092|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
94659696|NCT05799495|324208089|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
94659697|NCT05799495|324208090|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
94659698|NCT05799495|324208091|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
94659699|NCT05799495|324208092|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
94659700|NCT03694548|324208093|FG000|Part A Survey|Protocol Violation|3|||
94659701|NCT03694548|324208094|FG001|Part A Survey|Protocol Violation|3|||
94659702|NCT03694548|324208095|FG002|Part A Survey|Protocol Violation|0|||
94659703|NCT03694548|324208093|FG000|Part B Yoga Program|Protocol Violation|0|||
94659704|NCT03694548|324208094|FG001|Part B Yoga Program|Protocol Violation|0|||
94659705|NCT03694548|324208095|FG002|Part B Yoga Program|Protocol Violation|3|||
94659706|NCT03694548|324208093|FG000|Part B Yoga Program|Did not attend intervention|0|||
94659707|NCT03694548|324208094|FG001|Part B Yoga Program|Did not attend intervention|0|||
94659708|NCT03694548|324208095|FG002|Part B Yoga Program|Did not attend intervention|8|||
94659709|NCT03351049|324208096|FG000|Overall Study|Withdrawal|26|||
94659710|NCT03351049|324208097|FG001|Overall Study|Withdrawal|22|||
94659711|NCT05070897|324208113|FG000|Overall Study|Protocol Violation|123|||
94659712|NCT05070897|324208114|FG001|Overall Study|Protocol Violation|68|||
94659713|NCT02239510|324209932|FG000|Overall Study|Lost to Follow-up|2|||
94659714|NCT02239510|324209933|FG001|Overall Study|Lost to Follow-up|1|||
94659715|NCT00464542|324209936|FG000|Pre-treatment|Withdrawal by Subject|2|||
94659716|NCT01773226|324209937|FG000|Overall Study|Withdrawal by Subject|1|||
94659717|NCT01404312|324209939|FG000|Overall Study|Death|21|||
94659718|NCT01404312|324209940|FG001|Overall Study|Death|27|||
94659719|NCT01404312|324209939|FG000|Overall Study|Withdrawal by Subject|15|||
94659720|NCT01404312|324209940|FG001|Overall Study|Withdrawal by Subject|18|||
94659721|NCT01404312|324209939|FG000|Overall Study|Participant Unable to get to clinic|93|||
94659722|NCT01404312|324209940|FG001|Overall Study|Participant Unable to get to clinic|103|||
94659723|NCT01404312|324209939|FG000|Overall Study|Lost to Follow-up|115|||
94659724|NCT01404312|324209940|FG001|Overall Study|Lost to Follow-up|111|||
94659725|NCT01404312|324209939|FG000|Overall Study|Site closed|22|||
94659726|NCT01404312|324209940|FG001|Overall Study|Site closed|21|||
94659727|NCT01404312|324209939|FG000|Overall Study|Participant not willing to adhere to req|31|||
94659728|NCT01404312|324209940|FG001|Overall Study|Participant not willing to adhere to req|29|||
94659729|NCT01404312|324209939|FG000|Overall Study|Severe debilitation, unable to continue|1|||
94659730|NCT01404312|324209940|FG001|Overall Study|Severe debilitation, unable to continue|2|||
94659731|NCT04419493|324209941|FG000|Wash-out After Period 1|Adverse Event|1|||
94659732|NCT04419493|324209942|FG001|Wash-out After Period 1|Adverse Event|2|||
94243470|NCT02628028|322684515|FG001|Dosing Period|Study Terminated by Sponsor|0|||
94243471|NCT02628028|322684516|FG002|Dosing Period|Study Terminated by Sponsor|0|||
94243472|NCT02628028|322684517|FG003|Dosing Period|Study Terminated by Sponsor|0|||
94243473|NCT02628028|322684518|FG004|Dosing Period|Study Terminated by Sponsor|7|||
94243474|NCT02628028|322684519|FG005|Dosing Period|Study Terminated by Sponsor|6|||
94659733|NCT04419493|324209943|FG002|Wash-out After Period 1|Adverse Event|1|||
94659734|NCT04419493|324209944|FG003|Wash-out After Period 1|Adverse Event|0|||
94659735|NCT01045447|324209947|FG000|Overall Study|Adverse Event|0|||
94659736|NCT01045447|324209948|FG001|Overall Study|Adverse Event|1|||
94659737|NCT01045447|324209947|FG000|Overall Study|Lack of Efficacy|3|||
94659738|NCT01045447|324209948|FG001|Overall Study|Lack of Efficacy|1|||
94659739|NCT01045447|324209947|FG000|Overall Study|Protocol Violation|6|||
94659740|NCT01045447|324209948|FG001|Overall Study|Protocol Violation|3|||
94243475|NCT02628028|322684520|FG006|Dosing Period|Study Terminated by Sponsor|7|||
94659741|NCT01045447|324209947|FG000|Overall Study|Withdrawal Criteria|10|||
94659742|NCT01045447|324209948|FG001|Overall Study|Withdrawal Criteria|10|||
94659743|NCT01045447|324209947|FG000|Overall Study|Unclassified|17|||
94659744|NCT01045447|324209948|FG001|Overall Study|Unclassified|13|||
94659745|NCT00993447|324209949|FG000|Overall Study|Withdrawal by Subject|23|||
94659746|NCT00993447|324209950|FG001|Overall Study|Withdrawal by Subject|8|||
94659747|NCT00993447|324209949|FG000|Overall Study|Protocol Violation|12|||
94589318|NCT02745080|323959402|FG000|Overall Study|Lack of Efficacy|11|||
94589319|NCT02745080|323959403|FG001|Overall Study|Lack of Efficacy|23|||
94589320|NCT02745080|323959402|FG000|Overall Study|Lost to Follow-up|3|||
94589321|NCT02745080|323959403|FG001|Overall Study|Lost to Follow-up|3|||
94589322|NCT02745080|323959402|FG000|Overall Study|Physician Decision|3|||
94589323|NCT02745080|323959403|FG001|Overall Study|Physician Decision|0|||
94589324|NCT02745080|323959402|FG000|Overall Study|Protocol Violation|3|||
94589325|NCT02745080|323959403|FG001|Overall Study|Protocol Violation|1|||
94589326|NCT02745080|323959402|FG000|Overall Study|Withdrawal by Subject|22|||
94589327|NCT02745080|323959403|FG001|Overall Study|Withdrawal by Subject|41|||
94589328|NCT00715910|323959404|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
94589329|NCT00715910|323959405|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
94589330|NCT00715910|323959406|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
94589331|NCT00715910|323959407|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
94589332|NCT00715910|323959408|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
94589333|NCT00715910|323959409|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
94589334|NCT00715910|323959404|FG000|Booster and ESFU Phase|Other|0|||
94589335|NCT00715910|323959405|FG001|Booster and ESFU Phase|Other|0|||
94589336|NCT00715910|323959406|FG002|Booster and ESFU Phase|Other|0|||
94589337|NCT00715910|323959407|FG003|Booster and ESFU Phase|Other|5|||
94589338|NCT00715910|323959408|FG004|Booster and ESFU Phase|Other|1|||
94589339|NCT00715910|323959409|FG005|Booster and ESFU Phase|Other|0|||
94589340|NCT00282308|323959410|FG000|Treatment Period|Lost to Follow-up|1|||
94659748|NCT00993447|324209950|FG001|Overall Study|Protocol Violation|8|||
94243476|NCT02628028|322684521|FG007|Dosing Period|Study Terminated by Sponsor|7|||
94243477|NCT02628028|322684514|FG000|Dosing Period|Physician Decision|0|||
94589341|NCT00282308|323959411|FG001|Treatment Period|Lost to Follow-up|0|||
94589342|NCT00282308|323959412|FG002|Treatment Period|Lost to Follow-up|0|||
94589343|NCT00282308|323959410|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
94589344|NCT00282308|323959411|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
94589345|NCT00282308|323959412|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
94589346|NCT00282308|323959410|FG000|Treatment Period|Adverse Event|0|||
94589347|NCT00282308|323959411|FG001|Treatment Period|Adverse Event|2|||
94589348|NCT00282308|323959412|FG002|Treatment Period|Adverse Event|0|||
94589349|NCT00282308|323959410|FG000|Treatment Period|Not Treated with Study Drug|1|||
94589350|NCT00282308|323959411|FG001|Treatment Period|Not Treated with Study Drug|0|||
94589351|NCT00282308|323959412|FG002|Treatment Period|Not Treated with Study Drug|0|||
94589352|NCT00282308|323959410|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
94589353|NCT00282308|323959411|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
94589354|NCT00282308|323959412|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
94589355|NCT00282308|323959410|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
94589356|NCT00282308|323959411|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
94589357|NCT00282308|323959412|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
94589358|NCT00282308|323959410|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
94589359|NCT00282308|323959411|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
94589360|NCT00282308|323959412|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
94243478|NCT02628028|322684515|FG001|Dosing Period|Physician Decision|0|||
94243479|NCT02628028|322684516|FG002|Dosing Period|Physician Decision|0|||
94243480|NCT02628028|322684517|FG003|Dosing Period|Physician Decision|0|||
94589361|NCT00282308|323959410|FG000|Safety Follow-up Period|Adverse Event|0|||
94589362|NCT00282308|323959411|FG001|Safety Follow-up Period|Adverse Event|0|||
94589363|NCT00282308|323959412|FG002|Safety Follow-up Period|Adverse Event|1|||
94589364|NCT00282308|323959410|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
94589365|NCT00282308|323959411|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
94589366|NCT00282308|323959412|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
94589367|NCT00282308|323959410|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
94589368|NCT00282308|323959411|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
94589369|NCT00282308|323959412|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
94589370|NCT00282308|323959410|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
94589371|NCT00282308|323959411|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
94589372|NCT00282308|323959412|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
94589373|NCT00661427|323959413|FG000|Overall Study|Adverse Event|5|||
94589374|NCT00661427|323959414|FG001|Overall Study|Adverse Event|5|||
94589375|NCT00661427|323959413|FG000|Overall Study|Patient not treated|0|||
94589376|NCT00661427|323959414|FG001|Overall Study|Patient not treated|2|||
94589377|NCT01821560|323959415|FG000|Overall Study|Lost to Follow-up|5|||
94589378|NCT01821560|323959416|FG001|Overall Study|Lost to Follow-up|5|||
94589379|NCT01821560|323959415|FG000|Overall Study|Withdrawal by Subject|1|||
94589380|NCT01821560|323959416|FG001|Overall Study|Withdrawal by Subject|1|||
94589381|NCT01821560|323959415|FG000|Overall Study|Protocol Violation|0|||
94589382|NCT01821560|323959416|FG001|Overall Study|Protocol Violation|1|||
94589383|NCT00531427|323959419|FG000|Overall Study|Withdrawal by Subject|7|||
94589384|NCT00531427|323959420|FG001|Overall Study|Withdrawal by Subject|13|||
94589385|NCT00531427|323959419|FG000|Overall Study|Adverse Event|44|||
94589386|NCT00531427|323959420|FG001|Overall Study|Adverse Event|30|||
94589387|NCT00531427|323959419|FG000|Overall Study|Lost to Follow-up|4|||
94589388|NCT00531427|323959420|FG001|Overall Study|Lost to Follow-up|3|||
94589389|NCT00531427|323959419|FG000|Overall Study|Lack of Efficacy|14|||
94589390|NCT00531427|323959420|FG001|Overall Study|Lack of Efficacy|39|||
94589391|NCT00531427|323959419|FG000|Overall Study|Administrative|4|||
94589392|NCT00531427|323959420|FG001|Overall Study|Administrative|9|||
94589393|NCT00530504|323959421|FG000|Overall Study|Death|54|||
94589394|NCT00530504|323959421|FG000|Overall Study|Lost to Follow-up|26|||
94589395|NCT00530504|323959421|FG000|Overall Study|Withdrawal by Subject|39|||
94589396|NCT00530504|323959421|FG000|Overall Study|Exited study due to other reasons|33|||
94589397|NCT00006289|323959422|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
94589398|NCT00006289|323959423|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
94243481|NCT02628028|322684518|FG004|Dosing Period|Physician Decision|0|||
94589399|NCT00006289|323959422|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
94589400|NCT00006289|323959423|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
94589401|NCT04359901|323959427|FG000|Overall Study|Withdrawal by Subject|0|||
94589402|NCT04359901|323959428|FG001|Overall Study|Withdrawal by Subject|1|||
94589403|NCT04359901|323959427|FG000|Overall Study|Death|6|||
94659749|NCT00993447|324209949|FG000|Overall Study|Lost to Follow-up|1|||
94659750|NCT00993447|324209950|FG001|Overall Study|Lost to Follow-up|3|||
94589404|NCT04359901|323959428|FG001|Overall Study|Death|2|||
94243482|NCT02628028|322684519|FG005|Dosing Period|Physician Decision|1|||
94589405|NCT03304249|323959431|FG000|Overall Study|Lost to Follow-up|8|||
94589406|NCT03304249|323959432|FG001|Overall Study|Lost to Follow-up|10|||
94589407|NCT03304249|323959431|FG000|Overall Study|Withdrawal by Subject|12|||
94589408|NCT03304249|323959432|FG001|Overall Study|Withdrawal by Subject|2|||
94589409|NCT03304249|323959431|FG000|Overall Study|Moved Out of District|4|||
94589410|NCT03304249|323959432|FG001|Overall Study|Moved Out of District|2|||
94589411|NCT01675167|323959433|FG000|Open-label Titration Phase|Adverse Event|81|||
94589412|NCT01675167|323959434|FG001|Open-label Titration Phase|Adverse Event|0|||
94589413|NCT01675167|323959435|FG002|Open-label Titration Phase|Adverse Event|0|||
94589414|NCT01675167|323959433|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
94589415|NCT01675167|323959434|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
94589416|NCT01675167|323959435|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
94589417|NCT01675167|323959433|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
94589418|NCT01675167|323959434|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
94589419|NCT01675167|323959435|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
94589420|NCT01675167|323959433|FG000|Open-label Titration Phase|Protocol Violation|43|||
94589421|NCT01675167|323959434|FG001|Open-label Titration Phase|Protocol Violation|0|||
94589422|NCT01675167|323959435|FG002|Open-label Titration Phase|Protocol Violation|0|||
94589423|NCT01675167|323959433|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
94589424|NCT01675167|323959434|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
94589425|NCT01675167|323959435|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
94589426|NCT01675167|323959433|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
94589427|NCT01675167|323959434|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
94589428|NCT01675167|323959435|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
94589429|NCT01675167|323959433|FG000|Open-label Titration Phase|Other|55|||
94589430|NCT01675167|323959434|FG001|Open-label Titration Phase|Other|0|||
94589431|NCT01675167|323959435|FG002|Open-label Titration Phase|Other|0|||
94589432|NCT01675167|323959433|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
94589433|NCT01675167|323959434|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
94589434|NCT01675167|323959435|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
94589435|NCT01675167|323959433|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
94589436|NCT01675167|323959434|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
94589437|NCT01675167|323959435|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
94589438|NCT01675167|323959433|FG000|Double-blind Treatment Phase|Adverse Event|0|||
94589439|NCT01675167|323959434|FG001|Double-blind Treatment Phase|Adverse Event|5|||
94589440|NCT01675167|323959435|FG002|Double-blind Treatment Phase|Adverse Event|13|||
94589441|NCT01675167|323959433|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
94589442|NCT01675167|323959434|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
94589443|NCT01675167|323959435|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
94243483|NCT02628028|322684520|FG006|Dosing Period|Physician Decision|0|||
94243484|NCT02628028|322684521|FG007|Dosing Period|Physician Decision|0|||
94243485|NCT02628028|322684514|FG000|Dosing Period|Site Terminated by Sponsor|0|||
94589444|NCT01675167|323959433|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
94589445|NCT01675167|323959434|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
94589446|NCT01675167|323959435|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
94589447|NCT01675167|323959433|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
94243486|NCT02628028|322684515|FG001|Dosing Period|Site Terminated by Sponsor|0|||
94243487|NCT02628028|322684516|FG002|Dosing Period|Site Terminated by Sponsor|0|||
94589448|NCT01675167|323959434|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
94589449|NCT01675167|323959435|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
94589450|NCT01675167|323959433|FG000|Double-blind Treatment Phase|Other|0|||
94243488|NCT02628028|322684517|FG003|Dosing Period|Site Terminated by Sponsor|0|||
94243489|NCT02628028|322684518|FG004|Dosing Period|Site Terminated by Sponsor|0|||
94243490|NCT02628028|322684519|FG005|Dosing Period|Site Terminated by Sponsor|1|||
94243491|NCT02628028|322684520|FG006|Dosing Period|Site Terminated by Sponsor|1|||
94243492|NCT02628028|322684521|FG007|Dosing Period|Site Terminated by Sponsor|0|||
94243493|NCT02628028|322684514|FG000|Dosing Period|Lost to Follow-up|0|||
94243494|NCT02628028|322684515|FG001|Dosing Period|Lost to Follow-up|0|||
94243495|NCT02628028|322684516|FG002|Dosing Period|Lost to Follow-up|0|||
94243496|NCT02628028|322684517|FG003|Dosing Period|Lost to Follow-up|0|||
94243497|NCT02628028|322684518|FG004|Dosing Period|Lost to Follow-up|0|||
94243498|NCT02628028|322684519|FG005|Dosing Period|Lost to Follow-up|0|||
94243499|NCT02628028|322684520|FG006|Dosing Period|Lost to Follow-up|1|||
94243500|NCT02628028|322684521|FG007|Dosing Period|Lost to Follow-up|0|||
94243501|NCT02628028|322684514|FG000|Dosing Period|Other|0|||
94243502|NCT02628028|322684515|FG001|Dosing Period|Other|0|||
94243503|NCT02628028|322684516|FG002|Dosing Period|Other|0|||
94243504|NCT02628028|322684517|FG003|Dosing Period|Other|0|||
94243505|NCT02628028|322684518|FG004|Dosing Period|Other|2|||
94243506|NCT02628028|322684519|FG005|Dosing Period|Other|1|||
94243507|NCT02628028|322684520|FG006|Dosing Period|Other|2|||
94243508|NCT02628028|322684521|FG007|Dosing Period|Other|4|||
94243509|NCT02628028|322684514|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
94243510|NCT02628028|322684515|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
94243511|NCT02628028|322684516|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
94243512|NCT02628028|322684517|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
94243513|NCT02628028|322684518|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
94243514|NCT02628028|322684519|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
94243515|NCT02628028|322684520|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
94243516|NCT02628028|322684521|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
94243517|NCT02628028|322684514|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
94243518|NCT02628028|322684515|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
94243519|NCT02628028|322684516|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
94243520|NCT02628028|322684517|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
94243521|NCT02628028|322684518|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
94243522|NCT02628028|322684519|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
94243523|NCT02628028|322684520|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
94243524|NCT02628028|322684521|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
94243525|NCT02628028|322684514|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
94243526|NCT02628028|322684515|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
94243527|NCT02628028|322684516|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
94243528|NCT02628028|322684517|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
94243529|NCT02628028|322684518|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
94243530|NCT02628028|322684519|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
94243531|NCT02628028|322684520|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
94243532|NCT02628028|322684521|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
94243533|NCT02628028|322684514|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
94243534|NCT02628028|322684515|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
94243535|NCT02628028|322684516|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
94243536|NCT02628028|322684517|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
94243537|NCT02628028|322684518|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
94243538|NCT02628028|322684519|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
94243539|NCT02628028|322684520|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
94243540|NCT02628028|322684521|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
94243541|NCT02628028|322684514|FG000|Long-term Extension (LTE) Period|Other|0|||
94243542|NCT02628028|322684515|FG001|Long-term Extension (LTE) Period|Other|0|||
94243543|NCT02628028|322684516|FG002|Long-term Extension (LTE) Period|Other|0|||
94243544|NCT02628028|322684517|FG003|Long-term Extension (LTE) Period|Other|0|||
94243545|NCT02628028|322684518|FG004|Long-term Extension (LTE) Period|Other|0|||
94243546|NCT02628028|322684519|FG005|Long-term Extension (LTE) Period|Other|3|||
94243547|NCT02628028|322684520|FG006|Long-term Extension (LTE) Period|Other|4|||
94243548|NCT02628028|322684521|FG007|Long-term Extension (LTE) Period|Other|3|||
94243549|NCT00623805|322684522|FG000|Overall Study|Adverse Event|9|||
94243550|NCT00623805|322684523|FG001|Overall Study|Adverse Event|6|||
94243551|NCT00623805|322684522|FG000|Overall Study|Death|2|||
94243552|NCT00623805|322684523|FG001|Overall Study|Death|0|||
94243553|NCT00623805|322684522|FG000|Overall Study|Lack of Efficacy|3|||
94243554|NCT00623805|322684523|FG001|Overall Study|Lack of Efficacy|7|||
94243555|NCT00623805|322684522|FG000|Overall Study|Lost to Follow-up|2|||
94354460|NCT02681094|323080245|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
94354461|NCT02681094|323080243|FG000|1 -Modified Enrolled Participants Set|Other|6|||
94354462|NCT02681094|323080244|FG001|1 -Modified Enrolled Participants Set|Other|6|||
94354463|NCT02681094|323080245|FG002|1 -Modified Enrolled Participants Set|Other|7|||
94354464|NCT02681094|323080243|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
94354465|NCT02681094|323080244|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
94354466|NCT02681094|323080245|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
94354467|NCT02681094|323080243|FG000|2 - Enrolled Participants Set|Participant decision|7|||
94354468|NCT02681094|323080244|FG001|2 - Enrolled Participants Set|Participant decision|10|||
94354469|NCT02681094|323080245|FG002|2 - Enrolled Participants Set|Participant decision|9|||
94354470|NCT02681094|323080243|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
94354471|NCT02681094|323080244|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
94354472|NCT02681094|323080245|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
94354473|NCT02681094|323080243|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
94456099|NCT02244463|323458202|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
94456100|NCT02244463|323458197|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
94456101|NCT02244463|323458198|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
94243556|NCT00623805|322684523|FG001|Overall Study|Lost to Follow-up|2|||
94243557|NCT00623805|322684522|FG000|Overall Study|Protocol Violation|1|||
94243558|NCT00623805|322684523|FG001|Overall Study|Protocol Violation|1|||
94243559|NCT00623805|322684522|FG000|Overall Study|Reason not Specified|3|||
94243560|NCT00623805|322684523|FG001|Overall Study|Reason not Specified|6|||
94243561|NCT05543707|322684525|FG000|Overall Study|Study drug non-compliance/|5|||
94243562|NCT05543707|322684526|FG001|Overall Study|Study drug non-compliance/|0|||
94243563|NCT05543707|322684525|FG000|Overall Study|Withdrawal by Subject|1|||
94243564|NCT05543707|322684526|FG001|Overall Study|Withdrawal by Subject|1|||
94243565|NCT05543707|322684525|FG000|Overall Study|Adverse Event|1|||
94243566|NCT05543707|322684526|FG001|Overall Study|Adverse Event|0|||
94243567|NCT05543707|322684525|FG000|Overall Study|concurrent illness|0|||
94243568|NCT05543707|322684526|FG001|Overall Study|concurrent illness|1|||
94243569|NCT05543707|322684525|FG000|Overall Study|Pregnancy|1|||
94243570|NCT05543707|322684526|FG001|Overall Study|Pregnancy|1|||
94243571|NCT01241604|322684527|FG000|Screening Period|Screen Failure|3|||
94243572|NCT01241604|322684528|FG001|Screening Period|Screen Failure|0|||
94243573|NCT01241604|322684529|FG002|Screening Period|Screen Failure|0|||
94243574|NCT01133418|322684530|FG000|Overall Study|Lost to Follow-up|5|||
94243575|NCT01133418|322684531|FG001|Overall Study|Lost to Follow-up|6|||
94243576|NCT03345576|322684533|FG000|Overall Study|Withdrawal by Subject|2|||
94243577|NCT03345576|322684534|FG001|Overall Study|Withdrawal by Subject|2|||
94243578|NCT03345576|322684533|FG000|Overall Study|Adverse Event|1|||
94243579|NCT03345576|322684534|FG001|Overall Study|Adverse Event|0|||
94243580|NCT03829501|322686871|FG000|Overall Study|Withdrawal of Consent|2|||
94243581|NCT03829501|322686872|FG001|Overall Study|Withdrawal of Consent|0|||
94243582|NCT03829501|322686873|FG002|Overall Study|Withdrawal of Consent|3|||
94243583|NCT03829501|322686874|FG003|Overall Study|Withdrawal of Consent|0|||
94243584|NCT03829501|322686875|FG004|Overall Study|Withdrawal of Consent|1|||
94243585|NCT03829501|322686876|FG005|Overall Study|Withdrawal of Consent|1|||
94243586|NCT03829501|322686877|FG006|Overall Study|Withdrawal of Consent|0|||
94243587|NCT03829501|322686878|FG007|Overall Study|Withdrawal of Consent|10|||
94243588|NCT03829501|322686879|FG008|Overall Study|Withdrawal of Consent|10|||
94243589|NCT03829501|322686880|FG009|Overall Study|Withdrawal of Consent|3|||
94243590|NCT03829501|322686881|FG010|Overall Study|Withdrawal of Consent|4|||
94243591|NCT03829501|322686882|FG011|Overall Study|Withdrawal of Consent|4|||
94243592|NCT03829501|322686883|FG012|Overall Study|Withdrawal of Consent|4|||
94243593|NCT03829501|322686884|FG013|Overall Study|Withdrawal of Consent|0|||
94243594|NCT03829501|322686885|FG014|Overall Study|Withdrawal of Consent|3|||
94243595|NCT03829501|322686886|FG015|Overall Study|Withdrawal of Consent|0|||
94243596|NCT03829501|322686887|FG016|Overall Study|Withdrawal of Consent|1|||
94243597|NCT03829501|322686888|FG017|Overall Study|Withdrawal of Consent|1|||
94243598|NCT03829501|322686889|FG018|Overall Study|Withdrawal of Consent|0|||
94243599|NCT03829501|322686890|FG019|Overall Study|Withdrawal of Consent|0|||
94243600|NCT03829501|322686891|FG020|Overall Study|Withdrawal of Consent|3|||
94243601|NCT03829501|322686892|FG021|Overall Study|Withdrawal of Consent|0|||
94243602|NCT03829501|322686893|FG022|Overall Study|Withdrawal of Consent|1|||
94243603|NCT03829501|322686871|FG000|Overall Study|PD|0|||
94243604|NCT03829501|322686872|FG001|Overall Study|PD|0|||
94243605|NCT03829501|322686873|FG002|Overall Study|PD|0|||
94243606|NCT03829501|322686874|FG003|Overall Study|PD|2|||
94243607|NCT03829501|322686875|FG004|Overall Study|PD|0|||
94243608|NCT03829501|322686876|FG005|Overall Study|PD|0|||
94243609|NCT03829501|322686877|FG006|Overall Study|PD|0|||
94243610|NCT03829501|322686878|FG007|Overall Study|PD|0|||
94243611|NCT03829501|322686879|FG008|Overall Study|PD|0|||
94243612|NCT03829501|322686880|FG009|Overall Study|PD|0|||
94243613|NCT03829501|322686881|FG010|Overall Study|PD|0|||
94243614|NCT03829501|322686882|FG011|Overall Study|PD|0|||
94243615|NCT03829501|322686883|FG012|Overall Study|PD|0|||
94243616|NCT03829501|322686884|FG013|Overall Study|PD|0|||
94243617|NCT03829501|322686885|FG014|Overall Study|PD|0|||
94243618|NCT03829501|322686886|FG015|Overall Study|PD|1|||
94243619|NCT03829501|322686887|FG016|Overall Study|PD|0|||
94243620|NCT03829501|322686888|FG017|Overall Study|PD|0|||
94243621|NCT03829501|322686889|FG018|Overall Study|PD|0|||
94243622|NCT03829501|322686890|FG019|Overall Study|PD|0|||
94243623|NCT03829501|322686891|FG020|Overall Study|PD|1|||
94243624|NCT03829501|322686892|FG021|Overall Study|PD|0|||
94243625|NCT03829501|322686893|FG022|Overall Study|PD|0|||
94243626|NCT03829501|322686871|FG000|Overall Study|Study Terminated by Sponsor|0|||
94243627|NCT03829501|322686872|FG001|Overall Study|Study Terminated by Sponsor|0|||
94243628|NCT03829501|322686873|FG002|Overall Study|Study Terminated by Sponsor|0|||
94243629|NCT03829501|322686874|FG003|Overall Study|Study Terminated by Sponsor|0|||
94243630|NCT03829501|322686875|FG004|Overall Study|Study Terminated by Sponsor|0|||
94243631|NCT03829501|322686876|FG005|Overall Study|Study Terminated by Sponsor|0|||
94243632|NCT03829501|322686877|FG006|Overall Study|Study Terminated by Sponsor|0|||
94243633|NCT03829501|322686878|FG007|Overall Study|Study Terminated by Sponsor|3|||
94243634|NCT03829501|322686879|FG008|Overall Study|Study Terminated by Sponsor|1|||
94243635|NCT03829501|322686880|FG009|Overall Study|Study Terminated by Sponsor|0|||
94243636|NCT03829501|322686881|FG010|Overall Study|Study Terminated by Sponsor|0|||
94243637|NCT03829501|322686882|FG011|Overall Study|Study Terminated by Sponsor|0|||
94243638|NCT03829501|322686883|FG012|Overall Study|Study Terminated by Sponsor|0|||
94243639|NCT03829501|322686884|FG013|Overall Study|Study Terminated by Sponsor|0|||
94243640|NCT03829501|322686885|FG014|Overall Study|Study Terminated by Sponsor|3|||
94589451|NCT01675167|323959434|FG001|Double-blind Treatment Phase|Other|7|||
94589452|NCT01675167|323959435|FG002|Double-blind Treatment Phase|Other|5|||
94243641|NCT03829501|322686886|FG015|Overall Study|Study Terminated by Sponsor|2|||
94243642|NCT03829501|322686887|FG016|Overall Study|Study Terminated by Sponsor|2|||
94243643|NCT03829501|322686888|FG017|Overall Study|Study Terminated by Sponsor|0|||
94243644|NCT03829501|322686889|FG018|Overall Study|Study Terminated by Sponsor|0|||
94243645|NCT03829501|322686890|FG019|Overall Study|Study Terminated by Sponsor|0|||
94243646|NCT03829501|322686891|FG020|Overall Study|Study Terminated by Sponsor|1|||
94243647|NCT03829501|322686892|FG021|Overall Study|Study Terminated by Sponsor|0|||
94243648|NCT03829501|322686893|FG022|Overall Study|Study Terminated by Sponsor|3|||
94243649|NCT03829501|322686871|FG000|Overall Study|Lost to Follow Up|0|||
94243650|NCT03829501|322686872|FG001|Overall Study|Lost to Follow Up|0|||
94243651|NCT03829501|322686873|FG002|Overall Study|Lost to Follow Up|0|||
94243652|NCT03829501|322686874|FG003|Overall Study|Lost to Follow Up|0|||
94243653|NCT03829501|322686875|FG004|Overall Study|Lost to Follow Up|1|||
94243654|NCT03829501|322686876|FG005|Overall Study|Lost to Follow Up|0|||
94243655|NCT03829501|322686877|FG006|Overall Study|Lost to Follow Up|0|||
94243656|NCT03829501|322686878|FG007|Overall Study|Lost to Follow Up|2|||
94243657|NCT03829501|322686879|FG008|Overall Study|Lost to Follow Up|2|||
94243658|NCT03829501|322686880|FG009|Overall Study|Lost to Follow Up|0|||
94243659|NCT03829501|322686881|FG010|Overall Study|Lost to Follow Up|2|||
94243660|NCT03829501|322686882|FG011|Overall Study|Lost to Follow Up|1|||
94243661|NCT03829501|322686883|FG012|Overall Study|Lost to Follow Up|0|||
94243662|NCT03829501|322686884|FG013|Overall Study|Lost to Follow Up|1|||
94243663|NCT03829501|322686885|FG014|Overall Study|Lost to Follow Up|1|||
94243664|NCT03829501|322686886|FG015|Overall Study|Lost to Follow Up|0|||
94243665|NCT03829501|322686887|FG016|Overall Study|Lost to Follow Up|0|||
94243666|NCT03829501|322686888|FG017|Overall Study|Lost to Follow Up|0|||
94243667|NCT03829501|322686889|FG018|Overall Study|Lost to Follow Up|0|||
94243668|NCT03829501|322686890|FG019|Overall Study|Lost to Follow Up|0|||
94243669|NCT03829501|322686891|FG020|Overall Study|Lost to Follow Up|0|||
94243670|NCT03829501|322686892|FG021|Overall Study|Lost to Follow Up|0|||
94243671|NCT03829501|322686893|FG022|Overall Study|Lost to Follow Up|1|||
94243672|NCT03829501|322686871|FG000|Overall Study|Death|2|||
94243673|NCT03829501|322686872|FG001|Overall Study|Death|4|||
94243674|NCT03829501|322686873|FG002|Overall Study|Death|5|||
94243675|NCT03829501|322686874|FG003|Overall Study|Death|6|||
94243676|NCT03829501|322686875|FG004|Overall Study|Death|5|||
94243677|NCT03829501|322686876|FG005|Overall Study|Death|4|||
94243678|NCT03829501|322686877|FG006|Overall Study|Death|5|||
94243679|NCT03829501|322686878|FG007|Overall Study|Death|24|||
94243680|NCT03829501|322686879|FG008|Overall Study|Death|22|||
94243681|NCT03829501|322686880|FG009|Overall Study|Death|6|||
94243682|NCT03829501|322686881|FG010|Overall Study|Death|3|||
94243683|NCT03829501|322686882|FG011|Overall Study|Death|10|||
94243684|NCT03829501|322686883|FG012|Overall Study|Death|10|||
94243685|NCT03829501|322686884|FG013|Overall Study|Death|5|||
94243686|NCT03829501|322686885|FG014|Overall Study|Death|7|||
94243687|NCT03829501|322686886|FG015|Overall Study|Death|2|||
94243688|NCT03829501|322686887|FG016|Overall Study|Death|2|||
94243689|NCT03829501|322686888|FG017|Overall Study|Death|1|||
94243690|NCT03829501|322686889|FG018|Overall Study|Death|1|||
94243691|NCT03829501|322686890|FG019|Overall Study|Death|1|||
94243692|NCT03829501|322686891|FG020|Overall Study|Death|1|||
94243693|NCT03829501|322686892|FG021|Overall Study|Death|2|||
94243694|NCT03829501|322686893|FG022|Overall Study|Death|3|||
94243695|NCT03829501|322686871|FG000|Overall Study|Miscellaneous|0|||
94243696|NCT03829501|322686872|FG001|Overall Study|Miscellaneous|0|||
94243697|NCT03829501|322686873|FG002|Overall Study|Miscellaneous|1|||
94243698|NCT03829501|322686874|FG003|Overall Study|Miscellaneous|0|||
94243699|NCT03829501|322686875|FG004|Overall Study|Miscellaneous|0|||
94243700|NCT03829501|322686876|FG005|Overall Study|Miscellaneous|0|||
94243701|NCT03829501|322686877|FG006|Overall Study|Miscellaneous|0|||
94243702|NCT03829501|322686878|FG007|Overall Study|Miscellaneous|1|||
94243703|NCT03829501|322686879|FG008|Overall Study|Miscellaneous|0|||
94243704|NCT03829501|322686880|FG009|Overall Study|Miscellaneous|0|||
94243705|NCT03829501|322686881|FG010|Overall Study|Miscellaneous|0|||
94243706|NCT03829501|322686882|FG011|Overall Study|Miscellaneous|0|||
94243707|NCT03829501|322686883|FG012|Overall Study|Miscellaneous|0|||
94243708|NCT03829501|322686884|FG013|Overall Study|Miscellaneous|0|||
94243709|NCT03829501|322686885|FG014|Overall Study|Miscellaneous|0|||
94243710|NCT03829501|322686886|FG015|Overall Study|Miscellaneous|0|||
94243711|NCT03829501|322686887|FG016|Overall Study|Miscellaneous|0|||
94243712|NCT03829501|322686888|FG017|Overall Study|Miscellaneous|0|||
94243713|NCT03829501|322686889|FG018|Overall Study|Miscellaneous|0|||
94243714|NCT03829501|322686890|FG019|Overall Study|Miscellaneous|0|||
94243715|NCT03829501|322686891|FG020|Overall Study|Miscellaneous|0|||
94243716|NCT03829501|322686892|FG021|Overall Study|Miscellaneous|0|||
94243717|NCT03829501|322686893|FG022|Overall Study|Miscellaneous|1|||
94243718|NCT00387426|322686894|FG000|Overall Study|Lack of Response|7|||
94243719|NCT00387426|322686894|FG000|Overall Study|Toxicities|4|||
94243720|NCT00387426|322686894|FG000|Overall Study|Disease Progression|3|||
94243721|NCT00747227|322686895|FG000|Overall Study|Death|3|||
94243722|NCT00747227|322686896|FG001|Overall Study|Death|1|||
94243723|NCT00747227|322686895|FG000|Overall Study|Withdrawal by Subject|1|||
94243724|NCT00747227|322686896|FG001|Overall Study|Withdrawal by Subject|0|||
94243725|NCT00747227|322686895|FG000|Overall Study|Lost to Follow-up|1|||
94243726|NCT00747227|322686896|FG001|Overall Study|Lost to Follow-up|2|||
94243727|NCT00747227|322686895|FG000|Overall Study|Illness|1|||
94243728|NCT00747227|322686896|FG001|Overall Study|Illness|1|||
94243729|NCT01253135|322686897|FG000|Original Protocol|Protocol Amendment|15|||
94243730|NCT01253135|322686897|FG000|Amended Protocol|Non-compliance|1|||
94456102|NCT02244463|323458199|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
94456103|NCT02244463|323458200|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
94456104|NCT02244463|323458201|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
94589453|NCT02923921|323960800|FG000|Overall Study|Sponsor Decision|39|||
94354474|NCT02681094|323080244|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
94243731|NCT04138576|322686904|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
94243732|NCT01283152|322686906|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
94243733|NCT01283152|322686907|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
94243734|NCT01283152|322686906|FG000|Overall Study|Refused HESA|1|||
94243735|NCT01283152|322686907|FG001|Overall Study|Refused HESA|0|||
94243736|NCT00567567|322686908|FG000|Overall Study|Adverse Event|0|||
94243737|NCT00567567|322686909|FG001|Overall Study|Adverse Event|2|||
94243738|NCT00567567|322686910|FG002|Overall Study|Adverse Event|5|||
94243739|NCT00567567|322686908|FG000|Overall Study|Death|8|||
94243740|NCT00567567|322686909|FG001|Overall Study|Death|1|||
94243741|NCT00567567|322686910|FG002|Overall Study|Death|5|||
94243742|NCT00567567|322686908|FG000|Overall Study|Lack of Efficacy|16|||
94243743|NCT00567567|322686909|FG001|Overall Study|Lack of Efficacy|17|||
94243744|NCT00567567|322686910|FG002|Overall Study|Lack of Efficacy|48|||
94243745|NCT00567567|322686908|FG000|Overall Study|Lost to Follow-up|0|||
94243746|NCT00567567|322686909|FG001|Overall Study|Lost to Follow-up|0|||
94243747|NCT00567567|322686910|FG002|Overall Study|Lost to Follow-up|1|||
94243748|NCT00567567|322686908|FG000|Overall Study|Physician Decision|16|||
94243749|NCT00567567|322686909|FG001|Overall Study|Physician Decision|18|||
94243750|NCT00567567|322686910|FG002|Overall Study|Physician Decision|84|||
94243751|NCT00567567|322686908|FG000|Overall Study|Withdrawal by Subject|0|||
94243752|NCT00567567|322686909|FG001|Overall Study|Withdrawal by Subject|0|||
94243753|NCT00567567|322686910|FG002|Overall Study|Withdrawal by Subject|2|||
94243754|NCT00567567|322686908|FG000|Overall Study|Ineligible|4|||
94243755|NCT00567567|322686909|FG001|Overall Study|Ineligible|0|||
94589454|NCT02923921|323960801|FG001|Overall Study|Sponsor Decision|38|||
94589455|NCT02923921|323960800|FG000|Overall Study|Lost to Follow-up|1|||
94243756|NCT00567567|322686910|FG002|Overall Study|Ineligible|9|||
94243757|NCT00567567|322686908|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
94243758|NCT00567567|322686909|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
94243759|NCT00567567|322686910|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
94243760|NCT00567567|322686908|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
94243761|NCT00567567|322686909|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
94243762|NCT00567567|322686910|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
94243763|NCT00567567|322686908|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
94243764|NCT00567567|322686909|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
94243765|NCT00567567|322686910|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
94243766|NCT05540717|322686913|FG000|Overall Study|Lost to Follow-up|2|||
94243767|NCT05540717|322686914|FG001|Overall Study|Lost to Follow-up|5|||
94243768|NCT05540717|322686913|FG000|Overall Study|Withdrawal by Subject|6|||
94243769|NCT05540717|322686914|FG001|Overall Study|Withdrawal by Subject|6|||
94243770|NCT05540717|322686913|FG000|Overall Study|Sponsor request|1|||
94243771|NCT05540717|322686914|FG001|Overall Study|Sponsor request|0|||
94243772|NCT05540717|322686913|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
94243773|NCT05540717|322686914|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
94243774|NCT05540717|322686913|FG000|Overall Study|Other|0|||
94243775|NCT05540717|322686914|FG001|Overall Study|Other|1|||
94243776|NCT02071290|322686919|FG000|Overall Study|Death|1|||
94243777|NCT02071290|322686920|FG001|Overall Study|Death|0|||
94243778|NCT02071290|322686919|FG000|Overall Study|Withdrawal by Subject|0|||
94243779|NCT02071290|322686920|FG001|Overall Study|Withdrawal by Subject|1|||
94243780|NCT02071290|322686919|FG000|Overall Study|Protocol Violation|3|||
94243781|NCT02071290|322686920|FG001|Overall Study|Protocol Violation|5|||
94243782|NCT02071290|322686919|FG000|Overall Study|Physician Decision|0|||
94243783|NCT02071290|322686920|FG001|Overall Study|Physician Decision|1|||
94243784|NCT04546425|322686922|FG000|Overall Study|Protocol Violation|1|||
94243785|NCT04546425|322686923|FG001|Overall Study|Protocol Violation|1|||
94243786|NCT04546425|322686924|FG002|Overall Study|Protocol Violation|0|||
94243787|NCT04546425|322686925|FG003|Overall Study|Protocol Violation|0|||
94354475|NCT02681094|323080245|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
94354476|NCT02681094|323080243|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
94243788|NCT04546425|322686922|FG000|Overall Study|Adverse Event|3|||
94354477|NCT02681094|323080244|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
94243789|NCT04546425|322686923|FG001|Overall Study|Adverse Event|0|||
94243790|NCT04546425|322686924|FG002|Overall Study|Adverse Event|0|||
94243791|NCT04546425|322686925|FG003|Overall Study|Adverse Event|0|||
94243792|NCT04546425|322686922|FG000|Overall Study|Lost to Follow-up|5|||
94243793|NCT04546425|322686923|FG001|Overall Study|Lost to Follow-up|4|||
94243794|NCT04546425|322686924|FG002|Overall Study|Lost to Follow-up|0|||
94243795|NCT04546425|322686925|FG003|Overall Study|Lost to Follow-up|0|||
94243796|NCT04546425|322686922|FG000|Overall Study|No Longer met eligibility criteria|3|||
94243797|NCT04546425|322686923|FG001|Overall Study|No Longer met eligibility criteria|3|||
94589456|NCT02923921|323960801|FG001|Overall Study|Lost to Follow-up|0|||
94589457|NCT02923921|323960800|FG000|Overall Study|Withdrawal by Subject|6|||
94659751|NCT00993447|324209949|FG000|Overall Study|Adverse Event|1|||
94354478|NCT02681094|323080245|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
94354479|NCT02681094|323080243|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
94354480|NCT02681094|323080244|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
94354481|NCT02681094|323080245|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
94354482|NCT02681094|323080243|FG000|2 - Enrolled Participants Set|Other|6|||
94354483|NCT02681094|323080244|FG001|2 - Enrolled Participants Set|Other|6|||
94354484|NCT02681094|323080245|FG002|2 - Enrolled Participants Set|Other|7|||
94354485|NCT02681094|323080243|FG000|2 - Enrolled Participants Set|No treatment given|0|||
94354486|NCT02681094|323080244|FG001|2 - Enrolled Participants Set|No treatment given|1|||
94354487|NCT02681094|323080245|FG002|2 - Enrolled Participants Set|No treatment given|1|||
94354488|NCT01474291|323080251|FG000|Overall Study|Not Evaluable for Efficacy|26|||
94354489|NCT01474291|323080251|FG000|Overall Study|Lack of Treatment Efficacy|88|||
94354490|NCT01474291|323080251|FG000|Overall Study|Adverse Event|53|||
94354491|NCT01474291|323080251|FG000|Overall Study|Lost to Follow-up|29|||
94589458|NCT02923921|323960801|FG001|Overall Study|Withdrawal by Subject|13|||
94589459|NCT02923921|323960800|FG000|Overall Study|Unknown, Not Collected|7|||
94354492|NCT01474291|323080251|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
94354493|NCT01474291|323080251|FG000|Overall Study|No Reason Reported|10|||
94354494|NCT01474291|323080251|FG000|Overall Study|Death|2|||
94354495|NCT02918968|323080264|FG000|1st Line AAT|Progressive disease|9|||
94354496|NCT02918968|323080265|FG001|1st Line AAT|Progressive disease|4|||
94354497|NCT02918968|323080264|FG000|1st Line AAT|Adverse Event|12|||
94354498|NCT02918968|323080265|FG001|1st Line AAT|Adverse Event|3|||
94354499|NCT02918968|323080264|FG000|1st Line AAT|Physician Decision|4|||
94354500|NCT02918968|323080265|FG001|1st Line AAT|Physician Decision|2|||
94589460|NCT02923921|323960801|FG001|Overall Study|Unknown, Not Collected|6|||
94589461|NCT00479687|323960802|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
94589462|NCT00479687|323960803|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
94589463|NCT00479687|323960804|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
94589464|NCT00479687|323960802|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
94589465|NCT00479687|323960803|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
94589466|NCT00479687|323960804|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
94589467|NCT00479687|323960802|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
94589468|NCT00479687|323960803|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
94589469|NCT00479687|323960804|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
94589470|NCT00479687|323960802|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
94589471|NCT00479687|323960803|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
94589472|NCT00479687|323960804|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
94589473|NCT00479687|323960802|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
94589474|NCT00479687|323960803|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
94589475|NCT00479687|323960804|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
94589476|NCT00479687|323960802|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
94589477|NCT00479687|323960803|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
94589478|NCT00479687|323960804|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
94589479|NCT00479687|323960802|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
94589480|NCT00479687|323960803|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
94589481|NCT00479687|323960804|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
94589482|NCT00479687|323960802|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
94589483|NCT00479687|323960803|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
94589484|NCT00479687|323960804|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
94589485|NCT00479687|323960802|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
94589486|NCT00479687|323960803|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
94589487|NCT00479687|323960804|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
94589488|NCT02260180|323960805|FG000|Overall Study|Adverse Event|2|||
94589489|NCT02260180|323960806|FG001|Overall Study|Adverse Event|0|||
94589490|NCT02260180|323960807|FG002|Overall Study|Adverse Event|1|||
94589491|NCT03844945|323960812|FG000|Overall Study|Adverse Event|1|||
94589492|NCT03844945|323960813|FG001|Overall Study|Adverse Event|1|||
94589493|NCT03844945|323960814|FG002|Overall Study|Adverse Event|4|||
94589494|NCT03844945|323960815|FG003|Overall Study|Adverse Event|0|||
94589495|NCT03844945|323960812|FG000|Overall Study|Withdrawal by Subject|0|||
94354501|NCT02918968|323080264|FG000|1st Line AAT|Withdrawal by Subject|2|||
94354502|NCT02918968|323080265|FG001|1st Line AAT|Withdrawal by Subject|1|||
94589496|NCT03844945|323960813|FG001|Overall Study|Withdrawal by Subject|0|||
94354503|NCT02918968|323080264|FG000|1st Line AAT|Lost to Follow-up|0|||
94354504|NCT02918968|323080265|FG001|1st Line AAT|Lost to Follow-up|1|||
94354505|NCT02918968|323080264|FG000|1st Line AAT|Death|1|||
94589497|NCT03844945|323960814|FG002|Overall Study|Withdrawal by Subject|1|||
94354506|NCT02918968|323080265|FG001|1st Line AAT|Death|0|||
94354507|NCT02918968|323080264|FG000|1st Line AAT|Miscellaneous|1|||
94589498|NCT03844945|323960815|FG003|Overall Study|Withdrawal by Subject|0|||
94589499|NCT03844945|323960812|FG000|Overall Study|Lack of Efficacy|0|||
94589500|NCT03844945|323960813|FG001|Overall Study|Lack of Efficacy|0|||
94589501|NCT03844945|323960814|FG002|Overall Study|Lack of Efficacy|0|||
94589502|NCT03844945|323960815|FG003|Overall Study|Lack of Efficacy|1|||
94589503|NCT01761162|323960818|FG000|Overall Study|Withdrawal by Subject|3|||
94589504|NCT02139592|323960819|FG000|Overall Study|Case Report Forms Uncollected|8|||
94589505|NCT01193257|323960833|FG000|Overall Study|Death|202|||
94589506|NCT01193257|323960834|FG001|Overall Study|Death|391|||
94589507|NCT01193257|323960833|FG000|Overall Study|Study termination by sponsor|0|||
94589508|NCT01193257|323960834|FG001|Overall Study|Study termination by sponsor|3|||
94243798|NCT04546425|322686924|FG002|Overall Study|No Longer met eligibility criteria|1|||
94243799|NCT04546425|322686925|FG003|Overall Study|No Longer met eligibility criteria|1|||
94243800|NCT04546425|322686922|FG000|Overall Study|Withdrawal by parent/guardian|6|||
94243801|NCT04546425|322686923|FG001|Overall Study|Withdrawal by parent/guardian|5|||
94243802|NCT04546425|322686924|FG002|Overall Study|Withdrawal by parent/guardian|1|||
94243803|NCT04546425|322686925|FG003|Overall Study|Withdrawal by parent/guardian|1|||
94243804|NCT02175641|322686926|FG000|Overall Study|Death|3|||
94243805|NCT02175641|322686927|FG001|Overall Study|Death|4|||
94243806|NCT02175641|322686926|FG000|Overall Study|Lost to Follow-up|4|||
94243807|NCT02175641|322686927|FG001|Overall Study|Lost to Follow-up|4|||
94243808|NCT02175641|322686926|FG000|Overall Study|Withdrawal by Subject|7|||
94243809|NCT02175641|322686927|FG001|Overall Study|Withdrawal by Subject|4|||
94243810|NCT02175641|322686926|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
94243811|NCT02175641|322686927|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
94243812|NCT02175641|322686926|FG000|Overall Study|Developed Contraindicated Condition|8|||
94243813|NCT02175641|322686927|FG001|Overall Study|Developed Contraindicated Condition|0|||
94243814|NCT01923467|322686932|FG000|Overall Study|Lost to Follow-up|62|||
94243815|NCT01923467|322686932|FG000|Overall Study|Subject non-interest|479|||
94243816|NCT03921723|322686933|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
94243817|NCT03921723|322686933|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
94243818|NCT03015129|322686934|FG000|Overall Study|Death|2|||
94243819|NCT03015129|322686935|FG001|Overall Study|Death|2|||
94243820|NCT03015129|322686934|FG000|Overall Study|Lost to Follow-up|0|||
94243821|NCT03015129|322686935|FG001|Overall Study|Lost to Follow-up|1|||
94243822|NCT03015129|322686934|FG000|Overall Study|Progression of disease|38|||
94243823|NCT03015129|322686935|FG001|Overall Study|Progression of disease|33|||
94243824|NCT03015129|322686934|FG000|Overall Study|Adverse Event|0|||
94243825|NCT03015129|322686935|FG001|Overall Study|Adverse Event|4|||
94243826|NCT02242097|322686939|FG000|Ibrutinib Treatment|Adverse Event|16|||
94243827|NCT02242097|322686939|FG000|Ibrutinib Treatment|Physician Decision|1|||
94243828|NCT02242097|322686939|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
94243829|NCT02242097|322686939|FG000|Ibrutinib Treatment|Death|1|||
94243830|NCT02242097|322686939|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
94243831|NCT02242097|322686939|FG000|Post Therapy Follow Up|Death|3|||
94243832|NCT02242097|322686939|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
94243833|NCT01075958|322686940|FG000|Overall Study|Blood sample could not be obtained|44|||
94243834|NCT01232738|322686944|FG000|Overall Study|Death|3|||
94243835|NCT01232738|322686944|FG000|Overall Study|Physician Decision|2|||
94243836|NCT01232738|322686944|FG000|Overall Study|Lost to Follow-up|1|||
94243837|NCT01232738|322686944|FG000|Overall Study|Withdrawal by Subject|2|||
94243838|NCT01232738|322686944|FG000|Overall Study|Adverse Event|5|||
94243839|NCT02979249|322686945|FG000|Overall Study|Lost to Follow-up|2|||
94243840|NCT02979249|322686945|FG000|Overall Study|Withdrawal by Subject|4|||
94243841|NCT00338962|322686946|FG000|Overall Study|Lost to Follow-up|3|||
94243842|NCT00338962|322686947|FG001|Overall Study|Lost to Follow-up|3|||
94589509|NCT01193257|323960833|FG000|Overall Study|Withdrawal by Subject|26|||
94589510|NCT01193257|323960834|FG001|Overall Study|Withdrawal by Subject|86|||
94659752|NCT00993447|324209950|FG001|Overall Study|Adverse Event|0|||
94659753|NCT00129987|324209951|FG000|1st Educational Session|Withdrawal by Subject|141|||
94659754|NCT00129987|324209952|FG001|1st Educational Session|Withdrawal by Subject|109|||
94659755|NCT00129987|324209951|FG000|1 Year|Withdrawal by Subject|32|||
94659756|NCT00129987|324209952|FG001|1 Year|Withdrawal by Subject|21|||
94243843|NCT00338962|322686948|FG002|Overall Study|Lost to Follow-up|2|||
94243844|NCT00338962|322686949|FG003|Overall Study|Lost to Follow-up|3|||
94243845|NCT00338962|322686946|FG000|Overall Study|Withdrawal by Subject|1|||
94243846|NCT00338962|322686947|FG001|Overall Study|Withdrawal by Subject|0|||
94243847|NCT00338962|322686948|FG002|Overall Study|Withdrawal by Subject|0|||
94243848|NCT00338962|322686949|FG003|Overall Study|Withdrawal by Subject|0|||
94243849|NCT00338962|322686946|FG000|Overall Study|No Transportation|2|||
94354508|NCT02918968|323080265|FG001|1st Line AAT|Miscellaneous|0|||
94354509|NCT02918968|323080264|FG000|2nd Line AAT|Progressive disease|21|||
94354510|NCT02918968|323080265|FG001|2nd Line AAT|Progressive disease|3|||
94354511|NCT02918968|323080264|FG000|2nd Line AAT|Adverse Event|2|||
94354512|NCT02918968|323080265|FG001|2nd Line AAT|Adverse Event|5|||
94589511|NCT01193257|323960833|FG000|Overall Study|Lost to Follow-up|2|||
94589512|NCT01193257|323960834|FG001|Overall Study|Lost to Follow-up|3|||
94354513|NCT02918968|323080264|FG000|2nd Line AAT|Physician Decision|0|||
94589513|NCT01193257|323960833|FG000|Overall Study|Unblinded due to futility|135|||
94354514|NCT02918968|323080265|FG001|2nd Line AAT|Physician Decision|1|||
94354515|NCT02918968|323080264|FG000|2nd Line AAT|Withdrawal by Subject|2|||
94354516|NCT02918968|323080265|FG001|2nd Line AAT|Withdrawal by Subject|2|||
94354517|NCT02918968|323080264|FG000|2nd Line AAT|Death|0|||
94354518|NCT02918968|323080265|FG001|2nd Line AAT|Death|1|||
94354519|NCT01589185|323080276|FG000|Overall Study|Death|1|||
94354520|NCT01589185|323080277|FG001|Overall Study|Death|2|||
94354521|NCT01589185|323080278|FG002|Overall Study|Death|2|||
94354522|NCT01589185|323080279|FG003|Overall Study|Death|0|||
94354523|NCT01589185|323080280|FG004|Overall Study|Death|1|||
94354524|NCT01589185|323080276|FG000|Overall Study|Lost to Follow-up|1|||
94354525|NCT01589185|323080277|FG001|Overall Study|Lost to Follow-up|0|||
94354526|NCT01589185|323080278|FG002|Overall Study|Lost to Follow-up|2|||
94354527|NCT01589185|323080279|FG003|Overall Study|Lost to Follow-up|3|||
94354528|NCT01589185|323080280|FG004|Overall Study|Lost to Follow-up|0|||
94354529|NCT00598442|323080281|FG000|Overall Study|Adverse Event|3|||
94354530|NCT00598442|323080282|FG001|Overall Study|Adverse Event|0|||
94354531|NCT00598442|323080283|FG002|Overall Study|Adverse Event|0|||
94354532|NCT00598442|323080281|FG000|Overall Study|Death|19|||
94354533|NCT00598442|323080282|FG001|Overall Study|Death|11|||
94354534|NCT00598442|323080283|FG002|Overall Study|Death|11|||
94354535|NCT00598442|323080281|FG000|Overall Study|Lost to Follow-up|4|||
94354536|NCT00598442|323080282|FG001|Overall Study|Lost to Follow-up|3|||
94354537|NCT00598442|323080283|FG002|Overall Study|Lost to Follow-up|3|||
94354538|NCT00598442|323080281|FG000|Overall Study|Physician Decision|2|||
94354539|NCT00598442|323080282|FG001|Overall Study|Physician Decision|1|||
94354540|NCT00598442|323080283|FG002|Overall Study|Physician Decision|1|||
94354541|NCT00598442|323080281|FG000|Overall Study|Withdrawal by Subject|8|||
94354542|NCT00598442|323080282|FG001|Overall Study|Withdrawal by Subject|16|||
94354543|NCT00598442|323080283|FG002|Overall Study|Withdrawal by Subject|6|||
94354544|NCT00598442|323080281|FG000|Overall Study|Noncompliance|0|||
94354545|NCT00598442|323080282|FG001|Overall Study|Noncompliance|2|||
94354546|NCT00598442|323080283|FG002|Overall Study|Noncompliance|1|||
94354547|NCT00598442|323080281|FG000|Overall Study|Relocation|1|||
94354548|NCT00598442|323080282|FG001|Overall Study|Relocation|4|||
94354549|NCT00598442|323080283|FG002|Overall Study|Relocation|0|||
94354550|NCT00598442|323080281|FG000|Overall Study|Renal transplant|0|||
94354551|NCT00598442|323080282|FG001|Overall Study|Renal transplant|0|||
94354552|NCT00598442|323080283|FG002|Overall Study|Renal transplant|1|||
94354553|NCT00598442|323080281|FG000|Overall Study|Site closed by sponsor|5|||
94354554|NCT00598442|323080282|FG001|Overall Study|Site closed by sponsor|2|||
94354555|NCT00598442|323080283|FG002|Overall Study|Site closed by sponsor|1|||
94354556|NCT00598442|323080281|FG000|Overall Study|Started dialysis|1|||
94354557|NCT00598442|323080282|FG001|Overall Study|Started dialysis|0|||
94354558|NCT00598442|323080283|FG002|Overall Study|Started dialysis|0|||
94354559|NCT01729559|323080287|FG000|Overall Study|Protocol Violation|31|||
94354560|NCT01729559|323080288|FG001|Overall Study|Protocol Violation|28|||
94354561|NCT00368069|323080290|FG000|Overall Study|Adverse Event|5|||
94354562|NCT00368069|323080291|FG001|Overall Study|Adverse Event|2|||
94354563|NCT00368069|323080290|FG000|Overall Study|Lack of Efficacy|0|||
94354564|NCT00368069|323080291|FG001|Overall Study|Lack of Efficacy|1|||
94354565|NCT00368069|323080290|FG000|Overall Study|Lost to Follow-up|1|||
94354566|NCT00368069|323080291|FG001|Overall Study|Lost to Follow-up|0|||
94354567|NCT00368069|323080290|FG000|Overall Study|Protocol Violation|0|||
94354568|NCT00368069|323080291|FG001|Overall Study|Protocol Violation|2|||
94354569|NCT00368069|323080290|FG000|Overall Study|Withdrawal of Consent|2|||
94354570|NCT00368069|323080291|FG001|Overall Study|Withdrawal of Consent|1|||
94354571|NCT00368069|323080290|FG000|Overall Study|no blood sampling possible|0|||
94354572|NCT00368069|323080291|FG001|Overall Study|no blood sampling possible|1|||
94354573|NCT01430559|323080296|FG000|Overall Study|Adverse Event|7|||
94354574|NCT01430559|323080297|FG001|Overall Study|Adverse Event|3|||
94354575|NCT01430559|323080296|FG000|Overall Study|Entry criteria not met|1|||
94589514|NCT01193257|323960834|FG001|Overall Study|Unblinded due to futility|251|||
94354576|NCT01430559|323080297|FG001|Overall Study|Entry criteria not met|1|||
94354577|NCT01430559|323080296|FG000|Overall Study|Lost to Follow-up|1|||
94354578|NCT01430559|323080297|FG001|Overall Study|Lost to Follow-up|0|||
94354579|NCT01430559|323080296|FG000|Overall Study|Medication error|1|||
94589515|NCT01675544|323960838|FG000|Overall Study|Withdrawal by Subject|2|||
94589516|NCT03126344|323960839|FG000|Overall Study|Lost to Follow-up|0|||
94354580|NCT01430559|323080297|FG001|Overall Study|Medication error|0|||
94354581|NCT01430559|323080296|FG000|Overall Study|Withdrawal by Subject|3|||
94354582|NCT01430559|323080297|FG001|Overall Study|Withdrawal by Subject|2|||
94354583|NCT01430559|323080296|FG000|Overall Study|Protocol Violation|1|||
94354584|NCT01430559|323080297|FG001|Overall Study|Protocol Violation|0|||
94354585|NCT01430559|323080296|FG000|Overall Study|Other|3|||
94589517|NCT03126344|323960840|FG001|Overall Study|Lost to Follow-up|0|||
94354586|NCT01430559|323080297|FG001|Overall Study|Other|3|||
94354587|NCT01430559|323080296|FG000|Overall Study|Randomized, Not Treated|3|||
94354588|NCT01430559|323080297|FG001|Overall Study|Randomized, Not Treated|3|||
94354589|NCT02463097|323080298|FG000|Overall Study|Withdrawal by Subject|1|||
94354590|NCT01177943|323080299|FG000|First Intervention|Withdrawal by Subject|2|||
94589518|NCT03126344|323960841|FG002|Overall Study|Lost to Follow-up|5|||
94589519|NCT02736890|323960842|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
94589520|NCT02736890|323960843|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
94589521|NCT02736890|323960842|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
94589522|NCT02736890|323960843|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
94589523|NCT01027273|323960844|FG000|Overall Study|Lost to Follow-up|57|||
94243850|NCT00338962|322686947|FG001|Overall Study|No Transportation|0|||
94243851|NCT00338962|322686948|FG002|Overall Study|No Transportation|0|||
94243852|NCT00338962|322686949|FG003|Overall Study|No Transportation|0|||
94243853|NCT00338962|322686946|FG000|Overall Study|Time Constraint|2|||
94243854|NCT00338962|322686947|FG001|Overall Study|Time Constraint|0|||
94243855|NCT00338962|322686948|FG002|Overall Study|Time Constraint|0|||
94243856|NCT00338962|322686949|FG003|Overall Study|Time Constraint|0|||
94243857|NCT00338962|322686946|FG000|Overall Study|Moved|0|||
94243858|NCT00338962|322686947|FG001|Overall Study|Moved|1|||
94243859|NCT00338962|322686948|FG002|Overall Study|Moved|0|||
94243860|NCT00338962|322686949|FG003|Overall Study|Moved|0|||
94243861|NCT00338962|322686946|FG000|Overall Study|Adverse Event|0|||
94243862|NCT00338962|322686947|FG001|Overall Study|Adverse Event|0|||
94243863|NCT00338962|322686948|FG002|Overall Study|Adverse Event|2|||
94243864|NCT00338962|322686949|FG003|Overall Study|Adverse Event|0|||
94243865|NCT00338962|322686946|FG000|Overall Study|Poor Compliance|0|||
94243866|NCT00338962|322686947|FG001|Overall Study|Poor Compliance|0|||
94243867|NCT00338962|322686948|FG002|Overall Study|Poor Compliance|2|||
94243868|NCT00338962|322686949|FG003|Overall Study|Poor Compliance|0|||
94243869|NCT02574845|322686950|FG000|Overall Study|Consent withdrawn further participation|0|||
94243870|NCT02574845|322686951|FG001|Overall Study|Consent withdrawn further participation|0|||
94243871|NCT02574845|322686952|FG002|Overall Study|Consent withdrawn further participation|0|||
94243872|NCT02574845|322686953|FG003|Overall Study|Consent withdrawn further participation|0|||
94243873|NCT02574845|322686954|FG004|Overall Study|Consent withdrawn further participation|1|||
94243874|NCT02574845|322686955|FG005|Overall Study|Consent withdrawn further participation|0|||
94243875|NCT02574845|322686950|FG000|Overall Study|Adverse Event|0|||
94243876|NCT02574845|322686951|FG001|Overall Study|Adverse Event|1|||
94243877|NCT02574845|322686952|FG002|Overall Study|Adverse Event|0|||
94243878|NCT02574845|322686953|FG003|Overall Study|Adverse Event|0|||
94243879|NCT02574845|322686954|FG004|Overall Study|Adverse Event|0|||
94243880|NCT02574845|322686955|FG005|Overall Study|Adverse Event|1|||
94243881|NCT00659880|322686957|FG000|Overall Study|Lost to Follow-up|5|||
94243882|NCT03435692|322686958|FG000|Overall Study|Lack of Efficacy|2|||
94243883|NCT03435692|322686959|FG001|Overall Study|Lack of Efficacy|2|||
94243884|NCT03435692|322686960|FG002|Overall Study|Lack of Efficacy|0|||
94243885|NCT04488770|322686961|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
94243886|NCT04488770|322686962|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
94243887|NCT04488770|322686963|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
94243888|NCT04488770|322686964|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
94243889|NCT04488770|322686965|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
94243890|NCT04488770|322686966|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
94243891|NCT04488770|322686967|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
94243892|NCT04488770|322686968|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
94243893|NCT04488770|322686969|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
94243894|NCT04488770|322686970|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
94243895|NCT04488770|322686971|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
94243896|NCT04488770|322686972|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
94243897|NCT04488770|322686973|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
94243898|NCT04488770|322686961|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
94243899|NCT04488770|322686962|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
94243900|NCT04488770|322686963|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
94243901|NCT04488770|322686964|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
94243902|NCT04488770|322686965|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
94243903|NCT04488770|322686966|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
94243904|NCT04488770|322686967|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
94243905|NCT04488770|322686968|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
94243906|NCT04488770|322686969|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
94243907|NCT04488770|322686970|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
94243908|NCT04488770|322686971|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
94589524|NCT01027273|323960845|FG001|Overall Study|Lost to Follow-up|31|||
94589525|NCT01027273|323960844|FG000|Overall Study|Death|2|||
94589526|NCT01027273|323960845|FG001|Overall Study|Death|2|||
94589527|NCT00555061|323960847|FG000|Overall Study|Adverse Event|3|||
94589528|NCT00555061|323960847|FG000|Overall Study|Protocol Violation|1|||
94243909|NCT04488770|322686972|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
94243910|NCT04488770|322686973|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
94243911|NCT04488770|322686961|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
94243912|NCT04488770|322686962|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
94243913|NCT04488770|322686963|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
94243914|NCT04488770|322686964|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
94243915|NCT04488770|322686965|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
94589529|NCT00555061|323960847|FG000|Overall Study|Lost to Follow-up|2|||
94589530|NCT00555061|323960847|FG000|Overall Study|Withdrawal by Subject|2|||
94589531|NCT00555061|323960847|FG000|Overall Study|Participant enrolled, but never treated|1|||
94589532|NCT03926611|323960848|FG000|Overall Study|Adverse Event|0|||
94589533|NCT03926611|323960849|FG001|Overall Study|Adverse Event|0|||
94589534|NCT03926611|323960850|FG002|Overall Study|Adverse Event|0|||
94589535|NCT03926611|323960851|FG003|Overall Study|Adverse Event|3|||
94589536|NCT03926611|323960852|FG004|Overall Study|Adverse Event|1|||
94589537|NCT03926611|323960853|FG005|Overall Study|Adverse Event|3|||
94589538|NCT03926611|323960854|FG006|Overall Study|Adverse Event|0|||
94589539|NCT03926611|323960848|FG000|Overall Study|Lack of Efficacy|1|||
94589540|NCT03926611|323960849|FG001|Overall Study|Lack of Efficacy|2|||
94589541|NCT03926611|323960850|FG002|Overall Study|Lack of Efficacy|0|||
94589542|NCT03926611|323960851|FG003|Overall Study|Lack of Efficacy|0|||
94589543|NCT03926611|323960852|FG004|Overall Study|Lack of Efficacy|1|||
94589544|NCT03926611|323960853|FG005|Overall Study|Lack of Efficacy|0|||
94589545|NCT03926611|323960854|FG006|Overall Study|Lack of Efficacy|1|||
94589546|NCT03926611|323960848|FG000|Overall Study|Physician Decision|0|||
94589547|NCT03926611|323960849|FG001|Overall Study|Physician Decision|0|||
94589548|NCT03926611|323960850|FG002|Overall Study|Physician Decision|0|||
94589549|NCT03926611|323960851|FG003|Overall Study|Physician Decision|0|||
94589550|NCT03926611|323960852|FG004|Overall Study|Physician Decision|0|||
94589551|NCT03926611|323960853|FG005|Overall Study|Physician Decision|1|||
94589552|NCT03926611|323960854|FG006|Overall Study|Physician Decision|0|||
94589553|NCT03926611|323960848|FG000|Overall Study|Protocol Violation|1|||
94354591|NCT01177943|323080300|FG001|First Intervention|Withdrawal by Subject|0|||
94354592|NCT01757821|323080301|FG000|Overall Study|Adverse Event|1|||
94354593|NCT01258803|323080302|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
94354594|NCT01258803|323080303|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
94354595|NCT01258803|323080304|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
94354596|NCT01258803|323080305|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
94354597|NCT01258803|323080306|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
94354598|NCT01258803|323080307|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
94354599|NCT01258803|323080302|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
94354600|NCT01258803|323080303|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
94354601|NCT01258803|323080304|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
94354602|NCT01258803|323080305|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
94354603|NCT01258803|323080306|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
94354604|NCT01258803|323080307|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
94354605|NCT01258803|323080302|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
94354606|NCT01258803|323080303|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
94354607|NCT01258803|323080304|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
94354608|NCT01258803|323080305|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
94354609|NCT01258803|323080306|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
94354610|NCT01258803|323080307|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
94354611|NCT00672490|323080308|FG000|Overall Study|Withdrawal by Subject|8|||
94354612|NCT00672490|323080309|FG001|Overall Study|Withdrawal by Subject|8|||
94354613|NCT00672490|323080308|FG000|Overall Study|Lack of Compliance|2|||
94354614|NCT00672490|323080309|FG001|Overall Study|Lack of Compliance|7|||
94354615|NCT00672490|323080308|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
94354616|NCT00672490|323080309|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
94354617|NCT00672490|323080308|FG000|Overall Study|Adverse Event|5|||
94354618|NCT00672490|323080309|FG001|Overall Study|Adverse Event|8|||
94589554|NCT03926611|323960849|FG001|Overall Study|Protocol Violation|0|||
94589555|NCT03926611|323960850|FG002|Overall Study|Protocol Violation|0|||
94589556|NCT03926611|323960851|FG003|Overall Study|Protocol Violation|1|||
94589557|NCT03926611|323960852|FG004|Overall Study|Protocol Violation|1|||
94589558|NCT03926611|323960853|FG005|Overall Study|Protocol Violation|1|||
94589559|NCT03926611|323960854|FG006|Overall Study|Protocol Violation|1|||
94589560|NCT03926611|323960848|FG000|Overall Study|Technical problems|0|||
94589561|NCT03926611|323960849|FG001|Overall Study|Technical problems|0|||
94589562|NCT03926611|323960850|FG002|Overall Study|Technical problems|0|||
94243916|NCT04488770|322686966|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
94243917|NCT04488770|322686967|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
94243918|NCT04488770|322686968|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
94243919|NCT04488770|322686969|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
94243920|NCT04488770|322686970|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
94243921|NCT04488770|322686971|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
94243922|NCT04488770|322686972|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
94243923|NCT04488770|322686973|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
94243924|NCT04488770|322686961|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
94243925|NCT04488770|322686962|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
94243926|NCT04488770|322686963|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
94243927|NCT04488770|322686964|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
94243928|NCT04488770|322686965|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
94589563|NCT03926611|323960851|FG003|Overall Study|Technical problems|0|||
94589564|NCT03926611|323960852|FG004|Overall Study|Technical problems|0|||
94589565|NCT03926611|323960853|FG005|Overall Study|Technical problems|1|||
94589566|NCT03926611|323960854|FG006|Overall Study|Technical problems|0|||
94589567|NCT03926611|323960848|FG000|Overall Study|Withdrawal by Subject|1|||
94354619|NCT00672490|323080308|FG000|Overall Study|Violation of Concomitant Medicine|1|||
94354620|NCT00672490|323080309|FG001|Overall Study|Violation of Concomitant Medicine|0|||
94243929|NCT04488770|322686966|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
94243930|NCT04488770|322686967|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
94354621|NCT00672490|323080308|FG000|Overall Study|Intolerance|0|||
94354622|NCT00672490|323080309|FG001|Overall Study|Intolerance|2|||
94354623|NCT00672490|323080308|FG000|Overall Study|Lost to Follow-up|1|||
94354624|NCT00672490|323080309|FG001|Overall Study|Lost to Follow-up|5|||
94354625|NCT00672490|323080308|FG000|Overall Study|No reason was provided|6|||
94354626|NCT00672490|323080309|FG001|Overall Study|No reason was provided|2|||
94589568|NCT03926611|323960849|FG001|Overall Study|Withdrawal by Subject|1|||
94354627|NCT00787527|323080322|FG000|Overall Study|Toxicity|3|||
94354628|NCT01303159|323080323|FG000|Overall Study|Death|16|||
94354629|NCT01303159|323080323|FG000|Overall Study|Study Termination|7|||
94589569|NCT03926611|323960850|FG002|Overall Study|Withdrawal by Subject|1|||
94589570|NCT03926611|323960851|FG003|Overall Study|Withdrawal by Subject|0|||
94589571|NCT03926611|323960852|FG004|Overall Study|Withdrawal by Subject|0|||
94589572|NCT03926611|323960853|FG005|Overall Study|Withdrawal by Subject|1|||
94589573|NCT03926611|323960854|FG006|Overall Study|Withdrawal by Subject|3|||
94589574|NCT03926611|323960848|FG000|Overall Study|Covid-19 pandemic|0|||
94589575|NCT03926611|323960849|FG001|Overall Study|Covid-19 pandemic|0|||
94589576|NCT03926611|323960850|FG002|Overall Study|Covid-19 pandemic|1|||
94589577|NCT03926611|323960851|FG003|Overall Study|Covid-19 pandemic|0|||
94589578|NCT03926611|323960852|FG004|Overall Study|Covid-19 pandemic|1|||
94589579|NCT03926611|323960853|FG005|Overall Study|Covid-19 pandemic|2|||
94589580|NCT03926611|323960854|FG006|Overall Study|Covid-19 pandemic|0|||
94589581|NCT00970684|323960856|FG000|Overall Study|Lack of Efficacy|5|||
94589582|NCT00970684|323960856|FG000|Overall Study|Adverse Event|4|||
94589583|NCT00970684|323960856|FG000|Overall Study|Withdrawal by Subject|1|||
94589584|NCT03539549|323960861|FG000|Overall Study|Adverse Event|12|||
94589585|NCT03539549|323960861|FG000|Overall Study|Lost to Follow-up|1|||
94589586|NCT03539549|323960861|FG000|Overall Study|Death|2|||
94589587|NCT03539549|323960861|FG000|Overall Study|Progressive Disease|1|||
94589588|NCT03539549|323960861|FG000|Overall Study|Reason not Specified|1|||
94589589|NCT04027608|323960862|FG000|Overall Study|Withdrawal by Subject|13|||
94589590|NCT04027608|323960863|FG001|Overall Study|Withdrawal by Subject|2|||
94589591|NCT04027608|323960862|FG000|Overall Study|Protocol Violation|2|||
94589592|NCT04027608|323960863|FG001|Overall Study|Protocol Violation|1|||
94589593|NCT04027608|323960862|FG000|Overall Study|Physician Decision|1|||
94589594|NCT04027608|323960863|FG001|Overall Study|Physician Decision|0|||
94589595|NCT04027608|323960862|FG000|Overall Study|Lost to Follow-up|20|||
94589596|NCT04027608|323960863|FG001|Overall Study|Lost to Follow-up|4|||
94589597|NCT02405442|323960864|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
94589598|NCT02405442|323960865|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
94589599|NCT02405442|323960866|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
94589600|NCT02405442|323960867|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
94589601|NCT02405442|323960864|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
94589602|NCT02405442|323960865|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
94589603|NCT02405442|323960866|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
94354630|NCT03258710|323080324|FG000|Overall Study|Adverse Event|1|||
94589604|NCT02405442|323960867|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
94589605|NCT02405442|323960864|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
94589606|NCT02405442|323960865|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
94589607|NCT02405442|323960866|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
94589608|NCT02405442|323960867|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
94589609|NCT02405442|323960864|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
94589610|NCT02405442|323960865|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
94589611|NCT02405442|323960866|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
94589612|NCT02405442|323960867|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
94589613|NCT02405442|323960864|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
94589614|NCT02405442|323960865|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
94589615|NCT02405442|323960866|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
94589616|NCT02405442|323960867|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
94589617|NCT02405442|323960864|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
94589618|NCT02405442|323960865|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
94589619|NCT02405442|323960866|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
94589620|NCT02405442|323960867|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
94589621|NCT02405442|323960864|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
94589622|NCT02405442|323960865|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
94589623|NCT02405442|323960866|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
94589624|NCT02405442|323960867|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
94589625|NCT02405442|323960864|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
94589626|NCT02405442|323960865|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
94589627|NCT02405442|323960866|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
94589628|NCT02405442|323960867|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
94589629|NCT02405442|323960864|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
94589630|NCT02405442|323960865|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
94589631|NCT02405442|323960866|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
94589632|NCT02405442|323960867|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
94589633|NCT02405442|323960864|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
94589634|NCT02405442|323960865|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
94589635|NCT02405442|323960866|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
94589636|NCT02405442|323960867|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
94589637|NCT02405442|323960864|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
94589638|NCT02405442|323960865|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
94456105|NCT02244463|323458202|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
94589639|NCT02405442|323960866|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
94589640|NCT02405442|323960867|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
94589641|NCT02405442|323960864|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
94354631|NCT03258710|323080324|FG000|Overall Study|Protocol-defined stopping criteria|1|||
94354632|NCT03258710|323080324|FG000|Overall Study|Physician Decision|1|||
94354633|NCT04034225|323080327|FG000|Overall Study|Death|3|||
94354634|NCT04034225|323080327|FG000|Overall Study|Withdrawal by Subject|2|||
94354635|NCT04034225|323080327|FG000|Overall Study|Study termination by Sponsor|18|||
94354636|NCT04034225|323080327|FG000|Overall Study|Physician Decision|1|||
94354637|NCT04034225|323080327|FG000|Overall Study|Lack of Efficacy|1|||
94354638|NCT03759340|323080328|FG000|Overall Study|Adverse Event|2|||
94354639|NCT03759340|323080328|FG000|Overall Study|Lost to Follow-up|1|||
94354640|NCT03759340|323080328|FG000|Overall Study|Withdrawal by Subject|15|||
94354641|NCT03759340|323080328|FG000|Overall Study|Study Terminated by Sponsor|38|||
94354642|NCT01000311|323080329|FG000|Overall Study|Adverse Event|2|||
94456106|NCT02244463|323458197|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
94354643|NCT01000311|323080330|FG001|Overall Study|Adverse Event|5|||
94354644|NCT01000311|323080329|FG000|Overall Study|Withdrawal by Subject|16|||
94354645|NCT01000311|323080330|FG001|Overall Study|Withdrawal by Subject|24|||
94589642|NCT02405442|323960865|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
94589643|NCT02405442|323960866|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
94589644|NCT02405442|323960867|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
94243931|NCT04488770|322686968|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
94243932|NCT04488770|322686969|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
94456107|NCT02244463|323458198|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
94456108|NCT02244463|323458199|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
94456109|NCT02244463|323458200|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
94456110|NCT02244463|323458201|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
94456111|NCT02244463|323458202|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
94456112|NCT02244463|323458197|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
94456113|NCT02244463|323458198|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
94456114|NCT02244463|323458199|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
94589645|NCT02405442|323960864|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
94589646|NCT02405442|323960865|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
94589647|NCT02405442|323960866|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
94456115|NCT02244463|323458200|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
94456116|NCT02244463|323458201|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
94456117|NCT02244463|323458202|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
94589648|NCT02405442|323960867|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
94589649|NCT02405442|323960864|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
94589650|NCT02405442|323960865|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
94456118|NCT02244463|323458197|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
94456119|NCT02244463|323458198|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
94456120|NCT02244463|323458199|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
94589651|NCT02405442|323960866|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
94589652|NCT02405442|323960867|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
94589653|NCT00373113|323960868|FG000|Overall Study|Death|1|||
94589654|NCT00373113|323960869|FG001|Overall Study|Death|7|||
94589655|NCT00373113|323960868|FG000|Overall Study|Adverse Event|38|||
94589656|NCT00373113|323960869|FG001|Overall Study|Adverse Event|24|||
94589657|NCT00373113|323960868|FG000|Overall Study|Study terminated by sponsor|9|||
94589658|NCT00373113|323960869|FG001|Overall Study|Study terminated by sponsor|1|||
94589659|NCT00373113|323960868|FG000|Overall Study|Global deterioration of health status|10|||
94589660|NCT00373113|323960869|FG001|Overall Study|Global deterioration of health status|7|||
94589661|NCT00373113|323960868|FG000|Overall Study|Lost to Follow-up|1|||
94589662|NCT00373113|323960869|FG001|Overall Study|Lost to Follow-up|3|||
94589663|NCT00373113|323960868|FG000|Overall Study|Objective progression or relapse|150|||
94589664|NCT00373113|323960869|FG001|Overall Study|Objective progression or relapse|169|||
94589665|NCT00373113|323960868|FG000|Overall Study|Other|14|||
94589666|NCT00373113|323960869|FG001|Overall Study|Other|17|||
94589667|NCT00373113|323960868|FG000|Overall Study|Protocol Violation|5|||
94589668|NCT00373113|323960869|FG001|Overall Study|Protocol Violation|1|||
94589669|NCT00373113|323960868|FG000|Overall Study|Withdrawal by Subject|10|||
94589670|NCT00373113|323960869|FG001|Overall Study|Withdrawal by Subject|15|||
94589671|NCT04248491|323960870|FG000|Overall Study|Lost to Follow-up|1|||
94589672|NCT04248491|323960871|FG001|Overall Study|Lost to Follow-up|0|||
94589673|NCT04335136|323960874|FG000|Overall Study|Death|8|||
94589674|NCT04335136|323960875|FG001|Overall Study|Death|4|||
94589675|NCT04335136|323960874|FG000|Overall Study|Lost to Follow-up|2|||
94589676|NCT04335136|323960875|FG001|Overall Study|Lost to Follow-up|0|||
94589677|NCT04335136|323960874|FG000|Overall Study|Protocol Violation|1|||
94589678|NCT04335136|323960875|FG001|Overall Study|Protocol Violation|0|||
94589679|NCT04335136|323960874|FG000|Overall Study|Withdrawal by Subject|1|||
94589680|NCT04335136|323960875|FG001|Overall Study|Withdrawal by Subject|1|||
94589681|NCT04335136|323960874|FG000|Overall Study|Health-threatening condition|0|||
94589682|NCT04335136|323960875|FG001|Overall Study|Health-threatening condition|1|||
94589683|NCT04335136|323960874|FG000|Overall Study|Adverse Event|0|||
94589684|NCT04335136|323960875|FG001|Overall Study|Adverse Event|1|||
94589685|NCT04335136|323960874|FG000|Overall Study|Erroneously randomized|2|||
94589686|NCT04335136|323960875|FG001|Overall Study|Erroneously randomized|0|||
94589687|NCT00975689|323960876|FG000|Overall Study|Adverse Event|0|||
94589688|NCT00975689|323960877|FG001|Overall Study|Adverse Event|3|||
94589689|NCT00975689|323960876|FG000|Overall Study|Withdrawal by Subject|1|||
94589690|NCT00975689|323960877|FG001|Overall Study|Withdrawal by Subject|0|||
94589691|NCT00975689|323960876|FG000|Overall Study|Physician Decision|1|||
94589692|NCT00975689|323960877|FG001|Overall Study|Physician Decision|0|||
94589693|NCT03120351|323960878|FG000|Overall Study|Physician Decision|1|||
94589694|NCT03120351|323960879|FG001|Overall Study|Physician Decision|1|||
94589695|NCT00796978|323960880|FG000|Overall Study|Cardiac adverse event|5|||
94589696|NCT00796978|323960880|FG000|Overall Study|Adverse Event|4|||
94589697|NCT00796978|323960880|FG000|Overall Study|Withdrawal by Subject|3|||
94589698|NCT00905645|323960881|FG000|Overall Study|Death (not device related)|10|||
94589699|NCT00905645|323960882|FG001|Overall Study|Death (not device related)|4|||
94589700|NCT00905645|323960883|FG002|Overall Study|Death (not device related)|15|||
94589701|NCT00905645|323960884|FG003|Overall Study|Death (not device related)|8|||
94589702|NCT00905645|323960881|FG000|Overall Study|Explantation of study device(s)|78|||
94589703|NCT00905645|323960882|FG001|Overall Study|Explantation of study device(s)|47|||
94354646|NCT01000311|323080329|FG000|Overall Study|Lost to Follow-up|15|||
94354647|NCT01000311|323080330|FG001|Overall Study|Lost to Follow-up|24|||
94354648|NCT01000311|323080329|FG000|Overall Study|Protocol Violation|1|||
94354649|NCT01000311|323080330|FG001|Overall Study|Protocol Violation|2|||
94354650|NCT01000311|323080329|FG000|Overall Study|Inappropriate enrollment|2|||
94354651|NCT01000311|323080330|FG001|Overall Study|Inappropriate enrollment|0|||
94354652|NCT01000311|323080329|FG000|Overall Study|Administrative reason|9|||
94354653|NCT01000311|323080330|FG001|Overall Study|Administrative reason|15|||
94354654|NCT02815670|323080333|FG000|Overall Study|Prematurely discontinued of the trial|1|||
94354655|NCT00945815|323080334|FG000|Overall Study|Death|3|||
94354656|NCT00945815|323080334|FG000|Overall Study|Not protocol specified|1|||
94354657|NCT00945815|323080334|FG000|Overall Study|Ineligible|3|||
94354658|NCT00945815|323080334|FG000|Overall Study|Did not begin protocol therapy|1|||
94354659|NCT01728194|323080343|FG000|Overall Study|Lost to Follow-up|4|||
94354660|NCT01728194|323080344|FG001|Overall Study|Lost to Follow-up|3|||
94354661|NCT01728194|323080343|FG000|Overall Study|Physician Decision|4|||
94354662|NCT01728194|323080344|FG001|Overall Study|Physician Decision|0|||
94354663|NCT01728194|323080343|FG000|Overall Study|Withdrawal by Subject|7|||
94354664|NCT01728194|323080344|FG001|Overall Study|Withdrawal by Subject|3|||
94354665|NCT01728194|323080343|FG000|Overall Study|Perceived Medication Side Effects|4|||
94354666|NCT01728194|323080344|FG001|Overall Study|Perceived Medication Side Effects|0|||
94354667|NCT01728194|323080343|FG000|Overall Study|Family Member Request|1|||
94354668|NCT01728194|323080344|FG001|Overall Study|Family Member Request|0|||
94354669|NCT03289676|323080345|FG000|Overall Study|Withdrawal by Subject|2|||
94354670|NCT03289676|323080346|FG001|Overall Study|Withdrawal by Subject|0|||
94354671|NCT03289676|323080345|FG000|Overall Study|Protocol Violation|2|||
94354672|NCT03289676|323080346|FG001|Overall Study|Protocol Violation|0|||
94354673|NCT03289676|323080345|FG000|Overall Study|Lost to Follow-up|0|||
94354674|NCT03289676|323080346|FG001|Overall Study|Lost to Follow-up|1|||
94354675|NCT01314261|323080347|FG000|Overall Study|Adverse Event|1|||
94589704|NCT00905645|323960883|FG002|Overall Study|Explantation of study device(s)|28|||
94589705|NCT00905645|323960884|FG003|Overall Study|Explantation of study device(s)|21|||
94589706|NCT00905645|323960881|FG000|Overall Study|Subject Request|41|||
94589707|NCT00905645|323960882|FG001|Overall Study|Subject Request|17|||
94354676|NCT01314261|323080348|FG001|Overall Study|Adverse Event|0|||
94354677|NCT01314261|323080349|FG002|Overall Study|Adverse Event|0|||
94354678|NCT01314261|323080350|FG003|Overall Study|Adverse Event|0|||
94354679|NCT01314261|323080347|FG000|Overall Study|Withdrawal by Subject|0|||
94354680|NCT01314261|323080348|FG001|Overall Study|Withdrawal by Subject|3|||
94354681|NCT01314261|323080349|FG002|Overall Study|Withdrawal by Subject|1|||
94354682|NCT01314261|323080350|FG003|Overall Study|Withdrawal by Subject|0|||
94354683|NCT01314261|323080347|FG000|Overall Study|Lost to Follow-up|1|||
94354684|NCT01314261|323080348|FG001|Overall Study|Lost to Follow-up|0|||
94354685|NCT01314261|323080349|FG002|Overall Study|Lost to Follow-up|2|||
94354686|NCT01314261|323080350|FG003|Overall Study|Lost to Follow-up|2|||
94354687|NCT01314261|323080347|FG000|Overall Study|Virologic Failure|0|||
94354688|NCT01314261|323080348|FG001|Overall Study|Virologic Failure|1|||
94354689|NCT01314261|323080349|FG002|Overall Study|Virologic Failure|0|||
94354690|NCT01314261|323080350|FG003|Overall Study|Virologic Failure|1|||
94354691|NCT02129192|323080351|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
94354692|NCT02129192|323080352|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
94354693|NCT01231620|323080353|FG000|Overall Study|Physician Decision|3|||
94354694|NCT01231620|323080354|FG001|Overall Study|Physician Decision|5|||
94354695|NCT01231620|323080355|FG002|Overall Study|Physician Decision|10|||
94354696|NCT01231620|323080353|FG000|Overall Study|Death|12|||
94354697|NCT01231620|323080354|FG001|Overall Study|Death|14|||
94354698|NCT01231620|323080355|FG002|Overall Study|Death|11|||
94354699|NCT01231620|323080353|FG000|Overall Study|Adverse Event|2|||
94354700|NCT01231620|323080354|FG001|Overall Study|Adverse Event|2|||
94354701|NCT01231620|323080355|FG002|Overall Study|Adverse Event|1|||
94354702|NCT01231620|323080353|FG000|Overall Study|Withdrawal by Subject|6|||
94354703|NCT01231620|323080354|FG001|Overall Study|Withdrawal by Subject|6|||
94354704|NCT01231620|323080355|FG002|Overall Study|Withdrawal by Subject|8|||
94354705|NCT01231620|323080353|FG000|Overall Study|Lost to Follow-up|3|||
94354706|NCT01231620|323080354|FG001|Overall Study|Lost to Follow-up|4|||
94354707|NCT01231620|323080355|FG002|Overall Study|Lost to Follow-up|9|||
94354708|NCT02400281|323080356|FG000|Overall Study|Adverse Event|0|||
94354709|NCT02400281|323080357|FG001|Overall Study|Adverse Event|0|||
94354710|NCT02400281|323080358|FG002|Overall Study|Adverse Event|1|||
94354711|NCT02400281|323080359|FG003|Overall Study|Adverse Event|0|||
94354712|NCT02400281|323080360|FG004|Overall Study|Adverse Event|1|||
94354713|NCT02400281|323080361|FG005|Overall Study|Adverse Event|0|||
94354714|NCT02400281|323080356|FG000|Overall Study|Physician Decision|0|||
94354715|NCT02400281|323080357|FG001|Overall Study|Physician Decision|0|||
94354716|NCT02400281|323080358|FG002|Overall Study|Physician Decision|1|||
94354717|NCT02400281|323080359|FG003|Overall Study|Physician Decision|0|||
94354718|NCT02400281|323080360|FG004|Overall Study|Physician Decision|0|||
94354719|NCT02400281|323080361|FG005|Overall Study|Physician Decision|0|||
94354720|NCT04524507|323080362|FG000|Overall Study|Lost to Follow-up|2|||
94354721|NCT04524507|323080363|FG001|Overall Study|Lost to Follow-up|4|||
94354722|NCT04524507|323080362|FG000|Overall Study|Withdrawal by Subject|2|||
94354723|NCT04524507|323080363|FG001|Overall Study|Withdrawal by Subject|9|||
94354724|NCT04524507|323080362|FG000|Overall Study|Death|2|||
94354725|NCT04524507|323080363|FG001|Overall Study|Death|10|||
94354726|NCT00412360|323080364|FG000|Overall Study|Lost to Follow-up|0|||
94354727|NCT00412360|323080365|FG001|Overall Study|Lost to Follow-up|1|||
94354728|NCT00412360|323080364|FG000|Overall Study|Not Transplanted|1|||
94354729|NCT00412360|323080365|FG001|Overall Study|Not Transplanted|2|||
94354730|NCT02711306|323080366|FG000|Overall Study|Withdrawal by Subject|2|||
94354731|NCT02711306|323080367|FG001|Overall Study|Withdrawal by Subject|2|||
94354732|NCT02576652|323080369|FG000|Overall Study|Withdrawal by Subject|2|||
94354733|NCT01087944|323080378|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
94354734|NCT01087944|323080379|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
94354735|NCT01087944|323080378|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
94354736|NCT01087944|323080379|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
94354737|NCT03575975|323080382|FG000|Overall Study|Lost to Follow-up|1|||
94354738|NCT03575975|323080383|FG001|Overall Study|Lost to Follow-up|0|||
94354739|NCT03575975|323080384|FG002|Overall Study|Lost to Follow-up|0|||
94354740|NCT01393444|323080385|FG000|Overall Study|Withdrawal by Subject|1|||
94354741|NCT01393444|323080385|FG000|Overall Study|Determined ineligible during screening.|2|||
94354742|NCT01684930|323081907|FG000|Overall Study|Withdrawal by Subject|3|||
94354743|NCT01684930|323081908|FG001|Overall Study|Withdrawal by Subject|1|||
94354744|NCT03922945|323081911|FG000|Overall Study|Adverse Event|1|||
94354745|NCT03922945|323081912|FG001|Overall Study|Adverse Event|1|||
94354746|NCT03922945|323081913|FG002|Overall Study|Adverse Event|2|||
94589708|NCT00905645|323960883|FG002|Overall Study|Subject Request|13|||
94456121|NCT02244463|323458200|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
94456122|NCT02244463|323458201|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
94456123|NCT02244463|323458202|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
94354747|NCT03922945|323081911|FG000|Overall Study|Lost to Follow-up|13|||
94354748|NCT03922945|323081912|FG001|Overall Study|Lost to Follow-up|9|||
94354749|NCT03922945|323081913|FG002|Overall Study|Lost to Follow-up|20|||
94354750|NCT03922945|323081911|FG000|Overall Study|Lack of Efficacy|2|||
94354751|NCT03922945|323081912|FG001|Overall Study|Lack of Efficacy|0|||
94354752|NCT03922945|323081913|FG002|Overall Study|Lack of Efficacy|1|||
94354753|NCT03922945|323081911|FG000|Overall Study|Protocol Non-Compliance|0|||
94354754|NCT03922945|323081912|FG001|Overall Study|Protocol Non-Compliance|0|||
94354755|NCT03922945|323081913|FG002|Overall Study|Protocol Non-Compliance|1|||
94354756|NCT03922945|323081911|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
94354757|NCT03922945|323081912|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
94354758|NCT03922945|323081913|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
94354759|NCT03922945|323081911|FG000|Overall Study|All Other Personal Reasons|1|||
94354760|NCT03922945|323081912|FG001|Overall Study|All Other Personal Reasons|1|||
94354761|NCT03922945|323081913|FG002|Overall Study|All Other Personal Reasons|2|||
94354762|NCT03159455|323081914|FG000|Overall Study|Adverse Event|0|||
94354763|NCT03159455|323081915|FG001|Overall Study|Adverse Event|0|||
94354764|NCT03159455|323081916|FG002|Overall Study|Adverse Event|0|||
94354765|NCT03159455|323081917|FG003|Overall Study|Adverse Event|0|||
94354766|NCT03159455|323081918|FG004|Overall Study|Adverse Event|0|||
94354767|NCT03159455|323081919|FG005|Overall Study|Adverse Event|1|||
94354768|NCT02058940|323081920|FG000|Overall Study|Discharged from Critical Care Unit|1|||
94354769|NCT00548340|323081921|FG000|Overall Study|Protocol Violation|2|||
94354770|NCT00548340|323081922|FG001|Overall Study|Protocol Violation|3|||
94354771|NCT00548340|323081923|FG002|Overall Study|Protocol Violation|3|||
94354772|NCT00548340|323081921|FG000|Overall Study|Adverse Event|2|||
94354773|NCT00548340|323081922|FG001|Overall Study|Adverse Event|2|||
94354774|NCT00548340|323081923|FG002|Overall Study|Adverse Event|2|||
94354775|NCT00548340|323081921|FG000|Overall Study|Lost to Follow-up|1|||
94354776|NCT00548340|323081922|FG001|Overall Study|Lost to Follow-up|1|||
94354777|NCT00548340|323081923|FG002|Overall Study|Lost to Follow-up|0|||
94354778|NCT00548340|323081921|FG000|Overall Study|Withdrawal by Subject|2|||
94354779|NCT00548340|323081922|FG001|Overall Study|Withdrawal by Subject|4|||
94354780|NCT00548340|323081923|FG002|Overall Study|Withdrawal by Subject|3|||
94354781|NCT00548340|323081921|FG000|Overall Study|Other|1|||
94354782|NCT00548340|323081922|FG001|Overall Study|Other|1|||
94354783|NCT00548340|323081923|FG002|Overall Study|Other|1|||
94354784|NCT02600559|323081926|FG000|Overall Study|Withdrawal by Subject|3|||
94589709|NCT00905645|323960884|FG003|Overall Study|Subject Request|11|||
94589710|NCT00905645|323960881|FG000|Overall Study|Lost to Follow-up|299|||
94456124|NCT02244463|323458197|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
94456125|NCT02244463|323458198|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
94456126|NCT02244463|323458199|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
94456127|NCT02244463|323458200|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
94456128|NCT02244463|323458201|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
94456129|NCT02244463|323458202|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
94456130|NCT02244463|323458197|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
94589711|NCT00905645|323960882|FG001|Overall Study|Lost to Follow-up|103|||
94589712|NCT00905645|323960883|FG002|Overall Study|Lost to Follow-up|51|||
94243933|NCT04488770|322686970|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
94243934|NCT04488770|322686971|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
94243935|NCT04488770|322686972|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
94243936|NCT04488770|322686973|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
94243937|NCT01867333|322686974|FG000|Overall Study|Withdrawal by Subject|1|||
94243938|NCT01867333|322686975|FG001|Overall Study|Withdrawal by Subject|0|||
94243939|NCT01867333|322686974|FG000|Overall Study|Adverse Event|1|||
94243940|NCT01867333|322686975|FG001|Overall Study|Adverse Event|0|||
94243941|NCT01867333|322686974|FG000|Overall Study|Participant choice|1|||
94243942|NCT01867333|322686975|FG001|Overall Study|Participant choice|2|||
94243943|NCT01867333|322686974|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
94243944|NCT01867333|322686975|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
94243945|NCT01867333|322686974|FG000|Overall Study|Death|0|||
94243946|NCT01867333|322686975|FG001|Overall Study|Death|1|||
94243947|NCT01867333|322686974|FG000|Overall Study|Physician Decision|3|||
94243948|NCT01867333|322686975|FG001|Overall Study|Physician Decision|2|||
94243949|NCT01867333|322686974|FG000|Overall Study|Switched to alternative treatment|1|||
94243950|NCT01867333|322686975|FG001|Overall Study|Switched to alternative treatment|0|||
94243951|NCT02416453|322686976|FG000|Overall Study|Adverse Event|0|||
94243952|NCT02416453|322686977|FG001|Overall Study|Adverse Event|0|||
94243953|NCT02416453|322686978|FG002|Overall Study|Adverse Event|0|||
94243954|NCT02416453|322686979|FG003|Overall Study|Adverse Event|2|||
94243955|NCT02416453|322686980|FG004|Overall Study|Adverse Event|0|||
94354785|NCT02600559|323081926|FG000|Overall Study|Lost to Follow-up|20|||
94354786|NCT01982942|323081927|FG000|Overall Study|Adverse Event|10|||
94589713|NCT00905645|323960884|FG003|Overall Study|Lost to Follow-up|12|||
94243956|NCT02416453|322686981|FG005|Overall Study|Adverse Event|1|||
94243957|NCT02416453|322686982|FG006|Overall Study|Adverse Event|0|||
94354787|NCT01982942|323081928|FG001|Overall Study|Adverse Event|5|||
94354788|NCT01982942|323081927|FG000|Overall Study|Lost to Follow-up|4|||
94354789|NCT01982942|323081928|FG001|Overall Study|Lost to Follow-up|3|||
94354790|NCT01982942|323081927|FG000|Overall Study|Multiple sclerosis progression|3|||
94354791|NCT01982942|323081928|FG001|Overall Study|Multiple sclerosis progression|2|||
94354792|NCT01982942|323081927|FG000|Overall Study|Wanted to try therapy not permitted|1|||
94354793|NCT01982942|323081928|FG001|Overall Study|Wanted to try therapy not permitted|0|||
94354794|NCT01982942|323081927|FG000|Overall Study|Subject declined future visits|0|||
94589714|NCT01049009|323960886|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
94243958|NCT02416453|322686983|FG007|Overall Study|Adverse Event|0|||
94243959|NCT02416453|322686984|FG008|Overall Study|Adverse Event|0|||
94243960|NCT02416453|322686985|FG009|Overall Study|Adverse Event|0|||
94243961|NCT02416453|322686986|FG010|Overall Study|Adverse Event|0|||
94243962|NCT02416453|322686976|FG000|Overall Study|Lost to Follow-up|1|||
94243963|NCT02416453|322686977|FG001|Overall Study|Lost to Follow-up|3|||
94243964|NCT02416453|322686978|FG002|Overall Study|Lost to Follow-up|0|||
94243965|NCT02416453|322686979|FG003|Overall Study|Lost to Follow-up|8|||
94243966|NCT02416453|322686980|FG004|Overall Study|Lost to Follow-up|0|||
94243967|NCT02416453|322686981|FG005|Overall Study|Lost to Follow-up|5|||
94243968|NCT02416453|322686982|FG006|Overall Study|Lost to Follow-up|1|||
94243969|NCT02416453|322686983|FG007|Overall Study|Lost to Follow-up|3|||
94243970|NCT02416453|322686984|FG008|Overall Study|Lost to Follow-up|1|||
94243971|NCT02416453|322686985|FG009|Overall Study|Lost to Follow-up|0|||
94243972|NCT02416453|322686986|FG010|Overall Study|Lost to Follow-up|0|||
94243973|NCT02416453|322686976|FG000|Overall Study|Physician Decision|0|||
94243974|NCT02416453|322686977|FG001|Overall Study|Physician Decision|0|||
94243975|NCT02416453|322686978|FG002|Overall Study|Physician Decision|0|||
94243976|NCT02416453|322686979|FG003|Overall Study|Physician Decision|0|||
94243977|NCT02416453|322686980|FG004|Overall Study|Physician Decision|0|||
94243978|NCT02416453|322686981|FG005|Overall Study|Physician Decision|1|||
94243979|NCT02416453|322686982|FG006|Overall Study|Physician Decision|1|||
94243980|NCT02416453|322686983|FG007|Overall Study|Physician Decision|1|||
94243981|NCT02416453|322686984|FG008|Overall Study|Physician Decision|0|||
94243982|NCT02416453|322686985|FG009|Overall Study|Physician Decision|0|||
94243983|NCT02416453|322686986|FG010|Overall Study|Physician Decision|0|||
94243984|NCT02416453|322686976|FG000|Overall Study|Withdrawal by Subject|2|||
94243985|NCT02416453|322686977|FG001|Overall Study|Withdrawal by Subject|0|||
94243986|NCT02416453|322686978|FG002|Overall Study|Withdrawal by Subject|0|||
94243987|NCT02416453|322686979|FG003|Overall Study|Withdrawal by Subject|5|||
94243988|NCT02416453|322686980|FG004|Overall Study|Withdrawal by Subject|1|||
94243989|NCT02416453|322686981|FG005|Overall Study|Withdrawal by Subject|8|||
94243990|NCT02416453|322686982|FG006|Overall Study|Withdrawal by Subject|0|||
94243991|NCT02416453|322686983|FG007|Overall Study|Withdrawal by Subject|8|||
94243992|NCT02416453|322686984|FG008|Overall Study|Withdrawal by Subject|4|||
94243993|NCT02416453|322686985|FG009|Overall Study|Withdrawal by Subject|0|||
94243994|NCT02416453|322686986|FG010|Overall Study|Withdrawal by Subject|0|||
94243995|NCT02416453|322686976|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
94243996|NCT02416453|322686977|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
94243997|NCT02416453|322686978|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
94243998|NCT02416453|322686979|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
94243999|NCT02416453|322686980|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
94244000|NCT02416453|322686981|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
94244001|NCT02416453|322686982|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
94244002|NCT02416453|322686983|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
94244003|NCT02416453|322686984|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
94244004|NCT02416453|322686985|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
94244005|NCT02416453|322686986|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
94244006|NCT02416453|322686976|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
94244007|NCT02416453|322686977|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
94244008|NCT02416453|322686978|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
94244009|NCT02416453|322686979|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
94244010|NCT02416453|322686980|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
94244011|NCT02416453|322686981|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
94244012|NCT02416453|322686982|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
94244013|NCT02416453|322686983|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
94244014|NCT02416453|322686984|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
94244015|NCT02416453|322686985|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
94244016|NCT02416453|322686986|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
94244017|NCT04145700|322686988|FG000|Overall Study|Withdrawal by Subject|8|||
94244018|NCT04145700|322686989|FG001|Overall Study|Withdrawal by Subject|3|||
94244019|NCT03525392|322686990|FG000|Overall Study|Adverse Event|1|||
94244020|NCT03525392|322686991|FG001|Overall Study|Adverse Event|0|||
94244021|NCT03525392|322686992|FG002|Overall Study|Adverse Event|2|||
94244022|NCT03525392|322686993|FG003|Overall Study|Adverse Event|0|||
94244023|NCT03525392|322686994|FG004|Overall Study|Adverse Event|0|||
94244024|NCT03525392|322686990|FG000|Overall Study|Progressive disease|0|||
94244025|NCT03525392|322686991|FG001|Overall Study|Progressive disease|1|||
94589715|NCT01049009|323960887|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
94244026|NCT03525392|322686992|FG002|Overall Study|Progressive disease|1|||
94244027|NCT03525392|322686993|FG003|Overall Study|Progressive disease|3|||
94244028|NCT03525392|322686994|FG004|Overall Study|Progressive disease|1|||
94244029|NCT03284203|322686997|FG000|Overall Study|Lost to Follow-up|3|||
94244030|NCT01253018|322686998|FG000|Overall Study|Lost to Follow-up|1|||
94244031|NCT01253018|322686999|FG001|Overall Study|Lost to Follow-up|1|||
94244032|NCT01253018|322686998|FG000|Overall Study|Robot Repair Issues|2|||
94244033|NCT01253018|322686999|FG001|Overall Study|Robot Repair Issues|0|||
94244034|NCT01253018|322686998|FG000|Overall Study|Withdrawal by Subject|1|||
94244035|NCT01253018|322686999|FG001|Overall Study|Withdrawal by Subject|1|||
94244036|NCT04276415|322687000|FG000|Overall Study|Adverse Event|0|||
94244037|NCT04276415|322687001|FG001|Overall Study|Adverse Event|0|||
94244038|NCT04276415|322687002|FG002|Overall Study|Adverse Event|0|||
94244039|NCT04276415|322687003|FG003|Overall Study|Adverse Event|3|||
94244040|NCT04276415|322687004|FG004|Overall Study|Adverse Event|0|||
94244041|NCT04276415|322687005|FG005|Overall Study|Adverse Event|0|||
94244042|NCT04276415|322687000|FG000|Overall Study|Clinical progression|1|||
94244043|NCT04276415|322687001|FG001|Overall Study|Clinical progression|1|||
94244044|NCT04276415|322687002|FG002|Overall Study|Clinical progression|0|||
94244045|NCT04276415|322687003|FG003|Overall Study|Clinical progression|0|||
94244046|NCT04276415|322687004|FG004|Overall Study|Clinical progression|1|||
94244047|NCT04276415|322687005|FG005|Overall Study|Clinical progression|0|||
94244048|NCT04276415|322687000|FG000|Overall Study|Other|0|||
94244049|NCT04276415|322687001|FG001|Overall Study|Other|0|||
94244050|NCT04276415|322687002|FG002|Overall Study|Other|0|||
94244051|NCT04276415|322687003|FG003|Overall Study|Other|1|||
94244052|NCT04276415|322687004|FG004|Overall Study|Other|0|||
94244053|NCT04276415|322687005|FG005|Overall Study|Other|0|||
94244054|NCT04276415|322687000|FG000|Overall Study|Physician Decision|0|||
94244055|NCT04276415|322687001|FG001|Overall Study|Physician Decision|0|||
94244056|NCT04276415|322687002|FG002|Overall Study|Physician Decision|1|||
94244057|NCT04276415|322687003|FG003|Overall Study|Physician Decision|3|||
94244058|NCT04276415|322687004|FG004|Overall Study|Physician Decision|2|||
94244059|NCT04276415|322687005|FG005|Overall Study|Physician Decision|0|||
94244060|NCT04276415|322687000|FG000|Overall Study|Progressive disease|3|||
94244061|NCT04276415|322687001|FG001|Overall Study|Progressive disease|3|||
94244062|NCT04276415|322687002|FG002|Overall Study|Progressive disease|4|||
94244063|NCT04276415|322687003|FG003|Overall Study|Progressive disease|5|||
94244064|NCT04276415|322687004|FG004|Overall Study|Progressive disease|1|||
94244065|NCT04276415|322687005|FG005|Overall Study|Progressive disease|2|||
94244066|NCT04276415|322687000|FG000|Overall Study|Withdrawal by patient|0|||
94244067|NCT04276415|322687001|FG001|Overall Study|Withdrawal by patient|0|||
94244068|NCT04276415|322687002|FG002|Overall Study|Withdrawal by patient|0|||
94244069|NCT04276415|322687003|FG003|Overall Study|Withdrawal by patient|1|||
94244070|NCT04276415|322687004|FG004|Overall Study|Withdrawal by patient|2|||
94244071|NCT04276415|322687005|FG005|Overall Study|Withdrawal by patient|0|||
94244072|NCT02387970|322687008|FG000|Overall Study|Did not complete 1-year follow up|1|||
94244073|NCT02387970|322687009|FG001|Overall Study|Did not complete 1-year follow up|2|||
94244074|NCT00283244|322687014|FG000|Overall Study|Adverse Event|0|||
94244075|NCT00283244|322687015|FG001|Overall Study|Adverse Event|8|||
94244076|NCT00283244|322687016|FG002|Overall Study|Adverse Event|11|||
94244077|NCT00283244|322687014|FG000|Overall Study|Death|4|||
94244078|NCT00283244|322687015|FG001|Overall Study|Death|3|||
94244079|NCT00283244|322687016|FG002|Overall Study|Death|2|||
94244080|NCT00283244|322687014|FG000|Overall Study|Lack of Efficacy|8|||
94244081|NCT00283244|322687015|FG001|Overall Study|Lack of Efficacy|32|||
94244082|NCT00283244|322687016|FG002|Overall Study|Lack of Efficacy|26|||
94244083|NCT00283244|322687014|FG000|Overall Study|Withdrawal by Subject|1|||
94244084|NCT00283244|322687015|FG001|Overall Study|Withdrawal by Subject|2|||
94244085|NCT00283244|322687016|FG002|Overall Study|Withdrawal by Subject|2|||
94244086|NCT00283244|322687014|FG000|Overall Study|Physician Decision|0|||
94244087|NCT00283244|322687015|FG001|Overall Study|Physician Decision|0|||
94244088|NCT00283244|322687016|FG002|Overall Study|Physician Decision|1|||
94244089|NCT00283244|322687014|FG000|Overall Study|Medical illness (other complicating dz)|4|||
94244090|NCT00283244|322687015|FG001|Overall Study|Medical illness (other complicating dz)|3|||
94244091|NCT00283244|322687016|FG002|Overall Study|Medical illness (other complicating dz)|6|||
94244092|NCT00283244|322687014|FG000|Overall Study|Clinical deterioration|1|||
94244093|NCT00283244|322687015|FG001|Overall Study|Clinical deterioration|3|||
94244094|NCT00283244|322687016|FG002|Overall Study|Clinical deterioration|3|||
94244095|NCT02145468|322687017|FG000|Overall Study|Withdrawal by Subject|5|||
94244096|NCT02145468|322687018|FG001|Overall Study|Withdrawal by Subject|8|||
94244097|NCT02001064|322687021|FG000|Overall Study|Withdrawal by Subject|2|||
94456131|NCT02244463|323458198|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
94244098|NCT02001064|322687022|FG001|Overall Study|Withdrawal by Subject|1|||
94244099|NCT01609062|322687023|FG000|Extension Phase|Terminated by Sponsor|14|||
94244100|NCT01609062|322687024|FG001|Extension Phase|Terminated by Sponsor|9|||
94244101|NCT01609062|322687023|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
94244102|NCT01609062|322687024|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
94244103|NCT01609062|322687023|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
94244104|NCT01609062|322687024|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
94244105|NCT00438672|322687025|FG000|Overall Study|Lost to Follow-up|7|||
94244106|NCT00438672|322687026|FG001|Overall Study|Lost to Follow-up|9|||
94354795|NCT01982942|323081928|FG001|Overall Study|Subject declined future visits|1|||
94354796|NCT01982942|323081927|FG000|Overall Study|Left geographical area|2|||
94354797|NCT01982942|323081928|FG001|Overall Study|Left geographical area|0|||
94354798|NCT01982942|323081927|FG000|Overall Study|Too many pills|1|||
94354799|NCT01982942|323081928|FG001|Overall Study|Too many pills|0|||
94354800|NCT01982942|323081927|FG000|Overall Study|MS Relapse|0|||
94354801|NCT01982942|323081928|FG001|Overall Study|MS Relapse|1|||
94354802|NCT01982942|323081927|FG000|Overall Study|Chose to join a stem cell trial|0|||
94354803|NCT01982942|323081928|FG001|Overall Study|Chose to join a stem cell trial|1|||
94354804|NCT01982942|323081927|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
94354805|NCT01982942|323081928|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
94354806|NCT04511533|323081929|FG000|Treatment|Other|2|||
94354807|NCT04511533|323081929|FG000|Treatment|Withdrawal by Subject|11|||
94354808|NCT04511533|323081929|FG000|Treatment|Death|5|||
94354809|NCT04511533|323081929|FG000|Treatment|Physician Decision|1|||
94354810|NCT04511533|323081929|FG000|Treatment|Progressive Disease|61|||
94354811|NCT04511533|323081929|FG000|Follow-Up|Other|7|||
94354812|NCT04511533|323081929|FG000|Follow-Up|Withdrawal by Subject|5|||
94354813|NCT04511533|323081929|FG000|Follow-Up|Lost to Follow-up|2|||
94354814|NCT04511533|323081929|FG000|Follow-Up|Death|4|||
94354815|NCT01224171|323081930|FG000|Overall Study|Adverse Event|8|||
94354816|NCT01224171|323081931|FG001|Overall Study|Adverse Event|4|||
94354817|NCT01224171|323081930|FG000|Overall Study|Protocol Violation|0|||
94354818|NCT01224171|323081931|FG001|Overall Study|Protocol Violation|1|||
94354819|NCT01224171|323081930|FG000|Overall Study|Lack of Efficacy|5|||
94354820|NCT01224171|323081931|FG001|Overall Study|Lack of Efficacy|1|||
94354821|NCT01224171|323081930|FG000|Overall Study|Withdrawal of Consent|2|||
94354822|NCT01224171|323081931|FG001|Overall Study|Withdrawal of Consent|4|||
94354823|NCT01224171|323081930|FG000|Overall Study|Lost to Follow-up|0|||
94354824|NCT01224171|323081931|FG001|Overall Study|Lost to Follow-up|3|||
94354825|NCT00635804|323081932|FG000|Overall Study|Adverse Event|0|||
94354826|NCT00635804|323081933|FG001|Overall Study|Adverse Event|0|||
94354827|NCT00635804|323081934|FG002|Overall Study|Adverse Event|0|||
94354828|NCT00635804|323081935|FG003|Overall Study|Adverse Event|0|||
94354829|NCT00635804|323081936|FG004|Overall Study|Adverse Event|0|||
94354830|NCT00635804|323081937|FG005|Overall Study|Adverse Event|1|||
94354831|NCT00635804|323081938|FG006|Overall Study|Adverse Event|0|||
94354832|NCT00635804|323081939|FG007|Overall Study|Adverse Event|0|||
94354833|NCT00635804|323081932|FG000|Overall Study|Withdrawal by Subject|1|||
94354834|NCT00635804|323081933|FG001|Overall Study|Withdrawal by Subject|0|||
94354835|NCT00635804|323081934|FG002|Overall Study|Withdrawal by Subject|0|||
94354836|NCT00635804|323081935|FG003|Overall Study|Withdrawal by Subject|0|||
94354837|NCT00635804|323081936|FG004|Overall Study|Withdrawal by Subject|0|||
94354838|NCT00635804|323081937|FG005|Overall Study|Withdrawal by Subject|0|||
94354839|NCT00635804|323081938|FG006|Overall Study|Withdrawal by Subject|0|||
94354840|NCT00635804|323081939|FG007|Overall Study|Withdrawal by Subject|0|||
94354841|NCT01270139|323081940|FG000|Overall Study|Adverse Event|8|||
94354842|NCT01270139|323081941|FG001|Overall Study|Adverse Event|17|||
94354843|NCT01270139|323081942|FG002|Overall Study|Adverse Event|18|||
94354844|NCT01270139|323081940|FG000|Overall Study|Lost to Follow-up|10|||
94354845|NCT01270139|323081941|FG001|Overall Study|Lost to Follow-up|9|||
94354846|NCT01270139|323081942|FG002|Overall Study|Lost to Follow-up|2|||
94354847|NCT03704194|323081943|FG000|Overall Study|Withdrawal by Subject|0|||
94354848|NCT03704194|323081944|FG001|Overall Study|Withdrawal by Subject|1|||
94354849|NCT02452320|323081945|FG000|Overall Study|Adverse Event|0|||
94354850|NCT02452320|323081946|FG001|Overall Study|Adverse Event|1|||
94354851|NCT03382639|323081947|FG000|Overall Study|Adverse Event|2|||
94354852|NCT03382639|323081948|FG001|Overall Study|Adverse Event|0|||
94354853|NCT03382639|323081949|FG002|Overall Study|Adverse Event|1|||
94354854|NCT03382639|323081950|FG003|Overall Study|Adverse Event|1|||
94354855|NCT03382639|323081947|FG000|Overall Study|Lost to Follow-up|1|||
94354856|NCT03382639|323081948|FG001|Overall Study|Lost to Follow-up|0|||
94354857|NCT03382639|323081949|FG002|Overall Study|Lost to Follow-up|0|||
94354858|NCT03382639|323081950|FG003|Overall Study|Lost to Follow-up|0|||
94354859|NCT03382639|323081947|FG000|Overall Study|Withdrawal by Subject|4|||
94354860|NCT03382639|323081948|FG001|Overall Study|Withdrawal by Subject|3|||
94354861|NCT03382639|323081949|FG002|Overall Study|Withdrawal by Subject|2|||
94354862|NCT03382639|323081950|FG003|Overall Study|Withdrawal by Subject|3|||
94354863|NCT03382639|323081947|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
94354864|NCT03382639|323081948|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
94354865|NCT03382639|323081949|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
94354866|NCT03382639|323081950|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
94354867|NCT03382639|323081947|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
94354868|NCT03382639|323081948|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
94354869|NCT03382639|323081949|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
94354870|NCT03382639|323081950|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
94354871|NCT03382639|323081947|FG000|Overall Study|Other|2|||
94354872|NCT03382639|323081948|FG001|Overall Study|Other|0|||
94354873|NCT03382639|323081949|FG002|Overall Study|Other|0|||
94354874|NCT03382639|323081950|FG003|Overall Study|Other|3|||
94354875|NCT02477215|323081959|FG000|Dose Escalation Phase|Physician Decision|1|||
94354876|NCT02477215|323081960|FG001|Dose Escalation Phase|Physician Decision|2|||
94354877|NCT02477215|323081961|FG002|Dose Escalation Phase|Physician Decision|0|||
94354878|NCT02477215|323081959|FG000|Fixed Dose Phase|Physician Decision|0|||
94354879|NCT02477215|323081960|FG001|Fixed Dose Phase|Physician Decision|7|||
94354880|NCT02477215|323081961|FG002|Fixed Dose Phase|Physician Decision|0|||
94354881|NCT00649220|323081966|FG000|Overall Study|Adverse Event|2|||
94354882|NCT00649220|323081966|FG000|Overall Study|Withdrawal by Subject|1|||
94354883|NCT03339999|323081967|FG000|Overall Study|Adverse Event|1|||
94354884|NCT03339999|323081968|FG001|Overall Study|Adverse Event|2|||
94354885|NCT03339999|323081969|FG002|Overall Study|Adverse Event|2|||
94354886|NCT03339999|323081970|FG003|Overall Study|Adverse Event|1|||
94354887|NCT03339999|323081967|FG000|Overall Study|Lack of Efficacy|0|||
94354888|NCT03339999|323081968|FG001|Overall Study|Lack of Efficacy|1|||
94354889|NCT03339999|323081969|FG002|Overall Study|Lack of Efficacy|0|||
94354890|NCT03339999|323081970|FG003|Overall Study|Lack of Efficacy|0|||
94354891|NCT03339999|323081967|FG000|Overall Study|Lost to Follow-up|0|||
94354892|NCT03339999|323081968|FG001|Overall Study|Lost to Follow-up|0|||
94354893|NCT03339999|323081969|FG002|Overall Study|Lost to Follow-up|0|||
94354894|NCT03339999|323081970|FG003|Overall Study|Lost to Follow-up|1|||
94354895|NCT03339999|323081967|FG000|Overall Study|Study Terminated by Sponsor|6|||
94354896|NCT03339999|323081968|FG001|Overall Study|Study Terminated by Sponsor|3|||
94354897|NCT03339999|323081969|FG002|Overall Study|Study Terminated by Sponsor|4|||
94354898|NCT03339999|323081970|FG003|Overall Study|Study Terminated by Sponsor|3|||
94354899|NCT04594213|323081971|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
94354900|NCT04594213|323081972|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
94354901|NCT04594213|323081973|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
94354902|NCT04594213|323081974|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
94354903|NCT04594213|323081975|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
94354904|NCT04594213|323081976|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
94354905|NCT04594213|323081971|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
94354906|NCT04594213|323081972|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
94354907|NCT04594213|323081973|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
94354908|NCT04594213|323081974|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
94354909|NCT04594213|323081975|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
94354910|NCT04594213|323081976|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
94354911|NCT04594213|323081971|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
94354912|NCT04594213|323081972|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
94659757|NCT00116805|324209956|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
94354913|NCT04594213|323081973|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
94354914|NCT04594213|323081974|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
94354915|NCT04594213|323081975|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
94354916|NCT04594213|323081976|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
94354917|NCT04594213|323081971|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
94354918|NCT04594213|323081972|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
94354919|NCT04594213|323081973|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
94589716|NCT01049009|323960886|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
94589717|NCT01049009|323960887|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
94589718|NCT01049009|323960886|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
94589719|NCT01049009|323960887|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
94589720|NCT01049009|323960886|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
94589721|NCT01049009|323960887|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
94589722|NCT02350478|323960888|FG000|Overall Study|Lost to Follow-up|5|||
94589723|NCT02350478|323960889|FG001|Overall Study|Lost to Follow-up|1|||
94659758|NCT00116805|324209957|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
94244107|NCT04157400|322687027|FG000|Overall Study|Withdrawal by Subject|1|||
94244108|NCT04157400|322687027|FG000|Overall Study|Lost to Follow-up|3|||
94244109|NCT04828837|322687032|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
94244110|NCT04828837|322687033|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
94244111|NCT04828837|322687032|FG000|Overall Study|Lost to Follow-up|2|||
94244112|NCT04828837|322687033|FG001|Overall Study|Lost to Follow-up|6|||
94244113|NCT04828837|322687032|FG000|Overall Study|Lack of Efficacy|1|||
94244114|NCT04828837|322687033|FG001|Overall Study|Lack of Efficacy|0|||
94244115|NCT04828837|322687032|FG000|Overall Study|Admitted due to pneumothorax.|1|||
94244116|NCT04828837|322687033|FG001|Overall Study|Admitted due to pneumothorax.|0|||
94244117|NCT04828837|322687032|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
94244118|NCT04828837|322687033|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
94244119|NCT00320528|322687034|FG000|Study Period II|Adverse Event|3|||
94244120|NCT00320528|322687035|FG001|Study Period II|Adverse Event|4|||
94244121|NCT00320528|322687036|FG002|Study Period II|Adverse Event|8|||
94244122|NCT00320528|322687034|FG000|Study Period II|Parent/Caregiver Decision|8|||
94244123|NCT00320528|322687035|FG001|Study Period II|Parent/Caregiver Decision|3|||
94244124|NCT00320528|322687036|FG002|Study Period II|Parent/Caregiver Decision|11|||
94244125|NCT00320528|322687034|FG000|Study Period II|Withdrawal by Subject|0|||
94244126|NCT00320528|322687035|FG001|Study Period II|Withdrawal by Subject|1|||
94244127|NCT00320528|322687036|FG002|Study Period II|Withdrawal by Subject|1|||
94244128|NCT00320528|322687034|FG000|Study Period II|Entry Criteria Exclusion|0|||
94244129|NCT00320528|322687035|FG001|Study Period II|Entry Criteria Exclusion|2|||
94244130|NCT00320528|322687036|FG002|Study Period II|Entry Criteria Exclusion|2|||
94244131|NCT00320528|322687034|FG000|Study Period III|Adverse Event|1|||
94244132|NCT00320528|322687035|FG001|Study Period III|Adverse Event|0|||
94244133|NCT00320528|322687036|FG002|Study Period III|Adverse Event|0|||
94244134|NCT00320528|322687034|FG000|Study Period III|Lost to Follow-up|1|||
94244135|NCT00320528|322687035|FG001|Study Period III|Lost to Follow-up|0|||
94244136|NCT00320528|322687036|FG002|Study Period III|Lost to Follow-up|0|||
94244137|NCT00320528|322687034|FG000|Study Period III|Withdrawal by Subject|1|||
94244138|NCT00320528|322687035|FG001|Study Period III|Withdrawal by Subject|1|||
94244139|NCT00320528|322687036|FG002|Study Period III|Withdrawal by Subject|2|||
94244140|NCT00320528|322687034|FG000|Study Period III|Lack of Efficacy|2|||
94244141|NCT00320528|322687035|FG001|Study Period III|Lack of Efficacy|0|||
94244142|NCT00320528|322687036|FG002|Study Period III|Lack of Efficacy|0|||
94244143|NCT00320528|322687034|FG000|Study Period III|Parent/Caregiver Decision|14|||
94244144|NCT00320528|322687035|FG001|Study Period III|Parent/Caregiver Decision|3|||
94244145|NCT00320528|322687036|FG002|Study Period III|Parent/Caregiver Decision|11|||
94244146|NCT00320528|322687034|FG000|Study Period III|Protocol Violation|0|||
94244147|NCT00320528|322687035|FG001|Study Period III|Protocol Violation|1|||
94244148|NCT00320528|322687036|FG002|Study Period III|Protocol Violation|0|||
94244149|NCT00320528|322687034|FG000|Study Period III|Physician Decision|0|||
94244150|NCT00320528|322687035|FG001|Study Period III|Physician Decision|1|||
94244151|NCT00320528|322687036|FG002|Study Period III|Physician Decision|2|||
94244152|NCT00320528|322687034|FG000|Study Period III|Sponsor Decision|0|||
94244153|NCT00320528|322687035|FG001|Study Period III|Sponsor Decision|0|||
94244154|NCT00320528|322687036|FG002|Study Period III|Sponsor Decision|1|||
94244155|NCT00320528|322687034|FG000|Study Period III|Atomoxetine Commercially Available|68|||
94244156|NCT00320528|322687035|FG001|Study Period III|Atomoxetine Commercially Available|25|||
94244157|NCT00320528|322687036|FG002|Study Period III|Atomoxetine Commercially Available|90|||
94244158|NCT01022112|322687037|FG000|Overall Study|Adverse Event|1|||
94244159|NCT01022112|322687038|FG001|Overall Study|Adverse Event|2|||
94244160|NCT01022112|322687039|FG002|Overall Study|Adverse Event|0|||
94244161|NCT01022112|322687040|FG003|Overall Study|Adverse Event|1|||
94244162|NCT01022112|322687041|FG004|Overall Study|Adverse Event|0|||
94244163|NCT01022112|322687037|FG000|Overall Study|Lack of Efficacy|1|||
94244164|NCT01022112|322687038|FG001|Overall Study|Lack of Efficacy|0|||
94244165|NCT01022112|322687039|FG002|Overall Study|Lack of Efficacy|0|||
94244166|NCT01022112|322687040|FG003|Overall Study|Lack of Efficacy|0|||
94244167|NCT01022112|322687041|FG004|Overall Study|Lack of Efficacy|1|||
94244168|NCT01022112|322687037|FG000|Overall Study|Physician Decision|0|||
94244169|NCT01022112|322687038|FG001|Overall Study|Physician Decision|0|||
94244170|NCT01022112|322687039|FG002|Overall Study|Physician Decision|1|||
94244171|NCT01022112|322687040|FG003|Overall Study|Physician Decision|0|||
94589724|NCT00459186|323960904|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
94589725|NCT00459186|323960904|FG000|PET Imaging and Assessment|Adverse Event|3|||
94244172|NCT01022112|322687041|FG004|Overall Study|Physician Decision|1|||
94589726|NCT01134705|323960909|FG000|Overall Study|Adverse Event|1|||
94589727|NCT01134705|323960910|FG001|Overall Study|Adverse Event|7|||
94589728|NCT01134705|323960909|FG000|Overall Study|Withdrawal by Subject|6|||
94589729|NCT01134705|323960910|FG001|Overall Study|Withdrawal by Subject|6|||
94589730|NCT01134705|323960909|FG000|Overall Study|Pregnancy|1|||
94589731|NCT01134705|323960910|FG001|Overall Study|Pregnancy|0|||
94589732|NCT01134705|323960909|FG000|Overall Study|Lost to Follow-up|5|||
94589733|NCT01134705|323960910|FG001|Overall Study|Lost to Follow-up|2|||
94589734|NCT01134705|323960909|FG000|Overall Study|Protocol Violation|1|||
94244173|NCT01022112|322687037|FG000|Overall Study|Withdrawal by Subject|0|||
94244174|NCT01022112|322687038|FG001|Overall Study|Withdrawal by Subject|1|||
94244175|NCT01022112|322687039|FG002|Overall Study|Withdrawal by Subject|2|||
94244176|NCT01022112|322687040|FG003|Overall Study|Withdrawal by Subject|2|||
94244177|NCT01022112|322687041|FG004|Overall Study|Withdrawal by Subject|1|||
94244178|NCT01022112|322687037|FG000|Overall Study|Fasting plasma glucose level increased|1|||
94244179|NCT01022112|322687038|FG001|Overall Study|Fasting plasma glucose level increased|0|||
94244180|NCT01022112|322687039|FG002|Overall Study|Fasting plasma glucose level increased|0|||
94244181|NCT01022112|322687040|FG003|Overall Study|Fasting plasma glucose level increased|0|||
94244182|NCT01022112|322687041|FG004|Overall Study|Fasting plasma glucose level increased|7|||
94244183|NCT00513305|322687042|FG000|Overall Study|Adverse Event|6|||
94244184|NCT00513305|322687043|FG001|Overall Study|Adverse Event|2|||
94244185|NCT00513305|322687042|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
94244186|NCT00513305|322687043|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
94244187|NCT00513305|322687042|FG000|Overall Study|Lack of Efficacy|8|||
94244188|NCT00513305|322687043|FG001|Overall Study|Lack of Efficacy|13|||
94244189|NCT00513305|322687042|FG000|Overall Study|Withdrawal by Subject|1|||
94244190|NCT00513305|322687043|FG001|Overall Study|Withdrawal by Subject|2|||
94244191|NCT00513305|322687042|FG000|Overall Study|Disease progression|8|||
94244192|NCT00513305|322687043|FG001|Overall Study|Disease progression|5|||
94244193|NCT00513305|322687042|FG000|Overall Study|Eligible for stem cell transplant|1|||
94244194|NCT00513305|322687043|FG001|Overall Study|Eligible for stem cell transplant|0|||
94244195|NCT00513305|322687042|FG000|Overall Study|Hematologic counts did not recover|1|||
94244196|NCT00513305|322687043|FG001|Overall Study|Hematologic counts did not recover|0|||
94244197|NCT00513305|322687042|FG000|Overall Study|Physician Decision|1|||
94244198|NCT00513305|322687043|FG001|Overall Study|Physician Decision|0|||
94244199|NCT00513305|322687042|FG000|Overall Study|Persistent hypocellularity|0|||
94244200|NCT00513305|322687043|FG001|Overall Study|Persistent hypocellularity|1|||
94244201|NCT00513305|322687042|FG000|Overall Study|Sponsor Decision|0|||
94244202|NCT00513305|322687043|FG001|Overall Study|Sponsor Decision|2|||
94244203|NCT01144377|322687047|FG000|52 Week Treatment Period|Adverse Event|0|||
94244204|NCT01144377|322687048|FG001|52 Week Treatment Period|Adverse Event|0|||
94244205|NCT01144377|322687049|FG002|52 Week Treatment Period|Adverse Event|3|||
94244206|NCT01144377|322687050|FG003|52 Week Treatment Period|Adverse Event|2|||
94244207|NCT01144377|322687051|FG004|52 Week Treatment Period|Adverse Event|1|||
94244208|NCT01144377|322687047|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
94244209|NCT01144377|322687048|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
94244210|NCT01144377|322687049|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
94244211|NCT01144377|322687050|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
94244212|NCT01144377|322687051|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
94589735|NCT01134705|323960910|FG001|Overall Study|Protocol Violation|1|||
94589736|NCT01134705|323960909|FG000|Overall Study|Other|1|||
94589737|NCT01134705|323960910|FG001|Overall Study|Other|6|||
94589738|NCT02762370|323960911|FG000|Overall Study|Protocol Violation|1|||
94589739|NCT02762370|323960912|FG001|Overall Study|Protocol Violation|0|||
94589740|NCT00246740|323960913|FG000|Initial Enrollment|Death|1|||
94589741|NCT00246740|323960914|FG001|Initial Enrollment|Death|0|||
94589742|NCT00246740|323960913|FG000|Initial Enrollment|Additional surgery scheduled|0|||
94589743|NCT00246740|323960914|FG001|Initial Enrollment|Additional surgery scheduled|2|||
94589744|NCT00246740|323960913|FG000|Initial Enrollment|Surgery schedule change|4|||
94589745|NCT00246740|323960914|FG001|Initial Enrollment|Surgery schedule change|4|||
94244213|NCT01144377|322687047|FG000|52 Week Treatment Period|Protocol Violation|0|||
94244214|NCT01144377|322687048|FG001|52 Week Treatment Period|Protocol Violation|0|||
94244215|NCT01144377|322687049|FG002|52 Week Treatment Period|Protocol Violation|0|||
94244216|NCT01144377|322687050|FG003|52 Week Treatment Period|Protocol Violation|0|||
94244217|NCT01144377|322687051|FG004|52 Week Treatment Period|Protocol Violation|1|||
94456132|NCT02244463|323458199|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
94589746|NCT00246740|323960913|FG000|Initial Enrollment|Other|1|||
94244218|NCT01144377|322687047|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
94244219|NCT01144377|322687048|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
94589747|NCT00246740|323960914|FG001|Initial Enrollment|Other|2|||
94589748|NCT02152956|323960915|FG000|Overall Study|Adverse Event|0|||
94589749|NCT02152956|323960916|FG001|Overall Study|Adverse Event|0|||
94589750|NCT02152956|323960917|FG002|Overall Study|Adverse Event|0|||
94589751|NCT02152956|323960918|FG003|Overall Study|Adverse Event|0|||
94244220|NCT01144377|322687049|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
94354920|NCT04594213|323081974|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
94354921|NCT04594213|323081975|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
94354922|NCT04594213|323081976|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
94354923|NCT04594213|323081971|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
94354924|NCT04594213|323081972|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
94354925|NCT04594213|323081973|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
94354926|NCT04594213|323081974|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
94354927|NCT04594213|323081975|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
94354928|NCT04594213|323081976|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
94354929|NCT04594213|323081971|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
94354930|NCT04594213|323081972|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
94354931|NCT04594213|323081973|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
94354932|NCT04594213|323081974|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
94354933|NCT04594213|323081975|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
94354934|NCT04594213|323081976|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
94354935|NCT04594213|323081971|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
94354936|NCT04594213|323081972|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
94354937|NCT04594213|323081973|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
94354938|NCT04594213|323081974|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
94354939|NCT04594213|323081975|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
94354940|NCT04594213|323081976|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
94354941|NCT04594213|323081971|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
94354942|NCT04594213|323081972|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
94354943|NCT04594213|323081973|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
94354944|NCT04594213|323081974|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
94354945|NCT04594213|323081975|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
94354946|NCT04594213|323081976|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
94354947|NCT04594213|323081971|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
94354948|NCT04594213|323081972|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
94354949|NCT04594213|323081973|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
94354950|NCT04594213|323081974|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
94354951|NCT04594213|323081975|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
94354952|NCT04594213|323081976|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
94244221|NCT01144377|322687050|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
94244222|NCT01144377|322687051|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
94244223|NCT01144377|322687047|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
94244224|NCT01144377|322687048|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
94244225|NCT01144377|322687049|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
94354953|NCT04594213|323081971|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
94354954|NCT04594213|323081972|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
94354955|NCT04594213|323081973|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
94354956|NCT04594213|323081974|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
94244226|NCT01144377|322687050|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
94244227|NCT01144377|322687051|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
94244228|NCT01144377|322687047|FG000|52 Week Treatment Period|Sponsor Decision|0|||
94244229|NCT01144377|322687048|FG001|52 Week Treatment Period|Sponsor Decision|0|||
94244230|NCT01144377|322687049|FG002|52 Week Treatment Period|Sponsor Decision|0|||
94244231|NCT01144377|322687050|FG003|52 Week Treatment Period|Sponsor Decision|0|||
94244232|NCT01144377|322687051|FG004|52 Week Treatment Period|Sponsor Decision|1|||
94244233|NCT01144377|322687047|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
94244234|NCT01144377|322687048|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
94244235|NCT01144377|322687049|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
94244236|NCT01144377|322687050|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
94244237|NCT01144377|322687051|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
94244238|NCT01144377|322687047|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
94244239|NCT01144377|322687048|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
94244240|NCT01144377|322687049|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
94244241|NCT01144377|322687050|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
94244242|NCT01144377|322687051|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
94244243|NCT01144377|322687047|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
94244244|NCT01144377|322687048|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
94244245|NCT01144377|322687049|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
94244246|NCT01144377|322687050|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
94244247|NCT01144377|322687051|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
94244248|NCT01147536|322687052|FG000|Overall Study|Administrative study close|2|||
94244249|NCT01147536|322687052|FG000|Overall Study|Death|1|||
94244250|NCT00607724|322687054|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
94244251|NCT00607724|322687055|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
94244252|NCT00607724|322687056|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
94244253|NCT00607724|322687057|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
94244254|NCT00607724|322687058|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
94244255|NCT00607724|322687059|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
94244256|NCT00607724|322687060|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
94244257|NCT00607724|322687054|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
94244258|NCT00607724|322687055|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
94244259|NCT00607724|322687056|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
94244260|NCT00607724|322687057|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
94244261|NCT00607724|322687058|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
94244262|NCT00607724|322687059|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
94244263|NCT00607724|322687060|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
94244264|NCT00607724|322687054|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
94244265|NCT00607724|322687055|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
94244266|NCT00607724|322687056|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
94244267|NCT00607724|322687057|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
94244268|NCT00607724|322687058|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
94244269|NCT00607724|322687059|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
94244270|NCT00607724|322687060|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
94244271|NCT00607724|322687054|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
94244272|NCT00607724|322687055|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
94244273|NCT00607724|322687056|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
94244274|NCT00607724|322687057|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
94244275|NCT00607724|322687058|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
94244276|NCT00607724|322687059|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
94244277|NCT00607724|322687060|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
94244278|NCT00607724|322687054|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
94244279|NCT00607724|322687055|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
94244280|NCT00607724|322687056|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
94244281|NCT00607724|322687057|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
94244282|NCT00607724|322687058|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
94244283|NCT00607724|322687059|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
94244284|NCT00607724|322687060|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
94244285|NCT00357110|322688866|FG000|Overall Study|Early study termination|5|||
94244286|NCT00357110|322688867|FG001|Overall Study|Early study termination|5|||
94244287|NCT01302080|322688868|FG000|Overall Study|Withdrew Consent|92|||
94244288|NCT01302080|322688869|FG001|Overall Study|Withdrew Consent|39|||
94244289|NCT01302080|322688868|FG000|Overall Study|Patient/Family Moved|28|||
94244290|NCT01302080|322688869|FG001|Overall Study|Patient/Family Moved|3|||
94244291|NCT01302080|322688868|FG000|Overall Study|Lost to Follow-up|192|||
94244292|NCT01302080|322688869|FG001|Overall Study|Lost to Follow-up|93|||
94244293|NCT01302080|322688868|FG000|Overall Study|Death|1|||
94244294|NCT01302080|322688869|FG001|Overall Study|Death|0|||
94354957|NCT04594213|323081975|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
94244295|NCT01302080|322688868|FG000|Overall Study|Other|52|||
94244296|NCT01302080|322688869|FG001|Overall Study|Other|8|||
94244297|NCT01302080|322688868|FG000|Overall Study|Reason Missing For Discontinuation|1|||
94244298|NCT01302080|322688869|FG001|Overall Study|Reason Missing For Discontinuation|0|||
94244299|NCT04996004|322688870|FG000|Phase I|Death|1|||
94244300|NCT04996004|322688871|FG001|Phase I|Death|2|||
94244301|NCT04996004|322688872|FG002|Phase I|Death|1|||
94244302|NCT04996004|322688873|FG003|Phase I|Death|0|||
94244303|NCT04996004|322688874|FG004|Phase I|Death|0|||
94244304|NCT04996004|322688875|FG005|Phase I|Death|0|||
94244305|NCT04996004|322688870|FG000|Phase I|Study terminated by sponsor|2|||
94244306|NCT04996004|322688871|FG001|Phase I|Study terminated by sponsor|1|||
94244307|NCT04996004|322688872|FG002|Phase I|Study terminated by sponsor|2|||
94244308|NCT04996004|322688873|FG003|Phase I|Study terminated by sponsor|0|||
94244309|NCT04996004|322688874|FG004|Phase I|Study terminated by sponsor|0|||
94354958|NCT04594213|323081976|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
94589752|NCT02152956|323960919|FG004|Overall Study|Adverse Event|0|||
94244310|NCT04996004|322688875|FG005|Phase I|Study terminated by sponsor|0|||
94244311|NCT04996004|322688870|FG000|Phase II|Study terminated by sponsor|0|||
94244312|NCT04996004|322688871|FG001|Phase II|Study terminated by sponsor|0|||
94244313|NCT04996004|322688872|FG002|Phase II|Study terminated by sponsor|0|||
94354959|NCT04594213|323081971|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
94244314|NCT04996004|322688873|FG003|Phase II|Study terminated by sponsor|20|||
94244315|NCT04996004|322688874|FG004|Phase II|Study terminated by sponsor|10|||
94244316|NCT04996004|322688875|FG005|Phase II|Study terminated by sponsor|10|||
94354960|NCT04594213|323081972|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
94354961|NCT04594213|323081973|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
94354962|NCT04594213|323081974|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
94354963|NCT04594213|323081975|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
94354964|NCT04594213|323081976|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
94354965|NCT03814499|323081977|FG000|Overall Study|Lost to Follow-up|3|||
94354966|NCT02046993|323081978|FG000|Overall Study|Withdrawal by Subject|2|||
94354967|NCT02046993|323081979|FG001|Overall Study|Withdrawal by Subject|10|||
94354968|NCT02046993|323081978|FG000|Overall Study|Lost to Follow-up|1|||
94354969|NCT02046993|323081979|FG001|Overall Study|Lost to Follow-up|1|||
94354970|NCT03246152|323081980|FG000|Overall Study|Lost to Follow-up|2|||
94354971|NCT03246152|323081980|FG000|Overall Study|Protocol Violation|1|||
94354972|NCT00361504|323081981|FG000|Overall Study|Withdrawal by Subject|94|||
94354973|NCT00361504|323081982|FG001|Overall Study|Withdrawal by Subject|31|||
94354974|NCT00361504|323081981|FG000|Overall Study|Lost to Follow-up|40|||
94354975|NCT00361504|323081982|FG001|Overall Study|Lost to Follow-up|7|||
94354976|NCT00361504|323081981|FG000|Overall Study|Adverse Event|203|||
94354977|NCT00361504|323081982|FG001|Overall Study|Adverse Event|82|||
94354978|NCT00361504|323081981|FG000|Overall Study|Lack of Efficacy|72|||
94589753|NCT02152956|323960920|FG005|Overall Study|Adverse Event|0|||
94354979|NCT00361504|323081982|FG001|Overall Study|Lack of Efficacy|7|||
94354980|NCT00361504|323081981|FG000|Overall Study|Resolution of Pain|2|||
94354981|NCT00361504|323081982|FG001|Overall Study|Resolution of Pain|0|||
94354982|NCT00361504|323081981|FG000|Overall Study|Study medication non compliant|42|||
94354983|NCT00361504|323081982|FG001|Overall Study|Study medication non compliant|15|||
94354984|NCT00361504|323081981|FG000|Overall Study|All other|28|||
94354985|NCT00361504|323081982|FG001|Overall Study|All other|3|||
94354986|NCT01654666|323081987|FG000|Overall Study|Protocol Violation|7|||
94354987|NCT01654666|323081988|FG001|Overall Study|Protocol Violation|4|||
94354988|NCT01654666|323081989|FG002|Overall Study|Protocol Violation|8|||
94354989|NCT01654666|323081987|FG000|Overall Study|Lost to Follow-up|4|||
94354990|NCT01654666|323081988|FG001|Overall Study|Lost to Follow-up|5|||
94354991|NCT01654666|323081989|FG002|Overall Study|Lost to Follow-up|5|||
94354992|NCT01654666|323081987|FG000|Overall Study|Withdrawal by Subject|4|||
94354993|NCT01654666|323081988|FG001|Overall Study|Withdrawal by Subject|4|||
94354994|NCT01654666|323081989|FG002|Overall Study|Withdrawal by Subject|1|||
94354995|NCT00535262|323081992|FG000|Overall Study|No funding|3|||
94354996|NCT00399542|323082002|FG000|Overall Study|Adverse Event|18|||
94354997|NCT00399542|323082003|FG001|Overall Study|Adverse Event|15|||
94354998|NCT00399542|323082002|FG000|Overall Study|Protocol Violation|13|||
94354999|NCT00399542|323082003|FG001|Overall Study|Protocol Violation|3|||
94355000|NCT00399542|323082002|FG000|Overall Study|Withdrawal by Subject|28|||
94355001|NCT00399542|323082003|FG001|Overall Study|Withdrawal by Subject|10|||
94355002|NCT00399542|323082002|FG000|Overall Study|Lack of Efficacy|18|||
94355003|NCT00399542|323082003|FG001|Overall Study|Lack of Efficacy|8|||
94355004|NCT00399542|323082002|FG000|Overall Study|Lost to Follow-up|6|||
94355005|NCT00399542|323082003|FG001|Overall Study|Lost to Follow-up|6|||
94355006|NCT00399542|323082002|FG000|Overall Study|Other|1|||
94355007|NCT00399542|323082003|FG001|Overall Study|Other|0|||
94589754|NCT02152956|323960921|FG006|Overall Study|Adverse Event|0|||
94589755|NCT02152956|323960922|FG007|Overall Study|Adverse Event|0|||
94589756|NCT02152956|323960923|FG008|Overall Study|Adverse Event|0|||
94589757|NCT02152956|323960924|FG009|Overall Study|Adverse Event|0|||
94589758|NCT02152956|323960925|FG010|Overall Study|Adverse Event|0|||
94589759|NCT02152956|323960926|FG011|Overall Study|Adverse Event|4|||
94589760|NCT02152956|323960927|FG012|Overall Study|Adverse Event|0|||
94589761|NCT02152956|323960915|FG000|Overall Study|Death|0|||
94589762|NCT02152956|323960916|FG001|Overall Study|Death|3|||
94589763|NCT02152956|323960917|FG002|Overall Study|Death|3|||
94589764|NCT02152956|323960918|FG003|Overall Study|Death|4|||
94589765|NCT02152956|323960919|FG004|Overall Study|Death|1|||
94589766|NCT02152956|323960920|FG005|Overall Study|Death|2|||
94589767|NCT02152956|323960921|FG006|Overall Study|Death|6|||
94355008|NCT00399542|323082002|FG000|Overall Study|Physician Decision|0|||
94355009|NCT00399542|323082003|FG001|Overall Study|Physician Decision|1|||
94355010|NCT00634933|323082004|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
94355011|NCT00634933|323082005|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
94589768|NCT02152956|323960922|FG007|Overall Study|Death|6|||
94589769|NCT02152956|323960923|FG008|Overall Study|Death|4|||
94355012|NCT00634933|323082006|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
94355013|NCT00634933|323082007|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
94589770|NCT02152956|323960924|FG009|Overall Study|Death|5|||
94589771|NCT02152956|323960925|FG010|Overall Study|Death|3|||
94355014|NCT00634933|323082008|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
94355015|NCT00634933|323082004|FG000|Part A: Baseline to Week 24|Death|1|||
94355016|NCT00634933|323082005|FG001|Part A: Baseline to Week 24|Death|0|||
94589772|NCT02152956|323960926|FG011|Overall Study|Death|143|||
94589773|NCT02152956|323960927|FG012|Overall Study|Death|12|||
94589774|NCT02152956|323960915|FG000|Overall Study|Lost to Follow-up|0|||
94589775|NCT02152956|323960916|FG001|Overall Study|Lost to Follow-up|1|||
94589776|NCT02152956|323960917|FG002|Overall Study|Lost to Follow-up|0|||
94589777|NCT02152956|323960918|FG003|Overall Study|Lost to Follow-up|0|||
94589778|NCT02152956|323960919|FG004|Overall Study|Lost to Follow-up|0|||
94589779|NCT02152956|323960920|FG005|Overall Study|Lost to Follow-up|0|||
94589780|NCT02152956|323960921|FG006|Overall Study|Lost to Follow-up|0|||
94589781|NCT02152956|323960922|FG007|Overall Study|Lost to Follow-up|0|||
94589782|NCT02152956|323960923|FG008|Overall Study|Lost to Follow-up|0|||
94589783|NCT02152956|323960924|FG009|Overall Study|Lost to Follow-up|0|||
94589784|NCT02152956|323960925|FG010|Overall Study|Lost to Follow-up|0|||
94589785|NCT02152956|323960926|FG011|Overall Study|Lost to Follow-up|3|||
94589786|NCT02152956|323960927|FG012|Overall Study|Lost to Follow-up|0|||
94589787|NCT02152956|323960915|FG000|Overall Study|Withdrawal by Subject|1|||
94589788|NCT02152956|323960916|FG001|Overall Study|Withdrawal by Subject|0|||
94589789|NCT02152956|323960917|FG002|Overall Study|Withdrawal by Subject|1|||
94589790|NCT02152956|323960918|FG003|Overall Study|Withdrawal by Subject|0|||
94589791|NCT02152956|323960919|FG004|Overall Study|Withdrawal by Subject|2|||
94589792|NCT02152956|323960920|FG005|Overall Study|Withdrawal by Subject|2|||
94589793|NCT02152956|323960921|FG006|Overall Study|Withdrawal by Subject|0|||
94456133|NCT02244463|323458200|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
94589794|NCT02152956|323960922|FG007|Overall Study|Withdrawal by Subject|0|||
94589795|NCT02152956|323960923|FG008|Overall Study|Withdrawal by Subject|1|||
94659759|NCT00116805|324209956|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
94589796|NCT02152956|323960924|FG009|Overall Study|Withdrawal by Subject|0|||
94355017|NCT00634933|323082006|FG002|Part A: Baseline to Week 24|Death|0|||
94355018|NCT00634933|323082007|FG003|Part A: Baseline to Week 24|Death|0|||
94355019|NCT00634933|323082008|FG004|Part A: Baseline to Week 24|Death|0|||
94355020|NCT00634933|323082004|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
94355021|NCT00634933|323082005|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
94355022|NCT00634933|323082006|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
94355023|NCT00634933|323082007|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
94355024|NCT00634933|323082008|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
94355025|NCT00634933|323082004|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
94355026|NCT00634933|323082005|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
94355027|NCT00634933|323082006|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
94355028|NCT00634933|323082007|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
94355029|NCT00634933|323082008|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
94355030|NCT00634933|323082004|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
94355031|NCT00634933|323082005|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
94355032|NCT00634933|323082006|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
94355033|NCT00634933|323082007|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
94355034|NCT00634933|323082008|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
94355035|NCT00634933|323082004|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
94355036|NCT00634933|323082005|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
94355037|NCT00634933|323082006|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
94355038|NCT00634933|323082007|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
94355039|NCT00634933|323082008|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
94355040|NCT00634933|323082004|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
94355041|NCT00634933|323082005|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
94355042|NCT00634933|323082006|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
94355043|NCT00634933|323082007|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
94355044|NCT00634933|323082008|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
94355045|NCT00634933|323082004|FG000|Part A: Baseline to Week 24|Other|1|||
94244317|NCT04996004|322688870|FG000|Phase II|Withdrawal by Subject|0|||
94355046|NCT00634933|323082005|FG001|Part A: Baseline to Week 24|Other|8|||
94589797|NCT02152956|323960925|FG010|Overall Study|Withdrawal by Subject|0|||
94589798|NCT02152956|323960926|FG011|Overall Study|Withdrawal by Subject|4|||
94244318|NCT04996004|322688871|FG001|Phase II|Withdrawal by Subject|0|||
94244319|NCT04996004|322688872|FG002|Phase II|Withdrawal by Subject|0|||
94244320|NCT04996004|322688873|FG003|Phase II|Withdrawal by Subject|0|||
94244321|NCT04996004|322688874|FG004|Phase II|Withdrawal by Subject|1|||
94244322|NCT04996004|322688875|FG005|Phase II|Withdrawal by Subject|2|||
94244323|NCT04996004|322688870|FG000|Phase II|Death|0|||
94244324|NCT04996004|322688871|FG001|Phase II|Death|0|||
94244325|NCT04996004|322688872|FG002|Phase II|Death|0|||
94244326|NCT04996004|322688873|FG003|Phase II|Death|12|||
94244327|NCT04996004|322688874|FG004|Phase II|Death|2|||
94244328|NCT04996004|322688875|FG005|Phase II|Death|9|||
94244329|NCT04996004|322688870|FG000|Phase II|Other|0|||
94244330|NCT04996004|322688871|FG001|Phase II|Other|0|||
94589799|NCT02152956|323960927|FG012|Overall Study|Withdrawal by Subject|0|||
94589800|NCT02152956|323960915|FG000|Overall Study|Physician Decision|0|||
94589801|NCT02152956|323960916|FG001|Overall Study|Physician Decision|0|||
94589802|NCT02152956|323960917|FG002|Overall Study|Physician Decision|0|||
94244331|NCT04996004|322688872|FG002|Phase II|Other|0|||
94244332|NCT04996004|322688873|FG003|Phase II|Other|0|||
94589803|NCT02152956|323960918|FG003|Overall Study|Physician Decision|0|||
94589804|NCT02152956|323960919|FG004|Overall Study|Physician Decision|0|||
94244333|NCT04996004|322688874|FG004|Phase II|Other|0|||
94244334|NCT04996004|322688875|FG005|Phase II|Other|1|||
94244335|NCT02248818|322688876|FG000|Screening|Protocol Violation|0|||
94244336|NCT02248818|322688877|FG001|Screening|Protocol Violation|0|||
94244337|NCT02248818|322688878|FG002|Screening|Protocol Violation|0|||
94244338|NCT02248818|322688879|FG003|Screening|Protocol Violation|0|||
94244339|NCT02248818|322688880|FG004|Screening|Protocol Violation|0|||
94244340|NCT02248818|322688881|FG005|Screening|Protocol Violation|0|||
94244341|NCT02248818|322688882|FG006|Screening|Protocol Violation|0|||
94244342|NCT02248818|322688883|FG007|Screening|Protocol Violation|0|||
94244343|NCT02248818|322688884|FG008|Screening|Protocol Violation|7|||
94244344|NCT02248818|322688876|FG000|Screening|Study fully enrolled|0|||
94244345|NCT02248818|322688877|FG001|Screening|Study fully enrolled|0|||
94244346|NCT02248818|322688878|FG002|Screening|Study fully enrolled|0|||
94244347|NCT02248818|322688879|FG003|Screening|Study fully enrolled|0|||
94244348|NCT02248818|322688880|FG004|Screening|Study fully enrolled|0|||
94244349|NCT02248818|322688881|FG005|Screening|Study fully enrolled|0|||
94244350|NCT02248818|322688882|FG006|Screening|Study fully enrolled|0|||
94244351|NCT02248818|322688883|FG007|Screening|Study fully enrolled|0|||
94244352|NCT02248818|322688884|FG008|Screening|Study fully enrolled|14|||
94244353|NCT02248818|322688876|FG000|Screening|Physician Decision|0|||
94244354|NCT02248818|322688877|FG001|Screening|Physician Decision|0|||
94244355|NCT02248818|322688878|FG002|Screening|Physician Decision|0|||
94244356|NCT02248818|322688879|FG003|Screening|Physician Decision|0|||
94244357|NCT02248818|322688880|FG004|Screening|Physician Decision|0|||
94244358|NCT02248818|322688881|FG005|Screening|Physician Decision|0|||
94244359|NCT02248818|322688882|FG006|Screening|Physician Decision|0|||
94244360|NCT02248818|322688883|FG007|Screening|Physician Decision|0|||
94244361|NCT02248818|322688884|FG008|Screening|Physician Decision|73|||
94244362|NCT02248818|322688876|FG000|Screening|Withdrawal by Subject|0|||
94244363|NCT02248818|322688877|FG001|Screening|Withdrawal by Subject|0|||
94244364|NCT02248818|322688878|FG002|Screening|Withdrawal by Subject|0|||
94244365|NCT02248818|322688879|FG003|Screening|Withdrawal by Subject|0|||
94244366|NCT02248818|322688880|FG004|Screening|Withdrawal by Subject|0|||
94244367|NCT02248818|322688881|FG005|Screening|Withdrawal by Subject|0|||
94244368|NCT02248818|322688882|FG006|Screening|Withdrawal by Subject|0|||
94244369|NCT02248818|322688883|FG007|Screening|Withdrawal by Subject|0|||
94244370|NCT02248818|322688884|FG008|Screening|Withdrawal by Subject|6|||
94244371|NCT02248818|322688876|FG000|Screening|Lost to Follow-up|0|||
94244372|NCT02248818|322688877|FG001|Screening|Lost to Follow-up|0|||
94244373|NCT02248818|322688878|FG002|Screening|Lost to Follow-up|0|||
94244374|NCT02248818|322688879|FG003|Screening|Lost to Follow-up|0|||
94244375|NCT02248818|322688880|FG004|Screening|Lost to Follow-up|0|||
94244376|NCT02248818|322688881|FG005|Screening|Lost to Follow-up|0|||
94244377|NCT02248818|322688882|FG006|Screening|Lost to Follow-up|0|||
94244378|NCT02248818|322688883|FG007|Screening|Lost to Follow-up|0|||
94355047|NCT00634933|323082006|FG002|Part A: Baseline to Week 24|Other|5|||
94244379|NCT02248818|322688884|FG008|Screening|Lost to Follow-up|7|||
94244380|NCT02248818|322688876|FG000|Randomised Study|Administrative - randomization error|0|||
94244381|NCT02248818|322688877|FG001|Randomised Study|Administrative - randomization error|0|||
94244382|NCT02248818|322688878|FG002|Randomised Study|Administrative - randomization error|0|||
94244383|NCT02248818|322688879|FG003|Randomised Study|Administrative - randomization error|0|||
94244384|NCT02248818|322688880|FG004|Randomised Study|Administrative - randomization error|0|||
94244385|NCT02248818|322688881|FG005|Randomised Study|Administrative - randomization error|8|||
94244386|NCT02248818|322688882|FG006|Randomised Study|Administrative - randomization error|0|||
94244387|NCT02248818|322688883|FG007|Randomised Study|Administrative - randomization error|0|||
94244388|NCT02248818|322688884|FG008|Randomised Study|Administrative - randomization error|0|||
94244389|NCT02787044|322688887|FG000|Overall Study|Lost to Follow-up|15|||
94244390|NCT02787044|322688888|FG001|Overall Study|Lost to Follow-up|19|||
94244391|NCT03889704|322688891|FG000|Overall Study|Study terminated due to pandemic|1|||
94244392|NCT03482466|322688892|FG000|Overall Study|Protocol Violation|2|||
94244393|NCT04833127|322688893|FG000|Overall Study|Lost to Follow-up|1|||
94244394|NCT04833127|322688894|FG001|Overall Study|Lost to Follow-up|1|||
94244395|NCT04552899|322688899|FG000|Overall Study|Adverse Event|4|||
94244396|NCT04552899|322688900|FG001|Overall Study|Adverse Event|3|||
94244397|NCT04552899|322688899|FG000|Overall Study|Death|4|||
94244398|NCT04552899|322688900|FG001|Overall Study|Death|4|||
94244399|NCT04552899|322688899|FG000|Overall Study|Lost to Follow-up|8|||
94244400|NCT04552899|322688900|FG001|Overall Study|Lost to Follow-up|13|||
94244401|NCT04552899|322688899|FG000|Overall Study|Lung Transplant|4|||
94244402|NCT04552899|322688900|FG001|Overall Study|Lung Transplant|3|||
94244403|NCT04552899|322688899|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
94244404|NCT04552899|322688900|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
94244405|NCT04552899|322688899|FG000|Overall Study|Physician Decision|3|||
94244406|NCT04552899|322688900|FG001|Overall Study|Physician Decision|4|||
94244407|NCT04552899|322688899|FG000|Overall Study|Study Terminated By Sponsor|237|||
94244408|NCT04552899|322688900|FG001|Overall Study|Study Terminated By Sponsor|239|||
94244409|NCT04552899|322688899|FG000|Overall Study|Withdrawal by Subject|15|||
94244410|NCT04552899|322688900|FG001|Overall Study|Withdrawal by Subject|17|||
94244411|NCT04335591|322688901|FG000|Overall Study|Adverse Event|5|||
94244412|NCT04335591|322688902|FG001|Overall Study|Adverse Event|2|||
94244413|NCT04335591|322688903|FG002|Overall Study|Adverse Event|3|||
94244414|NCT04335591|322688904|FG003|Overall Study|Adverse Event|2|||
94244415|NCT04335591|322688901|FG000|Overall Study|Protocol Violation|1|||
94244416|NCT04335591|322688902|FG001|Overall Study|Protocol Violation|0|||
94244417|NCT04335591|322688903|FG002|Overall Study|Protocol Violation|0|||
94244418|NCT04335591|322688904|FG003|Overall Study|Protocol Violation|0|||
94244419|NCT04335591|322688901|FG000|Overall Study|Withdrawal by Subject|8|||
94244420|NCT04335591|322688902|FG001|Overall Study|Withdrawal by Subject|4|||
94244421|NCT04335591|322688903|FG002|Overall Study|Withdrawal by Subject|4|||
94244422|NCT04335591|322688904|FG003|Overall Study|Withdrawal by Subject|5|||
94244423|NCT04335591|322688901|FG000|Overall Study|Subject planning pregnancy|0|||
94244424|NCT04335591|322688902|FG001|Overall Study|Subject planning pregnancy|1|||
94244425|NCT04335591|322688903|FG002|Overall Study|Subject planning pregnancy|0|||
94244426|NCT04335591|322688904|FG003|Overall Study|Subject planning pregnancy|0|||
94244427|NCT04335591|322688901|FG000|Overall Study|Ukrainian Russian war conflict|4|||
94244428|NCT04335591|322688902|FG001|Overall Study|Ukrainian Russian war conflict|5|||
94244429|NCT04335591|322688903|FG002|Overall Study|Ukrainian Russian war conflict|2|||
94244430|NCT04335591|322688904|FG003|Overall Study|Ukrainian Russian war conflict|0|||
94244431|NCT02591953|322688905|FG000|Overall Study|Lost to Follow-up|6|||
94244432|NCT02591953|322688906|FG001|Overall Study|Lost to Follow-up|6|||
94244433|NCT00461981|322688908|FG000|Overall Study|Lost to Follow-up|9|||
94244434|NCT00461981|322688909|FG001|Overall Study|Lost to Follow-up|6|||
94244435|NCT00461981|322688908|FG000|Overall Study|Withdrawal by Subject|2|||
94244436|NCT00461981|322688909|FG001|Overall Study|Withdrawal by Subject|3|||
94244437|NCT01896557|322688912|FG000|Clopidogrel Alone|Adverse Event|1|||
94244438|NCT01896557|322688913|FG001|Clopidogrel Alone|Adverse Event|0|||
94244439|NCT01896557|322688912|FG000|Clopidogrel + GI Protector|low adherence|1|||
94244440|NCT01896557|322688913|FG001|Clopidogrel + GI Protector|low adherence|1|||
94244441|NCT01896557|322688912|FG000|Clopidogrel + GI Protector|Reading error|1|||
94244442|NCT01896557|322688913|FG001|Clopidogrel + GI Protector|Reading error|3|||
94244443|NCT04798781|322688916|FG000|Overall Study|Withdrawal by Subject|1|||
94244444|NCT00702962|322688917|FG000|Overall Study|Progressive disease|0|||
94244445|NCT00702962|322688918|FG001|Overall Study|Progressive disease|1|||
94244446|NCT00702962|322688917|FG000|Overall Study|Hospitalized for other health disorder|1|||
94244447|NCT00702962|322688918|FG001|Overall Study|Hospitalized for other health disorder|0|||
94244448|NCT00951015|322688926|FG000|Randomization Phase 96 Week|Adverse Event|1|||
94244449|NCT00951015|322688927|FG001|Randomization Phase 96 Week|Adverse Event|1|||
94244450|NCT00951015|322688928|FG002|Randomization Phase 96 Week|Adverse Event|2|||
94244451|NCT00951015|322688929|FG003|Randomization Phase 96 Week|Adverse Event|5|||
94244452|NCT00951015|322688930|FG004|Randomization Phase 96 Week|Adverse Event|0|||
94244453|NCT00951015|322688926|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
94244454|NCT00951015|322688927|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
94244455|NCT00951015|322688928|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
94244456|NCT00951015|322688929|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
94244457|NCT00951015|322688930|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
94244458|NCT00951015|322688926|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
94244459|NCT00951015|322688927|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
94244460|NCT00951015|322688928|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
94244461|NCT00951015|322688929|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
94244462|NCT00951015|322688930|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
94244463|NCT00951015|322688926|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
94244464|NCT00951015|322688927|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
94244465|NCT00951015|322688928|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
94244466|NCT00951015|322688929|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
94244467|NCT00951015|322688930|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
94244468|NCT00951015|322688926|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
94244469|NCT00951015|322688927|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
94244470|NCT00951015|322688928|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
94244471|NCT00951015|322688929|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
94244472|NCT00951015|322688930|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
94244473|NCT00951015|322688926|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
94244474|NCT00951015|322688927|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
94355048|NCT00634933|323082007|FG003|Part A: Baseline to Week 24|Other|0|||
94355049|NCT00634933|323082008|FG004|Part A: Baseline to Week 24|Other|0|||
94355050|NCT00634933|323082004|FG000|Between Part A and Part B|Physician Decision|0|||
94355051|NCT00634933|323082005|FG001|Between Part A and Part B|Physician Decision|1|||
94355052|NCT00634933|323082006|FG002|Between Part A and Part B|Physician Decision|0|||
94355053|NCT00634933|323082007|FG003|Between Part A and Part B|Physician Decision|0|||
94355054|NCT00634933|323082008|FG004|Between Part A and Part B|Physician Decision|0|||
94355055|NCT00634933|323082004|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
94355056|NCT00634933|323082005|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
94355057|NCT00634933|323082006|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
94355058|NCT00634933|323082007|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
94355059|NCT00634933|323082008|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
94355060|NCT00634933|323082004|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
94355061|NCT00634933|323082005|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
94355062|NCT00634933|323082006|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
94355063|NCT00634933|323082007|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
94355064|NCT00634933|323082008|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
94355065|NCT00634933|323082004|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
94355066|NCT00634933|323082005|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
94355067|NCT00634933|323082006|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
94355068|NCT00634933|323082007|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
94355069|NCT00634933|323082008|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
94355070|NCT00634933|323082004|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
94355071|NCT00634933|323082005|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
94355072|NCT00634933|323082006|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
94355073|NCT00634933|323082007|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
94355074|NCT00634933|323082008|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
94355075|NCT00634933|323082004|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
94355076|NCT00634933|323082005|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
94355077|NCT00634933|323082006|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
94355078|NCT00634933|323082007|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
94355079|NCT00634933|323082008|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
94355080|NCT00634933|323082004|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
94355081|NCT00634933|323082005|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
94355082|NCT00634933|323082006|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
94355083|NCT00634933|323082007|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
94355084|NCT00634933|323082008|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
94355085|NCT00634933|323082004|FG000|Part B: Week 24 to Week 52|Other|0|||
94355086|NCT00634933|323082005|FG001|Part B: Week 24 to Week 52|Other|0|||
94355087|NCT00634933|323082006|FG002|Part B: Week 24 to Week 52|Other|5|||
94355088|NCT00634933|323082007|FG003|Part B: Week 24 to Week 52|Other|0|||
94355089|NCT00634933|323082008|FG004|Part B: Week 24 to Week 52|Other|1|||
94355090|NCT03831282|323082009|FG000|Overall Study|Could not place sensor|1|||
94355091|NCT01326312|323082015|FG000|Overall Study|Adverse Event|11|||
94355092|NCT01326312|323082016|FG001|Overall Study|Adverse Event|11|||
94355093|NCT01326312|323082017|FG002|Overall Study|Adverse Event|1|||
94355094|NCT01326312|323082015|FG000|Overall Study|Withdrawal by Subject|1|||
94355095|NCT01326312|323082016|FG001|Overall Study|Withdrawal by Subject|2|||
94355096|NCT01326312|323082017|FG002|Overall Study|Withdrawal by Subject|1|||
94355097|NCT01326312|323082015|FG000|Overall Study|Protocol Violation|0|||
94355098|NCT01326312|323082016|FG001|Overall Study|Protocol Violation|1|||
94355099|NCT01326312|323082017|FG002|Overall Study|Protocol Violation|0|||
94355100|NCT01326312|323082015|FG000|Overall Study|Lack of Efficacy|13|||
94244475|NCT00951015|322688928|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
94244476|NCT00951015|322688929|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
94244477|NCT00951015|322688930|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
94244478|NCT00951015|322688926|FG000|Open-label Phase|Adverse Event|0|||
94244479|NCT00951015|322688927|FG001|Open-label Phase|Adverse Event|0|||
94244480|NCT00951015|322688928|FG002|Open-label Phase|Adverse Event|0|||
94244481|NCT00951015|322688929|FG003|Open-label Phase|Adverse Event|0|||
94244482|NCT00951015|322688930|FG004|Open-label Phase|Adverse Event|3|||
94244483|NCT00951015|322688926|FG000|Open-label Phase|Lack of Efficacy|0|||
94244484|NCT00951015|322688927|FG001|Open-label Phase|Lack of Efficacy|0|||
94244485|NCT00951015|322688928|FG002|Open-label Phase|Lack of Efficacy|0|||
94244486|NCT00951015|322688929|FG003|Open-label Phase|Lack of Efficacy|0|||
94244487|NCT00951015|322688930|FG004|Open-label Phase|Lack of Efficacy|1|||
94244488|NCT00951015|322688926|FG000|Open-label Phase|Protocol Violation|0|||
94244489|NCT00951015|322688927|FG001|Open-label Phase|Protocol Violation|0|||
94244490|NCT00951015|322688928|FG002|Open-label Phase|Protocol Violation|0|||
94244491|NCT00951015|322688929|FG003|Open-label Phase|Protocol Violation|0|||
94244492|NCT00951015|322688930|FG004|Open-label Phase|Protocol Violation|12|||
94244493|NCT00951015|322688926|FG000|Open-label Phase|Lost to Follow-up|0|||
94244494|NCT00951015|322688927|FG001|Open-label Phase|Lost to Follow-up|0|||
94244495|NCT00951015|322688928|FG002|Open-label Phase|Lost to Follow-up|0|||
94244496|NCT00951015|322688929|FG003|Open-label Phase|Lost to Follow-up|0|||
94244497|NCT00951015|322688930|FG004|Open-label Phase|Lost to Follow-up|12|||
94244498|NCT00951015|322688926|FG000|Open-label Phase|Withdrawal by Subject|0|||
94355101|NCT01326312|323082016|FG001|Overall Study|Lack of Efficacy|7|||
94355102|NCT01326312|323082017|FG002|Overall Study|Lack of Efficacy|1|||
94355103|NCT01326312|323082015|FG000|Overall Study|Death|1|||
94355104|NCT01326312|323082016|FG001|Overall Study|Death|0|||
94355105|NCT01326312|323082017|FG002|Overall Study|Death|1|||
94355106|NCT01326312|323082015|FG000|Overall Study|progressive disease|0|||
94355107|NCT01326312|323082016|FG001|Overall Study|progressive disease|1|||
94355108|NCT01326312|323082017|FG002|Overall Study|progressive disease|1|||
94355109|NCT01326312|323082015|FG000|Overall Study|Study terminated by Sponsor|8|||
94355110|NCT01326312|323082016|FG001|Overall Study|Study terminated by Sponsor|32|||
94456134|NCT02244463|323458201|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
94456135|NCT02244463|323458202|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
94244499|NCT00951015|322688927|FG001|Open-label Phase|Withdrawal by Subject|0|||
94244500|NCT00951015|322688928|FG002|Open-label Phase|Withdrawal by Subject|0|||
94244501|NCT00951015|322688929|FG003|Open-label Phase|Withdrawal by Subject|0|||
94244502|NCT00951015|322688930|FG004|Open-label Phase|Withdrawal by Subject|14|||
94244503|NCT00951015|322688926|FG000|Open-label Phase|Physician Decision|0|||
94244504|NCT00951015|322688927|FG001|Open-label Phase|Physician Decision|0|||
94355111|NCT01326312|323082017|FG002|Overall Study|Study terminated by Sponsor|46|||
94355112|NCT01326312|323082015|FG000|Overall Study|Treatment arm terminated|19|||
94355113|NCT01326312|323082016|FG001|Overall Study|Treatment arm terminated|0|||
94355114|NCT01326312|323082017|FG002|Overall Study|Treatment arm terminated|0|||
94589805|NCT02152956|323960920|FG005|Overall Study|Physician Decision|0|||
94589806|NCT02152956|323960921|FG006|Overall Study|Physician Decision|0|||
94589807|NCT02152956|323960922|FG007|Overall Study|Physician Decision|0|||
94589808|NCT02152956|323960923|FG008|Overall Study|Physician Decision|0|||
94589809|NCT02152956|323960924|FG009|Overall Study|Physician Decision|0|||
94589810|NCT02152956|323960925|FG010|Overall Study|Physician Decision|0|||
94589811|NCT02152956|323960926|FG011|Overall Study|Physician Decision|1|||
94589812|NCT02152956|323960927|FG012|Overall Study|Physician Decision|0|||
94589813|NCT02152956|323960915|FG000|Overall Study|Study terminated by sponsor|0|||
94589814|NCT02152956|323960916|FG001|Overall Study|Study terminated by sponsor|0|||
94589815|NCT02152956|323960917|FG002|Overall Study|Study terminated by sponsor|0|||
94244505|NCT00951015|322688928|FG002|Open-label Phase|Physician Decision|0|||
94244506|NCT00951015|322688929|FG003|Open-label Phase|Physician Decision|0|||
94244507|NCT00951015|322688930|FG004|Open-label Phase|Physician Decision|8|||
94244508|NCT01208103|322688933|FG000|Overall Study|Adverse Event|1|||
94244509|NCT01208103|322688933|FG000|Overall Study|Withdrawal by Subject|1|||
94244510|NCT03361605|322688939|FG000|Overall Study|Analyzable data not available|3|||
94244511|NCT02770612|322688940|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
94244512|NCT01840410|322688949|FG000|Overall Study|Physician Decision|1|||
94244513|NCT01840410|322688950|FG001|Overall Study|Physician Decision|2|||
94244514|NCT01840410|322688949|FG000|Overall Study|Pregnancy|1|||
94244515|NCT01840410|322688950|FG001|Overall Study|Pregnancy|0|||
94244516|NCT01840410|322688949|FG000|Overall Study|Protocol deviation|1|||
94244517|NCT01840410|322688950|FG001|Overall Study|Protocol deviation|0|||
94244518|NCT01840410|322688949|FG000|Overall Study|Lost to Follow-up|1|||
94244519|NCT01840410|322688950|FG001|Overall Study|Lost to Follow-up|0|||
94244520|NCT01840410|322688949|FG000|Overall Study|Withdrawal by Subject|2|||
94244521|NCT01840410|322688950|FG001|Overall Study|Withdrawal by Subject|1|||
94244522|NCT01840410|322688949|FG000|Overall Study|Adverse Event|1|||
94244523|NCT01840410|322688950|FG001|Overall Study|Adverse Event|1|||
94244524|NCT04445987|322688952|FG000|Overall Study|Adverse Event|0|||
94244525|NCT04445987|322688953|FG001|Overall Study|Adverse Event|0|||
94244526|NCT04445987|322688954|FG002|Overall Study|Adverse Event|1|||
94244527|NCT04445987|322688955|FG003|Overall Study|Adverse Event|0|||
94244528|NCT04445987|322688956|FG004|Overall Study|Adverse Event|4|||
94244529|NCT04445987|322688957|FG005|Overall Study|Adverse Event|0|||
94244530|NCT04445987|322688952|FG000|Overall Study|Lost to Follow-up|4|||
94244531|NCT04445987|322688953|FG001|Overall Study|Lost to Follow-up|3|||
94244532|NCT04445987|322688954|FG002|Overall Study|Lost to Follow-up|1|||
94244533|NCT04445987|322688955|FG003|Overall Study|Lost to Follow-up|1|||
94244534|NCT04445987|322688956|FG004|Overall Study|Lost to Follow-up|29|||
94244535|NCT04445987|322688957|FG005|Overall Study|Lost to Follow-up|0|||
94244536|NCT04445987|322688952|FG000|Overall Study|Physician Decision|0|||
94244537|NCT04445987|322688953|FG001|Overall Study|Physician Decision|0|||
94244538|NCT04445987|322688954|FG002|Overall Study|Physician Decision|0|||
94355115|NCT01326312|323082015|FG000|Overall Study|QTc > 500|0|||
94355116|NCT01326312|323082016|FG001|Overall Study|QTc > 500|1|||
94589816|NCT02152956|323960918|FG003|Overall Study|Study terminated by sponsor|0|||
94589817|NCT02152956|323960919|FG004|Overall Study|Study terminated by sponsor|0|||
94589818|NCT02152956|323960920|FG005|Overall Study|Study terminated by sponsor|0|||
94589819|NCT02152956|323960921|FG006|Overall Study|Study terminated by sponsor|0|||
94589820|NCT02152956|323960922|FG007|Overall Study|Study terminated by sponsor|0|||
94659760|NCT00116805|324209957|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
94589821|NCT02152956|323960923|FG008|Overall Study|Study terminated by sponsor|0|||
94589822|NCT02152956|323960924|FG009|Overall Study|Study terminated by sponsor|0|||
94589823|NCT02152956|323960925|FG010|Overall Study|Study terminated by sponsor|0|||
94589824|NCT02152956|323960926|FG011|Overall Study|Study terminated by sponsor|29|||
94589825|NCT02152956|323960927|FG012|Overall Study|Study terminated by sponsor|0|||
94589826|NCT02152956|323960915|FG000|Overall Study|progressive disease|0|||
94589827|NCT02152956|323960916|FG001|Overall Study|progressive disease|0|||
94589828|NCT02152956|323960917|FG002|Overall Study|progressive disease|0|||
94589829|NCT02152956|323960918|FG003|Overall Study|progressive disease|0|||
94589830|NCT02152956|323960919|FG004|Overall Study|progressive disease|0|||
94589831|NCT02152956|323960920|FG005|Overall Study|progressive disease|0|||
94589832|NCT02152956|323960921|FG006|Overall Study|progressive disease|0|||
94589833|NCT02152956|323960922|FG007|Overall Study|progressive disease|0|||
94589834|NCT02152956|323960923|FG008|Overall Study|progressive disease|1|||
94589835|NCT02152956|323960924|FG009|Overall Study|progressive disease|0|||
94589836|NCT02152956|323960925|FG010|Overall Study|progressive disease|0|||
94589837|NCT02152956|323960926|FG011|Overall Study|progressive disease|1|||
94589838|NCT02152956|323960927|FG012|Overall Study|progressive disease|0|||
94589839|NCT05661851|323960928|FG000|Overall Study|Protocol Violation|1|||
94589840|NCT05661851|323960929|FG001|Overall Study|Protocol Violation|1|||
94589841|NCT05661851|323960928|FG000|Overall Study|Covid-19 Related|3|||
94589842|NCT05661851|323960929|FG001|Overall Study|Covid-19 Related|4|||
94589843|NCT05661851|323960928|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
94589844|NCT05661851|323960929|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
94589845|NCT05661851|323960928|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
94589846|NCT05661851|323960929|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
94589847|NCT01388985|323960930|FG000|Overall Study|Death|0|||
94589848|NCT01388985|323960931|FG001|Overall Study|Death|1|||
94589849|NCT01388985|323960930|FG000|Overall Study|Lost to Follow-up|30|||
94589850|NCT01388985|323960931|FG001|Overall Study|Lost to Follow-up|30|||
94589851|NCT01388985|323960930|FG000|Overall Study|Withdrawal by Subject|13|||
94244539|NCT04445987|322688955|FG003|Overall Study|Physician Decision|0|||
94589852|NCT01388985|323960931|FG001|Overall Study|Withdrawal by Subject|4|||
94244540|NCT04445987|322688956|FG004|Overall Study|Physician Decision|1|||
94589853|NCT01388985|323960930|FG000|Overall Study|Subject unavailable|1|||
94589854|NCT01388985|323960931|FG001|Overall Study|Subject unavailable|1|||
94244541|NCT04445987|322688957|FG005|Overall Study|Physician Decision|0|||
94244542|NCT04445987|322688952|FG000|Overall Study|Protocol Violation|1|||
94589855|NCT01388985|323960930|FG000|Overall Study|Other (no reason)|0|||
94589856|NCT01388985|323960931|FG001|Overall Study|Other (no reason)|1|||
94589857|NCT01388985|323960930|FG000|Overall Study|Error of nurse|5|||
94589858|NCT01388985|323960931|FG001|Overall Study|Error of nurse|1|||
94589859|NCT02954172|323960932|FG000|Overall Study|Protocol Violation|3|||
94589860|NCT02954172|323960933|FG001|Overall Study|Protocol Violation|0|||
94589861|NCT02954172|323960932|FG000|Overall Study|allergic reaction|2|||
94589862|NCT02954172|323960933|FG001|Overall Study|allergic reaction|1|||
94589863|NCT02954172|323960932|FG000|Overall Study|non-measurable lesions at baseline|1|||
94589864|NCT02954172|323960933|FG001|Overall Study|non-measurable lesions at baseline|2|||
94589865|NCT01601652|323960941|FG000|Overall Study|Death|1|||
94589866|NCT01006291|323962719|FG000|Overall Study|Adverse Event|2|||
94589867|NCT01006291|323962720|FG001|Overall Study|Adverse Event|1|||
94589868|NCT01006291|323962721|FG002|Overall Study|Adverse Event|2|||
94589869|NCT01006291|323962719|FG000|Overall Study|Lack of Efficacy|2|||
94589870|NCT01006291|323962720|FG001|Overall Study|Lack of Efficacy|2|||
94589871|NCT01006291|323962721|FG002|Overall Study|Lack of Efficacy|1|||
94589872|NCT01006291|323962719|FG000|Overall Study|Protocol Violation|3|||
94589873|NCT01006291|323962720|FG001|Overall Study|Protocol Violation|3|||
94589874|NCT01006291|323962721|FG002|Overall Study|Protocol Violation|3|||
94589875|NCT01006291|323962719|FG000|Overall Study|Withdrawal criteria|5|||
94589876|NCT01006291|323962720|FG001|Overall Study|Withdrawal criteria|4|||
94589877|NCT01006291|323962721|FG002|Overall Study|Withdrawal criteria|4|||
94589878|NCT01006291|323962719|FG000|Overall Study|Other|14|||
94589879|NCT01006291|323962720|FG001|Overall Study|Other|14|||
94589880|NCT01006291|323962721|FG002|Overall Study|Other|17|||
94589881|NCT01657461|323962722|FG000|Overall Study|Death|9|||
94589882|NCT01657461|323962723|FG001|Overall Study|Death|12|||
94589883|NCT01657461|323962722|FG000|Overall Study|Lost to Follow-up|0|||
94589884|NCT01657461|323962723|FG001|Overall Study|Lost to Follow-up|3|||
94589885|NCT01657461|323962722|FG000|Overall Study|Physician Decision|0|||
94589886|NCT01657461|323962723|FG001|Overall Study|Physician Decision|2|||
94589887|NCT01657461|323962722|FG000|Overall Study|Withdrawal by Subject|1|||
94589888|NCT01657461|323962723|FG001|Overall Study|Withdrawal by Subject|3|||
94589889|NCT01865552|323962724|FG000|Period 1|Adverse Event|1|||
94589890|NCT01865552|323962725|FG001|Period 1|Adverse Event|0|||
94589891|NCT01865552|323962726|FG002|Period 1|Adverse Event|0|||
94589892|NCT01865552|323962727|FG003|Period 1|Adverse Event|1|||
94589893|NCT01865552|323962728|FG004|Period 1|Adverse Event|1|||
94589894|NCT01865552|323962729|FG005|Period 1|Adverse Event|1|||
94659761|NCT00116805|324209956|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
94659762|NCT00116805|324209957|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
94244543|NCT04445987|322688953|FG001|Overall Study|Protocol Violation|0|||
94244544|NCT04445987|322688954|FG002|Overall Study|Protocol Violation|0|||
94244545|NCT04445987|322688955|FG003|Overall Study|Protocol Violation|0|||
94244546|NCT04445987|322688956|FG004|Overall Study|Protocol Violation|2|||
94244547|NCT04445987|322688957|FG005|Overall Study|Protocol Violation|0|||
94244548|NCT04445987|322688952|FG000|Overall Study|Withdrawal by Subject|4|||
94244549|NCT04445987|322688953|FG001|Overall Study|Withdrawal by Subject|0|||
94244550|NCT04445987|322688954|FG002|Overall Study|Withdrawal by Subject|1|||
94244551|NCT04445987|322688955|FG003|Overall Study|Withdrawal by Subject|0|||
94244552|NCT04445987|322688956|FG004|Overall Study|Withdrawal by Subject|18|||
94244553|NCT04445987|322688957|FG005|Overall Study|Withdrawal by Subject|1|||
94244554|NCT04445987|322688952|FG000|Overall Study|Other reason|0|||
94355117|NCT01326312|323082017|FG002|Overall Study|QTc > 500|0|||
94244555|NCT04445987|322688953|FG001|Overall Study|Other reason|0|||
94244556|NCT04445987|322688954|FG002|Overall Study|Other reason|1|||
94244557|NCT04445987|322688955|FG003|Overall Study|Other reason|0|||
94244558|NCT04445987|322688956|FG004|Overall Study|Other reason|2|||
94355118|NCT04652245|323082018|FG000|Wash-Out Period|Adverse Event|0|||
94589895|NCT01865552|323962724|FG000|Period 1|Pathological lab|0|||
94244559|NCT04445987|322688957|FG005|Overall Study|Other reason|0|||
94355119|NCT04652245|323082019|FG001|Wash-Out Period|Adverse Event|2|||
94589896|NCT01865552|323962725|FG001|Period 1|Pathological lab|0|||
94589897|NCT01865552|323962726|FG002|Period 1|Pathological lab|0|||
94589898|NCT01865552|323962727|FG003|Period 1|Pathological lab|0|||
94589899|NCT01865552|323962728|FG004|Period 1|Pathological lab|1|||
94589900|NCT01865552|323962729|FG005|Period 1|Pathological lab|0|||
94589901|NCT01865552|323962724|FG000|Period 1|Other|0|||
94589902|NCT01865552|323962725|FG001|Period 1|Other|0|||
94589903|NCT01865552|323962726|FG002|Period 1|Other|0|||
94589904|NCT01865552|323962727|FG003|Period 1|Other|0|||
94589905|NCT01865552|323962728|FG004|Period 1|Other|1|||
94589906|NCT01865552|323962729|FG005|Period 1|Other|0|||
94589907|NCT02051933|323962730|FG000|Overall Study|Physician Decision|0|||
94589908|NCT02051933|323962731|FG001|Overall Study|Physician Decision|1|||
94589909|NCT03860818|323962737|FG000|Overall Study|Death|144|||
94589910|NCT03860818|323962738|FG001|Overall Study|Death|195|||
94589911|NCT03860818|323962737|FG000|Overall Study|Graft Loss|32|||
94589912|NCT03860818|323962738|FG001|Overall Study|Graft Loss|45|||
94589913|NCT01139008|323962739|FG000|Overall Study|Withdrawal by Subject|5|||
94589914|NCT01139008|323962739|FG000|Overall Study|Non-compliant, lost product|1|||
94589915|NCT01715857|323962742|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
94589916|NCT02338882|323962743|FG000|Overall Study|Death|1|||
94589917|NCT02338882|323962744|FG001|Overall Study|Death|0|||
94589918|NCT02338882|323962743|FG000|Overall Study|Lost to Follow-up|6|||
94589919|NCT02338882|323962744|FG001|Overall Study|Lost to Follow-up|3|||
94589920|NCT02248675|323962747|FG000|Overall Study|Lost to Follow-up|3|||
94589921|NCT02248675|323962748|FG001|Overall Study|Lost to Follow-up|1|||
94589922|NCT05367492|323962752|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
94589923|NCT05367492|323962753|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
94589924|NCT05367492|323962754|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
94244560|NCT02738853|322688958|FG000|Enrollment|Inclusion/Exclusion not met|21|||
94589925|NCT05367492|323962752|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
94589926|NCT05367492|323962753|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
94589927|NCT05367492|323962754|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
94589928|NCT05367492|323962752|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
94659763|NCT00116805|324209956|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
94659764|NCT00116805|324209957|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
94659765|NCT00116805|324209956|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
94659766|NCT00116805|324209957|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
94659767|NCT00116805|324209956|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
94659768|NCT00116805|324209957|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
94659769|NCT00116805|324209956|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
94659770|NCT00116805|324209957|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
94659771|NCT00116805|324209956|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
94659772|NCT00116805|324209957|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
94659773|NCT00116805|324209956|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
94659774|NCT00116805|324209957|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
94659775|NCT00116805|324209956|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
94659776|NCT00116805|324209957|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
94659777|NCT00116805|324209956|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
94659778|NCT00116805|324209957|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
94659779|NCT00116805|324209956|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
94659780|NCT00116805|324209957|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
94659781|NCT00116805|324209956|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
94659782|NCT00116805|324209957|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
94659783|NCT00116805|324209956|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
94659784|NCT00116805|324209957|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
94659785|NCT00116805|324209956|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
94659786|NCT00116805|324209957|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
94659787|NCT00116805|324209956|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
94659788|NCT00116805|324209957|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
94244561|NCT02738853|322688958|FG000|Enrollment|Withdrawal by Subject|3|||
94244562|NCT02738853|322688958|FG000|Enrollment|Subject treated with commercially available device|6|||
94244563|NCT02738853|322688958|FG000|Enrollment|Study Enrollment Closed|3|||
94244564|NCT02738853|322688958|FG000|Procedure|Death|1|||
94244565|NCT02738853|322688958|FG000|1 Month|Death|2|||
94244566|NCT02738853|322688958|FG000|6 Month|Death|4|||
94244567|NCT02738853|322688958|FG000|6 Month|Withdrawal by Subject|2|||
94244568|NCT02738853|322688958|FG000|1 Year|Death|6|||
94244569|NCT02738853|322688958|FG000|1 Year|Withdrawal by Subject|1|||
94244570|NCT02738853|322688958|FG000|2 Year|Death|2|||
94244571|NCT02738853|322688958|FG000|2 Year|Lost to Follow-up|1|||
94244572|NCT02738853|322688958|FG000|3 Year|Death|2|||
94244573|NCT02738853|322688958|FG000|3 Year|Withdrawal by Subject|1|||
94456136|NCT02244463|323458197|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
94456137|NCT02244463|323458198|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
94659789|NCT00116805|324209956|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
94659790|NCT00116805|324209957|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
94659791|NCT00116805|324209956|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
94659792|NCT00116805|324209957|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
94244574|NCT02738853|322688958|FG000|4 Year|Death|9|||
94244575|NCT02738853|322688958|FG000|5 Year|Lost to Follow-up|4|||
94244576|NCT00680992|322688959|FG000|Overall Study|Complete Resection (as per protocol)|25|||
94244577|NCT00680992|322688960|FG001|Overall Study|Complete Resection (as per protocol)|121|||
94244578|NCT00680992|322688961|FG002|Overall Study|Complete Resection (as per protocol)|0|||
94244579|NCT00680992|322688959|FG000|Overall Study|Administrative Decision|83|||
94589929|NCT05367492|323962753|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
94589930|NCT05367492|323962754|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
94589931|NCT05367492|323962752|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
94589932|NCT05367492|323962753|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
94589933|NCT05367492|323962754|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
94589934|NCT01088048|323962755|FG000|Overall Study|Adverse Event|7|||
94589935|NCT01088048|323962756|FG001|Overall Study|Adverse Event|9|||
94589936|NCT01088048|323962757|FG002|Overall Study|Adverse Event|7|||
94589937|NCT01088048|323962758|FG003|Overall Study|Adverse Event|5|||
94589938|NCT01088048|323962759|FG004|Overall Study|Adverse Event|6|||
94589939|NCT01088048|323962760|FG005|Overall Study|Adverse Event|3|||
94589940|NCT01088048|323962761|FG006|Overall Study|Adverse Event|3|||
94589941|NCT01088048|323962762|FG007|Overall Study|Adverse Event|0|||
94589942|NCT01088048|323962763|FG008|Overall Study|Adverse Event|2|||
94589943|NCT01088048|323962764|FG009|Overall Study|Adverse Event|2|||
94589944|NCT01088048|323962755|FG000|Overall Study|Withdrew Consent|1|||
94589945|NCT01088048|323962756|FG001|Overall Study|Withdrew Consent|1|||
94589946|NCT01088048|323962757|FG002|Overall Study|Withdrew Consent|1|||
94589947|NCT01088048|323962758|FG003|Overall Study|Withdrew Consent|1|||
94589948|NCT01088048|323962759|FG004|Overall Study|Withdrew Consent|2|||
94589949|NCT01088048|323962760|FG005|Overall Study|Withdrew Consent|1|||
94589950|NCT01088048|323962761|FG006|Overall Study|Withdrew Consent|0|||
94589951|NCT01088048|323962762|FG007|Overall Study|Withdrew Consent|2|||
94589952|NCT01088048|323962763|FG008|Overall Study|Withdrew Consent|2|||
94589953|NCT01088048|323962764|FG009|Overall Study|Withdrew Consent|1|||
94589954|NCT01088048|323962755|FG000|Overall Study|Concomitant Medication Prohibited|1|||
94589955|NCT01088048|323962756|FG001|Overall Study|Concomitant Medication Prohibited|0|||
94589956|NCT01088048|323962757|FG002|Overall Study|Concomitant Medication Prohibited|0|||
94589957|NCT01088048|323962758|FG003|Overall Study|Concomitant Medication Prohibited|0|||
94589958|NCT01088048|323962759|FG004|Overall Study|Concomitant Medication Prohibited|0|||
94589959|NCT01088048|323962760|FG005|Overall Study|Concomitant Medication Prohibited|0|||
94589960|NCT01088048|323962761|FG006|Overall Study|Concomitant Medication Prohibited|0|||
94589961|NCT01088048|323962762|FG007|Overall Study|Concomitant Medication Prohibited|0|||
94589962|NCT01088048|323962763|FG008|Overall Study|Concomitant Medication Prohibited|0|||
94589963|NCT01088048|323962764|FG009|Overall Study|Concomitant Medication Prohibited|0|||
94589964|NCT01088048|323962755|FG000|Overall Study|Investigator Request|2|||
94589965|NCT01088048|323962756|FG001|Overall Study|Investigator Request|2|||
94589966|NCT01088048|323962757|FG002|Overall Study|Investigator Request|0|||
94589967|NCT01088048|323962758|FG003|Overall Study|Investigator Request|0|||
94589968|NCT01088048|323962759|FG004|Overall Study|Investigator Request|3|||
94589969|NCT01088048|323962760|FG005|Overall Study|Investigator Request|1|||
94589970|NCT01088048|323962761|FG006|Overall Study|Investigator Request|1|||
94589971|NCT01088048|323962762|FG007|Overall Study|Investigator Request|0|||
94589972|NCT01088048|323962763|FG008|Overall Study|Investigator Request|0|||
94589973|NCT01088048|323962764|FG009|Overall Study|Investigator Request|0|||
94589974|NCT01088048|323962755|FG000|Overall Study|Patient Non-compliance|0|||
94589975|NCT01088048|323962756|FG001|Overall Study|Patient Non-compliance|1|||
94589976|NCT01088048|323962757|FG002|Overall Study|Patient Non-compliance|0|||
94589977|NCT01088048|323962758|FG003|Overall Study|Patient Non-compliance|0|||
94589978|NCT01088048|323962759|FG004|Overall Study|Patient Non-compliance|0|||
94589979|NCT01088048|323962760|FG005|Overall Study|Patient Non-compliance|0|||
94244580|NCT00680992|322688960|FG001|Overall Study|Administrative Decision|42|||
94244581|NCT00680992|322688961|FG002|Overall Study|Administrative Decision|5|||
94244582|NCT00680992|322688959|FG000|Overall Study|End of Trial|32|||
94244583|NCT00680992|322688960|FG001|Overall Study|End of Trial|12|||
94244584|NCT00680992|322688961|FG002|Overall Study|End of Trial|3|||
94244585|NCT00680992|322688959|FG000|Overall Study|Withdrawal by Subject|33|||
94244586|NCT00680992|322688960|FG001|Overall Study|Withdrawal by Subject|11|||
94244587|NCT00680992|322688961|FG002|Overall Study|Withdrawal by Subject|1|||
94244588|NCT00680992|322688959|FG000|Overall Study|Adverse Event|21|||
94244589|NCT00680992|322688960|FG001|Overall Study|Adverse Event|19|||
94244590|NCT00680992|322688961|FG002|Overall Study|Adverse Event|1|||
94244591|NCT00680992|322688959|FG000|Overall Study|Other|19|||
94244592|NCT00680992|322688960|FG001|Overall Study|Other|14|||
94589980|NCT01088048|323962761|FG006|Overall Study|Patient Non-compliance|0|||
94589981|NCT01088048|323962762|FG007|Overall Study|Patient Non-compliance|0|||
94589982|NCT01088048|323962763|FG008|Overall Study|Patient Non-compliance|0|||
94589983|NCT01088048|323962764|FG009|Overall Study|Patient Non-compliance|0|||
94244593|NCT00680992|322688961|FG002|Overall Study|Other|1|||
94589984|NCT01088048|323962755|FG000|Overall Study|Disease Progression|7|||
94244594|NCT00680992|322688959|FG000|Overall Study|Disease Progression|21|||
94244595|NCT00680992|322688960|FG001|Overall Study|Disease Progression|9|||
94589985|NCT01088048|323962756|FG001|Overall Study|Disease Progression|4|||
94589986|NCT01088048|323962757|FG002|Overall Study|Disease Progression|3|||
94589987|NCT01088048|323962758|FG003|Overall Study|Disease Progression|5|||
94589988|NCT01088048|323962759|FG004|Overall Study|Disease Progression|3|||
94589989|NCT01088048|323962760|FG005|Overall Study|Disease Progression|3|||
94589990|NCT01088048|323962761|FG006|Overall Study|Disease Progression|2|||
94589991|NCT01088048|323962762|FG007|Overall Study|Disease Progression|1|||
94589992|NCT01088048|323962763|FG008|Overall Study|Disease Progression|0|||
94589993|NCT01088048|323962764|FG009|Overall Study|Disease Progression|0|||
94589994|NCT01088048|323962755|FG000|Overall Study|Death|1|||
94589995|NCT01088048|323962756|FG001|Overall Study|Death|5|||
94589996|NCT01088048|323962757|FG002|Overall Study|Death|3|||
94589997|NCT01088048|323962758|FG003|Overall Study|Death|3|||
94589998|NCT01088048|323962759|FG004|Overall Study|Death|1|||
94589999|NCT01088048|323962760|FG005|Overall Study|Death|3|||
94590000|NCT01088048|323962761|FG006|Overall Study|Death|0|||
94590001|NCT01088048|323962762|FG007|Overall Study|Death|0|||
94590002|NCT01088048|323962763|FG008|Overall Study|Death|3|||
94590003|NCT01088048|323962764|FG009|Overall Study|Death|1|||
94590004|NCT01088048|323962755|FG000|Overall Study|Other|3|||
94590005|NCT01088048|323962756|FG001|Overall Study|Other|5|||
94590006|NCT01088048|323962757|FG002|Overall Study|Other|0|||
94590007|NCT01088048|323962758|FG003|Overall Study|Other|0|||
94590008|NCT01088048|323962759|FG004|Overall Study|Other|2|||
94590009|NCT01088048|323962760|FG005|Overall Study|Other|0|||
94590010|NCT01088048|323962761|FG006|Overall Study|Other|0|||
94590011|NCT01088048|323962762|FG007|Overall Study|Other|2|||
94590012|NCT01088048|323962763|FG008|Overall Study|Other|0|||
94590013|NCT01088048|323962764|FG009|Overall Study|Other|0|||
94590014|NCT02891070|323962765|FG000|Overall Study|Adverse Event|1|||
94590015|NCT02891070|323962766|FG001|Overall Study|Adverse Event|0|||
94590016|NCT02891070|323962765|FG000|Overall Study|Physician Decision|0|||
94590017|NCT02891070|323962766|FG001|Overall Study|Physician Decision|1|||
94590018|NCT02891070|323962765|FG000|Overall Study|Lost to Follow-up|4|||
94590019|NCT02891070|323962766|FG001|Overall Study|Lost to Follow-up|4|||
94659793|NCT00116805|324209956|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
94244596|NCT00680992|322688961|FG002|Overall Study|Disease Progression|0|||
94244597|NCT00680992|322688959|FG000|Overall Study|Lost to Follow-up|12|||
94244598|NCT00680992|322688960|FG001|Overall Study|Lost to Follow-up|14|||
94244599|NCT00680992|322688961|FG002|Overall Study|Lost to Follow-up|0|||
94244600|NCT00680992|322688959|FG000|Overall Study|Noncompliance|4|||
94244601|NCT00680992|322688960|FG001|Overall Study|Noncompliance|6|||
94244602|NCT00680992|322688961|FG002|Overall Study|Noncompliance|0|||
94244603|NCT00680992|322688959|FG000|Overall Study|Requirement for Alternative Therapy|8|||
94244604|NCT00680992|322688960|FG001|Overall Study|Requirement for Alternative Therapy|2|||
94244605|NCT00680992|322688961|FG002|Overall Study|Requirement for Alternative Therapy|0|||
94244606|NCT00680992|322688959|FG000|Overall Study|Pregnancy|5|||
94244607|NCT00680992|322688960|FG001|Overall Study|Pregnancy|0|||
94456138|NCT02244463|323458199|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
94590020|NCT02891070|323962765|FG000|Overall Study|Other|1|||
94590021|NCT02891070|323962766|FG001|Overall Study|Other|0|||
94244608|NCT00680992|322688961|FG002|Overall Study|Pregnancy|1|||
94244609|NCT00680992|322688959|FG000|Overall Study|Death|5|||
94244610|NCT00680992|322688960|FG001|Overall Study|Death|1|||
94244611|NCT00680992|322688961|FG002|Overall Study|Death|0|||
94659794|NCT00116805|324209957|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
94590022|NCT02891070|323962765|FG000|Overall Study|Protocol Violation|0|||
94590023|NCT02891070|323962766|FG001|Overall Study|Protocol Violation|1|||
94688610|NCT04076020|324315529|FG001|Overall Study|Withdrawal by Subject|8|||
94590024|NCT02891070|323962765|FG000|Overall Study|Withdrawal by Subject|1|||
94244612|NCT00680992|322688959|FG000|Overall Study|Ineligibility Determined|0|||
94590025|NCT02891070|323962766|FG001|Overall Study|Withdrawal by Subject|2|||
94590026|NCT02891070|323962765|FG000|Overall Study|Death|3|||
94590027|NCT02891070|323962766|FG001|Overall Study|Death|0|||
94590028|NCT00942994|323962767|FG000|Overall Study|Adverse Event|7|||
94244613|NCT00680992|322688960|FG001|Overall Study|Ineligibility Determined|1|||
94590029|NCT00942994|323962768|FG001|Overall Study|Adverse Event|4|||
94244614|NCT00680992|322688961|FG002|Overall Study|Ineligibility Determined|0|||
94244615|NCT01468181|322688962|FG000|Overall Study|Adverse Event|8|||
94244616|NCT01468181|322688963|FG001|Overall Study|Adverse Event|1|||
94244617|NCT01468181|322688964|FG002|Overall Study|Adverse Event|6|||
94244618|NCT01468181|322688965|FG003|Overall Study|Adverse Event|2|||
94244619|NCT01468181|322688966|FG004|Overall Study|Adverse Event|2|||
94244620|NCT01468181|322688962|FG000|Overall Study|Protocol Violation|2|||
94244621|NCT01468181|322688963|FG001|Overall Study|Protocol Violation|0|||
94244622|NCT01468181|322688964|FG002|Overall Study|Protocol Violation|1|||
94244623|NCT01468181|322688965|FG003|Overall Study|Protocol Violation|0|||
94244624|NCT01468181|322688966|FG004|Overall Study|Protocol Violation|1|||
94244625|NCT01468181|322688962|FG000|Overall Study|Physician Decision|0|||
94244626|NCT01468181|322688963|FG001|Overall Study|Physician Decision|0|||
94244627|NCT01468181|322688964|FG002|Overall Study|Physician Decision|0|||
94244628|NCT01468181|322688965|FG003|Overall Study|Physician Decision|1|||
94244629|NCT01468181|322688966|FG004|Overall Study|Physician Decision|1|||
94244630|NCT01468181|322688962|FG000|Overall Study|Lost to Follow-up|0|||
94244631|NCT01468181|322688963|FG001|Overall Study|Lost to Follow-up|0|||
94244632|NCT01468181|322688964|FG002|Overall Study|Lost to Follow-up|1|||
94244633|NCT01468181|322688965|FG003|Overall Study|Lost to Follow-up|0|||
94244634|NCT01468181|322688966|FG004|Overall Study|Lost to Follow-up|1|||
94244635|NCT01468181|322688962|FG000|Overall Study|Withdrawal by Subject|0|||
94244636|NCT01468181|322688963|FG001|Overall Study|Withdrawal by Subject|1|||
94244637|NCT01468181|322688964|FG002|Overall Study|Withdrawal by Subject|0|||
94244638|NCT01468181|322688965|FG003|Overall Study|Withdrawal by Subject|0|||
94244639|NCT01468181|322688966|FG004|Overall Study|Withdrawal by Subject|0|||
94244640|NCT00925353|322688967|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
94244641|NCT00545753|322688968|FG000|Overall Study|Withdrawal by Subject|0|||
94244642|NCT00545753|322688969|FG001|Overall Study|Withdrawal by Subject|1|||
94244643|NCT00545753|322688970|FG002|Overall Study|Withdrawal by Subject|10|||
94244644|NCT00545753|322688968|FG000|Overall Study|Lost to Follow-up|13|||
94244645|NCT00545753|322688969|FG001|Overall Study|Lost to Follow-up|3|||
94244646|NCT00545753|322688970|FG002|Overall Study|Lost to Follow-up|12|||
94244647|NCT00545753|322688968|FG000|Overall Study|Protocol Violation|3|||
94244648|NCT00545753|322688969|FG001|Overall Study|Protocol Violation|1|||
94244649|NCT00545753|322688970|FG002|Overall Study|Protocol Violation|4|||
94244650|NCT03772587|322688971|FG000|Overall Study|COVID-19|0|||
94244651|NCT03772587|322688972|FG001|Overall Study|COVID-19|0|||
94244652|NCT03772587|322688973|FG002|Overall Study|COVID-19|1|||
94244653|NCT03772587|322688974|FG003|Overall Study|COVID-19|1|||
94244654|NCT03772587|322688975|FG004|Overall Study|COVID-19|0|||
94244655|NCT03772587|322688971|FG000|Overall Study|Withdrawal by Subject|1|||
94244656|NCT03772587|322688972|FG001|Overall Study|Withdrawal by Subject|0|||
94244657|NCT03772587|322688973|FG002|Overall Study|Withdrawal by Subject|0|||
94244658|NCT03772587|322688974|FG003|Overall Study|Withdrawal by Subject|0|||
94244659|NCT03772587|322688975|FG004|Overall Study|Withdrawal by Subject|0|||
94244660|NCT03014479|322688981|FG000|Overall Study|Adverse Event|0|||
94244661|NCT03014479|322688982|FG001|Overall Study|Adverse Event|1|||
94244662|NCT03014479|322688981|FG000|Overall Study|Voluntary Withdrawal|0|||
94244663|NCT03014479|322688982|FG001|Overall Study|Voluntary Withdrawal|2|||
94244664|NCT03014479|322688981|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
94244665|NCT03014479|322688982|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
94244666|NCT02227199|322688983|FG000|Overall Study|Physician Decision|0|||
94244667|NCT02227199|322688984|FG001|Overall Study|Physician Decision|0|||
94244668|NCT02227199|322688985|FG002|Overall Study|Physician Decision|1|||
94244669|NCT02227199|322688983|FG000|Overall Study|Adverse Event|0|||
94244670|NCT02227199|322688984|FG001|Overall Study|Adverse Event|0|||
94244671|NCT02227199|322688985|FG002|Overall Study|Adverse Event|3|||
94244672|NCT05038163|322688989|FG000|Stage 1|Did not complete survey|374|||
94244673|NCT05038163|322688990|FG001|Stage 1|Did not complete survey|0|||
94244674|NCT05038163|322688991|FG002|Stage 1|Did not complete survey|0|||
94244675|NCT05038163|322688992|FG003|Stage 1|Did not complete survey|0|||
94244676|NCT05038163|322688993|FG004|Stage 1|Did not complete survey|0|||
94244677|NCT05038163|322688994|FG005|Stage 1|Did not complete survey|0|||
94244678|NCT05038163|322688989|FG000|Stage 2|Did not complete Stage 2 survey|0|||
94244679|NCT05038163|322688990|FG001|Stage 2|Did not complete Stage 2 survey|29|||
94244680|NCT05038163|322688991|FG002|Stage 2|Did not complete Stage 2 survey|30|||
94244681|NCT05038163|322688992|FG003|Stage 2|Did not complete Stage 2 survey|24|||
94244682|NCT05038163|322688993|FG004|Stage 2|Did not complete Stage 2 survey|21|||
94244683|NCT05038163|322688994|FG005|Stage 2|Did not complete Stage 2 survey|100|||
94244684|NCT01200290|322688998|FG000|Treatment Period|Adverse Event|1|||
94244685|NCT01200290|322688998|FG000|Post-Treatment Follow-Up Period|Death|2|||
94244686|NCT03762200|322689007|FG000|Overall Study|Death|2|||
94244687|NCT02489968|322689008|FG000|Open-label Treatment Period|Adverse Event|14|||
94244688|NCT02489968|322689009|FG001|Open-label Treatment Period|Adverse Event|7|||
94244689|NCT02489968|322689010|FG002|Open-label Treatment Period|Adverse Event|0|||
94244690|NCT02489968|322689011|FG003|Open-label Treatment Period|Adverse Event|0|||
94355120|NCT04652245|323082018|FG000|Wash-Out Period|Withdrawal by Subject|0|||
94355121|NCT04652245|323082019|FG001|Wash-Out Period|Withdrawal by Subject|2|||
94355122|NCT01484691|323082022|FG000|Overall Study|Withdrawal by Subject|1|||
94244691|NCT02489968|322689012|FG004|Open-label Treatment Period|Adverse Event|0|||
94244692|NCT02489968|322689013|FG005|Open-label Treatment Period|Adverse Event|0|||
94244693|NCT02489968|322689008|FG000|Open-label Treatment Period|Protocol Violation|2|||
94244694|NCT02489968|322689009|FG001|Open-label Treatment Period|Protocol Violation|2|||
94244695|NCT02489968|322689010|FG002|Open-label Treatment Period|Protocol Violation|0|||
94244696|NCT02489968|322689011|FG003|Open-label Treatment Period|Protocol Violation|0|||
94244697|NCT02489968|322689012|FG004|Open-label Treatment Period|Protocol Violation|0|||
94244698|NCT02489968|322689013|FG005|Open-label Treatment Period|Protocol Violation|0|||
94244699|NCT02489968|322689008|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
94244700|NCT02489968|322689009|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
94244701|NCT02489968|322689010|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
94244702|NCT02489968|322689011|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
94244703|NCT02489968|322689012|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
94244704|NCT02489968|322689013|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
94244705|NCT02489968|322689008|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
94244706|NCT02489968|322689009|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
94244707|NCT02489968|322689010|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
94244708|NCT02489968|322689011|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
94244709|NCT02489968|322689012|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
94244710|NCT02489968|322689013|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
94244711|NCT02489968|322689008|FG000|Open-label Treatment Period|Other than specified above|204|||
94244712|NCT02489968|322689009|FG001|Open-label Treatment Period|Other than specified above|189|||
94355123|NCT01484691|323082023|FG001|Overall Study|Withdrawal by Subject|1|||
94355124|NCT01484691|323082024|FG002|Overall Study|Withdrawal by Subject|1|||
94355125|NCT01484691|323082022|FG000|Overall Study|Physician Decision|0|||
94244713|NCT02489968|322689010|FG002|Open-label Treatment Period|Other than specified above|0|||
94355126|NCT01484691|323082023|FG001|Overall Study|Physician Decision|2|||
94244714|NCT02489968|322689011|FG003|Open-label Treatment Period|Other than specified above|0|||
94244715|NCT02489968|322689012|FG004|Open-label Treatment Period|Other than specified above|0|||
94244716|NCT02489968|322689013|FG005|Open-label Treatment Period|Other than specified above|0|||
94244717|NCT02489968|322689008|FG000|Double-blind Treatment Period|Adverse Event|0|||
94244718|NCT02489968|322689009|FG001|Double-blind Treatment Period|Adverse Event|0|||
94244719|NCT02489968|322689010|FG002|Double-blind Treatment Period|Adverse Event|2|||
94244720|NCT02489968|322689011|FG003|Double-blind Treatment Period|Adverse Event|6|||
94244721|NCT02489968|322689012|FG004|Double-blind Treatment Period|Adverse Event|4|||
94244722|NCT02489968|322689013|FG005|Double-blind Treatment Period|Adverse Event|5|||
94244723|NCT02489968|322689008|FG000|Double-blind Treatment Period|Protocol Violation|0|||
94244724|NCT02489968|322689009|FG001|Double-blind Treatment Period|Protocol Violation|0|||
94244725|NCT02489968|322689010|FG002|Double-blind Treatment Period|Protocol Violation|0|||
94244726|NCT02489968|322689011|FG003|Double-blind Treatment Period|Protocol Violation|0|||
94244727|NCT02489968|322689012|FG004|Double-blind Treatment Period|Protocol Violation|1|||
94244728|NCT02489968|322689013|FG005|Double-blind Treatment Period|Protocol Violation|1|||
94355127|NCT01484691|323082024|FG002|Overall Study|Physician Decision|1|||
94355128|NCT05146999|323082025|FG000|Overall Study|Withdrew consent|6|||
94355129|NCT05146999|323082026|FG001|Overall Study|Withdrew consent|1|||
94355130|NCT05146999|323082025|FG000|Overall Study|Lost to Follow-up|3|||
94244729|NCT02489968|322689008|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
94355131|NCT05146999|323082026|FG001|Overall Study|Lost to Follow-up|2|||
94355132|NCT05146999|323082025|FG000|Overall Study|Other|1|||
94355133|NCT05146999|323082026|FG001|Overall Study|Other|3|||
94355134|NCT00938366|323082027|FG000|Overall Study|Withdrawal by Subject|1|||
94355135|NCT00938366|323082028|FG001|Overall Study|Withdrawal by Subject|0|||
94244730|NCT02489968|322689009|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
94244731|NCT02489968|322689010|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
94244732|NCT02489968|322689011|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
94244733|NCT02489968|322689012|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
94244734|NCT02489968|322689013|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
94244735|NCT02489968|322689008|FG000|Double-blind Treatment Period|Other than specified above|0|||
94244736|NCT02489968|322689009|FG001|Double-blind Treatment Period|Other than specified above|0|||
94244737|NCT02489968|322689010|FG002|Double-blind Treatment Period|Other than specified above|0|||
94244738|NCT02489968|322689011|FG003|Double-blind Treatment Period|Other than specified above|0|||
94590030|NCT00942994|323962767|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94244739|NCT02489968|322689012|FG004|Double-blind Treatment Period|Other than specified above|1|||
94355136|NCT01016912|323082029|FG000|End of Treatment Period|Lack of Efficacy|0|||
94590031|NCT00942994|323962768|FG001|Overall Study|Abnormal laboratory value(s)|0|||
94590032|NCT00942994|323962767|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94355137|NCT01016912|323082030|FG001|End of Treatment Period|Lack of Efficacy|1|||
94355138|NCT01016912|323082031|FG002|End of Treatment Period|Lack of Efficacy|0|||
94590033|NCT00942994|323962768|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
94355139|NCT01016912|323082032|FG003|End of Treatment Period|Lack of Efficacy|4|||
94355140|NCT01016912|323082033|FG004|End of Treatment Period|Lack of Efficacy|4|||
94244740|NCT02489968|322689013|FG005|Double-blind Treatment Period|Other than specified above|0|||
94244741|NCT01525238|322689014|FG000|Overall Study|Withdrawal by Subject|1|||
94244742|NCT01525238|322689015|FG001|Overall Study|Withdrawal by Subject|0|||
94244743|NCT01525238|322689016|FG002|Overall Study|Withdrawal by Subject|0|||
94244744|NCT04577001|322689017|FG000|Overall Study|Subject became ineligible|0|||
94244745|NCT04577001|322689018|FG001|Overall Study|Subject became ineligible|1|||
94244746|NCT01593787|322689019|FG000|Overall Study|Adverse Event|1|||
94244747|NCT01593787|322689020|FG001|Overall Study|Adverse Event|0|||
94244748|NCT01593787|322689021|FG002|Overall Study|Adverse Event|0|||
94244749|NCT01865747|322689022|FG000|Overall Study (ITT)|Adverse Event|32|||
94244750|NCT01865747|322689023|FG001|Overall Study (ITT)|Adverse Event|31|||
94244751|NCT01865747|322689022|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
94244752|NCT01865747|322689023|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
94244753|NCT01865747|322689022|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
94244754|NCT01865747|322689023|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
94244755|NCT01865747|322689022|FG000|Overall Study (ITT)|Protocol Violation|1|||
94244756|NCT01865747|322689023|FG001|Overall Study (ITT)|Protocol Violation|1|||
94244757|NCT01865747|322689022|FG000|Overall Study (ITT)|Physician Decision|5|||
94244758|NCT01865747|322689023|FG001|Overall Study (ITT)|Physician Decision|2|||
94244759|NCT01865747|322689022|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
94244760|NCT01865747|322689023|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
94244761|NCT01865747|322689022|FG000|Overall Study (ITT)|Sponsor Decision|0|||
94244762|NCT01865747|322689023|FG001|Overall Study (ITT)|Sponsor Decision|1|||
94244763|NCT01865747|322689022|FG000|Overall Study (ITT)|Progressive Disease|122|||
94244764|NCT01865747|322689023|FG001|Overall Study (ITT)|Progressive Disease|158|||
94244765|NCT01865747|322689022|FG000|Overall Study (ITT)|Reason Not Provided|0|||
94244766|NCT01865747|322689023|FG001|Overall Study (ITT)|Reason Not Provided|1|||
94244767|NCT01865747|322689022|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
94244768|NCT01865747|322689023|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
94244769|NCT01865747|322689022|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
94456139|NCT02244463|323458200|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
94244770|NCT01865747|322689023|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
94456140|NCT02244463|323458201|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
94244771|NCT01865747|322689022|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
94244772|NCT01865747|322689023|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
94244773|NCT01865747|322689022|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
94244774|NCT01865747|322689023|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
94244775|NCT01865747|322689022|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
94244776|NCT01865747|322689023|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
94244777|NCT01865747|322689022|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
94244778|NCT01865747|322689023|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
94244779|NCT01865747|322689022|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
94244780|NCT01865747|322689023|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
94244781|NCT01865747|322689022|FG000|Primary Intent to Treat (PITT)|Other|0|||
94244782|NCT01865747|322689023|FG001|Primary Intent to Treat (PITT)|Other|1|||
94244783|NCT01901432|322690265|FG000|Overall Study|Adverse Event|0|||
94244784|NCT01901432|322690266|FG001|Overall Study|Adverse Event|1|||
94244785|NCT01901432|322690267|FG002|Overall Study|Adverse Event|1|||
94244786|NCT01901432|322690268|FG003|Overall Study|Adverse Event|0|||
94244787|NCT01901432|322690269|FG004|Overall Study|Adverse Event|1|||
94244788|NCT01901432|322690265|FG000|Overall Study|Withdrawal by Subject|0|||
94244789|NCT01901432|322690266|FG001|Overall Study|Withdrawal by Subject|0|||
94244790|NCT01901432|322690267|FG002|Overall Study|Withdrawal by Subject|1|||
94244791|NCT01901432|322690268|FG003|Overall Study|Withdrawal by Subject|0|||
94244792|NCT01901432|322690269|FG004|Overall Study|Withdrawal by Subject|5|||
94244793|NCT01901432|322690265|FG000|Overall Study|Physician Decision|0|||
94244794|NCT01901432|322690266|FG001|Overall Study|Physician Decision|0|||
94244795|NCT01901432|322690267|FG002|Overall Study|Physician Decision|0|||
94244796|NCT01901432|322690268|FG003|Overall Study|Physician Decision|0|||
94244797|NCT01901432|322690269|FG004|Overall Study|Physician Decision|2|||
94244798|NCT01901432|322690265|FG000|Overall Study|Patient decision to stop study drug|0|||
94244799|NCT01901432|322690266|FG001|Overall Study|Patient decision to stop study drug|0|||
94244800|NCT01901432|322690267|FG002|Overall Study|Patient decision to stop study drug|0|||
94244801|NCT01901432|322690268|FG003|Overall Study|Patient decision to stop study drug|0|||
94244802|NCT01901432|322690269|FG004|Overall Study|Patient decision to stop study drug|1|||
94244803|NCT01202903|322690270|FG000|Overall Study|Administrative Probelms|1|||
94244804|NCT01202903|322690271|FG001|Overall Study|Administrative Probelms|4|||
94244805|NCT01202903|322690270|FG000|Overall Study|Protocol Violation|0|||
94244806|NCT01202903|322690271|FG001|Overall Study|Protocol Violation|1|||
94244807|NCT01202903|322690270|FG000|Overall Study|Death|1|||
94244808|NCT01202903|322690271|FG001|Overall Study|Death|0|||
94244809|NCT01202903|322690270|FG000|Overall Study|Lost to Follow-up|1|||
94244810|NCT01202903|322690271|FG001|Overall Study|Lost to Follow-up|1|||
94244811|NCT01202903|322690270|FG000|Overall Study|Lack of Efficacy|1|||
94244812|NCT01202903|322690271|FG001|Overall Study|Lack of Efficacy|3|||
94244813|NCT01202903|322690270|FG000|Overall Study|Adverse Event|3|||
94244814|NCT01202903|322690271|FG001|Overall Study|Adverse Event|3|||
94244815|NCT01202903|322690270|FG000|Overall Study|Withdrawal by Subject|4|||
94244816|NCT01202903|322690271|FG001|Overall Study|Withdrawal by Subject|4|||
94244817|NCT00568178|322690272|FG000|Double Blind Base Study|Adverse Event|0|||
94244818|NCT00568178|322690273|FG001|Double Blind Base Study|Adverse Event|2|||
94244819|NCT00568178|322690274|FG002|Double Blind Base Study|Adverse Event|1|||
94244820|NCT00568178|322690275|FG003|Double Blind Base Study|Adverse Event|2|||
94244821|NCT00568178|322690276|FG004|Double Blind Base Study|Adverse Event|0|||
94244822|NCT00568178|322690277|FG005|Double Blind Base Study|Adverse Event|0|||
94244823|NCT00568178|322690272|FG000|Double Blind Base Study|Lost to Follow-up|1|||
94244824|NCT00568178|322690273|FG001|Double Blind Base Study|Lost to Follow-up|0|||
94244825|NCT00568178|322690274|FG002|Double Blind Base Study|Lost to Follow-up|0|||
94244826|NCT00568178|322690275|FG003|Double Blind Base Study|Lost to Follow-up|1|||
94244827|NCT00568178|322690276|FG004|Double Blind Base Study|Lost to Follow-up|0|||
94244828|NCT00568178|322690277|FG005|Double Blind Base Study|Lost to Follow-up|0|||
94244829|NCT00568178|322690272|FG000|Double Blind Base Study|Physician Decision|1|||
94456141|NCT02244463|323458202|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
94456142|NCT02244463|323458197|FG000|Period 5: Phase II|Disease Progression|0|||
94456143|NCT02244463|323458198|FG001|Period 5: Phase II|Disease Progression|0|||
94244830|NCT00568178|322690273|FG001|Double Blind Base Study|Physician Decision|1|||
94244831|NCT00568178|322690274|FG002|Double Blind Base Study|Physician Decision|0|||
94244832|NCT00568178|322690275|FG003|Double Blind Base Study|Physician Decision|1|||
94244833|NCT00568178|322690276|FG004|Double Blind Base Study|Physician Decision|0|||
94244834|NCT00568178|322690277|FG005|Double Blind Base Study|Physician Decision|0|||
94244835|NCT00568178|322690272|FG000|Double Blind Base Study|Protocol Violation|3|||
94244836|NCT00568178|322690273|FG001|Double Blind Base Study|Protocol Violation|2|||
94456144|NCT02244463|323458199|FG002|Period 5: Phase II|Disease Progression|0|||
94244837|NCT00568178|322690274|FG002|Double Blind Base Study|Protocol Violation|0|||
94244838|NCT00568178|322690275|FG003|Double Blind Base Study|Protocol Violation|0|||
94244839|NCT00568178|322690276|FG004|Double Blind Base Study|Protocol Violation|0|||
94244840|NCT00568178|322690277|FG005|Double Blind Base Study|Protocol Violation|0|||
94244841|NCT00568178|322690272|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
94244842|NCT00568178|322690273|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
94244843|NCT00568178|322690274|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
94244844|NCT00568178|322690275|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
94244845|NCT00568178|322690276|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
94244846|NCT00568178|322690277|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
94244847|NCT00568178|322690272|FG000|Double Blind Base Study|Progressive Disease|0|||
94244848|NCT00568178|322690273|FG001|Double Blind Base Study|Progressive Disease|0|||
94244849|NCT00568178|322690274|FG002|Double Blind Base Study|Progressive Disease|0|||
94244850|NCT00568178|322690275|FG003|Double Blind Base Study|Progressive Disease|1|||
94244851|NCT00568178|322690276|FG004|Double Blind Base Study|Progressive Disease|0|||
94244852|NCT00568178|322690277|FG005|Double Blind Base Study|Progressive Disease|0|||
94244853|NCT00568178|322690272|FG000|Open Label Extension|Adverse Event|0|||
94244854|NCT00568178|322690273|FG001|Open Label Extension|Adverse Event|0|||
94244855|NCT00568178|322690274|FG002|Open Label Extension|Adverse Event|0|||
94244856|NCT00568178|322690275|FG003|Open Label Extension|Adverse Event|0|||
94244857|NCT00568178|322690276|FG004|Open Label Extension|Adverse Event|11|||
94244858|NCT00568178|322690277|FG005|Open Label Extension|Adverse Event|8|||
94244859|NCT00568178|322690272|FG000|Open Label Extension|Protocol Violation|0|||
94244860|NCT00568178|322690273|FG001|Open Label Extension|Protocol Violation|0|||
94244861|NCT00568178|322690274|FG002|Open Label Extension|Protocol Violation|0|||
94244862|NCT00568178|322690275|FG003|Open Label Extension|Protocol Violation|0|||
94244863|NCT00568178|322690276|FG004|Open Label Extension|Protocol Violation|1|||
94244864|NCT00568178|322690277|FG005|Open Label Extension|Protocol Violation|0|||
94244865|NCT00568178|322690272|FG000|Open Label Extension|Lost to Follow-up|0|||
94244866|NCT00568178|322690273|FG001|Open Label Extension|Lost to Follow-up|0|||
94244867|NCT00568178|322690274|FG002|Open Label Extension|Lost to Follow-up|0|||
94244868|NCT00568178|322690275|FG003|Open Label Extension|Lost to Follow-up|0|||
94244869|NCT00568178|322690276|FG004|Open Label Extension|Lost to Follow-up|6|||
94244870|NCT00568178|322690277|FG005|Open Label Extension|Lost to Follow-up|11|||
94244871|NCT00568178|322690272|FG000|Open Label Extension|Physician Decision|0|||
94244872|NCT00568178|322690273|FG001|Open Label Extension|Physician Decision|0|||
94244873|NCT00568178|322690274|FG002|Open Label Extension|Physician Decision|0|||
94244874|NCT00568178|322690275|FG003|Open Label Extension|Physician Decision|0|||
94244875|NCT00568178|322690276|FG004|Open Label Extension|Physician Decision|9|||
94244876|NCT00568178|322690277|FG005|Open Label Extension|Physician Decision|8|||
94244877|NCT00568178|322690272|FG000|Open Label Extension|Pregnancy|0|||
94244878|NCT00568178|322690273|FG001|Open Label Extension|Pregnancy|0|||
94244879|NCT00568178|322690274|FG002|Open Label Extension|Pregnancy|0|||
94244880|NCT00568178|322690275|FG003|Open Label Extension|Pregnancy|0|||
94244881|NCT00568178|322690276|FG004|Open Label Extension|Pregnancy|0|||
94244882|NCT00568178|322690277|FG005|Open Label Extension|Pregnancy|1|||
94244883|NCT00568178|322690272|FG000|Open Label Extension|Progressive Disease|0|||
94244884|NCT00568178|322690273|FG001|Open Label Extension|Progressive Disease|0|||
94244885|NCT00568178|322690274|FG002|Open Label Extension|Progressive Disease|0|||
94244886|NCT00568178|322690275|FG003|Open Label Extension|Progressive Disease|0|||
94244887|NCT00568178|322690276|FG004|Open Label Extension|Progressive Disease|3|||
94244888|NCT00568178|322690277|FG005|Open Label Extension|Progressive Disease|1|||
94244889|NCT00568178|322690272|FG000|Open Label Extension|Termination of Trial|0|||
94244890|NCT00568178|322690273|FG001|Open Label Extension|Termination of Trial|0|||
94244891|NCT00568178|322690274|FG002|Open Label Extension|Termination of Trial|0|||
94244892|NCT00568178|322690275|FG003|Open Label Extension|Termination of Trial|0|||
94244893|NCT00568178|322690276|FG004|Open Label Extension|Termination of Trial|45|||
94244894|NCT00568178|322690277|FG005|Open Label Extension|Termination of Trial|47|||
94244895|NCT00568178|322690272|FG000|Open Label Extension|Withdrawal by Subject|0|||
94244896|NCT00568178|322690273|FG001|Open Label Extension|Withdrawal by Subject|0|||
94244897|NCT00568178|322690274|FG002|Open Label Extension|Withdrawal by Subject|0|||
94244898|NCT00568178|322690275|FG003|Open Label Extension|Withdrawal by Subject|0|||
94244899|NCT00568178|322690276|FG004|Open Label Extension|Withdrawal by Subject|4|||
94244900|NCT00568178|322690277|FG005|Open Label Extension|Withdrawal by Subject|4|||
94244901|NCT00288639|322690278|FG000|Overall Study|Adverse Event|5|||
94244902|NCT00288639|322690278|FG000|Overall Study|Lack of Efficacy|4|||
94244903|NCT00288639|322690278|FG000|Overall Study|Withdrawal by Subject|2|||
94244904|NCT00288639|322690278|FG000|Overall Study|Other|1|||
94244905|NCT04476251|322690282|FG000|Overall Study|Not treated|1|||
94244906|NCT00626990|322690292|FG000|Overall Study|Lack of Efficacy|6|||
94244907|NCT00626990|322690293|FG001|Overall Study|Lack of Efficacy|7|||
94244908|NCT00626990|322690294|FG002|Overall Study|Lack of Efficacy|49|||
94244909|NCT00626990|322690295|FG003|Overall Study|Lack of Efficacy|40|||
94244910|NCT00626990|322690292|FG000|Overall Study|Adverse Event|1|||
94244911|NCT00626990|322690293|FG001|Overall Study|Adverse Event|7|||
94244912|NCT00626990|322690294|FG002|Overall Study|Adverse Event|14|||
94244913|NCT00626990|322690295|FG003|Overall Study|Adverse Event|28|||
94355141|NCT01016912|323082029|FG000|End of Treatment Period|Adverse Event|0|||
94355142|NCT01016912|323082030|FG001|End of Treatment Period|Adverse Event|1|||
94355143|NCT01016912|323082031|FG002|End of Treatment Period|Adverse Event|1|||
94355144|NCT01016912|323082032|FG003|End of Treatment Period|Adverse Event|0|||
94244914|NCT00626990|322690292|FG000|Overall Study|Death|0|||
94244915|NCT00626990|322690293|FG001|Overall Study|Death|1|||
94355145|NCT01016912|323082033|FG004|End of Treatment Period|Adverse Event|0|||
94244916|NCT00626990|322690294|FG002|Overall Study|Death|0|||
94244917|NCT00626990|322690295|FG003|Overall Study|Death|0|||
94244918|NCT00626990|322690292|FG000|Overall Study|Withdrawal by Subject|3|||
94244919|NCT00626990|322690293|FG001|Overall Study|Withdrawal by Subject|1|||
94244920|NCT00626990|322690294|FG002|Overall Study|Withdrawal by Subject|5|||
94244921|NCT00626990|322690295|FG003|Overall Study|Withdrawal by Subject|11|||
94244922|NCT00626990|322690292|FG000|Overall Study|Protocol Violation|0|||
94244923|NCT00626990|322690293|FG001|Overall Study|Protocol Violation|1|||
94244924|NCT00626990|322690294|FG002|Overall Study|Protocol Violation|1|||
94244925|NCT00626990|322690295|FG003|Overall Study|Protocol Violation|0|||
94244926|NCT00626990|322690292|FG000|Overall Study|Various different reasons/missing|4|||
94244927|NCT00626990|322690293|FG001|Overall Study|Various different reasons/missing|8|||
94244928|NCT00626990|322690294|FG002|Overall Study|Various different reasons/missing|8|||
94244929|NCT00626990|322690295|FG003|Overall Study|Various different reasons/missing|16|||
94244930|NCT02187159|322690298|FG000|Overall Study|Protocol Violation|4|||
94244931|NCT02187159|322690299|FG001|Overall Study|Protocol Violation|6|||
94244932|NCT02187159|322690300|FG002|Overall Study|Protocol Violation|3|||
94244933|NCT02187159|322690301|FG003|Overall Study|Protocol Violation|4|||
94244934|NCT02187159|322690298|FG000|Overall Study|Lack of Efficacy|10|||
94244935|NCT02187159|322690299|FG001|Overall Study|Lack of Efficacy|5|||
94244936|NCT02187159|322690300|FG002|Overall Study|Lack of Efficacy|4|||
94244937|NCT02187159|322690301|FG003|Overall Study|Lack of Efficacy|7|||
94244938|NCT02187159|322690298|FG000|Overall Study|Adverse Event|28|||
94244939|NCT02187159|322690299|FG001|Overall Study|Adverse Event|33|||
94244940|NCT02187159|322690300|FG002|Overall Study|Adverse Event|42|||
94244941|NCT02187159|322690301|FG003|Overall Study|Adverse Event|50|||
94244942|NCT02187159|322690298|FG000|Overall Study|Withdrawal by Subject|24|||
94244943|NCT02187159|322690299|FG001|Overall Study|Withdrawal by Subject|28|||
94244944|NCT02187159|322690300|FG002|Overall Study|Withdrawal by Subject|25|||
94244945|NCT02187159|322690301|FG003|Overall Study|Withdrawal by Subject|26|||
94244946|NCT02187159|322690298|FG000|Overall Study|Other|3|||
94244947|NCT02187159|322690299|FG001|Overall Study|Other|7|||
94244948|NCT02187159|322690300|FG002|Overall Study|Other|3|||
94244949|NCT02187159|322690301|FG003|Overall Study|Other|9|||
94244950|NCT02898077|322690308|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
94456145|NCT02244463|323458200|FG003|Period 5: Phase II|Disease Progression|0|||
94456146|NCT02244463|323458201|FG004|Period 5: Phase II|Disease Progression|10|||
94590034|NCT00942994|323962767|FG000|Overall Study|Patient withdrew consent|5|||
94590035|NCT00942994|323962768|FG001|Overall Study|Patient withdrew consent|8|||
94590036|NCT00942994|323962767|FG000|Overall Study|Lost to Follow-up|1|||
94590037|NCT00942994|323962768|FG001|Overall Study|Lost to Follow-up|4|||
94590038|NCT00942994|323962767|FG000|Overall Study|Protocol deviation|1|||
94590039|NCT00942994|323962768|FG001|Overall Study|Protocol deviation|2|||
94590040|NCT03583385|323962769|FG000|Treatment Period 1|Withdrawal by Subject|1|||
94590041|NCT03583385|323962770|FG001|Treatment Period 1|Withdrawal by Subject|1|||
94590042|NCT03583385|323962769|FG000|Treatment Period 2|Adverse Event|1|||
94590043|NCT03583385|323962770|FG001|Treatment Period 2|Adverse Event|0|||
94590044|NCT00545272|323962773|FG000|Overall Study|Protocol deviation|0|||
94244951|NCT02898077|322690309|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
94244952|NCT02898077|322690308|FG000|Overall Study|Lost to Follow-up|4|||
94244953|NCT02898077|322690309|FG001|Overall Study|Lost to Follow-up|3|||
94244954|NCT02898077|322690308|FG000|Overall Study|Physician Decision|0|||
94456147|NCT02244463|323458202|FG005|Period 5: Phase II|Disease Progression|11|||
94244955|NCT02898077|322690309|FG001|Overall Study|Physician Decision|2|||
94244956|NCT02898077|322690308|FG000|Overall Study|Sponsor Decision|32|||
94244957|NCT02898077|322690309|FG001|Overall Study|Sponsor Decision|13|||
94244958|NCT02898077|322690308|FG000|Overall Study|Withdrawal by Subject|6|||
94590045|NCT00545272|323962774|FG001|Overall Study|Protocol deviation|1|||
94590046|NCT00545272|323962775|FG002|Overall Study|Protocol deviation|0|||
94590047|NCT00545272|323962776|FG003|Overall Study|Protocol deviation|1|||
94244959|NCT02898077|322690309|FG001|Overall Study|Withdrawal by Subject|3|||
94244960|NCT02898077|322690308|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
94244961|NCT02898077|322690309|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
94244962|NCT02898077|322690308|FG000|Overall Study|Ended extension period|3|||
94244963|NCT02898077|322690309|FG001|Overall Study|Ended extension period|0|||
94244964|NCT02643303|322690311|FG000|Overall Study|Progressive Disease|4|||
94244965|NCT02643303|322690312|FG001|Overall Study|Progressive Disease|4|||
94244966|NCT02643303|322690313|FG002|Overall Study|Progressive Disease|1|||
94244967|NCT02643303|322690314|FG003|Overall Study|Progressive Disease|12|||
94244968|NCT02643303|322690315|FG004|Overall Study|Progressive Disease|6|||
94244969|NCT02643303|322690316|FG005|Overall Study|Progressive Disease|4|||
94244970|NCT02643303|322690317|FG006|Overall Study|Progressive Disease|8|||
94244971|NCT02643303|322690318|FG007|Overall Study|Progressive Disease|2|||
94244972|NCT02643303|322690319|FG008|Overall Study|Progressive Disease|6|||
94244973|NCT02643303|322690311|FG000|Overall Study|Adverse Event|0|||
94244974|NCT02643303|322690312|FG001|Overall Study|Adverse Event|1|||
94244975|NCT02643303|322690313|FG002|Overall Study|Adverse Event|0|||
94244976|NCT02643303|322690314|FG003|Overall Study|Adverse Event|0|||
94244977|NCT02643303|322690315|FG004|Overall Study|Adverse Event|1|||
94244978|NCT02643303|322690316|FG005|Overall Study|Adverse Event|0|||
94244979|NCT02643303|322690317|FG006|Overall Study|Adverse Event|0|||
94244980|NCT02643303|322690318|FG007|Overall Study|Adverse Event|0|||
94244981|NCT02643303|322690319|FG008|Overall Study|Adverse Event|0|||
94244982|NCT02643303|322690311|FG000|Overall Study|Withdrawal by Subject|0|||
94244983|NCT02643303|322690312|FG001|Overall Study|Withdrawal by Subject|0|||
94244984|NCT02643303|322690313|FG002|Overall Study|Withdrawal by Subject|0|||
94244985|NCT02643303|322690314|FG003|Overall Study|Withdrawal by Subject|1|||
94244986|NCT02643303|322690315|FG004|Overall Study|Withdrawal by Subject|0|||
94244987|NCT02643303|322690316|FG005|Overall Study|Withdrawal by Subject|0|||
94244988|NCT02643303|322690317|FG006|Overall Study|Withdrawal by Subject|1|||
94244989|NCT02643303|322690318|FG007|Overall Study|Withdrawal by Subject|1|||
94244990|NCT02643303|322690319|FG008|Overall Study|Withdrawal by Subject|1|||
94244991|NCT01940939|322690320|FG000|Overall Study|Withdrawal by Subject|2|||
94244992|NCT01940939|322690321|FG001|Overall Study|Withdrawal by Subject|8|||
94244993|NCT01470001|322690322|FG000|Overall Study|Lost to Follow-up|1|||
94244994|NCT01470001|322690323|FG001|Overall Study|Lost to Follow-up|1|||
94244995|NCT01470001|322690322|FG000|Overall Study|Physician Decision|2|||
94244996|NCT01470001|322690323|FG001|Overall Study|Physician Decision|0|||
94244997|NCT01470001|322690322|FG000|Overall Study|Withdrawal by Subject|2|||
94244998|NCT01470001|322690323|FG001|Overall Study|Withdrawal by Subject|1|||
94244999|NCT03268603|322690324|FG000|Overall Study|Withdrawal by Subject|6|||
94245000|NCT03268603|322690324|FG000|Overall Study|Physician Decision|1|||
94245001|NCT03268603|322690324|FG000|Overall Study|Withdrawn due to disease progression|2|||
94245002|NCT01499303|322690327|FG000|Overall Study|Ongoing|2|||
94245003|NCT01499303|322690328|FG001|Overall Study|Ongoing|1|||
94245004|NCT01499303|322690327|FG000|Overall Study|Withdrawal by Subject|0|||
94245005|NCT01499303|322690328|FG001|Overall Study|Withdrawal by Subject|1|||
94245006|NCT01499303|322690327|FG000|Overall Study|Adverse Event|1|||
94245007|NCT01499303|322690328|FG001|Overall Study|Adverse Event|4|||
94245008|NCT01499303|322690327|FG000|Overall Study|Other|0|||
94245009|NCT01499303|322690328|FG001|Overall Study|Other|1|||
94245010|NCT02060370|322690329|FG000|Overall Study|Physician Decision|1|||
94245011|NCT01280357|322690332|FG000|Overall Study|Excluded no internal monitoring|14|||
94245012|NCT01280357|322690332|FG000|Overall Study|IInsufficient data/No data supplied|12|||
94245013|NCT01259089|322690333|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
94245014|NCT01259089|322690334|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
94245015|NCT01259089|322690335|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
94245016|NCT01259089|322690336|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
94245017|NCT01259089|322690337|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
94245018|NCT01259089|322690338|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
94245019|NCT01259089|322690333|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
94245020|NCT01259089|322690334|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
94245021|NCT01259089|322690335|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
94245022|NCT01259089|322690336|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
94245023|NCT01259089|322690337|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
94245024|NCT01259089|322690338|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
94245025|NCT01259089|322690333|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
94355146|NCT01016912|323082029|FG000|End of Treatment Period|Completed double-blind period only|0|||
94355147|NCT01016912|323082030|FG001|End of Treatment Period|Completed double-blind period only|1|||
94590048|NCT00545272|323962777|FG004|Overall Study|Protocol deviation|0|||
94245026|NCT01259089|322690334|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
94245027|NCT01259089|322690335|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
94245028|NCT01259089|322690336|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
94245029|NCT01259089|322690337|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
94245030|NCT01259089|322690338|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
94245031|NCT01259089|322690333|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
94245032|NCT01259089|322690334|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
94245033|NCT01259089|322690335|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
94245034|NCT01259089|322690336|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
94245035|NCT01259089|322690337|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
94245036|NCT01259089|322690338|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
94245037|NCT01259089|322690333|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
94245038|NCT01259089|322690334|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
94245039|NCT01259089|322690335|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
94245040|NCT01259089|322690336|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
94590049|NCT00545272|323962778|FG005|Overall Study|Protocol deviation|1|||
94590050|NCT00545272|323962773|FG000|Overall Study|Adverse Event|0|||
94590051|NCT00545272|323962774|FG001|Overall Study|Adverse Event|0|||
94590052|NCT00545272|323962775|FG002|Overall Study|Adverse Event|1|||
94355148|NCT01016912|323082031|FG002|End of Treatment Period|Completed double-blind period only|0|||
94355149|NCT01016912|323082032|FG003|End of Treatment Period|Completed double-blind period only|0|||
94355150|NCT01016912|323082033|FG004|End of Treatment Period|Completed double-blind period only|0|||
94355151|NCT01016912|323082029|FG000|Follow-up Period|Other reason|0|||
94355152|NCT01016912|323082030|FG001|Follow-up Period|Other reason|0|||
94355153|NCT01016912|323082031|FG002|Follow-up Period|Other reason|1|||
94355154|NCT01016912|323082032|FG003|Follow-up Period|Other reason|1|||
94355155|NCT01016912|323082033|FG004|Follow-up Period|Other reason|0|||
94355156|NCT02260791|323082036|FG000|Overall Study|Lost to Follow-up|4|||
94355157|NCT02260791|323082037|FG001|Overall Study|Lost to Follow-up|4|||
94355158|NCT02260791|323082036|FG000|Overall Study|Lack of Efficacy|2|||
94355159|NCT02260791|323082037|FG001|Overall Study|Lack of Efficacy|1|||
94245041|NCT01259089|322690337|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
94245042|NCT01259089|322690338|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
94245043|NCT01259089|322690333|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
94355160|NCT02260791|323082036|FG000|Overall Study|Adverse Event|13|||
94355161|NCT02260791|323082037|FG001|Overall Study|Adverse Event|9|||
94355162|NCT02260791|323082036|FG000|Overall Study|Death|1|||
94355163|NCT02260791|323082037|FG001|Overall Study|Death|0|||
94355164|NCT02260791|323082036|FG000|Overall Study|Withdrawal by Subject|11|||
94355165|NCT02260791|323082037|FG001|Overall Study|Withdrawal by Subject|16|||
94355166|NCT02260791|323082036|FG000|Overall Study|Screen failure|0|||
94355167|NCT02260791|323082037|FG001|Overall Study|Screen failure|1|||
94355168|NCT02260791|323082036|FG000|Overall Study|Protocol deviation|2|||
94355169|NCT02260791|323082037|FG001|Overall Study|Protocol deviation|3|||
94355170|NCT02442284|323082038|FG000|Overall Study|Adverse Event|1|||
94355171|NCT02442284|323082038|FG000|Overall Study|Withdrew Consent|2|||
94355172|NCT02442284|323082038|FG000|Overall Study|Lost to Follow-up|3|||
94355173|NCT02442284|323082038|FG000|Overall Study|Other|1|||
94355174|NCT01610752|323082039|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
94355175|NCT01610752|323082040|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
94355176|NCT01610752|323082041|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
94355177|NCT00736840|323082042|FG000|Overall Study|Lost to Follow-up|13|||
94590053|NCT00545272|323962776|FG003|Overall Study|Adverse Event|0|||
94355178|NCT01038609|323082045|FG000|Overall Study|Adverse Event|0|||
94355179|NCT01038609|323082046|FG001|Overall Study|Adverse Event|0|||
94355180|NCT01038609|323082047|FG002|Overall Study|Adverse Event|1|||
94355181|NCT01038609|323082048|FG003|Overall Study|Adverse Event|0|||
94245044|NCT01259089|322690334|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
94355182|NCT01038609|323082049|FG004|Overall Study|Adverse Event|0|||
94355183|NCT01038609|323082045|FG000|Overall Study|Dosing Error|0|||
94355184|NCT01038609|323082046|FG001|Overall Study|Dosing Error|0|||
94355185|NCT01038609|323082047|FG002|Overall Study|Dosing Error|0|||
94590054|NCT00545272|323962777|FG004|Overall Study|Adverse Event|0|||
94590055|NCT00545272|323962778|FG005|Overall Study|Adverse Event|1|||
94590056|NCT00545272|323962773|FG000|Overall Study|Abnormal laboratory value(s)|0|||
94590057|NCT00545272|323962774|FG001|Overall Study|Abnormal laboratory value(s)|0|||
94590058|NCT00545272|323962775|FG002|Overall Study|Abnormal laboratory value(s)|0|||
94245045|NCT01259089|322690335|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
94245046|NCT01259089|322690336|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
94245047|NCT01259089|322690337|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
94245048|NCT01259089|322690338|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
94245049|NCT01259089|322690333|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
94245050|NCT01259089|322690334|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
94245051|NCT01259089|322690335|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
94245052|NCT01259089|322690336|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
94245053|NCT01259089|322690337|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
94355186|NCT01038609|323082048|FG003|Overall Study|Dosing Error|1|||
94355187|NCT01038609|323082049|FG004|Overall Study|Dosing Error|1|||
94355188|NCT01038609|323082045|FG000|Overall Study|Death in the Family|1|||
94355189|NCT01038609|323082046|FG001|Overall Study|Death in the Family|0|||
94355190|NCT01038609|323082047|FG002|Overall Study|Death in the Family|0|||
94355191|NCT01038609|323082048|FG003|Overall Study|Death in the Family|0|||
94590059|NCT00545272|323962776|FG003|Overall Study|Abnormal laboratory value(s)|0|||
94245054|NCT01259089|322690338|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
94245055|NCT01259089|322690333|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
94245056|NCT01259089|322690334|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
94355192|NCT01038609|323082049|FG004|Overall Study|Death in the Family|0|||
94355193|NCT01038609|323082045|FG000|Overall Study|Refusal of Blood Draws|0|||
94355194|NCT01038609|323082046|FG001|Overall Study|Refusal of Blood Draws|1|||
94590060|NCT00545272|323962777|FG004|Overall Study|Abnormal laboratory value(s)|0|||
94590061|NCT00545272|323962778|FG005|Overall Study|Abnormal laboratory value(s)|1|||
94355195|NCT01038609|323082047|FG002|Overall Study|Refusal of Blood Draws|0|||
94355196|NCT01038609|323082048|FG003|Overall Study|Refusal of Blood Draws|0|||
94355197|NCT01038609|323082049|FG004|Overall Study|Refusal of Blood Draws|0|||
94688611|NCT02572817|324315530|FG000|Overall Study|Death|6|||
94355198|NCT03655951|323082053|FG000|Overall Study|Lost to Follow-up|39|||
94355199|NCT03655951|323082054|FG001|Overall Study|Lost to Follow-up|20|||
94355200|NCT03655951|323082053|FG000|Overall Study|Withdrawal by Subject|0|||
94355201|NCT03655951|323082054|FG001|Overall Study|Withdrawal by Subject|1|||
94355202|NCT00129220|323082056|FG000|Study Period II|Adverse Event|9|||
94355203|NCT00129220|323082057|FG001|Study Period II|Adverse Event|5|||
94355204|NCT00129220|323082058|FG002|Study Period II|Adverse Event|7|||
94355205|NCT00129220|323082056|FG000|Study Period II|Lack of Efficacy|15|||
94355206|NCT00129220|323082057|FG001|Study Period II|Lack of Efficacy|1|||
94355207|NCT00129220|323082058|FG002|Study Period II|Lack of Efficacy|28|||
94355208|NCT00129220|323082056|FG000|Study Period II|Entry Criteria Not Met|2|||
94355209|NCT00129220|323082057|FG001|Study Period II|Entry Criteria Not Met|0|||
94355210|NCT00129220|323082058|FG002|Study Period II|Entry Criteria Not Met|2|||
94355211|NCT00129220|323082056|FG000|Study Period II|Protocol Violation|4|||
94355212|NCT00129220|323082057|FG001|Study Period II|Protocol Violation|2|||
94355213|NCT00129220|323082058|FG002|Study Period II|Protocol Violation|1|||
94355214|NCT00129220|323082056|FG000|Study Period II|Physician Decision|0|||
94355215|NCT00129220|323082057|FG001|Study Period II|Physician Decision|1|||
94355216|NCT00129220|323082058|FG002|Study Period II|Physician Decision|0|||
94355217|NCT00129220|323082056|FG000|Study Period II|Withdrawal by Subject|1|||
94355218|NCT00129220|323082057|FG001|Study Period II|Withdrawal by Subject|3|||
94355219|NCT00129220|323082058|FG002|Study Period II|Withdrawal by Subject|4|||
94355220|NCT00129220|323082056|FG000|Study Period II|Reason Not Specified|2|||
94355221|NCT00129220|323082057|FG001|Study Period II|Reason Not Specified|0|||
94355222|NCT00129220|323082058|FG002|Study Period II|Reason Not Specified|5|||
94355223|NCT00129220|323082056|FG000|Study Period III|Adverse Event|1|||
94355224|NCT00129220|323082057|FG001|Study Period III|Adverse Event|0|||
94245057|NCT01259089|322690335|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
94245058|NCT01259089|322690336|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
94245059|NCT01259089|322690337|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
94245060|NCT01259089|322690338|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
94245061|NCT01259089|322690333|FG000|Survival Follow up for Two Years|Death|3|||
94245062|NCT01259089|322690334|FG001|Survival Follow up for Two Years|Death|2|||
94245063|NCT01259089|322690335|FG002|Survival Follow up for Two Years|Death|2|||
94245064|NCT01259089|322690336|FG003|Survival Follow up for Two Years|Death|3|||
94245065|NCT01259089|322690337|FG004|Survival Follow up for Two Years|Death|6|||
94355225|NCT00129220|323082058|FG002|Study Period III|Adverse Event|3|||
94355226|NCT00129220|323082056|FG000|Study Period III|Protocol Violation|1|||
94355227|NCT00129220|323082057|FG001|Study Period III|Protocol Violation|1|||
94355228|NCT00129220|323082058|FG002|Study Period III|Protocol Violation|2|||
94355229|NCT00129220|323082056|FG000|Study Period III|Withdrawal by Subject|1|||
94355230|NCT00129220|323082057|FG001|Study Period III|Withdrawal by Subject|0|||
94355231|NCT00129220|323082058|FG002|Study Period III|Withdrawal by Subject|3|||
94355232|NCT00129220|323082056|FG000|Study Period III|Sponsor Decision|1|||
94355233|NCT00129220|323082057|FG001|Study Period III|Sponsor Decision|0|||
94355234|NCT00129220|323082058|FG002|Study Period III|Sponsor Decision|0|||
94355235|NCT00129220|323082056|FG000|Study Period III|Reason Not Specified|9|||
94355236|NCT00129220|323082057|FG001|Study Period III|Reason Not Specified|0|||
94355237|NCT00129220|323082058|FG002|Study Period III|Reason Not Specified|2|||
94355238|NCT00422227|323082061|FG000|Overall Study|Adverse Event|3|||
94355239|NCT00422227|323082062|FG001|Overall Study|Adverse Event|8|||
94355240|NCT00422227|323082061|FG000|Overall Study|Lost to Follow-up|1|||
94355241|NCT00422227|323082062|FG001|Overall Study|Lost to Follow-up|3|||
94355242|NCT00422227|323082061|FG000|Overall Study|Withdrawal by Subject|0|||
94355243|NCT00422227|323082062|FG001|Overall Study|Withdrawal by Subject|4|||
94355244|NCT00686894|323082063|FG000|Overall Study|Relapse|2|||
94355245|NCT00686894|323082063|FG000|Overall Study|Protocol Violation|4|||
94355246|NCT00765726|323082064|FG000|Overall Study|Withdrawal by Subject|1|||
94355247|NCT00765726|323082064|FG000|Overall Study|Discontinuation of study by sponsor|8|||
94355248|NCT02926833|323083536|FG000|Overall Study|Death|1|||
94355249|NCT02926833|323083537|FG001|Overall Study|Death|1|||
94355250|NCT02926833|323083538|FG002|Overall Study|Death|2|||
94355251|NCT02926833|323083539|FG003|Overall Study|Death|13|||
94355252|NCT02926833|323083536|FG000|Overall Study|Lost to Follow-up|1|||
94355253|NCT02926833|323083537|FG001|Overall Study|Lost to Follow-up|2|||
94355254|NCT02926833|323083538|FG002|Overall Study|Lost to Follow-up|0|||
94355255|NCT02926833|323083539|FG003|Overall Study|Lost to Follow-up|3|||
94355256|NCT02926833|323083536|FG000|Overall Study|Full Consent Withdrawal|0|||
94355257|NCT02926833|323083537|FG001|Overall Study|Full Consent Withdrawal|0|||
94355258|NCT02926833|323083538|FG002|Overall Study|Full Consent Withdrawal|0|||
94456148|NCT02244463|323458197|FG000|Period 5: Phase II|Physician Decision|0|||
94456149|NCT02244463|323458198|FG001|Period 5: Phase II|Physician Decision|0|||
94355259|NCT02926833|323083539|FG003|Overall Study|Full Consent Withdrawal|2|||
94355260|NCT02926833|323083536|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
94355261|NCT02926833|323083537|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
94355262|NCT02926833|323083538|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
94688612|NCT02572817|324315531|FG001|Overall Study|Death|3|||
94590062|NCT00545272|323962773|FG000|Overall Study|Abnormal test procedure result(s)|0|||
94590063|NCT00545272|323962774|FG001|Overall Study|Abnormal test procedure result(s)|0|||
94590064|NCT00545272|323962775|FG002|Overall Study|Abnormal test procedure result(s)|0|||
94590065|NCT00545272|323962776|FG003|Overall Study|Abnormal test procedure result(s)|0|||
94590066|NCT00545272|323962777|FG004|Overall Study|Abnormal test procedure result(s)|1|||
94590067|NCT00545272|323962778|FG005|Overall Study|Abnormal test procedure result(s)|0|||
94590068|NCT00545272|323962773|FG000|Overall Study|Lost to Follow-up|0|||
94590069|NCT00545272|323962774|FG001|Overall Study|Lost to Follow-up|0|||
94590070|NCT00545272|323962775|FG002|Overall Study|Lost to Follow-up|0|||
94590071|NCT00545272|323962776|FG003|Overall Study|Lost to Follow-up|0|||
94590072|NCT00545272|323962777|FG004|Overall Study|Lost to Follow-up|1|||
94590073|NCT00545272|323962778|FG005|Overall Study|Lost to Follow-up|0|||
94590074|NCT01837823|323962781|FG000|Overall Study|Lost to Follow-up|6|||
94590075|NCT01874340|323962782|FG000|Overall Study|Study terminated by Sponsor|6|||
94590076|NCT01874340|323962783|FG001|Overall Study|Study terminated by Sponsor|8|||
94590077|NCT01874340|323962784|FG002|Overall Study|Study terminated by Sponsor|8|||
94590078|NCT01874340|323962785|FG003|Overall Study|Study terminated by Sponsor|4|||
94590079|NCT01874340|323962782|FG000|Overall Study|Withdrawal by Subject|0|||
94590080|NCT01874340|323962783|FG001|Overall Study|Withdrawal by Subject|0|||
94590081|NCT01874340|323962784|FG002|Overall Study|Withdrawal by Subject|0|||
94590082|NCT01874340|323962785|FG003|Overall Study|Withdrawal by Subject|1|||
94590083|NCT02934503|323962786|FG000|Overall Study|progression of disease|3|||
94590084|NCT02934503|323962786|FG000|Overall Study|Withdrawal by Subject|1|||
94590085|NCT02314637|323962787|FG000|Overall Study|Adverse Event|4|||
94590086|NCT02314637|323962788|FG001|Overall Study|Adverse Event|8|||
94590087|NCT02314637|323962787|FG000|Overall Study|Lack of Efficacy|1|||
94590088|NCT02314637|323962788|FG001|Overall Study|Lack of Efficacy|0|||
94590089|NCT02314637|323962787|FG000|Overall Study|Physician Decision|5|||
94590090|NCT02314637|323962788|FG001|Overall Study|Physician Decision|2|||
94590091|NCT02314637|323962787|FG000|Overall Study|Withdrawal by Subject|5|||
94590092|NCT02314637|323962788|FG001|Overall Study|Withdrawal by Subject|4|||
94590093|NCT02314637|323962787|FG000|Overall Study|Other Reason|1|||
94590094|NCT02314637|323962788|FG001|Overall Study|Other Reason|0|||
94590095|NCT00724867|323962791|FG000|Overall Study|Adverse Event|25|||
94590096|NCT00724867|323962791|FG000|Overall Study|Lack of Efficacy|14|||
94590097|NCT00724867|323962791|FG000|Overall Study|Lost to Follow-up|12|||
94590098|NCT00724867|323962791|FG000|Overall Study|Non-compliance with study drug|6|||
94590099|NCT00724867|323962791|FG000|Overall Study|Physician Decision|17|||
94590100|NCT00724867|323962791|FG000|Overall Study|Protocol Violation|1|||
94590101|NCT00724867|323962791|FG000|Overall Study|Withdrawal by Subject|31|||
94590102|NCT00724867|323962791|FG000|Overall Study|Sponsor decision to end study|14|||
94590103|NCT00724867|323962791|FG000|Overall Study|Subject incarcerated|1|||
94590104|NCT00724867|323962791|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
94590105|NCT00724867|323962791|FG000|Overall Study|Subject moved out of state|1|||
94590106|NCT00724867|323962791|FG000|Overall Study|Elected to exit due to site closure|2|||
94590107|NCT04050202|323962794|FG000|Overall Study|Lost to Follow-up|2|||
94590108|NCT00436345|323962795|FG000|Overall Study|ICU resident beyond follow-up period|3|||
94590109|NCT00436345|323962796|FG001|Overall Study|ICU resident beyond follow-up period|0|||
94590110|NCT01175083|323962797|FG000|Primary Epoch|Withdrawal by Subject|0|||
94590111|NCT01175083|323962798|FG001|Primary Epoch|Withdrawal by Subject|0|||
94590112|NCT01175083|323962799|FG002|Primary Epoch|Withdrawal by Subject|0|||
94245066|NCT01259089|322690338|FG005|Survival Follow up for Two Years|Death|13|||
94590113|NCT01175083|323962800|FG003|Primary Epoch|Withdrawal by Subject|0|||
94590114|NCT01175083|323962801|FG004|Primary Epoch|Withdrawal by Subject|0|||
94590115|NCT01175083|323962802|FG005|Primary Epoch|Withdrawal by Subject|2|||
94590116|NCT01175083|323962797|FG000|Primary Epoch|Lost to Follow-up|0|||
94590117|NCT01175083|323962798|FG001|Primary Epoch|Lost to Follow-up|0|||
94590118|NCT01175083|323962799|FG002|Primary Epoch|Lost to Follow-up|0|||
94590119|NCT01175083|323962800|FG003|Primary Epoch|Lost to Follow-up|0|||
94590120|NCT01175083|323962801|FG004|Primary Epoch|Lost to Follow-up|0|||
94590121|NCT01175083|323962802|FG005|Primary Epoch|Lost to Follow-up|1|||
94590122|NCT01175083|323962797|FG000|Booster Epoch|Death|0|||
94590123|NCT01175083|323962798|FG001|Booster Epoch|Death|0|||
94245067|NCT01259089|322690333|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
94245068|NCT01259089|322690334|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
94245069|NCT01259089|322690335|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
94245070|NCT01259089|322690336|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
94590124|NCT01175083|323962799|FG002|Booster Epoch|Death|1|||
94590125|NCT01175083|323962800|FG003|Booster Epoch|Death|0|||
94590126|NCT01175083|323962801|FG004|Booster Epoch|Death|0|||
94590127|NCT01175083|323962802|FG005|Booster Epoch|Death|0|||
94590128|NCT01175083|323962797|FG000|Booster Epoch|Withdrawal by Subject|0|||
94590129|NCT01175083|323962798|FG001|Booster Epoch|Withdrawal by Subject|0|||
94590130|NCT01175083|323962799|FG002|Booster Epoch|Withdrawal by Subject|0|||
94590131|NCT01175083|323962800|FG003|Booster Epoch|Withdrawal by Subject|1|||
94659795|NCT00116805|324209956|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
94659796|NCT00116805|324209957|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
94659797|NCT00116805|324209956|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
94659798|NCT00116805|324209957|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
94659799|NCT00116805|324209956|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
94659800|NCT00116805|324209957|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
94659801|NCT00116805|324209956|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
94659802|NCT00116805|324209957|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
94659803|NCT00116805|324209956|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
94659804|NCT00116805|324209957|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
94659805|NCT00116805|324209956|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
94659806|NCT00116805|324209957|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
94659807|NCT00116805|324209956|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
94659808|NCT00116805|324209957|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
94659809|NCT00116805|324209956|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
94659810|NCT00116805|324209957|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
94659811|NCT00116805|324209956|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
94245071|NCT01259089|322690337|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
94245072|NCT01259089|322690338|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
94245073|NCT01259089|322690333|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
94245074|NCT01259089|322690334|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
94245075|NCT01259089|322690335|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
94245076|NCT01259089|322690336|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
94245077|NCT01259089|322690337|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
94590132|NCT01175083|323962801|FG004|Booster Epoch|Withdrawal by Subject|0|||
94659812|NCT00116805|324209957|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
94659813|NCT00116805|324209956|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
94590133|NCT01175083|323962802|FG005|Booster Epoch|Withdrawal by Subject|0|||
94590134|NCT00481091|323962803|FG000|Overall Study|Withdrawal by Subject|0|||
94590135|NCT00481091|323962804|FG001|Overall Study|Withdrawal by Subject|1|||
94590136|NCT00481091|323962805|FG002|Overall Study|Withdrawal by Subject|1|||
94590137|NCT00481091|323962806|FG003|Overall Study|Withdrawal by Subject|0|||
94590138|NCT00481091|323962807|FG004|Overall Study|Withdrawal by Subject|0|||
94590139|NCT00481091|323962808|FG005|Overall Study|Withdrawal by Subject|0|||
94590140|NCT00481091|323962809|FG006|Overall Study|Withdrawal by Subject|0|||
94590141|NCT00481091|323962810|FG007|Overall Study|Withdrawal by Subject|0|||
94590142|NCT00481091|323962811|FG008|Overall Study|Withdrawal by Subject|1|||
94590143|NCT00481091|323962812|FG009|Overall Study|Withdrawal by Subject|6|||
94590144|NCT00481091|323962803|FG000|Overall Study|Other, Not Specified|0|||
94590145|NCT00481091|323962804|FG001|Overall Study|Other, Not Specified|1|||
94590146|NCT00481091|323962805|FG002|Overall Study|Other, Not Specified|1|||
94590147|NCT00481091|323962806|FG003|Overall Study|Other, Not Specified|0|||
94590148|NCT00481091|323962807|FG004|Overall Study|Other, Not Specified|0|||
94590149|NCT00481091|323962808|FG005|Overall Study|Other, Not Specified|1|||
94590150|NCT00481091|323962809|FG006|Overall Study|Other, Not Specified|0|||
94590151|NCT00481091|323962810|FG007|Overall Study|Other, Not Specified|0|||
94590152|NCT00481091|323962811|FG008|Overall Study|Other, Not Specified|0|||
94590153|NCT00481091|323962812|FG009|Overall Study|Other, Not Specified|4|||
94590154|NCT00481091|323962803|FG000|Overall Study|Adverse Event|1|||
94590155|NCT00481091|323962804|FG001|Overall Study|Adverse Event|2|||
94590156|NCT00481091|323962805|FG002|Overall Study|Adverse Event|0|||
94590157|NCT00481091|323962806|FG003|Overall Study|Adverse Event|1|||
94590158|NCT00481091|323962807|FG004|Overall Study|Adverse Event|1|||
94590159|NCT00481091|323962808|FG005|Overall Study|Adverse Event|1|||
94590160|NCT00481091|323962809|FG006|Overall Study|Adverse Event|2|||
94590161|NCT00481091|323962810|FG007|Overall Study|Adverse Event|1|||
94590162|NCT00481091|323962811|FG008|Overall Study|Adverse Event|1|||
94590163|NCT00481091|323962812|FG009|Overall Study|Adverse Event|6|||
94590164|NCT00481091|323962803|FG000|Overall Study|Progressive disease clinical|0|||
94590165|NCT00481091|323962804|FG001|Overall Study|Progressive disease clinical|0|||
94590166|NCT00481091|323962805|FG002|Overall Study|Progressive disease clinical|0|||
94590167|NCT00481091|323962806|FG003|Overall Study|Progressive disease clinical|0|||
94590168|NCT00481091|323962807|FG004|Overall Study|Progressive disease clinical|0|||
94590169|NCT00481091|323962808|FG005|Overall Study|Progressive disease clinical|0|||
94590170|NCT00481091|323962809|FG006|Overall Study|Progressive disease clinical|0|||
94590171|NCT00481091|323962810|FG007|Overall Study|Progressive disease clinical|0|||
94590172|NCT00481091|323962811|FG008|Overall Study|Progressive disease clinical|1|||
94590173|NCT00481091|323962812|FG009|Overall Study|Progressive disease clinical|7|||
94590174|NCT00481091|323962803|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
94590175|NCT00481091|323962804|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
94590176|NCT00481091|323962805|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
94590177|NCT00481091|323962806|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
94590178|NCT00481091|323962807|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
94590179|NCT00481091|323962808|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
94590180|NCT00481091|323962809|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
94590181|NCT00481091|323962810|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
94590182|NCT00481091|323962811|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
94590183|NCT00481091|323962812|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
94590184|NCT00481091|323962803|FG000|Overall Study|Progressive disease other|1|||
94590185|NCT00481091|323962804|FG001|Overall Study|Progressive disease other|1|||
94590186|NCT00481091|323962805|FG002|Overall Study|Progressive disease other|0|||
94590187|NCT00481091|323962806|FG003|Overall Study|Progressive disease other|1|||
94590188|NCT00481091|323962807|FG004|Overall Study|Progressive disease other|1|||
94590189|NCT00481091|323962808|FG005|Overall Study|Progressive disease other|1|||
94590190|NCT00481091|323962809|FG006|Overall Study|Progressive disease other|0|||
94590191|NCT00481091|323962810|FG007|Overall Study|Progressive disease other|2|||
94590192|NCT00481091|323962811|FG008|Overall Study|Progressive disease other|0|||
94590193|NCT00481091|323962812|FG009|Overall Study|Progressive disease other|0|||
94590194|NCT00481091|323962803|FG000|Overall Study|No reason given|0|||
94590195|NCT00481091|323962804|FG001|Overall Study|No reason given|0|||
94590196|NCT00481091|323962805|FG002|Overall Study|No reason given|1|||
94590197|NCT00481091|323962806|FG003|Overall Study|No reason given|1|||
94590198|NCT00481091|323962807|FG004|Overall Study|No reason given|1|||
94590199|NCT00481091|323962808|FG005|Overall Study|No reason given|0|||
94590200|NCT00481091|323962809|FG006|Overall Study|No reason given|1|||
94590201|NCT00481091|323962810|FG007|Overall Study|No reason given|1|||
94590202|NCT00481091|323962811|FG008|Overall Study|No reason given|1|||
94590203|NCT00481091|323962812|FG009|Overall Study|No reason given|4|||
94590204|NCT01296672|323962813|FG000|Overall Study|Lost to Follow-up|73|||
94245078|NCT01259089|322690338|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
94245079|NCT00132873|322690339|FG000|Overall Study|Adverse Event|3|||
94245080|NCT00132873|322690339|FG000|Overall Study|Lost to Follow-up|1|||
94245081|NCT00132873|322690339|FG000|Overall Study|Lack of Efficacy|1|||
94245082|NCT00132873|322690339|FG000|Overall Study|Withdrawal by Subject|3|||
94245083|NCT00132873|322690339|FG000|Overall Study|Planned Pregnancy|1|||
94245084|NCT01747551|322690340|FG000|Overall Study|Progressive Disease|24|||
94245085|NCT01747551|322690341|FG001|Overall Study|Progressive Disease|17|||
94245086|NCT01747551|322690340|FG000|Overall Study|Death|3|||
94245087|NCT01747551|322690341|FG001|Overall Study|Death|1|||
94245088|NCT01747551|322690340|FG000|Overall Study|Adverse Event|7|||
94245089|NCT01747551|322690341|FG001|Overall Study|Adverse Event|1|||
94245090|NCT01747551|322690340|FG000|Overall Study|Prolonged Treatment Delay|2|||
94245091|NCT01747551|322690341|FG001|Overall Study|Prolonged Treatment Delay|0|||
94245092|NCT01747551|322690340|FG000|Overall Study|Withdrawal by Subject|3|||
94245093|NCT01747551|322690341|FG001|Overall Study|Withdrawal by Subject|1|||
94245094|NCT01747551|322690340|FG000|Overall Study|Physician Decision|2|||
94245095|NCT01747551|322690341|FG001|Overall Study|Physician Decision|1|||
94245096|NCT01747551|322690340|FG000|Overall Study|Other|2|||
94590205|NCT01296672|323962814|FG001|Overall Study|Lost to Follow-up|18|||
94590206|NCT02881567|323962815|FG000|Overall Study|Adverse Event|1|||
94590207|NCT02881567|323962815|FG000|Overall Study|Lost to Follow-up|3|||
94590208|NCT02881567|323962815|FG000|Overall Study|Consent withdrawn|1|||
94245097|NCT01747551|322690341|FG001|Overall Study|Other|0|||
94245098|NCT00737698|322690344|FG000|Overall Study|Withdrawal by Subject|6|||
94245099|NCT00737698|322690345|FG001|Overall Study|Withdrawal by Subject|5|||
94245100|NCT00737698|322690346|FG002|Overall Study|Withdrawal by Subject|3|||
94245101|NCT00737698|322690344|FG000|Overall Study|Death|0|||
94245102|NCT00737698|322690345|FG001|Overall Study|Death|0|||
94245103|NCT00737698|322690346|FG002|Overall Study|Death|1|||
94245104|NCT03406078|322690347|FG000|Overall Study|Death|1|||
94245105|NCT03406078|322690348|FG001|Overall Study|Death|0|||
94245106|NCT03406078|322690347|FG000|Overall Study|Lost to Follow-up|0|||
94245107|NCT03406078|322690348|FG001|Overall Study|Lost to Follow-up|1|||
94245108|NCT03406078|322690347|FG000|Overall Study|Withdrawal by Subject|5|||
94245109|NCT03406078|322690348|FG001|Overall Study|Withdrawal by Subject|2|||
94245110|NCT02091206|322690349|FG000|Treatment Period|Adverse Event|0|||
94245111|NCT02091206|322690350|FG001|Treatment Period|Adverse Event|1|||
94245112|NCT02091206|322690351|FG002|Treatment Period|Adverse Event|0|||
94245113|NCT02091206|322690352|FG003|Treatment Period|Adverse Event|0|||
94245114|NCT02091206|322690349|FG000|Treatment Period|Met withdrawal criteria|0|||
94245115|NCT02091206|322690350|FG001|Treatment Period|Met withdrawal criteria|0|||
94245116|NCT02091206|322690351|FG002|Treatment Period|Met withdrawal criteria|1|||
94456150|NCT02244463|323458199|FG002|Period 5: Phase II|Physician Decision|0|||
94456151|NCT02244463|323458200|FG003|Period 5: Phase II|Physician Decision|0|||
94456152|NCT02244463|323458201|FG004|Period 5: Phase II|Physician Decision|3|||
94456153|NCT02244463|323458202|FG005|Period 5: Phase II|Physician Decision|2|||
94456154|NCT02244463|323458197|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
94456155|NCT02244463|323458198|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
94456156|NCT02244463|323458199|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
94456157|NCT02244463|323458200|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
94456158|NCT02244463|323458201|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
94456159|NCT02244463|323458202|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
94456160|NCT02244463|323458197|FG000|Period 5: Phase II|Intercurrent Illness|0|||
94456161|NCT02244463|323458198|FG001|Period 5: Phase II|Intercurrent Illness|0|||
94456162|NCT02244463|323458199|FG002|Period 5: Phase II|Intercurrent Illness|0|||
94456163|NCT02244463|323458200|FG003|Period 5: Phase II|Intercurrent Illness|0|||
94456164|NCT02244463|323458201|FG004|Period 5: Phase II|Intercurrent Illness|2|||
94456165|NCT02244463|323458202|FG005|Period 5: Phase II|Intercurrent Illness|0|||
94456166|NCT02244463|323458197|FG000|Period 5: Phase II|Adverse Event|0|||
94456167|NCT02244463|323458198|FG001|Period 5: Phase II|Adverse Event|0|||
94456168|NCT02244463|323458199|FG002|Period 5: Phase II|Adverse Event|0|||
94456169|NCT02244463|323458200|FG003|Period 5: Phase II|Adverse Event|0|||
94456170|NCT02244463|323458201|FG004|Period 5: Phase II|Adverse Event|0|||
94456171|NCT02244463|323458202|FG005|Period 5: Phase II|Adverse Event|2|||
94456172|NCT02244463|323458197|FG000|Period 5: Phase II|Still On treatment|0|||
94456173|NCT02244463|323458198|FG001|Period 5: Phase II|Still On treatment|0|||
94456174|NCT02244463|323458199|FG002|Period 5: Phase II|Still On treatment|0|||
94456175|NCT02244463|323458200|FG003|Period 5: Phase II|Still On treatment|0|||
94456176|NCT02244463|323458201|FG004|Period 5: Phase II|Still On treatment|0|||
94456177|NCT02244463|323458202|FG005|Period 5: Phase II|Still On treatment|3|||
94456178|NCT01137110|323458212|FG000|Overall Study|Protocol Violation|1|||
94456179|NCT01137110|323458213|FG001|Overall Study|Protocol Violation|0|||
94456180|NCT00355147|323458214|FG000|Overall Study|Lost to Follow-up|10|||
94456181|NCT00355147|323458215|FG001|Overall Study|Lost to Follow-up|8|||
94456182|NCT00355147|323458214|FG000|Overall Study|Withdrawal by Subject|8|||
94456183|NCT00355147|323458215|FG001|Overall Study|Withdrawal by Subject|12|||
94456184|NCT00330343|323458216|FG000|Overall Study|Lost to Follow-up|5|||
94456185|NCT03614078|323458217|FG000|Overall Study|Withdrawal by Subject|2|||
94456186|NCT03614078|323458218|FG001|Overall Study|Withdrawal by Subject|2|||
94456187|NCT03614078|323458219|FG002|Overall Study|Withdrawal by Subject|3|||
94456188|NCT03614078|323458217|FG000|Overall Study|Participant Did Not Return for Visit|0|||
94456189|NCT03614078|323458218|FG001|Overall Study|Participant Did Not Return for Visit|1|||
94456190|NCT03614078|323458219|FG002|Overall Study|Participant Did Not Return for Visit|0|||
94456191|NCT03614078|323458217|FG000|Overall Study|High Neutrophils|0|||
94456192|NCT03614078|323458218|FG001|Overall Study|High Neutrophils|0|||
94456193|NCT03614078|323458219|FG002|Overall Study|High Neutrophils|2|||
94456194|NCT03614078|323458217|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
94456195|NCT03614078|323458218|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
94456196|NCT03614078|323458219|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
94456197|NCT03614078|323458217|FG000|Overall Study|Exacerbation of Psoriasis|0|||
94456198|NCT03614078|323458218|FG001|Overall Study|Exacerbation of Psoriasis|1|||
94456199|NCT03614078|323458219|FG002|Overall Study|Exacerbation of Psoriasis|0|||
94456200|NCT03614078|323458217|FG000|Overall Study|Adverse Event|0|||
94590209|NCT02881567|323962815|FG000|Overall Study|Investigator decision|1|||
94245117|NCT02091206|322690352|FG003|Treatment Period|Met withdrawal criteria|0|||
94245118|NCT02091206|322690349|FG000|Taper Period|Participant refused study drug|1|||
94590210|NCT02881567|323962815|FG000|Overall Study|Study terminated by sponsor|9|||
94245119|NCT02091206|322690350|FG001|Taper Period|Participant refused study drug|0|||
94456201|NCT03614078|323458218|FG001|Overall Study|Adverse Event|2|||
94590211|NCT02881567|323962815|FG000|Overall Study|Reason not Specified|3|||
94245120|NCT02091206|322690351|FG002|Taper Period|Participant refused study drug|0|||
94245121|NCT02091206|322690352|FG003|Taper Period|Participant refused study drug|1|||
94245122|NCT02091206|322690349|FG000|Taper Period|Lost to Follow-up|0|||
94245123|NCT02091206|322690350|FG001|Taper Period|Lost to Follow-up|0|||
94245124|NCT02091206|322690351|FG002|Taper Period|Lost to Follow-up|0|||
94245125|NCT02091206|322690352|FG003|Taper Period|Lost to Follow-up|1|||
94245126|NCT03026075|322690353|FG000|Overall Study|Physician Decision|1|||
94245127|NCT03381339|322690354|FG000|Overall Study|Protocol Violation|4|||
94245128|NCT03381339|322690355|FG001|Overall Study|Protocol Violation|3|||
94245129|NCT03381339|322690354|FG000|Overall Study|Lost to Follow-up|0|||
94245130|NCT03381339|322690355|FG001|Overall Study|Lost to Follow-up|1|||
94245131|NCT04531904|322690356|FG000|Overall Study|Lost to Follow-up|1|||
94245132|NCT04531904|322690356|FG000|Overall Study|Death|14|||
94245133|NCT03117998|322690357|FG000|Overall Study|Adverse Event|1|||
94245134|NCT03117998|322690358|FG001|Overall Study|Adverse Event|0|||
94245135|NCT03117998|322690359|FG002|Overall Study|Adverse Event|0|||
94245136|NCT03117998|322690360|FG003|Overall Study|Adverse Event|0|||
94245137|NCT03117998|322690361|FG004|Overall Study|Adverse Event|0|||
94245138|NCT03117998|322690362|FG005|Overall Study|Adverse Event|0|||
94245139|NCT03117998|322690357|FG000|Overall Study|Withdrawal by Subject|0|||
94245140|NCT03117998|322690358|FG001|Overall Study|Withdrawal by Subject|0|||
94245141|NCT03117998|322690359|FG002|Overall Study|Withdrawal by Subject|2|||
94245142|NCT03117998|322690360|FG003|Overall Study|Withdrawal by Subject|3|||
94245143|NCT03117998|322690361|FG004|Overall Study|Withdrawal by Subject|3|||
94245144|NCT03117998|322690362|FG005|Overall Study|Withdrawal by Subject|0|||
94245145|NCT03117998|322690357|FG000|Overall Study|Physician Decision|0|||
94245146|NCT03117998|322690358|FG001|Overall Study|Physician Decision|1|||
94245147|NCT03117998|322690359|FG002|Overall Study|Physician Decision|1|||
94245148|NCT03117998|322690360|FG003|Overall Study|Physician Decision|0|||
94245149|NCT03117998|322690361|FG004|Overall Study|Physician Decision|0|||
94245150|NCT03117998|322690362|FG005|Overall Study|Physician Decision|0|||
94245151|NCT03117998|322690357|FG000|Overall Study|Lost to Follow-up|0|||
94245152|NCT03117998|322690358|FG001|Overall Study|Lost to Follow-up|0|||
94245153|NCT03117998|322690359|FG002|Overall Study|Lost to Follow-up|0|||
94245154|NCT03117998|322690360|FG003|Overall Study|Lost to Follow-up|1|||
94245155|NCT03117998|322690361|FG004|Overall Study|Lost to Follow-up|4|||
94245156|NCT03117998|322690362|FG005|Overall Study|Lost to Follow-up|0|||
94590212|NCT01086358|323962821|FG000|First Intervention|Lost to Follow-up|9|||
94590213|NCT01086358|323962822|FG001|First Intervention|Lost to Follow-up|4|||
94590214|NCT01086358|323962821|FG000|First Intervention|Withdrawal by Subject|0|||
94590215|NCT01086358|323962822|FG001|First Intervention|Withdrawal by Subject|1|||
94590216|NCT01086358|323962821|FG000|Second Intervention|Lost to Follow-up|4|||
94590217|NCT01086358|323962822|FG001|Second Intervention|Lost to Follow-up|4|||
94590218|NCT00578292|323962823|FG000|Overall Study|Death|1|||
94590219|NCT00578292|323962823|FG000|Overall Study|Graft failure|2|||
94590220|NCT02238080|323962829|FG000|Overall Study|Death|13|||
94590221|NCT02238080|323962829|FG000|Overall Study|Treatment interrupted|6|||
94590222|NCT02238080|323962829|FG000|Overall Study|Withdrawal by Subject|2|||
94590223|NCT02238080|323962829|FG000|Overall Study|Other|4|||
94590224|NCT01519869|323962838|FG000|Overall Study|Lost to Follow-up|1|||
94590225|NCT00918736|323962841|FG000|Overall Study|Withdrawal by Subject|4|||
94245157|NCT03117998|322690357|FG000|Overall Study|Subject noncompliance|0|||
94245158|NCT03117998|322690358|FG001|Overall Study|Subject noncompliance|0|||
94245159|NCT03117998|322690359|FG002|Overall Study|Subject noncompliance|1|||
94245160|NCT03117998|322690360|FG003|Overall Study|Subject noncompliance|0|||
94245161|NCT03117998|322690361|FG004|Overall Study|Subject noncompliance|0|||
94590226|NCT01137604|323962843|FG000|Overall Study|Adverse Event|3|||
94590227|NCT01137604|323962844|FG001|Overall Study|Adverse Event|6|||
94590228|NCT01137604|323962845|FG002|Overall Study|Adverse Event|9|||
94590229|NCT01137604|323962846|FG003|Overall Study|Adverse Event|9|||
94590230|NCT01137604|323962843|FG000|Overall Study|Participant Choice|0|||
94590231|NCT01137604|323962844|FG001|Overall Study|Participant Choice|2|||
94590232|NCT01137604|323962845|FG002|Overall Study|Participant Choice|2|||
94590233|NCT01137604|323962846|FG003|Overall Study|Participant Choice|0|||
94590234|NCT01137604|323962843|FG000|Overall Study|Withdrawal of consent|0|||
94590235|NCT01137604|323962844|FG001|Overall Study|Withdrawal of consent|0|||
94590236|NCT01137604|323962845|FG002|Overall Study|Withdrawal of consent|0|||
94590237|NCT01137604|323962846|FG003|Overall Study|Withdrawal of consent|2|||
94590238|NCT01137604|323962843|FG000|Overall Study|Clinical progression/deterioration|1|||
94688613|NCT02572817|324315530|FG000|Overall Study|Lost to Follow-up|3|||
94245162|NCT03117998|322690362|FG005|Overall Study|Subject noncompliance|2|||
94456202|NCT03614078|323458219|FG002|Overall Study|Adverse Event|0|||
94456203|NCT03614078|323458217|FG000|Overall Study|Dizziness and Rash|0|||
94456204|NCT03614078|323458218|FG001|Overall Study|Dizziness and Rash|1|||
94456205|NCT03614078|323458219|FG002|Overall Study|Dizziness and Rash|0|||
94456206|NCT02004886|323458220|FG000|Overall Study|Adverse Event|0|||
94456207|NCT02004886|323458221|FG001|Overall Study|Adverse Event|1|||
94456208|NCT02004886|323458222|FG002|Overall Study|Adverse Event|0|||
94456209|NCT02004886|323458223|FG003|Overall Study|Adverse Event|0|||
94456210|NCT02004886|323458220|FG000|Overall Study|Unable to attend future visits|1|||
94456211|NCT02004886|323458221|FG001|Overall Study|Unable to attend future visits|0|||
94456212|NCT02004886|323458222|FG002|Overall Study|Unable to attend future visits|0|||
94456213|NCT02004886|323458223|FG003|Overall Study|Unable to attend future visits|0|||
94456214|NCT03696108|323458224|FG000|Overall Study|Physician Decision|1|||
94456215|NCT03696108|323458225|FG001|Overall Study|Physician Decision|0|||
94456216|NCT03696108|323458224|FG000|Overall Study|Withdrawal by Subject|3|||
94456217|NCT03696108|323458225|FG001|Overall Study|Withdrawal by Subject|6|||
94456218|NCT05239494|323458226|FG000|Overall Study|Lost to Follow-up|1|||
94456219|NCT00679289|323458227|FG000|Overall Study|Progressive disease|4|||
94456220|NCT00679289|323458228|FG001|Overall Study|Progressive disease|5|||
94456221|NCT00679289|323458229|FG002|Overall Study|Progressive disease|18|||
94456222|NCT00679289|323458227|FG000|Overall Study|Withdrawal by Subject|0|||
94456223|NCT00679289|323458228|FG001|Overall Study|Withdrawal by Subject|1|||
94456224|NCT00679289|323458229|FG002|Overall Study|Withdrawal by Subject|1|||
94456225|NCT00679289|323458227|FG000|Overall Study|Adverse Event|0|||
94456226|NCT00679289|323458228|FG001|Overall Study|Adverse Event|0|||
94456227|NCT00679289|323458229|FG002|Overall Study|Adverse Event|3|||
94456228|NCT00679289|323458227|FG000|Overall Study|Physician Decision|1|||
94456229|NCT00679289|323458228|FG001|Overall Study|Physician Decision|0|||
94456230|NCT00679289|323458229|FG002|Overall Study|Physician Decision|1|||
94456231|NCT02235077|323458236|FG000|Overall Study|Death|5|||
94456232|NCT02235077|323458237|FG001|Overall Study|Death|7|||
94456233|NCT02235077|323458236|FG000|Overall Study|Lost to Follow-up|5|||
94456234|NCT02235077|323458237|FG001|Overall Study|Lost to Follow-up|6|||
94456235|NCT02235077|323458236|FG000|Overall Study|Withdrawal by Subject|8|||
94456236|NCT02235077|323458237|FG001|Overall Study|Withdrawal by Subject|5|||
94456237|NCT02235077|323458236|FG000|Overall Study|Physician Decision|0|||
94456238|NCT02235077|323458237|FG001|Overall Study|Physician Decision|1|||
94456239|NCT02964208|323458238|FG000|Overall Study|Death|103|||
94456240|NCT02964208|323458238|FG000|Overall Study|Withdrawal by Subject|6|||
94456241|NCT02964208|323458238|FG000|Overall Study|Lost to Follow-up|6|||
94456242|NCT02964208|323458238|FG000|Overall Study|Unsuccessful Procedure|5|||
94456243|NCT02964208|323458238|FG000|Overall Study|Device Explant|1|||
94456244|NCT02964208|323458238|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
94456245|NCT02841280|323458239|FG000|Overall Study|Adverse Event|2|||
94456246|NCT02841280|323458240|FG001|Overall Study|Adverse Event|1|||
94456247|NCT02841280|323458239|FG000|Overall Study|Death|1|||
94456248|NCT02841280|323458240|FG001|Overall Study|Death|0|||
94456249|NCT02841280|323458239|FG000|Overall Study|Lost to Follow-up|2|||
94456250|NCT02841280|323458240|FG001|Overall Study|Lost to Follow-up|2|||
94456251|NCT02841280|323458239|FG000|Overall Study|Withdrawal by Subject|7|||
94456252|NCT02841280|323458240|FG001|Overall Study|Withdrawal by Subject|3|||
94456253|NCT02841280|323458239|FG000|Overall Study|Stop Point: BP above threshold|2|||
94456254|NCT02841280|323458240|FG001|Overall Study|Stop Point: BP above threshold|0|||
94456255|NCT03003494|323458241|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
94456256|NCT01738503|323458242|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
94456257|NCT01738503|323458243|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
94456258|NCT01738503|323458244|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
94456259|NCT01738503|323458245|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
94456260|NCT01738503|323458246|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
94456261|NCT01738503|323458247|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
94456262|NCT01738503|323458248|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
94456263|NCT01738503|323458242|FG000|Treatment Period|Adverse Event|0|||
94456264|NCT01738503|323458243|FG001|Treatment Period|Adverse Event|1|||
94456265|NCT01738503|323458244|FG002|Treatment Period|Adverse Event|0|||
94456266|NCT01738503|323458245|FG003|Treatment Period|Adverse Event|1|||
94456267|NCT01738503|323458246|FG004|Treatment Period|Adverse Event|2|||
94456268|NCT01738503|323458247|FG005|Treatment Period|Adverse Event|2|||
94456269|NCT01738503|323458248|FG006|Treatment Period|Adverse Event|2|||
94456270|NCT01738503|323458242|FG000|Treatment Period|Lost to Follow-up|0|||
94456271|NCT01738503|323458243|FG001|Treatment Period|Lost to Follow-up|0|||
94456272|NCT01738503|323458244|FG002|Treatment Period|Lost to Follow-up|3|||
94456273|NCT01738503|323458245|FG003|Treatment Period|Lost to Follow-up|4|||
94456274|NCT01738503|323458246|FG004|Treatment Period|Lost to Follow-up|1|||
94590239|NCT01137604|323962844|FG001|Overall Study|Clinical progression/deterioration|2|||
94456275|NCT01738503|323458247|FG005|Treatment Period|Lost to Follow-up|1|||
94456276|NCT01738503|323458248|FG006|Treatment Period|Lost to Follow-up|5|||
94245163|NCT03117998|322690357|FG000|Overall Study|Protocol Violation|0|||
94245164|NCT03117998|322690358|FG001|Overall Study|Protocol Violation|0|||
94245165|NCT03117998|322690359|FG002|Overall Study|Protocol Violation|0|||
94245166|NCT03117998|322690360|FG003|Overall Study|Protocol Violation|0|||
94245167|NCT03117998|322690361|FG004|Overall Study|Protocol Violation|0|||
94245168|NCT03117998|322690362|FG005|Overall Study|Protocol Violation|1|||
94245169|NCT00586612|322690363|FG000|Primary Phase|Protocol Violation|1|||
94245170|NCT00586612|322690364|FG001|Primary Phase|Protocol Violation|0|||
94245171|NCT00586612|322690363|FG000|Primary Phase|Lost to Follow-up|0|||
94245172|NCT00586612|322690364|FG001|Primary Phase|Lost to Follow-up|1|||
94245173|NCT00586612|322690363|FG000|Primary Phase|Withdrawal by Subject|0|||
94245174|NCT00586612|322690364|FG001|Primary Phase|Withdrawal by Subject|2|||
94245175|NCT00586612|322690363|FG000|Booster Phase|Lost to Follow-up|3|||
94245176|NCT00586612|322690364|FG001|Booster Phase|Lost to Follow-up|1|||
94245177|NCT01585155|322690365|FG000|Overall Study|Adverse Event|1|||
94245178|NCT01585155|322690365|FG000|Overall Study|Lack of Efficacy|2|||
94245179|NCT01585155|322690365|FG000|Overall Study|Worsening ulcerative colitis|2|||
94245180|NCT05597787|322690366|FG000|Overall Study|Withdrawal by Subject|0|||
94245181|NCT05597787|322690367|FG001|Overall Study|Withdrawal by Subject|0|||
94245182|NCT05597787|322690368|FG002|Overall Study|Withdrawal by Subject|1|||
94245183|NCT05384938|322690369|FG000|Overall Study|Withdrawal by Subject|8|||
94245184|NCT05384938|322690369|FG000|Overall Study|Lost to Follow-up|6|||
94245185|NCT05384938|322690369|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
94245186|NCT01905150|322690370|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
94245187|NCT01905150|322690371|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
94456277|NCT01738503|323458242|FG000|Treatment Period|Withdrawal by Subject|0|||
94456278|NCT01738503|323458243|FG001|Treatment Period|Withdrawal by Subject|1|||
94456279|NCT01738503|323458244|FG002|Treatment Period|Withdrawal by Subject|0|||
94456280|NCT01738503|323458245|FG003|Treatment Period|Withdrawal by Subject|1|||
94456281|NCT01738503|323458246|FG004|Treatment Period|Withdrawal by Subject|1|||
94456282|NCT01738503|323458247|FG005|Treatment Period|Withdrawal by Subject|1|||
94456283|NCT01738503|323458248|FG006|Treatment Period|Withdrawal by Subject|1|||
94456284|NCT01738503|323458242|FG000|Treatment Period|Protocol Violation|0|||
94456285|NCT01738503|323458243|FG001|Treatment Period|Protocol Violation|3|||
94456286|NCT01738503|323458244|FG002|Treatment Period|Protocol Violation|1|||
94456287|NCT01738503|323458245|FG003|Treatment Period|Protocol Violation|0|||
94456288|NCT01738503|323458246|FG004|Treatment Period|Protocol Violation|4|||
94456289|NCT01738503|323458247|FG005|Treatment Period|Protocol Violation|2|||
94456290|NCT01738503|323458248|FG006|Treatment Period|Protocol Violation|0|||
94456291|NCT01738503|323458242|FG000|Treatment Period|Other|0|||
94456292|NCT01738503|323458243|FG001|Treatment Period|Other|0|||
94456293|NCT01738503|323458244|FG002|Treatment Period|Other|1|||
94456294|NCT01738503|323458245|FG003|Treatment Period|Other|0|||
94456295|NCT01738503|323458246|FG004|Treatment Period|Other|0|||
94456296|NCT01738503|323458247|FG005|Treatment Period|Other|0|||
94456297|NCT01738503|323458248|FG006|Treatment Period|Other|0|||
94456298|NCT01738503|323458242|FG000|PET Imaging Sub-study|Adverse Event|0|||
94456299|NCT01738503|323458243|FG001|PET Imaging Sub-study|Adverse Event|0|||
94456300|NCT01738503|323458244|FG002|PET Imaging Sub-study|Adverse Event|0|||
94456301|NCT01738503|323458245|FG003|PET Imaging Sub-study|Adverse Event|0|||
94456302|NCT01738503|323458246|FG004|PET Imaging Sub-study|Adverse Event|0|||
94456303|NCT01738503|323458247|FG005|PET Imaging Sub-study|Adverse Event|1|||
94456304|NCT01738503|323458248|FG006|PET Imaging Sub-study|Adverse Event|0|||
94456305|NCT01738503|323458242|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
94245188|NCT05453201|322690372|FG000|Overall Study|Withdrawal by Subject|1|||
94245189|NCT01934790|322690373|FG000|Treatment|Adverse Event|3|||
94355263|NCT02926833|323083539|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
94355264|NCT02926833|323083536|FG000|Overall Study|Investigator Decision|0|||
94355265|NCT02926833|323083537|FG001|Overall Study|Investigator Decision|1|||
94355266|NCT02926833|323083538|FG002|Overall Study|Investigator Decision|0|||
94355267|NCT02926833|323083539|FG003|Overall Study|Investigator Decision|0|||
94355268|NCT02926833|323083536|FG000|Overall Study|Adverse Event|0|||
94355269|NCT02926833|323083537|FG001|Overall Study|Adverse Event|0|||
94355270|NCT02926833|323083538|FG002|Overall Study|Adverse Event|1|||
94355271|NCT02926833|323083539|FG003|Overall Study|Adverse Event|0|||
94355272|NCT02926833|323083536|FG000|Overall Study|Partial Withdrawal of Consent|0|||
94355273|NCT02926833|323083537|FG001|Overall Study|Partial Withdrawal of Consent|0|||
94355274|NCT02926833|323083538|FG002|Overall Study|Partial Withdrawal of Consent|0|||
94355275|NCT02926833|323083539|FG003|Overall Study|Partial Withdrawal of Consent|1|||
94355276|NCT01041027|323083542|FG000|Overall Study|Withdrawal by Subject|2|||
94355277|NCT01041027|323083542|FG000|Overall Study|Protocol Violation|1|||
94355278|NCT01041027|323083542|FG000|Overall Study|Delayed Radiation Therapy|1|||
94456306|NCT01738503|323458243|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
94456307|NCT01738503|323458244|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
94688614|NCT02572817|324315531|FG001|Overall Study|Lost to Follow-up|3|||
94590240|NCT01137604|323962845|FG002|Overall Study|Clinical progression/deterioration|2|||
94590241|NCT01137604|323962846|FG003|Overall Study|Clinical progression/deterioration|0|||
94590242|NCT03615040|323962847|FG000|Overall Study|Withdrawal by Subject|2|||
94590243|NCT03615040|323962848|FG001|Overall Study|Withdrawal by Subject|1|||
94590244|NCT03615040|323962847|FG000|Overall Study|Physician Decision|2|||
94590245|NCT03615040|323962848|FG001|Overall Study|Physician Decision|2|||
94590246|NCT03615040|323962847|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
94590247|NCT03615040|323962848|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
94590248|NCT03615040|323962847|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
94590249|NCT03615040|323962848|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
94590250|NCT03615040|323962847|FG000|Overall Study|Death|0|||
94590251|NCT03615040|323962848|FG001|Overall Study|Death|2|||
94590252|NCT01776307|323962849|FG000|Overall Study|Not dosed|0|||
94590253|NCT01776307|323962850|FG001|Overall Study|Not dosed|0|||
94590254|NCT01776307|323962851|FG002|Overall Study|Not dosed|1|||
94590255|NCT00573144|323962852|FG000|Overall Study|Withdrawal by Subject|2|||
94590256|NCT00573144|323962853|FG001|Overall Study|Withdrawal by Subject|3|||
94590257|NCT03052426|323962854|FG000|Overall Study|Withdrawal by Subject|0|||
94590258|NCT03052426|323962855|FG001|Overall Study|Withdrawal by Subject|1|||
94590259|NCT03052426|323962856|FG002|Overall Study|Withdrawal by Subject|0|||
94590260|NCT03052426|323962854|FG000|Overall Study|Lost to Follow-up|2|||
94590261|NCT03052426|323962855|FG001|Overall Study|Lost to Follow-up|0|||
94590262|NCT03052426|323962856|FG002|Overall Study|Lost to Follow-up|1|||
94590263|NCT03083990|323962861|FG000|Overall Study|Adverse Event|1|||
94590264|NCT03083990|323962862|FG001|Overall Study|Adverse Event|0|||
94590265|NCT01015638|323962863|FG000|Overall Study|Withdrawal by Subject|1|||
94590266|NCT01015638|323962864|FG001|Overall Study|Withdrawal by Subject|0|||
94590267|NCT01018810|323962865|FG000|Overall Study|Withdrawal by Subject|0|||
94590268|NCT01018810|323962866|FG001|Overall Study|Withdrawal by Subject|1|||
94590269|NCT01018810|323962867|FG002|Overall Study|Withdrawal by Subject|0|||
94590270|NCT01018810|323962868|FG003|Overall Study|Withdrawal by Subject|0|||
94590271|NCT01018810|323962869|FG004|Overall Study|Withdrawal by Subject|0|||
94590272|NCT01018810|323962865|FG000|Overall Study|Sponsor Decision|2|||
94590273|NCT01018810|323962866|FG001|Overall Study|Sponsor Decision|0|||
94590274|NCT01018810|323962867|FG002|Overall Study|Sponsor Decision|1|||
94590275|NCT01018810|323962868|FG003|Overall Study|Sponsor Decision|1|||
94590276|NCT01018810|323962869|FG004|Overall Study|Sponsor Decision|1|||
94590277|NCT00706342|323962873|FG000|Overall Study|Adverse Event|3|||
94590278|NCT00706342|323962873|FG000|Overall Study|Not responding to treatment|2|||
94590279|NCT00706342|323962873|FG000|Overall Study|Withdrawn due to failure to respond|1|||
94590280|NCT00706342|323962873|FG000|Overall Study|Death|1|||
94590281|NCT00706342|323962873|FG000|Overall Study|Withdrew from the study on his own.|1|||
94590282|NCT00706342|323962873|FG000|Overall Study|Investigator discretion|2|||
94590283|NCT00706342|323962873|FG000|Overall Study|Non-responder Week 12|1|||
94590284|NCT00706342|323962873|FG000|Overall Study|Ongoing|6|||
94590285|NCT00706342|323962873|FG000|Overall Study|WIthdrawal of consent|1|||
94590286|NCT03179605|323962874|FG000|Overall Study|Withdrawal by Subject|1|||
94590287|NCT01781299|323962875|FG000|Overall Study|Withdrawal by Subject|0|||
94590288|NCT01781299|323962876|FG001|Overall Study|Withdrawal by Subject|1|||
94590289|NCT01396057|323962878|FG000|Overall Study|Adverse Event|2|||
94590290|NCT01396057|323962879|FG001|Overall Study|Adverse Event|6|||
94590291|NCT01396057|323962878|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
94590292|NCT01396057|323962879|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
94590293|NCT01396057|323962878|FG000|Overall Study|Protocol deviation|4|||
94590294|NCT01396057|323962879|FG001|Overall Study|Protocol deviation|4|||
94590295|NCT01396057|323962878|FG000|Overall Study|Consent withdrawn|3|||
94590296|NCT01396057|323962879|FG001|Overall Study|Consent withdrawn|2|||
94590297|NCT04530136|323962880|FG000|Overall Study|Lost to Follow-up|2|||
94590298|NCT04530136|323962881|FG001|Overall Study|Lost to Follow-up|3|||
94590299|NCT04530136|323962880|FG000|Overall Study|Withdrawal by Subject|1|||
94590300|NCT04530136|323962881|FG001|Overall Study|Withdrawal by Subject|0|||
94590301|NCT04530136|323962880|FG000|Overall Study|Death|0|||
94590302|NCT04530136|323962881|FG001|Overall Study|Death|1|||
94590303|NCT01994889|323962882|FG000|Overall Study|Adverse Event|5|||
94590304|NCT01994889|323962883|FG001|Overall Study|Adverse Event|12|||
94590305|NCT01994889|323962884|FG002|Overall Study|Adverse Event|11|||
94590306|NCT01994889|323962882|FG000|Overall Study|Cardiac Device Implantation|0|||
94590307|NCT01994889|323962883|FG001|Overall Study|Cardiac Device Implantation|2|||
94590308|NCT01994889|323962884|FG002|Overall Study|Cardiac Device Implantation|0|||
94590309|NCT01994889|323962882|FG000|Overall Study|Organ Transplantation|1|||
94590310|NCT01994889|323962883|FG001|Overall Study|Organ Transplantation|5|||
94590311|NCT01994889|323962884|FG002|Overall Study|Organ Transplantation|5|||
94590312|NCT01994889|323962882|FG000|Overall Study|No longer willing to participate|8|||
94245190|NCT01934790|322690373|FG000|Treatment|Clinical progression|6|||
94245191|NCT01934790|322690373|FG000|Treatment|Radiological progression|4|||
94245192|NCT01934790|322690373|FG000|Treatment|Withdrawal by Subject|2|||
94245193|NCT01934790|322690373|FG000|Treatment|Study drug never administered|1|||
94245194|NCT01934790|322690373|FG000|Active Follow up|Death|20|||
94245195|NCT01934790|322690373|FG000|Active Follow up|Physician Decision|2|||
94245196|NCT01934790|322690373|FG000|Active Follow up|Progressive disease|1|||
94245197|NCT01934790|322690373|FG000|Active Follow up|Other reason|1|||
94245198|NCT03798691|322690376|FG000|Overall Study|Lost to Follow-up|2|||
94245199|NCT03798691|322690377|FG001|Overall Study|Lost to Follow-up|2|||
94245200|NCT00552929|322690378|FG000|Overall Study|Lost to Follow-up|0|||
94245201|NCT00552929|322690379|FG001|Overall Study|Lost to Follow-up|0|||
94590313|NCT01994889|323962883|FG001|Overall Study|No longer willing to participate|17|||
94245202|NCT00552929|322690380|FG002|Overall Study|Lost to Follow-up|0|||
94245203|NCT00552929|322690381|FG003|Overall Study|Lost to Follow-up|0|||
94245204|NCT00552929|322690382|FG004|Overall Study|Lost to Follow-up|0|||
94590314|NCT01994889|323962884|FG002|Overall Study|No longer willing to participate|37|||
94590315|NCT01994889|323962882|FG000|Overall Study|Lost to Follow-up|0|||
94590316|NCT01994889|323962883|FG001|Overall Study|Lost to Follow-up|1|||
94590317|NCT01994889|323962884|FG002|Overall Study|Lost to Follow-up|0|||
94590318|NCT01994889|323962882|FG000|Overall Study|Protocol Violation|0|||
94245205|NCT00552929|322690383|FG005|Overall Study|Lost to Follow-up|0|||
94245206|NCT00552929|322690384|FG006|Overall Study|Lost to Follow-up|0|||
94590319|NCT01994889|323962883|FG001|Overall Study|Protocol Violation|1|||
94590320|NCT01994889|323962884|FG002|Overall Study|Protocol Violation|1|||
94590321|NCT01994889|323962882|FG000|Overall Study|Death|14|||
94590322|NCT01994889|323962883|FG001|Overall Study|Death|25|||
94590323|NCT01994889|323962884|FG002|Overall Study|Death|38|||
94590324|NCT01536392|323962885|FG000|Overall Study|Adverse Event|2|||
94590325|NCT01536392|323962886|FG001|Overall Study|Adverse Event|2|||
94245207|NCT00552929|322690385|FG007|Overall Study|Lost to Follow-up|0|||
94590326|NCT01536392|323962885|FG000|Overall Study|Physician Decision|2|||
94590327|NCT01536392|323962886|FG001|Overall Study|Physician Decision|3|||
94590328|NCT01536392|323962885|FG000|Overall Study|Withdrawal by Subject|3|||
94590329|NCT01536392|323962886|FG001|Overall Study|Withdrawal by Subject|6|||
94245208|NCT00552929|322690386|FG008|Overall Study|Lost to Follow-up|1|||
94245209|NCT00552929|322690387|FG009|Overall Study|Lost to Follow-up|0|||
94245210|NCT00552929|322690378|FG000|Overall Study|Not Eligible|0|||
94245211|NCT00552929|322690379|FG001|Overall Study|Not Eligible|0|||
94245212|NCT00552929|322690380|FG002|Overall Study|Not Eligible|0|||
94245213|NCT00552929|322690381|FG003|Overall Study|Not Eligible|0|||
94245214|NCT00552929|322690382|FG004|Overall Study|Not Eligible|0|||
94245215|NCT00552929|322690383|FG005|Overall Study|Not Eligible|1|||
94245216|NCT00552929|322690384|FG006|Overall Study|Not Eligible|0|||
94245217|NCT00552929|322690385|FG007|Overall Study|Not Eligible|0|||
94245218|NCT00552929|322690386|FG008|Overall Study|Not Eligible|0|||
94245219|NCT00552929|322690387|FG009|Overall Study|Not Eligible|0|||
94245220|NCT01602822|322690388|FG000|Overall Study|Adverse Event|11|||
94245221|NCT04372121|322690389|FG000|Overall Study|Lost to Follow-up|0|||
94245222|NCT04372121|322690390|FG001|Overall Study|Lost to Follow-up|0|||
94245223|NCT04372121|322690391|FG002|Overall Study|Lost to Follow-up|0|||
94245224|NCT04372121|322690392|FG003|Overall Study|Lost to Follow-up|1|||
94245225|NCT04372121|322690389|FG000|Overall Study|Protocol Violation|0|||
94245226|NCT04372121|322690390|FG001|Overall Study|Protocol Violation|0|||
94245227|NCT04372121|322690391|FG002|Overall Study|Protocol Violation|1|||
94245228|NCT04372121|322690392|FG003|Overall Study|Protocol Violation|0|||
94245229|NCT04372121|322690389|FG000|Overall Study|Withdrawal by Subject|3|||
94245230|NCT04372121|322690390|FG001|Overall Study|Withdrawal by Subject|1|||
94245231|NCT04372121|322690391|FG002|Overall Study|Withdrawal by Subject|0|||
94245232|NCT04372121|322690392|FG003|Overall Study|Withdrawal by Subject|0|||
94245233|NCT04372121|322690389|FG000|Overall Study|Study termination|6|||
94245234|NCT04372121|322690390|FG001|Overall Study|Study termination|5|||
94245235|NCT04372121|322690391|FG002|Overall Study|Study termination|1|||
94245236|NCT04372121|322690392|FG003|Overall Study|Study termination|1|||
94245237|NCT04372121|322690389|FG000|Overall Study|Hysterectomy planned|1|||
94245238|NCT04372121|322690390|FG001|Overall Study|Hysterectomy planned|0|||
94245239|NCT04372121|322690391|FG002|Overall Study|Hysterectomy planned|0|||
94245240|NCT04372121|322690392|FG003|Overall Study|Hysterectomy planned|0|||
94245241|NCT05618912|322690393|FG000|Overall Study|Lost to Follow-up|14|||
94245242|NCT05618912|322690394|FG001|Overall Study|Lost to Follow-up|19|||
94245243|NCT05110690|322690395|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
94245244|NCT05110690|322690395|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
94245245|NCT05110690|322690395|FG000|Completion of Intervention|Lost to Follow-up|1|||
94590330|NCT01536392|323962885|FG000|Overall Study|Non Compliance|3|||
94590331|NCT01536392|323962886|FG001|Overall Study|Non Compliance|4|||
94590332|NCT01536392|323962885|FG000|Overall Study|Completed therapy early|3|||
94590333|NCT01536392|323962886|FG001|Overall Study|Completed therapy early|0|||
94590334|NCT03425253|323962887|FG000|Overall Study|Adverse Event|2|||
94590335|NCT03425253|323962887|FG000|Overall Study|Lost to Follow-up|3|||
94590336|NCT03425253|323962887|FG000|Overall Study|Withdrew Consent|6|||
94590337|NCT03425253|323962887|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
94590338|NCT01014910|323962889|FG000|Overall Study|Withdrawal by Subject|0|||
94590339|NCT01014910|323962890|FG001|Overall Study|Withdrawal by Subject|2|||
94590340|NCT03753789|323962891|FG000|Overall Study|Withdrawal by Subject|2|||
94590341|NCT04270370|323962892|FG000|Overall Study|Lost to Follow-up|1|||
94590342|NCT04270370|323962893|FG001|Overall Study|Lost to Follow-up|0|||
94590343|NCT04270370|323962894|FG002|Overall Study|Lost to Follow-up|0|||
94590344|NCT04270370|323962895|FG003|Overall Study|Lost to Follow-up|0|||
94590345|NCT04270370|323962896|FG004|Overall Study|Lost to Follow-up|0|||
94590346|NCT04270370|323962897|FG005|Overall Study|Lost to Follow-up|0|||
94590347|NCT04270370|323962898|FG006|Overall Study|Lost to Follow-up|0|||
94590348|NCT04270370|323962899|FG007|Overall Study|Lost to Follow-up|0|||
94590349|NCT04270370|323962900|FG008|Overall Study|Lost to Follow-up|1|||
94590350|NCT04270370|323962901|FG009|Overall Study|Lost to Follow-up|0|||
94590351|NCT04270370|323962902|FG010|Overall Study|Lost to Follow-up|0|||
94590352|NCT04270370|323962903|FG011|Overall Study|Lost to Follow-up|0|||
94590353|NCT03698591|323962908|FG000|Overall Study|Withdrawal by Subject|2|||
94590354|NCT03698591|323962909|FG001|Overall Study|Withdrawal by Subject|2|||
94590355|NCT03698591|323962908|FG000|Overall Study|Failed drug screen|1|||
94590356|NCT03698591|323962909|FG001|Overall Study|Failed drug screen|1|||
94590357|NCT03698591|323962908|FG000|Overall Study|Failed health screen|0|||
94590358|NCT03698591|323962909|FG001|Overall Study|Failed health screen|1|||
94590359|NCT03698591|323962908|FG000|Overall Study|Ineligible for financial compensation|1|||
94590360|NCT03698591|323962909|FG001|Overall Study|Ineligible for financial compensation|0|||
94590361|NCT03698591|323962908|FG000|Overall Study|Equipment Error|1|||
94590362|NCT03698591|323962909|FG001|Overall Study|Equipment Error|0|||
94590363|NCT03698591|323962908|FG000|Overall Study|Could not establish TMS dosage|0|||
94590364|NCT03698591|323962909|FG001|Overall Study|Could not establish TMS dosage|1|||
94590365|NCT02872285|323962914|FG000|Overall Study|Withdrawal by Subject|2|||
94590366|NCT02872285|323962915|FG001|Overall Study|Withdrawal by Subject|0|||
94590367|NCT02872285|323962914|FG000|Overall Study|Lost to Follow-up|2|||
94590368|NCT02872285|323962915|FG001|Overall Study|Lost to Follow-up|2|||
94590369|NCT02872285|323962914|FG000|Overall Study|Discontinued due to back surgery|1|||
94590370|NCT02872285|323962915|FG001|Overall Study|Discontinued due to back surgery|0|||
94590371|NCT02660983|323962916|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
94590372|NCT02660983|323962917|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
94590373|NCT02660983|323962916|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
94590374|NCT02660983|323962917|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
94590375|NCT02660983|323962916|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
94355279|NCT01041027|323083542|FG000|Overall Study|Adverse Event|4|||
94590376|NCT02660983|323962917|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
94590377|NCT02660983|323962916|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
94590378|NCT02660983|323962917|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
94590379|NCT02660983|323962916|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
94590380|NCT02660983|323962917|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
94590381|NCT02660983|323962916|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
94590382|NCT02660983|323962917|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
94590383|NCT02660983|323962916|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
94590384|NCT02660983|323962917|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
94590385|NCT01165216|323962918|FG000|Overall Study|Adverse Event|6|||
94590386|NCT01165216|323962919|FG001|Overall Study|Adverse Event|3|||
94590387|NCT01165216|323962918|FG000|Overall Study|Withdrawal by Subject|1|||
94590388|NCT01165216|323962919|FG001|Overall Study|Withdrawal by Subject|1|||
94590389|NCT01165216|323962918|FG000|Overall Study|Disease progression|1|||
94590390|NCT01165216|323962919|FG001|Overall Study|Disease progression|3|||
94590391|NCT01217307|323965087|FG000|Overall Study|Withdrawal by Subject|0|||
94590392|NCT01217307|323965088|FG001|Overall Study|Withdrawal by Subject|1|||
94590393|NCT00295880|323965091|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
94590394|NCT00295880|323965091|FG000|Overall Study|Unit randomization did not occur|1|||
94590395|NCT00843284|323965092|FG000|Overall Study|Adverse Event|39|||
94590396|NCT00843284|323965092|FG000|Overall Study|Lack of Efficacy|5|||
94590397|NCT00843284|323965092|FG000|Overall Study|Lost to Follow-up|11|||
94590398|NCT00843284|323965092|FG000|Overall Study|Other|10|||
94590399|NCT00843284|323965092|FG000|Overall Study|Withdrawal by Subject|4|||
94590400|NCT00843284|323965092|FG000|Overall Study|Death|3|||
94590401|NCT01474239|323965093|FG000|Overall Study|Disease Progression|37|||
94590402|NCT01474239|323965094|FG001|Overall Study|Disease Progression|25|||
94590403|NCT01474239|323965093|FG000|Overall Study|Adverse Event|12|||
94590404|NCT01474239|323965094|FG001|Overall Study|Adverse Event|3|||
94590405|NCT01474239|323965093|FG000|Overall Study|Withdrawal by Subject|1|||
94590406|NCT01474239|323965094|FG001|Overall Study|Withdrawal by Subject|2|||
94590407|NCT01474239|323965093|FG000|Overall Study|Death|1|||
94590408|NCT01474239|323965094|FG001|Overall Study|Death|1|||
94590409|NCT01474239|323965093|FG000|Overall Study|Clinical Disease Progression|7|||
94590410|NCT01474239|323965094|FG001|Overall Study|Clinical Disease Progression|1|||
94590411|NCT01474239|323965093|FG000|Overall Study|Withdrawal for Economic Reason|1|||
94590412|NCT01474239|323965094|FG001|Overall Study|Withdrawal for Economic Reason|0|||
94590413|NCT01243242|323965095|FG000|Overall Study|Adverse Event|1|||
94590414|NCT01243242|323965096|FG001|Overall Study|Adverse Event|1|||
94590415|NCT01243242|323965095|FG000|Overall Study|Withdrawal by Subject|1|||
94590416|NCT01243242|323965096|FG001|Overall Study|Withdrawal by Subject|1|||
94590417|NCT01243242|323965095|FG000|Overall Study|Physician Decision|0|||
94590418|NCT01243242|323965096|FG001|Overall Study|Physician Decision|1|||
94590419|NCT01243242|323965095|FG000|Overall Study|sponsor decision|0|||
94590420|NCT01243242|323965096|FG001|Overall Study|sponsor decision|1|||
94590421|NCT01243242|323965095|FG000|Overall Study|non compliance|1|||
94590422|NCT01243242|323965096|FG001|Overall Study|non compliance|0|||
94590423|NCT01282463|323965104|FG000|Overall Study|Lost to Follow-up|1|||
94590424|NCT01282463|323965105|FG001|Overall Study|Lost to Follow-up|0|||
94590425|NCT01282463|323965106|FG002|Overall Study|Lost to Follow-up|0|||
94590426|NCT01282463|323965104|FG000|Overall Study|Withdrawal by Subject|6|||
94590427|NCT01282463|323965105|FG001|Overall Study|Withdrawal by Subject|2|||
94590428|NCT01282463|323965106|FG002|Overall Study|Withdrawal by Subject|3|||
94590429|NCT01282463|323965104|FG000|Overall Study|"Never Treated Death"|0|||
94590430|NCT01282463|323965105|FG001|Overall Study|"Never Treated Death"|1|||
94590431|NCT01282463|323965106|FG002|Overall Study|"Never Treated Death"|0|||
94590432|NCT01282463|323965104|FG000|Overall Study|"Never Treated PD"|0|||
94590433|NCT01282463|323965105|FG001|Overall Study|"Never Treated PD"|1|||
94590434|NCT01282463|323965106|FG002|Overall Study|"Never Treated PD"|0|||
94590435|NCT01282463|323965104|FG000|Overall Study|Protocol Violation|0|||
94590436|NCT01282463|323965105|FG001|Overall Study|Protocol Violation|0|||
94590437|NCT01282463|323965106|FG002|Overall Study|Protocol Violation|1|||
94590438|NCT01282463|323965104|FG000|Overall Study|Physician Decision|1|||
94590439|NCT01282463|323965105|FG001|Overall Study|Physician Decision|0|||
94590440|NCT01282463|323965106|FG002|Overall Study|Physician Decision|0|||
94590441|NCT00798759|323965109|FG000|Overall Study|Adverse Event|3|||
94590442|NCT00798759|323965110|FG001|Overall Study|Adverse Event|3|||
94590443|NCT00798759|323965109|FG000|Overall Study|Lost to Follow-up|1|||
94590444|NCT00798759|323965110|FG001|Overall Study|Lost to Follow-up|1|||
94590445|NCT00798759|323965109|FG000|Overall Study|Protocol Violation|4|||
94590446|NCT00798759|323965110|FG001|Overall Study|Protocol Violation|8|||
94590447|NCT00798759|323965109|FG000|Overall Study|Other|0|||
94590448|NCT00798759|323965110|FG001|Overall Study|Other|1|||
94590449|NCT00476008|323965112|FG000|Overall Study|Adverse Event|4|||
94590450|NCT00476008|323965113|FG001|Overall Study|Adverse Event|4|||
94590451|NCT00476008|323965112|FG000|Overall Study|Placebo concerns|2|||
94590452|NCT00476008|323965113|FG001|Overall Study|Placebo concerns|2|||
94590453|NCT00476008|323965112|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
94590454|NCT00476008|323965113|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
94590455|NCT00476008|323965112|FG000|Overall Study|Withdrawal by Subject|0|||
94590456|NCT00476008|323965113|FG001|Overall Study|Withdrawal by Subject|1|||
94590457|NCT00476008|323965112|FG000|Overall Study|Death|1|||
94590458|NCT00476008|323965113|FG001|Overall Study|Death|0|||
94590459|NCT01368562|323965117|FG000|Overall Study|Adverse Event|1|||
94590460|NCT01368562|323965117|FG000|Overall Study|Disease progression|1|||
94590461|NCT01368562|323965117|FG000|Overall Study|Lost to Follow-up|1|||
94590462|NCT01368562|323965117|FG000|Overall Study|Death|6|||
94590463|NCT01368562|323965117|FG000|Overall Study|Unresponsive to treatment|5|||
94590464|NCT01368562|323965117|FG000|Overall Study|Other|3|||
94590465|NCT01368562|323965117|FG000|Overall Study|Other than specified|2|||
94590466|NCT00387790|323965120|FG000|Overall Study|Adverse Event|5|||
94590467|NCT00387790|323965120|FG000|Overall Study|Lack of Efficacy|2|||
94590468|NCT00387790|323965120|FG000|Overall Study|Physician Decision|2|||
94590469|NCT00387790|323965120|FG000|Overall Study|Withdrawal by Subject|3|||
94590470|NCT00387790|323965120|FG000|Overall Study|Ineligible for study|2|||
94590471|NCT00475306|323965121|FG000|Overall Study|Protocol Violation|1|||
94590472|NCT00475306|323965122|FG001|Overall Study|Protocol Violation|1|||
94659814|NCT00116805|324209957|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
94590473|NCT00475306|323965123|FG002|Overall Study|Protocol Violation|0|||
94590474|NCT00475306|323965124|FG003|Overall Study|Protocol Violation|1|||
94590475|NCT02078960|323965126|FG000|Treatment Period|Other|0|||
94590476|NCT02078960|323965127|FG001|Treatment Period|Other|0|||
94590477|NCT02078960|323965128|FG002|Treatment Period|Other|1|||
94590478|NCT02078960|323965126|FG000|Treatment Period|Lack of Efficacy|0|||
94590479|NCT02078960|323965127|FG001|Treatment Period|Lack of Efficacy|1|||
94590480|NCT02078960|323965128|FG002|Treatment Period|Lack of Efficacy|0|||
94590481|NCT02078960|323965126|FG000|Treatment Period|Disease progression - accelerated phase|0|||
94590482|NCT02078960|323965127|FG001|Treatment Period|Disease progression - accelerated phase|1|||
94590483|NCT02078960|323965128|FG002|Treatment Period|Disease progression - accelerated phase|0|||
94590484|NCT02078960|323965126|FG000|Treatment Period|Disease progression - blast phase|1|||
94590485|NCT02078960|323965127|FG001|Treatment Period|Disease progression - blast phase|0|||
94590486|NCT02078960|323965128|FG002|Treatment Period|Disease progression - blast phase|0|||
94590487|NCT02078960|323965126|FG000|Treatment Period|Withdrawal by Subject|0|||
94245246|NCT05110690|322690395|FG000|Completion of Intervention|Death|1|||
94245247|NCT05110690|322690395|FG000|Completion of Intervention|Withdrawal by Subject|2|||
94245248|NCT04500769|322691683|FG000|Overall Study|Withdrawal by Subject|5|||
94245249|NCT01967147|322691684|FG000|Overall Study|Adverse Event|5|||
94245250|NCT01967147|322691685|FG001|Overall Study|Adverse Event|2|||
94245251|NCT01967147|322691684|FG000|Overall Study|Lack of Efficacy|1|||
94245252|NCT01967147|322691685|FG001|Overall Study|Lack of Efficacy|4|||
94245253|NCT01967147|322691684|FG000|Overall Study|Lost to Follow-up|1|||
94245254|NCT01967147|322691685|FG001|Overall Study|Lost to Follow-up|2|||
94245255|NCT01967147|322691684|FG000|Overall Study|Withdrawal by Subject|2|||
94245256|NCT01967147|322691685|FG001|Overall Study|Withdrawal by Subject|4|||
94245257|NCT01967147|322691684|FG000|Overall Study|Non-compliance with Study Drug|0|||
94245258|NCT01967147|322691685|FG001|Overall Study|Non-compliance with Study Drug|3|||
94245259|NCT01967147|322691684|FG000|Overall Study|Other|4|||
94245260|NCT01967147|322691685|FG001|Overall Study|Other|5|||
94245261|NCT01099215|322691686|FG000|Overall Study|Withdrawal by Subject|1|||
94245262|NCT01099215|322691687|FG001|Overall Study|Withdrawal by Subject|0|||
94245263|NCT01099215|322691686|FG000|Overall Study|Adverse Event|0|||
94245264|NCT01099215|322691687|FG001|Overall Study|Adverse Event|1|||
94245265|NCT00890695|322691688|FG000|Overall Study|Protocol Violation|1|||
94245266|NCT00890695|322691689|FG001|Overall Study|Protocol Violation|0|||
94245267|NCT03284229|322691692|FG000|Overall Study|Lost to Follow-up|3|||
94245268|NCT01732822|322691693|FG000|Overall Study|Withdrawal by Subject|123|||
94245269|NCT01732822|322691694|FG001|Overall Study|Withdrawal by Subject|113|||
94245270|NCT00379288|322691698|FG000|Overall Study|Adverse Event|5|||
94245271|NCT00379288|322691699|FG001|Overall Study|Adverse Event|6|||
94245272|NCT00379288|322691700|FG002|Overall Study|Adverse Event|2|||
94590488|NCT02078960|323965127|FG001|Treatment Period|Withdrawal by Subject|1|||
94590489|NCT02078960|323965128|FG002|Treatment Period|Withdrawal by Subject|1|||
94590490|NCT02078960|323965126|FG000|Treatment Period|Adverse Event|1|||
94245273|NCT00379288|322691701|FG003|Overall Study|Adverse Event|0|||
94245274|NCT00379288|322691698|FG000|Overall Study|Treatment Failure|0|||
94245275|NCT00379288|322691699|FG001|Overall Study|Treatment Failure|1|||
94245276|NCT00379288|322691700|FG002|Overall Study|Treatment Failure|0|||
94590491|NCT02078960|323965127|FG001|Treatment Period|Adverse Event|0|||
94245277|NCT00379288|322691701|FG003|Overall Study|Treatment Failure|1|||
94245278|NCT00379288|322691698|FG000|Overall Study|Lost to Follow-up|3|||
94245279|NCT00379288|322691699|FG001|Overall Study|Lost to Follow-up|3|||
94245280|NCT00379288|322691700|FG002|Overall Study|Lost to Follow-up|2|||
94245281|NCT00379288|322691701|FG003|Overall Study|Lost to Follow-up|0|||
94245282|NCT00379288|322691698|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
94590492|NCT02078960|323965128|FG002|Treatment Period|Adverse Event|0|||
94590493|NCT02078960|323965126|FG000|Treatment Period|Death|0|||
94590494|NCT02078960|323965127|FG001|Treatment Period|Death|0|||
94590495|NCT02078960|323965128|FG002|Treatment Period|Death|1|||
94590496|NCT02078960|323965126|FG000|Follow-up Period|Death|2|||
94590497|NCT02078960|323965127|FG001|Follow-up Period|Death|0|||
94590498|NCT02078960|323965128|FG002|Follow-up Period|Death|0|||
94590499|NCT02078960|323965126|FG000|Follow-up Period|Lost to Follow-up|0|||
94590500|NCT02078960|323965127|FG001|Follow-up Period|Lost to Follow-up|1|||
94590501|NCT02078960|323965128|FG002|Follow-up Period|Lost to Follow-up|0|||
94590502|NCT02834793|323965132|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
94590503|NCT02834793|323965133|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
94590504|NCT02834793|323965134|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
94590505|NCT02834793|323965135|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
94590506|NCT02834793|323965132|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
94590507|NCT02834793|323965133|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
94590508|NCT02834793|323965134|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
94590509|NCT02834793|323965135|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
94590510|NCT02834793|323965132|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
94590511|NCT02834793|323965133|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
94590512|NCT02834793|323965134|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
94590513|NCT02834793|323965135|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
94590514|NCT02834793|323965132|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
94590515|NCT02834793|323965133|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
94590516|NCT02834793|323965134|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
94590517|NCT02834793|323965135|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
94590518|NCT02834793|323965132|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
94590519|NCT02834793|323965133|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
94590520|NCT02834793|323965134|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
94590521|NCT02834793|323965135|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
94590522|NCT02834793|323965132|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
94590523|NCT02834793|323965133|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
94590524|NCT02834793|323965134|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
94590525|NCT02834793|323965135|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
94590526|NCT02834793|323965132|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
94590527|NCT02834793|323965133|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
94590528|NCT02834793|323965134|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
94590529|NCT02834793|323965135|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
94590530|NCT02834793|323965132|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
94590531|NCT02834793|323965133|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
94590532|NCT02834793|323965134|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
94590533|NCT02834793|323965135|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
94590534|NCT02834793|323965132|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
94590535|NCT02834793|323965133|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
94590536|NCT02834793|323965134|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
94590537|NCT02834793|323965135|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
94590538|NCT02834793|323965132|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
94590539|NCT02834793|323965133|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
94590540|NCT02834793|323965134|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
94355280|NCT00656669|323083550|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
94355281|NCT00656669|323083550|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
94355282|NCT00656669|323083550|FG000|AC (Cycles 6-9)|Adverse Event|1|||
94590541|NCT02834793|323965135|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
94590542|NCT02834793|323965132|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
94590543|NCT02834793|323965133|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
94590544|NCT02834793|323965134|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
94590545|NCT02834793|323965135|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
94355283|NCT00656669|323083550|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
94355284|NCT00151775|323083562|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
94590546|NCT02834793|323965132|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
94590547|NCT02834793|323965133|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
94590548|NCT02834793|323965134|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
94590549|NCT02834793|323965135|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
94590550|NCT02834793|323965132|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
94590551|NCT02834793|323965133|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
94590552|NCT02834793|323965134|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
94590553|NCT02834793|323965135|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
94590554|NCT02834793|323965132|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
94590555|NCT02834793|323965133|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
94590556|NCT02834793|323965134|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
94590557|NCT02834793|323965135|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
94590558|NCT02834793|323965132|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
94590559|NCT02834793|323965133|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
94590560|NCT02834793|323965134|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
94590561|NCT02834793|323965135|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
94590562|NCT02364336|323965136|FG000|Overall Study|Adverse Event|0|||
94590563|NCT02364336|323965137|FG001|Overall Study|Adverse Event|1|||
94590564|NCT01386970|323965138|FG000|Overall Study|Withdrawal by Subject|0|||
94590565|NCT01386970|323965139|FG001|Overall Study|Withdrawal by Subject|1|||
94590566|NCT01386970|323965138|FG000|Overall Study|Adverse Event|4|||
94590567|NCT01386970|323965139|FG001|Overall Study|Adverse Event|1|||
94590568|NCT01731938|323965140|FG000|Preliminary Part I|Withdrawal by Subject|2|||
94590569|NCT01731938|323965141|FG001|Preliminary Part I|Withdrawal by Subject|2|||
94590570|NCT01731938|323965140|FG000|Preliminary Part I|Physician Decision|1|||
94590571|NCT01731938|323965141|FG001|Preliminary Part I|Physician Decision|0|||
94590572|NCT01731938|323965140|FG000|Preliminary Part I|Lost to Follow-up|0|||
94590573|NCT01731938|323965141|FG001|Preliminary Part I|Lost to Follow-up|3|||
94590574|NCT01731938|323965140|FG000|Preliminary Part I|Missed Week 6 visit|0|||
94590575|NCT01731938|323965141|FG001|Preliminary Part I|Missed Week 6 visit|3|||
94590576|NCT01731938|323965140|FG000|Primary Part II|Withdrawal by Subject|5|||
94590577|NCT01731938|323965141|FG001|Primary Part II|Withdrawal by Subject|4|||
94590578|NCT01731938|323965140|FG000|Primary Part II|Lost to Follow-up|4|||
94590579|NCT01731938|323965141|FG001|Primary Part II|Lost to Follow-up|5|||
94590580|NCT01731938|323965140|FG000|Primary Part II|Death|2|||
94590581|NCT01731938|323965141|FG001|Primary Part II|Death|1|||
94590582|NCT01731938|323965140|FG000|Primary Part II|Missed Week 6 visit|2|||
94590583|NCT01731938|323965141|FG001|Primary Part II|Missed Week 6 visit|3|||
94590584|NCT04931888|323965142|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
94590585|NCT04931888|323965143|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
94590586|NCT04931888|323965144|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
94590587|NCT04931888|323965145|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
94590588|NCT00344487|323965147|FG000|Overall Study|immunologic failure|1|||
94590589|NCT00452361|323965149|FG000|Overall Study|Adverse Event|8|||
94590590|NCT00452361|323965150|FG001|Overall Study|Adverse Event|0|||
94590591|NCT00452361|323965149|FG000|Overall Study|Withdrawal by Subject|0|||
94590592|NCT00452361|323965150|FG001|Overall Study|Withdrawal by Subject|1|||
94590593|NCT00452361|323965149|FG000|Overall Study|Premature termination|13|||
94590594|NCT00452361|323965150|FG001|Overall Study|Premature termination|9|||
94590595|NCT03116152|323965153|FG000|Overall Study|Disease Progression|49|||
94590596|NCT03116152|323965154|FG001|Overall Study|Disease Progression|47|||
94590597|NCT03116152|323965153|FG000|Overall Study|Death|5|||
94590598|NCT03116152|323965154|FG001|Overall Study|Death|2|||
94590599|NCT03116152|323965153|FG000|Overall Study|Adverse Event|21|||
94590600|NCT03116152|323965154|FG001|Overall Study|Adverse Event|7|||
94590601|NCT03116152|323965153|FG000|Overall Study|Protocol Violation|2|||
94590602|NCT03116152|323965154|FG001|Overall Study|Protocol Violation|2|||
94590603|NCT03116152|323965153|FG000|Overall Study|Withdrawal by Subject|0|||
94590604|NCT03116152|323965154|FG001|Overall Study|Withdrawal by Subject|1|||
94590605|NCT03116152|323965153|FG000|Overall Study|Physician Decision|3|||
94590606|NCT03116152|323965154|FG001|Overall Study|Physician Decision|2|||
94590607|NCT03116152|323965153|FG000|Overall Study|other|11|||
94590608|NCT03116152|323965154|FG001|Overall Study|other|34|||
94590609|NCT02791763|323965155|FG000|Overall Study|Protocol Violation|0|||
94590610|NCT02791763|323965156|FG001|Overall Study|Protocol Violation|0|||
94590611|NCT02791763|323965157|FG002|Overall Study|Protocol Violation|1|||
94590612|NCT02791763|323965155|FG000|Overall Study|Withdrawal by Subject|5|||
94590613|NCT02791763|323965156|FG001|Overall Study|Withdrawal by Subject|1|||
94590614|NCT02791763|323965157|FG002|Overall Study|Withdrawal by Subject|0|||
94590615|NCT02791763|323965155|FG000|Overall Study|Physician Decision|0|||
94590616|NCT02791763|323965156|FG001|Overall Study|Physician Decision|1|||
94590617|NCT02791763|323965157|FG002|Overall Study|Physician Decision|0|||
94590618|NCT02791763|323965155|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
94590619|NCT02791763|323965156|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
94590620|NCT02791763|323965157|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
94590621|NCT02791763|323965155|FG000|Overall Study|Cancer event|1|||
94590622|NCT02791763|323965156|FG001|Overall Study|Cancer event|3|||
94590623|NCT02791763|323965157|FG002|Overall Study|Cancer event|0|||
94590624|NCT02791763|323965155|FG000|Overall Study|Participant had renal transplant|3|||
94590625|NCT02791763|323965156|FG001|Overall Study|Participant had renal transplant|0|||
94245283|NCT00379288|322691699|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
94245284|NCT00379288|322691700|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
94245285|NCT00379288|322691701|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
94590626|NCT02791763|323965157|FG002|Overall Study|Participant had renal transplant|0|||
94590627|NCT02791763|323965155|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
94590628|NCT02791763|323965156|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
94590629|NCT02791763|323965157|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
94590630|NCT02791763|323965155|FG000|Overall Study|Adverse Event|12|||
94590631|NCT02791763|323965156|FG001|Overall Study|Adverse Event|13|||
94590632|NCT02791763|323965157|FG002|Overall Study|Adverse Event|7|||
94590633|NCT00910299|323965158|FG000|Overall Study|Withdrawal by Subject|16|||
94659815|NCT00116805|324209956|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
94659816|NCT00116805|324209957|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
94659817|NCT00116805|324209956|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
94659818|NCT00116805|324209957|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
94659819|NCT00116805|324209956|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
94659820|NCT00116805|324209957|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
94659821|NCT00116805|324209956|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
94659822|NCT00116805|324209957|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
94659823|NCT00116805|324209956|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
94659824|NCT00116805|324209957|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
94659825|NCT00116805|324209956|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
94659826|NCT00116805|324209957|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
94590634|NCT00910299|323965159|FG001|Overall Study|Withdrawal by Subject|13|||
94590635|NCT00910299|323965158|FG000|Overall Study|Sponsor Decision|58|||
94590636|NCT00910299|323965159|FG001|Overall Study|Sponsor Decision|60|||
94590637|NCT00910299|323965158|FG000|Overall Study|Didn't receive any study drug|2|||
94590638|NCT00910299|323965159|FG001|Overall Study|Didn't receive any study drug|1|||
94590639|NCT01456897|323965160|FG000|Overall Study|Adverse Event|19|||
94590640|NCT01456897|323965161|FG001|Overall Study|Adverse Event|22|||
94590641|NCT01456897|323965160|FG000|Overall Study|Protocol Violation|3|||
94590642|NCT01456897|323965161|FG001|Overall Study|Protocol Violation|4|||
94590643|NCT01456897|323965160|FG000|Overall Study|Physician Decision|5|||
94590644|NCT01456897|323965161|FG001|Overall Study|Physician Decision|3|||
94590645|NCT01456897|323965160|FG000|Overall Study|Withdrawal by Subject|44|||
94590646|NCT01456897|323965161|FG001|Overall Study|Withdrawal by Subject|17|||
94590647|NCT01456897|323965160|FG000|Overall Study|Lack of Efficacy|4|||
94590648|NCT01456897|323965161|FG001|Overall Study|Lack of Efficacy|11|||
94590649|NCT01798849|323965162|FG000|Overall Study|Physician Decision|0|||
94590650|NCT01798849|323965163|FG001|Overall Study|Physician Decision|0|||
94590651|NCT01798849|323965164|FG002|Overall Study|Physician Decision|1|||
94590652|NCT02032238|323965165|FG000|Overall Study|Lost to Follow-up|2|||
94590653|NCT02032238|323965166|FG001|Overall Study|Lost to Follow-up|0|||
94659827|NCT00116805|324209956|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
94659828|NCT00116805|324209957|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
94590654|NCT00612105|323965167|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
94590655|NCT00612105|323965168|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
94590656|NCT00612105|323965167|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
94590657|NCT00612105|323965168|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
94590658|NCT00612105|323965167|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
94590659|NCT00612105|323965168|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
94590660|NCT00612105|323965167|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
94590661|NCT00612105|323965168|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
94590662|NCT00612105|323965167|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
94590663|NCT00612105|323965168|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
94590664|NCT00612105|323965167|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
94590665|NCT00612105|323965168|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
94590666|NCT00612105|323965167|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
94659829|NCT00116805|324209956|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
94659830|NCT00116805|324209957|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
94590667|NCT00612105|323965168|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
94590668|NCT00612105|323965167|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
94590669|NCT00612105|323965168|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
94590670|NCT00612105|323965167|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
94590671|NCT00612105|323965168|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
94659831|NCT00116805|324209956|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
94659832|NCT00116805|324209957|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
94590672|NCT00612105|323965167|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
94590673|NCT00612105|323965168|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
94659833|NCT00116805|324209956|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
94659834|NCT00116805|324209957|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
94590674|NCT00612105|323965167|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
94590675|NCT00612105|323965168|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
94590676|NCT00612105|323965167|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
94590677|NCT00612105|323965168|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
94590678|NCT02929407|323965172|FG000|Overall Study|Adverse Event|1|||
94590679|NCT00743106|323965174|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
94659835|NCT00116805|324209956|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
94659836|NCT00116805|324209957|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
94245286|NCT00379288|322691698|FG000|Overall Study|Subject withdrew-related to study drug|1|||
94456308|NCT01738503|323458245|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
94456309|NCT01738503|323458246|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
94456310|NCT01738503|323458247|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
94456311|NCT01738503|323458248|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
94456312|NCT05238025|323458249|FG000|Overall Study|Adverse Event|2|||
94456313|NCT05238025|323458250|FG001|Overall Study|Adverse Event|2|||
94456314|NCT05238025|323458249|FG000|Overall Study|Lost to Follow-up|334|||
94456315|NCT05238025|323458250|FG001|Overall Study|Lost to Follow-up|339|||
94456316|NCT05238025|323458249|FG000|Overall Study|Withdrawal by Subject|203|||
94456317|NCT05238025|323458250|FG001|Overall Study|Withdrawal by Subject|222|||
94456318|NCT05238025|323458249|FG000|Overall Study|Physician Decision|20|||
94456319|NCT05238025|323458250|FG001|Overall Study|Physician Decision|8|||
94456320|NCT05238025|323458249|FG000|Overall Study|Protocol Violation|6|||
94456321|NCT05238025|323458250|FG001|Overall Study|Protocol Violation|2|||
94456322|NCT05238025|323458249|FG000|Overall Study|Death|38|||
94456323|NCT05238025|323458250|FG001|Overall Study|Death|32|||
94456324|NCT05238025|323458249|FG000|Overall Study|Study terminated by Sponsor|6358|||
94456325|NCT05238025|323458250|FG001|Overall Study|Study terminated by Sponsor|6358|||
94456326|NCT05238025|323458249|FG000|Overall Study|Other Reason|669|||
94456327|NCT05238025|323458250|FG001|Overall Study|Other Reason|690|||
94456328|NCT03489707|323458253|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
94456329|NCT03489707|323458254|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
94456330|NCT03489707|323458253|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
94456331|NCT03489707|323458254|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
94456332|NCT03626363|323458255|FG000|Overall Study|Protocol Violation|4|||
94456333|NCT03626363|323458256|FG001|Overall Study|Protocol Violation|0|||
94456334|NCT03626363|323458255|FG000|Overall Study|Lost to Follow-up|5|||
94456335|NCT03626363|323458256|FG001|Overall Study|Lost to Follow-up|7|||
94456336|NCT00533702|323458257|FG000|Overall Study|Withdrawal by Subject|3|||
94456337|NCT00533702|323458258|FG001|Overall Study|Withdrawal by Subject|1|||
94456338|NCT00533702|323458257|FG000|Overall Study|Found ineligible after randomization|2|||
94456339|NCT00533702|323458258|FG001|Overall Study|Found ineligible after randomization|1|||
94456340|NCT01817582|323458259|FG000|Overall Study|Withdrawal by Subject|0|||
94456341|NCT01817582|323458260|FG001|Overall Study|Withdrawal by Subject|1|||
94456342|NCT01817582|323458261|FG002|Overall Study|Withdrawal by Subject|0|||
94456343|NCT01817582|323458259|FG000|Overall Study|Participant revealed masked treatment|1|||
94456344|NCT01817582|323458260|FG001|Overall Study|Participant revealed masked treatment|0|||
94456345|NCT01817582|323458261|FG002|Overall Study|Participant revealed masked treatment|0|||
94456346|NCT01817582|323458259|FG000|Overall Study|Randomized but exclusion criteria met|1|||
94456347|NCT01817582|323458260|FG001|Overall Study|Randomized but exclusion criteria met|0|||
94456348|NCT01817582|323458261|FG002|Overall Study|Randomized but exclusion criteria met|0|||
94456349|NCT00199797|323460452|FG000|Overall Study|Progressive Disease|1|||
94456350|NCT00199797|323460452|FG000|Overall Study|Adverse Event|1|||
94456351|NCT00199797|323460452|FG000|Overall Study|Physician Decision|1|||
94456352|NCT01106677|323460459|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
94456353|NCT01106677|323460460|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
94456354|NCT01106677|323460461|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
94456355|NCT01106677|323460462|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
94456356|NCT01106677|323460459|FG000|Core Period: Baseline to Week 26|Death|0|||
94456357|NCT01106677|323460460|FG001|Core Period: Baseline to Week 26|Death|0|||
94456358|NCT01106677|323460461|FG002|Core Period: Baseline to Week 26|Death|1|||
94456359|NCT01106677|323460462|FG003|Core Period: Baseline to Week 26|Death|0|||
94456360|NCT01106677|323460459|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
94456361|NCT01106677|323460460|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
94456362|NCT01106677|323460461|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
94456363|NCT01106677|323460462|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
94456364|NCT01106677|323460459|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
94590680|NCT00743106|323965175|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
94590681|NCT01309282|323965182|FG000|Overall Study|Lost to Follow-up|1|||
94590682|NCT04556383|323965183|FG000|PCP|Lack of Efficacy|28|||
94590683|NCT04556383|323965184|FG001|PCP|Lack of Efficacy|23|||
94590684|NCT04556383|323965185|FG002|PCP|Lack of Efficacy|23|||
94590685|NCT04556383|323965186|FG003|PCP|Lack of Efficacy|0|||
94590686|NCT04556383|323965183|FG000|PCP|Study terminated by sponsor|15|||
94590687|NCT04556383|323965184|FG001|PCP|Study terminated by sponsor|13|||
94590688|NCT04556383|323965185|FG002|PCP|Study terminated by sponsor|16|||
94590689|NCT04556383|323965186|FG003|PCP|Study terminated by sponsor|0|||
94590690|NCT04556383|323965183|FG000|PCP|Withdrawal by Subject|8|||
94590691|NCT04556383|323965184|FG001|PCP|Withdrawal by Subject|6|||
94590692|NCT04556383|323965185|FG002|PCP|Withdrawal by Subject|6|||
94590693|NCT04556383|323965186|FG003|PCP|Withdrawal by Subject|0|||
94590694|NCT04556383|323965183|FG000|PCP|Adverse Event|1|||
94590695|NCT04556383|323965184|FG001|PCP|Adverse Event|7|||
94590696|NCT04556383|323965185|FG002|PCP|Adverse Event|7|||
94590697|NCT04556383|323965186|FG003|PCP|Adverse Event|0|||
94590698|NCT04556383|323965183|FG000|PCP|Other, Not Specified|1|||
94590699|NCT04556383|323965184|FG001|PCP|Other, Not Specified|2|||
94590700|NCT04556383|323965185|FG002|PCP|Other, Not Specified|1|||
94590701|NCT04556383|323965186|FG003|PCP|Other, Not Specified|0|||
94590702|NCT04556383|323965183|FG000|PCP|Protocol Violation|1|||
94590703|NCT04556383|323965184|FG001|PCP|Protocol Violation|0|||
94590704|NCT04556383|323965185|FG002|PCP|Protocol Violation|1|||
94590705|NCT04556383|323965186|FG003|PCP|Protocol Violation|0|||
94590706|NCT04556383|323965183|FG000|PCP|Lost to Follow-up|1|||
94590707|NCT04556383|323965184|FG001|PCP|Lost to Follow-up|0|||
94590708|NCT04556383|323965185|FG002|PCP|Lost to Follow-up|0|||
94590709|NCT04556383|323965186|FG003|PCP|Lost to Follow-up|0|||
94590710|NCT04556383|323965183|FG000|PCP|Physician Decision|0|||
94590711|NCT04556383|323965184|FG001|PCP|Physician Decision|1|||
94590712|NCT04556383|323965185|FG002|PCP|Physician Decision|0|||
94590713|NCT04556383|323965186|FG003|PCP|Physician Decision|0|||
94590714|NCT04556383|323965183|FG000|PCP|Site terminated by sponsor|0|||
94590715|NCT04556383|323965184|FG001|PCP|Site terminated by sponsor|1|||
94590716|NCT04556383|323965185|FG002|PCP|Site terminated by sponsor|0|||
94590717|NCT04556383|323965186|FG003|PCP|Site terminated by sponsor|0|||
94590718|NCT04556383|323965183|FG000|OLE|Study terminated by sponsor|0|||
94590719|NCT04556383|323965184|FG001|OLE|Study terminated by sponsor|0|||
94590720|NCT04556383|323965185|FG002|OLE|Study terminated by sponsor|0|||
94590721|NCT04556383|323965186|FG003|OLE|Study terminated by sponsor|68|||
94590722|NCT04556383|323965183|FG000|OLE|Withdrawal by Subject|0|||
94590723|NCT04556383|323965184|FG001|OLE|Withdrawal by Subject|0|||
94590724|NCT04556383|323965185|FG002|OLE|Withdrawal by Subject|0|||
94590725|NCT04556383|323965186|FG003|OLE|Withdrawal by Subject|10|||
94590726|NCT04556383|323965183|FG000|OLE|Lack of Efficacy|0|||
94590727|NCT04556383|323965184|FG001|OLE|Lack of Efficacy|0|||
94590728|NCT04556383|323965185|FG002|OLE|Lack of Efficacy|0|||
94590729|NCT04556383|323965186|FG003|OLE|Lack of Efficacy|7|||
94590730|NCT04556383|323965183|FG000|OLE|Adverse Event|0|||
94590731|NCT04556383|323965184|FG001|OLE|Adverse Event|0|||
94590732|NCT04556383|323965185|FG002|OLE|Adverse Event|0|||
94590733|NCT04556383|323965186|FG003|OLE|Adverse Event|2|||
94590734|NCT04556383|323965183|FG000|OLE|Other, Not Specified|0|||
94590735|NCT04556383|323965184|FG001|OLE|Other, Not Specified|0|||
94590736|NCT04556383|323965185|FG002|OLE|Other, Not Specified|0|||
94590737|NCT04556383|323965186|FG003|OLE|Other, Not Specified|2|||
94590738|NCT04556383|323965183|FG000|OLE|Death|0|||
94590739|NCT04556383|323965184|FG001|OLE|Death|0|||
94590740|NCT04556383|323965185|FG002|OLE|Death|0|||
94590741|NCT04556383|323965186|FG003|OLE|Death|1|||
94590742|NCT04556383|323965183|FG000|OLE|Lost to Follow-up|0|||
94590743|NCT04556383|323965184|FG001|OLE|Lost to Follow-up|0|||
94590744|NCT04556383|323965185|FG002|OLE|Lost to Follow-up|0|||
94590745|NCT04556383|323965186|FG003|OLE|Lost to Follow-up|1|||
94590746|NCT01387542|323965187|FG000|Overall Study|Adverse Event|3|||
94590747|NCT01387542|323965187|FG000|Overall Study|Withdrawal by Subject|1|||
94590748|NCT01387542|323965187|FG000|Overall Study|Changed diagnosis|1|||
94590749|NCT01387542|323965187|FG000|Overall Study|Insufficient response|1|||
94590750|NCT01387542|323965187|FG000|Overall Study|Non-compliant|1|||
94590751|NCT01387542|323965187|FG000|Overall Study|Lost to Follow-up|1|||
94590752|NCT00509145|323965188|FG000|Overall Study|Death|0|||
94590753|NCT00509145|323965189|FG001|Overall Study|Death|2|||
94590754|NCT00509145|323965188|FG000|Overall Study|Adverse Event|42|||
94590755|NCT00509145|323965189|FG001|Overall Study|Adverse Event|28|||
94590756|NCT00509145|323965188|FG000|Overall Study|Withdrawal by Subject|32|||
94590757|NCT00509145|323965189|FG001|Overall Study|Withdrawal by Subject|38|||
94590758|NCT00509145|323965188|FG000|Overall Study|Physician Decision|11|||
94590759|NCT00509145|323965189|FG001|Overall Study|Physician Decision|14|||
94590760|NCT00509145|323965188|FG000|Overall Study|Protocol Violation|1|||
94590761|NCT00509145|323965189|FG001|Overall Study|Protocol Violation|6|||
94590762|NCT00509145|323965188|FG000|Overall Study|Pregnancy|3|||
94590763|NCT00509145|323965189|FG001|Overall Study|Pregnancy|8|||
94590764|NCT00509145|323965188|FG000|Overall Study|Lost to Follow-up|6|||
94590765|NCT00509145|323965189|FG001|Overall Study|Lost to Follow-up|5|||
94590766|NCT00509145|323965188|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
94590767|NCT00509145|323965189|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
94590768|NCT00509145|323965188|FG000|Overall Study|Other|6|||
94590769|NCT00509145|323965189|FG001|Overall Study|Other|6|||
94590770|NCT02969655|323965191|FG000|Overall Study|Withdrawal by Subject|3|||
94590771|NCT02969655|323965192|FG001|Overall Study|Withdrawal by Subject|2|||
94590772|NCT02969655|323965191|FG000|Overall Study|Physician Decision|4|||
94590773|NCT02969655|323965192|FG001|Overall Study|Physician Decision|3|||
94245287|NCT00379288|322691699|FG001|Overall Study|Subject withdrew-related to study drug|0|||
94590774|NCT02969655|323965191|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
94590775|NCT02969655|323965192|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
94590776|NCT02969655|323965191|FG000|Overall Study|Adverse Event|10|||
94590777|NCT02969655|323965192|FG001|Overall Study|Adverse Event|8|||
94590778|NCT00929643|323965193|FG000|Overall Study|Protocol Violation|2|||
94590779|NCT00934440|323965196|FG000|Overall Study|Lost to Follow-up|1|||
94590780|NCT02445794|323965199|FG000|Overall Study|Adverse Event|0|||
94590781|NCT02445794|323965200|FG001|Overall Study|Adverse Event|0|||
94590782|NCT02445794|323965201|FG002|Overall Study|Adverse Event|2|||
94590783|NCT02445794|323965202|FG003|Overall Study|Adverse Event|0|||
94590784|NCT02873429|323965203|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
94590785|NCT02873429|323965204|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
94590786|NCT02873429|323965203|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
94590787|NCT02873429|323965204|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
94590788|NCT02873429|323965203|FG000|16 Weeks|Lost to Follow-up|3|||
94590789|NCT02873429|323965204|FG001|16 Weeks|Lost to Follow-up|0|||
94590790|NCT00612807|323965206|FG000|Overall Study|Withdrawal by Subject|2|||
94590791|NCT00612807|323965207|FG001|Overall Study|Withdrawal by Subject|0|||
94590792|NCT00145977|323965208|FG000|Overall Study|Lack of Efficacy|0|||
94590793|NCT00145977|323965209|FG001|Overall Study|Lack of Efficacy|4|||
94590794|NCT00145977|323965208|FG000|Overall Study|Lost to Follow-up|1|||
94590795|NCT00145977|323965209|FG001|Overall Study|Lost to Follow-up|0|||
94590796|NCT00145977|323965208|FG000|Overall Study|Withdrawal by Subject|1|||
94590797|NCT00145977|323965209|FG001|Overall Study|Withdrawal by Subject|0|||
94590798|NCT01590758|323965212|FG000|Overall Study|Withdrawal by Subject|0|||
94590799|NCT01590758|323965213|FG001|Overall Study|Withdrawal by Subject|3|||
94590800|NCT01590758|323965212|FG000|Overall Study|Physician Decision|1|||
94590801|NCT01590758|323965213|FG001|Overall Study|Physician Decision|2|||
94590802|NCT01590758|323965212|FG000|Overall Study|Lost to Follow-up|4|||
94590803|NCT01590758|323965213|FG001|Overall Study|Lost to Follow-up|2|||
94590804|NCT00744042|323965214|FG000|Overall Study|Withdrawal by Subject|1|||
94590805|NCT02756806|323965216|FG000|Overall Study|Study terminated early|5|||
94590806|NCT02717832|323965220|FG000|Overall Study|Inability to place IV|3|||
94590807|NCT01215097|323965221|FG000|Overall Study|Adverse Event|1|||
94590808|NCT01215097|323965222|FG001|Overall Study|Adverse Event|3|||
94590809|NCT01215097|323965221|FG000|Overall Study|Protocol Violation|0|||
94590810|NCT01215097|323965222|FG001|Overall Study|Protocol Violation|2|||
94590811|NCT01215097|323965221|FG000|Overall Study|Lost to Follow-up|2|||
94590812|NCT01215097|323965222|FG001|Overall Study|Lost to Follow-up|0|||
94590813|NCT01215097|323965221|FG000|Overall Study|Withdrawal by Subject|6|||
94590814|NCT01215097|323965222|FG001|Overall Study|Withdrawal by Subject|3|||
94590815|NCT01215097|323965221|FG000|Overall Study|Lack of Efficacy|0|||
94590816|NCT01215097|323965222|FG001|Overall Study|Lack of Efficacy|3|||
94590817|NCT01215097|323965221|FG000|Overall Study|patient's refusal to come|2|||
94590818|NCT01215097|323965222|FG001|Overall Study|patient's refusal to come|2|||
94590819|NCT01215097|323965221|FG000|Overall Study|patient's private reason|1|||
94590820|NCT01215097|323965222|FG001|Overall Study|patient's private reason|1|||
94590821|NCT01711216|323965223|FG000|Overall Study|Adverse Event|4|||
94590822|NCT01711216|323965223|FG000|Overall Study|Pregnancy|56|||
94590823|NCT01711216|323965223|FG000|Overall Study|Withdrawal by Subject|6|||
94590824|NCT01711216|323965223|FG000|Overall Study|Lost to Follow-up|46|||
94590825|NCT01711216|323965223|FG000|Overall Study|variety of other minor reasons|83|||
94590826|NCT01711216|323965223|FG000|Overall Study|no reason specified|22|||
94590827|NCT03158285|323965224|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
94245288|NCT00379288|322691700|FG002|Overall Study|Subject withdrew-related to study drug|0|||
94590828|NCT03158285|323965225|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
94590829|NCT03158285|323965226|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
94590830|NCT03158285|323965224|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
94590831|NCT03158285|323965225|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
94590832|NCT03158285|323965226|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
94590833|NCT03158285|323965224|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
94590834|NCT03158285|323965225|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
94590835|NCT03158285|323965226|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
94590836|NCT03158285|323965224|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
94590837|NCT03158285|323965225|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
94590838|NCT03158285|323965226|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
94590839|NCT03158285|323965224|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
94590840|NCT03158285|323965225|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
94590841|NCT03158285|323965226|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
94590842|NCT03158285|323965224|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
94590843|NCT03158285|323965225|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
94590844|NCT03158285|323965226|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
94590845|NCT03158285|323965224|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
94590846|NCT03158285|323965225|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
94590847|NCT03158285|323965226|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
94590848|NCT03158285|323965224|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
94590849|NCT03158285|323965225|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
94590850|NCT03158285|323965226|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
94590851|NCT03158285|323965224|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
94590852|NCT03158285|323965225|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
94590853|NCT03158285|323965226|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
94590854|NCT03158285|323965224|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
94590855|NCT03158285|323965225|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
94590856|NCT03158285|323965226|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
94590857|NCT03158285|323965224|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
94590858|NCT03158285|323965225|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
94590859|NCT03158285|323965226|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
94590860|NCT03158285|323965224|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
94590861|NCT03158285|323965225|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
94590862|NCT03158285|323965226|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
94590863|NCT03158285|323965224|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
94590864|NCT03158285|323965225|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
94590865|NCT03158285|323965226|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
94590866|NCT03158285|323965224|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
94590867|NCT03158285|323965225|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
94590868|NCT03158285|323965226|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
94590869|NCT03158285|323965224|FG000|Active Treatment Period: Week 52-100|Death|1|||
94590870|NCT03158285|323965225|FG001|Active Treatment Period: Week 52-100|Death|0|||
94590871|NCT03158285|323965226|FG002|Active Treatment Period: Week 52-100|Death|0|||
94590872|NCT03158285|323965224|FG000|Active Treatment Period: Week 52-100|Other|4|||
94590873|NCT03158285|323965225|FG001|Active Treatment Period: Week 52-100|Other|1|||
94590874|NCT03158285|323965226|FG002|Active Treatment Period: Week 52-100|Other|0|||
94590875|NCT01516034|323965229|FG000|Overall Study|Physician Decision|1|||
94590876|NCT01516034|323965229|FG000|Overall Study|Lack of Efficacy|7|||
94590877|NCT03060551|323965230|FG000|Overall Study|Withdrawal by Subject|1|||
94590878|NCT03060551|323965230|FG000|Overall Study|Adverse Event|1|||
94590879|NCT01497366|323965231|FG000|Overall Study|Virologic failure|2|||
94590880|NCT01497366|323965232|FG001|Overall Study|Virologic failure|50|||
94590881|NCT01497366|323965231|FG000|Overall Study|Lost to Follow-up|11|||
94590882|NCT01497366|323965232|FG001|Overall Study|Lost to Follow-up|10|||
94590883|NCT01497366|323965231|FG000|Overall Study|Withdrawal by Subject|6|||
94590884|NCT01497366|323965232|FG001|Overall Study|Withdrawal by Subject|6|||
94590885|NCT01497366|323965231|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
94590886|NCT01497366|323965232|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
94590887|NCT01497366|323965231|FG000|Overall Study|Other|5|||
94659837|NCT00116805|324209956|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
94659838|NCT00116805|324209957|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
94245289|NCT00379288|322691701|FG003|Overall Study|Subject withdrew-related to study drug|1|||
94245290|NCT00379288|322691698|FG000|Overall Study|Noncompliance with protocol|8|||
94245291|NCT00379288|322691699|FG001|Overall Study|Noncompliance with protocol|6|||
94590888|NCT01497366|323965232|FG001|Overall Study|Other|0|||
94590889|NCT01497366|323965231|FG000|Overall Study|Death|1|||
94590890|NCT01497366|323965232|FG001|Overall Study|Death|1|||
94590891|NCT01497366|323965231|FG000|Overall Study|Randomized but not treated|7|||
94590892|NCT01497366|323965232|FG001|Overall Study|Randomized but not treated|21|||
94590893|NCT01001325|323965233|FG000|Overall Study|Lost to Follow-up|16|||
94590894|NCT01001325|323965234|FG001|Overall Study|Lost to Follow-up|10|||
94590895|NCT01001325|323965233|FG000|Overall Study|Protocol Violation|2|||
94590896|NCT01001325|323965234|FG001|Overall Study|Protocol Violation|0|||
94590897|NCT01395524|323967292|FG000|Overall Study|Non-compliance with study schedule|1|||
94590898|NCT01395524|323967293|FG001|Overall Study|Non-compliance with study schedule|0|||
94590899|NCT01395524|323967294|FG002|Overall Study|Non-compliance with study schedule|1|||
94590900|NCT01395524|323967292|FG000|Overall Study|Lost to Follow-up|3|||
94590901|NCT01395524|323967293|FG001|Overall Study|Lost to Follow-up|1|||
94590902|NCT01395524|323967294|FG002|Overall Study|Lost to Follow-up|1|||
94590903|NCT01395524|323967292|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
94590904|NCT01395524|323967293|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
94590905|NCT01395524|323967294|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
94590906|NCT01395524|323967292|FG000|Overall Study|Severe noncompliance with protocol|1|||
94590907|NCT01395524|323967293|FG001|Overall Study|Severe noncompliance with protocol|0|||
94590908|NCT01395524|323967294|FG002|Overall Study|Severe noncompliance with protocol|0|||
94590909|NCT01395524|323967292|FG000|Overall Study|Adverse Event|4|||
94590910|NCT01395524|323967293|FG001|Overall Study|Adverse Event|4|||
94590911|NCT01395524|323967294|FG002|Overall Study|Adverse Event|3|||
94590912|NCT01395524|323967292|FG000|Overall Study|Death|1|||
94590913|NCT01395524|323967293|FG001|Overall Study|Death|0|||
94590914|NCT01395524|323967294|FG002|Overall Study|Death|0|||
94590915|NCT01395524|323967292|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
94590916|NCT01395524|323967293|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
94590917|NCT01395524|323967294|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
94590918|NCT01395524|323967292|FG000|Overall Study|Withdrawal by Subject|4|||
94590919|NCT01395524|323967293|FG001|Overall Study|Withdrawal by Subject|8|||
94590920|NCT01395524|323967294|FG002|Overall Study|Withdrawal by Subject|8|||
94355285|NCT00151775|323083563|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
94590921|NCT01395524|323967292|FG000|Overall Study|Did not receive treatment|1|||
94590922|NCT01395524|323967293|FG001|Overall Study|Did not receive treatment|1|||
94590923|NCT01395524|323967294|FG002|Overall Study|Did not receive treatment|3|||
94590924|NCT01395524|323967292|FG000|Overall Study|Subject had spinal surgery|0|||
94590925|NCT01395524|323967293|FG001|Overall Study|Subject had spinal surgery|0|||
94590926|NCT01395524|323967294|FG002|Overall Study|Subject had spinal surgery|1|||
94590927|NCT03751657|323967295|FG000|Overall Study|Physician Decision|0|||
94590928|NCT03751657|323967296|FG001|Overall Study|Physician Decision|1|||
94590929|NCT03751657|323967295|FG000|Overall Study|Withdrawal by Subject|1|||
94590930|NCT03751657|323967296|FG001|Overall Study|Withdrawal by Subject|1|||
94590931|NCT03751657|323967295|FG000|Overall Study|Lost to Follow-up|2|||
94590932|NCT03751657|323967296|FG001|Overall Study|Lost to Follow-up|1|||
94590933|NCT01349049|323967301|FG000|Overall Study|Disease progression|3|||
94590934|NCT01349049|323967302|FG001|Overall Study|Disease progression|5|||
94659839|NCT00116805|324209956|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
94590935|NCT01349049|323967303|FG002|Overall Study|Disease progression|3|||
94590936|NCT01349049|323967304|FG003|Overall Study|Disease progression|2|||
94590937|NCT01349049|323967305|FG004|Overall Study|Disease progression|2|||
94590938|NCT01349049|323967306|FG005|Overall Study|Disease progression|2|||
94590939|NCT01349049|323967307|FG006|Overall Study|Disease progression|3|||
94590940|NCT01349049|323967308|FG007|Overall Study|Disease progression|2|||
94245292|NCT00379288|322691700|FG002|Overall Study|Noncompliance with protocol|2|||
94659840|NCT00116805|324209957|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
94245293|NCT00379288|322691701|FG003|Overall Study|Noncompliance with protocol|1|||
94245294|NCT00379288|322691698|FG000|Overall Study|Did not meet protocol eligibility|0|||
94245295|NCT00379288|322691699|FG001|Overall Study|Did not meet protocol eligibility|1|||
94245296|NCT00379288|322691700|FG002|Overall Study|Did not meet protocol eligibility|0|||
94245297|NCT00379288|322691701|FG003|Overall Study|Did not meet protocol eligibility|2|||
94245298|NCT00379288|322691698|FG000|Overall Study|Administrative|2|||
94245299|NCT00379288|322691699|FG001|Overall Study|Administrative|2|||
94245300|NCT00379288|322691700|FG002|Overall Study|Administrative|0|||
94590941|NCT01349049|323967309|FG008|Overall Study|Disease progression|33|||
94590942|NCT01349049|323967301|FG000|Overall Study|Adverse Event|0|||
94590943|NCT01349049|323967302|FG001|Overall Study|Adverse Event|1|||
94590944|NCT01349049|323967303|FG002|Overall Study|Adverse Event|0|||
94590945|NCT01349049|323967304|FG003|Overall Study|Adverse Event|0|||
94590946|NCT01349049|323967305|FG004|Overall Study|Adverse Event|0|||
94590947|NCT01349049|323967306|FG005|Overall Study|Adverse Event|3|||
94590948|NCT01349049|323967307|FG006|Overall Study|Adverse Event|1|||
94590949|NCT01349049|323967308|FG007|Overall Study|Adverse Event|0|||
94590950|NCT01349049|323967309|FG008|Overall Study|Adverse Event|4|||
94590951|NCT01349049|323967301|FG000|Overall Study|Physician Decision|0|||
94590952|NCT01349049|323967302|FG001|Overall Study|Physician Decision|1|||
94590953|NCT01349049|323967303|FG002|Overall Study|Physician Decision|0|||
94590954|NCT01349049|323967304|FG003|Overall Study|Physician Decision|0|||
94590955|NCT01349049|323967305|FG004|Overall Study|Physician Decision|0|||
94590956|NCT01349049|323967306|FG005|Overall Study|Physician Decision|0|||
94590957|NCT01349049|323967307|FG006|Overall Study|Physician Decision|0|||
94590958|NCT01349049|323967308|FG007|Overall Study|Physician Decision|0|||
94590959|NCT01349049|323967309|FG008|Overall Study|Physician Decision|2|||
94590960|NCT01349049|323967301|FG000|Overall Study|Protocol Violation|0|||
94590961|NCT01349049|323967302|FG001|Overall Study|Protocol Violation|0|||
94590962|NCT01349049|323967303|FG002|Overall Study|Protocol Violation|0|||
94590963|NCT01349049|323967304|FG003|Overall Study|Protocol Violation|0|||
94590964|NCT01349049|323967305|FG004|Overall Study|Protocol Violation|0|||
94590965|NCT01349049|323967306|FG005|Overall Study|Protocol Violation|0|||
94590966|NCT01349049|323967307|FG006|Overall Study|Protocol Violation|0|||
94590967|NCT01349049|323967308|FG007|Overall Study|Protocol Violation|0|||
94590968|NCT01349049|323967309|FG008|Overall Study|Protocol Violation|1|||
94590969|NCT01349049|323967301|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
94590970|NCT01349049|323967302|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
94590971|NCT01349049|323967303|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
94590972|NCT01349049|323967304|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
94590973|NCT01349049|323967305|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
94590974|NCT01349049|323967306|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
94590975|NCT01349049|323967307|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
94245301|NCT00379288|322691701|FG003|Overall Study|Administrative|1|||
94245302|NCT01255631|322691704|FG000|Overall Study|poor enrollment, no data analyzed|9|||
94245303|NCT01255631|322691705|FG001|Overall Study|poor enrollment, no data analyzed|6|||
94245304|NCT01531673|322691713|FG000|Overall Study|Non-Compliance|0|||
94590976|NCT01349049|323967308|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
94590977|NCT01349049|323967309|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
94590978|NCT01349049|323967301|FG000|Overall Study|Other|0|||
94590979|NCT01349049|323967302|FG001|Overall Study|Other|0|||
94590980|NCT01349049|323967303|FG002|Overall Study|Other|0|||
94590981|NCT01349049|323967304|FG003|Overall Study|Other|0|||
94590982|NCT01349049|323967305|FG004|Overall Study|Other|0|||
94590983|NCT01349049|323967306|FG005|Overall Study|Other|1|||
94590984|NCT01349049|323967307|FG006|Overall Study|Other|0|||
94590985|NCT01349049|323967308|FG007|Overall Study|Other|0|||
94590986|NCT01349049|323967309|FG008|Overall Study|Other|4|||
94590987|NCT01349049|323967301|FG000|Overall Study|Death|0|||
94590988|NCT01349049|323967302|FG001|Overall Study|Death|0|||
94590989|NCT01349049|323967303|FG002|Overall Study|Death|0|||
94590990|NCT01349049|323967304|FG003|Overall Study|Death|0|||
94590991|NCT01349049|323967305|FG004|Overall Study|Death|0|||
94590992|NCT01349049|323967306|FG005|Overall Study|Death|0|||
94590993|NCT01349049|323967307|FG006|Overall Study|Death|0|||
94590994|NCT01349049|323967308|FG007|Overall Study|Death|1|||
94590995|NCT01349049|323967309|FG008|Overall Study|Death|5|||
94590996|NCT01349049|323967301|FG000|Overall Study|Non-compliance|0|||
94590997|NCT01349049|323967302|FG001|Overall Study|Non-compliance|0|||
94590998|NCT01349049|323967303|FG002|Overall Study|Non-compliance|0|||
94590999|NCT01349049|323967304|FG003|Overall Study|Non-compliance|1|||
94591000|NCT01349049|323967305|FG004|Overall Study|Non-compliance|0|||
94591001|NCT01349049|323967306|FG005|Overall Study|Non-compliance|0|||
94591002|NCT01349049|323967307|FG006|Overall Study|Non-compliance|0|||
94591003|NCT01349049|323967308|FG007|Overall Study|Non-compliance|0|||
94591004|NCT01349049|323967309|FG008|Overall Study|Non-compliance|0|||
94591005|NCT01349049|323967301|FG000|Overall Study|Withdrawal by Subject|0|||
94591006|NCT01349049|323967302|FG001|Overall Study|Withdrawal by Subject|0|||
94591007|NCT01349049|323967303|FG002|Overall Study|Withdrawal by Subject|0|||
94591008|NCT01349049|323967304|FG003|Overall Study|Withdrawal by Subject|0|||
94591009|NCT01349049|323967305|FG004|Overall Study|Withdrawal by Subject|0|||
94591010|NCT01349049|323967306|FG005|Overall Study|Withdrawal by Subject|0|||
94591011|NCT01349049|323967307|FG006|Overall Study|Withdrawal by Subject|0|||
94591012|NCT01349049|323967308|FG007|Overall Study|Withdrawal by Subject|0|||
94591013|NCT01349049|323967309|FG008|Overall Study|Withdrawal by Subject|6|||
94591014|NCT00724711|323967310|FG000|Overall Study|Adverse Event|7|||
94591015|NCT00724711|323967311|FG001|Overall Study|Adverse Event|3|||
94591016|NCT00724711|323967310|FG000|Overall Study|Pregnancy|0|||
94591017|NCT00724711|323967311|FG001|Overall Study|Pregnancy|1|||
94591018|NCT00724711|323967310|FG000|Overall Study|Lack of Efficacy|0|||
94591019|NCT00724711|323967311|FG001|Overall Study|Lack of Efficacy|1|||
94591020|NCT00724711|323967310|FG000|Overall Study|Physician Decision|0|||
94591021|NCT00724711|323967311|FG001|Overall Study|Physician Decision|3|||
94591022|NCT00724711|323967310|FG000|Overall Study|Withdrawal by Subject|5|||
94591023|NCT00724711|323967311|FG001|Overall Study|Withdrawal by Subject|4|||
94591024|NCT00724711|323967310|FG000|Overall Study|Lost to Follow-up|4|||
94591025|NCT00724711|323967311|FG001|Overall Study|Lost to Follow-up|5|||
94591026|NCT00724711|323967310|FG000|Overall Study|Protocol Violation|1|||
94591027|NCT00724711|323967311|FG001|Overall Study|Protocol Violation|0|||
94456365|NCT01106677|323460460|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
94456366|NCT01106677|323460461|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
94591028|NCT01945710|323967312|FG000|Overall Study|Progressive Disease|5|||
94591029|NCT01945710|323967313|FG001|Overall Study|Progressive Disease|4|||
94591030|NCT01945710|323967314|FG002|Overall Study|Progressive Disease|3|||
94591031|NCT01945710|323967315|FG003|Overall Study|Progressive Disease|2|||
94591032|NCT01945710|323967316|FG004|Overall Study|Progressive Disease|7|||
94591033|NCT01945710|323967317|FG005|Overall Study|Progressive Disease|3|||
94591034|NCT01945710|323967318|FG006|Overall Study|Progressive Disease|19|||
94591035|NCT01945710|323967312|FG000|Overall Study|Adverse Event|0|||
94591036|NCT01945710|323967313|FG001|Overall Study|Adverse Event|1|||
94591037|NCT01945710|323967314|FG002|Overall Study|Adverse Event|0|||
94591038|NCT01945710|323967315|FG003|Overall Study|Adverse Event|0|||
94591039|NCT01945710|323967316|FG004|Overall Study|Adverse Event|0|||
94591040|NCT01945710|323967317|FG005|Overall Study|Adverse Event|0|||
94591041|NCT01945710|323967318|FG006|Overall Study|Adverse Event|0|||
94591042|NCT01945710|323967312|FG000|Overall Study|Other|2|||
94591043|NCT01945710|323967313|FG001|Overall Study|Other|0|||
94591044|NCT01945710|323967314|FG002|Overall Study|Other|3|||
94591045|NCT01945710|323967315|FG003|Overall Study|Other|1|||
94591046|NCT01945710|323967316|FG004|Overall Study|Other|1|||
94591047|NCT01945710|323967317|FG005|Overall Study|Other|0|||
94591048|NCT01945710|323967318|FG006|Overall Study|Other|4|||
94591049|NCT01945710|323967312|FG000|Overall Study|Withdrawal by Subject|0|||
94591050|NCT01945710|323967313|FG001|Overall Study|Withdrawal by Subject|1|||
94591051|NCT01945710|323967314|FG002|Overall Study|Withdrawal by Subject|1|||
94591052|NCT01945710|323967315|FG003|Overall Study|Withdrawal by Subject|0|||
94591053|NCT01945710|323967316|FG004|Overall Study|Withdrawal by Subject|1|||
94591054|NCT01945710|323967317|FG005|Overall Study|Withdrawal by Subject|0|||
94591055|NCT01945710|323967318|FG006|Overall Study|Withdrawal by Subject|0|||
94591056|NCT02730195|323967319|FG000|Overall Study|Withdrawal by Subject|1|||
94591057|NCT02810444|323967320|FG000|Overall Study|Screen Failures|14|||
94591058|NCT02810444|323967320|FG000|Overall Study|Withdrawal by Subject|4|||
94591059|NCT02810444|323967320|FG000|Overall Study|Adverse Event|3|||
94591060|NCT02785770|323967321|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
94591061|NCT02785770|323967322|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
94591062|NCT02785770|323967323|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
94591063|NCT02785770|323967324|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
94591064|NCT02785770|323967321|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
94591065|NCT02785770|323967322|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
94591066|NCT02785770|323967323|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
94591067|NCT02785770|323967324|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
94591068|NCT02785770|323967321|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
94591069|NCT02785770|323967322|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
94591070|NCT02785770|323967323|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
94591071|NCT02785770|323967324|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
94591072|NCT04518995|323967330|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
94591073|NCT04518995|323967331|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
94591074|NCT04518995|323967332|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
94591075|NCT04518995|323967330|FG000|Overall Study|Lack of Efficacy|2|||
94591076|NCT04518995|323967331|FG001|Overall Study|Lack of Efficacy|1|||
94591077|NCT04518995|323967332|FG002|Overall Study|Lack of Efficacy|0|||
94591078|NCT04518995|323967330|FG000|Overall Study|Non-compliance With Study Drug|0|||
94591079|NCT04518995|323967331|FG001|Overall Study|Non-compliance With Study Drug|3|||
94591080|NCT04518995|323967332|FG002|Overall Study|Non-compliance With Study Drug|2|||
94591081|NCT04518995|323967330|FG000|Overall Study|Pregnancy|0|||
94591082|NCT04518995|323967331|FG001|Overall Study|Pregnancy|0|||
94591083|NCT04518995|323967332|FG002|Overall Study|Pregnancy|1|||
94591084|NCT04518995|323967330|FG000|Overall Study|Protocol Violation|2|||
94591085|NCT04518995|323967331|FG001|Overall Study|Protocol Violation|0|||
94591086|NCT04518995|323967332|FG002|Overall Study|Protocol Violation|1|||
94591087|NCT04518995|323967330|FG000|Overall Study|Reason not Specified|4|||
94591088|NCT04518995|323967331|FG001|Overall Study|Reason not Specified|11|||
94591089|NCT04518995|323967332|FG002|Overall Study|Reason not Specified|2|||
94591090|NCT04518995|323967330|FG000|Overall Study|Lost to Follow-up|1|||
94591091|NCT04518995|323967331|FG001|Overall Study|Lost to Follow-up|10|||
94591092|NCT04518995|323967332|FG002|Overall Study|Lost to Follow-up|6|||
94591093|NCT00669409|323967337|FG000|Part 2|Withdrawal by Subject|0|||
94591094|NCT00669409|323967338|FG001|Part 2|Withdrawal by Subject|0|||
94591095|NCT00669409|323967339|FG002|Part 2|Withdrawal by Subject|0|||
94591096|NCT00669409|323967340|FG003|Part 2|Withdrawal by Subject|0|||
94591097|NCT00669409|323967341|FG004|Part 2|Withdrawal by Subject|0|||
94591098|NCT00669409|323967342|FG005|Part 2|Withdrawal by Subject|0|||
94591099|NCT00669409|323967343|FG006|Part 2|Withdrawal by Subject|0|||
94591100|NCT00669409|323967344|FG007|Part 2|Withdrawal by Subject|0|||
94591101|NCT00669409|323967345|FG008|Part 2|Withdrawal by Subject|0|||
94591102|NCT00669409|323967346|FG009|Part 2|Withdrawal by Subject|1|||
94591103|NCT00669409|323967347|FG010|Part 2|Withdrawal by Subject|0|||
94591104|NCT02864862|323967351|FG000|Overall Study|Lost to Follow-up|1|||
94591105|NCT02864862|323967352|FG001|Overall Study|Lost to Follow-up|0|||
94591106|NCT02864862|323967353|FG002|Overall Study|Lost to Follow-up|1|||
94591107|NCT02864862|323967351|FG000|Overall Study|Protocol Violation|0|||
94591108|NCT02864862|323967352|FG001|Overall Study|Protocol Violation|0|||
94591109|NCT02864862|323967353|FG002|Overall Study|Protocol Violation|1|||
94591110|NCT03830892|323967354|FG000|Overall Study|Physician Decision|2|||
94591111|NCT03830892|323967355|FG001|Overall Study|Physician Decision|3|||
94245305|NCT01531673|322691714|FG001|Overall Study|Non-Compliance|0|||
94591112|NCT03830892|323967354|FG000|Overall Study|Study terminated due to COVID|4|||
94591113|NCT03830892|323967355|FG001|Overall Study|Study terminated due to COVID|0|||
94245306|NCT01531673|322691715|FG002|Overall Study|Non-Compliance|0|||
94456367|NCT01106677|323460462|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
94456368|NCT01106677|323460459|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
94456369|NCT01106677|323460460|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
94456370|NCT01106677|323460461|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
94456371|NCT01106677|323460462|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
94456372|NCT01106677|323460459|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
94456373|NCT01106677|323460460|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
94456374|NCT01106677|323460461|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
94456375|NCT01106677|323460462|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
94456376|NCT01106677|323460459|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
94456377|NCT01106677|323460460|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
94456378|NCT01106677|323460461|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
94456379|NCT01106677|323460462|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
94456380|NCT01106677|323460459|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
94456381|NCT01106677|323460460|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
94456382|NCT01106677|323460461|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
94456383|NCT01106677|323460462|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
94456384|NCT01106677|323460459|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
94456385|NCT01106677|323460460|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
94456386|NCT01106677|323460461|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
94456387|NCT01106677|323460462|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
94456388|NCT01106677|323460459|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
94456389|NCT01106677|323460460|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
94456390|NCT01106677|323460461|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
94456391|NCT01106677|323460462|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
94456392|NCT01106677|323460459|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
94456393|NCT01106677|323460460|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
94456394|NCT01106677|323460461|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
94456395|NCT01106677|323460462|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
94456396|NCT01106677|323460459|FG000|Core Period: Baseline to Week 26|Other|8|||
94456397|NCT01106677|323460460|FG001|Core Period: Baseline to Week 26|Other|14|||
94456398|NCT01106677|323460461|FG002|Core Period: Baseline to Week 26|Other|8|||
94456399|NCT01106677|323460462|FG003|Core Period: Baseline to Week 26|Other|23|||
94456400|NCT01106677|323460459|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
94456401|NCT01106677|323460460|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
94456402|NCT01106677|323460461|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
94456403|NCT01106677|323460462|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
94456404|NCT01106677|323460459|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
94456405|NCT01106677|323460460|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
94456406|NCT01106677|323460461|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
94456407|NCT01106677|323460462|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
94456408|NCT01106677|323460459|FG000|Extension Period: Week 26 to Week 52|Death|0|||
94456409|NCT01106677|323460460|FG001|Extension Period: Week 26 to Week 52|Death|0|||
94456410|NCT01106677|323460461|FG002|Extension Period: Week 26 to Week 52|Death|0|||
94456411|NCT01106677|323460462|FG003|Extension Period: Week 26 to Week 52|Death|1|||
94456412|NCT01106677|323460459|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
94456413|NCT01106677|323460460|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
94456414|NCT01106677|323460461|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
94456415|NCT01106677|323460462|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
94456416|NCT01106677|323460459|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
94456417|NCT01106677|323460460|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
94456418|NCT01106677|323460461|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
94456419|NCT01106677|323460462|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
94456420|NCT01106677|323460459|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
94456421|NCT01106677|323460460|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
94456422|NCT01106677|323460461|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
94456423|NCT01106677|323460462|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
94456424|NCT01106677|323460459|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
94456425|NCT01106677|323460460|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
94591114|NCT03830892|323967354|FG000|Overall Study|Protocol Violation|0|||
94591115|NCT03830892|323967355|FG001|Overall Study|Protocol Violation|1|||
94591116|NCT03830892|323967354|FG000|Overall Study|Withdrawal by Subject|0|||
94591117|NCT03830892|323967355|FG001|Overall Study|Withdrawal by Subject|2|||
94591118|NCT00080899|323967357|FG000|Overall Study|Adverse Event|1|||
94591119|NCT00865280|323967358|FG000|Overall Study|Withdrawal by Subject|4|||
94591120|NCT00865280|323967359|FG001|Overall Study|Withdrawal by Subject|1|||
94591121|NCT00865280|323967358|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
94591122|NCT00865280|323967359|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
94591123|NCT00865280|323967358|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
94591124|NCT00865280|323967359|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
94591125|NCT00865280|323967358|FG000|Overall Study|Exclusion Condition|1|||
94591126|NCT00865280|323967359|FG001|Overall Study|Exclusion Condition|0|||
94591127|NCT00865280|323967358|FG000|Overall Study|Adverse Event|0|||
94591128|NCT00865280|323967359|FG001|Overall Study|Adverse Event|1|||
94591129|NCT02379637|323967361|FG000|Overall Study|Protocol Violation|0|||
94591130|NCT02379637|323967362|FG001|Overall Study|Protocol Violation|1|||
94591131|NCT02379637|323967361|FG000|Overall Study|Adverse Event|1|||
94591132|NCT02379637|323967362|FG001|Overall Study|Adverse Event|0|||
94591133|NCT02379637|323967361|FG000|Overall Study|Withdrawal by Subject|1|||
94591134|NCT02379637|323967362|FG001|Overall Study|Withdrawal by Subject|0|||
94591135|NCT02259088|323967366|FG000|Overall Study|Adverse Event|6|||
94591136|NCT02259088|323967367|FG001|Overall Study|Adverse Event|4|||
94591137|NCT02259088|323967366|FG000|Overall Study|Lost to Follow-up|2|||
94591138|NCT02259088|323967367|FG001|Overall Study|Lost to Follow-up|0|||
94591139|NCT02259088|323967366|FG000|Overall Study|Death|2|||
94591140|NCT02259088|323967367|FG001|Overall Study|Death|0|||
94591141|NCT02259088|323967366|FG000|Overall Study|Physician Decision|5|||
94591142|NCT02259088|323967367|FG001|Overall Study|Physician Decision|2|||
94591143|NCT02259088|323967366|FG000|Overall Study|Protocol deviation|5|||
94591144|NCT02259088|323967367|FG001|Overall Study|Protocol deviation|0|||
94591145|NCT02259088|323967366|FG000|Overall Study|Subject/guardian decision|8|||
94591146|NCT02259088|323967367|FG001|Overall Study|Subject/guardian decision|8|||
94591147|NCT01818752|323967369|FG000|Overall Study|Adverse Event|64|||
94591148|NCT01818752|323967370|FG001|Overall Study|Adverse Event|74|||
94245307|NCT01531673|322691716|FG003|Overall Study|Non-Compliance|0|||
94591149|NCT01818752|323967369|FG000|Overall Study|Death|14|||
94591150|NCT01818752|323967370|FG001|Overall Study|Death|18|||
94591151|NCT01818752|323967369|FG000|Overall Study|Non-compliance|16|||
94591152|NCT01818752|323967370|FG001|Overall Study|Non-compliance|20|||
94245308|NCT01531673|322691717|FG004|Overall Study|Non-Compliance|0|||
94245309|NCT01531673|322691718|FG005|Overall Study|Non-Compliance|1|||
94591153|NCT01818752|323967369|FG000|Overall Study|Withdrawal by Subject|15|||
94591154|NCT01818752|323967370|FG001|Overall Study|Withdrawal by Subject|14|||
94591155|NCT01818752|323967369|FG000|Overall Study|Physician Decision|9|||
94591156|NCT01818752|323967370|FG001|Overall Study|Physician Decision|8|||
94591157|NCT01818752|323967369|FG000|Overall Study|Disease Progression|54|||
94591158|NCT01818752|323967370|FG001|Overall Study|Disease Progression|48|||
94591159|NCT01818752|323967369|FG000|Overall Study|Other|7|||
94591160|NCT01818752|323967370|FG001|Overall Study|Other|8|||
94591161|NCT01818752|323967369|FG000|Overall Study|Continuing Treatment|1|||
94591162|NCT01818752|323967370|FG001|Overall Study|Continuing Treatment|4|||
94245310|NCT01531673|322691719|FG006|Overall Study|Non-Compliance|0|||
94245311|NCT01531673|322691720|FG007|Overall Study|Non-Compliance|0|||
94245312|NCT01531673|322691721|FG008|Overall Study|Non-Compliance|0|||
94245313|NCT01531673|322691722|FG009|Overall Study|Non-Compliance|0|||
94245314|NCT01531673|322691723|FG010|Overall Study|Non-Compliance|0|||
94245315|NCT01531673|322691724|FG011|Overall Study|Non-Compliance|0|||
94245316|NCT01531673|322691725|FG012|Overall Study|Non-Compliance|0|||
94245317|NCT01531673|322691713|FG000|Overall Study|Adverse Event|0|||
94245318|NCT01531673|322691714|FG001|Overall Study|Adverse Event|1|||
94245319|NCT01531673|322691715|FG002|Overall Study|Adverse Event|0|||
94245320|NCT01531673|322691716|FG003|Overall Study|Adverse Event|0|||
94355286|NCT00151775|323083564|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
94591163|NCT01818752|323967369|FG000|Overall Study|Randomized but not Dosed|7|||
94591164|NCT01818752|323967370|FG001|Overall Study|Randomized but not Dosed|4|||
94591165|NCT01033448|323967371|FG000|Overall Study|Withdrawal by Subject|4|||
94591166|NCT01033448|323967371|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
94591167|NCT01033448|323967371|FG000|Overall Study|Lost to Follow-up|3|||
94591168|NCT01033448|323967371|FG000|Overall Study|Withdrew due to other reasons|3|||
94591169|NCT01033448|323967371|FG000|Overall Study|Unknown disposition|1|||
94591170|NCT02228980|323967372|FG000|Overall Study|Adverse Event|14|||
94591171|NCT02228980|323967373|FG001|Overall Study|Adverse Event|0|||
94591172|NCT02228980|323967374|FG002|Overall Study|Adverse Event|0|||
94591173|NCT02228980|323967375|FG003|Overall Study|Adverse Event|0|||
94591174|NCT02228980|323967372|FG000|Overall Study|Protocol Violation|7|||
94591175|NCT02228980|323967373|FG001|Overall Study|Protocol Violation|0|||
94591176|NCT02228980|323967374|FG002|Overall Study|Protocol Violation|0|||
94591177|NCT02228980|323967375|FG003|Overall Study|Protocol Violation|0|||
94591178|NCT02228980|323967372|FG000|Overall Study|Withdrawal by Subject|3|||
94591179|NCT02228980|323967373|FG001|Overall Study|Withdrawal by Subject|3|||
94591180|NCT02228980|323967374|FG002|Overall Study|Withdrawal by Subject|2|||
94591181|NCT02228980|323967375|FG003|Overall Study|Withdrawal by Subject|3|||
94591182|NCT01324141|323967376|FG000|Overall Study|Declined to participate before treatment started|1|||
94591183|NCT01324141|323967376|FG000|Overall Study|Disease progression on study|1|||
94591184|NCT02744040|323967379|FG000|Overall Study|Withdrawal by Subject|3|||
94591185|NCT02744040|323967380|FG001|Overall Study|Withdrawal by Subject|2|||
94591186|NCT02744040|323967381|FG002|Overall Study|Withdrawal by Subject|2|||
94591187|NCT02744040|323967379|FG000|Overall Study|Physician Decision|0|||
94355287|NCT00151775|323083565|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
94591188|NCT02744040|323967380|FG001|Overall Study|Physician Decision|8|||
94591189|NCT02744040|323967381|FG002|Overall Study|Physician Decision|13|||
94245321|NCT01531673|322691717|FG004|Overall Study|Adverse Event|0|||
94245322|NCT01531673|322691718|FG005|Overall Study|Adverse Event|0|||
94245323|NCT01531673|322691719|FG006|Overall Study|Adverse Event|0|||
94456426|NCT01106677|323460461|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
94456427|NCT01106677|323460462|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
94456428|NCT01106677|323460459|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
94355288|NCT00151775|323083566|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
94355289|NCT00151775|323083567|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
94355290|NCT00151775|323083568|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
94355291|NCT00151775|323083569|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
94355292|NCT00151775|323083570|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
94355293|NCT00151775|323083571|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
94355294|NCT00151775|323083572|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
94355295|NCT00151775|323083573|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
94355296|NCT00151775|323083562|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
94355297|NCT00151775|323083563|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
94591190|NCT02744040|323967379|FG000|Overall Study|Lost to Follow-up|3|||
94355298|NCT00151775|323083564|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
94591191|NCT02744040|323967380|FG001|Overall Study|Lost to Follow-up|1|||
94591192|NCT02744040|323967381|FG002|Overall Study|Lost to Follow-up|7|||
94591193|NCT00750152|323967382|FG000|Overall Study|Adverse Event|2|||
94591194|NCT00750152|323967383|FG001|Overall Study|Adverse Event|1|||
94591195|NCT00750152|323967382|FG000|Overall Study|Lost to Follow-up|8|||
94591196|NCT00750152|323967383|FG001|Overall Study|Lost to Follow-up|13|||
94591197|NCT00750152|323967382|FG000|Overall Study|Withdrawal by Subject|3|||
94591198|NCT00750152|323967383|FG001|Overall Study|Withdrawal by Subject|3|||
94591199|NCT00750152|323967382|FG000|Overall Study|Physician Decision|1|||
94591200|NCT00750152|323967383|FG001|Overall Study|Physician Decision|1|||
94591201|NCT00750152|323967382|FG000|Overall Study|Non-compliance|0|||
94591202|NCT00750152|323967383|FG001|Overall Study|Non-compliance|1|||
94591203|NCT00750152|323967382|FG000|Overall Study|Termination by sponsor|1|||
94591204|NCT00750152|323967383|FG001|Overall Study|Termination by sponsor|0|||
94591205|NCT00750152|323967382|FG000|Overall Study|Other|7|||
94591206|NCT00750152|323967383|FG001|Overall Study|Other|8|||
94591207|NCT01008423|323967387|FG000|Overall Study|Adverse Event|13|||
94591208|NCT01008423|323967388|FG001|Overall Study|Adverse Event|6|||
94591209|NCT01008423|323967387|FG000|Overall Study|Withdrawal by Subject|4|||
94591210|NCT01008423|323967388|FG001|Overall Study|Withdrawal by Subject|7|||
94591211|NCT01008423|323967387|FG000|Overall Study|Lost to Follow-up|0|||
94591212|NCT01008423|323967388|FG001|Overall Study|Lost to Follow-up|2|||
94591213|NCT01008423|323967387|FG000|Overall Study|Low Cortisol|0|||
94591214|NCT01008423|323967388|FG001|Overall Study|Low Cortisol|1|||
94591215|NCT01008423|323967387|FG000|Overall Study|Lack of Efficacy|0|||
94591216|NCT01008423|323967388|FG001|Overall Study|Lack of Efficacy|5|||
94591217|NCT01008423|323967387|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
94591218|NCT01008423|323967388|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
94591219|NCT01008423|323967387|FG000|Overall Study|Personal Conflict|1|||
94591220|NCT01008423|323967388|FG001|Overall Study|Personal Conflict|0|||
94591221|NCT01008423|323967387|FG000|Overall Study|Other|0|||
94591222|NCT01008423|323967388|FG001|Overall Study|Other|1|||
94591223|NCT00439738|323967394|FG000|Overall Study|Withdrawal by Subject|16|||
94245324|NCT01531673|322691720|FG007|Overall Study|Adverse Event|0|||
94245325|NCT01531673|322691721|FG008|Overall Study|Adverse Event|0|||
94245326|NCT01531673|322691722|FG009|Overall Study|Adverse Event|0|||
94245327|NCT01531673|322691723|FG010|Overall Study|Adverse Event|0|||
94245328|NCT01531673|322691724|FG011|Overall Study|Adverse Event|0|||
94245329|NCT01531673|322691725|FG012|Overall Study|Adverse Event|0|||
94245330|NCT01531673|322691713|FG000|Overall Study|Lost to Follow-up|0|||
94245331|NCT01531673|322691714|FG001|Overall Study|Lost to Follow-up|0|||
94245332|NCT01531673|322691715|FG002|Overall Study|Lost to Follow-up|0|||
94245333|NCT01531673|322691716|FG003|Overall Study|Lost to Follow-up|0|||
94245334|NCT01531673|322691717|FG004|Overall Study|Lost to Follow-up|1|||
94245335|NCT01531673|322691718|FG005|Overall Study|Lost to Follow-up|0|||
94245336|NCT01531673|322691719|FG006|Overall Study|Lost to Follow-up|0|||
94245337|NCT01531673|322691720|FG007|Overall Study|Lost to Follow-up|0|||
94245338|NCT01531673|322691721|FG008|Overall Study|Lost to Follow-up|0|||
94245339|NCT01531673|322691722|FG009|Overall Study|Lost to Follow-up|0|||
94245340|NCT01531673|322691723|FG010|Overall Study|Lost to Follow-up|0|||
94245341|NCT01531673|322691724|FG011|Overall Study|Lost to Follow-up|0|||
94245342|NCT01531673|322691725|FG012|Overall Study|Lost to Follow-up|0|||
94456429|NCT01106677|323460460|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
94245343|NCT01531673|322691713|FG000|Overall Study|Other|0|||
94245344|NCT01531673|322691714|FG001|Overall Study|Other|0|||
94245345|NCT01531673|322691715|FG002|Overall Study|Other|0|||
94245346|NCT01531673|322691716|FG003|Overall Study|Other|1|||
94245347|NCT01531673|322691717|FG004|Overall Study|Other|0|||
94245348|NCT01531673|322691718|FG005|Overall Study|Other|0|||
94245349|NCT01531673|322691719|FG006|Overall Study|Other|0|||
94245350|NCT01531673|322691720|FG007|Overall Study|Other|0|||
94245351|NCT01531673|322691721|FG008|Overall Study|Other|0|||
94245352|NCT01531673|322691722|FG009|Overall Study|Other|1|||
94245353|NCT01531673|322691723|FG010|Overall Study|Other|0|||
94245354|NCT01531673|322691724|FG011|Overall Study|Other|0|||
94245355|NCT01531673|322691725|FG012|Overall Study|Other|0|||
94245356|NCT00264303|322691726|FG000|Overall Study|Adverse Event|4|||
94245357|NCT00264303|322691727|FG001|Overall Study|Adverse Event|3|||
94245358|NCT00264303|322691726|FG000|Overall Study|Lack of Efficacy|10|||
94245359|NCT00264303|322691727|FG001|Overall Study|Lack of Efficacy|13|||
94245360|NCT00264303|322691726|FG000|Overall Study|Lost to Follow-up|3|||
94245361|NCT00264303|322691727|FG001|Overall Study|Lost to Follow-up|3|||
94245362|NCT00264303|322691726|FG000|Overall Study|Withdrawal by Subject|2|||
94456430|NCT01106677|323460461|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
94456431|NCT01106677|323460462|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
94456432|NCT01106677|323460459|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
94456433|NCT01106677|323460460|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
94456434|NCT01106677|323460461|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
94456435|NCT01106677|323460462|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
94456436|NCT01106677|323460459|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
94456437|NCT01106677|323460460|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
94456438|NCT01106677|323460461|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
94659841|NCT00116805|324209956|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
94659842|NCT00116805|324209957|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
94245363|NCT00264303|322691727|FG001|Overall Study|Withdrawal by Subject|3|||
94245364|NCT00264303|322691726|FG000|Overall Study|Various reasons listed in study report|6|||
94245365|NCT00264303|322691727|FG001|Overall Study|Various reasons listed in study report|7|||
94245366|NCT02389452|322691728|FG000|Overall Study|Lost to Follow-up|13|||
94245367|NCT02389452|322691728|FG000|Overall Study|Adverse Event|1|||
94245368|NCT02389452|322691728|FG000|Overall Study|Withdrawal by Subject|5|||
94245369|NCT02389452|322691728|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
94245370|NCT02304705|322691729|FG000|Overall Study|Withdrawal by Subject|2|||
94456439|NCT01106677|323460462|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
94245371|NCT02304705|322691730|FG001|Overall Study|Withdrawal by Subject|0|||
94659843|NCT00116805|324209956|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
94659844|NCT00116805|324209957|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
94245372|NCT02304705|322691729|FG000|Overall Study|Physician Decision|2|||
94245373|NCT02304705|322691730|FG001|Overall Study|Physician Decision|4|||
94245374|NCT02304705|322691729|FG000|Overall Study|Death|0|||
94591224|NCT00439738|323967395|FG001|Overall Study|Withdrawal by Subject|13|||
94591225|NCT00439738|323967394|FG000|Overall Study|Adverse Event|6|||
94591226|NCT00439738|323967395|FG001|Overall Study|Adverse Event|4|||
94591227|NCT00439738|323967394|FG000|Overall Study|Lost to Follow-up|5|||
94591228|NCT00439738|323967395|FG001|Overall Study|Lost to Follow-up|6|||
94591229|NCT00439738|323967394|FG000|Overall Study|Protocol Violation|6|||
94591230|NCT00439738|323967395|FG001|Overall Study|Protocol Violation|3|||
94591231|NCT00439738|323967394|FG000|Overall Study|Lack of Efficacy|2|||
94456440|NCT01106677|323460459|FG000|Extension Period: Week 26 to Week 52|Other|6|||
94591232|NCT00439738|323967395|FG001|Overall Study|Lack of Efficacy|2|||
94591233|NCT00439738|323967394|FG000|Overall Study|Abnormal Lab Values|1|||
94456441|NCT01106677|323460460|FG001|Extension Period: Week 26 to Week 52|Other|5|||
94456442|NCT01106677|323460461|FG002|Extension Period: Week 26 to Week 52|Other|8|||
94456443|NCT01106677|323460462|FG003|Extension Period: Week 26 to Week 52|Other|5|||
94355299|NCT00151775|323083565|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
94355300|NCT00151775|323083566|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
94355301|NCT00151775|323083567|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
94355302|NCT00151775|323083568|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
94355303|NCT00151775|323083569|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
94355304|NCT00151775|323083570|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
94355305|NCT00151775|323083571|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
94355306|NCT00151775|323083572|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
94355307|NCT00151775|323083573|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
94355308|NCT00151775|323083562|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
94355309|NCT00151775|323083563|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
94355310|NCT00151775|323083564|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
94355311|NCT00151775|323083565|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
94355312|NCT00151775|323083566|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
94355313|NCT00151775|323083567|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
94355314|NCT00151775|323083568|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
94355315|NCT00151775|323083569|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
94355316|NCT00151775|323083570|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
94355317|NCT00151775|323083571|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
94355318|NCT00151775|323083572|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
94355319|NCT00151775|323083573|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
94355320|NCT00151775|323083562|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
94355321|NCT00151775|323083563|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
94355322|NCT00151775|323083564|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
94355323|NCT00151775|323083565|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
94355324|NCT00151775|323083566|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
94355325|NCT00151775|323083567|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
94355326|NCT00151775|323083568|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
94355327|NCT00151775|323083569|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
94355328|NCT00151775|323083570|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
94355329|NCT00151775|323083571|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
94355330|NCT00151775|323083572|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
94355331|NCT00151775|323083573|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
94355332|NCT00151775|323083562|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
94355333|NCT00151775|323083563|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
94355334|NCT00151775|323083564|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
94355335|NCT00151775|323083565|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
94355336|NCT00151775|323083566|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
94355337|NCT00151775|323083567|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
94355338|NCT00151775|323083568|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
94355339|NCT00151775|323083569|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
94355340|NCT00151775|323083570|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
94355341|NCT00151775|323083571|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
94355342|NCT00151775|323083572|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
94355343|NCT00151775|323083573|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
94355344|NCT00151775|323083562|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
94355345|NCT00151775|323083563|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
94355346|NCT00151775|323083564|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
94355347|NCT00151775|323083565|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
94591234|NCT00439738|323967395|FG001|Overall Study|Abnormal Lab Values|0|||
94591235|NCT03288142|323967401|FG000|Overall Study|Lost to Follow-up|22|||
94591236|NCT03288142|323967402|FG001|Overall Study|Lost to Follow-up|15|||
94591237|NCT01584440|323967405|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
94591238|NCT01584440|323967406|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
94591239|NCT01584440|323967407|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
94591240|NCT01584440|323967408|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
94591241|NCT01584440|323967409|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
94591242|NCT01584440|323967405|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
94591243|NCT01584440|323967406|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
94591244|NCT01584440|323967407|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
94591245|NCT01584440|323967408|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
94591246|NCT01584440|323967409|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
94591247|NCT01584440|323967405|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
94591248|NCT01584440|323967406|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
94591249|NCT01584440|323967407|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
94591250|NCT01584440|323967408|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
94591251|NCT01584440|323967409|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
94591252|NCT01584440|323967405|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
94591253|NCT01584440|323967406|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
94591254|NCT01584440|323967407|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
94591255|NCT01584440|323967408|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
94591256|NCT01584440|323967409|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
94591257|NCT01584440|323967405|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
94591258|NCT01584440|323967406|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
94591259|NCT01584440|323967407|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
94591260|NCT01584440|323967408|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
94591261|NCT01584440|323967409|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
94591262|NCT01584440|323967405|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
94591263|NCT01584440|323967406|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
94591264|NCT01584440|323967407|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
94591265|NCT01584440|323967408|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
94591266|NCT01584440|323967409|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
94591267|NCT01584440|323967405|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
94591268|NCT01584440|323967406|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
94591269|NCT01584440|323967407|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
94591270|NCT01584440|323967408|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
94591271|NCT01584440|323967409|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
94591272|NCT01584440|323967405|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
94591273|NCT01584440|323967406|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
94591274|NCT01584440|323967407|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
94591275|NCT01584440|323967408|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
94591276|NCT01584440|323967409|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
94591277|NCT01584440|323967405|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
94591278|NCT01584440|323967406|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
94591279|NCT01584440|323967407|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
94591280|NCT01584440|323967408|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
94591281|NCT01584440|323967409|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
94659845|NCT00116805|324209956|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
94591282|NCT01338298|323967412|FG000|Overall Study|Withdrawal by Subject|1|||
94591283|NCT01338298|323967413|FG001|Overall Study|Withdrawal by Subject|1|||
94591284|NCT01338298|323967412|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
94591285|NCT01338298|323967413|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
94591286|NCT01338298|323967412|FG000|Overall Study|Administrative error|0|||
94591287|NCT01338298|323967413|FG001|Overall Study|Administrative error|1|||
94591288|NCT01338298|323967412|FG000|Overall Study|Positive symptom worsening|1|||
94591289|NCT01338298|323967413|FG001|Overall Study|Positive symptom worsening|0|||
94591290|NCT01338298|323967412|FG000|Overall Study|Depressive symptoms and nausea|1|||
94591291|NCT01338298|323967413|FG001|Overall Study|Depressive symptoms and nausea|0|||
94591292|NCT01338298|323967412|FG000|Overall Study|Non-adherence|1|||
94591293|NCT01338298|323967413|FG001|Overall Study|Non-adherence|0|||
94591294|NCT00557856|323967417|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
94591295|NCT00557856|323967418|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
94591296|NCT00557856|323967419|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
94591297|NCT00557856|323967420|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
94591298|NCT00557856|323967421|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
94591299|NCT00557856|323967422|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
94591300|NCT00557856|323967423|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
94591301|NCT00557856|323967424|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
94591302|NCT00557856|323967425|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
94591303|NCT00557856|323967417|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
94591304|NCT00557856|323967418|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
94591305|NCT00557856|323967419|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
94591306|NCT00557856|323967420|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
94591307|NCT00557856|323967421|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
94591308|NCT00557856|323967422|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
94591309|NCT00557856|323967423|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
94591310|NCT00557856|323967424|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
94591311|NCT00557856|323967425|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
94591312|NCT00557856|323967417|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
94591313|NCT00557856|323967418|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
94591314|NCT00557856|323967419|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
94591315|NCT00557856|323967420|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
94591316|NCT00557856|323967421|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
94591317|NCT00557856|323967422|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
94591318|NCT00557856|323967423|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
94591319|NCT00557856|323967424|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
94591320|NCT00557856|323967425|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
94591321|NCT00557856|323967417|FG000|Part 1: Dose Escalation Phase|Other|0|||
94591322|NCT00557856|323967418|FG001|Part 1: Dose Escalation Phase|Other|0|||
94591323|NCT00557856|323967419|FG002|Part 1: Dose Escalation Phase|Other|1|||
94591324|NCT00557856|323967420|FG003|Part 1: Dose Escalation Phase|Other|1|||
94591325|NCT00557856|323967421|FG004|Part 1: Dose Escalation Phase|Other|0|||
94591326|NCT00557856|323967422|FG005|Part 1: Dose Escalation Phase|Other|0|||
94591327|NCT00557856|323967423|FG006|Part 1: Dose Escalation Phase|Other|0|||
94591328|NCT00557856|323967424|FG007|Part 1: Dose Escalation Phase|Other|1|||
94591329|NCT00557856|323967425|FG008|Part 1: Dose Escalation Phase|Other|0|||
94591330|NCT00557856|323967417|FG000|Part 1: Dose Escalation Phase|Death|0|||
94591331|NCT00557856|323967418|FG001|Part 1: Dose Escalation Phase|Death|0|||
94591332|NCT00557856|323967419|FG002|Part 1: Dose Escalation Phase|Death|0|||
94591333|NCT00557856|323967420|FG003|Part 1: Dose Escalation Phase|Death|0|||
94591334|NCT00557856|323967421|FG004|Part 1: Dose Escalation Phase|Death|0|||
94591335|NCT00557856|323967422|FG005|Part 1: Dose Escalation Phase|Death|1|||
94591336|NCT00557856|323967423|FG006|Part 1: Dose Escalation Phase|Death|0|||
94591337|NCT00557856|323967424|FG007|Part 1: Dose Escalation Phase|Death|0|||
94591338|NCT00557856|323967425|FG008|Part 1: Dose Escalation Phase|Death|0|||
94591339|NCT00557856|323967417|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
94591340|NCT00557856|323967418|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
94591341|NCT00557856|323967419|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
94591342|NCT00557856|323967420|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
94591343|NCT00557856|323967421|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
94591344|NCT00557856|323967422|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
94591345|NCT00557856|323967423|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
94591346|NCT00557856|323967424|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
94591347|NCT00557856|323967425|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
94591348|NCT00557856|323967417|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
94591349|NCT00557856|323967418|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
94591350|NCT00557856|323967419|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
94591351|NCT00557856|323967420|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
94591352|NCT00557856|323967421|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
94591353|NCT00557856|323967422|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
94591354|NCT00557856|323967423|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
94591355|NCT00557856|323967424|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
94591356|NCT00557856|323967425|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
94591357|NCT00557856|323967417|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
94591358|NCT00557856|323967418|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
94591359|NCT00557856|323967419|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
94591360|NCT00557856|323967420|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
94591361|NCT00557856|323967421|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
94591362|NCT00557856|323967422|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
94591363|NCT00557856|323967423|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
94591364|NCT00557856|323967424|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
94591365|NCT00557856|323967425|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
94591366|NCT00557856|323967417|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
94591367|NCT00557856|323967418|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
94591368|NCT00557856|323967419|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
94591369|NCT00557856|323967420|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
94591370|NCT00557856|323967421|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
94591371|NCT00557856|323967422|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
94591372|NCT00557856|323967423|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
94591373|NCT00557856|323967424|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
94591374|NCT00557856|323967425|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
94591375|NCT00557856|323967417|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
94591376|NCT00557856|323967418|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
94591377|NCT00557856|323967419|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
94591378|NCT00557856|323967420|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
94591379|NCT00557856|323967421|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
94591380|NCT00557856|323967422|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
94591381|NCT00557856|323967423|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
94591382|NCT00557856|323967424|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
94591383|NCT00557856|323967425|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
94591384|NCT00557856|323967417|FG000|Part 2: Exploratory Phase|Other|0|||
94591385|NCT00557856|323967418|FG001|Part 2: Exploratory Phase|Other|0|||
94591386|NCT00557856|323967419|FG002|Part 2: Exploratory Phase|Other|0|||
94591387|NCT00557856|323967420|FG003|Part 2: Exploratory Phase|Other|0|||
94591388|NCT00557856|323967421|FG004|Part 2: Exploratory Phase|Other|0|||
94591389|NCT00557856|323967422|FG005|Part 2: Exploratory Phase|Other|0|||
94245375|NCT02304705|322691730|FG001|Overall Study|Death|1|||
94591390|NCT00557856|323967423|FG006|Part 2: Exploratory Phase|Other|0|||
94591391|NCT00557856|323967424|FG007|Part 2: Exploratory Phase|Other|0|||
94591392|NCT00557856|323967425|FG008|Part 2: Exploratory Phase|Other|1|||
94591393|NCT00557856|323967417|FG000|Part 2: Exploratory Phase|Death|0|||
94591394|NCT00557856|323967418|FG001|Part 2: Exploratory Phase|Death|0|||
94591395|NCT00557856|323967419|FG002|Part 2: Exploratory Phase|Death|0|||
94591396|NCT00557856|323967420|FG003|Part 2: Exploratory Phase|Death|0|||
94591397|NCT00557856|323967421|FG004|Part 2: Exploratory Phase|Death|0|||
94591398|NCT00557856|323967422|FG005|Part 2: Exploratory Phase|Death|0|||
94591399|NCT00557856|323967423|FG006|Part 2: Exploratory Phase|Death|0|||
94591400|NCT00557856|323967424|FG007|Part 2: Exploratory Phase|Death|0|||
94591401|NCT00557856|323967425|FG008|Part 2: Exploratory Phase|Death|2|||
94591402|NCT00557856|323967417|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
94591403|NCT00557856|323967418|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
94591404|NCT00557856|323967419|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
94591405|NCT00557856|323967420|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
94591406|NCT00557856|323967421|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
94591407|NCT00557856|323967422|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
94591408|NCT00557856|323967423|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
94591409|NCT00557856|323967424|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
94591410|NCT00557856|323967425|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
94591411|NCT02509026|323967426|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
94591412|NCT02509026|323967426|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
94591413|NCT02509026|323967426|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
94591414|NCT02509026|323967426|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
94591415|NCT02509026|323967426|FG000|Induction Period (24 Weeks)|Other|2|||
94591416|NCT02509026|323967426|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
94591417|NCT02509026|323967426|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
94591418|NCT02509026|323967426|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
94591419|NCT02509026|323967426|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
94591420|NCT02509026|323967426|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
94591421|NCT02509026|323967426|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
94591422|NCT02509026|323967426|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
94591423|NCT02509026|323967426|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
94591424|NCT03976648|323967427|FG000|Overall Study|Adverse Event|0|||
94591425|NCT03976648|323967428|FG001|Overall Study|Adverse Event|2|||
94591426|NCT03976648|323967427|FG000|Overall Study|Study terminated by sponsor|21|||
94591427|NCT03976648|323967428|FG001|Overall Study|Study terminated by sponsor|8|||
94591428|NCT01525225|323967429|FG000|Enrollment|No longer met study criteria|1|||
94591429|NCT01525225|323967429|FG000|Enrollment|Other|1|||
94591430|NCT03645434|323967433|FG000|Period 1|Adverse Event|0|||
94591431|NCT03645434|323967434|FG001|Period 1|Adverse Event|0|||
94591432|NCT03645434|323967435|FG002|Period 1|Adverse Event|0|||
94591433|NCT03645434|323967436|FG003|Period 1|Adverse Event|1|||
94591434|NCT03645434|323967437|FG004|Period 1|Adverse Event|0|||
94591435|NCT03645434|323967438|FG005|Period 1|Adverse Event|0|||
94591436|NCT03645434|323967433|FG000|Period 1|COPD exacerbation|0|||
94591437|NCT03645434|323967434|FG001|Period 1|COPD exacerbation|0|||
94591438|NCT03645434|323967435|FG002|Period 1|COPD exacerbation|0|||
94591439|NCT03645434|323967436|FG003|Period 1|COPD exacerbation|0|||
94591440|NCT03645434|323967437|FG004|Period 1|COPD exacerbation|1|||
94591441|NCT03645434|323967438|FG005|Period 1|COPD exacerbation|0|||
94591442|NCT00881868|323967439|FG000|Overall Study|Adverse Event|0|||
94591443|NCT00881868|323967440|FG001|Overall Study|Adverse Event|1|||
94591444|NCT00881868|323967439|FG000|Overall Study|Lost to Follow-up|2|||
94591445|NCT00881868|323967440|FG001|Overall Study|Lost to Follow-up|1|||
94245376|NCT02304705|322691729|FG000|Overall Study|Lost to Follow-up|0|||
94245377|NCT02304705|322691730|FG001|Overall Study|Lost to Follow-up|2|||
94245378|NCT01014208|322691731|FG000|Overall Study|Lost to Follow-up|2|||
94245379|NCT01014208|322691732|FG001|Overall Study|Lost to Follow-up|5|||
94245380|NCT01014208|322691731|FG000|Overall Study|Participant Withdrew Consent|12|||
94245381|NCT01014208|322691732|FG001|Overall Study|Participant Withdrew Consent|12|||
94591446|NCT00881868|323967439|FG000|Overall Study|Physician Decision|4|||
94591447|NCT00881868|323967440|FG001|Overall Study|Physician Decision|0|||
94591448|NCT00881868|323967439|FG000|Overall Study|Protocol Violation|2|||
94591449|NCT00881868|323967440|FG001|Overall Study|Protocol Violation|0|||
94245382|NCT01014208|322691731|FG000|Overall Study|Did Not Receive Study Drug|2|||
94245383|NCT01014208|322691732|FG001|Overall Study|Did Not Receive Study Drug|0|||
94591450|NCT01182844|323967441|FG000|Overall Study|Withdrawal by Subject|0|||
94245384|NCT01014208|322691731|FG000|Overall Study|Study Closed/terminated|78|||
94591451|NCT01182844|323967442|FG001|Overall Study|Withdrawal by Subject|2|||
94591452|NCT01379508|323967443|FG000|Treatment to Week 104|Adverse Event|2|||
94591453|NCT01379508|323967444|FG001|Treatment to Week 104|Adverse Event|0|||
94245385|NCT01014208|322691732|FG001|Overall Study|Study Closed/terminated|83|||
94591454|NCT01379508|323967445|FG002|Treatment to Week 104|Adverse Event|5|||
94591455|NCT01379508|323967446|FG003|Treatment to Week 104|Adverse Event|0|||
94591456|NCT01379508|323967443|FG000|Treatment to Week 104|Abnormal lab value|1|||
94591457|NCT01379508|323967444|FG001|Treatment to Week 104|Abnormal lab value|0|||
94591458|NCT01379508|323967445|FG002|Treatment to Week 104|Abnormal lab value|0|||
94591459|NCT01379508|323967446|FG003|Treatment to Week 104|Abnormal lab value|0|||
94591460|NCT01379508|323967443|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
94591461|NCT01379508|323967444|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
94591462|NCT01379508|323967445|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
94591463|NCT01379508|323967446|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
94591464|NCT01379508|323967443|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
94591465|NCT01379508|323967444|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
94591466|NCT01379508|323967445|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
94591467|NCT01379508|323967446|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
94591468|NCT01379508|323967443|FG000|Treatment to Week 104|Lost to Follow-up|5|||
94591469|NCT01379508|323967444|FG001|Treatment to Week 104|Lost to Follow-up|0|||
94591470|NCT01379508|323967445|FG002|Treatment to Week 104|Lost to Follow-up|3|||
94591471|NCT01379508|323967446|FG003|Treatment to Week 104|Lost to Follow-up|0|||
94591472|NCT01379508|323967443|FG000|Treatment to Week 104|Administrative problems|3|||
94591473|NCT01379508|323967444|FG001|Treatment to Week 104|Administrative problems|1|||
94591474|NCT01379508|323967445|FG002|Treatment to Week 104|Administrative problems|0|||
94591475|NCT01379508|323967446|FG003|Treatment to Week 104|Administrative problems|0|||
94591476|NCT01379508|323967443|FG000|Treatment to Week 104|Protocol Violation|1|||
94591477|NCT01379508|323967444|FG001|Treatment to Week 104|Protocol Violation|1|||
94591478|NCT01379508|323967445|FG002|Treatment to Week 104|Protocol Violation|1|||
94591479|NCT01379508|323967446|FG003|Treatment to Week 104|Protocol Violation|0|||
94591480|NCT01379508|323967443|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
94591481|NCT01379508|323967444|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
94591482|NCT01379508|323967445|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
94591483|NCT01379508|323967446|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
94591484|NCT01379508|323967443|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
94591485|NCT01379508|323967444|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
94591486|NCT01379508|323967445|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
94591487|NCT01379508|323967446|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
94591488|NCT01379508|323967443|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
94591489|NCT01379508|323967444|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
94591490|NCT01379508|323967445|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
94591491|NCT01379508|323967446|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
94591492|NCT01379508|323967443|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
94591493|NCT01379508|323967444|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
94591494|NCT01379508|323967445|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
94591495|NCT01379508|323967446|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
94591496|NCT02537015|323967447|FG000|Overall Study|Adverse Event|3|||
94591497|NCT02537015|323967447|FG000|Overall Study|Withdrawal by Subject|2|||
94591498|NCT02537015|323967447|FG000|Overall Study|Other Miscellaneous Reasons|1|||
94591499|NCT01256294|323968923|FG000|Overall Study|Adverse Event|1|||
94591500|NCT01256294|323968924|FG001|Overall Study|Adverse Event|0|||
94591501|NCT01256294|323968923|FG000|Overall Study|Withdrawal by Subject|1|||
94591502|NCT01256294|323968924|FG001|Overall Study|Withdrawal by Subject|1|||
94591503|NCT01256294|323968923|FG000|Overall Study|Protocol deviation|2|||
94591504|NCT01256294|323968924|FG001|Overall Study|Protocol deviation|1|||
94591505|NCT02160899|323968925|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
94591506|NCT02160899|323968926|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
94591507|NCT02160899|323968927|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
94591508|NCT02160899|323968928|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
94591509|NCT02160899|323968929|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
94659846|NCT00116805|324209957|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
94591510|NCT02160899|323968930|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
94591511|NCT04129151|323968931|FG000|Overall Study|Adverse Event|1|||
94591512|NCT04129151|323968931|FG000|Overall Study|Disease Progression|7|||
94591513|NCT04129151|323968931|FG000|Overall Study|Study closure|1|||
94591514|NCT01643772|323968932|FG000|Overall Study|Protocol Violation|0|||
94591515|NCT01643772|323968933|FG001|Overall Study|Protocol Violation|0|||
94591516|NCT01643772|323968934|FG002|Overall Study|Protocol Violation|0|||
94591517|NCT01643772|323968935|FG003|Overall Study|Protocol Violation|1|||
94591518|NCT01643772|323968932|FG000|Overall Study|Adverse Event|0|||
94591519|NCT01643772|323968933|FG001|Overall Study|Adverse Event|0|||
94591520|NCT01643772|323968934|FG002|Overall Study|Adverse Event|0|||
94591521|NCT01643772|323968935|FG003|Overall Study|Adverse Event|1|||
94591522|NCT01311024|323968937|FG000|Overall Study|Protocol Violation|35|||
94591523|NCT01311024|323968938|FG001|Overall Study|Protocol Violation|22|||
94591524|NCT01523275|323968946|FG000|Overall Study|Lost to Follow-up|1|||
94591525|NCT01523275|323968947|FG001|Overall Study|Lost to Follow-up|2|||
94591526|NCT01523275|323968946|FG000|Overall Study|Withdrawal by Subject|1|||
94591527|NCT01523275|323968947|FG001|Overall Study|Withdrawal by Subject|0|||
94591528|NCT00444678|323968948|FG000|Overall Study|Toxicity|11|||
94591529|NCT00444678|323968948|FG000|Overall Study|Disease Progression|12|||
94591530|NCT00444678|323968948|FG000|Overall Study|Death|3|||
94591531|NCT00444678|323968948|FG000|Overall Study|Physician Decision|3|||
94591532|NCT00444678|323968948|FG000|Overall Study|Withdrawal by Subject|2|||
94591533|NCT00668733|323968949|FG000|Overall Study|Lost to Follow-up|2|||
94591534|NCT00668733|323968950|FG001|Overall Study|Lost to Follow-up|3|||
94591535|NCT00668733|323968949|FG000|Overall Study|Withdrawal by Subject|0|||
94591536|NCT00668733|323968950|FG001|Overall Study|Withdrawal by Subject|4|||
94591537|NCT00606905|323968951|FG000|Overall Study|No Pregnancy|9|||
94591538|NCT00606905|323968952|FG001|Overall Study|No Pregnancy|6|||
94591539|NCT00606905|323968951|FG000|Overall Study|Non-Index Pregnancy|1|||
94591540|NCT00606905|323968952|FG001|Overall Study|Non-Index Pregnancy|4|||
94591541|NCT00606905|323968951|FG000|Overall Study|Withdrew|5|||
94591542|NCT00606905|323968952|FG001|Overall Study|Withdrew|5|||
94591543|NCT04657666|323968953|FG000|Period 1|Withdrawal of participant consent|2|||
94591544|NCT04657666|323968954|FG001|Period 1|Withdrawal of participant consent|1|||
94591545|NCT04657666|323968953|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
94591546|NCT04657666|323968954|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
94591547|NCT04657666|323968953|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
94245386|NCT00095056|322691733|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
94245387|NCT00095056|322691734|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
94245388|NCT00095056|322691733|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
94245389|NCT00095056|322691734|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
94245390|NCT00095056|322691733|FG000|Phase A (Weeks 0-12)|Death|1|||
94245391|NCT00095056|322691734|FG001|Phase A (Weeks 0-12)|Death|0|||
94245392|NCT00095056|322691733|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
94245393|NCT00095056|322691734|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
94245394|NCT00095056|322691733|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
94591548|NCT04657666|323968954|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
94591549|NCT04657666|323968953|FG000|Period 2|Other|2|||
94591550|NCT04657666|323968954|FG001|Period 2|Other|0|||
94591551|NCT04657666|323968953|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
94591552|NCT04657666|323968954|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
94591553|NCT01256190|323968960|FG000|Overall Study|Lost to Follow-up|2|||
94591554|NCT01256190|323968961|FG001|Overall Study|Lost to Follow-up|0|||
94591555|NCT03700684|323968962|FG000|Overall Study|COVID-19|0|||
94591556|NCT03700684|323968963|FG001|Overall Study|COVID-19|0|||
94591557|NCT03700684|323968964|FG002|Overall Study|COVID-19|2|||
94591558|NCT02136069|323968965|FG000|Overall Study|UC flare-up|1|||
94591559|NCT02136069|323968966|FG001|Overall Study|UC flare-up|0|||
94591560|NCT02136069|323968965|FG000|Overall Study|Adverse Event|6|||
94591561|NCT02136069|323968966|FG001|Overall Study|Adverse Event|8|||
94591562|NCT02136069|323968965|FG000|Overall Study|Death|0|||
94591563|NCT02136069|323968966|FG001|Overall Study|Death|1|||
94591564|NCT02136069|323968965|FG000|Overall Study|Lack of Efficacy|10|||
94245395|NCT00095056|322691734|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
94591565|NCT02136069|323968966|FG001|Overall Study|Lack of Efficacy|4|||
94591566|NCT02136069|323968965|FG000|Overall Study|Lost to Follow-up|1|||
94591567|NCT02136069|323968966|FG001|Overall Study|Lost to Follow-up|0|||
94591568|NCT02136069|323968965|FG000|Overall Study|Non-Compliance|1|||
94659847|NCT02627677|324209958|FG000|Overall Study|Adverse event (not progressive disease)|1|||
94659848|NCT02627677|324209959|FG001|Overall Study|Adverse event (not progressive disease)|4|||
94659849|NCT02627677|324209960|FG002|Overall Study|Adverse event (not progressive disease)|1|||
94659850|NCT02627677|324209958|FG000|Overall Study|Progressive disease|1|||
94659851|NCT02627677|324209959|FG001|Overall Study|Progressive disease|3|||
94659852|NCT02627677|324209960|FG002|Overall Study|Progressive disease|0|||
94659853|NCT02627677|324209958|FG000|Overall Study|Lack of Efficacy|1|||
94659854|NCT02627677|324209959|FG001|Overall Study|Lack of Efficacy|2|||
94659855|NCT02627677|324209960|FG002|Overall Study|Lack of Efficacy|0|||
94659856|NCT02627677|324209958|FG000|Overall Study|Lost to Follow-up|0|||
94659857|NCT02627677|324209959|FG001|Overall Study|Lost to Follow-up|0|||
94659858|NCT02627677|324209960|FG002|Overall Study|Lost to Follow-up|1|||
94659859|NCT02627677|324209958|FG000|Overall Study|Pregnancy|0|||
94659860|NCT02627677|324209959|FG001|Overall Study|Pregnancy|1|||
94659861|NCT02627677|324209960|FG002|Overall Study|Pregnancy|0|||
94659862|NCT02627677|324209958|FG000|Overall Study|Study Terminated by Sponsor|5|||
94659863|NCT02627677|324209959|FG001|Overall Study|Study Terminated by Sponsor|10|||
94659864|NCT02627677|324209960|FG002|Overall Study|Study Terminated by Sponsor|6|||
94659865|NCT02627677|324209958|FG000|Overall Study|Physician Decision|0|||
94659866|NCT02627677|324209959|FG001|Overall Study|Physician Decision|0|||
94659867|NCT02627677|324209960|FG002|Overall Study|Physician Decision|2|||
94659868|NCT02627677|324209958|FG000|Overall Study|Withdrawal by Subject|2|||
94659869|NCT02627677|324209959|FG001|Overall Study|Withdrawal by Subject|1|||
94659870|NCT02627677|324209960|FG002|Overall Study|Withdrawal by Subject|1|||
94659871|NCT02627677|324209958|FG000|Overall Study|Reason not Specified|0|||
94659872|NCT02627677|324209959|FG001|Overall Study|Reason not Specified|0|||
94659873|NCT02627677|324209960|FG002|Overall Study|Reason not Specified|1|||
94659874|NCT02627677|324209958|FG000|Overall Study|Randomized but not Treated|1|||
94659875|NCT02627677|324209959|FG001|Overall Study|Randomized but not Treated|0|||
94659876|NCT02627677|324209960|FG002|Overall Study|Randomized but not Treated|0|||
94659877|NCT03521635|324209961|FG000|Overall Study|Adverse Event|1|||
94355348|NCT00151775|323083566|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
94355349|NCT00151775|323083567|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
94355350|NCT00151775|323083568|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
94355351|NCT00151775|323083569|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
94355352|NCT00151775|323083570|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
94355353|NCT00151775|323083571|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
94355354|NCT00151775|323083572|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
94355355|NCT00151775|323083573|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
94355356|NCT00151775|323083562|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
94659878|NCT03521635|324209962|FG001|Overall Study|Adverse Event|1|||
94659879|NCT03521635|324209961|FG000|Overall Study|Refused to complete study visit|1|||
94659880|NCT03521635|324209962|FG001|Overall Study|Refused to complete study visit|0|||
94659881|NCT03521635|324209961|FG000|Overall Study|Refused to continue trial medication|2|||
94659882|NCT03521635|324209962|FG001|Overall Study|Refused to continue trial medication|2|||
94659883|NCT03521635|324209961|FG000|Overall Study|Lost to Follow-up|0|||
94245396|NCT00095056|322691733|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
94245397|NCT00095056|322691734|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
94245398|NCT00095056|322691733|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
94245399|NCT00095056|322691734|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
94245400|NCT00095056|322691733|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
94245401|NCT00095056|322691734|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
94245402|NCT00095056|322691733|FG000|Phase B (Weeks 12-54)|Death|3|||
94245403|NCT00095056|322691734|FG001|Phase B (Weeks 12-54)|Death|1|||
94456444|NCT01669174|323460464|FG000|Overall Study|Subject withdrew consent|2|||
94456445|NCT01669174|323460465|FG001|Overall Study|Subject withdrew consent|2|||
94456446|NCT01669174|323460464|FG000|Overall Study|Lost to Follow-up|1|||
94456447|NCT01669174|323460465|FG001|Overall Study|Lost to Follow-up|0|||
94456448|NCT01669174|323460464|FG000|Overall Study|Adverse Event|2|||
94456449|NCT01669174|323460465|FG001|Overall Study|Adverse Event|2|||
94456450|NCT01669174|323460464|FG000|Overall Study|Administrative problems|1|||
94456451|NCT01669174|323460465|FG001|Overall Study|Administrative problems|2|||
94456452|NCT00970632|323460476|FG000|Overall Study|Adverse Event|2|||
94456453|NCT00970632|323460477|FG001|Overall Study|Adverse Event|2|||
94456454|NCT00970632|323460478|FG002|Overall Study|Adverse Event|1|||
94456455|NCT00970632|323460476|FG000|Overall Study|Lack of Efficacy|3|||
94456456|NCT00970632|323460477|FG001|Overall Study|Lack of Efficacy|0|||
94456457|NCT00970632|323460478|FG002|Overall Study|Lack of Efficacy|0|||
94456458|NCT00970632|323460476|FG000|Overall Study|Lost to Follow-up|3|||
94456459|NCT00970632|323460477|FG001|Overall Study|Lost to Follow-up|0|||
94456460|NCT00970632|323460478|FG002|Overall Study|Lost to Follow-up|2|||
94456461|NCT00970632|323460476|FG000|Overall Study|Protocol Violation|8|||
94456462|NCT00970632|323460477|FG001|Overall Study|Protocol Violation|5|||
94456463|NCT00970632|323460478|FG002|Overall Study|Protocol Violation|8|||
94456464|NCT00970632|323460476|FG000|Overall Study|Withdrawal by Subject|7|||
94456465|NCT00970632|323460477|FG001|Overall Study|Withdrawal by Subject|6|||
94456466|NCT00970632|323460478|FG002|Overall Study|Withdrawal by Subject|4|||
94456467|NCT00970632|323460476|FG000|Overall Study|Entry criteria not met|0|||
94456468|NCT00970632|323460477|FG001|Overall Study|Entry criteria not met|2|||
94456469|NCT00970632|323460478|FG002|Overall Study|Entry criteria not met|2|||
94456470|NCT00970632|323460476|FG000|Overall Study|Sponsor decision|1|||
94456471|NCT00970632|323460477|FG001|Overall Study|Sponsor decision|0|||
94456472|NCT00970632|323460478|FG002|Overall Study|Sponsor decision|1|||
94456473|NCT02817516|323460479|FG000|Overall Study|Other|0|||
94456474|NCT02817516|323460480|FG001|Overall Study|Other|0|||
94456475|NCT02817516|323460481|FG002|Overall Study|Other|1|||
94456476|NCT02817516|323460482|FG003|Overall Study|Other|0|||
94456477|NCT01943851|323460483|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
94456478|NCT01943851|323460484|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
94456479|NCT01943851|323460485|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
94456480|NCT01943851|323460486|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
94456481|NCT01943851|323460487|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
94456482|NCT01943851|323460488|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
94456483|NCT01943851|323460489|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
94456484|NCT01943851|323460490|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
94456485|NCT01943851|323460491|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
94456486|NCT01943851|323460492|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
94456487|NCT01943851|323460493|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
94456488|NCT01943851|323460494|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
94245404|NCT00095056|322691733|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
94456489|NCT01943851|323460495|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
94456490|NCT01943851|323460496|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
94456491|NCT01943851|323460497|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
94456492|NCT01943851|323460498|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
94456493|NCT01943851|323460499|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
94456494|NCT01943851|323460500|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
94456495|NCT01943851|323460483|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
94591569|NCT02136069|323968966|FG001|Overall Study|Non-Compliance|0|||
94245405|NCT00095056|322691734|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
94245406|NCT00095056|322691733|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
94591570|NCT02136069|323968965|FG000|Overall Study|Physician Decision|5|||
94591571|NCT02136069|323968966|FG001|Overall Study|Physician Decision|4|||
94591572|NCT02136069|323968965|FG000|Overall Study|Withdrawal by Subject|10|||
94591573|NCT02136069|323968966|FG001|Overall Study|Withdrawal by Subject|11|||
94591574|NCT01767142|323968967|FG000|Overall Study|Lost to Follow-up|3|||
94591575|NCT02471612|323968968|FG000|Overall Study|Lost to Follow-up|2|||
94591576|NCT01727024|323968969|FG000|Period 1|Lost to Follow-up|1|||
94591577|NCT01727024|323968970|FG001|Period 1|Lost to Follow-up|1|||
94591578|NCT01727024|323968969|FG000|Period 1|Withdrawal by Subject|2|||
94591579|NCT01727024|323968970|FG001|Period 1|Withdrawal by Subject|3|||
94591580|NCT01598129|323968971|FG000|Overall Study|Disease progression|6|||
94591581|NCT01598129|323968971|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
94245407|NCT00095056|322691734|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
94245408|NCT00770029|322691735|FG000|Overall Study|Lost to Follow-up|2|||
94591582|NCT01598129|323968971|FG000|Overall Study|Withdrawal by Subject|1|||
94591583|NCT02433080|323968973|FG000|Overall Study|Lost to Follow-up|1|||
94591584|NCT02433080|323968974|FG001|Overall Study|Lost to Follow-up|2|||
94591585|NCT02433080|323968973|FG000|Overall Study|Withdrawal by Subject|0|||
94591586|NCT02433080|323968974|FG001|Overall Study|Withdrawal by Subject|2|||
94591587|NCT01363349|323968981|FG000|Overall Study|Adverse Event|6|||
94591588|NCT01363349|323968982|FG001|Overall Study|Adverse Event|7|||
94591589|NCT01363349|323968981|FG000|Overall Study|Lack of Efficacy|3|||
94591590|NCT01363349|323968982|FG001|Overall Study|Lack of Efficacy|10|||
94591591|NCT01363349|323968981|FG000|Overall Study|Non compliance/Protocol deviations|2|||
94591592|NCT01363349|323968982|FG001|Overall Study|Non compliance/Protocol deviations|2|||
94591593|NCT01363349|323968981|FG000|Overall Study|Withdrawal by Subject|14|||
94591594|NCT01363349|323968982|FG001|Overall Study|Withdrawal by Subject|6|||
94591595|NCT01363349|323968981|FG000|Overall Study|Lost to Follow-up|5|||
94591596|NCT01363349|323968982|FG001|Overall Study|Lost to Follow-up|6|||
94591597|NCT01363349|323968981|FG000|Overall Study|Not reported|36|||
94591598|NCT01363349|323968982|FG001|Overall Study|Not reported|37|||
94591599|NCT01363349|323968981|FG000|Overall Study|missing|1|||
94591600|NCT01363349|323968982|FG001|Overall Study|missing|2|||
94591601|NCT02745145|323968983|FG000|Overall Study|Adverse Event|1|||
94591602|NCT02745145|323968984|FG001|Overall Study|Adverse Event|0|||
94591603|NCT02745145|323968985|FG002|Overall Study|Adverse Event|0|||
94591604|NCT02745145|323968983|FG000|Overall Study|Death|0|||
94591605|NCT02745145|323968984|FG001|Overall Study|Death|1|||
94591606|NCT02745145|323968985|FG002|Overall Study|Death|0|||
94591607|NCT02745145|323968983|FG000|Overall Study|Progressive disease|0|||
94591608|NCT02745145|323968984|FG001|Overall Study|Progressive disease|0|||
94591609|NCT02745145|323968985|FG002|Overall Study|Progressive disease|1|||
94591610|NCT02745145|323968983|FG000|Overall Study|Withdrew consent|1|||
94591611|NCT02745145|323968984|FG001|Overall Study|Withdrew consent|1|||
94591612|NCT02745145|323968985|FG002|Overall Study|Withdrew consent|1|||
94659884|NCT03521635|324209962|FG001|Overall Study|Lost to Follow-up|1|||
94659885|NCT03521635|324209961|FG000|Overall Study|Meet exclusion criteria|0|||
94245409|NCT00770029|322691736|FG001|Overall Study|Lost to Follow-up|0|||
94245410|NCT00770029|322691735|FG000|Overall Study|Withdrawal by Subject|3|||
94591613|NCT02745145|323968983|FG000|Overall Study|Study Termination|8|||
94591614|NCT02745145|323968984|FG001|Overall Study|Study Termination|3|||
94591615|NCT02745145|323968985|FG002|Overall Study|Study Termination|7|||
94591616|NCT02366091|323968988|FG000|Overall Study|Withdrawal by Subject|3|||
94591617|NCT02366091|323968989|FG001|Overall Study|Withdrawal by Subject|7|||
94659886|NCT03521635|324209962|FG001|Overall Study|Meet exclusion criteria|1|||
94245411|NCT00770029|322691736|FG001|Overall Study|Withdrawal by Subject|3|||
94591618|NCT02366091|323968990|FG002|Overall Study|Withdrawal by Subject|3|||
94591619|NCT02366091|323968991|FG003|Overall Study|Withdrawal by Subject|1|||
94591620|NCT05194579|323968992|FG000|Overall Study|Lost to Follow-up|2|||
94591621|NCT05194579|323968993|FG001|Overall Study|Lost to Follow-up|3|||
94591622|NCT05194579|323968992|FG000|Overall Study|Withdrawal by Subject|3|||
94591623|NCT05194579|323968993|FG001|Overall Study|Withdrawal by Subject|4|||
94591624|NCT05194579|323968992|FG000|Overall Study|Refused further study procedures|0|||
94591625|NCT05194579|323968993|FG001|Overall Study|Refused further study procedures|1|||
94591626|NCT05194579|323968992|FG000|Overall Study|Protocol deviation|1|||
94591627|NCT05194579|323968993|FG001|Overall Study|Protocol deviation|0|||
94591628|NCT03462511|323968994|FG000|Overall Study|Withdrawal by Subject|2|||
94591629|NCT03462511|323968995|FG001|Overall Study|Withdrawal by Subject|3|||
94591630|NCT03890666|323968996|FG000|Overall Study|Withdrawal by Subject|0|||
94591631|NCT03890666|323968997|FG001|Overall Study|Withdrawal by Subject|1|||
94591632|NCT03890666|323968996|FG000|Overall Study|Protocol deviation|1|||
94355357|NCT00151775|323083563|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
94355358|NCT00151775|323083564|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
94591633|NCT03890666|323968997|FG001|Overall Study|Protocol deviation|4|||
94591634|NCT03890666|323968996|FG000|Overall Study|Lost to Follow-up|2|||
94591635|NCT03890666|323968997|FG001|Overall Study|Lost to Follow-up|5|||
94591636|NCT03890666|323968996|FG000|Overall Study|Other than specified|1|||
94591637|NCT03890666|323968997|FG001|Overall Study|Other than specified|8|||
94591638|NCT02925416|323968999|FG000|Overall Study|Adverse Event|2|||
94591639|NCT02925416|323969000|FG001|Overall Study|Adverse Event|0|||
94591640|NCT03595228|323969001|FG000|Overall Study|Death|2|||
94591641|NCT03595228|323969001|FG000|Overall Study|Lack of Efficacy|13|||
94591642|NCT03595228|323969001|FG000|Overall Study|Withdrawal by Subject|3|||
94591643|NCT03595228|323969001|FG000|Overall Study|Withdrawal by Sponsor|1|||
94591644|NCT01639729|323969002|FG000|Overall Study|Withdrawal by Subject|1|||
94591645|NCT01639729|323969003|FG001|Overall Study|Withdrawal by Subject|0|||
94591646|NCT01639729|323969004|FG002|Overall Study|Withdrawal by Subject|1|||
94591647|NCT01639729|323969005|FG003|Overall Study|Withdrawal by Subject|1|||
94591648|NCT01639729|323969006|FG004|Overall Study|Withdrawal by Subject|0|||
94591649|NCT01639729|323969007|FG005|Overall Study|Withdrawal by Subject|0|||
94591650|NCT00759564|323969008|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
94591651|NCT00759564|323969009|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
94591652|NCT00759564|323969010|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
94591653|NCT00759564|323969011|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
94591654|NCT00759564|323969012|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
94591655|NCT00357760|323969022|FG000|Overall Study|Disease progression|44|||
94591656|NCT00357760|323969023|FG001|Overall Study|Disease progression|17|||
94591657|NCT00357760|323969022|FG000|Overall Study|Adverse Event|10|||
94591658|NCT00357760|323969023|FG001|Overall Study|Adverse Event|7|||
94591659|NCT00357760|323969022|FG000|Overall Study|Death|0|||
94591660|NCT00357760|323969023|FG001|Overall Study|Death|3|||
94591661|NCT00357760|323969022|FG000|Overall Study|Alternative therapy|1|||
94591662|NCT00357760|323969023|FG001|Overall Study|Alternative therapy|0|||
94591663|NCT00357760|323969022|FG000|Overall Study|Withdrawal by Subject|0|||
94591664|NCT00357760|323969023|FG001|Overall Study|Withdrawal by Subject|2|||
94591665|NCT00357760|323969022|FG000|Overall Study|Never started treatment|2|||
94591666|NCT00357760|323969023|FG001|Overall Study|Never started treatment|1|||
94591667|NCT00357760|323969022|FG000|Overall Study|Ineligible|0|||
94591668|NCT00357760|323969023|FG001|Overall Study|Ineligible|2|||
94591669|NCT00357760|323969022|FG000|Overall Study|Physician Decision|2|||
94591670|NCT00357760|323969023|FG001|Overall Study|Physician Decision|1|||
94591671|NCT00357760|323969022|FG000|Overall Study|Protocol Violation|0|||
94591672|NCT00357760|323969023|FG001|Overall Study|Protocol Violation|1|||
94591673|NCT00357760|323969022|FG000|Overall Study|To receive hospice care|0|||
94591674|NCT00357760|323969023|FG001|Overall Study|To receive hospice care|1|||
94591675|NCT02353143|323969024|FG000|Overall Study|Withdrawal by Subject|1|||
94591676|NCT02353143|323969025|FG001|Overall Study|Withdrawal by Subject|0|||
94591677|NCT02353143|323969026|FG002|Overall Study|Withdrawal by Subject|0|||
94591678|NCT02353143|323969027|FG003|Overall Study|Withdrawal by Subject|0|||
94591679|NCT02353143|323969028|FG004|Overall Study|Withdrawal by Subject|1|||
94591680|NCT02353143|323969029|FG005|Overall Study|Withdrawal by Subject|0|||
94591681|NCT02353143|323969030|FG006|Overall Study|Withdrawal by Subject|0|||
94591682|NCT02353143|323969031|FG007|Overall Study|Withdrawal by Subject|1|||
94591683|NCT02353143|323969032|FG008|Overall Study|Withdrawal by Subject|1|||
94591684|NCT02353143|323969024|FG000|Overall Study|Lack of Efficacy|2|||
94591685|NCT02353143|323969025|FG001|Overall Study|Lack of Efficacy|1|||
94591686|NCT02353143|323969026|FG002|Overall Study|Lack of Efficacy|2|||
94591687|NCT02353143|323969027|FG003|Overall Study|Lack of Efficacy|4|||
94591688|NCT02353143|323969028|FG004|Overall Study|Lack of Efficacy|13|||
94591689|NCT02353143|323969029|FG005|Overall Study|Lack of Efficacy|2|||
94591690|NCT02353143|323969030|FG006|Overall Study|Lack of Efficacy|2|||
94591691|NCT02353143|323969031|FG007|Overall Study|Lack of Efficacy|2|||
94659887|NCT03521635|324209961|FG000|Overall Study|Patient not taken study medicine|0|||
94591692|NCT02353143|323969032|FG008|Overall Study|Lack of Efficacy|1|||
94591693|NCT02353143|323969024|FG000|Overall Study|reason not specified|1|||
94591694|NCT02353143|323969025|FG001|Overall Study|reason not specified|2|||
94591695|NCT02353143|323969026|FG002|Overall Study|reason not specified|0|||
94591696|NCT02353143|323969027|FG003|Overall Study|reason not specified|0|||
94591697|NCT02353143|323969028|FG004|Overall Study|reason not specified|6|||
94591698|NCT02353143|323969029|FG005|Overall Study|reason not specified|1|||
94591699|NCT02353143|323969030|FG006|Overall Study|reason not specified|0|||
94591700|NCT02353143|323969031|FG007|Overall Study|reason not specified|3|||
94591701|NCT02353143|323969032|FG008|Overall Study|reason not specified|1|||
94591702|NCT02353143|323969024|FG000|Overall Study|Physician Decision|0|||
94591703|NCT02353143|323969025|FG001|Overall Study|Physician Decision|4|||
94591704|NCT02353143|323969026|FG002|Overall Study|Physician Decision|2|||
94591705|NCT02353143|323969027|FG003|Overall Study|Physician Decision|3|||
94591706|NCT02353143|323969028|FG004|Overall Study|Physician Decision|4|||
94591707|NCT02353143|323969029|FG005|Overall Study|Physician Decision|0|||
94591708|NCT02353143|323969030|FG006|Overall Study|Physician Decision|1|||
94591709|NCT02353143|323969031|FG007|Overall Study|Physician Decision|2|||
94591710|NCT02353143|323969032|FG008|Overall Study|Physician Decision|0|||
94591711|NCT02353143|323969024|FG000|Overall Study|Adverse Event|0|||
94591712|NCT02353143|323969025|FG001|Overall Study|Adverse Event|0|||
94591713|NCT02353143|323969026|FG002|Overall Study|Adverse Event|1|||
94591714|NCT02353143|323969027|FG003|Overall Study|Adverse Event|0|||
94591715|NCT02353143|323969028|FG004|Overall Study|Adverse Event|1|||
94591716|NCT02353143|323969029|FG005|Overall Study|Adverse Event|1|||
94591717|NCT02353143|323969030|FG006|Overall Study|Adverse Event|0|||
94591718|NCT02353143|323969031|FG007|Overall Study|Adverse Event|0|||
94591719|NCT02353143|323969032|FG008|Overall Study|Adverse Event|0|||
94591720|NCT02353143|323969024|FG000|Overall Study|patient receiving other treatment for AML|0|||
94591721|NCT02353143|323969025|FG001|Overall Study|patient receiving other treatment for AML|0|||
94591722|NCT02353143|323969026|FG002|Overall Study|patient receiving other treatment for AML|1|||
94591723|NCT02353143|323969027|FG003|Overall Study|patient receiving other treatment for AML|0|||
94591724|NCT02353143|323969028|FG004|Overall Study|patient receiving other treatment for AML|0|||
94591725|NCT02353143|323969029|FG005|Overall Study|patient receiving other treatment for AML|0|||
94591726|NCT02353143|323969030|FG006|Overall Study|patient receiving other treatment for AML|0|||
94591727|NCT02353143|323969031|FG007|Overall Study|patient receiving other treatment for AML|0|||
94591728|NCT02353143|323969032|FG008|Overall Study|patient receiving other treatment for AML|0|||
94591729|NCT02353143|323969024|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
94591730|NCT02353143|323969025|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
94591731|NCT02353143|323969026|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
94591732|NCT02353143|323969027|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
94591733|NCT02353143|323969028|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
94591734|NCT02353143|323969029|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
94591735|NCT02353143|323969030|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
94591736|NCT02353143|323969031|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
94591737|NCT02353143|323969032|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
94591738|NCT02238067|323969033|FG000|Overall Study|Not completed survey at Month 6|45|||
94591739|NCT00984620|323969036|FG000|Overall Study|Adverse Event|5|||
94591740|NCT00984620|323969037|FG001|Overall Study|Adverse Event|5|||
94591741|NCT00984620|323969036|FG000|Overall Study|Lost to Follow-up|1|||
94591742|NCT00984620|323969037|FG001|Overall Study|Lost to Follow-up|1|||
94591743|NCT00984620|323969036|FG000|Overall Study|Withdrawal by Subject|0|||
94591744|NCT00984620|323969037|FG001|Overall Study|Withdrawal by Subject|2|||
94591745|NCT00984620|323969036|FG000|Overall Study|reason other than listed above|0|||
94591746|NCT00984620|323969037|FG001|Overall Study|reason other than listed above|4|||
94591747|NCT01290796|323969038|FG000|Overall Study|Lost to Follow-up|21|||
94591748|NCT01290796|323969038|FG000|Overall Study|Withdrawal by Subject|4|||
94591749|NCT01290796|323969038|FG000|Overall Study|Physician Decision|2|||
94591750|NCT01290796|323969038|FG000|Overall Study|Secondary Surgical Intervention|2|||
94591751|NCT01290796|323969038|FG000|Overall Study|Withdrawal by Sponsor|1|||
94591752|NCT00835211|323969040|FG000|First Intervention|Withdrawal by Subject|0|||
94591753|NCT00835211|323969041|FG001|First Intervention|Withdrawal by Subject|1|||
94659888|NCT03521635|324209962|FG001|Overall Study|Patient not taken study medicine|1|||
94659889|NCT02244944|324209963|FG000|Overall Study|Withdrawal by Subject|1|||
94659890|NCT02244944|324209963|FG000|Overall Study|Study Terminated|1|||
94659891|NCT01153633|324209968|FG000|Overall Study|Protocol Violation|1|||
94591754|NCT00835211|323969040|FG000|Washout: 7 Days|Adverse Event|2|||
94591755|NCT00835211|323969041|FG001|Washout: 7 Days|Adverse Event|1|||
94591756|NCT00835211|323969040|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
94591757|NCT00835211|323969041|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
94591758|NCT03087617|323969042|FG000|Overall Study|Lost to Follow-up|32|||
94591759|NCT03087617|323969043|FG001|Overall Study|Lost to Follow-up|30|||
94591760|NCT03087617|323969044|FG002|Overall Study|Lost to Follow-up|30|||
94591761|NCT03087617|323969045|FG003|Overall Study|Lost to Follow-up|39|||
94591762|NCT01090323|323969047|FG000|Overall Study|Adverse Event|12|||
94591763|NCT01090323|323969048|FG001|Overall Study|Adverse Event|2|||
94591764|NCT01090323|323969047|FG000|Overall Study|Abnormal Lab Values|3|||
94659892|NCT01153633|324209969|FG001|Overall Study|Protocol Violation|1|||
94591765|NCT01090323|323969048|FG001|Overall Study|Abnormal Lab Values|1|||
94591766|NCT01090323|323969047|FG000|Overall Study|Abnormal Test Procedure Results|2|||
94591767|NCT01090323|323969048|FG001|Overall Study|Abnormal Test Procedure Results|0|||
94591768|NCT01090323|323969047|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
94591769|NCT01090323|323969048|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
94591770|NCT01090323|323969047|FG000|Overall Study|Condition no longer requires drug|5|||
94591771|NCT01090323|323969048|FG001|Overall Study|Condition no longer requires drug|4|||
94591772|NCT01090323|323969047|FG000|Overall Study|Protocol Violation|2|||
94591773|NCT01090323|323969048|FG001|Overall Study|Protocol Violation|1|||
94591774|NCT01090323|323969047|FG000|Overall Study|Withdrew consent|33|||
94591775|NCT01090323|323969048|FG001|Overall Study|Withdrew consent|11|||
94591776|NCT01090323|323969047|FG000|Overall Study|Lost to Follow-up|11|||
94591777|NCT01090323|323969048|FG001|Overall Study|Lost to Follow-up|6|||
94591778|NCT01090323|323969047|FG000|Overall Study|Administrative problems|6|||
94591779|NCT01090323|323969048|FG001|Overall Study|Administrative problems|4|||
94591780|NCT01090323|323969047|FG000|Overall Study|Death|1|||
94245412|NCT00770029|322691735|FG000|Overall Study|Adverse Event|1|||
94245413|NCT00770029|322691736|FG001|Overall Study|Adverse Event|0|||
94591781|NCT01090323|323969048|FG001|Overall Study|Death|2|||
94591782|NCT01090323|323969047|FG000|Overall Study|Stopped end of core|7|||
94245414|NCT02124811|322691737|FG000|Overall Study|Early termination|2|||
94245415|NCT02124811|322691738|FG001|Overall Study|Early termination|2|||
94245416|NCT02124811|322691737|FG000|Overall Study|Withdrawal by Subject|1|||
94245417|NCT02124811|322691738|FG001|Overall Study|Withdrawal by Subject|0|||
94245418|NCT00414908|322691741|FG000|Overall Study|Protocol Violation|1|||
94245419|NCT00414908|322691742|FG001|Overall Study|Protocol Violation|1|||
94245420|NCT00818168|322691743|FG000|Overall Study|Lack of Efficacy|18|||
94245421|NCT00818168|322691743|FG000|Overall Study|Pregnancy|2|||
94245422|NCT00818168|322691743|FG000|Overall Study|Withdrawal by Subject|16|||
94245423|NCT00818168|322691743|FG000|Overall Study|Lost to Follow-up|7|||
94245424|NCT00818168|322691743|FG000|Overall Study|Adverse Event|19|||
94245425|NCT00818168|322691743|FG000|Overall Study|Reason for Non-completion Not reported|6|||
94245426|NCT00818168|322691743|FG000|Overall Study|Participant Moved|2|||
94245427|NCT01498887|322691748|FG000|Overall Study|Administrative problems|1|||
94245428|NCT01498887|322691749|FG001|Overall Study|Administrative problems|0|||
94245429|NCT01498887|322691748|FG000|Overall Study|Lost to Follow-up|1|||
94245430|NCT01498887|322691749|FG001|Overall Study|Lost to Follow-up|1|||
94245431|NCT01498887|322691748|FG000|Overall Study|Withdrawal by Subject|1|||
94245432|NCT01498887|322691749|FG001|Overall Study|Withdrawal by Subject|0|||
94245433|NCT01498887|322691748|FG000|Overall Study|Protocol Violation|1|||
94245434|NCT01498887|322691749|FG001|Overall Study|Protocol Violation|3|||
94245435|NCT01498887|322691748|FG000|Overall Study|Lack of Efficacy|5|||
94245436|NCT01498887|322691749|FG001|Overall Study|Lack of Efficacy|3|||
94245437|NCT01498887|322691748|FG000|Overall Study|Abnormal result from test procedure|1|||
94245438|NCT01498887|322691749|FG001|Overall Study|Abnormal result from test procedure|1|||
94245439|NCT01498887|322691748|FG000|Overall Study|Abnormal laboratory value|2|||
94245440|NCT01498887|322691749|FG001|Overall Study|Abnormal laboratory value|2|||
94245441|NCT01498887|322691748|FG000|Overall Study|Adverse Event|4|||
94245442|NCT01498887|322691749|FG001|Overall Study|Adverse Event|1|||
94245443|NCT00574873|322691752|FG000|Overall Study|Withdrawal by Subject|18|||
94245444|NCT00574873|322691753|FG001|Overall Study|Withdrawal by Subject|19|||
94245445|NCT00574873|322691752|FG000|Overall Study|Investigator request|18|||
94245446|NCT00574873|322691753|FG001|Overall Study|Investigator request|8|||
94245447|NCT00574873|322691752|FG000|Overall Study|Death|15|||
94245448|NCT00574873|322691753|FG001|Overall Study|Death|14|||
94245449|NCT00574873|322691752|FG000|Overall Study|Lost to Follow-up|14|||
94245450|NCT00574873|322691753|FG001|Overall Study|Lost to Follow-up|5|||
94245451|NCT00574873|322691752|FG000|Overall Study|Other|40|||
94245452|NCT00574873|322691753|FG001|Overall Study|Other|4|||
94245453|NCT00574873|322691752|FG000|Overall Study|Discontinuation of study by sponsor|5|||
94245454|NCT00574873|322691753|FG001|Overall Study|Discontinuation of study by sponsor|199|||
94245455|NCT00574873|322691752|FG000|Overall Study|Blank, site closed per local regulations|2|||
94591783|NCT01090323|323969048|FG001|Overall Study|Stopped end of core|0|||
94591784|NCT01090323|323969047|FG000|Overall Study|Stopped end of extension 1#|3|||
94245456|NCT00574873|322691753|FG001|Overall Study|Blank, site closed per local regulations|2|||
94591785|NCT01090323|323969048|FG001|Overall Study|Stopped end of extension 1#|1|||
94245457|NCT00574873|322691752|FG000|Overall Study|Extension Study|126|||
94245458|NCT00574873|322691753|FG001|Overall Study|Extension Study|0|||
94591786|NCT00638183|323969055|FG000|Overall Study|Adverse Event|23|||
94245459|NCT03563157|322691754|FG000|Overall Study|Progressive Disease|2|||
94245460|NCT05262517|322691755|FG000|Overall Study|Randomized but not treated|5|||
94245461|NCT05262517|322691756|FG001|Overall Study|Randomized but not treated|11|||
94591787|NCT00638183|323969055|FG000|Overall Study|Lack of Efficacy|14|||
94591788|NCT00638183|323969055|FG000|Overall Study|Physician Decision|9|||
94591789|NCT00638183|323969055|FG000|Overall Study|Lost to Follow-up|46|||
94591790|NCT00638183|323969055|FG000|Overall Study|Other reason not defined above|27|||
94591791|NCT02059291|323969056|FG000|Epoch 2|Lack of Efficacy|0|||
94591792|NCT02059291|323969057|FG001|Epoch 2|Lack of Efficacy|0|||
94245462|NCT03582943|322691758|FG000|Allocated to Groups|Withdrawal by Subject|1|||
94591793|NCT02059291|323969058|FG002|Epoch 2|Lack of Efficacy|0|||
94591794|NCT02059291|323969059|FG003|Epoch 2|Lack of Efficacy|1|||
94591795|NCT02059291|323969060|FG004|Epoch 2|Lack of Efficacy|0|||
94591796|NCT02059291|323969061|FG005|Epoch 2|Lack of Efficacy|1|||
94591797|NCT02059291|323969062|FG006|Epoch 2|Lack of Efficacy|0|||
94591798|NCT02059291|323969063|FG007|Epoch 2|Lack of Efficacy|0|||
94591799|NCT02059291|323969064|FG008|Epoch 2|Lack of Efficacy|0|||
94591800|NCT02059291|323969065|FG009|Epoch 2|Lack of Efficacy|0|||
94591801|NCT02059291|323969066|FG010|Epoch 2|Lack of Efficacy|0|||
94591802|NCT02059291|323969067|FG011|Epoch 2|Lack of Efficacy|0|||
94591803|NCT02059291|323969068|FG012|Epoch 2|Lack of Efficacy|0|||
94591804|NCT02059291|323969069|FG013|Epoch 2|Lack of Efficacy|0|||
94591805|NCT02059291|323969070|FG014|Epoch 2|Lack of Efficacy|0|||
94591806|NCT02059291|323969071|FG015|Epoch 2|Lack of Efficacy|0|||
94591807|NCT02059291|323969072|FG016|Epoch 2|Lack of Efficacy|0|||
94591808|NCT02059291|323969073|FG017|Epoch 2|Lack of Efficacy|0|||
94591809|NCT02059291|323969074|FG018|Epoch 2|Lack of Efficacy|0|||
94591810|NCT02059291|323969075|FG019|Epoch 2|Lack of Efficacy|0|||
94591811|NCT02059291|323969076|FG020|Epoch 2|Lack of Efficacy|0|||
94591812|NCT02059291|323969077|FG021|Epoch 2|Lack of Efficacy|0|||
94591813|NCT02059291|323969078|FG022|Epoch 2|Lack of Efficacy|0|||
94591814|NCT02059291|323969079|FG023|Epoch 2|Lack of Efficacy|0|||
94591815|NCT02059291|323969080|FG024|Epoch 2|Lack of Efficacy|0|||
94591816|NCT02059291|323969056|FG000|Epoch 2|Adverse Event|0|||
94591817|NCT02059291|323969057|FG001|Epoch 2|Adverse Event|0|||
94591818|NCT02059291|323969058|FG002|Epoch 2|Adverse Event|1|||
94591819|NCT02059291|323969059|FG003|Epoch 2|Adverse Event|1|||
94591820|NCT02059291|323969060|FG004|Epoch 2|Adverse Event|0|||
94591821|NCT02059291|323969061|FG005|Epoch 2|Adverse Event|0|||
94591822|NCT02059291|323969062|FG006|Epoch 2|Adverse Event|0|||
94591823|NCT02059291|323969063|FG007|Epoch 2|Adverse Event|1|||
94591824|NCT02059291|323969064|FG008|Epoch 2|Adverse Event|1|||
94591825|NCT02059291|323969065|FG009|Epoch 2|Adverse Event|0|||
94591826|NCT02059291|323969066|FG010|Epoch 2|Adverse Event|0|||
94591827|NCT02059291|323969067|FG011|Epoch 2|Adverse Event|0|||
94591828|NCT02059291|323969068|FG012|Epoch 2|Adverse Event|0|||
94591829|NCT02059291|323969069|FG013|Epoch 2|Adverse Event|0|||
94591830|NCT02059291|323969070|FG014|Epoch 2|Adverse Event|0|||
94591831|NCT02059291|323969071|FG015|Epoch 2|Adverse Event|0|||
94591832|NCT02059291|323969072|FG016|Epoch 2|Adverse Event|0|||
94591833|NCT02059291|323969073|FG017|Epoch 2|Adverse Event|0|||
94591834|NCT02059291|323969074|FG018|Epoch 2|Adverse Event|0|||
94245463|NCT03582943|322691759|FG001|Allocated to Groups|Withdrawal by Subject|1|||
94245464|NCT03582943|322691758|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
94245465|NCT03582943|322691759|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
94245466|NCT03582943|322691758|FG000|Analyzed|Protocol Violation|4|||
94245467|NCT03582943|322691759|FG001|Analyzed|Protocol Violation|1|||
94591835|NCT02059291|323969075|FG019|Epoch 2|Adverse Event|0|||
94245468|NCT01659853|322691762|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
94245469|NCT01659853|322691763|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
94591836|NCT02059291|323969076|FG020|Epoch 2|Adverse Event|0|||
94591837|NCT02059291|323969077|FG021|Epoch 2|Adverse Event|0|||
94591838|NCT02059291|323969078|FG022|Epoch 2|Adverse Event|0|||
94591839|NCT02059291|323969079|FG023|Epoch 2|Adverse Event|0|||
94591840|NCT02059291|323969080|FG024|Epoch 2|Adverse Event|0|||
94591841|NCT02059291|323969056|FG000|Epoch 2|Withdrawal by Subject|0|||
94591842|NCT02059291|323969057|FG001|Epoch 2|Withdrawal by Subject|1|||
94591843|NCT02059291|323969058|FG002|Epoch 2|Withdrawal by Subject|0|||
94591844|NCT02059291|323969059|FG003|Epoch 2|Withdrawal by Subject|0|||
94591845|NCT02059291|323969060|FG004|Epoch 2|Withdrawal by Subject|0|||
94591846|NCT02059291|323969061|FG005|Epoch 2|Withdrawal by Subject|1|||
94591847|NCT02059291|323969062|FG006|Epoch 2|Withdrawal by Subject|0|||
94591848|NCT02059291|323969063|FG007|Epoch 2|Withdrawal by Subject|0|||
94591849|NCT02059291|323969064|FG008|Epoch 2|Withdrawal by Subject|1|||
94591850|NCT02059291|323969065|FG009|Epoch 2|Withdrawal by Subject|0|||
94591851|NCT02059291|323969066|FG010|Epoch 2|Withdrawal by Subject|0|||
94591852|NCT02059291|323969067|FG011|Epoch 2|Withdrawal by Subject|0|||
94591853|NCT02059291|323969068|FG012|Epoch 2|Withdrawal by Subject|0|||
94591854|NCT02059291|323969069|FG013|Epoch 2|Withdrawal by Subject|0|||
94591855|NCT02059291|323969070|FG014|Epoch 2|Withdrawal by Subject|0|||
94591856|NCT02059291|323969071|FG015|Epoch 2|Withdrawal by Subject|0|||
94591857|NCT02059291|323969072|FG016|Epoch 2|Withdrawal by Subject|0|||
94591858|NCT02059291|323969073|FG017|Epoch 2|Withdrawal by Subject|0|||
94591859|NCT02059291|323969074|FG018|Epoch 2|Withdrawal by Subject|0|||
94591860|NCT02059291|323969075|FG019|Epoch 2|Withdrawal by Subject|0|||
94591861|NCT02059291|323969076|FG020|Epoch 2|Withdrawal by Subject|0|||
94591862|NCT02059291|323969077|FG021|Epoch 2|Withdrawal by Subject|0|||
94591863|NCT02059291|323969078|FG022|Epoch 2|Withdrawal by Subject|0|||
94591864|NCT02059291|323969079|FG023|Epoch 2|Withdrawal by Subject|0|||
94591865|NCT02059291|323969080|FG024|Epoch 2|Withdrawal by Subject|0|||
94591866|NCT02059291|323969056|FG000|Epoch 3|Physician Decision|0|||
94591867|NCT02059291|323969057|FG001|Epoch 3|Physician Decision|0|||
94591868|NCT02059291|323969058|FG002|Epoch 3|Physician Decision|0|||
94591869|NCT02059291|323969059|FG003|Epoch 3|Physician Decision|0|||
94591870|NCT02059291|323969060|FG004|Epoch 3|Physician Decision|0|||
94591871|NCT02059291|323969061|FG005|Epoch 3|Physician Decision|0|||
94591872|NCT02059291|323969062|FG006|Epoch 3|Physician Decision|0|||
94591873|NCT02059291|323969063|FG007|Epoch 3|Physician Decision|0|||
94591874|NCT02059291|323969064|FG008|Epoch 3|Physician Decision|0|||
94591875|NCT02059291|323969065|FG009|Epoch 3|Physician Decision|0|||
94591876|NCT02059291|323969066|FG010|Epoch 3|Physician Decision|0|||
94591877|NCT02059291|323969067|FG011|Epoch 3|Physician Decision|0|||
94591878|NCT02059291|323969068|FG012|Epoch 3|Physician Decision|0|||
94591879|NCT02059291|323969069|FG013|Epoch 3|Physician Decision|1|||
94591880|NCT02059291|323969070|FG014|Epoch 3|Physician Decision|0|||
94591881|NCT02059291|323969071|FG015|Epoch 3|Physician Decision|1|||
94591882|NCT02059291|323969072|FG016|Epoch 3|Physician Decision|0|||
94591883|NCT02059291|323969073|FG017|Epoch 3|Physician Decision|0|||
94591884|NCT02059291|323969074|FG018|Epoch 3|Physician Decision|0|||
94591885|NCT02059291|323969075|FG019|Epoch 3|Physician Decision|0|||
94591886|NCT02059291|323969076|FG020|Epoch 3|Physician Decision|0|||
94591887|NCT02059291|323969077|FG021|Epoch 3|Physician Decision|0|||
94591888|NCT02059291|323969078|FG022|Epoch 3|Physician Decision|0|||
94591889|NCT02059291|323969079|FG023|Epoch 3|Physician Decision|0|||
94591890|NCT02059291|323969080|FG024|Epoch 3|Physician Decision|0|||
94591891|NCT02059291|323969056|FG000|Epoch 3|Adverse Event|0|||
94591892|NCT02059291|323969057|FG001|Epoch 3|Adverse Event|0|||
94591893|NCT02059291|323969058|FG002|Epoch 3|Adverse Event|0|||
94591894|NCT02059291|323969059|FG003|Epoch 3|Adverse Event|0|||
94591895|NCT02059291|323969060|FG004|Epoch 3|Adverse Event|0|||
94591896|NCT02059291|323969061|FG005|Epoch 3|Adverse Event|0|||
94591897|NCT02059291|323969062|FG006|Epoch 3|Adverse Event|0|||
94591898|NCT02059291|323969063|FG007|Epoch 3|Adverse Event|0|||
94591899|NCT02059291|323969064|FG008|Epoch 3|Adverse Event|0|||
94591900|NCT02059291|323969065|FG009|Epoch 3|Adverse Event|0|||
94591901|NCT02059291|323969066|FG010|Epoch 3|Adverse Event|0|||
94591902|NCT02059291|323969067|FG011|Epoch 3|Adverse Event|0|||
94591903|NCT02059291|323969068|FG012|Epoch 3|Adverse Event|0|||
94591904|NCT02059291|323969069|FG013|Epoch 3|Adverse Event|0|||
94591905|NCT02059291|323969070|FG014|Epoch 3|Adverse Event|0|||
94591906|NCT02059291|323969071|FG015|Epoch 3|Adverse Event|1|||
94591907|NCT02059291|323969072|FG016|Epoch 3|Adverse Event|0|||
94591908|NCT02059291|323969073|FG017|Epoch 3|Adverse Event|0|||
94591909|NCT02059291|323969074|FG018|Epoch 3|Adverse Event|0|||
94591910|NCT02059291|323969075|FG019|Epoch 3|Adverse Event|0|||
94591911|NCT02059291|323969076|FG020|Epoch 3|Adverse Event|0|||
94591912|NCT02059291|323969077|FG021|Epoch 3|Adverse Event|0|||
94591913|NCT02059291|323969078|FG022|Epoch 3|Adverse Event|0|||
94591914|NCT02059291|323969079|FG023|Epoch 3|Adverse Event|0|||
94591915|NCT02059291|323969080|FG024|Epoch 3|Adverse Event|0|||
94591916|NCT02059291|323969056|FG000|Epoch 3|Lack of Efficacy|0|||
94591917|NCT02059291|323969057|FG001|Epoch 3|Lack of Efficacy|0|||
94591918|NCT02059291|323969058|FG002|Epoch 3|Lack of Efficacy|0|||
94591919|NCT02059291|323969059|FG003|Epoch 3|Lack of Efficacy|0|||
94591920|NCT02059291|323969060|FG004|Epoch 3|Lack of Efficacy|0|||
94591921|NCT02059291|323969061|FG005|Epoch 3|Lack of Efficacy|0|||
94591922|NCT02059291|323969062|FG006|Epoch 3|Lack of Efficacy|0|||
94591923|NCT02059291|323969063|FG007|Epoch 3|Lack of Efficacy|0|||
94591924|NCT02059291|323969064|FG008|Epoch 3|Lack of Efficacy|0|||
94591925|NCT02059291|323969065|FG009|Epoch 3|Lack of Efficacy|0|||
94591926|NCT02059291|323969066|FG010|Epoch 3|Lack of Efficacy|0|||
94591927|NCT02059291|323969067|FG011|Epoch 3|Lack of Efficacy|0|||
94591928|NCT02059291|323969068|FG012|Epoch 3|Lack of Efficacy|0|||
94591929|NCT02059291|323969069|FG013|Epoch 3|Lack of Efficacy|0|||
94591930|NCT02059291|323969070|FG014|Epoch 3|Lack of Efficacy|0|||
94591931|NCT02059291|323969071|FG015|Epoch 3|Lack of Efficacy|3|||
94591932|NCT02059291|323969072|FG016|Epoch 3|Lack of Efficacy|0|||
94591933|NCT02059291|323969073|FG017|Epoch 3|Lack of Efficacy|0|||
94591934|NCT02059291|323969074|FG018|Epoch 3|Lack of Efficacy|0|||
94591935|NCT02059291|323969075|FG019|Epoch 3|Lack of Efficacy|0|||
94591936|NCT02059291|323969076|FG020|Epoch 3|Lack of Efficacy|0|||
94591937|NCT02059291|323969077|FG021|Epoch 3|Lack of Efficacy|0|||
94591938|NCT02059291|323969078|FG022|Epoch 3|Lack of Efficacy|0|||
94591939|NCT02059291|323969079|FG023|Epoch 3|Lack of Efficacy|0|||
94591940|NCT02059291|323969080|FG024|Epoch 3|Lack of Efficacy|0|||
94591941|NCT02059291|323969056|FG000|Epoch 3|Withdrawal by Subject|0|||
94591942|NCT02059291|323969057|FG001|Epoch 3|Withdrawal by Subject|0|||
94591943|NCT02059291|323969058|FG002|Epoch 3|Withdrawal by Subject|0|||
94591944|NCT02059291|323969059|FG003|Epoch 3|Withdrawal by Subject|0|||
94591945|NCT02059291|323969060|FG004|Epoch 3|Withdrawal by Subject|0|||
94591946|NCT02059291|323969061|FG005|Epoch 3|Withdrawal by Subject|0|||
94591947|NCT02059291|323969062|FG006|Epoch 3|Withdrawal by Subject|0|||
94591948|NCT02059291|323969063|FG007|Epoch 3|Withdrawal by Subject|0|||
94591949|NCT02059291|323969064|FG008|Epoch 3|Withdrawal by Subject|0|||
94591950|NCT02059291|323969065|FG009|Epoch 3|Withdrawal by Subject|0|||
94591951|NCT02059291|323969066|FG010|Epoch 3|Withdrawal by Subject|0|||
94591952|NCT02059291|323969067|FG011|Epoch 3|Withdrawal by Subject|0|||
94591953|NCT02059291|323969068|FG012|Epoch 3|Withdrawal by Subject|0|||
94591954|NCT02059291|323969069|FG013|Epoch 3|Withdrawal by Subject|0|||
94591955|NCT02059291|323969070|FG014|Epoch 3|Withdrawal by Subject|0|||
94591956|NCT02059291|323969071|FG015|Epoch 3|Withdrawal by Subject|1|||
94591957|NCT02059291|323969072|FG016|Epoch 3|Withdrawal by Subject|0|||
94591958|NCT02059291|323969073|FG017|Epoch 3|Withdrawal by Subject|0|||
94591959|NCT02059291|323969074|FG018|Epoch 3|Withdrawal by Subject|0|||
94591960|NCT02059291|323969075|FG019|Epoch 3|Withdrawal by Subject|0|||
94591961|NCT02059291|323969076|FG020|Epoch 3|Withdrawal by Subject|0|||
94591962|NCT02059291|323969077|FG021|Epoch 3|Withdrawal by Subject|0|||
94591963|NCT02059291|323969078|FG022|Epoch 3|Withdrawal by Subject|0|||
94591964|NCT02059291|323969079|FG023|Epoch 3|Withdrawal by Subject|0|||
94591965|NCT02059291|323969080|FG024|Epoch 3|Withdrawal by Subject|0|||
94591966|NCT02059291|323969056|FG000|Epoch 4|Adverse Event|0|||
94591967|NCT02059291|323969057|FG001|Epoch 4|Adverse Event|0|||
94591968|NCT02059291|323969058|FG002|Epoch 4|Adverse Event|0|||
94591969|NCT02059291|323969059|FG003|Epoch 4|Adverse Event|0|||
94591970|NCT02059291|323969060|FG004|Epoch 4|Adverse Event|0|||
94591971|NCT02059291|323969061|FG005|Epoch 4|Adverse Event|0|||
94591972|NCT02059291|323969062|FG006|Epoch 4|Adverse Event|0|||
94591973|NCT02059291|323969063|FG007|Epoch 4|Adverse Event|0|||
94591974|NCT02059291|323969064|FG008|Epoch 4|Adverse Event|0|||
94591975|NCT02059291|323969065|FG009|Epoch 4|Adverse Event|0|||
94591976|NCT02059291|323969066|FG010|Epoch 4|Adverse Event|0|||
94591977|NCT02059291|323969067|FG011|Epoch 4|Adverse Event|0|||
94591978|NCT02059291|323969068|FG012|Epoch 4|Adverse Event|0|||
94591979|NCT02059291|323969069|FG013|Epoch 4|Adverse Event|0|||
94591980|NCT02059291|323969070|FG014|Epoch 4|Adverse Event|0|||
94591981|NCT02059291|323969071|FG015|Epoch 4|Adverse Event|0|||
94591982|NCT02059291|323969072|FG016|Epoch 4|Adverse Event|1|||
94591983|NCT02059291|323969073|FG017|Epoch 4|Adverse Event|0|||
94591984|NCT02059291|323969074|FG018|Epoch 4|Adverse Event|0|||
94591985|NCT02059291|323969075|FG019|Epoch 4|Adverse Event|0|||
94591986|NCT02059291|323969076|FG020|Epoch 4|Adverse Event|0|||
94591987|NCT02059291|323969077|FG021|Epoch 4|Adverse Event|0|||
94591988|NCT02059291|323969078|FG022|Epoch 4|Adverse Event|1|||
94591989|NCT02059291|323969079|FG023|Epoch 4|Adverse Event|0|||
94591990|NCT02059291|323969080|FG024|Epoch 4|Adverse Event|0|||
94591991|NCT02059291|323969056|FG000|Epoch 4|Pregnancy|0|||
94591992|NCT02059291|323969057|FG001|Epoch 4|Pregnancy|0|||
94591993|NCT02059291|323969058|FG002|Epoch 4|Pregnancy|0|||
94591994|NCT02059291|323969059|FG003|Epoch 4|Pregnancy|0|||
94591995|NCT02059291|323969060|FG004|Epoch 4|Pregnancy|0|||
94591996|NCT02059291|323969061|FG005|Epoch 4|Pregnancy|0|||
94591997|NCT02059291|323969062|FG006|Epoch 4|Pregnancy|0|||
94591998|NCT02059291|323969063|FG007|Epoch 4|Pregnancy|0|||
94591999|NCT02059291|323969064|FG008|Epoch 4|Pregnancy|0|||
94592000|NCT02059291|323969065|FG009|Epoch 4|Pregnancy|0|||
94592001|NCT02059291|323969066|FG010|Epoch 4|Pregnancy|0|||
94592002|NCT02059291|323969067|FG011|Epoch 4|Pregnancy|0|||
94592003|NCT02059291|323969068|FG012|Epoch 4|Pregnancy|0|||
94592004|NCT02059291|323969069|FG013|Epoch 4|Pregnancy|0|||
94592005|NCT02059291|323969070|FG014|Epoch 4|Pregnancy|0|||
94592006|NCT02059291|323969071|FG015|Epoch 4|Pregnancy|0|||
94592007|NCT02059291|323969072|FG016|Epoch 4|Pregnancy|1|||
94592008|NCT02059291|323969073|FG017|Epoch 4|Pregnancy|0|||
94592009|NCT02059291|323969074|FG018|Epoch 4|Pregnancy|0|||
94592010|NCT02059291|323969075|FG019|Epoch 4|Pregnancy|0|||
94592011|NCT02059291|323969076|FG020|Epoch 4|Pregnancy|0|||
94592012|NCT02059291|323969077|FG021|Epoch 4|Pregnancy|0|||
94592013|NCT02059291|323969078|FG022|Epoch 4|Pregnancy|0|||
94592014|NCT02059291|323969079|FG023|Epoch 4|Pregnancy|0|||
94592015|NCT02059291|323969080|FG024|Epoch 4|Pregnancy|0|||
94592016|NCT02059291|323969056|FG000|Epoch 4|Withdrawal by Subject|0|||
94592017|NCT02059291|323969057|FG001|Epoch 4|Withdrawal by Subject|0|||
94592018|NCT02059291|323969058|FG002|Epoch 4|Withdrawal by Subject|0|||
94592019|NCT02059291|323969059|FG003|Epoch 4|Withdrawal by Subject|0|||
94592020|NCT02059291|323969060|FG004|Epoch 4|Withdrawal by Subject|0|||
94592021|NCT02059291|323969061|FG005|Epoch 4|Withdrawal by Subject|0|||
94592022|NCT02059291|323969062|FG006|Epoch 4|Withdrawal by Subject|0|||
94592023|NCT02059291|323969063|FG007|Epoch 4|Withdrawal by Subject|0|||
94592024|NCT02059291|323969064|FG008|Epoch 4|Withdrawal by Subject|0|||
94592025|NCT02059291|323969065|FG009|Epoch 4|Withdrawal by Subject|0|||
94592026|NCT02059291|323969066|FG010|Epoch 4|Withdrawal by Subject|0|||
94592027|NCT02059291|323969067|FG011|Epoch 4|Withdrawal by Subject|0|||
94592028|NCT02059291|323969068|FG012|Epoch 4|Withdrawal by Subject|0|||
94592029|NCT02059291|323969069|FG013|Epoch 4|Withdrawal by Subject|0|||
94592030|NCT02059291|323969070|FG014|Epoch 4|Withdrawal by Subject|0|||
94592031|NCT02059291|323969071|FG015|Epoch 4|Withdrawal by Subject|0|||
94592032|NCT02059291|323969072|FG016|Epoch 4|Withdrawal by Subject|0|||
94592033|NCT02059291|323969073|FG017|Epoch 4|Withdrawal by Subject|0|||
94592034|NCT02059291|323969074|FG018|Epoch 4|Withdrawal by Subject|0|||
94592035|NCT02059291|323969075|FG019|Epoch 4|Withdrawal by Subject|0|||
94592036|NCT02059291|323969076|FG020|Epoch 4|Withdrawal by Subject|1|||
94592037|NCT02059291|323969077|FG021|Epoch 4|Withdrawal by Subject|0|||
94592038|NCT02059291|323969078|FG022|Epoch 4|Withdrawal by Subject|0|||
94592039|NCT02059291|323969079|FG023|Epoch 4|Withdrawal by Subject|0|||
94592040|NCT02059291|323969080|FG024|Epoch 4|Withdrawal by Subject|0|||
94592041|NCT02059291|323969056|FG000|Epoch 4|Lack of Efficacy|0|||
94592042|NCT02059291|323969057|FG001|Epoch 4|Lack of Efficacy|0|||
94592043|NCT02059291|323969058|FG002|Epoch 4|Lack of Efficacy|0|||
94592044|NCT02059291|323969059|FG003|Epoch 4|Lack of Efficacy|0|||
94592045|NCT02059291|323969060|FG004|Epoch 4|Lack of Efficacy|0|||
94592046|NCT02059291|323969061|FG005|Epoch 4|Lack of Efficacy|0|||
94592047|NCT02059291|323969062|FG006|Epoch 4|Lack of Efficacy|0|||
94592048|NCT02059291|323969063|FG007|Epoch 4|Lack of Efficacy|0|||
94592049|NCT02059291|323969064|FG008|Epoch 4|Lack of Efficacy|0|||
94592050|NCT02059291|323969065|FG009|Epoch 4|Lack of Efficacy|0|||
94592051|NCT02059291|323969066|FG010|Epoch 4|Lack of Efficacy|0|||
94592052|NCT02059291|323969067|FG011|Epoch 4|Lack of Efficacy|0|||
94592053|NCT02059291|323969068|FG012|Epoch 4|Lack of Efficacy|0|||
94592054|NCT02059291|323969069|FG013|Epoch 4|Lack of Efficacy|0|||
94592055|NCT02059291|323969070|FG014|Epoch 4|Lack of Efficacy|0|||
94355359|NCT00151775|323083565|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
94592056|NCT02059291|323969071|FG015|Epoch 4|Lack of Efficacy|0|||
94592057|NCT02059291|323969072|FG016|Epoch 4|Lack of Efficacy|0|||
94592058|NCT02059291|323969073|FG017|Epoch 4|Lack of Efficacy|0|||
94592059|NCT02059291|323969074|FG018|Epoch 4|Lack of Efficacy|0|||
94592060|NCT02059291|323969075|FG019|Epoch 4|Lack of Efficacy|0|||
94592061|NCT02059291|323969076|FG020|Epoch 4|Lack of Efficacy|0|||
94592062|NCT02059291|323969077|FG021|Epoch 4|Lack of Efficacy|0|||
94355360|NCT00151775|323083566|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
94592063|NCT02059291|323969078|FG022|Epoch 4|Lack of Efficacy|0|||
94592064|NCT02059291|323969079|FG023|Epoch 4|Lack of Efficacy|1|||
94592065|NCT02059291|323969080|FG024|Epoch 4|Lack of Efficacy|0|||
94592066|NCT02640508|323969081|FG000|Overall Study|Death|19|||
94592067|NCT02640508|323969081|FG000|Overall Study|Withdrawal by Subject|8|||
94592068|NCT02640508|323969081|FG000|Overall Study|Physician Decision|1|||
94592069|NCT02640508|323969081|FG000|Overall Study|Lost to Follow-up|1|||
94592070|NCT04343235|323969082|FG000|Overall Study|Lost to Follow-up|3|||
94592071|NCT04343235|323969083|FG001|Overall Study|Lost to Follow-up|2|||
94592072|NCT01763996|323969084|FG000|Treatment Period 2|Adverse Event|0|||
94592073|NCT01763996|323969085|FG001|Treatment Period 2|Adverse Event|1|||
94592074|NCT01950013|323969086|FG000|Overall Study|Withdrawal by Subject|0|||
94592075|NCT01950013|323969087|FG001|Overall Study|Withdrawal by Subject|2|||
94592076|NCT01950013|323969088|FG002|Overall Study|Withdrawal by Subject|0|||
94592077|NCT03091348|323969091|FG000|Overall Study|Lost to Follow-up|2|||
94592078|NCT03091348|323969092|FG001|Overall Study|Lost to Follow-up|1|||
94592079|NCT01419197|323969096|FG000|Overall Study|Death|247|||
94592080|NCT01419197|323969097|FG001|Overall Study|Death|122|||
94592081|NCT01419197|323969096|FG000|Overall Study|Physician Decision|4|||
94592082|NCT01419197|323969097|FG001|Overall Study|Physician Decision|4|||
94592083|NCT01419197|323969096|FG000|Overall Study|Non-compliance|3|||
94592084|NCT01419197|323969097|FG001|Overall Study|Non-compliance|1|||
94592085|NCT01419197|323969096|FG000|Overall Study|Withdrawal by Subject|33|||
94592086|NCT01419197|323969097|FG001|Overall Study|Withdrawal by Subject|32|||
94592087|NCT01419197|323969096|FG000|Overall Study|Study Completed by Sponsor|103|||
94592088|NCT01419197|323969097|FG001|Overall Study|Study Completed by Sponsor|34|||
94592089|NCT01419197|323969096|FG000|Overall Study|Reason Not Specified|0|||
94592090|NCT01419197|323969097|FG001|Overall Study|Reason Not Specified|1|||
94592091|NCT01419197|323969096|FG000|Overall Study|Lost to Follow-up|14|||
94592092|NCT01419197|323969097|FG001|Overall Study|Lost to Follow-up|4|||
94592093|NCT00653939|323969098|FG000|Overall Study|Adverse Event|1|||
94592094|NCT00653939|323969099|FG001|Overall Study|Adverse Event|3|||
94592095|NCT00653939|323969098|FG000|Overall Study|Withdrawal by Subject|3|||
94592096|NCT00653939|323969099|FG001|Overall Study|Withdrawal by Subject|3|||
94592097|NCT00653939|323969098|FG000|Overall Study|Physician Decision|4|||
94592098|NCT00653939|323969099|FG001|Overall Study|Physician Decision|0|||
94592099|NCT00653939|323969098|FG000|Overall Study|Disease Progression|2|||
94592100|NCT00653939|323969099|FG001|Overall Study|Disease Progression|3|||
94592101|NCT00653939|323969098|FG000|Overall Study|Other|2|||
94592102|NCT00653939|323969099|FG001|Overall Study|Other|6|||
94592103|NCT00796523|323969103|FG000|Overall Study|Lost to Follow-up|9|||
94592104|NCT00796523|323969104|FG001|Overall Study|Lost to Follow-up|7|||
94592105|NCT02156271|323971307|FG000|Overall Study|Physician Decision|4|||
94592106|NCT02156271|323971308|FG001|Overall Study|Physician Decision|3|||
94245470|NCT01659853|322691762|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
94245471|NCT01659853|322691763|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
94245472|NCT01493427|322691764|FG000|Overall Study|Adverse Event|10|||
94245473|NCT01493427|322691764|FG000|Overall Study|Personal Reasons|4|||
94245474|NCT01493427|322691764|FG000|Overall Study|Lost to Follow-up|2|||
94245475|NCT01493427|322691764|FG000|Overall Study|Inability to Follow Instructions|2|||
94245476|NCT01493427|322691764|FG000|Overall Study|Other|2|||
94245477|NCT05775991|322691765|FG000|Overall Study|Withdrawal by Subject|0|||
94245478|NCT05775991|322691766|FG001|Overall Study|Withdrawal by Subject|0|||
94245479|NCT05775991|322691767|FG002|Overall Study|Withdrawal by Subject|2|||
94245480|NCT02075073|322691772|FG000|Overall Study|Withdrawal by Subject|0|||
94245481|NCT02075073|322691773|FG001|Overall Study|Withdrawal by Subject|1|||
94245482|NCT02075073|322691774|FG002|Overall Study|Withdrawal by Subject|0|||
94245483|NCT00403767|322691775|FG000|Overall Study|Adverse Event|993|||
94245484|NCT00403767|322691776|FG001|Overall Study|Adverse Event|919|||
94245485|NCT00403767|322691775|FG000|Overall Study|Non-compliant with study medication|134|||
94245486|NCT00403767|322691776|FG001|Overall Study|Non-compliant with study medication|164|||
94245487|NCT00403767|322691775|FG000|Overall Study|Consent withdrawn|671|||
94245488|NCT00403767|322691776|FG001|Overall Study|Consent withdrawn|673|||
94245489|NCT00403767|322691775|FG000|Overall Study|Investigator dec./not protocol-related|191|||
94245490|NCT00403767|322691776|FG001|Overall Study|Investigator dec./not protocol-related|178|||
94245491|NCT00403767|322691775|FG000|Overall Study|Lost to Follow-up|6|||
94245492|NCT00403767|322691776|FG001|Overall Study|Lost to Follow-up|8|||
94245493|NCT00403767|322691775|FG000|Overall Study|Protocol Violation|142|||
94245494|NCT00403767|322691776|FG001|Overall Study|Protocol Violation|124|||
94245495|NCT00403767|322691775|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
94245496|NCT00403767|322691776|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
94592107|NCT03254108|323971311|FG000|Overall Study|Adverse Event|0|||
94245497|NCT00403767|322691775|FG000|Overall Study|Study terminated by sponsor|82|||
94592108|NCT03254108|323971312|FG001|Overall Study|Adverse Event|2|||
94592109|NCT03254108|323971313|FG002|Overall Study|Adverse Event|0|||
94592110|NCT03254108|323971314|FG003|Overall Study|Adverse Event|1|||
94245498|NCT00403767|322691776|FG001|Overall Study|Study terminated by sponsor|69|||
94245499|NCT00403767|322691775|FG000|Overall Study|Missing/incomplete data|1|||
94245500|NCT00403767|322691776|FG001|Overall Study|Missing/incomplete data|1|||
94592111|NCT03254108|323971315|FG004|Overall Study|Adverse Event|1|||
94592112|NCT03254108|323971311|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
94592113|NCT03254108|323971312|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
94592114|NCT03254108|323971313|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
94592115|NCT03254108|323971314|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
94592116|NCT03254108|323971315|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
94592117|NCT00588861|323971316|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
94592118|NCT00588861|323971317|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
94592119|NCT00588861|323971316|FG000|6 Months|Patients did not return for follow-up|98|||
94592120|NCT00588861|323971317|FG001|6 Months|Patients did not return for follow-up|73|||
94592121|NCT00588861|323971316|FG000|1 Year|Patients did not return for follow-up|89|||
94592122|NCT00588861|323971317|FG001|1 Year|Patients did not return for follow-up|82|||
94592123|NCT00588861|323971316|FG000|2 Years|Patients did not return for follow-up|92|||
94592124|NCT00588861|323971317|FG001|2 Years|Patients did not return for follow-up|87|||
94592125|NCT00588861|323971316|FG000|4 Years|Patients did not return for follow-up|91|||
94592126|NCT00588861|323971317|FG001|4 Years|Patients did not return for follow-up|103|||
94592127|NCT00588861|323971316|FG000|6 Years|Patients did not return for follow-up|104|||
94592128|NCT00588861|323971317|FG001|6 Years|Patients did not return for follow-up|109|||
94592129|NCT00588861|323971316|FG000|8 Years|Patients did not return for follow-up|105|||
94245501|NCT05330676|322691780|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
94245502|NCT05330676|322691781|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
94245503|NCT03653208|322691782|FG000|Overall Study|Withdrawal by Subject|0|||
94245504|NCT03653208|322691783|FG001|Overall Study|Withdrawal by Subject|0|||
94245505|NCT03653208|322691784|FG002|Overall Study|Withdrawal by Subject|0|||
94592130|NCT00588861|323971317|FG001|8 Years|Patients did not return for follow-up|114|||
94592131|NCT00588861|323971316|FG000|10 Years|Incomplete due to study termination|107|||
94592132|NCT00588861|323971317|FG001|10 Years|Incomplete due to study termination|114|||
94592133|NCT00490529|323971318|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
94592134|NCT00490529|323971318|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
94592135|NCT00490529|323971318|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
94245506|NCT03653208|322691785|FG003|Overall Study|Withdrawal by Subject|0|||
94245507|NCT03653208|322691786|FG004|Overall Study|Withdrawal by Subject|1|||
94245508|NCT03653208|322691787|FG005|Overall Study|Withdrawal by Subject|0|||
94592136|NCT00490529|323971318|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
94592137|NCT00490529|323971318|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
94592138|NCT00490529|323971318|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
94592139|NCT03254459|323971320|FG000|Overall Study|Adverse Event|7|||
94592140|NCT03254459|323971321|FG001|Overall Study|Adverse Event|20|||
94592141|NCT03254459|323971320|FG000|Overall Study|Withdrawal by Subject Consent|3|||
94592142|NCT03254459|323971321|FG001|Overall Study|Withdrawal by Subject Consent|1|||
94592143|NCT03254459|323971320|FG000|Overall Study|Lost to Follow-up|0|||
94592144|NCT03254459|323971321|FG001|Overall Study|Lost to Follow-up|1|||
94245509|NCT03653208|322691788|FG006|Overall Study|Withdrawal by Subject|0|||
94245510|NCT03653208|322691789|FG007|Overall Study|Withdrawal by Subject|1|||
94245511|NCT03653208|322691790|FG008|Overall Study|Withdrawal by Subject|1|||
94245512|NCT00436605|322691791|FG000|Overall Study|Protocol Violation|3|||
94592145|NCT03254459|323971320|FG000|Overall Study|Miscellaneous|0|||
94592146|NCT03254459|323971321|FG001|Overall Study|Miscellaneous|1|||
94592147|NCT01239992|323971322|FG000|Overall Study|Withdrawal by Subject|2|||
94592148|NCT01120782|323971335|FG000|Overall Study|Test article shipping error|11|||
94592149|NCT03255629|323971336|FG000|Overall Study|Adverse Event|1|||
94592150|NCT03255629|323971337|FG001|Overall Study|Adverse Event|0|||
94592151|NCT03255629|323971336|FG000|Overall Study|did not experience hypoglycemia|2|||
94592152|NCT03255629|323971337|FG001|Overall Study|did not experience hypoglycemia|1|||
94592153|NCT00910624|323971341|FG000|Treatment Phase|Adverse Event|2|||
94592154|NCT00910624|323971342|FG001|Treatment Phase|Adverse Event|6|||
94592155|NCT00910624|323971343|FG002|Treatment Phase|Adverse Event|6|||
94592156|NCT00910624|323971344|FG003|Treatment Phase|Adverse Event|0|||
94592157|NCT00910624|323971341|FG000|Treatment Phase|Treatment Failure|23|||
94592158|NCT00910624|323971342|FG001|Treatment Phase|Treatment Failure|10|||
94592159|NCT00910624|323971343|FG002|Treatment Phase|Treatment Failure|0|||
94592160|NCT00910624|323971344|FG003|Treatment Phase|Treatment Failure|0|||
94592161|NCT00910624|323971341|FG000|Treatment Phase|Lost to Follow-up|0|||
94592162|NCT00910624|323971342|FG001|Treatment Phase|Lost to Follow-up|0|||
94592163|NCT00910624|323971343|FG002|Treatment Phase|Lost to Follow-up|1|||
94592164|NCT00910624|323971344|FG003|Treatment Phase|Lost to Follow-up|0|||
94592165|NCT00910624|323971341|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
94592166|NCT00910624|323971342|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
94592167|NCT00910624|323971343|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
94592168|NCT00910624|323971344|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
94592169|NCT00910624|323971341|FG000|Treatment Phase|Withdrawal by Subject|2|||
94245513|NCT01559129|322691793|FG000|Treatment Phase|Adverse Event|0|||
94245514|NCT01559129|322691794|FG001|Treatment Phase|Adverse Event|2|||
94245515|NCT01559129|322691793|FG000|Treatment Phase|Progressive Disease|1|||
94245516|NCT01559129|322691794|FG001|Treatment Phase|Progressive Disease|1|||
94245517|NCT01559129|322691793|FG000|Treatment Phase|Lack of Efficacy|0|||
94245518|NCT01559129|322691794|FG001|Treatment Phase|Lack of Efficacy|1|||
94245519|NCT01559129|322691793|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
94245520|NCT01559129|322691794|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
94592170|NCT00910624|323971342|FG001|Treatment Phase|Withdrawal by Subject|1|||
94592171|NCT00910624|323971343|FG002|Treatment Phase|Withdrawal by Subject|0|||
94592172|NCT00910624|323971344|FG003|Treatment Phase|Withdrawal by Subject|0|||
94592173|NCT00910624|323971341|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
94592174|NCT00910624|323971342|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
94659893|NCT01153633|324209968|FG000|Overall Study|Therapeutic failure|3|||
94659894|NCT01153633|324209969|FG001|Overall Study|Therapeutic failure|3|||
94659895|NCT02696850|324209970|FG000|Overall Study|Withdrawal by Subject|3|||
94592175|NCT00910624|323971343|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
94592176|NCT00910624|323971344|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
94592177|NCT00910624|323971341|FG000|Follow-Up Phase|Adverse Event|0|||
94592178|NCT00910624|323971342|FG001|Follow-Up Phase|Adverse Event|0|||
94592179|NCT00910624|323971343|FG002|Follow-Up Phase|Adverse Event|1|||
94592180|NCT00910624|323971344|FG003|Follow-Up Phase|Adverse Event|0|||
94592181|NCT00910624|323971341|FG000|Follow-Up Phase|Lost to Follow-up|3|||
94592182|NCT00910624|323971342|FG001|Follow-Up Phase|Lost to Follow-up|1|||
94592183|NCT00910624|323971343|FG002|Follow-Up Phase|Lost to Follow-up|2|||
94592184|NCT00910624|323971344|FG003|Follow-Up Phase|Lost to Follow-up|0|||
94592185|NCT00910624|323971341|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
94245521|NCT01559129|322691793|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
94245522|NCT01559129|322691794|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
94245523|NCT01559129|322691793|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
94592186|NCT00910624|323971342|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
94659896|NCT02696850|324209971|FG001|Overall Study|Withdrawal by Subject|3|||
94659897|NCT02696850|324209970|FG000|Overall Study|Lost to Follow-up|8|||
94659898|NCT02696850|324209971|FG001|Overall Study|Lost to Follow-up|5|||
94659899|NCT03725982|324209972|FG000|First Intervention|Withdrawal by Subject|0|||
94659900|NCT03725982|324209973|FG001|First Intervention|Withdrawal by Subject|1|||
94659901|NCT03725982|324209972|FG000|First Intervention|Physician Decision|1|||
94659902|NCT03725982|324209973|FG001|First Intervention|Physician Decision|1|||
94245524|NCT01559129|322691794|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
94245525|NCT01559129|322691793|FG000|Open-label Extension Period|Adverse Event|1|||
94245526|NCT01559129|322691794|FG001|Open-label Extension Period|Adverse Event|0|||
94245527|NCT01559129|322691793|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
94659903|NCT00673049|324209974|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
94659904|NCT00673049|324209975|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
94659905|NCT00673049|324209976|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
94659906|NCT00673049|324209977|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
94245528|NCT01559129|322691794|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
94245529|NCT02310100|322691803|FG000|Overall Study|Physician Decision|3|||
94659907|NCT00673049|324209974|FG000|Before Progression on Erlotinib|Death|235|||
94659908|NCT00673049|324209975|FG001|Before Progression on Erlotinib|Death|167|||
94245530|NCT02310100|322691803|FG000|Overall Study|Withdrawal by Subject|10|||
94592187|NCT00910624|323971343|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
94592188|NCT00910624|323971344|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
94592189|NCT00910624|323971341|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
94592190|NCT00910624|323971342|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
94592191|NCT00910624|323971343|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
94592192|NCT00910624|323971344|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
94592193|NCT00910624|323971341|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
94592194|NCT00910624|323971342|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
94592195|NCT00910624|323971343|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
94592196|NCT00910624|323971344|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
94592197|NCT00910624|323971341|FG000|Follow-Up Phase|Administrative|0|||
94592198|NCT00910624|323971342|FG001|Follow-Up Phase|Administrative|1|||
94592199|NCT00910624|323971343|FG002|Follow-Up Phase|Administrative|1|||
94592200|NCT00910624|323971344|FG003|Follow-Up Phase|Administrative|0|||
94592201|NCT00859638|323971345|FG000|Overall Study|Lost to Follow-up|6|||
94592202|NCT00859638|323971346|FG001|Overall Study|Lost to Follow-up|1|||
94592203|NCT00859638|323971345|FG000|Overall Study|Withdrawal by Subject|3|||
94592204|NCT00859638|323971346|FG001|Overall Study|Withdrawal by Subject|2|||
94592205|NCT00859638|323971345|FG000|Overall Study|Ill health|1|||
94592206|NCT00859638|323971346|FG001|Overall Study|Ill health|1|||
94592207|NCT00412373|323971347|FG000|Overall Study|Adverse Event|8|||
94592208|NCT00412373|323971348|FG001|Overall Study|Adverse Event|13|||
94592209|NCT00412373|323971347|FG000|Overall Study|Lack of Efficacy|16|||
94592210|NCT00412373|323971348|FG001|Overall Study|Lack of Efficacy|22|||
94592211|NCT00412373|323971347|FG000|Overall Study|Lost to Follow-up|7|||
94592212|NCT00412373|323971348|FG001|Overall Study|Lost to Follow-up|13|||
94592213|NCT00412373|323971347|FG000|Overall Study|Withdrawal by Subject|8|||
94592214|NCT00412373|323971348|FG001|Overall Study|Withdrawal by Subject|27|||
94592215|NCT00412373|323971347|FG000|Overall Study|Other|2|||
94592216|NCT00412373|323971348|FG001|Overall Study|Other|2|||
94592217|NCT02969408|323971350|FG000|Overall Study|Adverse Event|2|||
94592218|NCT02969408|323971350|FG000|Overall Study|Withdrawal by Subject|8|||
94592219|NCT02969408|323971350|FG000|Overall Study|Lost to Follow-up|4|||
94592220|NCT02969408|323971350|FG000|Overall Study|Protocol Violation|1|||
94592221|NCT02969408|323971350|FG000|Overall Study|Other than specified|1|||
94592222|NCT01104376|323971351|FG000|Overall Study|Withdrawal by Subject|15|||
94592223|NCT01104376|323971351|FG000|Overall Study|Consented but excluded after labs|13|||
94592224|NCT00797966|323971352|FG000|Phase A|Lost to Follow-up|0|||
94592225|NCT00797966|323971353|FG001|Phase A|Lost to Follow-up|0|||
94592226|NCT00797966|323971354|FG002|Phase A|Lost to Follow-up|0|||
94592227|NCT00797966|323971355|FG003|Phase A|Lost to Follow-up|0|||
94592228|NCT00797966|323971356|FG004|Phase A|Lost to Follow-up|33|||
94592229|NCT00797966|323971357|FG005|Phase A|Lost to Follow-up|0|||
94592230|NCT00797966|323971352|FG000|Phase A|Adverse Event|0|||
94592231|NCT00797966|323971353|FG001|Phase A|Adverse Event|0|||
94592232|NCT00797966|323971354|FG002|Phase A|Adverse Event|0|||
94592233|NCT00797966|323971355|FG003|Phase A|Adverse Event|0|||
94592234|NCT00797966|323971356|FG004|Phase A|Adverse Event|46|||
94592235|NCT00797966|323971357|FG005|Phase A|Adverse Event|0|||
94592236|NCT00797966|323971352|FG000|Phase A|Met withdrawal criteria|0|||
94592237|NCT00797966|323971353|FG001|Phase A|Met withdrawal criteria|0|||
94592238|NCT00797966|323971354|FG002|Phase A|Met withdrawal criteria|0|||
94592239|NCT00797966|323971355|FG003|Phase A|Met withdrawal criteria|0|||
94592240|NCT00797966|323971356|FG004|Phase A|Met withdrawal criteria|4|||
94592241|NCT00797966|323971357|FG005|Phase A|Met withdrawal criteria|0|||
94592242|NCT00797966|323971352|FG000|Phase A|Physician Decision|0|||
94592243|NCT00797966|323971353|FG001|Phase A|Physician Decision|0|||
94592244|NCT00797966|323971354|FG002|Phase A|Physician Decision|0|||
94592245|NCT00797966|323971355|FG003|Phase A|Physician Decision|0|||
94456496|NCT01943851|323460484|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
94456497|NCT01943851|323460485|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
94592246|NCT00797966|323971356|FG004|Phase A|Physician Decision|13|||
94592247|NCT00797966|323971357|FG005|Phase A|Physician Decision|0|||
94592248|NCT00797966|323971352|FG000|Phase A|Withdrawal by Subject|0|||
94592249|NCT00797966|323971353|FG001|Phase A|Withdrawal by Subject|0|||
94592250|NCT00797966|323971354|FG002|Phase A|Withdrawal by Subject|0|||
94592251|NCT00797966|323971355|FG003|Phase A|Withdrawal by Subject|0|||
94592252|NCT00797966|323971356|FG004|Phase A|Withdrawal by Subject|33|||
94592253|NCT00797966|323971357|FG005|Phase A|Withdrawal by Subject|0|||
94592254|NCT00797966|323971352|FG000|Phase A|Protocol deviation|0|||
94592255|NCT00797966|323971353|FG001|Phase A|Protocol deviation|0|||
94592256|NCT00797966|323971354|FG002|Phase A|Protocol deviation|0|||
94592257|NCT00797966|323971355|FG003|Phase A|Protocol deviation|0|||
94592258|NCT00797966|323971356|FG004|Phase A|Protocol deviation|56|||
94592259|NCT00797966|323971357|FG005|Phase A|Protocol deviation|0|||
94592260|NCT00797966|323971352|FG000|Phase B|Lost to Follow-up|0|||
94592261|NCT00797966|323971353|FG001|Phase B|Lost to Follow-up|1|||
94592262|NCT00797966|323971354|FG002|Phase B|Lost to Follow-up|3|||
94245531|NCT02310100|322691803|FG000|Overall Study|Enrollment closure|1|||
94592263|NCT00797966|323971355|FG003|Phase B|Lost to Follow-up|0|||
94592264|NCT00797966|323971356|FG004|Phase B|Lost to Follow-up|0|||
94245532|NCT02310100|322691803|FG000|Overall Study|Unapproved ablation operator|1|||
94245533|NCT02310100|322691803|FG000|Overall Study|Visit compliance|1|||
94245534|NCT02310100|322691803|FG000|Overall Study|Lost to Follow-up|2|||
94245535|NCT01669577|322691807|FG000|Overall Study|Death|22|||
94245536|NCT01669577|322691807|FG000|Overall Study|Lost to Follow-up|78|||
94245537|NCT01669577|322691807|FG000|Overall Study|Physician Decision|34|||
94245538|NCT00444275|322691818|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
94245539|NCT00444275|322691819|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
94245540|NCT00444275|322691820|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
94245541|NCT00444275|322691821|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
94245542|NCT00444275|322691822|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
94245543|NCT00444275|322691818|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
94245544|NCT00444275|322691819|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
94245545|NCT00444275|322691820|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
94245546|NCT00444275|322691821|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
94245547|NCT00444275|322691822|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
94245548|NCT00444275|322691818|FG000|Maintenance Treatment Phase|Adverse Event|0|||
94245549|NCT00444275|322691819|FG001|Maintenance Treatment Phase|Adverse Event|0|||
94245550|NCT00444275|322691820|FG002|Maintenance Treatment Phase|Adverse Event|3|||
94245551|NCT00444275|322691821|FG003|Maintenance Treatment Phase|Adverse Event|2|||
94245552|NCT00444275|322691822|FG004|Maintenance Treatment Phase|Adverse Event|13|||
94245553|NCT00444275|322691818|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
94245554|NCT00444275|322691819|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
94245555|NCT00444275|322691820|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
94245556|NCT00444275|322691821|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
94592265|NCT00797966|323971357|FG005|Phase B|Lost to Follow-up|0|||
94592266|NCT00797966|323971352|FG000|Phase B|Adverse Event|2|||
94592267|NCT00797966|323971353|FG001|Phase B|Adverse Event|1|||
94592268|NCT00797966|323971354|FG002|Phase B|Adverse Event|3|||
94592269|NCT00797966|323971355|FG003|Phase B|Adverse Event|1|||
94592270|NCT00797966|323971356|FG004|Phase B|Adverse Event|0|||
94592271|NCT00797966|323971357|FG005|Phase B|Adverse Event|0|||
94592272|NCT00797966|323971352|FG000|Phase B|Met Withdrawal Criteria|3|||
94592273|NCT00797966|323971353|FG001|Phase B|Met Withdrawal Criteria|3|||
94592274|NCT00797966|323971354|FG002|Phase B|Met Withdrawal Criteria|6|||
94592275|NCT00797966|323971355|FG003|Phase B|Met Withdrawal Criteria|1|||
94592276|NCT00797966|323971356|FG004|Phase B|Met Withdrawal Criteria|0|||
94245557|NCT00444275|322691822|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
94456498|NCT01943851|323460486|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
94456499|NCT01943851|323460487|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
94592277|NCT00797966|323971357|FG005|Phase B|Met Withdrawal Criteria|0|||
94592278|NCT00797966|323971352|FG000|Phase B|Physician Decision|1|||
94659909|NCT00673049|324209976|FG002|Before Progression on Erlotinib|Death|1|||
94592279|NCT00797966|323971353|FG001|Phase B|Physician Decision|0|||
94592280|NCT00797966|323971354|FG002|Phase B|Physician Decision|3|||
94245558|NCT00444275|322691818|FG000|Maintenance Treatment Phase|Patient's wish|0|||
94245559|NCT00444275|322691819|FG001|Maintenance Treatment Phase|Patient's wish|0|||
94245560|NCT00444275|322691820|FG002|Maintenance Treatment Phase|Patient's wish|19|||
94592281|NCT00797966|323971355|FG003|Phase B|Physician Decision|1|||
94245561|NCT00444275|322691821|FG003|Maintenance Treatment Phase|Patient's wish|9|||
94245562|NCT00444275|322691822|FG004|Maintenance Treatment Phase|Patient's wish|20|||
94245563|NCT00444275|322691818|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
94245564|NCT00444275|322691819|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
94245565|NCT00444275|322691820|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
94245566|NCT00444275|322691821|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
94245567|NCT00444275|322691822|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
94245568|NCT00444275|322691818|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
94245569|NCT00444275|322691819|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
94245570|NCT00444275|322691820|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
94245571|NCT00444275|322691821|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
94245572|NCT00444275|322691822|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
94245573|NCT01204710|322691823|FG000|Randomization Treatment|Lost to Follow-up|1|||
94245574|NCT01204710|322691824|FG001|Randomization Treatment|Lost to Follow-up|0|||
94245575|NCT01204710|322691823|FG000|Randomization Treatment|Withdrawal by Subject|6|||
94245576|NCT01204710|322691824|FG001|Randomization Treatment|Withdrawal by Subject|5|||
94245577|NCT01204710|322691823|FG000|Randomization Treatment|Physician Decision|3|||
94245578|NCT01204710|322691824|FG001|Randomization Treatment|Physician Decision|2|||
94245579|NCT01204710|322691823|FG000|Randomization Treatment|Entry criteria not met|0|||
94245580|NCT01204710|322691824|FG001|Randomization Treatment|Entry criteria not met|1|||
94245581|NCT01204710|322691823|FG000|Randomization Treatment|Adverse Event|4|||
94245582|NCT01204710|322691824|FG001|Randomization Treatment|Adverse Event|2|||
94245583|NCT01204710|322691823|FG000|Randomization Treatment|Sponsor Decision|0|||
94592282|NCT00797966|323971356|FG004|Phase B|Physician Decision|0|||
94592283|NCT00797966|323971357|FG005|Phase B|Physician Decision|0|||
94592284|NCT00797966|323971352|FG000|Phase B|Withdrawal by Subject|1|||
94592285|NCT00797966|323971353|FG001|Phase B|Withdrawal by Subject|4|||
94592286|NCT00797966|323971354|FG002|Phase B|Withdrawal by Subject|3|||
94592287|NCT00797966|323971355|FG003|Phase B|Withdrawal by Subject|3|||
94245584|NCT01204710|322691824|FG001|Randomization Treatment|Sponsor Decision|1|||
94245585|NCT01204710|322691823|FG000|Randomization Treatment|Worsening of General condition|0|||
94245586|NCT01204710|322691824|FG001|Randomization Treatment|Worsening of General condition|1|||
94245587|NCT01204710|322691823|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
94245588|NCT01204710|322691824|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
94592288|NCT00797966|323971356|FG004|Phase B|Withdrawal by Subject|0|||
94592289|NCT00797966|323971357|FG005|Phase B|Withdrawal by Subject|0|||
94592290|NCT00797966|323971352|FG000|Phase B|Protocol Deviation|4|||
94592291|NCT00797966|323971353|FG001|Phase B|Protocol Deviation|8|||
94592292|NCT00797966|323971354|FG002|Phase B|Protocol Deviation|2|||
94592293|NCT00797966|323971355|FG003|Phase B|Protocol Deviation|6|||
94592294|NCT00797966|323971356|FG004|Phase B|Protocol Deviation|0|||
94592295|NCT00797966|323971357|FG005|Phase B|Protocol Deviation|0|||
94592296|NCT00797966|323971352|FG000|Phase B|Lack of Efficacy|0|||
94592297|NCT00797966|323971353|FG001|Phase B|Lack of Efficacy|1|||
94592298|NCT00797966|323971354|FG002|Phase B|Lack of Efficacy|1|||
94592299|NCT00797966|323971355|FG003|Phase B|Lack of Efficacy|4|||
94245589|NCT01204710|322691823|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
94592300|NCT00797966|323971356|FG004|Phase B|Lack of Efficacy|0|||
94592301|NCT00797966|323971357|FG005|Phase B|Lack of Efficacy|0|||
94659910|NCT00673049|324209977|FG003|Before Progression on Erlotinib|Death|0|||
94659911|NCT00673049|324209974|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
94592302|NCT00797966|323971352|FG000|Phase A+|Lost to Follow-up|0|||
94592303|NCT00797966|323971353|FG001|Phase A+|Lost to Follow-up|0|||
94592304|NCT00797966|323971354|FG002|Phase A+|Lost to Follow-up|0|||
94592305|NCT00797966|323971355|FG003|Phase A+|Lost to Follow-up|0|||
94592306|NCT00797966|323971356|FG004|Phase A+|Lost to Follow-up|0|||
94592307|NCT00797966|323971357|FG005|Phase A+|Lost to Follow-up|9|||
94592308|NCT00797966|323971352|FG000|Phase A+|Met withdrawal criteria|0|||
94592309|NCT00797966|323971353|FG001|Phase A+|Met withdrawal criteria|0|||
94592310|NCT00797966|323971354|FG002|Phase A+|Met withdrawal criteria|0|||
94592311|NCT00797966|323971355|FG003|Phase A+|Met withdrawal criteria|0|||
94592312|NCT00797966|323971356|FG004|Phase A+|Met withdrawal criteria|0|||
94592313|NCT00797966|323971357|FG005|Phase A+|Met withdrawal criteria|5|||
94592314|NCT00797966|323971352|FG000|Phase A+|Withdrawal by Subject|0|||
94592315|NCT00797966|323971353|FG001|Phase A+|Withdrawal by Subject|0|||
94592316|NCT00797966|323971354|FG002|Phase A+|Withdrawal by Subject|0|||
94592317|NCT00797966|323971355|FG003|Phase A+|Withdrawal by Subject|0|||
94592318|NCT00797966|323971356|FG004|Phase A+|Withdrawal by Subject|0|||
94592319|NCT00797966|323971357|FG005|Phase A+|Withdrawal by Subject|6|||
94592320|NCT00797966|323971352|FG000|Phase A+|Adverse Event|0|||
94592321|NCT00797966|323971353|FG001|Phase A+|Adverse Event|0|||
94592322|NCT00797966|323971354|FG002|Phase A+|Adverse Event|0|||
94592323|NCT00797966|323971355|FG003|Phase A+|Adverse Event|0|||
94592324|NCT00797966|323971356|FG004|Phase A+|Adverse Event|0|||
94592325|NCT00797966|323971357|FG005|Phase A+|Adverse Event|4|||
94592326|NCT00797966|323971352|FG000|Phase A+|Protocol deviation|0|||
94592327|NCT00797966|323971353|FG001|Phase A+|Protocol deviation|0|||
94592328|NCT00797966|323971354|FG002|Phase A+|Protocol deviation|0|||
94592329|NCT00797966|323971355|FG003|Phase A+|Protocol deviation|0|||
94592330|NCT00797966|323971356|FG004|Phase A+|Protocol deviation|0|||
94592331|NCT00797966|323971357|FG005|Phase A+|Protocol deviation|4|||
94592332|NCT02722304|323971368|FG000|Overall Study|Study Terminated by Sponsor|1|||
94592333|NCT02722304|323971369|FG001|Overall Study|Study Terminated by Sponsor|0|||
94592334|NCT02722304|323971370|FG002|Overall Study|Study Terminated by Sponsor|2|||
94592335|NCT02722304|323971371|FG003|Overall Study|Study Terminated by Sponsor|1|||
94592336|NCT02722304|323971372|FG004|Overall Study|Study Terminated by Sponsor|1|||
94592337|NCT02722304|323971368|FG000|Overall Study|Other|0|||
94592338|NCT02722304|323971369|FG001|Overall Study|Other|0|||
94592339|NCT02722304|323971370|FG002|Overall Study|Other|0|||
94592340|NCT02722304|323971371|FG003|Overall Study|Other|1|||
94592341|NCT02722304|323971372|FG004|Overall Study|Other|1|||
94592342|NCT00635219|323971373|FG000|Overall Study|Adverse Event|12|||
94592343|NCT00635219|323971374|FG001|Overall Study|Adverse Event|10|||
94592344|NCT00635219|323971375|FG002|Overall Study|Adverse Event|18|||
94592345|NCT00635219|323971376|FG003|Overall Study|Adverse Event|15|||
94592346|NCT00635219|323971377|FG004|Overall Study|Adverse Event|19|||
94592347|NCT00635219|323971373|FG000|Overall Study|Lack of Efficacy|5|||
94592348|NCT00635219|323971374|FG001|Overall Study|Lack of Efficacy|6|||
94592349|NCT00635219|323971375|FG002|Overall Study|Lack of Efficacy|3|||
94592350|NCT00635219|323971376|FG003|Overall Study|Lack of Efficacy|4|||
94592351|NCT00635219|323971377|FG004|Overall Study|Lack of Efficacy|6|||
94659912|NCT00673049|324209975|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
94659913|NCT00673049|324209976|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
94592352|NCT00635219|323971373|FG000|Overall Study|Non-compliance With Study Product|0|||
94592353|NCT00635219|323971374|FG001|Overall Study|Non-compliance With Study Product|0|||
94592354|NCT00635219|323971375|FG002|Overall Study|Non-compliance With Study Product|0|||
94659914|NCT00673049|324209977|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
94592355|NCT00635219|323971376|FG003|Overall Study|Non-compliance With Study Product|2|||
94592356|NCT00635219|323971377|FG004|Overall Study|Non-compliance With Study Product|1|||
94592357|NCT00635219|323971373|FG000|Overall Study|Protocol Violation|0|||
94592358|NCT00635219|323971374|FG001|Overall Study|Protocol Violation|2|||
94592359|NCT00635219|323971375|FG002|Overall Study|Protocol Violation|3|||
94592360|NCT00635219|323971376|FG003|Overall Study|Protocol Violation|2|||
94592361|NCT00635219|323971377|FG004|Overall Study|Protocol Violation|4|||
94592362|NCT00635219|323971373|FG000|Overall Study|Withdrawal of Consent|8|||
94592363|NCT00635219|323971374|FG001|Overall Study|Withdrawal of Consent|6|||
94592364|NCT00635219|323971375|FG002|Overall Study|Withdrawal of Consent|8|||
94592365|NCT00635219|323971376|FG003|Overall Study|Withdrawal of Consent|11|||
94592366|NCT00635219|323971377|FG004|Overall Study|Withdrawal of Consent|8|||
94592367|NCT00635219|323971373|FG000|Overall Study|Lost to Follow-up|0|||
94592368|NCT00635219|323971374|FG001|Overall Study|Lost to Follow-up|0|||
94592369|NCT00635219|323971375|FG002|Overall Study|Lost to Follow-up|2|||
94592370|NCT00635219|323971376|FG003|Overall Study|Lost to Follow-up|0|||
94592371|NCT00635219|323971377|FG004|Overall Study|Lost to Follow-up|3|||
94592372|NCT00635219|323971373|FG000|Overall Study|Administrative or Other Reasons|0|||
94592373|NCT00635219|323971374|FG001|Overall Study|Administrative or Other Reasons|1|||
94592374|NCT00635219|323971375|FG002|Overall Study|Administrative or Other Reasons|1|||
94592375|NCT00635219|323971376|FG003|Overall Study|Administrative or Other Reasons|0|||
94592376|NCT00635219|323971377|FG004|Overall Study|Administrative or Other Reasons|1|||
94592377|NCT00435045|323971384|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
94592378|NCT00435045|323971385|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
94592379|NCT00435045|323971384|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
94592380|NCT00435045|323971385|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
94592381|NCT00435045|323971384|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
94592382|NCT00435045|323971385|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
94592383|NCT00435045|323971384|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
94592384|NCT00435045|323971385|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
94592385|NCT00435045|323971384|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
94592386|NCT00435045|323971385|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
94592387|NCT00435045|323971384|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
94592388|NCT00435045|323971385|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
94592389|NCT00435045|323971384|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
94592390|NCT00435045|323971385|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
94592391|NCT00435045|323971384|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
94592392|NCT00435045|323971385|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
94592393|NCT00435045|323971384|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
94592394|NCT00435045|323971385|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
94592395|NCT00435045|323971384|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
94592396|NCT00435045|323971385|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
94592397|NCT00435045|323971384|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
94592398|NCT00435045|323971385|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
94592399|NCT01853839|323971386|FG000|Overall Study|Violated inclusion criteria|2|||
94592400|NCT01853839|323971386|FG000|Overall Study|Not meet ITT population definition|58|||
94592401|NCT01853839|323971386|FG000|Overall Study|End of treatment visit too early|33|||
94592402|NCT01853839|323971386|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
94592403|NCT03672097|323971387|FG000|Period 1|Withdrawal by Subject|2|||
94592404|NCT03672097|323971387|FG000|Period 1|Adverse Event|1|||
94592405|NCT03672097|323971387|FG000|Period 1|Did not receive treatment|1|||
94592406|NCT03672097|323971387|FG000|Period 2|Withdrawal by Subject|3|||
94245590|NCT01204710|322691824|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
94245591|NCT01204710|322691823|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
94245592|NCT01204710|322691824|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
94245593|NCT01204710|322691823|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
94245594|NCT01204710|322691824|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
94245595|NCT01769326|322691825|FG000|Overall Study|Lost to Follow-up|1|||
94245596|NCT01769326|322691826|FG001|Overall Study|Lost to Follow-up|2|||
94245597|NCT01769326|322691827|FG002|Overall Study|Lost to Follow-up|0|||
94245598|NCT01769326|322691828|FG003|Overall Study|Lost to Follow-up|0|||
94245599|NCT01769326|322691825|FG000|Overall Study|unrelated injry|1|||
94245600|NCT01769326|322691826|FG001|Overall Study|unrelated injry|1|||
94245601|NCT01769326|322691827|FG002|Overall Study|unrelated injry|0|||
94245602|NCT01769326|322691828|FG003|Overall Study|unrelated injry|0|||
94245603|NCT01769326|322691825|FG000|Overall Study|got a job|0|||
94245604|NCT01769326|322691826|FG001|Overall Study|got a job|1|||
94245605|NCT01769326|322691827|FG002|Overall Study|got a job|0|||
94245606|NCT01769326|322691828|FG003|Overall Study|got a job|0|||
94245607|NCT01769326|322691825|FG000|Overall Study|Got sick and could not complete study|0|||
94245608|NCT01769326|322691826|FG001|Overall Study|Got sick and could not complete study|0|||
94245609|NCT01769326|322691827|FG002|Overall Study|Got sick and could not complete study|1|||
94245610|NCT01769326|322691828|FG003|Overall Study|Got sick and could not complete study|0|||
94245611|NCT02153073|322691829|FG000|Overall Study|Case Report Forms Uncollected|230|||
94245612|NCT02153073|322691829|FG000|Overall Study|Protocol Deviation|68|||
94245613|NCT01276379|322691830|FG000|Overall Study|Screening failure|40|||
94245614|NCT03590366|322691831|FG000|Overall Study|Adverse Event|0|||
94245615|NCT03590366|322691832|FG001|Overall Study|Adverse Event|3|||
94245616|NCT03590366|322691831|FG000|Overall Study|Lost to Follow-up|3|||
94245617|NCT03590366|322691832|FG001|Overall Study|Lost to Follow-up|3|||
94245618|NCT03590366|322691831|FG000|Overall Study|Withdrawal by Subject|0|||
94245619|NCT03590366|322691832|FG001|Overall Study|Withdrawal by Subject|2|||
94245620|NCT03309813|322691833|FG000|Main Randomized Study|Withdrawal by Subject|1|||
94245621|NCT03309813|322691834|FG001|Main Randomized Study|Withdrawal by Subject|0|||
94592407|NCT03672097|323971387|FG000|Period 2|Other|1|||
94592408|NCT02709538|323971388|FG000|Overall Study|Adverse Event|13|||
94592409|NCT02709538|323971389|FG001|Overall Study|Adverse Event|2|||
94456500|NCT01943851|323460488|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
94456501|NCT01943851|323460489|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
94456502|NCT01943851|323460490|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
94456503|NCT01943851|323460491|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
94456504|NCT01943851|323460492|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
94456505|NCT01943851|323460493|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
94592410|NCT02709538|323971390|FG002|Overall Study|Adverse Event|3|||
94245622|NCT00911768|322691835|FG000|Overall Study|Protocol Violation|5|||
94245623|NCT00911768|322691836|FG001|Overall Study|Protocol Violation|4|||
94245624|NCT00911768|322691835|FG000|Overall Study|Withdrawal by Subject|1|||
94245625|NCT00911768|322691836|FG001|Overall Study|Withdrawal by Subject|0|||
94245626|NCT04664400|322691837|FG000|Overall Study|Withdrawal by Subject|2|||
94245627|NCT00515853|322691838|FG000|Overall Study|Lost to Follow-up|9|||
94245628|NCT00515853|322691839|FG001|Overall Study|Lost to Follow-up|13|||
94245629|NCT00515853|322691838|FG000|Overall Study|Withdrawal by Subject|6|||
94245630|NCT00515853|322691839|FG001|Overall Study|Withdrawal by Subject|4|||
94245631|NCT03992846|322691842|FG000|Overall Study|Adverse Event|8|||
94245632|NCT03992846|322691843|FG001|Overall Study|Adverse Event|6|||
94355361|NCT00151775|323083567|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
94355362|NCT00151775|323083568|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
94355363|NCT00151775|323083569|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
94355364|NCT00151775|323083570|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
94355365|NCT00151775|323083571|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
94355366|NCT00151775|323083572|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
94355367|NCT00151775|323083573|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
94355368|NCT00151775|323083562|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
94355369|NCT00151775|323083563|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
94355370|NCT00151775|323083564|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
94355371|NCT00151775|323083565|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
94355372|NCT00151775|323083566|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
94355373|NCT00151775|323083567|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
94355374|NCT00151775|323083568|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
94355375|NCT00151775|323083569|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
94355376|NCT00151775|323083570|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
94355377|NCT00151775|323083571|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
94355378|NCT00151775|323083572|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
94355379|NCT00151775|323083573|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
94355380|NCT00151775|323083562|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
94355381|NCT00151775|323083563|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
94355382|NCT00151775|323083564|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
94245633|NCT03992846|322691844|FG002|Overall Study|Adverse Event|3|||
94245634|NCT03992846|322691842|FG000|Overall Study|Lost to Follow-up|0|||
94245635|NCT03992846|322691843|FG001|Overall Study|Lost to Follow-up|1|||
94245636|NCT03992846|322691844|FG002|Overall Study|Lost to Follow-up|1|||
94245637|NCT03992846|322691842|FG000|Overall Study|Pregnancy|2|||
94245638|NCT03992846|322691843|FG001|Overall Study|Pregnancy|0|||
94355383|NCT00151775|323083565|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
94245639|NCT03992846|322691844|FG002|Overall Study|Pregnancy|1|||
94245640|NCT03992846|322691842|FG000|Overall Study|Protocol Violation|1|||
94245641|NCT03992846|322691843|FG001|Overall Study|Protocol Violation|2|||
94245642|NCT03992846|322691844|FG002|Overall Study|Protocol Violation|0|||
94245643|NCT03992846|322691842|FG000|Overall Study|Withdrawal by Subject|8|||
94245644|NCT03992846|322691843|FG001|Overall Study|Withdrawal by Subject|10|||
94245645|NCT03992846|322691844|FG002|Overall Study|Withdrawal by Subject|20|||
94245646|NCT03992846|322691842|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
94245647|NCT03992846|322691843|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
94245648|NCT03992846|322691844|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
94245649|NCT02311673|322693670|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
94245650|NCT02311673|322693671|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
94245651|NCT02311673|322693672|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
94245652|NCT02311673|322693673|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
94245653|NCT01076153|322693681|FG000|Overall Study|Symptoms improved/resolved|10|||
94592411|NCT02709538|323971388|FG000|Overall Study|Lack of Efficacy|1|||
94245654|NCT01076153|322693681|FG000|Overall Study|Adverse Event|1|||
94245655|NCT04165031|322693682|FG000|Overall Study|Adverse Event|1|||
94245656|NCT04165031|322693683|FG001|Overall Study|Adverse Event|1|||
94245657|NCT04165031|322693684|FG002|Overall Study|Adverse Event|0|||
94245658|NCT04165031|322693685|FG003|Overall Study|Adverse Event|0|||
94245659|NCT04165031|322693686|FG004|Overall Study|Adverse Event|0|||
94245660|NCT04165031|322693687|FG005|Overall Study|Adverse Event|0|||
94245661|NCT04165031|322693682|FG000|Overall Study|Withdrawal by Subject|0|||
94245662|NCT04165031|322693683|FG001|Overall Study|Withdrawal by Subject|0|||
94245663|NCT04165031|322693684|FG002|Overall Study|Withdrawal by Subject|1|||
94245664|NCT04165031|322693685|FG003|Overall Study|Withdrawal by Subject|0|||
94245665|NCT04165031|322693686|FG004|Overall Study|Withdrawal by Subject|0|||
94245666|NCT04165031|322693687|FG005|Overall Study|Withdrawal by Subject|0|||
94245667|NCT02731690|322693688|FG000|Overall Study|Adverse Event|1|||
94245668|NCT02731690|322693688|FG000|Overall Study|Withdrawal by Subject|3|||
94245669|NCT02731690|322693688|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
94245670|NCT02735577|322693689|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
94245671|NCT02735577|322693689|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
94245672|NCT03140280|322693690|FG000|Overall Study|Physician Decision|5|||
94245673|NCT00663702|322693691|FG000|Overall Study|Adverse Event|8|||
94245674|NCT00663702|322693692|FG001|Overall Study|Adverse Event|4|||
94245675|NCT00663702|322693691|FG000|Overall Study|Withdrawal by Subject|3|||
94245676|NCT00663702|322693692|FG001|Overall Study|Withdrawal by Subject|1|||
94245677|NCT00663702|322693691|FG000|Overall Study|Pregnancy|0|||
94245678|NCT00663702|322693692|FG001|Overall Study|Pregnancy|1|||
94245679|NCT00663702|322693691|FG000|Overall Study|Lost to Follow-up|3|||
94245680|NCT00663702|322693692|FG001|Overall Study|Lost to Follow-up|0|||
94245681|NCT00663702|322693691|FG000|Overall Study|Death|1|||
94245682|NCT00663702|322693692|FG001|Overall Study|Death|1|||
94245683|NCT00663702|322693691|FG000|Overall Study|Lack of Efficacy|3|||
94245684|NCT00663702|322693692|FG001|Overall Study|Lack of Efficacy|3|||
94245685|NCT01552603|322693694|FG000|Overall Study|Physician Decision|1|||
94245686|NCT01144052|322693695|FG000|Overall Study|Withdrawal by Subject|1|||
94245687|NCT01144052|322693696|FG001|Overall Study|Withdrawal by Subject|1|||
94245688|NCT03896152|322693697|FG000|Overall Study|Patient/guardian decision|1|||
94245689|NCT03896152|322693698|FG001|Overall Study|Patient/guardian decision|1|||
94245690|NCT03896152|322693697|FG000|Overall Study|Adverse Event|0|||
94245691|NCT03896152|322693698|FG001|Overall Study|Adverse Event|1|||
94245692|NCT03896152|322693697|FG000|Overall Study|Physician Decision|1|||
94245693|NCT03896152|322693698|FG001|Overall Study|Physician Decision|0|||
94245694|NCT03896152|322693697|FG000|Overall Study|Technical problems|1|||
94245695|NCT03896152|322693698|FG001|Overall Study|Technical problems|0|||
94245696|NCT00436852|322693699|FG000|Overall Study|Death|23|||
94245697|NCT00436852|322693700|FG001|Overall Study|Death|34|||
94245698|NCT00436852|322693699|FG000|Overall Study|Lack of Efficacy|9|||
94245699|NCT00436852|322693700|FG001|Overall Study|Lack of Efficacy|7|||
94245700|NCT00436852|322693699|FG000|Overall Study|Withdrawal by Subject|2|||
94245701|NCT00436852|322693700|FG001|Overall Study|Withdrawal by Subject|4|||
94245702|NCT00436852|322693699|FG000|Overall Study|Ineligible|1|||
94245703|NCT00436852|322693700|FG001|Overall Study|Ineligible|0|||
94245704|NCT02182947|322693701|FG000|Overall Study|Withdrawal by Subject|7|||
94245705|NCT02182947|322693701|FG000|Overall Study|Lost to Follow-up|3|||
94245706|NCT02182947|322693701|FG000|Overall Study|Failed screening activities|8|||
94245707|NCT01656200|322693702|FG000|Overall Study|Withdrawal by Subject|1|||
94245708|NCT02236988|322693703|FG000|Overall Study|Lost to Follow-up|0|||
94245709|NCT02236988|322693704|FG001|Overall Study|Lost to Follow-up|0|||
94245710|NCT02236988|322693705|FG002|Overall Study|Lost to Follow-up|0|||
94245711|NCT02236988|322693706|FG003|Overall Study|Lost to Follow-up|1|||
94245712|NCT02236988|322693703|FG000|Overall Study|Unable to Comply with Study Visits|0|||
94245713|NCT02236988|322693704|FG001|Overall Study|Unable to Comply with Study Visits|0|||
94245714|NCT02236988|322693705|FG002|Overall Study|Unable to Comply with Study Visits|0|||
94245715|NCT02236988|322693706|FG003|Overall Study|Unable to Comply with Study Visits|2|||
94245716|NCT00730275|322693707|FG000|Overall Study|Withdrawal by Subject|0|||
94245717|NCT00730275|322693708|FG001|Overall Study|Withdrawal by Subject|0|||
94245718|NCT00730275|322693709|FG002|Overall Study|Withdrawal by Subject|0|||
94245719|NCT00730275|322693710|FG003|Overall Study|Withdrawal by Subject|1|||
94245720|NCT00356408|322693711|FG000|Overall Study|Adverse Event|9|||
94245721|NCT00356408|322693711|FG000|Overall Study|Lack of Efficacy|36|||
94245722|NCT00356408|322693711|FG000|Overall Study|Lost to Follow-up|2|||
94245723|NCT00356408|322693711|FG000|Overall Study|Withdrawal by Subject|6|||
94245724|NCT00356408|322693711|FG000|Overall Study|Other: Principal investigator discretion|3|||
94245725|NCT00356408|322693711|FG000|Overall Study|Other: Sponsor request|1|||
94245726|NCT00356408|322693711|FG000|Overall Study|Other: Azathioprine stopped|1|||
94245727|NCT00356408|322693711|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
94456506|NCT01943851|323460494|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
94456507|NCT01943851|323460495|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
94456508|NCT01943851|323460496|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
94456509|NCT01943851|323460497|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
94456510|NCT01943851|323460498|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
94456511|NCT01943851|323460499|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
94456512|NCT01943851|323460500|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
94456513|NCT01943851|323460483|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
94456514|NCT01943851|323460484|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
94456515|NCT01943851|323460485|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
94456516|NCT01943851|323460486|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
94456517|NCT01943851|323460487|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
94456518|NCT01943851|323460488|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
94456519|NCT01943851|323460489|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
94456520|NCT01943851|323460490|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
94456521|NCT01943851|323460491|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
94456522|NCT01943851|323460492|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
94456523|NCT01943851|323460493|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
94456524|NCT01943851|323460494|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
94456525|NCT01943851|323460495|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
94456526|NCT01943851|323460496|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
94456527|NCT01943851|323460497|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
94456528|NCT01943851|323460498|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
94456529|NCT01943851|323460499|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
94592412|NCT02709538|323971389|FG001|Overall Study|Lack of Efficacy|0|||
94456530|NCT01943851|323460500|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
94659915|NCT00673049|324209974|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
94659916|NCT00673049|324209975|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
94659917|NCT00673049|324209976|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
94659918|NCT00673049|324209977|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
94659919|NCT00673049|324209974|FG000|Before Progression on Erlotinib|Other|1|||
94659920|NCT00673049|324209975|FG001|Before Progression on Erlotinib|Other|2|||
94659921|NCT00673049|324209976|FG002|Before Progression on Erlotinib|Other|0|||
94659922|NCT00673049|324209977|FG003|Before Progression on Erlotinib|Other|0|||
94659923|NCT00673049|324209974|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
94659924|NCT00673049|324209975|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
94659925|NCT00673049|324209976|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
94659926|NCT00673049|324209977|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
94659927|NCT00673049|324209974|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
94659928|NCT00673049|324209975|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
94659929|NCT00673049|324209976|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
94659930|NCT00673049|324209977|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
94659931|NCT00673049|324209974|FG000|After Progression on Erlotinib|Death|0|||
94659932|NCT00673049|324209975|FG001|After Progression on Erlotinib|Death|0|||
94659933|NCT00673049|324209976|FG002|After Progression on Erlotinib|Death|0|||
94659934|NCT00673049|324209977|FG003|After Progression on Erlotinib|Death|71|||
94659935|NCT00673049|324209974|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
94659936|NCT00673049|324209975|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
94659937|NCT00673049|324209976|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
94659938|NCT00673049|324209977|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
94659939|NCT00673049|324209974|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
94659940|NCT00673049|324209975|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
94659941|NCT00673049|324209976|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
94659942|NCT00673049|324209977|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
94659943|NCT00673049|324209974|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
94659944|NCT00673049|324209975|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
94659945|NCT00673049|324209976|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
94456531|NCT01943851|323460483|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
94456532|NCT01943851|323460484|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
94456533|NCT01943851|323460485|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
94456534|NCT01943851|323460486|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
94456535|NCT01943851|323460487|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
94456536|NCT01943851|323460488|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
94456537|NCT01943851|323460489|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
94456538|NCT01943851|323460490|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
94456539|NCT01943851|323460491|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
94456540|NCT01943851|323460492|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
94456541|NCT01943851|323460493|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
94456542|NCT01943851|323460494|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
94456543|NCT01943851|323460495|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
94456544|NCT01943851|323460496|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
94456545|NCT01943851|323460497|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
94456546|NCT01943851|323460498|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
94456547|NCT01943851|323460499|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
94456548|NCT01943851|323460500|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
94456549|NCT01943851|323460483|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
94456550|NCT01943851|323460484|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
94456551|NCT01943851|323460485|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
94456552|NCT01943851|323460486|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
94456553|NCT01943851|323460487|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
94456554|NCT01943851|323460488|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
94456555|NCT01943851|323460489|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
94456556|NCT01943851|323460490|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
94456557|NCT01943851|323460491|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
94456558|NCT01943851|323460492|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
94456559|NCT01943851|323460493|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
94456560|NCT01943851|323460494|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
94456561|NCT01943851|323460495|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
94456562|NCT01943851|323460496|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
94456563|NCT01943851|323460497|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
94456564|NCT01943851|323460498|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
94456565|NCT01943851|323460499|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
94456566|NCT01943851|323460500|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
94456567|NCT04481191|323460501|FG000|Overall Study|Withdrawn by parent/guardian|15|||
94456568|NCT04481191|323460502|FG001|Overall Study|Withdrawn by parent/guardian|10|||
94456569|NCT01482065|323460523|FG000|Overall Study|Withdrawal by Subject|0|||
94456570|NCT01482065|323460524|FG001|Overall Study|Withdrawal by Subject|1|||
94456571|NCT04666259|323460525|FG000|Overall Study|ongoing at data cut-off|6|||
94456572|NCT04666259|323460526|FG001|Overall Study|ongoing at data cut-off|14|||
94456573|NCT04666259|323460527|FG002|Overall Study|ongoing at data cut-off|0|||
94456574|NCT04666259|323460525|FG000|Overall Study|Progressive Disease|0|||
94456575|NCT04666259|323460526|FG001|Overall Study|Progressive Disease|1|||
94456576|NCT04666259|323460527|FG002|Overall Study|Progressive Disease|0|||
94456577|NCT04666259|323460525|FG000|Overall Study|Physician Decision|9|||
94456578|NCT04666259|323460526|FG001|Overall Study|Physician Decision|3|||
94456579|NCT04666259|323460527|FG002|Overall Study|Physician Decision|3|||
94456580|NCT04666259|323460525|FG000|Overall Study|Adverse Event|3|||
94456581|NCT04666259|323460526|FG001|Overall Study|Adverse Event|1|||
94456582|NCT04666259|323460527|FG002|Overall Study|Adverse Event|0|||
94456583|NCT04666259|323460525|FG000|Overall Study|Withdrawal by Subject|1|||
94456584|NCT04666259|323460526|FG001|Overall Study|Withdrawal by Subject|2|||
94456585|NCT04666259|323460527|FG002|Overall Study|Withdrawal by Subject|0|||
94456586|NCT04666259|323460525|FG000|Overall Study|Enrolled but not treated and discontinued|1|||
94456587|NCT04666259|323460526|FG001|Overall Study|Enrolled but not treated and discontinued|0|||
94456588|NCT04666259|323460527|FG002|Overall Study|Enrolled but not treated and discontinued|0|||
94456589|NCT02222545|323460535|FG000|Overall Study|Adverse Event|1|||
94456590|NCT02222545|323460536|FG001|Overall Study|Adverse Event|0|||
94456591|NCT02222545|323460537|FG002|Overall Study|Adverse Event|2|||
94456592|NCT02222545|323460535|FG000|Overall Study|Death|0|||
94456593|NCT02222545|323460536|FG001|Overall Study|Death|0|||
94456594|NCT02222545|323460537|FG002|Overall Study|Death|9|||
94456595|NCT02222545|323460535|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
94456596|NCT02222545|323460536|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
94456597|NCT02222545|323460537|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
94456598|NCT02222545|323460535|FG000|Overall Study|Withdrawal by Subject|0|||
94456599|NCT02222545|323460536|FG001|Overall Study|Withdrawal by Subject|0|||
94456600|NCT02222545|323460537|FG002|Overall Study|Withdrawal by Subject|3|||
94456601|NCT02222545|323460535|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
94456602|NCT02222545|323460536|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
94456603|NCT02222545|323460537|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
94456604|NCT00761280|323460538|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
94456605|NCT00761280|323460539|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
94456606|NCT00761280|323460538|FG000|Randomization to First Dose|Sponsor decision|1|||
94456607|NCT00761280|323460539|FG001|Randomization to First Dose|Sponsor decision|0|||
94456608|NCT00761280|323460538|FG000|Randomization to First Dose|Other|1|||
94456609|NCT00761280|323460539|FG001|Randomization to First Dose|Other|0|||
94456610|NCT00761280|323460538|FG000|First Dose to End of Study|End of trial|5|||
94456611|NCT00761280|323460539|FG001|First Dose to End of Study|End of trial|5|||
94456612|NCT00761280|323460538|FG000|First Dose to End of Study|Progressive disease|5|||
94456613|NCT00761280|323460539|FG001|First Dose to End of Study|Progressive disease|3|||
94456614|NCT00761280|323460538|FG000|First Dose to End of Study|Sponsor decision|1|||
94456615|NCT00761280|323460539|FG001|First Dose to End of Study|Sponsor decision|2|||
94456616|NCT00761280|323460538|FG000|First Dose to End of Study|Death|1|||
94456617|NCT00761280|323460539|FG001|First Dose to End of Study|Death|0|||
94456618|NCT00761280|323460538|FG000|First Dose to End of Study|Lost to Follow-up|0|||
94456619|NCT00761280|323460539|FG001|First Dose to End of Study|Lost to Follow-up|1|||
94456620|NCT00090220|323460540|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
94456621|NCT00090220|323460541|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
94456622|NCT00090220|323460542|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
94456623|NCT00090220|323460543|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
94456624|NCT00090220|323460544|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
94245728|NCT00356408|322693711|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
94245729|NCT04032613|322693713|FG000|Overall Study|Did not complete post-program assessment|5|||
94245730|NCT04032613|322693714|FG001|Overall Study|Did not complete post-program assessment|2|||
94245731|NCT03053518|322693719|FG000|Overall Study|Withdrawal by Subject|3|||
94245732|NCT03053518|322693719|FG000|Overall Study|Lost to Follow-up|2|||
94245733|NCT03053518|322693719|FG000|Overall Study|Ineligible|5|||
94245734|NCT01156376|322693720|FG000|Overall Study|Adverse Event|1|||
94245735|NCT01156376|322693721|FG001|Overall Study|Adverse Event|0|||
94245736|NCT01156376|322693722|FG002|Overall Study|Adverse Event|1|||
94245737|NCT01156376|322693720|FG000|Overall Study|Withdrawal by Subject|0|||
94245738|NCT01156376|322693721|FG001|Overall Study|Withdrawal by Subject|0|||
94245739|NCT01156376|322693722|FG002|Overall Study|Withdrawal by Subject|3|||
94245740|NCT00565773|322693723|FG000|Overall Study|Withdrawal by Subject|1|||
94245741|NCT00565773|322693723|FG000|Overall Study|Physician Decision|1|||
94245742|NCT01461811|322693724|FG000|Overall Study|Adverse Event|2|||
94245743|NCT01461811|322693725|FG001|Overall Study|Adverse Event|1|||
94245744|NCT01461811|322693724|FG000|Overall Study|Subject decision unrelated to an AE|1|||
94456625|NCT00090220|323460545|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
94592413|NCT02709538|323971390|FG002|Overall Study|Lack of Efficacy|0|||
94355384|NCT00151775|323083566|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
94592414|NCT02709538|323971388|FG000|Overall Study|Lost to Follow-up|24|||
94355385|NCT00151775|323083567|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
94592415|NCT02709538|323971389|FG001|Overall Study|Lost to Follow-up|8|||
94245745|NCT01461811|322693725|FG001|Overall Study|Subject decision unrelated to an AE|1|||
94245746|NCT01461811|322693724|FG000|Overall Study|Noncompliance|1|||
94245747|NCT01461811|322693725|FG001|Overall Study|Noncompliance|1|||
94245748|NCT01072630|322693727|FG000|Overall Study|Adverse Event|11|||
94245749|NCT01072630|322693728|FG001|Overall Study|Adverse Event|19|||
94245750|NCT01072630|322693729|FG002|Overall Study|Adverse Event|2|||
94245751|NCT01072630|322693727|FG000|Overall Study|Lack of Efficacy|10|||
94245752|NCT01072630|322693728|FG001|Overall Study|Lack of Efficacy|10|||
94245753|NCT01072630|322693729|FG002|Overall Study|Lack of Efficacy|1|||
94245754|NCT01072630|322693727|FG000|Overall Study|Withdrawal by Subject|8|||
94245755|NCT01072630|322693728|FG001|Overall Study|Withdrawal by Subject|7|||
94245756|NCT01072630|322693729|FG002|Overall Study|Withdrawal by Subject|2|||
94245757|NCT01072630|322693727|FG000|Overall Study|Protocol Violation|10|||
94245758|NCT01072630|322693728|FG001|Overall Study|Protocol Violation|8|||
94245759|NCT01072630|322693729|FG002|Overall Study|Protocol Violation|4|||
94245760|NCT01072630|322693727|FG000|Overall Study|Lost to Follow-up|11|||
94245761|NCT01072630|322693728|FG001|Overall Study|Lost to Follow-up|11|||
94245762|NCT01072630|322693729|FG002|Overall Study|Lost to Follow-up|1|||
94245763|NCT01072630|322693727|FG000|Overall Study|Noncompliance with study medication|1|||
94245764|NCT01072630|322693728|FG001|Overall Study|Noncompliance with study medication|1|||
94245765|NCT01072630|322693729|FG002|Overall Study|Noncompliance with study medication|1|||
94245766|NCT01072630|322693727|FG000|Overall Study|Noncompliance with study procedures|1|||
94245767|NCT01072630|322693728|FG001|Overall Study|Noncompliance with study procedures|2|||
94245768|NCT01072630|322693729|FG002|Overall Study|Noncompliance with study procedures|1|||
94245769|NCT01072630|322693727|FG000|Overall Study|Other|3|||
94245770|NCT01072630|322693728|FG001|Overall Study|Other|2|||
94245771|NCT01072630|322693729|FG002|Overall Study|Other|1|||
94245772|NCT03214640|322693730|FG000|Overall Study|Protocol Violation|1|||
94245773|NCT03214640|322693731|FG001|Overall Study|Protocol Violation|2|||
94245774|NCT03214640|322693732|FG002|Overall Study|Protocol Violation|1|||
94245775|NCT03214640|322693733|FG003|Overall Study|Protocol Violation|4|||
94245776|NCT04514510|322693739|FG000|Overall Study|Lost to Follow-up|0|||
94245777|NCT04514510|322693740|FG001|Overall Study|Lost to Follow-up|1|||
94245778|NCT04514510|322693739|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
94245779|NCT04514510|322693740|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
94245780|NCT03231800|322693749|FG000|Overall Study|Lost to Follow-up|0|||
94245781|NCT03231800|322693750|FG001|Overall Study|Lost to Follow-up|2|||
94355386|NCT00151775|323083568|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
94355387|NCT00151775|323083569|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
94355388|NCT00151775|323083570|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
94245782|NCT03231800|322693749|FG000|Overall Study|Protocol Violation|1|||
94245783|NCT03231800|322693750|FG001|Overall Study|Protocol Violation|1|||
94245784|NCT03231800|322693749|FG000|Overall Study|reason not provided|2|||
94456626|NCT00090220|323460540|FG000|Base Study Vaccination Period|Adverse Event|6|||
94456627|NCT00090220|323460541|FG001|Base Study Vaccination Period|Adverse Event|1|||
94245785|NCT03231800|322693750|FG001|Overall Study|reason not provided|0|||
94456628|NCT00090220|323460542|FG002|Base Study Vaccination Period|Adverse Event|0|||
94659946|NCT00673049|324209977|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
94245786|NCT00488475|322693751|FG000|Overall Study|Other|1754|||
94245787|NCT00406692|322693752|FG000|Overall Study|Withdrawal by Subject|4|||
94456629|NCT00090220|323460543|FG003|Base Study Vaccination Period|Adverse Event|0|||
94659947|NCT04837482|324209979|FG000|Period 2|Withdrawal by Subject|0|||
94456630|NCT00090220|323460544|FG004|Base Study Vaccination Period|Adverse Event|0|||
94245788|NCT00406692|322693752|FG000|Overall Study|Physician Decision|1|||
94245789|NCT00406692|322693752|FG000|Overall Study|Adverse Event|1|||
94245790|NCT00406692|322693752|FG000|Overall Study|Lack of Efficacy|1|||
94245791|NCT00941070|322693753|FG000|Overall Study|Patient non-compliant|1|||
94245792|NCT01416389|322693769|FG000|Overall Study|Lost to Follow-up|1|||
94245793|NCT01416389|322693770|FG001|Overall Study|Lost to Follow-up|0|||
94245794|NCT01416389|322693769|FG000|Overall Study|Started New Therapy|2|||
94245795|NCT01416389|322693770|FG001|Overall Study|Started New Therapy|0|||
94245796|NCT01365481|322693771|FG000|Overall Study|Adverse Event|6|||
94245797|NCT01365481|322693772|FG001|Overall Study|Adverse Event|9|||
94245798|NCT01365481|322693773|FG002|Overall Study|Adverse Event|0|||
94245799|NCT01365481|322693774|FG003|Overall Study|Adverse Event|2|||
94245800|NCT01365481|322693771|FG000|Overall Study|Withdrawal by Subject|0|||
94245801|NCT01365481|322693772|FG001|Overall Study|Withdrawal by Subject|2|||
94245802|NCT01365481|322693773|FG002|Overall Study|Withdrawal by Subject|1|||
94245803|NCT01365481|322693774|FG003|Overall Study|Withdrawal by Subject|1|||
94245804|NCT01365481|322693771|FG000|Overall Study|Lost to Follow-up|1|||
94245805|NCT01365481|322693772|FG001|Overall Study|Lost to Follow-up|1|||
94245806|NCT01365481|322693773|FG002|Overall Study|Lost to Follow-up|2|||
94245807|NCT01365481|322693774|FG003|Overall Study|Lost to Follow-up|3|||
94245808|NCT01365481|322693771|FG000|Overall Study|Abnormal laboratory value(s)|0|||
94245809|NCT01365481|322693772|FG001|Overall Study|Abnormal laboratory value(s)|1|||
94245810|NCT01365481|322693773|FG002|Overall Study|Abnormal laboratory value(s)|0|||
94245811|NCT01365481|322693774|FG003|Overall Study|Abnormal laboratory value(s)|0|||
94245812|NCT01365481|322693771|FG000|Overall Study|Administrative problems|0|||
94245813|NCT01365481|322693772|FG001|Overall Study|Administrative problems|1|||
94245814|NCT01365481|322693773|FG002|Overall Study|Administrative problems|0|||
94245815|NCT01365481|322693774|FG003|Overall Study|Administrative problems|0|||
94245816|NCT01365481|322693771|FG000|Overall Study|Protocol deviation|0|||
94245817|NCT01365481|322693772|FG001|Overall Study|Protocol deviation|1|||
94245818|NCT01365481|322693773|FG002|Overall Study|Protocol deviation|0|||
94245819|NCT01365481|322693774|FG003|Overall Study|Protocol deviation|1|||
94245820|NCT01365481|322693771|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94245821|NCT01365481|322693772|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94245822|NCT01365481|322693773|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
94245823|NCT01365481|322693774|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
94245824|NCT01163292|322693784|FG000|Overall Study|Lack of Efficacy|9|||
94245825|NCT01163292|322693785|FG001|Overall Study|Lack of Efficacy|0|||
94245826|NCT01163292|322693784|FG000|Overall Study|Adverse Event|6|||
94245827|NCT01163292|322693785|FG001|Overall Study|Adverse Event|0|||
94245828|NCT01163292|322693784|FG000|Overall Study|Initiation of biological therapy|0|||
94245829|NCT01163292|322693785|FG001|Overall Study|Initiation of biological therapy|15|||
94245830|NCT01163292|322693784|FG000|Overall Study|Sufficient response to adalimumab|8|||
94245831|NCT01163292|322693785|FG001|Overall Study|Sufficient response to adalimumab|0|||
94245832|NCT01163292|322693784|FG000|Overall Study|Refusal to receive adalimumab|7|||
94245833|NCT01163292|322693785|FG001|Overall Study|Refusal to receive adalimumab|0|||
94245834|NCT01163292|322693784|FG000|Overall Study|Economic reasons|6|||
94245835|NCT01163292|322693785|FG001|Overall Study|Economic reasons|0|||
94245836|NCT01163292|322693784|FG000|Overall Study|No further visits|5|||
94245837|NCT01163292|322693785|FG001|Overall Study|No further visits|7|||
94245838|NCT01127763|322693788|FG000|Overall Study|Adverse Event|2|||
94245839|NCT01127763|322693788|FG000|Overall Study|Withdrawal by Subject|1|||
94245840|NCT01127763|322693788|FG000|Overall Study|Physician Decision|2|||
94245841|NCT00532493|322693798|FG000|Overall Study|Death|1|||
94245842|NCT00532493|322693799|FG001|Overall Study|Death|1|||
94245843|NCT00532493|322693798|FG000|Overall Study|Lost to Follow-up|10|||
94245844|NCT00532493|322693799|FG001|Overall Study|Lost to Follow-up|7|||
94245845|NCT00532493|322693798|FG000|Overall Study|Withdrawal by Subject|7|||
94245846|NCT00532493|322693799|FG001|Overall Study|Withdrawal by Subject|9|||
94245847|NCT00532493|322693798|FG000|Overall Study|Physician Decision|1|||
94245848|NCT00532493|322693799|FG001|Overall Study|Physician Decision|6|||
94245849|NCT00532493|322693798|FG000|Overall Study|Adverse Event|6|||
94245850|NCT00532493|322693799|FG001|Overall Study|Adverse Event|5|||
94245851|NCT00532493|322693798|FG000|Overall Study|Protocol Deviation|1|||
94245852|NCT00532493|322693799|FG001|Overall Study|Protocol Deviation|0|||
94456631|NCT00090220|323460545|FG005|Base Study Vaccination Period|Adverse Event|0|||
94245853|NCT00532493|322693798|FG000|Overall Study|Subject Moved Away|3|||
94245854|NCT00532493|322693799|FG001|Overall Study|Subject Moved Away|1|||
94245855|NCT00532493|322693798|FG000|Overall Study|Contraindicative Medication|1|||
94245856|NCT00532493|322693799|FG001|Overall Study|Contraindicative Medication|0|||
94245857|NCT03291288|322693800|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
94245858|NCT03291288|322693801|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
94245859|NCT03291288|322693800|FG000|Drug-drug Interaction Phase|Disease progression|1|||
94245860|NCT03291288|322693801|FG001|Drug-drug Interaction Phase|Disease progression|0|||
94245861|NCT03291288|322693800|FG000|Drug-drug Interaction Phase|Other|3|||
94245862|NCT03291288|322693801|FG001|Drug-drug Interaction Phase|Other|0|||
94245863|NCT03291288|322693800|FG000|Pexidartinib Only|Ongoing|0|||
94245864|NCT03291288|322693801|FG001|Pexidartinib Only|Ongoing|2|||
94245865|NCT05086276|322693802|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
94245866|NCT05086276|322693803|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
94245867|NCT00287690|322693804|FG000|Overall Study|Protocol Violation|20|||
94245868|NCT00287690|322693805|FG001|Overall Study|Protocol Violation|26|||
94245869|NCT01142115|322693806|FG000|First Intervention|Lack of Efficacy|1|||
94245870|NCT01142115|322693807|FG001|First Intervention|Lack of Efficacy|1|||
94245871|NCT01142115|322693806|FG000|First Intervention|Adverse Event|1|||
94245872|NCT01142115|322693807|FG001|First Intervention|Adverse Event|0|||
94245873|NCT01015560|322695137|FG000|Overall Study|Adverse Event|1|||
94245874|NCT01015560|322695137|FG000|Overall Study|Not protocol specified|1|||
94245875|NCT01015560|322695137|FG000|Overall Study|Withdrawal by Subject|1|||
94245876|NCT00837694|322695140|FG000|Overall Study|Lost to Follow-up|2|||
94245877|NCT00837694|322695141|FG001|Overall Study|Lost to Follow-up|0|||
94245878|NCT00837694|322695142|FG002|Overall Study|Lost to Follow-up|2|||
94245879|NCT00837694|322695143|FG003|Overall Study|Lost to Follow-up|1|||
94245880|NCT00837694|322695144|FG004|Overall Study|Lost to Follow-up|1|||
94245881|NCT00837694|322695145|FG005|Overall Study|Lost to Follow-up|1|||
94245882|NCT02040259|322695148|FG000|Overall Study|Death|280|||
94245883|NCT02040259|322695148|FG000|Overall Study|Lost to Follow-up|76|||
94245884|NCT02040259|322695148|FG000|Overall Study|Assessment not completed|3|||
94245885|NCT02040259|322695148|FG000|Overall Study|Withdrawal by Subject|4|||
94456632|NCT00090220|323460540|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
94456633|NCT00090220|323460541|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
94456634|NCT00090220|323460542|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
94245886|NCT00297427|322695151|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
94245887|NCT00297427|322695152|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
94245888|NCT00297427|322695151|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
94245889|NCT00297427|322695152|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
94245890|NCT00297427|322695151|FG000|Phase 1: Initial Intervention|Death|0|||
94245891|NCT00297427|322695152|FG001|Phase 1: Initial Intervention|Death|1|||
94456635|NCT00090220|323460543|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
94456636|NCT00090220|323460544|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
94245892|NCT00297427|322695151|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
94245893|NCT00297427|322695152|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
94245894|NCT00297427|322695151|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
94245895|NCT00297427|322695152|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
94245896|NCT00297427|322695151|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
94245897|NCT00297427|322695152|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
94245898|NCT00297427|322695151|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
94245899|NCT00297427|322695152|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
94245900|NCT00297427|322695151|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
94245901|NCT00297427|322695152|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
94245902|NCT03241927|322695153|FG000|Overall Study|study terminated|1|||
94245903|NCT03241927|322695154|FG001|Overall Study|study terminated|0|||
94245904|NCT00201643|322695158|FG000|Overall Study|Withdrawal by Subject|5|||
94245905|NCT00201643|322695159|FG001|Overall Study|Withdrawal by Subject|4|||
94355389|NCT00151775|323083571|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
94592416|NCT02709538|323971390|FG002|Overall Study|Lost to Follow-up|4|||
94355390|NCT00151775|323083572|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
94355391|NCT00151775|323083573|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
94592417|NCT02709538|323971388|FG000|Overall Study|Physician Decision|1|||
94245906|NCT02942277|322695160|FG000|Year 1|Withdrawal by Subject|0|||
94659948|NCT04837482|324209980|FG001|Period 2|Withdrawal by Subject|1|||
94659949|NCT02044510|324209981|FG000|Overall Study|Adverse Event|1|||
94659950|NCT02044510|324209982|FG001|Overall Study|Adverse Event|2|||
94659951|NCT00924950|324209983|FG000|Overall Study|Lost to Follow-up|2|||
94659952|NCT00581945|324209984|FG000|Overall Study|Adverse Event|4|||
94659953|NCT00581945|324209985|FG001|Overall Study|Adverse Event|4|||
94659954|NCT00581945|324209984|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
94592418|NCT02709538|323971389|FG001|Overall Study|Physician Decision|0|||
94592419|NCT02709538|323971390|FG002|Overall Study|Physician Decision|0|||
94592420|NCT02709538|323971388|FG000|Overall Study|Withdrawal by Subject|40|||
94592421|NCT02709538|323971389|FG001|Overall Study|Withdrawal by Subject|7|||
94592422|NCT02709538|323971390|FG002|Overall Study|Withdrawal by Subject|4|||
94592423|NCT02709538|323971388|FG000|Overall Study|Non-compliance with study procedures|5|||
94592424|NCT02709538|323971389|FG001|Overall Study|Non-compliance with study procedures|0|||
94592425|NCT02709538|323971390|FG002|Overall Study|Non-compliance with study procedures|0|||
94592426|NCT02709538|323971388|FG000|Overall Study|Non-compliance with study drug|2|||
94592427|NCT02709538|323971389|FG001|Overall Study|Non-compliance with study drug|0|||
94592428|NCT02709538|323971390|FG002|Overall Study|Non-compliance with study drug|0|||
94592429|NCT02709538|323971388|FG000|Overall Study|Protocol deviation|10|||
94592430|NCT02709538|323971389|FG001|Overall Study|Protocol deviation|4|||
94592431|NCT02709538|323971390|FG002|Overall Study|Protocol deviation|4|||
94592432|NCT02709538|323971388|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
94592433|NCT02709538|323971389|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
94592434|NCT02709538|323971390|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
94592435|NCT02709538|323971388|FG000|Overall Study|Other|16|||
94592436|NCT02709538|323971389|FG001|Overall Study|Other|7|||
94592437|NCT02709538|323971390|FG002|Overall Study|Other|5|||
94592438|NCT02343549|323971391|FG000|Overall Study|Death|11|||
94592439|NCT02343549|323971391|FG000|Overall Study|Withdrawal by Subject|2|||
94592440|NCT02160041|323971392|FG000|Overall Study|Adverse Event|11|||
94592441|NCT02160041|323971392|FG000|Overall Study|Death|2|||
94592442|NCT02160041|323971392|FG000|Overall Study|disease progression|57|||
94592443|NCT02160041|323971392|FG000|Overall Study|Protocol Violation|1|||
94592444|NCT02160041|323971392|FG000|Overall Study|non-compliance with study|1|||
94592445|NCT02160041|323971392|FG000|Overall Study|Physician Decision|3|||
94592446|NCT02160041|323971392|FG000|Overall Study|Withdrawal by Subject|8|||
94592447|NCT02160041|323971392|FG000|Overall Study|study terminated by by sponsor|1|||
94592448|NCT00763698|323971393|FG000|Overall Study|Unsuccessful Implant|5|||
94592449|NCT00763698|323971393|FG000|Overall Study|Death|4|||
94592450|NCT00763698|323971393|FG000|Overall Study|Withdrawal by Subject|1|||
94592451|NCT03531632|323971394|FG000|Overall Study|Adverse Event|0|||
94592452|NCT03531632|323971395|FG001|Overall Study|Adverse Event|0|||
94592453|NCT03531632|323971396|FG002|Overall Study|Adverse Event|1|||
94592454|NCT03531632|323971394|FG000|Overall Study|Death|4|||
94592455|NCT03531632|323971395|FG001|Overall Study|Death|0|||
94592456|NCT03531632|323971396|FG002|Overall Study|Death|14|||
94592457|NCT03531632|323971394|FG000|Overall Study|Study Terminated|1|||
94592458|NCT03531632|323971395|FG001|Overall Study|Study Terminated|3|||
94592459|NCT03531632|323971396|FG002|Overall Study|Study Terminated|11|||
94592460|NCT00470834|323971397|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
94592461|NCT00470834|323971398|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
94592462|NCT00470834|323971397|FG000|Treatment Period (18 Months)|Adverse Event|7|||
94592463|NCT00470834|323971398|FG001|Treatment Period (18 Months)|Adverse Event|6|||
94592464|NCT00470834|323971397|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
94592465|NCT00470834|323971398|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
94592466|NCT00470834|323971397|FG000|Treatment Period (18 Months)|Physician Decision|4|||
94592467|NCT00470834|323971398|FG001|Treatment Period (18 Months)|Physician Decision|4|||
94592468|NCT00470834|323971397|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
94592469|NCT00470834|323971398|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
94592470|NCT00470834|323971397|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
94592471|NCT00470834|323971398|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
94659955|NCT00581945|324209985|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94592472|NCT00470834|323971397|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
94592473|NCT00470834|323971398|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
94592474|NCT00470834|323971397|FG000|Treatment Period (18 Months)|Non-compliance|1|||
94659956|NCT00581945|324209984|FG000|Overall Study|Withdrawal by Subject|2|||
94659957|NCT00581945|324209985|FG001|Overall Study|Withdrawal by Subject|6|||
94592475|NCT00470834|323971398|FG001|Treatment Period (18 Months)|Non-compliance|0|||
94592476|NCT00470834|323971397|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
94592477|NCT00470834|323971398|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
94592478|NCT00470834|323971397|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
94592479|NCT00470834|323971398|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
94592480|NCT00470834|323971397|FG000|Extension Period (24 Months)|Adverse Event|3|||
94592481|NCT00470834|323971398|FG001|Extension Period (24 Months)|Adverse Event|4|||
94592482|NCT00470834|323971397|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
94592483|NCT00470834|323971398|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
94592484|NCT00470834|323971397|FG000|Extension Period (24 Months)|Physician Decision|4|||
94592485|NCT00470834|323971398|FG001|Extension Period (24 Months)|Physician Decision|3|||
94592486|NCT00470834|323971397|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
94592487|NCT00470834|323971398|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
94592488|NCT00470834|323971397|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
94592489|NCT00470834|323971398|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
94592490|NCT00470834|323971397|FG000|Extension Period (24 Months)|Non-compliance|0|||
94592491|NCT00470834|323971398|FG001|Extension Period (24 Months)|Non-compliance|1|||
94592492|NCT00470834|323971397|FG000|Extension Period (24 Months)|Disease Progression|0|||
94592493|NCT00470834|323971398|FG001|Extension Period (24 Months)|Disease Progression|1|||
94592494|NCT02636361|323971401|FG000|Period 4|Physician Decision|0|||
94592495|NCT02636361|323971402|FG001|Period 4|Physician Decision|0|||
94592496|NCT02636361|323971403|FG002|Period 4|Physician Decision|0|||
94592497|NCT02636361|323971404|FG003|Period 4|Physician Decision|1|||
94592498|NCT02636361|323971405|FG004|Period 4|Physician Decision|0|||
94592499|NCT00271505|323971406|FG000|Overall Study|Screen Failure|3|||
94592500|NCT00271505|323971406|FG000|Overall Study|Adverse Event|1|||
94592501|NCT00271505|323971406|FG000|Overall Study|Death|1|||
94592502|NCT00119678|323971407|FG000|Double-blind Treatment Period|Death|1|||
94592503|NCT00119678|323971408|FG001|Double-blind Treatment Period|Death|0|||
94592504|NCT00119678|323971407|FG000|Double-blind Treatment Period|Adverse Event|7|||
94592505|NCT00119678|323971408|FG001|Double-blind Treatment Period|Adverse Event|1|||
94592506|NCT00119678|323971407|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
94592507|NCT00119678|323971408|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
94592508|NCT00119678|323971407|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
94592509|NCT00119678|323971408|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
94592510|NCT00119678|323971407|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
94592511|NCT00119678|323971408|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
94592512|NCT00119678|323971407|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
94592513|NCT00119678|323971408|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
94592514|NCT00119678|323971407|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
94592515|NCT00119678|323971408|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
94592516|NCT00119678|323971407|FG000|Double-blind Treatment Period|Pregnancy|0|||
94592517|NCT00119678|323971408|FG001|Double-blind Treatment Period|Pregnancy|2|||
94592518|NCT00119678|323971407|FG000|Double-blind Treatment Period|Not treated|1|||
94592519|NCT00119678|323971408|FG001|Double-blind Treatment Period|Not treated|2|||
94659958|NCT00581945|324209984|FG000|Overall Study|Death|1|||
94659959|NCT00581945|324209985|FG001|Overall Study|Death|0|||
94659960|NCT02979535|324209986|FG000|Overall Study|Non compliance with the protocol|78|||
94659961|NCT02979535|324209987|FG001|Overall Study|Non compliance with the protocol|82|||
94245907|NCT02942277|322695161|FG001|Year 1|Withdrawal by Subject|0|||
94245908|NCT02942277|322695162|FG002|Year 1|Withdrawal by Subject|0|||
94245909|NCT02942277|322695163|FG003|Year 1|Withdrawal by Subject|0|||
94245910|NCT02942277|322695164|FG004|Year 1|Withdrawal by Subject|1|||
94245911|NCT02942277|322695165|FG005|Year 1|Withdrawal by Subject|3|||
94245912|NCT02942277|322695166|FG006|Year 1|Withdrawal by Subject|0|||
94245913|NCT02942277|322695167|FG007|Year 1|Withdrawal by Subject|1|||
94245914|NCT02942277|322695168|FG008|Year 1|Withdrawal by Subject|0|||
94245915|NCT02942277|322695169|FG009|Year 1|Withdrawal by Subject|0|||
94592520|NCT00119678|323971407|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
94592521|NCT00119678|323971408|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
94592522|NCT00119678|323971407|FG000|Open-label Treatment Period|Death|1|||
94592523|NCT00119678|323971408|FG001|Open-label Treatment Period|Death|0|||
94592524|NCT00119678|323971407|FG000|Open-label Treatment Period|Adverse Event|3|||
94592525|NCT00119678|323971408|FG001|Open-label Treatment Period|Adverse Event|0|||
94592526|NCT00119678|323971407|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
94592527|NCT00119678|323971408|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
94592528|NCT00119678|323971407|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
94592529|NCT00119678|323971408|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
94592530|NCT00119678|323971407|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
94592531|NCT00119678|323971408|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
94592532|NCT00119678|323971407|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
94592533|NCT00119678|323971408|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
94592534|NCT00119678|323971407|FG000|Open-label Treatment Period|Pregnancy|1|||
94592535|NCT00119678|323971408|FG001|Open-label Treatment Period|Pregnancy|0|||
94592536|NCT00119678|323971407|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
94592537|NCT00119678|323971408|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
94592538|NCT02720042|323971409|FG000|Overall Study|Death|3|||
94245916|NCT02942277|322695170|FG010|Year 1|Withdrawal by Subject|3|||
94245917|NCT02942277|322695160|FG000|Year 1|Travel|0|||
94245918|NCT02942277|322695161|FG001|Year 1|Travel|1|||
94245919|NCT02942277|322695162|FG002|Year 1|Travel|0|||
94245920|NCT02942277|322695163|FG003|Year 1|Travel|0|||
94245921|NCT02942277|322695164|FG004|Year 1|Travel|4|||
94245922|NCT02942277|322695165|FG005|Year 1|Travel|5|||
94245923|NCT02942277|322695166|FG006|Year 1|Travel|0|||
94245924|NCT02942277|322695167|FG007|Year 1|Travel|0|||
94245925|NCT02942277|322695168|FG008|Year 1|Travel|0|||
94245926|NCT02942277|322695169|FG009|Year 1|Travel|0|||
94245927|NCT02942277|322695170|FG010|Year 1|Travel|8|||
94245928|NCT02942277|322695160|FG000|Year 1|Joined Army|0|||
94245929|NCT02942277|322695161|FG001|Year 1|Joined Army|1|||
94245930|NCT02942277|322695162|FG002|Year 1|Joined Army|0|||
94245931|NCT02942277|322695163|FG003|Year 1|Joined Army|0|||
94245932|NCT02942277|322695164|FG004|Year 1|Joined Army|0|||
94245933|NCT02942277|322695165|FG005|Year 1|Joined Army|0|||
94245934|NCT02942277|322695166|FG006|Year 1|Joined Army|0|||
94245935|NCT02942277|322695167|FG007|Year 1|Joined Army|0|||
94245936|NCT02942277|322695168|FG008|Year 1|Joined Army|0|||
94592539|NCT02720042|323971409|FG000|Overall Study|Lost to Follow-up|4|||
94245937|NCT02942277|322695169|FG009|Year 1|Joined Army|0|||
94245938|NCT02942277|322695170|FG010|Year 1|Joined Army|0|||
94245939|NCT02942277|322695160|FG000|Year 1|Subject met withdrawal criteria|0|||
94245940|NCT02942277|322695161|FG001|Year 1|Subject met withdrawal criteria|0|||
94245941|NCT02942277|322695162|FG002|Year 1|Subject met withdrawal criteria|0|||
94592540|NCT02720042|323971409|FG000|Overall Study|Withdrawal by Subject|1|||
94592541|NCT02720042|323971409|FG000|Overall Study|Physician Decision|3|||
94245942|NCT02942277|322695163|FG003|Year 1|Subject met withdrawal criteria|1|||
94245943|NCT02942277|322695164|FG004|Year 1|Subject met withdrawal criteria|0|||
94245944|NCT02942277|322695165|FG005|Year 1|Subject met withdrawal criteria|0|||
94245945|NCT02942277|322695166|FG006|Year 1|Subject met withdrawal criteria|0|||
94245946|NCT02942277|322695167|FG007|Year 1|Subject met withdrawal criteria|0|||
94245947|NCT02942277|322695168|FG008|Year 1|Subject met withdrawal criteria|0|||
94245948|NCT02942277|322695169|FG009|Year 1|Subject met withdrawal criteria|0|||
94245949|NCT02942277|322695170|FG010|Year 1|Subject met withdrawal criteria|0|||
94245950|NCT02942277|322695160|FG000|Year 1|Lost to Follow-up|0|||
94245951|NCT02942277|322695161|FG001|Year 1|Lost to Follow-up|0|||
94245952|NCT02942277|322695162|FG002|Year 1|Lost to Follow-up|0|||
94245953|NCT02942277|322695163|FG003|Year 1|Lost to Follow-up|0|||
94245954|NCT02942277|322695164|FG004|Year 1|Lost to Follow-up|1|||
94245955|NCT02942277|322695165|FG005|Year 1|Lost to Follow-up|0|||
94245956|NCT02942277|322695166|FG006|Year 1|Lost to Follow-up|0|||
94245957|NCT02942277|322695167|FG007|Year 1|Lost to Follow-up|0|||
94245958|NCT02942277|322695168|FG008|Year 1|Lost to Follow-up|0|||
94245959|NCT02942277|322695169|FG009|Year 1|Lost to Follow-up|0|||
94245960|NCT02942277|322695170|FG010|Year 1|Lost to Follow-up|2|||
94245961|NCT02942277|322695160|FG000|Year 1|Protocol Violation|0|||
94245962|NCT02942277|322695161|FG001|Year 1|Protocol Violation|0|||
94245963|NCT02942277|322695162|FG002|Year 1|Protocol Violation|0|||
94245964|NCT02942277|322695163|FG003|Year 1|Protocol Violation|0|||
94245965|NCT02942277|322695164|FG004|Year 1|Protocol Violation|1|||
94245966|NCT02942277|322695165|FG005|Year 1|Protocol Violation|1|||
94245967|NCT02942277|322695166|FG006|Year 1|Protocol Violation|0|||
94245968|NCT02942277|322695167|FG007|Year 1|Protocol Violation|0|||
94245969|NCT02942277|322695168|FG008|Year 1|Protocol Violation|0|||
94245970|NCT02942277|322695169|FG009|Year 1|Protocol Violation|0|||
94245971|NCT02942277|322695170|FG010|Year 1|Protocol Violation|2|||
94245972|NCT02942277|322695160|FG000|Year 1|Pregnancy|0|||
94245973|NCT02942277|322695161|FG001|Year 1|Pregnancy|0|||
94245974|NCT02942277|322695162|FG002|Year 1|Pregnancy|0|||
94245975|NCT02942277|322695163|FG003|Year 1|Pregnancy|0|||
94245976|NCT02942277|322695164|FG004|Year 1|Pregnancy|0|||
94245977|NCT02942277|322695165|FG005|Year 1|Pregnancy|1|||
94245978|NCT02942277|322695166|FG006|Year 1|Pregnancy|0|||
94245979|NCT02942277|322695167|FG007|Year 1|Pregnancy|0|||
94245980|NCT02942277|322695168|FG008|Year 1|Pregnancy|0|||
94245981|NCT02942277|322695169|FG009|Year 1|Pregnancy|0|||
94245982|NCT02942277|322695170|FG010|Year 1|Pregnancy|0|||
94245983|NCT02942277|322695160|FG000|Year 2|Lost to Follow-up|0|||
94245984|NCT02942277|322695161|FG001|Year 2|Lost to Follow-up|0|||
94245985|NCT02942277|322695162|FG002|Year 2|Lost to Follow-up|0|||
94245986|NCT02942277|322695163|FG003|Year 2|Lost to Follow-up|0|||
94245987|NCT02942277|322695164|FG004|Year 2|Lost to Follow-up|2|||
94245988|NCT02942277|322695165|FG005|Year 2|Lost to Follow-up|1|||
94245989|NCT02942277|322695166|FG006|Year 2|Lost to Follow-up|0|||
94245990|NCT02942277|322695167|FG007|Year 2|Lost to Follow-up|0|||
94245991|NCT02942277|322695168|FG008|Year 2|Lost to Follow-up|0|||
94245992|NCT02942277|322695169|FG009|Year 2|Lost to Follow-up|0|||
94592542|NCT02720042|323971409|FG000|Overall Study|Phasix Mesh explanted|1|||
94592543|NCT02720042|323971409|FG000|Overall Study|unable due to non-study-related illness|3|||
94592544|NCT01761240|323971410|FG000|Overall Study|Progressive disease:radiology assessment|3|||
94592545|NCT01761240|323971411|FG001|Overall Study|Progressive disease:radiology assessment|3|||
94592546|NCT01761240|323971412|FG002|Overall Study|Progressive disease:radiology assessment|0|||
94355392|NCT00151775|323083562|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
94592547|NCT01761240|323971413|FG003|Overall Study|Progressive disease:radiology assessment|0|||
94592548|NCT01761240|323971414|FG004|Overall Study|Progressive disease:radiology assessment|0|||
94245993|NCT02942277|322695170|FG010|Year 2|Lost to Follow-up|0|||
94245994|NCT02942277|322695160|FG000|Year 2|Did not rescreen|0|||
94245995|NCT02942277|322695161|FG001|Year 2|Did not rescreen|0|||
94245996|NCT02942277|322695162|FG002|Year 2|Did not rescreen|1|||
94245997|NCT02942277|322695163|FG003|Year 2|Did not rescreen|1|||
94245998|NCT02942277|322695164|FG004|Year 2|Did not rescreen|9|||
94245999|NCT02942277|322695165|FG005|Year 2|Did not rescreen|6|||
94246000|NCT02942277|322695166|FG006|Year 2|Did not rescreen|0|||
94246001|NCT02942277|322695167|FG007|Year 2|Did not rescreen|1|||
94246002|NCT02942277|322695168|FG008|Year 2|Did not rescreen|0|||
94246003|NCT02942277|322695169|FG009|Year 2|Did not rescreen|0|||
94246004|NCT02942277|322695170|FG010|Year 2|Did not rescreen|21|||
94246005|NCT02942277|322695160|FG000|Year 2|Met withdrawal criteria|0|||
94246006|NCT02942277|322695161|FG001|Year 2|Met withdrawal criteria|0|||
94246007|NCT02942277|322695162|FG002|Year 2|Met withdrawal criteria|0|||
94246008|NCT02942277|322695163|FG003|Year 2|Met withdrawal criteria|0|||
94592549|NCT01761240|323971410|FG000|Overall Study|Progressive disease:clinical assessment|0|||
94592550|NCT01761240|323971411|FG001|Overall Study|Progressive disease:clinical assessment|0|||
94592551|NCT01761240|323971412|FG002|Overall Study|Progressive disease:clinical assessment|3|||
94592552|NCT01761240|323971413|FG003|Overall Study|Progressive disease:clinical assessment|1|||
94592553|NCT01761240|323971414|FG004|Overall Study|Progressive disease:clinical assessment|0|||
94592554|NCT01761240|323971410|FG000|Overall Study|Withdrawal by Subject|0|||
94592555|NCT01761240|323971411|FG001|Overall Study|Withdrawal by Subject|0|||
94592556|NCT01761240|323971412|FG002|Overall Study|Withdrawal by Subject|0|||
94592557|NCT01761240|323971413|FG003|Overall Study|Withdrawal by Subject|3|||
94592558|NCT01761240|323971414|FG004|Overall Study|Withdrawal by Subject|1|||
94592559|NCT01761240|323971410|FG000|Overall Study|Adverse Event|0|||
94592560|NCT01761240|323971411|FG001|Overall Study|Adverse Event|0|||
94592561|NCT01761240|323971412|FG002|Overall Study|Adverse Event|0|||
94592562|NCT01761240|323971413|FG003|Overall Study|Adverse Event|1|||
94592563|NCT01761240|323971414|FG004|Overall Study|Adverse Event|6|||
94592564|NCT01761240|323971410|FG000|Overall Study|Death|0|||
94592565|NCT01761240|323971411|FG001|Overall Study|Death|1|||
94592566|NCT01761240|323971412|FG002|Overall Study|Death|1|||
94592567|NCT01761240|323971413|FG003|Overall Study|Death|2|||
94592568|NCT01761240|323971414|FG004|Overall Study|Death|1|||
94592569|NCT01761240|323971410|FG000|Overall Study|Non-compliance|0|||
94592570|NCT01761240|323971411|FG001|Overall Study|Non-compliance|0|||
94592571|NCT01761240|323971412|FG002|Overall Study|Non-compliance|1|||
94592572|NCT01761240|323971413|FG003|Overall Study|Non-compliance|0|||
94592573|NCT01761240|323971414|FG004|Overall Study|Non-compliance|0|||
94592574|NCT04784442|323971415|FG000|Overall Study|Adverse Event|1|||
94592575|NCT04784442|323971416|FG001|Overall Study|Adverse Event|0|||
94592576|NCT04784442|323971417|FG002|Overall Study|Adverse Event|2|||
94592577|NCT04784442|323971418|FG003|Overall Study|Adverse Event|1|||
94592578|NCT04784442|323971415|FG000|Overall Study|Protocol Violation|1|||
94592579|NCT04784442|323971416|FG001|Overall Study|Protocol Violation|0|||
94592580|NCT04784442|323971417|FG002|Overall Study|Protocol Violation|0|||
94592581|NCT04784442|323971418|FG003|Overall Study|Protocol Violation|0|||
94592582|NCT04784442|323971415|FG000|Overall Study|Non-compliance with study drug|1|||
94592583|NCT04784442|323971416|FG001|Overall Study|Non-compliance with study drug|0|||
94592584|NCT04784442|323971417|FG002|Overall Study|Non-compliance with study drug|0|||
94592585|NCT04784442|323971418|FG003|Overall Study|Non-compliance with study drug|0|||
94592586|NCT01510769|323971419|FG000|Overall Study|Adverse Event|7|||
94592587|NCT01510769|323971420|FG001|Overall Study|Adverse Event|6|||
94592588|NCT01510769|323971421|FG002|Overall Study|Adverse Event|4|||
94592589|NCT01510769|323971419|FG000|Overall Study|Gout Flare|0|||
94592590|NCT01510769|323971420|FG001|Overall Study|Gout Flare|3|||
94592591|NCT01510769|323971421|FG002|Overall Study|Gout Flare|1|||
94592592|NCT01510769|323971419|FG000|Overall Study|Protocol Violation|11|||
94592593|NCT01510769|323971420|FG001|Overall Study|Protocol Violation|10|||
94592594|NCT01510769|323971421|FG002|Overall Study|Protocol Violation|9|||
94592595|NCT01510769|323971419|FG000|Overall Study|Lost to Follow-up|5|||
94592596|NCT01510769|323971420|FG001|Overall Study|Lost to Follow-up|1|||
94592597|NCT01510769|323971421|FG002|Overall Study|Lost to Follow-up|5|||
94592598|NCT01510769|323971419|FG000|Overall Study|Withdrawal by Subject|3|||
94592599|NCT01510769|323971420|FG001|Overall Study|Withdrawal by Subject|4|||
94592600|NCT01510769|323971421|FG002|Overall Study|Withdrawal by Subject|3|||
94592601|NCT01510769|323971419|FG000|Overall Study|Death|1|||
94592602|NCT01510769|323971420|FG001|Overall Study|Death|1|||
94592603|NCT01510769|323971421|FG002|Overall Study|Death|0|||
94592604|NCT00171834|323971427|FG000|Overall Study|Adverse Event|2|||
94592605|NCT00171834|323971428|FG001|Overall Study|Adverse Event|1|||
94592606|NCT00171834|323971429|FG002|Overall Study|Adverse Event|3|||
94592607|NCT00171834|323971430|FG003|Overall Study|Adverse Event|2|||
94592608|NCT00171834|323971431|FG004|Overall Study|Adverse Event|2|||
94592609|NCT00171834|323971432|FG005|Overall Study|Adverse Event|15|||
94592610|NCT00171834|323971433|FG006|Overall Study|Adverse Event|1|||
94592611|NCT00171834|323971427|FG000|Overall Study|Withdrawal by Subject|0|||
94592612|NCT00171834|323971428|FG001|Overall Study|Withdrawal by Subject|2|||
94246009|NCT02942277|322695164|FG004|Year 2|Met withdrawal criteria|1|||
94592613|NCT00171834|323971429|FG002|Overall Study|Withdrawal by Subject|0|||
94592614|NCT00171834|323971430|FG003|Overall Study|Withdrawal by Subject|1|||
94592615|NCT00171834|323971431|FG004|Overall Study|Withdrawal by Subject|1|||
94592616|NCT00171834|323971432|FG005|Overall Study|Withdrawal by Subject|1|||
94592617|NCT00171834|323971433|FG006|Overall Study|Withdrawal by Subject|0|||
94592618|NCT00171834|323971427|FG000|Overall Study|Death from study indication|0|||
94592619|NCT00171834|323971428|FG001|Overall Study|Death from study indication|1|||
94592620|NCT00171834|323971429|FG002|Overall Study|Death from study indication|0|||
94592621|NCT00171834|323971430|FG003|Overall Study|Death from study indication|0|||
94592622|NCT00171834|323971431|FG004|Overall Study|Death from study indication|1|||
94592623|NCT00171834|323971432|FG005|Overall Study|Death from study indication|0|||
94592624|NCT00171834|323971433|FG006|Overall Study|Death from study indication|0|||
94592625|NCT00171834|323971427|FG000|Overall Study|Disease Progression|4|||
94246010|NCT02942277|322695165|FG005|Year 2|Met withdrawal criteria|2|||
94592626|NCT00171834|323971428|FG001|Overall Study|Disease Progression|8|||
94592627|NCT00171834|323971429|FG002|Overall Study|Disease Progression|8|||
94592628|NCT00171834|323971430|FG003|Overall Study|Disease Progression|9|||
94592629|NCT00171834|323971431|FG004|Overall Study|Disease Progression|2|||
94592630|NCT00171834|323971432|FG005|Overall Study|Disease Progression|18|||
94592631|NCT00171834|323971433|FG006|Overall Study|Disease Progression|3|||
94592632|NCT00171834|323971427|FG000|Overall Study|Treatment Duration Completed|0|||
94592633|NCT00171834|323971428|FG001|Overall Study|Treatment Duration Completed|0|||
94592634|NCT00171834|323971429|FG002|Overall Study|Treatment Duration Completed|1|||
94592635|NCT00171834|323971430|FG003|Overall Study|Treatment Duration Completed|0|||
94592636|NCT00171834|323971431|FG004|Overall Study|Treatment Duration Completed|2|||
94592637|NCT00171834|323971432|FG005|Overall Study|Treatment Duration Completed|1|||
94592638|NCT00171834|323971433|FG006|Overall Study|Treatment Duration Completed|0|||
94592639|NCT01136785|323971434|FG000|Overall Study|Protocol Violation|2|||
94592640|NCT01136785|323971435|FG001|Overall Study|Protocol Violation|1|||
94592641|NCT04345367|323971436|FG000|Overall Study|Other|3|||
94592642|NCT04345367|323971437|FG001|Overall Study|Other|4|||
94592643|NCT04345367|323971436|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
94592644|NCT04345367|323971437|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
94592645|NCT04345367|323971436|FG000|Overall Study|Withdrawal by Subject|11|||
94592646|NCT04345367|323971437|FG001|Overall Study|Withdrawal by Subject|11|||
94592647|NCT04345367|323971436|FG000|Overall Study|Protocol Violation|4|||
94592648|NCT04345367|323971437|FG001|Overall Study|Protocol Violation|3|||
94592649|NCT04345367|323971436|FG000|Overall Study|Lost to Follow-up|2|||
94592650|NCT04345367|323971437|FG001|Overall Study|Lost to Follow-up|4|||
94592651|NCT04345367|323971436|FG000|Overall Study|Lack of Efficacy|2|||
94592652|NCT04345367|323971437|FG001|Overall Study|Lack of Efficacy|0|||
94592653|NCT04345367|323971436|FG000|Overall Study|Death|2|||
94246011|NCT02942277|322695166|FG006|Year 2|Met withdrawal criteria|0|||
94246012|NCT02942277|322695167|FG007|Year 2|Met withdrawal criteria|0|||
94246013|NCT02942277|322695168|FG008|Year 2|Met withdrawal criteria|0|||
94246014|NCT02942277|322695169|FG009|Year 2|Met withdrawal criteria|0|||
94246015|NCT02942277|322695170|FG010|Year 2|Met withdrawal criteria|1|||
94246016|NCT02942277|322695160|FG000|Year 2|Travel|0|||
94246017|NCT02942277|322695161|FG001|Year 2|Travel|1|||
94246018|NCT02942277|322695162|FG002|Year 2|Travel|0|||
94246019|NCT02942277|322695163|FG003|Year 2|Travel|0|||
94246020|NCT02942277|322695164|FG004|Year 2|Travel|0|||
94246021|NCT02942277|322695165|FG005|Year 2|Travel|1|||
94246022|NCT02942277|322695166|FG006|Year 2|Travel|0|||
94246023|NCT02942277|322695167|FG007|Year 2|Travel|0|||
94246024|NCT02942277|322695168|FG008|Year 2|Travel|0|||
94246025|NCT02942277|322695169|FG009|Year 2|Travel|1|||
94246026|NCT02942277|322695170|FG010|Year 2|Travel|3|||
94246027|NCT02942277|322695160|FG000|Year 2|Non-compliant|0|||
94246028|NCT02942277|322695161|FG001|Year 2|Non-compliant|0|||
94246029|NCT02942277|322695162|FG002|Year 2|Non-compliant|0|||
94246030|NCT02942277|322695163|FG003|Year 2|Non-compliant|0|||
94246031|NCT02942277|322695164|FG004|Year 2|Non-compliant|1|||
94246032|NCT02942277|322695165|FG005|Year 2|Non-compliant|1|||
94246033|NCT02942277|322695166|FG006|Year 2|Non-compliant|0|||
94246034|NCT02942277|322695167|FG007|Year 2|Non-compliant|0|||
94246035|NCT02942277|322695168|FG008|Year 2|Non-compliant|0|||
94246036|NCT02942277|322695169|FG009|Year 2|Non-compliant|0|||
94246037|NCT02942277|322695170|FG010|Year 2|Non-compliant|0|||
94592654|NCT04345367|323971437|FG001|Overall Study|Death|0|||
94246038|NCT02942277|322695160|FG000|Year 2|Withdrawal by Subject|0|||
94246039|NCT02942277|322695161|FG001|Year 2|Withdrawal by Subject|0|||
94246040|NCT02942277|322695162|FG002|Year 2|Withdrawal by Subject|0|||
94592655|NCT04345367|323971436|FG000|Overall Study|Adverse Event|10|||
94592656|NCT04345367|323971437|FG001|Overall Study|Adverse Event|9|||
94246041|NCT02942277|322695163|FG003|Year 2|Withdrawal by Subject|0|||
94246042|NCT02942277|322695164|FG004|Year 2|Withdrawal by Subject|0|||
94246043|NCT02942277|322695165|FG005|Year 2|Withdrawal by Subject|0|||
94246044|NCT02942277|322695166|FG006|Year 2|Withdrawal by Subject|1|||
94592657|NCT01578850|323971438|FG000|Period 1|Insufficient Clinical Response|1|||
94592658|NCT01578850|323971439|FG001|Period 1|Insufficient Clinical Response|0|||
94592659|NCT01578850|323971440|FG002|Period 1|Insufficient Clinical Response|0|||
94592660|NCT01578850|323971438|FG000|Period 1|Adverse Event|11|||
94592661|NCT01578850|323971439|FG001|Period 1|Adverse Event|0|||
94592662|NCT01578850|323971440|FG002|Period 1|Adverse Event|0|||
94592663|NCT01578850|323971438|FG000|Period 1|Death|1|||
94592664|NCT01578850|323971439|FG001|Period 1|Death|0|||
94592665|NCT01578850|323971440|FG002|Period 1|Death|0|||
94592666|NCT01578850|323971438|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
94592667|NCT01578850|323971439|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
94592668|NCT01578850|323971440|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
94592669|NCT01578850|323971438|FG000|Period 1|Withdrawal by Subject|9|||
94592670|NCT01578850|323971439|FG001|Period 1|Withdrawal by Subject|0|||
94592671|NCT01578850|323971440|FG002|Period 1|Withdrawal by Subject|0|||
94592672|NCT01578850|323971438|FG000|Period 1|Study Terminated by Sponsor|3|||
94592673|NCT01578850|323971439|FG001|Period 1|Study Terminated by Sponsor|0|||
94592674|NCT01578850|323971440|FG002|Period 1|Study Terminated by Sponsor|0|||
94592675|NCT01578850|323971438|FG000|Period 2|Insufficient Clinical Response|0|||
94592676|NCT01578850|323971439|FG001|Period 2|Insufficient Clinical Response|1|||
94592677|NCT01578850|323971440|FG002|Period 2|Insufficient Clinical Response|0|||
94592678|NCT01578850|323971438|FG000|Period 2|Adverse Event|0|||
94592679|NCT01578850|323971439|FG001|Period 2|Adverse Event|3|||
94592680|NCT01578850|323971440|FG002|Period 2|Adverse Event|6|||
94592681|NCT01578850|323971438|FG000|Period 2|Lost to Follow-up|0|||
94592682|NCT01578850|323971439|FG001|Period 2|Lost to Follow-up|1|||
94592683|NCT01578850|323971440|FG002|Period 2|Lost to Follow-up|2|||
94592684|NCT01578850|323971438|FG000|Period 2|Withdrawal by Subject|0|||
94592685|NCT01578850|323971439|FG001|Period 2|Withdrawal by Subject|2|||
94592686|NCT01578850|323971440|FG002|Period 2|Withdrawal by Subject|2|||
94592687|NCT01578850|323971438|FG000|Period 2|Study Terminated by Sponsor|0|||
94592688|NCT01578850|323971439|FG001|Period 2|Study Terminated by Sponsor|5|||
94592689|NCT01578850|323971440|FG002|Period 2|Study Terminated by Sponsor|4|||
94592690|NCT01578850|323971438|FG000|Period 2|Unspecified Reasons|0|||
94592691|NCT01578850|323971439|FG001|Period 2|Unspecified Reasons|1|||
94592692|NCT01578850|323971440|FG002|Period 2|Unspecified Reasons|0|||
94592693|NCT00870584|323971442|FG000|Overall Study|Adverse Event|3|||
94592694|NCT00870584|323971443|FG001|Overall Study|Adverse Event|3|||
94592695|NCT00870584|323971442|FG000|Overall Study|Withdrawal by Subject|6|||
94592696|NCT00870584|323971443|FG001|Overall Study|Withdrawal by Subject|7|||
94592697|NCT00870584|323971442|FG000|Overall Study|Lost to Follow-up|5|||
94592698|NCT00870584|323971443|FG001|Overall Study|Lost to Follow-up|1|||
94592699|NCT00870584|323971442|FG000|Overall Study|Protocol Deviation|2|||
94592700|NCT00870584|323971443|FG001|Overall Study|Protocol Deviation|2|||
94592701|NCT02560025|323971444|FG000|Overall Study|Ineligible after consent/ registration|3|||
94592702|NCT00978757|323971445|FG000|Overall Study|Physician Decision|1|||
94592703|NCT00978757|323971446|FG001|Overall Study|Physician Decision|3|||
94592704|NCT00402740|323971450|FG000|Overall Study|Withdrawal by Subject|18|||
94592705|NCT00402740|323971450|FG000|Overall Study|Death|50|||
94592706|NCT00402740|323971450|FG000|Overall Study|Lost to Follow-up|6|||
94592707|NCT00402740|323971450|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
94592708|NCT00402740|323971450|FG000|Overall Study|Subject disposition unknown.|1|||
94592709|NCT01028300|323971451|FG000|Overall Study|Study Terminated|4|||
94592710|NCT02703337|323971454|FG000|Period One (Part A)|Withdrawal by Subject|0|||
94592711|NCT02703337|323971455|FG001|Period One (Part A)|Withdrawal by Subject|0|||
94592712|NCT02703337|323971456|FG002|Period One (Part A)|Withdrawal by Subject|0|||
94592713|NCT02703337|323971457|FG003|Period One (Part A)|Withdrawal by Subject|0|||
94592714|NCT02703337|323971458|FG004|Period One (Part A)|Withdrawal by Subject|1|||
94592715|NCT02703337|323971459|FG005|Period One (Part A)|Withdrawal by Subject|0|||
94659962|NCT02979535|324209986|FG000|Overall Study|Consent withdrawn by participant|11|||
94659963|NCT02979535|324209987|FG001|Overall Study|Consent withdrawn by participant|18|||
94659964|NCT02979535|324209986|FG000|Overall Study|Lost to Follow-up|6|||
94659965|NCT02979535|324209987|FG001|Overall Study|Lost to Follow-up|1|||
94659966|NCT00003457|324209990|FG000|Overall Study|Not evaluable|9|||
94659967|NCT02246998|324209991|FG000|Overall Study|Adverse Event|0|||
94592716|NCT02703337|323971460|FG006|Period One (Part A)|Withdrawal by Subject|0|||
94659968|NCT02246998|324209992|FG001|Overall Study|Adverse Event|1|||
94592717|NCT02703337|323971461|FG007|Period One (Part A)|Withdrawal by Subject|0|||
94592718|NCT01214395|323971466|FG000|Overall Study|All patients had infection|5|||
94592719|NCT02034409|323971467|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
94592720|NCT02034409|323971468|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
94592721|NCT02034409|323971467|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
94592722|NCT02034409|323971468|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
94592723|NCT02034409|323971467|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
94659969|NCT02246998|324209993|FG002|Overall Study|Adverse Event|1|||
94659970|NCT02246998|324209994|FG003|Overall Study|Adverse Event|0|||
94659971|NCT02246998|324209991|FG000|Overall Study|Lost to Follow-up|1|||
94592724|NCT02034409|323971468|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
94592725|NCT02034409|323971467|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
94246045|NCT02942277|322695167|FG007|Year 2|Withdrawal by Subject|0|||
94246046|NCT02942277|322695168|FG008|Year 2|Withdrawal by Subject|0|||
94246047|NCT02942277|322695169|FG009|Year 2|Withdrawal by Subject|0|||
94246048|NCT02942277|322695170|FG010|Year 2|Withdrawal by Subject|0|||
94592726|NCT02034409|323971468|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
94592727|NCT02034409|323971467|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
94592728|NCT02034409|323971468|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
94592729|NCT02034409|323971467|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
94592730|NCT02034409|323971468|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
94592731|NCT00095147|323971469|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
94592732|NCT00095147|323971470|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
94592733|NCT00095147|323971471|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
94592734|NCT00095147|323971472|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
94592735|NCT00095147|323971473|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
94592736|NCT00095147|323971469|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
94592737|NCT00095147|323971470|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
94592738|NCT00095147|323971471|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
94592739|NCT00095147|323971472|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
94592740|NCT00095147|323971473|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
94592741|NCT00095147|323971469|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
94592742|NCT00095147|323971470|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
94592743|NCT00095147|323971471|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
94592744|NCT00095147|323971472|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
94592745|NCT00095147|323971473|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
94592746|NCT00095147|323971469|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
94592747|NCT00095147|323971470|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
94592748|NCT00095147|323971471|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
94592749|NCT00095147|323971472|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
94592750|NCT00095147|323971473|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
94592751|NCT00095147|323971469|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
94592752|NCT00095147|323971470|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
94592753|NCT00095147|323971471|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
94592754|NCT00095147|323971472|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
94592755|NCT00095147|323971473|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
94592756|NCT00095147|323971469|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
94592757|NCT00095147|323971470|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
94592758|NCT00095147|323971471|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
94592759|NCT00095147|323971472|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
94592760|NCT00095147|323971473|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
94592761|NCT00095147|323971469|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
94592762|NCT00095147|323971470|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
94592763|NCT00095147|323971471|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
94592764|NCT00095147|323971472|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
94592765|NCT00095147|323971473|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
94592766|NCT00095147|323971469|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
94592767|NCT00095147|323971470|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
94592768|NCT00095147|323971471|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
94592769|NCT00095147|323971472|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
94592770|NCT00095147|323971473|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
94592771|NCT00095147|323971469|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
94246049|NCT05096221|322695176|FG000|Part 2|Ongoing in Part 2 of the Study|63|||
94246050|NCT05096221|322695177|FG001|Part 2|Ongoing in Part 2 of the Study|62|||
94246051|NCT01638429|322695180|FG000|Overall Study|Withdrawal by Subject|1|||
94246052|NCT03207451|322695182|FG000|Overall Study|scheduling conflict|1|||
94246053|NCT03207451|322695183|FG001|Overall Study|scheduling conflict|0|||
94246054|NCT03207451|322695184|FG002|Overall Study|scheduling conflict|2|||
94246055|NCT03207451|322695185|FG003|Overall Study|scheduling conflict|2|||
94246056|NCT03207451|322695182|FG000|Overall Study|Adverse Event|0|||
94246057|NCT03207451|322695183|FG001|Overall Study|Adverse Event|0|||
94246058|NCT03207451|322695184|FG002|Overall Study|Adverse Event|0|||
94246059|NCT03207451|322695185|FG003|Overall Study|Adverse Event|1|||
94246060|NCT01239043|322695186|FG000|Overall Study|Protocol Violation|2|||
94246061|NCT01239043|322695187|FG001|Overall Study|Protocol Violation|1|||
94592772|NCT00095147|323971470|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
94246062|NCT03339583|322695190|FG000|First Intervention (14 Days)|Adverse Event|1|||
94592773|NCT00095147|323971471|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
94592774|NCT00095147|323971472|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
94592775|NCT00095147|323971473|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
94592776|NCT00095147|323971469|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
94246063|NCT03339583|322695191|FG001|First Intervention (14 Days)|Adverse Event|0|||
94592777|NCT00095147|323971470|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
94592778|NCT00095147|323971471|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
94592779|NCT00095147|323971472|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
94592780|NCT00095147|323971473|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
94592781|NCT00095147|323971469|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
94592782|NCT00095147|323971470|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
94592783|NCT00095147|323971471|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
94592784|NCT00095147|323971472|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
94592785|NCT00095147|323971473|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
94592786|NCT00095147|323971469|FG000|Long-term Extension Period|Death|0|||
94592787|NCT00095147|323971470|FG001|Long-term Extension Period|Death|0|||
94592788|NCT00095147|323971471|FG002|Long-term Extension Period|Death|0|||
94592789|NCT00095147|323971472|FG003|Long-term Extension Period|Death|0|||
94592790|NCT00095147|323971473|FG004|Long-term Extension Period|Death|3|||
94592791|NCT00095147|323971469|FG000|Long-term Extension Period|Adverse Event|0|||
94592792|NCT00095147|323971470|FG001|Long-term Extension Period|Adverse Event|0|||
94592793|NCT00095147|323971471|FG002|Long-term Extension Period|Adverse Event|0|||
94592794|NCT00095147|323971472|FG003|Long-term Extension Period|Adverse Event|0|||
94592795|NCT00095147|323971473|FG004|Long-term Extension Period|Adverse Event|11|||
94592796|NCT00095147|323971469|FG000|Long-term Extension Period|Lack of Efficacy|0|||
94592797|NCT00095147|323971470|FG001|Long-term Extension Period|Lack of Efficacy|0|||
94592798|NCT00095147|323971471|FG002|Long-term Extension Period|Lack of Efficacy|0|||
94592799|NCT00095147|323971472|FG003|Long-term Extension Period|Lack of Efficacy|0|||
94592800|NCT00095147|323971473|FG004|Long-term Extension Period|Lack of Efficacy|9|||
94592801|NCT00095147|323971469|FG000|Long-term Extension Period|Lost to Follow-up|0|||
94592802|NCT00095147|323971470|FG001|Long-term Extension Period|Lost to Follow-up|0|||
94592803|NCT00095147|323971471|FG002|Long-term Extension Period|Lost to Follow-up|0|||
94592804|NCT00095147|323971472|FG003|Long-term Extension Period|Lost to Follow-up|0|||
94592805|NCT00095147|323971473|FG004|Long-term Extension Period|Lost to Follow-up|6|||
94592806|NCT00095147|323971469|FG000|Long-term Extension Period|Withdrawal of consent|0|||
94592807|NCT00095147|323971470|FG001|Long-term Extension Period|Withdrawal of consent|0|||
94592808|NCT00095147|323971471|FG002|Long-term Extension Period|Withdrawal of consent|0|||
94592809|NCT00095147|323971472|FG003|Long-term Extension Period|Withdrawal of consent|0|||
94592810|NCT00095147|323971473|FG004|Long-term Extension Period|Withdrawal of consent|12|||
94592811|NCT00095147|323971469|FG000|Long-term Extension Period|Pregnancy|0|||
94592812|NCT00095147|323971470|FG001|Long-term Extension Period|Pregnancy|0|||
94592813|NCT00095147|323971471|FG002|Long-term Extension Period|Pregnancy|0|||
94592814|NCT00095147|323971472|FG003|Long-term Extension Period|Pregnancy|0|||
94592815|NCT00095147|323971473|FG004|Long-term Extension Period|Pregnancy|1|||
94592816|NCT00095147|323971469|FG000|Long-term Extension Period|No longer meets study criteria|0|||
94592817|NCT00095147|323971470|FG001|Long-term Extension Period|No longer meets study criteria|0|||
94592818|NCT00095147|323971471|FG002|Long-term Extension Period|No longer meets study criteria|0|||
94592819|NCT00095147|323971472|FG003|Long-term Extension Period|No longer meets study criteria|0|||
94592820|NCT00095147|323971473|FG004|Long-term Extension Period|No longer meets study criteria|1|||
94592821|NCT00095147|323971469|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
94592822|NCT00095147|323971470|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
94592823|NCT00095147|323971471|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
94592824|NCT00095147|323971472|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
94592825|NCT00095147|323971473|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
94246064|NCT03339583|322695190|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
94246065|NCT03339583|322695191|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
94246066|NCT03339583|322695190|FG000|Second Intervention (14 Days)|Adverse Event|0|||
94592826|NCT00095147|323971469|FG000|Long-term Extension Period|Leaving country|0|||
94592827|NCT00095147|323971470|FG001|Long-term Extension Period|Leaving country|0|||
94592828|NCT00095147|323971471|FG002|Long-term Extension Period|Leaving country|0|||
94592829|NCT00095147|323971472|FG003|Long-term Extension Period|Leaving country|0|||
94592830|NCT00095147|323971473|FG004|Long-term Extension Period|Leaving country|1|||
94592831|NCT00946153|323971474|FG000|Phase 2|Adverse Event|0|||
94592832|NCT00946153|323971475|FG001|Phase 2|Adverse Event|0|||
94592833|NCT00946153|323971476|FG002|Phase 2|Adverse Event|0|||
94592834|NCT00946153|323971477|FG003|Phase 2|Adverse Event|0|||
94592835|NCT00946153|323971478|FG004|Phase 2|Adverse Event|6|||
94592836|NCT00946153|323971474|FG000|Phase 2|Need more reduction of dose|0|||
94592837|NCT00946153|323971475|FG001|Phase 2|Need more reduction of dose|0|||
94592838|NCT00946153|323971476|FG002|Phase 2|Need more reduction of dose|0|||
94592839|NCT00946153|323971477|FG003|Phase 2|Need more reduction of dose|0|||
94592840|NCT00946153|323971478|FG004|Phase 2|Need more reduction of dose|2|||
94592841|NCT00946153|323971474|FG000|Phase 2|Physician Decision|0|||
94592842|NCT00946153|323971475|FG001|Phase 2|Physician Decision|0|||
94592843|NCT00946153|323971476|FG002|Phase 2|Physician Decision|0|||
94592844|NCT00946153|323971477|FG003|Phase 2|Physician Decision|0|||
94592845|NCT00946153|323971478|FG004|Phase 2|Physician Decision|1|||
94592846|NCT00946153|323971474|FG000|Phase 2|14 days washout for recovery due to AE|0|||
94592847|NCT00946153|323971475|FG001|Phase 2|14 days washout for recovery due to AE|0|||
94592848|NCT00946153|323971476|FG002|Phase 2|14 days washout for recovery due to AE|0|||
94592849|NCT00946153|323971477|FG003|Phase 2|14 days washout for recovery due to AE|0|||
94592850|NCT00946153|323971478|FG004|Phase 2|14 days washout for recovery due to AE|4|||
94592851|NCT00934843|323971479|FG000|Overall Study|Protocol Violation|0|||
94592852|NCT00934843|323971480|FG001|Overall Study|Protocol Violation|1|||
94592853|NCT01030666|323971481|FG000|Overall Study|Lost to Follow-up|3|||
94592854|NCT01030666|323971482|FG001|Overall Study|Lost to Follow-up|2|||
94592855|NCT01011309|323971488|FG000|Overall Study|Adverse Event|2|||
94592856|NCT01011309|323971489|FG001|Overall Study|Adverse Event|1|||
94659972|NCT02246998|324209992|FG001|Overall Study|Lost to Follow-up|0|||
94659973|NCT02246998|324209993|FG002|Overall Study|Lost to Follow-up|0|||
94659974|NCT02246998|324209994|FG003|Overall Study|Lost to Follow-up|1|||
94659975|NCT02246998|324209991|FG000|Overall Study|Randomized but Never Dosed|1|||
94659976|NCT02246998|324209992|FG001|Overall Study|Randomized but Never Dosed|2|||
94659977|NCT02246998|324209993|FG002|Overall Study|Randomized but Never Dosed|2|||
94659978|NCT02246998|324209994|FG003|Overall Study|Randomized but Never Dosed|1|||
94659979|NCT01303627|324209999|FG000|Overall Study|the failure while performing URS|0|||
94659980|NCT01303627|324210000|FG001|Overall Study|the failure while performing URS|1|||
94592857|NCT01011309|323971490|FG002|Overall Study|Adverse Event|2|||
94592858|NCT01011309|323971488|FG000|Overall Study|Lack of Efficacy|0|||
94355393|NCT00151775|323083563|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
94592859|NCT01011309|323971489|FG001|Overall Study|Lack of Efficacy|1|||
94592860|NCT01011309|323971490|FG002|Overall Study|Lack of Efficacy|0|||
94592861|NCT01011309|323971488|FG000|Overall Study|Protocol Violation|0|||
94592862|NCT01011309|323971489|FG001|Overall Study|Protocol Violation|1|||
94592863|NCT01011309|323971490|FG002|Overall Study|Protocol Violation|3|||
94592864|NCT01451437|323971491|FG000|Overall Study|Adverse Event|0|||
94592865|NCT01451437|323971492|FG001|Overall Study|Adverse Event|0|||
94592866|NCT01451437|323971493|FG002|Overall Study|Adverse Event|0|||
94592867|NCT01451437|323971494|FG003|Overall Study|Adverse Event|0|||
94592868|NCT01451437|323971495|FG004|Overall Study|Adverse Event|0|||
94592869|NCT01451437|323971496|FG005|Overall Study|Adverse Event|1|||
94592870|NCT01451437|323971497|FG006|Overall Study|Adverse Event|1|||
94592871|NCT01451437|323971498|FG007|Overall Study|Adverse Event|2|||
94592872|NCT01451437|323971499|FG008|Overall Study|Adverse Event|1|||
94592873|NCT01451437|323971491|FG000|Overall Study|Physician Decision|1|||
94592874|NCT01451437|323971492|FG001|Overall Study|Physician Decision|1|||
94592875|NCT01451437|323971493|FG002|Overall Study|Physician Decision|2|||
94592876|NCT01451437|323971494|FG003|Overall Study|Physician Decision|0|||
94592877|NCT01451437|323971495|FG004|Overall Study|Physician Decision|0|||
94592878|NCT01451437|323971496|FG005|Overall Study|Physician Decision|0|||
94592879|NCT01451437|323971497|FG006|Overall Study|Physician Decision|0|||
94592880|NCT01451437|323971498|FG007|Overall Study|Physician Decision|0|||
94592881|NCT01451437|323971499|FG008|Overall Study|Physician Decision|0|||
94592882|NCT01451437|323971491|FG000|Overall Study|Disease Progression|0|||
94592883|NCT01451437|323971492|FG001|Overall Study|Disease Progression|0|||
94592884|NCT01451437|323971493|FG002|Overall Study|Disease Progression|1|||
94592885|NCT01451437|323971494|FG003|Overall Study|Disease Progression|1|||
94592886|NCT01451437|323971495|FG004|Overall Study|Disease Progression|3|||
94592887|NCT01451437|323971496|FG005|Overall Study|Disease Progression|2|||
94592888|NCT01451437|323971497|FG006|Overall Study|Disease Progression|3|||
94592889|NCT01451437|323971498|FG007|Overall Study|Disease Progression|1|||
94592890|NCT01451437|323971499|FG008|Overall Study|Disease Progression|3|||
94592891|NCT01451437|323971491|FG000|Overall Study|Protocol Violation|0|||
94592892|NCT01451437|323971492|FG001|Overall Study|Protocol Violation|0|||
94592893|NCT01451437|323971493|FG002|Overall Study|Protocol Violation|0|||
94592894|NCT01451437|323971494|FG003|Overall Study|Protocol Violation|0|||
94592895|NCT01451437|323971495|FG004|Overall Study|Protocol Violation|0|||
94592896|NCT01451437|323971496|FG005|Overall Study|Protocol Violation|0|||
94592897|NCT01451437|323971497|FG006|Overall Study|Protocol Violation|1|||
94592898|NCT01451437|323971498|FG007|Overall Study|Protocol Violation|0|||
94592899|NCT01451437|323971499|FG008|Overall Study|Protocol Violation|0|||
94592900|NCT01451437|323971491|FG000|Overall Study|Withdrawal by Subject|0|||
94592901|NCT01451437|323971492|FG001|Overall Study|Withdrawal by Subject|0|||
94592902|NCT01451437|323971493|FG002|Overall Study|Withdrawal by Subject|0|||
94592903|NCT01451437|323971494|FG003|Overall Study|Withdrawal by Subject|0|||
94592904|NCT01451437|323971495|FG004|Overall Study|Withdrawal by Subject|1|||
94592905|NCT01451437|323971496|FG005|Overall Study|Withdrawal by Subject|0|||
94592906|NCT01451437|323971497|FG006|Overall Study|Withdrawal by Subject|1|||
94592907|NCT01451437|323971498|FG007|Overall Study|Withdrawal by Subject|0|||
94592908|NCT01451437|323971499|FG008|Overall Study|Withdrawal by Subject|0|||
94592909|NCT01097005|323971500|FG000|Overall Study|Case Report Form not collected|18|||
94592910|NCT01097005|323971500|FG000|Overall Study|Subjects cannot visit the hospital|1|||
94592911|NCT01097005|323971500|FG000|Overall Study|Poor medication compliance|1|||
94592912|NCT01097005|323971500|FG000|Overall Study|No examination data available|244|||
94592913|NCT01097005|323971500|FG000|Overall Study|Deviation from exclusion criteria|37|||
94592914|NCT01097005|323971500|FG000|Overall Study|Adverse Event|14|||
94592915|NCT01097005|323971500|FG000|Overall Study|Discontinuance by complication|50|||
94592916|NCT01868542|323973594|FG000|Overall Study|Protocol Violation|0|||
94592917|NCT01868542|323973595|FG001|Overall Study|Protocol Violation|1|||
94592918|NCT01868542|323973594|FG000|Overall Study|Unclassified|0|||
94592919|NCT01868542|323973595|FG001|Overall Study|Unclassified|1|||
94592920|NCT01124864|323973597|FG000|Overall Study|Follow up phase competed as per protocol|18|||
94592921|NCT01124864|323973598|FG001|Overall Study|Follow up phase competed as per protocol|22|||
94592922|NCT01124864|323973599|FG002|Overall Study|Follow up phase competed as per protocol|24|||
94592923|NCT01124864|323973600|FG003|Overall Study|Follow up phase competed as per protocol|18|||
94592924|NCT01124864|323973601|FG004|Overall Study|Follow up phase competed as per protocol|26|||
94592925|NCT01124864|323973602|FG005|Overall Study|Follow up phase competed as per protocol|2|||
94592926|NCT01124864|323973597|FG000|Overall Study|Death|6|||
94592927|NCT01124864|323973598|FG001|Overall Study|Death|9|||
94592928|NCT01124864|323973599|FG002|Overall Study|Death|6|||
94592929|NCT01124864|323973600|FG003|Overall Study|Death|2|||
94592930|NCT01124864|323973601|FG004|Overall Study|Death|1|||
94592931|NCT01124864|323973602|FG005|Overall Study|Death|0|||
94592932|NCT01124864|323973597|FG000|Overall Study|Withdrawal by Subject|2|||
94592933|NCT01124864|323973598|FG001|Overall Study|Withdrawal by Subject|3|||
94592934|NCT01124864|323973599|FG002|Overall Study|Withdrawal by Subject|4|||
94592935|NCT01124864|323973600|FG003|Overall Study|Withdrawal by Subject|0|||
94592936|NCT01124864|323973601|FG004|Overall Study|Withdrawal by Subject|2|||
94592937|NCT01124864|323973602|FG005|Overall Study|Withdrawal by Subject|1|||
94592938|NCT01124864|323973597|FG000|Overall Study|Lost to Follow-up|1|||
94592939|NCT01124864|323973598|FG001|Overall Study|Lost to Follow-up|1|||
94592940|NCT01124864|323973599|FG002|Overall Study|Lost to Follow-up|0|||
94592941|NCT01124864|323973600|FG003|Overall Study|Lost to Follow-up|1|||
94592942|NCT01124864|323973601|FG004|Overall Study|Lost to Follow-up|0|||
94592943|NCT01124864|323973602|FG005|Overall Study|Lost to Follow-up|0|||
94592944|NCT01124864|323973597|FG000|Overall Study|Protocol Violation|1|||
94592945|NCT01124864|323973598|FG001|Overall Study|Protocol Violation|0|||
94592946|NCT01124864|323973599|FG002|Overall Study|Protocol Violation|0|||
94592947|NCT01124864|323973600|FG003|Overall Study|Protocol Violation|0|||
94592948|NCT01124864|323973601|FG004|Overall Study|Protocol Violation|1|||
94592949|NCT01124864|323973602|FG005|Overall Study|Protocol Violation|0|||
94592950|NCT01511055|323973607|FG000|Overall Study|Withdrawal by Subject|6|||
94592951|NCT01343693|323973610|FG000|Overall Study|Lost to Follow-up|9|||
94592952|NCT01235598|323973613|FG000|Overall Study|Adverse Event|0|||
94592953|NCT01235598|323973614|FG001|Overall Study|Adverse Event|3|||
94592954|NCT01235598|323973613|FG000|Overall Study|Lack of Efficacy|0|||
94592955|NCT01235598|323973614|FG001|Overall Study|Lack of Efficacy|1|||
94592956|NCT01235598|323973613|FG000|Overall Study|Withdrawal by Subject|1|||
94592957|NCT01235598|323973614|FG001|Overall Study|Withdrawal by Subject|0|||
94592958|NCT02551991|323973615|FG000|Overall Study|Death|5|||
94592959|NCT02551991|323973616|FG001|Overall Study|Death|7|||
94592960|NCT02551991|323973617|FG002|Overall Study|Death|8|||
94592961|NCT02551991|323973618|FG003|Overall Study|Death|7|||
94592962|NCT02551991|323973619|FG004|Overall Study|Death|17|||
94592963|NCT02551991|323973615|FG000|Overall Study|Withdrawal by Subject|1|||
94592964|NCT02551991|323973616|FG001|Overall Study|Withdrawal by Subject|0|||
94592965|NCT02551991|323973617|FG002|Overall Study|Withdrawal by Subject|0|||
94592966|NCT02551991|323973618|FG003|Overall Study|Withdrawal by Subject|0|||
94592967|NCT02551991|323973619|FG004|Overall Study|Withdrawal by Subject|2|||
94592968|NCT02551991|323973615|FG000|Overall Study|Lost to Follow-up|0|||
94592969|NCT02551991|323973616|FG001|Overall Study|Lost to Follow-up|0|||
94592970|NCT02551991|323973617|FG002|Overall Study|Lost to Follow-up|1|||
94592971|NCT02551991|323973618|FG003|Overall Study|Lost to Follow-up|0|||
94592972|NCT02551991|323973619|FG004|Overall Study|Lost to Follow-up|0|||
94592973|NCT02551991|323973615|FG000|Overall Study|Sponsor Decision|1|||
94592974|NCT02551991|323973616|FG001|Overall Study|Sponsor Decision|0|||
94592975|NCT02551991|323973617|FG002|Overall Study|Sponsor Decision|1|||
94592976|NCT02551991|323973618|FG003|Overall Study|Sponsor Decision|0|||
94592977|NCT02551991|323973619|FG004|Overall Study|Sponsor Decision|5|||
94592978|NCT02551991|323973615|FG000|Overall Study|Other|0|||
94592979|NCT02551991|323973616|FG001|Overall Study|Other|0|||
94592980|NCT02551991|323973617|FG002|Overall Study|Other|0|||
94592981|NCT02551991|323973618|FG003|Overall Study|Other|0|||
94592982|NCT02551991|323973619|FG004|Overall Study|Other|1|||
94592983|NCT00265148|323973620|FG000|Overall Study|Adverse Event|2|||
94592984|NCT00265148|323973621|FG001|Overall Study|Adverse Event|2|||
94592985|NCT00265148|323973620|FG000|Overall Study|Lack of Efficacy|0|||
94592986|NCT00265148|323973621|FG001|Overall Study|Lack of Efficacy|2|||
94592987|NCT00265148|323973620|FG000|Overall Study|Protocol Violation|3|||
94592988|NCT00265148|323973621|FG001|Overall Study|Protocol Violation|2|||
94592989|NCT00265148|323973620|FG000|Overall Study|Lost to Follow-up|0|||
94592990|NCT00265148|323973621|FG001|Overall Study|Lost to Follow-up|1|||
94592991|NCT00265148|323973620|FG000|Overall Study|Withdrawal by Subject|2|||
94592992|NCT00265148|323973621|FG001|Overall Study|Withdrawal by Subject|1|||
94592993|NCT00265148|323973620|FG000|Overall Study|Physician Decision|1|||
94592994|NCT00265148|323973621|FG001|Overall Study|Physician Decision|0|||
94592995|NCT00265148|323973620|FG000|Overall Study|Increasing frailty|0|||
94592996|NCT00265148|323973621|FG001|Overall Study|Increasing frailty|1|||
94456637|NCT00090220|323460545|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
94592997|NCT00265148|323973620|FG000|Overall Study|Subject chose to change of the dose|1|||
94592998|NCT00265148|323973621|FG001|Overall Study|Subject chose to change of the dose|0|||
94592999|NCT00095940|323973622|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
94593000|NCT00095940|323973623|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
94593001|NCT00095940|323973624|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
94593002|NCT00095940|323973625|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
94593003|NCT00095940|323973626|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
94593004|NCT00095940|323973627|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
94593005|NCT00095940|323973628|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
94593006|NCT00095940|323973629|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
94593007|NCT00095940|323973630|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
94593008|NCT00095940|323973622|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
94593009|NCT00095940|323973623|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
94593010|NCT00095940|323973624|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
94593011|NCT00095940|323973625|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
94593012|NCT00095940|323973626|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
94593013|NCT00095940|323973627|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
94593014|NCT00095940|323973628|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
94593015|NCT00095940|323973629|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
94593016|NCT00095940|323973630|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
94593017|NCT00095940|323973622|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
94593018|NCT00095940|323973623|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
94593019|NCT00095940|323973624|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
94593020|NCT00095940|323973625|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
94593021|NCT00095940|323973626|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
94593022|NCT00095940|323973627|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
94593023|NCT00095940|323973628|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
94593024|NCT00095940|323973629|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
94593025|NCT00095940|323973630|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
94593026|NCT04491604|323973631|FG000|Overall Study|Withdrawal by Subject|3|||
94593027|NCT00615901|323973632|FG000|Overall Study|Withdrawal by Subject|2|||
94593028|NCT00615901|323973632|FG000|Overall Study|Adverse Event|7|||
94593029|NCT03263702|323973633|FG000|Overall Study|Lost to Follow-up|2|||
94593030|NCT03263702|323973634|FG001|Overall Study|Lost to Follow-up|2|||
94593031|NCT03263702|323973633|FG000|Overall Study|Withdrawal by Subject|1|||
94593032|NCT03263702|323973634|FG001|Overall Study|Withdrawal by Subject|2|||
94593033|NCT03598114|323973635|FG000|Overall Study|Staff turnover/left the program|3|||
94593034|NCT03598114|323973636|FG001|Overall Study|Staff turnover/left the program|39|||
94593035|NCT02386189|323973648|FG000|Overall Study|Lost to Follow-up|2|||
94593036|NCT02386189|323973649|FG001|Overall Study|Lost to Follow-up|3|||
94593037|NCT02386189|323973648|FG000|Overall Study|Withdrawal by Subject|1|||
94456638|NCT00090220|323460540|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
94456639|NCT00090220|323460541|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
94456640|NCT00090220|323460542|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
94456641|NCT00090220|323460543|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
94456642|NCT00090220|323460544|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
94456643|NCT00090220|323460545|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
94456644|NCT00090220|323460540|FG000|Base Study Vaccination Period|Patient Moved|6|||
94456645|NCT00090220|323460541|FG001|Base Study Vaccination Period|Patient Moved|2|||
94456646|NCT00090220|323460542|FG002|Base Study Vaccination Period|Patient Moved|0|||
94456647|NCT00090220|323460543|FG003|Base Study Vaccination Period|Patient Moved|0|||
94456648|NCT00090220|323460544|FG004|Base Study Vaccination Period|Patient Moved|0|||
94456649|NCT00090220|323460545|FG005|Base Study Vaccination Period|Patient Moved|0|||
94456650|NCT00090220|323460540|FG000|Base Study Vaccination Period|Other|4|||
94456651|NCT00090220|323460541|FG001|Base Study Vaccination Period|Other|4|||
94593038|NCT02386189|323973649|FG001|Overall Study|Withdrawal by Subject|0|||
94593039|NCT02386189|323973648|FG000|Overall Study|Death|1|||
94593040|NCT02386189|323973649|FG001|Overall Study|Death|0|||
94593041|NCT03319745|323973650|FG000|Overall Study|Death|1|||
94593042|NCT03319745|323973650|FG000|Overall Study|Toxicity Precluding Surgery|1|||
94593043|NCT00640224|323973651|FG000|Overall Study|Lost to Follow-up|5|||
94593044|NCT00640224|323973652|FG001|Overall Study|Lost to Follow-up|2|||
94593045|NCT00640224|323973653|FG002|Overall Study|Lost to Follow-up|0|||
94593046|NCT00640224|323973654|FG003|Overall Study|Lost to Follow-up|0|||
94593047|NCT00640224|323973651|FG000|Overall Study|Withdrawal by Subject|1|||
94593048|NCT00640224|323973652|FG001|Overall Study|Withdrawal by Subject|0|||
94593049|NCT00640224|323973653|FG002|Overall Study|Withdrawal by Subject|0|||
94593050|NCT00640224|323973654|FG003|Overall Study|Withdrawal by Subject|0|||
94593051|NCT00640224|323973651|FG000|Overall Study|Headaches|0|||
94593052|NCT00640224|323973652|FG001|Overall Study|Headaches|1|||
94593053|NCT00640224|323973653|FG002|Overall Study|Headaches|0|||
94593054|NCT00640224|323973654|FG003|Overall Study|Headaches|0|||
94593055|NCT03206788|323973657|FG000|Overall Study|Withdrawal by Subject|0|||
94593056|NCT03206788|323973658|FG001|Overall Study|Withdrawal by Subject|1|||
94355394|NCT00151775|323083564|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
94355395|NCT00151775|323083565|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
94355396|NCT00151775|323083566|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
94593057|NCT03206788|323973657|FG000|Overall Study|Adverse Event|0|||
94593058|NCT03206788|323973658|FG001|Overall Study|Adverse Event|1|||
94593059|NCT03206788|323973657|FG000|Overall Study|Physician Decision|0|||
94593060|NCT03206788|323973658|FG001|Overall Study|Physician Decision|1|||
94593061|NCT00361634|323973659|FG000|Overall Study|Lost to Follow-up|1|||
94593062|NCT00361634|323973659|FG000|Overall Study|Withdrawal by Subject|1|||
94593063|NCT02082340|323973660|FG000|Overall Study|Lost to Follow-up|1|||
94593064|NCT02082340|323973661|FG001|Overall Study|Lost to Follow-up|1|||
94593065|NCT01625260|323973662|FG000|Overall Study|Adverse Event|3|||
94593066|NCT01625260|323973663|FG001|Overall Study|Adverse Event|0|||
94593067|NCT01625260|323973662|FG000|Overall Study|Study Terminated by Investigator|2|||
94593068|NCT01625260|323973663|FG001|Overall Study|Study Terminated by Investigator|0|||
94593069|NCT01625260|323973662|FG000|Overall Study|Disease Progression|2|||
94593070|NCT01625260|323973663|FG001|Overall Study|Disease Progression|0|||
94593071|NCT01625260|323973662|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
94593072|NCT01625260|323973663|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
94593073|NCT00591318|323973666|FG000|Overall Study|Lack of Efficacy|2|||
94593074|NCT00591318|323973667|FG001|Overall Study|Lack of Efficacy|0|||
94593075|NCT00591318|323973666|FG000|Overall Study|Adverse Event|2|||
94593076|NCT00591318|323973667|FG001|Overall Study|Adverse Event|0|||
94593077|NCT04074161|323973670|FG000|Overall Study|Withdrawal by Subject|2|||
94593078|NCT04074161|323973671|FG001|Overall Study|Withdrawal by Subject|4|||
94593079|NCT04074161|323973672|FG002|Overall Study|Withdrawal by Subject|1|||
94593080|NCT04074161|323973670|FG000|Overall Study|Lost to Follow-up|4|||
94593081|NCT04074161|323973671|FG001|Overall Study|Lost to Follow-up|5|||
94593082|NCT04074161|323973672|FG002|Overall Study|Lost to Follow-up|3|||
94593083|NCT01689532|323973673|FG000|Overall Study|Adverse Event|9|||
94593084|NCT01689532|323973674|FG001|Overall Study|Adverse Event|5|||
94593085|NCT01689532|323973673|FG000|Overall Study|Lack of Efficacy|2|||
94593086|NCT01689532|323973674|FG001|Overall Study|Lack of Efficacy|2|||
94593087|NCT01689532|323973673|FG000|Overall Study|Withdrawal by Subject|1|||
94593088|NCT01689532|323973674|FG001|Overall Study|Withdrawal by Subject|2|||
94593089|NCT01689532|323973673|FG000|Overall Study|Physician Decision|2|||
94593090|NCT01689532|323973674|FG001|Overall Study|Physician Decision|0|||
94593091|NCT01024309|323973675|FG000|Overall Study|Physician Decision|4|||
94593092|NCT01024309|323973676|FG001|Overall Study|Physician Decision|0|||
94593093|NCT01024309|323973675|FG000|Overall Study|Withdrawal by Subject|4|||
94593094|NCT01024309|323973676|FG001|Overall Study|Withdrawal by Subject|4|||
94593095|NCT02208063|323973679|FG000|Overall Study|Death|3|||
94593096|NCT02208063|323973680|FG001|Overall Study|Death|5|||
94593097|NCT02208063|323973679|FG000|Overall Study|Not Specified in report|3|||
94593098|NCT02208063|323973680|FG001|Overall Study|Not Specified in report|4|||
94593099|NCT02208063|323973679|FG000|Overall Study|Withdrawal by Subject|5|||
94593100|NCT02208063|323973680|FG001|Overall Study|Withdrawal by Subject|2|||
94593101|NCT02208063|323973679|FG000|Overall Study|Lost to Follow-up|1|||
94593102|NCT02208063|323973680|FG001|Overall Study|Lost to Follow-up|0|||
94593103|NCT00388583|323973684|FG000|Overall Study|Protocol Violation|1|||
94355397|NCT00151775|323083567|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
94593104|NCT00388583|323973685|FG001|Overall Study|Protocol Violation|0|||
94593105|NCT00388583|323973684|FG000|Overall Study|Withdrawal by Subject|3|||
94593106|NCT00388583|323973685|FG001|Overall Study|Withdrawal by Subject|3|||
94593107|NCT00388583|323973684|FG000|Overall Study|Serious Adverse Event|2|||
94355398|NCT00151775|323083568|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
94593108|NCT00388583|323973685|FG001|Overall Study|Serious Adverse Event|0|||
94593109|NCT00388583|323973684|FG000|Overall Study|Did not receive vaccine|0|||
94355399|NCT00151775|323083569|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
94593110|NCT00388583|323973685|FG001|Overall Study|Did not receive vaccine|1|||
94593111|NCT00006409|323973686|FG000|Baseline|Protocol Violation|48|||
94593112|NCT00006409|323973687|FG001|Baseline|Protocol Violation|70|||
94593113|NCT00006409|323973688|FG002|Baseline|Protocol Violation|0|||
94593114|NCT00006409|323973689|FG003|Baseline|Protocol Violation|0|||
94593115|NCT00006409|323973690|FG004|Baseline|Protocol Violation|0|||
94593116|NCT00006409|323973691|FG005|Baseline|Protocol Violation|0|||
94593117|NCT00006409|323973686|FG000|Post-2 Year Intervention|Protocol Violation|0|||
94593118|NCT00006409|323973687|FG001|Post-2 Year Intervention|Protocol Violation|0|||
94593119|NCT00006409|323973688|FG002|Post-2 Year Intervention|Protocol Violation|251|||
94355400|NCT00151775|323083570|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
94355401|NCT00151775|323083571|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
94593120|NCT00006409|323973689|FG003|Post-2 Year Intervention|Protocol Violation|168|||
94593121|NCT00006409|323973690|FG004|Post-2 Year Intervention|Protocol Violation|0|||
94593122|NCT00006409|323973691|FG005|Post-2 Year Intervention|Protocol Violation|0|||
94593123|NCT00006409|323973686|FG000|Post-3 Year Intervention|Protocol Violation|0|||
94593124|NCT00006409|323973687|FG001|Post-3 Year Intervention|Protocol Violation|0|||
94593125|NCT00006409|323973688|FG002|Post-3 Year Intervention|Protocol Violation|0|||
94593126|NCT00006409|323973689|FG003|Post-3 Year Intervention|Protocol Violation|0|||
94593127|NCT00006409|323973690|FG004|Post-3 Year Intervention|Protocol Violation|62|||
94593128|NCT00006409|323973691|FG005|Post-3 Year Intervention|Protocol Violation|62|||
94593129|NCT01433289|323973692|FG000|Overall Study|Pregnancy|0|||
94246067|NCT03339583|322695191|FG001|Second Intervention (14 Days)|Adverse Event|1|||
94246068|NCT03339583|322695190|FG000|Follow-up (14 Days)|Physician Decision|6|||
94246069|NCT03339583|322695191|FG001|Follow-up (14 Days)|Physician Decision|3|||
94246070|NCT00943852|322695192|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
94246071|NCT00943852|322695193|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
94246072|NCT00943852|322695194|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
94246073|NCT00943852|322695195|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
94246074|NCT00943852|322695196|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
94246075|NCT00943852|322695197|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
94246076|NCT00943852|322695198|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
94246077|NCT00943852|322695199|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
94246078|NCT00943852|322695200|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
94246079|NCT00943852|322695201|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
94246080|NCT00943852|322695192|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
94246081|NCT00943852|322695193|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
94246082|NCT00943852|322695194|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
94246083|NCT00943852|322695195|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
94246084|NCT00943852|322695196|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
94246085|NCT00943852|322695197|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
94246086|NCT00943852|322695198|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
94246087|NCT00943852|322695199|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
94246088|NCT00943852|322695200|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
94246089|NCT00943852|322695201|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
94246090|NCT00943852|322695192|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
94246091|NCT00943852|322695193|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
94246092|NCT00943852|322695194|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
94246093|NCT00943852|322695195|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
94246094|NCT00943852|322695196|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
94246095|NCT00943852|322695197|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
94246096|NCT00943852|322695198|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
94246097|NCT00943852|322695199|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
94246098|NCT00943852|322695200|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
94246099|NCT00943852|322695201|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
94246100|NCT00943852|322695192|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
94246101|NCT00943852|322695193|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
94246102|NCT00943852|322695194|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
94246103|NCT00943852|322695195|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
94246104|NCT00943852|322695196|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
94355402|NCT00151775|323083572|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
94355403|NCT00151775|323083573|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
94355404|NCT00151775|323083562|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
94355405|NCT00151775|323083563|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
94355406|NCT00151775|323083564|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
94355407|NCT00151775|323083565|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
94355408|NCT00151775|323083566|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
94355409|NCT00151775|323083567|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
94355410|NCT00151775|323083568|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
94355411|NCT00151775|323083569|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
94593130|NCT01433289|323973693|FG001|Overall Study|Pregnancy|1|||
94593131|NCT01433289|323973694|FG002|Overall Study|Pregnancy|0|||
94355412|NCT00151775|323083570|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
94593132|NCT01433289|323973695|FG003|Overall Study|Pregnancy|0|||
94593133|NCT02410343|323973704|FG000|Core Period (24 Weeks)|Adverse Event|1|||
94593134|NCT02410343|323973705|FG001|Core Period (24 Weeks)|Adverse Event|0|||
94593135|NCT02410343|323973704|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
94355413|NCT00151775|323083571|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
94355414|NCT00151775|323083572|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
94355415|NCT00151775|323083573|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
94355416|NCT00151775|323083562|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
94355417|NCT00151775|323083563|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
94355418|NCT00151775|323083564|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
94355419|NCT00151775|323083565|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
94355420|NCT00151775|323083566|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
94355421|NCT00151775|323083567|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
94355422|NCT00151775|323083568|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
94355423|NCT00151775|323083569|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
94355424|NCT00151775|323083570|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
94355425|NCT00151775|323083571|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
94593136|NCT02410343|323973705|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
94593137|NCT02410343|323973704|FG000|Extension Period (12 Months)|Adverse Event|1|||
94593138|NCT02410343|323973705|FG001|Extension Period (12 Months)|Adverse Event|0|||
94593139|NCT02410343|323973704|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
94593140|NCT02410343|323973705|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
94593141|NCT00280748|323973707|FG000|Overall Study|Decline in performance|3|||
94593142|NCT00280748|323973707|FG000|Overall Study|Extra-cranial disease progression|1|||
94593143|NCT00228553|323973710|FG000|Overall Study|Adverse Event|112|||
94593144|NCT00228553|323973710|FG000|Overall Study|Lack of Efficacy|34|||
94593145|NCT00228553|323973710|FG000|Overall Study|Lost to Follow-up|67|||
94593146|NCT00228553|323973710|FG000|Overall Study|Physician Decision|48|||
94246105|NCT00943852|322695197|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
94246106|NCT00943852|322695198|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
94246107|NCT00943852|322695199|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
94246108|NCT00943852|322695200|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
94246109|NCT00943852|322695201|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
94246110|NCT00943852|322695192|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
94246111|NCT00943852|322695193|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
94246112|NCT00943852|322695194|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
94246113|NCT00943852|322695195|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
94246114|NCT00943852|322695196|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
94246115|NCT00943852|322695197|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
94246116|NCT00943852|322695198|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
94246117|NCT00943852|322695199|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
94246118|NCT00943852|322695200|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
94246119|NCT00943852|322695201|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
94246120|NCT02141620|322695202|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
94246121|NCT02141620|322695203|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
94246122|NCT00772330|322695204|FG000|Overall Study|Lost to Follow-up|3|||
94246123|NCT01519089|322695205|FG000|Overall Study|Adverse Event|4|||
94246124|NCT01519089|322695206|FG001|Overall Study|Adverse Event|4|||
94246125|NCT01519089|322695205|FG000|Overall Study|Lack of Efficacy|0|||
94246126|NCT01519089|322695206|FG001|Overall Study|Lack of Efficacy|2|||
94246127|NCT01519089|322695205|FG000|Overall Study|Lost to Follow-up|1|||
94246128|NCT01519089|322695206|FG001|Overall Study|Lost to Follow-up|0|||
94246129|NCT01519089|322695205|FG000|Overall Study|Withdrawal by Subject|0|||
94246130|NCT01519089|322695206|FG001|Overall Study|Withdrawal by Subject|2|||
94593147|NCT00228553|323973710|FG000|Overall Study|Protocol Violation|6|||
94593148|NCT00228553|323973710|FG000|Overall Study|Withdrawal by Subject|115|||
94593149|NCT00228553|323973710|FG000|Overall Study|Pregnancy|2|||
94593150|NCT00228553|323973710|FG000|Overall Study|Miscellaneous|46|||
94593151|NCT03704636|323973717|FG000|Overall Study|Inadequate Venous Flow|3|||
94593152|NCT00539188|323973722|FG000|Overall Study|Withdrawal by Subject|1|||
94593153|NCT00539188|323973723|FG001|Overall Study|Withdrawal by Subject|0|||
94593154|NCT00539188|323973722|FG000|Overall Study|Lost to Follow-up|2|||
94593155|NCT00539188|323973723|FG001|Overall Study|Lost to Follow-up|1|||
94593156|NCT02674204|323973727|FG000|Overall Study|Adverse Event|1|||
94593157|NCT02674204|323973728|FG001|Overall Study|Adverse Event|0|||
94593158|NCT02466659|323973731|FG000|Overall Study|Lost to Follow-up|5|||
94593159|NCT02466659|323973732|FG001|Overall Study|Lost to Follow-up|2|||
94593160|NCT02874144|323973733|FG000|Overall Study|Lost to Follow-up|3|||
94593161|NCT02874144|323973734|FG001|Overall Study|Lost to Follow-up|5|||
94593162|NCT00486811|323973736|FG000|Overall Study|Adverse Event|28|||
94593163|NCT00486811|323973737|FG001|Overall Study|Adverse Event|60|||
94593164|NCT00486811|323973738|FG002|Overall Study|Adverse Event|135|||
94593165|NCT00486811|323973736|FG000|Overall Study|Lack of Efficacy|34|||
94593166|NCT00486811|323973737|FG001|Overall Study|Lack of Efficacy|14|||
94593167|NCT00486811|323973738|FG002|Overall Study|Lack of Efficacy|7|||
94593168|NCT00486811|323973736|FG000|Overall Study|Lost to Follow-up|4|||
94593169|NCT00486811|323973737|FG001|Overall Study|Lost to Follow-up|6|||
94593170|NCT00486811|323973738|FG002|Overall Study|Lost to Follow-up|4|||
94593171|NCT00486811|323973736|FG000|Overall Study|Withdrawal by Subject|33|||
94593172|NCT00486811|323973737|FG001|Overall Study|Withdrawal by Subject|44|||
94593173|NCT00486811|323973738|FG002|Overall Study|Withdrawal by Subject|58|||
94593174|NCT00486811|323973736|FG000|Overall Study|Study drug non-compliant|5|||
94593175|NCT00486811|323973737|FG001|Overall Study|Study drug non-compliant|6|||
94593176|NCT00486811|323973738|FG002|Overall Study|Study drug non-compliant|3|||
94593177|NCT00486811|323973736|FG000|Overall Study|All other|18|||
94593178|NCT00486811|323973737|FG001|Overall Study|All other|11|||
94593179|NCT00486811|323973738|FG002|Overall Study|All other|7|||
94593180|NCT02929498|323973739|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
94593181|NCT02929498|323973740|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
94593182|NCT02929498|323973741|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
94593183|NCT02929498|323973739|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
94593184|NCT02929498|323973740|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
94593185|NCT02929498|323973741|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
94593186|NCT00096356|323973742|FG000|Overall Study|Adverse Event|11|||
94593187|NCT00096356|323973743|FG001|Overall Study|Adverse Event|9|||
94593188|NCT00096356|323973742|FG000|Overall Study|Physician Decision|5|||
94593189|NCT00096356|323973743|FG001|Overall Study|Physician Decision|3|||
94593190|NCT00096356|323973742|FG000|Overall Study|Withdrawal by Subject|17|||
94593191|NCT00096356|323973743|FG001|Overall Study|Withdrawal by Subject|23|||
94593192|NCT00096356|323973742|FG000|Overall Study|Lack of Efficacy|1|||
94593193|NCT00096356|323973743|FG001|Overall Study|Lack of Efficacy|0|||
94593194|NCT00096356|323973742|FG000|Overall Study|multiple reasons|10|||
94593195|NCT00096356|323973743|FG001|Overall Study|multiple reasons|18|||
94593196|NCT00781885|323973744|FG000|Overall Study|Physician Decision|1|||
94593197|NCT01755026|323973745|FG000|Overall Study|Adverse Event|1|||
94593198|NCT01755026|323973746|FG001|Overall Study|Adverse Event|0|||
94593199|NCT01755026|323973745|FG000|Overall Study|Withdrawal by Subject|1|||
94593200|NCT01755026|323973746|FG001|Overall Study|Withdrawal by Subject|1|||
94246131|NCT01519089|322695205|FG000|Overall Study|Other|2|||
94246132|NCT01519089|322695206|FG001|Overall Study|Other|6|||
94246133|NCT01519089|322695205|FG000|Overall Study|Not received study drug|0|||
94593201|NCT01700387|323973747|FG000|Overall Study|Withdrawal by Subject|1|||
94593202|NCT01700387|323973748|FG001|Overall Study|Withdrawal by Subject|2|||
94593203|NCT01700387|323973747|FG000|Overall Study|Adverse Event|1|||
94593204|NCT01700387|323973748|FG001|Overall Study|Adverse Event|1|||
94593205|NCT01700387|323973747|FG000|Overall Study|Lost to Follow-up|2|||
94593206|NCT01700387|323973748|FG001|Overall Study|Lost to Follow-up|1|||
94246134|NCT01519089|322695206|FG001|Overall Study|Not received study drug|1|||
94246135|NCT00127205|322695207|FG000|Overall Study|Adverse Event|228|||
94593207|NCT01306929|323973754|FG000|Overall Study|Withdrawal by Subject|23|||
94593208|NCT01306929|323973754|FG000|Overall Study|Adverse Event|21|||
94593209|NCT01306929|323973754|FG000|Overall Study|Physician Decision|13|||
94246136|NCT00127205|322695208|FG001|Overall Study|Adverse Event|387|||
94593210|NCT01306929|323973754|FG000|Overall Study|Death|8|||
94593211|NCT01306929|323973754|FG000|Overall Study|Withdrawal by parent/guardian|5|||
94593212|NCT01306929|323973754|FG000|Overall Study|Protocol Violation|3|||
94593213|NCT01306929|323973754|FG000|Overall Study|Non-compliance with study drug|2|||
94593214|NCT01306929|323973754|FG000|Overall Study|Lost to Follow-up|2|||
94593215|NCT01306929|323973754|FG000|Overall Study|Various|17|||
94593216|NCT01870076|323973756|FG000|Overall Study|Withdrawal by Subject|1|||
94593217|NCT01870076|323973757|FG001|Overall Study|Withdrawal by Subject|0|||
94593218|NCT01870076|323973758|FG002|Overall Study|Withdrawal by Subject|1|||
94593219|NCT01870076|323973759|FG003|Overall Study|Withdrawal by Subject|0|||
94593220|NCT03073733|323973762|FG000|Overall Study|Lost to Follow-up|1|||
94593221|NCT03073733|323973763|FG001|Overall Study|Lost to Follow-up|0|||
94593222|NCT03073733|323973764|FG002|Overall Study|Lost to Follow-up|0|||
94593223|NCT03073733|323973762|FG000|Overall Study|Physician Decision|0|||
94593224|NCT03073733|323973763|FG001|Overall Study|Physician Decision|1|||
94593225|NCT03073733|323973764|FG002|Overall Study|Physician Decision|0|||
94593226|NCT03073733|323973762|FG000|Overall Study|Withdrawal by Subject|0|||
94593227|NCT03073733|323973763|FG001|Overall Study|Withdrawal by Subject|0|||
94593228|NCT03073733|323973764|FG002|Overall Study|Withdrawal by Subject|1|||
94593229|NCT00243841|323973765|FG000|Overall Study|Physician Decision|0|||
94593230|NCT00243841|323973766|FG001|Overall Study|Physician Decision|0|||
94593231|NCT00243841|323973767|FG002|Overall Study|Physician Decision|1|||
94593232|NCT00243841|323973768|FG003|Overall Study|Physician Decision|0|||
94593233|NCT00243841|323973769|FG004|Overall Study|Physician Decision|0|||
94593234|NCT00243841|323973770|FG005|Overall Study|Physician Decision|2|||
94593235|NCT01808092|323973771|FG000|Overall Study|Death|39|||
94593236|NCT01808092|323973772|FG001|Overall Study|Death|29|||
94593237|NCT01808092|323973771|FG000|Overall Study|Lost to Follow-up|3|||
94593238|NCT01808092|323973772|FG001|Overall Study|Lost to Follow-up|7|||
94593239|NCT01808092|323973771|FG000|Overall Study|Withdrawal by Subject|9|||
94246137|NCT00127205|322695209|FG002|Overall Study|Adverse Event|273|||
94246138|NCT00127205|322695207|FG000|Overall Study|Death|8|||
94593240|NCT01808092|323973772|FG001|Overall Study|Withdrawal by Subject|4|||
94593241|NCT01808092|323973771|FG000|Overall Study|Other Eligibility criteria|3|||
94593242|NCT01808092|323973772|FG001|Overall Study|Other Eligibility criteria|5|||
94593243|NCT02123251|323975193|FG000|Overall Study|Death|1|||
94593244|NCT02123251|323975194|FG001|Overall Study|Death|1|||
94593245|NCT02123251|323975193|FG000|Overall Study|Withdrawal by Subject|0|||
94593246|NCT02123251|323975194|FG001|Overall Study|Withdrawal by Subject|3|||
94593247|NCT02123251|323975193|FG000|Overall Study|Lost Medicaid eligibility|29|||
94593248|NCT02123251|323975194|FG001|Overall Study|Lost Medicaid eligibility|22|||
94593249|NCT02123251|323975193|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
94593250|NCT02123251|323975194|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
94593251|NCT01589653|323975195|FG000|Overall Study|Protocol Violation|3|||
94593252|NCT01589653|323975196|FG001|Overall Study|Protocol Violation|1|||
94593253|NCT01589653|323975195|FG000|Overall Study|Withdrawal criteria|4|||
94593254|NCT01589653|323975196|FG001|Overall Study|Withdrawal criteria|7|||
94593255|NCT01589653|323975195|FG000|Overall Study|Unclassified|0|||
94593256|NCT01589653|323975196|FG001|Overall Study|Unclassified|3|||
94593257|NCT00200356|323975199|FG000|Overall Study|Lack of Efficacy|3|||
94246139|NCT00127205|322695208|FG001|Overall Study|Death|6|||
94246140|NCT00127205|322695209|FG002|Overall Study|Death|5|||
94246141|NCT00127205|322695207|FG000|Overall Study|Withdrawal by Subject|318|||
94246142|NCT00127205|322695208|FG001|Overall Study|Withdrawal by Subject|310|||
94246143|NCT00127205|322695209|FG002|Overall Study|Withdrawal by Subject|172|||
94246144|NCT00127205|322695207|FG000|Overall Study|Other-non protocol specified|142|||
94246145|NCT00127205|322695208|FG001|Overall Study|Other-non protocol specified|129|||
94246146|NCT00127205|322695209|FG002|Overall Study|Other-non protocol specified|77|||
94246147|NCT00127205|322695207|FG000|Overall Study|Data not reported|6|||
94246148|NCT00127205|322695208|FG001|Overall Study|Data not reported|10|||
94246149|NCT00127205|322695209|FG002|Overall Study|Data not reported|1|||
94246150|NCT00127205|322695207|FG000|Overall Study|Progression|127|||
94593258|NCT00200356|323975200|FG001|Overall Study|Lack of Efficacy|3|||
94246151|NCT00127205|322695208|FG001|Overall Study|Progression|131|||
94246152|NCT00127205|322695209|FG002|Overall Study|Progression|84|||
94246153|NCT00734591|322695210|FG000|Screening for Prospective Period|Site did not participate|1604|||
94593259|NCT00200356|323975199|FG000|Overall Study|Protocol Violation|4|||
94246154|NCT00734591|322695211|FG001|Screening for Prospective Period|Site did not participate|1488|||
94593260|NCT00200356|323975200|FG001|Overall Study|Protocol Violation|4|||
94593261|NCT00200356|323975199|FG000|Overall Study|Nontreatment|1|||
94593262|NCT00200356|323975200|FG001|Overall Study|Nontreatment|0|||
94593263|NCT01782469|323975202|FG000|Overall Study|Lost to Follow-up|1|||
94593264|NCT01864005|323975203|FG000|Overall Study|Protocol Violation|0|||
94246155|NCT00734591|322695210|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
94246156|NCT00734591|322695211|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
94593265|NCT01864005|323975204|FG001|Overall Study|Protocol Violation|1|||
94593266|NCT01864005|323975203|FG000|Overall Study|Withdrawal by Subject|0|||
94593267|NCT01864005|323975204|FG001|Overall Study|Withdrawal by Subject|1|||
94246157|NCT00734591|322695210|FG000|Prospective Period|Withdrawal by Subject|11|||
94593268|NCT01864005|323975203|FG000|Overall Study|Incorrect enrolment|1|||
94593269|NCT01864005|323975204|FG001|Overall Study|Incorrect enrolment|0|||
94593270|NCT01864005|323975203|FG000|Overall Study|Disease need|1|||
94593271|NCT01864005|323975204|FG001|Overall Study|Disease need|1|||
94593272|NCT01864005|323975203|FG000|Overall Study|Need GP IIb/IIIa|1|||
94593273|NCT01864005|323975204|FG001|Overall Study|Need GP IIb/IIIa|3|||
94593274|NCT02743611|323975205|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
94593275|NCT02743611|323975206|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
94593276|NCT02743611|323975207|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
94593277|NCT02743611|323975208|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
94593278|NCT04620798|323975213|FG000|Overall Study|Lost to Follow-up|126|||
94593279|NCT04620798|323975214|FG001|Overall Study|Lost to Follow-up|138|||
94593280|NCT01989208|323975217|FG000|200 mg (7 Days)|Protocol Violation|0|||
94593281|NCT01989208|323975218|FG001|200 mg (7 Days)|Protocol Violation|1|||
94593282|NCT01616693|323975219|FG000|Evaluated for Safety|Physician Decision|1|||
94593283|NCT01616693|323975220|FG001|Evaluated for Safety|Physician Decision|0|||
94593284|NCT01616693|323975221|FG002|Evaluated for Safety|Physician Decision|1|||
94593285|NCT01616693|323975222|FG003|Evaluated for Safety|Physician Decision|0|||
94593286|NCT01616693|323975219|FG000|Received Both Vaccines|Adverse Event|2|||
94593287|NCT01616693|323975220|FG001|Received Both Vaccines|Adverse Event|0|||
94593288|NCT01616693|323975221|FG002|Received Both Vaccines|Adverse Event|0|||
94593289|NCT01616693|323975222|FG003|Received Both Vaccines|Adverse Event|0|||
94593290|NCT01616693|323975219|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
94593291|NCT01616693|323975220|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
94593292|NCT01616693|323975221|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
94593293|NCT01616693|323975222|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
94593294|NCT01616693|323975219|FG000|Received Both Vaccines|Lost to Follow-up|4|||
94593295|NCT01616693|323975220|FG001|Received Both Vaccines|Lost to Follow-up|3|||
94593296|NCT01616693|323975221|FG002|Received Both Vaccines|Lost to Follow-up|4|||
94593297|NCT01616693|323975222|FG003|Received Both Vaccines|Lost to Follow-up|4|||
94593298|NCT01616693|323975219|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
94593299|NCT01616693|323975220|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
94593300|NCT01616693|323975221|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
94593301|NCT01616693|323975222|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
94593302|NCT01788215|323975223|FG000|Overall Study|Withdrawal by Subject|0|||
94593303|NCT01788215|323975224|FG001|Overall Study|Withdrawal by Subject|1|||
94593304|NCT01788215|323975223|FG000|Overall Study|Lost to Follow-up|2|||
94593305|NCT01788215|323975224|FG001|Overall Study|Lost to Follow-up|0|||
94593306|NCT00275340|323975225|FG000|Overall Study|Lost to Follow-up|2|||
94593307|NCT00275340|323975226|FG001|Overall Study|Lost to Follow-up|4|||
94593308|NCT00862641|323975229|FG000|Overall Study|Randomized, but drug not received|1|||
94593309|NCT00862641|323975230|FG001|Overall Study|Randomized, but drug not received|4|||
94593310|NCT00862641|323975231|FG002|Overall Study|Randomized, but drug not received|1|||
94593311|NCT00862641|323975232|FG003|Overall Study|Randomized, but drug not received|4|||
94593312|NCT02365480|323975233|FG000|Overall Study|Withdrawal by Subject|2|||
94593313|NCT02365480|323975234|FG001|Overall Study|Withdrawal by Subject|0|||
94593314|NCT00146848|323975235|FG000|Pre-randomization|Death|19|||
94593315|NCT00146848|323975236|FG001|Pre-randomization|Death|0|||
94593316|NCT00146848|323975237|FG002|Pre-randomization|Death|0|||
94246158|NCT00734591|322695211|FG001|Prospective Period|Withdrawal by Subject|9|||
94246159|NCT00734591|322695210|FG000|Prospective Period|Lost to Follow-up|37|||
94246160|NCT00734591|322695211|FG001|Prospective Period|Lost to Follow-up|33|||
94246161|NCT00734591|322695210|FG000|Prospective Period|Study Terminated|1|||
94593317|NCT00146848|323975235|FG000|Pre-randomization|Lost to Follow-up|70|||
94593318|NCT00146848|323975236|FG001|Pre-randomization|Lost to Follow-up|0|||
94593319|NCT00146848|323975237|FG002|Pre-randomization|Lost to Follow-up|0|||
94593320|NCT00146848|323975235|FG000|Pre-randomization|Physician Decision|8|||
94593321|NCT00146848|323975236|FG001|Pre-randomization|Physician Decision|0|||
94593322|NCT00146848|323975237|FG002|Pre-randomization|Physician Decision|0|||
94593323|NCT00146848|323975235|FG000|Pre-randomization|Protocol Violation|172|||
94593324|NCT00146848|323975236|FG001|Pre-randomization|Protocol Violation|0|||
94593325|NCT00146848|323975237|FG002|Pre-randomization|Protocol Violation|0|||
94593326|NCT00146848|323975235|FG000|Pre-randomization|Withdrawal by Subject|40|||
94593327|NCT00146848|323975236|FG001|Pre-randomization|Withdrawal by Subject|0|||
94593328|NCT00146848|323975237|FG002|Pre-randomization|Withdrawal by Subject|0|||
94593329|NCT00146848|323975235|FG000|Post-randomization|Lost to Follow-up|12|||
94593330|NCT00146848|323975236|FG001|Post-randomization|Lost to Follow-up|15|||
94593331|NCT00146848|323975237|FG002|Post-randomization|Lost to Follow-up|12|||
94593332|NCT00146848|323975235|FG000|Post-randomization|Withdrawn|26|||
94593333|NCT00146848|323975236|FG001|Post-randomization|Withdrawn|32|||
94593334|NCT00146848|323975237|FG002|Post-randomization|Withdrawn|27|||
94593335|NCT00717236|323975238|FG000|Double-Blind Period|Adverse Event|33|||
94593336|NCT00717236|323975239|FG001|Double-Blind Period|Adverse Event|6|||
94593337|NCT00717236|323975238|FG000|Double-Blind Period|Lack of Efficacy|6|||
94593338|NCT00717236|323975239|FG001|Double-Blind Period|Lack of Efficacy|6|||
94246162|NCT00734591|322695211|FG001|Prospective Period|Study Terminated|0|||
94246163|NCT00734591|322695210|FG000|Prospective Period|Other|2|||
94246164|NCT00734591|322695211|FG001|Prospective Period|Other|2|||
94246165|NCT01517295|322695212|FG000|Overall Study|Physician Decision|1|||
94593339|NCT00717236|323975238|FG000|Double-Blind Period|Lost to Follow-up|3|||
94593340|NCT00717236|323975239|FG001|Double-Blind Period|Lost to Follow-up|5|||
94593341|NCT00717236|323975238|FG000|Double-Blind Period|Withdrawal by Subject|10|||
94593342|NCT00717236|323975239|FG001|Double-Blind Period|Withdrawal by Subject|2|||
94246166|NCT01517295|322695213|FG001|Overall Study|Physician Decision|0|||
94246167|NCT03377699|322695214|FG000|Overall Study|Withdrawal by Subject|2|||
94246168|NCT03377699|322695215|FG001|Overall Study|Withdrawal by Subject|9|||
94246169|NCT03377699|322695214|FG000|Overall Study|Lost to Follow-up|1|||
94246170|NCT03377699|322695215|FG001|Overall Study|Lost to Follow-up|1|||
94246171|NCT03377699|322695214|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
94246172|NCT03377699|322695215|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
94246173|NCT03377699|322695214|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
94246174|NCT03377699|322695215|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
94246175|NCT03377699|322695214|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
94246176|NCT03377699|322695215|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
94246177|NCT03377699|322695214|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
94246178|NCT03377699|322695215|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
94246179|NCT00224887|322695216|FG000|Overall Study|Pregnancy|6|||
94246180|NCT00224887|322695217|FG001|Overall Study|Pregnancy|6|||
94246181|NCT01353859|322695220|FG000|Overall Study|Adverse Event|3|||
94246182|NCT01353859|322695220|FG000|Overall Study|Lack of Efficacy|1|||
94246183|NCT05560243|322695224|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
94246184|NCT00939822|322695225|FG000|Overall Study|Lost to Follow-up|1|||
94246185|NCT00939822|322695226|FG001|Overall Study|Lost to Follow-up|0|||
94246186|NCT00939822|322695225|FG000|Overall Study|withdrew from study due to busy schedule|1|||
94246187|NCT00939822|322695226|FG001|Overall Study|withdrew from study due to busy schedule|1|||
94246188|NCT00939822|322695225|FG000|Overall Study|Mental health issues|0|||
94246189|NCT00939822|322695226|FG001|Overall Study|Mental health issues|2|||
94246190|NCT00910039|322695229|FG000|Overall Study|Physician Decision|1|||
94246191|NCT00831129|322695237|FG000|Overall Study|Adverse Event|0|||
94246192|NCT00831129|322695238|FG001|Overall Study|Adverse Event|1|||
94246193|NCT00831129|322695237|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
94246194|NCT00831129|322695238|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
94246195|NCT01877239|322695239|FG000|Overall Study|Adverse Event|4|||
94246196|NCT01877239|322695239|FG000|Overall Study|Disease Remission|1|||
94246197|NCT01877239|322695239|FG000|Overall Study|Withdrawal by Subject|4|||
94246198|NCT01877239|322695239|FG000|Overall Study|Other|2|||
94246199|NCT01877239|322695239|FG000|Overall Study|Lack of Efficacy|4|||
94246200|NCT01877239|322695239|FG000|Overall Study|Data not available|35|||
94246201|NCT00992225|322695240|FG000|Overall Study|Entry Criteria Not Met|8|||
94593343|NCT00717236|323975238|FG000|Double-Blind Period|Loss of efficacy|3|||
94659981|NCT01075074|324210001|FG000|Overall Study|Surgeon changed to open incisional case|1|||
94659982|NCT01075074|324210002|FG001|Overall Study|Surgeon changed to open incisional case|2|||
94659983|NCT01075074|324210003|FG002|Overall Study|Surgeon changed to open incisional case|2|||
94246202|NCT00992225|322695240|FG000|Overall Study|Adverse Event|2|||
94246203|NCT03466073|322695241|FG000|Overall Study|Death|1|||
94246204|NCT03466073|322695242|FG001|Overall Study|Death|0|||
94246205|NCT03466073|322695243|FG002|Overall Study|Death|0|||
94246206|NCT03466073|322695244|FG003|Overall Study|Death|0|||
94246207|NCT03466073|322695245|FG004|Overall Study|Death|0|||
94246208|NCT03466073|322695246|FG005|Overall Study|Death|1|||
94246209|NCT01283516|322695248|FG000|Overall Study|Adverse Event|0|||
94246210|NCT01283516|322695249|FG001|Overall Study|Adverse Event|0|||
94355426|NCT00151775|323083572|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
94593344|NCT00717236|323975239|FG001|Double-Blind Period|Loss of efficacy|0|||
94659984|NCT01154166|324210005|FG000|Overall Study|Adverse Event|14|||
94659985|NCT01154166|324210006|FG001|Overall Study|Adverse Event|9|||
94659986|NCT01154166|324210005|FG000|Overall Study|Lost to Follow-up|1|||
94246211|NCT01283516|322695250|FG002|Overall Study|Adverse Event|0|||
94246212|NCT01283516|322695251|FG003|Overall Study|Adverse Event|0|||
94246213|NCT01283516|322695252|FG004|Overall Study|Adverse Event|0|||
94246214|NCT01283516|322695253|FG005|Overall Study|Adverse Event|0|||
94246215|NCT01283516|322695254|FG006|Overall Study|Adverse Event|2|||
94593345|NCT00717236|323975238|FG000|Double-Blind Period|Other: Death|1|||
94659987|NCT01154166|324210006|FG001|Overall Study|Lost to Follow-up|1|||
94246216|NCT01283516|322695255|FG007|Overall Study|Adverse Event|0|||
94246217|NCT01283516|322695256|FG008|Overall Study|Adverse Event|28|||
94246218|NCT01283516|322695248|FG000|Overall Study|Death|0|||
94246219|NCT01283516|322695249|FG001|Overall Study|Death|0|||
94246220|NCT01283516|322695250|FG002|Overall Study|Death|0|||
94246221|NCT01283516|322695251|FG003|Overall Study|Death|0|||
94246222|NCT01283516|322695252|FG004|Overall Study|Death|0|||
94246223|NCT01283516|322695253|FG005|Overall Study|Death|1|||
94246224|NCT01283516|322695254|FG006|Overall Study|Death|0|||
94246225|NCT01283516|322695255|FG007|Overall Study|Death|1|||
94246226|NCT01283516|322695256|FG008|Overall Study|Death|12|||
94246227|NCT01283516|322695248|FG000|Overall Study|Disease Progression|2|||
94246228|NCT01283516|322695249|FG001|Overall Study|Disease Progression|2|||
94246229|NCT01283516|322695250|FG002|Overall Study|Disease Progression|3|||
94246230|NCT01283516|322695251|FG003|Overall Study|Disease Progression|3|||
94246231|NCT01283516|322695252|FG004|Overall Study|Disease Progression|13|||
94246232|NCT01283516|322695253|FG005|Overall Study|Disease Progression|8|||
94246233|NCT01283516|322695254|FG006|Overall Study|Disease Progression|6|||
94246234|NCT01283516|322695255|FG007|Overall Study|Disease Progression|3|||
94246235|NCT01283516|322695256|FG008|Overall Study|Disease Progression|139|||
94246236|NCT01283516|322695248|FG000|Overall Study|Withdrawal by Subject|0|||
94246237|NCT01283516|322695249|FG001|Overall Study|Withdrawal by Subject|0|||
94246238|NCT01283516|322695250|FG002|Overall Study|Withdrawal by Subject|0|||
94593346|NCT00717236|323975239|FG001|Double-Blind Period|Other: Death|0|||
94593347|NCT00717236|323975238|FG000|Double-Blind Period|Other: Pregnancy|1|||
94593348|NCT00717236|323975239|FG001|Double-Blind Period|Other: Pregnancy|0|||
94593349|NCT00717236|323975238|FG000|Double-Blind Period|Other: Protocol Violation|2|||
94593350|NCT00717236|323975239|FG001|Double-Blind Period|Other: Protocol Violation|0|||
94593351|NCT00717236|323975238|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
94593352|NCT00717236|323975239|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
94593353|NCT00717236|323975238|FG000|Double-Blind Period|Other: Site withdrew|2|||
94593354|NCT00717236|323975239|FG001|Double-Blind Period|Other: Site withdrew|0|||
94593355|NCT00717236|323975238|FG000|Double-Blind Period|Other: Screening failure|1|||
94593356|NCT00717236|323975239|FG001|Double-Blind Period|Other: Screening failure|0|||
94593357|NCT00717236|323975238|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
94593358|NCT00717236|323975239|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
94593359|NCT00717236|323975238|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
94659988|NCT01154166|324210005|FG000|Overall Study|Protocol Violation|4|||
94659989|NCT01154166|324210006|FG001|Overall Study|Protocol Violation|1|||
94246239|NCT01283516|322695251|FG003|Overall Study|Withdrawal by Subject|0|||
94246240|NCT01283516|322695252|FG004|Overall Study|Withdrawal by Subject|1|||
94246241|NCT01283516|322695253|FG005|Overall Study|Withdrawal by Subject|0|||
94246242|NCT01283516|322695254|FG006|Overall Study|Withdrawal by Subject|1|||
94246243|NCT01283516|322695255|FG007|Overall Study|Withdrawal by Subject|0|||
94246244|NCT01283516|322695256|FG008|Overall Study|Withdrawal by Subject|36|||
94246245|NCT01283516|322695248|FG000|Overall Study|Administrative problems|0|||
94246246|NCT01283516|322695249|FG001|Overall Study|Administrative problems|0|||
94246247|NCT01283516|322695250|FG002|Overall Study|Administrative problems|0|||
94246248|NCT01283516|322695251|FG003|Overall Study|Administrative problems|0|||
94246249|NCT01283516|322695252|FG004|Overall Study|Administrative problems|0|||
94593360|NCT00717236|323975239|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
94246250|NCT01283516|322695253|FG005|Overall Study|Administrative problems|1|||
94246251|NCT01283516|322695254|FG006|Overall Study|Administrative problems|1|||
94246252|NCT01283516|322695255|FG007|Overall Study|Administrative problems|1|||
94246253|NCT01283516|322695256|FG008|Overall Study|Administrative problems|39|||
94246254|NCT01283516|322695248|FG000|Overall Study|Lost to Follow-up|0|||
94593361|NCT00717236|323975238|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
94593362|NCT00717236|323975239|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
94593363|NCT00717236|323975238|FG000|Double-Blind Period|Other: History of cancer|1|||
94593364|NCT00717236|323975239|FG001|Double-Blind Period|Other: History of cancer|0|||
94593365|NCT00717236|323975238|FG000|Double-Blind Period|Other: Sponsor request|1|||
94593366|NCT00717236|323975239|FG001|Double-Blind Period|Other: Sponsor request|0|||
94593367|NCT00717236|323975238|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
94593368|NCT00717236|323975239|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
94593369|NCT00717236|323975238|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
94593370|NCT00717236|323975239|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
94593371|NCT00717236|323975238|FG000|Double-Blind Period|Other: Subject moved|1|||
94593372|NCT00717236|323975239|FG001|Double-Blind Period|Other: Subject moved|1|||
94593373|NCT00717236|323975238|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
94593374|NCT00717236|323975239|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
94593375|NCT00717236|323975238|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
94593376|NCT00717236|323975239|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
94593377|NCT00717236|323975238|FG000|Double-Blind Period|Other: Transportation problems|0|||
94593378|NCT00717236|323975239|FG001|Double-Blind Period|Other: Transportation problems|1|||
94593379|NCT00717236|323975238|FG000|Double-Blind Period|Other: Investigator Decision|0|||
94593380|NCT00717236|323975239|FG001|Double-Blind Period|Other: Investigator Decision|1|||
94593381|NCT00717236|323975238|FG000|Open-Label Period|Adverse Event|29|||
94593382|NCT00717236|323975239|FG001|Open-Label Period|Adverse Event|4|||
94593383|NCT00717236|323975238|FG000|Open-Label Period|Lack of Efficacy|30|||
94593384|NCT00717236|323975239|FG001|Open-Label Period|Lack of Efficacy|8|||
94593385|NCT00717236|323975238|FG000|Open-Label Period|Lost to Follow-up|28|||
94593386|NCT00717236|323975239|FG001|Open-Label Period|Lost to Follow-up|4|||
94593387|NCT00717236|323975238|FG000|Open-Label Period|Withdrawal by Subject|20|||
94593388|NCT00717236|323975239|FG001|Open-Label Period|Withdrawal by Subject|2|||
94593389|NCT00717236|323975238|FG000|Open-Label Period|Loss of Efficacy|6|||
94593390|NCT00717236|323975239|FG001|Open-Label Period|Loss of Efficacy|1|||
94593391|NCT00717236|323975238|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
94593392|NCT00717236|323975239|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
94593393|NCT00717236|323975238|FG000|Open-Label Period|Other: Lack of Compliance|1|||
94593394|NCT00717236|323975239|FG001|Open-Label Period|Other: Lack of Compliance|1|||
94593395|NCT00717236|323975238|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
94593396|NCT00717236|323975239|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
94593397|NCT00717236|323975238|FG000|Open-Label Period|Other: Moved|1|||
94593398|NCT00717236|323975239|FG001|Open-Label Period|Other: Moved|0|||
94593399|NCT00717236|323975238|FG000|Open-Label Period|Other: Investigator Decision|1|||
94593400|NCT00717236|323975239|FG001|Open-Label Period|Other: Investigator Decision|0|||
94593401|NCT00717236|323975238|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
94593402|NCT00717236|323975239|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
94593403|NCT00717236|323975238|FG000|Open-Label Period|Other: Sponsor Request|3|||
94593404|NCT00717236|323975239|FG001|Open-Label Period|Other: Sponsor Request|0|||
94593405|NCT00717236|323975238|FG000|Open-Label Period|Other: Cataract Surgery|1|||
94593406|NCT00717236|323975239|FG001|Open-Label Period|Other: Cataract Surgery|0|||
94593407|NCT00717236|323975238|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
94593408|NCT00717236|323975239|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
94593409|NCT00717236|323975238|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
94593410|NCT00717236|323975239|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
94593411|NCT00717236|323975238|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
94593412|NCT00717236|323975239|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
94593413|NCT01105767|323975240|FG000|Overall Study|Lost to Follow-up|1160|||
94593414|NCT01105767|323975241|FG001|Overall Study|Lost to Follow-up|1614|||
94593415|NCT01105767|323975242|FG002|Overall Study|Lost to Follow-up|1184|||
94593416|NCT00475982|323975243|FG000|Overall Study|surgery rescheduled|7|||
94593417|NCT00475982|323975244|FG001|Overall Study|surgery rescheduled|3|||
94593418|NCT00636363|323975245|FG000|Overall Study|Conjunctivitis|0|||
94593419|NCT00636363|323975246|FG001|Overall Study|Conjunctivitis|0|||
94593420|NCT00636363|323975247|FG002|Overall Study|Conjunctivitis|1|||
94593421|NCT00636363|323975245|FG000|Overall Study|Adverse Event|0|||
94593422|NCT00636363|323975246|FG001|Overall Study|Adverse Event|0|||
94593423|NCT00636363|323975247|FG002|Overall Study|Adverse Event|1|||
94593424|NCT00636363|323975245|FG000|Overall Study|Positive slit lamp finding|0|||
94593425|NCT00636363|323975246|FG001|Overall Study|Positive slit lamp finding|2|||
94593426|NCT00636363|323975247|FG002|Overall Study|Positive slit lamp finding|1|||
94593427|NCT00636363|323975245|FG000|Overall Study|Study related symptoms/complaints|8|||
94593428|NCT00636363|323975246|FG001|Overall Study|Study related symptoms/complaints|7|||
94593429|NCT00636363|323975247|FG002|Overall Study|Study related symptoms/complaints|4|||
94593430|NCT00636363|323975245|FG000|Overall Study|Met ineligibility criteria|0|||
94593431|NCT00636363|323975246|FG001|Overall Study|Met ineligibility criteria|0|||
94593432|NCT00636363|323975247|FG002|Overall Study|Met ineligibility criteria|3|||
94593433|NCT00636363|323975245|FG000|Overall Study|Missed > 1 visit|0|||
94593434|NCT00636363|323975246|FG001|Overall Study|Missed > 1 visit|1|||
94593435|NCT00636363|323975247|FG002|Overall Study|Missed > 1 visit|3|||
94593436|NCT00636363|323975245|FG000|Overall Study|Lack of motivation|1|||
94593437|NCT00636363|323975246|FG001|Overall Study|Lack of motivation|0|||
94593438|NCT00636363|323975247|FG002|Overall Study|Lack of motivation|1|||
94593439|NCT00636363|323975245|FG000|Overall Study|Protocol Violation|0|||
94593440|NCT00636363|323975246|FG001|Overall Study|Protocol Violation|3|||
94593441|NCT00636363|323975247|FG002|Overall Study|Protocol Violation|0|||
94593442|NCT00636363|323975245|FG000|Overall Study|Lost to Follow-up|3|||
94593443|NCT00636363|323975246|FG001|Overall Study|Lost to Follow-up|4|||
94593444|NCT00636363|323975247|FG002|Overall Study|Lost to Follow-up|2|||
94593445|NCT00636363|323975245|FG000|Overall Study|Withdrawal by Subject|1|||
94593446|NCT00636363|323975246|FG001|Overall Study|Withdrawal by Subject|3|||
94593447|NCT00636363|323975247|FG002|Overall Study|Withdrawal by Subject|2|||
94593448|NCT00029146|323975250|FG000|Overall Study|Lost to Follow-up|2|||
94593449|NCT00029146|323975251|FG001|Overall Study|Lost to Follow-up|1|||
94593450|NCT01765218|323975252|FG000|Overall Study|Protocol Violation|1|||
94593451|NCT01765218|323975253|FG001|Overall Study|Protocol Violation|2|||
94593452|NCT00946985|323975254|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
94593453|NCT00946985|323975254|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
94593454|NCT00946985|323975254|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
94593455|NCT00946985|323975254|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
94593456|NCT00946985|323975254|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
94593457|NCT00946985|323975254|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
94593458|NCT00946985|323975254|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
94593459|NCT00946985|323975254|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
94593460|NCT00946985|323975254|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
94593461|NCT01546623|323975255|FG000|Overall Study|Adverse Event|2|||
94593462|NCT01546623|323975256|FG001|Overall Study|Adverse Event|3|||
94593463|NCT01546623|323975255|FG000|Overall Study|Major Protocol Deviation|1|||
94593464|NCT01546623|323975256|FG001|Overall Study|Major Protocol Deviation|1|||
94593465|NCT01546623|323975255|FG000|Overall Study|High Prostate specific antigen|2|||
94593466|NCT01546623|323975256|FG001|Overall Study|High Prostate specific antigen|1|||
94593467|NCT01546623|323975255|FG000|Overall Study|Did Not Receive Study Drug|1|||
94593468|NCT01546623|323975256|FG001|Overall Study|Did Not Receive Study Drug|1|||
94593469|NCT01642615|323975259|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
94593470|NCT01642615|323975260|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
94593471|NCT01642615|323975261|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
94593472|NCT01642615|323975259|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
94593473|NCT01642615|323975260|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
94593474|NCT01642615|323975261|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
94593475|NCT01642615|323975259|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
94593476|NCT01642615|323975260|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
94593477|NCT01642615|323975261|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
94593478|NCT01642615|323975259|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
94593479|NCT01642615|323975260|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
94593480|NCT01642615|323975261|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
94593481|NCT01642615|323975259|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
94593482|NCT01642615|323975260|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
94593483|NCT01642615|323975261|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
94593484|NCT01642615|323975259|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
94593485|NCT01642615|323975260|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
94593486|NCT01642615|323975261|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
94593487|NCT01642615|323975259|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
94593488|NCT01642615|323975260|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
94593489|NCT01642615|323975261|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
94593490|NCT01642615|323975259|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
94593491|NCT01642615|323975260|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
94593492|NCT01642615|323975261|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
94593493|NCT01642615|323975259|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
94593494|NCT01642615|323975260|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
94593495|NCT01642615|323975261|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
94593496|NCT01185353|323975266|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
94593497|NCT01185353|323975267|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
94593498|NCT01185353|323975268|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
94593499|NCT01185353|323975269|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
94593500|NCT01185353|323975270|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
94593501|NCT01185353|323975271|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
94593502|NCT01185353|323975272|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
94593503|NCT01185353|323975273|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
94593504|NCT01185353|323975274|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
94593505|NCT01185353|323975275|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
94593506|NCT01185353|323975266|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
94593507|NCT01185353|323975267|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
94593508|NCT01185353|323975268|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
94593509|NCT01185353|323975269|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
94593510|NCT01185353|323975270|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
94593511|NCT01185353|323975271|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
94593512|NCT01185353|323975272|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
94593513|NCT01185353|323975273|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
94593514|NCT01185353|323975274|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
94593515|NCT01185353|323975275|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
94593516|NCT01185353|323975266|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
94593517|NCT01185353|323975267|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
94593518|NCT01185353|323975268|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
94593519|NCT01185353|323975269|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
94593520|NCT01185353|323975270|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
94593521|NCT01185353|323975271|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
94593522|NCT01185353|323975272|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
94593523|NCT01185353|323975273|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
94593524|NCT01185353|323975274|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
94593525|NCT01185353|323975275|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
94593526|NCT01185353|323975266|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
94593527|NCT01185353|323975267|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
94593528|NCT01185353|323975268|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
94593529|NCT01185353|323975269|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
94593530|NCT01185353|323975270|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
94593531|NCT01185353|323975271|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
94593532|NCT01185353|323975272|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
94593533|NCT01185353|323975273|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
94593534|NCT01185353|323975274|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
94593535|NCT01185353|323975275|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
94593536|NCT01185353|323975266|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
94593537|NCT01185353|323975267|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
94246255|NCT01283516|322695249|FG001|Overall Study|Lost to Follow-up|0|||
94246256|NCT01283516|322695250|FG002|Overall Study|Lost to Follow-up|0|||
94246257|NCT01283516|322695251|FG003|Overall Study|Lost to Follow-up|0|||
94246258|NCT01283516|322695252|FG004|Overall Study|Lost to Follow-up|0|||
94246259|NCT01283516|322695253|FG005|Overall Study|Lost to Follow-up|0|||
94246260|NCT01283516|322695254|FG006|Overall Study|Lost to Follow-up|0|||
94593538|NCT01185353|323975268|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
94593539|NCT01185353|323975269|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
94593540|NCT01185353|323975270|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
94593541|NCT01185353|323975271|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
94593542|NCT01185353|323975272|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
94593543|NCT01185353|323975273|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
94659990|NCT01154166|324210005|FG000|Overall Study|Withdrawal by Subject|10|||
94593544|NCT01185353|323975274|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
94593545|NCT01185353|323975275|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
94593546|NCT01185353|323975266|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
94593547|NCT01185353|323975267|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
94659991|NCT01154166|324210006|FG001|Overall Study|Withdrawal by Subject|1|||
94659992|NCT01154166|324210005|FG000|Overall Study|Lack of Efficacy|3|||
94659993|NCT01154166|324210006|FG001|Overall Study|Lack of Efficacy|0|||
94659994|NCT01154166|324210005|FG000|Overall Study|Disease Progression|1|||
94659995|NCT01154166|324210006|FG001|Overall Study|Disease Progression|0|||
94659996|NCT01154166|324210005|FG000|Overall Study|Poor Compliance|1|||
94659997|NCT01154166|324210006|FG001|Overall Study|Poor Compliance|0|||
94659998|NCT02301143|324210007|FG000|Induction Period|Enrolled But Not Treated|1|||
94246261|NCT01283516|322695255|FG007|Overall Study|Lost to Follow-up|0|||
94246262|NCT01283516|322695256|FG008|Overall Study|Lost to Follow-up|1|||
94246263|NCT03459443|322695260|FG000|Overall Study|Lack of Efficacy|3|||
94593548|NCT01185353|323975268|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
94593549|NCT01185353|323975269|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
94593550|NCT01185353|323975270|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
94593551|NCT01185353|323975271|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
94593552|NCT01185353|323975272|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
94593553|NCT01185353|323975273|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
94659999|NCT02301143|324210008|FG001|Induction Period|Enrolled But Not Treated|0|||
94660000|NCT02301143|324210007|FG000|Induction Period|Death|1|||
94660001|NCT02301143|324210008|FG001|Induction Period|Death|0|||
94593554|NCT01185353|323975274|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
94593555|NCT01185353|323975275|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
94593556|NCT01185353|323975266|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
94593557|NCT01185353|323975267|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
94593558|NCT01185353|323975268|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
94593559|NCT01185353|323975269|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
94593560|NCT01185353|323975270|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
94593561|NCT01185353|323975271|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
94593562|NCT01185353|323975272|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
94593563|NCT01185353|323975273|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
94593564|NCT01185353|323975274|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
94593565|NCT01185353|323975275|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
94593566|NCT01185353|323975266|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
94593567|NCT01185353|323975267|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
94593568|NCT01185353|323975268|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
94593569|NCT01185353|323975269|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
94593570|NCT01185353|323975270|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
94246264|NCT03459443|322695260|FG000|Overall Study|Adverse Event|1|||
94593571|NCT01185353|323975271|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
94593572|NCT01185353|323975272|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
94593573|NCT01185353|323975273|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
94593574|NCT01185353|323975274|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
94593575|NCT01185353|323975275|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
94593576|NCT01185353|323975266|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
94593577|NCT01185353|323975267|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
94593578|NCT01185353|323975268|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
94593579|NCT01185353|323975269|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
94593580|NCT01185353|323975270|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
94593581|NCT01185353|323975271|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
94593582|NCT01185353|323975272|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
94593583|NCT01185353|323975273|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
94593584|NCT01185353|323975274|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
94593585|NCT01185353|323975275|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
94593586|NCT01185353|323975266|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
94593587|NCT01185353|323975267|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
94593588|NCT01185353|323975268|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
94593589|NCT01185353|323975269|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
94593590|NCT01185353|323975270|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
94593591|NCT01185353|323975271|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
94593592|NCT01185353|323975272|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
94593593|NCT01185353|323975273|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
94593594|NCT01185353|323975274|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
94593595|NCT01185353|323975275|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
94593596|NCT01185353|323975266|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
94593597|NCT01185353|323975267|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
94593598|NCT01185353|323975268|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
94593599|NCT01185353|323975269|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
94593600|NCT01185353|323975270|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
94593601|NCT01185353|323975271|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
94593602|NCT01185353|323975272|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
94593603|NCT01185353|323975273|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
94593604|NCT01185353|323975274|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
94593605|NCT01185353|323975275|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
94593606|NCT01185353|323975266|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
94593607|NCT01185353|323975267|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
94593608|NCT01185353|323975268|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
94593609|NCT01185353|323975269|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
94593610|NCT01185353|323975270|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
94593611|NCT01185353|323975271|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
94593612|NCT01185353|323975272|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
94593613|NCT01185353|323975273|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
94593614|NCT01185353|323975274|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
94593615|NCT01185353|323975275|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
94593616|NCT01185353|323975266|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
94593617|NCT01185353|323975267|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
94593618|NCT01185353|323975268|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
94593619|NCT01185353|323975269|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
94593620|NCT01185353|323975270|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
94593621|NCT01185353|323975271|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
94593622|NCT01185353|323975272|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
94593623|NCT01185353|323975273|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
94593624|NCT01185353|323975274|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
94593625|NCT01185353|323975275|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
94593626|NCT01185353|323975266|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
94593627|NCT01185353|323975267|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
94593628|NCT01185353|323975268|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
94246265|NCT03459443|322695260|FG000|Overall Study|Sponsor's decision to close the study|18|||
94246266|NCT01080716|322695261|FG000|Part 1|Physician Decision|1|||
94246267|NCT01080716|322695262|FG001|Part 1|Physician Decision|0|||
94593629|NCT01185353|323975269|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
94593630|NCT01185353|323975270|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
94660002|NCT02301143|324210007|FG000|Induction Period|Adverse Event|22|||
94246268|NCT01080716|322695263|FG002|Part 1|Physician Decision|0|||
94593631|NCT01185353|323975271|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
94593632|NCT01185353|323975272|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
94593633|NCT01185353|323975273|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
94246269|NCT01080716|322695264|FG003|Part 1|Physician Decision|0|||
94593634|NCT01185353|323975274|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
94593635|NCT01185353|323975275|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
94593636|NCT01185353|323975266|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
94593637|NCT01185353|323975267|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
94593638|NCT01185353|323975268|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
94593639|NCT01185353|323975269|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
94593640|NCT01185353|323975270|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
94593641|NCT01185353|323975271|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
94593642|NCT01185353|323975272|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
94593643|NCT01185353|323975273|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
94593644|NCT01185353|323975274|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
94593645|NCT01185353|323975275|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
94593646|NCT01185353|323975266|FG000|Part C (Weeks 24 Through 76)|Death|0|||
94593647|NCT01185353|323975267|FG001|Part C (Weeks 24 Through 76)|Death|0|||
94593648|NCT01185353|323975268|FG002|Part C (Weeks 24 Through 76)|Death|0|||
94593649|NCT01185353|323975269|FG003|Part C (Weeks 24 Through 76)|Death|0|||
94593650|NCT01185353|323975270|FG004|Part C (Weeks 24 Through 76)|Death|0|||
94593651|NCT01185353|323975271|FG005|Part C (Weeks 24 Through 76)|Death|0|||
94593652|NCT01185353|323975272|FG006|Part C (Weeks 24 Through 76)|Death|0|||
94593653|NCT01185353|323975273|FG007|Part C (Weeks 24 Through 76)|Death|0|||
94593654|NCT01185353|323975274|FG008|Part C (Weeks 24 Through 76)|Death|0|||
94593655|NCT01185353|323975275|FG009|Part C (Weeks 24 Through 76)|Death|1|||
94593656|NCT01185353|323975266|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
94593657|NCT01185353|323975267|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
94593658|NCT01185353|323975268|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
94593659|NCT01185353|323975269|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
94593660|NCT01185353|323975270|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
94593661|NCT01185353|323975271|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
94593662|NCT01185353|323975272|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
94593663|NCT01185353|323975273|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
94593664|NCT01185353|323975274|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
94593665|NCT01185353|323975275|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
94593666|NCT01185353|323975266|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
94593667|NCT01185353|323975267|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
94593668|NCT01185353|323975268|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
94593669|NCT01185353|323975269|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
94593670|NCT01185353|323975270|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
94593671|NCT01185353|323975271|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
94593672|NCT01185353|323975272|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
94593673|NCT01185353|323975273|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
94593674|NCT01185353|323975274|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
94593675|NCT01185353|323975275|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
94593676|NCT01185353|323975266|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
94593677|NCT01185353|323975267|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
94593678|NCT01185353|323975268|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
94593679|NCT01185353|323975269|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
94660003|NCT02301143|324210008|FG001|Induction Period|Adverse Event|0|||
94593680|NCT01185353|323975270|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
94593681|NCT01185353|323975271|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
94593682|NCT01185353|323975272|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
94593683|NCT01185353|323975273|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
94593684|NCT01185353|323975274|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
94593685|NCT01185353|323975275|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
94593686|NCT01185353|323975266|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
94593687|NCT01185353|323975267|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
94593688|NCT01185353|323975268|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
94593689|NCT01185353|323975269|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
94593690|NCT01185353|323975270|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
94593691|NCT01185353|323975271|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
94593692|NCT01185353|323975272|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
94593693|NCT01185353|323975273|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
94593694|NCT01185353|323975274|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
94593695|NCT01185353|323975275|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
94593696|NCT01185353|323975266|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
94593697|NCT01185353|323975267|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
94593698|NCT01185353|323975268|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
94593699|NCT01185353|323975269|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
94593700|NCT01185353|323975270|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
94593701|NCT01185353|323975271|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
94593702|NCT01185353|323975272|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
94593703|NCT01185353|323975273|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
94593704|NCT01185353|323975274|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
94593705|NCT01185353|323975275|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
94593706|NCT01185353|323975266|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
94593707|NCT01185353|323975267|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
94593708|NCT01185353|323975268|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
94593709|NCT01185353|323975269|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
94593710|NCT01185353|323975270|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
94593711|NCT01185353|323975271|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
94593712|NCT01185353|323975272|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
94593713|NCT01185353|323975273|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
94593714|NCT01185353|323975274|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
94593715|NCT01185353|323975275|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
94593716|NCT02365233|323975276|FG000|Overall Study|IRB withheld the data|1|||
94593717|NCT02365233|323975277|FG001|Overall Study|IRB withheld the data|2|||
94593718|NCT02365233|323975278|FG002|Overall Study|IRB withheld the data|2|||
94593719|NCT02270944|323975279|FG000|Overall Study|Lost to Follow-up|9|||
94593720|NCT02270944|323975280|FG001|Overall Study|Lost to Follow-up|4|||
94593721|NCT02270944|323975279|FG000|Overall Study|Withdrawal by Subject|2|||
94593722|NCT02270944|323975280|FG001|Overall Study|Withdrawal by Subject|1|||
94593723|NCT00160667|323975281|FG000|Overall Study|Adverse Event|3|||
94593724|NCT00160667|323975282|FG001|Overall Study|Adverse Event|1|||
94593725|NCT00160667|323975283|FG002|Overall Study|Adverse Event|4|||
94593726|NCT00160667|323975281|FG000|Overall Study|Withdrawal by Subject|2|||
94593727|NCT00160667|323975282|FG001|Overall Study|Withdrawal by Subject|0|||
94593728|NCT00160667|323975283|FG002|Overall Study|Withdrawal by Subject|1|||
94593729|NCT00160667|323975281|FG000|Overall Study|Lack of Efficacy|0|||
94593730|NCT00160667|323975282|FG001|Overall Study|Lack of Efficacy|1|||
94593731|NCT00160667|323975283|FG002|Overall Study|Lack of Efficacy|0|||
94593732|NCT00160667|323975281|FG000|Overall Study|Protocol Violation|0|||
94593733|NCT00160667|323975282|FG001|Overall Study|Protocol Violation|1|||
94593734|NCT00160667|323975283|FG002|Overall Study|Protocol Violation|0|||
94593735|NCT00160667|323975281|FG000|Overall Study|Patient decision|0|||
94593736|NCT00160667|323975282|FG001|Overall Study|Patient decision|0|||
94593737|NCT00160667|323975283|FG002|Overall Study|Patient decision|1|||
94593738|NCT01144299|323975286|FG000|Overall Study|Lost to Follow-up|1|||
94593739|NCT01144299|323975287|FG001|Overall Study|Lost to Follow-up|0|||
94593740|NCT01144299|323975286|FG000|Overall Study|Withdrawal by Subject|1|||
94593741|NCT01144299|323975287|FG001|Overall Study|Withdrawal by Subject|0|||
94593742|NCT01699867|323975290|FG000|Overall Study|Screening Failure|3|||
94593743|NCT03041129|323975295|FG000|Overall Study|Withdrawal by Subject|2|||
94593744|NCT03041129|323975296|FG001|Overall Study|Withdrawal by Subject|0|||
94593745|NCT03041129|323975297|FG002|Overall Study|Withdrawal by Subject|0|||
94593746|NCT03041129|323975298|FG003|Overall Study|Withdrawal by Subject|0|||
94593747|NCT02282293|323975300|FG000|Overall Study|Lost to Follow-up|2|||
94593748|NCT02282293|323975301|FG001|Overall Study|Lost to Follow-up|2|||
94355427|NCT00151775|323083573|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
94355428|NCT00151775|323083562|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
94355429|NCT00151775|323083563|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
94355430|NCT00151775|323083564|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
94593749|NCT02282293|323975300|FG000|Overall Study|Unable to comply with study procedures|1|||
94593750|NCT02282293|323975301|FG001|Overall Study|Unable to comply with study procedures|0|||
94593751|NCT02282293|323975300|FG000|Overall Study|Moved out of study area|0|||
94593752|NCT02282293|323975301|FG001|Overall Study|Moved out of study area|1|||
94593753|NCT01375075|323975302|FG000|Overall Study|Adverse Event|0|||
94593754|NCT01375075|323975303|FG001|Overall Study|Adverse Event|0|||
94593755|NCT01375075|323975304|FG002|Overall Study|Adverse Event|3|||
94593756|NCT01375075|323975305|FG003|Overall Study|Adverse Event|1|||
94593757|NCT01375075|323975306|FG004|Overall Study|Adverse Event|0|||
94593758|NCT01375075|323975307|FG005|Overall Study|Adverse Event|1|||
94593759|NCT01375075|323975302|FG000|Overall Study|Entry Criterion Not Met|1|||
94593760|NCT01375075|323975303|FG001|Overall Study|Entry Criterion Not Met|0|||
94593761|NCT01375075|323975304|FG002|Overall Study|Entry Criterion Not Met|0|||
94593762|NCT01375075|323975305|FG003|Overall Study|Entry Criterion Not Met|0|||
94593763|NCT01375075|323975306|FG004|Overall Study|Entry Criterion Not Met|0|||
94593764|NCT01375075|323975307|FG005|Overall Study|Entry Criterion Not Met|1|||
94593765|NCT01375075|323975302|FG000|Overall Study|Withdrawal by Subject|0|||
94593766|NCT01375075|323975303|FG001|Overall Study|Withdrawal by Subject|1|||
94593767|NCT01375075|323975304|FG002|Overall Study|Withdrawal by Subject|0|||
94593768|NCT01375075|323975305|FG003|Overall Study|Withdrawal by Subject|0|||
94593769|NCT01375075|323975306|FG004|Overall Study|Withdrawal by Subject|0|||
94593770|NCT01375075|323975307|FG005|Overall Study|Withdrawal by Subject|1|||
94593771|NCT00821509|323975308|FG000|Overall Study|Withdrawal by Subject|12|||
94593772|NCT00821509|323975309|FG001|Overall Study|Withdrawal by Subject|11|||
94593773|NCT00821509|323975310|FG002|Overall Study|Withdrawal by Subject|34|||
94593774|NCT01576159|323975312|FG000|Overall Study|Withdrawal by Subject|0|||
94593775|NCT01576159|323975313|FG001|Overall Study|Withdrawal by Subject|1|||
94593776|NCT01576159|323975314|FG002|Overall Study|Withdrawal by Subject|0|||
94593777|NCT01576159|323975315|FG003|Overall Study|Withdrawal by Subject|0|||
94593778|NCT01576159|323975312|FG000|Overall Study|Physician Decision|0|||
94593779|NCT01576159|323975313|FG001|Overall Study|Physician Decision|0|||
94593780|NCT01576159|323975314|FG002|Overall Study|Physician Decision|1|||
94593781|NCT01576159|323975315|FG003|Overall Study|Physician Decision|0|||
94593782|NCT01576159|323975312|FG000|Overall Study|Lost to Follow-up|0|||
94593783|NCT01576159|323975313|FG001|Overall Study|Lost to Follow-up|0|||
94593784|NCT01576159|323975314|FG002|Overall Study|Lost to Follow-up|0|||
94593785|NCT01576159|323975315|FG003|Overall Study|Lost to Follow-up|1|||
94593786|NCT01576159|323975312|FG000|Overall Study|Protocol Violation|1|||
94593787|NCT01576159|323975313|FG001|Overall Study|Protocol Violation|0|||
94593788|NCT01576159|323975314|FG002|Overall Study|Protocol Violation|0|||
94593789|NCT01576159|323975315|FG003|Overall Study|Protocol Violation|0|||
94593790|NCT04463069|323975316|FG000|Overall Study|Withdrawal by Subject|2|||
94593791|NCT04463069|323975317|FG001|Overall Study|Withdrawal by Subject|10|||
94593792|NCT04463069|323975316|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
94593793|NCT04463069|323975317|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
94593794|NCT01181986|323975318|FG000|Phase 1|Lost to Follow-up|0|||
94593795|NCT01181986|323975319|FG001|Phase 1|Lost to Follow-up|1|||
94593796|NCT01181986|323975320|FG002|Phase 1|Lost to Follow-up|1|||
94593797|NCT01181986|323975318|FG000|Phase 1|Adverse Event|0|||
94593798|NCT01181986|323975319|FG001|Phase 1|Adverse Event|0|||
94593799|NCT01181986|323975320|FG002|Phase 1|Adverse Event|1|||
94593800|NCT01181986|323975318|FG000|Phase 1|Protocol Violation|1|||
94593801|NCT01181986|323975319|FG001|Phase 1|Protocol Violation|0|||
94593802|NCT01181986|323975320|FG002|Phase 1|Protocol Violation|0|||
94593803|NCT01181986|323975318|FG000|Phase 2|Adverse Event|0|||
94593804|NCT01181986|323975319|FG001|Phase 2|Adverse Event|3|||
94593805|NCT01181986|323975320|FG002|Phase 2|Adverse Event|0|||
94593806|NCT01181986|323975318|FG000|Phase 2|Medical condition|0|||
94593807|NCT01181986|323975319|FG001|Phase 2|Medical condition|1|||
94593808|NCT01181986|323975320|FG002|Phase 2|Medical condition|0|||
94593809|NCT00831493|323975322|FG000|Overall Study|Intractable nausea and vomiting|1|||
94593810|NCT03255083|323975329|FG000|Overall Study|Clinical progression|1|||
94593811|NCT03255083|323975330|FG001|Overall Study|Clinical progression|0|||
94593812|NCT03255083|323975331|FG002|Overall Study|Clinical progression|0|||
94593813|NCT03255083|323975332|FG003|Overall Study|Clinical progression|0|||
94593814|NCT03255083|323975329|FG000|Overall Study|Adverse Event|0|||
94593815|NCT03255083|323975330|FG001|Overall Study|Adverse Event|1|||
94593816|NCT03255083|323975331|FG002|Overall Study|Adverse Event|0|||
94593817|NCT03255083|323975332|FG003|Overall Study|Adverse Event|0|||
94593818|NCT03255083|323975329|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
94593819|NCT03255083|323975330|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
94593820|NCT03255083|323975331|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
94593821|NCT03255083|323975332|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
94593822|NCT03255083|323975329|FG000|Overall Study|Withdrawal by Subject|1|||
94593823|NCT03255083|323975330|FG001|Overall Study|Withdrawal by Subject|1|||
94593824|NCT03255083|323975331|FG002|Overall Study|Withdrawal by Subject|1|||
94593825|NCT03255083|323975332|FG003|Overall Study|Withdrawal by Subject|0|||
94593826|NCT01981551|323975333|FG000|Overall Study|Refused further treatment|8|||
94593827|NCT01981551|323975333|FG000|Overall Study|Adverse Event|1|||
94593828|NCT00363545|323975334|FG000|Overall Study|Serious Adverse Event|0|||
94593829|NCT00363545|323975335|FG001|Overall Study|Serious Adverse Event|1|||
94593830|NCT00363545|323975334|FG000|Overall Study|Withdrawal by Subject|12|||
94593831|NCT00363545|323975335|FG001|Overall Study|Withdrawal by Subject|15|||
94593832|NCT00363545|323975334|FG000|Overall Study|Migrated/moved from study area|3|||
94593833|NCT00363545|323975335|FG001|Overall Study|Migrated/moved from study area|6|||
94593834|NCT00363545|323975334|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
94593835|NCT00363545|323975335|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
94593836|NCT00363545|323975334|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
94593837|NCT00363545|323975335|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
94593838|NCT00363545|323975334|FG000|Overall Study|Others|1|||
94593839|NCT00363545|323975335|FG001|Overall Study|Others|0|||
94593840|NCT00960570|323975336|FG000|21 Day Washout Period|Adverse Event|1|||
94593841|NCT00960570|323975336|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
94593842|NCT00960570|323975336|FG000|1 Day Period Between Dosing|Adverse Event|2|||
94593843|NCT00960570|323975336|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
94593844|NCT01457352|323975337|FG000|Period 1|Adverse Event|2|||
94593845|NCT01457352|323975338|FG001|Period 1|Adverse Event|0|||
94593846|NCT01457352|323975337|FG000|Period 1|Withdrawal by Subject|2|||
94593847|NCT01457352|323975338|FG001|Period 1|Withdrawal by Subject|0|||
94593848|NCT01457352|323975337|FG000|Period 1|Physician Decision|2|||
94593849|NCT01457352|323975338|FG001|Period 1|Physician Decision|0|||
94593850|NCT01457352|323975337|FG000|Period 1|MS related disease progression|1|||
94593851|NCT01457352|323975338|FG001|Period 1|MS related disease progression|0|||
94593852|NCT01457352|323975337|FG000|Period 1|Withdrawn|1|||
94593853|NCT01457352|323975338|FG001|Period 1|Withdrawn|0|||
94593854|NCT01457352|323975337|FG000|Period 1|withdrew per sponsor|1|||
94593855|NCT01457352|323975338|FG001|Period 1|withdrew per sponsor|0|||
94593856|NCT01457352|323975337|FG000|Period 1|Protocol Violation|4|||
94593857|NCT01457352|323975338|FG001|Period 1|Protocol Violation|0|||
94593858|NCT01457352|323975337|FG000|Period 1|Did not meet eligibility criteria|3|||
94593859|NCT01457352|323975338|FG001|Period 1|Did not meet eligibility criteria|0|||
94593860|NCT01457352|323975337|FG000|Period 2|Withdrawal by Subject|23|||
94593861|NCT01457352|323975338|FG001|Period 2|Withdrawal by Subject|0|||
94593862|NCT01457352|323975337|FG000|Period 2|Adverse Event|22|||
94593863|NCT01457352|323975338|FG001|Period 2|Adverse Event|0|||
94593864|NCT01457352|323975337|FG000|Period 2|no analysis|10|||
94593865|NCT01457352|323975338|FG001|Period 2|no analysis|0|||
94593866|NCT01457352|323975337|FG000|Period 2|Lack of Efficacy|8|||
94246270|NCT03592745|322695265|FG000|Overall Study|Adverse Event|0|||
94246271|NCT03592745|322695266|FG001|Overall Study|Adverse Event|2|||
94246272|NCT03592745|322695265|FG000|Overall Study|Lost to Follow-up|2|||
94593867|NCT01457352|323975338|FG001|Period 2|Lack of Efficacy|0|||
94593868|NCT01457352|323975337|FG000|Period 2|Protocol Violation|4|||
94593869|NCT01457352|323975338|FG001|Period 2|Protocol Violation|0|||
94593870|NCT01457352|323975337|FG000|Period 2|Sponsor's withdrawal|7|||
94593871|NCT01457352|323975338|FG001|Period 2|Sponsor's withdrawal|0|||
94593872|NCT01457352|323975337|FG000|Period 2|Lost to Follow-up|1|||
94593873|NCT01457352|323975338|FG001|Period 2|Lost to Follow-up|0|||
94593874|NCT01457352|323975337|FG000|Period 2|dose change|1|||
94593875|NCT01457352|323975338|FG001|Period 2|dose change|0|||
94593876|NCT01457352|323975337|FG000|Period 2|Physician Decision|1|||
94593877|NCT01457352|323975338|FG001|Period 2|Physician Decision|0|||
94593878|NCT01457352|323975337|FG000|Period 2|Did not meet eligibility criteria|3|||
94593879|NCT01457352|323975338|FG001|Period 2|Did not meet eligibility criteria|0|||
94593880|NCT01457352|323975337|FG000|Period 3|Adverse Event|1|||
94593881|NCT01457352|323975338|FG001|Period 3|Adverse Event|1|||
94593882|NCT01457352|323975337|FG000|Period 3|Withdrawal by Subject|0|||
94593883|NCT01457352|323975338|FG001|Period 3|Withdrawal by Subject|2|||
94593884|NCT01457352|323975337|FG000|Period 3|incorrect treatment|0|||
94593885|NCT01457352|323975338|FG001|Period 3|incorrect treatment|1|||
94593886|NCT01457352|323975337|FG000|Period 3|Sponsor's withdrawal|0|||
94593887|NCT01457352|323975338|FG001|Period 3|Sponsor's withdrawal|1|||
94593888|NCT03320824|323977206|FG000|Overall Study|Withdrawal by Subject|8|||
94593889|NCT03320824|323977207|FG001|Overall Study|Withdrawal by Subject|1|||
94593890|NCT03320824|323977206|FG000|Overall Study|Lost to Follow-up|10|||
94246273|NCT03592745|322695266|FG001|Overall Study|Lost to Follow-up|0|||
94246274|NCT03592745|322695265|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
94593891|NCT03320824|323977207|FG001|Overall Study|Lost to Follow-up|1|||
94593892|NCT03320824|323977206|FG000|Overall Study|moved out of state|0|||
94593893|NCT03320824|323977207|FG001|Overall Study|moved out of state|1|||
94593894|NCT03320824|323977206|FG000|Overall Study|could not complete final visit|0|||
94593895|NCT03320824|323977207|FG001|Overall Study|could not complete final visit|1|||
94593896|NCT01106092|323977208|FG000|Overall Study|Withdrawal by Subject|0|||
94593897|NCT01106092|323977209|FG001|Overall Study|Withdrawal by Subject|0|||
94593898|NCT01106092|323977210|FG002|Overall Study|Withdrawal by Subject|0|||
94593899|NCT01106092|323977211|FG003|Overall Study|Withdrawal by Subject|1|||
94593900|NCT00813943|323977212|FG000|Overall Study|Ongoing at cut-off date|5|||
94593901|NCT00813943|323977213|FG001|Overall Study|Ongoing at cut-off date|5|||
94593902|NCT00813943|323977214|FG002|Overall Study|Ongoing at cut-off date|3|||
94593903|NCT02894502|323977219|FG000|Baseline|Withdrawal by Subject|24|||
94593904|NCT02894502|323977220|FG001|Baseline|Withdrawal by Subject|31|||
94246275|NCT03592745|322695266|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
94246276|NCT01942785|322695280|FG000|Overall Study|Adverse Event|2|||
94246277|NCT01942785|322695280|FG000|Overall Study|Withdrawal by Subject|1|||
94593905|NCT02894502|323977221|FG002|Baseline|Withdrawal by Subject|36|||
94593906|NCT02894502|323977219|FG000|Baseline|Death|3|||
94593907|NCT02894502|323977220|FG001|Baseline|Death|1|||
94593908|NCT02894502|323977221|FG002|Baseline|Death|9|||
94593909|NCT02894502|323977219|FG000|First Follow up|Withdrawal by Subject|32|||
94593910|NCT02894502|323977220|FG001|First Follow up|Withdrawal by Subject|29|||
94593911|NCT02894502|323977221|FG002|First Follow up|Withdrawal by Subject|37|||
94593912|NCT02894502|323977219|FG000|First Follow up|Death|2|||
94593913|NCT02894502|323977220|FG001|First Follow up|Death|2|||
94593914|NCT02894502|323977221|FG002|First Follow up|Death|3|||
94593915|NCT02894502|323977219|FG000|Second Follow up|Withdrawal by Subject|13|||
94593916|NCT02894502|323977220|FG001|Second Follow up|Withdrawal by Subject|15|||
94246278|NCT01942785|322695280|FG000|Overall Study|Protocol Violation|1|||
94593917|NCT02894502|323977221|FG002|Second Follow up|Withdrawal by Subject|13|||
94593918|NCT02894502|323977219|FG000|Second Follow up|Death|2|||
94593919|NCT02894502|323977220|FG001|Second Follow up|Death|3|||
94593920|NCT02894502|323977221|FG002|Second Follow up|Death|1|||
94593921|NCT02894502|323977219|FG000|Third Follow up|Withdrawal by Subject|5|||
94593922|NCT02894502|323977220|FG001|Third Follow up|Withdrawal by Subject|6|||
94593923|NCT02894502|323977221|FG002|Third Follow up|Withdrawal by Subject|3|||
94593924|NCT02894502|323977219|FG000|Third Follow up|Death|1|||
94246279|NCT00727311|322695281|FG000|Overall Study|Did not receive drug|316|||
94593925|NCT02894502|323977220|FG001|Third Follow up|Death|1|||
94593926|NCT02894502|323977221|FG002|Third Follow up|Death|0|||
94593927|NCT04605991|323977222|FG000|Overall Study|Adverse Event|5|||
94593928|NCT04605991|323977222|FG000|Overall Study|Lack of Efficacy|1|||
94593929|NCT04605991|323977222|FG000|Overall Study|Lost to Follow-up|8|||
94593930|NCT04605991|323977222|FG000|Overall Study|Physician Decision|4|||
94593931|NCT04605991|323977222|FG000|Overall Study|Withdrawal by Subject|14|||
94593932|NCT04605991|323977222|FG000|Overall Study|Non-compliance with study|1|||
94593933|NCT01410357|323977223|FG000|Overall Study|Death|2|||
94593934|NCT01410357|323977224|FG001|Overall Study|Death|1|||
94593935|NCT01410357|323977223|FG000|Overall Study|Withdrawal by Subject|1|||
94593936|NCT01410357|323977224|FG001|Overall Study|Withdrawal by Subject|2|||
94593937|NCT01410357|323977223|FG000|Overall Study|Lost to Follow-up|23|||
94593938|NCT01410357|323977224|FG001|Overall Study|Lost to Follow-up|21|||
94593939|NCT00874939|323977226|FG000|Overall Study|Study terminated|4|||
94593940|NCT00966875|323977227|FG000|Part A|Adverse Event|2|||
94593941|NCT00966875|323977228|FG001|Part A|Adverse Event|1|||
94593942|NCT00966875|323977229|FG002|Part A|Adverse Event|0|||
94593943|NCT00966875|323977230|FG003|Part A|Adverse Event|1|||
94593944|NCT00966875|323977231|FG004|Part A|Adverse Event|0|||
94593945|NCT00966875|323977232|FG005|Part A|Adverse Event|1|||
94593946|NCT00966875|323977233|FG006|Part A|Adverse Event|0|||
94593947|NCT00966875|323977234|FG007|Part A|Adverse Event|3|||
94593948|NCT00966875|323977235|FG008|Part A|Adverse Event|3|||
94593949|NCT00966875|323977227|FG000|Part A|Entry Criteria|0|||
94593950|NCT00966875|323977228|FG001|Part A|Entry Criteria|0|||
94593951|NCT00966875|323977229|FG002|Part A|Entry Criteria|0|||
94593952|NCT00966875|323977230|FG003|Part A|Entry Criteria|0|||
94593953|NCT00966875|323977231|FG004|Part A|Entry Criteria|0|||
94593954|NCT00966875|323977232|FG005|Part A|Entry Criteria|2|||
94593955|NCT00966875|323977233|FG006|Part A|Entry Criteria|0|||
94593956|NCT00966875|323977234|FG007|Part A|Entry Criteria|0|||
94593957|NCT00966875|323977235|FG008|Part A|Entry Criteria|0|||
94593958|NCT00966875|323977227|FG000|Part A|Lack of Efficacy|0|||
94593959|NCT00966875|323977228|FG001|Part A|Lack of Efficacy|1|||
94593960|NCT00966875|323977229|FG002|Part A|Lack of Efficacy|0|||
94593961|NCT00966875|323977230|FG003|Part A|Lack of Efficacy|0|||
94593962|NCT00966875|323977231|FG004|Part A|Lack of Efficacy|0|||
94593963|NCT00966875|323977232|FG005|Part A|Lack of Efficacy|0|||
94593964|NCT00966875|323977233|FG006|Part A|Lack of Efficacy|4|||
94593965|NCT00966875|323977234|FG007|Part A|Lack of Efficacy|0|||
94593966|NCT00966875|323977235|FG008|Part A|Lack of Efficacy|0|||
94593967|NCT00966875|323977227|FG000|Part A|Lost to Follow-up|2|||
94593968|NCT00966875|323977228|FG001|Part A|Lost to Follow-up|0|||
94593969|NCT00966875|323977229|FG002|Part A|Lost to Follow-up|0|||
94593970|NCT00966875|323977230|FG003|Part A|Lost to Follow-up|0|||
94593971|NCT00966875|323977231|FG004|Part A|Lost to Follow-up|0|||
94593972|NCT00966875|323977232|FG005|Part A|Lost to Follow-up|1|||
94593973|NCT00966875|323977233|FG006|Part A|Lost to Follow-up|0|||
94593974|NCT00966875|323977234|FG007|Part A|Lost to Follow-up|0|||
94593975|NCT00966875|323977235|FG008|Part A|Lost to Follow-up|0|||
94593976|NCT00966875|323977227|FG000|Part A|Parent/Caregiver Decision|0|||
94593977|NCT00966875|323977228|FG001|Part A|Parent/Caregiver Decision|0|||
94593978|NCT00966875|323977229|FG002|Part A|Parent/Caregiver Decision|0|||
94593979|NCT00966875|323977230|FG003|Part A|Parent/Caregiver Decision|1|||
94593980|NCT00966875|323977231|FG004|Part A|Parent/Caregiver Decision|0|||
94593981|NCT00966875|323977232|FG005|Part A|Parent/Caregiver Decision|0|||
94593982|NCT00966875|323977233|FG006|Part A|Parent/Caregiver Decision|0|||
94593983|NCT00966875|323977234|FG007|Part A|Parent/Caregiver Decision|0|||
94593984|NCT00966875|323977235|FG008|Part A|Parent/Caregiver Decision|0|||
94593985|NCT00966875|323977227|FG000|Part A|Physician Decision|0|||
94593986|NCT00966875|323977228|FG001|Part A|Physician Decision|0|||
94593987|NCT00966875|323977229|FG002|Part A|Physician Decision|0|||
94593988|NCT00966875|323977230|FG003|Part A|Physician Decision|0|||
94660004|NCT02301143|324210007|FG000|Induction Period|Progressive Disease|8|||
94660005|NCT02301143|324210008|FG001|Induction Period|Progressive Disease|0|||
94593989|NCT00966875|323977231|FG004|Part A|Physician Decision|1|||
94593990|NCT00966875|323977232|FG005|Part A|Physician Decision|0|||
94593991|NCT00966875|323977233|FG006|Part A|Physician Decision|1|||
94593992|NCT00966875|323977234|FG007|Part A|Physician Decision|0|||
94593993|NCT00966875|323977235|FG008|Part A|Physician Decision|2|||
94593994|NCT00966875|323977227|FG000|Part A|Sponsor Decision|0|||
94593995|NCT00966875|323977228|FG001|Part A|Sponsor Decision|0|||
94593996|NCT00966875|323977229|FG002|Part A|Sponsor Decision|1|||
94593997|NCT00966875|323977230|FG003|Part A|Sponsor Decision|0|||
94660006|NCT02301143|324210007|FG000|Induction Period|Withdrawal by Subject|3|||
94660007|NCT02301143|324210008|FG001|Induction Period|Withdrawal by Subject|0|||
94593998|NCT00966875|323977231|FG004|Part A|Sponsor Decision|1|||
94593999|NCT00966875|323977232|FG005|Part A|Sponsor Decision|0|||
94594000|NCT00966875|323977233|FG006|Part A|Sponsor Decision|0|||
94594001|NCT00966875|323977234|FG007|Part A|Sponsor Decision|2|||
94594002|NCT00966875|323977235|FG008|Part A|Sponsor Decision|1|||
94594003|NCT00966875|323977227|FG000|Part A|Withdrawal by Subject|2|||
94594004|NCT00966875|323977228|FG001|Part A|Withdrawal by Subject|2|||
94594005|NCT00966875|323977229|FG002|Part A|Withdrawal by Subject|1|||
94594006|NCT00966875|323977230|FG003|Part A|Withdrawal by Subject|1|||
94456652|NCT00090220|323460542|FG002|Base Study Vaccination Period|Other|0|||
94456653|NCT00090220|323460543|FG003|Base Study Vaccination Period|Other|0|||
94456654|NCT00090220|323460544|FG004|Base Study Vaccination Period|Other|0|||
94456655|NCT00090220|323460545|FG005|Base Study Vaccination Period|Other|0|||
94456656|NCT00090220|323460540|FG000|Base Study Follow-up Period|Adverse Event|6|||
94456657|NCT00090220|323460541|FG001|Base Study Follow-up Period|Adverse Event|1|||
94456658|NCT00090220|323460542|FG002|Base Study Follow-up Period|Adverse Event|0|||
94456659|NCT00090220|323460543|FG003|Base Study Follow-up Period|Adverse Event|0|||
94456660|NCT00090220|323460544|FG004|Base Study Follow-up Period|Adverse Event|0|||
94456661|NCT00090220|323460545|FG005|Base Study Follow-up Period|Adverse Event|0|||
94456662|NCT00090220|323460540|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
94456663|NCT00090220|323460541|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
94456664|NCT00090220|323460542|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
94456665|NCT00090220|323460543|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
94456666|NCT00090220|323460544|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
94456667|NCT00090220|323460545|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
94456668|NCT00090220|323460540|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
94456669|NCT00090220|323460541|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
94456670|NCT00090220|323460542|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
94456671|NCT00090220|323460543|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
94456672|NCT00090220|323460544|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
94456673|NCT00090220|323460545|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
94456674|NCT00090220|323460540|FG000|Base Study Follow-up Period|Patient Moved|20|||
94456675|NCT00090220|323460541|FG001|Base Study Follow-up Period|Patient Moved|28|||
94456676|NCT00090220|323460542|FG002|Base Study Follow-up Period|Patient Moved|0|||
94456677|NCT00090220|323460543|FG003|Base Study Follow-up Period|Patient Moved|0|||
94456678|NCT00090220|323460544|FG004|Base Study Follow-up Period|Patient Moved|0|||
94456679|NCT00090220|323460545|FG005|Base Study Follow-up Period|Patient Moved|0|||
94456680|NCT00090220|323460540|FG000|Base Study Follow-up Period|Other|19|||
94456681|NCT00090220|323460541|FG001|Base Study Follow-up Period|Other|21|||
94456682|NCT00090220|323460542|FG002|Base Study Follow-up Period|Other|0|||
94456683|NCT00090220|323460543|FG003|Base Study Follow-up Period|Other|0|||
94456684|NCT00090220|323460544|FG004|Base Study Follow-up Period|Other|0|||
94456685|NCT00090220|323460545|FG005|Base Study Follow-up Period|Other|0|||
94456686|NCT00090220|323460540|FG000|Extension 1 (EXT1)|Adverse Event|0|||
94456687|NCT00090220|323460541|FG001|Extension 1 (EXT1)|Adverse Event|0|||
94456688|NCT00090220|323460542|FG002|Extension 1 (EXT1)|Adverse Event|4|||
94456689|NCT00090220|323460543|FG003|Extension 1 (EXT1)|Adverse Event|0|||
94456690|NCT00090220|323460544|FG004|Extension 1 (EXT1)|Adverse Event|0|||
94456691|NCT00090220|323460545|FG005|Extension 1 (EXT1)|Adverse Event|0|||
94456692|NCT00090220|323460540|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
94456693|NCT00090220|323460541|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
94456694|NCT00090220|323460542|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
94456695|NCT00090220|323460543|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
94456696|NCT00090220|323460544|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
94456697|NCT00090220|323460545|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
94456698|NCT00090220|323460540|FG000|Extension 1 (EXT1)|Moved|0|||
94456699|NCT00090220|323460541|FG001|Extension 1 (EXT1)|Moved|0|||
94456700|NCT00090220|323460542|FG002|Extension 1 (EXT1)|Moved|2|||
94456701|NCT00090220|323460543|FG003|Extension 1 (EXT1)|Moved|1|||
94456702|NCT00090220|323460544|FG004|Extension 1 (EXT1)|Moved|0|||
94456703|NCT00090220|323460545|FG005|Extension 1 (EXT1)|Moved|0|||
94456704|NCT00090220|323460540|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
94456705|NCT00090220|323460541|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
94456706|NCT00090220|323460542|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
94456707|NCT00090220|323460543|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
94456708|NCT00090220|323460544|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
94456709|NCT00090220|323460545|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
94456710|NCT00090220|323460540|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
94456711|NCT00090220|323460541|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
94456712|NCT00090220|323460542|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
94456713|NCT00090220|323460543|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
94456714|NCT00090220|323460544|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
94456715|NCT00090220|323460545|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
94456716|NCT00090220|323460540|FG000|Extension 1 (EXT1)|Other reason|0|||
94456717|NCT00090220|323460541|FG001|Extension 1 (EXT1)|Other reason|0|||
94456718|NCT00090220|323460542|FG002|Extension 1 (EXT1)|Other reason|2|||
94456719|NCT00090220|323460543|FG003|Extension 1 (EXT1)|Other reason|0|||
94456720|NCT00090220|323460544|FG004|Extension 1 (EXT1)|Other reason|0|||
94456721|NCT00090220|323460545|FG005|Extension 1 (EXT1)|Other reason|0|||
94456722|NCT00090220|323460540|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
94456723|NCT00090220|323460541|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
94456724|NCT00090220|323460542|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
94456725|NCT00090220|323460543|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
94456726|NCT00090220|323460544|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
94456727|NCT00090220|323460545|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
94594007|NCT00966875|323977231|FG004|Part A|Withdrawal by Subject|3|||
94594008|NCT00966875|323977232|FG005|Part A|Withdrawal by Subject|0|||
94594009|NCT00966875|323977233|FG006|Part A|Withdrawal by Subject|5|||
94594010|NCT00966875|323977234|FG007|Part A|Withdrawal by Subject|1|||
94594011|NCT00966875|323977235|FG008|Part A|Withdrawal by Subject|1|||
94594012|NCT00966875|323977227|FG000|Part A|Protocol Violation|0|||
94355431|NCT00151775|323083565|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
94355432|NCT00151775|323083566|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
94355433|NCT00151775|323083567|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
94355434|NCT00151775|323083568|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
94355435|NCT00151775|323083569|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
94355436|NCT00151775|323083570|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
94355437|NCT00151775|323083571|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
94355438|NCT00151775|323083572|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
94355439|NCT00151775|323083573|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
94355440|NCT00151775|323083562|FG000|Period 4: Open Label|Increased blood pressure|0|||
94355441|NCT00151775|323083563|FG001|Period 4: Open Label|Increased blood pressure|0|||
94355442|NCT00151775|323083564|FG002|Period 4: Open Label|Increased blood pressure|0|||
94355443|NCT00151775|323083565|FG003|Period 4: Open Label|Increased blood pressure|0|||
94355444|NCT00151775|323083566|FG004|Period 4: Open Label|Increased blood pressure|1|||
94355445|NCT00151775|323083567|FG005|Period 4: Open Label|Increased blood pressure|0|||
94355446|NCT00151775|323083568|FG006|Period 4: Open Label|Increased blood pressure|0|||
94355447|NCT00151775|323083569|FG007|Period 4: Open Label|Increased blood pressure|0|||
94355448|NCT00151775|323083570|FG008|Period 4: Open Label|Increased blood pressure|0|||
94355449|NCT00151775|323083571|FG009|Period 4: Open Label|Increased blood pressure|1|||
94355450|NCT00151775|323083572|FG010|Period 4: Open Label|Increased blood pressure|0|||
94355451|NCT00151775|323083573|FG011|Period 4: Open Label|Increased blood pressure|0|||
94594013|NCT00966875|323977228|FG001|Part A|Protocol Violation|0|||
94594014|NCT00966875|323977229|FG002|Part A|Protocol Violation|0|||
94355452|NCT00151775|323083562|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
94355453|NCT00151775|323083563|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
94594015|NCT00966875|323977230|FG003|Part A|Protocol Violation|0|||
94594016|NCT00966875|323977231|FG004|Part A|Protocol Violation|0|||
94594017|NCT00966875|323977232|FG005|Part A|Protocol Violation|0|||
94594018|NCT00966875|323977233|FG006|Part A|Protocol Violation|2|||
94355454|NCT00151775|323083564|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
94355455|NCT00151775|323083565|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
94355456|NCT00151775|323083566|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
94355457|NCT00151775|323083567|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
94355458|NCT00151775|323083568|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
94355459|NCT00151775|323083569|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
94355460|NCT00151775|323083570|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
94355461|NCT00151775|323083571|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
94355462|NCT00151775|323083572|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
94355463|NCT00151775|323083573|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
94355464|NCT00151775|323083562|FG000|Period 4: Open Label|Adverse Event|0|||
94355465|NCT00151775|323083563|FG001|Period 4: Open Label|Adverse Event|0|||
94355466|NCT00151775|323083564|FG002|Period 4: Open Label|Adverse Event|0|||
94355467|NCT00151775|323083565|FG003|Period 4: Open Label|Adverse Event|0|||
94456728|NCT00090220|323460540|FG000|Long-term Follow-up (EXT2)|Death|0|||
94355468|NCT00151775|323083566|FG004|Period 4: Open Label|Adverse Event|1|||
94355469|NCT00151775|323083567|FG005|Period 4: Open Label|Adverse Event|0|||
94456729|NCT00090220|323460541|FG001|Long-term Follow-up (EXT2)|Death|0|||
94456730|NCT00090220|323460542|FG002|Long-term Follow-up (EXT2)|Death|0|||
94456731|NCT00090220|323460543|FG003|Long-term Follow-up (EXT2)|Death|0|||
94456732|NCT00090220|323460544|FG004|Long-term Follow-up (EXT2)|Death|1|||
94456733|NCT00090220|323460545|FG005|Long-term Follow-up (EXT2)|Death|1|||
94456734|NCT00090220|323460540|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
94456735|NCT00090220|323460541|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
94456736|NCT00090220|323460542|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
94594019|NCT00966875|323977234|FG007|Part A|Protocol Violation|1|||
94594020|NCT00966875|323977235|FG008|Part A|Protocol Violation|1|||
94594021|NCT00966875|323977227|FG000|Part B|Adverse Event|0|||
94355470|NCT00151775|323083568|FG006|Period 4: Open Label|Adverse Event|0|||
94456737|NCT00090220|323460543|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
94594022|NCT00966875|323977228|FG001|Part B|Adverse Event|1|||
94660008|NCT02301143|324210007|FG000|Induction Period|Noncompliance with Study Drug|1|||
94660009|NCT02301143|324210008|FG001|Induction Period|Noncompliance with Study Drug|0|||
94660010|NCT02301143|324210007|FG000|Induction Period|Physician Decision|4|||
94660011|NCT02301143|324210008|FG001|Induction Period|Physician Decision|0|||
94660012|NCT02301143|324210007|FG000|Induction Period|Symptomatic Deterioration|2|||
94660013|NCT02301143|324210008|FG001|Induction Period|Symptomatic Deterioration|0|||
94660014|NCT02301143|324210007|FG000|Induction Period|Protocol Violation|2|||
94660015|NCT02301143|324210008|FG001|Induction Period|Protocol Violation|0|||
94660016|NCT02301143|324210007|FG000|Induction Period|Other|1|||
94660017|NCT02301143|324210008|FG001|Induction Period|Other|0|||
94660018|NCT02301143|324210007|FG000|Investigator's Choice|Adverse Event|0|||
94660019|NCT02301143|324210008|FG001|Investigator's Choice|Adverse Event|3|||
94660020|NCT02301143|324210007|FG000|Investigator's Choice|Progressive Disease|0|||
94660021|NCT02301143|324210008|FG001|Investigator's Choice|Progressive Disease|3|||
94660022|NCT02301143|324210007|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
94660023|NCT02301143|324210008|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
94660024|NCT02301143|324210007|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
94660025|NCT02301143|324210008|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
94660026|NCT02301143|324210007|FG000|Investigator's Choice|Other|0|||
94660027|NCT02301143|324210008|FG001|Investigator's Choice|Other|1|||
94660028|NCT02301143|324210007|FG000|Investigator's Choice|Unresectable Surgery|0|||
94660029|NCT02301143|324210008|FG001|Investigator's Choice|Unresectable Surgery|1|||
94660030|NCT02554773|324210009|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
94660031|NCT02554773|324210010|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
94660032|NCT02554773|324210009|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
94660033|NCT02554773|324210010|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
94660034|NCT02554773|324210009|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
94660035|NCT02554773|324210010|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
94660036|NCT02554773|324210009|FG000|Original Dose Regimen (SAS 1)|Death|1|||
94660037|NCT02554773|324210010|FG001|Original Dose Regimen (SAS 1)|Death|0|||
94660038|NCT02554773|324210009|FG000|Original Dose Regimen (SAS 1)|Other|4|||
94660039|NCT02554773|324210010|FG001|Original Dose Regimen (SAS 1)|Other|0|||
94660040|NCT02554773|324210009|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
94660041|NCT02554773|324210010|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
94660042|NCT02554773|324210009|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
94660043|NCT02554773|324210010|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
94246280|NCT00727311|322695281|FG000|Overall Study|Missing end of therapy data|205|||
94246281|NCT00727311|322695281|FG000|Overall Study|Adverse Event|58|||
94246282|NCT00727311|322695281|FG000|Overall Study|Lack of Efficacy|242|||
94246283|NCT00727311|322695281|FG000|Overall Study|Lost to Follow-up|73|||
94246284|NCT00727311|322695281|FG000|Overall Study|Withdrawal by Subject|77|||
94246285|NCT00727311|322695281|FG000|Overall Study|Other|97|||
94246286|NCT00727311|322695281|FG000|Overall Study|Multiple reasons|39|||
94246287|NCT03973931|322695282|FG000|Overall Study|Lost to Follow-up|47|||
94246288|NCT03973931|322695283|FG001|Overall Study|Lost to Follow-up|63|||
94246289|NCT03973931|322695284|FG002|Overall Study|Lost to Follow-up|51|||
94246290|NCT03973931|322695285|FG003|Overall Study|Lost to Follow-up|54|||
94246291|NCT03973931|322695282|FG000|Overall Study|opted out|6|||
94246292|NCT03973931|322695283|FG001|Overall Study|opted out|5|||
94660044|NCT02554773|324210009|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
94660045|NCT02554773|324210010|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
94660046|NCT02554773|324210009|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
94660047|NCT02554773|324210010|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
94246293|NCT03973931|322695284|FG002|Overall Study|opted out|5|||
94246294|NCT03973931|322695285|FG003|Overall Study|opted out|1|||
94246295|NCT02314780|322696979|FG000|Overall Study|organizational reasons|0|||
94246296|NCT02314780|322696980|FG001|Overall Study|organizational reasons|2|||
94246297|NCT02314780|322696981|FG002|Overall Study|organizational reasons|0|||
94246298|NCT02314780|322696979|FG000|Overall Study|Adverse Event|0|||
94246299|NCT02314780|322696980|FG001|Overall Study|Adverse Event|1|||
94246300|NCT02314780|322696981|FG002|Overall Study|Adverse Event|0|||
94246301|NCT00215137|322696982|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
94246302|NCT00215137|322696983|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
94246303|NCT00215137|322696984|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
94246304|NCT00215137|322696982|FG000|Randomization Period|Lost to Follow-up|0|||
94246305|NCT00215137|322696983|FG001|Randomization Period|Lost to Follow-up|1|||
94246306|NCT00215137|322696984|FG002|Randomization Period|Lost to Follow-up|0|||
94246307|NCT00215137|322696982|FG000|Randomization Period|Withdrawal by Subject|0|||
94246308|NCT00215137|322696983|FG001|Randomization Period|Withdrawal by Subject|1|||
94246309|NCT00215137|322696984|FG002|Randomization Period|Withdrawal by Subject|0|||
94246310|NCT03333876|322696985|FG000|Screening Period|Screen Failure|4|||
94355471|NCT00151775|323083569|FG007|Period 4: Open Label|Adverse Event|0|||
94355472|NCT00151775|323083570|FG008|Period 4: Open Label|Adverse Event|0|||
94355473|NCT00151775|323083571|FG009|Period 4: Open Label|Adverse Event|2|||
94355474|NCT00151775|323083572|FG010|Period 4: Open Label|Adverse Event|0|||
94355475|NCT00151775|323083573|FG011|Period 4: Open Label|Adverse Event|0|||
94246311|NCT03333876|322696985|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
94246312|NCT03333876|322696985|FG000|Mandibular Advancement|Adverse Event|2|||
94246313|NCT03333876|322696985|FG000|Mandibular Advancement|Product Damage|2|||
94246314|NCT03986944|322696987|FG000|Overall Study|Adverse Event|1|||
94246315|NCT03986944|322696988|FG001|Overall Study|Adverse Event|2|||
94246316|NCT03986944|322696989|FG002|Overall Study|Adverse Event|3|||
94246317|NCT03986944|322696987|FG000|Overall Study|Protocol Violation|0|||
94246318|NCT03986944|322696988|FG001|Overall Study|Protocol Violation|1|||
94246319|NCT03986944|322696989|FG002|Overall Study|Protocol Violation|1|||
94246320|NCT03986944|322696987|FG000|Overall Study|Withdrawal by Subject|3|||
94246321|NCT03986944|322696988|FG001|Overall Study|Withdrawal by Subject|5|||
94246322|NCT03986944|322696989|FG002|Overall Study|Withdrawal by Subject|5|||
94246323|NCT03986944|322696987|FG000|Overall Study|Study termination|10|||
94246324|NCT03986944|322696988|FG001|Overall Study|Study termination|10|||
94246325|NCT03986944|322696989|FG002|Overall Study|Study termination|10|||
94246326|NCT03986944|322696987|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
94246327|NCT03986944|322696988|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
94246328|NCT03986944|322696989|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
94246329|NCT03986944|322696987|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
94246330|NCT03986944|322696988|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
94246331|NCT03986944|322696989|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
94246332|NCT03002220|322696991|FG000|Overall Study|Lack of Efficacy|2|||
94246333|NCT03002220|322696991|FG000|Overall Study|Withdrawal by Subject|3|||
94246334|NCT03002220|322696991|FG000|Overall Study|Adverse Event|2|||
94246335|NCT03002220|322696991|FG000|Overall Study|Disease progression|13|||
94246336|NCT03002220|322696991|FG000|Overall Study|Physician Decision|1|||
94246337|NCT01183260|322696992|FG000|Overall Study|Intraop screen failure|2|||
94246338|NCT01183260|322696993|FG001|Overall Study|Intraop screen failure|0|||
94246339|NCT01183260|322696992|FG000|Overall Study|Withdrawal by Subject|1|||
94246340|NCT01183260|322696993|FG001|Overall Study|Withdrawal by Subject|1|||
94246341|NCT01183260|322696992|FG000|Overall Study|Revised within 30 days|0|||
94246342|NCT01183260|322696993|FG001|Overall Study|Revised within 30 days|1|||
94246343|NCT01183260|322696992|FG000|Overall Study|Death|1|||
94246344|NCT01183260|322696993|FG001|Overall Study|Death|0|||
94246345|NCT00128102|322696994|FG000|Overall Study|Site Discontinued|3|||
94246346|NCT00128102|322696995|FG001|Overall Study|Site Discontinued|6|||
94246347|NCT00128102|322696994|FG000|Overall Study|Other|0|||
94246348|NCT00128102|322696995|FG001|Overall Study|Other|1|||
94246349|NCT00128102|322696994|FG000|Overall Study|Progressive Disease|255|||
94246350|NCT00128102|322696995|FG001|Overall Study|Progressive Disease|285|||
94246351|NCT00128102|322696994|FG000|Overall Study|Adverse Event|34|||
94246352|NCT00128102|322696995|FG001|Overall Study|Adverse Event|11|||
94246353|NCT00128102|322696994|FG000|Overall Study|Death|12|||
94246354|NCT00128102|322696995|FG001|Overall Study|Death|13|||
94246355|NCT00128102|322696994|FG000|Overall Study|Physician Decision|3|||
94355476|NCT00151775|323083562|FG000|Period 4: Open Label|Lost to Follow-up|0|||
94246356|NCT00128102|322696995|FG001|Overall Study|Physician Decision|3|||
94246357|NCT00128102|322696994|FG000|Overall Study|Withdrawal by Subject|19|||
94246358|NCT00128102|322696995|FG001|Overall Study|Withdrawal by Subject|11|||
94246359|NCT00128102|322696994|FG000|Overall Study|Protocol Violation|2|||
94246360|NCT00128102|322696995|FG001|Overall Study|Protocol Violation|2|||
94246361|NCT03339245|322696997|FG000|Overall Study|Adverse Event|1|||
94246362|NCT03339245|322696998|FG001|Overall Study|Adverse Event|1|||
94355477|NCT00151775|323083563|FG001|Period 4: Open Label|Lost to Follow-up|0|||
94456738|NCT00090220|323460544|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
94456739|NCT00090220|323460545|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
94456740|NCT00090220|323460540|FG000|Long-term Follow-up (EXT2)|Other|0|||
94456741|NCT00090220|323460541|FG001|Long-term Follow-up (EXT2)|Other|0|||
94456742|NCT00090220|323460542|FG002|Long-term Follow-up (EXT2)|Other|0|||
94456743|NCT00090220|323460543|FG003|Long-term Follow-up (EXT2)|Other|0|||
94456744|NCT00090220|323460544|FG004|Long-term Follow-up (EXT2)|Other|1|||
94456745|NCT00090220|323460545|FG005|Long-term Follow-up (EXT2)|Other|0|||
94456746|NCT03875482|323460546|FG000|Overall Study|Adverse Event|0|||
94456747|NCT03875482|323460547|FG001|Overall Study|Adverse Event|1|||
94456748|NCT03875482|323460546|FG000|Overall Study|Withdrew consent|5|||
94456749|NCT03875482|323460547|FG001|Overall Study|Withdrew consent|6|||
94456750|NCT03875482|323460546|FG000|Overall Study|Lost to Follow-up|8|||
94456751|NCT03875482|323460547|FG001|Overall Study|Lost to Follow-up|2|||
94456752|NCT03875482|323460546|FG000|Overall Study|Lack of Efficacy|0|||
94456753|NCT03875482|323460547|FG001|Overall Study|Lack of Efficacy|11|||
94456754|NCT00941863|323460548|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
94456755|NCT00941863|323460549|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
94456756|NCT00941863|323460550|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
94456757|NCT00941863|323460551|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
94456758|NCT00941863|323460552|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
94456759|NCT00941863|323460548|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
94456760|NCT00941863|323460549|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
94456761|NCT00941863|323460550|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
94456762|NCT00941863|323460551|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
94456763|NCT00941863|323460552|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
94456764|NCT00941863|323460548|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
94456765|NCT00941863|323460549|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
94456766|NCT00941863|323460550|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
94456767|NCT00941863|323460551|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
94456768|NCT00941863|323460552|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
94456769|NCT00941863|323460548|FG000|Until Primary Completion Date (PCD)|Death|0|||
94456770|NCT00941863|323460549|FG001|Until Primary Completion Date (PCD)|Death|0|||
94456771|NCT00941863|323460550|FG002|Until Primary Completion Date (PCD)|Death|1|||
94456772|NCT00941863|323460551|FG003|Until Primary Completion Date (PCD)|Death|2|||
94456773|NCT00941863|323460552|FG004|Until Primary Completion Date (PCD)|Death|7|||
94456774|NCT00941863|323460548|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
94456775|NCT00941863|323460549|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
94456776|NCT00941863|323460550|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
94456777|NCT00941863|323460551|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
94456778|NCT00941863|323460552|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
94456779|NCT00941863|323460548|FG000|Continued After PCD|Withdrawal by Subject|0|||
94456780|NCT00941863|323460549|FG001|Continued After PCD|Withdrawal by Subject|0|||
94456781|NCT00941863|323460550|FG002|Continued After PCD|Withdrawal by Subject|0|||
94456782|NCT00941863|323460551|FG003|Continued After PCD|Withdrawal by Subject|0|||
94456783|NCT00941863|323460552|FG004|Continued After PCD|Withdrawal by Subject|1|||
94456784|NCT00941863|323460548|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
94456785|NCT00941863|323460549|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
94456786|NCT00941863|323460550|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
94456787|NCT00941863|323460551|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
94456788|NCT00941863|323460552|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
94456789|NCT02137850|323460553|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
94456790|NCT02137850|323460554|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
94456791|NCT02137850|323460555|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
94456792|NCT02137850|323460553|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
94456793|NCT02137850|323460554|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
94456794|NCT02137850|323460555|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
94456795|NCT02137850|323460553|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
94456796|NCT02137850|323460554|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
94456797|NCT02137850|323460555|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
94594023|NCT00966875|323977229|FG002|Part B|Adverse Event|1|||
94660048|NCT00097591|324210011|FG000|Overall Study|Withdrawal of consent|342|||
94660049|NCT00097591|324210012|FG001|Overall Study|Withdrawal of consent|323|||
94660050|NCT00097591|324210011|FG000|Overall Study|Less than 6 months on study drug|9|||
94660051|NCT00097591|324210012|FG001|Overall Study|Less than 6 months on study drug|7|||
94660052|NCT00097591|324210011|FG000|Overall Study|Unable to attend termination visit|53|||
94660053|NCT00097591|324210012|FG001|Overall Study|Unable to attend termination visit|51|||
94660054|NCT00097591|324210011|FG000|Overall Study|Lost to follow up|6|||
94456798|NCT02137850|323460553|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
94660055|NCT00097591|324210012|FG001|Overall Study|Lost to follow up|10|||
94660056|NCT00097591|324210011|FG000|Overall Study|Other|0|||
94660057|NCT00097591|324210012|FG001|Overall Study|Other|3|||
94660058|NCT02031276|324210015|FG000|Period 1 Double-blind IV|Adverse Event|6|||
94660059|NCT02031276|324210016|FG001|Period 1 Double-blind IV|Adverse Event|5|||
94660060|NCT02031276|324210017|FG002|Period 1 Double-blind IV|Adverse Event|1|||
94660061|NCT02031276|324210015|FG000|Period 1 Double-blind IV|Other|0|||
94660062|NCT02031276|324210016|FG001|Period 1 Double-blind IV|Other|1|||
94660063|NCT02031276|324210017|FG002|Period 1 Double-blind IV|Other|0|||
94660064|NCT02031276|324210015|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
94660065|NCT02031276|324210016|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
94660066|NCT02031276|324210017|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
94660067|NCT02031276|324210015|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
94660068|NCT02031276|324210016|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
94660069|NCT02031276|324210017|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
94660070|NCT02031276|324210015|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
94660071|NCT02031276|324210016|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
94660072|NCT02031276|324210017|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
94660073|NCT02031276|324210015|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
94660074|NCT02031276|324210016|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
94660075|NCT02031276|324210017|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
94660076|NCT02031276|324210015|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
94660077|NCT02031276|324210016|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
94660078|NCT02031276|324210017|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
94660079|NCT02031276|324210015|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
94660080|NCT02031276|324210016|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
94660081|NCT02031276|324210017|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
94660082|NCT02031276|324210015|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
94660083|NCT02031276|324210016|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
94660084|NCT02031276|324210017|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
94660085|NCT01148810|324210018|FG000|Overall Study|Adverse Event|0|||
94660086|NCT01148810|324210019|FG001|Overall Study|Adverse Event|2|||
94660087|NCT01148810|324210018|FG000|Overall Study|Lack of Efficacy|0|||
94660088|NCT01148810|324210019|FG001|Overall Study|Lack of Efficacy|1|||
94660089|NCT01148810|324210018|FG000|Overall Study|Withdrawal by Subject|0|||
94660090|NCT01148810|324210019|FG001|Overall Study|Withdrawal by Subject|2|||
94660091|NCT01148810|324210018|FG000|Overall Study|Protocol Violation|1|||
94660092|NCT01148810|324210019|FG001|Overall Study|Protocol Violation|0|||
94660093|NCT02536508|324210024|FG000|Overall Study|Withdrawal by Subject|18|||
94660094|NCT02536508|324210025|FG001|Overall Study|Withdrawal by Subject|13|||
94660095|NCT02536508|324210026|FG002|Overall Study|Withdrawal by Subject|7|||
94660096|NCT02536508|324210024|FG000|Overall Study|Adverse Event|14|||
94660097|NCT02536508|324210025|FG001|Overall Study|Adverse Event|13|||
94660098|NCT02536508|324210026|FG002|Overall Study|Adverse Event|6|||
94660099|NCT02536508|324210024|FG000|Overall Study|Lost to Follow-up|12|||
94660100|NCT02536508|324210025|FG001|Overall Study|Lost to Follow-up|4|||
94660101|NCT02536508|324210026|FG002|Overall Study|Lost to Follow-up|0|||
94660102|NCT02536508|324210024|FG000|Overall Study|Lack of Efficacy|3|||
94660103|NCT02536508|324210025|FG001|Overall Study|Lack of Efficacy|5|||
94246363|NCT03339245|322696997|FG000|Overall Study|Withdrawal by Subject|1|||
94246364|NCT03339245|322696998|FG001|Overall Study|Withdrawal by Subject|0|||
94246365|NCT01342341|322696999|FG000|Overall Study|Lost to Follow-up|4|||
94246366|NCT01342341|322697000|FG001|Overall Study|Lost to Follow-up|4|||
94246367|NCT01332630|322697001|FG000|Overall Study|Withdrawal by Subject|3|||
94246368|NCT00316602|322697003|FG000|Overall Study|Withdrawal by Subject|3|||
94246369|NCT00316602|322697004|FG001|Overall Study|Withdrawal by Subject|2|||
94246370|NCT00316602|322697003|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
94246371|NCT00316602|322697004|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
94246372|NCT00316602|322697003|FG000|Overall Study|Adverse Event|1|||
94456799|NCT02137850|323460554|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
94456800|NCT02137850|323460555|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
94660104|NCT02536508|324210026|FG002|Overall Study|Lack of Efficacy|4|||
94660105|NCT02536508|324210024|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
94660106|NCT02536508|324210025|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
94246373|NCT00316602|322697004|FG001|Overall Study|Adverse Event|0|||
94246374|NCT00316602|322697003|FG000|Overall Study|Other|3|||
94456801|NCT02137850|323460553|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
94456802|NCT02137850|323460554|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
94456803|NCT02137850|323460555|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
94456804|NCT02137850|323460553|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
94456805|NCT02137850|323460554|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
94456806|NCT02137850|323460555|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
94456807|NCT02137850|323460553|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
94456808|NCT02137850|323460554|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
94456809|NCT02137850|323460555|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
94456810|NCT02137850|323460553|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
94456811|NCT02137850|323460554|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
94456812|NCT02137850|323460555|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
94456813|NCT02137850|323460553|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
94456814|NCT02137850|323460554|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
94456815|NCT02137850|323460555|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
94456816|NCT02137850|323460553|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
94456817|NCT02137850|323460554|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
94456818|NCT02137850|323460555|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
94456819|NCT02137850|323460553|FG000|Main Phase: Prophylaxis|Other|0|||
94456820|NCT02137850|323460554|FG001|Main Phase: Prophylaxis|Other|1|||
94456821|NCT02137850|323460555|FG002|Main Phase: Prophylaxis|Other|0|||
94456822|NCT02137850|323460553|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
94456823|NCT02137850|323460554|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
94456824|NCT02137850|323460555|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
94456825|NCT02137850|323460553|FG000|Main Phase: Prophylaxis|Early site closure|0|||
94456826|NCT02137850|323460554|FG001|Main Phase: Prophylaxis|Early site closure|2|||
94456827|NCT02137850|323460555|FG002|Main Phase: Prophylaxis|Early site closure|0|||
94456828|NCT02137850|323460553|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
94456829|NCT02137850|323460554|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
94456830|NCT02137850|323460555|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
94456831|NCT02137850|323460553|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
94456832|NCT02137850|323460554|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
94456833|NCT02137850|323460555|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
94456834|NCT02137850|323460553|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
94456835|NCT02137850|323460554|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
94594024|NCT00966875|323977230|FG003|Part B|Adverse Event|0|||
94594025|NCT00966875|323977231|FG004|Part B|Adverse Event|1|||
94594026|NCT00966875|323977232|FG005|Part B|Adverse Event|0|||
94594027|NCT00966875|323977233|FG006|Part B|Adverse Event|5|||
94594028|NCT00966875|323977234|FG007|Part B|Adverse Event|2|||
94594029|NCT00966875|323977235|FG008|Part B|Adverse Event|2|||
94594030|NCT00966875|323977227|FG000|Part B|Death|0|||
94594031|NCT00966875|323977228|FG001|Part B|Death|0|||
94594032|NCT00966875|323977229|FG002|Part B|Death|1|||
94594033|NCT00966875|323977230|FG003|Part B|Death|0|||
94594034|NCT00966875|323977231|FG004|Part B|Death|0|||
94594035|NCT00966875|323977232|FG005|Part B|Death|0|||
94594036|NCT00966875|323977233|FG006|Part B|Death|0|||
94594037|NCT00966875|323977234|FG007|Part B|Death|1|||
94594038|NCT00966875|323977235|FG008|Part B|Death|0|||
94594039|NCT00966875|323977227|FG000|Part B|Lack of Efficacy|2|||
94355478|NCT00151775|323083564|FG002|Period 4: Open Label|Lost to Follow-up|0|||
94355479|NCT00151775|323083565|FG003|Period 4: Open Label|Lost to Follow-up|0|||
94355480|NCT00151775|323083566|FG004|Period 4: Open Label|Lost to Follow-up|17|||
94355481|NCT00151775|323083567|FG005|Period 4: Open Label|Lost to Follow-up|0|||
94355482|NCT00151775|323083568|FG006|Period 4: Open Label|Lost to Follow-up|0|||
94355483|NCT00151775|323083569|FG007|Period 4: Open Label|Lost to Follow-up|0|||
94355484|NCT00151775|323083570|FG008|Period 4: Open Label|Lost to Follow-up|0|||
94355485|NCT00151775|323083571|FG009|Period 4: Open Label|Lost to Follow-up|7|||
94355486|NCT00151775|323083572|FG010|Period 4: Open Label|Lost to Follow-up|0|||
94355487|NCT00151775|323083573|FG011|Period 4: Open Label|Lost to Follow-up|0|||
94355488|NCT00151775|323083562|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
94355489|NCT00151775|323083563|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
94355490|NCT00151775|323083564|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
94355491|NCT00151775|323083565|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
94355492|NCT00151775|323083566|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
94355493|NCT00151775|323083567|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
94246375|NCT00316602|322697004|FG001|Overall Study|Other|6|||
94246376|NCT03828747|322697006|FG000|Double-Blind Treatment Period|Adverse Event|6|||
94246377|NCT03828747|322697007|FG001|Double-Blind Treatment Period|Adverse Event|6|||
94246378|NCT03828747|322697006|FG000|Double-Blind Treatment Period|Death|1|||
94246379|NCT03828747|322697007|FG001|Double-Blind Treatment Period|Death|1|||
94246380|NCT03828747|322697006|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
94246381|NCT03828747|322697007|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
94246382|NCT03828747|322697006|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
94246383|NCT03828747|322697007|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
94246384|NCT03828747|322697006|FG000|Double-Blind Treatment Period|Physician Decision|1|||
94246385|NCT03828747|322697007|FG001|Double-Blind Treatment Period|Physician Decision|4|||
94246386|NCT03828747|322697006|FG000|Double-Blind Treatment Period|Various reasons|5|||
94246387|NCT03828747|322697007|FG001|Double-Blind Treatment Period|Various reasons|3|||
94246388|NCT03828747|322697006|FG000|Open-Label Extension|Adverse Event|9|||
94246389|NCT03828747|322697007|FG001|Open-Label Extension|Adverse Event|7|||
94246390|NCT03828747|322697006|FG000|Open-Label Extension|Death|0|||
94246391|NCT03828747|322697007|FG001|Open-Label Extension|Death|2|||
94246392|NCT03828747|322697006|FG000|Open-Label Extension|Lost to Follow-up|4|||
94246393|NCT03828747|322697007|FG001|Open-Label Extension|Lost to Follow-up|0|||
94246394|NCT03828747|322697006|FG000|Open-Label Extension|Withdrawal by Subject|31|||
94246395|NCT03828747|322697007|FG001|Open-Label Extension|Withdrawal by Subject|30|||
94246396|NCT03828747|322697006|FG000|Open-Label Extension|Various reasons|4|||
94246397|NCT03828747|322697007|FG001|Open-Label Extension|Various reasons|4|||
94246398|NCT03828747|322697006|FG000|Open-Label Extension|Physician Decision|6|||
94246399|NCT03828747|322697007|FG001|Open-Label Extension|Physician Decision|2|||
94246400|NCT03245151|322697008|FG000|Overall Study|Withdrawal by Subject|2|||
94246401|NCT03245151|322697009|FG001|Overall Study|Withdrawal by Subject|0|||
94246402|NCT03245151|322697010|FG002|Overall Study|Withdrawal by Subject|0|||
94246403|NCT03245151|322697011|FG003|Overall Study|Withdrawal by Subject|2|||
94246404|NCT03245151|322697012|FG004|Overall Study|Withdrawal by Subject|1|||
94456836|NCT02137850|323460555|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
94456837|NCT02137850|323460553|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
94456838|NCT02137850|323460554|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
94456839|NCT02137850|323460555|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
94456840|NCT02137850|323460553|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
94456841|NCT02137850|323460554|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
94456842|NCT02137850|323460555|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
94456843|NCT02137850|323460553|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
94456844|NCT02137850|323460554|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
94456845|NCT02137850|323460555|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
94456846|NCT02137850|323460553|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
94456847|NCT02137850|323460554|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
94456848|NCT02137850|323460555|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
94456849|NCT02137850|323460553|FG000|Extension Phase: Prophylaxis|Other|0|||
94456850|NCT02137850|323460554|FG001|Extension Phase: Prophylaxis|Other|1|||
94456851|NCT02137850|323460555|FG002|Extension Phase: Prophylaxis|Other|0|||
94456852|NCT02137850|323460553|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
94456853|NCT02137850|323460554|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
94456854|NCT02137850|323460555|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
94456855|NCT00537316|323460556|FG000|Part 1|Adverse Event|7|||
94456856|NCT00537316|323460557|FG001|Part 1|Adverse Event|11|||
94456857|NCT00537316|323460558|FG002|Part 1|Adverse Event|8|||
94456858|NCT00537316|323460559|FG003|Part 1|Adverse Event|0|||
94456859|NCT00537316|323460560|FG004|Part 1|Adverse Event|0|||
94456860|NCT00537316|323460561|FG005|Part 1|Adverse Event|0|||
94456861|NCT00537316|323460562|FG006|Part 1|Adverse Event|0|||
94456862|NCT00537316|323460556|FG000|Part 1|Protocol defined clinical event|1|||
94456863|NCT00537316|323460557|FG001|Part 1|Protocol defined clinical event|0|||
94456864|NCT00537316|323460558|FG002|Part 1|Protocol defined clinical event|0|||
94456865|NCT00537316|323460559|FG003|Part 1|Protocol defined clinical event|0|||
94456866|NCT00537316|323460560|FG004|Part 1|Protocol defined clinical event|0|||
94594040|NCT00966875|323977228|FG001|Part B|Lack of Efficacy|1|||
94246405|NCT03245151|322697008|FG000|Overall Study|Death|3|||
94246406|NCT03245151|322697009|FG001|Overall Study|Death|14|||
94246407|NCT03245151|322697010|FG002|Overall Study|Death|9|||
94246408|NCT03245151|322697011|FG003|Overall Study|Death|16|||
94456867|NCT00537316|323460561|FG005|Part 1|Protocol defined clinical event|0|||
94456868|NCT00537316|323460562|FG006|Part 1|Protocol defined clinical event|0|||
94456869|NCT00537316|323460556|FG000|Part 1|Lost to Follow-up|1|||
94594041|NCT00966875|323977229|FG002|Part B|Lack of Efficacy|1|||
94246409|NCT03245151|322697012|FG004|Overall Study|Death|7|||
94246410|NCT03245151|322697008|FG000|Overall Study|Sponsor's decision|0|||
94246411|NCT03245151|322697009|FG001|Overall Study|Sponsor's decision|1|||
94246412|NCT03245151|322697010|FG002|Overall Study|Sponsor's decision|0|||
94246413|NCT03245151|322697011|FG003|Overall Study|Sponsor's decision|0|||
94246414|NCT03245151|322697012|FG004|Overall Study|Sponsor's decision|0|||
94246415|NCT03900416|322697013|FG000|Six Week Follow-up|Lost to Follow-up|1|||
94246416|NCT03900416|322697014|FG001|Six Week Follow-up|Lost to Follow-up|0|||
94246417|NCT03900416|322697013|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
94246418|NCT03900416|322697014|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
94456870|NCT00537316|323460557|FG001|Part 1|Lost to Follow-up|0|||
94456871|NCT00537316|323460558|FG002|Part 1|Lost to Follow-up|0|||
94456872|NCT00537316|323460559|FG003|Part 1|Lost to Follow-up|0|||
94456873|NCT00537316|323460560|FG004|Part 1|Lost to Follow-up|0|||
94456874|NCT00537316|323460561|FG005|Part 1|Lost to Follow-up|0|||
94456875|NCT00537316|323460562|FG006|Part 1|Lost to Follow-up|0|||
94456876|NCT00537316|323460556|FG000|Part 1|Withdrawal by Subject|3|||
94456877|NCT00537316|323460557|FG001|Part 1|Withdrawal by Subject|8|||
94456878|NCT00537316|323460558|FG002|Part 1|Withdrawal by Subject|4|||
94456879|NCT00537316|323460559|FG003|Part 1|Withdrawal by Subject|0|||
94456880|NCT00537316|323460560|FG004|Part 1|Withdrawal by Subject|0|||
94456881|NCT00537316|323460561|FG005|Part 1|Withdrawal by Subject|0|||
94456882|NCT00537316|323460562|FG006|Part 1|Withdrawal by Subject|0|||
94456883|NCT00537316|323460556|FG000|Part 1|Protocol Violation|1|||
94456884|NCT00537316|323460557|FG001|Part 1|Protocol Violation|5|||
94456885|NCT00537316|323460558|FG002|Part 1|Protocol Violation|1|||
94456886|NCT00537316|323460559|FG003|Part 1|Protocol Violation|0|||
94456887|NCT00537316|323460560|FG004|Part 1|Protocol Violation|0|||
94456888|NCT00537316|323460561|FG005|Part 1|Protocol Violation|0|||
94456889|NCT00537316|323460562|FG006|Part 1|Protocol Violation|0|||
94456890|NCT00537316|323460556|FG000|Part 1|Did not meet protocol eligibility|1|||
94456891|NCT00537316|323460557|FG001|Part 1|Did not meet protocol eligibility|3|||
94456892|NCT00537316|323460558|FG002|Part 1|Did not meet protocol eligibility|2|||
94456893|NCT00537316|323460559|FG003|Part 1|Did not meet protocol eligibility|0|||
94456894|NCT00537316|323460560|FG004|Part 1|Did not meet protocol eligibility|0|||
94456895|NCT00537316|323460561|FG005|Part 1|Did not meet protocol eligibility|0|||
94456896|NCT00537316|323460562|FG006|Part 1|Did not meet protocol eligibility|0|||
94456897|NCT00537316|323460556|FG000|Part 1|Administrative|0|||
94456898|NCT00537316|323460557|FG001|Part 1|Administrative|0|||
94456899|NCT00537316|323460558|FG002|Part 1|Administrative|2|||
94456900|NCT00537316|323460559|FG003|Part 1|Administrative|0|||
94456901|NCT00537316|323460560|FG004|Part 1|Administrative|0|||
94456902|NCT00537316|323460561|FG005|Part 1|Administrative|0|||
94456903|NCT00537316|323460562|FG006|Part 1|Administrative|0|||
94456904|NCT00537316|323460556|FG000|Part 2|Never entered follow-up|0|||
94456905|NCT00537316|323460557|FG001|Part 2|Never entered follow-up|0|||
94456906|NCT00537316|323460558|FG002|Part 2|Never entered follow-up|0|||
94456907|NCT00537316|323460559|FG003|Part 2|Never entered follow-up|0|||
94456908|NCT00537316|323460560|FG004|Part 2|Never entered follow-up|0|||
94456909|NCT00537316|323460561|FG005|Part 2|Never entered follow-up|0|||
94456910|NCT00537316|323460562|FG006|Part 2|Never entered follow-up|1|||
94456911|NCT00537316|323460556|FG000|Part 2|Adverse Event|4|||
94456912|NCT00537316|323460557|FG001|Part 2|Adverse Event|0|||
94456913|NCT00537316|323460558|FG002|Part 2|Adverse Event|2|||
94456914|NCT00537316|323460559|FG003|Part 2|Adverse Event|0|||
94456915|NCT00537316|323460560|FG004|Part 2|Adverse Event|0|||
94456916|NCT00537316|323460561|FG005|Part 2|Adverse Event|0|||
94456917|NCT00537316|323460562|FG006|Part 2|Adverse Event|0|||
94456918|NCT00537316|323460556|FG000|Part 2|Lost to Follow-up|1|||
94456919|NCT00537316|323460557|FG001|Part 2|Lost to Follow-up|0|||
94456920|NCT00537316|323460558|FG002|Part 2|Lost to Follow-up|2|||
94456921|NCT00537316|323460559|FG003|Part 2|Lost to Follow-up|0|||
94456922|NCT00537316|323460560|FG004|Part 2|Lost to Follow-up|0|||
94456923|NCT00537316|323460561|FG005|Part 2|Lost to Follow-up|0|||
94456924|NCT00537316|323460562|FG006|Part 2|Lost to Follow-up|0|||
94456925|NCT00537316|323460556|FG000|Part 2|Withdrawal by Subject|5|||
94456926|NCT00537316|323460557|FG001|Part 2|Withdrawal by Subject|1|||
94246419|NCT03900416|322697013|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
94456927|NCT00537316|323460558|FG002|Part 2|Withdrawal by Subject|4|||
94456928|NCT00537316|323460559|FG003|Part 2|Withdrawal by Subject|0|||
94246420|NCT03900416|322697014|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
94246421|NCT03900416|322697013|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
94456929|NCT00537316|323460560|FG004|Part 2|Withdrawal by Subject|0|||
94456930|NCT00537316|323460561|FG005|Part 2|Withdrawal by Subject|0|||
94456931|NCT00537316|323460562|FG006|Part 2|Withdrawal by Subject|0|||
94456932|NCT00537316|323460556|FG000|Part 2|Administrative|16|||
94456933|NCT00537316|323460557|FG001|Part 2|Administrative|8|||
94456934|NCT00537316|323460558|FG002|Part 2|Administrative|24|||
94456935|NCT00537316|323460559|FG003|Part 2|Administrative|3|||
94456936|NCT00537316|323460560|FG004|Part 2|Administrative|1|||
94456937|NCT00537316|323460561|FG005|Part 2|Administrative|4|||
94456938|NCT00537316|323460562|FG006|Part 2|Administrative|1|||
94246422|NCT03900416|322697014|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
94456939|NCT02651155|323460563|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
94456940|NCT02651155|323460564|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
94456941|NCT02651155|323460563|FG000|Overall Study|Voluntary Withdrawal|5|||
94456942|NCT02651155|323460564|FG001|Overall Study|Voluntary Withdrawal|0|||
94456943|NCT01867710|323460568|FG000|Overall Study|Death|25|||
94456944|NCT01867710|323460569|FG001|Overall Study|Death|15|||
94456945|NCT01867710|323460570|FG002|Overall Study|Death|27|||
94456946|NCT01867710|323460571|FG003|Overall Study|Death|20|||
94456947|NCT01867710|323460568|FG000|Overall Study|Lost to Follow-up|3|||
94456948|NCT01867710|323460569|FG001|Overall Study|Lost to Follow-up|4|||
94456949|NCT01867710|323460570|FG002|Overall Study|Lost to Follow-up|3|||
94456950|NCT01867710|323460571|FG003|Overall Study|Lost to Follow-up|2|||
94456951|NCT01867710|323460568|FG000|Overall Study|Withdrawal of consent|2|||
94456952|NCT01867710|323460569|FG001|Overall Study|Withdrawal of consent|5|||
94456953|NCT01867710|323460570|FG002|Overall Study|Withdrawal of consent|1|||
94456954|NCT01867710|323460571|FG003|Overall Study|Withdrawal of consent|2|||
94456955|NCT01867710|323460568|FG000|Overall Study|Study Terminated by Sponsor|9|||
94456956|NCT01867710|323460569|FG001|Overall Study|Study Terminated by Sponsor|13|||
94456957|NCT01867710|323460570|FG002|Overall Study|Study Terminated by Sponsor|8|||
94456958|NCT01867710|323460571|FG003|Overall Study|Study Terminated by Sponsor|16|||
94456959|NCT01867710|323460568|FG000|Overall Study|Biochemical progression|0|||
94456960|NCT01867710|323460569|FG001|Overall Study|Biochemical progression|1|||
94456961|NCT01867710|323460570|FG002|Overall Study|Biochemical progression|0|||
94456962|NCT01867710|323460571|FG003|Overall Study|Biochemical progression|0|||
94456963|NCT01867710|323460568|FG000|Overall Study|Clinical progression|0|||
94456964|NCT01867710|323460569|FG001|Overall Study|Clinical progression|0|||
94456965|NCT01867710|323460570|FG002|Overall Study|Clinical progression|1|||
94456966|NCT01867710|323460571|FG003|Overall Study|Clinical progression|0|||
94456967|NCT01867710|323460568|FG000|Overall Study|Disease progression|1|||
94456968|NCT01867710|323460569|FG001|Overall Study|Disease progression|0|||
94456969|NCT01867710|323460570|FG002|Overall Study|Disease progression|0|||
94456970|NCT01867710|323460571|FG003|Overall Study|Disease progression|0|||
94456971|NCT01867710|323460568|FG000|Overall Study|Patient decision|0|||
94456972|NCT01867710|323460569|FG001|Overall Study|Patient decision|0|||
94456973|NCT01867710|323460570|FG002|Overall Study|Patient decision|0|||
94456974|NCT01867710|323460571|FG003|Overall Study|Patient decision|1|||
94456975|NCT01867710|323460568|FG000|Overall Study|Patient to follow subsequent treatment|0|||
94456976|NCT01867710|323460569|FG001|Overall Study|Patient to follow subsequent treatment|1|||
94456977|NCT01867710|323460570|FG002|Overall Study|Patient to follow subsequent treatment|0|||
94456978|NCT01867710|323460571|FG003|Overall Study|Patient to follow subsequent treatment|0|||
94456979|NCT01867710|323460568|FG000|Overall Study|Progressive disease|1|||
94456980|NCT01867710|323460569|FG001|Overall Study|Progressive disease|0|||
94456981|NCT01867710|323460570|FG002|Overall Study|Progressive disease|0|||
94456982|NCT01867710|323460571|FG003|Overall Study|Progressive disease|0|||
94456983|NCT01867710|323460568|FG000|Overall Study|Protocol Violation|0|||
94456984|NCT01867710|323460569|FG001|Overall Study|Protocol Violation|0|||
94456985|NCT01867710|323460570|FG002|Overall Study|Protocol Violation|0|||
94456986|NCT01867710|323460571|FG003|Overall Study|Protocol Violation|1|||
94456987|NCT01867710|323460568|FG000|Overall Study|PSA-progression|0|||
94456988|NCT01867710|323460569|FG001|Overall Study|PSA-progression|1|||
94456989|NCT01867710|323460570|FG002|Overall Study|PSA-progression|0|||
94456990|NCT01867710|323460571|FG003|Overall Study|PSA-progression|0|||
94456991|NCT01867710|323460568|FG000|Overall Study|Study medication no longer effective|0|||
94456992|NCT01867710|323460569|FG001|Overall Study|Study medication no longer effective|1|||
94456993|NCT01867710|323460570|FG002|Overall Study|Study medication no longer effective|0|||
94456994|NCT01867710|323460571|FG003|Overall Study|Study medication no longer effective|0|||
94456995|NCT04533412|323460575|FG000|Overall Study|Withdrawal by Subject|1|||
94456996|NCT04533412|323460576|FG001|Overall Study|Withdrawal by Subject|1|||
94456997|NCT04533412|323460575|FG000|Overall Study|Lost to Follow-up|1|||
94456998|NCT04533412|323460576|FG001|Overall Study|Lost to Follow-up|4|||
94456999|NCT05113979|323460577|FG000|Overall Study|Death|2|||
94457000|NCT05113979|323460577|FG000|Overall Study|Lost to Follow-up|1|||
94457001|NCT01489254|323460582|FG000|Double-blind Part|Adverse Event|7|||
94457002|NCT01489254|323460583|FG001|Double-blind Part|Adverse Event|2|||
94457003|NCT01489254|323460584|FG002|Double-blind Part|Adverse Event|2|||
94457004|NCT01489254|323460585|FG003|Double-blind Part|Adverse Event|0|||
94457005|NCT01489254|323460582|FG000|Double-blind Part|Pregnancy|1|||
94457006|NCT01489254|323460583|FG001|Double-blind Part|Pregnancy|3|||
94457007|NCT01489254|323460584|FG002|Double-blind Part|Pregnancy|0|||
94457008|NCT01489254|323460585|FG003|Double-blind Part|Pregnancy|0|||
94457009|NCT01489254|323460582|FG000|Double-blind Part|Withdrawal by Subject|12|||
94457010|NCT01489254|323460583|FG001|Double-blind Part|Withdrawal by Subject|20|||
94457011|NCT01489254|323460584|FG002|Double-blind Part|Withdrawal by Subject|1|||
94457012|NCT01489254|323460585|FG003|Double-blind Part|Withdrawal by Subject|0|||
94457013|NCT01489254|323460582|FG000|Double-blind Part|Lost to Follow-up|1|||
94457014|NCT01489254|323460583|FG001|Double-blind Part|Lost to Follow-up|2|||
94457015|NCT01489254|323460584|FG002|Double-blind Part|Lost to Follow-up|0|||
94457016|NCT01489254|323460585|FG003|Double-blind Part|Lost to Follow-up|0|||
94457017|NCT01489254|323460582|FG000|Double-blind Part|Other reasons for not completing study|4|||
94457018|NCT01489254|323460583|FG001|Double-blind Part|Other reasons for not completing study|6|||
94457019|NCT01489254|323460584|FG002|Double-blind Part|Other reasons for not completing study|0|||
94457020|NCT01489254|323460585|FG003|Double-blind Part|Other reasons for not completing study|0|||
94457021|NCT01489254|323460582|FG000|Open-label Extension Part|Adverse Event|0|||
94457022|NCT01489254|323460583|FG001|Open-label Extension Part|Adverse Event|0|||
94457023|NCT01489254|323460584|FG002|Open-label Extension Part|Adverse Event|0|||
94457024|NCT01489254|323460585|FG003|Open-label Extension Part|Adverse Event|10|||
94457025|NCT01489254|323460582|FG000|Open-label Extension Part|Pregnancy|0|||
94457026|NCT01489254|323460583|FG001|Open-label Extension Part|Pregnancy|0|||
94457027|NCT01489254|323460584|FG002|Open-label Extension Part|Pregnancy|0|||
94457028|NCT01489254|323460585|FG003|Open-label Extension Part|Pregnancy|3|||
94457029|NCT01489254|323460582|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
94457030|NCT01489254|323460583|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
94457031|NCT01489254|323460584|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
94457032|NCT01489254|323460585|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
94457033|NCT01489254|323460582|FG000|Open-label Extension Part|Protocol Violation|0|||
94457034|NCT01489254|323460583|FG001|Open-label Extension Part|Protocol Violation|0|||
94457035|NCT01489254|323460584|FG002|Open-label Extension Part|Protocol Violation|0|||
94457036|NCT01489254|323460585|FG003|Open-label Extension Part|Protocol Violation|1|||
94457037|NCT01489254|323460582|FG000|Open-label Extension Part|Lost to Follow-up|0|||
94457038|NCT01489254|323460583|FG001|Open-label Extension Part|Lost to Follow-up|0|||
94457039|NCT01489254|323460584|FG002|Open-label Extension Part|Lost to Follow-up|0|||
94457040|NCT01489254|323460585|FG003|Open-label Extension Part|Lost to Follow-up|9|||
94457041|NCT01489254|323460582|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
94457042|NCT01489254|323460583|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
94457043|NCT01489254|323460584|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
94457044|NCT01489254|323460585|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
94457045|NCT03843541|323460589|FG000|Overall Study|Adverse Event|4|||
94246423|NCT03900416|322697013|FG000|Twelve Week Follow-up|Adverse Event|1|||
94246424|NCT03900416|322697014|FG001|Twelve Week Follow-up|Adverse Event|1|||
94246425|NCT03900416|322697013|FG000|Six Month Follow-up|Lost to Follow-up|4|||
94246426|NCT03900416|322697014|FG001|Six Month Follow-up|Lost to Follow-up|3|||
94246427|NCT03900416|322697013|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
94246428|NCT03900416|322697014|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
94246429|NCT03446781|322697015|FG000|Overall Study|Lost to Follow-up|11|||
94246430|NCT03446781|322697016|FG001|Overall Study|Lost to Follow-up|5|||
94246431|NCT03446781|322697015|FG000|Overall Study|Withdrawal by Subject|9|||
94246432|NCT03446781|322697016|FG001|Overall Study|Withdrawal by Subject|7|||
94246433|NCT03446781|322697015|FG000|Overall Study|Adverse Event|8|||
94246434|NCT03446781|322697016|FG001|Overall Study|Adverse Event|2|||
94246435|NCT03446781|322697015|FG000|Overall Study|Protocol Violation|0|||
94246436|NCT03446781|322697016|FG001|Overall Study|Protocol Violation|3|||
94246437|NCT02040584|322697017|FG000|Overall Study|Adverse Event|13|||
94246438|NCT02040584|322697018|FG001|Overall Study|Adverse Event|6|||
94246439|NCT02040584|322697017|FG000|Overall Study|Protocol Violation|9|||
94246440|NCT02040584|322697018|FG001|Overall Study|Protocol Violation|11|||
94246441|NCT02040584|322697017|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94246442|NCT02040584|322697018|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
94246443|NCT02040584|322697017|FG000|Overall Study|Death|6|||
94246444|NCT02040584|322697018|FG001|Overall Study|Death|3|||
94246445|NCT02040584|322697017|FG000|Overall Study|Transplant rejection/retransplant|0|||
94246446|NCT02040584|322697018|FG001|Overall Study|Transplant rejection/retransplant|1|||
94246447|NCT02040584|322697017|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
94355494|NCT00151775|323083568|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
94355495|NCT00151775|323083569|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
94355496|NCT00151775|323083570|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
94355497|NCT00151775|323083571|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
94355498|NCT00151775|323083572|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
94355499|NCT00151775|323083573|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
94355500|NCT00151775|323083562|FG000|Period 4: Open Label|Other|0|||
94355501|NCT00151775|323083563|FG001|Period 4: Open Label|Other|0|||
94355502|NCT00151775|323083564|FG002|Period 4: Open Label|Other|0|||
94355503|NCT00151775|323083565|FG003|Period 4: Open Label|Other|0|||
94355504|NCT00151775|323083566|FG004|Period 4: Open Label|Other|1|||
94355505|NCT00151775|323083567|FG005|Period 4: Open Label|Other|0|||
94355506|NCT00151775|323083568|FG006|Period 4: Open Label|Other|0|||
94355507|NCT00151775|323083569|FG007|Period 4: Open Label|Other|0|||
94355508|NCT00151775|323083570|FG008|Period 4: Open Label|Other|0|||
94355509|NCT00151775|323083571|FG009|Period 4: Open Label|Other|3|||
94355510|NCT00151775|323083572|FG010|Period 4: Open Label|Other|0|||
94355511|NCT00151775|323083573|FG011|Period 4: Open Label|Other|0|||
94355512|NCT00151775|323083562|FG000|Period 4: Open Label|Physician Decision|0|||
94355513|NCT00151775|323083563|FG001|Period 4: Open Label|Physician Decision|0|||
94355514|NCT00151775|323083564|FG002|Period 4: Open Label|Physician Decision|0|||
94355515|NCT00151775|323083565|FG003|Period 4: Open Label|Physician Decision|0|||
94355516|NCT00151775|323083566|FG004|Period 4: Open Label|Physician Decision|0|||
94355517|NCT00151775|323083567|FG005|Period 4: Open Label|Physician Decision|0|||
94355518|NCT00151775|323083568|FG006|Period 4: Open Label|Physician Decision|0|||
94355519|NCT00151775|323083569|FG007|Period 4: Open Label|Physician Decision|0|||
94355520|NCT00151775|323083570|FG008|Period 4: Open Label|Physician Decision|0|||
94355521|NCT00151775|323083571|FG009|Period 4: Open Label|Physician Decision|2|||
94355522|NCT00151775|323083572|FG010|Period 4: Open Label|Physician Decision|0|||
94355523|NCT00151775|323083573|FG011|Period 4: Open Label|Physician Decision|0|||
94355524|NCT00151775|323083562|FG000|Period 4: Open Label|Protocol Violation|0|||
94355525|NCT00151775|323083563|FG001|Period 4: Open Label|Protocol Violation|0|||
94355526|NCT00151775|323083564|FG002|Period 4: Open Label|Protocol Violation|0|||
94355527|NCT00151775|323083565|FG003|Period 4: Open Label|Protocol Violation|0|||
94355528|NCT00151775|323083566|FG004|Period 4: Open Label|Protocol Violation|1|||
94355529|NCT00151775|323083567|FG005|Period 4: Open Label|Protocol Violation|0|||
94355530|NCT00151775|323083568|FG006|Period 4: Open Label|Protocol Violation|0|||
94660107|NCT02536508|324210026|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
94660108|NCT02536508|324210024|FG000|Overall Study|Physician Decision|0|||
94246448|NCT02040584|322697018|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
94246449|NCT00309959|322697019|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
94355531|NCT00151775|323083569|FG007|Period 4: Open Label|Protocol Violation|0|||
94355532|NCT00151775|323083570|FG008|Period 4: Open Label|Protocol Violation|0|||
94355533|NCT00151775|323083571|FG009|Period 4: Open Label|Protocol Violation|0|||
94355534|NCT00151775|323083572|FG010|Period 4: Open Label|Protocol Violation|0|||
94355535|NCT00151775|323083573|FG011|Period 4: Open Label|Protocol Violation|0|||
94457046|NCT03843541|323460590|FG001|Overall Study|Adverse Event|2|||
94660109|NCT02536508|324210025|FG001|Overall Study|Physician Decision|4|||
94246450|NCT00400725|322697020|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
94246451|NCT00400725|322697021|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
94246452|NCT00400725|322697022|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
94457047|NCT03843541|323460591|FG002|Overall Study|Adverse Event|3|||
94457048|NCT03843541|323460589|FG000|Overall Study|Death|1|||
94457049|NCT03843541|323460590|FG001|Overall Study|Death|0|||
94457050|NCT03843541|323460591|FG002|Overall Study|Death|0|||
94457051|NCT03843541|323460589|FG000|Overall Study|Lack of adherence to study medication|0|||
94457052|NCT03843541|323460590|FG001|Overall Study|Lack of adherence to study medication|0|||
94457053|NCT03843541|323460591|FG002|Overall Study|Lack of adherence to study medication|1|||
94457054|NCT03843541|323460589|FG000|Overall Study|Physician Decision|1|||
94457055|NCT03843541|323460590|FG001|Overall Study|Physician Decision|2|||
94457056|NCT03843541|323460591|FG002|Overall Study|Physician Decision|2|||
94457057|NCT03843541|323460589|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
94457058|NCT03843541|323460590|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
94457059|NCT03843541|323460591|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
94457060|NCT03843541|323460589|FG000|Overall Study|Withdrawal by Subject|6|||
94457061|NCT03843541|323460590|FG001|Overall Study|Withdrawal by Subject|9|||
94457062|NCT03843541|323460591|FG002|Overall Study|Withdrawal by Subject|7|||
94457063|NCT03843541|323460589|FG000|Overall Study|Administration of rescue mucolytic|0|||
94660110|NCT02536508|324210026|FG002|Overall Study|Physician Decision|2|||
94660111|NCT02536508|324210024|FG000|Overall Study|Major Protocol Deviation|2|||
94457064|NCT03843541|323460590|FG001|Overall Study|Administration of rescue mucolytic|0|||
94457065|NCT03843541|323460591|FG002|Overall Study|Administration of rescue mucolytic|1|||
94457066|NCT03843541|323460589|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
94457067|NCT03843541|323460590|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
94660112|NCT02536508|324210025|FG001|Overall Study|Major Protocol Deviation|2|||
94457068|NCT03843541|323460591|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
94457069|NCT01254318|323460592|FG000|Overall Study|Lost to Follow-up|5|||
94457070|NCT01254318|323460592|FG000|Overall Study|Death|47|||
94457071|NCT00623935|323460601|FG000|Overall Study|Death|1|||
94457072|NCT00623935|323460601|FG000|Overall Study|Patient Declined Transplant|1|||
94457073|NCT02394340|323460612|FG000|Overall Study|Failed drug screen test|1|||
94457074|NCT02394340|323460612|FG000|Overall Study|Adverse Event|1|||
94457075|NCT00256854|323460613|FG000|Overall Study|Withdrawal by Subject|2|||
94457076|NCT00256854|323460614|FG001|Overall Study|Withdrawal by Subject|3|||
94457077|NCT00256854|323460615|FG002|Overall Study|Withdrawal by Subject|0|||
94457078|NCT00256854|323460616|FG003|Overall Study|Withdrawal by Subject|0|||
94457079|NCT00256854|323460617|FG004|Overall Study|Withdrawal by Subject|0|||
94457080|NCT00256854|323460618|FG005|Overall Study|Withdrawal by Subject|0|||
94457081|NCT00256854|323460613|FG000|Overall Study|Lack of Efficacy|1|||
94457082|NCT00256854|323460614|FG001|Overall Study|Lack of Efficacy|0|||
94457083|NCT00256854|323460615|FG002|Overall Study|Lack of Efficacy|0|||
94457084|NCT00256854|323460616|FG003|Overall Study|Lack of Efficacy|0|||
94457085|NCT00256854|323460617|FG004|Overall Study|Lack of Efficacy|0|||
94457086|NCT00256854|323460618|FG005|Overall Study|Lack of Efficacy|0|||
94457087|NCT00256854|323460613|FG000|Overall Study|Protocol Violation|0|||
94457088|NCT00256854|323460614|FG001|Overall Study|Protocol Violation|1|||
94457089|NCT00256854|323460615|FG002|Overall Study|Protocol Violation|1|||
94457090|NCT00256854|323460616|FG003|Overall Study|Protocol Violation|1|||
94457091|NCT00256854|323460617|FG004|Overall Study|Protocol Violation|0|||
94457092|NCT00256854|323460618|FG005|Overall Study|Protocol Violation|0|||
94457093|NCT00256854|323460613|FG000|Overall Study|Adverse Event|0|||
94457094|NCT00256854|323460614|FG001|Overall Study|Adverse Event|0|||
94457095|NCT00256854|323460615|FG002|Overall Study|Adverse Event|2|||
94457096|NCT00256854|323460616|FG003|Overall Study|Adverse Event|2|||
94457097|NCT00256854|323460617|FG004|Overall Study|Adverse Event|0|||
94457098|NCT00256854|323460618|FG005|Overall Study|Adverse Event|1|||
94457099|NCT00256854|323460613|FG000|Overall Study|Not compliant with the study drug|0|||
94457100|NCT00256854|323460614|FG001|Overall Study|Not compliant with the study drug|0|||
94457101|NCT00256854|323460615|FG002|Overall Study|Not compliant with the study drug|0|||
94457102|NCT00256854|323460616|FG003|Overall Study|Not compliant with the study drug|0|||
94457103|NCT00256854|323460617|FG004|Overall Study|Not compliant with the study drug|1|||
94457104|NCT00256854|323460618|FG005|Overall Study|Not compliant with the study drug|0|||
94457105|NCT03990571|323460619|FG000|Overall Study|Withdrawal by Subject|1|||
94660113|NCT02536508|324210026|FG002|Overall Study|Major Protocol Deviation|2|||
94457106|NCT03990571|323460619|FG000|Overall Study|Insurance Issues|3|||
94660114|NCT02536508|324210024|FG000|Overall Study|Administrative Reasons|0|||
94660115|NCT02536508|324210025|FG001|Overall Study|Administrative Reasons|1|||
94660116|NCT02536508|324210026|FG002|Overall Study|Administrative Reasons|0|||
94660117|NCT00941603|324210027|FG000|Overall Study|Adverse Event|10|||
94660118|NCT00941603|324210028|FG001|Overall Study|Adverse Event|15|||
94660119|NCT00941603|324210029|FG002|Overall Study|Adverse Event|5|||
94660120|NCT00941603|324210030|FG003|Overall Study|Adverse Event|1|||
94660121|NCT00941603|324210031|FG004|Overall Study|Adverse Event|4|||
94660122|NCT00941603|324210032|FG005|Overall Study|Adverse Event|0|||
94660123|NCT00941603|324210027|FG000|Overall Study|Lost to Follow-up|0|||
94660124|NCT00941603|324210028|FG001|Overall Study|Lost to Follow-up|0|||
94660125|NCT00941603|324210029|FG002|Overall Study|Lost to Follow-up|0|||
94660126|NCT00941603|324210030|FG003|Overall Study|Lost to Follow-up|1|||
94660127|NCT00941603|324210031|FG004|Overall Study|Lost to Follow-up|0|||
94660128|NCT00941603|324210032|FG005|Overall Study|Lost to Follow-up|2|||
94660129|NCT00941603|324210027|FG000|Overall Study|Withdrawal by Subject|0|||
94660130|NCT00941603|324210028|FG001|Overall Study|Withdrawal by Subject|0|||
94660131|NCT00941603|324210029|FG002|Overall Study|Withdrawal by Subject|0|||
94660132|NCT00941603|324210030|FG003|Overall Study|Withdrawal by Subject|2|||
94660133|NCT00941603|324210031|FG004|Overall Study|Withdrawal by Subject|0|||
94660134|NCT00941603|324210032|FG005|Overall Study|Withdrawal by Subject|1|||
94660135|NCT00941603|324210027|FG000|Overall Study|Protocol Violation|0|||
94457107|NCT03990571|323460619|FG000|Overall Study|Covid Restrictions|2|||
94660136|NCT00941603|324210028|FG001|Overall Study|Protocol Violation|1|||
94660137|NCT00941603|324210029|FG002|Overall Study|Protocol Violation|0|||
94660138|NCT00941603|324210030|FG003|Overall Study|Protocol Violation|0|||
94660139|NCT00941603|324210031|FG004|Overall Study|Protocol Violation|0|||
94660140|NCT00941603|324210032|FG005|Overall Study|Protocol Violation|0|||
94660141|NCT00941603|324210027|FG000|Overall Study|Did not meet protocol eligibility|1|||
94457108|NCT01075646|323460620|FG000|Overall Study|Lost to Follow-up|4|||
94457109|NCT01075646|323460621|FG001|Overall Study|Lost to Follow-up|3|||
94457110|NCT01075646|323460622|FG002|Overall Study|Lost to Follow-up|1|||
94457111|NCT01075646|323460623|FG003|Overall Study|Lost to Follow-up|2|||
94457112|NCT01730534|323460624|FG000|Overall Study|Withdrawal by Subject|97|||
94457113|NCT01730534|323460625|FG001|Overall Study|Withdrawal by Subject|127|||
94457114|NCT01730534|323460624|FG000|Overall Study|Lost to Follow-up|12|||
94457115|NCT01730534|323460625|FG001|Overall Study|Lost to Follow-up|18|||
94660142|NCT00941603|324210028|FG001|Overall Study|Did not meet protocol eligibility|0|||
94246453|NCT00400725|322697020|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
94246454|NCT00400725|322697021|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
94246455|NCT00400725|322697022|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
94246456|NCT00400725|322697020|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
94246457|NCT00400725|322697021|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
94246458|NCT00400725|322697022|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
94246459|NCT00400725|322697020|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
94246460|NCT00400725|322697021|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
94246461|NCT00400725|322697022|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
94246462|NCT00400725|322697020|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
94246463|NCT00400725|322697021|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
94246464|NCT00400725|322697022|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
94246465|NCT00400725|322697020|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
94246466|NCT00400725|322697021|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
94246467|NCT00400725|322697022|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
94246468|NCT00400725|322697020|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
94246469|NCT00400725|322697021|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
94246470|NCT00400725|322697022|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
94246471|NCT00400725|322697020|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
94246472|NCT00400725|322697021|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
94246473|NCT00400725|322697022|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
94246474|NCT00400725|322697020|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
94246475|NCT00400725|322697021|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
94246476|NCT00400725|322697022|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
94246477|NCT04510090|322697023|FG000|FE-HS|Withdrawal by Subject|0|||
94246478|NCT04510090|322697024|FG001|FE-HS|Withdrawal by Subject|0|||
94246479|NCT04510090|322697025|FG002|FE-HS|Withdrawal by Subject|0|||
94246480|NCT04510090|322697026|FG003|FE-HS|Withdrawal by Subject|0|||
94246481|NCT04510090|322697027|FG004|FE-HS|Withdrawal by Subject|1|||
94246482|NCT04510090|322697028|FG005|FE-HS|Withdrawal by Subject|0|||
94246483|NCT04510090|322697029|FG006|FE-HS|Withdrawal by Subject|0|||
94246484|NCT04510090|322697030|FG007|FE-HS|Withdrawal by Subject|0|||
94355536|NCT00772031|323083578|FG000|Overall Study|Early termination of trial|12|||
94355537|NCT00772031|323083579|FG001|Overall Study|Early termination of trial|10|||
94246485|NCT01605019|322697033|FG000|Overall Study|pt did not meet transplant endpoint|3|||
94246486|NCT01605019|322697034|FG001|Overall Study|pt did not meet transplant endpoint|0|||
94355538|NCT00772031|323083578|FG000|Overall Study|Lost to Follow-up|20|||
94355539|NCT00772031|323083579|FG001|Overall Study|Lost to Follow-up|33|||
94355540|NCT02624713|323083580|FG000|Overall Study|Lost to Follow-up|14|||
94355541|NCT02624713|323083581|FG001|Overall Study|Lost to Follow-up|0|||
94355542|NCT00285857|323083582|FG000|Overall Study|Withdrawal by Subject|2|||
94355543|NCT00285857|323083582|FG000|Overall Study|Inadequate initial breast cytology|1|||
94355544|NCT00285857|323083582|FG000|Overall Study|Adverse Event|1|||
94355545|NCT01911546|323083590|FG000|Overall Study|Lost to Follow-up|1|||
94355546|NCT01911546|323083590|FG000|Overall Study|Everolimus was discontinued|5|||
94355547|NCT02210559|323083592|FG000|Overall Study|Progressive Disease|3|||
94355548|NCT02210559|323083593|FG001|Overall Study|Progressive Disease|2|||
94355549|NCT02210559|323083592|FG000|Overall Study|Adverse Event|2|||
94355550|NCT02210559|323083593|FG001|Overall Study|Adverse Event|2|||
94355551|NCT02210559|323083592|FG000|Overall Study|Physician Decision|1|||
94355552|NCT02210559|323083593|FG001|Overall Study|Physician Decision|0|||
94355553|NCT02210559|323083592|FG000|Overall Study|Withdrawal by Subject|0|||
94355554|NCT02210559|323083593|FG001|Overall Study|Withdrawal by Subject|1|||
94355555|NCT02210559|323083592|FG000|Overall Study|Other than specified|0|||
94355556|NCT02210559|323083593|FG001|Overall Study|Other than specified|1|||
94355557|NCT02546193|323083594|FG000|Overall Study|Withdrawal by Subject|2|||
94355558|NCT02546193|323083595|FG001|Overall Study|Withdrawal by Subject|0|||
94355559|NCT02546193|323083596|FG002|Overall Study|Withdrawal by Subject|1|||
94355560|NCT02546193|323083597|FG003|Overall Study|Withdrawal by Subject|0|||
94355561|NCT02546193|323083594|FG000|Overall Study|Not eligible at time of induction|4|||
94355562|NCT02546193|323083595|FG001|Overall Study|Not eligible at time of induction|6|||
94355563|NCT02546193|323083596|FG002|Overall Study|Not eligible at time of induction|1|||
94355564|NCT02546193|323083597|FG003|Overall Study|Not eligible at time of induction|0|||
94355565|NCT01098266|323083605|FG000|Overall Study|Physician Decision|1|||
94355566|NCT01098266|323083606|FG001|Overall Study|Physician Decision|0|||
94355567|NCT01098266|323083605|FG000|Overall Study|Death|3|||
94355568|NCT01098266|323083606|FG001|Overall Study|Death|2|||
94355569|NCT01098266|323083605|FG000|Overall Study|Withdrawal by Subject|3|||
94355570|NCT01098266|323083606|FG001|Overall Study|Withdrawal by Subject|5|||
94355571|NCT01308476|323083607|FG000|Overall Study|Lost to Follow-up|2|||
94355572|NCT01308476|323083608|FG001|Overall Study|Lost to Follow-up|2|||
94355573|NCT01308476|323083607|FG000|Overall Study|Other|1|||
94355574|NCT01308476|323083608|FG001|Overall Study|Other|0|||
94355575|NCT03911401|323083609|FG000|Overall Study|Adverse Event|1|||
94355576|NCT03911401|323083610|FG001|Overall Study|Adverse Event|2|||
94355577|NCT03911401|323083611|FG002|Overall Study|Adverse Event|5|||
94355578|NCT03911401|323083609|FG000|Overall Study|Lack of Efficacy|1|||
94355579|NCT03911401|323083610|FG001|Overall Study|Lack of Efficacy|1|||
94355580|NCT03911401|323083611|FG002|Overall Study|Lack of Efficacy|8|||
94355581|NCT03911401|323083609|FG000|Overall Study|Physician Decision|0|||
94355582|NCT03911401|323083610|FG001|Overall Study|Physician Decision|0|||
94355583|NCT03911401|323083611|FG002|Overall Study|Physician Decision|1|||
94355584|NCT03911401|323083609|FG000|Overall Study|Withdrawal by Subject|1|||
94355585|NCT03911401|323083610|FG001|Overall Study|Withdrawal by Subject|2|||
94355586|NCT03911401|323083611|FG002|Overall Study|Withdrawal by Subject|0|||
94355587|NCT03911401|323083609|FG000|Overall Study|Withdrawal by parent/guardian|4|||
94355588|NCT03911401|323083610|FG001|Overall Study|Withdrawal by parent/guardian|4|||
94355589|NCT03911401|323083611|FG002|Overall Study|Withdrawal by parent/guardian|11|||
94355590|NCT01980056|323083614|FG000|Overall Study|Death|1|||
94355591|NCT01980056|323083615|FG001|Overall Study|Death|1|||
94355592|NCT01980056|323083616|FG002|Overall Study|Death|0|||
94355593|NCT00351611|323083617|FG000|Overall Study|Adverse Event|11|||
94355594|NCT00351611|323083618|FG001|Overall Study|Adverse Event|3|||
94355595|NCT00351611|323083617|FG000|Overall Study|Death|1|||
94355596|NCT00351611|323083618|FG001|Overall Study|Death|0|||
94355597|NCT00351611|323083617|FG000|Overall Study|Lost to Follow-up|1|||
94355598|NCT00351611|323083618|FG001|Overall Study|Lost to Follow-up|0|||
94355599|NCT00351611|323083617|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
94355600|NCT00351611|323083618|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
94355601|NCT00351611|323083617|FG000|Overall Study|Other|1|||
94355602|NCT00351611|323083618|FG001|Overall Study|Other|0|||
94355603|NCT00351611|323083617|FG000|Overall Study|Protocol Violation|0|||
94355604|NCT00351611|323083618|FG001|Overall Study|Protocol Violation|2|||
94355605|NCT02708524|323083624|FG000|Overall Study|Adverse Event|0|||
94355606|NCT02708524|323083625|FG001|Overall Study|Adverse Event|1|||
94355607|NCT02708524|323083626|FG002|Overall Study|Adverse Event|0|||
94355608|NCT02708524|323083627|FG003|Overall Study|Adverse Event|0|||
94355609|NCT02708524|323083624|FG000|Overall Study|Lens Discomfort|1|||
94355610|NCT02708524|323083625|FG001|Overall Study|Lens Discomfort|0|||
94355611|NCT02708524|323083626|FG002|Overall Study|Lens Discomfort|1|||
94355612|NCT02708524|323083627|FG003|Overall Study|Lens Discomfort|0|||
94355613|NCT02708524|323083624|FG000|Overall Study|Lost to Follow-up|1|||
94355614|NCT02708524|323083625|FG001|Overall Study|Lost to Follow-up|1|||
94355615|NCT02708524|323083626|FG002|Overall Study|Lost to Follow-up|1|||
94355616|NCT02708524|323083627|FG003|Overall Study|Lost to Follow-up|0|||
94355617|NCT02708524|323083624|FG000|Overall Study|Protocol Violation|0|||
94355618|NCT02708524|323083625|FG001|Overall Study|Protocol Violation|1|||
94355619|NCT02708524|323083626|FG002|Overall Study|Protocol Violation|0|||
94355620|NCT02708524|323083627|FG003|Overall Study|Protocol Violation|0|||
94355621|NCT02708524|323083624|FG000|Overall Study|Withdrawal by Subject|1|||
94355622|NCT02708524|323083625|FG001|Overall Study|Withdrawal by Subject|1|||
94355623|NCT02708524|323083626|FG002|Overall Study|Withdrawal by Subject|0|||
94355624|NCT02708524|323083627|FG003|Overall Study|Withdrawal by Subject|0|||
94355625|NCT02708524|323083624|FG000|Overall Study|Dispensed incorrect study lens|0|||
94355626|NCT02708524|323083625|FG001|Overall Study|Dispensed incorrect study lens|1|||
94355627|NCT02708524|323083626|FG002|Overall Study|Dispensed incorrect study lens|1|||
94355628|NCT02708524|323083627|FG003|Overall Study|Dispensed incorrect study lens|0|||
94355629|NCT02708524|323083624|FG000|Overall Study|Did not wear lens at final visit|0|||
94355630|NCT02708524|323083625|FG001|Overall Study|Did not wear lens at final visit|1|||
94355631|NCT02708524|323083626|FG002|Overall Study|Did not wear lens at final visit|0|||
94355632|NCT02708524|323083627|FG003|Overall Study|Did not wear lens at final visit|0|||
94355633|NCT02708524|323083624|FG000|Overall Study|Subject lost study lens|1|||
94355634|NCT02708524|323083625|FG001|Overall Study|Subject lost study lens|0|||
94355635|NCT02708524|323083626|FG002|Overall Study|Subject lost study lens|0|||
94355636|NCT02708524|323083627|FG003|Overall Study|Subject lost study lens|0|||
94355637|NCT03781167|323083633|FG000|Overall Study|Adverse Event|23|||
94355638|NCT03781167|323083634|FG001|Overall Study|Adverse Event|25|||
94355639|NCT03781167|323083633|FG000|Overall Study|Withdrew consent|16|||
94355640|NCT03781167|323083634|FG001|Overall Study|Withdrew consent|12|||
94355641|NCT03781167|323083633|FG000|Overall Study|Lost to Follow-up|0|||
94355642|NCT03781167|323083634|FG001|Overall Study|Lost to Follow-up|1|||
94355643|NCT03781167|323083633|FG000|Overall Study|Lack of Efficacy|4|||
94355644|NCT03781167|323083634|FG001|Overall Study|Lack of Efficacy|5|||
94355645|NCT03781167|323083633|FG000|Overall Study|Difficulty with drug delivery system|2|||
94355646|NCT03781167|323083634|FG001|Overall Study|Difficulty with drug delivery system|3|||
94355647|NCT03781167|323083633|FG000|Overall Study|Other, not specified|2|||
94355648|NCT03781167|323083634|FG001|Overall Study|Other, not specified|2|||
94355649|NCT00462501|323083635|FG000|Overall Study|Not treated|3|||
94355650|NCT00462501|323083635|FG000|Overall Study|Adverse Event|2|||
94355651|NCT01590628|323083647|FG000|Overall Study|Death|2|||
94355652|NCT01590628|323083648|FG001|Overall Study|Death|0|||
94355653|NCT00475657|323083649|FG000|Overall Study|Death|1|||
94355654|NCT00475657|323083649|FG000|Overall Study|Sponsor's Decision|3|||
94355655|NCT00761735|323083650|FG000|Overall Study|Lost to Follow-up|6|||
94355656|NCT00761735|323083650|FG000|Overall Study|Withdrawal by Subject|6|||
94355657|NCT00761735|323083650|FG000|Overall Study|Non-compliance with protocol|1|||
94355658|NCT00761735|323083650|FG000|Overall Study|Administrative|1|||
94355659|NCT00383292|323083651|FG000|Overall Study|Adverse Event|4|||
94355660|NCT00383292|323083652|FG001|Overall Study|Adverse Event|1|||
94355661|NCT00383292|323083653|FG002|Overall Study|Adverse Event|2|||
94355662|NCT00383292|323083651|FG000|Overall Study|Death|3|||
94355663|NCT00383292|323083652|FG001|Overall Study|Death|3|||
94355664|NCT00383292|323083653|FG002|Overall Study|Death|3|||
94355665|NCT00383292|323083651|FG000|Overall Study|Physician Decision|4|||
94355666|NCT00383292|323083652|FG001|Overall Study|Physician Decision|0|||
94355667|NCT00383292|323083653|FG002|Overall Study|Physician Decision|1|||
94355668|NCT00383292|323083651|FG000|Overall Study|Withdrawal by Subject|3|||
94355669|NCT00383292|323083652|FG001|Overall Study|Withdrawal by Subject|2|||
94355670|NCT00383292|323083653|FG002|Overall Study|Withdrawal by Subject|2|||
94355671|NCT00383292|323083651|FG000|Overall Study|Other|1|||
94355672|NCT00383292|323083652|FG001|Overall Study|Other|0|||
94355673|NCT00383292|323083653|FG002|Overall Study|Other|0|||
94355674|NCT03457701|323083654|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
94355675|NCT03457701|323083655|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
94355676|NCT03457701|323083654|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
94355677|NCT03457701|323083655|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
94355678|NCT00796367|323083658|FG000|Overall Study|Adverse Event|6|||
94355679|NCT00796367|323083659|FG001|Overall Study|Adverse Event|4|||
94660143|NCT00941603|324210029|FG002|Overall Study|Did not meet protocol eligibility|0|||
94660144|NCT00941603|324210030|FG003|Overall Study|Did not meet protocol eligibility|0|||
94660145|NCT00941603|324210031|FG004|Overall Study|Did not meet protocol eligibility|0|||
94660146|NCT00941603|324210032|FG005|Overall Study|Did not meet protocol eligibility|0|||
94660147|NCT02014116|324210033|FG000|Overall Study|Progressive Disease|3|||
94660148|NCT02014116|324210034|FG001|Overall Study|Progressive Disease|4|||
94660149|NCT02014116|324210035|FG002|Overall Study|Progressive Disease|2|||
94660150|NCT02014116|324210036|FG003|Overall Study|Progressive Disease|6|||
94660151|NCT02014116|324210037|FG004|Overall Study|Progressive Disease|1|||
94660152|NCT02014116|324210038|FG005|Overall Study|Progressive Disease|13|||
94660153|NCT02014116|324210039|FG006|Overall Study|Progressive Disease|1|||
94660154|NCT02014116|324210040|FG007|Overall Study|Progressive Disease|3|||
94660155|NCT02014116|324210041|FG008|Overall Study|Progressive Disease|7|||
94660156|NCT02014116|324210033|FG000|Overall Study|Adverse Event|0|||
94660157|NCT02014116|324210034|FG001|Overall Study|Adverse Event|0|||
94660158|NCT02014116|324210035|FG002|Overall Study|Adverse Event|0|||
94660159|NCT02014116|324210036|FG003|Overall Study|Adverse Event|0|||
94660160|NCT02014116|324210037|FG004|Overall Study|Adverse Event|1|||
94660161|NCT02014116|324210038|FG005|Overall Study|Adverse Event|0|||
94660162|NCT02014116|324210039|FG006|Overall Study|Adverse Event|0|||
94660163|NCT02014116|324210040|FG007|Overall Study|Adverse Event|1|||
94660164|NCT02014116|324210041|FG008|Overall Study|Adverse Event|0|||
94660165|NCT02014116|324210033|FG000|Overall Study|Lost to Follow-up|0|||
94660166|NCT02014116|324210034|FG001|Overall Study|Lost to Follow-up|0|||
94660167|NCT02014116|324210035|FG002|Overall Study|Lost to Follow-up|0|||
94660168|NCT02014116|324210036|FG003|Overall Study|Lost to Follow-up|0|||
94660169|NCT02014116|324210037|FG004|Overall Study|Lost to Follow-up|0|||
94660170|NCT02014116|324210038|FG005|Overall Study|Lost to Follow-up|1|||
94660171|NCT02014116|324210039|FG006|Overall Study|Lost to Follow-up|0|||
94660172|NCT02014116|324210040|FG007|Overall Study|Lost to Follow-up|0|||
94660173|NCT02014116|324210041|FG008|Overall Study|Lost to Follow-up|1|||
94660174|NCT02014116|324210033|FG000|Overall Study|Death|0|||
94660175|NCT02014116|324210034|FG001|Overall Study|Death|0|||
94660176|NCT02014116|324210035|FG002|Overall Study|Death|0|||
94660177|NCT02014116|324210036|FG003|Overall Study|Death|0|||
94660178|NCT02014116|324210037|FG004|Overall Study|Death|0|||
94660179|NCT02014116|324210038|FG005|Overall Study|Death|0|||
94660180|NCT02014116|324210039|FG006|Overall Study|Death|0|||
94660181|NCT02014116|324210040|FG007|Overall Study|Death|1|||
94660182|NCT02014116|324210041|FG008|Overall Study|Death|1|||
94660183|NCT02014116|324210033|FG000|Overall Study|Withdrawal by Subject|0|||
94660184|NCT02014116|324210034|FG001|Overall Study|Withdrawal by Subject|0|||
94660185|NCT02014116|324210035|FG002|Overall Study|Withdrawal by Subject|1|||
94660186|NCT02014116|324210036|FG003|Overall Study|Withdrawal by Subject|1|||
94660187|NCT02014116|324210037|FG004|Overall Study|Withdrawal by Subject|0|||
94660188|NCT02014116|324210038|FG005|Overall Study|Withdrawal by Subject|1|||
94660189|NCT02014116|324210039|FG006|Overall Study|Withdrawal by Subject|0|||
94660190|NCT02014116|324210040|FG007|Overall Study|Withdrawal by Subject|0|||
94660191|NCT02014116|324210041|FG008|Overall Study|Withdrawal by Subject|0|||
94660192|NCT02014116|324210033|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
94660193|NCT02014116|324210034|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
94660194|NCT02014116|324210035|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
94660195|NCT02014116|324210036|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
94660196|NCT02014116|324210037|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
94660197|NCT02014116|324210038|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
94660198|NCT02014116|324210039|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
94660199|NCT02014116|324210040|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
94660200|NCT02014116|324210041|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
94660201|NCT02014116|324210033|FG000|Overall Study|Physician Decision|0|||
94660202|NCT02014116|324210034|FG001|Overall Study|Physician Decision|0|||
94660203|NCT02014116|324210035|FG002|Overall Study|Physician Decision|0|||
94355680|NCT00796367|323083660|FG002|Overall Study|Adverse Event|7|||
94355681|NCT00796367|323083658|FG000|Overall Study|Lost to Follow-up|5|||
94355682|NCT00796367|323083659|FG001|Overall Study|Lost to Follow-up|4|||
94355683|NCT00796367|323083660|FG002|Overall Study|Lost to Follow-up|21|||
94355684|NCT00796367|323083658|FG000|Overall Study|Withdrawal by Subject|9|||
94355685|NCT00796367|323083659|FG001|Overall Study|Withdrawal by Subject|11|||
94355686|NCT00796367|323083660|FG002|Overall Study|Withdrawal by Subject|12|||
94355687|NCT00796367|323083658|FG000|Overall Study|Lack of Efficacy|2|||
94355688|NCT00796367|323083659|FG001|Overall Study|Lack of Efficacy|1|||
94355689|NCT00796367|323083660|FG002|Overall Study|Lack of Efficacy|0|||
94355690|NCT00796367|323083658|FG000|Overall Study|non compliance|3|||
94355691|NCT00796367|323083659|FG001|Overall Study|non compliance|1|||
94355692|NCT00796367|323083660|FG002|Overall Study|non compliance|1|||
94355693|NCT00796367|323083658|FG000|Overall Study|Pregnancy|1|||
94355694|NCT00796367|323083659|FG001|Overall Study|Pregnancy|0|||
94355695|NCT00796367|323083660|FG002|Overall Study|Pregnancy|1|||
94355696|NCT00796367|323083658|FG000|Overall Study|Requirement for restricted medication|2|||
94457116|NCT00282113|323460628|FG000|Overall Study|Removed at parents request|1|||
94457117|NCT00282113|323460629|FG001|Overall Study|Removed at parents request|0|||
94457118|NCT00282113|323460630|FG002|Overall Study|Removed at parents request|0|||
94457119|NCT01508130|323460631|FG000|Overall Study|Adverse Event|81|||
94457120|NCT01508130|323460632|FG001|Overall Study|Adverse Event|28|||
94457121|NCT01508130|323460631|FG000|Overall Study|Death|3|||
94457122|NCT01508130|323460632|FG001|Overall Study|Death|1|||
94457123|NCT01508130|323460631|FG000|Overall Study|Protocol Violation|2|||
94457124|NCT01508130|323460632|FG001|Overall Study|Protocol Violation|0|||
94457125|NCT01508130|323460631|FG000|Overall Study|Lost to Follow-up|25|||
94457126|NCT01508130|323460632|FG001|Overall Study|Lost to Follow-up|2|||
94457127|NCT01508130|323460631|FG000|Overall Study|Withdrawal by Subject|3|||
94457128|NCT01508130|323460632|FG001|Overall Study|Withdrawal by Subject|3|||
94457129|NCT01508130|323460631|FG000|Overall Study|Subject's substantial non-compliance|25|||
94457130|NCT01508130|323460632|FG001|Overall Study|Subject's substantial non-compliance|9|||
94457131|NCT01508130|323460631|FG000|Overall Study|Insufficient therapeutic response|74|||
94457132|NCT01508130|323460632|FG001|Overall Study|Insufficient therapeutic response|23|||
94457133|NCT01508130|323460631|FG000|Overall Study|Administrative|14|||
94457134|NCT01508130|323460632|FG001|Overall Study|Administrative|3|||
94457135|NCT03467217|323463469|FG000|Overall Study|Trial stopped early|5|||
94457136|NCT03467217|323463470|FG001|Overall Study|Trial stopped early|2|||
94457137|NCT03467217|323463469|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
94457138|NCT03467217|323463470|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
94457139|NCT03467217|323463469|FG000|Overall Study|Lost to Follow-up|0|||
94457140|NCT03467217|323463470|FG001|Overall Study|Lost to Follow-up|2|||
94457141|NCT00174967|323463471|FG000|Overall Study|Adverse Event|1|||
94457142|NCT00174967|323463472|FG001|Overall Study|Adverse Event|2|||
94457143|NCT00174967|323463473|FG002|Overall Study|Adverse Event|2|||
94457144|NCT00174967|323463474|FG003|Overall Study|Adverse Event|1|||
94457145|NCT00174967|323463471|FG000|Overall Study|Gout Flare|0|||
94457146|NCT00174967|323463472|FG001|Overall Study|Gout Flare|0|||
94457147|NCT00174967|323463473|FG002|Overall Study|Gout Flare|0|||
94457148|NCT00174967|323463474|FG003|Overall Study|Gout Flare|1|||
94457149|NCT00174967|323463471|FG000|Overall Study|Other|0|||
94457150|NCT00174967|323463472|FG001|Overall Study|Other|1|||
94457151|NCT00174967|323463473|FG002|Overall Study|Other|0|||
94457152|NCT00174967|323463474|FG003|Overall Study|Other|0|||
94457153|NCT00784238|323463475|FG000|Overall Study|Adverse Event|14|||
94457154|NCT00784238|323463475|FG000|Overall Study|Death|2|||
94457155|NCT00784238|323463475|FG000|Overall Study|Lack of Efficacy|33|||
94457156|NCT00784238|323463475|FG000|Overall Study|Lost to Follow-up|29|||
94457157|NCT00784238|323463475|FG000|Overall Study|Pregnancy|1|||
94457158|NCT00784238|323463475|FG000|Overall Study|Withdrawal by Subject|26|||
94457159|NCT00784238|323463475|FG000|Overall Study|Other|14|||
94457160|NCT03693612|323463476|FG000|Overall Study|Lost to Follow-up|0|||
94457161|NCT03693612|323463477|FG001|Overall Study|Lost to Follow-up|0|||
94457162|NCT03693612|323463478|FG002|Overall Study|Lost to Follow-up|0|||
94457163|NCT03693612|323463479|FG003|Overall Study|Lost to Follow-up|0|||
94457164|NCT03693612|323463480|FG004|Overall Study|Lost to Follow-up|1|||
94457165|NCT03693612|323463481|FG005|Overall Study|Lost to Follow-up|0|||
94457166|NCT03693612|323463482|FG006|Overall Study|Lost to Follow-up|0|||
94457167|NCT03693612|323463476|FG000|Overall Study|Withdrawal by Subject|0|||
94660204|NCT02014116|324210036|FG003|Overall Study|Physician Decision|0|||
94660205|NCT02014116|324210037|FG004|Overall Study|Physician Decision|0|||
94660206|NCT02014116|324210038|FG005|Overall Study|Physician Decision|0|||
94660207|NCT02014116|324210039|FG006|Overall Study|Physician Decision|0|||
94660208|NCT02014116|324210040|FG007|Overall Study|Physician Decision|0|||
94660209|NCT02014116|324210041|FG008|Overall Study|Physician Decision|1|||
94660210|NCT00583557|324210042|FG000|Overall Study|Withdrawal by Subject|18|||
94660211|NCT00583557|324210042|FG000|Overall Study|Adverse Event|9|||
94660212|NCT00583557|324210042|FG000|Overall Study|Lack of Efficacy|31|||
94660213|NCT00583557|324210042|FG000|Overall Study|Lack of Compliance|5|||
94660214|NCT00583557|324210042|FG000|Overall Study|Other|5|||
94660215|NCT00583557|324210042|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
94660216|NCT02682264|324210043|FG000|Overall Study|Withdrawal by Subject|56|||
94660217|NCT02682264|324210044|FG001|Overall Study|Withdrawal by Subject|45|||
94457168|NCT03693612|323463477|FG001|Overall Study|Withdrawal by Subject|0|||
94457169|NCT03693612|323463478|FG002|Overall Study|Withdrawal by Subject|1|||
94457170|NCT03693612|323463479|FG003|Overall Study|Withdrawal by Subject|0|||
94457171|NCT03693612|323463480|FG004|Overall Study|Withdrawal by Subject|2|||
94457172|NCT03693612|323463481|FG005|Overall Study|Withdrawal by Subject|0|||
94457173|NCT03693612|323463482|FG006|Overall Study|Withdrawal by Subject|0|||
94457174|NCT03693612|323463476|FG000|Overall Study|Study Terminated by Sponsor|0|||
94457175|NCT03693612|323463477|FG001|Overall Study|Study Terminated by Sponsor|1|||
94457176|NCT03693612|323463478|FG002|Overall Study|Study Terminated by Sponsor|0|||
94660218|NCT02682264|324210043|FG000|Overall Study|Lost to Follow-up|49|||
94660219|NCT02682264|324210044|FG001|Overall Study|Lost to Follow-up|41|||
94660220|NCT02682264|324210043|FG000|Overall Study|Lack of Efficacy|14|||
94594042|NCT00966875|323977230|FG003|Part B|Lack of Efficacy|1|||
94594043|NCT00966875|323977231|FG004|Part B|Lack of Efficacy|2|||
94594044|NCT00966875|323977232|FG005|Part B|Lack of Efficacy|3|||
94594045|NCT00966875|323977233|FG006|Part B|Lack of Efficacy|12|||
94594046|NCT00966875|323977234|FG007|Part B|Lack of Efficacy|9|||
94355697|NCT00796367|323083659|FG001|Overall Study|Requirement for restricted medication|0|||
94355698|NCT00796367|323083660|FG002|Overall Study|Requirement for restricted medication|2|||
94355699|NCT00796367|323083658|FG000|Overall Study|other|2|||
94355700|NCT00796367|323083659|FG001|Overall Study|other|4|||
94355701|NCT00796367|323083660|FG002|Overall Study|other|3|||
94355702|NCT01288911|323083661|FG000|Double-blind Period|Death|11|||
94355703|NCT01288911|323083662|FG001|Double-blind Period|Death|7|||
94355704|NCT01288911|323083661|FG000|Double-blind Period|Lost to Follow-up|0|||
94355705|NCT01288911|323083662|FG001|Double-blind Period|Lost to Follow-up|2|||
94355706|NCT01288911|323083661|FG000|Double-blind Period|Progressive Disease|75|||
94355707|NCT01288911|323083662|FG001|Double-blind Period|Progressive Disease|103|||
94355708|NCT01288911|323083661|FG000|Double-blind Period|Protocol Violation|1|||
94355709|NCT01288911|323083662|FG001|Double-blind Period|Protocol Violation|0|||
94355710|NCT01288911|323083661|FG000|Double-blind Period|Withdrawal by Subject|25|||
94355711|NCT01288911|323083662|FG001|Double-blind Period|Withdrawal by Subject|26|||
94355712|NCT01288911|323083661|FG000|Double-blind Period|Miscellaneous Reason|29|||
94355713|NCT01288911|323083662|FG001|Double-blind Period|Miscellaneous Reason|42|||
94355714|NCT01288911|323083661|FG000|Double-blind Period|Randomized but never received study drug|1|||
94355715|NCT01288911|323083662|FG001|Double-blind Period|Randomized but never received study drug|2|||
94355716|NCT01288911|323083661|FG000|Open-label Period (All Enzalutamide)|Death|0|||
94355717|NCT01288911|323083662|FG001|Open-label Period (All Enzalutamide)|Death|1|||
94355718|NCT01288911|323083661|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
94355719|NCT01288911|323083662|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
94355720|NCT01288911|323083661|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
94355721|NCT01288911|323083662|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
94355722|NCT01288911|323083661|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
94355723|NCT01288911|323083662|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
94355724|NCT01288911|323083661|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
94355725|NCT01288911|323083662|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
94355726|NCT01288911|323083661|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
94355727|NCT01288911|323083662|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
94355728|NCT02500732|323083677|FG000|Overall Study|Physician Decision|0|||
94355729|NCT02500732|323083678|FG001|Overall Study|Physician Decision|1|||
94355730|NCT01958619|323083679|FG000|Overall Study|Protocol Violation|2|||
94355731|NCT01958619|323083680|FG001|Overall Study|Protocol Violation|0|||
94355732|NCT01958619|323083681|FG002|Overall Study|Protocol Violation|1|||
94355733|NCT01958619|323083682|FG003|Overall Study|Protocol Violation|0|||
94355734|NCT04236986|323083684|FG000|Overall Study|Withdrawal by Subject|3|||
94355735|NCT04236986|323083685|FG001|Overall Study|Withdrawal by Subject|1|||
94355736|NCT00972309|323083686|FG000|Overall Study|Switched to alternative treatment|0|||
94355737|NCT00972309|323083687|FG001|Overall Study|Switched to alternative treatment|2|||
94355738|NCT00972309|323083686|FG000|Overall Study|Refused further treatment|0|||
94594047|NCT00966875|323977235|FG008|Part B|Lack of Efficacy|6|||
94594048|NCT00966875|323977227|FG000|Part B|Lost to Follow-up|0|||
94594049|NCT00966875|323977228|FG001|Part B|Lost to Follow-up|0|||
94246487|NCT01125514|322697035|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
94246488|NCT01125514|322697035|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
94246489|NCT01125514|322697035|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
94246490|NCT01125514|322697035|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
94246491|NCT01125514|322697035|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
94246492|NCT01125514|322697035|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
94246493|NCT00858364|322697038|FG000|Overall Study|Administrative Decision|3|||
94246494|NCT00858364|322697039|FG001|Overall Study|Administrative Decision|2|||
94246495|NCT00858364|322697038|FG000|Overall Study|Adverse Event|5|||
94246496|NCT00858364|322697039|FG001|Overall Study|Adverse Event|2|||
94246497|NCT00858364|322697038|FG000|Overall Study|Withdrawal by Subject|44|||
94246498|NCT00858364|322697039|FG001|Overall Study|Withdrawal by Subject|118|||
94246499|NCT00858364|322697038|FG000|Overall Study|Ineligibility Determined|1|||
94246500|NCT00858364|322697039|FG001|Overall Study|Ineligibility Determined|10|||
94246501|NCT00858364|322697038|FG000|Overall Study|Lost to Follow-up|24|||
94246502|NCT00858364|322697039|FG001|Overall Study|Lost to Follow-up|54|||
94246503|NCT00858364|322697038|FG000|Overall Study|Noncompliance|3|||
94246504|NCT00858364|322697039|FG001|Overall Study|Noncompliance|4|||
94246505|NCT00858364|322697038|FG000|Overall Study|Protocol Deviation|0|||
94246506|NCT00858364|322697039|FG001|Overall Study|Protocol Deviation|2|||
94246507|NCT00858364|322697038|FG000|Overall Study|Other|9|||
94246508|NCT00858364|322697039|FG001|Overall Study|Other|17|||
94246509|NCT00858364|322697038|FG000|Overall Study|Missing|1|||
94246510|NCT00858364|322697039|FG001|Overall Study|Missing|1|||
94246511|NCT00858364|322697038|FG000|Overall Study|Still on-study|114|||
94246512|NCT00858364|322697039|FG001|Overall Study|Still on-study|247|||
94246513|NCT01655693|322697040|FG000|Overall Study|Progression of Disease|92|||
94246514|NCT01655693|322697041|FG001|Overall Study|Progression of Disease|76|||
94246515|NCT01655693|322697042|FG002|Overall Study|Progression of Disease|58|||
94246516|NCT01655693|322697040|FG000|Overall Study|Death|8|||
94246517|NCT01655693|322697041|FG001|Overall Study|Death|9|||
94246518|NCT01655693|322697042|FG002|Overall Study|Death|12|||
94246519|NCT01655693|322697040|FG000|Overall Study|Serious Adverse Event|3|||
94246520|NCT01655693|322697041|FG001|Overall Study|Serious Adverse Event|15|||
94246521|NCT01655693|322697042|FG002|Overall Study|Serious Adverse Event|11|||
94246522|NCT01655693|322697040|FG000|Overall Study|Withdrawal by Subject|3|||
94246523|NCT01655693|322697041|FG001|Overall Study|Withdrawal by Subject|2|||
94246524|NCT01655693|322697042|FG002|Overall Study|Withdrawal by Subject|20|||
94246525|NCT01655693|322697040|FG000|Overall Study|Adverse Event|3|||
94246526|NCT01655693|322697041|FG001|Overall Study|Adverse Event|11|||
94246527|NCT01655693|322697042|FG002|Overall Study|Adverse Event|3|||
94457177|NCT03693612|323463479|FG003|Overall Study|Study Terminated by Sponsor|0|||
94457178|NCT03693612|323463480|FG004|Overall Study|Study Terminated by Sponsor|3|||
94457179|NCT03693612|323463481|FG005|Overall Study|Study Terminated by Sponsor|0|||
94457180|NCT03693612|323463482|FG006|Overall Study|Study Terminated by Sponsor|0|||
94457181|NCT03233529|323463484|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
94457182|NCT03233529|323463484|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
94457183|NCT04310397|323463488|FG000|Overall Study|Lack of Efficacy|3|||
94457184|NCT04310397|323463488|FG000|Overall Study|Withdrawal by Subject|1|||
94457185|NCT00723255|323463489|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
94457186|NCT00723255|323463489|FG000|Overall Study|Ineligible: Second primary|1|||
94457187|NCT00723255|323463489|FG000|Overall Study|Ineligible: Wrong Primary|2|||
94457188|NCT03854370|323463492|FG000|Overall Study|samples not collected|1|||
94457189|NCT03854370|323463493|FG001|Overall Study|samples not collected|1|||
94457190|NCT03854370|323463494|FG002|Overall Study|samples not collected|1|||
94457191|NCT03854370|323463495|FG003|Overall Study|samples not collected|1|||
94457192|NCT00076752|323463497|FG000|Overall Study|Death|2|||
94660221|NCT02682264|324210044|FG001|Overall Study|Lack of Efficacy|16|||
94660222|NCT02682264|324210043|FG000|Overall Study|Withdrawal by Parent|6|||
94660223|NCT02682264|324210044|FG001|Overall Study|Withdrawal by Parent|7|||
94660224|NCT02682264|324210043|FG000|Overall Study|Adverse Event|9|||
94660225|NCT02682264|324210044|FG001|Overall Study|Adverse Event|0|||
94660226|NCT02682264|324210043|FG000|Overall Study|Noncompliance with study drug|1|||
94660227|NCT02682264|324210044|FG001|Overall Study|Noncompliance with study drug|4|||
94660228|NCT02682264|324210043|FG000|Overall Study|Pregnancy|1|||
94660229|NCT02682264|324210044|FG001|Overall Study|Pregnancy|2|||
94246528|NCT01655693|322697040|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
94246529|NCT01655693|322697041|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
94246530|NCT01655693|322697042|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
94246531|NCT01655693|322697040|FG000|Overall Study|Non-Compliance|0|||
94246532|NCT01655693|322697041|FG001|Overall Study|Non-Compliance|0|||
94457193|NCT00076752|323463497|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
94246533|NCT01655693|322697042|FG002|Overall Study|Non-Compliance|7|||
94246534|NCT01655693|322697040|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
94660230|NCT02682264|324210043|FG000|Overall Study|Recovery|1|||
94660231|NCT02682264|324210044|FG001|Overall Study|Recovery|2|||
94660232|NCT02682264|324210043|FG000|Overall Study|Progressive Disease|1|||
94660233|NCT02682264|324210044|FG001|Overall Study|Progressive Disease|0|||
94660234|NCT02682264|324210043|FG000|Overall Study|Technical Problems|0|||
94660235|NCT02682264|324210044|FG001|Overall Study|Technical Problems|1|||
94660236|NCT02682264|324210043|FG000|Overall Study|Moved abroad and unable to continue|0|||
94660237|NCT02682264|324210044|FG001|Overall Study|Moved abroad and unable to continue|3|||
94660238|NCT02682264|324210043|FG000|Overall Study|Stopped test article application|0|||
94660239|NCT02682264|324210044|FG001|Overall Study|Stopped test article application|1|||
94660240|NCT02843568|324210046|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
94355739|NCT00972309|323083687|FG001|Overall Study|Refused further treatment|1|||
94355740|NCT00972309|323083686|FG000|Overall Study|Late determination of ineligibility|0|||
94355741|NCT00972309|323083687|FG001|Overall Study|Late determination of ineligibility|1|||
94355742|NCT00972309|323083686|FG000|Overall Study|Second malignancy|1|||
94355743|NCT00972309|323083687|FG001|Overall Study|Second malignancy|1|||
94355744|NCT00972309|323083686|FG000|Overall Study|Visa issues|0|||
94355745|NCT00972309|323083687|FG001|Overall Study|Visa issues|1|||
94355746|NCT00972309|323083686|FG000|Overall Study|Secondary cancer (SCC)|0|||
94355747|NCT00972309|323083687|FG001|Overall Study|Secondary cancer (SCC)|1|||
94355748|NCT00972309|323083686|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
94355749|NCT00972309|323083687|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
94355750|NCT00972309|323083686|FG000|Overall Study|Lost to Follow-up|1|||
94355751|NCT00972309|323083687|FG001|Overall Study|Lost to Follow-up|1|||
94355752|NCT00972309|323083686|FG000|Overall Study|Disease progression on study|10|||
94355753|NCT00972309|323083687|FG001|Overall Study|Disease progression on study|4|||
94355754|NCT01883362|323083700|FG000|Treatment|Adverse Event|1|||
94355755|NCT01883362|323083701|FG001|Treatment|Adverse Event|8|||
94355756|NCT01883362|323083700|FG000|Treatment|Withdrawal by Subject|6|||
94355757|NCT01883362|323083701|FG001|Treatment|Withdrawal by Subject|2|||
94355758|NCT01883362|323083700|FG000|Treatment|Administrative problems|4|||
94355759|NCT01883362|323083701|FG001|Treatment|Administrative problems|1|||
94355760|NCT01883362|323083700|FG000|Treatment|Relapse|4|||
94355761|NCT01883362|323083701|FG001|Treatment|Relapse|2|||
94355762|NCT01883362|323083700|FG000|Treatment|Randomized, not treated|1|||
94355763|NCT01883362|323083701|FG001|Treatment|Randomized, not treated|1|||
94355764|NCT01883362|323083700|FG000|Post Treatment Follow-up|Protocol Violation|0|||
94355765|NCT01883362|323083701|FG001|Post Treatment Follow-up|Protocol Violation|1|||
94355766|NCT01883362|323083700|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
94355767|NCT01883362|323083701|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
94355768|NCT01883362|323083700|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
94355769|NCT01883362|323083701|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
94355770|NCT01883362|323083700|FG000|Post Treatment Follow-up|Administrative problems|2|||
94355771|NCT01883362|323083701|FG001|Post Treatment Follow-up|Administrative problems|0|||
94355772|NCT01883362|323083700|FG000|Post Treatment Follow-up|Death|8|||
94355773|NCT01883362|323083701|FG001|Post Treatment Follow-up|Death|4|||
94355774|NCT01883362|323083700|FG000|Post Treatment Follow-up|Relapse|1|||
94355775|NCT01883362|323083701|FG001|Post Treatment Follow-up|Relapse|2|||
94355776|NCT01383317|323083702|FG000|Overall Study|Lost to Follow-up|2|||
94355777|NCT01383317|323083703|FG001|Overall Study|Lost to Follow-up|1|||
94355778|NCT01383317|323083702|FG000|Overall Study|Death|1|||
94355779|NCT01383317|323083703|FG001|Overall Study|Death|0|||
94355780|NCT01383317|323083702|FG000|Overall Study|Adverse Event|0|||
94355781|NCT01383317|323083703|FG001|Overall Study|Adverse Event|1|||
94355782|NCT02569996|323083704|FG000|Overall Study|Adverse Event|6|||
94355783|NCT02569996|323083704|FG000|Overall Study|Physician Decision|3|||
94355784|NCT02569996|323083704|FG000|Overall Study|Progression of the disease|18|||
94355785|NCT02569996|323083704|FG000|Overall Study|New anti-lymphoma treatment|1|||
94355786|NCT02569996|323083704|FG000|Overall Study|Non-compliance|9|||
94355787|NCT02569996|323083704|FG000|Overall Study|Withdrawal by Subject|5|||
94355788|NCT02569996|323083704|FG000|Overall Study|Lost to Follow-up|5|||
94355789|NCT02569996|323083704|FG000|Overall Study|Complete remission|7|||
94355790|NCT02569996|323083704|FG000|Overall Study|Unknown reason|1|||
94355791|NCT02451137|323083713|FG000|Overall Study|Randomized but not treated|19|||
94355792|NCT02451137|323083714|FG001|Overall Study|Randomized but not treated|27|||
94355793|NCT02451137|323083713|FG000|Overall Study|Adverse Event|43|||
94355794|NCT02451137|323083714|FG001|Overall Study|Adverse Event|42|||
94355795|NCT02451137|323083713|FG000|Overall Study|Lack of Efficacy|4|||
94355796|NCT02451137|323083714|FG001|Overall Study|Lack of Efficacy|9|||
94660241|NCT02843568|324210047|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
94457194|NCT00452673|323463498|FG000|Dose Escalation Period|Disease Progression|6|||
94457195|NCT00452673|323463499|FG001|Dose Escalation Period|Disease Progression|6|||
94457196|NCT00452673|323463500|FG002|Dose Escalation Period|Disease Progression|2|||
94457197|NCT00452673|323463501|FG003|Dose Escalation Period|Disease Progression|6|||
94457198|NCT00452673|323463502|FG004|Dose Escalation Period|Disease Progression|0|||
94457199|NCT00452673|323463498|FG000|Dose Escalation Period|study drug toxicity|1|||
94457200|NCT00452673|323463499|FG001|Dose Escalation Period|study drug toxicity|3|||
94457201|NCT00452673|323463500|FG002|Dose Escalation Period|study drug toxicity|3|||
94457202|NCT00452673|323463501|FG003|Dose Escalation Period|study drug toxicity|1|||
94457203|NCT00452673|323463502|FG004|Dose Escalation Period|study drug toxicity|0|||
94457204|NCT00452673|323463498|FG000|Dose Escalation Period|Other|0|||
94457205|NCT00452673|323463499|FG001|Dose Escalation Period|Other|0|||
94457206|NCT00452673|323463500|FG002|Dose Escalation Period|Other|1|||
94457207|NCT00452673|323463501|FG003|Dose Escalation Period|Other|0|||
94457208|NCT00452673|323463502|FG004|Dose Escalation Period|Other|0|||
94457209|NCT00452673|323463498|FG000|Dose Escalation Period|Adverse Event|0|||
94457210|NCT00452673|323463499|FG001|Dose Escalation Period|Adverse Event|0|||
94457211|NCT00452673|323463500|FG002|Dose Escalation Period|Adverse Event|0|||
94457212|NCT00452673|323463501|FG003|Dose Escalation Period|Adverse Event|1|||
94457213|NCT00452673|323463502|FG004|Dose Escalation Period|Adverse Event|0|||
94457214|NCT00452673|323463498|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
94457215|NCT00452673|323463499|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
94457216|NCT00452673|323463500|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
94457217|NCT00452673|323463501|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
94457218|NCT00452673|323463502|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
94457219|NCT00452673|323463498|FG000|Dose Expansion Period|Disease Progression|0|||
94457220|NCT00452673|323463499|FG001|Dose Expansion Period|Disease Progression|0|||
94457221|NCT00452673|323463500|FG002|Dose Expansion Period|Disease Progression|0|||
94457222|NCT00452673|323463501|FG003|Dose Expansion Period|Disease Progression|0|||
94457223|NCT00452673|323463502|FG004|Dose Expansion Period|Disease Progression|19|||
94457224|NCT00452673|323463498|FG000|Dose Expansion Period|Other|0|||
94457225|NCT00452673|323463499|FG001|Dose Expansion Period|Other|0|||
94457226|NCT00452673|323463500|FG002|Dose Expansion Period|Other|0|||
94457227|NCT00452673|323463501|FG003|Dose Expansion Period|Other|0|||
94457228|NCT00452673|323463502|FG004|Dose Expansion Period|Other|2|||
94457229|NCT02461524|323463503|FG000|Overall Study|Death|16|||
94457230|NCT02461524|323463503|FG000|Overall Study|Withdrawal by Subject|4|||
94457231|NCT02461524|323463503|FG000|Overall Study|Device Explanted|5|||
94457232|NCT02461524|323463503|FG000|Overall Study|Missed Visit|6|||
94457233|NCT01936181|323463504|FG000|Randomised, Double-blind|Adverse Event|27|||
94457234|NCT01936181|323463505|FG001|Randomised, Double-blind|Adverse Event|21|||
94457235|NCT01936181|323463506|FG002|Randomised, Double-blind|Adverse Event|0|||
94457236|NCT01936181|323463507|FG003|Randomised, Double-blind|Adverse Event|0|||
94457237|NCT01936181|323463504|FG000|Randomised, Double-blind|Protocol Violation|1|||
94457238|NCT01936181|323463505|FG001|Randomised, Double-blind|Protocol Violation|5|||
94457239|NCT01936181|323463506|FG002|Randomised, Double-blind|Protocol Violation|0|||
94457240|NCT01936181|323463507|FG003|Randomised, Double-blind|Protocol Violation|0|||
94457241|NCT01936181|323463504|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
94594050|NCT00966875|323977229|FG002|Part B|Lost to Follow-up|0|||
94594051|NCT00966875|323977230|FG003|Part B|Lost to Follow-up|1|||
94594052|NCT00966875|323977231|FG004|Part B|Lost to Follow-up|0|||
94594053|NCT00966875|323977232|FG005|Part B|Lost to Follow-up|0|||
94594054|NCT00966875|323977233|FG006|Part B|Lost to Follow-up|0|||
94594055|NCT00966875|323977234|FG007|Part B|Lost to Follow-up|0|||
94594056|NCT00966875|323977235|FG008|Part B|Lost to Follow-up|1|||
94594057|NCT00966875|323977227|FG000|Part B|Physician Decision|0|||
94594058|NCT00966875|323977228|FG001|Part B|Physician Decision|0|||
94594059|NCT00966875|323977229|FG002|Part B|Physician Decision|1|||
94594060|NCT00966875|323977230|FG003|Part B|Physician Decision|0|||
94594061|NCT00966875|323977231|FG004|Part B|Physician Decision|2|||
94457242|NCT01936181|323463505|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
94457243|NCT01936181|323463506|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
94457244|NCT01936181|323463507|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
94457245|NCT01936181|323463504|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
94594062|NCT00966875|323977232|FG005|Part B|Physician Decision|1|||
94246535|NCT01655693|322697041|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
94246536|NCT01655693|322697042|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
94246537|NCT01655693|322697040|FG000|Overall Study|Protocol Violation|1|||
94246538|NCT01655693|322697041|FG001|Overall Study|Protocol Violation|0|||
94246539|NCT01655693|322697042|FG002|Overall Study|Protocol Violation|3|||
94246540|NCT01655693|322697040|FG000|Overall Study|Lost to Follow-up|1|||
94246541|NCT01655693|322697041|FG001|Overall Study|Lost to Follow-up|0|||
94246542|NCT01655693|322697042|FG002|Overall Study|Lost to Follow-up|1|||
94246543|NCT01655693|322697040|FG000|Overall Study|Screening Failure|1|||
94246544|NCT01655693|322697041|FG001|Overall Study|Screening Failure|0|||
94246545|NCT01655693|322697042|FG002|Overall Study|Screening Failure|0|||
94246546|NCT01655693|322697040|FG000|Overall Study|Other|8|||
94246547|NCT01655693|322697041|FG001|Overall Study|Other|6|||
94246548|NCT01655693|322697042|FG002|Overall Study|Other|15|||
94246549|NCT03014011|322697043|FG000|First Intervention|Withdrawal by Subject|1|||
94246550|NCT03014011|322697044|FG001|First Intervention|Withdrawal by Subject|0|||
94246551|NCT03014011|322697043|FG000|Washout|Withdrawal by Subject|1|||
94246552|NCT03014011|322697044|FG001|Washout|Withdrawal by Subject|0|||
94246553|NCT02535091|322697045|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
94246554|NCT02535091|322697046|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
94246555|NCT02535091|322697047|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
94246556|NCT02535091|322697045|FG000|Overall Study|Withdrawal by Subject|14|||
94246557|NCT02535091|322697046|FG001|Overall Study|Withdrawal by Subject|5|||
94246558|NCT02535091|322697047|FG002|Overall Study|Withdrawal by Subject|121|||
94246559|NCT02535091|322697045|FG000|Overall Study|Adverse Event|9|||
94246560|NCT02535091|322697046|FG001|Overall Study|Adverse Event|4|||
94246561|NCT02535091|322697047|FG002|Overall Study|Adverse Event|170|||
94457246|NCT01936181|323463505|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
94457247|NCT01936181|323463506|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
94457248|NCT01936181|323463507|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
94457249|NCT01936181|323463504|FG000|Randomised, Double-blind|Pregnancy|0|||
94457250|NCT01936181|323463505|FG001|Randomised, Double-blind|Pregnancy|1|||
94457251|NCT01936181|323463506|FG002|Randomised, Double-blind|Pregnancy|0|||
94457252|NCT01936181|323463507|FG003|Randomised, Double-blind|Pregnancy|0|||
94457253|NCT01936181|323463504|FG000|Randomised, Double-blind|Physician Decision|4|||
94457254|NCT01936181|323463505|FG001|Randomised, Double-blind|Physician Decision|4|||
94457255|NCT01936181|323463506|FG002|Randomised, Double-blind|Physician Decision|0|||
94457256|NCT01936181|323463507|FG003|Randomised, Double-blind|Physician Decision|0|||
94457257|NCT01936181|323463504|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
94457258|NCT01936181|323463505|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
94457259|NCT01936181|323463506|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
94457260|NCT01936181|323463507|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
94457261|NCT01936181|323463504|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
94457262|NCT01936181|323463505|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
94457263|NCT01936181|323463506|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
94457264|NCT01936181|323463507|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
94457265|NCT01936181|323463504|FG000|Transition-extension|Adverse Event|3|||
94457266|NCT01936181|323463505|FG001|Transition-extension|Adverse Event|0|||
94457267|NCT01936181|323463506|FG002|Transition-extension|Adverse Event|3|||
94457268|NCT01936181|323463507|FG003|Transition-extension|Adverse Event|1|||
94457269|NCT01936181|323463504|FG000|Transition-extension|Lost to Follow-up|3|||
94457270|NCT01936181|323463505|FG001|Transition-extension|Lost to Follow-up|0|||
94457271|NCT01936181|323463506|FG002|Transition-extension|Lost to Follow-up|1|||
94457272|NCT01936181|323463507|FG003|Transition-extension|Lost to Follow-up|2|||
94457273|NCT01936181|323463504|FG000|Transition-extension|Physician Decision|2|||
94457274|NCT01936181|323463505|FG001|Transition-extension|Physician Decision|0|||
94457275|NCT01936181|323463506|FG002|Transition-extension|Physician Decision|0|||
94457276|NCT01936181|323463507|FG003|Transition-extension|Physician Decision|1|||
94457277|NCT01936181|323463504|FG000|Transition-extension|Withdrawal by Subject|7|||
94457278|NCT01936181|323463505|FG001|Transition-extension|Withdrawal by Subject|0|||
94457279|NCT01936181|323463506|FG002|Transition-extension|Withdrawal by Subject|2|||
94246562|NCT02535091|322697045|FG000|Overall Study|Other|4|||
94246563|NCT02535091|322697046|FG001|Overall Study|Other|3|||
94246564|NCT02535091|322697047|FG002|Overall Study|Other|81|||
94246565|NCT02535091|322697045|FG000|Overall Study|Lost to Follow-up|0|||
94246566|NCT02535091|322697046|FG001|Overall Study|Lost to Follow-up|1|||
94246567|NCT02535091|322697047|FG002|Overall Study|Lost to Follow-up|19|||
94246568|NCT02535091|322697045|FG000|Overall Study|Protocol Violation|0|||
94246569|NCT02535091|322697046|FG001|Overall Study|Protocol Violation|1|||
94246570|NCT02535091|322697047|FG002|Overall Study|Protocol Violation|11|||
94246571|NCT02535091|322697045|FG000|Overall Study|Pregnancy|0|||
94457280|NCT01936181|323463507|FG003|Transition-extension|Withdrawal by Subject|1|||
94457281|NCT00664859|323463508|FG000|Overall Study|Adverse Event|2|||
94457282|NCT00664859|323463509|FG001|Overall Study|Adverse Event|1|||
94457283|NCT00664859|323463510|FG002|Overall Study|Adverse Event|3|||
94457284|NCT00664859|323463508|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
94457285|NCT00664859|323463509|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
94457286|NCT00664859|323463510|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
94457287|NCT00664859|323463508|FG000|Overall Study|Noncompliance with protocol|1|||
94457288|NCT00664859|323463509|FG001|Overall Study|Noncompliance with protocol|0|||
94457289|NCT00664859|323463510|FG002|Overall Study|Noncompliance with protocol|4|||
94457290|NCT00664859|323463508|FG000|Overall Study|Laboratory abnormality|2|||
94457291|NCT00664859|323463509|FG001|Overall Study|Laboratory abnormality|1|||
94457292|NCT00664859|323463510|FG002|Overall Study|Laboratory abnormality|4|||
94457293|NCT00664859|323463508|FG000|Overall Study|Withdrawal by Subject|4|||
94355797|NCT02451137|323083713|FG000|Overall Study|Participant decision:discontinue insulin|41|||
94355798|NCT02451137|323083714|FG001|Overall Study|Participant decision:discontinue insulin|43|||
94355799|NCT02451137|323083713|FG000|Overall Study|Hypoglycemia|2|||
94355800|NCT02451137|323083714|FG001|Overall Study|Hypoglycemia|1|||
94355801|NCT02451137|323083713|FG000|Overall Study|Investigator's decision|23|||
94457294|NCT00664859|323463509|FG001|Overall Study|Withdrawal by Subject|1|||
94457295|NCT00664859|323463510|FG002|Overall Study|Withdrawal by Subject|3|||
94457296|NCT00664859|323463508|FG000|Overall Study|Lost to Follow-up|2|||
94457297|NCT00664859|323463509|FG001|Overall Study|Lost to Follow-up|2|||
94457298|NCT00664859|323463510|FG002|Overall Study|Lost to Follow-up|1|||
94457299|NCT00664859|323463508|FG000|Overall Study|Other|0|||
94457300|NCT00664859|323463509|FG001|Overall Study|Other|1|||
94457301|NCT00664859|323463510|FG002|Overall Study|Other|2|||
94457302|NCT00348595|323463511|FG000|Overall Study|Adverse Event|5|||
94457303|NCT00348595|323463512|FG001|Overall Study|Adverse Event|8|||
94457304|NCT00900757|323463513|FG000|Overall Study|screen failure|19|||
94457305|NCT03164564|323463514|FG000|Overall Study|Death|3|||
94457306|NCT03164564|323463515|FG001|Overall Study|Death|0|||
94457307|NCT03164564|323463514|FG000|Overall Study|Withdrawal by Subject|20|||
94457308|NCT03164564|323463515|FG001|Overall Study|Withdrawal by Subject|15|||
94457309|NCT03164564|323463514|FG000|Overall Study|Lost to Follow-up|2|||
94457310|NCT03164564|323463515|FG001|Overall Study|Lost to Follow-up|0|||
94457311|NCT03164564|323463514|FG000|Overall Study|Physician Decision|0|||
94457312|NCT03164564|323463515|FG001|Overall Study|Physician Decision|1|||
94457313|NCT03164564|323463514|FG000|Overall Study|Adverse Event|0|||
94457314|NCT03164564|323463515|FG001|Overall Study|Adverse Event|1|||
94457315|NCT03164564|323463514|FG000|Overall Study|Ongoing|1586|||
94457316|NCT03164564|323463515|FG001|Overall Study|Ongoing|1586|||
94457317|NCT03557931|323463516|FG000|Overall Study|Adverse Event|4|||
94457318|NCT03557931|323463517|FG001|Overall Study|Adverse Event|6|||
94457319|NCT03557931|323463518|FG002|Overall Study|Adverse Event|1|||
94457320|NCT03557931|323463516|FG000|Overall Study|Lost to Follow-up|4|||
94457321|NCT03557931|323463517|FG001|Overall Study|Lost to Follow-up|4|||
94457322|NCT03557931|323463518|FG002|Overall Study|Lost to Follow-up|1|||
94457323|NCT03557931|323463516|FG000|Overall Study|Protocol Violation|1|||
94457324|NCT03557931|323463517|FG001|Overall Study|Protocol Violation|4|||
94457325|NCT03557931|323463518|FG002|Overall Study|Protocol Violation|1|||
94457326|NCT03557931|323463516|FG000|Overall Study|Withdrawal by Subject|14|||
94457327|NCT03557931|323463517|FG001|Overall Study|Withdrawal by Subject|0|||
94457328|NCT03557931|323463518|FG002|Overall Study|Withdrawal by Subject|7|||
94457329|NCT03557931|323463516|FG000|Overall Study|Miscellaneous|8|||
94457330|NCT03557931|323463517|FG001|Overall Study|Miscellaneous|5|||
94457331|NCT03557931|323463518|FG002|Overall Study|Miscellaneous|3|||
94457332|NCT02828124|323463519|FG000|Overall Study|Disease Progression|1|||
94457333|NCT02828124|323463520|FG001|Overall Study|Disease Progression|2|||
94457334|NCT02828124|323463521|FG002|Overall Study|Disease Progression|1|||
94457335|NCT02828124|323463522|FG003|Overall Study|Disease Progression|4|||
94457336|NCT02828124|323463519|FG000|Overall Study|AE Unrelated to Study Drug|0|||
94457337|NCT02828124|323463520|FG001|Overall Study|AE Unrelated to Study Drug|0|||
94457338|NCT02828124|323463521|FG002|Overall Study|AE Unrelated to Study Drug|0|||
94457339|NCT02828124|323463522|FG003|Overall Study|AE Unrelated to Study Drug|1|||
94457340|NCT02828124|323463519|FG000|Overall Study|Subject Withdrew Consent|0|||
94457341|NCT02828124|323463520|FG001|Overall Study|Subject Withdrew Consent|0|||
94457342|NCT02828124|323463521|FG002|Overall Study|Subject Withdrew Consent|0|||
94355802|NCT02451137|323083714|FG001|Overall Study|Investigator's decision|19|||
94355803|NCT02451137|323083713|FG000|Overall Study|Lost to Follow-up|53|||
94355804|NCT02451137|323083714|FG001|Overall Study|Lost to Follow-up|61|||
94355805|NCT02451137|323083713|FG000|Overall Study|Physician Decision|6|||
94355806|NCT02451137|323083714|FG001|Overall Study|Physician Decision|5|||
94457343|NCT02828124|323463522|FG003|Overall Study|Subject Withdrew Consent|1|||
94457344|NCT00747474|323463524|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
94457345|NCT00747474|323463525|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
94457346|NCT00747474|323463526|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
94457347|NCT00747474|323463527|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
94457348|NCT00747474|323463528|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
94457349|NCT00747474|323463529|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
94457350|NCT00747474|323463530|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
94355807|NCT02451137|323083713|FG000|Overall Study|Sponsor decision|13|||
94355808|NCT02451137|323083714|FG001|Overall Study|Sponsor decision|25|||
94355809|NCT02451137|323083713|FG000|Overall Study|Withdrawal by Subject|40|||
94355810|NCT02451137|323083714|FG001|Overall Study|Withdrawal by Subject|63|||
94355811|NCT02451137|323083713|FG000|Overall Study|Other than specified above|2|||
94355812|NCT02451137|323083714|FG001|Overall Study|Other than specified above|3|||
94355813|NCT01233076|323085704|FG000|Period 2, One Week|Lost to Follow-up|1|||
94355814|NCT01233076|323085705|FG001|Period 2, One Week|Lost to Follow-up|0|||
94355815|NCT01266967|323085706|FG000|Overall Study|Death|69|||
94355816|NCT01266967|323085707|FG001|Overall Study|Death|61|||
94355817|NCT01266967|323085706|FG000|Overall Study|Study Closed/Terminated|15|||
94355818|NCT01266967|323085707|FG001|Overall Study|Study Closed/Terminated|17|||
94355819|NCT01266967|323085706|FG000|Overall Study|Lost to Follow-up|2|||
94355820|NCT01266967|323085707|FG001|Overall Study|Lost to Follow-up|1|||
94355821|NCT01266967|323085706|FG000|Overall Study|Physician Decision|0|||
94355822|NCT01266967|323085707|FG001|Overall Study|Physician Decision|1|||
94355823|NCT01266967|323085706|FG000|Overall Study|Withdrawal by Subject|3|||
94355824|NCT01266967|323085707|FG001|Overall Study|Withdrawal by Subject|3|||
94355825|NCT02493712|323085708|FG000|Overall Study|Withdrawal by Subject|1|||
94355826|NCT02493712|323085709|FG001|Overall Study|Withdrawal by Subject|0|||
94355827|NCT02493712|323085710|FG002|Overall Study|Withdrawal by Subject|2|||
94355828|NCT02493712|323085708|FG000|Overall Study|Protocol Violation|0|||
94355829|NCT02493712|323085709|FG001|Overall Study|Protocol Violation|0|||
94355830|NCT02493712|323085710|FG002|Overall Study|Protocol Violation|1|||
94355831|NCT02493712|323085708|FG000|Overall Study|Lost to Follow-up|1|||
94355832|NCT02493712|323085709|FG001|Overall Study|Lost to Follow-up|0|||
94355833|NCT02493712|323085710|FG002|Overall Study|Lost to Follow-up|0|||
94355834|NCT02493712|323085708|FG000|Overall Study|Physician Decision|0|||
94355835|NCT02493712|323085709|FG001|Overall Study|Physician Decision|1|||
94355836|NCT02493712|323085710|FG002|Overall Study|Physician Decision|0|||
94457351|NCT00747474|323463531|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
94594063|NCT00966875|323977233|FG006|Part B|Physician Decision|0|||
94355837|NCT02493712|323085708|FG000|Overall Study|Lack of Efficacy|0|||
94355838|NCT02493712|323085709|FG001|Overall Study|Lack of Efficacy|5|||
94457352|NCT00747474|323463532|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
94457353|NCT00747474|323463533|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
94457354|NCT00747474|323463534|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
94457355|NCT00747474|323463535|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
94457356|NCT02829723|323463536|FG000|Overall Study|Adverse Event|0|||
94457357|NCT02829723|323463537|FG001|Overall Study|Adverse Event|0|||
94457358|NCT02829723|323463538|FG002|Overall Study|Adverse Event|1|||
94457359|NCT02829723|323463539|FG003|Overall Study|Adverse Event|1|||
94457360|NCT02829723|323463540|FG004|Overall Study|Adverse Event|0|||
94457361|NCT02829723|323463541|FG005|Overall Study|Adverse Event|0|||
94457362|NCT02829723|323463542|FG006|Overall Study|Adverse Event|0|||
94457363|NCT02829723|323463543|FG007|Overall Study|Adverse Event|1|||
94457364|NCT02829723|323463544|FG008|Overall Study|Adverse Event|0|||
94457365|NCT02829723|323463545|FG009|Overall Study|Adverse Event|0|||
94457366|NCT02829723|323463546|FG010|Overall Study|Adverse Event|0|||
94457367|NCT02829723|323463547|FG011|Overall Study|Adverse Event|0|||
94457368|NCT02829723|323463548|FG012|Overall Study|Adverse Event|0|||
94457369|NCT02829723|323463549|FG013|Overall Study|Adverse Event|0|||
94457370|NCT02829723|323463550|FG014|Overall Study|Adverse Event|1|||
94457371|NCT02829723|323463551|FG015|Overall Study|Adverse Event|1|||
94457372|NCT02829723|323463552|FG016|Overall Study|Adverse Event|1|||
94457373|NCT02829723|323463553|FG017|Overall Study|Adverse Event|2|||
94457374|NCT02829723|323463554|FG018|Overall Study|Adverse Event|1|||
94457375|NCT02829723|323463555|FG019|Overall Study|Adverse Event|1|||
94457376|NCT02829723|323463556|FG020|Overall Study|Adverse Event|3|||
94457377|NCT02829723|323463557|FG021|Overall Study|Adverse Event|0|||
94457378|NCT02829723|323463558|FG022|Overall Study|Adverse Event|0|||
94457379|NCT02829723|323463559|FG023|Overall Study|Adverse Event|1|||
94457380|NCT02829723|323463560|FG024|Overall Study|Adverse Event|1|||
94457381|NCT02829723|323463561|FG025|Overall Study|Adverse Event|3|||
94457382|NCT02829723|323463562|FG026|Overall Study|Adverse Event|5|||
94594064|NCT00966875|323977234|FG007|Part B|Physician Decision|0|||
94594065|NCT00966875|323977235|FG008|Part B|Physician Decision|2|||
94594066|NCT00966875|323977227|FG000|Part B|Sponsor Decision|1|||
94594067|NCT00966875|323977228|FG001|Part B|Sponsor Decision|0|||
94594068|NCT00966875|323977229|FG002|Part B|Sponsor Decision|0|||
94594069|NCT00966875|323977230|FG003|Part B|Sponsor Decision|0|||
94594070|NCT00966875|323977231|FG004|Part B|Sponsor Decision|0|||
94594071|NCT00966875|323977232|FG005|Part B|Sponsor Decision|1|||
94457383|NCT02829723|323463536|FG000|Overall Study|Death|1|||
94457384|NCT02829723|323463537|FG001|Overall Study|Death|0|||
94594072|NCT00966875|323977233|FG006|Part B|Sponsor Decision|0|||
94594073|NCT00966875|323977234|FG007|Part B|Sponsor Decision|2|||
94594074|NCT00966875|323977235|FG008|Part B|Sponsor Decision|1|||
94594075|NCT00966875|323977227|FG000|Part B|Withdrawal by Subject|2|||
94457385|NCT02829723|323463538|FG002|Overall Study|Death|1|||
94457386|NCT02829723|323463539|FG003|Overall Study|Death|1|||
94457387|NCT02829723|323463540|FG004|Overall Study|Death|0|||
94457388|NCT02829723|323463541|FG005|Overall Study|Death|0|||
94594076|NCT00966875|323977228|FG001|Part B|Withdrawal by Subject|1|||
94594077|NCT00966875|323977229|FG002|Part B|Withdrawal by Subject|2|||
94594078|NCT00966875|323977230|FG003|Part B|Withdrawal by Subject|1|||
94594079|NCT00966875|323977231|FG004|Part B|Withdrawal by Subject|2|||
94594080|NCT00966875|323977232|FG005|Part B|Withdrawal by Subject|1|||
94594081|NCT00966875|323977233|FG006|Part B|Withdrawal by Subject|4|||
94594082|NCT00966875|323977234|FG007|Part B|Withdrawal by Subject|5|||
94594083|NCT00966875|323977235|FG008|Part B|Withdrawal by Subject|5|||
94594084|NCT00966875|323977227|FG000|Part B|Entry Criteria|0|||
94594085|NCT00966875|323977228|FG001|Part B|Entry Criteria|0|||
94594086|NCT00966875|323977229|FG002|Part B|Entry Criteria|0|||
94594087|NCT00966875|323977230|FG003|Part B|Entry Criteria|0|||
94594088|NCT00966875|323977231|FG004|Part B|Entry Criteria|0|||
94594089|NCT00966875|323977232|FG005|Part B|Entry Criteria|0|||
94594090|NCT00966875|323977233|FG006|Part B|Entry Criteria|1|||
94594091|NCT00966875|323977234|FG007|Part B|Entry Criteria|0|||
94594092|NCT00966875|323977235|FG008|Part B|Entry Criteria|1|||
94594093|NCT02870933|323977236|FG000|Overall Study|Death|2|||
94594094|NCT02870933|323977237|FG001|Overall Study|Death|1|||
94594095|NCT02870933|323977236|FG000|Overall Study|Withdrawal by Subject|0|||
94594096|NCT02870933|323977237|FG001|Overall Study|Withdrawal by Subject|1|||
94594097|NCT01206322|323977238|FG000|Overall Study|Adverse Event|0|||
94594098|NCT01206322|323977239|FG001|Overall Study|Adverse Event|0|||
94594099|NCT01206322|323977240|FG002|Overall Study|Adverse Event|0|||
94594100|NCT01206322|323977241|FG003|Overall Study|Adverse Event|1|||
94594101|NCT01250496|323977242|FG000|Overall Study|Study terminated|124|||
94594102|NCT01250496|323977243|FG001|Overall Study|Study terminated|124|||
94594103|NCT00003590|323977244|FG000|Overall Study|Ineligible Patient|1|||
94594104|NCT00003590|323977244|FG000|Overall Study|Adverse Event|7|||
94594105|NCT00003590|323977244|FG000|Overall Study|Withdrawal by Subject|1|||
94594106|NCT00003590|323977244|FG000|Overall Study|Lack of Efficacy|11|||
94594107|NCT00003590|323977244|FG000|Overall Study|Death|1|||
94594108|NCT00003590|323977244|FG000|Overall Study|Physician Decision|1|||
94594109|NCT01425463|323977250|FG000|Overall Study|Adverse Event|5|||
94594110|NCT01425463|323977251|FG001|Overall Study|Adverse Event|7|||
94594111|NCT01425463|323977250|FG000|Overall Study|Lack of Efficacy|1|||
94594112|NCT01425463|323977251|FG001|Overall Study|Lack of Efficacy|1|||
94594113|NCT01425463|323977250|FG000|Overall Study|Protocol Violation|2|||
94594114|NCT01425463|323977251|FG001|Overall Study|Protocol Violation|2|||
94594115|NCT01425463|323977250|FG000|Overall Study|Lost to Follow-up|5|||
94594116|NCT01425463|323977251|FG001|Overall Study|Lost to Follow-up|2|||
94594117|NCT01425463|323977250|FG000|Overall Study|Withdrawal by Subject|7|||
94594118|NCT01425463|323977251|FG001|Overall Study|Withdrawal by Subject|5|||
94594119|NCT01425463|323977250|FG000|Overall Study|Unknown Reason|4|||
94594120|NCT01425463|323977251|FG001|Overall Study|Unknown Reason|7|||
94594121|NCT01332799|323977254|FG000|Overall Study|Insufficient funding|10|||
94594122|NCT01332799|323977255|FG001|Overall Study|Insufficient funding|10|||
94594123|NCT01317550|323977267|FG000|Overall Study|Withdrawal by Subject|1|||
94594124|NCT01317550|323977268|FG001|Overall Study|Withdrawal by Subject|0|||
94246572|NCT02535091|322697046|FG001|Overall Study|Pregnancy|0|||
94594125|NCT01317550|323977269|FG002|Overall Study|Withdrawal by Subject|0|||
94457389|NCT02829723|323463542|FG006|Overall Study|Death|2|||
94457390|NCT02829723|323463543|FG007|Overall Study|Death|0|||
94457391|NCT02829723|323463544|FG008|Overall Study|Death|1|||
94457392|NCT02829723|323463545|FG009|Overall Study|Death|0|||
94457393|NCT02829723|323463546|FG010|Overall Study|Death|0|||
94457394|NCT02829723|323463547|FG011|Overall Study|Death|0|||
94457395|NCT02829723|323463548|FG012|Overall Study|Death|2|||
94457396|NCT02829723|323463549|FG013|Overall Study|Death|1|||
94457397|NCT02829723|323463550|FG014|Overall Study|Death|0|||
94457398|NCT02829723|323463551|FG015|Overall Study|Death|0|||
94457399|NCT02829723|323463552|FG016|Overall Study|Death|0|||
94457400|NCT02829723|323463553|FG017|Overall Study|Death|0|||
94457401|NCT02829723|323463554|FG018|Overall Study|Death|0|||
94457402|NCT02829723|323463555|FG019|Overall Study|Death|0|||
94457403|NCT02829723|323463556|FG020|Overall Study|Death|0|||
94457404|NCT02829723|323463557|FG021|Overall Study|Death|2|||
94457405|NCT02829723|323463558|FG022|Overall Study|Death|0|||
94457406|NCT02829723|323463559|FG023|Overall Study|Death|0|||
94457407|NCT02829723|323463560|FG024|Overall Study|Death|0|||
94457408|NCT02829723|323463561|FG025|Overall Study|Death|1|||
94457409|NCT02829723|323463562|FG026|Overall Study|Death|2|||
94457410|NCT02829723|323463536|FG000|Overall Study|Physician Decision|0|||
94457411|NCT02829723|323463537|FG001|Overall Study|Physician Decision|0|||
94457412|NCT02829723|323463538|FG002|Overall Study|Physician Decision|0|||
94457413|NCT02829723|323463539|FG003|Overall Study|Physician Decision|0|||
94457414|NCT02829723|323463540|FG004|Overall Study|Physician Decision|0|||
94457415|NCT02829723|323463541|FG005|Overall Study|Physician Decision|0|||
94457416|NCT02829723|323463542|FG006|Overall Study|Physician Decision|0|||
94457417|NCT02829723|323463543|FG007|Overall Study|Physician Decision|0|||
94457418|NCT02829723|323463544|FG008|Overall Study|Physician Decision|0|||
94457419|NCT02829723|323463545|FG009|Overall Study|Physician Decision|1|||
94457420|NCT02829723|323463546|FG010|Overall Study|Physician Decision|1|||
94457421|NCT02829723|323463547|FG011|Overall Study|Physician Decision|0|||
94457422|NCT02829723|323463548|FG012|Overall Study|Physician Decision|0|||
94457423|NCT02829723|323463549|FG013|Overall Study|Physician Decision|1|||
94457424|NCT02829723|323463550|FG014|Overall Study|Physician Decision|0|||
94457425|NCT02829723|323463551|FG015|Overall Study|Physician Decision|0|||
94457426|NCT02829723|323463552|FG016|Overall Study|Physician Decision|2|||
94457427|NCT02829723|323463553|FG017|Overall Study|Physician Decision|0|||
94457428|NCT02829723|323463554|FG018|Overall Study|Physician Decision|0|||
94457429|NCT02829723|323463555|FG019|Overall Study|Physician Decision|0|||
94457430|NCT02829723|323463556|FG020|Overall Study|Physician Decision|0|||
94457431|NCT02829723|323463557|FG021|Overall Study|Physician Decision|0|||
94457432|NCT02829723|323463558|FG022|Overall Study|Physician Decision|1|||
94457433|NCT02829723|323463559|FG023|Overall Study|Physician Decision|1|||
94457434|NCT02829723|323463560|FG024|Overall Study|Physician Decision|1|||
94457435|NCT02829723|323463561|FG025|Overall Study|Physician Decision|1|||
94457436|NCT02829723|323463562|FG026|Overall Study|Physician Decision|3|||
94457437|NCT02829723|323463536|FG000|Overall Study|Progressive disease|4|||
94457438|NCT02829723|323463537|FG001|Overall Study|Progressive disease|6|||
94457439|NCT02829723|323463538|FG002|Overall Study|Progressive disease|3|||
94457440|NCT02829723|323463539|FG003|Overall Study|Progressive disease|3|||
94457441|NCT02829723|323463540|FG004|Overall Study|Progressive disease|3|||
94457442|NCT02829723|323463541|FG005|Overall Study|Progressive disease|5|||
94457443|NCT02829723|323463542|FG006|Overall Study|Progressive disease|4|||
94457444|NCT02829723|323463543|FG007|Overall Study|Progressive disease|6|||
94457445|NCT02829723|323463544|FG008|Overall Study|Progressive disease|8|||
94457446|NCT02829723|323463545|FG009|Overall Study|Progressive disease|4|||
94457447|NCT02829723|323463546|FG010|Overall Study|Progressive disease|9|||
94457448|NCT02829723|323463547|FG011|Overall Study|Progressive disease|0|||
94457449|NCT02829723|323463548|FG012|Overall Study|Progressive disease|3|||
94457450|NCT02829723|323463549|FG013|Overall Study|Progressive disease|4|||
94457451|NCT02829723|323463550|FG014|Overall Study|Progressive disease|2|||
94457452|NCT02829723|323463551|FG015|Overall Study|Progressive disease|4|||
94246573|NCT02535091|322697047|FG002|Overall Study|Pregnancy|7|||
94457453|NCT02829723|323463552|FG016|Overall Study|Progressive disease|5|||
94246574|NCT02643472|322697048|FG000|Overall Study|Death|2|||
94246575|NCT02643472|322697049|FG001|Overall Study|Death|5|||
94246576|NCT02643472|322697048|FG000|Overall Study|Withdrawal by Subject|3|||
94246577|NCT02643472|322697049|FG001|Overall Study|Withdrawal by Subject|2|||
94246578|NCT02643472|322697048|FG000|Overall Study|Protocol Violation|0|||
94246579|NCT02643472|322697049|FG001|Overall Study|Protocol Violation|1|||
94246580|NCT02643472|322697048|FG000|Overall Study|Lost to Follow-up|22|||
94246581|NCT02643472|322697049|FG001|Overall Study|Lost to Follow-up|26|||
94246582|NCT01012414|322697050|FG000|Overall Study|Withdrawal by Subject|2|||
94246583|NCT01012414|322697050|FG000|Overall Study|Lost to Follow-up|1|||
94246584|NCT01012414|322697050|FG000|Overall Study|Trial was stopped before completed|7|||
94246585|NCT00506441|322697051|FG000|Period 1; Open-label Period|Adverse Event|21|||
94246586|NCT00506441|322697052|FG001|Period 1; Open-label Period|Adverse Event|0|||
94246587|NCT00506441|322697051|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
94246588|NCT00506441|322697052|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
94594126|NCT01317550|323977270|FG003|Overall Study|Withdrawal by Subject|0|||
94594127|NCT01317550|323977267|FG000|Overall Study|Lack of compliance study med|1|||
94594128|NCT01317550|323977268|FG001|Overall Study|Lack of compliance study med|0|||
94594129|NCT01317550|323977269|FG002|Overall Study|Lack of compliance study med|0|||
94594130|NCT01317550|323977270|FG003|Overall Study|Lack of compliance study med|0|||
94594131|NCT03179202|323977271|FG000|Overall Study|Screen Failure|67|||
94594132|NCT03179202|323977271|FG000|Overall Study|Subject Lost to Follow Up|12|||
94594133|NCT03179202|323977271|FG000|Overall Study|Withdrawal by Subject|7|||
94594134|NCT03179202|323977271|FG000|Overall Study|Adverse Event|3|||
94594135|NCT03179202|323977271|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
94594136|NCT03179202|323977271|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
94594137|NCT03085914|323977284|FG000|Overall Study|Death|6|||
94594138|NCT03085914|323977285|FG001|Overall Study|Death|6|||
94594139|NCT03085914|323977286|FG002|Overall Study|Death|4|||
94594140|NCT03085914|323977287|FG003|Overall Study|Death|1|||
94594141|NCT03085914|323977288|FG004|Overall Study|Death|5|||
94594142|NCT03085914|323977289|FG005|Overall Study|Death|2|||
94594143|NCT03085914|323977290|FG006|Overall Study|Death|2|||
94594144|NCT03085914|323977284|FG000|Overall Study|Withdrawal by Subject|1|||
94594145|NCT03085914|323977285|FG001|Overall Study|Withdrawal by Subject|1|||
94594146|NCT03085914|323977286|FG002|Overall Study|Withdrawal by Subject|2|||
94594147|NCT03085914|323977287|FG003|Overall Study|Withdrawal by Subject|2|||
94594148|NCT03085914|323977288|FG004|Overall Study|Withdrawal by Subject|2|||
94594149|NCT03085914|323977289|FG005|Overall Study|Withdrawal by Subject|0|||
94594150|NCT03085914|323977290|FG006|Overall Study|Withdrawal by Subject|1|||
94594151|NCT03085914|323977284|FG000|Overall Study|Lost to Follow-up|0|||
94594152|NCT03085914|323977285|FG001|Overall Study|Lost to Follow-up|0|||
94594153|NCT03085914|323977286|FG002|Overall Study|Lost to Follow-up|1|||
94594154|NCT03085914|323977287|FG003|Overall Study|Lost to Follow-up|0|||
94594155|NCT03085914|323977288|FG004|Overall Study|Lost to Follow-up|0|||
94594156|NCT03085914|323977289|FG005|Overall Study|Lost to Follow-up|1|||
94594157|NCT03085914|323977290|FG006|Overall Study|Lost to Follow-up|1|||
94594158|NCT03085914|323977284|FG000|Overall Study|Reason was not specified,|2|||
94594159|NCT03085914|323977285|FG001|Overall Study|Reason was not specified,|2|||
94594160|NCT03085914|323977286|FG002|Overall Study|Reason was not specified,|2|||
94594161|NCT03085914|323977287|FG003|Overall Study|Reason was not specified,|3|||
94594162|NCT03085914|323977288|FG004|Overall Study|Reason was not specified,|3|||
94594163|NCT03085914|323977289|FG005|Overall Study|Reason was not specified,|3|||
94594164|NCT03085914|323977290|FG006|Overall Study|Reason was not specified,|6|||
94594165|NCT03085914|323977284|FG000|Overall Study|Progressive Disease|0|||
94594166|NCT03085914|323977285|FG001|Overall Study|Progressive Disease|0|||
94594167|NCT03085914|323977286|FG002|Overall Study|Progressive Disease|2|||
94594168|NCT03085914|323977287|FG003|Overall Study|Progressive Disease|2|||
94594169|NCT03085914|323977288|FG004|Overall Study|Progressive Disease|1|||
94594170|NCT03085914|323977289|FG005|Overall Study|Progressive Disease|1|||
94594171|NCT03085914|323977290|FG006|Overall Study|Progressive Disease|1|||
94594172|NCT03085914|323977284|FG000|Overall Study|Study Terminated by the Sponsor|0|||
94594173|NCT03085914|323977285|FG001|Overall Study|Study Terminated by the Sponsor|0|||
94594174|NCT03085914|323977286|FG002|Overall Study|Study Terminated by the Sponsor|0|||
94594175|NCT03085914|323977287|FG003|Overall Study|Study Terminated by the Sponsor|1|||
94594176|NCT03085914|323977288|FG004|Overall Study|Study Terminated by the Sponsor|2|||
94594177|NCT03085914|323977289|FG005|Overall Study|Study Terminated by the Sponsor|1|||
94594178|NCT03085914|323977290|FG006|Overall Study|Study Terminated by the Sponsor|0|||
94594179|NCT03135119|323977291|FG000|Overall Study|Lost to Follow-up|2|||
94594180|NCT03135119|323977292|FG001|Overall Study|Lost to Follow-up|0|||
94594181|NCT03135119|323977291|FG000|Overall Study|Physician Decision|1|||
94594182|NCT03135119|323977292|FG001|Overall Study|Physician Decision|1|||
94594183|NCT03135119|323977291|FG000|Overall Study|COVID-19 Shutdown|2|||
94594184|NCT03135119|323977292|FG001|Overall Study|COVID-19 Shutdown|2|||
94594185|NCT05315908|323977293|FG000|Overall Study|Lost to Follow-up|4477|||
94594186|NCT05315908|323977294|FG001|Overall Study|Lost to Follow-up|4606|||
94594187|NCT01561898|323977295|FG000|Overall Study|Withdrawal by Subject|0|||
94660242|NCT02843568|324210046|FG000|Overall Study|Death|3|||
94594188|NCT01561898|323977296|FG001|Overall Study|Withdrawal by Subject|8|||
94355839|NCT02493712|323085710|FG002|Overall Study|Lack of Efficacy|3|||
94594189|NCT01561898|323977297|FG002|Overall Study|Withdrawal by Subject|12|||
94594190|NCT01561898|323977298|FG003|Overall Study|Withdrawal by Subject|5|||
94594191|NCT01561898|323977295|FG000|Overall Study|Lack of Efficacy|0|||
94594192|NCT01561898|323977296|FG001|Overall Study|Lack of Efficacy|8|||
94594193|NCT01561898|323977297|FG002|Overall Study|Lack of Efficacy|10|||
94594194|NCT01561898|323977298|FG003|Overall Study|Lack of Efficacy|5|||
94594195|NCT01561898|323977295|FG000|Overall Study|Worsening of complications|0|||
94660243|NCT02843568|324210047|FG001|Overall Study|Death|3|||
94594196|NCT01561898|323977296|FG001|Overall Study|Worsening of complications|1|||
94594197|NCT01561898|323977297|FG002|Overall Study|Worsening of complications|0|||
94660244|NCT02843568|324210046|FG000|Overall Study|Withdrawal by Subject|1|||
94594198|NCT01561898|323977298|FG003|Overall Study|Worsening of complications|0|||
94594199|NCT01561898|323977295|FG000|Overall Study|Lost to Follow-up|0|||
94594200|NCT01561898|323977296|FG001|Overall Study|Lost to Follow-up|0|||
94594201|NCT01561898|323977297|FG002|Overall Study|Lost to Follow-up|1|||
94594202|NCT01561898|323977298|FG003|Overall Study|Lost to Follow-up|0|||
94594203|NCT01561898|323977295|FG000|Overall Study|Adverse Event|1|||
94594204|NCT01561898|323977296|FG001|Overall Study|Adverse Event|19|||
94594205|NCT01561898|323977297|FG002|Overall Study|Adverse Event|14|||
94594206|NCT01561898|323977298|FG003|Overall Study|Adverse Event|9|||
94594207|NCT01561898|323977295|FG000|Overall Study|Physician Decision|1|||
94594208|NCT01561898|323977296|FG001|Overall Study|Physician Decision|5|||
94594209|NCT01561898|323977297|FG002|Overall Study|Physician Decision|7|||
94594210|NCT01561898|323977298|FG003|Overall Study|Physician Decision|1|||
94594211|NCT01883453|323977305|FG000|Overall Study|No episode of common cold|25|||
94594212|NCT01883453|323977306|FG001|Overall Study|No episode of common cold|23|||
94594213|NCT00505076|323977309|FG000|Overall Study|Adverse Event|1|||
94594214|NCT00505076|323977310|FG001|Overall Study|Adverse Event|0|||
94594215|NCT00505076|323977311|FG002|Overall Study|Adverse Event|1|||
94594216|NCT00505076|323977309|FG000|Overall Study|Protocol Violation|2|||
94594217|NCT00505076|323977310|FG001|Overall Study|Protocol Violation|1|||
94594218|NCT00505076|323977311|FG002|Overall Study|Protocol Violation|2|||
94594219|NCT00505076|323977309|FG000|Overall Study|Withdrawal by Subject|0|||
94594220|NCT00505076|323977310|FG001|Overall Study|Withdrawal by Subject|1|||
94594221|NCT00505076|323977311|FG002|Overall Study|Withdrawal by Subject|2|||
94594222|NCT02123472|323977312|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
94594223|NCT02123472|323977313|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
94594224|NCT03642132|323977314|FG000|Chemotherapy Period|Adverse Event|1|||
94594225|NCT03642132|323977315|FG001|Chemotherapy Period|Adverse Event|1|||
94594226|NCT03642132|323977316|FG002|Chemotherapy Period|Adverse Event|0|||
94594227|NCT03642132|323977314|FG000|Chemotherapy Period|Physician's decision|4|||
94594228|NCT03642132|323977315|FG001|Chemotherapy Period|Physician's decision|1|||
94594229|NCT03642132|323977316|FG002|Chemotherapy Period|Physician's decision|0|||
94594230|NCT03642132|323977314|FG000|Chemotherapy Period|Progressive disease|0|||
94594231|NCT03642132|323977315|FG001|Chemotherapy Period|Progressive disease|0|||
94594232|NCT03642132|323977316|FG002|Chemotherapy Period|Progressive disease|1|||
94594233|NCT03642132|323977314|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
94594234|NCT03642132|323977315|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
94594235|NCT03642132|323977316|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
94246589|NCT00506441|322697051|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
94246590|NCT00506441|322697052|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
94246591|NCT00506441|322697051|FG000|Period 1; Open-label Period|Physician Decision|5|||
94594236|NCT03642132|323977314|FG000|Chemotherapy Period|Other|1|||
94594237|NCT03642132|323977315|FG001|Chemotherapy Period|Other|0|||
94594238|NCT03642132|323977316|FG002|Chemotherapy Period|Other|2|||
94594239|NCT03642132|323977314|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
94594240|NCT03642132|323977315|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
94594241|NCT03642132|323977316|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
94594242|NCT03642132|323977314|FG000|Maintenance Period|Adverse Event|1|||
94594243|NCT03642132|323977315|FG001|Maintenance Period|Adverse Event|2|||
94594244|NCT03642132|323977316|FG002|Maintenance Period|Adverse Event|0|||
94594245|NCT03642132|323977314|FG000|Maintenance Period|Non-compliance with study drug|0|||
94594246|NCT03642132|323977315|FG001|Maintenance Period|Non-compliance with study drug|0|||
94355840|NCT01945866|323085711|FG000|Overall Study|Eyes did not complete or were dropped|2|||
94594247|NCT03642132|323977316|FG002|Maintenance Period|Non-compliance with study drug|1|||
94594248|NCT03642132|323977314|FG000|Maintenance Period|Physician's decision|2|||
94594249|NCT03642132|323977315|FG001|Maintenance Period|Physician's decision|2|||
94355841|NCT01945866|323085712|FG001|Overall Study|Eyes did not complete or were dropped|0|||
94355842|NCT01336647|323085713|FG000|Overall Study|Lost to Follow-up|4|||
94355843|NCT01336647|323085714|FG001|Overall Study|Lost to Follow-up|1|||
94355844|NCT01336647|323085715|FG002|Overall Study|Lost to Follow-up|3|||
94355845|NCT03808298|323085716|FG000|Overall Study|Adverse Event|3|||
94355846|NCT03808298|323085716|FG000|Overall Study|Physician Decision|1|||
94355847|NCT03808298|323085716|FG000|Overall Study|Withdrawal by Subject|1|||
94355848|NCT03808298|323085716|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
94355849|NCT01004822|323085720|FG000|Overall Study|Objective progression or relapse|3|||
94355850|NCT01004822|323085721|FG001|Overall Study|Objective progression or relapse|3|||
94355851|NCT01004822|323085722|FG002|Overall Study|Objective progression or relapse|0|||
94355852|NCT01004822|323085723|FG003|Overall Study|Objective progression or relapse|1|||
94355853|NCT01004822|323085724|FG004|Overall Study|Objective progression or relapse|2|||
94355854|NCT01004822|323085725|FG005|Overall Study|Objective progression or relapse|2|||
94355855|NCT01004822|323085726|FG006|Overall Study|Objective progression or relapse|1|||
94355856|NCT01004822|323085727|FG007|Overall Study|Objective progression or relapse|4|||
94355857|NCT01004822|323085720|FG000|Overall Study|Global deterioration of health status|0|||
94355858|NCT01004822|323085721|FG001|Overall Study|Global deterioration of health status|0|||
94355859|NCT01004822|323085722|FG002|Overall Study|Global deterioration of health status|0|||
94355860|NCT01004822|323085723|FG003|Overall Study|Global deterioration of health status|1|||
94355861|NCT01004822|323085724|FG004|Overall Study|Global deterioration of health status|0|||
94355862|NCT01004822|323085725|FG005|Overall Study|Global deterioration of health status|0|||
94355863|NCT01004822|323085726|FG006|Overall Study|Global deterioration of health status|1|||
94355864|NCT01004822|323085727|FG007|Overall Study|Global deterioration of health status|0|||
94355865|NCT01004822|323085720|FG000|Overall Study|No longer willing to continue|0|||
94355866|NCT01004822|323085721|FG001|Overall Study|No longer willing to continue|0|||
94355867|NCT01004822|323085722|FG002|Overall Study|No longer willing to continue|0|||
94355868|NCT01004822|323085723|FG003|Overall Study|No longer willing to continue|1|||
94355869|NCT01004822|323085724|FG004|Overall Study|No longer willing to continue|2|||
94355870|NCT01004822|323085725|FG005|Overall Study|No longer willing to continue|1|||
94355871|NCT01004822|323085726|FG006|Overall Study|No longer willing to continue|1|||
94355872|NCT01004822|323085727|FG007|Overall Study|No longer willing to continue|0|||
94355873|NCT01004822|323085720|FG000|Overall Study|Adverse Event|0|||
94355874|NCT01004822|323085721|FG001|Overall Study|Adverse Event|0|||
94355875|NCT01004822|323085722|FG002|Overall Study|Adverse Event|0|||
94355876|NCT01004822|323085723|FG003|Overall Study|Adverse Event|0|||
94355877|NCT01004822|323085724|FG004|Overall Study|Adverse Event|0|||
94355878|NCT01004822|323085725|FG005|Overall Study|Adverse Event|0|||
94355879|NCT01004822|323085726|FG006|Overall Study|Adverse Event|1|||
94355880|NCT01004822|323085727|FG007|Overall Study|Adverse Event|1|||
94355881|NCT01004822|323085720|FG000|Overall Study|Other|0|||
94355882|NCT01004822|323085721|FG001|Overall Study|Other|0|||
94355883|NCT01004822|323085722|FG002|Overall Study|Other|4|||
94355884|NCT01004822|323085723|FG003|Overall Study|Other|1|||
94355885|NCT01004822|323085724|FG004|Overall Study|Other|0|||
94355886|NCT01004822|323085725|FG005|Overall Study|Other|1|||
94355887|NCT01004822|323085726|FG006|Overall Study|Other|0|||
94355888|NCT01004822|323085727|FG007|Overall Study|Other|0|||
94355889|NCT01674010|323085728|FG000|Open Treatment Phase 1|Adverse Event|10|||
94355890|NCT01674010|323085729|FG001|Open Treatment Phase 1|Adverse Event|0|||
94355891|NCT01674010|323085730|FG002|Open Treatment Phase 1|Adverse Event|0|||
94355892|NCT01674010|323085728|FG000|Open Treatment Phase 1|Death|1|||
94355893|NCT01674010|323085729|FG001|Open Treatment Phase 1|Death|0|||
94355894|NCT01674010|323085730|FG002|Open Treatment Phase 1|Death|0|||
94355895|NCT01674010|323085728|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
94355896|NCT01674010|323085729|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
94355897|NCT01674010|323085730|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
94355898|NCT01674010|323085728|FG000|Open Treatment Phase 1|Physician Decision|9|||
94355899|NCT01674010|323085729|FG001|Open Treatment Phase 1|Physician Decision|0|||
94355900|NCT01674010|323085730|FG002|Open Treatment Phase 1|Physician Decision|0|||
94355901|NCT01674010|323085728|FG000|Open Treatment Phase 1|Protocol Violation|7|||
94355902|NCT01674010|323085729|FG001|Open Treatment Phase 1|Protocol Violation|0|||
94355903|NCT01674010|323085730|FG002|Open Treatment Phase 1|Protocol Violation|0|||
94355904|NCT01674010|323085728|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
94355905|NCT01674010|323085729|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
94355906|NCT01674010|323085730|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
94355907|NCT01674010|323085728|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
94355908|NCT01674010|323085729|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
94355909|NCT01674010|323085730|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
94594250|NCT03642132|323977316|FG002|Maintenance Period|Physician's decision|2|||
94594251|NCT03642132|323977314|FG000|Maintenance Period|Progressive disease|9|||
94594252|NCT03642132|323977315|FG001|Maintenance Period|Progressive disease|3|||
94594253|NCT03642132|323977316|FG002|Maintenance Period|Progressive disease|6|||
94594254|NCT03642132|323977314|FG000|Maintenance Period|Other|0|||
94594255|NCT03642132|323977315|FG001|Maintenance Period|Other|0|||
94594256|NCT03642132|323977316|FG002|Maintenance Period|Other|3|||
94594257|NCT03642132|323977314|FG000|Maintenance Period|Withdrawal by Subject|1|||
94594258|NCT03642132|323977315|FG001|Maintenance Period|Withdrawal by Subject|1|||
94594259|NCT03642132|323977316|FG002|Maintenance Period|Withdrawal by Subject|2|||
94594260|NCT03642132|323977314|FG000|Follow-up Period|Other|0|||
94594261|NCT03642132|323977315|FG001|Follow-up Period|Other|0|||
94594262|NCT03642132|323977316|FG002|Follow-up Period|Other|1|||
94594263|NCT03642132|323977314|FG000|Follow-up Period|Withdrawal by Subject|1|||
94594264|NCT03642132|323977315|FG001|Follow-up Period|Withdrawal by Subject|2|||
94594265|NCT03642132|323977316|FG002|Follow-up Period|Withdrawal by Subject|0|||
94594266|NCT03642132|323977314|FG000|Follow-up Period|Study terminated by sponsor|1|||
94594267|NCT03642132|323977315|FG001|Follow-up Period|Study terminated by sponsor|0|||
94594268|NCT03642132|323977316|FG002|Follow-up Period|Study terminated by sponsor|1|||
94594269|NCT03642132|323977314|FG000|Follow-up Period|Lack of Efficacy|1|||
94594270|NCT03642132|323977315|FG001|Follow-up Period|Lack of Efficacy|0|||
94594271|NCT03642132|323977316|FG002|Follow-up Period|Lack of Efficacy|0|||
94594272|NCT03642132|323977314|FG000|Follow-up Period|Death|1|||
94594273|NCT03642132|323977315|FG001|Follow-up Period|Death|0|||
94594274|NCT03642132|323977316|FG002|Follow-up Period|Death|2|||
94594275|NCT03642132|323977314|FG000|Follow-up Period|Adverse Event|1|||
94594276|NCT03642132|323977315|FG001|Follow-up Period|Adverse Event|0|||
94594277|NCT03642132|323977316|FG002|Follow-up Period|Adverse Event|0|||
94594278|NCT00647270|323977317|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
94594279|NCT00647270|323977318|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
94594280|NCT00647270|323977319|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
94594281|NCT00647270|323977317|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
94594282|NCT00647270|323977318|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
94594283|NCT00647270|323977319|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
94594284|NCT00647270|323977317|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
94594285|NCT00647270|323977318|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
94594286|NCT00647270|323977319|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
94594287|NCT00647270|323977317|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
94594288|NCT00647270|323977318|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
94594289|NCT00647270|323977319|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
94594290|NCT00647270|323977317|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
94594291|NCT00647270|323977318|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
94594292|NCT00647270|323977319|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
94594293|NCT00647270|323977317|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
94594294|NCT00647270|323977318|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
94594295|NCT00647270|323977319|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
94594296|NCT00647270|323977317|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
94594297|NCT00647270|323977318|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
94594298|NCT00647270|323977319|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
94594299|NCT03337490|323977320|FG000|Overall Study|Withdrawal by Subject|1|||
94594300|NCT03337490|323977321|FG001|Overall Study|Withdrawal by Subject|0|||
94594301|NCT03337490|323977322|FG002|Overall Study|Withdrawal by Subject|0|||
94594302|NCT03337490|323977320|FG000|Overall Study|Lack of Efficacy|10|||
94594303|NCT03337490|323977321|FG001|Overall Study|Lack of Efficacy|12|||
94594304|NCT03337490|323977322|FG002|Overall Study|Lack of Efficacy|35|||
94594305|NCT03337490|323977320|FG000|Overall Study|Physician Decision|0|||
94594306|NCT03337490|323977321|FG001|Overall Study|Physician Decision|1|||
94594307|NCT03337490|323977322|FG002|Overall Study|Physician Decision|0|||
94594308|NCT03337490|323977320|FG000|Overall Study|Lost to Follow-up|0|||
94594309|NCT03337490|323977321|FG001|Overall Study|Lost to Follow-up|1|||
94594310|NCT03337490|323977322|FG002|Overall Study|Lost to Follow-up|0|||
94594311|NCT04493892|323977323|FG000|Overall Study|Withdrawal by Subject|15|||
94594312|NCT01541397|323977324|FG000|Overall Study|Study ended prior to data collection|4|||
94594313|NCT01541397|323977325|FG001|Overall Study|Study ended prior to data collection|2|||
94594314|NCT03595618|323977326|FG000|Overall Study|Adverse Event|16|||
94594315|NCT03595618|323977327|FG001|Overall Study|Adverse Event|17|||
94594316|NCT03595618|323977328|FG002|Overall Study|Adverse Event|20|||
94594317|NCT03595618|323977329|FG003|Overall Study|Adverse Event|8|||
94594318|NCT03595618|323977326|FG000|Overall Study|Withdrawal by Subject|12|||
94594319|NCT03595618|323977327|FG001|Overall Study|Withdrawal by Subject|14|||
94594320|NCT03595618|323977328|FG002|Overall Study|Withdrawal by Subject|14|||
94594321|NCT03595618|323977329|FG003|Overall Study|Withdrawal by Subject|10|||
94594322|NCT03595618|323977326|FG000|Overall Study|Lost to Follow-up|6|||
94594323|NCT03595618|323977327|FG001|Overall Study|Lost to Follow-up|4|||
94594324|NCT03595618|323977328|FG002|Overall Study|Lost to Follow-up|5|||
94594325|NCT03595618|323977329|FG003|Overall Study|Lost to Follow-up|6|||
94246592|NCT00506441|322697052|FG001|Period 1; Open-label Period|Physician Decision|0|||
94246593|NCT00506441|322697051|FG000|Period 1; Open-label Period|Protocol Violation|9|||
94246594|NCT00506441|322697052|FG001|Period 1; Open-label Period|Protocol Violation|0|||
94246595|NCT00506441|322697051|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
94246596|NCT00506441|322697052|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
94246597|NCT00506441|322697051|FG000|Period 1; Open-label Period|Other Reasons|13|||
94246598|NCT00506441|322697052|FG001|Period 1; Open-label Period|Other Reasons|0|||
94594326|NCT03595618|323977326|FG000|Overall Study|Protocol Violation|2|||
94594327|NCT03595618|323977327|FG001|Overall Study|Protocol Violation|0|||
94594328|NCT03595618|323977328|FG002|Overall Study|Protocol Violation|6|||
94594329|NCT03595618|323977329|FG003|Overall Study|Protocol Violation|2|||
94594330|NCT03595618|323977326|FG000|Overall Study|Physician Decision|0|||
94594331|NCT03595618|323977327|FG001|Overall Study|Physician Decision|0|||
94594332|NCT03595618|323977328|FG002|Overall Study|Physician Decision|1|||
94594333|NCT03595618|323977329|FG003|Overall Study|Physician Decision|2|||
94594334|NCT03595618|323977326|FG000|Overall Study|Miscellaneous|7|||
94594335|NCT03595618|323977327|FG001|Overall Study|Miscellaneous|5|||
94594336|NCT03595618|323977328|FG002|Overall Study|Miscellaneous|10|||
94594337|NCT03595618|323977329|FG003|Overall Study|Miscellaneous|6|||
94594338|NCT03554486|323977336|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
94594339|NCT03554486|323977337|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
94594340|NCT03554486|323977338|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
94594341|NCT03554486|323977336|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
94594342|NCT03554486|323977337|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
94594343|NCT03554486|323977338|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
94594344|NCT03554486|323977336|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
94594345|NCT03554486|323977337|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
94594346|NCT03554486|323977338|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
94594347|NCT00441116|323977345|FG000|Overall Study|Adverse Event|1|||
94594348|NCT00441116|323977346|FG001|Overall Study|Adverse Event|1|||
94594349|NCT00441116|323977345|FG000|Overall Study|Withdrawal by Subject|1|||
94594350|NCT00441116|323977346|FG001|Overall Study|Withdrawal by Subject|0|||
94594351|NCT00441116|323977345|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
94594352|NCT00441116|323977346|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
94594353|NCT01738477|323977347|FG000|Overall Study|Lost to Follow-up|1|||
94594354|NCT01738477|323977348|FG001|Overall Study|Lost to Follow-up|4|||
94594355|NCT01915303|323977349|FG000|Core Phase|Adverse Event|7|||
94594356|NCT01915303|323977349|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
94594357|NCT01915303|323977349|FG000|Core Phase|Death|2|||
94594358|NCT01915303|323977349|FG000|Core Phase|Protocol Violation|2|||
94594359|NCT01915303|323977349|FG000|Core Phase|Abnormal lab value|1|||
94594360|NCT01915303|323977349|FG000|Core Phase|Withdrawal by Subject|1|||
94594361|NCT01915303|323977349|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
94594362|NCT01915303|323977349|FG000|Extension Phase|Withdrawal by Subject|4|||
94594363|NCT01915303|323977349|FG000|Extension Phase|Adverse Event|3|||
94594364|NCT01915303|323977349|FG000|Extension Phase|Death|1|||
94594365|NCT01915303|323977349|FG000|Extension Phase|Protocol Violation|1|||
94594366|NCT02509117|323977351|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
94594367|NCT02509117|323977352|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
94594368|NCT02509117|323977353|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
94246599|NCT00506441|322697051|FG000|Period 2; Double-blind Period|Adverse Event|0|||
94246600|NCT00506441|322697052|FG001|Period 2; Double-blind Period|Adverse Event|1|||
94246601|NCT00506441|322697051|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
94355910|NCT01674010|323085728|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
94355911|NCT01674010|323085729|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
94594369|NCT02509117|323977354|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
94594370|NCT02509117|323977355|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
94594371|NCT02509117|323977356|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
94594372|NCT02509117|323977357|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
94594373|NCT02509117|323977358|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
94594374|NCT02509117|323977359|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
94246602|NCT00506441|322697052|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
94594375|NCT02509117|323977360|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
94594376|NCT02509117|323977351|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
94594377|NCT02509117|323977352|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
94594378|NCT02509117|323977353|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
94594379|NCT02509117|323977354|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
94594380|NCT02509117|323977355|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
94594381|NCT02509117|323977356|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
94594382|NCT02509117|323977357|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
94594383|NCT02509117|323977358|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
94594384|NCT02509117|323977359|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
94660245|NCT02843568|324210047|FG001|Overall Study|Withdrawal by Subject|1|||
94660246|NCT02843568|324210046|FG000|Overall Study|Lost to Follow-up|2|||
94660247|NCT02843568|324210047|FG001|Overall Study|Lost to Follow-up|0|||
94660248|NCT00797667|324210050|FG000|Overall Study|Lack of Efficacy|0|||
94660249|NCT00797667|324210051|FG001|Overall Study|Lack of Efficacy|1|||
94660250|NCT00797667|324210052|FG002|Overall Study|Lack of Efficacy|0|||
94660251|NCT00797667|324210050|FG000|Overall Study|Lost to Follow-up|8|||
94660252|NCT00797667|324210051|FG001|Overall Study|Lost to Follow-up|12|||
94594385|NCT02509117|323977360|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
94594386|NCT02509117|323977351|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
94594387|NCT02509117|323977352|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
94594388|NCT02509117|323977353|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
94594389|NCT02509117|323977354|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
94594390|NCT02509117|323977355|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
94594391|NCT02509117|323977356|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
94594392|NCT02509117|323977357|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
94594393|NCT02509117|323977358|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
94594394|NCT02509117|323977359|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
94594395|NCT02509117|323977360|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
94594396|NCT00145119|323977361|FG000|Overall Study|Death|45|||
94594397|NCT00832624|323977362|FG000|Overall Study|Study Terminated|10|||
94594398|NCT00796991|323977370|FG000|Overall Study|Adverse Event|0|||
94594399|NCT00796991|323977371|FG001|Overall Study|Adverse Event|0|||
94594400|NCT00796991|323977372|FG002|Overall Study|Adverse Event|1|||
94594401|NCT00796991|323977370|FG000|Overall Study|Death|2|||
94594402|NCT00796991|323977371|FG001|Overall Study|Death|0|||
94594403|NCT00796991|323977372|FG002|Overall Study|Death|0|||
94594404|NCT00796991|323977370|FG000|Overall Study|Disease Progression|10|||
94594405|NCT00796991|323977371|FG001|Overall Study|Disease Progression|9|||
94594406|NCT00796991|323977372|FG002|Overall Study|Disease Progression|7|||
94594407|NCT00796991|323977370|FG000|Overall Study|Study Drug Toxicity|3|||
94594408|NCT00796991|323977371|FG001|Overall Study|Study Drug Toxicity|3|||
94594409|NCT00796991|323977372|FG002|Overall Study|Study Drug Toxicity|5|||
94594410|NCT00796991|323977370|FG000|Overall Study|Withdrawal by Subject|0|||
94594411|NCT00796991|323977371|FG001|Overall Study|Withdrawal by Subject|0|||
94594412|NCT00796991|323977372|FG002|Overall Study|Withdrawal by Subject|1|||
94594413|NCT01031836|323980239|FG000|Stage I|Adverse Event|1|||
94594414|NCT01031836|323980240|FG001|Stage I|Adverse Event|1|||
94594415|NCT01031836|323980241|FG002|Stage I|Adverse Event|0|||
94594416|NCT01031836|323980242|FG003|Stage I|Adverse Event|0|||
94594417|NCT01031836|323980243|FG004|Stage I|Adverse Event|0|||
94594418|NCT01031836|323980244|FG005|Stage I|Adverse Event|0|||
94594419|NCT01031836|323980239|FG000|Stage I|Other|0|||
94594420|NCT01031836|323980240|FG001|Stage I|Other|1|||
94594421|NCT01031836|323980241|FG002|Stage I|Other|0|||
94594422|NCT01031836|323980242|FG003|Stage I|Other|0|||
94594423|NCT01031836|323980243|FG004|Stage I|Other|0|||
94594424|NCT01031836|323980244|FG005|Stage I|Other|1|||
94594425|NCT01031836|323980239|FG000|Stage II|Adverse Event|0|||
94594426|NCT01031836|323980240|FG001|Stage II|Adverse Event|0|||
94594427|NCT01031836|323980241|FG002|Stage II|Adverse Event|2|||
94594428|NCT01031836|323980242|FG003|Stage II|Adverse Event|2|||
94594429|NCT01031836|323980243|FG004|Stage II|Adverse Event|1|||
94594430|NCT01031836|323980244|FG005|Stage II|Adverse Event|1|||
94594431|NCT01031836|323980239|FG000|Stage II|Other|2|||
94594432|NCT01031836|323980240|FG001|Stage II|Other|0|||
94594433|NCT01031836|323980241|FG002|Stage II|Other|0|||
94594434|NCT01031836|323980242|FG003|Stage II|Other|1|||
94594435|NCT01031836|323980243|FG004|Stage II|Other|1|||
94594436|NCT01031836|323980244|FG005|Stage II|Other|0|||
94594437|NCT01330017|323980248|FG000|Overall Study|Adverse Event|0|||
94594438|NCT01330017|323980249|FG001|Overall Study|Adverse Event|1|||
94246603|NCT00506441|322697051|FG000|Period 2; Double-blind Period|Physician Decision|1|||
94246604|NCT00506441|322697052|FG001|Period 2; Double-blind Period|Physician Decision|1|||
94246605|NCT00506441|322697051|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
94457454|NCT02829723|323463553|FG017|Overall Study|Progressive disease|3|||
94594439|NCT01330017|323980250|FG002|Overall Study|Adverse Event|1|||
94594440|NCT01330017|323980251|FG003|Overall Study|Adverse Event|4|||
94594441|NCT01330017|323980252|FG004|Overall Study|Adverse Event|0|||
94246606|NCT00506441|322697052|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
94246607|NCT00506441|322697051|FG000|Period 2; Double-blind Period|Other Reason|1|||
94246608|NCT00506441|322697052|FG001|Period 2; Double-blind Period|Other Reason|1|||
94246609|NCT00688870|322697055|FG000|Infant Series|Parent or legal guardian request|4|||
94246610|NCT00688870|322697056|FG001|Infant Series|Parent or legal guardian request|0|||
94246611|NCT00528931|322697057|FG000|Overall Study|Lost to Follow-up|1|||
94246612|NCT00291642|322697060|FG000|Overall Study|Adverse Event|1|||
94246613|NCT00291642|322697061|FG001|Overall Study|Adverse Event|0|||
94246614|NCT00291642|322697062|FG002|Overall Study|Adverse Event|1|||
94246615|NCT00291642|322697063|FG003|Overall Study|Adverse Event|0|||
94246616|NCT00291642|322697064|FG004|Overall Study|Adverse Event|1|||
94246617|NCT00291642|322697060|FG000|Overall Study|Patient missed visit|0|||
94246618|NCT00291642|322697061|FG001|Overall Study|Patient missed visit|0|||
94246619|NCT00291642|322697062|FG002|Overall Study|Patient missed visit|1|||
94246620|NCT00291642|322697063|FG003|Overall Study|Patient missed visit|0|||
94246621|NCT00291642|322697064|FG004|Overall Study|Patient missed visit|0|||
94246622|NCT00291642|322697060|FG000|Overall Study|Intake of prohibited medication|1|||
94594442|NCT01330017|323980248|FG000|Overall Study|Withdrawal by Subject|0|||
94594443|NCT01330017|323980249|FG001|Overall Study|Withdrawal by Subject|0|||
94594444|NCT01330017|323980250|FG002|Overall Study|Withdrawal by Subject|1|||
94594445|NCT01330017|323980251|FG003|Overall Study|Withdrawal by Subject|0|||
94594446|NCT01330017|323980252|FG004|Overall Study|Withdrawal by Subject|1|||
94594447|NCT01330017|323980248|FG000|Overall Study|Lost to Follow-up|0|||
94594448|NCT01330017|323980249|FG001|Overall Study|Lost to Follow-up|0|||
94594449|NCT01330017|323980250|FG002|Overall Study|Lost to Follow-up|1|||
94594450|NCT01330017|323980251|FG003|Overall Study|Lost to Follow-up|0|||
94594451|NCT01330017|323980252|FG004|Overall Study|Lost to Follow-up|0|||
94594452|NCT01330017|323980248|FG000|Overall Study|Protocol Violation|0|||
94594453|NCT01330017|323980249|FG001|Overall Study|Protocol Violation|0|||
94594454|NCT01330017|323980250|FG002|Overall Study|Protocol Violation|0|||
94594455|NCT01330017|323980251|FG003|Overall Study|Protocol Violation|1|||
94594456|NCT01330017|323980252|FG004|Overall Study|Protocol Violation|0|||
94594457|NCT01330017|323980248|FG000|Overall Study|Unknown Reason|5|||
94594458|NCT01330017|323980249|FG001|Overall Study|Unknown Reason|3|||
94594459|NCT01330017|323980250|FG002|Overall Study|Unknown Reason|5|||
94594460|NCT01330017|323980251|FG003|Overall Study|Unknown Reason|7|||
94594461|NCT01330017|323980252|FG004|Overall Study|Unknown Reason|2|||
94594462|NCT01888432|323980253|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
94594463|NCT01888432|323980254|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
94594464|NCT01888432|323980253|FG000|12-month Analysis (FAS)|Physician Decision|1|||
94594465|NCT01888432|323980254|FG001|12-month Analysis (FAS)|Physician Decision|1|||
94594466|NCT01888432|323980253|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
94594467|NCT01888432|323980254|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
94594468|NCT01888432|323980253|FG000|12-month Analysis (FAS)|Death|4|||
94594469|NCT01888432|323980254|FG001|12-month Analysis (FAS)|Death|3|||
94594470|NCT01888432|323980253|FG000|24-month Analysis (FAS)|Graft loss|0|||
94594471|NCT01888432|323980254|FG001|24-month Analysis (FAS)|Graft loss|1|||
94594472|NCT01888432|323980253|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
94594473|NCT01888432|323980254|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
94594474|NCT01888432|323980253|FG000|24-month Analysis (FAS)|Physician Decision|2|||
94594475|NCT01888432|323980254|FG001|24-month Analysis (FAS)|Physician Decision|4|||
94594476|NCT01888432|323980253|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
94594477|NCT01888432|323980254|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
94594478|NCT01888432|323980253|FG000|24-month Analysis (FAS)|Death|8|||
94594479|NCT01888432|323980254|FG001|24-month Analysis (FAS)|Death|4|||
94594480|NCT01888432|323980253|FG000|36-month Analysis (Extension)|Death|1|||
94594481|NCT01888432|323980254|FG001|36-month Analysis (Extension)|Death|0|||
94594482|NCT00130247|323980257|FG000|Overall Study|Pregnancy|1|||
94594483|NCT00130247|323980258|FG001|Overall Study|Pregnancy|0|||
94594484|NCT00130247|323980257|FG000|Overall Study|Post-randomization exclusion|1|||
94594485|NCT00130247|323980258|FG001|Overall Study|Post-randomization exclusion|2|||
94594486|NCT00130247|323980257|FG000|Overall Study|Not compliant with DOT|0|||
94594487|NCT00130247|323980258|FG001|Overall Study|Not compliant with DOT|2|||
94594488|NCT01696929|323980259|FG000|Overall Study|Physician Decision|1|||
94594489|NCT04681352|323980260|FG000|Overall Study|Lost to Follow-up|2|||
94594490|NCT04681352|323980260|FG000|Overall Study|Withdrawal by Subject|22|||
94594491|NCT00336856|323980261|FG000|Overall Study|Withdrawal by Subject|3|||
94594492|NCT00336856|323980261|FG000|Overall Study|Found ineligible at time of analysis|1|||
94594493|NCT04473235|323980262|FG000|Overall Study|Lost to Follow-up|6|||
94594494|NCT04473235|323980263|FG001|Overall Study|Lost to Follow-up|5|||
94594495|NCT04473235|323980262|FG000|Overall Study|Declined continuation|2|||
94594496|NCT04473235|323980263|FG001|Overall Study|Declined continuation|0|||
94594497|NCT04473235|323980262|FG000|Overall Study|Physician Decision|1|||
94594498|NCT04473235|323980263|FG001|Overall Study|Physician Decision|1|||
94594499|NCT04473235|323980262|FG000|Overall Study|Protocol Violation|10|||
94594500|NCT04473235|323980263|FG001|Overall Study|Protocol Violation|6|||
94594501|NCT02522624|323980264|FG000|Overall Study|Technical failure|1|||
94594502|NCT02522624|323980265|FG001|Overall Study|Technical failure|0|||
94594503|NCT01754402|323980266|FG000|Overall Study|Death|0|||
94594504|NCT01754402|323980267|FG001|Overall Study|Death|0|||
94594505|NCT01754402|323980268|FG002|Overall Study|Death|1|||
94594506|NCT01754402|323980266|FG000|Overall Study|Adverse Event|2|||
94594507|NCT01754402|323980267|FG001|Overall Study|Adverse Event|2|||
94594508|NCT01754402|323980268|FG002|Overall Study|Adverse Event|1|||
94594509|NCT01754402|323980266|FG000|Overall Study|Withdrawal by Subject|0|||
94594510|NCT01754402|323980267|FG001|Overall Study|Withdrawal by Subject|0|||
94594511|NCT01754402|323980268|FG002|Overall Study|Withdrawal by Subject|1|||
94594512|NCT01754402|323980266|FG000|Overall Study|Lack of Efficacy|0|||
94594513|NCT01754402|323980267|FG001|Overall Study|Lack of Efficacy|0|||
94594514|NCT01754402|323980268|FG002|Overall Study|Lack of Efficacy|1|||
94246623|NCT00291642|322697061|FG001|Overall Study|Intake of prohibited medication|0|||
94246624|NCT00291642|322697062|FG002|Overall Study|Intake of prohibited medication|0|||
94246625|NCT00291642|322697063|FG003|Overall Study|Intake of prohibited medication|0|||
94246626|NCT00291642|322697064|FG004|Overall Study|Intake of prohibited medication|0|||
94246627|NCT00744757|322697065|FG000|Overall Study|Objective disease progression|7|||
94246628|NCT00744757|322697065|FG000|Overall Study|Physician Decision|5|||
94246629|NCT00744757|322697065|FG000|Overall Study|Withdrawal by Subject|1|||
94246630|NCT00744757|322697065|FG000|Overall Study|Death|6|||
94246631|NCT00744757|322697065|FG000|Overall Study|Adverse Event|2|||
94246632|NCT00735475|322697066|FG000|Overall Study|Adverse Event|0|||
94246633|NCT00735475|322697067|FG001|Overall Study|Adverse Event|1|||
94246634|NCT00735475|322697066|FG000|Overall Study|Death|1|||
94246635|NCT00735475|322697067|FG001|Overall Study|Death|1|||
94246636|NCT00735475|322697066|FG000|Overall Study|Lost to Follow-up|3|||
94246637|NCT00735475|322697067|FG001|Overall Study|Lost to Follow-up|3|||
94246638|NCT00735475|322697066|FG000|Overall Study|Physician Decision|0|||
94246639|NCT00735475|322697067|FG001|Overall Study|Physician Decision|1|||
94246640|NCT00735475|322697066|FG000|Overall Study|Withdrawal by Subject|4|||
94246641|NCT00735475|322697067|FG001|Overall Study|Withdrawal by Subject|5|||
94246642|NCT01278173|322697068|FG000|Overall Study|Lack of Efficacy|13|||
94246643|NCT01278173|322697068|FG000|Overall Study|Adverse Event|8|||
94246644|NCT01278173|322697068|FG000|Overall Study|Administrative or other reason|4|||
94246645|NCT01278173|322697068|FG000|Overall Study|Protocol Violation|1|||
94246646|NCT01278173|322697068|FG000|Overall Study|Withdrawal by Subject|1|||
94246647|NCT02217501|322697079|FG000|Overall Study|Death|3|||
94246648|NCT02217501|322697080|FG001|Overall Study|Death|4|||
94246649|NCT01394978|322697081|FG000|Overall Study|Withdrawal by Subject|2|||
94246650|NCT01394978|322697082|FG001|Overall Study|Withdrawal by Subject|4|||
94246651|NCT01394978|322697081|FG000|Overall Study|Lost to Follow-up|13|||
94246652|NCT01394978|322697082|FG001|Overall Study|Lost to Follow-up|20|||
94246653|NCT01394978|322697081|FG000|Overall Study|Death|6|||
94246654|NCT01394978|322697082|FG001|Overall Study|Death|7|||
94246655|NCT00658788|322697083|FG000|Overall Study|Adverse Event|11|||
94246656|NCT00658788|322697083|FG000|Overall Study|Withdrawal by Subject|13|||
94246657|NCT00658788|322697083|FG000|Overall Study|Lost to Follow-up|18|||
94246658|NCT00658788|322697083|FG000|Overall Study|Treatment Discontinuation|32|||
94246659|NCT00653523|322697084|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
94246660|NCT00653523|322697084|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
94246661|NCT00653523|322697084|FG000|Overall Study|Adverse Event|7|||
94246662|NCT00653523|322697084|FG000|Overall Study|Withdrawal by Subject|6|||
94246663|NCT00653523|322697084|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
94246664|NCT00653523|322697084|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
94246665|NCT02297139|322697085|FG000|Overall Study|Disease progression|0|||
94246666|NCT02297139|322697086|FG001|Overall Study|Disease progression|1|||
94246667|NCT02297139|322697085|FG000|Overall Study|Study drug toxicity|0|||
94246668|NCT02297139|322697086|FG001|Overall Study|Study drug toxicity|4|||
94246669|NCT02297139|322697085|FG000|Overall Study|Participant request to discontinue study treatment|0|||
94246670|NCT02297139|322697086|FG001|Overall Study|Participant request to discontinue study treatment|1|||
94246671|NCT02297139|322697085|FG000|Overall Study|Maximum clinical benefit|1|||
94246672|NCT02297139|322697086|FG001|Overall Study|Maximum clinical benefit|0|||
94246673|NCT02297139|322697085|FG000|Overall Study|Administrative reason by sponsor|0|||
94246674|NCT02297139|322697086|FG001|Overall Study|Administrative reason by sponsor|2|||
94246675|NCT02297139|322697085|FG000|Overall Study|Other reasons|0|||
94246676|NCT02297139|322697086|FG001|Overall Study|Other reasons|8|||
94246677|NCT00847808|322697087|FG000|Overall Study|Adverse Event|7|||
94246678|NCT00847808|322697087|FG000|Overall Study|Protocol Violation|1|||
94246679|NCT00847808|322697087|FG000|Overall Study|Lost to Follow-up|1|||
94246680|NCT00847808|322697087|FG000|Overall Study|Withdrawal by Subject|4|||
94246681|NCT00847808|322697087|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
94246682|NCT00847808|322697087|FG000|Overall Study|Participant Took Excluded Medication|1|||
94246683|NCT02432196|322697088|FG000|Overall Study|Exit - did not receive study device|1|||
94246684|NCT02432196|322697088|FG000|Overall Study|Death|2|||
94246685|NCT02432196|322697088|FG000|Overall Study|Reoperation|3|||
94246686|NCT01698905|322697092|FG000|Overall Study|Adverse Event|4|||
94246687|NCT01698905|322697092|FG000|Overall Study|Physician Decision|2|||
94594515|NCT00955305|323980269|FG000|Overall Study|Disease progression|39|||
94594516|NCT00955305|323980270|FG001|Overall Study|Disease progression|41|||
94594517|NCT00955305|323980269|FG000|Overall Study|Adverse Event|22|||
94594518|NCT00955305|323980270|FG001|Overall Study|Adverse Event|22|||
94594519|NCT00955305|323980269|FG000|Overall Study|Death|2|||
94594520|NCT00955305|323980270|FG001|Overall Study|Death|1|||
94594521|NCT00955305|323980269|FG000|Overall Study|Withdrawal by Subject|5|||
94594522|NCT00955305|323980270|FG001|Overall Study|Withdrawal by Subject|4|||
94594523|NCT00955305|323980269|FG000|Overall Study|Alternative therapy|4|||
94594524|NCT00955305|323980270|FG001|Overall Study|Alternative therapy|0|||
94594525|NCT00955305|323980269|FG000|Overall Study|Other complicating disease|2|||
94594526|NCT00955305|323980270|FG001|Overall Study|Other complicating disease|4|||
94594527|NCT00955305|323980269|FG000|Overall Study|Physician Decision|1|||
94594528|NCT00955305|323980270|FG001|Overall Study|Physician Decision|0|||
94594529|NCT00955305|323980269|FG000|Overall Study|Continued presence of residual disease|0|||
94594530|NCT00955305|323980270|FG001|Overall Study|Continued presence of residual disease|1|||
94594531|NCT00955305|323980269|FG000|Overall Study|Functional decline|2|||
94594532|NCT00955305|323980270|FG001|Overall Study|Functional decline|0|||
94594533|NCT00955305|323980269|FG000|Overall Study|Maximum response achieved|0|||
94594534|NCT00955305|323980270|FG001|Overall Study|Maximum response achieved|1|||
94594535|NCT00955305|323980269|FG000|Overall Study|Lost to Follow-up|0|||
94594536|NCT00955305|323980270|FG001|Overall Study|Lost to Follow-up|1|||
94594537|NCT00955305|323980269|FG000|Overall Study|No off-treatment reason submitted|1|||
94594538|NCT00955305|323980270|FG001|Overall Study|No off-treatment reason submitted|0|||
94594539|NCT00955305|323980269|FG000|Overall Study|Never started protocol treatment|5|||
94594540|NCT00955305|323980270|FG001|Overall Study|Never started protocol treatment|5|||
94594541|NCT00955305|323980269|FG000|Overall Study|Ineligible|5|||
94594542|NCT00955305|323980270|FG001|Overall Study|Ineligible|7|||
94594543|NCT00109590|323980271|FG000|Overall Study|Lost to Follow-up|1|||
94594544|NCT00109590|323980272|FG001|Overall Study|Lost to Follow-up|0|||
94594545|NCT00109590|323980273|FG002|Overall Study|Lost to Follow-up|1|||
94594546|NCT00109590|323980271|FG000|Overall Study|Never Started Treatment|1|||
94594547|NCT00109590|323980272|FG001|Overall Study|Never Started Treatment|2|||
94594548|NCT00109590|323980273|FG002|Overall Study|Never Started Treatment|3|||
94594549|NCT01221285|323980274|FG000|Overall Study|Withdrawal by Subject|1|||
94594550|NCT01325337|323980282|FG000|Overall Study|Adverse Event|0|||
94594551|NCT01325337|323980283|FG001|Overall Study|Adverse Event|2|||
94594552|NCT01325337|323980284|FG002|Overall Study|Adverse Event|2|||
94594553|NCT01325337|323980285|FG003|Overall Study|Adverse Event|1|||
94594554|NCT01325337|323980286|FG004|Overall Study|Adverse Event|2|||
94594555|NCT01325337|323980282|FG000|Overall Study|Lost to Follow-up|2|||
94594556|NCT01325337|323980283|FG001|Overall Study|Lost to Follow-up|2|||
94594557|NCT01325337|323980284|FG002|Overall Study|Lost to Follow-up|2|||
94594558|NCT01325337|323980285|FG003|Overall Study|Lost to Follow-up|1|||
94594559|NCT01325337|323980286|FG004|Overall Study|Lost to Follow-up|2|||
94594560|NCT01325337|323980282|FG000|Overall Study|Personal Reasons|2|||
94594561|NCT01325337|323980283|FG001|Overall Study|Personal Reasons|5|||
94594562|NCT01325337|323980284|FG002|Overall Study|Personal Reasons|4|||
94594563|NCT01325337|323980285|FG003|Overall Study|Personal Reasons|8|||
94594564|NCT01325337|323980286|FG004|Overall Study|Personal Reasons|3|||
94594565|NCT01325337|323980282|FG000|Overall Study|Withdrawal by Subject|1|||
94594566|NCT01325337|323980283|FG001|Overall Study|Withdrawal by Subject|0|||
94246688|NCT01698905|322697092|FG000|Overall Study|Pregnancy|1|||
94594567|NCT01325337|323980284|FG002|Overall Study|Withdrawal by Subject|1|||
94594568|NCT01325337|323980285|FG003|Overall Study|Withdrawal by Subject|0|||
94246689|NCT01698905|322697092|FG000|Overall Study|Protocol Violation|1|||
94594569|NCT01325337|323980286|FG004|Overall Study|Withdrawal by Subject|1|||
94594570|NCT03472547|323980289|FG000|Overall Study|Withdrawal by Subject|30|||
94594571|NCT00727441|323980290|FG000|Overall Study|Disease Progression|11|||
94594572|NCT00727441|323980291|FG001|Overall Study|Disease Progression|14|||
94594573|NCT00727441|323980292|FG002|Overall Study|Disease Progression|17|||
94594574|NCT00727441|323980290|FG000|Overall Study|Eligibility|7|||
94594575|NCT00727441|323980291|FG001|Overall Study|Eligibility|5|||
94594576|NCT00727441|323980292|FG002|Overall Study|Eligibility|7|||
94594577|NCT00727441|323980290|FG000|Overall Study|Death|0|||
94594578|NCT00727441|323980291|FG001|Overall Study|Death|1|||
94594579|NCT00727441|323980292|FG002|Overall Study|Death|1|||
94594580|NCT00727441|323980290|FG000|Overall Study|Physician Decision|0|||
94594581|NCT00727441|323980291|FG001|Overall Study|Physician Decision|1|||
94594582|NCT00727441|323980292|FG002|Overall Study|Physician Decision|0|||
94594583|NCT00727441|323980290|FG000|Overall Study|Withdrawal by Subject|0|||
94594584|NCT00727441|323980291|FG001|Overall Study|Withdrawal by Subject|1|||
94594585|NCT00727441|323980292|FG002|Overall Study|Withdrawal by Subject|0|||
94594586|NCT00745849|323980293|FG000|First Intervention|Withdrawal by Subject|0|||
94594587|NCT00745849|323980294|FG001|First Intervention|Withdrawal by Subject|1|||
94594588|NCT00745849|323980293|FG000|First Intervention|Lost to Follow-up|1|||
94594589|NCT00745849|323980294|FG001|First Intervention|Lost to Follow-up|1|||
94594590|NCT00745849|323980293|FG000|Second Intervention|Lost to Follow-up|2|||
94594591|NCT00745849|323980294|FG001|Second Intervention|Lost to Follow-up|1|||
94594592|NCT01904773|323980301|FG000|Screen|Screen failure|3|||
94594593|NCT01904773|323980302|FG001|Screen|Screen failure|0|||
94594594|NCT01904773|323980303|FG002|Screen|Screen failure|0|||
94594595|NCT01904773|323980304|FG003|Screen|Screen failure|0|||
94594596|NCT01904773|323980305|FG004|Screen|Screen failure|0|||
94594597|NCT01904773|323980306|FG005|Screen|Screen failure|0|||
94594598|NCT01904773|323980307|FG006|Screen|Screen failure|0|||
94594599|NCT01904773|323980308|FG007|Screen|Screen failure|0|||
94594600|NCT01904773|323980309|FG008|Screen|Screen failure|0|||
94594601|NCT01904773|323980301|FG000|Screen|Withdrawal by Subject|1|||
94594602|NCT01904773|323980302|FG001|Screen|Withdrawal by Subject|0|||
94594603|NCT01904773|323980303|FG002|Screen|Withdrawal by Subject|0|||
94594604|NCT01904773|323980304|FG003|Screen|Withdrawal by Subject|0|||
94594605|NCT01904773|323980305|FG004|Screen|Withdrawal by Subject|0|||
94594606|NCT01904773|323980306|FG005|Screen|Withdrawal by Subject|0|||
94594607|NCT01904773|323980307|FG006|Screen|Withdrawal by Subject|0|||
94594608|NCT01904773|323980308|FG007|Screen|Withdrawal by Subject|0|||
94594609|NCT01904773|323980309|FG008|Screen|Withdrawal by Subject|0|||
94594610|NCT01904773|323980301|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
94594611|NCT01904773|323980302|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
94594612|NCT01904773|323980303|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
94594613|NCT01904773|323980304|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
94594614|NCT01904773|323980305|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
94594615|NCT01904773|323980306|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
94594616|NCT01904773|323980307|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
94594617|NCT01904773|323980308|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
94660253|NCT00797667|324210052|FG002|Overall Study|Lost to Follow-up|2|||
94660254|NCT00797667|324210050|FG000|Overall Study|Physician Decision|3|||
94660255|NCT00797667|324210051|FG001|Overall Study|Physician Decision|1|||
94660256|NCT00797667|324210052|FG002|Overall Study|Physician Decision|0|||
94660257|NCT00797667|324210050|FG000|Overall Study|Pregnancy|2|||
94660258|NCT00797667|324210051|FG001|Overall Study|Pregnancy|0|||
94457455|NCT02829723|323463554|FG018|Overall Study|Progressive disease|4|||
94457456|NCT02829723|323463555|FG019|Overall Study|Progressive disease|4|||
94457457|NCT02829723|323463556|FG020|Overall Study|Progressive disease|7|||
94457458|NCT02829723|323463557|FG021|Overall Study|Progressive disease|6|||
94457459|NCT02829723|323463558|FG022|Overall Study|Progressive disease|3|||
94457460|NCT02829723|323463559|FG023|Overall Study|Progressive disease|3|||
94457461|NCT02829723|323463560|FG024|Overall Study|Progressive disease|3|||
94457462|NCT02829723|323463561|FG025|Overall Study|Progressive disease|16|||
94457463|NCT02829723|323463562|FG026|Overall Study|Progressive disease|10|||
94457464|NCT02829723|323463536|FG000|Overall Study|Subject/guardian decision|0|||
94457465|NCT02829723|323463537|FG001|Overall Study|Subject/guardian decision|1|||
94457466|NCT02829723|323463538|FG002|Overall Study|Subject/guardian decision|0|||
94457467|NCT02829723|323463539|FG003|Overall Study|Subject/guardian decision|1|||
94457468|NCT02829723|323463540|FG004|Overall Study|Subject/guardian decision|0|||
94457469|NCT02829723|323463541|FG005|Overall Study|Subject/guardian decision|0|||
94457470|NCT02829723|323463542|FG006|Overall Study|Subject/guardian decision|0|||
94457471|NCT02829723|323463543|FG007|Overall Study|Subject/guardian decision|1|||
94457472|NCT02829723|323463544|FG008|Overall Study|Subject/guardian decision|0|||
94457473|NCT02829723|323463545|FG009|Overall Study|Subject/guardian decision|0|||
94457474|NCT02829723|323463546|FG010|Overall Study|Subject/guardian decision|0|||
94457475|NCT02829723|323463547|FG011|Overall Study|Subject/guardian decision|0|||
94457476|NCT02829723|323463548|FG012|Overall Study|Subject/guardian decision|0|||
94457477|NCT02829723|323463549|FG013|Overall Study|Subject/guardian decision|0|||
94457478|NCT02829723|323463550|FG014|Overall Study|Subject/guardian decision|1|||
94457479|NCT02829723|323463551|FG015|Overall Study|Subject/guardian decision|0|||
94457480|NCT02829723|323463552|FG016|Overall Study|Subject/guardian decision|1|||
94457481|NCT02829723|323463553|FG017|Overall Study|Subject/guardian decision|0|||
94457482|NCT02829723|323463554|FG018|Overall Study|Subject/guardian decision|1|||
94457483|NCT02829723|323463555|FG019|Overall Study|Subject/guardian decision|0|||
94457484|NCT02829723|323463556|FG020|Overall Study|Subject/guardian decision|1|||
94457485|NCT02829723|323463557|FG021|Overall Study|Subject/guardian decision|0|||
94457486|NCT02829723|323463558|FG022|Overall Study|Subject/guardian decision|0|||
94594618|NCT01904773|323980309|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
94594619|NCT01904773|323980301|FG000|First Intervention|Adverse Event|0|||
94594620|NCT01904773|323980302|FG001|First Intervention|Adverse Event|0|||
94594621|NCT01904773|323980303|FG002|First Intervention|Adverse Event|0|||
94594622|NCT01904773|323980304|FG003|First Intervention|Adverse Event|0|||
94594623|NCT01904773|323980305|FG004|First Intervention|Adverse Event|0|||
94457487|NCT02829723|323463559|FG023|Overall Study|Subject/guardian decision|1|||
94457488|NCT02829723|323463560|FG024|Overall Study|Subject/guardian decision|0|||
94457489|NCT02829723|323463561|FG025|Overall Study|Subject/guardian decision|1|||
94594624|NCT01904773|323980306|FG005|First Intervention|Adverse Event|0|||
94594625|NCT01904773|323980307|FG006|First Intervention|Adverse Event|1|||
94594626|NCT01904773|323980308|FG007|First Intervention|Adverse Event|0|||
94594627|NCT01904773|323980309|FG008|First Intervention|Adverse Event|0|||
94594628|NCT01904773|323980301|FG000|Placebo Washout First Intervention|Condition worsened|0|||
94594629|NCT01904773|323980302|FG001|Placebo Washout First Intervention|Condition worsened|1|||
94594630|NCT01904773|323980303|FG002|Placebo Washout First Intervention|Condition worsened|0|||
94594631|NCT01904773|323980304|FG003|Placebo Washout First Intervention|Condition worsened|0|||
94594632|NCT01904773|323980305|FG004|Placebo Washout First Intervention|Condition worsened|0|||
94594633|NCT01904773|323980306|FG005|Placebo Washout First Intervention|Condition worsened|0|||
94594634|NCT01904773|323980307|FG006|Placebo Washout First Intervention|Condition worsened|0|||
94594635|NCT01904773|323980308|FG007|Placebo Washout First Intervention|Condition worsened|0|||
94594636|NCT01904773|323980309|FG008|Placebo Washout First Intervention|Condition worsened|0|||
94594637|NCT01904773|323980301|FG000|Fifth Intervention|Adverse Event|0|||
94594638|NCT01904773|323980302|FG001|Fifth Intervention|Adverse Event|0|||
94594639|NCT01904773|323980303|FG002|Fifth Intervention|Adverse Event|0|||
94594640|NCT01904773|323980304|FG003|Fifth Intervention|Adverse Event|0|||
94594641|NCT01904773|323980305|FG004|Fifth Intervention|Adverse Event|0|||
94594642|NCT01904773|323980306|FG005|Fifth Intervention|Adverse Event|0|||
94594643|NCT01904773|323980307|FG006|Fifth Intervention|Adverse Event|0|||
94594644|NCT01904773|323980308|FG007|Fifth Intervention|Adverse Event|1|||
94594645|NCT01904773|323980309|FG008|Fifth Intervention|Adverse Event|0|||
94594646|NCT01904773|323980301|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
94594647|NCT01904773|323980302|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
94594648|NCT01904773|323980303|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
94594649|NCT01904773|323980304|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
94594650|NCT01904773|323980305|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
94594651|NCT01904773|323980306|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
94594652|NCT01904773|323980307|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
94594653|NCT01904773|323980308|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
94594654|NCT01904773|323980309|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
94594655|NCT00220779|323980313|FG000|Overall Study|Adverse Event|1|||
94594656|NCT00220779|323980314|FG001|Overall Study|Adverse Event|0|||
94594657|NCT00220779|323980315|FG002|Overall Study|Adverse Event|0|||
94594658|NCT00220779|323980313|FG000|Overall Study|Withdrawal by Subject|1|||
94594659|NCT00220779|323980314|FG001|Overall Study|Withdrawal by Subject|4|||
94594660|NCT00220779|323980315|FG002|Overall Study|Withdrawal by Subject|1|||
94594661|NCT00220779|323980313|FG000|Overall Study|Non-compliance|1|||
94594662|NCT00220779|323980314|FG001|Overall Study|Non-compliance|0|||
94594663|NCT00220779|323980315|FG002|Overall Study|Non-compliance|0|||
94594664|NCT00220779|323980313|FG000|Overall Study|Too time consuming|1|||
94594665|NCT00220779|323980314|FG001|Overall Study|Too time consuming|0|||
94594666|NCT00220779|323980315|FG002|Overall Study|Too time consuming|0|||
94246690|NCT01698905|322697092|FG000|Overall Study|Subject/guardian decision|2|||
94246691|NCT01698905|322697092|FG000|Overall Study|Death|1|||
94246692|NCT05000931|322697095|FG000|Overall Study|Lost to Follow-up|1|||
94246693|NCT05148962|322697096|FG000|Overall Study|Withdrawal by Subject|1|||
94246694|NCT05148962|322697097|FG001|Overall Study|Withdrawal by Subject|1|||
94246695|NCT05148962|322697098|FG002|Overall Study|Withdrawal by Subject|0|||
94246696|NCT05148962|322697099|FG003|Overall Study|Withdrawal by Subject|1|||
94246697|NCT05148962|322697100|FG004|Overall Study|Withdrawal by Subject|0|||
94246698|NCT05148962|322697096|FG000|Overall Study|Participant was early terminated per protocol|0|||
94246699|NCT05148962|322697097|FG001|Overall Study|Participant was early terminated per protocol|0|||
94246700|NCT05148962|322697098|FG002|Overall Study|Participant was early terminated per protocol|3|||
94246701|NCT05148962|322697099|FG003|Overall Study|Participant was early terminated per protocol|5|||
94246702|NCT05148962|322697100|FG004|Overall Study|Participant was early terminated per protocol|2|||
94246703|NCT05148962|322697096|FG000|Overall Study|Miscellaneous|0|||
94246704|NCT05148962|322697097|FG001|Overall Study|Miscellaneous|0|||
94246705|NCT05148962|322697098|FG002|Overall Study|Miscellaneous|0|||
94246706|NCT05148962|322697099|FG003|Overall Study|Miscellaneous|1|||
94246707|NCT05148962|322697100|FG004|Overall Study|Miscellaneous|0|||
94246708|NCT02631577|322697108|FG000|Overall Study|Death|1|||
94594667|NCT00220779|323980313|FG000|Overall Study|Pregnancy|0|||
94594668|NCT00220779|323980314|FG001|Overall Study|Pregnancy|0|||
94594669|NCT00220779|323980315|FG002|Overall Study|Pregnancy|2|||
94594670|NCT00220779|323980313|FG000|Overall Study|Lack of Efficacy|3|||
94594671|NCT00220779|323980314|FG001|Overall Study|Lack of Efficacy|0|||
94246709|NCT02631577|322697109|FG001|Overall Study|Death|7|||
94246710|NCT02631577|322697108|FG000|Overall Study|Withdrawal by Subject|0|||
94246711|NCT02631577|322697109|FG001|Overall Study|Withdrawal by Subject|3|||
94246712|NCT03738423|322697110|FG000|Overall Study|Withdrawal by Subject|9|||
94594672|NCT00220779|323980315|FG002|Overall Study|Lack of Efficacy|1|||
94594673|NCT00791076|323980316|FG000|Overall Study|Study was terminated,PI left institution|8|||
94594674|NCT00409331|323980318|FG000|Overall Study|Physician Decision|1|||
94594675|NCT02184455|323980319|FG000|Overall Study|Lost to Follow-up|1|||
94594676|NCT03390101|323980328|FG000|Weeks 0-12|Withdrawal by Subject|0|||
94594677|NCT03390101|323980329|FG001|Weeks 0-12|Withdrawal by Subject|1|||
94594678|NCT03390101|323980330|FG002|Weeks 0-12|Withdrawal by Subject|1|||
94594679|NCT03390101|323980328|FG000|Weeks 0-12|Lost to Follow-up|0|||
94594680|NCT03390101|323980329|FG001|Weeks 0-12|Lost to Follow-up|1|||
94594681|NCT03390101|323980330|FG002|Weeks 0-12|Lost to Follow-up|0|||
94594682|NCT03390101|323980328|FG000|Weeks 12-54|Withdrawal by Subject|0|||
94594683|NCT03390101|323980329|FG001|Weeks 12-54|Withdrawal by Subject|3|||
94594684|NCT03390101|323980330|FG002|Weeks 12-54|Withdrawal by Subject|1|||
94594685|NCT03390101|323980328|FG000|Weeks 12-54|Pregnancy|1|||
94594686|NCT03390101|323980329|FG001|Weeks 12-54|Pregnancy|0|||
94594687|NCT03390101|323980330|FG002|Weeks 12-54|Pregnancy|0|||
94594688|NCT03390101|323980328|FG000|Weeks 12-54|Adverse Event|2|||
94594689|NCT03390101|323980329|FG001|Weeks 12-54|Adverse Event|1|||
94594690|NCT03390101|323980330|FG002|Weeks 12-54|Adverse Event|1|||
94594691|NCT00281658|323980332|FG000|Randomized Phase|Adverse Event|0|||
94594692|NCT00281658|323980333|FG001|Randomized Phase|Adverse Event|2|||
94594693|NCT00281658|323980334|FG002|Randomized Phase|Adverse Event|0|||
94594694|NCT00281658|323980335|FG003|Randomized Phase|Adverse Event|0|||
94594695|NCT00281658|323980332|FG000|Randomized Phase|Lost to Follow-up|34|||
94594696|NCT00281658|323980333|FG001|Randomized Phase|Lost to Follow-up|27|||
94594697|NCT00281658|323980334|FG002|Randomized Phase|Lost to Follow-up|0|||
94594698|NCT00281658|323980335|FG003|Randomized Phase|Lost to Follow-up|0|||
94594699|NCT00281658|323980332|FG000|Randomized Phase|Withdrawal by Subject|8|||
94594700|NCT00281658|323980333|FG001|Randomized Phase|Withdrawal by Subject|7|||
94594701|NCT00281658|323980334|FG002|Randomized Phase|Withdrawal by Subject|0|||
94594702|NCT00281658|323980335|FG003|Randomized Phase|Withdrawal by Subject|0|||
94594703|NCT00281658|323980332|FG000|Randomized Phase|Study closed/terminated|1|||
94594704|NCT00281658|323980333|FG001|Randomized Phase|Study closed/terminated|1|||
94594705|NCT00281658|323980334|FG002|Randomized Phase|Study closed/terminated|0|||
94594706|NCT00281658|323980335|FG003|Randomized Phase|Study closed/terminated|0|||
94594707|NCT00281658|323980332|FG000|Randomized Phase|Disease progression|36|||
94594708|NCT00281658|323980333|FG001|Randomized Phase|Disease progression|27|||
94594709|NCT00281658|323980334|FG002|Randomized Phase|Disease progression|0|||
94594710|NCT00281658|323980335|FG003|Randomized Phase|Disease progression|0|||
94594711|NCT00281658|323980332|FG000|Randomized Phase|Physician Decision|1|||
94594712|NCT00281658|323980333|FG001|Randomized Phase|Physician Decision|1|||
94594713|NCT00281658|323980334|FG002|Randomized Phase|Physician Decision|0|||
94594714|NCT00281658|323980335|FG003|Randomized Phase|Physician Decision|0|||
94594715|NCT00281658|323980332|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
94594716|NCT00281658|323980333|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
94594717|NCT00281658|323980334|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
94594718|NCT00281658|323980335|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
94594719|NCT00281658|323980332|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
94594720|NCT00281658|323980333|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
94594721|NCT00281658|323980334|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
94594722|NCT00281658|323980335|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
94594723|NCT00281658|323980332|FG000|Randomized Phase|Treatment ongoing|1|||
94594724|NCT00281658|323980333|FG001|Randomized Phase|Treatment ongoing|0|||
94594725|NCT00281658|323980334|FG002|Randomized Phase|Treatment ongoing|0|||
94594726|NCT00281658|323980335|FG003|Randomized Phase|Treatment ongoing|0|||
94246713|NCT03738423|322697111|FG001|Overall Study|Withdrawal by Subject|12|||
94246714|NCT03738423|322697112|FG002|Overall Study|Withdrawal by Subject|9|||
94246715|NCT03738423|322697113|FG003|Overall Study|Withdrawal by Subject|12|||
94246716|NCT03738423|322697114|FG004|Overall Study|Withdrawal by Subject|10|||
94246717|NCT03738423|322697110|FG000|Overall Study|Lack of Efficacy|3|||
94246718|NCT03738423|322697111|FG001|Overall Study|Lack of Efficacy|1|||
94246719|NCT03738423|322697112|FG002|Overall Study|Lack of Efficacy|1|||
94246720|NCT03738423|322697113|FG003|Overall Study|Lack of Efficacy|1|||
94246721|NCT03738423|322697114|FG004|Overall Study|Lack of Efficacy|2|||
94355912|NCT01674010|323085730|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
94355913|NCT01674010|323085728|FG000|Randomization Phase 2|Adverse Event|0|||
94594727|NCT00281658|323980332|FG000|Open Label Phase|Adverse Event|0|||
94594728|NCT00281658|323980333|FG001|Open Label Phase|Adverse Event|0|||
94594729|NCT00281658|323980334|FG002|Open Label Phase|Adverse Event|1|||
94594730|NCT00281658|323980335|FG003|Open Label Phase|Adverse Event|0|||
94594731|NCT00281658|323980332|FG000|Open Label Phase|Lost to Follow-up|0|||
94594732|NCT00281658|323980333|FG001|Open Label Phase|Lost to Follow-up|0|||
94594733|NCT00281658|323980334|FG002|Open Label Phase|Lost to Follow-up|16|||
94594734|NCT00281658|323980335|FG003|Open Label Phase|Lost to Follow-up|2|||
94594735|NCT00281658|323980332|FG000|Open Label Phase|Withdrawal by Subject|0|||
94594736|NCT00281658|323980333|FG001|Open Label Phase|Withdrawal by Subject|0|||
94594737|NCT00281658|323980334|FG002|Open Label Phase|Withdrawal by Subject|3|||
94594738|NCT00281658|323980335|FG003|Open Label Phase|Withdrawal by Subject|2|||
94594739|NCT00281658|323980332|FG000|Open Label Phase|Disease progression|0|||
94594740|NCT00281658|323980333|FG001|Open Label Phase|Disease progression|0|||
94594741|NCT00281658|323980334|FG002|Open Label Phase|Disease progression|18|||
94594742|NCT00281658|323980335|FG003|Open Label Phase|Disease progression|0|||
94594743|NCT00281658|323980332|FG000|Open Label Phase|Physician Decision|0|||
94594744|NCT00281658|323980333|FG001|Open Label Phase|Physician Decision|0|||
94594745|NCT00281658|323980334|FG002|Open Label Phase|Physician Decision|1|||
94594746|NCT00281658|323980335|FG003|Open Label Phase|Physician Decision|0|||
94594747|NCT00281658|323980332|FG000|Open Label Phase|Relocation of patient|0|||
94594748|NCT00281658|323980333|FG001|Open Label Phase|Relocation of patient|0|||
94594749|NCT00281658|323980334|FG002|Open Label Phase|Relocation of patient|1|||
94594750|NCT00281658|323980335|FG003|Open Label Phase|Relocation of patient|0|||
94594751|NCT00281658|323980332|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
94594752|NCT00281658|323980333|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
94594753|NCT00281658|323980334|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
94594754|NCT00281658|323980335|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
94594755|NCT00507728|323980336|FG000|Randomization to Month 3|Lost to Follow-up|15|||
94457490|NCT02829723|323463562|FG026|Overall Study|Subject/guardian decision|1|||
94594756|NCT00507728|323980337|FG001|Randomization to Month 3|Lost to Follow-up|14|||
94594757|NCT00507728|323980338|FG002|Randomization to Month 3|Lost to Follow-up|20|||
94594758|NCT00507728|323980336|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
94594759|NCT00507728|323980337|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
94594760|NCT00507728|323980338|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
94594761|NCT04590248|323980339|FG000|Overall Study|Lost to Follow-up|1|||
94594762|NCT04590248|323980339|FG000|Overall Study|Withdrawal by Subject|16|||
94594763|NCT04590248|323980339|FG000|Overall Study|Other|2|||
94594764|NCT02052414|323980342|FG000|Overall Study|Adverse Event|12|||
94594765|NCT02052414|323980342|FG000|Overall Study|Lack of Efficacy|2|||
94594766|NCT02052414|323980342|FG000|Overall Study|Withdrawal by Subject|3|||
94246722|NCT03738423|322697110|FG000|Overall Study|Lost to Follow-up|1|||
94246723|NCT03738423|322697111|FG001|Overall Study|Lost to Follow-up|0|||
94246724|NCT03738423|322697112|FG002|Overall Study|Lost to Follow-up|1|||
94246725|NCT03738423|322697113|FG003|Overall Study|Lost to Follow-up|1|||
94246726|NCT03738423|322697114|FG004|Overall Study|Lost to Follow-up|0|||
94246727|NCT03738423|322697110|FG000|Overall Study|Protocol Violation|1|||
94246728|NCT03738423|322697111|FG001|Overall Study|Protocol Violation|0|||
94246729|NCT03738423|322697112|FG002|Overall Study|Protocol Violation|0|||
94594767|NCT02704143|323980347|FG000|Overall Study|disease progression|10|||
94594768|NCT02151773|323980348|FG000|Overall Study|Protocol Deviation|64|||
94246730|NCT03738423|322697113|FG003|Overall Study|Protocol Violation|0|||
94246731|NCT03738423|322697114|FG004|Overall Study|Protocol Violation|1|||
94594769|NCT00395343|323980349|FG000|Overall Study|Adverse Event|13|||
94594770|NCT00395343|323980350|FG001|Overall Study|Adverse Event|5|||
94594771|NCT00395343|323980349|FG000|Overall Study|Lack of Efficacy|0|||
94594772|NCT00395343|323980350|FG001|Overall Study|Lack of Efficacy|1|||
94594773|NCT00395343|323980349|FG000|Overall Study|Lost to Follow-up|4|||
94594774|NCT00395343|323980350|FG001|Overall Study|Lost to Follow-up|4|||
94594775|NCT00395343|323980349|FG000|Overall Study|Physician Decision|2|||
94594776|NCT00395343|323980350|FG001|Overall Study|Physician Decision|4|||
94594777|NCT00395343|323980349|FG000|Overall Study|Protocol Violation|6|||
94594778|NCT00395343|323980350|FG001|Overall Study|Protocol Violation|8|||
94594779|NCT00395343|323980349|FG000|Overall Study|Withdrawal by Subject|11|||
94594780|NCT00395343|323980350|FG001|Overall Study|Withdrawal by Subject|12|||
94594781|NCT00395343|323980349|FG000|Overall Study|Other|5|||
94594782|NCT00395343|323980350|FG001|Overall Study|Other|2|||
94457491|NCT02829723|323463536|FG000|Overall Study|Study terminated by sponsor|0|||
94594783|NCT03680742|323980351|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
94594784|NCT01463007|323980356|FG000|Overall Study|Physician Decision|1|||
94594785|NCT02527200|323980357|FG000|Overall Study|Withdrawal by Subject|3|||
94594786|NCT02527200|323980358|FG001|Overall Study|Withdrawal by Subject|2|||
94594787|NCT02527200|323980359|FG002|Overall Study|Withdrawal by Subject|1|||
94594788|NCT02527200|323980360|FG003|Overall Study|Withdrawal by Subject|0|||
94594789|NCT02527200|323980357|FG000|Overall Study|Unclassified|0|||
94594790|NCT02527200|323980358|FG001|Overall Study|Unclassified|1|||
94594791|NCT02527200|323980359|FG002|Overall Study|Unclassified|0|||
94594792|NCT02527200|323980360|FG003|Overall Study|Unclassified|0|||
94594793|NCT02527200|323980357|FG000|Overall Study|Lost to Follow-up|0|||
94594794|NCT02527200|323980358|FG001|Overall Study|Lost to Follow-up|0|||
94594795|NCT02527200|323980359|FG002|Overall Study|Lost to Follow-up|1|||
94594796|NCT02527200|323980360|FG003|Overall Study|Lost to Follow-up|0|||
94594797|NCT00689117|323980361|FG000|Overall Study|Adverse Event|6|||
94594798|NCT00689117|323980362|FG001|Overall Study|Adverse Event|0|||
94594799|NCT00689117|323980363|FG002|Overall Study|Adverse Event|5|||
94594800|NCT00689117|323980364|FG003|Overall Study|Adverse Event|0|||
94594801|NCT00689117|323980361|FG000|Overall Study|Lost to Follow-up|26|||
94594802|NCT00689117|323980362|FG001|Overall Study|Lost to Follow-up|19|||
94594803|NCT00689117|323980363|FG002|Overall Study|Lost to Follow-up|17|||
94594804|NCT00689117|323980364|FG003|Overall Study|Lost to Follow-up|11|||
94594805|NCT00689117|323980361|FG000|Overall Study|Lack of Efficacy|1|||
94594806|NCT00689117|323980362|FG001|Overall Study|Lack of Efficacy|2|||
94594807|NCT00689117|323980363|FG002|Overall Study|Lack of Efficacy|2|||
94594808|NCT00689117|323980364|FG003|Overall Study|Lack of Efficacy|2|||
94594809|NCT00689117|323980361|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
94594810|NCT00689117|323980362|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
94594811|NCT00689117|323980363|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
94594812|NCT00689117|323980364|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
94594813|NCT00689117|323980361|FG000|Overall Study|Withdrawal by Subject|19|||
94594814|NCT00689117|323980362|FG001|Overall Study|Withdrawal by Subject|18|||
94594815|NCT00689117|323980363|FG002|Overall Study|Withdrawal by Subject|26|||
94594816|NCT00689117|323980364|FG003|Overall Study|Withdrawal by Subject|13|||
94594817|NCT00689117|323980361|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
94660259|NCT00797667|324210052|FG002|Overall Study|Pregnancy|0|||
94660260|NCT00797667|324210050|FG000|Overall Study|Protocol Violation|2|||
94594818|NCT00689117|323980362|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
94594819|NCT00689117|323980363|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
94594820|NCT00689117|323980364|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
94246732|NCT03738423|322697110|FG000|Overall Study|Physician Decision|0|||
94246733|NCT03738423|322697111|FG001|Overall Study|Physician Decision|0|||
94246734|NCT03738423|322697112|FG002|Overall Study|Physician Decision|1|||
94246735|NCT03738423|322697113|FG003|Overall Study|Physician Decision|0|||
94246736|NCT03738423|322697114|FG004|Overall Study|Physician Decision|1|||
94594821|NCT00689117|323980361|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
94594822|NCT00689117|323980362|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
94594823|NCT00689117|323980363|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
94594824|NCT00689117|323980364|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
94594825|NCT00689117|323980361|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
94594826|NCT00689117|323980362|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
94594827|NCT00689117|323980363|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
94594828|NCT00689117|323980364|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
94594829|NCT00689117|323980361|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
94594830|NCT00689117|323980362|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
94594831|NCT00689117|323980363|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
94594832|NCT00689117|323980364|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
94594833|NCT00689117|323980361|FG000|Overall Study|Use of Prohibitive Medication|2|||
94594834|NCT00689117|323980362|FG001|Overall Study|Use of Prohibitive Medication|1|||
94594835|NCT00689117|323980363|FG002|Overall Study|Use of Prohibitive Medication|3|||
94594836|NCT00689117|323980364|FG003|Overall Study|Use of Prohibitive Medication|0|||
94594837|NCT00689117|323980361|FG000|Overall Study|Pregnancy|0|||
94594838|NCT00689117|323980362|FG001|Overall Study|Pregnancy|2|||
94594839|NCT00689117|323980363|FG002|Overall Study|Pregnancy|0|||
94594840|NCT00689117|323980364|FG003|Overall Study|Pregnancy|2|||
94594841|NCT00689117|323980361|FG000|Overall Study|Incarceration|2|||
94594842|NCT00689117|323980362|FG001|Overall Study|Incarceration|0|||
94594843|NCT00689117|323980363|FG002|Overall Study|Incarceration|0|||
94594844|NCT00689117|323980364|FG003|Overall Study|Incarceration|0|||
94594845|NCT00689117|323980361|FG000|Overall Study|Fear of Birth Defects|0|||
94594846|NCT00689117|323980362|FG001|Overall Study|Fear of Birth Defects|0|||
94246737|NCT03738423|322697110|FG000|Overall Study|Death|0|||
94246738|NCT03738423|322697111|FG001|Overall Study|Death|0|||
94246739|NCT03738423|322697112|FG002|Overall Study|Death|0|||
94246740|NCT03738423|322697113|FG003|Overall Study|Death|0|||
94246741|NCT03738423|322697114|FG004|Overall Study|Death|1|||
94246742|NCT03738423|322697110|FG000|Overall Study|Randomized but never treated|0|||
94246743|NCT03738423|322697111|FG001|Overall Study|Randomized but never treated|0|||
94246744|NCT03738423|322697112|FG002|Overall Study|Randomized but never treated|1|||
94246745|NCT03738423|322697113|FG003|Overall Study|Randomized but never treated|1|||
94246746|NCT03738423|322697114|FG004|Overall Study|Randomized but never treated|0|||
94246747|NCT05172050|322697115|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
94246748|NCT05172050|322697116|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
94594847|NCT00689117|323980363|FG002|Overall Study|Fear of Birth Defects|1|||
94594848|NCT00689117|323980364|FG003|Overall Study|Fear of Birth Defects|0|||
94594849|NCT00689117|323980361|FG000|Overall Study|Transportation|1|||
94594850|NCT00689117|323980362|FG001|Overall Study|Transportation|0|||
94594851|NCT00689117|323980363|FG002|Overall Study|Transportation|0|||
94594852|NCT00689117|323980364|FG003|Overall Study|Transportation|0|||
94594853|NCT00689117|323980361|FG000|Overall Study|Patient Withdrew from Study|0|||
94594854|NCT00689117|323980362|FG001|Overall Study|Patient Withdrew from Study|0|||
94594855|NCT00689117|323980363|FG002|Overall Study|Patient Withdrew from Study|0|||
94594856|NCT00689117|323980364|FG003|Overall Study|Patient Withdrew from Study|1|||
94594857|NCT00689117|323980361|FG000|Overall Study|Personal Reason|0|||
94594858|NCT00689117|323980362|FG001|Overall Study|Personal Reason|1|||
94594859|NCT00689117|323980363|FG002|Overall Study|Personal Reason|0|||
94594860|NCT00689117|323980364|FG003|Overall Study|Personal Reason|0|||
94660261|NCT00797667|324210051|FG001|Overall Study|Protocol Violation|7|||
94594861|NCT00689117|323980361|FG000|Overall Study|Dispensing Error|0|||
94660262|NCT00797667|324210052|FG002|Overall Study|Protocol Violation|0|||
94660263|NCT00797667|324210050|FG000|Overall Study|Study Terminated by Sponsor|217|||
94660264|NCT00797667|324210051|FG001|Overall Study|Study Terminated by Sponsor|216|||
94594862|NCT00689117|323980362|FG001|Overall Study|Dispensing Error|1|||
94594863|NCT00689117|323980363|FG002|Overall Study|Dispensing Error|0|||
94246749|NCT05172050|322697117|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
94246750|NCT05172050|322697115|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
94246751|NCT05172050|322697116|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
94246752|NCT05172050|322697117|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
94246753|NCT05172050|322697115|FG000|Overall Study|Other|2|||
94246754|NCT05172050|322697116|FG001|Overall Study|Other|2|||
94246755|NCT05172050|322697117|FG002|Overall Study|Other|1|||
94594864|NCT00689117|323980364|FG003|Overall Study|Dispensing Error|0|||
94594865|NCT02168387|323980366|FG000|Overall Study|Planned exubation|6|||
94594866|NCT02168387|323980367|FG001|Overall Study|Planned exubation|3|||
94594867|NCT02168387|323980366|FG000|Overall Study|Death|1|||
94594868|NCT02168387|323980367|FG001|Overall Study|Death|0|||
94594869|NCT04093024|323980370|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
94594870|NCT04093024|323980371|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
94660265|NCT00797667|324210052|FG002|Overall Study|Study Terminated by Sponsor|115|||
94660266|NCT00797667|324210050|FG000|Overall Study|Withdrawal by Subject|9|||
94660267|NCT00797667|324210051|FG001|Overall Study|Withdrawal by Subject|14|||
94660268|NCT00797667|324210052|FG002|Overall Study|Withdrawal by Subject|2|||
94594871|NCT04093024|323980370|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
94660269|NCT00797667|324210050|FG000|Overall Study|Adverse Event|19|||
94660270|NCT00797667|324210051|FG001|Overall Study|Adverse Event|8|||
94246756|NCT03465904|322697120|FG000|Overall Study|Withdrawal by Subject|9|||
94246757|NCT03465904|322697121|FG001|Overall Study|Withdrawal by Subject|5|||
94246758|NCT03465904|322697120|FG000|Overall Study|Lost to Follow-up|11|||
94594872|NCT04093024|323980371|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
94660271|NCT00797667|324210052|FG002|Overall Study|Adverse Event|8|||
94660272|NCT01229436|324210053|FG000|Overall Study|Withdrawal by Subject|2|||
94246759|NCT03465904|322697121|FG001|Overall Study|Lost to Follow-up|9|||
94246760|NCT03465904|322697120|FG000|Overall Study|Protocol Violation|20|||
94246761|NCT03465904|322697121|FG001|Overall Study|Protocol Violation|15|||
94246762|NCT00370682|322698950|FG000|Overall Study|Moved from area|0|||
94246763|NCT00370682|322698951|FG001|Overall Study|Moved from area|2|||
94660273|NCT01229436|324210053|FG000|Overall Study|Lost to Follow-up|3|||
94660274|NCT01775137|324210054|FG000|Overall Study|Death|1|||
94660275|NCT01775137|324210054|FG000|Overall Study|Protocol deviation|2|||
94246764|NCT00370682|322698952|FG002|Overall Study|Moved from area|0|||
94246765|NCT00370682|322698950|FG000|Overall Study|Lost to Follow-up|0|||
94660276|NCT01775137|324210054|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
94660277|NCT01775137|324210054|FG000|Overall Study|Adverse Event|1|||
94355914|NCT01674010|323085729|FG001|Randomization Phase 2|Adverse Event|1|||
94246766|NCT00370682|322698951|FG001|Overall Study|Lost to Follow-up|1|||
94246767|NCT00370682|322698952|FG002|Overall Study|Lost to Follow-up|1|||
94246768|NCT03167359|322698953|FG000|Overall Study|Physician Decision|1|||
94246769|NCT03167359|322698953|FG000|Overall Study|Lost to Follow-up|1|||
94246770|NCT03651622|322698956|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
94246771|NCT03651622|322698957|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
94246772|NCT03651622|322698958|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
94246773|NCT03651622|322698956|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
94246774|NCT03651622|322698957|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
94246775|NCT03651622|322698958|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
94246776|NCT03651622|322698956|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
94246777|NCT03651622|322698957|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
94246778|NCT03651622|322698958|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
94246779|NCT03651622|322698956|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
94246780|NCT03651622|322698957|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
94246781|NCT03651622|322698958|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
94246782|NCT03651622|322698956|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
94246783|NCT03651622|322698957|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
94246784|NCT03651622|322698958|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
94246785|NCT01327495|322698959|FG000|Overall Study|Adverse Event|2|||
94246786|NCT01327495|322698960|FG001|Overall Study|Adverse Event|1|||
94246787|NCT01327495|322698961|FG002|Overall Study|Adverse Event|1|||
94246788|NCT01327495|322698962|FG003|Overall Study|Adverse Event|0|||
94246789|NCT01327495|322698963|FG004|Overall Study|Adverse Event|0|||
94246790|NCT01327495|322698964|FG005|Overall Study|Adverse Event|2|||
94246791|NCT01327495|322698959|FG000|Overall Study|Withdrawal by Subject|0|||
94246792|NCT01327495|322698960|FG001|Overall Study|Withdrawal by Subject|1|||
94246793|NCT01327495|322698961|FG002|Overall Study|Withdrawal by Subject|1|||
94246794|NCT01327495|322698962|FG003|Overall Study|Withdrawal by Subject|0|||
94246795|NCT01327495|322698963|FG004|Overall Study|Withdrawal by Subject|1|||
94246796|NCT01327495|322698964|FG005|Overall Study|Withdrawal by Subject|0|||
94246797|NCT01327495|322698959|FG000|Overall Study|Physician Decision|0|||
94246798|NCT01327495|322698960|FG001|Overall Study|Physician Decision|0|||
94246799|NCT01327495|322698961|FG002|Overall Study|Physician Decision|0|||
94246800|NCT01327495|322698962|FG003|Overall Study|Physician Decision|0|||
94246801|NCT01327495|322698963|FG004|Overall Study|Physician Decision|2|||
94246802|NCT01327495|322698964|FG005|Overall Study|Physician Decision|0|||
94246803|NCT00307684|322698965|FG000|Open Label Phase|Lack of Efficacy|0|||
94246804|NCT00307684|322698966|FG001|Open Label Phase|Lack of Efficacy|0|||
94246805|NCT00307684|322698967|FG002|Open Label Phase|Lack of Efficacy|3|||
94246806|NCT00307684|322698965|FG000|Open Label Phase|Adverse Event|0|||
94246807|NCT00307684|322698966|FG001|Open Label Phase|Adverse Event|0|||
94246808|NCT00307684|322698967|FG002|Open Label Phase|Adverse Event|16|||
94246809|NCT00307684|322698965|FG000|Open Label Phase|Withdrawal by Subject|0|||
94246810|NCT00307684|322698966|FG001|Open Label Phase|Withdrawal by Subject|0|||
94246811|NCT00307684|322698967|FG002|Open Label Phase|Withdrawal by Subject|15|||
94246812|NCT00307684|322698965|FG000|Open Label Phase|Lost to Follow-up|0|||
94246813|NCT00307684|322698966|FG001|Open Label Phase|Lost to Follow-up|0|||
94246814|NCT00307684|322698967|FG002|Open Label Phase|Lost to Follow-up|11|||
94246815|NCT00307684|322698965|FG000|Open Label Phase|non compliance|0|||
94246816|NCT00307684|322698966|FG001|Open Label Phase|non compliance|0|||
94246817|NCT00307684|322698967|FG002|Open Label Phase|non compliance|5|||
94246818|NCT00307684|322698965|FG000|Open Label Phase|other|0|||
94246819|NCT00307684|322698966|FG001|Open Label Phase|other|0|||
94246820|NCT00307684|322698967|FG002|Open Label Phase|other|6|||
94246821|NCT00307684|322698965|FG000|Double Blind Phase|Lack of Efficacy|2|||
94246822|NCT00307684|322698966|FG001|Double Blind Phase|Lack of Efficacy|5|||
94246823|NCT00307684|322698967|FG002|Double Blind Phase|Lack of Efficacy|0|||
94246824|NCT00006011|322698968|FG000|Overall Study|Disease progression|13|||
94246825|NCT00006011|322698969|FG001|Overall Study|Disease progression|6|||
94246826|NCT00006011|322698970|FG002|Overall Study|Disease progression|26|||
94246827|NCT00006011|322698968|FG000|Overall Study|Refused further treatment|15|||
94246828|NCT00006011|322698969|FG001|Overall Study|Refused further treatment|13|||
94246829|NCT00006011|322698970|FG002|Overall Study|Refused further treatment|26|||
94246830|NCT00006011|322698968|FG000|Overall Study|Adverse Event|15|||
94246831|NCT00006011|322698969|FG001|Overall Study|Adverse Event|39|||
94246832|NCT00006011|322698970|FG002|Overall Study|Adverse Event|5|||
94246833|NCT00006011|322698968|FG000|Overall Study|Death|0|||
94246834|NCT00006011|322698969|FG001|Overall Study|Death|1|||
94246835|NCT00006011|322698970|FG002|Overall Study|Death|2|||
94246836|NCT00006011|322698968|FG000|Overall Study|Other|4|||
94355915|NCT01674010|323085730|FG002|Randomization Phase 2|Adverse Event|1|||
94355916|NCT01674010|323085728|FG000|Randomization Phase 2|Lost to Follow-up|0|||
94246837|NCT00006011|322698969|FG001|Overall Study|Other|2|||
94246838|NCT00006011|322698970|FG002|Overall Study|Other|5|||
94246839|NCT00006011|322698968|FG000|Overall Study|Ineligible|18|||
94246840|NCT00006011|322698969|FG001|Overall Study|Ineligible|16|||
94246841|NCT00006011|322698970|FG002|Overall Study|Ineligible|9|||
94246842|NCT03248882|322698971|FG000|Overall Study|Adverse Event|3|||
94246843|NCT03248882|322698972|FG001|Overall Study|Adverse Event|3|||
94457492|NCT02829723|323463537|FG001|Overall Study|Study terminated by sponsor|0|||
94246844|NCT03248882|322698973|FG002|Overall Study|Adverse Event|2|||
94246845|NCT03248882|322698974|FG003|Overall Study|Adverse Event|6|||
94246846|NCT03248882|322698975|FG004|Overall Study|Adverse Event|9|||
94246847|NCT03248882|322698971|FG000|Overall Study|Lost to Follow-up|0|||
94246848|NCT03248882|322698972|FG001|Overall Study|Lost to Follow-up|0|||
94246849|NCT03248882|322698973|FG002|Overall Study|Lost to Follow-up|0|||
94246850|NCT03248882|322698974|FG003|Overall Study|Lost to Follow-up|0|||
94246851|NCT03248882|322698975|FG004|Overall Study|Lost to Follow-up|1|||
94246852|NCT03248882|322698971|FG000|Overall Study|Protocol Violation|2|||
94246853|NCT03248882|322698972|FG001|Overall Study|Protocol Violation|0|||
94246854|NCT03248882|322698973|FG002|Overall Study|Protocol Violation|2|||
94246855|NCT03248882|322698974|FG003|Overall Study|Protocol Violation|0|||
94246856|NCT03248882|322698975|FG004|Overall Study|Protocol Violation|1|||
94246857|NCT03248882|322698971|FG000|Overall Study|Withdrawal by Subject|2|||
94246858|NCT03248882|322698972|FG001|Overall Study|Withdrawal by Subject|2|||
94594873|NCT04093024|323980370|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
94594874|NCT04093024|323980371|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
94594875|NCT04093024|323980370|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
94594876|NCT04093024|323980371|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
94594877|NCT01128621|323980380|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
94594878|NCT01128621|323980381|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
94594879|NCT03560518|323980382|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
94594880|NCT03560518|323980383|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
94594881|NCT03560518|323980384|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
94594882|NCT03560518|323980382|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
94594883|NCT03560518|323980383|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
94594884|NCT03560518|323980384|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
94594885|NCT03560518|323980382|FG000|Double Blind Treatment Period|Protocol Violation|1|||
94594886|NCT03560518|323980383|FG001|Double Blind Treatment Period|Protocol Violation|2|||
94594887|NCT03560518|323980384|FG002|Double Blind Treatment Period|Protocol Violation|0|||
94594888|NCT03560518|323980382|FG000|Double Blind Treatment Period|Pregnancy|0|||
94246859|NCT03248882|322698973|FG002|Overall Study|Withdrawal by Subject|3|||
94246860|NCT03248882|322698974|FG003|Overall Study|Withdrawal by Subject|4|||
94246861|NCT03248882|322698975|FG004|Overall Study|Withdrawal by Subject|2|||
94246862|NCT01215188|322698976|FG000|Overall Study|Lost to Follow-up|22|||
94246863|NCT01215188|322698977|FG001|Overall Study|Lost to Follow-up|22|||
94246864|NCT01215188|322698978|FG002|Overall Study|Lost to Follow-up|16|||
94594889|NCT03560518|323980383|FG001|Double Blind Treatment Period|Pregnancy|2|||
94594890|NCT03560518|323980384|FG002|Double Blind Treatment Period|Pregnancy|0|||
94594891|NCT03560518|323980382|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
94594892|NCT03560518|323980383|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
94594893|NCT03560518|323980384|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
94246865|NCT01215188|322698976|FG000|Overall Study|Adverse Event|1|||
94246866|NCT01215188|322698977|FG001|Overall Study|Adverse Event|1|||
94246867|NCT01215188|322698978|FG002|Overall Study|Adverse Event|3|||
94246868|NCT01215188|322698976|FG000|Overall Study|Physician Decision|2|||
94246869|NCT01215188|322698977|FG001|Overall Study|Physician Decision|1|||
94594894|NCT03560518|323980382|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
94594895|NCT03560518|323980383|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
94594896|NCT03560518|323980384|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
94594897|NCT03560518|323980382|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
94594898|NCT03560518|323980383|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
94594899|NCT03560518|323980384|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
94594900|NCT03560518|323980382|FG000|Double Blind Treatment Period|Adverse Event|0|||
94594901|NCT03560518|323980383|FG001|Double Blind Treatment Period|Adverse Event|3|||
94594902|NCT03560518|323980384|FG002|Double Blind Treatment Period|Adverse Event|1|||
94594903|NCT00233454|323980385|FG000|Overall Study|Death|6|||
94594904|NCT00796445|323980386|FG000|Overall Study|Protocol Violation|5|||
94594905|NCT00796445|323980387|FG001|Overall Study|Protocol Violation|3|||
94594906|NCT00796445|323980386|FG000|Overall Study|Adverse event, serious fatal|10|||
94594907|NCT00796445|323980387|FG001|Overall Study|Adverse event, serious fatal|5|||
94594908|NCT00796445|323980386|FG000|Overall Study|Adverse event, non-fatal|4|||
94594909|NCT00796445|323980387|FG001|Overall Study|Adverse event, non-fatal|0|||
94594910|NCT00796445|323980386|FG000|Overall Study|Disease progression/recurrence|537|||
94594911|NCT00796445|323980387|FG001|Overall Study|Disease progression/recurrence|268|||
94594912|NCT00796445|323980386|FG000|Overall Study|Other|10|||
94594913|NCT00796445|323980387|FG001|Overall Study|Other|7|||
94594914|NCT00796445|323980386|FG000|Overall Study|Withdrawal by Subject|18|||
94594915|NCT00796445|323980387|FG001|Overall Study|Withdrawal by Subject|9|||
94594916|NCT00796445|323980386|FG000|Overall Study|Invalid Informed Consent Form|1|||
94594917|NCT00796445|323980387|FG001|Overall Study|Invalid Informed Consent Form|0|||
94594918|NCT00913458|323980388|FG000|Phase 1|Non-Responder|54|||
94594919|NCT00913458|323980389|FG001|Phase 1|Non-Responder|0|||
94594920|NCT00913458|323980390|FG002|Phase 1|Non-Responder|0|||
94594921|NCT00913458|323980391|FG003|Phase 1|Non-Responder|0|||
94594922|NCT00913458|323980392|FG004|Phase 1|Non-Responder|0|||
94594923|NCT00913458|323980393|FG005|Phase 1|Non-Responder|0|||
94594924|NCT00913458|323980394|FG006|Phase 1|Non-Responder|0|||
94594925|NCT00913458|323980388|FG000|Phase 1|Subject Request|17|||
94594926|NCT00913458|323980389|FG001|Phase 1|Subject Request|0|||
94594927|NCT00913458|323980390|FG002|Phase 1|Subject Request|0|||
94594928|NCT00913458|323980391|FG003|Phase 1|Subject Request|0|||
94594929|NCT00913458|323980392|FG004|Phase 1|Subject Request|0|||
94594930|NCT00913458|323980393|FG005|Phase 1|Subject Request|0|||
94594931|NCT00913458|323980394|FG006|Phase 1|Subject Request|0|||
94594932|NCT00913458|323980388|FG000|Phase 1|Adverse Event|20|||
94594933|NCT00913458|323980389|FG001|Phase 1|Adverse Event|0|||
94594934|NCT00913458|323980390|FG002|Phase 1|Adverse Event|0|||
94594935|NCT00913458|323980391|FG003|Phase 1|Adverse Event|0|||
94594936|NCT00913458|323980392|FG004|Phase 1|Adverse Event|0|||
94594937|NCT00913458|323980393|FG005|Phase 1|Adverse Event|0|||
94594938|NCT00913458|323980394|FG006|Phase 1|Adverse Event|0|||
94594939|NCT00913458|323980388|FG000|Phase 1|Lost to Follow-up|2|||
94594940|NCT00913458|323980389|FG001|Phase 1|Lost to Follow-up|0|||
94594941|NCT00913458|323980390|FG002|Phase 1|Lost to Follow-up|0|||
94594942|NCT00913458|323980391|FG003|Phase 1|Lost to Follow-up|0|||
94594943|NCT00913458|323980392|FG004|Phase 1|Lost to Follow-up|0|||
94594944|NCT00913458|323980393|FG005|Phase 1|Lost to Follow-up|0|||
94594945|NCT00913458|323980394|FG006|Phase 1|Lost to Follow-up|0|||
94594946|NCT00913458|323980388|FG000|Phase 1|Protocol Violation|10|||
94594947|NCT00913458|323980389|FG001|Phase 1|Protocol Violation|0|||
94594948|NCT00913458|323980390|FG002|Phase 1|Protocol Violation|0|||
94594949|NCT00913458|323980391|FG003|Phase 1|Protocol Violation|0|||
94594950|NCT00913458|323980392|FG004|Phase 1|Protocol Violation|0|||
94594951|NCT00913458|323980393|FG005|Phase 1|Protocol Violation|0|||
94594952|NCT00913458|323980394|FG006|Phase 1|Protocol Violation|0|||
94594953|NCT00913458|323980388|FG000|Phase 1|Sponsor|2|||
94594954|NCT00913458|323980389|FG001|Phase 1|Sponsor|0|||
94594955|NCT00913458|323980390|FG002|Phase 1|Sponsor|0|||
94594956|NCT00913458|323980391|FG003|Phase 1|Sponsor|0|||
94594957|NCT00913458|323980392|FG004|Phase 1|Sponsor|0|||
94594958|NCT00913458|323980393|FG005|Phase 1|Sponsor|0|||
94594959|NCT00913458|323980394|FG006|Phase 1|Sponsor|0|||
94594960|NCT00913458|323980388|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
94594961|NCT00913458|323980389|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
94594962|NCT00913458|323980390|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
94594963|NCT00913458|323980391|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
94594964|NCT00913458|323980392|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
94355917|NCT01674010|323085729|FG001|Randomization Phase 2|Lost to Follow-up|1|||
94594965|NCT00913458|323980393|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
94594966|NCT00913458|323980394|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
94594967|NCT00913458|323980388|FG000|Phase 2|Non-Responder|0|||
94594968|NCT00913458|323980389|FG001|Phase 2|Non-Responder|5|||
94594969|NCT00913458|323980390|FG002|Phase 2|Non-Responder|7|||
94594970|NCT00913458|323980391|FG003|Phase 2|Non-Responder|12|||
94594971|NCT00913458|323980392|FG004|Phase 2|Non-Responder|0|||
94594972|NCT00913458|323980393|FG005|Phase 2|Non-Responder|0|||
94594973|NCT00913458|323980394|FG006|Phase 2|Non-Responder|0|||
94660278|NCT01775137|324210054|FG000|Overall Study|Withdrawal by participants|5|||
94660279|NCT05348681|324210067|FG000|Overall Study|Study terminated by Sponsor|8|||
94660280|NCT05348681|324210068|FG001|Overall Study|Study terminated by Sponsor|3|||
94660281|NCT05348681|324210067|FG000|Overall Study|Withdrawal by Subject|1|||
94660282|NCT05348681|324210068|FG001|Overall Study|Withdrawal by Subject|1|||
94660283|NCT05348681|324210067|FG000|Overall Study|Lost to Follow-up|1|||
94660284|NCT05348681|324210068|FG001|Overall Study|Lost to Follow-up|1|||
94660285|NCT05348681|324210067|FG000|Overall Study|Adverse Event|1|||
94660286|NCT05348681|324210068|FG001|Overall Study|Adverse Event|0|||
94660287|NCT05348681|324210067|FG000|Overall Study|Other|2|||
94660288|NCT05348681|324210068|FG001|Overall Study|Other|1|||
94660289|NCT03029208|324210072|FG000|Overall Study|Withdrawal by Subject|2|||
94660290|NCT03029208|324210073|FG001|Overall Study|Withdrawal by Subject|3|||
94660291|NCT03029208|324210072|FG000|Overall Study|Lost to Follow-up|0|||
94660292|NCT03029208|324210073|FG001|Overall Study|Lost to Follow-up|1|||
94660293|NCT02334748|324210074|FG000|Overall Study|Adverse Event|1|||
94660294|NCT02334748|324210074|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
94660295|NCT02334748|324210074|FG000|Overall Study|Patient no longer required study drug|2|||
94660296|NCT02334748|324210074|FG000|Overall Study|Lack of Efficacy|4|||
94660297|NCT03321981|324210083|FG000|Overall Study|Progressive Disease (PD)|15|||
94660298|NCT03321981|324210084|FG001|Overall Study|Progressive Disease (PD)|30|||
94660299|NCT03321981|324210085|FG002|Overall Study|Progressive Disease (PD)|47|||
94660300|NCT03321981|324210083|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
94660301|NCT03321981|324210084|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
94660302|NCT03321981|324210085|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
94660303|NCT03321981|324210083|FG000|Overall Study|Adverse Event|0|||
94660304|NCT03321981|324210084|FG001|Overall Study|Adverse Event|0|||
94594974|NCT00913458|323980388|FG000|Phase 2|Subject Request|0|||
94594975|NCT00913458|323980389|FG001|Phase 2|Subject Request|0|||
94594976|NCT00913458|323980390|FG002|Phase 2|Subject Request|1|||
94594977|NCT00913458|323980391|FG003|Phase 2|Subject Request|2|||
94594978|NCT00913458|323980392|FG004|Phase 2|Subject Request|0|||
94594979|NCT00913458|323980393|FG005|Phase 2|Subject Request|0|||
94355918|NCT01674010|323085730|FG002|Randomization Phase 2|Lost to Follow-up|2|||
94355919|NCT01674010|323085728|FG000|Randomization Phase 2|Mood episode recurrence|0|||
94355920|NCT01674010|323085729|FG001|Randomization Phase 2|Mood episode recurrence|8|||
94355921|NCT01674010|323085730|FG002|Randomization Phase 2|Mood episode recurrence|2|||
94660305|NCT03321981|324210085|FG002|Overall Study|Adverse Event|2|||
94660306|NCT03321981|324210083|FG000|Overall Study|symptomatic deterioration|0|||
94594980|NCT00913458|323980394|FG006|Phase 2|Subject Request|0|||
94594981|NCT00913458|323980388|FG000|Phase 2|Adverse Event|0|||
94594982|NCT00913458|323980389|FG001|Phase 2|Adverse Event|3|||
94594983|NCT00913458|323980390|FG002|Phase 2|Adverse Event|0|||
94594984|NCT00913458|323980391|FG003|Phase 2|Adverse Event|1|||
94594985|NCT00913458|323980392|FG004|Phase 2|Adverse Event|0|||
94594986|NCT00913458|323980393|FG005|Phase 2|Adverse Event|0|||
94594987|NCT00913458|323980394|FG006|Phase 2|Adverse Event|0|||
94594988|NCT00913458|323980388|FG000|Phase 2|Lost to Follow-up|0|||
94594989|NCT00913458|323980389|FG001|Phase 2|Lost to Follow-up|0|||
94594990|NCT00913458|323980390|FG002|Phase 2|Lost to Follow-up|0|||
94594991|NCT00913458|323980391|FG003|Phase 2|Lost to Follow-up|1|||
94594992|NCT00913458|323980392|FG004|Phase 2|Lost to Follow-up|0|||
94594993|NCT00913458|323980393|FG005|Phase 2|Lost to Follow-up|0|||
94594994|NCT00913458|323980394|FG006|Phase 2|Lost to Follow-up|0|||
94594995|NCT00913458|323980388|FG000|Phase 2|Protocol Violation|0|||
94594996|NCT00913458|323980389|FG001|Phase 2|Protocol Violation|2|||
94594997|NCT00913458|323980390|FG002|Phase 2|Protocol Violation|0|||
94594998|NCT00913458|323980391|FG003|Phase 2|Protocol Violation|0|||
94594999|NCT00913458|323980392|FG004|Phase 2|Protocol Violation|0|||
94595000|NCT00913458|323980393|FG005|Phase 2|Protocol Violation|0|||
94595001|NCT00913458|323980394|FG006|Phase 2|Protocol Violation|0|||
94595002|NCT00913458|323980388|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
94595003|NCT00913458|323980389|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
94595004|NCT00913458|323980390|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
94595005|NCT00913458|323980391|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
94595006|NCT00913458|323980392|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
94595007|NCT00913458|323980393|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
94595008|NCT00913458|323980394|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
94595009|NCT00913458|323980388|FG000|Phase 3|Adverse Event|0|||
94595010|NCT00913458|323980389|FG001|Phase 3|Adverse Event|0|||
94595011|NCT00913458|323980390|FG002|Phase 3|Adverse Event|0|||
94595012|NCT00913458|323980391|FG003|Phase 3|Adverse Event|0|||
94595013|NCT00913458|323980392|FG004|Phase 3|Adverse Event|5|||
94595014|NCT00913458|323980393|FG005|Phase 3|Adverse Event|4|||
94595015|NCT00913458|323980394|FG006|Phase 3|Adverse Event|1|||
94595016|NCT00913458|323980388|FG000|Phase 3|Lost to Follow-up|0|||
94595017|NCT00913458|323980389|FG001|Phase 3|Lost to Follow-up|0|||
94595018|NCT00913458|323980390|FG002|Phase 3|Lost to Follow-up|0|||
94595019|NCT00913458|323980391|FG003|Phase 3|Lost to Follow-up|0|||
94660307|NCT03321981|324210084|FG001|Overall Study|symptomatic deterioration|1|||
94660308|NCT03321981|324210085|FG002|Overall Study|symptomatic deterioration|1|||
94660309|NCT03321981|324210083|FG000|Overall Study|Lack of compliance|0|||
94595020|NCT00913458|323980392|FG004|Phase 3|Lost to Follow-up|2|||
94595021|NCT00913458|323980393|FG005|Phase 3|Lost to Follow-up|0|||
94595022|NCT00913458|323980394|FG006|Phase 3|Lost to Follow-up|0|||
94595023|NCT00913458|323980388|FG000|Phase 3|Non-Responder|0|||
94595024|NCT00913458|323980389|FG001|Phase 3|Non-Responder|0|||
94595025|NCT00913458|323980390|FG002|Phase 3|Non-Responder|0|||
94595026|NCT00913458|323980391|FG003|Phase 3|Non-Responder|0|||
94595027|NCT00913458|323980392|FG004|Phase 3|Non-Responder|0|||
94595028|NCT00913458|323980393|FG005|Phase 3|Non-Responder|1|||
94595029|NCT00913458|323980394|FG006|Phase 3|Non-Responder|3|||
94595030|NCT00913458|323980388|FG000|Phase 3|Withdrawal by Subject|0|||
94595031|NCT00913458|323980389|FG001|Phase 3|Withdrawal by Subject|0|||
94595032|NCT00913458|323980390|FG002|Phase 3|Withdrawal by Subject|0|||
94595033|NCT00913458|323980391|FG003|Phase 3|Withdrawal by Subject|0|||
94595034|NCT00913458|323980392|FG004|Phase 3|Withdrawal by Subject|1|||
94595035|NCT00913458|323980393|FG005|Phase 3|Withdrawal by Subject|2|||
94595036|NCT00913458|323980394|FG006|Phase 3|Withdrawal by Subject|0|||
94595037|NCT00913458|323980388|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
94595038|NCT00913458|323980389|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
94595039|NCT00913458|323980390|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
94595040|NCT00913458|323980391|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
94595041|NCT00913458|323980392|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
94595042|NCT00913458|323980393|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
94595043|NCT00913458|323980394|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
94595044|NCT00561977|323980395|FG000|Overall Study|Withdrawal by Subject|0|||
94595045|NCT00561977|323980396|FG001|Overall Study|Withdrawal by Subject|2|||
94595046|NCT00561977|323980397|FG002|Overall Study|Withdrawal by Subject|1|||
94595047|NCT00561977|323980395|FG000|Overall Study|Pregnancy|0|||
94595048|NCT00561977|323980396|FG001|Overall Study|Pregnancy|1|||
94595049|NCT00561977|323980397|FG002|Overall Study|Pregnancy|1|||
94595050|NCT00783198|323980404|FG000|Overall Study|Adverse Event|15|||
94595051|NCT00783198|323980405|FG001|Overall Study|Adverse Event|19|||
94595052|NCT00783198|323980406|FG002|Overall Study|Adverse Event|3|||
94595053|NCT00783198|323980404|FG000|Overall Study|Lost to Follow-up|11|||
94595054|NCT00783198|323980405|FG001|Overall Study|Lost to Follow-up|1|||
94595055|NCT00783198|323980406|FG002|Overall Study|Lost to Follow-up|7|||
94595056|NCT00783198|323980404|FG000|Overall Study|Withdrawal by Subject|22|||
94595057|NCT00783198|323980405|FG001|Overall Study|Withdrawal by Subject|14|||
94595058|NCT00783198|323980406|FG002|Overall Study|Withdrawal by Subject|20|||
94595059|NCT00783198|323980404|FG000|Overall Study|Noncompliance with protocol|7|||
94595060|NCT00783198|323980405|FG001|Overall Study|Noncompliance with protocol|7|||
94595061|NCT00783198|323980406|FG002|Overall Study|Noncompliance with protocol|10|||
94595062|NCT00783198|323980404|FG000|Overall Study|Did not meet protocol eligibility|0|||
94595063|NCT00783198|323980405|FG001|Overall Study|Did not meet protocol eligibility|1|||
94595064|NCT00783198|323980406|FG002|Overall Study|Did not meet protocol eligibility|0|||
94595065|NCT00783198|323980404|FG000|Overall Study|Administrative|2|||
94595066|NCT00783198|323980405|FG001|Overall Study|Administrative|1|||
94595067|NCT00783198|323980406|FG002|Overall Study|Administrative|2|||
94595068|NCT03567343|323980408|FG000|Overall Study|Lost to Follow-up|2|||
94595069|NCT03567343|323980409|FG001|Overall Study|Lost to Follow-up|1|||
94595070|NCT03567343|323980408|FG000|Overall Study|No longer eligible|2|||
94595071|NCT03567343|323980409|FG001|Overall Study|No longer eligible|1|||
94595072|NCT03567343|323980408|FG000|Overall Study|Adverse Event|1|||
94595073|NCT03567343|323980409|FG001|Overall Study|Adverse Event|0|||
94595074|NCT03567343|323980408|FG000|Overall Study|Protocol Violation|1|||
94595075|NCT03567343|323980409|FG001|Overall Study|Protocol Violation|1|||
94595076|NCT02660138|323980410|FG000|Overall Study|Adverse Event|0|||
94595077|NCT02660138|323980411|FG001|Overall Study|Adverse Event|3|||
94595078|NCT02660138|323980412|FG002|Overall Study|Adverse Event|2|||
94595079|NCT02660138|323980410|FG000|Overall Study|Lack of Efficacy|1|||
94595080|NCT02660138|323980411|FG001|Overall Study|Lack of Efficacy|2|||
94595081|NCT02660138|323980412|FG002|Overall Study|Lack of Efficacy|1|||
94595082|NCT02660138|323980410|FG000|Overall Study|Withdrawal by Subject|7|||
94595083|NCT02660138|323980411|FG001|Overall Study|Withdrawal by Subject|6|||
94595084|NCT02660138|323980412|FG002|Overall Study|Withdrawal by Subject|6|||
94595085|NCT02660138|323980410|FG000|Overall Study|Lost to Follow-up|4|||
94595086|NCT02660138|323980411|FG001|Overall Study|Lost to Follow-up|4|||
94595087|NCT02660138|323980412|FG002|Overall Study|Lost to Follow-up|1|||
94595088|NCT02660138|323980410|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
94595089|NCT02660138|323980411|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
94595090|NCT02660138|323980412|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
94595091|NCT02660138|323980410|FG000|Overall Study|Other|1|||
94595092|NCT02660138|323980411|FG001|Overall Study|Other|1|||
94595093|NCT02660138|323980412|FG002|Overall Study|Other|0|||
94595094|NCT02660138|323980410|FG000|Overall Study|Not treated|0|||
94595095|NCT02660138|323980411|FG001|Overall Study|Not treated|1|||
94595096|NCT02660138|323980412|FG002|Overall Study|Not treated|0|||
94595097|NCT01978938|323980413|FG000|Overall Study|Lost to Follow-up|12|||
94595098|NCT01978938|323980414|FG001|Overall Study|Lost to Follow-up|6|||
94595099|NCT01978938|323980413|FG000|Overall Study|Withdrawal by Subject|8|||
94595100|NCT01978938|323980414|FG001|Overall Study|Withdrawal by Subject|4|||
94595101|NCT01978938|323980413|FG000|Overall Study|Adverse Event, non-fatal|2|||
94595102|NCT01978938|323980414|FG001|Overall Study|Adverse Event, non-fatal|1|||
94595103|NCT01978938|323980413|FG000|Overall Study|Participant noncompliance|1|||
94595104|NCT01978938|323980414|FG001|Overall Study|Participant noncompliance|1|||
94595105|NCT01978938|323980413|FG000|Overall Study|Did not meet inclusion criteria|0|||
94595106|NCT01978938|323980414|FG001|Overall Study|Did not meet inclusion criteria|1|||
94595107|NCT01978938|323980413|FG000|Overall Study|Previously scheduled procedure|0|||
94595108|NCT01978938|323980414|FG001|Overall Study|Previously scheduled procedure|1|||
94595109|NCT00952380|323980415|FG000|Overall Study|Other|0|||
94595110|NCT00952380|323980416|FG001|Overall Study|Other|0|||
94595111|NCT00952380|323980417|FG002|Overall Study|Other|0|||
94595112|NCT00952380|323980418|FG003|Overall Study|Other|0|||
94595113|NCT00952380|323980419|FG004|Overall Study|Other|1|||
94595114|NCT00952380|323980415|FG000|Overall Study|Withdrawal by Subject|0|||
94595115|NCT00952380|323980416|FG001|Overall Study|Withdrawal by Subject|0|||
94595116|NCT00952380|323980417|FG002|Overall Study|Withdrawal by Subject|1|||
94595117|NCT00952380|323980418|FG003|Overall Study|Withdrawal by Subject|0|||
94595118|NCT00952380|323980419|FG004|Overall Study|Withdrawal by Subject|2|||
94595119|NCT00952380|323980415|FG000|Overall Study|Adverse Event|0|||
94595120|NCT00952380|323980416|FG001|Overall Study|Adverse Event|1|||
94595121|NCT00952380|323980417|FG002|Overall Study|Adverse Event|0|||
94595122|NCT00952380|323980418|FG003|Overall Study|Adverse Event|0|||
94595123|NCT00952380|323980419|FG004|Overall Study|Adverse Event|3|||
94595124|NCT00952380|323980415|FG000|Overall Study|Physician Decision|0|||
94595125|NCT00952380|323980416|FG001|Overall Study|Physician Decision|0|||
94595126|NCT00952380|323980417|FG002|Overall Study|Physician Decision|1|||
94595127|NCT00952380|323980418|FG003|Overall Study|Physician Decision|2|||
94595128|NCT00952380|323980419|FG004|Overall Study|Physician Decision|0|||
94595129|NCT00952380|323980415|FG000|Overall Study|Non-compliant to protocol|0|||
94595130|NCT00952380|323980416|FG001|Overall Study|Non-compliant to protocol|0|||
94595131|NCT00952380|323980417|FG002|Overall Study|Non-compliant to protocol|0|||
94595132|NCT00952380|323980418|FG003|Overall Study|Non-compliant to protocol|1|||
94595133|NCT00952380|323980419|FG004|Overall Study|Non-compliant to protocol|0|||
94246870|NCT01215188|322698978|FG002|Overall Study|Physician Decision|0|||
94246871|NCT01215188|322698976|FG000|Overall Study|Lack of Efficacy|0|||
94246872|NCT01215188|322698977|FG001|Overall Study|Lack of Efficacy|0|||
94246873|NCT01215188|322698978|FG002|Overall Study|Lack of Efficacy|1|||
94246874|NCT01215188|322698976|FG000|Overall Study|Protocol Violation|1|||
94595134|NCT02342418|323980420|FG000|Overall Study|Adverse Event|0|||
94595135|NCT02342418|323980421|FG001|Overall Study|Adverse Event|1|||
94595136|NCT04255394|323980422|FG000|Overall Study|Death|35|||
94595137|NCT04255394|323980423|FG001|Overall Study|Death|25|||
94595138|NCT04255394|323980422|FG000|Overall Study|Device removed|2|||
94595139|NCT04255394|323980423|FG001|Overall Study|Device removed|10|||
94595140|NCT04255394|323980422|FG000|Overall Study|Withdrawal by Subject|9|||
94595141|NCT04255394|323980423|FG001|Overall Study|Withdrawal by Subject|8|||
94595142|NCT04255394|323980422|FG000|Overall Study|Screen Failure/Not treated|12|||
94595143|NCT04255394|323980423|FG001|Overall Study|Screen Failure/Not treated|8|||
94595144|NCT04255394|323980422|FG000|Overall Study|Lost to Follow-up|123|||
94595145|NCT04255394|323980423|FG001|Overall Study|Lost to Follow-up|265|||
94595146|NCT04255394|323980422|FG000|Overall Study|Adverse Event|1|||
94595147|NCT04255394|323980423|FG001|Overall Study|Adverse Event|3|||
94595148|NCT00835731|323980432|FG000|Overall Study|Withdrawal by Subject|1|||
94595149|NCT00835731|323980433|FG001|Overall Study|Withdrawal by Subject|0|||
94595150|NCT00835731|323980432|FG000|Overall Study|Physician Decision|1|||
94595151|NCT00835731|323980433|FG001|Overall Study|Physician Decision|1|||
94595152|NCT00348881|323980434|FG000|Overall Study|Lost to Follow-up|12|||
94595153|NCT00348881|323980435|FG001|Overall Study|Lost to Follow-up|6|||
94595154|NCT00348881|323980434|FG000|Overall Study|Withdrawal by Subject|3|||
94595155|NCT00348881|323980435|FG001|Overall Study|Withdrawal by Subject|4|||
94595156|NCT00348881|323980434|FG000|Overall Study|Adverse Event|2|||
94595157|NCT00348881|323980435|FG001|Overall Study|Adverse Event|0|||
94595158|NCT00348881|323980434|FG000|Overall Study|Serious Adverse Event|0|||
94246875|NCT01215188|322698977|FG001|Overall Study|Protocol Violation|1|||
94246876|NCT01215188|322698978|FG002|Overall Study|Protocol Violation|1|||
94246877|NCT01215188|322698976|FG000|Overall Study|Withdrawal by Subject|32|||
94246878|NCT01215188|322698977|FG001|Overall Study|Withdrawal by Subject|34|||
94246879|NCT01215188|322698978|FG002|Overall Study|Withdrawal by Subject|31|||
94246880|NCT03181789|322698981|FG000|Overall Study|Withdrawal by Subject|0|||
94246881|NCT03181789|322698982|FG001|Overall Study|Withdrawal by Subject|1|||
94246882|NCT03181789|322698983|FG002|Overall Study|Withdrawal by Subject|1|||
94246883|NCT03181789|322698984|FG003|Overall Study|Withdrawal by Subject|0|||
94246884|NCT03181789|322698981|FG000|Overall Study|Lost to Follow-up|7|||
94246885|NCT03181789|322698982|FG001|Overall Study|Lost to Follow-up|1|||
94246886|NCT03181789|322698983|FG002|Overall Study|Lost to Follow-up|0|||
94246887|NCT03181789|322698984|FG003|Overall Study|Lost to Follow-up|0|||
94246888|NCT03181789|322698981|FG000|Overall Study|Participant unable to adhere to visit|0|||
94246889|NCT03181789|322698982|FG001|Overall Study|Participant unable to adhere to visit|1|||
94246890|NCT03181789|322698983|FG002|Overall Study|Participant unable to adhere to visit|0|||
94246891|NCT03181789|322698984|FG003|Overall Study|Participant unable to adhere to visit|0|||
94246892|NCT02624791|322698987|FG000|Overall Study|Withdrawal by Subject|2|||
94246893|NCT02624791|322698988|FG001|Overall Study|Withdrawal by Subject|0|||
94595159|NCT00348881|323980435|FG001|Overall Study|Serious Adverse Event|2|||
94595160|NCT00534599|323980436|FG000|Overall Study|Adverse Event|25|||
94595161|NCT00534599|323980437|FG001|Overall Study|Adverse Event|4|||
94595162|NCT00534599|323980436|FG000|Overall Study|Incorrect enrollment|2|||
94595163|NCT00534599|323980437|FG001|Overall Study|Incorrect enrollment|1|||
94595164|NCT00534599|323980436|FG000|Overall Study|Mis-randomization|2|||
94595165|NCT00534599|323980437|FG001|Overall Study|Mis-randomization|2|||
94595166|NCT00534599|323980436|FG000|Overall Study|Developed study-specific d/c criteria|5|||
94595167|NCT00534599|323980437|FG001|Overall Study|Developed study-specific d/c criteria|0|||
94595168|NCT00534599|323980436|FG000|Overall Study|Lack of Efficacy|0|||
94595169|NCT00534599|323980437|FG001|Overall Study|Lack of Efficacy|1|||
94595170|NCT00534599|323980436|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
94595171|NCT00534599|323980437|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
94595172|NCT00534599|323980436|FG000|Overall Study|Protocol Violation|1|||
94595173|NCT00534599|323980437|FG001|Overall Study|Protocol Violation|3|||
94595174|NCT00534599|323980436|FG000|Overall Study|Lost to Follow-up|11|||
94595175|NCT00534599|323980437|FG001|Overall Study|Lost to Follow-up|14|||
94595176|NCT00534599|323980436|FG000|Overall Study|Withdrawal by Subject|4|||
94595177|NCT00534599|323980437|FG001|Overall Study|Withdrawal by Subject|6|||
94595178|NCT00534599|323980436|FG000|Overall Study|Other|7|||
94595179|NCT00534599|323980437|FG001|Overall Study|Other|0|||
94595180|NCT03387111|323981682|FG000|Overall Study|Progressive Disease|3|||
94595181|NCT03387111|323981682|FG000|Overall Study|Other|1|||
94595182|NCT02434471|323981683|FG000|Overall Study|Physician Decision|9|||
94595183|NCT00369629|323981684|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
94595184|NCT00369629|323981685|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
94595185|NCT00369629|323981686|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
94595186|NCT00369629|323981687|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
94595187|NCT00369629|323981684|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
94595188|NCT00369629|323981685|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
94595189|NCT00369629|323981686|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
94595190|NCT00369629|323981687|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
94595191|NCT00369629|323981684|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
94595192|NCT00369629|323981685|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
94595193|NCT00369629|323981686|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
94595194|NCT00369629|323981687|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
94595195|NCT00369629|323981684|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
94595196|NCT00369629|323981685|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
94595197|NCT00369629|323981686|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
94595198|NCT00369629|323981687|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
94595199|NCT00369629|323981684|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
94595200|NCT00369629|323981685|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
94595201|NCT00369629|323981686|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
94595202|NCT00369629|323981687|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
94595203|NCT00369629|323981684|FG000|Completed 4 More Cycles|Progressive disease|2|||
94595204|NCT00369629|323981685|FG001|Completed 4 More Cycles|Progressive disease|1|||
94595205|NCT00369629|323981686|FG002|Completed 4 More Cycles|Progressive disease|2|||
94595206|NCT00369629|323981687|FG003|Completed 4 More Cycles|Progressive disease|0|||
94595207|NCT00369629|323981684|FG000|Follow up for 1 Year|Death|2|||
94595208|NCT00369629|323981685|FG001|Follow up for 1 Year|Death|1|||
94595209|NCT00369629|323981686|FG002|Follow up for 1 Year|Death|1|||
94595210|NCT00369629|323981687|FG003|Follow up for 1 Year|Death|0|||
94595211|NCT00369629|323981684|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
94595212|NCT00369629|323981685|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
94595213|NCT00369629|323981686|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
94595214|NCT00369629|323981687|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
94595215|NCT00369629|323981684|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
94595216|NCT00369629|323981685|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
94595217|NCT00369629|323981686|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
94595218|NCT00369629|323981687|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
94595219|NCT01129583|323981688|FG000|Overall Study|Death|1|||
94595220|NCT01129583|323981689|FG001|Overall Study|Death|0|||
94595221|NCT01129583|323981688|FG000|Overall Study|Lost to Follow-up|1|||
94595222|NCT01129583|323981689|FG001|Overall Study|Lost to Follow-up|1|||
94595223|NCT01129583|323981688|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
94595224|NCT01129583|323981689|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
94595225|NCT02600871|323981690|FG000|Overall Study|Lost to Follow-up|13|||
94595226|NCT02600871|323981691|FG001|Overall Study|Lost to Follow-up|10|||
94595227|NCT01909791|323981692|FG000|Overall Study|Death|9|||
94595228|NCT01909791|323981693|FG001|Overall Study|Death|8|||
94595229|NCT01909791|323981694|FG002|Overall Study|Death|4|||
94595230|NCT01909791|323981692|FG000|Overall Study|Withdrawal by Subject|5|||
94595231|NCT01909791|323981693|FG001|Overall Study|Withdrawal by Subject|9|||
94595232|NCT01909791|323981694|FG002|Overall Study|Withdrawal by Subject|13|||
94595233|NCT01909791|323981692|FG000|Overall Study|Lost to Follow-up|5|||
94595234|NCT01909791|323981693|FG001|Overall Study|Lost to Follow-up|11|||
94595235|NCT01909791|323981694|FG002|Overall Study|Lost to Follow-up|10|||
94595236|NCT01909791|323981692|FG000|Overall Study|Missed Visit|2|||
94595237|NCT01909791|323981693|FG001|Overall Study|Missed Visit|0|||
94595238|NCT01909791|323981694|FG002|Overall Study|Missed Visit|1|||
94595239|NCT00945906|323981695|FG000|Overall Study|Withdrawal by Subject|1|||
94595240|NCT00945906|323981695|FG000|Overall Study|Did not want to return for last visit|2|||
94595241|NCT00945906|323981695|FG000|Overall Study|Unable to return for last visit|2|||
94595242|NCT00945906|323981695|FG000|Overall Study|Moved to another country|2|||
94595243|NCT01236547|323981696|FG000|Overall Study|Protocol Violation|0|||
94595244|NCT01236547|323981697|FG001|Overall Study|Protocol Violation|1|||
94595245|NCT01236547|323981698|FG002|Overall Study|Protocol Violation|1|||
94595246|NCT01236547|323981699|FG003|Overall Study|Protocol Violation|6|||
94595247|NCT01236547|323981700|FG004|Overall Study|Protocol Violation|12|||
94595248|NCT01022398|323981701|FG000|Overall Study|Study terminated|2|||
94595249|NCT01022398|323981702|FG001|Overall Study|Study terminated|2|||
94660310|NCT03321981|324210084|FG001|Overall Study|Lack of compliance|1|||
94660311|NCT03321981|324210085|FG002|Overall Study|Lack of compliance|0|||
94660312|NCT03321981|324210083|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
94660313|NCT03321981|324210084|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
94595250|NCT03565367|323981703|FG000|Overall Study|No scan due to technical issues|4|||
94595251|NCT03565367|323981704|FG001|Overall Study|No scan due to technical issues|0|||
94595252|NCT01122264|323981705|FG000|Overall Study|Adverse Event|6|||
94595253|NCT01122264|323981706|FG001|Overall Study|Adverse Event|5|||
94457493|NCT02829723|323463538|FG002|Overall Study|Study terminated by sponsor|0|||
94457494|NCT02829723|323463539|FG003|Overall Study|Study terminated by sponsor|0|||
94457495|NCT02829723|323463540|FG004|Overall Study|Study terminated by sponsor|0|||
94457496|NCT02829723|323463541|FG005|Overall Study|Study terminated by sponsor|0|||
94457497|NCT02829723|323463542|FG006|Overall Study|Study terminated by sponsor|0|||
94595254|NCT01122264|323981707|FG002|Overall Study|Adverse Event|7|||
94595255|NCT01122264|323981705|FG000|Overall Study|Death|1|||
94595256|NCT01122264|323981706|FG001|Overall Study|Death|0|||
94595257|NCT01122264|323981707|FG002|Overall Study|Death|0|||
94595258|NCT01122264|323981705|FG000|Overall Study|Lost to Follow-up|5|||
94595259|NCT01122264|323981706|FG001|Overall Study|Lost to Follow-up|9|||
94595260|NCT01122264|323981707|FG002|Overall Study|Lost to Follow-up|13|||
94595261|NCT01122264|323981705|FG000|Overall Study|Entry Criteria Not Met|1|||
94595262|NCT01122264|323981706|FG001|Overall Study|Entry Criteria Not Met|0|||
94595263|NCT01122264|323981707|FG002|Overall Study|Entry Criteria Not Met|0|||
94595264|NCT01122264|323981705|FG000|Overall Study|Protocol Violation|7|||
94595265|NCT01122264|323981706|FG001|Overall Study|Protocol Violation|7|||
94595266|NCT01122264|323981707|FG002|Overall Study|Protocol Violation|9|||
94595267|NCT01122264|323981705|FG000|Overall Study|Withdrawal by Subject|6|||
94595268|NCT01122264|323981706|FG001|Overall Study|Withdrawal by Subject|6|||
94595269|NCT01122264|323981707|FG002|Overall Study|Withdrawal by Subject|16|||
94595270|NCT01122264|323981705|FG000|Overall Study|Physician Decision|3|||
94595271|NCT01122264|323981706|FG001|Overall Study|Physician Decision|1|||
94595272|NCT01122264|323981707|FG002|Overall Study|Physician Decision|1|||
94595273|NCT01122264|323981705|FG000|Overall Study|Lack of Efficacy|3|||
94595274|NCT01122264|323981706|FG001|Overall Study|Lack of Efficacy|1|||
94595275|NCT01122264|323981707|FG002|Overall Study|Lack of Efficacy|1|||
94595276|NCT03005873|323981708|FG000|Overall Study|Prohibited medication use post radnomization|1|||
94595277|NCT03005873|323981709|FG001|Overall Study|Prohibited medication use post radnomization|1|||
94595278|NCT03005873|323981710|FG002|Overall Study|Prohibited medication use post radnomization|1|||
94595279|NCT03005873|323981708|FG000|Overall Study|Withdrew consent|0|||
94595280|NCT03005873|323981709|FG001|Overall Study|Withdrew consent|1|||
94595281|NCT03005873|323981710|FG002|Overall Study|Withdrew consent|2|||
94595282|NCT03005873|323981708|FG000|Overall Study|Lost to Follow-up|0|||
94595283|NCT03005873|323981709|FG001|Overall Study|Lost to Follow-up|1|||
94595284|NCT03005873|323981710|FG002|Overall Study|Lost to Follow-up|0|||
94595285|NCT03005873|323981708|FG000|Overall Study|Ineligible post randomization|0|||
94595286|NCT03005873|323981709|FG001|Overall Study|Ineligible post randomization|0|||
94595287|NCT03005873|323981710|FG002|Overall Study|Ineligible post randomization|1|||
94595288|NCT03859973|323981716|FG000|Overall Study|Other reason than listed|3|||
94595289|NCT03859973|323981717|FG001|Overall Study|Other reason than listed|2|||
94595290|NCT03859973|323981716|FG000|Overall Study|COVID-19 related, not due to AE|3|||
94595291|NCT03859973|323981717|FG001|Overall Study|COVID-19 related, not due to AE|4|||
94595292|NCT03859973|323981716|FG000|Overall Study|Withdrawal by Subject|8|||
94595293|NCT03859973|323981717|FG001|Overall Study|Withdrawal by Subject|9|||
94595294|NCT03859973|323981716|FG000|Overall Study|Lost to Follow-up|2|||
94595295|NCT03859973|323981717|FG001|Overall Study|Lost to Follow-up|3|||
94595296|NCT03859973|323981716|FG000|Overall Study|Protocol Violation|1|||
94595297|NCT03859973|323981717|FG001|Overall Study|Protocol Violation|3|||
94595298|NCT03859973|323981716|FG000|Overall Study|Adverse Event|3|||
94595299|NCT03859973|323981717|FG001|Overall Study|Adverse Event|5|||
94595300|NCT01369329|323981722|FG000|Overall Study|Withdrawal by Subject|8|||
94595301|NCT01369329|323981723|FG001|Overall Study|Withdrawal by Subject|6|||
94595302|NCT01369329|323981724|FG002|Overall Study|Withdrawal by Subject|10|||
94595303|NCT01369329|323981722|FG000|Overall Study|Lost to Follow-up|2|||
94595304|NCT01369329|323981723|FG001|Overall Study|Lost to Follow-up|2|||
94246894|NCT02624791|322698989|FG002|Overall Study|Withdrawal by Subject|0|||
94246895|NCT02624791|322698990|FG003|Overall Study|Withdrawal by Subject|0|||
94246896|NCT02624791|322698991|FG004|Overall Study|Withdrawal by Subject|0|||
94246897|NCT02624791|322698992|FG005|Overall Study|Withdrawal by Subject|0|||
94246898|NCT00548262|322698993|FG000|Overall Study|Death|21|||
94246899|NCT00548262|322698993|FG000|Overall Study|Adverse Event|2|||
94246900|NCT00548262|322698993|FG000|Overall Study|Lack of Efficacy|4|||
94246901|NCT00548262|322698993|FG000|Overall Study|Lost to Follow-up|1|||
94246902|NCT00548262|322698993|FG000|Overall Study|Other|3|||
94246903|NCT00548262|322698993|FG000|Overall Study|Withdrawal by Subject|1|||
94246904|NCT02442336|322698997|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
94595305|NCT01369329|323981724|FG002|Overall Study|Lost to Follow-up|2|||
94595306|NCT01369329|323981722|FG000|Overall Study|Other|2|||
94595307|NCT01369329|323981723|FG001|Overall Study|Other|3|||
94595308|NCT01369329|323981724|FG002|Overall Study|Other|2|||
94595309|NCT00833417|323981725|FG000|Overall Study|Adverse Event|5|||
94595310|NCT00833417|323981726|FG001|Overall Study|Adverse Event|16|||
94595311|NCT00833417|323981725|FG000|Overall Study|Death|1|||
94595312|NCT00833417|323981726|FG001|Overall Study|Death|3|||
94595313|NCT00833417|323981725|FG000|Overall Study|Lost to Follow-up|1|||
94595314|NCT00833417|323981726|FG001|Overall Study|Lost to Follow-up|2|||
94595315|NCT00833417|323981725|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
94595316|NCT00833417|323981726|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
94595317|NCT00833417|323981725|FG000|Overall Study|Patient Decision to Withdraw|4|||
94595318|NCT00833417|323981726|FG001|Overall Study|Patient Decision to Withdraw|23|||
94595319|NCT00833417|323981725|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
94595320|NCT00833417|323981726|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
94595321|NCT00833417|323981725|FG000|Overall Study|Disease Progression|18|||
94595322|NCT00833417|323981726|FG001|Overall Study|Disease Progression|17|||
94595323|NCT00833417|323981725|FG000|Overall Study|Reason Not Specified|0|||
94595324|NCT00833417|323981726|FG001|Overall Study|Reason Not Specified|1|||
94595325|NCT03032380|323981727|FG000|Overall Study|Adverse Event|0|||
94595326|NCT03032380|323981728|FG001|Overall Study|Adverse Event|1|||
94595327|NCT03032380|323981727|FG000|Overall Study|Lack of Efficacy|1|||
94595328|NCT03032380|323981728|FG001|Overall Study|Lack of Efficacy|0|||
94595329|NCT03032380|323981727|FG000|Overall Study|Withdrawal by Subject|2|||
94595330|NCT03032380|323981728|FG001|Overall Study|Withdrawal by Subject|3|||
94595331|NCT03032380|323981727|FG000|Overall Study|Recovery|0|||
94595332|NCT03032380|323981728|FG001|Overall Study|Recovery|1|||
94595333|NCT03032380|323981727|FG000|Overall Study|Death|39|||
94595334|NCT03032380|323981728|FG001|Overall Study|Death|34|||
94595335|NCT03032380|323981727|FG000|Overall Study|Other - Miscellaneous|0|||
94595336|NCT03032380|323981728|FG001|Overall Study|Other - Miscellaneous|1|||
94595337|NCT04644315|323981729|FG000|Overall Study|Subject withdrawal of consent|1|||
94595338|NCT00294762|323981730|FG000|Overall Study|Did not receive study treatment|3|||
94595339|NCT00294762|323981731|FG001|Overall Study|Did not receive study treatment|3|||
94595340|NCT02937584|323981732|FG000|Period 1|Adverse Event|1|||
94595341|NCT02937584|323981733|FG001|Period 1|Adverse Event|2|||
94595342|NCT02937584|323981732|FG000|Washout|Adverse Event|0|||
94595343|NCT02937584|323981733|FG001|Washout|Adverse Event|1|||
94595344|NCT01738646|323981735|FG000|Overall Study|Still Receiving Treatment|2|||
94595345|NCT02267317|323981738|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
94595346|NCT02267317|323981739|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
94595347|NCT02267317|323981740|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
94595348|NCT02267317|323981741|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
94595349|NCT02267317|323981742|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
94595350|NCT02267317|323981743|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
94595351|NCT02267317|323981738|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
94595352|NCT02267317|323981739|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
94595353|NCT02267317|323981740|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
94595354|NCT02267317|323981741|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
94595355|NCT02267317|323981742|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
94457498|NCT02829723|323463543|FG007|Overall Study|Study terminated by sponsor|0|||
94595356|NCT02267317|323981743|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
94595357|NCT01155011|323981752|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
94595358|NCT01155011|323981753|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
94595359|NCT01155011|323981752|FG000|Baseline to 6 Months|investigator decision, moved|4|||
94264099|NCT03684642|322761830|FG002|Overall Study|Randomized and not treated|1|||
94595360|NCT01155011|323981753|FG001|Baseline to 6 Months|investigator decision, moved|5|||
94595361|NCT01155011|323981752|FG000|Baseline to 6 Months|Death|0|||
94595362|NCT01155011|323981753|FG001|Baseline to 6 Months|Death|1|||
94595363|NCT01155011|323981752|FG000|6 to 12 Months|Withdrawal by Subject|8|||
94595364|NCT01155011|323981753|FG001|6 to 12 Months|Withdrawal by Subject|5|||
94264100|NCT03684642|322761828|FG000|Overall Study|Missing completion status but alive at last contact|0|||
94264101|NCT03684642|322761829|FG001|Overall Study|Missing completion status but alive at last contact|1|||
94264102|NCT03684642|322761830|FG002|Overall Study|Missing completion status but alive at last contact|2|||
94264103|NCT01431534|322761831|FG000|Treatment Phase|Adverse Event|0|||
94264104|NCT01431534|322761832|FG001|Treatment Phase|Adverse Event|0|||
94264105|NCT01431534|322761833|FG002|Treatment Phase|Adverse Event|1|||
94264106|NCT01431534|322761831|FG000|Treatment Phase|Progressive Disease|4|||
94264107|NCT01431534|322761832|FG001|Treatment Phase|Progressive Disease|3|||
94264108|NCT01431534|322761833|FG002|Treatment Phase|Progressive Disease|10|||
94264109|NCT01009554|322761839|FG000|Overall Study|Adverse Event|1|||
94264110|NCT01009554|322761840|FG001|Overall Study|Adverse Event|1|||
94264111|NCT01009554|322761839|FG000|Overall Study|Withdrawal by Subject|1|||
94355922|NCT01674010|323085728|FG000|Randomization Phase 2|Physician Decision|0|||
94355923|NCT01674010|323085729|FG001|Randomization Phase 2|Physician Decision|0|||
94355924|NCT01674010|323085730|FG002|Randomization Phase 2|Physician Decision|2|||
94355925|NCT01674010|323085728|FG000|Randomization Phase 2|Pregnancy|0|||
94355926|NCT01674010|323085729|FG001|Randomization Phase 2|Pregnancy|1|||
94595365|NCT01155011|323981752|FG000|6 to 12 Months|Death|1|||
94595366|NCT01155011|323981753|FG001|6 to 12 Months|Death|5|||
94595367|NCT02350764|323981754|FG000|Overall Study|Adverse Event|4|||
94595368|NCT02350764|323981754|FG000|Overall Study|Death|3|||
94595369|NCT02350764|323981754|FG000|Overall Study|Physician Decision|2|||
94595370|NCT02350764|323981754|FG000|Overall Study|Withdrawal by Subject|2|||
94595371|NCT01328444|323981755|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
94595372|NCT01328444|323981756|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
94595373|NCT01328444|323981757|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
94595374|NCT01328444|323981758|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
94595375|NCT01328444|323981759|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
94595376|NCT01328444|323981760|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
94595377|NCT01328444|323981755|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
94595378|NCT01328444|323981756|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
94595379|NCT01328444|323981757|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
94595380|NCT01328444|323981758|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
94595381|NCT01328444|323981759|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
94595382|NCT01328444|323981760|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
94595383|NCT01328444|323981755|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
94595384|NCT01328444|323981756|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
94595385|NCT01328444|323981757|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
94595386|NCT01328444|323981758|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
94595387|NCT01328444|323981759|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
94595388|NCT01328444|323981760|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
94595389|NCT01328444|323981755|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
94595390|NCT01328444|323981756|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
94595391|NCT01328444|323981757|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
94595392|NCT01328444|323981758|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
94595393|NCT01328444|323981759|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
94595394|NCT01328444|323981760|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
94246905|NCT02442336|322698997|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
94246906|NCT02442336|322698997|FG000|Overall Study|Lost to Follow-up|11|||
94246907|NCT00998790|322698998|FG000|Overall Study|Withdrawal by Subject|21|||
94246908|NCT00948766|322699002|FG000|Core Study|Adverse Event|73|||
94246909|NCT00948766|322699003|FG001|Core Study|Adverse Event|51|||
94246910|NCT00948766|322699002|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
94595395|NCT01328444|323981755|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
94595396|NCT01328444|323981756|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
94595397|NCT01328444|323981757|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
94595398|NCT01328444|323981758|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
94595399|NCT01328444|323981759|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
94595400|NCT01328444|323981760|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
94595401|NCT01328444|323981755|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
94595402|NCT01328444|323981756|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
94595403|NCT01328444|323981757|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
94595404|NCT01328444|323981758|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
94246911|NCT00948766|322699003|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
94246912|NCT00948766|322699002|FG000|Core Study|Patient Withdrew Consent|27|||
94246913|NCT00948766|322699003|FG001|Core Study|Patient Withdrew Consent|46|||
94246914|NCT00948766|322699002|FG000|Core Study|Lost to Follow-up|3|||
94246915|NCT00948766|322699003|FG001|Core Study|Lost to Follow-up|2|||
94595405|NCT01328444|323981759|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
94595406|NCT01328444|323981760|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
94595407|NCT01328444|323981755|FG000|Washout Period (14 Days)|Adverse Event|1|||
94246916|NCT00948766|322699002|FG000|Core Study|Administrative Problems|2|||
94246917|NCT00948766|322699003|FG001|Core Study|Administrative Problems|2|||
94355927|NCT01674010|323085730|FG002|Randomization Phase 2|Pregnancy|1|||
94355928|NCT01674010|323085728|FG000|Randomization Phase 2|Protocol Violation|0|||
94355929|NCT01674010|323085729|FG001|Randomization Phase 2|Protocol Violation|1|||
94595408|NCT01328444|323981756|FG001|Washout Period (14 Days)|Adverse Event|1|||
94595409|NCT01328444|323981757|FG002|Washout Period (14 Days)|Adverse Event|0|||
94246918|NCT00948766|322699002|FG000|Core Study|Death|1|||
94246919|NCT00948766|322699003|FG001|Core Study|Death|1|||
94246920|NCT00948766|322699002|FG000|Core Study|Protocol Deviation|8|||
94355930|NCT01674010|323085730|FG002|Randomization Phase 2|Protocol Violation|1|||
94355931|NCT01674010|323085728|FG000|Randomization Phase 2|Sponsor Decision|0|||
94457499|NCT02829723|323463544|FG008|Overall Study|Study terminated by sponsor|0|||
94595410|NCT01328444|323981758|FG003|Washout Period (14 Days)|Adverse Event|1|||
94595411|NCT01328444|323981759|FG004|Washout Period (14 Days)|Adverse Event|1|||
94595412|NCT01328444|323981760|FG005|Washout Period (14 Days)|Adverse Event|2|||
94595413|NCT01328444|323981755|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
94595414|NCT01328444|323981756|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
94595415|NCT01328444|323981757|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
94595416|NCT01328444|323981758|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
94595417|NCT01328444|323981759|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
94595418|NCT01328444|323981760|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
94595419|NCT01328444|323981755|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
94595420|NCT01328444|323981756|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
94595421|NCT01328444|323981757|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
94595422|NCT01328444|323981758|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
94595423|NCT01328444|323981759|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
94595424|NCT01328444|323981760|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
94595425|NCT01328444|323981755|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
94595426|NCT01328444|323981756|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
94595427|NCT01328444|323981757|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
94595428|NCT01328444|323981758|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
94595429|NCT01328444|323981759|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
94595430|NCT01328444|323981760|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
94595431|NCT01328444|323981755|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
94595432|NCT01328444|323981756|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
94595433|NCT01328444|323981757|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
94595434|NCT01328444|323981758|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
94595435|NCT01328444|323981759|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
94595436|NCT01328444|323981760|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
94595437|NCT01328444|323981755|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
94595438|NCT01328444|323981756|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
94595439|NCT01328444|323981757|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
94595440|NCT01328444|323981758|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
94595441|NCT01328444|323981759|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
94595442|NCT01328444|323981760|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
94595443|NCT01328444|323981755|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
94595444|NCT01328444|323981756|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
94595445|NCT01328444|323981757|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
94595446|NCT01328444|323981758|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
94595447|NCT01328444|323981759|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
94595448|NCT01328444|323981760|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
94595449|NCT01328444|323981755|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
94595450|NCT01328444|323981756|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
94595451|NCT01328444|323981757|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
94595452|NCT01328444|323981758|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
94595453|NCT01328444|323981759|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
94595454|NCT01328444|323981760|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
94595455|NCT01328444|323981755|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
94595456|NCT01328444|323981756|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
94595457|NCT01328444|323981757|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
94595458|NCT01328444|323981758|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
94595459|NCT01328444|323981759|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
94595460|NCT01328444|323981760|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
94595461|NCT00600119|323981761|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
94595462|NCT00600119|323981762|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
94595463|NCT00600119|323981763|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
94595464|NCT00600119|323981764|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
94595465|NCT00600119|323981765|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
94595466|NCT00600119|323981766|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
94595467|NCT00600119|323981761|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
94595468|NCT00600119|323981762|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
94595469|NCT00600119|323981763|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
94595470|NCT00600119|323981764|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
94595471|NCT00600119|323981765|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
94595472|NCT00600119|323981766|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
94595473|NCT00600119|323981761|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
94595474|NCT00600119|323981762|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
94595475|NCT00600119|323981763|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
94246921|NCT00948766|322699003|FG001|Core Study|Protocol Deviation|10|||
94595476|NCT00600119|323981764|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
94595477|NCT00600119|323981765|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
94595478|NCT00600119|323981766|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
94595479|NCT00600119|323981761|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
94595480|NCT00600119|323981762|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
94595481|NCT00600119|323981763|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
94595482|NCT00600119|323981764|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
94595483|NCT00600119|323981765|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
94595484|NCT00600119|323981766|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
94595485|NCT00600119|323981761|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
94595486|NCT00600119|323981762|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
94595487|NCT00600119|323981763|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
94595488|NCT00600119|323981764|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
94595489|NCT00600119|323981765|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
94595490|NCT00600119|323981766|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
94595491|NCT00600119|323981761|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
94595492|NCT00600119|323981762|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
94595493|NCT00600119|323981763|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
94595494|NCT00600119|323981764|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
94595495|NCT00600119|323981765|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
94595496|NCT00600119|323981766|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
94595497|NCT00600119|323981761|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
94595498|NCT00600119|323981762|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
94595499|NCT00600119|323981763|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
94595500|NCT00600119|323981764|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
94595501|NCT00600119|323981765|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
94595502|NCT00600119|323981766|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
94595503|NCT00600119|323981761|FG000|Double-blind Treatment Period|Other|0|||
94595504|NCT00600119|323981762|FG001|Double-blind Treatment Period|Other|0|||
94595505|NCT00600119|323981763|FG002|Double-blind Treatment Period|Other|0|||
94595506|NCT00600119|323981764|FG003|Double-blind Treatment Period|Other|0|||
94595507|NCT00600119|323981765|FG004|Double-blind Treatment Period|Other|2|||
94595508|NCT00600119|323981766|FG005|Double-blind Treatment Period|Other|1|||
94595509|NCT00600119|323981761|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
94595510|NCT00600119|323981762|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
94595511|NCT00600119|323981763|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
94595512|NCT00600119|323981764|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
94595513|NCT00600119|323981765|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
94595514|NCT00600119|323981766|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
94595515|NCT00600119|323981761|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
94595516|NCT00600119|323981762|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
94595517|NCT00600119|323981763|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
94595518|NCT00600119|323981764|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
94595519|NCT00600119|323981765|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
94595520|NCT00600119|323981766|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
94595521|NCT00600119|323981761|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
94595522|NCT00600119|323981762|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
94595523|NCT00600119|323981763|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
94595524|NCT00600119|323981764|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
94595525|NCT00600119|323981765|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
94595526|NCT00600119|323981766|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
94595527|NCT00600119|323981761|FG000|Double-blind Treatment Period|Physician Decision|2|||
94595528|NCT00600119|323981762|FG001|Double-blind Treatment Period|Physician Decision|0|||
94595529|NCT00600119|323981763|FG002|Double-blind Treatment Period|Physician Decision|0|||
94595530|NCT00600119|323981764|FG003|Double-blind Treatment Period|Physician Decision|0|||
94595531|NCT00600119|323981765|FG004|Double-blind Treatment Period|Physician Decision|0|||
94595532|NCT00600119|323981766|FG005|Double-blind Treatment Period|Physician Decision|0|||
94595533|NCT00600119|323981761|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
94595534|NCT00600119|323981762|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
94595535|NCT00600119|323981763|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
94595536|NCT00600119|323981764|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
94595537|NCT00600119|323981765|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
94595538|NCT00600119|323981766|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
94595539|NCT00600119|323981761|FG000|Double-blind Treatment Period|Adverse Event|1|||
94595540|NCT00600119|323981762|FG001|Double-blind Treatment Period|Adverse Event|1|||
94595541|NCT00600119|323981763|FG002|Double-blind Treatment Period|Adverse Event|0|||
94595542|NCT00600119|323981764|FG003|Double-blind Treatment Period|Adverse Event|1|||
94595543|NCT00600119|323981765|FG004|Double-blind Treatment Period|Adverse Event|2|||
94595544|NCT00600119|323981766|FG005|Double-blind Treatment Period|Adverse Event|10|||
94595545|NCT00600119|323981761|FG000|Follow-up Period|Adverse Event|0|||
94595546|NCT00600119|323981762|FG001|Follow-up Period|Adverse Event|0|||
94595547|NCT00600119|323981763|FG002|Follow-up Period|Adverse Event|0|||
94595548|NCT00600119|323981764|FG003|Follow-up Period|Adverse Event|0|||
94595549|NCT00600119|323981765|FG004|Follow-up Period|Adverse Event|0|||
94595550|NCT00600119|323981766|FG005|Follow-up Period|Adverse Event|1|||
94595551|NCT00600119|323981761|FG000|Follow-up Period|Other|1|||
94457500|NCT02829723|323463545|FG009|Overall Study|Study terminated by sponsor|0|||
94457501|NCT02829723|323463546|FG010|Overall Study|Study terminated by sponsor|0|||
94595552|NCT00600119|323981762|FG001|Follow-up Period|Other|0|||
94595553|NCT00600119|323981763|FG002|Follow-up Period|Other|0|||
94595554|NCT00600119|323981764|FG003|Follow-up Period|Other|0|||
94595555|NCT00600119|323981765|FG004|Follow-up Period|Other|0|||
94595556|NCT00600119|323981766|FG005|Follow-up Period|Other|0|||
94595557|NCT00729469|323981767|FG000|Overall Study|Adverse Event|14|||
94595558|NCT00729469|323981768|FG001|Overall Study|Adverse Event|25|||
94595559|NCT00729469|323981767|FG000|Overall Study|Lost to Follow-up|9|||
94595560|NCT00729469|323981768|FG001|Overall Study|Lost to Follow-up|9|||
94595561|NCT00729469|323981767|FG000|Overall Study|Protocol Violation|2|||
94595562|NCT00729469|323981768|FG001|Overall Study|Protocol Violation|1|||
94595563|NCT00729469|323981767|FG000|Overall Study|Withdrawal by Subject|19|||
94595564|NCT00729469|323981768|FG001|Overall Study|Withdrawal by Subject|8|||
94595565|NCT00729469|323981767|FG000|Overall Study|Other-Not mentioned|9|||
94595566|NCT00729469|323981768|FG001|Overall Study|Other-Not mentioned|4|||
94595567|NCT04740905|323981769|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
94595568|NCT04740905|323981770|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
94595569|NCT04740905|323981769|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
94595570|NCT04740905|323981770|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
94595571|NCT04740905|323981769|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
94595572|NCT04740905|323981770|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
94595573|NCT04740905|323981769|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
94595574|NCT04740905|323981770|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
94595575|NCT04740905|323981769|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
94595576|NCT04740905|323981770|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
94595577|NCT04740905|323981769|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
94595578|NCT04740905|323981770|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
94595579|NCT04740905|323981769|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
94595580|NCT04740905|323981770|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
94595581|NCT04740905|323981769|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
94595582|NCT04740905|323981770|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
94595583|NCT04740905|323981769|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
94595584|NCT04740905|323981770|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
94595585|NCT04740905|323981769|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
94595586|NCT04740905|323981770|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
94595587|NCT04740905|323981769|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
94595588|NCT04740905|323981770|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
94660314|NCT03321981|324210085|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
94595589|NCT04740905|323981769|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
94595590|NCT04740905|323981770|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
94660315|NCT03321981|324210083|FG000|Overall Study|Death|0|||
94660316|NCT03321981|324210084|FG001|Overall Study|Death|1|||
94660317|NCT03321981|324210085|FG002|Overall Study|Death|0|||
94660318|NCT03321981|324210083|FG000|Overall Study|Subject withdrawal of investigational product|0|||
94660319|NCT03321981|324210084|FG001|Overall Study|Subject withdrawal of investigational product|1|||
94660320|NCT03321981|324210085|FG002|Overall Study|Subject withdrawal of investigational product|0|||
94660321|NCT03321981|324210083|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
94660322|NCT03321981|324210084|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
94595591|NCT04740905|323981769|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
94457502|NCT02829723|323463547|FG011|Overall Study|Study terminated by sponsor|0|||
94595592|NCT04740905|323981770|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
94595593|NCT04740905|323981769|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
94595594|NCT04740905|323981770|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
94595595|NCT02158364|323981771|FG000|Overall Study|Case report forms uncollected|10|||
94595596|NCT02158364|323981771|FG000|Overall Study|Protocol Deviation|50|||
94595597|NCT02412488|323981772|FG000|Overall Study|Lost to Follow-up|10|||
94595598|NCT02412488|323981772|FG000|Overall Study|Withdrawal by Subject|5|||
94595599|NCT02412488|323981772|FG000|Overall Study|Physician Decision|1|||
94457503|NCT02829723|323463548|FG012|Overall Study|Study terminated by sponsor|0|||
94595600|NCT02412488|323981772|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
94595601|NCT02412488|323981772|FG000|Overall Study|Reveal LINQ explant|1|||
94595602|NCT01989468|323981773|FG000|Overall Study|Adverse Event|10|||
94595603|NCT01989468|323981774|FG001|Overall Study|Adverse Event|15|||
94595604|NCT01989468|323981775|FG002|Overall Study|Adverse Event|4|||
94595605|NCT01989468|323981776|FG003|Overall Study|Adverse Event|5|||
94595606|NCT01989468|323981777|FG004|Overall Study|Adverse Event|4|||
94595607|NCT01989468|323981773|FG000|Overall Study|Lack of Efficacy|11|||
94595608|NCT01989468|323981774|FG001|Overall Study|Lack of Efficacy|11|||
94457504|NCT02829723|323463549|FG013|Overall Study|Study terminated by sponsor|0|||
94595609|NCT01989468|323981775|FG002|Overall Study|Lack of Efficacy|7|||
94595610|NCT01989468|323981776|FG003|Overall Study|Lack of Efficacy|4|||
94457505|NCT02829723|323463550|FG014|Overall Study|Study terminated by sponsor|0|||
94457506|NCT02829723|323463551|FG015|Overall Study|Study terminated by sponsor|0|||
94457507|NCT02829723|323463552|FG016|Overall Study|Study terminated by sponsor|0|||
94457508|NCT02829723|323463553|FG017|Overall Study|Study terminated by sponsor|0|||
94457509|NCT02829723|323463554|FG018|Overall Study|Study terminated by sponsor|0|||
94457510|NCT02829723|323463555|FG019|Overall Study|Study terminated by sponsor|0|||
94457511|NCT02829723|323463556|FG020|Overall Study|Study terminated by sponsor|0|||
94457512|NCT02829723|323463557|FG021|Overall Study|Study terminated by sponsor|1|||
94457513|NCT02829723|323463558|FG022|Overall Study|Study terminated by sponsor|0|||
94457514|NCT02829723|323463559|FG023|Overall Study|Study terminated by sponsor|0|||
94457515|NCT02829723|323463560|FG024|Overall Study|Study terminated by sponsor|0|||
94457516|NCT02829723|323463561|FG025|Overall Study|Study terminated by sponsor|0|||
94457517|NCT02829723|323463562|FG026|Overall Study|Study terminated by sponsor|0|||
94457518|NCT00281632|323463563|FG000|Overall Study|Adverse Event|7|||
94457519|NCT00281632|323463563|FG000|Overall Study|Withdrawal by Subject|2|||
94457520|NCT00281632|323463563|FG000|Overall Study|Disease Progression|22|||
94457521|NCT00281632|323463563|FG000|Overall Study|Death|1|||
94457522|NCT00281632|323463563|FG000|Overall Study|Physician Decision|1|||
94457523|NCT00281632|323463563|FG000|Overall Study|Ongoing|3|||
94457524|NCT00782184|323463565|FG000|Overall Study|Adverse Event|1|||
94457525|NCT00782184|323463566|FG001|Overall Study|Adverse Event|2|||
94457526|NCT00782184|323463565|FG000|Overall Study|Protocol Violation|0|||
94457527|NCT00782184|323463566|FG001|Overall Study|Protocol Violation|1|||
94457528|NCT00782184|323463565|FG000|Overall Study|Withdrawal by Subject|3|||
94457529|NCT00782184|323463566|FG001|Overall Study|Withdrawal by Subject|2|||
94457530|NCT00890084|323463567|FG000|Overall Study|Adverse Event|16|||
94457531|NCT00890084|323463567|FG000|Overall Study|Lost to Follow-up|126|||
94457532|NCT01438294|323463568|FG000|Overall Study|Lost to Follow-up|3|||
94457533|NCT01438294|323463569|FG001|Overall Study|Lost to Follow-up|7|||
94457534|NCT01346189|323463572|FG000|Overall Study|Withdrawal by Subject|7|||
94457535|NCT01346189|323463573|FG001|Overall Study|Withdrawal by Subject|5|||
94457536|NCT01346189|323463574|FG002|Overall Study|Withdrawal by Subject|3|||
94457537|NCT01346189|323463575|FG003|Overall Study|Withdrawal by Subject|5|||
94457538|NCT01346189|323463572|FG000|Overall Study|Physician Decision|4|||
94457539|NCT01346189|323463573|FG001|Overall Study|Physician Decision|0|||
94457540|NCT01346189|323463574|FG002|Overall Study|Physician Decision|0|||
94457541|NCT01346189|323463575|FG003|Overall Study|Physician Decision|0|||
94457542|NCT01346189|323463572|FG000|Overall Study|Moved|3|||
94457543|NCT01346189|323463573|FG001|Overall Study|Moved|0|||
94457544|NCT01346189|323463574|FG002|Overall Study|Moved|4|||
94457545|NCT01346189|323463575|FG003|Overall Study|Moved|0|||
94457546|NCT01346189|323463572|FG000|Overall Study|Other|2|||
94457547|NCT01346189|323463573|FG001|Overall Study|Other|4|||
94457548|NCT01346189|323463574|FG002|Overall Study|Other|7|||
94457549|NCT01346189|323463575|FG003|Overall Study|Other|3|||
94457550|NCT01346189|323463572|FG000|Overall Study|Death|0|||
94457551|NCT01346189|323463573|FG001|Overall Study|Death|3|||
94457552|NCT01346189|323463574|FG002|Overall Study|Death|0|||
94457553|NCT01346189|323463575|FG003|Overall Study|Death|0|||
94457554|NCT01346189|323463572|FG000|Overall Study|Non-health system primary care physician|0|||
94457555|NCT01346189|323463573|FG001|Overall Study|Non-health system primary care physician|5|||
94457556|NCT01346189|323463574|FG002|Overall Study|Non-health system primary care physician|0|||
94457557|NCT01346189|323463575|FG003|Overall Study|Non-health system primary care physician|0|||
94457558|NCT01346189|323463572|FG000|Overall Study|Travel|0|||
94457559|NCT01346189|323463573|FG001|Overall Study|Travel|0|||
94457560|NCT01346189|323463574|FG002|Overall Study|Travel|0|||
94457561|NCT01346189|323463575|FG003|Overall Study|Travel|3|||
94457562|NCT01895608|323463583|FG000|Overall Study|change in health status|0|||
94457563|NCT01895608|323463584|FG001|Overall Study|change in health status|1|||
94457564|NCT01895608|323463585|FG002|Overall Study|change in health status|1|||
94457565|NCT01895608|323463586|FG003|Overall Study|change in health status|0|||
94457566|NCT01895608|323463583|FG000|Overall Study|Withdrawal by Subject|0|||
94457567|NCT01895608|323463584|FG001|Overall Study|Withdrawal by Subject|0|||
94457568|NCT01895608|323463585|FG002|Overall Study|Withdrawal by Subject|2|||
94457569|NCT01895608|323463586|FG003|Overall Study|Withdrawal by Subject|0|||
94457570|NCT02691936|323463587|FG000|Overall Study|Withdrawal by Subject|2|||
94457571|NCT02691936|323463588|FG001|Overall Study|Withdrawal by Subject|5|||
94595611|NCT01989468|323981777|FG004|Overall Study|Lack of Efficacy|2|||
94595612|NCT01989468|323981773|FG000|Overall Study|Lost to Follow-up|5|||
94595613|NCT01989468|323981774|FG001|Overall Study|Lost to Follow-up|2|||
94595614|NCT01989468|323981775|FG002|Overall Study|Lost to Follow-up|0|||
94595615|NCT01989468|323981776|FG003|Overall Study|Lost to Follow-up|1|||
94595616|NCT01989468|323981777|FG004|Overall Study|Lost to Follow-up|1|||
94595617|NCT01989468|323981773|FG000|Overall Study|Physician Decision|4|||
94595618|NCT01989468|323981774|FG001|Overall Study|Physician Decision|1|||
94595619|NCT01989468|323981775|FG002|Overall Study|Physician Decision|0|||
94595620|NCT01989468|323981776|FG003|Overall Study|Physician Decision|1|||
94595621|NCT01989468|323981777|FG004|Overall Study|Physician Decision|0|||
94595622|NCT01989468|323981773|FG000|Overall Study|Pregnancy|0|||
94595623|NCT01989468|323981774|FG001|Overall Study|Pregnancy|1|||
94595624|NCT01989468|323981775|FG002|Overall Study|Pregnancy|0|||
94595625|NCT01989468|323981776|FG003|Overall Study|Pregnancy|0|||
94595626|NCT01989468|323981777|FG004|Overall Study|Pregnancy|0|||
94595627|NCT01989468|323981773|FG000|Overall Study|Technical Problems|3|||
94595628|NCT01989468|323981774|FG001|Overall Study|Technical Problems|1|||
94595629|NCT01989468|323981775|FG002|Overall Study|Technical Problems|3|||
94595630|NCT01989468|323981776|FG003|Overall Study|Technical Problems|1|||
94595631|NCT01989468|323981777|FG004|Overall Study|Technical Problems|0|||
94595632|NCT01989468|323981773|FG000|Overall Study|Subject Guardian Decision|11|||
94595633|NCT01989468|323981774|FG001|Overall Study|Subject Guardian Decision|6|||
94595634|NCT01989468|323981775|FG002|Overall Study|Subject Guardian Decision|4|||
94595635|NCT01989468|323981776|FG003|Overall Study|Subject Guardian Decision|4|||
94595636|NCT01989468|323981777|FG004|Overall Study|Subject Guardian Decision|1|||
94595637|NCT01989468|323981773|FG000|Overall Study|Death|3|||
94595638|NCT01989468|323981774|FG001|Overall Study|Death|0|||
94595639|NCT01989468|323981775|FG002|Overall Study|Death|1|||
94595640|NCT01989468|323981776|FG003|Overall Study|Death|0|||
94595641|NCT01989468|323981777|FG004|Overall Study|Death|0|||
94595642|NCT02395172|323981778|FG000|Overall Study|Participants randomized but not treated|3|||
94595643|NCT02395172|323981779|FG001|Overall Study|Participants randomized but not treated|31|||
94595644|NCT02576145|323981780|FG000|Overall Study|Adverse Event|1|||
94595645|NCT02576145|323981781|FG001|Overall Study|Adverse Event|0|||
94595646|NCT02576145|323981780|FG000|Overall Study|Withdrawal by Subject|1|||
94595647|NCT02576145|323981781|FG001|Overall Study|Withdrawal by Subject|0|||
94595648|NCT02576145|323981780|FG000|Overall Study|Acute rejection|1|||
94595649|NCT02576145|323981781|FG001|Overall Study|Acute rejection|0|||
94595650|NCT02576145|323981780|FG000|Overall Study|Tetanus Titers Decreased|0|||
94595651|NCT02576145|323981781|FG001|Overall Study|Tetanus Titers Decreased|1|||
94595652|NCT04268823|323981782|FG000|Overall Study|Adverse Event|1|||
94595653|NCT04268823|323981783|FG001|Overall Study|Adverse Event|0|||
94595654|NCT04268823|323981782|FG000|Overall Study|Participant Decision|1|||
94595655|NCT04268823|323981783|FG001|Overall Study|Participant Decision|0|||
94595656|NCT01947855|323981790|FG000|Overall Study|Withdrawal by Subject|1|||
94595657|NCT01947855|323981791|FG001|Overall Study|Withdrawal by Subject|0|||
94595658|NCT01947855|323981792|FG002|Overall Study|Withdrawal by Subject|0|||
94595659|NCT01924429|323981793|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
94595660|NCT01924429|323981794|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
94595661|NCT04054947|323981797|FG000|Overall Study|Withdrawal by Subject|1|||
94595662|NCT04054947|323981798|FG001|Overall Study|Withdrawal by Subject|0|||
94595663|NCT04054947|323981797|FG000|Overall Study|Lost to Follow-up|2|||
94660323|NCT03321981|324210085|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
94660324|NCT03321981|324210083|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
94595664|NCT04054947|323981798|FG001|Overall Study|Lost to Follow-up|5|||
94595665|NCT03720652|323981801|FG000|Overall Study|Withdrawal by Subject|2|||
94595666|NCT03720652|323981802|FG001|Overall Study|Withdrawal by Subject|7|||
94595667|NCT03720652|323981801|FG000|Overall Study|Lost to Follow-up|0|||
94595668|NCT03720652|323981802|FG001|Overall Study|Lost to Follow-up|4|||
94595669|NCT01454778|323981803|FG000|Overall Study|Lost to Follow-up|2|||
94595670|NCT01454778|323981803|FG000|Overall Study|Death|1|||
94595671|NCT00538785|323983435|FG000|Overall Study|Death|9|||
94595672|NCT00538785|323983436|FG001|Overall Study|Death|10|||
94595673|NCT00538785|323983435|FG000|Overall Study|Withdrawal of consent|9|||
94595674|NCT00538785|323983436|FG001|Overall Study|Withdrawal of consent|7|||
94595675|NCT00538785|323983435|FG000|Overall Study|Lost to Follow-up|1|||
94595676|NCT00538785|323983436|FG001|Overall Study|Lost to Follow-up|0|||
94595677|NCT03086967|323983442|FG000|Overall Study|Screen Failure|2|||
94595678|NCT03086967|323983443|FG001|Overall Study|Screen Failure|2|||
94595679|NCT02230527|323983445|FG000|Overall Study|Withdrawal by Subject|1|||
94595680|NCT02230527|323983446|FG001|Overall Study|Withdrawal by Subject|1|||
94595681|NCT02230527|323983445|FG000|Overall Study|Death|1|||
94595682|NCT02230527|323983446|FG001|Overall Study|Death|0|||
94595683|NCT02230527|323983445|FG000|Overall Study|Lost to Follow-up|2|||
94595684|NCT02230527|323983446|FG001|Overall Study|Lost to Follow-up|1|||
94595685|NCT02230527|323983445|FG000|Overall Study|Other|1|||
94595686|NCT02230527|323983446|FG001|Overall Study|Other|0|||
94595687|NCT02661178|323983447|FG000|Part 1|Protocol Violation|1|||
94660325|NCT03321981|324210084|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
94660326|NCT03321981|324210085|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
94660327|NCT03105362|324210086|FG000|Overall Study|Withdrawal by Subject|1|||
94660328|NCT03105362|324210086|FG000|Overall Study|Lost to Follow-up|1|||
94660329|NCT01337245|324210087|FG000|Overall Study|Lost to Follow-up|1|||
94595688|NCT02661178|323983448|FG001|Part 1|Protocol Violation|0|||
94595689|NCT02661178|323983449|FG002|Part 1|Protocol Violation|0|||
94595690|NCT02661178|323983450|FG003|Part 1|Protocol Violation|0|||
94595691|NCT02661178|323983451|FG004|Part 1|Protocol Violation|0|||
94595692|NCT02661178|323983452|FG005|Part 1|Protocol Violation|0|||
94595693|NCT02661178|323983453|FG006|Part 1|Protocol Violation|0|||
94595694|NCT02661178|323983454|FG007|Part 1|Protocol Violation|0|||
94595695|NCT02661178|323983455|FG008|Part 1|Protocol Violation|0|||
94595696|NCT02661178|323983456|FG009|Part 1|Protocol Violation|0|||
94595697|NCT02661178|323983457|FG010|Part 1|Protocol Violation|0|||
94595698|NCT02661178|323983458|FG011|Part 1|Protocol Violation|0|||
94595699|NCT02661178|323983459|FG012|Part 1|Protocol Violation|0|||
94595700|NCT02661178|323983460|FG013|Part 1|Protocol Violation|0|||
94595701|NCT02661178|323983461|FG014|Part 1|Protocol Violation|0|||
94595702|NCT04461600|323983463|FG000|Overall Study|Death|6|||
94595703|NCT04461600|323983464|FG001|Overall Study|Death|5|||
94595704|NCT04461600|323983463|FG000|Overall Study|Withdrawal by Subject|0|||
94595705|NCT04461600|323983464|FG001|Overall Study|Withdrawal by Subject|1|||
94595706|NCT02855541|323983465|FG000|Overall Study|Change in health status|2|||
94595707|NCT02855541|323983465|FG000|Overall Study|Withdrawal by Subject|2|||
94595708|NCT00422513|323983466|FG000|Overall Study|Lack of Efficacy|4|||
94595709|NCT00422513|323983467|FG001|Overall Study|Lack of Efficacy|5|||
94595710|NCT00422513|323983466|FG000|Overall Study|Protocol Violation|23|||
94595711|NCT00422513|323983467|FG001|Overall Study|Protocol Violation|7|||
94595712|NCT00422513|323983466|FG000|Overall Study|Refused Treatment|4|||
94660330|NCT01003249|324210088|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
94660331|NCT01003249|324210089|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
94660332|NCT01003249|324210088|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
94660333|NCT01003249|324210089|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
94660334|NCT01003249|324210088|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
94660335|NCT01003249|324210089|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
94660336|NCT01003249|324210088|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
94595713|NCT00422513|323983467|FG001|Overall Study|Refused Treatment|2|||
94595714|NCT00422513|323983466|FG000|Overall Study|Withdrawal by Subject|2|||
94595715|NCT00422513|323983467|FG001|Overall Study|Withdrawal by Subject|1|||
94595716|NCT00422513|323983466|FG000|Overall Study|early termination of the study|67|||
94595717|NCT00422513|323983467|FG001|Overall Study|early termination of the study|80|||
94595718|NCT00422513|323983466|FG000|Overall Study|Adverse Event|4|||
94595719|NCT00422513|323983467|FG001|Overall Study|Adverse Event|4|||
94660337|NCT01003249|324210089|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
94660338|NCT02194621|324210090|FG000|Overall Study|6 withdrew prior to randomization|2|||
94660339|NCT02194621|324210091|FG001|Overall Study|6 withdrew prior to randomization|2|||
94660340|NCT02194621|324210092|FG002|Overall Study|6 withdrew prior to randomization|2|||
94595720|NCT00422513|323983466|FG000|Overall Study|Death|3|||
94595721|NCT00422513|323983467|FG001|Overall Study|Death|7|||
94595722|NCT01242813|323983468|FG000|Overall Study|Lost to Follow-up|2|||
94595723|NCT01478048|323983469|FG000|Overall Study|Disease Progression|52|||
94595724|NCT01478048|323983470|FG001|Overall Study|Disease Progression|35|||
94595725|NCT01478048|323983469|FG000|Overall Study|study drug toxicity|11|||
94595726|NCT01478048|323983470|FG001|Overall Study|study drug toxicity|14|||
94595727|NCT01478048|323983469|FG000|Overall Study|Adverse Event|2|||
94595728|NCT01478048|323983470|FG001|Overall Study|Adverse Event|11|||
94595729|NCT01478048|323983469|FG000|Overall Study|subject request to discontinue treatment|3|||
94595730|NCT01478048|323983470|FG001|Overall Study|subject request to discontinue treatment|5|||
94595731|NCT01478048|323983469|FG000|Overall Study|Withdrawal by Subject|2|||
94595732|NCT01478048|323983470|FG001|Overall Study|Withdrawal by Subject|5|||
94595733|NCT01478048|323983469|FG000|Overall Study|non-specified|6|||
94595734|NCT01478048|323983470|FG001|Overall Study|non-specified|4|||
94595735|NCT01478048|323983469|FG000|Overall Study|poor/non-compliance|0|||
94595736|NCT01478048|323983470|FG001|Overall Study|poor/non-compliance|1|||
94595737|NCT01478048|323983469|FG000|Overall Study|no longer meets study criteria|1|||
94595738|NCT01478048|323983470|FG001|Overall Study|no longer meets study criteria|0|||
94595739|NCT00704522|323983473|FG000|Overall Study|Lack of Efficacy|65|||
94595740|NCT00704522|323983474|FG001|Overall Study|Lack of Efficacy|17|||
94595741|NCT00704522|323983473|FG000|Overall Study|Failure to appear again at hospital|56|||
94595742|NCT00704522|323983474|FG001|Overall Study|Failure to appear again at hospital|10|||
94595743|NCT00704522|323983473|FG000|Overall Study|Withdrawal by Subject|17|||
94595744|NCT00704522|323983474|FG001|Overall Study|Withdrawal by Subject|8|||
94595745|NCT00704522|323983473|FG000|Overall Study|Adverse Event|9|||
94595746|NCT00704522|323983474|FG001|Overall Study|Adverse Event|1|||
94595747|NCT00704522|323983473|FG000|Overall Study|Undefined causes|9|||
94595748|NCT00704522|323983474|FG001|Overall Study|Undefined causes|7|||
94246922|NCT00948766|322699002|FG000|Extension Study|Adverse Event|43|||
94595749|NCT00704522|323983473|FG000|Overall Study|No information on therapy end|27|||
94595750|NCT00704522|323983474|FG001|Overall Study|No information on therapy end|2|||
94595751|NCT04224688|323983475|FG000|Overall Study|Withdrawal by Subject|1|||
94595752|NCT04224688|323983476|FG001|Overall Study|Withdrawal by Subject|3|||
94595753|NCT04224688|323983475|FG000|Overall Study|Lack of Efficacy|1|||
94595754|NCT04224688|323983476|FG001|Overall Study|Lack of Efficacy|1|||
94595755|NCT04224688|323983475|FG000|Overall Study|Adverse event, not fatal|0|||
94595756|NCT04224688|323983476|FG001|Overall Study|Adverse event, not fatal|2|||
94595757|NCT04224688|323983475|FG000|Overall Study|COVID-19|0|||
94595758|NCT04224688|323983476|FG001|Overall Study|COVID-19|1|||
94595759|NCT01958489|323983479|FG000|Period 2|Adverse Event|0|||
94595760|NCT01958489|323983480|FG001|Period 2|Adverse Event|1|||
94595761|NCT00713310|323983481|FG000|Overall Study|Adverse Event|5|||
94246923|NCT00948766|322699003|FG001|Extension Study|Adverse Event|0|||
94246924|NCT00948766|322699002|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
94246925|NCT00948766|322699003|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
94246926|NCT00948766|322699002|FG000|Extension Study|Study Drug No Longer Required|1|||
94246927|NCT00948766|322699003|FG001|Extension Study|Study Drug No Longer Required|0|||
94246928|NCT00948766|322699002|FG000|Extension Study|Patient Withdrew Consent|32|||
94246929|NCT00948766|322699003|FG001|Extension Study|Patient Withdrew Consent|0|||
94246930|NCT00948766|322699002|FG000|Extension Study|Lost to Follow-up|8|||
94246931|NCT00948766|322699003|FG001|Extension Study|Lost to Follow-up|0|||
94595762|NCT00713310|323983482|FG001|Overall Study|Adverse Event|2|||
94246932|NCT00948766|322699002|FG000|Extension Study|Administrative Problems|1|||
94246933|NCT00948766|322699003|FG001|Extension Study|Administrative Problems|0|||
94246934|NCT00948766|322699002|FG000|Extension Study|Death|4|||
94246935|NCT00948766|322699003|FG001|Extension Study|Death|0|||
94246936|NCT00888927|322699009|FG000|Overall Study|Adverse Event|0|||
94246937|NCT00888927|322699010|FG001|Overall Study|Adverse Event|0|||
94246938|NCT00888927|322699011|FG002|Overall Study|Adverse Event|0|||
94595763|NCT00713310|323983481|FG000|Overall Study|Lack of Efficacy|0|||
94595764|NCT00713310|323983482|FG001|Overall Study|Lack of Efficacy|2|||
94595765|NCT00713310|323983481|FG000|Overall Study|Withdrawal by Subject|0|||
94595766|NCT00713310|323983482|FG001|Overall Study|Withdrawal by Subject|2|||
94595767|NCT01105065|323983485|FG000|Overall Study|Adverse Event|5|||
94595768|NCT01105065|323983485|FG000|Overall Study|Technical Problems|1|||
94595769|NCT01215916|323983486|FG000|Overall Study|Progressive Disease|0|||
94246939|NCT00888927|322699012|FG003|Overall Study|Adverse Event|1|||
94246940|NCT00888927|322699009|FG000|Overall Study|Withdrawal of consent|0|||
94246941|NCT00888927|322699010|FG001|Overall Study|Withdrawal of consent|0|||
94246942|NCT00888927|322699011|FG002|Overall Study|Withdrawal of consent|0|||
94246943|NCT00888927|322699012|FG003|Overall Study|Withdrawal of consent|1|||
94246944|NCT01056718|322699013|FG000|Overall Study|Withdrawal by Subject|2|||
94246945|NCT01056718|322699013|FG000|Overall Study|Ischemia on baseline stress test|1|||
94246946|NCT03189745|322699014|FG000|Overall Study|Conflict in work schedule of participant|1|||
94246947|NCT03189745|322699015|FG001|Overall Study|Conflict in work schedule of participant|1|||
94246948|NCT00738894|322699016|FG000|Overall Study|Lost to Follow-up|23|||
94246949|NCT00738894|322699017|FG001|Overall Study|Lost to Follow-up|13|||
94246950|NCT00738894|322699016|FG000|Overall Study|Withdrawal by Subject|10|||
94246951|NCT00738894|322699017|FG001|Overall Study|Withdrawal by Subject|15|||
94246952|NCT00738894|322699016|FG000|Overall Study|Physician Decision|4|||
94246953|NCT00738894|322699017|FG001|Overall Study|Physician Decision|5|||
94355932|NCT01674010|323085729|FG001|Randomization Phase 2|Sponsor Decision|42|||
94355933|NCT01674010|323085730|FG002|Randomization Phase 2|Sponsor Decision|45|||
94355934|NCT01674010|323085728|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
94355935|NCT01674010|323085729|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
94595770|NCT01215916|323983487|FG001|Overall Study|Progressive Disease|2|||
94595771|NCT01215916|323983488|FG002|Overall Study|Progressive Disease|1|||
94595772|NCT01215916|323983489|FG003|Overall Study|Progressive Disease|2|||
94595773|NCT01215916|323983490|FG004|Overall Study|Progressive Disease|5|||
94660341|NCT02194621|324210090|FG000|Overall Study|Withdrawal by Subject|4|||
94246954|NCT00738894|322699016|FG000|Overall Study|Death|2|||
94246955|NCT00738894|322699017|FG001|Overall Study|Death|0|||
94246956|NCT01081665|322699018|FG000|Overall Study|Death|41|||
94246957|NCT01081665|322699018|FG000|Overall Study|Lost to Follow-up|18|||
94355936|NCT01674010|323085730|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
94595774|NCT01215916|323983491|FG005|Overall Study|Progressive Disease|4|||
94457572|NCT00749684|323463589|FG000|Overall Study|Death|1|||
94595775|NCT01215916|323983492|FG006|Overall Study|Progressive Disease|5|||
94595776|NCT01215916|323983493|FG007|Overall Study|Progressive Disease|3|||
94595777|NCT01215916|323983494|FG008|Overall Study|Progressive Disease|1|||
94595778|NCT01215916|323983486|FG000|Overall Study|Adverse Event|1|||
94595779|NCT01215916|323983487|FG001|Overall Study|Adverse Event|1|||
94595780|NCT01215916|323983488|FG002|Overall Study|Adverse Event|0|||
94660342|NCT02194621|324210091|FG001|Overall Study|Withdrawal by Subject|4|||
94246958|NCT01081665|322699018|FG000|Overall Study|Withdrawal by Subject|17|||
94246959|NCT01081665|322699018|FG000|Overall Study|Change of dialysis unit|10|||
94246960|NCT01081665|322699018|FG000|Overall Study|Regulation of iPTH|5|||
94246961|NCT01081665|322699018|FG000|Overall Study|Change in renal replacement therapy|2|||
94246962|NCT01081665|322699018|FG000|Overall Study|Adverse Event|1|||
94246963|NCT01081665|322699018|FG000|Overall Study|Lack of Efficacy|1|||
94246964|NCT02546921|322699022|FG000|Overall Study|Adverse Event|0|||
94246965|NCT02546921|322699023|FG001|Overall Study|Adverse Event|5|||
94246966|NCT02546921|322699024|FG002|Overall Study|Adverse Event|2|||
94246967|NCT02546921|322699025|FG003|Overall Study|Adverse Event|0|||
94246968|NCT02546921|322699026|FG004|Overall Study|Adverse Event|0|||
94246969|NCT02546921|322699027|FG005|Overall Study|Adverse Event|0|||
94246970|NCT02546921|322699028|FG006|Overall Study|Adverse Event|0|||
94246971|NCT02546921|322699022|FG000|Overall Study|Evidence of Disease Progression|1|||
94246972|NCT02546921|322699023|FG001|Overall Study|Evidence of Disease Progression|0|||
94246973|NCT02546921|322699024|FG002|Overall Study|Evidence of Disease Progression|0|||
94246974|NCT02546921|322699025|FG003|Overall Study|Evidence of Disease Progression|0|||
94595781|NCT01215916|323983489|FG003|Overall Study|Adverse Event|1|||
94595782|NCT01215916|323983490|FG004|Overall Study|Adverse Event|0|||
94246975|NCT02546921|322699026|FG004|Overall Study|Evidence of Disease Progression|1|||
94246976|NCT02546921|322699027|FG005|Overall Study|Evidence of Disease Progression|0|||
94246977|NCT02546921|322699028|FG006|Overall Study|Evidence of Disease Progression|0|||
94246978|NCT02546921|322699022|FG000|Overall Study|Patient Choice|0|||
94246979|NCT02546921|322699023|FG001|Overall Study|Patient Choice|1|||
94246980|NCT02546921|322699024|FG002|Overall Study|Patient Choice|0|||
94246981|NCT02546921|322699025|FG003|Overall Study|Patient Choice|0|||
94246982|NCT02546921|322699026|FG004|Overall Study|Patient Choice|0|||
94246983|NCT02546921|322699027|FG005|Overall Study|Patient Choice|1|||
94246984|NCT02546921|322699028|FG006|Overall Study|Patient Choice|0|||
94246985|NCT00700778|322699029|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
94246986|NCT04927247|322699035|FG000|Overall Study|Other|2|||
94246987|NCT04927247|322699036|FG001|Overall Study|Other|1|||
94246988|NCT04927247|322699035|FG000|Overall Study|Physician Decision|0|||
94246989|NCT04927247|322699036|FG001|Overall Study|Physician Decision|1|||
94246990|NCT04927247|322699035|FG000|Overall Study|Adverse Event|1|||
94246991|NCT04927247|322699036|FG001|Overall Study|Adverse Event|0|||
94246992|NCT00293059|322699037|FG000|Overall Study|Adverse Event|12|||
94246993|NCT00293059|322699038|FG001|Overall Study|Adverse Event|4|||
94246994|NCT00293059|322699037|FG000|Overall Study|Lack of Efficacy|2|||
94246995|NCT00293059|322699038|FG001|Overall Study|Lack of Efficacy|0|||
94246996|NCT00293059|322699037|FG000|Overall Study|Lost to Follow-up|2|||
94246997|NCT00293059|322699038|FG001|Overall Study|Lost to Follow-up|3|||
94595783|NCT01215916|323983491|FG005|Overall Study|Adverse Event|0|||
94595784|NCT01215916|323983492|FG006|Overall Study|Adverse Event|3|||
94595785|NCT01215916|323983493|FG007|Overall Study|Adverse Event|0|||
94595786|NCT01215916|323983494|FG008|Overall Study|Adverse Event|0|||
94595787|NCT01215916|323983486|FG000|Overall Study|Withdrawal by Subject|0|||
94595788|NCT01215916|323983487|FG001|Overall Study|Withdrawal by Subject|1|||
94595789|NCT01215916|323983488|FG002|Overall Study|Withdrawal by Subject|1|||
94595790|NCT01215916|323983489|FG003|Overall Study|Withdrawal by Subject|2|||
94595791|NCT01215916|323983490|FG004|Overall Study|Withdrawal by Subject|0|||
94595792|NCT01215916|323983491|FG005|Overall Study|Withdrawal by Subject|0|||
94595793|NCT01215916|323983492|FG006|Overall Study|Withdrawal by Subject|1|||
94595794|NCT01215916|323983493|FG007|Overall Study|Withdrawal by Subject|0|||
94595795|NCT01215916|323983494|FG008|Overall Study|Withdrawal by Subject|0|||
94595796|NCT01215916|323983486|FG000|Overall Study|Death|0|||
94595797|NCT01215916|323983487|FG001|Overall Study|Death|1|||
94595798|NCT01215916|323983488|FG002|Overall Study|Death|0|||
94595799|NCT01215916|323983489|FG003|Overall Study|Death|0|||
94595800|NCT01215916|323983490|FG004|Overall Study|Death|1|||
94595801|NCT01215916|323983491|FG005|Overall Study|Death|0|||
94246998|NCT00293059|322699037|FG000|Overall Study|Pregnancy|1|||
94246999|NCT00293059|322699038|FG001|Overall Study|Pregnancy|1|||
94595802|NCT01215916|323983492|FG006|Overall Study|Death|0|||
94595803|NCT01215916|323983493|FG007|Overall Study|Death|0|||
94595804|NCT01215916|323983494|FG008|Overall Study|Death|1|||
94595805|NCT01215916|323983486|FG000|Overall Study|Physician Decision|0|||
94595806|NCT01215916|323983487|FG001|Overall Study|Physician Decision|0|||
94595807|NCT01215916|323983488|FG002|Overall Study|Physician Decision|1|||
94247000|NCT00293059|322699037|FG000|Overall Study|Protocol Violation|2|||
94247001|NCT00293059|322699038|FG001|Overall Study|Protocol Violation|0|||
94247002|NCT00293059|322699037|FG000|Overall Study|Withdrawal by Subject|11|||
94247003|NCT00293059|322699038|FG001|Overall Study|Withdrawal by Subject|5|||
94247004|NCT00293059|322699037|FG000|Overall Study|Participant moved out of state|1|||
94247005|NCT00293059|322699038|FG001|Overall Study|Participant moved out of state|0|||
94595808|NCT01215916|323983489|FG003|Overall Study|Physician Decision|1|||
94595809|NCT01215916|323983490|FG004|Overall Study|Physician Decision|0|||
94595810|NCT01215916|323983491|FG005|Overall Study|Physician Decision|0|||
94595811|NCT01215916|323983492|FG006|Overall Study|Physician Decision|0|||
94595812|NCT01215916|323983493|FG007|Overall Study|Physician Decision|0|||
94595813|NCT01215916|323983494|FG008|Overall Study|Physician Decision|0|||
94247006|NCT00293059|322699037|FG000|Overall Study|Participant stopped study drug|1|||
94247007|NCT00293059|322699038|FG001|Overall Study|Participant stopped study drug|0|||
94247008|NCT00293059|322699037|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
94247009|NCT00293059|322699038|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
94247010|NCT00293059|322699037|FG000|Overall Study|missing|3|||
94247011|NCT00293059|322699038|FG001|Overall Study|missing|5|||
94247012|NCT00350103|322699043|FG000|Overall Study|Adverse Event|12|||
94247013|NCT00350103|322699044|FG001|Overall Study|Adverse Event|29|||
94247014|NCT00350103|322699045|FG002|Overall Study|Adverse Event|17|||
94247015|NCT00350103|322699043|FG000|Overall Study|Lack of Efficacy|5|||
94247016|NCT00350103|322699044|FG001|Overall Study|Lack of Efficacy|1|||
94247017|NCT00350103|322699045|FG002|Overall Study|Lack of Efficacy|3|||
94247018|NCT00350103|322699043|FG000|Overall Study|Withdrawal by Subject|6|||
94247019|NCT00350103|322699044|FG001|Overall Study|Withdrawal by Subject|6|||
94247020|NCT00350103|322699045|FG002|Overall Study|Withdrawal by Subject|8|||
94247021|NCT00350103|322699043|FG000|Overall Study|Protocol Violation|0|||
94247022|NCT00350103|322699044|FG001|Overall Study|Protocol Violation|0|||
94247023|NCT00350103|322699045|FG002|Overall Study|Protocol Violation|1|||
94247024|NCT00350103|322699043|FG000|Overall Study|Unsatisfactory Compliance|2|||
94247025|NCT00350103|322699044|FG001|Overall Study|Unsatisfactory Compliance|2|||
94247026|NCT00350103|322699045|FG002|Overall Study|Unsatisfactory Compliance|1|||
94247027|NCT00350103|322699043|FG000|Overall Study|Investigator´s decision|1|||
94247028|NCT00350103|322699044|FG001|Overall Study|Investigator´s decision|1|||
94247029|NCT00350103|322699045|FG002|Overall Study|Investigator´s decision|0|||
94247030|NCT00350103|322699043|FG000|Overall Study|Exclusion criteria met|0|||
94247031|NCT00350103|322699044|FG001|Overall Study|Exclusion criteria met|0|||
94247032|NCT00350103|322699045|FG002|Overall Study|Exclusion criteria met|1|||
94247033|NCT00350103|322699043|FG000|Overall Study|Patient relocated|0|||
94247034|NCT00350103|322699044|FG001|Overall Study|Patient relocated|0|||
94247035|NCT00350103|322699045|FG002|Overall Study|Patient relocated|1|||
94247036|NCT00350103|322699043|FG000|Overall Study|Need for prohibited medication|1|||
94247037|NCT00350103|322699044|FG001|Overall Study|Need for prohibited medication|0|||
94247038|NCT00350103|322699045|FG002|Overall Study|Need for prohibited medication|0|||
94247039|NCT00350103|322699043|FG000|Overall Study|Personal reasons|0|||
94247040|NCT00350103|322699044|FG001|Overall Study|Personal reasons|0|||
94247041|NCT00350103|322699045|FG002|Overall Study|Personal reasons|1|||
94247042|NCT00350103|322699043|FG000|Overall Study|Patient stopped feeling pain|1|||
94247043|NCT00350103|322699044|FG001|Overall Study|Patient stopped feeling pain|0|||
94247044|NCT00350103|322699045|FG002|Overall Study|Patient stopped feeling pain|0|||
94247045|NCT00350103|322699043|FG000|Overall Study|PR greater than 250ms|0|||
94247046|NCT00350103|322699044|FG001|Overall Study|PR greater than 250ms|0|||
94247047|NCT00350103|322699045|FG002|Overall Study|PR greater than 250ms|1|||
94247048|NCT00350103|322699043|FG000|Overall Study|Wrong calculation of QT interval|0|||
94247049|NCT00350103|322699044|FG001|Overall Study|Wrong calculation of QT interval|0|||
94247050|NCT00350103|322699045|FG002|Overall Study|Wrong calculation of QT interval|1|||
94247051|NCT00350103|322699043|FG000|Overall Study|Sponsor mistake|1|||
94247052|NCT00350103|322699044|FG001|Overall Study|Sponsor mistake|0|||
94247053|NCT00350103|322699045|FG002|Overall Study|Sponsor mistake|0|||
94247054|NCT00350103|322699043|FG000|Overall Study|Randomization mistake|0|||
94247055|NCT00350103|322699044|FG001|Overall Study|Randomization mistake|1|||
94247056|NCT00350103|322699045|FG002|Overall Study|Randomization mistake|1|||
94247057|NCT00350103|322699043|FG000|Overall Study|Sponsor´s decision|0|||
94247058|NCT00350103|322699044|FG001|Overall Study|Sponsor´s decision|1|||
94247059|NCT00350103|322699045|FG002|Overall Study|Sponsor´s decision|0|||
94247060|NCT00350103|322699043|FG000|Overall Study|Lost, Reason unknown|1|||
94247061|NCT00350103|322699044|FG001|Overall Study|Lost, Reason unknown|1|||
94247062|NCT00350103|322699045|FG002|Overall Study|Lost, Reason unknown|0|||
94247063|NCT01262027|322699046|FG000|Overall Study|Adverse Event|1|||
94247064|NCT01262027|322699046|FG000|Overall Study|Withdrawal by Subject|3|||
94247065|NCT01262027|322699046|FG000|Overall Study|Protocol Violation|1|||
94247066|NCT02101385|322699048|FG000|Study Treatment|Disease Progression|9|||
94247067|NCT02101385|322699049|FG001|Study Treatment|Disease Progression|3|||
94247068|NCT02101385|322699048|FG000|Study Treatment|Alternative therapy|0|||
94247069|NCT02101385|322699049|FG001|Study Treatment|Alternative therapy|1|||
94247070|NCT02101385|322699048|FG000|Study Treatment|No treatment, per protocol criteria|0|||
94247071|NCT02101385|322699049|FG001|Study Treatment|No treatment, per protocol criteria|4|||
94247072|NCT02101385|322699048|FG000|Study Treatment|Patient Non compliance|0|||
94247073|NCT02101385|322699049|FG001|Study Treatment|Patient Non compliance|2|||
94247074|NCT02101385|322699048|FG000|Study Treatment|Withdrawal by Subject|5|||
94247075|NCT02101385|322699049|FG001|Study Treatment|Withdrawal by Subject|2|||
94247076|NCT02101385|322699048|FG000|Study Treatment|screen failure|1|||
94247077|NCT02101385|322699049|FG001|Study Treatment|screen failure|0|||
94247078|NCT02101385|322699048|FG000|Study Treatment|AE/Side Effects/Complications|8|||
94247079|NCT02101385|322699049|FG001|Study Treatment|AE/Side Effects/Complications|0|||
94247080|NCT02101385|322699048|FG000|Study Treatment|Lost to Follow-up|1|||
94247081|NCT02101385|322699049|FG001|Study Treatment|Lost to Follow-up|0|||
94457573|NCT00749684|323463589|FG000|Overall Study|Adverse Event|27|||
94457574|NCT00749684|323463589|FG000|Overall Study|Participant's Wish|10|||
94457575|NCT00749684|323463589|FG000|Overall Study|Not Documented|1|||
94457576|NCT00749684|323463589|FG000|Overall Study|Progressive Desease|31|||
94457577|NCT00749684|323463589|FG000|Overall Study|Therapy according to protocol + AE|2|||
94457578|NCT00749684|323463589|FG000|Overall Study|AE+discontinuation on participants wish|1|||
94457579|NCT00749684|323463589|FG000|Overall Study|Missing|9|||
94457580|NCT03505593|323463590|FG000|Overall Study|Withdrawal by Subject|1|||
94457581|NCT03505593|323463590|FG000|Overall Study|Died before procedure|1|||
94457582|NCT03505593|323463590|FG000|Overall Study|Anatomical abnormality|1|||
94457583|NCT03505593|323463590|FG000|Overall Study|Unable to pass through esophagus|1|||
94457584|NCT03505593|323463590|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
94457585|NCT01023256|323463591|FG000|Overall Study|Protocol Violation|2|||
94457586|NCT01023256|323463592|FG001|Overall Study|Protocol Violation|3|||
94457587|NCT01023256|323463593|FG002|Overall Study|Protocol Violation|0|||
94457588|NCT01023256|323463594|FG003|Overall Study|Protocol Violation|0|||
94457589|NCT01023256|323463591|FG000|Overall Study|Randomized but not treated|1|||
94457590|NCT01023256|323463592|FG001|Overall Study|Randomized but not treated|0|||
94457591|NCT01023256|323463593|FG002|Overall Study|Randomized but not treated|1|||
94457592|NCT01023256|323463594|FG003|Overall Study|Randomized but not treated|0|||
94595814|NCT03232333|323983495|FG000|Overall Study|Infection or Osteomyelitis|9|||
94595815|NCT03232333|323983495|FG000|Overall Study|Lost to Follow-up|4|||
94595816|NCT03232333|323983495|FG000|Overall Study|Withdrawal by Subject|2|||
94595817|NCT05277337|323983498|FG000|Overall Study|Lost to Follow-up|2|||
94457593|NCT01023256|323463591|FG000|Overall Study|Other|1|||
94457594|NCT01023256|323463592|FG001|Overall Study|Other|0|||
94457595|NCT01023256|323463593|FG002|Overall Study|Other|0|||
94457596|NCT01023256|323463594|FG003|Overall Study|Other|2|||
94457597|NCT01023256|323463591|FG000|Overall Study|Adverse Event|0|||
94457598|NCT01023256|323463592|FG001|Overall Study|Adverse Event|0|||
94457599|NCT01023256|323463593|FG002|Overall Study|Adverse Event|0|||
94457600|NCT01023256|323463594|FG003|Overall Study|Adverse Event|1|||
94457601|NCT01023256|323463591|FG000|Overall Study|Withdrawal by Subject|0|||
94457602|NCT01023256|323463592|FG001|Overall Study|Withdrawal by Subject|0|||
94457603|NCT01023256|323463593|FG002|Overall Study|Withdrawal by Subject|0|||
94457604|NCT01023256|323463594|FG003|Overall Study|Withdrawal by Subject|2|||
94457605|NCT03089697|323463595|FG000|Overall Study|Adverse Event|1|||
94457606|NCT03089697|323463596|FG001|Overall Study|Adverse Event|2|||
94457607|NCT03089697|323463595|FG000|Overall Study|Withdrawal by Subject|1|||
94457608|NCT03089697|323463596|FG001|Overall Study|Withdrawal by Subject|0|||
94457609|NCT01880086|323463597|FG000|Overall Study|Lost to Follow-up|1|||
94457610|NCT01880086|323463598|FG001|Overall Study|Lost to Follow-up|1|||
94457611|NCT01992653|323463603|FG000|Overall Study|Death|0|||
94457612|NCT01992653|323463604|FG001|Overall Study|Death|0|||
94595818|NCT05277337|323983499|FG001|Overall Study|Lost to Follow-up|0|||
94595819|NCT05277337|323983498|FG000|Overall Study|Withdrawal by Subject|1|||
94595820|NCT05277337|323983499|FG001|Overall Study|Withdrawal by Subject|0|||
94595821|NCT00322621|323983500|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
94595822|NCT00322621|323983501|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
94595823|NCT00322621|323983502|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
94595824|NCT00322621|323983500|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
94595825|NCT00322621|323983501|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
94595826|NCT00322621|323983502|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
94595827|NCT00322621|323983500|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
94595828|NCT00322621|323983501|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
94595829|NCT00322621|323983502|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
94595830|NCT00322621|323983500|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
94595831|NCT00322621|323983501|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
94595832|NCT00322621|323983502|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
94595833|NCT00322621|323983500|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
94595834|NCT00322621|323983501|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
94595835|NCT00322621|323983502|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
94595836|NCT00322621|323983500|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
94595837|NCT00322621|323983501|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
94595838|NCT00322621|323983502|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
94595839|NCT00322621|323983500|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
94595840|NCT00322621|323983501|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
94457613|NCT01992653|323463605|FG002|Overall Study|Death|1|||
94457614|NCT01992653|323463606|FG003|Overall Study|Death|0|||
94457615|NCT01992653|323463607|FG004|Overall Study|Death|1|||
94457616|NCT01992653|323463608|FG005|Overall Study|Death|0|||
94457617|NCT01992653|323463609|FG006|Overall Study|Death|4|||
94457618|NCT01992653|323463610|FG007|Overall Study|Death|2|||
94457619|NCT01992653|323463603|FG000|Overall Study|Lost to Follow-up|0|||
94457620|NCT01992653|323463604|FG001|Overall Study|Lost to Follow-up|0|||
94457621|NCT01992653|323463605|FG002|Overall Study|Lost to Follow-up|0|||
94595841|NCT00322621|323983502|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
94595842|NCT00322621|323983500|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
94595843|NCT00322621|323983501|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
94595844|NCT00322621|323983502|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
94595845|NCT00322621|323983500|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
94595846|NCT00322621|323983501|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
94595847|NCT00322621|323983502|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
94595848|NCT00322621|323983500|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
94595849|NCT00322621|323983501|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
94595850|NCT00322621|323983502|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
94595851|NCT00322621|323983500|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
94595852|NCT00322621|323983501|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
94595853|NCT00322621|323983502|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
94595854|NCT02683746|323983503|FG000|Overall Study|Adverse Event|3|||
94595855|NCT02683746|323983504|FG001|Overall Study|Adverse Event|2|||
94595856|NCT02683746|323983503|FG000|Overall Study|Lost to Follow-up|5|||
94595857|NCT02683746|323983504|FG001|Overall Study|Lost to Follow-up|6|||
94595858|NCT02683746|323983503|FG000|Overall Study|Withdrawal by Subject|6|||
94595859|NCT02683746|323983504|FG001|Overall Study|Withdrawal by Subject|5|||
94595860|NCT02683746|323983503|FG000|Overall Study|Physician Decision|2|||
94595861|NCT02683746|323983504|FG001|Overall Study|Physician Decision|1|||
94595862|NCT03726996|323983511|FG000|Overall Study|Parent's decision|2|||
94595863|NCT03726996|323983511|FG000|Overall Study|Study early termination|2|||
94595864|NCT03180619|323983512|FG000|Overall Study|Withdrew Consent|5|||
94595865|NCT03180619|323983513|FG001|Overall Study|Withdrew Consent|0|||
94595866|NCT03180619|323983514|FG002|Overall Study|Withdrew Consent|2|||
94595867|NCT03180619|323983512|FG000|Overall Study|Death|2|||
94595868|NCT03180619|323983513|FG001|Overall Study|Death|1|||
94595869|NCT03180619|323983514|FG002|Overall Study|Death|2|||
94595870|NCT03180619|323983512|FG000|Overall Study|Adverse Event|2|||
94595871|NCT03180619|323983513|FG001|Overall Study|Adverse Event|0|||
94595872|NCT03180619|323983514|FG002|Overall Study|Adverse Event|1|||
94595873|NCT03180619|323983512|FG000|Overall Study|Investigator's discretion|2|||
94595874|NCT03180619|323983513|FG001|Overall Study|Investigator's discretion|0|||
94595875|NCT03180619|323983514|FG002|Overall Study|Investigator's discretion|1|||
94595876|NCT00393510|323983517|FG000|Overall Study|Physician Decision|3|||
94595877|NCT00393510|323983518|FG001|Overall Study|Physician Decision|9|||
94595878|NCT03077087|323983521|FG000|Overall Study|Physician Decision|2|||
94595879|NCT02536404|323983522|FG000|Overall Study|Adverse Event|5|||
94595880|NCT02536404|323983523|FG001|Overall Study|Adverse Event|0|||
94595881|NCT02536404|323983522|FG000|Overall Study|Withdrawal by Subject|4|||
94595882|NCT02536404|323983523|FG001|Overall Study|Withdrawal by Subject|1|||
94595883|NCT02536404|323983522|FG000|Overall Study|Physician Decision|10|||
94595884|NCT02536404|323983523|FG001|Overall Study|Physician Decision|0|||
94595885|NCT02536404|323983522|FG000|Overall Study|Sponsor decision|1|||
94595886|NCT02536404|323983523|FG001|Overall Study|Sponsor decision|0|||
94595887|NCT02486627|323983532|FG000|Overall Study|Death|1|||
94595888|NCT02486627|323983533|FG001|Overall Study|Death|0|||
94595889|NCT02486627|323983532|FG000|Overall Study|Other Unspecified|0|||
94595890|NCT02486627|323983533|FG001|Overall Study|Other Unspecified|2|||
94595891|NCT02486627|323983532|FG000|Overall Study|Consent Withdrawn by Participant|4|||
94595892|NCT02486627|323983533|FG001|Overall Study|Consent Withdrawn by Participant|3|||
94595893|NCT02486627|323983532|FG000|Overall Study|Significant Participant Noncompliance|1|||
94595894|NCT02486627|323983533|FG001|Overall Study|Significant Participant Noncompliance|1|||
94595895|NCT02486627|323983532|FG000|Overall Study|Lost to Follow-up|1|||
94595896|NCT02486627|323983533|FG001|Overall Study|Lost to Follow-up|3|||
94595897|NCT02112045|323983534|FG000|Overall Study|Withdrawal by Subject|1|||
94595898|NCT02112045|323983535|FG001|Overall Study|Withdrawal by Subject|0|||
94595899|NCT00065429|323983536|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
94595900|NCT00065429|323983537|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
94595901|NCT00065429|323983538|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
94595902|NCT00065429|323983539|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
94595903|NCT00065429|323983540|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
94595904|NCT00065429|323983541|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
94595905|NCT00065429|323983542|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
94595906|NCT00065429|323983536|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
94595907|NCT00065429|323983537|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
94595908|NCT00065429|323983538|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
94595909|NCT00065429|323983539|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
94595910|NCT00065429|323983540|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
94595911|NCT00065429|323983541|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
94595912|NCT00065429|323983542|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
94595913|NCT00065429|323983536|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
94595914|NCT00065429|323983537|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
94595915|NCT00065429|323983538|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
94595916|NCT00065429|323983539|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
94595917|NCT00065429|323983540|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
94595918|NCT00065429|323983541|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
94595919|NCT00065429|323983542|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
94595920|NCT00065429|323983536|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
94595921|NCT00065429|323983537|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
94595922|NCT00065429|323983538|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
94595923|NCT00065429|323983539|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
94595924|NCT00065429|323983540|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
94595925|NCT00065429|323983541|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
94595926|NCT00065429|323983542|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
94595927|NCT00065429|323983536|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
94595928|NCT00065429|323983537|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
94595929|NCT00065429|323983538|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
94595930|NCT00065429|323983539|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
94595931|NCT00065429|323983540|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
94595932|NCT00065429|323983541|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
94595933|NCT00065429|323983542|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
94595934|NCT00065429|323983536|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
94595935|NCT00065429|323983537|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
94595936|NCT00065429|323983538|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
94595937|NCT00065429|323983539|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
94595938|NCT00065429|323983540|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
94595939|NCT00065429|323983541|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
94595940|NCT00065429|323983542|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
94595941|NCT00065429|323983536|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
94595942|NCT00065429|323983537|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
94595943|NCT00065429|323983538|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
94595944|NCT00065429|323983539|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
94595945|NCT00065429|323983540|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
94595946|NCT00065429|323983541|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
94595947|NCT00065429|323983542|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
94595948|NCT01509053|323983543|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
94595949|NCT01509053|323983543|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
94595950|NCT01509053|323983543|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
94595951|NCT01509053|323983543|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
94595952|NCT01509053|323983543|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
94595953|NCT01509053|323983543|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
94595954|NCT00548184|323983547|FG000|Overall Study|Adverse Event|3|||
94595955|NCT00548184|323983547|FG000|Overall Study|took other drug|1|||
94595956|NCT00548184|323983547|FG000|Overall Study|Found Her2 negative|1|||
94595957|NCT03148691|323983548|FG000|Overall Study|Protocol Violation|1|||
94595958|NCT03148691|323983549|FG001|Overall Study|Protocol Violation|2|||
94595959|NCT03148691|323983550|FG002|Overall Study|Protocol Violation|7|||
94595960|NCT03148691|323983548|FG000|Overall Study|Lost to Follow-up|0|||
94595961|NCT03148691|323983549|FG001|Overall Study|Lost to Follow-up|0|||
94595962|NCT03148691|323983550|FG002|Overall Study|Lost to Follow-up|1|||
94595963|NCT03148691|323983548|FG000|Overall Study|Other|1|||
94595964|NCT03148691|323983549|FG001|Overall Study|Other|0|||
94595965|NCT03148691|323983550|FG002|Overall Study|Other|0|||
94595966|NCT03148691|323983548|FG000|Overall Study|Withdrawal by Subject|1|||
94595967|NCT03148691|323983549|FG001|Overall Study|Withdrawal by Subject|0|||
94595968|NCT03148691|323983550|FG002|Overall Study|Withdrawal by Subject|0|||
94595969|NCT00834080|323983551|FG000|Overall Study|Adverse Event|7|||
94595970|NCT00834080|323983551|FG000|Overall Study|Lost to Follow-up|7|||
94595971|NCT00834080|323983551|FG000|Overall Study|Withdrawal by Subject|5|||
94595972|NCT00834080|323983551|FG000|Overall Study|Other - Pregnancy|1|||
94595973|NCT00834080|323983551|FG000|Overall Study|Other - False positive tests of the UDS|1|||
94595974|NCT00834080|323983551|FG000|Overall Study|Physician Decision|1|||
94595975|NCT00834080|323983551|FG000|Overall Study|Subject Relocated|1|||
94595976|NCT00852371|323983552|FG000|Overall Study|Lost to Follow-up|2|||
94595977|NCT00852371|323983553|FG001|Overall Study|Lost to Follow-up|3|||
94457622|NCT01992653|323463606|FG003|Overall Study|Lost to Follow-up|0|||
94595978|NCT00852371|323983554|FG002|Overall Study|Lost to Follow-up|4|||
94595979|NCT00852371|323983555|FG003|Overall Study|Lost to Follow-up|2|||
94595980|NCT04525885|323983556|FG000|Overall Study|Screen Failure|1|||
94595981|NCT04525885|323983557|FG001|Overall Study|Screen Failure|0|||
94595982|NCT04525885|323983558|FG002|Overall Study|Screen Failure|0|||
94595983|NCT04525885|323983556|FG000|Overall Study|Withdrawal by Subject|14|||
94595984|NCT04525885|323983557|FG001|Overall Study|Withdrawal by Subject|6|||
94595985|NCT04525885|323983558|FG002|Overall Study|Withdrawal by Subject|20|||
94595986|NCT04525885|323983556|FG000|Overall Study|Physician Decision|1|||
94595987|NCT04525885|323983557|FG001|Overall Study|Physician Decision|0|||
94595988|NCT04525885|323983558|FG002|Overall Study|Physician Decision|1|||
94595989|NCT00321646|323983562|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
94595990|NCT00321646|323983562|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
94595991|NCT00321646|323983562|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
94595992|NCT00995566|323983576|FG000|Overall Study|Adverse Event|2|||
94595993|NCT00995566|323983576|FG000|Overall Study|Early study termination|52|||
94595994|NCT00510653|323983580|FG000|Overall Study|Withdrawal by Subject|8|||
94595995|NCT00510653|323983580|FG000|Overall Study|Monetary|3|||
94595996|NCT00890045|323983581|FG000|Overall Study|Death|0|||
94595997|NCT00890045|323983582|FG001|Overall Study|Death|1|||
94247082|NCT02101385|322699048|FG000|Study Treatment|Disease Progression before treatment|1|||
94247083|NCT02101385|322699049|FG001|Study Treatment|Disease Progression before treatment|0|||
94247084|NCT02101385|322699048|FG000|Study Treatment|Death|1|||
94595998|NCT00890045|323983581|FG000|Overall Study|Did not receive HeRO Graft|0|||
94595999|NCT00890045|323983582|FG001|Overall Study|Did not receive HeRO Graft|2|||
94596000|NCT00890045|323983581|FG000|Overall Study|Lost to Follow-up|5|||
94596001|NCT00890045|323983582|FG001|Overall Study|Lost to Follow-up|7|||
94596002|NCT00621621|323983583|FG000|Overall Study|Subjects were exited at EP study|30|||
94596003|NCT00621621|323983584|FG001|Overall Study|Subjects were exited at EP study|0|||
94596004|NCT03011892|323983587|FG000|Double Blind (DB) Period|Adverse Event|0|||
94596005|NCT03011892|323983588|FG001|Double Blind (DB) Period|Adverse Event|1|||
94596006|NCT03011892|323983589|FG002|Double Blind (DB) Period|Adverse Event|1|||
94596007|NCT03011892|323983590|FG003|Double Blind (DB) Period|Adverse Event|0|||
94596008|NCT03011892|323983591|FG004|Double Blind (DB) Period|Adverse Event|0|||
94596009|NCT03011892|323983592|FG005|Double Blind (DB) Period|Adverse Event|0|||
94596010|NCT03011892|323983593|FG006|Double Blind (DB) Period|Adverse Event|0|||
94596011|NCT03011892|323983594|FG007|Double Blind (DB) Period|Adverse Event|0|||
94596012|NCT03011892|323983595|FG008|Double Blind (DB) Period|Adverse Event|0|||
94596013|NCT03011892|323983596|FG009|Double Blind (DB) Period|Adverse Event|0|||
94247085|NCT02101385|322699049|FG001|Study Treatment|Death|0|||
94247086|NCT02101385|322699048|FG000|Follow up|Lost to Follow-up|4|||
94247087|NCT02101385|322699049|FG001|Follow up|Lost to Follow-up|9|||
94247088|NCT02101385|322699048|FG000|Follow up|Refused to follow up|5|||
94247089|NCT02101385|322699049|FG001|Follow up|Refused to follow up|4|||
94247090|NCT02101385|322699048|FG000|Follow up|Death|21|||
94247091|NCT02101385|322699049|FG001|Follow up|Death|39|||
94247092|NCT02101385|322699048|FG000|Follow up|study completed|33|||
94247093|NCT02101385|322699049|FG001|Follow up|study completed|52|||
94247094|NCT02101385|322699048|FG000|Follow up|screen failure|2|||
94247095|NCT02101385|322699049|FG001|Follow up|screen failure|0|||
94247096|NCT02101385|322699048|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
94247097|NCT02101385|322699049|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
94247098|NCT02101385|322699048|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
94247099|NCT02101385|322699049|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
94247100|NCT02101385|322699048|FG000|Follow up|Withdrawal by Subject|2|||
94247101|NCT02101385|322699049|FG001|Follow up|Withdrawal by Subject|2|||
94247102|NCT02101385|322699048|FG000|Follow up|PI requested closure of site|0|||
94247103|NCT02101385|322699049|FG001|Follow up|PI requested closure of site|5|||
94247104|NCT01892540|322699051|FG000|Overall Study|Did not complete PET/MRI|0|||
94247105|NCT01892540|322699052|FG001|Overall Study|Did not complete PET/MRI|0|||
94247106|NCT01892540|322699053|FG002|Overall Study|Did not complete PET/MRI|2|||
94247107|NCT01892540|322699051|FG000|Overall Study|Did not fit in scanner|0|||
94247108|NCT01892540|322699052|FG001|Overall Study|Did not fit in scanner|0|||
94247109|NCT01892540|322699053|FG002|Overall Study|Did not fit in scanner|1|||
94247110|NCT01370590|322699054|FG000|Period 1|Adverse Event|8|||
94247111|NCT01370590|322699055|FG001|Period 1|Adverse Event|4|||
94247112|NCT01370590|322699054|FG000|Period 1|Lost to Follow-up|2|||
94247113|NCT01370590|322699055|FG001|Period 1|Lost to Follow-up|2|||
94247114|NCT01370590|322699054|FG000|Period 1|Protocol Violation|2|||
94247115|NCT01370590|322699055|FG001|Period 1|Protocol Violation|2|||
94247116|NCT01370590|322699054|FG000|Period 1|Withdrawal by Subject|4|||
94247117|NCT01370590|322699055|FG001|Period 1|Withdrawal by Subject|2|||
94247118|NCT01370590|322699054|FG000|Period 1|Could not access randomization system|0|||
94247119|NCT01370590|322699055|FG001|Period 1|Could not access randomization system|1|||
94247120|NCT01370590|322699054|FG000|Crossover Washout Period|Adverse Event|1|||
94247121|NCT01370590|322699055|FG001|Crossover Washout Period|Adverse Event|4|||
94247122|NCT01370590|322699054|FG000|Crossover Washout Period|Lost to Follow-up|2|||
94247123|NCT01370590|322699055|FG001|Crossover Washout Period|Lost to Follow-up|0|||
94247124|NCT01370590|322699054|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
94247125|NCT01370590|322699055|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
94247126|NCT01370590|322699054|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
94596014|NCT03011892|323983597|FG010|Double Blind (DB) Period|Adverse Event|0|||
94596015|NCT03011892|323983598|FG011|Double Blind (DB) Period|Adverse Event|0|||
94596016|NCT03011892|323983587|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
94596017|NCT03011892|323983588|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
94596018|NCT03011892|323983589|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
94596019|NCT03011892|323983590|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
94596020|NCT03011892|323983591|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
94596021|NCT03011892|323983592|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
94596022|NCT03011892|323983593|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
94596023|NCT03011892|323983594|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
94596024|NCT03011892|323983595|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
94596025|NCT03011892|323983596|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
94596026|NCT03011892|323983597|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
94596027|NCT03011892|323983598|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
94596028|NCT03011892|323983587|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
94596029|NCT03011892|323983588|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
94596030|NCT03011892|323983589|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
94596031|NCT03011892|323983590|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
94596032|NCT03011892|323983591|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
94596033|NCT03011892|323983592|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
94596034|NCT03011892|323983593|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
94596035|NCT03011892|323983594|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
94596036|NCT03011892|323983595|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
94596037|NCT03011892|323983596|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
94596038|NCT03011892|323983597|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
94596039|NCT03011892|323983598|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
94596040|NCT03011892|323983587|FG000|Double Blind (DB) Period|Other|1|||
94596041|NCT03011892|323983588|FG001|Double Blind (DB) Period|Other|1|||
94596042|NCT03011892|323983589|FG002|Double Blind (DB) Period|Other|1|||
94596043|NCT03011892|323983590|FG003|Double Blind (DB) Period|Other|0|||
94596044|NCT03011892|323983591|FG004|Double Blind (DB) Period|Other|1|||
94596045|NCT03011892|323983592|FG005|Double Blind (DB) Period|Other|0|||
94596046|NCT03011892|323983593|FG006|Double Blind (DB) Period|Other|0|||
94596047|NCT03011892|323983594|FG007|Double Blind (DB) Period|Other|0|||
94596048|NCT03011892|323983595|FG008|Double Blind (DB) Period|Other|0|||
94596049|NCT03011892|323983596|FG009|Double Blind (DB) Period|Other|0|||
94596050|NCT03011892|323983597|FG010|Double Blind (DB) Period|Other|0|||
94596051|NCT03011892|323983598|FG011|Double Blind (DB) Period|Other|0|||
94596052|NCT03011892|323983587|FG000|Double Blind (DB) Period|Physician Decision|1|||
94596053|NCT03011892|323983588|FG001|Double Blind (DB) Period|Physician Decision|0|||
94596054|NCT03011892|323983589|FG002|Double Blind (DB) Period|Physician Decision|1|||
94596055|NCT03011892|323983590|FG003|Double Blind (DB) Period|Physician Decision|0|||
94596056|NCT03011892|323983591|FG004|Double Blind (DB) Period|Physician Decision|0|||
94596057|NCT03011892|323983592|FG005|Double Blind (DB) Period|Physician Decision|0|||
94596058|NCT03011892|323983593|FG006|Double Blind (DB) Period|Physician Decision|0|||
94596059|NCT03011892|323983594|FG007|Double Blind (DB) Period|Physician Decision|0|||
94596060|NCT03011892|323983595|FG008|Double Blind (DB) Period|Physician Decision|0|||
94596061|NCT03011892|323983596|FG009|Double Blind (DB) Period|Physician Decision|0|||
94596062|NCT03011892|323983597|FG010|Double Blind (DB) Period|Physician Decision|0|||
94596063|NCT03011892|323983598|FG011|Double Blind (DB) Period|Physician Decision|0|||
94596064|NCT03011892|323983587|FG000|Double Blind (DB) Period|Pregnancy|0|||
94596065|NCT03011892|323983588|FG001|Double Blind (DB) Period|Pregnancy|0|||
94596066|NCT03011892|323983589|FG002|Double Blind (DB) Period|Pregnancy|0|||
94596067|NCT03011892|323983590|FG003|Double Blind (DB) Period|Pregnancy|0|||
94596068|NCT03011892|323983591|FG004|Double Blind (DB) Period|Pregnancy|1|||
94596069|NCT03011892|323983592|FG005|Double Blind (DB) Period|Pregnancy|0|||
94596070|NCT03011892|323983593|FG006|Double Blind (DB) Period|Pregnancy|0|||
94596071|NCT03011892|323983594|FG007|Double Blind (DB) Period|Pregnancy|0|||
94596072|NCT03011892|323983595|FG008|Double Blind (DB) Period|Pregnancy|0|||
94596073|NCT03011892|323983596|FG009|Double Blind (DB) Period|Pregnancy|0|||
94596074|NCT03011892|323983597|FG010|Double Blind (DB) Period|Pregnancy|0|||
94596075|NCT03011892|323983598|FG011|Double Blind (DB) Period|Pregnancy|0|||
94596076|NCT03011892|323983587|FG000|Double Blind (DB) Period|Protocol Violation|1|||
94596077|NCT03011892|323983588|FG001|Double Blind (DB) Period|Protocol Violation|0|||
94596078|NCT03011892|323983589|FG002|Double Blind (DB) Period|Protocol Violation|0|||
94596079|NCT03011892|323983590|FG003|Double Blind (DB) Period|Protocol Violation|0|||
94596080|NCT03011892|323983591|FG004|Double Blind (DB) Period|Protocol Violation|0|||
94596081|NCT03011892|323983592|FG005|Double Blind (DB) Period|Protocol Violation|0|||
94596082|NCT03011892|323983593|FG006|Double Blind (DB) Period|Protocol Violation|0|||
94596083|NCT03011892|323983594|FG007|Double Blind (DB) Period|Protocol Violation|0|||
94596084|NCT03011892|323983595|FG008|Double Blind (DB) Period|Protocol Violation|0|||
94596085|NCT03011892|323983596|FG009|Double Blind (DB) Period|Protocol Violation|0|||
94596086|NCT03011892|323983597|FG010|Double Blind (DB) Period|Protocol Violation|0|||
94596087|NCT03011892|323983598|FG011|Double Blind (DB) Period|Protocol Violation|0|||
94596088|NCT03011892|323983587|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
94596089|NCT03011892|323983588|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
94596090|NCT03011892|323983589|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
94596091|NCT03011892|323983590|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
94596092|NCT03011892|323983591|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
94596093|NCT03011892|323983592|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
94596094|NCT03011892|323983593|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
94596095|NCT03011892|323983594|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
94596096|NCT03011892|323983595|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
94596097|NCT03011892|323983596|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
94596098|NCT03011892|323983597|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
94596099|NCT03011892|323983598|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
94596100|NCT03011892|323983587|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
94596101|NCT03011892|323983588|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
94596102|NCT03011892|323983589|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
94596103|NCT03011892|323983590|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
94596104|NCT03011892|323983591|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
94596105|NCT03011892|323983592|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
94596106|NCT03011892|323983593|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
94596107|NCT03011892|323983594|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
94596108|NCT03011892|323983595|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
94596109|NCT03011892|323983596|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
94596110|NCT03011892|323983597|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
94596111|NCT03011892|323983598|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
94596112|NCT03011892|323983587|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
94596113|NCT03011892|323983588|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
94596114|NCT03011892|323983589|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
94596115|NCT03011892|323983590|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
94596116|NCT03011892|323983591|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
94596117|NCT03011892|323983592|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
94596118|NCT03011892|323983593|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
94596119|NCT03011892|323983594|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
94596120|NCT03011892|323983595|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
94596121|NCT03011892|323983596|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
94596122|NCT03011892|323983597|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
94596123|NCT03011892|323983598|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
94596124|NCT03011892|323983587|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
94596125|NCT03011892|323983588|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
94596126|NCT03011892|323983589|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
94596127|NCT03011892|323983590|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
94596128|NCT03011892|323983591|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
94596129|NCT03011892|323983592|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
94596130|NCT03011892|323983593|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
94596131|NCT03011892|323983594|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
94596132|NCT03011892|323983595|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
94596133|NCT03011892|323983596|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
94596134|NCT03011892|323983597|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
94596135|NCT03011892|323983598|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
94596136|NCT03011892|323983587|FG000|Open Label (OL) Period|Reason not specified|0|||
94596137|NCT03011892|323983588|FG001|Open Label (OL) Period|Reason not specified|0|||
94596138|NCT03011892|323983589|FG002|Open Label (OL) Period|Reason not specified|0|||
94596139|NCT03011892|323983590|FG003|Open Label (OL) Period|Reason not specified|0|||
94596140|NCT03011892|323983591|FG004|Open Label (OL) Period|Reason not specified|0|||
94596141|NCT03011892|323983592|FG005|Open Label (OL) Period|Reason not specified|0|||
94596142|NCT03011892|323983593|FG006|Open Label (OL) Period|Reason not specified|0|||
94596143|NCT03011892|323983594|FG007|Open Label (OL) Period|Reason not specified|1|||
94596144|NCT03011892|323983595|FG008|Open Label (OL) Period|Reason not specified|0|||
94596145|NCT03011892|323983596|FG009|Open Label (OL) Period|Reason not specified|0|||
94596146|NCT03011892|323983597|FG010|Open Label (OL) Period|Reason not specified|0|||
94596147|NCT03011892|323983598|FG011|Open Label (OL) Period|Reason not specified|0|||
94596148|NCT00217464|323983600|FG000|Overall Study|Progression|15|||
94596149|NCT00217464|323983600|FG000|Overall Study|Other|2|||
94596150|NCT01159431|323983601|FG000|Overall Study|Adverse Event|1|||
94596151|NCT01159431|323983602|FG001|Overall Study|Adverse Event|2|||
94247127|NCT01370590|322699055|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
94596152|NCT01159431|323983601|FG000|Overall Study|non-compliance|1|||
94596153|NCT01159431|323983602|FG001|Overall Study|non-compliance|1|||
94596154|NCT01159431|323983601|FG000|Overall Study|Lack of Efficacy|0|||
94596155|NCT01159431|323983602|FG001|Overall Study|Lack of Efficacy|3|||
94596156|NCT00311584|323983603|FG000|Overall Study|Death|1|||
94596157|NCT00311584|323983604|FG001|Overall Study|Death|0|||
94596158|NCT00311584|323983603|FG000|Overall Study|Lack of Efficacy|12|||
94596159|NCT00311584|323983604|FG001|Overall Study|Lack of Efficacy|15|||
94596160|NCT00311584|323983603|FG000|Overall Study|Physician Decision|4|||
94247128|NCT01370590|322699054|FG000|Period 2|Adverse Event|0|||
94596161|NCT00311584|323983604|FG001|Overall Study|Physician Decision|5|||
94596162|NCT00311584|323983603|FG000|Overall Study|Withdrawal by Subject|1|||
94596163|NCT00311584|323983604|FG001|Overall Study|Withdrawal by Subject|1|||
94596164|NCT00311584|323983603|FG000|Overall Study|ineligible|2|||
94596165|NCT00311584|323983604|FG001|Overall Study|ineligible|2|||
94247129|NCT01370590|322699055|FG001|Period 2|Adverse Event|1|||
94247130|NCT01370590|322699054|FG000|Period 2|Withdrawal by Subject|1|||
94247131|NCT01370590|322699055|FG001|Period 2|Withdrawal by Subject|1|||
94247132|NCT00151281|322699061|FG000|Overall Study|Not evaluable|3|||
94247133|NCT00604825|322699064|FG000|Overall Study|Adverse Event|2|||
94596166|NCT02880956|323983605|FG000|Overall Study|Adverse Event|3|||
94596167|NCT02880956|323983606|FG001|Overall Study|Adverse Event|6|||
94596168|NCT02880956|323983607|FG002|Overall Study|Adverse Event|5|||
94596169|NCT02880956|323983608|FG003|Overall Study|Adverse Event|4|||
94596170|NCT02880956|323983605|FG000|Overall Study|Withdrawal by Subject|9|||
94596171|NCT02880956|323983606|FG001|Overall Study|Withdrawal by Subject|4|||
94596172|NCT02880956|323983607|FG002|Overall Study|Withdrawal by Subject|6|||
94596173|NCT02880956|323983608|FG003|Overall Study|Withdrawal by Subject|11|||
94596174|NCT02880956|323983605|FG000|Overall Study|Lost to Follow-up|0|||
94596175|NCT02880956|323983606|FG001|Overall Study|Lost to Follow-up|1|||
94596176|NCT02880956|323983607|FG002|Overall Study|Lost to Follow-up|0|||
94596177|NCT02880956|323983608|FG003|Overall Study|Lost to Follow-up|0|||
94596178|NCT02880956|323983605|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
94596179|NCT02880956|323983606|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
94596180|NCT02880956|323983607|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
94247134|NCT00604825|322699065|FG001|Overall Study|Adverse Event|6|||
94247135|NCT00604825|322699066|FG002|Overall Study|Adverse Event|7|||
94247136|NCT00604825|322699067|FG003|Overall Study|Adverse Event|4|||
94247137|NCT00604825|322699064|FG000|Overall Study|Lost to Follow-up|0|||
94247138|NCT00604825|322699065|FG001|Overall Study|Lost to Follow-up|3|||
94247139|NCT00604825|322699066|FG002|Overall Study|Lost to Follow-up|1|||
94247140|NCT00604825|322699067|FG003|Overall Study|Lost to Follow-up|0|||
94247141|NCT00604825|322699064|FG000|Overall Study|Protocol Violation|0|||
94247142|NCT00604825|322699065|FG001|Overall Study|Protocol Violation|1|||
94247143|NCT00604825|322699066|FG002|Overall Study|Protocol Violation|0|||
94247144|NCT00604825|322699067|FG003|Overall Study|Protocol Violation|0|||
94247145|NCT00604825|322699064|FG000|Overall Study|Withdrawal by Subject|4|||
94247146|NCT00604825|322699065|FG001|Overall Study|Withdrawal by Subject|3|||
94247147|NCT00604825|322699066|FG002|Overall Study|Withdrawal by Subject|5|||
94247148|NCT00604825|322699067|FG003|Overall Study|Withdrawal by Subject|5|||
94247149|NCT00604825|322699064|FG000|Overall Study|Lack of Efficacy|3|||
94247150|NCT00604825|322699065|FG001|Overall Study|Lack of Efficacy|2|||
94247151|NCT00604825|322699066|FG002|Overall Study|Lack of Efficacy|1|||
94247152|NCT00604825|322699067|FG003|Overall Study|Lack of Efficacy|0|||
94247153|NCT00604825|322699064|FG000|Overall Study|Did not meet eligibility criteria|0|||
94247154|NCT00604825|322699065|FG001|Overall Study|Did not meet eligibility criteria|0|||
94247155|NCT00604825|322699066|FG002|Overall Study|Did not meet eligibility criteria|2|||
94247156|NCT00604825|322699067|FG003|Overall Study|Did not meet eligibility criteria|0|||
94355937|NCT01519700|323085737|FG000|Overall Study|Death|1|||
94596181|NCT02880956|323983608|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
94596182|NCT02880956|323983605|FG000|Overall Study|Other, Not Specified|4|||
94596183|NCT02880956|323983606|FG001|Overall Study|Other, Not Specified|2|||
94596184|NCT02880956|323983607|FG002|Overall Study|Other, Not Specified|0|||
94596185|NCT02880956|323983608|FG003|Overall Study|Other, Not Specified|3|||
94247157|NCT00604825|322699064|FG000|Overall Study|Physician Decision|0|||
94247158|NCT00604825|322699065|FG001|Overall Study|Physician Decision|0|||
94247159|NCT00604825|322699066|FG002|Overall Study|Physician Decision|0|||
94247160|NCT00604825|322699067|FG003|Overall Study|Physician Decision|1|||
94596186|NCT01794338|323985506|FG000|Overall Study|Death|2|||
94596187|NCT01794338|323985507|FG001|Overall Study|Death|0|||
94596188|NCT01794338|323985506|FG000|Overall Study|Lost to Follow-up|6|||
94596189|NCT01794338|323985507|FG001|Overall Study|Lost to Follow-up|9|||
94596190|NCT01771809|323985513|FG000|Overall Study|Adverse Event|4|||
94596191|NCT01771809|323985514|FG001|Overall Study|Adverse Event|12|||
94596192|NCT01771809|323985513|FG000|Overall Study|Protocol Violation|0|||
94596193|NCT01771809|323985514|FG001|Overall Study|Protocol Violation|1|||
94596194|NCT01771809|323985513|FG000|Overall Study|Withdrawal by Subject|34|||
94596195|NCT01771809|323985514|FG001|Overall Study|Withdrawal by Subject|42|||
94596196|NCT01771809|323985513|FG000|Overall Study|Lost to Follow-up|1|||
94596197|NCT01771809|323985514|FG001|Overall Study|Lost to Follow-up|3|||
94596198|NCT01771809|323985513|FG000|Overall Study|Other (Insufficient clinical response)|22|||
94596199|NCT01771809|323985514|FG001|Overall Study|Other (Insufficient clinical response)|20|||
94596200|NCT01771809|323985513|FG000|Overall Study|Death|1|||
94596201|NCT01771809|323985514|FG001|Overall Study|Death|0|||
94596202|NCT01771809|323985513|FG000|Overall Study|Other (other)|9|||
94596203|NCT01771809|323985514|FG001|Overall Study|Other (other)|5|||
94596204|NCT00362180|323985515|FG000|Treated Period|Withdrawal by Subject|1|||
94596205|NCT00362180|323985516|FG001|Treated Period|Withdrawal by Subject|0|||
94596206|NCT00362180|323985517|FG002|Treated Period|Withdrawal by Subject|0|||
94596207|NCT00362180|323985518|FG003|Treated Period|Withdrawal by Subject|0|||
94596208|NCT00362180|323985519|FG004|Treated Period|Withdrawal by Subject|0|||
94596209|NCT00362180|323985520|FG005|Treated Period|Withdrawal by Subject|0|||
94596210|NCT00362180|323985521|FG006|Treated Period|Withdrawal by Subject|0|||
94596211|NCT00362180|323985522|FG007|Treated Period|Withdrawal by Subject|0|||
94596212|NCT00362180|323985523|FG008|Treated Period|Withdrawal by Subject|0|||
94596213|NCT00362180|323985515|FG000|Treated Period|Adverse Event|0|||
94596214|NCT00362180|323985516|FG001|Treated Period|Adverse Event|0|||
94596215|NCT00362180|323985517|FG002|Treated Period|Adverse Event|0|||
94596216|NCT00362180|323985518|FG003|Treated Period|Adverse Event|0|||
94596217|NCT00362180|323985519|FG004|Treated Period|Adverse Event|0|||
94596218|NCT00362180|323985520|FG005|Treated Period|Adverse Event|1|||
94596219|NCT00362180|323985521|FG006|Treated Period|Adverse Event|0|||
94596220|NCT00362180|323985522|FG007|Treated Period|Adverse Event|1|||
94596221|NCT00362180|323985523|FG008|Treated Period|Adverse Event|0|||
94596222|NCT01444092|323985526|FG000|Overall Study|Adverse Event|8|||
94596223|NCT01444092|323985526|FG000|Overall Study|Protocol Violation|1|||
94596224|NCT01444092|323985526|FG000|Overall Study|Withdrawal by Subject|1|||
94596225|NCT01444092|323985526|FG000|Overall Study|Other Eligibility criteria|7|||
94596226|NCT00870103|323985527|FG000|Overall Study|Physician Decision|2|||
94596227|NCT00870103|323985527|FG000|Overall Study|Lost to Follow-up|2|||
94596228|NCT04585009|323985528|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
94596229|NCT04585009|323985529|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
94596230|NCT04585009|323985530|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
94596231|NCT04585009|323985531|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
94596232|NCT04585009|323985532|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
94596233|NCT04585009|323985533|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
94596234|NCT04585009|323985534|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
94596235|NCT04585009|323985535|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
94596236|NCT04585009|323985536|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
94596237|NCT04585009|323985537|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
94596238|NCT04585009|323985538|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
94596239|NCT04585009|323985539|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
94596240|NCT04585009|323985528|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
94596241|NCT04585009|323985529|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
94596242|NCT04585009|323985530|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
94596243|NCT04585009|323985531|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
94596244|NCT04585009|323985532|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
94596245|NCT04585009|323985533|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
94596246|NCT04585009|323985534|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
94596247|NCT04585009|323985535|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
94596248|NCT04585009|323985536|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
94596249|NCT04585009|323985537|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
94596250|NCT04585009|323985538|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
94596251|NCT04585009|323985539|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
94596252|NCT04585009|323985528|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
94596253|NCT04585009|323985529|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
94596254|NCT04585009|323985530|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
94596255|NCT04585009|323985531|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
94596256|NCT04585009|323985532|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
94596257|NCT04585009|323985533|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
94596258|NCT04585009|323985534|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
94596259|NCT04585009|323985535|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
94596260|NCT04585009|323985536|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
94247161|NCT00604825|322699064|FG000|Overall Study|Exclusion criterion met|0|||
94247162|NCT00604825|322699065|FG001|Overall Study|Exclusion criterion met|0|||
94247163|NCT00604825|322699066|FG002|Overall Study|Exclusion criterion met|0|||
94247164|NCT00604825|322699067|FG003|Overall Study|Exclusion criterion met|1|||
94247165|NCT04617275|322699068|FG000|Treatment Period|Adverse Event|1|||
94596261|NCT04585009|323985537|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
94596262|NCT04585009|323985538|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
94596263|NCT04585009|323985539|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
94596264|NCT04585009|323985528|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
94596265|NCT04585009|323985529|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
94596266|NCT04585009|323985530|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
94596267|NCT04585009|323985531|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
94596268|NCT04585009|323985532|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
94596269|NCT04585009|323985533|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
94596270|NCT04585009|323985534|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
94596271|NCT04585009|323985535|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
94596272|NCT04585009|323985536|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
94596273|NCT04585009|323985537|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
94596274|NCT04585009|323985538|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
94596275|NCT04585009|323985539|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
94596276|NCT04585009|323985528|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
94596277|NCT04585009|323985529|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
94596278|NCT04585009|323985530|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
94596279|NCT04585009|323985531|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
94596280|NCT04585009|323985532|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
94596281|NCT04585009|323985533|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
94596282|NCT04585009|323985534|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
94596283|NCT04585009|323985535|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
94596284|NCT04585009|323985536|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
94596285|NCT04585009|323985537|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
94596286|NCT04585009|323985538|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
94596287|NCT04585009|323985539|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
94596288|NCT04585009|323985528|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
94596289|NCT04585009|323985529|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
94596290|NCT04585009|323985530|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
94660343|NCT02194621|324210092|FG002|Overall Study|Withdrawal by Subject|7|||
94660344|NCT00809757|324210095|FG000|Overall Study|Adverse Event|2|||
94660345|NCT00809757|324210096|FG001|Overall Study|Adverse Event|3|||
94660346|NCT00809757|324210097|FG002|Overall Study|Adverse Event|3|||
94660347|NCT00809757|324210095|FG000|Overall Study|Lost to Follow-up|0|||
94660348|NCT00809757|324210096|FG001|Overall Study|Lost to Follow-up|0|||
94660349|NCT00809757|324210097|FG002|Overall Study|Lost to Follow-up|1|||
94660350|NCT00809757|324210095|FG000|Overall Study|Protocol Violation|1|||
94660351|NCT00809757|324210096|FG001|Overall Study|Protocol Violation|1|||
94660352|NCT00809757|324210097|FG002|Overall Study|Protocol Violation|1|||
94596291|NCT04585009|323985531|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
94596292|NCT04585009|323985532|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
94596293|NCT04585009|323985533|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
94596294|NCT04585009|323985534|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
94596295|NCT04585009|323985535|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
94596296|NCT04585009|323985536|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
94596297|NCT04585009|323985537|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
94596298|NCT04585009|323985538|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
94596299|NCT04585009|323985539|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
94596300|NCT01713933|323985540|FG000|Overall Study|Lost to Follow-up|2|||
94596301|NCT01713933|323985540|FG000|Overall Study|Withdrawal by Subject|3|||
94596302|NCT01713933|323985540|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
94596303|NCT00528970|323985541|FG000|Overall Study|Adverse Event|6|||
94596304|NCT00528970|323985542|FG001|Overall Study|Adverse Event|8|||
94660353|NCT00809757|324210095|FG000|Overall Study|Withdrawal by Subject|2|||
94660354|NCT00809757|324210096|FG001|Overall Study|Withdrawal by Subject|1|||
94660355|NCT00809757|324210097|FG002|Overall Study|Withdrawal by Subject|3|||
94660356|NCT00809757|324210095|FG000|Overall Study|Subject Uncooperative|1|||
94596305|NCT00528970|323985543|FG002|Overall Study|Adverse Event|5|||
94596306|NCT00528970|323985541|FG000|Overall Study|Lost to Follow-up|0|||
94596307|NCT00528970|323985542|FG001|Overall Study|Lost to Follow-up|0|||
94596308|NCT00528970|323985543|FG002|Overall Study|Lost to Follow-up|1|||
94596309|NCT00528970|323985541|FG000|Overall Study|Other than specified|2|||
94660357|NCT00809757|324210096|FG001|Overall Study|Subject Uncooperative|0|||
94660358|NCT00809757|324210097|FG002|Overall Study|Subject Uncooperative|2|||
94660359|NCT00809757|324210095|FG000|Overall Study|Noncompliance with Medication|0|||
94660360|NCT00809757|324210096|FG001|Overall Study|Noncompliance with Medication|0|||
94660361|NCT00809757|324210097|FG002|Overall Study|Noncompliance with Medication|1|||
94596310|NCT00528970|323985542|FG001|Overall Study|Other than specified|3|||
94596311|NCT00528970|323985543|FG002|Overall Study|Other than specified|3|||
94596312|NCT00528970|323985541|FG000|Overall Study|Protocol Violation|2|||
94596313|NCT00528970|323985542|FG001|Overall Study|Protocol Violation|1|||
94596314|NCT00528970|323985543|FG002|Overall Study|Protocol Violation|4|||
94596315|NCT00528970|323985541|FG000|Overall Study|Lack of Efficacy|0|||
94596316|NCT00528970|323985542|FG001|Overall Study|Lack of Efficacy|0|||
94596317|NCT00528970|323985543|FG002|Overall Study|Lack of Efficacy|1|||
94596318|NCT00528970|323985541|FG000|Overall Study|Withdrawal by Subject|4|||
94596319|NCT00528970|323985542|FG001|Overall Study|Withdrawal by Subject|3|||
94596320|NCT00528970|323985543|FG002|Overall Study|Withdrawal by Subject|5|||
94596321|NCT00528970|323985541|FG000|Overall Study|Randomized but not treated|0|||
94596322|NCT00528970|323985542|FG001|Overall Study|Randomized but not treated|0|||
94596323|NCT00528970|323985543|FG002|Overall Study|Randomized but not treated|1|||
94596324|NCT01009840|323985545|FG000|Overall Study|Lost to Follow-up|1|||
94596325|NCT01009840|323985545|FG000|Overall Study|Adverse Event|4|||
94596326|NCT01009840|323985545|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
94596327|NCT01009840|323985545|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
94596328|NCT01009840|323985545|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
94596329|NCT04022733|323985546|FG000|Overall Study|conversion to open surgery|3|||
94596330|NCT04022733|323985547|FG001|Overall Study|conversion to open surgery|2|||
94596331|NCT04022733|323985546|FG000|Overall Study|bradycardia|0|||
94596332|NCT04022733|323985547|FG001|Overall Study|bradycardia|1|||
94596333|NCT01002820|323985550|FG000|Overall Study|Adverse Event|1|||
94596334|NCT01002820|323985550|FG000|Overall Study|Withdrawal by Subject|2|||
94596335|NCT01002820|323985550|FG000|Overall Study|Lack of Efficacy|1|||
94596336|NCT01252667|323985555|FG000|Overall Study|Transplant aborted post-conditioning|0|||
94596337|NCT01252667|323985556|FG001|Overall Study|Transplant aborted post-conditioning|0|||
94596338|NCT01252667|323985557|FG002|Overall Study|Transplant aborted post-conditioning|0|||
94596339|NCT01252667|323985558|FG003|Overall Study|Transplant aborted post-conditioning|0|||
94596340|NCT01252667|323985559|FG004|Overall Study|Transplant aborted post-conditioning|0|||
94596341|NCT01252667|323985560|FG005|Overall Study|Transplant aborted post-conditioning|1|||
94596342|NCT03330002|323985561|FG000|Overall Study|Lost to Follow-up|15|||
94596343|NCT03330002|323985561|FG000|Overall Study|Death|7|||
94596344|NCT01836276|323985562|FG000|Overall Study|Lost to Follow-up|28|||
94596345|NCT01836276|323985563|FG001|Overall Study|Lost to Follow-up|51|||
94596346|NCT00331552|323985566|FG000|Period 3: Phase II|Neurological Symptoms|1|||
94596347|NCT00331552|323985567|FG001|Period 3: Phase II|Neurological Symptoms|0|||
94596348|NCT00331552|323985566|FG000|Period 3: Phase II|Severe Nausea|1|||
94596349|NCT00331552|323985567|FG001|Period 3: Phase II|Severe Nausea|0|||
94596350|NCT01445548|323985568|FG000|Overall Study|Adverse Event|1|||
94596351|NCT02577887|323985569|FG000|Overall Study|Death|93|||
94596352|NCT02577887|323985569|FG000|Overall Study|Protocol Violation|125|||
94596353|NCT02577887|323985569|FG000|Overall Study|Withdrawal by Subject|80|||
94596354|NCT00422084|323985570|FG000|Overall Study|Adverse Event|21|||
94596355|NCT00422084|323985571|FG001|Overall Study|Adverse Event|7|||
94596356|NCT00422084|323985570|FG000|Overall Study|Withdrawal by Subject|12|||
94596357|NCT00422084|323985571|FG001|Overall Study|Withdrawal by Subject|9|||
94596358|NCT00422084|323985570|FG000|Overall Study|Lost to Follow-up|14|||
94596359|NCT00422084|323985571|FG001|Overall Study|Lost to Follow-up|9|||
94596360|NCT00422084|323985570|FG000|Overall Study|Protocol Violation|4|||
94596361|NCT00422084|323985571|FG001|Overall Study|Protocol Violation|1|||
94596362|NCT00422084|323985570|FG000|Overall Study|Lack of Efficacy|40|||
94596363|NCT00422084|323985571|FG001|Overall Study|Lack of Efficacy|42|||
94596364|NCT00422084|323985570|FG000|Overall Study|P. vivax infection|3|||
94596365|NCT00422084|323985571|FG001|Overall Study|P. vivax infection|6|||
94596366|NCT00422084|323985570|FG000|Overall Study|Cyesis|1|||
94596367|NCT00422084|323985571|FG001|Overall Study|Cyesis|0|||
94596368|NCT00422084|323985570|FG000|Overall Study|Withdrawn from study accidentally|1|||
94596369|NCT00422084|323985571|FG001|Overall Study|Withdrawn from study accidentally|0|||
94596370|NCT00422084|323985570|FG000|Overall Study|Non-compliance|1|||
94596371|NCT00422084|323985571|FG001|Overall Study|Non-compliance|0|||
94596372|NCT00422084|323985570|FG000|Overall Study|Re-location|0|||
94596373|NCT00422084|323985571|FG001|Overall Study|Re-location|1|||
94596374|NCT00422084|323985570|FG000|Overall Study|Not defined|1|||
94596375|NCT00422084|323985571|FG001|Overall Study|Not defined|1|||
94596376|NCT00958438|323985572|FG000|Overall Study|Protocol Violation|3|||
94596377|NCT00958438|323985573|FG001|Overall Study|Protocol Violation|2|||
94596378|NCT00958438|323985574|FG002|Overall Study|Protocol Violation|2|||
94596379|NCT00958438|323985572|FG000|Overall Study|Withdrawal by Subject|4|||
94596380|NCT00958438|323985573|FG001|Overall Study|Withdrawal by Subject|2|||
94596381|NCT00958438|323985574|FG002|Overall Study|Withdrawal by Subject|1|||
94596382|NCT00958438|323985572|FG000|Overall Study|Adverse Event|0|||
94596383|NCT00958438|323985573|FG001|Overall Study|Adverse Event|3|||
94596384|NCT00958438|323985574|FG002|Overall Study|Adverse Event|0|||
94596385|NCT00958438|323985572|FG000|Overall Study|Physician Decision|1|||
94596386|NCT00958438|323985573|FG001|Overall Study|Physician Decision|0|||
94596387|NCT00958438|323985574|FG002|Overall Study|Physician Decision|1|||
94596388|NCT00958438|323985572|FG000|Overall Study|Other than specified above|2|||
94596389|NCT00958438|323985573|FG001|Overall Study|Other than specified above|3|||
94596390|NCT00958438|323985574|FG002|Overall Study|Other than specified above|2|||
94596391|NCT02788279|323985575|FG000|Overall Study|Death|62|||
94596392|NCT02788279|323985576|FG001|Overall Study|Death|136|||
94596393|NCT02788279|323985577|FG002|Overall Study|Death|72|||
94596394|NCT02788279|323985575|FG000|Overall Study|Withdrawal by Subject|10|||
94596395|NCT02788279|323985576|FG001|Overall Study|Withdrawal by Subject|15|||
94596396|NCT02788279|323985577|FG002|Overall Study|Withdrawal by Subject|5|||
94596397|NCT02788279|323985575|FG000|Overall Study|Lost to Follow-up|0|||
94596398|NCT02788279|323985576|FG001|Overall Study|Lost to Follow-up|3|||
94596399|NCT02788279|323985577|FG002|Overall Study|Lost to Follow-up|2|||
94596400|NCT02788279|323985575|FG000|Overall Study|Sponsor decision|18|||
94596401|NCT02788279|323985576|FG001|Overall Study|Sponsor decision|29|||
94596402|NCT02788279|323985577|FG002|Overall Study|Sponsor decision|11|||
94596403|NCT01101308|323985580|FG000|Period 1|Adverse Event|2|||
94596404|NCT01101308|323985581|FG001|Period 1|Adverse Event|1|||
94596405|NCT01101308|323985580|FG000|Period 1|Positive for cotinine|1|||
94596406|NCT01101308|323985581|FG001|Period 1|Positive for cotinine|0|||
94596407|NCT00653432|323985582|FG000|Overall Study|Adverse Event|4|||
94596408|NCT00653432|323985583|FG001|Overall Study|Adverse Event|1|||
94596409|NCT00653432|323985582|FG000|Overall Study|Withdrawal by Subject|4|||
94596410|NCT00653432|323985583|FG001|Overall Study|Withdrawal by Subject|5|||
94596411|NCT00653432|323985582|FG000|Overall Study|Lost to Follow-up|7|||
94596412|NCT00653432|323985583|FG001|Overall Study|Lost to Follow-up|6|||
94596413|NCT00653432|323985582|FG000|Overall Study|Use/Need of Con Therapy|2|||
94596414|NCT00653432|323985583|FG001|Overall Study|Use/Need of Con Therapy|1|||
94596415|NCT00653432|323985582|FG000|Overall Study|Other - Reason Not Provided|5|||
94596416|NCT00653432|323985583|FG001|Overall Study|Other - Reason Not Provided|3|||
94596417|NCT02984943|323985584|FG000|Overall Study|Withdrawal by Subject|3|||
94596418|NCT02984943|323985584|FG000|Overall Study|Physician Decision|1|||
94596419|NCT00567255|323985585|FG000|Overall Study|Adverse Event|241|||
94596420|NCT00567255|323985586|FG001|Overall Study|Adverse Event|68|||
94596421|NCT00567255|323985585|FG000|Overall Study|Lost to Follow-up|77|||
94596422|NCT00567255|323985586|FG001|Overall Study|Lost to Follow-up|48|||
94596423|NCT00567255|323985585|FG000|Overall Study|Withdrawal by Subject|75|||
94596424|NCT00567255|323985586|FG001|Overall Study|Withdrawal by Subject|56|||
94596425|NCT00567255|323985585|FG000|Overall Study|Lack of Efficacy|19|||
94596426|NCT00567255|323985586|FG001|Overall Study|Lack of Efficacy|33|||
94596427|NCT00567255|323985585|FG000|Overall Study|Protocol Violation|20|||
94596428|NCT00567255|323985586|FG001|Overall Study|Protocol Violation|8|||
94596429|NCT00567255|323985585|FG000|Overall Study|Pregnancy|6|||
94596430|NCT00567255|323985586|FG001|Overall Study|Pregnancy|0|||
94596431|NCT00567255|323985585|FG000|Overall Study|Drug noncompliance,moved,other|25|||
94596432|NCT00567255|323985586|FG001|Overall Study|Drug noncompliance,moved,other|15|||
94596433|NCT02047318|323985588|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
94596434|NCT02047318|323985588|FG000|Core Study Period|Adverse Event|1|||
94596435|NCT02047318|323985588|FG000|Core Study Period|Withdrawal by caregiver|3|||
94596436|NCT02047318|323985588|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
94596437|NCT01038869|323985591|FG000|Overall Study|Withdrawal by Subject|1|||
94596438|NCT01038869|323985591|FG000|Overall Study|Lost to Follow-up|6|||
94596439|NCT00711516|323985592|FG000|Overall Study|Adverse Event|1|||
94596440|NCT00711516|323985593|FG001|Overall Study|Adverse Event|1|||
94596441|NCT00711516|323985592|FG000|Overall Study|Withdrawal by Subject|0|||
94596442|NCT00711516|323985593|FG001|Overall Study|Withdrawal by Subject|1|||
94596443|NCT00711516|323985592|FG000|Overall Study|Protocol Violation|0|||
94596444|NCT00711516|323985593|FG001|Overall Study|Protocol Violation|1|||
94596445|NCT04136444|323985597|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
94596446|NCT04136444|323985598|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
94596447|NCT01565343|323985599|FG000|Overall Study|Administrative decision/technical issues|1|||
94596448|NCT01565343|323985600|FG001|Overall Study|Administrative decision/technical issues|0|||
94596449|NCT01565343|323985601|FG002|Overall Study|Administrative decision/technical issues|0|||
94596450|NCT00869778|323985604|FG000|Overall Study|Adverse Event|2|||
94596451|NCT00869778|323985605|FG001|Overall Study|Adverse Event|0|||
94596452|NCT00869778|323985606|FG002|Overall Study|Adverse Event|0|||
94596453|NCT00869778|323985604|FG000|Overall Study|Withdrawal by Subject|3|||
94596454|NCT00869778|323985605|FG001|Overall Study|Withdrawal by Subject|4|||
94596455|NCT00869778|323985606|FG002|Overall Study|Withdrawal by Subject|5|||
94596456|NCT00869778|323985604|FG000|Overall Study|Pregnancy|1|||
94596457|NCT00869778|323985605|FG001|Overall Study|Pregnancy|0|||
94596458|NCT00869778|323985606|FG002|Overall Study|Pregnancy|0|||
94596459|NCT00869778|323985604|FG000|Overall Study|Protocol Violation|5|||
94596460|NCT00869778|323985605|FG001|Overall Study|Protocol Violation|3|||
94596461|NCT00869778|323985606|FG002|Overall Study|Protocol Violation|5|||
94596462|NCT00869778|323985604|FG000|Overall Study|Unblinding|1|||
94596463|NCT00869778|323985605|FG001|Overall Study|Unblinding|0|||
94596464|NCT00869778|323985606|FG002|Overall Study|Unblinding|0|||
94596465|NCT03339297|323985607|FG000|Overall Study|Relapse of Hematologic Disease|1|||
94596466|NCT03339297|323985608|FG001|Overall Study|Relapse of Hematologic Disease|0|||
94596467|NCT03339297|323985607|FG000|Overall Study|Death|10|||
94596468|NCT03339297|323985608|FG001|Overall Study|Death|7|||
94596469|NCT03339297|323985607|FG000|Overall Study|Hepatic Candidosis|1|||
94596470|NCT03339297|323985608|FG001|Overall Study|Hepatic Candidosis|0|||
94596471|NCT03339297|323985607|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
94596472|NCT03339297|323985608|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
94596473|NCT03339297|323985607|FG000|Overall Study|Consent Withdrawn by Participant|3|||
94596474|NCT03339297|323985608|FG001|Overall Study|Consent Withdrawn by Participant|3|||
94247166|NCT04617275|322699069|FG001|Treatment Period|Adverse Event|6|||
94596475|NCT03339297|323985607|FG000|Overall Study|Disease Relapse|2|||
94596476|NCT03339297|323985608|FG001|Overall Study|Disease Relapse|0|||
94596477|NCT03339297|323985607|FG000|Overall Study|Physician Decision|1|||
94596478|NCT03339297|323985608|FG001|Overall Study|Physician Decision|1|||
94596479|NCT03339297|323985607|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
94596480|NCT03339297|323985608|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
94596481|NCT03339297|323985607|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
94596482|NCT03339297|323985608|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
94596483|NCT03339297|323985607|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
94596484|NCT03339297|323985608|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
94596485|NCT03339297|323985607|FG000|Overall Study|Adverse Event, Non-fatal|1|||
94596486|NCT03339297|323985608|FG001|Overall Study|Adverse Event, Non-fatal|0|||
94596487|NCT03339297|323985607|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
94596488|NCT03339297|323985608|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
94596489|NCT03339297|323985607|FG000|Overall Study|Patient Was Not Eligible|1|||
94596490|NCT03339297|323985608|FG001|Overall Study|Patient Was Not Eligible|0|||
94596491|NCT01403948|323985609|FG000|Overall Study|Progressive disease|0|||
94596492|NCT01403948|323985610|FG001|Overall Study|Progressive disease|2|||
94596493|NCT01403948|323985611|FG002|Overall Study|Progressive disease|2|||
94596494|NCT01403948|323985612|FG003|Overall Study|Progressive disease|4|||
94596495|NCT01403948|323985613|FG004|Overall Study|Progressive disease|2|||
94596496|NCT01403948|323985614|FG005|Overall Study|Progressive disease|6|||
94596497|NCT01403948|323985615|FG006|Overall Study|Progressive disease|2|||
94596498|NCT01403948|323985616|FG007|Overall Study|Progressive disease|4|||
94596499|NCT01403948|323985617|FG008|Overall Study|Progressive disease|5|||
94596500|NCT01403948|323985618|FG009|Overall Study|Progressive disease|5|||
94596501|NCT01403948|323985609|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
94596502|NCT01403948|323985610|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
94596503|NCT01403948|323985611|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
94596504|NCT01403948|323985612|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
94596505|NCT01403948|323985613|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
94596506|NCT01403948|323985614|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
94596507|NCT01403948|323985615|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
94596508|NCT01403948|323985616|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
94596509|NCT01403948|323985617|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
94596510|NCT01403948|323985618|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
94596511|NCT01403948|323985609|FG000|Overall Study|Lost to Follow-up|0|||
94596512|NCT01403948|323985610|FG001|Overall Study|Lost to Follow-up|0|||
94596513|NCT01403948|323985611|FG002|Overall Study|Lost to Follow-up|0|||
94596514|NCT01403948|323985612|FG003|Overall Study|Lost to Follow-up|0|||
94596515|NCT01403948|323985613|FG004|Overall Study|Lost to Follow-up|0|||
94596516|NCT01403948|323985614|FG005|Overall Study|Lost to Follow-up|0|||
94596517|NCT01403948|323985615|FG006|Overall Study|Lost to Follow-up|0|||
94596518|NCT01403948|323985616|FG007|Overall Study|Lost to Follow-up|0|||
94596519|NCT01403948|323985617|FG008|Overall Study|Lost to Follow-up|0|||
94596520|NCT01403948|323985618|FG009|Overall Study|Lost to Follow-up|1|||
94596521|NCT01403948|323985609|FG000|Overall Study|Refused cont. medication|0|||
94596522|NCT01403948|323985610|FG001|Overall Study|Refused cont. medication|0|||
94596523|NCT01403948|323985611|FG002|Overall Study|Refused cont. medication|0|||
94596524|NCT01403948|323985612|FG003|Overall Study|Refused cont. medication|0|||
94596525|NCT01403948|323985613|FG004|Overall Study|Refused cont. medication|1|||
94596526|NCT01403948|323985614|FG005|Overall Study|Refused cont. medication|0|||
94596527|NCT01403948|323985615|FG006|Overall Study|Refused cont. medication|0|||
94596528|NCT01403948|323985616|FG007|Overall Study|Refused cont. medication|0|||
94596529|NCT01403948|323985617|FG008|Overall Study|Refused cont. medication|0|||
94596530|NCT01403948|323985618|FG009|Overall Study|Refused cont. medication|1|||
94596531|NCT01403948|323985609|FG000|Overall Study|other than above|1|||
94596532|NCT01403948|323985610|FG001|Overall Study|other than above|2|||
94596533|NCT01403948|323985611|FG002|Overall Study|other than above|1|||
94596534|NCT01403948|323985612|FG003|Overall Study|other than above|0|||
94596535|NCT01403948|323985613|FG004|Overall Study|other than above|1|||
94596536|NCT01403948|323985614|FG005|Overall Study|other than above|1|||
94596537|NCT01403948|323985615|FG006|Overall Study|other than above|2|||
94596538|NCT01403948|323985616|FG007|Overall Study|other than above|0|||
94596539|NCT01403948|323985617|FG008|Overall Study|other than above|0|||
94596540|NCT01403948|323985618|FG009|Overall Study|other than above|0|||
94596541|NCT05498701|323985619|FG000|Period 3|Adverse Event|1|||
94596542|NCT05498701|323985620|FG001|Period 3|Adverse Event|0|||
94596543|NCT02184572|323985621|FG000|Overall Study|Lost to Follow-up|29|||
94596544|NCT02184572|323985622|FG001|Overall Study|Lost to Follow-up|21|||
94596545|NCT02184572|323985621|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
94247167|NCT04617275|322699070|FG002|Treatment Period|Adverse Event|4|||
94596546|NCT02184572|323985622|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
94596547|NCT02184572|323985621|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
94596548|NCT02184572|323985622|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
94596549|NCT02184572|323985621|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
94660362|NCT03712917|324210100|FG000|Overall Study|Pregnancy|0|||
94247168|NCT04617275|322699071|FG003|Treatment Period|Adverse Event|6|||
94247169|NCT04617275|322699072|FG004|Treatment Period|Adverse Event|7|||
94247170|NCT04617275|322699073|FG005|Treatment Period|Adverse Event|8|||
94247171|NCT04617275|322699074|FG006|Treatment Period|Adverse Event|0|||
94247172|NCT04617275|322699075|FG007|Treatment Period|Adverse Event|12|||
94247173|NCT04617275|322699068|FG000|Treatment Period|Lost to Follow-up|0|||
94247174|NCT04617275|322699069|FG001|Treatment Period|Lost to Follow-up|0|||
94596550|NCT02184572|323985622|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
94596551|NCT02184572|323985621|FG000|Overall Study|Traveling Outside The Country|1|||
94596552|NCT02184572|323985622|FG001|Overall Study|Traveling Outside The Country|0|||
94596553|NCT02184572|323985621|FG000|Overall Study|Withdrawal by Subject|14|||
94596554|NCT02184572|323985622|FG001|Overall Study|Withdrawal by Subject|9|||
94596555|NCT01270802|323985623|FG000|Overall Study|Withdrawal by Subject|1|||
94596556|NCT01270802|323985624|FG001|Overall Study|Withdrawal by Subject|0|||
94596557|NCT01270802|323985623|FG000|Overall Study|Adverse Event|1|||
94596558|NCT01270802|323985624|FG001|Overall Study|Adverse Event|0|||
94596559|NCT01270802|323985623|FG000|Overall Study|Lost to Follow-up|0|||
94596560|NCT01270802|323985624|FG001|Overall Study|Lost to Follow-up|1|||
94596561|NCT02586506|323985625|FG000|Overall Study|Protocol Violation|6|||
94596562|NCT02586506|323985625|FG000|Overall Study|Lost to Follow-up|1|||
94596563|NCT02586506|323985625|FG000|Overall Study|Other Reason|2|||
94596564|NCT01566214|323985626|FG000|Overall Study|Lost to Follow-up|3|||
94596565|NCT01566214|323985627|FG001|Overall Study|Lost to Follow-up|0|||
94596566|NCT03051620|323985628|FG000|Overall Study|Lost to Follow-up|6|||
94596567|NCT03051620|323985628|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
94596568|NCT03499964|323985629|FG000|Overall Study|Lack of Efficacy|6|||
94596569|NCT03499964|323985630|FG001|Overall Study|Lack of Efficacy|26|||
94596570|NCT03499964|323985629|FG000|Overall Study|Adverse Event|1|||
94596571|NCT03499964|323985630|FG001|Overall Study|Adverse Event|0|||
94596572|NCT03499964|323985629|FG000|Overall Study|Death|1|||
94596573|NCT03499964|323985630|FG001|Overall Study|Death|0|||
94596574|NCT03499964|323985629|FG000|Overall Study|Withdrawal by Subject|2|||
94596575|NCT03499964|323985630|FG001|Overall Study|Withdrawal by Subject|1|||
94596576|NCT03499964|323985629|FG000|Overall Study|Lost to Follow-up|1|||
94596577|NCT03499964|323985630|FG001|Overall Study|Lost to Follow-up|0|||
94596578|NCT00816023|323985633|FG000|Overall Study|Lost to Follow-up|1|||
94596579|NCT00816023|323985634|FG001|Overall Study|Lost to Follow-up|1|||
94596580|NCT00816023|323985635|FG002|Overall Study|Lost to Follow-up|0|||
94596581|NCT00816023|323985636|FG003|Overall Study|Lost to Follow-up|0|||
94596582|NCT00816023|323985633|FG000|Overall Study|Withdrawal by Subject|1|||
94596583|NCT00816023|323985634|FG001|Overall Study|Withdrawal by Subject|0|||
94596584|NCT00816023|323985635|FG002|Overall Study|Withdrawal by Subject|0|||
94596585|NCT00816023|323985636|FG003|Overall Study|Withdrawal by Subject|0|||
94596586|NCT00816023|323985633|FG000|Overall Study|Physician Decision|0|||
94596587|NCT00816023|323985634|FG001|Overall Study|Physician Decision|0|||
94596588|NCT00816023|323985635|FG002|Overall Study|Physician Decision|1|||
94596589|NCT00816023|323985636|FG003|Overall Study|Physician Decision|0|||
94596590|NCT00816023|323985633|FG000|Overall Study|assessments complete prior to window|1|||
94596591|NCT00816023|323985634|FG001|Overall Study|assessments complete prior to window|1|||
94596592|NCT00816023|323985635|FG002|Overall Study|assessments complete prior to window|2|||
94596593|NCT00816023|323985636|FG003|Overall Study|assessments complete prior to window|1|||
94596594|NCT00816023|323985633|FG000|Overall Study|Randomized Not Treated|6|||
94596595|NCT00816023|323985634|FG001|Overall Study|Randomized Not Treated|4|||
94596596|NCT00816023|323985635|FG002|Overall Study|Randomized Not Treated|6|||
94596597|NCT00816023|323985636|FG003|Overall Study|Randomized Not Treated|11|||
94596598|NCT01960907|323985639|FG000|Overall Study|Death|4|||
94596599|NCT01960907|323985640|FG001|Overall Study|Death|3|||
94596600|NCT01960907|323985639|FG000|Overall Study|Withdrawal by Subject|32|||
94596601|NCT01960907|323985640|FG001|Overall Study|Withdrawal by Subject|42|||
94596602|NCT01073462|323985641|FG000|Overall Study|Death|14|||
94596603|NCT01073462|323985641|FG000|Overall Study|Kidney transplant|10|||
94596604|NCT01073462|323985641|FG000|Overall Study|Low parathyroid hormone levels|8|||
94596605|NCT01073462|323985641|FG000|Overall Study|Serious adverse event|2|||
94596606|NCT01073462|323985641|FG000|Overall Study|Lost to Follow-up|7|||
94596607|NCT02925338|323985645|FG000|Overall Study|Death|0|||
94247175|NCT04617275|322699070|FG002|Treatment Period|Lost to Follow-up|2|||
94247176|NCT04617275|322699071|FG003|Treatment Period|Lost to Follow-up|0|||
94596608|NCT02925338|323985646|FG001|Overall Study|Death|2|||
94596609|NCT02925338|323985647|FG002|Overall Study|Death|1|||
94596610|NCT02925338|323985648|FG003|Overall Study|Death|0|||
94247177|NCT04617275|322699072|FG004|Treatment Period|Lost to Follow-up|0|||
94596611|NCT02925338|323985649|FG004|Overall Study|Death|0|||
94247178|NCT04617275|322699073|FG005|Treatment Period|Lost to Follow-up|3|||
94596612|NCT02925338|323985645|FG000|Overall Study|Lost to Follow-up|30|||
94596613|NCT02925338|323985646|FG001|Overall Study|Lost to Follow-up|10|||
94596614|NCT02925338|323985647|FG002|Overall Study|Lost to Follow-up|1|||
94596615|NCT02925338|323985648|FG003|Overall Study|Lost to Follow-up|16|||
94596616|NCT02925338|323985649|FG004|Overall Study|Lost to Follow-up|3|||
94596617|NCT02925338|323985645|FG000|Overall Study|Withdrawal by Subject|3|||
94596618|NCT02925338|323985646|FG001|Overall Study|Withdrawal by Subject|0|||
94596619|NCT02925338|323985647|FG002|Overall Study|Withdrawal by Subject|3|||
94596620|NCT02925338|323985648|FG003|Overall Study|Withdrawal by Subject|2|||
94596621|NCT02925338|323985649|FG004|Overall Study|Withdrawal by Subject|2|||
94596622|NCT02925338|323985645|FG000|Overall Study|Missing|38|||
94596623|NCT02925338|323985646|FG001|Overall Study|Missing|27|||
94596624|NCT02925338|323985647|FG002|Overall Study|Missing|0|||
94596625|NCT02925338|323985648|FG003|Overall Study|Missing|3|||
94596626|NCT02925338|323985649|FG004|Overall Study|Missing|2|||
94596627|NCT02925338|323985645|FG000|Overall Study|Participant's Decision|11|||
94596628|NCT02925338|323985646|FG001|Overall Study|Participant's Decision|7|||
94596629|NCT02925338|323985647|FG002|Overall Study|Participant's Decision|3|||
94596630|NCT02925338|323985648|FG003|Overall Study|Participant's Decision|8|||
94596631|NCT02925338|323985649|FG004|Overall Study|Participant's Decision|1|||
94596632|NCT02925338|323985645|FG000|Overall Study|Treatment Discontinuation|144|||
94596633|NCT02925338|323985646|FG001|Overall Study|Treatment Discontinuation|65|||
94596634|NCT02925338|323985647|FG002|Overall Study|Treatment Discontinuation|56|||
94596635|NCT02925338|323985648|FG003|Overall Study|Treatment Discontinuation|131|||
94596636|NCT02925338|323985649|FG004|Overall Study|Treatment Discontinuation|22|||
94596637|NCT00313781|323985653|FG000|Before Crossover|Death|22|||
94596638|NCT00313781|323985654|FG001|Before Crossover|Death|8|||
94596639|NCT00313781|323985655|FG002|Before Crossover|Death|0|||
94596640|NCT00313781|323985653|FG000|Before Crossover|Lost to Follow-up|0|||
94596641|NCT00313781|323985654|FG001|Before Crossover|Lost to Follow-up|3|||
94596642|NCT00313781|323985655|FG002|Before Crossover|Lost to Follow-up|0|||
94596643|NCT00313781|323985653|FG000|Before Crossover|Withdrawal by Subject|3|||
94596644|NCT00313781|323985654|FG001|Before Crossover|Withdrawal by Subject|1|||
94596645|NCT00313781|323985655|FG002|Before Crossover|Withdrawal by Subject|0|||
94596646|NCT00313781|323985653|FG000|Before Crossover|Other|45|||
94596647|NCT00313781|323985654|FG001|Before Crossover|Other|30|||
94596648|NCT00313781|323985655|FG002|Before Crossover|Other|0|||
94596649|NCT00313781|323985653|FG000|Before Crossover|Crossover|0|||
94596650|NCT00313781|323985654|FG001|Before Crossover|Crossover|37|||
94596651|NCT00313781|323985655|FG002|Before Crossover|Crossover|0|||
94596652|NCT00313781|323985653|FG000|Before Crossover|Randomized, not treated|5|||
94596653|NCT00313781|323985654|FG001|Before Crossover|Randomized, not treated|0|||
94596654|NCT00313781|323985655|FG002|Before Crossover|Randomized, not treated|0|||
94596655|NCT00313781|323985653|FG000|After Crossover|Death|0|||
94596656|NCT00313781|323985654|FG001|After Crossover|Death|0|||
94596657|NCT00313781|323985655|FG002|After Crossover|Death|6|||
94596658|NCT00313781|323985653|FG000|After Crossover|Withdrawal by Subject|0|||
94596659|NCT00313781|323985654|FG001|After Crossover|Withdrawal by Subject|0|||
94596660|NCT00313781|323985655|FG002|After Crossover|Withdrawal by Subject|3|||
94596661|NCT00313781|323985653|FG000|After Crossover|Other|0|||
94596662|NCT00313781|323985654|FG001|After Crossover|Other|0|||
94596663|NCT00313781|323985655|FG002|After Crossover|Other|18|||
94596664|NCT02431260|323985662|FG000|Overall Study|Subject Decision|0|||
94596665|NCT02431260|323985663|FG001|Overall Study|Subject Decision|1|||
94596666|NCT02431260|323985664|FG002|Overall Study|Subject Decision|1|||
94596667|NCT02431260|323985665|FG003|Overall Study|Subject Decision|0|||
94596668|NCT02431260|323985666|FG004|Overall Study|Subject Decision|0|||
94596669|NCT02431260|323985667|FG005|Overall Study|Subject Decision|0|||
94596670|NCT02431260|323985668|FG006|Overall Study|Subject Decision|0|||
94596671|NCT02431260|323985669|FG007|Overall Study|Subject Decision|0|||
94596672|NCT02431260|323985670|FG008|Overall Study|Subject Decision|1|||
94596673|NCT02431260|323985671|FG009|Overall Study|Subject Decision|1|||
94596674|NCT02431260|323985672|FG010|Overall Study|Subject Decision|0|||
94596675|NCT02431260|323985673|FG011|Overall Study|Subject Decision|1|||
94596676|NCT02431260|323985674|FG012|Overall Study|Subject Decision|0|||
94596677|NCT02431260|323985675|FG013|Overall Study|Subject Decision|0|||
94596678|NCT02431260|323985662|FG000|Overall Study|Death|4|||
94596679|NCT02431260|323985663|FG001|Overall Study|Death|4|||
94596680|NCT02431260|323985664|FG002|Overall Study|Death|3|||
94596681|NCT02431260|323985665|FG003|Overall Study|Death|4|||
94596682|NCT02431260|323985666|FG004|Overall Study|Death|2|||
94596683|NCT02431260|323985667|FG005|Overall Study|Death|2|||
94596684|NCT02431260|323985668|FG006|Overall Study|Death|3|||
94596685|NCT02431260|323985669|FG007|Overall Study|Death|1|||
94596686|NCT02431260|323985670|FG008|Overall Study|Death|6|||
94596687|NCT02431260|323985671|FG009|Overall Study|Death|6|||
94596688|NCT02431260|323985672|FG010|Overall Study|Death|3|||
94596689|NCT02431260|323985673|FG011|Overall Study|Death|2|||
94596690|NCT02431260|323985674|FG012|Overall Study|Death|5|||
94596691|NCT02431260|323985675|FG013|Overall Study|Death|1|||
94596692|NCT02431260|323985662|FG000|Overall Study|Lost to Follow-up|0|||
94596693|NCT02431260|323985663|FG001|Overall Study|Lost to Follow-up|0|||
94596694|NCT02431260|323985664|FG002|Overall Study|Lost to Follow-up|0|||
94596695|NCT02431260|323985665|FG003|Overall Study|Lost to Follow-up|0|||
94596696|NCT02431260|323985666|FG004|Overall Study|Lost to Follow-up|0|||
94596697|NCT02431260|323985667|FG005|Overall Study|Lost to Follow-up|1|||
94596698|NCT02431260|323985668|FG006|Overall Study|Lost to Follow-up|0|||
94247179|NCT04617275|322699074|FG006|Treatment Period|Lost to Follow-up|0|||
94247180|NCT04617275|322699075|FG007|Treatment Period|Lost to Follow-up|2|||
94247181|NCT04617275|322699068|FG000|Treatment Period|No longer meets eligibility criteria|0|||
94247182|NCT04617275|322699069|FG001|Treatment Period|No longer meets eligibility criteria|0|||
94247183|NCT04617275|322699070|FG002|Treatment Period|No longer meets eligibility criteria|0|||
94247184|NCT04617275|322699071|FG003|Treatment Period|No longer meets eligibility criteria|1|||
94247185|NCT04617275|322699072|FG004|Treatment Period|No longer meets eligibility criteria|0|||
94247186|NCT04617275|322699073|FG005|Treatment Period|No longer meets eligibility criteria|0|||
94247187|NCT04617275|322699074|FG006|Treatment Period|No longer meets eligibility criteria|0|||
94247188|NCT04617275|322699075|FG007|Treatment Period|No longer meets eligibility criteria|0|||
94247189|NCT04617275|322699068|FG000|Treatment Period|Other|0|||
94247190|NCT04617275|322699069|FG001|Treatment Period|Other|1|||
94247191|NCT04617275|322699070|FG002|Treatment Period|Other|0|||
94247192|NCT04617275|322699071|FG003|Treatment Period|Other|0|||
94247193|NCT04617275|322699072|FG004|Treatment Period|Other|0|||
94247194|NCT04617275|322699073|FG005|Treatment Period|Other|0|||
94247195|NCT04617275|322699074|FG006|Treatment Period|Other|0|||
94247196|NCT04617275|322699075|FG007|Treatment Period|Other|0|||
94247197|NCT04617275|322699068|FG000|Treatment Period|Withdrawal by Subject|2|||
94247198|NCT04617275|322699069|FG001|Treatment Period|Withdrawal by Subject|0|||
94247199|NCT04617275|322699070|FG002|Treatment Period|Withdrawal by Subject|0|||
94247200|NCT04617275|322699071|FG003|Treatment Period|Withdrawal by Subject|2|||
94247201|NCT04617275|322699072|FG004|Treatment Period|Withdrawal by Subject|2|||
94247202|NCT04617275|322699073|FG005|Treatment Period|Withdrawal by Subject|0|||
94247203|NCT04617275|322699074|FG006|Treatment Period|Withdrawal by Subject|1|||
94247204|NCT04617275|322699075|FG007|Treatment Period|Withdrawal by Subject|2|||
94247205|NCT04617275|322699068|FG000|Follow-up Period|Adverse Event|1|||
94247206|NCT04617275|322699069|FG001|Follow-up Period|Adverse Event|1|||
94247207|NCT04617275|322699070|FG002|Follow-up Period|Adverse Event|2|||
94247208|NCT04617275|322699071|FG003|Follow-up Period|Adverse Event|3|||
94247209|NCT04617275|322699072|FG004|Follow-up Period|Adverse Event|4|||
94247210|NCT04617275|322699073|FG005|Follow-up Period|Adverse Event|3|||
94247211|NCT04617275|322699074|FG006|Follow-up Period|Adverse Event|0|||
94247212|NCT04617275|322699075|FG007|Follow-up Period|Adverse Event|3|||
94247213|NCT04617275|322699068|FG000|Follow-up Period|Lost to Follow-up|0|||
94247214|NCT04617275|322699069|FG001|Follow-up Period|Lost to Follow-up|1|||
94247215|NCT04617275|322699070|FG002|Follow-up Period|Lost to Follow-up|2|||
94247216|NCT04617275|322699071|FG003|Follow-up Period|Lost to Follow-up|0|||
94457623|NCT01992653|323463607|FG004|Overall Study|Lost to Follow-up|0|||
94457624|NCT01992653|323463608|FG005|Overall Study|Lost to Follow-up|0|||
94457625|NCT01992653|323463609|FG006|Overall Study|Lost to Follow-up|0|||
94457626|NCT01992653|323463610|FG007|Overall Study|Lost to Follow-up|1|||
94247217|NCT04617275|322699072|FG004|Follow-up Period|Lost to Follow-up|0|||
94247218|NCT04617275|322699073|FG005|Follow-up Period|Lost to Follow-up|4|||
94247219|NCT04617275|322699074|FG006|Follow-up Period|Lost to Follow-up|0|||
94247220|NCT04617275|322699075|FG007|Follow-up Period|Lost to Follow-up|3|||
94247221|NCT04617275|322699068|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
94247222|NCT04617275|322699069|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
94247223|NCT04617275|322699070|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
94247224|NCT04617275|322699071|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
94247225|NCT04617275|322699072|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
94247226|NCT04617275|322699073|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
94247227|NCT04617275|322699074|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
94247228|NCT04617275|322699075|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
94247229|NCT04617275|322699068|FG000|Follow-up Period|Other|0|||
94247230|NCT04617275|322699069|FG001|Follow-up Period|Other|1|||
94247231|NCT04617275|322699070|FG002|Follow-up Period|Other|0|||
94247232|NCT04617275|322699071|FG003|Follow-up Period|Other|0|||
94247233|NCT04617275|322699072|FG004|Follow-up Period|Other|0|||
94247234|NCT04617275|322699073|FG005|Follow-up Period|Other|0|||
94247235|NCT04617275|322699074|FG006|Follow-up Period|Other|0|||
94247236|NCT04617275|322699075|FG007|Follow-up Period|Other|0|||
94247237|NCT04617275|322699068|FG000|Follow-up Period|Withdrawal by Subject|2|||
94247238|NCT04617275|322699069|FG001|Follow-up Period|Withdrawal by Subject|0|||
94247239|NCT04617275|322699070|FG002|Follow-up Period|Withdrawal by Subject|0|||
94247240|NCT04617275|322699071|FG003|Follow-up Period|Withdrawal by Subject|2|||
94247241|NCT04617275|322699072|FG004|Follow-up Period|Withdrawal by Subject|2|||
94247242|NCT04617275|322699073|FG005|Follow-up Period|Withdrawal by Subject|0|||
94247243|NCT04617275|322699074|FG006|Follow-up Period|Withdrawal by Subject|1|||
94247244|NCT04617275|322699075|FG007|Follow-up Period|Withdrawal by Subject|2|||
94247245|NCT04927884|322699081|FG000|Overall Study|Progressive Disease|2|||
94247246|NCT05917470|322699082|FG000|Overall Study|Progressive Disease|1|||
94247247|NCT05917470|322699083|FG001|Overall Study|Progressive Disease|1|||
94457627|NCT01992653|323463603|FG000|Overall Study|Study Completed|0|||
94247248|NCT05917470|322699084|FG002|Overall Study|Progressive Disease|2|||
94247249|NCT05917470|322699085|FG003|Overall Study|Progressive Disease|3|||
94457628|NCT01992653|323463604|FG001|Overall Study|Study Completed|0|||
94596699|NCT02431260|323985669|FG007|Overall Study|Lost to Follow-up|0|||
94596700|NCT02431260|323985670|FG008|Overall Study|Lost to Follow-up|0|||
94596701|NCT02431260|323985671|FG009|Overall Study|Lost to Follow-up|0|||
94596702|NCT02431260|323985672|FG010|Overall Study|Lost to Follow-up|0|||
94596703|NCT02431260|323985673|FG011|Overall Study|Lost to Follow-up|0|||
94596704|NCT02431260|323985674|FG012|Overall Study|Lost to Follow-up|0|||
94596705|NCT02431260|323985675|FG013|Overall Study|Lost to Follow-up|0|||
94596706|NCT02431260|323985662|FG000|Overall Study|Study Terminated by the Sponsor|0|||
94596707|NCT02431260|323985663|FG001|Overall Study|Study Terminated by the Sponsor|0|||
94596708|NCT02431260|323985664|FG002|Overall Study|Study Terminated by the Sponsor|2|||
94596709|NCT02431260|323985665|FG003|Overall Study|Study Terminated by the Sponsor|1|||
94596710|NCT02431260|323985666|FG004|Overall Study|Study Terminated by the Sponsor|1|||
94596711|NCT02431260|323985667|FG005|Overall Study|Study Terminated by the Sponsor|0|||
94596712|NCT02431260|323985668|FG006|Overall Study|Study Terminated by the Sponsor|1|||
94596713|NCT02431260|323985669|FG007|Overall Study|Study Terminated by the Sponsor|2|||
94596714|NCT02431260|323985670|FG008|Overall Study|Study Terminated by the Sponsor|1|||
94596715|NCT02431260|323985671|FG009|Overall Study|Study Terminated by the Sponsor|1|||
94596716|NCT02431260|323985672|FG010|Overall Study|Study Terminated by the Sponsor|1|||
94596717|NCT02431260|323985673|FG011|Overall Study|Study Terminated by the Sponsor|0|||
94596718|NCT02431260|323985674|FG012|Overall Study|Study Terminated by the Sponsor|4|||
94596719|NCT02431260|323985675|FG013|Overall Study|Study Terminated by the Sponsor|0|||
94596720|NCT02431260|323985662|FG000|Overall Study|Physician Decision|0|||
94596721|NCT02431260|323985663|FG001|Overall Study|Physician Decision|0|||
94596722|NCT02431260|323985664|FG002|Overall Study|Physician Decision|0|||
94596723|NCT02431260|323985665|FG003|Overall Study|Physician Decision|0|||
94596724|NCT02431260|323985666|FG004|Overall Study|Physician Decision|0|||
94596725|NCT02431260|323985667|FG005|Overall Study|Physician Decision|1|||
94596726|NCT02431260|323985668|FG006|Overall Study|Physician Decision|0|||
94596727|NCT02431260|323985669|FG007|Overall Study|Physician Decision|0|||
94596728|NCT02431260|323985670|FG008|Overall Study|Physician Decision|0|||
94596729|NCT02431260|323985671|FG009|Overall Study|Physician Decision|0|||
94596730|NCT02431260|323985672|FG010|Overall Study|Physician Decision|0|||
94596731|NCT02431260|323985673|FG011|Overall Study|Physician Decision|0|||
94596732|NCT02431260|323985674|FG012|Overall Study|Physician Decision|0|||
94596733|NCT02431260|323985675|FG013|Overall Study|Physician Decision|0|||
94596734|NCT02431260|323985662|FG000|Overall Study|Other Unspecified|0|||
94596735|NCT02431260|323985663|FG001|Overall Study|Other Unspecified|0|||
94596736|NCT02431260|323985664|FG002|Overall Study|Other Unspecified|0|||
94596737|NCT02431260|323985665|FG003|Overall Study|Other Unspecified|0|||
94596738|NCT02431260|323985666|FG004|Overall Study|Other Unspecified|0|||
94596739|NCT02431260|323985667|FG005|Overall Study|Other Unspecified|0|||
94596740|NCT02431260|323985668|FG006|Overall Study|Other Unspecified|0|||
94596741|NCT02431260|323985669|FG007|Overall Study|Other Unspecified|0|||
94596742|NCT02431260|323985670|FG008|Overall Study|Other Unspecified|0|||
94596743|NCT02431260|323985671|FG009|Overall Study|Other Unspecified|0|||
94596744|NCT02431260|323985672|FG010|Overall Study|Other Unspecified|0|||
94596745|NCT02431260|323985673|FG011|Overall Study|Other Unspecified|1|||
94596746|NCT02431260|323985674|FG012|Overall Study|Other Unspecified|1|||
94596747|NCT02431260|323985675|FG013|Overall Study|Other Unspecified|0|||
94596748|NCT00392379|323985678|FG000|Overall Study|Withdrawal by Subject|17|||
94596749|NCT00392379|323985679|FG001|Overall Study|Withdrawal by Subject|28|||
94596750|NCT00392379|323985678|FG000|Overall Study|Lost to Follow-up|4|||
94596751|NCT00392379|323985679|FG001|Overall Study|Lost to Follow-up|9|||
94596752|NCT00392379|323985678|FG000|Overall Study|Adverse Event|1|||
94596753|NCT00392379|323985679|FG001|Overall Study|Adverse Event|1|||
94596754|NCT01642732|323985681|FG000|Overall Study|Withdrawal by Subject|1|||
94596755|NCT01806662|323985682|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
94596756|NCT01806662|323985683|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
94596757|NCT01806662|323985682|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
94596758|NCT01806662|323985683|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
94596759|NCT01806662|323985682|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
94596760|NCT01806662|323985683|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
94596761|NCT01806662|323985682|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
94596762|NCT01806662|323985683|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
94247250|NCT05917470|322699086|FG004|Overall Study|Progressive Disease|1|||
94247251|NCT05917470|322699087|FG005|Overall Study|Progressive Disease|1|||
94247252|NCT05917470|322699088|FG006|Overall Study|Progressive Disease|0|||
94247253|NCT05917470|322699089|FG007|Overall Study|Progressive Disease|0|||
94596763|NCT01892384|323985684|FG000|Overall Study|Withdrawal by Subject|1|||
94596764|NCT01892384|323985685|FG001|Overall Study|Withdrawal by Subject|1|||
94596765|NCT01892384|323985686|FG002|Overall Study|Withdrawal by Subject|0|||
94596766|NCT01892384|323985687|FG003|Overall Study|Withdrawal by Subject|0|||
94457629|NCT01992653|323463605|FG002|Overall Study|Study Completed|0|||
94596767|NCT02545543|323985689|FG000|Overall Study|Lost to Follow-up|67|||
94596768|NCT02545543|323985690|FG001|Overall Study|Lost to Follow-up|25|||
94596769|NCT02545543|323985689|FG000|Overall Study|Physician Decision|3|||
94596770|NCT02545543|323985690|FG001|Overall Study|Physician Decision|0|||
94596771|NCT02545543|323985689|FG000|Overall Study|Withdrawal by Subject|9|||
94596772|NCT02545543|323985690|FG001|Overall Study|Withdrawal by Subject|8|||
94596773|NCT02545543|323985689|FG000|Overall Study|Noncomplaince|1|||
94596774|NCT02545543|323985690|FG001|Overall Study|Noncomplaince|0|||
94596775|NCT02545543|323985689|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
94596776|NCT02545543|323985690|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
94596777|NCT02654717|323985691|FG000|Overall Study|Adverse Event|2|||
94596778|NCT02654717|323985692|FG001|Overall Study|Adverse Event|2|||
94596779|NCT02654717|323985691|FG000|Overall Study|Protocol Violation|1|||
94596780|NCT02654717|323985692|FG001|Overall Study|Protocol Violation|2|||
94596781|NCT02654717|323985691|FG000|Overall Study|Withdrawal by Subject|0|||
94596782|NCT02654717|323985692|FG001|Overall Study|Withdrawal by Subject|1|||
94596783|NCT02654717|323985691|FG000|Overall Study|Non-permitted medication|3|||
94596784|NCT02654717|323985692|FG001|Overall Study|Non-permitted medication|0|||
94596785|NCT03658876|323987635|FG000|Overall Study|Protocol Violation|3|||
94596786|NCT03658876|323987636|FG001|Overall Study|Protocol Violation|2|||
94596787|NCT03658876|323987635|FG000|Overall Study|Withdrawal by Subject|2|||
94596788|NCT03658876|323987636|FG001|Overall Study|Withdrawal by Subject|0|||
94596789|NCT03658876|323987635|FG000|Overall Study|Death|0|||
94596790|NCT03658876|323987636|FG001|Overall Study|Death|1|||
94596791|NCT03658876|323987635|FG000|Overall Study|Intercurrent illness|6|||
94596792|NCT03658876|323987636|FG001|Overall Study|Intercurrent illness|4|||
94596793|NCT03658876|323987635|FG000|Overall Study|Transplantation/other operation|1|||
94596794|NCT03658876|323987636|FG001|Overall Study|Transplantation/other operation|5|||
94596795|NCT03137069|323987638|FG000|Overall Study|Withdrawal by Subject|1|||
94596796|NCT03137069|323987639|FG001|Overall Study|Withdrawal by Subject|2|||
94596797|NCT03137069|323987640|FG002|Overall Study|Withdrawal by Subject|2|||
94596798|NCT03137069|323987641|FG003|Overall Study|Withdrawal by Subject|2|||
94596799|NCT03137069|323987642|FG004|Overall Study|Withdrawal by Subject|0|||
94596800|NCT03137069|323987643|FG005|Overall Study|Withdrawal by Subject|0|||
94596801|NCT03137069|323987638|FG000|Overall Study|Adverse Event|0|||
94596802|NCT03137069|323987639|FG001|Overall Study|Adverse Event|3|||
94596803|NCT03137069|323987640|FG002|Overall Study|Adverse Event|1|||
94596804|NCT03137069|323987641|FG003|Overall Study|Adverse Event|1|||
94596805|NCT03137069|323987642|FG004|Overall Study|Adverse Event|0|||
94596806|NCT03137069|323987643|FG005|Overall Study|Adverse Event|1|||
94596807|NCT03137069|323987638|FG000|Overall Study|Protocol Violation|0|||
94596808|NCT03137069|323987639|FG001|Overall Study|Protocol Violation|1|||
94596809|NCT03137069|323987640|FG002|Overall Study|Protocol Violation|0|||
94596810|NCT03137069|323987641|FG003|Overall Study|Protocol Violation|1|||
94596811|NCT03137069|323987642|FG004|Overall Study|Protocol Violation|1|||
94596812|NCT03137069|323987643|FG005|Overall Study|Protocol Violation|1|||
94596813|NCT03137069|323987638|FG000|Overall Study|Physician Decision|0|||
94596814|NCT03137069|323987639|FG001|Overall Study|Physician Decision|0|||
94596815|NCT03137069|323987640|FG002|Overall Study|Physician Decision|0|||
94596816|NCT03137069|323987641|FG003|Overall Study|Physician Decision|1|||
94596817|NCT03137069|323987642|FG004|Overall Study|Physician Decision|0|||
94596818|NCT03137069|323987643|FG005|Overall Study|Physician Decision|0|||
94596819|NCT03137069|323987638|FG000|Overall Study|Study Terminated by Sponsor|0|||
94596820|NCT03137069|323987639|FG001|Overall Study|Study Terminated by Sponsor|0|||
94596821|NCT03137069|323987640|FG002|Overall Study|Study Terminated by Sponsor|0|||
94596822|NCT03137069|323987641|FG003|Overall Study|Study Terminated by Sponsor|0|||
94596823|NCT03137069|323987642|FG004|Overall Study|Study Terminated by Sponsor|1|||
94596824|NCT03137069|323987643|FG005|Overall Study|Study Terminated by Sponsor|0|||
94596825|NCT03137069|323987638|FG000|Overall Study|Data Entry Error|0|||
94596826|NCT03137069|323987639|FG001|Overall Study|Data Entry Error|0|||
94596827|NCT03137069|323987640|FG002|Overall Study|Data Entry Error|0|||
94596828|NCT03137069|323987641|FG003|Overall Study|Data Entry Error|1|||
94596829|NCT03137069|323987642|FG004|Overall Study|Data Entry Error|0|||
94596830|NCT03137069|323987643|FG005|Overall Study|Data Entry Error|0|||
94596831|NCT02043899|323987645|FG000|Overall Study|Adverse Event|3|||
94596832|NCT02043899|323987645|FG000|Overall Study|Physician Decision|1|||
94596833|NCT02043899|323987645|FG000|Overall Study|Withdrawal by Subject|2|||
94596834|NCT02043899|323987645|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
94355938|NCT01519700|323085738|FG001|Overall Study|Death|0|||
94355939|NCT01519700|323085739|FG002|Overall Study|Death|0|||
94596835|NCT02043899|323987645|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
94596836|NCT02043899|323987645|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
94596837|NCT02043899|323987645|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
94596838|NCT02043899|323987645|FG000|Overall Study|Treatment delayed|1|||
94596839|NCT01954927|323987647|FG000|Overall Study|Withdrawal by Subject|3|||
94596840|NCT01954927|323987648|FG001|Overall Study|Withdrawal by Subject|1|||
94355940|NCT01519700|323085740|FG003|Overall Study|Death|0|||
94355941|NCT01519700|323085737|FG000|Overall Study|Lost to Follow-up|0|||
94596841|NCT00535288|323987657|FG000|Overall Study|Adverse Event|20|||
94596842|NCT00535288|323987658|FG001|Overall Study|Adverse Event|19|||
94596843|NCT00535288|323987659|FG002|Overall Study|Adverse Event|25|||
94247254|NCT05917470|322699082|FG000|Overall Study|Withdrawal by Subject|0|||
94247255|NCT05917470|322699083|FG001|Overall Study|Withdrawal by Subject|0|||
94247256|NCT05917470|322699084|FG002|Overall Study|Withdrawal by Subject|1|||
94247257|NCT05917470|322699085|FG003|Overall Study|Withdrawal by Subject|0|||
94247258|NCT05917470|322699086|FG004|Overall Study|Withdrawal by Subject|0|||
94247259|NCT05917470|322699087|FG005|Overall Study|Withdrawal by Subject|0|||
94247260|NCT05917470|322699088|FG006|Overall Study|Withdrawal by Subject|0|||
94247261|NCT05917470|322699089|FG007|Overall Study|Withdrawal by Subject|0|||
94247262|NCT05917470|322699082|FG000|Overall Study|Sponsor Decision|0|||
94247263|NCT05917470|322699083|FG001|Overall Study|Sponsor Decision|0|||
94247264|NCT05917470|322699084|FG002|Overall Study|Sponsor Decision|1|||
94247265|NCT05917470|322699085|FG003|Overall Study|Sponsor Decision|0|||
94247266|NCT05917470|322699086|FG004|Overall Study|Sponsor Decision|2|||
94247267|NCT05917470|322699087|FG005|Overall Study|Sponsor Decision|1|||
94247268|NCT05917470|322699088|FG006|Overall Study|Sponsor Decision|3|||
94247269|NCT05917470|322699089|FG007|Overall Study|Sponsor Decision|3|||
94247270|NCT05917470|322699082|FG000|Overall Study|Adverse Event|0|||
94247271|NCT05917470|322699083|FG001|Overall Study|Adverse Event|0|||
94247272|NCT05917470|322699084|FG002|Overall Study|Adverse Event|0|||
94247273|NCT05917470|322699085|FG003|Overall Study|Adverse Event|0|||
94247274|NCT05917470|322699086|FG004|Overall Study|Adverse Event|0|||
94247275|NCT05917470|322699087|FG005|Overall Study|Adverse Event|1|||
94247276|NCT05917470|322699088|FG006|Overall Study|Adverse Event|0|||
94247277|NCT05917470|322699089|FG007|Overall Study|Adverse Event|0|||
94247278|NCT05593445|322699092|FG000|12-Week DBVC Period|Adverse Event|1|||
94247279|NCT05593445|322699093|FG001|12-Week DBVC Period|Adverse Event|0|||
94247280|NCT05593445|322699094|FG002|12-Week DBVC Period|Adverse Event|0|||
94247281|NCT05593445|322699095|FG003|12-Week DBVC Period|Adverse Event|0|||
94247282|NCT05593445|322699092|FG000|12-Week DBVC Period|Physician Decision|0|||
94247283|NCT05593445|322699093|FG001|12-Week DBVC Period|Physician Decision|1|||
94247284|NCT05593445|322699094|FG002|12-Week DBVC Period|Physician Decision|0|||
94247285|NCT05593445|322699095|FG003|12-Week DBVC Period|Physician Decision|0|||
94247286|NCT05593445|322699092|FG000|12-Week DBVC Period|Protocol Violation|0|||
94247287|NCT05593445|322699093|FG001|12-Week DBVC Period|Protocol Violation|1|||
94247288|NCT05593445|322699094|FG002|12-Week DBVC Period|Protocol Violation|0|||
94247289|NCT05593445|322699095|FG003|12-Week DBVC Period|Protocol Violation|0|||
94247290|NCT05593445|322699092|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
94247291|NCT05593445|322699093|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
94247292|NCT05593445|322699094|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
94247293|NCT05593445|322699095|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
94247294|NCT05593445|322699092|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
94247295|NCT05593445|322699093|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
94247296|NCT05593445|322699094|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
94247297|NCT05593445|322699095|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
94247298|NCT05593445|322699092|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
94247299|NCT05593445|322699093|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
94247300|NCT05593445|322699094|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
94247301|NCT05593445|322699095|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
94247302|NCT05593445|322699092|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
94247303|NCT05593445|322699093|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
94247304|NCT05593445|322699094|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
94247305|NCT05593445|322699095|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
94247306|NCT05593445|322699092|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
94247307|NCT05593445|322699093|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
94247308|NCT05593445|322699094|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
94596844|NCT00535288|323987660|FG003|Overall Study|Adverse Event|20|||
94596845|NCT00535288|323987661|FG004|Overall Study|Adverse Event|30|||
94596846|NCT00535288|323987657|FG000|Overall Study|Lost to Follow-up|0|||
94596847|NCT00535288|323987658|FG001|Overall Study|Lost to Follow-up|3|||
94596848|NCT00535288|323987659|FG002|Overall Study|Lost to Follow-up|0|||
94247309|NCT05593445|322699095|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
94247310|NCT03981861|322699096|FG000|Overall Study|Withdrawal by Subject|3|||
94247311|NCT05718466|322701053|FG000|Overall Study|Withdrawal by Subject|1|||
94247312|NCT05718466|322701054|FG001|Overall Study|Withdrawal by Subject|2|||
94247313|NCT05718466|322701053|FG000|Overall Study|Death|0|||
94596849|NCT00535288|323987660|FG003|Overall Study|Lost to Follow-up|0|||
94596850|NCT00535288|323987661|FG004|Overall Study|Lost to Follow-up|0|||
94660363|NCT03712917|324210101|FG001|Overall Study|Pregnancy|0|||
94247314|NCT05718466|322701054|FG001|Overall Study|Death|1|||
94247315|NCT00166712|322701058|FG000|Overall Study|Death|0|||
94247316|NCT00166712|322701059|FG001|Overall Study|Death|1|||
94660364|NCT03712917|324210102|FG002|Overall Study|Pregnancy|1|||
94660365|NCT03712917|324210100|FG000|Overall Study|Adverse Event|0|||
94247317|NCT00166712|322701058|FG000|Overall Study|Adverse Event|1|||
94596851|NCT00535288|323987657|FG000|Overall Study|Lack of Efficacy|26|||
94596852|NCT00535288|323987658|FG001|Overall Study|Lack of Efficacy|3|||
94596853|NCT00535288|323987659|FG002|Overall Study|Lack of Efficacy|4|||
94596854|NCT00535288|323987660|FG003|Overall Study|Lack of Efficacy|4|||
94596855|NCT00535288|323987661|FG004|Overall Study|Lack of Efficacy|7|||
94596856|NCT00535288|323987657|FG000|Overall Study|Unwilling to cooperate|6|||
94596857|NCT00535288|323987658|FG001|Overall Study|Unwilling to cooperate|6|||
94596858|NCT00535288|323987659|FG002|Overall Study|Unwilling to cooperate|3|||
94660366|NCT03712917|324210101|FG001|Overall Study|Adverse Event|4|||
94660367|NCT03712917|324210102|FG002|Overall Study|Adverse Event|3|||
94660368|NCT03712917|324210100|FG000|Overall Study|Lost to Follow-up|9|||
94660369|NCT03712917|324210101|FG001|Overall Study|Lost to Follow-up|4|||
94660370|NCT03712917|324210102|FG002|Overall Study|Lost to Follow-up|5|||
94660371|NCT00660010|324210103|FG000|Overall Study|Withdrawal by Subject|2|||
94660372|NCT00660010|324210103|FG000|Overall Study|Lost to Follow-up|3|||
94660373|NCT00660010|324210103|FG000|Overall Study|Adverse Event|1|||
94660374|NCT00660010|324210103|FG000|Overall Study|Noncompliance with visit schedule|3|||
94596859|NCT00535288|323987660|FG003|Overall Study|Unwilling to cooperate|3|||
94596860|NCT00535288|323987661|FG004|Overall Study|Unwilling to cooperate|4|||
94596861|NCT00535288|323987657|FG000|Overall Study|Other|2|||
94596862|NCT00535288|323987658|FG001|Overall Study|Other|1|||
94596863|NCT00535288|323987659|FG002|Overall Study|Other|1|||
94596864|NCT00535288|323987660|FG003|Overall Study|Other|2|||
94596865|NCT00535288|323987661|FG004|Overall Study|Other|1|||
94596866|NCT01258998|323987662|FG000|Overall Study|Ineligible|1|||
94596867|NCT04839562|323987663|FG000|Overall Study|Withdrawal by Subject|0|||
94596868|NCT04839562|323987664|FG001|Overall Study|Withdrawal by Subject|1|||
94660375|NCT00932893|324210108|FG000|Overall Study|Death|115|||
94596869|NCT04839562|323987663|FG000|Overall Study|Physician Decision|0|||
94596870|NCT04839562|323987664|FG001|Overall Study|Physician Decision|1|||
94596871|NCT03338959|323987665|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
94596872|NCT03338959|323987665|FG000|Overall Study|Physician Decision|1|||
94596873|NCT02848729|323987666|FG000|Overall Study|Withdrawal by Subject|1|||
94596874|NCT02848729|323987667|FG001|Overall Study|Withdrawal by Subject|0|||
94596875|NCT02848729|323987666|FG000|Overall Study|Emesis|15|||
94596876|NCT02848729|323987667|FG001|Overall Study|Emesis|11|||
94596877|NCT02617485|323987676|FG000|Treatment and Observation Period|Adverse Event|9|||
94596878|NCT02617485|323987677|FG001|Treatment and Observation Period|Adverse Event|1|||
94596879|NCT02617485|323987676|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
94596880|NCT02617485|323987677|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
94596881|NCT02617485|323987676|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
94596882|NCT02617485|323987677|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
94596883|NCT02617485|323987676|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
94660376|NCT00932893|324210109|FG001|Overall Study|Death|24|||
94660377|NCT00932893|324210108|FG000|Overall Study|Lost to Follow-up|8|||
94660378|NCT00932893|324210109|FG001|Overall Study|Lost to Follow-up|0|||
94660379|NCT00932893|324210108|FG000|Overall Study|Withdrawal by Subject|5|||
94596884|NCT02617485|323987677|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
94596885|NCT02617485|323987676|FG000|Treatment and Observation Period|Physician Decision|0|||
94596886|NCT02617485|323987677|FG001|Treatment and Observation Period|Physician Decision|1|||
94596887|NCT02617485|323987676|FG000|Follow-up Period|Adverse Event|1|||
94596888|NCT02617485|323987677|FG001|Follow-up Period|Adverse Event|0|||
94596889|NCT02617485|323987676|FG000|Follow-up Period|Withdrawal by Subject|1|||
94596890|NCT02617485|323987677|FG001|Follow-up Period|Withdrawal by Subject|0|||
94596891|NCT02617485|323987676|FG000|Follow-up Period|Disease progression|2|||
94596892|NCT02617485|323987677|FG001|Follow-up Period|Disease progression|1|||
94596893|NCT02617485|323987676|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
94596894|NCT02617485|323987677|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
94596895|NCT02617485|323987676|FG000|Follow-up Period|Patient needed radiotherapy|9|||
94596896|NCT02617485|323987677|FG001|Follow-up Period|Patient needed radiotherapy|5|||
94596897|NCT02617485|323987676|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
94596898|NCT02617485|323987677|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
94596899|NCT01604278|323987680|FG000|Overall Study|Lack of Efficacy|0|||
94596900|NCT01604278|323987681|FG001|Overall Study|Lack of Efficacy|1|||
94660380|NCT00932893|324210109|FG001|Overall Study|Withdrawal by Subject|2|||
94247318|NCT00166712|322701059|FG001|Overall Study|Adverse Event|0|||
94596901|NCT01604278|323987680|FG000|Overall Study|Lost to Follow-up|1|||
94596902|NCT01604278|323987681|FG001|Overall Study|Lost to Follow-up|0|||
94596903|NCT01604278|323987680|FG000|Overall Study|Administrative problems|2|||
94596904|NCT01604278|323987681|FG001|Overall Study|Administrative problems|1|||
94596905|NCT01604278|323987680|FG000|Overall Study|Withdrawal by Subject|3|||
94596906|NCT01604278|323987681|FG001|Overall Study|Withdrawal by Subject|3|||
94596907|NCT01604278|323987680|FG000|Overall Study|Adverse Event|3|||
94660381|NCT00932893|324210108|FG000|Overall Study|Other|5|||
94660382|NCT00932893|324210109|FG001|Overall Study|Other|144|||
94660383|NCT02055352|324211636|FG000|Overall Study|Adverse Event|0|||
94660384|NCT02055352|324211637|FG001|Overall Study|Adverse Event|1|||
94596908|NCT01604278|323987681|FG001|Overall Study|Adverse Event|5|||
94596909|NCT01604278|323987680|FG000|Overall Study|Protocol Deviation|5|||
94596910|NCT01604278|323987681|FG001|Overall Study|Protocol Deviation|3|||
94596911|NCT00830869|323987686|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
94596912|NCT00830869|323987687|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
94596913|NCT00830869|323987688|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
94596914|NCT00830869|323987689|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
94596915|NCT00830869|323987690|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
94596916|NCT00830869|323987691|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
94596917|NCT00830869|323987692|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
94596918|NCT00830869|323987693|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
94596919|NCT00830869|323987694|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
94596920|NCT00830869|323987695|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
94596921|NCT00830869|323987696|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
94596922|NCT00830869|323987697|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
94596923|NCT00830869|323987686|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
94596924|NCT00830869|323987687|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
94596925|NCT00830869|323987688|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
94596926|NCT00830869|323987689|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
94596927|NCT00830869|323987690|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
94596928|NCT00830869|323987691|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
94596929|NCT00830869|323987692|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
94596930|NCT00830869|323987693|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
94596931|NCT00830869|323987694|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
94596932|NCT00830869|323987695|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
94596933|NCT00830869|323987696|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
94596934|NCT00830869|323987697|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
94596935|NCT00830869|323987686|FG000|Period 1: Part 1|Adverse Event|0|||
94596936|NCT00830869|323987687|FG001|Period 1: Part 1|Adverse Event|0|||
94596937|NCT00830869|323987688|FG002|Period 1: Part 1|Adverse Event|0|||
94596938|NCT00830869|323987689|FG003|Period 1: Part 1|Adverse Event|0|||
94596939|NCT00830869|323987690|FG004|Period 1: Part 1|Adverse Event|0|||
94596940|NCT00830869|323987691|FG005|Period 1: Part 1|Adverse Event|1|||
94596941|NCT00830869|323987692|FG006|Period 1: Part 1|Adverse Event|1|||
94596942|NCT00830869|323987693|FG007|Period 1: Part 1|Adverse Event|0|||
94596943|NCT00830869|323987694|FG008|Period 1: Part 1|Adverse Event|0|||
94596944|NCT00830869|323987695|FG009|Period 1: Part 1|Adverse Event|0|||
94596945|NCT00830869|323987696|FG010|Period 1: Part 1|Adverse Event|0|||
94596946|NCT00830869|323987697|FG011|Period 1: Part 1|Adverse Event|0|||
94596947|NCT00830869|323987686|FG000|Period 1: Part 1|Progressive disease|1|||
94596948|NCT00830869|323987687|FG001|Period 1: Part 1|Progressive disease|0|||
94596949|NCT00830869|323987688|FG002|Period 1: Part 1|Progressive disease|1|||
94596950|NCT00830869|323987689|FG003|Period 1: Part 1|Progressive disease|6|||
94596951|NCT00830869|323987690|FG004|Period 1: Part 1|Progressive disease|4|||
94596952|NCT00830869|323987691|FG005|Period 1: Part 1|Progressive disease|4|||
94596953|NCT00830869|323987692|FG006|Period 1: Part 1|Progressive disease|1|||
94596954|NCT00830869|323987693|FG007|Period 1: Part 1|Progressive disease|0|||
94596955|NCT00830869|323987694|FG008|Period 1: Part 1|Progressive disease|0|||
94596956|NCT00830869|323987695|FG009|Period 1: Part 1|Progressive disease|0|||
94596957|NCT00830869|323987696|FG010|Period 1: Part 1|Progressive disease|0|||
94596958|NCT00830869|323987697|FG011|Period 1: Part 1|Progressive disease|0|||
94596959|NCT00830869|323987686|FG000|Period 2: Part 2|Protocol Violation|0|||
94596960|NCT00830869|323987687|FG001|Period 2: Part 2|Protocol Violation|0|||
94596961|NCT00830869|323987688|FG002|Period 2: Part 2|Protocol Violation|0|||
94596962|NCT00830869|323987689|FG003|Period 2: Part 2|Protocol Violation|0|||
94596963|NCT00830869|323987690|FG004|Period 2: Part 2|Protocol Violation|0|||
94596964|NCT00830869|323987691|FG005|Period 2: Part 2|Protocol Violation|0|||
94596965|NCT00830869|323987692|FG006|Period 2: Part 2|Protocol Violation|0|||
94596966|NCT00830869|323987693|FG007|Period 2: Part 2|Protocol Violation|1|||
94596967|NCT00830869|323987694|FG008|Period 2: Part 2|Protocol Violation|0|||
94596968|NCT00830869|323987695|FG009|Period 2: Part 2|Protocol Violation|1|||
94596969|NCT00830869|323987696|FG010|Period 2: Part 2|Protocol Violation|0|||
94596970|NCT00830869|323987697|FG011|Period 2: Part 2|Protocol Violation|0|||
94596971|NCT00830869|323987686|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
94596972|NCT00830869|323987687|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
94596973|NCT00830869|323987688|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
94596974|NCT00830869|323987689|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
94596975|NCT00830869|323987690|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
94596976|NCT00830869|323987691|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
94596977|NCT00830869|323987692|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
94596978|NCT00830869|323987693|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
94596979|NCT00830869|323987694|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
94596980|NCT00830869|323987695|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
94596981|NCT00830869|323987696|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
94596982|NCT00830869|323987697|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
94596983|NCT00830869|323987686|FG000|Period 2: Part 2|Adverse Event|0|||
94596984|NCT00830869|323987687|FG001|Period 2: Part 2|Adverse Event|0|||
94596985|NCT00830869|323987688|FG002|Period 2: Part 2|Adverse Event|0|||
94596986|NCT00830869|323987689|FG003|Period 2: Part 2|Adverse Event|0|||
94596987|NCT00830869|323987690|FG004|Period 2: Part 2|Adverse Event|0|||
94596988|NCT00830869|323987691|FG005|Period 2: Part 2|Adverse Event|0|||
94596989|NCT00830869|323987692|FG006|Period 2: Part 2|Adverse Event|0|||
94596990|NCT00830869|323987693|FG007|Period 2: Part 2|Adverse Event|4|||
94596991|NCT00830869|323987694|FG008|Period 2: Part 2|Adverse Event|3|||
94596992|NCT00830869|323987695|FG009|Period 2: Part 2|Adverse Event|2|||
94596993|NCT00830869|323987696|FG010|Period 2: Part 2|Adverse Event|2|||
94596994|NCT00830869|323987697|FG011|Period 2: Part 2|Adverse Event|0|||
94596995|NCT00830869|323987686|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
94596996|NCT00830869|323987687|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
94596997|NCT00830869|323987688|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
94596998|NCT00830869|323987689|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
94596999|NCT00830869|323987690|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
94597000|NCT00830869|323987691|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
94597001|NCT00830869|323987692|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
94597002|NCT00830869|323987693|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
94597003|NCT00830869|323987694|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
94597004|NCT00830869|323987695|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
94597005|NCT00830869|323987696|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
94597006|NCT00830869|323987697|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
94597007|NCT00830869|323987686|FG000|Period 2: Part 2|Progressive disease|0|||
94597008|NCT00830869|323987687|FG001|Period 2: Part 2|Progressive disease|0|||
94597009|NCT00830869|323987688|FG002|Period 2: Part 2|Progressive disease|0|||
94597010|NCT00830869|323987689|FG003|Period 2: Part 2|Progressive disease|0|||
94597011|NCT00830869|323987690|FG004|Period 2: Part 2|Progressive disease|0|||
94597012|NCT00830869|323987691|FG005|Period 2: Part 2|Progressive disease|0|||
94597013|NCT00830869|323987692|FG006|Period 2: Part 2|Progressive disease|0|||
94597014|NCT00830869|323987693|FG007|Period 2: Part 2|Progressive disease|14|||
94597015|NCT00830869|323987694|FG008|Period 2: Part 2|Progressive disease|11|||
94597016|NCT00830869|323987695|FG009|Period 2: Part 2|Progressive disease|12|||
94597017|NCT00830869|323987696|FG010|Period 2: Part 2|Progressive disease|8|||
94597018|NCT00830869|323987697|FG011|Period 2: Part 2|Progressive disease|15|||
94597019|NCT00830869|323987686|FG000|Period 2: Part 2|Other|0|||
94597020|NCT00830869|323987687|FG001|Period 2: Part 2|Other|0|||
94597021|NCT00830869|323987688|FG002|Period 2: Part 2|Other|0|||
94597022|NCT00830869|323987689|FG003|Period 2: Part 2|Other|0|||
94597023|NCT00830869|323987690|FG004|Period 2: Part 2|Other|0|||
94597024|NCT00830869|323987691|FG005|Period 2: Part 2|Other|0|||
94597025|NCT00830869|323987692|FG006|Period 2: Part 2|Other|0|||
94597026|NCT00830869|323987693|FG007|Period 2: Part 2|Other|0|||
94597027|NCT00830869|323987694|FG008|Period 2: Part 2|Other|0|||
94597028|NCT00830869|323987695|FG009|Period 2: Part 2|Other|1|||
94597029|NCT00830869|323987696|FG010|Period 2: Part 2|Other|0|||
94597030|NCT00830869|323987697|FG011|Period 2: Part 2|Other|0|||
94597031|NCT00877773|323987698|FG000|Overall Study|Disease Progression|44|||
94597032|NCT00617669|323987699|FG000|Overall Study|Withdrawal by Subject|71|||
94597033|NCT00617669|323987700|FG001|Overall Study|Withdrawal by Subject|77|||
94597034|NCT00617669|323987699|FG000|Overall Study|Lost to Follow-up|3|||
94597035|NCT00617669|323987700|FG001|Overall Study|Lost to Follow-up|2|||
94597036|NCT00617669|323987699|FG000|Overall Study|Adverse Event|87|||
94597037|NCT00617669|323987700|FG001|Overall Study|Adverse Event|76|||
94597038|NCT00617669|323987699|FG000|Overall Study|Protocol Violation|2|||
94597039|NCT00617669|323987700|FG001|Overall Study|Protocol Violation|3|||
94597040|NCT00617669|323987699|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
94597041|NCT00617669|323987700|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
94597042|NCT00617669|323987699|FG000|Overall Study|Patients randomized but not treated|2|||
94597043|NCT00617669|323987700|FG001|Overall Study|Patients randomized but not treated|3|||
94597044|NCT02446171|323987701|FG000|Overall Study|Withdrawal by Subject|0|||
94597045|NCT02446171|323987702|FG001|Overall Study|Withdrawal by Subject|0|||
94597046|NCT02446171|323987703|FG002|Overall Study|Withdrawal by Subject|2|||
94597047|NCT02446171|323987704|FG003|Overall Study|Withdrawal by Subject|0|||
94597048|NCT00003472|323987705|FG000|Overall Study|Not evaluable|3|||
94597049|NCT01964755|323987706|FG000|Overall Study|Death|2|||
94597050|NCT01012219|323987707|FG000|Period 1|Withdrawal by Subject|1|||
94597051|NCT01012219|323987707|FG000|Period 2|Withdrawal by Subject|1|||
94597052|NCT00883688|323987708|FG000|Overall Study|Ineligible|2|||
94597053|NCT01659554|323987709|FG000|Overall Study|Study Termination|4|||
94597054|NCT03467152|323987712|FG000|Overall Study|Adverse Event|4|||
94597055|NCT03467152|323987713|FG001|Overall Study|Adverse Event|5|||
94597056|NCT03467152|323987714|FG002|Overall Study|Adverse Event|0|||
94597057|NCT03467152|323987712|FG000|Overall Study|Subject Choice|1|||
94597058|NCT03467152|323987713|FG001|Overall Study|Subject Choice|3|||
94597059|NCT03467152|323987714|FG002|Overall Study|Subject Choice|0|||
94597060|NCT03467152|323987712|FG000|Overall Study|Lost to Follow-up|1|||
94597061|NCT03467152|323987713|FG001|Overall Study|Lost to Follow-up|0|||
94597062|NCT03467152|323987714|FG002|Overall Study|Lost to Follow-up|0|||
94597063|NCT03467152|323987712|FG000|Overall Study|Withdrawal by Subject|4|||
94597064|NCT03467152|323987713|FG001|Overall Study|Withdrawal by Subject|2|||
94597065|NCT03467152|323987714|FG002|Overall Study|Withdrawal by Subject|0|||
94457630|NCT01992653|323463606|FG003|Overall Study|Study Completed|0|||
94457631|NCT01992653|323463607|FG004|Overall Study|Study Completed|0|||
94457632|NCT01992653|323463608|FG005|Overall Study|Study Completed|0|||
94457633|NCT01992653|323463609|FG006|Overall Study|Study Completed|0|||
94457634|NCT01992653|323463610|FG007|Overall Study|Study Completed|1|||
94457635|NCT01992653|323463603|FG000|Overall Study|Disease Progression|0|||
94457636|NCT01992653|323463604|FG001|Overall Study|Disease Progression|0|||
94457637|NCT01992653|323463605|FG002|Overall Study|Disease Progression|0|||
94457638|NCT01992653|323463606|FG003|Overall Study|Disease Progression|0|||
94457639|NCT01992653|323463607|FG004|Overall Study|Disease Progression|0|||
94457640|NCT01992653|323463608|FG005|Overall Study|Disease Progression|0|||
94457641|NCT01992653|323463609|FG006|Overall Study|Disease Progression|4|||
94457642|NCT01992653|323463610|FG007|Overall Study|Disease Progression|0|||
94457643|NCT02847494|323463615|FG000|Overall Study|Lost to Follow-up|8|||
94457644|NCT02847494|323463616|FG001|Overall Study|Lost to Follow-up|5|||
94457645|NCT00125242|323463617|FG000|Overall Study|did not qualify|7|||
94457646|NCT00125242|323463618|FG001|Overall Study|did not qualify|2|||
94457647|NCT00957268|323463622|FG000|Overall Study|Voluntary Withdrawal|0|||
94457648|NCT00957268|323463623|FG001|Overall Study|Voluntary Withdrawal|0|||
94457649|NCT00957268|323463624|FG002|Overall Study|Voluntary Withdrawal|1|||
94457650|NCT00957268|323463625|FG003|Overall Study|Voluntary Withdrawal|0|||
94457651|NCT00957268|323463626|FG004|Overall Study|Voluntary Withdrawal|0|||
94457652|NCT00794040|323463627|FG000|Overall Study|Withdrawal by Subject|3|||
94457653|NCT00794040|323463628|FG001|Overall Study|Withdrawal by Subject|4|||
94457654|NCT00794040|323463627|FG000|Overall Study|Physician Decision|0|||
94457655|NCT00794040|323463628|FG001|Overall Study|Physician Decision|1|||
94457656|NCT01340027|323463631|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
94457657|NCT01340027|323463632|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
94457658|NCT01340027|323463633|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
94457659|NCT01340027|323463634|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
94457660|NCT01340027|323463635|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
94457661|NCT01340027|323463636|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
94457662|NCT01340027|323463637|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
94457663|NCT01340027|323463638|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
94457664|NCT01340027|323463639|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
94457665|NCT01340027|323463640|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
94457666|NCT01340027|323463641|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
94457667|NCT01340027|323463642|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
94457668|NCT01340027|323463631|FG000|Overall Study|Adverse Event|0|||
94457669|NCT01340027|323463632|FG001|Overall Study|Adverse Event|1|||
94457670|NCT01340027|323463633|FG002|Overall Study|Adverse Event|2|||
94457671|NCT01340027|323463634|FG003|Overall Study|Adverse Event|0|||
94457672|NCT01340027|323463635|FG004|Overall Study|Adverse Event|1|||
94457673|NCT01340027|323463636|FG005|Overall Study|Adverse Event|2|||
94457674|NCT01340027|323463637|FG006|Overall Study|Adverse Event|2|||
94457675|NCT01340027|323463638|FG007|Overall Study|Adverse Event|1|||
94457676|NCT01340027|323463639|FG008|Overall Study|Adverse Event|4|||
94457677|NCT01340027|323463640|FG009|Overall Study|Adverse Event|1|||
94457678|NCT01340027|323463641|FG010|Overall Study|Adverse Event|1|||
94457679|NCT01340027|323463642|FG011|Overall Study|Adverse Event|3|||
94457680|NCT01340027|323463631|FG000|Overall Study|Lack of Efficacy|0|||
94457681|NCT01340027|323463632|FG001|Overall Study|Lack of Efficacy|0|||
94457682|NCT01340027|323463633|FG002|Overall Study|Lack of Efficacy|0|||
94457683|NCT01340027|323463634|FG003|Overall Study|Lack of Efficacy|0|||
94457684|NCT01340027|323463635|FG004|Overall Study|Lack of Efficacy|0|||
94457685|NCT01340027|323463636|FG005|Overall Study|Lack of Efficacy|0|||
94457686|NCT01340027|323463637|FG006|Overall Study|Lack of Efficacy|1|||
94457687|NCT01340027|323463638|FG007|Overall Study|Lack of Efficacy|1|||
94457688|NCT01340027|323463639|FG008|Overall Study|Lack of Efficacy|1|||
94457689|NCT01340027|323463640|FG009|Overall Study|Lack of Efficacy|0|||
94457690|NCT01340027|323463641|FG010|Overall Study|Lack of Efficacy|0|||
94457691|NCT01340027|323463642|FG011|Overall Study|Lack of Efficacy|0|||
94457692|NCT01340027|323463631|FG000|Overall Study|Lost to Follow-up|0|||
94457693|NCT01340027|323463632|FG001|Overall Study|Lost to Follow-up|1|||
94457694|NCT01340027|323463633|FG002|Overall Study|Lost to Follow-up|0|||
94457695|NCT01340027|323463634|FG003|Overall Study|Lost to Follow-up|0|||
94457696|NCT01340027|323463635|FG004|Overall Study|Lost to Follow-up|0|||
94457697|NCT01340027|323463636|FG005|Overall Study|Lost to Follow-up|0|||
94457698|NCT01340027|323463637|FG006|Overall Study|Lost to Follow-up|1|||
94457699|NCT01340027|323463638|FG007|Overall Study|Lost to Follow-up|0|||
94457700|NCT01340027|323463639|FG008|Overall Study|Lost to Follow-up|0|||
94457701|NCT01340027|323463640|FG009|Overall Study|Lost to Follow-up|1|||
94457702|NCT01340027|323463641|FG010|Overall Study|Lost to Follow-up|0|||
94457703|NCT01340027|323463642|FG011|Overall Study|Lost to Follow-up|0|||
94597066|NCT03467152|323987712|FG000|Overall Study|Others|3|||
94597067|NCT03467152|323987713|FG001|Overall Study|Others|0|||
94597068|NCT03467152|323987714|FG002|Overall Study|Others|0|||
94597069|NCT03467152|323987712|FG000|Overall Study|Not treated|3|||
94597070|NCT03467152|323987713|FG001|Overall Study|Not treated|1|||
94597071|NCT03467152|323987714|FG002|Overall Study|Not treated|6|||
94597072|NCT04250077|323987715|FG000|Overall Study|Withdrawal by Subject|0|||
94597073|NCT04250077|323987716|FG001|Overall Study|Withdrawal by Subject|1|||
94597074|NCT04250077|323987717|FG002|Overall Study|Withdrawal by Subject|0|||
94597075|NCT04250077|323987715|FG000|Overall Study|Lost to Follow-up|2|||
94597076|NCT04250077|323987716|FG001|Overall Study|Lost to Follow-up|3|||
94597077|NCT04250077|323987717|FG002|Overall Study|Lost to Follow-up|0|||
94597078|NCT01328366|323987718|FG000|Overall Study|Death|1|||
94597079|NCT01328366|323987718|FG000|Overall Study|Withdrawal by Subject|2|||
94597080|NCT01328366|323987718|FG000|Overall Study|Lost to Follow-up|7|||
94597081|NCT00097981|323987719|FG000|Overall Study|Adverse Event|31|||
94597082|NCT00097981|323987720|FG001|Overall Study|Adverse Event|44|||
94597083|NCT00097981|323987719|FG000|Overall Study|Withdrawal by Subject|10|||
94597084|NCT00097981|323987720|FG001|Overall Study|Withdrawal by Subject|8|||
94597085|NCT00097981|323987719|FG000|Overall Study|Protocol Violation|1|||
94597086|NCT00097981|323987720|FG001|Overall Study|Protocol Violation|1|||
94597087|NCT00097981|323987719|FG000|Overall Study|Death|2|||
94597088|NCT00097981|323987720|FG001|Overall Study|Death|4|||
94597089|NCT00097981|323987719|FG000|Overall Study|Physician Decision|7|||
94597090|NCT00097981|323987720|FG001|Overall Study|Physician Decision|1|||
94597091|NCT00097981|323987719|FG000|Overall Study|Disease Progression|8|||
94597092|NCT00097981|323987720|FG001|Overall Study|Disease Progression|2|||
94597093|NCT00097981|323987719|FG000|Overall Study|Transplant planned|28|||
94597094|NCT00097981|323987720|FG001|Overall Study|Transplant planned|27|||
94597095|NCT00097981|323987719|FG000|Overall Study|Other|19|||
94597096|NCT00097981|323987720|FG001|Overall Study|Other|13|||
94597097|NCT04140227|323987721|FG000|Overall Study|Withdrawal by Subject|26|||
94597098|NCT04140227|323987721|FG000|Overall Study|Lost to Follow-up|8|||
94597099|NCT04140227|323987721|FG000|Overall Study|Adverse Event|8|||
94597100|NCT04140227|323987721|FG000|Overall Study|Death|1|||
94597101|NCT04140227|323987721|FG000|Overall Study|Other|3|||
94597102|NCT04140227|323987721|FG000|Overall Study|Protocol Violation|2|||
94597103|NCT00917644|323987724|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
94597104|NCT00917644|323987725|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
94597105|NCT00917644|323987724|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
94597106|NCT00917644|323987725|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
94597107|NCT00917644|323987724|FG000|Period 2: Second Intervention|family emergency|1|||
94597108|NCT00917644|323987725|FG001|Period 2: Second Intervention|family emergency|0|||
94597109|NCT02338232|323987726|FG000|Overall Study|Screen Failure|3|||
94597110|NCT02338232|323987726|FG000|Overall Study|Withdrawal by Subject|6|||
94597111|NCT02338232|323987726|FG000|Overall Study|Adverse Event|2|||
94597112|NCT02500056|323987727|FG000|Overall Study|Lost to Follow-up|3|||
94597113|NCT02500056|323987728|FG001|Overall Study|Lost to Follow-up|7|||
94597114|NCT02500056|323987727|FG000|Overall Study|Recurrence|1|||
94597115|NCT02500056|323987728|FG001|Overall Study|Recurrence|0|||
94597116|NCT02500056|323987727|FG000|Overall Study|Death|3|||
94597117|NCT02500056|323987728|FG001|Overall Study|Death|1|||
94597118|NCT00864916|323987729|FG000|Overall Study|Lost to Follow-up|4|||
94597119|NCT00864916|323987730|FG001|Overall Study|Lost to Follow-up|4|||
94597120|NCT00864916|323987729|FG000|Overall Study|Protocol Violation|1|||
94597121|NCT00864916|323987730|FG001|Overall Study|Protocol Violation|0|||
94597122|NCT00864916|323987729|FG000|Overall Study|Withdrawal by Subject|1|||
94597123|NCT00864916|323987730|FG001|Overall Study|Withdrawal by Subject|0|||
94597124|NCT01087736|323987733|FG000|Overall Study|Lost to Follow-up|1|||
94597125|NCT01087736|323987734|FG001|Overall Study|Lost to Follow-up|0|||
94597126|NCT01087736|323987733|FG000|Overall Study|Death|0|||
94597127|NCT01087736|323987734|FG001|Overall Study|Death|1|||
94597128|NCT01087736|323987733|FG000|Overall Study|Withdrawal by Subject|0|||
94597129|NCT01087736|323987734|FG001|Overall Study|Withdrawal by Subject|1|||
94597130|NCT01253811|323987735|FG000|Overall Study|Withdrawal criteria|1|||
94597131|NCT01395784|323987736|FG000|Overall Study|Lost to Follow-up|7|||
94597132|NCT01395784|323987736|FG000|Overall Study|Withdrawal by Subject|3|||
94597133|NCT01395784|323987736|FG000|Overall Study|Physician Decision|5|||
94597134|NCT03774823|323987737|FG000|Overall Study|Withdrawal by Subject|1|||
94597135|NCT03774823|323987738|FG001|Overall Study|Withdrawal by Subject|1|||
94597136|NCT03996369|323987744|FG000|Overall Study|Protocol deviation|1|||
94597137|NCT03996369|323987745|FG001|Overall Study|Protocol deviation|1|||
94597138|NCT03996369|323987744|FG000|Overall Study|Physician Decision|4|||
94597139|NCT03996369|323987745|FG001|Overall Study|Physician Decision|2|||
94597140|NCT03996369|323987744|FG000|Overall Study|Participant decision|0|||
94597141|NCT03996369|323987745|FG001|Overall Study|Participant decision|1|||
94597142|NCT03996369|323987744|FG000|Overall Study|Lack of Efficacy|4|||
94660385|NCT02055352|324211636|FG000|Overall Study|Non-eligible|0|||
94597143|NCT03996369|323987745|FG001|Overall Study|Lack of Efficacy|0|||
94597144|NCT03996369|323987744|FG000|Overall Study|Adverse Event|9|||
94597145|NCT03996369|323987745|FG001|Overall Study|Adverse Event|0|||
94597146|NCT03996369|323987744|FG000|Overall Study|Withdrawal by Subject|6|||
94597147|NCT03996369|323987745|FG001|Overall Study|Withdrawal by Subject|8|||
94597148|NCT03996369|323987744|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
94597149|NCT03996369|323987745|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
94597150|NCT03996369|323987744|FG000|Overall Study|Lost to Follow-up|0|||
94597151|NCT03996369|323987745|FG001|Overall Study|Lost to Follow-up|1|||
94597152|NCT01579812|323987748|FG000|Overall Study|Ineligible after treatment start|40|||
94597153|NCT01579812|323987748|FG000|Overall Study|Patient choice|3|||
94597154|NCT01579812|323987748|FG000|Overall Study|Noncompliance|3|||
94597155|NCT01579812|323987748|FG000|Overall Study|Withdrawal by Subject|6|||
94597156|NCT01133990|323987749|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
94597157|NCT01133990|323987750|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
94597158|NCT01133990|323987751|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
94597159|NCT01133990|323987752|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
94597160|NCT01133990|323987753|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
94597161|NCT01133990|323987754|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
94597162|NCT01133990|323987749|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
94597163|NCT01133990|323987750|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
94597164|NCT01133990|323987751|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
94597165|NCT01133990|323987752|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
94597166|NCT01133990|323987753|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
94597167|NCT01133990|323987754|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
94597168|NCT01133990|323987749|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
94597169|NCT01133990|323987750|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
94597170|NCT01133990|323987751|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
94597171|NCT01133990|323987752|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
94597172|NCT01133990|323987753|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
94597173|NCT01133990|323987754|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
94597174|NCT01133990|323987749|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
94597175|NCT01133990|323987750|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
94597176|NCT01133990|323987751|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
94597177|NCT01133990|323987752|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
94597178|NCT01133990|323987753|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
94597179|NCT01133990|323987754|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
94597180|NCT02282345|323987759|FG000|Overall Study|Progression|0|||
94597181|NCT02282345|323987760|FG001|Overall Study|Progression|1|||
94597182|NCT01185301|323987761|FG000|Overall Study|Adverse Event|3|||
94597183|NCT01185301|323987762|FG001|Overall Study|Adverse Event|0|||
94597184|NCT01185301|323987763|FG002|Overall Study|Adverse Event|2|||
94597185|NCT01185301|323987764|FG003|Overall Study|Adverse Event|3|||
94597186|NCT01185301|323987761|FG000|Overall Study|Withdrawal by Subject|7|||
94597187|NCT01185301|323987762|FG001|Overall Study|Withdrawal by Subject|5|||
94597188|NCT01185301|323987763|FG002|Overall Study|Withdrawal by Subject|2|||
94597189|NCT01185301|323987764|FG003|Overall Study|Withdrawal by Subject|3|||
94597190|NCT01185301|323987761|FG000|Overall Study|Lost to Follow-up|2|||
94597191|NCT01185301|323987762|FG001|Overall Study|Lost to Follow-up|0|||
94597192|NCT01185301|323987763|FG002|Overall Study|Lost to Follow-up|0|||
94597193|NCT01185301|323987764|FG003|Overall Study|Lost to Follow-up|1|||
94597194|NCT01185301|323987761|FG000|Overall Study|Other Reason|3|||
94597195|NCT01185301|323987762|FG001|Overall Study|Other Reason|2|||
94597196|NCT01185301|323987763|FG002|Overall Study|Other Reason|2|||
94597197|NCT01185301|323987764|FG003|Overall Study|Other Reason|2|||
94597198|NCT02946931|323987769|FG000|Overall Study|Did not require collection of CRFs|588|||
94597199|NCT02946931|323987769|FG000|Overall Study|Other than listed|37|||
94597200|NCT02946931|323987769|FG000|Overall Study|Discharge from hospital|118|||
94597201|NCT02946931|323987769|FG000|Overall Study|Adverse Event|81|||
94597202|NCT02946931|323987769|FG000|Overall Study|CRFs not valid|1|||
94597203|NCT02946931|323987769|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
94597204|NCT02108262|323987770|FG000|Overall Study|Non-compliance|0|||
94247319|NCT00166712|322701058|FG000|Overall Study|Withdrawal by Subject|1|||
94247320|NCT00166712|322701059|FG001|Overall Study|Withdrawal by Subject|2|||
94597205|NCT02108262|323987771|FG001|Overall Study|Non-compliance|2|||
94247321|NCT00166712|322701058|FG000|Overall Study|Physician Decision|0|||
94247322|NCT00166712|322701059|FG001|Overall Study|Physician Decision|2|||
94597206|NCT02108262|323987772|FG002|Overall Study|Non-compliance|1|||
94597207|NCT02108262|323987773|FG003|Overall Study|Non-compliance|1|||
94597208|NCT02108262|323987770|FG000|Overall Study|Randomized by error/screen failure|0|||
94597209|NCT02108262|323987771|FG001|Overall Study|Randomized by error/screen failure|0|||
94597210|NCT02108262|323987772|FG002|Overall Study|Randomized by error/screen failure|1|||
94597211|NCT02108262|323987773|FG003|Overall Study|Randomized by error/screen failure|0|||
94597212|NCT02108262|323987770|FG000|Overall Study|Distance to center|0|||
94597213|NCT02108262|323987771|FG001|Overall Study|Distance to center|1|||
94597214|NCT02108262|323987772|FG002|Overall Study|Distance to center|1|||
94597215|NCT02108262|323987773|FG003|Overall Study|Distance to center|0|||
94597216|NCT02108262|323987770|FG000|Overall Study|Adverse Event|0|||
94597217|NCT02108262|323987771|FG001|Overall Study|Adverse Event|11|||
94597218|NCT02108262|323987772|FG002|Overall Study|Adverse Event|6|||
94597219|NCT02108262|323987773|FG003|Overall Study|Adverse Event|12|||
94597220|NCT02108262|323987770|FG000|Overall Study|Death|0|||
94597221|NCT02108262|323987771|FG001|Overall Study|Death|2|||
94597222|NCT02108262|323987772|FG002|Overall Study|Death|2|||
94247323|NCT02075476|322701062|FG000|Overall Study|Death|2|||
94355942|NCT01519700|323085738|FG001|Overall Study|Lost to Follow-up|0|||
94355943|NCT01519700|323085739|FG002|Overall Study|Lost to Follow-up|1|||
94355944|NCT01519700|323085740|FG003|Overall Study|Lost to Follow-up|1|||
94355945|NCT01519700|323085737|FG000|Overall Study|Physician Decision|1|||
94355946|NCT01519700|323085738|FG001|Overall Study|Physician Decision|1|||
94355947|NCT01519700|323085739|FG002|Overall Study|Physician Decision|3|||
94355948|NCT01519700|323085740|FG003|Overall Study|Physician Decision|0|||
94355949|NCT01519700|323085737|FG000|Overall Study|Withdrawal by Subject|5|||
94355950|NCT01519700|323085738|FG001|Overall Study|Withdrawal by Subject|3|||
94355951|NCT01519700|323085739|FG002|Overall Study|Withdrawal by Subject|3|||
94355952|NCT01519700|323085740|FG003|Overall Study|Withdrawal by Subject|2|||
94355953|NCT01519700|323085737|FG000|Overall Study|Other Reason|2|||
94355954|NCT01519700|323085738|FG001|Overall Study|Other Reason|2|||
94247324|NCT02075476|322701063|FG001|Overall Study|Death|2|||
94247325|NCT02075476|322701062|FG000|Overall Study|Lost to Follow-up|1|||
94247326|NCT02075476|322701063|FG001|Overall Study|Lost to Follow-up|3|||
94597223|NCT02108262|323987773|FG003|Overall Study|Death|1|||
94597224|NCT02108262|323987770|FG000|Overall Study|Lost to Follow-up|0|||
94247327|NCT00503139|322701064|FG000|Overall Study|Case Report Forms were not collected|4|||
94247328|NCT00503139|322701064|FG000|Overall Study|Protocol Violation|4|||
94247329|NCT01142232|322701073|FG000|Overall Study|Adverse Event|1|||
94247330|NCT01142232|322701074|FG001|Overall Study|Adverse Event|2|||
94247331|NCT01142232|322701075|FG002|Overall Study|Adverse Event|1|||
94247332|NCT01142232|322701076|FG003|Overall Study|Adverse Event|0|||
94247333|NCT01142232|322701077|FG004|Overall Study|Adverse Event|4|||
94355955|NCT01519700|323085739|FG002|Overall Study|Other Reason|0|||
94355956|NCT01519700|323085740|FG003|Overall Study|Other Reason|4|||
94355957|NCT00346775|323085741|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
94457704|NCT01340027|323463631|FG000|Overall Study|Protocol Violation|1|||
94457705|NCT01340027|323463632|FG001|Overall Study|Protocol Violation|2|||
94457706|NCT01340027|323463633|FG002|Overall Study|Protocol Violation|0|||
94457707|NCT01340027|323463634|FG003|Overall Study|Protocol Violation|0|||
94457708|NCT01340027|323463635|FG004|Overall Study|Protocol Violation|6|||
94457709|NCT01340027|323463636|FG005|Overall Study|Protocol Violation|0|||
94457710|NCT01340027|323463637|FG006|Overall Study|Protocol Violation|0|||
94457711|NCT01340027|323463638|FG007|Overall Study|Protocol Violation|1|||
94457712|NCT01340027|323463639|FG008|Overall Study|Protocol Violation|2|||
94457713|NCT01340027|323463640|FG009|Overall Study|Protocol Violation|2|||
94457714|NCT01340027|323463641|FG010|Overall Study|Protocol Violation|0|||
94457715|NCT01340027|323463642|FG011|Overall Study|Protocol Violation|0|||
94457716|NCT01340027|323463631|FG000|Overall Study|Withdrawal by Subject|4|||
94457717|NCT01340027|323463632|FG001|Overall Study|Withdrawal by Subject|3|||
94457718|NCT01340027|323463633|FG002|Overall Study|Withdrawal by Subject|1|||
94457719|NCT01340027|323463634|FG003|Overall Study|Withdrawal by Subject|3|||
94457720|NCT01340027|323463635|FG004|Overall Study|Withdrawal by Subject|3|||
94457721|NCT01340027|323463636|FG005|Overall Study|Withdrawal by Subject|2|||
94457722|NCT01340027|323463637|FG006|Overall Study|Withdrawal by Subject|3|||
94457723|NCT01340027|323463638|FG007|Overall Study|Withdrawal by Subject|4|||
94457724|NCT01340027|323463639|FG008|Overall Study|Withdrawal by Subject|1|||
94457725|NCT01340027|323463640|FG009|Overall Study|Withdrawal by Subject|2|||
94457726|NCT01340027|323463641|FG010|Overall Study|Withdrawal by Subject|0|||
94457727|NCT01340027|323463642|FG011|Overall Study|Withdrawal by Subject|1|||
94457728|NCT01340027|323463631|FG000|Overall Study|Miscellaneous|0|||
94457729|NCT01340027|323463632|FG001|Overall Study|Miscellaneous|0|||
94457730|NCT01340027|323463633|FG002|Overall Study|Miscellaneous|0|||
94597225|NCT02108262|323987771|FG001|Overall Study|Lost to Follow-up|0|||
94247334|NCT01142232|322701073|FG000|Overall Study|Death|0|||
94247335|NCT01142232|322701074|FG001|Overall Study|Death|0|||
94247336|NCT01142232|322701075|FG002|Overall Study|Death|0|||
94355958|NCT00346775|323085742|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
94355959|NCT00346775|323085741|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
94355960|NCT00346775|323085742|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
94457731|NCT01340027|323463634|FG003|Overall Study|Miscellaneous|1|||
94457732|NCT01340027|323463635|FG004|Overall Study|Miscellaneous|0|||
94457733|NCT01340027|323463636|FG005|Overall Study|Miscellaneous|0|||
94457734|NCT01340027|323463637|FG006|Overall Study|Miscellaneous|0|||
94457735|NCT01340027|323463638|FG007|Overall Study|Miscellaneous|0|||
94597226|NCT02108262|323987772|FG002|Overall Study|Lost to Follow-up|1|||
94597227|NCT02108262|323987773|FG003|Overall Study|Lost to Follow-up|0|||
94597228|NCT02108262|323987770|FG000|Overall Study|Physician Decision|0|||
94597229|NCT02108262|323987771|FG001|Overall Study|Physician Decision|0|||
94660386|NCT02055352|324211637|FG001|Overall Study|Non-eligible|1|||
94660387|NCT02055352|324211636|FG000|Overall Study|Poor compliance|1|||
94660388|NCT02055352|324211637|FG001|Overall Study|Poor compliance|1|||
94660389|NCT02055352|324211636|FG000|Overall Study|Death|1|||
94660390|NCT02055352|324211637|FG001|Overall Study|Death|2|||
94660391|NCT02055352|324211636|FG000|Overall Study|Patient decision|1|||
94660392|NCT02055352|324211637|FG001|Overall Study|Patient decision|1|||
94660393|NCT02055352|324211636|FG000|Overall Study|Use of prohibited treatment|0|||
94660394|NCT02055352|324211637|FG001|Overall Study|Use of prohibited treatment|3|||
94660395|NCT02055352|324211636|FG000|Overall Study|AE, study drug would be detrimental|1|||
94660396|NCT02055352|324211637|FG001|Overall Study|AE, study drug would be detrimental|3|||
94660397|NCT02055352|324211636|FG000|Overall Study|Withdrawal of informed consent|1|||
94660398|NCT02055352|324211637|FG001|Overall Study|Withdrawal of informed consent|0|||
94660399|NCT02055352|324211636|FG000|Overall Study|Reason unknown|1|||
94660400|NCT02055352|324211637|FG001|Overall Study|Reason unknown|5|||
94660401|NCT00524134|324211638|FG000|Overall Study|Withdrawal by Subject|1|||
94660402|NCT00524134|324211638|FG000|Overall Study|Physician Decision|1|||
94660403|NCT00970502|324211647|FG000|Overall Study|Withdrawal by Subject|1|||
94660404|NCT03811912|324211648|FG000|Overall Study|Withdrew Consent|4|||
94660405|NCT03811912|324211649|FG001|Overall Study|Withdrew Consent|2|||
94660406|NCT04401579|324211650|FG000|Overall Study|Death|23|||
94660407|NCT04401579|324211651|FG001|Overall Study|Death|36|||
94660408|NCT04401579|324211650|FG000|Overall Study|Lost to Follow-up|40|||
94660409|NCT04401579|324211651|FG001|Overall Study|Lost to Follow-up|41|||
94660410|NCT04401579|324211650|FG000|Overall Study|Withdrawal by Subject|8|||
94247337|NCT01142232|322701076|FG003|Overall Study|Death|0|||
94457736|NCT01340027|323463639|FG008|Overall Study|Miscellaneous|0|||
94597230|NCT02108262|323987772|FG002|Overall Study|Physician Decision|2|||
94597231|NCT02108262|323987773|FG003|Overall Study|Physician Decision|0|||
94597232|NCT02108262|323987770|FG000|Overall Study|Withdrawal by Subject|0|||
94597233|NCT02108262|323987771|FG001|Overall Study|Withdrawal by Subject|7|||
94597234|NCT02108262|323987772|FG002|Overall Study|Withdrawal by Subject|3|||
94597235|NCT02108262|323987773|FG003|Overall Study|Withdrawal by Subject|4|||
94597236|NCT02108262|323987770|FG000|Overall Study|Due to key hepatic values|0|||
94597237|NCT02108262|323987771|FG001|Overall Study|Due to key hepatic values|1|||
94597238|NCT02108262|323987772|FG002|Overall Study|Due to key hepatic values|0|||
94597239|NCT02108262|323987773|FG003|Overall Study|Due to key hepatic values|0|||
94597240|NCT02108262|323987770|FG000|Overall Study|Unable to contact patient|0|||
94597241|NCT02108262|323987771|FG001|Overall Study|Unable to contact patient|3|||
94597242|NCT02108262|323987772|FG002|Overall Study|Unable to contact patient|1|||
94597243|NCT02108262|323987773|FG003|Overall Study|Unable to contact patient|2|||
94597244|NCT02108262|323987770|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
94597245|NCT02108262|323987771|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
94597246|NCT02108262|323987772|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
94597247|NCT02108262|323987773|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
94597248|NCT02108262|323987770|FG000|Overall Study|Patient did not want another infusion|0|||
94597249|NCT02108262|323987771|FG001|Overall Study|Patient did not want another infusion|3|||
94597250|NCT02108262|323987772|FG002|Overall Study|Patient did not want another infusion|3|||
94597251|NCT02108262|323987773|FG003|Overall Study|Patient did not want another infusion|2|||
94597252|NCT02108262|323987770|FG000|Overall Study|Vacation|0|||
94597253|NCT02108262|323987771|FG001|Overall Study|Vacation|1|||
94597254|NCT02108262|323987772|FG002|Overall Study|Vacation|0|||
94597255|NCT02108262|323987773|FG003|Overall Study|Vacation|0|||
94597256|NCT02108262|323987770|FG000|Overall Study|Patient decision|0|||
94597257|NCT02108262|323987771|FG001|Overall Study|Patient decision|7|||
94597258|NCT02108262|323987772|FG002|Overall Study|Patient decision|9|||
94597259|NCT02108262|323987773|FG003|Overall Study|Patient decision|14|||
94597260|NCT02108262|323987770|FG000|Overall Study|Missed IV due to pharmacy error|0|||
94597261|NCT02108262|323987771|FG001|Overall Study|Missed IV due to pharmacy error|0|||
94597262|NCT02108262|323987772|FG002|Overall Study|Missed IV due to pharmacy error|1|||
94597263|NCT02108262|323987773|FG003|Overall Study|Missed IV due to pharmacy error|0|||
94597264|NCT03316911|323987774|FG000|Overall Study|Lost to Follow-up|33|||
94597265|NCT03316911|323987775|FG001|Overall Study|Lost to Follow-up|29|||
94597266|NCT00770146|323987785|FG000|Treatment Period|Withdrawal by Subject|6|||
94597267|NCT00770146|323987786|FG001|Treatment Period|Withdrawal by Subject|13|||
94597268|NCT00770146|323987785|FG000|Treatment Period|Adverse Event|2|||
94597269|NCT00770146|323987786|FG001|Treatment Period|Adverse Event|26|||
94597270|NCT00770146|323987785|FG000|Treatment Period|Other|1|||
94597271|NCT00770146|323987786|FG001|Treatment Period|Other|5|||
94660411|NCT04401579|324211651|FG001|Overall Study|Withdrawal by Subject|16|||
94660412|NCT04401579|324211650|FG000|Overall Study|Physician Decision|1|||
94660413|NCT04401579|324211651|FG001|Overall Study|Physician Decision|2|||
94660414|NCT04401579|324211650|FG000|Overall Study|Became ineligible after enrollment|1|||
94660415|NCT04401579|324211651|FG001|Overall Study|Became ineligible after enrollment|1|||
94660416|NCT04401579|324211650|FG000|Overall Study|Enrolled but treatment not administered|7|||
94597272|NCT00770146|323987785|FG000|Treatment Period|Protocol non-compliance|0|||
94597273|NCT00770146|323987786|FG001|Treatment Period|Protocol non-compliance|1|||
94597274|NCT00770146|323987785|FG000|Follow-up Period|Withdrawal by Subject|7|||
94597275|NCT00770146|323987786|FG001|Follow-up Period|Withdrawal by Subject|13|||
94597276|NCT00770146|323987785|FG000|Follow-up Period|Adverse Event|0|||
94597277|NCT00770146|323987786|FG001|Follow-up Period|Adverse Event|2|||
94597278|NCT00770146|323987785|FG000|Follow-up Period|Other|4|||
94597279|NCT00770146|323987786|FG001|Follow-up Period|Other|5|||
94597280|NCT00899353|323987789|FG000|Overall Study|Adverse Event|2|||
94597281|NCT00899353|323987789|FG000|Overall Study|Lost to Follow-up|1|||
94597282|NCT00899353|323987789|FG000|Overall Study|Withdrawal by Subject|2|||
94597283|NCT01284491|323987790|FG000|Overall Study|Study termination|13|||
94597284|NCT01087788|323987794|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
94597285|NCT01087788|323987795|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
94597286|NCT01087788|323987796|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
94597287|NCT01087788|323987794|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
94597288|NCT01087788|323987795|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
94597289|NCT01087788|323987796|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
94597290|NCT01087788|323987794|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
94597291|NCT01087788|323987795|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
94597292|NCT01087788|323987796|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
94597293|NCT01087788|323987794|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
94597294|NCT01087788|323987795|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
94597295|NCT01087788|323987796|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
94597296|NCT01087788|323987794|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
94597297|NCT01087788|323987795|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
94597298|NCT01087788|323987796|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
94457737|NCT01340027|323463640|FG009|Overall Study|Miscellaneous|0|||
94457738|NCT01340027|323463641|FG010|Overall Study|Miscellaneous|1|||
94457739|NCT01340027|323463642|FG011|Overall Study|Miscellaneous|0|||
94457740|NCT02572076|323463643|FG000|Overall Study|Protocol Violation|1|||
94457741|NCT01758731|323463644|FG000|Overall Study|Physician Decision|1|||
94457742|NCT02836236|323465606|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
94457743|NCT02836236|323465607|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
94457744|NCT02836236|323465608|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
94457745|NCT02836236|323465609|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
94457746|NCT02836236|323465606|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
94457747|NCT02836236|323465607|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
94457748|NCT02836236|323465608|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
94457749|NCT02836236|323465609|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
94457750|NCT02836236|323465606|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
94457751|NCT02836236|323465607|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
94457752|NCT02836236|323465608|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
94457753|NCT02836236|323465609|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
94457754|NCT02836236|323465606|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
94457755|NCT02836236|323465607|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
94457756|NCT02836236|323465608|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
94457757|NCT02836236|323465609|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
94457758|NCT02836236|323465606|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
94457759|NCT02836236|323465607|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
94457760|NCT02836236|323465608|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
94597299|NCT01087788|323987794|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
94597300|NCT01087788|323987795|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
94597301|NCT01087788|323987796|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
94597302|NCT01087788|323987794|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
94597303|NCT01087788|323987795|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
94597304|NCT01087788|323987796|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
94597305|NCT01087788|323987794|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
94597306|NCT01087788|323987795|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
94597307|NCT01087788|323987796|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
94247338|NCT01142232|322701077|FG004|Overall Study|Death|1|||
94597308|NCT01087788|323987794|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
94247339|NCT01142232|322701073|FG000|Overall Study|Disease Progression|2|||
94247340|NCT01142232|322701074|FG001|Overall Study|Disease Progression|0|||
94247341|NCT01142232|322701075|FG002|Overall Study|Disease Progression|1|||
94247342|NCT01142232|322701076|FG003|Overall Study|Disease Progression|2|||
94247343|NCT01142232|322701077|FG004|Overall Study|Disease Progression|12|||
94597309|NCT01087788|323987795|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
94597310|NCT01087788|323987796|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
94597311|NCT01087788|323987794|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
94597312|NCT01087788|323987795|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
94247344|NCT01142232|322701073|FG000|Overall Study|Withdrawal by Subject|0|||
94597313|NCT01087788|323987796|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
94597314|NCT01087788|323987794|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
94597315|NCT01087788|323987795|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
94597316|NCT01087788|323987796|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
94597317|NCT01087788|323987794|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
94597318|NCT01087788|323987795|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
94597319|NCT01087788|323987796|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
94597320|NCT01087788|323987794|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
94597321|NCT01087788|323987795|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
94597322|NCT01087788|323987796|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
94597323|NCT01087788|323987794|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
94597324|NCT01087788|323987795|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
94597325|NCT01087788|323987796|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
94597326|NCT01087788|323987794|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
94247345|NCT01142232|322701074|FG001|Overall Study|Withdrawal by Subject|0|||
94247346|NCT01142232|322701075|FG002|Overall Study|Withdrawal by Subject|0|||
94247347|NCT01142232|322701076|FG003|Overall Study|Withdrawal by Subject|1|||
94247348|NCT01142232|322701077|FG004|Overall Study|Withdrawal by Subject|3|||
94247349|NCT01142232|322701073|FG000|Overall Study|Physician Decision|0|||
94597327|NCT01087788|323987795|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
94597328|NCT01087788|323987796|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
94597329|NCT01087788|323987794|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
94597330|NCT01087788|323987795|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
94597331|NCT01087788|323987796|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
94597332|NCT01087788|323987794|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
94597333|NCT01087788|323987795|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
94597334|NCT01087788|323987796|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
94597335|NCT01087788|323987794|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
94597336|NCT01087788|323987795|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
94597337|NCT01087788|323987796|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
94597338|NCT01087788|323987794|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
94597339|NCT01087788|323987795|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
94597340|NCT01087788|323987796|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
94597341|NCT01087788|323987794|FG000|24-weeks Dose-blind Period|Patient moved|0|||
94597342|NCT01087788|323987795|FG001|24-weeks Dose-blind Period|Patient moved|0|||
94597343|NCT01087788|323987796|FG002|24-weeks Dose-blind Period|Patient moved|1|||
94597344|NCT01087788|323987794|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
94597345|NCT01087788|323987795|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
94597346|NCT01087788|323987796|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
94597347|NCT01087788|323987794|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
94597348|NCT01087788|323987795|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
94597349|NCT01087788|323987796|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
94597350|NCT01087788|323987794|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
94597351|NCT01087788|323987795|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
94597352|NCT01087788|323987796|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
94597353|NCT01087788|323987794|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
94597354|NCT01087788|323987795|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
94597355|NCT01087788|323987796|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
94597356|NCT01087788|323987794|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
94597357|NCT01087788|323987795|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
94597358|NCT01087788|323987796|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
94597359|NCT01087788|323987794|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
94247350|NCT01142232|322701074|FG001|Overall Study|Physician Decision|1|||
94597360|NCT01087788|323987795|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
94597361|NCT01087788|323987796|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
94597362|NCT01087788|323987794|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
94597363|NCT01087788|323987795|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
94597364|NCT01087788|323987796|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
94597365|NCT01087788|323987794|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
94247351|NCT01142232|322701075|FG002|Overall Study|Physician Decision|0|||
94247352|NCT01142232|322701076|FG003|Overall Study|Physician Decision|2|||
94247353|NCT01142232|322701077|FG004|Overall Study|Physician Decision|10|||
94355961|NCT00346775|323085741|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
94597366|NCT01087788|323987795|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
94247354|NCT01142232|322701073|FG000|Overall Study|Alternative Therapy|0|||
94355962|NCT00346775|323085742|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
94355963|NCT02946515|323085743|FG000|Overall Study|Lost to Follow-up|2|||
94355964|NCT02946515|323085744|FG001|Overall Study|Lost to Follow-up|1|||
94247355|NCT01142232|322701074|FG001|Overall Study|Alternative Therapy|1|||
94597367|NCT01087788|323987796|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
94597368|NCT01087788|323987794|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
94597369|NCT01087788|323987795|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
94597370|NCT01087788|323987796|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
94597371|NCT01087788|323987794|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
94597372|NCT01087788|323987795|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
94597373|NCT01087788|323987796|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
94597374|NCT01087788|323987794|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
94597375|NCT01087788|323987795|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
94597376|NCT01087788|323987796|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
94597377|NCT01087788|323987794|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
94597378|NCT01087788|323987795|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
94597379|NCT01087788|323987796|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
94597380|NCT01087788|323987794|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
94597381|NCT01087788|323987795|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
94597382|NCT01087788|323987796|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
94597383|NCT00534313|323987797|FG000|Short-term Period|Adverse Event|1|||
94597384|NCT00534313|323987798|FG001|Short-term Period|Adverse Event|2|||
94597385|NCT00534313|323987799|FG002|Short-term Period|Adverse Event|1|||
94597386|NCT00534313|323987800|FG003|Short-term Period|Adverse Event|3|||
94597387|NCT00534313|323987797|FG000|Short-term Period|Lack of Efficacy|3|||
94597388|NCT00534313|323987798|FG001|Short-term Period|Lack of Efficacy|4|||
94597389|NCT00534313|323987799|FG002|Short-term Period|Lack of Efficacy|0|||
94597390|NCT00534313|323987800|FG003|Short-term Period|Lack of Efficacy|3|||
94597391|NCT00534313|323987797|FG000|Short-term Period|Participant not meeting study criteria|0|||
94597392|NCT00534313|323987798|FG001|Short-term Period|Participant not meeting study criteria|0|||
94597393|NCT00534313|323987799|FG002|Short-term Period|Participant not meeting study criteria|0|||
94597394|NCT00534313|323987800|FG003|Short-term Period|Participant not meeting study criteria|1|||
94597395|NCT00534313|323987797|FG000|Short-term Period|Participant withdrew consent|2|||
94597396|NCT00534313|323987798|FG001|Short-term Period|Participant withdrew consent|0|||
94597397|NCT00534313|323987799|FG002|Short-term Period|Participant withdrew consent|0|||
94597398|NCT00534313|323987800|FG003|Short-term Period|Participant withdrew consent|2|||
94597399|NCT00534313|323987797|FG000|Short-term Period|Pregnancy|0|||
94597400|NCT00534313|323987798|FG001|Short-term Period|Pregnancy|0|||
94597401|NCT00534313|323987799|FG002|Short-term Period|Pregnancy|1|||
94597402|NCT00534313|323987800|FG003|Short-term Period|Pregnancy|0|||
94597403|NCT00534313|323987797|FG000|Long-term Period|Adverse Event|2|||
94597404|NCT00534313|323987798|FG001|Long-term Period|Adverse Event|1|||
94597405|NCT00534313|323987799|FG002|Long-term Period|Adverse Event|0|||
94597406|NCT00534313|323987800|FG003|Long-term Period|Adverse Event|1|||
94597407|NCT00534313|323987797|FG000|Long-term Period|Lack of Efficacy|14|||
94597408|NCT00534313|323987798|FG001|Long-term Period|Lack of Efficacy|10|||
94597409|NCT00534313|323987799|FG002|Long-term Period|Lack of Efficacy|14|||
94597410|NCT00534313|323987800|FG003|Long-term Period|Lack of Efficacy|12|||
94597411|NCT00534313|323987797|FG000|Long-term Period|Lost to Follow-up|1|||
94597412|NCT00534313|323987798|FG001|Long-term Period|Lost to Follow-up|2|||
94597413|NCT00534313|323987799|FG002|Long-term Period|Lost to Follow-up|0|||
94597414|NCT00534313|323987800|FG003|Long-term Period|Lost to Follow-up|0|||
94597415|NCT00534313|323987797|FG000|Long-term Period|Withdrawal by Subject|2|||
94597416|NCT00534313|323987798|FG001|Long-term Period|Withdrawal by Subject|2|||
94597417|NCT00534313|323987799|FG002|Long-term Period|Withdrawal by Subject|0|||
94247356|NCT01142232|322701075|FG002|Overall Study|Alternative Therapy|1|||
94247357|NCT01142232|322701076|FG003|Overall Study|Alternative Therapy|0|||
94247358|NCT01142232|322701077|FG004|Overall Study|Alternative Therapy|1|||
94597418|NCT00534313|323987800|FG003|Long-term Period|Withdrawal by Subject|0|||
94597419|NCT00534313|323987797|FG000|Long-term Period|No longer meets study criteria|0|||
94597420|NCT00534313|323987798|FG001|Long-term Period|No longer meets study criteria|1|||
94597421|NCT00534313|323987799|FG002|Long-term Period|No longer meets study criteria|0|||
94597422|NCT00534313|323987800|FG003|Long-term Period|No longer meets study criteria|0|||
94597423|NCT00534313|323987797|FG000|Long-term Period|Poor compliance/noncompliance|0|||
94597424|NCT00534313|323987798|FG001|Long-term Period|Poor compliance/noncompliance|1|||
94597425|NCT00534313|323987799|FG002|Long-term Period|Poor compliance/noncompliance|1|||
94597426|NCT00534313|323987800|FG003|Long-term Period|Poor compliance/noncompliance|0|||
94597427|NCT00534313|323987797|FG000|Long-term Period|Administrative reason by sponsor|17|||
94597428|NCT00534313|323987798|FG001|Long-term Period|Administrative reason by sponsor|15|||
94597429|NCT00534313|323987799|FG002|Long-term Period|Administrative reason by sponsor|26|||
94597430|NCT00534313|323987800|FG003|Long-term Period|Administrative reason by sponsor|18|||
94247359|NCT01142232|322701073|FG000|Overall Study|Off Trt for other complicating disease|0|||
94597431|NCT00534313|323987797|FG000|Long-term Period|Other|1|||
94597432|NCT00534313|323987798|FG001|Long-term Period|Other|2|||
94597433|NCT00534313|323987799|FG002|Long-term Period|Other|2|||
94597434|NCT00534313|323987800|FG003|Long-term Period|Other|2|||
94597435|NCT02081859|323987803|FG000|Overall Study|No fertilization|2|||
94597436|NCT02081859|323987804|FG001|Overall Study|No fertilization|2|||
94247360|NCT01142232|322701074|FG001|Overall Study|Off Trt for other complicating disease|0|||
94247361|NCT01142232|322701075|FG002|Overall Study|Off Trt for other complicating disease|0|||
94247362|NCT01142232|322701076|FG003|Overall Study|Off Trt for other complicating disease|0|||
94247363|NCT01142232|322701077|FG004|Overall Study|Off Trt for other complicating disease|1|||
94247364|NCT01142232|322701073|FG000|Overall Study|Noncompliance|0|||
94247365|NCT01142232|322701074|FG001|Overall Study|Noncompliance|0|||
94247366|NCT01142232|322701075|FG002|Overall Study|Noncompliance|0|||
94247367|NCT01142232|322701076|FG003|Overall Study|Noncompliance|0|||
94247368|NCT01142232|322701077|FG004|Overall Study|Noncompliance|2|||
94247369|NCT02738203|322701081|FG000|Overall Study|Failed IUD Insertion|2|||
94247370|NCT02738203|322701082|FG001|Overall Study|Failed IUD Insertion|2|||
94247371|NCT02738203|322701081|FG000|Overall Study|Protocol Violation|0|||
94457761|NCT02836236|323465609|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
94457762|NCT02836236|323465606|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
94457763|NCT02836236|323465607|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
94457764|NCT02836236|323465608|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
94457765|NCT02836236|323465609|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
94457766|NCT02836236|323465606|FG000|Open-Label TAF Treatment Phase|Death|0|||
94457767|NCT02836236|323465607|FG001|Open-Label TAF Treatment Phase|Death|0|||
94457768|NCT02836236|323465608|FG002|Open-Label TAF Treatment Phase|Death|1|||
94457769|NCT02836236|323465609|FG003|Open-Label TAF Treatment Phase|Death|1|||
94457770|NCT02836236|323465606|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
94457771|NCT02836236|323465607|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
94457772|NCT02836236|323465608|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
94457773|NCT02836236|323465609|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
94457774|NCT03937908|323465614|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
94457775|NCT03937908|323465615|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
94457776|NCT05413369|323465616|FG000|Overall Study|Adverse Event|1|||
94457777|NCT05413369|323465617|FG001|Overall Study|Adverse Event|1|||
94457778|NCT05413369|323465616|FG000|Overall Study|Withdrawal by Subject|13|||
94457779|NCT05413369|323465617|FG001|Overall Study|Withdrawal by Subject|4|||
94457780|NCT05413369|323465616|FG000|Overall Study|Non-compliance with study schedule|2|||
94457781|NCT05413369|323465617|FG001|Overall Study|Non-compliance with study schedule|1|||
94457782|NCT05413369|323465616|FG000|Overall Study|Other|1|||
94457783|NCT05413369|323465617|FG001|Overall Study|Other|1|||
94457784|NCT01154296|323465619|FG000|Randomization and Intervention|Decided to decline|1|||
94457785|NCT01154296|323465620|FG001|Randomization and Intervention|Decided to decline|1|||
94457786|NCT01154296|323465619|FG000|Randomization and Intervention|Declined by staff|1|||
94457787|NCT01154296|323465620|FG001|Randomization and Intervention|Declined by staff|0|||
94457788|NCT01154296|323465619|FG000|Randomization and Intervention|Did not return|1|||
94457789|NCT01154296|323465620|FG001|Randomization and Intervention|Did not return|0|||
94457790|NCT01154296|323465619|FG000|Randomization and Intervention|Left before test|0|||
94457791|NCT01154296|323465620|FG001|Randomization and Intervention|Left before test|1|||
94457792|NCT01154296|323465619|FG000|Randomization and Intervention|Left clinic early|2|||
94457793|NCT01154296|323465620|FG001|Randomization and Intervention|Left clinic early|0|||
94457794|NCT01154296|323465619|FG000|6-month Follow-up|Lost contact|269|||
94457795|NCT01154296|323465620|FG001|6-month Follow-up|Lost contact|275|||
94457796|NCT01154296|323465619|FG000|6-month Follow-up|Incarcerated|37|||
94457797|NCT01154296|323465620|FG001|6-month Follow-up|Incarcerated|32|||
94457798|NCT01154296|323465619|FG000|6-month Follow-up|Withdrew consent|14|||
94457799|NCT01154296|323465620|FG001|6-month Follow-up|Withdrew consent|15|||
94457800|NCT01154296|323465619|FG000|6-month Follow-up|Death|3|||
94457801|NCT01154296|323465620|FG001|6-month Follow-up|Death|2|||
94457802|NCT01154296|323465619|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
94457803|NCT01154296|323465620|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
94457804|NCT00614523|323465621|FG000|Overall Study|Adverse Event|4|||
94457805|NCT00614523|323465622|FG001|Overall Study|Adverse Event|20|||
94457806|NCT00614523|323465621|FG000|Overall Study|Death|5|||
94457807|NCT00614523|323465622|FG001|Overall Study|Death|8|||
94457808|NCT00614523|323465621|FG000|Overall Study|Lack of Efficacy|9|||
94457809|NCT00614523|323465622|FG001|Overall Study|Lack of Efficacy|11|||
94457810|NCT00614523|323465621|FG000|Overall Study|Lost to Follow-up|0|||
94457811|NCT00614523|323465622|FG001|Overall Study|Lost to Follow-up|1|||
94457812|NCT00614523|323465621|FG000|Overall Study|Protocol Violation|3|||
94457813|NCT00614523|323465622|FG001|Overall Study|Protocol Violation|2|||
94457814|NCT00614523|323465621|FG000|Overall Study|Withdrawal by Subject|12|||
94457815|NCT00614523|323465622|FG001|Overall Study|Withdrawal by Subject|22|||
94457816|NCT00614523|323465621|FG000|Overall Study|Other|6|||
94457817|NCT00614523|323465622|FG001|Overall Study|Other|11|||
94597437|NCT02081859|323987803|FG000|Overall Study|No sperm|1|||
94597438|NCT02081859|323987804|FG001|Overall Study|No sperm|0|||
94597439|NCT02081859|323987803|FG000|Overall Study|Unanticipated freeze all cycle|2|||
94597440|NCT02081859|323987804|FG001|Overall Study|Unanticipated freeze all cycle|6|||
94597441|NCT02081859|323987803|FG000|Overall Study|< 4 embryos|27|||
94457818|NCT00614523|323465621|FG000|Overall Study|Ineligibility Determined|1|||
94597442|NCT02081859|323987804|FG001|Overall Study|< 4 embryos|23|||
94597443|NCT02081859|323987803|FG000|Overall Study|Other reasons|2|||
94597444|NCT02081859|323987804|FG001|Overall Study|Other reasons|0|||
94597445|NCT00483756|323987805|FG000|Overall Study|Death|2|||
94597446|NCT00483756|323987806|FG001|Overall Study|Death|0|||
94597447|NCT00483756|323987807|FG002|Overall Study|Death|1|||
94597448|NCT00483756|323987805|FG000|Overall Study|Adverse Event|19|||
94597449|NCT00483756|323987806|FG001|Overall Study|Adverse Event|38|||
94597450|NCT00483756|323987807|FG002|Overall Study|Adverse Event|40|||
94597451|NCT00483756|323987805|FG000|Overall Study|Lack of Efficacy|1|||
94597452|NCT00483756|323987806|FG001|Overall Study|Lack of Efficacy|0|||
94597453|NCT00483756|323987807|FG002|Overall Study|Lack of Efficacy|0|||
94597454|NCT00483756|323987805|FG000|Overall Study|Lost to Follow-up|3|||
94597455|NCT00483756|323987806|FG001|Overall Study|Lost to Follow-up|1|||
94597456|NCT00483756|323987807|FG002|Overall Study|Lost to Follow-up|0|||
94597457|NCT00483756|323987805|FG000|Overall Study|Withdrawal by Subject|5|||
94597458|NCT00483756|323987806|FG001|Overall Study|Withdrawal by Subject|3|||
94597459|NCT00483756|323987807|FG002|Overall Study|Withdrawal by Subject|4|||
94597460|NCT00483756|323987805|FG000|Overall Study|Other|2|||
94597461|NCT00483756|323987806|FG001|Overall Study|Other|4|||
94597462|NCT00483756|323987807|FG002|Overall Study|Other|3|||
94597463|NCT00483756|323987805|FG000|Overall Study|Randomized, Not Treated|1|||
94597464|NCT00483756|323987806|FG001|Overall Study|Randomized, Not Treated|4|||
94597465|NCT00483756|323987807|FG002|Overall Study|Randomized, Not Treated|4|||
94597466|NCT00053898|323987819|FG000|Overall Study|No follow-up data from any source|9|||
94597467|NCT00053898|323987820|FG001|Overall Study|No follow-up data from any source|12|||
94597468|NCT00053898|323987819|FG000|Overall Study|Follow-up from telephone contact only|5|||
94597469|NCT00053898|323987820|FG001|Overall Study|Follow-up from telephone contact only|1|||
94597470|NCT00906971|323987823|FG000|Overall Study|Withdrawal by Subject|8|||
94597471|NCT00906971|323987824|FG001|Overall Study|Withdrawal by Subject|2|||
94597472|NCT00906971|323987823|FG000|Overall Study|Lost to Follow-up|0|||
94597473|NCT00906971|323987824|FG001|Overall Study|Lost to Follow-up|1|||
94597474|NCT00545129|323987825|FG000|Overall Study|Lack of Efficacy|2|||
94597475|NCT00545129|323987826|FG001|Overall Study|Lack of Efficacy|5|||
94597476|NCT00545129|323987825|FG000|Overall Study|Death|2|||
94597477|NCT00545129|323987826|FG001|Overall Study|Death|1|||
94597478|NCT00545129|323987825|FG000|Overall Study|Adverse Event|1|||
94597479|NCT00545129|323987826|FG001|Overall Study|Adverse Event|1|||
94597480|NCT00545129|323987825|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
94597481|NCT00545129|323987826|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
94597482|NCT00545129|323987825|FG000|Overall Study|Other|3|||
94597483|NCT00545129|323987826|FG001|Overall Study|Other|3|||
94597484|NCT00843778|323989675|FG000|Overall Study|Adverse Event|15|||
94597485|NCT00843778|323989675|FG000|Overall Study|Lack of Efficacy|14|||
94597486|NCT00843778|323989675|FG000|Overall Study|Loss of efficacy|2|||
94597487|NCT00843778|323989675|FG000|Overall Study|Withdrawal by Subject|4|||
94597488|NCT02276027|323989676|FG000|Overall Study|Death|1|||
94597489|NCT02276027|323989677|FG001|Overall Study|Death|0|||
94597490|NCT02276027|323989678|FG002|Overall Study|Death|0|||
94597491|NCT02276027|323989679|FG003|Overall Study|Death|2|||
94597492|NCT02276027|323989676|FG000|Overall Study|Physician Decision|0|||
94597493|NCT02276027|323989677|FG001|Overall Study|Physician Decision|0|||
94597494|NCT02276027|323989678|FG002|Overall Study|Physician Decision|0|||
94597495|NCT02276027|323989679|FG003|Overall Study|Physician Decision|1|||
94597496|NCT02276027|323989676|FG000|Overall Study|Progressive disease|1|||
94597497|NCT02276027|323989677|FG001|Overall Study|Progressive disease|13|||
94597498|NCT02276027|323989678|FG002|Overall Study|Progressive disease|12|||
94597499|NCT02276027|323989679|FG003|Overall Study|Progressive disease|14|||
94597500|NCT02276027|323989676|FG000|Overall Study|Subject/guardian decision|0|||
94597501|NCT02276027|323989677|FG001|Overall Study|Subject/guardian decision|1|||
94597502|NCT02276027|323989678|FG002|Overall Study|Subject/guardian decision|0|||
94355965|NCT03799198|323085745|FG000|Overall Study|Lost to Follow-up|4|||
94597503|NCT02276027|323989679|FG003|Overall Study|Subject/guardian decision|3|||
94597504|NCT02276027|323989676|FG000|Overall Study|Adverse Event|0|||
94597505|NCT02276027|323989677|FG001|Overall Study|Adverse Event|2|||
94597506|NCT02276027|323989678|FG002|Overall Study|Adverse Event|8|||
94597507|NCT02276027|323989679|FG003|Overall Study|Adverse Event|2|||
94597508|NCT03745820|323989680|FG000|Overall Study|Adverse Event|0|||
94597509|NCT03745820|323989681|FG001|Overall Study|Adverse Event|3|||
94597510|NCT03745820|323989682|FG002|Overall Study|Adverse Event|2|||
94597511|NCT03745820|323989680|FG000|Overall Study|Non-Compliance with Study Drug|4|||
94660417|NCT04401579|324211651|FG001|Overall Study|Enrolled but treatment not administered|9|||
94247372|NCT02738203|322701082|FG001|Overall Study|Protocol Violation|1|||
94597512|NCT03745820|323989681|FG001|Overall Study|Non-Compliance with Study Drug|3|||
94597513|NCT03745820|323989682|FG002|Overall Study|Non-Compliance with Study Drug|0|||
94597514|NCT03745820|323989680|FG000|Overall Study|Withdrawal by Subject|4|||
94597515|NCT03745820|323989681|FG001|Overall Study|Withdrawal by Subject|4|||
94597516|NCT03745820|323989682|FG002|Overall Study|Withdrawal by Subject|4|||
94247373|NCT00616902|322701083|FG000|Overall Study|Termination of study|6|||
94597517|NCT03745820|323989680|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
94597518|NCT03745820|323989681|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
94597519|NCT03745820|323989682|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
94597520|NCT03745820|323989680|FG000|Overall Study|Lost to Follow-up|2|||
94597521|NCT03745820|323989681|FG001|Overall Study|Lost to Follow-up|0|||
94597522|NCT03745820|323989682|FG002|Overall Study|Lost to Follow-up|3|||
94597523|NCT03745820|323989680|FG000|Overall Study|Reason not Specified|2|||
94597524|NCT03745820|323989681|FG001|Overall Study|Reason not Specified|4|||
94597525|NCT03745820|323989682|FG002|Overall Study|Reason not Specified|1|||
94597526|NCT03328182|323989683|FG000|Overall Study|Withdrawal by Subject|1|||
94597527|NCT03328182|323989683|FG000|Overall Study|Protocol Violation|2|||
94597528|NCT03328182|323989683|FG000|Overall Study|No Product Evaluated|1|||
94597529|NCT01347580|323989686|FG000|Overall Study|Withdrawal by Subject|13|||
94597530|NCT01347580|323989687|FG001|Overall Study|Withdrawal by Subject|23|||
94597531|NCT01347580|323989686|FG000|Overall Study|Death|30|||
94597532|NCT01347580|323989687|FG001|Overall Study|Death|19|||
94597533|NCT01347580|323989686|FG000|Overall Study|Protocol Violation|10|||
94597534|NCT01347580|323989687|FG001|Overall Study|Protocol Violation|7|||
94597535|NCT01347580|323989686|FG000|Overall Study|Lost to Follow-up|3|||
94597536|NCT01347580|323989687|FG001|Overall Study|Lost to Follow-up|1|||
94597537|NCT01347580|323989686|FG000|Overall Study|Had other reason|9|||
94597538|NCT01347580|323989687|FG001|Overall Study|Had other reason|6|||
94597539|NCT02160002|323989695|FG000|Overall Study|Withdrawal by Subject|2|||
94597540|NCT02160002|323989696|FG001|Overall Study|Withdrawal by Subject|1|||
94597541|NCT00775203|323989697|FG000|Overall Study|Adverse Event|25|||
94597542|NCT00775203|323989698|FG001|Overall Study|Adverse Event|6|||
94597543|NCT00775203|323989697|FG000|Overall Study|Lack of Efficacy|8|||
94597544|NCT00775203|323989698|FG001|Overall Study|Lack of Efficacy|9|||
94597545|NCT00775203|323989697|FG000|Overall Study|Withdrawal by Subject|11|||
94597546|NCT00775203|323989698|FG001|Overall Study|Withdrawal by Subject|9|||
94597547|NCT00775203|323989697|FG000|Overall Study|Lost to Follow-up|11|||
94597548|NCT00775203|323989698|FG001|Overall Study|Lost to Follow-up|15|||
94597549|NCT00775203|323989697|FG000|Overall Study|Administrative reason|2|||
94597550|NCT00775203|323989698|FG001|Overall Study|Administrative reason|0|||
94597551|NCT00775203|323989697|FG000|Overall Study|Noncompliance|4|||
94597552|NCT00775203|323989698|FG001|Overall Study|Noncompliance|2|||
94597553|NCT00775203|323989697|FG000|Overall Study|Protocol Violation|0|||
94597554|NCT00775203|323989698|FG001|Overall Study|Protocol Violation|1|||
94597555|NCT00775203|323989697|FG000|Overall Study|Entered other study|1|||
94597556|NCT00775203|323989698|FG001|Overall Study|Entered other study|0|||
94597557|NCT00775203|323989697|FG000|Overall Study|Physician Decision|0|||
94597558|NCT00775203|323989698|FG001|Overall Study|Physician Decision|1|||
94597559|NCT00701662|323989699|FG000|Overall Study|Lack of Efficacy|1|||
94597560|NCT00635024|323989701|FG000|Overall Study|Adverse Event|1|||
94597561|NCT00045942|323989703|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
94597562|NCT00045942|323989704|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
94597563|NCT00045942|323989705|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
94597564|NCT00045942|323989706|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
94597565|NCT00045942|323989707|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
94597566|NCT00045942|323989708|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
94597567|NCT00045942|323989709|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
94597568|NCT00045942|323989710|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
94597569|NCT00045942|323989711|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
94597570|NCT00045942|323989703|FG000|PKC412A2104 (Core)|Adverse Event|5|||
94597571|NCT00045942|323989704|FG001|PKC412A2104 (Core)|Adverse Event|0|||
94597572|NCT00045942|323989705|FG002|PKC412A2104 (Core)|Adverse Event|0|||
94597573|NCT00045942|323989706|FG003|PKC412A2104 (Core)|Adverse Event|0|||
94597574|NCT00045942|323989707|FG004|PKC412A2104 (Core)|Adverse Event|0|||
94597575|NCT00045942|323989708|FG005|PKC412A2104 (Core)|Adverse Event|0|||
94597576|NCT00045942|323989709|FG006|PKC412A2104 (Core)|Adverse Event|0|||
94597577|NCT00045942|323989710|FG007|PKC412A2104 (Core)|Adverse Event|0|||
94597578|NCT00045942|323989711|FG008|PKC412A2104 (Core)|Adverse Event|0|||
94597579|NCT00045942|323989703|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
94597580|NCT00045942|323989704|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
94597581|NCT00045942|323989705|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
94597582|NCT00045942|323989706|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
94597583|NCT00045942|323989707|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
94597584|NCT00045942|323989708|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
94597585|NCT00045942|323989709|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
94597586|NCT00045942|323989710|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
94597587|NCT00045942|323989711|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
94597588|NCT00045942|323989703|FG000|PKC412A2104 (Core)|Death|1|||
94660418|NCT04401579|324211650|FG000|Overall Study|Adverse Event|2|||
94597589|NCT00045942|323989704|FG001|PKC412A2104 (Core)|Death|0|||
94597590|NCT00045942|323989705|FG002|PKC412A2104 (Core)|Death|0|||
94597591|NCT00045942|323989706|FG003|PKC412A2104 (Core)|Death|0|||
94597592|NCT00045942|323989707|FG004|PKC412A2104 (Core)|Death|0|||
94597593|NCT00045942|323989708|FG005|PKC412A2104 (Core)|Death|0|||
94247374|NCT00616902|322701084|FG001|Overall Study|Termination of study|6|||
94247375|NCT00490490|322701085|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
94247376|NCT00490490|322701085|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
94247377|NCT04772898|322701086|FG000|Overall Study|Withdrawal by Subject|0|||
94247378|NCT04772898|322701087|FG001|Overall Study|Withdrawal by Subject|1|||
94247379|NCT00473265|322701088|FG000|Overall Study|Unrelated adverse event|5|||
94247380|NCT00473265|322701088|FG000|Overall Study|Off treatment early|15|||
94247381|NCT03292432|322701092|FG000|Overall Study|Lost to Follow-up|11|||
94247382|NCT03292432|322701093|FG001|Overall Study|Lost to Follow-up|8|||
94247383|NCT03292432|322701092|FG000|Overall Study|Death|2|||
94247384|NCT03292432|322701093|FG001|Overall Study|Death|1|||
94247385|NCT03292432|322701092|FG000|Overall Study|Withdrawal by Subject|1|||
94247386|NCT03292432|322701093|FG001|Overall Study|Withdrawal by Subject|2|||
94247387|NCT03292432|322701092|FG000|Overall Study|Site closed before any data collected|1|||
94247388|NCT03292432|322701093|FG001|Overall Study|Site closed before any data collected|0|||
94247389|NCT01153321|322701094|FG000|Overall Study|Development of study withdrawal criteria|0|||
94247390|NCT01153321|322701095|FG001|Overall Study|Development of study withdrawal criteria|1|||
94247391|NCT01153321|322701094|FG000|Overall Study|Withdrawal by Subject|0|||
94247392|NCT01153321|322701095|FG001|Overall Study|Withdrawal by Subject|1|||
94247393|NCT01153321|322701094|FG000|Overall Study|Adverse Event|1|||
94247394|NCT01153321|322701095|FG001|Overall Study|Adverse Event|1|||
94247395|NCT03527550|322701096|FG000|Overall Study|Lost to Follow-up|4|||
94247396|NCT03527550|322701097|FG001|Overall Study|Lost to Follow-up|2|||
94247397|NCT03527550|322701096|FG000|Overall Study|Withdrawal by Subject|4|||
94247398|NCT03527550|322701097|FG001|Overall Study|Withdrawal by Subject|1|||
94247399|NCT03527550|322701096|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
94247400|NCT03527550|322701097|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
94247401|NCT04638920|322701098|FG000|Overall Study|Withdrawal by Subject|5|||
94247402|NCT05383508|322701099|FG000|Overall Study|Withdrawal by Subject|1|||
94247403|NCT05383508|322701100|FG001|Overall Study|Withdrawal by Subject|0|||
94247404|NCT05383508|322701101|FG002|Overall Study|Withdrawal by Subject|1|||
94247405|NCT05383508|322701102|FG003|Overall Study|Withdrawal by Subject|1|||
94247406|NCT05383508|322701103|FG004|Overall Study|Withdrawal by Subject|2|||
94247407|NCT05383508|322701104|FG005|Overall Study|Withdrawal by Subject|0|||
94247408|NCT03775434|322701105|FG000|Overall Study|Adverse Event|2|||
94247409|NCT03775434|322701105|FG000|Overall Study|Withdrawal by Subject|1|||
94247410|NCT01859988|322701106|FG000|Overall Study|Withdrawal by Subject|6|||
94247411|NCT01859988|322701107|FG001|Overall Study|Withdrawal by Subject|3|||
94247412|NCT01859988|322701108|FG002|Overall Study|Withdrawal by Subject|4|||
94247413|NCT01859988|322701109|FG003|Overall Study|Withdrawal by Subject|3|||
94247414|NCT01859988|322701110|FG004|Overall Study|Withdrawal by Subject|2|||
94247415|NCT01859988|322701111|FG005|Overall Study|Withdrawal by Subject|2|||
94247416|NCT01859988|322701106|FG000|Overall Study|Lack of Efficacy|1|||
94247417|NCT01859988|322701107|FG001|Overall Study|Lack of Efficacy|1|||
94247418|NCT01859988|322701108|FG002|Overall Study|Lack of Efficacy|5|||
94247419|NCT01859988|322701109|FG003|Overall Study|Lack of Efficacy|0|||
94247420|NCT01859988|322701110|FG004|Overall Study|Lack of Efficacy|7|||
94247421|NCT01859988|322701111|FG005|Overall Study|Lack of Efficacy|9|||
94247422|NCT01859988|322701106|FG000|Overall Study|Physician Decision|1|||
94247423|NCT01859988|322701107|FG001|Overall Study|Physician Decision|3|||
94247424|NCT01859988|322701108|FG002|Overall Study|Physician Decision|1|||
94247425|NCT01859988|322701109|FG003|Overall Study|Physician Decision|3|||
94247426|NCT01859988|322701110|FG004|Overall Study|Physician Decision|4|||
94247427|NCT01859988|322701111|FG005|Overall Study|Physician Decision|1|||
94247428|NCT01859988|322701106|FG000|Overall Study|Adverse Event|2|||
94247429|NCT01859988|322701107|FG001|Overall Study|Adverse Event|1|||
94247430|NCT01859988|322701108|FG002|Overall Study|Adverse Event|3|||
94247431|NCT01859988|322701109|FG003|Overall Study|Adverse Event|1|||
94247432|NCT01859988|322701110|FG004|Overall Study|Adverse Event|2|||
94247433|NCT01859988|322701111|FG005|Overall Study|Adverse Event|2|||
94247434|NCT01859988|322701106|FG000|Overall Study|Lost to Follow-up|1|||
94247435|NCT01859988|322701107|FG001|Overall Study|Lost to Follow-up|2|||
94247436|NCT01859988|322701108|FG002|Overall Study|Lost to Follow-up|3|||
94247437|NCT01859988|322701109|FG003|Overall Study|Lost to Follow-up|0|||
94247438|NCT01859988|322701110|FG004|Overall Study|Lost to Follow-up|3|||
94247439|NCT01859988|322701111|FG005|Overall Study|Lost to Follow-up|2|||
94597594|NCT00045942|323989709|FG006|PKC412A2104 (Core)|Death|0|||
94247440|NCT01859988|322701106|FG000|Overall Study|Protocol Violation|0|||
94597595|NCT00045942|323989710|FG007|PKC412A2104 (Core)|Death|0|||
94247441|NCT01859988|322701107|FG001|Overall Study|Protocol Violation|0|||
94247442|NCT01859988|322701108|FG002|Overall Study|Protocol Violation|1|||
94247443|NCT01859988|322701109|FG003|Overall Study|Protocol Violation|0|||
94247444|NCT01859988|322701110|FG004|Overall Study|Protocol Violation|0|||
94247445|NCT01859988|322701111|FG005|Overall Study|Protocol Violation|0|||
94247446|NCT01859988|322701106|FG000|Overall Study|Other than specified above|0|||
94247447|NCT01859988|322701107|FG001|Overall Study|Other than specified above|2|||
94247448|NCT01859988|322701108|FG002|Overall Study|Other than specified above|11|||
94247449|NCT01859988|322701109|FG003|Overall Study|Other than specified above|3|||
94247450|NCT01859988|322701110|FG004|Overall Study|Other than specified above|5|||
94247451|NCT01859988|322701111|FG005|Overall Study|Other than specified above|3|||
94247452|NCT02334423|322701112|FG000|Overall Study|Protocol Violation|10|||
94247453|NCT02334423|322701113|FG001|Overall Study|Protocol Violation|3|||
94247454|NCT04155047|322701116|FG000|Overall Study|Adverse Event|1|||
94247455|NCT04155047|322701117|FG001|Overall Study|Adverse Event|0|||
94247456|NCT04155047|322701116|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
94247457|NCT04155047|322701117|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
94247458|NCT00859222|322701118|FG000|Overall Study|Adverse Event|2|||
94247459|NCT00859222|322701119|FG001|Overall Study|Adverse Event|3|||
94247460|NCT00859222|322701120|FG002|Overall Study|Adverse Event|6|||
94247461|NCT00859222|322701121|FG003|Overall Study|Adverse Event|24|||
94247462|NCT00859222|322701122|FG004|Overall Study|Adverse Event|15|||
94247463|NCT00859222|322701118|FG000|Overall Study|DLT|1|||
94247464|NCT00859222|322701119|FG001|Overall Study|DLT|0|||
94247465|NCT00859222|322701120|FG002|Overall Study|DLT|0|||
94247466|NCT00859222|322701121|FG003|Overall Study|DLT|0|||
94247467|NCT00859222|322701122|FG004|Overall Study|DLT|0|||
94247468|NCT01871805|322701123|FG000|Phase I|Death|7|||
94247469|NCT01871805|322701124|FG001|Phase I|Death|4|||
94247470|NCT01871805|322701125|FG002|Phase I|Death|6|||
94247471|NCT01871805|322701126|FG003|Phase I|Death|2|||
94247472|NCT01871805|322701127|FG004|Phase I|Death|9|||
94247473|NCT01871805|322701128|FG005|Phase I|Death|0|||
94247474|NCT01871805|322701123|FG000|Phase I|Alive in Survival Follow-up|0|||
94247475|NCT01871805|322701124|FG001|Phase I|Alive in Survival Follow-up|2|||
94247476|NCT01871805|322701125|FG002|Phase I|Alive in Survival Follow-up|4|||
94247477|NCT01871805|322701126|FG003|Phase I|Alive in Survival Follow-up|5|||
94457819|NCT00614523|323465622|FG001|Overall Study|Ineligibility Determined|2|||
94457820|NCT00614523|323465621|FG000|Overall Study|Disease Progression|0|||
94597596|NCT00045942|323989711|FG008|PKC412A2104 (Core)|Death|0|||
94597597|NCT00045942|323989703|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
94597598|NCT00045942|323989704|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
94597599|NCT00045942|323989705|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
94597600|NCT00045942|323989706|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
94597601|NCT00045942|323989707|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
94597602|NCT00045942|323989708|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
94597603|NCT00045942|323989709|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
94597604|NCT00045942|323989710|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
94597605|NCT00045942|323989711|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
94597606|NCT00045942|323989703|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
94597607|NCT00045942|323989704|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
94597608|NCT00045942|323989705|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
94597609|NCT00045942|323989706|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
94597610|NCT00045942|323989707|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
94597611|NCT00045942|323989708|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
94597612|NCT00045942|323989709|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
94597613|NCT00045942|323989710|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
94597614|NCT00045942|323989711|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
94597615|NCT00045942|323989703|FG000|PKC412A2104E1|Lack of Efficacy|0|||
94597616|NCT00045942|323989704|FG001|PKC412A2104E1|Lack of Efficacy|11|||
94597617|NCT00045942|323989705|FG002|PKC412A2104E1|Lack of Efficacy|11|||
94597618|NCT00045942|323989706|FG003|PKC412A2104E1|Lack of Efficacy|23|||
94597619|NCT00045942|323989707|FG004|PKC412A2104E1|Lack of Efficacy|17|||
94597620|NCT00045942|323989708|FG005|PKC412A2104E1|Lack of Efficacy|0|||
94597621|NCT00045942|323989709|FG006|PKC412A2104E1|Lack of Efficacy|0|||
94597622|NCT00045942|323989710|FG007|PKC412A2104E1|Lack of Efficacy|0|||
94597623|NCT00045942|323989711|FG008|PKC412A2104E1|Lack of Efficacy|0|||
94597624|NCT00045942|323989703|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
94597625|NCT00045942|323989704|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
94597626|NCT00045942|323989705|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
94597627|NCT00045942|323989706|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
94597628|NCT00045942|323989707|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
94597629|NCT00045942|323989708|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
94597630|NCT00045942|323989709|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
94247478|NCT01871805|322701127|FG004|Phase I|Alive in Survival Follow-up|4|||
94597631|NCT00045942|323989710|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
94660419|NCT04401579|324211651|FG001|Overall Study|Adverse Event|1|||
94247479|NCT01871805|322701128|FG005|Phase I|Alive in Survival Follow-up|0|||
94247480|NCT01871805|322701123|FG000|Phase I|Lost to Follow-up|0|||
94247481|NCT01871805|322701124|FG001|Phase I|Lost to Follow-up|1|||
94247482|NCT01871805|322701125|FG002|Phase I|Lost to Follow-up|3|||
94247483|NCT01871805|322701126|FG003|Phase I|Lost to Follow-up|0|||
94247484|NCT01871805|322701127|FG004|Phase I|Lost to Follow-up|0|||
94247485|NCT01871805|322701128|FG005|Phase I|Lost to Follow-up|0|||
94247486|NCT01871805|322701123|FG000|Phase II|Death|0|||
94247487|NCT01871805|322701124|FG001|Phase II|Death|0|||
94247488|NCT01871805|322701125|FG002|Phase II|Death|0|||
94597632|NCT00045942|323989711|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
94597633|NCT00045942|323989703|FG000|PKC412A2104E1|Adverse Event|0|||
94597634|NCT00045942|323989704|FG001|PKC412A2104E1|Adverse Event|1|||
94597635|NCT00045942|323989705|FG002|PKC412A2104E1|Adverse Event|1|||
94597636|NCT00045942|323989706|FG003|PKC412A2104E1|Adverse Event|3|||
94597637|NCT00045942|323989707|FG004|PKC412A2104E1|Adverse Event|6|||
94597638|NCT00045942|323989708|FG005|PKC412A2104E1|Adverse Event|0|||
94597639|NCT00045942|323989709|FG006|PKC412A2104E1|Adverse Event|0|||
94597640|NCT00045942|323989710|FG007|PKC412A2104E1|Adverse Event|0|||
94597641|NCT00045942|323989711|FG008|PKC412A2104E1|Adverse Event|0|||
94597642|NCT00045942|323989703|FG000|PKC412A2104E1|Death|0|||
94597643|NCT00045942|323989704|FG001|PKC412A2104E1|Death|4|||
94597644|NCT00045942|323989705|FG002|PKC412A2104E1|Death|1|||
94597645|NCT00045942|323989706|FG003|PKC412A2104E1|Death|1|||
94597646|NCT00045942|323989707|FG004|PKC412A2104E1|Death|1|||
94597647|NCT00045942|323989708|FG005|PKC412A2104E1|Death|0|||
94597648|NCT00045942|323989709|FG006|PKC412A2104E1|Death|0|||
94597649|NCT00045942|323989710|FG007|PKC412A2104E1|Death|0|||
94597650|NCT00045942|323989711|FG008|PKC412A2104E1|Death|0|||
94597651|NCT00045942|323989703|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
94597652|NCT00045942|323989704|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
94597653|NCT00045942|323989705|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
94597654|NCT00045942|323989706|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
94597655|NCT00045942|323989707|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
94597656|NCT00045942|323989708|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
94597657|NCT00045942|323989709|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
94597658|NCT00045942|323989710|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
94597659|NCT00045942|323989711|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
94597660|NCT00045942|323989703|FG000|PKC412A2104E2|Lost to Follow-up|0|||
94597661|NCT00045942|323989704|FG001|PKC412A2104E2|Lost to Follow-up|0|||
94597662|NCT00045942|323989705|FG002|PKC412A2104E2|Lost to Follow-up|0|||
94597663|NCT00045942|323989706|FG003|PKC412A2104E2|Lost to Follow-up|0|||
94597664|NCT00045942|323989707|FG004|PKC412A2104E2|Lost to Follow-up|0|||
94597665|NCT00045942|323989708|FG005|PKC412A2104E2|Lost to Follow-up|0|||
94597666|NCT00045942|323989709|FG006|PKC412A2104E2|Lost to Follow-up|0|||
94597667|NCT00045942|323989710|FG007|PKC412A2104E2|Lost to Follow-up|3|||
94597668|NCT00045942|323989711|FG008|PKC412A2104E2|Lost to Follow-up|0|||
94597669|NCT00045942|323989703|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
94597670|NCT00045942|323989704|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
94597671|NCT00045942|323989705|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
94597672|NCT00045942|323989706|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
94597673|NCT00045942|323989707|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
94597674|NCT00045942|323989708|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
94597675|NCT00045942|323989709|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
94597676|NCT00045942|323989710|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
94597677|NCT00045942|323989711|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
94597678|NCT00045942|323989703|FG000|PKC412A2104E2|Lack of Efficacy|0|||
94597679|NCT00045942|323989704|FG001|PKC412A2104E2|Lack of Efficacy|0|||
94597680|NCT00045942|323989705|FG002|PKC412A2104E2|Lack of Efficacy|0|||
94597681|NCT00045942|323989706|FG003|PKC412A2104E2|Lack of Efficacy|0|||
94597682|NCT00045942|323989707|FG004|PKC412A2104E2|Lack of Efficacy|0|||
94597683|NCT00045942|323989708|FG005|PKC412A2104E2|Lack of Efficacy|3|||
94597684|NCT00045942|323989709|FG006|PKC412A2104E2|Lack of Efficacy|2|||
94597685|NCT00045942|323989710|FG007|PKC412A2104E2|Lack of Efficacy|2|||
94597686|NCT00045942|323989711|FG008|PKC412A2104E2|Lack of Efficacy|6|||
94597687|NCT00045942|323989703|FG000|PKC412A2104E2|Adverse Event|0|||
94597688|NCT00045942|323989704|FG001|PKC412A2104E2|Adverse Event|0|||
94597689|NCT00045942|323989705|FG002|PKC412A2104E2|Adverse Event|0|||
94597690|NCT00045942|323989706|FG003|PKC412A2104E2|Adverse Event|0|||
94597691|NCT00045942|323989707|FG004|PKC412A2104E2|Adverse Event|0|||
94597692|NCT00045942|323989708|FG005|PKC412A2104E2|Adverse Event|4|||
94597693|NCT00045942|323989709|FG006|PKC412A2104E2|Adverse Event|3|||
94597694|NCT00045942|323989710|FG007|PKC412A2104E2|Adverse Event|1|||
94247489|NCT01871805|322701126|FG003|Phase II|Death|0|||
94247490|NCT01871805|322701127|FG004|Phase II|Death|0|||
94597695|NCT00045942|323989711|FG008|PKC412A2104E2|Adverse Event|0|||
94597696|NCT00045942|323989703|FG000|PKC412A2104E2|Death|0|||
94597697|NCT00045942|323989704|FG001|PKC412A2104E2|Death|0|||
94597698|NCT00045942|323989705|FG002|PKC412A2104E2|Death|0|||
94597699|NCT00045942|323989706|FG003|PKC412A2104E2|Death|0|||
94597700|NCT00045942|323989707|FG004|PKC412A2104E2|Death|0|||
94597701|NCT00045942|323989708|FG005|PKC412A2104E2|Death|1|||
94597702|NCT00045942|323989709|FG006|PKC412A2104E2|Death|2|||
94597703|NCT00045942|323989710|FG007|PKC412A2104E2|Death|0|||
94597704|NCT00045942|323989711|FG008|PKC412A2104E2|Death|0|||
94597705|NCT02142387|323989712|FG000|Overall Study|<19 years old|49|||
94597706|NCT02142387|323989713|FG001|Overall Study|<19 years old|326|||
94597707|NCT02142387|323989712|FG000|Overall Study|non-cardiac etiology|504|||
94597708|NCT02142387|323989713|FG001|Overall Study|non-cardiac etiology|3431|||
94597709|NCT02142387|323989712|FG000|Overall Study|CPR not performed|74|||
94597710|NCT02142387|323989713|FG001|Overall Study|CPR not performed|473|||
94597711|NCT02142387|323989712|FG000|Overall Study|witnessed by paramedic|139|||
94597712|NCT02142387|323989713|FG001|Overall Study|witnessed by paramedic|917|||
94597713|NCT02142387|323989712|FG000|Overall Study|incomplete data|1|||
94597714|NCT02142387|323989713|FG001|Overall Study|incomplete data|9|||
94597715|NCT02142387|323989712|FG000|Overall Study|occurred not at home|298|||
94597716|NCT02142387|323989713|FG001|Overall Study|occurred not at home|2474|||
94597717|NCT05028361|323989714|FG000|Overall Study|Withdrawal by Subject|1|||
94597718|NCT05028361|323989715|FG001|Overall Study|Withdrawal by Subject|0|||
94597719|NCT02122783|323989723|FG000|Overall Study|Adverse Event|0|||
94597720|NCT02122783|323989724|FG001|Overall Study|Adverse Event|1|||
94597721|NCT00329849|323989725|FG000|Overall Study|Withdrawal by Subject|6|||
94597722|NCT00329849|323989726|FG001|Overall Study|Withdrawal by Subject|4|||
94597723|NCT01743001|323989730|FG000|Overall Study|Physician Decision|1|||
94597724|NCT01743001|323989731|FG001|Overall Study|Physician Decision|0|||
94597725|NCT01743001|323989730|FG000|Overall Study|Pregnancy|1|||
94597726|NCT01743001|323989731|FG001|Overall Study|Pregnancy|0|||
94457821|NCT00614523|323465622|FG001|Overall Study|Disease Progression|8|||
94597727|NCT01743001|323989730|FG000|Overall Study|Death|1|||
94597728|NCT01743001|323989731|FG001|Overall Study|Death|0|||
94597729|NCT04987944|323989736|FG000|Overall Study|Adverse Event|0|||
94597730|NCT04987944|323989737|FG001|Overall Study|Adverse Event|1|||
94597731|NCT04987944|323989736|FG000|Overall Study|Withdrawal by Subject|0|||
94597732|NCT04987944|323989737|FG001|Overall Study|Withdrawal by Subject|1|||
94597733|NCT04905498|323989744|FG000|Overall Study|Lost to Follow-up|0|||
94597734|NCT04905498|323989745|FG001|Overall Study|Lost to Follow-up|2|||
94597735|NCT04905498|323989744|FG000|Overall Study|COVID lockdown|1|||
94597736|NCT04905498|323989745|FG001|Overall Study|COVID lockdown|0|||
94597737|NCT02239120|323989746|FG000|Overall Study|Death|56|||
94597738|NCT02239120|323989747|FG001|Overall Study|Death|58|||
94597739|NCT02239120|323989746|FG000|Overall Study|Lost to Follow-up|19|||
94597740|NCT02239120|323989747|FG001|Overall Study|Lost to Follow-up|14|||
94597741|NCT00466687|323989748|FG000|Overall Study|Adverse Event|1|||
94597742|NCT00466687|323989748|FG000|Overall Study|Other complicating illness|3|||
94597743|NCT00466687|323989748|FG000|Overall Study|Withdrawal by Subject|1|||
94597744|NCT00466687|323989748|FG000|Overall Study|Disease progression|29|||
94597745|NCT02213133|323989749|FG000|Overall Study|Participant discontinued study therapy|2|||
94597746|NCT02213133|323989750|FG001|Overall Study|Participant discontinued study therapy|0|||
94597747|NCT02213133|323989751|FG002|Overall Study|Participant discontinued study therapy|0|||
94597748|NCT02213133|323989749|FG000|Overall Study|Participant withdrew informed consent|2|||
94597749|NCT02213133|323989750|FG001|Overall Study|Participant withdrew informed consent|1|||
94597750|NCT02213133|323989751|FG002|Overall Study|Participant withdrew informed consent|2|||
94597751|NCT02213133|323989749|FG000|Overall Study|Disease progression|11|||
94597752|NCT02213133|323989750|FG001|Overall Study|Disease progression|2|||
94597753|NCT02213133|323989751|FG002|Overall Study|Disease progression|0|||
94597754|NCT02213133|323989749|FG000|Overall Study|Adverse Event (AE)|1|||
94597755|NCT02213133|323989750|FG001|Overall Study|Adverse Event (AE)|0|||
94597756|NCT02213133|323989751|FG002|Overall Study|Adverse Event (AE)|0|||
94597757|NCT02213133|323989749|FG000|Overall Study|Death|16|||
94597758|NCT02213133|323989750|FG001|Overall Study|Death|2|||
94597759|NCT02213133|323989751|FG002|Overall Study|Death|1|||
94597760|NCT02213133|323989749|FG000|Overall Study|Other|5|||
94597761|NCT02213133|323989750|FG001|Overall Study|Other|0|||
94597762|NCT02213133|323989751|FG002|Overall Study|Other|0|||
94597763|NCT01224782|323989774|FG000|Overall Study|Lost to Follow-up|177|||
94597764|NCT01224782|323989774|FG000|Overall Study|Withdrawal by Subject|16|||
94597765|NCT01224782|323989774|FG000|Overall Study|Death|14|||
94597766|NCT01224782|323989774|FG000|Overall Study|Improvement|13|||
94597767|NCT01224782|323989774|FG000|Overall Study|Adverse Event|12|||
94597768|NCT01224782|323989774|FG000|Overall Study|Adverse Reaction|11|||
94597769|NCT01224782|323989774|FG000|Overall Study|Noncompliance|10|||
94597770|NCT01224782|323989774|FG000|Overall Study|Other|4|||
94597771|NCT01224782|323989774|FG000|Overall Study|Start of Dialysis|3|||
94597772|NCT01224782|323989774|FG000|Overall Study|Change of Treatment|1|||
94597773|NCT01224782|323989774|FG000|Overall Study|Financial Reasons|1|||
94597774|NCT01224782|323989774|FG000|Overall Study|Deterioration|1|||
94597775|NCT01224782|323989774|FG000|Overall Study|Transplantation|1|||
94597776|NCT01238588|323989781|FG000|Overall Study|Withdrawal by Subject|1|||
94597777|NCT01238588|323989781|FG000|Overall Study|Physician Decision|2|||
94597778|NCT01587898|323989786|FG000|Overall Study|Adverse Event|1|||
94597779|NCT01587898|323989787|FG001|Overall Study|Adverse Event|1|||
94597780|NCT01587898|323989788|FG002|Overall Study|Adverse Event|0|||
94597781|NCT01587898|323989789|FG003|Overall Study|Adverse Event|0|||
94597782|NCT01587898|323989786|FG000|Overall Study|Protocol Violation|0|||
94597783|NCT01587898|323989787|FG001|Overall Study|Protocol Violation|2|||
94597784|NCT01587898|323989788|FG002|Overall Study|Protocol Violation|1|||
94597785|NCT01587898|323989789|FG003|Overall Study|Protocol Violation|1|||
94597786|NCT01587898|323989786|FG000|Overall Study|Lost to Follow-up|0|||
94597787|NCT01587898|323989787|FG001|Overall Study|Lost to Follow-up|0|||
94597788|NCT01587898|323989788|FG002|Overall Study|Lost to Follow-up|0|||
94597789|NCT01587898|323989789|FG003|Overall Study|Lost to Follow-up|1|||
94247491|NCT01871805|322701128|FG005|Phase II|Death|45|||
94247492|NCT01871805|322701123|FG000|Phase II|Alive in Survival Follow-up|0|||
94247493|NCT01871805|322701124|FG001|Phase II|Alive in Survival Follow-up|0|||
94247494|NCT01871805|322701125|FG002|Phase II|Alive in Survival Follow-up|0|||
94247495|NCT01871805|322701126|FG003|Phase II|Alive in Survival Follow-up|0|||
94247496|NCT01871805|322701127|FG004|Phase II|Alive in Survival Follow-up|0|||
94247497|NCT01871805|322701128|FG005|Phase II|Alive in Survival Follow-up|29|||
94247498|NCT01871805|322701123|FG000|Phase II|Lost to Follow-up|0|||
94247499|NCT01871805|322701124|FG001|Phase II|Lost to Follow-up|0|||
94247500|NCT01871805|322701125|FG002|Phase II|Lost to Follow-up|0|||
94247501|NCT01871805|322701126|FG003|Phase II|Lost to Follow-up|0|||
94247502|NCT01871805|322701127|FG004|Phase II|Lost to Follow-up|0|||
94247503|NCT01871805|322701128|FG005|Phase II|Lost to Follow-up|13|||
94247504|NCT00635427|322701129|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
94247505|NCT00635427|322701130|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
94247506|NCT00635427|322701131|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
94247507|NCT00635427|322701132|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
94247508|NCT00635427|322701133|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
94247509|NCT00635427|322701129|FG000|Overall Study|Death|0|||
94247510|NCT00635427|322701130|FG001|Overall Study|Death|0|||
94247511|NCT00635427|322701131|FG002|Overall Study|Death|0|||
94247512|NCT00635427|322701132|FG003|Overall Study|Death|1|||
94247513|NCT00635427|322701133|FG004|Overall Study|Death|0|||
94247514|NCT00635427|322701129|FG000|Overall Study|Termination Of Study By Sponsor|12|||
94247515|NCT00635427|322701130|FG001|Overall Study|Termination Of Study By Sponsor|6|||
94247516|NCT00635427|322701131|FG002|Overall Study|Termination Of Study By Sponsor|10|||
94247517|NCT00635427|322701132|FG003|Overall Study|Termination Of Study By Sponsor|6|||
94247518|NCT00635427|322701133|FG004|Overall Study|Termination Of Study By Sponsor|6|||
94247519|NCT00635427|322701129|FG000|Overall Study|Withdrawal Of Consent|0|||
94247520|NCT00635427|322701130|FG001|Overall Study|Withdrawal Of Consent|0|||
94247521|NCT00635427|322701131|FG002|Overall Study|Withdrawal Of Consent|0|||
94247522|NCT00635427|322701132|FG003|Overall Study|Withdrawal Of Consent|2|||
94247523|NCT00635427|322701133|FG004|Overall Study|Withdrawal Of Consent|2|||
94247524|NCT02081417|322701134|FG000|Overall Study|Lost to Follow-up|26|||
94247525|NCT02081417|322701135|FG001|Overall Study|Lost to Follow-up|23|||
94247526|NCT02081417|322701134|FG000|Overall Study|Moved Away|1|||
94247527|NCT02081417|322701135|FG001|Overall Study|Moved Away|2|||
94247528|NCT02081417|322701134|FG000|Overall Study|Incarcerated|2|||
94247529|NCT02081417|322701135|FG001|Overall Study|Incarcerated|2|||
94247530|NCT02081417|322701134|FG000|Overall Study|Death|4|||
94247531|NCT02081417|322701135|FG001|Overall Study|Death|3|||
94247532|NCT02081417|322701134|FG000|Overall Study|Withdrawal by Subject|4|||
94247533|NCT02081417|322701135|FG001|Overall Study|Withdrawal by Subject|0|||
94247534|NCT02081417|322701134|FG000|Overall Study|Admitted to Residential Treatment|2|||
94247535|NCT02081417|322701135|FG001|Overall Study|Admitted to Residential Treatment|0|||
94247536|NCT02081417|322701134|FG000|Overall Study|Did not start treatment|17|||
94247537|NCT02081417|322701135|FG001|Overall Study|Did not start treatment|21|||
94247538|NCT04075994|322701136|FG000|Overall Study|Withdrawal by Subject|8|||
94247539|NCT04075994|322701137|FG001|Overall Study|Withdrawal by Subject|9|||
94247540|NCT04075994|322701136|FG000|Overall Study|Adverse Event|2|||
94247541|NCT04075994|322701137|FG001|Overall Study|Adverse Event|2|||
94247542|NCT04075994|322701136|FG000|Overall Study|Investigator withdrew|3|||
94247543|NCT04075994|322701137|FG001|Overall Study|Investigator withdrew|1|||
94247544|NCT01145898|322701139|FG000|3-year Treatment|medication change by treating physician|3|||
94247545|NCT01145898|322701140|FG001|3-year Treatment|medication change by treating physician|16|||
94247546|NCT02884908|322701141|FG000|Overall Study|Lost to Follow-up|13|||
94247547|NCT02884908|322701142|FG001|Overall Study|Lost to Follow-up|18|||
94355966|NCT03799198|323085746|FG001|Overall Study|Lost to Follow-up|8|||
94355967|NCT03799198|323085745|FG000|Overall Study|Death|0|||
94355968|NCT03799198|323085746|FG001|Overall Study|Death|1|||
94355969|NCT01153971|323085754|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
94247548|NCT04860297|322701143|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
94247549|NCT04860297|322701144|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
94247550|NCT04860297|322701145|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
94247551|NCT04860297|322701146|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
94247552|NCT04860297|322701147|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
94247553|NCT04860297|322701148|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
94247554|NCT04860297|322701149|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
94247555|NCT04860297|322701150|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
94247556|NCT04860297|322701143|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
94247557|NCT04860297|322701144|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
94247558|NCT04860297|322701145|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
94247559|NCT04860297|322701146|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
94247560|NCT04860297|322701147|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
94355970|NCT01153971|323085754|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
94660420|NCT04401579|324211650|FG000|Overall Study|Scheduling error|1|||
94597790|NCT01587898|323989786|FG000|Overall Study|Withdrawal by Subject|2|||
94597791|NCT01587898|323989787|FG001|Overall Study|Withdrawal by Subject|1|||
94597792|NCT01587898|323989788|FG002|Overall Study|Withdrawal by Subject|0|||
94247561|NCT04860297|322701148|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
94247562|NCT04860297|322701149|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
94597793|NCT01587898|323989789|FG003|Overall Study|Withdrawal by Subject|0|||
94247563|NCT04860297|322701150|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
94247564|NCT04860297|322701143|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
94247565|NCT04860297|322701144|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
94247566|NCT04860297|322701145|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
94247567|NCT04860297|322701146|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
94247568|NCT04860297|322701147|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
94247569|NCT04860297|322701148|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
94247570|NCT04860297|322701149|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
94247571|NCT04860297|322701150|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
94247572|NCT04860297|322701143|FG000|Part B (Booster Dose)|Other Than Specified|0|||
94247573|NCT04860297|322701144|FG001|Part B (Booster Dose)|Other Than Specified|0|||
94247574|NCT04860297|322701145|FG002|Part B (Booster Dose)|Other Than Specified|0|||
94247575|NCT04860297|322701146|FG003|Part B (Booster Dose)|Other Than Specified|0|||
94247576|NCT04860297|322701147|FG004|Part B (Booster Dose)|Other Than Specified|0|||
94247577|NCT04860297|322701148|FG005|Part B (Booster Dose)|Other Than Specified|1|||
94247578|NCT04860297|322701149|FG006|Part B (Booster Dose)|Other Than Specified|1|||
94247579|NCT04860297|322701150|FG007|Part B (Booster Dose)|Other Than Specified|0|||
94247580|NCT04860297|322701143|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
94247581|NCT04860297|322701144|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
94247582|NCT04860297|322701145|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
94247583|NCT04860297|322701146|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
94247584|NCT04860297|322701147|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
94247585|NCT04860297|322701148|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
94247586|NCT04860297|322701149|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
94247587|NCT04860297|322701150|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
94247588|NCT04860297|322701143|FG000|Part B (Booster Dose)|Death|0|||
94247589|NCT04860297|322701144|FG001|Part B (Booster Dose)|Death|0|||
94247590|NCT04860297|322701145|FG002|Part B (Booster Dose)|Death|0|||
94247591|NCT04860297|322701146|FG003|Part B (Booster Dose)|Death|0|||
94247592|NCT04860297|322701147|FG004|Part B (Booster Dose)|Death|1|||
94247593|NCT04860297|322701148|FG005|Part B (Booster Dose)|Death|2|||
94247594|NCT04860297|322701149|FG006|Part B (Booster Dose)|Death|1|||
94597794|NCT01587898|323989786|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
94247595|NCT04860297|322701150|FG007|Part B (Booster Dose)|Death|0|||
94247596|NCT04860297|322701143|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
94247597|NCT04860297|322701144|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
94247598|NCT04860297|322701145|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
94247599|NCT04860297|322701146|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
94247600|NCT04860297|322701147|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
94247601|NCT04860297|322701148|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
94247602|NCT04860297|322701149|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
94247603|NCT04860297|322701150|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
94247604|NCT00958841|322701154|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94247605|NCT00958841|322701154|FG000|Overall Study|Abnormal test procedure result(s)|3|||
94247606|NCT00958841|322701154|FG000|Overall Study|Administrative problems|1|||
94247607|NCT00958841|322701154|FG000|Overall Study|Adverse Event|8|||
94247608|NCT00958841|322701154|FG000|Overall Study|New cancer therapy|5|||
94247609|NCT00958841|322701154|FG000|Overall Study|Withdrawal by Subject|1|||
94247610|NCT00958841|322701154|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
94247611|NCT00958841|322701154|FG000|Overall Study|Completed M6/did not enter extension|27|||
94247612|NCT00958841|322701154|FG000|Overall Study|Discontinued prior to M*|28|||
94597795|NCT01587898|323989787|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
94597796|NCT01587898|323989788|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
94247613|NCT00468559|322701158|FG000|Open-label Treatment Phase|Adverse Event|5|||
94247614|NCT00468559|322701159|FG001|Open-label Treatment Phase|Adverse Event|0|||
94597797|NCT01587898|323989789|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
94597798|NCT00502203|323989790|FG000|Overall Study|Inevaluable|1|||
94597799|NCT00308581|323989791|FG000|Induction Phase|Adverse Event|0|||
94247615|NCT00468559|322701160|FG002|Open-label Treatment Phase|Adverse Event|0|||
94597800|NCT00308581|323989792|FG001|Induction Phase|Adverse Event|0|||
94597801|NCT00308581|323989793|FG002|Induction Phase|Adverse Event|37|||
94247616|NCT00468559|322701158|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
94247617|NCT00468559|322701159|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
94247618|NCT00468559|322701160|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
94247619|NCT00468559|322701158|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
94597802|NCT00308581|323989791|FG000|Induction Phase|Lack of Efficacy|0|||
94597803|NCT00308581|323989792|FG001|Induction Phase|Lack of Efficacy|0|||
94597804|NCT00308581|323989793|FG002|Induction Phase|Lack of Efficacy|121|||
94355971|NCT01153971|323085754|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
94355972|NCT01153971|323085754|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
94355973|NCT01153971|323085754|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
94355974|NCT01153971|323085754|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
94355975|NCT01153971|323085754|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
94355976|NCT00953576|323085755|FG000|Overall Study|Adverse Event|0|||
94355977|NCT00953576|323085756|FG001|Overall Study|Adverse Event|1|||
94355978|NCT00953576|323085755|FG000|Overall Study|Ineligible after Consent|2|||
94355979|NCT00953576|323085756|FG001|Overall Study|Ineligible after Consent|0|||
94355980|NCT03039686|323085759|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
94355981|NCT03039686|323085760|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
94355982|NCT03039686|323085761|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
94355983|NCT03039686|323085759|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
94355984|NCT03039686|323085760|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
94355985|NCT03039686|323085761|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
94355986|NCT03039686|323085759|FG000|Double-blind Period|Withdrawal by Subject|2|||
94355987|NCT03039686|323085760|FG001|Double-blind Period|Withdrawal by Subject|2|||
94355988|NCT03039686|323085761|FG002|Double-blind Period|Withdrawal by Subject|1|||
94355989|NCT03039686|323085759|FG000|Double-blind Period|Death|0|||
94355990|NCT03039686|323085760|FG001|Double-blind Period|Death|0|||
94355991|NCT03039686|323085761|FG002|Double-blind Period|Death|1|||
94355992|NCT03039686|323085759|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
94355993|NCT03039686|323085760|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
94355994|NCT03039686|323085761|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
94355995|NCT03039686|323085759|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
94597805|NCT00308581|323989791|FG000|Induction Phase|Withdrawal by Subject|0|||
94597806|NCT00308581|323989792|FG001|Induction Phase|Withdrawal by Subject|0|||
94597807|NCT00308581|323989793|FG002|Induction Phase|Withdrawal by Subject|5|||
94597808|NCT00308581|323989791|FG000|Induction Phase|Unknown reason|0|||
94597809|NCT00308581|323989792|FG001|Induction Phase|Unknown reason|0|||
94597810|NCT00308581|323989793|FG002|Induction Phase|Unknown reason|3|||
94597811|NCT00308581|323989791|FG000|Randomized Maintenance Phase|Adverse Event|10|||
94597812|NCT00308581|323989792|FG001|Randomized Maintenance Phase|Adverse Event|17|||
94597813|NCT00308581|323989793|FG002|Randomized Maintenance Phase|Adverse Event|0|||
94597814|NCT00308581|323989791|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
94597815|NCT00308581|323989792|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
94597816|NCT00308581|323989793|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
94597817|NCT00308581|323989791|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
94597818|NCT00308581|323989792|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
94597819|NCT00308581|323989793|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
94597820|NCT00308581|323989791|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
94597821|NCT00308581|323989792|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
94597822|NCT00308581|323989793|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
94597823|NCT00308581|323989791|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
94597824|NCT00308581|323989792|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
94597825|NCT00308581|323989793|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
94597826|NCT00308581|323989791|FG000|Randomized Maintenance Phase|Unknown reason|3|||
94597827|NCT00308581|323989792|FG001|Randomized Maintenance Phase|Unknown reason|0|||
94597828|NCT00308581|323989793|FG002|Randomized Maintenance Phase|Unknown reason|0|||
94597829|NCT01917656|323989794|FG000|Overall Study|Adverse Event|11|||
94247620|NCT00468559|322701159|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
94247621|NCT00468559|322701160|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
94247622|NCT00468559|322701158|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
94247623|NCT00468559|322701159|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
94247624|NCT00468559|322701160|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
94247625|NCT00468559|322701158|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
94247626|NCT00468559|322701159|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
94247627|NCT00468559|322701160|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
94247628|NCT04811131|322701161|FG000|Overall Study|Adverse Event|0|||
94247629|NCT04811131|322701162|FG001|Overall Study|Adverse Event|0|||
94247630|NCT04811131|322701163|FG002|Overall Study|Adverse Event|1|||
94247631|NCT04811131|322701164|FG003|Overall Study|Adverse Event|0|||
94247632|NCT04811131|322701161|FG000|Overall Study|Lack of Efficacy|0|||
94247633|NCT04811131|322701162|FG001|Overall Study|Lack of Efficacy|0|||
94247634|NCT04811131|322701163|FG002|Overall Study|Lack of Efficacy|0|||
94247635|NCT04811131|322701164|FG003|Overall Study|Lack of Efficacy|1|||
94247636|NCT04811131|322701161|FG000|Overall Study|Lost to Follow-up|0|||
94247637|NCT04811131|322701162|FG001|Overall Study|Lost to Follow-up|1|||
94247638|NCT04811131|322701163|FG002|Overall Study|Lost to Follow-up|0|||
94247639|NCT04811131|322701164|FG003|Overall Study|Lost to Follow-up|0|||
94247640|NCT04811131|322701161|FG000|Overall Study|Sponsor request|31|||
94247641|NCT04811131|322701162|FG001|Overall Study|Sponsor request|35|||
94247642|NCT04811131|322701163|FG002|Overall Study|Sponsor request|27|||
94247643|NCT04811131|322701164|FG003|Overall Study|Sponsor request|10|||
94247644|NCT04811131|322701161|FG000|Overall Study|Withdrawal by Subject|3|||
94247645|NCT04811131|322701162|FG001|Overall Study|Withdrawal by Subject|1|||
94247646|NCT04811131|322701163|FG002|Overall Study|Withdrawal by Subject|3|||
94247647|NCT04811131|322701164|FG003|Overall Study|Withdrawal by Subject|1|||
94247648|NCT00862719|322701165|FG000|Overall Study|Disease Progression|5|||
94247649|NCT00862719|322701166|FG001|Overall Study|Disease Progression|0|||
94247650|NCT00862719|322701167|FG002|Overall Study|Disease Progression|1|||
94247651|NCT00862719|322701168|FG003|Overall Study|Disease Progression|0|||
94247652|NCT00862719|322701165|FG000|Overall Study|Death|5|||
94247653|NCT00862719|322701166|FG001|Overall Study|Death|6|||
94247654|NCT00862719|322701167|FG002|Overall Study|Death|1|||
94247655|NCT00862719|322701168|FG003|Overall Study|Death|1|||
94247656|NCT00862719|322701165|FG000|Overall Study|Engraftment failure|0|||
94247657|NCT00862719|322701166|FG001|Overall Study|Engraftment failure|0|||
94247658|NCT00862719|322701167|FG002|Overall Study|Engraftment failure|1|||
94247659|NCT00862719|322701168|FG003|Overall Study|Engraftment failure|0|||
94247660|NCT00862719|322701165|FG000|Overall Study|Veno-Occlusive Disease|0|||
94247661|NCT00862719|322701166|FG001|Overall Study|Veno-Occlusive Disease|0|||
94247662|NCT00862719|322701167|FG002|Overall Study|Veno-Occlusive Disease|1|||
94247663|NCT00862719|322701168|FG003|Overall Study|Veno-Occlusive Disease|0|||
94247664|NCT03980808|322701169|FG000|Overall Study|Lost to Follow-up|2|||
94247665|NCT03980808|322701170|FG001|Overall Study|Lost to Follow-up|2|||
94247666|NCT02755818|322701173|FG000|Overall Study|Withdrawal by Subject|0|||
94247667|NCT02755818|322701174|FG001|Overall Study|Withdrawal by Subject|0|||
94247668|NCT02755818|322701175|FG002|Overall Study|Withdrawal by Subject|0|||
94247669|NCT02755818|322701176|FG003|Overall Study|Withdrawal by Subject|2|||
94247670|NCT02755818|322701173|FG000|Overall Study|withdrawal by PI|0|||
94247671|NCT02755818|322701174|FG001|Overall Study|withdrawal by PI|0|||
94247672|NCT02755818|322701175|FG002|Overall Study|withdrawal by PI|1|||
94247673|NCT02755818|322701176|FG003|Overall Study|withdrawal by PI|1|||
94247674|NCT01806623|322701177|FG000|Overall Study|Withdrawal by Subject|1|||
94247675|NCT01806623|322701177|FG000|Overall Study|Adverse Event|1|||
94247676|NCT01806623|322701177|FG000|Overall Study|Did not meet the inclusion criteria|56|||
94247677|NCT00929110|322701180|FG000|Overall Study|Adverse Event|40|||
94247678|NCT00929110|322701181|FG001|Overall Study|Adverse Event|29|||
94247679|NCT00929110|322701182|FG002|Overall Study|Adverse Event|18|||
94247680|NCT00929110|322701180|FG000|Overall Study|Subject withdrew consent|40|||
94247681|NCT00929110|322701181|FG001|Overall Study|Subject withdrew consent|23|||
94247682|NCT00929110|322701182|FG002|Overall Study|Subject withdrew consent|26|||
94247683|NCT00929110|322701180|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
94247684|NCT00929110|322701181|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
94247685|NCT00929110|322701182|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
94247686|NCT00929110|322701180|FG000|Overall Study|Lost to Follow-up|7|||
94247687|NCT00929110|322701181|FG001|Overall Study|Lost to Follow-up|7|||
94247688|NCT00929110|322701182|FG002|Overall Study|Lost to Follow-up|3|||
94247689|NCT00929110|322701180|FG000|Overall Study|Protocol deviation|5|||
94247690|NCT00929110|322701181|FG001|Overall Study|Protocol deviation|2|||
94247691|NCT00929110|322701182|FG002|Overall Study|Protocol deviation|4|||
94247692|NCT00929110|322701180|FG000|Overall Study|Administrative problems|4|||
94247693|NCT00929110|322701181|FG001|Overall Study|Administrative problems|1|||
94247694|NCT00929110|322701182|FG002|Overall Study|Administrative problems|2|||
94247695|NCT00929110|322701180|FG000|Overall Study|Death|2|||
94247696|NCT00929110|322701181|FG001|Overall Study|Death|2|||
94247697|NCT00929110|322701182|FG002|Overall Study|Death|2|||
94247698|NCT00929110|322701180|FG000|Overall Study|Abnormal laboratory value(s)|0|||
94247699|NCT00929110|322701181|FG001|Overall Study|Abnormal laboratory value(s)|1|||
94247700|NCT00929110|322701182|FG002|Overall Study|Abnormal laboratory value(s)|0|||
94247701|NCT00929110|322701180|FG000|Overall Study|Abnormal test procedure result(s)|0|||
94247702|NCT00929110|322701181|FG001|Overall Study|Abnormal test procedure result(s)|1|||
94247703|NCT00929110|322701182|FG002|Overall Study|Abnormal test procedure result(s)|1|||
94247704|NCT00929110|322701180|FG000|Overall Study|Patient inability to use the device|0|||
94247705|NCT00929110|322701181|FG001|Overall Study|Patient inability to use the device|1|||
94355996|NCT03039686|323085760|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
94355997|NCT03039686|323085761|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
94355998|NCT03039686|323085759|FG000|Open Label Period|Withdrawal by Subject|0|||
94660421|NCT04401579|324211651|FG001|Overall Study|Scheduling error|2|||
94660422|NCT04401579|324211650|FG000|Overall Study|Transferred to another hospital|1|||
94247706|NCT00929110|322701182|FG002|Overall Study|Patient inability to use the device|0|||
94247707|NCT01964924|322701183|FG000|Trametinib Monotherapy|Progression|19|||
94247708|NCT01964924|322701184|FG001|Trametinib Monotherapy|Progression|0|||
94247709|NCT02217475|322701185|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
94247710|NCT02217475|322701186|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
94247711|NCT02217475|322701187|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
94457822|NCT00614523|323465621|FG000|Overall Study|Administrative Decision|23|||
94597830|NCT01917656|323989795|FG001|Overall Study|Adverse Event|0|||
94597831|NCT01917656|323989794|FG000|Overall Study|Withdrawal criteria|8|||
94597832|NCT01917656|323989795|FG001|Overall Study|Withdrawal criteria|14|||
94597833|NCT01917656|323989794|FG000|Overall Study|Unclassified|0|||
94597834|NCT01917656|323989795|FG001|Overall Study|Unclassified|3|||
94597835|NCT01917656|323989794|FG000|Overall Study|Withdrawal by Subject|4|||
94597836|NCT01917656|323989795|FG001|Overall Study|Withdrawal by Subject|3|||
94597837|NCT01917656|323989794|FG000|Overall Study|Lost to Follow-up|3|||
94597838|NCT01917656|323989795|FG001|Overall Study|Lost to Follow-up|4|||
94597839|NCT02285062|323989796|FG000|Pre-Treatment Period|Protocol Violation|0|||
94597840|NCT02285062|323989797|FG001|Pre-Treatment Period|Protocol Violation|2|||
94597841|NCT02285062|323989796|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
94597842|NCT02285062|323989797|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
94597843|NCT03709576|323989798|FG000|Overall Study|progression prior to enrollment|1|||
94597844|NCT01700439|323989802|FG000|Overall Study|Lost to Follow-up|47|||
94597845|NCT01700439|323989802|FG000|Overall Study|Withdrawal by Subject|183|||
94597846|NCT01700439|323989802|FG000|Overall Study|Death|186|||
94597847|NCT03678870|323989803|FG000|Overall Study|prescribed non- protocol medications|10|||
94597848|NCT03678870|323989804|FG001|Overall Study|prescribed non- protocol medications|6|||
94597849|NCT03678870|323989803|FG000|Overall Study|Lost to Follow-up|3|||
94597850|NCT03678870|323989804|FG001|Overall Study|Lost to Follow-up|2|||
94597851|NCT03612856|323989805|FG000|Pre-dose Period|Physician Decision|0|||
94597852|NCT03612856|323989806|FG001|Pre-dose Period|Physician Decision|1|||
94597853|NCT03612856|323989807|FG002|Pre-dose Period|Physician Decision|1|||
94597854|NCT03612856|323989805|FG000|Pre-dose Period|Withdrawal by Subject|0|||
94597855|NCT03612856|323989806|FG001|Pre-dose Period|Withdrawal by Subject|1|||
94597856|NCT03612856|323989807|FG002|Pre-dose Period|Withdrawal by Subject|0|||
94597857|NCT00169442|323989808|FG000|Overall Study|Withdrawal by Subject|0|||
94597858|NCT00169442|323989809|FG001|Overall Study|Withdrawal by Subject|0|||
94597859|NCT00169442|323989810|FG002|Overall Study|Withdrawal by Subject|1|||
94597860|NCT00169442|323989811|FG003|Overall Study|Withdrawal by Subject|0|||
94597861|NCT00169442|323989812|FG004|Overall Study|Withdrawal by Subject|0|||
94597862|NCT00169442|323989813|FG005|Overall Study|Withdrawal by Subject|0|||
94597863|NCT00169442|323989808|FG000|Overall Study|Migrated/moved from study area|0|||
94597864|NCT00169442|323989809|FG001|Overall Study|Migrated/moved from study area|0|||
94597865|NCT00169442|323989810|FG002|Overall Study|Migrated/moved from study area|0|||
94597866|NCT00169442|323989811|FG003|Overall Study|Migrated/moved from study area|0|||
94597867|NCT00169442|323989812|FG004|Overall Study|Migrated/moved from study area|0|||
94597868|NCT00169442|323989813|FG005|Overall Study|Migrated/moved from study area|2|||
94597869|NCT00169442|323989808|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
94597870|NCT00169442|323989809|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
94597871|NCT00169442|323989810|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
94660423|NCT04401579|324211651|FG001|Overall Study|Transferred to another hospital|2|||
94660424|NCT01863680|324211652|FG000|Overall Study|Adverse Event|17|||
94597872|NCT00169442|323989811|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
94597873|NCT00169442|323989812|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
94597874|NCT00169442|323989813|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
94597875|NCT00169442|323989808|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
94597876|NCT00169442|323989809|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
94597877|NCT00169442|323989810|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
94597878|NCT00169442|323989811|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
94597879|NCT00169442|323989812|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
94597880|NCT00169442|323989813|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
94597881|NCT01426789|323989814|FG000|Part 1|Protocol deviation|0|||
94597882|NCT01426789|323989815|FG001|Part 1|Protocol deviation|1|||
94597883|NCT01426789|323989816|FG002|Part 1|Protocol deviation|0|||
94597884|NCT01426789|323989817|FG003|Part 1|Protocol deviation|0|||
94597885|NCT01426789|323989818|FG004|Part 1|Protocol deviation|0|||
94597886|NCT01426789|323989819|FG005|Part 1|Protocol deviation|0|||
94597887|NCT01426789|323989814|FG000|Part 1|Lost to Follow-up|1|||
94597888|NCT01426789|323989815|FG001|Part 1|Lost to Follow-up|2|||
94597889|NCT01426789|323989816|FG002|Part 1|Lost to Follow-up|0|||
94597890|NCT01426789|323989817|FG003|Part 1|Lost to Follow-up|0|||
94597891|NCT01426789|323989818|FG004|Part 1|Lost to Follow-up|0|||
94597892|NCT01426789|323989819|FG005|Part 1|Lost to Follow-up|0|||
94597893|NCT01426789|323989814|FG000|Part 1|Lack of Efficacy|2|||
94597894|NCT01426789|323989815|FG001|Part 1|Lack of Efficacy|1|||
94597895|NCT01426789|323989816|FG002|Part 1|Lack of Efficacy|0|||
94597896|NCT01426789|323989817|FG003|Part 1|Lack of Efficacy|0|||
94597897|NCT01426789|323989818|FG004|Part 1|Lack of Efficacy|0|||
94597898|NCT01426789|323989819|FG005|Part 1|Lack of Efficacy|0|||
94597899|NCT01426789|323989814|FG000|Part 1|Adverse Event|3|||
94597900|NCT01426789|323989815|FG001|Part 1|Adverse Event|0|||
94597901|NCT01426789|323989816|FG002|Part 1|Adverse Event|0|||
94597902|NCT01426789|323989817|FG003|Part 1|Adverse Event|0|||
94597903|NCT01426789|323989818|FG004|Part 1|Adverse Event|0|||
94247712|NCT02217475|322701185|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
94247713|NCT02217475|322701186|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
94247714|NCT02217475|322701187|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
94247715|NCT02217475|322701185|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
94247716|NCT02217475|322701186|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
94247717|NCT02217475|322701187|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
94247718|NCT02217475|322701185|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
94247719|NCT02217475|322701186|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
94247720|NCT02217475|322701187|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
94247721|NCT02217475|322701185|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
94247722|NCT02217475|322701186|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
94247723|NCT02217475|322701187|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
94247724|NCT02217475|322701185|FG000|Discontinued After Period 1|Adverse Event|1|||
94247725|NCT02217475|322701186|FG001|Discontinued After Period 1|Adverse Event|2|||
94247726|NCT02217475|322701187|FG002|Discontinued After Period 1|Adverse Event|0|||
94247727|NCT02217475|322701185|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
94247728|NCT02217475|322701186|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
94247729|NCT02217475|322701187|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
94247730|NCT02217475|322701185|FG000|Discontinued After Period 1|Physician Decision|0|||
94247731|NCT02217475|322701186|FG001|Discontinued After Period 1|Physician Decision|0|||
94247732|NCT02217475|322701187|FG002|Discontinued After Period 1|Physician Decision|1|||
94247733|NCT02217475|322701185|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
94247734|NCT02217475|322701186|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
94247735|NCT02217475|322701187|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
94247736|NCT02217475|322701185|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
94247737|NCT02217475|322701186|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
94247738|NCT02217475|322701187|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
94247739|NCT02217475|322701185|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
94247740|NCT02217475|322701186|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
94247741|NCT02217475|322701187|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
94247742|NCT02217475|322701185|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
94247743|NCT02217475|322701186|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
94247744|NCT02217475|322701187|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
94247745|NCT02217475|322701185|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
94247746|NCT02217475|322701186|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
94247747|NCT02217475|322701187|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
94247748|NCT00844532|322701188|FG000|Overall Study|Death|16|||
94247749|NCT00844532|322701188|FG000|Overall Study|Withdrawal by Subject|16|||
94247750|NCT00844532|322701188|FG000|Overall Study|Lost to Follow-up|7|||
94247751|NCT02576587|322701189|FG000|Baseline|Equipment failure|0|||
94247752|NCT02576587|322701190|FG001|Baseline|Equipment failure|1|||
94247753|NCT02576587|322701189|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
94247754|NCT02576587|322701190|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
94247755|NCT02576587|322701189|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
94247756|NCT02576587|322701190|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
94247757|NCT02576587|322701189|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
94247758|NCT02576587|322701190|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
94247759|NCT02656329|322701191|FG000|Overall Study|Lost to Follow-up|2|||
94247760|NCT02656329|322701192|FG001|Overall Study|Lost to Follow-up|3|||
94247761|NCT02656329|322701191|FG000|Overall Study|Withdrawal by Subject|7|||
94247762|NCT02656329|322701192|FG001|Overall Study|Withdrawal by Subject|6|||
94247763|NCT02656329|322701191|FG000|Overall Study|Study termination by Sponsor|150|||
94247764|NCT02656329|322701192|FG001|Overall Study|Study termination by Sponsor|142|||
94247765|NCT02656329|322701191|FG000|Overall Study|Other than specified above|5|||
94247766|NCT02656329|322701192|FG001|Overall Study|Other than specified above|6|||
94247767|NCT03208036|322701193|FG000|Baseline Assessment|Withdrawal by Subject|1|||
94247768|NCT03208036|322701194|FG001|Baseline Assessment|Withdrawal by Subject|1|||
94247769|NCT03208036|322701193|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
94247770|NCT03208036|322701194|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
94597904|NCT01426789|323989819|FG005|Part 1|Adverse Event|0|||
94597905|NCT01426789|323989814|FG000|Part 2|Protocol deviation|0|||
94597906|NCT01426789|323989815|FG001|Part 2|Protocol deviation|0|||
94597907|NCT01426789|323989816|FG002|Part 2|Protocol deviation|1|||
94597908|NCT01426789|323989817|FG003|Part 2|Protocol deviation|0|||
94597909|NCT01426789|323989818|FG004|Part 2|Protocol deviation|0|||
94597910|NCT01426789|323989819|FG005|Part 2|Protocol deviation|0|||
94597911|NCT01426789|323989814|FG000|Part 2|Death|0|||
94597912|NCT01426789|323989815|FG001|Part 2|Death|0|||
94597913|NCT01426789|323989816|FG002|Part 2|Death|1|||
94597914|NCT01426789|323989817|FG003|Part 2|Death|0|||
94597915|NCT01426789|323989818|FG004|Part 2|Death|1|||
94597916|NCT01426789|323989819|FG005|Part 2|Death|0|||
94597917|NCT01426789|323989814|FG000|Part 2|Administrative problems|0|||
94597918|NCT01426789|323989815|FG001|Part 2|Administrative problems|0|||
94597919|NCT01426789|323989816|FG002|Part 2|Administrative problems|2|||
94597920|NCT01426789|323989817|FG003|Part 2|Administrative problems|0|||
94597921|NCT01426789|323989818|FG004|Part 2|Administrative problems|1|||
94597922|NCT01426789|323989819|FG005|Part 2|Administrative problems|0|||
94597923|NCT01426789|323989814|FG000|Part 2|Lost to Follow-up|0|||
94597924|NCT01426789|323989815|FG001|Part 2|Lost to Follow-up|0|||
94597925|NCT01426789|323989816|FG002|Part 2|Lost to Follow-up|4|||
94597926|NCT01426789|323989817|FG003|Part 2|Lost to Follow-up|0|||
94597927|NCT01426789|323989818|FG004|Part 2|Lost to Follow-up|1|||
94597928|NCT01426789|323989819|FG005|Part 2|Lost to Follow-up|0|||
94597929|NCT01426789|323989814|FG000|Part 2|Withdrawal by Subject|0|||
94597930|NCT01426789|323989815|FG001|Part 2|Withdrawal by Subject|0|||
94597931|NCT01426789|323989816|FG002|Part 2|Withdrawal by Subject|0|||
94597932|NCT01426789|323989817|FG003|Part 2|Withdrawal by Subject|1|||
94597933|NCT01426789|323989818|FG004|Part 2|Withdrawal by Subject|2|||
94597934|NCT01426789|323989819|FG005|Part 2|Withdrawal by Subject|0|||
94597935|NCT01426789|323989814|FG000|Part 2|Lack of Efficacy|0|||
94597936|NCT01426789|323989815|FG001|Part 2|Lack of Efficacy|0|||
94597937|NCT01426789|323989816|FG002|Part 2|Lack of Efficacy|5|||
94597938|NCT01426789|323989817|FG003|Part 2|Lack of Efficacy|0|||
94597939|NCT01426789|323989818|FG004|Part 2|Lack of Efficacy|2|||
94597940|NCT01426789|323989819|FG005|Part 2|Lack of Efficacy|0|||
94597941|NCT01426789|323989814|FG000|Part 2|Adverse Event|0|||
94597942|NCT01426789|323989815|FG001|Part 2|Adverse Event|0|||
94597943|NCT01426789|323989816|FG002|Part 2|Adverse Event|2|||
94597944|NCT01426789|323989817|FG003|Part 2|Adverse Event|0|||
94597945|NCT01426789|323989818|FG004|Part 2|Adverse Event|1|||
94597946|NCT01426789|323989819|FG005|Part 2|Adverse Event|0|||
94597947|NCT01606878|323989820|FG000|Overall Study|Adverse Event|1|||
94597948|NCT01606878|323989821|FG001|Overall Study|Adverse Event|1|||
94597949|NCT01606878|323989822|FG002|Overall Study|Adverse Event|0|||
94597950|NCT01606878|323989823|FG003|Overall Study|Adverse Event|0|||
94597951|NCT01606878|323989824|FG004|Overall Study|Adverse Event|0|||
94597952|NCT01606878|323989825|FG005|Overall Study|Adverse Event|0|||
94597953|NCT01606878|323989826|FG006|Overall Study|Adverse Event|1|||
94597954|NCT01606878|323989827|FG007|Overall Study|Adverse Event|0|||
94597955|NCT01606878|323989828|FG008|Overall Study|Adverse Event|1|||
94597956|NCT01606878|323989829|FG009|Overall Study|Adverse Event|3|||
94597957|NCT01606878|323989830|FG010|Overall Study|Adverse Event|0|||
94597958|NCT01606878|323989820|FG000|Overall Study|Lack of Efficacy|1|||
94597959|NCT01606878|323989821|FG001|Overall Study|Lack of Efficacy|1|||
94597960|NCT01606878|323989822|FG002|Overall Study|Lack of Efficacy|1|||
94597961|NCT01606878|323989823|FG003|Overall Study|Lack of Efficacy|2|||
94597962|NCT01606878|323989824|FG004|Overall Study|Lack of Efficacy|1|||
94597963|NCT01606878|323989825|FG005|Overall Study|Lack of Efficacy|2|||
94597964|NCT01606878|323989826|FG006|Overall Study|Lack of Efficacy|1|||
94597965|NCT01606878|323989827|FG007|Overall Study|Lack of Efficacy|2|||
94597966|NCT01606878|323989828|FG008|Overall Study|Lack of Efficacy|2|||
94597967|NCT01606878|323989829|FG009|Overall Study|Lack of Efficacy|0|||
94597968|NCT01606878|323989830|FG010|Overall Study|Lack of Efficacy|1|||
94597969|NCT01606878|323989820|FG000|Overall Study|Physician Decision|1|||
94597970|NCT01606878|323989821|FG001|Overall Study|Physician Decision|0|||
94597971|NCT01606878|323989822|FG002|Overall Study|Physician Decision|2|||
94597972|NCT01606878|323989823|FG003|Overall Study|Physician Decision|1|||
94597973|NCT01606878|323989824|FG004|Overall Study|Physician Decision|1|||
94597974|NCT01606878|323989825|FG005|Overall Study|Physician Decision|1|||
94597975|NCT01606878|323989826|FG006|Overall Study|Physician Decision|2|||
94597976|NCT01606878|323989827|FG007|Overall Study|Physician Decision|0|||
94597977|NCT01606878|323989828|FG008|Overall Study|Physician Decision|1|||
94597978|NCT01606878|323989829|FG009|Overall Study|Physician Decision|0|||
94597979|NCT01606878|323989830|FG010|Overall Study|Physician Decision|0|||
94597980|NCT01606878|323989820|FG000|Overall Study|Withdrawal by Subject|3|||
94597981|NCT01606878|323989821|FG001|Overall Study|Withdrawal by Subject|2|||
94597982|NCT01606878|323989822|FG002|Overall Study|Withdrawal by Subject|2|||
94597983|NCT01606878|323989823|FG003|Overall Study|Withdrawal by Subject|0|||
94597984|NCT01606878|323989824|FG004|Overall Study|Withdrawal by Subject|1|||
94597985|NCT01606878|323989825|FG005|Overall Study|Withdrawal by Subject|1|||
94597986|NCT01606878|323989826|FG006|Overall Study|Withdrawal by Subject|2|||
94597987|NCT01606878|323989827|FG007|Overall Study|Withdrawal by Subject|1|||
94597988|NCT01606878|323989828|FG008|Overall Study|Withdrawal by Subject|2|||
94597989|NCT01606878|323989829|FG009|Overall Study|Withdrawal by Subject|0|||
94597990|NCT01606878|323989830|FG010|Overall Study|Withdrawal by Subject|2|||
94597991|NCT00329901|323991367|FG000|Overall Study|Withdrawal by Subject|4|||
94597992|NCT00329901|323991368|FG001|Overall Study|Withdrawal by Subject|3|||
94597993|NCT00329901|323991369|FG002|Overall Study|Withdrawal by Subject|2|||
94597994|NCT00329901|323991367|FG000|Overall Study|Lost to Follow-up|2|||
94597995|NCT00329901|323991368|FG001|Overall Study|Lost to Follow-up|0|||
94597996|NCT00329901|323991369|FG002|Overall Study|Lost to Follow-up|1|||
94597997|NCT00329901|323991367|FG000|Overall Study|Protocol Violation|1|||
94597998|NCT00329901|323991368|FG001|Overall Study|Protocol Violation|0|||
94597999|NCT00329901|323991369|FG002|Overall Study|Protocol Violation|1|||
94598000|NCT00329901|323991367|FG000|Overall Study|Unable to classify|2|||
94247771|NCT03208036|322701193|FG000|Intervention|Withdrawal by Subject|3|||
94247772|NCT03208036|322701194|FG001|Intervention|Withdrawal by Subject|2|||
94247773|NCT03208036|322701193|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
94247774|NCT03208036|322701194|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
94247775|NCT01373151|322701195|FG000|Period 1|Lack of Efficacy|3|||
94247776|NCT01373151|322701196|FG001|Period 1|Lack of Efficacy|0|||
94247777|NCT01373151|322701197|FG002|Period 1|Lack of Efficacy|0|||
94247778|NCT01373151|322701198|FG003|Period 1|Lack of Efficacy|0|||
94247779|NCT01373151|322701199|FG004|Period 1|Lack of Efficacy|1|||
94247780|NCT01373151|322701200|FG005|Period 1|Lack of Efficacy|0|||
94247781|NCT01373151|322701201|FG006|Period 1|Lack of Efficacy|0|||
94247782|NCT01373151|322701195|FG000|Period 1|Adverse Event|0|||
94247783|NCT01373151|322701196|FG001|Period 1|Adverse Event|0|||
94247784|NCT01373151|322701197|FG002|Period 1|Adverse Event|1|||
94247785|NCT01373151|322701198|FG003|Period 1|Adverse Event|0|||
94247786|NCT01373151|322701199|FG004|Period 1|Adverse Event|4|||
94247787|NCT01373151|322701200|FG005|Period 1|Adverse Event|3|||
94247788|NCT01373151|322701201|FG006|Period 1|Adverse Event|0|||
94247789|NCT01373151|322701195|FG000|Period 1|Withdrawal by Subject|2|||
94247790|NCT01373151|322701196|FG001|Period 1|Withdrawal by Subject|0|||
94247791|NCT01373151|322701197|FG002|Period 1|Withdrawal by Subject|3|||
94247792|NCT01373151|322701198|FG003|Period 1|Withdrawal by Subject|1|||
94247793|NCT01373151|322701199|FG004|Period 1|Withdrawal by Subject|0|||
94247794|NCT01373151|322701200|FG005|Period 1|Withdrawal by Subject|1|||
94247795|NCT01373151|322701201|FG006|Period 1|Withdrawal by Subject|0|||
94247796|NCT01373151|322701195|FG000|Period 2|Lack of Efficacy|9|||
94247797|NCT01373151|322701196|FG001|Period 2|Lack of Efficacy|0|||
94247798|NCT01373151|322701197|FG002|Period 2|Lack of Efficacy|0|||
94247799|NCT01373151|322701198|FG003|Period 2|Lack of Efficacy|1|||
94247800|NCT01373151|322701199|FG004|Period 2|Lack of Efficacy|2|||
94247801|NCT01373151|322701200|FG005|Period 2|Lack of Efficacy|0|||
94247802|NCT01373151|322701201|FG006|Period 2|Lack of Efficacy|3|||
94247803|NCT01373151|322701195|FG000|Period 2|Adverse Event|0|||
94247804|NCT01373151|322701196|FG001|Period 2|Adverse Event|0|||
94247805|NCT01373151|322701197|FG002|Period 2|Adverse Event|3|||
94247806|NCT01373151|322701198|FG003|Period 2|Adverse Event|3|||
94247807|NCT01373151|322701199|FG004|Period 2|Adverse Event|0|||
94598001|NCT00329901|323991368|FG001|Overall Study|Unable to classify|2|||
94598002|NCT00329901|323991369|FG002|Overall Study|Unable to classify|0|||
94598003|NCT01433250|323991372|FG000|Overall Study|Protocol Violation|0|||
94598004|NCT01433250|323991373|FG001|Overall Study|Protocol Violation|1|||
94598005|NCT01433250|323991372|FG000|Overall Study|Withdrawal by Subject|3|||
94598006|NCT01433250|323991373|FG001|Overall Study|Withdrawal by Subject|2|||
94598007|NCT00899392|323991374|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
94598008|NCT00899392|323991375|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
94598009|NCT01903252|323991376|FG000|Double-Blind Induction|Adverse Event|20|||
94598010|NCT01903252|323991377|FG001|Double-Blind Induction|Adverse Event|18|||
94598011|NCT01903252|323991378|FG002|Double-Blind Induction|Adverse Event|0|||
94598012|NCT01903252|323991379|FG003|Double-Blind Induction|Adverse Event|0|||
94598013|NCT01903252|323991380|FG004|Double-Blind Induction|Adverse Event|0|||
94598014|NCT01903252|323991381|FG005|Double-Blind Induction|Adverse Event|0|||
94598015|NCT01903252|323991376|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
94598016|NCT01903252|323991377|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
94598017|NCT01903252|323991378|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
94598018|NCT01903252|323991379|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
94598019|NCT01903252|323991380|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
94598020|NCT01903252|323991381|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
94598021|NCT01903252|323991376|FG000|Double-Blind Induction|Physician Decision|2|||
94598022|NCT01903252|323991377|FG001|Double-Blind Induction|Physician Decision|3|||
94598023|NCT01903252|323991378|FG002|Double-Blind Induction|Physician Decision|0|||
94598024|NCT01903252|323991379|FG003|Double-Blind Induction|Physician Decision|0|||
94598025|NCT01903252|323991380|FG004|Double-Blind Induction|Physician Decision|0|||
94598026|NCT01903252|323991381|FG005|Double-Blind Induction|Physician Decision|0|||
94598027|NCT01903252|323991376|FG000|Double-Blind Induction|non-compliance,|7|||
94247808|NCT01373151|322701200|FG005|Period 2|Adverse Event|0|||
94598028|NCT01903252|323991377|FG001|Double-Blind Induction|non-compliance,|7|||
94598029|NCT01903252|323991378|FG002|Double-Blind Induction|non-compliance,|0|||
94660425|NCT01863680|324211652|FG000|Overall Study|Risk of OHSS|17|||
94247809|NCT01373151|322701201|FG006|Period 2|Adverse Event|1|||
94247810|NCT01373151|322701195|FG000|Period 2|subject request to discontinue|0|||
94247811|NCT01373151|322701196|FG001|Period 2|subject request to discontinue|1|||
94247812|NCT01373151|322701197|FG002|Period 2|subject request to discontinue|0|||
94247813|NCT01373151|322701198|FG003|Period 2|subject request to discontinue|0|||
94247814|NCT01373151|322701199|FG004|Period 2|subject request to discontinue|0|||
94247815|NCT01373151|322701200|FG005|Period 2|subject request to discontinue|0|||
94247816|NCT01373151|322701201|FG006|Period 2|subject request to discontinue|0|||
94247817|NCT01373151|322701195|FG000|Period 2|Withdrawal by Subject|0|||
94247818|NCT01373151|322701196|FG001|Period 2|Withdrawal by Subject|0|||
94247819|NCT01373151|322701197|FG002|Period 2|Withdrawal by Subject|0|||
94355999|NCT03039686|323085760|FG001|Open Label Period|Withdrawal by Subject|3|||
94356000|NCT03039686|323085761|FG002|Open Label Period|Withdrawal by Subject|1|||
94356001|NCT02992743|323085770|FG000|Overall Study|Withdrawal by Subject|1|||
94356002|NCT02992743|323085771|FG001|Overall Study|Withdrawal by Subject|1|||
94356003|NCT02992743|323085770|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
94598030|NCT01903252|323991379|FG003|Double-Blind Induction|non-compliance,|0|||
94598031|NCT01903252|323991380|FG004|Double-Blind Induction|non-compliance,|0|||
94598032|NCT01903252|323991381|FG005|Double-Blind Induction|non-compliance,|0|||
94598033|NCT01903252|323991376|FG000|Extended Induction, Open-Label|Adverse Event|0|||
94598034|NCT01903252|323991377|FG001|Extended Induction, Open-Label|Adverse Event|0|||
94598035|NCT01903252|323991378|FG002|Extended Induction, Open-Label|Adverse Event|17|||
94598036|NCT01903252|323991379|FG003|Extended Induction, Open-Label|Adverse Event|0|||
94598037|NCT01903252|323991380|FG004|Extended Induction, Open-Label|Adverse Event|0|||
94598038|NCT01903252|323991381|FG005|Extended Induction, Open-Label|Adverse Event|0|||
94598039|NCT01903252|323991376|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
94598040|NCT01903252|323991377|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
94598041|NCT01903252|323991378|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
94598042|NCT01903252|323991379|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
94598043|NCT01903252|323991380|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
94598044|NCT01903252|323991381|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
94598045|NCT01903252|323991376|FG000|Extended Induction, Open-Label|Physician Decision|0|||
94598046|NCT01903252|323991377|FG001|Extended Induction, Open-Label|Physician Decision|0|||
94598047|NCT01903252|323991378|FG002|Extended Induction, Open-Label|Physician Decision|1|||
94598048|NCT01903252|323991379|FG003|Extended Induction, Open-Label|Physician Decision|0|||
94598049|NCT01903252|323991380|FG004|Extended Induction, Open-Label|Physician Decision|0|||
94598050|NCT01903252|323991381|FG005|Extended Induction, Open-Label|Physician Decision|0|||
94598051|NCT01903252|323991376|FG000|Maintenance, Open-Label|Adverse Event|0|||
94598052|NCT01903252|323991377|FG001|Maintenance, Open-Label|Adverse Event|0|||
94598053|NCT01903252|323991378|FG002|Maintenance, Open-Label|Adverse Event|0|||
94598054|NCT01903252|323991379|FG003|Maintenance, Open-Label|Adverse Event|3|||
94598055|NCT01903252|323991380|FG004|Maintenance, Open-Label|Adverse Event|9|||
94598056|NCT01903252|323991381|FG005|Maintenance, Open-Label|Adverse Event|14|||
94598057|NCT01903252|323991376|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
94598058|NCT01903252|323991377|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
94598059|NCT01903252|323991378|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
94598060|NCT01903252|323991379|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
94598061|NCT01903252|323991380|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
94598062|NCT01903252|323991381|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
94598063|NCT01903252|323991376|FG000|Maintenance, Open-Label|Other|0|||
94598064|NCT01903252|323991377|FG001|Maintenance, Open-Label|Other|0|||
94598065|NCT01903252|323991378|FG002|Maintenance, Open-Label|Other|0|||
94598066|NCT01903252|323991379|FG003|Maintenance, Open-Label|Other|2|||
94598067|NCT01903252|323991380|FG004|Maintenance, Open-Label|Other|6|||
94598068|NCT01903252|323991381|FG005|Maintenance, Open-Label|Other|2|||
94598069|NCT02437110|323991382|FG000|Screening|Lost to Follow-up|3|||
94598070|NCT02437110|323991382|FG000|Screening|Physician Decision|1|||
94598071|NCT02437110|323991382|FG000|ART|Adverse Event|3|||
94598072|NCT02437110|323991382|FG000|ART|Protocol Violation|3|||
94598073|NCT02437110|323991382|FG000|ART|Withdrawal by Subject|4|||
94598074|NCT02437110|323991382|FG000|ART|Lost to follow-up prior to start of intervention|1|||
94598075|NCT02437110|323991382|FG000|ART|Physician decision prior to start of intervention|2|||
94598076|NCT02437110|323991382|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
94598077|NCT02437110|323991382|FG000|Post-ART|Lost to Follow-up|3|||
94598078|NCT02437110|323991382|FG000|Post-ART|Protocol Violation|4|||
94598079|NCT02437110|323991382|FG000|Post-ART|Withdrawal by Subject|3|||
94598080|NCT01431638|323991386|FG000|Overall Study|Adverse Event|1|||
94598081|NCT01431638|323991387|FG001|Overall Study|Adverse Event|3|||
94598082|NCT01431638|323991388|FG002|Overall Study|Adverse Event|1|||
94598083|NCT01431638|323991386|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
94598084|NCT01431638|323991387|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
94598085|NCT01431638|323991388|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
94598086|NCT01431638|323991386|FG000|Overall Study|Participants condition no longer requires study drug|0|||
94598087|NCT01431638|323991387|FG001|Overall Study|Participants condition no longer requires study drug|1|||
94598088|NCT01431638|323991388|FG002|Overall Study|Participants condition no longer requires study drug|0|||
94598089|NCT01431638|323991386|FG000|Overall Study|Participant withdrew consent|14|||
94598090|NCT01431638|323991387|FG001|Overall Study|Participant withdrew consent|5|||
94598091|NCT01431638|323991388|FG002|Overall Study|Participant withdrew consent|8|||
94598092|NCT01431638|323991386|FG000|Overall Study|Lost to Follow-up|7|||
94598093|NCT01431638|323991387|FG001|Overall Study|Lost to Follow-up|9|||
94598094|NCT01431638|323991388|FG002|Overall Study|Lost to Follow-up|7|||
94598095|NCT01431638|323991386|FG000|Overall Study|Administrative problems|1|||
94598096|NCT01431638|323991387|FG001|Overall Study|Administrative problems|4|||
94356004|NCT02992743|323085771|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
94598097|NCT01431638|323991388|FG002|Overall Study|Administrative problems|6|||
94598098|NCT01431638|323991386|FG000|Overall Study|Death|1|||
94598099|NCT01431638|323991387|FG001|Overall Study|Death|0|||
94598100|NCT01431638|323991388|FG002|Overall Study|Death|0|||
94598101|NCT01431638|323991386|FG000|Overall Study|Protocol deviation|1|||
94598102|NCT01431638|323991387|FG001|Overall Study|Protocol deviation|1|||
94598103|NCT01431638|323991388|FG002|Overall Study|Protocol deviation|4|||
94598104|NCT01431638|323991386|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
94598105|NCT01431638|323991387|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
94598106|NCT01431638|323991388|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
94598107|NCT01261780|323991389|FG000|Overall Study|Withdrawal by Subject|1|||
94598108|NCT01261780|323991390|FG001|Overall Study|Withdrawal by Subject|0|||
94598109|NCT01261780|323991389|FG000|Overall Study|Event not related to subject|1|||
94247820|NCT01373151|322701198|FG003|Period 2|Withdrawal by Subject|1|||
94247821|NCT01373151|322701199|FG004|Period 2|Withdrawal by Subject|0|||
94247822|NCT01373151|322701200|FG005|Period 2|Withdrawal by Subject|0|||
94247823|NCT01373151|322701201|FG006|Period 2|Withdrawal by Subject|0|||
94247824|NCT01373151|322701195|FG000|Period 2|Other|0|||
94247825|NCT01373151|322701196|FG001|Period 2|Other|0|||
94247826|NCT01373151|322701197|FG002|Period 2|Other|1|||
94247827|NCT01373151|322701198|FG003|Period 2|Other|0|||
94247828|NCT01373151|322701199|FG004|Period 2|Other|0|||
94247829|NCT01373151|322701200|FG005|Period 2|Other|0|||
94247830|NCT01373151|322701201|FG006|Period 2|Other|1|||
94247831|NCT02842151|322701202|FG000|Overall Study|Adverse Event|1|||
94247832|NCT02842151|322701202|FG000|Overall Study|Subject moved too far away|1|||
94247833|NCT02712905|322701203|FG000|Monotherapy|Death|2|||
94247834|NCT02712905|322701204|FG001|Monotherapy|Death|5|||
94247835|NCT02712905|322701205|FG002|Monotherapy|Death|0|||
94247836|NCT02712905|322701206|FG003|Monotherapy|Death|3|||
94247837|NCT02712905|322701207|FG004|Monotherapy|Death|15|||
94247838|NCT02712905|322701208|FG005|Monotherapy|Death|1|||
94247839|NCT02712905|322701209|FG006|Monotherapy|Death|3|||
94247840|NCT02712905|322701210|FG007|Monotherapy|Death|3|||
94247841|NCT02712905|322701211|FG008|Monotherapy|Death|0|||
94247842|NCT02712905|322701212|FG009|Monotherapy|Death|27|||
94247843|NCT02712905|322701213|FG010|Monotherapy|Death|2|||
94247844|NCT02712905|322701214|FG011|Monotherapy|Death|5|||
94247845|NCT02712905|322701215|FG012|Monotherapy|Death|0|||
94247846|NCT02712905|322701216|FG013|Monotherapy|Death|0|||
94247847|NCT02712905|322701217|FG014|Monotherapy|Death|0|||
94247848|NCT02712905|322701218|FG015|Monotherapy|Death|0|||
94247849|NCT02712905|322701219|FG016|Monotherapy|Death|0|||
94247850|NCT02712905|322701220|FG017|Monotherapy|Death|0|||
94247851|NCT02712905|322701203|FG000|Monotherapy|Lost to Follow-up|0|||
94247852|NCT02712905|322701204|FG001|Monotherapy|Lost to Follow-up|1|||
94247853|NCT02712905|322701205|FG002|Monotherapy|Lost to Follow-up|0|||
94247854|NCT02712905|322701206|FG003|Monotherapy|Lost to Follow-up|1|||
94247855|NCT02712905|322701207|FG004|Monotherapy|Lost to Follow-up|0|||
94247856|NCT02712905|322701208|FG005|Monotherapy|Lost to Follow-up|0|||
94247857|NCT02712905|322701209|FG006|Monotherapy|Lost to Follow-up|0|||
94247858|NCT02712905|322701210|FG007|Monotherapy|Lost to Follow-up|0|||
94598110|NCT01261780|323991390|FG001|Overall Study|Event not related to subject|2|||
94247859|NCT02712905|322701211|FG008|Monotherapy|Lost to Follow-up|0|||
94247860|NCT02712905|322701212|FG009|Monotherapy|Lost to Follow-up|2|||
94247861|NCT02712905|322701213|FG010|Monotherapy|Lost to Follow-up|0|||
94247862|NCT02712905|322701214|FG011|Monotherapy|Lost to Follow-up|0|||
94247863|NCT02712905|322701215|FG012|Monotherapy|Lost to Follow-up|0|||
94247864|NCT02712905|322701216|FG013|Monotherapy|Lost to Follow-up|0|||
94247865|NCT02712905|322701217|FG014|Monotherapy|Lost to Follow-up|0|||
94247866|NCT02712905|322701218|FG015|Monotherapy|Lost to Follow-up|0|||
94247867|NCT02712905|322701219|FG016|Monotherapy|Lost to Follow-up|0|||
94247868|NCT02712905|322701220|FG017|Monotherapy|Lost to Follow-up|0|||
94247869|NCT02712905|322701203|FG000|Monotherapy|Physician Decision|1|||
94247870|NCT02712905|322701204|FG001|Monotherapy|Physician Decision|0|||
94247871|NCT02712905|322701205|FG002|Monotherapy|Physician Decision|0|||
94247872|NCT02712905|322701206|FG003|Monotherapy|Physician Decision|1|||
94247873|NCT02712905|322701207|FG004|Monotherapy|Physician Decision|0|||
94247874|NCT02712905|322701208|FG005|Monotherapy|Physician Decision|0|||
94247875|NCT02712905|322701209|FG006|Monotherapy|Physician Decision|0|||
94247876|NCT02712905|322701210|FG007|Monotherapy|Physician Decision|0|||
94598111|NCT01239732|323991391|FG000|Overall Study|Termination of study per protocol|667|||
94598112|NCT01239732|323991391|FG000|Overall Study|Death|226|||
94598113|NCT01239732|323991391|FG000|Overall Study|Withdrawal by Subject|87|||
94247877|NCT02712905|322701211|FG008|Monotherapy|Physician Decision|0|||
94247878|NCT02712905|322701212|FG009|Monotherapy|Physician Decision|1|||
94247879|NCT02712905|322701213|FG010|Monotherapy|Physician Decision|0|||
94247880|NCT02712905|322701214|FG011|Monotherapy|Physician Decision|0|||
94247881|NCT02712905|322701215|FG012|Monotherapy|Physician Decision|0|||
94247882|NCT02712905|322701216|FG013|Monotherapy|Physician Decision|0|||
94247883|NCT02712905|322701217|FG014|Monotherapy|Physician Decision|0|||
94247884|NCT02712905|322701218|FG015|Monotherapy|Physician Decision|0|||
94247885|NCT02712905|322701219|FG016|Monotherapy|Physician Decision|0|||
94247886|NCT02712905|322701220|FG017|Monotherapy|Physician Decision|0|||
94247887|NCT02712905|322701203|FG000|Monotherapy|Study Terminated by Sponsor|0|||
94598114|NCT01239732|323991391|FG000|Overall Study|Adverse Event|6|||
94598115|NCT01239732|323991391|FG000|Overall Study|Protocol Violation|3|||
94598116|NCT01239732|323991391|FG000|Overall Study|Participant non compliance|5|||
94598117|NCT01239732|323991391|FG000|Overall Study|Study termination by sponsor|2|||
94598118|NCT01239732|323991391|FG000|Overall Study|Investigator's decision|4|||
94598119|NCT01239732|323991391|FG000|Overall Study|Treatment failure|2|||
94598120|NCT01239732|323991391|FG000|Overall Study|Other|19|||
94598121|NCT00732940|323991392|FG000|Overall Study|Withdrawal by Subject|1|||
94598122|NCT00732940|323991393|FG001|Overall Study|Withdrawal by Subject|2|||
94598123|NCT00732940|323991392|FG000|Overall Study|Adverse Event|0|||
94598124|NCT00732940|323991393|FG001|Overall Study|Adverse Event|1|||
94598125|NCT00732940|323991392|FG000|Overall Study|Lost to Follow-up|1|||
94598126|NCT00732940|323991393|FG001|Overall Study|Lost to Follow-up|0|||
94598127|NCT00773838|323991396|FG000|Overall Study|Adverse Event|29|||
94598128|NCT00773838|323991396|FG000|Overall Study|Lost to Follow-up|1|||
94598129|NCT00773838|323991396|FG000|Overall Study|Physician Decision|8|||
94598130|NCT00773838|323991396|FG000|Overall Study|Progressive Disease|82|||
94598131|NCT00773838|323991396|FG000|Overall Study|Protocol Violation|2|||
94598132|NCT00773838|323991396|FG000|Overall Study|Withdrawal by Subject|21|||
94598133|NCT01227824|323991398|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
94598134|NCT01227824|323991399|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
94598135|NCT01227824|323991400|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
94598136|NCT01227824|323991398|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
94598137|NCT01227824|323991399|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
94598138|NCT01227824|323991400|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
94598139|NCT01227824|323991398|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
94598140|NCT01227824|323991399|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
94598141|NCT01227824|323991400|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
94598142|NCT01227824|323991398|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
94598143|NCT01227824|323991399|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
94598144|NCT01227824|323991400|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
94598145|NCT01227824|323991398|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
94598146|NCT01227824|323991399|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
94598147|NCT01227824|323991400|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
94598148|NCT01227824|323991398|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
94598149|NCT01227824|323991399|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
94598150|NCT01227824|323991400|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
94598151|NCT01227824|323991398|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
94598152|NCT01227824|323991399|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
94598153|NCT01227824|323991400|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
94598154|NCT01227824|323991398|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
94598155|NCT01227824|323991399|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
94598156|NCT01227824|323991400|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
94598157|NCT01227824|323991398|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
94598158|NCT01227824|323991399|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
94598159|NCT01227824|323991400|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
94598160|NCT01227824|323991398|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
94598161|NCT01227824|323991399|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
94598162|NCT01227824|323991400|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
94598163|NCT01227824|323991398|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
94598164|NCT01227824|323991399|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
94598165|NCT01227824|323991400|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
94598166|NCT01227824|323991398|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
94598167|NCT01227824|323991399|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
94598168|NCT01227824|323991400|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
94598169|NCT01227824|323991398|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
94598170|NCT01227824|323991399|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
94598171|NCT01227824|323991400|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
94598172|NCT01227824|323991398|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
94598173|NCT01227824|323991399|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
94598174|NCT01227824|323991400|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
94598175|NCT01227824|323991398|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
94598176|NCT01227824|323991399|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
94247888|NCT02712905|322701204|FG001|Monotherapy|Study Terminated by Sponsor|0|||
94247889|NCT02712905|322701205|FG002|Monotherapy|Study Terminated by Sponsor|0|||
94598177|NCT01227824|323991400|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
94356005|NCT02992743|323085770|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
94356006|NCT02992743|323085771|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
94356007|NCT02992743|323085770|FG000|Overall Study|No measurable disease|1|||
94598178|NCT03836001|323991401|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
94598179|NCT03836001|323991402|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
94598180|NCT03836001|323991403|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
94598181|NCT03836001|323991401|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
94598182|NCT03836001|323991402|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
94598183|NCT03836001|323991403|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
94598184|NCT03836001|323991401|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
94598185|NCT03836001|323991402|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
94598186|NCT03836001|323991403|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
94598187|NCT03836001|323991401|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
94598188|NCT03836001|323991402|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
94598189|NCT03836001|323991403|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
94598190|NCT01381562|323991404|FG000|Overall Study|Adverse Event|0|||
94598191|NCT01381562|323991405|FG001|Overall Study|Adverse Event|1|||
94598192|NCT01381562|323991406|FG002|Overall Study|Adverse Event|0|||
94598193|NCT02694757|323991412|FG000|Overall Study|Lack of Efficacy|3|||
94598194|NCT02395302|323991415|FG000|Overall Study|Screen Failure|3|||
94598195|NCT02395302|323991415|FG000|Overall Study|Run In Failure|7|||
94598196|NCT02395302|323991415|FG000|Overall Study|Withdrawal by Subject|2|||
94598197|NCT02395302|323991415|FG000|Overall Study|Physician Decision|2|||
94598198|NCT04604132|323991416|FG000|Overall Study|Adverse Event|2|||
94598199|NCT04604132|323991417|FG001|Overall Study|Adverse Event|0|||
94598200|NCT04604132|323991418|FG002|Overall Study|Adverse Event|0|||
94598201|NCT04604132|323991419|FG003|Overall Study|Adverse Event|1|||
94598202|NCT04604132|323991420|FG004|Overall Study|Adverse Event|2|||
94598203|NCT04604132|323991416|FG000|Overall Study|Study terminated by sponsor|0|||
94598204|NCT04604132|323991417|FG001|Overall Study|Study terminated by sponsor|0|||
94598205|NCT04604132|323991418|FG002|Overall Study|Study terminated by sponsor|0|||
94598206|NCT04604132|323991419|FG003|Overall Study|Study terminated by sponsor|0|||
94598207|NCT04604132|323991420|FG004|Overall Study|Study terminated by sponsor|1|||
94598208|NCT04604132|323991416|FG000|Overall Study|Progressive disease: Clinical progression|0|||
94598209|NCT04604132|323991417|FG001|Overall Study|Progressive disease: Clinical progression|0|||
94598210|NCT04604132|323991418|FG002|Overall Study|Progressive disease: Clinical progression|1|||
94598211|NCT04604132|323991419|FG003|Overall Study|Progressive disease: Clinical progression|0|||
94598212|NCT04604132|323991420|FG004|Overall Study|Progressive disease: Clinical progression|0|||
94598213|NCT04604132|323991416|FG000|Overall Study|Progressive disease: Radiological progression|8|||
94598214|NCT04604132|323991417|FG001|Overall Study|Progressive disease: Radiological progression|7|||
94598215|NCT04604132|323991418|FG002|Overall Study|Progressive disease: Radiological progression|10|||
94598216|NCT04604132|323991419|FG003|Overall Study|Progressive disease: Radiological progression|4|||
94598217|NCT04604132|323991420|FG004|Overall Study|Progressive disease: Radiological progression|3|||
94598218|NCT04604132|323991416|FG000|Overall Study|Death|3|||
94598219|NCT04604132|323991417|FG001|Overall Study|Death|1|||
94598220|NCT04604132|323991418|FG002|Overall Study|Death|2|||
94598221|NCT04604132|323991419|FG003|Overall Study|Death|1|||
94598222|NCT04604132|323991420|FG004|Overall Study|Death|0|||
94598223|NCT03400956|323991421|FG000|Treatment Period 1|Adverse Event|0|||
94598224|NCT03400956|323991422|FG001|Treatment Period 1|Adverse Event|1|||
94598225|NCT03400956|323991423|FG002|Treatment Period 1|Adverse Event|0|||
94598226|NCT03400956|323991421|FG000|Treatment Period 1|Lost to Follow-up|0|||
94598227|NCT03400956|323991422|FG001|Treatment Period 1|Lost to Follow-up|0|||
94598228|NCT03400956|323991423|FG002|Treatment Period 1|Lost to Follow-up|1|||
94598229|NCT03400956|323991421|FG000|Treatment Period 1|Protocol Violation|0|||
94598230|NCT03400956|323991422|FG001|Treatment Period 1|Protocol Violation|2|||
94598231|NCT03400956|323991423|FG002|Treatment Period 1|Protocol Violation|0|||
94598232|NCT03400956|323991421|FG000|Treatment Period 1|Study terminated by sponsor|3|||
94356008|NCT02992743|323085771|FG001|Overall Study|No measurable disease|0|||
94598233|NCT03400956|323991422|FG001|Treatment Period 1|Study terminated by sponsor|1|||
94598234|NCT03400956|323991423|FG002|Treatment Period 1|Study terminated by sponsor|1|||
94598235|NCT03400956|323991421|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94598236|NCT03400956|323991422|FG001|Treatment Period 1|Withdrawal by Subject|2|||
94598237|NCT03400956|323991423|FG002|Treatment Period 1|Withdrawal by Subject|4|||
94598238|NCT03400956|323991421|FG000|Treatment Period 1|Other|1|||
94598239|NCT03400956|323991422|FG001|Treatment Period 1|Other|2|||
94598240|NCT03400956|323991423|FG002|Treatment Period 1|Other|3|||
94598241|NCT03400956|323991421|FG000|Post-treatment Period 1|Adverse Event|0|||
94598242|NCT03400956|323991422|FG001|Post-treatment Period 1|Adverse Event|0|||
94598243|NCT03400956|323991423|FG002|Post-treatment Period 1|Adverse Event|1|||
94598244|NCT03400956|323991421|FG000|Post-treatment Period 1|Physician Decision|2|||
94598245|NCT03400956|323991422|FG001|Post-treatment Period 1|Physician Decision|3|||
94598246|NCT03400956|323991423|FG002|Post-treatment Period 1|Physician Decision|0|||
94598247|NCT03400956|323991421|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
94598248|NCT03400956|323991422|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
94598249|NCT03400956|323991423|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
94598250|NCT03400956|323991421|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
94598251|NCT03400956|323991422|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
94598252|NCT03400956|323991423|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
94598253|NCT03400956|323991421|FG000|Post-treatment Period 1|Other|4|||
94598254|NCT03400956|323991422|FG001|Post-treatment Period 1|Other|3|||
94598255|NCT03400956|323991423|FG002|Post-treatment Period 1|Other|4|||
94598256|NCT03400956|323991421|FG000|Treatment Period 2|Adverse Event|2|||
94598257|NCT03400956|323991422|FG001|Treatment Period 2|Adverse Event|1|||
94598258|NCT03400956|323991423|FG002|Treatment Period 2|Adverse Event|1|||
94598259|NCT03400956|323991421|FG000|Treatment Period 2|Lost to Follow-up|1|||
94598260|NCT03400956|323991422|FG001|Treatment Period 2|Lost to Follow-up|1|||
94598261|NCT03400956|323991423|FG002|Treatment Period 2|Lost to Follow-up|0|||
94598262|NCT03400956|323991421|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94598263|NCT03400956|323991422|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94598264|NCT03400956|323991423|FG002|Treatment Period 2|Withdrawal by Subject|3|||
94598265|NCT03400956|323991421|FG000|Treatment Period 2|Other|1|||
94598266|NCT03400956|323991422|FG001|Treatment Period 2|Other|1|||
94598267|NCT03400956|323991423|FG002|Treatment Period 2|Other|0|||
94598268|NCT03400956|323991421|FG000|Follow-up Period|Withdrawal by Subject|0|||
94598269|NCT03400956|323991422|FG001|Follow-up Period|Withdrawal by Subject|0|||
94598270|NCT03400956|323991423|FG002|Follow-up Period|Withdrawal by Subject|1|||
94598271|NCT03400956|323991421|FG000|Follow-up Period|Other|0|||
94598272|NCT03400956|323991422|FG001|Follow-up Period|Other|0|||
94598273|NCT03400956|323991423|FG002|Follow-up Period|Other|1|||
94598274|NCT00725842|323991424|FG000|Overall Study|Lost to Follow-up|19|||
94598275|NCT00725842|323991424|FG000|Overall Study|Death|1|||
94598276|NCT00725842|323991424|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
94598277|NCT00725842|323991424|FG000|Overall Study|Consent date prior to study start date|5|||
94598278|NCT00725842|323991424|FG000|Overall Study|Inclusion criterion not met|1|||
94598279|NCT00725842|323991424|FG000|Overall Study|No Visit 1 data|1|||
94598280|NCT00927940|323991427|FG000|Overall Study|Death|1|||
94598281|NCT04658940|323991428|FG000|Overall Study|Withdrawal by Subject|1|||
94598282|NCT00043550|323991429|FG000|Overall Study|Withdrawal by Subject|22|||
94598283|NCT00043550|323991430|FG001|Overall Study|Withdrawal by Subject|12|||
94598284|NCT00043550|323991431|FG002|Overall Study|Withdrawal by Subject|20|||
94598285|NCT02015221|323991439|FG000|Overall Study|Withdrawal by Subject|8|||
94598286|NCT02015221|323991440|FG001|Overall Study|Withdrawal by Subject|6|||
94598287|NCT02015221|323991439|FG000|Overall Study|Lost to Follow-up|1|||
94598288|NCT02015221|323991440|FG001|Overall Study|Lost to Follow-up|0|||
94598289|NCT00492063|323991441|FG000|Overall Study|Death|0|||
94598290|NCT00492063|323991442|FG001|Overall Study|Death|0|||
94598291|NCT00492063|323991443|FG002|Overall Study|Death|1|||
94598292|NCT00492063|323991444|FG003|Overall Study|Death|2|||
94598293|NCT00492063|323991441|FG000|Overall Study|Withdrawal by Subject|4|||
94598294|NCT00492063|323991442|FG001|Overall Study|Withdrawal by Subject|3|||
94598295|NCT00492063|323991443|FG002|Overall Study|Withdrawal by Subject|5|||
94598296|NCT00492063|323991444|FG003|Overall Study|Withdrawal by Subject|4|||
94598297|NCT00492063|323991441|FG000|Overall Study|Lost to Follow-up|6|||
94598298|NCT00492063|323991442|FG001|Overall Study|Lost to Follow-up|11|||
94598299|NCT00492063|323991443|FG002|Overall Study|Lost to Follow-up|5|||
94598300|NCT00492063|323991444|FG003|Overall Study|Lost to Follow-up|3|||
94598301|NCT00492063|323991441|FG000|Overall Study|Protocol Violation|0|||
94598302|NCT00492063|323991442|FG001|Overall Study|Protocol Violation|0|||
94598303|NCT00492063|323991443|FG002|Overall Study|Protocol Violation|0|||
94598304|NCT00492063|323991444|FG003|Overall Study|Protocol Violation|1|||
94598305|NCT03044574|323991460|FG000|Overall Study|Lost to Follow-up|37|||
94247890|NCT02712905|322701206|FG003|Monotherapy|Study Terminated by Sponsor|0|||
94247891|NCT02712905|322701207|FG004|Monotherapy|Study Terminated by Sponsor|1|||
94247892|NCT02712905|322701208|FG005|Monotherapy|Study Terminated by Sponsor|0|||
94247893|NCT02712905|322701209|FG006|Monotherapy|Study Terminated by Sponsor|0|||
94598306|NCT03044574|323991461|FG001|Overall Study|Lost to Follow-up|45|||
94598307|NCT00710762|323991466|FG000|Overall Study|Progressive disease|27|||
94598308|NCT00710762|323991467|FG001|Overall Study|Progressive disease|30|||
94598309|NCT00710762|323991466|FG000|Overall Study|Adverse Event other disease worsening|2|||
94598310|NCT00710762|323991467|FG001|Overall Study|Adverse Event other disease worsening|1|||
94598311|NCT00710762|323991466|FG000|Overall Study|Other Adverse Event|7|||
94598312|NCT00710762|323991467|FG001|Overall Study|Other Adverse Event|7|||
94598313|NCT00710762|323991466|FG000|Overall Study|Lost to Follow-up|1|||
94598314|NCT00710762|323991467|FG001|Overall Study|Lost to Follow-up|0|||
94598315|NCT00710762|323991466|FG000|Overall Study|Reason other than listed above|2|||
94598316|NCT00710762|323991467|FG001|Overall Study|Reason other than listed above|2|||
94598317|NCT00436501|323991468|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
94598318|NCT00436501|323991469|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
94598319|NCT00436501|323991468|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
94598320|NCT00436501|323991469|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
94598321|NCT00495040|323991471|FG000|Overall Study|Withdrawal by Subject|3|||
94598322|NCT02518464|323991472|FG000|Overall Study|Adverse Event|2|||
94598323|NCT01829243|323991481|FG000|First Intervention|Screen Failure|4|||
94598324|NCT01829243|323991482|FG001|First Intervention|Screen Failure|2|||
94598325|NCT00608569|323991483|FG000|Overall Study|Death|4|||
94598326|NCT00608569|323991484|FG001|Overall Study|Death|3|||
94598327|NCT00608569|323991483|FG000|Overall Study|Lost to Follow-up|4|||
94598328|NCT00608569|323991484|FG001|Overall Study|Lost to Follow-up|5|||
94598329|NCT00608569|323991483|FG000|Overall Study|Withdrawal by Subject|1|||
94598330|NCT00608569|323991484|FG001|Overall Study|Withdrawal by Subject|0|||
94598331|NCT00608569|323991483|FG000|Overall Study|Adverse Event|1|||
94598332|NCT00608569|323991484|FG001|Overall Study|Adverse Event|0|||
94598333|NCT00608569|323991483|FG000|Overall Study|Unable to adhere with study requirements|0|||
94598334|NCT00608569|323991484|FG001|Overall Study|Unable to adhere with study requirements|1|||
94598335|NCT00384111|323991496|FG000|Overall Study|Disease Progression|3|||
94598336|NCT00384111|323991496|FG000|Overall Study|Adverse Event|1|||
94598337|NCT00384111|323991496|FG000|Overall Study|Investigator Decision|3|||
94598338|NCT00384111|323991496|FG000|Overall Study|Study Terminated by the Sponsor|19|||
94598339|NCT03353740|323991497|FG000|Overall Study|Images for these participants not viable|52|||
94598340|NCT01037088|323991498|FG000|Overall Study|Withdrawal by Subject|3|||
94598341|NCT01227629|323991499|FG000|Overall Study|Adverse Event|2|||
94598342|NCT01227629|323991500|FG001|Overall Study|Adverse Event|2|||
94598343|NCT01227629|323991501|FG002|Overall Study|Adverse Event|1|||
94598344|NCT01227629|323991502|FG003|Overall Study|Adverse Event|6|||
94598345|NCT01227629|323991503|FG004|Overall Study|Adverse Event|1|||
94598346|NCT01227629|323991504|FG005|Overall Study|Adverse Event|1|||
94598347|NCT01227629|323991505|FG006|Overall Study|Adverse Event|6|||
94598348|NCT01227629|323991506|FG007|Overall Study|Adverse Event|6|||
94598349|NCT01227629|323991507|FG008|Overall Study|Adverse Event|4|||
94598350|NCT01227629|323991508|FG009|Overall Study|Adverse Event|0|||
94598351|NCT01227629|323991499|FG000|Overall Study|Protocol Violation|0|||
94598352|NCT01227629|323991500|FG001|Overall Study|Protocol Violation|0|||
94598353|NCT01227629|323991501|FG002|Overall Study|Protocol Violation|0|||
94598354|NCT01227629|323991502|FG003|Overall Study|Protocol Violation|1|||
94598355|NCT01227629|323991503|FG004|Overall Study|Protocol Violation|0|||
94598356|NCT01227629|323991504|FG005|Overall Study|Protocol Violation|0|||
94598357|NCT01227629|323991505|FG006|Overall Study|Protocol Violation|0|||
94598358|NCT01227629|323991506|FG007|Overall Study|Protocol Violation|0|||
94598359|NCT01227629|323991507|FG008|Overall Study|Protocol Violation|0|||
94598360|NCT01227629|323991508|FG009|Overall Study|Protocol Violation|0|||
94598361|NCT01227629|323991499|FG000|Overall Study|Lost to Follow-up|0|||
94598362|NCT01227629|323991500|FG001|Overall Study|Lost to Follow-up|0|||
94598363|NCT01227629|323991501|FG002|Overall Study|Lost to Follow-up|0|||
94598364|NCT01227629|323991502|FG003|Overall Study|Lost to Follow-up|0|||
94598365|NCT01227629|323991503|FG004|Overall Study|Lost to Follow-up|1|||
94598366|NCT01227629|323991504|FG005|Overall Study|Lost to Follow-up|0|||
94598367|NCT01227629|323991505|FG006|Overall Study|Lost to Follow-up|0|||
94598368|NCT01227629|323991506|FG007|Overall Study|Lost to Follow-up|0|||
94598369|NCT01227629|323991507|FG008|Overall Study|Lost to Follow-up|0|||
94598370|NCT01227629|323991508|FG009|Overall Study|Lost to Follow-up|0|||
94598371|NCT01227629|323991499|FG000|Overall Study|Withdrawal by Subject|0|||
94598372|NCT01227629|323991500|FG001|Overall Study|Withdrawal by Subject|0|||
94598373|NCT01227629|323991501|FG002|Overall Study|Withdrawal by Subject|0|||
94598374|NCT01227629|323991502|FG003|Overall Study|Withdrawal by Subject|0|||
94598375|NCT01227629|323991503|FG004|Overall Study|Withdrawal by Subject|0|||
94598376|NCT01227629|323991504|FG005|Overall Study|Withdrawal by Subject|0|||
94598377|NCT01227629|323991505|FG006|Overall Study|Withdrawal by Subject|2|||
94598378|NCT01227629|323991506|FG007|Overall Study|Withdrawal by Subject|0|||
94598379|NCT01227629|323991507|FG008|Overall Study|Withdrawal by Subject|0|||
94598380|NCT01227629|323991508|FG009|Overall Study|Withdrawal by Subject|1|||
94598381|NCT01227629|323991499|FG000|Overall Study|Other|0|||
94598382|NCT01227629|323991500|FG001|Overall Study|Other|0|||
94598383|NCT01227629|323991501|FG002|Overall Study|Other|0|||
94598384|NCT01227629|323991502|FG003|Overall Study|Other|1|||
94598385|NCT01227629|323991503|FG004|Overall Study|Other|0|||
94598386|NCT01227629|323991504|FG005|Overall Study|Other|0|||
94598387|NCT01227629|323991505|FG006|Overall Study|Other|0|||
94598388|NCT01227629|323991506|FG007|Overall Study|Other|0|||
94598389|NCT01227629|323991507|FG008|Overall Study|Other|2|||
94598390|NCT01227629|323991508|FG009|Overall Study|Other|1|||
94598391|NCT02216812|323991513|FG000|Overall Study|Lost to Follow-up|10|||
94598392|NCT02216812|323991514|FG001|Overall Study|Lost to Follow-up|5|||
94598393|NCT02232880|323991516|FG000|Overall Study|study stopped prior to randomization|1|||
94598394|NCT02055365|323992578|FG000|Overall Study|Prematurely Withdrawn|1|||
94598395|NCT01925131|323992579|FG000|Overall Study|Death|0|||
94598396|NCT01925131|323992580|FG001|Overall Study|Death|0|||
94598397|NCT01925131|323992581|FG002|Overall Study|Death|1|||
94598398|NCT01925131|323992582|FG003|Overall Study|Death|0|||
94598399|NCT01925131|323992583|FG004|Overall Study|Death|0|||
94598400|NCT01925131|323992584|FG005|Overall Study|Death|0|||
94598401|NCT01925131|323992579|FG000|Overall Study|Progression/Relapse|1|||
94598402|NCT01925131|323992580|FG001|Overall Study|Progression/Relapse|1|||
94598403|NCT01925131|323992581|FG002|Overall Study|Progression/Relapse|4|||
94598404|NCT01925131|323992582|FG003|Overall Study|Progression/Relapse|0|||
94598405|NCT01925131|323992583|FG004|Overall Study|Progression/Relapse|0|||
94598406|NCT01925131|323992584|FG005|Overall Study|Progression/Relapse|1|||
94598407|NCT01925131|323992579|FG000|Overall Study|Patient Refusal|1|||
94598408|NCT01925131|323992580|FG001|Overall Study|Patient Refusal|0|||
94598409|NCT01925131|323992581|FG002|Overall Study|Patient Refusal|0|||
94598410|NCT01925131|323992582|FG003|Overall Study|Patient Refusal|0|||
94598411|NCT01925131|323992583|FG004|Overall Study|Patient Refusal|0|||
94598412|NCT01925131|323992584|FG005|Overall Study|Patient Refusal|0|||
94598413|NCT01925131|323992579|FG000|Overall Study|Adverse Event|0|||
94598414|NCT01925131|323992580|FG001|Overall Study|Adverse Event|0|||
94598415|NCT01925131|323992581|FG002|Overall Study|Adverse Event|2|||
94598416|NCT01925131|323992582|FG003|Overall Study|Adverse Event|0|||
94598417|NCT01925131|323992583|FG004|Overall Study|Adverse Event|1|||
94598418|NCT01925131|323992584|FG005|Overall Study|Adverse Event|3|||
94598419|NCT01925131|323992579|FG000|Overall Study|Other - Not Protocol Specified|3|||
94598420|NCT01925131|323992580|FG001|Overall Study|Other - Not Protocol Specified|1|||
94598421|NCT01925131|323992581|FG002|Overall Study|Other - Not Protocol Specified|2|||
94598422|NCT01925131|323992582|FG003|Overall Study|Other - Not Protocol Specified|5|||
94598423|NCT01925131|323992583|FG004|Overall Study|Other - Not Protocol Specified|10|||
94598424|NCT01925131|323992584|FG005|Overall Study|Other - Not Protocol Specified|6|||
94598425|NCT01948193|323992586|FG000|Overall Study|Serious event|2|||
94598426|NCT01948193|323992586|FG000|Overall Study|Lost to Follow-up|7|||
94598427|NCT01143389|323992587|FG000|Overall Study|Lost to Follow-up|26|||
94598428|NCT01143389|323992588|FG001|Overall Study|Lost to Follow-up|25|||
94598429|NCT04966910|323992589|FG000|Baseline|Participant did not complete measure|0|||
94598430|NCT04966910|323992590|FG001|Baseline|Participant did not complete measure|0|||
94598431|NCT04966910|323992591|FG002|Baseline|Participant did not complete measure|1|||
94598432|NCT04966910|323992592|FG003|Baseline|Participant did not complete measure|0|||
94598433|NCT04966910|323992589|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
94598434|NCT04966910|323992590|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
94598435|NCT04966910|323992591|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
94598436|NCT04966910|323992592|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
94598437|NCT04966910|323992589|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
94598438|NCT04966910|323992590|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
94598439|NCT04966910|323992591|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
94598440|NCT04966910|323992592|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
94598441|NCT04966910|323992589|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
94598442|NCT04966910|323992590|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
94598443|NCT04966910|323992591|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
94598444|NCT04966910|323992592|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
94598445|NCT04531462|323992601|FG000|Overall Study|Withdrawal by Subject|3|||
94598446|NCT04531462|323992602|FG001|Overall Study|Withdrawal by Subject|1|||
94598447|NCT04531462|323992601|FG000|Overall Study|Adverse Event|3|||
94598448|NCT04531462|323992602|FG001|Overall Study|Adverse Event|3|||
94598449|NCT05347147|323992603|FG000|Overall Study|Lost to Follow-up|0|||
94598450|NCT05347147|323992604|FG001|Overall Study|Lost to Follow-up|1|||
94598451|NCT05347147|323992603|FG000|Overall Study|Sponsor request|3|||
94598452|NCT05347147|323992604|FG001|Overall Study|Sponsor request|3|||
94598453|NCT05347147|323992603|FG000|Overall Study|Study termination|2|||
94598454|NCT05347147|323992604|FG001|Overall Study|Study termination|1|||
94598455|NCT03188042|323992605|FG000|Overall Study|Withdrawal by Subject|1|||
94598456|NCT03188042|323992606|FG001|Overall Study|Withdrawal by Subject|1|||
94598457|NCT03860935|323992616|FG000|Overall Study|Withdrawal of Consent|15|||
94598458|NCT03860935|323992617|FG001|Overall Study|Withdrawal of Consent|6|||
94598459|NCT03860935|323992616|FG000|Overall Study|Death|75|||
94598460|NCT03860935|323992617|FG001|Overall Study|Death|51|||
94598461|NCT01673347|323992618|FG000|Overall Study|failure of allograft|7|||
94598462|NCT01430754|323992619|FG000|Run-In Phase|Circadian Period Ineligible|24|||
94598463|NCT01430754|323992620|FG001|Run-In Phase|Circadian Period Ineligible|0|||
94598464|NCT01430754|323992619|FG000|Run-In Phase|Protocol Violation|6|||
94598465|NCT01430754|323992620|FG001|Run-In Phase|Protocol Violation|0|||
94598466|NCT01430754|323992619|FG000|Run-In Phase|Adverse Event|2|||
94598467|NCT01430754|323992620|FG001|Run-In Phase|Adverse Event|0|||
94598468|NCT01430754|323992619|FG000|Run-In Phase|Other|2|||
94598469|NCT01430754|323992620|FG001|Run-In Phase|Other|0|||
94598470|NCT01430754|323992619|FG000|Run-In Phase|Withdrawal by Subject|2|||
94598471|NCT01430754|323992620|FG001|Run-In Phase|Withdrawal by Subject|0|||
94598472|NCT01430754|323992619|FG000|Run-In Phase|Lost to Follow-up|1|||
94598473|NCT01430754|323992620|FG001|Run-In Phase|Lost to Follow-up|0|||
94598474|NCT01343823|323992621|FG000|Overall Study|Study Terminated|1|||
94598475|NCT01343823|323992622|FG001|Overall Study|Study Terminated|0|||
94598476|NCT01343823|323992623|FG002|Overall Study|Study Terminated|0|||
94598477|NCT01343823|323992624|FG003|Overall Study|Study Terminated|1|||
94598478|NCT01343823|323992621|FG000|Overall Study|Withdrawal by Subject|1|||
94598479|NCT01343823|323992622|FG001|Overall Study|Withdrawal by Subject|0|||
94598480|NCT01343823|323992623|FG002|Overall Study|Withdrawal by Subject|0|||
94598481|NCT01343823|323992624|FG003|Overall Study|Withdrawal by Subject|0|||
94598482|NCT03874429|323992626|FG000|Overall Study|Adverse Event|2|||
94598483|NCT03874429|323992627|FG001|Overall Study|Adverse Event|2|||
94598484|NCT03874429|323992626|FG000|Overall Study|Lack of Efficacy|0|||
94598485|NCT03874429|323992627|FG001|Overall Study|Lack of Efficacy|1|||
94598486|NCT03874429|323992626|FG000|Overall Study|Covid-19 pandemic|4|||
94598487|NCT03874429|323992627|FG001|Overall Study|Covid-19 pandemic|2|||
94598488|NCT02279407|323992628|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
94598489|NCT02279407|323992629|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
94598490|NCT02279407|323992630|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
94598491|NCT02279407|323992631|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
94598492|NCT02279407|323992628|FG000|Overall Study|Withdrawal by Subject|1|||
94598493|NCT02279407|323992629|FG001|Overall Study|Withdrawal by Subject|0|||
94598494|NCT02279407|323992630|FG002|Overall Study|Withdrawal by Subject|1|||
94598495|NCT02279407|323992631|FG003|Overall Study|Withdrawal by Subject|1|||
94598496|NCT02279407|323992628|FG000|Overall Study|Adverse Event|1|||
94598497|NCT02279407|323992629|FG001|Overall Study|Adverse Event|1|||
94598498|NCT02279407|323992630|FG002|Overall Study|Adverse Event|2|||
94598499|NCT02279407|323992631|FG003|Overall Study|Adverse Event|0|||
94598500|NCT00686634|323992632|FG000|Overall Study|Protocol Violation|6|||
94598501|NCT01925989|323992635|FG000|Period 1|Sponsor Decision|1|||
94598502|NCT01925989|323992636|FG001|Period 1|Sponsor Decision|1|||
94598503|NCT01925989|323992637|FG002|Period 1|Sponsor Decision|0|||
94598504|NCT01925989|323992635|FG000|Period 1|Withdrawal by Subject|0|||
94598505|NCT01925989|323992636|FG001|Period 1|Withdrawal by Subject|1|||
94598506|NCT01925989|323992637|FG002|Period 1|Withdrawal by Subject|0|||
94598507|NCT01119937|323992638|FG000|Overall Study|Adverse Event|11|||
94598508|NCT01119937|323992639|FG001|Overall Study|Adverse Event|5|||
94598509|NCT01119937|323992638|FG000|Overall Study|Protocol deviation|3|||
94598510|NCT01119937|323992639|FG001|Overall Study|Protocol deviation|1|||
94598511|NCT01119937|323992638|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
94598512|NCT01119937|323992639|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94598513|NCT01119937|323992638|FG000|Overall Study|Withdrawal by Subject|2|||
94598514|NCT01119937|323992639|FG001|Overall Study|Withdrawal by Subject|1|||
94598515|NCT01534182|323992641|FG000|Overall Study|Administrative problems|1|||
94598516|NCT01534182|323992642|FG001|Overall Study|Administrative problems|0|||
94598517|NCT01534182|323992641|FG000|Overall Study|Withdrawal by Subject|4|||
94598518|NCT01534182|323992642|FG001|Overall Study|Withdrawal by Subject|7|||
94598519|NCT01534182|323992641|FG000|Overall Study|Adverse Event|7|||
94598520|NCT01534182|323992642|FG001|Overall Study|Adverse Event|3|||
94598521|NCT01203852|323992645|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
94598522|NCT01203852|323992645|FG000|Washout 2 Weeks|Physician Decision|46|||
94598523|NCT00977080|323992646|FG000|Overall Study|Adverse Event|2|||
94598524|NCT00977080|323992647|FG001|Overall Study|Adverse Event|7|||
94598525|NCT00977080|323992648|FG002|Overall Study|Adverse Event|7|||
94598526|NCT00977080|323992649|FG003|Overall Study|Adverse Event|7|||
94598527|NCT00977080|323992646|FG000|Overall Study|Withdrawal by Subject|1|||
94598528|NCT00977080|323992647|FG001|Overall Study|Withdrawal by Subject|5|||
94598529|NCT00977080|323992648|FG002|Overall Study|Withdrawal by Subject|1|||
94598530|NCT00977080|323992649|FG003|Overall Study|Withdrawal by Subject|5|||
94598531|NCT00977080|323992646|FG000|Overall Study|Protocol Violation|7|||
94598532|NCT00977080|323992647|FG001|Overall Study|Protocol Violation|3|||
94598533|NCT00977080|323992648|FG002|Overall Study|Protocol Violation|4|||
94598534|NCT00977080|323992649|FG003|Overall Study|Protocol Violation|3|||
94598535|NCT00977080|323992646|FG000|Overall Study|Noncompliance|0|||
94598536|NCT00977080|323992647|FG001|Overall Study|Noncompliance|2|||
94356009|NCT02992743|323085770|FG000|Overall Study|Lost to Follow-up|0|||
94598537|NCT00977080|323992648|FG002|Overall Study|Noncompliance|1|||
94598538|NCT00977080|323992649|FG003|Overall Study|Noncompliance|0|||
94598539|NCT00977080|323992646|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
94598540|NCT00977080|323992647|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
94598541|NCT00977080|323992648|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
94598542|NCT00977080|323992649|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
94598543|NCT00977080|323992646|FG000|Overall Study|Required kidney transplantation|1|||
94598544|NCT00977080|323992647|FG001|Overall Study|Required kidney transplantation|3|||
94598545|NCT00977080|323992648|FG002|Overall Study|Required kidney transplantation|3|||
94598546|NCT00977080|323992649|FG003|Overall Study|Required kidney transplantation|1|||
94598547|NCT00977080|323992646|FG000|Overall Study|Travel for family reasons|1|||
94598548|NCT00977080|323992647|FG001|Overall Study|Travel for family reasons|0|||
94598549|NCT00977080|323992648|FG002|Overall Study|Travel for family reasons|0|||
94598550|NCT00977080|323992649|FG003|Overall Study|Travel for family reasons|0|||
94598551|NCT02730793|323992653|FG000|Overall Study|Physician Decision|0|||
94598552|NCT02730793|323992654|FG001|Overall Study|Physician Decision|1|||
94598553|NCT02730793|323992653|FG000|Overall Study|Withdrawal by Subject|0|||
94598554|NCT02730793|323992654|FG001|Overall Study|Withdrawal by Subject|1|||
94598555|NCT00402233|323992658|FG000|Overall Study|Adverse Event|1|||
94598556|NCT00402233|323992659|FG001|Overall Study|Adverse Event|7|||
94598557|NCT00402233|323992660|FG002|Overall Study|Adverse Event|9|||
94598558|NCT00402233|323992661|FG003|Overall Study|Adverse Event|9|||
94598559|NCT00402233|323992658|FG000|Overall Study|Protocol Violation|0|||
94598560|NCT00402233|323992659|FG001|Overall Study|Protocol Violation|1|||
94598561|NCT00402233|323992660|FG002|Overall Study|Protocol Violation|0|||
94598562|NCT00402233|323992661|FG003|Overall Study|Protocol Violation|0|||
94598563|NCT00402233|323992658|FG000|Overall Study|Withdrawal by Subject|2|||
94598564|NCT00402233|323992659|FG001|Overall Study|Withdrawal by Subject|1|||
94598565|NCT00402233|323992660|FG002|Overall Study|Withdrawal by Subject|2|||
94598566|NCT00402233|323992661|FG003|Overall Study|Withdrawal by Subject|2|||
94598567|NCT00402233|323992658|FG000|Overall Study|Worsening of disease under study|2|||
94598568|NCT00402233|323992659|FG001|Overall Study|Worsening of disease under study|0|||
94598569|NCT00402233|323992660|FG002|Overall Study|Worsening of disease under study|0|||
94598570|NCT00402233|323992661|FG003|Overall Study|Worsening of disease under study|0|||
94598571|NCT00402233|323992658|FG000|Overall Study|Worsening of other pre-existing disease|0|||
94598572|NCT00402233|323992659|FG001|Overall Study|Worsening of other pre-existing disease|1|||
94598573|NCT00402233|323992660|FG002|Overall Study|Worsening of other pre-existing disease|0|||
94598574|NCT00402233|323992661|FG003|Overall Study|Worsening of other pre-existing disease|0|||
94598575|NCT03007888|323992663|FG000|First Intervention (14 Days)|Adverse Event|1|||
94598576|NCT03007888|323992664|FG001|First Intervention (14 Days)|Adverse Event|0|||
94598577|NCT03579602|323992667|FG000|Overall Study|Subject unable to receive study drug|0|||
94598578|NCT03579602|323992668|FG001|Overall Study|Subject unable to receive study drug|2|||
94598579|NCT03579602|323992667|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
94598580|NCT03579602|323992668|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
94598581|NCT01894568|323992673|FG000|Overall Study|Adverse Event|2|||
94598582|NCT01894568|323992674|FG001|Overall Study|Adverse Event|3|||
94598583|NCT01894568|323992673|FG000|Overall Study|Protocol required discontinuation|2|||
94598584|NCT01894568|323992674|FG001|Overall Study|Protocol required discontinuation|1|||
94598585|NCT01894568|323992673|FG000|Overall Study|Withdrawal by Subject|5|||
94598586|NCT01894568|323992674|FG001|Overall Study|Withdrawal by Subject|5|||
94598587|NCT01894568|323992673|FG000|Overall Study|Physician Decision|1|||
94598588|NCT01894568|323992674|FG001|Overall Study|Physician Decision|0|||
94598589|NCT01894568|323992673|FG000|Overall Study|Lost to Follow-up|0|||
94598590|NCT01894568|323992674|FG001|Overall Study|Lost to Follow-up|1|||
94598591|NCT00807573|323992675|FG000|Overall Study|Withdrawal by Subject|1|||
94598592|NCT00807573|323992675|FG000|Overall Study|Adverse Event|1|||
94598593|NCT01470989|323992676|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
94598594|NCT01470989|323992677|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
94598595|NCT01470989|323992676|FG000|Overall Study|Adverse Event|2|||
94598596|NCT01470989|323992677|FG001|Overall Study|Adverse Event|5|||
94598597|NCT01470989|323992676|FG000|Overall Study|Abnormal laboratory value|1|||
94598598|NCT01470989|323992677|FG001|Overall Study|Abnormal laboratory value|1|||
94598599|NCT01470989|323992676|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94598600|NCT01470989|323992677|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
94598601|NCT01470989|323992676|FG000|Overall Study|Withdrawal by Subject|19|||
94598602|NCT01470989|323992677|FG001|Overall Study|Withdrawal by Subject|17|||
94598603|NCT01470989|323992676|FG000|Overall Study|Lost to Follow-up|18|||
94598604|NCT01470989|323992677|FG001|Overall Study|Lost to Follow-up|13|||
94598605|NCT01470989|323992676|FG000|Overall Study|Administrative problems|2|||
94598606|NCT01470989|323992677|FG001|Overall Study|Administrative problems|4|||
94598607|NCT01470989|323992676|FG000|Overall Study|Death|2|||
94598608|NCT01470989|323992677|FG001|Overall Study|Death|2|||
94598609|NCT01470989|323992676|FG000|Overall Study|Protocol deviation|1|||
94598610|NCT01470989|323992677|FG001|Overall Study|Protocol deviation|2|||
94598611|NCT01089361|323992679|FG000|Overall Study|Death|1|||
94598612|NCT01089361|323992680|FG001|Overall Study|Death|0|||
94598613|NCT01514370|323992681|FG000|Overall Study|Protocol Violation|2|||
94598614|NCT01514370|323992682|FG001|Overall Study|Protocol Violation|3|||
94598615|NCT01514370|323992681|FG000|Overall Study|Lost to Follow-up|0|||
94598616|NCT01514370|323992682|FG001|Overall Study|Lost to Follow-up|2|||
94598617|NCT01514370|323992681|FG000|Overall Study|Withdrawal by Subject|2|||
94598618|NCT01514370|323992682|FG001|Overall Study|Withdrawal by Subject|1|||
94598619|NCT01514370|323992681|FG000|Overall Study|Adverse Event|1|||
94598620|NCT01514370|323992682|FG001|Overall Study|Adverse Event|3|||
94598621|NCT01514370|323992681|FG000|Overall Study|Other|6|||
94598622|NCT01514370|323992682|FG001|Overall Study|Other|7|||
94598623|NCT01551420|323992683|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
94598624|NCT01551420|323992684|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
94598625|NCT01551420|323992683|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
94598626|NCT01551420|323992684|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
94356010|NCT02992743|323085771|FG001|Overall Study|Lost to Follow-up|1|||
94356011|NCT00505765|323085772|FG000|Overall Study|Withdrawal by Subject|1|||
94598627|NCT01551420|323992683|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
94598628|NCT01551420|323992684|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
94598629|NCT01551420|323992683|FG000|Screened for Part B Eligibility|Declined participation|8|||
94598630|NCT01551420|323992684|FG001|Screened for Part B Eligibility|Declined participation|1|||
94598631|NCT01551420|323992683|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
94598632|NCT01551420|323992684|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
94598633|NCT01551420|323992683|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
94598634|NCT01551420|323992684|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
94598635|NCT01551420|323992683|FG000|Home Use (Part B)|Withdrawal by staff|0|||
94598636|NCT01551420|323992684|FG001|Home Use (Part B)|Withdrawal by staff|1|||
94598637|NCT00278915|323992685|FG000|Overall Study|Disease progression|1|||
94598638|NCT02520089|323992686|FG000|Overall Study|Lost to Follow-up|3|||
94598639|NCT02520089|323992687|FG001|Overall Study|Lost to Follow-up|4|||
94598640|NCT00129311|323992690|FG000|Overall Study|Withdrawal by Subject|12|||
94598641|NCT00129311|323992691|FG001|Overall Study|Withdrawal by Subject|19|||
94598642|NCT02207946|323992692|FG000|Overall Study|Lost to Follow-up|1|||
94598643|NCT02207946|323992693|FG001|Overall Study|Lost to Follow-up|0|||
94598644|NCT02207946|323992692|FG000|Overall Study|Adverse Event|0|||
94598645|NCT02207946|323992693|FG001|Overall Study|Adverse Event|1|||
94598646|NCT01155167|323992697|FG000|Overall Study|Insufficient ultrasound data|2|||
94598647|NCT01155167|323992698|FG001|Overall Study|Insufficient ultrasound data|0|||
94356012|NCT00505765|323085773|FG001|Overall Study|Withdrawal by Subject|0|||
94356013|NCT00505765|323085774|FG002|Overall Study|Withdrawal by Subject|0|||
94598648|NCT01155167|323992697|FG000|Overall Study|Access site changed to femoral artery|1|||
94598649|NCT01155167|323992698|FG001|Overall Study|Access site changed to femoral artery|0|||
94598650|NCT00167778|323992699|FG000|Overall Study|Withdrawal by Subject|1|||
94598651|NCT04236141|323993945|FG000|Overall Study|Death|18|||
94598652|NCT04236141|323993946|FG001|Overall Study|Death|10|||
94598653|NCT04236141|323993945|FG000|Overall Study|Withdrawal by Participant|1|||
94598654|NCT04236141|323993946|FG001|Overall Study|Withdrawal by Participant|0|||
94598655|NCT04236141|323993945|FG000|Overall Study|Reason not Specified|1|||
94598656|NCT04236141|323993946|FG001|Overall Study|Reason not Specified|0|||
94598657|NCT04236141|323993945|FG000|Overall Study|Study terminated by Sponsor|8|||
94598658|NCT04236141|323993946|FG001|Overall Study|Study terminated by Sponsor|4|||
94660426|NCT01863680|324211652|FG000|Overall Study|Spontaneous pregnancy|2|||
94660427|NCT01863680|324211652|FG000|Overall Study|Withdrawal by Subject|1|||
94598659|NCT00576420|323993952|FG000|Overall Study|Death|0|||
94598660|NCT00576420|323993953|FG001|Overall Study|Death|0|||
94598661|NCT00576420|323993954|FG002|Overall Study|Death|1|||
94598662|NCT02616146|323993955|FG000|Overall Study|Adverse Event|64|||
94598663|NCT02616146|323993956|FG001|Overall Study|Adverse Event|24|||
94598664|NCT02616146|323993955|FG000|Overall Study|Lost to Follow-up|23|||
94598665|NCT02616146|323993956|FG001|Overall Study|Lost to Follow-up|13|||
94598666|NCT02616146|323993955|FG000|Overall Study|Non-compliance with study protocol|2|||
94598667|NCT02616146|323993956|FG001|Overall Study|Non-compliance with study protocol|0|||
94598668|NCT02616146|323993955|FG000|Overall Study|Non-compliance with study drug|4|||
94598669|NCT02616146|323993956|FG001|Overall Study|Non-compliance with study drug|2|||
94598670|NCT02616146|323993955|FG000|Overall Study|Pregnancy|2|||
94598671|NCT02616146|323993956|FG001|Overall Study|Pregnancy|2|||
94598672|NCT02616146|323993955|FG000|Overall Study|Pregnancy wish|3|||
94356014|NCT00505765|323085772|FG000|Overall Study|Adverse Event|1|||
94356015|NCT00505765|323085773|FG001|Overall Study|Adverse Event|2|||
94598673|NCT02616146|323993956|FG001|Overall Study|Pregnancy wish|0|||
94598674|NCT02616146|323993955|FG000|Overall Study|Protocol Violation|6|||
94598675|NCT02616146|323993956|FG001|Overall Study|Protocol Violation|3|||
94598676|NCT02616146|323993955|FG000|Overall Study|Study terminated by sponsor|1372|||
94660428|NCT01863680|324211652|FG000|Overall Study|Did not undergo IVF/ET|14|||
94356016|NCT00505765|323085774|FG002|Overall Study|Adverse Event|0|||
94598677|NCT02616146|323993956|FG001|Overall Study|Study terminated by sponsor|432|||
94598678|NCT02616146|323993955|FG000|Overall Study|Participant moved|4|||
94598679|NCT02616146|323993956|FG001|Overall Study|Participant moved|3|||
94598680|NCT02616146|323993955|FG000|Overall Study|Withdrawal by Subject|30|||
94598681|NCT02616146|323993956|FG001|Overall Study|Withdrawal by Subject|24|||
94598682|NCT02616146|323993955|FG000|Overall Study|Physician Decision|2|||
94598683|NCT02616146|323993956|FG001|Overall Study|Physician Decision|1|||
94598684|NCT01221272|323993957|FG000|Period 1|Adverse Event|2|||
94598685|NCT01221272|323993958|FG001|Period 1|Adverse Event|0|||
94598686|NCT01221272|323993957|FG000|Period 1|Consent Withdrawal|0|||
94598687|NCT01221272|323993958|FG001|Period 1|Consent Withdrawal|1|||
94598688|NCT01221272|323993957|FG000|Period 1|Significant Dosing Noncompliance|0|||
94598689|NCT01221272|323993958|FG001|Period 1|Significant Dosing Noncompliance|1|||
94356017|NCT00505765|323085772|FG000|Overall Study|Noncompliance|0|||
94598690|NCT01221272|323993957|FG000|Period 2|Adverse Event|0|||
94598691|NCT01221272|323993958|FG001|Period 2|Adverse Event|2|||
94598692|NCT00814333|323993959|FG000|Enrollment|Lost to Follow-up|1|||
94598693|NCT00814333|323993960|FG001|Enrollment|Lost to Follow-up|0|||
94598694|NCT01246466|323993961|FG000|Overall Study|Death|1|||
94598695|NCT01246466|323993961|FG000|Overall Study|Withdrawal by Subject|1|||
94598696|NCT03811093|323993962|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
94598697|NCT03811093|323993963|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
94598698|NCT03811093|323993962|FG000|Overall Study|Unable to measure body fat percentage|2|||
94598699|NCT03811093|323993963|FG001|Overall Study|Unable to measure body fat percentage|0|||
94598700|NCT01095094|323993969|FG000|Overall Study|Withdrawal by Subject|1|||
94598701|NCT01095094|323993969|FG000|Overall Study|Death|1|||
94457823|NCT00614523|323465622|FG001|Overall Study|Administrative Decision|46|||
94457824|NCT04598451|323465631|FG000|Overall Study|Adverse Event|3|||
94457825|NCT04598451|323465632|FG001|Overall Study|Adverse Event|2|||
94457826|NCT04598451|323465631|FG000|Overall Study|Withdrawal by Subject|3|||
94457827|NCT04598451|323465632|FG001|Overall Study|Withdrawal by Subject|7|||
94457828|NCT04598451|323465631|FG000|Overall Study|Lost to Follow-up|2|||
94457829|NCT04598451|323465632|FG001|Overall Study|Lost to Follow-up|0|||
94457830|NCT04598451|323465631|FG000|Overall Study|Physician Decision|4|||
94457831|NCT04598451|323465632|FG001|Overall Study|Physician Decision|1|||
94457832|NCT04598451|323465631|FG000|Overall Study|Requires Prohibited Medication|1|||
94457833|NCT04598451|323465632|FG001|Overall Study|Requires Prohibited Medication|0|||
94457834|NCT04598451|323465631|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
94457835|NCT04598451|323465632|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
94457836|NCT00381238|323465637|FG000|Overall Study|Adverse Event|3|||
94457837|NCT00381238|323465637|FG000|Overall Study|Protocol Violation|1|||
94457838|NCT00381238|323465637|FG000|Overall Study|Withdrawal by Subject|4|||
94457839|NCT00381238|323465637|FG000|Overall Study|Lack of Efficacy|2|||
94457840|NCT00381238|323465637|FG000|Overall Study|Withdrew by physician|1|||
94457841|NCT00381238|323465637|FG000|Overall Study|Disease progression|1|||
94457842|NCT00843037|323465638|FG000|Overall Study|Lost to Follow-up|1|||
94457843|NCT02424630|323465639|FG000|Overall Study|No rotator cuff tear|1|||
94457844|NCT02424630|323465640|FG001|Overall Study|No rotator cuff tear|2|||
94457845|NCT02424630|323465639|FG000|Overall Study|Open procedure|0|||
94457846|NCT02424630|323465640|FG001|Overall Study|Open procedure|1|||
94457847|NCT00976820|323465644|FG000|Overall Study|Lost to Follow-up|5|||
94457848|NCT00976820|323465645|FG001|Overall Study|Lost to Follow-up|16|||
94457849|NCT00976820|323465646|FG002|Overall Study|Lost to Follow-up|2|||
94457850|NCT00976820|323465647|FG003|Overall Study|Lost to Follow-up|3|||
94457851|NCT00976820|323465644|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
94457852|NCT00976820|323465645|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
94457853|NCT00976820|323465646|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
94457854|NCT00976820|323465647|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
94457855|NCT00976820|323465644|FG000|Overall Study|Withdrawal by Subject|2|||
94457856|NCT00976820|323465645|FG001|Overall Study|Withdrawal by Subject|4|||
94457857|NCT00976820|323465646|FG002|Overall Study|Withdrawal by Subject|1|||
94457858|NCT00976820|323465647|FG003|Overall Study|Withdrawal by Subject|4|||
94457859|NCT03261674|323465650|FG000|Overall Study|Lost to Follow-up|6|||
94457860|NCT03261674|323465651|FG001|Overall Study|Lost to Follow-up|7|||
94457861|NCT03261674|323465650|FG000|Overall Study|Protocol Violation|1|||
94457862|NCT03261674|323465651|FG001|Overall Study|Protocol Violation|4|||
94457863|NCT03261674|323465650|FG000|Overall Study|Withdrawal by Subject|1|||
94457864|NCT03261674|323465651|FG001|Overall Study|Withdrawal by Subject|4|||
94457865|NCT03261674|323465650|FG000|Overall Study|Physician Decision|1|||
94457866|NCT03261674|323465651|FG001|Overall Study|Physician Decision|0|||
94457867|NCT02691013|323465654|FG000|Overall Study|Withdrawal by Subject|3|||
94457868|NCT02691013|323465655|FG001|Overall Study|Withdrawal by Subject|0|||
94457869|NCT02989649|323465656|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
94457870|NCT02989649|323465656|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
94457871|NCT02989649|323465656|FG000|Overall Study|Lost For Observation During Study|3|||
94457872|NCT02989649|323465656|FG000|Overall Study|Reason Not Specified|13|||
94457873|NCT04507256|323465660|FG000|Overall Study|Withdrawal by Subject|1|||
94457874|NCT04507256|323465661|FG001|Overall Study|Withdrawal by Subject|0|||
94457875|NCT04507256|323465662|FG002|Overall Study|Withdrawal by Subject|0|||
94457876|NCT04507256|323465663|FG003|Overall Study|Withdrawal by Subject|1|||
94457877|NCT04507256|323465664|FG004|Overall Study|Withdrawal by Subject|0|||
94457878|NCT04507256|323465665|FG005|Overall Study|Withdrawal by Subject|0|||
94598702|NCT01095094|323993969|FG000|Overall Study|Physician Decision|1|||
94598703|NCT00464490|323993970|FG000|Overall Study|Physician Decision|11|||
94457879|NCT00631410|323465666|FG000|Overall Study|Adverse Event|1|||
94598704|NCT00464490|323993971|FG001|Overall Study|Physician Decision|11|||
94457880|NCT00631410|323465667|FG001|Overall Study|Adverse Event|3|||
94457881|NCT00631410|323465666|FG000|Overall Study|Objective Progression or Relapse|4|||
94457882|NCT00631410|323465667|FG001|Overall Study|Objective Progression or Relapse|3|||
94598705|NCT01350544|323993972|FG000|Overall Study|Administrative Withdrawal|0|||
94598706|NCT01350544|323993973|FG001|Overall Study|Administrative Withdrawal|1|||
94598707|NCT01350544|323993972|FG000|Overall Study|Death|1|||
94598708|NCT01350544|323993973|FG001|Overall Study|Death|2|||
94598709|NCT01350544|323993972|FG000|Overall Study|Moved out of LA County|2|||
94598710|NCT01350544|323993973|FG001|Overall Study|Moved out of LA County|2|||
94598711|NCT01350544|323993972|FG000|Overall Study|Medical Issues|1|||
94598712|NCT01350544|323993973|FG001|Overall Study|Medical Issues|1|||
94598713|NCT01350544|323993972|FG000|Overall Study|Withdrawal by Subject|0|||
94598714|NCT01350544|323993973|FG001|Overall Study|Withdrawal by Subject|1|||
94598715|NCT01350544|323993972|FG000|Overall Study|Incarceration|1|||
94598716|NCT01350544|323993973|FG001|Overall Study|Incarceration|0|||
94598717|NCT01350544|323993972|FG000|Overall Study|Lost to Follow-up|18|||
94598718|NCT01350544|323993973|FG001|Overall Study|Lost to Follow-up|15|||
94598719|NCT00603590|323993974|FG000|Overall Study|Did not attend study clinic|39|||
94598720|NCT00603590|323993975|FG001|Overall Study|Did not attend study clinic|30|||
94598721|NCT00603590|323993974|FG000|Overall Study|Refused blood test|5|||
94598722|NCT00603590|323993975|FG001|Overall Study|Refused blood test|1|||
94598723|NCT00603590|323993974|FG000|Overall Study|Patient discontinued study drug|22|||
94598724|NCT00603590|323993975|FG001|Overall Study|Patient discontinued study drug|15|||
94598725|NCT00603590|323993974|FG000|Overall Study|Adverse Event|2|||
94598726|NCT00603590|323993975|FG001|Overall Study|Adverse Event|0|||
94598727|NCT00603590|323993974|FG000|Overall Study|Lost to Follow-up|8|||
94598728|NCT00603590|323993975|FG001|Overall Study|Lost to Follow-up|4|||
94598729|NCT00603590|323993974|FG000|Overall Study|Cardiovascular event|0|||
94598730|NCT00603590|323993975|FG001|Overall Study|Cardiovascular event|1|||
94598731|NCT00895011|323993983|FG000|Overall Study|Withdrawal by Subject|14|||
94598732|NCT00895011|323993984|FG001|Overall Study|Withdrawal by Subject|7|||
94598733|NCT00895011|323993985|FG002|Overall Study|Withdrawal by Subject|2|||
94598734|NCT00895011|323993983|FG000|Overall Study|Lost to Follow-up|5|||
94598735|NCT00895011|323993984|FG001|Overall Study|Lost to Follow-up|4|||
94598736|NCT00895011|323993985|FG002|Overall Study|Lost to Follow-up|1|||
94598737|NCT00895011|323993983|FG000|Overall Study|Protocol Violation|3|||
94598738|NCT00895011|323993984|FG001|Overall Study|Protocol Violation|1|||
94598739|NCT00895011|323993985|FG002|Overall Study|Protocol Violation|3|||
94598740|NCT00895011|323993983|FG000|Overall Study|Adverse Event|1|||
94598741|NCT00895011|323993984|FG001|Overall Study|Adverse Event|2|||
94598742|NCT00895011|323993985|FG002|Overall Study|Adverse Event|2|||
94598743|NCT00895011|323993983|FG000|Overall Study|schedule conflict|1|||
94598744|NCT00895011|323993984|FG001|Overall Study|schedule conflict|0|||
94598745|NCT00895011|323993985|FG002|Overall Study|schedule conflict|0|||
94598746|NCT00923364|323993991|FG000|Overall Study|Death|3|||
94598747|NCT00923364|323993992|FG001|Overall Study|Death|0|||
94598748|NCT00923364|323993991|FG000|Overall Study|Did not go to transplant|1|||
94598749|NCT00923364|323993992|FG001|Overall Study|Did not go to transplant|0|||
94598750|NCT01752036|323993993|FG000|Overall Study|Death|2|||
94598751|NCT01011478|323993994|FG000|Overall Study|No follow up data|12|||
94598752|NCT01011478|323993995|FG001|Overall Study|No follow up data|7|||
94598753|NCT00075270|323993996|FG000|Overall Study|Withdrawal by Subject|28|||
94598754|NCT00075270|323993997|FG001|Overall Study|Withdrawal by Subject|21|||
94598755|NCT00075270|323993996|FG000|Overall Study|Lost to Follow-up|25|||
94598756|NCT00075270|323993997|FG001|Overall Study|Lost to Follow-up|28|||
94598757|NCT00075270|323993996|FG000|Overall Study|Protocol Violation|0|||
94598758|NCT00075270|323993997|FG001|Overall Study|Protocol Violation|2|||
94598759|NCT00075270|323993996|FG000|Overall Study|Death|198|||
94598760|NCT00075270|323993997|FG001|Overall Study|Death|215|||
94598761|NCT00075270|323993996|FG000|Overall Study|Other/Unknown|9|||
94598762|NCT00075270|323993997|FG001|Overall Study|Other/Unknown|5|||
94598763|NCT00075270|323993996|FG000|Overall Study|Missing|26|||
94598764|NCT00075270|323993997|FG001|Overall Study|Missing|13|||
94598765|NCT00246571|323993998|FG000|Overall Study|Adverse Event|7|||
94598766|NCT00246571|323993999|FG001|Overall Study|Adverse Event|0|||
94598767|NCT00246571|323993998|FG000|Overall Study|Protocol Violation|0|||
94598768|NCT00246571|323993999|FG001|Overall Study|Protocol Violation|1|||
94598769|NCT00246571|323993998|FG000|Overall Study|Withdrawal by Subject|2|||
94598770|NCT00246571|323993999|FG001|Overall Study|Withdrawal by Subject|3|||
94598771|NCT00246571|323993998|FG000|Overall Study|Lack of Efficacy|84|||
94598772|NCT00246571|323993999|FG001|Overall Study|Lack of Efficacy|21|||
94598773|NCT00246571|323993998|FG000|Overall Study|Death|17|||
94598774|NCT00246571|323993999|FG001|Overall Study|Death|3|||
94598775|NCT00246571|323993998|FG000|Overall Study|Sponsor|0|||
94598776|NCT00246571|323993999|FG001|Overall Study|Sponsor|1|||
94598777|NCT00246571|323993998|FG000|Overall Study|Did not meet entrance criteria|2|||
94598778|NCT00246571|323993999|FG001|Overall Study|Did not meet entrance criteria|1|||
94598779|NCT00246571|323993998|FG000|Overall Study|Laboratory abnormalities|1|||
94598780|NCT00246571|323993999|FG001|Overall Study|Laboratory abnormalities|0|||
94598781|NCT00246571|323993998|FG000|Overall Study|Crossover participants|0|||
94598782|NCT00246571|323993999|FG001|Overall Study|Crossover participants|74|||
94598783|NCT04896229|323994000|FG000|Overall Study|Lost to Follow-up|113|||
94598784|NCT04896229|323994001|FG001|Overall Study|Lost to Follow-up|113|||
94598785|NCT00275821|323994008|FG000|Overall Study|Adverse Event|4|||
94598786|NCT00275821|323994009|FG001|Overall Study|Adverse Event|12|||
94598787|NCT00275821|323994010|FG002|Overall Study|Adverse Event|5|||
94598788|NCT00275821|323994008|FG000|Overall Study|Administrative problems|3|||
94598789|NCT00275821|323994009|FG001|Overall Study|Administrative problems|4|||
94598790|NCT00275821|323994010|FG002|Overall Study|Administrative problems|4|||
94660429|NCT01863680|324211652|FG000|Overall Study|Other|6|||
94598791|NCT00275821|323994008|FG000|Overall Study|Withdrawal by Subject|0|||
94598792|NCT00275821|323994009|FG001|Overall Study|Withdrawal by Subject|2|||
94598793|NCT00275821|323994010|FG002|Overall Study|Withdrawal by Subject|1|||
94660430|NCT02707055|324211653|FG000|Phase 1|Withdrawal by Subject|1|||
94660431|NCT02707055|324211654|FG001|Phase 1|Withdrawal by Subject|2|||
94247894|NCT02712905|322701210|FG007|Monotherapy|Study Terminated by Sponsor|0|||
94598794|NCT00275821|323994008|FG000|Overall Study|Lost to Follow-up|0|||
94598795|NCT00275821|323994009|FG001|Overall Study|Lost to Follow-up|1|||
94247895|NCT02712905|322701211|FG008|Monotherapy|Study Terminated by Sponsor|0|||
94247896|NCT02712905|322701212|FG009|Monotherapy|Study Terminated by Sponsor|2|||
94247897|NCT02712905|322701213|FG010|Monotherapy|Study Terminated by Sponsor|0|||
94247898|NCT02712905|322701214|FG011|Monotherapy|Study Terminated by Sponsor|0|||
94247899|NCT02712905|322701215|FG012|Monotherapy|Study Terminated by Sponsor|0|||
94247900|NCT02712905|322701216|FG013|Monotherapy|Study Terminated by Sponsor|0|||
94247901|NCT02712905|322701217|FG014|Monotherapy|Study Terminated by Sponsor|0|||
94247902|NCT02712905|322701218|FG015|Monotherapy|Study Terminated by Sponsor|0|||
94247903|NCT02712905|322701219|FG016|Monotherapy|Study Terminated by Sponsor|0|||
94247904|NCT02712905|322701220|FG017|Monotherapy|Study Terminated by Sponsor|0|||
94247905|NCT02712905|322701203|FG000|Monotherapy|Withdrawal by Subject|0|||
94247906|NCT02712905|322701204|FG001|Monotherapy|Withdrawal by Subject|0|||
94247907|NCT02712905|322701205|FG002|Monotherapy|Withdrawal by Subject|1|||
94247908|NCT02712905|322701206|FG003|Monotherapy|Withdrawal by Subject|0|||
94247909|NCT02712905|322701207|FG004|Monotherapy|Withdrawal by Subject|2|||
94247910|NCT02712905|322701208|FG005|Monotherapy|Withdrawal by Subject|0|||
94247911|NCT02712905|322701209|FG006|Monotherapy|Withdrawal by Subject|0|||
94247912|NCT02712905|322701210|FG007|Monotherapy|Withdrawal by Subject|0|||
94247913|NCT02712905|322701211|FG008|Monotherapy|Withdrawal by Subject|0|||
94247914|NCT02712905|322701212|FG009|Monotherapy|Withdrawal by Subject|4|||
94247915|NCT02712905|322701213|FG010|Monotherapy|Withdrawal by Subject|1|||
94598796|NCT00275821|323994010|FG002|Overall Study|Lost to Follow-up|1|||
94598797|NCT00275821|323994008|FG000|Overall Study|Death|0|||
94598798|NCT00275821|323994009|FG001|Overall Study|Death|2|||
94598799|NCT00275821|323994010|FG002|Overall Study|Death|1|||
94598800|NCT00275821|323994008|FG000|Overall Study|Lack of Efficacy|2|||
94598801|NCT00275821|323994009|FG001|Overall Study|Lack of Efficacy|1|||
94598802|NCT00275821|323994010|FG002|Overall Study|Lack of Efficacy|0|||
94598803|NCT00275821|323994008|FG000|Overall Study|Protocol Violation|5|||
94598804|NCT00275821|323994009|FG001|Overall Study|Protocol Violation|1|||
94598805|NCT00275821|323994010|FG002|Overall Study|Protocol Violation|0|||
94598806|NCT00934648|323994011|FG000|Overall Study|Failure to return|8|||
94598807|NCT00934648|323994011|FG000|Overall Study|Withdrawal by Subject|1|||
94598808|NCT00779259|323994012|FG000|Quinine Alone|Adverse Event|2|||
94598809|NCT00924781|323994013|FG000|Overall Study|Study terminated by sponsor|12|||
94598810|NCT00924781|323994014|FG001|Overall Study|Study terminated by sponsor|10|||
94598811|NCT02296138|323994015|FG000|Overall Study|Adverse Event|348|||
94598812|NCT02296138|323994016|FG001|Overall Study|Adverse Event|259|||
94598813|NCT02296138|323994015|FG000|Overall Study|Lack of Efficacy|59|||
94598814|NCT02296138|323994016|FG001|Overall Study|Lack of Efficacy|37|||
94598815|NCT02296138|323994015|FG000|Overall Study|Protocol Violation|35|||
94598816|NCT02296138|323994016|FG001|Overall Study|Protocol Violation|36|||
94598817|NCT02296138|323994015|FG000|Overall Study|Lost to Follow-up|9|||
94598818|NCT02296138|323994016|FG001|Overall Study|Lost to Follow-up|12|||
94598819|NCT02296138|323994015|FG000|Overall Study|Withdrawal by Subject|184|||
94598820|NCT02296138|323994016|FG001|Overall Study|Withdrawal by Subject|131|||
94598821|NCT02296138|323994015|FG000|Overall Study|Not Treated|1|||
94598822|NCT02296138|323994016|FG001|Overall Study|Not Treated|1|||
94598823|NCT02296138|323994015|FG000|Overall Study|Patients with data irregularities|10|||
94598824|NCT02296138|323994016|FG001|Overall Study|Patients with data irregularities|11|||
94598825|NCT02296138|323994015|FG000|Overall Study|Other than specified|15|||
94598826|NCT02296138|323994016|FG001|Overall Study|Other than specified|13|||
94598827|NCT01075191|323994022|FG000|Overall Study|Death|1|||
94598828|NCT01075191|323994022|FG000|Overall Study|Intensification|3|||
94598829|NCT01075191|323994022|FG000|Overall Study|Co-morbidities|1|||
94598830|NCT01075191|323994022|FG000|Overall Study|Adverse Event|4|||
94598831|NCT01075191|323994022|FG000|Overall Study|Noncompliance|3|||
94598832|NCT01075191|323994022|FG000|Overall Study|Therapy Break|3|||
94598833|NCT01075191|323994022|FG000|Overall Study|Patient's Wish|2|||
94598834|NCT01075191|323994022|FG000|Overall Study|Unknown Reasons|1|||
94598835|NCT00592774|323994023|FG000|Overall Study|Adverse Event|5|||
94247916|NCT02712905|322701214|FG011|Monotherapy|Withdrawal by Subject|2|||
94247917|NCT02712905|322701215|FG012|Monotherapy|Withdrawal by Subject|0|||
94247918|NCT02712905|322701216|FG013|Monotherapy|Withdrawal by Subject|0|||
94247919|NCT02712905|322701217|FG014|Monotherapy|Withdrawal by Subject|0|||
94247920|NCT02712905|322701218|FG015|Monotherapy|Withdrawal by Subject|0|||
94247921|NCT02712905|322701219|FG016|Monotherapy|Withdrawal by Subject|0|||
94247922|NCT02712905|322701220|FG017|Monotherapy|Withdrawal by Subject|0|||
94247923|NCT02712905|322701203|FG000|Monotherapy|Started New Cancer Drug|0|||
94247924|NCT02712905|322701204|FG001|Monotherapy|Started New Cancer Drug|0|||
94247925|NCT02712905|322701205|FG002|Monotherapy|Started New Cancer Drug|0|||
94247926|NCT02712905|322701206|FG003|Monotherapy|Started New Cancer Drug|0|||
94247927|NCT02712905|322701207|FG004|Monotherapy|Started New Cancer Drug|0|||
94247928|NCT02712905|322701208|FG005|Monotherapy|Started New Cancer Drug|1|||
94598836|NCT00592774|323994024|FG001|Overall Study|Adverse Event|19|||
94598837|NCT00592774|323994025|FG002|Overall Study|Adverse Event|2|||
94598838|NCT00592774|323994026|FG003|Overall Study|Adverse Event|14|||
94598839|NCT00592774|323994027|FG004|Overall Study|Adverse Event|8|||
94598840|NCT00592774|323994023|FG000|Overall Study|Protocol Violation|0|||
94598841|NCT00592774|323994024|FG001|Overall Study|Protocol Violation|1|||
94247929|NCT02712905|322701209|FG006|Monotherapy|Started New Cancer Drug|0|||
94247930|NCT02712905|322701210|FG007|Monotherapy|Started New Cancer Drug|0|||
94247931|NCT02712905|322701211|FG008|Monotherapy|Started New Cancer Drug|0|||
94247932|NCT02712905|322701212|FG009|Monotherapy|Started New Cancer Drug|0|||
94247933|NCT02712905|322701213|FG010|Monotherapy|Started New Cancer Drug|0|||
94247934|NCT02712905|322701214|FG011|Monotherapy|Started New Cancer Drug|0|||
94247935|NCT02712905|322701215|FG012|Monotherapy|Started New Cancer Drug|0|||
94247936|NCT02712905|322701216|FG013|Monotherapy|Started New Cancer Drug|0|||
94247937|NCT02712905|322701217|FG014|Monotherapy|Started New Cancer Drug|0|||
94247938|NCT02712905|322701218|FG015|Monotherapy|Started New Cancer Drug|0|||
94247939|NCT02712905|322701219|FG016|Monotherapy|Started New Cancer Drug|0|||
94247940|NCT02712905|322701220|FG017|Monotherapy|Started New Cancer Drug|0|||
94247941|NCT02712905|322701203|FG000|Monotherapy|Adverse Event|0|||
94247942|NCT02712905|322701204|FG001|Monotherapy|Adverse Event|0|||
94247943|NCT02712905|322701205|FG002|Monotherapy|Adverse Event|0|||
94247944|NCT02712905|322701206|FG003|Monotherapy|Adverse Event|0|||
94247945|NCT02712905|322701207|FG004|Monotherapy|Adverse Event|0|||
94247946|NCT02712905|322701208|FG005|Monotherapy|Adverse Event|0|||
94247947|NCT02712905|322701209|FG006|Monotherapy|Adverse Event|0|||
94247948|NCT02712905|322701210|FG007|Monotherapy|Adverse Event|0|||
94247949|NCT02712905|322701211|FG008|Monotherapy|Adverse Event|1|||
94247950|NCT02712905|322701212|FG009|Monotherapy|Adverse Event|0|||
94247951|NCT02712905|322701213|FG010|Monotherapy|Adverse Event|0|||
94247952|NCT02712905|322701214|FG011|Monotherapy|Adverse Event|0|||
94247953|NCT02712905|322701215|FG012|Monotherapy|Adverse Event|0|||
94247954|NCT02712905|322701216|FG013|Monotherapy|Adverse Event|0|||
94247955|NCT02712905|322701217|FG014|Monotherapy|Adverse Event|0|||
94247956|NCT02712905|322701218|FG015|Monotherapy|Adverse Event|0|||
94247957|NCT02712905|322701219|FG016|Monotherapy|Adverse Event|0|||
94247958|NCT02712905|322701220|FG017|Monotherapy|Adverse Event|0|||
94247959|NCT02712905|322701203|FG000|Combination Therapy|Death|0|||
94247960|NCT02712905|322701204|FG001|Combination Therapy|Death|0|||
94247961|NCT02712905|322701205|FG002|Combination Therapy|Death|0|||
94247962|NCT02712905|322701206|FG003|Combination Therapy|Death|0|||
94247963|NCT02712905|322701207|FG004|Combination Therapy|Death|0|||
94247964|NCT02712905|322701208|FG005|Combination Therapy|Death|0|||
94247965|NCT02712905|322701209|FG006|Combination Therapy|Death|0|||
94247966|NCT02712905|322701210|FG007|Combination Therapy|Death|0|||
94247967|NCT02712905|322701211|FG008|Combination Therapy|Death|0|||
94598842|NCT00592774|323994025|FG002|Overall Study|Protocol Violation|0|||
94598843|NCT00592774|323994026|FG003|Overall Study|Protocol Violation|0|||
94598844|NCT00592774|323994027|FG004|Overall Study|Protocol Violation|1|||
94598845|NCT00592774|323994023|FG000|Overall Study|Withdrawal by Subject|3|||
94598846|NCT00592774|323994024|FG001|Overall Study|Withdrawal by Subject|7|||
94598847|NCT00592774|323994025|FG002|Overall Study|Withdrawal by Subject|0|||
94598848|NCT00592774|323994026|FG003|Overall Study|Withdrawal by Subject|0|||
94598849|NCT00592774|323994027|FG004|Overall Study|Withdrawal by Subject|0|||
94598850|NCT00592774|323994023|FG000|Overall Study|Lack of Efficacy|3|||
94598851|NCT00592774|323994024|FG001|Overall Study|Lack of Efficacy|3|||
94598852|NCT00592774|323994025|FG002|Overall Study|Lack of Efficacy|0|||
94598853|NCT00592774|323994026|FG003|Overall Study|Lack of Efficacy|0|||
94598854|NCT00592774|323994027|FG004|Overall Study|Lack of Efficacy|2|||
94598855|NCT00592774|323994023|FG000|Overall Study|Physician Decision|0|||
94598856|NCT00592774|323994024|FG001|Overall Study|Physician Decision|1|||
94598857|NCT00592774|323994025|FG002|Overall Study|Physician Decision|1|||
94598858|NCT00592774|323994026|FG003|Overall Study|Physician Decision|0|||
94598859|NCT00592774|323994027|FG004|Overall Study|Physician Decision|1|||
94247968|NCT02712905|322701212|FG009|Combination Therapy|Death|0|||
94598860|NCT00592774|323994023|FG000|Overall Study|Other|0|||
94598861|NCT00592774|323994024|FG001|Overall Study|Other|1|||
94598862|NCT00592774|323994025|FG002|Overall Study|Other|1|||
94247969|NCT02712905|322701213|FG010|Combination Therapy|Death|0|||
94247970|NCT02712905|322701214|FG011|Combination Therapy|Death|0|||
94598863|NCT00592774|323994026|FG003|Overall Study|Other|0|||
94598864|NCT00592774|323994027|FG004|Overall Study|Other|2|||
94598865|NCT00555425|323994028|FG000|Overall Study|Missed Medication > 1 wk|34|||
94598866|NCT00555425|323994029|FG001|Overall Study|Missed Medication > 1 wk|15|||
94247971|NCT02712905|322701215|FG012|Combination Therapy|Death|5|||
94247972|NCT02712905|322701216|FG013|Combination Therapy|Death|6|||
94247973|NCT02712905|322701217|FG014|Combination Therapy|Death|1|||
94247974|NCT02712905|322701218|FG015|Combination Therapy|Death|3|||
94247975|NCT02712905|322701219|FG016|Combination Therapy|Death|1|||
94247976|NCT02712905|322701220|FG017|Combination Therapy|Death|3|||
94247977|NCT02712905|322701203|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
94247978|NCT02712905|322701204|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
94247979|NCT02712905|322701205|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
94247980|NCT02712905|322701206|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
94247981|NCT02712905|322701207|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
94247982|NCT02712905|322701208|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
94598867|NCT00555425|323994028|FG000|Overall Study|Missed 3 physician management visits|1|||
94598868|NCT00555425|323994029|FG001|Overall Study|Missed 3 physician management visits|0|||
94660432|NCT02707055|324211653|FG000|Phase 1|Physician Decision|0|||
94356018|NCT00505765|323085773|FG001|Overall Study|Noncompliance|1|||
94356019|NCT00505765|323085774|FG002|Overall Study|Noncompliance|3|||
94356020|NCT00450814|323085775|FG000|Overall Study|Failed to complete the initial therapy|0|||
94356021|NCT00450814|323085776|FG001|Overall Study|Failed to complete the initial therapy|0|||
94356022|NCT00450814|323085777|FG002|Overall Study|Failed to complete the initial therapy|0|||
94356023|NCT00450814|323085778|FG003|Overall Study|Failed to complete the initial therapy|1|||
94356024|NCT00450814|323085779|FG004|Overall Study|Failed to complete the initial therapy|1|||
94598869|NCT00555425|323994028|FG000|Overall Study|Met criteria for protective transfer|16|||
94598870|NCT00555425|323994029|FG001|Overall Study|Met criteria for protective transfer|3|||
94598871|NCT00555425|323994028|FG000|Overall Study|Became pregnant and transferred care|0|||
94598872|NCT00555425|323994029|FG001|Overall Study|Became pregnant and transferred care|1|||
94598873|NCT02674854|323994030|FG000|Overall Study|Adverse Event|17|||
94598874|NCT02674854|323994031|FG001|Overall Study|Adverse Event|15|||
94598875|NCT02674854|323994032|FG002|Overall Study|Adverse Event|5|||
94598876|NCT02674854|323994030|FG000|Overall Study|Withdrawal by Subject|1|||
94598877|NCT02674854|323994031|FG001|Overall Study|Withdrawal by Subject|5|||
94598878|NCT02674854|323994032|FG002|Overall Study|Withdrawal by Subject|4|||
94598879|NCT02674854|323994030|FG000|Overall Study|No-compliant subject|1|||
94598880|NCT02674854|323994031|FG001|Overall Study|No-compliant subject|0|||
94598881|NCT02674854|323994032|FG002|Overall Study|No-compliant subject|1|||
94598882|NCT02674854|323994030|FG000|Overall Study|Lost to Follow-up|1|||
94598883|NCT02674854|323994031|FG001|Overall Study|Lost to Follow-up|0|||
94598884|NCT02674854|323994032|FG002|Overall Study|Lost to Follow-up|2|||
94598885|NCT02674854|323994030|FG000|Overall Study|Lack of Efficacy|0|||
94598886|NCT02674854|323994031|FG001|Overall Study|Lack of Efficacy|3|||
94598887|NCT02674854|323994032|FG002|Overall Study|Lack of Efficacy|0|||
94660433|NCT02707055|324211654|FG001|Phase 1|Physician Decision|1|||
94356025|NCT00450814|323085780|FG005|Overall Study|Failed to complete the initial therapy|1|||
94598888|NCT02674854|323994030|FG000|Overall Study|Disallowed Concurrent Medication|2|||
94598889|NCT02674854|323994031|FG001|Overall Study|Disallowed Concurrent Medication|2|||
94247983|NCT02712905|322701209|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
94247984|NCT02712905|322701210|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
94247985|NCT02712905|322701211|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
94247986|NCT02712905|322701212|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
94247987|NCT02712905|322701213|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
94247988|NCT02712905|322701214|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
94247989|NCT02712905|322701215|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
94247990|NCT02712905|322701216|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
94598890|NCT02674854|323994032|FG002|Overall Study|Disallowed Concurrent Medication|0|||
94598891|NCT02674854|323994030|FG000|Overall Study|Protocol Violation|1|||
94247991|NCT02712905|322701217|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
94247992|NCT02712905|322701218|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
94247993|NCT02712905|322701219|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
94247994|NCT02712905|322701220|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
94247995|NCT02712905|322701203|FG000|Combination Therapy|Withdrawal by Subject|0|||
94247996|NCT02712905|322701204|FG001|Combination Therapy|Withdrawal by Subject|0|||
94247997|NCT02712905|322701205|FG002|Combination Therapy|Withdrawal by Subject|0|||
94247998|NCT02712905|322701206|FG003|Combination Therapy|Withdrawal by Subject|0|||
94247999|NCT02712905|322701207|FG004|Combination Therapy|Withdrawal by Subject|0|||
94248000|NCT02712905|322701208|FG005|Combination Therapy|Withdrawal by Subject|0|||
94248001|NCT02712905|322701209|FG006|Combination Therapy|Withdrawal by Subject|0|||
94248002|NCT02712905|322701210|FG007|Combination Therapy|Withdrawal by Subject|0|||
94248003|NCT02712905|322701211|FG008|Combination Therapy|Withdrawal by Subject|0|||
94248004|NCT02712905|322701212|FG009|Combination Therapy|Withdrawal by Subject|0|||
94248005|NCT02712905|322701213|FG010|Combination Therapy|Withdrawal by Subject|0|||
94248006|NCT02712905|322701214|FG011|Combination Therapy|Withdrawal by Subject|0|||
94248007|NCT02712905|322701215|FG012|Combination Therapy|Withdrawal by Subject|0|||
94248008|NCT02712905|322701216|FG013|Combination Therapy|Withdrawal by Subject|0|||
94248009|NCT02712905|322701217|FG014|Combination Therapy|Withdrawal by Subject|0|||
94356026|NCT00450814|323085781|FG006|Overall Study|Failed to complete the initial therapy|0|||
94598892|NCT02674854|323994031|FG001|Overall Study|Protocol Violation|1|||
94598893|NCT02674854|323994032|FG002|Overall Study|Protocol Violation|2|||
94598894|NCT02674854|323994030|FG000|Overall Study|Death|0|||
94598895|NCT02674854|323994031|FG001|Overall Study|Death|1|||
94598896|NCT02674854|323994032|FG002|Overall Study|Death|0|||
94598897|NCT02674854|323994030|FG000|Overall Study|Subject missed V6.2|1|||
94598898|NCT02674854|323994031|FG001|Overall Study|Subject missed V6.2|0|||
94598899|NCT02674854|323994032|FG002|Overall Study|Subject missed V6.2|0|||
94598900|NCT01120067|323994038|FG000|Overall Study|Lost to Follow-up|3|||
94598901|NCT01120067|323994039|FG001|Overall Study|Lost to Follow-up|1|||
94598902|NCT01120067|323994038|FG000|Overall Study|fail to engage >3 sessions|2|||
94598903|NCT01120067|323994039|FG001|Overall Study|fail to engage >3 sessions|0|||
94598904|NCT02312687|323994040|FG000|Overall Study|Other, Not Specified|1|||
94598905|NCT04738318|323994041|FG000|Overall Study|Protocol Violation|1|||
94598906|NCT04738318|323994042|FG001|Overall Study|Protocol Violation|0|||
94598907|NCT03104816|323994043|FG000|Overall Study|Lack of Efficacy|0|||
94598908|NCT03104816|323994044|FG001|Overall Study|Lack of Efficacy|2|||
94598909|NCT03104816|323994045|FG002|Overall Study|Lack of Efficacy|0|||
94598910|NCT03104816|323994043|FG000|Overall Study|Protocol Violation|2|||
94598911|NCT03104816|323994044|FG001|Overall Study|Protocol Violation|0|||
94598912|NCT03104816|323994045|FG002|Overall Study|Protocol Violation|2|||
94598913|NCT02290431|323994046|FG000|Overall Study|Adverse Event|20|||
94598914|NCT02290431|323994046|FG000|Overall Study|Progressive disease|4|||
94598915|NCT02290431|323994046|FG000|Overall Study|Study terminated by Sponsor|1|||
94598916|NCT02290431|323994046|FG000|Overall Study|Physician Decision|2|||
94598917|NCT03473548|323994047|FG000|Overall Study|Did not attempt HST testing|3|||
94598918|NCT03473548|323994048|FG001|Overall Study|Did not attempt HST testing|0|||
94598919|NCT05985980|323994053|FG000|Overall Study|Withdrawal by Subject|1|||
94598920|NCT05985980|323994053|FG000|Overall Study|Withdrawal by Subject|1|||
94598921|NCT05985980|323994053|FG000|Overall Study|Withdrawal by Subject|1|||
94598922|NCT05985980|323994053|FG000|Overall Study|Withdrawal by Subject|1|||
94598923|NCT00523367|323994054|FG000|Overall Study|19 screen failures|19|||
94660434|NCT02707055|324211653|FG000|Phase 2|Adverse Event|1|||
94660435|NCT02707055|324211654|FG001|Phase 2|Adverse Event|2|||
94248010|NCT02712905|322701218|FG015|Combination Therapy|Withdrawal by Subject|1|||
94248011|NCT02712905|322701219|FG016|Combination Therapy|Withdrawal by Subject|0|||
94356027|NCT00450814|323085782|FG007|Overall Study|Failed to complete the initial therapy|0|||
94356028|NCT00450814|323085783|FG008|Overall Study|Failed to complete the initial therapy|0|||
94356029|NCT00450814|323085784|FG009|Overall Study|Failed to complete the initial therapy|0|||
94248012|NCT02712905|322701220|FG017|Combination Therapy|Withdrawal by Subject|2|||
94598924|NCT00523367|323994054|FG000|Overall Study|4 Withdrawn by PI|4|||
94598925|NCT00811642|323994055|FG000|Overall Study|Adverse Event|3|||
94598926|NCT00811642|323994055|FG000|Overall Study|Protocol Violation|1|||
94598927|NCT00811642|323994055|FG000|Overall Study|Death|2|||
94598928|NCT00811642|323994055|FG000|Overall Study|Withdrawal by Subject|7|||
94660436|NCT03564496|324211655|FG000|Overall Study|Withdrawal by Subject|1|||
94248013|NCT02712905|322701203|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
94248014|NCT02712905|322701204|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
94248015|NCT02712905|322701205|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
94248016|NCT02712905|322701206|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
94248017|NCT02712905|322701207|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
94248018|NCT02712905|322701208|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
94248019|NCT02712905|322701209|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
94248020|NCT02712905|322701210|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
94248021|NCT02712905|322701211|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
94598929|NCT00811642|323994055|FG000|Overall Study|Cumulative use of antifungal agent|2|||
94598930|NCT00282347|323994062|FG000|Treatment Period|Death|2|||
94598931|NCT00282347|323994063|FG001|Treatment Period|Death|0|||
94598932|NCT00282347|323994062|FG000|Treatment Period|Lost to Follow-up|2|||
94598933|NCT00282347|323994063|FG001|Treatment Period|Lost to Follow-up|5|||
94598934|NCT00282347|323994062|FG000|Treatment Period|Withdrawal by Subject|1|||
94598935|NCT00282347|323994063|FG001|Treatment Period|Withdrawal by Subject|3|||
94598936|NCT00282347|323994062|FG000|Treatment Period|Physician Decision|0|||
94598937|NCT00282347|323994063|FG001|Treatment Period|Physician Decision|1|||
94598938|NCT00282347|323994062|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
94598939|NCT00282347|323994063|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
94598940|NCT00282347|323994062|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
94598941|NCT00282347|323994063|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
94598942|NCT00282347|323994062|FG000|Safety Follow-up Period|Physician Decision|1|||
94598943|NCT00282347|323994063|FG001|Safety Follow-up Period|Physician Decision|1|||
94598944|NCT00282347|323994062|FG000|Safety Follow-up Period|Protocol Deviation|0|||
94598945|NCT00282347|323994063|FG001|Safety Follow-up Period|Protocol Deviation|2|||
94598946|NCT00282347|323994062|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
94598947|NCT00282347|323994063|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
94598948|NCT00282347|323994062|FG000|B Cell Follow-up Period|Physician Decision|1|||
94598949|NCT00282347|323994063|FG001|B Cell Follow-up Period|Physician Decision|0|||
94598950|NCT00282347|323994062|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
94598951|NCT00282347|323994063|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
94598952|NCT01006603|323994067|FG000|Overall Study|Withdrawal by Subject|17|||
94598953|NCT01006603|323994068|FG001|Overall Study|Withdrawal by Subject|19|||
94598954|NCT01006603|323994067|FG000|Overall Study|Lost to Follow-up|0|||
94598955|NCT01006603|323994068|FG001|Overall Study|Lost to Follow-up|1|||
94598956|NCT01006603|323994067|FG000|Overall Study|Safety reason|1|||
94598957|NCT01006603|323994068|FG001|Overall Study|Safety reason|1|||
94598958|NCT01006603|323994067|FG000|Overall Study|Protocol Violation|1|||
94598959|NCT01006603|323994068|FG001|Overall Study|Protocol Violation|3|||
94598960|NCT01006603|323994067|FG000|Overall Study|Incorrect enrolment|0|||
94457883|NCT00631410|323465666|FG000|Overall Study|Surgery|1|||
94457884|NCT00631410|323465667|FG001|Overall Study|Surgery|0|||
94598961|NCT01006603|323994068|FG001|Overall Study|Incorrect enrolment|2|||
94598962|NCT01006603|323994067|FG000|Overall Study|Adverse Event|15|||
94598963|NCT01006603|323994068|FG001|Overall Study|Adverse Event|7|||
94598964|NCT01006603|323994067|FG000|Overall Study|Death|1|||
94598965|NCT01006603|323994068|FG001|Overall Study|Death|1|||
94598966|NCT01006603|323994067|FG000|Overall Study|Study specific discontinuation criteria|33|||
94598967|NCT01006603|323994068|FG001|Overall Study|Study specific discontinuation criteria|34|||
94598968|NCT01006603|323994067|FG000|Overall Study|Other|3|||
94598969|NCT01006603|323994068|FG001|Overall Study|Other|7|||
94598970|NCT00853970|323994069|FG000|Overall Study|Withdrawal by Subject|2|||
94598971|NCT00853970|323994070|FG001|Overall Study|Withdrawal by Subject|1|||
94598972|NCT00853970|323994069|FG000|Overall Study|Cancelled surgery|4|||
94598973|NCT00853970|323994070|FG001|Overall Study|Cancelled surgery|2|||
94598974|NCT01340872|323995585|FG000|Double-blind Phase|Adverse Event|6|||
94598975|NCT01340872|323995586|FG001|Double-blind Phase|Adverse Event|4|||
94598976|NCT01340872|323995587|FG002|Double-blind Phase|Adverse Event|0|||
94598977|NCT01340872|323995588|FG003|Double-blind Phase|Adverse Event|0|||
94598978|NCT01340872|323995585|FG000|Double-blind Phase|Withdrawal by Subject|3|||
94598979|NCT01340872|323995586|FG001|Double-blind Phase|Withdrawal by Subject|5|||
94598980|NCT01340872|323995587|FG002|Double-blind Phase|Withdrawal by Subject|0|||
94598981|NCT01340872|323995588|FG003|Double-blind Phase|Withdrawal by Subject|0|||
94598982|NCT01340872|323995585|FG000|Double-blind Phase|Lost to Follow-up|0|||
94598983|NCT01340872|323995586|FG001|Double-blind Phase|Lost to Follow-up|1|||
94598984|NCT01340872|323995587|FG002|Double-blind Phase|Lost to Follow-up|0|||
94598985|NCT01340872|323995588|FG003|Double-blind Phase|Lost to Follow-up|0|||
94598986|NCT01340872|323995585|FG000|Double-blind Phase|Protocol Violation|0|||
94598987|NCT01340872|323995586|FG001|Double-blind Phase|Protocol Violation|1|||
94598988|NCT01340872|323995587|FG002|Double-blind Phase|Protocol Violation|0|||
94598989|NCT01340872|323995588|FG003|Double-blind Phase|Protocol Violation|0|||
94598990|NCT01340872|323995585|FG000|Open-label Phase|Physician Decision|0|||
94598991|NCT01340872|323995586|FG001|Open-label Phase|Physician Decision|0|||
94598992|NCT01340872|323995587|FG002|Open-label Phase|Physician Decision|2|||
94598993|NCT01340872|323995588|FG003|Open-label Phase|Physician Decision|1|||
94598994|NCT01340872|323995585|FG000|Open-label Phase|Pregnancy|0|||
94598995|NCT01340872|323995586|FG001|Open-label Phase|Pregnancy|0|||
94598996|NCT01340872|323995587|FG002|Open-label Phase|Pregnancy|1|||
94598997|NCT01340872|323995588|FG003|Open-label Phase|Pregnancy|0|||
94248022|NCT02712905|322701212|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
94248023|NCT02712905|322701213|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
94248024|NCT02712905|322701214|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
94248025|NCT02712905|322701215|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
94248026|NCT02712905|322701216|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
94248027|NCT02712905|322701217|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
94248028|NCT02712905|322701218|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
94248029|NCT02712905|322701219|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
94248030|NCT02712905|322701220|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
94598998|NCT01340872|323995585|FG000|Open-label Phase|Adverse Event|0|||
94598999|NCT01340872|323995586|FG001|Open-label Phase|Adverse Event|0|||
94599000|NCT01340872|323995587|FG002|Open-label Phase|Adverse Event|8|||
94599001|NCT01340872|323995588|FG003|Open-label Phase|Adverse Event|4|||
94599002|NCT01340872|323995585|FG000|Open-label Phase|Withdrawal by Subject|0|||
94599003|NCT01340872|323995586|FG001|Open-label Phase|Withdrawal by Subject|0|||
94599004|NCT01340872|323995587|FG002|Open-label Phase|Withdrawal by Subject|1|||
94599005|NCT01340872|323995588|FG003|Open-label Phase|Withdrawal by Subject|6|||
94599006|NCT01340872|323995585|FG000|Open-label Phase|Worsening of IBD|0|||
94599007|NCT01340872|323995586|FG001|Open-label Phase|Worsening of IBD|0|||
94599008|NCT01340872|323995587|FG002|Open-label Phase|Worsening of IBD|1|||
94599009|NCT01340872|323995588|FG003|Open-label Phase|Worsening of IBD|0|||
94599010|NCT00002931|323995597|FG000|Overall Study|rapidly progressing disease during|2|||
94599011|NCT03224598|323995598|FG000|Overall Study|Lost to Follow-up|0|||
94599012|NCT03224598|323995599|FG001|Overall Study|Lost to Follow-up|2|||
94599013|NCT03224598|323995600|FG002|Overall Study|Lost to Follow-up|0|||
94599014|NCT03224598|323995598|FG000|Overall Study|Other|0|||
94599015|NCT03224598|323995599|FG001|Overall Study|Other|1|||
94599016|NCT03224598|323995600|FG002|Overall Study|Other|0|||
94599017|NCT02907892|323995606|FG000|Overall Study|Lost to Follow-up|27|||
94599018|NCT02907892|323995607|FG001|Overall Study|Lost to Follow-up|40|||
94599019|NCT01974765|323995608|FG000|Overall Study|Withdrawal by Subject|1|||
94599020|NCT01974765|323995608|FG000|Overall Study|Death|1|||
94599021|NCT01974765|323995608|FG000|Overall Study|Adverse Event|2|||
94599022|NCT02292784|323995611|FG000|Overall Study|Lost to Follow-up|1|||
94599023|NCT02292784|323995612|FG001|Overall Study|Lost to Follow-up|17|||
94599024|NCT02292784|323995613|FG002|Overall Study|Lost to Follow-up|18|||
94599025|NCT02292784|323995611|FG000|Overall Study|Withdrawal by Subject|0|||
94599026|NCT02292784|323995612|FG001|Overall Study|Withdrawal by Subject|3|||
94599027|NCT02292784|323995613|FG002|Overall Study|Withdrawal by Subject|3|||
94599028|NCT00348933|323995614|FG000|Overall Study|Withdrawal by Subject|10|||
94599029|NCT00348933|323995614|FG000|Overall Study|Lost to Follow-up|6|||
94599030|NCT00348933|323995614|FG000|Overall Study|Protocol Violation|2|||
94599031|NCT00348933|323995614|FG000|Overall Study|Adverse Event|7|||
94599032|NCT01264081|323995615|FG000|Participants Screened|Screening failures|30|||
94599033|NCT01264081|323995615|FG000|Started Treatment|Withdrawal by Subject|1|||
94599034|NCT01264081|323995615|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
94599035|NCT01489111|323995616|FG000|Overall Study|Withdrawal criterion|1|||
94599036|NCT00134784|323995617|FG000|Overall Study|Withdrawal by Subject|2|||
94599037|NCT00134784|323995618|FG001|Overall Study|Withdrawal by Subject|2|||
94599038|NCT00134784|323995619|FG002|Overall Study|Withdrawal by Subject|2|||
94599039|NCT00134784|323995620|FG003|Overall Study|Withdrawal by Subject|1|||
94599040|NCT02716896|323995621|FG000|Overall Study|Physician Decision|0|||
94599041|NCT02716896|323995622|FG001|Overall Study|Physician Decision|1|||
94599042|NCT01727700|323995623|FG000|Overall Study|Adverse Event|0|||
94599043|NCT01727700|323995624|FG001|Overall Study|Adverse Event|7|||
94599044|NCT01727700|323995625|FG002|Overall Study|Adverse Event|1|||
94599045|NCT01727700|323995623|FG000|Overall Study|Particpant withdrew consent|0|||
94248031|NCT01397422|322701221|FG000|Overall Study|Adverse Event|0|||
94248032|NCT01397422|322701222|FG001|Overall Study|Adverse Event|3|||
94248033|NCT01397422|322701223|FG002|Overall Study|Adverse Event|3|||
94248034|NCT01397422|322701224|FG003|Overall Study|Adverse Event|8|||
94248035|NCT01397422|322701221|FG000|Overall Study|Withdrawal by Subject|1|||
94248036|NCT01397422|322701222|FG001|Overall Study|Withdrawal by Subject|0|||
94599046|NCT01727700|323995624|FG001|Overall Study|Particpant withdrew consent|3|||
94599047|NCT01727700|323995625|FG002|Overall Study|Particpant withdrew consent|1|||
94599048|NCT01727700|323995623|FG000|Overall Study|Protocol Violation|2|||
94599049|NCT01727700|323995624|FG001|Overall Study|Protocol Violation|0|||
94599050|NCT01727700|323995625|FG002|Overall Study|Protocol Violation|0|||
94599051|NCT02054481|323995629|FG000|Overall Study|Adverse Event|1|||
94599052|NCT02054481|323995630|FG001|Overall Study|Adverse Event|1|||
94599053|NCT02054481|323995631|FG002|Overall Study|Adverse Event|0|||
94599054|NCT02054481|323995632|FG003|Overall Study|Adverse Event|1|||
94599055|NCT02054481|323995629|FG000|Overall Study|Lost to Follow-up|1|||
94599056|NCT02054481|323995630|FG001|Overall Study|Lost to Follow-up|0|||
94248037|NCT01397422|322701223|FG002|Overall Study|Withdrawal by Subject|0|||
94248038|NCT01397422|322701224|FG003|Overall Study|Withdrawal by Subject|0|||
94248039|NCT01397422|322701221|FG000|Overall Study|Increased bradykinesia related to PD|1|||
94248040|NCT01397422|322701222|FG001|Overall Study|Increased bradykinesia related to PD|0|||
94248041|NCT01397422|322701223|FG002|Overall Study|Increased bradykinesia related to PD|0|||
94248042|NCT01397422|322701224|FG003|Overall Study|Increased bradykinesia related to PD|0|||
94248043|NCT00760474|322701227|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
94248044|NCT00760474|322701228|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
94248045|NCT00760474|322701227|FG000|Placebo Washout Period|Other|0|||
94248046|NCT00760474|322701228|FG001|Placebo Washout Period|Other|1|||
94248047|NCT00760474|322701227|FG000|Period 2 (P2)|Lost to Follow-up|1|||
94248048|NCT00760474|322701228|FG001|Period 2 (P2)|Lost to Follow-up|0|||
94248049|NCT00760474|322701227|FG000|Period 2 (P2)|Adverse Event|0|||
94248050|NCT00760474|322701228|FG001|Period 2 (P2)|Adverse Event|1|||
94248051|NCT01011153|322701229|FG000|Overall Study|Less than 78 cases completed|8|||
94248052|NCT01011153|322701230|FG001|Overall Study|Less than 78 cases completed|11|||
94248053|NCT01011153|322701231|FG002|Overall Study|Less than 78 cases completed|9|||
94248054|NCT01081132|322701232|FG000|Overall Study|Lack of Efficacy|25|||
94248055|NCT01081132|322701233|FG001|Overall Study|Lack of Efficacy|9|||
94248056|NCT01081132|322701232|FG000|Overall Study|Withdrawal by Subject|13|||
94248057|NCT01081132|322701233|FG001|Overall Study|Withdrawal by Subject|16|||
94248058|NCT01081132|322701232|FG000|Overall Study|Lost to Follow-up|4|||
94248059|NCT01081132|322701233|FG001|Overall Study|Lost to Follow-up|11|||
94248060|NCT01081132|322701232|FG000|Overall Study|Adverse Event|3|||
94248061|NCT01081132|322701233|FG001|Overall Study|Adverse Event|9|||
94248062|NCT01081132|322701232|FG000|Overall Study|Non Compliance|4|||
94248063|NCT01081132|322701233|FG001|Overall Study|Non Compliance|2|||
94248064|NCT01081132|322701232|FG000|Overall Study|Lack Of Compliance|0|||
94248065|NCT01081132|322701233|FG001|Overall Study|Lack Of Compliance|1|||
94248066|NCT01081132|322701232|FG000|Overall Study|Missed Visits|1|||
94248067|NCT01081132|322701233|FG001|Overall Study|Missed Visits|1|||
94248068|NCT01081132|322701232|FG000|Overall Study|Stopped Taking Meds|2|||
94248069|NCT01081132|322701233|FG001|Overall Study|Stopped Taking Meds|0|||
94248070|NCT01081132|322701232|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
94248071|NCT01081132|322701233|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
94248072|NCT01081132|322701232|FG000|Overall Study|Declined Taper Phase|0|||
94248073|NCT01081132|322701233|FG001|Overall Study|Declined Taper Phase|1|||
94248074|NCT01081132|322701232|FG000|Overall Study|Protocol Violation|3|||
94248075|NCT01081132|322701233|FG001|Overall Study|Protocol Violation|1|||
94248076|NCT02019667|322701234|FG000|First Intervention (6 Months)|Adverse Event|0|||
94248077|NCT02019667|322701235|FG001|First Intervention (6 Months)|Adverse Event|1|||
94248078|NCT02019667|322701234|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
94248079|NCT02019667|322701235|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
94248080|NCT02019667|322701234|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
94248081|NCT02019667|322701235|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
94248082|NCT00095498|322702964|FG000|Overall Study|Physician Decision|9|||
94248083|NCT00095498|322702965|FG001|Overall Study|Physician Decision|10|||
94248084|NCT00095498|322702966|FG002|Overall Study|Physician Decision|8|||
94248085|NCT00095498|322702964|FG000|Overall Study|Adverse Event|1|||
94248086|NCT00095498|322702965|FG001|Overall Study|Adverse Event|0|||
94248087|NCT00095498|322702966|FG002|Overall Study|Adverse Event|1|||
94248088|NCT00095498|322702964|FG000|Overall Study|Withdrawal by Subject|15|||
94248089|NCT00095498|322702965|FG001|Overall Study|Withdrawal by Subject|16|||
94248090|NCT00095498|322702966|FG002|Overall Study|Withdrawal by Subject|15|||
94248091|NCT00095498|322702964|FG000|Overall Study|Disease progression|0|||
94248092|NCT00095498|322702965|FG001|Overall Study|Disease progression|1|||
94248093|NCT00095498|322702966|FG002|Overall Study|Disease progression|1|||
94248094|NCT00095498|322702964|FG000|Overall Study|Ineligibility determined|3|||
94248095|NCT00095498|322702965|FG001|Overall Study|Ineligibility determined|0|||
94248096|NCT00095498|322702966|FG002|Overall Study|Ineligibility determined|2|||
94248097|NCT00095498|322702964|FG000|Overall Study|Lost to Follow-up|1|||
94248098|NCT00095498|322702965|FG001|Overall Study|Lost to Follow-up|1|||
94248099|NCT00095498|322702966|FG002|Overall Study|Lost to Follow-up|2|||
94660437|NCT03564496|324211656|FG001|Overall Study|Withdrawal by Subject|1|||
94248100|NCT00095498|322702964|FG000|Overall Study|Noncompliance|1|||
94248101|NCT00095498|322702965|FG001|Overall Study|Noncompliance|0|||
94248102|NCT00095498|322702966|FG002|Overall Study|Noncompliance|1|||
94248103|NCT00095498|322702964|FG000|Overall Study|Other|6|||
94248104|NCT00095498|322702965|FG001|Overall Study|Other|7|||
94248105|NCT00095498|322702966|FG002|Overall Study|Other|6|||
94248106|NCT00095498|322702964|FG000|Overall Study|Protocol Violation|0|||
94248107|NCT00095498|322702965|FG001|Overall Study|Protocol Violation|0|||
94248108|NCT00095498|322702966|FG002|Overall Study|Protocol Violation|1|||
94248109|NCT00095498|322702964|FG000|Overall Study|Requirement for alternative therapy|1|||
94248110|NCT00095498|322702965|FG001|Overall Study|Requirement for alternative therapy|0|||
94248111|NCT00095498|322702966|FG002|Overall Study|Requirement for alternative therapy|2|||
94248112|NCT05020327|322702969|FG000|Overall Study|Physician Decision|3|||
94248113|NCT05020327|322702970|FG001|Overall Study|Physician Decision|0|||
94248114|NCT05020327|322702971|FG002|Overall Study|Physician Decision|0|||
94248115|NCT05020327|322702969|FG000|Overall Study|Withdrawal by Subject|1|||
94248116|NCT05020327|322702970|FG001|Overall Study|Withdrawal by Subject|1|||
94248117|NCT05020327|322702971|FG002|Overall Study|Withdrawal by Subject|0|||
94248118|NCT05020327|322702969|FG000|Overall Study|personal/cultural, ineligible|12|||
94248119|NCT05020327|322702970|FG001|Overall Study|personal/cultural, ineligible|0|||
94248120|NCT05020327|322702971|FG002|Overall Study|personal/cultural, ineligible|0|||
94248121|NCT04684394|322702972|FG000|Overall Study|Death|1|||
94248122|NCT04684394|322702973|FG001|Overall Study|Death|2|||
94248123|NCT04684394|322702972|FG000|Overall Study|Lost to Follow-up|1|||
94248124|NCT04684394|322702973|FG001|Overall Study|Lost to Follow-up|0|||
94248125|NCT04684394|322702972|FG000|Overall Study|Withdrawal by Subject|2|||
94248126|NCT04684394|322702973|FG001|Overall Study|Withdrawal by Subject|0|||
94248127|NCT04684394|322702972|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
94248128|NCT04684394|322702973|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
94248129|NCT00833261|322702974|FG000|Overall Study|Withdrawal by Subject|4|||
94248130|NCT00306670|322702978|FG000|Overall Study|patients recruited; Genentech, the st|0|||
94248131|NCT00306670|322702979|FG001|Overall Study|patients recruited; Genentech, the st|2|||
94248132|NCT01994837|322702982|FG000|Overall Study|Progressive disease per protocol|23|||
94248133|NCT01994837|322702982|FG000|Overall Study|Adv event related to progressive disease|3|||
94248134|NCT01994837|322702982|FG000|Overall Study|Fatal progressive disease|2|||
94248135|NCT01994837|322702982|FG000|Overall Study|Adverse event not related to progression|1|||
94248136|NCT01994837|322702982|FG000|Overall Study|Chose palliative care|1|||
94248137|NCT01994837|322702982|FG000|Overall Study|Proceeded to transplant|1|||
94248138|NCT01994837|322702982|FG000|Overall Study|Removed from study due to no response|1|||
94248139|NCT02233543|322702983|FG000|Period 1|Withdrawal by Subject|1|||
94248140|NCT02233543|322702984|FG001|Period 1|Withdrawal by Subject|0|||
94248141|NCT02233543|322702983|FG000|Period 1|Participants required other treatment.|2|||
94248142|NCT02233543|322702984|FG001|Period 1|Participants required other treatment.|3|||
94248143|NCT02233543|322702983|FG000|Period 2|Adverse Event|1|||
94599057|NCT02054481|323995631|FG002|Overall Study|Lost to Follow-up|0|||
94599058|NCT02054481|323995632|FG003|Overall Study|Lost to Follow-up|0|||
94599059|NCT02054481|323995629|FG000|Overall Study|Other reason|2|||
94599060|NCT02054481|323995630|FG001|Overall Study|Other reason|1|||
94599061|NCT02054481|323995631|FG002|Overall Study|Other reason|2|||
94599062|NCT02054481|323995632|FG003|Overall Study|Other reason|0|||
94599063|NCT01842633|323995635|FG000|Overall Study|Screen Failure|1|||
94248144|NCT02233543|322702984|FG001|Period 2|Adverse Event|0|||
94248145|NCT02233543|322702983|FG000|Period 2|Participant required other treatment.|0|||
94599064|NCT01842633|323995636|FG001|Overall Study|Screen Failure|0|||
94599065|NCT01842633|323995637|FG002|Overall Study|Screen Failure|0|||
94599066|NCT01842633|323995635|FG000|Overall Study|Adverse Event|1|||
94599067|NCT01842633|323995636|FG001|Overall Study|Adverse Event|1|||
94599068|NCT01842633|323995637|FG002|Overall Study|Adverse Event|0|||
94599069|NCT01842633|323995635|FG000|Overall Study|Withdrawal by Subject|0|||
94599070|NCT01842633|323995636|FG001|Overall Study|Withdrawal by Subject|1|||
94599071|NCT01842633|323995637|FG002|Overall Study|Withdrawal by Subject|0|||
94599072|NCT01842633|323995635|FG000|Overall Study|Technical issues|1|||
94599073|NCT01842633|323995636|FG001|Overall Study|Technical issues|0|||
94599074|NCT01842633|323995637|FG002|Overall Study|Technical issues|0|||
94599075|NCT01397825|323995638|FG000|Overall Study|Progressive Disease|10|||
94248146|NCT02233543|322702984|FG001|Period 2|Participant required other treatment.|1|||
94248147|NCT02233543|322702983|FG000|Period 2|COPD exacerbation|1|||
94599076|NCT01397825|323995639|FG001|Overall Study|Progressive Disease|3|||
94599077|NCT01397825|323995640|FG002|Overall Study|Progressive Disease|11|||
94599078|NCT01397825|323995641|FG003|Overall Study|Progressive Disease|1|||
94599079|NCT01397825|323995642|FG004|Overall Study|Progressive Disease|0|||
94599080|NCT01397825|323995638|FG000|Overall Study|Symptomatic Deterioration|2|||
94599081|NCT01397825|323995639|FG001|Overall Study|Symptomatic Deterioration|0|||
94660438|NCT03564496|324211657|FG002|Overall Study|Withdrawal by Subject|0|||
94660439|NCT03564496|324211655|FG000|Overall Study|Screen failure|0|||
94660440|NCT03564496|324211656|FG001|Overall Study|Screen failure|3|||
94660441|NCT03564496|324211657|FG002|Overall Study|Screen failure|0|||
94660442|NCT03266588|324211658|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
94660443|NCT03266588|324211659|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
94660444|NCT03266588|324211660|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
94660445|NCT03266588|324211658|FG000|Observational Period|Withdrawal by Subject|44|||
94660446|NCT03266588|324211659|FG001|Observational Period|Withdrawal by Subject|22|||
94660447|NCT03266588|324211660|FG002|Observational Period|Withdrawal by Subject|13|||
94660448|NCT03266588|324211658|FG000|Observational Period|Non-compliance|18|||
94660449|NCT03266588|324211659|FG001|Observational Period|Non-compliance|12|||
94660450|NCT03266588|324211660|FG002|Observational Period|Non-compliance|10|||
94660451|NCT03266588|324211658|FG000|Observational Period|Lost to Follow-up|8|||
94660452|NCT03266588|324211659|FG001|Observational Period|Lost to Follow-up|12|||
94660453|NCT03266588|324211660|FG002|Observational Period|Lost to Follow-up|4|||
94660454|NCT03266588|324211658|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
94660455|NCT03266588|324211659|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
94660456|NCT03266588|324211660|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
94660457|NCT03266588|324211658|FG000|Observational Period|Protocol Deviation|1|||
94660458|NCT03266588|324211659|FG001|Observational Period|Protocol Deviation|0|||
94248148|NCT02233543|322702984|FG001|Period 2|COPD exacerbation|0|||
94248149|NCT01302067|322702985|FG000|Overall Study|Death|0|||
94248150|NCT01302067|322702986|FG001|Overall Study|Death|0|||
94248151|NCT01302067|322702987|FG002|Overall Study|Death|1|||
94248152|NCT01302067|322702985|FG000|Overall Study|Physician Decision|9|||
94248153|NCT01302067|322702986|FG001|Overall Study|Physician Decision|5|||
94248154|NCT01302067|322702987|FG002|Overall Study|Physician Decision|14|||
94248155|NCT01302067|322702985|FG000|Overall Study|Lack of Efficacy|8|||
94599082|NCT01397825|323995640|FG002|Overall Study|Symptomatic Deterioration|4|||
94599083|NCT01397825|323995641|FG003|Overall Study|Symptomatic Deterioration|0|||
94599084|NCT01397825|323995642|FG004|Overall Study|Symptomatic Deterioration|0|||
94599085|NCT01397825|323995638|FG000|Overall Study|Adverse Event|0|||
94599086|NCT01397825|323995639|FG001|Overall Study|Adverse Event|1|||
94599087|NCT01397825|323995640|FG002|Overall Study|Adverse Event|5|||
94599088|NCT01397825|323995641|FG003|Overall Study|Adverse Event|1|||
94599089|NCT01397825|323995642|FG004|Overall Study|Adverse Event|0|||
94599090|NCT01397825|323995638|FG000|Overall Study|Withdrawal by Subject|1|||
94599091|NCT01397825|323995639|FG001|Overall Study|Withdrawal by Subject|0|||
94599092|NCT01397825|323995640|FG002|Overall Study|Withdrawal by Subject|5|||
94599093|NCT01397825|323995641|FG003|Overall Study|Withdrawal by Subject|1|||
94599094|NCT01397825|323995642|FG004|Overall Study|Withdrawal by Subject|0|||
94599095|NCT01931670|323995644|FG000|Treatment Period|Exclusionary Medication Received|1|||
94599096|NCT01931670|323995645|FG001|Treatment Period|Exclusionary Medication Received|1|||
94599097|NCT01931670|323995646|FG002|Treatment Period|Exclusionary Medication Received|1|||
94599098|NCT01931670|323995644|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
94599099|NCT01931670|323995645|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
94599100|NCT01931670|323995646|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
94599101|NCT01931670|323995644|FG000|Treatment Period|Subject Noncompliant|4|||
94248156|NCT01302067|322702986|FG001|Overall Study|Lack of Efficacy|4|||
94248157|NCT01302067|322702987|FG002|Overall Study|Lack of Efficacy|2|||
94248158|NCT01302067|322702985|FG000|Overall Study|Lost to Follow-up|9|||
94248159|NCT01302067|322702986|FG001|Overall Study|Lost to Follow-up|4|||
94599102|NCT01931670|323995645|FG001|Treatment Period|Subject Noncompliant|9|||
94248160|NCT01302067|322702987|FG002|Overall Study|Lost to Follow-up|15|||
94248161|NCT01302067|322702985|FG000|Overall Study|Withdrawal by Subject|13|||
94599103|NCT01931670|323995646|FG002|Treatment Period|Subject Noncompliant|5|||
94599104|NCT01931670|323995644|FG000|Treatment Period|Adverse Event|19|||
94599105|NCT01931670|323995645|FG001|Treatment Period|Adverse Event|8|||
94599106|NCT01931670|323995646|FG002|Treatment Period|Adverse Event|21|||
94599107|NCT01931670|323995644|FG000|Treatment Period|Lack of Efficacy|11|||
94599108|NCT01931670|323995645|FG001|Treatment Period|Lack of Efficacy|2|||
94599109|NCT01931670|323995646|FG002|Treatment Period|Lack of Efficacy|2|||
94599110|NCT01931670|323995644|FG000|Treatment Period|Pregnancy|7|||
94599111|NCT01931670|323995645|FG001|Treatment Period|Pregnancy|2|||
94599112|NCT01931670|323995646|FG002|Treatment Period|Pregnancy|0|||
94599113|NCT01931670|323995644|FG000|Treatment Period|Other|8|||
94599114|NCT01931670|323995645|FG001|Treatment Period|Other|7|||
94599115|NCT01931670|323995646|FG002|Treatment Period|Other|2|||
94599116|NCT01931670|323995644|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
94599117|NCT01931670|323995645|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
94599118|NCT01931670|323995646|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
94599119|NCT01931670|323995644|FG000|Treatment Period|Lost to Follow-up|19|||
94599120|NCT01931670|323995645|FG001|Treatment Period|Lost to Follow-up|5|||
94599121|NCT01931670|323995646|FG002|Treatment Period|Lost to Follow-up|7|||
94599122|NCT01931670|323995644|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
94599123|NCT01931670|323995645|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
94599124|NCT01931670|323995646|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
94599125|NCT01931670|323995644|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
94599126|NCT01931670|323995645|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
94599127|NCT01931670|323995646|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
94599128|NCT01931670|323995644|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
94599129|NCT01931670|323995645|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
94599130|NCT01931670|323995646|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
94599131|NCT01931670|323995644|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
94599132|NCT01931670|323995645|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
94356030|NCT00450814|323085785|FG010|Overall Study|Failed to complete the initial therapy|0|||
94599133|NCT01931670|323995646|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
94599134|NCT01931670|323995644|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
94599135|NCT01931670|323995645|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
94599136|NCT01931670|323995646|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
94599137|NCT01931670|323995644|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
94599138|NCT01931670|323995645|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
94599139|NCT01931670|323995646|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
94599140|NCT00095238|323995652|FG000|Overall Study|Lack of Efficacy|9|||
94248162|NCT01302067|322702986|FG001|Overall Study|Withdrawal by Subject|6|||
94248163|NCT01302067|322702987|FG002|Overall Study|Withdrawal by Subject|10|||
94248164|NCT01302067|322702985|FG000|Overall Study|Other|1|||
94599141|NCT00095238|323995653|FG001|Overall Study|Lack of Efficacy|9|||
94599142|NCT00095238|323995652|FG000|Overall Study|Adverse Event|331|||
94599143|NCT00095238|323995653|FG001|Overall Study|Adverse Event|287|||
94599144|NCT00095238|323995652|FG000|Overall Study|Subject Withdrew Consent|208|||
94599145|NCT00095238|323995653|FG001|Overall Study|Subject Withdrew Consent|223|||
94599146|NCT00095238|323995652|FG000|Overall Study|Death|154|||
94599147|NCT00095238|323995653|FG001|Overall Study|Death|170|||
94599148|NCT00095238|323995652|FG000|Overall Study|Lost to Follow-up|19|||
94599149|NCT00095238|323995653|FG001|Overall Study|Lost to Follow-up|24|||
94599150|NCT00095238|323995652|FG000|Overall Study|Noncompliance|44|||
94599151|NCT00095238|323995653|FG001|Overall Study|Noncompliance|45|||
94599152|NCT00095238|323995652|FG000|Overall Study|No longer met study criteria|4|||
94599153|NCT00095238|323995653|FG001|Overall Study|No longer met study criteria|5|||
94599154|NCT00095238|323995652|FG000|Overall Study|Study terminated by sponsor|0|||
94599155|NCT00095238|323995653|FG001|Overall Study|Study terminated by sponsor|1|||
94599156|NCT00095238|323995652|FG000|Overall Study|Missing|1|||
94599157|NCT00095238|323995653|FG001|Overall Study|Missing|0|||
94599158|NCT00095238|323995652|FG000|Overall Study|Other Reasons|87|||
94599159|NCT00095238|323995653|FG001|Overall Study|Other Reasons|88|||
94599160|NCT01437995|323995654|FG000|Overall Study|Lost to Follow-up|11|||
94599161|NCT01437995|323995655|FG001|Overall Study|Lost to Follow-up|18|||
94599162|NCT01437995|323995656|FG002|Overall Study|Lost to Follow-up|20|||
94599163|NCT04393298|323995657|FG000|Overall Study|Adverse Event|0|||
94599164|NCT04393298|323995658|FG001|Overall Study|Adverse Event|0|||
94599165|NCT04393298|323995659|FG002|Overall Study|Adverse Event|0|||
94599166|NCT04393298|323995660|FG003|Overall Study|Adverse Event|0|||
94599167|NCT04393298|323995661|FG004|Overall Study|Adverse Event|1|||
94599168|NCT04393298|323995662|FG005|Overall Study|Adverse Event|0|||
94599169|NCT04393298|323995663|FG006|Overall Study|Adverse Event|0|||
94599170|NCT04393298|323995664|FG007|Overall Study|Adverse Event|0|||
94599171|NCT04393298|323995665|FG008|Overall Study|Adverse Event|2|||
94599172|NCT04393298|323995666|FG009|Overall Study|Adverse Event|0|||
94599173|NCT04393298|323995667|FG010|Overall Study|Adverse Event|0|||
94599174|NCT04393298|323995668|FG011|Overall Study|Adverse Event|0|||
94599175|NCT04393298|323995669|FG012|Overall Study|Adverse Event|1|||
94599176|NCT04393298|323995670|FG013|Overall Study|Adverse Event|1|||
94599177|NCT04393298|323995671|FG014|Overall Study|Adverse Event|0|||
94599178|NCT04393298|323995657|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
94599179|NCT04393298|323995658|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
94599180|NCT04393298|323995659|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
94599181|NCT04393298|323995660|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
94599182|NCT04393298|323995661|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
94599183|NCT04393298|323995662|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
94599184|NCT04393298|323995663|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
94599185|NCT04393298|323995664|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
94599186|NCT04393298|323995665|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
94599187|NCT04393298|323995666|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
94599188|NCT04393298|323995667|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
94599189|NCT04393298|323995668|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
94599190|NCT04393298|323995669|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
94599191|NCT04393298|323995670|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
94599192|NCT04393298|323995671|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
94599193|NCT04393298|323995657|FG000|Overall Study|Lack of Efficacy|0|||
94599194|NCT04393298|323995658|FG001|Overall Study|Lack of Efficacy|0|||
94599195|NCT04393298|323995659|FG002|Overall Study|Lack of Efficacy|0|||
94660459|NCT03266588|324211660|FG002|Observational Period|Protocol Deviation|0|||
94599196|NCT04393298|323995660|FG003|Overall Study|Lack of Efficacy|0|||
94599197|NCT04393298|323995661|FG004|Overall Study|Lack of Efficacy|0|||
94599198|NCT04393298|323995662|FG005|Overall Study|Lack of Efficacy|0|||
94599199|NCT04393298|323995663|FG006|Overall Study|Lack of Efficacy|0|||
94599200|NCT04393298|323995664|FG007|Overall Study|Lack of Efficacy|0|||
94599201|NCT04393298|323995665|FG008|Overall Study|Lack of Efficacy|0|||
94599202|NCT04393298|323995666|FG009|Overall Study|Lack of Efficacy|0|||
94599203|NCT04393298|323995667|FG010|Overall Study|Lack of Efficacy|0|||
94599204|NCT04393298|323995668|FG011|Overall Study|Lack of Efficacy|0|||
94599205|NCT04393298|323995669|FG012|Overall Study|Lack of Efficacy|0|||
94599206|NCT04393298|323995670|FG013|Overall Study|Lack of Efficacy|0|||
94599207|NCT04393298|323995671|FG014|Overall Study|Lack of Efficacy|1|||
94599208|NCT04393298|323995657|FG000|Overall Study|Progression|1|||
94599209|NCT04393298|323995658|FG001|Overall Study|Progression|0|||
94599210|NCT04393298|323995659|FG002|Overall Study|Progression|0|||
94599211|NCT04393298|323995660|FG003|Overall Study|Progression|0|||
94599212|NCT04393298|323995661|FG004|Overall Study|Progression|0|||
94599213|NCT04393298|323995662|FG005|Overall Study|Progression|0|||
94599214|NCT04393298|323995663|FG006|Overall Study|Progression|0|||
94599215|NCT04393298|323995664|FG007|Overall Study|Progression|0|||
94599216|NCT04393298|323995665|FG008|Overall Study|Progression|0|||
94599217|NCT04393298|323995666|FG009|Overall Study|Progression|0|||
94660460|NCT03266588|324211658|FG000|Observational Period|Other Reasons|3|||
94660461|NCT03266588|324211659|FG001|Observational Period|Other Reasons|0|||
94660462|NCT03266588|324211660|FG002|Observational Period|Other Reasons|1|||
94660463|NCT03266588|324211658|FG000|Long-term Treatment Period|Adverse Event|33|||
94599218|NCT04393298|323995667|FG010|Overall Study|Progression|1|||
94599219|NCT04393298|323995668|FG011|Overall Study|Progression|1|||
94599220|NCT04393298|323995669|FG012|Overall Study|Progression|0|||
94599221|NCT04393298|323995670|FG013|Overall Study|Progression|0|||
94599222|NCT04393298|323995671|FG014|Overall Study|Progression|0|||
94599223|NCT04393298|323995657|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
94599224|NCT04393298|323995658|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
94599225|NCT04393298|323995659|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
94599226|NCT04393298|323995660|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
94599227|NCT04393298|323995661|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
94599228|NCT04393298|323995662|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
94599229|NCT04393298|323995663|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
94599230|NCT04393298|323995664|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
94599231|NCT04393298|323995665|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
94599232|NCT04393298|323995666|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
94599233|NCT04393298|323995667|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
94599234|NCT04393298|323995668|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
94599235|NCT04393298|323995669|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
94599236|NCT04393298|323995670|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
94599237|NCT04393298|323995671|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
94599238|NCT04393298|323995657|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
94599239|NCT04393298|323995658|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
94599240|NCT04393298|323995659|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
94599241|NCT04393298|323995660|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
94599242|NCT04393298|323995661|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
94599243|NCT04393298|323995662|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
94599244|NCT04393298|323995663|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
94599245|NCT04393298|323995664|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
94599246|NCT04393298|323995665|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
94599247|NCT04393298|323995666|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
94599248|NCT04393298|323995667|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
94599249|NCT04393298|323995668|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
94599250|NCT04393298|323995669|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
94599251|NCT04393298|323995670|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
94599252|NCT04393298|323995671|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
94599253|NCT04393298|323995657|FG000|Overall Study|Clinical Progression|0|||
94599254|NCT04393298|323995658|FG001|Overall Study|Clinical Progression|2|||
94660464|NCT03266588|324211659|FG001|Long-term Treatment Period|Adverse Event|17|||
94660465|NCT03266588|324211660|FG002|Long-term Treatment Period|Adverse Event|8|||
94599255|NCT04393298|323995659|FG002|Overall Study|Clinical Progression|0|||
94248165|NCT01302067|322702986|FG001|Overall Study|Other|1|||
94599256|NCT04393298|323995660|FG003|Overall Study|Clinical Progression|0|||
94660466|NCT03266588|324211658|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
94599257|NCT04393298|323995661|FG004|Overall Study|Clinical Progression|0|||
94599258|NCT04393298|323995662|FG005|Overall Study|Clinical Progression|0|||
94599259|NCT04393298|323995663|FG006|Overall Study|Clinical Progression|0|||
94599260|NCT04393298|323995664|FG007|Overall Study|Clinical Progression|0|||
94599261|NCT04393298|323995665|FG008|Overall Study|Clinical Progression|0|||
94599262|NCT04393298|323995666|FG009|Overall Study|Clinical Progression|0|||
94599263|NCT04393298|323995667|FG010|Overall Study|Clinical Progression|0|||
94599264|NCT04393298|323995668|FG011|Overall Study|Clinical Progression|0|||
94599265|NCT04393298|323995669|FG012|Overall Study|Clinical Progression|0|||
94599266|NCT04393298|323995670|FG013|Overall Study|Clinical Progression|0|||
94599267|NCT04393298|323995671|FG014|Overall Study|Clinical Progression|0|||
94599268|NCT04393298|323995657|FG000|Overall Study|Disease Progression|0|||
94599269|NCT04393298|323995658|FG001|Overall Study|Disease Progression|1|||
94599270|NCT04393298|323995659|FG002|Overall Study|Disease Progression|0|||
94599271|NCT04393298|323995660|FG003|Overall Study|Disease Progression|0|||
94599272|NCT04393298|323995661|FG004|Overall Study|Disease Progression|0|||
94599273|NCT04393298|323995662|FG005|Overall Study|Disease Progression|3|||
94599274|NCT04393298|323995663|FG006|Overall Study|Disease Progression|2|||
94599275|NCT04393298|323995664|FG007|Overall Study|Disease Progression|1|||
94599276|NCT04393298|323995665|FG008|Overall Study|Disease Progression|2|||
94599277|NCT04393298|323995666|FG009|Overall Study|Disease Progression|1|||
94599278|NCT04393298|323995667|FG010|Overall Study|Disease Progression|0|||
94599279|NCT04393298|323995668|FG011|Overall Study|Disease Progression|3|||
94599280|NCT04393298|323995669|FG012|Overall Study|Disease Progression|0|||
94599281|NCT04393298|323995670|FG013|Overall Study|Disease Progression|0|||
94599282|NCT04393298|323995671|FG014|Overall Study|Disease Progression|1|||
94599283|NCT04393298|323995657|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
94599284|NCT04393298|323995658|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
94599285|NCT04393298|323995659|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
94599286|NCT04393298|323995660|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
94599287|NCT04393298|323995661|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
94599288|NCT04393298|323995662|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
94599289|NCT04393298|323995663|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
94599290|NCT04393298|323995664|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
94599291|NCT04393298|323995665|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
94599292|NCT04393298|323995666|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
94599293|NCT04393298|323995667|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
94599294|NCT04393298|323995668|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
94599295|NCT04393298|323995669|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
94599296|NCT04393298|323995670|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
94599297|NCT04393298|323995671|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
94599298|NCT04393298|323995657|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
94599299|NCT04393298|323995658|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
94599300|NCT04393298|323995659|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
94599301|NCT04393298|323995660|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
94599302|NCT04393298|323995661|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
94599303|NCT04393298|323995662|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
94599304|NCT04393298|323995663|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
94599305|NCT04393298|323995664|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
94599306|NCT04393298|323995665|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
94599307|NCT04393298|323995666|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
94599308|NCT04393298|323995667|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
94599309|NCT04393298|323995668|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
94599310|NCT04393298|323995669|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
94599311|NCT04393298|323995670|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
94599312|NCT04393298|323995671|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
94599313|NCT04393298|323995657|FG000|Overall Study|Progressive Disease (PD)|0|||
94248166|NCT01302067|322702987|FG002|Overall Study|Other|3|||
94248167|NCT01302067|322702985|FG000|Overall Study|Protocol Violation|11|||
94599314|NCT04393298|323995658|FG001|Overall Study|Progressive Disease (PD)|0|||
94599315|NCT04393298|323995659|FG002|Overall Study|Progressive Disease (PD)|0|||
94599316|NCT04393298|323995660|FG003|Overall Study|Progressive Disease (PD)|3|||
94599317|NCT04393298|323995661|FG004|Overall Study|Progressive Disease (PD)|0|||
94599318|NCT04393298|323995662|FG005|Overall Study|Progressive Disease (PD)|0|||
94248168|NCT01302067|322702986|FG001|Overall Study|Protocol Violation|0|||
94248169|NCT01302067|322702987|FG002|Overall Study|Protocol Violation|8|||
94599319|NCT04393298|323995663|FG006|Overall Study|Progressive Disease (PD)|0|||
94599320|NCT04393298|323995664|FG007|Overall Study|Progressive Disease (PD)|0|||
94599321|NCT04393298|323995665|FG008|Overall Study|Progressive Disease (PD)|0|||
94599322|NCT04393298|323995666|FG009|Overall Study|Progressive Disease (PD)|0|||
94248170|NCT01302067|322702985|FG000|Overall Study|Adverse Event|27|||
94599323|NCT04393298|323995667|FG010|Overall Study|Progressive Disease (PD)|0|||
94599324|NCT04393298|323995668|FG011|Overall Study|Progressive Disease (PD)|0|||
94599325|NCT04393298|323995669|FG012|Overall Study|Progressive Disease (PD)|0|||
94599326|NCT04393298|323995670|FG013|Overall Study|Progressive Disease (PD)|0|||
94599327|NCT04393298|323995671|FG014|Overall Study|Progressive Disease (PD)|0|||
94599328|NCT04393298|323995657|FG000|Overall Study|Started a New Cancer Treatment|0|||
94599329|NCT04393298|323995658|FG001|Overall Study|Started a New Cancer Treatment|0|||
94599330|NCT04393298|323995659|FG002|Overall Study|Started a New Cancer Treatment|0|||
94599331|NCT04393298|323995660|FG003|Overall Study|Started a New Cancer Treatment|0|||
94599332|NCT04393298|323995661|FG004|Overall Study|Started a New Cancer Treatment|1|||
94599333|NCT04393298|323995662|FG005|Overall Study|Started a New Cancer Treatment|0|||
94599334|NCT04393298|323995663|FG006|Overall Study|Started a New Cancer Treatment|0|||
94599335|NCT04393298|323995664|FG007|Overall Study|Started a New Cancer Treatment|0|||
94599336|NCT04393298|323995665|FG008|Overall Study|Started a New Cancer Treatment|0|||
94599337|NCT04393298|323995666|FG009|Overall Study|Started a New Cancer Treatment|0|||
94599338|NCT04393298|323995667|FG010|Overall Study|Started a New Cancer Treatment|0|||
94599339|NCT04393298|323995668|FG011|Overall Study|Started a New Cancer Treatment|0|||
94599340|NCT04393298|323995669|FG012|Overall Study|Started a New Cancer Treatment|0|||
94599341|NCT04393298|323995670|FG013|Overall Study|Started a New Cancer Treatment|0|||
94599342|NCT04393298|323995671|FG014|Overall Study|Started a New Cancer Treatment|0|||
94599343|NCT04393298|323995657|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
94599344|NCT04393298|323995658|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
94599345|NCT04393298|323995659|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
94599346|NCT04393298|323995660|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
94599347|NCT04393298|323995661|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
94599348|NCT04393298|323995662|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
94599349|NCT04393298|323995663|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
94599350|NCT04393298|323995664|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
94599351|NCT04393298|323995665|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
94599352|NCT04393298|323995666|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
94599353|NCT04393298|323995667|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
94599354|NCT04393298|323995668|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
94248171|NCT01302067|322702986|FG001|Overall Study|Adverse Event|14|||
94248172|NCT01302067|322702987|FG002|Overall Study|Adverse Event|45|||
94248173|NCT00603304|322702988|FG000|Overall Study|Lost to Follow-up|5|||
94248174|NCT00603304|322702989|FG001|Overall Study|Lost to Follow-up|7|||
94599355|NCT04393298|323995669|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
94599356|NCT04393298|323995670|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
94599357|NCT04393298|323995671|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
94599358|NCT04393298|323995657|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
94599359|NCT04393298|323995658|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
94599360|NCT04393298|323995659|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
94599361|NCT04393298|323995660|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
94599362|NCT04393298|323995661|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
94599363|NCT04393298|323995662|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
94599364|NCT04393298|323995663|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
94599365|NCT04393298|323995664|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
94599366|NCT04393298|323995665|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
94599367|NCT04393298|323995666|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
94599368|NCT04393298|323995667|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
94599369|NCT04393298|323995668|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
94599370|NCT04393298|323995669|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
94599371|NCT04393298|323995670|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
94599372|NCT04393298|323995671|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
94599373|NCT04393298|323995657|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
94599374|NCT04393298|323995658|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
94599375|NCT04393298|323995659|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
94599376|NCT04393298|323995660|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
94599377|NCT04393298|323995661|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
94599378|NCT04393298|323995662|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
94599379|NCT04393298|323995663|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
94599380|NCT04393298|323995664|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
94599381|NCT04393298|323995665|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
94599382|NCT04393298|323995666|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
94248175|NCT00603304|322702988|FG000|Overall Study|Withdrawal by Subject|8|||
94248176|NCT00603304|322702989|FG001|Overall Study|Withdrawal by Subject|5|||
94599383|NCT04393298|323995667|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
94599384|NCT04393298|323995668|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
94599385|NCT04393298|323995669|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
94599386|NCT04393298|323995670|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
94599387|NCT04393298|323995671|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
94599388|NCT04393298|323995657|FG000|Overall Study|Death|0|||
94599389|NCT04393298|323995658|FG001|Overall Study|Death|0|||
94599390|NCT04393298|323995659|FG002|Overall Study|Death|0|||
94599391|NCT04393298|323995660|FG003|Overall Study|Death|0|||
94599392|NCT04393298|323995661|FG004|Overall Study|Death|0|||
94599393|NCT04393298|323995662|FG005|Overall Study|Death|1|||
94599394|NCT04393298|323995663|FG006|Overall Study|Death|1|||
94599395|NCT04393298|323995664|FG007|Overall Study|Death|0|||
94599396|NCT04393298|323995665|FG008|Overall Study|Death|1|||
94599397|NCT04393298|323995666|FG009|Overall Study|Death|1|||
94599398|NCT04393298|323995667|FG010|Overall Study|Death|0|||
94599399|NCT04393298|323995668|FG011|Overall Study|Death|1|||
94599400|NCT04393298|323995669|FG012|Overall Study|Death|1|||
94599401|NCT04393298|323995670|FG013|Overall Study|Death|0|||
94599402|NCT04393298|323995671|FG014|Overall Study|Death|1|||
94599403|NCT04393298|323995657|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
94599404|NCT04393298|323995658|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
94599405|NCT04393298|323995659|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
94599406|NCT04393298|323995660|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
94599407|NCT04393298|323995661|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
94599408|NCT04393298|323995662|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
94599409|NCT04393298|323995663|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
94599410|NCT04393298|323995664|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
94599411|NCT04393298|323995665|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
94599412|NCT04393298|323995666|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
94599413|NCT04393298|323995667|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
94599414|NCT04393298|323995668|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
94599415|NCT04393298|323995669|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
94599416|NCT04393298|323995670|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
94599417|NCT04393298|323995671|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
94599418|NCT04393298|323995657|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
94599419|NCT04393298|323995658|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
94599420|NCT04393298|323995659|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
94599421|NCT04393298|323995660|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
94599422|NCT04393298|323995661|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
94599423|NCT04393298|323995662|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
94599424|NCT04393298|323995663|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
94599425|NCT04393298|323995664|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
94599426|NCT04393298|323995665|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
94599427|NCT04393298|323995666|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
94599428|NCT04393298|323995667|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
94599429|NCT04393298|323995668|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
94599430|NCT04393298|323995669|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
94599431|NCT04393298|323995670|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
94599432|NCT04393298|323995671|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
94599433|NCT04393298|323995657|FG000|Overall Study|Patient Passed Away|0|||
94599434|NCT04393298|323995658|FG001|Overall Study|Patient Passed Away|0|||
94599435|NCT04393298|323995659|FG002|Overall Study|Patient Passed Away|0|||
94599436|NCT04393298|323995660|FG003|Overall Study|Patient Passed Away|0|||
94599437|NCT04393298|323995661|FG004|Overall Study|Patient Passed Away|0|||
94599438|NCT04393298|323995662|FG005|Overall Study|Patient Passed Away|0|||
94599439|NCT04393298|323995663|FG006|Overall Study|Patient Passed Away|0|||
94599440|NCT04393298|323995664|FG007|Overall Study|Patient Passed Away|1|||
94599441|NCT04393298|323995665|FG008|Overall Study|Patient Passed Away|0|||
94599442|NCT04393298|323995666|FG009|Overall Study|Patient Passed Away|0|||
94599443|NCT04393298|323995667|FG010|Overall Study|Patient Passed Away|0|||
94599444|NCT04393298|323995668|FG011|Overall Study|Patient Passed Away|0|||
94599445|NCT04393298|323995669|FG012|Overall Study|Patient Passed Away|0|||
94599446|NCT04393298|323995670|FG013|Overall Study|Patient Passed Away|0|||
94599447|NCT04393298|323995671|FG014|Overall Study|Patient Passed Away|0|||
94599448|NCT04393298|323995657|FG000|Overall Study|Patient Deceased|0|||
94599449|NCT04393298|323995658|FG001|Overall Study|Patient Deceased|0|||
94599450|NCT04393298|323995659|FG002|Overall Study|Patient Deceased|0|||
94248177|NCT00603304|322702988|FG000|Overall Study|Protocol Violation|1|||
94248178|NCT00603304|322702989|FG001|Overall Study|Protocol Violation|0|||
94248179|NCT00603304|322702988|FG000|Overall Study|Adverse Event|4|||
94248180|NCT00603304|322702989|FG001|Overall Study|Adverse Event|2|||
94248181|NCT00603304|322702988|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
94248182|NCT00603304|322702989|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
94248183|NCT00603304|322702988|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
94248184|NCT00603304|322702989|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
94248185|NCT00603304|322702988|FG000|Overall Study|Exclusionary Medication|2|||
94248186|NCT00603304|322702989|FG001|Overall Study|Exclusionary Medication|3|||
94248187|NCT00603304|322702988|FG000|Overall Study|Non-Compliant|0|||
94248188|NCT00603304|322702989|FG001|Overall Study|Non-Compliant|1|||
94248189|NCT00603304|322702988|FG000|Overall Study|Moved Away|0|||
94248190|NCT00603304|322702989|FG001|Overall Study|Moved Away|2|||
94248191|NCT00603304|322702988|FG000|Overall Study|Other|2|||
94248192|NCT00603304|322702989|FG001|Overall Study|Other|0|||
94248193|NCT00603304|322702988|FG000|Overall Study|Patient Decision|2|||
94248194|NCT00603304|322702989|FG001|Overall Study|Patient Decision|0|||
94248195|NCT01262677|322702991|FG000|Overall Study|Does not meet entrance criteria|0|||
94248196|NCT01262677|322702992|FG001|Overall Study|Does not meet entrance criteria|2|||
94248197|NCT01262677|322702993|FG002|Overall Study|Does not meet entrance criteria|0|||
94248198|NCT01262677|322702991|FG000|Overall Study|Insufficient clinical response|0|||
94248199|NCT01262677|322702992|FG001|Overall Study|Insufficient clinical response|0|||
94248200|NCT01262677|322702993|FG002|Overall Study|Insufficient clinical response|1|||
94248201|NCT01262677|322702991|FG000|Overall Study|Lost to Follow-up|1|||
94248202|NCT01262677|322702992|FG001|Overall Study|Lost to Follow-up|0|||
94248203|NCT01262677|322702993|FG002|Overall Study|Lost to Follow-up|2|||
94248204|NCT01262677|322702991|FG000|Overall Study|No longer willing to participate|3|||
94599451|NCT04393298|323995660|FG003|Overall Study|Patient Deceased|0|||
94599452|NCT04393298|323995661|FG004|Overall Study|Patient Deceased|0|||
94599453|NCT04393298|323995662|FG005|Overall Study|Patient Deceased|0|||
94599454|NCT04393298|323995663|FG006|Overall Study|Patient Deceased|0|||
94599455|NCT04393298|323995664|FG007|Overall Study|Patient Deceased|1|||
94599456|NCT04393298|323995665|FG008|Overall Study|Patient Deceased|0|||
94599457|NCT04393298|323995666|FG009|Overall Study|Patient Deceased|0|||
94599458|NCT04393298|323995667|FG010|Overall Study|Patient Deceased|0|||
94248205|NCT01262677|322702992|FG001|Overall Study|No longer willing to participate|3|||
94248206|NCT01262677|322702993|FG002|Overall Study|No longer willing to participate|2|||
94248207|NCT01262677|322702991|FG000|Overall Study|Reason not provided|2|||
94248208|NCT01262677|322702992|FG001|Overall Study|Reason not provided|1|||
94248209|NCT01262677|322702993|FG002|Overall Study|Reason not provided|3|||
94248210|NCT01262677|322702991|FG000|Overall Study|Protocol Violation|0|||
94248211|NCT01262677|322702992|FG001|Overall Study|Protocol Violation|1|||
94248212|NCT01262677|322702993|FG002|Overall Study|Protocol Violation|1|||
94248213|NCT01262677|322702991|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
94248214|NCT01262677|322702992|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
94248215|NCT01262677|322702993|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
94248216|NCT05816330|322702997|FG000|Overall Study|Withdrawal by Subject|4|||
94248217|NCT05816330|322702998|FG001|Overall Study|Withdrawal by Subject|1|||
94248218|NCT00836745|322702999|FG000|Overall Study|Death|2|||
94248219|NCT00836745|322702999|FG000|Overall Study|Lost to Follow-up|10|||
94248220|NCT00836745|322702999|FG000|Overall Study|Adverse Event|3|||
94248221|NCT00836745|322702999|FG000|Overall Study|Objective progression or relapse|4|||
94248222|NCT00836745|322702999|FG000|Overall Study|Other|2|||
94248223|NCT01895101|322703005|FG000|Overall Study|OPCAB procedure|1|||
94248224|NCT01895101|322703006|FG001|Overall Study|OPCAB procedure|1|||
94248225|NCT01895101|322703007|FG002|Overall Study|OPCAB procedure|3|||
94248226|NCT01895101|322703005|FG000|Overall Study|Withdrawal by Subject|0|||
94248227|NCT01895101|322703006|FG001|Overall Study|Withdrawal by Subject|1|||
94248228|NCT01895101|322703007|FG002|Overall Study|Withdrawal by Subject|2|||
94248229|NCT01895101|322703005|FG000|Overall Study|another study, enrolled in other study|0|||
94248230|NCT01895101|322703006|FG001|Overall Study|another study, enrolled in other study|1|||
94248231|NCT01895101|322703007|FG002|Overall Study|another study, enrolled in other study|0|||
94248232|NCT01895101|322703005|FG000|Overall Study|Death|0|||
94248233|NCT01895101|322703006|FG001|Overall Study|Death|1|||
94248234|NCT01895101|322703007|FG002|Overall Study|Death|0|||
94248235|NCT01895101|322703005|FG000|Overall Study|coagulation disorder|0|||
94660467|NCT03266588|324211659|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
94248236|NCT01895101|322703006|FG001|Overall Study|coagulation disorder|1|||
94248237|NCT01895101|322703007|FG002|Overall Study|coagulation disorder|0|||
94248238|NCT00037830|322703014|FG000|Overall Study|Adverse Event|2|||
94248239|NCT00037830|322703015|FG001|Overall Study|Adverse Event|0|||
94248240|NCT00037830|322703016|FG002|Overall Study|Adverse Event|0|||
94248241|NCT00037830|322703014|FG000|Overall Study|Withdrawal by Subject|4|||
94248242|NCT00037830|322703015|FG001|Overall Study|Withdrawal by Subject|5|||
94248243|NCT00037830|322703016|FG002|Overall Study|Withdrawal by Subject|1|||
94660468|NCT03266588|324211660|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
94599459|NCT04393298|323995668|FG011|Overall Study|Patient Deceased|0|||
94599460|NCT04393298|323995669|FG012|Overall Study|Patient Deceased|0|||
94248244|NCT00037830|322703014|FG000|Overall Study|Protocol Violation|2|||
94248245|NCT00037830|322703015|FG001|Overall Study|Protocol Violation|2|||
94248246|NCT00037830|322703016|FG002|Overall Study|Protocol Violation|0|||
94248247|NCT00037830|322703014|FG000|Overall Study|Unrelated Medical Problem|2|||
94248248|NCT00037830|322703015|FG001|Overall Study|Unrelated Medical Problem|0|||
94248249|NCT00037830|322703016|FG002|Overall Study|Unrelated Medical Problem|0|||
94248250|NCT01888900|322703017|FG000|Overall Study|failed treatment|0|||
94248251|NCT01888900|322703018|FG001|Overall Study|failed treatment|2|||
94248252|NCT01639560|322703019|FG000|Overall Study|Withdrawal by Subject|9|||
94248253|NCT01639560|322703020|FG001|Overall Study|Withdrawal by Subject|14|||
94248254|NCT01639560|322703019|FG000|Overall Study|Lack of Efficacy|1|||
94248255|NCT01639560|322703020|FG001|Overall Study|Lack of Efficacy|2|||
94248256|NCT01639560|322703019|FG000|Overall Study|Lost to Follow-up|9|||
94248257|NCT01639560|322703020|FG001|Overall Study|Lost to Follow-up|11|||
94248258|NCT01639560|322703019|FG000|Overall Study|Adverse Event|0|||
94248259|NCT01639560|322703020|FG001|Overall Study|Adverse Event|2|||
94248260|NCT01004848|322703021|FG000|Overall Study|Lost to Follow-up|55|||
94248261|NCT01004848|322703022|FG001|Overall Study|Lost to Follow-up|45|||
94248262|NCT00766363|322703026|FG000|Overall Study|Withdrawal by Subject|1|||
94248263|NCT00766363|322703027|FG001|Overall Study|Withdrawal by Subject|0|||
94248264|NCT00766363|322703028|FG002|Overall Study|Withdrawal by Subject|0|||
94248265|NCT00766363|322703029|FG003|Overall Study|Withdrawal by Subject|0|||
94248266|NCT00766363|322703026|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
94248267|NCT00766363|322703027|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
94248268|NCT00766363|322703028|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
94248269|NCT00766363|322703029|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
94248270|NCT01631227|322703030|FG000|Overall Study|withdrawn consent|27|||
94248271|NCT01631227|322703031|FG001|Overall Study|withdrawn consent|21|||
94248272|NCT01631227|322703030|FG000|Overall Study|Adverse Event|1|||
94248273|NCT01631227|322703031|FG001|Overall Study|Adverse Event|0|||
94248274|NCT01631227|322703030|FG000|Overall Study|administrative|2|||
94248275|NCT01631227|322703031|FG001|Overall Study|administrative|1|||
94248276|NCT02683876|322703034|FG000|Overall Study|samples damaged during shipping|2|||
94248277|NCT02683876|322703035|FG001|Overall Study|samples damaged during shipping|0|||
94248278|NCT01941719|322703042|FG000|Overall Study|Lost to Follow-up|20|||
94248279|NCT01941719|322703043|FG001|Overall Study|Lost to Follow-up|19|||
94248280|NCT00324116|322703044|FG000|Overall Study|Adverse Event|5|||
94248281|NCT00324116|322703044|FG000|Overall Study|Lack of Efficacy|17|||
94248282|NCT00324116|322703044|FG000|Overall Study|Withdrawal by Subject|5|||
94248283|NCT00324116|322703044|FG000|Overall Study|Other|5|||
94248284|NCT01451827|322703047|FG000|Overall Study|Adverse Event|2|||
94248285|NCT01451827|322703048|FG001|Overall Study|Adverse Event|0|||
94248286|NCT01451827|322703049|FG002|Overall Study|Adverse Event|1|||
94248287|NCT01451827|322703050|FG003|Overall Study|Adverse Event|1|||
94248288|NCT01451827|322703047|FG000|Overall Study|Protocol deviation|1|||
94248289|NCT01451827|322703048|FG001|Overall Study|Protocol deviation|0|||
94248290|NCT01451827|322703049|FG002|Overall Study|Protocol deviation|0|||
94248291|NCT01451827|322703050|FG003|Overall Study|Protocol deviation|0|||
94248292|NCT01451827|322703047|FG000|Overall Study|Lost to Follow-up|0|||
94248293|NCT01451827|322703048|FG001|Overall Study|Lost to Follow-up|3|||
94248294|NCT01451827|322703049|FG002|Overall Study|Lost to Follow-up|0|||
94356031|NCT00450814|323085775|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
94599461|NCT04393298|323995670|FG013|Overall Study|Patient Deceased|0|||
94599462|NCT04393298|323995671|FG014|Overall Study|Patient Deceased|0|||
94599463|NCT04393298|323995657|FG000|Overall Study|Patient Discharged to Hospice|0|||
94599464|NCT04393298|323995658|FG001|Overall Study|Patient Discharged to Hospice|0|||
94599465|NCT04393298|323995659|FG002|Overall Study|Patient Discharged to Hospice|0|||
94599466|NCT04393298|323995660|FG003|Overall Study|Patient Discharged to Hospice|0|||
94599467|NCT04393298|323995661|FG004|Overall Study|Patient Discharged to Hospice|0|||
94248295|NCT01451827|322703050|FG003|Overall Study|Lost to Follow-up|2|||
94248296|NCT01451827|322703047|FG000|Overall Study|Participant met withdrawal criteria|0|||
94248297|NCT01451827|322703048|FG001|Overall Study|Participant met withdrawal criteria|2|||
94248298|NCT01451827|322703049|FG002|Overall Study|Participant met withdrawal criteria|0|||
94248299|NCT01451827|322703050|FG003|Overall Study|Participant met withdrawal criteria|0|||
94248300|NCT01451827|322703047|FG000|Overall Study|Withdrawal by Subject|0|||
94248301|NCT01451827|322703048|FG001|Overall Study|Withdrawal by Subject|0|||
94248302|NCT01451827|322703049|FG002|Overall Study|Withdrawal by Subject|1|||
94248303|NCT01451827|322703050|FG003|Overall Study|Withdrawal by Subject|1|||
94248304|NCT03223662|322703051|FG000|Overall Study|Physician Decision|1|||
94248305|NCT03223662|322703051|FG000|Overall Study|Study closure|1|||
94356032|NCT00450814|323085776|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
94599468|NCT04393298|323995662|FG005|Overall Study|Patient Discharged to Hospice|0|||
94248306|NCT01258595|322703052|FG000|Overall Study|Lost to Follow-up|1|||
94248307|NCT01258595|322703053|FG001|Overall Study|Lost to Follow-up|0|||
94248308|NCT01258595|322703052|FG000|Overall Study|Withdrawal by Subject|0|||
94248309|NCT01258595|322703053|FG001|Overall Study|Withdrawal by Subject|1|||
94599469|NCT04393298|323995663|FG006|Overall Study|Patient Discharged to Hospice|0|||
94599470|NCT04393298|323995664|FG007|Overall Study|Patient Discharged to Hospice|0|||
94599471|NCT04393298|323995665|FG008|Overall Study|Patient Discharged to Hospice|1|||
94599472|NCT04393298|323995666|FG009|Overall Study|Patient Discharged to Hospice|0|||
94599473|NCT04393298|323995667|FG010|Overall Study|Patient Discharged to Hospice|0|||
94599474|NCT04393298|323995668|FG011|Overall Study|Patient Discharged to Hospice|0|||
94599475|NCT04393298|323995669|FG012|Overall Study|Patient Discharged to Hospice|0|||
94660469|NCT03266588|324211658|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
94660470|NCT03266588|324211659|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
94660471|NCT03266588|324211660|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
94660472|NCT03266588|324211658|FG000|Long-term Treatment Period|Non-Compliance|126|||
94660473|NCT03266588|324211659|FG001|Long-term Treatment Period|Non-Compliance|57|||
94660474|NCT03266588|324211660|FG002|Long-term Treatment Period|Non-Compliance|7|||
94660475|NCT03266588|324211658|FG000|Long-term Treatment Period|Pregnancy|11|||
94599476|NCT04393298|323995670|FG013|Overall Study|Patient Discharged to Hospice|0|||
94660476|NCT03266588|324211659|FG001|Long-term Treatment Period|Pregnancy|5|||
94660477|NCT03266588|324211660|FG002|Long-term Treatment Period|Pregnancy|0|||
94599477|NCT04393298|323995671|FG014|Overall Study|Patient Discharged to Hospice|0|||
94599478|NCT04393298|323995657|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
94599479|NCT04393298|323995658|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
94599480|NCT04393298|323995659|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
94599481|NCT04393298|323995660|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
94599482|NCT04393298|323995661|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
94599483|NCT04393298|323995662|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
94248310|NCT00371683|322703054|FG000|DB Treatment Period-Randomized Patients|Death|1|||
94248311|NCT00371683|322703055|FG001|DB Treatment Period-Randomized Patients|Death|1|||
94248312|NCT00371683|322703054|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
94248313|NCT00371683|322703055|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
94248314|NCT00371683|322703054|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
94248315|NCT00371683|322703055|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
94248316|NCT00371683|322703054|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
94248317|NCT00371683|322703055|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
94248318|NCT00371683|322703054|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
94248319|NCT00371683|322703055|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
94248320|NCT00371683|322703054|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
94248321|NCT00371683|322703055|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
94248322|NCT00371683|322703054|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
94248323|NCT00371683|322703055|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
94248324|NCT00371683|322703054|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
94248325|NCT00371683|322703055|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
94248326|NCT00371683|322703054|FG000|Follow-Up Period - Randomized Patients|Death|0|||
94248327|NCT00371683|322703055|FG001|Follow-Up Period - Randomized Patients|Death|2|||
94248328|NCT00371683|322703054|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
94248329|NCT00371683|322703055|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
94248330|NCT00371683|322703054|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
94248331|NCT00371683|322703055|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
94248332|NCT02285153|322703056|FG000|Overall Study|Adverse Event|1|||
94248333|NCT02285153|322703057|FG001|Overall Study|Adverse Event|0|||
94248334|NCT02150343|322703058|FG000|Overall Study|Adverse Event|2|||
94248335|NCT02150343|322703059|FG001|Overall Study|Adverse Event|0|||
94248336|NCT02150343|322703060|FG002|Overall Study|Adverse Event|1|||
94248337|NCT02150343|322703061|FG003|Overall Study|Adverse Event|1|||
94248338|NCT02150343|322703058|FG000|Overall Study|Withdrawal by Subject|13|||
94248339|NCT02150343|322703059|FG001|Overall Study|Withdrawal by Subject|10|||
94248340|NCT02150343|322703060|FG002|Overall Study|Withdrawal by Subject|9|||
94248341|NCT02150343|322703061|FG003|Overall Study|Withdrawal by Subject|4|||
94248342|NCT02150343|322703058|FG000|Overall Study|Lost to Follow-up|4|||
94248343|NCT02150343|322703059|FG001|Overall Study|Lost to Follow-up|4|||
94248344|NCT02150343|322703060|FG002|Overall Study|Lost to Follow-up|2|||
94248345|NCT02150343|322703061|FG003|Overall Study|Lost to Follow-up|3|||
94248346|NCT02150343|322703058|FG000|Overall Study|Other|2|||
94248347|NCT02150343|322703059|FG001|Overall Study|Other|6|||
94248348|NCT02150343|322703060|FG002|Overall Study|Other|0|||
94599484|NCT04393298|323995663|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
94599485|NCT04393298|323995664|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
94599486|NCT04393298|323995665|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
94599487|NCT04393298|323995666|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
94599488|NCT04393298|323995667|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
94599489|NCT04393298|323995668|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
94599490|NCT04393298|323995669|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
94599491|NCT04393298|323995670|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
94599492|NCT04393298|323995671|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
94599493|NCT04393298|323995657|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
94599494|NCT04393298|323995658|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
94599495|NCT04393298|323995659|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
94599496|NCT04393298|323995660|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
94599497|NCT04393298|323995661|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
94599498|NCT04393298|323995662|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
94599499|NCT04393298|323995663|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
94599500|NCT04393298|323995664|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
94599501|NCT04393298|323995665|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
94599502|NCT04393298|323995666|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
94599503|NCT04393298|323995667|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
94599504|NCT04393298|323995668|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
94248349|NCT02150343|322703061|FG003|Overall Study|Other|2|||
94599505|NCT04393298|323995669|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
94599506|NCT04393298|323995670|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
94599507|NCT04393298|323995671|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
94599508|NCT05338671|323995674|FG000|Overall Study|Lost to Follow-up|2|||
94599509|NCT05338671|323995675|FG001|Overall Study|Lost to Follow-up|2|||
94599510|NCT05338671|323995674|FG000|Overall Study|Root canal completed in a single visit|1|||
94599511|NCT05338671|323995675|FG001|Overall Study|Root canal completed in a single visit|0|||
94599512|NCT04456673|323995676|FG000|Overall Study|Adverse Event|7|||
94599513|NCT04456673|323995677|FG001|Overall Study|Adverse Event|14|||
94599514|NCT04456673|323995676|FG000|Overall Study|Poor compliance to protocol|1|||
94599515|NCT04456673|323995677|FG001|Overall Study|Poor compliance to protocol|0|||
94599516|NCT04456673|323995676|FG000|Overall Study|Withdrawal by Subject|31|||
94599517|NCT04456673|323995677|FG001|Overall Study|Withdrawal by Subject|23|||
94599518|NCT04456673|323995676|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
94599519|NCT04456673|323995677|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
94599520|NCT03459690|323995684|FG000|Overall Study|Lost to Follow-up|0|||
94599521|NCT03459690|323995685|FG001|Overall Study|Lost to Follow-up|1|||
94599522|NCT03459690|323995684|FG000|Overall Study|Withdrawal by Subject|1|||
94660478|NCT03266588|324211658|FG000|Long-term Treatment Period|Protocol Deviation|17|||
94248350|NCT01993927|322703065|FG000|Overall Study|Case Report Forms Uncollected|18|||
94248351|NCT01993927|322703065|FG000|Overall Study|Protocol Violation|11|||
94248352|NCT00895154|322703066|FG000|Overall Study|Lost to Follow-up|1|||
94248353|NCT00895154|322703067|FG001|Overall Study|Lost to Follow-up|1|||
94599523|NCT03459690|323995685|FG001|Overall Study|Withdrawal by Subject|1|||
94599524|NCT02815280|323995686|FG000|Double-Blind Phase|Adverse Event|1|||
94599525|NCT02815280|323995687|FG001|Double-Blind Phase|Adverse Event|1|||
94599526|NCT02815280|323995686|FG000|Double-Blind Phase|Lost to Follow-up|10|||
94599527|NCT02815280|323995687|FG001|Double-Blind Phase|Lost to Follow-up|9|||
94599528|NCT02815280|323995686|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
94248354|NCT00895154|322703066|FG000|Overall Study|Withdrawal by Subject|0|||
94248355|NCT00895154|322703067|FG001|Overall Study|Withdrawal by Subject|1|||
94248356|NCT03702231|322703068|FG000|Overall Study|Withdrawal by Subject|1|||
94248357|NCT03702231|322703069|FG001|Overall Study|Withdrawal by Subject|0|||
94248358|NCT03702231|322703070|FG002|Overall Study|Withdrawal by Subject|0|||
94248359|NCT03702231|322703068|FG000|Overall Study|Protocol Violation|0|||
94248360|NCT03702231|322703069|FG001|Overall Study|Protocol Violation|0|||
94248361|NCT03702231|322703070|FG002|Overall Study|Protocol Violation|1|||
94248362|NCT03702231|322703068|FG000|Overall Study|Change in CLL Treatment|0|||
94248363|NCT03702231|322703069|FG001|Overall Study|Change in CLL Treatment|0|||
94248364|NCT03702231|322703070|FG002|Overall Study|Change in CLL Treatment|1|||
94248365|NCT03702231|322703068|FG000|Overall Study|COVID Pandemic|1|||
94248366|NCT03702231|322703069|FG001|Overall Study|COVID Pandemic|4|||
94248367|NCT03702231|322703070|FG002|Overall Study|COVID Pandemic|1|||
94248368|NCT03702231|322703068|FG000|Overall Study|Non-compliance|0|||
94248369|NCT03702231|322703069|FG001|Overall Study|Non-compliance|0|||
94248370|NCT03702231|322703070|FG002|Overall Study|Non-compliance|1|||
94248371|NCT00777088|322703071|FG000|Overall Study|PED Treatment not attempted|1|||
94248372|NCT00540046|322703073|FG000|Overall Study|Lost to Follow-up|33|||
94248373|NCT00540046|322703074|FG001|Overall Study|Lost to Follow-up|23|||
94248374|NCT00903682|322703079|FG000|Overall Study|Adverse Event|6|||
94248375|NCT00903682|322703080|FG001|Overall Study|Adverse Event|13|||
94248376|NCT00903682|322703079|FG000|Overall Study|Lost to Follow-up|1|||
94248377|NCT00903682|322703080|FG001|Overall Study|Lost to Follow-up|0|||
94248378|NCT00903682|322703079|FG000|Overall Study|Withdrawal by Subject|5|||
94248379|NCT00903682|322703080|FG001|Overall Study|Withdrawal by Subject|0|||
94248380|NCT00903682|322703079|FG000|Overall Study|Pregnancy|0|||
94248381|NCT00903682|322703080|FG001|Overall Study|Pregnancy|1|||
94248382|NCT00903682|322703079|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
94248383|NCT00903682|322703080|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
94248384|NCT00903682|322703079|FG000|Overall Study|Subject Non-Compliant|1|||
94248385|NCT00903682|322703080|FG001|Overall Study|Subject Non-Compliant|0|||
94248386|NCT00903682|322703079|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
94248387|NCT00903682|322703080|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
94248388|NCT00903682|322703079|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
94248389|NCT00903682|322703080|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
94248390|NCT02495792|322703083|FG000|Overall Study|Lost to Follow-up|5|||
94248391|NCT02495792|322703084|FG001|Overall Study|Lost to Follow-up|9|||
94248392|NCT02495792|322703083|FG000|Overall Study|Protocol Violation|32|||
94248393|NCT02495792|322703084|FG001|Overall Study|Protocol Violation|31|||
94599529|NCT02815280|323995687|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
94599530|NCT02815280|323995686|FG000|Double-Blind Phase|Protocol Violation|2|||
94599531|NCT02815280|323995687|FG001|Double-Blind Phase|Protocol Violation|2|||
94599532|NCT02815280|323995686|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
94599533|NCT02815280|323995687|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
94599534|NCT02815280|323995686|FG000|Open-Label Phase|Adverse Event|2|||
94248394|NCT00529958|322703085|FG000|2-Year Follow-up|Lost to Follow-up|1|||
94248395|NCT00529958|322703086|FG001|2-Year Follow-up|Lost to Follow-up|2|||
94248396|NCT00529958|322703087|FG002|2-Year Follow-up|Lost to Follow-up|2|||
94248397|NCT00529958|322703085|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
94248398|NCT00529958|322703086|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
94248399|NCT00529958|322703087|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
94599535|NCT02815280|323995687|FG001|Open-Label Phase|Adverse Event|3|||
94599536|NCT02815280|323995686|FG000|Open-Label Phase|Lost to Follow-up|18|||
94248400|NCT00529958|322703085|FG000|5-Year Follow-up|Lost to Follow-up|2|||
94248401|NCT00529958|322703086|FG001|5-Year Follow-up|Lost to Follow-up|3|||
94248402|NCT00529958|322703087|FG002|5-Year Follow-up|Lost to Follow-up|1|||
94248403|NCT00529958|322703085|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
94248404|NCT00529958|322703086|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
94248405|NCT00529958|322703087|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
94248406|NCT03562975|322703089|FG000|Overall Study|Death|1|||
94248407|NCT03562975|322703089|FG000|Overall Study|Lost to Follow-up|1|||
94248408|NCT03562975|322703089|FG000|Overall Study|Withdrawal by Subject|1|||
94248409|NCT00935818|322703090|FG000|Overall Study|Withdrawal by Subject|45|||
94599537|NCT02815280|323995687|FG001|Open-Label Phase|Lost to Follow-up|9|||
94599538|NCT02815280|323995686|FG000|Open-Label Phase|Withdrawal by Subject|33|||
94599539|NCT02815280|323995687|FG001|Open-Label Phase|Withdrawal by Subject|18|||
94599540|NCT02815280|323995686|FG000|Open-Label Phase|Protocol Violation|3|||
94599541|NCT02815280|323995687|FG001|Open-Label Phase|Protocol Violation|0|||
94599542|NCT02815280|323995686|FG000|Open-Label Phase|Administrative|26|||
94599543|NCT02815280|323995687|FG001|Open-Label Phase|Administrative|12|||
94599544|NCT02815280|323995686|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
94599545|NCT02815280|323995687|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
94599546|NCT00548405|323995696|FG000|Overall Study|Adverse Event|6|||
94599547|NCT00548405|323995697|FG001|Overall Study|Adverse Event|2|||
94599548|NCT00548405|323995698|FG002|Overall Study|Adverse Event|0|||
94599549|NCT00548405|323995696|FG000|Overall Study|Lack of Efficacy|6|||
94599550|NCT00548405|323995697|FG001|Overall Study|Lack of Efficacy|0|||
94599551|NCT00548405|323995698|FG002|Overall Study|Lack of Efficacy|0|||
94599552|NCT00548405|323995696|FG000|Overall Study|Physician Decision|3|||
94599553|NCT00548405|323995697|FG001|Overall Study|Physician Decision|4|||
94599554|NCT00548405|323995698|FG002|Overall Study|Physician Decision|1|||
94599555|NCT00548405|323995696|FG000|Overall Study|Pregnancy|1|||
94599556|NCT00548405|323995697|FG001|Overall Study|Pregnancy|0|||
94599557|NCT00548405|323995698|FG002|Overall Study|Pregnancy|0|||
94599558|NCT00548405|323995696|FG000|Overall Study|Protocol Violation|1|||
94599559|NCT00548405|323995697|FG001|Overall Study|Protocol Violation|0|||
94599560|NCT00548405|323995698|FG002|Overall Study|Protocol Violation|0|||
94599561|NCT00548405|323995696|FG000|Overall Study|Withdrawal by Subject|36|||
94599562|NCT00548405|323995697|FG001|Overall Study|Withdrawal by Subject|12|||
94599563|NCT00548405|323995698|FG002|Overall Study|Withdrawal by Subject|5|||
94599564|NCT00548405|323995696|FG000|Overall Study|Lost to Follow-up|1|||
94599565|NCT00548405|323995697|FG001|Overall Study|Lost to Follow-up|1|||
94599566|NCT00548405|323995698|FG002|Overall Study|Lost to Follow-up|2|||
94599567|NCT00548405|323995696|FG000|Overall Study|Death|0|||
94599568|NCT00548405|323995697|FG001|Overall Study|Death|1|||
94599569|NCT00548405|323995698|FG002|Overall Study|Death|1|||
94599570|NCT00548405|323995696|FG000|Overall Study|Sponsor decision|1|||
94599571|NCT00548405|323995697|FG001|Overall Study|Sponsor decision|0|||
94599572|NCT00548405|323995698|FG002|Overall Study|Sponsor decision|0|||
94599573|NCT00548405|323995696|FG000|Overall Study|Randomized but not treated|1|||
94599574|NCT00548405|323995697|FG001|Overall Study|Randomized but not treated|0|||
94599575|NCT00548405|323995698|FG002|Overall Study|Randomized but not treated|0|||
94599576|NCT04449029|323995699|FG000|Overall Study|Adverse Event|0|||
94599577|NCT04449029|323995700|FG001|Overall Study|Adverse Event|1|||
94599578|NCT04449029|323995701|FG002|Overall Study|Adverse Event|1|||
94599579|NCT04449029|323995702|FG003|Overall Study|Adverse Event|0|||
94599580|NCT04449029|323995703|FG004|Overall Study|Adverse Event|1|||
94599581|NCT04449029|323995704|FG005|Overall Study|Adverse Event|0|||
94599582|NCT04449029|323995705|FG006|Overall Study|Adverse Event|1|||
94599583|NCT04449029|323995706|FG007|Overall Study|Adverse Event|0|||
94599584|NCT04449029|323995699|FG000|Overall Study|Lost to Follow-up|0|||
94599585|NCT04449029|323995700|FG001|Overall Study|Lost to Follow-up|1|||
94599586|NCT04449029|323995701|FG002|Overall Study|Lost to Follow-up|0|||
94599587|NCT04449029|323995702|FG003|Overall Study|Lost to Follow-up|0|||
94599588|NCT04449029|323995703|FG004|Overall Study|Lost to Follow-up|0|||
94599589|NCT04449029|323995704|FG005|Overall Study|Lost to Follow-up|0|||
94599590|NCT04449029|323995705|FG006|Overall Study|Lost to Follow-up|0|||
94599591|NCT04449029|323995706|FG007|Overall Study|Lost to Follow-up|0|||
94599592|NCT04449029|323995699|FG000|Overall Study|Protocol Violation|0|||
94599593|NCT04449029|323995700|FG001|Overall Study|Protocol Violation|1|||
94599594|NCT04449029|323995701|FG002|Overall Study|Protocol Violation|0|||
94599595|NCT04449029|323995702|FG003|Overall Study|Protocol Violation|0|||
94599596|NCT04449029|323995703|FG004|Overall Study|Protocol Violation|0|||
94599597|NCT04449029|323995704|FG005|Overall Study|Protocol Violation|0|||
94599598|NCT04449029|323995705|FG006|Overall Study|Protocol Violation|0|||
94599599|NCT04449029|323995706|FG007|Overall Study|Protocol Violation|0|||
94599600|NCT04449029|323995699|FG000|Overall Study|Physician Decision|0|||
94599601|NCT04449029|323995700|FG001|Overall Study|Physician Decision|0|||
94599602|NCT04449029|323995701|FG002|Overall Study|Physician Decision|0|||
94599603|NCT04449029|323995702|FG003|Overall Study|Physician Decision|0|||
94599604|NCT04449029|323995703|FG004|Overall Study|Physician Decision|0|||
94599605|NCT04449029|323995704|FG005|Overall Study|Physician Decision|1|||
94599606|NCT04449029|323995705|FG006|Overall Study|Physician Decision|0|||
94599607|NCT04449029|323995706|FG007|Overall Study|Physician Decision|0|||
94599608|NCT04449029|323995699|FG000|Overall Study|Withdrawal by Subject|3|||
94660479|NCT03266588|324211659|FG001|Long-term Treatment Period|Protocol Deviation|10|||
94660480|NCT03266588|324211660|FG002|Long-term Treatment Period|Protocol Deviation|4|||
94599609|NCT04449029|323995700|FG001|Overall Study|Withdrawal by Subject|0|||
94599610|NCT04449029|323995701|FG002|Overall Study|Withdrawal by Subject|1|||
94599611|NCT04449029|323995702|FG003|Overall Study|Withdrawal by Subject|1|||
94599612|NCT04449029|323995703|FG004|Overall Study|Withdrawal by Subject|5|||
94599613|NCT04449029|323995704|FG005|Overall Study|Withdrawal by Subject|1|||
94599614|NCT04449029|323995705|FG006|Overall Study|Withdrawal by Subject|4|||
94599615|NCT04449029|323995706|FG007|Overall Study|Withdrawal by Subject|0|||
94599616|NCT05027971|323995707|FG000|Overall Study|Physician Decision|7|||
94599617|NCT05027971|323995708|FG001|Overall Study|Physician Decision|3|||
94599618|NCT05027971|323995707|FG000|Overall Study|Lost to Follow-up|1|||
94599619|NCT05027971|323995708|FG001|Overall Study|Lost to Follow-up|1|||
94599620|NCT05027971|323995707|FG000|Overall Study|Withdrawal by Subject|0|||
94599621|NCT05027971|323995708|FG001|Overall Study|Withdrawal by Subject|2|||
94599622|NCT05027971|323995707|FG000|Overall Study|Non-study fiber used.|0|||
94599623|NCT05027971|323995708|FG001|Overall Study|Non-study fiber used.|1|||
94599624|NCT05027971|323995707|FG000|Overall Study|Protocol Violation|0|||
94599625|NCT05027971|323995708|FG001|Overall Study|Protocol Violation|2|||
94599626|NCT02025556|323995709|FG000|Overall Study|Adverse Event|0|||
94599627|NCT02025556|323995710|FG001|Overall Study|Adverse Event|4|||
94599628|NCT02025556|323995711|FG002|Overall Study|Adverse Event|2|||
94599629|NCT02025556|323995709|FG000|Overall Study|Lack of Efficacy|2|||
94599630|NCT02025556|323995710|FG001|Overall Study|Lack of Efficacy|1|||
94599631|NCT02025556|323995711|FG002|Overall Study|Lack of Efficacy|0|||
94599632|NCT02025556|323995709|FG000|Overall Study|Protocol Violation|2|||
94599633|NCT02025556|323995710|FG001|Overall Study|Protocol Violation|1|||
94599634|NCT02025556|323995711|FG002|Overall Study|Protocol Violation|0|||
94599635|NCT02025556|323995709|FG000|Overall Study|Withdrawal by Subject|0|||
94599636|NCT02025556|323995710|FG001|Overall Study|Withdrawal by Subject|3|||
94599637|NCT02025556|323995711|FG002|Overall Study|Withdrawal by Subject|6|||
94599638|NCT02025556|323995709|FG000|Overall Study|Lost to Follow-up|2|||
94599639|NCT02025556|323995710|FG001|Overall Study|Lost to Follow-up|4|||
94599640|NCT02025556|323995711|FG002|Overall Study|Lost to Follow-up|0|||
94599641|NCT02025556|323995709|FG000|Overall Study|Reason not reported|0|||
94599642|NCT02025556|323995710|FG001|Overall Study|Reason not reported|0|||
94599643|NCT02025556|323995711|FG002|Overall Study|Reason not reported|1|||
94599644|NCT04098224|323995712|FG000|Overall Study|Adverse Event|1|||
94599645|NCT04098224|323995713|FG001|Overall Study|Adverse Event|0|||
94599646|NCT04098224|323995712|FG000|Overall Study|Physician Decision|1|||
94599647|NCT04098224|323995713|FG001|Overall Study|Physician Decision|0|||
94599648|NCT04098224|323995712|FG000|Overall Study|Patient not required enteral feeding|1|||
94599649|NCT04098224|323995713|FG001|Overall Study|Patient not required enteral feeding|0|||
94599650|NCT04098224|323995712|FG000|Overall Study|Patient failure nasogastric tube|1|||
94599651|NCT04098224|323995713|FG001|Overall Study|Patient failure nasogastric tube|0|||
94599652|NCT04098224|323995712|FG000|Overall Study|Patient early extubation|1|||
94599653|NCT04098224|323995713|FG001|Overall Study|Patient early extubation|3|||
94599654|NCT04391569|323995714|FG000|Overall Study|Death|15|||
94599655|NCT04391569|323995715|FG001|Overall Study|Death|10|||
94599656|NCT04391569|323995714|FG000|Overall Study|Withdrawal by Subject|1|||
94599657|NCT04391569|323995715|FG001|Overall Study|Withdrawal by Subject|0|||
94599658|NCT04391569|323995714|FG000|Overall Study|Lost to Follow-up|3|||
94599659|NCT04391569|323995715|FG001|Overall Study|Lost to Follow-up|2|||
94599660|NCT04391569|323995714|FG000|Overall Study|Lack of Efficacy|0|||
94599661|NCT04391569|323995715|FG001|Overall Study|Lack of Efficacy|1|||
94599662|NCT04391569|323995714|FG000|Overall Study|Participant discharged to hospice facility|0|||
94599663|NCT04391569|323995715|FG001|Overall Study|Participant discharged to hospice facility|1|||
94599664|NCT04391569|323995714|FG000|Overall Study|Participant family decision|1|||
94599665|NCT04391569|323995715|FG001|Overall Study|Participant family decision|0|||
94599666|NCT04391569|323995714|FG000|Overall Study|Participant discharged prematurely|1|||
94599667|NCT04391569|323995715|FG001|Overall Study|Participant discharged prematurely|0|||
94599668|NCT02241889|323995716|FG000|Overall Study|device issues|0|||
94660481|NCT03266588|324211658|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
94599669|NCT02241889|323995717|FG001|Overall Study|device issues|0|||
94599670|NCT02241889|323995718|FG002|Overall Study|device issues|1|||
94599671|NCT02241889|323995719|FG003|Overall Study|device issues|0|||
94599672|NCT02241889|323995720|FG004|Overall Study|device issues|0|||
94599673|NCT02241889|323995721|FG005|Overall Study|device issues|0|||
94248410|NCT00935818|322703091|FG001|Overall Study|Withdrawal by Subject|50|||
94248411|NCT00935818|322703090|FG000|Overall Study|Lost to Follow-up|40|||
94248412|NCT00935818|322703091|FG001|Overall Study|Lost to Follow-up|42|||
94248413|NCT00935818|322703090|FG000|Overall Study|Adverse Event|6|||
94248414|NCT00935818|322703091|FG001|Overall Study|Adverse Event|7|||
94248415|NCT00935818|322703090|FG000|Overall Study|Physician Decision|0|||
94248416|NCT00935818|322703091|FG001|Overall Study|Physician Decision|1|||
94599674|NCT02241889|323995716|FG000|Overall Study|Withdrawal by Subject|0|||
94248417|NCT02349425|322704822|FG000|Period 1|Adverse Event|1|||
94248418|NCT02349425|322704823|FG001|Period 1|Adverse Event|1|||
94248419|NCT02349425|322704824|FG002|Period 1|Adverse Event|0|||
94248420|NCT02349425|322704825|FG003|Period 1|Adverse Event|0|||
94248421|NCT02349425|322704822|FG000|Period 2|Adverse Event|0|||
94248422|NCT02349425|322704823|FG001|Period 2|Adverse Event|1|||
94248423|NCT02349425|322704824|FG002|Period 2|Adverse Event|1|||
94248424|NCT02349425|322704825|FG003|Period 2|Adverse Event|0|||
94599675|NCT02241889|323995717|FG001|Overall Study|Withdrawal by Subject|0|||
94599676|NCT02241889|323995718|FG002|Overall Study|Withdrawal by Subject|0|||
94599677|NCT02241889|323995719|FG003|Overall Study|Withdrawal by Subject|0|||
94599678|NCT02241889|323995720|FG004|Overall Study|Withdrawal by Subject|0|||
94599679|NCT02241889|323995721|FG005|Overall Study|Withdrawal by Subject|1|||
94599680|NCT00783302|323995722|FG000|Overall Study|Lost to Follow-up|17|||
94599681|NCT00783302|323995722|FG000|Overall Study|Technical Problems|11|||
94599682|NCT00783302|323995722|FG000|Overall Study|Protocol Violation|3|||
94599683|NCT00783302|323995722|FG000|Overall Study|Physician Decision|1|||
94599684|NCT00783302|323995722|FG000|Overall Study|Withdrawal by Subject|3|||
94599685|NCT00266877|323995723|FG000|Overall Study|Death|1|||
94599686|NCT00266877|323995724|FG001|Overall Study|Death|1|||
94599687|NCT00266877|323995725|FG002|Overall Study|Death|1|||
94599688|NCT00266877|323995723|FG000|Overall Study|Adverse Event|6|||
94599689|NCT00266877|323995724|FG001|Overall Study|Adverse Event|4|||
94599690|NCT00266877|323995725|FG002|Overall Study|Adverse Event|1|||
94599691|NCT00266877|323995723|FG000|Overall Study|Physician Decision|2|||
94599692|NCT00266877|323995724|FG001|Overall Study|Physician Decision|1|||
94599693|NCT00266877|323995725|FG002|Overall Study|Physician Decision|1|||
94599694|NCT00266877|323995723|FG000|Overall Study|Withdrawal by Subject|3|||
94599695|NCT00266877|323995724|FG001|Overall Study|Withdrawal by Subject|1|||
94599696|NCT00266877|323995725|FG002|Overall Study|Withdrawal by Subject|1|||
94599697|NCT00266877|323995723|FG000|Overall Study|Disease Progression|72|||
94599698|NCT00266877|323995724|FG001|Overall Study|Disease Progression|37|||
94599699|NCT00266877|323995725|FG002|Overall Study|Disease Progression|23|||
94599700|NCT00266877|323995723|FG000|Overall Study|Symptomatic Deterioration|6|||
94599701|NCT00266877|323995724|FG001|Overall Study|Symptomatic Deterioration|3|||
94599702|NCT00266877|323995725|FG002|Overall Study|Symptomatic Deterioration|1|||
94599703|NCT00266877|323995723|FG000|Overall Study|Hospitalization|1|||
94599704|NCT00266877|323995724|FG001|Overall Study|Hospitalization|0|||
94599705|NCT00266877|323995725|FG002|Overall Study|Hospitalization|0|||
94599706|NCT00266877|323995723|FG000|Overall Study|Concomitant Radiotherapy|0|||
94599707|NCT00266877|323995724|FG001|Overall Study|Concomitant Radiotherapy|1|||
94599708|NCT00266877|323995725|FG002|Overall Study|Concomitant Radiotherapy|0|||
94599709|NCT01423604|323995727|FG000|Safety Run-In|Adverse Event|3|||
94599710|NCT01423604|323995728|FG001|Safety Run-In|Adverse Event|0|||
94599711|NCT01423604|323995727|FG000|Safety Run-In|Death|1|||
94599712|NCT01423604|323995728|FG001|Safety Run-In|Death|0|||
94599713|NCT01423604|323995727|FG000|Safety Run-In|Physician Decision|1|||
94599714|NCT01423604|323995728|FG001|Safety Run-In|Physician Decision|0|||
94599715|NCT01423604|323995727|FG000|Safety Run-In|Disease progression|3|||
94599716|NCT01423604|323995728|FG001|Safety Run-In|Disease progression|0|||
94599717|NCT01423604|323995727|FG000|Safety Run-In|Patient decision|1|||
94599718|NCT01423604|323995728|FG001|Safety Run-In|Patient decision|0|||
94599719|NCT01423604|323995727|FG000|Randomized|Adverse Event|4|||
94599720|NCT01423604|323995728|FG001|Randomized|Adverse Event|10|||
94599721|NCT01423604|323995727|FG000|Randomized|Death|1|||
94599722|NCT01423604|323995728|FG001|Randomized|Death|0|||
94599723|NCT01423604|323995727|FG000|Randomized|Physician Decision|16|||
94599724|NCT01423604|323995728|FG001|Randomized|Physician Decision|13|||
94599725|NCT01423604|323995727|FG000|Randomized|Other - unspecified|37|||
94248425|NCT03056300|322704826|FG000|Overall Study|Surgical reason per study protocol|3|||
94248426|NCT02383056|322704829|FG000|Overall Study|Adverse Event|1|||
94248427|NCT02383056|322704830|FG001|Overall Study|Adverse Event|0|||
94599726|NCT01423604|323995728|FG001|Randomized|Other - unspecified|31|||
94599727|NCT01423604|323995727|FG000|Randomized|Patient decision|5|||
94599728|NCT01423604|323995728|FG001|Randomized|Patient decision|9|||
94599729|NCT01226121|323995729|FG000|Overall Study|Lost to Follow-up|2|||
94599730|NCT01226121|323995730|FG001|Overall Study|Lost to Follow-up|0|||
94599731|NCT01226121|323995731|FG002|Overall Study|Lost to Follow-up|1|||
94599732|NCT04231981|323995732|FG000|Overall Study|Adverse Event|1|||
94248428|NCT02383056|322704829|FG000|Overall Study|Lost to Follow-up|0|||
94599733|NCT04231981|323995732|FG000|Overall Study|Death|16|||
94599734|NCT04231981|323995732|FG000|Overall Study|Lost to Follow-up|1|||
94599735|NCT00969280|323995737|FG000|Overall Study|Protocol Violation|2|||
94599736|NCT00969280|323995738|FG001|Overall Study|Protocol Violation|1|||
94599737|NCT00969280|323995737|FG000|Overall Study|Withdrawal by Subject|0|||
94599738|NCT00969280|323995738|FG001|Overall Study|Withdrawal by Subject|1|||
94599739|NCT00969280|323995737|FG000|Overall Study|infection of influenza A(H1N1)|0|||
94599740|NCT00969280|323995738|FG001|Overall Study|infection of influenza A(H1N1)|1|||
94599741|NCT02119676|323995742|FG000|Overall Study|Adverse Event|9|||
94599742|NCT02119676|323995743|FG001|Overall Study|Adverse Event|17|||
94599743|NCT02119676|323995744|FG002|Overall Study|Adverse Event|10|||
94599744|NCT02119676|323995745|FG003|Overall Study|Adverse Event|10|||
94599745|NCT02119676|323995742|FG000|Overall Study|Disease progression|53|||
94599746|NCT02119676|323995743|FG001|Overall Study|Disease progression|55|||
94599747|NCT02119676|323995744|FG002|Overall Study|Disease progression|68|||
94599748|NCT02119676|323995745|FG003|Overall Study|Disease progression|73|||
94599749|NCT02119676|323995742|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
94599750|NCT02119676|323995743|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
94599751|NCT02119676|323995744|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
94599752|NCT02119676|323995745|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
94599753|NCT02119676|323995742|FG000|Overall Study|Physician Decision|4|||
94599754|NCT02119676|323995743|FG001|Overall Study|Physician Decision|2|||
94599755|NCT02119676|323995744|FG002|Overall Study|Physician Decision|3|||
94599756|NCT02119676|323995745|FG003|Overall Study|Physician Decision|2|||
94599757|NCT02119676|323995742|FG000|Overall Study|Death|9|||
94599758|NCT02119676|323995743|FG001|Overall Study|Death|3|||
94599759|NCT02119676|323995744|FG002|Overall Study|Death|2|||
94599760|NCT02119676|323995745|FG003|Overall Study|Death|1|||
94599761|NCT02119676|323995742|FG000|Overall Study|Noncompliance|0|||
94599762|NCT02119676|323995743|FG001|Overall Study|Noncompliance|1|||
94599763|NCT02119676|323995744|FG002|Overall Study|Noncompliance|0|||
94599764|NCT02119676|323995745|FG003|Overall Study|Noncompliance|0|||
94599765|NCT02119676|323995742|FG000|Overall Study|Lost to Follow-up|0|||
94599766|NCT02119676|323995743|FG001|Overall Study|Lost to Follow-up|0|||
94599767|NCT02119676|323995744|FG002|Overall Study|Lost to Follow-up|1|||
94599768|NCT02119676|323995745|FG003|Overall Study|Lost to Follow-up|0|||
94599769|NCT02119676|323995742|FG000|Overall Study|Protocol deviation|0|||
94599770|NCT02119676|323995743|FG001|Overall Study|Protocol deviation|0|||
94599771|NCT02119676|323995744|FG002|Overall Study|Protocol deviation|1|||
94599772|NCT02119676|323995745|FG003|Overall Study|Protocol deviation|0|||
94599773|NCT02119676|323995742|FG000|Overall Study|Other, unspecified|2|||
94599774|NCT02119676|323995743|FG001|Overall Study|Other, unspecified|1|||
94599775|NCT02119676|323995744|FG002|Overall Study|Other, unspecified|3|||
94599776|NCT02119676|323995745|FG003|Overall Study|Other, unspecified|4|||
94599777|NCT02119676|323995742|FG000|Overall Study|Did not receive study med|2|||
94599778|NCT02119676|323995743|FG001|Overall Study|Did not receive study med|2|||
94599779|NCT02119676|323995744|FG002|Overall Study|Did not receive study med|4|||
94599780|NCT02119676|323995745|FG003|Overall Study|Did not receive study med|5|||
94599781|NCT00586664|323995747|FG000|Overall Study|Withdrawal by Subject|3|||
94599782|NCT00586664|323995748|FG001|Overall Study|Withdrawal by Subject|7|||
94599783|NCT00586664|323995749|FG002|Overall Study|Withdrawal by Subject|1|||
94599784|NCT00586664|323995747|FG000|Overall Study|Exclusion criteria met|2|||
94599785|NCT00586664|323995748|FG001|Overall Study|Exclusion criteria met|0|||
94599786|NCT00586664|323995749|FG002|Overall Study|Exclusion criteria met|0|||
94599787|NCT00686998|323995752|FG000|Overall Study|Adverse Event|3|||
94599788|NCT00686998|323995753|FG001|Overall Study|Adverse Event|2|||
94599789|NCT00686998|323995754|FG002|Overall Study|Adverse Event|1|||
94599790|NCT00686998|323995752|FG000|Overall Study|Withdrawal by Subject|2|||
94599791|NCT00686998|323995753|FG001|Overall Study|Withdrawal by Subject|1|||
94599792|NCT00686998|323995754|FG002|Overall Study|Withdrawal by Subject|2|||
94660482|NCT03266588|324211659|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
94248429|NCT02383056|322704830|FG001|Overall Study|Lost to Follow-up|2|||
94599793|NCT00686998|323995752|FG000|Overall Study|Lack of Efficacy|7|||
94599794|NCT00686998|323995753|FG001|Overall Study|Lack of Efficacy|5|||
94599795|NCT00686998|323995754|FG002|Overall Study|Lack of Efficacy|0|||
94599796|NCT00686998|323995752|FG000|Overall Study|Other|0|||
94599797|NCT00686998|323995753|FG001|Overall Study|Other|0|||
94599798|NCT00686998|323995754|FG002|Overall Study|Other|1|||
94599799|NCT00686998|323995752|FG000|Overall Study|Safety Reasons|1|||
94599800|NCT00686998|323995753|FG001|Overall Study|Safety Reasons|0|||
94599801|NCT00686998|323995754|FG002|Overall Study|Safety Reasons|0|||
94599802|NCT03865316|323997333|FG000|Overall Study|Procedure Cancelled|4|||
94599803|NCT03865316|323997333|FG000|Overall Study|Equipment failure|4|||
94599804|NCT02656680|323997334|FG000|Overall Study|Lost to Follow-up|0|||
94599805|NCT02656680|323997335|FG001|Overall Study|Lost to Follow-up|1|||
94599806|NCT02656680|323997336|FG002|Overall Study|Lost to Follow-up|7|||
94599807|NCT02320903|323997337|FG000|Overall Study|Withdrawal by Subject|0|||
94599808|NCT02320903|323997338|FG001|Overall Study|Withdrawal by Subject|9|||
94599809|NCT02320903|323997339|FG002|Overall Study|Withdrawal by Subject|9|||
94599810|NCT02320903|323997337|FG000|Overall Study|Exited therapy; no longer eligible|8|||
94599811|NCT02320903|323997338|FG001|Overall Study|Exited therapy; no longer eligible|2|||
94599812|NCT02320903|323997339|FG002|Overall Study|Exited therapy; no longer eligible|2|||
94599813|NCT02320903|323997337|FG000|Overall Study|Lost to Follow-up|0|||
94599814|NCT02320903|323997338|FG001|Overall Study|Lost to Follow-up|5|||
94599815|NCT02320903|323997339|FG002|Overall Study|Lost to Follow-up|5|||
94599816|NCT02519855|323997341|FG000|Overall Study|Adverse Event|0|||
94599817|NCT02519855|323997342|FG001|Overall Study|Adverse Event|1|||
94599818|NCT02519855|323997341|FG000|Overall Study|Lost to Follow-up|3|||
94599819|NCT02519855|323997342|FG001|Overall Study|Lost to Follow-up|3|||
94599820|NCT03621475|323997343|FG000|Overall Study|No longer required restraints at initiation|0|||
94599821|NCT03621475|323997344|FG001|Overall Study|No longer required restraints at initiation|1|||
94599822|NCT00003830|323997358|FG000|Overall Study|No follow up data|3|||
94599823|NCT00003830|323997359|FG001|Overall Study|No follow up data|0|||
94599824|NCT00003830|323997358|FG000|Overall Study|Sentinel node positive patients|829|||
94599825|NCT00003830|323997359|FG001|Overall Study|Sentinel node positive patients|793|||
94599826|NCT03699475|323997362|FG000|Overall Study|Death|1|||
94599827|NCT00137839|323997363|FG000|Overall Study|Adverse Event|7|||
94599828|NCT00137839|323997363|FG000|Overall Study|Physician Decision|7|||
94599829|NCT00137839|323997363|FG000|Overall Study|Death|8|||
94599830|NCT00137839|323997363|FG000|Overall Study|Disease Progression|60|||
94599831|NCT00137839|323997363|FG000|Overall Study|Not Start Treatment|1|||
94599832|NCT00137839|323997363|FG000|Overall Study|Prolonged Treatment Delay|1|||
94599833|NCT01099709|323997364|FG000|Period 1|Withdrawal by Subject|0|||
94599834|NCT01099709|323997365|FG001|Period 1|Withdrawal by Subject|1|||
94599835|NCT01099709|323997364|FG000|Period 1|Positive cotinine test|0|||
94599836|NCT01099709|323997365|FG001|Period 1|Positive cotinine test|1|||
94599837|NCT01099709|323997364|FG000|Period 1|Adverse Event|1|||
94599838|NCT01099709|323997365|FG001|Period 1|Adverse Event|0|||
94599839|NCT02882152|323997366|FG000|Overall Study|Lost to Follow-up|1|||
94599840|NCT02882152|323997367|FG001|Overall Study|Lost to Follow-up|0|||
94599841|NCT03234881|323997368|FG000|Overall Study|Lost to Follow-up|9|||
94599842|NCT03234881|323997369|FG001|Overall Study|Lost to Follow-up|3|||
94599843|NCT04418661|323997379|FG000|Overall Study|Adverse Event|0|||
94599844|NCT04418661|323997380|FG001|Overall Study|Adverse Event|1|||
94599845|NCT04418661|323997381|FG002|Overall Study|Adverse Event|5|||
94599846|NCT04418661|323997382|FG003|Overall Study|Adverse Event|3|||
94599847|NCT04418661|323997383|FG004|Overall Study|Adverse Event|0|||
94599848|NCT04418661|323997384|FG005|Overall Study|Adverse Event|2|||
94599849|NCT04418661|323997379|FG000|Overall Study|Progressive disease|4|||
94599850|NCT04418661|323997380|FG001|Overall Study|Progressive disease|11|||
94599851|NCT04418661|323997381|FG002|Overall Study|Progressive disease|6|||
94599852|NCT04418661|323997382|FG003|Overall Study|Progressive disease|11|||
94599853|NCT04418661|323997383|FG004|Overall Study|Progressive disease|1|||
94599854|NCT04418661|323997384|FG005|Overall Study|Progressive disease|12|||
94599855|NCT04418661|323997379|FG000|Overall Study|Withdrawal by Subject|0|||
94599856|NCT04418661|323997380|FG001|Overall Study|Withdrawal by Subject|1|||
94599857|NCT04418661|323997381|FG002|Overall Study|Withdrawal by Subject|0|||
94599858|NCT04418661|323997382|FG003|Overall Study|Withdrawal by Subject|1|||
94599859|NCT04418661|323997383|FG004|Overall Study|Withdrawal by Subject|0|||
94599860|NCT04418661|323997384|FG005|Overall Study|Withdrawal by Subject|0|||
94599861|NCT04418661|323997379|FG000|Overall Study|Other|0|||
94599862|NCT04418661|323997380|FG001|Overall Study|Other|0|||
94599863|NCT04418661|323997381|FG002|Overall Study|Other|1|||
94599864|NCT04418661|323997382|FG003|Overall Study|Other|3|||
94599865|NCT04418661|323997383|FG004|Overall Study|Other|0|||
94599866|NCT04418661|323997384|FG005|Overall Study|Other|1|||
94599867|NCT01129024|323997385|FG000|Overall Study|Physician Decision|5|||
94599868|NCT01129024|323997385|FG000|Overall Study|Study Terminated by Sponsor|8|||
94599869|NCT01129024|323997385|FG000|Overall Study|Withdrawal by Subject|2|||
94599870|NCT01129024|323997385|FG000|Overall Study|Lack of Efficacy|3|||
94599871|NCT01129024|323997385|FG000|Overall Study|Needed a Platelet Transfusion|1|||
94599872|NCT00992589|323997389|FG000|Open-Label Phase|Adverse Event|4|||
94660483|NCT03266588|324211660|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
94660484|NCT03266588|324211658|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
94660485|NCT03266588|324211659|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
94660486|NCT03266588|324211660|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
94660487|NCT03266588|324211658|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
94660488|NCT03266588|324211659|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
94660489|NCT03266588|324211660|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
94660490|NCT03266588|324211658|FG000|Long-term Treatment Period|Other Reasons|5|||
94660491|NCT03266588|324211659|FG001|Long-term Treatment Period|Other Reasons|0|||
94660492|NCT03266588|324211660|FG002|Long-term Treatment Period|Other Reasons|0|||
94660493|NCT03266588|324211658|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
94660494|NCT03266588|324211659|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
94660495|NCT03266588|324211660|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
94660496|NCT01159938|324211661|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
94660497|NCT01159938|324211662|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
94660498|NCT01159938|324211663|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
94660499|NCT01159938|324211664|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
94660500|NCT01159938|324211665|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
94660501|NCT00384085|324211666|FG000|Overall Study|Adverse Event|5|||
94660502|NCT00384085|324211667|FG001|Overall Study|Adverse Event|5|||
94660503|NCT00384085|324211668|FG002|Overall Study|Adverse Event|4|||
94599873|NCT00992589|323997390|FG001|Open-Label Phase|Adverse Event|0|||
94599874|NCT00992589|323997391|FG002|Open-Label Phase|Adverse Event|0|||
94660504|NCT00384085|324211666|FG000|Overall Study|Lack of Efficacy|0|||
94599875|NCT00992589|323997392|FG003|Open-Label Phase|Adverse Event|0|||
94599876|NCT00992589|323997389|FG000|Open-Label Phase|Withdrawal by Subject|20|||
94599877|NCT00992589|323997390|FG001|Open-Label Phase|Withdrawal by Subject|0|||
94599878|NCT00992589|323997391|FG002|Open-Label Phase|Withdrawal by Subject|0|||
94599879|NCT00992589|323997392|FG003|Open-Label Phase|Withdrawal by Subject|0|||
94599880|NCT00992589|323997389|FG000|Open-Label Phase|Lost to Follow-up|1|||
94599881|NCT00992589|323997390|FG001|Open-Label Phase|Lost to Follow-up|0|||
94599882|NCT00992589|323997391|FG002|Open-Label Phase|Lost to Follow-up|0|||
94599883|NCT00992589|323997392|FG003|Open-Label Phase|Lost to Follow-up|0|||
94599884|NCT00992589|323997389|FG000|Open-Label Phase|Protocol Violation|3|||
94599885|NCT00992589|323997390|FG001|Open-Label Phase|Protocol Violation|0|||
94599886|NCT00992589|323997391|FG002|Open-Label Phase|Protocol Violation|0|||
94599887|NCT00992589|323997392|FG003|Open-Label Phase|Protocol Violation|0|||
94599888|NCT00992589|323997389|FG000|Open-Label Phase|Physician Decision|4|||
94599889|NCT00992589|323997390|FG001|Open-Label Phase|Physician Decision|0|||
94599890|NCT00992589|323997391|FG002|Open-Label Phase|Physician Decision|0|||
94599891|NCT00992589|323997392|FG003|Open-Label Phase|Physician Decision|0|||
94599892|NCT00992589|323997389|FG000|Open-Label Phase|Other|45|||
94599893|NCT00992589|323997390|FG001|Open-Label Phase|Other|0|||
94599894|NCT00992589|323997391|FG002|Open-Label Phase|Other|0|||
94599895|NCT00992589|323997392|FG003|Open-Label Phase|Other|0|||
94599896|NCT00992589|323997389|FG000|Double-Blind Phase|Adverse Event|0|||
94599897|NCT00992589|323997390|FG001|Double-Blind Phase|Adverse Event|6|||
94599898|NCT00992589|323997391|FG002|Double-Blind Phase|Adverse Event|2|||
94599899|NCT00992589|323997392|FG003|Double-Blind Phase|Adverse Event|3|||
94660505|NCT00384085|324211667|FG001|Overall Study|Lack of Efficacy|3|||
94660506|NCT00384085|324211668|FG002|Overall Study|Lack of Efficacy|2|||
94660507|NCT00384085|324211666|FG000|Overall Study|No longer Requires Study Treatment|1|||
94599900|NCT00992589|323997389|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
94599901|NCT00992589|323997390|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
94599902|NCT00992589|323997391|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
94599903|NCT00992589|323997392|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
94660508|NCT00384085|324211667|FG001|Overall Study|No longer Requires Study Treatment|0|||
94660509|NCT00384085|324211668|FG002|Overall Study|No longer Requires Study Treatment|1|||
94660510|NCT00384085|324211666|FG000|Overall Study|Protocol Violation|2|||
94660511|NCT00384085|324211667|FG001|Overall Study|Protocol Violation|2|||
94660512|NCT00384085|324211668|FG002|Overall Study|Protocol Violation|2|||
94660513|NCT00384085|324211666|FG000|Overall Study|Lost to Follow-up|9|||
94660514|NCT00384085|324211667|FG001|Overall Study|Lost to Follow-up|9|||
94660515|NCT00384085|324211668|FG002|Overall Study|Lost to Follow-up|10|||
94660516|NCT00384085|324211666|FG000|Overall Study|Progressive Disease|0|||
94660517|NCT00384085|324211667|FG001|Overall Study|Progressive Disease|1|||
94660518|NCT00384085|324211668|FG002|Overall Study|Progressive Disease|0|||
94660519|NCT00384085|324211666|FG000|Overall Study|Withdrawal by Subject|14|||
94660520|NCT00384085|324211667|FG001|Overall Study|Withdrawal by Subject|19|||
94660521|NCT00384085|324211668|FG002|Overall Study|Withdrawal by Subject|29|||
94660522|NCT00384085|324211666|FG000|Overall Study|Patient non-compliant|4|||
94660523|NCT00384085|324211667|FG001|Overall Study|Patient non-compliant|4|||
94660524|NCT00384085|324211668|FG002|Overall Study|Patient non-compliant|5|||
94660525|NCT00384085|324211666|FG000|Overall Study|Physician Decision|1|||
94660526|NCT00384085|324211667|FG001|Overall Study|Physician Decision|0|||
94660527|NCT00384085|324211668|FG002|Overall Study|Physician Decision|0|||
94660528|NCT00384085|324211666|FG000|Overall Study|Loss of site personnel|1|||
94660529|NCT00384085|324211667|FG001|Overall Study|Loss of site personnel|0|||
94660530|NCT00384085|324211668|FG002|Overall Study|Loss of site personnel|1|||
94660531|NCT00384085|324211666|FG000|Overall Study|Sponsor decision|1|||
94660532|NCT00384085|324211667|FG001|Overall Study|Sponsor decision|2|||
94660533|NCT00384085|324211668|FG002|Overall Study|Sponsor decision|1|||
94660534|NCT00384085|324211666|FG000|Overall Study|Patient moved|1|||
94660535|NCT00384085|324211667|FG001|Overall Study|Patient moved|0|||
94660536|NCT00384085|324211668|FG002|Overall Study|Patient moved|1|||
94660537|NCT00384085|324211666|FG000|Overall Study|Patient required surgery|0|||
94660538|NCT00384085|324211667|FG001|Overall Study|Patient required surgery|1|||
94660539|NCT00384085|324211668|FG002|Overall Study|Patient required surgery|0|||
94660540|NCT01073618|324211671|FG000|Overall Study|Death|208|||
94660541|NCT01073618|324211671|FG000|Overall Study|Adverse Event|19|||
94660542|NCT01073618|324211671|FG000|Overall Study|Other|80|||
94660543|NCT04495374|324211683|FG000|Overall Study|Protocol Violation|2|||
94660544|NCT04495374|324211684|FG001|Overall Study|Protocol Violation|1|||
94660545|NCT02807948|324211685|FG000|Overall Study|Physician Decision|1|||
94660546|NCT02807948|324211686|FG001|Overall Study|Physician Decision|0|||
94660547|NCT01343082|324211688|FG000|The run-in Period|Not meeting criteria|3|||
94660548|NCT01343082|324211689|FG001|The run-in Period|Not meeting criteria|4|||
94660549|NCT01343082|324211690|FG002|The run-in Period|Not meeting criteria|5|||
94660550|NCT01343082|324211688|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
94660551|NCT01343082|324211689|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
94660552|NCT01343082|324211690|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
94660553|NCT01343082|324211688|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
94660554|NCT01343082|324211689|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
94660555|NCT01343082|324211690|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
94660556|NCT01343082|324211688|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
94660557|NCT01343082|324211689|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
94660558|NCT01343082|324211690|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
94660559|NCT01343082|324211688|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
94248430|NCT01775475|322704831|FG000|Overall Study|Death|3|||
94248431|NCT01775475|322704832|FG001|Overall Study|Death|3|||
94248432|NCT04797650|322704833|FG000|Overall Study|Reason Not Specified|5|||
94248433|NCT04797650|322704834|FG001|Overall Study|Reason Not Specified|12|||
94248434|NCT04797650|322704835|FG002|Overall Study|Reason Not Specified|5|||
94248435|NCT04797650|322704833|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
94660560|NCT01343082|324211689|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
94660561|NCT01343082|324211690|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
94660562|NCT04265755|324211691|FG000|Overall Study|Withdrawal by Subject|39|||
94660563|NCT04265755|324211691|FG000|Overall Study|Decision by sponsor|2|||
94660564|NCT04265755|324211691|FG000|Overall Study|Lost to Follow-up|11|||
94660565|NCT04265755|324211691|FG000|Overall Study|Death|1|||
94660566|NCT02099838|324211692|FG000|Overall Study|Death|1|||
94660567|NCT02099838|324211693|FG001|Overall Study|Death|0|||
94660568|NCT02099838|324211692|FG000|Overall Study|Lost to Follow-up|3|||
94660569|NCT02099838|324211693|FG001|Overall Study|Lost to Follow-up|1|||
94660570|NCT02099838|324211692|FG000|Overall Study|Withdrawal by Subject|0|||
94660571|NCT02099838|324211693|FG001|Overall Study|Withdrawal by Subject|1|||
94599904|NCT00992589|323997389|FG000|Double-Blind Phase|Lost to Follow-up|0|||
94599905|NCT00992589|323997390|FG001|Double-Blind Phase|Lost to Follow-up|0|||
94599906|NCT00992589|323997391|FG002|Double-Blind Phase|Lost to Follow-up|0|||
94599907|NCT00992589|323997392|FG003|Double-Blind Phase|Lost to Follow-up|2|||
94599908|NCT00992589|323997389|FG000|Double-Blind Phase|Other|0|||
94599909|NCT00992589|323997390|FG001|Double-Blind Phase|Other|1|||
94599910|NCT00992589|323997391|FG002|Double-Blind Phase|Other|6|||
94599911|NCT00992589|323997392|FG003|Double-Blind Phase|Other|3|||
94599912|NCT04575597|323997395|FG000|Overall Study|Death|0|||
94599913|NCT04575597|323997396|FG001|Overall Study|Death|0|||
94599914|NCT04575597|323997397|FG002|Overall Study|Death|0|||
94599915|NCT04575597|323997398|FG003|Overall Study|Death|1|||
94599916|NCT04575597|323997399|FG004|Overall Study|Death|3|||
94599917|NCT04575597|323997400|FG005|Overall Study|Death|14|||
94599918|NCT04575597|323997395|FG000|Overall Study|Lost to Follow-up|2|||
94599919|NCT04575597|323997396|FG001|Overall Study|Lost to Follow-up|1|||
94599920|NCT04575597|323997397|FG002|Overall Study|Lost to Follow-up|1|||
94599921|NCT04575597|323997398|FG003|Overall Study|Lost to Follow-up|2|||
94599922|NCT04575597|323997399|FG004|Overall Study|Lost to Follow-up|10|||
94599923|NCT04575597|323997400|FG005|Overall Study|Lost to Follow-up|8|||
94599924|NCT04575597|323997395|FG000|Overall Study|Withdrawal by Subject|2|||
94599925|NCT04575597|323997396|FG001|Overall Study|Withdrawal by Subject|2|||
94599926|NCT04575597|323997397|FG002|Overall Study|Withdrawal by Subject|4|||
94599927|NCT04575597|323997398|FG003|Overall Study|Withdrawal by Subject|2|||
94599928|NCT04575597|323997399|FG004|Overall Study|Withdrawal by Subject|25|||
94599929|NCT04575597|323997400|FG005|Overall Study|Withdrawal by Subject|28|||
94599930|NCT04575597|323997395|FG000|Overall Study|Not Recorded|0|||
94599931|NCT04575597|323997396|FG001|Overall Study|Not Recorded|0|||
94599932|NCT04575597|323997397|FG002|Overall Study|Not Recorded|0|||
94599933|NCT04575597|323997398|FG003|Overall Study|Not Recorded|0|||
94599934|NCT04575597|323997399|FG004|Overall Study|Not Recorded|0|||
94599935|NCT04575597|323997400|FG005|Overall Study|Not Recorded|2|||
94599936|NCT04575597|323997395|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94599937|NCT04575597|323997396|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94599938|NCT04575597|323997397|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94599939|NCT04575597|323997398|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94599940|NCT04575597|323997399|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
94599941|NCT04575597|323997400|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
94599942|NCT00420641|323997403|FG000|Overall Study|Adverse Event|3|||
94599943|NCT00420641|323997404|FG001|Overall Study|Adverse Event|25|||
94599944|NCT00420641|323997405|FG002|Overall Study|Adverse Event|10|||
94599945|NCT00420641|323997403|FG000|Overall Study|Lost to Follow-up|2|||
94599946|NCT00420641|323997404|FG001|Overall Study|Lost to Follow-up|4|||
94599947|NCT00420641|323997405|FG002|Overall Study|Lost to Follow-up|2|||
94599948|NCT00420641|323997403|FG000|Overall Study|Protocol Violation|8|||
94599949|NCT00420641|323997404|FG001|Overall Study|Protocol Violation|8|||
94599950|NCT00420641|323997405|FG002|Overall Study|Protocol Violation|7|||
94599951|NCT00420641|323997403|FG000|Overall Study|Withdrawal by Subject|15|||
94599952|NCT00420641|323997404|FG001|Overall Study|Withdrawal by Subject|21|||
94599953|NCT00420641|323997405|FG002|Overall Study|Withdrawal by Subject|14|||
94599954|NCT00420641|323997403|FG000|Overall Study|Lack of Efficacy|6|||
94599955|NCT00420641|323997404|FG001|Overall Study|Lack of Efficacy|5|||
94599956|NCT00420641|323997405|FG002|Overall Study|Lack of Efficacy|4|||
94599957|NCT00420641|323997403|FG000|Overall Study|Non-compliance|7|||
94599958|NCT00420641|323997404|FG001|Overall Study|Non-compliance|5|||
94599959|NCT00420641|323997405|FG002|Overall Study|Non-compliance|4|||
94599960|NCT00420641|323997403|FG000|Overall Study|Other|4|||
94599961|NCT00420641|323997404|FG001|Overall Study|Other|4|||
94599962|NCT00420641|323997405|FG002|Overall Study|Other|3|||
94599963|NCT01589770|323997413|FG000|Overall Study|EGFR <60ml/min|6|||
94599964|NCT01589770|323997414|FG001|Overall Study|EGFR <60ml/min|4|||
94599965|NCT01589770|323997413|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
94599966|NCT01589770|323997414|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
94599967|NCT01853618|323997417|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
94599968|NCT01853618|323997418|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
94599969|NCT01853618|323997419|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
94599970|NCT01853618|323997420|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
94599971|NCT01853618|323997421|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
94599972|NCT01853618|323997417|FG000|Overall Study|Progressive disease|1|||
94599973|NCT01853618|323997418|FG001|Overall Study|Progressive disease|1|||
94599974|NCT01853618|323997419|FG002|Overall Study|Progressive disease|1|||
94599975|NCT01853618|323997420|FG003|Overall Study|Progressive disease|1|||
94599976|NCT01853618|323997421|FG004|Overall Study|Progressive disease|2|||
94599977|NCT01853618|323997417|FG000|Overall Study|Physician Decision|0|||
94660572|NCT01227889|324211694|FG000|Randomized Phase (RP)|Adverse Event|13|||
94660573|NCT01227889|324211695|FG001|Randomized Phase (RP)|Adverse Event|0|||
94660574|NCT01227889|324211694|FG000|Randomized Phase (RP)|Physician Decision|13|||
94660575|NCT01227889|324211695|FG001|Randomized Phase (RP)|Physician Decision|5|||
94660576|NCT01227889|324211694|FG000|Randomized Phase (RP)|Progressive Disease|135|||
94660577|NCT01227889|324211695|FG001|Randomized Phase (RP)|Progressive Disease|52|||
94660578|NCT01227889|324211694|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
94660579|NCT01227889|324211695|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
94660580|NCT01227889|324211694|FG000|Randomized Phase (RP)|Missing|1|||
94660581|NCT01227889|324211695|FG001|Randomized Phase (RP)|Missing|3|||
94660582|NCT01227889|324211694|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
94660583|NCT01227889|324211695|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
94660584|NCT01227889|324211694|FG000|Crossover Phase|Adverse Event|0|||
94660585|NCT01227889|324211695|FG001|Crossover Phase|Adverse Event|1|||
94660586|NCT01227889|324211694|FG000|Crossover Phase|Physician Decision|0|||
94660587|NCT01227889|324211695|FG001|Crossover Phase|Physician Decision|3|||
94660588|NCT01227889|324211694|FG000|Crossover Phase|Progressive Disease|0|||
94660589|NCT01227889|324211695|FG001|Crossover Phase|Progressive Disease|31|||
94660590|NCT01227889|324211694|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
94660591|NCT01227889|324211695|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
94660592|NCT01227889|324211694|FG000|Crossover Phase|Withdrawal by Subject|0|||
94660593|NCT01227889|324211695|FG001|Crossover Phase|Withdrawal by Subject|1|||
94660594|NCT04121962|324211696|FG000|Overall Study|Lost to Follow-up|42|||
94660595|NCT04121962|324211697|FG001|Overall Study|Lost to Follow-up|39|||
94660596|NCT00774787|324211698|FG000|Overall Study|Lost to Follow-up|1|||
94660597|NCT01163682|324211699|FG000|Overall Study|Lost to Follow-up|6|||
94660598|NCT01163682|324211700|FG001|Overall Study|Lost to Follow-up|9|||
94660599|NCT01033747|324211703|FG000|Overall Study|Adverse Event|9|||
94660600|NCT01033747|324211704|FG001|Overall Study|Adverse Event|4|||
94660601|NCT01033747|324211703|FG000|Overall Study|Abnormal Laboratory Value|1|||
94660602|NCT01033747|324211704|FG001|Overall Study|Abnormal Laboratory Value|0|||
94660603|NCT01033747|324211703|FG000|Overall Study|Abnormal test procedure|0|||
94660604|NCT01033747|324211704|FG001|Overall Study|Abnormal test procedure|1|||
94660605|NCT01033747|324211703|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
94660606|NCT01033747|324211704|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
94660607|NCT01033747|324211703|FG000|Overall Study|Protocol Violation|1|||
94660608|NCT01033747|324211704|FG001|Overall Study|Protocol Violation|0|||
94660609|NCT01033747|324211703|FG000|Overall Study|Withdrawal by Subject|9|||
94660610|NCT01033747|324211704|FG001|Overall Study|Withdrawal by Subject|6|||
94660611|NCT01033747|324211703|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
94660612|NCT01033747|324211704|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
94660613|NCT01033747|324211703|FG000|Overall Study|Stopped at end of Extension 1|2|||
94660614|NCT01033747|324211704|FG001|Overall Study|Stopped at end of Extension 1|0|||
94660615|NCT00844194|324211705|FG000|Overall Study|Adverse Event|17|||
94660616|NCT00844194|324211706|FG001|Overall Study|Adverse Event|5|||
94660617|NCT00844194|324211705|FG000|Overall Study|Protocol Violation|1|||
94660618|NCT00844194|324211706|FG001|Overall Study|Protocol Violation|1|||
94660619|NCT00844194|324211705|FG000|Overall Study|Lost to Follow-up|1|||
94660620|NCT00844194|324211706|FG001|Overall Study|Lost to Follow-up|1|||
94660621|NCT00844194|324211705|FG000|Overall Study|Withdrawal by Subject|2|||
94660622|NCT00844194|324211706|FG001|Overall Study|Withdrawal by Subject|1|||
94660623|NCT00844194|324211705|FG000|Overall Study|Lack of Efficacy|3|||
94660624|NCT00844194|324211706|FG001|Overall Study|Lack of Efficacy|0|||
94660625|NCT00844194|324211705|FG000|Overall Study|Other reason (not specified)|1|||
94660626|NCT00844194|324211706|FG001|Overall Study|Other reason (not specified)|0|||
94660627|NCT00803023|324211707|FG000|Overall Study|Adverse Event|5|||
94660628|NCT00803023|324211708|FG001|Overall Study|Adverse Event|4|||
94660629|NCT00803023|324211709|FG002|Overall Study|Adverse Event|8|||
94660630|NCT00803023|324211710|FG003|Overall Study|Adverse Event|6|||
94660631|NCT00803023|324211707|FG000|Overall Study|Withdrawal by Subject|0|||
94660632|NCT00803023|324211708|FG001|Overall Study|Withdrawal by Subject|2|||
94660633|NCT00803023|324211709|FG002|Overall Study|Withdrawal by Subject|0|||
94660634|NCT00803023|324211710|FG003|Overall Study|Withdrawal by Subject|0|||
94660635|NCT00803023|324211707|FG000|Overall Study|Lost to Follow-up|0|||
94660636|NCT00803023|324211708|FG001|Overall Study|Lost to Follow-up|1|||
94660637|NCT00803023|324211709|FG002|Overall Study|Lost to Follow-up|2|||
94660638|NCT00803023|324211710|FG003|Overall Study|Lost to Follow-up|1|||
94660639|NCT00803023|324211707|FG000|Overall Study|Lack of Efficacy|0|||
94660640|NCT00803023|324211708|FG001|Overall Study|Lack of Efficacy|1|||
94660641|NCT00803023|324211709|FG002|Overall Study|Lack of Efficacy|1|||
94660642|NCT00803023|324211710|FG003|Overall Study|Lack of Efficacy|1|||
94660643|NCT02417246|324211713|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
94660644|NCT02417246|324211714|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
94599978|NCT01853618|323997418|FG001|Overall Study|Physician Decision|1|||
94599979|NCT01853618|323997419|FG002|Overall Study|Physician Decision|1|||
94599980|NCT01853618|323997420|FG003|Overall Study|Physician Decision|0|||
94599981|NCT01853618|323997421|FG004|Overall Study|Physician Decision|0|||
94599982|NCT01853618|323997417|FG000|Overall Study|Refused further treatment|0|||
94599983|NCT01853618|323997418|FG001|Overall Study|Refused further treatment|0|||
94599984|NCT01853618|323997419|FG002|Overall Study|Refused further treatment|0|||
94599985|NCT01853618|323997420|FG003|Overall Study|Refused further treatment|0|||
94356033|NCT00450814|323085777|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
94356034|NCT00450814|323085778|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
94356035|NCT00450814|323085779|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
94599986|NCT01853618|323997421|FG004|Overall Study|Refused further treatment|1|||
94599987|NCT05615935|323997422|FG000|Overall Study|Lost to Follow-up|1|||
94599988|NCT05615935|323997423|FG001|Overall Study|Lost to Follow-up|1|||
94599989|NCT01658813|323997424|FG000|Overall Study|Disease progression|3|||
94599990|NCT00827931|323997425|FG000|Overall Study|Death|3|||
94599991|NCT00827931|323997426|FG001|Overall Study|Death|5|||
94599992|NCT00827931|323997425|FG000|Overall Study|Adverse Event|1|||
94599993|NCT00827931|323997426|FG001|Overall Study|Adverse Event|0|||
94599994|NCT00827931|323997425|FG000|Overall Study|Lost to Follow-up|1|||
94599995|NCT00827931|323997426|FG001|Overall Study|Lost to Follow-up|0|||
94599996|NCT00827931|323997425|FG000|Overall Study|Withdrawal by Subject|0|||
94599997|NCT00827931|323997426|FG001|Overall Study|Withdrawal by Subject|1|||
94599998|NCT00827931|323997425|FG000|Overall Study|Other|1|||
94599999|NCT00827931|323997426|FG001|Overall Study|Other|0|||
94600000|NCT02009384|323997427|FG000|Overall Study|Death|2|||
94600001|NCT01077375|323997433|FG000|Overall Study|Adverse Event|2|||
94356036|NCT00450814|323085780|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
94600002|NCT01077375|323997434|FG001|Overall Study|Adverse Event|15|||
94600003|NCT01077375|323997433|FG000|Overall Study|Lack of Efficacy|6|||
94356037|NCT00450814|323085781|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
94356038|NCT00450814|323085782|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
94356039|NCT00450814|323085783|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
94356040|NCT00450814|323085784|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
94356041|NCT00450814|323085785|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
94356042|NCT00401726|323085786|FG000|Overall Study|Adverse Event|34|||
94356043|NCT00401726|323085787|FG001|Overall Study|Adverse Event|45|||
94356044|NCT00401726|323085786|FG000|Overall Study|Death|0|||
94356045|NCT00401726|323085787|FG001|Overall Study|Death|3|||
94356046|NCT00401726|323085786|FG000|Overall Study|Sponsor Request|0|||
94600004|NCT01077375|323997434|FG001|Overall Study|Lack of Efficacy|8|||
94600005|NCT01077375|323997433|FG000|Overall Study|Withdrawal by Subject|0|||
94600006|NCT01077375|323997434|FG001|Overall Study|Withdrawal by Subject|6|||
94600007|NCT01077375|323997433|FG000|Overall Study|Lost to Follow-up|2|||
94600008|NCT01077375|323997434|FG001|Overall Study|Lost to Follow-up|5|||
94600009|NCT01077375|323997433|FG000|Overall Study|Other Reason|0|||
94600010|NCT01077375|323997434|FG001|Overall Study|Other Reason|1|||
94600011|NCT03985878|323997441|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
94600012|NCT03985878|323997441|FG000|Overall Study|Study Terminated by Sponsor|12|||
94600013|NCT03985878|323997441|FG000|Overall Study|Withdrawal by Subject|1|||
94600014|NCT00266864|323997442|FG000|Overall Study|Lost to Follow-up|4|||
94600015|NCT00266864|323997443|FG001|Overall Study|Lost to Follow-up|1|||
94600016|NCT00266864|323997442|FG000|Overall Study|Withdrawal by Subject|1|||
94600017|NCT00266864|323997443|FG001|Overall Study|Withdrawal by Subject|1|||
94600018|NCT02829944|323997445|FG000|Overall Study|Physician Decision|0|||
94600019|NCT02829944|323997446|FG001|Overall Study|Physician Decision|1|||
94600020|NCT02829944|323997445|FG000|Overall Study|Screen Failure|2|||
94600021|NCT02829944|323997446|FG001|Overall Study|Screen Failure|2|||
94600022|NCT02829944|323997445|FG000|Overall Study|Inadequate Neuraxial Block|1|||
94600023|NCT02829944|323997446|FG001|Overall Study|Inadequate Neuraxial Block|1|||
94600024|NCT02829944|323997445|FG000|Overall Study|Withdrawal by Subject|2|||
94356047|NCT00401726|323085787|FG001|Overall Study|Sponsor Request|1|||
94356048|NCT00401726|323085786|FG000|Overall Study|Physician Decision|3|||
94356049|NCT00401726|323085787|FG001|Overall Study|Physician Decision|6|||
94600025|NCT02829944|323997446|FG001|Overall Study|Withdrawal by Subject|1|||
94600026|NCT02829944|323997445|FG000|Overall Study|Catheter Displacement|1|||
94600027|NCT02829944|323997446|FG001|Overall Study|Catheter Displacement|0|||
94600028|NCT02829944|323997445|FG000|Overall Study|Catheter broke|0|||
94600029|NCT02829944|323997446|FG001|Overall Study|Catheter broke|1|||
94600030|NCT02829944|323997445|FG000|Overall Study|Staff unavailable|0|||
94600031|NCT02829944|323997446|FG001|Overall Study|Staff unavailable|1|||
94600032|NCT04480424|323997447|FG000|Overall Study|Withdrawal by Subject|0|||
94356050|NCT00401726|323085786|FG000|Overall Study|Lost to Follow-up|23|||
94600033|NCT04480424|323997448|FG001|Overall Study|Withdrawal by Subject|2|||
94356051|NCT00401726|323085787|FG001|Overall Study|Lost to Follow-up|20|||
94600034|NCT04480424|323997447|FG000|Overall Study|Lost to Follow-up|3|||
94600035|NCT04480424|323997448|FG001|Overall Study|Lost to Follow-up|3|||
94600036|NCT04480424|323997447|FG000|Overall Study|Death|14|||
94600037|NCT04480424|323997448|FG001|Overall Study|Death|16|||
94600038|NCT04480424|323997447|FG000|Overall Study|Reason not Specified|5|||
94600039|NCT04480424|323997448|FG001|Overall Study|Reason not Specified|5|||
94600040|NCT01163318|323997449|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
94600041|NCT01163318|323997449|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
94600042|NCT01163318|323997449|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
94600043|NCT01163318|323997449|FG000|Overall Study|Participants Without Case Report Form|7|||
94600044|NCT01163318|323997449|FG000|Overall Study|Multiple Reasons Per Participant|224|||
94600045|NCT00734747|323997455|FG000|SRS Procedure|No staples placed|3|||
94600046|NCT00734747|323997455|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
94600047|NCT03039621|323999056|FG000|Overall Study|Violation of inclusion criteria|3|||
94600048|NCT03039621|323999057|FG001|Overall Study|Violation of inclusion criteria|2|||
94600049|NCT03039621|323999056|FG000|Overall Study|Non-compliance with protocol requirement|4|||
94600050|NCT03039621|323999057|FG001|Overall Study|Non-compliance with protocol requirement|5|||
94600051|NCT03039621|323999056|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
94600052|NCT03039621|323999057|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
94600053|NCT03039621|323999056|FG000|Overall Study|Violation of non-inclusion criteria|1|||
94600054|NCT03039621|323999057|FG001|Overall Study|Violation of non-inclusion criteria|2|||
94600055|NCT00730028|323999058|FG000|Overall Study|Adverse Event|23|||
94600056|NCT00730028|323999059|FG001|Overall Study|Adverse Event|26|||
94600057|NCT00730028|323999060|FG002|Overall Study|Adverse Event|16|||
94600058|NCT00730028|323999061|FG003|Overall Study|Adverse Event|20|||
94600059|NCT00730028|323999062|FG004|Overall Study|Adverse Event|43|||
94600060|NCT00730028|323999058|FG000|Overall Study|Lost to Follow-up|13|||
94600061|NCT00730028|323999059|FG001|Overall Study|Lost to Follow-up|26|||
94600062|NCT00730028|323999060|FG002|Overall Study|Lost to Follow-up|22|||
94600063|NCT00730028|323999061|FG003|Overall Study|Lost to Follow-up|26|||
94600064|NCT00730028|323999062|FG004|Overall Study|Lost to Follow-up|25|||
94600065|NCT00730028|323999058|FG000|Overall Study|Protocol Violation|6|||
94600066|NCT00730028|323999059|FG001|Overall Study|Protocol Violation|1|||
94600067|NCT00730028|323999060|FG002|Overall Study|Protocol Violation|1|||
94600068|NCT00730028|323999061|FG003|Overall Study|Protocol Violation|2|||
94600069|NCT00730028|323999062|FG004|Overall Study|Protocol Violation|0|||
94600070|NCT00730028|323999058|FG000|Overall Study|Withdrawal by Subject|9|||
94600071|NCT00730028|323999059|FG001|Overall Study|Withdrawal by Subject|5|||
94600072|NCT00730028|323999060|FG002|Overall Study|Withdrawal by Subject|4|||
94600073|NCT00730028|323999061|FG003|Overall Study|Withdrawal by Subject|5|||
94600074|NCT00730028|323999062|FG004|Overall Study|Withdrawal by Subject|9|||
94600075|NCT00730028|323999058|FG000|Overall Study|Physician Decision|3|||
94600076|NCT00730028|323999059|FG001|Overall Study|Physician Decision|3|||
94600077|NCT00730028|323999060|FG002|Overall Study|Physician Decision|2|||
94600078|NCT00730028|323999061|FG003|Overall Study|Physician Decision|3|||
94600079|NCT00730028|323999062|FG004|Overall Study|Physician Decision|2|||
94600080|NCT00730028|323999058|FG000|Overall Study|Treatment Failure|5|||
94600081|NCT00730028|323999059|FG001|Overall Study|Treatment Failure|5|||
94600082|NCT00730028|323999060|FG002|Overall Study|Treatment Failure|0|||
94600083|NCT00730028|323999061|FG003|Overall Study|Treatment Failure|0|||
94600084|NCT00730028|323999062|FG004|Overall Study|Treatment Failure|1|||
94600085|NCT00730028|323999058|FG000|Overall Study|Randomization Error|1|||
94600086|NCT00730028|323999059|FG001|Overall Study|Randomization Error|0|||
94600087|NCT00730028|323999060|FG002|Overall Study|Randomization Error|0|||
94600088|NCT00730028|323999061|FG003|Overall Study|Randomization Error|0|||
94600089|NCT00730028|323999062|FG004|Overall Study|Randomization Error|2|||
94600090|NCT01288976|323999065|FG000|Overall Study|Withdrawal by Subject|58|||
94600091|NCT01288976|323999066|FG001|Overall Study|Withdrawal by Subject|12|||
94600092|NCT01288976|323999067|FG002|Overall Study|Withdrawal by Subject|9|||
94600093|NCT01288976|323999065|FG000|Overall Study|Death|98|||
94600094|NCT01288976|323999066|FG001|Overall Study|Death|6|||
94660645|NCT02417246|324211713|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
94660646|NCT02417246|324211714|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
94660647|NCT02417246|324211713|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
94660648|NCT02417246|324211714|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
94660649|NCT02417246|324211713|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
94660650|NCT02417246|324211714|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
94660651|NCT01308749|324211715|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
94660652|NCT01308749|324211716|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
94660653|NCT01308749|324211715|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
94660654|NCT01308749|324211716|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
94660655|NCT01308749|324211715|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
94660656|NCT01308749|324211716|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
94660657|NCT04726709|324211717|FG000|Overall Study|Withdrawal by Subject|2|||
94660658|NCT04726709|324211718|FG001|Overall Study|Withdrawal by Subject|2|||
94660659|NCT02548962|324211721|FG000|Overall Study|Withdrawal by Subject|1|||
94660660|NCT02548962|324211722|FG001|Overall Study|Withdrawal by Subject|0|||
94660661|NCT03936244|324211723|FG000|Overall Study|Lost to Follow-up|5|||
94660662|NCT03936244|324211724|FG001|Overall Study|Lost to Follow-up|1|||
94660663|NCT03936244|324211723|FG000|Overall Study|Physician Decision|7|||
94660664|NCT03936244|324211724|FG001|Overall Study|Physician Decision|3|||
94660665|NCT04479618|324211728|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
94660666|NCT04479618|324211729|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
94660667|NCT04479618|324211730|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
94660668|NCT04479618|324211728|FG000|Overall Study|Lack of Efficacy|1|||
94660669|NCT04479618|324211729|FG001|Overall Study|Lack of Efficacy|0|||
94660670|NCT04479618|324211730|FG002|Overall Study|Lack of Efficacy|0|||
94660671|NCT04479618|324211728|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
94660672|NCT04479618|324211729|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
94660673|NCT04479618|324211730|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
94660674|NCT04479618|324211728|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
94660675|NCT04479618|324211729|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
94660676|NCT04479618|324211730|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
94660677|NCT04479618|324211728|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
94660678|NCT04479618|324211729|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
94660679|NCT04479618|324211730|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
94600095|NCT01288976|323999067|FG002|Overall Study|Death|4|||
94600096|NCT01288976|323999065|FG000|Overall Study|Data unavailable|22|||
94600097|NCT01288976|323999066|FG001|Overall Study|Data unavailable|9|||
94600098|NCT01288976|323999067|FG002|Overall Study|Data unavailable|7|||
94600099|NCT00976508|323999070|FG000|Overall Study|Death|7|||
94600100|NCT00976508|323999071|FG001|Overall Study|Death|1|||
94600101|NCT00976508|323999070|FG000|Overall Study|Lost to Follow-up|1|||
94600102|NCT00976508|323999071|FG001|Overall Study|Lost to Follow-up|0|||
94600103|NCT00976508|323999070|FG000|Overall Study|Withdrawal by Subject|1|||
94600104|NCT00976508|323999071|FG001|Overall Study|Withdrawal by Subject|0|||
94600105|NCT00976508|323999070|FG000|Overall Study|Disease Progression|4|||
94600106|NCT00976508|323999071|FG001|Overall Study|Disease Progression|4|||
94600107|NCT00976508|323999070|FG000|Overall Study|Subject Enrolled in Hospice|1|||
94600108|NCT00976508|323999071|FG001|Overall Study|Subject Enrolled in Hospice|0|||
94600109|NCT00976508|323999070|FG000|Overall Study|Terminated by the Sponsor|0|||
94600110|NCT00976508|323999071|FG001|Overall Study|Terminated by the Sponsor|1|||
94600111|NCT04352127|323999072|FG000|Overall Study|Unable to obtain readings|4|||
94600112|NCT04352127|323999073|FG001|Overall Study|Unable to obtain readings|1|||
94600113|NCT01992159|323999074|FG000|Overall Study|Withdrawal by Subject|4|||
94600114|NCT01992159|323999075|FG001|Overall Study|Withdrawal by Subject|7|||
94600115|NCT01992159|323999076|FG002|Overall Study|Withdrawal by Subject|0|||
94600116|NCT01992159|323999077|FG003|Overall Study|Withdrawal by Subject|3|||
94600117|NCT01992159|323999074|FG000|Overall Study|Adverse Event|0|||
94600118|NCT01992159|323999075|FG001|Overall Study|Adverse Event|1|||
94600119|NCT01992159|323999076|FG002|Overall Study|Adverse Event|0|||
94600120|NCT01992159|323999077|FG003|Overall Study|Adverse Event|1|||
94600121|NCT01992159|323999074|FG000|Overall Study|Death|0|||
94600122|NCT01992159|323999075|FG001|Overall Study|Death|0|||
94600123|NCT01992159|323999076|FG002|Overall Study|Death|1|||
94600124|NCT01992159|323999077|FG003|Overall Study|Death|0|||
94600125|NCT00997438|323999080|FG000|Overall Study|Blood draw difficulty|2|||
94600126|NCT00997438|323999081|FG001|Overall Study|Blood draw difficulty|0|||
94600127|NCT00997438|323999082|FG002|Overall Study|Blood draw difficulty|1|||
94660680|NCT04479618|324211728|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
94660681|NCT04479618|324211729|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
94660682|NCT04479618|324211730|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
94660683|NCT01202773|324211731|FG000|Overall Study|Adverse Event|4|||
94660684|NCT01202773|324211732|FG001|Overall Study|Adverse Event|5|||
94660685|NCT01202773|324211733|FG002|Overall Study|Adverse Event|5|||
94660686|NCT01202773|324211731|FG000|Overall Study|Lack of Efficacy|5|||
94660687|NCT01202773|324211732|FG001|Overall Study|Lack of Efficacy|4|||
94660688|NCT01202773|324211733|FG002|Overall Study|Lack of Efficacy|9|||
94660689|NCT01202773|324211731|FG000|Overall Study|Entry Criteria Not Met|2|||
94660690|NCT01202773|324211732|FG001|Overall Study|Entry Criteria Not Met|0|||
94660691|NCT01202773|324211733|FG002|Overall Study|Entry Criteria Not Met|1|||
94660692|NCT01202773|324211731|FG000|Overall Study|Lost to Follow-up|1|||
94660693|NCT01202773|324211732|FG001|Overall Study|Lost to Follow-up|2|||
94660694|NCT01202773|324211733|FG002|Overall Study|Lost to Follow-up|2|||
94660695|NCT01202773|324211731|FG000|Overall Study|Withdrawal by Subject|13|||
94660696|NCT01202773|324211732|FG001|Overall Study|Withdrawal by Subject|6|||
94660697|NCT01202773|324211733|FG002|Overall Study|Withdrawal by Subject|5|||
94660698|NCT01202773|324211731|FG000|Overall Study|Physician Decision|2|||
94660699|NCT01202773|324211732|FG001|Overall Study|Physician Decision|0|||
94660700|NCT01202773|324211733|FG002|Overall Study|Physician Decision|0|||
94660701|NCT01202773|324211731|FG000|Overall Study|Protocol Violation|11|||
94660702|NCT01202773|324211732|FG001|Overall Study|Protocol Violation|6|||
94660703|NCT01202773|324211733|FG002|Overall Study|Protocol Violation|10|||
94660704|NCT01202773|324211731|FG000|Overall Study|Sponsor Decision|19|||
94660705|NCT01202773|324211732|FG001|Overall Study|Sponsor Decision|20|||
94660706|NCT01202773|324211733|FG002|Overall Study|Sponsor Decision|23|||
94660707|NCT03646513|324211734|FG000|Overall Study|Premature study termination|4|||
94660708|NCT03634579|324211737|FG000|Overall Study|study termination|9|||
94660709|NCT00856583|324211741|FG000|Overall Study|Lack of Efficacy|389|||
94660710|NCT00856583|324211742|FG001|Overall Study|Lack of Efficacy|377|||
94660711|NCT00856583|324211741|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
94660712|NCT00856583|324211742|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
94660713|NCT00856583|324211741|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
94660714|NCT00856583|324211742|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
94660715|NCT00856583|324211741|FG000|Overall Study|Non-compliance|305|||
94660716|NCT00856583|324211742|FG001|Overall Study|Non-compliance|262|||
94660717|NCT00856583|324211741|FG000|Overall Study|Withdrawal by Subject|1092|||
94660718|NCT00856583|324211742|FG001|Overall Study|Withdrawal by Subject|919|||
94660719|NCT00856583|324211741|FG000|Overall Study|Physician Decision|59|||
94660720|NCT00856583|324211742|FG001|Overall Study|Physician Decision|82|||
94660721|NCT00856583|324211741|FG000|Overall Study|Pregnancy|14|||
94660722|NCT00856583|324211742|FG001|Overall Study|Pregnancy|5|||
94660723|NCT00856583|324211741|FG000|Overall Study|Other|92|||
94660724|NCT00856583|324211742|FG001|Overall Study|Other|104|||
94660725|NCT00856583|324211741|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
94660726|NCT00856583|324211742|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
94660727|NCT00305058|324211743|FG000|Overall Study|Participant too young|1|||
94660728|NCT00305058|324211744|FG001|Overall Study|Participant too young|0|||
94660729|NCT00305058|324211743|FG000|Overall Study|Missing data collection instrument|3|||
94660730|NCT00305058|324211744|FG001|Overall Study|Missing data collection instrument|2|||
94660731|NCT00305058|324211743|FG000|Overall Study|Missing outcome data|3|||
94660732|NCT00305058|324211744|FG001|Overall Study|Missing outcome data|2|||
94660733|NCT00661492|324211747|FG000|Overall Study|Adverse Event|16|||
94660734|NCT00661492|324211748|FG001|Overall Study|Adverse Event|13|||
94660735|NCT00661492|324211747|FG000|Overall Study|Disease Progression|44|||
94660736|NCT00661492|324211748|FG001|Overall Study|Disease Progression|14|||
94660737|NCT00661492|324211747|FG000|Overall Study|Patient Request|6|||
94660738|NCT00661492|324211748|FG001|Overall Study|Patient Request|1|||
94660739|NCT00661492|324211747|FG000|Overall Study|Investigator Request|1|||
94660740|NCT00661492|324211748|FG001|Overall Study|Investigator Request|0|||
94660741|NCT00661492|324211747|FG000|Overall Study|Lost to Follow-up|0|||
94660742|NCT00661492|324211748|FG001|Overall Study|Lost to Follow-up|1|||
94660743|NCT00661492|324211747|FG000|Overall Study|Other|1|||
94660744|NCT00661492|324211748|FG001|Overall Study|Other|0|||
94660745|NCT00784043|324211749|FG000|Overall Study|Withdrawal by Subject|8|||
94660746|NCT00784043|324211750|FG001|Overall Study|Withdrawal by Subject|5|||
94660747|NCT00784043|324211749|FG000|Overall Study|Protocol Terminated|23|||
94660748|NCT00784043|324211750|FG001|Overall Study|Protocol Terminated|1|||
94660749|NCT00099983|324211753|FG000|Overall Study|Lost to Follow-up|2|||
94660750|NCT00099983|324211754|FG001|Overall Study|Lost to Follow-up|3|||
94660751|NCT00099983|324211753|FG000|Overall Study|Missing Source Documents|14|||
94600128|NCT00997438|323999080|FG000|Overall Study|Withdrawal by Subject|1|||
94600129|NCT00997438|323999081|FG001|Overall Study|Withdrawal by Subject|1|||
94600130|NCT00997438|323999082|FG002|Overall Study|Withdrawal by Subject|0|||
94600131|NCT00997438|323999080|FG000|Overall Study|Exclusion criteria at visit 1|2|||
94600132|NCT00997438|323999081|FG001|Overall Study|Exclusion criteria at visit 1|2|||
94600133|NCT00997438|323999082|FG002|Overall Study|Exclusion criteria at visit 1|3|||
94600134|NCT03754972|323999083|FG000|Overall Study|Protocol Violation|25|||
94600135|NCT02311582|323999084|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
94600136|NCT02311582|323999085|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
94600137|NCT02311582|323999086|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
94600138|NCT02311582|323999087|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
94600139|NCT02311582|323999088|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
94600140|NCT04391049|323999090|FG000|Overall Study|Protocol Violation|1|||
94600141|NCT02095132|323999093|FG000|Overall Study|Adverse Event|0|||
94600142|NCT02095132|323999094|FG001|Overall Study|Adverse Event|0|||
94600143|NCT02095132|323999095|FG002|Overall Study|Adverse Event|0|||
94600144|NCT02095132|323999096|FG003|Overall Study|Adverse Event|0|||
94600145|NCT02095132|323999097|FG004|Overall Study|Adverse Event|1|||
94600146|NCT02095132|323999098|FG005|Overall Study|Adverse Event|0|||
94600147|NCT02095132|323999099|FG006|Overall Study|Adverse Event|1|||
94600148|NCT02095132|323999100|FG007|Overall Study|Adverse Event|0|||
94600149|NCT02095132|323999101|FG008|Overall Study|Adverse Event|0|||
94600150|NCT02095132|323999093|FG000|Overall Study|Death|0|||
94600151|NCT02095132|323999094|FG001|Overall Study|Death|0|||
94600152|NCT02095132|323999095|FG002|Overall Study|Death|0|||
94600153|NCT02095132|323999096|FG003|Overall Study|Death|0|||
94600154|NCT02095132|323999097|FG004|Overall Study|Death|0|||
94600155|NCT02095132|323999098|FG005|Overall Study|Death|0|||
94600156|NCT02095132|323999099|FG006|Overall Study|Death|1|||
94600157|NCT02095132|323999100|FG007|Overall Study|Death|0|||
94600158|NCT02095132|323999101|FG008|Overall Study|Death|0|||
94600159|NCT02095132|323999093|FG000|Overall Study|Lack of Efficacy|3|||
94600160|NCT02095132|323999094|FG001|Overall Study|Lack of Efficacy|5|||
94600161|NCT02095132|323999095|FG002|Overall Study|Lack of Efficacy|2|||
94600162|NCT02095132|323999096|FG003|Overall Study|Lack of Efficacy|8|||
94600163|NCT02095132|323999097|FG004|Overall Study|Lack of Efficacy|3|||
94600164|NCT02095132|323999098|FG005|Overall Study|Lack of Efficacy|6|||
94600165|NCT02095132|323999099|FG006|Overall Study|Lack of Efficacy|10|||
94600166|NCT02095132|323999100|FG007|Overall Study|Lack of Efficacy|9|||
94600167|NCT02095132|323999101|FG008|Overall Study|Lack of Efficacy|8|||
94600168|NCT02095132|323999093|FG000|Overall Study|Physician Decision|1|||
94600169|NCT02095132|323999094|FG001|Overall Study|Physician Decision|0|||
94600170|NCT02095132|323999095|FG002|Overall Study|Physician Decision|0|||
94600171|NCT02095132|323999096|FG003|Overall Study|Physician Decision|0|||
94600172|NCT02095132|323999097|FG004|Overall Study|Physician Decision|0|||
94600173|NCT02095132|323999098|FG005|Overall Study|Physician Decision|0|||
94600174|NCT02095132|323999099|FG006|Overall Study|Physician Decision|1|||
94600175|NCT02095132|323999100|FG007|Overall Study|Physician Decision|0|||
94600176|NCT02095132|323999101|FG008|Overall Study|Physician Decision|2|||
94600177|NCT02095132|323999093|FG000|Overall Study|Withdrawal by Subject|0|||
94600178|NCT02095132|323999094|FG001|Overall Study|Withdrawal by Subject|0|||
94600179|NCT02095132|323999095|FG002|Overall Study|Withdrawal by Subject|2|||
94600180|NCT02095132|323999096|FG003|Overall Study|Withdrawal by Subject|2|||
94600181|NCT02095132|323999097|FG004|Overall Study|Withdrawal by Subject|3|||
94600182|NCT02095132|323999098|FG005|Overall Study|Withdrawal by Subject|0|||
94600183|NCT02095132|323999099|FG006|Overall Study|Withdrawal by Subject|5|||
94660752|NCT00099983|324211754|FG001|Overall Study|Missing Source Documents|15|||
94660753|NCT00099983|324211753|FG000|Overall Study|Withdrawal by Subject|3|||
94248436|NCT04797650|322704834|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
94248437|NCT04797650|322704835|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
94248438|NCT04797650|322704833|FG000|Overall Study|Lack of Efficacy|1|||
94248439|NCT04797650|322704834|FG001|Overall Study|Lack of Efficacy|0|||
94248440|NCT04797650|322704835|FG002|Overall Study|Lack of Efficacy|1|||
94248441|NCT04797650|322704833|FG000|Overall Study|Non-compliance with Study Drug|0|||
94248442|NCT04797650|322704834|FG001|Overall Study|Non-compliance with Study Drug|0|||
94600184|NCT02095132|323999100|FG007|Overall Study|Withdrawal by Subject|0|||
94600185|NCT02095132|323999101|FG008|Overall Study|Withdrawal by Subject|0|||
94600186|NCT01029405|323999102|FG000|Overall Study|Withdrawal by Subject|0|||
94600187|NCT01029405|323999103|FG001|Overall Study|Withdrawal by Subject|1|||
94248443|NCT04797650|322704835|FG002|Overall Study|Non-compliance with Study Drug|2|||
94600188|NCT01029405|323999104|FG002|Overall Study|Withdrawal by Subject|2|||
94600189|NCT01029405|323999105|FG003|Overall Study|Withdrawal by Subject|0|||
94600190|NCT01029405|323999102|FG000|Overall Study|Protocol Violation|0|||
94600191|NCT01029405|323999103|FG001|Overall Study|Protocol Violation|0|||
94600192|NCT01029405|323999104|FG002|Overall Study|Protocol Violation|0|||
94600193|NCT01029405|323999105|FG003|Overall Study|Protocol Violation|1|||
94600194|NCT01029405|323999102|FG000|Overall Study|Adverse Event|0|||
94600195|NCT01029405|323999103|FG001|Overall Study|Adverse Event|0|||
94600196|NCT01029405|323999104|FG002|Overall Study|Adverse Event|1|||
94600197|NCT01029405|323999105|FG003|Overall Study|Adverse Event|1|||
94600198|NCT01029405|323999102|FG000|Overall Study|Lost to Follow-up|2|||
94600199|NCT01029405|323999103|FG001|Overall Study|Lost to Follow-up|1|||
94600200|NCT01029405|323999104|FG002|Overall Study|Lost to Follow-up|1|||
94600201|NCT01029405|323999105|FG003|Overall Study|Lost to Follow-up|2|||
94600202|NCT01029405|323999102|FG000|Overall Study|Other|0|||
94600203|NCT01029405|323999103|FG001|Overall Study|Other|1|||
94600204|NCT01029405|323999104|FG002|Overall Study|Other|0|||
94600205|NCT01029405|323999105|FG003|Overall Study|Other|1|||
94600206|NCT01268579|323999112|FG000|Overall Study|Adverse Event|1|||
94600207|NCT01268579|323999112|FG000|Overall Study|Withdrawal by Subject|2|||
94600208|NCT02692651|323999113|FG000|Study Treatment|Death|7|||
94600209|NCT02692651|323999114|FG001|Study Treatment|Death|3|||
94600210|NCT02692651|323999113|FG000|Study Treatment|comfort care|1|||
94600211|NCT02692651|323999114|FG001|Study Treatment|comfort care|1|||
94600212|NCT02692651|323999113|FG000|Study Treatment|Protocol violation per treating team preference|8|||
94600213|NCT02692651|323999114|FG001|Study Treatment|Protocol violation per treating team preference|6|||
94600214|NCT02692651|323999113|FG000|Post Study Treatment Follow-up|Death|4|||
94600215|NCT02692651|323999114|FG001|Post Study Treatment Follow-up|Death|4|||
94600216|NCT03490981|323999115|FG000|Overall Study|Lost to Follow-up|1|||
94600217|NCT03490981|323999116|FG001|Overall Study|Lost to Follow-up|2|||
94600218|NCT00282464|323999123|FG000|Overall Study|Adverse Event|26|||
94600219|NCT00282464|323999124|FG001|Overall Study|Adverse Event|20|||
94600220|NCT00282464|323999123|FG000|Overall Study|Lack of Efficacy|8|||
94600221|NCT00282464|323999124|FG001|Overall Study|Lack of Efficacy|8|||
94600222|NCT00282464|323999123|FG000|Overall Study|Lost to Follow-up|10|||
94600223|NCT00282464|323999124|FG001|Overall Study|Lost to Follow-up|10|||
94600224|NCT00282464|323999123|FG000|Overall Study|Withdrawal by Subject|24|||
94600225|NCT00282464|323999124|FG001|Overall Study|Withdrawal by Subject|10|||
94600226|NCT00282464|323999123|FG000|Overall Study|laboratory abnormality|1|||
94600227|NCT00282464|323999124|FG001|Overall Study|laboratory abnormality|2|||
94600228|NCT00282464|323999123|FG000|Overall Study|Protocol Violation|0|||
94600229|NCT00282464|323999124|FG001|Overall Study|Protocol Violation|7|||
94600230|NCT00282464|323999123|FG000|Overall Study|Patient moved|1|||
94600231|NCT00282464|323999124|FG001|Overall Study|Patient moved|0|||
94600232|NCT00282464|323999123|FG000|Overall Study|patient non-compliant|3|||
94600233|NCT00282464|323999124|FG001|Overall Study|patient non-compliant|0|||
94600234|NCT00282464|323999123|FG000|Overall Study|patient no show|0|||
94600235|NCT00282464|323999124|FG001|Overall Study|patient no show|1|||
94600236|NCT00282464|323999123|FG000|Overall Study|patient incarcerated|0|||
94600237|NCT00282464|323999124|FG001|Overall Study|patient incarcerated|1|||
94600238|NCT00282464|323999123|FG000|Overall Study|family crisis|0|||
94600239|NCT00282464|323999124|FG001|Overall Study|family crisis|1|||
94600240|NCT00282464|323999123|FG000|Overall Study|dispensed wrong kit|0|||
94600241|NCT00282464|323999124|FG001|Overall Study|dispensed wrong kit|1|||
94600242|NCT00282464|323999123|FG000|Overall Study|dropped due to missed visits|0|||
94600243|NCT00282464|323999124|FG001|Overall Study|dropped due to missed visits|1|||
94600244|NCT00475423|323999125|FG000|Overall Study|Protocol Violation|5|||
94600245|NCT00475423|323999125|FG000|Overall Study|Adverse Event|4|||
94600246|NCT00475423|323999125|FG000|Overall Study|Withdrawal by Subject|6|||
94600247|NCT00475423|323999125|FG000|Overall Study|Lack of Efficacy|8|||
94600248|NCT00475423|323999125|FG000|Overall Study|Death|1|||
94600249|NCT00475423|323999125|FG000|Overall Study|Reason not specified|1|||
94600250|NCT00475423|323999125|FG000|Overall Study|Lost to Follow-up|7|||
94600251|NCT00740051|323999129|FG000|Overall Study|Lack of Efficacy|2|||
94600252|NCT00740051|323999130|FG001|Overall Study|Lack of Efficacy|5|||
94600253|NCT00740051|323999129|FG000|Overall Study|Adverse Event|1|||
94600254|NCT00740051|323999130|FG001|Overall Study|Adverse Event|4|||
94600255|NCT00740051|323999129|FG000|Overall Study|Protocol Violation|2|||
94600256|NCT00740051|323999130|FG001|Overall Study|Protocol Violation|6|||
94600257|NCT00740051|323999129|FG000|Overall Study|Lost to Follow-up|3|||
94600258|NCT00740051|323999130|FG001|Overall Study|Lost to Follow-up|8|||
94600259|NCT00740051|323999129|FG000|Overall Study|Withdrawal by Subject|6|||
94600260|NCT00740051|323999130|FG001|Overall Study|Withdrawal by Subject|8|||
94600261|NCT00740051|323999129|FG000|Overall Study|Other reason (not specified)|4|||
94600262|NCT00740051|323999130|FG001|Overall Study|Other reason (not specified)|1|||
94600263|NCT01903525|323999131|FG000|Overall Study|Lost to Follow-up|5|||
94600264|NCT01903525|323999132|FG001|Overall Study|Lost to Follow-up|9|||
94600265|NCT01903525|323999131|FG000|Overall Study|Adverse Event|0|||
94600266|NCT01903525|323999132|FG001|Overall Study|Adverse Event|1|||
94600267|NCT00582816|323999134|FG000|Overall Study|Engraftment Failure|3|||
94248444|NCT04797650|322704833|FG000|Overall Study|Lost to Follow-up|4|||
94600268|NCT00674154|323999137|FG000|Overall Study|Withdrawal by Subject|3|||
94600269|NCT00674154|323999138|FG001|Overall Study|Withdrawal by Subject|1|||
94600270|NCT00674154|323999137|FG000|Overall Study|Did not want parathyroidectomy|0|||
94600271|NCT00674154|323999138|FG001|Overall Study|Did not want parathyroidectomy|2|||
94600272|NCT01107379|323999139|FG000|Overall Study|Withdrawal by Subject|18|||
94600273|NCT01107379|323999139|FG000|Overall Study|Lost to Follow-up|3|||
94600274|NCT00627445|323999144|FG000|Overall Study|Adverse Event|3|||
94600275|NCT00627445|323999145|FG001|Overall Study|Adverse Event|3|||
94600276|NCT00627445|323999144|FG000|Overall Study|Lack of Efficacy|0|||
94600277|NCT00627445|323999145|FG001|Overall Study|Lack of Efficacy|1|||
94600278|NCT00627445|323999144|FG000|Overall Study|Other|6|||
94600279|NCT00627445|323999145|FG001|Overall Study|Other|8|||
94600280|NCT00247611|323999149|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
94600281|NCT00247611|323999150|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
94600282|NCT00247611|323999149|FG000|Baselined|Completed baseline only|9|||
94600283|NCT00247611|323999150|FG001|Baselined|Completed baseline only|8|||
94600284|NCT02582684|323999152|FG000|Overall Study|Unable to contact subject/parent|4|||
94600285|NCT02582684|323999152|FG000|Overall Study|Subject not able to get to clinic|10|||
94600286|NCT02582684|323999152|FG000|Overall Study|Subject withdrew consent|1|||
94600287|NCT02582684|323999152|FG000|Overall Study|Found to be ineligible after enrollment|2|||
94600288|NCT05395091|323999153|FG000|Baseline to Month 12|Adverse Event|7|||
94600289|NCT05395091|323999154|FG001|Baseline to Month 12|Adverse Event|2|||
94600290|NCT05395091|323999155|FG002|Baseline to Month 12|Adverse Event|0|||
94600291|NCT05395091|323999153|FG000|Baseline to Month 12|Death|3|||
94600292|NCT05395091|323999154|FG001|Baseline to Month 12|Death|1|||
94600293|NCT05395091|323999155|FG002|Baseline to Month 12|Death|0|||
94600294|NCT05395091|323999153|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
94600295|NCT05395091|323999154|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
94600296|NCT05395091|323999155|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
94600297|NCT05395091|323999153|FG000|Baseline to Month 12|Protocol Violation|2|||
94600298|NCT05395091|323999154|FG001|Baseline to Month 12|Protocol Violation|3|||
94600299|NCT05395091|323999155|FG002|Baseline to Month 12|Protocol Violation|0|||
94600300|NCT05395091|323999153|FG000|Baseline to Month 12|Physician Decision|1|||
94600301|NCT05395091|323999154|FG001|Baseline to Month 12|Physician Decision|0|||
94600302|NCT05395091|323999155|FG002|Baseline to Month 12|Physician Decision|0|||
94600303|NCT05395091|323999153|FG000|Month 12 to Month 18|Death|1|||
94600304|NCT05395091|323999154|FG001|Month 12 to Month 18|Death|0|||
94600305|NCT05395091|323999155|FG002|Month 12 to Month 18|Death|0|||
94600306|NCT05395091|323999153|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
94600307|NCT05395091|323999154|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
94600308|NCT05395091|323999155|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
94600309|NCT05395091|323999153|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
94600310|NCT05395091|323999154|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
94600311|NCT05395091|323999155|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
94600312|NCT05395091|323999153|FG000|Month 12 to Month 18|Other reasons|0|||
94600313|NCT05395091|323999154|FG001|Month 12 to Month 18|Other reasons|0|||
94600314|NCT05395091|323999155|FG002|Month 12 to Month 18|Other reasons|1|||
94600315|NCT01878149|323999158|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
94600316|NCT01878149|323999159|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
94600317|NCT03562767|323999161|FG000|Overall Study|Physician Decision|2|||
94600318|NCT03562767|323999162|FG001|Overall Study|Physician Decision|0|||
94600319|NCT03562767|323999163|FG002|Overall Study|Physician Decision|0|||
94600320|NCT03562767|323999161|FG000|Overall Study|Logistic Reason|1|||
94600321|NCT03562767|323999162|FG001|Overall Study|Logistic Reason|3|||
94600322|NCT03562767|323999163|FG002|Overall Study|Logistic Reason|0|||
94600323|NCT00938886|323999166|FG000|Overall Study|Death|0|||
94600324|NCT00938886|323999167|FG001|Overall Study|Death|1|||
94600325|NCT00938886|323999166|FG000|Overall Study|Withdrawal by Subject|4|||
94600326|NCT00938886|323999167|FG001|Overall Study|Withdrawal by Subject|7|||
94600327|NCT00938886|323999166|FG000|Overall Study|Lost to Follow-up|3|||
94600328|NCT00938886|323999167|FG001|Overall Study|Lost to Follow-up|2|||
94600329|NCT01715129|323999168|FG000|Overall Study|Adverse Event, fatal|1|||
94600330|NCT01715129|323999168|FG000|Overall Study|Lack of Efficacy|3|||
94600331|NCT01715129|323999168|FG000|Overall Study|Protocol Violation|1|||
94600332|NCT01715129|323999168|FG000|Overall Study|Consent Withdrawn|2|||
94600333|NCT01715129|323999168|FG000|Overall Study|Lost to Follow-up|1|||
94600334|NCT01715129|323999168|FG000|Overall Study|Other|1|||
94600335|NCT02793622|323999169|FG000|Overall Study|Lost to Follow-up|31|||
94600336|NCT02793622|323999170|FG001|Overall Study|Lost to Follow-up|19|||
94600337|NCT02793622|323999169|FG000|Overall Study|Withdrawal by Subject|21|||
94600338|NCT02793622|323999170|FG001|Overall Study|Withdrawal by Subject|17|||
94600339|NCT02793622|323999169|FG000|Overall Study|Adverse Event|0|||
94248445|NCT04797650|322704834|FG001|Overall Study|Lost to Follow-up|6|||
94248446|NCT04797650|322704835|FG002|Overall Study|Lost to Follow-up|1|||
94600340|NCT02793622|323999170|FG001|Overall Study|Adverse Event|1|||
94600341|NCT02793622|323999169|FG000|Overall Study|Protocol Violation|1|||
94600342|NCT02793622|323999170|FG001|Overall Study|Protocol Violation|5|||
94600343|NCT00913692|323999171|FG000|Screening (4 Months)|Physician Decision|3|||
94600344|NCT00913692|323999171|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
94600345|NCT00913692|323999171|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
94600346|NCT03761797|323999172|FG000|Overall Study|Changing hospital|11|||
94600347|NCT03761797|323999172|FG000|Overall Study|Improvement/remission|6|||
94660754|NCT00099983|324211754|FG001|Overall Study|Withdrawal by Subject|2|||
94660755|NCT00099983|324211753|FG000|Overall Study|Adverse Event|1|||
94660756|NCT00099983|324211754|FG001|Overall Study|Adverse Event|1|||
94660757|NCT00099983|324211753|FG000|Overall Study|Lack of Efficacy|0|||
94660758|NCT00099983|324211754|FG001|Overall Study|Lack of Efficacy|1|||
94660759|NCT00099983|324211753|FG000|Overall Study|Unable to return for appointments|1|||
94660760|NCT00099983|324211754|FG001|Overall Study|Unable to return for appointments|1|||
94660761|NCT00099983|324211753|FG000|Overall Study|Moved|1|||
94660762|NCT00099983|324211754|FG001|Overall Study|Moved|0|||
94600348|NCT03761797|323999172|FG000|Overall Study|Withdrawal by Subject|19|||
94600349|NCT03761797|323999172|FG000|Overall Study|Lost to Follow-up|33|||
94600350|NCT03761797|323999172|FG000|Overall Study|Adverse Event|37|||
94600351|NCT03761797|323999172|FG000|Overall Study|Case report form (CRF) not collected|5|||
94600352|NCT03761797|323999172|FG000|Overall Study|No patient visit after entry|13|||
94600353|NCT03761797|323999172|FG000|Overall Study|Switch to other diabetes medication|10|||
94600354|NCT03761797|323999172|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
94600355|NCT03761797|323999172|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
94600356|NCT03761797|323999172|FG000|Overall Study|Insufficient effectives|2|||
94600357|NCT03761797|323999172|FG000|Overall Study|Excessive alcohol intake|1|||
94600358|NCT00400153|323999176|FG000|Overall Study|AE due to study disease worsening|14|||
94600359|NCT00400153|323999177|FG001|Overall Study|AE due to study disease worsening|19|||
94600360|NCT00400153|323999178|FG002|Overall Study|AE due to study disease worsening|20|||
94660763|NCT00099983|324211753|FG000|Overall Study|Other psychiatric problem|1|||
94660764|NCT00099983|324211754|FG001|Overall Study|Other psychiatric problem|0|||
94600361|NCT00400153|323999176|FG000|Overall Study|AE due to other disease worsening|2|||
94600362|NCT00400153|323999177|FG001|Overall Study|AE due to other disease worsening|1|||
94600363|NCT00400153|323999178|FG002|Overall Study|AE due to other disease worsening|0|||
94600364|NCT00400153|323999176|FG000|Overall Study|AE due to other condition|3|||
94600365|NCT00400153|323999177|FG001|Overall Study|AE due to other condition|14|||
94600366|NCT00400153|323999178|FG002|Overall Study|AE due to other condition|15|||
94660765|NCT00099983|324211753|FG000|Overall Study|Incarcerated|0|||
94660766|NCT00099983|324211754|FG001|Overall Study|Incarcerated|1|||
94660767|NCT00099983|324211753|FG000|Overall Study|Intolerant of burden of visits|0|||
94600367|NCT00400153|323999176|FG000|Overall Study|Protocol Violation|7|||
94660768|NCT00099983|324211754|FG001|Overall Study|Intolerant of burden of visits|1|||
94660769|NCT00099983|324211753|FG000|Overall Study|Other issue|1|||
94660770|NCT00099983|324211754|FG001|Overall Study|Other issue|0|||
94660771|NCT02641080|324211755|FG000|Overall Study|Physician Decision|2|||
94600368|NCT00400153|323999177|FG001|Overall Study|Protocol Violation|4|||
94600369|NCT00400153|323999178|FG002|Overall Study|Protocol Violation|9|||
94600370|NCT00400153|323999176|FG000|Overall Study|Lost to Follow-up|2|||
94600371|NCT00400153|323999177|FG001|Overall Study|Lost to Follow-up|1|||
94600372|NCT00400153|323999178|FG002|Overall Study|Lost to Follow-up|4|||
94600373|NCT00400153|323999176|FG000|Overall Study|Withdrawal by Subject|12|||
94600374|NCT00400153|323999177|FG001|Overall Study|Withdrawal by Subject|11|||
94600375|NCT00400153|323999178|FG002|Overall Study|Withdrawal by Subject|10|||
94600376|NCT00400153|323999176|FG000|Overall Study|Other reasons - not mentioned above|8|||
94660772|NCT02641080|324211756|FG001|Overall Study|Physician Decision|0|||
94660773|NCT02641080|324211755|FG000|Overall Study|Withdrawal by Subject|0|||
94660774|NCT02641080|324211756|FG001|Overall Study|Withdrawal by Subject|1|||
94660775|NCT02641080|324211755|FG000|Overall Study|Rehab Center denied use of pumps|0|||
94660776|NCT02641080|324211756|FG001|Overall Study|Rehab Center denied use of pumps|3|||
94660777|NCT02641080|324211755|FG000|Overall Study|Lost to Follow-up|0|||
94660778|NCT02641080|324211756|FG001|Overall Study|Lost to Follow-up|3|||
94660779|NCT03021187|324211757|FG000|Overall Study|Death|0|||
94660780|NCT03021187|324211758|FG001|Overall Study|Death|0|||
94660781|NCT03021187|324211759|FG002|Overall Study|Death|3|||
94660782|NCT03021187|324211760|FG003|Overall Study|Death|0|||
94660783|NCT03021187|324211757|FG000|Overall Study|Withdrawal by Subject|0|||
94660784|NCT03021187|324211758|FG001|Overall Study|Withdrawal by Subject|6|||
94660785|NCT03021187|324211759|FG002|Overall Study|Withdrawal by Subject|2|||
94457885|NCT02980341|323465671|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
94600377|NCT00400153|323999177|FG001|Overall Study|Other reasons - not mentioned above|5|||
94660786|NCT03021187|324211760|FG003|Overall Study|Withdrawal by Subject|5|||
94660787|NCT03021187|324211757|FG000|Overall Study|Lost to Follow-up|10|||
94660788|NCT03021187|324211758|FG001|Overall Study|Lost to Follow-up|3|||
94660789|NCT03021187|324211759|FG002|Overall Study|Lost to Follow-up|1|||
94457886|NCT02980341|323465672|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
94600378|NCT00400153|323999178|FG002|Overall Study|Other reasons - not mentioned above|3|||
94600379|NCT00219544|323999179|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
94600380|NCT00219544|323999180|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
94600381|NCT00219544|323999179|FG000|Single Blind Treatment Period|Adverse Event|9|||
94660790|NCT03021187|324211760|FG003|Overall Study|Lost to Follow-up|4|||
94660791|NCT03283670|324211761|FG000|Placebo Gas|Withdrawal by Subject|2|||
94660792|NCT03283670|324211761|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
94600382|NCT00219544|323999180|FG001|Single Blind Treatment Period|Adverse Event|0|||
94600383|NCT00219544|323999179|FG000|Single Blind Treatment Period|Protocol Violation|4|||
94600384|NCT00219544|323999180|FG001|Single Blind Treatment Period|Protocol Violation|0|||
94600385|NCT00219544|323999179|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
94600386|NCT00219544|323999180|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
94600387|NCT00219544|323999179|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
94600388|NCT00219544|323999180|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
94600389|NCT00219544|323999179|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
94600390|NCT00219544|323999180|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
94600391|NCT01585584|323999185|FG000|Overall Study|Lack of Efficacy|1|||
94600392|NCT01585584|323999185|FG000|Overall Study|Withdrawal by Subject|1|||
94600393|NCT01585584|323999185|FG000|Overall Study|Physician Decision|2|||
94600394|NCT03036800|323999186|FG000|Overall Study|Protocol Violation|1|||
94600395|NCT03036800|323999187|FG001|Overall Study|Protocol Violation|0|||
94600396|NCT03036800|323999186|FG000|Overall Study|Non-compliance|1|||
94600397|NCT03036800|323999187|FG001|Overall Study|Non-compliance|0|||
94600398|NCT03036800|323999186|FG000|Overall Study|Lost to Follow-up|1|||
94600399|NCT03036800|323999187|FG001|Overall Study|Lost to Follow-up|0|||
94600400|NCT03036800|323999186|FG000|Overall Study|Death|1|||
94600401|NCT03036800|323999187|FG001|Overall Study|Death|0|||
94600402|NCT03036800|323999186|FG000|Overall Study|Tolerance|5|||
94600403|NCT03036800|323999187|FG001|Overall Study|Tolerance|0|||
94600404|NCT03036800|323999186|FG000|Overall Study|Unknown/no reason given|50|||
94600405|NCT03036800|323999187|FG001|Overall Study|Unknown/no reason given|39|||
94600406|NCT03603509|324000624|FG000|Overall Study|Lost to Follow-up|3|||
94600407|NCT03603509|324000625|FG001|Overall Study|Lost to Follow-up|4|||
94600408|NCT01527357|324000628|FG000|Overall Study|Death|8|||
94600409|NCT01527357|324000629|FG001|Overall Study|Death|2|||
94600410|NCT01527357|324000628|FG000|Overall Study|Lost to Follow-up|6|||
94600411|NCT01527357|324000629|FG001|Overall Study|Lost to Follow-up|4|||
94600412|NCT01527357|324000628|FG000|Overall Study|Withdrew Consent|1|||
94600413|NCT01527357|324000629|FG001|Overall Study|Withdrew Consent|1|||
94660793|NCT03283670|324211761|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
94660794|NCT05819749|324211762|FG000|Overall Study|Lost to Follow-up|1|||
94457887|NCT02980341|323465673|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
94248447|NCT00657020|322704837|FG000|PERIOD 1|Adverse Event|0|||
94248448|NCT00657020|322704838|FG001|PERIOD 1|Adverse Event|1|||
94248449|NCT02121301|322704839|FG000|Overall Study|Protocol Violation|1|||
94248450|NCT02121301|322704840|FG001|Overall Study|Protocol Violation|4|||
94248451|NCT02121301|322704841|FG002|Overall Study|Protocol Violation|1|||
94248452|NCT01879722|322704842|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
94248453|NCT01879722|322704843|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
94248454|NCT01879722|322704844|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
94248455|NCT01879722|322704845|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
94248456|NCT01879722|322704846|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
94248457|NCT01879722|322704847|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
94248458|NCT01879722|322704848|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
94248459|NCT01879722|322704849|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
94248460|NCT01879722|322704850|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
94248461|NCT01879722|322704851|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
94248462|NCT01879722|322704842|FG000|Overall Study|Voluntary Withdrawal|0|||
94248463|NCT01879722|322704843|FG001|Overall Study|Voluntary Withdrawal|0|||
94248464|NCT01879722|322704844|FG002|Overall Study|Voluntary Withdrawal|0|||
94248465|NCT01879722|322704845|FG003|Overall Study|Voluntary Withdrawal|0|||
94600414|NCT01527357|324000628|FG000|Overall Study|Non-compliance|0|||
94600415|NCT01527357|324000629|FG001|Overall Study|Non-compliance|1|||
94600416|NCT01527357|324000628|FG000|Overall Study|No Day 29 Visit|0|||
94600417|NCT01527357|324000629|FG001|Overall Study|No Day 29 Visit|1|||
94600418|NCT01527357|324000628|FG000|Overall Study|Did Not Receive Treatment|2|||
94600419|NCT01527357|324000629|FG001|Overall Study|Did Not Receive Treatment|0|||
94660795|NCT03268811|324213751|FG000|Overall Study|Adverse Event|0|||
94660796|NCT03268811|324213752|FG001|Overall Study|Adverse Event|1|||
94660797|NCT02819726|324213757|FG000|Part A (All Participants)|Lost to Follow-up|0|||
94660798|NCT02819726|324213758|FG001|Part A (All Participants)|Lost to Follow-up|1|||
94660799|NCT02819726|324213759|FG002|Part A (All Participants)|Lost to Follow-up|0|||
94660800|NCT02819726|324213760|FG003|Part A (All Participants)|Lost to Follow-up|0|||
94660801|NCT02819726|324213757|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
94660802|NCT02819726|324213758|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
94660803|NCT02819726|324213759|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
94660804|NCT02819726|324213760|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
94660805|NCT02819726|324213757|FG000|Part A (All Participants)|Protocol non-compliance|3|||
94660806|NCT02819726|324213758|FG001|Part A (All Participants)|Protocol non-compliance|4|||
94660807|NCT02819726|324213759|FG002|Part A (All Participants)|Protocol non-compliance|5|||
94660808|NCT02819726|324213760|FG003|Part A (All Participants)|Protocol non-compliance|0|||
94660809|NCT02819726|324213757|FG000|Part B (All Participants)|Lost to Follow-up|1|||
94660810|NCT02819726|324213758|FG001|Part B (All Participants)|Lost to Follow-up|1|||
94660811|NCT02819726|324213759|FG002|Part B (All Participants)|Lost to Follow-up|2|||
94660812|NCT02819726|324213760|FG003|Part B (All Participants)|Lost to Follow-up|2|||
94660813|NCT02819726|324213757|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
94660814|NCT02819726|324213758|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
94660815|NCT02819726|324213759|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
94660816|NCT02819726|324213760|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
94660817|NCT02819726|324213757|FG000|Part B (All Participants)|Protocol non-compliance|0|||
94660818|NCT02819726|324213758|FG001|Part B (All Participants)|Protocol non-compliance|0|||
94660819|NCT02819726|324213759|FG002|Part B (All Participants)|Protocol non-compliance|1|||
94660820|NCT02819726|324213760|FG003|Part B (All Participants)|Protocol non-compliance|0|||
94660821|NCT02613481|324213761|FG000|Overall Study|Lost to Follow-up|7|||
94660822|NCT02613481|324213761|FG000|Overall Study|Withdrawal by Subject|2|||
94660823|NCT00562159|324213766|FG000|Overall Study|Adverse Event|11|||
94660824|NCT00562159|324213767|FG001|Overall Study|Adverse Event|8|||
94660825|NCT00562159|324213766|FG000|Overall Study|Lost to Follow-up|5|||
94660826|NCT00562159|324213767|FG001|Overall Study|Lost to Follow-up|4|||
94660827|NCT00562159|324213766|FG000|Overall Study|Withdrawal by Subject|9|||
94660828|NCT00562159|324213767|FG001|Overall Study|Withdrawal by Subject|8|||
94660829|NCT00562159|324213766|FG000|Overall Study|Protocol Violation|12|||
94660830|NCT00562159|324213767|FG001|Overall Study|Protocol Violation|12|||
94660831|NCT00562159|324213766|FG000|Overall Study|Did not meet protocol eligibility|1|||
94600420|NCT01142089|324000630|FG000|Overall Study|Physician Decision|1|||
94660832|NCT00562159|324213767|FG001|Overall Study|Did not meet protocol eligibility|1|||
94660833|NCT01197950|324213772|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
94660834|NCT01197950|324213773|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
94660835|NCT01197950|324213774|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
94660836|NCT04831736|324213775|FG000|Overall Study|Withdrawal by Subject|0|||
94660837|NCT04831736|324213776|FG001|Overall Study|Withdrawal by Subject|1|||
94600421|NCT01142089|324000631|FG001|Overall Study|Physician Decision|0|||
94600422|NCT01142089|324000630|FG000|Overall Study|Withdrawal by Subject|1|||
94600423|NCT01142089|324000631|FG001|Overall Study|Withdrawal by Subject|2|||
94600424|NCT01142089|324000630|FG000|Overall Study|Use of prohibited medications|0|||
94600425|NCT01142089|324000631|FG001|Overall Study|Use of prohibited medications|1|||
94600426|NCT01142089|324000630|FG000|Overall Study|Noncompliance with study procedures|2|||
94600427|NCT01142089|324000631|FG001|Overall Study|Noncompliance with study procedures|1|||
94600428|NCT01142089|324000630|FG000|Overall Study|Patient required rescue medication|8|||
94600429|NCT01142089|324000631|FG001|Overall Study|Patient required rescue medication|17|||
94600430|NCT00910247|324000632|FG000|Overall Study|Adverse Event|15|||
94600431|NCT00910247|324000632|FG000|Overall Study|Death|2|||
94660838|NCT01205685|324213777|FG000|Overall Study|Disease Progression|10|||
94600432|NCT00910247|324000632|FG000|Overall Study|Lost to Follow-up|10|||
94600433|NCT00910247|324000632|FG000|Overall Study|Physician Decision|3|||
94600434|NCT00910247|324000632|FG000|Overall Study|Protocol Violation|10|||
94660839|NCT01205685|324213777|FG000|Overall Study|Withdrawal by Subject|1|||
94660840|NCT02862106|324213779|FG000|Overall Study|Adverse Event|4|||
94660841|NCT02862106|324213780|FG001|Overall Study|Adverse Event|0|||
94600435|NCT00910247|324000632|FG000|Overall Study|Withdrawal by Subject|25|||
94600436|NCT00910247|324000632|FG000|Overall Study|Not collected|4|||
94248466|NCT01879722|322704846|FG004|Overall Study|Voluntary Withdrawal|0|||
94248467|NCT01879722|322704847|FG005|Overall Study|Voluntary Withdrawal|0|||
94248468|NCT01879722|322704848|FG006|Overall Study|Voluntary Withdrawal|0|||
94600437|NCT01122394|324000633|FG000|Overall Study|Withdrawal by Subject|1|||
94600438|NCT01122394|324000634|FG001|Overall Study|Withdrawal by Subject|1|||
94600439|NCT01122394|324000633|FG000|Overall Study|Lost to Follow-up|2|||
94600440|NCT01122394|324000634|FG001|Overall Study|Lost to Follow-up|2|||
94600441|NCT01122394|324000633|FG000|Overall Study|Adverse Event|0|||
94600442|NCT01122394|324000634|FG001|Overall Study|Adverse Event|1|||
94600443|NCT03739242|324000635|FG000|Overall Study|Withdrawal by Subject|1|||
94600444|NCT03739242|324000636|FG001|Overall Study|Withdrawal by Subject|1|||
94600445|NCT03739242|324000635|FG000|Overall Study|Protocol Violation|0|||
94600446|NCT03739242|324000636|FG001|Overall Study|Protocol Violation|1|||
94600447|NCT02186301|324000637|FG000|Overall Study|Progressive Disease|7|||
94600448|NCT02186301|324000638|FG001|Overall Study|Progressive Disease|22|||
94600449|NCT02186301|324000639|FG002|Overall Study|Progressive Disease|27|||
94600450|NCT02186301|324000637|FG000|Overall Study|Adverse Event|5|||
94600451|NCT02186301|324000638|FG001|Overall Study|Adverse Event|5|||
94600452|NCT02186301|324000639|FG002|Overall Study|Adverse Event|5|||
94600453|NCT02186301|324000637|FG000|Overall Study|Death|1|||
94600454|NCT02186301|324000638|FG001|Overall Study|Death|0|||
94600455|NCT02186301|324000639|FG002|Overall Study|Death|0|||
94600456|NCT02186301|324000637|FG000|Overall Study|Withdrawal by Subject|5|||
94600457|NCT02186301|324000638|FG001|Overall Study|Withdrawal by Subject|1|||
94600458|NCT02186301|324000639|FG002|Overall Study|Withdrawal by Subject|3|||
94600459|NCT02186301|324000637|FG000|Overall Study|Physician Decision|1|||
94600460|NCT02186301|324000638|FG001|Overall Study|Physician Decision|0|||
94600461|NCT02186301|324000639|FG002|Overall Study|Physician Decision|1|||
94600462|NCT02186301|324000637|FG000|Overall Study|Study Terminated by Sponsor|1|||
94600463|NCT02186301|324000638|FG001|Overall Study|Study Terminated by Sponsor|0|||
94600464|NCT02186301|324000639|FG002|Overall Study|Study Terminated by Sponsor|11|||
94600465|NCT02186301|324000637|FG000|Overall Study|Protocol Deviation|0|||
94600466|NCT02186301|324000638|FG001|Overall Study|Protocol Deviation|2|||
94600467|NCT02186301|324000639|FG002|Overall Study|Protocol Deviation|0|||
94600468|NCT02186301|324000637|FG000|Overall Study|Missing|0|||
94600469|NCT02186301|324000638|FG001|Overall Study|Missing|0|||
94600470|NCT02186301|324000639|FG002|Overall Study|Missing|2|||
94600471|NCT02186301|324000637|FG000|Overall Study|Other|0|||
94600472|NCT02186301|324000638|FG001|Overall Study|Other|0|||
94600473|NCT02186301|324000639|FG002|Overall Study|Other|1|||
94600474|NCT04369924|324000640|FG000|Overall Study|Lost to Follow-up|302|||
94600475|NCT04369924|324000641|FG001|Overall Study|Lost to Follow-up|339|||
94600476|NCT03780400|324000642|FG000|Overall Study|Lost to Follow-up|5|||
94600477|NCT03780400|324000642|FG000|Overall Study|Withdrawal by Subject|2|||
94600478|NCT01653132|324000643|FG000|First Intervention|Protocol Violation|1|||
94600479|NCT01653132|324000644|FG001|First Intervention|Protocol Violation|0|||
94600480|NCT02554279|324000645|FG000|Overall Study|Adverse Event|2|||
94600481|NCT02554279|324000646|FG001|Overall Study|Adverse Event|5|||
94600482|NCT02554279|324000645|FG000|Overall Study|Lost to Follow-up|3|||
94600483|NCT02554279|324000646|FG001|Overall Study|Lost to Follow-up|2|||
94600484|NCT02554279|324000645|FG000|Overall Study|Withdrawal by Subject|6|||
94600485|NCT02554279|324000646|FG001|Overall Study|Withdrawal by Subject|4|||
94600486|NCT02554279|324000645|FG000|Overall Study|Protocol Violation|2|||
94600487|NCT02554279|324000646|FG001|Overall Study|Protocol Violation|1|||
94600488|NCT02554279|324000645|FG000|Overall Study|Other reason|19|||
94600489|NCT02554279|324000646|FG001|Overall Study|Other reason|6|||
94600490|NCT05463198|324000647|FG000|Overall Study|Withdrawal by Subject|19|||
94600491|NCT05463198|324000647|FG000|Overall Study|Procedure Notes Missing|18|||
94600492|NCT01944839|324000650|FG000|Overall Study|Physician Decision|2|||
94600493|NCT01944839|324000651|FG001|Overall Study|Physician Decision|2|||
94600494|NCT01944839|324000650|FG000|Overall Study|Protocol Violation|0|||
94600495|NCT01944839|324000651|FG001|Overall Study|Protocol Violation|1|||
94600496|NCT01944839|324000650|FG000|Overall Study|Adverse Event|10|||
94248469|NCT01879722|322704849|FG007|Overall Study|Voluntary Withdrawal|0|||
94600497|NCT01944839|324000651|FG001|Overall Study|Adverse Event|5|||
94600498|NCT01944839|324000650|FG000|Overall Study|Withdrawal by Subject|9|||
94600499|NCT01944839|324000651|FG001|Overall Study|Withdrawal by Subject|17|||
94600500|NCT01944839|324000650|FG000|Overall Study|Lost to Follow-up|1|||
94248470|NCT01879722|322704850|FG008|Overall Study|Voluntary Withdrawal|1|||
94600501|NCT01944839|324000651|FG001|Overall Study|Lost to Follow-up|0|||
94600502|NCT01944839|324000650|FG000|Overall Study|Subject non-compliance|0|||
94600503|NCT01944839|324000651|FG001|Overall Study|Subject non-compliance|3|||
94600504|NCT02915874|324000653|FG000|Overall Study|Lost to Follow-up|5|||
94600505|NCT02915874|324000654|FG001|Overall Study|Lost to Follow-up|4|||
94600506|NCT02915874|324000653|FG000|Overall Study|Withdrawal by Subject|1|||
94600507|NCT02915874|324000654|FG001|Overall Study|Withdrawal by Subject|1|||
94600508|NCT02915874|324000653|FG000|Overall Study|Started New Anxiety Medication|0|||
94600509|NCT02915874|324000654|FG001|Overall Study|Started New Anxiety Medication|1|||
94600510|NCT03915860|324000655|FG000|Overall Study|Adverse Event|3|||
94660842|NCT02862106|324213779|FG000|Overall Study|Protocol Violation|16|||
94660843|NCT02862106|324213780|FG001|Overall Study|Protocol Violation|1|||
94660844|NCT02862106|324213779|FG000|Overall Study|Lost to Follow-up|15|||
94660845|NCT02862106|324213780|FG001|Overall Study|Lost to Follow-up|5|||
94660846|NCT02862106|324213779|FG000|Overall Study|Withdrawal by Subject|2|||
94660847|NCT02862106|324213780|FG001|Overall Study|Withdrawal by Subject|0|||
94660848|NCT02862106|324213779|FG000|Overall Study|Subjects moved to other city|1|||
94660849|NCT02862106|324213780|FG001|Overall Study|Subjects moved to other city|0|||
94660850|NCT03434119|324213784|FG000|Overall Study|Randomized but not treated|1|||
94660851|NCT03434119|324213785|FG001|Overall Study|Randomized but not treated|0|||
94660852|NCT03434119|324213784|FG000|Overall Study|Adverse Event|1|||
94660853|NCT03434119|324213785|FG001|Overall Study|Adverse Event|0|||
94660854|NCT03434119|324213784|FG000|Overall Study|Poor Compliance to Protocol|0|||
94660855|NCT03434119|324213785|FG001|Overall Study|Poor Compliance to Protocol|1|||
94660856|NCT03434119|324213784|FG000|Overall Study|Study Terminated by Sponsor|91|||
94660857|NCT03434119|324213785|FG001|Overall Study|Study Terminated by Sponsor|102|||
94660858|NCT03434119|324213784|FG000|Overall Study|Withdrawal by Subject|7|||
94660859|NCT03434119|324213785|FG001|Overall Study|Withdrawal by Subject|5|||
94660860|NCT03434119|324213784|FG000|Overall Study|Other than specified|7|||
94660861|NCT03434119|324213785|FG001|Overall Study|Other than specified|5|||
94660862|NCT00320216|324213788|FG000|Overall Study|Adverse Event|0|||
94660863|NCT00320216|324213789|FG001|Overall Study|Adverse Event|6|||
94660864|NCT00320216|324213790|FG002|Overall Study|Adverse Event|0|||
94660865|NCT00320216|324213791|FG003|Overall Study|Adverse Event|2|||
94660866|NCT00320216|324213792|FG004|Overall Study|Adverse Event|2|||
94660867|NCT00320216|324213788|FG000|Overall Study|Lack of Efficacy|6|||
94600511|NCT03915860|324000655|FG000|Overall Study|Withdrawal by Subject|6|||
94600512|NCT03915860|324000655|FG000|Overall Study|Lost to Follow-up|2|||
94600513|NCT03915860|324000655|FG000|Overall Study|Other than specified|3|||
94600514|NCT03222492|324000657|FG000|Overall Study|Withdrawal by Subject|0|||
94600515|NCT03222492|324000658|FG001|Overall Study|Withdrawal by Subject|0|||
94600516|NCT03222492|324000659|FG002|Overall Study|Withdrawal by Subject|1|||
94600517|NCT03222492|324000660|FG003|Overall Study|Withdrawal by Subject|0|||
94600518|NCT03222492|324000657|FG000|Overall Study|COVID-19 related|0|||
94600519|NCT03222492|324000658|FG001|Overall Study|COVID-19 related|0|||
94600520|NCT03222492|324000659|FG002|Overall Study|COVID-19 related|1|||
94600521|NCT03222492|324000660|FG003|Overall Study|COVID-19 related|0|||
94600522|NCT04559529|324000664|FG000|First Intervention (1 Day)|Adverse Event|0|||
94600523|NCT04559529|324000665|FG001|First Intervention (1 Day)|Adverse Event|0|||
94600524|NCT04559529|324000666|FG002|First Intervention (1 Day)|Adverse Event|0|||
94600525|NCT04559529|324000667|FG003|First Intervention (1 Day)|Adverse Event|1|||
94600526|NCT04559529|324000664|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
94600527|NCT04559529|324000665|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
94600528|NCT04559529|324000666|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
94600529|NCT04559529|324000667|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
94600530|NCT04559529|324000664|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
94600531|NCT04559529|324000665|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
94600532|NCT04559529|324000666|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
94600533|NCT04559529|324000667|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
94600534|NCT00609362|324000668|FG000|Overall Study|Withdrawal by Subject|2|||
94600535|NCT00609362|324000669|FG001|Overall Study|Withdrawal by Subject|1|||
94600536|NCT00609362|324000668|FG000|Overall Study|Adverse Event|1|||
94600537|NCT00609362|324000669|FG001|Overall Study|Adverse Event|0|||
94600538|NCT01009281|324000672|FG000|Overall Study|Administrative problems|7|||
94600539|NCT05093790|324000673|FG000|Overall Study|Failure to meet continuation criteria|0|||
94600540|NCT05093790|324000674|FG001|Overall Study|Failure to meet continuation criteria|0|||
94600541|NCT05093790|324000675|FG002|Overall Study|Failure to meet continuation criteria|1|||
94660868|NCT00320216|324213789|FG001|Overall Study|Lack of Efficacy|2|||
94660869|NCT00320216|324213790|FG002|Overall Study|Lack of Efficacy|1|||
94600542|NCT05093790|324000676|FG003|Overall Study|Failure to meet continuation criteria|0|||
94600543|NCT05093790|324000673|FG000|Overall Study|Adverse Event|1|||
94600544|NCT05093790|324000674|FG001|Overall Study|Adverse Event|0|||
94600545|NCT05093790|324000675|FG002|Overall Study|Adverse Event|0|||
94600546|NCT05093790|324000676|FG003|Overall Study|Adverse Event|0|||
94600547|NCT01525901|324000677|FG000|Period 2: 12 Weeks|Adverse Event|0|||
94600548|NCT01525901|324000678|FG001|Period 2: 12 Weeks|Adverse Event|1|||
94600549|NCT01525901|324000679|FG002|Period 2: 12 Weeks|Adverse Event|0|||
94600550|NCT01525901|324000680|FG003|Period 2: 12 Weeks|Adverse Event|0|||
94600551|NCT01609478|324000682|FG000|Overall Study|Adverse Event|3|||
94600552|NCT01609478|324000683|FG001|Overall Study|Adverse Event|1|||
94660870|NCT00320216|324213791|FG003|Overall Study|Lack of Efficacy|0|||
94660871|NCT00320216|324213792|FG004|Overall Study|Lack of Efficacy|1|||
94660872|NCT00320216|324213788|FG000|Overall Study|Lost to Follow-up|3|||
94660873|NCT00320216|324213789|FG001|Overall Study|Lost to Follow-up|0|||
94660874|NCT00320216|324213790|FG002|Overall Study|Lost to Follow-up|0|||
94660875|NCT00320216|324213791|FG003|Overall Study|Lost to Follow-up|0|||
94600553|NCT01609478|324000684|FG002|Overall Study|Adverse Event|5|||
94600554|NCT01609478|324000682|FG000|Overall Study|Protocol Deviation|0|||
94248471|NCT01879722|322704851|FG009|Overall Study|Voluntary Withdrawal|0|||
94248472|NCT05398237|322704852|FG000|Overall Study|Withdrawal by Subject|1|||
94248473|NCT01253304|322704853|FG000|Overall Study|Adverse Event|0|||
94248474|NCT01253304|322704854|FG001|Overall Study|Adverse Event|0|||
94248475|NCT01253304|322704855|FG002|Overall Study|Adverse Event|0|||
94248476|NCT01253304|322704856|FG003|Overall Study|Adverse Event|1|||
94248477|NCT02580305|322704859|FG000|Overall Study|Adverse Event|15|||
94248478|NCT02580305|322704860|FG001|Overall Study|Adverse Event|19|||
94248479|NCT02580305|322704861|FG002|Overall Study|Adverse Event|10|||
94248480|NCT02580305|322704859|FG000|Overall Study|Lack of Efficacy|5|||
94248481|NCT02580305|322704860|FG001|Overall Study|Lack of Efficacy|0|||
94248482|NCT02580305|322704861|FG002|Overall Study|Lack of Efficacy|2|||
94248483|NCT02580305|322704859|FG000|Overall Study|Protocol Violation|4|||
94248484|NCT02580305|322704860|FG001|Overall Study|Protocol Violation|9|||
94248485|NCT02580305|322704861|FG002|Overall Study|Protocol Violation|6|||
94248486|NCT02580305|322704859|FG000|Overall Study|Lost to Follow-up|4|||
94356052|NCT00401726|323085786|FG000|Overall Study|Protocol Violation|6|||
94600555|NCT01609478|324000683|FG001|Overall Study|Protocol Deviation|1|||
94600556|NCT01609478|324000684|FG002|Overall Study|Protocol Deviation|1|||
94600557|NCT01609478|324000682|FG000|Overall Study|Non-Compliance with study treatment|1|||
94600558|NCT01609478|324000683|FG001|Overall Study|Non-Compliance with study treatment|0|||
94600559|NCT01609478|324000684|FG002|Overall Study|Non-Compliance with study treatment|0|||
94600560|NCT01609478|324000682|FG000|Overall Study|Physician Decision|1|||
94600561|NCT01609478|324000683|FG001|Overall Study|Physician Decision|0|||
94600562|NCT01609478|324000684|FG002|Overall Study|Physician Decision|1|||
94600563|NCT01609478|324000682|FG000|Overall Study|Withdrawal by Subject|2|||
94600564|NCT01609478|324000683|FG001|Overall Study|Withdrawal by Subject|0|||
94600565|NCT01609478|324000684|FG002|Overall Study|Withdrawal by Subject|2|||
94600566|NCT00924170|324000685|FG000|Overall Study|Refused further treatment|0|||
94600567|NCT00924170|324000686|FG001|Overall Study|Refused further treatment|1|||
94600568|NCT00924170|324000685|FG000|Overall Study|Physician Decision|0|||
94600569|NCT00924170|324000686|FG001|Overall Study|Physician Decision|1|||
94600570|NCT00924170|324000685|FG000|Overall Study|Progressive disease|3|||
94600571|NCT00924170|324000686|FG001|Overall Study|Progressive disease|6|||
94600572|NCT00924170|324000685|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
94600573|NCT00924170|324000686|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
94600574|NCT00924170|324000685|FG000|Overall Study|Death|1|||
94600575|NCT00924170|324000686|FG001|Overall Study|Death|0|||
94600576|NCT01056380|324000691|FG000|Overall Study|Lost to Follow-up|2|||
94600577|NCT01056380|324000692|FG001|Overall Study|Lost to Follow-up|3|||
94600578|NCT01624870|324000693|FG000|Overall Study|Death|19|||
94600579|NCT01624870|324000693|FG000|Overall Study|Withdrawal by Subject|1|||
94356053|NCT00401726|323085787|FG001|Overall Study|Protocol Violation|3|||
94356054|NCT00401726|323085786|FG000|Overall Study|Withdrawal by Subject|18|||
94356055|NCT00401726|323085787|FG001|Overall Study|Withdrawal by Subject|24|||
94356056|NCT00401726|323085786|FG000|Overall Study|Lack of Efficacy|4|||
94600580|NCT01624870|324000693|FG000|Overall Study|CoreValve not implanted|6|||
94248487|NCT02580305|322704860|FG001|Overall Study|Lost to Follow-up|4|||
94248488|NCT02580305|322704861|FG002|Overall Study|Lost to Follow-up|2|||
94248489|NCT02580305|322704859|FG000|Overall Study|Withdrawal by Subject|11|||
94248490|NCT02580305|322704860|FG001|Overall Study|Withdrawal by Subject|9|||
94248491|NCT02580305|322704861|FG002|Overall Study|Withdrawal by Subject|7|||
94248492|NCT02580305|322704859|FG000|Overall Study|Randomized in error and never treated|4|||
94600581|NCT01624870|324000693|FG000|Overall Study|Lost to follow up|1|||
94600582|NCT00768469|324000695|FG000|Overall Study|Adverse Event|0|||
94600583|NCT00768469|324000696|FG001|Overall Study|Adverse Event|2|||
94600584|NCT00768469|324000695|FG000|Overall Study|Disease Progression|3|||
94600585|NCT00768469|324000696|FG001|Overall Study|Disease Progression|4|||
94600586|NCT00768469|324000695|FG000|Overall Study|Withdrawal by Subject|0|||
94600587|NCT00768469|324000696|FG001|Overall Study|Withdrawal by Subject|1|||
94457888|NCT02980341|323465674|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
94457889|NCT02980341|323465675|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
94457890|NCT02980341|323465676|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
94457891|NCT02980341|323465677|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
94457892|NCT02980341|323465678|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
94457893|NCT02980341|323465679|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
94457894|NCT02980341|323465680|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
94457895|NCT02980341|323465681|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
94457896|NCT02980341|323465671|FG000|Dose Escalation|Clinical progression|0|||
94457897|NCT02980341|323465672|FG001|Dose Escalation|Clinical progression|0|||
94457898|NCT02980341|323465673|FG002|Dose Escalation|Clinical progression|2|||
94457899|NCT02980341|323465674|FG003|Dose Escalation|Clinical progression|1|||
94457900|NCT02980341|323465675|FG004|Dose Escalation|Clinical progression|0|||
94457901|NCT02980341|323465676|FG005|Dose Escalation|Clinical progression|0|||
94457902|NCT02980341|323465677|FG006|Dose Escalation|Clinical progression|0|||
94457903|NCT02980341|323465678|FG007|Dose Escalation|Clinical progression|0|||
94457904|NCT02980341|323465679|FG008|Dose Escalation|Clinical progression|0|||
94457905|NCT02980341|323465680|FG009|Dose Escalation|Clinical progression|0|||
94457906|NCT02980341|323465681|FG010|Dose Escalation|Clinical progression|0|||
94457907|NCT02980341|323465671|FG000|Dose Escalation|Adverse Event|0|||
94457908|NCT02980341|323465672|FG001|Dose Escalation|Adverse Event|0|||
94457909|NCT02980341|323465673|FG002|Dose Escalation|Adverse Event|1|||
94457910|NCT02980341|323465674|FG003|Dose Escalation|Adverse Event|2|||
94457911|NCT02980341|323465675|FG004|Dose Escalation|Adverse Event|2|||
94457912|NCT02980341|323465676|FG005|Dose Escalation|Adverse Event|0|||
94457913|NCT02980341|323465677|FG006|Dose Escalation|Adverse Event|0|||
94457914|NCT02980341|323465678|FG007|Dose Escalation|Adverse Event|0|||
94457915|NCT02980341|323465679|FG008|Dose Escalation|Adverse Event|0|||
94457916|NCT02980341|323465680|FG009|Dose Escalation|Adverse Event|0|||
94457917|NCT02980341|323465681|FG010|Dose Escalation|Adverse Event|0|||
94457918|NCT02980341|323465671|FG000|Dose Escalation|Withdrawal by Subject|0|||
94457919|NCT02980341|323465672|FG001|Dose Escalation|Withdrawal by Subject|0|||
94457920|NCT02980341|323465673|FG002|Dose Escalation|Withdrawal by Subject|1|||
94457921|NCT02980341|323465674|FG003|Dose Escalation|Withdrawal by Subject|0|||
94457922|NCT02980341|323465675|FG004|Dose Escalation|Withdrawal by Subject|0|||
94457923|NCT02980341|323465676|FG005|Dose Escalation|Withdrawal by Subject|0|||
94457924|NCT02980341|323465677|FG006|Dose Escalation|Withdrawal by Subject|0|||
94457925|NCT02980341|323465678|FG007|Dose Escalation|Withdrawal by Subject|0|||
94457926|NCT02980341|323465679|FG008|Dose Escalation|Withdrawal by Subject|0|||
94457927|NCT02980341|323465680|FG009|Dose Escalation|Withdrawal by Subject|0|||
94457928|NCT02980341|323465681|FG010|Dose Escalation|Withdrawal by Subject|0|||
94457929|NCT02980341|323465671|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
94457930|NCT02980341|323465672|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
94457931|NCT02980341|323465673|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
94457932|NCT02980341|323465674|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
94457933|NCT02980341|323465675|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
94457934|NCT02980341|323465676|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
94457935|NCT02980341|323465677|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
94457936|NCT02980341|323465678|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
94457937|NCT02980341|323465679|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
94457938|NCT02980341|323465680|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
94457939|NCT02980341|323465681|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
94457940|NCT02980341|323465671|FG000|Dose Escalation|Due to investigator's decision|0|||
94457941|NCT02980341|323465672|FG001|Dose Escalation|Due to investigator's decision|0|||
94457942|NCT02980341|323465673|FG002|Dose Escalation|Due to investigator's decision|0|||
94457943|NCT02980341|323465674|FG003|Dose Escalation|Due to investigator's decision|0|||
94457944|NCT02980341|323465675|FG004|Dose Escalation|Due to investigator's decision|1|||
94457945|NCT02980341|323465676|FG005|Dose Escalation|Due to investigator's decision|0|||
94457946|NCT02980341|323465677|FG006|Dose Escalation|Due to investigator's decision|0|||
94457947|NCT02980341|323465678|FG007|Dose Escalation|Due to investigator's decision|0|||
94457948|NCT02980341|323465679|FG008|Dose Escalation|Due to investigator's decision|0|||
94457949|NCT02980341|323465680|FG009|Dose Escalation|Due to investigator's decision|0|||
94457950|NCT02980341|323465681|FG010|Dose Escalation|Due to investigator's decision|0|||
94457951|NCT02980341|323465671|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
94457952|NCT02980341|323465672|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
94457953|NCT02980341|323465673|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
94457954|NCT02980341|323465674|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
94457955|NCT02980341|323465675|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
94457956|NCT02980341|323465676|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
94600588|NCT04971226|324000697|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
94600589|NCT04971226|324000698|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
94600590|NCT04971226|324000699|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
94600591|NCT04971226|324000700|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
94600592|NCT04971226|324000697|FG000|Overall Study|Adverse Event|6|||
94600593|NCT04971226|324000698|FG001|Overall Study|Adverse Event|5|||
94600594|NCT04971226|324000699|FG002|Overall Study|Adverse Event|11|||
94600595|NCT04971226|324000700|FG003|Overall Study|Adverse Event|10|||
94600596|NCT04971226|324000697|FG000|Overall Study|Progressive disease|2|||
94600597|NCT04971226|324000698|FG001|Overall Study|Progressive disease|0|||
94600598|NCT04971226|324000699|FG002|Overall Study|Progressive disease|3|||
94600599|NCT04971226|324000700|FG003|Overall Study|Progressive disease|1|||
94600600|NCT04971226|324000697|FG000|Overall Study|Protocol Deviation|1|||
94600601|NCT04971226|324000698|FG001|Overall Study|Protocol Deviation|0|||
94600602|NCT04971226|324000699|FG002|Overall Study|Protocol Deviation|1|||
94457957|NCT02980341|323465677|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
94600603|NCT04971226|324000700|FG003|Overall Study|Protocol Deviation|1|||
94600604|NCT04971226|324000697|FG000|Overall Study|Subject Decision|0|||
94600605|NCT04971226|324000698|FG001|Overall Study|Subject Decision|1|||
94600606|NCT04971226|324000699|FG002|Overall Study|Subject Decision|1|||
94600607|NCT04971226|324000700|FG003|Overall Study|Subject Decision|1|||
94600608|NCT04971226|324000697|FG000|Overall Study|Pregnancy|0|||
94600609|NCT04971226|324000698|FG001|Overall Study|Pregnancy|0|||
94600610|NCT04971226|324000699|FG002|Overall Study|Pregnancy|0|||
94600611|NCT04971226|324000700|FG003|Overall Study|Pregnancy|1|||
94600612|NCT04971226|324000697|FG000|Overall Study|Participants not treated|1|||
94600613|NCT04971226|324000698|FG001|Overall Study|Participants not treated|0|||
94600614|NCT04971226|324000699|FG002|Overall Study|Participants not treated|2|||
94600615|NCT04971226|324000700|FG003|Overall Study|Participants not treated|1|||
94600616|NCT02217527|324000701|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
94600617|NCT02217527|324000702|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
94600618|NCT02217527|324000701|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
94600619|NCT02217527|324000702|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
94600620|NCT02650921|324000703|FG000|Overall Study|Withdrawal by Subject|4|||
94600621|NCT02650921|324000703|FG000|Overall Study|Lost to Follow-up|2|||
94600622|NCT02650921|324000703|FG000|Overall Study|Adverse Event|1|||
94600623|NCT02650921|324000703|FG000|Overall Study|Due to Medical Condition|1|||
94600624|NCT02581943|324000704|FG000|Overall Study|Death|5|||
94600625|NCT02581943|324000705|FG001|Overall Study|Death|2|||
94600626|NCT02581943|324000704|FG000|Overall Study|Disease Progression|12|||
94600627|NCT02581943|324000705|FG001|Overall Study|Disease Progression|15|||
94600628|NCT02581943|324000704|FG000|Overall Study|Withdrawal by Subject|1|||
94600629|NCT02581943|324000705|FG001|Overall Study|Withdrawal by Subject|2|||
94600630|NCT01007253|324000706|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
94600631|NCT01007253|324000707|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
94600632|NCT01007253|324000708|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
94600633|NCT01007253|324000709|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
94600634|NCT00814801|324000710|FG000|Overall Study|Adverse Event|15|||
94600635|NCT00814801|324000711|FG001|Overall Study|Adverse Event|16|||
94600636|NCT00814801|324000712|FG002|Overall Study|Adverse Event|19|||
94600637|NCT00814801|324000710|FG000|Overall Study|Withdrawal by Subject|9|||
94600638|NCT00814801|324000711|FG001|Overall Study|Withdrawal by Subject|11|||
94600639|NCT00814801|324000712|FG002|Overall Study|Withdrawal by Subject|14|||
94600640|NCT00814801|324000710|FG000|Overall Study|Inappropriate as a subject|1|||
94600641|NCT00814801|324000711|FG001|Overall Study|Inappropriate as a subject|1|||
94600642|NCT00814801|324000712|FG002|Overall Study|Inappropriate as a subject|1|||
94600643|NCT00814801|324000710|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
94600644|NCT00814801|324000711|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
94600645|NCT00814801|324000712|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
94600646|NCT00814801|324000710|FG000|Overall Study|Missing or change of caregiver|6|||
94600647|NCT00814801|324000711|FG001|Overall Study|Missing or change of caregiver|2|||
94600648|NCT00814801|324000712|FG002|Overall Study|Missing or change of caregiver|4|||
94600649|NCT00814801|324000710|FG000|Overall Study|Non-compliance|0|||
94600650|NCT00814801|324000711|FG001|Overall Study|Non-compliance|1|||
94600651|NCT00814801|324000712|FG002|Overall Study|Non-compliance|1|||
94600652|NCT00814801|324000710|FG000|Overall Study|Other|2|||
94600653|NCT00814801|324000711|FG001|Overall Study|Other|6|||
94600654|NCT00814801|324000712|FG002|Overall Study|Other|4|||
94600655|NCT04221230|324000715|FG000|Overall Study|Lost to Follow-up|12|||
94600656|NCT04221230|324000716|FG001|Overall Study|Lost to Follow-up|12|||
94600657|NCT04221230|324000715|FG000|Overall Study|Protocol Violation|2|||
94600658|NCT04221230|324000716|FG001|Overall Study|Protocol Violation|2|||
94600659|NCT04221230|324000715|FG000|Overall Study|Adverse Event|0|||
94600660|NCT04221230|324000716|FG001|Overall Study|Adverse Event|8|||
94600661|NCT04221230|324000715|FG000|Overall Study|Physician Decision|1|||
94600662|NCT04221230|324000716|FG001|Overall Study|Physician Decision|0|||
94600663|NCT04221230|324000715|FG000|Overall Study|Withdrawal by Subject|13|||
94600664|NCT04221230|324000716|FG001|Overall Study|Withdrawal by Subject|11|||
94600665|NCT04221230|324000715|FG000|Overall Study|Non-Compliance with Study Drug|1|||
94600666|NCT04221230|324000716|FG001|Overall Study|Non-Compliance with Study Drug|1|||
94600667|NCT04221230|324000715|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
94600668|NCT04221230|324000716|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
94600669|NCT04221230|324000715|FG000|Overall Study|Pregnancy|0|||
94600670|NCT04221230|324000716|FG001|Overall Study|Pregnancy|1|||
94600671|NCT04221230|324000715|FG000|Overall Study|Other|1|||
94600672|NCT04221230|324000716|FG001|Overall Study|Other|2|||
94600673|NCT00527488|324000727|FG000|Overall Study|Withdrawn prior to dosing|0|||
94600674|NCT00527488|324000728|FG001|Overall Study|Withdrawn prior to dosing|1|||
94600675|NCT00527488|324000729|FG002|Overall Study|Withdrawn prior to dosing|1|||
94600676|NCT00527488|324000730|FG003|Overall Study|Withdrawn prior to dosing|0|||
94600677|NCT00829933|324000731|FG000|Overall Study|Adverse Event|2|||
94600678|NCT00829933|324000732|FG001|Overall Study|Adverse Event|3|||
94600679|NCT00829933|324000733|FG002|Overall Study|Adverse Event|2|||
94600680|NCT00829933|324000734|FG003|Overall Study|Adverse Event|1|||
94600681|NCT00829933|324000731|FG000|Overall Study|Death|0|||
94600682|NCT00829933|324000732|FG001|Overall Study|Death|0|||
94600683|NCT00829933|324000733|FG002|Overall Study|Death|1|||
94600684|NCT00829933|324000734|FG003|Overall Study|Death|1|||
94600685|NCT00829933|324000731|FG000|Overall Study|Lack of Efficacy|0|||
94600686|NCT00829933|324000732|FG001|Overall Study|Lack of Efficacy|1|||
94600687|NCT00829933|324000733|FG002|Overall Study|Lack of Efficacy|0|||
94600688|NCT00829933|324000734|FG003|Overall Study|Lack of Efficacy|0|||
94600689|NCT00829933|324000731|FG000|Overall Study|Physician Decision|5|||
94600690|NCT00829933|324000732|FG001|Overall Study|Physician Decision|7|||
94600691|NCT00829933|324000733|FG002|Overall Study|Physician Decision|8|||
94600692|NCT00829933|324000734|FG003|Overall Study|Physician Decision|1|||
94600693|NCT00829933|324000731|FG000|Overall Study|Pregnancy|0|||
94600694|NCT00829933|324000732|FG001|Overall Study|Pregnancy|0|||
94600695|NCT00829933|324000733|FG002|Overall Study|Pregnancy|0|||
94600696|NCT00829933|324000734|FG003|Overall Study|Pregnancy|2|||
94600697|NCT00829933|324000731|FG000|Overall Study|Protocol Violation|2|||
94600698|NCT00829933|324000732|FG001|Overall Study|Protocol Violation|1|||
94600699|NCT00829933|324000733|FG002|Overall Study|Protocol Violation|0|||
94600700|NCT00829933|324000734|FG003|Overall Study|Protocol Violation|0|||
94600701|NCT00829933|324000731|FG000|Overall Study|withdrew before treatment started|5|||
94600702|NCT00829933|324000732|FG001|Overall Study|withdrew before treatment started|1|||
94600703|NCT00829933|324000733|FG002|Overall Study|withdrew before treatment started|2|||
94600704|NCT00829933|324000734|FG003|Overall Study|withdrew before treatment started|9|||
94600705|NCT01077154|324000735|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
94600706|NCT01077154|324000736|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
94600707|NCT01077154|324000735|FG000|Overall Study|Withdrawal by Subject|369|||
94600708|NCT01077154|324000736|FG001|Overall Study|Withdrawal by Subject|385|||
94600709|NCT01077154|324000735|FG000|Overall Study|Death|215|||
94600710|NCT01077154|324000736|FG001|Overall Study|Death|214|||
94600711|NCT01077154|324000735|FG000|Overall Study|Lost to Follow-up|43|||
94600712|NCT01077154|324000736|FG001|Overall Study|Lost to Follow-up|35|||
94600713|NCT01077154|324000735|FG000|Overall Study|Noncompliance|22|||
94600714|NCT01077154|324000736|FG001|Overall Study|Noncompliance|20|||
94600715|NCT01077154|324000735|FG000|Overall Study|Disease Progression|18|||
94600716|NCT01077154|324000736|FG001|Overall Study|Disease Progression|20|||
94600717|NCT01077154|324000735|FG000|Overall Study|Ineligibility Determined|10|||
94600718|NCT01077154|324000736|FG001|Overall Study|Ineligibility Determined|14|||
94600719|NCT01077154|324000735|FG000|Overall Study|Other|14|||
94600720|NCT01077154|324000736|FG001|Overall Study|Other|11|||
94600721|NCT01077154|324000735|FG000|Overall Study|Adverse Event|9|||
94600722|NCT01077154|324000736|FG001|Overall Study|Adverse Event|9|||
94600723|NCT01077154|324000735|FG000|Overall Study|Administrative Decision|1|||
94600724|NCT01077154|324000736|FG001|Overall Study|Administrative Decision|6|||
94600725|NCT01077154|324000735|FG000|Overall Study|Protocol Deviation|1|||
94600726|NCT01077154|324000736|FG001|Overall Study|Protocol Deviation|0|||
94600727|NCT00604214|324000737|FG000|Baseline to Day 28|Death|223|||
94600728|NCT00604214|324000738|FG001|Baseline to Day 28|Death|202|||
94600729|NCT00604214|324000737|FG000|Baseline to Day 28|Lost to Follow-up|2|||
94600730|NCT00604214|324000738|FG001|Baseline to Day 28|Lost to Follow-up|4|||
94600731|NCT00604214|324000737|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
94600732|NCT00604214|324000738|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
94600733|NCT00604214|324000737|FG000|Day 29 to Day 90|Death|64|||
94457958|NCT02980341|323465678|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
94457959|NCT02980341|323465679|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
94600734|NCT00604214|324000738|FG001|Day 29 to Day 90|Death|67|||
94600735|NCT00604214|324000737|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
94600736|NCT00604214|324000738|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
94600737|NCT00604214|324000737|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
94600738|NCT00604214|324000738|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
94600739|NCT00604214|324000737|FG000|Day 91 to Day 180|Death|19|||
94600740|NCT00604214|324000738|FG001|Day 91 to Day 180|Death|23|||
94660876|NCT00320216|324213792|FG004|Overall Study|Lost to Follow-up|0|||
94660877|NCT00320216|324213788|FG000|Overall Study|Other|7|||
94660878|NCT00320216|324213789|FG001|Overall Study|Other|2|||
94660879|NCT00320216|324213790|FG002|Overall Study|Other|5|||
94660880|NCT00320216|324213791|FG003|Overall Study|Other|1|||
94660881|NCT00320216|324213792|FG004|Overall Study|Other|3|||
94660882|NCT00779246|324213798|FG000|Overall Study|Missing sufficient data for analysis|33|||
94660883|NCT00779246|324213799|FG001|Overall Study|Missing sufficient data for analysis|53|||
94660884|NCT00148343|324213802|FG000|Overall Study|Withdrawal by Subject|12|||
94660885|NCT00148343|324213803|FG001|Overall Study|Withdrawal by Subject|7|||
94660886|NCT00148343|324213802|FG000|Overall Study|Physician Decision|3|||
94660887|NCT00148343|324213803|FG001|Overall Study|Physician Decision|4|||
94660888|NCT03465540|324213806|FG000|Overall Study|Withdrawal by Subject|0|||
94600741|NCT00604214|324000737|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
94600742|NCT00604214|324000738|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
94600743|NCT00604214|324000737|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
94600744|NCT00604214|324000738|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
94600745|NCT04030026|324000739|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
94600746|NCT04030026|324000740|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
94600747|NCT04030026|324000739|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
94600748|NCT04030026|324000740|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
94600749|NCT04030026|324000739|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
94600750|NCT04030026|324000740|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
94600751|NCT04030026|324000739|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
94600752|NCT04030026|324000740|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
94600753|NCT04030026|324000739|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
94600754|NCT04030026|324000740|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
94600755|NCT04030026|324000739|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
94600756|NCT04030026|324000740|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
94600757|NCT04030026|324000739|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
94600758|NCT04030026|324000740|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
94600759|NCT00491556|324000741|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
94600760|NCT00491556|324000742|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
94600761|NCT00491556|324000741|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
94600762|NCT00491556|324000742|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
94600763|NCT00491556|324000741|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
94600764|NCT00491556|324000742|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
94600765|NCT00491556|324000741|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
94600766|NCT00491556|324000742|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
94600767|NCT00491556|324000741|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
94600768|NCT00491556|324000742|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
94600769|NCT00491556|324000741|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
94600770|NCT00491556|324000742|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
94600771|NCT00491556|324000741|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
94600772|NCT00491556|324000742|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
94600773|NCT00491556|324000741|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
94600774|NCT00491556|324000742|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
94600775|NCT00491556|324000741|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
94600776|NCT00491556|324000742|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
94600777|NCT00491556|324000741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
94660889|NCT03465540|324213807|FG001|Overall Study|Withdrawal by Subject|0|||
94660890|NCT03465540|324213808|FG002|Overall Study|Withdrawal by Subject|1|||
94600778|NCT00491556|324000742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
94600779|NCT00491556|324000741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
94600780|NCT00491556|324000742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
94660891|NCT03465540|324213809|FG003|Overall Study|Withdrawal by Subject|1|||
94660892|NCT03465540|324213810|FG004|Overall Study|Withdrawal by Subject|1|||
94660893|NCT03465540|324213811|FG005|Overall Study|Withdrawal by Subject|0|||
94660894|NCT03465540|324213806|FG000|Overall Study|Lost to Follow-up|0|||
94660895|NCT03465540|324213807|FG001|Overall Study|Lost to Follow-up|1|||
94660896|NCT03465540|324213808|FG002|Overall Study|Lost to Follow-up|0|||
94660897|NCT03465540|324213809|FG003|Overall Study|Lost to Follow-up|0|||
94660898|NCT03465540|324213810|FG004|Overall Study|Lost to Follow-up|1|||
94660899|NCT03465540|324213811|FG005|Overall Study|Lost to Follow-up|0|||
94660900|NCT03465540|324213806|FG000|Overall Study|Death|1|||
94660901|NCT03465540|324213807|FG001|Overall Study|Death|1|||
94660902|NCT03465540|324213808|FG002|Overall Study|Death|0|||
94660903|NCT03465540|324213809|FG003|Overall Study|Death|2|||
94660904|NCT03465540|324213810|FG004|Overall Study|Death|0|||
94660905|NCT03465540|324213811|FG005|Overall Study|Death|2|||
94660906|NCT03465540|324213806|FG000|Overall Study|Protocol specified criteria|0|||
94660907|NCT03465540|324213807|FG001|Overall Study|Protocol specified criteria|2|||
94660908|NCT03465540|324213808|FG002|Overall Study|Protocol specified criteria|2|||
94660909|NCT03465540|324213809|FG003|Overall Study|Protocol specified criteria|0|||
94660910|NCT03465540|324213810|FG004|Overall Study|Protocol specified criteria|2|||
94660911|NCT03465540|324213811|FG005|Overall Study|Protocol specified criteria|0|||
94660912|NCT00736996|324213813|FG000|Overall Study|Lost to Follow-up|1|||
94660913|NCT00736996|324213814|FG001|Overall Study|Lost to Follow-up|9|||
94660914|NCT00736996|324213815|FG002|Overall Study|Lost to Follow-up|2|||
94660915|NCT03713593|324213816|FG000|Overall Study|Participants Ongoing|140|||
94660916|NCT03713593|324213817|FG001|Overall Study|Participants Ongoing|114|||
94600781|NCT00491556|324000741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
94600782|NCT00491556|324000742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
94600783|NCT00491556|324000741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
94600784|NCT00491556|324000742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
94600785|NCT00491556|324000741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
94600786|NCT00491556|324000742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
94600787|NCT00491556|324000741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
94600788|NCT00491556|324000742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
94600789|NCT00491556|324000741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
94600790|NCT00491556|324000742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
94600791|NCT00491556|324000741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
94660917|NCT03713593|324213816|FG000|Overall Study|Withdrawal by Subject|3|||
94660918|NCT03713593|324213817|FG001|Overall Study|Withdrawal by Subject|6|||
94660919|NCT03713593|324213816|FG000|Overall Study|Death|252|||
94660920|NCT03713593|324213817|FG001|Overall Study|Death|279|||
94660921|NCT01040130|324213819|FG000|Overall Study|Adverse Event|1|||
94660922|NCT01040130|324213820|FG001|Overall Study|Adverse Event|1|||
94660923|NCT01040130|324213821|FG002|Overall Study|Adverse Event|0|||
94660924|NCT01040130|324213822|FG003|Overall Study|Adverse Event|5|||
94660925|NCT01040130|324213823|FG004|Overall Study|Adverse Event|0|||
94660926|NCT01040130|324213824|FG005|Overall Study|Adverse Event|3|||
94660927|NCT01040130|324213819|FG000|Overall Study|Protocol Violation|0|||
94660928|NCT01040130|324213820|FG001|Overall Study|Protocol Violation|0|||
94660929|NCT01040130|324213821|FG002|Overall Study|Protocol Violation|2|||
94660930|NCT01040130|324213822|FG003|Overall Study|Protocol Violation|0|||
94660931|NCT01040130|324213823|FG004|Overall Study|Protocol Violation|0|||
94660932|NCT01040130|324213824|FG005|Overall Study|Protocol Violation|0|||
94660933|NCT01040130|324213819|FG000|Overall Study|Withdrawal by Subject|0|||
94660934|NCT01040130|324213820|FG001|Overall Study|Withdrawal by Subject|2|||
94660935|NCT01040130|324213821|FG002|Overall Study|Withdrawal by Subject|0|||
94660936|NCT01040130|324213822|FG003|Overall Study|Withdrawal by Subject|0|||
94660937|NCT01040130|324213823|FG004|Overall Study|Withdrawal by Subject|0|||
94660938|NCT01040130|324213824|FG005|Overall Study|Withdrawal by Subject|1|||
94660939|NCT01040130|324213819|FG000|Overall Study|Other reasons not listed above|2|||
94660940|NCT01040130|324213820|FG001|Overall Study|Other reasons not listed above|0|||
94660941|NCT01040130|324213821|FG002|Overall Study|Other reasons not listed above|0|||
94660942|NCT01040130|324213822|FG003|Overall Study|Other reasons not listed above|0|||
94660943|NCT01040130|324213823|FG004|Overall Study|Other reasons not listed above|0|||
94600792|NCT00491556|324000742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
94600793|NCT00491556|324000741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
94660944|NCT01040130|324213824|FG005|Overall Study|Other reasons not listed above|0|||
94660945|NCT03207750|324213826|FG000|Overall Study|Adverse Event|3|||
94660946|NCT03207750|324213827|FG001|Overall Study|Adverse Event|2|||
94660947|NCT03207750|324213826|FG000|Overall Study|Lost to Follow-up|21|||
94660948|NCT03207750|324213827|FG001|Overall Study|Lost to Follow-up|29|||
94660949|NCT03207750|324213826|FG000|Overall Study|Protocol Violation|0|||
94660950|NCT03207750|324213827|FG001|Overall Study|Protocol Violation|1|||
94660951|NCT03207750|324213826|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
94660952|NCT03207750|324213827|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
94660953|NCT03207750|324213826|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
94660954|NCT03207750|324213827|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
94660955|NCT03207750|324213826|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
94660956|NCT03207750|324213827|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
94600794|NCT00491556|324000742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
94600795|NCT00491556|324000741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
94600796|NCT00491556|324000742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
94600797|NCT00491556|324000741|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
94600798|NCT00491556|324000742|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
94600799|NCT00782795|324000743|FG000|Overall Study|Withdrawal by Subject|1|||
94600800|NCT00782795|324000744|FG001|Overall Study|Withdrawal by Subject|2|||
94600801|NCT04158648|324000745|FG000|Overall Study|Ongoing in the Study|69|||
94600802|NCT04158648|324000745|FG000|Overall Study|Withdrawal by Subject|4|||
94600803|NCT02418156|324000746|FG000|Overall Study|Lost to Follow-up|12|||
94600804|NCT02418156|324000746|FG000|Overall Study|Death|2|||
94600805|NCT02418156|324000746|FG000|Overall Study|Physician Decision|1|||
94600806|NCT02418156|324000746|FG000|Overall Study|Withdrawal by Subject|1|||
94600807|NCT02418156|324000746|FG000|Overall Study|Subject refused to return|1|||
94600808|NCT00993044|324000747|FG000|Irinotecan 50 mg|Physician Decision|1|||
94600809|NCT03468543|324002381|FG000|Overall Study|Protocol stopping rules met|3|||
94600810|NCT00470158|324002382|FG000|Overall Study|Death|0|||
94600811|NCT00470158|324002383|FG001|Overall Study|Death|0|||
94600812|NCT00470158|324002384|FG002|Overall Study|Death|0|||
94600813|NCT00470158|324002385|FG003|Overall Study|Death|0|||
94600814|NCT00470158|324002386|FG004|Overall Study|Death|2|||
94600815|NCT00470158|324002382|FG000|Overall Study|Lost to Follow-up|7|||
94600816|NCT00470158|324002383|FG001|Overall Study|Lost to Follow-up|8|||
94600817|NCT00470158|324002384|FG002|Overall Study|Lost to Follow-up|8|||
94600818|NCT00470158|324002385|FG003|Overall Study|Lost to Follow-up|5|||
94600819|NCT00470158|324002386|FG004|Overall Study|Lost to Follow-up|4|||
94600820|NCT00470158|324002382|FG000|Overall Study|Protocol Violation|1|||
94600821|NCT00470158|324002383|FG001|Overall Study|Protocol Violation|0|||
94600822|NCT00470158|324002384|FG002|Overall Study|Protocol Violation|0|||
94600823|NCT00470158|324002385|FG003|Overall Study|Protocol Violation|0|||
94600824|NCT00470158|324002386|FG004|Overall Study|Protocol Violation|0|||
94600825|NCT02038829|324002391|FG000|Washout Period 1|Death|0|||
94600826|NCT02038829|324002392|FG001|Washout Period 1|Death|0|||
94600827|NCT02038829|324002393|FG002|Washout Period 1|Death|0|||
94600828|NCT02038829|324002394|FG003|Washout Period 1|Death|0|||
94600829|NCT02038829|324002395|FG004|Washout Period 1|Death|1|||
94600830|NCT02038829|324002396|FG005|Washout Period 1|Death|0|||
94600831|NCT02038829|324002397|FG006|Washout Period 1|Death|0|||
94600832|NCT02038829|324002398|FG007|Washout Period 1|Death|0|||
94600833|NCT02038829|324002399|FG008|Washout Period 1|Death|0|||
94600834|NCT02038829|324002400|FG009|Washout Period 1|Death|0|||
94600835|NCT02038829|324002401|FG010|Washout Period 1|Death|0|||
94600836|NCT02038829|324002402|FG011|Washout Period 1|Death|0|||
94600837|NCT02038829|324002391|FG000|Treatment Period 2|Adverse Event|0|||
94600838|NCT02038829|324002392|FG001|Treatment Period 2|Adverse Event|0|||
94600839|NCT02038829|324002393|FG002|Treatment Period 2|Adverse Event|0|||
94600840|NCT02038829|324002394|FG003|Treatment Period 2|Adverse Event|0|||
94600841|NCT02038829|324002395|FG004|Treatment Period 2|Adverse Event|0|||
94600842|NCT02038829|324002396|FG005|Treatment Period 2|Adverse Event|0|||
94600843|NCT02038829|324002397|FG006|Treatment Period 2|Adverse Event|0|||
94600844|NCT02038829|324002398|FG007|Treatment Period 2|Adverse Event|0|||
94600845|NCT02038829|324002399|FG008|Treatment Period 2|Adverse Event|0|||
94600846|NCT02038829|324002400|FG009|Treatment Period 2|Adverse Event|0|||
94600847|NCT02038829|324002401|FG010|Treatment Period 2|Adverse Event|1|||
94600848|NCT02038829|324002402|FG011|Treatment Period 2|Adverse Event|0|||
94600849|NCT02038829|324002391|FG000|Treatment Period 2|Withdrawal by Subject|1|||
94600850|NCT02038829|324002392|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94600851|NCT02038829|324002393|FG002|Treatment Period 2|Withdrawal by Subject|0|||
94600852|NCT02038829|324002394|FG003|Treatment Period 2|Withdrawal by Subject|0|||
94600853|NCT02038829|324002395|FG004|Treatment Period 2|Withdrawal by Subject|0|||
94660957|NCT03207750|324213826|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
94600854|NCT02038829|324002396|FG005|Treatment Period 2|Withdrawal by Subject|0|||
94600855|NCT02038829|324002397|FG006|Treatment Period 2|Withdrawal by Subject|0|||
94600856|NCT02038829|324002398|FG007|Treatment Period 2|Withdrawal by Subject|0|||
94600857|NCT02038829|324002399|FG008|Treatment Period 2|Withdrawal by Subject|0|||
94600858|NCT02038829|324002400|FG009|Treatment Period 2|Withdrawal by Subject|0|||
94600859|NCT02038829|324002401|FG010|Treatment Period 2|Withdrawal by Subject|0|||
94600860|NCT02038829|324002402|FG011|Treatment Period 2|Withdrawal by Subject|0|||
94600861|NCT02038829|324002391|FG000|Washout Period 2|Adverse Event|0|||
94600862|NCT02038829|324002392|FG001|Washout Period 2|Adverse Event|0|||
94600863|NCT02038829|324002393|FG002|Washout Period 2|Adverse Event|0|||
94600864|NCT02038829|324002394|FG003|Washout Period 2|Adverse Event|0|||
94600865|NCT02038829|324002395|FG004|Washout Period 2|Adverse Event|0|||
94600866|NCT02038829|324002396|FG005|Washout Period 2|Adverse Event|0|||
94660958|NCT03207750|324213827|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
94600867|NCT02038829|324002397|FG006|Washout Period 2|Adverse Event|0|||
94600868|NCT02038829|324002398|FG007|Washout Period 2|Adverse Event|0|||
94600869|NCT02038829|324002399|FG008|Washout Period 2|Adverse Event|1|||
94600870|NCT02038829|324002400|FG009|Washout Period 2|Adverse Event|0|||
94356057|NCT00401726|323085787|FG001|Overall Study|Lack of Efficacy|6|||
94600871|NCT02038829|324002401|FG010|Washout Period 2|Adverse Event|0|||
94600872|NCT02038829|324002402|FG011|Washout Period 2|Adverse Event|0|||
94600873|NCT02038829|324002391|FG000|Washout Period 2|Withdrawal by Subject|0|||
94600874|NCT02038829|324002392|FG001|Washout Period 2|Withdrawal by Subject|0|||
94600875|NCT02038829|324002393|FG002|Washout Period 2|Withdrawal by Subject|0|||
94600876|NCT02038829|324002394|FG003|Washout Period 2|Withdrawal by Subject|0|||
94600877|NCT02038829|324002395|FG004|Washout Period 2|Withdrawal by Subject|0|||
94600878|NCT02038829|324002396|FG005|Washout Period 2|Withdrawal by Subject|1|||
94600879|NCT02038829|324002397|FG006|Washout Period 2|Withdrawal by Subject|0|||
94600880|NCT02038829|324002398|FG007|Washout Period 2|Withdrawal by Subject|0|||
94600881|NCT02038829|324002399|FG008|Washout Period 2|Withdrawal by Subject|0|||
94600882|NCT02038829|324002400|FG009|Washout Period 2|Withdrawal by Subject|0|||
94600883|NCT02038829|324002401|FG010|Washout Period 2|Withdrawal by Subject|0|||
94600884|NCT02038829|324002402|FG011|Washout Period 2|Withdrawal by Subject|0|||
94600885|NCT02038829|324002391|FG000|Treatment Period 4|Adverse Event|0|||
94600886|NCT02038829|324002392|FG001|Treatment Period 4|Adverse Event|1|||
94600887|NCT02038829|324002393|FG002|Treatment Period 4|Adverse Event|0|||
94600888|NCT02038829|324002394|FG003|Treatment Period 4|Adverse Event|0|||
94600889|NCT02038829|324002395|FG004|Treatment Period 4|Adverse Event|0|||
94600890|NCT02038829|324002396|FG005|Treatment Period 4|Adverse Event|0|||
94600891|NCT02038829|324002397|FG006|Treatment Period 4|Adverse Event|0|||
94600892|NCT02038829|324002398|FG007|Treatment Period 4|Adverse Event|0|||
94600893|NCT02038829|324002399|FG008|Treatment Period 4|Adverse Event|0|||
94600894|NCT02038829|324002400|FG009|Treatment Period 4|Adverse Event|0|||
94600895|NCT02038829|324002401|FG010|Treatment Period 4|Adverse Event|0|||
94600896|NCT02038829|324002402|FG011|Treatment Period 4|Adverse Event|0|||
94600897|NCT02038829|324002391|FG000|Washout Period 4|Adverse Event|0|||
94600898|NCT02038829|324002392|FG001|Washout Period 4|Adverse Event|0|||
94600899|NCT02038829|324002393|FG002|Washout Period 4|Adverse Event|0|||
94600900|NCT02038829|324002394|FG003|Washout Period 4|Adverse Event|0|||
94600901|NCT02038829|324002395|FG004|Washout Period 4|Adverse Event|0|||
94600902|NCT02038829|324002396|FG005|Washout Period 4|Adverse Event|0|||
94600903|NCT02038829|324002397|FG006|Washout Period 4|Adverse Event|1|||
94600904|NCT02038829|324002398|FG007|Washout Period 4|Adverse Event|0|||
94600905|NCT02038829|324002399|FG008|Washout Period 4|Adverse Event|0|||
94600906|NCT02038829|324002400|FG009|Washout Period 4|Adverse Event|0|||
94600907|NCT02038829|324002401|FG010|Washout Period 4|Adverse Event|0|||
94600908|NCT02038829|324002402|FG011|Washout Period 4|Adverse Event|0|||
94600909|NCT02038829|324002391|FG000|Treatment Period 6|Adverse Event|0|||
94600910|NCT02038829|324002392|FG001|Treatment Period 6|Adverse Event|0|||
94600911|NCT02038829|324002393|FG002|Treatment Period 6|Adverse Event|1|||
94600912|NCT02038829|324002394|FG003|Treatment Period 6|Adverse Event|0|||
94600913|NCT02038829|324002395|FG004|Treatment Period 6|Adverse Event|0|||
94600914|NCT02038829|324002396|FG005|Treatment Period 6|Adverse Event|0|||
94600915|NCT02038829|324002397|FG006|Treatment Period 6|Adverse Event|0|||
94600916|NCT02038829|324002398|FG007|Treatment Period 6|Adverse Event|0|||
94600917|NCT02038829|324002399|FG008|Treatment Period 6|Adverse Event|0|||
94600918|NCT02038829|324002400|FG009|Treatment Period 6|Adverse Event|0|||
94600919|NCT02038829|324002401|FG010|Treatment Period 6|Adverse Event|0|||
94600920|NCT02038829|324002402|FG011|Treatment Period 6|Adverse Event|0|||
94600921|NCT04535167|324002403|FG000|Treatment|Adverse Event|0|||
94600922|NCT04535167|324002404|FG001|Treatment|Adverse Event|0|||
94600923|NCT04535167|324002405|FG002|Treatment|Adverse Event|0|||
94600924|NCT04535167|324002406|FG003|Treatment|Adverse Event|0|||
94356058|NCT00401726|323085786|FG000|Overall Study|Protocol Deviation|9|||
94356059|NCT00401726|323085787|FG001|Overall Study|Protocol Deviation|4|||
94356060|NCT04837807|323085788|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
94356061|NCT04837807|323085789|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
94356062|NCT01050998|323085791|FG000|Overall Study|Adverse Event|1|||
94600925|NCT04535167|324002407|FG004|Treatment|Adverse Event|0|||
94600926|NCT04535167|324002408|FG005|Treatment|Adverse Event|0|||
94600927|NCT04535167|324002409|FG006|Treatment|Adverse Event|1|||
94600928|NCT04535167|324002403|FG000|Follow-Up|Death|0|||
94600929|NCT04535167|324002404|FG001|Follow-Up|Death|0|||
94600930|NCT04535167|324002405|FG002|Follow-Up|Death|0|||
94600931|NCT04535167|324002406|FG003|Follow-Up|Death|0|||
94600932|NCT04535167|324002407|FG004|Follow-Up|Death|0|||
94600933|NCT04535167|324002408|FG005|Follow-Up|Death|0|||
94600934|NCT04535167|324002409|FG006|Follow-Up|Death|1|||
94600935|NCT04535167|324002403|FG000|Follow-Up|Lost to Follow-up|0|||
94600936|NCT04535167|324002404|FG001|Follow-Up|Lost to Follow-up|0|||
94600937|NCT04535167|324002405|FG002|Follow-Up|Lost to Follow-up|0|||
94600938|NCT04535167|324002406|FG003|Follow-Up|Lost to Follow-up|1|||
94600939|NCT04535167|324002407|FG004|Follow-Up|Lost to Follow-up|0|||
94600940|NCT04535167|324002408|FG005|Follow-Up|Lost to Follow-up|0|||
94600941|NCT04535167|324002409|FG006|Follow-Up|Lost to Follow-up|0|||
94600942|NCT00978432|324002410|FG000|Overall Study|Withdrawal by Subject|0|||
94600943|NCT00978432|324002411|FG001|Overall Study|Withdrawal by Subject|0|||
94600944|NCT00978432|324002412|FG002|Overall Study|Withdrawal by Subject|1|||
94600945|NCT00978432|324002410|FG000|Overall Study|Lack of Efficacy|1|||
94600946|NCT00978432|324002411|FG001|Overall Study|Lack of Efficacy|1|||
94600947|NCT00978432|324002412|FG002|Overall Study|Lack of Efficacy|3|||
94600948|NCT00978432|324002410|FG000|Overall Study|Adverse Event|2|||
94600949|NCT00978432|324002411|FG001|Overall Study|Adverse Event|0|||
94600950|NCT00978432|324002412|FG002|Overall Study|Adverse Event|1|||
94600951|NCT04618770|324002413|FG000|Overall Study|Censored from Analysis|12|||
94600952|NCT04618770|324002413|FG000|Overall Study|Early Termination|25|||
94600953|NCT02579928|324002414|FG000|Overall Study|Withdrawal by Subject|1|||
94600954|NCT02579928|324002415|FG001|Overall Study|Withdrawal by Subject|0|||
94600955|NCT00737464|324002416|FG000|Overall Study|Adverse Event|1|||
94600956|NCT00737464|324002416|FG000|Overall Study|Death|6|||
94600957|NCT00737464|324002416|FG000|Overall Study|Other - Failure to Return|1|||
94600958|NCT00737464|324002416|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
94600959|NCT00737464|324002416|FG000|Overall Study|Other reasons|4|||
94600960|NCT04972630|324002419|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
94600961|NCT04972630|324002420|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
94600962|NCT04972630|324002421|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
94600963|NCT02742246|324002422|FG000|Overall Study|Never initiated treatment|5|||
94600964|NCT02742246|324002423|FG001|Overall Study|Never initiated treatment|3|||
94600965|NCT02742246|324002424|FG002|Overall Study|Never initiated treatment|1|||
94600966|NCT02742246|324002422|FG000|Overall Study|dropped out during treatment|7|||
94600967|NCT02742246|324002423|FG001|Overall Study|dropped out during treatment|13|||
94600968|NCT02742246|324002424|FG002|Overall Study|dropped out during treatment|10|||
94600969|NCT02742246|324002422|FG000|Overall Study|Death|1|||
94600970|NCT02742246|324002423|FG001|Overall Study|Death|0|||
94600971|NCT02742246|324002424|FG002|Overall Study|Death|0|||
94600972|NCT00159822|324002429|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
94600973|NCT00159822|324002429|FG000|Voriconazole Treatment Period|Adverse Event|9|||
94600974|NCT00159822|324002429|FG000|Voriconazole Treatment Period|Death|4|||
94600975|NCT00159822|324002429|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
94600976|NCT00159822|324002429|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
94600977|NCT00159822|324002429|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
94600978|NCT00159822|324002429|FG000|Post-treatment Follow-up Period|Death|1|||
94600979|NCT00159822|324002429|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
94600980|NCT00159822|324002429|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
94600981|NCT02361580|324002433|FG000|Overall Study|Lost to Follow-up|6|||
94600982|NCT02361580|324002434|FG001|Overall Study|Lost to Follow-up|3|||
94600983|NCT03828370|324002437|FG000|3 Month Follow-up|Lost to Follow-up|4|||
94600984|NCT03828370|324002438|FG001|3 Month Follow-up|Lost to Follow-up|12|||
94600985|NCT03828370|324002437|FG000|9 Month Follow up|Lost to Follow-up|12|||
94600986|NCT03828370|324002438|FG001|9 Month Follow up|Lost to Follow-up|20|||
94600987|NCT00409175|324002439|FG000|Overall Study|Adverse Event|4|||
94600988|NCT00409175|324002440|FG001|Overall Study|Adverse Event|3|||
94600989|NCT00409175|324002439|FG000|Overall Study|Withdrawal by Subject|1|||
94600990|NCT00409175|324002440|FG001|Overall Study|Withdrawal by Subject|2|||
94600991|NCT00409175|324002439|FG000|Overall Study|Negative genotype|0|||
94600992|NCT00409175|324002440|FG001|Overall Study|Negative genotype|1|||
94600993|NCT00409175|324002439|FG000|Overall Study|Liver transplantation|13|||
94600994|NCT00409175|324002440|FG001|Overall Study|Liver transplantation|13|||
94600995|NCT00662532|324002448|FG000|Overall Study|Adverse Event|0|||
94600996|NCT00662532|324002449|FG001|Overall Study|Adverse Event|1|||
94600997|NCT00662532|324002448|FG000|Overall Study|Lost to Follow-up|0|||
94600998|NCT00662532|324002449|FG001|Overall Study|Lost to Follow-up|1|||
94600999|NCT01209832|324002450|FG000|Period 1|Sponsor Decision and was not dosed|1|||
94601000|NCT01209832|324002450|FG000|Period 2|Sponsor Decision|1|||
94601001|NCT00761150|324002451|FG000|Open-label Period|Adverse Event|36|||
94601002|NCT00761150|324002452|FG001|Open-label Period|Adverse Event|0|||
94601003|NCT00761150|324002453|FG002|Open-label Period|Adverse Event|0|||
94601004|NCT00761150|324002451|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
94601005|NCT00761150|324002452|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
94601006|NCT00761150|324002453|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
94601007|NCT00761150|324002451|FG000|Open-label Period|Lost to Follow-up|7|||
94601008|NCT00761150|324002452|FG001|Open-label Period|Lost to Follow-up|0|||
94601009|NCT00761150|324002453|FG002|Open-label Period|Lost to Follow-up|0|||
94601010|NCT00761150|324002451|FG000|Open-label Period|Lack of Efficacy|4|||
94601011|NCT00761150|324002452|FG001|Open-label Period|Lack of Efficacy|0|||
94601012|NCT00761150|324002453|FG002|Open-label Period|Lack of Efficacy|0|||
94601013|NCT00761150|324002451|FG000|Open-label Period|Withdrawal by Subject|5|||
94601014|NCT00761150|324002452|FG001|Open-label Period|Withdrawal by Subject|0|||
94601015|NCT00761150|324002453|FG002|Open-label Period|Withdrawal by Subject|0|||
94601016|NCT00761150|324002451|FG000|Open-label Period|Noncompliance|2|||
94601017|NCT00761150|324002452|FG001|Open-label Period|Noncompliance|0|||
94601018|NCT00761150|324002453|FG002|Open-label Period|Noncompliance|0|||
94601019|NCT00761150|324002451|FG000|Open-label Period|Other|5|||
94601020|NCT00761150|324002452|FG001|Open-label Period|Other|0|||
94601021|NCT00761150|324002453|FG002|Open-label Period|Other|0|||
94601022|NCT00761150|324002451|FG000|Double-blind Period|Lack of Efficacy|0|||
94601023|NCT00761150|324002452|FG001|Double-blind Period|Lack of Efficacy|2|||
94601024|NCT00761150|324002453|FG002|Double-blind Period|Lack of Efficacy|19|||
94601025|NCT00761150|324002451|FG000|Double-blind Period|Adverse Event|0|||
94601026|NCT00761150|324002452|FG001|Double-blind Period|Adverse Event|3|||
94601027|NCT00761150|324002453|FG002|Double-blind Period|Adverse Event|3|||
94601028|NCT00761150|324002451|FG000|Double-blind Period|Withdrawal by Subject|0|||
94601029|NCT00761150|324002452|FG001|Double-blind Period|Withdrawal by Subject|3|||
94601030|NCT00761150|324002453|FG002|Double-blind Period|Withdrawal by Subject|2|||
94601031|NCT00761150|324002451|FG000|Double-blind Period|Lost to Follow-up|0|||
94601032|NCT00761150|324002452|FG001|Double-blind Period|Lost to Follow-up|2|||
94601033|NCT00761150|324002453|FG002|Double-blind Period|Lost to Follow-up|1|||
94601034|NCT00761150|324002451|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
94601035|NCT00761150|324002452|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
94601036|NCT00761150|324002453|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
94601037|NCT00761150|324002451|FG000|Double-blind Period|Noncompliance|0|||
94601038|NCT00761150|324002452|FG001|Double-blind Period|Noncompliance|1|||
94601039|NCT00761150|324002453|FG002|Double-blind Period|Noncompliance|0|||
94601040|NCT00761150|324002451|FG000|Double-blind Period|Other|0|||
94601041|NCT00761150|324002452|FG001|Double-blind Period|Other|3|||
94601042|NCT00761150|324002453|FG002|Double-blind Period|Other|3|||
94601043|NCT00868517|324002454|FG000|Overall Study|Withdrawal by Subject|3|||
94601044|NCT00868517|324002455|FG001|Overall Study|Withdrawal by Subject|3|||
94601045|NCT00868517|324002456|FG002|Overall Study|Withdrawal by Subject|2|||
94601046|NCT00868517|324002454|FG000|Overall Study|Protocol Violation|1|||
94601047|NCT00868517|324002455|FG001|Overall Study|Protocol Violation|1|||
94601048|NCT00868517|324002456|FG002|Overall Study|Protocol Violation|0|||
94601049|NCT03823378|324002457|FG000|Overall Study|Adverse Event|2|||
94601050|NCT03823378|324002458|FG001|Overall Study|Adverse Event|2|||
94601051|NCT03823378|324002459|FG002|Overall Study|Adverse Event|0|||
94601052|NCT03823378|324002460|FG003|Overall Study|Adverse Event|0|||
94601053|NCT03823378|324002461|FG004|Overall Study|Adverse Event|0|||
94601054|NCT03823378|324002462|FG005|Overall Study|Adverse Event|0|||
94601055|NCT03823378|324002457|FG000|Overall Study|Lost to Follow-up|0|||
94601056|NCT03823378|324002458|FG001|Overall Study|Lost to Follow-up|1|||
94601057|NCT03823378|324002459|FG002|Overall Study|Lost to Follow-up|0|||
94601058|NCT03823378|324002460|FG003|Overall Study|Lost to Follow-up|0|||
94601059|NCT03823378|324002461|FG004|Overall Study|Lost to Follow-up|1|||
94601060|NCT03823378|324002462|FG005|Overall Study|Lost to Follow-up|0|||
94601061|NCT03823378|324002457|FG000|Overall Study|Withdrawal by Subject|0|||
94601062|NCT03823378|324002458|FG001|Overall Study|Withdrawal by Subject|1|||
94601063|NCT03823378|324002459|FG002|Overall Study|Withdrawal by Subject|4|||
94601064|NCT03823378|324002460|FG003|Overall Study|Withdrawal by Subject|2|||
94601065|NCT03823378|324002461|FG004|Overall Study|Withdrawal by Subject|0|||
94601066|NCT03823378|324002462|FG005|Overall Study|Withdrawal by Subject|1|||
94601067|NCT03823378|324002457|FG000|Overall Study|Other, not specified|19|||
94601068|NCT03823378|324002458|FG001|Overall Study|Other, not specified|12|||
94601069|NCT03823378|324002459|FG002|Overall Study|Other, not specified|6|||
94601070|NCT03823378|324002460|FG003|Overall Study|Other, not specified|8|||
94601071|NCT03823378|324002461|FG004|Overall Study|Other, not specified|17|||
94601072|NCT03823378|324002462|FG005|Overall Study|Other, not specified|7|||
94601073|NCT02497976|324002463|FG000|Overall Study|Withdrawal by Subject|2|||
94601074|NCT02497976|324002464|FG001|Overall Study|Withdrawal by Subject|0|||
94601075|NCT02497976|324002463|FG000|Overall Study|Moved out of area|0|||
94601076|NCT02497976|324002464|FG001|Overall Study|Moved out of area|1|||
94601077|NCT05442775|324002465|FG000|Overall Study|Trial terminated|61|||
94601078|NCT05442775|324002465|FG000|Overall Study|Lack of Efficacy|4|||
94601079|NCT05442775|324002465|FG000|Overall Study|Withdrawal by Subject|4|||
94601080|NCT05442775|324002465|FG000|Overall Study|Death|1|||
94601081|NCT05442775|324002465|FG000|Overall Study|Participant removed at Sponsor request|1|||
94601082|NCT00584740|324002467|FG000|Overall Study|Adverse Event|1|||
94601083|NCT00584740|324002468|FG001|Overall Study|Adverse Event|1|||
94601084|NCT00584740|324002467|FG000|Overall Study|Lack of Efficacy|8|||
94601085|NCT00584740|324002468|FG001|Overall Study|Lack of Efficacy|2|||
94601086|NCT00584740|324002467|FG000|Overall Study|Withdrawal by Subject|3|||
94601087|NCT00584740|324002468|FG001|Overall Study|Withdrawal by Subject|2|||
94601088|NCT00584740|324002467|FG000|Overall Study|Lost to Follow-up|0|||
94601089|NCT00584740|324002468|FG001|Overall Study|Lost to Follow-up|1|||
94660959|NCT03207750|324213826|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
94660960|NCT03207750|324213827|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
94660961|NCT02493361|324213828|FG000|Overall Study|Withdrawal by Subject|3|||
94660962|NCT01046643|324213829|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
94601090|NCT00991952|324002469|FG000|Overall Study|Adverse Event|0|||
94601091|NCT00991952|324002470|FG001|Overall Study|Adverse Event|1|||
94601092|NCT02483533|324002471|FG000|Overall Study|Lack of Efficacy|50|||
94601093|NCT02483533|324002472|FG001|Overall Study|Lack of Efficacy|50|||
94601094|NCT02514473|324002475|FG000|Overall Study|Adverse Event|0|||
94601095|NCT02514473|324002476|FG001|Overall Study|Adverse Event|2|||
94601096|NCT02514473|324002475|FG000|Overall Study|Withdrawal by Subject|2|||
94660963|NCT01046643|324213830|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
94660964|NCT01046643|324213831|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
94660965|NCT01046643|324213832|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
94660966|NCT00096135|324213836|FG000|Overall Study|Physician Decision|20|||
94660967|NCT00096135|324213837|FG001|Overall Study|Physician Decision|4|||
94660968|NCT00096135|324213836|FG000|Overall Study|Refusal of further protocol therapy|4|||
94660969|NCT00096135|324213837|FG001|Overall Study|Refusal of further protocol therapy|1|||
94660970|NCT00096135|324213836|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
94660971|NCT00096135|324213837|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
94601097|NCT02514473|324002476|FG001|Overall Study|Withdrawal by Subject|1|||
94601098|NCT02514473|324002475|FG000|Overall Study|Lost to Follow-up|0|||
94660972|NCT00096135|324213836|FG000|Overall Study|Other, specify|15|||
94660973|NCT00096135|324213837|FG001|Overall Study|Other, specify|3|||
94660974|NCT00096135|324213836|FG000|Overall Study|Ineligible|2|||
94660975|NCT00096135|324213837|FG001|Overall Study|Ineligible|0|||
94660976|NCT00817089|324213839|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
94660977|NCT00817089|324213840|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
94660978|NCT00817089|324213841|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
94660979|NCT00817089|324213842|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
94660980|NCT00817089|324213839|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
94660981|NCT00817089|324213840|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
94660982|NCT00817089|324213841|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
94660983|NCT00817089|324213842|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
94660984|NCT01944046|324213843|FG000|Randomized to DB|Adverse Event|5|||
94660985|NCT01944046|324213844|FG001|Randomized to DB|Adverse Event|2|||
94660986|NCT01944046|324213843|FG000|Randomized to DB|Clinical Worsening|3|||
94660987|NCT01944046|324213844|FG001|Randomized to DB|Clinical Worsening|2|||
94660988|NCT01944046|324213843|FG000|Randomized to DB|Lost to Follow-up|3|||
94660989|NCT01944046|324213844|FG001|Randomized to DB|Lost to Follow-up|3|||
94660990|NCT01944046|324213843|FG000|Randomized to DB|Withdrawal by Subject|2|||
94660991|NCT01944046|324213844|FG001|Randomized to DB|Withdrawal by Subject|4|||
94660992|NCT01944046|324213843|FG000|Randomized to DB|Physician Decision|1|||
94660993|NCT01944046|324213844|FG001|Randomized to DB|Physician Decision|2|||
94660994|NCT01944046|324213843|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
94660995|NCT01944046|324213844|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
94660996|NCT01944046|324213843|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
94660997|NCT01944046|324213844|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
94660998|NCT01944046|324213843|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
94660999|NCT01944046|324213844|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
94661000|NCT01944046|324213843|FG000|Open Label Eligible and Consented|Adverse Event|6|||
94661001|NCT01944046|324213844|FG001|Open Label Eligible and Consented|Adverse Event|1|||
94661002|NCT01944046|324213843|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
94661003|NCT01944046|324213844|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
94661004|NCT01944046|324213843|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
94661005|NCT01944046|324213844|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
94661006|NCT02543346|324213850|FG000|Second Priming Visit|Withdrawal by Subject|0|||
94661007|NCT02543346|324213851|FG001|Second Priming Visit|Withdrawal by Subject|2|||
94661008|NCT02543346|324213852|FG002|Second Priming Visit|Withdrawal by Subject|2|||
94661009|NCT02543346|324213853|FG003|Second Priming Visit|Withdrawal by Subject|2|||
94601099|NCT02514473|324002476|FG001|Overall Study|Lost to Follow-up|1|||
94601100|NCT02514473|324002475|FG000|Overall Study|Other|1|||
94661010|NCT02543346|324213850|FG000|Second Priming Visit|Adverse Event|1|||
94661011|NCT02543346|324213851|FG001|Second Priming Visit|Adverse Event|0|||
94661012|NCT02543346|324213852|FG002|Second Priming Visit|Adverse Event|0|||
94661013|NCT02543346|324213853|FG003|Second Priming Visit|Adverse Event|0|||
94661014|NCT00144339|324213854|FG000|Overall Study|Adverse Event|746|||
94661015|NCT00144339|324213855|FG001|Overall Study|Adverse Event|627|||
94661016|NCT00144339|324213854|FG000|Overall Study|Protocol Violation|75|||
94601101|NCT02514473|324002476|FG001|Overall Study|Other|1|||
94601102|NCT02129777|324002481|FG000|Double-Blind Period|Adverse Event|0|||
94601103|NCT02129777|324002482|FG001|Double-Blind Period|Adverse Event|0|||
94601104|NCT02129777|324002483|FG002|Double-Blind Period|Adverse Event|0|||
94601105|NCT02129777|324002484|FG003|Double-Blind Period|Adverse Event|0|||
94601106|NCT02129777|324002485|FG004|Double-Blind Period|Adverse Event|1|||
94601107|NCT02129777|324002486|FG005|Double-Blind Period|Adverse Event|0|||
94601108|NCT02129777|324002487|FG006|Double-Blind Period|Adverse Event|0|||
94601109|NCT02129777|324002481|FG000|Double-Blind Period|Lost to Follow-up|1|||
94601110|NCT02129777|324002482|FG001|Double-Blind Period|Lost to Follow-up|1|||
94601111|NCT02129777|324002483|FG002|Double-Blind Period|Lost to Follow-up|1|||
94601112|NCT02129777|324002484|FG003|Double-Blind Period|Lost to Follow-up|2|||
94601113|NCT02129777|324002485|FG004|Double-Blind Period|Lost to Follow-up|0|||
94601114|NCT02129777|324002486|FG005|Double-Blind Period|Lost to Follow-up|0|||
94601115|NCT02129777|324002487|FG006|Double-Blind Period|Lost to Follow-up|0|||
94601116|NCT02129777|324002481|FG000|Double-Blind Period|Withdrawal by Subject|2|||
94601117|NCT02129777|324002482|FG001|Double-Blind Period|Withdrawal by Subject|4|||
94601118|NCT02129777|324002483|FG002|Double-Blind Period|Withdrawal by Subject|3|||
94601119|NCT02129777|324002484|FG003|Double-Blind Period|Withdrawal by Subject|2|||
94601120|NCT02129777|324002485|FG004|Double-Blind Period|Withdrawal by Subject|3|||
94601121|NCT02129777|324002486|FG005|Double-Blind Period|Withdrawal by Subject|0|||
94601122|NCT02129777|324002487|FG006|Double-Blind Period|Withdrawal by Subject|0|||
94601123|NCT02129777|324002481|FG000|Double-Blind Period|Pregnancy|0|||
94601124|NCT02129777|324002482|FG001|Double-Blind Period|Pregnancy|0|||
94601125|NCT02129777|324002483|FG002|Double-Blind Period|Pregnancy|0|||
94601126|NCT02129777|324002484|FG003|Double-Blind Period|Pregnancy|0|||
94601127|NCT02129777|324002485|FG004|Double-Blind Period|Pregnancy|1|||
94601128|NCT02129777|324002486|FG005|Double-Blind Period|Pregnancy|0|||
94601129|NCT02129777|324002487|FG006|Double-Blind Period|Pregnancy|0|||
94601130|NCT02129777|324002481|FG000|Double-Blind Period|Lack of Efficacy|3|||
94601131|NCT02129777|324002482|FG001|Double-Blind Period|Lack of Efficacy|1|||
94601132|NCT02129777|324002483|FG002|Double-Blind Period|Lack of Efficacy|0|||
94601133|NCT02129777|324002484|FG003|Double-Blind Period|Lack of Efficacy|3|||
94601134|NCT02129777|324002485|FG004|Double-Blind Period|Lack of Efficacy|2|||
94601135|NCT02129777|324002486|FG005|Double-Blind Period|Lack of Efficacy|0|||
94601136|NCT02129777|324002487|FG006|Double-Blind Period|Lack of Efficacy|0|||
94601137|NCT02129777|324002481|FG000|Double-Blind Period|Other|1|||
94601138|NCT02129777|324002482|FG001|Double-Blind Period|Other|2|||
94601139|NCT02129777|324002483|FG002|Double-Blind Period|Other|0|||
94601140|NCT02129777|324002484|FG003|Double-Blind Period|Other|0|||
94601141|NCT02129777|324002485|FG004|Double-Blind Period|Other|0|||
94601142|NCT02129777|324002486|FG005|Double-Blind Period|Other|0|||
94601143|NCT02129777|324002487|FG006|Double-Blind Period|Other|0|||
94601144|NCT02129777|324002481|FG000|Open-Label Period|Lack of Efficacy|0|||
94601145|NCT02129777|324002482|FG001|Open-Label Period|Lack of Efficacy|0|||
94601146|NCT02129777|324002483|FG002|Open-Label Period|Lack of Efficacy|0|||
94601147|NCT02129777|324002484|FG003|Open-Label Period|Lack of Efficacy|0|||
94601148|NCT02129777|324002485|FG004|Open-Label Period|Lack of Efficacy|0|||
94601149|NCT02129777|324002486|FG005|Open-Label Period|Lack of Efficacy|0|||
94601150|NCT02129777|324002487|FG006|Open-Label Period|Lack of Efficacy|5|||
94601151|NCT02129777|324002481|FG000|Open-Label Period|Lost to Follow-up|0|||
94601152|NCT02129777|324002482|FG001|Open-Label Period|Lost to Follow-up|0|||
94601153|NCT02129777|324002483|FG002|Open-Label Period|Lost to Follow-up|0|||
94601154|NCT02129777|324002484|FG003|Open-Label Period|Lost to Follow-up|0|||
94601155|NCT02129777|324002485|FG004|Open-Label Period|Lost to Follow-up|0|||
94601156|NCT02129777|324002486|FG005|Open-Label Period|Lost to Follow-up|1|||
94601157|NCT02129777|324002487|FG006|Open-Label Period|Lost to Follow-up|1|||
94601158|NCT02129777|324002481|FG000|Open-Label Period|Withdrawal by Subject|0|||
94601159|NCT02129777|324002482|FG001|Open-Label Period|Withdrawal by Subject|0|||
94601160|NCT02129777|324002483|FG002|Open-Label Period|Withdrawal by Subject|0|||
94601161|NCT02129777|324002484|FG003|Open-Label Period|Withdrawal by Subject|0|||
94601162|NCT02129777|324002485|FG004|Open-Label Period|Withdrawal by Subject|0|||
94601163|NCT02129777|324002486|FG005|Open-Label Period|Withdrawal by Subject|1|||
94601164|NCT02129777|324002487|FG006|Open-Label Period|Withdrawal by Subject|3|||
94601165|NCT02129777|324002481|FG000|Open-Label Period|Study Termination|0|||
94601166|NCT02129777|324002482|FG001|Open-Label Period|Study Termination|0|||
94601167|NCT02129777|324002483|FG002|Open-Label Period|Study Termination|0|||
94601168|NCT02129777|324002484|FG003|Open-Label Period|Study Termination|0|||
94601169|NCT02129777|324002485|FG004|Open-Label Period|Study Termination|0|||
94601170|NCT02129777|324002486|FG005|Open-Label Period|Study Termination|10|||
94601171|NCT02129777|324002487|FG006|Open-Label Period|Study Termination|39|||
94601172|NCT04381988|324002489|FG000|Overall Study|The study was terminated|4|||
94601173|NCT04381988|324002490|FG001|Overall Study|The study was terminated|0|||
94601174|NCT01001299|324002491|FG000|Overall Study|Insufficient Therapeutic Response|20|||
94601175|NCT01001299|324002491|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
94601176|NCT01001299|324002491|FG000|Overall Study|Death|1|||
94601177|NCT01001299|324002491|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
94248493|NCT02580305|322704860|FG001|Overall Study|Randomized in error and never treated|8|||
94248494|NCT02580305|322704861|FG002|Overall Study|Randomized in error and never treated|5|||
94248495|NCT01160289|322704865|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
94248496|NCT01160289|322704866|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
94248497|NCT01160289|322704867|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
94248498|NCT01160289|322704868|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
94248499|NCT01160289|322704869|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
94356063|NCT01050998|323085792|FG001|Overall Study|Adverse Event|0|||
94601178|NCT01001299|324002491|FG000|Overall Study|Withdrew Consent|1|||
94601179|NCT02106923|324002492|FG000|Overall Study|Protocol Violation|0|||
94601180|NCT02106923|324002493|FG001|Overall Study|Protocol Violation|0|||
94601181|NCT02106923|324002494|FG002|Overall Study|Protocol Violation|0|||
94601182|NCT02106923|324002495|FG003|Overall Study|Protocol Violation|0|||
94601183|NCT02106923|324002496|FG004|Overall Study|Protocol Violation|0|||
94601184|NCT02106923|324002497|FG005|Overall Study|Protocol Violation|1|||
94601185|NCT03485495|324002498|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
94601186|NCT03485495|324002499|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
94601187|NCT01323920|324002500|FG000|Overall Study|Death|5|||
94601188|NCT01323920|324002500|FG000|Overall Study|Withdrawal by Subject|1|||
94601189|NCT02195011|324002501|FG000|Overall Study|Adverse Event|4|||
94601190|NCT02195011|324002502|FG001|Overall Study|Adverse Event|0|||
94601191|NCT02195011|324002501|FG000|Overall Study|Progressive Disease|18|||
94601192|NCT02195011|324002502|FG001|Overall Study|Progressive Disease|1|||
94601193|NCT02195011|324002501|FG000|Overall Study|Withdrawal by Subject|3|||
94601194|NCT02195011|324002502|FG001|Overall Study|Withdrawal by Subject|0|||
94601195|NCT03901456|324002503|FG000|Overall Study|Withdrawal by Subject|0|||
94601196|NCT03901456|324002504|FG001|Overall Study|Withdrawal by Subject|0|||
94601197|NCT03901456|324002505|FG002|Overall Study|Withdrawal by Subject|1|||
94601198|NCT03901456|324002503|FG000|Overall Study|Lost to Follow-up|0|||
94601199|NCT03901456|324002504|FG001|Overall Study|Lost to Follow-up|1|||
94601200|NCT03901456|324002505|FG002|Overall Study|Lost to Follow-up|0|||
94601201|NCT04672252|324002508|FG000|Overall Study|Protocol Violation|1|||
94601202|NCT04672252|324002509|FG001|Overall Study|Protocol Violation|0|||
94601203|NCT03025035|324002512|FG000|Overall Study|Death|2|||
94601204|NCT03025035|324002512|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
94601205|NCT02522871|324002513|FG000|Overall Study|Protocol Violation|1|||
94601206|NCT02522871|324002514|FG001|Overall Study|Protocol Violation|4|||
94601207|NCT02522871|324002513|FG000|Overall Study|Treated without randomization|1|||
94601208|NCT02522871|324002514|FG001|Overall Study|Treated without randomization|0|||
94601209|NCT02522871|324002513|FG000|Overall Study|Death|9|||
94601210|NCT02522871|324002514|FG001|Overall Study|Death|9|||
94601211|NCT02522871|324002513|FG000|Overall Study|Died in operating room prior to transplant|0|||
94601212|NCT02522871|324002514|FG001|Overall Study|Died in operating room prior to transplant|1|||
94601213|NCT00509262|324002515|FG000|Overall Study|Adverse Event|16|||
94601214|NCT00509262|324002516|FG001|Overall Study|Adverse Event|18|||
94601215|NCT00509262|324002515|FG000|Overall Study|Other|2|||
94601216|NCT00509262|324002516|FG001|Overall Study|Other|2|||
94601217|NCT00509262|324002515|FG000|Overall Study|Lack of Efficacy|1|||
94601218|NCT00509262|324002516|FG001|Overall Study|Lack of Efficacy|0|||
94601219|NCT00509262|324002515|FG000|Overall Study|Lost to Follow-up|1|||
94601220|NCT00509262|324002516|FG001|Overall Study|Lost to Follow-up|6|||
94601221|NCT00509262|324002515|FG000|Overall Study|Physician Decision|1|||
94601222|NCT00509262|324002516|FG001|Overall Study|Physician Decision|3|||
94601223|NCT00509262|324002515|FG000|Overall Study|Protocol Violation|2|||
94601224|NCT00509262|324002516|FG001|Overall Study|Protocol Violation|2|||
94601225|NCT00509262|324002515|FG000|Overall Study|Withdrawal by Subject|24|||
94601226|NCT00509262|324002516|FG001|Overall Study|Withdrawal by Subject|11|||
94601227|NCT02048241|324002517|FG000|Overall Study|Withdrawal by Subject|0|||
94601228|NCT02048241|324002518|FG001|Overall Study|Withdrawal by Subject|1|||
94601229|NCT00393042|324002519|FG000|First Intervention|Withdrawal by Subject|1|||
94601230|NCT00393042|324002520|FG001|First Intervention|Withdrawal by Subject|2|||
94601231|NCT00393042|324002519|FG000|First Intervention|Lost to Follow-up|3|||
94601232|NCT00393042|324002520|FG001|First Intervention|Lost to Follow-up|3|||
94601233|NCT00393042|324002519|FG000|First Intervention|Protocol Violation|1|||
94601234|NCT00393042|324002520|FG001|First Intervention|Protocol Violation|0|||
94248500|NCT01160289|322704870|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
94601235|NCT00393042|324002519|FG000|First Intervention|Adverse Event|0|||
94601236|NCT00393042|324002520|FG001|First Intervention|Adverse Event|1|||
94601237|NCT00393042|324002519|FG000|Second Intervetion|Adverse Event|0|||
94601238|NCT00393042|324002520|FG001|Second Intervetion|Adverse Event|3|||
94601239|NCT00393042|324002519|FG000|Second Intervetion|Withdrawal by Subject|0|||
94601240|NCT00393042|324002520|FG001|Second Intervetion|Withdrawal by Subject|2|||
94601241|NCT00393042|324002519|FG000|Second Intervetion|Lack of Efficacy|1|||
94601242|NCT00393042|324002520|FG001|Second Intervetion|Lack of Efficacy|0|||
94601243|NCT00393042|324002519|FG000|Second Intervetion|Lost to Follow-up|0|||
94248501|NCT01160289|322704865|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
94601244|NCT00393042|324002520|FG001|Second Intervetion|Lost to Follow-up|2|||
94601245|NCT00393042|324002519|FG000|Second Intervetion|Protocol Violation|1|||
94601246|NCT00393042|324002520|FG001|Second Intervetion|Protocol Violation|1|||
94601247|NCT01150474|324002522|FG000|Overall Study|Withdrawal by Subject|5|||
94601248|NCT01150474|324002523|FG001|Overall Study|Withdrawal by Subject|2|||
94601249|NCT01150474|324002522|FG000|Overall Study|Cancer found|1|||
94601250|NCT01150474|324002523|FG001|Overall Study|Cancer found|0|||
94601251|NCT01150474|324002522|FG000|Overall Study|Multiple Studies|0|||
94601252|NCT01150474|324002523|FG001|Overall Study|Multiple Studies|1|||
94601253|NCT01150474|324002522|FG000|Overall Study|Rectotomy|1|||
94601254|NCT01150474|324002523|FG001|Overall Study|Rectotomy|0|||
94601255|NCT01150474|324002522|FG000|Overall Study|Drug did not arrive in time|1|||
94601256|NCT01150474|324002523|FG001|Overall Study|Drug did not arrive in time|0|||
94601257|NCT01150474|324002522|FG000|Overall Study|Drug not administered|1|||
94601258|NCT01150474|324002523|FG001|Overall Study|Drug not administered|0|||
94601259|NCT01150474|324002522|FG000|Overall Study|Surgery Changed|1|||
94601260|NCT01150474|324002523|FG001|Overall Study|Surgery Changed|0|||
94601261|NCT00424255|324002525|FG000|Overall Study|Death|115|||
94601262|NCT00424255|324002526|FG001|Overall Study|Death|111|||
94601263|NCT00424255|324002525|FG000|Overall Study|Lost to Follow-up|26|||
94601264|NCT00424255|324002526|FG001|Overall Study|Lost to Follow-up|20|||
94601265|NCT00424255|324002525|FG000|Overall Study|Protocol Violation|0|||
94601266|NCT00424255|324002526|FG001|Overall Study|Protocol Violation|1|||
94601267|NCT00424255|324002525|FG000|Overall Study|Withdrawal by Subject|34|||
94601268|NCT00424255|324002526|FG001|Overall Study|Withdrawal by Subject|38|||
94601269|NCT00424255|324002525|FG000|Overall Study|Physician Decision|3|||
94601270|NCT00424255|324002526|FG001|Overall Study|Physician Decision|7|||
94601271|NCT00424255|324002525|FG000|Overall Study|Cognitive Disturbance|1|||
94601272|NCT00424255|324002526|FG001|Overall Study|Cognitive Disturbance|0|||
94601273|NCT00424255|324002525|FG000|Overall Study|Non-compliance by Participants|1|||
94601274|NCT00424255|324002526|FG001|Overall Study|Non-compliance by Participants|0|||
94601275|NCT00424255|324002525|FG000|Overall Study|Fatigue|1|||
94601276|NCT00424255|324002526|FG001|Overall Study|Fatigue|0|||
94601277|NCT00424255|324002525|FG000|Overall Study|Disease Progression|0|||
94601278|NCT00424255|324002526|FG001|Overall Study|Disease Progression|2|||
94601279|NCT00424255|324002525|FG000|Overall Study|Sponsor Terminated Study|161|||
94601280|NCT00424255|324002526|FG001|Overall Study|Sponsor Terminated Study|167|||
94601281|NCT02889562|324002529|FG000|Overall Study|Physician Decision|0|||
94601282|NCT02889562|324002530|FG001|Overall Study|Physician Decision|1|||
94601283|NCT02889562|324002529|FG000|Overall Study|Withdrawal by Subject|0|||
94601284|NCT02889562|324002530|FG001|Overall Study|Withdrawal by Subject|1|||
94601285|NCT00570232|324002531|FG000|Overall Study|Adverse Event|10|||
94601286|NCT00570232|324002531|FG000|Overall Study|discontinued due to medical condition|3|||
94601287|NCT00570232|324002531|FG000|Overall Study|discontinued due to recurrence|8|||
94601288|NCT00570232|324002531|FG000|Overall Study|discontinued due to noncompliance|2|||
94601289|NCT02125604|324002532|FG000|Overall Study|Other|4|||
94601290|NCT02125604|324002532|FG000|Overall Study|Investigator Decision|1|||
94601291|NCT02125604|324002532|FG000|Overall Study|Lost to Follow-up|2|||
94601292|NCT02125604|324002532|FG000|Overall Study|Consent Withdrawn|4|||
94601293|NCT02125604|324002532|FG000|Overall Study|Adverse Event|20|||
94601294|NCT05772702|324002538|FG000|Overall Study|Adverse Event|1|||
94601295|NCT01909453|324002539|FG000|Overall Study|Ongoing|118|||
94601296|NCT01909453|324002540|FG001|Overall Study|Ongoing|103|||
94601297|NCT01909453|324002541|FG002|Overall Study|Ongoing|83|||
94601298|NCT01909453|324002542|FG003|Overall Study|Ongoing|164|||
94601299|NCT01909453|324002543|FG004|Overall Study|Ongoing|50|||
94601300|NCT01909453|324002539|FG000|Overall Study|Death|69|||
94601301|NCT01909453|324002540|FG001|Overall Study|Death|74|||
94601302|NCT01909453|324002541|FG002|Overall Study|Death|88|||
94601303|NCT01909453|324002542|FG003|Overall Study|Death|86|||
94601304|NCT01909453|324002543|FG004|Overall Study|Death|29|||
94601305|NCT01909453|324002539|FG000|Overall Study|Lost to Follow-up|3|||
94601306|NCT01909453|324002540|FG001|Overall Study|Lost to Follow-up|4|||
94601307|NCT01909453|324002541|FG002|Overall Study|Lost to Follow-up|4|||
94601308|NCT01909453|324002542|FG003|Overall Study|Lost to Follow-up|3|||
94601309|NCT01909453|324002543|FG004|Overall Study|Lost to Follow-up|3|||
94601310|NCT01909453|324002539|FG000|Overall Study|Withdrawal by Subject|2|||
94601311|NCT01909453|324002540|FG001|Overall Study|Withdrawal by Subject|13|||
94601312|NCT01909453|324002541|FG002|Overall Study|Withdrawal by Subject|16|||
94601313|NCT01909453|324002542|FG003|Overall Study|Withdrawal by Subject|5|||
94601314|NCT01909453|324002543|FG004|Overall Study|Withdrawal by Subject|4|||
94601315|NCT04224272|324002544|FG000|Part 1 - Dose Finding|Death|4|||
94601316|NCT04224272|324002544|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
94601317|NCT04224272|324002544|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
94601318|NCT04224272|324002544|FG000|Part 2 - Dose Expansion|Death|10|||
94601319|NCT04224272|324002544|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
94601320|NCT00706849|324004311|FG000|Treatment Period|Adverse Event|0|||
94601321|NCT00706849|324004312|FG001|Treatment Period|Adverse Event|9|||
94601322|NCT00706849|324004311|FG000|Treatment Period|Other|0|||
94601323|NCT00706849|324004312|FG001|Treatment Period|Other|1|||
94601324|NCT00706849|324004311|FG000|Follow-up Period|Withdrawal by Subject|0|||
94601325|NCT00706849|324004312|FG001|Follow-up Period|Withdrawal by Subject|2|||
94601326|NCT00706849|324004311|FG000|Follow-up Period|Protocol non-compliance|0|||
94601327|NCT00706849|324004312|FG001|Follow-up Period|Protocol non-compliance|1|||
94601328|NCT02616601|324004313|FG000|Overall Study|Withdrawal by Subject|4|||
94601329|NCT02616601|324004314|FG001|Overall Study|Withdrawal by Subject|4|||
94601330|NCT02616601|324004315|FG002|Overall Study|Withdrawal by Subject|3|||
94601331|NCT02616601|324004313|FG000|Overall Study|Adverse Event|2|||
94601332|NCT02616601|324004314|FG001|Overall Study|Adverse Event|0|||
94601333|NCT02616601|324004315|FG002|Overall Study|Adverse Event|2|||
94601334|NCT02616601|324004313|FG000|Overall Study|Death|1|||
94601335|NCT02616601|324004314|FG001|Overall Study|Death|0|||
94601336|NCT02616601|324004315|FG002|Overall Study|Death|0|||
94601337|NCT02616601|324004313|FG000|Overall Study|Lost to Follow-up|1|||
94601338|NCT02616601|324004314|FG001|Overall Study|Lost to Follow-up|0|||
94601339|NCT02616601|324004315|FG002|Overall Study|Lost to Follow-up|1|||
94601340|NCT02616601|324004313|FG000|Overall Study|Non-Compliance with Test Article|1|||
94601341|NCT02616601|324004314|FG001|Overall Study|Non-Compliance with Test Article|0|||
94601342|NCT02616601|324004315|FG002|Overall Study|Non-Compliance with Test Article|1|||
94601343|NCT02446743|324004316|FG000|Overall Study|Withdrawal by Subject|1|||
94601344|NCT02446743|324004317|FG001|Overall Study|Withdrawal by Subject|1|||
94601345|NCT02446743|324004316|FG000|Overall Study|Lost to Follow-up|1|||
94601346|NCT02446743|324004317|FG001|Overall Study|Lost to Follow-up|0|||
94601347|NCT02446743|324004316|FG000|Overall Study|Adverse Event|1|||
94601348|NCT02446743|324004317|FG001|Overall Study|Adverse Event|1|||
94601349|NCT02446743|324004316|FG000|Overall Study|Other|2|||
94601350|NCT02446743|324004317|FG001|Overall Study|Other|3|||
94601351|NCT01205581|324004324|FG000|Overall Study|Withdrawal by Subject|1|||
94601352|NCT01205581|324004325|FG001|Overall Study|Withdrawal by Subject|0|||
94601353|NCT01205581|324004326|FG002|Overall Study|Withdrawal by Subject|0|||
94601354|NCT01205581|324004327|FG003|Overall Study|Withdrawal by Subject|0|||
94601355|NCT01205581|324004328|FG004|Overall Study|Withdrawal by Subject|0|||
94601356|NCT01205581|324004329|FG005|Overall Study|Withdrawal by Subject|0|||
94601357|NCT04179890|324004330|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
94601358|NCT04179890|324004331|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
94601359|NCT04179890|324004330|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
94601360|NCT04179890|324004331|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
94601361|NCT04179890|324004330|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
94601362|NCT04179890|324004331|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
94601363|NCT04179890|324004330|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
94601364|NCT04179890|324004331|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
94601365|NCT04179890|324004330|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
94601366|NCT04179890|324004331|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
94601367|NCT04179890|324004330|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
94601368|NCT04179890|324004331|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
94661017|NCT00144339|324213855|FG001|Overall Study|Protocol Violation|48|||
94661018|NCT00144339|324213854|FG000|Overall Study|Withdrawal by Subject|403|||
94661019|NCT00144339|324213855|FG001|Overall Study|Withdrawal by Subject|300|||
94661020|NCT00144339|324213854|FG000|Overall Study|Lost to Follow-up|76|||
94661021|NCT00144339|324213855|FG001|Overall Study|Lost to Follow-up|64|||
94601369|NCT04179890|324004330|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
94661022|NCT00144339|324213854|FG000|Overall Study|Other|58|||
94661023|NCT00144339|324213855|FG001|Overall Study|Other|60|||
94601370|NCT04179890|324004331|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
94601371|NCT04179890|324004330|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
94661024|NCT01109992|324213856|FG000|Overall Study|Withdrawal by Subject|0|||
94661025|NCT01109992|324213857|FG001|Overall Study|Withdrawal by Subject|1|||
94661026|NCT01109992|324213856|FG000|Overall Study|Movement during rest scan.|0|||
94661027|NCT01109992|324213857|FG001|Overall Study|Movement during rest scan.|1|||
94661028|NCT02338362|324213858|FG000|Overall Study|Withdrawal by Subject|1|||
94661029|NCT02338362|324213859|FG001|Overall Study|Withdrawal by Subject|1|||
94661030|NCT00690755|324213862|FG000|Overall Study|Physician Decision|2|||
94661031|NCT00690755|324213863|FG001|Overall Study|Physician Decision|0|||
94661032|NCT00690755|324213864|FG002|Overall Study|Physician Decision|46|||
94661033|NCT00690755|324213865|FG003|Overall Study|Physician Decision|5|||
94661034|NCT00690755|324213866|FG004|Overall Study|Physician Decision|0|||
94661035|NCT00690755|324213867|FG005|Overall Study|Physician Decision|4|||
94661036|NCT00690755|324213868|FG006|Overall Study|Physician Decision|0|||
94661037|NCT04313634|324213869|FG000|Overall Study|Adverse Event|2|||
94661038|NCT04313634|324213870|FG001|Overall Study|Adverse Event|2|||
94661039|NCT04313634|324213871|FG002|Overall Study|Adverse Event|0|||
94661040|NCT04313634|324213869|FG000|Overall Study|Withdrawal by Subject|1|||
94661041|NCT04313634|324213870|FG001|Overall Study|Withdrawal by Subject|0|||
94661042|NCT04313634|324213871|FG002|Overall Study|Withdrawal by Subject|1|||
94661043|NCT04313634|324213869|FG000|Overall Study|Protocol Violation|0|||
94661044|NCT04313634|324213870|FG001|Overall Study|Protocol Violation|0|||
94661045|NCT04313634|324213871|FG002|Overall Study|Protocol Violation|1|||
94661046|NCT04307186|324213874|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
94661047|NCT04307186|324213874|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
94661048|NCT04307186|324213874|FG000|Washout 3-14 Days|Progressive disease|1|||
94661049|NCT04307186|324213874|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
94661050|NCT04307186|324213874|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
94661051|NCT00288587|324213876|FG000|Overall Study|Death|4|||
94661052|NCT00288587|324213877|FG001|Overall Study|Death|4|||
94661053|NCT00288587|324213876|FG000|Overall Study|Transplant|0|||
94661054|NCT00288587|324213877|FG001|Overall Study|Transplant|3|||
94661055|NCT00288587|324213876|FG000|Overall Study|Adverse Event|0|||
94661056|NCT00288587|324213877|FG001|Overall Study|Adverse Event|1|||
94661057|NCT00288587|324213876|FG000|Overall Study|Physician Decision|0|||
94661058|NCT00288587|324213877|FG001|Overall Study|Physician Decision|2|||
94661059|NCT00288587|324213876|FG000|Overall Study|Severe Aortic Stenosis|1|||
94601372|NCT04179890|324004331|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
94601373|NCT04179890|324004330|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
94601374|NCT04179890|324004331|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
94601375|NCT02195687|324004335|FG000|Overall Study|Personal Reasons|1|||
94601376|NCT02195687|324004336|FG001|Overall Study|Personal Reasons|1|||
94601377|NCT02195687|324004335|FG000|Overall Study|Lost to Follow-up|4|||
94601378|NCT02195687|324004336|FG001|Overall Study|Lost to Follow-up|1|||
94601379|NCT00708201|324004337|FG000|Overall Study|Adverse Event|4|||
94661060|NCT00288587|324213877|FG001|Overall Study|Severe Aortic Stenosis|0|||
94661061|NCT03538626|324213878|FG000|Overall Study|Withdrawal by Subject|0|||
94661062|NCT03538626|324213879|FG001|Overall Study|Withdrawal by Subject|1|||
94661063|NCT03538626|324213880|FG002|Overall Study|Withdrawal by Subject|0|||
94661064|NCT03538626|324213881|FG003|Overall Study|Withdrawal by Subject|0|||
94661065|NCT03538626|324213882|FG004|Overall Study|Withdrawal by Subject|0|||
94661066|NCT03538626|324213883|FG005|Overall Study|Withdrawal by Subject|0|||
94661067|NCT03538626|324213884|FG006|Overall Study|Withdrawal by Subject|0|||
94661068|NCT03538626|324213885|FG007|Overall Study|Withdrawal by Subject|0|||
94661069|NCT03538626|324213878|FG000|Overall Study|Lost to Follow-up|0|||
94661070|NCT03538626|324213879|FG001|Overall Study|Lost to Follow-up|0|||
94661071|NCT03538626|324213880|FG002|Overall Study|Lost to Follow-up|0|||
94661072|NCT03538626|324213881|FG003|Overall Study|Lost to Follow-up|0|||
94661073|NCT03538626|324213882|FG004|Overall Study|Lost to Follow-up|0|||
94661074|NCT03538626|324213883|FG005|Overall Study|Lost to Follow-up|0|||
94661075|NCT03538626|324213884|FG006|Overall Study|Lost to Follow-up|1|||
94661076|NCT03538626|324213885|FG007|Overall Study|Lost to Follow-up|0|||
94661077|NCT01434602|324213891|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
94661078|NCT01434602|324213892|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
94601380|NCT00708201|324004338|FG001|Overall Study|Adverse Event|4|||
94601381|NCT00708201|324004337|FG000|Overall Study|Withdrawal by Subject|1|||
94601382|NCT00708201|324004338|FG001|Overall Study|Withdrawal by Subject|1|||
94601383|NCT00708201|324004337|FG000|Overall Study|Lost to Follow-up|2|||
94601384|NCT00708201|324004338|FG001|Overall Study|Lost to Follow-up|0|||
94601385|NCT00708201|324004337|FG000|Overall Study|Protocol Violation|0|||
94601386|NCT00708201|324004338|FG001|Overall Study|Protocol Violation|1|||
94601387|NCT03312751|324004339|FG000|Overall Study|Death|7|||
94601388|NCT03312751|324004340|FG001|Overall Study|Death|9|||
94601389|NCT03312751|324004339|FG000|Overall Study|Study discontinuation due to other reason|0|||
94601390|NCT03312751|324004340|FG001|Overall Study|Study discontinuation due to other reason|1|||
94601391|NCT02480712|324004341|FG000|Overall Study|Enrolled but Never Treated|1|||
94601392|NCT02480712|324004341|FG000|Overall Study|Lost to Follow-up|5|||
94601393|NCT02480712|324004341|FG000|Overall Study|Withdrew Consent|3|||
94601394|NCT02480712|324004341|FG000|Overall Study|Death|1|||
94601395|NCT02480712|324004341|FG000|Overall Study|Lack of Efficacy|1|||
94601396|NCT01857310|324004342|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
94601397|NCT01857310|324004343|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
94601398|NCT02360605|324004344|FG000|Overall Study|Withdrawal by Subject|4|||
94601399|NCT02360605|324004345|FG001|Overall Study|Withdrawal by Subject|9|||
94601400|NCT02360605|324004344|FG000|Overall Study|Lost to Follow-up|7|||
94601401|NCT02360605|324004345|FG001|Overall Study|Lost to Follow-up|8|||
94601402|NCT02360605|324004344|FG000|Overall Study|Death|0|||
94601403|NCT02360605|324004345|FG001|Overall Study|Death|1|||
94601404|NCT01860846|324004346|FG000|Overall Study|Lost to Follow-up|33|||
94601405|NCT00058539|324004347|FG000|Overall Study|Disease progression|24|||
94601406|NCT00058539|324004347|FG000|Overall Study|Adverse Event|3|||
94601407|NCT00058539|324004347|FG000|Overall Study|Withdrawal by Subject|5|||
94601408|NCT00058539|324004347|FG000|Overall Study|Physician Decision|9|||
94601409|NCT00058539|324004347|FG000|Overall Study|Death|1|||
94601410|NCT00274924|324004348|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
94601411|NCT00274924|324004349|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
94601412|NCT00274924|324004350|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
94601413|NCT00274924|324004348|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
94601414|NCT00274924|324004349|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
94601415|NCT00274924|324004350|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
94601416|NCT00274924|324004348|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
94601417|NCT00274924|324004349|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
94601418|NCT00274924|324004350|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
94601419|NCT00274924|324004348|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
94601420|NCT00274924|324004349|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
94601421|NCT00274924|324004350|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
94601422|NCT00274924|324004348|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
94601423|NCT00274924|324004349|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
94601424|NCT00274924|324004350|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
94601425|NCT00274924|324004348|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
94601426|NCT00274924|324004349|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
94601427|NCT00274924|324004350|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
94601428|NCT00274924|324004348|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
94601429|NCT00274924|324004349|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
94601430|NCT00274924|324004350|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
94601431|NCT00274924|324004348|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
94601432|NCT00274924|324004349|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
94601433|NCT00274924|324004350|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
94601434|NCT00274924|324004348|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
94601435|NCT00274924|324004349|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
94601436|NCT00274924|324004350|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
94601437|NCT00274924|324004348|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
94601438|NCT00274924|324004349|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
94601439|NCT00274924|324004350|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
94601440|NCT00274924|324004348|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
94601441|NCT00274924|324004349|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
94601442|NCT00274924|324004350|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
94601443|NCT00274924|324004348|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
94601444|NCT00274924|324004349|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
94601445|NCT00274924|324004350|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
94601446|NCT00274924|324004348|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
94601447|NCT00274924|324004349|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
94601448|NCT00274924|324004350|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
94601449|NCT02093026|324004353|FG000|Overall Study|Adverse Event|26|||
94601450|NCT02093026|324004353|FG000|Overall Study|Death|10|||
94601451|NCT02093026|324004353|FG000|Overall Study|Other|157|||
94601452|NCT01673282|324004354|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
94601453|NCT01673282|324004355|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
94601454|NCT01673282|324004354|FG000|Overall Study|Lack of Efficacy|9|||
94601455|NCT01673282|324004355|FG001|Overall Study|Lack of Efficacy|2|||
94601456|NCT01673282|324004354|FG000|Overall Study|Lost to Follow-up|11|||
94601457|NCT01673282|324004355|FG001|Overall Study|Lost to Follow-up|10|||
94601458|NCT01673282|324004354|FG000|Overall Study|Withdrawal by Subject|3|||
94601459|NCT01673282|324004355|FG001|Overall Study|Withdrawal by Subject|3|||
94601460|NCT01673282|324004354|FG000|Overall Study|Other|1|||
94601461|NCT01673282|324004355|FG001|Overall Study|Other|6|||
94601462|NCT04068896|324004357|FG000|Overall Study|Adverse Event|2|||
94601463|NCT04068896|324004358|FG001|Overall Study|Adverse Event|0|||
94601464|NCT04068896|324004359|FG002|Overall Study|Adverse Event|1|||
94601465|NCT04068896|324004360|FG003|Overall Study|Adverse Event|0|||
94601466|NCT04068896|324004361|FG004|Overall Study|Adverse Event|0|||
94601467|NCT04068896|324004362|FG005|Overall Study|Adverse Event|0|||
94601468|NCT04068896|324004357|FG000|Overall Study|Death|3|||
94601469|NCT04068896|324004358|FG001|Overall Study|Death|1|||
94601470|NCT04068896|324004359|FG002|Overall Study|Death|3|||
94601471|NCT04068896|324004360|FG003|Overall Study|Death|19|||
94601472|NCT04068896|324004361|FG004|Overall Study|Death|17|||
94601473|NCT04068896|324004362|FG005|Overall Study|Death|0|||
94601474|NCT04068896|324004357|FG000|Overall Study|Physician Decision|0|||
94601475|NCT04068896|324004358|FG001|Overall Study|Physician Decision|0|||
94601476|NCT04068896|324004359|FG002|Overall Study|Physician Decision|0|||
94601477|NCT04068896|324004360|FG003|Overall Study|Physician Decision|1|||
94601478|NCT04068896|324004361|FG004|Overall Study|Physician Decision|0|||
94601479|NCT04068896|324004362|FG005|Overall Study|Physician Decision|0|||
94601480|NCT04068896|324004357|FG000|Overall Study|progressive disease|3|||
94601481|NCT04068896|324004358|FG001|Overall Study|progressive disease|5|||
94601482|NCT04068896|324004359|FG002|Overall Study|progressive disease|3|||
94601483|NCT04068896|324004360|FG003|Overall Study|progressive disease|2|||
94601484|NCT04068896|324004361|FG004|Overall Study|progressive disease|1|||
94601485|NCT04068896|324004362|FG005|Overall Study|progressive disease|2|||
94601486|NCT04068896|324004357|FG000|Overall Study|Study terminated by sponsor|0|||
94601487|NCT04068896|324004358|FG001|Overall Study|Study terminated by sponsor|0|||
94601488|NCT04068896|324004359|FG002|Overall Study|Study terminated by sponsor|1|||
94601489|NCT04068896|324004360|FG003|Overall Study|Study terminated by sponsor|2|||
94601490|NCT04068896|324004361|FG004|Overall Study|Study terminated by sponsor|1|||
94601491|NCT04068896|324004362|FG005|Overall Study|Study terminated by sponsor|4|||
94601492|NCT04068896|324004357|FG000|Overall Study|Protocol Violation|0|||
94601493|NCT04068896|324004358|FG001|Overall Study|Protocol Violation|0|||
94601494|NCT04068896|324004359|FG002|Overall Study|Protocol Violation|0|||
94601495|NCT04068896|324004360|FG003|Overall Study|Protocol Violation|1|||
94601496|NCT04068896|324004361|FG004|Overall Study|Protocol Violation|0|||
94601497|NCT04068896|324004362|FG005|Overall Study|Protocol Violation|0|||
94601498|NCT04068896|324004357|FG000|Overall Study|Withdrawal by Subject|0|||
94601499|NCT04068896|324004358|FG001|Overall Study|Withdrawal by Subject|3|||
94601500|NCT04068896|324004359|FG002|Overall Study|Withdrawal by Subject|0|||
94601501|NCT04068896|324004360|FG003|Overall Study|Withdrawal by Subject|2|||
94601502|NCT04068896|324004361|FG004|Overall Study|Withdrawal by Subject|1|||
94601503|NCT04068896|324004362|FG005|Overall Study|Withdrawal by Subject|0|||
94601504|NCT04068896|324004357|FG000|Overall Study|Symptomatic deterioration|2|||
94601505|NCT04068896|324004358|FG001|Overall Study|Symptomatic deterioration|0|||
94601506|NCT04068896|324004359|FG002|Overall Study|Symptomatic deterioration|0|||
94601507|NCT04068896|324004360|FG003|Overall Study|Symptomatic deterioration|0|||
94601508|NCT04068896|324004361|FG004|Overall Study|Symptomatic deterioration|0|||
94601509|NCT04068896|324004362|FG005|Overall Study|Symptomatic deterioration|0|||
94661079|NCT01434602|324213893|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
94601510|NCT02953509|324004363|FG000|Overall Study|Death|1|||
94601511|NCT02953509|324004364|FG001|Overall Study|Death|3|||
94601512|NCT02953509|324004365|FG002|Overall Study|Death|3|||
94248502|NCT01160289|322704866|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
94601513|NCT02953509|324004366|FG003|Overall Study|Death|4|||
94601514|NCT02953509|324004367|FG004|Overall Study|Death|12|||
94248503|NCT01160289|322704867|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
94248504|NCT01160289|322704868|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
94248505|NCT01160289|322704869|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
94601515|NCT02953509|324004368|FG005|Overall Study|Death|3|||
94601516|NCT02953509|324004369|FG006|Overall Study|Death|25|||
94601517|NCT02953509|324004370|FG007|Overall Study|Death|10|||
94601518|NCT02953509|324004371|FG008|Overall Study|Death|21|||
94601519|NCT02953509|324004372|FG009|Overall Study|Death|20|||
94601520|NCT02953509|324004363|FG000|Overall Study|Reason Not Specified|0|||
94601521|NCT02953509|324004364|FG001|Overall Study|Reason Not Specified|2|||
94601522|NCT02953509|324004365|FG002|Overall Study|Reason Not Specified|8|||
94601523|NCT02953509|324004366|FG003|Overall Study|Reason Not Specified|2|||
94601524|NCT02953509|324004367|FG004|Overall Study|Reason Not Specified|11|||
94601525|NCT02953509|324004368|FG005|Overall Study|Reason Not Specified|4|||
94601526|NCT02953509|324004369|FG006|Overall Study|Reason Not Specified|12|||
94601527|NCT02953509|324004370|FG007|Overall Study|Reason Not Specified|2|||
94601528|NCT02953509|324004371|FG008|Overall Study|Reason Not Specified|7|||
94601529|NCT02953509|324004372|FG009|Overall Study|Reason Not Specified|2|||
94601530|NCT02953509|324004363|FG000|Overall Study|Consent Withdrawn|1|||
94601531|NCT02953509|324004364|FG001|Overall Study|Consent Withdrawn|1|||
94601532|NCT02953509|324004365|FG002|Overall Study|Consent Withdrawn|2|||
94601533|NCT02953509|324004366|FG003|Overall Study|Consent Withdrawn|1|||
94601534|NCT02953509|324004367|FG004|Overall Study|Consent Withdrawn|3|||
94601535|NCT02953509|324004368|FG005|Overall Study|Consent Withdrawn|0|||
94601536|NCT02953509|324004369|FG006|Overall Study|Consent Withdrawn|4|||
94601537|NCT02953509|324004370|FG007|Overall Study|Consent Withdrawn|1|||
94601538|NCT02953509|324004371|FG008|Overall Study|Consent Withdrawn|1|||
94601539|NCT02953509|324004372|FG009|Overall Study|Consent Withdrawn|4|||
94601540|NCT02953509|324004363|FG000|Overall Study|Lost to Follow-up|0|||
94601541|NCT02953509|324004364|FG001|Overall Study|Lost to Follow-up|0|||
94601542|NCT02953509|324004365|FG002|Overall Study|Lost to Follow-up|0|||
94601543|NCT02953509|324004366|FG003|Overall Study|Lost to Follow-up|0|||
94601544|NCT02953509|324004367|FG004|Overall Study|Lost to Follow-up|0|||
94601545|NCT02953509|324004368|FG005|Overall Study|Lost to Follow-up|0|||
94601546|NCT02953509|324004369|FG006|Overall Study|Lost to Follow-up|1|||
94601547|NCT02953509|324004370|FG007|Overall Study|Lost to Follow-up|1|||
94601548|NCT02953509|324004371|FG008|Overall Study|Lost to Follow-up|1|||
94601549|NCT02953509|324004372|FG009|Overall Study|Lost to Follow-up|1|||
94601550|NCT02953509|324004363|FG000|Overall Study|Study terminated by sponsor|1|||
94601551|NCT02953509|324004364|FG001|Overall Study|Study terminated by sponsor|0|||
94601552|NCT02953509|324004365|FG002|Overall Study|Study terminated by sponsor|0|||
94601553|NCT02953509|324004366|FG003|Overall Study|Study terminated by sponsor|0|||
94601554|NCT02953509|324004367|FG004|Overall Study|Study terminated by sponsor|0|||
94601555|NCT02953509|324004368|FG005|Overall Study|Study terminated by sponsor|0|||
94601556|NCT02953509|324004369|FG006|Overall Study|Study terminated by sponsor|1|||
94601557|NCT02953509|324004370|FG007|Overall Study|Study terminated by sponsor|0|||
94601558|NCT02953509|324004371|FG008|Overall Study|Study terminated by sponsor|1|||
94601559|NCT02953509|324004372|FG009|Overall Study|Study terminated by sponsor|1|||
94601560|NCT00484185|324004375|FG000|Overall Study|Lost to Follow-up|44|||
94601561|NCT00484185|324004375|FG000|Overall Study|Other|20|||
94601562|NCT00484185|324004375|FG000|Overall Study|Randomized but not treated|5|||
94601563|NCT00484185|324004375|FG000|Overall Study|Death|2|||
94601564|NCT00645788|324004376|FG000|Overall Study|Did not receive study drug|1|||
94601565|NCT00645788|324004377|FG001|Overall Study|Did not receive study drug|1|||
94601566|NCT00645788|324004378|FG002|Overall Study|Did not receive study drug|0|||
94601567|NCT00645788|324004379|FG003|Overall Study|Did not receive study drug|0|||
94601568|NCT00645788|324004376|FG000|Overall Study|Adverse Event|4|||
94601569|NCT00645788|324004377|FG001|Overall Study|Adverse Event|9|||
94601570|NCT00645788|324004378|FG002|Overall Study|Adverse Event|5|||
94601571|NCT00645788|324004379|FG003|Overall Study|Adverse Event|3|||
94601572|NCT00645788|324004376|FG000|Overall Study|Lost to Follow-up|1|||
94601573|NCT00645788|324004377|FG001|Overall Study|Lost to Follow-up|0|||
94601574|NCT00645788|324004378|FG002|Overall Study|Lost to Follow-up|0|||
94601575|NCT00645788|324004379|FG003|Overall Study|Lost to Follow-up|0|||
94601576|NCT00645788|324004376|FG000|Overall Study|Protocol Violation|1|||
94601577|NCT00645788|324004377|FG001|Overall Study|Protocol Violation|0|||
94601578|NCT00645788|324004378|FG002|Overall Study|Protocol Violation|2|||
94601579|NCT00645788|324004379|FG003|Overall Study|Protocol Violation|0|||
94601580|NCT00645788|324004376|FG000|Overall Study|Withdrawal by Subject|0|||
94601581|NCT00645788|324004377|FG001|Overall Study|Withdrawal by Subject|1|||
94601582|NCT00645788|324004378|FG002|Overall Study|Withdrawal by Subject|0|||
94601583|NCT00645788|324004379|FG003|Overall Study|Withdrawal by Subject|2|||
94248506|NCT01160289|322704870|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
94248507|NCT01160289|322704865|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
94601584|NCT00645788|324004376|FG000|Overall Study|Pulmonary exacerbation|13|||
94601585|NCT00645788|324004377|FG001|Overall Study|Pulmonary exacerbation|16|||
94601586|NCT00645788|324004378|FG002|Overall Study|Pulmonary exacerbation|11|||
94661080|NCT01434602|324213894|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
94661081|NCT01434602|324213895|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
94661082|NCT01434602|324213891|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
94661083|NCT01434602|324213892|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
94661084|NCT01434602|324213893|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
94661085|NCT01434602|324213894|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
94661086|NCT01434602|324213895|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
94356064|NCT01050998|323085793|FG002|Overall Study|Adverse Event|1|||
94601587|NCT00645788|324004379|FG003|Overall Study|Pulmonary exacerbation|9|||
94601588|NCT03149848|324004380|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
94601589|NCT03149848|324004380|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
94601590|NCT00591578|324004381|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
94601591|NCT00591578|324004382|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
94661087|NCT01434602|324213891|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
94661088|NCT01434602|324213892|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
94661089|NCT01434602|324213893|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
94661090|NCT01434602|324213894|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
94661091|NCT01434602|324213895|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
94661092|NCT01434602|324213891|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
94661093|NCT01434602|324213892|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
94661094|NCT01434602|324213893|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
94661095|NCT01434602|324213894|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
94661096|NCT01434602|324213895|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
94661097|NCT01434602|324213891|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
94661098|NCT01434602|324213892|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
94661099|NCT01434602|324213893|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
94661100|NCT01434602|324213894|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
94661101|NCT01434602|324213895|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
94661102|NCT01434602|324213891|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
94661103|NCT01434602|324213892|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
94601592|NCT00591578|324004383|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
94601593|NCT00591578|324004381|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
94601594|NCT00591578|324004382|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
94601595|NCT00591578|324004383|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
94601596|NCT00591578|324004381|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
94601597|NCT00591578|324004382|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
94601598|NCT00591578|324004383|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
94601599|NCT00591578|324004381|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
94601600|NCT00591578|324004382|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
94661104|NCT01434602|324213893|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
94661105|NCT01434602|324213894|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
94661106|NCT01434602|324213895|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
94661107|NCT01434602|324213891|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
94661108|NCT01434602|324213892|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
94661109|NCT01434602|324213893|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
94661110|NCT01434602|324213894|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
94661111|NCT01434602|324213895|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
94661112|NCT01434602|324213891|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
94248508|NCT01160289|322704866|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
94248509|NCT01160289|322704867|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
94248510|NCT01160289|322704868|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
94248511|NCT01160289|322704869|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
94248512|NCT01160289|322704870|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
94248513|NCT01160289|322704865|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
94248514|NCT01160289|322704866|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
94248515|NCT01160289|322704867|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
94248516|NCT01160289|322704868|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
94248517|NCT01160289|322704869|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
94248518|NCT01160289|322704870|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
94248519|NCT01160289|322704865|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
94248520|NCT01160289|322704866|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
94248521|NCT01160289|322704867|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
94248522|NCT01160289|322704868|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
94248523|NCT01160289|322704869|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
94248524|NCT01160289|322704870|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
94248525|NCT01160289|322704865|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
94248526|NCT01160289|322704866|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
94248527|NCT01160289|322704867|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
94248528|NCT01160289|322704868|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
94248529|NCT01160289|322704869|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
94601601|NCT00591578|324004383|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
94601602|NCT00591578|324004381|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
94601603|NCT00591578|324004382|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
94601604|NCT00591578|324004383|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
94601605|NCT00591578|324004381|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
94601606|NCT00591578|324004382|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
94601607|NCT00591578|324004383|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
94601608|NCT00591578|324004381|FG000|Double-Blind Treatment Phase|Other|4|||
94601609|NCT00591578|324004382|FG001|Double-Blind Treatment Phase|Other|9|||
94601610|NCT00591578|324004383|FG002|Double-Blind Treatment Phase|Other|4|||
94601611|NCT00591578|324004381|FG000|Open-Label Extension Phase|Adverse Event|3|||
94601612|NCT00591578|324004382|FG001|Open-Label Extension Phase|Adverse Event|5|||
94601613|NCT00591578|324004383|FG002|Open-Label Extension Phase|Adverse Event|0|||
94601614|NCT00591578|324004381|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
94601615|NCT00591578|324004382|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
94601616|NCT00591578|324004383|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
94601617|NCT00591578|324004381|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
94601618|NCT00591578|324004382|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
94601619|NCT00591578|324004383|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
94601620|NCT00591578|324004381|FG000|Open-Label Extension Phase|Other|1|||
94601621|NCT00591578|324004382|FG001|Open-Label Extension Phase|Other|0|||
94601622|NCT00591578|324004383|FG002|Open-Label Extension Phase|Other|0|||
94601623|NCT03224546|324004389|FG000|Overall Study|Lost to Follow-up|9|||
94601624|NCT03224546|324004390|FG001|Overall Study|Lost to Follow-up|8|||
94601625|NCT03224546|324004391|FG002|Overall Study|Lost to Follow-up|3|||
94601626|NCT03224546|324004389|FG000|Overall Study|Withdrawal by Subject|7|||
94601627|NCT03224546|324004390|FG001|Overall Study|Withdrawal by Subject|14|||
94601628|NCT03224546|324004391|FG002|Overall Study|Withdrawal by Subject|12|||
94601629|NCT01163032|324004392|FG000|Randomization Phase|Withdrawal by Subject|2|||
94601630|NCT01163032|324004393|FG001|Randomization Phase|Withdrawal by Subject|3|||
94601631|NCT01163032|324004394|FG002|Randomization Phase|Withdrawal by Subject|0|||
94601632|NCT01163032|324004392|FG000|Randomization Phase|Adverse Event|3|||
94601633|NCT01163032|324004393|FG001|Randomization Phase|Adverse Event|3|||
94601634|NCT01163032|324004394|FG002|Randomization Phase|Adverse Event|0|||
94601635|NCT01163032|324004392|FG000|Randomization Phase|Protocol Violation|0|||
94601636|NCT01163032|324004393|FG001|Randomization Phase|Protocol Violation|1|||
94601637|NCT01163032|324004394|FG002|Randomization Phase|Protocol Violation|0|||
94601638|NCT01163032|324004392|FG000|Randomization Phase|Various*|5|||
94601639|NCT01163032|324004393|FG001|Randomization Phase|Various*|4|||
94601640|NCT01163032|324004394|FG002|Randomization Phase|Various*|0|||
94601641|NCT01163032|324004392|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
94601642|NCT01163032|324004393|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
94601643|NCT01163032|324004394|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
94248530|NCT01160289|322704870|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
94601644|NCT01163032|324004392|FG000|Open Label Extension Phase|Adverse Event|0|||
94601645|NCT01163032|324004393|FG001|Open Label Extension Phase|Adverse Event|0|||
94601646|NCT01163032|324004394|FG002|Open Label Extension Phase|Adverse Event|3|||
94601647|NCT01163032|324004392|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
94601648|NCT01163032|324004393|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
94661113|NCT01434602|324213892|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
94661114|NCT01434602|324213893|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
94661115|NCT01434602|324213894|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
94661116|NCT01434602|324213895|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
94601649|NCT01163032|324004394|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
94601650|NCT01163032|324004392|FG000|Open Label Extension Phase|Protocol Violation|0|||
94601651|NCT01163032|324004393|FG001|Open Label Extension Phase|Protocol Violation|0|||
94661117|NCT01434602|324213891|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
94661118|NCT01434602|324213892|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
94601652|NCT01163032|324004394|FG002|Open Label Extension Phase|Protocol Violation|1|||
94601653|NCT01163032|324004392|FG000|Open Label Extension Phase|Study Termination|0|||
94601654|NCT01163032|324004393|FG001|Open Label Extension Phase|Study Termination|0|||
94601655|NCT01163032|324004394|FG002|Open Label Extension Phase|Study Termination|7|||
94601656|NCT01163032|324004392|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
94601657|NCT01163032|324004393|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
94601658|NCT01163032|324004394|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
94601659|NCT02751931|324004400|FG000|Overall Study|Adverse Event|3|||
94601660|NCT02751931|324004401|FG001|Overall Study|Adverse Event|0|||
94601661|NCT02751931|324004400|FG000|Overall Study|Other: Miscelleneous|10|||
94601662|NCT02751931|324004401|FG001|Overall Study|Other: Miscelleneous|8|||
94601663|NCT01307020|324004406|FG000|Overall Study|Lost to Follow-up|0|||
94601664|NCT01307020|324004407|FG001|Overall Study|Lost to Follow-up|0|||
94601665|NCT01307020|324004408|FG002|Overall Study|Lost to Follow-up|1|||
94601666|NCT01307020|324004409|FG003|Overall Study|Lost to Follow-up|1|||
94601667|NCT01307020|324004410|FG004|Overall Study|Lost to Follow-up|0|||
94601668|NCT01307020|324004411|FG005|Overall Study|Lost to Follow-up|0|||
94661119|NCT01434602|324213893|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
94661120|NCT01434602|324213894|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
94661121|NCT01434602|324213895|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
94661122|NCT01434602|324213891|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
94661123|NCT01434602|324213892|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
94661124|NCT01434602|324213893|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
94661125|NCT01434602|324213894|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
94601669|NCT01307020|324004412|FG006|Overall Study|Lost to Follow-up|1|||
94601670|NCT01307020|324004413|FG007|Overall Study|Lost to Follow-up|0|||
94601671|NCT01307020|324004414|FG008|Overall Study|Lost to Follow-up|0|||
94601672|NCT01307020|324004415|FG009|Overall Study|Lost to Follow-up|0|||
94601673|NCT01307020|324004406|FG000|Overall Study|Electronic data capture failure|0|||
94601674|NCT01307020|324004407|FG001|Overall Study|Electronic data capture failure|1|||
94601675|NCT01307020|324004408|FG002|Overall Study|Electronic data capture failure|0|||
94601676|NCT01307020|324004409|FG003|Overall Study|Electronic data capture failure|0|||
94601677|NCT01307020|324004410|FG004|Overall Study|Electronic data capture failure|0|||
94601678|NCT01307020|324004411|FG005|Overall Study|Electronic data capture failure|0|||
94601679|NCT01307020|324004412|FG006|Overall Study|Electronic data capture failure|0|||
94601680|NCT01307020|324004413|FG007|Overall Study|Electronic data capture failure|0|||
94601681|NCT01307020|324004414|FG008|Overall Study|Electronic data capture failure|0|||
94601682|NCT01307020|324004415|FG009|Overall Study|Electronic data capture failure|0|||
94601683|NCT02380690|324004416|FG000|Overall Study|Lost to Follow-up|14|||
94601684|NCT02380690|324004417|FG001|Overall Study|Lost to Follow-up|4|||
94601685|NCT02380690|324004416|FG000|Overall Study|Withdrawal by Subject|20|||
94601686|NCT02380690|324004417|FG001|Overall Study|Withdrawal by Subject|8|||
94661126|NCT01434602|324213895|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
94661127|NCT01220557|324213901|FG000|Overall Study|Lost to Follow-up|5|||
94661128|NCT01220557|324213902|FG001|Overall Study|Lost to Follow-up|3|||
94661129|NCT01220557|324213901|FG000|Overall Study|attended less than 6 lessons|1|||
94661130|NCT01220557|324213902|FG001|Overall Study|attended less than 6 lessons|2|||
94356065|NCT01050998|323085794|FG003|Overall Study|Adverse Event|0|||
94356066|NCT01050998|323085795|FG004|Overall Study|Adverse Event|2|||
94661131|NCT05077267|324213903|FG000|Treatment Period|Lost to Follow-up|0|||
94661132|NCT05077267|324213904|FG001|Treatment Period|Lost to Follow-up|1|||
94356067|NCT01050998|323085791|FG000|Overall Study|Withdrawal by Subject|0|||
94601687|NCT01958827|324004420|FG000|Overall Study|Adverse Event|3|||
94601688|NCT01958827|324004420|FG000|Overall Study|Lack of Efficacy|6|||
94601689|NCT01958827|324004420|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
94601690|NCT00727532|324004421|FG000|Overall Study|Adverse Event|1|||
94601691|NCT00727532|324004421|FG000|Overall Study|Withdrawal by Subject|1|||
94601692|NCT01986933|324004422|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
94601693|NCT01986933|324004423|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
94601694|NCT01986933|324004424|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
94601695|NCT01986933|324004425|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
94601696|NCT01986933|324004426|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
94601697|NCT01986933|324004422|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
94601698|NCT01986933|324004423|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
94601699|NCT01986933|324004424|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
94601700|NCT01986933|324004425|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
94601701|NCT01986933|324004426|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
94601702|NCT01986933|324004422|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
94601703|NCT01986933|324004423|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
94601704|NCT01986933|324004424|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
94601705|NCT01986933|324004425|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
94601706|NCT01986933|324004426|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
94601707|NCT01986933|324004422|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
94601708|NCT01986933|324004423|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
94601709|NCT01986933|324004424|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
94601710|NCT01986933|324004425|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
94601711|NCT01986933|324004426|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
94601712|NCT01986933|324004422|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
94601713|NCT01986933|324004423|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
94601714|NCT01986933|324004424|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
94601715|NCT01986933|324004425|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
94601716|NCT01986933|324004426|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
94601717|NCT01986933|324004422|FG000|Active-to-active (Part B)|Adverse Event|0|||
94601718|NCT01986933|324004423|FG001|Active-to-active (Part B)|Adverse Event|2|||
94661133|NCT05077267|324213905|FG002|Treatment Period|Lost to Follow-up|0|||
94661134|NCT05077267|324213903|FG000|Treatment Period|Withdrawal by Subject|0|||
94661135|NCT05077267|324213904|FG001|Treatment Period|Withdrawal by Subject|1|||
94661136|NCT05077267|324213905|FG002|Treatment Period|Withdrawal by Subject|0|||
94661137|NCT05077267|324213903|FG000|Follow-up Period|Lost to Follow-up|0|||
94661138|NCT05077267|324213904|FG001|Follow-up Period|Lost to Follow-up|5|||
94661139|NCT05077267|324213905|FG002|Follow-up Period|Lost to Follow-up|7|||
94661140|NCT05077267|324213903|FG000|Follow-up Period|Withdrawal by Subject|0|||
94661141|NCT05077267|324213904|FG001|Follow-up Period|Withdrawal by Subject|2|||
94661142|NCT05077267|324213905|FG002|Follow-up Period|Withdrawal by Subject|5|||
94601719|NCT01986933|324004424|FG002|Active-to-active (Part B)|Adverse Event|0|||
94601720|NCT01986933|324004425|FG003|Active-to-active (Part B)|Adverse Event|1|||
94601721|NCT01986933|324004426|FG004|Active-to-active (Part B)|Adverse Event|3|||
94601722|NCT01986933|324004422|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
94601723|NCT01986933|324004423|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
94601724|NCT01986933|324004424|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
94601725|NCT01986933|324004425|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
94601726|NCT01986933|324004426|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
94601727|NCT01986933|324004422|FG000|Active-to-active (Part B)|Pregnancy|0|||
94601728|NCT01986933|324004423|FG001|Active-to-active (Part B)|Pregnancy|0|||
94601729|NCT01986933|324004424|FG002|Active-to-active (Part B)|Pregnancy|0|||
94601730|NCT01986933|324004425|FG003|Active-to-active (Part B)|Pregnancy|0|||
94601731|NCT01986933|324004426|FG004|Active-to-active (Part B)|Pregnancy|1|||
94601732|NCT01986933|324004422|FG000|Active-to-active (Part B)|Physician Decision|0|||
94601733|NCT01986933|324004423|FG001|Active-to-active (Part B)|Physician Decision|0|||
94601734|NCT01986933|324004424|FG002|Active-to-active (Part B)|Physician Decision|1|||
94601735|NCT01986933|324004425|FG003|Active-to-active (Part B)|Physician Decision|1|||
94601736|NCT01986933|324004426|FG004|Active-to-active (Part B)|Physician Decision|0|||
94601737|NCT01986933|324004422|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
94601738|NCT01986933|324004423|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
94601739|NCT01986933|324004424|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
94601740|NCT01986933|324004425|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
94601741|NCT01986933|324004426|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
94601742|NCT01986933|324004422|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
94601743|NCT01986933|324004423|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
94601744|NCT01986933|324004424|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
94601745|NCT01986933|324004425|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
94601746|NCT01986933|324004426|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
94661143|NCT05077267|324213903|FG000|Follow-up Period|Study terminated by sponsor|0|||
94661144|NCT05077267|324213904|FG001|Follow-up Period|Study terminated by sponsor|27|||
94661145|NCT05077267|324213905|FG002|Follow-up Period|Study terminated by sponsor|23|||
94601747|NCT01986933|324004422|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
94661146|NCT05077267|324213903|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
94661147|NCT05077267|324213904|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
94601748|NCT01986933|324004423|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
94601749|NCT01986933|324004424|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
94601750|NCT01986933|324004425|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
94601751|NCT01986933|324004426|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
94601752|NCT01986933|324004422|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
94601753|NCT01986933|324004423|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
94661148|NCT05077267|324213905|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
94601754|NCT01986933|324004424|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
94601755|NCT01986933|324004425|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
94601756|NCT01986933|324004426|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
94601757|NCT01986933|324004422|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
94601758|NCT01986933|324004423|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
94601759|NCT01986933|324004424|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
94601760|NCT01986933|324004425|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
94601761|NCT01986933|324004426|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
94601762|NCT01986933|324004422|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
94601763|NCT01986933|324004423|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
94601764|NCT01986933|324004424|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
94601765|NCT01986933|324004425|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
94661149|NCT05077267|324213903|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
94661150|NCT05077267|324213904|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
94601766|NCT01986933|324004426|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
94601767|NCT01986933|324004422|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
94661151|NCT05077267|324213905|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
94661152|NCT02911948|324213906|FG000|Overall Study|Protocol Violation|0|||
94661153|NCT02911948|324213907|FG001|Overall Study|Protocol Violation|1|||
94661154|NCT02911948|324213906|FG000|Overall Study|Withdrawal by Subject|0|||
94661155|NCT02911948|324213907|FG001|Overall Study|Withdrawal by Subject|2|||
94661156|NCT02911948|324213906|FG000|Overall Study|Lack of Efficacy|0|||
94661157|NCT02911948|324213907|FG001|Overall Study|Lack of Efficacy|1|||
94661158|NCT02911948|324213906|FG000|Overall Study|Unclassified|0|||
94661159|NCT02911948|324213907|FG001|Overall Study|Unclassified|3|||
94661160|NCT01136291|324213909|FG000|Overall Study|Lost to Follow-up|1|||
94661161|NCT01136291|324213910|FG001|Overall Study|Lost to Follow-up|1|||
94661162|NCT00759109|324213911|FG000|Overall Study|Adverse Event|17|||
94661163|NCT00759109|324213912|FG001|Overall Study|Adverse Event|12|||
94661164|NCT00759109|324213911|FG000|Overall Study|Inability to comply|1|||
94661165|NCT00759109|324213912|FG001|Overall Study|Inability to comply|1|||
94661166|NCT00759109|324213911|FG000|Overall Study|Withdrawal by Subject|9|||
94661167|NCT00759109|324213912|FG001|Overall Study|Withdrawal by Subject|5|||
94661168|NCT00759109|324213911|FG000|Overall Study|Death|4|||
94661169|NCT00759109|324213912|FG001|Overall Study|Death|3|||
94661170|NCT00759109|324213911|FG000|Overall Study|Lost to Follow-up|4|||
94661171|NCT00759109|324213912|FG001|Overall Study|Lost to Follow-up|6|||
94661172|NCT00759109|324213911|FG000|Overall Study|Started new therapy|2|||
94661173|NCT00759109|324213912|FG001|Overall Study|Started new therapy|6|||
94661174|NCT00759109|324213911|FG000|Overall Study|HCV RNA negative|1|||
94661175|NCT00759109|324213912|FG001|Overall Study|HCV RNA negative|0|||
94661176|NCT00759109|324213911|FG000|Overall Study|Participant moved to a different city|0|||
94661177|NCT00759109|324213912|FG001|Overall Study|Participant moved to a different city|1|||
94661178|NCT00759109|324213911|FG000|Overall Study|Participant had a liver transplant|0|||
94661179|NCT00759109|324213912|FG001|Overall Study|Participant had a liver transplant|1|||
94661180|NCT00759109|324213911|FG000|Overall Study|Lost during study|1|||
94661181|NCT00759109|324213912|FG001|Overall Study|Lost during study|0|||
94661182|NCT02308033|324213913|FG000|Overall Study|Normal Gram stain at Baseline|13|||
94661183|NCT02308033|324213914|FG001|Overall Study|Normal Gram stain at Baseline|10|||
94661184|NCT02308033|324213913|FG000|Overall Study|Positive for STD at Baseline|7|||
94661185|NCT02308033|324213914|FG001|Overall Study|Positive for STD at Baseline|4|||
94661186|NCT02308033|324213913|FG000|Overall Study|Lost to Follow-up|6|||
94661187|NCT02308033|324213914|FG001|Overall Study|Lost to Follow-up|5|||
94661188|NCT00499889|324213915|FG000|Overall Study|Infection prior to treatment|1|||
94661189|NCT01660763|324213916|FG000|Overall Study|Lack of Efficacy|45|||
94661190|NCT01660763|324213917|FG001|Overall Study|Lack of Efficacy|50|||
94661191|NCT01660763|324213916|FG000|Overall Study|Adverse Event|22|||
94601768|NCT01986933|324004423|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
94601769|NCT01986933|324004424|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
94661192|NCT01660763|324213917|FG001|Overall Study|Adverse Event|7|||
94661193|NCT01660763|324213916|FG000|Overall Study|Protocol Violation|1|||
94661194|NCT01660763|324213917|FG001|Overall Study|Protocol Violation|0|||
94661195|NCT01660763|324213916|FG000|Overall Study|Withdrawal by Subject|4|||
94601770|NCT01986933|324004425|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
94661196|NCT01660763|324213917|FG001|Overall Study|Withdrawal by Subject|0|||
94661197|NCT01660763|324213916|FG000|Overall Study|Patient ready for early discharge|28|||
94661198|NCT01660763|324213917|FG001|Overall Study|Patient ready for early discharge|4|||
94601771|NCT01986933|324004426|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
94601772|NCT01986933|324004422|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
94601773|NCT01986933|324004423|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
94601774|NCT01986933|324004424|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
94601775|NCT01986933|324004425|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
94601776|NCT01986933|324004426|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
94601777|NCT00596362|324004428|FG000|Overall Study|Progressive Disease|1|||
94601778|NCT00817479|324004429|FG000|Overall Study|Physician Decision|1|||
94601779|NCT00817479|324004430|FG001|Overall Study|Physician Decision|1|||
94601780|NCT01074047|324004431|FG000|Treatment Phase|Adverse Event|89|||
94601781|NCT01074047|324004432|FG001|Treatment Phase|Adverse Event|66|||
94601782|NCT01074047|324004431|FG000|Treatment Phase|Disease Progression|16|||
94601783|NCT01074047|324004432|FG001|Treatment Phase|Disease Progression|21|||
94601784|NCT01074047|324004431|FG000|Treatment Phase|Withdrawal by Subject|27|||
94601785|NCT01074047|324004432|FG001|Treatment Phase|Withdrawal by Subject|48|||
94601786|NCT01074047|324004431|FG000|Treatment Phase|Death|53|||
94601787|NCT01074047|324004432|FG001|Treatment Phase|Death|58|||
94601788|NCT01074047|324004431|FG000|Treatment Phase|Lost to Follow-up|0|||
94601789|NCT01074047|324004432|FG001|Treatment Phase|Lost to Follow-up|1|||
94601790|NCT01074047|324004431|FG000|Treatment Phase|Protocol Violation|0|||
94601791|NCT01074047|324004432|FG001|Treatment Phase|Protocol Violation|1|||
94601792|NCT01074047|324004431|FG000|Treatment Phase|Miscellaneous|32|||
94601793|NCT01074047|324004432|FG001|Treatment Phase|Miscellaneous|39|||
94601794|NCT01074047|324004431|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
94601795|NCT01074047|324004432|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
94601796|NCT01074047|324004431|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
94601797|NCT01074047|324004432|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
94601798|NCT01074047|324004431|FG000|Survival Follow-Up Phase|Death|116|||
94601799|NCT01074047|324004432|FG001|Survival Follow-Up Phase|Death|124|||
94601800|NCT01074047|324004431|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
94601801|NCT01074047|324004432|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
94601802|NCT01074047|324004431|FG000|Extension Phase|Physician Decision|1|||
94601803|NCT01074047|324004432|FG001|Extension Phase|Physician Decision|0|||
94601804|NCT01074047|324004431|FG000|Extension Phase|Adverse Event|5|||
94601805|NCT01074047|324004432|FG001|Extension Phase|Adverse Event|0|||
94601806|NCT01074047|324004431|FG000|Extension Phase|Disease Progression|9|||
94601807|NCT01074047|324004432|FG001|Extension Phase|Disease Progression|0|||
94601808|NCT01074047|324004431|FG000|Extension Phase|Withdrawal by Subject|2|||
94601809|NCT01074047|324004432|FG001|Extension Phase|Withdrawal by Subject|0|||
94601810|NCT01074047|324004431|FG000|Extension Phase|Death|5|||
94601811|NCT01074047|324004432|FG001|Extension Phase|Death|0|||
94601812|NCT04340063|324004433|FG000|Overall Study|Withdrawal by Subject|1|||
94601813|NCT04340063|324004434|FG001|Overall Study|Withdrawal by Subject|2|||
94601814|NCT04340063|324004433|FG000|Overall Study|Lost to Follow-up|3|||
94601815|NCT04340063|324004434|FG001|Overall Study|Lost to Follow-up|1|||
94601816|NCT04340063|324004433|FG000|Overall Study|Protocol Violation|0|||
94601817|NCT04340063|324004434|FG001|Overall Study|Protocol Violation|1|||
94601818|NCT03287635|324004437|FG000|Overall Study|Lost to Follow-up|5|||
94601819|NCT03287635|324004437|FG000|Overall Study|Withdrawal by Subject|1|||
94601820|NCT03287635|324004437|FG000|Overall Study|Physician Decision|1|||
94601821|NCT01757691|324005948|FG000|Overall Study|Administrative problems|2|||
94601822|NCT01757691|324005949|FG001|Overall Study|Administrative problems|0|||
94601823|NCT00920907|324005952|FG000|Induction Period|Adverse Event|0|||
94601824|NCT00920907|324005953|FG001|Induction Period|Adverse Event|2|||
94601825|NCT00920907|324005952|FG000|Induction Period|Death|1|||
94601826|NCT00920907|324005953|FG001|Induction Period|Death|1|||
94601827|NCT00920907|324005952|FG000|Induction Period|Disease Progression|12|||
94601828|NCT00920907|324005953|FG001|Induction Period|Disease Progression|11|||
94601829|NCT00920907|324005952|FG000|Induction Period|Study Drug Toxicity|8|||
94601830|NCT00920907|324005953|FG001|Induction Period|Study Drug Toxicity|6|||
94601831|NCT00920907|324005952|FG000|Induction Period|No longer meets study criteria|0|||
94601832|NCT00920907|324005953|FG001|Induction Period|No longer meets study criteria|1|||
94601833|NCT00920907|324005952|FG000|Induction Period|Withdrawal by Subject|1|||
94601834|NCT00920907|324005953|FG001|Induction Period|Withdrawal by Subject|1|||
94601835|NCT00920907|324005952|FG000|Maintenance Period|Disease Progression|3|||
94601836|NCT00920907|324005953|FG001|Maintenance Period|Disease Progression|7|||
94601837|NCT00920907|324005952|FG000|Maintenance Period|Administrative (study closure)|7|||
94661199|NCT00345397|324213918|FG000|Overall Study|Death|1|||
94661200|NCT00718718|324213919|FG000|Prior to Week 12|Adverse Event|0|||
94661201|NCT00718718|324213920|FG001|Prior to Week 12|Adverse Event|0|||
94601838|NCT00920907|324005953|FG001|Maintenance Period|Administrative (study closure)|2|||
94601839|NCT00920907|324005952|FG000|Maintenance Period|Study Drug Toxicity|0|||
94601840|NCT00920907|324005953|FG001|Maintenance Period|Study Drug Toxicity|2|||
94601841|NCT00920907|324005952|FG000|Maintenance Period|Death|1|||
94601842|NCT00920907|324005953|FG001|Maintenance Period|Death|1|||
94601843|NCT00920907|324005952|FG000|Maintenance Period|Withdrawal by Subject|1|||
94661202|NCT00718718|324213921|FG002|Prior to Week 12|Adverse Event|0|||
94661203|NCT00718718|324213922|FG003|Prior to Week 12|Adverse Event|0|||
94661204|NCT00718718|324213923|FG004|Prior to Week 12|Adverse Event|0|||
94661205|NCT00718718|324213924|FG005|Prior to Week 12|Adverse Event|0|||
94661206|NCT00718718|324213925|FG006|Prior to Week 12|Adverse Event|0|||
94661207|NCT00718718|324213926|FG007|Prior to Week 12|Adverse Event|1|||
94661208|NCT00718718|324213927|FG008|Prior to Week 12|Adverse Event|1|||
94661209|NCT00718718|324213928|FG009|Prior to Week 12|Adverse Event|0|||
94661210|NCT00718718|324213919|FG000|Prior to Week 12|Withdrawal by Subject|0|||
94661211|NCT00718718|324213920|FG001|Prior to Week 12|Withdrawal by Subject|0|||
94661212|NCT00718718|324213921|FG002|Prior to Week 12|Withdrawal by Subject|0|||
94661213|NCT00718718|324213922|FG003|Prior to Week 12|Withdrawal by Subject|0|||
94661214|NCT00718718|324213923|FG004|Prior to Week 12|Withdrawal by Subject|3|||
94601844|NCT00920907|324005953|FG001|Maintenance Period|Withdrawal by Subject|0|||
94601845|NCT00920907|324005952|FG000|Maintenance Period|Adverse Event|0|||
94601846|NCT00920907|324005953|FG001|Maintenance Period|Adverse Event|1|||
94601847|NCT04656275|324005954|FG000|Overall Study|Study terminated by sponsor|2|||
94601848|NCT04656275|324005955|FG001|Overall Study|Study terminated by sponsor|4|||
94601849|NCT01993836|324005956|FG000|Overall Study|Surgery Cancelled|3|||
94601850|NCT01993836|324005957|FG001|Overall Study|Surgery Cancelled|0|||
94601851|NCT01993836|324005958|FG002|Overall Study|Surgery Cancelled|0|||
94601852|NCT01993836|324005956|FG000|Overall Study|Physician Decision|2|||
94601853|NCT01993836|324005957|FG001|Overall Study|Physician Decision|1|||
94601854|NCT01993836|324005958|FG002|Overall Study|Physician Decision|0|||
94601855|NCT01993836|324005956|FG000|Overall Study|Death|0|||
94601856|NCT01993836|324005957|FG001|Overall Study|Death|2|||
94601857|NCT01993836|324005958|FG002|Overall Study|Death|0|||
94601858|NCT01993836|324005956|FG000|Overall Study|Withdrawal by Subject|12|||
94601859|NCT01993836|324005957|FG001|Overall Study|Withdrawal by Subject|10|||
94601860|NCT01993836|324005958|FG002|Overall Study|Withdrawal by Subject|5|||
94601861|NCT03584373|324005961|FG000|Overall Study|Lost to Follow-up|7|||
94601862|NCT03584373|324005962|FG001|Overall Study|Lost to Follow-up|8|||
94601863|NCT01487577|324005963|FG000|Overall Study|Became ineligible after signing consent|1|||
94601864|NCT01653782|324005965|FG000|Overall Study|Withdrawal by Subject|9|||
94601865|NCT01653782|324005966|FG001|Overall Study|Withdrawal by Subject|15|||
94601866|NCT01653782|324005967|FG002|Overall Study|Withdrawal by Subject|4|||
94601867|NCT01653782|324005965|FG000|Overall Study|Lost to Follow-up|7|||
94601868|NCT01653782|324005966|FG001|Overall Study|Lost to Follow-up|3|||
94601869|NCT01653782|324005967|FG002|Overall Study|Lost to Follow-up|2|||
94601870|NCT01895361|324005968|FG000|Overall Study|Adverse Event|1|||
94601871|NCT01895361|324005969|FG001|Overall Study|Adverse Event|1|||
94601872|NCT01895361|324005970|FG002|Overall Study|Adverse Event|3|||
94601873|NCT01895361|324005968|FG000|Overall Study|Death|2|||
94601874|NCT01895361|324005969|FG001|Overall Study|Death|1|||
94601875|NCT01895361|324005970|FG002|Overall Study|Death|2|||
94601876|NCT01895361|324005968|FG000|Overall Study|Lost to Follow-up|4|||
94601877|NCT01895361|324005969|FG001|Overall Study|Lost to Follow-up|4|||
94601878|NCT01895361|324005970|FG002|Overall Study|Lost to Follow-up|6|||
94601879|NCT01895361|324005968|FG000|Overall Study|Non-compliance with study|1|||
94601880|NCT01895361|324005969|FG001|Overall Study|Non-compliance with study|3|||
94601881|NCT01895361|324005970|FG002|Overall Study|Non-compliance with study|1|||
94601882|NCT01895361|324005968|FG000|Overall Study|Physician Decision|2|||
94601883|NCT01895361|324005969|FG001|Overall Study|Physician Decision|2|||
94601884|NCT01895361|324005970|FG002|Overall Study|Physician Decision|2|||
94601885|NCT01895361|324005968|FG000|Overall Study|Withdrawal by Subject|7|||
94601886|NCT01895361|324005969|FG001|Overall Study|Withdrawal by Subject|6|||
94601887|NCT01895361|324005970|FG002|Overall Study|Withdrawal by Subject|6|||
94601888|NCT01895361|324005968|FG000|Overall Study|Lack of Efficacy|0|||
94661215|NCT00718718|324213924|FG005|Prior to Week 12|Withdrawal by Subject|0|||
94661216|NCT00718718|324213925|FG006|Prior to Week 12|Withdrawal by Subject|1|||
94661217|NCT00718718|324213926|FG007|Prior to Week 12|Withdrawal by Subject|1|||
94601889|NCT01895361|324005969|FG001|Overall Study|Lack of Efficacy|1|||
94601890|NCT01895361|324005970|FG002|Overall Study|Lack of Efficacy|0|||
94601891|NCT01895361|324005968|FG000|Overall Study|Reasons different from categories above|7|||
94601892|NCT01895361|324005969|FG001|Overall Study|Reasons different from categories above|3|||
94601893|NCT01895361|324005970|FG002|Overall Study|Reasons different from categories above|4|||
94601894|NCT00367770|324005971|FG000|Overall Study|Adverse Event|1|||
94601895|NCT00367770|324005971|FG000|Overall Study|Withdrawal by Subject|1|||
94601896|NCT03355664|324005972|FG000|Overall Study|Adverse Event|1|||
94601897|NCT03355664|324005973|FG001|Overall Study|Adverse Event|2|||
94601898|NCT03355664|324005972|FG000|Overall Study|Lost to Follow-up|11|||
94601899|NCT03355664|324005973|FG001|Overall Study|Lost to Follow-up|7|||
94661218|NCT00718718|324213927|FG008|Prior to Week 12|Withdrawal by Subject|1|||
94601900|NCT03355664|324005972|FG000|Overall Study|Protocol Violation|1|||
94601901|NCT03355664|324005973|FG001|Overall Study|Protocol Violation|2|||
94601902|NCT03355664|324005972|FG000|Overall Study|Withdrawal by Subject|2|||
94601903|NCT03355664|324005973|FG001|Overall Study|Withdrawal by Subject|1|||
94601904|NCT00761748|324005974|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
94601905|NCT00761748|324005975|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
94601906|NCT00761748|324005974|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
94601907|NCT00761748|324005975|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
94601908|NCT01155479|324005978|FG000|Part I|Adverse Event|13|||
94601909|NCT01155479|324005979|FG001|Part I|Adverse Event|8|||
94601910|NCT01155479|324005980|FG002|Part I|Adverse Event|18|||
94601911|NCT01155479|324005981|FG003|Part I|Adverse Event|7|||
94601912|NCT01155479|324005982|FG004|Part I|Adverse Event|6|||
94601913|NCT01155479|324005978|FG000|Part I|Administrative|2|||
94601914|NCT01155479|324005979|FG001|Part I|Administrative|2|||
94601915|NCT01155479|324005980|FG002|Part I|Administrative|2|||
94601916|NCT01155479|324005981|FG003|Part I|Administrative|0|||
94601917|NCT01155479|324005982|FG004|Part I|Administrative|0|||
94601918|NCT01155479|324005978|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
94601919|NCT01155479|324005979|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
94601920|NCT01155479|324005980|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
94601921|NCT01155479|324005981|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
94601922|NCT01155479|324005982|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
94601923|NCT01155479|324005978|FG000|Part I|Withdrawal by Subject|11|||
94601924|NCT01155479|324005979|FG001|Part I|Withdrawal by Subject|13|||
94601925|NCT01155479|324005980|FG002|Part I|Withdrawal by Subject|8|||
94601926|NCT01155479|324005981|FG003|Part I|Withdrawal by Subject|8|||
94601927|NCT01155479|324005982|FG004|Part I|Withdrawal by Subject|9|||
94601928|NCT01155479|324005978|FG000|Part I|Lost to Follow-up|0|||
94601929|NCT01155479|324005979|FG001|Part I|Lost to Follow-up|0|||
94601930|NCT01155479|324005980|FG002|Part I|Lost to Follow-up|1|||
94601931|NCT01155479|324005981|FG003|Part I|Lost to Follow-up|1|||
94601932|NCT01155479|324005982|FG004|Part I|Lost to Follow-up|0|||
94601933|NCT01155479|324005978|FG000|Part I|Treatment Failure|3|||
94601934|NCT01155479|324005979|FG001|Part I|Treatment Failure|0|||
94601935|NCT01155479|324005980|FG002|Part I|Treatment Failure|3|||
94601936|NCT01155479|324005981|FG003|Part I|Treatment Failure|1|||
94601937|NCT01155479|324005982|FG004|Part I|Treatment Failure|2|||
94601938|NCT01155479|324005978|FG000|Part I|Did Not Receive Treatment|4|||
94601939|NCT01155479|324005979|FG001|Part I|Did Not Receive Treatment|2|||
94601940|NCT01155479|324005980|FG002|Part I|Did Not Receive Treatment|2|||
94601941|NCT01155479|324005981|FG003|Part I|Did Not Receive Treatment|6|||
94601942|NCT01155479|324005982|FG004|Part I|Did Not Receive Treatment|1|||
94601943|NCT01155479|324005978|FG000|Part I|Non-Compliance with Protocol|2|||
94601944|NCT01155479|324005979|FG001|Part I|Non-Compliance with Protocol|1|||
94601945|NCT01155479|324005980|FG002|Part I|Non-Compliance with Protocol|3|||
94601946|NCT01155479|324005981|FG003|Part I|Non-Compliance with Protocol|3|||
94601947|NCT01155479|324005982|FG004|Part I|Non-Compliance with Protocol|2|||
94601948|NCT01155479|324005978|FG000|Part II|Adverse Event|7|||
94601949|NCT01155479|324005979|FG001|Part II|Adverse Event|6|||
94601950|NCT01155479|324005980|FG002|Part II|Adverse Event|8|||
94601951|NCT01155479|324005981|FG003|Part II|Adverse Event|3|||
94601952|NCT01155479|324005982|FG004|Part II|Adverse Event|4|||
94601953|NCT01155479|324005978|FG000|Part II|Administrative|43|||
94601954|NCT01155479|324005979|FG001|Part II|Administrative|49|||
94601955|NCT01155479|324005980|FG002|Part II|Administrative|36|||
94601956|NCT01155479|324005981|FG003|Part II|Administrative|38|||
94601957|NCT01155479|324005982|FG004|Part II|Administrative|46|||
94601958|NCT01155479|324005978|FG000|Part II|Withdrawal by Subject|8|||
94601959|NCT01155479|324005979|FG001|Part II|Withdrawal by Subject|4|||
94601960|NCT01155479|324005980|FG002|Part II|Withdrawal by Subject|12|||
94601961|NCT01155479|324005981|FG003|Part II|Withdrawal by Subject|7|||
94601962|NCT01155479|324005982|FG004|Part II|Withdrawal by Subject|3|||
94601963|NCT01155479|324005978|FG000|Part II|Lost to Follow-up|1|||
94601964|NCT01155479|324005979|FG001|Part II|Lost to Follow-up|0|||
94601965|NCT01155479|324005980|FG002|Part II|Lost to Follow-up|0|||
94601966|NCT01155479|324005981|FG003|Part II|Lost to Follow-up|0|||
94601967|NCT01155479|324005982|FG004|Part II|Lost to Follow-up|1|||
94601968|NCT01155479|324005978|FG000|Part II|Treatment Failure|0|||
94601969|NCT01155479|324005979|FG001|Part II|Treatment Failure|1|||
94601970|NCT01155479|324005980|FG002|Part II|Treatment Failure|2|||
94601971|NCT01155479|324005981|FG003|Part II|Treatment Failure|0|||
94601972|NCT01155479|324005982|FG004|Part II|Treatment Failure|1|||
94601973|NCT01155479|324005978|FG000|Part II|Non-Compliance with Protocol|0|||
94601974|NCT01155479|324005979|FG001|Part II|Non-Compliance with Protocol|1|||
94601975|NCT01155479|324005980|FG002|Part II|Non-Compliance with Protocol|0|||
94601976|NCT01155479|324005981|FG003|Part II|Non-Compliance with Protocol|2|||
94601977|NCT01155479|324005982|FG004|Part II|Non-Compliance with Protocol|0|||
94601978|NCT01214174|324005983|FG000|Overall Study|Withdrawal by Subject|0|||
94601979|NCT01214174|324005984|FG001|Overall Study|Withdrawal by Subject|0|||
94601980|NCT01214174|324005985|FG002|Overall Study|Withdrawal by Subject|1|||
94601981|NCT00290407|324005986|FG000|Overall Study|Physician Decision|2|||
94601982|NCT01634178|324005987|FG000|Treatment Period 1|Adverse Event|0|||
94601983|NCT01634178|324005988|FG001|Treatment Period 1|Adverse Event|1|||
94601984|NCT01634178|324005987|FG000|Treatment Period 2|Adverse Event|1|||
94601985|NCT01634178|324005988|FG001|Treatment Period 2|Adverse Event|0|||
94601986|NCT01933789|324005997|FG000|Overall Study|Death|0|||
94601987|NCT01933789|324005998|FG001|Overall Study|Death|0|||
94601988|NCT01933789|324005999|FG002|Overall Study|Death|0|||
94601989|NCT01933789|324006000|FG003|Overall Study|Death|0|||
94601990|NCT01933789|324006001|FG004|Overall Study|Death|21|||
94601991|NCT01933789|324006002|FG005|Overall Study|Death|32|||
94601992|NCT01933789|324006003|FG006|Overall Study|Death|0|||
94601993|NCT01933789|324006004|FG007|Overall Study|Death|0|||
94601994|NCT01933789|324006005|FG008|Overall Study|Death|0|||
94601995|NCT01933789|324005997|FG000|Overall Study|Lost to Follow-up|0|||
94601996|NCT01933789|324005998|FG001|Overall Study|Lost to Follow-up|0|||
94601997|NCT01933789|324005999|FG002|Overall Study|Lost to Follow-up|0|||
94601998|NCT01933789|324006000|FG003|Overall Study|Lost to Follow-up|1|||
94601999|NCT01933789|324006001|FG004|Overall Study|Lost to Follow-up|8|||
94602000|NCT01933789|324006002|FG005|Overall Study|Lost to Follow-up|9|||
94602001|NCT01933789|324006003|FG006|Overall Study|Lost to Follow-up|1|||
94602002|NCT01933789|324006004|FG007|Overall Study|Lost to Follow-up|4|||
94602003|NCT01933789|324006005|FG008|Overall Study|Lost to Follow-up|0|||
94602004|NCT01933789|324005997|FG000|Overall Study|Withdrawal by Subject|2|||
94602005|NCT01933789|324005998|FG001|Overall Study|Withdrawal by Subject|1|||
94602006|NCT01933789|324005999|FG002|Overall Study|Withdrawal by Subject|0|||
94602007|NCT01933789|324006000|FG003|Overall Study|Withdrawal by Subject|0|||
94602008|NCT01933789|324006001|FG004|Overall Study|Withdrawal by Subject|17|||
94602009|NCT01933789|324006002|FG005|Overall Study|Withdrawal by Subject|16|||
94602010|NCT01933789|324006003|FG006|Overall Study|Withdrawal by Subject|1|||
94602011|NCT01933789|324006004|FG007|Overall Study|Withdrawal by Subject|4|||
94602012|NCT01933789|324006005|FG008|Overall Study|Withdrawal by Subject|0|||
94602013|NCT01933789|324005997|FG000|Overall Study|Became Ineligible|4|||
94602014|NCT01933789|324005998|FG001|Overall Study|Became Ineligible|0|||
94602015|NCT01933789|324005999|FG002|Overall Study|Became Ineligible|0|||
94602016|NCT01933789|324006000|FG003|Overall Study|Became Ineligible|0|||
94602017|NCT01933789|324006001|FG004|Overall Study|Became Ineligible|13|||
94602018|NCT01933789|324006002|FG005|Overall Study|Became Ineligible|10|||
94602019|NCT01933789|324006003|FG006|Overall Study|Became Ineligible|13|||
94602020|NCT01933789|324006004|FG007|Overall Study|Became Ineligible|6|||
94602021|NCT01933789|324006005|FG008|Overall Study|Became Ineligible|0|||
94602022|NCT03452527|324006019|FG000|Overall Study|Withdrawal by Subject|1|||
94602023|NCT03452527|324006020|FG001|Overall Study|Withdrawal by Subject|1|||
94602024|NCT03452527|324006019|FG000|Overall Study|Study Terminated|2|||
94602025|NCT03452527|324006020|FG001|Overall Study|Study Terminated|3|||
94602026|NCT01101191|324006024|FG000|Period 1|Withdrawal by Subject|1|||
94602027|NCT01101191|324006025|FG001|Period 1|Withdrawal by Subject|0|||
94602028|NCT01101191|324006024|FG000|Period 1|Adverse Event|1|||
94602029|NCT01101191|324006025|FG001|Period 1|Adverse Event|2|||
94602030|NCT01146860|324006026|FG000|Overall Study|Withdrawal by Subject|0|||
94602031|NCT01146860|324006027|FG001|Overall Study|Withdrawal by Subject|1|||
94602032|NCT01092832|324006028|FG000|Overall Study|Other|1|||
94602033|NCT01092832|324006029|FG001|Overall Study|Other|0|||
94602034|NCT00450385|324006030|FG000|Overall Study|Death|3|||
94602035|NCT00450385|324006030|FG000|Overall Study|Protocol Violation|1|||
94602036|NCT00450385|324006030|FG000|Overall Study|Withdrawal by Subject|2|||
94602037|NCT00450385|324006030|FG000|Overall Study|Lack of Efficacy|2|||
94602038|NCT00450385|324006030|FG000|Overall Study|Adverse Event|1|||
94602039|NCT00450385|324006030|FG000|Overall Study|Physician Decision|1|||
94602040|NCT00450385|324006030|FG000|Overall Study|Other|3|||
94602041|NCT01244490|324006031|FG000|Overall Study|Lack of Efficacy|14|||
94602042|NCT01244490|324006032|FG001|Overall Study|Lack of Efficacy|5|||
94602043|NCT01244490|324006033|FG002|Overall Study|Lack of Efficacy|5|||
94602044|NCT01244490|324006031|FG000|Overall Study|Withdrawal by Subject|4|||
94602045|NCT01244490|324006032|FG001|Overall Study|Withdrawal by Subject|4|||
94602046|NCT01244490|324006033|FG002|Overall Study|Withdrawal by Subject|9|||
94602047|NCT01244490|324006031|FG000|Overall Study|Adverse Event|1|||
94602048|NCT01244490|324006032|FG001|Overall Study|Adverse Event|9|||
94602049|NCT01244490|324006033|FG002|Overall Study|Adverse Event|5|||
94602050|NCT01244490|324006031|FG000|Overall Study|Lost to Follow-up|0|||
94602051|NCT01244490|324006032|FG001|Overall Study|Lost to Follow-up|6|||
94602052|NCT01244490|324006033|FG002|Overall Study|Lost to Follow-up|3|||
94602053|NCT01244490|324006031|FG000|Overall Study|Other|0|||
94602054|NCT01244490|324006032|FG001|Overall Study|Other|0|||
94602055|NCT01244490|324006033|FG002|Overall Study|Other|1|||
94602056|NCT01390220|324006039|FG000|Test Dose Phase|Adverse Event|17|||
94602057|NCT01390220|324006040|FG001|Test Dose Phase|Adverse Event|0|||
94602058|NCT01390220|324006041|FG002|Test Dose Phase|Adverse Event|0|||
94602059|NCT01390220|324006039|FG000|Test Dose Phase|Withdrawal by Subject|8|||
94602060|NCT01390220|324006040|FG001|Test Dose Phase|Withdrawal by Subject|0|||
94602061|NCT01390220|324006041|FG002|Test Dose Phase|Withdrawal by Subject|0|||
94602062|NCT01390220|324006039|FG000|Test Dose Phase|Lost to Follow-up|2|||
94602063|NCT01390220|324006040|FG001|Test Dose Phase|Lost to Follow-up|0|||
94602064|NCT01390220|324006041|FG002|Test Dose Phase|Lost to Follow-up|0|||
94602065|NCT01390220|324006039|FG000|Test Dose Phase|Protocol Violation|8|||
94602066|NCT01390220|324006040|FG001|Test Dose Phase|Protocol Violation|0|||
94602067|NCT01390220|324006041|FG002|Test Dose Phase|Protocol Violation|0|||
94602068|NCT01390220|324006039|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
94602069|NCT01390220|324006040|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
94602070|NCT01390220|324006041|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
94602071|NCT01390220|324006039|FG000|Test Dose Phase|Study/Site closure|6|||
94602072|NCT01390220|324006040|FG001|Test Dose Phase|Study/Site closure|0|||
94602073|NCT01390220|324006041|FG002|Test Dose Phase|Study/Site closure|0|||
94602074|NCT01390220|324006039|FG000|Test Dose Phase|Caregiver no longer available|5|||
94602075|NCT01390220|324006040|FG001|Test Dose Phase|Caregiver no longer available|0|||
94602076|NCT01390220|324006041|FG002|Test Dose Phase|Caregiver no longer available|0|||
94602077|NCT01390220|324006039|FG000|Test Dose Phase|Noncompliance|2|||
94602078|NCT01390220|324006040|FG001|Test Dose Phase|Noncompliance|0|||
94602079|NCT01390220|324006041|FG002|Test Dose Phase|Noncompliance|0|||
94602080|NCT01390220|324006039|FG000|Test Dose Phase|Logistical|6|||
94602081|NCT01390220|324006040|FG001|Test Dose Phase|Logistical|0|||
94602082|NCT01390220|324006041|FG002|Test Dose Phase|Logistical|0|||
94602083|NCT01390220|324006039|FG000|Comparative Phase|Withdrawal by Subject|0|||
94602084|NCT01390220|324006040|FG001|Comparative Phase|Withdrawal by Subject|1|||
94602085|NCT01390220|324006041|FG002|Comparative Phase|Withdrawal by Subject|0|||
94602086|NCT02045303|324006045|FG000|Overall Study|Protocol Violation|2|||
94602087|NCT02045303|324006046|FG001|Overall Study|Protocol Violation|1|||
94602088|NCT02045303|324006047|FG002|Overall Study|Protocol Violation|0|||
94602089|NCT02045303|324006045|FG000|Overall Study|Withdrawal by Subject|0|||
94602090|NCT02045303|324006046|FG001|Overall Study|Withdrawal by Subject|2|||
94602091|NCT02045303|324006047|FG002|Overall Study|Withdrawal by Subject|0|||
94602092|NCT03533686|324006048|FG000|Overall Study|Withdrawal by Subject|1|||
94602093|NCT03533686|324006049|FG001|Overall Study|Withdrawal by Subject|0|||
94602094|NCT03533686|324006050|FG002|Overall Study|Withdrawal by Subject|0|||
94602095|NCT03533686|324006051|FG003|Overall Study|Withdrawal by Subject|3|||
94602096|NCT03533686|324006052|FG004|Overall Study|Withdrawal by Subject|5|||
94602097|NCT03533686|324006053|FG005|Overall Study|Withdrawal by Subject|1|||
94602098|NCT03533686|324006048|FG000|Overall Study|Lost to Follow-up|0|||
94602099|NCT03533686|324006049|FG001|Overall Study|Lost to Follow-up|1|||
94602100|NCT03533686|324006050|FG002|Overall Study|Lost to Follow-up|0|||
94602101|NCT03533686|324006051|FG003|Overall Study|Lost to Follow-up|0|||
94602102|NCT03533686|324006052|FG004|Overall Study|Lost to Follow-up|2|||
94602103|NCT03533686|324006053|FG005|Overall Study|Lost to Follow-up|0|||
94602104|NCT03533686|324006048|FG000|Overall Study|Screen Failure|0|||
94602105|NCT03533686|324006049|FG001|Overall Study|Screen Failure|0|||
94602106|NCT03533686|324006050|FG002|Overall Study|Screen Failure|0|||
94602107|NCT03533686|324006051|FG003|Overall Study|Screen Failure|2|||
94602108|NCT03533686|324006052|FG004|Overall Study|Screen Failure|0|||
94602109|NCT03533686|324006053|FG005|Overall Study|Screen Failure|0|||
94602110|NCT02632838|324006054|FG000|Overall Study|Withdrawal by Subject|3|||
94602111|NCT02632838|324006055|FG001|Overall Study|Withdrawal by Subject|0|||
94602112|NCT02632838|324006054|FG000|Overall Study|Lost to Follow-up|0|||
94602113|NCT02632838|324006055|FG001|Overall Study|Lost to Follow-up|2|||
94602114|NCT03945175|324006056|FG000|Overall Study|Did not meet inclusion criteria|31|||
94602115|NCT03945175|324006056|FG000|Overall Study|Withdrew consent|2|||
94602116|NCT03945175|324006056|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
94602117|NCT03945175|324006056|FG000|Overall Study|Early termination during Mydayis treatment|1|||
94602118|NCT01076075|324006064|FG000|Overall Study|Adverse Event|3|||
94602119|NCT01076075|324006065|FG001|Overall Study|Adverse Event|9|||
94602120|NCT01076075|324006064|FG000|Overall Study|Lack of Efficacy|5|||
94602121|NCT01076075|324006065|FG001|Overall Study|Lack of Efficacy|4|||
94602122|NCT01076075|324006064|FG000|Overall Study|Lost to Follow-up|6|||
94602123|NCT01076075|324006065|FG001|Overall Study|Lost to Follow-up|5|||
94602124|NCT01076075|324006064|FG000|Overall Study|other|19|||
94602125|NCT01076075|324006065|FG001|Overall Study|other|9|||
94661219|NCT00718718|324213928|FG009|Prior to Week 12|Withdrawal by Subject|0|||
94661220|NCT00718718|324213919|FG000|Prior to Week 12|Other|1|||
94602126|NCT01076075|324006064|FG000|Overall Study|Protocol Violation|0|||
94602127|NCT01076075|324006065|FG001|Overall Study|Protocol Violation|1|||
94602128|NCT01076075|324006064|FG000|Overall Study|Withdrawal by Subject|8|||
94602129|NCT01076075|324006065|FG001|Overall Study|Withdrawal by Subject|19|||
94602130|NCT01017575|324006066|FG000|Overall Study|Lack of Efficacy|0|||
94602131|NCT01017575|324006067|FG001|Overall Study|Lack of Efficacy|1|||
94602132|NCT01017575|324006068|FG002|Overall Study|Lack of Efficacy|0|||
94602133|NCT01017575|324006069|FG003|Overall Study|Lack of Efficacy|1|||
94602134|NCT01017575|324006070|FG004|Overall Study|Lack of Efficacy|1|||
94602135|NCT01017575|324006066|FG000|Overall Study|Adverse Event|0|||
94602136|NCT01017575|324006067|FG001|Overall Study|Adverse Event|1|||
94602137|NCT01017575|324006068|FG002|Overall Study|Adverse Event|0|||
94602138|NCT01017575|324006069|FG003|Overall Study|Adverse Event|0|||
94602139|NCT01017575|324006070|FG004|Overall Study|Adverse Event|2|||
94602140|NCT01017575|324006066|FG000|Overall Study|Withdrawal by Subject|1|||
94602141|NCT01017575|324006067|FG001|Overall Study|Withdrawal by Subject|0|||
94602142|NCT01017575|324006068|FG002|Overall Study|Withdrawal by Subject|0|||
94602143|NCT01017575|324006069|FG003|Overall Study|Withdrawal by Subject|0|||
94602144|NCT01017575|324006070|FG004|Overall Study|Withdrawal by Subject|0|||
94602145|NCT03640559|324006071|FG000|Overall Study|Physician Decision|1|||
94602146|NCT03640559|324006072|FG001|Overall Study|Physician Decision|1|||
94602147|NCT03640559|324006071|FG000|Overall Study|Withdrawal by Subject|1|||
94602148|NCT03640559|324006072|FG001|Overall Study|Withdrawal by Subject|0|||
94602149|NCT02361346|324006073|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
94602150|NCT02361346|324006074|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
94602151|NCT02361346|324006075|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
94602152|NCT02361346|324006076|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
94602153|NCT02361346|324006077|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
94602154|NCT02361346|324006078|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
94602155|NCT02361346|324006079|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
94602156|NCT02361346|324006080|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
94602157|NCT02361346|324006081|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
94602158|NCT02361346|324006073|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
94602159|NCT02361346|324006074|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
94602160|NCT02361346|324006075|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
94602161|NCT02361346|324006076|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
94602162|NCT02361346|324006077|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
94602163|NCT02361346|324006078|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
94602164|NCT02361346|324006079|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
94602165|NCT02361346|324006080|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
94602166|NCT02361346|324006081|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
94602167|NCT02361346|324006073|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
94602168|NCT02361346|324006074|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
94602169|NCT02361346|324006075|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
94602170|NCT02361346|324006076|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
94602171|NCT02361346|324006077|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
94602172|NCT02361346|324006078|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
94602173|NCT02361346|324006079|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
94602174|NCT02361346|324006080|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
94602175|NCT02361346|324006081|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
94602176|NCT02361346|324006073|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
94602177|NCT02361346|324006074|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
94602178|NCT02361346|324006075|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
94602179|NCT02361346|324006076|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
94602180|NCT02361346|324006077|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
94602181|NCT02361346|324006078|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
94602182|NCT02361346|324006079|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
94602183|NCT02361346|324006080|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
94602184|NCT02361346|324006081|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
94602185|NCT02361346|324006073|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
94602186|NCT02361346|324006074|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
94602187|NCT02361346|324006075|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
94602188|NCT02361346|324006076|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
94602189|NCT02361346|324006077|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
94602190|NCT02361346|324006078|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
94602191|NCT02361346|324006079|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
94602192|NCT02361346|324006080|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
94602193|NCT02361346|324006081|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
94602194|NCT02361346|324006073|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
94602195|NCT02361346|324006074|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
94602196|NCT02361346|324006075|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
94602197|NCT02361346|324006076|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
94602198|NCT02361346|324006077|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
94602199|NCT02361346|324006078|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
94602200|NCT02361346|324006079|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
94602201|NCT02361346|324006080|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
94602202|NCT02361346|324006081|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
94602203|NCT01857583|324006082|FG000|Overall Study|Adverse Event|0|||
94602204|NCT01857583|324006083|FG001|Overall Study|Adverse Event|0|||
94602205|NCT01857583|324006084|FG002|Overall Study|Adverse Event|1|||
94602206|NCT01857583|324006085|FG003|Overall Study|Adverse Event|1|||
94602207|NCT01857583|324006082|FG000|Overall Study|Death|0|||
94602208|NCT01857583|324006083|FG001|Overall Study|Death|1|||
94602209|NCT01857583|324006084|FG002|Overall Study|Death|1|||
94602210|NCT01857583|324006085|FG003|Overall Study|Death|0|||
94602211|NCT01857583|324006082|FG000|Overall Study|Physician Decision|0|||
94602212|NCT01857583|324006083|FG001|Overall Study|Physician Decision|0|||
94602213|NCT01857583|324006084|FG002|Overall Study|Physician Decision|0|||
94602214|NCT01857583|324006085|FG003|Overall Study|Physician Decision|1|||
94602215|NCT01857583|324006082|FG000|Overall Study|Withdrawal by Subject|1|||
94602216|NCT01857583|324006083|FG001|Overall Study|Withdrawal by Subject|0|||
94602217|NCT01857583|324006084|FG002|Overall Study|Withdrawal by Subject|1|||
94602218|NCT01857583|324006085|FG003|Overall Study|Withdrawal by Subject|2|||
94602219|NCT02211638|324006086|FG000|Overall Study|Case Report Forms Uncollected|291|||
94602220|NCT02211638|324006086|FG000|Overall Study|Protocol Violation|692|||
94602221|NCT04382755|324006087|FG000|Overall Study|Withdrawal by Subject|1|||
94602222|NCT04382755|324006088|FG001|Overall Study|Withdrawal by Subject|0|||
94602223|NCT04382755|324006087|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
94602224|NCT04382755|324006088|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
94602225|NCT04382755|324006087|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
94602226|NCT04382755|324006088|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
94602227|NCT03670836|324006092|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
94602228|NCT03670836|324006093|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
94602229|NCT03670836|324006092|FG000|Per Protocol Population (PP)|Physician Decision|9|||
94602230|NCT03670836|324006093|FG001|Per Protocol Population (PP)|Physician Decision|10|||
94602231|NCT03670836|324006092|FG000|Per Protocol Population (PP)|Physician Decision|4|||
94602232|NCT03670836|324006093|FG001|Per Protocol Population (PP)|Physician Decision|6|||
94602233|NCT03670836|324006092|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
94602234|NCT03670836|324006093|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
94602235|NCT04085367|324007103|FG000|Overall Study|Adverse Event|1|||
94602236|NCT04085367|324007104|FG001|Overall Study|Adverse Event|1|||
94602237|NCT04085367|324007103|FG000|Overall Study|Withdrawal by Subject|13|||
94602238|NCT04085367|324007104|FG001|Overall Study|Withdrawal by Subject|4|||
94602239|NCT04085367|324007103|FG000|Overall Study|Lost to Follow-up|3|||
94602240|NCT04085367|324007104|FG001|Overall Study|Lost to Follow-up|1|||
94602241|NCT04085367|324007103|FG000|Overall Study|Other unspecified|2|||
94602242|NCT04085367|324007104|FG001|Overall Study|Other unspecified|1|||
94602243|NCT04085367|324007103|FG000|Overall Study|Status Unknown|1|||
94602244|NCT04085367|324007104|FG001|Overall Study|Status Unknown|1|||
94602245|NCT00130442|324007105|FG000|Overall Study|Withdrawal by Subject|0|||
94602246|NCT00130442|324007106|FG001|Overall Study|Withdrawal by Subject|1|||
94602247|NCT00130442|324007105|FG000|Overall Study|did not meet criteria|1|||
94602248|NCT00130442|324007106|FG001|Overall Study|did not meet criteria|1|||
94602249|NCT00773383|324007109|FG000|Overall Study|Adverse Event|4|||
94602250|NCT00773383|324007109|FG000|Overall Study|Death|1|||
94602251|NCT00773383|324007109|FG000|Overall Study|Progression of Disease|23|||
94602252|NCT00773383|324007109|FG000|Overall Study|Other|2|||
94602253|NCT00773383|324007109|FG000|Overall Study|No study dose received|1|||
94602254|NCT00400946|324007110|FG000|Overall Study|Ineligible|0|||
94602255|NCT00400946|324007111|FG001|Overall Study|Ineligible|0|||
94602256|NCT00400946|324007112|FG002|Overall Study|Ineligible|0|||
94602257|NCT00400946|324007113|FG003|Overall Study|Ineligible|5|||
94602258|NCT00400946|324007114|FG004|Overall Study|Ineligible|1|||
94602259|NCT00400946|324007110|FG000|Overall Study|Induction Failure|0|||
94602260|NCT00400946|324007111|FG001|Overall Study|Induction Failure|0|||
94602261|NCT00400946|324007112|FG002|Overall Study|Induction Failure|0|||
94602262|NCT00400946|324007113|FG003|Overall Study|Induction Failure|11|||
94602263|NCT00400946|324007114|FG004|Overall Study|Induction Failure|8|||
94602264|NCT00400946|324007110|FG000|Overall Study|Induction Death|0|||
94602265|NCT00400946|324007111|FG001|Overall Study|Induction Death|0|||
94602266|NCT00400946|324007112|FG002|Overall Study|Induction Death|0|||
94602267|NCT00400946|324007113|FG003|Overall Study|Induction Death|13|||
94602268|NCT00400946|324007114|FG004|Overall Study|Induction Death|3|||
94602269|NCT00400946|324007110|FG000|Overall Study|Lost to Follow-up|1|||
94602270|NCT00400946|324007111|FG001|Overall Study|Lost to Follow-up|1|||
94602271|NCT00400946|324007112|FG002|Overall Study|Lost to Follow-up|0|||
94602272|NCT00400946|324007113|FG003|Overall Study|Lost to Follow-up|0|||
94602273|NCT00400946|324007114|FG004|Overall Study|Lost to Follow-up|1|||
94602274|NCT00400946|324007110|FG000|Overall Study|Remission Death|1|||
94602275|NCT00400946|324007111|FG001|Overall Study|Remission Death|1|||
94602276|NCT00400946|324007112|FG002|Overall Study|Remission Death|0|||
94602277|NCT00400946|324007113|FG003|Overall Study|Remission Death|0|||
94602278|NCT00400946|324007114|FG004|Overall Study|Remission Death|1|||
94602279|NCT00400946|324007110|FG000|Overall Study|Relapse|9|||
94602280|NCT00400946|324007111|FG001|Overall Study|Relapse|2|||
94602281|NCT00400946|324007112|FG002|Overall Study|Relapse|1|||
94602282|NCT00400946|324007113|FG003|Overall Study|Relapse|1|||
94602283|NCT00400946|324007114|FG004|Overall Study|Relapse|5|||
94602284|NCT00400946|324007110|FG000|Overall Study|Transplant in CR1|0|||
94602285|NCT00400946|324007111|FG001|Overall Study|Transplant in CR1|0|||
94602286|NCT00400946|324007112|FG002|Overall Study|Transplant in CR1|0|||
94602287|NCT00400946|324007113|FG003|Overall Study|Transplant in CR1|10|||
94602288|NCT00400946|324007114|FG004|Overall Study|Transplant in CR1|1|||
94602289|NCT00400946|324007110|FG000|Overall Study|Withdrawal by Subject|2|||
94602290|NCT00400946|324007111|FG001|Overall Study|Withdrawal by Subject|5|||
94602291|NCT00400946|324007112|FG002|Overall Study|Withdrawal by Subject|1|||
94602292|NCT00400946|324007113|FG003|Overall Study|Withdrawal by Subject|5|||
94602293|NCT00400946|324007114|FG004|Overall Study|Withdrawal by Subject|8|||
94602294|NCT00400946|324007110|FG000|Overall Study|Clinical|1|||
94602295|NCT00400946|324007111|FG001|Overall Study|Clinical|2|||
94602296|NCT00400946|324007112|FG002|Overall Study|Clinical|0|||
94602297|NCT00400946|324007113|FG003|Overall Study|Clinical|2|||
94602298|NCT00400946|324007114|FG004|Overall Study|Clinical|9|||
94602299|NCT00400946|324007110|FG000|Overall Study|Other|0|||
94602300|NCT00400946|324007111|FG001|Overall Study|Other|0|||
94602301|NCT00400946|324007112|FG002|Overall Study|Other|0|||
94602302|NCT00400946|324007113|FG003|Overall Study|Other|0|||
94602303|NCT00400946|324007114|FG004|Overall Study|Other|1|||
94602304|NCT03442764|324007115|FG000|Overall Study|Adverse Event|1|||
94602305|NCT03442764|324007116|FG001|Overall Study|Adverse Event|0|||
94602306|NCT03442764|324007117|FG002|Overall Study|Adverse Event|0|||
94602307|NCT01547780|324007121|FG000|Baseline PET Scan|Physician Decision|1|||
94602308|NCT01547780|324007122|FG001|Baseline PET Scan|Physician Decision|0|||
94602309|NCT01547780|324007123|FG002|Baseline PET Scan|Physician Decision|1|||
94602310|NCT01547780|324007124|FG003|Baseline PET Scan|Physician Decision|0|||
94602311|NCT01547780|324007121|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
94457960|NCT02980341|323465680|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
94457961|NCT02980341|323465681|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
94457962|NCT02980341|323465671|FG000|Dose Finding|Adverse Event|0|||
94457963|NCT02980341|323465672|FG001|Dose Finding|Adverse Event|0|||
94457964|NCT02980341|323465673|FG002|Dose Finding|Adverse Event|0|||
94457965|NCT02980341|323465674|FG003|Dose Finding|Adverse Event|0|||
94457966|NCT02980341|323465675|FG004|Dose Finding|Adverse Event|0|||
94457967|NCT02980341|323465676|FG005|Dose Finding|Adverse Event|3|||
94457968|NCT02980341|323465677|FG006|Dose Finding|Adverse Event|0|||
94457969|NCT02980341|323465678|FG007|Dose Finding|Adverse Event|0|||
94457970|NCT02980341|323465679|FG008|Dose Finding|Adverse Event|0|||
94457971|NCT02980341|323465680|FG009|Dose Finding|Adverse Event|0|||
94457972|NCT02980341|323465681|FG010|Dose Finding|Adverse Event|0|||
94457973|NCT02980341|323465671|FG000|Dose Finding|Withdrawal by Subject|0|||
94457974|NCT02980341|323465672|FG001|Dose Finding|Withdrawal by Subject|0|||
94457975|NCT02980341|323465673|FG002|Dose Finding|Withdrawal by Subject|0|||
94457976|NCT02980341|323465674|FG003|Dose Finding|Withdrawal by Subject|0|||
94457977|NCT02980341|323465675|FG004|Dose Finding|Withdrawal by Subject|0|||
94457978|NCT02980341|323465676|FG005|Dose Finding|Withdrawal by Subject|1|||
94602312|NCT01547780|324007122|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
94602313|NCT01547780|324007123|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
94602314|NCT01547780|324007124|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
94602315|NCT03269552|324007132|FG000|Overall Study|Adverse Event|2|||
94602316|NCT00039871|324007133|FG000|Overall Study|Adverse Event|165|||
94602317|NCT00039871|324007133|FG000|Overall Study|Lost to Follow-up|18|||
94602318|NCT00039871|324007133|FG000|Overall Study|Protocol Violation|24|||
94602319|NCT00039871|324007133|FG000|Overall Study|Withdrawal by Subject|97|||
94602320|NCT00039871|324007133|FG000|Overall Study|Did not meet eligibility criteria|11|||
94602321|NCT00039871|324007133|FG000|Overall Study|Administrative|1|||
94248531|NCT01160289|322704865|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
94248532|NCT01160289|322704866|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
94248533|NCT01160289|322704867|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
94248534|NCT01160289|322704868|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
94248535|NCT01160289|322704869|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
94248536|NCT01160289|322704870|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
94248537|NCT01160289|322704865|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
94248538|NCT01160289|322704866|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
94248539|NCT01160289|322704867|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
94248540|NCT01160289|322704868|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
94248541|NCT01160289|322704869|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
94248542|NCT01160289|322704870|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
94248543|NCT01160289|322704865|FG000|Post-Randomization Period|Adverse Event|0|||
94248544|NCT01160289|322704866|FG001|Post-Randomization Period|Adverse Event|4|||
94248545|NCT01160289|322704867|FG002|Post-Randomization Period|Adverse Event|4|||
94248546|NCT01160289|322704868|FG003|Post-Randomization Period|Adverse Event|2|||
94248547|NCT01160289|322704869|FG004|Post-Randomization Period|Adverse Event|0|||
94248548|NCT01160289|322704870|FG005|Post-Randomization Period|Adverse Event|0|||
94248549|NCT01160289|322704865|FG000|Post-Randomization Period|Death|0|||
94248550|NCT01160289|322704866|FG001|Post-Randomization Period|Death|0|||
94248551|NCT01160289|322704867|FG002|Post-Randomization Period|Death|0|||
94248552|NCT01160289|322704868|FG003|Post-Randomization Period|Death|1|||
94248553|NCT01160289|322704869|FG004|Post-Randomization Period|Death|0|||
94248554|NCT01160289|322704870|FG005|Post-Randomization Period|Death|0|||
94248555|NCT01160289|322704865|FG000|Post-Randomization Period|Lack of Efficacy|0|||
94248556|NCT01160289|322704866|FG001|Post-Randomization Period|Lack of Efficacy|1|||
94248557|NCT01160289|322704867|FG002|Post-Randomization Period|Lack of Efficacy|0|||
94602322|NCT00039871|324007133|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
94602323|NCT00039871|324007133|FG000|Overall Study|Never entered follow-up|7|||
94602324|NCT00371761|324007134|FG000|Overall Study|Adverse Event|1|||
94602325|NCT00371761|324007135|FG001|Overall Study|Adverse Event|1|||
94602326|NCT00371761|324007134|FG000|Overall Study|Withdrawal by Subject|1|||
94602327|NCT00371761|324007135|FG001|Overall Study|Withdrawal by Subject|3|||
94602328|NCT00371761|324007134|FG000|Overall Study|Investigator Judgment|2|||
94602329|NCT00371761|324007135|FG001|Overall Study|Investigator Judgment|3|||
94602330|NCT00371761|324007134|FG000|Overall Study|Study termination|4|||
94602331|NCT00371761|324007135|FG001|Overall Study|Study termination|3|||
94602332|NCT03560739|324007137|FG000|Overall Study|Adverse Event|0|||
94602333|NCT03560739|324007138|FG001|Overall Study|Adverse Event|1|||
94602334|NCT03560739|324007139|FG002|Overall Study|Adverse Event|0|||
94602335|NCT03560739|324007140|FG003|Overall Study|Adverse Event|0|||
94602336|NCT03361176|324007141|FG000|Overall Study|Lost to Follow-up|1|||
94602337|NCT03361176|324007142|FG001|Overall Study|Lost to Follow-up|2|||
94602338|NCT03361176|324007141|FG000|Overall Study|Adverse Event|0|||
94602339|NCT03361176|324007142|FG001|Overall Study|Adverse Event|2|||
94602340|NCT03361176|324007141|FG000|Overall Study|Withdrawal by Subject|0|||
94602341|NCT03361176|324007142|FG001|Overall Study|Withdrawal by Subject|1|||
94602342|NCT02478398|324007143|FG000|Overall Study|Adverse Event|20|||
94602343|NCT02478398|324007144|FG001|Overall Study|Adverse Event|5|||
94602344|NCT02478398|324007143|FG000|Overall Study|Lost to Follow-up|5|||
94602345|NCT02478398|324007144|FG001|Overall Study|Lost to Follow-up|4|||
94248558|NCT01160289|322704868|FG003|Post-Randomization Period|Lack of Efficacy|3|||
94602346|NCT02478398|324007143|FG000|Overall Study|Non-Compliance With Study Drug|5|||
94602347|NCT02478398|324007144|FG001|Overall Study|Non-Compliance With Study Drug|1|||
94602348|NCT02478398|324007143|FG000|Overall Study|Protocol Violation|3|||
94602349|NCT02478398|324007144|FG001|Overall Study|Protocol Violation|1|||
94602350|NCT02478398|324007143|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
94602351|NCT02478398|324007144|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
94602352|NCT02478398|324007143|FG000|Overall Study|Withdrawal By Participant|10|||
94602353|NCT02478398|324007144|FG001|Overall Study|Withdrawal By Participant|4|||
94602354|NCT03718299|324007145|FG000|Overall Study|Adverse Event|1|||
94602355|NCT03718299|324007145|FG000|Overall Study|Withdrawal by Subject|6|||
94602356|NCT03718299|324007145|FG000|Overall Study|Physician Decision|2|||
94602357|NCT03718299|324007145|FG000|Overall Study|Lost to Follow-up|1|||
94602358|NCT01362595|324007146|FG000|Overall Study|Screen failure|10|||
94602359|NCT01362595|324007146|FG000|Overall Study|Withdrawal by Subject|2|||
94602360|NCT04389970|324007147|FG000|Overall Study|Lost to Follow-up|1|||
94602361|NCT03123185|324007148|FG000|Overall Study|Withdrawal by Subject|0|||
94602362|NCT03123185|324007149|FG001|Overall Study|Withdrawal by Subject|0|||
94602363|NCT03123185|324007150|FG002|Overall Study|Withdrawal by Subject|0|||
94602364|NCT03123185|324007151|FG003|Overall Study|Withdrawal by Subject|0|||
94602365|NCT03123185|324007152|FG004|Overall Study|Withdrawal by Subject|0|||
94602366|NCT03123185|324007153|FG005|Overall Study|Withdrawal by Subject|0|||
94602367|NCT03123185|324007154|FG006|Overall Study|Withdrawal by Subject|0|||
94602368|NCT03123185|324007155|FG007|Overall Study|Withdrawal by Subject|0|||
94602369|NCT03123185|324007156|FG008|Overall Study|Withdrawal by Subject|0|||
94602370|NCT03123185|324007157|FG009|Overall Study|Withdrawal by Subject|0|||
94602371|NCT03123185|324007158|FG010|Overall Study|Withdrawal by Subject|0|||
94602372|NCT03123185|324007159|FG011|Overall Study|Withdrawal by Subject|0|||
94602373|NCT03123185|324007160|FG012|Overall Study|Withdrawal by Subject|1|||
94602374|NCT03123185|324007161|FG013|Overall Study|Withdrawal by Subject|0|||
94602375|NCT01475071|324007162|FG000|Overall Study|Physician Decision|1|||
94602376|NCT01475071|324007162|FG000|Overall Study|Withdrawal by Subject|6|||
94602377|NCT01475071|324007162|FG000|Overall Study|Lost to Follow-up|1|||
94602378|NCT02469038|324007165|FG000|Overall Study|Physician Decision|4|||
94602379|NCT02469038|324007166|FG001|Overall Study|Physician Decision|5|||
94602380|NCT00636987|324007167|FG000|Overall Study|Death|44|||
94602381|NCT00636987|324007167|FG000|Overall Study|Explanted|13|||
94602382|NCT00636987|324007167|FG000|Overall Study|Lost to Follow-up|63|||
94602383|NCT00636987|324007167|FG000|Overall Study|5 year visit window not complete|69|||
94602384|NCT02987660|324007174|FG000|Overall Study|Study terminated by sponsor|10|||
94602385|NCT02987660|324007175|FG001|Overall Study|Study terminated by sponsor|10|||
94602386|NCT03422627|324007176|FG000|Overall Study|Protocol-specified Criteria|1|||
94602387|NCT03422627|324007177|FG001|Overall Study|Protocol-specified Criteria|1|||
94602388|NCT03422627|324007178|FG002|Overall Study|Protocol-specified Criteria|0|||
94602389|NCT03422627|324007179|FG003|Overall Study|Protocol-specified Criteria|0|||
94602390|NCT03422627|324007180|FG004|Overall Study|Protocol-specified Criteria|2|||
94602391|NCT03422627|324007176|FG000|Overall Study|Requirement for Alternative Therapy|1|||
94602392|NCT03422627|324007177|FG001|Overall Study|Requirement for Alternative Therapy|1|||
94602393|NCT03422627|324007178|FG002|Overall Study|Requirement for Alternative Therapy|2|||
94602394|NCT03422627|324007179|FG003|Overall Study|Requirement for Alternative Therapy|0|||
94602395|NCT03422627|324007180|FG004|Overall Study|Requirement for Alternative Therapy|0|||
94602396|NCT03422627|324007176|FG000|Overall Study|Disease Progression|1|||
94602397|NCT03422627|324007177|FG001|Overall Study|Disease Progression|0|||
94602398|NCT03422627|324007178|FG002|Overall Study|Disease Progression|1|||
94248559|NCT01160289|322704869|FG004|Post-Randomization Period|Lack of Efficacy|0|||
94248560|NCT01160289|322704870|FG005|Post-Randomization Period|Lack of Efficacy|0|||
94248561|NCT01160289|322704865|FG000|Post-Randomization Period|Lost to Follow-up|0|||
94248562|NCT01160289|322704866|FG001|Post-Randomization Period|Lost to Follow-up|3|||
94248563|NCT01160289|322704867|FG002|Post-Randomization Period|Lost to Follow-up|2|||
94248564|NCT01160289|322704868|FG003|Post-Randomization Period|Lost to Follow-up|5|||
94248565|NCT01160289|322704869|FG004|Post-Randomization Period|Lost to Follow-up|3|||
94248566|NCT01160289|322704870|FG005|Post-Randomization Period|Lost to Follow-up|4|||
94248567|NCT01160289|322704865|FG000|Post-Randomization Period|Physician Decision|0|||
94248568|NCT01160289|322704866|FG001|Post-Randomization Period|Physician Decision|0|||
94248569|NCT01160289|322704867|FG002|Post-Randomization Period|Physician Decision|1|||
94602399|NCT03422627|324007179|FG003|Overall Study|Disease Progression|2|||
94602400|NCT03422627|324007180|FG004|Overall Study|Disease Progression|0|||
94248570|NCT01160289|322704868|FG003|Post-Randomization Period|Physician Decision|0|||
94602401|NCT03422627|324007176|FG000|Overall Study|Adverse Event|2|||
94602402|NCT03422627|324007177|FG001|Overall Study|Adverse Event|1|||
94602403|NCT03422627|324007178|FG002|Overall Study|Adverse Event|0|||
94602404|NCT03422627|324007179|FG003|Overall Study|Adverse Event|0|||
94248571|NCT01160289|322704869|FG004|Post-Randomization Period|Physician Decision|0|||
94248572|NCT01160289|322704870|FG005|Post-Randomization Period|Physician Decision|0|||
94248573|NCT01160289|322704865|FG000|Post-Randomization Period|Protocol Violation|0|||
94602405|NCT03422627|324007180|FG004|Overall Study|Adverse Event|2|||
94602406|NCT03422627|324007176|FG000|Overall Study|Ineligibility Determined|0|||
94602407|NCT03422627|324007177|FG001|Overall Study|Ineligibility Determined|1|||
94602408|NCT03422627|324007178|FG002|Overall Study|Ineligibility Determined|0|||
94602409|NCT03422627|324007179|FG003|Overall Study|Ineligibility Determined|0|||
94602410|NCT03422627|324007180|FG004|Overall Study|Ineligibility Determined|0|||
94602411|NCT03422627|324007176|FG000|Overall Study|Death|0|||
94602412|NCT03422627|324007177|FG001|Overall Study|Death|1|||
94602413|NCT03422627|324007178|FG002|Overall Study|Death|1|||
94602414|NCT03422627|324007179|FG003|Overall Study|Death|0|||
94602415|NCT03422627|324007180|FG004|Overall Study|Death|0|||
94602416|NCT03422627|324007176|FG000|Overall Study|Withdrawal by Subject|0|||
94602417|NCT03422627|324007177|FG001|Overall Study|Withdrawal by Subject|0|||
94602418|NCT03422627|324007178|FG002|Overall Study|Withdrawal by Subject|0|||
94602419|NCT03422627|324007179|FG003|Overall Study|Withdrawal by Subject|1|||
94602420|NCT03422627|324007180|FG004|Overall Study|Withdrawal by Subject|0|||
94602421|NCT01479985|324007185|FG000|Overall Study|Tablet malfunction, no data saved|1|||
94602422|NCT01479985|324007186|FG001|Overall Study|Tablet malfunction, no data saved|1|||
94602423|NCT01479985|324007185|FG000|Overall Study|No decisional conflict scale responses|0|||
94602424|NCT01479985|324007186|FG001|Overall Study|No decisional conflict scale responses|2|||
94602425|NCT01479985|324007185|FG000|Overall Study|No post-visit survey|5|||
94602426|NCT01479985|324007186|FG001|Overall Study|No post-visit survey|3|||
94602427|NCT02677324|324007189|FG000|Overall Study|Disease Progression|6|||
94602428|NCT02677324|324007189|FG000|Overall Study|Inability to Swallow pills|1|||
94602429|NCT02677324|324007189|FG000|Overall Study|Non-compliance|1|||
94602430|NCT02677324|324007189|FG000|Overall Study|Lack of Efficacy|1|||
94602431|NCT02677324|324007189|FG000|Overall Study|Medical insurance coverage|1|||
94602432|NCT02677324|324007189|FG000|Overall Study|Adverse Event|1|||
94602433|NCT02677324|324007189|FG000|Overall Study|IgM Myeloma diagnosis|1|||
94602434|NCT01850602|324007190|FG000|Overall Study|Adverse Event|7|||
94602435|NCT01850602|324007191|FG001|Overall Study|Adverse Event|10|||
94602436|NCT01850602|324007190|FG000|Overall Study|Physician Decision|2|||
94602437|NCT01850602|324007191|FG001|Overall Study|Physician Decision|1|||
94602438|NCT01850602|324007190|FG000|Overall Study|Withdrawal by Subject|2|||
94602439|NCT01850602|324007191|FG001|Overall Study|Withdrawal by Subject|4|||
94602440|NCT01850602|324007190|FG000|Overall Study|Decrease in serum calcium|2|||
94602441|NCT01850602|324007191|FG001|Overall Study|Decrease in serum calcium|3|||
94602442|NCT01850602|324007190|FG000|Overall Study|Increase in serum ferritin|1|||
94602443|NCT01850602|324007191|FG001|Overall Study|Increase in serum ferritin|0|||
94602444|NCT01142128|324007192|FG000|Overall Study|Physician Decision|1|||
94602445|NCT01142128|324007192|FG000|Overall Study|Lost to Follow-up|1|||
94602446|NCT01142128|324007192|FG000|Overall Study|Withdrawal by Subject|2|||
94602447|NCT00812487|324007193|FG000|Overall Study|Lost to Follow-up|2|||
94602448|NCT00812487|324007194|FG001|Overall Study|Lost to Follow-up|0|||
94602449|NCT00812487|324007193|FG000|Overall Study|Withdrawal by Subject|3|||
94602450|NCT00812487|324007194|FG001|Overall Study|Withdrawal by Subject|2|||
94602451|NCT00812487|324007193|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
94602452|NCT00812487|324007194|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
94602453|NCT00812487|324007193|FG000|Overall Study|Protocol Violation|0|||
94602454|NCT00812487|324007194|FG001|Overall Study|Protocol Violation|1|||
94602455|NCT04761627|324007195|FG000|Run-in Period|Death|1|||
94602456|NCT04761627|324007196|FG001|Run-in Period|Death|0|||
94602457|NCT04761627|324007197|FG002|Run-in Period|Death|0|||
94602458|NCT04761627|324007195|FG000|Run-in Period|Required alternative therapy|2|||
94602459|NCT04761627|324007196|FG001|Run-in Period|Required alternative therapy|0|||
94602460|NCT04761627|324007197|FG002|Run-in Period|Required alternative therapy|0|||
94602461|NCT04761627|324007195|FG000|Run-in Period|Lost to Follow-up|2|||
94602462|NCT04761627|324007196|FG001|Run-in Period|Lost to Follow-up|0|||
94602463|NCT04761627|324007197|FG002|Run-in Period|Lost to Follow-up|0|||
94602464|NCT04761627|324007195|FG000|Run-in Period|Protocol Violation|3|||
94602465|NCT04761627|324007196|FG001|Run-in Period|Protocol Violation|0|||
94602466|NCT04761627|324007197|FG002|Run-in Period|Protocol Violation|0|||
94602467|NCT04761627|324007195|FG000|Run-in Period|Abnormal liver function|1|||
94602468|NCT04761627|324007196|FG001|Run-in Period|Abnormal liver function|0|||
94602469|NCT04761627|324007197|FG002|Run-in Period|Abnormal liver function|0|||
94602470|NCT04761627|324007195|FG000|Run-in Period|Adverse Event|6|||
94602471|NCT04761627|324007196|FG001|Run-in Period|Adverse Event|0|||
94602472|NCT04761627|324007197|FG002|Run-in Period|Adverse Event|0|||
94602473|NCT04761627|324007195|FG000|Run-in Period|Withdrawal by Subject|7|||
94602474|NCT04761627|324007196|FG001|Run-in Period|Withdrawal by Subject|0|||
94602475|NCT04761627|324007197|FG002|Run-in Period|Withdrawal by Subject|0|||
94602476|NCT04761627|324007195|FG000|Run-in Period|Did not meet PASI 50|15|||
94602477|NCT04761627|324007196|FG001|Run-in Period|Did not meet PASI 50|0|||
94602478|NCT04761627|324007197|FG002|Run-in Period|Did not meet PASI 50|0|||
94602479|NCT04761627|324007195|FG000|Run-in Period|Study site closure|2|||
94602480|NCT04761627|324007196|FG001|Run-in Period|Study site closure|0|||
94602481|NCT04761627|324007197|FG002|Run-in Period|Study site closure|0|||
94602482|NCT04761627|324007195|FG000|Run-in Period|Pregnancy|2|||
94602483|NCT04761627|324007196|FG001|Run-in Period|Pregnancy|0|||
94602484|NCT04761627|324007197|FG002|Run-in Period|Pregnancy|0|||
94602485|NCT04761627|324007195|FG000|Post-randomization Period|Military service|0|||
94602486|NCT04761627|324007196|FG001|Post-randomization Period|Military service|1|||
94602487|NCT04761627|324007197|FG002|Post-randomization Period|Military service|0|||
94602488|NCT04761627|324007195|FG000|Post-randomization Period|Adverse Event|0|||
94602489|NCT04761627|324007196|FG001|Post-randomization Period|Adverse Event|4|||
94602490|NCT04761627|324007197|FG002|Post-randomization Period|Adverse Event|2|||
94602491|NCT04761627|324007195|FG000|Post-randomization Period|Lost to Follow-up|0|||
94602492|NCT04761627|324007196|FG001|Post-randomization Period|Lost to Follow-up|6|||
94602493|NCT04761627|324007197|FG002|Post-randomization Period|Lost to Follow-up|6|||
94602494|NCT04761627|324007195|FG000|Post-randomization Period|Withdrawal by Subject|0|||
94602495|NCT04761627|324007196|FG001|Post-randomization Period|Withdrawal by Subject|7|||
94602496|NCT04761627|324007197|FG002|Post-randomization Period|Withdrawal by Subject|6|||
94602497|NCT04761627|324007195|FG000|Post-randomization Period|Pregnancy|0|||
94602498|NCT04761627|324007196|FG001|Post-randomization Period|Pregnancy|0|||
94248574|NCT01160289|322704866|FG001|Post-Randomization Period|Protocol Violation|4|||
94248575|NCT01160289|322704867|FG002|Post-Randomization Period|Protocol Violation|2|||
94248576|NCT01160289|322704868|FG003|Post-Randomization Period|Protocol Violation|0|||
94248577|NCT01160289|322704869|FG004|Post-Randomization Period|Protocol Violation|1|||
94248578|NCT01160289|322704870|FG005|Post-Randomization Period|Protocol Violation|3|||
94248579|NCT01160289|322704865|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
94248580|NCT01160289|322704866|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
94248581|NCT01160289|322704867|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
94248582|NCT01160289|322704868|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
94248583|NCT01160289|322704869|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
94248584|NCT01160289|322704870|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
94248585|NCT01160289|322704865|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
94248586|NCT01160289|322704866|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
94248587|NCT01160289|322704867|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
94248588|NCT01160289|322704868|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
94248589|NCT01160289|322704869|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
94248590|NCT01160289|322704870|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
94248591|NCT01160289|322704865|FG000|Post-Randomization Period|Sponsor Decision|0|||
94248592|NCT01160289|322704866|FG001|Post-Randomization Period|Sponsor Decision|1|||
94248593|NCT01160289|322704867|FG002|Post-Randomization Period|Sponsor Decision|0|||
94248594|NCT01160289|322704868|FG003|Post-Randomization Period|Sponsor Decision|0|||
94248595|NCT01160289|322704869|FG004|Post-Randomization Period|Sponsor Decision|0|||
94248596|NCT01160289|322704870|FG005|Post-Randomization Period|Sponsor Decision|0|||
94248597|NCT03932812|322704871|FG000|Overall Study|Lost to Follow-up|12|||
94248598|NCT03932812|322704872|FG001|Overall Study|Lost to Follow-up|14|||
94248599|NCT03932812|322704871|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
94248600|NCT03932812|322704872|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
94248601|NCT00774930|322704877|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
94248602|NCT00774930|322704878|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
94248603|NCT00774930|322704877|FG000|DB Phase|Adverse Event|1|||
94248604|NCT00774930|322704878|FG001|DB Phase|Adverse Event|2|||
94248605|NCT00774930|322704877|FG000|DB Phase|Subject Decision|1|||
94248606|NCT00774930|322704878|FG001|DB Phase|Subject Decision|5|||
94248607|NCT00774930|322704877|FG000|DB Phase|Sponsor Decision|0|||
94248608|NCT00774930|322704878|FG001|DB Phase|Sponsor Decision|1|||
94248609|NCT00774930|322704877|FG000|DB Phase|Disease Progression|1|||
94248610|NCT00774930|322704878|FG001|DB Phase|Disease Progression|1|||
94248611|NCT00774930|322704877|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
94248612|NCT00774930|322704878|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
94248613|NCT00774930|322704877|FG000|IOL Phase|Adverse Event|1|||
94248614|NCT00774930|322704878|FG001|IOL Phase|Adverse Event|1|||
94248615|NCT00774930|322704877|FG000|IOL Phase|Subject Decision|4|||
94248616|NCT00774930|322704878|FG001|IOL Phase|Subject Decision|3|||
94248617|NCT00774930|322704877|FG000|IOL Phase|Physician Decision|3|||
94248618|NCT00774930|322704878|FG001|IOL Phase|Physician Decision|2|||
94248619|NCT00774930|322704877|FG000|IOL Phase|Sponsor Decision|1|||
94248620|NCT00774930|322704878|FG001|IOL Phase|Sponsor Decision|0|||
94248621|NCT00774930|322704877|FG000|IOL Phase|Disease Progression|2|||
94602499|NCT04761627|324007197|FG002|Post-randomization Period|Pregnancy|1|||
94248622|NCT00774930|322704878|FG001|IOL Phase|Disease Progression|1|||
94248623|NCT00774930|322704877|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
94248624|NCT00774930|322704878|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
94248625|NCT00774930|322704877|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
94248626|NCT00774930|322704878|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
94248627|NCT00774930|322704877|FG000|IOL Phase|Other|1|||
94248628|NCT00774930|322704878|FG001|IOL Phase|Other|0|||
94248629|NCT00774930|322704877|FG000|IOL Phase|Brain radiation|0|||
94602500|NCT04761627|324007195|FG000|Post-randomization Period|Study site closure|0|||
94602501|NCT04761627|324007196|FG001|Post-randomization Period|Study site closure|0|||
94356068|NCT01050998|323085792|FG001|Overall Study|Withdrawal by Subject|0|||
94356069|NCT01050998|323085793|FG002|Overall Study|Withdrawal by Subject|0|||
94356070|NCT01050998|323085794|FG003|Overall Study|Withdrawal by Subject|1|||
94356071|NCT01050998|323085795|FG004|Overall Study|Withdrawal by Subject|3|||
94356072|NCT01050998|323085791|FG000|Overall Study|Other|3|||
94356073|NCT01050998|323085792|FG001|Overall Study|Other|2|||
94356074|NCT01050998|323085793|FG002|Overall Study|Other|1|||
94356075|NCT01050998|323085794|FG003|Overall Study|Other|1|||
94356076|NCT01050998|323085795|FG004|Overall Study|Other|5|||
94356077|NCT01050998|323085791|FG000|Overall Study|Data integrity issues|0|||
94356078|NCT01050998|323085792|FG001|Overall Study|Data integrity issues|0|||
94356079|NCT01050998|323085793|FG002|Overall Study|Data integrity issues|1|||
94356080|NCT01050998|323085794|FG003|Overall Study|Data integrity issues|1|||
94356081|NCT01050998|323085795|FG004|Overall Study|Data integrity issues|4|||
94356082|NCT01428882|323085798|FG000|Overall Study|Lack of Efficacy|2|||
94356083|NCT01428882|323085799|FG001|Overall Study|Lack of Efficacy|7|||
94356084|NCT01428882|323085798|FG000|Overall Study|Protocol Violation|4|||
94356085|NCT01428882|323085799|FG001|Overall Study|Protocol Violation|3|||
94356086|NCT01694849|323085801|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
94356087|NCT01694849|323085802|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
94356088|NCT01694849|323085803|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
94356089|NCT01694849|323085801|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
94356090|NCT01694849|323085802|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
94356091|NCT01694849|323085803|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
94356092|NCT01694849|323085801|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
94356093|NCT01694849|323085802|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
94356094|NCT01694849|323085803|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
94356095|NCT01694849|323085801|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
94356096|NCT01694849|323085802|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
94356097|NCT01694849|323085803|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
94356098|NCT01694849|323085801|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
94356099|NCT01694849|323085802|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
94356100|NCT01694849|323085803|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
94356101|NCT01694849|323085801|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
94356102|NCT01694849|323085802|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
94356103|NCT01694849|323085803|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
94356104|NCT01694849|323085801|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
94356105|NCT01694849|323085802|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
94356106|NCT01694849|323085803|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
94356107|NCT01694849|323085801|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
94356108|NCT01694849|323085802|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
94356109|NCT01694849|323085803|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
94356110|NCT05147311|323085804|FG000|Overall Study|Did not complete survey|2|||
94356111|NCT05147311|323085805|FG001|Overall Study|Did not complete survey|1|||
94356112|NCT05147311|323085804|FG000|Overall Study|Patient too sick|1|||
94356113|NCT05147311|323085805|FG001|Overall Study|Patient too sick|2|||
94356114|NCT05147311|323085804|FG000|Overall Study|Death|0|||
94356115|NCT05147311|323085805|FG001|Overall Study|Death|1|||
94356116|NCT05147311|323085804|FG000|Overall Study|Declined survey|1|||
94356117|NCT05147311|323085805|FG001|Overall Study|Declined survey|0|||
94356118|NCT00499694|323085808|FG000|Overall Study|Patient never received treatment.|1|||
94356119|NCT02304484|323085809|FG000|Overall Study|Death|9|||
94356120|NCT02304484|323085809|FG000|Overall Study|Withdrawal by Subject|14|||
94356121|NCT02304484|323085809|FG000|Overall Study|Lost to Follow-up|2|||
94356122|NCT00145795|323085810|FG000|Overall Study|Adverse Event|1|||
94356123|NCT00145795|323085811|FG001|Overall Study|Adverse Event|0|||
94356124|NCT02967055|323085812|FG000|Overall Study|Excluded|40|||
94356125|NCT02967055|323085812|FG000|Overall Study|Screen fail|3|||
94602502|NCT04761627|324007197|FG002|Post-randomization Period|Study site closure|1|||
94356126|NCT02967055|323085812|FG000|Overall Study|Lost to Follow-up|2|||
94602503|NCT04761627|324007195|FG000|Post-randomization Period|Family planning|0|||
94602504|NCT04761627|324007196|FG001|Post-randomization Period|Family planning|1|||
94356127|NCT02967055|323085812|FG000|Overall Study|Stopped due to side effects|3|||
94457979|NCT02980341|323465677|FG006|Dose Finding|Withdrawal by Subject|1|||
94457980|NCT02980341|323465678|FG007|Dose Finding|Withdrawal by Subject|0|||
94602505|NCT04761627|324007197|FG002|Post-randomization Period|Family planning|0|||
94356128|NCT02967055|323085812|FG000|Overall Study|Stopped due to drug cost|1|||
94356129|NCT00903357|323085813|FG000|First Intervention|Withdrawal by Subject|5|||
94356130|NCT00903357|323085814|FG001|First Intervention|Withdrawal by Subject|3|||
94356131|NCT00903357|323085813|FG000|First Intervention|Flu|0|||
94356132|NCT00903357|323085814|FG001|First Intervention|Flu|1|||
94356133|NCT00903357|323085813|FG000|Wash Out Period of 2 Weeks|Flu|0|||
94356134|NCT00903357|323085814|FG001|Wash Out Period of 2 Weeks|Flu|1|||
94457981|NCT02980341|323465679|FG008|Dose Finding|Withdrawal by Subject|0|||
94602506|NCT01117792|324007200|FG000|Overall Study|Death|1|||
94602507|NCT01117792|324007200|FG000|Overall Study|Adverse Event|3|||
94602508|NCT00046891|324007201|FG000|Overall Study|Cancels|5|||
94602509|NCT00046891|324007202|FG001|Overall Study|Cancels|9|||
94602510|NCT00046891|324007201|FG000|Overall Study|Ineligible|1|||
94602511|NCT00046891|324007202|FG001|Overall Study|Ineligible|1|||
94602512|NCT00046891|324007201|FG000|Overall Study|Withdrawal by Subject|18|||
94602513|NCT00046891|324007202|FG001|Overall Study|Withdrawal by Subject|15|||
94602514|NCT00046891|324007201|FG000|Overall Study|Adverse Event|5|||
94602515|NCT00046891|324007202|FG001|Overall Study|Adverse Event|5|||
94602516|NCT00723203|324007203|FG000|Overall Study|Withdrawal by Subject|3|||
94602517|NCT04966741|324007204|FG000|Overall Study|Lost to Follow-up|1|||
94602518|NCT04966741|324007205|FG001|Overall Study|Lost to Follow-up|0|||
94602519|NCT01582854|324007206|FG000|Overall Study|Death|8|||
94602520|NCT01582854|324007207|FG001|Overall Study|Death|5|||
94602521|NCT01582854|324007206|FG000|Overall Study|Adverse Event|2|||
94602522|NCT01582854|324007207|FG001|Overall Study|Adverse Event|3|||
94602523|NCT01582854|324007206|FG000|Overall Study|Withdrawal by Participant|8|||
94602524|NCT01582854|324007207|FG001|Overall Study|Withdrawal by Participant|11|||
94602525|NCT01582854|324007206|FG000|Overall Study|Lost to Follow-up|1|||
94602526|NCT01582854|324007207|FG001|Overall Study|Lost to Follow-up|2|||
94602527|NCT01582854|324007206|FG000|Overall Study|Physician Decision|0|||
94602528|NCT01582854|324007207|FG001|Overall Study|Physician Decision|1|||
94602529|NCT01582854|324007206|FG000|Overall Study|Recurrent Stroke|13|||
94602530|NCT01582854|324007207|FG001|Overall Study|Recurrent Stroke|8|||
94602531|NCT01582854|324007206|FG000|Overall Study|Disallowed Concomitant Medication|3|||
94602532|NCT01582854|324007207|FG001|Overall Study|Disallowed Concomitant Medication|2|||
94602533|NCT01582854|324007206|FG000|Overall Study|Carotid or Neurosurgery|0|||
94602534|NCT01582854|324007207|FG001|Overall Study|Carotid or Neurosurgery|1|||
94602535|NCT01582854|324007206|FG000|Overall Study|General Anaesthesia|0|||
94602536|NCT01582854|324007207|FG001|Overall Study|General Anaesthesia|1|||
94602537|NCT01582854|324007206|FG000|Overall Study|Other Miscellaneous Reason|1|||
94602538|NCT01582854|324007207|FG001|Overall Study|Other Miscellaneous Reason|0|||
94602539|NCT00459056|324007210|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
94602540|NCT00459056|324007211|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
94602541|NCT02283177|324007212|FG000|Overall Study|Withdrawal by Subject|1|||
94602542|NCT02283177|324007213|FG001|Overall Study|Withdrawal by Subject|1|||
94602543|NCT02398227|324007218|FG000|Overall Study|Lost to Follow-up|21|||
94602544|NCT02398227|324007219|FG001|Overall Study|Lost to Follow-up|12|||
94602545|NCT02398227|324007218|FG000|Overall Study|Withdrawal by Subject|5|||
94602546|NCT02398227|324007219|FG001|Overall Study|Withdrawal by Subject|6|||
94602547|NCT02398227|324007218|FG000|Overall Study|Removed from treatment and dropped out|1|||
94602548|NCT02398227|324007219|FG001|Overall Study|Removed from treatment and dropped out|0|||
94602549|NCT00722371|324007220|FG000|Overall Study|Adverse Event|6|||
94602550|NCT00722371|324007221|FG001|Overall Study|Adverse Event|13|||
94602551|NCT00722371|324007222|FG002|Overall Study|Adverse Event|9|||
94602552|NCT00722371|324007223|FG003|Overall Study|Adverse Event|10|||
94602553|NCT00722371|324007224|FG004|Overall Study|Adverse Event|6|||
94602554|NCT00722371|324007225|FG005|Overall Study|Adverse Event|8|||
94602555|NCT00722371|324007226|FG006|Overall Study|Adverse Event|4|||
94602556|NCT00722371|324007220|FG000|Overall Study|Contraindication|0|||
94602557|NCT00722371|324007221|FG001|Overall Study|Contraindication|0|||
94602558|NCT00722371|324007222|FG002|Overall Study|Contraindication|1|||
94602559|NCT00722371|324007223|FG003|Overall Study|Contraindication|0|||
94602560|NCT00722371|324007224|FG004|Overall Study|Contraindication|0|||
94602561|NCT00722371|324007225|FG005|Overall Study|Contraindication|0|||
94602562|NCT00722371|324007226|FG006|Overall Study|Contraindication|0|||
94602563|NCT00722371|324007220|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
94602564|NCT00722371|324007221|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
94602565|NCT00722371|324007222|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
94602566|NCT00722371|324007223|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
94602567|NCT00722371|324007224|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
94602568|NCT00722371|324007225|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
94602569|NCT00722371|324007226|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
94602570|NCT00722371|324007220|FG000|Overall Study|Excluded medication|0|||
94661221|NCT00718718|324213920|FG001|Prior to Week 12|Other|0|||
94602571|NCT00722371|324007221|FG001|Overall Study|Excluded medication|1|||
94602572|NCT00722371|324007222|FG002|Overall Study|Excluded medication|1|||
94602573|NCT00722371|324007223|FG003|Overall Study|Excluded medication|0|||
94602574|NCT00722371|324007224|FG004|Overall Study|Excluded medication|0|||
94602575|NCT00722371|324007225|FG005|Overall Study|Excluded medication|0|||
94661222|NCT00718718|324213921|FG002|Prior to Week 12|Other|1|||
94248630|NCT00774930|322704878|FG001|IOL Phase|Brain radiation|1|||
94248631|NCT00774930|322704877|FG000|LTOLE Phase|Adverse Event|7|||
94248632|NCT00774930|322704878|FG001|LTOLE Phase|Adverse Event|3|||
94248633|NCT00774930|322704877|FG000|LTOLE Phase|Subject decision|0|||
94248634|NCT00774930|322704878|FG001|LTOLE Phase|Subject decision|5|||
94248635|NCT00774930|322704877|FG000|LTOLE Phase|Physician Decision|4|||
94248636|NCT00774930|322704878|FG001|LTOLE Phase|Physician Decision|1|||
94248637|NCT00774930|322704877|FG000|LTOLE Phase|Sponsor decision|2|||
94248638|NCT00774930|322704878|FG001|LTOLE Phase|Sponsor decision|1|||
94248639|NCT00774930|322704877|FG000|LTOLE Phase|Disease Progression|2|||
94248640|NCT00774930|322704878|FG001|LTOLE Phase|Disease Progression|5|||
94248641|NCT00774930|322704877|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
94248642|NCT00774930|322704878|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
94248643|NCT00774930|322704877|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
94248644|NCT00774930|322704878|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
94248645|NCT03020576|322704880|FG000|Overall Study|Withdrawal by Subject|1|||
94248646|NCT03020576|322704881|FG001|Overall Study|Withdrawal by Subject|2|||
94248647|NCT01097707|322704890|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
94248648|NCT01097707|322704891|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
94248649|NCT01097707|322704892|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
94248650|NCT01097707|322704893|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
94248651|NCT01097707|322704894|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
94248652|NCT01097707|322704890|FG000|Overall Study|Adverse Event|4|||
94248653|NCT01097707|322704891|FG001|Overall Study|Adverse Event|2|||
94248654|NCT01097707|322704892|FG002|Overall Study|Adverse Event|3|||
94248655|NCT01097707|322704893|FG003|Overall Study|Adverse Event|1|||
94248656|NCT01097707|322704894|FG004|Overall Study|Adverse Event|3|||
94248657|NCT01097707|322704890|FG000|Overall Study|Entry Criteria Not Met|2|||
94248658|NCT01097707|322704891|FG001|Overall Study|Entry Criteria Not Met|1|||
94248659|NCT01097707|322704892|FG002|Overall Study|Entry Criteria Not Met|1|||
94248660|NCT01097707|322704893|FG003|Overall Study|Entry Criteria Not Met|0|||
94248661|NCT01097707|322704894|FG004|Overall Study|Entry Criteria Not Met|1|||
94248662|NCT01097707|322704890|FG000|Overall Study|Lack of Efficacy|1|||
94248663|NCT01097707|322704891|FG001|Overall Study|Lack of Efficacy|0|||
94248664|NCT01097707|322704892|FG002|Overall Study|Lack of Efficacy|0|||
94248665|NCT01097707|322704893|FG003|Overall Study|Lack of Efficacy|1|||
94248666|NCT01097707|322704894|FG004|Overall Study|Lack of Efficacy|0|||
94248667|NCT01097707|322704890|FG000|Overall Study|Lost to Follow-up|1|||
94248668|NCT01097707|322704891|FG001|Overall Study|Lost to Follow-up|1|||
94248669|NCT01097707|322704892|FG002|Overall Study|Lost to Follow-up|2|||
94248670|NCT01097707|322704893|FG003|Overall Study|Lost to Follow-up|0|||
94248671|NCT01097707|322704894|FG004|Overall Study|Lost to Follow-up|3|||
94248672|NCT01097707|322704890|FG000|Overall Study|Protocol Violation|2|||
94248673|NCT01097707|322704891|FG001|Overall Study|Protocol Violation|2|||
94248674|NCT01097707|322704892|FG002|Overall Study|Protocol Violation|3|||
94248675|NCT01097707|322704893|FG003|Overall Study|Protocol Violation|2|||
94248676|NCT01097707|322704894|FG004|Overall Study|Protocol Violation|2|||
94248677|NCT01097707|322704890|FG000|Overall Study|Sponsor Decision|31|||
94248678|NCT01097707|322704891|FG001|Overall Study|Sponsor Decision|31|||
94248679|NCT01097707|322704892|FG002|Overall Study|Sponsor Decision|34|||
94248680|NCT01097707|322704893|FG003|Overall Study|Sponsor Decision|35|||
94248681|NCT01097707|322704894|FG004|Overall Study|Sponsor Decision|36|||
94248682|NCT01097707|322704890|FG000|Overall Study|Withdrawal by Subject|3|||
94248683|NCT01097707|322704891|FG001|Overall Study|Withdrawal by Subject|6|||
94248684|NCT01097707|322704892|FG002|Overall Study|Withdrawal by Subject|1|||
94248685|NCT01097707|322704893|FG003|Overall Study|Withdrawal by Subject|4|||
94248686|NCT01097707|322704894|FG004|Overall Study|Withdrawal by Subject|3|||
94248687|NCT01097707|322704890|FG000|Overall Study|Reason unknown|0|||
94248688|NCT01097707|322704891|FG001|Overall Study|Reason unknown|0|||
94248689|NCT01097707|322704892|FG002|Overall Study|Reason unknown|0|||
94248690|NCT01097707|322704893|FG003|Overall Study|Reason unknown|0|||
94356135|NCT00903357|323085813|FG000|Second Intervention|Lost to Follow-up|1|||
94356136|NCT00903357|323085814|FG001|Second Intervention|Lost to Follow-up|0|||
94356137|NCT01333501|323085820|FG000|Overall Study|Adverse Event|3|||
94602576|NCT00722371|324007226|FG006|Overall Study|Excluded medication|1|||
94248691|NCT01097707|322704894|FG004|Overall Study|Reason unknown|1|||
94248692|NCT00911937|322704895|FG000|Overall Study|Death|1|||
94248693|NCT00911937|322704896|FG001|Overall Study|Death|0|||
94248694|NCT00911937|322704895|FG000|Overall Study|Lost to Follow-up|8|||
94248695|NCT00911937|322704896|FG001|Overall Study|Lost to Follow-up|5|||
94248696|NCT00911937|322704895|FG000|Overall Study|Withdrawal by Subject|10|||
94248697|NCT00911937|322704896|FG001|Overall Study|Withdrawal by Subject|7|||
94248698|NCT00911937|322704895|FG000|Overall Study|Withdrawn due to pregnancy|1|||
94248699|NCT00911937|322704896|FG001|Overall Study|Withdrawn due to pregnancy|0|||
94248700|NCT00911937|322704895|FG000|Overall Study|Adverse Event|11|||
94248701|NCT00911937|322704896|FG001|Overall Study|Adverse Event|25|||
94248702|NCT00911937|322704895|FG000|Overall Study|Lack of Efficacy|11|||
94248703|NCT00911937|322704896|FG001|Overall Study|Lack of Efficacy|6|||
94356138|NCT01333501|323085821|FG001|Overall Study|Adverse Event|1|||
94356139|NCT01333501|323085820|FG000|Overall Study|Abnormal laboratory value|2|||
94602577|NCT00722371|324007220|FG000|Overall Study|Hyperglycemia|2|||
94602578|NCT00722371|324007221|FG001|Overall Study|Hyperglycemia|6|||
94602579|NCT00722371|324007222|FG002|Overall Study|Hyperglycemia|4|||
94602580|NCT00722371|324007223|FG003|Overall Study|Hyperglycemia|2|||
94602581|NCT00722371|324007224|FG004|Overall Study|Hyperglycemia|5|||
94602582|NCT00722371|324007225|FG005|Overall Study|Hyperglycemia|1|||
94248704|NCT00911937|322704895|FG000|Overall Study|Did not meet inclusion criteria|9|||
94248705|NCT00911937|322704896|FG001|Overall Study|Did not meet inclusion criteria|11|||
94248706|NCT00911937|322704895|FG000|Overall Study|Protocol Violation|14|||
94248707|NCT00911937|322704896|FG001|Overall Study|Protocol Violation|23|||
94248708|NCT00911937|322704895|FG000|Overall Study|Randomized but not treated|13|||
94248709|NCT00911937|322704896|FG001|Overall Study|Randomized but not treated|13|||
94248710|NCT00911937|322704895|FG000|Overall Study|Other|9|||
94248711|NCT00911937|322704896|FG001|Overall Study|Other|5|||
94248712|NCT01712659|322704902|FG000|Dose Escalation|Physician Decision|0|||
94248713|NCT01712659|322704903|FG001|Dose Escalation|Physician Decision|1|||
94248714|NCT01712659|322704904|FG002|Dose Escalation|Physician Decision|0|||
94248715|NCT01712659|322704905|FG003|Dose Escalation|Physician Decision|0|||
94248716|NCT01712659|322704906|FG004|Dose Escalation|Physician Decision|0|||
94248717|NCT01712659|322704902|FG000|Dose Escalation|Unable to take study drug|0|||
94248718|NCT01712659|322704903|FG001|Dose Escalation|Unable to take study drug|1|||
94248719|NCT01712659|322704904|FG002|Dose Escalation|Unable to take study drug|0|||
94248720|NCT01712659|322704905|FG003|Dose Escalation|Unable to take study drug|0|||
94248721|NCT01712659|322704906|FG004|Dose Escalation|Unable to take study drug|0|||
94248722|NCT01712659|322704902|FG000|Dose Expansion|Early disease progression|1|||
94248723|NCT01712659|322704903|FG001|Dose Expansion|Early disease progression|0|||
94248724|NCT01712659|322704904|FG002|Dose Expansion|Early disease progression|0|||
94248725|NCT01712659|322704905|FG003|Dose Expansion|Early disease progression|0|||
94248726|NCT01712659|322704906|FG004|Dose Expansion|Early disease progression|0|||
94248727|NCT01712659|322704902|FG000|Dose Expansion|Physician Decision|1|||
94248728|NCT01712659|322704903|FG001|Dose Expansion|Physician Decision|0|||
94248729|NCT01712659|322704904|FG002|Dose Expansion|Physician Decision|0|||
94248730|NCT01712659|322704905|FG003|Dose Expansion|Physician Decision|0|||
94248731|NCT01712659|322704906|FG004|Dose Expansion|Physician Decision|0|||
94248732|NCT02996474|322704910|FG000|Overall Study|Physician Decision|5|||
94248733|NCT05017103|322704911|FG000|Overall Study|Death|2|||
94248734|NCT01139580|322704915|FG000|Overall Study|Adverse Event|5|||
94248735|NCT01139580|322704916|FG001|Overall Study|Adverse Event|4|||
94248736|NCT01139580|322704915|FG000|Overall Study|Lost to Follow-up|9|||
94248737|NCT01139580|322704916|FG001|Overall Study|Lost to Follow-up|1|||
94248738|NCT01139580|322704915|FG000|Overall Study|Lack of Efficacy|0|||
94248739|NCT01139580|322704916|FG001|Overall Study|Lack of Efficacy|2|||
94248740|NCT01139580|322704915|FG000|Overall Study|Withdrawal by Subject|6|||
94248741|NCT01139580|322704916|FG001|Overall Study|Withdrawal by Subject|9|||
94248742|NCT01139580|322704915|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
94248743|NCT01139580|322704916|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
94248744|NCT01139580|322704915|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
94248745|NCT01139580|322704916|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
94248746|NCT01139580|322704915|FG000|Overall Study|Misrandomized|1|||
94248747|NCT01139580|322704916|FG001|Overall Study|Misrandomized|0|||
94248748|NCT01139580|322704915|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
94248749|NCT01139580|322704916|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
94248750|NCT01139580|322704915|FG000|Overall Study|Participant Randomization in Error|0|||
94248751|NCT01139580|322704916|FG001|Overall Study|Participant Randomization in Error|1|||
94248752|NCT00633880|322704917|FG000|Open Label Titration|Lack of Efficacy|1|||
94248753|NCT00633880|322704918|FG001|Open Label Titration|Lack of Efficacy|0|||
94248754|NCT00633880|322704919|FG002|Open Label Titration|Lack of Efficacy|0|||
94248755|NCT00633880|322704917|FG000|Open Label Titration|Adverse Event|13|||
94356140|NCT01333501|323085821|FG001|Overall Study|Abnormal laboratory value|1|||
94356141|NCT01333501|323085820|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94356142|NCT01333501|323085821|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
94602583|NCT00722371|324007226|FG006|Overall Study|Hyperglycemia|1|||
94602584|NCT00722371|324007220|FG000|Overall Study|Hypoglycemia|1|||
94602585|NCT00722371|324007221|FG001|Overall Study|Hypoglycemia|0|||
94602586|NCT00722371|324007222|FG002|Overall Study|Hypoglycemia|0|||
94248756|NCT00633880|322704918|FG001|Open Label Titration|Adverse Event|0|||
94248757|NCT00633880|322704919|FG002|Open Label Titration|Adverse Event|0|||
94248758|NCT00633880|322704917|FG000|Open Label Titration|Treatment Failure|55|||
94248759|NCT00633880|322704918|FG001|Open Label Titration|Treatment Failure|0|||
94356143|NCT01333501|323085820|FG000|Overall Study|Withdrawn consent|3|||
94602587|NCT00722371|324007223|FG003|Overall Study|Hypoglycemia|0|||
94356144|NCT01333501|323085821|FG001|Overall Study|Withdrawn consent|12|||
94248760|NCT00633880|322704919|FG002|Open Label Titration|Treatment Failure|0|||
94248761|NCT00633880|322704917|FG000|Open Label Titration|Protocol Violation|6|||
94248762|NCT00633880|322704918|FG001|Open Label Titration|Protocol Violation|0|||
94602588|NCT00722371|324007224|FG004|Overall Study|Hypoglycemia|0|||
94602589|NCT00722371|324007225|FG005|Overall Study|Hypoglycemia|0|||
94602590|NCT00722371|324007226|FG006|Overall Study|Hypoglycemia|0|||
94602591|NCT00722371|324007220|FG000|Overall Study|Lack of Efficacy|4|||
94602592|NCT00722371|324007221|FG001|Overall Study|Lack of Efficacy|6|||
94602593|NCT00722371|324007222|FG002|Overall Study|Lack of Efficacy|6|||
94602594|NCT00722371|324007223|FG003|Overall Study|Lack of Efficacy|6|||
94602595|NCT00722371|324007224|FG004|Overall Study|Lack of Efficacy|2|||
94602596|NCT00722371|324007225|FG005|Overall Study|Lack of Efficacy|3|||
94602597|NCT00722371|324007226|FG006|Overall Study|Lack of Efficacy|0|||
94602598|NCT00722371|324007220|FG000|Overall Study|Lost to Follow-up|11|||
94602599|NCT00722371|324007221|FG001|Overall Study|Lost to Follow-up|14|||
94602600|NCT00722371|324007222|FG002|Overall Study|Lost to Follow-up|21|||
94602601|NCT00722371|324007223|FG003|Overall Study|Lost to Follow-up|13|||
94602602|NCT00722371|324007224|FG004|Overall Study|Lost to Follow-up|8|||
94602603|NCT00722371|324007225|FG005|Overall Study|Lost to Follow-up|16|||
94602604|NCT00722371|324007226|FG006|Overall Study|Lost to Follow-up|13|||
94602605|NCT00722371|324007220|FG000|Overall Study|Physician Decision|5|||
94602606|NCT00722371|324007221|FG001|Overall Study|Physician Decision|2|||
94602607|NCT00722371|324007222|FG002|Overall Study|Physician Decision|2|||
94602608|NCT00722371|324007223|FG003|Overall Study|Physician Decision|5|||
94602609|NCT00722371|324007224|FG004|Overall Study|Physician Decision|2|||
94602610|NCT00722371|324007225|FG005|Overall Study|Physician Decision|3|||
94602611|NCT00722371|324007226|FG006|Overall Study|Physician Decision|4|||
94661223|NCT00718718|324213922|FG003|Prior to Week 12|Other|0|||
94661224|NCT00718718|324213923|FG004|Prior to Week 12|Other|0|||
94661225|NCT00718718|324213924|FG005|Prior to Week 12|Other|0|||
94661226|NCT00718718|324213925|FG006|Prior to Week 12|Other|0|||
94661227|NCT00718718|324213926|FG007|Prior to Week 12|Other|0|||
94661228|NCT00718718|324213927|FG008|Prior to Week 12|Other|0|||
94661229|NCT00718718|324213928|FG009|Prior to Week 12|Other|0|||
94661230|NCT00718718|324213919|FG000|Week 12 to End of Study|Adverse Event|0|||
94661231|NCT00718718|324213920|FG001|Week 12 to End of Study|Adverse Event|0|||
94661232|NCT00718718|324213921|FG002|Week 12 to End of Study|Adverse Event|0|||
94661233|NCT00718718|324213922|FG003|Week 12 to End of Study|Adverse Event|0|||
94661234|NCT00718718|324213923|FG004|Week 12 to End of Study|Adverse Event|0|||
94661235|NCT00718718|324213924|FG005|Week 12 to End of Study|Adverse Event|0|||
94661236|NCT00718718|324213925|FG006|Week 12 to End of Study|Adverse Event|0|||
94661237|NCT00718718|324213926|FG007|Week 12 to End of Study|Adverse Event|1|||
94661238|NCT00718718|324213927|FG008|Week 12 to End of Study|Adverse Event|0|||
94661239|NCT00718718|324213928|FG009|Week 12 to End of Study|Adverse Event|0|||
94661240|NCT00718718|324213919|FG000|Week 12 to End of Study|Death|0|||
94661241|NCT00718718|324213920|FG001|Week 12 to End of Study|Death|0|||
94661242|NCT00718718|324213921|FG002|Week 12 to End of Study|Death|0|||
94661243|NCT00718718|324213922|FG003|Week 12 to End of Study|Death|0|||
94661244|NCT00718718|324213923|FG004|Week 12 to End of Study|Death|0|||
94661245|NCT00718718|324213924|FG005|Week 12 to End of Study|Death|1|||
94661246|NCT00718718|324213925|FG006|Week 12 to End of Study|Death|0|||
94661247|NCT00718718|324213926|FG007|Week 12 to End of Study|Death|0|||
94661248|NCT00718718|324213927|FG008|Week 12 to End of Study|Death|0|||
94661249|NCT00718718|324213928|FG009|Week 12 to End of Study|Death|0|||
94661250|NCT00718718|324213919|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
94661251|NCT00718718|324213920|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
94661252|NCT00718718|324213921|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
94661253|NCT00718718|324213922|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
94661254|NCT00718718|324213923|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
94356145|NCT02370173|323085824|FG000|Overall Study|Protocol Violation|1|||
94356146|NCT02370173|323085825|FG001|Overall Study|Protocol Violation|1|||
94356147|NCT02370173|323085824|FG000|Overall Study|Withdrawal by Subject|2|||
94356148|NCT02370173|323085825|FG001|Overall Study|Withdrawal by Subject|2|||
94356149|NCT04794491|323085826|FG000|Overall Study|Adverse Event|1|||
94602612|NCT00722371|324007220|FG000|Overall Study|Pregnancy|1|||
94602613|NCT00722371|324007221|FG001|Overall Study|Pregnancy|1|||
94602614|NCT00722371|324007222|FG002|Overall Study|Pregnancy|0|||
94602615|NCT00722371|324007223|FG003|Overall Study|Pregnancy|0|||
94602616|NCT00722371|324007224|FG004|Overall Study|Pregnancy|0|||
94661255|NCT00718718|324213924|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
94661256|NCT00718718|324213925|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
94661257|NCT00718718|324213926|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
94661258|NCT00718718|324213927|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
94661259|NCT00718718|324213928|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
94661260|NCT00718718|324213919|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
94661261|NCT00718718|324213920|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
94356150|NCT04794491|323085826|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
94602617|NCT00722371|324007225|FG005|Overall Study|Pregnancy|1|||
94602618|NCT00722371|324007226|FG006|Overall Study|Pregnancy|0|||
94602619|NCT00722371|324007220|FG000|Overall Study|Protocol Violation|6|||
94602620|NCT00722371|324007221|FG001|Overall Study|Protocol Violation|1|||
94602621|NCT00722371|324007222|FG002|Overall Study|Protocol Violation|0|||
94661262|NCT00718718|324213921|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
94661263|NCT00718718|324213922|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
94661264|NCT00718718|324213923|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
94661265|NCT00718718|324213924|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
94661266|NCT00718718|324213925|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
94661267|NCT00718718|324213926|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
94661268|NCT00718718|324213927|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
94661269|NCT00718718|324213928|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
94661270|NCT00718718|324213919|FG000|Week 12 to End of Study|Other|0|||
94661271|NCT00718718|324213920|FG001|Week 12 to End of Study|Other|1|||
94661272|NCT00718718|324213921|FG002|Week 12 to End of Study|Other|0|||
94661273|NCT00718718|324213922|FG003|Week 12 to End of Study|Other|1|||
94661274|NCT00718718|324213923|FG004|Week 12 to End of Study|Other|0|||
94661275|NCT00718718|324213924|FG005|Week 12 to End of Study|Other|0|||
94661276|NCT00718718|324213925|FG006|Week 12 to End of Study|Other|1|||
94661277|NCT00718718|324213926|FG007|Week 12 to End of Study|Other|0|||
94661278|NCT00718718|324213927|FG008|Week 12 to End of Study|Other|0|||
94661279|NCT00718718|324213928|FG009|Week 12 to End of Study|Other|0|||
94661280|NCT04598152|324213929|FG000|Overall Study|Lost to Follow-up|0|||
94661281|NCT04598152|324213930|FG001|Overall Study|Lost to Follow-up|1|||
94661282|NCT03394924|324213936|FG000|Overall Study|Adverse Event|0|||
94661283|NCT03394924|324213937|FG001|Overall Study|Adverse Event|5|||
94661284|NCT03394924|324213938|FG002|Overall Study|Adverse Event|0|||
94661285|NCT03394924|324213936|FG000|Overall Study|Withdrawal by Subject|2|||
94661286|NCT03394924|324213937|FG001|Overall Study|Withdrawal by Subject|0|||
94661287|NCT03394924|324213938|FG002|Overall Study|Withdrawal by Subject|0|||
94661288|NCT03394924|324213936|FG000|Overall Study|Lost to Follow-up|0|||
94661289|NCT03394924|324213937|FG001|Overall Study|Lost to Follow-up|1|||
94661290|NCT03394924|324213938|FG002|Overall Study|Lost to Follow-up|0|||
94661291|NCT03394924|324213936|FG000|Overall Study|Did not meet all inclusion criteria|1|||
94661292|NCT03394924|324213937|FG001|Overall Study|Did not meet all inclusion criteria|0|||
94661293|NCT03394924|324213938|FG002|Overall Study|Did not meet all inclusion criteria|0|||
94661294|NCT00253864|324213942|FG000|Overall Study|Lost to Follow-up|5|||
94661295|NCT00253864|324213943|FG001|Overall Study|Lost to Follow-up|8|||
94661296|NCT00110617|324213944|FG000|Overall Study|Adverse Event|2|||
94661297|NCT00110617|324213945|FG001|Overall Study|Adverse Event|4|||
94661298|NCT00110617|324213944|FG000|Overall Study|Abnormal Laboratory Value|4|||
94661299|NCT00110617|324213945|FG001|Overall Study|Abnormal Laboratory Value|2|||
94661300|NCT00110617|324213944|FG000|Overall Study|Lack of Efficacy|1|||
94661301|NCT00110617|324213945|FG001|Overall Study|Lack of Efficacy|0|||
94661302|NCT00110617|324213944|FG000|Overall Study|Patient no longer requires study drug|1|||
94661303|NCT00110617|324213945|FG001|Overall Study|Patient no longer requires study drug|0|||
94661304|NCT00110617|324213944|FG000|Overall Study|Protocol Violation|5|||
94661305|NCT00110617|324213945|FG001|Overall Study|Protocol Violation|0|||
94661306|NCT00110617|324213944|FG000|Overall Study|Withdrawal by Subject|10|||
94661307|NCT00110617|324213945|FG001|Overall Study|Withdrawal by Subject|4|||
94661308|NCT00110617|324213944|FG000|Overall Study|Lost to Follow-up|9|||
94661309|NCT00110617|324213945|FG001|Overall Study|Lost to Follow-up|1|||
94661310|NCT00110617|324213944|FG000|Overall Study|Administrative problems|6|||
94661311|NCT00110617|324213945|FG001|Overall Study|Administrative problems|5|||
94661312|NCT00110617|324213944|FG000|Overall Study|Death|1|||
94661313|NCT00110617|324213945|FG001|Overall Study|Death|1|||
94661314|NCT00110617|324213944|FG000|Overall Study|Did not receive study drug|0|||
94661315|NCT00110617|324213945|FG001|Overall Study|Did not receive study drug|12|||
94661316|NCT02416791|324215682|FG000|6 Months|Lost to Follow-up|0|||
94661317|NCT02416791|324215683|FG001|6 Months|Lost to Follow-up|0|||
94661318|NCT02416791|324215684|FG002|6 Months|Lost to Follow-up|1|||
94661319|NCT01181921|324215689|FG000|Overall Study|Lost to Follow-up|1|||
94661320|NCT00406029|324215692|FG000|Overall Study|Adverse Event|12|||
94661321|NCT00406029|324215693|FG001|Overall Study|Adverse Event|2|||
94661322|NCT00406029|324215694|FG002|Overall Study|Adverse Event|5|||
94661323|NCT00406029|324215695|FG003|Overall Study|Adverse Event|10|||
94661324|NCT00406029|324215696|FG004|Overall Study|Adverse Event|7|||
94661325|NCT00406029|324215692|FG000|Overall Study|Withdrawal by Subject|3|||
94661326|NCT00406029|324215693|FG001|Overall Study|Withdrawal by Subject|4|||
94661327|NCT00406029|324215694|FG002|Overall Study|Withdrawal by Subject|2|||
94661328|NCT00406029|324215695|FG003|Overall Study|Withdrawal by Subject|2|||
94661329|NCT00406029|324215696|FG004|Overall Study|Withdrawal by Subject|0|||
94661330|NCT00406029|324215692|FG000|Overall Study|Protocol Violation|1|||
94661331|NCT00406029|324215693|FG001|Overall Study|Protocol Violation|2|||
94661332|NCT00406029|324215694|FG002|Overall Study|Protocol Violation|0|||
94661333|NCT00406029|324215695|FG003|Overall Study|Protocol Violation|2|||
94661334|NCT00406029|324215696|FG004|Overall Study|Protocol Violation|0|||
94661335|NCT00406029|324215692|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
94661336|NCT00406029|324215693|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
94661337|NCT00406029|324215694|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
94661338|NCT00406029|324215695|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
94661339|NCT00406029|324215696|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
94661340|NCT00406029|324215692|FG000|Overall Study|Randomized in Error|0|||
94248763|NCT00633880|322704919|FG002|Open Label Titration|Protocol Violation|0|||
94248764|NCT00633880|322704917|FG000|Open Label Titration|Physician Decision|1|||
94248765|NCT00633880|322704918|FG001|Open Label Titration|Physician Decision|0|||
94248766|NCT00633880|322704919|FG002|Open Label Titration|Physician Decision|0|||
94248767|NCT00633880|322704917|FG000|Open Label Titration|Withdrawal by Subject|4|||
94661341|NCT00406029|324215693|FG001|Overall Study|Randomized in Error|0|||
94661342|NCT00406029|324215694|FG002|Overall Study|Randomized in Error|2|||
94661343|NCT00406029|324215695|FG003|Overall Study|Randomized in Error|3|||
94661344|NCT00406029|324215696|FG004|Overall Study|Randomized in Error|1|||
94661345|NCT04408469|324215699|FG000|Overall Study|Lost to Follow-up|6|||
94661346|NCT04408469|324215700|FG001|Overall Study|Lost to Follow-up|9|||
94661347|NCT04408469|324215699|FG000|Overall Study|Withdrawal by Subject|6|||
94661348|NCT04408469|324215700|FG001|Overall Study|Withdrawal by Subject|1|||
94661349|NCT04408469|324215699|FG000|Overall Study|Dismissal due to ineligibility|0|||
94661350|NCT04408469|324215700|FG001|Overall Study|Dismissal due to ineligibility|1|||
94661351|NCT01286779|324215702|FG000|Overall Study|Withdrawal by Subject|9|||
94661352|NCT01286779|324215702|FG000|Overall Study|Protocol Violation|5|||
94661353|NCT01286779|324215702|FG000|Overall Study|Physician Decision|2|||
94661354|NCT01286779|324215702|FG000|Overall Study|Participant had scheduled surgery|1|||
94661355|NCT01286779|324215702|FG000|Overall Study|Participant moved to another country|1|||
94661356|NCT01286779|324215702|FG000|Overall Study|Discontinued by sponsor|1|||
94661357|NCT04258020|324215706|FG000|Overall Study|Withdrawal by Subject|1|||
94661358|NCT04258020|324215707|FG001|Overall Study|Withdrawal by Subject|0|||
94661359|NCT00599326|324215708|FG000|Overall Study|Lost to Follow-up|1|||
94661360|NCT00599326|324215708|FG000|Overall Study|Noncompliant|1|||
94661361|NCT00563784|324215709|FG000|Overall Study|Withdrawal by Subject|2|||
94661362|NCT00563784|324215709|FG000|Overall Study|Screen Failures|20|||
94661363|NCT03579459|324215712|FG000|Overall Study|Adverse Event|7|||
94661364|NCT03579459|324215713|FG001|Overall Study|Adverse Event|6|||
94661365|NCT03579459|324215714|FG002|Overall Study|Adverse Event|2|||
94661366|NCT03579459|324215715|FG003|Overall Study|Adverse Event|6|||
94248768|NCT00633880|322704918|FG001|Open Label Titration|Withdrawal by Subject|0|||
94248769|NCT00633880|322704919|FG002|Open Label Titration|Withdrawal by Subject|0|||
94248770|NCT01879553|322704923|FG000|Overall Study|Withdrawal by Subject|1|||
94248771|NCT01879553|322704924|FG001|Overall Study|Withdrawal by Subject|0|||
94248772|NCT00591851|322704925|FG000|Overall Study|Withdrawal by Subject|3|||
94248773|NCT00591851|322704925|FG000|Overall Study|Adverse Event|2|||
94248774|NCT00591851|322704925|FG000|Overall Study|Progressive Disease|1|||
94248775|NCT02559895|322704927|FG000|Overall Study|Adverse Event|3|||
94248776|NCT02559895|322704928|FG001|Overall Study|Adverse Event|3|||
94248777|NCT02559895|322704929|FG002|Overall Study|Adverse Event|2|||
94248778|NCT02559895|322704930|FG003|Overall Study|Adverse Event|1|||
94248779|NCT02559895|322704927|FG000|Overall Study|Lack of Efficacy|2|||
94248780|NCT02559895|322704928|FG001|Overall Study|Lack of Efficacy|3|||
94248781|NCT02559895|322704929|FG002|Overall Study|Lack of Efficacy|2|||
94248782|NCT02559895|322704930|FG003|Overall Study|Lack of Efficacy|8|||
94248783|NCT02559895|322704927|FG000|Overall Study|Lost to Follow-up|22|||
94248784|NCT02559895|322704928|FG001|Overall Study|Lost to Follow-up|16|||
94248785|NCT02559895|322704929|FG002|Overall Study|Lost to Follow-up|12|||
94248786|NCT02559895|322704930|FG003|Overall Study|Lost to Follow-up|17|||
94248787|NCT02559895|322704927|FG000|Overall Study|Physician Decision|1|||
94248788|NCT02559895|322704928|FG001|Overall Study|Physician Decision|1|||
94248789|NCT02559895|322704929|FG002|Overall Study|Physician Decision|3|||
94248790|NCT02559895|322704930|FG003|Overall Study|Physician Decision|0|||
94248791|NCT02559895|322704927|FG000|Overall Study|Withdrawal by Subject|16|||
94248792|NCT02559895|322704928|FG001|Overall Study|Withdrawal by Subject|9|||
94661367|NCT03579459|324215712|FG000|Overall Study|Death|1|||
94661368|NCT03579459|324215713|FG001|Overall Study|Death|0|||
94661369|NCT03579459|324215714|FG002|Overall Study|Death|1|||
94661370|NCT03579459|324215715|FG003|Overall Study|Death|2|||
94661371|NCT03579459|324215712|FG000|Overall Study|Lost to Follow-up|6|||
94661372|NCT03579459|324215713|FG001|Overall Study|Lost to Follow-up|2|||
94248793|NCT02559895|322704929|FG002|Overall Study|Withdrawal by Subject|20|||
94356151|NCT04794491|323085826|FG000|Overall Study|Noncompliance With Study Intervention|1|||
94661373|NCT03579459|324215714|FG002|Overall Study|Lost to Follow-up|4|||
94356152|NCT04794491|323085826|FG000|Overall Study|Withdrawal by Subject|2|||
94661374|NCT03579459|324215715|FG003|Overall Study|Lost to Follow-up|1|||
94248794|NCT02559895|322704930|FG003|Overall Study|Withdrawal by Subject|9|||
94248795|NCT02559895|322704927|FG000|Overall Study|Study Burden|10|||
94248796|NCT02559895|322704928|FG001|Overall Study|Study Burden|16|||
94248797|NCT02559895|322704929|FG002|Overall Study|Study Burden|12|||
94248798|NCT02559895|322704930|FG003|Overall Study|Study Burden|22|||
94248799|NCT02559895|322704927|FG000|Overall Study|Other|1|||
94248800|NCT02559895|322704928|FG001|Overall Study|Other|5|||
94248801|NCT02559895|322704929|FG002|Overall Study|Other|3|||
94661375|NCT03579459|324215712|FG000|Overall Study|Physician Decision|0|||
94661376|NCT03579459|324215713|FG001|Overall Study|Physician Decision|1|||
94248802|NCT02559895|322704930|FG003|Overall Study|Other|3|||
94248803|NCT01028027|322704934|FG000|Overall Study|Lost to Follow-up|4|||
94248804|NCT01028027|322704935|FG001|Overall Study|Lost to Follow-up|1|||
94248805|NCT01028027|322704934|FG000|Overall Study|Withdrawal by Subject|5|||
94248806|NCT01028027|322704935|FG001|Overall Study|Withdrawal by Subject|3|||
94248807|NCT01028027|322704934|FG000|Overall Study|Adverse Event|4|||
94248808|NCT01028027|322704935|FG001|Overall Study|Adverse Event|7|||
94248809|NCT01028027|322704934|FG000|Overall Study|Protocol Violation|3|||
94248810|NCT01028027|322704935|FG001|Overall Study|Protocol Violation|1|||
94248811|NCT01028027|322704934|FG000|Overall Study|Lack of Efficacy|0|||
94248812|NCT01028027|322704935|FG001|Overall Study|Lack of Efficacy|1|||
94248813|NCT05326815|322704944|FG000|Overall Study|Withdrawal by Subject|3|||
94248814|NCT05326815|322704944|FG000|Overall Study|Did not complete required labs|6|||
94248815|NCT05326815|322704944|FG000|Overall Study|Screen fail- abnormal labs|5|||
94248816|NCT03149549|322704945|FG000|Study Discontinuation--Treatment Period|Death|0|||
94248817|NCT03149549|322704946|FG001|Study Discontinuation--Treatment Period|Death|0|||
94248818|NCT03149549|322704947|FG002|Study Discontinuation--Treatment Period|Death|0|||
94248819|NCT03149549|322704948|FG003|Study Discontinuation--Treatment Period|Death|1|||
94248820|NCT03149549|322704949|FG004|Study Discontinuation--Treatment Period|Death|2|||
94248821|NCT03149549|322704950|FG005|Study Discontinuation--Treatment Period|Death|1|||
94248822|NCT03149549|322704951|FG006|Study Discontinuation--Treatment Period|Death|1|||
94248823|NCT03149549|322704952|FG007|Study Discontinuation--Treatment Period|Death|2|||
94248824|NCT03149549|322704953|FG008|Study Discontinuation--Treatment Period|Death|4|||
94248825|NCT03149549|322704954|FG009|Study Discontinuation--Treatment Period|Death|1|||
94248826|NCT03149549|322704955|FG010|Study Discontinuation--Treatment Period|Death|0|||
94248827|NCT03149549|322704956|FG011|Study Discontinuation--Treatment Period|Death|0|||
94248828|NCT03149549|322704957|FG012|Study Discontinuation--Treatment Period|Death|1|||
94248829|NCT03149549|322704945|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
94248830|NCT03149549|322704946|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
94248831|NCT03149549|322704947|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
94248832|NCT03149549|322704948|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
94248833|NCT03149549|322704949|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
94248834|NCT03149549|322704950|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
94248835|NCT03149549|322704951|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
94602622|NCT00722371|324007223|FG003|Overall Study|Protocol Violation|1|||
94602623|NCT00722371|324007224|FG004|Overall Study|Protocol Violation|4|||
94602624|NCT00722371|324007225|FG005|Overall Study|Protocol Violation|2|||
94602625|NCT00722371|324007226|FG006|Overall Study|Protocol Violation|1|||
94602626|NCT00722371|324007220|FG000|Overall Study|Withdrawal by Subject|18|||
94602627|NCT00722371|324007221|FG001|Overall Study|Withdrawal by Subject|27|||
94602628|NCT00722371|324007222|FG002|Overall Study|Withdrawal by Subject|19|||
94602629|NCT00722371|324007223|FG003|Overall Study|Withdrawal by Subject|23|||
94602630|NCT00722371|324007224|FG004|Overall Study|Withdrawal by Subject|19|||
94602631|NCT00722371|324007225|FG005|Overall Study|Withdrawal by Subject|18|||
94602632|NCT00722371|324007226|FG006|Overall Study|Withdrawal by Subject|26|||
94602633|NCT02068768|324007227|FG000|Overall Study|Lost to Follow-up|5|||
94602634|NCT02068768|324007227|FG000|Overall Study|Early Termination by Sponsor|2|||
94602635|NCT01185834|324007228|FG000|Overall Study|Lost to Follow-up|2|||
94602636|NCT01185834|324007228|FG000|Overall Study|Discomfort|4|||
94602637|NCT01185834|324007228|FG000|Overall Study|Biomicroscopy|4|||
94602638|NCT01185834|324007228|FG000|Overall Study|Time/Job Conflict|2|||
94602639|NCT01185834|324007228|FG000|Overall Study|Early exit - Site error|2|||
94602640|NCT00378079|324007232|FG000|Overall Study|Lost to Follow-up|6|||
94602641|NCT00378079|324007233|FG001|Overall Study|Lost to Follow-up|1|||
94602642|NCT00378079|324007234|FG002|Overall Study|Lost to Follow-up|0|||
94602643|NCT02274038|324007235|FG000|Overall Study|Death|1|||
94602644|NCT02942576|324007237|FG000|Overall Study|Adverse Event|28|||
94602645|NCT02942576|324007238|FG001|Overall Study|Adverse Event|6|||
94602646|NCT02942576|324007237|FG000|Overall Study|Withdrawal by Subject|7|||
94602647|NCT02942576|324007238|FG001|Overall Study|Withdrawal by Subject|5|||
94602648|NCT02942576|324007237|FG000|Overall Study|Physician Decision|1|||
94602649|NCT02942576|324007238|FG001|Overall Study|Physician Decision|4|||
94602650|NCT02942576|324007237|FG000|Overall Study|Other|10|||
94602651|NCT02942576|324007238|FG001|Overall Study|Other|8|||
94602652|NCT00504582|324008463|FG000|Overall Study|Lost to Follow-up|1|||
94602653|NCT00504582|324008464|FG001|Overall Study|Lost to Follow-up|0|||
94248836|NCT03149549|322704952|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
94248837|NCT03149549|322704953|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
94248838|NCT03149549|322704954|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
94248839|NCT03149549|322704955|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
94248840|NCT03149549|322704956|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
94602654|NCT00504582|324008465|FG002|Overall Study|Lost to Follow-up|0|||
94602655|NCT01879579|324008466|FG000|Overall Study|Phone incompatible with texting platform|3|||
94602656|NCT01879579|324008467|FG001|Overall Study|Phone incompatible with texting platform|0|||
94602657|NCT01879579|324008466|FG000|Overall Study|Did not enroll in texting platform|1|||
94602658|NCT01879579|324008467|FG001|Overall Study|Did not enroll in texting platform|0|||
94602659|NCT01879579|324008466|FG000|Overall Study|Did not initiate insulin treatment|1|||
94602660|NCT01879579|324008467|FG001|Overall Study|Did not initiate insulin treatment|0|||
94602661|NCT01879579|324008466|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
94602662|NCT01879579|324008467|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
94602663|NCT01879579|324008466|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
94602664|NCT01879579|324008467|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
94602665|NCT02927067|324008468|FG000|Overall Study|Withdrawn Consent|20|||
94602666|NCT02927067|324008469|FG001|Overall Study|Withdrawn Consent|12|||
94602667|NCT02927067|324008468|FG000|Overall Study|Death|18|||
94602668|NCT02927067|324008469|FG001|Overall Study|Death|31|||
94602669|NCT02927067|324008468|FG000|Overall Study|Adverse Event|13|||
94602670|NCT02927067|324008469|FG001|Overall Study|Adverse Event|10|||
94602671|NCT02927067|324008468|FG000|Overall Study|Noncompliance|5|||
94602672|NCT02927067|324008469|FG001|Overall Study|Noncompliance|2|||
94602673|NCT02927067|324008468|FG000|Overall Study|Reason not Specified|4|||
94602674|NCT02927067|324008469|FG001|Overall Study|Reason not Specified|6|||
94602675|NCT02919969|324008475|FG000|Overall Study|Lack of Efficacy|22|||
94602676|NCT02919969|324008475|FG000|Overall Study|Death|4|||
94602677|NCT02919969|324008475|FG000|Overall Study|Physician Decision|3|||
94602678|NCT02919969|324008475|FG000|Overall Study|Withdrawal by Subject|2|||
94602679|NCT02093351|324008476|FG000|Part A|Adverse Event|0|||
94602680|NCT02093351|324008477|FG001|Part A|Adverse Event|1|||
94602681|NCT02093351|324008478|FG002|Part A|Adverse Event|1|||
94602682|NCT02093351|324008479|FG003|Part A|Adverse Event|0|||
94602683|NCT02093351|324008476|FG000|Part A|Condition under investigation worsened|2|||
94602684|NCT02093351|324008477|FG001|Part A|Condition under investigation worsened|0|||
94602685|NCT02093351|324008478|FG002|Part A|Condition under investigation worsened|2|||
94602686|NCT02093351|324008479|FG003|Part A|Condition under investigation worsened|0|||
94602687|NCT02093351|324008476|FG000|Part A|Death|0|||
94602688|NCT02093351|324008477|FG001|Part A|Death|1|||
94602689|NCT02093351|324008478|FG002|Part A|Death|0|||
94602690|NCT02093351|324008479|FG003|Part A|Death|0|||
94602691|NCT02093351|324008476|FG000|Part B|Patient decision|0|||
94602692|NCT02093351|324008477|FG001|Part B|Patient decision|0|||
94602693|NCT02093351|324008478|FG002|Part B|Patient decision|0|||
94602694|NCT02093351|324008479|FG003|Part B|Patient decision|3|||
94602695|NCT02093351|324008476|FG000|Part B|Disease progression|0|||
94602696|NCT02093351|324008477|FG001|Part B|Disease progression|0|||
94602697|NCT02093351|324008478|FG002|Part B|Disease progression|0|||
94602698|NCT02093351|324008479|FG003|Part B|Disease progression|4|||
94602699|NCT02093351|324008476|FG000|Part B|Complete response|0|||
94602700|NCT02093351|324008477|FG001|Part B|Complete response|0|||
94602701|NCT02093351|324008478|FG002|Part B|Complete response|0|||
94602702|NCT02093351|324008479|FG003|Part B|Complete response|1|||
94602703|NCT02093351|324008476|FG000|Part B|Adverse event + disease progression|0|||
94602704|NCT02093351|324008477|FG001|Part B|Adverse event + disease progression|0|||
94602705|NCT02093351|324008478|FG002|Part B|Adverse event + disease progression|0|||
94602706|NCT02093351|324008479|FG003|Part B|Adverse event + disease progression|1|||
94602707|NCT02093351|324008476|FG000|Part B|Lack of therapeutic response|0|||
94602708|NCT02093351|324008477|FG001|Part B|Lack of therapeutic response|0|||
94602709|NCT02093351|324008478|FG002|Part B|Lack of therapeutic response|0|||
94602710|NCT02093351|324008479|FG003|Part B|Lack of therapeutic response|12|||
94602711|NCT02093351|324008476|FG000|Part B|Condition under investigation worsened|0|||
94661377|NCT03579459|324215714|FG002|Overall Study|Physician Decision|0|||
94661378|NCT03579459|324215715|FG003|Overall Study|Physician Decision|1|||
94661379|NCT03579459|324215712|FG000|Overall Study|Protocol Violation|1|||
94661380|NCT03579459|324215713|FG001|Overall Study|Protocol Violation|2|||
94661381|NCT03579459|324215714|FG002|Overall Study|Protocol Violation|3|||
94457982|NCT02980341|323465680|FG009|Dose Finding|Withdrawal by Subject|0|||
94602712|NCT02093351|324008477|FG001|Part B|Condition under investigation worsened|0|||
94602713|NCT02093351|324008478|FG002|Part B|Condition under investigation worsened|0|||
94602714|NCT02093351|324008479|FG003|Part B|Condition under investigation worsened|39|||
94602715|NCT02093351|324008476|FG000|Part B|Adverse Event|0|||
94602716|NCT02093351|324008477|FG001|Part B|Adverse Event|0|||
94602717|NCT02093351|324008478|FG002|Part B|Adverse Event|0|||
94602718|NCT02093351|324008479|FG003|Part B|Adverse Event|2|||
94661382|NCT03579459|324215715|FG003|Overall Study|Protocol Violation|5|||
94602719|NCT02093351|324008476|FG000|Part B|Death|0|||
94602720|NCT02093351|324008477|FG001|Part B|Death|0|||
94602721|NCT02093351|324008478|FG002|Part B|Death|0|||
94602722|NCT02093351|324008479|FG003|Part B|Death|1|||
94602723|NCT02448680|324008481|FG000|Overall Study|Physician Decision|1|||
94602724|NCT02448680|324008482|FG001|Overall Study|Physician Decision|1|||
94602725|NCT02448680|324008481|FG000|Overall Study|Withdrawal by Subject|0|||
94602726|NCT02448680|324008482|FG001|Overall Study|Withdrawal by Subject|2|||
94602727|NCT00718081|324008485|FG000|Overall Study|Adverse Event|0|||
94602728|NCT00718081|324008486|FG001|Overall Study|Adverse Event|1|||
94602729|NCT00718081|324008487|FG002|Overall Study|Adverse Event|0|||
94602730|NCT00718081|324008485|FG000|Overall Study|Lack of Efficacy|7|||
94602731|NCT00718081|324008486|FG001|Overall Study|Lack of Efficacy|3|||
94602732|NCT00718081|324008487|FG002|Overall Study|Lack of Efficacy|21|||
94602733|NCT00815516|324008488|FG000|Overall Study|Death|3|||
94602734|NCT00815516|324008489|FG001|Overall Study|Death|1|||
94602735|NCT00815516|324008488|FG000|Overall Study|Physician Decision|1|||
94602736|NCT00815516|324008489|FG001|Overall Study|Physician Decision|0|||
94602737|NCT03023046|324008502|FG000|Overall Study|Withdrawal by Subject|1|||
94602738|NCT02278471|324008506|FG000|Overall Study|Lost to Follow-up|6|||
94602739|NCT02278471|324008507|FG001|Overall Study|Lost to Follow-up|15|||
94602740|NCT02278471|324008506|FG000|Overall Study|Death|2|||
94602741|NCT02278471|324008507|FG001|Overall Study|Death|2|||
94602742|NCT02278471|324008506|FG000|Overall Study|Withdrawal by Subject|0|||
94602743|NCT02278471|324008507|FG001|Overall Study|Withdrawal by Subject|3|||
94602744|NCT01236118|324008508|FG000|Overall Study|Adverse Event|2|||
94602745|NCT01236118|324008509|FG001|Overall Study|Adverse Event|0|||
94602746|NCT01236118|324008510|FG002|Overall Study|Adverse Event|2|||
94602747|NCT01236118|324008508|FG000|Overall Study|Physician Decision|0|||
94602748|NCT01236118|324008509|FG001|Overall Study|Physician Decision|1|||
94602749|NCT01236118|324008510|FG002|Overall Study|Physician Decision|0|||
94602750|NCT01236118|324008508|FG000|Overall Study|Withdrawal by Subject|0|||
94602751|NCT01236118|324008509|FG001|Overall Study|Withdrawal by Subject|0|||
94602752|NCT01236118|324008510|FG002|Overall Study|Withdrawal by Subject|1|||
94602753|NCT03410823|324008511|FG000|Overall Study|Death|1|||
94602754|NCT03410823|324008511|FG000|Overall Study|Withdrawal by Subject|2|||
94602755|NCT03410823|324008511|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
94602756|NCT04423939|324008512|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
94602757|NCT04423939|324008513|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
94602758|NCT04423939|324008512|FG000|Overall Study|Death|3|||
94602759|NCT04423939|324008513|FG001|Overall Study|Death|0|||
94602760|NCT04423939|324008512|FG000|Overall Study|Withdrawal by Subject|3|||
94602761|NCT04423939|324008513|FG001|Overall Study|Withdrawal by Subject|0|||
94602762|NCT04423939|324008512|FG000|Overall Study|Caregiver to patient who died|0|||
94602763|NCT04423939|324008513|FG001|Overall Study|Caregiver to patient who died|3|||
94602764|NCT04423939|324008512|FG000|Overall Study|Caregiver to patient who withdrew|0|||
94602765|NCT04423939|324008513|FG001|Overall Study|Caregiver to patient who withdrew|3|||
94602766|NCT02821910|324008516|FG000|Overall Study|Withdrawal by Subject|0|||
94602767|NCT02821910|324008517|FG001|Overall Study|Withdrawal by Subject|0|||
94602768|NCT02821910|324008518|FG002|Overall Study|Withdrawal by Subject|1|||
94602769|NCT02821910|324008519|FG003|Overall Study|Withdrawal by Subject|0|||
94602770|NCT02821910|324008520|FG004|Overall Study|Withdrawal by Subject|0|||
94602771|NCT02821910|324008521|FG005|Overall Study|Withdrawal by Subject|1|||
94602772|NCT02821910|324008516|FG000|Overall Study|Other than specified|1|||
94602773|NCT02821910|324008517|FG001|Overall Study|Other than specified|0|||
94602774|NCT02821910|324008518|FG002|Overall Study|Other than specified|1|||
94356153|NCT00931515|323085827|FG000|Overall Study|Lost to Follow-up|2|||
94356154|NCT00931515|323085828|FG001|Overall Study|Lost to Follow-up|5|||
94602775|NCT02821910|324008519|FG003|Overall Study|Other than specified|0|||
94602776|NCT02821910|324008520|FG004|Overall Study|Other than specified|0|||
94602777|NCT02821910|324008521|FG005|Overall Study|Other than specified|0|||
94602778|NCT01439347|324008522|FG000|Overall Study|Death|10|||
94602779|NCT01439347|324008523|FG001|Overall Study|Death|9|||
94602780|NCT01439347|324008522|FG000|Overall Study|Withdrawal by Subject|0|||
94602781|NCT01439347|324008523|FG001|Overall Study|Withdrawal by Subject|1|||
94356155|NCT03795233|323085829|FG000|Overall Study|Withdrawal by Subject|2|||
94356156|NCT03795233|323085830|FG001|Overall Study|Withdrawal by Subject|1|||
94356157|NCT03795233|323085829|FG000|Overall Study|Lost to Follow-up|1|||
94356158|NCT03795233|323085830|FG001|Overall Study|Lost to Follow-up|0|||
94356159|NCT03795233|323085829|FG000|Overall Study|Death|1|||
94356160|NCT03795233|323085830|FG001|Overall Study|Death|0|||
94356161|NCT02950831|323085831|FG000|Overall Study|Lost to Follow-up|1|||
94356162|NCT02950831|323085831|FG000|Overall Study|Withdrawal by Subject|3|||
94356163|NCT02950831|323085831|FG000|Overall Study|stimulation trail failure|5|||
94356164|NCT01003691|323085832|FG000|Overall Study|Adverse Event|0|||
94356165|NCT01003691|323085833|FG001|Overall Study|Adverse Event|0|||
94356166|NCT01003691|323085834|FG002|Overall Study|Adverse Event|0|||
94356167|NCT01003691|323085835|FG003|Overall Study|Adverse Event|1|||
94356168|NCT01875731|323085837|FG000|Overall Study|Fail to obtain lab sample|1|||
94356169|NCT01875731|323085838|FG001|Overall Study|Fail to obtain lab sample|0|||
94356170|NCT02576951|323085839|FG000|Overall Study|Lost to Follow-up|0|||
94356171|NCT02576951|323085840|FG001|Overall Study|Lost to Follow-up|0|||
94356172|NCT02576951|323085841|FG002|Overall Study|Lost to Follow-up|2|||
94356173|NCT02576951|323085842|FG003|Overall Study|Lost to Follow-up|2|||
94356174|NCT02576951|323085839|FG000|Overall Study|Withdrawal by Subject|1|||
94356175|NCT02576951|323085840|FG001|Overall Study|Withdrawal by Subject|0|||
94356176|NCT02576951|323085841|FG002|Overall Study|Withdrawal by Subject|0|||
94356177|NCT02576951|323085842|FG003|Overall Study|Withdrawal by Subject|2|||
94356178|NCT02576951|323085839|FG000|Overall Study|Protocol Violation|0|||
94356179|NCT02576951|323085840|FG001|Overall Study|Protocol Violation|0|||
94356180|NCT02576951|323085841|FG002|Overall Study|Protocol Violation|0|||
94356181|NCT02576951|323085842|FG003|Overall Study|Protocol Violation|1|||
94356182|NCT00495794|323085843|FG000|Overall Study|Pharmacist did not activate patient|522|||
94356183|NCT00495794|323085844|FG001|Overall Study|Pharmacist did not activate patient|0|||
94356184|NCT03417102|323085845|FG000|Overall Study|Adverse Event|0|||
94356185|NCT03417102|323085846|FG001|Overall Study|Adverse Event|1|||
94356186|NCT03417102|323085845|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
94356187|NCT03417102|323085846|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
94356188|NCT03417102|323085845|FG000|Overall Study|Other|0|||
94356189|NCT03417102|323085846|FG001|Overall Study|Other|1|||
94356190|NCT03145207|323085848|FG000|Overall Study|volunteer started taking allergy shots|1|||
94356191|NCT03145207|323085848|FG000|Overall Study|baseline blood pressure high|1|||
94356192|NCT04502862|323085851|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
94356193|NCT04502862|323085852|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
94356194|NCT04502862|323085851|FG000|Overall Study|Withdrawal by Subject|1|||
94356195|NCT04502862|323085852|FG001|Overall Study|Withdrawal by Subject|0|||
94356196|NCT04502862|323085851|FG000|Overall Study|Adverse Event|1|||
94356197|NCT04502862|323085852|FG001|Overall Study|Adverse Event|1|||
94356198|NCT00223990|323085853|FG000|Overall Study|Moved from area|2|||
94356199|NCT00223990|323085854|FG001|Overall Study|Moved from area|1|||
94356200|NCT00223990|323085853|FG000|Overall Study|Withdrawal by Subject|4|||
94356201|NCT00223990|323085854|FG001|Overall Study|Withdrawal by Subject|8|||
94356202|NCT00223990|323085853|FG000|Overall Study|Lost to Follow-up|1|||
94356203|NCT00223990|323085854|FG001|Overall Study|Lost to Follow-up|0|||
94356204|NCT00421928|323087087|FG000|Overall Study|Adverse Event|61|||
94356205|NCT00421928|323087088|FG001|Overall Study|Adverse Event|140|||
94356206|NCT00421928|323087089|FG002|Overall Study|Adverse Event|22|||
94356207|NCT00421928|323087087|FG000|Overall Study|Lost to Follow-up|5|||
94602782|NCT01439347|324008522|FG000|Overall Study|Physician Decision|1|||
94602783|NCT01439347|324008523|FG001|Overall Study|Physician Decision|0|||
94602784|NCT01439347|324008522|FG000|Overall Study|Sponsor Terminated Study|2|||
94602785|NCT01439347|324008523|FG001|Overall Study|Sponsor Terminated Study|3|||
94602786|NCT05342532|324008525|FG000|Overall Study|Adverse Event|5|||
94602787|NCT05342532|324008526|FG001|Overall Study|Adverse Event|20|||
94602788|NCT05342532|324008525|FG000|Overall Study|Lost to Follow-up|10|||
94602789|NCT05342532|324008526|FG001|Overall Study|Lost to Follow-up|15|||
94602790|NCT00718237|324008533|FG000|Overall Study|Adverse Event|1|||
94602791|NCT00718237|324008534|FG001|Overall Study|Adverse Event|3|||
94602792|NCT00718237|324008533|FG000|Overall Study|Lost to Follow-up|2|||
94602793|NCT00718237|324008534|FG001|Overall Study|Lost to Follow-up|2|||
94602794|NCT00718237|324008533|FG000|Overall Study|Physician Decision|1|||
94602795|NCT00718237|324008534|FG001|Overall Study|Physician Decision|0|||
94602796|NCT00718237|324008533|FG000|Overall Study|Withdrawal by Subject|9|||
94602797|NCT00718237|324008534|FG001|Overall Study|Withdrawal by Subject|10|||
94602798|NCT02635646|324008538|FG000|Overall Study|Lost to Follow-up|24|||
94602799|NCT02635646|324008539|FG001|Overall Study|Lost to Follow-up|25|||
94602800|NCT02635646|324008538|FG000|Overall Study|Pregnancy|1|||
94602801|NCT02635646|324008539|FG001|Overall Study|Pregnancy|1|||
94602802|NCT03189381|324008548|FG000|Overall Study|Death|1|||
94602803|NCT03189381|324008549|FG001|Overall Study|Death|0|||
94602804|NCT01975831|324008550|FG000|Overall Study|Adverse Event|1|||
94248841|NCT03149549|322704957|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
94248842|NCT03149549|322704945|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
94248843|NCT03149549|322704946|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
94248844|NCT03149549|322704947|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
94248845|NCT03149549|322704948|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
94248846|NCT03149549|322704949|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
94248847|NCT03149549|322704950|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
94248848|NCT03149549|322704951|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
94602805|NCT01975831|324008551|FG001|Overall Study|Adverse Event|2|||
94248849|NCT03149549|322704952|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
94248850|NCT03149549|322704953|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
94248851|NCT03149549|322704954|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
94248852|NCT03149549|322704955|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
94248853|NCT03149549|322704956|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
94248854|NCT03149549|322704957|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
94248855|NCT03149549|322704945|FG000|Study Discontinuation--Treatment Period|Other|0|||
94248856|NCT03149549|322704946|FG001|Study Discontinuation--Treatment Period|Other|0|||
94248857|NCT03149549|322704947|FG002|Study Discontinuation--Treatment Period|Other|0|||
94248858|NCT03149549|322704948|FG003|Study Discontinuation--Treatment Period|Other|0|||
94248859|NCT03149549|322704949|FG004|Study Discontinuation--Treatment Period|Other|0|||
94248860|NCT03149549|322704950|FG005|Study Discontinuation--Treatment Period|Other|0|||
94248861|NCT03149549|322704951|FG006|Study Discontinuation--Treatment Period|Other|0|||
94602806|NCT01975831|324008552|FG002|Overall Study|Adverse Event|2|||
94248862|NCT03149549|322704952|FG007|Study Discontinuation--Treatment Period|Other|1|||
94248863|NCT03149549|322704953|FG008|Study Discontinuation--Treatment Period|Other|0|||
94248864|NCT03149549|322704954|FG009|Study Discontinuation--Treatment Period|Other|1|||
94248865|NCT03149549|322704955|FG010|Study Discontinuation--Treatment Period|Other|0|||
94248866|NCT03149549|322704956|FG011|Study Discontinuation--Treatment Period|Other|0|||
94248867|NCT03149549|322704957|FG012|Study Discontinuation--Treatment Period|Other|0|||
94248868|NCT03149549|322704945|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
94248869|NCT03149549|322704946|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
94248870|NCT03149549|322704947|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
94248871|NCT03149549|322704948|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
94248872|NCT03149549|322704949|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
94248873|NCT03149549|322704950|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
94248874|NCT03149549|322704951|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
94248875|NCT03149549|322704952|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
94602807|NCT01975831|324008553|FG003|Overall Study|Adverse Event|0|||
94602808|NCT01975831|324008554|FG004|Overall Study|Adverse Event|1|||
94602809|NCT01975831|324008555|FG005|Overall Study|Adverse Event|1|||
94602810|NCT01975831|324008556|FG006|Overall Study|Adverse Event|3|||
94602811|NCT01975831|324008557|FG007|Overall Study|Adverse Event|4|||
94602812|NCT01975831|324008558|FG008|Overall Study|Adverse Event|1|||
94602813|NCT01975831|324008550|FG000|Overall Study|Death|1|||
94356208|NCT00421928|323087088|FG001|Overall Study|Lost to Follow-up|0|||
94602814|NCT01975831|324008551|FG001|Overall Study|Death|1|||
94602815|NCT01975831|324008552|FG002|Overall Study|Death|0|||
94602816|NCT01975831|324008553|FG003|Overall Study|Death|0|||
94602817|NCT01975831|324008554|FG004|Overall Study|Death|1|||
94602818|NCT01975831|324008555|FG005|Overall Study|Death|0|||
94602819|NCT01975831|324008556|FG006|Overall Study|Death|1|||
94602820|NCT01975831|324008557|FG007|Overall Study|Death|0|||
94602821|NCT01975831|324008558|FG008|Overall Study|Death|0|||
94602822|NCT01975831|324008550|FG000|Overall Study|Progressive Disease|1|||
94602823|NCT01975831|324008551|FG001|Overall Study|Progressive Disease|3|||
94602824|NCT01975831|324008552|FG002|Overall Study|Progressive Disease|2|||
94602825|NCT01975831|324008553|FG003|Overall Study|Progressive Disease|4|||
94602826|NCT01975831|324008554|FG004|Overall Study|Progressive Disease|13|||
94602827|NCT01975831|324008555|FG005|Overall Study|Progressive Disease|9|||
94602828|NCT01975831|324008556|FG006|Overall Study|Progressive Disease|10|||
94602829|NCT01975831|324008557|FG007|Overall Study|Progressive Disease|8|||
94602830|NCT01975831|324008558|FG008|Overall Study|Progressive Disease|10|||
94602831|NCT01975831|324008550|FG000|Overall Study|Withdrawal by Subject|0|||
94602832|NCT01975831|324008551|FG001|Overall Study|Withdrawal by Subject|3|||
94602833|NCT01975831|324008552|FG002|Overall Study|Withdrawal by Subject|0|||
94602834|NCT01975831|324008553|FG003|Overall Study|Withdrawal by Subject|0|||
94602835|NCT01975831|324008554|FG004|Overall Study|Withdrawal by Subject|3|||
94602836|NCT01975831|324008555|FG005|Overall Study|Withdrawal by Subject|1|||
94602837|NCT01975831|324008556|FG006|Overall Study|Withdrawal by Subject|1|||
94602838|NCT01975831|324008557|FG007|Overall Study|Withdrawal by Subject|0|||
94602839|NCT01975831|324008558|FG008|Overall Study|Withdrawal by Subject|0|||
94602840|NCT01975831|324008550|FG000|Overall Study|Physician Decision|0|||
94356209|NCT00421928|323087089|FG002|Overall Study|Lost to Follow-up|3|||
94356210|NCT00421928|323087087|FG000|Overall Study|Withdrawal by Subject|50|||
94602841|NCT01975831|324008551|FG001|Overall Study|Physician Decision|0|||
94602842|NCT01975831|324008552|FG002|Overall Study|Physician Decision|0|||
94602843|NCT01975831|324008553|FG003|Overall Study|Physician Decision|0|||
94602844|NCT01975831|324008554|FG004|Overall Study|Physician Decision|0|||
94602845|NCT01975831|324008555|FG005|Overall Study|Physician Decision|1|||
94602846|NCT01975831|324008556|FG006|Overall Study|Physician Decision|0|||
94602847|NCT01975831|324008557|FG007|Overall Study|Physician Decision|1|||
94602848|NCT01975831|324008558|FG008|Overall Study|Physician Decision|0|||
94602849|NCT01975831|324008550|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
94602850|NCT01975831|324008551|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
94602851|NCT01975831|324008552|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
94602852|NCT01975831|324008553|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
94602853|NCT01975831|324008554|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
94602854|NCT01975831|324008555|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
94602855|NCT01975831|324008556|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
94602856|NCT01975831|324008557|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
94602857|NCT01975831|324008558|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
94602858|NCT01975831|324008550|FG000|Overall Study|Entered Hospice|0|||
94602859|NCT01975831|324008551|FG001|Overall Study|Entered Hospice|0|||
94602860|NCT01975831|324008552|FG002|Overall Study|Entered Hospice|0|||
94602861|NCT01975831|324008553|FG003|Overall Study|Entered Hospice|0|||
94602862|NCT01975831|324008554|FG004|Overall Study|Entered Hospice|0|||
94602863|NCT01975831|324008555|FG005|Overall Study|Entered Hospice|1|||
94602864|NCT01975831|324008556|FG006|Overall Study|Entered Hospice|0|||
94602865|NCT01975831|324008557|FG007|Overall Study|Entered Hospice|0|||
94602866|NCT01975831|324008558|FG008|Overall Study|Entered Hospice|0|||
94602867|NCT01975831|324008550|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
94602868|NCT01975831|324008551|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
94602869|NCT01975831|324008552|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
94602870|NCT01975831|324008553|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
94602871|NCT01975831|324008554|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
94602872|NCT01975831|324008555|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
94602873|NCT01975831|324008556|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
94602874|NCT01975831|324008557|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
94602875|NCT01975831|324008558|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
94602876|NCT01401959|324008559|FG000|Enrolled|Withdrawal by Subject|1|||
94602877|NCT01401959|324008560|FG001|Enrolled|Withdrawal by Subject|0|||
94602878|NCT01401959|324008561|FG002|Enrolled|Withdrawal by Subject|0|||
94602879|NCT01401959|324008559|FG000|Treated|Disease Progression|2|||
94602880|NCT01401959|324008560|FG001|Treated|Disease Progression|2|||
94602881|NCT01401959|324008561|FG002|Treated|Disease Progression|1|||
94602882|NCT01401959|324008559|FG000|Treated|Adverse Event|4|||
94602883|NCT01401959|324008560|FG001|Treated|Adverse Event|3|||
94602884|NCT01401959|324008561|FG002|Treated|Adverse Event|2|||
94602885|NCT01401959|324008559|FG000|Treated|Withdrawal by Subject|1|||
94602886|NCT01401959|324008560|FG001|Treated|Withdrawal by Subject|2|||
94602887|NCT01401959|324008561|FG002|Treated|Withdrawal by Subject|2|||
94602888|NCT01401959|324008559|FG000|Treated|Protocol Violation|0|||
94602889|NCT01401959|324008560|FG001|Treated|Protocol Violation|1|||
94602890|NCT01401959|324008561|FG002|Treated|Protocol Violation|0|||
94602891|NCT00251004|324008562|FG000|Overall Study|Withdrawal by Subject|23|||
94602892|NCT00251004|324008563|FG001|Overall Study|Withdrawal by Subject|16|||
94602893|NCT00251004|324008564|FG002|Overall Study|Withdrawal by Subject|14|||
94602894|NCT00251004|324008562|FG000|Overall Study|Death|9|||
94602895|NCT00251004|324008563|FG001|Overall Study|Death|10|||
94602896|NCT00251004|324008564|FG002|Overall Study|Death|8|||
94602897|NCT00251004|324008562|FG000|Overall Study|Lost to Follow-up|1|||
94602898|NCT00251004|324008563|FG001|Overall Study|Lost to Follow-up|2|||
94602899|NCT00251004|324008564|FG002|Overall Study|Lost to Follow-up|1|||
94602900|NCT00251004|324008562|FG000|Overall Study|Graft Loss|12|||
94602901|NCT00251004|324008563|FG001|Overall Study|Graft Loss|13|||
94602902|NCT00251004|324008564|FG002|Overall Study|Graft Loss|8|||
94602903|NCT00887744|324008565|FG000|Overall Study|Adverse Event|3|||
94602904|NCT00887744|324008565|FG000|Overall Study|Death|1|||
94602905|NCT00887744|324008565|FG000|Overall Study|Lost to Follow-up|3|||
94602906|NCT00887744|324008565|FG000|Overall Study|Withdrawal by Subject|18|||
94602907|NCT00887744|324008565|FG000|Overall Study|Various reasons|9|||
94602908|NCT02694718|324008570|FG000|Overall Study|Death|1|||
94602909|NCT02694718|324008570|FG000|Overall Study|Withdrawal by Subject|1|||
94602910|NCT02925793|324008571|FG000|Overall Study|Adverse Event|3|||
94602911|NCT02925793|324008572|FG001|Overall Study|Adverse Event|3|||
94602912|NCT02925793|324008573|FG002|Overall Study|Adverse Event|6|||
94602913|NCT02925793|324008571|FG000|Overall Study|Withdrawal by Subject|16|||
94602914|NCT02925793|324008572|FG001|Overall Study|Withdrawal by Subject|15|||
94602915|NCT02925793|324008573|FG002|Overall Study|Withdrawal by Subject|13|||
94602916|NCT02925793|324008571|FG000|Overall Study|Investigator Discretion|0|||
94602917|NCT02925793|324008572|FG001|Overall Study|Investigator Discretion|1|||
94602918|NCT02925793|324008573|FG002|Overall Study|Investigator Discretion|1|||
94602919|NCT02925793|324008571|FG000|Overall Study|Lost to Follow-up|2|||
94602920|NCT02925793|324008572|FG001|Overall Study|Lost to Follow-up|3|||
94602921|NCT02925793|324008573|FG002|Overall Study|Lost to Follow-up|1|||
94602922|NCT02925793|324008571|FG000|Overall Study|Lack of Efficacy|2|||
94602923|NCT02925793|324008572|FG001|Overall Study|Lack of Efficacy|6|||
94602924|NCT02925793|324008573|FG002|Overall Study|Lack of Efficacy|4|||
94602925|NCT02925793|324008571|FG000|Overall Study|Other:|2|||
94602926|NCT02925793|324008572|FG001|Overall Study|Other:|1|||
94602927|NCT02925793|324008573|FG002|Overall Study|Other:|3|||
94602928|NCT00879879|324008574|FG000|Overall Study|Death|1|||
94602929|NCT00879879|324008574|FG000|Overall Study|Withdrawal by Subject|1|||
94602930|NCT00879879|324008574|FG000|Overall Study|Physician Decision|1|||
94602931|NCT00327470|324008578|FG000|Overall Study|Randomized, but not treated|0|||
94602932|NCT00327470|324008579|FG001|Overall Study|Randomized, but not treated|2|||
94602933|NCT00327470|324008578|FG000|Overall Study|Adverse Event|9|||
94602934|NCT00327470|324008579|FG001|Overall Study|Adverse Event|14|||
94602935|NCT00327470|324008578|FG000|Overall Study|Lack of Efficacy|7|||
94602936|NCT00327470|324008579|FG001|Overall Study|Lack of Efficacy|19|||
94602937|NCT00327470|324008578|FG000|Overall Study|Other|5|||
94602938|NCT00327470|324008579|FG001|Overall Study|Other|9|||
94602939|NCT00327470|324008578|FG000|Overall Study|Lost to Follow-up|1|||
94602940|NCT00327470|324008579|FG001|Overall Study|Lost to Follow-up|3|||
94602941|NCT00327470|324008578|FG000|Overall Study|Withdrawal by Subject|6|||
94602942|NCT00327470|324008579|FG001|Overall Study|Withdrawal by Subject|12|||
94602943|NCT00327470|324008578|FG000|Overall Study|Death|1|||
94602944|NCT00327470|324008579|FG001|Overall Study|Death|4|||
94602945|NCT03021564|324008580|FG000|Overall Study|Death|84|||
94602946|NCT03021564|324008581|FG001|Overall Study|Death|466|||
94602947|NCT03021564|324008580|FG000|Overall Study|Lost to Follow-up|0|||
94602948|NCT03021564|324008581|FG001|Overall Study|Lost to Follow-up|2|||
94602949|NCT05080660|324008585|FG000|Overall Study|Adverse Event|4|||
94602950|NCT05080660|324008586|FG001|Overall Study|Adverse Event|0|||
94602951|NCT05080660|324008585|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
94602952|NCT05080660|324008586|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
94602953|NCT05080660|324008585|FG000|Overall Study|Physician Decision|1|||
94602954|NCT05080660|324008586|FG001|Overall Study|Physician Decision|0|||
94602955|NCT05080660|324008585|FG000|Overall Study|Protocol Deviation|2|||
94602956|NCT05080660|324008586|FG001|Overall Study|Protocol Deviation|0|||
94602957|NCT05080660|324008585|FG000|Overall Study|Withdrawal by Subject|5|||
94602958|NCT05080660|324008586|FG001|Overall Study|Withdrawal by Subject|2|||
94602959|NCT00937391|324008587|FG000|Stage 2|Withdrawal by Subject|1|||
94602960|NCT03687970|324008595|FG000|Overall Study|visit scheduling conflicts|2|||
94602961|NCT03687970|324008596|FG001|Overall Study|visit scheduling conflicts|0|||
94602962|NCT03119701|324008597|FG000|6-day Dosing|Death|4|||
94602963|NCT03119701|324008598|FG001|6-day Dosing|Death|1|||
94602964|NCT03119701|324008597|FG000|6-day Dosing|Adverse Event|3|||
94602965|NCT03119701|324008598|FG001|6-day Dosing|Adverse Event|0|||
94602966|NCT03119701|324008597|FG000|6-day Dosing|Physician Decision|0|||
94602967|NCT03119701|324008598|FG001|6-day Dosing|Physician Decision|1|||
94602968|NCT03119701|324008597|FG000|6-day Dosing|Withdrawal by Subject|0|||
94602969|NCT03119701|324008598|FG001|6-day Dosing|Withdrawal by Subject|1|||
94602970|NCT03119701|324008597|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
94602971|NCT03119701|324008598|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
94602972|NCT00336583|324010166|FG000|Overall Study|Lost to Follow-up|1|||
94602973|NCT00336583|324010166|FG000|Overall Study|Death|1|||
94602974|NCT00719264|324010168|FG000|Overall Study|Adverse Event|41|||
94602975|NCT00719264|324010169|FG001|Overall Study|Adverse Event|49|||
94602976|NCT00719264|324010168|FG000|Overall Study|Death|13|||
94602977|NCT00719264|324010169|FG001|Overall Study|Death|10|||
94602978|NCT00719264|324010168|FG000|Overall Study|Administrative Problems|6|||
94602979|NCT00719264|324010169|FG001|Overall Study|Administrative Problems|4|||
94602980|NCT00719264|324010168|FG000|Overall Study|Lost to Follow-up|1|||
94602981|NCT00719264|324010169|FG001|Overall Study|Lost to Follow-up|1|||
94661383|NCT03579459|324215712|FG000|Overall Study|Withdrawal by Subject|12|||
94248876|NCT03149549|322704953|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
94248877|NCT03149549|322704954|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
94248878|NCT03149549|322704955|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
94248879|NCT03149549|322704956|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
94248880|NCT03149549|322704957|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
94248881|NCT03149549|322704945|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
94248882|NCT03149549|322704946|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
94248883|NCT03149549|322704947|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
94248884|NCT03149549|322704948|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
94248885|NCT03149549|322704949|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
94602982|NCT00719264|324010168|FG000|Overall Study|Withdrawal by Subject|12|||
94602983|NCT00719264|324010169|FG001|Overall Study|Withdrawal by Subject|7|||
94602984|NCT00719264|324010168|FG000|Overall Study|Protocol Deviation|1|||
94602985|NCT00719264|324010169|FG001|Overall Study|Protocol Deviation|3|||
94602986|NCT00719264|324010168|FG000|Overall Study|New Cancer Therapy|4|||
94602987|NCT00719264|324010169|FG001|Overall Study|New Cancer Therapy|2|||
94602988|NCT00719264|324010168|FG000|Overall Study|Disease Progression|104|||
94602989|NCT00719264|324010169|FG001|Overall Study|Disease Progression|107|||
94602990|NCT00814879|324010170|FG000|By Week 24|Cancer Diagnosis|1|||
94602991|NCT00814879|324010171|FG001|By Week 24|Cancer Diagnosis|0|||
94602992|NCT00814879|324010170|FG000|By Week 24|Incarceration|0|||
94602993|NCT00814879|324010171|FG001|By Week 24|Incarceration|1|||
94602994|NCT00814879|324010170|FG000|By Week 48|Lost to Follow-up|2|||
94602995|NCT00814879|324010171|FG001|By Week 48|Lost to Follow-up|2|||
94602996|NCT00814879|324010170|FG000|By Week 48|Death|0|||
94602997|NCT00814879|324010171|FG001|By Week 48|Death|1|||
94602998|NCT01611454|324010172|FG000|Overall Study|Lack of Efficacy|18|||
94248886|NCT03149549|322704950|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
94248887|NCT03149549|322704951|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
94248888|NCT03149549|322704952|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
94248889|NCT03149549|322704953|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
94248890|NCT03149549|322704954|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
94457983|NCT02980341|323465681|FG010|Dose Finding|Withdrawal by Subject|0|||
94457984|NCT02980341|323465671|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
94457985|NCT02980341|323465672|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
94457986|NCT02980341|323465673|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
94457987|NCT02980341|323465674|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
94457988|NCT02980341|323465675|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
94457989|NCT02980341|323465676|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
94457990|NCT02980341|323465677|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
94457991|NCT02980341|323465678|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
94457992|NCT02980341|323465679|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
94457993|NCT02980341|323465680|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
94457994|NCT02980341|323465681|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
94457995|NCT02980341|323465671|FG000|Dose Expansion|Clinical progression|0|||
94457996|NCT02980341|323465672|FG001|Dose Expansion|Clinical progression|0|||
94457997|NCT02980341|323465673|FG002|Dose Expansion|Clinical progression|0|||
94457998|NCT02980341|323465674|FG003|Dose Expansion|Clinical progression|0|||
94457999|NCT02980341|323465675|FG004|Dose Expansion|Clinical progression|0|||
94458000|NCT02980341|323465676|FG005|Dose Expansion|Clinical progression|0|||
94458001|NCT02980341|323465677|FG006|Dose Expansion|Clinical progression|0|||
94458002|NCT02980341|323465678|FG007|Dose Expansion|Clinical progression|4|||
94458003|NCT02980341|323465679|FG008|Dose Expansion|Clinical progression|3|||
94458004|NCT02980341|323465680|FG009|Dose Expansion|Clinical progression|1|||
94458005|NCT02980341|323465681|FG010|Dose Expansion|Clinical progression|4|||
94458006|NCT02980341|323465671|FG000|Dose Expansion|Adverse Event|0|||
94458007|NCT02980341|323465672|FG001|Dose Expansion|Adverse Event|0|||
94458008|NCT02980341|323465673|FG002|Dose Expansion|Adverse Event|0|||
94458009|NCT02980341|323465674|FG003|Dose Expansion|Adverse Event|0|||
94458010|NCT02980341|323465675|FG004|Dose Expansion|Adverse Event|0|||
94458011|NCT02980341|323465676|FG005|Dose Expansion|Adverse Event|0|||
94458012|NCT02980341|323465677|FG006|Dose Expansion|Adverse Event|0|||
94458013|NCT02980341|323465678|FG007|Dose Expansion|Adverse Event|3|||
94458014|NCT02980341|323465679|FG008|Dose Expansion|Adverse Event|0|||
94458015|NCT02980341|323465680|FG009|Dose Expansion|Adverse Event|1|||
94458016|NCT02980341|323465681|FG010|Dose Expansion|Adverse Event|3|||
94458017|NCT02980341|323465671|FG000|Dose Expansion|Death|0|||
94458018|NCT02980341|323465672|FG001|Dose Expansion|Death|0|||
94458019|NCT02980341|323465673|FG002|Dose Expansion|Death|0|||
94458020|NCT02980341|323465674|FG003|Dose Expansion|Death|0|||
94458021|NCT02980341|323465675|FG004|Dose Expansion|Death|0|||
94458022|NCT02980341|323465676|FG005|Dose Expansion|Death|0|||
94458023|NCT02980341|323465677|FG006|Dose Expansion|Death|0|||
94458024|NCT02980341|323465678|FG007|Dose Expansion|Death|0|||
94458025|NCT02980341|323465679|FG008|Dose Expansion|Death|2|||
94458026|NCT02980341|323465680|FG009|Dose Expansion|Death|1|||
94458027|NCT02980341|323465681|FG010|Dose Expansion|Death|0|||
94458028|NCT02980341|323465671|FG000|Dose Expansion|Withdrawal by Subject|0|||
94458029|NCT02980341|323465672|FG001|Dose Expansion|Withdrawal by Subject|0|||
94458030|NCT02980341|323465673|FG002|Dose Expansion|Withdrawal by Subject|0|||
94458031|NCT02980341|323465674|FG003|Dose Expansion|Withdrawal by Subject|0|||
94458032|NCT02980341|323465675|FG004|Dose Expansion|Withdrawal by Subject|0|||
94458033|NCT02980341|323465676|FG005|Dose Expansion|Withdrawal by Subject|0|||
94458034|NCT02980341|323465677|FG006|Dose Expansion|Withdrawal by Subject|0|||
94458035|NCT02980341|323465678|FG007|Dose Expansion|Withdrawal by Subject|2|||
94458036|NCT02980341|323465679|FG008|Dose Expansion|Withdrawal by Subject|0|||
94458037|NCT02980341|323465680|FG009|Dose Expansion|Withdrawal by Subject|1|||
94458038|NCT02980341|323465681|FG010|Dose Expansion|Withdrawal by Subject|0|||
94458039|NCT02980341|323465671|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
94458040|NCT02980341|323465672|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
94458041|NCT02980341|323465673|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
94458042|NCT02980341|323465674|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
94458043|NCT02980341|323465675|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
94458044|NCT02980341|323465676|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
94458045|NCT02980341|323465677|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
94458046|NCT02980341|323465678|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
94458047|NCT02980341|323465679|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
94465951|NCT04769739|323494960|FG001|Overall Study|Poor bowel preparation|0|||
94248891|NCT03149549|322704955|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
94602999|NCT01611454|324010173|FG001|Overall Study|Lack of Efficacy|10|||
94603000|NCT01461057|324010174|FG000|Overall Study|Death|10|||
94603001|NCT01461057|324010175|FG001|Overall Study|Death|9|||
94603002|NCT01461057|324010174|FG000|Overall Study|Withdrawal by Subject|2|||
94603003|NCT01461057|324010175|FG001|Overall Study|Withdrawal by Subject|3|||
94603004|NCT01461057|324010174|FG000|Overall Study|Physician Decision|0|||
94603005|NCT01461057|324010175|FG001|Overall Study|Physician Decision|2|||
94603006|NCT01461057|324010174|FG000|Overall Study|Adverse Event|0|||
94603007|NCT01461057|324010175|FG001|Overall Study|Adverse Event|1|||
94603008|NCT01461057|324010174|FG000|Overall Study|Progression of Disease|1|||
94603009|NCT01461057|324010175|FG001|Overall Study|Progression of Disease|0|||
94603010|NCT01461057|324010174|FG000|Overall Study|Study Terminated by Sponsor|2|||
94603011|NCT01461057|324010175|FG001|Overall Study|Study Terminated by Sponsor|0|||
94603012|NCT01275339|324010176|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
94603013|NCT01275339|324010177|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
94603014|NCT01275339|324010178|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
94603015|NCT01275339|324010179|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
94603016|NCT01275339|324010176|FG000|Overall Study|Withdrawal by Subject|0|||
94603017|NCT01275339|324010177|FG001|Overall Study|Withdrawal by Subject|0|||
94603018|NCT01275339|324010178|FG002|Overall Study|Withdrawal by Subject|1|||
94603019|NCT01275339|324010179|FG003|Overall Study|Withdrawal by Subject|0|||
94603020|NCT00959374|324010180|FG000|Overall Study|Withdrawal by Subject|2|||
94603021|NCT00959374|324010180|FG000|Overall Study|Lost to Follow-up|14|||
94603022|NCT00959374|324010180|FG000|Overall Study|Death|1|||
94603023|NCT00959374|324010180|FG000|Overall Study|Protocol Violation|1|||
94603024|NCT00959374|324010180|FG000|Overall Study|Implant Removed/Not Replaced|4|||
94603025|NCT00959374|324010180|FG000|Overall Study|Physician Decision|1|||
94603026|NCT03435640|324010181|FG000|Overall Study|Withdrawal by Subject|0|||
94603027|NCT03435640|324010182|FG001|Overall Study|Withdrawal by Subject|1|||
94603028|NCT03435640|324010183|FG002|Overall Study|Withdrawal by Subject|0|||
94603029|NCT03435640|324010184|FG003|Overall Study|Withdrawal by Subject|2|||
94603030|NCT03435640|324010185|FG004|Overall Study|Withdrawal by Subject|0|||
94603031|NCT03435640|324010186|FG005|Overall Study|Withdrawal by Subject|0|||
94603032|NCT03435640|324010187|FG006|Overall Study|Withdrawal by Subject|3|||
94603033|NCT03435640|324010188|FG007|Overall Study|Withdrawal by Subject|0|||
94603034|NCT03435640|324010189|FG008|Overall Study|Withdrawal by Subject|0|||
94603035|NCT03435640|324010190|FG009|Overall Study|Withdrawal by Subject|2|||
94603036|NCT03435640|324010191|FG010|Overall Study|Withdrawal by Subject|3|||
94603037|NCT03435640|324010181|FG000|Overall Study|Lost to Follow-up|0|||
94603038|NCT03435640|324010182|FG001|Overall Study|Lost to Follow-up|0|||
94603039|NCT03435640|324010183|FG002|Overall Study|Lost to Follow-up|1|||
94603040|NCT03435640|324010184|FG003|Overall Study|Lost to Follow-up|0|||
94603041|NCT03435640|324010185|FG004|Overall Study|Lost to Follow-up|0|||
94603042|NCT03435640|324010186|FG005|Overall Study|Lost to Follow-up|0|||
94603043|NCT03435640|324010187|FG006|Overall Study|Lost to Follow-up|0|||
94603044|NCT03435640|324010188|FG007|Overall Study|Lost to Follow-up|0|||
94603045|NCT03435640|324010189|FG008|Overall Study|Lost to Follow-up|0|||
94603046|NCT03435640|324010190|FG009|Overall Study|Lost to Follow-up|0|||
94603047|NCT03435640|324010191|FG010|Overall Study|Lost to Follow-up|0|||
94603048|NCT01736657|324010192|FG000|Overall Study|insufficient vascular access|1|||
94603049|NCT02284178|324010195|FG000|Overall Study|Met exclusion criteria|49|||
94603050|NCT02284178|324010196|FG001|Overall Study|Met exclusion criteria|54|||
94603051|NCT01741012|324010197|FG000|Overall Study|Lost to Follow-up|1|||
94603052|NCT01741012|324010197|FG000|Overall Study|Withdrawal by Subject|2|||
94603053|NCT00640835|324010198|FG000|Overall Study|Adverse Event|5|||
94603054|NCT00640835|324010199|FG001|Overall Study|Adverse Event|3|||
94603055|NCT00640835|324010198|FG000|Overall Study|Withdrawal by Subject|12|||
94603056|NCT00640835|324010199|FG001|Overall Study|Withdrawal by Subject|14|||
94603057|NCT00640835|324010198|FG000|Overall Study|Physician Decision|10|||
94603058|NCT00640835|324010199|FG001|Overall Study|Physician Decision|14|||
94603059|NCT00640835|324010198|FG000|Overall Study|Sponsor's Decision|11|||
94603060|NCT00640835|324010199|FG001|Overall Study|Sponsor's Decision|7|||
94603061|NCT00640835|324010198|FG000|Overall Study|Protocol Violation|2|||
94603062|NCT00640835|324010199|FG001|Overall Study|Protocol Violation|2|||
94603063|NCT00640835|324010198|FG000|Overall Study|Lost to Follow-up|17|||
94603064|NCT00640835|324010199|FG001|Overall Study|Lost to Follow-up|13|||
94603065|NCT00640835|324010198|FG000|Overall Study|Other Reason|19|||
94603066|NCT00640835|324010199|FG001|Overall Study|Other Reason|4|||
94603067|NCT01249118|324010204|FG000|First Washout Period|Physician Decision|0|||
94603068|NCT01249118|324010205|FG001|First Washout Period|Physician Decision|1|||
94603069|NCT01249118|324010206|FG002|First Washout Period|Physician Decision|0|||
94603070|NCT00880685|324010207|FG000|Memantine 10mg|Lost to Follow-up|2|||
94603071|NCT00880685|324010207|FG000|Memantine 20mg|Withdrawal by Subject|1|||
94603072|NCT01721577|324010219|FG000|Overall Study|Lack of Efficacy|1|||
94603073|NCT01721577|324010220|FG001|Overall Study|Lack of Efficacy|0|||
94603074|NCT01721577|324010219|FG000|Overall Study|Death|1|||
94603075|NCT01721577|324010220|FG001|Overall Study|Death|0|||
94356211|NCT00421928|323087088|FG001|Overall Study|Withdrawal by Subject|48|||
94356212|NCT00421928|323087089|FG002|Overall Study|Withdrawal by Subject|43|||
94356213|NCT00421928|323087087|FG000|Overall Study|Lack of Efficacy|15|||
94356214|NCT00421928|323087088|FG001|Overall Study|Lack of Efficacy|7|||
94356215|NCT00421928|323087089|FG002|Overall Study|Lack of Efficacy|35|||
94356216|NCT00421928|323087087|FG000|Overall Study|Study drug non-compliant|6|||
94603076|NCT01721577|324010219|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
94603077|NCT01721577|324010220|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
94603078|NCT01721577|324010219|FG000|Overall Study|Adverse Event|0|||
94603079|NCT01721577|324010220|FG001|Overall Study|Adverse Event|2|||
94603080|NCT02496676|324010221|FG000|Phase 1 - Period 1|Adverse Event|0|||
94603081|NCT02496676|324010222|FG001|Phase 1 - Period 1|Adverse Event|1|||
94603082|NCT02496676|324010221|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
94603083|NCT02496676|324010222|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
94603084|NCT03977454|324010223|FG000|Overall Study|immediate postoperative revision|2|||
94603085|NCT03977454|324010224|FG001|Overall Study|immediate postoperative revision|2|||
94603086|NCT02131532|324010227|FG000|Overall Study|Withdrawal by Subject|1|||
94603087|NCT02131532|324010227|FG000|Overall Study|Physician Decision|1|||
94603088|NCT02131532|324010227|FG000|Overall Study|Other health conditions|2|||
94603089|NCT01565499|324010228|FG000|Overall Study|Physician Decision|1|||
94603090|NCT01565499|324010228|FG000|Overall Study|Adverse Event|5|||
94603091|NCT01565499|324010228|FG000|Overall Study|Withdrawal by Subject|2|||
94603092|NCT01466595|324010229|FG000|Overall Study|Withdrawal by Subject|0|||
94603093|NCT01466595|324010230|FG001|Overall Study|Withdrawal by Subject|1|||
94603094|NCT03418571|324010233|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
94603095|NCT03418571|324010234|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
94603096|NCT02376829|324010235|FG000|Overall Study|Withdrawal by Subject|27|||
94603097|NCT02376829|324010236|FG001|Overall Study|Withdrawal by Subject|44|||
94603098|NCT01255787|324010237|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
94603099|NCT01255787|324010238|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
94603100|NCT01255787|324010239|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
94603101|NCT01255787|324010240|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
94603102|NCT01255787|324010237|FG000|Overall Study|Major Protocol Deviation|1|||
94603103|NCT01255787|324010238|FG001|Overall Study|Major Protocol Deviation|1|||
94603104|NCT01255787|324010239|FG002|Overall Study|Major Protocol Deviation|0|||
94603105|NCT01255787|324010240|FG003|Overall Study|Major Protocol Deviation|4|||
94603106|NCT01255787|324010237|FG000|Overall Study|Lost to Follow-up|1|||
94603107|NCT01255787|324010238|FG001|Overall Study|Lost to Follow-up|2|||
94603108|NCT01255787|324010239|FG002|Overall Study|Lost to Follow-up|4|||
94603109|NCT01255787|324010240|FG003|Overall Study|Lost to Follow-up|2|||
94356217|NCT00421928|323087088|FG001|Overall Study|Study drug non-compliant|7|||
94603110|NCT01255787|324010237|FG000|Overall Study|Withdrawal of Consent|3|||
94603111|NCT01255787|324010238|FG001|Overall Study|Withdrawal of Consent|9|||
94603112|NCT01255787|324010239|FG002|Overall Study|Withdrawal of Consent|3|||
94603113|NCT01255787|324010240|FG003|Overall Study|Withdrawal of Consent|4|||
94603114|NCT01255787|324010237|FG000|Overall Study|Pregnancy|0|||
94603115|NCT01255787|324010238|FG001|Overall Study|Pregnancy|0|||
94603116|NCT01255787|324010239|FG002|Overall Study|Pregnancy|0|||
94603117|NCT01255787|324010240|FG003|Overall Study|Pregnancy|1|||
94603118|NCT01255787|324010237|FG000|Overall Study|Lack of Efficacy|2|||
94603119|NCT01255787|324010238|FG001|Overall Study|Lack of Efficacy|2|||
94603120|NCT01255787|324010239|FG002|Overall Study|Lack of Efficacy|2|||
94603121|NCT01255787|324010240|FG003|Overall Study|Lack of Efficacy|2|||
94603122|NCT01255787|324010237|FG000|Overall Study|Noncompliance with Study Drug|3|||
94603123|NCT01255787|324010238|FG001|Overall Study|Noncompliance with Study Drug|1|||
94603124|NCT01255787|324010239|FG002|Overall Study|Noncompliance with Study Drug|0|||
94603125|NCT01255787|324010240|FG003|Overall Study|Noncompliance with Study Drug|0|||
94603126|NCT00476047|324010241|FG000|Overall Study|Lost to Follow-up|1|||
94603127|NCT00586326|324010242|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
94603128|NCT00586326|324010242|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
94603129|NCT00586326|324010242|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
94603130|NCT00586326|324010242|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
94603131|NCT00586326|324010242|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
94603132|NCT00586326|324010242|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
94603133|NCT00586326|324010242|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
94603134|NCT00586326|324010242|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
94603135|NCT00586326|324010242|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
94603136|NCT00586326|324010242|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
94603137|NCT00586326|324010242|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
94603138|NCT00586326|324010242|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
94603139|NCT00586326|324010242|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
94603140|NCT00586326|324010242|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
94603141|NCT00586326|324010242|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
94603142|NCT00586326|324010242|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
94603143|NCT00586326|324010242|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
94603144|NCT02117414|324010243|FG000|Overall Study|Death|5|||
94603145|NCT02117414|324010244|FG001|Overall Study|Death|2|||
94603146|NCT02117414|324010243|FG000|Overall Study|Withdrawal by Subject|10|||
94603147|NCT02117414|324010244|FG001|Overall Study|Withdrawal by Subject|4|||
94603148|NCT00322153|324010248|FG000|Overall Study|Adverse Event|21|||
94603149|NCT00322153|324010249|FG001|Overall Study|Adverse Event|34|||
94603150|NCT00322153|324010248|FG000|Overall Study|Protocol Violation|6|||
94603151|NCT00322153|324010249|FG001|Overall Study|Protocol Violation|14|||
94603152|NCT00322153|324010248|FG000|Overall Study|Withdrawal by Subject|18|||
94603153|NCT00322153|324010249|FG001|Overall Study|Withdrawal by Subject|10|||
94603154|NCT00322153|324010248|FG000|Overall Study|Lack of Efficacy|8|||
94603155|NCT00322153|324010249|FG001|Overall Study|Lack of Efficacy|3|||
94603156|NCT00322153|324010248|FG000|Overall Study|Lost to Follow-up|5|||
94603157|NCT00322153|324010249|FG001|Overall Study|Lost to Follow-up|4|||
94603158|NCT00322153|324010248|FG000|Overall Study|Withdrawn for other reasons|5|||
94603159|NCT00322153|324010249|FG001|Overall Study|Withdrawn for other reasons|4|||
94603160|NCT03963401|324010252|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
94603161|NCT03963401|324010253|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
94603162|NCT03963401|324010254|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
94603163|NCT03963401|324010255|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
94603164|NCT03963401|324010256|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
94603165|NCT03963401|324010257|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
94603166|NCT03963401|324010252|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
94603167|NCT03963401|324010253|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
94603168|NCT03963401|324010254|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
94603169|NCT03963401|324010255|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
94603170|NCT03963401|324010256|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
94603171|NCT03963401|324010257|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
94603172|NCT03963401|324010252|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
94603173|NCT03963401|324010253|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
94603174|NCT03963401|324010254|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
94603175|NCT03963401|324010255|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
94603176|NCT03963401|324010256|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
94603177|NCT03963401|324010257|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
94603178|NCT03963401|324010252|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
94603179|NCT03963401|324010253|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
94603180|NCT03963401|324010254|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
94603181|NCT03963401|324010255|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
94603182|NCT03963401|324010256|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
94603183|NCT03963401|324010257|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
94603184|NCT03963401|324010252|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
94603185|NCT03963401|324010253|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
94603186|NCT03963401|324010254|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
94603187|NCT03963401|324010255|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
94603188|NCT03963401|324010256|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
94603189|NCT03963401|324010257|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
94603190|NCT03963401|324010252|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
94603191|NCT03963401|324010253|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
94603192|NCT03963401|324010254|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
94603193|NCT03963401|324010255|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
94603194|NCT03963401|324010256|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
94603195|NCT03963401|324010257|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
94603196|NCT03963401|324010252|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
94603197|NCT03963401|324010253|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
94603198|NCT03963401|324010254|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
94603199|NCT03963401|324010255|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
94603200|NCT03963401|324010256|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
94603201|NCT03963401|324010257|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
94603202|NCT03963401|324010252|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
94603203|NCT03963401|324010253|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
94603204|NCT03963401|324010254|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
94603205|NCT03963401|324010255|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
94603206|NCT03963401|324010256|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
94603207|NCT03963401|324010257|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
94603208|NCT03963401|324010252|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
94603209|NCT03963401|324010253|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
94603210|NCT03963401|324010254|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
94603211|NCT03963401|324010255|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
94603212|NCT03963401|324010256|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
94603213|NCT03963401|324010257|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
94603214|NCT03963401|324010252|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
94603215|NCT03963401|324010253|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
94603216|NCT03963401|324010254|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
94603217|NCT03963401|324010255|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
94603218|NCT03963401|324010256|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
94603219|NCT03963401|324010257|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
94603220|NCT03963401|324010252|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
94603221|NCT03963401|324010253|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
94603222|NCT03963401|324010254|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
94603223|NCT03963401|324010255|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
94603224|NCT03963401|324010256|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
94603225|NCT03963401|324010257|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
94603226|NCT01445886|324010261|FG000|Overall Study|Lost to Follow-up|2|||
94603227|NCT01445886|324010261|FG000|Overall Study|Protocol Violation|3|||
94603228|NCT03500679|324010262|FG000|Overall Study|Lost to Follow-up|6|||
94603229|NCT03500679|324010263|FG001|Overall Study|Lost to Follow-up|3|||
94603230|NCT03500679|324010262|FG000|Overall Study|Withdrawal by Subject|3|||
94603231|NCT03500679|324010263|FG001|Overall Study|Withdrawal by Subject|0|||
94603232|NCT00744471|324010264|FG000|Overall Study|Randomized but not treated|1|||
94603233|NCT00744471|324010265|FG001|Overall Study|Randomized but not treated|1|||
94603234|NCT00744471|324010266|FG002|Overall Study|Randomized but not treated|4|||
94603235|NCT00744471|324010267|FG003|Overall Study|Randomized but not treated|0|||
94603236|NCT00744471|324010264|FG000|Overall Study|Death|0|||
94603237|NCT00744471|324010265|FG001|Overall Study|Death|0|||
94603238|NCT00744471|324010266|FG002|Overall Study|Death|0|||
94603239|NCT00744471|324010267|FG003|Overall Study|Death|1|||
94603240|NCT00744471|324010264|FG000|Overall Study|Adverse Event|6|||
94603241|NCT00744471|324010265|FG001|Overall Study|Adverse Event|7|||
94603242|NCT00744471|324010266|FG002|Overall Study|Adverse Event|5|||
94603243|NCT00744471|324010267|FG003|Overall Study|Adverse Event|9|||
94603244|NCT00744471|324010264|FG000|Overall Study|Withdrawal by Subject|9|||
94603245|NCT00744471|324010265|FG001|Overall Study|Withdrawal by Subject|9|||
94603246|NCT00744471|324010266|FG002|Overall Study|Withdrawal by Subject|15|||
94603247|NCT00744471|324010267|FG003|Overall Study|Withdrawal by Subject|12|||
94603248|NCT00744471|324010264|FG000|Overall Study|Protocol Violation|1|||
94603249|NCT00744471|324010265|FG001|Overall Study|Protocol Violation|4|||
94603250|NCT00744471|324010266|FG002|Overall Study|Protocol Violation|1|||
94603251|NCT00744471|324010267|FG003|Overall Study|Protocol Violation|2|||
94603252|NCT00744471|324010264|FG000|Overall Study|Entered extension study|41|||
94603253|NCT00744471|324010265|FG001|Overall Study|Entered extension study|84|||
94603254|NCT00744471|324010266|FG002|Overall Study|Entered extension study|100|||
94603255|NCT00744471|324010267|FG003|Overall Study|Entered extension study|91|||
94603256|NCT00744471|324010264|FG000|Overall Study|Other|2|||
94603257|NCT00744471|324010265|FG001|Overall Study|Other|3|||
94603258|NCT00744471|324010266|FG002|Overall Study|Other|6|||
94603259|NCT00744471|324010267|FG003|Overall Study|Other|2|||
94603260|NCT00744471|324010264|FG000|Overall Study|Lack of Efficacy|83|||
94603261|NCT00744471|324010265|FG001|Overall Study|Lack of Efficacy|37|||
94603262|NCT00744471|324010266|FG002|Overall Study|Lack of Efficacy|19|||
94603263|NCT00744471|324010267|FG003|Overall Study|Lack of Efficacy|31|||
94603264|NCT00744471|324010264|FG000|Overall Study|Lost to Follow-up|0|||
94603265|NCT00744471|324010265|FG001|Overall Study|Lost to Follow-up|0|||
94603266|NCT00744471|324010266|FG002|Overall Study|Lost to Follow-up|2|||
94603267|NCT00744471|324010267|FG003|Overall Study|Lost to Follow-up|0|||
94603268|NCT02730208|324010268|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
94603269|NCT02730208|324010269|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
94603270|NCT00995865|324010270|FG000|Overall Study|Protocol Violation|2|||
94603271|NCT00995865|324010271|FG001|Overall Study|Protocol Violation|0|||
94603272|NCT00995865|324010272|FG002|Overall Study|Protocol Violation|0|||
94603273|NCT00995865|324010270|FG000|Overall Study|Lost to Follow-up|0|||
94603274|NCT00995865|324010271|FG001|Overall Study|Lost to Follow-up|0|||
94603275|NCT00995865|324010272|FG002|Overall Study|Lost to Follow-up|1|||
94603276|NCT02021656|324010290|FG000|Overall Study|Adverse Event|1|||
94603277|NCT02021656|324010290|FG000|Overall Study|Lack of Efficacy|2|||
94603278|NCT02021656|324010290|FG000|Overall Study|Lost to Follow-up|1|||
94603279|NCT02021656|324010290|FG000|Overall Study|Withdrew Consent|2|||
94603280|NCT03194490|324010291|FG000|Overall Study|Lost to Follow-up|1|||
94603281|NCT03194490|324010292|FG001|Overall Study|Lost to Follow-up|3|||
94603282|NCT03194490|324010291|FG000|Overall Study|participant developed specific neck pain|1|||
94603283|NCT03194490|324010292|FG001|Overall Study|participant developed specific neck pain|0|||
94603284|NCT01888003|324010293|FG000|Overall Study|Study Terminated|5|||
94603285|NCT01888003|324010294|FG001|Overall Study|Study Terminated|6|||
94603286|NCT01888003|324010295|FG002|Overall Study|Study Terminated|40|||
94603287|NCT02359851|324010296|FG000|Overall Study|Death|1|||
94603288|NCT02359851|324010296|FG000|Overall Study|Disease progression|1|||
94603289|NCT00055471|324010297|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
94603290|NCT00055471|324010298|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
94603291|NCT00055471|324010299|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
94603292|NCT00055471|324010297|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
94603293|NCT00055471|324010298|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
94603294|NCT00055471|324010299|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
94603295|NCT00055471|324010297|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
94603296|NCT00055471|324010298|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
94603297|NCT00055471|324010299|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
94603298|NCT01854944|324010300|FG000|Overall Study|Withdrawal by Subject|0|||
94603299|NCT01854944|324010301|FG001|Overall Study|Withdrawal by Subject|0|||
94603300|NCT01854944|324010302|FG002|Overall Study|Withdrawal by Subject|1|||
94603301|NCT02101112|324010303|FG000|Overall Study|Adverse Event|0|||
94603302|NCT02101112|324010304|FG001|Overall Study|Adverse Event|0|||
94603303|NCT02101112|324010305|FG002|Overall Study|Adverse Event|1|||
94603304|NCT02101112|324010306|FG003|Overall Study|Adverse Event|0|||
94603305|NCT02101112|324010307|FG004|Overall Study|Adverse Event|0|||
94603306|NCT02101112|324010308|FG005|Overall Study|Adverse Event|0|||
94603307|NCT02101112|324010303|FG000|Overall Study|Withdrawal by Subject|0|||
94603308|NCT02101112|324010304|FG001|Overall Study|Withdrawal by Subject|0|||
94603309|NCT02101112|324010305|FG002|Overall Study|Withdrawal by Subject|0|||
94603310|NCT02101112|324010306|FG003|Overall Study|Withdrawal by Subject|0|||
94248892|NCT03149549|322704956|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
94248893|NCT03149549|322704957|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
94248894|NCT03149549|322704945|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
94248895|NCT03149549|322704946|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
94248896|NCT03149549|322704947|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
94248897|NCT03149549|322704948|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
94248898|NCT03149549|322704949|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
94248899|NCT03149549|322704950|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
94248900|NCT03149549|322704951|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
94248901|NCT03149549|322704952|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
94248902|NCT03149549|322704953|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
94248903|NCT03149549|322704954|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
94248904|NCT03149549|322704955|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
94248905|NCT03149549|322704956|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
94248906|NCT03149549|322704957|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
94248907|NCT03149549|322704945|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
94248908|NCT03149549|322704946|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
94356218|NCT00421928|323087089|FG002|Overall Study|Study drug non-compliant|4|||
94356219|NCT00421928|323087087|FG000|Overall Study|All other|26|||
94356220|NCT00421928|323087088|FG001|Overall Study|All other|21|||
94356221|NCT00421928|323087089|FG002|Overall Study|All other|27|||
94356222|NCT00421928|323087087|FG000|Overall Study|Death|0|||
94356223|NCT00421928|323087088|FG001|Overall Study|Death|1|||
94356224|NCT00421928|323087089|FG002|Overall Study|Death|0|||
94356225|NCT04120116|323087092|FG000|Overall Study|Lost to Follow-up|0|||
94356226|NCT04120116|323087093|FG001|Overall Study|Lost to Follow-up|1|||
94356227|NCT04120116|323087094|FG002|Overall Study|Lost to Follow-up|0|||
94356228|NCT04120116|323087095|FG003|Overall Study|Lost to Follow-up|2|||
94356229|NCT04120116|323087092|FG000|Overall Study|Withdrawal by Subject|1|||
94356230|NCT04120116|323087093|FG001|Overall Study|Withdrawal by Subject|0|||
94356231|NCT04120116|323087094|FG002|Overall Study|Withdrawal by Subject|1|||
94356232|NCT04120116|323087095|FG003|Overall Study|Withdrawal by Subject|1|||
94356233|NCT04120116|323087092|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
94356234|NCT04120116|323087093|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
94356235|NCT04120116|323087094|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
94356236|NCT04120116|323087095|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
94356237|NCT01789476|323087096|FG000|Overall Study|Lack of Efficacy|6|||
94356238|NCT01789476|323087097|FG001|Overall Study|Lack of Efficacy|2|||
94356239|NCT01789476|323087096|FG000|Overall Study|Adverse Event|1|||
94356240|NCT01789476|323087097|FG001|Overall Study|Adverse Event|0|||
94603311|NCT02101112|324010307|FG004|Overall Study|Withdrawal by Subject|1|||
94603312|NCT02101112|324010308|FG005|Overall Study|Withdrawal by Subject|0|||
94603313|NCT00323869|324010310|FG000|Overall Study|Death|1|||
94603314|NCT01931202|324010311|FG000|Overall Study|Withdrawal by Subject|0|||
94603315|NCT01931202|324010312|FG001|Overall Study|Withdrawal by Subject|0|||
94603316|NCT01931202|324010313|FG002|Overall Study|Withdrawal by Subject|2|||
94603317|NCT01931202|324010311|FG000|Overall Study|Lost to Follow-up|0|||
94603318|NCT01931202|324010312|FG001|Overall Study|Lost to Follow-up|5|||
94603319|NCT01931202|324010313|FG002|Overall Study|Lost to Follow-up|2|||
94603320|NCT04597918|324010316|FG000|Overall Study|Withdrawal by Subject|6|||
94248909|NCT03149549|322704947|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
94248910|NCT03149549|322704948|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
94248911|NCT03149549|322704949|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
94248912|NCT03149549|322704950|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
94248913|NCT03149549|322704951|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
94248914|NCT03149549|322704952|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
94248915|NCT03149549|322704953|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
94248916|NCT03149549|322704954|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
94248917|NCT03149549|322704955|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
94248918|NCT03149549|322704956|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
94248919|NCT03149549|322704957|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
94248920|NCT03149549|322704945|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
94248921|NCT03149549|322704946|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
94248922|NCT03149549|322704947|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
94248923|NCT03149549|322704948|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
94248924|NCT03149549|322704949|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
94248925|NCT03149549|322704950|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
94248926|NCT03149549|322704951|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
94248927|NCT03149549|322704952|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
94248928|NCT03149549|322704953|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
94248929|NCT03149549|322704954|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
94248930|NCT03149549|322704955|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
94248931|NCT03149549|322704956|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
94248932|NCT03149549|322704957|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
94248933|NCT01758900|322704958|FG000|Overall Study|difficulty for further intubation|7|||
94248934|NCT01758900|322704959|FG001|Overall Study|difficulty for further intubation|8|||
94248935|NCT00867308|322704961|FG000|Overall Study|Death|1|||
94248936|NCT00867308|322704962|FG001|Overall Study|Death|0|||
94248937|NCT00867308|322704961|FG000|Overall Study|Adverse Event|1|||
94248938|NCT00867308|322704962|FG001|Overall Study|Adverse Event|4|||
94248939|NCT00867308|322704961|FG000|Overall Study|Lack of Efficacy|6|||
94248940|NCT00867308|322704962|FG001|Overall Study|Lack of Efficacy|12|||
94248941|NCT00867308|322704961|FG000|Overall Study|Withdrawal by Subject|1|||
94248942|NCT00867308|322704962|FG001|Overall Study|Withdrawal by Subject|2|||
94248943|NCT01775124|322704965|FG000|Core Period|Disease Progression|0|||
94248944|NCT01775124|322704966|FG001|Core Period|Disease Progression|1|||
94248945|NCT01775124|322704965|FG000|Core Period|Physician Decision|1|||
94248946|NCT01775124|322704966|FG001|Core Period|Physician Decision|1|||
94248947|NCT01775124|322704965|FG000|Core Period|Death|0|||
94248948|NCT01775124|322704966|FG001|Core Period|Death|1|||
94248949|NCT01775124|322704965|FG000|Core Period|Administrative problems|1|||
94248950|NCT01775124|322704966|FG001|Core Period|Administrative problems|0|||
94248951|NCT01775124|322704965|FG000|Core Period|Withdrawal by Subject|4|||
94248952|NCT01775124|322704966|FG001|Core Period|Withdrawal by Subject|2|||
94248953|NCT01775124|322704965|FG000|Core Period|Adverse Event|5|||
94248954|NCT01775124|322704966|FG001|Core Period|Adverse Event|5|||
94248955|NCT01775124|322704965|FG000|Extension Period|Adverse Event|3|||
94248956|NCT01775124|322704966|FG001|Extension Period|Adverse Event|2|||
94248957|NCT01775124|322704965|FG000|Extension Period|Physician Decision|0|||
94248958|NCT01775124|322704966|FG001|Extension Period|Physician Decision|2|||
94458048|NCT02980341|323465680|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
94458049|NCT02980341|323465681|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
94458050|NCT02980341|323465671|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
94458051|NCT02980341|323465672|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
94458052|NCT02980341|323465673|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
94458053|NCT02980341|323465674|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
94458054|NCT02980341|323465675|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
94458055|NCT02980341|323465676|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
94458056|NCT02980341|323465677|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
94603321|NCT04597918|324010316|FG000|Overall Study|Lost to Follow-up|3|||
94603322|NCT04597918|324010316|FG000|Overall Study|Death|1|||
94248959|NCT01775124|322704965|FG000|Extension Period|Administrative problems|0|||
94248960|NCT01775124|322704966|FG001|Extension Period|Administrative problems|1|||
94248961|NCT01775124|322704965|FG000|Extension Period|Lost to Follow-up|0|||
94248962|NCT01775124|322704966|FG001|Extension Period|Lost to Follow-up|1|||
94248963|NCT01775124|322704965|FG000|Extension Period|Withdrawal by Subject|9|||
94248964|NCT01775124|322704966|FG001|Extension Period|Withdrawal by Subject|12|||
94248965|NCT01305200|322704967|FG000|Overall Study|Physician Decision|4|||
94248966|NCT01305200|322704968|FG001|Overall Study|Physician Decision|6|||
94248967|NCT01305200|322704969|FG002|Overall Study|Physician Decision|1|||
94248968|NCT01305200|322704967|FG000|Overall Study|Withdrawal by Subject|24|||
94248969|NCT01305200|322704968|FG001|Overall Study|Withdrawal by Subject|21|||
94603323|NCT00356122|324010318|FG000|TREATMENT|Lack of Efficacy|26|||
94603324|NCT00356122|324010318|FG000|TREATMENT|Adverse Event|10|||
94603325|NCT00356122|324010318|FG000|TREATMENT|Subject's request|4|||
94603326|NCT00356122|324010318|FG000|TREATMENT|Other|4|||
94603327|NCT00356122|324010318|FG000|TREATMENT|Did not receive study medication|1|||
94603328|NCT00356122|324010318|FG000|FOLLOW-UP|Death|37|||
94603329|NCT00356122|324010318|FG000|FOLLOW-UP|Lost to Follow-up|2|||
94603330|NCT00356122|324010318|FG000|FOLLOW-UP|Other|2|||
94603331|NCT02782923|324010321|FG000|Overall Study|Lost to Follow-up|15|||
94603332|NCT00458536|324010324|FG000|Overall Study|Disease progression prior to treatment|7|||
94603333|NCT00458536|324010324|FG000|Overall Study|Unable to make vaccine|3|||
94603334|NCT00458536|324010324|FG000|Overall Study|No measurable disease after surgery|2|||
94603335|NCT00458536|324010324|FG000|Overall Study|Did not have renal cell carcinoma|2|||
94603336|NCT00458536|324010324|FG000|Overall Study|Patient did not have surgery|1|||
94603337|NCT00458536|324010324|FG000|Overall Study|Ineligible due to toxicity|1|||
94603338|NCT00458536|324010324|FG000|Overall Study|Withdrawal by Subject|1|||
94603339|NCT00458536|324010324|FG000|Overall Study|Progressive disease during treatment|2|||
94603340|NCT00285207|324010325|FG000|Overall Study|Lost to Follow-up|3|||
94603341|NCT00285207|324010326|FG001|Overall Study|Lost to Follow-up|2|||
94603342|NCT00285207|324010325|FG000|Overall Study|Withdrawal by Subject|5|||
94603343|NCT00285207|324010326|FG001|Overall Study|Withdrawal by Subject|2|||
94603344|NCT00285207|324010325|FG000|Overall Study|Pregnancy|1|||
94603345|NCT00285207|324010326|FG001|Overall Study|Pregnancy|1|||
94603346|NCT00285207|324010325|FG000|Overall Study|non-compliance|0|||
94603347|NCT00285207|324010326|FG001|Overall Study|non-compliance|1|||
94248970|NCT01305200|322704969|FG002|Overall Study|Withdrawal by Subject|1|||
94248971|NCT01305200|322704967|FG000|Overall Study|Ineligible|1|||
94248972|NCT01305200|322704968|FG001|Overall Study|Ineligible|2|||
94248973|NCT01305200|322704969|FG002|Overall Study|Ineligible|1|||
94603348|NCT03505671|324012153|FG000|Overall Study|Withdrawal by Subject|2|||
94603349|NCT03505671|324012154|FG001|Overall Study|Withdrawal by Subject|1|||
94603350|NCT03505671|324012153|FG000|Overall Study|Lost to Follow-up|1|||
94603351|NCT03505671|324012154|FG001|Overall Study|Lost to Follow-up|0|||
94603352|NCT01083173|324012155|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
94603353|NCT01083173|324012156|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
94603354|NCT01083173|324012155|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
94603355|NCT01083173|324012156|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
94603356|NCT01083173|324012155|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
94603357|NCT01083173|324012156|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
94603358|NCT01083173|324012155|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
94603359|NCT01083173|324012156|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
94603360|NCT01083173|324012155|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
94603361|NCT01083173|324012156|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
94603362|NCT01083173|324012155|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
94603363|NCT01083173|324012156|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
94603364|NCT01083173|324012155|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
94603365|NCT01083173|324012156|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
94603366|NCT01083173|324012155|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
94603367|NCT01083173|324012156|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
94603368|NCT01083173|324012155|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
94603369|NCT01083173|324012156|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
94603370|NCT01083173|324012155|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
94661384|NCT03579459|324215713|FG001|Overall Study|Withdrawal by Subject|8|||
94603371|NCT01083173|324012156|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
94661385|NCT03579459|324215714|FG002|Overall Study|Withdrawal by Subject|11|||
94603372|NCT01083173|324012155|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
94603373|NCT01083173|324012156|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
94603374|NCT04704154|324012157|FG000|Overall Study|Adverse Event|3|||
94603375|NCT04704154|324012158|FG001|Overall Study|Adverse Event|2|||
94603376|NCT04704154|324012159|FG002|Overall Study|Adverse Event|4|||
94603377|NCT04704154|324012160|FG003|Overall Study|Adverse Event|2|||
94603378|NCT04704154|324012161|FG004|Overall Study|Adverse Event|3|||
94603379|NCT04704154|324012162|FG005|Overall Study|Adverse Event|0|||
94603380|NCT04704154|324012157|FG000|Overall Study|Death|3|||
94603381|NCT04704154|324012158|FG001|Overall Study|Death|0|||
94603382|NCT04704154|324012159|FG002|Overall Study|Death|0|||
94603383|NCT04704154|324012160|FG003|Overall Study|Death|0|||
94603384|NCT04704154|324012161|FG004|Overall Study|Death|3|||
94603385|NCT04704154|324012162|FG005|Overall Study|Death|0|||
94603386|NCT04704154|324012157|FG000|Overall Study|Physician Decision|1|||
94603387|NCT04704154|324012158|FG001|Overall Study|Physician Decision|0|||
94603388|NCT04704154|324012159|FG002|Overall Study|Physician Decision|1|||
94603389|NCT04704154|324012160|FG003|Overall Study|Physician Decision|0|||
94603390|NCT04704154|324012161|FG004|Overall Study|Physician Decision|2|||
94603391|NCT04704154|324012162|FG005|Overall Study|Physician Decision|0|||
94603392|NCT04704154|324012157|FG000|Overall Study|Participant Decision|1|||
94603393|NCT04704154|324012158|FG001|Overall Study|Participant Decision|1|||
94603394|NCT04704154|324012159|FG002|Overall Study|Participant Decision|0|||
94603395|NCT04704154|324012160|FG003|Overall Study|Participant Decision|0|||
94603396|NCT04704154|324012161|FG004|Overall Study|Participant Decision|0|||
94603397|NCT04704154|324012162|FG005|Overall Study|Participant Decision|0|||
94603398|NCT04704154|324012157|FG000|Overall Study|Progressive Disease|19|||
94603399|NCT04704154|324012158|FG001|Overall Study|Progressive Disease|17|||
94603400|NCT04704154|324012159|FG002|Overall Study|Progressive Disease|20|||
94603401|NCT04704154|324012160|FG003|Overall Study|Progressive Disease|18|||
94603402|NCT04704154|324012161|FG004|Overall Study|Progressive Disease|36|||
94603403|NCT04704154|324012162|FG005|Overall Study|Progressive Disease|30|||
94603404|NCT04704154|324012157|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
94603405|NCT04704154|324012158|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
94603406|NCT04704154|324012159|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
94603407|NCT04704154|324012160|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
94603408|NCT04704154|324012161|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
94603409|NCT04704154|324012162|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
94603410|NCT04704154|324012157|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
94603411|NCT04704154|324012158|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
94603412|NCT04704154|324012159|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
94603413|NCT04704154|324012160|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
94603414|NCT04704154|324012161|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
94603415|NCT04704154|324012162|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
94603416|NCT04251156|324012163|FG000|Overall Study|Lost to Follow-up|1|||
94603417|NCT04251156|324012164|FG001|Overall Study|Lost to Follow-up|1|||
94603418|NCT04251156|324012163|FG000|Overall Study|Withdrawal by Subject|4|||
94603419|NCT04251156|324012164|FG001|Overall Study|Withdrawal by Subject|4|||
94603420|NCT03553836|324012165|FG000|Overall Study|Ongoing in Study|460|||
94603421|NCT03553836|324012166|FG001|Overall Study|Ongoing in Study|459|||
94603422|NCT03553836|324012165|FG000|Overall Study|Withdrawal by Subject|9|||
94603423|NCT03553836|324012166|FG001|Overall Study|Withdrawal by Subject|10|||
94603424|NCT03553836|324012165|FG000|Overall Study|Lost to Follow-up|1|||
94603425|NCT03553836|324012166|FG001|Overall Study|Lost to Follow-up|3|||
94603426|NCT03553836|324012165|FG000|Overall Study|Death|17|||
94603427|NCT03553836|324012166|FG001|Overall Study|Death|17|||
94603428|NCT03220438|324012167|FG000|Overall Study|Lost to Follow-up|0|||
94603429|NCT03220438|324012168|FG001|Overall Study|Lost to Follow-up|0|||
94603430|NCT03220438|324012169|FG002|Overall Study|Lost to Follow-up|1|||
94603431|NCT03220438|324012170|FG003|Overall Study|Lost to Follow-up|0|||
94603432|NCT04626310|324012173|FG000|Overall Study|4-miss from treatment|6|||
94603433|NCT04626310|324012174|FG001|Overall Study|4-miss from treatment|5|||
94603434|NCT04626310|324012175|FG002|Overall Study|4-miss from treatment|5|||
94603435|NCT04626310|324012173|FG000|Overall Study|Withdrawal by Subject|1|||
94603436|NCT04626310|324012174|FG001|Overall Study|Withdrawal by Subject|0|||
94603437|NCT04626310|324012175|FG002|Overall Study|Withdrawal by Subject|3|||
94603438|NCT02604017|324012176|FG000|Overall Study|Withdrew Consent|0|||
94603439|NCT02604017|324012177|FG001|Overall Study|Withdrew Consent|2|||
94603440|NCT02604017|324012176|FG000|Overall Study|Lost to Follow-up|5|||
94603441|NCT02604017|324012177|FG001|Overall Study|Lost to Follow-up|6|||
94603442|NCT02604017|324012176|FG000|Overall Study|Other|1|||
94603443|NCT02604017|324012177|FG001|Overall Study|Other|0|||
94603444|NCT00740246|324012178|FG000|Overall Study|Received Blood Transfusion|0|||
94603445|NCT00740246|324012179|FG001|Overall Study|Received Blood Transfusion|1|||
94603446|NCT00740246|324012178|FG000|Overall Study|Adverse Event|1|||
94603447|NCT00740246|324012179|FG001|Overall Study|Adverse Event|2|||
94603448|NCT00740246|324012178|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
94603449|NCT00740246|324012179|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
94603450|NCT00740246|324012178|FG000|Overall Study|Lost to Follow-up|2|||
94603451|NCT00740246|324012179|FG001|Overall Study|Lost to Follow-up|2|||
94603452|NCT00740246|324012178|FG000|Overall Study|Withdrawal by Subject|4|||
94603453|NCT00740246|324012179|FG001|Overall Study|Withdrawal by Subject|3|||
94603454|NCT00740246|324012178|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
94603455|NCT00740246|324012179|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
94603456|NCT00740246|324012178|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
94603457|NCT00740246|324012179|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
94603458|NCT00740246|324012178|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
94603459|NCT00740246|324012179|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
94603460|NCT00740246|324012178|FG000|Overall Study|Unable To Comply With Study Visits|2|||
94603461|NCT00740246|324012179|FG001|Overall Study|Unable To Comply With Study Visits|0|||
94603462|NCT00740246|324012178|FG000|Overall Study|Unable to Access Vein|0|||
94603463|NCT00740246|324012179|FG001|Overall Study|Unable to Access Vein|2|||
94603464|NCT00740246|324012178|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
94603465|NCT00740246|324012179|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
94603466|NCT01041495|324012180|FG000|Overall Study|Withdrawal by Subject|2|||
94603467|NCT01041495|324012181|FG001|Overall Study|Withdrawal by Subject|5|||
94603468|NCT01041495|324012180|FG000|Overall Study|Adverse Event|2|||
94603469|NCT01041495|324012181|FG001|Overall Study|Adverse Event|1|||
94603470|NCT01041495|324012180|FG000|Overall Study|Lost to Follow-up|0|||
94603471|NCT01041495|324012181|FG001|Overall Study|Lost to Follow-up|1|||
94603472|NCT00206076|324012182|FG000|Overall Study|Physician Decision|2|||
94603473|NCT00206076|324012183|FG001|Overall Study|Physician Decision|0|||
94603474|NCT00206076|324012182|FG000|Overall Study|Withdrawal by Subject|1|||
94603475|NCT00206076|324012183|FG001|Overall Study|Withdrawal by Subject|1|||
94603476|NCT00998764|324012184|FG000|Overall Study|Lack of Efficacy|3|||
94603477|NCT00998764|324012185|FG001|Overall Study|Lack of Efficacy|6|||
94603478|NCT00998764|324012184|FG000|Overall Study|Adverse Event|17|||
94603479|NCT00998764|324012185|FG001|Overall Study|Adverse Event|12|||
94603480|NCT00998764|324012184|FG000|Overall Study|Withdrawal by Subject|19|||
94603481|NCT00998764|324012185|FG001|Overall Study|Withdrawal by Subject|25|||
94603482|NCT00998764|324012184|FG000|Overall Study|Physician Decision|3|||
94603483|NCT00998764|324012185|FG001|Overall Study|Physician Decision|3|||
94603484|NCT00998764|324012184|FG000|Overall Study|Death|3|||
94603485|NCT00998764|324012185|FG001|Overall Study|Death|1|||
94603486|NCT00998764|324012184|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
94603487|NCT00998764|324012185|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
94603488|NCT00998764|324012184|FG000|Overall Study|Protocol Violation|0|||
94603489|NCT00998764|324012185|FG001|Overall Study|Protocol Violation|1|||
94603490|NCT00998764|324012184|FG000|Overall Study|Failed to Return|1|||
94603491|NCT00998764|324012185|FG001|Overall Study|Failed to Return|1|||
94356241|NCT01789476|323087096|FG000|Overall Study|Unable to get IV access|1|||
94356242|NCT01789476|323087097|FG001|Overall Study|Unable to get IV access|0|||
94603492|NCT00998764|324012184|FG000|Overall Study|Lost to Follow-up|1|||
94603493|NCT00998764|324012185|FG001|Overall Study|Lost to Follow-up|1|||
94603494|NCT00998764|324012184|FG000|Overall Study|Loss of Caregiver|0|||
94603495|NCT00998764|324012185|FG001|Overall Study|Loss of Caregiver|3|||
94603496|NCT00998764|324012184|FG000|Overall Study|Other|4|||
94603497|NCT00998764|324012185|FG001|Overall Study|Other|4|||
94603498|NCT00998764|324012184|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
94603499|NCT00998764|324012185|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
94603500|NCT00442468|324012186|FG000|Overall Study|Adverse Event|4|||
94603501|NCT00442468|324012186|FG000|Overall Study|Withdrawal by Subject|91|||
94603502|NCT00442468|324012186|FG000|Overall Study|Did not complete all study procedures|88|||
94603503|NCT00470184|324012189|FG000|Overall Study|Not Treated(became ineligible)|4|||
94603504|NCT00470184|324012189|FG000|Overall Study|Not treated (other)|1|||
94603505|NCT00470184|324012189|FG000|Overall Study|disease Progression|4|||
94603506|NCT00470184|324012189|FG000|Overall Study|Adverse Event|3|||
94603507|NCT00470184|324012189|FG000|Overall Study|Withdrawal by Subject|4|||
94603508|NCT00470184|324012189|FG000|Overall Study|other|5|||
94603509|NCT00470184|324012189|FG000|Overall Study|recurrence|1|||
94603510|NCT01082640|324012190|FG000|Overall Study|Adverse Event|9|||
94603511|NCT01082640|324012191|FG001|Overall Study|Adverse Event|5|||
94603512|NCT01082640|324012192|FG002|Overall Study|Adverse Event|3|||
94603513|NCT01082640|324012190|FG000|Overall Study|Withdrawal by Subject|3|||
94603514|NCT01082640|324012191|FG001|Overall Study|Withdrawal by Subject|3|||
94603515|NCT01082640|324012192|FG002|Overall Study|Withdrawal by Subject|2|||
94603516|NCT01082640|324012190|FG000|Overall Study|Major protocol deviation|3|||
94603517|NCT01082640|324012191|FG001|Overall Study|Major protocol deviation|3|||
94603518|NCT01082640|324012192|FG002|Overall Study|Major protocol deviation|0|||
94603519|NCT01082640|324012190|FG000|Overall Study|Lost to Follow-up|0|||
94603520|NCT01082640|324012191|FG001|Overall Study|Lost to Follow-up|3|||
94603521|NCT01082640|324012192|FG002|Overall Study|Lost to Follow-up|0|||
94603522|NCT01082640|324012190|FG000|Overall Study|Other|2|||
94603523|NCT01082640|324012191|FG001|Overall Study|Other|1|||
94603524|NCT01082640|324012192|FG002|Overall Study|Other|3|||
94603525|NCT01055496|324012196|FG000|Overall Study|Withdrawal by Subject|2|||
94603526|NCT01055496|324012197|FG001|Overall Study|Withdrawal by Subject|4|||
94603527|NCT01055496|324012196|FG000|Overall Study|Death|13|||
94603528|NCT01055496|324012197|FG001|Overall Study|Death|23|||
94603529|NCT01055496|324012196|FG000|Overall Study|Lost to Follow-up|0|||
94603530|NCT01055496|324012197|FG001|Overall Study|Lost to Follow-up|2|||
94603531|NCT01055496|324012196|FG000|Overall Study|Other - Unspecified|0|||
94603532|NCT01055496|324012197|FG001|Overall Study|Other - Unspecified|1|||
94603533|NCT01966432|324012198|FG000|Overall Study|Lost to Follow-up|3|||
94603534|NCT01966432|324012199|FG001|Overall Study|Lost to Follow-up|2|||
94603535|NCT01966432|324012200|FG002|Overall Study|Lost to Follow-up|5|||
94603536|NCT01966432|324012198|FG000|Overall Study|Withdrawal by Subject|1|||
94603537|NCT01966432|324012199|FG001|Overall Study|Withdrawal by Subject|3|||
94603538|NCT01966432|324012200|FG002|Overall Study|Withdrawal by Subject|0|||
94603539|NCT01966432|324012198|FG000|Overall Study|Subject Incarcerated|0|||
94603540|NCT01966432|324012199|FG001|Overall Study|Subject Incarcerated|0|||
94603541|NCT01966432|324012200|FG002|Overall Study|Subject Incarcerated|1|||
94603542|NCT01966432|324012198|FG000|Overall Study|SBIRT program ended|1|||
94603543|NCT01966432|324012199|FG001|Overall Study|SBIRT program ended|8|||
94603544|NCT01966432|324012200|FG002|Overall Study|SBIRT program ended|20|||
94603545|NCT02011893|324012204|FG000|Enrollment to Randomization|Adverse Event|2|||
94603546|NCT02011893|324012205|FG001|Enrollment to Randomization|Adverse Event|0|||
94603547|NCT02011893|324012206|FG002|Enrollment to Randomization|Adverse Event|0|||
94603548|NCT02011893|324012204|FG000|Enrollment to Randomization|Physician Decision|10|||
94603549|NCT02011893|324012205|FG001|Enrollment to Randomization|Physician Decision|0|||
94603550|NCT02011893|324012206|FG002|Enrollment to Randomization|Physician Decision|0|||
94603551|NCT02011893|324012204|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
94603552|NCT02011893|324012205|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
94603553|NCT02011893|324012206|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
94603554|NCT02011893|324012204|FG000|Enrollment to Randomization|Screening Failure|29|||
94603555|NCT02011893|324012205|FG001|Enrollment to Randomization|Screening Failure|0|||
94603556|NCT02011893|324012206|FG002|Enrollment to Randomization|Screening Failure|0|||
94603557|NCT02011893|324012204|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
94603558|NCT02011893|324012205|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
94603559|NCT02011893|324012206|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
94603560|NCT02011893|324012204|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
94603561|NCT02011893|324012205|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
94603562|NCT02011893|324012206|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
94603563|NCT02011893|324012204|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
94603564|NCT02011893|324012205|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
94603565|NCT02011893|324012206|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
94603566|NCT02011893|324012204|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
94603567|NCT02011893|324012205|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
94603568|NCT02011893|324012206|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
94603569|NCT02011893|324012204|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
94603570|NCT02011893|324012205|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
94603571|NCT02011893|324012206|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
94603572|NCT03416374|324012207|FG000|Between Treatment Period I and II|Other|0|||
94603573|NCT03416374|324012208|FG001|Between Treatment Period I and II|Other|9|||
94603574|NCT03416374|324012207|FG000|Treatment Period II|Lack of Efficacy|3|||
94603575|NCT03416374|324012208|FG001|Treatment Period II|Lack of Efficacy|11|||
94603576|NCT03416374|324012207|FG000|Treatment Period II|Adverse Event|1|||
94603577|NCT03416374|324012208|FG001|Treatment Period II|Adverse Event|4|||
94603578|NCT03416374|324012207|FG000|Treatment Period II|Death|0|||
94603579|NCT03416374|324012208|FG001|Treatment Period II|Death|1|||
94603580|NCT03416374|324012207|FG000|Treatment Period II|Other|0|||
94603581|NCT03416374|324012208|FG001|Treatment Period II|Other|2|||
94603582|NCT00930982|324012209|FG000|Overall Study|Adverse Event|19|||
94603583|NCT00930982|324012210|FG001|Overall Study|Adverse Event|23|||
94603584|NCT00930982|324012209|FG000|Overall Study|Protocol Violation|1|||
94603585|NCT00930982|324012210|FG001|Overall Study|Protocol Violation|5|||
94603586|NCT00930982|324012209|FG000|Overall Study|Withdrawal by Subject|1|||
94603587|NCT00930982|324012210|FG001|Overall Study|Withdrawal by Subject|1|||
94603588|NCT01289782|324012211|FG000|Overall Study|Lost to Follow-up|14|||
94603589|NCT01289782|324012212|FG001|Overall Study|Lost to Follow-up|7|||
94603590|NCT01289782|324012211|FG000|Overall Study|Protocol Violation|1|||
94603591|NCT01289782|324012212|FG001|Overall Study|Protocol Violation|1|||
94603592|NCT01289782|324012211|FG000|Overall Study|Withdrawal by Subject|8|||
94603593|NCT01289782|324012212|FG001|Overall Study|Withdrawal by Subject|2|||
94603594|NCT01289782|324012211|FG000|Overall Study|Sponsor's Decision|1|||
94603595|NCT01289782|324012212|FG001|Overall Study|Sponsor's Decision|0|||
94603596|NCT01289782|324012211|FG000|Overall Study|Reason not specified|1|||
94603597|NCT01289782|324012212|FG001|Overall Study|Reason not specified|2|||
94603598|NCT03116347|324012225|FG000|Overall Study|Withdrawal by Subject|1|||
94603599|NCT03116347|324012226|FG001|Overall Study|Withdrawal by Subject|2|||
94603600|NCT03170232|324012227|FG000|Overall Study|Adverse Event|0|||
94603601|NCT03170232|324012228|FG001|Overall Study|Adverse Event|1|||
94603602|NCT03170232|324012227|FG000|Overall Study|Protocol Violation|0|||
94603603|NCT03170232|324012228|FG001|Overall Study|Protocol Violation|1|||
94603604|NCT03170232|324012227|FG000|Overall Study|Lack of Efficacy|0|||
94603605|NCT03170232|324012228|FG001|Overall Study|Lack of Efficacy|1|||
94603606|NCT03170232|324012227|FG000|Overall Study|Study closed/terminated|26|||
94603607|NCT03170232|324012228|FG001|Overall Study|Study closed/terminated|23|||
94603608|NCT03170232|324012227|FG000|Overall Study|Lost to Follow-up|1|||
94603609|NCT03170232|324012228|FG001|Overall Study|Lost to Follow-up|0|||
94603610|NCT03170232|324012227|FG000|Overall Study|Withdrawal by Subject|0|||
94603611|NCT03170232|324012228|FG001|Overall Study|Withdrawal by Subject|1|||
94603612|NCT03882008|324012229|FG000|Overall Study|Withdrawal by Subject|1|||
94603613|NCT03882008|324012229|FG000|Overall Study|Lost to Follow-up|1|||
94603614|NCT02964507|324012230|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
94603615|NCT02964507|324012231|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
94603616|NCT02964507|324012232|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
94603617|NCT02964507|324012233|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
94603618|NCT02964507|324012234|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
94603619|NCT02964507|324012235|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
94248974|NCT01305200|322704967|FG000|Overall Study|Death|0|||
94248975|NCT01305200|322704968|FG001|Overall Study|Death|2|||
94248976|NCT01305200|322704969|FG002|Overall Study|Death|0|||
94248977|NCT02317432|322704970|FG000|Overall Study|Death|4|||
94248978|NCT02317432|322704971|FG001|Overall Study|Death|1|||
94248979|NCT02317432|322704970|FG000|Overall Study|Lost to Follow-up|0|||
94248980|NCT02317432|322704971|FG001|Overall Study|Lost to Follow-up|5|||
94248981|NCT02317432|322704970|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
94248982|NCT02317432|322704971|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
94248983|NCT05559476|322704972|FG000|Overall Study|Adverse Event|2|||
94248984|NCT05559476|322704973|FG001|Overall Study|Adverse Event|0|||
94248985|NCT05559476|322704972|FG000|Overall Study|Lost to Follow-up|13|||
94248986|NCT05559476|322704973|FG001|Overall Study|Lost to Follow-up|12|||
94248987|NCT05559476|322704972|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
94248988|NCT05559476|322704973|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
94248989|NCT05559476|322704972|FG000|Overall Study|Other|0|||
94248990|NCT05559476|322704973|FG001|Overall Study|Other|2|||
94248991|NCT03647488|322706505|FG000|Overall Study|Progressive disease|10|||
94248992|NCT03647488|322706506|FG001|Overall Study|Progressive disease|0|||
94248993|NCT03647488|322706507|FG002|Overall Study|Progressive disease|0|||
94248994|NCT03647488|322706505|FG000|Overall Study|Adverse Event|5|||
94603620|NCT02964507|324012236|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
94603621|NCT02964507|324012237|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
94603622|NCT02964507|324012230|FG000|Overall Study|Study terminated by Sponsor|9|||
94603623|NCT02964507|324012231|FG001|Overall Study|Study terminated by Sponsor|1|||
94603624|NCT02964507|324012232|FG002|Overall Study|Study terminated by Sponsor|9|||
94248995|NCT03647488|322706506|FG001|Overall Study|Adverse Event|0|||
94248996|NCT03647488|322706507|FG002|Overall Study|Adverse Event|0|||
94248997|NCT03647488|322706505|FG000|Overall Study|Clinical progression|2|||
94603625|NCT02964507|324012233|FG003|Overall Study|Study terminated by Sponsor|3|||
94603626|NCT02964507|324012234|FG004|Overall Study|Study terminated by Sponsor|3|||
94603627|NCT02964507|324012235|FG005|Overall Study|Study terminated by Sponsor|2|||
94603628|NCT02964507|324012236|FG006|Overall Study|Study terminated by Sponsor|0|||
94603629|NCT02964507|324012237|FG007|Overall Study|Study terminated by Sponsor|0|||
94356243|NCT00965458|323087100|FG000|Overall Study|Adverse Event|1|||
94356244|NCT00965458|323087101|FG001|Overall Study|Adverse Event|0|||
94356245|NCT00965458|323087100|FG000|Overall Study|Lost to Follow-up|1|||
94356246|NCT00965458|323087101|FG001|Overall Study|Lost to Follow-up|3|||
94356247|NCT00965458|323087100|FG000|Overall Study|Withdrawal by Subject|0|||
94356248|NCT00965458|323087101|FG001|Overall Study|Withdrawal by Subject|1|||
94356249|NCT03778021|323087105|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
94356250|NCT03778021|323087106|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
94356251|NCT01545375|323087109|FG000|Overall Study|Adverse Event|2|||
94356252|NCT01545375|323087110|FG001|Overall Study|Adverse Event|1|||
94356253|NCT01545375|323087109|FG000|Overall Study|Lost to Follow-up|34|||
94356254|NCT01545375|323087110|FG001|Overall Study|Lost to Follow-up|31|||
94356255|NCT01545375|323087109|FG000|Overall Study|Protocol Violation|3|||
94356256|NCT01545375|323087110|FG001|Overall Study|Protocol Violation|3|||
94356257|NCT01545375|323087109|FG000|Overall Study|Withdrawal by Subject|58|||
94356258|NCT01545375|323087110|FG001|Overall Study|Withdrawal by Subject|55|||
94356259|NCT00679042|323087111|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
94356260|NCT00679042|323087111|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
94356261|NCT00679042|323087111|FG000|5-Year Follow Up|Death|1|||
94356262|NCT00679042|323087111|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
94356263|NCT00679042|323087111|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
94603630|NCT02964507|324012230|FG000|Overall Study|Other|3|||
94603631|NCT02964507|324012231|FG001|Overall Study|Other|0|||
94603632|NCT02964507|324012232|FG002|Overall Study|Other|0|||
94603633|NCT02964507|324012233|FG003|Overall Study|Other|0|||
94603634|NCT02964507|324012234|FG004|Overall Study|Other|1|||
94603635|NCT02964507|324012235|FG005|Overall Study|Other|0|||
94603636|NCT02964507|324012236|FG006|Overall Study|Other|0|||
94603637|NCT02964507|324012237|FG007|Overall Study|Other|0|||
94603638|NCT02964507|324012230|FG000|Overall Study|Death|11|||
94603639|NCT02964507|324012231|FG001|Overall Study|Death|9|||
94603640|NCT02964507|324012232|FG002|Overall Study|Death|12|||
94603641|NCT02964507|324012233|FG003|Overall Study|Death|2|||
94603642|NCT02964507|324012234|FG004|Overall Study|Death|10|||
94603643|NCT02964507|324012235|FG005|Overall Study|Death|5|||
94603644|NCT02964507|324012236|FG006|Overall Study|Death|0|||
94603645|NCT02964507|324012237|FG007|Overall Study|Death|0|||
94603646|NCT02964507|324012230|FG000|Overall Study|Withdrawal by Subject|1|||
94603647|NCT02964507|324012231|FG001|Overall Study|Withdrawal by Subject|0|||
94603648|NCT02964507|324012232|FG002|Overall Study|Withdrawal by Subject|1|||
94603649|NCT02964507|324012233|FG003|Overall Study|Withdrawal by Subject|1|||
94603650|NCT02964507|324012234|FG004|Overall Study|Withdrawal by Subject|0|||
94603651|NCT02964507|324012235|FG005|Overall Study|Withdrawal by Subject|1|||
94603652|NCT02964507|324012236|FG006|Overall Study|Withdrawal by Subject|0|||
94603653|NCT02964507|324012237|FG007|Overall Study|Withdrawal by Subject|0|||
94603654|NCT02964507|324012230|FG000|Overall Study|Physician Decision|2|||
94603655|NCT02964507|324012231|FG001|Overall Study|Physician Decision|0|||
94603656|NCT02964507|324012232|FG002|Overall Study|Physician Decision|3|||
94603657|NCT02964507|324012233|FG003|Overall Study|Physician Decision|0|||
94603658|NCT02964507|324012234|FG004|Overall Study|Physician Decision|1|||
94603659|NCT02964507|324012235|FG005|Overall Study|Physician Decision|0|||
94603660|NCT02964507|324012236|FG006|Overall Study|Physician Decision|0|||
94603661|NCT02964507|324012237|FG007|Overall Study|Physician Decision|0|||
94603662|NCT04341662|324012238|FG000|Overall Study|Did not have source-verified blood loss data|423|||
94603663|NCT04341662|324012239|FG001|Overall Study|Did not have source-verified blood loss data|514|||
94603664|NCT03180684|324012240|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
94356264|NCT02687815|323087112|FG000|Overall Study|Lost to Follow-up|2|||
94356265|NCT02687815|323087113|FG001|Overall Study|Lost to Follow-up|4|||
94603665|NCT03180684|324012241|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
94603666|NCT03180684|324012240|FG000|Overall Study|Physician Decision|1|||
94603667|NCT03180684|324012241|FG001|Overall Study|Physician Decision|0|||
94603668|NCT03180684|324012240|FG000|Overall Study|Lost to Follow-up|1|||
94603669|NCT03180684|324012241|FG001|Overall Study|Lost to Follow-up|0|||
94603670|NCT03180684|324012240|FG000|Overall Study|Progressive Disease|1|||
94603671|NCT03180684|324012241|FG001|Overall Study|Progressive Disease|0|||
94356266|NCT02687815|323087112|FG000|Overall Study|Withdrawal by Subject|2|||
94356267|NCT02687815|323087113|FG001|Overall Study|Withdrawal by Subject|4|||
94356268|NCT02777554|323087114|FG000|Overall Study|Adverse Event|4|||
94356269|NCT02777554|323087115|FG001|Overall Study|Adverse Event|4|||
94356270|NCT02777554|323087116|FG002|Overall Study|Adverse Event|0|||
94603672|NCT03101267|324012242|FG000|Primary Study Period|Withdrawal by Subject|1|||
94603673|NCT03101267|324012243|FG001|Primary Study Period|Withdrawal by Subject|2|||
94603674|NCT03101267|324012244|FG002|Primary Study Period|Withdrawal by Subject|3|||
94603675|NCT03101267|324012242|FG000|Primary Study Period|Miscellaneous|2|||
94603676|NCT03101267|324012243|FG001|Primary Study Period|Miscellaneous|0|||
94603677|NCT03101267|324012244|FG002|Primary Study Period|Miscellaneous|0|||
94603678|NCT01233687|324012246|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
94603679|NCT01233687|324012246|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
94603680|NCT01233687|324012246|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
94603681|NCT03324581|324012249|FG000|Overall Study|Adverse Event|18|||
94603682|NCT03324581|324012250|FG001|Overall Study|Adverse Event|11|||
94603683|NCT03324581|324012251|FG002|Overall Study|Adverse Event|7|||
94603684|NCT03324581|324012249|FG000|Overall Study|Lack of Efficacy|0|||
94603685|NCT03324581|324012250|FG001|Overall Study|Lack of Efficacy|1|||
94603686|NCT03324581|324012251|FG002|Overall Study|Lack of Efficacy|0|||
94603687|NCT03324581|324012249|FG000|Overall Study|Lost to Follow-up|5|||
94603688|NCT03324581|324012250|FG001|Overall Study|Lost to Follow-up|3|||
94603689|NCT03324581|324012251|FG002|Overall Study|Lost to Follow-up|6|||
94603690|NCT03324581|324012249|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
94603691|NCT03324581|324012250|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
94603692|NCT03324581|324012251|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
94603693|NCT03324581|324012249|FG000|Overall Study|Physician Decision|0|||
94603694|NCT03324581|324012250|FG001|Overall Study|Physician Decision|1|||
94603695|NCT03324581|324012251|FG002|Overall Study|Physician Decision|2|||
94603696|NCT03324581|324012249|FG000|Overall Study|Protocol Deviation|8|||
94603697|NCT03324581|324012250|FG001|Overall Study|Protocol Deviation|9|||
94603698|NCT03324581|324012251|FG002|Overall Study|Protocol Deviation|4|||
94603699|NCT03324581|324012249|FG000|Overall Study|Withdrawal by Subject|6|||
94603700|NCT03324581|324012250|FG001|Overall Study|Withdrawal by Subject|8|||
94603701|NCT03324581|324012251|FG002|Overall Study|Withdrawal by Subject|6|||
94603702|NCT03324581|324012249|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
94603703|NCT03324581|324012250|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
94603704|NCT03324581|324012251|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
94603705|NCT00821327|324012252|FG000|Overall Study|Adverse Event|13|||
94603706|NCT00821327|324012252|FG000|Overall Study|Patient Request|1|||
94603707|NCT00821327|324012252|FG000|Overall Study|Investigator Request|2|||
94603708|NCT00821327|324012252|FG000|Overall Study|Sponsor Request|1|||
94603709|NCT00821327|324012252|FG000|Overall Study|Disease Progression|13|||
94603710|NCT00821327|324012252|FG000|Overall Study|Other/Unknown|5|||
94603711|NCT03783702|324012253|FG000|Overall Study|Lost to Follow-up|6|||
94603712|NCT03783702|324012254|FG001|Overall Study|Lost to Follow-up|8|||
94603713|NCT03783702|324012253|FG000|Overall Study|Protocol Violation|1|||
94603714|NCT03783702|324012254|FG001|Overall Study|Protocol Violation|3|||
94603715|NCT00745615|324012255|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
94603716|NCT00745615|324012256|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
94603717|NCT00745615|324012257|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
94603718|NCT00745615|324012258|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
94603719|NCT00745615|324012259|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
94603720|NCT00745615|324012260|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
94603721|NCT00745615|324012255|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
94603722|NCT00745615|324012256|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
94603723|NCT00745615|324012257|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
94603724|NCT00745615|324012258|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
94603725|NCT00745615|324012259|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
94603726|NCT00745615|324012260|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
94603727|NCT00745615|324012255|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
94603728|NCT00745615|324012256|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
94603729|NCT00745615|324012257|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
94603730|NCT00745615|324012258|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
94603731|NCT00745615|324012259|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
94603732|NCT00745615|324012260|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
94603733|NCT00745615|324012255|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
94603734|NCT00745615|324012256|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
94603735|NCT00745615|324012257|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
94603736|NCT00745615|324012258|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
94603737|NCT00745615|324012259|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
94603738|NCT00745615|324012260|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
94603739|NCT00745615|324012255|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
94603740|NCT00745615|324012256|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
94603741|NCT00745615|324012257|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
94603742|NCT00745615|324012258|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
94603743|NCT00745615|324012259|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
94603744|NCT00745615|324012260|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
94603745|NCT00745615|324012255|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
94603746|NCT00745615|324012256|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
94603747|NCT00745615|324012257|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
94603748|NCT00745615|324012258|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
94603749|NCT00745615|324012259|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
94603750|NCT00745615|324012260|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
94603751|NCT00745615|324012255|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
94603752|NCT00745615|324012256|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
94603753|NCT00745615|324012257|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
94603754|NCT00745615|324012258|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
94603755|NCT00745615|324012259|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
94603756|NCT00745615|324012260|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
94356271|NCT02777554|323087117|FG003|Overall Study|Adverse Event|1|||
94603757|NCT00745615|324012255|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
94603758|NCT00745615|324012256|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
94603759|NCT00745615|324012257|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
94603760|NCT00745615|324012258|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
94603761|NCT00745615|324012259|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
94603762|NCT00745615|324012260|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
94603763|NCT00745615|324012255|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
94603764|NCT00745615|324012256|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
94603765|NCT00745615|324012257|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
94603766|NCT00745615|324012258|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
94603767|NCT00745615|324012259|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
94603768|NCT00745615|324012260|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
94603769|NCT00745615|324012255|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
94603770|NCT00745615|324012256|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
94603771|NCT00745615|324012257|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
94603772|NCT00745615|324012258|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
94603773|NCT00745615|324012259|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
94603774|NCT00745615|324012260|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
94603775|NCT00745615|324012255|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
94603776|NCT00745615|324012256|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
94603777|NCT00745615|324012257|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
94603778|NCT00745615|324012258|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
94603779|NCT00745615|324012259|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
94603780|NCT00745615|324012260|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
94603781|NCT00745615|324012255|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
94603782|NCT00745615|324012256|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
94603783|NCT00745615|324012257|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
94603784|NCT00745615|324012258|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
94603785|NCT00745615|324012259|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
94603786|NCT00745615|324012260|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
94603787|NCT00745615|324012255|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
94603788|NCT00745615|324012256|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
94603789|NCT00745615|324012257|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
94603790|NCT00745615|324012258|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
94603791|NCT00745615|324012259|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
94603792|NCT00745615|324012260|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
94603793|NCT00745615|324012255|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
94603794|NCT00745615|324012256|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
94603795|NCT00745615|324012257|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
94603796|NCT00745615|324012258|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
94603797|NCT00745615|324012259|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
94603798|NCT00745615|324012260|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
94603799|NCT04706416|324012261|FG000|Overall Study|Lost to Follow-up|2|||
94603800|NCT04706416|324012262|FG001|Overall Study|Lost to Follow-up|0|||
94603801|NCT00976573|324012269|FG000|Overall Study|Ineligible|0|||
94603802|NCT00976573|324012270|FG001|Overall Study|Ineligible|1|||
94603803|NCT00976573|324012269|FG000|Overall Study|Cancel prior to receiving treatment|4|||
94603804|NCT00976573|324012270|FG001|Overall Study|Cancel prior to receiving treatment|2|||
94603805|NCT00144027|324012271|FG000|Overall Study|Lost to Follow-up|1|||
94603806|NCT00144027|324012272|FG001|Overall Study|Lost to Follow-up|3|||
94603807|NCT00144027|324012271|FG000|Overall Study|Withdrawal by Subject|2|||
94603808|NCT00144027|324012272|FG001|Overall Study|Withdrawal by Subject|2|||
94603809|NCT00144027|324012271|FG000|Overall Study|did not complete baseline assessment|0|||
94603810|NCT00144027|324012272|FG001|Overall Study|did not complete baseline assessment|6|||
94603811|NCT00510952|324012277|FG000|Overall Study|Adverse Event|1|||
94603812|NCT00510952|324012278|FG001|Overall Study|Adverse Event|0|||
94603813|NCT00510952|324012277|FG000|Overall Study|Entry Criteria Not Met|3|||
94603814|NCT00510952|324012278|FG001|Overall Study|Entry Criteria Not Met|1|||
94603815|NCT00510952|324012277|FG000|Overall Study|Lost to Follow-up|5|||
94603816|NCT00510952|324012278|FG001|Overall Study|Lost to Follow-up|3|||
94603817|NCT00510952|324012277|FG000|Overall Study|Physician Decision|1|||
94603818|NCT00510952|324012278|FG001|Overall Study|Physician Decision|1|||
94603819|NCT00510952|324012277|FG000|Overall Study|Protocol Violation|7|||
94603820|NCT00510952|324012278|FG001|Overall Study|Protocol Violation|4|||
94603821|NCT00510952|324012277|FG000|Overall Study|Sponsor Decision|1|||
94603822|NCT00510952|324012278|FG001|Overall Study|Sponsor Decision|0|||
94603823|NCT00510952|324012277|FG000|Overall Study|Withdrawal by Subject|6|||
94603824|NCT00510952|324012278|FG001|Overall Study|Withdrawal by Subject|7|||
94356272|NCT02777554|323087118|FG004|Overall Study|Adverse Event|0|||
94603825|NCT00510952|324012277|FG000|Overall Study|Did Not Receive Study Drug|2|||
94603826|NCT00510952|324012278|FG001|Overall Study|Did Not Receive Study Drug|0|||
94603827|NCT01505647|324012279|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
94603828|NCT01505647|324012280|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
94603829|NCT01505647|324012279|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
94603830|NCT01505647|324012280|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
94603831|NCT01505647|324012279|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
94603832|NCT01505647|324012280|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
94603833|NCT01505647|324012279|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
94603834|NCT01505647|324012280|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
94603835|NCT01505647|324012279|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
94603836|NCT01505647|324012280|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
94603837|NCT02793128|324012288|FG000|Overall Study|Death|4|||
94603838|NCT02793128|324012288|FG000|Overall Study|Withdrawal by Subject|2|||
94603839|NCT02793128|324012288|FG000|Overall Study|Physician Decision|1|||
94603840|NCT02793128|324012288|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
94603841|NCT02793128|324012288|FG000|Overall Study|Patient elected nephroureterectomy|1|||
94603842|NCT01876810|324012292|FG000|Overall Study|Physician Decision|0|||
94603843|NCT01876810|324012293|FG001|Overall Study|Physician Decision|1|||
94603844|NCT01015131|324012296|FG000|Overall Study|Physician Decision|1|||
94603845|NCT01015131|324012296|FG000|Overall Study|Protocol Violation|1|||
94603846|NCT01015131|324012296|FG000|Overall Study|Withdrawal by Subject|2|||
94603847|NCT01015131|324012296|FG000|Overall Study|Other Protocol Specified Criteria|4|||
94603848|NCT02775903|324012297|FG000|Overall Study|Death|7|||
94603849|NCT02775903|324012298|FG001|Overall Study|Death|11|||
94603850|NCT02775903|324012299|FG002|Overall Study|Death|12|||
94603851|NCT02775903|324012300|FG003|Overall Study|Death|11|||
94603852|NCT02775903|324012297|FG000|Overall Study|Adverse Event|0|||
94603853|NCT02775903|324012298|FG001|Overall Study|Adverse Event|1|||
94603854|NCT02775903|324012299|FG002|Overall Study|Adverse Event|12|||
94603855|NCT02775903|324012300|FG003|Overall Study|Adverse Event|3|||
94603856|NCT02775903|324012297|FG000|Overall Study|Progressive disease|15|||
94603857|NCT02775903|324012298|FG001|Overall Study|Progressive disease|14|||
94603858|NCT02775903|324012299|FG002|Overall Study|Progressive disease|30|||
94603859|NCT02775903|324012300|FG003|Overall Study|Progressive disease|20|||
94603860|NCT02775903|324012297|FG000|Overall Study|Lack of Efficacy|2|||
94603861|NCT02775903|324012298|FG001|Overall Study|Lack of Efficacy|2|||
94603862|NCT02775903|324012299|FG002|Overall Study|Lack of Efficacy|2|||
94603863|NCT02775903|324012300|FG003|Overall Study|Lack of Efficacy|6|||
94603864|NCT02775903|324012297|FG000|Overall Study|Withdrawal by Subject|7|||
94603865|NCT02775903|324012298|FG001|Overall Study|Withdrawal by Subject|5|||
94603866|NCT02775903|324012299|FG002|Overall Study|Withdrawal by Subject|5|||
94603867|NCT02775903|324012300|FG003|Overall Study|Withdrawal by Subject|8|||
94603868|NCT02775903|324012297|FG000|Overall Study|Other reasons|7|||
94603869|NCT02775903|324012298|FG001|Overall Study|Other reasons|8|||
94603870|NCT02775903|324012299|FG002|Overall Study|Other reasons|2|||
94603871|NCT02775903|324012300|FG003|Overall Study|Other reasons|12|||
94603872|NCT04571515|324012301|FG000|Overall Study|Physician Decision|0|||
94603873|NCT04571515|324012302|FG001|Overall Study|Physician Decision|0|||
94603874|NCT04571515|324012303|FG002|Overall Study|Physician Decision|0|||
94603875|NCT04571515|324012304|FG003|Overall Study|Physician Decision|0|||
94603876|NCT04571515|324012305|FG004|Overall Study|Physician Decision|1|||
94603877|NCT04571515|324012301|FG000|Overall Study|Withdrawal by Subject|0|||
94603878|NCT04571515|324012302|FG001|Overall Study|Withdrawal by Subject|0|||
94603879|NCT04571515|324012303|FG002|Overall Study|Withdrawal by Subject|0|||
94603880|NCT04571515|324012304|FG003|Overall Study|Withdrawal by Subject|0|||
94603881|NCT04571515|324012305|FG004|Overall Study|Withdrawal by Subject|1|||
94603882|NCT04571515|324012301|FG000|Overall Study|insufficient pain|1|||
94603883|NCT04571515|324012302|FG001|Overall Study|insufficient pain|0|||
94603884|NCT04571515|324012303|FG002|Overall Study|insufficient pain|0|||
94603885|NCT04571515|324012304|FG003|Overall Study|insufficient pain|0|||
94603886|NCT04571515|324012305|FG004|Overall Study|insufficient pain|1|||
94603887|NCT05140382|324012306|FG000|Overall Study|Death|3|||
94603888|NCT05140382|324012307|FG001|Overall Study|Death|0|||
94603889|NCT05140382|324012308|FG002|Overall Study|Death|0|||
94603890|NCT05140382|324012306|FG000|Overall Study|Investigator decision|1|||
94603891|NCT05140382|324012307|FG001|Overall Study|Investigator decision|0|||
94603892|NCT05140382|324012308|FG002|Overall Study|Investigator decision|0|||
94603893|NCT05140382|324012306|FG000|Overall Study|Other|4|||
94603894|NCT05140382|324012307|FG001|Overall Study|Other|0|||
94603895|NCT05140382|324012308|FG002|Overall Study|Other|1|||
94603896|NCT05140382|324012306|FG000|Overall Study|Progressive disease|20|||
94603897|NCT05140382|324012307|FG001|Overall Study|Progressive disease|1|||
94603898|NCT05140382|324012308|FG002|Overall Study|Progressive disease|12|||
94603899|NCT05140382|324012306|FG000|Overall Study|Subjective disease progression|2|||
94603900|NCT05140382|324012307|FG001|Overall Study|Subjective disease progression|1|||
94603901|NCT05140382|324012308|FG002|Overall Study|Subjective disease progression|0|||
94603902|NCT05140382|324012306|FG000|Overall Study|Unknown at data cut-off|0|||
94603903|NCT05140382|324012307|FG001|Overall Study|Unknown at data cut-off|0|||
94603904|NCT05140382|324012308|FG002|Overall Study|Unknown at data cut-off|1|||
94603905|NCT05140382|324012306|FG000|Overall Study|Withdrawal by Subject|1|||
94603906|NCT05140382|324012307|FG001|Overall Study|Withdrawal by Subject|0|||
94603907|NCT05140382|324012308|FG002|Overall Study|Withdrawal by Subject|4|||
94603908|NCT05140382|324012306|FG000|Overall Study|Withdrawal of consent|0|||
94603909|NCT05140382|324012307|FG001|Overall Study|Withdrawal of consent|0|||
94603910|NCT05140382|324012308|FG002|Overall Study|Withdrawal of consent|1|||
94651370|NCT02553421|324179753|FG001|Overall Study|Improper Device Placement|0|||
94651371|NCT03238911|324179758|FG000|Overall Study|Withdrawal by Subject|1|||
94651372|NCT03238911|324179759|FG001|Overall Study|Withdrawal by Subject|2|||
94651373|NCT03238911|324179758|FG000|Overall Study|Lost to Follow-up|2|||
94651374|NCT03238911|324179759|FG001|Overall Study|Lost to Follow-up|1|||
94651375|NCT00600821|324181637|FG000|Overall Study|Death|45|||
94651376|NCT00600821|324181638|FG001|Overall Study|Death|46|||
94651377|NCT00600821|324181637|FG000|Overall Study|Lost to Follow-up|2|||
94651378|NCT00600821|324181638|FG001|Overall Study|Lost to Follow-up|2|||
94651379|NCT00600821|324181637|FG000|Overall Study|Withdrawal by Subject|1|||
94651380|NCT00600821|324181638|FG001|Overall Study|Withdrawal by Subject|1|||
94651381|NCT00600821|324181637|FG000|Overall Study|Terminated by sponsor|8|||
94651382|NCT00600821|324181638|FG001|Overall Study|Terminated by sponsor|6|||
94651383|NCT00600821|324181637|FG000|Overall Study|Objective progression or relapse|0|||
94651384|NCT00600821|324181638|FG001|Overall Study|Objective progression or relapse|1|||
94651385|NCT00600821|324181637|FG000|Overall Study|Randomized but not treated|0|||
94651386|NCT00600821|324181638|FG001|Overall Study|Randomized but not treated|1|||
94651387|NCT00600821|324181637|FG000|Overall Study|Other|2|||
94651388|NCT00600821|324181638|FG001|Overall Study|Other|3|||
94651389|NCT02200042|324181641|FG000|Overall Study|Withdrawal by Subject|0|||
94651390|NCT02200042|324181642|FG001|Overall Study|Withdrawal by Subject|1|||
94651391|NCT00634647|324181643|FG000|Overall Study|death on study|3|||
94651392|NCT00634647|324181643|FG000|Overall Study|refused further treatment|3|||
94651393|NCT00634647|324181643|FG000|Overall Study|declined to participate before treatment|1|||
94651394|NCT00306592|324181646|FG000|Overall Study|Adverse Event|8|||
94651395|NCT00306592|324181647|FG001|Overall Study|Adverse Event|15|||
94651396|NCT00306592|324181646|FG000|Overall Study|Lost to Follow-up|1|||
94651397|NCT00306592|324181647|FG001|Overall Study|Lost to Follow-up|0|||
94651398|NCT00306592|324181646|FG000|Overall Study|Noncompliance|0|||
94651399|NCT00306592|324181647|FG001|Overall Study|Noncompliance|2|||
94651400|NCT00306592|324181646|FG000|Overall Study|Persistent Antibodies|6|||
94651401|NCT00306592|324181647|FG001|Overall Study|Persistent Antibodies|3|||
94651402|NCT00306592|324181646|FG000|Overall Study|Voluntary|10|||
94651403|NCT00306592|324181647|FG001|Overall Study|Voluntary|6|||
94651404|NCT00306592|324181646|FG000|Overall Study|Other|5|||
94651405|NCT00306592|324181647|FG001|Overall Study|Other|10|||
94651406|NCT00306592|324181646|FG000|Overall Study|Other|1|||
94651407|NCT00306592|324181647|FG001|Overall Study|Other|2|||
94651408|NCT00306592|324181646|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
94651409|NCT00306592|324181647|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
94651410|NCT02331446|324181648|FG000|Overall Study|Lost to Follow-up|2|||
94651411|NCT02331446|324181649|FG001|Overall Study|Lost to Follow-up|1|||
94651412|NCT02331446|324181650|FG002|Overall Study|Lost to Follow-up|0|||
94651413|NCT02331446|324181651|FG003|Overall Study|Lost to Follow-up|1|||
94651414|NCT02331446|324181648|FG000|Overall Study|Personal Problem|2|||
94651415|NCT02331446|324181649|FG001|Overall Study|Personal Problem|0|||
94651416|NCT02331446|324181650|FG002|Overall Study|Personal Problem|0|||
94651417|NCT02331446|324181651|FG003|Overall Study|Personal Problem|0|||
94248998|NCT03647488|322706506|FG001|Overall Study|Clinical progression|0|||
94248999|NCT03647488|322706507|FG002|Overall Study|Clinical progression|0|||
94249000|NCT03647488|322706505|FG000|Overall Study|Participant refused to take investigational product|1|||
94249001|NCT03647488|322706506|FG001|Overall Study|Participant refused to take investigational product|0|||
94651418|NCT02331446|324181648|FG000|Overall Study|Disease|0|||
94651419|NCT02331446|324181649|FG001|Overall Study|Disease|2|||
94651420|NCT02331446|324181650|FG002|Overall Study|Disease|2|||
94651421|NCT02331446|324181651|FG003|Overall Study|Disease|1|||
94651422|NCT02331446|324181648|FG000|Overall Study|Physician Decision|0|||
94651423|NCT02331446|324181649|FG001|Overall Study|Physician Decision|1|||
94651424|NCT02331446|324181650|FG002|Overall Study|Physician Decision|0|||
94651425|NCT02331446|324181651|FG003|Overall Study|Physician Decision|1|||
94651426|NCT02331446|324181648|FG000|Overall Study|Lost before baseline analysis|0|||
94603911|NCT02233946|324013873|FG000|Baseline|Withdrawal by Subject|2|||
94603912|NCT02233946|324013874|FG001|Baseline|Withdrawal by Subject|0|||
94603913|NCT02233946|324013873|FG000|3-months Follow-up|Lost to Follow-up|53|||
94603914|NCT02233946|324013874|FG001|3-months Follow-up|Lost to Follow-up|29|||
94603915|NCT02233946|324013873|FG000|6-months Follow-up|Lost to Follow-up|21|||
94603916|NCT02233946|324013874|FG001|6-months Follow-up|Lost to Follow-up|2|||
94603917|NCT02233946|324013873|FG000|9-month Follow-up|Lost to Follow-up|20|||
94603918|NCT02233946|324013874|FG001|9-month Follow-up|Lost to Follow-up|11|||
94603919|NCT02233946|324013873|FG000|12-month Follow-up|Lost to Follow-up|28|||
94603920|NCT02233946|324013874|FG001|12-month Follow-up|Lost to Follow-up|11|||
94603921|NCT01314911|324013878|FG000|Overall Study|Lost to Follow-up|3|||
94603922|NCT01314911|324013879|FG001|Overall Study|Lost to Follow-up|2|||
94603923|NCT01314911|324013878|FG000|Overall Study|Withdrawal by Subject|1|||
94603924|NCT01314911|324013879|FG001|Overall Study|Withdrawal by Subject|3|||
94603925|NCT01314911|324013878|FG000|Overall Study|Received Non-randomized Study Drug|0|||
94603926|NCT01314911|324013879|FG001|Overall Study|Received Non-randomized Study Drug|1|||
94603927|NCT01314911|324013878|FG000|Overall Study|Never Started Treatment|1|||
94603928|NCT01314911|324013879|FG001|Overall Study|Never Started Treatment|0|||
94603929|NCT03384693|324013884|FG000|Overall Study|Adverse Event|3|||
94603930|NCT03206073|324013885|FG000|Overall Study|Participant Noncompliance|0|||
94603931|NCT03206073|324013886|FG001|Overall Study|Participant Noncompliance|1|||
94603932|NCT03206073|324013887|FG002|Overall Study|Participant Noncompliance|0|||
94603933|NCT03206073|324013888|FG003|Overall Study|Participant Noncompliance|0|||
94603934|NCT03206073|324013885|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
94603935|NCT03206073|324013886|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
94603936|NCT03206073|324013887|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
94603937|NCT03206073|324013888|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
94603938|NCT03206073|324013885|FG000|Overall Study|Death|0|||
94603939|NCT03206073|324013886|FG001|Overall Study|Death|0|||
94603940|NCT03206073|324013887|FG002|Overall Study|Death|1|||
94603941|NCT03206073|324013888|FG003|Overall Study|Death|0|||
94603942|NCT03206073|324013885|FG000|Overall Study|Taken off active treatment|0|||
94603943|NCT03206073|324013886|FG001|Overall Study|Taken off active treatment|0|||
94603944|NCT03206073|324013887|FG002|Overall Study|Taken off active treatment|3|||
94603945|NCT03206073|324013888|FG003|Overall Study|Taken off active treatment|0|||
94603946|NCT03387150|324013889|FG000|Overall Study|Withdrawal by Subject|3|||
94603947|NCT03387150|324013890|FG001|Overall Study|Withdrawal by Subject|0|||
94603948|NCT03387150|324013891|FG002|Overall Study|Withdrawal by Subject|3|||
94603949|NCT03387150|324013892|FG003|Overall Study|Withdrawal by Subject|4|||
94603950|NCT03387150|324013893|FG004|Overall Study|Withdrawal by Subject|1|||
94603951|NCT03387150|324013894|FG005|Overall Study|Withdrawal by Subject|2|||
94603952|NCT03387150|324013895|FG006|Overall Study|Withdrawal by Subject|0|||
94603953|NCT03387150|324013889|FG000|Overall Study|Lost to Follow-up|3|||
94603954|NCT03387150|324013890|FG001|Overall Study|Lost to Follow-up|2|||
94603955|NCT03387150|324013891|FG002|Overall Study|Lost to Follow-up|2|||
94603956|NCT03387150|324013892|FG003|Overall Study|Lost to Follow-up|3|||
94603957|NCT03387150|324013893|FG004|Overall Study|Lost to Follow-up|3|||
94603958|NCT03387150|324013894|FG005|Overall Study|Lost to Follow-up|3|||
94603959|NCT03387150|324013895|FG006|Overall Study|Lost to Follow-up|0|||
94603960|NCT03387150|324013889|FG000|Overall Study|Participant unable to adhere to visit|0|||
94603961|NCT03387150|324013890|FG001|Overall Study|Participant unable to adhere to visit|1|||
94603962|NCT03387150|324013891|FG002|Overall Study|Participant unable to adhere to visit|0|||
94603963|NCT03387150|324013892|FG003|Overall Study|Participant unable to adhere to visit|0|||
94603964|NCT03387150|324013893|FG004|Overall Study|Participant unable to adhere to visit|2|||
94603965|NCT03387150|324013894|FG005|Overall Study|Participant unable to adhere to visit|2|||
94603966|NCT03387150|324013895|FG006|Overall Study|Participant unable to adhere to visit|0|||
94603967|NCT04163718|324013901|FG000|Overall Study|Study terminated|12|||
94603968|NCT00542451|324013902|FG000|Overall Study|Adverse Event|31|||
94603969|NCT00542451|324013902|FG000|Overall Study|Withdrawal by Subject|30|||
94603970|NCT00542451|324013902|FG000|Overall Study|Physician Decision|4|||
94603971|NCT00542451|324013902|FG000|Overall Study|Recurrent disease|1|||
94356273|NCT02777554|323087119|FG005|Overall Study|Adverse Event|0|||
94603972|NCT00542451|324013902|FG000|Overall Study|unknown reason|1|||
94603973|NCT00542451|324013902|FG000|Overall Study|Death|2|||
94603974|NCT00542451|324013902|FG000|Overall Study|Lost to Follow-up|10|||
94603975|NCT03739840|324013903|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
94603976|NCT03739840|324013904|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
94603977|NCT03739840|324013905|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
94603978|NCT03739840|324013906|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
94603979|NCT03739840|324013903|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
94603980|NCT03739840|324013904|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
94603981|NCT03739840|324013905|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
94603982|NCT03739840|324013906|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
94603983|NCT03739840|324013903|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
94603984|NCT03739840|324013904|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
94603985|NCT03739840|324013905|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
94603986|NCT03739840|324013906|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
94603987|NCT03739840|324013903|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
94603988|NCT03739840|324013904|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
94603989|NCT03739840|324013905|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
94603990|NCT03739840|324013906|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
94603991|NCT03739840|324013903|FG000|Treatment Period: Wk0-16|Program Termination|3|||
94603992|NCT03739840|324013904|FG001|Treatment Period: Wk0-16|Program Termination|0|||
94603993|NCT03739840|324013905|FG002|Treatment Period: Wk0-16|Program Termination|1|||
94603994|NCT03739840|324013906|FG003|Treatment Period: Wk0-16|Program Termination|1|||
94603995|NCT03739840|324013903|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
94603996|NCT03739840|324013904|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
94603997|NCT03739840|324013905|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
94603998|NCT03739840|324013906|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
94603999|NCT03739840|324013903|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
94604000|NCT03739840|324013904|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
94604001|NCT03739840|324013905|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
94604002|NCT03739840|324013906|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
94604003|NCT03739840|324013903|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
94604004|NCT03739840|324013904|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
94604005|NCT03739840|324013905|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
94604006|NCT03739840|324013906|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
94604007|NCT03739840|324013903|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
94604008|NCT03739840|324013904|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
94604009|NCT03739840|324013905|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
94604010|NCT03739840|324013906|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
94604011|NCT03739840|324013903|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
94604012|NCT03739840|324013904|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
94604013|NCT03739840|324013905|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
94604014|NCT03739840|324013906|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
94604015|NCT03739840|324013903|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
94604016|NCT03739840|324013904|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
94604017|NCT03739840|324013905|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
94604018|NCT03739840|324013906|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
94604019|NCT03739840|324013903|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
94604020|NCT03739840|324013904|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
94604021|NCT03739840|324013905|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
94604022|NCT03739840|324013906|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
94604023|NCT03739840|324013903|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
94661386|NCT03579459|324215715|FG003|Overall Study|Withdrawal by Subject|8|||
94661387|NCT03579459|324215712|FG000|Overall Study|Medication error without associated adverse event|2|||
94604024|NCT03739840|324013904|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
94604025|NCT03739840|324013905|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
94604026|NCT03739840|324013906|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
94604027|NCT03739840|324013903|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
94604028|NCT03739840|324013904|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
94604029|NCT03739840|324013905|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
94604030|NCT03739840|324013906|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
94604031|NCT03739840|324013903|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
94604032|NCT03739840|324013904|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
94604033|NCT03739840|324013905|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
94604034|NCT03739840|324013906|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
94604035|NCT03739840|324013903|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
94604036|NCT03739840|324013904|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
94604037|NCT03739840|324013905|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
94604038|NCT03739840|324013906|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
94604039|NCT03739840|324013903|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
94604040|NCT03739840|324013904|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
94604041|NCT03739840|324013905|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
94604042|NCT03739840|324013906|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
94604043|NCT03739840|324013903|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
94604044|NCT03739840|324013904|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
94604045|NCT03739840|324013905|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
94604046|NCT03739840|324013906|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
94604047|NCT03739840|324013903|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
94604048|NCT03739840|324013904|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
94604049|NCT03739840|324013905|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
94604050|NCT03739840|324013906|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
94604051|NCT03739840|324013903|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
94604052|NCT03739840|324013904|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
94604053|NCT03739840|324013905|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
94604054|NCT03739840|324013906|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
94604055|NCT03739840|324013903|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
94604056|NCT03739840|324013904|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
94604057|NCT03739840|324013905|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
94604058|NCT03739840|324013906|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
94604059|NCT03739840|324013903|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
94604060|NCT03739840|324013904|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
94604061|NCT03739840|324013905|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
94604062|NCT03739840|324013906|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
94604063|NCT03739840|324013903|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
94604064|NCT03739840|324013904|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
94604065|NCT03739840|324013905|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
94604066|NCT03739840|324013906|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
94604067|NCT03739840|324013903|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
94604068|NCT03739840|324013904|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
94604069|NCT03739840|324013905|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
94604070|NCT03739840|324013906|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
94604071|NCT03739840|324013903|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
94604072|NCT03739840|324013904|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
94604073|NCT03739840|324013905|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
94604074|NCT03739840|324013906|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
94604075|NCT05153473|324013907|FG000|Overall Study|Death|46|||
94604076|NCT05153473|324013907|FG000|Overall Study|Lost to Follow-up|3|||
94604077|NCT02788474|324013908|FG000|Double Blind Treatment Period|Not treated|1|||
94604078|NCT02788474|324013909|FG001|Double Blind Treatment Period|Not treated|0|||
94661388|NCT03579459|324215713|FG001|Overall Study|Medication error without associated adverse event|1|||
94604079|NCT02788474|324013908|FG000|Double Blind Treatment Period|Patient's refusal|3|||
94661389|NCT03579459|324215714|FG002|Overall Study|Medication error without associated adverse event|1|||
94661390|NCT03579459|324215715|FG003|Overall Study|Medication error without associated adverse event|0|||
94356274|NCT02777554|323087114|FG000|Overall Study|Withdrawal by Subject|3|||
94356275|NCT02777554|323087115|FG001|Overall Study|Withdrawal by Subject|1|||
94356276|NCT02777554|323087116|FG002|Overall Study|Withdrawal by Subject|1|||
94356277|NCT02777554|323087117|FG003|Overall Study|Withdrawal by Subject|0|||
94356278|NCT02777554|323087118|FG004|Overall Study|Withdrawal by Subject|0|||
94356279|NCT02777554|323087119|FG005|Overall Study|Withdrawal by Subject|0|||
94356280|NCT02777554|323087114|FG000|Overall Study|Discharged early due to hurricane|22|||
94356281|NCT02777554|323087115|FG001|Overall Study|Discharged early due to hurricane|20|||
94356282|NCT02777554|323087116|FG002|Overall Study|Discharged early due to hurricane|0|||
94356283|NCT02777554|323087117|FG003|Overall Study|Discharged early due to hurricane|0|||
94356284|NCT02777554|323087118|FG004|Overall Study|Discharged early due to hurricane|0|||
94356285|NCT02777554|323087119|FG005|Overall Study|Discharged early due to hurricane|0|||
94356286|NCT02777554|323087114|FG000|Overall Study|Other - Miscellaneous|1|||
94356287|NCT02777554|323087115|FG001|Overall Study|Other - Miscellaneous|0|||
94356288|NCT02777554|323087116|FG002|Overall Study|Other - Miscellaneous|0|||
94356289|NCT02777554|323087117|FG003|Overall Study|Other - Miscellaneous|0|||
94356290|NCT02777554|323087118|FG004|Overall Study|Other - Miscellaneous|0|||
94356291|NCT02777554|323087119|FG005|Overall Study|Other - Miscellaneous|0|||
94356292|NCT04177862|323087122|FG000|Overall Study|Protocol Violation|2|||
94356293|NCT04177862|323087123|FG001|Overall Study|Protocol Violation|7|||
94356294|NCT05111548|323087124|FG000|Overall Study|Withdrawal by Subject|2|||
94356295|NCT05111548|323087125|FG001|Overall Study|Withdrawal by Subject|1|||
94356296|NCT05111548|323087124|FG000|Overall Study|Adverse Event|1|||
94356297|NCT05111548|323087125|FG001|Overall Study|Adverse Event|0|||
94356298|NCT00379639|323087126|FG000|Overall Study|Disease Progression|3|||
94356299|NCT00379639|323087127|FG001|Overall Study|Disease Progression|3|||
94356300|NCT00379639|323087128|FG002|Overall Study|Disease Progression|3|||
94356301|NCT00379639|323087129|FG003|Overall Study|Disease Progression|4|||
94356302|NCT00379639|323087130|FG004|Overall Study|Disease Progression|4|||
94356303|NCT00379639|323087126|FG000|Overall Study|Physician Decision|0|||
94356304|NCT00379639|323087127|FG001|Overall Study|Physician Decision|2|||
94356305|NCT00379639|323087128|FG002|Overall Study|Physician Decision|1|||
94356306|NCT00379639|323087129|FG003|Overall Study|Physician Decision|1|||
94356307|NCT00379639|323087130|FG004|Overall Study|Physician Decision|0|||
94356308|NCT00379639|323087126|FG000|Overall Study|Symptomatic Deterioration|0|||
94356309|NCT00379639|323087127|FG001|Overall Study|Symptomatic Deterioration|0|||
94356310|NCT00379639|323087128|FG002|Overall Study|Symptomatic Deterioration|1|||
94356311|NCT00379639|323087129|FG003|Overall Study|Symptomatic Deterioration|0|||
94356312|NCT00379639|323087130|FG004|Overall Study|Symptomatic Deterioration|1|||
94356313|NCT00379639|323087126|FG000|Overall Study|Adverse Event|0|||
94356314|NCT00379639|323087127|FG001|Overall Study|Adverse Event|0|||
94356315|NCT00379639|323087128|FG002|Overall Study|Adverse Event|1|||
94356316|NCT00379639|323087129|FG003|Overall Study|Adverse Event|0|||
94356317|NCT00379639|323087130|FG004|Overall Study|Adverse Event|1|||
94356318|NCT00379639|323087126|FG000|Overall Study|Lost to Follow-up|0|||
94356319|NCT00379639|323087127|FG001|Overall Study|Lost to Follow-up|0|||
94356320|NCT00379639|323087128|FG002|Overall Study|Lost to Follow-up|0|||
94356321|NCT00379639|323087129|FG003|Overall Study|Lost to Follow-up|1|||
94356322|NCT00379639|323087130|FG004|Overall Study|Lost to Follow-up|0|||
94356323|NCT00379639|323087126|FG000|Overall Study|Other|0|||
94356324|NCT00379639|323087127|FG001|Overall Study|Other|0|||
94356325|NCT00379639|323087128|FG002|Overall Study|Other|3|||
94356326|NCT00379639|323087129|FG003|Overall Study|Other|0|||
94356327|NCT00379639|323087130|FG004|Overall Study|Other|0|||
94356328|NCT06045026|323087133|FG000|Overall Study|Lost to Follow-up|60|||
94356329|NCT06045026|323087133|FG000|Overall Study|Adverse Event|12|||
94356330|NCT06045026|323087133|FG000|Overall Study|Withdrawal by Subject|3|||
94356331|NCT06045026|323087133|FG000|Overall Study|Enrollment closed|1|||
94356332|NCT04576702|323087134|FG000|Overall Study|Death|1|||
94356333|NCT04576702|323087135|FG001|Overall Study|Death|0|||
94356334|NCT04576702|323087136|FG002|Overall Study|Death|0|||
94356335|NCT04576702|323087137|FG003|Overall Study|Death|0|||
94356336|NCT04576702|323087134|FG000|Overall Study|Withdrawal by Subject|0|||
94356337|NCT04576702|323087135|FG001|Overall Study|Withdrawal by Subject|2|||
94356338|NCT04576702|323087136|FG002|Overall Study|Withdrawal by Subject|1|||
94356339|NCT04576702|323087137|FG003|Overall Study|Withdrawal by Subject|0|||
94356340|NCT04576702|323087134|FG000|Overall Study|Lost to Follow-up|3|||
94356341|NCT04576702|323087135|FG001|Overall Study|Lost to Follow-up|3|||
94356342|NCT04576702|323087136|FG002|Overall Study|Lost to Follow-up|3|||
94356343|NCT04576702|323087137|FG003|Overall Study|Lost to Follow-up|4|||
94356344|NCT03737812|323087138|FG000|Overall Study|Withdrawal by Subject|1|||
94356345|NCT03737812|323087139|FG001|Overall Study|Withdrawal by Subject|2|||
94356346|NCT03737812|323087140|FG002|Overall Study|Withdrawal by Subject|1|||
94356347|NCT03737812|323087138|FG000|Overall Study|Sponsor Discontinued the Study|4|||
94356348|NCT03737812|323087139|FG001|Overall Study|Sponsor Discontinued the Study|3|||
94356349|NCT03737812|323087140|FG002|Overall Study|Sponsor Discontinued the Study|2|||
94356350|NCT03737812|323087138|FG000|Overall Study|Adverse Event|0|||
94356351|NCT03737812|323087139|FG001|Overall Study|Adverse Event|1|||
94604080|NCT02788474|324013909|FG001|Double Blind Treatment Period|Patient's refusal|0|||
94604081|NCT02788474|324013908|FG000|Double Blind Treatment Period|Adverse Event|6|||
94604082|NCT02788474|324013909|FG001|Double Blind Treatment Period|Adverse Event|4|||
94604083|NCT02788474|324013908|FG000|Open Label Treatment Period|Adverse Event|29|||
94604084|NCT02788474|324013909|FG001|Open Label Treatment Period|Adverse Event|9|||
94604085|NCT02788474|324013908|FG000|Open Label Treatment Period|Other than reason specified|1|||
94604086|NCT02788474|324013909|FG001|Open Label Treatment Period|Other than reason specified|0|||
94604087|NCT02788474|324013908|FG000|Open Label Treatment Period|Patient's refusal|1|||
94249002|NCT03647488|322706507|FG002|Overall Study|Participant refused to take investigational product|0|||
94249003|NCT01238900|322706508|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
94604088|NCT02788474|324013909|FG001|Open Label Treatment Period|Patient's refusal|3|||
94604089|NCT02788474|324013908|FG000|Open Label Treatment Period|Non-compliance|1|||
94604090|NCT02788474|324013909|FG001|Open Label Treatment Period|Non-compliance|0|||
94604091|NCT00984568|324013910|FG000|Overall Study|Withdrawal by Subject|1|||
94604092|NCT00984568|324013911|FG001|Overall Study|Withdrawal by Subject|2|||
94604093|NCT00984568|324013910|FG000|Overall Study|Lack of Efficacy|2|||
94604094|NCT00984568|324013911|FG001|Overall Study|Lack of Efficacy|0|||
94604095|NCT00984568|324013910|FG000|Overall Study|Adverse Event|2|||
94604096|NCT00984568|324013911|FG001|Overall Study|Adverse Event|0|||
94604097|NCT00984568|324013910|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
94604098|NCT00984568|324013911|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
94604099|NCT00984568|324013910|FG000|Overall Study|Lost to Follow-up|0|||
94604100|NCT00984568|324013911|FG001|Overall Study|Lost to Follow-up|1|||
94604101|NCT00984568|324013910|FG000|Overall Study|Opportunistic Infection|1|||
94604102|NCT00984568|324013911|FG001|Overall Study|Opportunistic Infection|0|||
94604103|NCT00984568|324013910|FG000|Overall Study|Unknown Reason|1|||
94604104|NCT00984568|324013911|FG001|Overall Study|Unknown Reason|3|||
94604105|NCT01262352|324013912|FG000|Period 1|Illness after randomization|1|||
94604106|NCT01262352|324013913|FG001|Period 1|Illness after randomization|0|||
94604107|NCT01262352|324013912|FG000|Washout|Adverse Event|1|||
94604108|NCT01262352|324013913|FG001|Washout|Adverse Event|1|||
94604109|NCT01262352|324013912|FG000|Washout|Extended Washout|0|||
94604110|NCT01262352|324013913|FG001|Washout|Extended Washout|1|||
94604111|NCT00064298|324013914|FG000|Overall Study|Withdrawal by Subject|2|||
94604112|NCT00064298|324013915|FG001|Overall Study|Withdrawal by Subject|1|||
94604113|NCT00064298|324013914|FG000|Overall Study|Lost to Follow-up|2|||
94604114|NCT00064298|324013915|FG001|Overall Study|Lost to Follow-up|2|||
94604115|NCT00064298|324013914|FG000|Overall Study|Death|0|||
94604116|NCT00064298|324013915|FG001|Overall Study|Death|1|||
94604117|NCT00064298|324013914|FG000|Overall Study|Disease Progression|2|||
94604118|NCT00064298|324013915|FG001|Overall Study|Disease Progression|1|||
94604119|NCT00256282|324013916|FG000|Overall Study|Disease progression, relapse during acti|12|||
94604120|NCT00256282|324013916|FG000|Overall Study|Adverse Event|3|||
94604121|NCT00256282|324013916|FG000|Overall Study|Physician Decision|1|||
94604122|NCT02431247|324013917|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
94604123|NCT02431247|324013918|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
94604124|NCT02431247|324013919|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
94249004|NCT01238900|322706508|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
94249005|NCT03573583|322706509|FG000|Overall Study|Lost to Follow-up|1|||
94249006|NCT03573583|322706510|FG001|Overall Study|Lost to Follow-up|0|||
94249007|NCT03573583|322706509|FG000|Overall Study|Withdrawal by Subject|1|||
94249008|NCT03573583|322706510|FG001|Overall Study|Withdrawal by Subject|1|||
94604125|NCT02431247|324013917|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
94604126|NCT02431247|324013918|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
94604127|NCT02431247|324013919|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
94604128|NCT02431247|324013917|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
94604129|NCT02431247|324013918|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
94604130|NCT02431247|324013919|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
94604131|NCT02431247|324013917|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
94604132|NCT02431247|324013918|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
94604133|NCT02431247|324013919|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
94604134|NCT02431247|324013917|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
94604135|NCT02431247|324013918|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
94604136|NCT02431247|324013919|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
94604137|NCT02431247|324013917|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
94604138|NCT02431247|324013918|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
94604139|NCT02431247|324013919|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
94604140|NCT02431247|324013917|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
94604141|NCT02431247|324013918|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
94604142|NCT02431247|324013919|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
94604143|NCT02431247|324013917|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
94249009|NCT01198756|322706511|FG000|Overall Study|Adverse Event|0|||
94458057|NCT02980341|323465678|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
94458058|NCT02980341|323465679|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
94458059|NCT02980341|323465680|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
94458060|NCT02980341|323465681|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
94458061|NCT02980341|323465671|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
94458062|NCT02980341|323465672|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
94458063|NCT02980341|323465673|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
94458064|NCT02980341|323465674|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
94458065|NCT02980341|323465675|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
94458066|NCT02980341|323465676|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
94458067|NCT02980341|323465677|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
94458068|NCT02980341|323465678|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
94458069|NCT02980341|323465679|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
94458070|NCT02980341|323465680|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
94458071|NCT02980341|323465681|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
94458072|NCT02980341|323465671|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
94458073|NCT02980341|323465672|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
94458074|NCT02980341|323465673|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
94458075|NCT02980341|323465674|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
94458076|NCT02980341|323465675|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
94458077|NCT02980341|323465676|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
94458078|NCT02980341|323465677|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
94458079|NCT02980341|323465678|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
94458080|NCT02980341|323465679|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
94458081|NCT02980341|323465680|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
94458082|NCT02980341|323465681|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
94458083|NCT01647516|323465682|FG000|Induction Period (IP)|Physician Decision|2|||
94458084|NCT01647516|323465683|FG001|Induction Period (IP)|Physician Decision|0|||
94458085|NCT01647516|323465684|FG002|Induction Period (IP)|Physician Decision|0|||
94249010|NCT01198756|322706512|FG001|Overall Study|Adverse Event|0|||
94249011|NCT01198756|322706513|FG002|Overall Study|Adverse Event|0|||
94249012|NCT01198756|322706514|FG003|Overall Study|Adverse Event|1|||
94249013|NCT01198756|322706511|FG000|Overall Study|Protocol Violation|0|||
94249014|NCT01198756|322706512|FG001|Overall Study|Protocol Violation|0|||
94249015|NCT01198756|322706513|FG002|Overall Study|Protocol Violation|0|||
94249016|NCT01198756|322706514|FG003|Overall Study|Protocol Violation|2|||
94249017|NCT01198756|322706511|FG000|Overall Study|Withdrawal by Subject|9|||
94249018|NCT01198756|322706512|FG001|Overall Study|Withdrawal by Subject|4|||
94249019|NCT01198756|322706513|FG002|Overall Study|Withdrawal by Subject|7|||
94249020|NCT01198756|322706514|FG003|Overall Study|Withdrawal by Subject|5|||
94249021|NCT01198756|322706511|FG000|Overall Study|Lost to Follow-up|29|||
94249022|NCT01198756|322706512|FG001|Overall Study|Lost to Follow-up|36|||
94249023|NCT01198756|322706513|FG002|Overall Study|Lost to Follow-up|23|||
94249024|NCT01198756|322706514|FG003|Overall Study|Lost to Follow-up|18|||
94249025|NCT01127893|322706515|FG000|Overall Study|Study Termination by the Sponsor|1|||
94249026|NCT03725085|322706516|FG000|Overall Study|Lost to Follow-up|2|||
94249027|NCT00423943|322706517|FG000|Overall Study|Withdrawal by Subject|3|||
94249028|NCT00423943|322706518|FG001|Overall Study|Withdrawal by Subject|1|||
94249029|NCT01802567|322706519|FG000|Overall Study|Withdrawal by Subject|2|||
94249030|NCT01802567|322706519|FG000|Overall Study|Physician Decision|1|||
94249031|NCT01802567|322706519|FG000|Overall Study|Lack of Efficacy|7|||
94249032|NCT01802567|322706519|FG000|Overall Study|Consented but did not start therapy|7|||
94249033|NCT01802567|322706519|FG000|Overall Study|Protocol Violation|1|||
94249034|NCT02663518|322706524|FG000|Part 1: Phase 1a Escalation|Death|0|||
94249035|NCT02663518|322706525|FG001|Part 1: Phase 1a Escalation|Death|0|||
94249036|NCT02663518|322706526|FG002|Part 1: Phase 1a Escalation|Death|1|||
94249037|NCT02663518|322706527|FG003|Part 1: Phase 1a Escalation|Death|0|||
94249038|NCT02663518|322706528|FG004|Part 1: Phase 1a Escalation|Death|0|||
94249039|NCT02663518|322706529|FG005|Part 1: Phase 1a Escalation|Death|0|||
94249040|NCT02663518|322706530|FG006|Part 1: Phase 1a Escalation|Death|0|||
94249041|NCT02663518|322706531|FG007|Part 1: Phase 1a Escalation|Death|0|||
94249042|NCT02663518|322706532|FG008|Part 1: Phase 1a Escalation|Death|0|||
94249043|NCT02663518|322706533|FG009|Part 1: Phase 1a Escalation|Death|0|||
94249044|NCT02663518|322706534|FG010|Part 1: Phase 1a Escalation|Death|0|||
94249045|NCT02663518|322706535|FG011|Part 1: Phase 1a Escalation|Death|0|||
94249046|NCT02663518|322706536|FG012|Part 1: Phase 1a Escalation|Death|0|||
94249047|NCT02663518|322706537|FG013|Part 1: Phase 1a Escalation|Death|0|||
94356352|NCT03737812|323087140|FG002|Overall Study|Adverse Event|0|||
94356353|NCT03737812|323087138|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
94356354|NCT03737812|323087139|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
94356355|NCT03737812|323087140|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
94356356|NCT00792467|323087142|FG000|Overall Study|progression of disease|17|||
94356357|NCT00792467|323087142|FG000|Overall Study|Adverse Event|1|||
94356358|NCT00792467|323087142|FG000|Overall Study|patient request|1|||
94356359|NCT00792467|323087142|FG000|Overall Study|Lost to Follow-up|1|||
94356360|NCT00792467|323087142|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
94356361|NCT00792467|323087142|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
94356362|NCT01287403|323087143|FG000|1st Intervention (1 Day)|Adverse Event|1|||
94356363|NCT01151085|323087144|FG000|Overall Study|Lost to Follow-up|31|||
94356364|NCT01151085|323087144|FG000|Overall Study|Protocol Violation|25|||
94356365|NCT04165824|323087145|FG000|Overall Study|Adverse Event|23|||
94356366|NCT04165824|323087145|FG000|Overall Study|Physician Decision|1|||
94356367|NCT04165824|323087145|FG000|Overall Study|Withdrawal by Subject|17|||
94356368|NCT04165824|323087145|FG000|Overall Study|Other|5|||
94356369|NCT00381680|323087146|FG000|Overall Study|Adverse Event|9|||
94356370|NCT00381680|323087147|FG001|Overall Study|Adverse Event|3|||
94356371|NCT00381680|323087146|FG000|Overall Study|Death|10|||
94356372|NCT00381680|323087147|FG001|Overall Study|Death|7|||
94356373|NCT00381680|323087146|FG000|Overall Study|Lost to Follow-up|3|||
94356374|NCT00381680|323087147|FG001|Overall Study|Lost to Follow-up|2|||
94356375|NCT00381680|323087146|FG000|Overall Study|Physician Decision|25|||
94356376|NCT00381680|323087147|FG001|Overall Study|Physician Decision|6|||
94356377|NCT00381680|323087146|FG000|Overall Study|Withdrawal by Subject|3|||
94356378|NCT00381680|323087147|FG001|Overall Study|Withdrawal by Subject|1|||
94356379|NCT00381680|323087146|FG000|Overall Study|Entry onto another COG Trial|1|||
94356380|NCT00381680|323087147|FG001|Overall Study|Entry onto another COG Trial|2|||
94356381|NCT00381680|323087146|FG000|Overall Study|Alternative Therapy|11|||
94356382|NCT00381680|323087147|FG001|Overall Study|Alternative Therapy|5|||
94356383|NCT00381680|323087146|FG000|Overall Study|Secondary Malignancy|3|||
94356384|NCT00381680|323087147|FG001|Overall Study|Secondary Malignancy|0|||
94356385|NCT00381680|323087146|FG000|Overall Study|Delay initiation|1|||
94356386|NCT00381680|323087147|FG001|Overall Study|Delay initiation|0|||
94356387|NCT00381680|323087146|FG000|Overall Study|Stem Cell Transplant|26|||
94356388|NCT00381680|323087147|FG001|Overall Study|Stem Cell Transplant|10|||
94356389|NCT00381680|323087146|FG000|Overall Study|Relapse|18|||
94356390|NCT00381680|323087147|FG001|Overall Study|Relapse|9|||
94356391|NCT00381680|323087146|FG000|Overall Study|Induction Failure|4|||
94356392|NCT00381680|323087147|FG001|Overall Study|Induction Failure|1|||
94356393|NCT00381680|323087146|FG000|Overall Study|Progression|1|||
94356394|NCT00381680|323087147|FG001|Overall Study|Progression|1|||
94356395|NCT00381680|323087146|FG000|Overall Study|Other not otherwise specified|7|||
94356396|NCT00381680|323087147|FG001|Overall Study|Other not otherwise specified|2|||
94356397|NCT00381680|323087146|FG000|Overall Study|Ineligible|3|||
94356398|NCT00381680|323087147|FG001|Overall Study|Ineligible|1|||
94356399|NCT03290131|323087148|FG000|Overall Study|Adverse Event|22|||
94356400|NCT03290131|323087149|FG001|Overall Study|Adverse Event|57|||
94356401|NCT03290131|323087150|FG002|Overall Study|Adverse Event|11|||
94356402|NCT03290131|323087148|FG000|Overall Study|Withdrawal by Subject|18|||
94356403|NCT03290131|323087149|FG001|Overall Study|Withdrawal by Subject|13|||
94356404|NCT03290131|323087150|FG002|Overall Study|Withdrawal by Subject|8|||
94356405|NCT03290131|323087148|FG000|Overall Study|MS Relapse|2|||
94356406|NCT03290131|323087149|FG001|Overall Study|MS Relapse|1|||
94356407|NCT03290131|323087150|FG002|Overall Study|MS Relapse|0|||
94356408|NCT03290131|323087148|FG000|Overall Study|Unknown reason|0|||
94356409|NCT03290131|323087149|FG001|Overall Study|Unknown reason|1|||
94356410|NCT03290131|323087150|FG002|Overall Study|Unknown reason|0|||
94356411|NCT01374516|323087163|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
94356412|NCT01374516|323087164|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
94356413|NCT01374516|323087163|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
94356414|NCT01374516|323087164|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
94356415|NCT01374516|323087163|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
94356416|NCT01374516|323087164|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
94356417|NCT01374516|323087163|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
94356418|NCT01374516|323087164|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
94356419|NCT01374516|323087163|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
94356420|NCT01374516|323087164|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
94356421|NCT01374516|323087163|FG000|Surveillance Expansion Period|Protocol Violation|386|||
94356422|NCT01374516|323087164|FG001|Surveillance Expansion Period|Protocol Violation|217|||
94356423|NCT01374516|323087163|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
94356424|NCT01374516|323087164|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
94356425|NCT01374516|323087163|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
94356426|NCT01374516|323087164|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
94661391|NCT03579459|324215712|FG000|Overall Study|Other|0|||
94604144|NCT02431247|324013918|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
94604145|NCT02431247|324013919|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
94604146|NCT02431247|324013917|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
94604147|NCT02431247|324013918|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
94249048|NCT02663518|322706524|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
94249049|NCT02663518|322706525|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
94249050|NCT02663518|322706526|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
94249051|NCT02663518|322706527|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
94249052|NCT02663518|322706528|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
94249053|NCT02663518|322706529|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
94249054|NCT02663518|322706530|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
94249055|NCT02663518|322706531|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
94249056|NCT02663518|322706532|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
94249057|NCT02663518|322706533|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
94249058|NCT02663518|322706534|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
94249059|NCT02663518|322706535|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
94249060|NCT02663518|322706536|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
94249061|NCT02663518|322706537|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
94249062|NCT02663518|322706524|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
94249063|NCT02663518|322706525|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
94249064|NCT02663518|322706526|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
94249065|NCT02663518|322706527|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
94249066|NCT02663518|322706528|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
94249067|NCT02663518|322706529|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
94249068|NCT02663518|322706530|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
94249069|NCT02663518|322706531|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
94249070|NCT02663518|322706532|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
94249071|NCT02663518|322706533|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
94249072|NCT02663518|322706534|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
94249073|NCT02663518|322706535|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
94249074|NCT02663518|322706536|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
94249075|NCT02663518|322706537|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
94249076|NCT02663518|322706524|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
94249077|NCT02663518|322706525|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
94249078|NCT02663518|322706526|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
94249079|NCT02663518|322706527|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
94249080|NCT02663518|322706528|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
94249081|NCT02663518|322706529|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
94249082|NCT02663518|322706530|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
94249083|NCT02663518|322706531|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
94249084|NCT02663518|322706532|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
94249085|NCT02663518|322706533|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
94249086|NCT02663518|322706534|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
94249087|NCT02663518|322706535|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
94249088|NCT02663518|322706536|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
94249089|NCT02663518|322706537|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
94249090|NCT02663518|322706524|FG000|Part 1: Phase 1a Escalation|Other|0|||
94249091|NCT02663518|322706525|FG001|Part 1: Phase 1a Escalation|Other|0|||
94249092|NCT02663518|322706526|FG002|Part 1: Phase 1a Escalation|Other|2|||
94249093|NCT02663518|322706527|FG003|Part 1: Phase 1a Escalation|Other|0|||
94249094|NCT02663518|322706528|FG004|Part 1: Phase 1a Escalation|Other|0|||
94249095|NCT02663518|322706529|FG005|Part 1: Phase 1a Escalation|Other|0|||
94458086|NCT01647516|323465685|FG003|Induction Period (IP)|Physician Decision|0|||
94458087|NCT01647516|323465686|FG004|Induction Period (IP)|Physician Decision|0|||
94458088|NCT01647516|323465687|FG005|Induction Period (IP)|Physician Decision|0|||
94458089|NCT01647516|323465682|FG000|Induction Period (IP)|Adverse Event|1|||
94458090|NCT01647516|323465683|FG001|Induction Period (IP)|Adverse Event|2|||
94458091|NCT01647516|323465684|FG002|Induction Period (IP)|Adverse Event|0|||
94458092|NCT01647516|323465685|FG003|Induction Period (IP)|Adverse Event|0|||
94458093|NCT01647516|323465686|FG004|Induction Period (IP)|Adverse Event|0|||
94458094|NCT01647516|323465687|FG005|Induction Period (IP)|Adverse Event|0|||
94458095|NCT01647516|323465682|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
94458096|NCT01647516|323465683|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
94458097|NCT01647516|323465684|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
94458098|NCT01647516|323465685|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
94458099|NCT01647516|323465686|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
94458100|NCT01647516|323465687|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
94458101|NCT01647516|323465682|FG000|Induction Period (IP)|Participant Choice|0|||
94458102|NCT01647516|323465683|FG001|Induction Period (IP)|Participant Choice|0|||
94458103|NCT01647516|323465684|FG002|Induction Period (IP)|Participant Choice|1|||
94458104|NCT01647516|323465685|FG003|Induction Period (IP)|Participant Choice|0|||
94458105|NCT01647516|323465686|FG004|Induction Period (IP)|Participant Choice|0|||
94458106|NCT01647516|323465687|FG005|Induction Period (IP)|Participant Choice|0|||
94458107|NCT01647516|323465682|FG000|Induction Period (IP)|Lack of Efficacy|1|||
94458108|NCT01647516|323465683|FG001|Induction Period (IP)|Lack of Efficacy|0|||
94458109|NCT01647516|323465684|FG002|Induction Period (IP)|Lack of Efficacy|0|||
94458110|NCT01647516|323465685|FG003|Induction Period (IP)|Lack of Efficacy|0|||
94458111|NCT01647516|323465686|FG004|Induction Period (IP)|Lack of Efficacy|0|||
94458112|NCT01647516|323465687|FG005|Induction Period (IP)|Lack of Efficacy|0|||
94458113|NCT01647516|323465682|FG000|Induction Period (IP)|No study drug received|1|||
94458114|NCT01647516|323465683|FG001|Induction Period (IP)|No study drug received|1|||
94458115|NCT01647516|323465684|FG002|Induction Period (IP)|No study drug received|0|||
94458116|NCT01647516|323465685|FG003|Induction Period (IP)|No study drug received|0|||
94458117|NCT01647516|323465686|FG004|Induction Period (IP)|No study drug received|0|||
94458118|NCT01647516|323465687|FG005|Induction Period (IP)|No study drug received|0|||
94458119|NCT01647516|323465682|FG000|Maintenance Period (MP)|Adverse Event|2|||
94458120|NCT01647516|323465683|FG001|Maintenance Period (MP)|Adverse Event|1|||
94458121|NCT01647516|323465684|FG002|Maintenance Period (MP)|Adverse Event|0|||
94458122|NCT01647516|323465685|FG003|Maintenance Period (MP)|Adverse Event|0|||
94458123|NCT01647516|323465686|FG004|Maintenance Period (MP)|Adverse Event|0|||
94458124|NCT01647516|323465687|FG005|Maintenance Period (MP)|Adverse Event|0|||
94458125|NCT01647516|323465682|FG000|Maintenance Period (MP)|Non-compliance|1|||
94458126|NCT01647516|323465683|FG001|Maintenance Period (MP)|Non-compliance|0|||
94458127|NCT01647516|323465684|FG002|Maintenance Period (MP)|Non-compliance|0|||
94458128|NCT01647516|323465685|FG003|Maintenance Period (MP)|Non-compliance|0|||
94458129|NCT01647516|323465686|FG004|Maintenance Period (MP)|Non-compliance|0|||
94458130|NCT01647516|323465687|FG005|Maintenance Period (MP)|Non-compliance|0|||
94458131|NCT01647516|323465682|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
94458132|NCT01647516|323465683|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
94249096|NCT02663518|322706530|FG006|Part 1: Phase 1a Escalation|Other|0|||
94458133|NCT01647516|323465684|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
94458134|NCT01647516|323465685|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
94458135|NCT01647516|323465686|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
94458136|NCT01647516|323465687|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
94458137|NCT01647516|323465682|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
94458138|NCT01647516|323465683|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
94458139|NCT01647516|323465684|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
94458140|NCT01647516|323465685|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
94458141|NCT01647516|323465686|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
94458142|NCT01647516|323465687|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
94458143|NCT01647516|323465682|FG000|Open-Label Period|Adverse Event|0|||
94458144|NCT01647516|323465683|FG001|Open-Label Period|Adverse Event|0|||
94458145|NCT01647516|323465684|FG002|Open-Label Period|Adverse Event|0|||
94458146|NCT01647516|323465685|FG003|Open-Label Period|Adverse Event|5|||
94458147|NCT01647516|323465686|FG004|Open-Label Period|Adverse Event|6|||
94458148|NCT01647516|323465687|FG005|Open-Label Period|Adverse Event|3|||
94458149|NCT01647516|323465682|FG000|Open-Label Period|Pregnancy|0|||
94458150|NCT01647516|323465683|FG001|Open-Label Period|Pregnancy|0|||
94249097|NCT02663518|322706531|FG007|Part 1: Phase 1a Escalation|Other|0|||
94249098|NCT02663518|322706532|FG008|Part 1: Phase 1a Escalation|Other|0|||
94249099|NCT02663518|322706533|FG009|Part 1: Phase 1a Escalation|Other|0|||
94249100|NCT02663518|322706534|FG010|Part 1: Phase 1a Escalation|Other|0|||
94249101|NCT02663518|322706535|FG011|Part 1: Phase 1a Escalation|Other|0|||
94249102|NCT02663518|322706536|FG012|Part 1: Phase 1a Escalation|Other|0|||
94249103|NCT02663518|322706537|FG013|Part 1: Phase 1a Escalation|Other|0|||
94249104|NCT02663518|322706524|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
94249105|NCT02663518|322706525|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
94249106|NCT02663518|322706526|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
94249107|NCT02663518|322706527|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
94249108|NCT02663518|322706528|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
94249109|NCT02663518|322706529|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
94249110|NCT02663518|322706530|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
94249111|NCT02663518|322706531|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
94249112|NCT02663518|322706532|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
94249113|NCT02663518|322706533|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
94249114|NCT02663518|322706534|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
94249115|NCT02663518|322706535|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
94249116|NCT02663518|322706536|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
94249117|NCT02663518|322706537|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
94249118|NCT02663518|322706524|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
94249119|NCT02663518|322706525|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
94249120|NCT02663518|322706526|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
94249121|NCT02663518|322706527|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
94249122|NCT02663518|322706528|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
94249123|NCT02663518|322706529|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
94249124|NCT02663518|322706530|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
94249125|NCT02663518|322706531|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
94249126|NCT02663518|322706532|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
94249127|NCT02663518|322706533|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
94249128|NCT02663518|322706534|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
94249129|NCT02663518|322706535|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
94249130|NCT02663518|322706536|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
94458151|NCT01647516|323465684|FG002|Open-Label Period|Pregnancy|0|||
94458152|NCT01647516|323465685|FG003|Open-Label Period|Pregnancy|0|||
94458153|NCT01647516|323465686|FG004|Open-Label Period|Pregnancy|0|||
94458154|NCT01647516|323465687|FG005|Open-Label Period|Pregnancy|1|||
94604148|NCT02431247|324013919|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
94604149|NCT02431247|324013917|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
94604150|NCT02431247|324013918|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
94604151|NCT02431247|324013919|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
94604152|NCT02431247|324013917|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
94604153|NCT02431247|324013918|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
94604154|NCT02431247|324013919|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
94604155|NCT02431247|324013917|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
94604156|NCT02431247|324013918|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
94604157|NCT02431247|324013919|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
94604158|NCT02431247|324013917|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
94604159|NCT02431247|324013918|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
94604160|NCT02431247|324013919|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
94604161|NCT02431247|324013917|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
94604162|NCT02431247|324013918|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
94604163|NCT02431247|324013919|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
94604164|NCT00136604|324013920|FG000|Overall Study|Lost to Follow-up|1|||
94604165|NCT00136604|324013921|FG001|Overall Study|Lost to Follow-up|0|||
94604166|NCT00136604|324013922|FG002|Overall Study|Lost to Follow-up|0|||
94604167|NCT00136604|324013923|FG003|Overall Study|Lost to Follow-up|0|||
94604168|NCT00136604|324013924|FG004|Overall Study|Lost to Follow-up|1|||
94604169|NCT00136604|324013920|FG000|Overall Study|Migrated/moved from study area|0|||
94604170|NCT00136604|324013921|FG001|Overall Study|Migrated/moved from study area|1|||
94604171|NCT00136604|324013922|FG002|Overall Study|Migrated/moved from study area|0|||
94604172|NCT00136604|324013923|FG003|Overall Study|Migrated/moved from study area|0|||
94604173|NCT00136604|324013924|FG004|Overall Study|Migrated/moved from study area|0|||
94604174|NCT02414139|324013925|FG000|Treatment Period|Adverse Event|11|||
94604175|NCT02414139|324013926|FG001|Treatment Period|Adverse Event|6|||
94604176|NCT02414139|324013927|FG002|Treatment Period|Adverse Event|8|||
94604177|NCT02414139|324013928|FG003|Treatment Period|Adverse Event|5|||
94604178|NCT02414139|324013929|FG004|Treatment Period|Adverse Event|14|||
94604179|NCT02414139|324013930|FG005|Treatment Period|Adverse Event|3|||
94604180|NCT02414139|324013931|FG006|Treatment Period|Adverse Event|6|||
94604181|NCT02414139|324013932|FG007|Treatment Period|Adverse Event|1|||
94604182|NCT02414139|324013933|FG008|Treatment Period|Adverse Event|6|||
94604183|NCT02414139|324013934|FG009|Treatment Period|Adverse Event|8|||
94604184|NCT02414139|324013925|FG000|Treatment Period|Death|0|||
94604185|NCT02414139|324013926|FG001|Treatment Period|Death|0|||
94604186|NCT02414139|324013927|FG002|Treatment Period|Death|1|||
94604187|NCT02414139|324013928|FG003|Treatment Period|Death|1|||
94604188|NCT02414139|324013929|FG004|Treatment Period|Death|0|||
94604189|NCT02414139|324013930|FG005|Treatment Period|Death|0|||
94604190|NCT02414139|324013931|FG006|Treatment Period|Death|0|||
94604191|NCT02414139|324013932|FG007|Treatment Period|Death|0|||
94604192|NCT02414139|324013933|FG008|Treatment Period|Death|0|||
94604193|NCT02414139|324013934|FG009|Treatment Period|Death|1|||
94604194|NCT02414139|324013925|FG000|Treatment Period|Physician Decision|5|||
94604195|NCT02414139|324013926|FG001|Treatment Period|Physician Decision|4|||
94604196|NCT02414139|324013927|FG002|Treatment Period|Physician Decision|6|||
94604197|NCT02414139|324013928|FG003|Treatment Period|Physician Decision|1|||
94604198|NCT02414139|324013929|FG004|Treatment Period|Physician Decision|4|||
94604199|NCT02414139|324013930|FG005|Treatment Period|Physician Decision|0|||
94604200|NCT02414139|324013931|FG006|Treatment Period|Physician Decision|2|||
94604201|NCT02414139|324013932|FG007|Treatment Period|Physician Decision|0|||
94604202|NCT02414139|324013933|FG008|Treatment Period|Physician Decision|1|||
94604203|NCT02414139|324013934|FG009|Treatment Period|Physician Decision|4|||
94604204|NCT02414139|324013925|FG000|Treatment Period|Progressive disease|48|||
94604205|NCT02414139|324013926|FG001|Treatment Period|Progressive disease|31|||
94604206|NCT02414139|324013927|FG002|Treatment Period|Progressive disease|37|||
94604207|NCT02414139|324013928|FG003|Treatment Period|Progressive disease|21|||
94604208|NCT02414139|324013929|FG004|Treatment Period|Progressive disease|43|||
94604209|NCT02414139|324013930|FG005|Treatment Period|Progressive disease|12|||
94604210|NCT02414139|324013931|FG006|Treatment Period|Progressive disease|16|||
94604211|NCT02414139|324013932|FG007|Treatment Period|Progressive disease|2|||
94604212|NCT02414139|324013933|FG008|Treatment Period|Progressive disease|20|||
94604213|NCT02414139|324013934|FG009|Treatment Period|Progressive disease|14|||
94604214|NCT02414139|324013925|FG000|Treatment Period|Protocol deviation|0|||
94604215|NCT02414139|324013926|FG001|Treatment Period|Protocol deviation|0|||
94604216|NCT02414139|324013927|FG002|Treatment Period|Protocol deviation|1|||
94604217|NCT02414139|324013928|FG003|Treatment Period|Protocol deviation|0|||
94604218|NCT02414139|324013929|FG004|Treatment Period|Protocol deviation|0|||
94604219|NCT02414139|324013930|FG005|Treatment Period|Protocol deviation|0|||
94604220|NCT02414139|324013931|FG006|Treatment Period|Protocol deviation|0|||
94604221|NCT02414139|324013932|FG007|Treatment Period|Protocol deviation|0|||
94604222|NCT02414139|324013933|FG008|Treatment Period|Protocol deviation|0|||
94604223|NCT02414139|324013934|FG009|Treatment Period|Protocol deviation|0|||
94604224|NCT02414139|324013925|FG000|Treatment Period|Subject/Guardian decision|5|||
94604225|NCT02414139|324013926|FG001|Treatment Period|Subject/Guardian decision|1|||
94604226|NCT02414139|324013927|FG002|Treatment Period|Subject/Guardian decision|1|||
94604227|NCT02414139|324013928|FG003|Treatment Period|Subject/Guardian decision|2|||
94604228|NCT02414139|324013929|FG004|Treatment Period|Subject/Guardian decision|5|||
94604229|NCT02414139|324013930|FG005|Treatment Period|Subject/Guardian decision|0|||
94604230|NCT02414139|324013931|FG006|Treatment Period|Subject/Guardian decision|2|||
94604231|NCT02414139|324013932|FG007|Treatment Period|Subject/Guardian decision|0|||
94604232|NCT02414139|324013933|FG008|Treatment Period|Subject/Guardian decision|1|||
94604233|NCT02414139|324013934|FG009|Treatment Period|Subject/Guardian decision|1|||
94604234|NCT02414139|324013925|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
94604235|NCT02414139|324013926|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
94604236|NCT02414139|324013927|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
94604237|NCT02414139|324013928|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
94604238|NCT02414139|324013929|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
94604239|NCT02414139|324013930|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
94604240|NCT02414139|324013931|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
94604241|NCT02414139|324013932|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
94604242|NCT02414139|324013933|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
94604243|NCT02414139|324013934|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
94604244|NCT02414139|324013925|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
94604245|NCT02414139|324013926|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
94604246|NCT02414139|324013927|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
94604247|NCT02414139|324013928|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
94604248|NCT02414139|324013929|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
94604249|NCT02414139|324013930|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
94604250|NCT02414139|324013931|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
94604251|NCT02414139|324013932|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
94604252|NCT02414139|324013933|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
94604253|NCT02414139|324013934|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
94604254|NCT02414139|324013925|FG000|Post-treatment Efficacy Follow-up|Death|0|||
94249131|NCT02663518|322706537|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
94249132|NCT02663518|322706524|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
94249133|NCT02663518|322706525|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
94249134|NCT02663518|322706526|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
94249135|NCT02663518|322706527|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
94249136|NCT02663518|322706528|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
94249137|NCT02663518|322706529|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
94249138|NCT02663518|322706530|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
94249139|NCT02663518|322706531|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
94249140|NCT02663518|322706532|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
94356427|NCT01374516|323087163|FG000|Surveillance Expansion Period|Serious adverse event|20|||
94356428|NCT01374516|323087164|FG001|Surveillance Expansion Period|Serious adverse event|5|||
94356429|NCT04145531|323087168|FG000|Part A|Adverse Event|2|||
94356430|NCT04145531|323087169|FG001|Part A|Adverse Event|12|||
94356431|NCT04145531|323087170|FG002|Part A|Adverse Event|6|||
94249141|NCT02663518|322706533|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
94356432|NCT04145531|323087171|FG003|Part A|Adverse Event|0|||
94356433|NCT04145531|323087168|FG000|Part A|Death|1|||
94604255|NCT02414139|324013926|FG001|Post-treatment Efficacy Follow-up|Death|1|||
94604256|NCT02414139|324013927|FG002|Post-treatment Efficacy Follow-up|Death|0|||
94604257|NCT02414139|324013928|FG003|Post-treatment Efficacy Follow-up|Death|0|||
94604258|NCT02414139|324013929|FG004|Post-treatment Efficacy Follow-up|Death|1|||
94604259|NCT02414139|324013930|FG005|Post-treatment Efficacy Follow-up|Death|0|||
94604260|NCT02414139|324013931|FG006|Post-treatment Efficacy Follow-up|Death|0|||
94604261|NCT02414139|324013932|FG007|Post-treatment Efficacy Follow-up|Death|0|||
94604262|NCT02414139|324013933|FG008|Post-treatment Efficacy Follow-up|Death|0|||
94604263|NCT02414139|324013934|FG009|Post-treatment Efficacy Follow-up|Death|1|||
94604264|NCT02414139|324013925|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
94604265|NCT02414139|324013926|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
94604266|NCT02414139|324013927|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
94604267|NCT02414139|324013928|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
94604268|NCT02414139|324013929|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
94604269|NCT02414139|324013930|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
94604270|NCT02414139|324013931|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
94604271|NCT02414139|324013932|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
94604272|NCT02414139|324013933|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
94604273|NCT02414139|324013934|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
94604274|NCT02414139|324013925|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
94604275|NCT02414139|324013926|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
94604276|NCT02414139|324013927|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
94604277|NCT02414139|324013928|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
94604278|NCT02414139|324013929|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
94604279|NCT02414139|324013930|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
94604280|NCT02414139|324013931|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
94604281|NCT02414139|324013932|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
94604282|NCT02414139|324013933|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
94604283|NCT02414139|324013934|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
94604284|NCT02414139|324013925|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
94604285|NCT02414139|324013926|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
94604286|NCT02414139|324013927|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
94661392|NCT03579459|324215713|FG001|Overall Study|Other|1|||
94249142|NCT02663518|322706534|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
94249143|NCT02663518|322706535|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
94249144|NCT02663518|322706536|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
94249145|NCT02663518|322706537|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
94249146|NCT02663518|322706524|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
94249147|NCT02663518|322706525|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
94249148|NCT02663518|322706526|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
94249149|NCT02663518|322706527|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
94249150|NCT02663518|322706528|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
94249151|NCT02663518|322706529|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
94249152|NCT02663518|322706530|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
94249153|NCT02663518|322706531|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
94249154|NCT02663518|322706532|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
94249155|NCT02663518|322706533|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
94249156|NCT02663518|322706534|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
94249157|NCT02663518|322706535|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
94249158|NCT02663518|322706536|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
94249159|NCT02663518|322706537|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
94249160|NCT02663518|322706524|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
94249161|NCT02663518|322706525|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
94249162|NCT02663518|322706526|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
94249163|NCT02663518|322706527|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
94249164|NCT02663518|322706528|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
94249165|NCT02663518|322706529|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
94249166|NCT02663518|322706530|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
94249167|NCT02663518|322706531|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
94249168|NCT02663518|322706532|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
94249169|NCT02663518|322706533|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
94249170|NCT02663518|322706534|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
94249171|NCT02663518|322706535|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
94249172|NCT02663518|322706536|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
94249173|NCT02663518|322706537|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
94249174|NCT02663518|322706524|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
94249175|NCT02663518|322706525|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
94249176|NCT02663518|322706526|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
94356434|NCT04145531|323087169|FG001|Part A|Death|2|||
94356435|NCT04145531|323087170|FG002|Part A|Death|0|||
94356436|NCT04145531|323087171|FG003|Part A|Death|0|||
94604287|NCT02414139|324013928|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
94604288|NCT02414139|324013929|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
94604289|NCT02414139|324013930|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
94604290|NCT02414139|324013931|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
94604291|NCT02414139|324013932|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
94604292|NCT02414139|324013933|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
94604293|NCT02414139|324013934|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
94604294|NCT02414139|324013925|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
94604295|NCT02414139|324013926|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
94604296|NCT02414139|324013927|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
94604297|NCT02414139|324013928|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
94604298|NCT02414139|324013929|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
94604299|NCT02414139|324013930|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
94604300|NCT02414139|324013931|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
94604301|NCT02414139|324013932|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
94604302|NCT02414139|324013933|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
94604303|NCT02414139|324013934|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
94604304|NCT02414139|324013925|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
94604305|NCT02414139|324013926|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
94604306|NCT02414139|324013927|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
94604307|NCT02414139|324013928|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
94604308|NCT02414139|324013929|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
94604309|NCT02414139|324013930|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
94604310|NCT02414139|324013931|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
94604311|NCT02414139|324013932|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
94661393|NCT03579459|324215714|FG002|Overall Study|Other|1|||
94661394|NCT03579459|324215715|FG003|Overall Study|Other|0|||
94249177|NCT02663518|322706527|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
94249178|NCT02663518|322706528|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
94249179|NCT02663518|322706529|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
94249180|NCT02663518|322706530|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
94249181|NCT02663518|322706531|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
94249182|NCT02663518|322706532|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
94249183|NCT02663518|322706533|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
94249184|NCT02663518|322706534|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
94249185|NCT02663518|322706535|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
94249186|NCT02663518|322706536|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
94249187|NCT02663518|322706537|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
94249188|NCT02663518|322706524|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
94249189|NCT02663518|322706525|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
94249190|NCT02663518|322706526|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
94249191|NCT02663518|322706527|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
94249192|NCT02663518|322706528|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
94249193|NCT02663518|322706529|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
94249194|NCT02663518|322706530|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
94249195|NCT02663518|322706531|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
94249196|NCT02663518|322706532|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
94249197|NCT02663518|322706533|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
94249198|NCT02663518|322706534|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
94249199|NCT02663518|322706535|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
94249200|NCT02663518|322706536|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
94249201|NCT02663518|322706537|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
94249202|NCT02663518|322706524|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
94249203|NCT02663518|322706525|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
94249204|NCT02663518|322706526|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
94249205|NCT02663518|322706527|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
94249206|NCT02663518|322706528|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
94249207|NCT02663518|322706529|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
94249208|NCT02663518|322706530|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
94249209|NCT02663518|322706531|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
94249210|NCT02663518|322706532|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
94249211|NCT02663518|322706533|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
94249212|NCT02663518|322706534|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
94249213|NCT02663518|322706535|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
94249214|NCT02663518|322706536|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
94249215|NCT02663518|322706537|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
94249216|NCT02663518|322706524|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
94604312|NCT02414139|324013933|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
94249217|NCT02663518|322706525|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
94249218|NCT02663518|322706526|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
94249219|NCT02663518|322706527|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
94249220|NCT02663518|322706528|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
94249221|NCT02663518|322706529|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
94249222|NCT02663518|322706530|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
94249223|NCT02663518|322706531|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
94249224|NCT02663518|322706532|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
94249225|NCT02663518|322706533|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
94249226|NCT02663518|322706534|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
94249227|NCT02663518|322706535|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
94249228|NCT02663518|322706536|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
94249229|NCT02663518|322706537|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
94249230|NCT02663518|322706524|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
94249231|NCT02663518|322706525|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
94249232|NCT02663518|322706526|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
94249233|NCT02663518|322706527|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
94249234|NCT02663518|322706528|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
94249235|NCT02663518|322706529|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
94249236|NCT02663518|322706530|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
94249237|NCT02663518|322706531|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
94249238|NCT02663518|322706532|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
94249239|NCT02663518|322706533|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
94249240|NCT02663518|322706534|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
94249241|NCT02663518|322706535|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
94249242|NCT02663518|322706536|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
94249243|NCT02663518|322706537|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
94249244|NCT02663518|322706524|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
94249245|NCT02663518|322706525|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
94249246|NCT02663518|322706526|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
94249247|NCT02663518|322706527|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
94249248|NCT02663518|322706528|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
94249249|NCT02663518|322706529|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
94249250|NCT02663518|322706530|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
94249251|NCT02663518|322706531|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
94249252|NCT02663518|322706532|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
94249253|NCT02663518|322706533|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
94249254|NCT02663518|322706534|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
94249255|NCT02663518|322706535|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
94249256|NCT02663518|322706536|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
94249257|NCT02663518|322706537|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
94249258|NCT02663518|322706524|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
94249259|NCT02663518|322706525|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
94249260|NCT02663518|322706526|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
94249261|NCT02663518|322706527|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
94249262|NCT02663518|322706528|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
94249263|NCT02663518|322706529|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
94249264|NCT02663518|322706530|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
94249265|NCT02663518|322706531|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
94249266|NCT02663518|322706532|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
94249267|NCT02663518|322706533|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
94249268|NCT02663518|322706534|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
94249269|NCT02663518|322706535|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
94249270|NCT02663518|322706536|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
94249271|NCT02663518|322706537|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
94249272|NCT02947087|322706540|FG000|Overall Study|Withdrawal by Subject|3|||
94249273|NCT02947087|322706541|FG001|Overall Study|Withdrawal by Subject|2|||
94604313|NCT02414139|324013934|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
94604314|NCT01343901|324013935|FG000|Overall Study|Death|85|||
94604315|NCT01343901|324013935|FG000|Overall Study|Physician Decision|4|||
94604316|NCT01343901|324013935|FG000|Overall Study|Lost to Follow-up|12|||
94604317|NCT01343901|324013935|FG000|Overall Study|Management by another medical team|11|||
94249274|NCT00700427|322706542|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
94249275|NCT00700427|322706543|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
94249276|NCT00700427|322706544|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
94604318|NCT01343901|324013935|FG000|Overall Study|Participant decision|1|||
94604319|NCT00870233|324013941|FG000|Overall Study|Withdrawal by Subject|18|||
94604320|NCT00870233|324013941|FG000|Overall Study|Did not undergo laparotomy|3|||
94604321|NCT00870233|324013941|FG000|Overall Study|Incompatible internet browser|2|||
94604322|NCT00870233|324013941|FG000|Overall Study|Death|1|||
94604323|NCT02220998|324013942|FG000|Overall Study|Randomized but Never Treated|1|||
94604324|NCT02220998|324013943|FG001|Overall Study|Randomized but Never Treated|2|||
94604325|NCT02220998|324013942|FG000|Overall Study|Death|2|||
94604326|NCT02220998|324013943|FG001|Overall Study|Death|0|||
94604327|NCT02220998|324013942|FG000|Overall Study|Lack of Efficacy|0|||
94604328|NCT02220998|324013943|FG001|Overall Study|Lack of Efficacy|5|||
94604329|NCT02220998|324013942|FG000|Overall Study|Lost to Follow-up|4|||
94604330|NCT02220998|324013943|FG001|Overall Study|Lost to Follow-up|4|||
94604331|NCT00769483|324013947|FG000|Overall Study|Withdrawal by Subject|0|||
94604332|NCT00769483|324013948|FG001|Overall Study|Withdrawal by Subject|1|||
94604333|NCT00769483|324013949|FG002|Overall Study|Withdrawal by Subject|0|||
94604334|NCT00769483|324013950|FG003|Overall Study|Withdrawal by Subject|0|||
94604335|NCT00769483|324013951|FG004|Overall Study|Withdrawal by Subject|1|||
94604336|NCT00769483|324013952|FG005|Overall Study|Withdrawal by Subject|0|||
94604337|NCT03455764|324013953|FG000|Overall Study|Adverse Event|1|||
94604338|NCT03455764|324013954|FG001|Overall Study|Adverse Event|0|||
94604339|NCT03455764|324013955|FG002|Overall Study|Adverse Event|0|||
94604340|NCT03455764|324013956|FG003|Overall Study|Adverse Event|0|||
94604341|NCT03455764|324013957|FG004|Overall Study|Adverse Event|0|||
94604342|NCT03455764|324013953|FG000|Overall Study|Disease Progression|4|||
94604343|NCT03455764|324013954|FG001|Overall Study|Disease Progression|0|||
94604344|NCT03455764|324013955|FG002|Overall Study|Disease Progression|0|||
94604345|NCT03455764|324013956|FG003|Overall Study|Disease Progression|0|||
94604346|NCT03455764|324013957|FG004|Overall Study|Disease Progression|0|||
94604347|NCT03455764|324013953|FG000|Overall Study|On Treatment|1|||
94604348|NCT03455764|324013954|FG001|Overall Study|On Treatment|0|||
94604349|NCT03455764|324013955|FG002|Overall Study|On Treatment|0|||
94604350|NCT03455764|324013956|FG003|Overall Study|On Treatment|0|||
94604351|NCT03455764|324013957|FG004|Overall Study|On Treatment|0|||
94604352|NCT01306877|324013958|FG000|Overall Study|Lost to Follow-up|3|||
94604353|NCT01306877|324013959|FG001|Overall Study|Lost to Follow-up|3|||
94604354|NCT01306877|324013958|FG000|Overall Study|Physician Decision|0|||
94604355|NCT01306877|324013959|FG001|Overall Study|Physician Decision|1|||
94604356|NCT00459979|324013960|FG000|Overall Study|Withdrawal by Subject|1|||
94604357|NCT00459979|324013960|FG000|Overall Study|Protocol Violation|1|||
94604358|NCT03523000|324013961|FG000|Overall Study|Withdrawal by Subject|3|||
94604359|NCT03523000|324013962|FG001|Overall Study|Withdrawal by Subject|0|||
94604360|NCT03523000|324013961|FG000|Overall Study|Unsuccessful trial|2|||
94604361|NCT03523000|324013962|FG001|Overall Study|Unsuccessful trial|0|||
94604362|NCT00006389|324013963|FG000|Overall Study|Adverse Event|1|||
94604363|NCT02862600|324013967|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
94604364|NCT02862600|324013967|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
94604365|NCT02862600|324013967|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
94604366|NCT02862600|324013967|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
94604367|NCT04650854|324013971|FG000|Overall Study|Adverse Event|1|||
94604368|NCT04650854|324013972|FG001|Overall Study|Adverse Event|12|||
94604369|NCT04650854|324013973|FG002|Overall Study|Adverse Event|14|||
94604370|NCT04650854|324013971|FG000|Overall Study|Lack of Efficacy|1|||
94604371|NCT04650854|324013972|FG001|Overall Study|Lack of Efficacy|3|||
94604372|NCT04650854|324013973|FG002|Overall Study|Lack of Efficacy|6|||
94604373|NCT04650854|324013971|FG000|Overall Study|Lost to Follow-up|1|||
94604374|NCT04650854|324013972|FG001|Overall Study|Lost to Follow-up|1|||
94604375|NCT04650854|324013973|FG002|Overall Study|Lost to Follow-up|0|||
94604376|NCT04650854|324013971|FG000|Overall Study|Withdrawal by Subject|2|||
94604377|NCT04650854|324013972|FG001|Overall Study|Withdrawal by Subject|17|||
94604378|NCT04650854|324013973|FG002|Overall Study|Withdrawal by Subject|9|||
94604379|NCT04650854|324013971|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
94604380|NCT04650854|324013972|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
94604381|NCT04650854|324013973|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
94458155|NCT01647516|323465682|FG000|Open-Label Period|Non-compliance|0|||
94458156|NCT01647516|323465683|FG001|Open-Label Period|Non-compliance|0|||
94458157|NCT01647516|323465684|FG002|Open-Label Period|Non-compliance|0|||
94604382|NCT04650854|324013971|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
94604383|NCT04650854|324013972|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
94604384|NCT04650854|324013973|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
94604385|NCT04650854|324013971|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
94604386|NCT04650854|324013972|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
94604387|NCT04650854|324013973|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
94604388|NCT04650854|324013971|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
94604389|NCT04650854|324013972|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
94604390|NCT04650854|324013973|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
94604391|NCT04650854|324013971|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
94604392|NCT04650854|324013972|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
94604393|NCT04650854|324013973|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
94604394|NCT04650854|324013971|FG000|Overall Study|Use of Rescue Medication|0|||
94604395|NCT04650854|324013972|FG001|Overall Study|Use of Rescue Medication|0|||
94604396|NCT04650854|324013973|FG002|Overall Study|Use of Rescue Medication|1|||
94604397|NCT04650854|324013971|FG000|Overall Study|Last Treatment Per Sponsor|0|||
94604398|NCT04650854|324013972|FG001|Overall Study|Last Treatment Per Sponsor|0|||
94604399|NCT04650854|324013973|FG002|Overall Study|Last Treatment Per Sponsor|2|||
94604400|NCT04650854|324013971|FG000|Overall Study|Rescue Medication|0|||
94604401|NCT04650854|324013972|FG001|Overall Study|Rescue Medication|0|||
94604402|NCT04650854|324013973|FG002|Overall Study|Rescue Medication|1|||
94604403|NCT04650854|324013971|FG000|Overall Study|Participant Want to Start a Family|0|||
94604404|NCT04650854|324013972|FG001|Overall Study|Participant Want to Start a Family|0|||
94604405|NCT04650854|324013973|FG002|Overall Study|Participant Want to Start a Family|1|||
94604406|NCT04650854|324013971|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
94604407|NCT04650854|324013972|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
94604408|NCT04650854|324013973|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
94604409|NCT04650854|324013971|FG000|Overall Study|Participant Screened For MG0020|0|||
94604410|NCT04650854|324013972|FG001|Overall Study|Participant Screened For MG0020|2|||
94604411|NCT04650854|324013973|FG002|Overall Study|Participant Screened For MG0020|3|||
94604412|NCT04650854|324013971|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
94604413|NCT04650854|324013972|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
94604414|NCT04650854|324013973|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
94604415|NCT04650854|324013971|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
94604416|NCT04650854|324013972|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
94604417|NCT04650854|324013973|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
94604418|NCT04650854|324013971|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
94604419|NCT04650854|324013972|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
94604420|NCT04650854|324013973|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
94604421|NCT04650854|324013971|FG000|Overall Study|End Of Study|0|||
94604422|NCT04650854|324013972|FG001|Overall Study|End Of Study|2|||
94604423|NCT04650854|324013973|FG002|Overall Study|End Of Study|1|||
94604424|NCT04650854|324013971|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
94604425|NCT04650854|324013972|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
94604426|NCT04650854|324013973|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
94604427|NCT04650854|324013971|FG000|Overall Study|Participant Received Rescue Medication|0|||
94604428|NCT04650854|324013972|FG001|Overall Study|Participant Received Rescue Medication|1|||
94604429|NCT04650854|324013973|FG002|Overall Study|Participant Received Rescue Medication|0|||
94604430|NCT04650854|324013971|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
94604431|NCT04650854|324013972|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
94604432|NCT04650854|324013973|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
94604433|NCT04650854|324013971|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
94604434|NCT04650854|324013972|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
94604435|NCT04650854|324013973|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
94604436|NCT04650854|324013971|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
94604437|NCT04650854|324013972|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
94604438|NCT04650854|324013973|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
94604439|NCT04650854|324013971|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
94604440|NCT04650854|324013972|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
94604441|NCT04650854|324013973|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
94604442|NCT04650854|324013971|FG000|Overall Study|Enrollment Cup|0|||
94604443|NCT04650854|324013972|FG001|Overall Study|Enrollment Cup|0|||
94604444|NCT04650854|324013973|FG002|Overall Study|Enrollment Cup|1|||
94604445|NCT01285960|324013982|FG000|Overall Study|Withdrawal by Subject|2|||
94604446|NCT01285960|324013982|FG000|Overall Study|Lost to Follow-up|2|||
94604447|NCT01285960|324013982|FG000|Overall Study|2 subjects received less 10 sonications|2|||
94604448|NCT01962922|324013987|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
94604449|NCT01962922|324013988|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
94604450|NCT01962922|324013987|FG000|PK Portion Day 7|non-compliance|1|||
94604451|NCT01962922|324013988|FG001|PK Portion Day 7|non-compliance|0|||
94249277|NCT00700427|322706545|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
94604452|NCT01962922|324013987|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
94604453|NCT01962922|324013988|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
94249278|NCT00700427|322706546|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
94249279|NCT00700427|322706542|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
94604454|NCT01962922|324013987|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
94604455|NCT01962922|324013988|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
94249280|NCT00700427|322706543|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
94249281|NCT00700427|322706544|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
94249282|NCT00700427|322706545|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
94249283|NCT00700427|322706546|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
94604456|NCT01476644|324013989|FG000|Overall Study|Death|5|||
94249284|NCT00700427|322706542|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
94604457|NCT01476644|324013989|FG000|Overall Study|moved to another state|2|||
94604458|NCT01476644|324013989|FG000|Overall Study|Lost to Follow-up|19|||
94604459|NCT01476644|324013989|FG000|Overall Study|Withdrawal by Subject|13|||
94604460|NCT00495131|324013990|FG000|Overall Study|Adverse Event|6|||
94604461|NCT00495131|324013991|FG001|Overall Study|Adverse Event|2|||
94604462|NCT00495131|324013990|FG000|Overall Study|Lack of Efficacy|0|||
94604463|NCT00495131|324013991|FG001|Overall Study|Lack of Efficacy|2|||
94604464|NCT00495131|324013990|FG000|Overall Study|Lost to Follow-up|0|||
94604465|NCT00495131|324013991|FG001|Overall Study|Lost to Follow-up|2|||
94604466|NCT00495131|324013990|FG000|Overall Study|Withdrawal by Subject|1|||
94249285|NCT00700427|322706543|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
94249286|NCT00700427|322706544|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
94249287|NCT00700427|322706545|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
94249288|NCT00700427|322706546|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
94249289|NCT00700427|322706542|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
94249290|NCT00700427|322706543|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
94249291|NCT00700427|322706544|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
94249292|NCT00700427|322706545|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
94249293|NCT00700427|322706546|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
94249294|NCT00700427|322706542|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
94249295|NCT00700427|322706543|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
94249296|NCT00700427|322706544|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
94249297|NCT00700427|322706545|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
94249298|NCT00700427|322706546|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
94249299|NCT00700427|322706542|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
94249300|NCT00700427|322706543|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
94249301|NCT00700427|322706544|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
94249302|NCT00700427|322706545|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
94249303|NCT00700427|322706546|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
94249304|NCT00700427|322706542|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
94249305|NCT00700427|322706543|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
94249306|NCT00700427|322706544|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
94249307|NCT00700427|322706545|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
94249308|NCT00700427|322706546|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
94604467|NCT00495131|324013991|FG001|Overall Study|Withdrawal by Subject|0|||
94604468|NCT02117427|324013997|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
94604469|NCT02117427|324013998|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
94604470|NCT02117427|324013999|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
94604471|NCT02117427|324013997|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
94604472|NCT02117427|324013998|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
94604473|NCT02117427|324013999|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
94604474|NCT02117427|324013997|FG000|Overall Study|Physician Decision|0|||
94604475|NCT02117427|324013998|FG001|Overall Study|Physician Decision|2|||
94604476|NCT02117427|324013999|FG002|Overall Study|Physician Decision|0|||
94249309|NCT00700427|322706542|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
94249310|NCT00700427|322706543|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
94249311|NCT00700427|322706544|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
94249312|NCT00700427|322706545|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
94249313|NCT00700427|322706546|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
94249314|NCT00700427|322706542|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
94249315|NCT00700427|322706543|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
94249316|NCT00700427|322706544|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
94249317|NCT00700427|322706545|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
94249318|NCT00700427|322706546|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
94249319|NCT00700427|322706542|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
94249320|NCT00700427|322706543|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
94604477|NCT02117427|324013997|FG000|Overall Study|No longer meets inclusion criteria|0|||
94604478|NCT02117427|324013998|FG001|Overall Study|No longer meets inclusion criteria|1|||
94604479|NCT02117427|324013999|FG002|Overall Study|No longer meets inclusion criteria|0|||
94604480|NCT02117427|324013997|FG000|Overall Study|Death|0|||
94604481|NCT02117427|324013998|FG001|Overall Study|Death|1|||
94604482|NCT02117427|324013999|FG002|Overall Study|Death|0|||
94604483|NCT03911843|324014000|FG000|Overall Study|Adverse Event|2|||
94604484|NCT03911843|324014001|FG001|Overall Study|Adverse Event|0|||
94604485|NCT03911843|324014000|FG000|Overall Study|Protocol Violation|2|||
94604486|NCT03911843|324014001|FG001|Overall Study|Protocol Violation|0|||
94604487|NCT03911843|324014000|FG000|Overall Study|Lost to Follow-up|0|||
94604488|NCT03911843|324014001|FG001|Overall Study|Lost to Follow-up|1|||
94604489|NCT01436162|324014002|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
94604490|NCT01436162|324014003|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
94604491|NCT01436162|324014004|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
94604492|NCT01436162|324014002|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
94604493|NCT01436162|324014003|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
94604494|NCT01436162|324014004|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
94604495|NCT01436162|324014002|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
94604496|NCT01436162|324014003|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
94604497|NCT01436162|324014004|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
94604498|NCT01436162|324014002|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
94604499|NCT01436162|324014003|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
94604500|NCT01436162|324014004|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
94604501|NCT01436162|324014002|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
94604502|NCT01436162|324014003|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
94604503|NCT01436162|324014004|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
94604504|NCT01436162|324014002|FG000|Single-blind Lead-in Phase|Other|107|||
94604505|NCT01436162|324014003|FG001|Single-blind Lead-in Phase|Other|0|||
94604506|NCT01436162|324014004|FG002|Single-blind Lead-in Phase|Other|0|||
94604507|NCT01436162|324014002|FG000|Randomized Phase|Adverse Event|1|||
94604508|NCT01436162|324014003|FG001|Randomized Phase|Adverse Event|5|||
94604509|NCT01436162|324014004|FG002|Randomized Phase|Adverse Event|6|||
94604510|NCT01436162|324014002|FG000|Randomized Phase|Protocol Violation|4|||
94604511|NCT01436162|324014003|FG001|Randomized Phase|Protocol Violation|4|||
94604512|NCT01436162|324014004|FG002|Randomized Phase|Protocol Violation|2|||
94604513|NCT01436162|324014002|FG000|Randomized Phase|Withdrawal by Subject|16|||
94604514|NCT01436162|324014003|FG001|Randomized Phase|Withdrawal by Subject|9|||
94604515|NCT01436162|324014004|FG002|Randomized Phase|Withdrawal by Subject|8|||
94604516|NCT01436162|324014002|FG000|Randomized Phase|Lost to Follow-up|17|||
94604517|NCT01436162|324014003|FG001|Randomized Phase|Lost to Follow-up|5|||
94604518|NCT01436162|324014004|FG002|Randomized Phase|Lost to Follow-up|4|||
94604519|NCT01436162|324014002|FG000|Randomized Phase|Lack of Efficacy|0|||
94604520|NCT01436162|324014003|FG001|Randomized Phase|Lack of Efficacy|1|||
94604521|NCT01436162|324014004|FG002|Randomized Phase|Lack of Efficacy|1|||
94604522|NCT01436162|324014002|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
94604523|NCT01436162|324014003|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
94604524|NCT01436162|324014004|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
94604525|NCT01436162|324014002|FG000|Randomized Phase|Other|2|||
94604526|NCT01436162|324014003|FG001|Randomized Phase|Other|5|||
94604527|NCT01436162|324014004|FG002|Randomized Phase|Other|4|||
94604528|NCT00760084|324014005|FG000|Overall Study|Physician Decision|5|||
94604529|NCT00760084|324014005|FG000|Overall Study|Withdrawal by Subject|2|||
94604530|NCT00760084|324014005|FG000|Overall Study|Progressive Disease|3|||
94604531|NCT02628769|324014006|FG000|First Intervention|Adverse Event|1|||
94604532|NCT02628769|324014007|FG001|First Intervention|Adverse Event|0|||
94604533|NCT02628769|324014006|FG000|First Intervention|Withdrawal by Subject|0|||
94604534|NCT02628769|324014007|FG001|First Intervention|Withdrawal by Subject|1|||
94604535|NCT02628769|324014006|FG000|Second Intervention|Adverse Event|2|||
94604536|NCT02628769|324014007|FG001|Second Intervention|Adverse Event|0|||
94604537|NCT02628769|324014006|FG000|Second Intervention|Physician Decision|0|||
94604538|NCT02628769|324014007|FG001|Second Intervention|Physician Decision|1|||
94604539|NCT00395538|324014008|FG000|Overall Study|Did not re-consent to revised protocol|1|||
94604540|NCT00395538|324014009|FG001|Overall Study|Did not re-consent to revised protocol|10|||
94604541|NCT00395538|324014010|FG002|Overall Study|Did not re-consent to revised protocol|0|||
94604542|NCT00395538|324014008|FG000|Overall Study|FDA partial hold on PTH|0|||
94604543|NCT00395538|324014009|FG001|Overall Study|FDA partial hold on PTH|0|||
94604544|NCT00395538|324014010|FG002|Overall Study|FDA partial hold on PTH|11|||
94604545|NCT00395538|324014008|FG000|Overall Study|Failed screening|0|||
94604546|NCT00395538|324014009|FG001|Overall Study|Failed screening|0|||
94604547|NCT00395538|324014010|FG002|Overall Study|Failed screening|4|||
94604548|NCT00395538|324014008|FG000|Overall Study|Switch to Natpara|0|||
94604549|NCT00395538|324014009|FG001|Overall Study|Switch to Natpara|0|||
94604550|NCT00395538|324014010|FG002|Overall Study|Switch to Natpara|3|||
94604551|NCT00395538|324014008|FG000|Overall Study|Adverse Event|1|||
94604552|NCT00395538|324014009|FG001|Overall Study|Adverse Event|0|||
94604553|NCT00395538|324014010|FG002|Overall Study|Adverse Event|2|||
94604554|NCT00395538|324014008|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
94604555|NCT00395538|324014009|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
94604556|NCT00395538|324014010|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
94604557|NCT00395538|324014008|FG000|Overall Study|Non-compliance with study protocol|0|||
94604558|NCT00395538|324014009|FG001|Overall Study|Non-compliance with study protocol|1|||
94604559|NCT00395538|324014010|FG002|Overall Study|Non-compliance with study protocol|0|||
94604560|NCT00395538|324014008|FG000|Overall Study|PTH resistance|0|||
94604561|NCT00395538|324014009|FG001|Overall Study|PTH resistance|0|||
94604562|NCT00395538|324014010|FG002|Overall Study|PTH resistance|1|||
94604563|NCT00395538|324014008|FG000|Overall Study|Pregnancy|1|||
94604564|NCT00395538|324014009|FG001|Overall Study|Pregnancy|0|||
94604565|NCT00395538|324014010|FG002|Overall Study|Pregnancy|0|||
94604566|NCT00395538|324014008|FG000|Overall Study|Partial recovery of parathyroid function|0|||
94604567|NCT00395538|324014009|FG001|Overall Study|Partial recovery of parathyroid function|0|||
94604568|NCT00395538|324014010|FG002|Overall Study|Partial recovery of parathyroid function|1|||
94604569|NCT00395538|324014008|FG000|Overall Study|Participant elected to discontinue|0|||
94604570|NCT00395538|324014009|FG001|Overall Study|Participant elected to discontinue|0|||
94604571|NCT00395538|324014010|FG002|Overall Study|Participant elected to discontinue|1|||
94604572|NCT04041700|324014011|FG000|Overall Study|Pregnancy|1|||
94604573|NCT04041700|324014011|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
94604574|NCT05523323|324015872|FG000|Overall Study|Death|26|||
94604575|NCT05523323|324015873|FG001|Overall Study|Death|21|||
94604576|NCT05523323|324015872|FG000|Overall Study|Ongoing participants|35|||
94604577|NCT05523323|324015873|FG001|Overall Study|Ongoing participants|30|||
94604578|NCT01711879|324015874|FG000|Overall Study|Death|1|||
94604579|NCT01711879|324015875|FG001|Overall Study|Death|0|||
94604580|NCT03868124|324015876|FG000|Overall Study|Withdrawal by Subject|4|||
94604581|NCT03868124|324015877|FG001|Overall Study|Withdrawal by Subject|0|||
94604582|NCT03868124|324015878|FG002|Overall Study|Withdrawal by Subject|1|||
94604583|NCT03868124|324015876|FG000|Overall Study|Physician Decision|1|||
94604584|NCT03868124|324015877|FG001|Overall Study|Physician Decision|0|||
94604585|NCT03868124|324015878|FG002|Overall Study|Physician Decision|1|||
94604586|NCT03868124|324015876|FG000|Overall Study|Lost to Follow-up|1|||
94604587|NCT03868124|324015877|FG001|Overall Study|Lost to Follow-up|1|||
94604588|NCT03868124|324015878|FG002|Overall Study|Lost to Follow-up|2|||
94604589|NCT03868124|324015876|FG000|Overall Study|Death|1|||
94604590|NCT03868124|324015877|FG001|Overall Study|Death|1|||
94604591|NCT03868124|324015878|FG002|Overall Study|Death|2|||
94604592|NCT03868124|324015876|FG000|Overall Study|Adverse Event|0|||
94604593|NCT03868124|324015877|FG001|Overall Study|Adverse Event|0|||
94604594|NCT03868124|324015878|FG002|Overall Study|Adverse Event|3|||
94604595|NCT03868124|324015876|FG000|Overall Study|Explanted|2|||
94604596|NCT03868124|324015877|FG001|Overall Study|Explanted|1|||
94604597|NCT03868124|324015878|FG002|Overall Study|Explanted|0|||
94604598|NCT03868124|324015876|FG000|Overall Study|Ongoing in study|176|||
94604599|NCT03868124|324015877|FG001|Overall Study|Ongoing in study|180|||
94604600|NCT03868124|324015878|FG002|Overall Study|Ongoing in study|183|||
94604601|NCT00521001|324015884|FG000|Overall Study|Ineligible|1|||
94604602|NCT05867342|324015885|FG000|Overall Study|Investigator Decision|3|||
94604603|NCT05867342|324015886|FG001|Overall Study|Investigator Decision|3|||
94604604|NCT01282203|324015889|FG000|Overall Study|Adverse Event|1|||
94604605|NCT03190369|324015890|FG000|Overall Study|Poor compliance to protocol|0|||
94604606|NCT03190369|324015891|FG001|Overall Study|Poor compliance to protocol|1|||
94604607|NCT03190369|324015890|FG000|Overall Study|Withdraw before treatment|1|||
94604608|NCT03190369|324015891|FG001|Overall Study|Withdraw before treatment|5|||
94604609|NCT03190369|324015890|FG000|Overall Study|Randomized but not treated|0|||
94604610|NCT03190369|324015891|FG001|Overall Study|Randomized but not treated|2|||
94604611|NCT02963831|324015892|FG000|Overall Study|Progressive Disease|3|||
94604612|NCT02963831|324015893|FG001|Overall Study|Progressive Disease|3|||
94604613|NCT02963831|324015894|FG002|Overall Study|Progressive Disease|16|||
94604614|NCT02963831|324015895|FG003|Overall Study|Progressive Disease|27|||
94604615|NCT02963831|324015892|FG000|Overall Study|Withdrawal by Subject|1|||
94604616|NCT02963831|324015893|FG001|Overall Study|Withdrawal by Subject|0|||
94604617|NCT02963831|324015894|FG002|Overall Study|Withdrawal by Subject|2|||
94604618|NCT02963831|324015895|FG003|Overall Study|Withdrawal by Subject|4|||
94604619|NCT02963831|324015892|FG000|Overall Study|Adverse Event|0|||
94604620|NCT02963831|324015893|FG001|Overall Study|Adverse Event|1|||
94604621|NCT02963831|324015894|FG002|Overall Study|Adverse Event|1|||
94604622|NCT02963831|324015895|FG003|Overall Study|Adverse Event|2|||
94604623|NCT02963831|324015892|FG000|Overall Study|Death|0|||
94604624|NCT02963831|324015893|FG001|Overall Study|Death|0|||
94604625|NCT02963831|324015894|FG002|Overall Study|Death|0|||
94604626|NCT02963831|324015895|FG003|Overall Study|Death|2|||
94604627|NCT01606254|324015898|FG000|Overall Study|Withdrawal by Subject|1|||
94604628|NCT01606254|324015899|FG001|Overall Study|Withdrawal by Subject|3|||
94604629|NCT01606254|324015900|FG002|Overall Study|Withdrawal by Subject|0|||
94604630|NCT01606254|324015901|FG003|Overall Study|Withdrawal by Subject|2|||
94604631|NCT01606254|324015898|FG000|Overall Study|Adverse Event|1|||
94604632|NCT01606254|324015899|FG001|Overall Study|Adverse Event|1|||
94604633|NCT01606254|324015900|FG002|Overall Study|Adverse Event|0|||
94604634|NCT01606254|324015901|FG003|Overall Study|Adverse Event|1|||
94604635|NCT04543409|324015902|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
94604636|NCT04543409|324015903|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
94604637|NCT04543409|324015902|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
94604638|NCT04543409|324015903|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
94604639|NCT04543409|324015902|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
94604640|NCT04543409|324015903|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
94604641|NCT04543409|324015902|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
94604642|NCT04543409|324015903|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
94604643|NCT04543409|324015902|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
94604644|NCT04543409|324015903|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
94604645|NCT04543409|324015902|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
94604646|NCT04543409|324015903|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
94604647|NCT04543409|324015902|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
94604648|NCT04543409|324015903|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
94604649|NCT04543409|324015902|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
94604650|NCT04543409|324015903|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
94604651|NCT04543409|324015902|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
94604652|NCT04543409|324015903|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
94604653|NCT04543409|324015902|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
94604654|NCT04543409|324015903|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
94604655|NCT04543409|324015902|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
94604656|NCT04543409|324015903|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
94604657|NCT01052844|324015905|FG000|Overall Study|Adverse Event|0|||
94604658|NCT01052844|324015906|FG001|Overall Study|Adverse Event|1|||
94604659|NCT03463031|324015907|FG000|Overall Study|Withdrawal by Subject|4|||
94604660|NCT03463031|324015908|FG001|Overall Study|Withdrawal by Subject|2|||
94604661|NCT03463031|324015907|FG000|Overall Study|Investigator/Sponsor Decision|0|||
94604662|NCT03463031|324015908|FG001|Overall Study|Investigator/Sponsor Decision|1|||
94604663|NCT03463031|324015907|FG000|Overall Study|Lost to Follow-up|1|||
94604664|NCT03463031|324015908|FG001|Overall Study|Lost to Follow-up|1|||
94604665|NCT03463031|324015907|FG000|Overall Study|Adverse Event|4|||
94604666|NCT03463031|324015908|FG001|Overall Study|Adverse Event|1|||
94604667|NCT03463031|324015907|FG000|Overall Study|Use of prohibited medication by subject|1|||
94604668|NCT03463031|324015908|FG001|Overall Study|Use of prohibited medication by subject|0|||
94604669|NCT04365257|324015909|FG000|Overall Study|Physician Decision|1|||
94604670|NCT04365257|324015910|FG001|Overall Study|Physician Decision|0|||
94604671|NCT04365257|324015909|FG000|Overall Study|Patient Noncompliance|1|||
94604672|NCT04365257|324015910|FG001|Overall Study|Patient Noncompliance|0|||
94604673|NCT04365257|324015909|FG000|Overall Study|Withdrawal by Subject|0|||
94604674|NCT04365257|324015910|FG001|Overall Study|Withdrawal by Subject|1|||
94604675|NCT00174291|324015917|FG000|Overall Study|Lost to Follow-up|1|||
94604676|NCT00174291|324015918|FG001|Overall Study|Lost to Follow-up|1|||
94604677|NCT00174291|324015917|FG000|Overall Study|Protocol Violation|0|||
94604678|NCT00174291|324015918|FG001|Overall Study|Protocol Violation|2|||
94604679|NCT00174291|324015917|FG000|Overall Study|Study terminated by sponsor|1|||
94604680|NCT00174291|324015918|FG001|Overall Study|Study terminated by sponsor|0|||
94604681|NCT00174291|324015917|FG000|Overall Study|Withdrawal by Subject|3|||
94604682|NCT00174291|324015918|FG001|Overall Study|Withdrawal by Subject|3|||
94604683|NCT00214500|324015921|FG000|Treatment Period|Adverse Event|1|||
94604684|NCT00214500|324015921|FG000|Extension Period|Withdrawal by Subject|2|||
94604685|NCT00433654|324015922|FG000|Overall Study|Death|4|||
94604686|NCT00433654|324015923|FG001|Overall Study|Death|0|||
94604687|NCT00433654|324015922|FG000|Overall Study|Missed visit|6|||
94604688|NCT00433654|324015923|FG001|Overall Study|Missed visit|3|||
94604689|NCT00433654|324015922|FG000|Overall Study|Subject not yet due for visit|4|||
94604690|NCT00433654|324015923|FG001|Overall Study|Subject not yet due for visit|0|||
94604691|NCT00433654|324015922|FG000|Overall Study|Withdrawal by Subject|1|||
94604692|NCT00433654|324015923|FG001|Overall Study|Withdrawal by Subject|2|||
94604693|NCT01151098|324015924|FG000|Overall Study|Adverse Event|82|||
94356437|NCT04145531|323087168|FG000|Part A|Physician Decision|2|||
94356438|NCT04145531|323087169|FG001|Part A|Physician Decision|5|||
94604694|NCT01151098|324015924|FG000|Overall Study|Lost to Follow-up|6|||
94604695|NCT01151098|324015924|FG000|Overall Study|Lack of Efficacy|15|||
94604696|NCT01151098|324015924|FG000|Overall Study|Protocol Violation|1|||
94604697|NCT01151098|324015924|FG000|Overall Study|Miscellaneous|13|||
94604698|NCT00417482|324015925|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
94356439|NCT04145531|323087170|FG002|Part A|Physician Decision|2|||
94604699|NCT00417482|324015926|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
94604700|NCT00417482|324015927|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
94604701|NCT00417482|324015925|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
94604702|NCT00417482|324015926|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
94604703|NCT00417482|324015927|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
94604704|NCT00417482|324015925|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
94604705|NCT00417482|324015926|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
94604706|NCT00417482|324015927|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
94604707|NCT00417482|324015925|FG000|Phase B 1st 16 Weeks|Death|1|||
94604708|NCT00417482|324015926|FG001|Phase B 1st 16 Weeks|Death|0|||
94604709|NCT00417482|324015927|FG002|Phase B 1st 16 Weeks|Death|0|||
94604710|NCT00417482|324015925|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
94604711|NCT00417482|324015926|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
94604712|NCT00417482|324015927|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
94604713|NCT00417482|324015925|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
94604714|NCT00417482|324015926|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
94604715|NCT00417482|324015927|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
94604716|NCT00417482|324015925|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
94604717|NCT00417482|324015926|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
94604718|NCT00417482|324015927|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
94604719|NCT00417482|324015925|FG000|Phase B 2nd 16 Weeks|Death|1|||
94604720|NCT00417482|324015926|FG001|Phase B 2nd 16 Weeks|Death|1|||
94604721|NCT00417482|324015927|FG002|Phase B 2nd 16 Weeks|Death|0|||
94604722|NCT06400979|324015930|FG000|Overall Study|Lost to Follow-up|29|||
94604723|NCT06400979|324015930|FG000|Overall Study|Withdrawal by Subject|1|||
94604724|NCT01058265|324015935|FG000|Overall Study|Lost to Follow-up|11|||
94604725|NCT01058265|324015936|FG001|Overall Study|Lost to Follow-up|12|||
94604726|NCT02962765|324015937|FG000|Overall Study|Protocol Violation|9|||
94604727|NCT02962765|324015937|FG000|Overall Study|Withdrawal by Subject|3|||
94604728|NCT02962765|324015937|FG000|Overall Study|Lost to Follow-up|1|||
94604729|NCT02962765|324015937|FG000|Overall Study|Death|1|||
94604730|NCT02962765|324015937|FG000|Overall Study|Limited access to study medication|3|||
94604731|NCT03519386|324015938|FG000|Overall Study|Withdrawal by Subject|4|||
94604732|NCT03519386|324015939|FG001|Overall Study|Withdrawal by Subject|1|||
94604733|NCT03519386|324015940|FG002|Overall Study|Withdrawal by Subject|2|||
94604734|NCT03519386|324015938|FG000|Overall Study|Physician Decision|1|||
94604735|NCT03519386|324015939|FG001|Overall Study|Physician Decision|1|||
94604736|NCT03519386|324015940|FG002|Overall Study|Physician Decision|1|||
94249321|NCT00700427|322706544|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
94604737|NCT03519386|324015938|FG000|Overall Study|Lost to Follow-up|0|||
94604738|NCT03519386|324015939|FG001|Overall Study|Lost to Follow-up|1|||
94604739|NCT03519386|324015940|FG002|Overall Study|Lost to Follow-up|1|||
94604740|NCT03519386|324015938|FG000|Overall Study|Death|1|||
94604741|NCT03519386|324015939|FG001|Overall Study|Death|0|||
94604742|NCT03519386|324015940|FG002|Overall Study|Death|4|||
94604743|NCT03519386|324015938|FG000|Overall Study|Adverse Event|2|||
94604744|NCT03519386|324015939|FG001|Overall Study|Adverse Event|1|||
94604745|NCT03519386|324015940|FG002|Overall Study|Adverse Event|2|||
94604746|NCT03519386|324015938|FG000|Overall Study|Explanted|2|||
94604747|NCT03519386|324015939|FG001|Overall Study|Explanted|1|||
94604748|NCT03519386|324015940|FG002|Overall Study|Explanted|0|||
94604749|NCT03519386|324015938|FG000|Overall Study|Ongoing in study|190|||
94604750|NCT03519386|324015939|FG001|Overall Study|Ongoing in study|192|||
94604751|NCT03519386|324015940|FG002|Overall Study|Ongoing in study|183|||
94604752|NCT04505540|324015941|FG000|Baseline|Protocol Violation|10|||
94604753|NCT04505540|324015941|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
94604754|NCT04505540|324015941|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
94604755|NCT04505540|324015941|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
94604756|NCT04505540|324015941|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
94249322|NCT00700427|322706545|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
94249323|NCT00700427|322706546|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
94249324|NCT00700427|322706542|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
94249325|NCT00700427|322706543|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
94249326|NCT00700427|322706544|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
94249327|NCT00700427|322706545|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
94249328|NCT00700427|322706546|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
94249329|NCT00700427|322706542|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
94249330|NCT00700427|322706543|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
94249331|NCT00700427|322706544|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
94249332|NCT00700427|322706545|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
94249333|NCT00700427|322706546|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
94249334|NCT00700427|322706542|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
94249335|NCT00700427|322706543|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
94249336|NCT00700427|322706544|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
94604757|NCT04505540|324015941|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
94604758|NCT04505540|324015941|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
94604759|NCT04505540|324015941|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
94604760|NCT04505540|324015941|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
94604761|NCT04505540|324015941|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
94604762|NCT04505540|324015941|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
94604763|NCT04505540|324015941|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
94604764|NCT04505540|324015941|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
94604765|NCT01367119|324015942|FG000|Overall Study|Adverse Event|1|||
94604766|NCT01367119|324015943|FG001|Overall Study|Adverse Event|0|||
94604767|NCT01367119|324015942|FG000|Overall Study|Withdrawal by Subject|1|||
94604768|NCT01367119|324015943|FG001|Overall Study|Withdrawal by Subject|1|||
94604769|NCT01856023|324015944|FG000|Overall Study|Death|1|||
94604770|NCT01856023|324015945|FG001|Overall Study|Death|2|||
94604771|NCT01856023|324015944|FG000|Overall Study|Adverse Event|2|||
94604772|NCT01856023|324015945|FG001|Overall Study|Adverse Event|1|||
94604773|NCT01856023|324015944|FG000|Overall Study|Lack of Efficacy|5|||
94604774|NCT01856023|324015945|FG001|Overall Study|Lack of Efficacy|5|||
94604775|NCT01856023|324015944|FG000|Overall Study|non compliance, study closure|1|||
94604776|NCT01856023|324015945|FG001|Overall Study|non compliance, study closure|3|||
94604777|NCT01856023|324015944|FG000|Overall Study|Withdrawal by Subject|1|||
94604778|NCT01856023|324015945|FG001|Overall Study|Withdrawal by Subject|1|||
94249337|NCT00700427|322706545|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
94249338|NCT00700427|322706546|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
94249339|NCT00700427|322706542|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
94249340|NCT00700427|322706543|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
94249341|NCT00700427|322706544|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
94249342|NCT00700427|322706545|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
94249343|NCT00700427|322706546|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
94249344|NCT00700427|322706542|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
94249345|NCT00700427|322706543|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
94249346|NCT00700427|322706544|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
94249347|NCT00700427|322706545|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
94604779|NCT00245583|324015948|FG000|Overall Study|Lost to Follow-up|1|||
94604780|NCT00245583|324015949|FG001|Overall Study|Lost to Follow-up|5|||
94249348|NCT00700427|322706546|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
94249349|NCT00700427|322706542|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
94249350|NCT00700427|322706543|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
94249351|NCT00700427|322706544|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
94604781|NCT00245583|324015948|FG000|Overall Study|Adverse Event|2|||
94604782|NCT00245583|324015949|FG001|Overall Study|Adverse Event|1|||
94249352|NCT00700427|322706545|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
94604783|NCT00245583|324015948|FG000|Overall Study|Lack of Efficacy|1|||
94604784|NCT00245583|324015949|FG001|Overall Study|Lack of Efficacy|0|||
94604785|NCT00245583|324015948|FG000|Overall Study|Withdrawal by Subject|2|||
94604786|NCT00245583|324015949|FG001|Overall Study|Withdrawal by Subject|3|||
94604787|NCT00829283|324015950|FG000|Overall Study|Lost to Follow-up|7|||
94604788|NCT00829283|324015951|FG001|Overall Study|Lost to Follow-up|25|||
94604789|NCT02273739|324015952|FG000|Overall Study|Progression of Disease|3|||
94604790|NCT02273739|324015953|FG001|Overall Study|Progression of Disease|4|||
94604791|NCT02273739|324015954|FG002|Overall Study|Progression of Disease|5|||
94604792|NCT02273739|324015955|FG003|Overall Study|Progression of Disease|2|||
94604793|NCT02273739|324015952|FG000|Overall Study|Death|0|||
94604794|NCT02273739|324015953|FG001|Overall Study|Death|0|||
94604795|NCT02273739|324015954|FG002|Overall Study|Death|0|||
94604796|NCT02273739|324015955|FG003|Overall Study|Death|2|||
94604797|NCT02273739|324015952|FG000|Overall Study|Adverse Event|0|||
94604798|NCT02273739|324015953|FG001|Overall Study|Adverse Event|0|||
94604799|NCT02273739|324015954|FG002|Overall Study|Adverse Event|0|||
94604800|NCT02273739|324015955|FG003|Overall Study|Adverse Event|1|||
94604801|NCT02273739|324015952|FG000|Overall Study|Withdrawal by Subject|0|||
94604802|NCT02273739|324015953|FG001|Overall Study|Withdrawal by Subject|0|||
94604803|NCT02273739|324015954|FG002|Overall Study|Withdrawal by Subject|2|||
94604804|NCT02273739|324015955|FG003|Overall Study|Withdrawal by Subject|1|||
94604805|NCT02273739|324015952|FG000|Overall Study|Physician Decision|0|||
94604806|NCT02273739|324015953|FG001|Overall Study|Physician Decision|0|||
94604807|NCT02273739|324015954|FG002|Overall Study|Physician Decision|0|||
94604808|NCT02273739|324015955|FG003|Overall Study|Physician Decision|1|||
94604809|NCT00667446|324015956|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
94604810|NCT00667446|324015957|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
94604811|NCT00667446|324015956|FG000|Treatment Period (36 Months)|Other|2|||
94604812|NCT00667446|324015957|FG001|Treatment Period (36 Months)|Other|2|||
94604813|NCT00667446|324015956|FG000|Treatment Period (36 Months)|Personal reasons|2|||
94604814|NCT00667446|324015957|FG001|Treatment Period (36 Months)|Personal reasons|2|||
94604815|NCT00667446|324015956|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
94604816|NCT00667446|324015957|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
94604817|NCT00667446|324015956|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
94604818|NCT00667446|324015957|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
94604819|NCT00667446|324015956|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
94356440|NCT04145531|323087171|FG003|Part A|Physician Decision|0|||
94604820|NCT00667446|324015957|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
94604821|NCT00667446|324015956|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
94604822|NCT00667446|324015957|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
94604823|NCT00667446|324015956|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
94604824|NCT00667446|324015957|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
94604825|NCT00667446|324015956|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
94604826|NCT00667446|324015957|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
94604827|NCT01309893|324015959|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
94604828|NCT01309893|324015960|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
94604829|NCT01309893|324015959|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
94604830|NCT01309893|324015960|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
94604831|NCT03631355|324015961|FG000|Overall Study|Lost to Follow-up|1|||
94604832|NCT03631355|324015962|FG001|Overall Study|Lost to Follow-up|2|||
94604833|NCT04473482|324015963|FG000|Overall Study|Death|0|||
94604834|NCT04473482|324015964|FG001|Overall Study|Death|3|||
94604835|NCT04473482|324015963|FG000|Overall Study|Lost to Follow-up|9|||
94604836|NCT04473482|324015964|FG001|Overall Study|Lost to Follow-up|7|||
94604837|NCT04473482|324015963|FG000|Overall Study|Withdrawal by Subject|2|||
94604838|NCT04473482|324015964|FG001|Overall Study|Withdrawal by Subject|1|||
94604839|NCT00938964|324015965|FG000|Overall Study|Death|3|||
94356441|NCT04145531|323087168|FG000|Part A|Progressive disease|0|||
94356442|NCT04145531|323087169|FG001|Part A|Progressive disease|2|||
94604840|NCT00938964|324015966|FG001|Overall Study|Death|3|||
94604841|NCT00938964|324015965|FG000|Overall Study|Lost to Follow-up|2|||
94604842|NCT00938964|324015966|FG001|Overall Study|Lost to Follow-up|3|||
94604843|NCT00938964|324015965|FG000|Overall Study|Withdrawal by Subject|22|||
94604844|NCT00938964|324015966|FG001|Overall Study|Withdrawal by Subject|18|||
94604845|NCT00938964|324015965|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
94604846|NCT00938964|324015966|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
94604847|NCT01858636|324015967|FG000|Overall Study|No Device Deployment Attempted|24|||
94604848|NCT01858636|324015967|FG000|Overall Study|Physician Decision|1|||
94604849|NCT01858636|324015967|FG000|Overall Study|Death|1|||
94604850|NCT01858636|324015967|FG000|Overall Study|Lost to Follow-up|1|||
94604851|NCT01858636|324015967|FG000|Overall Study|Withdrawal by Subject|1|||
94604852|NCT00321893|324015968|FG000|Overall Study|Non-Compliance/Refusal|16|||
94604853|NCT00321893|324015969|FG001|Overall Study|Non-Compliance/Refusal|10|||
94604854|NCT00321893|324015968|FG000|Overall Study|Lost to Follow-up|2|||
94604855|NCT00321893|324015969|FG001|Overall Study|Lost to Follow-up|1|||
94604856|NCT00321893|324015968|FG000|Overall Study|Adverse Event|6|||
94604857|NCT00321893|324015969|FG001|Overall Study|Adverse Event|3|||
94604858|NCT01227564|324015975|FG000|Overall Study|No Longer Willing to Participate|4|||
94604859|NCT01227564|324015976|FG001|Overall Study|No Longer Willing to Participate|2|||
94604860|NCT01227564|324015977|FG002|Overall Study|No Longer Willing to Participate|5|||
94604861|NCT01227564|324015975|FG000|Overall Study|Participant moved to another town|0|||
94604862|NCT01227564|324015976|FG001|Overall Study|Participant moved to another town|0|||
94604863|NCT01227564|324015977|FG002|Overall Study|Participant moved to another town|1|||
94604864|NCT00989573|324015988|FG000|Overall Study|Adverse Event|8|||
94604865|NCT00989573|324015989|FG001|Overall Study|Adverse Event|12|||
94604866|NCT00989573|324015990|FG002|Overall Study|Adverse Event|4|||
94604867|NCT00989573|324015988|FG000|Overall Study|Physician Decision|0|||
94604868|NCT00989573|324015989|FG001|Overall Study|Physician Decision|2|||
94604869|NCT00989573|324015990|FG002|Overall Study|Physician Decision|0|||
94604870|NCT00989573|324015988|FG000|Overall Study|Protocol Violation|1|||
94604871|NCT00989573|324015989|FG001|Overall Study|Protocol Violation|1|||
94604872|NCT00989573|324015990|FG002|Overall Study|Protocol Violation|1|||
94604873|NCT00989573|324015988|FG000|Overall Study|Withdrawal by Subject|4|||
94604874|NCT00989573|324015989|FG001|Overall Study|Withdrawal by Subject|7|||
94604875|NCT00989573|324015990|FG002|Overall Study|Withdrawal by Subject|3|||
94604876|NCT00772070|324015999|FG000|Overall Study|Lost to Follow-up|0|||
94604877|NCT00772070|324016000|FG001|Overall Study|Lost to Follow-up|8|||
94604878|NCT00772070|324015999|FG000|Overall Study|Withdrawal by Subject|0|||
94604879|NCT00772070|324016000|FG001|Overall Study|Withdrawal by Subject|2|||
94604880|NCT00772070|324015999|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
94604881|NCT00772070|324016000|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
94604882|NCT04271280|324016002|FG000|Overall Study|Lost to Follow-up|300|||
94604883|NCT04271280|324016002|FG000|Overall Study|Death|153|||
94604884|NCT04271280|324016002|FG000|Overall Study|Withdrawal of consent by patient|59|||
94604885|NCT04271280|324016002|FG000|Overall Study|Other|51|||
94604886|NCT04271280|324016002|FG000|Overall Study|No end of study information|42|||
94604887|NCT01226043|324016009|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
94604888|NCT01226043|324016010|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
94604889|NCT01226043|324016011|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
94604890|NCT01226043|324016012|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
94604891|NCT01226043|324016009|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
94604892|NCT01226043|324016010|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
94604893|NCT01226043|324016011|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
94604894|NCT01226043|324016012|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
94604895|NCT01226043|324016009|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
94604896|NCT01226043|324016010|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
94604897|NCT01226043|324016011|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
94604898|NCT01226043|324016012|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
94604899|NCT01226043|324016009|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
94604900|NCT01226043|324016010|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
94604901|NCT01226043|324016011|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
94604902|NCT01226043|324016012|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
94604903|NCT01226043|324016009|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
94604904|NCT01226043|324016010|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
94604905|NCT01226043|324016011|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
94604906|NCT01226043|324016012|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
94604907|NCT01226043|324016009|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
94604908|NCT01226043|324016010|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
94604909|NCT01226043|324016011|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
94604910|NCT01226043|324016012|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
94249353|NCT00700427|322706546|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
94249354|NCT00700427|322706542|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
94249355|NCT00700427|322706543|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
94249356|NCT00700427|322706544|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
94249357|NCT00700427|322706545|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
94249358|NCT00700427|322706546|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
94604911|NCT01226043|324016009|FG000|6-week Re-randomization Phase|Adverse Event|0|||
94604912|NCT01226043|324016010|FG001|6-week Re-randomization Phase|Adverse Event|0|||
94604913|NCT01226043|324016011|FG002|6-week Re-randomization Phase|Adverse Event|1|||
94604914|NCT01226043|324016012|FG003|6-week Re-randomization Phase|Adverse Event|1|||
94604915|NCT01226043|324016009|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
94604916|NCT01226043|324016010|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
94604917|NCT01226043|324016011|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
94604918|NCT01226043|324016012|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
94604919|NCT01226043|324016009|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
94356443|NCT04145531|323087170|FG002|Part A|Progressive disease|1|||
94356444|NCT04145531|323087171|FG003|Part A|Progressive disease|0|||
94356445|NCT04145531|323087168|FG000|Part A|Protocol deviation|0|||
94356446|NCT04145531|323087169|FG001|Part A|Protocol deviation|0|||
94356447|NCT04145531|323087170|FG002|Part A|Protocol deviation|1|||
94356448|NCT04145531|323087171|FG003|Part A|Protocol deviation|0|||
94356449|NCT04145531|323087168|FG000|Part A|Withdrawal by parent or guardian|1|||
94356450|NCT04145531|323087169|FG001|Part A|Withdrawal by parent or guardian|0|||
94356451|NCT04145531|323087170|FG002|Part A|Withdrawal by parent or guardian|0|||
94604920|NCT01226043|324016010|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
94604921|NCT01226043|324016011|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
94604922|NCT01226043|324016012|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
94604923|NCT01226043|324016009|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
94604924|NCT01226043|324016010|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
94604925|NCT01226043|324016011|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
94604926|NCT01226043|324016012|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
94604927|NCT01226043|324016009|FG000|6-week Re-randomization Phase|Physician Decision|0|||
94604928|NCT01226043|324016010|FG001|6-week Re-randomization Phase|Physician Decision|0|||
94604929|NCT01226043|324016011|FG002|6-week Re-randomization Phase|Physician Decision|3|||
94604930|NCT01226043|324016012|FG003|6-week Re-randomization Phase|Physician Decision|2|||
94604931|NCT01226043|324016009|FG000|6-week Re-randomization Phase|completed in error|0|||
94604932|NCT01226043|324016010|FG001|6-week Re-randomization Phase|completed in error|0|||
94604933|NCT01226043|324016011|FG002|6-week Re-randomization Phase|completed in error|0|||
94604934|NCT01226043|324016012|FG003|6-week Re-randomization Phase|completed in error|1|||
94604935|NCT01226043|324016009|FG000|30-week Observational Phase|Adverse Event|0|||
94604936|NCT01226043|324016010|FG001|30-week Observational Phase|Adverse Event|0|||
94604937|NCT01226043|324016011|FG002|30-week Observational Phase|Adverse Event|1|||
94604938|NCT01226043|324016012|FG003|30-week Observational Phase|Adverse Event|1|||
94604939|NCT01226043|324016009|FG000|30-week Observational Phase|Protocol Violation|0|||
94604940|NCT01226043|324016010|FG001|30-week Observational Phase|Protocol Violation|0|||
94604941|NCT01226043|324016011|FG002|30-week Observational Phase|Protocol Violation|0|||
94604942|NCT01226043|324016012|FG003|30-week Observational Phase|Protocol Violation|1|||
94604943|NCT01226043|324016009|FG000|30-week Observational Phase|Lost to Follow-up|0|||
94604944|NCT01226043|324016010|FG001|30-week Observational Phase|Lost to Follow-up|0|||
94604945|NCT01226043|324016011|FG002|30-week Observational Phase|Lost to Follow-up|2|||
94604946|NCT01226043|324016012|FG003|30-week Observational Phase|Lost to Follow-up|2|||
94604947|NCT01226043|324016009|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
94604948|NCT01226043|324016010|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
94604949|NCT01226043|324016011|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
94604950|NCT01226043|324016012|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
94604951|NCT01226043|324016009|FG000|30-week Observational Phase|Physician Decision|0|||
94604952|NCT01226043|324016010|FG001|30-week Observational Phase|Physician Decision|0|||
94604953|NCT01226043|324016011|FG002|30-week Observational Phase|Physician Decision|2|||
94604954|NCT01226043|324016012|FG003|30-week Observational Phase|Physician Decision|2|||
94604955|NCT02204007|324016013|FG000|Overall Study|Surgery Canceled|1|||
94604956|NCT02204007|324016014|FG001|Overall Study|Surgery Canceled|1|||
94604957|NCT01758289|324016021|FG000|Overall Study|Premature Study Termination|44|||
94604958|NCT01758289|324016021|FG000|Overall Study|Adverse Event|9|||
94604959|NCT01574079|324016022|FG000|Overall Study|Physician Decision|0|||
94604960|NCT01574079|324016023|FG001|Overall Study|Physician Decision|2|||
94604961|NCT01574079|324016022|FG000|Overall Study|Lost to Follow-up|1|||
94604962|NCT01574079|324016023|FG001|Overall Study|Lost to Follow-up|0|||
94604963|NCT00973349|324016026|FG000|Overall Study|Adverse Event|0|||
94604964|NCT00973349|324016027|FG001|Overall Study|Adverse Event|0|||
94604965|NCT00973349|324016028|FG002|Overall Study|Adverse Event|0|||
94604966|NCT00973349|324016029|FG003|Overall Study|Adverse Event|0|||
94604967|NCT00973349|324016030|FG004|Overall Study|Adverse Event|1|||
94604968|NCT00973349|324016031|FG005|Overall Study|Adverse Event|0|||
94604969|NCT00973349|324016032|FG006|Overall Study|Adverse Event|0|||
94604970|NCT00973349|324016033|FG007|Overall Study|Adverse Event|0|||
94604971|NCT00973349|324016034|FG008|Overall Study|Adverse Event|1|||
94604972|NCT00973349|324016035|FG009|Overall Study|Adverse Event|0|||
94356452|NCT04145531|323087171|FG003|Part A|Withdrawal by parent or guardian|0|||
94356453|NCT04145531|323087168|FG000|Part A|Withdrawal by participant|0|||
94356454|NCT04145531|323087169|FG001|Part A|Withdrawal by participant|0|||
94604973|NCT00973349|324016036|FG010|Overall Study|Adverse Event|0|||
94604974|NCT00973349|324016037|FG011|Overall Study|Adverse Event|0|||
94604975|NCT00973349|324016038|FG012|Overall Study|Adverse Event|0|||
94604976|NCT00973349|324016039|FG013|Overall Study|Adverse Event|0|||
94604977|NCT00973349|324016040|FG014|Overall Study|Adverse Event|1|||
94604978|NCT00973349|324016041|FG015|Overall Study|Adverse Event|0|||
94604979|NCT00973349|324016026|FG000|Overall Study|Withdrawal by Subject|1|||
94604980|NCT00973349|324016027|FG001|Overall Study|Withdrawal by Subject|2|||
94604981|NCT00973349|324016028|FG002|Overall Study|Withdrawal by Subject|2|||
94604982|NCT00973349|324016029|FG003|Overall Study|Withdrawal by Subject|3|||
94604983|NCT00973349|324016030|FG004|Overall Study|Withdrawal by Subject|2|||
94604984|NCT00973349|324016031|FG005|Overall Study|Withdrawal by Subject|0|||
94604985|NCT00973349|324016032|FG006|Overall Study|Withdrawal by Subject|2|||
94604986|NCT00973349|324016033|FG007|Overall Study|Withdrawal by Subject|2|||
94604987|NCT00973349|324016034|FG008|Overall Study|Withdrawal by Subject|0|||
94604988|NCT00973349|324016035|FG009|Overall Study|Withdrawal by Subject|2|||
94604989|NCT00973349|324016036|FG010|Overall Study|Withdrawal by Subject|0|||
94604990|NCT00973349|324016037|FG011|Overall Study|Withdrawal by Subject|1|||
94604991|NCT00973349|324016038|FG012|Overall Study|Withdrawal by Subject|0|||
94604992|NCT00973349|324016039|FG013|Overall Study|Withdrawal by Subject|0|||
94604993|NCT00973349|324016040|FG014|Overall Study|Withdrawal by Subject|0|||
94604994|NCT00973349|324016041|FG015|Overall Study|Withdrawal by Subject|0|||
94604995|NCT00973349|324016026|FG000|Overall Study|Lost to Follow-up|3|||
94604996|NCT00973349|324016027|FG001|Overall Study|Lost to Follow-up|1|||
94604997|NCT00973349|324016028|FG002|Overall Study|Lost to Follow-up|2|||
94604998|NCT00973349|324016029|FG003|Overall Study|Lost to Follow-up|2|||
94604999|NCT00973349|324016030|FG004|Overall Study|Lost to Follow-up|1|||
94605000|NCT00973349|324016031|FG005|Overall Study|Lost to Follow-up|3|||
94605001|NCT00973349|324016032|FG006|Overall Study|Lost to Follow-up|0|||
94605002|NCT00973349|324016033|FG007|Overall Study|Lost to Follow-up|1|||
94605003|NCT00973349|324016034|FG008|Overall Study|Lost to Follow-up|2|||
94605004|NCT00973349|324016035|FG009|Overall Study|Lost to Follow-up|1|||
94605005|NCT00973349|324016036|FG010|Overall Study|Lost to Follow-up|0|||
94605006|NCT00973349|324016037|FG011|Overall Study|Lost to Follow-up|1|||
94605007|NCT00973349|324016038|FG012|Overall Study|Lost to Follow-up|0|||
94605008|NCT00973349|324016039|FG013|Overall Study|Lost to Follow-up|0|||
94605009|NCT00973349|324016040|FG014|Overall Study|Lost to Follow-up|0|||
94605010|NCT00973349|324016041|FG015|Overall Study|Lost to Follow-up|1|||
94605011|NCT00973349|324016026|FG000|Overall Study|Inappropriate enrolment|0|||
94605012|NCT00973349|324016027|FG001|Overall Study|Inappropriate enrolment|0|||
94605013|NCT00973349|324016028|FG002|Overall Study|Inappropriate enrolment|1|||
94605014|NCT00973349|324016029|FG003|Overall Study|Inappropriate enrolment|0|||
94605015|NCT00973349|324016030|FG004|Overall Study|Inappropriate enrolment|0|||
94605016|NCT00973349|324016031|FG005|Overall Study|Inappropriate enrolment|0|||
94605017|NCT00973349|324016032|FG006|Overall Study|Inappropriate enrolment|0|||
94605018|NCT00973349|324016033|FG007|Overall Study|Inappropriate enrolment|0|||
94605019|NCT00973349|324016034|FG008|Overall Study|Inappropriate enrolment|0|||
94605020|NCT00973349|324016035|FG009|Overall Study|Inappropriate enrolment|2|||
94605021|NCT00973349|324016036|FG010|Overall Study|Inappropriate enrolment|0|||
94605022|NCT00973349|324016037|FG011|Overall Study|Inappropriate enrolment|0|||
94605023|NCT00973349|324016038|FG012|Overall Study|Inappropriate enrolment|1|||
94605024|NCT00973349|324016039|FG013|Overall Study|Inappropriate enrolment|0|||
94605025|NCT00973349|324016040|FG014|Overall Study|Inappropriate enrolment|1|||
94605026|NCT00973349|324016041|FG015|Overall Study|Inappropriate enrolment|1|||
94605027|NCT00973349|324016026|FG000|Overall Study|Protocol Violation|0|||
94605028|NCT00973349|324016027|FG001|Overall Study|Protocol Violation|0|||
94605029|NCT00973349|324016028|FG002|Overall Study|Protocol Violation|0|||
94605030|NCT00973349|324016029|FG003|Overall Study|Protocol Violation|0|||
94605031|NCT00973349|324016030|FG004|Overall Study|Protocol Violation|0|||
94605032|NCT00973349|324016031|FG005|Overall Study|Protocol Violation|0|||
94605033|NCT00973349|324016032|FG006|Overall Study|Protocol Violation|0|||
94605034|NCT00973349|324016033|FG007|Overall Study|Protocol Violation|0|||
94661395|NCT03579459|324215712|FG000|Overall Study|Randomized not vaccinated|0|||
94661396|NCT03579459|324215713|FG001|Overall Study|Randomized not vaccinated|2|||
94605035|NCT00973349|324016034|FG008|Overall Study|Protocol Violation|1|||
94605036|NCT00973349|324016035|FG009|Overall Study|Protocol Violation|0|||
94605037|NCT00973349|324016036|FG010|Overall Study|Protocol Violation|0|||
94605038|NCT00973349|324016037|FG011|Overall Study|Protocol Violation|0|||
94605039|NCT00973349|324016038|FG012|Overall Study|Protocol Violation|0|||
94605040|NCT00973349|324016039|FG013|Overall Study|Protocol Violation|0|||
94661397|NCT03579459|324215714|FG002|Overall Study|Randomized not vaccinated|0|||
94661398|NCT03579459|324215715|FG003|Overall Study|Randomized not vaccinated|1|||
94661399|NCT01854827|324215716|FG000|Overall Study|Death|1|||
94605041|NCT00973349|324016040|FG014|Overall Study|Protocol Violation|0|||
94605042|NCT00973349|324016041|FG015|Overall Study|Protocol Violation|0|||
94605043|NCT00973349|324016026|FG000|Overall Study|Unable to classify|0|||
94605044|NCT00973349|324016027|FG001|Overall Study|Unable to classify|0|||
94605045|NCT00973349|324016028|FG002|Overall Study|Unable to classify|0|||
94249359|NCT00700427|322706542|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
94249360|NCT00700427|322706543|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
94249361|NCT00700427|322706544|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
94605046|NCT00973349|324016029|FG003|Overall Study|Unable to classify|0|||
94605047|NCT00973349|324016030|FG004|Overall Study|Unable to classify|1|||
94605048|NCT00973349|324016031|FG005|Overall Study|Unable to classify|1|||
94605049|NCT00973349|324016032|FG006|Overall Study|Unable to classify|0|||
94605050|NCT00973349|324016033|FG007|Overall Study|Unable to classify|0|||
94605051|NCT00973349|324016034|FG008|Overall Study|Unable to classify|0|||
94605052|NCT00973349|324016035|FG009|Overall Study|Unable to classify|1|||
94605053|NCT00973349|324016036|FG010|Overall Study|Unable to classify|0|||
94605054|NCT00973349|324016037|FG011|Overall Study|Unable to classify|0|||
94605055|NCT00973349|324016038|FG012|Overall Study|Unable to classify|0|||
94605056|NCT00973349|324016039|FG013|Overall Study|Unable to classify|0|||
94605057|NCT00973349|324016040|FG014|Overall Study|Unable to classify|0|||
94605058|NCT00973349|324016041|FG015|Overall Study|Unable to classify|0|||
94605059|NCT02718300|324016048|FG000|Overall Study|Death|4|||
94605060|NCT02718300|324016049|FG001|Overall Study|Death|5|||
94605061|NCT02718300|324016050|FG002|Overall Study|Death|17|||
94605062|NCT02718300|324016048|FG000|Overall Study|Lost to Follow-up|1|||
94605063|NCT02718300|324016049|FG001|Overall Study|Lost to Follow-up|0|||
94605064|NCT02718300|324016050|FG002|Overall Study|Lost to Follow-up|2|||
94605065|NCT02718300|324016048|FG000|Overall Study|Physician Decision|1|||
94605066|NCT02718300|324016049|FG001|Overall Study|Physician Decision|0|||
94605067|NCT02718300|324016050|FG002|Overall Study|Physician Decision|2|||
94605068|NCT02718300|324016048|FG000|Overall Study|Study Terminated by Sponsor|6|||
94605069|NCT02718300|324016049|FG001|Overall Study|Study Terminated by Sponsor|3|||
94605070|NCT02718300|324016050|FG002|Overall Study|Study Terminated by Sponsor|4|||
94605071|NCT02718300|324016048|FG000|Overall Study|Withdrawal by Subject|0|||
94605072|NCT02718300|324016049|FG001|Overall Study|Withdrawal by Subject|4|||
94605073|NCT02718300|324016050|FG002|Overall Study|Withdrawal by Subject|3|||
94605074|NCT02718300|324016048|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
94605075|NCT02718300|324016049|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
94605076|NCT02718300|324016050|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
94605077|NCT02452697|324016053|FG000|Overall Study|Physician Decision|4|||
94605078|NCT02452697|324016054|FG001|Overall Study|Physician Decision|4|||
94605079|NCT02452697|324016055|FG002|Overall Study|Physician Decision|3|||
94605080|NCT02452697|324016056|FG003|Overall Study|Physician Decision|2|||
94605081|NCT02452697|324016053|FG000|Overall Study|Withdrawal by Subject|1|||
94605082|NCT02452697|324016054|FG001|Overall Study|Withdrawal by Subject|0|||
94605083|NCT02452697|324016055|FG002|Overall Study|Withdrawal by Subject|0|||
94605084|NCT02452697|324016056|FG003|Overall Study|Withdrawal by Subject|0|||
94605085|NCT02452697|324016053|FG000|Overall Study|still in follow-up|2|||
94605086|NCT02452697|324016054|FG001|Overall Study|still in follow-up|2|||
94605087|NCT02452697|324016055|FG002|Overall Study|still in follow-up|1|||
94605088|NCT02452697|324016056|FG003|Overall Study|still in follow-up|3|||
94605089|NCT00543855|324017893|FG000|Overall Study|Adverse Event|3|||
94605090|NCT00543855|324017894|FG001|Overall Study|Adverse Event|1|||
94605091|NCT00543855|324017895|FG002|Overall Study|Adverse Event|3|||
94605092|NCT00543855|324017896|FG003|Overall Study|Adverse Event|4|||
94605093|NCT00543855|324017893|FG000|Overall Study|Lost to Follow-up|0|||
94605094|NCT00543855|324017894|FG001|Overall Study|Lost to Follow-up|0|||
94605095|NCT00543855|324017895|FG002|Overall Study|Lost to Follow-up|1|||
94605096|NCT00543855|324017896|FG003|Overall Study|Lost to Follow-up|0|||
94605097|NCT00543855|324017893|FG000|Overall Study|Withdrawal by Subject|0|||
94605098|NCT00543855|324017894|FG001|Overall Study|Withdrawal by Subject|1|||
94605099|NCT00543855|324017895|FG002|Overall Study|Withdrawal by Subject|2|||
94605100|NCT00543855|324017896|FG003|Overall Study|Withdrawal by Subject|0|||
94605101|NCT00543855|324017893|FG000|Overall Study|Protocol Violation|1|||
94605102|NCT00543855|324017894|FG001|Overall Study|Protocol Violation|0|||
94605103|NCT00543855|324017895|FG002|Overall Study|Protocol Violation|0|||
94605104|NCT00543855|324017896|FG003|Overall Study|Protocol Violation|0|||
94605105|NCT00076024|324017897|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
94605106|NCT00076024|324017898|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
94605107|NCT00076024|324017899|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
94605108|NCT00076024|324017900|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
94605109|NCT00076024|324017897|FG000|Phase 1, Lead-in|Adverse Event|1|||
94605110|NCT00076024|324017898|FG001|Phase 1, Lead-in|Adverse Event|0|||
94605111|NCT00076024|324017899|FG002|Phase 1, Lead-in|Adverse Event|0|||
94249362|NCT00700427|322706545|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
94605112|NCT00076024|324017900|FG003|Phase 1, Lead-in|Adverse Event|0|||
94605113|NCT00076024|324017897|FG000|Phase 1, Lead-in|Clinical progression|1|||
94605114|NCT00076024|324017898|FG001|Phase 1, Lead-in|Clinical progression|0|||
94605115|NCT00076024|324017899|FG002|Phase 1, Lead-in|Clinical progression|0|||
94605116|NCT00076024|324017900|FG003|Phase 1, Lead-in|Clinical progression|0|||
94605117|NCT00076024|324017897|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
94249363|NCT00700427|322706546|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
94605118|NCT00076024|324017898|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
94605119|NCT00076024|324017899|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
94605120|NCT00076024|324017900|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
94605121|NCT00076024|324017897|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
94249364|NCT00700427|322706542|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
94249365|NCT00700427|322706543|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
94249366|NCT00700427|322706544|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
94249367|NCT00700427|322706545|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
94249368|NCT00700427|322706546|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
94249369|NCT00700427|322706542|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
94249370|NCT00700427|322706543|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
94249371|NCT00700427|322706544|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
94249372|NCT00700427|322706545|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
94249373|NCT00700427|322706546|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
94249374|NCT00700427|322706542|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
94249375|NCT00700427|322706543|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
94249376|NCT00700427|322706544|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
94249377|NCT00700427|322706545|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
94249378|NCT00700427|322706546|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
94249379|NCT00700427|322706542|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
94249380|NCT00700427|322706543|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
94249381|NCT00700427|322706544|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
94249382|NCT00700427|322706545|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
94249383|NCT00700427|322706546|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
94249384|NCT00700427|322706542|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
94249385|NCT00700427|322706543|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
94249386|NCT00700427|322706544|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
94249387|NCT00700427|322706545|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
94249388|NCT00700427|322706546|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
94249389|NCT00700427|322706542|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
94249390|NCT00700427|322706543|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
94249391|NCT00700427|322706544|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
94249392|NCT00700427|322706545|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
94249393|NCT00700427|322706546|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
94249394|NCT00700427|322706542|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
94249395|NCT00700427|322706543|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
94249396|NCT00700427|322706544|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
94249397|NCT00700427|322706545|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
94249398|NCT00700427|322706546|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
94249399|NCT00700427|322706542|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
94249400|NCT00700427|322706543|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
94249401|NCT00700427|322706544|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
94249402|NCT00700427|322706545|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
94249403|NCT00700427|322706546|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
94249404|NCT00700427|322706542|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
94249405|NCT00700427|322706543|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
94249406|NCT00700427|322706544|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
94249407|NCT00700427|322706545|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
94249408|NCT00700427|322706546|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
94249409|NCT00700427|322706542|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
94249410|NCT00700427|322706543|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
94249411|NCT00700427|322706544|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
94249412|NCT00700427|322706545|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
94249413|NCT00700427|322706546|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
94249414|NCT00700427|322706542|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
94249415|NCT00700427|322706543|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
94356455|NCT04145531|323087170|FG002|Part A|Withdrawal by participant|1|||
94356456|NCT04145531|323087171|FG003|Part A|Withdrawal by participant|0|||
94356457|NCT04145531|323087168|FG000|Part A|Other|0|||
94356458|NCT04145531|323087169|FG001|Part A|Other|0|||
94356459|NCT04145531|323087170|FG002|Part A|Other|1|||
94605122|NCT00076024|324017898|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
94605123|NCT00076024|324017899|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
94605124|NCT00076024|324017900|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
94605125|NCT00076024|324017897|FG000|Phase 2, Double-blind|Adverse Event|0|||
94605126|NCT00076024|324017898|FG001|Phase 2, Double-blind|Adverse Event|25|||
94458158|NCT01647516|323465685|FG003|Open-Label Period|Non-compliance|1|||
94605127|NCT00076024|324017899|FG002|Phase 2, Double-blind|Adverse Event|6|||
94605128|NCT00076024|324017900|FG003|Phase 2, Double-blind|Adverse Event|0|||
94605129|NCT00076024|324017897|FG000|Phase 2, Double-blind|Un-specified|0|||
94605130|NCT00076024|324017898|FG001|Phase 2, Double-blind|Un-specified|14|||
94605131|NCT00076024|324017899|FG002|Phase 2, Double-blind|Un-specified|6|||
94605132|NCT00076024|324017900|FG003|Phase 2, Double-blind|Un-specified|0|||
94605133|NCT00076024|324017897|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
94605134|NCT00076024|324017898|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
94605135|NCT00076024|324017899|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
94605136|NCT00076024|324017900|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
94605137|NCT00076024|324017897|FG000|Phase 2, Open-label|Adverse Event|0|||
94605138|NCT00076024|324017898|FG001|Phase 2, Open-label|Adverse Event|0|||
94605139|NCT00076024|324017899|FG002|Phase 2, Open-label|Adverse Event|0|||
94605140|NCT00076024|324017900|FG003|Phase 2, Open-label|Adverse Event|2|||
94605141|NCT00076024|324017897|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
94605142|NCT00076024|324017898|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
94605143|NCT00076024|324017899|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
94605144|NCT00076024|324017900|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
94356460|NCT04145531|323087171|FG003|Part A|Other|0|||
94356461|NCT04145531|323087168|FG000|Part B|Adverse Event|0|||
94356462|NCT04145531|323087169|FG001|Part B|Adverse Event|0|||
94356463|NCT04145531|323087170|FG002|Part B|Adverse Event|0|||
94356464|NCT04145531|323087171|FG003|Part B|Adverse Event|21|||
94458159|NCT01647516|323465686|FG004|Open-Label Period|Non-compliance|0|||
94458160|NCT01647516|323465687|FG005|Open-Label Period|Non-compliance|1|||
94458161|NCT01647516|323465682|FG000|Open-Label Period|Physician Decision|0|||
94458162|NCT01647516|323465683|FG001|Open-Label Period|Physician Decision|0|||
94458163|NCT01647516|323465684|FG002|Open-Label Period|Physician Decision|0|||
94458164|NCT01647516|323465685|FG003|Open-Label Period|Physician Decision|1|||
94458165|NCT01647516|323465686|FG004|Open-Label Period|Physician Decision|1|||
94458166|NCT01647516|323465687|FG005|Open-Label Period|Physician Decision|0|||
94458167|NCT01647516|323465682|FG000|Open-Label Period|Withdrawal by Subject|0|||
94458168|NCT01647516|323465683|FG001|Open-Label Period|Withdrawal by Subject|0|||
94458169|NCT01647516|323465684|FG002|Open-Label Period|Withdrawal by Subject|0|||
94458170|NCT01647516|323465685|FG003|Open-Label Period|Withdrawal by Subject|9|||
94458171|NCT01647516|323465686|FG004|Open-Label Period|Withdrawal by Subject|11|||
94458172|NCT01647516|323465687|FG005|Open-Label Period|Withdrawal by Subject|6|||
94458173|NCT01647516|323465682|FG000|Open-Label Period|Lost to Follow-up|0|||
94458174|NCT01647516|323465683|FG001|Open-Label Period|Lost to Follow-up|0|||
94458175|NCT01647516|323465684|FG002|Open-Label Period|Lost to Follow-up|0|||
94458176|NCT01647516|323465685|FG003|Open-Label Period|Lost to Follow-up|1|||
94458177|NCT01647516|323465686|FG004|Open-Label Period|Lost to Follow-up|0|||
94458178|NCT01647516|323465687|FG005|Open-Label Period|Lost to Follow-up|1|||
94458179|NCT01647516|323465682|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
94458180|NCT01647516|323465683|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
94458181|NCT01647516|323465684|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
94458182|NCT01647516|323465685|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
94458183|NCT01647516|323465686|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
94458184|NCT01647516|323465687|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
94458185|NCT01647516|323465682|FG000|Open-Label Period|Lack of Efficacy|0|||
94458186|NCT01647516|323465683|FG001|Open-Label Period|Lack of Efficacy|0|||
94458187|NCT01647516|323465684|FG002|Open-Label Period|Lack of Efficacy|0|||
94458188|NCT01647516|323465685|FG003|Open-Label Period|Lack of Efficacy|7|||
94458189|NCT01647516|323465686|FG004|Open-Label Period|Lack of Efficacy|9|||
94458190|NCT01647516|323465687|FG005|Open-Label Period|Lack of Efficacy|10|||
94458191|NCT01647516|323465682|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
94458192|NCT01647516|323465683|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
94458193|NCT01647516|323465684|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
94458194|NCT01647516|323465685|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
94458195|NCT01647516|323465686|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
94458196|NCT01647516|323465687|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
94605145|NCT00076024|324017897|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
94356465|NCT04145531|323087168|FG000|Part B|Physician Decision|0|||
94356466|NCT04145531|323087169|FG001|Part B|Physician Decision|0|||
94356467|NCT04145531|323087170|FG002|Part B|Physician Decision|0|||
94458197|NCT01647516|323465682|FG000|Open-Label Period|No completion / discontinuation visit|0|||
94605146|NCT00076024|324017898|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
94356468|NCT04145531|323087171|FG003|Part B|Physician Decision|7|||
94356469|NCT04145531|323087168|FG000|Part B|Progressive disease|0|||
94605147|NCT00076024|324017899|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
94605148|NCT00076024|324017900|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
94605149|NCT00076024|324017897|FG000|Phase 2, Open-label|Other|0|||
94605150|NCT00076024|324017898|FG001|Phase 2, Open-label|Other|0|||
94356470|NCT04145531|323087169|FG001|Part B|Progressive disease|0|||
94249416|NCT00700427|322706544|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
94249417|NCT00700427|322706545|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
94249418|NCT00700427|322706546|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
94249419|NCT00700427|322706542|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
94249420|NCT00700427|322706543|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
94249421|NCT00700427|322706544|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
94249422|NCT00700427|322706545|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
94249423|NCT00700427|322706546|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
94249424|NCT00700427|322706542|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
94249425|NCT00700427|322706543|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
94249426|NCT00700427|322706544|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
94249427|NCT00700427|322706545|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
94249428|NCT00700427|322706546|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
94249429|NCT00700427|322706542|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
94249430|NCT00700427|322706543|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
94249431|NCT00700427|322706544|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
94249432|NCT00700427|322706545|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
94249433|NCT00700427|322706546|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
94249434|NCT00700427|322706542|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
94249435|NCT00700427|322706543|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
94249436|NCT00700427|322706544|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
94249437|NCT00700427|322706545|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
94249438|NCT00700427|322706546|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
94249439|NCT00700427|322706542|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
94249440|NCT00700427|322706543|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
94249441|NCT00700427|322706544|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
94249442|NCT00700427|322706545|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
94249443|NCT00700427|322706546|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
94605151|NCT00076024|324017899|FG002|Phase 2, Open-label|Other|0|||
94605152|NCT00076024|324017900|FG003|Phase 2, Open-label|Other|2|||
94605153|NCT04006119|324017904|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
94605154|NCT04006119|324017904|FG000|End of Treatment Veledimex|Adverse Event|2|||
94605155|NCT04006119|324017904|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
94605156|NCT04006119|324017904|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
94605157|NCT04006119|324017904|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
94605158|NCT04006119|324017904|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
94605159|NCT04617795|324017905|FG000|Main Study|Lost to Follow-up|1|||
94605160|NCT04617795|324017906|FG001|Main Study|Lost to Follow-up|0|||
94605161|NCT00472459|324017907|FG000|Overall Study|Adverse Event|13|||
94605162|NCT00472459|324017908|FG001|Overall Study|Adverse Event|13|||
94605163|NCT00472459|324017907|FG000|Overall Study|Withdrawal by Subject|5|||
94605164|NCT00472459|324017908|FG001|Overall Study|Withdrawal by Subject|5|||
94605165|NCT00472459|324017907|FG000|Overall Study|Protocol Violation|3|||
94605166|NCT00472459|324017908|FG001|Overall Study|Protocol Violation|3|||
94605167|NCT00472459|324017907|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
94605168|NCT00472459|324017908|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
94605169|NCT00472459|324017907|FG000|Overall Study|Lost to Follow-up|1|||
94605170|NCT00472459|324017908|FG001|Overall Study|Lost to Follow-up|1|||
94605171|NCT04850313|324017909|FG000|Overall Study|Withdrawal by Subject|0|||
94605172|NCT04850313|324017910|FG001|Overall Study|Withdrawal by Subject|1|||
94605173|NCT04761822|324017911|FG000|Overall Study|Adverse Event|3|||
94605174|NCT04761822|324017912|FG001|Overall Study|Adverse Event|1|||
94605175|NCT04761822|324017913|FG002|Overall Study|Adverse Event|1|||
94605176|NCT04761822|324017914|FG003|Overall Study|Adverse Event|3|||
94605177|NCT04761822|324017911|FG000|Overall Study|Lost to Follow-up|1|||
94605178|NCT04761822|324017912|FG001|Overall Study|Lost to Follow-up|0|||
94605179|NCT04761822|324017913|FG002|Overall Study|Lost to Follow-up|2|||
94249444|NCT00700427|322706542|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
94249445|NCT00700427|322706543|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
94249446|NCT00700427|322706544|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
94249447|NCT00700427|322706545|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
94249448|NCT00700427|322706546|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
94605180|NCT04761822|324017914|FG003|Overall Study|Lost to Follow-up|3|||
94605181|NCT04761822|324017911|FG000|Overall Study|Physician Decision|0|||
94249449|NCT00700427|322706542|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
94605182|NCT04761822|324017912|FG001|Overall Study|Physician Decision|1|||
94605183|NCT04761822|324017913|FG002|Overall Study|Physician Decision|0|||
94605184|NCT04761822|324017914|FG003|Overall Study|Physician Decision|0|||
94605185|NCT04761822|324017911|FG000|Overall Study|Withdrawal by Subject|3|||
94605186|NCT04761822|324017912|FG001|Overall Study|Withdrawal by Subject|8|||
94605187|NCT04761822|324017913|FG002|Overall Study|Withdrawal by Subject|1|||
94661400|NCT01519206|324215718|FG000|Overall Study|Lost to Follow-up|3|||
94661401|NCT01519206|324215718|FG000|Overall Study|Missed Visit|2|||
94661402|NCT01753193|324215719|FG000|Overall Study|Withdrawal by Subject|23|||
94661403|NCT01753193|324215719|FG000|Overall Study|Lost to Follow-up|6|||
94661404|NCT01753193|324215719|FG000|Overall Study|Death|1|||
94661405|NCT01753193|324215719|FG000|Overall Study|Other|16|||
94661406|NCT01131312|324215720|FG000|Overall Study|Lost to Follow-up|425|||
94249450|NCT00700427|322706543|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
94249451|NCT00700427|322706544|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
94249452|NCT00700427|322706545|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
94249453|NCT00700427|322706546|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
94249454|NCT00700427|322706542|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
94249455|NCT00700427|322706543|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
94249456|NCT00700427|322706544|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
94249457|NCT00700427|322706545|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
94249458|NCT00700427|322706546|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
94249459|NCT00700427|322706542|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
94458198|NCT01647516|323465683|FG001|Open-Label Period|No completion / discontinuation visit|0|||
94458199|NCT01647516|323465684|FG002|Open-Label Period|No completion / discontinuation visit|0|||
94458200|NCT01647516|323465685|FG003|Open-Label Period|No completion / discontinuation visit|0|||
94458201|NCT01647516|323465686|FG004|Open-Label Period|No completion / discontinuation visit|2|||
94458202|NCT01647516|323465687|FG005|Open-Label Period|No completion / discontinuation visit|1|||
94458203|NCT01676896|323465688|FG000|Overall Study|Withdrawal by Subject|12|||
94458204|NCT01676896|323465689|FG001|Overall Study|Withdrawal by Subject|7|||
94458205|NCT01676896|323465690|FG002|Overall Study|Withdrawal by Subject|19|||
94458206|NCT03605862|323465696|FG000|Overall Study|Withdrawal by Subject|12|||
94458207|NCT03605862|323465697|FG001|Overall Study|Withdrawal by Subject|9|||
94458208|NCT03605862|323465696|FG000|Overall Study|Adverse Event|2|||
94458209|NCT03605862|323465697|FG001|Overall Study|Adverse Event|1|||
94458210|NCT03605862|323465696|FG000|Overall Study|Physician Decision|3|||
94605188|NCT04761822|324017914|FG003|Overall Study|Withdrawal by Subject|11|||
94605189|NCT04761822|324017911|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
94605190|NCT04761822|324017912|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
94605191|NCT04761822|324017913|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
94605192|NCT04761822|324017914|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
94605193|NCT04761822|324017911|FG000|Overall Study|Participant requested unblinding|0|||
94605194|NCT04761822|324017912|FG001|Overall Study|Participant requested unblinding|0|||
94605195|NCT04761822|324017913|FG002|Overall Study|Participant requested unblinding|0|||
94605196|NCT04761822|324017914|FG003|Overall Study|Participant requested unblinding|1|||
94661407|NCT01131312|324215721|FG001|Overall Study|Lost to Follow-up|229|||
94249460|NCT00700427|322706543|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
94249461|NCT00700427|322706544|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
94249462|NCT00700427|322706545|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
94249463|NCT00700427|322706546|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
94249464|NCT00993668|322706547|FG000|Single-Blind Period|Adverse Event|1|||
94249465|NCT00993668|322706548|FG001|Single-Blind Period|Adverse Event|1|||
94249466|NCT00993668|322706547|FG000|Single-Blind Period|Lack of Efficacy|0|||
94249467|NCT00993668|322706548|FG001|Single-Blind Period|Lack of Efficacy|1|||
94249468|NCT00993668|322706547|FG000|Single-Blind Period|Lost to Follow-up|3|||
94249469|NCT00993668|322706548|FG001|Single-Blind Period|Lost to Follow-up|1|||
94249470|NCT00993668|322706547|FG000|Open-Label Period|Adverse Event|9|||
94249471|NCT00993668|322706548|FG001|Open-Label Period|Adverse Event|8|||
94249472|NCT00993668|322706547|FG000|Open-Label Period|Lack of Efficacy|4|||
94249473|NCT00993668|322706548|FG001|Open-Label Period|Lack of Efficacy|3|||
94249474|NCT00993668|322706547|FG000|Open-Label Period|Withdrawal by Subject|4|||
94249475|NCT00993668|322706548|FG001|Open-Label Period|Withdrawal by Subject|3|||
94249476|NCT00993668|322706547|FG000|Open-Label Period|Lost to Follow-up|6|||
94249477|NCT00993668|322706548|FG001|Open-Label Period|Lost to Follow-up|1|||
94249478|NCT02207569|322706549|FG000|1-Month|Death|6|||
94249479|NCT02207569|322706549|FG000|1-Month|Withdrawal by Subject|2|||
94249480|NCT02207569|322706549|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
94249481|NCT02207569|322706549|FG000|6-Month|Death|8|||
94249482|NCT02207569|322706549|FG000|6-Month|Withdrawal by Subject|2|||
94249483|NCT02207569|322706549|FG000|12-Month|Death|14|||
94249484|NCT02207569|322706549|FG000|12-Month|Withdrawal by Subject|2|||
94249485|NCT02207569|322706549|FG000|24-Month|Death|23|||
94249486|NCT02207569|322706549|FG000|24-Month|Withdrawal by Subject|3|||
94249487|NCT02207569|322706549|FG000|36-Month|Death|23|||
94249488|NCT02207569|322706549|FG000|36-Month|Withdrawal by Subject|4|||
94661408|NCT01131312|324215722|FG002|Overall Study|Lost to Follow-up|351|||
94249489|NCT02207569|322706549|FG000|48-Month|Death|25|||
94249490|NCT02207569|322706549|FG000|48-Month|Withdrawal by Subject|2|||
94249491|NCT02207569|322706549|FG000|48-Month|Lost to Follow-up|4|||
94249492|NCT02207569|322706549|FG000|60-Month|Death|1|||
94605197|NCT01277042|324017916|FG000|Overall Study|Adverse Event|4|||
94605198|NCT01277042|324017917|FG001|Overall Study|Adverse Event|3|||
94605199|NCT01277042|324017916|FG000|Overall Study|Lost to Follow-up|2|||
94605200|NCT01277042|324017917|FG001|Overall Study|Lost to Follow-up|2|||
94605201|NCT01277042|324017916|FG000|Overall Study|Withdrawal by Subject|2|||
94605202|NCT01277042|324017917|FG001|Overall Study|Withdrawal by Subject|0|||
94605203|NCT02239224|324017922|FG000|Overall Study|Administrative|0|||
94605204|NCT02239224|324017923|FG001|Overall Study|Administrative|0|||
94605205|NCT02239224|324017924|FG002|Overall Study|Administrative|3|||
94605206|NCT02239224|324017925|FG003|Overall Study|Administrative|1|||
94605207|NCT03569293|324017930|FG000|Overall Study|Adverse Event|4|||
94605208|NCT03569293|324017931|FG001|Overall Study|Adverse Event|1|||
94605209|NCT03569293|324017932|FG002|Overall Study|Adverse Event|5|||
94661409|NCT01343056|324215725|FG000|Overall Study|Lost to Follow-up|7|||
94661410|NCT01343056|324215726|FG001|Overall Study|Lost to Follow-up|5|||
94605210|NCT03569293|324017933|FG003|Overall Study|Adverse Event|1|||
94661411|NCT01343056|324215727|FG002|Overall Study|Lost to Follow-up|3|||
94661412|NCT01343056|324215728|FG003|Overall Study|Lost to Follow-up|9|||
94661413|NCT02219932|324215732|FG000|Overall Study|Other|5|||
94661414|NCT02219932|324215733|FG001|Overall Study|Other|11|||
94661415|NCT02219932|324215732|FG000|Overall Study|Death|1|||
94661416|NCT02219932|324215733|FG001|Overall Study|Death|1|||
94661417|NCT02219932|324215732|FG000|Overall Study|Investigator Decision|0|||
94249493|NCT02207569|322706549|FG000|60-Month|Lost to Follow-up|1|||
94249494|NCT02207569|322706549|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
94661418|NCT02219932|324215733|FG001|Overall Study|Investigator Decision|1|||
94661419|NCT02219932|324215732|FG000|Overall Study|Consent Withdrawn|11|||
94661420|NCT02219932|324215733|FG001|Overall Study|Consent Withdrawn|7|||
94661421|NCT02219932|324215732|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
94661422|NCT02219932|324215733|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
94661423|NCT02219932|324215732|FG000|Overall Study|Protocol Violation|10|||
94661424|NCT02219932|324215733|FG001|Overall Study|Protocol Violation|6|||
94661425|NCT02219932|324215732|FG000|Overall Study|Pregnancy|1|||
94249495|NCT02207569|322706549|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
94249496|NCT01014143|322706558|FG000|Second Intervention|Lost to Follow-up|2|||
94249497|NCT01014143|322706559|FG001|Second Intervention|Lost to Follow-up|0|||
94249498|NCT01014143|322706560|FG002|Second Intervention|Lost to Follow-up|0|||
94249499|NCT00424385|322706561|FG000|Cohort 0|Withdrawal by Subject|5|||
94249500|NCT00424385|322706561|FG000|Cohort 0|Physician Decision|1|||
94249501|NCT00424385|322706561|FG000|Cohort 1|Withdrawal by Subject|1|||
94249502|NCT00964886|322706568|FG000|Overall Study|Lost to Follow-up|2|||
94249503|NCT00964886|322706569|FG001|Overall Study|Lost to Follow-up|2|||
94249504|NCT00964886|322706570|FG002|Overall Study|Lost to Follow-up|6|||
94249505|NCT00964886|322706571|FG003|Overall Study|Lost to Follow-up|4|||
94249506|NCT00964886|322706568|FG000|Overall Study|Withdrawal by Subject|6|||
94356471|NCT04145531|323087170|FG002|Part B|Progressive disease|0|||
94356472|NCT04145531|323087171|FG003|Part B|Progressive disease|1|||
94356473|NCT04145531|323087168|FG000|Part B|Recurrent disease|0|||
94356474|NCT04145531|323087169|FG001|Part B|Recurrent disease|0|||
94249507|NCT00964886|322706569|FG001|Overall Study|Withdrawal by Subject|2|||
94249508|NCT00964886|322706570|FG002|Overall Study|Withdrawal by Subject|5|||
94249509|NCT00964886|322706571|FG003|Overall Study|Withdrawal by Subject|3|||
94249510|NCT00964886|322706568|FG000|Overall Study|Adverse Event|3|||
94356475|NCT04145531|323087170|FG002|Part B|Recurrent disease|0|||
94356476|NCT04145531|323087171|FG003|Part B|Recurrent disease|1|||
94356477|NCT04145531|323087168|FG000|Part B|Withdrawal by parent or guardian|0|||
94356478|NCT04145531|323087169|FG001|Part B|Withdrawal by parent or guardian|0|||
94356479|NCT04145531|323087170|FG002|Part B|Withdrawal by parent or guardian|0|||
94356480|NCT04145531|323087171|FG003|Part B|Withdrawal by parent or guardian|3|||
94356481|NCT04145531|323087168|FG000|Part B|Withdrawal by participant|0|||
94356482|NCT04145531|323087169|FG001|Part B|Withdrawal by participant|0|||
94605211|NCT03569293|324017934|FG004|Overall Study|Adverse Event|0|||
94605212|NCT03569293|324017935|FG005|Overall Study|Adverse Event|0|||
94249511|NCT00964886|322706569|FG001|Overall Study|Adverse Event|1|||
94661426|NCT02219932|324215733|FG001|Overall Study|Pregnancy|0|||
94661427|NCT02219932|324215732|FG000|Overall Study|Lost to Follow-up|4|||
94661428|NCT02219932|324215733|FG001|Overall Study|Lost to Follow-up|2|||
94661429|NCT02219932|324215732|FG000|Overall Study|Adverse Event|23|||
94458211|NCT03605862|323465697|FG001|Overall Study|Physician Decision|1|||
94458212|NCT03605862|323465696|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
94458213|NCT03605862|323465697|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
94458214|NCT02822573|323465699|FG000|Overall Study|Lost to Follow-up|5|||
94458215|NCT02822573|323465700|FG001|Overall Study|Lost to Follow-up|3|||
94458216|NCT02822573|323465699|FG000|Overall Study|Physician Decision|1|||
94458217|NCT02822573|323465700|FG001|Overall Study|Physician Decision|1|||
94458218|NCT02822573|323465699|FG000|Overall Study|Withdrawal by Subject|9|||
94458219|NCT02822573|323465700|FG001|Overall Study|Withdrawal by Subject|5|||
94458220|NCT02822573|323465699|FG000|Overall Study|Protocol Violation|6|||
94458221|NCT02822573|323465700|FG001|Overall Study|Protocol Violation|4|||
94458222|NCT02822573|323465699|FG000|Overall Study|Too sick or ill|2|||
94458223|NCT02822573|323465700|FG001|Overall Study|Too sick or ill|1|||
94458224|NCT02822573|323465699|FG000|Overall Study|Disease Progression|1|||
94458225|NCT02822573|323465700|FG001|Overall Study|Disease Progression|1|||
94458226|NCT02822573|323465699|FG000|Overall Study|No reason given|6|||
94458227|NCT02822573|323465700|FG001|Overall Study|No reason given|4|||
94458228|NCT01053962|323465701|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
94458229|NCT01053962|323465702|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
94458230|NCT01053962|323465703|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
94458231|NCT01053962|323465704|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
94458232|NCT01053962|323465705|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
94458233|NCT01053962|323465701|FG000|Pretreatment Period|Venipuncture Failure|0|||
94458234|NCT01053962|323465702|FG001|Pretreatment Period|Venipuncture Failure|0|||
94458235|NCT01053962|323465703|FG002|Pretreatment Period|Venipuncture Failure|1|||
94458236|NCT01053962|323465704|FG003|Pretreatment Period|Venipuncture Failure|0|||
94458237|NCT01053962|323465705|FG004|Pretreatment Period|Venipuncture Failure|0|||
94458238|NCT01053962|323465701|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
94458239|NCT01053962|323465702|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
94458240|NCT01053962|323465703|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
94458241|NCT01053962|323465704|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
94458242|NCT01053962|323465705|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
94458243|NCT01053962|323465701|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
94458244|NCT01053962|323465702|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
94458245|NCT01053962|323465703|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
94458246|NCT01053962|323465704|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
94458247|NCT01053962|323465705|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
94458248|NCT01053962|323465701|FG000|Treatment Period|Lack of Efficacy|0|||
94458249|NCT01053962|323465702|FG001|Treatment Period|Lack of Efficacy|0|||
94458250|NCT01053962|323465703|FG002|Treatment Period|Lack of Efficacy|0|||
94458251|NCT01053962|323465704|FG003|Treatment Period|Lack of Efficacy|0|||
94458252|NCT01053962|323465705|FG004|Treatment Period|Lack of Efficacy|1|||
94458253|NCT01053962|323465701|FG000|Treatment Period|Adverse Event|0|||
94458254|NCT01053962|323465702|FG001|Treatment Period|Adverse Event|0|||
94458255|NCT01053962|323465703|FG002|Treatment Period|Adverse Event|0|||
94458256|NCT01053962|323465704|FG003|Treatment Period|Adverse Event|0|||
94458257|NCT01053962|323465705|FG004|Treatment Period|Adverse Event|1|||
94458258|NCT01053962|323465701|FG000|Treatment Period|Withdrawal by Subject|0|||
94458259|NCT01053962|323465702|FG001|Treatment Period|Withdrawal by Subject|0|||
94605213|NCT03569293|324017930|FG000|Overall Study|Withdrawal by Subject|16|||
94458260|NCT01053962|323465703|FG002|Treatment Period|Withdrawal by Subject|0|||
94458261|NCT01053962|323465704|FG003|Treatment Period|Withdrawal by Subject|0|||
94458262|NCT01053962|323465705|FG004|Treatment Period|Withdrawal by Subject|1|||
94605214|NCT03569293|324017931|FG001|Overall Study|Withdrawal by Subject|2|||
94458263|NCT01053962|323465701|FG000|Treatment Period|Noncompliance with protocol|1|||
94458264|NCT01053962|323465702|FG001|Treatment Period|Noncompliance with protocol|0|||
94605215|NCT03569293|324017932|FG002|Overall Study|Withdrawal by Subject|4|||
94605216|NCT03569293|324017933|FG003|Overall Study|Withdrawal by Subject|1|||
94458265|NCT01053962|323465703|FG002|Treatment Period|Noncompliance with protocol|0|||
94458266|NCT01053962|323465704|FG003|Treatment Period|Noncompliance with protocol|0|||
94458267|NCT01053962|323465705|FG004|Treatment Period|Noncompliance with protocol|0|||
94458268|NCT02275780|323465706|FG000|Base Study: 96 Weeks|Adverse Event|6|||
94458269|NCT02275780|323465707|FG001|Base Study: 96 Weeks|Adverse Event|14|||
94458270|NCT02275780|323465706|FG000|Base Study: 96 Weeks|Death|3|||
94458271|NCT02275780|323465707|FG001|Base Study: 96 Weeks|Death|1|||
94458272|NCT02275780|323465706|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
94458273|NCT02275780|323465707|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
94458274|NCT02275780|323465706|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
94458275|NCT02275780|323465707|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
94458276|NCT02275780|323465706|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
94458277|NCT02275780|323465707|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
94458278|NCT02275780|323465706|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
94458279|NCT02275780|323465707|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
94458280|NCT02275780|323465706|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
94458281|NCT02275780|323465707|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
94458282|NCT02275780|323465706|FG000|Base Study: 96 Weeks|Physician Decision|2|||
94458283|NCT02275780|323465707|FG001|Base Study: 96 Weeks|Physician Decision|4|||
94458284|NCT02275780|323465706|FG000|Base Study: 96 Weeks|Pregnancy|2|||
94458285|NCT02275780|323465707|FG001|Base Study: 96 Weeks|Pregnancy|1|||
94458286|NCT02275780|323465706|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
94458287|NCT02275780|323465707|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
94458288|NCT02275780|323465706|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
94458289|NCT02275780|323465707|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
94458290|NCT02275780|323465706|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
94458291|NCT02275780|323465707|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
94458292|NCT02275780|323465706|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
94458293|NCT02275780|323465707|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
94458294|NCT02275780|323465706|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
94458295|NCT02275780|323465707|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
94458296|NCT02275780|323465706|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
94458297|NCT02275780|323465707|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
94458298|NCT02275780|323465706|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
94458299|NCT02275780|323465707|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
94458300|NCT02275780|323465706|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
94458301|NCT02275780|323465707|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
94458302|NCT02275780|323465706|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
94458303|NCT02275780|323465707|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
94458304|NCT02275780|323465706|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
94458305|NCT02275780|323465707|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
94458306|NCT02275780|323465706|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
94458307|NCT02275780|323465707|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
94458308|NCT02275780|323465706|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
94458309|NCT02275780|323465707|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
94458310|NCT02275780|323465706|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
94458311|NCT02275780|323465707|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
94458312|NCT02275780|323465706|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
94458313|NCT02275780|323465707|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
94458314|NCT02275780|323465706|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
94458315|NCT02275780|323465707|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
94458316|NCT02275780|323465706|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
94458317|NCT02275780|323465707|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
94458318|NCT02275780|323465706|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
94249512|NCT00964886|322706570|FG002|Overall Study|Adverse Event|5|||
94605217|NCT03569293|324017934|FG004|Overall Study|Withdrawal by Subject|0|||
94605218|NCT03569293|324017935|FG005|Overall Study|Withdrawal by Subject|0|||
94605219|NCT03569293|324017930|FG000|Overall Study|Lost to Follow-up|1|||
94605220|NCT03569293|324017931|FG001|Overall Study|Lost to Follow-up|3|||
94605221|NCT03569293|324017932|FG002|Overall Study|Lost to Follow-up|1|||
94605222|NCT03569293|324017933|FG003|Overall Study|Lost to Follow-up|1|||
94605223|NCT03569293|324017934|FG004|Overall Study|Lost to Follow-up|0|||
94605224|NCT03569293|324017935|FG005|Overall Study|Lost to Follow-up|0|||
94605225|NCT03569293|324017930|FG000|Overall Study|Other|8|||
94605226|NCT03569293|324017931|FG001|Overall Study|Other|2|||
94605227|NCT03569293|324017932|FG002|Overall Study|Other|1|||
94249513|NCT00964886|322706571|FG003|Overall Study|Adverse Event|2|||
94249514|NCT00964886|322706568|FG000|Overall Study|Protocol Violation|0|||
94356483|NCT04145531|323087170|FG002|Part B|Withdrawal by participant|0|||
94356484|NCT04145531|323087171|FG003|Part B|Withdrawal by participant|1|||
94356485|NCT04145531|323087168|FG000|Part B|Other|0|||
94356486|NCT04145531|323087169|FG001|Part B|Other|0|||
94356487|NCT04145531|323087170|FG002|Part B|Other|0|||
94356488|NCT04145531|323087171|FG003|Part B|Other|1|||
94356489|NCT02985996|323087172|FG000|Overall Study|Withdrawal by Subject|0|||
94356490|NCT02985996|323087173|FG001|Overall Study|Withdrawal by Subject|0|||
94356491|NCT02985996|323087174|FG002|Overall Study|Withdrawal by Subject|1|||
94356492|NCT02985996|323087175|FG003|Overall Study|Withdrawal by Subject|0|||
94356493|NCT02985996|323087176|FG004|Overall Study|Withdrawal by Subject|0|||
94356494|NCT02985996|323087172|FG000|Overall Study|Protocol Violation|0|||
94356495|NCT02985996|323087173|FG001|Overall Study|Protocol Violation|1|||
94356496|NCT02985996|323087174|FG002|Overall Study|Protocol Violation|0|||
94356497|NCT02985996|323087175|FG003|Overall Study|Protocol Violation|0|||
94605228|NCT03569293|324017933|FG003|Overall Study|Other|1|||
94605229|NCT03569293|324017934|FG004|Overall Study|Other|0|||
94605230|NCT03569293|324017935|FG005|Overall Study|Other|0|||
94605231|NCT03569293|324017930|FG000|Overall Study|Ongoing at Time of Analysis|8|||
94605232|NCT03569293|324017931|FG001|Overall Study|Ongoing at Time of Analysis|1|||
94605233|NCT03569293|324017932|FG002|Overall Study|Ongoing at Time of Analysis|3|||
94605234|NCT03569293|324017933|FG003|Overall Study|Ongoing at Time of Analysis|0|||
94605235|NCT03569293|324017934|FG004|Overall Study|Ongoing at Time of Analysis|0|||
94605236|NCT03569293|324017935|FG005|Overall Study|Ongoing at Time of Analysis|0|||
94249515|NCT00964886|322706569|FG001|Overall Study|Protocol Violation|2|||
94249516|NCT00964886|322706570|FG002|Overall Study|Protocol Violation|0|||
94249517|NCT00964886|322706571|FG003|Overall Study|Protocol Violation|0|||
94249518|NCT00523640|322706572|FG000|Overall Study|Death|1|||
94249519|NCT03047395|322706574|FG000|Overall Study|Adverse Event|142|||
94249520|NCT03047395|322706574|FG000|Overall Study|Withdrawal by Subject|155|||
94249521|NCT03047395|322706574|FG000|Overall Study|Lost to Follow-up|144|||
94249522|NCT03047395|322706574|FG000|Overall Study|COVID-19 Infection|2|||
94249523|NCT03047395|322706574|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
94249524|NCT03047395|322706574|FG000|Overall Study|Other, Not Specified|117|||
94249525|NCT02399254|322706575|FG000|Overall Study|Physician Decision|2|||
94249526|NCT02930226|322706576|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
94249527|NCT02930226|322706577|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
94249528|NCT02930226|322706578|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
94249529|NCT02930226|322706579|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
94249530|NCT02930226|322706580|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
94249531|NCT02930226|322706581|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
94249532|NCT00652327|322706582|FG000|Overall Study|Adverse Event|0|||
94249533|NCT00652327|322706583|FG001|Overall Study|Adverse Event|2|||
94249534|NCT00652327|322706582|FG000|Overall Study|Lost to Follow-up|0|||
94249535|NCT00652327|322706583|FG001|Overall Study|Lost to Follow-up|3|||
94249536|NCT01076647|322706584|FG000|Overall Study|Adverse Event|4|||
94249537|NCT01076647|322706585|FG001|Overall Study|Adverse Event|1|||
94249538|NCT01076647|322706584|FG000|Overall Study|Lack of Efficacy|0|||
94605237|NCT03981822|324017942|FG000|Overall Study|Lost to Follow-up|0|||
94605238|NCT03981822|324017943|FG001|Overall Study|Lost to Follow-up|1|||
94605239|NCT03981822|324017944|FG002|Overall Study|Lost to Follow-up|1|||
94605240|NCT03981822|324017945|FG003|Overall Study|Lost to Follow-up|0|||
94605241|NCT03981822|324017946|FG004|Overall Study|Lost to Follow-up|6|||
94605242|NCT03981822|324017947|FG005|Overall Study|Lost to Follow-up|4|||
94605243|NCT03981822|324017948|FG006|Overall Study|Lost to Follow-up|4|||
94605244|NCT03981822|324017949|FG007|Overall Study|Lost to Follow-up|2|||
94605245|NCT03981822|324017942|FG000|Overall Study|Withdrawal by Subject|0|||
94249539|NCT01076647|322706585|FG001|Overall Study|Lack of Efficacy|1|||
94356498|NCT02985996|323087176|FG004|Overall Study|Protocol Violation|0|||
94356499|NCT00976989|323087178|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
94356500|NCT00976989|323087179|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
94356501|NCT00976989|323087180|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
94356502|NCT00976989|323087178|FG000|Overall Study|Death|5|||
94356503|NCT00976989|323087179|FG001|Overall Study|Death|7|||
94356504|NCT00976989|323087180|FG002|Overall Study|Death|10|||
94356505|NCT00976989|323087178|FG000|Overall Study|Refused Treatment|4|||
94356506|NCT00976989|323087179|FG001|Overall Study|Refused Treatment|3|||
94356507|NCT00976989|323087180|FG002|Overall Study|Refused Treatment|5|||
94356508|NCT00976989|323087178|FG000|Overall Study|Failure to Return|2|||
94356509|NCT00976989|323087179|FG001|Overall Study|Failure to Return|1|||
94605246|NCT03981822|324017943|FG001|Overall Study|Withdrawal by Subject|1|||
94605247|NCT03981822|324017944|FG002|Overall Study|Withdrawal by Subject|0|||
94605248|NCT03981822|324017945|FG003|Overall Study|Withdrawal by Subject|0|||
94249540|NCT01076647|322706584|FG000|Overall Study|Protocol Violation|7|||
94249541|NCT01076647|322706585|FG001|Overall Study|Protocol Violation|9|||
94249542|NCT01076647|322706584|FG000|Overall Study|Withdrawal criteria|2|||
94249543|NCT01076647|322706585|FG001|Overall Study|Withdrawal criteria|2|||
94249544|NCT01076647|322706584|FG000|Overall Study|Unclassified|12|||
94249545|NCT01076647|322706585|FG001|Overall Study|Unclassified|12|||
94249546|NCT01157676|322706602|FG000|Randomization|Death|1|||
94249547|NCT01157676|322706603|FG001|Randomization|Death|1|||
94249548|NCT01157676|322706602|FG000|Randomization|unresectable|2|||
94249549|NCT01157676|322706603|FG001|Randomization|unresectable|3|||
94249550|NCT01157676|322706602|FG000|Randomization|Withdrawal by Subject|17|||
94249551|NCT01157676|322706603|FG001|Randomization|Withdrawal by Subject|13|||
94249552|NCT01157676|322706602|FG000|Randomization|Physician Decision|1|||
94249553|NCT01157676|322706603|FG001|Randomization|Physician Decision|0|||
94249554|NCT01157676|322706602|FG000|Surgery|underwent open cystectomy|0|||
94249555|NCT01157676|322706603|FG001|Surgery|underwent open cystectomy|4|||
94249556|NCT01157676|322706602|FG000|Surgery|converted to open procedure|0|||
94249557|NCT01157676|322706603|FG001|Surgery|converted to open procedure|5|||
94249558|NCT01157676|322706602|FG000|Surgery|underwent robotic cystectomy|1|||
94249559|NCT01157676|322706603|FG001|Surgery|underwent robotic cystectomy|0|||
94249560|NCT01263665|322706607|FG000|Overall Study|Withdrew Consent|1|||
94249561|NCT01263665|322706607|FG000|Overall Study|Lost to Follow-up|3|||
94249562|NCT01263665|322706607|FG000|Overall Study|Death|2|||
94249563|NCT01263665|322706607|FG000|Overall Study|Amputation above the ankle|1|||
94249564|NCT01263665|322706607|FG000|Overall Study|Surgical Bypass|2|||
94249565|NCT00141219|322706609|FG000|Overall Study|Protocol violations|5|||
94249566|NCT00141219|322706610|FG001|Overall Study|Protocol violations|4|||
94249567|NCT00141219|322706609|FG000|Overall Study|Adverse Event|8|||
94249568|NCT00141219|322706610|FG001|Overall Study|Adverse Event|6|||
94249569|NCT00141219|322706609|FG000|Overall Study|Lack of Efficacy|5|||
94249570|NCT00141219|322706610|FG001|Overall Study|Lack of Efficacy|4|||
94249571|NCT00141219|322706609|FG000|Overall Study|Withdrawal by Subject|6|||
94249572|NCT00141219|322706610|FG001|Overall Study|Withdrawal by Subject|2|||
94249573|NCT00324675|322706614|FG000|Overall Study|Adverse Event|1|||
94249574|NCT00324675|322706615|FG001|Overall Study|Adverse Event|0|||
94249575|NCT00122460|322706616|FG000|Overall Study|investigational study phase ongoing|7|||
94249576|NCT00122460|322706617|FG001|Overall Study|investigational study phase ongoing|1|||
94249577|NCT02595073|322706620|FG000|Overall Study|Progressive Disease|0|||
94249578|NCT02595073|322706621|FG001|Overall Study|Progressive Disease|1|||
94249579|NCT02595073|322706620|FG000|Overall Study|Protocol Violation|2|||
94249580|NCT02595073|322706621|FG001|Overall Study|Protocol Violation|0|||
94249581|NCT02962960|322706622|FG000|Overall Study|Withdrawal by Subject|1|||
94249582|NCT02962960|322706623|FG001|Overall Study|Withdrawal by Subject|1|||
94356510|NCT00976989|323087180|FG002|Overall Study|Failure to Return|0|||
94356511|NCT00976989|323087178|FG000|Overall Study|Recurrence of Disease|0|||
94356512|NCT00976989|323087179|FG001|Overall Study|Recurrence of Disease|1|||
94249583|NCT02962960|322706624|FG002|Overall Study|Withdrawal by Subject|0|||
94249584|NCT02962960|322706622|FG000|Overall Study|Adverse Event|1|||
94249585|NCT02962960|322706623|FG001|Overall Study|Adverse Event|1|||
94249586|NCT02962960|322706624|FG002|Overall Study|Adverse Event|0|||
94249587|NCT02962960|322706622|FG000|Overall Study|Protocol Violation|1|||
94249588|NCT02962960|322706623|FG001|Overall Study|Protocol Violation|0|||
94249589|NCT02962960|322706624|FG002|Overall Study|Protocol Violation|0|||
94249590|NCT01744392|322706626|FG000|Overall Study|Physician Decision|1|||
94458319|NCT02275780|323465707|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
94458320|NCT02275780|323465706|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
94458321|NCT02275780|323465707|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
94458322|NCT02275780|323465706|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
94458323|NCT02275780|323465707|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
94458324|NCT02275780|323465706|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
94458325|NCT02275780|323465707|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
94458326|NCT02275780|323465706|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
94458327|NCT02275780|323465707|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
94458328|NCT02275780|323465706|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
94458329|NCT02275780|323465707|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
94458330|NCT02892422|323465710|FG000|Overall Study|Enrolled not treated|4|||
94458331|NCT02892422|323465710|FG000|Overall Study|Adverse Event|38|||
94458332|NCT02892422|323465710|FG000|Overall Study|Lack of Efficacy|32|||
94458333|NCT02892422|323465710|FG000|Overall Study|Non-compliance with study drug|11|||
94458334|NCT02892422|323465710|FG000|Overall Study|Protocol Violation|4|||
94458335|NCT02892422|323465710|FG000|Overall Study|Withdrawal by Subject|56|||
94458336|NCT02892422|323465710|FG000|Overall Study|Lost to Follow-up|5|||
94458337|NCT02892422|323465710|FG000|Overall Study|sponsor information 16159A results|21|||
94458338|NCT02892422|323465710|FG000|Overall Study|withdrawal of consent|13|||
94458339|NCT02892422|323465710|FG000|Overall Study|exclusion criteria met|3|||
94458340|NCT02892422|323465710|FG000|Overall Study|moving elsewhere|4|||
94458341|NCT02892422|323465710|FG000|Overall Study|non-compliance|10|||
94458342|NCT02892422|323465710|FG000|Overall Study|patient legally incapable|1|||
94458343|NCT02892422|323465710|FG000|Overall Study|patient decision|7|||
94458344|NCT02892422|323465710|FG000|Overall Study|Investigator decision|1|||
94458345|NCT03155178|323465713|FG000|Overall Study|Did not meet treatment day baseline|7|||
94458346|NCT03155178|323465714|FG001|Overall Study|Did not meet treatment day baseline|7|||
94458347|NCT03155178|323465715|FG002|Overall Study|Did not meet treatment day baseline|7|||
94458348|NCT03155178|323465716|FG003|Overall Study|Did not meet treatment day baseline|7|||
94458349|NCT02833844|323465717|FG000|Double-Blind Period|Withdrawal by Subject|2|||
94458350|NCT02833844|323465718|FG001|Double-Blind Period|Withdrawal by Subject|3|||
94458351|NCT02833844|323465717|FG000|Double-Blind Period|Protocol Violation|0|||
94458352|NCT02833844|323465718|FG001|Double-Blind Period|Protocol Violation|4|||
94458353|NCT02833844|323465717|FG000|Open-Label Period|Death|0|||
94458354|NCT02833844|323465718|FG001|Open-Label Period|Death|2|||
94458355|NCT02833844|323465717|FG000|Open-Label Period|Lost to Follow-up|1|||
94458356|NCT02833844|323465718|FG001|Open-Label Period|Lost to Follow-up|0|||
94458357|NCT02833844|323465717|FG000|Open-Label Period|Withdrawal by Subject|1|||
94249591|NCT01801735|322706631|FG000|Overall Study|Adverse Event|79|||
94249592|NCT01801735|322706631|FG000|Overall Study|Lack of Efficacy|28|||
94249593|NCT01801735|322706631|FG000|Overall Study|Withdrawal by Subject|27|||
94249594|NCT01801735|322706631|FG000|Overall Study|Protocol Violation|25|||
94249595|NCT01801735|322706631|FG000|Overall Study|Lost to Follow-up|15|||
94249596|NCT01801735|322706631|FG000|Overall Study|Non-compliance with Trial Drug|13|||
94458358|NCT02833844|323465718|FG001|Open-Label Period|Withdrawal by Subject|0|||
94458359|NCT01500187|323465719|FG000|Overall Study|Lost to Follow-up|6|||
94458360|NCT01500187|323465720|FG001|Overall Study|Lost to Follow-up|0|||
94458361|NCT00150800|323465722|FG000|Overall Study|Adverse Event|89|||
94458362|NCT00150800|323465722|FG000|Overall Study|Death|18|||
94458363|NCT00150800|323465722|FG000|Overall Study|Lack of Efficacy|166|||
94458364|NCT00150800|323465722|FG000|Overall Study|Lost to Follow-up|58|||
94458365|NCT00150800|323465722|FG000|Overall Study|Subject's choice|90|||
94458366|NCT00150800|323465722|FG000|Overall Study|No compliance|18|||
94458367|NCT00150800|323465722|FG000|Overall Study|IP misshandling|1|||
94458368|NCT00150800|323465722|FG000|Overall Study|Site closure|24|||
94458369|NCT00150800|323465722|FG000|Overall Study|Protocol non-adherence|2|||
94458370|NCT00150800|323465722|FG000|Overall Study|Nobody to accompany patient|1|||
94458371|NCT00150800|323465722|FG000|Overall Study|Distance too long for patient|1|||
94458372|NCT00150800|323465722|FG000|Overall Study|Neurosurgery|2|||
94458373|NCT00150800|323465722|FG000|Overall Study|BRV monotherapy|1|||
94458374|NCT00150800|323465722|FG000|Overall Study|Visit refusal|3|||
94458375|NCT00150800|323465722|FG000|Overall Study|Sponsor's request|2|||
94458376|NCT00150800|323465722|FG000|Overall Study|Generalized Epilepsy|1|||
94458377|NCT00150800|323465722|FG000|Overall Study|Moved from area/country|8|||
94458378|NCT00150800|323465722|FG000|Overall Study|PI retiring|2|||
94458379|NCT00150800|323465722|FG000|Overall Study|PI leaving site|2|||
94458380|NCT00150800|323465722|FG000|Overall Study|Patient insurance|1|||
94458381|NCT00150800|323465722|FG000|Overall Study|Surgical intervention|4|||
94458382|NCT00150800|323465722|FG000|Overall Study|Pregnancy planned|1|||
94458383|NCT00150800|323465722|FG000|Overall Study|PI discontinuation request|1|||
94458384|NCT01931956|323465725|FG000|Overall Study|Death|42|||
94605249|NCT03981822|324017946|FG004|Overall Study|Withdrawal by Subject|0|||
94249597|NCT01801735|322706631|FG000|Overall Study|Physician Decision|3|||
94249598|NCT01801735|322706631|FG000|Overall Study|Death|1|||
94249599|NCT01801735|322706631|FG000|Overall Study|Other, including site closure|19|||
94249600|NCT00560066|322706632|FG000|Overall Study|Death|2|||
94249601|NCT00560066|322706633|FG001|Overall Study|Death|1|||
94249602|NCT00560066|322706632|FG000|Overall Study|Withdrawal by Subject|0|||
94249603|NCT00560066|322706633|FG001|Overall Study|Withdrawal by Subject|3|||
94249604|NCT00560066|322706632|FG000|Overall Study|Lost to Follow-up|4|||
94249605|NCT00560066|322706633|FG001|Overall Study|Lost to Follow-up|10|||
94249606|NCT00560066|322706632|FG000|Overall Study|Protocol Violation|0|||
94605250|NCT03981822|324017947|FG005|Overall Study|Withdrawal by Subject|1|||
94605251|NCT03981822|324017948|FG006|Overall Study|Withdrawal by Subject|0|||
94605252|NCT03981822|324017949|FG007|Overall Study|Withdrawal by Subject|2|||
94605253|NCT03981822|324017942|FG000|Overall Study|COVID-19 Related|0|||
94605254|NCT03981822|324017943|FG001|Overall Study|COVID-19 Related|0|||
94249607|NCT00560066|322706633|FG001|Overall Study|Protocol Violation|1|||
94249608|NCT00560066|322706632|FG000|Overall Study|Administrative reason|0|||
94249609|NCT00560066|322706633|FG001|Overall Study|Administrative reason|5|||
94249610|NCT00560066|322706632|FG000|Overall Study|Missing primary reason|0|||
94605255|NCT03981822|324017944|FG002|Overall Study|COVID-19 Related|0|||
94605256|NCT03981822|324017945|FG003|Overall Study|COVID-19 Related|0|||
94249611|NCT00560066|322706633|FG001|Overall Study|Missing primary reason|2|||
94249612|NCT00798590|322706634|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
94249613|NCT00798590|322706635|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
94249614|NCT03122223|322706643|FG000|Overall Study|Withdrawal by Subject|2|||
94249615|NCT03122223|322706644|FG001|Overall Study|Withdrawal by Subject|2|||
94249616|NCT03122223|322706645|FG002|Overall Study|Withdrawal by Subject|1|||
94249617|NCT03122223|322706646|FG003|Overall Study|Withdrawal by Subject|0|||
94249618|NCT03122223|322706643|FG000|Overall Study|Lost to Follow-up|0|||
94249619|NCT03122223|322706644|FG001|Overall Study|Lost to Follow-up|2|||
94249620|NCT03122223|322706645|FG002|Overall Study|Lost to Follow-up|2|||
94249621|NCT03122223|322706646|FG003|Overall Study|Lost to Follow-up|0|||
94605257|NCT03981822|324017946|FG004|Overall Study|COVID-19 Related|2|||
94605258|NCT03981822|324017947|FG005|Overall Study|COVID-19 Related|1|||
94605259|NCT03981822|324017948|FG006|Overall Study|COVID-19 Related|2|||
94605260|NCT03981822|324017949|FG007|Overall Study|COVID-19 Related|1|||
94605261|NCT06460493|324017950|FG000|Overall Study|Withdrawal by Subject|2|||
94605262|NCT05128929|324017951|FG000|Overall Study|Adverse Event|0|||
94605263|NCT05128929|324017952|FG001|Overall Study|Adverse Event|1|||
94605264|NCT00397943|324017953|FG000|Overall Study|Unspecified reasons|12|||
94605265|NCT00397943|324017954|FG001|Overall Study|Unspecified reasons|9|||
94605266|NCT00397943|324017955|FG002|Overall Study|Unspecified reasons|0|||
94605267|NCT00397943|324017956|FG003|Overall Study|Unspecified reasons|0|||
94605268|NCT00397943|324017957|FG004|Overall Study|Unspecified reasons|0|||
94605269|NCT03489551|324017960|FG000|Overall Study|Withdrawal by Subject|2|||
94605270|NCT00900601|324017964|FG000|Overall Study|Physician Decision|1|||
94661430|NCT02219932|324215733|FG001|Overall Study|Adverse Event|21|||
94249622|NCT03122223|322706643|FG000|Overall Study|Participant unable to adhere|1|||
94249623|NCT03122223|322706644|FG001|Overall Study|Participant unable to adhere|1|||
94249624|NCT03122223|322706645|FG002|Overall Study|Participant unable to adhere|1|||
94249625|NCT03122223|322706646|FG003|Overall Study|Participant unable to adhere|0|||
94249626|NCT02971761|322706647|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
94249627|NCT01131182|322706648|FG000|Overall Study|Withdrawal by Subject|1|||
94249628|NCT01131182|322706649|FG001|Overall Study|Withdrawal by Subject|1|||
94249629|NCT01131182|322706648|FG000|Overall Study|Lost to Follow-up|14|||
94249630|NCT01131182|322706649|FG001|Overall Study|Lost to Follow-up|15|||
94249631|NCT01131182|322706648|FG000|Overall Study|Other Reason|1|||
94249632|NCT01131182|322706649|FG001|Overall Study|Other Reason|0|||
94249633|NCT03001076|322706650|FG000|Overall Study|Withdrawal by patient|2|||
94249634|NCT03001076|322706651|FG001|Overall Study|Withdrawal by patient|0|||
94249635|NCT03001076|322706650|FG000|Overall Study|Other|1|||
94249636|NCT03001076|322706651|FG001|Overall Study|Other|0|||
94249637|NCT03001076|322706650|FG000|Overall Study|Adverse Event|3|||
94249638|NCT03001076|322706651|FG001|Overall Study|Adverse Event|3|||
94249639|NCT03001076|322706650|FG000|Overall Study|Sponsor decision|1|||
94249640|NCT03001076|322706651|FG001|Overall Study|Sponsor decision|0|||
94249641|NCT03001076|322706650|FG000|Overall Study|Lost to Follow-up|0|||
94249642|NCT03001076|322706651|FG001|Overall Study|Lost to Follow-up|2|||
94458385|NCT01931956|323465726|FG001|Overall Study|Death|7|||
94249643|NCT00752557|322706652|FG000|Overall Study|Withdrawal by Subject|4|||
94249644|NCT00752557|322706653|FG001|Overall Study|Withdrawal by Subject|3|||
94249645|NCT00752557|322706654|FG002|Overall Study|Withdrawal by Subject|3|||
94249646|NCT00752557|322706652|FG000|Overall Study|Unspecified resaons|0|||
94249647|NCT00752557|322706653|FG001|Overall Study|Unspecified resaons|2|||
94249648|NCT00752557|322706654|FG002|Overall Study|Unspecified resaons|2|||
94249649|NCT00752557|322706652|FG000|Overall Study|Lost to Follow-up|1|||
94249650|NCT00752557|322706653|FG001|Overall Study|Lost to Follow-up|0|||
94249651|NCT00752557|322706654|FG002|Overall Study|Lost to Follow-up|1|||
94249652|NCT02413333|322706655|FG000|Period 1|Adverse Event|1|||
94249653|NCT02413333|322706656|FG001|Period 1|Adverse Event|0|||
94661431|NCT00093145|324215734|FG000|Overall Study|Unacceptable Toxicity Only|2|||
94661432|NCT00093145|324215734|FG000|Overall Study|Physician Decision|5|||
94249654|NCT02413333|322706655|FG000|Period 1|Reason Not Specified|0|||
94458386|NCT01931956|323465727|FG002|Overall Study|Death|379|||
94458387|NCT01931956|323465728|FG003|Overall Study|Death|96|||
94249655|NCT02413333|322706656|FG001|Period 1|Reason Not Specified|1|||
94249656|NCT02413333|322706655|FG000|Period 2|Protocol Deviation|1|||
94249657|NCT02413333|322706656|FG001|Period 2|Protocol Deviation|0|||
94458388|NCT01931956|323465725|FG000|Overall Study|Withdrawal by Subject|5|||
94458389|NCT01931956|323465726|FG001|Overall Study|Withdrawal by Subject|0|||
94458390|NCT01931956|323465727|FG002|Overall Study|Withdrawal by Subject|70|||
94458391|NCT01931956|323465728|FG003|Overall Study|Withdrawal by Subject|30|||
94458392|NCT01931956|323465725|FG000|Overall Study|Lost to Follow-up|2|||
94458393|NCT01931956|323465726|FG001|Overall Study|Lost to Follow-up|0|||
94458394|NCT01931956|323465727|FG002|Overall Study|Lost to Follow-up|11|||
94458395|NCT01931956|323465728|FG003|Overall Study|Lost to Follow-up|7|||
94458396|NCT01931956|323465725|FG000|Overall Study|Expected|2|||
94458397|NCT01931956|323465726|FG001|Overall Study|Expected|0|||
94458398|NCT01931956|323465727|FG002|Overall Study|Expected|6|||
94458399|NCT01931956|323465728|FG003|Overall Study|Expected|0|||
94458400|NCT01931956|323465725|FG000|Overall Study|Not due|0|||
94458401|NCT01931956|323465726|FG001|Overall Study|Not due|0|||
94458402|NCT01931956|323465727|FG002|Overall Study|Not due|21|||
94458403|NCT01931956|323465728|FG003|Overall Study|Not due|0|||
94458404|NCT03005327|323465729|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
94458405|NCT03005327|323465730|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
94458406|NCT03005327|323465731|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
94458407|NCT03005327|323465732|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
94458408|NCT03005327|323465729|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94458409|NCT03005327|323465730|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
94458410|NCT03005327|323465731|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94458411|NCT03005327|323465732|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94458412|NCT01263782|323465736|FG000|Overall Study|Death|0|||
94458413|NCT01263782|323465737|FG001|Overall Study|Death|0|||
94458414|NCT01263782|323465738|FG002|Overall Study|Death|1|||
94458415|NCT01263782|323465739|FG003|Overall Study|Death|0|||
94458416|NCT01263782|323465736|FG000|Overall Study|Progressive disease|0|||
94458417|NCT01263782|323465737|FG001|Overall Study|Progressive disease|0|||
94458418|NCT01263782|323465738|FG002|Overall Study|Progressive disease|0|||
94458419|NCT01263782|323465739|FG003|Overall Study|Progressive disease|1|||
94458420|NCT01263782|323465736|FG000|Overall Study|Too early|0|||
94458421|NCT01263782|323465737|FG001|Overall Study|Too early|0|||
94458422|NCT01263782|323465738|FG002|Overall Study|Too early|1|||
94458423|NCT01263782|323465739|FG003|Overall Study|Too early|0|||
94458424|NCT01263782|323465736|FG000|Overall Study|Inevaluable|0|||
94458425|NCT01263782|323465737|FG001|Overall Study|Inevaluable|0|||
94458426|NCT01263782|323465738|FG002|Overall Study|Inevaluable|1|||
94458427|NCT01263782|323465739|FG003|Overall Study|Inevaluable|0|||
94458428|NCT01493284|323465746|FG000|Overall Study|Death|29|||
94458429|NCT01493284|323465746|FG000|Overall Study|Withdrawal by Subject|32|||
94458430|NCT04064411|323465747|FG000|Overall Study|Adverse Event|29|||
94458431|NCT04064411|323465748|FG001|Overall Study|Adverse Event|19|||
94458432|NCT04064411|323465747|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
94458433|NCT04064411|323465748|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
94458434|NCT04064411|323465747|FG000|Overall Study|Protocol Deviation|0|||
94249658|NCT03965351|322706669|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
94249659|NCT03965351|322706670|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
94249660|NCT03965351|322706669|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
94249661|NCT03965351|322706670|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
94249662|NCT00704405|322706671|FG000|Overall Study (NC Population)|Adverse Event|1|||
94249663|NCT00704405|322706672|FG001|Overall Study (NC Population)|Adverse Event|0|||
94249664|NCT00704405|322706673|FG002|Overall Study (NC Population)|Adverse Event|0|||
94458435|NCT04064411|323465748|FG001|Overall Study|Protocol Deviation|2|||
94458436|NCT04064411|323465747|FG000|Overall Study|Withdrawal by Subject|25|||
94458437|NCT04064411|323465748|FG001|Overall Study|Withdrawal by Subject|29|||
94458438|NCT04064411|323465747|FG000|Overall Study|Lost to Follow-up|5|||
94458439|NCT04064411|323465748|FG001|Overall Study|Lost to Follow-up|2|||
94458440|NCT04064411|323465747|FG000|Overall Study|Other than Specified|4|||
94458441|NCT04064411|323465748|FG001|Overall Study|Other than Specified|1|||
94458442|NCT04064411|323465747|FG000|Overall Study|Death|1|||
94458443|NCT04064411|323465748|FG001|Overall Study|Death|0|||
94458444|NCT03814720|323465749|FG000|Overall Study|Lost to Follow-up|0|||
94458445|NCT03814720|323465750|FG001|Overall Study|Lost to Follow-up|1|||
94458446|NCT03814720|323465751|FG002|Overall Study|Lost to Follow-up|0|||
94458447|NCT03814720|323465752|FG003|Overall Study|Lost to Follow-up|0|||
94249665|NCT00704405|322706674|FG003|Overall Study (NC Population)|Adverse Event|0|||
94458448|NCT03814720|323465753|FG004|Overall Study|Lost to Follow-up|0|||
94458449|NCT03053063|323465759|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
94458450|NCT03053063|323465760|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
94458451|NCT03053063|323465761|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
94458452|NCT03053063|323465762|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
94458453|NCT03053063|323465759|FG000|Randomized Phase|Withdrew consent|8|||
94249666|NCT00704405|322706675|FG004|Overall Study (NC Population)|Adverse Event|0|||
94249667|NCT00704405|322706671|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
94249668|NCT00704405|322706672|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
94249669|NCT00704405|322706673|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
94249670|NCT00704405|322706674|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
94249671|NCT00704405|322706675|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
94249672|NCT00704405|322706671|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
94249673|NCT00704405|322706672|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
94249674|NCT00704405|322706673|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
94249675|NCT00704405|322706674|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
94249676|NCT00704405|322706675|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
94249677|NCT00704405|322706671|FG000|Overall Study (NC Population)|Other|0|||
94249678|NCT00704405|322706672|FG001|Overall Study (NC Population)|Other|0|||
94249679|NCT00704405|322706673|FG002|Overall Study (NC Population)|Other|0|||
94249680|NCT00704405|322706674|FG003|Overall Study (NC Population)|Other|0|||
94249681|NCT00704405|322706675|FG004|Overall Study (NC Population)|Other|1|||
94356513|NCT00976989|323087180|FG002|Overall Study|Recurrence of Disease|0|||
94356514|NCT00976989|323087178|FG000|Overall Study|Other|1|||
94356515|NCT00976989|323087179|FG001|Overall Study|Other|0|||
94356516|NCT00976989|323087180|FG002|Overall Study|Other|1|||
94356517|NCT00570492|323087181|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
94356518|NCT00570492|323087182|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
94356519|NCT00570492|323087183|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
94356520|NCT00570492|323087181|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
94356521|NCT00570492|323087182|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
94356522|NCT00570492|323087183|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
94356523|NCT00570492|323087181|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
94356524|NCT00570492|323087182|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
94356525|NCT00570492|323087183|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
94356526|NCT00570492|323087181|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
94356527|NCT00570492|323087182|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
94356528|NCT00570492|323087183|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
94356529|NCT00570492|323087181|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
94356530|NCT00570492|323087182|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
94356531|NCT00570492|323087183|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
94356532|NCT00570492|323087181|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
94356533|NCT00570492|323087182|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
94356534|NCT00570492|323087183|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
94356535|NCT00570492|323087181|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
94356536|NCT00570492|323087182|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
94356537|NCT00570492|323087183|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
94356538|NCT00570492|323087181|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
94356539|NCT00570492|323087182|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
94356540|NCT00570492|323087183|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
94356541|NCT00570492|323087181|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
94356542|NCT00570492|323087182|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
94356543|NCT00570492|323087183|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
94356544|NCT00570492|323087181|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
94356545|NCT00570492|323087182|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
94356546|NCT00570492|323087183|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
94356547|NCT00570492|323087181|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
94356548|NCT00570492|323087182|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
94356549|NCT00570492|323087183|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
94356550|NCT00570492|323087181|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
94356551|NCT00570492|323087182|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
94356552|NCT00570492|323087183|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
94356553|NCT00570492|323087181|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
94356554|NCT00570492|323087182|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
94458454|NCT03053063|323465760|FG001|Randomized Phase|Withdrew consent|11|||
94249682|NCT00704405|322706671|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
94249683|NCT00704405|322706672|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
94249684|NCT00704405|322706673|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
94249685|NCT00704405|322706674|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
94249686|NCT00704405|322706675|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
94249687|NCT00704405|322706671|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
94249688|NCT00704405|322706672|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
94249689|NCT00704405|322706673|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
94249690|NCT00704405|322706674|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
94249691|NCT00704405|322706675|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
94249692|NCT01796548|322706676|FG000|Overall Study|Lost to Follow-up|1|||
94249693|NCT01796548|322706676|FG000|Overall Study|Other|2|||
94249694|NCT02523599|322706677|FG000|Overall Study|Adverse Event|1|||
94249695|NCT02523599|322706678|FG001|Overall Study|Adverse Event|0|||
94249696|NCT02523599|322706677|FG000|Overall Study|Physician Decision|1|||
94249697|NCT02523599|322706678|FG001|Overall Study|Physician Decision|0|||
94249698|NCT02523599|322706677|FG000|Overall Study|Lost to Follow-up|4|||
94249699|NCT02523599|322706678|FG001|Overall Study|Lost to Follow-up|1|||
94249700|NCT02523599|322706677|FG000|Overall Study|Did not return for Day 30 visit|2|||
94249701|NCT02523599|322706678|FG001|Overall Study|Did not return for Day 30 visit|0|||
94249702|NCT03141905|322706679|FG000|Overall Study|Death|3|||
94249703|NCT03141905|322706680|FG001|Overall Study|Death|2|||
94249704|NCT03141905|322706679|FG000|Overall Study|Withdrawal by Subject|1|||
94249705|NCT03141905|322706680|FG001|Overall Study|Withdrawal by Subject|0|||
94249706|NCT03141905|322706679|FG000|Overall Study|Lost to Follow-up|3|||
94249707|NCT03141905|322706680|FG001|Overall Study|Lost to Follow-up|7|||
94249708|NCT03141905|322706679|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
94249709|NCT03141905|322706680|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
94264112|NCT01009554|322761840|FG001|Overall Study|Withdrawal by Subject|3|||
94264113|NCT01009554|322761839|FG000|Overall Study|Noncompliant with Study Product|0|||
94264114|NCT01009554|322761840|FG001|Overall Study|Noncompliant with Study Product|3|||
94264115|NCT01605253|322761841|FG000|Overall Study|Physician Decision|3|||
94264116|NCT01605253|322761842|FG001|Overall Study|Physician Decision|2|||
94264117|NCT01605253|322761841|FG000|Overall Study|Lost to Follow-up|3|||
94264118|NCT01605253|322761842|FG001|Overall Study|Lost to Follow-up|1|||
94264119|NCT04936841|322761846|FG000|Overall Study|Death|1|||
94264120|NCT03739437|322761847|FG000|Overall Study|Lost to Follow-up|2|||
94264121|NCT03739437|322761848|FG001|Overall Study|Lost to Follow-up|5|||
94264122|NCT01184053|322761849|FG000|Overall Study|progression while on treatment|3|||
94264123|NCT01323621|322761851|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
94264124|NCT01323621|322761852|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
94264125|NCT01323621|322761853|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
94264126|NCT01323621|322761851|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
94264127|NCT01323621|322761852|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
94264128|NCT01323621|322761853|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
94264129|NCT01323621|322761851|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
94264130|NCT01323621|322761852|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
94264131|NCT01323621|322761853|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
94264132|NCT01323621|322761851|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
94264133|NCT01323621|322761852|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
94264134|NCT01323621|322761853|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
94264135|NCT01323621|322761851|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
94264136|NCT01323621|322761852|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
94264137|NCT01323621|322761853|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
94264138|NCT01323621|322761851|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
94264139|NCT01323621|322761852|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
94264140|NCT01323621|322761853|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
94264141|NCT01323621|322761851|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
94264142|NCT01323621|322761852|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
94264143|NCT01323621|322761853|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
94264144|NCT01323621|322761851|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
94264145|NCT01323621|322761852|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
94264146|NCT01323621|322761853|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
94264147|NCT01323621|322761851|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
94264148|NCT01323621|322761852|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
94264149|NCT01323621|322761853|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
94264150|NCT01323621|322761851|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
94264151|NCT01323621|322761852|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
94264152|NCT01323621|322761853|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
94264153|NCT01323621|322761851|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
94264154|NCT01323621|322761852|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
94264155|NCT01323621|322761853|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
94249710|NCT00978627|322708679|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
94249711|NCT00978627|322708680|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
94249712|NCT00978627|322708679|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
94249713|NCT00978627|322708680|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
94249714|NCT00978627|322708679|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
94249715|NCT00978627|322708680|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
94249716|NCT00978627|322708679|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
94249717|NCT00978627|322708680|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
94249718|NCT00978627|322708679|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
94249719|NCT00978627|322708680|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
94249720|NCT00978627|322708679|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
94249721|NCT00978627|322708680|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
94249722|NCT00978627|322708679|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
94249723|NCT00978627|322708680|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
94249724|NCT00978627|322708679|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
94249725|NCT00978627|322708680|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
94249726|NCT00978627|322708679|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
94249727|NCT00978627|322708680|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
94249728|NCT00969709|322708681|FG000|Overall Study|Adverse Event|3|||
94249729|NCT00969709|322708682|FG001|Overall Study|Adverse Event|13|||
94249730|NCT00969709|322708683|FG002|Overall Study|Adverse Event|26|||
94249731|NCT00969709|322708684|FG003|Overall Study|Adverse Event|12|||
94249732|NCT00969709|322708681|FG000|Overall Study|Lack of Efficacy|7|||
94249733|NCT00969709|322708682|FG001|Overall Study|Lack of Efficacy|4|||
94249734|NCT00969709|322708683|FG002|Overall Study|Lack of Efficacy|1|||
94249735|NCT00969709|322708684|FG003|Overall Study|Lack of Efficacy|3|||
94249736|NCT00969709|322708681|FG000|Overall Study|Protocol Violation|9|||
94249737|NCT00969709|322708682|FG001|Overall Study|Protocol Violation|5|||
94249738|NCT00969709|322708683|FG002|Overall Study|Protocol Violation|9|||
94249739|NCT00969709|322708684|FG003|Overall Study|Protocol Violation|10|||
94249740|NCT00969709|322708681|FG000|Overall Study|Withdrawal by Subject|9|||
94249741|NCT00969709|322708682|FG001|Overall Study|Withdrawal by Subject|12|||
94249742|NCT00969709|322708683|FG002|Overall Study|Withdrawal by Subject|11|||
94249743|NCT00969709|322708684|FG003|Overall Study|Withdrawal by Subject|23|||
94249744|NCT00969709|322708681|FG000|Overall Study|Lost to Follow-up|10|||
94249745|NCT00969709|322708682|FG001|Overall Study|Lost to Follow-up|14|||
94249746|NCT00969709|322708683|FG002|Overall Study|Lost to Follow-up|8|||
94249747|NCT00969709|322708684|FG003|Overall Study|Lost to Follow-up|15|||
94249748|NCT00969709|322708681|FG000|Overall Study|Other reasons|0|||
94249749|NCT00969709|322708682|FG001|Overall Study|Other reasons|0|||
94249750|NCT00969709|322708683|FG002|Overall Study|Other reasons|3|||
94249751|NCT00969709|322708684|FG003|Overall Study|Other reasons|0|||
94249752|NCT00640133|322708686|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
94249753|NCT00640133|322708687|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
94249754|NCT00640133|322708686|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
94249755|NCT00640133|322708687|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
94249756|NCT00640133|322708686|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
94249757|NCT00640133|322708687|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
94249758|NCT00872989|322708690|FG000|Overall Study|Adverse Event|7|||
94249759|NCT00872989|322708691|FG001|Overall Study|Adverse Event|15|||
94249760|NCT00872989|322708690|FG000|Overall Study|Withdrawal by Subject|8|||
94249761|NCT00872989|322708691|FG001|Overall Study|Withdrawal by Subject|5|||
94249762|NCT00872989|322708690|FG000|Overall Study|Progression/relapse|47|||
94249763|NCT00872989|322708691|FG001|Overall Study|Progression/relapse|35|||
94249764|NCT00872989|322708690|FG000|Overall Study|Not protocol specified|3|||
94249765|NCT00872989|322708691|FG001|Overall Study|Not protocol specified|8|||
94249766|NCT00923260|322708692|FG000|Overall Study|Lost to Follow-up|1|||
94249767|NCT00923260|322708693|FG001|Overall Study|Lost to Follow-up|1|||
94249768|NCT01034176|322708698|FG000|Overall Study|Physician Decision|2|||
94249769|NCT01034176|322708699|FG001|Overall Study|Physician Decision|0|||
94249770|NCT01034176|322708698|FG000|Overall Study|Withdrawal by Subject|0|||
94249771|NCT01034176|322708699|FG001|Overall Study|Withdrawal by Subject|1|||
94249772|NCT01034176|322708698|FG000|Overall Study|Lost to Follow-up|0|||
94249773|NCT01034176|322708699|FG001|Overall Study|Lost to Follow-up|1|||
94249774|NCT00266227|322708700|FG000|Initial Treatment|Adverse Event|0|||
94249775|NCT00266227|322708701|FG001|Initial Treatment|Adverse Event|0|||
94249776|NCT00266227|322708702|FG002|Initial Treatment|Adverse Event|13|||
94249777|NCT00266227|322708700|FG000|Initial Treatment|Lost to Follow-up|0|||
94249778|NCT00266227|322708701|FG001|Initial Treatment|Lost to Follow-up|0|||
94249779|NCT00266227|322708702|FG002|Initial Treatment|Lost to Follow-up|6|||
94249780|NCT00266227|322708700|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
94249781|NCT00266227|322708701|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
94249782|NCT00266227|322708702|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
94249783|NCT00266227|322708700|FG000|Initial Treatment|Physician decision to withdraw|0|||
94249784|NCT00266227|322708701|FG001|Initial Treatment|Physician decision to withdraw|0|||
94249785|NCT00266227|322708702|FG002|Initial Treatment|Physician decision to withdraw|12|||
94249786|NCT00266227|322708700|FG000|Initial Treatment|Pregnancy|0|||
94249787|NCT00266227|322708701|FG001|Initial Treatment|Pregnancy|0|||
94249788|NCT00266227|322708702|FG002|Initial Treatment|Pregnancy|1|||
94249789|NCT00266227|322708700|FG000|Retreatment: Up to Week 48|Death|1|||
94249790|NCT00266227|322708701|FG001|Retreatment: Up to Week 48|Death|0|||
94249791|NCT00266227|322708702|FG002|Retreatment: Up to Week 48|Death|0|||
94249792|NCT00266227|322708700|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
94249793|NCT00266227|322708701|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
94249794|NCT00266227|322708702|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
94249795|NCT00266227|322708700|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
94249796|NCT00266227|322708701|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
94249797|NCT00266227|322708702|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
94249798|NCT00266227|322708700|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
94249799|NCT00266227|322708701|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
94249800|NCT00266227|322708702|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
94249801|NCT00266227|322708700|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
94356555|NCT00570492|323087183|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
94356556|NCT00570492|323087181|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
94356557|NCT00570492|323087182|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
94356558|NCT00570492|323087183|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
94356559|NCT01539512|323087184|FG000|Overall Study|Adverse Event|9|||
94356560|NCT01539512|323087185|FG001|Overall Study|Adverse Event|7|||
94356561|NCT01539512|323087184|FG000|Overall Study|Physician Decision|1|||
94356562|NCT01539512|323087185|FG001|Overall Study|Physician Decision|1|||
94356563|NCT01539512|323087184|FG000|Overall Study|Withdrawal by Subject|12|||
94356564|NCT01539512|323087185|FG001|Overall Study|Withdrawal by Subject|5|||
94356565|NCT01539512|323087184|FG000|Overall Study|Richter's Transformation|1|||
94356566|NCT01539512|323087185|FG001|Overall Study|Richter's Transformation|0|||
94356567|NCT04298229|323087186|FG000|Overall Study|Physician Decision|1|||
94356568|NCT04298229|323087187|FG001|Overall Study|Physician Decision|1|||
94356569|NCT04298229|323087186|FG000|Overall Study|Withdrawal by Subject|1|||
94356570|NCT04298229|323087187|FG001|Overall Study|Withdrawal by Subject|1|||
94356571|NCT04298229|323087186|FG000|Overall Study|Did not receive IV loop diuretics|2|||
94356572|NCT04298229|323087187|FG001|Overall Study|Did not receive IV loop diuretics|0|||
94356573|NCT00674440|323087192|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
94356574|NCT00674440|323087192|FG000|Overall Study|did not have surgery, so unevaluable|7|||
94356575|NCT00674440|323087192|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
94356576|NCT03329404|323087193|FG000|Overall Study|The study was suspended.|1|||
94356577|NCT03329404|323087194|FG001|Overall Study|The study was suspended.|4|||
94356578|NCT01233284|323087196|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
94356579|NCT01233284|323087197|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
94356580|NCT01233284|323087198|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
94356581|NCT01233284|323087199|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
94356582|NCT01233284|323087200|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
94356583|NCT01233284|323087196|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
94356584|NCT01233284|323087197|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
94356585|NCT01233284|323087198|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
94356586|NCT01233284|323087199|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
94356587|NCT01233284|323087200|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
94356588|NCT01233284|323087196|FG000|Period 1 (4 Weeks)|Other|0|||
94356589|NCT01233284|323087197|FG001|Period 1 (4 Weeks)|Other|0|||
94356590|NCT01233284|323087198|FG002|Period 1 (4 Weeks)|Other|1|||
94356591|NCT01233284|323087199|FG003|Period 1 (4 Weeks)|Other|0|||
94356592|NCT01233284|323087200|FG004|Period 1 (4 Weeks)|Other|0|||
94356593|NCT01233284|323087196|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
94356594|NCT01233284|323087197|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
94356595|NCT01233284|323087198|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
94356596|NCT01233284|323087199|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
94356597|NCT01233284|323087200|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
94356598|NCT01233284|323087196|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
94356599|NCT01233284|323087197|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
94356600|NCT01233284|323087198|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
94356601|NCT01233284|323087199|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
94356602|NCT01233284|323087200|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
94356603|NCT01233284|323087196|FG000|Period 3 (4 Weeks)|Other|0|||
94249802|NCT00266227|322708701|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
94356604|NCT01233284|323087197|FG001|Period 3 (4 Weeks)|Other|0|||
94356605|NCT01233284|323087198|FG002|Period 3 (4 Weeks)|Other|0|||
94356606|NCT01233284|323087199|FG003|Period 3 (4 Weeks)|Other|1|||
94356607|NCT01233284|323087200|FG004|Period 3 (4 Weeks)|Other|0|||
94356608|NCT01233284|323087196|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
94356609|NCT01233284|323087197|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
94605271|NCT03026088|324017965|FG000|Overall Study|Study termination|20|||
94249803|NCT00266227|322708702|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
94249804|NCT00266227|322708700|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
94249805|NCT00266227|322708701|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
94249806|NCT00266227|322708702|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
94249807|NCT00266227|322708700|FG000|Retreatment: Week 48 to Week 72|Death|1|||
94249808|NCT00266227|322708701|FG001|Retreatment: Week 48 to Week 72|Death|1|||
94249809|NCT00266227|322708702|FG002|Retreatment: Week 48 to Week 72|Death|0|||
94249810|NCT00266227|322708700|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
94249811|NCT00266227|322708701|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
94249812|NCT00266227|322708702|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
94249813|NCT00266227|322708700|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
94249814|NCT00266227|322708701|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
94249815|NCT00266227|322708702|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
94249816|NCT00266227|322708700|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
94249817|NCT00266227|322708701|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
94249818|NCT00266227|322708702|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
94249819|NCT00266227|322708700|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
94249820|NCT00266227|322708701|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
94249821|NCT00266227|322708702|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
94249822|NCT00591721|322708705|FG000|Overall Study|Withdrawal by Subject|10|||
94249823|NCT00591721|322708706|FG001|Overall Study|Withdrawal by Subject|10|||
94249824|NCT00591721|322708705|FG000|Overall Study|Lost to Follow-up|1|||
94249825|NCT00591721|322708706|FG001|Overall Study|Lost to Follow-up|4|||
94249826|NCT00591721|322708705|FG000|Overall Study|Intervention not received|10|||
94249827|NCT00591721|322708706|FG001|Overall Study|Intervention not received|8|||
94249828|NCT00759915|322708707|FG000|Overall Study|Withdrawal by Subject|1|||
94249829|NCT00759915|322708708|FG001|Overall Study|Withdrawal by Subject|0|||
94249830|NCT00759915|322708707|FG000|Overall Study|Adverse Event|0|||
94249831|NCT00759915|322708708|FG001|Overall Study|Adverse Event|1|||
94249832|NCT03809429|322708709|FG000|Overall Study|Withdrawal by Subject|7|||
94249833|NCT03809429|322708710|FG001|Overall Study|Withdrawal by Subject|3|||
94249834|NCT03809429|322708709|FG000|Overall Study|Adverse Event|6|||
94249835|NCT03809429|322708710|FG001|Overall Study|Adverse Event|9|||
94249836|NCT03809429|322708709|FG000|Overall Study|COVID-19|3|||
94249837|NCT03809429|322708710|FG001|Overall Study|COVID-19|1|||
94249838|NCT03809429|322708709|FG000|Overall Study|Participant was discontinued by investigator|12|||
94249839|NCT03809429|322708710|FG001|Overall Study|Participant was discontinued by investigator|7|||
94249840|NCT00621777|322708714|FG000|Open Phase|Adverse Event|20|||
94249841|NCT00621777|322708715|FG001|Open Phase|Adverse Event|0|||
94249842|NCT00621777|322708714|FG000|Open Phase|Did not abstain during open phase|56|||
94249843|NCT00621777|322708715|FG001|Open Phase|Did not abstain during open phase|0|||
94249844|NCT00621777|322708714|FG000|Open Phase|Withdrawal by Subject|17|||
94249845|NCT00621777|322708715|FG001|Open Phase|Withdrawal by Subject|0|||
94249846|NCT00621777|322708714|FG000|Open Phase|administrative|13|||
94249847|NCT00621777|322708715|FG001|Open Phase|administrative|0|||
94249848|NCT00621777|322708714|FG000|Open Phase|Lost to Follow-up|10|||
94249849|NCT00621777|322708715|FG001|Open Phase|Lost to Follow-up|0|||
94249850|NCT00621777|322708714|FG000|Randomized Phase|Adverse Event|3|||
94249851|NCT00621777|322708715|FG001|Randomized Phase|Adverse Event|3|||
94249852|NCT00621777|322708714|FG000|Randomized Phase|Lost to Follow-up|3|||
94249853|NCT00621777|322708715|FG001|Randomized Phase|Lost to Follow-up|3|||
94249854|NCT00621777|322708714|FG000|Randomized Phase|Withdrawal by Subject|1|||
94249855|NCT00621777|322708715|FG001|Randomized Phase|Withdrawal by Subject|9|||
94249856|NCT00621777|322708714|FG000|Randomized Phase|administrative|0|||
94249857|NCT00621777|322708715|FG001|Randomized Phase|administrative|3|||
94249858|NCT00621777|322708714|FG000|Randomized Phase|Death|0|||
94249859|NCT00621777|322708715|FG001|Randomized Phase|Death|1|||
94249860|NCT04101318|322708716|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
94249861|NCT04101318|322708717|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
94249862|NCT04101318|322708716|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
94249863|NCT04101318|322708717|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
94249864|NCT04101318|322708716|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
94249865|NCT04101318|322708717|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
94249866|NCT00446043|322708718|FG000|Overall Study|Adverse Event|9|||
94249867|NCT00446043|322708718|FG000|Overall Study|Withdrawal by Subject|70|||
94249868|NCT00446043|322708718|FG000|Overall Study|Protocol Violation|2|||
94249869|NCT00446043|322708718|FG000|Overall Study|Lost to Follow-up|42|||
94249870|NCT00446043|322708718|FG000|Overall Study|Pregnancy|2|||
94249871|NCT04289051|322708721|FG000|Overall Study|Lost to Follow-up|0|||
94249872|NCT04289051|322708722|FG001|Overall Study|Lost to Follow-up|0|||
94249873|NCT04289051|322708723|FG002|Overall Study|Lost to Follow-up|2|||
94249874|NCT02929329|322708724|FG000|Overall Study|Withdrawal by Subject|24|||
94249875|NCT02929329|322708725|FG001|Overall Study|Withdrawal by Subject|21|||
94249876|NCT02929329|322708724|FG000|Overall Study|Lost to Follow-up|26|||
94249877|NCT02929329|322708725|FG001|Overall Study|Lost to Follow-up|20|||
94249878|NCT02929329|322708724|FG000|Overall Study|Death|1054|||
94249879|NCT02929329|322708725|FG001|Overall Study|Death|1051|||
94249880|NCT00996476|322708726|FG000|Overall Study|Withdrawal by Subject|1|||
94249881|NCT00996476|322708727|FG001|Overall Study|Withdrawal by Subject|2|||
94249882|NCT00996476|322708728|FG002|Overall Study|Withdrawal by Subject|1|||
94249883|NCT00996476|322708729|FG003|Overall Study|Withdrawal by Subject|0|||
94249884|NCT00996476|322708730|FG004|Overall Study|Withdrawal by Subject|1|||
94249885|NCT00996476|322708726|FG000|Overall Study|Adverse Event|0|||
94249886|NCT00996476|322708727|FG001|Overall Study|Adverse Event|1|||
94249887|NCT00996476|322708728|FG002|Overall Study|Adverse Event|0|||
94249888|NCT00996476|322708729|FG003|Overall Study|Adverse Event|0|||
94249889|NCT00996476|322708730|FG004|Overall Study|Adverse Event|1|||
94249890|NCT03836716|322708739|FG000|Overall Study|Adverse Event|3|||
94249891|NCT03836716|322708739|FG000|Overall Study|Death|22|||
94249892|NCT03836716|322708739|FG000|Overall Study|Withdrawal by Subject|8|||
94249893|NCT03836716|322708739|FG000|Overall Study|Study terminated by sponsor|87|||
94249894|NCT01983254|322708740|FG000|Overall Study|Death|6|||
94249895|NCT01983254|322708741|FG001|Overall Study|Death|6|||
94249896|NCT01983254|322708740|FG000|Overall Study|Lost to Follow-up|17|||
94249897|NCT01983254|322708741|FG001|Overall Study|Lost to Follow-up|16|||
94249898|NCT01983254|322708740|FG000|Overall Study|too ill|11|||
94249899|NCT01983254|322708741|FG001|Overall Study|too ill|8|||
94249900|NCT00434213|322708744|FG000|Overall Study|Adverse Event|12|||
94249901|NCT00434213|322708744|FG000|Overall Study|Lack of Efficacy|9|||
94249902|NCT00434213|322708744|FG000|Overall Study|Lost to Follow-up|14|||
94356610|NCT01233284|323087198|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
94356611|NCT01233284|323087199|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
94356612|NCT01233284|323087200|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
94356613|NCT01233284|323087196|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
94356614|NCT01233284|323087197|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
94356615|NCT01233284|323087198|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
94356616|NCT01233284|323087199|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
94356617|NCT01233284|323087200|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
94356618|NCT00948896|323087201|FG000|Randomization to 24 Months of Age|Death|1|||
94356619|NCT00948896|323087202|FG001|Randomization to 24 Months of Age|Death|0|||
94356620|NCT00948896|323087203|FG002|Randomization to 24 Months of Age|Death|0|||
94356621|NCT00948896|323087204|FG003|Randomization to 24 Months of Age|Death|0|||
94356622|NCT00948896|323087205|FG004|Randomization to 24 Months of Age|Death|2|||
94356623|NCT00948896|323087206|FG005|Randomization to 24 Months of Age|Death|1|||
94356624|NCT00948896|323087207|FG006|Randomization to 24 Months of Age|Death|2|||
94356625|NCT00948896|323087208|FG007|Randomization to 24 Months of Age|Death|1|||
94356626|NCT00948896|323087201|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
94356627|NCT00948896|323087202|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
94356628|NCT00948896|323087203|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
94356629|NCT00948896|323087204|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
94356630|NCT00948896|323087205|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
94356631|NCT00948896|323087206|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
94356632|NCT00948896|323087207|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
94356633|NCT00948896|323087208|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
94356634|NCT00948896|323087201|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
94356635|NCT00948896|323087202|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
94356636|NCT00948896|323087203|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
94356637|NCT00948896|323087204|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
94356638|NCT00948896|323087205|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
94356639|NCT00948896|323087206|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
94356640|NCT00948896|323087207|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
94356641|NCT00948896|323087208|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
94356642|NCT00948896|323087201|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
94356643|NCT00948896|323087202|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
94356644|NCT00948896|323087203|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
94356645|NCT00948896|323087204|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
94356646|NCT00948896|323087205|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
94356647|NCT00948896|323087206|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
94356648|NCT00948896|323087207|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
94356649|NCT00948896|323087208|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
94356650|NCT00948896|323087201|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
94356651|NCT00948896|323087202|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
94356652|NCT00948896|323087203|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
94356653|NCT00948896|323087204|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
94249903|NCT00434213|322708744|FG000|Overall Study|Withdrawal by Subject|7|||
94249904|NCT00434213|322708744|FG000|Overall Study|Protocol Violation|3|||
94249905|NCT00434213|322708744|FG000|Overall Study|Unable to comply with study visit window|2|||
94249906|NCT00434213|322708744|FG000|Overall Study|Application site reaction|1|||
94249907|NCT00434213|322708744|FG000|Overall Study|Non-compliant to study schedule|1|||
94249908|NCT04988867|322708745|FG000|Overall Study|Study terminated by Sponsor|12|||
94249909|NCT04988867|322708745|FG000|Overall Study|Adverse Event|2|||
94249910|NCT04988867|322708745|FG000|Overall Study|Study drug noncompliance|1|||
94249911|NCT01699503|322708746|FG000|Overall Study|Death|31|||
94249912|NCT01699503|322708747|FG001|Overall Study|Death|40|||
94249913|NCT01699503|322708746|FG000|Overall Study|Withdrawal by Subject|65|||
94249914|NCT01699503|322708747|FG001|Overall Study|Withdrawal by Subject|57|||
94249915|NCT01699503|322708746|FG000|Overall Study|Lost to Follow-up|121|||
94249916|NCT01699503|322708747|FG001|Overall Study|Lost to Follow-up|117|||
94249917|NCT01699503|322708746|FG000|Overall Study|Excluded due to quality|783|||
94249918|NCT01699503|322708747|FG001|Overall Study|Excluded due to quality|791|||
94249919|NCT01156792|322708752|FG000|Overall Study|Adverse Event|1|||
94249920|NCT01156792|322708752|FG000|Overall Study|Lack of Efficacy|36|||
94249921|NCT01156792|322708752|FG000|Overall Study|Protocol Violation|6|||
94249922|NCT01156792|322708752|FG000|Overall Study|Lost to Follow-up|3|||
94249923|NCT01156792|322708752|FG000|Overall Study|Physician Decision|3|||
94249924|NCT01156792|322708752|FG000|Overall Study|Withdrawal by Subject|9|||
94249925|NCT01156792|322708752|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
94249926|NCT00768079|322708753|FG000|Overall Study|Lost to Follow-up|2|||
94249927|NCT00768079|322708754|FG001|Overall Study|Lost to Follow-up|0|||
94249928|NCT00768079|322708755|FG002|Overall Study|Lost to Follow-up|4|||
94249929|NCT00768079|322708753|FG000|Overall Study|Participant incarcerated|0|||
94249930|NCT00768079|322708754|FG001|Overall Study|Participant incarcerated|1|||
94249931|NCT00768079|322708755|FG002|Overall Study|Participant incarcerated|0|||
94249932|NCT01177800|322708756|FG000|Overall Study|Adverse Event|9|||
94249933|NCT01177800|322708757|FG001|Overall Study|Adverse Event|3|||
94249934|NCT01177800|322708756|FG000|Overall Study|Protocol Violation|0|||
94249935|NCT01177800|322708757|FG001|Overall Study|Protocol Violation|1|||
94249936|NCT01177800|322708756|FG000|Overall Study|Physician Decision|1|||
94249937|NCT01177800|322708757|FG001|Overall Study|Physician Decision|0|||
94249938|NCT01177800|322708756|FG000|Overall Study|Withdrawal of informed consent|0|||
94249939|NCT01177800|322708757|FG001|Overall Study|Withdrawal of informed consent|1|||
94249940|NCT03412747|322708759|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
94249941|NCT03412747|322708760|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
94249942|NCT03412747|322708761|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
94249943|NCT03412747|322708759|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
94249944|NCT03412747|322708760|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
94249945|NCT03412747|322708761|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
94249946|NCT03412747|322708759|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
94249947|NCT03412747|322708760|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
94249948|NCT03412747|322708761|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
94249949|NCT03412747|322708759|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
94249950|NCT03412747|322708760|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
94249951|NCT03412747|322708761|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
94249952|NCT03412747|322708759|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
94249953|NCT03412747|322708760|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
94249954|NCT03412747|322708761|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
94249955|NCT03412747|322708759|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
94249956|NCT03412747|322708760|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
94249957|NCT03412747|322708761|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
94249958|NCT03412747|322708759|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
94249959|NCT03412747|322708760|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
94249960|NCT03412747|322708761|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
94249961|NCT03412747|322708759|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
94249962|NCT03412747|322708760|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
94249963|NCT03412747|322708761|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
94249964|NCT03412747|322708759|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
94249965|NCT03412747|322708760|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
94249966|NCT03412747|322708761|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
94249967|NCT03412747|322708759|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
94249968|NCT03412747|322708760|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
94249969|NCT03412747|322708761|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
94249970|NCT03412747|322708759|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
94249971|NCT03412747|322708760|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
94249972|NCT03412747|322708761|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
94249973|NCT03412747|322708759|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
94249974|NCT03412747|322708760|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
94249975|NCT03412747|322708761|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
94249976|NCT03412747|322708759|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
94249977|NCT03412747|322708760|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
94249978|NCT03412747|322708761|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
94249979|NCT03412747|322708759|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
94249980|NCT03412747|322708760|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
94249981|NCT03412747|322708761|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
94249982|NCT03412747|322708759|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
94249983|NCT03412747|322708760|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
94249984|NCT03412747|322708761|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
94249985|NCT03412747|322708759|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
94249986|NCT03412747|322708760|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
94458455|NCT03053063|323465761|FG002|Randomized Phase|Withdrew consent|5|||
94605272|NCT01869725|324017968|FG000|Overall Study|ineligible after registration|1|||
94605273|NCT01869725|324017968|FG000|Overall Study|Death|1|||
94605274|NCT01869725|324017968|FG000|Overall Study|Lost to Follow-up|2|||
94605275|NCT01923168|324017973|FG000|Overall Study|Protocol Violation|1|||
94605276|NCT01923168|324017974|FG001|Overall Study|Protocol Violation|1|||
94605277|NCT01923168|324017975|FG002|Overall Study|Protocol Violation|0|||
94605278|NCT01923168|324017973|FG000|Overall Study|Subject/guardian decision|14|||
94605279|NCT01923168|324017974|FG001|Overall Study|Subject/guardian decision|14|||
94605280|NCT01923168|324017975|FG002|Overall Study|Subject/guardian decision|4|||
94605281|NCT01923168|324017973|FG000|Overall Study|Adverse Event|12|||
94605282|NCT01923168|324017974|FG001|Overall Study|Adverse Event|12|||
94605283|NCT01923168|324017975|FG002|Overall Study|Adverse Event|0|||
94605284|NCT01923168|324017973|FG000|Overall Study|Physician Decision|6|||
94605285|NCT01923168|324017974|FG001|Overall Study|Physician Decision|9|||
94605286|NCT01923168|324017975|FG002|Overall Study|Physician Decision|5|||
94605287|NCT01923168|324017973|FG000|Overall Study|Progressive disease|4|||
94605288|NCT01923168|324017974|FG001|Overall Study|Progressive disease|3|||
94605289|NCT01923168|324017975|FG002|Overall Study|Progressive disease|7|||
94605290|NCT01923168|324017973|FG000|Overall Study|Death|0|||
94605291|NCT01923168|324017974|FG001|Overall Study|Death|0|||
94605292|NCT01923168|324017975|FG002|Overall Study|Death|1|||
94605293|NCT00450112|324017976|FG000|Overall Study|Other Treatment Required|5|||
94605294|NCT00450112|324017977|FG001|Overall Study|Other Treatment Required|1|||
94605295|NCT00450112|324017976|FG000|Overall Study|Withdrawal by Subject|4|||
94605296|NCT00450112|324017977|FG001|Overall Study|Withdrawal by Subject|1|||
94605297|NCT00450112|324017976|FG000|Overall Study|Lost to Follow-up|2|||
94605298|NCT00450112|324017977|FG001|Overall Study|Lost to Follow-up|1|||
94605299|NCT00450112|324017976|FG000|Overall Study|Others|2|||
94605300|NCT00450112|324017977|FG001|Overall Study|Others|3|||
94605301|NCT02310321|324017982|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
94605302|NCT02310321|324017983|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
94605303|NCT02310321|324017984|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
94605304|NCT02310321|324017982|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
94605305|NCT02310321|324017983|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
94605306|NCT02310321|324017984|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
94605307|NCT02310321|324017982|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
94605308|NCT02310321|324017983|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
94605309|NCT02310321|324017984|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
94605310|NCT02310321|324017982|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
94605311|NCT02310321|324017983|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
94605312|NCT02310321|324017984|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
94605313|NCT02310321|324017982|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
94605314|NCT02310321|324017983|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
94605315|NCT02310321|324017984|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
94605316|NCT02310321|324017982|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
94605317|NCT02310321|324017983|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
94605318|NCT02310321|324017984|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
94605319|NCT02310321|324017982|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
94249987|NCT03412747|322708761|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
94249988|NCT02224690|322708762|FG000|Overall Study|Adverse Event|8|||
94249989|NCT02224690|322708763|FG001|Overall Study|Adverse Event|1|||
94249990|NCT02224690|322708762|FG000|Overall Study|Met Withdrawal Criteria|4|||
94249991|NCT02224690|322708763|FG001|Overall Study|Met Withdrawal Criteria|0|||
94249992|NCT02224690|322708762|FG000|Overall Study|Use of G-tube|1|||
94249993|NCT02224690|322708763|FG001|Overall Study|Use of G-tube|0|||
94249994|NCT02224690|322708762|FG000|Overall Study|Did not meet eligibility criteria|1|||
94249995|NCT02224690|322708763|FG001|Overall Study|Did not meet eligibility criteria|0|||
94249996|NCT00381615|322708764|FG000|Overall Study|Withdrawal by Subject|1|||
94249997|NCT00381615|322708765|FG001|Overall Study|Withdrawal by Subject|3|||
94249998|NCT00381615|322708766|FG002|Overall Study|Withdrawal by Subject|0|||
94249999|NCT00381615|322708767|FG003|Overall Study|Withdrawal by Subject|1|||
94250000|NCT00381615|322708764|FG000|Overall Study|Lost to Follow-up|3|||
94250001|NCT00381615|322708765|FG001|Overall Study|Lost to Follow-up|2|||
94250002|NCT00381615|322708766|FG002|Overall Study|Lost to Follow-up|0|||
94250003|NCT00381615|322708767|FG003|Overall Study|Lost to Follow-up|1|||
94250004|NCT00381615|322708764|FG000|Overall Study|Protocol Violation|0|||
94250005|NCT00381615|322708765|FG001|Overall Study|Protocol Violation|0|||
94250006|NCT00381615|322708766|FG002|Overall Study|Protocol Violation|1|||
94250007|NCT00381615|322708767|FG003|Overall Study|Protocol Violation|0|||
94250008|NCT00620282|322708770|FG000|Overall Study|Adverse Event|0|||
94250009|NCT00620282|322708771|FG001|Overall Study|Adverse Event|1|||
94250010|NCT00620282|322708772|FG002|Overall Study|Adverse Event|0|||
94250011|NCT00620282|322708770|FG000|Overall Study|Arterial line unable to be placed|0|||
94250012|NCT00620282|322708771|FG001|Overall Study|Arterial line unable to be placed|0|||
94250013|NCT00620282|322708772|FG002|Overall Study|Arterial line unable to be placed|1|||
94250014|NCT00620282|322708770|FG000|Overall Study|Withdrawal by Subject|0|||
94250015|NCT00620282|322708771|FG001|Overall Study|Withdrawal by Subject|1|||
94250016|NCT00620282|322708772|FG002|Overall Study|Withdrawal by Subject|0|||
94250017|NCT01528345|322708773|FG000|Overall Study|Adverse Event|10|||
94250018|NCT01528345|322708774|FG001|Overall Study|Adverse Event|1|||
94250019|NCT01528345|322708773|FG000|Overall Study|Death|1|||
94250020|NCT01528345|322708774|FG001|Overall Study|Death|1|||
94250021|NCT01528345|322708773|FG000|Overall Study|Non-compliance with study treatment|1|||
94250022|NCT01528345|322708774|FG001|Overall Study|Non-compliance with study treatment|0|||
94250023|NCT01528345|322708773|FG000|Overall Study|Progressive Disease|26|||
94250024|NCT01528345|322708774|FG001|Overall Study|Progressive Disease|40|||
94250025|NCT01528345|322708773|FG000|Overall Study|Study Terminated by Sponsor|4|||
94250026|NCT01528345|322708774|FG001|Overall Study|Study Terminated by Sponsor|8|||
94250027|NCT01528345|322708773|FG000|Overall Study|Subject/Guardian Decision|5|||
94250028|NCT01528345|322708774|FG001|Overall Study|Subject/Guardian Decision|0|||
94250029|NCT01151410|322708775|FG000|Overall Study|Withdrawal by Subject|3|||
94250030|NCT01151410|322708776|FG001|Overall Study|Withdrawal by Subject|5|||
94250031|NCT01151410|322708775|FG000|Overall Study|Lost to Follow-up|3|||
94250032|NCT01151410|322708776|FG001|Overall Study|Lost to Follow-up|4|||
94250033|NCT01151410|322708775|FG000|Overall Study|Adverse Event|1|||
94250034|NCT01151410|322708776|FG001|Overall Study|Adverse Event|2|||
94250035|NCT01151410|322708775|FG000|Overall Study|Protocol deviation|2|||
94250036|NCT01151410|322708776|FG001|Overall Study|Protocol deviation|1|||
94250037|NCT01151410|322708775|FG000|Overall Study|Administrative problems|1|||
94250038|NCT01151410|322708776|FG001|Overall Study|Administrative problems|1|||
94250039|NCT01151410|322708775|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94250040|NCT01151410|322708776|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
94250041|NCT01151410|322708775|FG000|Overall Study|Abnormal laboratory value(s)|0|||
94250042|NCT01151410|322708776|FG001|Overall Study|Abnormal laboratory value(s)|1|||
94250043|NCT04602221|322708777|FG000|Overall Study|Discontinuation of trial treatment|0|||
94250044|NCT04602221|322708778|FG001|Overall Study|Discontinuation of trial treatment|0|||
94250045|NCT04602221|322708779|FG002|Overall Study|Discontinuation of trial treatment|1|||
94250046|NCT04602221|322708780|FG003|Overall Study|Discontinuation of trial treatment|0|||
94250047|NCT04602221|322708781|FG004|Overall Study|Discontinuation of trial treatment|0|||
94250048|NCT04602221|322708782|FG005|Overall Study|Discontinuation of trial treatment|0|||
94250049|NCT04602221|322708783|FG006|Overall Study|Discontinuation of trial treatment|0|||
94356654|NCT00948896|323087205|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
94250050|NCT04602221|322708784|FG007|Overall Study|Discontinuation of trial treatment|0|||
94250051|NCT04602221|322708785|FG008|Overall Study|Discontinuation of trial treatment|0|||
94250052|NCT04602221|322708786|FG009|Overall Study|Discontinuation of trial treatment|0|||
94250053|NCT04602221|322708787|FG010|Overall Study|Discontinuation of trial treatment|0|||
94250054|NCT04602221|322708788|FG011|Overall Study|Discontinuation of trial treatment|0|||
94250055|NCT04602221|322708789|FG012|Overall Study|Discontinuation of trial treatment|0|||
94250056|NCT04602221|322708790|FG013|Overall Study|Discontinuation of trial treatment|0|||
94250057|NCT04602221|322708791|FG014|Overall Study|Discontinuation of trial treatment|0|||
94356655|NCT00948896|323087206|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
94250058|NCT04602221|322708792|FG015|Overall Study|Discontinuation of trial treatment|0|||
94250059|NCT04602221|322708793|FG016|Overall Study|Discontinuation of trial treatment|0|||
94250060|NCT04602221|322708794|FG017|Overall Study|Discontinuation of trial treatment|0|||
94250061|NCT04602221|322708777|FG000|Overall Study|Other than listed|0|||
94250062|NCT04602221|322708778|FG001|Overall Study|Other than listed|0|||
94250063|NCT04602221|322708779|FG002|Overall Study|Other than listed|0|||
94250064|NCT04602221|322708780|FG003|Overall Study|Other than listed|0|||
94250065|NCT04602221|322708781|FG004|Overall Study|Other than listed|0|||
94250066|NCT04602221|322708782|FG005|Overall Study|Other than listed|0|||
94250067|NCT04602221|322708783|FG006|Overall Study|Other than listed|0|||
94250068|NCT04602221|322708784|FG007|Overall Study|Other than listed|0|||
94250069|NCT04602221|322708785|FG008|Overall Study|Other than listed|0|||
94250070|NCT04602221|322708786|FG009|Overall Study|Other than listed|0|||
94250071|NCT04602221|322708787|FG010|Overall Study|Other than listed|0|||
94250072|NCT04602221|322708788|FG011|Overall Study|Other than listed|0|||
94250073|NCT04602221|322708789|FG012|Overall Study|Other than listed|0|||
94250074|NCT04602221|322708790|FG013|Overall Study|Other than listed|0|||
94250075|NCT04602221|322708791|FG014|Overall Study|Other than listed|0|||
94250076|NCT04602221|322708792|FG015|Overall Study|Other than listed|1|||
94250077|NCT04602221|322708793|FG016|Overall Study|Other than listed|0|||
94250078|NCT04602221|322708794|FG017|Overall Study|Other than listed|1|||
94250079|NCT04602221|322708777|FG000|Overall Study|Withdrawal by Subject|0|||
94250080|NCT04602221|322708778|FG001|Overall Study|Withdrawal by Subject|0|||
94250081|NCT04602221|322708779|FG002|Overall Study|Withdrawal by Subject|0|||
94250082|NCT04602221|322708780|FG003|Overall Study|Withdrawal by Subject|0|||
94250083|NCT04602221|322708781|FG004|Overall Study|Withdrawal by Subject|0|||
94250084|NCT04602221|322708782|FG005|Overall Study|Withdrawal by Subject|0|||
94250085|NCT04602221|322708783|FG006|Overall Study|Withdrawal by Subject|0|||
94250086|NCT04602221|322708784|FG007|Overall Study|Withdrawal by Subject|0|||
94250087|NCT04602221|322708785|FG008|Overall Study|Withdrawal by Subject|0|||
94250088|NCT04602221|322708786|FG009|Overall Study|Withdrawal by Subject|0|||
94250089|NCT04602221|322708787|FG010|Overall Study|Withdrawal by Subject|0|||
94250090|NCT04602221|322708788|FG011|Overall Study|Withdrawal by Subject|0|||
94250091|NCT04602221|322708789|FG012|Overall Study|Withdrawal by Subject|1|||
94250092|NCT04602221|322708790|FG013|Overall Study|Withdrawal by Subject|0|||
94250093|NCT04602221|322708791|FG014|Overall Study|Withdrawal by Subject|0|||
94250094|NCT04602221|322708792|FG015|Overall Study|Withdrawal by Subject|0|||
94250095|NCT04602221|322708793|FG016|Overall Study|Withdrawal by Subject|0|||
94250096|NCT04602221|322708794|FG017|Overall Study|Withdrawal by Subject|0|||
94250097|NCT04602221|322708777|FG000|Overall Study|Lost to Follow-up|0|||
94250098|NCT04602221|322708778|FG001|Overall Study|Lost to Follow-up|0|||
94250099|NCT04602221|322708779|FG002|Overall Study|Lost to Follow-up|0|||
94250100|NCT04602221|322708780|FG003|Overall Study|Lost to Follow-up|0|||
94250101|NCT04602221|322708781|FG004|Overall Study|Lost to Follow-up|0|||
94250102|NCT04602221|322708782|FG005|Overall Study|Lost to Follow-up|1|||
94250103|NCT04602221|322708783|FG006|Overall Study|Lost to Follow-up|0|||
94250104|NCT04602221|322708784|FG007|Overall Study|Lost to Follow-up|0|||
94250105|NCT04602221|322708785|FG008|Overall Study|Lost to Follow-up|0|||
94250106|NCT04602221|322708786|FG009|Overall Study|Lost to Follow-up|0|||
94250107|NCT04602221|322708787|FG010|Overall Study|Lost to Follow-up|0|||
94250108|NCT04602221|322708788|FG011|Overall Study|Lost to Follow-up|0|||
94250109|NCT04602221|322708789|FG012|Overall Study|Lost to Follow-up|0|||
94250110|NCT04602221|322708790|FG013|Overall Study|Lost to Follow-up|0|||
94250111|NCT04602221|322708791|FG014|Overall Study|Lost to Follow-up|0|||
94250112|NCT04602221|322708792|FG015|Overall Study|Lost to Follow-up|0|||
94250113|NCT04602221|322708793|FG016|Overall Study|Lost to Follow-up|0|||
94356656|NCT00948896|323087207|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
94356657|NCT00948896|323087208|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
94356658|NCT00948896|323087201|FG000|24 Months of Age to 36 Months of Age|Death|0|||
94356659|NCT00948896|323087202|FG001|24 Months of Age to 36 Months of Age|Death|2|||
94356660|NCT00948896|323087203|FG002|24 Months of Age to 36 Months of Age|Death|2|||
94356661|NCT00948896|323087204|FG003|24 Months of Age to 36 Months of Age|Death|0|||
94356662|NCT00948896|323087205|FG004|24 Months of Age to 36 Months of Age|Death|0|||
94356663|NCT00948896|323087206|FG005|24 Months of Age to 36 Months of Age|Death|1|||
94356664|NCT00948896|323087207|FG006|24 Months of Age to 36 Months of Age|Death|0|||
94356665|NCT00948896|323087208|FG007|24 Months of Age to 36 Months of Age|Death|0|||
94356666|NCT00948896|323087201|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
94356667|NCT00948896|323087202|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
94356668|NCT00948896|323087203|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
94356669|NCT00948896|323087204|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
94356670|NCT00948896|323087205|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
94356671|NCT00948896|323087206|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
94356672|NCT00948896|323087207|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
94250114|NCT04602221|322708794|FG017|Overall Study|Lost to Follow-up|0|||
94250115|NCT01200589|322708795|FG000|Overall Study|Withdrawal by Subject|13|||
94250116|NCT01200589|322708796|FG001|Overall Study|Withdrawal by Subject|11|||
94250117|NCT01200589|322708795|FG000|Overall Study|Physician Decision|2|||
94605320|NCT02310321|324017983|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
94605321|NCT02310321|324017984|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
94605322|NCT02310321|324017982|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
94605323|NCT02310321|324017983|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
94605324|NCT02310321|324017984|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
94605325|NCT02310321|324017982|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
94250118|NCT01200589|322708796|FG001|Overall Study|Physician Decision|2|||
94250119|NCT01200589|322708795|FG000|Overall Study|Lost to Follow-up|5|||
94250120|NCT01200589|322708796|FG001|Overall Study|Lost to Follow-up|4|||
94250121|NCT01200589|322708795|FG000|Overall Study|Study terminated|170|||
94250122|NCT01200589|322708796|FG001|Overall Study|Study terminated|172|||
94250123|NCT00439231|322708797|FG000|Overall Study|Lack of Efficacy|28|||
94250124|NCT00986973|322708798|FG000|Overall Study|Withdrawn by study team|1|||
94250125|NCT01146782|322708799|FG000|Screening Cohort|Screen Failure|187|||
94250126|NCT01146782|322708799|FG000|Screening Cohort|Lost to Follow-up|4|||
94250127|NCT01146782|322708799|FG000|Screening Cohort|Physician Decision|1|||
94250128|NCT01146782|322708799|FG000|Screening Cohort|Withdrawal by Subject|29|||
94250129|NCT01146782|322708799|FG000|Safety Cohort|Screen Failure|61|||
94250130|NCT01146782|322708799|FG000|Safety Cohort|Withdrawal by Subject|4|||
94250131|NCT01146782|322708799|FG000|Safety Cohort|Control AHI <5|4|||
94250132|NCT01146782|322708799|FG000|Safety Cohort|TST <4 hrs|14|||
94250133|NCT01146782|322708799|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
94356673|NCT00948896|323087208|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
94356674|NCT00948896|323087201|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
94356675|NCT00948896|323087202|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
94356676|NCT00948896|323087203|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
94356677|NCT00948896|323087204|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
94356678|NCT00948896|323087205|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
94356679|NCT00948896|323087206|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
94356680|NCT00948896|323087207|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
94356681|NCT00948896|323087208|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
94356682|NCT00948896|323087201|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
94356683|NCT00948896|323087202|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
94356684|NCT00948896|323087203|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
94356685|NCT00948896|323087204|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
94356686|NCT00948896|323087205|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
94356687|NCT00948896|323087206|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
94356688|NCT00948896|323087207|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
94356689|NCT00948896|323087208|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
94356690|NCT00948896|323087201|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
94356691|NCT00948896|323087202|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
94356692|NCT00948896|323087203|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
94356693|NCT00948896|323087204|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
94356694|NCT00948896|323087205|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
94356695|NCT00948896|323087206|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
94356696|NCT00948896|323087207|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
94356697|NCT00948896|323087208|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
94356698|NCT04678557|323087211|FG000|Overall Study|Withdrawal by Subject|1|||
94356699|NCT04678557|323087212|FG001|Overall Study|Withdrawal by Subject|0|||
94356700|NCT04678557|323087211|FG000|Overall Study|Lack of Efficacy|0|||
94356701|NCT04678557|323087212|FG001|Overall Study|Lack of Efficacy|13|||
94356702|NCT04678557|323087211|FG000|Overall Study|Safety Evaluation|0|||
94356703|NCT04678557|323087212|FG001|Overall Study|Safety Evaluation|1|||
94356704|NCT04398030|323089459|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
94605326|NCT02310321|324017983|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
94605327|NCT02310321|324017984|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
94605328|NCT02310321|324017982|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
94605329|NCT02310321|324017983|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
94605330|NCT02310321|324017984|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
94605331|NCT02310321|324017982|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
94605332|NCT02310321|324017983|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
94605333|NCT02310321|324017984|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
94605334|NCT02310321|324017982|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
94605335|NCT02310321|324017983|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
94605336|NCT02310321|324017984|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
94605337|NCT02310321|324017982|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
94605338|NCT02310321|324017983|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
94605339|NCT02310321|324017984|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
94605340|NCT02310321|324017982|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
94605341|NCT02310321|324017983|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
94605342|NCT02310321|324017984|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
94605343|NCT02310321|324017982|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
94605344|NCT02310321|324017983|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
94356705|NCT04398030|323089460|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
94356706|NCT04398030|323089459|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
94356707|NCT04398030|323089460|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
94356708|NCT01786707|323089461|FG000|Overall Study|Lost to Follow-up|1|||
94356709|NCT01786707|323089462|FG001|Overall Study|Lost to Follow-up|1|||
94356710|NCT02513732|323089469|FG000|Overall Study|Lost to Follow-up|11|||
94356711|NCT02513732|323089469|FG000|Overall Study|Death|9|||
94356712|NCT02513732|323089469|FG000|Overall Study|Changing hospital|2|||
94356713|NCT03410693|323089471|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
94356714|NCT03410693|323089472|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
94356715|NCT03410693|323089471|FG000|Overall Study|Disc trt: Lost to follow up|0|||
94356716|NCT03410693|323089472|FG001|Overall Study|Disc trt: Lost to follow up|1|||
94356717|NCT03410693|323089471|FG000|Overall Study|Disc trt: radiological progression|58|||
94605345|NCT02310321|324017984|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
94356718|NCT03410693|323089472|FG001|Overall Study|Disc trt: radiological progression|50|||
94356719|NCT03410693|323089471|FG000|Overall Study|Disc trt: Other|1|||
94605346|NCT02310321|324017982|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|0|||
94605347|NCT02310321|324017983|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|0|||
94605348|NCT02310321|324017984|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|16|||
94605349|NCT02310321|324017982|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
94605350|NCT02310321|324017983|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
94605351|NCT02310321|324017984|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|3|||
94605352|NCT02310321|324017982|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
94605353|NCT02310321|324017983|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
94605354|NCT02310321|324017984|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|3|||
94605355|NCT02310321|324017982|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
94605356|NCT02310321|324017983|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
94605357|NCT02310321|324017984|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|3|||
94605358|NCT02310321|324017982|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|0|||
94250134|NCT01146782|322708799|FG000|Primary Endpoint Cohort|Physician Decision|1|||
94250135|NCT00196976|322708806|FG000|Primary Study|Migrated from study area|0|||
94250136|NCT00196976|322708807|FG001|Primary Study|Migrated from study area|0|||
94250137|NCT00196976|322708808|FG002|Primary Study|Migrated from study area|0|||
94250138|NCT00196976|322708809|FG003|Primary Study|Migrated from study area|0|||
94250139|NCT00196976|322708810|FG004|Primary Study|Migrated from study area|0|||
94250140|NCT00196976|322708811|FG005|Primary Study|Migrated from study area|0|||
94250141|NCT00196976|322708812|FG006|Primary Study|Migrated from study area|0|||
94250142|NCT00196976|322708813|FG007|Primary Study|Migrated from study area|1|||
94250143|NCT00196976|322708814|FG008|Primary Study|Migrated from study area|0|||
94250144|NCT00196976|322708815|FG009|Primary Study|Migrated from study area|0|||
94250145|NCT00196976|322708816|FG010|Primary Study|Migrated from study area|0|||
94250146|NCT00196976|322708817|FG011|Primary Study|Migrated from study area|0|||
94250147|NCT00196976|322708818|FG012|Primary Study|Migrated from study area|0|||
94250148|NCT00196976|322708819|FG013|Primary Study|Migrated from study area|0|||
94250149|NCT00196976|322708806|FG000|Primary Study|Protocol Violation|0|||
94250150|NCT00196976|322708807|FG001|Primary Study|Protocol Violation|1|||
94250151|NCT00196976|322708808|FG002|Primary Study|Protocol Violation|1|||
94250152|NCT00196976|322708809|FG003|Primary Study|Protocol Violation|0|||
94250153|NCT00196976|322708810|FG004|Primary Study|Protocol Violation|0|||
94250154|NCT00196976|322708811|FG005|Primary Study|Protocol Violation|0|||
94250155|NCT00196976|322708812|FG006|Primary Study|Protocol Violation|0|||
94250156|NCT00196976|322708813|FG007|Primary Study|Protocol Violation|0|||
94250157|NCT00196976|322708814|FG008|Primary Study|Protocol Violation|0|||
94250158|NCT00196976|322708815|FG009|Primary Study|Protocol Violation|0|||
94250159|NCT00196976|322708816|FG010|Primary Study|Protocol Violation|0|||
94250160|NCT00196976|322708817|FG011|Primary Study|Protocol Violation|0|||
94250161|NCT00196976|322708818|FG012|Primary Study|Protocol Violation|0|||
94250162|NCT00196976|322708819|FG013|Primary Study|Protocol Violation|0|||
94250163|NCT00196976|322708806|FG000|Primary Study|Withdrawal by Subject|1|||
94250164|NCT00196976|322708807|FG001|Primary Study|Withdrawal by Subject|0|||
94250165|NCT00196976|322708808|FG002|Primary Study|Withdrawal by Subject|1|||
94250166|NCT00196976|322708809|FG003|Primary Study|Withdrawal by Subject|1|||
94250167|NCT00196976|322708810|FG004|Primary Study|Withdrawal by Subject|2|||
94250168|NCT00196976|322708811|FG005|Primary Study|Withdrawal by Subject|1|||
94250169|NCT00196976|322708812|FG006|Primary Study|Withdrawal by Subject|0|||
94250170|NCT00196976|322708813|FG007|Primary Study|Withdrawal by Subject|0|||
94250171|NCT00196976|322708814|FG008|Primary Study|Withdrawal by Subject|0|||
94250172|NCT00196976|322708815|FG009|Primary Study|Withdrawal by Subject|1|||
94250173|NCT00196976|322708816|FG010|Primary Study|Withdrawal by Subject|0|||
94356720|NCT03410693|323089472|FG001|Overall Study|Disc trt: Other|0|||
94356721|NCT03410693|323089471|FG000|Overall Study|Study drug never administered|1|||
94356722|NCT03410693|323089472|FG001|Overall Study|Study drug never administered|6|||
94356723|NCT03410693|323089471|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
94356724|NCT03410693|323089472|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
94356725|NCT03410693|323089471|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
94356726|NCT03410693|323089472|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
94356727|NCT03410693|323089471|FG000|Overall Study|Disc trt: Physician decision|0|||
94356728|NCT03410693|323089472|FG001|Overall Study|Disc trt: Physician decision|5|||
94356729|NCT03410693|323089471|FG000|Overall Study|Disc trt: clinical progression|1|||
94356730|NCT03410693|323089472|FG001|Overall Study|Disc trt: clinical progression|5|||
94356731|NCT03410693|323089471|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
94356732|NCT03410693|323089472|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
94356733|NCT00501969|323089473|FG000|Overall Study|Major Protocol Violation|4|||
94356734|NCT00501969|323089473|FG000|Overall Study|Lack of Efficacy|29|||
94356735|NCT00501969|323089473|FG000|Overall Study|Adverse Event|76|||
94356736|NCT00501969|323089473|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
94356737|NCT00501969|323089473|FG000|Overall Study|Subject withdrew consent|51|||
94356738|NCT00501969|323089473|FG000|Overall Study|Lost to Follow-up|4|||
94250174|NCT00196976|322708817|FG011|Primary Study|Withdrawal by Subject|0|||
94250175|NCT00196976|322708818|FG012|Primary Study|Withdrawal by Subject|0|||
94458456|NCT03053063|323465762|FG003|Randomized Phase|Withdrew consent|0|||
94605359|NCT02310321|324017983|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|0|||
94605360|NCT02310321|324017984|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|26|||
94605361|NCT02310321|324017982|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
94605362|NCT02310321|324017983|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
94605363|NCT02310321|324017984|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|1|||
94605364|NCT02310321|324017982|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
94605365|NCT02310321|324017983|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
94605366|NCT02310321|324017984|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|1|||
94605367|NCT01222403|324017986|FG000|Overall Study|Inappropriate enrollment|0|||
94250176|NCT00196976|322708819|FG013|Primary Study|Withdrawal by Subject|0|||
94250177|NCT00196976|322708806|FG000|Primary Study|Lost to Follow-up|0|||
94250178|NCT00196976|322708807|FG001|Primary Study|Lost to Follow-up|0|||
94605368|NCT01222403|324017987|FG001|Overall Study|Inappropriate enrollment|2|||
94605369|NCT02017171|324017988|FG000|Overall Study|Death|10|||
94605370|NCT02017171|324017989|FG001|Overall Study|Death|4|||
94605371|NCT02017171|324017988|FG000|Overall Study|Withdrawal by Subject|23|||
94605372|NCT02017171|324017989|FG001|Overall Study|Withdrawal by Subject|17|||
94605373|NCT02017171|324017988|FG000|Overall Study|Lost to Follow-up|21|||
94605374|NCT02017171|324017989|FG001|Overall Study|Lost to Follow-up|20|||
94605375|NCT02017171|324017988|FG000|Overall Study|ESKD|6|||
94605376|NCT02017171|324017989|FG001|Overall Study|ESKD|2|||
94605377|NCT02017171|324017988|FG000|Overall Study|Miscellaneous|2|||
94605378|NCT02017171|324017989|FG001|Overall Study|Miscellaneous|3|||
94605379|NCT01562873|324017990|FG000|Overall Study|Disease Progression per RECIST|10|||
94605380|NCT01562873|324017991|FG001|Overall Study|Disease Progression per RECIST|0|||
94605381|NCT01562873|324017990|FG000|Overall Study|Adverse Event|1|||
94605382|NCT01562873|324017991|FG001|Overall Study|Adverse Event|0|||
94605383|NCT01562873|324017990|FG000|Overall Study|Clinical Disease Progression|9|||
94605384|NCT01562873|324017991|FG001|Overall Study|Clinical Disease Progression|0|||
94605385|NCT01562873|324017990|FG000|Overall Study|Clinical PD and adverse event|1|||
94605386|NCT01562873|324017991|FG001|Overall Study|Clinical PD and adverse event|0|||
94605387|NCT01369485|324017992|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
94605388|NCT01369485|324017993|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
94605389|NCT01369485|324017992|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
94605390|NCT01369485|324017993|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
94605391|NCT01369485|324017992|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
94605392|NCT01369485|324017993|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
94605393|NCT01369485|324017992|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
94605394|NCT01369485|324017993|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
94605395|NCT01369485|324017992|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
94605396|NCT01369485|324017993|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
94605397|NCT01369485|324017992|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
94605398|NCT01369485|324017993|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
94605399|NCT01369485|324017992|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
94605400|NCT01369485|324017993|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
94605401|NCT01369485|324017992|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
94605402|NCT01369485|324017993|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
94605403|NCT01369485|324017992|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
94605404|NCT01369485|324017993|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
94605405|NCT01369485|324017992|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
94605406|NCT01369485|324017993|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
94605407|NCT03091777|324017996|FG000|Overall Study|Pregnancy|2|||
94605408|NCT03091777|324017997|FG001|Overall Study|Pregnancy|1|||
94605409|NCT03091777|324017998|FG002|Overall Study|Pregnancy|0|||
94250179|NCT00196976|322708808|FG002|Primary Study|Lost to Follow-up|0|||
94605410|NCT03091777|324017996|FG000|Overall Study|Adverse Event|2|||
94605411|NCT03091777|324017997|FG001|Overall Study|Adverse Event|1|||
94605412|NCT03091777|324017998|FG002|Overall Study|Adverse Event|4|||
94605413|NCT03091777|324017996|FG000|Overall Study|Withdrawal by Subject|4|||
94250180|NCT00196976|322708809|FG003|Primary Study|Lost to Follow-up|0|||
94250181|NCT00196976|322708810|FG004|Primary Study|Lost to Follow-up|1|||
94605414|NCT03091777|324017997|FG001|Overall Study|Withdrawal by Subject|2|||
94605415|NCT03091777|324017998|FG002|Overall Study|Withdrawal by Subject|6|||
94605416|NCT03091777|324017996|FG000|Overall Study|Protocol Violation|2|||
94605417|NCT03091777|324017997|FG001|Overall Study|Protocol Violation|1|||
94605418|NCT03091777|324017998|FG002|Overall Study|Protocol Violation|1|||
94605419|NCT03091777|324017996|FG000|Overall Study|Lost to Follow-up|12|||
94605420|NCT03091777|324017997|FG001|Overall Study|Lost to Follow-up|14|||
94605421|NCT03091777|324017998|FG002|Overall Study|Lost to Follow-up|7|||
94605422|NCT03091777|324017996|FG000|Overall Study|Lack of Efficacy|0|||
94605423|NCT03091777|324017997|FG001|Overall Study|Lack of Efficacy|0|||
94605424|NCT03091777|324017998|FG002|Overall Study|Lack of Efficacy|5|||
94250182|NCT00196976|322708811|FG005|Primary Study|Lost to Follow-up|1|||
94250183|NCT00196976|322708812|FG006|Primary Study|Lost to Follow-up|0|||
94250184|NCT00196976|322708813|FG007|Primary Study|Lost to Follow-up|2|||
94250185|NCT00196976|322708814|FG008|Primary Study|Lost to Follow-up|0|||
94250186|NCT00196976|322708815|FG009|Primary Study|Lost to Follow-up|0|||
94250187|NCT00196976|322708816|FG010|Primary Study|Lost to Follow-up|0|||
94250188|NCT00196976|322708817|FG011|Primary Study|Lost to Follow-up|0|||
94250189|NCT00196976|322708818|FG012|Primary Study|Lost to Follow-up|0|||
94250190|NCT00196976|322708819|FG013|Primary Study|Lost to Follow-up|0|||
94250191|NCT00196976|322708806|FG000|Primary Study|Other|0|||
94250192|NCT00196976|322708807|FG001|Primary Study|Other|0|||
94250193|NCT00196976|322708808|FG002|Primary Study|Other|2|||
94250194|NCT00196976|322708809|FG003|Primary Study|Other|0|||
94250195|NCT00196976|322708810|FG004|Primary Study|Other|0|||
94250196|NCT00196976|322708811|FG005|Primary Study|Other|0|||
94250197|NCT00196976|322708812|FG006|Primary Study|Other|0|||
94250198|NCT00196976|322708813|FG007|Primary Study|Other|0|||
94250199|NCT00196976|322708814|FG008|Primary Study|Other|0|||
94250200|NCT00196976|322708815|FG009|Primary Study|Other|0|||
94250201|NCT00196976|322708816|FG010|Primary Study|Other|0|||
94250202|NCT00196976|322708817|FG011|Primary Study|Other|0|||
94250203|NCT00196976|322708818|FG012|Primary Study|Other|0|||
94250204|NCT00196976|322708819|FG013|Primary Study|Other|0|||
94250205|NCT00196976|322708806|FG000|Booster Study|Withdrawal by Subject|0|||
94250206|NCT00196976|322708807|FG001|Booster Study|Withdrawal by Subject|0|||
94250207|NCT00196976|322708808|FG002|Booster Study|Withdrawal by Subject|0|||
94250208|NCT00196976|322708809|FG003|Booster Study|Withdrawal by Subject|0|||
94250209|NCT00196976|322708810|FG004|Booster Study|Withdrawal by Subject|0|||
94250210|NCT00196976|322708811|FG005|Booster Study|Withdrawal by Subject|0|||
94250211|NCT00196976|322708812|FG006|Booster Study|Withdrawal by Subject|0|||
94250212|NCT00196976|322708813|FG007|Booster Study|Withdrawal by Subject|0|||
94250213|NCT00196976|322708814|FG008|Booster Study|Withdrawal by Subject|0|||
94250214|NCT00196976|322708815|FG009|Booster Study|Withdrawal by Subject|0|||
94250215|NCT00196976|322708816|FG010|Booster Study|Withdrawal by Subject|1|||
94250216|NCT00196976|322708817|FG011|Booster Study|Withdrawal by Subject|0|||
94250217|NCT00196976|322708818|FG012|Booster Study|Withdrawal by Subject|0|||
94250218|NCT00196976|322708819|FG013|Booster Study|Withdrawal by Subject|0|||
94250219|NCT00196976|322708806|FG000|Booster Study|Lost to Follow-up|0|||
94250220|NCT00196976|322708807|FG001|Booster Study|Lost to Follow-up|0|||
94250221|NCT00196976|322708808|FG002|Booster Study|Lost to Follow-up|0|||
94250222|NCT00196976|322708809|FG003|Booster Study|Lost to Follow-up|0|||
94250223|NCT00196976|322708810|FG004|Booster Study|Lost to Follow-up|0|||
94250224|NCT00196976|322708811|FG005|Booster Study|Lost to Follow-up|0|||
94250225|NCT00196976|322708812|FG006|Booster Study|Lost to Follow-up|0|||
94250226|NCT00196976|322708813|FG007|Booster Study|Lost to Follow-up|0|||
94250227|NCT00196976|322708814|FG008|Booster Study|Lost to Follow-up|0|||
94250228|NCT00196976|322708815|FG009|Booster Study|Lost to Follow-up|0|||
94250229|NCT00196976|322708816|FG010|Booster Study|Lost to Follow-up|1|||
94250230|NCT00196976|322708817|FG011|Booster Study|Lost to Follow-up|2|||
94250231|NCT00196976|322708818|FG012|Booster Study|Lost to Follow-up|0|||
94250232|NCT00196976|322708819|FG013|Booster Study|Lost to Follow-up|0|||
94250233|NCT01942590|322708820|FG000|Overall Study|Withdrawal by Subject|0|||
94250234|NCT01942590|322708821|FG001|Overall Study|Withdrawal by Subject|1|||
94250235|NCT01942590|322708820|FG000|Overall Study|Adverse Event|1|||
94250236|NCT01942590|322708821|FG001|Overall Study|Adverse Event|0|||
94250237|NCT02665338|322708823|FG000|Overall Study|Withdrawal by Subject|0|||
94250238|NCT02665338|322708824|FG001|Overall Study|Withdrawal by Subject|1|||
94250239|NCT00126503|322708827|FG000|Overall Study|disease progression|23|||
94250240|NCT00126503|322708828|FG001|Overall Study|disease progression|14|||
94250241|NCT00126503|322708827|FG000|Overall Study|Withdrawal by Subject|0|||
94250242|NCT00126503|322708828|FG001|Overall Study|Withdrawal by Subject|1|||
94250243|NCT00126503|322708827|FG000|Overall Study|alternative therapy|1|||
94250244|NCT00126503|322708828|FG001|Overall Study|alternative therapy|1|||
94250245|NCT00126503|322708827|FG000|Overall Study|other complicating disease|4|||
94250246|NCT00126503|322708828|FG001|Overall Study|other complicating disease|1|||
94250247|NCT00126503|322708827|FG000|Overall Study|Death|3|||
94250248|NCT00126503|322708828|FG001|Overall Study|Death|0|||
94250249|NCT00126503|322708827|FG000|Overall Study|Adverse Event|13|||
94250250|NCT00126503|322708828|FG001|Overall Study|Adverse Event|3|||
94250251|NCT00126503|322708827|FG000|Overall Study|non-compliant|1|||
94605425|NCT03091777|324017996|FG000|Overall Study|Noncompliance with study drug|2|||
94605426|NCT03091777|324017997|FG001|Overall Study|Noncompliance with study drug|3|||
94605427|NCT03091777|324017998|FG002|Overall Study|Noncompliance with study drug|1|||
94605428|NCT03091777|324017996|FG000|Overall Study|Physician Decision|1|||
94605429|NCT03091777|324017997|FG001|Overall Study|Physician Decision|0|||
94356739|NCT00501969|323089473|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
94356740|NCT00501969|323089473|FG000|Overall Study|Other: Sponsors Request|10|||
94356741|NCT00501969|323089473|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
94356742|NCT00501969|323089473|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
94356743|NCT00501969|323089473|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
94356744|NCT00501969|323089473|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
94356745|NCT00501969|323089473|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
94356746|NCT00501969|323089473|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
94356747|NCT00501969|323089473|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
94356748|NCT00501969|323089473|FG000|Overall Study|Other: As Required by Local EC|2|||
94356749|NCT00501969|323089473|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
94356750|NCT00501969|323089473|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
94356751|NCT00451191|323089474|FG000|Overall Study|withdrawal or received alternate tx|15|||
94356752|NCT00451191|323089475|FG001|Overall Study|withdrawal or received alternate tx|11|||
94356753|NCT01238861|323089479|FG000|Overall Study|Lost to Follow-up|4|||
94356754|NCT01238861|323089480|FG001|Overall Study|Lost to Follow-up|2|||
94356755|NCT01238861|323089481|FG002|Overall Study|Lost to Follow-up|3|||
94356756|NCT01238861|323089482|FG003|Overall Study|Lost to Follow-up|1|||
94356757|NCT01238861|323089483|FG004|Overall Study|Lost to Follow-up|1|||
94356758|NCT01238861|323089484|FG005|Overall Study|Lost to Follow-up|2|||
94356759|NCT01238861|323089479|FG000|Overall Study|Unplanned surgery|1|||
94356760|NCT01238861|323089480|FG001|Overall Study|Unplanned surgery|0|||
94356761|NCT01238861|323089481|FG002|Overall Study|Unplanned surgery|0|||
94356762|NCT01238861|323089482|FG003|Overall Study|Unplanned surgery|0|||
94356763|NCT01238861|323089483|FG004|Overall Study|Unplanned surgery|0|||
94356764|NCT01238861|323089484|FG005|Overall Study|Unplanned surgery|0|||
94356765|NCT01238861|323089479|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
94356766|NCT01238861|323089480|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
94356767|NCT01238861|323089481|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
94356768|NCT01238861|323089482|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
94356769|NCT01238861|323089483|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
94356770|NCT01238861|323089484|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
94356771|NCT01238861|323089479|FG000|Overall Study|Incorrect enrollment/randomization|0|||
94356772|NCT01238861|323089480|FG001|Overall Study|Incorrect enrollment/randomization|0|||
94356773|NCT01238861|323089481|FG002|Overall Study|Incorrect enrollment/randomization|1|||
94605430|NCT03091777|324017998|FG002|Overall Study|Physician Decision|1|||
94605431|NCT03091777|324017996|FG000|Overall Study|Abnormal Laboratory Value|7|||
94605432|NCT03091777|324017997|FG001|Overall Study|Abnormal Laboratory Value|11|||
94605433|NCT03091777|324017998|FG002|Overall Study|Abnormal Laboratory Value|12|||
94605434|NCT02536833|324017999|FG000|Overall Study|Discontinued Before Treatment|0|||
94356774|NCT01238861|323089482|FG003|Overall Study|Incorrect enrollment/randomization|0|||
94356775|NCT01238861|323089483|FG004|Overall Study|Incorrect enrollment/randomization|1|||
94356776|NCT01238861|323089484|FG005|Overall Study|Incorrect enrollment/randomization|0|||
94458457|NCT03053063|323465759|FG000|Randomized Phase|Investigator's Discretion|8|||
94458458|NCT03053063|323465760|FG001|Randomized Phase|Investigator's Discretion|6|||
94458459|NCT03053063|323465761|FG002|Randomized Phase|Investigator's Discretion|2|||
94458460|NCT03053063|323465762|FG003|Randomized Phase|Investigator's Discretion|0|||
94356777|NCT01238861|323089479|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
94356778|NCT01238861|323089480|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
94356779|NCT01238861|323089481|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
94356780|NCT01238861|323089482|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
94356781|NCT01238861|323089483|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
94356782|NCT01238861|323089484|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
94356783|NCT01238861|323089479|FG000|Overall Study|Subject moved out of state/area|0|||
94458461|NCT03053063|323465759|FG000|Randomized Phase|Lost to Follow-up|3|||
94458462|NCT03053063|323465760|FG001|Randomized Phase|Lost to Follow-up|5|||
94458463|NCT03053063|323465761|FG002|Randomized Phase|Lost to Follow-up|1|||
94458464|NCT03053063|323465762|FG003|Randomized Phase|Lost to Follow-up|0|||
94458465|NCT03053063|323465759|FG000|Randomized Phase|Adverse Event|0|||
94356784|NCT01238861|323089480|FG001|Overall Study|Subject moved out of state/area|0|||
94356785|NCT01238861|323089481|FG002|Overall Study|Subject moved out of state/area|1|||
94356786|NCT01238861|323089482|FG003|Overall Study|Subject moved out of state/area|1|||
94356787|NCT01238861|323089483|FG004|Overall Study|Subject moved out of state/area|0|||
94458466|NCT03053063|323465760|FG001|Randomized Phase|Adverse Event|1|||
94458467|NCT03053063|323465761|FG002|Randomized Phase|Adverse Event|0|||
94458468|NCT03053063|323465762|FG003|Randomized Phase|Adverse Event|0|||
94605435|NCT02536833|324018000|FG001|Overall Study|Discontinued Before Treatment|0|||
94605436|NCT02536833|324018001|FG002|Overall Study|Discontinued Before Treatment|1|||
94458469|NCT03053063|323465759|FG000|Randomized Phase|Randomized but Never Treated|1|||
94458470|NCT03053063|323465760|FG001|Randomized Phase|Randomized but Never Treated|3|||
94458471|NCT03053063|323465761|FG002|Randomized Phase|Randomized but Never Treated|2|||
94458472|NCT03053063|323465762|FG003|Randomized Phase|Randomized but Never Treated|0|||
94458473|NCT03053063|323465759|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
94458474|NCT03053063|323465760|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
94458475|NCT03053063|323465761|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
94458476|NCT03053063|323465762|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
94458477|NCT03053063|323465759|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
94458478|NCT03053063|323465760|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
94458479|NCT03053063|323465761|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
94458480|NCT03053063|323465762|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
94458481|NCT03053063|323465759|FG000|Open-Label Phase|Death|0|||
94458482|NCT03053063|323465760|FG001|Open-Label Phase|Death|0|||
94458483|NCT03053063|323465761|FG002|Open-Label Phase|Death|0|||
94250252|NCT00126503|322708828|FG001|Overall Study|non-compliant|0|||
94250253|NCT00126503|322708827|FG000|Overall Study|Physician Decision|2|||
94250254|NCT00126503|322708828|FG001|Overall Study|Physician Decision|1|||
94250255|NCT02412371|322708829|FG000|Overall Study|Withdrawal by Subject|0|||
94250256|NCT02412371|322708830|FG001|Overall Study|Withdrawal by Subject|2|||
94250257|NCT02412371|322708831|FG002|Overall Study|Withdrawal by Subject|0|||
94250258|NCT02412371|322708832|FG003|Overall Study|Withdrawal by Subject|1|||
94250259|NCT02412371|322708833|FG004|Overall Study|Withdrawal by Subject|1|||
94250260|NCT02412371|322708834|FG005|Overall Study|Withdrawal by Subject|0|||
94250261|NCT02412371|322708829|FG000|Overall Study|Sponsor Discontinued Study|1|||
94250262|NCT02412371|322708830|FG001|Overall Study|Sponsor Discontinued Study|4|||
94250263|NCT02412371|322708831|FG002|Overall Study|Sponsor Discontinued Study|6|||
94250264|NCT02412371|322708832|FG003|Overall Study|Sponsor Discontinued Study|4|||
94250265|NCT02412371|322708833|FG004|Overall Study|Sponsor Discontinued Study|5|||
94250266|NCT02412371|322708834|FG005|Overall Study|Sponsor Discontinued Study|0|||
94250267|NCT02412371|322708829|FG000|Overall Study|Death|4|||
94250268|NCT02412371|322708830|FG001|Overall Study|Death|2|||
94250269|NCT02412371|322708831|FG002|Overall Study|Death|1|||
94250270|NCT02412371|322708832|FG003|Overall Study|Death|3|||
94250271|NCT02412371|322708833|FG004|Overall Study|Death|5|||
94250272|NCT02412371|322708834|FG005|Overall Study|Death|2|||
94250273|NCT02412371|322708829|FG000|Overall Study|Other|2|||
94250274|NCT02412371|322708830|FG001|Overall Study|Other|1|||
94250275|NCT02412371|322708831|FG002|Overall Study|Other|0|||
94250276|NCT02412371|322708832|FG003|Overall Study|Other|0|||
94250277|NCT02412371|322708833|FG004|Overall Study|Other|1|||
94250278|NCT02412371|322708834|FG005|Overall Study|Other|3|||
94250279|NCT02053792|322708835|FG000|Overall Study|Physician Decision|0|||
94250280|NCT02053792|322708836|FG001|Overall Study|Physician Decision|1|||
94250281|NCT02053792|322708835|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
94250282|NCT02053792|322708836|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
94250283|NCT02053792|322708835|FG000|Overall Study|Lack of Efficacy|1|||
94250284|NCT02053792|322708836|FG001|Overall Study|Lack of Efficacy|0|||
94250285|NCT02053792|322708835|FG000|Overall Study|Adverse Event|1|||
94250286|NCT02053792|322708836|FG001|Overall Study|Adverse Event|0|||
94250287|NCT02053792|322708835|FG000|Overall Study|Withdrawal by Subject|2|||
94250288|NCT02053792|322708836|FG001|Overall Study|Withdrawal by Subject|2|||
94250289|NCT02053792|322708835|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
94250290|NCT02053792|322708836|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
94250291|NCT02053792|322708835|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
94250292|NCT02053792|322708836|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
94250293|NCT00925132|322708839|FG000|Overall Study|Withdrawal by Subject|2|||
94250294|NCT00925132|322708840|FG001|Overall Study|Withdrawal by Subject|0|||
94250295|NCT00925132|322708841|FG002|Overall Study|Withdrawal by Subject|0|||
94250296|NCT00925132|322708842|FG003|Overall Study|Withdrawal by Subject|0|||
94250297|NCT00925132|322708843|FG004|Overall Study|Withdrawal by Subject|1|||
94250298|NCT00925132|322708839|FG000|Overall Study|Removed due to disease progression|0|||
94250299|NCT00925132|322708840|FG001|Overall Study|Removed due to disease progression|0|||
94250300|NCT00925132|322708841|FG002|Overall Study|Removed due to disease progression|0|||
94250301|NCT00925132|322708842|FG003|Overall Study|Removed due to disease progression|0|||
94250302|NCT00925132|322708843|FG004|Overall Study|Removed due to disease progression|4|||
94250303|NCT02545933|322708844|FG000|Overall Study|Adverse Event|3|||
94458484|NCT03053063|323465762|FG003|Open-Label Phase|Death|2|||
94458485|NCT03053063|323465759|FG000|Open-Label Phase|Investigator's discretion|0|||
94250304|NCT02545933|322708845|FG001|Overall Study|Adverse Event|0|||
94458486|NCT03053063|323465760|FG001|Open-Label Phase|Investigator's discretion|0|||
94458487|NCT03053063|323465761|FG002|Open-Label Phase|Investigator's discretion|0|||
94250305|NCT02545933|322708846|FG002|Overall Study|Adverse Event|0|||
94250306|NCT02545933|322708844|FG000|Overall Study|Withdrawal by Subject|2|||
94458488|NCT03053063|323465762|FG003|Open-Label Phase|Investigator's discretion|2|||
94458489|NCT01190410|323467385|FG000|Overall Study|Adverse Event|0|||
94458490|NCT01190410|323467386|FG001|Overall Study|Adverse Event|3|||
94458491|NCT01190410|323467385|FG000|Overall Study|Lack of Efficacy|0|||
94458492|NCT01190410|323467386|FG001|Overall Study|Lack of Efficacy|2|||
94458493|NCT01190410|323467385|FG000|Overall Study|Withdrawal by Subject|0|||
94458494|NCT01190410|323467386|FG001|Overall Study|Withdrawal by Subject|2|||
94458495|NCT01190410|323467385|FG000|Overall Study|Administrative decision|1|||
94458496|NCT01190410|323467386|FG001|Overall Study|Administrative decision|0|||
94458497|NCT01190410|323467385|FG000|Overall Study|PI discretion|0|||
94458498|NCT01190410|323467386|FG001|Overall Study|PI discretion|2|||
94458499|NCT01397786|323467392|FG000|Phase A|Lost to Follow-up|0|||
94458500|NCT01397786|323467393|FG001|Phase A|Lost to Follow-up|0|||
94458501|NCT01397786|323467394|FG002|Phase A|Lost to Follow-up|6|||
94458502|NCT01397786|323467392|FG000|Phase A|Adverse Event|0|||
94458503|NCT01397786|323467393|FG001|Phase A|Adverse Event|0|||
94458504|NCT01397786|323467394|FG002|Phase A|Adverse Event|8|||
94458505|NCT01397786|323467392|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
94458506|NCT01397786|323467393|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
94458507|NCT01397786|323467394|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
94458508|NCT01397786|323467392|FG000|Phase A|Physician Decision|0|||
94458509|NCT01397786|323467393|FG001|Phase A|Physician Decision|0|||
94458510|NCT01397786|323467394|FG002|Phase A|Physician Decision|1|||
94458511|NCT01397786|323467392|FG000|Phase A|Withdrawal by Subject|0|||
94661433|NCT00093145|324215734|FG000|Overall Study|Withdrawal by Subject|9|||
94661434|NCT00093145|324215734|FG000|Overall Study|Other|1|||
94661435|NCT02007577|324215735|FG000|Overall Study|Adverse Event|1|||
94661436|NCT02007577|324215736|FG001|Overall Study|Adverse Event|0|||
94661437|NCT02007577|324215735|FG000|Overall Study|Withdrawal by Subject|0|||
94661438|NCT02007577|324215736|FG001|Overall Study|Withdrawal by Subject|1|||
94661439|NCT02252211|324215737|FG000|Overall Study|Adverse Event|0|||
94661440|NCT02252211|324215738|FG001|Overall Study|Adverse Event|1|||
94661441|NCT02252211|324215739|FG002|Overall Study|Adverse Event|0|||
94661442|NCT02252211|324215737|FG000|Overall Study|Progressive disease|3|||
94661443|NCT02252211|324215738|FG001|Overall Study|Progressive disease|2|||
94661444|NCT02252211|324215739|FG002|Overall Study|Progressive disease|0|||
94661445|NCT02252211|324215737|FG000|Overall Study|Withdrawal by Subject|1|||
94661446|NCT02252211|324215738|FG001|Overall Study|Withdrawal by Subject|0|||
94661447|NCT02252211|324215739|FG002|Overall Study|Withdrawal by Subject|0|||
94661448|NCT02252211|324215737|FG000|Overall Study|Serious Adverse Event During Screening|1|||
94661449|NCT02252211|324215738|FG001|Overall Study|Serious Adverse Event During Screening|0|||
94661450|NCT02252211|324215739|FG002|Overall Study|Serious Adverse Event During Screening|1|||
94661451|NCT01985126|324215740|FG000|Overall Study|Death|15|||
94661452|NCT01985126|324215741|FG001|Overall Study|Death|69|||
94661453|NCT01985126|324215740|FG000|Overall Study|Lost to Follow-up|0|||
94661454|NCT01985126|324215741|FG001|Overall Study|Lost to Follow-up|8|||
94661455|NCT01985126|324215740|FG000|Overall Study|Study Terminated By Sponsor|1|||
94661456|NCT01985126|324215741|FG001|Overall Study|Study Terminated By Sponsor|22|||
94661457|NCT01985126|324215740|FG000|Overall Study|Withdrawal by Subject|2|||
94661458|NCT01985126|324215741|FG001|Overall Study|Withdrawal by Subject|7|||
94458512|NCT01397786|323467393|FG001|Phase A|Withdrawal by Subject|0|||
94661459|NCT00968669|324215742|FG000|Overall Study|Lost to Follow-up|5|||
94661460|NCT00968669|324215743|FG001|Overall Study|Lost to Follow-up|2|||
94250307|NCT02545933|322708845|FG001|Overall Study|Withdrawal by Subject|3|||
94250308|NCT02545933|322708846|FG002|Overall Study|Withdrawal by Subject|3|||
94250309|NCT02545933|322708844|FG000|Overall Study|Protocol Violation|1|||
94250310|NCT02545933|322708845|FG001|Overall Study|Protocol Violation|0|||
94661461|NCT00968669|324215744|FG002|Overall Study|Lost to Follow-up|1|||
94458513|NCT01397786|323467394|FG002|Phase A|Withdrawal by Subject|5|||
94458514|NCT01397786|323467392|FG000|Phase A|Lack of Efficacy|0|||
94661462|NCT00968669|324215745|FG003|Overall Study|Lost to Follow-up|4|||
94458515|NCT01397786|323467393|FG001|Phase A|Lack of Efficacy|0|||
94458516|NCT01397786|323467394|FG002|Phase A|Lack of Efficacy|1|||
94661463|NCT00968669|324215742|FG000|Overall Study|Withdrawal by Subject|9|||
94250311|NCT02545933|322708846|FG002|Overall Study|Protocol Violation|1|||
94458517|NCT01397786|323467392|FG000|Phase B|Lost to Follow-up|22|||
94458518|NCT01397786|323467393|FG001|Phase B|Lost to Follow-up|12|||
94661464|NCT00968669|324215743|FG001|Overall Study|Withdrawal by Subject|7|||
94661465|NCT00968669|324215744|FG002|Overall Study|Withdrawal by Subject|5|||
94661466|NCT00968669|324215745|FG003|Overall Study|Withdrawal by Subject|3|||
94605437|NCT02536833|324018002|FG003|Overall Study|Discontinued Before Treatment|2|||
94605438|NCT02536833|324017999|FG000|Overall Study|Adverse Event|1|||
94605439|NCT02536833|324018000|FG001|Overall Study|Adverse Event|3|||
94605440|NCT02536833|324018001|FG002|Overall Study|Adverse Event|4|||
94605441|NCT02536833|324018002|FG003|Overall Study|Adverse Event|1|||
94605442|NCT02536833|324017999|FG000|Overall Study|Lost to Follow-up|2|||
94605443|NCT02536833|324018000|FG001|Overall Study|Lost to Follow-up|1|||
94356788|NCT01238861|323089484|FG005|Overall Study|Subject moved out of state/area|0|||
94356789|NCT01238861|323089479|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
94356790|NCT01238861|323089480|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
94356791|NCT01238861|323089481|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
94356792|NCT01238861|323089482|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
94356793|NCT01238861|323089483|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
94356794|NCT01238861|323089484|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
94356795|NCT01238861|323089479|FG000|Overall Study|Personal problems|0|||
94356796|NCT01238861|323089480|FG001|Overall Study|Personal problems|0|||
94356797|NCT01238861|323089481|FG002|Overall Study|Personal problems|0|||
94356798|NCT01238861|323089482|FG003|Overall Study|Personal problems|1|||
94356799|NCT01238861|323089483|FG004|Overall Study|Personal problems|0|||
94356800|NCT01238861|323089484|FG005|Overall Study|Personal problems|0|||
94356801|NCT01238861|323089479|FG000|Overall Study|Unable to continue visits|0|||
94356802|NCT01238861|323089480|FG001|Overall Study|Unable to continue visits|0|||
94356803|NCT01238861|323089481|FG002|Overall Study|Unable to continue visits|0|||
94356804|NCT01238861|323089482|FG003|Overall Study|Unable to continue visits|1|||
94356805|NCT01238861|323089483|FG004|Overall Study|Unable to continue visits|0|||
94356806|NCT01238861|323089484|FG005|Overall Study|Unable to continue visits|1|||
94356807|NCT01238861|323089479|FG000|Overall Study|Serious adverse event|0|||
94356808|NCT01238861|323089480|FG001|Overall Study|Serious adverse event|0|||
94356809|NCT01238861|323089481|FG002|Overall Study|Serious adverse event|0|||
94356810|NCT01238861|323089482|FG003|Overall Study|Serious adverse event|0|||
94356811|NCT01238861|323089483|FG004|Overall Study|Serious adverse event|0|||
94356812|NCT01238861|323089484|FG005|Overall Study|Serious adverse event|1|||
94356813|NCT01238861|323089479|FG000|Overall Study|Lack of compliance|0|||
94356814|NCT01238861|323089480|FG001|Overall Study|Lack of compliance|0|||
94356815|NCT01238861|323089481|FG002|Overall Study|Lack of compliance|0|||
94356816|NCT01238861|323089482|FG003|Overall Study|Lack of compliance|0|||
94356817|NCT01238861|323089483|FG004|Overall Study|Lack of compliance|0|||
94356818|NCT01238861|323089484|FG005|Overall Study|Lack of compliance|1|||
94356819|NCT01238861|323089479|FG000|Overall Study|Adverse Event|0|||
94356820|NCT01238861|323089480|FG001|Overall Study|Adverse Event|1|||
94356821|NCT01238861|323089481|FG002|Overall Study|Adverse Event|0|||
94356822|NCT01238861|323089482|FG003|Overall Study|Adverse Event|0|||
94356823|NCT01238861|323089483|FG004|Overall Study|Adverse Event|0|||
94356824|NCT01238861|323089484|FG005|Overall Study|Adverse Event|0|||
94356825|NCT01238861|323089479|FG000|Overall Study|Withdrawal by Subject|6|||
94356826|NCT01238861|323089480|FG001|Overall Study|Withdrawal by Subject|5|||
94356827|NCT01238861|323089481|FG002|Overall Study|Withdrawal by Subject|4|||
94356828|NCT01238861|323089482|FG003|Overall Study|Withdrawal by Subject|8|||
94356829|NCT01238861|323089483|FG004|Overall Study|Withdrawal by Subject|10|||
94356830|NCT01238861|323089484|FG005|Overall Study|Withdrawal by Subject|9|||
94356831|NCT01548573|323089485|FG000|Overall Study|Death|3|||
94356832|NCT01548573|323089485|FG000|Overall Study|Withdrawal by Subject|2|||
94356833|NCT02392078|323089486|FG000|Overall Study|Did not have procedure|32|||
94356834|NCT02392078|323089487|FG001|Overall Study|Did not have procedure|43|||
94356835|NCT02392078|323089488|FG002|Overall Study|Did not have procedure|20|||
94605444|NCT02536833|324018001|FG002|Overall Study|Lost to Follow-up|2|||
94605445|NCT02536833|324018002|FG003|Overall Study|Lost to Follow-up|2|||
94605446|NCT02536833|324017999|FG000|Overall Study|Physician Decision|0|||
94458519|NCT01397786|323467394|FG002|Phase B|Lost to Follow-up|22|||
94458520|NCT01397786|323467392|FG000|Phase B|Adverse Event|109|||
94458521|NCT01397786|323467393|FG001|Phase B|Adverse Event|23|||
94458522|NCT01397786|323467394|FG002|Phase B|Adverse Event|27|||
94458523|NCT01397786|323467392|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
94458524|NCT01397786|323467393|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
94458525|NCT01397786|323467394|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
94458526|NCT01397786|323467392|FG000|Phase B|Physician Decision|9|||
94458527|NCT01397786|323467393|FG001|Phase B|Physician Decision|1|||
94458528|NCT01397786|323467394|FG002|Phase B|Physician Decision|3|||
94458529|NCT01397786|323467392|FG000|Phase B|Withdrawal by Subject|102|||
94458530|NCT01397786|323467393|FG001|Phase B|Withdrawal by Subject|45|||
94458531|NCT01397786|323467394|FG002|Phase B|Withdrawal by Subject|30|||
94458532|NCT01397786|323467392|FG000|Phase B|Protocol Deviation|1|||
94458533|NCT01397786|323467393|FG001|Phase B|Protocol Deviation|2|||
94458534|NCT01397786|323467394|FG002|Phase B|Protocol Deviation|4|||
94458535|NCT01397786|323467392|FG000|Phase B|Lack of Efficacy|22|||
94458536|NCT01397786|323467393|FG001|Phase B|Lack of Efficacy|7|||
94458537|NCT01397786|323467394|FG002|Phase B|Lack of Efficacy|14|||
94458538|NCT05318092|323467401|FG000|Overall Study|Lost to Follow-up|3|||
94458539|NCT05318092|323467401|FG000|Overall Study|Withdrawal by Subject|1|||
94458540|NCT03030989|323467405|FG000|Overall Study|Fever|2|||
94458541|NCT03030989|323467406|FG001|Overall Study|Fever|2|||
94458542|NCT03030989|323467405|FG000|Overall Study|Rash|2|||
94458543|NCT03030989|323467406|FG001|Overall Study|Rash|1|||
94458544|NCT03030989|323467405|FG000|Overall Study|Fatigue/Overwhelmed|1|||
94458545|NCT03030989|323467406|FG001|Overall Study|Fatigue/Overwhelmed|5|||
94458546|NCT03030989|323467405|FG000|Overall Study|Positive Blood Cultures|2|||
94458547|NCT03030989|323467406|FG001|Overall Study|Positive Blood Cultures|1|||
94458548|NCT03030989|323467405|FG000|Overall Study|Line Removed|0|||
94458549|NCT03030989|323467406|FG001|Overall Study|Line Removed|2|||
94458550|NCT03030989|323467405|FG000|Overall Study|No longer interested|5|||
94458551|NCT03030989|323467406|FG001|Overall Study|No longer interested|3|||
94458552|NCT01953601|323467413|FG000|Part 1 (Base Study)|Adverse Event|24|||
94458553|NCT01953601|323467414|FG001|Part 1 (Base Study)|Adverse Event|37|||
94458554|NCT01953601|323467415|FG002|Part 1 (Base Study)|Adverse Event|15|||
94458555|NCT01953601|323467413|FG000|Part 1 (Base Study)|Death|2|||
94458556|NCT01953601|323467414|FG001|Part 1 (Base Study)|Death|0|||
94458557|NCT01953601|323467415|FG002|Part 1 (Base Study)|Death|3|||
94458558|NCT01953601|323467413|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
94458559|NCT01953601|323467414|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
94458560|NCT01953601|323467415|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
94458561|NCT01953601|323467413|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
94458562|NCT01953601|323467414|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
94458563|NCT01953601|323467415|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
94458564|NCT01953601|323467413|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
94458565|NCT01953601|323467414|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
94250312|NCT00979134|322708847|FG000|Overall Study|Disease progression|18|||
94250313|NCT00979134|322708848|FG001|Overall Study|Disease progression|2|||
94250314|NCT00979134|322708849|FG002|Overall Study|Disease progression|5|||
94250315|NCT00979134|322708847|FG000|Overall Study|Adverse Event|0|||
94250316|NCT00979134|322708848|FG001|Overall Study|Adverse Event|0|||
94250317|NCT00979134|322708849|FG002|Overall Study|Adverse Event|2|||
94250318|NCT00979134|322708847|FG000|Overall Study|Withdrawal by Subject|1|||
94250319|NCT00979134|322708848|FG001|Overall Study|Withdrawal by Subject|1|||
94250320|NCT00979134|322708849|FG002|Overall Study|Withdrawal by Subject|2|||
94250321|NCT00979134|322708847|FG000|Overall Study|Lost to Follow-up|2|||
94250322|NCT00979134|322708848|FG001|Overall Study|Lost to Follow-up|2|||
94250323|NCT00979134|322708849|FG002|Overall Study|Lost to Follow-up|0|||
94250324|NCT00979134|322708847|FG000|Overall Study|Death|4|||
94250325|NCT00979134|322708848|FG001|Overall Study|Death|0|||
94250326|NCT00979134|322708849|FG002|Overall Study|Death|26|||
94250327|NCT00979134|322708847|FG000|Overall Study|Other|8|||
94250328|NCT00979134|322708848|FG001|Overall Study|Other|1|||
94458566|NCT01953601|323467415|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
94458567|NCT01953601|323467413|FG000|Part 1 (Base Study)|Physician Decision|3|||
94458568|NCT01953601|323467414|FG001|Part 1 (Base Study)|Physician Decision|7|||
94458569|NCT01953601|323467415|FG002|Part 1 (Base Study)|Physician Decision|4|||
94458570|NCT01953601|323467413|FG000|Part 1 (Base Study)|Screen failure|1|||
94250329|NCT00979134|322708849|FG002|Overall Study|Other|5|||
94250330|NCT05180500|322708850|FG000|Overall Study|Adverse Event|1|||
94250331|NCT05180500|322708851|FG001|Overall Study|Adverse Event|0|||
94458571|NCT01953601|323467414|FG001|Part 1 (Base Study)|Screen failure|0|||
94458572|NCT01953601|323467415|FG002|Part 1 (Base Study)|Screen failure|1|||
94458573|NCT01953601|323467413|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
94458574|NCT01953601|323467414|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
94458575|NCT01953601|323467415|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
94458576|NCT01953601|323467413|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
94458577|NCT01953601|323467414|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
94458578|NCT01953601|323467415|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
94458579|NCT01953601|323467413|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
94458580|NCT01953601|323467414|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
94458581|NCT01953601|323467415|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
94458582|NCT01953601|323467413|FG000|Part 1 (Base Study)|Subject moved|2|||
94458583|NCT01953601|323467414|FG001|Part 1 (Base Study)|Subject moved|2|||
94458584|NCT01953601|323467415|FG002|Part 1 (Base Study)|Subject moved|1|||
94458585|NCT01953601|323467413|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
94458586|NCT01953601|323467414|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
94605447|NCT02536833|324018000|FG001|Overall Study|Physician Decision|0|||
94605448|NCT02536833|324018001|FG002|Overall Study|Physician Decision|0|||
94605449|NCT02536833|324018002|FG003|Overall Study|Physician Decision|1|||
94605450|NCT02536833|324017999|FG000|Overall Study|Site Terminated by Sponsor|2|||
94605451|NCT02536833|324018000|FG001|Overall Study|Site Terminated by Sponsor|2|||
94605452|NCT02536833|324018001|FG002|Overall Study|Site Terminated by Sponsor|2|||
94605453|NCT02536833|324018002|FG003|Overall Study|Site Terminated by Sponsor|2|||
94458587|NCT01953601|323467415|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
94458588|NCT01953601|323467413|FG000|Part 2 (Extension Study)|Adverse Event|1|||
94458589|NCT01953601|323467414|FG001|Part 2 (Extension Study)|Adverse Event|1|||
94605454|NCT02536833|324017999|FG000|Overall Study|Subject Non-Compliance|0|||
94605455|NCT02536833|324018000|FG001|Overall Study|Subject Non-Compliance|1|||
94605456|NCT02536833|324018001|FG002|Overall Study|Subject Non-Compliance|1|||
94250332|NCT05180500|322708850|FG000|Overall Study|Withdrawal by Subject|2|||
94250333|NCT05180500|322708851|FG001|Overall Study|Withdrawal by Subject|0|||
94250334|NCT00812331|322710933|FG000|Overall Study|Adverse Event|1|||
94250335|NCT00812331|322710934|FG001|Overall Study|Adverse Event|0|||
94250336|NCT00812331|322710935|FG002|Overall Study|Adverse Event|0|||
94250337|NCT00812331|322710936|FG003|Overall Study|Adverse Event|0|||
94250338|NCT00812331|322710937|FG004|Overall Study|Adverse Event|0|||
94250339|NCT00565851|322710938|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
94250340|NCT00565851|322710939|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
94250341|NCT00565851|322710940|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
94250342|NCT00565851|322710941|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
94250343|NCT00565851|322710942|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
94250344|NCT00565851|322710943|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
94250345|NCT00565851|322710944|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
94250346|NCT00565851|322710945|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
94250347|NCT00565851|322710938|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
94250348|NCT00565851|322710939|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
94250349|NCT00565851|322710940|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
94250350|NCT00565851|322710941|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
94250351|NCT00565851|322710942|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
94250352|NCT00565851|322710943|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
94250353|NCT00565851|322710944|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
94250354|NCT00565851|322710945|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
94250355|NCT03694275|322710946|FG000|Overall Study|Adverse Event|0|||
94250356|NCT03694275|322710947|FG001|Overall Study|Adverse Event|1|||
94250357|NCT03694275|322710946|FG000|Overall Study|Reason not Specified|0|||
94250358|NCT03694275|322710947|FG001|Overall Study|Reason not Specified|1|||
94250359|NCT02980731|322710948|FG000|Overall Study|Death|63|||
94250360|NCT02980731|322710948|FG000|Overall Study|Withdrawal by Subject|6|||
94250361|NCT02980731|322710948|FG000|Overall Study|Lost to Follow-up|5|||
94250362|NCT02980731|322710948|FG000|Overall Study|Study terminated by Sponsor|4|||
94250363|NCT02980731|322710948|FG000|Overall Study|Completed survival follow-up period|65|||
94250364|NCT02980731|322710948|FG000|Overall Study|COVID-19 infection|1|||
94250365|NCT02980731|322710948|FG000|Overall Study|Other, not specified|66|||
94250366|NCT00591370|322710949|FG000|Overall Study|Not Treated|2|||
94458590|NCT01953601|323467415|FG002|Part 2 (Extension Study)|Adverse Event|10|||
94605457|NCT02536833|324018002|FG003|Overall Study|Subject Non-Compliance|0|||
94458591|NCT01953601|323467413|FG000|Part 2 (Extension Study)|Death|0|||
94458592|NCT01953601|323467414|FG001|Part 2 (Extension Study)|Death|3|||
94458593|NCT01953601|323467415|FG002|Part 2 (Extension Study)|Death|0|||
94458594|NCT01953601|323467413|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
94458595|NCT01953601|323467414|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
94458596|NCT01953601|323467415|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
94458597|NCT01953601|323467413|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
94458598|NCT01953601|323467414|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
94458599|NCT01953601|323467415|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
94458600|NCT01953601|323467413|FG000|Part 2 (Extension Study)|Physician Decision|2|||
94458601|NCT01953601|323467414|FG001|Part 2 (Extension Study)|Physician Decision|0|||
94458602|NCT01953601|323467415|FG002|Part 2 (Extension Study)|Physician Decision|2|||
94458603|NCT01953601|323467413|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
94458604|NCT01953601|323467414|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
94458605|NCT01953601|323467415|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
94458606|NCT01953601|323467413|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
94458607|NCT01953601|323467414|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
94458608|NCT01953601|323467415|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
94458609|NCT01953601|323467413|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
94458610|NCT01953601|323467414|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
94605458|NCT02536833|324017999|FG000|Overall Study|Withdrawal by Subject|4|||
94458611|NCT01953601|323467415|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
94458612|NCT01953601|323467413|FG000|Part 2 (Extension Study)|Subject moved|0|||
94458613|NCT01953601|323467414|FG001|Part 2 (Extension Study)|Subject moved|0|||
94458614|NCT01953601|323467415|FG002|Part 2 (Extension Study)|Subject moved|1|||
94458615|NCT01953601|323467413|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
94458616|NCT01953601|323467414|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
94605459|NCT02536833|324018000|FG001|Overall Study|Withdrawal by Subject|3|||
94605460|NCT02536833|324018001|FG002|Overall Study|Withdrawal by Subject|5|||
94605461|NCT02536833|324018002|FG003|Overall Study|Withdrawal by Subject|11|||
94356836|NCT02392078|323089489|FG003|Overall Study|Did not have procedure|1|||
94356837|NCT02957149|323089492|FG000|Overall Study|Withdrawal by Subject|5|||
94356838|NCT00643006|323089494|FG000|Overall Study|Lost to Follow-up|5|||
94356839|NCT00643006|323089495|FG001|Overall Study|Lost to Follow-up|4|||
94356840|NCT03471507|323089499|FG000|Overall Study|Lost to Follow-up|1|||
94356841|NCT03471507|323089500|FG001|Overall Study|Lost to Follow-up|3|||
94356842|NCT03471507|323089499|FG000|Overall Study|Physician Decision|0|||
94356843|NCT03471507|323089500|FG001|Overall Study|Physician Decision|1|||
94356844|NCT03471507|323089499|FG000|Overall Study|Withdrawal by Subject|2|||
94356845|NCT03471507|323089500|FG001|Overall Study|Withdrawal by Subject|1|||
94356846|NCT02213666|323089501|FG000|Overall Study|Withdrawal by Subject|1|||
94458617|NCT01953601|323467415|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
94605462|NCT03309046|324018003|FG000|Overall Study|Withdrawal by Subject|4|||
94605463|NCT03309046|324018004|FG001|Overall Study|Withdrawal by Subject|17|||
94605464|NCT02314143|324018005|FG000|Overall Study|Adverse Event|0|||
94605465|NCT02314143|324018006|FG001|Overall Study|Adverse Event|6|||
94605466|NCT02314143|324018007|FG002|Overall Study|Adverse Event|4|||
94605467|NCT02314143|324018005|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
94605468|NCT02314143|324018006|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
94605469|NCT02314143|324018007|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
94605470|NCT02314143|324018005|FG000|Overall Study|Physician Decision|2|||
94605471|NCT02314143|324018006|FG001|Overall Study|Physician Decision|1|||
94605472|NCT02314143|324018007|FG002|Overall Study|Physician Decision|0|||
94605473|NCT02314143|324018005|FG000|Overall Study|Withdrawal by Subject|1|||
94605474|NCT02314143|324018006|FG001|Overall Study|Withdrawal by Subject|0|||
94605475|NCT02314143|324018007|FG002|Overall Study|Withdrawal by Subject|1|||
94605476|NCT00873860|324018009|FG000|Overall Study|Lost to Follow-up|1|||
94458618|NCT01608087|323467421|FG000|Overall Study|Lost to Follow-up|0|||
94605477|NCT00873860|324018010|FG001|Overall Study|Lost to Follow-up|0|||
94605478|NCT00873860|324018011|FG002|Overall Study|Lost to Follow-up|0|||
94605479|NCT00873860|324018012|FG003|Overall Study|Lost to Follow-up|1|||
94605480|NCT00873860|324018009|FG000|Overall Study|Withdrawal by Subject|1|||
94458619|NCT01608087|323467422|FG001|Overall Study|Lost to Follow-up|1|||
94605481|NCT00873860|324018010|FG001|Overall Study|Withdrawal by Subject|0|||
94605482|NCT00873860|324018011|FG002|Overall Study|Withdrawal by Subject|2|||
94605483|NCT00873860|324018012|FG003|Overall Study|Withdrawal by Subject|0|||
94605484|NCT00873860|324018009|FG000|Overall Study|Death|1|||
94605485|NCT00873860|324018010|FG001|Overall Study|Death|0|||
94605486|NCT00873860|324018011|FG002|Overall Study|Death|0|||
94605487|NCT00873860|324018012|FG003|Overall Study|Death|0|||
94605488|NCT00873860|324018009|FG000|Overall Study|Other|1|||
94605489|NCT00873860|324018010|FG001|Overall Study|Other|0|||
94605490|NCT00873860|324018011|FG002|Overall Study|Other|1|||
94605491|NCT00873860|324018012|FG003|Overall Study|Other|0|||
94605492|NCT02764190|324018013|FG000|Overall Study|Lost to Follow-up|17|||
94605493|NCT02764190|324018014|FG001|Overall Study|Lost to Follow-up|13|||
94605494|NCT00089674|324018015|FG000|Overall Study|Physician Decision|4|||
94605495|NCT00089674|324018016|FG001|Overall Study|Physician Decision|2|||
94250367|NCT03037931|322710950|FG000|Overall Study|Death|354|||
94250368|NCT03037931|322710951|FG001|Overall Study|Death|367|||
94250369|NCT03037931|322710950|FG000|Overall Study|Lost to Follow-up|7|||
94605496|NCT00089674|324018015|FG000|Overall Study|Adverse Event|23|||
94605497|NCT00089674|324018016|FG001|Overall Study|Adverse Event|29|||
94250370|NCT03037931|322710951|FG001|Overall Study|Lost to Follow-up|4|||
94250371|NCT03037931|322710950|FG000|Overall Study|Withdrawal by Subject|48|||
94250372|NCT03037931|322710951|FG001|Overall Study|Withdrawal by Subject|41|||
94250373|NCT00605215|322710952|FG000|Overall Study|Death|0|||
94250374|NCT00605215|322710953|FG001|Overall Study|Death|0|||
94250375|NCT00605215|322710954|FG002|Overall Study|Death|1|||
94250376|NCT00605215|322710952|FG000|Overall Study|Adverse Event|19|||
94250377|NCT00605215|322710953|FG001|Overall Study|Adverse Event|21|||
94250378|NCT00605215|322710954|FG002|Overall Study|Adverse Event|26|||
94250379|NCT00605215|322710952|FG000|Overall Study|Refusal to sign the re-consent form|8|||
94250380|NCT00605215|322710953|FG001|Overall Study|Refusal to sign the re-consent form|3|||
94250381|NCT00605215|322710954|FG002|Overall Study|Refusal to sign the re-consent form|3|||
94250382|NCT00605215|322710952|FG000|Overall Study|Withdrawal by Subject|39|||
94605498|NCT00089674|324018015|FG000|Overall Study|Withdrawal by Subject|143|||
94605499|NCT00089674|324018016|FG001|Overall Study|Withdrawal by Subject|127|||
94605500|NCT00089674|324018015|FG000|Overall Study|Death|43|||
94605501|NCT00089674|324018016|FG001|Overall Study|Death|43|||
94605502|NCT00089674|324018015|FG000|Overall Study|Disease progression|21|||
94605503|NCT00089674|324018016|FG001|Overall Study|Disease progression|23|||
94605504|NCT00089674|324018015|FG000|Overall Study|Ineligibility determined|8|||
94605505|NCT00089674|324018016|FG001|Overall Study|Ineligibility determined|10|||
94605506|NCT00089674|324018015|FG000|Overall Study|Lost to Follow-up|21|||
94605507|NCT00089674|324018016|FG001|Overall Study|Lost to Follow-up|17|||
94605508|NCT00089674|324018015|FG000|Overall Study|Noncompliance|7|||
94605509|NCT00089674|324018016|FG001|Overall Study|Noncompliance|3|||
94605510|NCT00089674|324018015|FG000|Overall Study|Other|5|||
94605511|NCT00089674|324018016|FG001|Overall Study|Other|9|||
94605512|NCT00089674|324018015|FG000|Overall Study|Requirement for alternative therapy|14|||
94605513|NCT00089674|324018016|FG001|Overall Study|Requirement for alternative therapy|4|||
94605514|NCT01484938|324018021|FG000|Overall Study|Adverse Event|2|||
94605515|NCT01484938|324018021|FG000|Overall Study|Lost to Follow-up|1|||
94605516|NCT01484938|324018021|FG000|Overall Study|Noncompliance|1|||
94250383|NCT00605215|322710953|FG001|Overall Study|Withdrawal by Subject|37|||
94250384|NCT00605215|322710954|FG002|Overall Study|Withdrawal by Subject|27|||
94250385|NCT00605215|322710952|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
94250386|NCT00605215|322710953|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
94250387|NCT00605215|322710954|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
94250388|NCT00605215|322710952|FG000|Overall Study|Protocol Violation|3|||
94250389|NCT00605215|322710953|FG001|Overall Study|Protocol Violation|4|||
94250390|NCT00605215|322710954|FG002|Overall Study|Protocol Violation|1|||
94250391|NCT00605215|322710952|FG000|Overall Study|Pregnancy|8|||
94250392|NCT00605215|322710953|FG001|Overall Study|Pregnancy|5|||
94250393|NCT00605215|322710954|FG002|Overall Study|Pregnancy|4|||
94250394|NCT00605215|322710952|FG000|Overall Study|Lost to Follow-up|8|||
94250395|NCT00605215|322710953|FG001|Overall Study|Lost to Follow-up|5|||
94250396|NCT00605215|322710954|FG002|Overall Study|Lost to Follow-up|2|||
94250397|NCT00605215|322710952|FG000|Overall Study|Other than specified|0|||
94250398|NCT00605215|322710953|FG001|Overall Study|Other than specified|2|||
94250399|NCT00605215|322710954|FG002|Overall Study|Other than specified|1|||
94250400|NCT03439254|322710955|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
94250401|NCT03439254|322710956|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
94250402|NCT03439254|322710957|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
94605517|NCT00381381|324018024|FG000|Overall Study|Adverse Event|3|||
94605518|NCT00381381|324018024|FG000|Overall Study|Lost to Follow-up|52|||
94605519|NCT00381381|324018024|FG000|Overall Study|Withdrawal by Subject|9|||
94605520|NCT00999921|324018026|FG000|Overall Study|Lost to Follow-up|10|||
94605521|NCT00999921|324018027|FG001|Overall Study|Lost to Follow-up|19|||
94605522|NCT00194675|324018028|FG000|Overall Study|Lost to Follow-up|1|||
94605523|NCT00194675|324018029|FG001|Overall Study|Lost to Follow-up|1|||
94605524|NCT00194675|324018028|FG000|Overall Study|lack of interest|1|||
94605525|NCT00194675|324018029|FG001|Overall Study|lack of interest|1|||
94605526|NCT00194675|324018028|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
94605527|NCT00194675|324018029|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
94605528|NCT00194675|324018028|FG000|Overall Study|Protocol Violation|1|||
94605529|NCT00194675|324018029|FG001|Overall Study|Protocol Violation|0|||
94605530|NCT00194675|324018028|FG000|Overall Study|Death|1|||
94605531|NCT00194675|324018029|FG001|Overall Study|Death|0|||
94605532|NCT00473746|324018033|FG000|Period 1 (Phase 1)|Adverse Event|1|||
94605533|NCT00473746|324018034|FG001|Period 1 (Phase 1)|Adverse Event|0|||
94605534|NCT00473746|324018035|FG002|Period 1 (Phase 1)|Adverse Event|0|||
94605535|NCT00473746|324018036|FG003|Period 1 (Phase 1)|Adverse Event|0|||
94605536|NCT00473746|324018037|FG004|Period 1 (Phase 1)|Adverse Event|0|||
94605537|NCT00473746|324018033|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
94605538|NCT00473746|324018034|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
94605539|NCT00473746|324018035|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
94605540|NCT00473746|324018036|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
94605541|NCT00473746|324018037|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
94605542|NCT00473746|324018033|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
94605543|NCT00473746|324018034|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
94605544|NCT00473746|324018035|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
94605545|NCT00473746|324018036|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
94605546|NCT00473746|324018037|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
94605547|NCT00473746|324018033|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
94605548|NCT00473746|324018034|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
94605549|NCT00473746|324018035|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
94605550|NCT00473746|324018036|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
94605551|NCT00473746|324018037|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
94605552|NCT00473746|324018033|FG000|Period 1 (Phase 1)|Reason not specified|0|||
94605553|NCT00473746|324018034|FG001|Period 1 (Phase 1)|Reason not specified|1|||
94605554|NCT00473746|324018035|FG002|Period 1 (Phase 1)|Reason not specified|0|||
94605555|NCT00473746|324018036|FG003|Period 1 (Phase 1)|Reason not specified|0|||
94605556|NCT00473746|324018037|FG004|Period 1 (Phase 1)|Reason not specified|0|||
94605557|NCT00473746|324018033|FG000|Period 2 (Phase 2)|Adverse Event|0|||
94605558|NCT00473746|324018034|FG001|Period 2 (Phase 2)|Adverse Event|0|||
94458620|NCT01608087|323467423|FG002|Overall Study|Lost to Follow-up|0|||
94458621|NCT01608087|323467421|FG000|Overall Study|Other Reason|0|||
94458622|NCT01608087|323467422|FG001|Overall Study|Other Reason|1|||
94458623|NCT01608087|323467423|FG002|Overall Study|Other Reason|0|||
94458624|NCT01300338|323467424|FG000|Overall Study|Lost to Follow-up|5|||
94458625|NCT01300338|323467425|FG001|Overall Study|Lost to Follow-up|0|||
94458626|NCT00748189|323467428|FG000|Overall Study|Death|99|||
94458627|NCT00748189|323467429|FG001|Overall Study|Death|84|||
94458628|NCT00748189|323467428|FG000|Overall Study|Withdrawal by Subject|23|||
94458629|NCT00748189|323467429|FG001|Overall Study|Withdrawal by Subject|29|||
94458630|NCT00748189|323467428|FG000|Overall Study|Physician Decision|16|||
94458631|NCT00748189|323467429|FG001|Overall Study|Physician Decision|5|||
94250403|NCT03439254|322710958|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
94458632|NCT00748189|323467428|FG000|Overall Study|Lost to Follow-up|8|||
94605559|NCT00473746|324018035|FG002|Period 2 (Phase 2)|Adverse Event|0|||
94605560|NCT00473746|324018036|FG003|Period 2 (Phase 2)|Adverse Event|0|||
94605561|NCT00473746|324018037|FG004|Period 2 (Phase 2)|Adverse Event|3|||
94605562|NCT00473746|324018033|FG000|Period 2 (Phase 2)|Death|0|||
94605563|NCT00473746|324018034|FG001|Period 2 (Phase 2)|Death|0|||
94605564|NCT00473746|324018035|FG002|Period 2 (Phase 2)|Death|0|||
94605565|NCT00473746|324018036|FG003|Period 2 (Phase 2)|Death|0|||
94605566|NCT00473746|324018037|FG004|Period 2 (Phase 2)|Death|1|||
94605567|NCT00473746|324018033|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
94458633|NCT00748189|323467429|FG001|Overall Study|Lost to Follow-up|15|||
94605568|NCT00473746|324018034|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
94458634|NCT00748189|323467428|FG000|Overall Study|Study terminated by Sponsor|70|||
94458635|NCT00748189|323467429|FG001|Overall Study|Study terminated by Sponsor|79|||
94250404|NCT03439254|322710959|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
94250405|NCT03439254|322710960|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
94250406|NCT03439254|322710955|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
94250407|NCT03439254|322710956|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
94458636|NCT03320850|323467430|FG000|Overall Study|Lost to Follow-up|0|||
94458637|NCT03320850|323467431|FG001|Overall Study|Lost to Follow-up|0|||
94458638|NCT03320850|323467432|FG002|Overall Study|Lost to Follow-up|0|||
94458639|NCT03320850|323467433|FG003|Overall Study|Lost to Follow-up|0|||
94458640|NCT03320850|323467434|FG004|Overall Study|Lost to Follow-up|1|||
94458641|NCT03320850|323467435|FG005|Overall Study|Lost to Follow-up|2|||
94458642|NCT03320850|323467436|FG006|Overall Study|Lost to Follow-up|2|||
94458643|NCT03320850|323467437|FG007|Overall Study|Lost to Follow-up|0|||
94458644|NCT03320850|323467438|FG008|Overall Study|Lost to Follow-up|6|||
94458645|NCT03320850|323467439|FG009|Overall Study|Lost to Follow-up|4|||
94458646|NCT03320850|323467430|FG000|Overall Study|Withdrawal by Subject|0|||
94458647|NCT03320850|323467431|FG001|Overall Study|Withdrawal by Subject|0|||
94458648|NCT03320850|323467432|FG002|Overall Study|Withdrawal by Subject|0|||
94458649|NCT03320850|323467433|FG003|Overall Study|Withdrawal by Subject|0|||
94458650|NCT03320850|323467434|FG004|Overall Study|Withdrawal by Subject|1|||
94458651|NCT03320850|323467435|FG005|Overall Study|Withdrawal by Subject|2|||
94458652|NCT03320850|323467436|FG006|Overall Study|Withdrawal by Subject|4|||
94458653|NCT03320850|323467437|FG007|Overall Study|Withdrawal by Subject|5|||
94458654|NCT03320850|323467438|FG008|Overall Study|Withdrawal by Subject|2|||
94458655|NCT03320850|323467439|FG009|Overall Study|Withdrawal by Subject|1|||
94605569|NCT00473746|324018035|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
94605570|NCT00473746|324018036|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
94250408|NCT03439254|322710957|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
94458656|NCT03320850|323467430|FG000|Overall Study|Lack of Efficacy|0|||
94458657|NCT03320850|323467431|FG001|Overall Study|Lack of Efficacy|0|||
94458658|NCT03320850|323467432|FG002|Overall Study|Lack of Efficacy|0|||
94458659|NCT03320850|323467433|FG003|Overall Study|Lack of Efficacy|1|||
94458660|NCT03320850|323467434|FG004|Overall Study|Lack of Efficacy|0|||
94458661|NCT03320850|323467435|FG005|Overall Study|Lack of Efficacy|1|||
94458662|NCT03320850|323467436|FG006|Overall Study|Lack of Efficacy|0|||
94458663|NCT03320850|323467437|FG007|Overall Study|Lack of Efficacy|2|||
94458664|NCT03320850|323467438|FG008|Overall Study|Lack of Efficacy|0|||
94458665|NCT03320850|323467439|FG009|Overall Study|Lack of Efficacy|3|||
94458666|NCT03320850|323467430|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
94458667|NCT03320850|323467431|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
94250409|NCT03439254|322710958|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
94250410|NCT03439254|322710959|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
94458668|NCT03320850|323467432|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
94250411|NCT03439254|322710960|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
94250412|NCT03439254|322710955|FG000|Double-blind Phase (18 Months)|Death|1|||
94250413|NCT03439254|322710956|FG001|Double-blind Phase (18 Months)|Death|2|||
94250414|NCT03439254|322710957|FG002|Double-blind Phase (18 Months)|Death|2|||
94250415|NCT03439254|322710958|FG003|Double-blind Phase (18 Months)|Death|0|||
94250416|NCT03439254|322710959|FG004|Double-blind Phase (18 Months)|Death|0|||
94458669|NCT03320850|323467433|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
94458670|NCT03320850|323467434|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
94458671|NCT03320850|323467435|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
94458672|NCT03320850|323467436|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
94605571|NCT00473746|324018037|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
94250417|NCT03439254|322710960|FG005|Double-blind Phase (18 Months)|Death|0|||
94250418|NCT03439254|322710955|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
94250419|NCT03439254|322710956|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
94250420|NCT03439254|322710957|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
94250421|NCT03439254|322710958|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
94250422|NCT03439254|322710959|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
94250423|NCT03439254|322710960|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
94250424|NCT03439254|322710955|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
94250425|NCT03439254|322710956|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
94250426|NCT03439254|322710957|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
94250427|NCT03439254|322710958|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
94250428|NCT03439254|322710959|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
94458673|NCT03320850|323467437|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
94458674|NCT03320850|323467438|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
94458675|NCT03320850|323467439|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
94458676|NCT03320850|323467430|FG000|Overall Study|Adverse Event|0|||
94458677|NCT03320850|323467431|FG001|Overall Study|Adverse Event|0|||
94605572|NCT00473746|324018033|FG000|Period 2 (Phase 2)|Reason not specified|0|||
94458678|NCT03320850|323467432|FG002|Overall Study|Adverse Event|0|||
94458679|NCT03320850|323467433|FG003|Overall Study|Adverse Event|0|||
94458680|NCT03320850|323467434|FG004|Overall Study|Adverse Event|0|||
94458681|NCT03320850|323467435|FG005|Overall Study|Adverse Event|2|||
94458682|NCT03320850|323467436|FG006|Overall Study|Adverse Event|1|||
94458683|NCT03320850|323467437|FG007|Overall Study|Adverse Event|0|||
94458684|NCT03320850|323467438|FG008|Overall Study|Adverse Event|2|||
94458685|NCT03320850|323467439|FG009|Overall Study|Adverse Event|0|||
94458686|NCT03320850|323467430|FG000|Overall Study|Reason Not Specified|0|||
94458687|NCT03320850|323467431|FG001|Overall Study|Reason Not Specified|0|||
94458688|NCT03320850|323467432|FG002|Overall Study|Reason Not Specified|0|||
94458689|NCT03320850|323467433|FG003|Overall Study|Reason Not Specified|0|||
94458690|NCT03320850|323467434|FG004|Overall Study|Reason Not Specified|0|||
94458691|NCT03320850|323467435|FG005|Overall Study|Reason Not Specified|1|||
94458692|NCT03320850|323467436|FG006|Overall Study|Reason Not Specified|0|||
94458693|NCT03320850|323467437|FG007|Overall Study|Reason Not Specified|0|||
94458694|NCT03320850|323467438|FG008|Overall Study|Reason Not Specified|0|||
94458695|NCT03320850|323467439|FG009|Overall Study|Reason Not Specified|1|||
94458696|NCT03361865|323467440|FG000|Overall Study|Death|17|||
94458697|NCT03361865|323467441|FG001|Overall Study|Death|18|||
94458698|NCT03361865|323467440|FG000|Overall Study|Physician Decision|1|||
94458699|NCT03361865|323467441|FG001|Overall Study|Physician Decision|9|||
94458700|NCT03361865|323467440|FG000|Overall Study|Withdrawal by Subject|1|||
94458701|NCT03361865|323467441|FG001|Overall Study|Withdrawal by Subject|0|||
94458702|NCT02091375|323467444|FG000|Overall Study|Adverse Event|8|||
94458703|NCT02091375|323467445|FG001|Overall Study|Adverse Event|1|||
94458704|NCT02091375|323467444|FG000|Overall Study|Lost to Follow-up|0|||
94458705|NCT02091375|323467445|FG001|Overall Study|Lost to Follow-up|1|||
94458706|NCT02091375|323467444|FG000|Overall Study|Withdrawal by Subject|0|||
94458707|NCT02091375|323467445|FG001|Overall Study|Withdrawal by Subject|1|||
94458708|NCT02091375|323467444|FG000|Overall Study|Withdrawn by the investigator|1|||
94458709|NCT02091375|323467445|FG001|Overall Study|Withdrawn by the investigator|0|||
94458710|NCT01741792|323467446|FG000|Overall Study|Death|6|||
94458711|NCT01741792|323467447|FG001|Overall Study|Death|1|||
94458712|NCT01741792|323467448|FG002|Overall Study|Death|12|||
94458713|NCT00680901|323467449|FG000|Overall Study|Lost to Follow-up|8|||
94458714|NCT00680901|323467450|FG001|Overall Study|Lost to Follow-up|8|||
94458715|NCT00680901|323467449|FG000|Overall Study|Withdrawal by Subject|4|||
94458716|NCT00680901|323467450|FG001|Overall Study|Withdrawal by Subject|13|||
94458717|NCT00680901|323467449|FG000|Overall Study|Physician Decision|0|||
94458718|NCT00680901|323467450|FG001|Overall Study|Physician Decision|1|||
94458719|NCT00680901|323467449|FG000|Overall Study|Ongoing: On Study Treatment|16|||
94458720|NCT00680901|323467450|FG001|Overall Study|Ongoing: On Study Treatment|13|||
94458721|NCT00680901|323467449|FG000|Overall Study|Ongoing: In Follow Up|45|||
94458722|NCT00680901|323467450|FG001|Overall Study|Ongoing: In Follow Up|41|||
94458723|NCT03193801|323467459|FG000|Overall Study|Physician Decision|2|||
94458724|NCT03193801|323467459|FG000|Overall Study|Withdrawal by Subject|1|||
94458725|NCT02855359|323467460|FG000|Overall Study|Death|2|||
94458726|NCT02855359|323467461|FG001|Overall Study|Death|2|||
94458727|NCT02855359|323467462|FG002|Overall Study|Death|0|||
94458728|NCT02855359|323467463|FG003|Overall Study|Death|0|||
94458729|NCT02855359|323467460|FG000|Overall Study|Study Termination by Sponsor|9|||
94458730|NCT02855359|323467461|FG001|Overall Study|Study Termination by Sponsor|11|||
94458731|NCT02855359|323467462|FG002|Overall Study|Study Termination by Sponsor|0|||
94458732|NCT02855359|323467463|FG003|Overall Study|Study Termination by Sponsor|0|||
94458733|NCT00937040|323467464|FG000|Overall Study|Adverse Event|5|||
94458734|NCT00937040|323467465|FG001|Overall Study|Adverse Event|8|||
94458735|NCT00937040|323467464|FG000|Overall Study|Lost to Follow-up|12|||
94458736|NCT00937040|323467465|FG001|Overall Study|Lost to Follow-up|12|||
94458737|NCT00937040|323467464|FG000|Overall Study|Protocol Violation|3|||
94458738|NCT00937040|323467465|FG001|Overall Study|Protocol Violation|0|||
94458739|NCT00937040|323467464|FG000|Overall Study|Withdrawal by Subject|13|||
94458740|NCT00937040|323467465|FG001|Overall Study|Withdrawal by Subject|7|||
94458741|NCT00937040|323467464|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
94458742|NCT00937040|323467465|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
94458743|NCT00937040|323467464|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
94605573|NCT00473746|324018034|FG001|Period 2 (Phase 2)|Reason not specified|0|||
94605574|NCT00473746|324018035|FG002|Period 2 (Phase 2)|Reason not specified|0|||
94605575|NCT00473746|324018036|FG003|Period 2 (Phase 2)|Reason not specified|0|||
94458744|NCT00937040|323467465|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
94458745|NCT00638443|323467466|FG000|First Intervention|Adverse Event|2|||
94605576|NCT00473746|324018037|FG004|Period 2 (Phase 2)|Reason not specified|3|||
94458746|NCT00638443|323467467|FG001|First Intervention|Adverse Event|1|||
94458747|NCT01054300|323467468|FG000|Period 1|Adverse Event|1|||
94458748|NCT01054300|323467469|FG001|Period 1|Adverse Event|0|||
94458749|NCT01054300|323467470|FG002|Period 1|Adverse Event|0|||
94458750|NCT01054300|323467471|FG003|Period 1|Adverse Event|0|||
94605577|NCT00667420|324018038|FG000|Overall Study|Adverse Event|2|||
94458751|NCT01054300|323467468|FG000|Period 2|Withdrawal by Subject|0|||
94605578|NCT00667420|324018038|FG000|Overall Study|Lack of Efficacy|5|||
94605579|NCT00667420|324018038|FG000|Overall Study|Physician Decision|1|||
94605580|NCT00667420|324018038|FG000|Overall Study|Withdrawal by Subject|2|||
94605581|NCT03112590|324018051|FG000|Overall Study|Adverse Event|0|||
94605582|NCT03112590|324018052|FG001|Overall Study|Adverse Event|1|||
94605583|NCT03112590|324018053|FG002|Overall Study|Adverse Event|0|||
94605584|NCT00884377|324019072|FG000|Overall Study|Withdrawal by Subject|1|||
94605585|NCT00884377|324019073|FG001|Overall Study|Withdrawal by Subject|0|||
94605586|NCT00884377|324019072|FG000|Overall Study|Could not confirm diagnosis|1|||
94605587|NCT00884377|324019073|FG001|Overall Study|Could not confirm diagnosis|0|||
94605588|NCT00884377|324019072|FG000|Overall Study|Physician Decision|0|||
94605589|NCT00884377|324019073|FG001|Overall Study|Physician Decision|1|||
94605590|NCT01683019|324019074|FG000|Overall Study|Withdrawal by Subject|2|||
94605591|NCT01683019|324019075|FG001|Overall Study|Withdrawal by Subject|1|||
94605592|NCT01683019|324019076|FG002|Overall Study|Withdrawal by Subject|4|||
94605593|NCT02003365|324019077|FG000|Overall Study|Lost to Follow-up|0|||
94605594|NCT02003365|324019078|FG001|Overall Study|Lost to Follow-up|0|||
94605595|NCT02003365|324019079|FG002|Overall Study|Lost to Follow-up|1|||
94605596|NCT04285580|324019086|FG000|Overall Study|Protocol Violation|0|||
94605597|NCT04285580|324019087|FG001|Overall Study|Protocol Violation|1|||
94250429|NCT03439254|322710960|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
94250430|NCT03439254|322710955|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
94250431|NCT03439254|322710956|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
94250432|NCT03439254|322710957|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
94605598|NCT03729362|324019088|FG000|Overall Study|Withdrawal by Subject|2|||
94605599|NCT03729362|324019089|FG001|Overall Study|Withdrawal by Subject|0|||
94605600|NCT03729362|324019088|FG000|Overall Study|Physician Decision|1|||
94605601|NCT03729362|324019089|FG001|Overall Study|Physician Decision|0|||
94605602|NCT03729362|324019088|FG000|Overall Study|COVID-19 Pandemic|1|||
94605603|NCT03729362|324019089|FG001|Overall Study|COVID-19 Pandemic|0|||
94605604|NCT03729362|324019088|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
94605605|NCT03729362|324019089|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
94605606|NCT03729362|324019088|FG000|Overall Study|Adverse Event|0|||
94605607|NCT03729362|324019089|FG001|Overall Study|Adverse Event|1|||
94605608|NCT03729362|324019088|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
94605609|NCT03729362|324019089|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
94605610|NCT00562627|324019090|FG000|Overall Study|Protocol Violation|1|||
94605611|NCT00562627|324019091|FG001|Overall Study|Protocol Violation|1|||
94605612|NCT00562627|324019092|FG002|Overall Study|Protocol Violation|1|||
94250433|NCT03439254|322710958|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
94250434|NCT03439254|322710959|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
94250435|NCT03439254|322710960|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
94250436|NCT03439254|322710955|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
94250437|NCT03439254|322710956|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
94250438|NCT03439254|322710957|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
94250439|NCT03439254|322710958|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
94250440|NCT03439254|322710959|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
94250441|NCT03439254|322710960|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
94250442|NCT03439254|322710955|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
94250443|NCT03439254|322710956|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
94250444|NCT03439254|322710957|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
94250445|NCT03439254|322710958|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
94250446|NCT03439254|322710959|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
94250447|NCT03439254|322710960|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
94250448|NCT03439254|322710955|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
94250449|NCT03439254|322710956|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
94250450|NCT03439254|322710957|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
94250451|NCT03439254|322710958|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
94458752|NCT01054300|323467469|FG001|Period 2|Withdrawal by Subject|0|||
94458753|NCT01054300|323467470|FG002|Period 2|Withdrawal by Subject|1|||
94605613|NCT04099251|324019093|FG000|Pre-Treatment|Other reasons|1|||
94605614|NCT04099251|324019094|FG001|Pre-Treatment|Other reasons|0|||
94605615|NCT04099251|324019093|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
94605616|NCT04099251|324019094|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
94605617|NCT04099251|324019093|FG000|Blinded Treatment Phase|Other reasons|16|||
94605618|NCT04099251|324019094|FG001|Blinded Treatment Phase|Other reasons|7|||
94605619|NCT04099251|324019093|FG000|Blinded Treatment Phase|Disease recurrence|26|||
94605620|NCT04099251|324019094|FG001|Blinded Treatment Phase|Disease recurrence|41|||
94605621|NCT04099251|324019093|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
94605622|NCT04099251|324019094|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
94605623|NCT04099251|324019093|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
94605624|NCT04099251|324019094|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
94356847|NCT01319422|323089502|FG000|Overall Study|Withdrawal by Subject|1|||
94356848|NCT01319422|323089503|FG001|Overall Study|Withdrawal by Subject|0|||
94356849|NCT06104423|323089504|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
94356850|NCT06104423|323089505|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
94356851|NCT06104423|323089506|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
94356852|NCT06104423|323089504|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
94356853|NCT06104423|323089505|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
94356854|NCT06104423|323089506|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
94356855|NCT00812968|323089507|FG000|Overall Study|Relapse after erythroid response|6|||
94356856|NCT00812968|323089507|FG000|Overall Study|Disease progression|1|||
94356857|NCT00812968|323089507|FG000|Overall Study|No further treatment required|1|||
94356858|NCT00812968|323089507|FG000|Overall Study|Study closed due to marketing approval|3|||
94356859|NCT00727246|323089508|FG000|Overall Study|could not complete MRI|0|||
94356860|NCT00727246|323089509|FG001|Overall Study|could not complete MRI|1|||
94356861|NCT00727246|323089510|FG002|Overall Study|could not complete MRI|0|||
94356862|NCT00727246|323089511|FG003|Overall Study|could not complete MRI|1|||
94356863|NCT00727246|323089508|FG000|Overall Study|incidental finding|0|||
94356864|NCT00727246|323089509|FG001|Overall Study|incidental finding|0|||
94356865|NCT00727246|323089510|FG002|Overall Study|incidental finding|0|||
94356866|NCT00727246|323089511|FG003|Overall Study|incidental finding|1|||
94356867|NCT00727246|323089508|FG000|Overall Study|withdrawn|0|||
94356868|NCT00727246|323089509|FG001|Overall Study|withdrawn|0|||
94356869|NCT00727246|323089510|FG002|Overall Study|withdrawn|1|||
94356870|NCT00727246|323089511|FG003|Overall Study|withdrawn|0|||
94356871|NCT02059265|323089516|FG000|Overall Study|Ineligible|4|||
94356872|NCT00229931|323089518|FG000|Overall Study|Death|1|||
94356873|NCT00229931|323089519|FG001|Overall Study|Death|0|||
94356874|NCT00229931|323089518|FG000|Overall Study|Lost to Follow-up|3|||
94356875|NCT00229931|323089519|FG001|Overall Study|Lost to Follow-up|2|||
94356876|NCT00483574|323089525|FG000|Overall Study|Adverse Event|6|||
94356877|NCT00483574|323089526|FG001|Overall Study|Adverse Event|0|||
94356878|NCT00483574|323089525|FG000|Overall Study|Protocol Violation|28|||
94356879|NCT00483574|323089526|FG001|Overall Study|Protocol Violation|9|||
94356880|NCT00483574|323089525|FG000|Overall Study|Lost to Follow-up|16|||
94356881|NCT00483574|323089526|FG001|Overall Study|Lost to Follow-up|4|||
94356882|NCT00483574|323089525|FG000|Overall Study|Withdrawal by Subject|52|||
94356883|NCT00483574|323089526|FG001|Overall Study|Withdrawal by Subject|0|||
94356884|NCT00465101|323089527|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
94356885|NCT00465101|323089527|FG000|Overall Study|Change in health precluded follow up|4|||
94356886|NCT00465101|323089527|FG000|Overall Study|Did not meet study criteria|4|||
94356887|NCT00465101|323089527|FG000|Overall Study|Lost to Follow-up|5|||
94356888|NCT00465101|323089527|FG000|Overall Study|Other|6|||
94356889|NCT00465101|323089527|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
94356890|NCT00465101|323089527|FG000|Overall Study|Patient postponed procedure|1|||
94356891|NCT00465101|323089527|FG000|Overall Study|Site closed due to IRB expiration|1|||
94356892|NCT00465101|323089527|FG000|Overall Study|Unable to obtain IRB approval|1|||
94356893|NCT00465101|323089527|FG000|Overall Study|Death|3|||
94356894|NCT00465101|323089527|FG000|Overall Study|Withdrawal by Subject|25|||
94356895|NCT00465101|323089527|FG000|Overall Study|Physician Decision|1|||
94356896|NCT00465101|323089527|FG000|Overall Study|Withdrew consent prior to procedure|3|||
94356897|NCT03219372|323089528|FG000|Overall Study|Withdrawal by Subject|1|||
94356898|NCT03219372|323089529|FG001|Overall Study|Withdrawal by Subject|0|||
94356899|NCT00933543|323089530|FG000|Overall Study|Adverse Event|2|||
94356900|NCT00933543|323089531|FG001|Overall Study|Adverse Event|1|||
94356901|NCT00933543|323089530|FG000|Overall Study|Lost to Follow-up|0|||
94356902|NCT00933543|323089531|FG001|Overall Study|Lost to Follow-up|1|||
94356903|NCT00933543|323089530|FG000|Overall Study|Withdrawal by Subject|0|||
94356904|NCT00933543|323089531|FG001|Overall Study|Withdrawal by Subject|1|||
94356905|NCT00933543|323089530|FG000|Overall Study|Lack of Efficacy|0|||
94356906|NCT00933543|323089531|FG001|Overall Study|Lack of Efficacy|3|||
94356907|NCT00933543|323089530|FG000|Overall Study|Other|1|||
94356908|NCT00933543|323089531|FG001|Overall Study|Other|1|||
94356909|NCT03732534|323089534|FG000|Overall Study|Study terminated by Sponsor|6|||
94356910|NCT02190604|323089535|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
94356911|NCT02190604|323089536|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
94356912|NCT02190604|323089537|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
94356913|NCT02190604|323089538|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
94356914|NCT02190604|323089539|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
94356915|NCT02190604|323089540|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
94661467|NCT00968669|324215742|FG000|Overall Study|Pregnancy|0|||
94458754|NCT01054300|323467471|FG003|Period 2|Withdrawal by Subject|0|||
94458755|NCT02662764|323467477|FG000|Overall Study|Adverse Event|6|||
94458756|NCT02662764|323467477|FG000|Overall Study|Lack of Efficacy|8|||
94458757|NCT02662764|323467477|FG000|Overall Study|Protocol Violation|1|||
94458758|NCT02662764|323467477|FG000|Overall Study|Withdrawal by Subject|5|||
94458759|NCT02662764|323467477|FG000|Overall Study|Device failure|4|||
94458760|NCT02662764|323467477|FG000|Overall Study|Patient changed treatment|1|||
94458761|NCT02662764|323467477|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
94458762|NCT04712019|323467482|FG000|Overall Study|Withdrawal by Subject|2|||
94458763|NCT04712019|323467483|FG001|Overall Study|Withdrawal by Subject|2|||
94458764|NCT04712019|323467482|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
94458765|NCT04712019|323467483|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
94458766|NCT01154088|323467484|FG000|Overall Study|Lost to Follow-up|4|||
94458767|NCT01154088|323467485|FG001|Overall Study|Lost to Follow-up|6|||
94458768|NCT01154088|323467486|FG002|Overall Study|Lost to Follow-up|7|||
94605625|NCT04099251|324019093|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
94605626|NCT04099251|324019094|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
94605627|NCT04099251|324019093|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
94605628|NCT04099251|324019094|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
94605629|NCT04099251|324019093|FG000|Blinded Treatment Phase|Death|6|||
94605630|NCT04099251|324019094|FG001|Blinded Treatment Phase|Death|2|||
94605631|NCT04099251|324019093|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
94605632|NCT04099251|324019094|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
94605633|NCT04099251|324019093|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
94605634|NCT04099251|324019094|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
94605635|NCT04099251|324019093|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
94605636|NCT04099251|324019094|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
94605637|NCT04099251|324019093|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
94605638|NCT04099251|324019094|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
94605639|NCT04099251|324019093|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
94458769|NCT00319592|323467492|FG000|Overall Study|Protocol Violation|1|||
94458770|NCT00319592|323467493|FG001|Overall Study|Protocol Violation|0|||
94458771|NCT00319592|323467492|FG000|Overall Study|Physician Decision|0|||
94458772|NCT00319592|323467493|FG001|Overall Study|Physician Decision|1|||
94458773|NCT03429244|323467494|FG000|Overall Study|Withdrawal by Subject|2|||
94458774|NCT03429244|323467495|FG001|Overall Study|Withdrawal by Subject|1|||
94458775|NCT03429244|323467496|FG002|Overall Study|Withdrawal by Subject|1|||
94458776|NCT03843632|323467498|FG000|Overall Study|Withdrawal by Subject|1|||
94458777|NCT03843632|323467499|FG001|Overall Study|Withdrawal by Subject|0|||
94458778|NCT03843632|323467500|FG002|Overall Study|Withdrawal by Subject|0|||
94458779|NCT03843632|323467501|FG003|Overall Study|Withdrawal by Subject|0|||
94458780|NCT03403751|323467502|FG000|Overall Study|Death|5|||
94458781|NCT03403751|323467503|FG001|Overall Study|Death|6|||
94458782|NCT03403751|323467502|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
94458783|NCT03403751|323467503|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
94605640|NCT04099251|324019094|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
94458784|NCT00750139|323467504|FG000|Overall Study|Adverse Event|1|||
94458785|NCT00750139|323467505|FG001|Overall Study|Adverse Event|2|||
94605641|NCT04099251|324019093|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
94605642|NCT04099251|324019094|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
94605643|NCT04099251|324019093|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
94605644|NCT04099251|324019094|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
94605645|NCT04099251|324019093|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
94605646|NCT04099251|324019094|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
94605647|NCT04099251|324019093|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
94605648|NCT04099251|324019094|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
94605649|NCT01107418|324019095|FG000|Overall Study|Disease Progression|45|||
94605650|NCT01107418|324019095|FG000|Overall Study|Adverse Event|3|||
94605651|NCT01107418|324019095|FG000|Overall Study|Withdrawal by Subject|1|||
94605652|NCT01107418|324019095|FG000|Overall Study|Study Closing|1|||
94605653|NCT01107418|324019095|FG000|Overall Study|Started Other Therapy|1|||
94605654|NCT01107418|324019095|FG000|Overall Study|Entered Extension Study|1|||
94605655|NCT00597701|324019096|FG000|Overall Study|Withdrawal by Subject|5|||
94605656|NCT00597701|324019097|FG001|Overall Study|Withdrawal by Subject|5|||
94605657|NCT00597701|324019096|FG000|Overall Study|Death|0|||
94605658|NCT00597701|324019097|FG001|Overall Study|Death|1|||
94605659|NCT00597701|324019096|FG000|Overall Study|Physician Decision|2|||
94605660|NCT00597701|324019097|FG001|Overall Study|Physician Decision|0|||
94605661|NCT00597701|324019096|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
94605662|NCT00597701|324019097|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
94605663|NCT00301821|324019098|FG000|Overall Study|Ineligible|25|||
94605664|NCT00301821|324019098|FG000|Overall Study|Cancel|1|||
94605665|NCT03150485|324019099|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
94605666|NCT03150485|324019100|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
94605667|NCT03150485|324019101|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
94605668|NCT03150485|324019102|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
94605669|NCT03150485|324019103|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
94605670|NCT03150485|324019104|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
94605671|NCT01251146|324019105|FG000|Overall Study|Lost to Follow-up|3|||
94605672|NCT01251146|324019106|FG001|Overall Study|Lost to Follow-up|10|||
94605673|NCT00642473|324019107|FG000|Overall Study|Withdrawal by Subject|0|||
94605674|NCT00642473|324019108|FG001|Overall Study|Withdrawal by Subject|5|||
94605675|NCT00642473|324019107|FG000|Overall Study|Progression or death|2|||
94605676|NCT00642473|324019108|FG001|Overall Study|Progression or death|4|||
94605677|NCT00642473|324019107|FG000|Overall Study|Other|2|||
94605678|NCT00642473|324019108|FG001|Overall Study|Other|2|||
94605679|NCT01466179|324019117|FG000|Overall Study|Ongoing in core study|2|||
94605680|NCT01466179|324019117|FG000|Overall Study|Physician Decision|46|||
94605681|NCT01466179|324019117|FG000|Overall Study|Progressive disease|43|||
94605682|NCT01466179|324019117|FG000|Overall Study|Adverse Event|32|||
94605683|NCT01466179|324019117|FG000|Overall Study|Disease relapse|23|||
94605684|NCT01466179|324019117|FG000|Overall Study|Lack of Efficacy|14|||
94605685|NCT01466179|324019117|FG000|Overall Study|Death|7|||
94605686|NCT01466179|324019117|FG000|Overall Study|Withdrawal by Subject|7|||
94605687|NCT01466179|324019117|FG000|Overall Study|Protocol Violation|2|||
94605688|NCT01466179|324019117|FG000|Overall Study|Other|3|||
94605689|NCT00749580|324019118|FG000|Overall Study|Lost to Follow-up|4|||
94605690|NCT00749580|324019119|FG001|Overall Study|Lost to Follow-up|8|||
94605691|NCT00749580|324019118|FG000|Overall Study|Adverse Event|0|||
94605692|NCT00749580|324019119|FG001|Overall Study|Adverse Event|1|||
94605693|NCT03563716|324019121|FG000|Overall Study|Death|20|||
94605694|NCT03563716|324019122|FG001|Overall Study|Death|14|||
94605695|NCT03563716|324019121|FG000|Overall Study|Withdrawal by Subject|3|||
94605696|NCT03563716|324019122|FG001|Overall Study|Withdrawal by Subject|3|||
94605697|NCT03563716|324019121|FG000|Overall Study|Still on Study|45|||
94605698|NCT03563716|324019122|FG001|Overall Study|Still on Study|50|||
94605699|NCT03707184|324019125|FG000|Overall Study|Withdrawal by Subject|2|||
94605700|NCT04062123|324019126|FG000|Overall Study|Withdrawal by Subject|0|||
94605701|NCT04062123|324019127|FG001|Overall Study|Withdrawal by Subject|1|||
94458786|NCT00750139|323467506|FG002|Overall Study|Adverse Event|0|||
94458787|NCT00750139|323467507|FG003|Overall Study|Adverse Event|1|||
94458788|NCT00750139|323467504|FG000|Overall Study|Lost to Follow-up|17|||
94458789|NCT00750139|323467505|FG001|Overall Study|Lost to Follow-up|12|||
94458790|NCT00750139|323467506|FG002|Overall Study|Lost to Follow-up|15|||
94458791|NCT00750139|323467507|FG003|Overall Study|Lost to Follow-up|6|||
94458792|NCT00750139|323467504|FG000|Overall Study|Withdrawal by Subject|3|||
94458793|NCT00750139|323467505|FG001|Overall Study|Withdrawal by Subject|2|||
94458794|NCT00750139|323467506|FG002|Overall Study|Withdrawal by Subject|6|||
94458795|NCT00750139|323467507|FG003|Overall Study|Withdrawal by Subject|2|||
94458796|NCT00750139|323467504|FG000|Overall Study|Physician Decision|1|||
94458797|NCT00750139|323467505|FG001|Overall Study|Physician Decision|1|||
94458798|NCT00750139|323467506|FG002|Overall Study|Physician Decision|0|||
94458799|NCT00750139|323467507|FG003|Overall Study|Physician Decision|0|||
94458800|NCT00750139|323467504|FG000|Overall Study|Non-compliance|1|||
94458801|NCT00750139|323467505|FG001|Overall Study|Non-compliance|0|||
94458802|NCT00750139|323467506|FG002|Overall Study|Non-compliance|1|||
94458803|NCT00750139|323467507|FG003|Overall Study|Non-compliance|3|||
94458804|NCT00750139|323467504|FG000|Overall Study|Termination by sponsor|4|||
94458805|NCT00750139|323467505|FG001|Overall Study|Termination by sponsor|0|||
94458806|NCT00750139|323467506|FG002|Overall Study|Termination by sponsor|0|||
94458807|NCT00750139|323467507|FG003|Overall Study|Termination by sponsor|1|||
94458808|NCT00750139|323467504|FG000|Overall Study|Non-specific|62|||
94458809|NCT00750139|323467505|FG001|Overall Study|Non-specific|42|||
94458810|NCT00750139|323467506|FG002|Overall Study|Non-specific|79|||
94458811|NCT00750139|323467507|FG003|Overall Study|Non-specific|33|||
94458812|NCT01820572|323467508|FG000|Randomization|Not Treated|2|||
94458813|NCT01820572|323467509|FG001|Randomization|Not Treated|1|||
94458814|NCT01820572|323467508|FG000|Treatment Period|Adverse Event|12|||
94458815|NCT01820572|323467509|FG001|Treatment Period|Adverse Event|7|||
94458816|NCT01820572|323467508|FG000|Treatment Period|Death|3|||
94458817|NCT01820572|323467509|FG001|Treatment Period|Death|3|||
94458818|NCT01820572|323467508|FG000|Treatment Period|Lack of Efficacy|1|||
94458819|NCT01820572|323467509|FG001|Treatment Period|Lack of Efficacy|0|||
94458820|NCT01820572|323467508|FG000|Treatment Period|poor/non compliance|0|||
94458821|NCT01820572|323467509|FG001|Treatment Period|poor/non compliance|3|||
94458822|NCT01820572|323467508|FG000|Treatment Period|request to discontinue|6|||
94458823|NCT01820572|323467509|FG001|Treatment Period|request to discontinue|11|||
94458824|NCT01820572|323467508|FG000|Treatment Period|No longer meets study criteria|3|||
94458825|NCT01820572|323467509|FG001|Treatment Period|No longer meets study criteria|10|||
94458826|NCT01820572|323467508|FG000|Treatment Period|withdrew consent|1|||
94458827|NCT01820572|323467509|FG001|Treatment Period|withdrew consent|2|||
94458828|NCT00595517|323467510|FG000|Overall Study|Adverse Event|6|||
94458829|NCT00595517|323467510|FG000|Overall Study|Withdrawal by Subject|4|||
94458830|NCT00595517|323467510|FG000|Overall Study|Protocol Violation|2|||
94458831|NCT00595517|323467510|FG000|Overall Study|Recurrence of ulcer|5|||
94458832|NCT00595517|323467510|FG000|Overall Study|usage of prohibited treatment|1|||
94458833|NCT00595517|323467510|FG000|Overall Study|No intention to attend regularly|1|||
94458834|NCT02880865|323467518|FG000|Overall Study|Adverse Event|1|||
94458835|NCT02880865|323467519|FG001|Overall Study|Adverse Event|0|||
94458836|NCT02880865|323467518|FG000|Overall Study|Withdrawal by Subject|0|||
94458837|NCT02880865|323467519|FG001|Overall Study|Withdrawal by Subject|2|||
94458838|NCT02880865|323467518|FG000|Overall Study|Physician Decision|0|||
94458839|NCT02880865|323467519|FG001|Overall Study|Physician Decision|1|||
94458840|NCT01597375|323467521|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
94458841|NCT01597375|323467522|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
94458842|NCT01597375|323467521|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
94458843|NCT01597375|323467522|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
94458844|NCT01597375|323467521|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
94458845|NCT01597375|323467522|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
94458846|NCT01597375|323467521|FG000|Washout (2 Weeks)|Adverse Event|1|||
94458847|NCT01597375|323467522|FG001|Washout (2 Weeks)|Adverse Event|0|||
94458848|NCT01597375|323467521|FG000|Second Intervention|Failed to react at both Aspirin|1|||
94458849|NCT01597375|323467522|FG001|Second Intervention|Failed to react at both Aspirin|1|||
94458850|NCT01343277|323467525|FG000|Overall Study|Other|3|||
94458851|NCT01343277|323467526|FG001|Overall Study|Other|3|||
94458852|NCT01343277|323467525|FG000|Overall Study|Withdrawal by Subject|18|||
94458853|NCT01343277|323467526|FG001|Overall Study|Withdrawal by Subject|13|||
94458854|NCT01343277|323467525|FG000|Overall Study|Physician Decision|1|||
94458855|NCT01343277|323467526|FG001|Overall Study|Physician Decision|2|||
94661468|NCT00968669|324215743|FG001|Overall Study|Pregnancy|0|||
94458856|NCT01343277|323467525|FG000|Overall Study|Death|10|||
94458857|NCT01343277|323467526|FG001|Overall Study|Death|1|||
94458858|NCT01343277|323467525|FG000|Overall Study|Adverse Event|67|||
94458859|NCT01343277|323467526|FG001|Overall Study|Adverse Event|13|||
94458860|NCT01343277|323467525|FG000|Overall Study|Disease progression|270|||
94458861|NCT01343277|323467526|FG001|Overall Study|Disease progression|138|||
94458862|NCT01343277|323467525|FG000|Overall Study|Randomized not treated|6|||
94458863|NCT01343277|323467526|FG001|Overall Study|Randomized not treated|21|||
94458864|NCT01343277|323467525|FG000|Overall Study|Treatment ongoing|8|||
94458865|NCT01343277|323467526|FG001|Overall Study|Treatment ongoing|2|||
94458866|NCT01343277|323467525|FG000|Overall Study|Subsequent anticancer therapy|1|||
94458867|NCT01343277|323467526|FG001|Overall Study|Subsequent anticancer therapy|0|||
94458868|NCT03852628|323467528|FG000|Overall Study|Lost to Follow-up|7|||
94458869|NCT03852628|323467529|FG001|Overall Study|Lost to Follow-up|6|||
94458870|NCT03852628|323467528|FG000|Overall Study|Lack of Efficacy|6|||
94458871|NCT03852628|323467529|FG001|Overall Study|Lack of Efficacy|6|||
94458872|NCT01698879|323467532|FG000|Overall Study|Withdrawal by Subject|1|||
94458873|NCT01698879|323467533|FG001|Overall Study|Withdrawal by Subject|0|||
94458874|NCT01698879|323467534|FG002|Overall Study|Withdrawal by Subject|0|||
94458875|NCT02272842|323467543|FG000|Overall Study|Lost to Follow-up|8|||
94458876|NCT02272842|323467544|FG001|Overall Study|Lost to Follow-up|8|||
94458877|NCT02272842|323467543|FG000|Overall Study|Withdrawal by Subject|8|||
94458878|NCT02272842|323467544|FG001|Overall Study|Withdrawal by Subject|2|||
94458879|NCT01273623|323467545|FG000|Overall Study|did not meet IVUS criteria|29|||
94458880|NCT00325156|323467546|FG000|Overall Study|Protocol Violation|8|||
94458881|NCT00325156|323467546|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
94458882|NCT00325156|323467546|FG000|Overall Study|Migrated/moved from study area|12|||
94458883|NCT00325156|323467546|FG000|Overall Study|Adverse event, non-fatal|3|||
94605702|NCT04062123|324019128|FG002|Overall Study|Withdrawal by Subject|0|||
94605703|NCT04902326|324019129|FG000|Overall Study|Withdrawal by Subject|1|||
94605704|NCT04902326|324019130|FG001|Overall Study|Withdrawal by Subject|3|||
94605705|NCT04902326|324019131|FG002|Overall Study|Withdrawal by Subject|0|||
94605706|NCT04902326|324019132|FG003|Overall Study|Withdrawal by Subject|1|||
94605707|NCT04902326|324019129|FG000|Overall Study|Lost to Follow-up|14|||
94605708|NCT04902326|324019130|FG001|Overall Study|Lost to Follow-up|14|||
94356916|NCT02190604|323089541|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
94356917|NCT02190604|323089542|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
94356918|NCT02190604|323089543|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
94356919|NCT02190604|323089544|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
94356920|NCT02190604|323089545|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
94356921|NCT02190604|323089546|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
94356922|NCT02190604|323089547|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
94356923|NCT02190604|323089548|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
94356924|NCT02190604|323089549|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
94356925|NCT02190604|323089550|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
94356926|NCT02190604|323089551|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
94356927|NCT02190604|323089552|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
94356928|NCT02190604|323089553|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
94356929|NCT02190604|323089535|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
94356930|NCT02190604|323089536|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
94356931|NCT02190604|323089537|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
94356932|NCT02190604|323089538|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
94356933|NCT02190604|323089539|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
94356934|NCT02190604|323089540|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
94356935|NCT02190604|323089541|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
94356936|NCT02190604|323089542|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
94356937|NCT02190604|323089543|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
94356938|NCT02190604|323089544|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
94356939|NCT02190604|323089545|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
94356940|NCT02190604|323089546|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
94356941|NCT02190604|323089547|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
94356942|NCT02190604|323089548|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
94356943|NCT02190604|323089549|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
94356944|NCT02190604|323089550|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
94458884|NCT00325156|323467546|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
94458885|NCT00325156|323467546|FG000|Overall Study|Other|1|||
94458886|NCT00325156|323467546|FG000|Overall Study|Withdrawal by Subject|31|||
94458887|NCT02009397|323467547|FG000|Overall Study|Protocol Violation|6|||
94458888|NCT02009397|323467547|FG000|Overall Study|Death|8|||
94458889|NCT02009397|323467547|FG000|Overall Study|Lost to Follow-up|6|||
94458890|NCT01970475|323467557|FG000|Overall Study|Withdrawal by Subject|11|||
94605709|NCT04902326|324019131|FG002|Overall Study|Lost to Follow-up|14|||
94356945|NCT02190604|323089551|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
94356946|NCT02190604|323089552|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
94356947|NCT02190604|323089553|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
94605710|NCT04902326|324019132|FG003|Overall Study|Lost to Follow-up|6|||
94605711|NCT01117051|324019138|FG000|Overall Study|Withdrawal by Subject|5|||
94605712|NCT01117051|324019139|FG001|Overall Study|Withdrawal by Subject|3|||
94605713|NCT01117051|324019138|FG000|Overall Study|Adverse Event|4|||
94605714|NCT01117051|324019139|FG001|Overall Study|Adverse Event|3|||
94605715|NCT01117051|324019138|FG000|Overall Study|Lost to Follow-up|0|||
94605716|NCT01117051|324019139|FG001|Overall Study|Lost to Follow-up|1|||
94605717|NCT01117051|324019138|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
94605718|NCT01117051|324019139|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
94605719|NCT01117051|324019138|FG000|Overall Study|Sponsor's decision|3|||
94605720|NCT01117051|324019139|FG001|Overall Study|Sponsor's decision|1|||
94250452|NCT03439254|322710959|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
94250453|NCT03439254|322710960|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
94250454|NCT03439254|322710955|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
94250455|NCT03439254|322710956|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
94250456|NCT03439254|322710957|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
94250457|NCT03439254|322710958|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
94250458|NCT03439254|322710959|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
94250459|NCT03439254|322710960|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
94250460|NCT03439254|322710955|FG000|Double-blind Phase (18 Months)|Site closure|0|||
94250461|NCT03439254|322710956|FG001|Double-blind Phase (18 Months)|Site closure|0|||
94250462|NCT03439254|322710957|FG002|Double-blind Phase (18 Months)|Site closure|1|||
94250463|NCT03439254|322710958|FG003|Double-blind Phase (18 Months)|Site closure|0|||
94250464|NCT03439254|322710959|FG004|Double-blind Phase (18 Months)|Site closure|0|||
94250465|NCT03439254|322710960|FG005|Double-blind Phase (18 Months)|Site closure|0|||
94250466|NCT03439254|322710955|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
94250467|NCT03439254|322710956|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
94250468|NCT03439254|322710957|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
94250469|NCT03439254|322710958|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
94250470|NCT03439254|322710959|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
94250471|NCT03439254|322710960|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
94250472|NCT03439254|322710955|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
94250473|NCT03439254|322710956|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
94250474|NCT03439254|322710957|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
94250475|NCT03439254|322710958|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
94250476|NCT03439254|322710959|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
94250477|NCT03439254|322710960|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
94250478|NCT03439254|322710955|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
94356948|NCT04281030|323089555|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
94356949|NCT04281030|323089556|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
94356950|NCT04281030|323089555|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
94356951|NCT04281030|323089556|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
94356952|NCT02369874|323089563|FG000|Overall Study|Lost to Follow-up|2|||
94356953|NCT02369874|323089564|FG001|Overall Study|Lost to Follow-up|2|||
94356954|NCT02369874|323089565|FG002|Overall Study|Lost to Follow-up|2|||
94356955|NCT02369874|323089563|FG000|Overall Study|Withdrawal by Subject|7|||
94356956|NCT02369874|323089564|FG001|Overall Study|Withdrawal by Subject|9|||
94356957|NCT02369874|323089565|FG002|Overall Study|Withdrawal by Subject|27|||
94356958|NCT02369874|323089563|FG000|Overall Study|Miscellaneous|1|||
94356959|NCT02369874|323089564|FG001|Overall Study|Miscellaneous|1|||
94356960|NCT02369874|323089565|FG002|Overall Study|Miscellaneous|0|||
94356961|NCT02369874|323089563|FG000|Overall Study|On Treatment/Off Study|34|||
94356962|NCT02369874|323089564|FG001|Overall Study|On Treatment/Off Study|45|||
94356963|NCT02369874|323089565|FG002|Overall Study|On Treatment/Off Study|32|||
94356964|NCT02058849|323089568|FG000|Overall Study|Hospitalization|1|||
94356965|NCT02058849|323089569|FG001|Overall Study|Hospitalization|1|||
94356966|NCT02058849|323089568|FG000|Overall Study|Death|1|||
94356967|NCT02058849|323089569|FG001|Overall Study|Death|0|||
94356968|NCT02058849|323089568|FG000|Overall Study|Lost to Follow-up|1|||
94356969|NCT02058849|323089569|FG001|Overall Study|Lost to Follow-up|0|||
94356970|NCT02058849|323089568|FG000|Overall Study|Withdrawal by Subject|4|||
94356971|NCT02058849|323089569|FG001|Overall Study|Withdrawal by Subject|0|||
94356972|NCT01049360|323089570|FG000|Period 1|Adverse Event|0|||
94356973|NCT01049360|323089571|FG001|Period 1|Adverse Event|1|||
94356974|NCT01049360|323089572|FG002|Period 1|Adverse Event|0|||
94605721|NCT01117051|324019138|FG000|Overall Study|Surgical procedure|0|||
94605722|NCT01117051|324019139|FG001|Overall Study|Surgical procedure|1|||
94605723|NCT01117051|324019138|FG000|Overall Study|Randomized by mistake|0|||
94605724|NCT01117051|324019139|FG001|Overall Study|Randomized by mistake|1|||
94605725|NCT01117051|324019138|FG000|Overall Study|Convenience issue|1|||
94605726|NCT01117051|324019139|FG001|Overall Study|Convenience issue|0|||
94605727|NCT00366340|324019140|FG000|Infant Series|Protocol Violation|3|||
94605728|NCT00366340|324019141|FG001|Infant Series|Protocol Violation|4|||
94605729|NCT00366340|324019140|FG000|Infant Series|Withdrawal by Subject|3|||
94605730|NCT00366340|324019141|FG001|Infant Series|Withdrawal by Subject|3|||
94605731|NCT00366340|324019140|FG000|Infant Series|Adverse Event|0|||
94605732|NCT00366340|324019141|FG001|Infant Series|Adverse Event|2|||
94605733|NCT00366340|324019140|FG000|Infant Series|Lost to Follow-up|1|||
94605734|NCT00366340|324019141|FG001|Infant Series|Lost to Follow-up|1|||
94605735|NCT00366340|324019140|FG000|Infant Series|Failure to return|1|||
94605736|NCT00366340|324019141|FG001|Infant Series|Failure to return|0|||
94605737|NCT00366340|324019140|FG000|After the Infant Series|Parent/legal guardian request|1|||
94605738|NCT00366340|324019141|FG001|After the Infant Series|Parent/legal guardian request|1|||
94605739|NCT00366340|324019140|FG000|After the Infant Series|Failed to return|0|||
94605740|NCT00366340|324019141|FG001|After the Infant Series|Failed to return|1|||
94605741|NCT00366340|324019140|FG000|After the Infant Series|Protocol Violation|2|||
94605742|NCT00366340|324019141|FG001|After the Infant Series|Protocol Violation|2|||
94605743|NCT00366340|324019140|FG000|After the Infant Series|Adverse Event|0|||
94605744|NCT00366340|324019141|FG001|After the Infant Series|Adverse Event|1|||
94605745|NCT00366340|324019140|FG000|After the Infant Series|Lost to Follow-up|0|||
94605746|NCT00366340|324019141|FG001|After the Infant Series|Lost to Follow-up|1|||
94605747|NCT00366340|324019140|FG000|Toddler Dose|Failed to return|1|||
94605748|NCT00366340|324019141|FG001|Toddler Dose|Failed to return|0|||
94605749|NCT00366340|324019140|FG000|Toddler Dose|Parent/legal guardian request|0|||
94605750|NCT00366340|324019141|FG001|Toddler Dose|Parent/legal guardian request|1|||
94605751|NCT01315236|324019142|FG000|Double-blind Phase|Death|1|||
94250479|NCT03439254|322710956|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
94250480|NCT03439254|322710957|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
94250481|NCT03439254|322710958|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
94250482|NCT03439254|322710959|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
94250483|NCT03439254|322710960|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
94250484|NCT03439254|322710955|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
94250485|NCT03439254|322710956|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
94250486|NCT03439254|322710957|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
94250487|NCT03439254|322710958|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
94250488|NCT03439254|322710959|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
94250489|NCT03439254|322710960|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
94250490|NCT03439254|322710955|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
94250491|NCT03439254|322710956|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
94250492|NCT03439254|322710957|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
94250493|NCT03439254|322710958|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
94250494|NCT03439254|322710959|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
94250495|NCT03439254|322710960|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
94250496|NCT03439254|322710955|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
94250497|NCT03439254|322710956|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
94250498|NCT03439254|322710957|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
94250499|NCT03439254|322710958|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
94250500|NCT03439254|322710959|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
94250501|NCT03439254|322710960|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
94250502|NCT03439254|322710955|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
94250503|NCT03439254|322710956|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
94250504|NCT03439254|322710957|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
94250505|NCT03439254|322710958|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
94250506|NCT03439254|322710959|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
94250507|NCT03439254|322710960|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
94250508|NCT03439254|322710955|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
94250509|NCT03439254|322710956|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
94250510|NCT03439254|322710957|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
94250511|NCT03439254|322710958|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
94250512|NCT03439254|322710959|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
94250513|NCT03439254|322710960|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
94250514|NCT03439254|322710955|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
94250515|NCT03439254|322710956|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
94250516|NCT03439254|322710957|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
94250517|NCT03439254|322710958|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
94605752|NCT01315236|324019143|FG001|Double-blind Phase|Death|0|||
94605753|NCT01315236|324019142|FG000|Double-blind Phase|Adverse Event|1|||
94605754|NCT01315236|324019143|FG001|Double-blind Phase|Adverse Event|0|||
94356975|NCT01049360|323089573|FG003|Period 1|Adverse Event|1|||
94356976|NCT01049360|323089574|FG004|Period 1|Adverse Event|0|||
94356977|NCT01049360|323089575|FG005|Period 1|Adverse Event|0|||
94356978|NCT01049360|323089576|FG006|Period 1|Adverse Event|0|||
94356979|NCT01049360|323089577|FG007|Period 1|Adverse Event|1|||
94356980|NCT01049360|323089578|FG008|Period 1|Adverse Event|0|||
94356981|NCT01049360|323089579|FG009|Period 1|Adverse Event|0|||
94356982|NCT01049360|323089580|FG010|Period 1|Adverse Event|0|||
94356983|NCT01049360|323089581|FG011|Period 1|Adverse Event|0|||
94356984|NCT01049360|323089582|FG012|Period 1|Adverse Event|1|||
94356985|NCT01049360|323089583|FG013|Period 1|Adverse Event|1|||
94356986|NCT01049360|323089584|FG014|Period 1|Adverse Event|0|||
94356987|NCT01049360|323089585|FG015|Period 1|Adverse Event|0|||
94356988|NCT01049360|323089586|FG016|Period 1|Adverse Event|1|||
94356989|NCT01049360|323089587|FG017|Period 1|Adverse Event|0|||
94356990|NCT01049360|323089588|FG018|Period 1|Adverse Event|1|||
94356991|NCT01049360|323089589|FG019|Period 1|Adverse Event|0|||
94356992|NCT01049360|323089570|FG000|Period 1|Did not meet inc/exc criteria|0|||
94356993|NCT01049360|323089571|FG001|Period 1|Did not meet inc/exc criteria|0|||
94356994|NCT01049360|323089572|FG002|Period 1|Did not meet inc/exc criteria|0|||
94356995|NCT01049360|323089573|FG003|Period 1|Did not meet inc/exc criteria|0|||
94356996|NCT01049360|323089574|FG004|Period 1|Did not meet inc/exc criteria|0|||
94356997|NCT01049360|323089575|FG005|Period 1|Did not meet inc/exc criteria|0|||
94356998|NCT01049360|323089576|FG006|Period 1|Did not meet inc/exc criteria|0|||
94356999|NCT01049360|323089577|FG007|Period 1|Did not meet inc/exc criteria|1|||
94250518|NCT03439254|322710959|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
94250519|NCT03439254|322710960|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
94250520|NCT03439254|322710955|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
94250521|NCT03439254|322710956|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
94250522|NCT03439254|322710957|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
94250523|NCT03439254|322710958|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
94250524|NCT03439254|322710959|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
94250525|NCT03439254|322710960|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
94357000|NCT01049360|323089578|FG008|Period 1|Did not meet inc/exc criteria|1|||
94357001|NCT01049360|323089579|FG009|Period 1|Did not meet inc/exc criteria|0|||
94357002|NCT01049360|323089580|FG010|Period 1|Did not meet inc/exc criteria|0|||
94357003|NCT01049360|323089581|FG011|Period 1|Did not meet inc/exc criteria|0|||
94458891|NCT01970475|323467558|FG001|Overall Study|Withdrawal by Subject|6|||
94458892|NCT01970475|323467557|FG000|Overall Study|Adverse Event|7|||
94605755|NCT01315236|324019142|FG000|Double-blind Phase|Withdrawal of Consent|1|||
94605756|NCT01315236|324019143|FG001|Double-blind Phase|Withdrawal of Consent|0|||
94605757|NCT01315236|324019142|FG000|Double-blind Phase|Lost to Follow-up|1|||
94605758|NCT01315236|324019143|FG001|Double-blind Phase|Lost to Follow-up|0|||
94605759|NCT01315236|324019142|FG000|Open-label Phase|Death|1|||
94605760|NCT01315236|324019143|FG001|Open-label Phase|Death|0|||
94605761|NCT01315236|324019142|FG000|Open-label Phase|Adverse Event|0|||
94605762|NCT01315236|324019143|FG001|Open-label Phase|Adverse Event|1|||
94605763|NCT01315236|324019142|FG000|Open-label Phase|Other|0|||
94605764|NCT01315236|324019143|FG001|Open-label Phase|Other|1|||
94605765|NCT01315236|324019142|FG000|12-Month Follow-up Period|Death|0|||
94605766|NCT01315236|324019143|FG001|12-Month Follow-up Period|Death|1|||
94605767|NCT01315236|324019142|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
94605768|NCT01315236|324019143|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
94605769|NCT01143207|324019147|FG000|Overall Study|Lost to Follow-up|2|||
94605770|NCT01241240|324019148|FG000|Overall Study|Adverse Event|5|||
94605771|NCT01241240|324019149|FG001|Overall Study|Adverse Event|4|||
94605772|NCT01241240|324019148|FG000|Overall Study|Lost to Follow-up|2|||
94605773|NCT01241240|324019149|FG001|Overall Study|Lost to Follow-up|4|||
94605774|NCT01241240|324019148|FG000|Overall Study|Personal Reasons|1|||
94605775|NCT01241240|324019149|FG001|Overall Study|Personal Reasons|1|||
94605776|NCT01025154|324019150|FG000|Overall Study|Lost to Follow-up|1|||
94605777|NCT01025154|324019150|FG000|Overall Study|Withdrawal by Subject|1|||
94605778|NCT01264016|324019155|FG000|Overall Study|Withdrawal by Subject|1|||
94250526|NCT03439254|322710955|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
94605779|NCT01264016|324019155|FG000|Overall Study|Felt faint at sight of blood|1|||
94605780|NCT01629706|324019156|FG000|Phase 1 PureVision|Screen Failure|4|||
94250527|NCT03439254|322710956|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
94357004|NCT01049360|323089582|FG012|Period 1|Did not meet inc/exc criteria|0|||
94357005|NCT01049360|323089583|FG013|Period 1|Did not meet inc/exc criteria|0|||
94357006|NCT01049360|323089584|FG014|Period 1|Did not meet inc/exc criteria|0|||
94357007|NCT01049360|323089585|FG015|Period 1|Did not meet inc/exc criteria|0|||
94357008|NCT01049360|323089586|FG016|Period 1|Did not meet inc/exc criteria|0|||
94357009|NCT01049360|323089587|FG017|Period 1|Did not meet inc/exc criteria|0|||
94357010|NCT01049360|323089588|FG018|Period 1|Did not meet inc/exc criteria|0|||
94357011|NCT01049360|323089589|FG019|Period 1|Did not meet inc/exc criteria|0|||
94357012|NCT01049360|323089570|FG000|Period 1|Withdrawal by Subject|0|||
94605781|NCT01629706|324019156|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
94250528|NCT03439254|322710957|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
94250529|NCT03439254|322710958|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
94250530|NCT03439254|322710959|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
94250531|NCT03439254|322710960|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
94250532|NCT03439254|322710955|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
94250533|NCT03439254|322710956|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
94250534|NCT03439254|322710957|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
94250535|NCT03439254|322710958|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
94250536|NCT03439254|322710959|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
94250537|NCT03439254|322710960|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
94250538|NCT02217332|322710961|FG000|Overall Study|Adverse Event|3|||
94250539|NCT02217332|322710961|FG000|Overall Study|Dose interruption >1 month|1|||
94250540|NCT02217332|322710961|FG000|Overall Study|Protocol Violation (eligibility)|1|||
94250541|NCT02217332|322710961|FG000|Overall Study|Withdrawal by Subject|1|||
94250542|NCT02217332|322710961|FG000|Overall Study|Lost to Follow-up|1|||
94250543|NCT02914275|322710964|FG000|Overall Study|Lost to Follow-up|84|||
94250544|NCT02914275|322710965|FG001|Overall Study|Lost to Follow-up|29|||
94250545|NCT02914275|322710964|FG000|Overall Study|Withdrawal by Subject|26|||
94250546|NCT02914275|322710965|FG001|Overall Study|Withdrawal by Subject|10|||
94250547|NCT02914275|322710964|FG000|Overall Study|Protocol Violation|1|||
94250548|NCT02914275|322710965|FG001|Overall Study|Protocol Violation|1|||
94250549|NCT02914275|322710964|FG000|Overall Study|Physician Decision|3|||
94250550|NCT02914275|322710965|FG001|Overall Study|Physician Decision|1|||
94250551|NCT02914275|322710964|FG000|Overall Study|Other|4|||
94250552|NCT02914275|322710965|FG001|Overall Study|Other|1|||
94605782|NCT01629706|324019156|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
94605783|NCT01629706|324019156|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
94605784|NCT01629706|324019156|FG000|Phase 2 Habitual|Screen Failure|6|||
94605785|NCT01629706|324019156|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
94605786|NCT01629706|324019156|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
94605787|NCT01629706|324019156|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
94605788|NCT01629706|324019156|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
94605789|NCT02537574|324019157|FG000|Overall Study|Adverse Event|1|||
94605790|NCT02537574|324019158|FG001|Overall Study|Adverse Event|3|||
94605791|NCT02537574|324019159|FG002|Overall Study|Adverse Event|2|||
94605792|NCT02537574|324019157|FG000|Overall Study|Lost to Follow-up|40|||
94605793|NCT02537574|324019158|FG001|Overall Study|Lost to Follow-up|51|||
94605794|NCT02537574|324019159|FG002|Overall Study|Lost to Follow-up|55|||
94250553|NCT02914275|322710964|FG000|Overall Study|Excluded due to invalid informed consent|3|||
94250554|NCT02914275|322710965|FG001|Overall Study|Excluded due to invalid informed consent|0|||
94250555|NCT04343872|322710969|FG000|Overall Study|Lost to Follow-up|6|||
94250556|NCT04343872|322710970|FG001|Overall Study|Lost to Follow-up|3|||
94605795|NCT02537574|324019157|FG000|Overall Study|Noncompliance with study drug|0|||
94250557|NCT02704754|322710971|FG000|Overall Study|Lost to Follow-up|1|||
94250558|NCT02704754|322710972|FG001|Overall Study|Lost to Follow-up|1|||
94357013|NCT01049360|323089571|FG001|Period 1|Withdrawal by Subject|0|||
94357014|NCT01049360|323089572|FG002|Period 1|Withdrawal by Subject|0|||
94357015|NCT01049360|323089573|FG003|Period 1|Withdrawal by Subject|0|||
94357016|NCT01049360|323089574|FG004|Period 1|Withdrawal by Subject|0|||
94357017|NCT01049360|323089575|FG005|Period 1|Withdrawal by Subject|0|||
94357018|NCT01049360|323089576|FG006|Period 1|Withdrawal by Subject|0|||
94357019|NCT01049360|323089577|FG007|Period 1|Withdrawal by Subject|0|||
94357020|NCT01049360|323089578|FG008|Period 1|Withdrawal by Subject|1|||
94357021|NCT01049360|323089579|FG009|Period 1|Withdrawal by Subject|0|||
94357022|NCT01049360|323089580|FG010|Period 1|Withdrawal by Subject|1|||
94605796|NCT02537574|324019158|FG001|Overall Study|Noncompliance with study drug|1|||
94605797|NCT02537574|324019159|FG002|Overall Study|Noncompliance with study drug|1|||
94605798|NCT02537574|324019157|FG000|Overall Study|Physician Decision|2|||
94605799|NCT02537574|324019158|FG001|Overall Study|Physician Decision|0|||
94605800|NCT02537574|324019159|FG002|Overall Study|Physician Decision|0|||
94605801|NCT02537574|324019157|FG000|Overall Study|Protocol Violation|4|||
94605802|NCT02537574|324019158|FG001|Overall Study|Protocol Violation|2|||
94605803|NCT02537574|324019159|FG002|Overall Study|Protocol Violation|3|||
94605804|NCT02537574|324019157|FG000|Overall Study|Withdrawal by Subject|37|||
94605805|NCT02537574|324019158|FG001|Overall Study|Withdrawal by Subject|27|||
94605806|NCT02537574|324019159|FG002|Overall Study|Withdrawal by Subject|29|||
94605807|NCT02537574|324019157|FG000|Overall Study|Lack of Efficacy|14|||
94605808|NCT02537574|324019158|FG001|Overall Study|Lack of Efficacy|16|||
94605809|NCT02537574|324019159|FG002|Overall Study|Lack of Efficacy|15|||
94605810|NCT02537574|324019157|FG000|Overall Study|Duplicate Patient|1|||
94605811|NCT02537574|324019158|FG001|Overall Study|Duplicate Patient|0|||
94605812|NCT02537574|324019159|FG002|Overall Study|Duplicate Patient|0|||
94605813|NCT02537574|324019157|FG000|Overall Study|Patient not Stable|0|||
94605814|NCT02537574|324019158|FG001|Overall Study|Patient not Stable|1|||
94605815|NCT02537574|324019159|FG002|Overall Study|Patient not Stable|0|||
94605816|NCT02537574|324019157|FG000|Overall Study|Incarceration|0|||
94605817|NCT02537574|324019158|FG001|Overall Study|Incarceration|1|||
94605818|NCT02537574|324019159|FG002|Overall Study|Incarceration|0|||
94605819|NCT02537574|324019157|FG000|Overall Study|Failed Naloxone Challenge|0|||
94605820|NCT02537574|324019158|FG001|Overall Study|Failed Naloxone Challenge|1|||
94605821|NCT02537574|324019159|FG002|Overall Study|Failed Naloxone Challenge|0|||
94605822|NCT02537574|324019157|FG000|Overall Study|Transportation Issues|0|||
94605823|NCT02537574|324019158|FG001|Overall Study|Transportation Issues|0|||
94605824|NCT02537574|324019159|FG002|Overall Study|Transportation Issues|1|||
94605825|NCT02537574|324019157|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
94605826|NCT02537574|324019158|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
94605827|NCT02537574|324019159|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
94605828|NCT02537574|324019157|FG000|Overall Study|Noncompliance with Protocol|0|||
94605829|NCT02537574|324019158|FG001|Overall Study|Noncompliance with Protocol|0|||
94605830|NCT02537574|324019159|FG002|Overall Study|Noncompliance with Protocol|1|||
94605831|NCT00925990|324019160|FG000|Overall Study|Adverse Event|1|||
94605832|NCT00925990|324019161|FG001|Overall Study|Adverse Event|3|||
94605833|NCT00925990|324019160|FG000|Overall Study|Withdrawal by Subject|2|||
94605834|NCT00925990|324019161|FG001|Overall Study|Withdrawal by Subject|2|||
94605835|NCT00925990|324019160|FG000|Overall Study|Lost to Follow-up|1|||
94605836|NCT00925990|324019161|FG001|Overall Study|Lost to Follow-up|3|||
94605837|NCT00925990|324019160|FG000|Overall Study|Physician Decision|1|||
94605838|NCT00925990|324019161|FG001|Overall Study|Physician Decision|1|||
94605839|NCT00925990|324019160|FG000|Overall Study|moved out of state, missed medication|0|||
94605840|NCT00925990|324019161|FG001|Overall Study|moved out of state, missed medication|2|||
94605841|NCT03370289|324019162|FG000|Overall Study|Screen Failure|1|||
94605842|NCT03370289|324019162|FG000|Overall Study|Sample Size Sufficient|4|||
94605843|NCT02140775|324019163|FG000|Overall Study|Withdrawal by Subject|30|||
94605844|NCT02140775|324019164|FG001|Overall Study|Withdrawal by Subject|7|||
94605845|NCT00364130|324019165|FG000|Intervention Period|Lost to Follow-up|4|||
94605846|NCT00364130|324019166|FG001|Intervention Period|Lost to Follow-up|3|||
94605847|NCT00364130|324019165|FG000|Intervention Period|Pregnancy|1|||
94357023|NCT01049360|323089581|FG011|Period 1|Withdrawal by Subject|0|||
94357024|NCT01049360|323089582|FG012|Period 1|Withdrawal by Subject|1|||
94605848|NCT00364130|324019166|FG001|Intervention Period|Pregnancy|0|||
94605849|NCT00364130|324019165|FG000|Intervention Period|Withdrawal by Subject|4|||
94605850|NCT00364130|324019166|FG001|Intervention Period|Withdrawal by Subject|5|||
94605851|NCT00364130|324019165|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
94605852|NCT00364130|324019166|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
94357025|NCT01049360|323089583|FG013|Period 1|Withdrawal by Subject|0|||
94357026|NCT01049360|323089584|FG014|Period 1|Withdrawal by Subject|0|||
94605853|NCT02301988|324019167|FG000|Overall Study|Withdrawal by Subject|2|||
94357027|NCT01049360|323089585|FG015|Period 1|Withdrawal by Subject|0|||
94357028|NCT01049360|323089586|FG016|Period 1|Withdrawal by Subject|0|||
94605854|NCT02301988|324019168|FG001|Overall Study|Withdrawal by Subject|1|||
94357029|NCT01049360|323089587|FG017|Period 1|Withdrawal by Subject|0|||
94357030|NCT01049360|323089588|FG018|Period 1|Withdrawal by Subject|0|||
94357031|NCT01049360|323089589|FG019|Period 1|Withdrawal by Subject|0|||
94605855|NCT02301988|324019167|FG000|Overall Study|Physician Decision|2|||
94605856|NCT02301988|324019168|FG001|Overall Study|Physician Decision|2|||
94605857|NCT02301988|324019167|FG000|Overall Study|Unknown Reason|1|||
94605858|NCT02301988|324019168|FG001|Overall Study|Unknown Reason|3|||
94605859|NCT02301988|324019167|FG000|Overall Study|Lack of Efficacy|3|||
94605860|NCT02301988|324019168|FG001|Overall Study|Lack of Efficacy|2|||
94605861|NCT02301988|324019167|FG000|Overall Study|Death|1|||
94605862|NCT02301988|324019168|FG001|Overall Study|Death|0|||
94605863|NCT02301988|324019167|FG000|Overall Study|Adverse Event|1|||
94605864|NCT02301988|324019168|FG001|Overall Study|Adverse Event|1|||
94605865|NCT05169567|324019170|FG000|Overall Study|On study treatment|116|||
94605866|NCT05169567|324019171|FG001|Overall Study|On study treatment|128|||
94605867|NCT05169567|324019170|FG000|Overall Study|Lost to Follow-up|1|||
94605868|NCT05169567|324019171|FG001|Overall Study|Lost to Follow-up|0|||
94605869|NCT05169567|324019170|FG000|Overall Study|Withdrawal by Subject|25|||
94605870|NCT05169567|324019171|FG001|Overall Study|Withdrawal by Subject|21|||
94605871|NCT05069259|324019172|FG000|Overall Study|Withdrawal by Subject|1|||
94605872|NCT05069259|324019172|FG000|Overall Study|Sponsor decision|1|||
94605873|NCT02582255|324020767|FG000|Overall Study|Protocol Violation|0|||
94605874|NCT02582255|324020768|FG001|Overall Study|Protocol Violation|3|||
94605875|NCT04854642|324020769|FG000|Overall Study|Adverse Event|1|||
94605876|NCT04854642|324020770|FG001|Overall Study|Adverse Event|2|||
94605877|NCT04854642|324020769|FG000|Overall Study|Withdrawal by Subject|0|||
94605878|NCT04854642|324020770|FG001|Overall Study|Withdrawal by Subject|1|||
94605879|NCT00622739|324020772|FG000|Overall Study|Physician Decision|1|||
94605880|NCT00622739|324020773|FG001|Overall Study|Physician Decision|0|||
94605881|NCT00622739|324020772|FG000|Overall Study|Adverse Event|1|||
94605882|NCT00622739|324020773|FG001|Overall Study|Adverse Event|2|||
94605883|NCT00622739|324020772|FG000|Overall Study|Lack of Efficacy|0|||
94605884|NCT00622739|324020773|FG001|Overall Study|Lack of Efficacy|2|||
94605885|NCT00622739|324020772|FG000|Overall Study|Withdrawal by Subject|0|||
94605886|NCT00622739|324020773|FG001|Overall Study|Withdrawal by Subject|1|||
94605887|NCT00622739|324020772|FG000|Overall Study|Lost to Follow-up|0|||
94605888|NCT00622739|324020773|FG001|Overall Study|Lost to Follow-up|1|||
94605889|NCT00084838|324020774|FG000|Overall Study|Death|1|||
94605890|NCT00084838|324020774|FG000|Overall Study|Adverse Event|2|||
94605891|NCT00084838|324020774|FG000|Overall Study|Withdrawal by Subject|1|||
94605892|NCT00084838|324020774|FG000|Overall Study|Progressive Disease|4|||
94605893|NCT00084838|324020774|FG000|Overall Study|Pt Non-Compliance|1|||
94357032|NCT01049360|323089570|FG000|Period 2|Protocol Violation|0|||
94605894|NCT00084838|324020774|FG000|Overall Study|Ineligible|4|||
94357033|NCT01049360|323089571|FG001|Period 2|Protocol Violation|0|||
94357034|NCT01049360|323089572|FG002|Period 2|Protocol Violation|0|||
94357035|NCT01049360|323089573|FG003|Period 2|Protocol Violation|1|||
94357036|NCT01049360|323089574|FG004|Period 2|Protocol Violation|0|||
94357037|NCT01049360|323089575|FG005|Period 2|Protocol Violation|0|||
94357038|NCT01049360|323089576|FG006|Period 2|Protocol Violation|0|||
94357039|NCT01049360|323089577|FG007|Period 2|Protocol Violation|0|||
94357040|NCT01049360|323089578|FG008|Period 2|Protocol Violation|0|||
94357041|NCT01049360|323089579|FG009|Period 2|Protocol Violation|0|||
94357042|NCT01049360|323089580|FG010|Period 2|Protocol Violation|0|||
94357043|NCT01049360|323089581|FG011|Period 2|Protocol Violation|0|||
94357044|NCT01049360|323089582|FG012|Period 2|Protocol Violation|0|||
94357045|NCT01049360|323089583|FG013|Period 2|Protocol Violation|0|||
94357046|NCT01049360|323089584|FG014|Period 2|Protocol Violation|1|||
94357047|NCT01049360|323089585|FG015|Period 2|Protocol Violation|1|||
94357048|NCT01049360|323089586|FG016|Period 2|Protocol Violation|0|||
94357049|NCT01049360|323089587|FG017|Period 2|Protocol Violation|0|||
94357050|NCT01049360|323089588|FG018|Period 2|Protocol Violation|0|||
94357051|NCT01049360|323089589|FG019|Period 2|Protocol Violation|0|||
94357052|NCT01049360|323089570|FG000|Period 2|Adverse Event|0|||
94357053|NCT01049360|323089571|FG001|Period 2|Adverse Event|1|||
94357054|NCT01049360|323089572|FG002|Period 2|Adverse Event|0|||
94605895|NCT00625742|324020776|FG000|Overall Study|Disease Progression|2|||
94605896|NCT00625742|324020776|FG000|Overall Study|Withdrawal by Subject|1|||
94605897|NCT00625742|324020776|FG000|Overall Study|Adverse Event|4|||
94605898|NCT00625742|324020776|FG000|Overall Study|Lost to Follow-up|4|||
94605899|NCT00625742|324020776|FG000|Overall Study|Ineligible|1|||
94605900|NCT01709578|324020777|FG000|Overall Study|Rescued and entered in long term safety|63|||
94605901|NCT01709578|324020778|FG001|Overall Study|Rescued and entered in long term safety|25|||
94605902|NCT01709578|324020779|FG002|Overall Study|Rescued and entered in long term safety|26|||
94605903|NCT01709578|324020777|FG000|Overall Study|Adverse Event|9|||
94605904|NCT01709578|324020778|FG001|Overall Study|Adverse Event|18|||
94605905|NCT01709578|324020779|FG002|Overall Study|Adverse Event|17|||
94605906|NCT01709578|324020777|FG000|Overall Study|Lack of Efficacy|5|||
94605907|NCT01709578|324020778|FG001|Overall Study|Lack of Efficacy|4|||
94605908|NCT01709578|324020779|FG002|Overall Study|Lack of Efficacy|2|||
94605909|NCT01709578|324020777|FG000|Overall Study|Poor compliance to protocol|1|||
94605910|NCT01709578|324020778|FG001|Overall Study|Poor compliance to protocol|2|||
94605911|NCT01709578|324020779|FG002|Overall Study|Poor compliance to protocol|1|||
94605912|NCT01709578|324020777|FG000|Overall Study|Other, not related to safety or efficacy|2|||
94605913|NCT01709578|324020778|FG001|Overall Study|Other, not related to safety or efficacy|7|||
94605914|NCT01709578|324020779|FG002|Overall Study|Other, not related to safety or efficacy|5|||
94605915|NCT04050371|324020780|FG000|Overall Study|Withdrawal by Subject|1|||
94605916|NCT04050371|324020781|FG001|Overall Study|Withdrawal by Subject|0|||
94605917|NCT01155219|324020785|FG000|Overall Study|Adverse Event|3|||
94605918|NCT01155219|324020786|FG001|Overall Study|Adverse Event|1|||
94605919|NCT01155219|324020785|FG000|Overall Study|non-medical reason|1|||
94605920|NCT01155219|324020786|FG001|Overall Study|non-medical reason|2|||
94605921|NCT01002482|324020788|FG000|Overall Study|Withdrawal by Subject|14|||
94605922|NCT01002482|324020789|FG001|Overall Study|Withdrawal by Subject|21|||
94605923|NCT01002482|324020788|FG000|Overall Study|Included twice|1|||
94605924|NCT01002482|324020789|FG001|Overall Study|Included twice|0|||
94605925|NCT02294773|324020790|FG000|Overall Study|Withdrawal by Subject|0|||
94605926|NCT02294773|324020791|FG001|Overall Study|Withdrawal by Subject|2|||
94605927|NCT03052764|324020792|FG000|Double-Blind Treatment Period|Adverse Event|2|||
94605928|NCT03052764|324020793|FG001|Double-Blind Treatment Period|Adverse Event|0|||
94605929|NCT03052764|324020792|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
94605930|NCT03052764|324020793|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
94605931|NCT03052764|324020792|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
94605932|NCT03052764|324020793|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
94605933|NCT03052764|324020792|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
94605934|NCT03052764|324020793|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
94605935|NCT03052764|324020792|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
94605936|NCT03052764|324020793|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
94605937|NCT00510874|324020797|FG000|Overall Study|Withdrawal by Subject|1|||
94605938|NCT00510874|324020798|FG001|Overall Study|Withdrawal by Subject|1|||
94605939|NCT00510874|324020799|FG002|Overall Study|Withdrawal by Subject|0|||
94357055|NCT01049360|323089573|FG003|Period 2|Adverse Event|0|||
94357056|NCT01049360|323089574|FG004|Period 2|Adverse Event|0|||
94357057|NCT01049360|323089575|FG005|Period 2|Adverse Event|0|||
94357058|NCT01049360|323089576|FG006|Period 2|Adverse Event|0|||
94357059|NCT01049360|323089577|FG007|Period 2|Adverse Event|0|||
94357060|NCT01049360|323089578|FG008|Period 2|Adverse Event|1|||
94605940|NCT00510874|324020800|FG003|Overall Study|Withdrawal by Subject|0|||
94357061|NCT01049360|323089579|FG009|Period 2|Adverse Event|0|||
94661469|NCT00968669|324215744|FG002|Overall Study|Pregnancy|2|||
94661470|NCT00968669|324215745|FG003|Overall Study|Pregnancy|0|||
94458893|NCT01970475|323467558|FG001|Overall Study|Adverse Event|3|||
94661471|NCT00968669|324215742|FG000|Overall Study|AE|1|||
94661472|NCT00968669|324215743|FG001|Overall Study|AE|0|||
94661473|NCT00968669|324215744|FG002|Overall Study|AE|0|||
94661474|NCT00968669|324215745|FG003|Overall Study|AE|0|||
94661475|NCT00968669|324215742|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
94661476|NCT00968669|324215743|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
94661477|NCT00968669|324215744|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
94661478|NCT00968669|324215745|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
94661479|NCT00968669|324215742|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
94661480|NCT00968669|324215743|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
94661481|NCT00968669|324215744|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
94661482|NCT00968669|324215745|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
94661483|NCT00968669|324215742|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
94661484|NCT00968669|324215743|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
94661485|NCT00968669|324215744|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
94661486|NCT00968669|324215745|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
94661487|NCT00968669|324215742|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
94661488|NCT00968669|324215743|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
94661489|NCT00968669|324215744|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
94661490|NCT00968669|324215745|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
94661491|NCT00968669|324215742|FG000|Overall Study|EARLY WITHDRAWAL|0|||
94661492|NCT00968669|324215743|FG001|Overall Study|EARLY WITHDRAWAL|1|||
94661493|NCT00968669|324215744|FG002|Overall Study|EARLY WITHDRAWAL|0|||
94661494|NCT00968669|324215745|FG003|Overall Study|EARLY WITHDRAWAL|0|||
94661495|NCT00968669|324215742|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
94661496|NCT00968669|324215743|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
94661497|NCT00968669|324215744|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
94661498|NCT00968669|324215745|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
94458894|NCT01970475|323467557|FG000|Overall Study|Lost to Follow-up|2|||
94605941|NCT00510874|324020801|FG004|Overall Study|Withdrawal by Subject|3|||
94605942|NCT00510874|324020802|FG005|Overall Study|Withdrawal by Subject|0|||
94605943|NCT00510874|324020803|FG006|Overall Study|Withdrawal by Subject|0|||
94605944|NCT00510874|324020797|FG000|Overall Study|Lost to Follow-up|2|||
94605945|NCT00510874|324020798|FG001|Overall Study|Lost to Follow-up|3|||
94605946|NCT00510874|324020799|FG002|Overall Study|Lost to Follow-up|1|||
94605947|NCT00510874|324020800|FG003|Overall Study|Lost to Follow-up|3|||
94605948|NCT00510874|324020801|FG004|Overall Study|Lost to Follow-up|4|||
94605949|NCT00510874|324020802|FG005|Overall Study|Lost to Follow-up|0|||
94605950|NCT00510874|324020803|FG006|Overall Study|Lost to Follow-up|1|||
94605951|NCT03350984|324020804|FG000|Overall Study|Death|1|||
94605952|NCT03350984|324020805|FG001|Overall Study|Death|0|||
94605953|NCT03350984|324020804|FG000|Overall Study|Lost to Follow-up|5|||
94605954|NCT03350984|324020805|FG001|Overall Study|Lost to Follow-up|6|||
94605955|NCT03350984|324020804|FG000|Overall Study|Protocol Violation|1|||
94605956|NCT03350984|324020805|FG001|Overall Study|Protocol Violation|2|||
94605957|NCT03350984|324020804|FG000|Overall Study|Physician Decision|1|||
94605958|NCT03350984|324020805|FG001|Overall Study|Physician Decision|0|||
94605959|NCT04963231|324020807|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
94605960|NCT04963231|324020808|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
94605961|NCT04963231|324020809|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
94605962|NCT04963231|324020807|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
94605963|NCT04963231|324020808|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
94605964|NCT04963231|324020809|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
94605965|NCT04963231|324020807|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
94605966|NCT04963231|324020808|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
94605967|NCT04963231|324020809|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
94605968|NCT04963231|324020807|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
94605969|NCT04963231|324020808|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
94605970|NCT04963231|324020809|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
94605971|NCT04963231|324020807|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
94605972|NCT04963231|324020808|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
94605973|NCT04963231|324020809|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
94605974|NCT04963231|324020807|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
94605975|NCT04963231|324020808|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
94605976|NCT04963231|324020809|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
94605977|NCT04963231|324020807|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
94250559|NCT02704754|322710971|FG000|Overall Study|Lack of Efficacy|1|||
94250560|NCT02704754|322710972|FG001|Overall Study|Lack of Efficacy|0|||
94250561|NCT02704754|322710971|FG000|Overall Study|Withdrawal by Subject|1|||
94250562|NCT02704754|322710972|FG001|Overall Study|Withdrawal by Subject|0|||
94250563|NCT03730480|322710973|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
94250564|NCT01119105|322710979|FG000|Overall Study|Withdrawal by Subject|1|||
94250565|NCT01119105|322710980|FG001|Overall Study|Withdrawal by Subject|1|||
94250566|NCT01119105|322710981|FG002|Overall Study|Withdrawal by Subject|1|||
94250567|NCT01119105|322710979|FG000|Overall Study|Lost to Follow-up|0|||
94250568|NCT01119105|322710980|FG001|Overall Study|Lost to Follow-up|2|||
94250569|NCT01119105|322710981|FG002|Overall Study|Lost to Follow-up|5|||
94250570|NCT01119105|322710979|FG000|Overall Study|Adverse Event|1|||
94250571|NCT01119105|322710980|FG001|Overall Study|Adverse Event|0|||
94250572|NCT01119105|322710981|FG002|Overall Study|Adverse Event|1|||
94250573|NCT01119105|322710979|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
94250574|NCT01119105|322710980|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
94250575|NCT01119105|322710981|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
94605978|NCT04963231|324020808|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
94605979|NCT04963231|324020809|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
94605980|NCT00054717|324020810|FG000|Overall Study|Randomized but not treated|2|||
94605981|NCT00054717|324020811|FG001|Overall Study|Randomized but not treated|8|||
94605982|NCT00054717|324020810|FG000|Overall Study|Adverse Event|70|||
94605983|NCT00054717|324020811|FG001|Overall Study|Adverse Event|22|||
94605984|NCT00054717|324020810|FG000|Overall Study|Protocol Violation|18|||
94605985|NCT00054717|324020811|FG001|Overall Study|Protocol Violation|19|||
94605986|NCT00054717|324020810|FG000|Overall Study|Lost to Follow-up|23|||
94605987|NCT00054717|324020811|FG001|Overall Study|Lost to Follow-up|13|||
94605988|NCT00054717|324020810|FG000|Overall Study|Withdrawal by Subject|32|||
94605989|NCT00054717|324020811|FG001|Overall Study|Withdrawal by Subject|20|||
94605990|NCT00054717|324020810|FG000|Overall Study|Other reason not defined above|117|||
94605991|NCT00054717|324020811|FG001|Overall Study|Other reason not defined above|217|||
94605992|NCT02806973|324020812|FG000|Period 1|Withdrawal by Subject|0|||
94605993|NCT02806973|324020813|FG001|Period 1|Withdrawal by Subject|2|||
94605994|NCT02806973|324020814|FG002|Period 1|Withdrawal by Subject|1|||
94605995|NCT02806973|324020815|FG003|Period 1|Withdrawal by Subject|1|||
94605996|NCT02806973|324020812|FG000|Period 1|Adverse Event|0|||
94605997|NCT02806973|324020813|FG001|Period 1|Adverse Event|0|||
94605998|NCT02806973|324020814|FG002|Period 1|Adverse Event|0|||
94605999|NCT02806973|324020815|FG003|Period 1|Adverse Event|1|||
94606000|NCT02806973|324020812|FG000|Period 3|Withdrawal by Subject|0|||
94606001|NCT02806973|324020813|FG001|Period 3|Withdrawal by Subject|0|||
94606002|NCT02806973|324020814|FG002|Period 3|Withdrawal by Subject|0|||
94606003|NCT02806973|324020815|FG003|Period 3|Withdrawal by Subject|3|||
94606004|NCT02806973|324020812|FG000|Period 3|Adverse Event|0|||
94606005|NCT02806973|324020813|FG001|Period 3|Adverse Event|0|||
94606006|NCT02806973|324020814|FG002|Period 3|Adverse Event|1|||
94606007|NCT02806973|324020815|FG003|Period 3|Adverse Event|0|||
94606008|NCT04209426|324020816|FG000|Overall Study|Lost to Follow-up|3|||
94606009|NCT04209426|324020817|FG001|Overall Study|Lost to Follow-up|2|||
94250576|NCT01119105|322710979|FG000|Overall Study|Other|1|||
94250577|NCT01119105|322710980|FG001|Overall Study|Other|1|||
94250578|NCT01119105|322710981|FG002|Overall Study|Other|0|||
94250579|NCT00581555|322710982|FG000|Overall Study|Adverse Event|4|||
94250580|NCT00581555|322710983|FG001|Overall Study|Adverse Event|3|||
94250581|NCT00581555|322710982|FG000|Overall Study|Physician Decision|3|||
94250582|NCT00581555|322710983|FG001|Overall Study|Physician Decision|2|||
94250583|NCT00581555|322710982|FG000|Overall Study|Withdrawal by Subject|18|||
94250584|NCT00581555|322710983|FG001|Overall Study|Withdrawal by Subject|9|||
94250585|NCT00581555|322710982|FG000|Overall Study|Lost to Follow-up|2|||
94250586|NCT00581555|322710983|FG001|Overall Study|Lost to Follow-up|2|||
94250587|NCT00581555|322710982|FG000|Overall Study|Other reasons|16|||
94250588|NCT00581555|322710983|FG001|Overall Study|Other reasons|4|||
94250589|NCT00007345|322710984|FG000|Overall Study|Refused further treatment|0|||
94250590|NCT00007345|322710985|FG001|Overall Study|Refused further treatment|7|||
94250591|NCT00007345|322710984|FG000|Overall Study|Switched to alternative treatment|0|||
94250592|NCT00007345|322710985|FG001|Overall Study|Switched to alternative treatment|3|||
94250593|NCT00007345|322710984|FG000|Overall Study|Intercurrent illness|1|||
94250594|NCT00007345|322710985|FG001|Overall Study|Intercurrent illness|0|||
94250595|NCT00007345|322710984|FG000|Overall Study|Death on study|1|||
94250596|NCT00007345|322710985|FG001|Overall Study|Death on study|1|||
94250597|NCT02245737|322710986|FG000|Overall Study|Adverse Event|23|||
94250598|NCT02245737|322710987|FG001|Overall Study|Adverse Event|26|||
94250599|NCT02245737|322710988|FG002|Overall Study|Adverse Event|33|||
94250600|NCT02245737|322710986|FG000|Overall Study|Condition Worsened|9|||
94250601|NCT02245737|322710987|FG001|Overall Study|Condition Worsened|10|||
94250602|NCT02245737|322710988|FG002|Overall Study|Condition Worsened|9|||
94250603|NCT02245737|322710986|FG000|Overall Study|Death|2|||
94250604|NCT02245737|322710987|FG001|Overall Study|Death|4|||
94250605|NCT02245737|322710988|FG002|Overall Study|Death|4|||
94250606|NCT02245737|322710986|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
94250607|NCT02245737|322710987|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
94250608|NCT02245737|322710988|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
94250609|NCT02245737|322710986|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
94250610|NCT02245737|322710987|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
94250611|NCT02245737|322710988|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
94250612|NCT02245737|322710986|FG000|Overall Study|Lost to Follow-up|2|||
94250613|NCT02245737|322710987|FG001|Overall Study|Lost to Follow-up|5|||
94458895|NCT01970475|323467558|FG001|Overall Study|Lost to Follow-up|2|||
94606010|NCT00427960|324020821|FG000|Overall Study|Adverse Event|2|||
94606011|NCT00427960|324020822|FG001|Overall Study|Adverse Event|0|||
94606012|NCT00427960|324020821|FG000|Overall Study|Withdrawal by Subject|0|||
94606013|NCT00427960|324020822|FG001|Overall Study|Withdrawal by Subject|3|||
94606014|NCT00427960|324020821|FG000|Overall Study|Other|0|||
94606015|NCT00427960|324020822|FG001|Overall Study|Other|1|||
94606016|NCT01751802|324020825|FG000|Overall Study|Adverse Event|4|||
94661499|NCT00968669|324215742|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
94357062|NCT01049360|323089580|FG010|Period 2|Adverse Event|0|||
94357063|NCT01049360|323089581|FG011|Period 2|Adverse Event|0|||
94357064|NCT01049360|323089582|FG012|Period 2|Adverse Event|0|||
94357065|NCT01049360|323089583|FG013|Period 2|Adverse Event|0|||
94357066|NCT01049360|323089584|FG014|Period 2|Adverse Event|0|||
94357067|NCT01049360|323089585|FG015|Period 2|Adverse Event|0|||
94357068|NCT01049360|323089586|FG016|Period 2|Adverse Event|0|||
94357069|NCT01049360|323089587|FG017|Period 2|Adverse Event|0|||
94357070|NCT01049360|323089588|FG018|Period 2|Adverse Event|0|||
94357071|NCT01049360|323089589|FG019|Period 2|Adverse Event|1|||
94357072|NCT01049360|323089570|FG000|Period 2|Withdrawal by Subject|0|||
94357073|NCT01049360|323089571|FG001|Period 2|Withdrawal by Subject|0|||
94357074|NCT01049360|323089572|FG002|Period 2|Withdrawal by Subject|0|||
94357075|NCT01049360|323089573|FG003|Period 2|Withdrawal by Subject|1|||
94357076|NCT01049360|323089574|FG004|Period 2|Withdrawal by Subject|0|||
94357077|NCT01049360|323089575|FG005|Period 2|Withdrawal by Subject|0|||
94250614|NCT02245737|322710988|FG002|Overall Study|Lost to Follow-up|4|||
94250615|NCT02245737|322710986|FG000|Overall Study|Other-determined by Investigator|9|||
94250616|NCT02245737|322710987|FG001|Overall Study|Other-determined by Investigator|10|||
94250617|NCT02245737|322710988|FG002|Overall Study|Other-determined by Investigator|10|||
94250618|NCT02245737|322710986|FG000|Overall Study|Physician Decision|6|||
94250619|NCT02245737|322710987|FG001|Overall Study|Physician Decision|3|||
94250620|NCT02245737|322710988|FG002|Overall Study|Physician Decision|6|||
94250621|NCT02245737|322710986|FG000|Overall Study|Protocol Violation|3|||
94250622|NCT02245737|322710987|FG001|Overall Study|Protocol Violation|2|||
94250623|NCT02245737|322710988|FG002|Overall Study|Protocol Violation|3|||
94357078|NCT01049360|323089576|FG006|Period 2|Withdrawal by Subject|0|||
94357079|NCT01049360|323089577|FG007|Period 2|Withdrawal by Subject|0|||
94357080|NCT01049360|323089578|FG008|Period 2|Withdrawal by Subject|0|||
94357081|NCT01049360|323089579|FG009|Period 2|Withdrawal by Subject|0|||
94357082|NCT01049360|323089580|FG010|Period 2|Withdrawal by Subject|0|||
94357083|NCT01049360|323089581|FG011|Period 2|Withdrawal by Subject|0|||
94357084|NCT01049360|323089582|FG012|Period 2|Withdrawal by Subject|0|||
94357085|NCT01049360|323089583|FG013|Period 2|Withdrawal by Subject|0|||
94357086|NCT01049360|323089584|FG014|Period 2|Withdrawal by Subject|1|||
94357087|NCT01049360|323089585|FG015|Period 2|Withdrawal by Subject|0|||
94357088|NCT01049360|323089586|FG016|Period 2|Withdrawal by Subject|0|||
94357089|NCT01049360|323089587|FG017|Period 2|Withdrawal by Subject|0|||
94357090|NCT01049360|323089588|FG018|Period 2|Withdrawal by Subject|0|||
94606017|NCT01751802|324020826|FG001|Overall Study|Adverse Event|2|||
94606018|NCT00589784|324020830|FG000|Overall Study|Withdrawal by Subject|0|||
94606019|NCT00589784|324020831|FG001|Overall Study|Withdrawal by Subject|6|||
94606020|NCT00589784|324020830|FG000|Overall Study|Patient inevaluable|1|||
94606021|NCT00589784|324020831|FG001|Overall Study|Patient inevaluable|0|||
94606022|NCT00589784|324020830|FG000|Overall Study|Adverse Event|0|||
94606023|NCT00589784|324020831|FG001|Overall Study|Adverse Event|4|||
94606024|NCT00287079|324020833|FG000|Overall Study|Qualifying relapse|12|||
94606025|NCT00287079|324020834|FG001|Overall Study|Qualifying relapse|1|||
94606026|NCT00287079|324020833|FG000|Overall Study|Non-qualifying relapse|1|||
94606027|NCT00287079|324020834|FG001|Overall Study|Non-qualifying relapse|0|||
94606028|NCT00287079|324020833|FG000|Overall Study|Adverse Event|5|||
94606029|NCT00287079|324020834|FG001|Overall Study|Adverse Event|0|||
94606030|NCT00287079|324020833|FG000|Overall Study|Protocol Violation|1|||
94606031|NCT00287079|324020834|FG001|Overall Study|Protocol Violation|0|||
94606032|NCT00287079|324020833|FG000|Overall Study|Other|3|||
94606033|NCT00287079|324020834|FG001|Overall Study|Other|0|||
94606034|NCT00608543|324020835|FG000|Overall Study|Adverse Event|4|||
94606035|NCT05128773|324020838|FG000|Overall Study|Sponsor decision to terminate study|3|||
94606036|NCT02545075|324020841|FG000|Randomization|Lost to Follow-up|0|||
94606037|NCT02545075|324020842|FG001|Randomization|Lost to Follow-up|1|||
94606038|NCT02545075|324020841|FG000|Randomization|Withdrawal by Subject|0|||
94606039|NCT02545075|324020842|FG001|Randomization|Withdrawal by Subject|6|||
94250624|NCT02245737|322710986|FG000|Overall Study|Withdrawal by Subject|40|||
94250625|NCT02245737|322710987|FG001|Overall Study|Withdrawal by Subject|41|||
94357091|NCT01049360|323089589|FG019|Period 2|Withdrawal by Subject|1|||
94357092|NCT01049360|323089570|FG000|Period 2|Lack of Efficacy|0|||
94357093|NCT01049360|323089571|FG001|Period 2|Lack of Efficacy|0|||
94357094|NCT01049360|323089572|FG002|Period 2|Lack of Efficacy|0|||
94357095|NCT01049360|323089573|FG003|Period 2|Lack of Efficacy|0|||
94357096|NCT01049360|323089574|FG004|Period 2|Lack of Efficacy|0|||
94606040|NCT02545075|324020841|FG000|Treatment|Disease progression|71|||
94606041|NCT02545075|324020842|FG001|Treatment|Disease progression|32|||
94606042|NCT02545075|324020841|FG000|Treatment|Participant dicontinued study treatment|7|||
94606043|NCT02545075|324020842|FG001|Treatment|Participant dicontinued study treatment|9|||
94606044|NCT02545075|324020841|FG000|Treatment|Withdrawal by Subject|1|||
94357097|NCT01049360|323089575|FG005|Period 2|Lack of Efficacy|1|||
94357098|NCT01049360|323089576|FG006|Period 2|Lack of Efficacy|0|||
94357099|NCT01049360|323089577|FG007|Period 2|Lack of Efficacy|0|||
94357100|NCT01049360|323089578|FG008|Period 2|Lack of Efficacy|0|||
94357101|NCT01049360|323089579|FG009|Period 2|Lack of Efficacy|0|||
94606045|NCT02545075|324020842|FG001|Treatment|Withdrawal by Subject|0|||
94250626|NCT02245737|322710988|FG002|Overall Study|Withdrawal by Subject|44|||
94250627|NCT02245737|322710986|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
94250628|NCT02245737|322710987|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
94250629|NCT02245737|322710988|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
94250630|NCT02245737|322710986|FG000|Overall Study|Sponsor Decision|445|||
94250631|NCT02245737|322710987|FG001|Overall Study|Sponsor Decision|430|||
94250632|NCT02245737|322710988|FG002|Overall Study|Sponsor Decision|432|||
94250633|NCT01171807|322710989|FG000|Overall Study|Treatment failure|2|||
94250634|NCT01171807|322710990|FG001|Overall Study|Treatment failure|4|||
94250635|NCT01171807|322710989|FG000|Overall Study|Non compliance|1|||
94250636|NCT01171807|322710990|FG001|Overall Study|Non compliance|0|||
94250637|NCT01171807|322710989|FG000|Overall Study|Lost to Follow-up|3|||
94250638|NCT01171807|322710990|FG001|Overall Study|Lost to Follow-up|0|||
94250639|NCT04410523|322710991|FG000|Overall Study|Study terminated by sponsor|1|||
94250640|NCT04410523|322710992|FG001|Overall Study|Study terminated by sponsor|3|||
94250641|NCT04410523|322710993|FG002|Overall Study|Study terminated by sponsor|2|||
94250642|NCT04410523|322710994|FG003|Overall Study|Study terminated by sponsor|6|||
94250643|NCT04410523|322710995|FG004|Overall Study|Study terminated by sponsor|3|||
94250644|NCT04410523|322710996|FG005|Overall Study|Study terminated by sponsor|4|||
94250645|NCT04410523|322710991|FG000|Overall Study|Adverse Event|1|||
94250646|NCT04410523|322710992|FG001|Overall Study|Adverse Event|0|||
94250647|NCT04410523|322710993|FG002|Overall Study|Adverse Event|0|||
94250648|NCT04410523|322710994|FG003|Overall Study|Adverse Event|0|||
94250649|NCT04410523|322710995|FG004|Overall Study|Adverse Event|0|||
94250650|NCT04410523|322710996|FG005|Overall Study|Adverse Event|2|||
94250651|NCT04410523|322710991|FG000|Overall Study|Lost to Follow-up|0|||
94250652|NCT04410523|322710992|FG001|Overall Study|Lost to Follow-up|1|||
94250653|NCT04410523|322710993|FG002|Overall Study|Lost to Follow-up|0|||
94250654|NCT04410523|322710994|FG003|Overall Study|Lost to Follow-up|0|||
94250655|NCT04410523|322710995|FG004|Overall Study|Lost to Follow-up|0|||
94250656|NCT04410523|322710996|FG005|Overall Study|Lost to Follow-up|0|||
94250657|NCT04410523|322710991|FG000|Overall Study|Physician Decision|0|||
94250658|NCT04410523|322710992|FG001|Overall Study|Physician Decision|1|||
94250659|NCT04410523|322710993|FG002|Overall Study|Physician Decision|0|||
94250660|NCT04410523|322710994|FG003|Overall Study|Physician Decision|0|||
94250661|NCT04410523|322710995|FG004|Overall Study|Physician Decision|0|||
94250662|NCT04410523|322710996|FG005|Overall Study|Physician Decision|0|||
94250663|NCT04410523|322710991|FG000|Overall Study|Pregnancy|0|||
94250664|NCT04410523|322710992|FG001|Overall Study|Pregnancy|0|||
94250665|NCT04410523|322710993|FG002|Overall Study|Pregnancy|0|||
94250666|NCT04410523|322710994|FG003|Overall Study|Pregnancy|0|||
94250667|NCT04410523|322710995|FG004|Overall Study|Pregnancy|0|||
94250668|NCT04410523|322710996|FG005|Overall Study|Pregnancy|1|||
94250669|NCT04410523|322710991|FG000|Overall Study|Protocol deviation|0|||
94250670|NCT04410523|322710992|FG001|Overall Study|Protocol deviation|0|||
94250671|NCT04410523|322710993|FG002|Overall Study|Protocol deviation|0|||
94250672|NCT04410523|322710994|FG003|Overall Study|Protocol deviation|0|||
94250673|NCT04410523|322710995|FG004|Overall Study|Protocol deviation|0|||
94250674|NCT04410523|322710996|FG005|Overall Study|Protocol deviation|2|||
94250675|NCT04410523|322710991|FG000|Overall Study|Subject decision|2|||
94250676|NCT04410523|322710992|FG001|Overall Study|Subject decision|0|||
94250677|NCT04410523|322710993|FG002|Overall Study|Subject decision|0|||
94250678|NCT04410523|322710994|FG003|Overall Study|Subject decision|1|||
94250679|NCT04410523|322710995|FG004|Overall Study|Subject decision|0|||
94250680|NCT04410523|322710996|FG005|Overall Study|Subject decision|1|||
94250681|NCT01901341|322710997|FG000|Overall Study|Adverse Event|4|||
94250682|NCT01901341|322710998|FG001|Overall Study|Adverse Event|2|||
94250683|NCT01901341|322710997|FG000|Overall Study|Lack of Efficacy|0|||
94250684|NCT01901341|322710998|FG001|Overall Study|Lack of Efficacy|2|||
94250685|NCT01901341|322710997|FG000|Overall Study|Lost to Follow-up|0|||
94250686|NCT01901341|322710998|FG001|Overall Study|Lost to Follow-up|1|||
94250687|NCT01901341|322710997|FG000|Overall Study|Protocol Violation|2|||
94250688|NCT01901341|322710998|FG001|Overall Study|Protocol Violation|0|||
94250689|NCT01901341|322710997|FG000|Overall Study|Study Terminated by Sponsor|13|||
94250690|NCT01901341|322710998|FG001|Overall Study|Study Terminated by Sponsor|15|||
94250691|NCT01901341|322710997|FG000|Overall Study|Withdrawal by Subject|1|||
94250692|NCT01901341|322710998|FG001|Overall Study|Withdrawal by Subject|1|||
94250693|NCT03212989|322710999|FG000|Overall Study|Physician Decision|8|||
94250694|NCT01621568|322711000|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
94250695|NCT01621568|322711001|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
94250696|NCT01621568|322711000|FG000|Week 5-6 No Treatment|Death|1|||
94250697|NCT01621568|322711001|FG001|Week 5-6 No Treatment|Death|0|||
94250698|NCT00252577|322711005|FG000|Overall Study|Lost to Follow-up|20|||
94250699|NCT01435616|322711009|FG000|Overall Study|Adverse Event|39|||
94250700|NCT01435616|322711010|FG001|Overall Study|Adverse Event|21|||
94250701|NCT01435616|322711009|FG000|Overall Study|Death|7|||
94250702|NCT01435616|322711010|FG001|Overall Study|Death|2|||
94250703|NCT01435616|322711009|FG000|Overall Study|Lost to Follow-up|22|||
94250704|NCT01435616|322711010|FG001|Overall Study|Lost to Follow-up|13|||
94606046|NCT02545075|324020841|FG000|Treatment|Adverse event not related to study drug|1|||
94606047|NCT02545075|324020842|FG001|Treatment|Adverse event not related to study drug|0|||
94606048|NCT02545075|324020841|FG000|Treatment|Death|1|||
94606049|NCT02545075|324020842|FG001|Treatment|Death|0|||
94606050|NCT02545075|324020841|FG000|Treatment|Participant drug toxicity|1|||
94606051|NCT02545075|324020842|FG001|Treatment|Participant drug toxicity|0|||
94606052|NCT02545075|324020841|FG000|Treatment|Completed treatment|40|||
94606053|NCT02545075|324020842|FG001|Treatment|Completed treatment|12|||
94606054|NCT00736879|324020843|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
94606055|NCT00736879|324020844|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
94606056|NCT00736879|324020845|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
94458896|NCT01970475|323467557|FG000|Overall Study|Protocol Violation|1|||
94606057|NCT00736879|324020846|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
94357102|NCT01049360|323089580|FG010|Period 2|Lack of Efficacy|0|||
94357103|NCT01049360|323089581|FG011|Period 2|Lack of Efficacy|0|||
94357104|NCT01049360|323089582|FG012|Period 2|Lack of Efficacy|0|||
94357105|NCT01049360|323089583|FG013|Period 2|Lack of Efficacy|0|||
94357106|NCT01049360|323089584|FG014|Period 2|Lack of Efficacy|0|||
94357107|NCT01049360|323089585|FG015|Period 2|Lack of Efficacy|0|||
94357108|NCT01049360|323089586|FG016|Period 2|Lack of Efficacy|0|||
94357109|NCT01049360|323089587|FG017|Period 2|Lack of Efficacy|0|||
94357110|NCT01049360|323089588|FG018|Period 2|Lack of Efficacy|0|||
94357111|NCT01049360|323089589|FG019|Period 2|Lack of Efficacy|0|||
94458897|NCT01970475|323467558|FG001|Overall Study|Protocol Violation|0|||
94606058|NCT00736879|324020843|FG000|Double Blind Treatment Period|Adverse Event|0|||
94357112|NCT01049360|323089570|FG000|Period 4|Protocol Violation|0|||
94357113|NCT01049360|323089571|FG001|Period 4|Protocol Violation|0|||
94357114|NCT01049360|323089572|FG002|Period 4|Protocol Violation|0|||
94458898|NCT02640404|323467560|FG000|Overall Study|Protocol Violation|1|||
94606059|NCT00736879|324020844|FG001|Double Blind Treatment Period|Adverse Event|1|||
94606060|NCT00736879|324020845|FG002|Double Blind Treatment Period|Adverse Event|1|||
94606061|NCT00736879|324020846|FG003|Double Blind Treatment Period|Adverse Event|0|||
94606062|NCT00736879|324020843|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
94606063|NCT00736879|324020844|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
94606064|NCT00736879|324020845|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
94606065|NCT00736879|324020846|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
94606066|NCT00736879|324020843|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
94606067|NCT00736879|324020844|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
94606068|NCT00736879|324020845|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
94606069|NCT00736879|324020846|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
94606070|NCT00736879|324020843|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
94606071|NCT00736879|324020844|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
94606072|NCT00736879|324020845|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
94606073|NCT00736879|324020846|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
94606074|NCT00736879|324020843|FG000|Double Blind Treatment Period|No longer met criteria|0|||
94606075|NCT00736879|324020844|FG001|Double Blind Treatment Period|No longer met criteria|1|||
94606076|NCT00736879|324020845|FG002|Double Blind Treatment Period|No longer met criteria|0|||
94606077|NCT00736879|324020846|FG003|Double Blind Treatment Period|No longer met criteria|0|||
94606078|NCT00736879|324020843|FG000|Double Blind Treatment Period|non-specified|0|||
94606079|NCT00736879|324020844|FG001|Double Blind Treatment Period|non-specified|1|||
94606080|NCT00736879|324020845|FG002|Double Blind Treatment Period|non-specified|0|||
94606081|NCT00736879|324020846|FG003|Double Blind Treatment Period|non-specified|0|||
94606082|NCT00736879|324020843|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
94606083|NCT00736879|324020844|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
94606084|NCT00736879|324020845|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
94606085|NCT00736879|324020846|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
94606086|NCT00736879|324020843|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
94606087|NCT00736879|324020844|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
94606088|NCT00736879|324020845|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
94606089|NCT00736879|324020846|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
94606090|NCT00735254|324020847|FG000|Overall Study|Protocol Violation|1|||
94606091|NCT00735254|324020848|FG001|Overall Study|Protocol Violation|1|||
94606092|NCT00735254|324020849|FG002|Overall Study|Protocol Violation|1|||
94606093|NCT00735254|324020850|FG003|Overall Study|Protocol Violation|0|||
94606094|NCT02663687|324020852|FG000|Overall Study|Adverse Event|1|||
94606095|NCT02663687|324020853|FG001|Overall Study|Adverse Event|0|||
94606096|NCT02663687|324020854|FG002|Overall Study|Adverse Event|0|||
94606097|NCT02663687|324020855|FG003|Overall Study|Adverse Event|0|||
94606098|NCT02663687|324020856|FG004|Overall Study|Adverse Event|0|||
94606099|NCT02663687|324020852|FG000|Overall Study|Other|1|||
94606100|NCT02663687|324020853|FG001|Overall Study|Other|0|||
94606101|NCT02663687|324020854|FG002|Overall Study|Other|1|||
94606102|NCT02663687|324020855|FG003|Overall Study|Other|0|||
94606103|NCT02663687|324020856|FG004|Overall Study|Other|0|||
94606104|NCT00751621|324020857|FG000|Overall Study|Adverse Event|1|||
94606105|NCT00751621|324020857|FG000|Overall Study|Withdrawal by Subject|1|||
94606106|NCT00751621|324020857|FG000|Overall Study|Subject moved to another country|1|||
94606107|NCT00751621|324020857|FG000|Overall Study|Poor adherence to asthma treatment|1|||
94606108|NCT00566501|324020861|FG000|Overall Study|Adverse Event|68|||
94606109|NCT00566501|324020862|FG001|Overall Study|Adverse Event|59|||
94606110|NCT00566501|324020861|FG000|Overall Study|Medication Non-compliance|5|||
94357115|NCT01049360|323089573|FG003|Period 4|Protocol Violation|0|||
94357116|NCT01049360|323089574|FG004|Period 4|Protocol Violation|0|||
94357117|NCT01049360|323089575|FG005|Period 4|Protocol Violation|0|||
94606111|NCT00566501|324020862|FG001|Overall Study|Medication Non-compliance|0|||
94606112|NCT00566501|324020861|FG000|Overall Study|Protocol Violation|2|||
94606113|NCT00566501|324020862|FG001|Overall Study|Protocol Violation|2|||
94357118|NCT01049360|323089576|FG006|Period 4|Protocol Violation|0|||
94357119|NCT01049360|323089577|FG007|Period 4|Protocol Violation|0|||
94357120|NCT01049360|323089578|FG008|Period 4|Protocol Violation|0|||
94357121|NCT01049360|323089579|FG009|Period 4|Protocol Violation|0|||
94357122|NCT01049360|323089580|FG010|Period 4|Protocol Violation|0|||
94357123|NCT01049360|323089581|FG011|Period 4|Protocol Violation|0|||
94357124|NCT01049360|323089582|FG012|Period 4|Protocol Violation|0|||
94357125|NCT01049360|323089583|FG013|Period 4|Protocol Violation|0|||
94357126|NCT01049360|323089584|FG014|Period 4|Protocol Violation|0|||
94357127|NCT01049360|323089585|FG015|Period 4|Protocol Violation|0|||
94357128|NCT01049360|323089586|FG016|Period 4|Protocol Violation|0|||
94357129|NCT01049360|323089587|FG017|Period 4|Protocol Violation|1|||
94357130|NCT01049360|323089588|FG018|Period 4|Protocol Violation|0|||
94357131|NCT01049360|323089589|FG019|Period 4|Protocol Violation|0|||
94357132|NCT01049360|323089570|FG000|Period 4|Withdrawal by Subject|0|||
94357133|NCT01049360|323089571|FG001|Period 4|Withdrawal by Subject|0|||
94357134|NCT01049360|323089572|FG002|Period 4|Withdrawal by Subject|0|||
94357135|NCT01049360|323089573|FG003|Period 4|Withdrawal by Subject|1|||
94357136|NCT01049360|323089574|FG004|Period 4|Withdrawal by Subject|0|||
94357137|NCT01049360|323089575|FG005|Period 4|Withdrawal by Subject|0|||
94357138|NCT01049360|323089576|FG006|Period 4|Withdrawal by Subject|0|||
94357139|NCT01049360|323089577|FG007|Period 4|Withdrawal by Subject|0|||
94357140|NCT01049360|323089578|FG008|Period 4|Withdrawal by Subject|0|||
94357141|NCT01049360|323089579|FG009|Period 4|Withdrawal by Subject|0|||
94357142|NCT01049360|323089580|FG010|Period 4|Withdrawal by Subject|0|||
94357143|NCT01049360|323089581|FG011|Period 4|Withdrawal by Subject|0|||
94357144|NCT01049360|323089582|FG012|Period 4|Withdrawal by Subject|0|||
94357145|NCT01049360|323089583|FG013|Period 4|Withdrawal by Subject|0|||
94357146|NCT01049360|323089584|FG014|Period 4|Withdrawal by Subject|0|||
94357147|NCT01049360|323089585|FG015|Period 4|Withdrawal by Subject|0|||
94357148|NCT01049360|323089586|FG016|Period 4|Withdrawal by Subject|0|||
94357149|NCT01049360|323089587|FG017|Period 4|Withdrawal by Subject|0|||
94357150|NCT01049360|323089588|FG018|Period 4|Withdrawal by Subject|0|||
94357151|NCT01049360|323089589|FG019|Period 4|Withdrawal by Subject|0|||
94357152|NCT00429026|323089590|FG000|Overall Study|Inevaluable for response.|40|||
94357153|NCT00920582|323089593|FG000|Overall Study|Lost to Follow-up|5|||
94357154|NCT00920582|323089594|FG001|Overall Study|Lost to Follow-up|1|||
94357155|NCT00920582|323089595|FG002|Overall Study|Lost to Follow-up|2|||
94357156|NCT00920582|323089596|FG003|Overall Study|Lost to Follow-up|0|||
94357157|NCT00920582|323089593|FG000|Overall Study|Withdrawal by Subject|5|||
94357158|NCT00920582|323089594|FG001|Overall Study|Withdrawal by Subject|4|||
94357159|NCT00920582|323089595|FG002|Overall Study|Withdrawal by Subject|6|||
94250705|NCT01435616|322711009|FG000|Overall Study|Protocol Violation|16|||
94250706|NCT01435616|322711010|FG001|Overall Study|Protocol Violation|13|||
94250707|NCT01435616|322711009|FG000|Overall Study|Withdrawal by Subject|66|||
94250708|NCT01435616|322711010|FG001|Overall Study|Withdrawal by Subject|24|||
94250709|NCT01435616|322711009|FG000|Overall Study|Physician Decision|20|||
94250710|NCT01435616|322711010|FG001|Overall Study|Physician Decision|7|||
94250711|NCT01435616|322711009|FG000|Overall Study|Sponsor Decision|1|||
94250712|NCT01435616|322711010|FG001|Overall Study|Sponsor Decision|0|||
94250713|NCT02601300|322711011|FG000|Induction Phase|Lack of Efficacy|2|||
94250714|NCT02601300|322711011|FG000|Induction Phase|Protocol Violation|1|||
94250715|NCT02601300|322711011|FG000|Extension Phase|Withdrawal by Subject|3|||
94250716|NCT02601300|322711011|FG000|Extension Phase|Adverse Event|4|||
94250717|NCT02601300|322711011|FG000|Extension Phase|Lack of Efficacy|10|||
94250718|NCT01034163|322711019|FG000|Overall Study|Treatment completed as per protocol|8|||
94250719|NCT01034163|322711020|FG001|Overall Study|Treatment completed as per protocol|7|||
94357160|NCT00920582|323089596|FG003|Overall Study|Withdrawal by Subject|3|||
94357161|NCT00920582|323089593|FG000|Overall Study|Protocol Violation|1|||
94357162|NCT00920582|323089594|FG001|Overall Study|Protocol Violation|0|||
94357163|NCT00920582|323089595|FG002|Overall Study|Protocol Violation|0|||
94357164|NCT00920582|323089596|FG003|Overall Study|Protocol Violation|0|||
94357165|NCT00920582|323089593|FG000|Overall Study|Other|2|||
94357166|NCT00920582|323089594|FG001|Overall Study|Other|1|||
94357167|NCT00920582|323089595|FG002|Overall Study|Other|3|||
94458899|NCT02640404|323467561|FG001|Overall Study|Protocol Violation|0|||
94458900|NCT02640404|323467560|FG000|Overall Study|Withdrawal by Subject|1|||
94357168|NCT00920582|323089596|FG003|Overall Study|Other|2|||
94357169|NCT01012765|323089599|FG000|Treatment Period 1|Adverse Event|1|||
94357170|NCT01012765|323089600|FG001|Treatment Period 1|Adverse Event|0|||
94357171|NCT01012765|323089601|FG002|Treatment Period 1|Adverse Event|1|||
94357172|NCT01012765|323089602|FG003|Treatment Period 1|Adverse Event|0|||
94357173|NCT01012765|323089603|FG004|Treatment Period 1|Adverse Event|0|||
94357174|NCT01012765|323089604|FG005|Treatment Period 1|Adverse Event|0|||
94357175|NCT01012765|323089599|FG000|Treatment Period 1|Withdrawal by Subject|2|||
94357176|NCT01012765|323089600|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94357177|NCT01012765|323089601|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94357178|NCT01012765|323089602|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94357179|NCT01012765|323089603|FG004|Treatment Period 1|Withdrawal by Subject|0|||
94357180|NCT01012765|323089604|FG005|Treatment Period 1|Withdrawal by Subject|0|||
94357181|NCT01012765|323089599|FG000|Treatment Period 1|Administrative problems|0|||
94250720|NCT01034163|322711019|FG000|Overall Study|Withdrawal by Subject|8|||
94250721|NCT01034163|322711020|FG001|Overall Study|Withdrawal by Subject|2|||
94250722|NCT01034163|322711019|FG000|Overall Study|Protocol deviation|1|||
94250723|NCT01034163|322711020|FG001|Overall Study|Protocol deviation|0|||
94250724|NCT01034163|322711019|FG000|Overall Study|Disease progression|3|||
94250725|NCT01034163|322711020|FG001|Overall Study|Disease progression|4|||
94250726|NCT01034163|322711019|FG000|Overall Study|Adverse Event|6|||
94250727|NCT01034163|322711020|FG001|Overall Study|Adverse Event|0|||
94250728|NCT01034163|322711019|FG000|Overall Study|Administrative problems|0|||
94250729|NCT01034163|322711020|FG001|Overall Study|Administrative problems|1|||
94250730|NCT01034163|322711019|FG000|Overall Study|Abnormal laboratory value|1|||
94250731|NCT01034163|322711020|FG001|Overall Study|Abnormal laboratory value|0|||
94250732|NCT02544451|322711022|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
94250733|NCT02544451|322711023|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
94250734|NCT02544451|322711024|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
94250735|NCT02544451|322711025|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
94250736|NCT02544451|322711022|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
94250737|NCT02544451|322711023|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
94250738|NCT02544451|322711024|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
94250739|NCT02544451|322711025|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
94250740|NCT02544451|322711022|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
94250741|NCT02544451|322711023|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
94250742|NCT02544451|322711024|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
94250743|NCT02544451|322711025|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
94250744|NCT02544451|322711022|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
94250745|NCT02544451|322711023|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
94250746|NCT02544451|322711024|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
94250747|NCT02544451|322711025|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
94250748|NCT02544451|322711022|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
94250749|NCT02544451|322711023|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
94250750|NCT02544451|322711024|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
94250751|NCT02544451|322711025|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
94250752|NCT02544451|322711022|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
94250753|NCT02544451|322711023|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
94250754|NCT02544451|322711024|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
94250755|NCT02544451|322711025|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
94250756|NCT01489891|322711026|FG000|Overall Study|Endoscopy failure|1|||
94250757|NCT01489891|322711027|FG001|Overall Study|Endoscopy failure|0|||
94250758|NCT00598273|322711028|FG000|Overall Study|Adverse Event|4|||
94250759|NCT00598273|322711029|FG001|Overall Study|Adverse Event|5|||
94250760|NCT00598273|322711030|FG002|Overall Study|Adverse Event|2|||
94250761|NCT00598273|322711028|FG000|Overall Study|Death|6|||
94250762|NCT00598273|322711029|FG001|Overall Study|Death|12|||
94250763|NCT00598273|322711030|FG002|Overall Study|Death|8|||
94250764|NCT00598273|322711028|FG000|Overall Study|Lost to Follow-up|8|||
94250765|NCT00598273|322711029|FG001|Overall Study|Lost to Follow-up|3|||
94250766|NCT00598273|322711030|FG002|Overall Study|Lost to Follow-up|5|||
94250767|NCT00598273|322711028|FG000|Overall Study|Physician Decision|0|||
94250768|NCT00598273|322711029|FG001|Overall Study|Physician Decision|0|||
94250769|NCT00598273|322711030|FG002|Overall Study|Physician Decision|1|||
94250770|NCT00598273|322711028|FG000|Overall Study|Withdrawal by Subject|12|||
94250771|NCT00598273|322711029|FG001|Overall Study|Withdrawal by Subject|10|||
94250772|NCT00598273|322711030|FG002|Overall Study|Withdrawal by Subject|10|||
94250773|NCT00598273|322711028|FG000|Overall Study|Noncompliance|3|||
94250774|NCT00598273|322711029|FG001|Overall Study|Noncompliance|2|||
94250775|NCT00598273|322711030|FG002|Overall Study|Noncompliance|3|||
94250776|NCT00598273|322711028|FG000|Overall Study|Relocation|0|||
94250777|NCT00598273|322711029|FG001|Overall Study|Relocation|2|||
94250778|NCT00598273|322711030|FG002|Overall Study|Relocation|4|||
94250779|NCT00598273|322711028|FG000|Overall Study|Renal transplant|1|||
94250780|NCT00598273|322711029|FG001|Overall Study|Renal transplant|0|||
94250781|NCT00598273|322711030|FG002|Overall Study|Renal transplant|1|||
94250782|NCT00598273|322711028|FG000|Overall Study|Site elected to close|1|||
94250783|NCT00598273|322711029|FG001|Overall Study|Site elected to close|0|||
94250784|NCT00598273|322711030|FG002|Overall Study|Site elected to close|0|||
94250785|NCT00598273|322711028|FG000|Overall Study|Started dialysis|6|||
94250786|NCT00598273|322711029|FG001|Overall Study|Started dialysis|4|||
94250787|NCT00598273|322711030|FG002|Overall Study|Started dialysis|5|||
94250788|NCT01605916|322711031|FG000|Overall Study|Adverse Event|1|||
94250789|NCT01605916|322711032|FG001|Overall Study|Adverse Event|0|||
94250790|NCT01605916|322711033|FG002|Overall Study|Adverse Event|0|||
94250791|NCT01605916|322711034|FG003|Overall Study|Adverse Event|1|||
94250792|NCT01605916|322711035|FG004|Overall Study|Adverse Event|0|||
94250793|NCT01605916|322711031|FG000|Overall Study|Lack of Efficacy|2|||
94250794|NCT01605916|322711032|FG001|Overall Study|Lack of Efficacy|3|||
94606114|NCT00566501|324020861|FG000|Overall Study|Request of Investigator or Sponsor|6|||
94606115|NCT00566501|324020862|FG001|Overall Study|Request of Investigator or Sponsor|7|||
94250795|NCT01605916|322711033|FG002|Overall Study|Lack of Efficacy|3|||
94250796|NCT01605916|322711034|FG003|Overall Study|Lack of Efficacy|5|||
94250797|NCT01605916|322711035|FG004|Overall Study|Lack of Efficacy|4|||
94250798|NCT01605916|322711031|FG000|Overall Study|Withdrawal by Subject|1|||
94250799|NCT01605916|322711032|FG001|Overall Study|Withdrawal by Subject|1|||
94250800|NCT01605916|322711033|FG002|Overall Study|Withdrawal by Subject|0|||
94250801|NCT01605916|322711034|FG003|Overall Study|Withdrawal by Subject|0|||
94250802|NCT01605916|322711035|FG004|Overall Study|Withdrawal by Subject|2|||
94250803|NCT02729831|322711038|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
94250804|NCT02729831|322711039|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
94250805|NCT02729831|322711040|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
94250806|NCT02729831|322711041|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
94250807|NCT02729831|322711038|FG000|1 Week Post-visit|Lost to Follow-up|43|||
94250808|NCT02729831|322711039|FG001|1 Week Post-visit|Lost to Follow-up|40|||
94250809|NCT02729831|322711040|FG002|1 Week Post-visit|Lost to Follow-up|38|||
94250810|NCT02729831|322711041|FG003|1 Week Post-visit|Lost to Follow-up|36|||
94250811|NCT02729831|322711038|FG000|6 Month Follow-up|Lost to Follow-up|54|||
94250812|NCT02729831|322711039|FG001|6 Month Follow-up|Lost to Follow-up|51|||
94250813|NCT02729831|322711040|FG002|6 Month Follow-up|Lost to Follow-up|48|||
94606116|NCT00566501|324020861|FG000|Overall Study|Withdrawal by Subject|33|||
94606117|NCT00566501|324020862|FG001|Overall Study|Withdrawal by Subject|30|||
94606118|NCT00566501|324020861|FG000|Overall Study|Lack of Efficacy|8|||
94606119|NCT00566501|324020862|FG001|Overall Study|Lack of Efficacy|3|||
94606120|NCT00566501|324020861|FG000|Overall Study|Other|25|||
94606121|NCT00566501|324020862|FG001|Overall Study|Other|21|||
94606122|NCT00750880|324020865|FG000|Overall Study|Adverse Event|76|||
94606123|NCT00750880|324020865|FG000|Overall Study|Death|4|||
94606124|NCT00750880|324020865|FG000|Overall Study|Lack of Efficacy|46|||
94606125|NCT00750880|324020865|FG000|Overall Study|Lost to Follow-up|10|||
94606126|NCT00750880|324020865|FG000|Overall Study|Protocol Violation|15|||
94606127|NCT00750880|324020865|FG000|Overall Study|Withdrawal by Subject|33|||
94606128|NCT00750880|324020865|FG000|Overall Study|Physician Decision|20|||
94606129|NCT00750880|324020865|FG000|Overall Study|Administrative|11|||
94606130|NCT02495233|324020868|FG000|Overall Study|Miscellaneous|0|||
94606131|NCT02495233|324020869|FG001|Overall Study|Miscellaneous|1|||
94606132|NCT03880461|324020871|FG000|Overall Study|Determined ineligible after enrollment|45|||
94606133|NCT03880461|324020872|FG001|Overall Study|Determined ineligible after enrollment|44|||
94606134|NCT03880461|324020871|FG000|Overall Study|No weight measurement after enrollment|24|||
94606135|NCT03880461|324020872|FG001|Overall Study|No weight measurement after enrollment|17|||
94606136|NCT02652767|324020877|FG000|Overall Study|Death|2|||
94606137|NCT02652767|324020877|FG000|Overall Study|Lost to Follow-up|1|||
94606138|NCT02652767|324020877|FG000|Overall Study|Withdrawal by Subject|1|||
94606139|NCT01115803|324020878|FG000|Overall Study|Withdrawal by Subject|0|||
94458901|NCT02640404|323467561|FG001|Overall Study|Withdrawal by Subject|0|||
94458902|NCT01399047|323469468|FG000|Overall Study|Withdrawal by Subject|0|||
94458903|NCT01399047|323469469|FG001|Overall Study|Withdrawal by Subject|1|||
94458904|NCT03652636|323469470|FG000|Overall Study|Withdrawal by Subject|7|||
94458905|NCT01275755|323469473|FG000|Double-blind Treatment Period|Adverse Event|0|||
94606140|NCT01115803|324020879|FG001|Overall Study|Withdrawal by Subject|0|||
94606141|NCT01115803|324020880|FG002|Overall Study|Withdrawal by Subject|0|||
94606142|NCT01115803|324020881|FG003|Overall Study|Withdrawal by Subject|0|||
94606143|NCT01115803|324020882|FG004|Overall Study|Withdrawal by Subject|0|||
94606144|NCT01115803|324020883|FG005|Overall Study|Withdrawal by Subject|0|||
94606145|NCT01115803|324020884|FG006|Overall Study|Withdrawal by Subject|1|||
94606146|NCT01115803|324020878|FG000|Overall Study|Lost to Follow-up|0|||
94250814|NCT02729831|322711041|FG003|6 Month Follow-up|Lost to Follow-up|42|||
94250815|NCT02729831|322711038|FG000|6 Month Follow-up|Death|1|||
94458906|NCT01275755|323469474|FG001|Double-blind Treatment Period|Adverse Event|2|||
94458907|NCT01275755|323469473|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
94458908|NCT01275755|323469474|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
94458909|NCT01275755|323469473|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
94458910|NCT01275755|323469474|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
94458911|NCT01275755|323469473|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
94606147|NCT01115803|324020879|FG001|Overall Study|Lost to Follow-up|0|||
94606148|NCT01115803|324020880|FG002|Overall Study|Lost to Follow-up|1|||
94250816|NCT02729831|322711039|FG001|6 Month Follow-up|Death|3|||
94458912|NCT01275755|323469474|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
94458913|NCT01283334|323469475|FG000|Overall Study|Withdrawal by Subject|1|||
94606149|NCT01115803|324020881|FG003|Overall Study|Lost to Follow-up|0|||
94606150|NCT01115803|324020882|FG004|Overall Study|Lost to Follow-up|0|||
94606151|NCT01115803|324020883|FG005|Overall Study|Lost to Follow-up|0|||
94606152|NCT01115803|324020884|FG006|Overall Study|Lost to Follow-up|0|||
94606153|NCT01115803|324020878|FG000|Overall Study|Progressive Disease during Cycle1|0|||
94250817|NCT02729831|322711040|FG002|6 Month Follow-up|Death|0|||
94250818|NCT02729831|322711041|FG003|6 Month Follow-up|Death|1|||
94250819|NCT00470366|322711042|FG000|Overall Study|Adverse Event|3|||
94357182|NCT01012765|323089600|FG001|Treatment Period 1|Administrative problems|0|||
94357183|NCT01012765|323089601|FG002|Treatment Period 1|Administrative problems|1|||
94357184|NCT01012765|323089602|FG003|Treatment Period 1|Administrative problems|1|||
94357185|NCT01012765|323089603|FG004|Treatment Period 1|Administrative problems|1|||
94357186|NCT01012765|323089604|FG005|Treatment Period 1|Administrative problems|0|||
94357187|NCT01012765|323089599|FG000|Treatment Period 1|Protocol Violation|0|||
94357188|NCT01012765|323089600|FG001|Treatment Period 1|Protocol Violation|0|||
94357189|NCT01012765|323089601|FG002|Treatment Period 1|Protocol Violation|0|||
94357190|NCT01012765|323089602|FG003|Treatment Period 1|Protocol Violation|2|||
94357191|NCT01012765|323089603|FG004|Treatment Period 1|Protocol Violation|1|||
94357192|NCT01012765|323089604|FG005|Treatment Period 1|Protocol Violation|0|||
94357193|NCT01012765|323089599|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
94357194|NCT01012765|323089600|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
94250820|NCT00470366|322711042|FG000|Overall Study|Poor compliance|1|||
94250821|NCT02414932|322711043|FG000|Overall Study|Withdrawal by Subject|2|||
94250822|NCT02414932|322711044|FG001|Overall Study|Withdrawal by Subject|3|||
94250823|NCT02414932|322711043|FG000|Overall Study|Adverse Event|1|||
94250824|NCT02414932|322711044|FG001|Overall Study|Adverse Event|0|||
94250825|NCT02891837|322711045|FG000|Overall Study|Lost to Follow-up|2|||
94250826|NCT02891837|322711046|FG001|Overall Study|Lost to Follow-up|0|||
94250827|NCT02891837|322711045|FG000|Overall Study|Withdrawal by Subject|1|||
94250828|NCT02891837|322711046|FG001|Overall Study|Withdrawal by Subject|0|||
94250829|NCT02047903|322711047|FG000|Overall Study|Adverse Event|14|||
94250830|NCT02047903|322711047|FG000|Overall Study|Serious adverse event|10|||
94250831|NCT02047903|322711047|FG000|Overall Study|Withdrawal by Subject|16|||
94250832|NCT02047903|322711047|FG000|Overall Study|Lost to Follow-up|4|||
94250833|NCT02047903|322711047|FG000|Overall Study|Reason not listed|6|||
94357195|NCT01012765|323089601|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
94357196|NCT01012765|323089602|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
94357197|NCT01012765|323089603|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
94357198|NCT01012765|323089604|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
94357199|NCT01012765|323089599|FG000|Treatment Period 2|Withdrawal by Subject|1|||
94357200|NCT01012765|323089600|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94357201|NCT01012765|323089601|FG002|Treatment Period 2|Withdrawal by Subject|1|||
94357202|NCT01012765|323089602|FG003|Treatment Period 2|Withdrawal by Subject|0|||
94357203|NCT01012765|323089603|FG004|Treatment Period 2|Withdrawal by Subject|1|||
94357204|NCT01012765|323089604|FG005|Treatment Period 2|Withdrawal by Subject|0|||
94357205|NCT01012765|323089599|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
94357206|NCT01012765|323089600|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
94357207|NCT01012765|323089601|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
94357208|NCT01012765|323089602|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
94357209|NCT01012765|323089603|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
94357210|NCT01012765|323089604|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
94357211|NCT01012765|323089599|FG000|Treatment Period 2|Adverse Event|0|||
94357212|NCT01012765|323089600|FG001|Treatment Period 2|Adverse Event|1|||
94357213|NCT01012765|323089601|FG002|Treatment Period 2|Adverse Event|1|||
94357214|NCT01012765|323089602|FG003|Treatment Period 2|Adverse Event|0|||
94357215|NCT01012765|323089603|FG004|Treatment Period 2|Adverse Event|0|||
94357216|NCT01012765|323089604|FG005|Treatment Period 2|Adverse Event|0|||
94357217|NCT01012765|323089599|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
94357218|NCT01012765|323089600|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
94357219|NCT01012765|323089601|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
94357220|NCT01012765|323089602|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
94357221|NCT01012765|323089603|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
94357222|NCT01012765|323089604|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
94357223|NCT02219477|323089605|FG000|Overall Study|Adverse Event|0|||
94357224|NCT02219477|323089606|FG001|Overall Study|Adverse Event|1|||
94357225|NCT02219477|323089607|FG002|Overall Study|Adverse Event|1|||
94357226|NCT02219477|323089605|FG000|Overall Study|Withdrawal by Subject|0|||
94357227|NCT02219477|323089606|FG001|Overall Study|Withdrawal by Subject|1|||
94606154|NCT01115803|324020879|FG001|Overall Study|Progressive Disease during Cycle1|0|||
94250834|NCT02047903|322711047|FG000|Overall Study|Not Treated|9|||
94250835|NCT00296400|322711048|FG000|Overall Study|Adverse Event|7|||
94250836|NCT00296400|322711049|FG001|Overall Study|Adverse Event|7|||
94357228|NCT02219477|323089607|FG002|Overall Study|Withdrawal by Subject|0|||
94357229|NCT04338685|323089612|FG000|Overall Study|Death|3|||
94357230|NCT04338685|323089613|FG001|Overall Study|Death|4|||
94357231|NCT04338685|323089614|FG002|Overall Study|Death|2|||
94357232|NCT04338685|323089615|FG003|Overall Study|Death|4|||
94357233|NCT04338685|323089616|FG004|Overall Study|Death|4|||
94606155|NCT01115803|324020880|FG002|Overall Study|Progressive Disease during Cycle1|0|||
94250837|NCT00296400|322711050|FG002|Overall Study|Adverse Event|7|||
94250838|NCT00296400|322711048|FG000|Overall Study|Withdrawal by Subject|5|||
94250839|NCT00296400|322711049|FG001|Overall Study|Withdrawal by Subject|6|||
94250840|NCT00296400|322711050|FG002|Overall Study|Withdrawal by Subject|2|||
94250841|NCT00296400|322711048|FG000|Overall Study|Incorrect enrollment|2|||
94250842|NCT00296400|322711049|FG001|Overall Study|Incorrect enrollment|0|||
94250843|NCT00296400|322711050|FG002|Overall Study|Incorrect enrollment|0|||
94250844|NCT00296400|322711048|FG000|Overall Study|Protocol Violation|1|||
94250845|NCT00296400|322711049|FG001|Overall Study|Protocol Violation|1|||
94250846|NCT00296400|322711050|FG002|Overall Study|Protocol Violation|1|||
94250847|NCT00296400|322711048|FG000|Overall Study|Lost to Follow-up|1|||
94250848|NCT00296400|322711049|FG001|Overall Study|Lost to Follow-up|1|||
94250849|NCT00296400|322711050|FG002|Overall Study|Lost to Follow-up|2|||
94250850|NCT00296400|322711048|FG000|Overall Study|Study specific discontinuation criteria|0|||
94250851|NCT00296400|322711049|FG001|Overall Study|Study specific discontinuation criteria|0|||
94250852|NCT00296400|322711050|FG002|Overall Study|Study specific discontinuation criteria|1|||
94250853|NCT00296400|322711048|FG000|Overall Study|Visit 10 was performed earlier|0|||
94250854|NCT00296400|322711049|FG001|Overall Study|Visit 10 was performed earlier|1|||
94250855|NCT00296400|322711050|FG002|Overall Study|Visit 10 was performed earlier|0|||
94250856|NCT00296400|322711048|FG000|Overall Study|Pregnancy|1|||
94250857|NCT00296400|322711049|FG001|Overall Study|Pregnancy|2|||
94250858|NCT00296400|322711050|FG002|Overall Study|Pregnancy|0|||
94250859|NCT01014533|322711051|FG000|Overall Study|Protocol Violation|3|||
94250860|NCT01014533|322711052|FG001|Overall Study|Protocol Violation|2|||
94250861|NCT01014533|322711051|FG000|Overall Study|Withdrawal by Subject|2|||
94250862|NCT01014533|322711052|FG001|Overall Study|Withdrawal by Subject|0|||
94250863|NCT01014533|322711051|FG000|Overall Study|unable to come to appointment|0|||
94250864|NCT01014533|322711052|FG001|Overall Study|unable to come to appointment|3|||
94250865|NCT01920854|322711058|FG000|Overall Study|Withdrawal by Subject|1|||
94250866|NCT01920854|322711059|FG001|Overall Study|Withdrawal by Subject|0|||
94250867|NCT01920854|322711060|FG002|Overall Study|Withdrawal by Subject|0|||
94250868|NCT01920854|322711061|FG003|Overall Study|Withdrawal by Subject|0|||
94250869|NCT01920854|322711062|FG004|Overall Study|Withdrawal by Subject|1|||
94250870|NCT01920854|322711063|FG005|Overall Study|Withdrawal by Subject|0|||
94357234|NCT04338685|323089617|FG005|Overall Study|Death|8|||
94357235|NCT04338685|323089618|FG006|Overall Study|Death|1|||
94357236|NCT04338685|323089619|FG007|Overall Study|Death|0|||
94357237|NCT04338685|323089620|FG008|Overall Study|Death|0|||
94250871|NCT01920854|322711064|FG006|Overall Study|Withdrawal by Subject|1|||
94250872|NCT02679508|322711065|FG000|Healing Phase|Protocol Violation|1|||
94250873|NCT02679508|322711066|FG001|Healing Phase|Protocol Violation|1|||
94250874|NCT02679508|322711065|FG000|Healing Phase|Lost to Follow-up|1|||
94250875|NCT02679508|322711066|FG001|Healing Phase|Lost to Follow-up|0|||
94250876|NCT02679508|322711065|FG000|Maintenance Phase|Adverse Event|12|||
94250877|NCT02679508|322711066|FG001|Maintenance Phase|Adverse Event|2|||
94250878|NCT02679508|322711065|FG000|Maintenance Phase|Lost to Follow-up|0|||
94250879|NCT02679508|322711066|FG001|Maintenance Phase|Lost to Follow-up|1|||
94250880|NCT02679508|322711065|FG000|Maintenance Phase|Withdrawal by Subject|15|||
94250881|NCT02679508|322711066|FG001|Maintenance Phase|Withdrawal by Subject|8|||
94250882|NCT02679508|322711065|FG000|Maintenance Phase|Other|5|||
94250883|NCT02679508|322711066|FG001|Maintenance Phase|Other|4|||
94250884|NCT03538301|322711069|FG000|Overall Study|Adverse Event|1|||
94250885|NCT03538301|322711070|FG001|Overall Study|Adverse Event|4|||
94250886|NCT03538301|322711071|FG002|Overall Study|Adverse Event|4|||
94250887|NCT03538301|322711069|FG000|Overall Study|Death|1|||
94250888|NCT03538301|322711070|FG001|Overall Study|Death|1|||
94250889|NCT03538301|322711071|FG002|Overall Study|Death|0|||
94250890|NCT03538301|322711069|FG000|Overall Study|Physician Decision|0|||
94250891|NCT03538301|322711070|FG001|Overall Study|Physician Decision|1|||
94250892|NCT03538301|322711071|FG002|Overall Study|Physician Decision|0|||
94250893|NCT03538301|322711069|FG000|Overall Study|Protocol Violation|0|||
94250894|NCT03538301|322711070|FG001|Overall Study|Protocol Violation|0|||
94250895|NCT03538301|322711071|FG002|Overall Study|Protocol Violation|1|||
94250896|NCT03538301|322711069|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
94357238|NCT04338685|323089612|FG000|Overall Study|Study terminated by Sponsor|0|||
94357239|NCT04338685|323089613|FG001|Overall Study|Study terminated by Sponsor|0|||
94357240|NCT04338685|323089614|FG002|Overall Study|Study terminated by Sponsor|1|||
94250897|NCT03538301|322711070|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
94250898|NCT03538301|322711071|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
94250899|NCT02112708|322711073|FG000|Baseline|Physician Decision|16|||
94250900|NCT02112708|322711074|FG001|Baseline|Physician Decision|11|||
94250901|NCT02112708|322711073|FG000|Baseline|Lost to Follow-up|12|||
94250902|NCT02112708|322711074|FG001|Baseline|Lost to Follow-up|0|||
94250903|NCT02112708|322711073|FG000|4 Month|Death|0|||
94250904|NCT02112708|322711074|FG001|4 Month|Death|1|||
94250905|NCT02112708|322711073|FG000|4 Month|Withdrawal by Subject|12|||
94250906|NCT02112708|322711074|FG001|4 Month|Withdrawal by Subject|0|||
94250907|NCT00953745|322711075|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
94661500|NCT00968669|324215743|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
94661501|NCT00968669|324215744|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
94661502|NCT00968669|324215745|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
94661503|NCT00968669|324215742|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
94661504|NCT00968669|324215743|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
94661505|NCT00968669|324215744|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
94661506|NCT00968669|324215745|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
94661507|NCT00968669|324215742|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
94661508|NCT00968669|324215743|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
94661509|NCT00968669|324215744|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
94661510|NCT00968669|324215745|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
94661511|NCT00968669|324215742|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
94661512|NCT00968669|324215743|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
94661513|NCT00968669|324215744|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
94661514|NCT00968669|324215745|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
94661515|NCT00968669|324215742|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
94661516|NCT00968669|324215743|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
94661517|NCT00968669|324215744|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
94661518|NCT00968669|324215745|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
94661519|NCT00968669|324215742|FG000|Overall Study|SPONSOR DECISION|0|||
94661520|NCT00968669|324215743|FG001|Overall Study|SPONSOR DECISION|1|||
94661521|NCT00968669|324215744|FG002|Overall Study|SPONSOR DECISION|0|||
94661522|NCT00968669|324215745|FG003|Overall Study|SPONSOR DECISION|0|||
94661523|NCT00968669|324215742|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
94661524|NCT00968669|324215743|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
94661525|NCT00968669|324215744|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
94661526|NCT00968669|324215745|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
94661527|NCT00968669|324215742|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
94606156|NCT01115803|324020881|FG003|Overall Study|Progressive Disease during Cycle1|0|||
94250908|NCT00953745|322711076|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
94250909|NCT00953745|322711075|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
94250910|NCT00953745|322711076|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
94250911|NCT00953745|322711075|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
94250912|NCT00953745|322711076|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
94606157|NCT01115803|324020882|FG004|Overall Study|Progressive Disease during Cycle1|0|||
94458914|NCT01283334|323469475|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
94458915|NCT01283334|323469475|FG000|Overall Study|Adverse Event|4|||
94458916|NCT01283334|323469475|FG000|Overall Study|Physician Decision|1|||
94458917|NCT00769067|323469476|FG000|Overall Study|Death|89|||
94458918|NCT00769067|323469477|FG001|Overall Study|Death|86|||
94458919|NCT00769067|323469476|FG000|Overall Study|Lost to Follow-up|3|||
94458920|NCT00769067|323469477|FG001|Overall Study|Lost to Follow-up|1|||
94458921|NCT00769067|323469476|FG000|Overall Study|Study terminated by sponsor|1|||
94458922|NCT00769067|323469477|FG001|Overall Study|Study terminated by sponsor|3|||
94458923|NCT00769067|323469476|FG000|Overall Study|Other|1|||
94458924|NCT00769067|323469477|FG001|Overall Study|Other|3|||
94458925|NCT00769067|323469476|FG000|Overall Study|Withdrawal by Subject|0|||
94458926|NCT00769067|323469477|FG001|Overall Study|Withdrawal by Subject|1|||
94458927|NCT04420585|323469478|FG000|Overall Study|Adverse Event|1|||
94458928|NCT04420585|323469478|FG000|Overall Study|Never initiated medication|2|||
94458929|NCT00972816|323469479|FG000|Overall Study|Adverse Event|0|||
94458930|NCT00972816|323469480|FG001|Overall Study|Adverse Event|0|||
94458931|NCT00972816|323469481|FG002|Overall Study|Adverse Event|1|||
94458932|NCT00972816|323469482|FG003|Overall Study|Adverse Event|0|||
94458933|NCT00972816|323469483|FG004|Overall Study|Adverse Event|0|||
94458934|NCT00972816|323469484|FG005|Overall Study|Adverse Event|0|||
94458935|NCT00972816|323469485|FG006|Overall Study|Adverse Event|0|||
94458936|NCT00972816|323469486|FG007|Overall Study|Adverse Event|0|||
94458937|NCT00972816|323469479|FG000|Overall Study|Withdrawal by Subject|4|||
94458938|NCT00972816|323469480|FG001|Overall Study|Withdrawal by Subject|2|||
94458939|NCT00972816|323469481|FG002|Overall Study|Withdrawal by Subject|1|||
94458940|NCT00972816|323469482|FG003|Overall Study|Withdrawal by Subject|3|||
94458941|NCT00972816|323469483|FG004|Overall Study|Withdrawal by Subject|0|||
94458942|NCT00972816|323469484|FG005|Overall Study|Withdrawal by Subject|1|||
94458943|NCT00972816|323469485|FG006|Overall Study|Withdrawal by Subject|1|||
94458944|NCT00972816|323469486|FG007|Overall Study|Withdrawal by Subject|2|||
94458945|NCT00972816|323469479|FG000|Overall Study|Lost to Follow-up|11|||
94458946|NCT00972816|323469480|FG001|Overall Study|Lost to Follow-up|9|||
94458947|NCT00972816|323469481|FG002|Overall Study|Lost to Follow-up|7|||
94458948|NCT00972816|323469482|FG003|Overall Study|Lost to Follow-up|5|||
94606158|NCT01115803|324020883|FG005|Overall Study|Progressive Disease during Cycle1|0|||
94606159|NCT01115803|324020884|FG006|Overall Study|Progressive Disease during Cycle1|1|||
94606160|NCT01569464|324020885|FG000|Overall Study|Adverse Event|4|||
94606161|NCT01569464|324020886|FG001|Overall Study|Adverse Event|0|||
94606162|NCT01569464|324020885|FG000|Overall Study|Lack of Efficacy|1|||
94250913|NCT00953745|322711075|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
94250914|NCT00953745|322711076|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
94250915|NCT00953745|322711075|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
94250916|NCT00953745|322711076|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
94250917|NCT00953745|322711075|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
94250918|NCT00953745|322711076|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
94250919|NCT01575028|322711077|FG000|Overall Study|Physician Decision|0|||
94250920|NCT01575028|322711078|FG001|Overall Study|Physician Decision|1|||
94250921|NCT01078454|322711079|FG000|Overall Study|Adverse Event|1|||
94250922|NCT01078454|322711080|FG001|Overall Study|Adverse Event|1|||
94250923|NCT01078454|322711079|FG000|Overall Study|Death|0|||
94250924|NCT01078454|322711080|FG001|Overall Study|Death|1|||
94250925|NCT04227704|322711081|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
94250926|NCT04227704|322711082|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
94250927|NCT04227704|322711083|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
94250928|NCT04227704|322711081|FG000|Overall Study|due to C/S being cancelled|1|||
94250929|NCT04227704|322711082|FG001|Overall Study|due to C/S being cancelled|0|||
94250930|NCT04227704|322711083|FG002|Overall Study|due to C/S being cancelled|0|||
94250931|NCT03432260|322711092|FG000|Overall Study|Lost to Follow-up|1|||
94250932|NCT03432260|322711093|FG001|Overall Study|Lost to Follow-up|1|||
94250933|NCT03432260|322711094|FG002|Overall Study|Lost to Follow-up|0|||
94250934|NCT03432260|322711095|FG003|Overall Study|Lost to Follow-up|0|||
94250935|NCT03432260|322711096|FG004|Overall Study|Lost to Follow-up|1|||
94250936|NCT01880528|322711097|FG000|Overall Study|Other|1|||
94250937|NCT01880528|322711098|FG001|Overall Study|Other|1|||
94458949|NCT00972816|323469483|FG004|Overall Study|Lost to Follow-up|11|||
94250938|NCT01439360|322711099|FG000|Overall Study|Adverse Event|4|||
94458950|NCT00972816|323469484|FG005|Overall Study|Lost to Follow-up|10|||
94458951|NCT00972816|323469485|FG006|Overall Study|Lost to Follow-up|7|||
94458952|NCT00972816|323469486|FG007|Overall Study|Lost to Follow-up|7|||
94458953|NCT00972816|323469479|FG000|Overall Study|Inappropriate enrolment|0|||
94458954|NCT00972816|323469480|FG001|Overall Study|Inappropriate enrolment|0|||
94606163|NCT01569464|324020886|FG001|Overall Study|Lack of Efficacy|0|||
94606164|NCT01569464|324020885|FG000|Overall Study|Protocol Violation|1|||
94250939|NCT01439360|322711100|FG001|Overall Study|Adverse Event|16|||
94458955|NCT00972816|323469481|FG002|Overall Study|Inappropriate enrolment|0|||
94458956|NCT00972816|323469482|FG003|Overall Study|Inappropriate enrolment|0|||
94250940|NCT01439360|322711099|FG000|Overall Study|Lost to Follow-up|43|||
94250941|NCT01439360|322711100|FG001|Overall Study|Lost to Follow-up|58|||
94250942|NCT01439360|322711099|FG000|Overall Study|Others|10|||
94250943|NCT01439360|322711100|FG001|Overall Study|Others|5|||
94250944|NCT01439360|322711099|FG000|Overall Study|Protocol Violation|1|||
94250945|NCT01439360|322711100|FG001|Overall Study|Protocol Violation|0|||
94250946|NCT01439360|322711099|FG000|Overall Study|Withdrawal by Subject|140|||
94250947|NCT01439360|322711100|FG001|Overall Study|Withdrawal by Subject|129|||
94250948|NCT00112047|322711102|FG000|Randomized Phase|Lost to Follow-up|26|||
94250949|NCT00112047|322711103|FG001|Randomized Phase|Lost to Follow-up|33|||
94250950|NCT00112047|322711102|FG000|Randomized Phase|Adverse Event|10|||
94250951|NCT00112047|322711103|FG001|Randomized Phase|Adverse Event|10|||
94250952|NCT00112047|322711102|FG000|Randomized Phase|Withrawal of consent|10|||
94250953|NCT00112047|322711103|FG001|Randomized Phase|Withrawal of consent|18|||
94250954|NCT00112047|322711102|FG000|Randomized Phase|Sub-optimal virological response|3|||
94250955|NCT00112047|322711103|FG001|Randomized Phase|Sub-optimal virological response|13|||
94250956|NCT00112047|322711102|FG000|Randomized Phase|Noncompliance|8|||
94250957|NCT00112047|322711103|FG001|Randomized Phase|Noncompliance|4|||
94250958|NCT00112047|322711102|FG000|Randomized Phase|Protocol Violation|2|||
94250959|NCT00112047|322711103|FG001|Randomized Phase|Protocol Violation|0|||
94250960|NCT00112047|322711102|FG000|Randomized Phase|Pregnancy|3|||
94250961|NCT00112047|322711103|FG001|Randomized Phase|Pregnancy|1|||
94250962|NCT00112047|322711102|FG000|Randomized Phase|Death|1|||
94250963|NCT00112047|322711103|FG001|Randomized Phase|Death|3|||
94250964|NCT00112047|322711102|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
94250965|NCT00112047|322711103|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
94606165|NCT01569464|324020886|FG001|Overall Study|Protocol Violation|0|||
94606166|NCT01569464|324020885|FG000|Overall Study|Lost to Follow-up|2|||
94606167|NCT01569464|324020886|FG001|Overall Study|Lost to Follow-up|3|||
94606168|NCT01569464|324020885|FG000|Overall Study|Withdrawal by Subject|1|||
94606169|NCT01569464|324020886|FG001|Overall Study|Withdrawal by Subject|1|||
94606170|NCT01569464|324020885|FG000|Overall Study|Other|1|||
94606171|NCT01569464|324020886|FG001|Overall Study|Other|1|||
94606172|NCT03475875|324020887|FG000|Period 1|Lost to Follow-up|1|||
94606173|NCT03475875|324020888|FG001|Period 1|Lost to Follow-up|0|||
94606174|NCT03475875|324020887|FG000|Period 1|Adverse Event|2|||
94606175|NCT03475875|324020888|FG001|Period 1|Adverse Event|1|||
94606176|NCT03475875|324020887|FG000|Period 2|Adverse Event|3|||
94606177|NCT03475875|324020888|FG001|Period 2|Adverse Event|0|||
94606178|NCT03475875|324020887|FG000|Period 2|Protocol Violation|0|||
94606179|NCT03475875|324020888|FG001|Period 2|Protocol Violation|1|||
94606180|NCT02992132|324020889|FG000|Overall Study|Adverse Event|4|||
94606181|NCT02992132|324020890|FG001|Overall Study|Adverse Event|1|||
94606182|NCT02992132|324020891|FG002|Overall Study|Adverse Event|3|||
94606183|NCT02992132|324020889|FG000|Overall Study|Lack of Efficacy|2|||
94250966|NCT00112047|322711102|FG000|Randomized Phase|Inability to swallow pills|0|||
94250967|NCT00112047|322711103|FG001|Randomized Phase|Inability to swallow pills|1|||
94606184|NCT02992132|324020890|FG001|Overall Study|Lack of Efficacy|0|||
94606185|NCT02992132|324020891|FG002|Overall Study|Lack of Efficacy|0|||
94606186|NCT02992132|324020889|FG000|Overall Study|Non-compliance with study drug|2|||
94606187|NCT02992132|324020890|FG001|Overall Study|Non-compliance with study drug|0|||
94606188|NCT02992132|324020891|FG002|Overall Study|Non-compliance with study drug|0|||
94606189|NCT02992132|324020889|FG000|Overall Study|Progressive disease|1|||
94606190|NCT02992132|324020890|FG001|Overall Study|Progressive disease|0|||
94606191|NCT02992132|324020891|FG002|Overall Study|Progressive disease|0|||
94606192|NCT02992132|324020889|FG000|Overall Study|Protocol Violation|2|||
94606193|NCT02992132|324020890|FG001|Overall Study|Protocol Violation|2|||
94357241|NCT04338685|323089615|FG003|Overall Study|Study terminated by Sponsor|4|||
94357242|NCT04338685|323089616|FG004|Overall Study|Study terminated by Sponsor|0|||
94357243|NCT04338685|323089617|FG005|Overall Study|Study terminated by Sponsor|5|||
94357244|NCT04338685|323089618|FG006|Overall Study|Study terminated by Sponsor|2|||
94357245|NCT04338685|323089619|FG007|Overall Study|Study terminated by Sponsor|4|||
94357246|NCT04338685|323089620|FG008|Overall Study|Study terminated by Sponsor|1|||
94357247|NCT04338685|323089612|FG000|Overall Study|Withdrawal by Subject|1|||
94357248|NCT04338685|323089613|FG001|Overall Study|Withdrawal by Subject|2|||
94357249|NCT04338685|323089614|FG002|Overall Study|Withdrawal by Subject|0|||
94357250|NCT04338685|323089615|FG003|Overall Study|Withdrawal by Subject|2|||
94357251|NCT04338685|323089616|FG004|Overall Study|Withdrawal by Subject|0|||
94357252|NCT04338685|323089617|FG005|Overall Study|Withdrawal by Subject|5|||
94357253|NCT04338685|323089618|FG006|Overall Study|Withdrawal by Subject|1|||
94357254|NCT04338685|323089619|FG007|Overall Study|Withdrawal by Subject|1|||
94357255|NCT04338685|323089620|FG008|Overall Study|Withdrawal by Subject|0|||
94357256|NCT00596466|323089621|FG000|Overall Study|Lack of Efficacy|5|||
94357257|NCT00596466|323089621|FG000|Overall Study|Adverse Event|4|||
94357258|NCT00596466|323089621|FG000|Overall Study|Withdrawal by Subject|2|||
94357259|NCT00596466|323089621|FG000|Overall Study|Protocol Violation|2|||
94357260|NCT00596466|323089621|FG000|Overall Study|Unpecified|2|||
94357261|NCT00596466|323089621|FG000|Overall Study|Enrolled, not treated|2|||
94606194|NCT02992132|324020891|FG002|Overall Study|Protocol Violation|0|||
94606195|NCT02992132|324020889|FG000|Overall Study|Caregiver withdrew consent|2|||
94606196|NCT02992132|324020890|FG001|Overall Study|Caregiver withdrew consent|3|||
94606197|NCT02992132|324020891|FG002|Overall Study|Caregiver withdrew consent|2|||
94606198|NCT02992132|324020889|FG000|Overall Study|Withdrawal by Subject|0|||
94606199|NCT02992132|324020890|FG001|Overall Study|Withdrawal by Subject|2|||
94606200|NCT02992132|324020891|FG002|Overall Study|Withdrawal by Subject|1|||
94606201|NCT02992132|324020889|FG000|Overall Study|Physician Decision|0|||
94606202|NCT02992132|324020890|FG001|Overall Study|Physician Decision|0|||
94606203|NCT02992132|324020891|FG002|Overall Study|Physician Decision|1|||
94606204|NCT01982331|324020892|FG000|Received Vaccination 2|Adverse Event|1|||
94357262|NCT03556202|323089622|FG000|Extension Treatment Period|Adverse Event|18|||
94357263|NCT03556202|323089623|FG001|Extension Treatment Period|Adverse Event|14|||
94357264|NCT03556202|323089624|FG002|Extension Treatment Period|Adverse Event|9|||
94606205|NCT01982331|324020893|FG001|Received Vaccination 2|Adverse Event|2|||
94606206|NCT01982331|324020892|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
94606207|NCT01982331|324020893|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
94606208|NCT01982331|324020892|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
94606209|NCT01982331|324020893|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
94606210|NCT00095628|324020894|FG000|Overall Study|Disease progression prior to treatment|1|||
94606211|NCT01280955|324020895|FG000|Overall Study|Death|2|||
94357265|NCT03556202|323089622|FG000|Extension Treatment Period|Death|2|||
94357266|NCT03556202|323089623|FG001|Extension Treatment Period|Death|6|||
94357267|NCT03556202|323089624|FG002|Extension Treatment Period|Death|0|||
94357268|NCT03556202|323089622|FG000|Extension Treatment Period|Lack of Efficacy|5|||
94357269|NCT03556202|323089623|FG001|Extension Treatment Period|Lack of Efficacy|12|||
94606212|NCT01280955|324020895|FG000|Overall Study|Withdrawal by Subject|1|||
94606213|NCT01484054|324020898|FG000|Period 1|Withdrawal by Subject|0|||
94606214|NCT01484054|324020899|FG001|Period 1|Withdrawal by Subject|1|||
94250968|NCT00112047|322711102|FG000|Randomized Phase|Incarceration|3|||
94250969|NCT00112047|322711103|FG001|Randomized Phase|Incarceration|2|||
94250970|NCT00112047|322711102|FG000|Randomized Phase|Moved out of State|0|||
94250971|NCT00112047|322711103|FG001|Randomized Phase|Moved out of State|1|||
94250972|NCT00112047|322711102|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
94250973|NCT00112047|322711103|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
94250974|NCT00112047|322711102|FG000|Randomized Phase|High Hepatitis B DNA|0|||
94250975|NCT00112047|322711103|FG001|Randomized Phase|High Hepatitis B DNA|1|||
94250976|NCT00112047|322711102|FG000|Atripla Phase|Adverse Event|2|||
94250977|NCT00112047|322711103|FG001|Atripla Phase|Adverse Event|1|||
94250978|NCT00112047|322711102|FG000|Atripla Phase|Lost to Follow-up|5|||
94250979|NCT00112047|322711103|FG001|Atripla Phase|Lost to Follow-up|7|||
94250980|NCT00112047|322711102|FG000|Atripla Phase|Pregnancy|0|||
94250981|NCT00112047|322711103|FG001|Atripla Phase|Pregnancy|1|||
94250982|NCT00112047|322711102|FG000|Atripla Phase|Death|0|||
94250983|NCT00112047|322711103|FG001|Atripla Phase|Death|2|||
94250984|NCT00112047|322711102|FG000|Atripla Phase|Withdrew consent|7|||
94250985|NCT00112047|322711103|FG001|Atripla Phase|Withdrew consent|7|||
94250986|NCT00112047|322711102|FG000|Atripla Phase|Sub-optimal virological response|0|||
94250987|NCT00112047|322711103|FG001|Atripla Phase|Sub-optimal virological response|1|||
94250988|NCT00112047|322711102|FG000|Atripla Phase|Non-compliance|1|||
94250989|NCT00112047|322711103|FG001|Atripla Phase|Non-compliance|0|||
94250990|NCT00112047|322711102|FG000|Atripla Phase|Other|3|||
94250991|NCT00112047|322711103|FG001|Atripla Phase|Other|1|||
94250992|NCT01307579|322711104|FG000|Overall Study|Death|3|||
94250993|NCT01307579|322711105|FG001|Overall Study|Death|6|||
94250994|NCT01307579|322711104|FG000|Overall Study|Physician Decision|26|||
94250995|NCT01307579|322711105|FG001|Overall Study|Physician Decision|29|||
94250996|NCT01307579|322711104|FG000|Overall Study|Withdrawal by Subject|7|||
94661528|NCT00968669|324215743|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
94250997|NCT01307579|322711105|FG001|Overall Study|Withdrawal by Subject|3|||
94661529|NCT00968669|324215744|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
94661530|NCT00968669|324215745|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
94661531|NCT00968669|324215742|FG000|Overall Study|SUBJECT INCARCERATED|0|||
94661532|NCT00968669|324215743|FG001|Overall Study|SUBJECT INCARCERATED|1|||
94661533|NCT00968669|324215744|FG002|Overall Study|SUBJECT INCARCERATED|0|||
94250998|NCT01307579|322711104|FG000|Overall Study|Institutional diagnosis of IFD|21|||
94661534|NCT00968669|324215745|FG003|Overall Study|SUBJECT INCARCERATED|0|||
94250999|NCT01307579|322711105|FG001|Overall Study|Institutional diagnosis of IFD|36|||
94251000|NCT01307579|322711104|FG000|Overall Study|Begin conditioning for HSCT|42|||
94251001|NCT01307579|322711105|FG001|Overall Study|Begin conditioning for HSCT|44|||
94251002|NCT01307579|322711104|FG000|Overall Study|Refractory or relapsed AML|38|||
94251003|NCT01307579|322711105|FG001|Overall Study|Refractory or relapsed AML|23|||
94251004|NCT01307579|322711104|FG000|Overall Study|Ineligible|3|||
94251005|NCT01307579|322711105|FG001|Overall Study|Ineligible|4|||
94251006|NCT00432666|322712783|FG000|Main Period|Adverse Event|1|||
94251007|NCT00432666|322712784|FG001|Main Period|Adverse Event|1|||
94251008|NCT00432666|322712783|FG000|Main Period|Consent Withdrawn|1|||
94251009|NCT00432666|322712784|FG001|Main Period|Consent Withdrawn|0|||
94251010|NCT00432666|322712783|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
94251011|NCT00432666|322712784|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
94251012|NCT00432666|322712783|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
94251013|NCT00432666|322712784|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
94251014|NCT00432666|322712783|FG000|Open-Label Extension Period|Adverse Event|5|||
94251015|NCT00432666|322712784|FG001|Open-Label Extension Period|Adverse Event|0|||
94251016|NCT00432666|322712783|FG000|Open-Label Extension Period|Consent withdrawn|10|||
94251017|NCT00432666|322712784|FG001|Open-Label Extension Period|Consent withdrawn|0|||
94251018|NCT00432666|322712783|FG000|Open-Label Extension Period|Physician Decision|3|||
94251019|NCT00432666|322712784|FG001|Open-Label Extension Period|Physician Decision|0|||
94251020|NCT01077271|322712785|FG000|Overall Study|Parental desire|8|||
94251021|NCT01077271|322712785|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
94251022|NCT01077271|322712785|FG000|Overall Study|Noncompliance|2|||
94251023|NCT01077271|322712785|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
94251024|NCT01077271|322712785|FG000|Overall Study|Changed doctors|2|||
94251025|NCT01077271|322712785|FG000|Overall Study|Parents thought too many injections|2|||
94251026|NCT01077271|322712785|FG000|Overall Study|End of RSV season nearly reached|1|||
94251027|NCT01077271|322712785|FG000|Overall Study|Mother unconvinced of the necessity|1|||
94251028|NCT02516332|322712786|FG000|Overall Study|Withdrawal by Subject|2|||
94251029|NCT02516332|322712787|FG001|Overall Study|Withdrawal by Subject|1|||
94251030|NCT02516332|322712788|FG002|Overall Study|Withdrawal by Subject|2|||
94251031|NCT03695237|322712789|FG000|Overall Study|Withdrawal by Subject|1|||
94251032|NCT03695237|322712790|FG001|Overall Study|Withdrawal by Subject|3|||
94251033|NCT03695237|322712789|FG000|Overall Study|Lost to Follow-up|1|||
94251034|NCT03695237|322712790|FG001|Overall Study|Lost to Follow-up|2|||
94251035|NCT03695237|322712789|FG000|Overall Study|Other, Not Specified|8|||
94251036|NCT03695237|322712790|FG001|Overall Study|Other, Not Specified|2|||
94606215|NCT01539317|324020900|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
94606216|NCT01539317|324020901|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
94606217|NCT02961218|324020902|FG000|Overall Study|Lost to Follow-up|0|||
94606218|NCT02961218|324020903|FG001|Overall Study|Lost to Follow-up|2|||
94606219|NCT02961218|324020902|FG000|Overall Study|Physician Decision|0|||
94606220|NCT02961218|324020903|FG001|Overall Study|Physician Decision|2|||
94606221|NCT02961218|324020902|FG000|Overall Study|Subject/Guardian Decision|3|||
94606222|NCT02961218|324020903|FG001|Overall Study|Subject/Guardian Decision|1|||
94606223|NCT01721070|324020904|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
94606224|NCT03187756|324020905|FG000|Overall Study|Termination of study|4|||
94606225|NCT05597020|324020916|FG000|Washout|Forbidden medication|2|||
94606226|NCT05597020|324020917|FG001|Washout|Forbidden medication|0|||
94606227|NCT05597020|324020916|FG000|Treatment Period II|Advice from primary care physician|1|||
94606228|NCT05597020|324020917|FG001|Treatment Period II|Advice from primary care physician|0|||
94606229|NCT05597020|324020916|FG000|Treatment Period II|Subject lost investigational product|1|||
94606230|NCT05597020|324020917|FG001|Treatment Period II|Subject lost investigational product|0|||
94606231|NCT05597020|324020916|FG000|Treatment Period II|Private reasons|0|||
94606232|NCT05597020|324020917|FG001|Treatment Period II|Private reasons|1|||
94606233|NCT00560885|324020918|FG000|Overall Study|Death|7|||
94606234|NCT00560885|324020918|FG000|Overall Study|Withdrawal by Subject|1|||
94606235|NCT01394718|324022198|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
94606236|NCT01394718|324022199|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
94606237|NCT02428608|324022203|FG000|Overall Study|Pregnancy|2|||
94606238|NCT02428608|324022203|FG000|Overall Study|Lost to Follow-up|37|||
94606239|NCT02428608|324022203|FG000|Overall Study|Withdrawal by Subject|2|||
94606240|NCT02428608|324022203|FG000|Overall Study|scheduling conflicts|15|||
94606241|NCT02428608|324022203|FG000|Overall Study|moved away|10|||
94606242|NCT02428608|324022203|FG000|Overall Study|Death|1|||
94606243|NCT02428608|324022203|FG000|Overall Study|various|16|||
94606244|NCT03954041|324022204|FG000|Overall Study|Lost to Follow-up|3|||
94606245|NCT03954041|324022205|FG001|Overall Study|Lost to Follow-up|3|||
94606246|NCT03954041|324022206|FG002|Overall Study|Lost to Follow-up|6|||
94251037|NCT00091169|322712801|FG000|Overall Study|Disease progression|3|||
94251038|NCT00091169|322712802|FG001|Overall Study|Disease progression|1|||
94606247|NCT03954041|324022204|FG000|Overall Study|Death|4|||
94606248|NCT03954041|324022205|FG001|Overall Study|Death|0|||
94251039|NCT00091169|322712801|FG000|Overall Study|Adverse Event|11|||
94606249|NCT03954041|324022206|FG002|Overall Study|Death|1|||
94606250|NCT03954041|324022204|FG000|Overall Study|Death by neurologic criteria|0|||
94606251|NCT03954041|324022205|FG001|Overall Study|Death by neurologic criteria|0|||
94606252|NCT03954041|324022206|FG002|Overall Study|Death by neurologic criteria|1|||
94606253|NCT03954041|324022204|FG000|Overall Study|Reason not specified|7|||
94606254|NCT03954041|324022205|FG001|Overall Study|Reason not specified|4|||
94606255|NCT03954041|324022206|FG002|Overall Study|Reason not specified|2|||
94606256|NCT03954041|324022204|FG000|Overall Study|Withdrew prior to dosing|4|||
94606257|NCT03954041|324022205|FG001|Overall Study|Withdrew prior to dosing|2|||
94606258|NCT03954041|324022206|FG002|Overall Study|Withdrew prior to dosing|0|||
94606259|NCT04565236|324022210|FG000|Overall Study|Patient/Guardian Decision|0|||
94606260|NCT04565236|324022211|FG001|Overall Study|Patient/Guardian Decision|0|||
94606261|NCT04565236|324022212|FG002|Overall Study|Patient/Guardian Decision|1|||
94606262|NCT04565236|324022213|FG003|Overall Study|Patient/Guardian Decision|0|||
94606263|NCT02278341|324022217|FG000|Overall Study|Randomized but never received study drug|1|||
94606264|NCT02278341|324022218|FG001|Overall Study|Randomized but never received study drug|1|||
94606265|NCT02278341|324022217|FG000|Overall Study|Adverse Event|3|||
94606266|NCT02278341|324022218|FG001|Overall Study|Adverse Event|0|||
94606267|NCT02278341|324022217|FG000|Overall Study|Death|68|||
94606268|NCT02278341|324022218|FG001|Overall Study|Death|56|||
94606269|NCT02278341|324022217|FG000|Overall Study|Withdrawal by Subject|30|||
94606270|NCT02278341|324022218|FG001|Overall Study|Withdrawal by Subject|19|||
94606271|NCT02278341|324022217|FG000|Overall Study|Lost to Follow-up|0|||
94606272|NCT02278341|324022218|FG001|Overall Study|Lost to Follow-up|1|||
94606273|NCT02278341|324022217|FG000|Overall Study|Physician Decision|1|||
94606274|NCT02278341|324022218|FG001|Overall Study|Physician Decision|1|||
94606275|NCT02278341|324022217|FG000|Overall Study|Miscellaneous|15|||
94606276|NCT02278341|324022218|FG001|Overall Study|Miscellaneous|14|||
94606277|NCT00518973|324022223|FG000|Overall Study|Withdrawal by Subject|3|||
94606278|NCT00518973|324022224|FG001|Overall Study|Withdrawal by Subject|2|||
94606279|NCT02694523|324022226|FG000|Part A|Adverse Event|7|||
94606280|NCT02694523|324022227|FG001|Part A|Adverse Event|3|||
94606281|NCT02694523|324022228|FG002|Part A|Adverse Event|0|||
94606282|NCT02694523|324022229|FG003|Part A|Adverse Event|0|||
94606283|NCT02694523|324022230|FG004|Part A|Adverse Event|0|||
94606284|NCT02694523|324022231|FG005|Part A|Adverse Event|0|||
94606285|NCT02694523|324022232|FG006|Part A|Adverse Event|0|||
94606286|NCT02694523|324022226|FG000|Part A|Protocol Violation|1|||
94606287|NCT02694523|324022227|FG001|Part A|Protocol Violation|0|||
94606288|NCT02694523|324022228|FG002|Part A|Protocol Violation|0|||
94606289|NCT02694523|324022229|FG003|Part A|Protocol Violation|0|||
94606290|NCT02694523|324022230|FG004|Part A|Protocol Violation|0|||
94606291|NCT02694523|324022231|FG005|Part A|Protocol Violation|0|||
94606292|NCT02694523|324022232|FG006|Part A|Protocol Violation|0|||
94606293|NCT02694523|324022226|FG000|Part A|Lost to Follow-up|1|||
94606294|NCT02694523|324022227|FG001|Part A|Lost to Follow-up|2|||
94606295|NCT02694523|324022228|FG002|Part A|Lost to Follow-up|0|||
94606296|NCT02694523|324022229|FG003|Part A|Lost to Follow-up|0|||
94606297|NCT02694523|324022230|FG004|Part A|Lost to Follow-up|0|||
94606298|NCT02694523|324022231|FG005|Part A|Lost to Follow-up|0|||
94606299|NCT02694523|324022232|FG006|Part A|Lost to Follow-up|0|||
94606300|NCT02694523|324022226|FG000|Part A|Withdrawal by Subject|3|||
94606301|NCT02694523|324022227|FG001|Part A|Withdrawal by Subject|1|||
94606302|NCT02694523|324022228|FG002|Part A|Withdrawal by Subject|0|||
94606303|NCT02694523|324022229|FG003|Part A|Withdrawal by Subject|0|||
94606304|NCT02694523|324022230|FG004|Part A|Withdrawal by Subject|0|||
94606305|NCT02694523|324022231|FG005|Part A|Withdrawal by Subject|0|||
94606306|NCT02694523|324022232|FG006|Part A|Withdrawal by Subject|0|||
94606307|NCT02694523|324022226|FG000|Part A|Other|1|||
94606308|NCT02694523|324022227|FG001|Part A|Other|1|||
94606309|NCT02694523|324022228|FG002|Part A|Other|0|||
94606310|NCT02694523|324022229|FG003|Part A|Other|0|||
94606311|NCT02694523|324022230|FG004|Part A|Other|0|||
94606312|NCT02694523|324022231|FG005|Part A|Other|0|||
94606313|NCT02694523|324022232|FG006|Part A|Other|0|||
94606314|NCT02694523|324022226|FG000|Part B|Adverse Event|0|||
94606315|NCT02694523|324022227|FG001|Part B|Adverse Event|0|||
94606316|NCT02694523|324022228|FG002|Part B|Adverse Event|7|||
94606317|NCT02694523|324022229|FG003|Part B|Adverse Event|1|||
94606318|NCT02694523|324022230|FG004|Part B|Adverse Event|1|||
94606319|NCT02694523|324022231|FG005|Part B|Adverse Event|2|||
94606320|NCT02694523|324022232|FG006|Part B|Adverse Event|0|||
94606321|NCT02694523|324022226|FG000|Part B|Protocol Violation|0|||
94606322|NCT02694523|324022227|FG001|Part B|Protocol Violation|0|||
94606323|NCT02694523|324022228|FG002|Part B|Protocol Violation|1|||
94606324|NCT02694523|324022229|FG003|Part B|Protocol Violation|0|||
94606325|NCT02694523|324022230|FG004|Part B|Protocol Violation|0|||
94606326|NCT02694523|324022231|FG005|Part B|Protocol Violation|0|||
94606327|NCT02694523|324022232|FG006|Part B|Protocol Violation|0|||
94458957|NCT00972816|323469483|FG004|Overall Study|Inappropriate enrolment|0|||
94606328|NCT02694523|324022226|FG000|Part B|Lost to Follow-up|0|||
94606329|NCT02694523|324022227|FG001|Part B|Lost to Follow-up|0|||
94606330|NCT02694523|324022228|FG002|Part B|Lost to Follow-up|2|||
94606331|NCT02694523|324022229|FG003|Part B|Lost to Follow-up|3|||
94606332|NCT02694523|324022230|FG004|Part B|Lost to Follow-up|2|||
94606333|NCT02694523|324022231|FG005|Part B|Lost to Follow-up|0|||
94606334|NCT02694523|324022232|FG006|Part B|Lost to Follow-up|1|||
94606335|NCT02694523|324022226|FG000|Part B|Withdrawal by Subject|0|||
94606336|NCT02694523|324022227|FG001|Part B|Withdrawal by Subject|0|||
94606337|NCT02694523|324022228|FG002|Part B|Withdrawal by Subject|9|||
94606338|NCT02694523|324022229|FG003|Part B|Withdrawal by Subject|0|||
94606339|NCT02694523|324022230|FG004|Part B|Withdrawal by Subject|1|||
94606340|NCT02694523|324022231|FG005|Part B|Withdrawal by Subject|3|||
94606341|NCT02694523|324022232|FG006|Part B|Withdrawal by Subject|0|||
94606342|NCT02694523|324022226|FG000|Part B|Other|0|||
94606343|NCT02694523|324022227|FG001|Part B|Other|0|||
94606344|NCT02694523|324022228|FG002|Part B|Other|1|||
94606345|NCT02694523|324022229|FG003|Part B|Other|0|||
94606346|NCT02694523|324022230|FG004|Part B|Other|0|||
94606347|NCT02694523|324022231|FG005|Part B|Other|0|||
94606348|NCT02694523|324022232|FG006|Part B|Other|1|||
94606349|NCT00679055|324022233|FG000|Overall Study|Adverse Event|0|||
94606350|NCT00679055|324022234|FG001|Overall Study|Adverse Event|1|||
94606351|NCT00679055|324022233|FG000|Overall Study|Other|0|||
94606352|NCT00679055|324022234|FG001|Overall Study|Other|3|||
94606353|NCT00679055|324022233|FG000|Overall Study|Study Terminated|2|||
94606354|NCT00679055|324022234|FG001|Overall Study|Study Terminated|1|||
94606355|NCT03583073|324022235|FG000|Overall Study|Lost to Follow-up|8|||
94606356|NCT03583073|324022236|FG001|Overall Study|Lost to Follow-up|12|||
94606357|NCT01400815|324022239|FG000|Overall Study|Adverse Event|3|||
94606358|NCT01400815|324022240|FG001|Overall Study|Adverse Event|0|||
94606359|NCT01400815|324022239|FG000|Overall Study|Death|0|||
94606360|NCT01400815|324022240|FG001|Overall Study|Death|1|||
94606361|NCT01400815|324022239|FG000|Overall Study|Lost to Follow-up|18|||
94606362|NCT01400815|324022240|FG001|Overall Study|Lost to Follow-up|11|||
94606363|NCT01400815|324022239|FG000|Overall Study|Protocol Violation|0|||
94606364|NCT01400815|324022240|FG001|Overall Study|Protocol Violation|1|||
94606365|NCT01400815|324022239|FG000|Overall Study|Physician Decision|1|||
94606366|NCT01400815|324022240|FG001|Overall Study|Physician Decision|0|||
94606367|NCT01400815|324022239|FG000|Overall Study|Withdrawal by Subject|15|||
94606368|NCT01400815|324022240|FG001|Overall Study|Withdrawal by Subject|8|||
94606369|NCT01400815|324022239|FG000|Overall Study|Subject in jail|1|||
94606370|NCT01400815|324022240|FG001|Overall Study|Subject in jail|0|||
94606371|NCT02057393|324022242|FG000|Overall Study|Withdrawal by Subject|1|||
94606372|NCT02057393|324022242|FG000|Overall Study|Patient did not meet criteria|1|||
94606373|NCT02675231|324022244|FG000|Overall Study|Withdrawal by Subject|2|||
94606374|NCT02675231|324022245|FG001|Overall Study|Withdrawal by Subject|4|||
94606375|NCT02675231|324022246|FG002|Overall Study|Withdrawal by Subject|2|||
94606376|NCT02675231|324022244|FG000|Overall Study|Lost to Follow-up|3|||
94606377|NCT02675231|324022245|FG001|Overall Study|Lost to Follow-up|4|||
94606378|NCT02675231|324022246|FG002|Overall Study|Lost to Follow-up|3|||
94606379|NCT03953183|324022248|FG000|Overall Study|Physician Decision|0|||
94606380|NCT03953183|324022249|FG001|Overall Study|Physician Decision|1|||
94606381|NCT03953183|324022248|FG000|Overall Study|Withdrawal by Subject|0|||
94606382|NCT03953183|324022249|FG001|Overall Study|Withdrawal by Subject|1|||
94606383|NCT04508140|324022252|FG000|Overall Study|Adverse Event|2|||
94606384|NCT04508140|324022253|FG001|Overall Study|Adverse Event|2|||
94606385|NCT04508140|324022252|FG000|Overall Study|Withdrawal by Subject|0|||
94606386|NCT04508140|324022253|FG001|Overall Study|Withdrawal by Subject|2|||
94606387|NCT04508140|324022252|FG000|Overall Study|progressive disease|9|||
94606388|NCT04508140|324022253|FG001|Overall Study|progressive disease|3|||
94606389|NCT00107952|324022254|FG000|Overall Study|Death|75|||
94606390|NCT00107952|324022255|FG001|Overall Study|Death|61|||
94606391|NCT00107952|324022254|FG000|Overall Study|Lost to Follow-up|0|||
94606392|NCT00107952|324022255|FG001|Overall Study|Lost to Follow-up|3|||
94606393|NCT00107952|324022254|FG000|Overall Study|Withdrawal by Subject|9|||
94606394|NCT00107952|324022255|FG001|Overall Study|Withdrawal by Subject|6|||
94606395|NCT00107952|324022254|FG000|Overall Study|Other|2|||
94606396|NCT00107952|324022255|FG001|Overall Study|Other|5|||
94606397|NCT00107952|324022254|FG000|Overall Study|Never received study treatment|9|||
94606398|NCT00107952|324022255|FG001|Overall Study|Never received study treatment|6|||
94606399|NCT03614975|324022256|FG000|Overall Study|Physician Decision|7|||
94606400|NCT03614975|324022257|FG001|Overall Study|Physician Decision|5|||
94606401|NCT03614975|324022256|FG000|Overall Study|Withdrawal by Subject|2|||
94606402|NCT03614975|324022257|FG001|Overall Study|Withdrawal by Subject|2|||
94606403|NCT03614975|324022256|FG000|Overall Study|Specimens not in lab batch shipment|1|||
94606404|NCT03614975|324022257|FG001|Overall Study|Specimens not in lab batch shipment|1|||
94606405|NCT01912963|324022275|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
94606406|NCT01912963|324022276|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
94606407|NCT01912963|324022277|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
94606408|NCT01912963|324022275|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
94606409|NCT01912963|324022276|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
94606410|NCT01912963|324022277|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
94606411|NCT01912963|324022275|FG000|Overall Study|Adverse Event|0|||
94606412|NCT01912963|324022276|FG001|Overall Study|Adverse Event|1|||
94606413|NCT01912963|324022277|FG002|Overall Study|Adverse Event|1|||
94606414|NCT01912963|324022275|FG000|Overall Study|Withdrawal by Subject|0|||
94606415|NCT01912963|324022276|FG001|Overall Study|Withdrawal by Subject|1|||
94606416|NCT01912963|324022277|FG002|Overall Study|Withdrawal by Subject|0|||
94606417|NCT01912963|324022275|FG000|Overall Study|Sought treatment locally|0|||
94606418|NCT01912963|324022276|FG001|Overall Study|Sought treatment locally|1|||
94606419|NCT01912963|324022277|FG002|Overall Study|Sought treatment locally|0|||
94606420|NCT05281601|324022283|FG000|Overall Study|Physician Decision|2|||
94606421|NCT05281601|324022284|FG001|Overall Study|Physician Decision|0|||
94606422|NCT05281601|324022283|FG000|Overall Study|Lost to Follow-up|2|||
94606423|NCT05281601|324022284|FG001|Overall Study|Lost to Follow-up|0|||
94606424|NCT05281601|324022283|FG000|Overall Study|Death|1|||
94606425|NCT05281601|324022284|FG001|Overall Study|Death|0|||
94606426|NCT05281601|324022283|FG000|Overall Study|Withdrawal by parent/guardian|2|||
94606427|NCT05281601|324022284|FG001|Overall Study|Withdrawal by parent/guardian|1|||
94606428|NCT00586846|324022287|FG000|Overall Study|Physician Decision|1|||
94606429|NCT00586846|324022287|FG000|Overall Study|Death|1|||
94606430|NCT00586846|324022287|FG000|Overall Study|Evaluable for Toxicity Only|4|||
94606431|NCT00410202|324022291|FG000|On-Treatment|Continuing treatment|69|||
94606432|NCT00410202|324022292|FG001|On-Treatment|Continuing treatment|71|||
94606433|NCT00410202|324022293|FG002|On-Treatment|Continuing treatment|66|||
94606434|NCT00410202|324022291|FG000|On-Treatment|Adverse Event|1|||
94606435|NCT00410202|324022292|FG001|On-Treatment|Adverse Event|3|||
94606436|NCT00410202|324022293|FG002|On-Treatment|Adverse Event|2|||
94606437|NCT00410202|324022291|FG000|On-Treatment|Death|1|||
94606438|NCT00410202|324022292|FG001|On-Treatment|Death|0|||
94606439|NCT00410202|324022293|FG002|On-Treatment|Death|0|||
94606440|NCT00410202|324022291|FG000|On-Treatment|Lost to Follow-up|1|||
94606441|NCT00410202|324022292|FG001|On-Treatment|Lost to Follow-up|0|||
94606442|NCT00410202|324022293|FG002|On-Treatment|Lost to Follow-up|1|||
94606443|NCT00410202|324022291|FG000|On-Treatment|Lack of Efficacy|1|||
94606444|NCT00410202|324022292|FG001|On-Treatment|Lack of Efficacy|4|||
94606445|NCT00410202|324022293|FG002|On-Treatment|Lack of Efficacy|0|||
94606446|NCT00410202|324022291|FG000|On-Treatment|Withdrawal by Subject|2|||
94606447|NCT00410202|324022292|FG001|On-Treatment|Withdrawal by Subject|1|||
94606448|NCT00410202|324022293|FG002|On-Treatment|Withdrawal by Subject|1|||
94606449|NCT00410202|324022291|FG000|On-Treatment|Other Reason|0|||
94606450|NCT00410202|324022292|FG001|On-Treatment|Other Reason|0|||
94606451|NCT00410202|324022293|FG002|On-Treatment|Other Reason|1|||
94606452|NCT00410202|324022291|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
94606453|NCT00410202|324022292|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
94606454|NCT00410202|324022293|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
94606455|NCT00410202|324022291|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
94606456|NCT00410202|324022292|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
94606457|NCT00410202|324022293|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
94606458|NCT00410202|324022291|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
94606459|NCT00410202|324022292|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
94606460|NCT00410202|324022293|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
94606461|NCT04263454|324022294|FG000|Overall Study|Adverse Event|0|||
94606462|NCT04263454|324022295|FG001|Overall Study|Adverse Event|2|||
94606463|NCT04263454|324022294|FG000|Overall Study|Physician Decision|3|||
94606464|NCT04263454|324022295|FG001|Overall Study|Physician Decision|5|||
94606465|NCT04263454|324022294|FG000|Overall Study|Poor Data Quality|0|||
94606466|NCT04263454|324022295|FG001|Overall Study|Poor Data Quality|1|||
94606467|NCT01674634|324022297|FG000|Overall Study|Withdrawal by Subject|3|||
94606468|NCT01674634|324022297|FG000|Overall Study|Lost to Follow-up|3|||
94606469|NCT01278160|324022312|FG000|Overall Study|Adverse Event|1|||
94606470|NCT01278160|324022313|FG001|Overall Study|Adverse Event|1|||
94606471|NCT01278160|324022312|FG000|Overall Study|Lost to Follow-up|0|||
94606472|NCT01278160|324022313|FG001|Overall Study|Lost to Follow-up|1|||
94606473|NCT01278160|324022312|FG000|Overall Study|Withdrawal by Subject|3|||
94606474|NCT01278160|324022313|FG001|Overall Study|Withdrawal by Subject|2|||
94606475|NCT01278160|324022312|FG000|Overall Study|Unclassified|1|||
94606476|NCT01278160|324022313|FG001|Overall Study|Unclassified|2|||
94606477|NCT00445978|324022314|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
94606478|NCT00445978|324022314|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
94606479|NCT00445978|324022314|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
94606480|NCT00445978|324022314|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
94606481|NCT00445978|324022314|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
94606482|NCT00445978|324022314|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
94606483|NCT00445978|324022314|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
94606484|NCT00445978|324022314|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
94606485|NCT00445978|324022314|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
94606486|NCT03438383|324022319|FG000|Overall Study|Protocol Violation|9|||
94606487|NCT03438383|324022320|FG001|Overall Study|Protocol Violation|3|||
94606488|NCT02819518|324022321|FG000|Overall Study|Death|9|||
94606489|NCT02819518|324022322|FG001|Overall Study|Death|12|||
94606490|NCT02819518|324022323|FG002|Overall Study|Death|9|||
94606491|NCT02819518|324022324|FG003|Overall Study|Death|475|||
94606492|NCT02819518|324022325|FG004|Overall Study|Death|244|||
94606493|NCT02819518|324022321|FG000|Overall Study|Withdrawal by Subject|0|||
94606494|NCT02819518|324022322|FG001|Overall Study|Withdrawal by Subject|0|||
94606495|NCT02819518|324022323|FG002|Overall Study|Withdrawal by Subject|0|||
94606496|NCT02819518|324022324|FG003|Overall Study|Withdrawal by Subject|25|||
94606497|NCT02819518|324022325|FG004|Overall Study|Withdrawal by Subject|8|||
94606498|NCT02819518|324022321|FG000|Overall Study|Lost to Follow-up|0|||
94606499|NCT02819518|324022322|FG001|Overall Study|Lost to Follow-up|0|||
94606500|NCT02819518|324022323|FG002|Overall Study|Lost to Follow-up|0|||
94606501|NCT02819518|324022324|FG003|Overall Study|Lost to Follow-up|0|||
94606502|NCT02819518|324022325|FG004|Overall Study|Lost to Follow-up|1|||
94606503|NCT02819518|324022321|FG000|Overall Study|Sponsor Decision|1|||
94606504|NCT02819518|324022322|FG001|Overall Study|Sponsor Decision|1|||
94606505|NCT02819518|324022323|FG002|Overall Study|Sponsor Decision|0|||
94606506|NCT02819518|324022324|FG003|Overall Study|Sponsor Decision|34|||
94606507|NCT02819518|324022325|FG004|Overall Study|Sponsor Decision|17|||
94606508|NCT02819518|324022321|FG000|Overall Study|Transferred to extension study|1|||
94606509|NCT02819518|324022322|FG001|Overall Study|Transferred to extension study|1|||
94606510|NCT02819518|324022323|FG002|Overall Study|Transferred to extension study|1|||
94606511|NCT02819518|324022324|FG003|Overall Study|Transferred to extension study|32|||
94606512|NCT02819518|324022325|FG004|Overall Study|Transferred to extension study|11|||
94606513|NCT00880165|324022326|FG000|Overall Study|Withdrawal by Subject|27|||
94606514|NCT00880165|324022327|FG001|Overall Study|Withdrawal by Subject|23|||
94606515|NCT00880165|324022326|FG000|Overall Study|Not diagnosed with OSA|14|||
94606516|NCT00880165|324022327|FG001|Overall Study|Not diagnosed with OSA|8|||
94606517|NCT00880165|324022326|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
94357270|NCT03556202|323089624|FG002|Extension Treatment Period|Lack of Efficacy|18|||
94357271|NCT03556202|323089622|FG000|Extension Treatment Period|Lost to Follow-up|9|||
94357272|NCT03556202|323089623|FG001|Extension Treatment Period|Lost to Follow-up|20|||
94357273|NCT03556202|323089624|FG002|Extension Treatment Period|Lost to Follow-up|2|||
94357274|NCT03556202|323089622|FG000|Extension Treatment Period|Pregnancy|2|||
94357275|NCT03556202|323089623|FG001|Extension Treatment Period|Pregnancy|4|||
94357276|NCT03556202|323089624|FG002|Extension Treatment Period|Pregnancy|3|||
94357277|NCT03556202|323089622|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
94357278|NCT03556202|323089623|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
94357279|NCT03556202|323089624|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
94357280|NCT03556202|323089622|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
94357281|NCT03556202|323089623|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
94357282|NCT03556202|323089624|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
94357283|NCT03556202|323089622|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
94357284|NCT03556202|323089623|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
94357285|NCT03556202|323089624|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
94357286|NCT03556202|323089622|FG000|Extension Treatment Period|Physician Decision|0|||
94357287|NCT03556202|323089623|FG001|Extension Treatment Period|Physician Decision|8|||
94357288|NCT03556202|323089624|FG002|Extension Treatment Period|Physician Decision|2|||
94357289|NCT03556202|323089622|FG000|Extension Treatment Period|Protocol Violation|0|||
94357290|NCT03556202|323089623|FG001|Extension Treatment Period|Protocol Violation|1|||
94251040|NCT00091169|322712802|FG001|Overall Study|Adverse Event|17|||
94251041|NCT00091169|322712801|FG000|Overall Study|Death|4|||
94357291|NCT03556202|323089624|FG002|Extension Treatment Period|Protocol Violation|1|||
94357292|NCT03556202|323089622|FG000|Extension Treatment Period|Sponsor Decision|0|||
94357293|NCT03556202|323089623|FG001|Extension Treatment Period|Sponsor Decision|1|||
94357294|NCT03556202|323089624|FG002|Extension Treatment Period|Sponsor Decision|0|||
94357295|NCT03556202|323089622|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
94357296|NCT03556202|323089623|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
94357297|NCT03556202|323089624|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
94357298|NCT03556202|323089622|FG000|Follow-Up Period (12 Weeks)|Death|1|||
94661535|NCT00968669|324215742|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
94661536|NCT00968669|324215743|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
94661537|NCT00968669|324215744|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
94251042|NCT00091169|322712802|FG001|Overall Study|Death|1|||
94251043|NCT00091169|322712801|FG000|Overall Study|Withdrawal by Subject|10|||
94251044|NCT00091169|322712802|FG001|Overall Study|Withdrawal by Subject|13|||
94251045|NCT00091169|322712801|FG000|Overall Study|Other|3|||
94251046|NCT00091169|322712802|FG001|Overall Study|Other|4|||
94251047|NCT00091169|322712801|FG000|Overall Study|Not start protocol therapy|26|||
94251048|NCT00091169|322712802|FG001|Overall Study|Not start protocol therapy|17|||
94251049|NCT00833833|322712803|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
94251050|NCT00833833|322712804|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
94251051|NCT00833833|322712805|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
94251052|NCT00833833|322712806|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
94251053|NCT00833833|322712807|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
94251054|NCT00833833|322712808|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
94251055|NCT00833833|322712803|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
94251056|NCT00833833|322712804|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
94357299|NCT03556202|323089623|FG001|Follow-Up Period (12 Weeks)|Death|0|||
94357300|NCT03556202|323089624|FG002|Follow-Up Period (12 Weeks)|Death|0|||
94357301|NCT03556202|323089622|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
94357302|NCT03556202|323089623|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
94357303|NCT03556202|323089624|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
94357304|NCT03556202|323089622|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
94357305|NCT03556202|323089623|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
94458958|NCT00972816|323469484|FG005|Overall Study|Inappropriate enrolment|0|||
94458959|NCT00972816|323469485|FG006|Overall Study|Inappropriate enrolment|2|||
94458960|NCT00972816|323469486|FG007|Overall Study|Inappropriate enrolment|0|||
94458961|NCT00972816|323469479|FG000|Overall Study|Unable to classify|2|||
94458962|NCT00972816|323469480|FG001|Overall Study|Unable to classify|0|||
94458963|NCT00972816|323469481|FG002|Overall Study|Unable to classify|0|||
94458964|NCT00972816|323469482|FG003|Overall Study|Unable to classify|0|||
94458965|NCT00972816|323469483|FG004|Overall Study|Unable to classify|1|||
94458966|NCT00972816|323469484|FG005|Overall Study|Unable to classify|0|||
94458967|NCT00972816|323469485|FG006|Overall Study|Unable to classify|0|||
94458968|NCT00972816|323469486|FG007|Overall Study|Unable to classify|0|||
94458969|NCT03104400|323469487|FG000|Overall Study|Adverse Event|5|||
94458970|NCT03104400|323469488|FG001|Overall Study|Adverse Event|7|||
94458971|NCT03104400|323469489|FG002|Overall Study|Adverse Event|11|||
94458972|NCT03104400|323469490|FG003|Overall Study|Adverse Event|9|||
94458973|NCT03104400|323469491|FG004|Overall Study|Adverse Event|21|||
94661538|NCT00968669|324215745|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
94606518|NCT00880165|324022327|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
94606519|NCT00880165|324022326|FG000|Overall Study|Lost to follow|9|||
94606520|NCT00880165|324022327|FG001|Overall Study|Lost to follow|15|||
94606521|NCT02766465|324022328|FG000|Overall Study|Withdrawal by Subject|0|||
94606522|NCT02766465|324022329|FG001|Overall Study|Withdrawal by Subject|10|||
94606523|NCT01907100|324022330|FG000|Overall Study|PD based on modified RECIST criteria|31|||
94606524|NCT01907100|324022331|FG001|Overall Study|PD based on modified RECIST criteria|32|||
94606525|NCT01907100|324022332|FG002|Overall Study|PD based on modified RECIST criteria|95|||
94606526|NCT01907100|324022333|FG003|Overall Study|PD based on modified RECIST criteria|92|||
94661539|NCT00968669|324215742|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
94357306|NCT03556202|323089624|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
94357307|NCT03556202|323089622|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
94357308|NCT03556202|323089623|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
94357309|NCT03556202|323089624|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
94357310|NCT03556202|323089622|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
94357311|NCT03556202|323089623|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
94357312|NCT03556202|323089624|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
94357313|NCT03556202|323089622|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
94357314|NCT03556202|323089623|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
94357315|NCT03556202|323089624|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
94357316|NCT03556202|323089622|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
94357317|NCT03556202|323089623|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
94357318|NCT03556202|323089624|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
94357319|NCT03556202|323089622|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
94357320|NCT03556202|323089623|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
94357321|NCT03556202|323089624|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
94357322|NCT03556202|323089622|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
94357323|NCT03556202|323089623|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
94357324|NCT03556202|323089624|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
94357325|NCT03556202|323089622|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
94357326|NCT03556202|323089623|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
94357327|NCT03556202|323089624|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
94357328|NCT03556202|323089622|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
94357329|NCT03556202|323089623|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
94357330|NCT03556202|323089624|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
94357331|NCT03556202|323089622|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
94357332|NCT03556202|323089623|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
94357333|NCT03556202|323089624|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
94357334|NCT03556202|323089622|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
94357335|NCT03556202|323089623|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
94357336|NCT03556202|323089624|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
94357337|NCT00908375|323089625|FG000|Overall Study|Withdrawal by Subject|2|||
94357338|NCT00908375|323089626|FG001|Overall Study|Withdrawal by Subject|4|||
94357339|NCT00908375|323089625|FG000|Overall Study|Lost to Follow-up|8|||
94357340|NCT00908375|323089626|FG001|Overall Study|Lost to Follow-up|6|||
94357341|NCT05807464|323089627|FG000|Overall Study|Adverse Event|1|||
94357342|NCT04668157|323089628|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
94357343|NCT04668157|323089629|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
94357344|NCT04668157|323089628|FG000|Treatment Period (52 Weeks)|Other|0|||
94357345|NCT04668157|323089629|FG001|Treatment Period (52 Weeks)|Other|2|||
94357346|NCT03958045|323089630|FG000|Overall Study|Withdrawal by Subject|1|||
94357347|NCT02283411|323089635|FG000|Overall Study|Withdrawal by Subject|3|||
94357348|NCT02283411|323089635|FG000|Overall Study|Screen Failed|28|||
94357349|NCT05261126|323089637|FG000|Overall Study|Death|0|||
94357350|NCT05261126|323089638|FG001|Overall Study|Death|0|||
94357351|NCT05261126|323089639|FG002|Overall Study|Death|1|||
94357352|NCT05261126|323089640|FG003|Overall Study|Death|0|||
94357353|NCT05261126|323089641|FG004|Overall Study|Death|0|||
94357354|NCT05261126|323089637|FG000|Overall Study|Lost to Follow-up|0|||
94357355|NCT05261126|323089638|FG001|Overall Study|Lost to Follow-up|0|||
94357356|NCT05261126|323089639|FG002|Overall Study|Lost to Follow-up|0|||
94357357|NCT05261126|323089640|FG003|Overall Study|Lost to Follow-up|0|||
94357358|NCT05261126|323089641|FG004|Overall Study|Lost to Follow-up|1|||
94357359|NCT05261126|323089637|FG000|Overall Study|Physician Decision|1|||
94357360|NCT05261126|323089638|FG001|Overall Study|Physician Decision|0|||
94357361|NCT05261126|323089639|FG002|Overall Study|Physician Decision|0|||
94357362|NCT05261126|323089640|FG003|Overall Study|Physician Decision|0|||
94357363|NCT05261126|323089641|FG004|Overall Study|Physician Decision|0|||
94357364|NCT05261126|323089637|FG000|Overall Study|Screen Failure|0|||
94357365|NCT05261126|323089638|FG001|Overall Study|Screen Failure|0|||
94357366|NCT05261126|323089639|FG002|Overall Study|Screen Failure|0|||
94458974|NCT03104400|323469487|FG000|Overall Study|Withdrawal by Subject|17|||
94458975|NCT03104400|323469488|FG001|Overall Study|Withdrawal by Subject|19|||
94458976|NCT03104400|323469489|FG002|Overall Study|Withdrawal by Subject|29|||
94458977|NCT03104400|323469490|FG003|Overall Study|Withdrawal by Subject|25|||
94458978|NCT03104400|323469491|FG004|Overall Study|Withdrawal by Subject|24|||
94458979|NCT03104400|323469487|FG000|Overall Study|Lost to Follow-up|4|||
94458980|NCT03104400|323469488|FG001|Overall Study|Lost to Follow-up|1|||
94458981|NCT03104400|323469489|FG002|Overall Study|Lost to Follow-up|4|||
94458982|NCT03104400|323469490|FG003|Overall Study|Lost to Follow-up|8|||
94357367|NCT05261126|323089640|FG003|Overall Study|Screen Failure|0|||
94458983|NCT03104400|323469491|FG004|Overall Study|Lost to Follow-up|7|||
94606527|NCT01907100|324022330|FG000|Overall Study|Withdrawal by Subject|2|||
94357368|NCT05261126|323089641|FG004|Overall Study|Screen Failure|1|||
94357369|NCT05261126|323089637|FG000|Overall Study|Withdrawal by Subject|1|||
94606528|NCT01907100|324022331|FG001|Overall Study|Withdrawal by Subject|5|||
94606529|NCT01907100|324022332|FG002|Overall Study|Withdrawal by Subject|10|||
94606530|NCT01907100|324022333|FG003|Overall Study|Withdrawal by Subject|13|||
94606531|NCT01907100|324022330|FG000|Overall Study|Protocol Violation|0|||
94606532|NCT01907100|324022331|FG001|Overall Study|Protocol Violation|0|||
94606533|NCT01907100|324022332|FG002|Overall Study|Protocol Violation|1|||
94606534|NCT01907100|324022333|FG003|Overall Study|Protocol Violation|1|||
94606535|NCT01907100|324022330|FG000|Overall Study|Lost to Follow-up|0|||
94606536|NCT01907100|324022331|FG001|Overall Study|Lost to Follow-up|0|||
94606537|NCT01907100|324022332|FG002|Overall Study|Lost to Follow-up|0|||
94606538|NCT01907100|324022333|FG003|Overall Study|Lost to Follow-up|1|||
94606539|NCT01907100|324022330|FG000|Overall Study|Not treated|2|||
94606540|NCT01907100|324022331|FG001|Overall Study|Not treated|0|||
94606541|NCT01907100|324022332|FG002|Overall Study|Not treated|1|||
94606542|NCT01907100|324022333|FG003|Overall Study|Not treated|2|||
94606543|NCT01907100|324022330|FG000|Overall Study|Other than reasons specified|1|||
94606544|NCT01907100|324022331|FG001|Overall Study|Other than reasons specified|0|||
94606545|NCT01907100|324022332|FG002|Overall Study|Other than reasons specified|10|||
94606546|NCT01907100|324022333|FG003|Overall Study|Other than reasons specified|6|||
94606547|NCT01907100|324022330|FG000|Overall Study|Adverse event (AE)|6|||
94606548|NCT01907100|324022331|FG001|Overall Study|Adverse event (AE)|3|||
94606549|NCT01907100|324022332|FG002|Overall Study|Adverse event (AE)|22|||
94606550|NCT01907100|324022333|FG003|Overall Study|Adverse event (AE)|23|||
94606551|NCT01907100|324022330|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
94606552|NCT01907100|324022331|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
94606553|NCT01907100|324022332|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
94606554|NCT01907100|324022333|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
94606555|NCT02059005|324022334|FG000|Overall Study|Death|1|||
94606556|NCT02059005|324022335|FG001|Overall Study|Death|3|||
94606557|NCT02059005|324022334|FG000|Overall Study|Lost to Follow-up|19|||
94606558|NCT02059005|324022335|FG001|Overall Study|Lost to Follow-up|19|||
94606559|NCT02059005|324022334|FG000|Overall Study|Incarceration|0|||
94606560|NCT02059005|324022335|FG001|Overall Study|Incarceration|1|||
94606561|NCT02059005|324022334|FG000|Overall Study|Inpatient|0|||
94606562|NCT02059005|324022335|FG001|Overall Study|Inpatient|1|||
94606563|NCT00739596|324022338|FG000|Overall Study|Adverse Event|12|||
94606564|NCT00739596|324022339|FG001|Overall Study|Adverse Event|6|||
94606565|NCT00739596|324022338|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
94606566|NCT00739596|324022339|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
94357370|NCT05261126|323089638|FG001|Overall Study|Withdrawal by Subject|0|||
94606567|NCT00739596|324022338|FG000|Overall Study|Patient Withdrew Consent|8|||
94251057|NCT00833833|322712805|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
94251058|NCT00833833|322712806|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
94251059|NCT00833833|322712807|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
94251060|NCT00833833|322712808|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
94251061|NCT00833833|322712803|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
94251062|NCT00833833|322712804|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
94251063|NCT00833833|322712805|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
94251064|NCT00833833|322712806|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
94251065|NCT00833833|322712807|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
94251066|NCT00833833|322712808|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
94251067|NCT00833833|322712803|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
94251068|NCT00833833|322712804|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
94251069|NCT00833833|322712805|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
94251070|NCT00833833|322712806|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
94251071|NCT00833833|322712807|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
94251072|NCT00833833|322712808|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
94251073|NCT00833833|322712803|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
94251074|NCT00833833|322712804|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
94251075|NCT00833833|322712805|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
94251076|NCT00833833|322712806|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
94251077|NCT00833833|322712807|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
94251078|NCT00833833|322712808|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
94251079|NCT00833833|322712803|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
94251080|NCT00833833|322712804|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
94251081|NCT00833833|322712805|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
94251082|NCT00833833|322712806|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
94251083|NCT00833833|322712807|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
94251084|NCT00833833|322712808|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
94251085|NCT00833833|322712803|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
94251086|NCT00833833|322712804|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
94251087|NCT00833833|322712805|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
94251088|NCT00833833|322712806|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
94251089|NCT00833833|322712807|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
94251090|NCT00833833|322712808|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
94251091|NCT00833833|322712803|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
94251092|NCT00833833|322712804|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
94251093|NCT00833833|322712805|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
94251094|NCT00833833|322712806|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
94251095|NCT00833833|322712807|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
94251096|NCT00833833|322712808|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
94251097|NCT00833833|322712803|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
94251098|NCT00833833|322712804|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
94251099|NCT00833833|322712805|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
94251100|NCT00833833|322712806|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
94251101|NCT00833833|322712807|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
94251102|NCT00833833|322712808|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
94251103|NCT00833833|322712803|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
94251104|NCT00833833|322712804|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
94251105|NCT00833833|322712805|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
94251106|NCT00833833|322712806|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
94251107|NCT00833833|322712807|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
94251108|NCT00833833|322712808|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
94251109|NCT00833833|322712803|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
94251110|NCT00833833|322712804|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
94251111|NCT00833833|322712805|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
94251112|NCT00833833|322712806|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
94251113|NCT00833833|322712807|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
94251114|NCT00833833|322712808|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
94251115|NCT00833833|322712803|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
94251116|NCT00833833|322712804|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
94251117|NCT00833833|322712805|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
94251118|NCT00833833|322712806|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
94251119|NCT00833833|322712807|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
94251120|NCT00833833|322712808|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
94357371|NCT05261126|323089639|FG002|Overall Study|Withdrawal by Subject|1|||
94251121|NCT00833833|322712803|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
94251122|NCT00833833|322712804|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
94251123|NCT00833833|322712805|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
94251124|NCT00833833|322712806|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
94606568|NCT00739596|324022339|FG001|Overall Study|Patient Withdrew Consent|8|||
94606569|NCT00739596|324022338|FG000|Overall Study|Lost to Follow-up|0|||
94606570|NCT00739596|324022339|FG001|Overall Study|Lost to Follow-up|2|||
94606571|NCT00739596|324022338|FG000|Overall Study|Protocol Deviation|1|||
94606572|NCT00739596|324022339|FG001|Overall Study|Protocol Deviation|1|||
94606573|NCT00908011|324022340|FG000|Overall Study|Withdrawal by Subject|2|||
94606574|NCT00908011|324022341|FG001|Overall Study|Withdrawal by Subject|2|||
94251125|NCT00833833|322712807|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
94251126|NCT00833833|322712808|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
94251127|NCT03507777|322712810|FG000|Overall Study|Lost to Follow-up|5|||
94251128|NCT03507777|322712811|FG001|Overall Study|Lost to Follow-up|7|||
94251129|NCT03507777|322712810|FG000|Overall Study|Withdrawal by Subject|6|||
94251130|NCT03507777|322712811|FG001|Overall Study|Withdrawal by Subject|11|||
94251131|NCT03507777|322712810|FG000|Overall Study|Death|30|||
94251132|NCT03507777|322712811|FG001|Overall Study|Death|44|||
94251133|NCT03507777|322712810|FG000|Overall Study|Other Reasons|3|||
94251134|NCT03507777|322712811|FG001|Overall Study|Other Reasons|8|||
94251135|NCT01346475|322712813|FG000|First Intervention|Lost to Follow-up|4|||
94251136|NCT01346475|322712814|FG001|First Intervention|Lost to Follow-up|3|||
94251137|NCT02366468|322712815|FG000|Overall Study|Adverse Event|2|||
94251138|NCT02366468|322712816|FG001|Overall Study|Adverse Event|0|||
94251139|NCT02366468|322712815|FG000|Overall Study|Withdrawal by Subject|1|||
94251140|NCT02366468|322712816|FG001|Overall Study|Withdrawal by Subject|5|||
94251141|NCT02366468|322712815|FG000|Overall Study|Lost to Follow-up|2|||
94251142|NCT02366468|322712816|FG001|Overall Study|Lost to Follow-up|0|||
94251143|NCT02366468|322712815|FG000|Overall Study|Death|1|||
94251144|NCT02366468|322712816|FG001|Overall Study|Death|2|||
94251145|NCT02366468|322712815|FG000|Overall Study|Other|0|||
94251146|NCT02366468|322712816|FG001|Overall Study|Other|2|||
94251147|NCT01776541|322712817|FG000|Overall Study|Administrative Reason|6|||
94251148|NCT01776541|322712818|FG001|Overall Study|Administrative Reason|2|||
94251149|NCT01776541|322712817|FG000|Overall Study|Death|4|||
94251150|NCT01776541|322712818|FG001|Overall Study|Death|0|||
94251151|NCT01776541|322712817|FG000|Overall Study|Lost to Follow-up|27|||
94251152|NCT01776541|322712818|FG001|Overall Study|Lost to Follow-up|48|||
94251153|NCT01776541|322712817|FG000|Overall Study|Unclassified|5|||
94251154|NCT01776541|322712818|FG001|Overall Study|Unclassified|4|||
94251155|NCT01776541|322712817|FG000|Overall Study|Protocol Violation|2|||
94251156|NCT01776541|322712818|FG001|Overall Study|Protocol Violation|1|||
94251157|NCT01776541|322712817|FG000|Overall Study|Withdrawal by Subject|12|||
94251158|NCT01776541|322712818|FG001|Overall Study|Withdrawal by Subject|20|||
94251159|NCT00618618|322712819|FG000|Overall Study|Patient Request|0|||
94251160|NCT00618618|322712820|FG001|Overall Study|Patient Request|0|||
94251161|NCT00618618|322712821|FG002|Overall Study|Patient Request|2|||
94251162|NCT00618618|322712822|FG003|Overall Study|Patient Request|0|||
94251163|NCT00618618|322712819|FG000|Overall Study|Inability to Complete Study Procedures|0|||
94251164|NCT00618618|322712820|FG001|Overall Study|Inability to Complete Study Procedures|1|||
94251165|NCT00618618|322712821|FG002|Overall Study|Inability to Complete Study Procedures|0|||
94251166|NCT00618618|322712822|FG003|Overall Study|Inability to Complete Study Procedures|0|||
94251167|NCT00618618|322712819|FG000|Overall Study|Lost to Follow-up|3|||
94251168|NCT00618618|322712820|FG001|Overall Study|Lost to Follow-up|0|||
94251169|NCT00618618|322712821|FG002|Overall Study|Lost to Follow-up|0|||
94251170|NCT00618618|322712822|FG003|Overall Study|Lost to Follow-up|1|||
94251171|NCT00618618|322712819|FG000|Overall Study|Non-compliance|1|||
94251172|NCT00618618|322712820|FG001|Overall Study|Non-compliance|1|||
94251173|NCT00618618|322712821|FG002|Overall Study|Non-compliance|0|||
94251174|NCT00618618|322712822|FG003|Overall Study|Non-compliance|0|||
94251175|NCT00618618|322712819|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
94251176|NCT00618618|322712820|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
94251177|NCT00618618|322712821|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
94251178|NCT00618618|322712822|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
94251179|NCT00618618|322712819|FG000|Overall Study|Death|0|||
94251180|NCT00618618|322712820|FG001|Overall Study|Death|1|||
94251181|NCT00618618|322712821|FG002|Overall Study|Death|0|||
94251182|NCT00618618|322712822|FG003|Overall Study|Death|0|||
94606575|NCT01994590|324024108|FG000|Overall Study|Adverse Event|1|||
94251183|NCT01183234|322712826|FG000|First Intervention|Adverse Event|1|||
94251184|NCT01183234|322712827|FG001|First Intervention|Adverse Event|0|||
94251185|NCT05062759|322712831|FG000|Overall Study|Death|0|||
94251186|NCT05062759|322712832|FG001|Overall Study|Death|1|||
94251187|NCT05062759|322712831|FG000|Overall Study|Lost to Follow-up|1|||
94251188|NCT05062759|322712832|FG001|Overall Study|Lost to Follow-up|0|||
94251189|NCT00903006|322712833|FG000|Overall Study|Withdrawal by Subject|2|||
94251190|NCT00903006|322712834|FG001|Overall Study|Withdrawal by Subject|0|||
94606576|NCT01994590|324024108|FG000|Overall Study|Trial Terminated|1|||
94606577|NCT04123665|324024111|FG000|Overall Study|Withdrawal by Subject|7|||
94606578|NCT04123665|324024112|FG001|Overall Study|Withdrawal by Subject|0|||
94606579|NCT04123665|324024111|FG000|Overall Study|Lost to Follow-up|1|||
94251191|NCT00903006|322712835|FG002|Overall Study|Withdrawal by Subject|0|||
94357372|NCT05261126|323089640|FG003|Overall Study|Withdrawal by Subject|1|||
94357373|NCT05261126|323089641|FG004|Overall Study|Withdrawal by Subject|0|||
94357374|NCT05261126|323089637|FG000|Overall Study|Not Recorded|0|||
94357375|NCT05261126|323089638|FG001|Overall Study|Not Recorded|0|||
94606580|NCT04123665|324024112|FG001|Overall Study|Lost to Follow-up|0|||
94606581|NCT02237911|324024115|FG000|Overall Study|Withdrawal by Subject|4|||
94606582|NCT02237911|324024116|FG001|Overall Study|Withdrawal by Subject|7|||
94606583|NCT02237911|324024117|FG002|Overall Study|Withdrawal by Subject|2|||
94606584|NCT02237911|324024115|FG000|Overall Study|Lost to Follow-up|3|||
94606585|NCT02237911|324024116|FG001|Overall Study|Lost to Follow-up|1|||
94606586|NCT02237911|324024117|FG002|Overall Study|Lost to Follow-up|1|||
94606587|NCT00053365|324024118|FG000|Overall Study|Incorrect cell type|1|||
94606588|NCT00053365|324024118|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
94606589|NCT00053365|324024118|FG000|Overall Study|Never treated|4|||
94606590|NCT01483690|324024119|FG000|Overall Study|Adverse Event|1|||
94606591|NCT01483690|324024120|FG001|Overall Study|Adverse Event|2|||
94606592|NCT01483690|324024119|FG000|Overall Study|clinical deterioration|1|||
94606593|NCT01483690|324024120|FG001|Overall Study|clinical deterioration|0|||
94606594|NCT01483690|324024119|FG000|Overall Study|Physician Decision|0|||
94606595|NCT01483690|324024120|FG001|Overall Study|Physician Decision|2|||
94606596|NCT01483690|324024119|FG000|Overall Study|exclusionary procedure|0|||
94606597|NCT01483690|324024120|FG001|Overall Study|exclusionary procedure|1|||
94606598|NCT03183778|324024121|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
94606599|NCT00721123|324024122|FG000|Overall Study|Adverse Event|96|||
94606600|NCT00721123|324024122|FG000|Overall Study|Death|10|||
94606601|NCT00721123|324024122|FG000|Overall Study|Insufficient Therapeutic Response|21|||
94606602|NCT00721123|324024122|FG000|Overall Study|Protocol Violation|1|||
94606603|NCT00721123|324024122|FG000|Overall Study|Refused Treatment|41|||
94606604|NCT00721123|324024122|FG000|Overall Study|Failure to Return|9|||
94606605|NCT00721123|324024122|FG000|Overall Study|Withdrawal by Subject|5|||
94606606|NCT01251744|324024124|FG000|Overall Study|Lost to Follow-up|1|||
94606607|NCT01251744|324024125|FG001|Overall Study|Lost to Follow-up|0|||
94606608|NCT03343067|324024126|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
94606609|NCT03343067|324024127|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
94606610|NCT03343067|324024128|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
94606611|NCT00116168|324024129|FG000|Overall Study|Lost to Follow-up|6|||
94606612|NCT00116168|324024130|FG001|Overall Study|Lost to Follow-up|5|||
94606613|NCT00116168|324024131|FG002|Overall Study|Lost to Follow-up|0|||
94606614|NCT00116168|324024132|FG003|Overall Study|Lost to Follow-up|0|||
94606615|NCT00048061|324024133|FG000|Overall Study|Adverse Event|41|||
94606616|NCT00048061|324024134|FG001|Overall Study|Adverse Event|32|||
94606617|NCT00048061|324024135|FG002|Overall Study|Adverse Event|44|||
94606618|NCT00048061|324024136|FG003|Overall Study|Adverse Event|37|||
94606619|NCT00048061|324024133|FG000|Overall Study|Lost to Follow-up|3|||
94606620|NCT00048061|324024134|FG001|Overall Study|Lost to Follow-up|2|||
94606621|NCT00048061|324024135|FG002|Overall Study|Lost to Follow-up|4|||
94606622|NCT00048061|324024136|FG003|Overall Study|Lost to Follow-up|5|||
94606623|NCT00048061|324024133|FG000|Overall Study|Withdrawal by Subject|20|||
94606624|NCT00048061|324024134|FG001|Overall Study|Withdrawal by Subject|29|||
94606625|NCT00048061|324024135|FG002|Overall Study|Withdrawal by Subject|29|||
94606626|NCT00048061|324024136|FG003|Overall Study|Withdrawal by Subject|32|||
94606627|NCT00048061|324024133|FG000|Overall Study|Did not follow-up|5|||
94606628|NCT00048061|324024134|FG001|Overall Study|Did not follow-up|5|||
94606629|NCT00048061|324024135|FG002|Overall Study|Did not follow-up|4|||
94606630|NCT00048061|324024136|FG003|Overall Study|Did not follow-up|5|||
94606631|NCT00048061|324024133|FG000|Overall Study|Early improvement|6|||
94606632|NCT00048061|324024134|FG001|Overall Study|Early improvement|5|||
94606633|NCT00048061|324024135|FG002|Overall Study|Early improvement|3|||
94606634|NCT00048061|324024136|FG003|Overall Study|Early improvement|0|||
94606635|NCT01323946|324024137|FG000|Overall Study|Lost to Follow-up|0|||
94606636|NCT01323946|324024138|FG001|Overall Study|Lost to Follow-up|1|||
94606637|NCT01323946|324024139|FG002|Overall Study|Lost to Follow-up|0|||
94606638|NCT01323946|324024137|FG000|Overall Study|Parents refused the last blood draw|1|||
94606639|NCT01323946|324024138|FG001|Overall Study|Parents refused the last blood draw|0|||
94357376|NCT05261126|323089639|FG002|Overall Study|Not Recorded|0|||
94357377|NCT05261126|323089640|FG003|Overall Study|Not Recorded|1|||
94606640|NCT01323946|324024139|FG002|Overall Study|Parents refused the last blood draw|0|||
94606641|NCT01323946|324024137|FG000|Overall Study|Withdrawal by Subject|2|||
94606642|NCT01323946|324024138|FG001|Overall Study|Withdrawal by Subject|2|||
94606643|NCT01323946|324024139|FG002|Overall Study|Withdrawal by Subject|0|||
94606644|NCT05896748|324024150|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
94606645|NCT05896748|324024150|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
94606646|NCT05896748|324024150|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
94606647|NCT05896748|324024150|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
94357378|NCT05261126|323089641|FG004|Overall Study|Not Recorded|0|||
94357379|NCT00467051|323090753|FG000|Overall Study|Adverse Event|2|||
94251192|NCT00903006|322712836|FG003|Overall Study|Withdrawal by Subject|0|||
94251193|NCT00903006|322712833|FG000|Overall Study|Progressive Disease|0|||
94251194|NCT00903006|322712834|FG001|Overall Study|Progressive Disease|3|||
94606648|NCT05896748|324024150|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
94606649|NCT02325791|324024152|FG000|Overall Study|Adverse Event|0|||
94606650|NCT02325791|324024153|FG001|Overall Study|Adverse Event|1|||
94606651|NCT02325791|324024154|FG002|Overall Study|Adverse Event|1|||
94606652|NCT02325791|324024155|FG003|Overall Study|Adverse Event|0|||
94606653|NCT02325791|324024152|FG000|Overall Study|Death|0|||
94606654|NCT02325791|324024153|FG001|Overall Study|Death|3|||
94606655|NCT02325791|324024154|FG002|Overall Study|Death|0|||
94606656|NCT02325791|324024155|FG003|Overall Study|Death|1|||
94606657|NCT02325791|324024152|FG000|Overall Study|Lost to Follow-up|0|||
94606658|NCT02325791|324024153|FG001|Overall Study|Lost to Follow-up|15|||
94606659|NCT02325791|324024154|FG002|Overall Study|Lost to Follow-up|14|||
94606660|NCT02325791|324024155|FG003|Overall Study|Lost to Follow-up|9|||
94606661|NCT02325791|324024152|FG000|Overall Study|Physician Decision|0|||
94606662|NCT02325791|324024153|FG001|Overall Study|Physician Decision|1|||
94606663|NCT02325791|324024154|FG002|Overall Study|Physician Decision|1|||
94606664|NCT02325791|324024155|FG003|Overall Study|Physician Decision|0|||
94606665|NCT02325791|324024152|FG000|Overall Study|Protocol Violation|0|||
94606666|NCT02325791|324024153|FG001|Overall Study|Protocol Violation|0|||
94606667|NCT02325791|324024154|FG002|Overall Study|Protocol Violation|1|||
94606668|NCT02325791|324024155|FG003|Overall Study|Protocol Violation|0|||
94606669|NCT02325791|324024152|FG000|Overall Study|Withdrawal by Subject|0|||
94606670|NCT02325791|324024153|FG001|Overall Study|Withdrawal by Subject|5|||
94606671|NCT02325791|324024154|FG002|Overall Study|Withdrawal by Subject|8|||
94606672|NCT02325791|324024155|FG003|Overall Study|Withdrawal by Subject|16|||
94606673|NCT01822678|324024157|FG000|Overall Study|Withdrawal by Subject|5|||
94606674|NCT01822678|324024158|FG001|Overall Study|Withdrawal by Subject|4|||
94606675|NCT01822678|324024159|FG002|Overall Study|Withdrawal by Subject|4|||
94606676|NCT01822678|324024157|FG000|Overall Study|Adverse Event|4|||
94606677|NCT01822678|324024158|FG001|Overall Study|Adverse Event|3|||
94606678|NCT01822678|324024159|FG002|Overall Study|Adverse Event|1|||
94606679|NCT01822678|324024157|FG000|Overall Study|Lack of Efficacy|3|||
94606680|NCT01822678|324024158|FG001|Overall Study|Lack of Efficacy|6|||
94606681|NCT01822678|324024159|FG002|Overall Study|Lack of Efficacy|5|||
94606682|NCT01822678|324024157|FG000|Overall Study|Lost to Follow-up|0|||
94606683|NCT01822678|324024158|FG001|Overall Study|Lost to Follow-up|2|||
94606684|NCT01822678|324024159|FG002|Overall Study|Lost to Follow-up|1|||
94251195|NCT00903006|322712835|FG002|Overall Study|Progressive Disease|1|||
94251196|NCT00903006|322712836|FG003|Overall Study|Progressive Disease|0|||
94251197|NCT01474434|322712837|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
94251198|NCT01474434|322712838|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
94251199|NCT01474434|322712839|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
94251200|NCT01474434|322712840|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
94251201|NCT01474434|322712837|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
94251202|NCT01474434|322712838|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
94251203|NCT01474434|322712839|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
94251204|NCT01474434|322712840|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
94251205|NCT01474434|322712837|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
94251206|NCT01474434|322712838|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
94251207|NCT01474434|322712839|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
94251208|NCT01474434|322712840|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
94251209|NCT01236534|322712848|FG000|Overall Study|Adverse Event|3|||
94251210|NCT01236534|322712849|FG001|Overall Study|Adverse Event|0|||
94357380|NCT01846442|323090755|FG000|Overall Study|Adverse Event|2|||
94357381|NCT01846442|323090756|FG001|Overall Study|Adverse Event|4|||
94606685|NCT00764504|324024160|FG000|Overall Study|Death|12|||
94606686|NCT00764504|324024161|FG001|Overall Study|Death|6|||
94606687|NCT00764504|324024162|FG002|Overall Study|Death|13|||
94606688|NCT00764504|324024160|FG000|Overall Study|Revision of Device|12|||
94606689|NCT00764504|324024161|FG001|Overall Study|Revision of Device|23|||
94606690|NCT00764504|324024162|FG002|Overall Study|Revision of Device|14|||
94606691|NCT00764504|324024160|FG000|Overall Study|Physician Decision|1|||
94606692|NCT00764504|324024161|FG001|Overall Study|Physician Decision|0|||
94606693|NCT00764504|324024162|FG002|Overall Study|Physician Decision|0|||
94606694|NCT00764504|324024160|FG000|Overall Study|Withdrawal by Subject|1|||
94251211|NCT00297232|322712850|FG000|Overall Study|Lack of Efficacy|7|||
94251212|NCT00297232|322712850|FG000|Overall Study|Lost to Follow-up|10|||
94357382|NCT01846442|323090757|FG002|Overall Study|Adverse Event|2|||
94357383|NCT01846442|323090758|FG003|Overall Study|Adverse Event|1|||
94357384|NCT01846442|323090755|FG000|Overall Study|Lost to Follow-up|0|||
94606695|NCT00764504|324024161|FG001|Overall Study|Withdrawal by Subject|7|||
94606696|NCT00764504|324024162|FG002|Overall Study|Withdrawal by Subject|4|||
94606697|NCT00764504|324024160|FG000|Overall Study|Lost to Follow-up|40|||
94606698|NCT00764504|324024161|FG001|Overall Study|Lost to Follow-up|34|||
94251213|NCT00297232|322712850|FG000|Overall Study|Adverse Event|63|||
94606699|NCT00764504|324024162|FG002|Overall Study|Lost to Follow-up|72|||
94606700|NCT01028378|324024163|FG000|Overall Study|Lost to Follow-up|12|||
94606701|NCT01028378|324024163|FG000|Overall Study|Withdrawal by Subject|1|||
94606702|NCT01028378|324024163|FG000|Overall Study|Adminstrative Reasons|4|||
94606703|NCT01465191|324024164|FG000|Overall Study|Protocol Violation|6|||
94606704|NCT01465191|324024165|FG001|Overall Study|Protocol Violation|3|||
94606705|NCT01465191|324024166|FG002|Overall Study|Protocol Violation|3|||
94606706|NCT01465191|324024164|FG000|Overall Study|Lost to Follow-up|3|||
94606707|NCT01465191|324024165|FG001|Overall Study|Lost to Follow-up|6|||
94606708|NCT01465191|324024166|FG002|Overall Study|Lost to Follow-up|4|||
94606709|NCT01298193|324024167|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
94606710|NCT01298193|324024167|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
94606711|NCT01298193|324024167|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
94606712|NCT01298193|324024167|FG000|Efficacy Phase (Second Cycle)|Death|1|||
94606713|NCT00943124|324024168|FG000|Period 1|Withdrawal by Subject|1|||
94606714|NCT00943124|324024169|FG001|Period 1|Withdrawal by Subject|1|||
94606715|NCT00943124|324024168|FG000|Period 1|Did Not Follow Study Procedures|1|||
94606716|NCT00943124|324024169|FG001|Period 1|Did Not Follow Study Procedures|0|||
94606717|NCT00943124|324024168|FG000|Period 1|Personal Reasons|0|||
94606718|NCT00943124|324024169|FG001|Period 1|Personal Reasons|1|||
94606719|NCT04010539|324024170|FG000|Overall Study|Withdrawal by Subject|4|||
94606720|NCT04010539|324024171|FG001|Overall Study|Withdrawal by Subject|1|||
94606721|NCT04010539|324024170|FG000|Overall Study|Physician Decision|0|||
94606722|NCT04010539|324024171|FG001|Overall Study|Physician Decision|2|||
94606723|NCT04010539|324024170|FG000|Overall Study|Lost to Follow-up|10|||
94606724|NCT04010539|324024171|FG001|Overall Study|Lost to Follow-up|14|||
94606725|NCT04010539|324024170|FG000|Overall Study|Adverse Event|3|||
94606726|NCT04010539|324024171|FG001|Overall Study|Adverse Event|0|||
94606727|NCT04010539|324024170|FG000|Overall Study|Participant Did Not Receive IP|0|||
94606728|NCT04010539|324024171|FG001|Overall Study|Participant Did Not Receive IP|1|||
94606729|NCT04010539|324024170|FG000|Overall Study|Protocol Deviation|0|||
94606730|NCT04010539|324024171|FG001|Overall Study|Protocol Deviation|1|||
94606731|NCT04010539|324024170|FG000|Overall Study|Randomized in Error/ Mistake|2|||
94606732|NCT04010539|324024171|FG001|Overall Study|Randomized in Error/ Mistake|0|||
94606733|NCT04010539|324024170|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
94606734|NCT04010539|324024171|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
94606735|NCT03063203|324024172|FG000|Overall Study|Chose alternative therapy|3|||
94606736|NCT03063203|324024172|FG000|Overall Study|Death|2|||
94606737|NCT03063203|324024172|FG000|Overall Study|Disease progression|4|||
94606738|NCT03063203|324024172|FG000|Overall Study|Physician Decision|5|||
94606739|NCT01642407|324024173|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
94606740|NCT01642407|324024173|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
94606741|NCT01642407|324024173|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
94606742|NCT00249288|324024174|FG000|Overall Study|Lost to Follow-up|3|||
94606743|NCT00249288|324024175|FG001|Overall Study|Lost to Follow-up|3|||
94606744|NCT00249288|324024174|FG000|Overall Study|Withdrawal by Subject|2|||
94606745|NCT00249288|324024175|FG001|Overall Study|Withdrawal by Subject|2|||
94606746|NCT03059446|324024176|FG000|Overall Study|Adverse Event|11|||
94606747|NCT03059446|324024176|FG000|Overall Study|Withdrawal of Consent|16|||
94606748|NCT03059446|324024176|FG000|Overall Study|Lost to Follow-up|3|||
94606749|NCT03059446|324024176|FG000|Overall Study|Protocol Violation|1|||
94606750|NCT03059446|324024176|FG000|Overall Study|Study Terminated by Sponsor|131|||
94606751|NCT03059446|324024176|FG000|Overall Study|Reason not Specified|5|||
94606752|NCT04718103|324024177|FG000|Overall Study|Adverse Event|1|||
94606753|NCT04718103|324024178|FG001|Overall Study|Adverse Event|1|||
94606754|NCT04718103|324024177|FG000|Overall Study|Lack of Efficacy|4|||
94606755|NCT04718103|324024178|FG001|Overall Study|Lack of Efficacy|1|||
94606756|NCT04718103|324024177|FG000|Overall Study|Lost to Follow-up|2|||
94606757|NCT04718103|324024178|FG001|Overall Study|Lost to Follow-up|2|||
94606758|NCT04718103|324024177|FG000|Overall Study|Physician Decision|2|||
94606759|NCT04718103|324024178|FG001|Overall Study|Physician Decision|0|||
94606760|NCT04718103|324024177|FG000|Overall Study|Pregnancy|0|||
94606761|NCT04718103|324024178|FG001|Overall Study|Pregnancy|1|||
94606762|NCT04718103|324024177|FG000|Overall Study|Withdrawal by Subject|10|||
94606763|NCT04718103|324024178|FG001|Overall Study|Withdrawal by Subject|6|||
94606764|NCT04718103|324024177|FG000|Overall Study|Randomized, not treated|4|||
94606765|NCT04718103|324024178|FG001|Overall Study|Randomized, not treated|1|||
94606766|NCT04718103|324024177|FG000|Overall Study|GCP violations|7|||
94606767|NCT04718103|324024178|FG001|Overall Study|GCP violations|5|||
94606768|NCT02810340|324024179|FG000|Overall Study|Withdrawal by Subject|1|||
94606769|NCT02810340|324024180|FG001|Overall Study|Withdrawal by Subject|0|||
94606770|NCT02810340|324024181|FG002|Overall Study|Withdrawal by Subject|0|||
94606771|NCT02810340|324024179|FG000|Overall Study|Incarceration|0|||
94606772|NCT02810340|324024180|FG001|Overall Study|Incarceration|1|||
94606773|NCT02810340|324024181|FG002|Overall Study|Incarceration|0|||
94606774|NCT02810340|324024179|FG000|Overall Study|Lost to Follow-up|0|||
94606775|NCT02810340|324024180|FG001|Overall Study|Lost to Follow-up|0|||
94606776|NCT02810340|324024181|FG002|Overall Study|Lost to Follow-up|1|||
94606777|NCT04795622|324024182|FG000|Overall Study|Adverse Event|1|||
94606778|NCT04795622|324024183|FG001|Overall Study|Adverse Event|0|||
94606779|NCT04795622|324024182|FG000|Overall Study|Withdrawal by Subject|3|||
94606780|NCT04795622|324024183|FG001|Overall Study|Withdrawal by Subject|3|||
94606781|NCT04795622|324024182|FG000|Overall Study|Protocol Violation|0|||
94606782|NCT04795622|324024183|FG001|Overall Study|Protocol Violation|2|||
94606783|NCT04795622|324024182|FG000|Overall Study|Lost to Follow-up|2|||
94606784|NCT04795622|324024183|FG001|Overall Study|Lost to Follow-up|3|||
94606785|NCT04795622|324024182|FG000|Overall Study|Other|7|||
94606786|NCT04795622|324024183|FG001|Overall Study|Other|8|||
94606787|NCT01070043|324024186|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
94606788|NCT01070043|324024187|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
94606789|NCT01070043|324024188|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
94606790|NCT01070043|324024186|FG000|Double-Blind Treatment|Adverse Event|0|||
94606791|NCT01070043|324024187|FG001|Double-Blind Treatment|Adverse Event|0|||
94606792|NCT01070043|324024188|FG002|Double-Blind Treatment|Adverse Event|2|||
94606793|NCT02280473|324024189|FG000|Overall Study|Adverse Event|1|||
94606794|NCT02280473|324024190|FG001|Overall Study|Adverse Event|1|||
94606795|NCT02280473|324024189|FG000|Overall Study|Lack of Efficacy|0|||
94606796|NCT02280473|324024190|FG001|Overall Study|Lack of Efficacy|1|||
94606797|NCT02280473|324024189|FG000|Overall Study|Lost to Follow-up|0|||
94606798|NCT02280473|324024190|FG001|Overall Study|Lost to Follow-up|1|||
94606799|NCT01610271|324024192|FG000|Overall Study|Surgery not complete|0|||
94606800|NCT01610271|324024193|FG001|Overall Study|Surgery not complete|1|||
94606801|NCT01610271|324024192|FG000|Overall Study|Prosthesis not implanted|2|||
94606802|NCT01610271|324024193|FG001|Overall Study|Prosthesis not implanted|3|||
94606803|NCT02393690|324024194|FG000|Overall Study|Ineligible|0|||
94606804|NCT02393690|324024195|FG001|Overall Study|Ineligible|1|||
94606805|NCT00467610|324024198|FG000|Overall Study|Withdrawal by Subject|1|||
94661540|NCT00968669|324215743|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
94661541|NCT00968669|324215744|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
94251214|NCT00297232|322712850|FG000|Overall Study|Voluntary Withdrawal|120|||
94251215|NCT00297232|322712850|FG000|Overall Study|Subject was Noncompliant|9|||
94251216|NCT00297232|322712850|FG000|Overall Study|Death|9|||
94251217|NCT00297232|322712850|FG000|Overall Study|Anti-natalizumab Positive|8|||
94251218|NCT00297232|322712850|FG000|Overall Study|Switched to Commercial Tysabri|22|||
94251219|NCT00297232|322712850|FG000|Overall Study|Disease Progression|8|||
94251220|NCT00297232|322712850|FG000|Overall Study|Fear of PML|10|||
94251221|NCT00297232|322712850|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
94251222|NCT00297232|322712850|FG000|Overall Study|Miscellaneous|5|||
94251223|NCT00297232|322712850|FG000|Overall Study|Sponsor Decision|34|||
94251224|NCT00297232|322712850|FG000|Overall Study|Subject Relocated|7|||
94251225|NCT00297232|322712850|FG000|Overall Study|Subject Withdrew Consent|37|||
94251226|NCT00297232|322712850|FG000|Overall Study|Persistently Positive Antibodies|11|||
94251227|NCT00297232|322712850|FG000|Overall Study|Investigator Withdrew From Program|19|||
94251228|NCT00297232|322712850|FG000|Overall Study|Did Not Enroll to Week 264|34|||
94251229|NCT00297232|322712850|FG000|Overall Study|Did Not Enroll to Week 480|17|||
94251230|NCT00297232|322712850|FG000|Overall Study|No data available after Week 264|161|||
94251231|NCT00297232|322712850|FG000|Overall Study|Other|1|||
94251232|NCT02257567|322712852|FG000|Overall Study|Adverse Event|0|||
94251233|NCT02257567|322712853|FG001|Overall Study|Adverse Event|0|||
94251234|NCT02257567|322712854|FG002|Overall Study|Adverse Event|0|||
94251235|NCT02257567|322712855|FG003|Overall Study|Adverse Event|1|||
94251236|NCT02257567|322712856|FG004|Overall Study|Adverse Event|1|||
94251237|NCT02257567|322712857|FG005|Overall Study|Adverse Event|0|||
94251238|NCT02257567|322712858|FG006|Overall Study|Adverse Event|0|||
94606806|NCT01369615|324024199|FG000|Overall Study|Withdrawal by Subject|0|||
94606807|NCT01369615|324024200|FG001|Overall Study|Withdrawal by Subject|1|||
94606808|NCT01369615|324024199|FG000|Overall Study|Lost to Follow-up|0|||
94606809|NCT01369615|324024200|FG001|Overall Study|Lost to Follow-up|1|||
94606810|NCT02676466|324024201|FG000|Overall Study|Death|0|||
94606811|NCT02676466|324024202|FG001|Overall Study|Death|2|||
94606812|NCT02676466|324024203|FG002|Overall Study|Death|1|||
94606813|NCT02676466|324024204|FG003|Overall Study|Death|0|||
94606814|NCT02676466|324024205|FG004|Overall Study|Death|0|||
94606815|NCT02676466|324024206|FG005|Overall Study|Death|0|||
94606816|NCT02676466|324024207|FG006|Overall Study|Death|0|||
94606817|NCT02676466|324024208|FG007|Overall Study|Death|0|||
94606818|NCT02676466|324024201|FG000|Overall Study|Withdrawal by Subject|4|||
94606819|NCT02676466|324024202|FG001|Overall Study|Withdrawal by Subject|3|||
94606820|NCT02676466|324024203|FG002|Overall Study|Withdrawal by Subject|1|||
94661542|NCT00968669|324215745|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
94661543|NCT04798586|324215748|FG000|Overall Study|Death|2|||
94661544|NCT04287920|324215749|FG000|Overall Study|Lost to Follow-up|1|||
94661545|NCT04287920|324215750|FG001|Overall Study|Lost to Follow-up|1|||
94661546|NCT04287920|324215749|FG000|Overall Study|Withdrawal by Subject|0|||
94661547|NCT04287920|324215750|FG001|Overall Study|Withdrawal by Subject|3|||
94661548|NCT01870843|324215758|FG000|Overall Study|Adverse Event|10|||
94661549|NCT01870843|324215758|FG000|Overall Study|Lost to Follow-up|24|||
94661550|NCT01870843|324215758|FG000|Overall Study|Death|1|||
94661551|NCT01870843|324215758|FG000|Overall Study|Withdrawal by Subject|18|||
94661552|NCT01910519|324215761|FG000|Overall Study|Withdrawal by Subject|2|||
94661553|NCT01910519|324215762|FG001|Overall Study|Withdrawal by Subject|0|||
94606821|NCT02676466|324024204|FG003|Overall Study|Withdrawal by Subject|0|||
94606822|NCT02676466|324024205|FG004|Overall Study|Withdrawal by Subject|3|||
94606823|NCT02676466|324024206|FG005|Overall Study|Withdrawal by Subject|1|||
94606824|NCT02676466|324024207|FG006|Overall Study|Withdrawal by Subject|1|||
94606825|NCT02676466|324024208|FG007|Overall Study|Withdrawal by Subject|1|||
94606826|NCT01178073|324024209|FG000|Overall Study|Adverse Event|34|||
94606827|NCT01178073|324024210|FG001|Overall Study|Adverse Event|27|||
94606828|NCT01178073|324024211|FG002|Overall Study|Adverse Event|24|||
94606829|NCT01178073|324024209|FG000|Overall Study|Protocol Violation|1|||
94606830|NCT01178073|324024210|FG001|Overall Study|Protocol Violation|1|||
94606831|NCT01178073|324024211|FG002|Overall Study|Protocol Violation|1|||
94606832|NCT01178073|324024209|FG000|Overall Study|Lost to Follow-up|2|||
94606833|NCT01178073|324024210|FG001|Overall Study|Lost to Follow-up|0|||
94606834|NCT01178073|324024211|FG002|Overall Study|Lost to Follow-up|3|||
94606835|NCT01178073|324024209|FG000|Overall Study|Physician Decision|14|||
94606836|NCT01178073|324024210|FG001|Overall Study|Physician Decision|10|||
94606837|NCT01178073|324024211|FG002|Overall Study|Physician Decision|10|||
94606838|NCT01178073|324024209|FG000|Overall Study|Withdrawal by Subject|10|||
94606839|NCT01178073|324024210|FG001|Overall Study|Withdrawal by Subject|6|||
94606840|NCT01178073|324024211|FG002|Overall Study|Withdrawal by Subject|8|||
94606841|NCT01178073|324024209|FG000|Overall Study|Missing Completion Status|1|||
94606842|NCT01178073|324024210|FG001|Overall Study|Missing Completion Status|0|||
94606843|NCT01178073|324024211|FG002|Overall Study|Missing Completion Status|0|||
94606844|NCT01702571|324024212|FG000|Overall Study|Death|1067|||
94606845|NCT01702571|324024213|FG001|Overall Study|Death|76|||
94606846|NCT01702571|324024212|FG000|Overall Study|Lost to Follow-up|144|||
94606847|NCT01702571|324024213|FG001|Overall Study|Lost to Follow-up|10|||
94606848|NCT01702571|324024212|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
94606849|NCT01702571|324024213|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
94606850|NCT01702571|324024212|FG000|Overall Study|Investigator Decision|5|||
94606851|NCT01702571|324024213|FG001|Overall Study|Investigator Decision|0|||
94606852|NCT01702571|324024212|FG000|Overall Study|Not Classifiable|1|||
94606853|NCT01702571|324024213|FG001|Overall Study|Not Classifiable|0|||
94661554|NCT01910519|324215761|FG000|Overall Study|Adverse Event|2|||
94661555|NCT01910519|324215762|FG001|Overall Study|Adverse Event|0|||
94661556|NCT04266028|324215763|FG000|Overall Study|Adverse Event|0|||
94661557|NCT04266028|324215764|FG001|Overall Study|Adverse Event|0|||
94661558|NCT04266028|324215765|FG002|Overall Study|Adverse Event|1|||
94661559|NCT04266028|324215766|FG003|Overall Study|Adverse Event|0|||
94661560|NCT04266028|324215767|FG004|Overall Study|Adverse Event|1|||
94661561|NCT04266028|324215768|FG005|Overall Study|Adverse Event|0|||
94661562|NCT04266028|324215769|FG006|Overall Study|Adverse Event|2|||
94661563|NCT04266028|324215770|FG007|Overall Study|Adverse Event|0|||
94661564|NCT04266028|324215763|FG000|Overall Study|temporary halt of the study|0|||
94661565|NCT04266028|324215764|FG001|Overall Study|temporary halt of the study|0|||
94661566|NCT04266028|324215765|FG002|Overall Study|temporary halt of the study|0|||
94606854|NCT01702571|324024212|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
94661567|NCT04266028|324215766|FG003|Overall Study|temporary halt of the study|0|||
94661568|NCT04266028|324215767|FG004|Overall Study|temporary halt of the study|0|||
94606855|NCT01702571|324024213|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
94606856|NCT01702571|324024212|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
94606857|NCT01702571|324024213|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
94606858|NCT01702571|324024212|FG000|Overall Study|Progressive Disease|3|||
94606859|NCT01702571|324024213|FG001|Overall Study|Progressive Disease|0|||
94661569|NCT04266028|324215768|FG005|Overall Study|temporary halt of the study|0|||
94661570|NCT04266028|324215769|FG006|Overall Study|temporary halt of the study|2|||
94661571|NCT04266028|324215770|FG007|Overall Study|temporary halt of the study|1|||
94661572|NCT04266028|324215763|FG000|Overall Study|Onset of birch pollen season|0|||
94661573|NCT04266028|324215764|FG001|Overall Study|Onset of birch pollen season|0|||
94606860|NCT01702571|324024212|FG000|Overall Study|Protocol Violation|2|||
94251239|NCT02257567|322712859|FG007|Overall Study|Adverse Event|0|||
94251240|NCT02257567|322712860|FG008|Overall Study|Adverse Event|1|||
94251241|NCT02257567|322712861|FG009|Overall Study|Adverse Event|0|||
94251242|NCT02257567|322712862|FG010|Overall Study|Adverse Event|0|||
94251243|NCT02257567|322712852|FG000|Overall Study|Death|2|||
94251244|NCT02257567|322712853|FG001|Overall Study|Death|2|||
94251245|NCT02257567|322712854|FG002|Overall Study|Death|2|||
94606861|NCT01702571|324024213|FG001|Overall Study|Protocol Violation|0|||
94606862|NCT01702571|324024212|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
94606863|NCT01702571|324024213|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
94606864|NCT01702571|324024212|FG000|Overall Study|Termination By Sponsor|4|||
94606865|NCT01702571|324024213|FG001|Overall Study|Termination By Sponsor|0|||
94606866|NCT01702571|324024212|FG000|Overall Study|Withdrawal by Subject|177|||
94606867|NCT01702571|324024213|FG001|Overall Study|Withdrawal by Subject|29|||
94606868|NCT00910988|324024214|FG000|Overall Study|Lost to Follow-up|2|||
94606869|NCT00910988|324024215|FG001|Overall Study|Lost to Follow-up|4|||
94606870|NCT00910988|324024216|FG002|Overall Study|Lost to Follow-up|3|||
94606871|NCT00910988|324024217|FG003|Overall Study|Lost to Follow-up|0|||
94606872|NCT03971071|324024223|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
94606873|NCT03971071|324024224|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
94606874|NCT03971071|324024225|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
94606875|NCT03971071|324024226|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
94606876|NCT03971071|324024227|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
94606877|NCT03971071|324024223|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
94606878|NCT03971071|324024224|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
94606879|NCT03971071|324024225|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
94606880|NCT03971071|324024226|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
94606881|NCT03971071|324024227|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
94606882|NCT03971071|324024223|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
94606883|NCT03971071|324024224|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
94606884|NCT03971071|324024225|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
94606885|NCT03971071|324024226|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
94606886|NCT03971071|324024227|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
94606887|NCT03971071|324024223|FG000|Open-label Treatment Period|Sponsor decision|0|||
94606888|NCT03971071|324024224|FG001|Open-label Treatment Period|Sponsor decision|0|||
94606889|NCT03971071|324024225|FG002|Open-label Treatment Period|Sponsor decision|0|||
94606890|NCT03971071|324024226|FG003|Open-label Treatment Period|Sponsor decision|0|||
94251246|NCT02257567|322712855|FG003|Overall Study|Death|4|||
94251247|NCT02257567|322712856|FG004|Overall Study|Death|15|||
94251248|NCT02257567|322712857|FG005|Overall Study|Death|11|||
94251249|NCT02257567|322712858|FG006|Overall Study|Death|26|||
94251250|NCT02257567|322712859|FG007|Overall Study|Death|30|||
94251251|NCT02257567|322712860|FG008|Overall Study|Death|2|||
94606891|NCT03971071|324024227|FG004|Open-label Treatment Period|Sponsor decision|1|||
94606892|NCT03971071|324024223|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
94606893|NCT03971071|324024224|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
94606894|NCT03971071|324024225|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
94606895|NCT03971071|324024226|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
94606896|NCT03971071|324024227|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
94606897|NCT03971071|324024223|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
94606898|NCT03971071|324024224|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
94606899|NCT03971071|324024225|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
94606900|NCT03971071|324024226|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
94606901|NCT03971071|324024227|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
94606902|NCT02898116|324024230|FG000|Overall Study|Adverse Event|1|||
94606903|NCT02898116|324024230|FG000|Overall Study|Progressive disease|1|||
94606904|NCT03805646|324024235|FG000|Overall Study|Death|40|||
94606905|NCT03805646|324024236|FG001|Overall Study|Death|49|||
94606906|NCT03805646|324024235|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
94606907|NCT03805646|324024236|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
94606908|NCT05521906|324024239|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
94606909|NCT05521906|324024240|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
94251252|NCT02257567|322712861|FG009|Overall Study|Death|18|||
94251253|NCT02257567|322712862|FG010|Overall Study|Death|65|||
94251254|NCT02257567|322712852|FG000|Overall Study|Lost to Follow-up|0|||
94606910|NCT03350620|324024241|FG000|Stage 2|Adverse Event|0|||
94606911|NCT03350620|324024242|FG001|Stage 2|Adverse Event|1|||
94606912|NCT03350620|324024243|FG002|Stage 2|Adverse Event|1|||
94606913|NCT03350620|324024241|FG000|Stage 2|Lack of Efficacy|0|||
94606914|NCT03350620|324024242|FG001|Stage 2|Lack of Efficacy|2|||
94606915|NCT03350620|324024243|FG002|Stage 2|Lack of Efficacy|0|||
94606916|NCT03350620|324024241|FG000|Stage 2|Lost to Follow-up|1|||
94606917|NCT03350620|324024242|FG001|Stage 2|Lost to Follow-up|2|||
94606918|NCT03350620|324024243|FG002|Stage 2|Lost to Follow-up|2|||
94606919|NCT03350620|324024241|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
94606920|NCT03350620|324024242|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
94606921|NCT03350620|324024243|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
94606922|NCT03803683|324024248|FG000|Overall Study|Lost to Follow-up|41|||
94606923|NCT03803683|324024249|FG001|Overall Study|Lost to Follow-up|18|||
94606924|NCT03803683|324024250|FG002|Overall Study|Lost to Follow-up|12|||
94606925|NCT03803683|324024248|FG000|Overall Study|Withdrawal by Subject|9|||
94606926|NCT03803683|324024249|FG001|Overall Study|Withdrawal by Subject|1|||
94606927|NCT03803683|324024250|FG002|Overall Study|Withdrawal by Subject|4|||
94606928|NCT02395016|324025259|FG000|Overall Study|Adverse Event|4|||
94606929|NCT02395016|324025260|FG001|Overall Study|Adverse Event|3|||
94606930|NCT02395016|324025259|FG000|Overall Study|Withdrawal by Subject|9|||
94606931|NCT02395016|324025260|FG001|Overall Study|Withdrawal by Subject|6|||
94251255|NCT02257567|322712853|FG001|Overall Study|Lost to Follow-up|0|||
94251256|NCT02257567|322712854|FG002|Overall Study|Lost to Follow-up|0|||
94251257|NCT02257567|322712855|FG003|Overall Study|Lost to Follow-up|0|||
94251258|NCT02257567|322712856|FG004|Overall Study|Lost to Follow-up|2|||
94251259|NCT02257567|322712857|FG005|Overall Study|Lost to Follow-up|2|||
94251260|NCT02257567|322712858|FG006|Overall Study|Lost to Follow-up|0|||
94251261|NCT02257567|322712859|FG007|Overall Study|Lost to Follow-up|0|||
94251262|NCT02257567|322712860|FG008|Overall Study|Lost to Follow-up|0|||
94251263|NCT02257567|322712861|FG009|Overall Study|Lost to Follow-up|1|||
94251264|NCT02257567|322712862|FG010|Overall Study|Lost to Follow-up|1|||
94251265|NCT02257567|322712852|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
94251266|NCT02257567|322712853|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
94251267|NCT02257567|322712854|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
94251268|NCT02257567|322712855|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
94251269|NCT02257567|322712856|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
94251270|NCT02257567|322712857|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
94251271|NCT02257567|322712858|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
94251272|NCT02257567|322712859|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
94251273|NCT02257567|322712860|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
94251274|NCT02257567|322712861|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
94251275|NCT02257567|322712862|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
94251276|NCT02257567|322712852|FG000|Overall Study|Physician Decision|0|||
94251277|NCT02257567|322712853|FG001|Overall Study|Physician Decision|0|||
94251278|NCT02257567|322712854|FG002|Overall Study|Physician Decision|0|||
94251279|NCT02257567|322712855|FG003|Overall Study|Physician Decision|0|||
94251280|NCT02257567|322712856|FG004|Overall Study|Physician Decision|0|||
94251281|NCT02257567|322712857|FG005|Overall Study|Physician Decision|0|||
94251282|NCT02257567|322712858|FG006|Overall Study|Physician Decision|0|||
94251283|NCT02257567|322712859|FG007|Overall Study|Physician Decision|2|||
94251284|NCT02257567|322712860|FG008|Overall Study|Physician Decision|0|||
94251285|NCT02257567|322712861|FG009|Overall Study|Physician Decision|1|||
94251286|NCT02257567|322712862|FG010|Overall Study|Physician Decision|0|||
94251287|NCT02257567|322712852|FG000|Overall Study|Withdrawal by Subject|0|||
94251288|NCT02257567|322712853|FG001|Overall Study|Withdrawal by Subject|0|||
94251289|NCT02257567|322712854|FG002|Overall Study|Withdrawal by Subject|2|||
94251290|NCT02257567|322712855|FG003|Overall Study|Withdrawal by Subject|0|||
94251291|NCT02257567|322712856|FG004|Overall Study|Withdrawal by Subject|0|||
94251292|NCT02257567|322712857|FG005|Overall Study|Withdrawal by Subject|6|||
94458984|NCT03104400|323469487|FG000|Overall Study|Lack of Efficacy|6|||
94606932|NCT02395016|324025259|FG000|Overall Study|Protocol Violation|2|||
94606933|NCT02395016|324025260|FG001|Overall Study|Protocol Violation|3|||
94606934|NCT00588952|324025261|FG000|Overall Study|Adverse Event|0|||
94606935|NCT00588952|324025262|FG001|Overall Study|Adverse Event|2|||
94606936|NCT00588952|324025261|FG000|Overall Study|Withdrawal by Subject|3|||
94606937|NCT00588952|324025262|FG001|Overall Study|Withdrawal by Subject|5|||
94606938|NCT03034200|324025263|FG000|Overall Study|Disease progression|8|||
94606939|NCT03034200|324025264|FG001|Overall Study|Disease progression|10|||
94251293|NCT02257567|322712858|FG006|Overall Study|Withdrawal by Subject|6|||
94606940|NCT03034200|324025265|FG002|Overall Study|Disease progression|4|||
94251294|NCT02257567|322712859|FG007|Overall Study|Withdrawal by Subject|6|||
94251295|NCT02257567|322712860|FG008|Overall Study|Withdrawal by Subject|1|||
94251296|NCT02257567|322712861|FG009|Overall Study|Withdrawal by Subject|1|||
94251297|NCT02257567|322712862|FG010|Overall Study|Withdrawal by Subject|10|||
94251298|NCT00069108|322712868|FG000|Overall Study|Withdrawal by Subject|5|||
94251299|NCT00069108|322712869|FG001|Overall Study|Withdrawal by Subject|9|||
94251300|NCT00069108|322712868|FG000|Overall Study|Adverse Event|64|||
94251301|NCT00069108|322712869|FG001|Overall Study|Adverse Event|42|||
94251302|NCT00069108|322712868|FG000|Overall Study|Death|6|||
94251303|NCT00069108|322712869|FG001|Overall Study|Death|6|||
94251304|NCT00069108|322712868|FG000|Overall Study|Administration|15|||
94251305|NCT00069108|322712869|FG001|Overall Study|Administration|4|||
94251306|NCT00069108|322712868|FG000|Overall Study|Insufficient therapy|117|||
94251307|NCT00069108|322712869|FG001|Overall Study|Insufficient therapy|144|||
94251308|NCT00069108|322712868|FG000|Overall Study|Violation criteria|1|||
94251309|NCT00069108|322712869|FG001|Overall Study|Violation criteria|4|||
94251310|NCT00069108|322712868|FG000|Overall Study|Refused treatment|5|||
94251311|NCT00069108|322712869|FG001|Overall Study|Refused treatment|10|||
94251312|NCT01065844|322712870|FG000|Overall Study|Adverse Event|5|||
94251313|NCT01415531|322712873|FG000|Overall Study|Adverse Event|7|||
94251314|NCT01415531|322712874|FG001|Overall Study|Adverse Event|10|||
94251315|NCT01415531|322712873|FG000|Overall Study|Lack of Efficacy|3|||
94251316|NCT01415531|322712874|FG001|Overall Study|Lack of Efficacy|2|||
94251317|NCT01415531|322712873|FG000|Overall Study|Protocol Violation|0|||
94251318|NCT01415531|322712874|FG001|Overall Study|Protocol Violation|1|||
94251319|NCT01415531|322712873|FG000|Overall Study|Withdrawal by Subject|5|||
94251320|NCT01415531|322712874|FG001|Overall Study|Withdrawal by Subject|4|||
94251321|NCT01415531|322712873|FG000|Overall Study|Lost to Follow-up|6|||
94251322|NCT01415531|322712874|FG001|Overall Study|Lost to Follow-up|14|||
94251323|NCT01415531|322712873|FG000|Overall Study|Lack of Compliance|1|||
94251324|NCT01415531|322712874|FG001|Overall Study|Lack of Compliance|4|||
94251325|NCT01415531|322712873|FG000|Overall Study|Other Reasons|3|||
94251326|NCT01415531|322712874|FG001|Overall Study|Other Reasons|2|||
94251327|NCT01506609|322712875|FG000|Overall Study|Adverse Event Related to Progression|0|||
94251328|NCT01506609|322712876|FG001|Overall Study|Adverse Event Related to Progression|0|||
94251329|NCT01506609|322712877|FG002|Overall Study|Adverse Event Related to Progression|0|||
94251330|NCT01506609|322712878|FG003|Overall Study|Adverse Event Related to Progression|3|||
94251331|NCT01506609|322712879|FG004|Overall Study|Adverse Event Related to Progression|7|||
94251332|NCT01506609|322712880|FG005|Overall Study|Adverse Event Related to Progression|3|||
94251333|NCT01506609|322712875|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
94251334|NCT01506609|322712876|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
94251335|NCT01506609|322712877|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
94251336|NCT01506609|322712878|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
94251337|NCT01506609|322712879|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
94251338|NCT01506609|322712880|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
94251339|NCT01506609|322712875|FG000|Overall Study|Withdrawal by Subject|0|||
94251340|NCT01506609|322712876|FG001|Overall Study|Withdrawal by Subject|0|||
94251341|NCT01506609|322712877|FG002|Overall Study|Withdrawal by Subject|0|||
94251342|NCT01506609|322712878|FG003|Overall Study|Withdrawal by Subject|9|||
94251343|NCT01506609|322712879|FG004|Overall Study|Withdrawal by Subject|7|||
94251344|NCT01506609|322712880|FG005|Overall Study|Withdrawal by Subject|7|||
94251345|NCT01506609|322712875|FG000|Overall Study|Lost to Follow-up|0|||
94251346|NCT01506609|322712876|FG001|Overall Study|Lost to Follow-up|0|||
94251347|NCT01506609|322712877|FG002|Overall Study|Lost to Follow-up|0|||
94251348|NCT01506609|322712878|FG003|Overall Study|Lost to Follow-up|1|||
94251349|NCT01506609|322712879|FG004|Overall Study|Lost to Follow-up|2|||
94251350|NCT01506609|322712880|FG005|Overall Study|Lost to Follow-up|0|||
94251351|NCT01506609|322712875|FG000|Overall Study|Sponsor Discontinued Study|0|||
94606941|NCT03034200|324025263|FG000|Overall Study|Physician Decision|2|||
94606942|NCT03034200|324025264|FG001|Overall Study|Physician Decision|0|||
94606943|NCT03034200|324025265|FG002|Overall Study|Physician Decision|3|||
94606944|NCT03034200|324025263|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
94251352|NCT01506609|322712876|FG001|Overall Study|Sponsor Discontinued Study|0|||
94251353|NCT01506609|322712877|FG002|Overall Study|Sponsor Discontinued Study|0|||
94251354|NCT01506609|322712878|FG003|Overall Study|Sponsor Discontinued Study|2|||
94251355|NCT01506609|322712879|FG004|Overall Study|Sponsor Discontinued Study|2|||
94251356|NCT01506609|322712880|FG005|Overall Study|Sponsor Discontinued Study|0|||
94251357|NCT01506609|322712875|FG000|Overall Study|Progressive Disease per Protocol|1|||
94251358|NCT01506609|322712876|FG001|Overall Study|Progressive Disease per Protocol|0|||
94251359|NCT01506609|322712877|FG002|Overall Study|Progressive Disease per Protocol|0|||
94251360|NCT01506609|322712878|FG003|Overall Study|Progressive Disease per Protocol|64|||
94251361|NCT01506609|322712879|FG004|Overall Study|Progressive Disease per Protocol|57|||
94606945|NCT03034200|324025264|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
94606946|NCT03034200|324025265|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
94661574|NCT04266028|324215765|FG002|Overall Study|Onset of birch pollen season|0|||
94661575|NCT04266028|324215766|FG003|Overall Study|Onset of birch pollen season|0|||
94661576|NCT04266028|324215767|FG004|Overall Study|Onset of birch pollen season|1|||
94606947|NCT03034200|324025263|FG000|Overall Study|Adjuvant Therapy|0|||
94606948|NCT03034200|324025264|FG001|Overall Study|Adjuvant Therapy|0|||
94606949|NCT03034200|324025265|FG002|Overall Study|Adjuvant Therapy|1|||
94606950|NCT01739400|324025266|FG000|Overall Study|Physician Decision|3|||
94606951|NCT01739400|324025267|FG001|Overall Study|Physician Decision|0|||
94606952|NCT01739400|324025266|FG000|Overall Study|Lost to Follow-up|2|||
94606953|NCT01739400|324025267|FG001|Overall Study|Lost to Follow-up|0|||
94606954|NCT01739400|324025266|FG000|Overall Study|Death|5|||
94606955|NCT01739400|324025267|FG001|Overall Study|Death|2|||
94606956|NCT01739400|324025266|FG000|Overall Study|Withdrawal by Subject|7|||
94606957|NCT01739400|324025267|FG001|Overall Study|Withdrawal by Subject|7|||
94606958|NCT00920829|324025279|FG000|Allocation|No post randomization data|3|||
94661577|NCT04266028|324215768|FG005|Overall Study|Onset of birch pollen season|0|||
94661578|NCT04266028|324215769|FG006|Overall Study|Onset of birch pollen season|0|||
94606959|NCT00920829|324025280|FG001|Allocation|No post randomization data|1|||
94606960|NCT00920829|324025281|FG002|Allocation|No post randomization data|0|||
94251362|NCT01506609|322712880|FG005|Overall Study|Progressive Disease per Protocol|74|||
94251363|NCT01506609|322712875|FG000|Overall Study|Other, Not Specified|0|||
94251364|NCT01506609|322712876|FG001|Overall Study|Other, Not Specified|0|||
94251365|NCT01506609|322712877|FG002|Overall Study|Other, Not Specified|0|||
94251366|NCT01506609|322712878|FG003|Overall Study|Other, Not Specified|10|||
94251367|NCT01506609|322712879|FG004|Overall Study|Other, Not Specified|7|||
94251368|NCT01506609|322712880|FG005|Overall Study|Other, Not Specified|3|||
94251369|NCT01506609|322712875|FG000|Overall Study|Missing / Unknown Reason|1|||
94251370|NCT01506609|322712876|FG001|Overall Study|Missing / Unknown Reason|0|||
94251371|NCT01506609|322712877|FG002|Overall Study|Missing / Unknown Reason|1|||
94251372|NCT01506609|322712878|FG003|Overall Study|Missing / Unknown Reason|4|||
94251373|NCT01506609|322712879|FG004|Overall Study|Missing / Unknown Reason|4|||
94251374|NCT01506609|322712880|FG005|Overall Study|Missing / Unknown Reason|2|||
94251375|NCT02703259|322712884|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
94251376|NCT02703259|322712885|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
94251377|NCT02703259|322712884|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
94251378|NCT02703259|322712885|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
94251379|NCT02703259|322712884|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
94251380|NCT02703259|322712885|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
94251381|NCT04738292|322712886|FG000|Overall Study|Death|1|||
94251382|NCT01820585|322712888|FG000|Overall Study|Adverse Event|9|||
94251383|NCT01820585|322712889|FG001|Overall Study|Adverse Event|13|||
94251384|NCT01820585|322712890|FG002|Overall Study|Adverse Event|23|||
94251385|NCT01820585|322712891|FG003|Overall Study|Adverse Event|34|||
94251386|NCT01820585|322712888|FG000|Overall Study|Lack of Efficacy|9|||
94251387|NCT01820585|322712889|FG001|Overall Study|Lack of Efficacy|7|||
94251388|NCT01820585|322712890|FG002|Overall Study|Lack of Efficacy|5|||
94251389|NCT01820585|322712891|FG003|Overall Study|Lack of Efficacy|1|||
94251390|NCT01820585|322712888|FG000|Overall Study|Withdrawal by Subject|3|||
94251391|NCT01820585|322712889|FG001|Overall Study|Withdrawal by Subject|7|||
94606961|NCT00920829|324025282|FG003|Allocation|No post randomization data|2|||
94606962|NCT00920829|324025279|FG000|Available for Analysis|Withdrawal by Subject|6|||
94606963|NCT00920829|324025280|FG001|Available for Analysis|Withdrawal by Subject|6|||
94606964|NCT00920829|324025281|FG002|Available for Analysis|Withdrawal by Subject|6|||
94606965|NCT00920829|324025282|FG003|Available for Analysis|Withdrawal by Subject|10|||
94606966|NCT00920829|324025279|FG000|Available for Analysis|Required Medical Treatment|0|||
94606967|NCT00920829|324025280|FG001|Available for Analysis|Required Medical Treatment|1|||
94606968|NCT00920829|324025281|FG002|Available for Analysis|Required Medical Treatment|2|||
94606969|NCT00920829|324025282|FG003|Available for Analysis|Required Medical Treatment|0|||
94606970|NCT00920829|324025279|FG000|Available for Analysis|Adverse Event|1|||
94606971|NCT00920829|324025280|FG001|Available for Analysis|Adverse Event|2|||
94606972|NCT00920829|324025281|FG002|Available for Analysis|Adverse Event|1|||
94606973|NCT00920829|324025282|FG003|Available for Analysis|Adverse Event|0|||
94606974|NCT00920829|324025279|FG000|Available for Analysis|Death|1|||
94606975|NCT00920829|324025280|FG001|Available for Analysis|Death|0|||
94606976|NCT00920829|324025281|FG002|Available for Analysis|Death|0|||
94606977|NCT00920829|324025282|FG003|Available for Analysis|Death|0|||
94606978|NCT00920829|324025279|FG000|Available for Analysis|Protocol Violation|0|||
94606979|NCT00920829|324025280|FG001|Available for Analysis|Protocol Violation|0|||
94606980|NCT00920829|324025281|FG002|Available for Analysis|Protocol Violation|1|||
94606981|NCT00920829|324025282|FG003|Available for Analysis|Protocol Violation|0|||
94606982|NCT00920829|324025279|FG000|Available for Analysis|Required more treatment|0|||
94606983|NCT00920829|324025280|FG001|Available for Analysis|Required more treatment|2|||
94606984|NCT00920829|324025281|FG002|Available for Analysis|Required more treatment|0|||
94606985|NCT00920829|324025282|FG003|Available for Analysis|Required more treatment|1|||
94606986|NCT04533880|324025283|FG000|Overall Study|Lost to Follow-up|0|||
94606987|NCT04533880|324025284|FG001|Overall Study|Lost to Follow-up|1|||
94606988|NCT04533880|324025285|FG002|Overall Study|Lost to Follow-up|1|||
94251392|NCT01820585|322712890|FG002|Overall Study|Withdrawal by Subject|3|||
94251393|NCT01820585|322712891|FG003|Overall Study|Withdrawal by Subject|8|||
94251394|NCT01820585|322712888|FG000|Overall Study|Lost to Follow-up|3|||
94251395|NCT01820585|322712889|FG001|Overall Study|Lost to Follow-up|3|||
94251396|NCT01820585|322712890|FG002|Overall Study|Lost to Follow-up|0|||
94251397|NCT01820585|322712891|FG003|Overall Study|Lost to Follow-up|3|||
94251398|NCT01820585|322712888|FG000|Overall Study|Protocol Violation|3|||
94251399|NCT01820585|322712889|FG001|Overall Study|Protocol Violation|1|||
94251400|NCT01820585|322712890|FG002|Overall Study|Protocol Violation|1|||
94606989|NCT00089284|324025288|FG000|Overall Study|Adverse event before starting treatment|0|||
94606990|NCT00089284|324025289|FG001|Overall Study|Adverse event before starting treatment|0|||
94661579|NCT04266028|324215770|FG007|Overall Study|Onset of birch pollen season|0|||
94251401|NCT01820585|322712891|FG003|Overall Study|Protocol Violation|1|||
94251402|NCT01820585|322712888|FG000|Overall Study|Subject non-compliance|0|||
94251403|NCT01820585|322712889|FG001|Overall Study|Subject non-compliance|0|||
94661580|NCT04964089|324215771|FG000|Overall Study|Adverse Event|8|||
94251404|NCT01820585|322712890|FG002|Overall Study|Subject non-compliance|1|||
94357385|NCT01846442|323090756|FG001|Overall Study|Lost to Follow-up|0|||
94357386|NCT01846442|323090757|FG002|Overall Study|Lost to Follow-up|1|||
94357387|NCT01846442|323090758|FG003|Overall Study|Lost to Follow-up|0|||
94357388|NCT01846442|323090755|FG000|Overall Study|Withdrawal by Subject|3|||
94357389|NCT01846442|323090756|FG001|Overall Study|Withdrawal by Subject|2|||
94357390|NCT01846442|323090757|FG002|Overall Study|Withdrawal by Subject|0|||
94357391|NCT01846442|323090758|FG003|Overall Study|Withdrawal by Subject|1|||
94357392|NCT01846442|323090755|FG000|Overall Study|Left the city/Lost medication|1|||
94357393|NCT01846442|323090756|FG001|Overall Study|Left the city/Lost medication|0|||
94357394|NCT01846442|323090757|FG002|Overall Study|Left the city/Lost medication|1|||
94357395|NCT01846442|323090758|FG003|Overall Study|Left the city/Lost medication|1|||
94357396|NCT03996694|323090760|FG000|First Washout (7 Days)|positive urine drug screen|0|||
94357397|NCT03996694|323090761|FG001|First Washout (7 Days)|positive urine drug screen|0|||
94357398|NCT03996694|323090762|FG002|First Washout (7 Days)|positive urine drug screen|1|||
94357399|NCT03996694|323090763|FG003|First Washout (7 Days)|positive urine drug screen|0|||
94357400|NCT03996694|323090764|FG004|First Washout (7 Days)|positive urine drug screen|0|||
94357401|NCT03996694|323090765|FG005|First Washout (7 Days)|positive urine drug screen|0|||
94357402|NCT03996694|323090760|FG000|First Washout (7 Days)|Adverse Event|0|||
94357403|NCT03996694|323090761|FG001|First Washout (7 Days)|Adverse Event|1|||
94357404|NCT03996694|323090762|FG002|First Washout (7 Days)|Adverse Event|0|||
94357405|NCT03996694|323090763|FG003|First Washout (7 Days)|Adverse Event|0|||
94357406|NCT03996694|323090764|FG004|First Washout (7 Days)|Adverse Event|0|||
94357407|NCT03996694|323090765|FG005|First Washout (7 Days)|Adverse Event|0|||
94357408|NCT03996694|323090760|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
94357409|NCT03996694|323090761|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
94357410|NCT03996694|323090762|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
94357411|NCT03996694|323090763|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
94357412|NCT03996694|323090764|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
94357413|NCT03996694|323090765|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
94357414|NCT03996694|323090760|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
94357415|NCT03996694|323090761|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
94357416|NCT03996694|323090762|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
94357417|NCT03996694|323090763|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
94357418|NCT03996694|323090764|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
94357419|NCT03996694|323090765|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
94357420|NCT01269346|323090774|FG000|Treatment Phase|Disease progression|3|||
94357421|NCT01269346|323090774|FG000|Treatment Phase|Adverse Event|3|||
94357422|NCT01269346|323090774|FG000|Treatment Phase|Withdrawal by Subject|1|||
94357423|NCT01269346|323090774|FG000|Treatment Phase|Other|2|||
94357424|NCT01269346|323090774|FG000|Extension Phase|Adverse Event|6|||
94357425|NCT01269346|323090774|FG000|Extension Phase|Withdrawal by Subject|4|||
94357426|NCT01269346|323090774|FG000|Extension Phase|Disease progression|22|||
94357427|NCT01269346|323090774|FG000|Extension Phase|Physician decision or participant choice|9|||
94357428|NCT01269346|323090774|FG000|Extension Phase|Clinical progression|1|||
94357429|NCT01269346|323090774|FG000|Extension Phase|Started a prohibited con med|1|||
94357430|NCT00247416|323090775|FG000|Overall Study|3 patients were found to be ineligible|1|||
94357431|NCT00247416|323090776|FG001|Overall Study|3 patients were found to be ineligible|2|||
94357432|NCT00278473|323090785|FG000|Overall Study|drop out|4|||
94357433|NCT00278473|323090786|FG001|Overall Study|drop out|3|||
94357434|NCT04854421|323090787|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
94357435|NCT04854421|323090788|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
94357436|NCT02181634|323090791|FG000|Overall Study|Lack of Efficacy|33|||
94357437|NCT02181634|323090791|FG000|Overall Study|Adverse Event|17|||
94606991|NCT00089284|324025290|FG002|Overall Study|Adverse event before starting treatment|0|||
94606992|NCT00089284|324025291|FG003|Overall Study|Adverse event before starting treatment|0|||
94606993|NCT00089284|324025292|FG004|Overall Study|Adverse event before starting treatment|0|||
94357438|NCT02181634|323090791|FG000|Overall Study|Physician Decision|8|||
94357439|NCT02181634|323090791|FG000|Overall Study|Withdrawal by Subject|5|||
94357440|NCT02181634|323090791|FG000|Overall Study|Death|2|||
94357441|NCT02181634|323090791|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
94357442|NCT02181634|323090791|FG000|Overall Study|Ineligible|1|||
94357443|NCT02181634|323090791|FG000|Overall Study|Max number of dose reduction|1|||
94357444|NCT02181634|323090791|FG000|Overall Study|Symptomatic progression|1|||
94606994|NCT00089284|324025293|FG005|Overall Study|Adverse event before starting treatment|0|||
94357445|NCT02181634|323090791|FG000|Overall Study|Patient opted to proceed to surgery|1|||
94357446|NCT04001790|323090792|FG000|Overall Study|Withdrawal by Subject|1|||
94357447|NCT04001790|323090793|FG001|Overall Study|Withdrawal by Subject|2|||
94606995|NCT00089284|324025294|FG006|Overall Study|Adverse event before starting treatment|1|||
94606996|NCT00958789|324025298|FG000|Overall Study|Death|5|||
94606997|NCT00958789|324025298|FG000|Overall Study|Lost to Follow-up|14|||
94606998|NCT00958789|324025298|FG000|Overall Study|Withdrawal by Subject|17|||
94606999|NCT00958789|324025298|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
94607000|NCT00958789|324025298|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
94251405|NCT01820585|322712891|FG003|Overall Study|Subject non-compliance|2|||
94251406|NCT01820585|322712888|FG000|Overall Study|at sponsor request|0|||
94251407|NCT01820585|322712889|FG001|Overall Study|at sponsor request|0|||
94251408|NCT01820585|322712890|FG002|Overall Study|at sponsor request|1|||
94251409|NCT01820585|322712891|FG003|Overall Study|at sponsor request|0|||
94251410|NCT01820585|322712888|FG000|Overall Study|Pregnancy|0|||
94251411|NCT01820585|322712889|FG001|Overall Study|Pregnancy|1|||
94251412|NCT01820585|322712890|FG002|Overall Study|Pregnancy|0|||
94251413|NCT01820585|322712891|FG003|Overall Study|Pregnancy|0|||
94251414|NCT00528645|322712892|FG000|Overall Study|Adverse Event|3|||
94251415|NCT01445301|322712893|FG000|Overall Study|Adverse Event|15|||
94251416|NCT01445301|322712894|FG001|Overall Study|Adverse Event|25|||
94251417|NCT01445301|322712895|FG002|Overall Study|Adverse Event|4|||
94251418|NCT01445301|322712893|FG000|Overall Study|Lack of Efficacy|0|||
94251419|NCT01445301|322712894|FG001|Overall Study|Lack of Efficacy|1|||
94251420|NCT01445301|322712895|FG002|Overall Study|Lack of Efficacy|0|||
94251421|NCT01445301|322712893|FG000|Overall Study|Protocol Violation|1|||
94251422|NCT01445301|322712894|FG001|Overall Study|Protocol Violation|0|||
94251423|NCT01445301|322712895|FG002|Overall Study|Protocol Violation|0|||
94251424|NCT01445301|322712893|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
94251425|NCT01445301|322712894|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
94251426|NCT01445301|322712895|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
94251427|NCT01445301|322712893|FG000|Overall Study|Physician Decision|0|||
94251428|NCT01445301|322712894|FG001|Overall Study|Physician Decision|2|||
94251429|NCT01445301|322712895|FG002|Overall Study|Physician Decision|0|||
94251430|NCT01445301|322712893|FG000|Overall Study|Withdrawal by Subject|5|||
94251431|NCT01445301|322712894|FG001|Overall Study|Withdrawal by Subject|6|||
94251432|NCT01445301|322712895|FG002|Overall Study|Withdrawal by Subject|4|||
94251433|NCT04493502|322712900|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
94251434|NCT04493502|322712901|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
94251435|NCT04493502|322712900|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
94251436|NCT04493502|322712901|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
94251437|NCT04493502|322712900|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
94251438|NCT04493502|322712901|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
94251439|NCT04493502|322712900|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
94251440|NCT04493502|322712901|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
94251441|NCT04493502|322712900|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
94251442|NCT04493502|322712901|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
94251443|NCT04493502|322712900|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
94251444|NCT04493502|322712901|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
94251445|NCT04493502|322712900|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
94251446|NCT04493502|322712901|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
94251447|NCT04493502|322712900|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
94357448|NCT03971422|323090796|FG000|Overall Study|Lost to Follow-up|0|||
94357449|NCT03971422|323090797|FG001|Overall Study|Lost to Follow-up|1|||
94607001|NCT00958789|324025298|FG000|Overall Study|Subject terminated|2|||
94607002|NCT00958789|324025298|FG000|Overall Study|Revision|7|||
94607003|NCT00478881|324025301|FG000|Overall Study|Adverse Event|31|||
94607004|NCT00478881|324025302|FG001|Overall Study|Adverse Event|12|||
94607005|NCT00478881|324025301|FG000|Overall Study|Lack of Efficacy|0|||
94607006|NCT00478881|324025302|FG001|Overall Study|Lack of Efficacy|3|||
94607007|NCT00478881|324025301|FG000|Overall Study|Lost to Follow-up|0|||
94607008|NCT00478881|324025302|FG001|Overall Study|Lost to Follow-up|1|||
94607009|NCT00478881|324025301|FG000|Overall Study|Protocol Violation|2|||
94607010|NCT00478881|324025302|FG001|Overall Study|Protocol Violation|2|||
94607011|NCT00478881|324025301|FG000|Overall Study|Withdrawal by Subject|6|||
94607012|NCT00478881|324025302|FG001|Overall Study|Withdrawal by Subject|2|||
94607013|NCT00478881|324025301|FG000|Overall Study|Non-Compliance with Study Medication|0|||
94607014|NCT00478881|324025302|FG001|Overall Study|Non-Compliance with Study Medication|2|||
94607015|NCT03960554|324025306|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
94607016|NCT03960554|324025307|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
94607017|NCT02360111|324025308|FG000|Overall Study|Death|2|||
94607018|NCT02943460|324025309|FG000|Blinded Study Phase|Adverse Event|3|||
94607019|NCT02943460|324025310|FG001|Blinded Study Phase|Adverse Event|0|||
94357450|NCT03971422|323090798|FG002|Overall Study|Lost to Follow-up|0|||
94607020|NCT02943460|324025311|FG002|Blinded Study Phase|Adverse Event|0|||
94251448|NCT04493502|322712901|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
94251449|NCT04493502|322712900|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
94251450|NCT04493502|322712901|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
94357451|NCT03971422|323090796|FG000|Overall Study|Lack of Efficacy|5|||
94607021|NCT02943460|324025309|FG000|Blinded Study Phase|Withdrew Consent|0|||
94607022|NCT02943460|324025310|FG001|Blinded Study Phase|Withdrew Consent|1|||
94251451|NCT04493502|322712900|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
94251452|NCT04493502|322712901|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
94357452|NCT03971422|323090797|FG001|Overall Study|Lack of Efficacy|1|||
94357453|NCT03971422|323090798|FG002|Overall Study|Lack of Efficacy|1|||
94357454|NCT03971422|323090796|FG000|Overall Study|Adverse event, not fatal|2|||
94357455|NCT03971422|323090797|FG001|Overall Study|Adverse event, not fatal|2|||
94357456|NCT03971422|323090798|FG002|Overall Study|Adverse event, not fatal|5|||
94357457|NCT03971422|323090796|FG000|Overall Study|Worsening of MG Symptoms|1|||
94357458|NCT03971422|323090797|FG001|Overall Study|Worsening of MG Symptoms|4|||
94357459|NCT03971422|323090798|FG002|Overall Study|Worsening of MG Symptoms|2|||
94357460|NCT03971422|323090796|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
94357461|NCT03971422|323090797|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
94357462|NCT03971422|323090798|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
94357463|NCT03971422|323090796|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
94357464|NCT03971422|323090797|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
94357465|NCT03971422|323090798|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
94357466|NCT03971422|323090796|FG000|Overall Study|Due to COVID-19 pandemic|0|||
94357467|NCT03971422|323090797|FG001|Overall Study|Due to COVID-19 pandemic|1|||
94357468|NCT03971422|323090798|FG002|Overall Study|Due to COVID-19 pandemic|1|||
94357469|NCT02706327|323090799|FG000|Overall Study|Lost to Follow-up|1|||
94357470|NCT02706327|323090800|FG001|Overall Study|Lost to Follow-up|1|||
94357471|NCT02706327|323090801|FG002|Overall Study|Lost to Follow-up|2|||
94357472|NCT03868410|323090805|FG000|Overall Study|Physician Decision|0|||
94357473|NCT03868410|323090806|FG001|Overall Study|Physician Decision|1|||
94357474|NCT00750061|323090807|FG000|Overall Study|Adverse Event|2|||
94357475|NCT00750061|323090808|FG001|Overall Study|Adverse Event|0|||
94357476|NCT00750061|323090807|FG000|Overall Study|Withdrawal by Subject|0|||
94607023|NCT02943460|324025311|FG002|Blinded Study Phase|Withdrew Consent|0|||
94607024|NCT02943460|324025309|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
94607025|NCT02943460|324025310|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
94607026|NCT02943460|324025311|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
94607027|NCT02943460|324025309|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
94607028|NCT02943460|324025310|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
94607029|NCT02943460|324025311|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
94607030|NCT02943460|324025309|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
94607031|NCT02943460|324025310|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
94607032|NCT02943460|324025311|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
94607033|NCT01068652|324025316|FG000|Overall Study|Adverse Event|4|||
94607034|NCT01068652|324025317|FG001|Overall Study|Adverse Event|0|||
94607035|NCT01068652|324025316|FG000|Overall Study|Lack of Efficacy|0|||
94607036|NCT01068652|324025317|FG001|Overall Study|Lack of Efficacy|2|||
94607037|NCT01068652|324025316|FG000|Overall Study|Lost to Follow-up|2|||
94607038|NCT01068652|324025317|FG001|Overall Study|Lost to Follow-up|1|||
94607039|NCT01068652|324025316|FG000|Overall Study|Protocol Violation|3|||
94607040|NCT01068652|324025317|FG001|Overall Study|Protocol Violation|6|||
94607041|NCT01068652|324025316|FG000|Overall Study|Withdrawal criteria|1|||
94607042|NCT01068652|324025317|FG001|Overall Study|Withdrawal criteria|2|||
94607043|NCT01068652|324025316|FG000|Overall Study|Patient was not eligible|1|||
94607044|NCT01068652|324025317|FG001|Overall Study|Patient was not eligible|0|||
94607045|NCT01068652|324025316|FG000|Overall Study|Unclassified|7|||
94607046|NCT01068652|324025317|FG001|Overall Study|Unclassified|4|||
94607047|NCT02147184|324025318|FG000|Overall Study|Lost to Follow-up|28|||
94607048|NCT02147184|324025319|FG001|Overall Study|Lost to Follow-up|15|||
94607049|NCT02147184|324025318|FG000|Overall Study|Study Burden|11|||
94607050|NCT02147184|324025319|FG001|Overall Study|Study Burden|7|||
94607051|NCT02147184|324025318|FG000|Overall Study|Pregnancy|6|||
94607052|NCT02147184|324025319|FG001|Overall Study|Pregnancy|0|||
94607053|NCT02147184|324025318|FG000|Overall Study|Moved out of state|3|||
94357477|NCT00750061|323090808|FG001|Overall Study|Withdrawal by Subject|1|||
94357478|NCT00750061|323090807|FG000|Overall Study|Physician Decision|0|||
94357479|NCT00750061|323090808|FG001|Overall Study|Physician Decision|1|||
94357480|NCT02696382|323090810|FG000|Overall Study|Death|7|||
94607054|NCT02147184|324025319|FG001|Overall Study|Moved out of state|3|||
94607055|NCT02147184|324025318|FG000|Overall Study|Physician Decision|0|||
94607056|NCT02147184|324025319|FG001|Overall Study|Physician Decision|2|||
94607057|NCT02147184|324025318|FG000|Overall Study|Other|1|||
94357481|NCT02696382|323090811|FG001|Overall Study|Death|2|||
94357482|NCT02696382|323090810|FG000|Overall Study|Withdrawal by Subject|5|||
94357483|NCT02696382|323090811|FG001|Overall Study|Withdrawal by Subject|12|||
94357484|NCT02696382|323090810|FG000|Overall Study|Lost to Follow-up|4|||
94357485|NCT02696382|323090811|FG001|Overall Study|Lost to Follow-up|7|||
94357486|NCT03417245|323090812|FG000|Overall Study|Adverse Event|1|||
94357487|NCT03417245|323090813|FG001|Overall Study|Adverse Event|0|||
94357488|NCT03417245|323090812|FG000|Overall Study|Protocol Violation|1|||
94357489|NCT03417245|323090813|FG001|Overall Study|Protocol Violation|0|||
94357490|NCT03417245|323090812|FG000|Overall Study|Withdrawal by Subject|1|||
94357491|NCT03417245|323090813|FG001|Overall Study|Withdrawal by Subject|1|||
94357492|NCT02067728|323090817|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
94357493|NCT02067728|323090818|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
94357494|NCT02067728|323090817|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
94357495|NCT02067728|323090818|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
94357496|NCT02067728|323090817|FG000|6 Month Measurements|Unable to attend|114|||
94357497|NCT02067728|323090818|FG001|6 Month Measurements|Unable to attend|97|||
94357498|NCT04988035|323090819|FG000|Overall Study|Death|19|||
94357499|NCT04988035|323090820|FG001|Overall Study|Death|13|||
94357500|NCT04988035|323090819|FG000|Overall Study|Lost to Follow-up|12|||
94357501|NCT04988035|323090820|FG001|Overall Study|Lost to Follow-up|6|||
94357502|NCT04988035|323090819|FG000|Overall Study|Protocol Violation|0|||
94357503|NCT04988035|323090820|FG001|Overall Study|Protocol Violation|1|||
94357504|NCT04988035|323090819|FG000|Overall Study|Withdrawal by Subject|2|||
94357505|NCT04988035|323090820|FG001|Overall Study|Withdrawal by Subject|4|||
94357506|NCT04988035|323090819|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
94357507|NCT04988035|323090820|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
94357508|NCT05966129|323090825|FG000|Overall Study|Death|1|||
94357509|NCT05966129|323090826|FG001|Overall Study|Death|2|||
94357510|NCT05966129|323090825|FG000|Overall Study|Lost to Follow-up|63|||
94357511|NCT05966129|323090826|FG001|Overall Study|Lost to Follow-up|66|||
94357512|NCT05966129|323090825|FG000|Overall Study|Protocol Violation|1|||
94251453|NCT04493502|322712900|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
94251454|NCT04493502|322712901|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
94251455|NCT04493502|322712900|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
94251456|NCT04493502|322712901|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
94251457|NCT04493502|322712900|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
94251458|NCT04493502|322712901|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
94251459|NCT00709852|322712904|FG000|Period 1|Adverse Event|2|||
94251460|NCT00709852|322712905|FG001|Period 1|Adverse Event|0|||
94251461|NCT00709852|322712904|FG000|Period 1|Withdrawal by Subject|4|||
94251462|NCT00709852|322712905|FG001|Period 1|Withdrawal by Subject|2|||
94357513|NCT05966129|323090826|FG001|Overall Study|Protocol Violation|0|||
94357514|NCT05966129|323090825|FG000|Overall Study|Withdrawal by Subject|26|||
94357515|NCT05966129|323090826|FG001|Overall Study|Withdrawal by Subject|25|||
94251463|NCT00709852|322712904|FG000|Period 1|Protocol Violation|1|||
94251464|NCT00709852|322712905|FG001|Period 1|Protocol Violation|0|||
94251465|NCT00709852|322712904|FG000|Period 1|Defective scanner|0|||
94251466|NCT00709852|322712905|FG001|Period 1|Defective scanner|1|||
94251467|NCT00709852|322712904|FG000|Period 1|Lost to Follow-up|1|||
94251468|NCT00709852|322712905|FG001|Period 1|Lost to Follow-up|0|||
94251469|NCT00709852|322712904|FG000|Period 2|Protocol Violation|4|||
94251470|NCT00709852|322712905|FG001|Period 2|Protocol Violation|1|||
94251471|NCT00709852|322712904|FG000|Period 2|Adverse Event|1|||
94251472|NCT00709852|322712905|FG001|Period 2|Adverse Event|1|||
94251473|NCT00709852|322712904|FG000|Period 2|Lost to Follow-up|1|||
94357516|NCT05966129|323090825|FG000|Overall Study|Surgery not completed|63|||
94357517|NCT05966129|323090826|FG001|Overall Study|Surgery not completed|69|||
94357518|NCT05966129|323090825|FG000|Overall Study|Surgery logistics issue|2|||
94357519|NCT05966129|323090826|FG001|Overall Study|Surgery logistics issue|1|||
94357520|NCT01083121|323090829|FG000|Overall Study|Use of Humira outside the approved label|81|||
94357521|NCT04409262|323090830|FG000|Overall Study|Adverse Event|0|||
94357522|NCT04409262|323090831|FG001|Overall Study|Adverse Event|2|||
94357523|NCT04409262|323090830|FG000|Overall Study|Death|55|||
94357524|NCT04409262|323090831|FG001|Overall Study|Death|97|||
94357525|NCT04409262|323090830|FG000|Overall Study|Lost to Follow-up|12|||
94357526|NCT04409262|323090831|FG001|Overall Study|Lost to Follow-up|23|||
94357527|NCT04409262|323090830|FG000|Overall Study|Lack of Staff|0|||
94357528|NCT04409262|323090831|FG001|Overall Study|Lack of Staff|1|||
94357529|NCT04409262|323090830|FG000|Overall Study|Protocol Violation|3|||
94357530|NCT04409262|323090831|FG001|Overall Study|Protocol Violation|1|||
94251474|NCT00709852|322712905|FG001|Period 2|Lost to Follow-up|0|||
94251475|NCT00709852|322712904|FG000|Period 2|No 72-hour follow-up|3|||
94251476|NCT00709852|322712905|FG001|Period 2|No 72-hour follow-up|0|||
94251477|NCT02751320|322712906|FG000|Overall Study|Adverse Event|2|||
94661581|NCT04964089|324215772|FG001|Overall Study|Adverse Event|6|||
94357531|NCT04409262|323090830|FG000|Overall Study|Withdrawal by Subject|5|||
94251478|NCT02751320|322712906|FG000|Overall Study|Withdrawal by Subject|1|||
94251479|NCT01021215|322712907|FG000|Overall Study|Lost to Follow-up|3|||
94251480|NCT01021215|322712908|FG001|Overall Study|Lost to Follow-up|0|||
94251481|NCT02549196|322712909|FG000|Overall Study|Protocol Violation|0|||
94607058|NCT02147184|324025319|FG001|Overall Study|Other|0|||
94607059|NCT03595774|324025320|FG000|Overall Study|Adverse Event|1|||
94251482|NCT02549196|322712910|FG001|Overall Study|Protocol Violation|0|||
94251483|NCT02549196|322712911|FG002|Overall Study|Protocol Violation|0|||
94251484|NCT02549196|322712912|FG003|Overall Study|Protocol Violation|1|||
94251485|NCT02549196|322712909|FG000|Overall Study|Withdrawal by Subject|1|||
94251486|NCT02549196|322712910|FG001|Overall Study|Withdrawal by Subject|0|||
94251487|NCT02549196|322712911|FG002|Overall Study|Withdrawal by Subject|1|||
94251488|NCT02549196|322712912|FG003|Overall Study|Withdrawal by Subject|0|||
94251489|NCT01103362|322712913|FG000|Overall Study|study terminated|596|||
94251490|NCT01178385|322712915|FG000|Overall Study|Withdrawal by Subject|2|||
94251491|NCT01178385|322712916|FG001|Overall Study|Withdrawal by Subject|0|||
94251492|NCT01226095|322712917|FG000|Overall Study|Poor compliance|1|||
94251493|NCT03683823|322712919|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
94251494|NCT03683823|322712920|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
94251495|NCT03683823|322712919|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
94251496|NCT03683823|322712920|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
94251497|NCT03683823|322712919|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
94251498|NCT03683823|322712920|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
94251499|NCT00490724|322712921|FG000|Period I|Physician Decision|0|||
94251500|NCT00490724|322712922|FG001|Period I|Physician Decision|0|||
94251501|NCT00490724|322712923|FG002|Period I|Physician Decision|1|||
94251502|NCT00490724|322712921|FG000|Period II|Treatment Discontinuation|3|||
94251503|NCT00490724|322712922|FG001|Period II|Treatment Discontinuation|1|||
94251504|NCT00490724|322712923|FG002|Period II|Treatment Discontinuation|3|||
94251505|NCT01395888|322712924|FG000|2-week Run-in Period|Adverse Event|2|||
94251506|NCT01395888|322712925|FG001|2-week Run-in Period|Adverse Event|0|||
94251507|NCT01395888|322712926|FG002|2-week Run-in Period|Adverse Event|0|||
94251508|NCT01395888|322712924|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
94251509|NCT01395888|322712925|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
94251510|NCT01395888|322712926|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
94251511|NCT01395888|322712924|FG000|2-week Run-in Period|Lost to Follow-up|1|||
94251512|NCT01395888|322712925|FG001|2-week Run-in Period|Lost to Follow-up|0|||
94251513|NCT01395888|322712926|FG002|2-week Run-in Period|Lost to Follow-up|0|||
94251514|NCT01395888|322712924|FG000|2-week Run-in Period|Protocol Violation|2|||
94251515|NCT01395888|322712925|FG001|2-week Run-in Period|Protocol Violation|0|||
94251516|NCT01395888|322712926|FG002|2-week Run-in Period|Protocol Violation|0|||
94251517|NCT01395888|322712924|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
94251518|NCT01395888|322712925|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
94251519|NCT01395888|322712926|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
94251520|NCT01395888|322712924|FG000|Treatment Period (TP)|Adverse Event|0|||
94251521|NCT01395888|322712925|FG001|Treatment Period (TP)|Adverse Event|7|||
94251522|NCT01395888|322712926|FG002|Treatment Period (TP)|Adverse Event|6|||
94251523|NCT01395888|322712924|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
94251524|NCT01395888|322712925|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
94251525|NCT01395888|322712926|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
94251526|NCT01395888|322712924|FG000|Treatment Period (TP)|Protocol Violation|0|||
94251527|NCT01395888|322712925|FG001|Treatment Period (TP)|Protocol Violation|1|||
94251528|NCT01395888|322712926|FG002|Treatment Period (TP)|Protocol Violation|5|||
94251529|NCT01395888|322712924|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
94251530|NCT01395888|322712925|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
94251531|NCT01395888|322712926|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
94251532|NCT01395888|322712924|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
94251533|NCT01395888|322712925|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
94251534|NCT01395888|322712926|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
94251535|NCT02008877|322712929|FG000|Overall Study|Inevaluable|0|||
94251536|NCT02008877|322712930|FG001|Overall Study|Inevaluable|1|||
94251537|NCT02008877|322712931|FG002|Overall Study|Inevaluable|0|||
94251538|NCT00589121|322712932|FG000|Overall Study|Protocol Violation|2|||
94251539|NCT00589121|322712933|FG001|Overall Study|Protocol Violation|6|||
94251540|NCT00589121|322712932|FG000|Overall Study|No protocol treatment received|0|||
94251541|NCT00589121|322712933|FG001|Overall Study|No protocol treatment received|1|||
94251542|NCT00775463|322714428|FG000|Overall Study|Withdrawal by Subject|0|||
94251543|NCT00775463|322714429|FG001|Overall Study|Withdrawal by Subject|1|||
94607060|NCT03595774|324025321|FG001|Overall Study|Adverse Event|0|||
94251544|NCT00775463|322714428|FG000|Overall Study|Adverse Event|7|||
94251545|NCT00775463|322714429|FG001|Overall Study|Adverse Event|9|||
94251546|NCT00775463|322714428|FG000|Overall Study|Protocol Violation|2|||
94251547|NCT00775463|322714429|FG001|Overall Study|Protocol Violation|2|||
94251548|NCT00775463|322714428|FG000|Overall Study|Lost to Follow-up|1|||
94251549|NCT00775463|322714429|FG001|Overall Study|Lost to Follow-up|0|||
94251550|NCT00775463|322714428|FG000|Overall Study|Lack of Efficacy|1|||
94251551|NCT00775463|322714429|FG001|Overall Study|Lack of Efficacy|1|||
94251552|NCT02407990|322714430|FG000|Overall Study|Death|2|||
94251553|NCT02407990|322714431|FG001|Overall Study|Death|22|||
94251554|NCT02407990|322714432|FG002|Overall Study|Death|23|||
94251555|NCT02407990|322714433|FG003|Overall Study|Death|7|||
94251556|NCT02407990|322714434|FG004|Overall Study|Death|17|||
94251557|NCT02407990|322714435|FG005|Overall Study|Death|16|||
94251558|NCT02407990|322714436|FG006|Overall Study|Death|10|||
94251559|NCT02407990|322714437|FG007|Overall Study|Death|248|||
94251560|NCT02407990|322714430|FG000|Overall Study|Lost to Follow-up|0|||
94251561|NCT02407990|322714431|FG001|Overall Study|Lost to Follow-up|1|||
94251562|NCT02407990|322714432|FG002|Overall Study|Lost to Follow-up|0|||
94251563|NCT02407990|322714433|FG003|Overall Study|Lost to Follow-up|0|||
94251564|NCT02407990|322714434|FG004|Overall Study|Lost to Follow-up|0|||
94251565|NCT02407990|322714435|FG005|Overall Study|Lost to Follow-up|0|||
94251566|NCT02407990|322714436|FG006|Overall Study|Lost to Follow-up|0|||
94251567|NCT02407990|322714437|FG007|Overall Study|Lost to Follow-up|17|||
94251568|NCT02407990|322714430|FG000|Overall Study|Progressive Disease|0|||
94251569|NCT02407990|322714431|FG001|Overall Study|Progressive Disease|0|||
94251570|NCT02407990|322714432|FG002|Overall Study|Progressive Disease|0|||
94251571|NCT02407990|322714433|FG003|Overall Study|Progressive Disease|0|||
94251572|NCT02407990|322714434|FG004|Overall Study|Progressive Disease|0|||
94251573|NCT02407990|322714435|FG005|Overall Study|Progressive Disease|0|||
94251574|NCT02407990|322714436|FG006|Overall Study|Progressive Disease|0|||
94251575|NCT02407990|322714437|FG007|Overall Study|Progressive Disease|1|||
94251576|NCT02407990|322714430|FG000|Overall Study|Withdrawal by Subject|0|||
94251577|NCT02407990|322714431|FG001|Overall Study|Withdrawal by Subject|0|||
94251578|NCT02407990|322714432|FG002|Overall Study|Withdrawal by Subject|0|||
94251579|NCT02407990|322714433|FG003|Overall Study|Withdrawal by Subject|0|||
94251580|NCT02407990|322714434|FG004|Overall Study|Withdrawal by Subject|1|||
94251581|NCT02407990|322714435|FG005|Overall Study|Withdrawal by Subject|0|||
94251582|NCT02407990|322714436|FG006|Overall Study|Withdrawal by Subject|0|||
94251583|NCT02407990|322714437|FG007|Overall Study|Withdrawal by Subject|30|||
94251584|NCT02407990|322714430|FG000|Overall Study|Study Terminated by Sponsor|1|||
94251585|NCT02407990|322714431|FG001|Overall Study|Study Terminated by Sponsor|3|||
94251586|NCT02407990|322714432|FG002|Overall Study|Study Terminated by Sponsor|3|||
94251587|NCT02407990|322714433|FG003|Overall Study|Study Terminated by Sponsor|0|||
94251588|NCT02407990|322714434|FG004|Overall Study|Study Terminated by Sponsor|3|||
94251589|NCT02407990|322714435|FG005|Overall Study|Study Terminated by Sponsor|4|||
94251590|NCT02407990|322714436|FG006|Overall Study|Study Terminated by Sponsor|3|||
94251591|NCT02407990|322714437|FG007|Overall Study|Study Terminated by Sponsor|37|||
94251592|NCT02407990|322714430|FG000|Overall Study|Logistics|0|||
94251593|NCT02407990|322714431|FG001|Overall Study|Logistics|0|||
94251594|NCT02407990|322714432|FG002|Overall Study|Logistics|0|||
94251595|NCT02407990|322714433|FG003|Overall Study|Logistics|0|||
94251596|NCT02407990|322714434|FG004|Overall Study|Logistics|0|||
94251597|NCT02407990|322714435|FG005|Overall Study|Logistics|0|||
94251598|NCT02407990|322714436|FG006|Overall Study|Logistics|0|||
94251599|NCT02407990|322714437|FG007|Overall Study|Logistics|1|||
94251600|NCT02407990|322714430|FG000|Overall Study|Rolled into long-term extension study|0|||
94251601|NCT02407990|322714431|FG001|Overall Study|Rolled into long-term extension study|0|||
94251602|NCT02407990|322714432|FG002|Overall Study|Rolled into long-term extension study|0|||
94251603|NCT02407990|322714433|FG003|Overall Study|Rolled into long-term extension study|0|||
94251604|NCT02407990|322714434|FG004|Overall Study|Rolled into long-term extension study|0|||
94251605|NCT02407990|322714435|FG005|Overall Study|Rolled into long-term extension study|0|||
94251606|NCT02407990|322714436|FG006|Overall Study|Rolled into long-term extension study|0|||
94251607|NCT02407990|322714437|FG007|Overall Study|Rolled into long-term extension study|1|||
94251608|NCT00734097|322714438|FG000|Screening|Protocol Violation|12|||
94251609|NCT00734097|322714438|FG000|Screening|Withdrawal by Subject|5|||
94251610|NCT00734097|322714438|FG000|Screening|Lost to Follow-up|2|||
94251611|NCT00734097|322714438|FG000|Screening|Unconfirmed pregnancy|1|||
94251612|NCT00734097|322714438|FG000|Open Label|Lost to Follow-up|7|||
94251613|NCT00734097|322714438|FG000|Open Label|Withdrawal by Subject|5|||
94458985|NCT03104400|323469488|FG001|Overall Study|Lack of Efficacy|3|||
94458986|NCT03104400|323469489|FG002|Overall Study|Lack of Efficacy|8|||
94251614|NCT00734097|322714438|FG000|Open Label|Protocol Violation|4|||
94251615|NCT00901186|322714439|FG000|Overall Study|Lack of Efficacy|0|||
94251616|NCT00901186|322714440|FG001|Overall Study|Lack of Efficacy|1|||
94458987|NCT03104400|323469490|FG003|Overall Study|Lack of Efficacy|2|||
94458988|NCT03104400|323469491|FG004|Overall Study|Lack of Efficacy|1|||
94458989|NCT03104400|323469487|FG000|Overall Study|COVID Logistical Restrictions|0|||
94251617|NCT00901186|322714439|FG000|Overall Study|Abnormal laboratory values|0|||
94251618|NCT00901186|322714440|FG001|Overall Study|Abnormal laboratory values|1|||
94251619|NCT00901186|322714439|FG000|Overall Study|Lost to Follow-up|2|||
94251620|NCT00901186|322714440|FG001|Overall Study|Lost to Follow-up|0|||
94251621|NCT00901186|322714439|FG000|Overall Study|Adverse Event|2|||
94251622|NCT00901186|322714440|FG001|Overall Study|Adverse Event|4|||
94251623|NCT00901186|322714439|FG000|Overall Study|Administration problems|0|||
94607061|NCT03595774|324025322|FG002|Overall Study|Adverse Event|1|||
94607062|NCT03595774|324025323|FG003|Overall Study|Adverse Event|0|||
94607063|NCT03595774|324025320|FG000|Overall Study|screen failure|0|||
94607064|NCT03595774|324025321|FG001|Overall Study|screen failure|1|||
94607065|NCT03595774|324025322|FG002|Overall Study|screen failure|0|||
94607066|NCT03595774|324025323|FG003|Overall Study|screen failure|1|||
94607067|NCT00117286|324025324|FG000|Overall Study|Adverse Event|12|||
94607068|NCT00117286|324025325|FG001|Overall Study|Adverse Event|6|||
94607069|NCT00117286|324025324|FG000|Overall Study|Lost to Follow-up|2|||
94607070|NCT00117286|324025325|FG001|Overall Study|Lost to Follow-up|0|||
94607071|NCT00117286|324025324|FG000|Overall Study|Protocol Violation|3|||
94607072|NCT00117286|324025325|FG001|Overall Study|Protocol Violation|3|||
94607073|NCT00117286|324025324|FG000|Overall Study|Withdrawal by Subject|6|||
94607074|NCT00117286|324025325|FG001|Overall Study|Withdrawal by Subject|2|||
94607075|NCT00117286|324025324|FG000|Overall Study|Physician Decision|3|||
94607076|NCT00117286|324025325|FG001|Overall Study|Physician Decision|7|||
94607077|NCT00117286|324025324|FG000|Overall Study|Lack of Efficacy|2|||
94607078|NCT00117286|324025325|FG001|Overall Study|Lack of Efficacy|1|||
94607079|NCT00117286|324025324|FG000|Overall Study|Research site closing|0|||
94607080|NCT00117286|324025325|FG001|Overall Study|Research site closing|2|||
94607081|NCT01243671|324025328|FG000|Overall Study|Adverse Event|3|||
94607082|NCT01243671|324025328|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
94607083|NCT01243671|324025328|FG000|Overall Study|Other|1|||
94607084|NCT01646073|324025329|FG000|Period A (12 Weeks)|Adverse Event|0|||
94607085|NCT01646073|324025330|FG001|Period A (12 Weeks)|Adverse Event|2|||
94607086|NCT01646073|324025329|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
94607087|NCT01646073|324025330|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
94607088|NCT01646073|324025329|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
94607089|NCT01646073|324025330|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
94607090|NCT01646073|324025329|FG000|Period A (12 Weeks)|Protocol Violation|0|||
94607091|NCT01646073|324025330|FG001|Period A (12 Weeks)|Protocol Violation|1|||
94607092|NCT01646073|324025329|FG000|Period A (12 Weeks)|Other|0|||
94607093|NCT01646073|324025330|FG001|Period A (12 Weeks)|Other|1|||
94607094|NCT01646073|324025329|FG000|Period B (12 Weeks)|Adverse Event|0|||
94607095|NCT01646073|324025330|FG001|Period B (12 Weeks)|Adverse Event|7|||
94607096|NCT01646073|324025329|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
94607097|NCT01646073|324025330|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
94251624|NCT00901186|322714440|FG001|Overall Study|Administration problems|1|||
94251625|NCT00901186|322714439|FG000|Overall Study|Protocol deviations|5|||
94251626|NCT00901186|322714440|FG001|Overall Study|Protocol deviations|4|||
94251627|NCT01190514|322714441|FG000|First Intervention (Period 1)|Adverse Event|1|||
94251628|NCT01190514|322714442|FG001|First Intervention (Period 1)|Adverse Event|0|||
94251629|NCT01190514|322714443|FG002|First Intervention (Period 1)|Adverse Event|0|||
94251630|NCT01190514|322714444|FG003|First Intervention (Period 1)|Adverse Event|0|||
94251631|NCT01190514|322714441|FG000|Third Intervention (Period 3)|Adverse Event|1|||
94251632|NCT01190514|322714442|FG001|Third Intervention (Period 3)|Adverse Event|0|||
94251633|NCT01190514|322714443|FG002|Third Intervention (Period 3)|Adverse Event|0|||
94251634|NCT01190514|322714444|FG003|Third Intervention (Period 3)|Adverse Event|0|||
94251635|NCT00512317|322714445|FG000|Overall Study|Insufficient clinical response|36|||
94251636|NCT00512317|322714445|FG000|Overall Study|Withdrawal by Subject|23|||
94251637|NCT00512317|322714445|FG000|Overall Study|Sponsor closure of study|21|||
94251638|NCT00512317|322714445|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
94251639|NCT00512317|322714445|FG000|Overall Study|Adverse Event|13|||
94251640|NCT00512317|322714445|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
94251641|NCT00512317|322714445|FG000|Overall Study|Lost to Follow-up|2|||
94251642|NCT00512317|322714445|FG000|Overall Study|Other|2|||
94251643|NCT02874924|322714446|FG000|Overall Study|Adverse Event|2|||
94251644|NCT02874924|322714447|FG001|Overall Study|Adverse Event|0|||
94251645|NCT02874924|322714448|FG002|Overall Study|Adverse Event|0|||
94251646|NCT02874924|322714446|FG000|Overall Study|Withdrawal by Subject|1|||
94251647|NCT02874924|322714447|FG001|Overall Study|Withdrawal by Subject|0|||
94251648|NCT02874924|322714448|FG002|Overall Study|Withdrawal by Subject|0|||
94251649|NCT01981473|322714456|FG000|Overall Study|Incorrect diagnosis of RA|0|||
94251650|NCT01981473|322714457|FG001|Overall Study|Incorrect diagnosis of RA|0|||
94251651|NCT01981473|322714458|FG002|Overall Study|Incorrect diagnosis of RA|1|||
94251652|NCT01981473|322714456|FG000|Overall Study|Received treatment for < 6 months|0|||
94251653|NCT01981473|322714457|FG001|Overall Study|Received treatment for < 6 months|0|||
94251654|NCT01981473|322714458|FG002|Overall Study|Received treatment for < 6 months|1|||
94251655|NCT01981473|322714456|FG000|Overall Study|Received treatment for >24 months|2|||
94251656|NCT01981473|322714457|FG001|Overall Study|Received treatment for >24 months|0|||
94251657|NCT01981473|322714458|FG002|Overall Study|Received treatment for >24 months|6|||
94251658|NCT00757588|322714460|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
94251659|NCT00757588|322714461|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
94251660|NCT00757588|322714460|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
94251661|NCT00757588|322714461|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
94251662|NCT00757588|322714460|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
94251663|NCT00757588|322714461|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
94251664|NCT00757588|322714460|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
94251665|NCT00757588|322714461|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
94251666|NCT00757588|322714460|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
94251667|NCT00757588|322714461|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
94251668|NCT00757588|322714460|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
94251669|NCT00757588|322714461|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
94251670|NCT00757588|322714460|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
94251671|NCT00757588|322714461|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
94251672|NCT00757588|322714460|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
94251673|NCT00757588|322714461|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
94251674|NCT00757588|322714460|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
94251675|NCT00757588|322714461|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
94251676|NCT00757588|322714460|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
94251677|NCT00757588|322714461|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
94251678|NCT00757588|322714460|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
94251679|NCT00757588|322714461|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
94251680|NCT00757588|322714460|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
94251681|NCT00757588|322714461|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
94251682|NCT00757588|322714460|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
94251683|NCT00757588|322714461|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
94251684|NCT00757588|322714460|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
94251685|NCT00757588|322714461|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
94251686|NCT00757588|322714460|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
94251687|NCT00757588|322714461|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
94251688|NCT00757588|322714460|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
94251689|NCT00757588|322714461|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
94251690|NCT02937454|322714462|FG000|Overall Study|Adverse Event|0|||
94458990|NCT03104400|323469488|FG001|Overall Study|COVID Logistical Restrictions|0|||
94661582|NCT04964089|324215771|FG000|Overall Study|Non-compliance with study schedule|1|||
94357532|NCT04409262|323090831|FG001|Overall Study|Withdrawal by Subject|10|||
94357533|NCT02396849|323090834|FG000|Overall Study|Lost to Follow-up|1|||
94357534|NCT02396849|323090835|FG001|Overall Study|Lost to Follow-up|1|||
94357535|NCT02396849|323090834|FG000|Overall Study|Did not tolerate intervention|1|||
94357536|NCT02396849|323090835|FG001|Overall Study|Did not tolerate intervention|1|||
94357537|NCT01054443|323090838|FG000|Overall Study|Withdrawal by Subject|0|||
94357538|NCT01054443|323090839|FG001|Overall Study|Withdrawal by Subject|0|||
94357539|NCT01054443|323090840|FG002|Overall Study|Withdrawal by Subject|0|||
94357540|NCT01054443|323090841|FG003|Overall Study|Withdrawal by Subject|1|||
94357541|NCT01119118|323090843|FG000|Overall Study|Adverse Event|1|||
94357542|NCT00167414|323090845|FG000|Overall Study|Death|10|||
94357543|NCT01593761|323090848|FG000|Overall Study|Lost to Follow-up|1|||
94357544|NCT01593761|323090848|FG000|Overall Study|culture negative for MRSA at baseline|5|||
94357545|NCT01593761|323090848|FG000|Overall Study|positive for hepatitis C virus|1|||
94357546|NCT01593761|323090848|FG000|Overall Study|secondary cellulitis|1|||
94357547|NCT01869959|323090849|FG000|Randomization Period|Physician Decision|0|||
94357548|NCT01869959|323090850|FG001|Randomization Period|Physician Decision|0|||
94357549|NCT01869959|323090851|FG002|Randomization Period|Physician Decision|0|||
94357550|NCT01869959|323090852|FG003|Randomization Period|Physician Decision|0|||
94357551|NCT01869959|323090853|FG004|Randomization Period|Physician Decision|1|||
94357552|NCT01869959|323090849|FG000|Treatment Period|Adverse Event|1|||
94357553|NCT01869959|323090850|FG001|Treatment Period|Adverse Event|0|||
94357554|NCT01869959|323090851|FG002|Treatment Period|Adverse Event|3|||
94357555|NCT01869959|323090852|FG003|Treatment Period|Adverse Event|1|||
94357556|NCT01869959|323090853|FG004|Treatment Period|Adverse Event|0|||
94357557|NCT01869959|323090849|FG000|Treatment Period|Sponsor decision|0|||
94357558|NCT01869959|323090850|FG001|Treatment Period|Sponsor decision|1|||
94357559|NCT01869959|323090851|FG002|Treatment Period|Sponsor decision|0|||
94357560|NCT01869959|323090852|FG003|Treatment Period|Sponsor decision|1|||
94357561|NCT01869959|323090853|FG004|Treatment Period|Sponsor decision|0|||
94357562|NCT01869959|323090849|FG000|Treatment Period|Withdrawal by Subject|0|||
94357563|NCT01869959|323090850|FG001|Treatment Period|Withdrawal by Subject|1|||
94357564|NCT01869959|323090851|FG002|Treatment Period|Withdrawal by Subject|0|||
94357565|NCT01869959|323090852|FG003|Treatment Period|Withdrawal by Subject|0|||
94357566|NCT01869959|323090853|FG004|Treatment Period|Withdrawal by Subject|0|||
94357567|NCT01965600|323090854|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
94357568|NCT01965600|323090855|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
94357569|NCT01965600|323090856|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
94357570|NCT01965600|323090857|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
94357571|NCT01965600|323090854|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
94357572|NCT01965600|323090855|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
94357573|NCT01965600|323090856|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
94357574|NCT01965600|323090857|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
94357575|NCT01965600|323090854|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
94357576|NCT01965600|323090855|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
94357577|NCT01965600|323090856|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
94357578|NCT01965600|323090857|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
94357579|NCT01965600|323090854|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
94357580|NCT01965600|323090855|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
94357581|NCT01965600|323090856|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
94357582|NCT01965600|323090857|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
94357583|NCT01965600|323090854|FG000|Second Intervention|Study terminated by Sponsor|0|||
94357584|NCT01965600|323090855|FG001|Second Intervention|Study terminated by Sponsor|0|||
94357585|NCT01965600|323090856|FG002|Second Intervention|Study terminated by Sponsor|2|||
94357586|NCT01965600|323090857|FG003|Second Intervention|Study terminated by Sponsor|2|||
94357587|NCT03418727|323090858|FG000|Overall Study|Adverse Event|1|||
94357588|NCT03418727|323090859|FG001|Overall Study|Adverse Event|2|||
94357589|NCT03418727|323090860|FG002|Overall Study|Adverse Event|0|||
94357590|NCT03418727|323090858|FG000|Overall Study|Withdrawal by Subject|0|||
94357591|NCT03418727|323090859|FG001|Overall Study|Withdrawal by Subject|0|||
94357592|NCT03418727|323090860|FG002|Overall Study|Withdrawal by Subject|2|||
94357593|NCT01018680|323092266|FG000|Overall Study|Adverse Event|23|||
94357594|NCT01018680|323092267|FG001|Overall Study|Adverse Event|40|||
94357595|NCT01018680|323092266|FG000|Overall Study|Withdrawal by Subject|10|||
94357596|NCT01018680|323092267|FG001|Overall Study|Withdrawal by Subject|10|||
94357597|NCT01018680|323092266|FG000|Overall Study|Protocol Violation|5|||
94357598|NCT01018680|323092267|FG001|Overall Study|Protocol Violation|8|||
94357599|NCT01018680|323092266|FG000|Overall Study|Sponsor Decision|6|||
94357600|NCT01018680|323092267|FG001|Overall Study|Sponsor Decision|7|||
94357601|NCT01018680|323092266|FG000|Overall Study|Lack of Efficacy|8|||
94357602|NCT01018680|323092267|FG001|Overall Study|Lack of Efficacy|2|||
94357603|NCT01018680|323092266|FG000|Overall Study|Lost to Follow-up|5|||
94357604|NCT01018680|323092267|FG001|Overall Study|Lost to Follow-up|3|||
94357605|NCT01018680|323092266|FG000|Overall Study|Entry Criteria Not Met|1|||
94357606|NCT01018680|323092267|FG001|Overall Study|Entry Criteria Not Met|4|||
94357607|NCT01018680|323092266|FG000|Overall Study|Physician Decision|3|||
94357608|NCT01018680|323092267|FG001|Overall Study|Physician Decision|1|||
94357609|NCT01714726|323092273|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
94357610|NCT01714726|323092274|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
94357611|NCT01714726|323092275|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
94357612|NCT01714726|323092276|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
94357613|NCT01714726|323092273|FG000|Double-Blinded Induction Period|Adverse Event|0|||
94357614|NCT01714726|323092274|FG001|Double-Blinded Induction Period|Adverse Event|1|||
94357615|NCT01714726|323092275|FG002|Double-Blinded Induction Period|Adverse Event|0|||
94357616|NCT01714726|323092276|FG003|Double-Blinded Induction Period|Adverse Event|0|||
94357617|NCT01714726|323092273|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
94357618|NCT01714726|323092274|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
94357619|NCT01714726|323092275|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
94357620|NCT01714726|323092276|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
94357621|NCT01714726|323092273|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
94357622|NCT01714726|323092274|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
94357623|NCT01714726|323092275|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
94357624|NCT01714726|323092276|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
94357625|NCT01714726|323092273|FG000|Open-Label Period|Other|0|||
94357626|NCT01714726|323092274|FG001|Open-Label Period|Other|0|||
94357627|NCT01714726|323092275|FG002|Open-Label Period|Other|1|||
94357628|NCT01714726|323092276|FG003|Open-Label Period|Other|3|||
94357629|NCT01714726|323092273|FG000|Open-Label Period|Adverse Event|0|||
94357630|NCT01714726|323092274|FG001|Open-Label Period|Adverse Event|0|||
94607098|NCT01646073|324025329|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
94607099|NCT01646073|324025330|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
94607100|NCT02169284|324025331|FG000|Overall Study|Physician Decision|0|||
94607101|NCT02169284|324025332|FG001|Overall Study|Physician Decision|1|||
94607102|NCT00573248|324025334|FG000|Overall Study|scheduling conflicts|15|||
94607103|NCT00573248|324025335|FG001|Overall Study|scheduling conflicts|11|||
94607104|NCT04025710|324025336|FG000|Overall Study|Death|3|||
94607105|NCT04025710|324025336|FG000|Overall Study|Lost to Follow-up|5|||
94607106|NCT04025710|324025336|FG000|Overall Study|Withdrawal by Subject|1|||
94607107|NCT04025710|324025336|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
94607108|NCT04025710|324025336|FG000|Overall Study|Drop-out according to protocol|34|||
94607109|NCT01172275|324025337|FG000|Overall Study|Lost to Follow-up|1|||
94607110|NCT01172275|324025338|FG001|Overall Study|Lost to Follow-up|0|||
94607111|NCT01172275|324025337|FG000|Overall Study|Protocol Violation|1|||
94607112|NCT01172275|324025338|FG001|Overall Study|Protocol Violation|0|||
94607113|NCT00704808|324025342|FG000|Overall Study|Discontinued prior to starting treatment|14|||
94607114|NCT00704808|324025342|FG000|Overall Study|Death|7|||
94607115|NCT00704808|324025342|FG000|Overall Study|Tumor progression|80|||
94607116|NCT00704808|324025342|FG000|Overall Study|Patient's decision|11|||
94607117|NCT00704808|324025342|FG000|Overall Study|Early therapy discontinuation|16|||
94607118|NCT00704808|324025342|FG000|Overall Study|Adverse Event|1|||
94607119|NCT00704808|324025342|FG000|Overall Study|Lost to Follow-up|1|||
94607120|NCT00704808|324025342|FG000|Overall Study|Treatment change|1|||
94607121|NCT01309308|324025343|FG000|Overall Study|Lost to Follow-up|6|||
94607122|NCT01309308|324025344|FG001|Overall Study|Lost to Follow-up|4|||
94607123|NCT04223232|324025345|FG000|Overall Study|Withdrawal by Subject|1|||
94607124|NCT00901927|324025346|FG000|Overall Study|Lack of Efficacy|1|||
94607125|NCT00901927|324025346|FG000|Overall Study|Protocol Violation|3|||
94607126|NCT00901927|324025346|FG000|Overall Study|Withdrawal by Subject|2|||
94607127|NCT02927262|324025347|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
94607128|NCT02927262|324025348|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
94357631|NCT01714726|323092275|FG002|Open-Label Period|Adverse Event|1|||
94357632|NCT01714726|323092276|FG003|Open-Label Period|Adverse Event|0|||
94357633|NCT01714726|323092273|FG000|Open-Label Period|Withdrawal by Subject|0|||
94357634|NCT01714726|323092274|FG001|Open-Label Period|Withdrawal by Subject|0|||
94357635|NCT01714726|323092275|FG002|Open-Label Period|Withdrawal by Subject|9|||
94607129|NCT02927262|324025347|FG000|Treatment Period (Up to 744 Days)|Death|1|||
94607130|NCT02927262|324025348|FG001|Treatment Period (Up to 744 Days)|Death|0|||
94607131|NCT02927262|324025347|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
94607132|NCT02927262|324025348|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
94357636|NCT01714726|323092276|FG003|Open-Label Period|Withdrawal by Subject|19|||
94458991|NCT03104400|323469489|FG002|Overall Study|COVID Logistical Restrictions|0|||
94357637|NCT01714726|323092273|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
94458992|NCT03104400|323469490|FG003|Overall Study|COVID Logistical Restrictions|1|||
94607133|NCT02927262|324025347|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
94607134|NCT02927262|324025348|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
94251691|NCT02937454|322714463|FG001|Overall Study|Adverse Event|1|||
94251692|NCT02937454|322714462|FG000|Overall Study|Death|98|||
94251693|NCT02937454|322714463|FG001|Overall Study|Death|95|||
94251694|NCT02937454|322714462|FG000|Overall Study|Lost to Follow-up|1|||
94251695|NCT02937454|322714463|FG001|Overall Study|Lost to Follow-up|1|||
94251696|NCT02937454|322714462|FG000|Overall Study|Physician Decision|0|||
94251697|NCT02937454|322714463|FG001|Overall Study|Physician Decision|1|||
94251698|NCT02937454|322714462|FG000|Overall Study|Protocol Violation|6|||
94251699|NCT02937454|322714463|FG001|Overall Study|Protocol Violation|10|||
94607135|NCT02927262|324025347|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
94251700|NCT02937454|322714462|FG000|Overall Study|Withdrawal by Subject|27|||
94251701|NCT02937454|322714463|FG001|Overall Study|Withdrawal by Subject|15|||
94251702|NCT02937454|322714462|FG000|Overall Study|Other|8|||
94251703|NCT02937454|322714463|FG001|Overall Study|Other|5|||
94251704|NCT01052103|322714466|FG000|Overall Study|Adverse Event|10|||
94251705|NCT01052103|322714467|FG001|Overall Study|Adverse Event|6|||
94251706|NCT01052103|322714466|FG000|Overall Study|Entry Criteria Not Met|3|||
94607136|NCT02927262|324025348|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
94607137|NCT02927262|324025347|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
94607138|NCT02927262|324025348|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
94607139|NCT02927262|324025347|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
94607140|NCT02927262|324025348|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
94607141|NCT02927262|324025347|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
94607142|NCT02927262|324025348|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
94607143|NCT02927262|324025347|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
94607144|NCT02927262|324025348|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
94607145|NCT02927262|324025347|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
94607146|NCT02927262|324025348|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
94607147|NCT02927262|324025347|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
94607148|NCT02927262|324025348|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
94607149|NCT02927262|324025347|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
94607150|NCT02927262|324025348|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
94357638|NCT01714726|323092274|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
94357639|NCT01714726|323092275|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
94357640|NCT01714726|323092276|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
94607151|NCT02927262|324025347|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
94607152|NCT02927262|324025348|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
94607153|NCT02927262|324025347|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
94607154|NCT02927262|324025348|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
94607155|NCT02927262|324025347|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
94607156|NCT02927262|324025348|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
94607157|NCT02927262|324025347|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
94607158|NCT02927262|324025348|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
94607159|NCT00923936|324025349|FG000|Overall Study|progressive disease on study|2|||
94607160|NCT00923936|324025350|FG001|Overall Study|progressive disease on study|1|||
94607161|NCT00923936|324025349|FG000|Overall Study|Adverse Event|2|||
94607162|NCT00923936|324025350|FG001|Overall Study|Adverse Event|1|||
94607163|NCT00923936|324025349|FG000|Overall Study|Lost to follow up|2|||
94607164|NCT00923936|324025350|FG001|Overall Study|Lost to follow up|0|||
94607165|NCT00923936|324025349|FG000|Overall Study|Continuing in follow up period|2|||
94607166|NCT00923936|324025350|FG001|Overall Study|Continuing in follow up period|1|||
94607167|NCT03538431|324025353|FG000|Overall Study|Physician Decision|0|||
94607168|NCT03538431|324025354|FG001|Overall Study|Physician Decision|1|||
94607169|NCT03538431|324025353|FG000|Overall Study|Withdrawal by Subject|1|||
94607170|NCT03538431|324025354|FG001|Overall Study|Withdrawal by Subject|0|||
94607171|NCT00292318|324025357|FG000|Overall Study|Study terminated by officials|2|||
94607172|NCT00292318|324025358|FG001|Overall Study|Study terminated by officials|1|||
94607173|NCT02567552|324025361|FG000|Overall Study|Adverse Event|0|||
94607174|NCT02567552|324025362|FG001|Overall Study|Adverse Event|1|||
94607175|NCT02750943|324025370|FG000|Overall Study|Lost to Follow-up|1|||
94607176|NCT02750943|324025371|FG001|Overall Study|Lost to Follow-up|2|||
94607177|NCT02750943|324025370|FG000|Overall Study|Withdrawal by Subject|5|||
94607178|NCT02750943|324025371|FG001|Overall Study|Withdrawal by Subject|7|||
94607179|NCT00171054|324025372|FG000|Overall Study|Protocol Violation|1|||
94607180|NCT00171054|324025373|FG001|Overall Study|Protocol Violation|2|||
94607181|NCT00171054|324025372|FG000|Overall Study|Patient withdrew consent|1|||
94607182|NCT00171054|324025373|FG001|Overall Study|Patient withdrew consent|0|||
94607183|NCT00171054|324025372|FG000|Overall Study|Lost to Follow-up|0|||
94607184|NCT00171054|324025373|FG001|Overall Study|Lost to Follow-up|1|||
94607185|NCT00171054|324025372|FG000|Overall Study|Adverse Event|8|||
94607186|NCT00171054|324025373|FG001|Overall Study|Adverse Event|8|||
94607187|NCT00171054|324025372|FG000|Overall Study|Condition no longer required study drug|0|||
94607188|NCT00171054|324025373|FG001|Overall Study|Condition no longer required study drug|1|||
94607189|NCT03507400|324025375|FG000|Overall Study|discontinued|5|||
94607190|NCT03507400|324025376|FG001|Overall Study|discontinued|1|||
94607191|NCT03507400|324025375|FG000|Overall Study|Lost to Follow-up|8|||
94607192|NCT03507400|324025376|FG001|Overall Study|Lost to Follow-up|6|||
94607193|NCT03507400|324025375|FG000|Overall Study|Protocol Violation|0|||
94607194|NCT03507400|324025376|FG001|Overall Study|Protocol Violation|1|||
94607195|NCT01104701|324027276|FG000|Overall Study|Withdrawal by Subject|0|||
94607196|NCT01104701|324027277|FG001|Overall Study|Withdrawal by Subject|1|||
94607197|NCT01104701|324027278|FG002|Overall Study|Withdrawal by Subject|2|||
94607198|NCT01104701|324027279|FG003|Overall Study|Withdrawal by Subject|1|||
94607199|NCT01104701|324027276|FG000|Overall Study|Adverse Event|0|||
94607200|NCT01104701|324027277|FG001|Overall Study|Adverse Event|0|||
94607201|NCT01104701|324027278|FG002|Overall Study|Adverse Event|0|||
94607202|NCT01104701|324027279|FG003|Overall Study|Adverse Event|1|||
94607203|NCT01104701|324027276|FG000|Overall Study|Physician Decision|0|||
94607204|NCT01104701|324027277|FG001|Overall Study|Physician Decision|2|||
94607205|NCT01104701|324027278|FG002|Overall Study|Physician Decision|0|||
94607206|NCT01104701|324027279|FG003|Overall Study|Physician Decision|0|||
94607207|NCT01397201|324027280|FG000|Overall Study|Not treated|0|||
94607208|NCT01397201|324027281|FG001|Overall Study|Not treated|0|||
94607209|NCT01397201|324027282|FG002|Overall Study|Not treated|1|||
94607210|NCT01397201|324027283|FG003|Overall Study|Not treated|0|||
94607211|NCT01397201|324027284|FG004|Overall Study|Not treated|0|||
94607212|NCT01397201|324027280|FG000|Overall Study|Not yet defined|3|||
94607213|NCT01397201|324027281|FG001|Overall Study|Not yet defined|6|||
94607214|NCT01397201|324027282|FG002|Overall Study|Not yet defined|5|||
94251707|NCT01052103|322714467|FG001|Overall Study|Entry Criteria Not Met|1|||
94251708|NCT01052103|322714466|FG000|Overall Study|Lost to Follow-up|3|||
94251709|NCT01052103|322714467|FG001|Overall Study|Lost to Follow-up|5|||
94607215|NCT01397201|324027283|FG003|Overall Study|Not yet defined|5|||
94607216|NCT01397201|324027284|FG004|Overall Study|Not yet defined|4|||
94607217|NCT01397201|324027280|FG000|Overall Study|Adverse Event|2|||
94607218|NCT01397201|324027281|FG001|Overall Study|Adverse Event|0|||
94607219|NCT01397201|324027282|FG002|Overall Study|Adverse Event|0|||
94607220|NCT01397201|324027283|FG003|Overall Study|Adverse Event|0|||
94251710|NCT01052103|322714466|FG000|Overall Study|Protocol Violation|10|||
94607221|NCT01397201|324027284|FG004|Overall Study|Adverse Event|0|||
94607222|NCT00215683|324027285|FG000|Overall Study|Adverse Event|15|||
94607223|NCT00215683|324027286|FG001|Overall Study|Adverse Event|16|||
94251711|NCT01052103|322714467|FG001|Overall Study|Protocol Violation|4|||
94251712|NCT01052103|322714466|FG000|Overall Study|Scheduling conflict|2|||
94251713|NCT01052103|322714467|FG001|Overall Study|Scheduling conflict|1|||
94251714|NCT01052103|322714466|FG000|Overall Study|Sponsor Decision|2|||
94251715|NCT01052103|322714467|FG001|Overall Study|Sponsor Decision|0|||
94251716|NCT01052103|322714466|FG000|Overall Study|Withdrawal by Subject|3|||
94251717|NCT01052103|322714467|FG001|Overall Study|Withdrawal by Subject|6|||
94251718|NCT01052103|322714466|FG000|Overall Study|Perceived Lack of Efficacy|1|||
94251719|NCT01052103|322714467|FG001|Overall Study|Perceived Lack of Efficacy|0|||
94251720|NCT00799513|322714469|FG000|Overall Study|Physician Decision|1|||
94251721|NCT00799513|322714469|FG000|Overall Study|Adverse Event|1|||
94251722|NCT03606668|322714476|FG000|Overall Study|Screen Failure|1|||
94251723|NCT03606668|322714476|FG000|Overall Study|Lost to Follow-up|1|||
94251724|NCT01844687|322714477|FG000|Visit 1|Protocol Violation|3|||
94251725|NCT01844687|322714477|FG000|Visit 1|Lost to Follow-up|5|||
94251726|NCT01844687|322714477|FG000|Visit 2|Withdrawal by Subject|1|||
94251727|NCT01844687|322714477|FG000|Visit 2|Protocol Violation|1|||
94251728|NCT01844687|322714477|FG000|Visit 3|Lost to Follow-up|1|||
94458993|NCT03104400|323469491|FG004|Overall Study|COVID Logistical Restrictions|0|||
94458994|NCT03104400|323469487|FG000|Overall Study|Other|2|||
94458995|NCT03104400|323469488|FG001|Overall Study|Other|3|||
94458996|NCT03104400|323469489|FG002|Overall Study|Other|7|||
94458997|NCT03104400|323469490|FG003|Overall Study|Other|6|||
94458998|NCT03104400|323469491|FG004|Overall Study|Other|4|||
94458999|NCT03104400|323469487|FG000|Overall Study|Other|0|||
94459000|NCT03104400|323469488|FG001|Overall Study|Other|1|||
94459001|NCT03104400|323469489|FG002|Overall Study|Other|0|||
94459002|NCT03104400|323469490|FG003|Overall Study|Other|0|||
94459003|NCT03104400|323469491|FG004|Overall Study|Other|0|||
94459004|NCT04114357|323469492|FG000|Baseline-Randomization|Adverse Event|2|||
94459005|NCT04114357|323469493|FG001|Baseline-Randomization|Adverse Event|1|||
94459006|NCT04114357|323469492|FG000|Baseline-Randomization|Lost to Follow-up|1|||
94459007|NCT04114357|323469493|FG001|Baseline-Randomization|Lost to Follow-up|1|||
94459008|NCT04114357|323469492|FG000|Cross-over|Adverse Event|0|||
94459009|NCT04114357|323469493|FG001|Cross-over|Adverse Event|1|||
94459010|NCT03558152|323469496|FG000|Overall Study|Adverse Event|0|||
94459011|NCT03558152|323469497|FG001|Overall Study|Adverse Event|0|||
94459012|NCT03558152|323469498|FG002|Overall Study|Adverse Event|1|||
94459013|NCT03558152|323469499|FG003|Overall Study|Adverse Event|1|||
94459014|NCT03558152|323469500|FG004|Overall Study|Adverse Event|2|||
94459015|NCT03558152|323469501|FG005|Overall Study|Adverse Event|1|||
94459016|NCT03558152|323469502|FG006|Overall Study|Adverse Event|1|||
94459017|NCT03558152|323469503|FG007|Overall Study|Adverse Event|0|||
94459018|NCT03558152|323469496|FG000|Overall Study|Death|0|||
94459019|NCT03558152|323469497|FG001|Overall Study|Death|0|||
94459020|NCT03558152|323469498|FG002|Overall Study|Death|0|||
94459021|NCT03558152|323469499|FG003|Overall Study|Death|0|||
94459022|NCT03558152|323469500|FG004|Overall Study|Death|1|||
94459023|NCT03558152|323469501|FG005|Overall Study|Death|0|||
94459024|NCT03558152|323469502|FG006|Overall Study|Death|0|||
94459025|NCT03558152|323469503|FG007|Overall Study|Death|0|||
94251729|NCT01844687|322714477|FG000|Visit 3|Withdrawal by Subject|3|||
94251730|NCT01844687|322714477|FG000|Visit 3|child care problems|1|||
94251731|NCT01844687|322714477|FG000|Visit 4|Pregnancy|1|||
94251732|NCT01844687|322714477|FG000|Visit 4|Lost to Follow-up|1|||
94251733|NCT01844687|322714477|FG000|Visit 4|Withdrawal by Subject|2|||
94251734|NCT01079663|322714478|FG000|Overall Study|Adverse Event|0|||
94251735|NCT01079663|322714479|FG001|Overall Study|Adverse Event|2|||
94251736|NCT01079663|322714478|FG000|Overall Study|Protocol Violation|0|||
94251737|NCT01079663|322714479|FG001|Overall Study|Protocol Violation|2|||
94251738|NCT02354508|322714480|FG000|Period 1: Core Phase|Adverse Event|1|||
94251739|NCT02354508|322714481|FG001|Period 1: Core Phase|Adverse Event|1|||
94251740|NCT02354508|322714482|FG002|Period 1: Core Phase|Adverse Event|2|||
94251741|NCT02354508|322714480|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
94459026|NCT03558152|323469496|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
94459027|NCT03558152|323469497|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
94459028|NCT03558152|323469498|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
94251742|NCT02354508|322714481|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
94251743|NCT02354508|322714482|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
94251744|NCT02354508|322714480|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
94251745|NCT02354508|322714481|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
94251746|NCT02354508|322714482|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
94251747|NCT02354508|322714480|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
94251748|NCT02354508|322714481|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
94251749|NCT02354508|322714482|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
94459029|NCT03558152|323469499|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
94459030|NCT03558152|323469500|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
94459031|NCT03558152|323469501|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
94607224|NCT00215683|324027287|FG002|Overall Study|Adverse Event|15|||
94607225|NCT00215683|324027285|FG000|Overall Study|Lack of Efficacy|5|||
94607226|NCT00215683|324027286|FG001|Overall Study|Lack of Efficacy|1|||
94607227|NCT00215683|324027287|FG002|Overall Study|Lack of Efficacy|2|||
94607228|NCT00215683|324027285|FG000|Overall Study|Lost to Follow-up|0|||
94607229|NCT00215683|324027286|FG001|Overall Study|Lost to Follow-up|2|||
94607230|NCT00215683|324027287|FG002|Overall Study|Lost to Follow-up|1|||
94607231|NCT00215683|324027285|FG000|Overall Study|Withdrawal by Subject|9|||
94607232|NCT00215683|324027286|FG001|Overall Study|Withdrawal by Subject|4|||
94607233|NCT00215683|324027287|FG002|Overall Study|Withdrawal by Subject|13|||
94251750|NCT02354508|322714480|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
94251751|NCT02354508|322714481|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
94251752|NCT02354508|322714482|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
94251753|NCT02354508|322714480|FG000|Period 2: Extension Phase|Physician Decision|5|||
94251754|NCT02354508|322714481|FG001|Period 2: Extension Phase|Physician Decision|0|||
94251755|NCT02354508|322714482|FG002|Period 2: Extension Phase|Physician Decision|1|||
94251756|NCT02354508|322714480|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
94251757|NCT02354508|322714481|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
94251758|NCT02354508|322714482|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
94251759|NCT02354508|322714480|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
94251760|NCT02354508|322714481|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
94607234|NCT00215683|324027285|FG000|Overall Study|Physician Decision|0|||
94607235|NCT00215683|324027286|FG001|Overall Study|Physician Decision|0|||
94607236|NCT00215683|324027287|FG002|Overall Study|Physician Decision|1|||
94607237|NCT00215683|324027285|FG000|Overall Study|Difficult to attend visits|0|||
94607238|NCT00215683|324027286|FG001|Overall Study|Difficult to attend visits|1|||
94607239|NCT00215683|324027287|FG002|Overall Study|Difficult to attend visits|0|||
94607240|NCT00215683|324027285|FG000|Overall Study|No study drug available|0|||
94607241|NCT00215683|324027286|FG001|Overall Study|No study drug available|1|||
94607242|NCT00215683|324027287|FG002|Overall Study|No study drug available|0|||
94607243|NCT00215683|324027285|FG000|Overall Study|Intermittent therapy required|0|||
94607244|NCT00215683|324027286|FG001|Overall Study|Intermittent therapy required|1|||
94661583|NCT04964089|324215772|FG001|Overall Study|Non-compliance with study schedule|0|||
94661584|NCT04964089|324215771|FG000|Overall Study|Withdrawal by Subject|6|||
94661585|NCT04964089|324215772|FG001|Overall Study|Withdrawal by Subject|5|||
94661586|NCT04964089|324215771|FG000|Overall Study|Lost to Follow-up|1|||
94661587|NCT04964089|324215772|FG001|Overall Study|Lost to Follow-up|1|||
94661588|NCT04964089|324215771|FG000|Overall Study|Progressive disease|4|||
94661589|NCT04964089|324215772|FG001|Overall Study|Progressive disease|0|||
94661590|NCT04964089|324215771|FG000|Overall Study|Physician Decision|1|||
94661591|NCT04964089|324215772|FG001|Overall Study|Physician Decision|0|||
94661592|NCT04964089|324215771|FG000|Overall Study|Participant did not want to continue study treatment|1|||
94661593|NCT04964089|324215772|FG001|Overall Study|Participant did not want to continue study treatment|0|||
94661594|NCT04964089|324215771|FG000|Overall Study|Participant moved to different state|1|||
94661595|NCT04964089|324215772|FG001|Overall Study|Participant moved to different state|0|||
94661596|NCT04964089|324215771|FG000|Overall Study|Participant decided to discontinue|0|||
94661597|NCT04964089|324215772|FG001|Overall Study|Participant decided to discontinue|1|||
94661598|NCT03738150|324215774|FG000|Base Study|Withdrawal by Subject|1|||
94251761|NCT02354508|322714482|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
94607245|NCT00215683|324027287|FG002|Overall Study|Intermittent therapy required|0|||
94661599|NCT03738150|324215774|FG000|Extension Study|Withdrawal by Subject|1|||
94661600|NCT01462344|324215777|FG000|Overall Study|Withdrawal by Subject|245|||
94661601|NCT01462344|324215778|FG001|Overall Study|Withdrawal by Subject|226|||
94661602|NCT01462344|324215777|FG000|Overall Study|Adverse Event|24|||
94607246|NCT04493333|324027288|FG000|Overall Study|Withdrawal by Subject|1|||
94661603|NCT01462344|324215778|FG001|Overall Study|Adverse Event|23|||
94607247|NCT04493333|324027289|FG001|Overall Study|Withdrawal by Subject|1|||
94607248|NCT04493333|324027288|FG000|Overall Study|Ineligible|0|||
94607249|NCT04493333|324027289|FG001|Overall Study|Ineligible|1|||
94607250|NCT04493333|324027288|FG000|Overall Study|Noncompliance|2|||
94607251|NCT04493333|324027289|FG001|Overall Study|Noncompliance|1|||
94607252|NCT02095223|324027295|FG000|Overall Study|Withdrawal by Subject|1|||
94607253|NCT02095223|324027296|FG001|Overall Study|Withdrawal by Subject|0|||
94607254|NCT03607422|324027297|FG000|Overall Study|Adverse Event|7|||
94607255|NCT03607422|324027298|FG001|Overall Study|Adverse Event|3|||
94607256|NCT03607422|324027299|FG002|Overall Study|Adverse Event|2|||
94607257|NCT03607422|324027300|FG003|Overall Study|Adverse Event|0|||
94607258|NCT03607422|324027301|FG004|Overall Study|Adverse Event|2|||
94607259|NCT03607422|324027302|FG005|Overall Study|Adverse Event|0|||
94607260|NCT03607422|324027297|FG000|Overall Study|Withdrawal by Subject|11|||
94607261|NCT03607422|324027298|FG001|Overall Study|Withdrawal by Subject|3|||
94251762|NCT02354508|322714480|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
94251763|NCT02354508|322714481|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
94251764|NCT02354508|322714482|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
94251765|NCT02313233|322714485|FG000|Overall Study|Withdrawal by Subject|1|||
94251766|NCT02313233|322714486|FG001|Overall Study|Withdrawal by Subject|2|||
94251767|NCT02313233|322714485|FG000|Overall Study|Administrative reason|1|||
94251768|NCT02313233|322714486|FG001|Overall Study|Administrative reason|1|||
94251769|NCT02476279|322714497|FG000|Overall Study|Lost to Follow-up|1|||
94251770|NCT02476279|322714498|FG001|Overall Study|Lost to Follow-up|1|||
94251771|NCT00682890|322714499|FG000|Overall Study|Lost to Follow-up|1|||
94251772|NCT00682890|322714500|FG001|Overall Study|Lost to Follow-up|1|||
94251773|NCT00682890|322714499|FG000|Overall Study|subject moved away|0|||
94251774|NCT00682890|322714500|FG001|Overall Study|subject moved away|1|||
94251775|NCT00682890|322714499|FG000|Overall Study|heavy menstrual bleeding|1|||
94251776|NCT00682890|322714500|FG001|Overall Study|heavy menstrual bleeding|0|||
94251777|NCT03545503|322714501|FG000|Overall Study|Protocol Violation|14|||
94251778|NCT03545503|322714502|FG001|Overall Study|Protocol Violation|16|||
94251779|NCT00577473|322714504|FG000|Overall Study|Protocol Violation|1|||
94251780|NCT00577473|322714505|FG001|Overall Study|Protocol Violation|4|||
94251781|NCT00577473|322714504|FG000|Overall Study|Adverse Event|8|||
94251782|NCT00577473|322714505|FG001|Overall Study|Adverse Event|5|||
94251783|NCT00577473|322714504|FG000|Overall Study|Withdrawal by Subject|2|||
94251784|NCT00577473|322714505|FG001|Overall Study|Withdrawal by Subject|6|||
94357641|NCT01714726|323092273|FG000|Open-Label Period|Lost to Follow-up|0|||
94357642|NCT01714726|323092274|FG001|Open-Label Period|Lost to Follow-up|0|||
94357643|NCT01714726|323092275|FG002|Open-Label Period|Lost to Follow-up|3|||
94357644|NCT01714726|323092276|FG003|Open-Label Period|Lost to Follow-up|4|||
94357645|NCT00198107|323092277|FG000|Double-Blind Period|Adverse Event|1|||
94357646|NCT00198107|323092278|FG001|Double-Blind Period|Adverse Event|1|||
94357647|NCT00198107|323092279|FG002|Double-Blind Period|Adverse Event|0|||
94357648|NCT00198107|323092277|FG000|Double-Blind Period|Lack of Efficacy|2|||
94357649|NCT00198107|323092278|FG001|Double-Blind Period|Lack of Efficacy|0|||
94459032|NCT03558152|323469502|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
94459033|NCT03558152|323469503|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
94459034|NCT03558152|323469496|FG000|Overall Study|Miscalculation in mmcs|0|||
94459035|NCT03558152|323469497|FG001|Overall Study|Miscalculation in mmcs|0|||
94459036|NCT03558152|323469498|FG002|Overall Study|Miscalculation in mmcs|0|||
94459037|NCT03558152|323469499|FG003|Overall Study|Miscalculation in mmcs|0|||
94251785|NCT00577473|322714504|FG000|Overall Study|Physician Decision|2|||
94251786|NCT00577473|322714505|FG001|Overall Study|Physician Decision|2|||
94357650|NCT00198107|323092279|FG002|Double-Blind Period|Lack of Efficacy|0|||
94357651|NCT00198107|323092277|FG000|Double-Blind Period|Lost to Follow-up|2|||
94357652|NCT00198107|323092278|FG001|Double-Blind Period|Lost to Follow-up|1|||
94357653|NCT00198107|323092279|FG002|Double-Blind Period|Lost to Follow-up|0|||
94357654|NCT00198107|323092277|FG000|Double-Blind Period|Physician Decision|1|||
94357655|NCT00198107|323092278|FG001|Double-Blind Period|Physician Decision|0|||
94459038|NCT03558152|323469500|FG004|Overall Study|Miscalculation in mmcs|0|||
94459039|NCT03558152|323469501|FG005|Overall Study|Miscalculation in mmcs|0|||
94607262|NCT03607422|324027299|FG002|Overall Study|Withdrawal by Subject|6|||
94607263|NCT03607422|324027300|FG003|Overall Study|Withdrawal by Subject|2|||
94357656|NCT00198107|323092279|FG002|Double-Blind Period|Physician Decision|0|||
94357657|NCT00198107|323092277|FG000|Double-Blind Period|Withdrawal by Subject|0|||
94357658|NCT00198107|323092278|FG001|Double-Blind Period|Withdrawal by Subject|1|||
94357659|NCT00198107|323092279|FG002|Double-Blind Period|Withdrawal by Subject|0|||
94607264|NCT03607422|324027301|FG004|Overall Study|Withdrawal by Subject|0|||
94251787|NCT00577473|322714504|FG000|Overall Study|Lack of Efficacy|8|||
94251788|NCT00577473|322714505|FG001|Overall Study|Lack of Efficacy|7|||
94251789|NCT01153958|322714507|FG000|Overall Study|Study Terminated|36|||
94251790|NCT01153958|322714508|FG001|Overall Study|Study Terminated|32|||
94251791|NCT00232544|322714511|FG000|Overall Study|Lost to Follow-up|20|||
94459040|NCT03558152|323469502|FG006|Overall Study|Miscalculation in mmcs|1|||
94607265|NCT03607422|324027302|FG005|Overall Study|Withdrawal by Subject|0|||
94607266|NCT03607422|324027297|FG000|Overall Study|Lost to Follow-up|0|||
94607267|NCT03607422|324027298|FG001|Overall Study|Lost to Follow-up|0|||
94607268|NCT03607422|324027299|FG002|Overall Study|Lost to Follow-up|1|||
94607269|NCT03607422|324027300|FG003|Overall Study|Lost to Follow-up|0|||
94607270|NCT03607422|324027301|FG004|Overall Study|Lost to Follow-up|0|||
94607271|NCT03607422|324027302|FG005|Overall Study|Lost to Follow-up|0|||
94607272|NCT03607422|324027297|FG000|Overall Study|Other|12|||
94251792|NCT00232544|322714512|FG001|Overall Study|Lost to Follow-up|15|||
94251793|NCT00116753|322714513|FG000|Overall Study|Adverse Event|16|||
94607273|NCT03607422|324027298|FG001|Overall Study|Other|4|||
94607274|NCT03607422|324027299|FG002|Overall Study|Other|1|||
94251794|NCT00116753|322714514|FG001|Overall Study|Adverse Event|10|||
94251795|NCT00116753|322714515|FG002|Overall Study|Adverse Event|7|||
94251796|NCT00116753|322714513|FG000|Overall Study|Withdrawal by Subject|11|||
94251797|NCT00116753|322714514|FG001|Overall Study|Withdrawal by Subject|12|||
94251798|NCT00116753|322714515|FG002|Overall Study|Withdrawal by Subject|8|||
94251799|NCT00116753|322714513|FG000|Overall Study|Lost to Follow-up|0|||
94251800|NCT00116753|322714514|FG001|Overall Study|Lost to Follow-up|2|||
94251801|NCT00116753|322714515|FG002|Overall Study|Lost to Follow-up|1|||
94251802|NCT00116753|322714513|FG000|Overall Study|Protocol Violation|0|||
94251803|NCT00116753|322714514|FG001|Overall Study|Protocol Violation|0|||
94251804|NCT00116753|322714515|FG002|Overall Study|Protocol Violation|1|||
94357660|NCT00198107|323092277|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
94357661|NCT00198107|323092278|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
94357662|NCT00198107|323092279|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
94357663|NCT01740297|323092280|FG000|Overall Study|Withdrawal by Subject|4|||
94357664|NCT01740297|323092281|FG001|Overall Study|Withdrawal by Subject|16|||
94357665|NCT01740297|323092282|FG002|Overall Study|Withdrawal by Subject|17|||
94357666|NCT01740297|323092280|FG000|Overall Study|Death|8|||
94357667|NCT01740297|323092281|FG001|Overall Study|Death|46|||
94357668|NCT01740297|323092282|FG002|Overall Study|Death|40|||
94357669|NCT01740297|323092280|FG000|Overall Study|Lost to Follow-up|1|||
94357670|NCT01740297|323092281|FG001|Overall Study|Lost to Follow-up|2|||
94357671|NCT01740297|323092282|FG002|Overall Study|Lost to Follow-up|4|||
94357672|NCT00761462|323092284|FG000|Treatment|Subjects never received study medication|23|||
94357673|NCT00761462|323092285|FG001|Treatment|Subjects never received study medication|12|||
94357674|NCT00761462|323092284|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
94357675|NCT00761462|323092285|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
94357676|NCT00761462|323092284|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
94607275|NCT03607422|324027300|FG003|Overall Study|Other|2|||
94251805|NCT00116753|322714513|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
94251806|NCT00116753|322714514|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
94251807|NCT00116753|322714515|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
94251808|NCT00116753|322714513|FG000|Overall Study|Disease Progression|3|||
94251809|NCT00116753|322714514|FG001|Overall Study|Disease Progression|4|||
94357677|NCT00761462|323092285|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
94607276|NCT03607422|324027301|FG004|Overall Study|Other|0|||
94607277|NCT03607422|324027302|FG005|Overall Study|Other|2|||
94607278|NCT03607422|324027297|FG000|Overall Study|Ongoing at Time of Analysis|8|||
94607279|NCT03607422|324027298|FG001|Overall Study|Ongoing at Time of Analysis|0|||
94607280|NCT03607422|324027299|FG002|Overall Study|Ongoing at Time of Analysis|2|||
94607281|NCT03607422|324027300|FG003|Overall Study|Ongoing at Time of Analysis|1|||
94607282|NCT03607422|324027301|FG004|Overall Study|Ongoing at Time of Analysis|1|||
94607283|NCT03607422|324027302|FG005|Overall Study|Ongoing at Time of Analysis|1|||
94607284|NCT04478123|324027303|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
94607285|NCT04478123|324027303|FG000|Overall Study|NE|1|||
94607286|NCT01801072|324027304|FG000|Overall Study|Lost to Follow-up|17|||
94607287|NCT01801072|324027305|FG001|Overall Study|Lost to Follow-up|14|||
94607288|NCT01801072|324027304|FG000|Overall Study|Physician Decision|2|||
94607289|NCT01801072|324027305|FG001|Overall Study|Physician Decision|3|||
94607290|NCT01801072|324027304|FG000|Overall Study|Withdrawal by Subject|1|||
94607291|NCT01801072|324027305|FG001|Overall Study|Withdrawal by Subject|0|||
94607292|NCT01801072|324027304|FG000|Overall Study|Protocol Violation|2|||
94607293|NCT01801072|324027305|FG001|Overall Study|Protocol Violation|0|||
94607294|NCT01801072|324027304|FG000|Overall Study|Death|7|||
94607295|NCT01801072|324027305|FG001|Overall Study|Death|8|||
94607296|NCT03693170|324027306|FG000|Overall Study|Disease Progression|48|||
94607297|NCT03693170|324027306|FG000|Overall Study|Adverse Event|16|||
94607298|NCT03693170|324027306|FG000|Overall Study|Physician Decision|6|||
94607299|NCT03693170|324027306|FG000|Overall Study|Protocol Violation|2|||
94459041|NCT03558152|323469503|FG007|Overall Study|Miscalculation in mmcs|0|||
94459042|NCT03558152|323469496|FG000|Overall Study|Mistake in calculation|0|||
94459043|NCT03558152|323469497|FG001|Overall Study|Mistake in calculation|0|||
94459044|NCT03558152|323469498|FG002|Overall Study|Mistake in calculation|0|||
94459045|NCT03558152|323469499|FG003|Overall Study|Mistake in calculation|1|||
94459046|NCT03558152|323469500|FG004|Overall Study|Mistake in calculation|0|||
94459047|NCT03558152|323469501|FG005|Overall Study|Mistake in calculation|0|||
94459048|NCT03558152|323469502|FG006|Overall Study|Mistake in calculation|0|||
94459049|NCT03558152|323469503|FG007|Overall Study|Mistake in calculation|0|||
94459050|NCT03558152|323469496|FG000|Overall Study|Mistake in evaluation of disease status|0|||
94459051|NCT03558152|323469497|FG001|Overall Study|Mistake in evaluation of disease status|0|||
94459052|NCT03558152|323469498|FG002|Overall Study|Mistake in evaluation of disease status|0|||
94459053|NCT03558152|323469499|FG003|Overall Study|Mistake in evaluation of disease status|0|||
94459054|NCT03558152|323469500|FG004|Overall Study|Mistake in evaluation of disease status|0|||
94459055|NCT03558152|323469501|FG005|Overall Study|Mistake in evaluation of disease status|0|||
94459056|NCT03558152|323469502|FG006|Overall Study|Mistake in evaluation of disease status|0|||
94459057|NCT03558152|323469503|FG007|Overall Study|Mistake in evaluation of disease status|1|||
94459058|NCT03558152|323469496|FG000|Overall Study|Physician Decision|0|||
94459059|NCT03558152|323469497|FG001|Overall Study|Physician Decision|0|||
94459060|NCT03558152|323469498|FG002|Overall Study|Physician Decision|0|||
94459061|NCT03558152|323469499|FG003|Overall Study|Physician Decision|0|||
94459062|NCT03558152|323469500|FG004|Overall Study|Physician Decision|0|||
94459063|NCT03558152|323469501|FG005|Overall Study|Physician Decision|0|||
94459064|NCT03558152|323469502|FG006|Overall Study|Physician Decision|1|||
94459065|NCT03558152|323469503|FG007|Overall Study|Physician Decision|0|||
94459066|NCT03558152|323469496|FG000|Overall Study|Withdrawal by Subject|2|||
94459067|NCT03558152|323469497|FG001|Overall Study|Withdrawal by Subject|3|||
94459068|NCT03558152|323469498|FG002|Overall Study|Withdrawal by Subject|2|||
94459069|NCT03558152|323469499|FG003|Overall Study|Withdrawal by Subject|1|||
94459070|NCT03558152|323469500|FG004|Overall Study|Withdrawal by Subject|1|||
94459071|NCT03558152|323469501|FG005|Overall Study|Withdrawal by Subject|1|||
94459072|NCT03558152|323469502|FG006|Overall Study|Withdrawal by Subject|3|||
94459073|NCT03558152|323469503|FG007|Overall Study|Withdrawal by Subject|2|||
94459074|NCT03558152|323469496|FG000|Overall Study|Lack of Efficacy|11|||
94459075|NCT03558152|323469497|FG001|Overall Study|Lack of Efficacy|11|||
94459076|NCT03558152|323469498|FG002|Overall Study|Lack of Efficacy|10|||
94459077|NCT03558152|323469499|FG003|Overall Study|Lack of Efficacy|11|||
94459078|NCT03558152|323469500|FG004|Overall Study|Lack of Efficacy|14|||
94459079|NCT03558152|323469501|FG005|Overall Study|Lack of Efficacy|12|||
94459080|NCT03558152|323469502|FG006|Overall Study|Lack of Efficacy|14|||
94459081|NCT03558152|323469503|FG007|Overall Study|Lack of Efficacy|13|||
94459082|NCT03558152|323469496|FG000|Overall Study|Protocol Violation|1|||
94459083|NCT03558152|323469497|FG001|Overall Study|Protocol Violation|1|||
94459084|NCT03558152|323469498|FG002|Overall Study|Protocol Violation|0|||
94251810|NCT00116753|322714515|FG002|Overall Study|Disease Progression|3|||
94251811|NCT00116753|322714513|FG000|Overall Study|Abnormal Echocardiogram|0|||
94251812|NCT00116753|322714514|FG001|Overall Study|Abnormal Echocardiogram|0|||
94251813|NCT00116753|322714515|FG002|Overall Study|Abnormal Echocardiogram|1|||
94251814|NCT00116753|322714513|FG000|Overall Study|Progressive Parkinson's Disease|1|||
94251815|NCT00116753|322714514|FG001|Overall Study|Progressive Parkinson's Disease|0|||
94251816|NCT00116753|322714515|FG002|Overall Study|Progressive Parkinson's Disease|0|||
94251817|NCT00116753|322714513|FG000|Overall Study|Dosing Error|0|||
94251818|NCT00116753|322714514|FG001|Overall Study|Dosing Error|1|||
94251819|NCT00116753|322714515|FG002|Overall Study|Dosing Error|0|||
94251820|NCT01642251|322714516|FG000|Overall Study|Progressive disease|0|||
94251821|NCT01642251|322714517|FG001|Overall Study|Progressive disease|0|||
94251822|NCT01642251|322714518|FG002|Overall Study|Progressive disease|3|||
94251823|NCT01642251|322714519|FG003|Overall Study|Progressive disease|3|||
94251824|NCT01642251|322714516|FG000|Overall Study|Adverse Event|0|||
94459085|NCT03558152|323469499|FG003|Overall Study|Protocol Violation|1|||
94459086|NCT03558152|323469500|FG004|Overall Study|Protocol Violation|1|||
94459087|NCT03558152|323469501|FG005|Overall Study|Protocol Violation|0|||
94607300|NCT03693170|324027306|FG000|Overall Study|Death|1|||
94607301|NCT03693170|324027306|FG000|Overall Study|Non compliance with study drug|1|||
94607302|NCT03693170|324027306|FG000|Overall Study|Withdrawal by Subject|1|||
94607303|NCT02316548|324027307|FG000|Overall Study|Protocol Violation|0|||
94459088|NCT03558152|323469502|FG006|Overall Study|Protocol Violation|2|||
94459089|NCT03558152|323469503|FG007|Overall Study|Protocol Violation|0|||
94459090|NCT00601172|323469504|FG000|Overall Study|Adverse Event|43|||
94607304|NCT02316548|324027308|FG001|Overall Study|Protocol Violation|1|||
94251825|NCT01642251|322714517|FG001|Overall Study|Adverse Event|0|||
94251826|NCT01642251|322714518|FG002|Overall Study|Adverse Event|5|||
94459091|NCT00601172|323469505|FG001|Overall Study|Adverse Event|32|||
94459092|NCT00601172|323469504|FG000|Overall Study|Lack of Efficacy|11|||
94459093|NCT00601172|323469505|FG001|Overall Study|Lack of Efficacy|12|||
94459094|NCT00601172|323469504|FG000|Overall Study|Protocol Violation|2|||
94459095|NCT00601172|323469505|FG001|Overall Study|Protocol Violation|5|||
94357678|NCT00761462|323092284|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
94357679|NCT00761462|323092285|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
94357680|NCT02383966|323092292|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
94357681|NCT02383966|323092293|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
94357682|NCT02383966|323092292|FG000|Overall Study|Randomized, but not treated|1|||
94357683|NCT02383966|323092293|FG001|Overall Study|Randomized, but not treated|3|||
94357684|NCT02163759|323092294|FG000|Overall Study|Withdrawal by Subject|1|||
94357685|NCT02163759|323092295|FG001|Overall Study|Withdrawal by Subject|5|||
94251827|NCT01642251|322714519|FG003|Overall Study|Adverse Event|4|||
94251828|NCT01642251|322714516|FG000|Overall Study|Death|0|||
94357686|NCT02163759|323092296|FG002|Overall Study|Withdrawal by Subject|1|||
94357687|NCT02163759|323092294|FG000|Overall Study|Adverse Event|0|||
94357688|NCT02163759|323092295|FG001|Overall Study|Adverse Event|0|||
94357689|NCT02163759|323092296|FG002|Overall Study|Adverse Event|1|||
94357690|NCT02163759|323092294|FG000|Overall Study|Death|0|||
94357691|NCT02163759|323092295|FG001|Overall Study|Death|0|||
94357692|NCT02163759|323092296|FG002|Overall Study|Death|1|||
94357693|NCT00665366|323092297|FG000|Overall Study|Lack of Efficacy|11|||
94357694|NCT00665366|323092298|FG001|Overall Study|Lack of Efficacy|10|||
94357695|NCT00665366|323092297|FG000|Overall Study|Adverse Event|25|||
94357696|NCT00665366|323092298|FG001|Overall Study|Adverse Event|23|||
94357697|NCT00665366|323092297|FG000|Overall Study|Withdrawal by Subject|11|||
94357698|NCT00665366|323092298|FG001|Overall Study|Withdrawal by Subject|14|||
94357699|NCT00665366|323092297|FG000|Overall Study|Lost to Follow-up|3|||
94357700|NCT00665366|323092298|FG001|Overall Study|Lost to Follow-up|5|||
94357701|NCT00665366|323092297|FG000|Overall Study|Poor compliance/noncompliance|3|||
94357702|NCT00665366|323092298|FG001|Overall Study|Poor compliance/noncompliance|5|||
94357703|NCT00665366|323092297|FG000|Overall Study|Pregnancy|1|||
94357704|NCT00665366|323092298|FG001|Overall Study|Pregnancy|0|||
94357705|NCT00665366|323092297|FG000|Overall Study|No longer meets study criteria|0|||
94357706|NCT00665366|323092298|FG001|Overall Study|No longer meets study criteria|1|||
94357707|NCT00665366|323092297|FG000|Overall Study|Other reasons|4|||
94357708|NCT00665366|323092298|FG001|Overall Study|Other reasons|1|||
94251829|NCT01642251|322714517|FG001|Overall Study|Death|0|||
94251830|NCT01642251|322714518|FG002|Overall Study|Death|1|||
94251831|NCT01642251|322714519|FG003|Overall Study|Death|3|||
94251832|NCT01642251|322714516|FG000|Overall Study|Withdrawal by Subject|0|||
94251833|NCT01642251|322714517|FG001|Overall Study|Withdrawal by Subject|0|||
94251834|NCT01642251|322714518|FG002|Overall Study|Withdrawal by Subject|1|||
94251835|NCT01642251|322714519|FG003|Overall Study|Withdrawal by Subject|3|||
94251836|NCT01642251|322714516|FG000|Overall Study|Alternative therapy|0|||
94251837|NCT01642251|322714517|FG001|Overall Study|Alternative therapy|0|||
94251838|NCT01642251|322714518|FG002|Overall Study|Alternative therapy|0|||
94251839|NCT01642251|322714519|FG003|Overall Study|Alternative therapy|2|||
94251840|NCT01642251|322714516|FG000|Overall Study|Other complicating disease|0|||
94251841|NCT01642251|322714517|FG001|Overall Study|Other complicating disease|0|||
94251842|NCT01642251|322714518|FG002|Overall Study|Other complicating disease|1|||
94251843|NCT01642251|322714519|FG003|Overall Study|Other complicating disease|0|||
94251844|NCT01642251|322714516|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
94251845|NCT01642251|322714517|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
94251846|NCT01642251|322714518|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
94251847|NCT01642251|322714519|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
94251848|NCT01237587|322714521|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
94251849|NCT01237587|322714522|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
94251850|NCT01237587|322714521|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
94251851|NCT01237587|322714522|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
94251852|NCT01237587|322714521|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
94251853|NCT01237587|322714522|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
94251854|NCT01237587|322714521|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
94357709|NCT03628781|323092306|FG000|Overall Study|Lost to Follow-up|16|||
94357710|NCT03628781|323092307|FG001|Overall Study|Lost to Follow-up|8|||
94357711|NCT03628781|323092306|FG000|Overall Study|Withdrawal by Subject|16|||
94357712|NCT03628781|323092307|FG001|Overall Study|Withdrawal by Subject|1|||
94357713|NCT03575806|323092312|FG000|Overall Study|Withdrawal by Subject|0|||
94357714|NCT03575806|323092313|FG001|Overall Study|Withdrawal by Subject|2|||
94357715|NCT03575806|323092312|FG000|Overall Study|Protocol Violation|0|||
94357716|NCT03575806|323092313|FG001|Overall Study|Protocol Violation|2|||
94357717|NCT00219349|323092314|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
94459096|NCT00601172|323469504|FG000|Overall Study|Lost to Follow-up|4|||
94459097|NCT00601172|323469505|FG001|Overall Study|Lost to Follow-up|3|||
94459098|NCT00601172|323469504|FG000|Overall Study|Physician Decision|27|||
94459099|NCT00601172|323469505|FG001|Overall Study|Physician Decision|28|||
94459100|NCT00601172|323469504|FG000|Overall Study|Withdrawal by Subject|35|||
94459101|NCT00601172|323469505|FG001|Overall Study|Withdrawal by Subject|27|||
94357718|NCT00219349|323092314|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
94607305|NCT01347307|324027309|FG000|Overall Study|Death|0|||
94607306|NCT01347307|324027310|FG001|Overall Study|Death|4|||
94607307|NCT01347307|324027309|FG000|Overall Study|Physician Decision|0|||
94607308|NCT01347307|324027310|FG001|Overall Study|Physician Decision|1|||
94607309|NCT00422097|324027311|FG000|Dose Level 2|Still on treatment|0|||
94607310|NCT00422097|324027312|FG001|Dose Level 2|Still on treatment|1|||
94607311|NCT00422097|324027313|FG002|Dose Level 2|Still on treatment|0|||
94607312|NCT00422097|324027314|FG003|Dose Level 2|Still on treatment|0|||
94607313|NCT00422097|324027315|FG004|Dose Level 2|Still on treatment|0|||
94357719|NCT00219349|323092314|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
94357720|NCT00219349|323092314|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
94357721|NCT00869362|323092316|FG000|Overall Study|Death|0|||
94357722|NCT00869362|323092317|FG001|Overall Study|Death|2|||
94357723|NCT00869362|323092316|FG000|Overall Study|Lost to Follow-up|1|||
94357724|NCT00869362|323092317|FG001|Overall Study|Lost to Follow-up|3|||
94357725|NCT01241591|323092318|FG000|Overall Study|Lack of Efficacy|5|||
94357726|NCT01241591|323092319|FG001|Overall Study|Lack of Efficacy|2|||
94357727|NCT01241591|323092320|FG002|Overall Study|Lack of Efficacy|2|||
94357728|NCT01241591|323092321|FG003|Overall Study|Lack of Efficacy|3|||
94357729|NCT01241591|323092318|FG000|Overall Study|Protocol Violation|5|||
94357730|NCT01241591|323092319|FG001|Overall Study|Protocol Violation|2|||
94357731|NCT01241591|323092320|FG002|Overall Study|Protocol Violation|3|||
94357732|NCT01241591|323092321|FG003|Overall Study|Protocol Violation|0|||
94357733|NCT01241591|323092318|FG000|Overall Study|Lost to Follow-up|1|||
94357734|NCT01241591|323092319|FG001|Overall Study|Lost to Follow-up|2|||
94357735|NCT01241591|323092320|FG002|Overall Study|Lost to Follow-up|2|||
94357736|NCT01241591|323092321|FG003|Overall Study|Lost to Follow-up|2|||
94357737|NCT01241591|323092318|FG000|Overall Study|Screen Failure|3|||
94357738|NCT01241591|323092319|FG001|Overall Study|Screen Failure|2|||
94357739|NCT01241591|323092320|FG002|Overall Study|Screen Failure|1|||
94357740|NCT01241591|323092321|FG003|Overall Study|Screen Failure|0|||
94357741|NCT01241591|323092318|FG000|Overall Study|Withdrawal by Subject|6|||
94357742|NCT01241591|323092319|FG001|Overall Study|Withdrawal by Subject|4|||
94357743|NCT01241591|323092320|FG002|Overall Study|Withdrawal by Subject|2|||
94357744|NCT01241591|323092321|FG003|Overall Study|Withdrawal by Subject|2|||
94357745|NCT01241591|323092318|FG000|Overall Study|Other|0|||
94357746|NCT01241591|323092319|FG001|Overall Study|Other|1|||
94357747|NCT01241591|323092320|FG002|Overall Study|Other|0|||
94357748|NCT01241591|323092321|FG003|Overall Study|Other|1|||
94357749|NCT01241591|323092318|FG000|Overall Study|Adverse Event|3|||
94357750|NCT01241591|323092319|FG001|Overall Study|Adverse Event|11|||
94357751|NCT01241591|323092320|FG002|Overall Study|Adverse Event|12|||
94357752|NCT01241591|323092321|FG003|Overall Study|Adverse Event|4|||
94357753|NCT01846039|323092322|FG000|Overall Study|Protocol Violation|1|||
94357754|NCT01846039|323092322|FG000|Overall Study|Subject Withdrew Consent|1|||
94357755|NCT03233009|323092323|FG000|Overall Study|Lost to Follow-up|1|||
94459102|NCT00601172|323469504|FG000|Overall Study|Did not meet continuation criteria|19|||
94459103|NCT00601172|323469505|FG001|Overall Study|Did not meet continuation criteria|20|||
94459104|NCT03917472|323469506|FG000|Overall Study|Physician Decision|4|||
94607314|NCT00422097|324027316|FG005|Dose Level 2|Still on treatment|0|||
94607315|NCT00422097|324027317|FG006|Dose Level 2|Still on treatment|0|||
94607316|NCT00422097|324027318|FG007|Dose Level 2|Still on treatment|0|||
94607317|NCT03468985|324027319|FG000|Overall Study|Adverse Event|0|||
94357756|NCT02158949|323092324|FG000|Overall Study|Withdrawal by Subject|1|||
94357757|NCT02158949|323092325|FG001|Overall Study|Withdrawal by Subject|0|||
94607318|NCT03468985|324027320|FG001|Overall Study|Adverse Event|2|||
94607319|NCT03468985|324027321|FG002|Overall Study|Adverse Event|0|||
94607320|NCT03468985|324027322|FG003|Overall Study|Adverse Event|0|||
94607321|NCT03468985|324027319|FG000|Overall Study|Withdrawal by Subject|0|||
94607322|NCT03468985|324027320|FG001|Overall Study|Withdrawal by Subject|0|||
94607323|NCT03468985|324027321|FG002|Overall Study|Withdrawal by Subject|0|||
94607324|NCT03468985|324027322|FG003|Overall Study|Withdrawal by Subject|1|||
94607325|NCT03646643|324027325|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
94607326|NCT03646643|324027326|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
94607327|NCT03646643|324027325|FG000|Overall Study|Lost to Follow-up|0|||
94607328|NCT03646643|324027326|FG001|Overall Study|Lost to Follow-up|1|||
94607329|NCT04521777|324027327|FG000|Overall Study|Death|2|||
94607330|NCT04521777|324027327|FG000|Overall Study|Withdrawal by Subject|2|||
94607331|NCT02923427|324027330|FG000|Overall Study|convert to laparatomy|2|||
94607332|NCT02923427|324027331|FG001|Overall Study|convert to laparatomy|2|||
94607333|NCT02923427|324027330|FG000|Overall Study|destaturation|1|||
94607334|NCT02923427|324027331|FG001|Overall Study|destaturation|0|||
94607335|NCT02923427|324027330|FG000|Overall Study|can not replace LMA|1|||
94607336|NCT02923427|324027331|FG001|Overall Study|can not replace LMA|0|||
94607337|NCT01325623|324027332|FG000|Overall Study|Withdrawal by Subject|3|||
94607338|NCT00145600|324027333|FG000|Overall Study|Death|1|||
94607339|NCT00145600|324027334|FG001|Overall Study|Death|2|||
94607340|NCT00145600|324027335|FG002|Overall Study|Death|2|||
94607341|NCT00145600|324027336|FG003|Overall Study|Death|6|||
94607342|NCT00145600|324027333|FG000|Overall Study|Ineligible|3|||
94251855|NCT01237587|322714522|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
94251856|NCT01237587|322714521|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
94251857|NCT01237587|322714522|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
94251858|NCT01237587|322714521|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
94251859|NCT01237587|322714522|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
94251860|NCT01237587|322714521|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
94251861|NCT01237587|322714522|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
94251862|NCT01237587|322714521|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
94251863|NCT01237587|322714522|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
94251864|NCT01237587|322714521|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
94251865|NCT01237587|322714522|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
94251866|NCT01237587|322714521|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
94251867|NCT01237587|322714522|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
94607343|NCT00145600|324027334|FG001|Overall Study|Ineligible|0|||
94607344|NCT00145600|324027335|FG002|Overall Study|Ineligible|1|||
94607345|NCT00145600|324027336|FG003|Overall Study|Ineligible|5|||
94607346|NCT00145600|324027333|FG000|Overall Study|Lost to Follow-up|2|||
94607347|NCT00145600|324027334|FG001|Overall Study|Lost to Follow-up|6|||
94607348|NCT00145600|324027335|FG002|Overall Study|Lost to Follow-up|2|||
94607349|NCT00145600|324027336|FG003|Overall Study|Lost to Follow-up|4|||
94251868|NCT01237587|322714521|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
94251869|NCT01237587|322714522|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
94251870|NCT01237587|322714521|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
94251871|NCT01237587|322714522|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
94251872|NCT01237587|322714521|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
94251873|NCT01237587|322714522|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
94251874|NCT01237587|322714521|FG000|Taper Phase|Adverse Event|0|||
94251875|NCT01237587|322714522|FG001|Taper Phase|Adverse Event|2|||
94251876|NCT01237587|322714521|FG000|Taper Phase|Protocol Violation|2|||
94251877|NCT01237587|322714522|FG001|Taper Phase|Protocol Violation|0|||
94251878|NCT01237587|322714521|FG000|Taper Phase|Lack of Efficacy|2|||
94251879|NCT01237587|322714522|FG001|Taper Phase|Lack of Efficacy|5|||
94251880|NCT01237587|322714521|FG000|Taper Phase|Parent/Guardian Decision|0|||
94251881|NCT01237587|322714522|FG001|Taper Phase|Parent/Guardian Decision|2|||
94251882|NCT01237587|322714521|FG000|Taper Phase|Sponsor Decision|1|||
94251883|NCT01237587|322714522|FG001|Taper Phase|Sponsor Decision|0|||
94251884|NCT01237587|322714521|FG000|Taper Phase|Withdrawal by Subject|0|||
94251885|NCT01237587|322714522|FG001|Taper Phase|Withdrawal by Subject|1|||
94251886|NCT03426605|322714523|FG000|Overall Study|AML relapse or progression|2|||
94251887|NCT03426605|322714524|FG001|Overall Study|AML relapse or progression|1|||
94251888|NCT03426605|322714525|FG002|Overall Study|AML relapse or progression|2|||
94251889|NCT03426605|322714526|FG003|Overall Study|AML relapse or progression|2|||
94251890|NCT03426605|322714523|FG000|Overall Study|Treatment failure|3|||
94251891|NCT03426605|322714524|FG001|Overall Study|Treatment failure|2|||
94251892|NCT03426605|322714525|FG002|Overall Study|Treatment failure|0|||
94251893|NCT03426605|322714526|FG003|Overall Study|Treatment failure|0|||
94251894|NCT03426605|322714523|FG000|Overall Study|Adverse Event|1|||
94251895|NCT03426605|322714524|FG001|Overall Study|Adverse Event|0|||
94251896|NCT03426605|322714525|FG002|Overall Study|Adverse Event|1|||
94607350|NCT00145600|324027333|FG000|Overall Study|Noncompliance|1|||
94251897|NCT03426605|322714526|FG003|Overall Study|Adverse Event|1|||
94251898|NCT03426605|322714523|FG000|Overall Study|Withdrawal by Subject|0|||
94251899|NCT03426605|322714524|FG001|Overall Study|Withdrawal by Subject|0|||
94251900|NCT03426605|322714525|FG002|Overall Study|Withdrawal by Subject|1|||
94607351|NCT00145600|324027334|FG001|Overall Study|Noncompliance|0|||
94607352|NCT00145600|324027335|FG002|Overall Study|Noncompliance|0|||
94607353|NCT00145600|324027336|FG003|Overall Study|Noncompliance|0|||
94607354|NCT00145600|324027333|FG000|Overall Study|Withdrawal by Subject|1|||
94607355|NCT00145600|324027334|FG001|Overall Study|Withdrawal by Subject|2|||
94607356|NCT00145600|324027335|FG002|Overall Study|Withdrawal by Subject|0|||
94607357|NCT00145600|324027336|FG003|Overall Study|Withdrawal by Subject|1|||
94607358|NCT01229397|324027337|FG000|Overall Study|Withdrawal by Subject|3|||
94251901|NCT03426605|322714526|FG003|Overall Study|Withdrawal by Subject|1|||
94251902|NCT00185965|322714527|FG000|Overall Study|Adverse Event|0|||
94251903|NCT00185965|322714528|FG001|Overall Study|Adverse Event|1|||
94251904|NCT02533531|322714529|FG000|Overall Study|Device did not turn on|1|||
94251905|NCT00412061|322714531|FG000|Double Blind Phase|Disease Progression|101|||
94251906|NCT00412061|322714532|FG001|Double Blind Phase|Disease Progression|154|||
94251907|NCT00412061|322714531|FG000|Double Blind Phase|Adverse Event|61|||
94251908|NCT00412061|322714532|FG001|Double Blind Phase|Adverse Event|16|||
94251909|NCT00412061|322714531|FG000|Double Blind Phase|Final Primary Analysis|26|||
94251910|NCT00412061|322714532|FG001|Double Blind Phase|Final Primary Analysis|14|||
94251911|NCT00412061|322714531|FG000|Double Blind Phase|Withdrawal by Subject|18|||
94357758|NCT02158949|323092324|FG000|Overall Study|Lost to Follow-up|5|||
94357759|NCT02158949|323092325|FG001|Overall Study|Lost to Follow-up|11|||
94357760|NCT02322866|323092326|FG000|Overall Study|Adverse Event|6|||
94357761|NCT02322866|323092327|FG001|Overall Study|Adverse Event|11|||
94357762|NCT02322866|323092326|FG000|Overall Study|Withdrawal of Consent|16|||
94357763|NCT02322866|323092327|FG001|Overall Study|Withdrawal of Consent|25|||
94357764|NCT02322866|323092326|FG000|Overall Study|Lost to Follow-up|36|||
94357765|NCT02322866|323092327|FG001|Overall Study|Lost to Follow-up|39|||
94357766|NCT02322866|323092326|FG000|Overall Study|Protocol Violation|1|||
94357767|NCT02322866|323092327|FG001|Overall Study|Protocol Violation|0|||
94357768|NCT02322866|323092326|FG000|Overall Study|Noncompliance with Treatment|3|||
94357769|NCT02322866|323092327|FG001|Overall Study|Noncompliance with Treatment|4|||
94357770|NCT02322866|323092326|FG000|Overall Study|Lack of Efficacy|3|||
94357771|NCT02322866|323092327|FG001|Overall Study|Lack of Efficacy|1|||
94357772|NCT02322866|323092326|FG000|Overall Study|Other Miscellaneous Reasons|6|||
94357773|NCT02322866|323092327|FG001|Overall Study|Other Miscellaneous Reasons|6|||
94357774|NCT00718809|323092328|FG000|Overall Study|Disease progression|9|||
94357775|NCT00718809|323092329|FG001|Overall Study|Disease progression|7|||
94357776|NCT00718809|323092328|FG000|Overall Study|Adverse Event|1|||
94357777|NCT00718809|323092329|FG001|Overall Study|Adverse Event|1|||
94357778|NCT00718809|323092328|FG000|Overall Study|Withdrawal by Subject|0|||
94357779|NCT00718809|323092329|FG001|Overall Study|Withdrawal by Subject|1|||
94357780|NCT00718809|323092328|FG000|Overall Study|Lost to Follow-up|1|||
94357781|NCT00718809|323092329|FG001|Overall Study|Lost to Follow-up|0|||
94357782|NCT00718809|323092328|FG000|Overall Study|Noncompliance|1|||
94357783|NCT00718809|323092329|FG001|Overall Study|Noncompliance|0|||
94357784|NCT00798161|323092330|FG000|Overall Study|Adverse Event|3|||
94357785|NCT00798161|323092331|FG001|Overall Study|Adverse Event|4|||
94607359|NCT01229397|324027338|FG001|Overall Study|Withdrawal by Subject|3|||
94251912|NCT00412061|322714532|FG001|Double Blind Phase|Withdrawal by Subject|20|||
94251913|NCT00412061|322714531|FG000|Double Blind Phase|Death|6|||
94251914|NCT00412061|322714532|FG001|Double Blind Phase|Death|3|||
94251915|NCT00412061|322714531|FG000|Double Blind Phase|Protocol Violation|3|||
94251916|NCT00412061|322714532|FG001|Double Blind Phase|Protocol Violation|4|||
94251917|NCT00412061|322714531|FG000|Double Blind Phase|New Cander Therapy|1|||
94607360|NCT01229397|324027337|FG000|Overall Study|Lost to Follow-up|7|||
94607361|NCT01229397|324027338|FG001|Overall Study|Lost to Follow-up|6|||
94607362|NCT01229397|324027337|FG000|Overall Study|Migrated/moved from study area|1|||
94607363|NCT01229397|324027338|FG001|Overall Study|Migrated/moved from study area|0|||
94607364|NCT00423670|324027339|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
94607365|NCT00423670|324027340|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
94607366|NCT00423670|324027341|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
94607367|NCT00423670|324027342|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
94607368|NCT00423670|324027343|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
94607369|NCT00423670|324027344|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
94607370|NCT00423670|324027345|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
94459105|NCT03917472|323469507|FG001|Overall Study|Physician Decision|0|||
94459106|NCT03917472|323469506|FG000|Overall Study|Adverse Event|3|||
94459107|NCT03917472|323469507|FG001|Overall Study|Adverse Event|1|||
94459108|NCT03917472|323469506|FG000|Overall Study|Death|7|||
94459109|NCT03917472|323469507|FG001|Overall Study|Death|5|||
94459110|NCT03917472|323469506|FG000|Overall Study|Withdrawal by Subject|11|||
94459111|NCT03917472|323469507|FG001|Overall Study|Withdrawal by Subject|4|||
94459112|NCT03917472|323469506|FG000|Overall Study|Lost to Follow-up|10|||
94459113|NCT03917472|323469507|FG001|Overall Study|Lost to Follow-up|5|||
94459114|NCT02706886|323469508|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
94459115|NCT02706886|323469509|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
94459116|NCT02706886|323469510|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
94459117|NCT02706886|323469511|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
94459118|NCT02706886|323469512|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
94459119|NCT02706886|323469513|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
94459120|NCT02706886|323469514|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
94459121|NCT02706886|323469515|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
94459122|NCT02706886|323469516|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
94459123|NCT02637895|323469530|FG000|Overall Study|Lost to Follow-up|4|||
94459124|NCT02637895|323469531|FG001|Overall Study|Lost to Follow-up|0|||
94459125|NCT02637895|323469530|FG000|Overall Study|Protocol Violation|0|||
94459126|NCT02637895|323469531|FG001|Overall Study|Protocol Violation|1|||
94459127|NCT02637895|323469530|FG000|Overall Study|Lack of Efficacy|1|||
94459128|NCT02637895|323469531|FG001|Overall Study|Lack of Efficacy|0|||
94459129|NCT02637895|323469530|FG000|Overall Study|Withdrawal by Subject|1|||
94459130|NCT02637895|323469531|FG001|Overall Study|Withdrawal by Subject|1|||
94459131|NCT02637895|323469530|FG000|Overall Study|Abnormal baseline lab|0|||
94459132|NCT02637895|323469531|FG001|Overall Study|Abnormal baseline lab|1|||
94459133|NCT00968981|323469532|FG000|Overall Study|Adverse Event|2|||
94459134|NCT00968981|323469533|FG001|Overall Study|Adverse Event|0|||
94459135|NCT00968981|323469534|FG002|Overall Study|Adverse Event|0|||
94459136|NCT00968981|323469532|FG000|Overall Study|Disease Progression|14|||
94459137|NCT00968981|323469533|FG001|Overall Study|Disease Progression|16|||
94459138|NCT00968981|323469534|FG002|Overall Study|Disease Progression|13|||
94459139|NCT00968981|323469532|FG000|Overall Study|Lost to Follow-up|0|||
94459140|NCT00968981|323469533|FG001|Overall Study|Lost to Follow-up|0|||
94459141|NCT00968981|323469534|FG002|Overall Study|Lost to Follow-up|1|||
94459142|NCT00968981|323469532|FG000|Overall Study|Physician Decision|5|||
94459143|NCT00968981|323469533|FG001|Overall Study|Physician Decision|3|||
94459144|NCT00968981|323469534|FG002|Overall Study|Physician Decision|5|||
94251918|NCT00412061|322714532|FG001|Double Blind Phase|New Cander Therapy|1|||
94251919|NCT00412061|322714531|FG000|Double Blind Phase|Lost to Follow-up|0|||
94251920|NCT00412061|322714532|FG001|Double Blind Phase|Lost to Follow-up|1|||
94251921|NCT00412061|322714531|FG000|Open Label Phase|Disease Progression|0|||
94251922|NCT00412061|322714532|FG001|Open Label Phase|Disease Progression|86|||
94251923|NCT00412061|322714531|FG000|Open Label Phase|Adverse Event|0|||
94251924|NCT00412061|322714532|FG001|Open Label Phase|Adverse Event|46|||
94251925|NCT00412061|322714531|FG000|Open Label Phase|Withdrawal by Subject|0|||
94251926|NCT00412061|322714532|FG001|Open Label Phase|Withdrawal by Subject|15|||
94251927|NCT00412061|322714531|FG000|Open Label Phase|Administrative Problems|0|||
94251928|NCT00412061|322714532|FG001|Open Label Phase|Administrative Problems|13|||
94251929|NCT00412061|322714531|FG000|Open Label Phase|Death|0|||
94251930|NCT00412061|322714532|FG001|Open Label Phase|Death|7|||
94251931|NCT00412061|322714531|FG000|Open Label Phase|Lost to Follow-up|0|||
94251932|NCT00412061|322714532|FG001|Open Label Phase|Lost to Follow-up|2|||
94251933|NCT00412061|322714531|FG000|Open Label Phase|New Cancer Therapy|0|||
94251934|NCT00412061|322714532|FG001|Open Label Phase|New Cancer Therapy|1|||
94251935|NCT01535560|322714534|FG000|Overall Study|Adverse Event|12|||
94251936|NCT01535560|322714535|FG001|Overall Study|Adverse Event|7|||
94251937|NCT01535560|322714534|FG000|Overall Study|Lost to Follow-up|1|||
94459145|NCT00968981|323469532|FG000|Overall Study|Withdrawal by Subject|1|||
94459146|NCT00968981|323469533|FG001|Overall Study|Withdrawal by Subject|3|||
94459147|NCT00968981|323469534|FG002|Overall Study|Withdrawal by Subject|3|||
94459148|NCT02045862|323469535|FG000|Overall Study|Death|0|||
94459149|NCT02045862|323469536|FG001|Overall Study|Death|0|||
94459150|NCT02045862|323469537|FG002|Overall Study|Death|1|||
94459151|NCT02045862|323469535|FG000|Overall Study|Miscellaneous|5|||
94459152|NCT02045862|323469536|FG001|Overall Study|Miscellaneous|0|||
94459153|NCT02045862|323469537|FG002|Overall Study|Miscellaneous|8|||
94459154|NCT02045862|323469535|FG000|Overall Study|Withdrawal by Patient|18|||
94251938|NCT01535560|322714535|FG001|Overall Study|Lost to Follow-up|3|||
94251939|NCT01535560|322714534|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
94251940|NCT01535560|322714535|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
94251941|NCT01535560|322714534|FG000|Overall Study|Treatment Failure|21|||
94251942|NCT01535560|322714535|FG001|Overall Study|Treatment Failure|83|||
94251943|NCT01535560|322714534|FG000|Overall Study|Other|0|||
94251944|NCT01535560|322714535|FG001|Overall Study|Other|1|||
94251945|NCT01535560|322714534|FG000|Overall Study|Randomized in Error|0|||
94251946|NCT01535560|322714535|FG001|Overall Study|Randomized in Error|1|||
94251947|NCT02689518|322714536|FG000|Overall Study|Withdrawal by Subject|3|||
94251948|NCT01011387|322714537|FG000|Overall Study|Withdrawal by Subject|3|||
94251949|NCT01011387|322714537|FG000|Overall Study|Adverse Event|2|||
94251950|NCT01011387|322714537|FG000|Overall Study|Protocol Violation|1|||
94251951|NCT02232243|322714538|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
94251952|NCT02232243|322714539|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
94251953|NCT02232243|322714540|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
94251954|NCT03218397|322714541|FG000|Overall Study|Prior positive blood culture|8|||
94251955|NCT03218397|322714542|FG001|Overall Study|Prior positive blood culture|13|||
94251956|NCT03218397|322714541|FG000|Overall Study|Comfort care|8|||
94251957|NCT03218397|322714542|FG001|Overall Study|Comfort care|5|||
94251958|NCT03218397|322714541|FG000|Overall Study|Comfort care and positive blood culture|1|||
94251959|NCT03218397|322714542|FG001|Overall Study|Comfort care and positive blood culture|0|||
94251960|NCT03218397|322714541|FG000|Overall Study|Comfort care and mixed culture|0|||
94251961|NCT03218397|322714542|FG001|Overall Study|Comfort care and mixed culture|1|||
94251962|NCT03218397|322714541|FG000|Overall Study|Mixed culture|2|||
94251963|NCT03218397|322714542|FG001|Overall Study|Mixed culture|2|||
94251964|NCT03218397|322714541|FG000|Overall Study|Inaccessible hospital records|2|||
94251965|NCT03218397|322714542|FG001|Overall Study|Inaccessible hospital records|5|||
94251966|NCT03218397|322714541|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
94251967|NCT03218397|322714542|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
94251968|NCT03218397|322714541|FG000|Overall Study|Randomized during laboratory off hours|2|||
94251969|NCT03218397|322714542|FG001|Overall Study|Randomized during laboratory off hours|1|||
94251970|NCT01049217|322714543|FG000|Overall Study|Adverse Event|2|||
94251971|NCT01049217|322714544|FG001|Overall Study|Adverse Event|1|||
94251972|NCT01049217|322714543|FG000|Overall Study|Lack of Efficacy|1|||
94251973|NCT01049217|322714544|FG001|Overall Study|Lack of Efficacy|1|||
94251974|NCT01049217|322714543|FG000|Overall Study|Lost to Follow-up|3|||
94251975|NCT01049217|322714544|FG001|Overall Study|Lost to Follow-up|8|||
94251976|NCT01049217|322714543|FG000|Overall Study|Withdrawal by Subject|4|||
94251977|NCT01049217|322714544|FG001|Overall Study|Withdrawal by Subject|3|||
94251978|NCT01049217|322714543|FG000|Overall Study|Protocol Violation|1|||
94251979|NCT01049217|322714544|FG001|Overall Study|Protocol Violation|3|||
94251980|NCT01049217|322714543|FG000|Overall Study|Pregnancy|1|||
94251981|NCT01049217|322714544|FG001|Overall Study|Pregnancy|0|||
94251982|NCT01049217|322714543|FG000|Overall Study|Study Terminated by Sponsor|43|||
94251983|NCT01049217|322714544|FG001|Overall Study|Study Terminated by Sponsor|43|||
94251984|NCT01049217|322714543|FG000|Overall Study|Other|1|||
94251985|NCT01049217|322714544|FG001|Overall Study|Other|2|||
94251986|NCT01049217|322714543|FG000|Overall Study|Randomized but not Treated|0|||
94251987|NCT01049217|322714544|FG001|Overall Study|Randomized but not Treated|2|||
94251988|NCT03534284|322714551|FG000|Overall Study|Death|2|||
94251989|NCT03534284|322714552|FG001|Overall Study|Death|3|||
94251990|NCT03534284|322714553|FG002|Overall Study|Death|3|||
94251991|NCT03534284|322714551|FG000|Overall Study|Withdrawal by Subject|5|||
94251992|NCT03534284|322714552|FG001|Overall Study|Withdrawal by Subject|0|||
94251993|NCT03534284|322714553|FG002|Overall Study|Withdrawal by Subject|0|||
94251994|NCT00959647|322714558|FG000|Overall Study|Adverse Event|2|||
94251995|NCT00959647|322714558|FG000|Overall Study|Progressive disease|6|||
94251996|NCT00959647|322714558|FG000|Overall Study|Study terminated by sponsor|4|||
94251997|NCT00959647|322714558|FG000|Overall Study|Withdrawal by Subject|7|||
94251998|NCT01506453|322716911|FG000|Overall Study|Withdrawal prior to treatment|0|||
94251999|NCT01506453|322716912|FG001|Overall Study|Withdrawal prior to treatment|2|||
94252000|NCT04375761|322716913|FG000|Overall Study|Death|1|||
94357786|NCT00798161|323092332|FG002|Overall Study|Adverse Event|6|||
94357787|NCT00798161|323092333|FG003|Overall Study|Adverse Event|6|||
94357788|NCT00798161|323092334|FG004|Overall Study|Adverse Event|5|||
94357789|NCT00798161|323092335|FG005|Overall Study|Adverse Event|2|||
94357790|NCT00798161|323092336|FG006|Overall Study|Adverse Event|4|||
94357791|NCT00798161|323092330|FG000|Overall Study|Protocol Violation|2|||
94357792|NCT00798161|323092331|FG001|Overall Study|Protocol Violation|1|||
94357793|NCT00798161|323092332|FG002|Overall Study|Protocol Violation|3|||
94357794|NCT00798161|323092333|FG003|Overall Study|Protocol Violation|3|||
94357795|NCT00798161|323092334|FG004|Overall Study|Protocol Violation|3|||
94357796|NCT00798161|323092335|FG005|Overall Study|Protocol Violation|2|||
94357797|NCT00798161|323092336|FG006|Overall Study|Protocol Violation|0|||
94357798|NCT00798161|323092330|FG000|Overall Study|Lost to Follow-up|1|||
94607371|NCT00423670|324027346|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
94252001|NCT04375761|322716914|FG001|Overall Study|Death|2|||
94252002|NCT04375761|322716913|FG000|Overall Study|Lost to Follow-up|203|||
94252003|NCT04375761|322716914|FG001|Overall Study|Lost to Follow-up|380|||
94252004|NCT04375761|322716913|FG000|Overall Study|Withdrawal by Subject|47|||
94252005|NCT04375761|322716914|FG001|Overall Study|Withdrawal by Subject|98|||
94252006|NCT04375761|322716913|FG000|Overall Study|Noncompliance with study procedure|121|||
94357799|NCT00798161|323092331|FG001|Overall Study|Lost to Follow-up|3|||
94357800|NCT00798161|323092332|FG002|Overall Study|Lost to Follow-up|4|||
94357801|NCT00798161|323092333|FG003|Overall Study|Lost to Follow-up|3|||
94459155|NCT02045862|323469536|FG001|Overall Study|Withdrawal by Patient|27|||
94459156|NCT02045862|323469537|FG002|Overall Study|Withdrawal by Patient|57|||
94459157|NCT02045862|323469535|FG000|Overall Study|Protocol Violation|0|||
94459158|NCT02045862|323469536|FG001|Overall Study|Protocol Violation|0|||
94459159|NCT02045862|323469537|FG002|Overall Study|Protocol Violation|6|||
94459160|NCT02045862|323469535|FG000|Overall Study|Lack of Efficacy|8|||
94459161|NCT02045862|323469536|FG001|Overall Study|Lack of Efficacy|4|||
94252007|NCT04375761|322716914|FG001|Overall Study|Noncompliance with study procedure|251|||
94252008|NCT04375761|322716913|FG000|Overall Study|Reimbursement not enough|1|||
94252009|NCT04375761|322716914|FG001|Overall Study|Reimbursement not enough|2|||
94252010|NCT04375761|322716913|FG000|Overall Study|Unforeseen family circumstances|1|||
94252011|NCT04375761|322716914|FG001|Overall Study|Unforeseen family circumstances|3|||
94252012|NCT04375761|322716913|FG000|Overall Study|Test too painful|1|||
94459162|NCT02045862|323469537|FG002|Overall Study|Lack of Efficacy|13|||
94459163|NCT02045862|323469535|FG000|Overall Study|Randomized but not Received Study Drug|0|||
94459164|NCT02045862|323469536|FG001|Overall Study|Randomized but not Received Study Drug|2|||
94459165|NCT02045862|323469537|FG002|Overall Study|Randomized but not Received Study Drug|8|||
94459166|NCT02045862|323469535|FG000|Overall Study|Adverse Event|7|||
94459167|NCT02045862|323469536|FG001|Overall Study|Adverse Event|5|||
94459168|NCT02045862|323469537|FG002|Overall Study|Adverse Event|27|||
94459169|NCT02045862|323469535|FG000|Overall Study|Lost to Follow-up|1|||
94459170|NCT02045862|323469536|FG001|Overall Study|Lost to Follow-up|2|||
94459171|NCT02045862|323469537|FG002|Overall Study|Lost to Follow-up|6|||
94459172|NCT01664949|323469541|FG000|Overall Study|Adverse Event|11|||
94459173|NCT01664949|323469542|FG001|Overall Study|Adverse Event|12|||
94459174|NCT01664949|323469541|FG000|Overall Study|Lack of Efficacy|1|||
94459175|NCT01664949|323469542|FG001|Overall Study|Lack of Efficacy|1|||
94459176|NCT01664949|323469541|FG000|Overall Study|Lost to Follow-up|1|||
94459177|NCT01664949|323469542|FG001|Overall Study|Lost to Follow-up|2|||
94459178|NCT01664949|323469541|FG000|Overall Study|Personal Reasons|3|||
94607372|NCT00423670|324027339|FG000|Treatment Period|Adverse Event|8|||
94459179|NCT01664949|323469542|FG001|Overall Study|Personal Reasons|4|||
94459180|NCT01664949|323469541|FG000|Overall Study|Protocol Violation|5|||
94459181|NCT01664949|323469542|FG001|Overall Study|Protocol Violation|5|||
94459182|NCT01664949|323469541|FG000|Overall Study|Other Miscellaneous Reasons|3|||
94459183|NCT01664949|323469542|FG001|Overall Study|Other Miscellaneous Reasons|1|||
94459184|NCT01867294|323469545|FG000|Overall Study|Withdrawal by Subject|1|||
94459185|NCT01867294|323469546|FG001|Overall Study|Withdrawal by Subject|1|||
94459186|NCT01867294|323469547|FG002|Overall Study|Withdrawal by Subject|0|||
94459187|NCT01867294|323469548|FG003|Overall Study|Withdrawal by Subject|0|||
94459188|NCT00656851|323469565|FG000|Overall Study|Withdrawal by Subject|0|||
94607373|NCT00423670|324027340|FG001|Treatment Period|Adverse Event|12|||
94607374|NCT00423670|324027341|FG002|Treatment Period|Adverse Event|15|||
94607375|NCT00423670|324027342|FG003|Treatment Period|Adverse Event|20|||
94607376|NCT00423670|324027343|FG004|Treatment Period|Adverse Event|9|||
94607377|NCT00423670|324027344|FG005|Treatment Period|Adverse Event|4|||
94607378|NCT00423670|324027345|FG006|Treatment Period|Adverse Event|7|||
94607379|NCT00423670|324027346|FG007|Treatment Period|Adverse Event|2|||
94607380|NCT00423670|324027339|FG000|Treatment Period|Protocol-defined clinical event|0|||
94607381|NCT00423670|324027340|FG001|Treatment Period|Protocol-defined clinical event|7|||
94607382|NCT00423670|324027341|FG002|Treatment Period|Protocol-defined clinical event|4|||
94607383|NCT00423670|324027342|FG003|Treatment Period|Protocol-defined clinical event|12|||
94607384|NCT00423670|324027343|FG004|Treatment Period|Protocol-defined clinical event|5|||
94607385|NCT00423670|324027344|FG005|Treatment Period|Protocol-defined clinical event|4|||
94607386|NCT00423670|324027345|FG006|Treatment Period|Protocol-defined clinical event|16|||
94607387|NCT00423670|324027346|FG007|Treatment Period|Protocol-defined clinical event|15|||
94607388|NCT00423670|324027339|FG000|Treatment Period|Lost to Follow-up|2|||
94607389|NCT00423670|324027340|FG001|Treatment Period|Lost to Follow-up|1|||
94607390|NCT00423670|324027341|FG002|Treatment Period|Lost to Follow-up|3|||
94607391|NCT00423670|324027342|FG003|Treatment Period|Lost to Follow-up|1|||
94607392|NCT00423670|324027343|FG004|Treatment Period|Lost to Follow-up|6|||
94607393|NCT00423670|324027344|FG005|Treatment Period|Lost to Follow-up|0|||
94607394|NCT00423670|324027345|FG006|Treatment Period|Lost to Follow-up|3|||
94607395|NCT00423670|324027346|FG007|Treatment Period|Lost to Follow-up|1|||
94607396|NCT00423670|324027339|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
94607397|NCT00423670|324027340|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
94607398|NCT00423670|324027341|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
94252013|NCT04375761|322716914|FG001|Overall Study|Test too painful|1|||
94252014|NCT04375761|322716913|FG000|Overall Study|Moved|0|||
94459189|NCT00656851|323469566|FG001|Overall Study|Withdrawal by Subject|4|||
94459190|NCT00978250|323469570|FG000|Overall Study|Late determination of ineligibility|0|||
94459191|NCT00978250|323469571|FG001|Overall Study|Late determination of ineligibility|1|||
94459192|NCT00978250|323469572|FG002|Overall Study|Late determination of ineligibility|0|||
94459193|NCT00978250|323469573|FG003|Overall Study|Late determination of ineligibility|1|||
94252015|NCT04375761|322716914|FG001|Overall Study|Moved|2|||
94459194|NCT03973918|323469574|FG000|Overall Study|Adverse Event|0|||
94607399|NCT00423670|324027342|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
94607400|NCT00423670|324027343|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
94607401|NCT00423670|324027344|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
94607402|NCT00423670|324027345|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
94607403|NCT00423670|324027346|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
94607404|NCT00423670|324027339|FG000|Treatment Period|Investigator decision|0|||
94607405|NCT00423670|324027340|FG001|Treatment Period|Investigator decision|0|||
94607406|NCT00423670|324027341|FG002|Treatment Period|Investigator decision|0|||
94607407|NCT00423670|324027342|FG003|Treatment Period|Investigator decision|0|||
94607408|NCT00423670|324027343|FG004|Treatment Period|Investigator decision|0|||
94607409|NCT00423670|324027344|FG005|Treatment Period|Investigator decision|0|||
94607410|NCT00423670|324027345|FG006|Treatment Period|Investigator decision|0|||
94607411|NCT00423670|324027346|FG007|Treatment Period|Investigator decision|1|||
94607412|NCT00423670|324027339|FG000|Treatment Period|Non-compliance with protocol|3|||
94607413|NCT00423670|324027340|FG001|Treatment Period|Non-compliance with protocol|1|||
94607414|NCT00423670|324027341|FG002|Treatment Period|Non-compliance with protocol|1|||
94607415|NCT00423670|324027342|FG003|Treatment Period|Non-compliance with protocol|3|||
94607416|NCT00423670|324027343|FG004|Treatment Period|Non-compliance with protocol|2|||
94607417|NCT00423670|324027344|FG005|Treatment Period|Non-compliance with protocol|0|||
94607418|NCT00423670|324027345|FG006|Treatment Period|Non-compliance with protocol|2|||
94607419|NCT00423670|324027346|FG007|Treatment Period|Non-compliance with protocol|2|||
94607420|NCT00423670|324027339|FG000|Follow-up Period|Lost to Follow-up|0|||
94607421|NCT00423670|324027340|FG001|Follow-up Period|Lost to Follow-up|12|||
94607422|NCT00423670|324027341|FG002|Follow-up Period|Lost to Follow-up|8|||
94607423|NCT00423670|324027342|FG003|Follow-up Period|Lost to Follow-up|3|||
94607424|NCT00423670|324027343|FG004|Follow-up Period|Lost to Follow-up|1|||
94607425|NCT00423670|324027344|FG005|Follow-up Period|Lost to Follow-up|0|||
94607426|NCT00423670|324027345|FG006|Follow-up Period|Lost to Follow-up|5|||
94607427|NCT00423670|324027346|FG007|Follow-up Period|Lost to Follow-up|0|||
94607428|NCT00423670|324027339|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
94252016|NCT04375761|322716913|FG000|Overall Study|Nonresponsive|0|||
94252017|NCT04375761|322716914|FG001|Overall Study|Nonresponsive|5|||
94252018|NCT03541174|322716915|FG000|Part 1 Double-Blind|Adverse Event|6|||
94252019|NCT03541174|322716916|FG001|Part 1 Double-Blind|Adverse Event|5|||
94252020|NCT03541174|322716917|FG002|Part 1 Double-Blind|Adverse Event|2|||
94252021|NCT03541174|322716918|FG003|Part 1 Double-Blind|Adverse Event|0|||
94252022|NCT03541174|322716919|FG004|Part 1 Double-Blind|Adverse Event|0|||
94252023|NCT03541174|322716920|FG005|Part 1 Double-Blind|Adverse Event|0|||
94252024|NCT03541174|322716915|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
94357802|NCT00798161|323092334|FG004|Overall Study|Lost to Follow-up|4|||
94357803|NCT00798161|323092335|FG005|Overall Study|Lost to Follow-up|0|||
94357804|NCT00798161|323092336|FG006|Overall Study|Lost to Follow-up|0|||
94357805|NCT00798161|323092330|FG000|Overall Study|Withdrawal by Subject|5|||
94357806|NCT00798161|323092331|FG001|Overall Study|Withdrawal by Subject|4|||
94357807|NCT00798161|323092332|FG002|Overall Study|Withdrawal by Subject|5|||
94357808|NCT00798161|323092333|FG003|Overall Study|Withdrawal by Subject|4|||
94357809|NCT00798161|323092334|FG004|Overall Study|Withdrawal by Subject|2|||
94357810|NCT00798161|323092335|FG005|Overall Study|Withdrawal by Subject|3|||
94357811|NCT00798161|323092336|FG006|Overall Study|Withdrawal by Subject|1|||
94357812|NCT00798161|323092330|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
94357813|NCT00798161|323092331|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
94357814|NCT00798161|323092332|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
94357815|NCT00798161|323092333|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
94357816|NCT00798161|323092334|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
94357817|NCT00798161|323092335|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
94357818|NCT00798161|323092336|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
94357819|NCT04579666|323092342|FG000|RTP (Up to Week 52)|Adverse Event|4|||
94357820|NCT04579666|323092343|FG001|RTP (Up to Week 52)|Adverse Event|3|||
94357821|NCT04579666|323092344|FG002|RTP (Up to Week 52)|Adverse Event|0|||
94357822|NCT04579666|323092345|FG003|RTP (Up to Week 52)|Adverse Event|0|||
94357823|NCT04579666|323092342|FG000|RTP (Up to Week 52)|Death|24|||
94357824|NCT04579666|323092343|FG001|RTP (Up to Week 52)|Death|9|||
94357825|NCT04579666|323092344|FG002|RTP (Up to Week 52)|Death|0|||
94357826|NCT04579666|323092345|FG003|RTP (Up to Week 52)|Death|0|||
94357827|NCT04579666|323092342|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
94357828|NCT04579666|323092343|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
94607429|NCT00423670|324027340|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
94607430|NCT00423670|324027341|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
94607431|NCT00423670|324027342|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
94357829|NCT04579666|323092344|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
94357830|NCT04579666|323092345|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
94357831|NCT04579666|323092342|FG000|RTP (Up to Week 52)|Physician Decision|4|||
94252025|NCT03541174|322716916|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
94252026|NCT03541174|322716917|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
94607432|NCT00423670|324027343|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
94607433|NCT00423670|324027344|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
94607434|NCT00423670|324027345|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
94607435|NCT00423670|324027346|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
94607436|NCT00423670|324027339|FG000|Follow-up Period|Non-compliance with protocol|2|||
94607437|NCT00423670|324027340|FG001|Follow-up Period|Non-compliance with protocol|0|||
94607438|NCT00423670|324027341|FG002|Follow-up Period|Non-compliance with protocol|1|||
94607439|NCT00423670|324027342|FG003|Follow-up Period|Non-compliance with protocol|1|||
94607440|NCT00423670|324027343|FG004|Follow-up Period|Non-compliance with protocol|0|||
94607441|NCT00423670|324027344|FG005|Follow-up Period|Non-compliance with protocol|0|||
94607442|NCT00423670|324027345|FG006|Follow-up Period|Non-compliance with protocol|3|||
94607443|NCT00423670|324027346|FG007|Follow-up Period|Non-compliance with protocol|2|||
94607444|NCT03282565|324027348|FG000|Overall Study|COVID-19 Research Shutdown|0|||
94607445|NCT03282565|324027349|FG001|Overall Study|COVID-19 Research Shutdown|2|||
94607446|NCT03282565|324027350|FG002|Overall Study|COVID-19 Research Shutdown|2|||
94607447|NCT00760214|324027351|FG000|Overall Study|Adverse Event|8|||
94607448|NCT00760214|324027352|FG001|Overall Study|Adverse Event|9|||
94607449|NCT00760214|324027353|FG002|Overall Study|Adverse Event|12|||
94607450|NCT00760214|324027351|FG000|Overall Study|Protocol Violation|3|||
94607451|NCT00760214|324027352|FG001|Overall Study|Protocol Violation|0|||
94607452|NCT00760214|324027353|FG002|Overall Study|Protocol Violation|3|||
94607453|NCT00760214|324027351|FG000|Overall Study|Lost to Follow-up|0|||
94607454|NCT00760214|324027352|FG001|Overall Study|Lost to Follow-up|0|||
94607455|NCT00760214|324027353|FG002|Overall Study|Lost to Follow-up|1|||
94607456|NCT00760214|324027351|FG000|Overall Study|Withdrawal by Subject|12|||
94607457|NCT00760214|324027352|FG001|Overall Study|Withdrawal by Subject|14|||
94252027|NCT03541174|322716918|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
94252028|NCT03541174|322716919|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
94252029|NCT03541174|322716920|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
94252030|NCT03541174|322716915|FG000|Part 1 Double-Blind|Other reasons|3|||
94252031|NCT03541174|322716916|FG001|Part 1 Double-Blind|Other reasons|2|||
94252032|NCT03541174|322716917|FG002|Part 1 Double-Blind|Other reasons|3|||
94252033|NCT03541174|322716918|FG003|Part 1 Double-Blind|Other reasons|0|||
94252034|NCT03541174|322716919|FG004|Part 1 Double-Blind|Other reasons|0|||
94252035|NCT03541174|322716920|FG005|Part 1 Double-Blind|Other reasons|0|||
94252036|NCT03541174|322716915|FG000|Part 2 Single-Blind|Adverse Event|0|||
94252037|NCT03541174|322716916|FG001|Part 2 Single-Blind|Adverse Event|0|||
94252038|NCT03541174|322716917|FG002|Part 2 Single-Blind|Adverse Event|0|||
94252039|NCT03541174|322716918|FG003|Part 2 Single-Blind|Adverse Event|25|||
94252040|NCT03541174|322716919|FG004|Part 2 Single-Blind|Adverse Event|0|||
94252041|NCT03541174|322716920|FG005|Part 2 Single-Blind|Adverse Event|0|||
94252042|NCT03541174|322716915|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
94252043|NCT03541174|322716916|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
94252044|NCT03541174|322716917|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
94252045|NCT03541174|322716918|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
94252046|NCT03541174|322716919|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
94252047|NCT03541174|322716920|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
94252048|NCT03541174|322716915|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
94252049|NCT03541174|322716916|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
94252050|NCT03541174|322716917|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
94252051|NCT03541174|322716918|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
94252052|NCT03541174|322716919|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
94252053|NCT03541174|322716920|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
94252054|NCT03541174|322716915|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
94252055|NCT03541174|322716916|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
94252056|NCT03541174|322716917|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
94252057|NCT03541174|322716918|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
94252058|NCT03541174|322716919|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
94252059|NCT03541174|322716920|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
94252060|NCT03541174|322716915|FG000|Part 2 Single-Blind|Death|0|||
94252061|NCT03541174|322716916|FG001|Part 2 Single-Blind|Death|0|||
94252062|NCT03541174|322716917|FG002|Part 2 Single-Blind|Death|0|||
94252063|NCT03541174|322716918|FG003|Part 2 Single-Blind|Death|5|||
94252064|NCT03541174|322716919|FG004|Part 2 Single-Blind|Death|0|||
94252065|NCT03541174|322716920|FG005|Part 2 Single-Blind|Death|0|||
94252066|NCT03541174|322716915|FG000|Part 2 Single-Blind|Pregnancy|0|||
94252067|NCT03541174|322716916|FG001|Part 2 Single-Blind|Pregnancy|0|||
94252068|NCT03541174|322716917|FG002|Part 2 Single-Blind|Pregnancy|0|||
94607458|NCT00760214|324027353|FG002|Overall Study|Withdrawal by Subject|13|||
94607459|NCT00760214|324027351|FG000|Overall Study|Lack of Efficacy|3|||
94607460|NCT00760214|324027352|FG001|Overall Study|Lack of Efficacy|2|||
94607461|NCT00760214|324027353|FG002|Overall Study|Lack of Efficacy|4|||
94607462|NCT00760214|324027351|FG000|Overall Study|Pregnancy|0|||
94252069|NCT03541174|322716918|FG003|Part 2 Single-Blind|Pregnancy|1|||
94252070|NCT03541174|322716919|FG004|Part 2 Single-Blind|Pregnancy|0|||
94252071|NCT03541174|322716920|FG005|Part 2 Single-Blind|Pregnancy|0|||
94252072|NCT03541174|322716915|FG000|Part 2 Single-Blind|Other reasons|0|||
94607463|NCT00760214|324027352|FG001|Overall Study|Pregnancy|0|||
94607464|NCT00760214|324027353|FG002|Overall Study|Pregnancy|1|||
94607465|NCT00760214|324027351|FG000|Overall Study|Physician Decision|1|||
94607466|NCT00760214|324027352|FG001|Overall Study|Physician Decision|1|||
94607467|NCT00760214|324027353|FG002|Overall Study|Physician Decision|1|||
94607468|NCT00760214|324027351|FG000|Overall Study|Other|3|||
94607469|NCT00760214|324027352|FG001|Overall Study|Other|4|||
94607470|NCT00760214|324027353|FG002|Overall Study|Other|6|||
94607471|NCT01810432|324027362|FG000|Washout|Protocol Violation|0|||
94607472|NCT01810432|324027363|FG001|Washout|Protocol Violation|1|||
94607473|NCT01810432|324027362|FG000|Washout|Adverse Event|1|||
94607474|NCT01810432|324027363|FG001|Washout|Adverse Event|0|||
94607475|NCT01810432|324027362|FG000|Period 2|Withdrawal by Subject|2|||
94607476|NCT01810432|324027363|FG001|Period 2|Withdrawal by Subject|1|||
94357832|NCT04579666|323092343|FG001|RTP (Up to Week 52)|Physician Decision|1|||
94357833|NCT04579666|323092344|FG002|RTP (Up to Week 52)|Physician Decision|0|||
94357834|NCT04579666|323092345|FG003|RTP (Up to Week 52)|Physician Decision|0|||
94357835|NCT04579666|323092342|FG000|RTP (Up to Week 52)|Progressive disease|1|||
94357836|NCT04579666|323092343|FG001|RTP (Up to Week 52)|Progressive disease|0|||
94357837|NCT04579666|323092344|FG002|RTP (Up to Week 52)|Progressive disease|0|||
94357838|NCT04579666|323092345|FG003|RTP (Up to Week 52)|Progressive disease|0|||
94357839|NCT04579666|323092342|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
94357840|NCT04579666|323092343|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
94357841|NCT04579666|323092344|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
94357842|NCT04579666|323092345|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
94357843|NCT04579666|323092342|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
94357844|NCT04579666|323092343|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
94357845|NCT04579666|323092344|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
94357846|NCT04579666|323092345|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
94357847|NCT04579666|323092342|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
94357848|NCT04579666|323092343|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
94357849|NCT04579666|323092344|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
94357850|NCT04579666|323092345|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
94357851|NCT04579666|323092342|FG000|RTP (Up to Week 52)|Other|2|||
94357852|NCT04579666|323092343|FG001|RTP (Up to Week 52)|Other|0|||
94357853|NCT04579666|323092344|FG002|RTP (Up to Week 52)|Other|0|||
94357854|NCT04579666|323092345|FG003|RTP (Up to Week 52)|Other|0|||
94357855|NCT04579666|323092342|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
94357856|NCT04579666|323092343|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
94607477|NCT01810432|324027362|FG000|Period 2|Physician Decision|1|||
94607478|NCT01810432|324027363|FG001|Period 2|Physician Decision|0|||
94607479|NCT01810432|324027362|FG000|Period 2|Lost to Follow-up|1|||
94607480|NCT01810432|324027363|FG001|Period 2|Lost to Follow-up|1|||
94607481|NCT01933217|324027368|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
94607482|NCT01933217|324027369|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
94607483|NCT01933217|324027368|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
94607484|NCT01933217|324027369|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
94607485|NCT03923738|324027370|FG000|Period 1|Adverse Event|1|||
94607486|NCT03923738|324027370|FG000|Period 1|Withdrawal by Subject|1|||
94357857|NCT04579666|323092344|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
94357858|NCT04579666|323092345|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
94607487|NCT03583164|324027372|FG000|Overall Study|Death in Main Phase|35|||
94607488|NCT03583164|324027372|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
94607489|NCT03583164|324027372|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
94607490|NCT03583164|324027372|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
94607491|NCT03583164|324027372|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
94607492|NCT03583164|324027372|FG000|Overall Study|Physician decision in Main Phase|1|||
94607493|NCT03583164|324027372|FG000|Overall Study|Physician decision in Extended Phase|2|||
94607494|NCT03583164|324027372|FG000|Overall Study|Death in Extended Phase|13|||
94607495|NCT03583164|324027372|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
94607496|NCT03583164|324027372|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
94607497|NCT03583164|324027372|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
94357859|NCT04579666|323092342|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
94357860|NCT04579666|323092343|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
94357861|NCT04579666|323092344|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
94357862|NCT04579666|323092345|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
94357863|NCT04579666|323092342|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
94357864|NCT04579666|323092343|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
94357865|NCT04579666|323092344|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
94357866|NCT04579666|323092345|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
94357867|NCT04579666|323092342|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
94357868|NCT04579666|323092343|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
94357869|NCT04579666|323092344|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
94357870|NCT04579666|323092345|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
94357871|NCT04579666|323092342|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
94357872|NCT04579666|323092343|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
94357873|NCT04579666|323092344|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
94357874|NCT04579666|323092345|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
94357875|NCT02506101|323092348|FG000|Overall Study|Transportation issues|1|||
94357876|NCT02506101|323092349|FG001|Overall Study|Transportation issues|0|||
94357877|NCT02506101|323092348|FG000|Overall Study|No enrollment and staff unavailability|1|||
94357878|NCT02506101|323092349|FG001|Overall Study|No enrollment and staff unavailability|0|||
94357879|NCT00814502|323092357|FG000|Overall Study|Adverse Event|1|||
94357880|NCT00814502|323092358|FG001|Overall Study|Adverse Event|0|||
94357881|NCT00814502|323092357|FG000|Overall Study|Withdrawal by Subject|0|||
94357882|NCT00814502|323092358|FG001|Overall Study|Withdrawal by Subject|2|||
94357883|NCT03735849|323092359|FG000|Overall Study|Lost to Follow-up|1|||
94357884|NCT03735849|323092360|FG001|Overall Study|Lost to Follow-up|0|||
94357885|NCT03735849|323092361|FG002|Overall Study|Lost to Follow-up|0|||
94357886|NCT03735849|323092359|FG000|Overall Study|Participant unable to adhere to visit|1|||
94357887|NCT03735849|323092360|FG001|Overall Study|Participant unable to adhere to visit|0|||
94357888|NCT03735849|323092361|FG002|Overall Study|Participant unable to adhere to visit|0|||
94459195|NCT03973918|323469575|FG001|Overall Study|Adverse Event|0|||
94661604|NCT01462344|324215777|FG000|Overall Study|Asthma Exacerbation|34|||
94357889|NCT03735849|323092359|FG000|Overall Study|Not Randomized|0|||
94357890|NCT03735849|323092360|FG001|Overall Study|Not Randomized|0|||
94357891|NCT03735849|323092361|FG002|Overall Study|Not Randomized|4|||
94357892|NCT04246593|323092364|FG000|Overall Study|Withdrawal by Subject|14|||
94357893|NCT04246593|323092365|FG001|Overall Study|Withdrawal by Subject|13|||
94357894|NCT04246593|323092364|FG000|Overall Study|Lost to Follow-up|124|||
94357895|NCT04246593|323092365|FG001|Overall Study|Lost to Follow-up|71|||
94357896|NCT04246593|323092364|FG000|Overall Study|Moved out of area/became ineligible|3|||
94459196|NCT03973918|323469576|FG002|Overall Study|Adverse Event|0|||
94459197|NCT03973918|323469577|FG003|Overall Study|Adverse Event|1|||
94459198|NCT03973918|323469574|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
94459199|NCT03973918|323469575|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
94459200|NCT03973918|323469576|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
94252073|NCT03541174|322716916|FG001|Part 2 Single-Blind|Other reasons|0|||
94252074|NCT03541174|322716917|FG002|Part 2 Single-Blind|Other reasons|0|||
94252075|NCT03541174|322716918|FG003|Part 2 Single-Blind|Other reasons|32|||
94252076|NCT03541174|322716919|FG004|Part 2 Single-Blind|Other reasons|0|||
94252077|NCT03541174|322716920|FG005|Part 2 Single-Blind|Other reasons|0|||
94252078|NCT03541174|322716915|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
94252079|NCT03541174|322716916|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
94252080|NCT03541174|322716917|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
94252081|NCT03541174|322716918|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
94252082|NCT03541174|322716919|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
94252083|NCT03541174|322716920|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
94252084|NCT03541174|322716915|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
94252085|NCT03541174|322716916|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
94252086|NCT03541174|322716917|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
94252087|NCT03541174|322716918|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
94252088|NCT03541174|322716919|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
94252089|NCT03541174|322716920|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
94252090|NCT03541174|322716915|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
94252091|NCT03541174|322716916|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
94252092|NCT03541174|322716917|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
94252093|NCT03541174|322716918|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
94252094|NCT03541174|322716919|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
94252095|NCT03541174|322716920|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
94252096|NCT03541174|322716915|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
94252097|NCT03541174|322716916|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
94252098|NCT03541174|322716917|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
94252099|NCT03541174|322716918|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
94252100|NCT03541174|322716919|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
94252101|NCT03541174|322716920|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
94252102|NCT03541174|322716915|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
94252103|NCT03541174|322716916|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
94252104|NCT03541174|322716917|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
94252105|NCT03541174|322716918|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
94252106|NCT03541174|322716919|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
94252107|NCT03541174|322716920|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
94252108|NCT04058366|322716921|FG000|Overall Study|Adverse Event|14|||
94252109|NCT04058366|322716921|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
94252110|NCT04058366|322716921|FG000|Overall Study|Commercial drug is available for participants|6|||
94252111|NCT04058366|322716921|FG000|Overall Study|Death|1|||
94252112|NCT04058366|322716921|FG000|Overall Study|Other non-compliance|2|||
94252113|NCT04058366|322716921|FG000|Overall Study|Other|6|||
94252114|NCT01789567|322716922|FG000|Overall Study|Death|6|||
94252115|NCT00192647|322716932|FG000|Overall Study|Death|1|||
94252116|NCT00192647|322716933|FG001|Overall Study|Death|1|||
94252117|NCT00192647|322716932|FG000|Overall Study|Adverse Event|35|||
94252118|NCT00192647|322716933|FG001|Overall Study|Adverse Event|29|||
94252119|NCT00192647|322716932|FG000|Overall Study|Laboratory Test Abnormality|4|||
94252120|NCT00192647|322716933|FG001|Overall Study|Laboratory Test Abnormality|2|||
94252121|NCT00192647|322716932|FG000|Overall Study|Insufficient Therapeutic Response|53|||
94252122|NCT00192647|322716933|FG001|Overall Study|Insufficient Therapeutic Response|83|||
94252123|NCT00192647|322716932|FG000|Overall Study|Entry Criteria Violation|6|||
94252124|NCT00192647|322716933|FG001|Overall Study|Entry Criteria Violation|6|||
94252125|NCT00192647|322716932|FG000|Overall Study|Protocol Violation|3|||
94252126|NCT00192647|322716933|FG001|Overall Study|Protocol Violation|1|||
94252127|NCT00192647|322716932|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
94252128|NCT00192647|322716933|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
94252129|NCT00192647|322716932|FG000|Overall Study|Failure to Return|11|||
94252130|NCT00192647|322716933|FG001|Overall Study|Failure to Return|13|||
94252131|NCT00192647|322716932|FG000|Overall Study|Other/Administrative|5|||
94252132|NCT00192647|322716933|FG001|Overall Study|Other/Administrative|3|||
94252133|NCT03207009|322716934|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
94252134|NCT01850446|322716935|FG000|Overall Study|Lack of Efficacy|1|||
94252135|NCT01850446|322716936|FG001|Overall Study|Lack of Efficacy|0|||
94252136|NCT01850446|322716935|FG000|Overall Study|Withdrawal by Subject|4|||
94252137|NCT01850446|322716936|FG001|Overall Study|Withdrawal by Subject|0|||
94252138|NCT01850446|322716935|FG000|Overall Study|Protocol Violation|0|||
94252139|NCT01850446|322716936|FG001|Overall Study|Protocol Violation|2|||
94252140|NCT01290315|322716937|FG000|Overall Study|Adverse Event|0|||
94252141|NCT01290315|322716938|FG001|Overall Study|Adverse Event|0|||
94252142|NCT01290315|322716939|FG002|Overall Study|Adverse Event|0|||
94252143|NCT01290315|322716940|FG003|Overall Study|Adverse Event|3|||
94252144|NCT01290315|322716937|FG000|Overall Study|Selection criteria/compliance|2|||
94252145|NCT01290315|322716938|FG001|Overall Study|Selection criteria/compliance|1|||
94252146|NCT01290315|322716939|FG002|Overall Study|Selection criteria/compliance|0|||
94252147|NCT01290315|322716940|FG003|Overall Study|Selection criteria/compliance|2|||
94252148|NCT01290315|322716937|FG000|Overall Study|Lost to Follow-up|0|||
94252149|NCT01290315|322716938|FG001|Overall Study|Lost to Follow-up|1|||
94252150|NCT01290315|322716939|FG002|Overall Study|Lost to Follow-up|0|||
94252151|NCT01290315|322716940|FG003|Overall Study|Lost to Follow-up|0|||
94252152|NCT01290315|322716937|FG000|Overall Study|Withdrawal by Subject|1|||
94252153|NCT01290315|322716938|FG001|Overall Study|Withdrawal by Subject|1|||
94252154|NCT01290315|322716939|FG002|Overall Study|Withdrawal by Subject|0|||
94252155|NCT01290315|322716940|FG003|Overall Study|Withdrawal by Subject|0|||
94252156|NCT00705679|322716945|FG000|Overall Study|Adverse Event|1|||
94252157|NCT00705679|322716946|FG001|Overall Study|Adverse Event|1|||
94252158|NCT00705679|322716947|FG002|Overall Study|Adverse Event|0|||
94252159|NCT00705679|322716948|FG003|Overall Study|Adverse Event|0|||
94252160|NCT00705679|322716949|FG004|Overall Study|Adverse Event|0|||
94252161|NCT00705679|322716945|FG000|Overall Study|Death|0|||
94252162|NCT00705679|322716946|FG001|Overall Study|Death|0|||
94252163|NCT00705679|322716947|FG002|Overall Study|Death|3|||
94252164|NCT00705679|322716948|FG003|Overall Study|Death|2|||
94252165|NCT00705679|322716949|FG004|Overall Study|Death|1|||
94252166|NCT00705679|322716945|FG000|Overall Study|Lost to Follow-up|32|||
94252167|NCT00705679|322716946|FG001|Overall Study|Lost to Follow-up|60|||
94252168|NCT00705679|322716947|FG002|Overall Study|Lost to Follow-up|44|||
94252169|NCT00705679|322716948|FG003|Overall Study|Lost to Follow-up|30|||
94252170|NCT00705679|322716949|FG004|Overall Study|Lost to Follow-up|35|||
94252171|NCT00705679|322716945|FG000|Overall Study|Physician Decision|0|||
94252172|NCT00705679|322716946|FG001|Overall Study|Physician Decision|1|||
94252173|NCT00705679|322716947|FG002|Overall Study|Physician Decision|0|||
94252174|NCT00705679|322716948|FG003|Overall Study|Physician Decision|1|||
94252175|NCT00705679|322716949|FG004|Overall Study|Physician Decision|0|||
94252176|NCT00705679|322716945|FG000|Overall Study|Withdrawal by Subject|32|||
94252177|NCT00705679|322716946|FG001|Overall Study|Withdrawal by Subject|77|||
94252178|NCT00705679|322716947|FG002|Overall Study|Withdrawal by Subject|68|||
94252179|NCT00705679|322716948|FG003|Overall Study|Withdrawal by Subject|47|||
94252180|NCT00705679|322716949|FG004|Overall Study|Withdrawal by Subject|33|||
94252181|NCT00700258|322716952|FG000|Overall Study|Premature discontinuation of documentation|136|||
94252182|NCT00700258|322716952|FG000|Overall Study|Type of study end not documented|1|||
94252183|NCT00700258|322716952|FG000|Overall Study|Lost to Follow-up|81|||
94252184|NCT00700258|322716952|FG000|Overall Study|Premature discontinuation of therapy|1013|||
94252185|NCT00370331|322716953|FG000|Overall Study|Adverse Event|4|||
94252186|NCT00370331|322716954|FG001|Overall Study|Adverse Event|13|||
94252187|NCT00370331|322716953|FG000|Overall Study|Withdrawal by Subject|2|||
94252188|NCT00370331|322716954|FG001|Overall Study|Withdrawal by Subject|4|||
94252189|NCT00370331|322716953|FG000|Overall Study|Lost to Follow-up|0|||
94252190|NCT00370331|322716954|FG001|Overall Study|Lost to Follow-up|3|||
94252191|NCT00370331|322716953|FG000|Overall Study|Lack of Efficacy|0|||
94252192|NCT00370331|322716954|FG001|Overall Study|Lack of Efficacy|1|||
94252193|NCT00370331|322716953|FG000|Overall Study|Non-compliance|0|||
94252194|NCT00370331|322716954|FG001|Overall Study|Non-compliance|1|||
94252195|NCT00370331|322716953|FG000|Overall Study|Protocol Violation|1|||
94252196|NCT00370331|322716954|FG001|Overall Study|Protocol Violation|1|||
94252197|NCT03484273|322716961|FG000|Overall Study|Equipment Malfunction|1|||
94252198|NCT03484273|322716961|FG000|Overall Study|Data excluded from analysis|1|||
94252199|NCT00249002|322716962|FG000|Overall Study|Adverse Event|2|||
94252200|NCT00249002|322716962|FG000|Overall Study|Study cancellation|3|||
94252201|NCT00249002|322716962|FG000|Overall Study|Other|2|||
94252202|NCT02084056|322716963|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
94252203|NCT02084056|322716964|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
94252204|NCT02084056|322716965|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
94252205|NCT02084056|322716966|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
94252206|NCT02084056|322716963|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
94252207|NCT02084056|322716964|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
94252208|NCT02084056|322716965|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
94252209|NCT02084056|322716966|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
94357897|NCT04246593|323092365|FG001|Overall Study|Moved out of area/became ineligible|1|||
94252210|NCT00577577|322716967|FG000|Overall Study|Adverse Event|3|||
94252211|NCT00577577|322716968|FG001|Overall Study|Adverse Event|2|||
94252212|NCT00577577|322716967|FG000|Overall Study|Lost to Follow-up|1|||
94252213|NCT00577577|322716968|FG001|Overall Study|Lost to Follow-up|0|||
94252214|NCT00577577|322716967|FG000|Overall Study|Protocol Violation|0|||
94252215|NCT00577577|322716968|FG001|Overall Study|Protocol Violation|3|||
94357898|NCT04246593|323092364|FG000|Overall Study|Reason unknown|4|||
94357899|NCT04246593|323092365|FG001|Overall Study|Reason unknown|2|||
94357900|NCT05437211|323092367|FG000|Overall Study|Patient's decision|1|||
94357901|NCT05437211|323092368|FG001|Overall Study|Patient's decision|1|||
94357902|NCT01463631|323092369|FG000|Overall Study|Withdrawal by Subject|0|||
94252216|NCT00577577|322716967|FG000|Overall Study|Transportation|1|||
94252217|NCT00577577|322716968|FG001|Overall Study|Transportation|0|||
94252218|NCT02424734|322716969|FG000|Overall Study|Treatment stopped to be discharged home|2|||
94252219|NCT02424734|322716970|FG001|Overall Study|Treatment stopped to be discharged home|2|||
94252220|NCT02424734|322716971|FG002|Overall Study|Treatment stopped to be discharged home|0|||
94252221|NCT02581631|322716972|FG000|Overall Study|Disease progression|29|||
94252222|NCT02581631|322716973|FG001|Overall Study|Disease progression|19|||
94252223|NCT02581631|322716974|FG002|Overall Study|Disease progression|13|||
94252224|NCT02581631|322716975|FG003|Overall Study|Disease progression|5|||
94252225|NCT02581631|322716976|FG004|Overall Study|Disease progression|8|||
94252226|NCT02581631|322716972|FG000|Overall Study|Study drug toxicity|4|||
94252227|NCT02581631|322716973|FG001|Overall Study|Study drug toxicity|6|||
94252228|NCT02581631|322716974|FG002|Overall Study|Study drug toxicity|7|||
94252229|NCT02581631|322716975|FG003|Overall Study|Study drug toxicity|0|||
94252230|NCT02581631|322716976|FG004|Overall Study|Study drug toxicity|3|||
94252231|NCT02581631|322716972|FG000|Overall Study|AE unrelated to study drug|3|||
94252232|NCT02581631|322716973|FG001|Overall Study|AE unrelated to study drug|1|||
94252233|NCT02581631|322716974|FG002|Overall Study|AE unrelated to study drug|1|||
94252234|NCT02581631|322716975|FG003|Overall Study|AE unrelated to study drug|0|||
94252235|NCT02581631|322716976|FG004|Overall Study|AE unrelated to study drug|2|||
94252236|NCT02581631|322716972|FG000|Overall Study|Request to discontinue|1|||
94252237|NCT02581631|322716973|FG001|Overall Study|Request to discontinue|0|||
94252238|NCT02581631|322716974|FG002|Overall Study|Request to discontinue|3|||
94252239|NCT02581631|322716975|FG003|Overall Study|Request to discontinue|0|||
94252240|NCT02581631|322716976|FG004|Overall Study|Request to discontinue|1|||
94252241|NCT02581631|322716972|FG000|Overall Study|participant withdrew consent|3|||
94252242|NCT02581631|322716973|FG001|Overall Study|participant withdrew consent|0|||
94252243|NCT02581631|322716974|FG002|Overall Study|participant withdrew consent|1|||
94252244|NCT02581631|322716975|FG003|Overall Study|participant withdrew consent|0|||
94357903|NCT01463631|323092370|FG001|Overall Study|Withdrawal by Subject|0|||
94357904|NCT01463631|323092371|FG002|Overall Study|Withdrawal by Subject|0|||
94357905|NCT01463631|323092372|FG003|Overall Study|Withdrawal by Subject|1|||
94357906|NCT01463631|323092369|FG000|Overall Study|Death|0|||
94357907|NCT01463631|323092370|FG001|Overall Study|Death|0|||
94357908|NCT01463631|323092371|FG002|Overall Study|Death|1|||
94357909|NCT01463631|323092372|FG003|Overall Study|Death|0|||
94357910|NCT01463631|323092369|FG000|Overall Study|Progressive Disease|0|||
94357911|NCT01463631|323092370|FG001|Overall Study|Progressive Disease|0|||
94357912|NCT01463631|323092371|FG002|Overall Study|Progressive Disease|0|||
94357913|NCT01463631|323092372|FG003|Overall Study|Progressive Disease|5|||
94357914|NCT01298323|323092374|FG000|Overall Study|Adverse Event|2|||
94357915|NCT01298323|323092375|FG001|Overall Study|Adverse Event|4|||
94357916|NCT01298323|323092374|FG000|Overall Study|Death|11|||
94357917|NCT01298323|323092375|FG001|Overall Study|Death|16|||
94357918|NCT01298323|323092374|FG000|Overall Study|Lost to Follow-up|1|||
94357919|NCT01298323|323092375|FG001|Overall Study|Lost to Follow-up|0|||
94357920|NCT01298323|323092374|FG000|Overall Study|Withdrawal by Subject|6|||
94357921|NCT01298323|323092375|FG001|Overall Study|Withdrawal by Subject|3|||
94357922|NCT01298323|323092374|FG000|Overall Study|Protocol Violation|1|||
94357923|NCT01298323|323092375|FG001|Overall Study|Protocol Violation|0|||
94357924|NCT01298323|323092374|FG000|Overall Study|Other|10|||
94357925|NCT01298323|323092375|FG001|Overall Study|Other|9|||
94357926|NCT01298323|323092374|FG000|Overall Study|Ongoing|55|||
94357927|NCT01298323|323092375|FG001|Overall Study|Ongoing|55|||
94357928|NCT01298323|323092374|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
94357929|NCT01298323|323092375|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
94357930|NCT04095039|323092376|FG000|Overall Study|Withdrawal by Subject|2|||
94252245|NCT02581631|322716976|FG004|Overall Study|participant withdrew consent|0|||
94252246|NCT02581631|322716972|FG000|Overall Study|Maximum clinical benefit|1|||
94357931|NCT04095039|323092377|FG001|Overall Study|Withdrawal by Subject|16|||
94357932|NCT04095039|323092376|FG000|Overall Study|Transplanted|21|||
94357933|NCT04095039|323092377|FG001|Overall Study|Transplanted|24|||
94357934|NCT04095039|323092376|FG000|Overall Study|Transferred to Non-study Facility|47|||
94357935|NCT04095039|323092377|FG001|Overall Study|Transferred to Non-study Facility|44|||
94252247|NCT02581631|322716973|FG001|Overall Study|Maximum clinical benefit|7|||
94357936|NCT04095039|323092376|FG000|Overall Study|Withdrawal from internvention target|0|||
94357937|NCT04095039|323092377|FG001|Overall Study|Withdrawal from internvention target|2|||
94357938|NCT04095039|323092376|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
94357939|NCT04095039|323092377|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
94252248|NCT02581631|322716974|FG002|Overall Study|Maximum clinical benefit|1|||
94252249|NCT02581631|322716975|FG003|Overall Study|Maximum clinical benefit|3|||
94252250|NCT02581631|322716976|FG004|Overall Study|Maximum clinical benefit|13|||
94607498|NCT03583164|324027372|FG000|Overall Study|Treatment failure in Main Phase|2|||
94607499|NCT03583164|324027372|FG000|Overall Study|Treatment failure in Extended Phase|4|||
94607500|NCT03583164|324027372|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
94607501|NCT03583164|324027372|FG000|Overall Study|Other not specified reason in Main Phase|2|||
94607502|NCT04697056|324027376|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
94607503|NCT04697056|324027377|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
94607504|NCT03875768|324027378|FG000|Overall Study|Lost to Follow-up|16|||
94607505|NCT03875768|324027379|FG001|Overall Study|Lost to Follow-up|13|||
94607506|NCT03875768|324027378|FG000|Overall Study|Withdrawal by Subject|10|||
94607507|NCT03875768|324027379|FG001|Overall Study|Withdrawal by Subject|21|||
94607508|NCT03875768|324027378|FG000|Overall Study|Did not complete assessment|21|||
94607509|NCT03875768|324027379|FG001|Overall Study|Did not complete assessment|12|||
94607510|NCT03875768|324027378|FG000|Overall Study|Became ineligible|1|||
94607511|NCT03875768|324027379|FG001|Overall Study|Became ineligible|0|||
94607512|NCT01925274|324027380|FG000|Overall Study|Death|1|||
94607513|NCT01925274|324027381|FG001|Overall Study|Death|0|||
94607514|NCT01925274|324027382|FG002|Overall Study|Death|0|||
94607515|NCT01925274|324027380|FG000|Overall Study|Lost to Follow-up|0|||
94607516|NCT01925274|324027381|FG001|Overall Study|Lost to Follow-up|1|||
94607517|NCT01925274|324027382|FG002|Overall Study|Lost to Follow-up|0|||
94607518|NCT01925274|324027380|FG000|Overall Study|Withdrawal by Subject|1|||
94607519|NCT01925274|324027381|FG001|Overall Study|Withdrawal by Subject|2|||
94607520|NCT01925274|324027382|FG002|Overall Study|Withdrawal by Subject|0|||
94607521|NCT01925274|324027380|FG000|Overall Study|Study terminated by sponsor|4|||
94607522|NCT01925274|324027381|FG001|Overall Study|Study terminated by sponsor|0|||
94607523|NCT01925274|324027382|FG002|Overall Study|Study terminated by sponsor|0|||
94607524|NCT01925274|324027380|FG000|Overall Study|Protocol amendment|1|||
94607525|NCT01925274|324027381|FG001|Overall Study|Protocol amendment|3|||
94607526|NCT01925274|324027382|FG002|Overall Study|Protocol amendment|6|||
94607527|NCT00057954|324027383|FG000|Overall Study|Death|1|||
94607528|NCT00057954|324027383|FG000|Overall Study|Disease progression|1|||
94607529|NCT00559754|324027384|FG000|Overall Study|Disease progression|1|||
94607530|NCT00559754|324027384|FG000|Overall Study|Adverse Event|5|||
94607531|NCT00559754|324027384|FG000|Overall Study|Protocol Violation|1|||
94607532|NCT00559754|324027384|FG000|Overall Study|Investigator criteria|2|||
94607533|NCT00559754|324027384|FG000|Overall Study|Withdrawal by Subject|2|||
94607534|NCT00147251|324027385|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
94607535|NCT00147251|324027386|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
94607536|NCT00777205|324027387|FG000|Overall Study|Lost to Follow-up|25|||
94607537|NCT00777205|324027388|FG001|Overall Study|Lost to Follow-up|9|||
94607538|NCT00777205|324027387|FG000|Overall Study|Withdrawal by Subject|6|||
94607539|NCT00777205|324027388|FG001|Overall Study|Withdrawal by Subject|4|||
94607540|NCT00777205|324027387|FG000|Overall Study|Death|0|||
94607541|NCT00777205|324027388|FG001|Overall Study|Death|2|||
94607542|NCT00777205|324027387|FG000|Overall Study|Protocol Violation|0|||
94607543|NCT00777205|324027388|FG001|Overall Study|Protocol Violation|56|||
94607544|NCT01272661|324027390|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
94661605|NCT01462344|324215778|FG001|Overall Study|Asthma Exacerbation|35|||
94252251|NCT02581631|322716972|FG000|Overall Study|Other Reasons|1|||
94252252|NCT02581631|322716973|FG001|Overall Study|Other Reasons|0|||
94252253|NCT02581631|322716974|FG002|Overall Study|Other Reasons|2|||
94252254|NCT02581631|322716975|FG003|Overall Study|Other Reasons|2|||
94252255|NCT02581631|322716976|FG004|Overall Study|Other Reasons|3|||
94252256|NCT02581631|322716972|FG000|Overall Study|Poor/Non-Compliance|0|||
94252257|NCT02581631|322716973|FG001|Overall Study|Poor/Non-Compliance|0|||
94252258|NCT02581631|322716974|FG002|Overall Study|Poor/Non-Compliance|1|||
94252259|NCT02581631|322716975|FG003|Overall Study|Poor/Non-Compliance|0|||
94252260|NCT02581631|322716976|FG004|Overall Study|Poor/Non-Compliance|0|||
94252261|NCT02729753|322716977|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
94252262|NCT02729753|322716978|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
94252263|NCT01191268|322716979|FG000|Overall Study|Withdrawal by Subject|19|||
94252264|NCT01191268|322716980|FG001|Overall Study|Withdrawal by Subject|25|||
94252265|NCT01191268|322716981|FG002|Overall Study|Withdrawal by Subject|21|||
94252266|NCT01191268|322716979|FG000|Overall Study|Adverse Event|21|||
94252267|NCT01191268|322716980|FG001|Overall Study|Adverse Event|13|||
94607545|NCT01272661|324027391|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
94607546|NCT01272661|324027392|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
94607547|NCT00915356|324027395|FG000|Overall Study|Withdrawal by Subject|1|||
94607548|NCT00915356|324027396|FG001|Overall Study|Withdrawal by Subject|0|||
94607549|NCT00915356|324027397|FG002|Overall Study|Withdrawal by Subject|0|||
94607550|NCT00915356|324027398|FG003|Overall Study|Withdrawal by Subject|0|||
94607551|NCT00915356|324027399|FG004|Overall Study|Withdrawal by Subject|0|||
94607552|NCT00771316|324027405|FG000|Overall Study|Adverse Event|0|||
94252268|NCT01191268|322716981|FG002|Overall Study|Adverse Event|8|||
94252269|NCT01191268|322716979|FG000|Overall Study|Physician Decision|6|||
94252270|NCT01191268|322716980|FG001|Overall Study|Physician Decision|8|||
94607553|NCT00771316|324027406|FG001|Overall Study|Adverse Event|1|||
94607554|NCT00771316|324027405|FG000|Overall Study|Patient withdrew consent|1|||
94607555|NCT00771316|324027406|FG001|Overall Study|Patient withdrew consent|0|||
94607556|NCT00771316|324027405|FG000|Overall Study|Discontinued due to early termination|1|||
94607557|NCT00771316|324027406|FG001|Overall Study|Discontinued due to early termination|0|||
94607558|NCT00602667|324027407|FG000|Overall Study|Still on Therapy|0|||
94607559|NCT00602667|324027408|FG001|Overall Study|Still on Therapy|2|||
94607560|NCT00602667|324027409|FG002|Overall Study|Still on Therapy|2|||
94607561|NCT00602667|324027407|FG000|Overall Study|Death|0|||
94607562|NCT00602667|324027408|FG001|Overall Study|Death|1|||
94607563|NCT00602667|324027409|FG002|Overall Study|Death|1|||
94607564|NCT00602667|324027407|FG000|Overall Study|Family request|3|||
94607565|NCT00602667|324027408|FG001|Overall Study|Family request|25|||
94607566|NCT00602667|324027409|FG002|Overall Study|Family request|6|||
94607567|NCT00602667|324027407|FG000|Overall Study|Excessive toxicity|1|||
94607568|NCT00602667|324027408|FG001|Overall Study|Excessive toxicity|1|||
94607569|NCT00602667|324027409|FG002|Overall Study|Excessive toxicity|0|||
94607570|NCT00602667|324027407|FG000|Overall Study|Second malignancy|0|||
94607571|NCT00602667|324027408|FG001|Overall Study|Second malignancy|1|||
94607572|NCT00602667|324027409|FG002|Overall Study|Second malignancy|0|||
94607573|NCT00602667|324027407|FG000|Overall Study|Physician Decision|2|||
94607574|NCT00602667|324027408|FG001|Overall Study|Physician Decision|3|||
94607575|NCT00602667|324027409|FG002|Overall Study|Physician Decision|8|||
94607576|NCT00602667|324027407|FG000|Overall Study|Progressive disease|13|||
94607577|NCT00602667|324027408|FG001|Overall Study|Progressive disease|48|||
94607578|NCT00602667|324027409|FG002|Overall Study|Progressive disease|45|||
94607579|NCT00602667|324027407|FG000|Overall Study|Progressive disease prior to therapy|0|||
94607580|NCT00602667|324027408|FG001|Overall Study|Progressive disease prior to therapy|0|||
94607581|NCT00602667|324027409|FG002|Overall Study|Progressive disease prior to therapy|1|||
94607582|NCT02027376|324027410|FG000|Overall Study|Death|1|||
94607583|NCT02027376|324027411|FG001|Overall Study|Death|0|||
94607584|NCT02027376|324027412|FG002|Overall Study|Death|0|||
94607585|NCT01626495|324027414|FG000|Overall Study|Adverse Event|3|||
94607586|NCT01626495|324027414|FG000|Overall Study|Disease progression|27|||
94607587|NCT01626495|324027414|FG000|Overall Study|Withdrawal by Subject|1|||
94607588|NCT01626495|324027414|FG000|Overall Study|Administrative problem|1|||
94607589|NCT01626495|324027414|FG000|Overall Study|Death|2|||
94607590|NCT01626495|324027414|FG000|Overall Study|Physician Decision|1|||
94661606|NCT01462344|324215777|FG000|Overall Study|Lack of Efficacy|5|||
94661607|NCT01462344|324215778|FG001|Overall Study|Lack of Efficacy|6|||
94661608|NCT01462344|324215777|FG000|Overall Study|Protocol Violation|68|||
94661609|NCT01462344|324215778|FG001|Overall Study|Protocol Violation|53|||
94661610|NCT01462344|324215777|FG000|Overall Study|Lost to Follow-up|7|||
94661611|NCT01462344|324215778|FG001|Overall Study|Lost to Follow-up|7|||
94661612|NCT01962974|324215781|FG000|Overall Study|Study termination|7|||
94661613|NCT01692197|324215783|FG000|Overall Study|Failed Screening|3|||
94661614|NCT03086447|324215784|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
94661615|NCT03086447|324215785|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
94661616|NCT03086447|324215784|FG000|Overall Study|Lost Lens|2|||
94661617|NCT03086447|324215785|FG001|Overall Study|Lost Lens|5|||
94661618|NCT03086447|324215784|FG000|Overall Study|Product quality complaint|0|||
94357940|NCT04095039|323092376|FG000|Overall Study|Cacliphylaxis|0|||
94357941|NCT04095039|323092377|FG001|Overall Study|Cacliphylaxis|1|||
94357942|NCT04095039|323092376|FG000|Overall Study|Pregnancy|1|||
94357943|NCT04095039|323092377|FG001|Overall Study|Pregnancy|0|||
94661619|NCT03086447|324215785|FG001|Overall Study|Product quality complaint|1|||
94661620|NCT03086447|324215784|FG000|Overall Study|Lens Damage|1|||
94661621|NCT03086447|324215785|FG001|Overall Study|Lens Damage|6|||
94661622|NCT03086447|324215784|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
94661623|NCT03086447|324215785|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
94661624|NCT03086447|324215784|FG000|Overall Study|Test Article No Longer Available|1|||
94661625|NCT03086447|324215785|FG001|Overall Study|Test Article No Longer Available|0|||
94661626|NCT03086447|324215784|FG000|Overall Study|Protocol Violation|2|||
94661627|NCT03086447|324215785|FG001|Overall Study|Protocol Violation|4|||
94661628|NCT03086447|324215784|FG000|Overall Study|Lost to Follow-up|0|||
94357944|NCT03635788|323092378|FG000|Step 1|Death|1|||
94357945|NCT03635788|323092379|FG001|Step 1|Death|0|||
94357946|NCT03635788|323092380|FG002|Step 1|Death|0|||
94357947|NCT03635788|323092378|FG000|Step 1|Lost to Follow-up|31|||
94357948|NCT03635788|323092379|FG001|Step 1|Lost to Follow-up|0|||
94357949|NCT03635788|323092380|FG002|Step 1|Lost to Follow-up|0|||
94661629|NCT03086447|324215785|FG001|Overall Study|Lost to Follow-up|1|||
94661630|NCT03086447|324215784|FG000|Overall Study|Adverse Event|3|||
94357950|NCT03635788|323092378|FG000|Step 1|Pregnancy|1|||
94357951|NCT03635788|323092379|FG001|Step 1|Pregnancy|0|||
94357952|NCT03635788|323092380|FG002|Step 1|Pregnancy|0|||
94357953|NCT03635788|323092378|FG000|Step 1|Protocol Violation|8|||
94357954|NCT03635788|323092379|FG001|Step 1|Protocol Violation|0|||
94357955|NCT03635788|323092380|FG002|Step 1|Protocol Violation|0|||
94357956|NCT03635788|323092378|FG000|Step 1|Withdrawal by Subject|13|||
94357957|NCT03635788|323092379|FG001|Step 1|Withdrawal by Subject|0|||
94357958|NCT03635788|323092380|FG002|Step 1|Withdrawal by Subject|0|||
94357959|NCT03635788|323092378|FG000|Step 1|Other reasons|12|||
94357960|NCT03635788|323092379|FG001|Step 1|Other reasons|0|||
94357961|NCT03635788|323092380|FG002|Step 1|Other reasons|0|||
94357962|NCT03635788|323092378|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
94357963|NCT03635788|323092379|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
94357964|NCT03635788|323092380|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
94357965|NCT03635788|323092378|FG000|Step 2|Lost to Follow-up|0|||
94357966|NCT03635788|323092379|FG001|Step 2|Lost to Follow-up|8|||
94357967|NCT03635788|323092380|FG002|Step 2|Lost to Follow-up|15|||
94357968|NCT03635788|323092378|FG000|Step 2|Withdrawal by Subject|0|||
94357969|NCT03635788|323092379|FG001|Step 2|Withdrawal by Subject|6|||
94357970|NCT03635788|323092380|FG002|Step 2|Withdrawal by Subject|6|||
94357971|NCT03635788|323092378|FG000|Step 2|Death|0|||
94357972|NCT03635788|323092379|FG001|Step 2|Death|2|||
94661631|NCT03086447|324215785|FG001|Overall Study|Adverse Event|0|||
94661632|NCT03086447|324215784|FG000|Overall Study|Lens Discomfort|2|||
94357973|NCT03635788|323092380|FG002|Step 2|Death|0|||
94661633|NCT03086447|324215785|FG001|Overall Study|Lens Discomfort|1|||
94661634|NCT01954017|324215786|FG000|Overall Study|Adverse Event|0|||
94661635|NCT01954017|324215787|FG001|Overall Study|Adverse Event|0|||
94661636|NCT01954017|324215788|FG002|Overall Study|Adverse Event|1|||
94357974|NCT03635788|323092378|FG000|Step 2|Incarceration|0|||
94357975|NCT03635788|323092379|FG001|Step 2|Incarceration|2|||
94661637|NCT01954017|324215786|FG000|Overall Study|Death|2|||
94661638|NCT01954017|324215787|FG001|Overall Study|Death|1|||
94357976|NCT03635788|323092380|FG002|Step 2|Incarceration|0|||
94357977|NCT03635788|323092378|FG000|Step 2|Non-Compliance With Study Requirements|0|||
94357978|NCT03635788|323092379|FG001|Step 2|Non-Compliance With Study Requirements|1|||
94357979|NCT03635788|323092380|FG002|Step 2|Non-Compliance With Study Requirements|1|||
94357980|NCT03635788|323092378|FG000|Step 2|Confounding Medical Condition|0|||
94357981|NCT03635788|323092379|FG001|Step 2|Confounding Medical Condition|0|||
94357982|NCT03635788|323092380|FG002|Step 2|Confounding Medical Condition|1|||
94357983|NCT03635788|323092378|FG000|Step 2|Out Of State With No Plan To Return|0|||
94357984|NCT03635788|323092379|FG001|Step 2|Out Of State With No Plan To Return|1|||
94661639|NCT01954017|324215788|FG002|Overall Study|Death|1|||
94661640|NCT01954017|324215786|FG000|Overall Study|Withdrawal by Subject|0|||
94661641|NCT01954017|324215787|FG001|Overall Study|Withdrawal by Subject|1|||
94661642|NCT01954017|324215788|FG002|Overall Study|Withdrawal by Subject|0|||
94661643|NCT01954017|324215786|FG000|Overall Study|Protocol Violation|0|||
94252271|NCT01191268|322716981|FG002|Overall Study|Physician Decision|9|||
94252272|NCT01191268|322716979|FG000|Overall Study|Lost to Follow-up|8|||
94252273|NCT01191268|322716980|FG001|Overall Study|Lost to Follow-up|5|||
94252274|NCT01191268|322716981|FG002|Overall Study|Lost to Follow-up|9|||
94252275|NCT01191268|322716979|FG000|Overall Study|Entry Criteria Not Met|3|||
94661644|NCT01954017|324215787|FG001|Overall Study|Protocol Violation|3|||
94661645|NCT01954017|324215788|FG002|Overall Study|Protocol Violation|2|||
94661646|NCT01954017|324215786|FG000|Overall Study|Necrotizing enterocolitis|1|||
94661647|NCT01954017|324215787|FG001|Overall Study|Necrotizing enterocolitis|0|||
94661648|NCT01954017|324215788|FG002|Overall Study|Necrotizing enterocolitis|1|||
94661649|NCT01954017|324215786|FG000|Overall Study|Enteral intake stopped >7 days|0|||
94661650|NCT01954017|324215787|FG001|Overall Study|Enteral intake stopped >7 days|1|||
94661651|NCT01954017|324215788|FG002|Overall Study|Enteral intake stopped >7 days|1|||
94661652|NCT01954017|324215786|FG000|Overall Study|All other reasons|2|||
94661653|NCT01954017|324215787|FG001|Overall Study|All other reasons|2|||
94661654|NCT01954017|324215788|FG002|Overall Study|All other reasons|7|||
94661655|NCT02863991|324215799|FG000|Overall Study|Death|0|||
94661656|NCT02863991|324215800|FG001|Overall Study|Death|3|||
94661657|NCT02863991|324215799|FG000|Overall Study|Lack of Efficacy|0|||
94252276|NCT01191268|322716980|FG001|Overall Study|Entry Criteria Not Met|1|||
94252277|NCT01191268|322716981|FG002|Overall Study|Entry Criteria Not Met|1|||
94252278|NCT01191268|322716979|FG000|Overall Study|Death|0|||
94252279|NCT01191268|322716980|FG001|Overall Study|Death|1|||
94252280|NCT01191268|322716981|FG002|Overall Study|Death|3|||
94252281|NCT01191268|322716979|FG000|Overall Study|Protocol Violation|1|||
94252282|NCT01191268|322716980|FG001|Overall Study|Protocol Violation|0|||
94252283|NCT01191268|322716981|FG002|Overall Study|Protocol Violation|1|||
94252284|NCT01191268|322716979|FG000|Overall Study|Sponsor Decision|0|||
94252285|NCT01191268|322716980|FG001|Overall Study|Sponsor Decision|2|||
94252286|NCT01191268|322716981|FG002|Overall Study|Sponsor Decision|0|||
94252287|NCT01465347|322716982|FG000|Overall Study|Withdrawal by Subject|1|||
94252288|NCT01465347|322716983|FG001|Overall Study|Withdrawal by Subject|1|||
94252289|NCT01465347|322716982|FG000|Overall Study|Physician Decision|0|||
94252290|NCT01465347|322716983|FG001|Overall Study|Physician Decision|1|||
94252291|NCT01465347|322716982|FG000|Overall Study|Admitted to hospice|0|||
94252292|NCT01465347|322716983|FG001|Overall Study|Admitted to hospice|1|||
94607591|NCT01626495|324027414|FG000|Overall Study|New cancer therapy|16|||
94607592|NCT01626495|324027414|FG000|Overall Study|Manufacturing failure|1|||
94607593|NCT02711345|324027415|FG000|Overall Study|Adverse Event|0|||
94607594|NCT02711345|324027416|FG001|Overall Study|Adverse Event|0|||
94607595|NCT02711345|324027417|FG002|Overall Study|Adverse Event|0|||
94607596|NCT02711345|324027418|FG003|Overall Study|Adverse Event|1|||
94607597|NCT02711345|324027419|FG004|Overall Study|Adverse Event|1|||
94607598|NCT02711345|324027420|FG005|Overall Study|Adverse Event|2|||
94607599|NCT02711345|324027421|FG006|Overall Study|Adverse Event|1|||
94607600|NCT02711345|324027422|FG007|Overall Study|Adverse Event|0|||
94607601|NCT02711345|324027423|FG008|Overall Study|Adverse Event|0|||
94607602|NCT02711345|324027424|FG009|Overall Study|Adverse Event|2|||
94607603|NCT02711345|324027415|FG000|Overall Study|Physician Decision|0|||
94607604|NCT02711345|324027416|FG001|Overall Study|Physician Decision|0|||
94607605|NCT02711345|324027417|FG002|Overall Study|Physician Decision|1|||
94607606|NCT02711345|324027418|FG003|Overall Study|Physician Decision|0|||
94607607|NCT02711345|324027419|FG004|Overall Study|Physician Decision|0|||
94607608|NCT02711345|324027420|FG005|Overall Study|Physician Decision|0|||
94607609|NCT02711345|324027421|FG006|Overall Study|Physician Decision|0|||
94607610|NCT02711345|324027422|FG007|Overall Study|Physician Decision|0|||
94607611|NCT02711345|324027423|FG008|Overall Study|Physician Decision|1|||
94607612|NCT02711345|324027424|FG009|Overall Study|Physician Decision|0|||
94607613|NCT02711345|324027415|FG000|Overall Study|Progressive disease|1|||
94607614|NCT02711345|324027416|FG001|Overall Study|Progressive disease|3|||
94607615|NCT02711345|324027417|FG002|Overall Study|Progressive disease|5|||
94607616|NCT02711345|324027418|FG003|Overall Study|Progressive disease|3|||
94607617|NCT02711345|324027419|FG004|Overall Study|Progressive disease|7|||
94607618|NCT02711345|324027420|FG005|Overall Study|Progressive disease|2|||
94607619|NCT02711345|324027421|FG006|Overall Study|Progressive disease|8|||
94607620|NCT02711345|324027422|FG007|Overall Study|Progressive disease|4|||
94607621|NCT02711345|324027423|FG008|Overall Study|Progressive disease|5|||
94607622|NCT02711345|324027424|FG009|Overall Study|Progressive disease|6|||
94661658|NCT02863991|324215800|FG001|Overall Study|Lack of Efficacy|1|||
94661659|NCT02863991|324215799|FG000|Overall Study|Study Terminated|2|||
94661660|NCT02863991|324215800|FG001|Overall Study|Study Terminated|8|||
94252293|NCT02270515|322716984|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
94252294|NCT02270515|322716984|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
94661661|NCT02132611|324215801|FG000|Overall Study|Death|2|||
94252295|NCT02270515|322716984|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
94252296|NCT02270515|322716984|FG000|Intervention Period 1: 0-6 Months|Death|7|||
94607623|NCT02711345|324027415|FG000|Overall Study|Subject/guardian decision|0|||
94607624|NCT02711345|324027416|FG001|Overall Study|Subject/guardian decision|0|||
94252297|NCT02270515|322716984|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
94252298|NCT02270515|322716984|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
94252299|NCT02270515|322716984|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
94252300|NCT02270515|322716984|FG000|Intervention Period 2: 6-12 Months|Death|5|||
94252301|NCT02270515|322716984|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
94252302|NCT02270515|322716984|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
94252303|NCT02270515|322716984|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
94252304|NCT02270515|322716984|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
94252305|NCT02270515|322716984|FG000|Intervention Period 3: 12-18 Months|Death|3|||
94252306|NCT02270515|322716984|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
94252307|NCT01590082|322716985|FG000|Overall Study|Withdrawal by Subject|1|||
94252308|NCT01590082|322716986|FG001|Overall Study|Withdrawal by Subject|0|||
94252309|NCT01590082|322716985|FG000|Overall Study|Ineligible|1|||
94252310|NCT01590082|322716986|FG001|Overall Study|Ineligible|0|||
94252311|NCT01210664|322716987|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
94252312|NCT01210664|322716988|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
94252313|NCT01210664|322716989|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
94252314|NCT01210664|322716990|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
94252315|NCT01210664|322716987|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
94252316|NCT01210664|322716988|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
94252317|NCT01210664|322716989|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
94252318|NCT01210664|322716990|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
94252319|NCT01210664|322716987|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
94252320|NCT01210664|322716988|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
94252321|NCT01210664|322716989|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
94252322|NCT01210664|322716990|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
94252323|NCT01771107|322716991|FG000|Overall Study|Adverse Event|1|||
94252324|NCT01771107|322716992|FG001|Overall Study|Adverse Event|3|||
94252325|NCT01771107|322716991|FG000|Overall Study|Withdrawal by Subject|0|||
94252326|NCT01771107|322716992|FG001|Overall Study|Withdrawal by Subject|2|||
94252327|NCT01771107|322716991|FG000|Overall Study|Lost to Follow-up|0|||
94252328|NCT01771107|322716992|FG001|Overall Study|Lost to Follow-up|1|||
94252329|NCT01771107|322716991|FG000|Overall Study|participant moved|0|||
94252330|NCT01771107|322716992|FG001|Overall Study|participant moved|1|||
94252331|NCT01771107|322716991|FG000|Overall Study|Other|0|||
94252332|NCT01771107|322716992|FG001|Overall Study|Other|1|||
94252333|NCT01853644|322716993|FG000|Registration and Treatment Start|Did not start treatment|1|||
94252334|NCT01853644|322716993|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
94252335|NCT01853644|322716993|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
94252336|NCT01853644|322716993|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
94252337|NCT01853644|322716993|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
94252338|NCT01853644|322716993|FG000|Continued Treatment After First Response|Adverse Event|2|||
94252339|NCT01853644|322716993|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
94252340|NCT02891408|322716994|FG000|Overall Study|Lost to Follow-up|0|||
94252341|NCT02891408|322716995|FG001|Overall Study|Lost to Follow-up|0|||
94252342|NCT02891408|322716996|FG002|Overall Study|Lost to Follow-up|1|||
94252343|NCT02891408|322716997|FG003|Overall Study|Lost to Follow-up|0|||
94252344|NCT02891408|322716998|FG004|Overall Study|Lost to Follow-up|0|||
94252345|NCT02891408|322716999|FG005|Overall Study|Lost to Follow-up|0|||
94252346|NCT02891408|322717000|FG006|Overall Study|Lost to Follow-up|0|||
94252347|NCT00825825|322717001|FG000|First Medication Period (14 Days)|Adverse Event|1|||
94252348|NCT00825825|322717002|FG001|First Medication Period (14 Days)|Adverse Event|0|||
94252349|NCT00825825|322717003|FG002|First Medication Period (14 Days)|Adverse Event|0|||
94252350|NCT00825825|322717004|FG003|First Medication Period (14 Days)|Adverse Event|0|||
94252351|NCT00825825|322717005|FG004|First Medication Period (14 Days)|Adverse Event|0|||
94252352|NCT00825825|322717006|FG005|First Medication Period (14 Days)|Adverse Event|1|||
94252353|NCT00825825|322717001|FG000|First Medication Period (14 Days)|Physician Decision|2|||
94252354|NCT00825825|322717002|FG001|First Medication Period (14 Days)|Physician Decision|0|||
94252355|NCT00825825|322717003|FG002|First Medication Period (14 Days)|Physician Decision|1|||
94252356|NCT00825825|322717004|FG003|First Medication Period (14 Days)|Physician Decision|0|||
94252357|NCT00825825|322717005|FG004|First Medication Period (14 Days)|Physician Decision|0|||
94252358|NCT00825825|322717006|FG005|First Medication Period (14 Days)|Physician Decision|1|||
94252359|NCT00825825|322717001|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
94252360|NCT00825825|322717002|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
94252361|NCT00825825|322717003|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
94252362|NCT00825825|322717004|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
94252363|NCT00825825|322717005|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
94252364|NCT00825825|322717006|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
94252365|NCT00825825|322717001|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
94607625|NCT02711345|324027417|FG002|Overall Study|Subject/guardian decision|0|||
94607626|NCT02711345|324027418|FG003|Overall Study|Subject/guardian decision|0|||
94252366|NCT00825825|322717002|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
94252367|NCT00825825|322717003|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
94252368|NCT00825825|322717004|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
94252369|NCT00825825|322717005|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
94252370|NCT00825825|322717006|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
94252371|NCT00825825|322717001|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
94252372|NCT00825825|322717002|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
94252373|NCT00825825|322717003|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
94252374|NCT00825825|322717004|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
94252375|NCT00825825|322717005|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
94252376|NCT00825825|322717006|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
94252377|NCT00825825|322717001|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
94252378|NCT00825825|322717002|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
94252379|NCT00825825|322717003|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
94252380|NCT00825825|322717004|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
94252381|NCT00825825|322717005|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
94252382|NCT00825825|322717006|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
94252383|NCT00825825|322717001|FG000|Third Medication Period (14 Days)|poor data quality|0|||
94252384|NCT00825825|322717002|FG001|Third Medication Period (14 Days)|poor data quality|1|||
94252385|NCT00825825|322717003|FG002|Third Medication Period (14 Days)|poor data quality|0|||
94252386|NCT00825825|322717004|FG003|Third Medication Period (14 Days)|poor data quality|0|||
94252387|NCT00825825|322717005|FG004|Third Medication Period (14 Days)|poor data quality|0|||
94252388|NCT00825825|322717006|FG005|Third Medication Period (14 Days)|poor data quality|0|||
94252389|NCT02649946|322717007|FG000|Overall Study|Withdrawal by Subject|1|||
94252390|NCT02649946|322717008|FG001|Overall Study|Withdrawal by Subject|1|||
94252391|NCT02649946|322717007|FG000|Overall Study|Death|7|||
94252392|NCT02649946|322717008|FG001|Overall Study|Death|9|||
94252393|NCT02649946|322717007|FG000|Overall Study|Physician Decision|1|||
94252394|NCT02649946|322717008|FG001|Overall Study|Physician Decision|0|||
94252395|NCT02649946|322717007|FG000|Overall Study|Lost to Follow-up|2|||
94252396|NCT02649946|322717008|FG001|Overall Study|Lost to Follow-up|1|||
94252397|NCT02649946|322717007|FG000|Overall Study|Erroneously enrolled|1|||
94252398|NCT02649946|322717008|FG001|Overall Study|Erroneously enrolled|0|||
94252399|NCT02649946|322717007|FG000|Overall Study|Missed 6-month follow-up visit|0|||
94252400|NCT02649946|322717008|FG001|Overall Study|Missed 6-month follow-up visit|4|||
94252401|NCT02433340|322717009|FG000|Overall Study|Adverse Event|0|||
94252402|NCT02433340|322717010|FG001|Overall Study|Adverse Event|0|||
94252403|NCT02433340|322717011|FG002|Overall Study|Adverse Event|1|||
94252404|NCT02433340|322717012|FG003|Overall Study|Adverse Event|0|||
94252405|NCT02433340|322717009|FG000|Overall Study|Withdrawal by Subject|1|||
94252406|NCT02433340|322717010|FG001|Overall Study|Withdrawal by Subject|0|||
94252407|NCT02433340|322717011|FG002|Overall Study|Withdrawal by Subject|1|||
94252408|NCT02433340|322717012|FG003|Overall Study|Withdrawal by Subject|2|||
94252409|NCT02433340|322717009|FG000|Overall Study|Lost to Follow-up|0|||
94252410|NCT02433340|322717010|FG001|Overall Study|Lost to Follow-up|1|||
94252411|NCT02433340|322717011|FG002|Overall Study|Lost to Follow-up|0|||
94252412|NCT02433340|322717012|FG003|Overall Study|Lost to Follow-up|0|||
94252413|NCT02433340|322717009|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
94252414|NCT02433340|322717010|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
94252415|NCT02433340|322717011|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
94252416|NCT02433340|322717012|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
94252417|NCT02433340|322717009|FG000|Overall Study|Other|0|||
94252418|NCT02433340|322717010|FG001|Overall Study|Other|1|||
94252419|NCT02433340|322717011|FG002|Overall Study|Other|0|||
94252420|NCT02433340|322717012|FG003|Overall Study|Other|0|||
94252421|NCT01285609|322717016|FG000|Randomized|Progressive Disease|41|||
94252422|NCT01285609|322717017|FG001|Randomized|Progressive Disease|61|||
94252423|NCT01285609|322717016|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
94252424|NCT01285609|322717017|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
94607627|NCT02711345|324027419|FG004|Overall Study|Subject/guardian decision|0|||
94252425|NCT01285609|322717016|FG000|Randomized|Study Drug Toxicity|13|||
94252426|NCT01285609|322717017|FG001|Randomized|Study Drug Toxicity|14|||
94252427|NCT01285609|322717016|FG000|Randomized|Death|5|||
94252428|NCT01285609|322717017|FG001|Randomized|Death|7|||
94252429|NCT01285609|322717016|FG000|Randomized|Withdrawal by Subject|8|||
94252430|NCT01285609|322717017|FG001|Randomized|Withdrawal by Subject|11|||
94252431|NCT01285609|322717016|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
94252432|NCT01285609|322717017|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
94252433|NCT01285609|322717016|FG000|Randomized|Undisclosed Reasons|1|||
94607628|NCT02711345|324027420|FG005|Overall Study|Subject/guardian decision|2|||
94252434|NCT01285609|322717017|FG001|Randomized|Undisclosed Reasons|0|||
94607629|NCT02711345|324027421|FG006|Overall Study|Subject/guardian decision|3|||
94252435|NCT01285609|322717016|FG000|Randomized|Randomized but not Treated|4|||
94252436|NCT01285609|322717017|FG001|Randomized|Randomized but not Treated|4|||
94252437|NCT01285609|322717016|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
94252438|NCT01285609|322717017|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
94252439|NCT01285609|322717016|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
94252440|NCT01285609|322717017|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
94252441|NCT01285609|322717016|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
94252442|NCT01285609|322717017|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
94252443|NCT01285609|322717016|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
94252444|NCT01285609|322717017|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
94252445|NCT01285609|322717016|FG000|Treated With Blinded Therapy|Death|11|||
94252446|NCT01285609|322717017|FG001|Treated With Blinded Therapy|Death|3|||
94252447|NCT01285609|322717016|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
94252448|NCT01285609|322717017|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
94252449|NCT01285609|322717016|FG000|Treated With Blinded Therapy|Not Reported|0|||
94252450|NCT01285609|322717017|FG001|Treated With Blinded Therapy|Not Reported|2|||
94252451|NCT01285609|322717016|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
94252452|NCT01285609|322717017|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
94252453|NCT01285609|322717016|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
94252454|NCT01285609|322717017|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
94252455|NCT01285609|322717016|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
94252456|NCT01285609|322717017|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
94252457|NCT01285609|322717016|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
94252458|NCT01285609|322717017|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
94252459|NCT01285609|322717016|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
94252460|NCT01285609|322717017|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
94252461|NCT01285609|322717016|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
94252462|NCT01285609|322717017|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
94252463|NCT01285609|322717016|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
94252464|NCT01285609|322717017|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
94252465|NCT01285609|322717016|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
94252466|NCT01285609|322717017|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
94252467|NCT01285609|322717016|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
94252468|NCT01285609|322717017|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
94252469|NCT01285609|322717016|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
94252470|NCT01285609|322717017|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
94252471|NCT01211288|322717022|FG000|Overall Study|Lost to Follow-up|1|||
94252472|NCT01211288|322717023|FG001|Overall Study|Lost to Follow-up|1|||
94252473|NCT03143166|322717024|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
94252474|NCT00994682|322717027|FG000|Double Bilnd|Withdrawal by Subject|5|||
94252475|NCT00994682|322717028|FG001|Double Bilnd|Withdrawal by Subject|6|||
94252476|NCT00994682|322717027|FG000|Double Bilnd|Lost to Follow-up|3|||
94252477|NCT00994682|322717028|FG001|Double Bilnd|Lost to Follow-up|3|||
94252478|NCT00994682|322717027|FG000|Double Bilnd|Adverse Event|1|||
94252479|NCT00994682|322717028|FG001|Double Bilnd|Adverse Event|0|||
94252480|NCT00994682|322717027|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
94252481|NCT00994682|322717028|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
94252482|NCT00994682|322717027|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
94252483|NCT00994682|322717028|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
94252484|NCT00994682|322717027|FG000|Pioglitazone Open Label|Physician Decision|6|||
94252485|NCT00994682|322717028|FG001|Pioglitazone Open Label|Physician Decision|1|||
94252486|NCT01323972|322717029|FG000|Overall Study|Withdrawal by Subject|1|||
94252487|NCT01323972|322717030|FG001|Overall Study|Withdrawal by Subject|0|||
94252488|NCT01323972|322717031|FG002|Overall Study|Withdrawal by Subject|1|||
94252489|NCT01323972|322717032|FG003|Overall Study|Withdrawal by Subject|0|||
94252490|NCT01323972|322717029|FG000|Overall Study|Migrated/moved from study area|1|||
94252491|NCT01323972|322717030|FG001|Overall Study|Migrated/moved from study area|2|||
94252492|NCT01323972|322717031|FG002|Overall Study|Migrated/moved from study area|0|||
94252493|NCT01323972|322717032|FG003|Overall Study|Migrated/moved from study area|0|||
94252494|NCT01323972|322717029|FG000|Overall Study|Lost to Follow-up|0|||
94252495|NCT01323972|322717030|FG001|Overall Study|Lost to Follow-up|1|||
94252496|NCT01323972|322717031|FG002|Overall Study|Lost to Follow-up|1|||
94252497|NCT01323972|322717032|FG003|Overall Study|Lost to Follow-up|1|||
94252498|NCT01946438|322717037|FG000|Overall Study|Adverse Event|0|||
94252499|NCT01946438|322717038|FG001|Overall Study|Adverse Event|0|||
94252500|NCT01946438|322717039|FG002|Overall Study|Adverse Event|0|||
94252501|NCT01946438|322717040|FG003|Overall Study|Adverse Event|1|||
94252502|NCT01946438|322717037|FG000|Overall Study|Serious Adverse event|1|||
94252503|NCT01946438|322717038|FG001|Overall Study|Serious Adverse event|0|||
94252504|NCT01946438|322717039|FG002|Overall Study|Serious Adverse event|0|||
94252505|NCT01946438|322717040|FG003|Overall Study|Serious Adverse event|0|||
94252506|NCT01946438|322717037|FG000|Overall Study|Protocol Violation|0|||
94252507|NCT01946438|322717038|FG001|Overall Study|Protocol Violation|0|||
94252508|NCT01946438|322717039|FG002|Overall Study|Protocol Violation|1|||
94252509|NCT01946438|322717040|FG003|Overall Study|Protocol Violation|0|||
94252510|NCT01946438|322717037|FG000|Overall Study|Withdrawal by Subject|1|||
94252511|NCT01946438|322717038|FG001|Overall Study|Withdrawal by Subject|0|||
94252512|NCT01946438|322717039|FG002|Overall Study|Withdrawal by Subject|0|||
94607630|NCT02711345|324027422|FG007|Overall Study|Subject/guardian decision|1|||
94252513|NCT01946438|322717040|FG003|Overall Study|Withdrawal by Subject|0|||
94252514|NCT01679405|322717041|FG000|Overall Study|Death|2|||
94252515|NCT01679405|322717042|FG001|Overall Study|Death|5|||
94252516|NCT04677179|322717043|FG000|Induction Treatment Period|Adverse Event|1|||
94252517|NCT04677179|322717044|FG001|Induction Treatment Period|Adverse Event|0|||
94252518|NCT04677179|322717045|FG002|Induction Treatment Period|Adverse Event|0|||
94252519|NCT04677179|322717046|FG003|Induction Treatment Period|Adverse Event|0|||
94252520|NCT04677179|322717047|FG004|Induction Treatment Period|Adverse Event|0|||
94252521|NCT04677179|322717048|FG005|Induction Treatment Period|Adverse Event|0|||
94252522|NCT04677179|322717049|FG006|Induction Treatment Period|Adverse Event|0|||
94252523|NCT04677179|322717050|FG007|Induction Treatment Period|Adverse Event|0|||
94252524|NCT04677179|322717051|FG008|Induction Treatment Period|Adverse Event|0|||
94252525|NCT04677179|322717052|FG009|Induction Treatment Period|Adverse Event|0|||
94252526|NCT04677179|322717043|FG000|Induction Treatment Period|Physician Decision|1|||
94252527|NCT04677179|322717044|FG001|Induction Treatment Period|Physician Decision|0|||
94252528|NCT04677179|322717045|FG002|Induction Treatment Period|Physician Decision|1|||
94252529|NCT04677179|322717046|FG003|Induction Treatment Period|Physician Decision|0|||
94252530|NCT04677179|322717047|FG004|Induction Treatment Period|Physician Decision|0|||
94252531|NCT04677179|322717048|FG005|Induction Treatment Period|Physician Decision|0|||
94252532|NCT04677179|322717049|FG006|Induction Treatment Period|Physician Decision|0|||
94252533|NCT04677179|322717050|FG007|Induction Treatment Period|Physician Decision|0|||
94252534|NCT04677179|322717051|FG008|Induction Treatment Period|Physician Decision|0|||
94252535|NCT04677179|322717052|FG009|Induction Treatment Period|Physician Decision|0|||
94252536|NCT04677179|322717043|FG000|Induction Treatment Period|Protocol Violation|0|||
94357985|NCT03635788|323092380|FG002|Step 2|Out Of State With No Plan To Return|0|||
94357986|NCT03635788|323092378|FG000|Step 2|Switched To Injectables|0|||
94357987|NCT03635788|323092379|FG001|Step 2|Switched To Injectables|0|||
94357988|NCT03635788|323092380|FG002|Step 2|Switched To Injectables|1|||
94357989|NCT03635788|323092378|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
94357990|NCT03635788|323092379|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
94357991|NCT03635788|323092380|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
94357992|NCT02930889|323093201|FG000|Overall Study|Lost to Follow-up|2|||
94357993|NCT02930889|323093201|FG000|Overall Study|Withdrawal by Subject|6|||
94357994|NCT02930889|323093201|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
94357995|NCT00934661|323093202|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
94357996|NCT00934661|323093203|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
94357997|NCT02079740|323093206|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
94357998|NCT02079740|323093207|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
94357999|NCT02079740|323093208|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
94358000|NCT02079740|323093209|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
94358001|NCT02079740|323093210|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
94358002|NCT02079740|323093211|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
94358003|NCT02079740|323093212|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
94358004|NCT02079740|323093213|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
94358005|NCT02079740|323093214|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
94358006|NCT02079740|323093215|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
94358007|NCT02079740|323093216|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
94358008|NCT02079740|323093217|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
94358009|NCT02079740|323093218|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
94358010|NCT02079740|323093206|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
94358011|NCT02079740|323093207|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
94358012|NCT02079740|323093208|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
94358013|NCT02079740|323093209|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
94358014|NCT02079740|323093210|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
94358015|NCT02079740|323093211|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
94358016|NCT02079740|323093212|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
94607631|NCT02711345|324027423|FG008|Overall Study|Subject/guardian decision|0|||
94358017|NCT02079740|323093213|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
94358018|NCT02079740|323093214|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
94252537|NCT04677179|322717044|FG001|Induction Treatment Period|Protocol Violation|1|||
94252538|NCT04677179|322717045|FG002|Induction Treatment Period|Protocol Violation|0|||
94252539|NCT04677179|322717046|FG003|Induction Treatment Period|Protocol Violation|0|||
94252540|NCT04677179|322717047|FG004|Induction Treatment Period|Protocol Violation|0|||
94252541|NCT04677179|322717048|FG005|Induction Treatment Period|Protocol Violation|0|||
94252542|NCT04677179|322717049|FG006|Induction Treatment Period|Protocol Violation|0|||
94252543|NCT04677179|322717050|FG007|Induction Treatment Period|Protocol Violation|0|||
94252544|NCT04677179|322717051|FG008|Induction Treatment Period|Protocol Violation|0|||
94252545|NCT04677179|322717052|FG009|Induction Treatment Period|Protocol Violation|0|||
94252546|NCT04677179|322717043|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
94252547|NCT04677179|322717044|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
94252548|NCT04677179|322717045|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
94252549|NCT04677179|322717046|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
94252550|NCT04677179|322717047|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
94252551|NCT04677179|322717048|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
94252552|NCT04677179|322717049|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
94252553|NCT04677179|322717050|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
94252554|NCT04677179|322717051|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
94252555|NCT04677179|322717052|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
94252556|NCT04677179|322717043|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
94252557|NCT04677179|322717044|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
94252558|NCT04677179|322717045|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
94252559|NCT04677179|322717046|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
94252560|NCT04677179|322717047|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
94252561|NCT04677179|322717048|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
94252562|NCT04677179|322717049|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
94252563|NCT04677179|322717050|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
94252564|NCT04677179|322717051|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
94252565|NCT04677179|322717052|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
94252566|NCT04677179|322717043|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
94252567|NCT04677179|322717044|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
94252568|NCT04677179|322717045|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
94252569|NCT04677179|322717046|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
94252570|NCT04677179|322717047|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
94252571|NCT04677179|322717048|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
94252572|NCT04677179|322717049|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
94252573|NCT04677179|322717050|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
94252574|NCT04677179|322717051|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
94252575|NCT04677179|322717052|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
94252576|NCT04677179|322717043|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
94252577|NCT04677179|322717044|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
94252578|NCT04677179|322717045|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
94252579|NCT04677179|322717046|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
94252580|NCT04677179|322717047|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
94252581|NCT04677179|322717048|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
94252582|NCT04677179|322717049|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
94252583|NCT04677179|322717050|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
94252584|NCT04677179|322717051|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
94252585|NCT04677179|322717052|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
94252586|NCT04677179|322717043|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
94252587|NCT04677179|322717044|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
94252588|NCT04677179|322717045|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
94252589|NCT04677179|322717046|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
94252590|NCT04677179|322717047|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
94252591|NCT04677179|322717048|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
94252592|NCT04677179|322717049|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
94252593|NCT04677179|322717050|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
94252594|NCT04677179|322717051|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
94252595|NCT04677179|322717052|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
94252596|NCT04677179|322717043|FG000|Extension Treatment Period|Lack of Efficacy|0|||
94252597|NCT04677179|322717044|FG001|Extension Treatment Period|Lack of Efficacy|0|||
94252598|NCT04677179|322717045|FG002|Extension Treatment Period|Lack of Efficacy|0|||
94252599|NCT04677179|322717046|FG003|Extension Treatment Period|Lack of Efficacy|0|||
94252600|NCT04677179|322717047|FG004|Extension Treatment Period|Lack of Efficacy|0|||
94252601|NCT04677179|322717048|FG005|Extension Treatment Period|Lack of Efficacy|0|||
94252602|NCT04677179|322717049|FG006|Extension Treatment Period|Lack of Efficacy|6|||
94252603|NCT04677179|322717050|FG007|Extension Treatment Period|Lack of Efficacy|0|||
94252604|NCT04677179|322717051|FG008|Extension Treatment Period|Lack of Efficacy|0|||
94252605|NCT04677179|322717052|FG009|Extension Treatment Period|Lack of Efficacy|0|||
94252606|NCT04677179|322717043|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
94252607|NCT04677179|322717044|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
94252608|NCT04677179|322717045|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
94252609|NCT04677179|322717046|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
94252610|NCT04677179|322717047|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
94607632|NCT02711345|324027424|FG009|Overall Study|Subject/guardian decision|4|||
94607633|NCT02711345|324027415|FG000|Overall Study|Death|1|||
94607634|NCT02711345|324027416|FG001|Overall Study|Death|0|||
94607635|NCT02711345|324027417|FG002|Overall Study|Death|0|||
94607636|NCT02711345|324027418|FG003|Overall Study|Death|0|||
94607637|NCT02711345|324027419|FG004|Overall Study|Death|0|||
94607638|NCT02711345|324027420|FG005|Overall Study|Death|0|||
94607639|NCT02711345|324027421|FG006|Overall Study|Death|0|||
94607640|NCT02711345|324027422|FG007|Overall Study|Death|1|||
94607641|NCT02711345|324027423|FG008|Overall Study|Death|0|||
94607642|NCT02711345|324027424|FG009|Overall Study|Death|0|||
94607643|NCT02435069|324027425|FG000|Dose Response - First Intervention|Adverse Event|0|||
94607644|NCT02435069|324027426|FG001|Dose Response - First Intervention|Adverse Event|1|||
94607645|NCT02435069|324027427|FG002|Dose Response - First Intervention|Adverse Event|1|||
94607646|NCT02435069|324027428|FG003|Dose Response - First Intervention|Adverse Event|0|||
94607647|NCT02435069|324027429|FG004|Dose Response - First Intervention|Adverse Event|0|||
94607648|NCT02435069|324027425|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
94607649|NCT02435069|324027426|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
94607650|NCT02435069|324027427|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
94607651|NCT02435069|324027428|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
94661662|NCT00363766|324215802|FG000|Overall Study|Progressive Disease|15|||
94252611|NCT04677179|322717048|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
94252612|NCT04677179|322717049|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
94252613|NCT04677179|322717050|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
94252614|NCT04677179|322717051|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
94252615|NCT04677179|322717052|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
94252616|NCT04677179|322717043|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
94252617|NCT04677179|322717044|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
94252618|NCT04677179|322717045|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
94252619|NCT04677179|322717046|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
94252620|NCT04677179|322717047|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
94252621|NCT04677179|322717048|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
94252622|NCT04677179|322717049|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
94252623|NCT04677179|322717050|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
94252624|NCT04677179|322717051|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
94252625|NCT04677179|322717052|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
94252626|NCT04677179|322717043|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
94252627|NCT04677179|322717044|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
94252628|NCT04677179|322717045|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
94252629|NCT04677179|322717046|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
94252630|NCT04677179|322717047|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
94252631|NCT04677179|322717048|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
94252632|NCT04677179|322717049|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
94252633|NCT04677179|322717050|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
94252634|NCT04677179|322717051|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
94252635|NCT04677179|322717052|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
94252636|NCT04677179|322717043|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
94252637|NCT04677179|322717044|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
94252638|NCT04677179|322717045|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
94252639|NCT04677179|322717046|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
94252640|NCT04677179|322717047|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
94252641|NCT04677179|322717048|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
94252642|NCT04677179|322717049|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
94252643|NCT04677179|322717050|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
94252644|NCT04677179|322717051|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
94252645|NCT04677179|322717052|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
94252646|NCT04677179|322717043|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
94252647|NCT04677179|322717044|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
94252648|NCT04677179|322717045|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
94252649|NCT04677179|322717046|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
94252650|NCT04677179|322717047|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
94252651|NCT04677179|322717048|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
94252652|NCT04677179|322717049|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
94252653|NCT04677179|322717050|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
94252654|NCT04677179|322717051|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
94252655|NCT04677179|322717052|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
94252656|NCT04677179|322717043|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
94252657|NCT04677179|322717044|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
94252658|NCT04677179|322717045|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
94252659|NCT04677179|322717046|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
94661663|NCT00363766|324215803|FG001|Overall Study|Progressive Disease|9|||
94607652|NCT02435069|324027429|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
94607653|NCT01011738|324027430|FG000|Overall Study|Death|12|||
94607654|NCT01011738|324027431|FG001|Overall Study|Death|3|||
94607655|NCT01011738|324027432|FG002|Overall Study|Death|0|||
94607656|NCT01011738|324027430|FG000|Overall Study|Unknown reasons|312|||
94607657|NCT01011738|324027431|FG001|Overall Study|Unknown reasons|291|||
94607658|NCT01011738|324027432|FG002|Overall Study|Unknown reasons|17|||
94607659|NCT02891161|324027433|FG000|Study Treatment|Disease Progression|2|||
94607660|NCT02891161|324027434|FG001|Study Treatment|Disease Progression|4|||
94607661|NCT02891161|324027433|FG000|Study Treatment|AE/Side Effects/Complications|1|||
94607662|NCT02891161|324027434|FG001|Study Treatment|AE/Side Effects/Complications|5|||
94607663|NCT02891161|324027433|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
94607664|NCT02891161|324027434|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
94607665|NCT02891161|324027433|FG000|Follow up|Death|4|||
94607666|NCT02891161|324027434|FG001|Follow up|Death|8|||
94607667|NCT02891161|324027433|FG000|Follow up|Refused to Follow up|0|||
94607668|NCT02891161|324027434|FG001|Follow up|Refused to Follow up|2|||
94607669|NCT02891161|324027433|FG000|Follow up|Symptomatic deterioration|0|||
94607670|NCT02891161|324027434|FG001|Follow up|Symptomatic deterioration|1|||
94607671|NCT02891161|324027433|FG000|Follow up|Study terminated|0|||
94607672|NCT02891161|324027434|FG001|Follow up|Study terminated|6|||
94607673|NCT02734433|324027435|FG000|Overall Study|Disease progression|1|||
94607674|NCT02734433|324027436|FG001|Overall Study|Disease progression|5|||
94607675|NCT02734433|324027435|FG000|Overall Study|Clinical progression|0|||
94607676|NCT02734433|324027436|FG001|Overall Study|Clinical progression|1|||
94607677|NCT02734433|324027435|FG000|Overall Study|Withdrawal by Subject|1|||
94607678|NCT02734433|324027436|FG001|Overall Study|Withdrawal by Subject|2|||
94607679|NCT03875118|324028697|FG000|Overall Study|Withdrawal by Subject|4|||
94607680|NCT03875118|324028698|FG001|Overall Study|Withdrawal by Subject|4|||
94607681|NCT02231918|324028711|FG000|Overall Study|Withdrawal by Subject|0|||
94607682|NCT02231918|324028712|FG001|Overall Study|Withdrawal by Subject|1|||
94607683|NCT02231918|324028713|FG002|Overall Study|Withdrawal by Subject|0|||
94607684|NCT02231918|324028711|FG000|Overall Study|Adverse Event|0|||
94607685|NCT02231918|324028712|FG001|Overall Study|Adverse Event|0|||
94607686|NCT02231918|324028713|FG002|Overall Study|Adverse Event|1|||
94607687|NCT02395666|324028716|FG000|Overall Study|Physician Decision|3|||
94607688|NCT02395666|324028717|FG001|Overall Study|Physician Decision|0|||
94607689|NCT02395666|324028716|FG000|Overall Study|Lost to Follow-up|1|||
94607690|NCT02395666|324028717|FG001|Overall Study|Lost to Follow-up|0|||
94607691|NCT02395666|324028716|FG000|Overall Study|Withdrawal by Subject|2|||
94607692|NCT02395666|324028717|FG001|Overall Study|Withdrawal by Subject|1|||
94607693|NCT01092507|324028718|FG000|Overall Study|Withdrawal by Subject|2|||
94607694|NCT01092507|324028719|FG001|Overall Study|Withdrawal by Subject|0|||
94607695|NCT05007717|324028723|FG000|Overall Study|Death|3|||
94607696|NCT05007717|324028724|FG001|Overall Study|Death|2|||
94607697|NCT05314478|324028725|FG000|Overall Study|Physician Decision|1|||
94607698|NCT04060862|324028726|FG000|Overall Study|Symptomatic Deterioration|1|||
94607699|NCT04060862|324028726|FG000|Overall Study|Un-specified|6|||
94607700|NCT04060862|324028726|FG000|Overall Study|Progressive disease|12|||
94607701|NCT04060862|324028726|FG000|Overall Study|Physician Decision|1|||
94607702|NCT02476422|324028728|FG000|Overall Study|Subject/guardian decision|0|||
94607703|NCT02476422|324028729|FG001|Overall Study|Subject/guardian decision|1|||
94607704|NCT01134315|324028731|FG000|Overall Study|Adverse Event|1|||
94607705|NCT01134315|324028732|FG001|Overall Study|Adverse Event|2|||
94607706|NCT01134315|324028731|FG000|Overall Study|Other Reason|8|||
94607707|NCT01134315|324028732|FG001|Overall Study|Other Reason|17|||
94607708|NCT03555435|324028733|FG000|Overall Study|Lost to Follow-up|17|||
94607709|NCT03555435|324028734|FG001|Overall Study|Lost to Follow-up|19|||
94607710|NCT03555435|324028735|FG002|Overall Study|Lost to Follow-up|8|||
94607711|NCT03053271|324028736|FG000|Overall Study|Did not meet randomization criteria|3|||
94607712|NCT03053271|324028736|FG000|Overall Study|Withdrawal by Subject|1|||
94607713|NCT04137224|324028738|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
94607714|NCT04137224|324028739|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
94661664|NCT00363766|324215802|FG000|Overall Study|Adverse Event|10|||
94607715|NCT04137224|324028738|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
94607716|NCT04137224|324028739|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
94607717|NCT04137224|324028738|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
94607718|NCT04137224|324028739|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
94607719|NCT01669928|324028740|FG000|First Intervention|Withdrawal by Subject|3|||
94607720|NCT01669928|324028741|FG001|First Intervention|Withdrawal by Subject|5|||
94607721|NCT00057876|324028745|FG000|Overall Study|Adverse Event|8|||
94607722|NCT00057876|324028746|FG001|Overall Study|Adverse Event|8|||
94607723|NCT00057876|324028745|FG000|Overall Study|Death|2|||
94607724|NCT00057876|324028746|FG001|Overall Study|Death|1|||
94607725|NCT00057876|324028745|FG000|Overall Study|Withdrawal by Subject|5|||
94607726|NCT00057876|324028746|FG001|Overall Study|Withdrawal by Subject|6|||
94661665|NCT00363766|324215803|FG001|Overall Study|Adverse Event|2|||
94252660|NCT04677179|322717047|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
94252661|NCT04677179|322717048|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
94252662|NCT04677179|322717049|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
94252663|NCT04677179|322717050|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
94252664|NCT04677179|322717051|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
94252665|NCT04677179|322717052|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
94252666|NCT04677179|322717043|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
94252667|NCT04677179|322717044|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
94252668|NCT04677179|322717045|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
94252669|NCT04677179|322717046|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
94252670|NCT04677179|322717047|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
94252671|NCT04677179|322717048|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
94252672|NCT04677179|322717049|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
94252673|NCT04677179|322717050|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
94252674|NCT04677179|322717051|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
94252675|NCT04677179|322717052|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
94252676|NCT00790751|322717058|FG000|Overall Study|Protocol non-compliance|16|||
94252677|NCT00790751|322717059|FG001|Overall Study|Protocol non-compliance|16|||
94252678|NCT00790751|322717060|FG002|Overall Study|Protocol non-compliance|10|||
94252679|NCT00790751|322717061|FG003|Overall Study|Protocol non-compliance|11|||
94252680|NCT00790751|322717058|FG000|Overall Study|Lost to Follow-up|4|||
94252681|NCT00790751|322717059|FG001|Overall Study|Lost to Follow-up|9|||
94252682|NCT00790751|322717060|FG002|Overall Study|Lost to Follow-up|4|||
94459201|NCT03973918|323469577|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
94459202|NCT05174949|323469578|FG000|Overall Study|Physician Decision|1|||
94459203|NCT05174949|323469579|FG001|Overall Study|Physician Decision|2|||
94459204|NCT05174949|323469580|FG002|Overall Study|Physician Decision|0|||
94459205|NCT05174949|323469581|FG003|Overall Study|Physician Decision|1|||
94459206|NCT05174949|323469582|FG004|Overall Study|Physician Decision|0|||
94459207|NCT05174949|323469583|FG005|Overall Study|Physician Decision|0|||
94459208|NCT05174949|323469578|FG000|Overall Study|Withdrawal by Subject|0|||
94459209|NCT05174949|323469579|FG001|Overall Study|Withdrawal by Subject|1|||
94459210|NCT05174949|323469580|FG002|Overall Study|Withdrawal by Subject|0|||
94459211|NCT05174949|323469581|FG003|Overall Study|Withdrawal by Subject|0|||
94459212|NCT05174949|323469582|FG004|Overall Study|Withdrawal by Subject|0|||
94459213|NCT05174949|323469583|FG005|Overall Study|Withdrawal by Subject|0|||
94459214|NCT05174949|323469578|FG000|Overall Study|Lost to Follow-up|0|||
94459215|NCT05174949|323469579|FG001|Overall Study|Lost to Follow-up|0|||
94459216|NCT05174949|323469580|FG002|Overall Study|Lost to Follow-up|0|||
94459217|NCT05174949|323469581|FG003|Overall Study|Lost to Follow-up|1|||
94459218|NCT05174949|323469582|FG004|Overall Study|Lost to Follow-up|0|||
94459219|NCT05174949|323469583|FG005|Overall Study|Lost to Follow-up|0|||
94459220|NCT02951533|323469584|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
94459221|NCT02951533|323469585|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
94459222|NCT02951533|323469586|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
94459223|NCT02951533|323469584|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
94459224|NCT02951533|323469585|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
94459225|NCT02951533|323469586|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
94459226|NCT02951533|323469584|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
94459227|NCT02951533|323469585|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
94459228|NCT02951533|323469586|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
94459229|NCT02951533|323469584|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
94459230|NCT02951533|323469585|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
94459231|NCT02951533|323469586|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
94459232|NCT02951533|323469584|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
94459233|NCT02951533|323469585|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
94459234|NCT02951533|323469586|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
94459235|NCT02951533|323469584|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
94459236|NCT02951533|323469585|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
94459237|NCT02951533|323469586|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
94459238|NCT02951533|323469584|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
94459239|NCT02951533|323469585|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
94459240|NCT02951533|323469586|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
94459241|NCT02951533|323469584|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
94459242|NCT02951533|323469585|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
94661666|NCT00363766|324215802|FG000|Overall Study|Disease Related Death|1|||
94252683|NCT00790751|322717061|FG003|Overall Study|Lost to Follow-up|5|||
94252684|NCT00790751|322717058|FG000|Overall Study|Adverse Event|5|||
94252685|NCT00790751|322717059|FG001|Overall Study|Adverse Event|3|||
94252686|NCT00790751|322717060|FG002|Overall Study|Adverse Event|5|||
94607727|NCT00057876|324028745|FG000|Overall Study|Lack of Efficacy|10|||
94607728|NCT00057876|324028746|FG001|Overall Study|Lack of Efficacy|8|||
94607729|NCT00057876|324028745|FG000|Overall Study|Ineligible|1|||
94607730|NCT00057876|324028746|FG001|Overall Study|Ineligible|2|||
94607731|NCT00057876|324028745|FG000|Overall Study|other reason|2|||
94607732|NCT00057876|324028746|FG001|Overall Study|other reason|2|||
94607733|NCT00057876|324028745|FG000|Overall Study|other complicating disease|1|||
94607734|NCT00057876|324028746|FG001|Overall Study|other complicating disease|0|||
94607735|NCT00629772|324028747|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
94607736|NCT00629772|324028748|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
94607737|NCT00629772|324028747|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
94607738|NCT00629772|324028748|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
94607739|NCT02791594|324028753|FG000|Overall Study|Physician Decision|2|||
94252687|NCT00790751|322717061|FG003|Overall Study|Adverse Event|4|||
94252688|NCT00790751|322717058|FG000|Overall Study|Requirement for restricted medication|0|||
94252689|NCT00790751|322717059|FG001|Overall Study|Requirement for restricted medication|2|||
94252690|NCT00790751|322717060|FG002|Overall Study|Requirement for restricted medication|0|||
94252691|NCT00790751|322717061|FG003|Overall Study|Requirement for restricted medication|0|||
94252692|NCT00790751|322717058|FG000|Overall Study|Death|0|||
94607740|NCT00857415|324028756|FG000|Overall Study|Image acquisition failure|2|||
94607741|NCT00857415|324028757|FG001|Overall Study|Image acquisition failure|0|||
94607742|NCT00857415|324028756|FG000|Overall Study|Invalid image or not imaged|3|||
94607743|NCT00857415|324028757|FG001|Overall Study|Invalid image or not imaged|0|||
94607744|NCT00857415|324028756|FG000|Overall Study|Subject still living at end of study|110|||
94607745|NCT00857415|324028757|FG001|Overall Study|Subject still living at end of study|0|||
94607746|NCT00857415|324028756|FG000|Overall Study|Deceased with no autopsy|2|||
94607747|NCT00857415|324028757|FG001|Overall Study|Deceased with no autopsy|0|||
94607748|NCT01199731|324028758|FG000|Overall Study|Adverse Event|0|||
94459243|NCT02951533|323469586|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
94459244|NCT02951533|323469584|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
94459245|NCT02951533|323469585|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
94459246|NCT02951533|323469586|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
94459247|NCT02951533|323469584|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
94459248|NCT02951533|323469585|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
94459249|NCT02951533|323469586|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
94459250|NCT02951533|323469584|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
94459251|NCT02951533|323469585|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
94459252|NCT02951533|323469586|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
94459253|NCT02253316|323469588|FG000|Consolidation|Progression|4|||
94459254|NCT02253316|323469589|FG001|Consolidation|Progression|0|||
94459255|NCT02253316|323469590|FG002|Consolidation|Progression|0|||
94459256|NCT02253316|323469588|FG000|Consolidation|Non-Compliance|1|||
94459257|NCT02253316|323469589|FG001|Consolidation|Non-Compliance|0|||
94459258|NCT02253316|323469590|FG002|Consolidation|Non-Compliance|0|||
94459259|NCT02253316|323469588|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
94459260|NCT02253316|323469589|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
94459261|NCT02253316|323469590|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
94459262|NCT02253316|323469588|FG000|Consolidation|Secondary Malignancy|2|||
94459263|NCT02253316|323469589|FG001|Consolidation|Secondary Malignancy|0|||
94459264|NCT02253316|323469590|FG002|Consolidation|Secondary Malignancy|0|||
94459265|NCT02253316|323469588|FG000|Consolidation|Adverse Event|7|||
94459266|NCT02253316|323469589|FG001|Consolidation|Adverse Event|0|||
94459267|NCT02253316|323469590|FG002|Consolidation|Adverse Event|0|||
94459268|NCT02253316|323469588|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
94459269|NCT02253316|323469589|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
94459270|NCT02253316|323469590|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
94459271|NCT02253316|323469588|FG000|Maintenance|Physician Decision|0|||
94459272|NCT02253316|323469589|FG001|Maintenance|Physician Decision|7|||
94459273|NCT02253316|323469590|FG002|Maintenance|Physician Decision|16|||
94607749|NCT01199731|324028759|FG001|Overall Study|Adverse Event|1|||
94607750|NCT01199731|324028760|FG002|Overall Study|Adverse Event|0|||
94607751|NCT01199731|324028758|FG000|Overall Study|Study closed/terminated|7|||
94607752|NCT01199731|324028759|FG001|Overall Study|Study closed/terminated|9|||
94607753|NCT01199731|324028760|FG002|Overall Study|Study closed/terminated|7|||
94607754|NCT01199731|324028758|FG000|Overall Study|Lost to Follow-up|0|||
94607755|NCT01199731|324028759|FG001|Overall Study|Lost to Follow-up|0|||
94607756|NCT01199731|324028760|FG002|Overall Study|Lost to Follow-up|2|||
94607757|NCT01199731|324028758|FG000|Overall Study|Physician Decision|0|||
94607758|NCT01199731|324028759|FG001|Overall Study|Physician Decision|1|||
94607759|NCT01199731|324028760|FG002|Overall Study|Physician Decision|1|||
94607760|NCT01199731|324028758|FG000|Overall Study|Withdrawal by Subject|2|||
94607761|NCT01199731|324028759|FG001|Overall Study|Withdrawal by Subject|0|||
94607762|NCT01199731|324028760|FG002|Overall Study|Withdrawal by Subject|0|||
94607763|NCT03766685|324028761|FG000|Overall Study|Lost to Follow-up|1|||
94607764|NCT03766685|324028762|FG001|Overall Study|Lost to Follow-up|1|||
94607765|NCT03766685|324028763|FG002|Overall Study|Lost to Follow-up|0|||
94607766|NCT03766685|324028764|FG003|Overall Study|Lost to Follow-up|0|||
94607767|NCT03766685|324028761|FG000|Overall Study|Adverse Event, not fatal|0|||
94459274|NCT02253316|323469588|FG000|Maintenance|Non-Compliance|0|||
94459275|NCT02253316|323469589|FG001|Maintenance|Non-Compliance|1|||
94459276|NCT02253316|323469590|FG002|Maintenance|Non-Compliance|1|||
94459277|NCT02253316|323469588|FG000|Maintenance|Secondary Malignancy|0|||
94459278|NCT02253316|323469589|FG001|Maintenance|Secondary Malignancy|2|||
94459279|NCT02253316|323469590|FG002|Maintenance|Secondary Malignancy|6|||
94459280|NCT02253316|323469588|FG000|Maintenance|Adverse Event|0|||
94607768|NCT03766685|324028762|FG001|Overall Study|Adverse Event, not fatal|1|||
94607769|NCT03766685|324028763|FG002|Overall Study|Adverse Event, not fatal|0|||
94607770|NCT03766685|324028764|FG003|Overall Study|Adverse Event, not fatal|1|||
94607771|NCT03766685|324028761|FG000|Overall Study|Withdrawal by Subject|0|||
94607772|NCT03766685|324028762|FG001|Overall Study|Withdrawal by Subject|2|||
94607773|NCT03766685|324028763|FG002|Overall Study|Withdrawal by Subject|0|||
94607774|NCT03766685|324028764|FG003|Overall Study|Withdrawal by Subject|0|||
94459281|NCT02253316|323469589|FG001|Maintenance|Adverse Event|8|||
94459282|NCT02253316|323469590|FG002|Maintenance|Adverse Event|12|||
94607775|NCT03766685|324028761|FG000|Overall Study|Protocol Violation|0|||
94607776|NCT03766685|324028762|FG001|Overall Study|Protocol Violation|1|||
94607777|NCT03766685|324028763|FG002|Overall Study|Protocol Violation|0|||
94459283|NCT02253316|323469588|FG000|Maintenance|Still receiving active treatment|0|||
94459284|NCT02253316|323469589|FG001|Maintenance|Still receiving active treatment|5|||
94459285|NCT02253316|323469590|FG002|Maintenance|Still receiving active treatment|0|||
94607778|NCT03766685|324028764|FG003|Overall Study|Protocol Violation|0|||
94607779|NCT03766685|324028761|FG000|Overall Study|Non-compliance|0|||
94607780|NCT03766685|324028762|FG001|Overall Study|Non-compliance|2|||
94607781|NCT03766685|324028763|FG002|Overall Study|Non-compliance|0|||
94607782|NCT03766685|324028764|FG003|Overall Study|Non-compliance|0|||
94607783|NCT02028871|324028766|FG000|Overall Study|Positive urine drug screen|1|||
94607784|NCT02028871|324028767|FG001|Overall Study|Positive urine drug screen|1|||
94607785|NCT02028871|324028766|FG000|Overall Study|Withdrawal by Subject|1|||
94607786|NCT02028871|324028767|FG001|Overall Study|Withdrawal by Subject|2|||
94607787|NCT02028871|324028766|FG000|Overall Study|IV placement difficulty|1|||
94607788|NCT02028871|324028767|FG001|Overall Study|IV placement difficulty|0|||
94607789|NCT02028871|324028766|FG000|Overall Study|Current Illness|1|||
94607790|NCT02028871|324028767|FG001|Overall Study|Current Illness|0|||
94252693|NCT00790751|322717059|FG001|Overall Study|Death|0|||
94252694|NCT00790751|322717060|FG002|Overall Study|Death|1|||
94252695|NCT00790751|322717061|FG003|Overall Study|Death|0|||
94252696|NCT00790751|322717058|FG000|Overall Study|Physician Decision|0|||
94252697|NCT00790751|322717059|FG001|Overall Study|Physician Decision|0|||
94252698|NCT00790751|322717060|FG002|Overall Study|Physician Decision|0|||
94252699|NCT00790751|322717061|FG003|Overall Study|Physician Decision|1|||
94252700|NCT00189488|322718701|FG000|Overall Study|Ineligibility determined|1|||
94252701|NCT00189488|322718702|FG001|Overall Study|Ineligibility determined|0|||
94252702|NCT00189488|322718701|FG000|Overall Study|Protocol deviation|2|||
94252703|NCT00189488|322718702|FG001|Overall Study|Protocol deviation|1|||
94252704|NCT00189488|322718701|FG000|Overall Study|Adverse Event|2|||
94252705|NCT00189488|322718702|FG001|Overall Study|Adverse Event|1|||
94358019|NCT02079740|323093215|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
94607791|NCT03488927|324028776|FG000|Overall Study|Withdrawal by Subject|44|||
94607792|NCT03488927|324028777|FG001|Overall Study|Withdrawal by Subject|118|||
94607793|NCT03488927|324028778|FG002|Overall Study|Withdrawal by Subject|217|||
94607794|NCT00986479|324028779|FG000|Period 1|Improved mood|1|||
94607795|NCT00986479|324028780|FG001|Period 1|Improved mood|0|||
94607796|NCT00986479|324028779|FG000|Period 1|Administrative reasons|1|||
94607797|NCT00986479|324028780|FG001|Period 1|Administrative reasons|0|||
94607798|NCT01231347|324028781|FG000|Overall Study|Full Consent withdrawn|19|||
94607799|NCT01231347|324028782|FG001|Overall Study|Full Consent withdrawn|19|||
94607800|NCT01231347|324028783|FG002|Overall Study|Full Consent withdrawn|11|||
94607801|NCT01231347|324028781|FG000|Overall Study|Lost to Follow-up|4|||
94607802|NCT01231347|324028782|FG001|Overall Study|Lost to Follow-up|2|||
94607803|NCT01231347|324028783|FG002|Overall Study|Lost to Follow-up|2|||
94607804|NCT01231347|324028781|FG000|Overall Study|Death|202|||
94607805|NCT01231347|324028782|FG001|Overall Study|Death|210|||
94607806|NCT01231347|324028783|FG002|Overall Study|Death|101|||
94607807|NCT01231347|324028781|FG000|Overall Study|other event|7|||
94607808|NCT01231347|324028782|FG001|Overall Study|other event|9|||
94607809|NCT01231347|324028783|FG002|Overall Study|other event|3|||
94607810|NCT00828854|324028784|FG000|Overall Study|Disease Progression|17|||
94607811|NCT00828854|324028784|FG000|Overall Study|Adverse Event|9|||
94607812|NCT00828854|324028784|FG000|Overall Study|Reason not Specified|1|||
94607813|NCT01917929|324028785|FG000|Overall Study|Death|5|||
94607814|NCT01917929|324028785|FG000|Overall Study|Lost to Follow-up|19|||
94607815|NCT01917929|324028785|FG000|Overall Study|Withdrawal by Subject|31|||
94607816|NCT01917929|324028785|FG000|Overall Study|Adverse Event|6|||
94358020|NCT02079740|323093216|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
94358021|NCT02079740|323093217|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
94358022|NCT02079740|323093218|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
94358023|NCT02079740|323093206|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
94358024|NCT02079740|323093207|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
94358025|NCT02079740|323093208|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
94358026|NCT02079740|323093209|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
94358027|NCT02079740|323093210|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
94358028|NCT02079740|323093211|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
94358029|NCT02079740|323093212|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
94358030|NCT02079740|323093213|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
94358031|NCT02079740|323093214|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
94607817|NCT01917929|324028785|FG000|Overall Study|Investigative Site Terminated|11|||
94252706|NCT00189488|322718701|FG000|Overall Study|Withdrawal by Subject|2|||
94459286|NCT04713592|323469600|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
94459287|NCT04713592|323469601|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
94607818|NCT01917929|324028785|FG000|Overall Study|Censored because study device not implanted|6|||
94252707|NCT00189488|322718702|FG001|Overall Study|Withdrawal by Subject|6|||
94252708|NCT00189488|322718701|FG000|Overall Study|Disease progression|2|||
94607819|NCT01917929|324028785|FG000|Overall Study|Censored because surgery not performed|3|||
94607820|NCT01917929|324028785|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
94607821|NCT01917929|324028785|FG000|Overall Study|No 5 year data|70|||
94607822|NCT01917929|324028785|FG000|Overall Study|Sponsor terminated study|26|||
94607823|NCT02001181|324028788|FG000|Overall Study|Adverse Event|0|||
94607824|NCT02001181|324028789|FG001|Overall Study|Adverse Event|2|||
94607825|NCT02001181|324028788|FG000|Overall Study|Lost to Follow-up|1|||
94252709|NCT00189488|322718702|FG001|Overall Study|Disease progression|4|||
94252710|NCT00189488|322718701|FG000|Overall Study|Administrative Decision|0|||
94607826|NCT02001181|324028789|FG001|Overall Study|Lost to Follow-up|0|||
94607827|NCT02001181|324028788|FG000|Overall Study|Withdrawal by Subject|0|||
94607828|NCT02001181|324028789|FG001|Overall Study|Withdrawal by Subject|1|||
94607829|NCT01090973|324028791|FG000|Overall Study|Disease progression|1|||
94607830|NCT03131453|324028792|FG000|Overall Study|Study terminated by Sponsor|424|||
94607831|NCT03131453|324028793|FG001|Overall Study|Study terminated by Sponsor|222|||
94607832|NCT03131453|324028794|FG002|Overall Study|Study terminated by Sponsor|438|||
94607833|NCT03131453|324028792|FG000|Overall Study|Withdrawal by Subject|18|||
94607834|NCT03131453|324028793|FG001|Overall Study|Withdrawal by Subject|7|||
94607835|NCT03131453|324028794|FG002|Overall Study|Withdrawal by Subject|13|||
94607836|NCT03131453|324028792|FG000|Overall Study|Adverse Event|10|||
94607837|NCT03131453|324028793|FG001|Overall Study|Adverse Event|3|||
94607838|NCT03131453|324028794|FG002|Overall Study|Adverse Event|3|||
94607839|NCT03131453|324028792|FG000|Overall Study|Lost to Follow-up|1|||
94607840|NCT03131453|324028793|FG001|Overall Study|Lost to Follow-up|0|||
94607841|NCT03131453|324028794|FG002|Overall Study|Lost to Follow-up|1|||
94607842|NCT03131453|324028792|FG000|Overall Study|Physician Decision|1|||
94607843|NCT03131453|324028793|FG001|Overall Study|Physician Decision|0|||
94607844|NCT03131453|324028794|FG002|Overall Study|Physician Decision|1|||
94607845|NCT03131453|324028792|FG000|Overall Study|Non-compliance with study treatment|1|||
94607846|NCT03131453|324028793|FG001|Overall Study|Non-compliance with study treatment|0|||
94607847|NCT03131453|324028794|FG002|Overall Study|Non-compliance with study treatment|0|||
94607848|NCT03131453|324028792|FG000|Overall Study|Technical problems|1|||
94607849|NCT03131453|324028793|FG001|Overall Study|Technical problems|0|||
94607850|NCT03131453|324028794|FG002|Overall Study|Technical problems|0|||
94607851|NCT03131453|324028792|FG000|Overall Study|Protocol deviation|0|||
94607852|NCT03131453|324028793|FG001|Overall Study|Protocol deviation|1|||
94607853|NCT03131453|324028794|FG002|Overall Study|Protocol deviation|0|||
94607854|NCT01822496|324028796|FG000|Overall Study|Protocol Violation|2|||
94607855|NCT01822496|324028797|FG001|Overall Study|Protocol Violation|2|||
94607856|NCT01822496|324028798|FG002|Overall Study|Protocol Violation|0|||
94607857|NCT01822496|324028799|FG003|Overall Study|Protocol Violation|1|||
94607858|NCT01822496|324028796|FG000|Overall Study|Withdrawal by Subject|0|||
94607859|NCT01822496|324028797|FG001|Overall Study|Withdrawal by Subject|0|||
94607860|NCT01822496|324028798|FG002|Overall Study|Withdrawal by Subject|0|||
94607861|NCT01822496|324028799|FG003|Overall Study|Withdrawal by Subject|3|||
94607862|NCT01898208|324028801|FG000|Overall Study|Positive blood culture|17|||
94607863|NCT01898208|324028802|FG001|Overall Study|Positive blood culture|23|||
94607864|NCT01898208|324028803|FG002|Overall Study|Positive blood culture|15|||
94607865|NCT01898208|324028801|FG000|Overall Study|Death/comfort care within 24 hours|10|||
94607866|NCT01898208|324028802|FG001|Overall Study|Death/comfort care within 24 hours|9|||
94607867|NCT01898208|324028803|FG002|Overall Study|Death/comfort care within 24 hours|8|||
94607868|NCT01898208|324028801|FG000|Overall Study|Negative Gram Stain|6|||
94607869|NCT01898208|324028802|FG001|Overall Study|Negative Gram Stain|9|||
94607870|NCT01898208|324028803|FG002|Overall Study|Negative Gram Stain|6|||
94607871|NCT01898208|324028801|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
94607872|NCT01898208|324028802|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
94607873|NCT01898208|324028803|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
94607874|NCT01898208|324028801|FG000|Overall Study|System/Technical Error|1|||
94607875|NCT01898208|324028802|FG001|Overall Study|System/Technical Error|2|||
94607876|NCT01898208|324028803|FG002|Overall Study|System/Technical Error|3|||
94607877|NCT01898208|324028801|FG000|Overall Study|Lost to Follow-up|3|||
94607878|NCT01898208|324028802|FG001|Overall Study|Lost to Follow-up|1|||
94607879|NCT01898208|324028803|FG002|Overall Study|Lost to Follow-up|1|||
94607880|NCT01631812|324028804|FG000|Overall Study|Adverse Event|25|||
94607881|NCT01631812|324028804|FG000|Overall Study|Lack of Efficacy|5|||
94607882|NCT01631812|324028804|FG000|Overall Study|Withdrawal by Subject|4|||
94607883|NCT01631812|324028804|FG000|Overall Study|Physician Decision|3|||
94607884|NCT00843726|324028807|FG000|Overall Study|Death|1|||
94607885|NCT00843726|324028808|FG001|Overall Study|Death|0|||
94607886|NCT00843726|324028807|FG000|Overall Study|Withdrawal by Subject|0|||
94607887|NCT00843726|324028808|FG001|Overall Study|Withdrawal by Subject|1|||
94607888|NCT02520661|324028809|FG000|Overall Study|Lost to Follow-up|7|||
94607889|NCT02520661|324028810|FG001|Overall Study|Lost to Follow-up|3|||
94607890|NCT02520661|324028809|FG000|Overall Study|Admitted from ED|49|||
94607891|NCT02520661|324028810|FG001|Overall Study|Admitted from ED|48|||
94607892|NCT02520661|324028809|FG000|Overall Study|ED greater than 24 hours|29|||
94607893|NCT02520661|324028810|FG001|Overall Study|ED greater than 24 hours|38|||
94607894|NCT02520661|324028809|FG000|Overall Study|other ineligibility|14|||
94607895|NCT02520661|324028810|FG001|Overall Study|other ineligibility|22|||
94607896|NCT02520661|324028809|FG000|Overall Study|Withdrawal by Subject|7|||
94607897|NCT02520661|324028810|FG001|Overall Study|Withdrawal by Subject|16|||
94661667|NCT00363766|324215803|FG001|Overall Study|Disease Related Death|3|||
94661668|NCT00363766|324215802|FG000|Overall Study|Not Disease Related Death|3|||
94607898|NCT00667602|324028811|FG000|Overall Study|Withdrawal by Subject|4|||
94607899|NCT00667602|324028812|FG001|Overall Study|Withdrawal by Subject|9|||
94607900|NCT00667602|324028813|FG002|Overall Study|Withdrawal by Subject|10|||
94607901|NCT00667602|324028811|FG000|Overall Study|Lost to Follow-up|4|||
94607902|NCT00667602|324028812|FG001|Overall Study|Lost to Follow-up|5|||
94607903|NCT00667602|324028813|FG002|Overall Study|Lost to Follow-up|6|||
94607904|NCT00667602|324028811|FG000|Overall Study|Administrative reason|0|||
94607905|NCT00667602|324028812|FG001|Overall Study|Administrative reason|0|||
94607906|NCT00667602|324028813|FG002|Overall Study|Administrative reason|2|||
94607907|NCT00667602|324028811|FG000|Overall Study|Protocol Violation|0|||
94607908|NCT00667602|324028812|FG001|Overall Study|Protocol Violation|1|||
94607909|NCT00667602|324028813|FG002|Overall Study|Protocol Violation|0|||
94607910|NCT00406718|324028814|FG000|Overall Study|Withdrawal by Subject|2|||
94607911|NCT00406718|324028815|FG001|Overall Study|Withdrawal by Subject|9|||
94607912|NCT00406718|324028816|FG002|Overall Study|Withdrawal by Subject|4|||
94607913|NCT00406718|324028814|FG000|Overall Study|Lost to Follow-up|2|||
94607914|NCT00406718|324028815|FG001|Overall Study|Lost to Follow-up|5|||
94607915|NCT00406718|324028816|FG002|Overall Study|Lost to Follow-up|4|||
94607916|NCT00072176|324028817|FG000|Overall Study|Withdrawal by Subject|1|||
94607917|NCT00072176|324028818|FG001|Overall Study|Withdrawal by Subject|0|||
94607918|NCT00072176|324028817|FG000|Overall Study|Protocol Violation|0|||
94661669|NCT00363766|324215803|FG001|Overall Study|Not Disease Related Death|4|||
94607919|NCT00072176|324028818|FG001|Overall Study|Protocol Violation|1|||
94607920|NCT02919696|324028819|FG000|Overall Study|Adverse Event|1|||
94607921|NCT02919696|324028820|FG001|Overall Study|Adverse Event|2|||
94607922|NCT02919696|324028819|FG000|Overall Study|Withdrawal by Subject|2|||
94607923|NCT02919696|324028820|FG001|Overall Study|Withdrawal by Subject|1|||
94607924|NCT02919696|324028819|FG000|Overall Study|Sponsor Decision|1|||
94607925|NCT02919696|324028820|FG001|Overall Study|Sponsor Decision|1|||
94607926|NCT02919696|324028819|FG000|Overall Study|Never Treated|0|||
94607927|NCT02919696|324028820|FG001|Overall Study|Never Treated|1|||
94607928|NCT00945555|324028821|FG000|Overall Study|Referred to another hospital|5|||
94607929|NCT00945555|324028821|FG000|Overall Study|Worsening condition, intensive care unit|1|||
94607930|NCT00945555|324028821|FG000|Overall Study|Withdrawal by Subject|2|||
94607931|NCT00945555|324028821|FG000|Overall Study|Participant continued treatment at home|1|||
94607932|NCT00945555|324028821|FG000|Overall Study|Death|18|||
94607933|NCT00945555|324028821|FG000|Overall Study|Other|1|||
94607934|NCT01467583|324028822|FG000|Overall Study|Death|1|||
94607935|NCT01467583|324028823|FG001|Overall Study|Death|1|||
94607936|NCT01467583|324028824|FG002|Overall Study|Death|0|||
94607937|NCT01467583|324028822|FG000|Overall Study|Withdrawal by Subject|1|||
94607938|NCT01467583|324028823|FG001|Overall Study|Withdrawal by Subject|0|||
94607939|NCT01467583|324028824|FG002|Overall Study|Withdrawal by Subject|0|||
94607940|NCT01467583|324028822|FG000|Overall Study|Protocol Violation|0|||
94607941|NCT01467583|324028823|FG001|Overall Study|Protocol Violation|0|||
94607942|NCT01467583|324028824|FG002|Overall Study|Protocol Violation|2|||
94607943|NCT04340193|324028825|FG000|Overall Study|Other reason|0|||
94607944|NCT04340193|324028826|FG001|Overall Study|Other reason|0|||
94607945|NCT04340193|324028827|FG002|Overall Study|Other reason|1|||
94607946|NCT04340193|324028825|FG000|Overall Study|Disease recurrence|0|||
94607947|NCT04340193|324028826|FG001|Overall Study|Disease recurrence|1|||
94607948|NCT04340193|324028827|FG002|Overall Study|Disease recurrence|0|||
94607949|NCT04340193|324028825|FG000|Overall Study|Study drug toxicity|1|||
94607950|NCT04340193|324028826|FG001|Overall Study|Study drug toxicity|0|||
94607951|NCT04340193|324028827|FG002|Overall Study|Study drug toxicity|0|||
94607952|NCT04340193|324028825|FG000|Overall Study|Disease progression|1|||
94607953|NCT04340193|324028826|FG001|Overall Study|Disease progression|2|||
94607954|NCT04340193|324028827|FG002|Overall Study|Disease progression|3|||
94607955|NCT04340193|324028825|FG000|Overall Study|Administrative reasons by sponsor|0|||
94607956|NCT04340193|324028826|FG001|Overall Study|Administrative reasons by sponsor|1|||
94607957|NCT04340193|324028827|FG002|Overall Study|Administrative reasons by sponsor|0|||
94607958|NCT04340193|324028825|FG000|Overall Study|Adverse Event|1|||
94607959|NCT04340193|324028826|FG001|Overall Study|Adverse Event|1|||
94607960|NCT04340193|324028827|FG002|Overall Study|Adverse Event|0|||
94607961|NCT01865084|324030758|FG000|Double Blind Period (DB)|Adverse Event|2|||
94607962|NCT01865084|324030759|FG001|Double Blind Period (DB)|Adverse Event|2|||
94607963|NCT01865084|324030760|FG002|Double Blind Period (DB)|Adverse Event|1|||
94607964|NCT01865084|324030758|FG000|Double Blind Period (DB)|Protocol Violation|0|||
94607965|NCT01865084|324030759|FG001|Double Blind Period (DB)|Protocol Violation|0|||
94607966|NCT01865084|324030760|FG002|Double Blind Period (DB)|Protocol Violation|1|||
94607967|NCT01865084|324030758|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
94607968|NCT01865084|324030759|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
94607969|NCT01865084|324030760|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
94607970|NCT01865084|324030758|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
94607971|NCT01865084|324030759|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
94607972|NCT01865084|324030760|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
94607973|NCT01865084|324030758|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
94607974|NCT01865084|324030759|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
94607975|NCT01865084|324030760|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
94607976|NCT01865084|324030758|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
94607977|NCT01865084|324030759|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
94607978|NCT01865084|324030760|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
94607979|NCT01865084|324030758|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
94607980|NCT01865084|324030759|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
94607981|NCT01865084|324030760|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
94607982|NCT01865084|324030758|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
94607983|NCT01865084|324030759|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
94607984|NCT01865084|324030760|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
94607985|NCT01865084|324030758|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
94607986|NCT01865084|324030759|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
94607987|NCT01865084|324030760|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
94607988|NCT05108922|324030764|FG000|Overall Study|Adverse Event|2|||
94661670|NCT00363766|324215802|FG000|Overall Study|Withdrawal by Subject|2|||
94661671|NCT00363766|324215803|FG001|Overall Study|Withdrawal by Subject|0|||
94607989|NCT05108922|324030765|FG001|Overall Study|Adverse Event|3|||
94607990|NCT05108922|324030764|FG000|Overall Study|Lost to Follow-up|2|||
94607991|NCT05108922|324030765|FG001|Overall Study|Lost to Follow-up|1|||
94607992|NCT05108922|324030764|FG000|Overall Study|Inadvertent enrollment|0|||
94607993|NCT05108922|324030765|FG001|Overall Study|Inadvertent enrollment|1|||
94607994|NCT05108922|324030764|FG000|Overall Study|Physician Decision|2|||
94607995|NCT05108922|324030765|FG001|Overall Study|Physician Decision|3|||
94607996|NCT05108922|324030764|FG000|Overall Study|Protocol deviation|1|||
94607997|NCT05108922|324030765|FG001|Overall Study|Protocol deviation|0|||
94607998|NCT05108922|324030764|FG000|Overall Study|Screen failure|1|||
94607999|NCT05108922|324030765|FG001|Overall Study|Screen failure|0|||
94608000|NCT05108922|324030764|FG000|Overall Study|Withdrawal by Subject|11|||
94608001|NCT05108922|324030765|FG001|Overall Study|Withdrawal by Subject|8|||
94608002|NCT00096954|324030766|FG000|Overall Study|Adverse Event|3|||
94661672|NCT00363766|324215802|FG000|Overall Study|Physician Decision|1|||
94358032|NCT02079740|323093215|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
94358033|NCT02079740|323093216|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
94358034|NCT02079740|323093217|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
94358035|NCT02079740|323093218|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
94358036|NCT02079740|323093206|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
94358037|NCT02079740|323093207|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
94459288|NCT04713592|323469602|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
94459289|NCT04713592|323469603|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
94459290|NCT04713592|323469600|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
94459291|NCT04713592|323469601|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
94459292|NCT04713592|323469602|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
94459293|NCT04713592|323469603|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
94459294|NCT04713592|323469600|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
94459295|NCT04713592|323469601|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
94459296|NCT04713592|323469602|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
94459297|NCT04713592|323469603|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
94459298|NCT04713592|323469600|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
94459299|NCT04713592|323469601|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
94459300|NCT04713592|323469602|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
94459301|NCT04713592|323469603|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
94459302|NCT04713592|323469600|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
94459303|NCT04713592|323469601|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
94459304|NCT04713592|323469602|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
94459305|NCT04713592|323469603|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
94459306|NCT04713592|323469600|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
94459307|NCT04713592|323469601|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
94459308|NCT04713592|323469602|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
94459309|NCT04713592|323469603|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
94608003|NCT00096954|324030767|FG001|Overall Study|Adverse Event|1|||
94358038|NCT02079740|323093208|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
94358039|NCT02079740|323093209|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
94358040|NCT02079740|323093210|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
94358041|NCT02079740|323093211|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
94358042|NCT02079740|323093212|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
94358043|NCT02079740|323093213|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
94358044|NCT02079740|323093214|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
94358045|NCT02079740|323093215|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
94358046|NCT02079740|323093216|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
94358047|NCT02079740|323093217|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
94358048|NCT02079740|323093218|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
94358049|NCT02079740|323093206|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
94358050|NCT02079740|323093207|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
94358051|NCT02079740|323093208|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
94358052|NCT02079740|323093209|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
94358053|NCT02079740|323093210|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
94358054|NCT02079740|323093211|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
94358055|NCT02079740|323093212|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
94358056|NCT02079740|323093213|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
94358057|NCT02079740|323093214|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
94358058|NCT02079740|323093215|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
94358059|NCT02079740|323093216|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
94358060|NCT02079740|323093217|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
94358061|NCT02079740|323093218|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
94358062|NCT02842736|323093219|FG000|Overall Study|Lost to Follow-up|13|||
94358063|NCT02842736|323093219|FG000|Overall Study|Intervention for menstrual bleeding|17|||
94358064|NCT02842736|323093219|FG000|Overall Study|Withdrawal by Subject|4|||
94358065|NCT02842736|323093219|FG000|Overall Study|Pregnancy|3|||
94358066|NCT02842736|323093219|FG000|Overall Study|Hysterectomy for fibroids|2|||
94358067|NCT02842736|323093219|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
94358068|NCT02842736|323093219|FG000|Overall Study|IUD: Mirena|1|||
94358069|NCT01748162|323093231|FG000|Overall Study|no additional croup episodes to evaluate|2|||
94358070|NCT01748162|323093232|FG001|Overall Study|no additional croup episodes to evaluate|2|||
94358071|NCT01748162|323093231|FG000|Overall Study|participant consented but did not begin|0|||
94358072|NCT01748162|323093232|FG001|Overall Study|participant consented but did not begin|1|||
94358073|NCT01748162|323093231|FG000|Overall Study|reasons not available|3|||
94358074|NCT01748162|323093232|FG001|Overall Study|reasons not available|2|||
94608004|NCT00096954|324030766|FG000|Overall Study|Withdrawal by Subject|9|||
94608005|NCT00096954|324030767|FG001|Overall Study|Withdrawal by Subject|8|||
94608006|NCT00096954|324030766|FG000|Overall Study|Physician Decision|1|||
94608007|NCT00096954|324030767|FG001|Overall Study|Physician Decision|1|||
94608008|NCT00096954|324030766|FG000|Overall Study|Sponsors Decision|1|||
94608009|NCT00096954|324030767|FG001|Overall Study|Sponsors Decision|1|||
94608010|NCT00096954|324030766|FG000|Overall Study|Pregnancy|1|||
94608011|NCT00096954|324030767|FG001|Overall Study|Pregnancy|1|||
94608012|NCT00096954|324030766|FG000|Overall Study|Initiation of immunotherapy|1|||
94608013|NCT00096954|324030767|FG001|Overall Study|Initiation of immunotherapy|0|||
94608014|NCT00096954|324030766|FG000|Overall Study|Non-compliance|0|||
94608015|NCT00096954|324030767|FG001|Overall Study|Non-compliance|3|||
94608016|NCT00096954|324030766|FG000|Overall Study|Lost to Follow-up|8|||
94608017|NCT00096954|324030767|FG001|Overall Study|Lost to Follow-up|5|||
94608018|NCT04444895|324030768|FG000|Overall Study|Adverse Event|2|||
94608019|NCT04444895|324030768|FG000|Overall Study|Lost to Follow-up|2|||
94608020|NCT04444895|324030768|FG000|Overall Study|Withdrawal by Subject|5|||
94608021|NCT01920555|324030769|FG000|Overall Study|Physician Decision|1|||
94608022|NCT01920555|324030770|FG001|Overall Study|Physician Decision|2|||
94608023|NCT01920555|324030771|FG002|Overall Study|Physician Decision|1|||
94608024|NCT01920555|324030772|FG003|Overall Study|Physician Decision|2|||
94608025|NCT01920555|324030773|FG004|Overall Study|Physician Decision|0|||
94608026|NCT01920555|324030769|FG000|Overall Study|Lack of Efficacy|2|||
94608027|NCT01920555|324030770|FG001|Overall Study|Lack of Efficacy|0|||
94608028|NCT01920555|324030771|FG002|Overall Study|Lack of Efficacy|0|||
94358075|NCT04629534|323093233|FG000|Overall Study|Physician Decision|1|||
94608029|NCT01920555|324030772|FG003|Overall Study|Lack of Efficacy|0|||
94608030|NCT01920555|324030773|FG004|Overall Study|Lack of Efficacy|0|||
94608031|NCT01920555|324030769|FG000|Overall Study|Travel Difficulties|1|||
94608032|NCT01920555|324030770|FG001|Overall Study|Travel Difficulties|1|||
94608033|NCT01920555|324030771|FG002|Overall Study|Travel Difficulties|0|||
94608034|NCT01920555|324030772|FG003|Overall Study|Travel Difficulties|0|||
94608035|NCT01920555|324030773|FG004|Overall Study|Travel Difficulties|1|||
94608036|NCT01920555|324030769|FG000|Overall Study|Lost to Follow-up|0|||
94608037|NCT01920555|324030770|FG001|Overall Study|Lost to Follow-up|1|||
94608038|NCT01920555|324030771|FG002|Overall Study|Lost to Follow-up|0|||
94608039|NCT01920555|324030772|FG003|Overall Study|Lost to Follow-up|1|||
94608040|NCT01920555|324030773|FG004|Overall Study|Lost to Follow-up|0|||
94661673|NCT00363766|324215803|FG001|Overall Study|Physician Decision|2|||
94358076|NCT04629534|323093234|FG001|Overall Study|Physician Decision|0|||
94608041|NCT02486302|324030776|FG000|Overall Study|Discontinued prematurely|410|||
94608042|NCT02486302|324030776|FG000|Overall Study|Documentation not completed|255|||
94608043|NCT02486302|324030776|FG000|Overall Study|Excluded due to legal reasons|8|||
94608044|NCT02486302|324030776|FG000|Overall Study|Not treated|3|||
94608045|NCT02213042|324030777|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
94608046|NCT02213042|324030778|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
94608047|NCT02213042|324030779|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
94608048|NCT02213042|324030777|FG000|Overall Study|Adverse Event|2|||
94252711|NCT00189488|322718702|FG001|Overall Study|Administrative Decision|2|||
94252712|NCT00189488|322718701|FG000|Overall Study|Death|5|||
94252713|NCT00189488|322718702|FG001|Overall Study|Death|8|||
94608049|NCT02213042|324030778|FG001|Overall Study|Adverse Event|1|||
94608050|NCT02213042|324030779|FG002|Overall Study|Adverse Event|0|||
94608051|NCT02213042|324030777|FG000|Overall Study|Withdrawal by Subject|0|||
94608052|NCT02213042|324030778|FG001|Overall Study|Withdrawal by Subject|1|||
94608053|NCT02213042|324030779|FG002|Overall Study|Withdrawal by Subject|1|||
94608054|NCT02213042|324030777|FG000|Overall Study|Protocol Violation|1|||
94608055|NCT02213042|324030778|FG001|Overall Study|Protocol Violation|0|||
94608056|NCT02213042|324030779|FG002|Overall Study|Protocol Violation|0|||
94608057|NCT02213042|324030777|FG000|Overall Study|Investigator discretion|0|||
94608058|NCT02213042|324030778|FG001|Overall Study|Investigator discretion|0|||
94608059|NCT02213042|324030779|FG002|Overall Study|Investigator discretion|1|||
94608060|NCT04416633|324030780|FG000|Overall Study|Death|1|||
94252714|NCT00189488|322718701|FG000|Overall Study|Other|1|||
94252715|NCT00189488|322718702|FG001|Overall Study|Other|0|||
94252716|NCT02924428|322718703|FG000|Overall Study|Adverse Event|1|||
94608061|NCT04416633|324030780|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
94608062|NCT04416633|324030780|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
94608063|NCT04416633|324030780|FG000|Overall Study|Adverse Event|6|||
94608064|NCT04416633|324030780|FG000|Overall Study|Withdrawal by Subject|6|||
94608065|NCT04622735|324030783|FG000|Overall Study|Lost to Follow-up|1|||
94608066|NCT04622735|324030784|FG001|Overall Study|Lost to Follow-up|2|||
94608067|NCT04622735|324030785|FG002|Overall Study|Lost to Follow-up|1|||
94608068|NCT04622735|324030783|FG000|Overall Study|Adverse Event|0|||
94608069|NCT04622735|324030784|FG001|Overall Study|Adverse Event|0|||
94608070|NCT04622735|324030785|FG002|Overall Study|Adverse Event|1|||
94608071|NCT04622735|324030783|FG000|Overall Study|Protocol Violation|1|||
94608072|NCT04622735|324030784|FG001|Overall Study|Protocol Violation|0|||
94608073|NCT04622735|324030785|FG002|Overall Study|Protocol Violation|0|||
94608074|NCT04612790|324030786|FG000|DB Period (Up to 36 Weeks)|Death|1|||
94608075|NCT04612790|324030787|FG001|DB Period (Up to 36 Weeks)|Death|1|||
94608076|NCT04612790|324030788|FG002|DB Period (Up to 36 Weeks)|Death|0|||
94608077|NCT04612790|324030789|FG003|DB Period (Up to 36 Weeks)|Death|0|||
94608078|NCT04612790|324030786|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
94608079|NCT04612790|324030787|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
94608080|NCT04612790|324030788|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
94608081|NCT04612790|324030789|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
94608082|NCT04612790|324030786|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
94608083|NCT04612790|324030787|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
94608084|NCT04612790|324030788|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
94608085|NCT04612790|324030789|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
94608086|NCT04612790|324030786|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
94608087|NCT04612790|324030787|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
94608088|NCT04612790|324030788|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
94608089|NCT04612790|324030789|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
94608090|NCT04612790|324030786|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
94608091|NCT04612790|324030787|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
94608092|NCT04612790|324030788|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
94608093|NCT04612790|324030789|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
94252717|NCT02924428|322718704|FG001|Overall Study|Adverse Event|0|||
94252718|NCT02924428|322718703|FG000|Overall Study|Physician Decision|1|||
94252719|NCT02924428|322718704|FG001|Overall Study|Physician Decision|0|||
94252720|NCT02924428|322718703|FG000|Overall Study|Lost to Follow-up|2|||
94252721|NCT02924428|322718704|FG001|Overall Study|Lost to Follow-up|4|||
94252722|NCT02924428|322718703|FG000|Overall Study|Pregnancy|0|||
94252723|NCT02924428|322718704|FG001|Overall Study|Pregnancy|1|||
94252724|NCT01248780|322718705|FG000|Overall Study|Lack of Efficacy|2|||
94608094|NCT04612790|324030786|FG000|DB Period (Up to 36 Weeks)|Other|1|||
94608095|NCT04612790|324030787|FG001|DB Period (Up to 36 Weeks)|Other|0|||
94608096|NCT04612790|324030788|FG002|DB Period (Up to 36 Weeks)|Other|0|||
94608097|NCT04612790|324030789|FG003|DB Period (Up to 36 Weeks)|Other|0|||
94608098|NCT04612790|324030786|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
94608099|NCT04612790|324030787|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
94608100|NCT04612790|324030788|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
94608101|NCT04612790|324030789|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
94608102|NCT04612790|324030786|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
94608103|NCT04612790|324030787|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
94608104|NCT04612790|324030788|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
94608105|NCT04612790|324030789|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
94608106|NCT04612790|324030786|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
94608107|NCT04612790|324030787|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
94608108|NCT04612790|324030788|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
94661674|NCT00558285|324215804|FG000|Overall Study|Adverse Event|1|||
94252725|NCT01248780|322718706|FG001|Overall Study|Lack of Efficacy|0|||
94252726|NCT01248780|322718705|FG000|Overall Study|Lost to Follow-up|0|||
94252727|NCT01248780|322718706|FG001|Overall Study|Lost to Follow-up|1|||
94252728|NCT01248780|322718705|FG000|Overall Study|Death|0|||
94252729|NCT01248780|322718706|FG001|Overall Study|Death|1|||
94252730|NCT01248780|322718705|FG000|Overall Study|Adverse Event|2|||
94252731|NCT01248780|322718706|FG001|Overall Study|Adverse Event|7|||
94252732|NCT01248780|322718705|FG000|Overall Study|Protocol Violation|1|||
94252733|NCT01248780|322718706|FG001|Overall Study|Protocol Violation|1|||
94252734|NCT01248780|322718705|FG000|Overall Study|Withdrawal by Subject|4|||
94252735|NCT01248780|322718706|FG001|Overall Study|Withdrawal by Subject|4|||
94252736|NCT01248780|322718705|FG000|Overall Study|Not treated|0|||
94608109|NCT04612790|324030789|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
94608110|NCT04612790|324030786|FG000|OLE Period (Up to 1 Year)|Other|0|||
94608111|NCT04612790|324030787|FG001|OLE Period (Up to 1 Year)|Other|0|||
94608112|NCT04612790|324030788|FG002|OLE Period (Up to 1 Year)|Other|0|||
94608113|NCT04612790|324030789|FG003|OLE Period (Up to 1 Year)|Other|1|||
94608114|NCT00761579|324030790|FG000|Overall Study|Adverse Event|10|||
94608115|NCT00761579|324030790|FG000|Overall Study|Death|2|||
94608116|NCT00761579|324030790|FG000|Overall Study|Lack of Efficacy|21|||
94608117|NCT00761579|324030790|FG000|Overall Study|Lost to Follow-up|16|||
94608118|NCT00761579|324030790|FG000|Overall Study|Pregnancy|1|||
94608119|NCT00761579|324030790|FG000|Overall Study|Withdrawal by Subject|34|||
94608120|NCT00761579|324030790|FG000|Overall Study|Lack of compliance|2|||
94608121|NCT00761579|324030790|FG000|Overall Study|Protocol deviation|1|||
94252737|NCT01248780|322718706|FG001|Overall Study|Not treated|1|||
94252738|NCT01227577|322718710|FG000|Overall Study|Protocol deviation|3|||
94358077|NCT04629534|323093233|FG000|Overall Study|Protocol Violation|0|||
94358078|NCT04629534|323093234|FG001|Overall Study|Protocol Violation|2|||
94358079|NCT02686749|323093237|FG000|Overall Study|terminated for poor enrollment|2|||
94358080|NCT02686749|323093238|FG001|Overall Study|terminated for poor enrollment|2|||
94358081|NCT00234533|323093241|FG000|Overall Study|Withdrawal by Subject|6|||
94358082|NCT00234533|323093241|FG000|Overall Study|Adverse Event|2|||
94358083|NCT00234533|323093241|FG000|Overall Study|Enrolled but not treated|3|||
94358084|NCT04784455|323093242|FG000|Overall Study|Death|4|||
94358085|NCT00859313|323093243|FG000|Overall Study|Lack of Efficacy|2|||
94358086|NCT00859313|323093243|FG000|Overall Study|Adverse Event|1|||
94358087|NCT00859313|323093243|FG000|Overall Study|staff error|1|||
94358088|NCT03792633|323093244|FG000|Overall Study|Alternative Treatment|17|||
94358089|NCT03792633|323093245|FG001|Overall Study|Alternative Treatment|19|||
94358090|NCT03792633|323093244|FG000|Overall Study|Death|2|||
94358091|NCT03792633|323093245|FG001|Overall Study|Death|0|||
94358092|NCT03792633|323093244|FG000|Overall Study|Disease progression|8|||
94358093|NCT03792633|323093245|FG001|Overall Study|Disease progression|9|||
94358094|NCT03792633|323093244|FG000|Overall Study|Lost to Follow-up|1|||
94608122|NCT00761579|324030790|FG000|Overall Study|Drug overdose|1|||
94608123|NCT00761579|324030790|FG000|Overall Study|Aggravation of depression|1|||
94608124|NCT00761579|324030790|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
94608125|NCT00761579|324030790|FG000|Overall Study|Lost survey form|1|||
94608126|NCT00761579|324030790|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
94608127|NCT03611010|324030791|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
94608128|NCT03611010|324030792|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
94608129|NCT03611010|324030793|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
94608130|NCT03611010|324030794|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
94608131|NCT00598702|324030795|FG000|Overall Study|Other|0|||
94608132|NCT00598702|324030796|FG001|Overall Study|Other|2|||
94608133|NCT00598702|324030797|FG002|Overall Study|Other|0|||
94608134|NCT00598702|324030798|FG003|Overall Study|Other|0|||
94608135|NCT00598702|324030799|FG004|Overall Study|Other|0|||
94608136|NCT00598702|324030800|FG005|Overall Study|Other|1|||
94608137|NCT00598702|324030801|FG006|Overall Study|Other|0|||
94608138|NCT00598702|324030802|FG007|Overall Study|Other|0|||
94252739|NCT01227577|322718710|FG000|Overall Study|Death|3|||
94358095|NCT03792633|323093245|FG001|Overall Study|Lost to Follow-up|1|||
94358096|NCT03792633|323093244|FG000|Overall Study|Screen fail|1|||
94358097|NCT03792633|323093245|FG001|Overall Study|Screen fail|0|||
94358098|NCT03792633|323093244|FG000|Overall Study|Second malignancy|0|||
94358099|NCT03792633|323093245|FG001|Overall Study|Second malignancy|1|||
94608139|NCT00598702|324030795|FG000|Overall Study|Early discharge from hospital|0|||
94608140|NCT00598702|324030796|FG001|Overall Study|Early discharge from hospital|0|||
94608141|NCT00598702|324030797|FG002|Overall Study|Early discharge from hospital|2|||
94608142|NCT00598702|324030798|FG003|Overall Study|Early discharge from hospital|5|||
94608143|NCT00598702|324030799|FG004|Overall Study|Early discharge from hospital|0|||
94608144|NCT00598702|324030800|FG005|Overall Study|Early discharge from hospital|10|||
94608145|NCT00598702|324030801|FG006|Overall Study|Early discharge from hospital|1|||
94608146|NCT00598702|324030802|FG007|Overall Study|Early discharge from hospital|0|||
94608147|NCT00598702|324030795|FG000|Overall Study|Adverse Event|0|||
94252740|NCT01227577|322718710|FG000|Overall Study|Administrative problems|2|||
94252741|NCT01227577|322718710|FG000|Overall Study|Lost to Follow-up|1|||
94358100|NCT03901274|323093246|FG000|Overall Study|Lost to Follow-up|120|||
94608148|NCT00598702|324030796|FG001|Overall Study|Adverse Event|0|||
94608149|NCT00598702|324030797|FG002|Overall Study|Adverse Event|0|||
94608150|NCT00598702|324030798|FG003|Overall Study|Adverse Event|1|||
94608151|NCT00598702|324030799|FG004|Overall Study|Adverse Event|0|||
94608152|NCT00598702|324030800|FG005|Overall Study|Adverse Event|0|||
94608153|NCT00598702|324030801|FG006|Overall Study|Adverse Event|0|||
94608154|NCT00598702|324030802|FG007|Overall Study|Adverse Event|0|||
94608155|NCT00598702|324030795|FG000|Overall Study|Withdrawal by Subject|0|||
94608156|NCT00598702|324030796|FG001|Overall Study|Withdrawal by Subject|0|||
94608157|NCT00598702|324030797|FG002|Overall Study|Withdrawal by Subject|0|||
94608158|NCT00598702|324030798|FG003|Overall Study|Withdrawal by Subject|1|||
94608159|NCT00598702|324030799|FG004|Overall Study|Withdrawal by Subject|1|||
94608160|NCT00598702|324030800|FG005|Overall Study|Withdrawal by Subject|0|||
94608161|NCT00598702|324030801|FG006|Overall Study|Withdrawal by Subject|0|||
94608162|NCT00598702|324030802|FG007|Overall Study|Withdrawal by Subject|0|||
94608163|NCT00598702|324030795|FG000|Overall Study|Physician Decision|0|||
94608164|NCT00598702|324030796|FG001|Overall Study|Physician Decision|0|||
94608165|NCT00598702|324030797|FG002|Overall Study|Physician Decision|0|||
94608166|NCT00598702|324030798|FG003|Overall Study|Physician Decision|0|||
94608167|NCT00598702|324030799|FG004|Overall Study|Physician Decision|1|||
94608168|NCT00598702|324030800|FG005|Overall Study|Physician Decision|0|||
94608169|NCT00598702|324030801|FG006|Overall Study|Physician Decision|0|||
94608170|NCT00598702|324030802|FG007|Overall Study|Physician Decision|0|||
94608171|NCT00598702|324030795|FG000|Overall Study|Dose limiting toxicity|0|||
94608172|NCT00598702|324030796|FG001|Overall Study|Dose limiting toxicity|0|||
94608173|NCT00598702|324030797|FG002|Overall Study|Dose limiting toxicity|0|||
94608174|NCT00598702|324030798|FG003|Overall Study|Dose limiting toxicity|1|||
94608175|NCT00598702|324030799|FG004|Overall Study|Dose limiting toxicity|1|||
94608176|NCT00598702|324030800|FG005|Overall Study|Dose limiting toxicity|1|||
94608177|NCT00598702|324030801|FG006|Overall Study|Dose limiting toxicity|0|||
94608178|NCT00598702|324030802|FG007|Overall Study|Dose limiting toxicity|0|||
94608179|NCT00950911|324030803|FG000|Overall Study|Adverse Event|0|||
94608180|NCT00950911|324030804|FG001|Overall Study|Adverse Event|2|||
94608181|NCT00950911|324030803|FG000|Overall Study|Death|4|||
94608182|NCT00950911|324030804|FG001|Overall Study|Death|6|||
94608183|NCT00950911|324030803|FG000|Overall Study|Disease progression|2|||
94608184|NCT00950911|324030804|FG001|Overall Study|Disease progression|2|||
94608185|NCT00950911|324030803|FG000|Overall Study|Consent withdrawn|1|||
94608186|NCT00950911|324030804|FG001|Overall Study|Consent withdrawn|3|||
94608187|NCT00950911|324030803|FG000|Overall Study|Administrative decision|3|||
94608188|NCT00950911|324030804|FG001|Overall Study|Administrative decision|1|||
94608189|NCT00950911|324030803|FG000|Overall Study|Ineligibility determined|1|||
94608190|NCT00950911|324030804|FG001|Overall Study|Ineligibility determined|0|||
94608191|NCT00950911|324030803|FG000|Overall Study|Noncompliance|1|||
94608192|NCT00950911|324030804|FG001|Overall Study|Noncompliance|0|||
94608193|NCT00950911|324030803|FG000|Overall Study|Poor performance status|0|||
94608194|NCT00950911|324030804|FG001|Overall Study|Poor performance status|1|||
94608195|NCT02063880|324030807|FG000|Overall Study|Death|21|||
94608196|NCT02063880|324030808|FG001|Overall Study|Death|18|||
94608197|NCT02063880|324030807|FG000|Overall Study|Lost to Follow-up|7|||
94608198|NCT02063880|324030808|FG001|Overall Study|Lost to Follow-up|7|||
94608199|NCT02063880|324030807|FG000|Overall Study|Ineligible|0|||
94608200|NCT02063880|324030808|FG001|Overall Study|Ineligible|2|||
94608201|NCT02106910|324030809|FG000|Overall Study|Lost to Follow-up|1|||
94608202|NCT02106910|324030810|FG001|Overall Study|Lost to Follow-up|1|||
94608203|NCT04087213|324030811|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
94608204|NCT04087213|324030811|FG000|In-Facility Introduction|Adverse Event|1|||
94608205|NCT04087213|324030811|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
94608206|NCT04087213|324030811|FG000|Assisted Evaluable Period|Personal reasons|3|||
94608207|NCT04087213|324030811|FG000|Transition Period B|Renal Transplantation|1|||
94608208|NCT01859143|324030812|FG000|Overall Study|Lost to Follow-up|2|||
94608209|NCT01859143|324030813|FG001|Overall Study|Lost to Follow-up|0|||
94608210|NCT02556203|324030820|FG000|Overall Study|Withdrawal by Subject|21|||
94608211|NCT02556203|324030821|FG001|Overall Study|Withdrawal by Subject|21|||
94608212|NCT02556203|324030820|FG000|Overall Study|Lost to Follow-up|5|||
94608213|NCT02556203|324030821|FG001|Overall Study|Lost to Follow-up|5|||
94608214|NCT02556203|324030820|FG000|Overall Study|Adverse Event|1|||
94608215|NCT02556203|324030821|FG001|Overall Study|Adverse Event|0|||
94608216|NCT04327674|324030824|FG000|Overall Study|Protocol Violation|19|||
94608217|NCT02642029|324030825|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
94608218|NCT02642029|324030826|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
94608219|NCT02642029|324030827|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
94608220|NCT02642029|324030828|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
94608221|NCT02642029|324030829|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
94608222|NCT02642029|324030830|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
94661675|NCT00558285|324215805|FG001|Overall Study|Adverse Event|1|||
94661676|NCT00558285|324215806|FG002|Overall Study|Adverse Event|4|||
94661677|NCT00558285|324215807|FG003|Overall Study|Adverse Event|1|||
94661678|NCT00558285|324215808|FG004|Overall Study|Adverse Event|2|||
94661679|NCT00558285|324215804|FG000|Overall Study|Abnormal test procedure result(s)|1|||
94661680|NCT00558285|324215805|FG001|Overall Study|Abnormal test procedure result(s)|0|||
94661681|NCT00558285|324215806|FG002|Overall Study|Abnormal test procedure result(s)|0|||
94661682|NCT00558285|324215807|FG003|Overall Study|Abnormal test procedure result(s)|0|||
94661683|NCT00558285|324215808|FG004|Overall Study|Abnormal test procedure result(s)|0|||
94661684|NCT00558285|324215804|FG000|Overall Study|Subject withdrew consent|2|||
94661685|NCT00558285|324215805|FG001|Overall Study|Subject withdrew consent|0|||
94358101|NCT03901274|323093247|FG001|Overall Study|Lost to Follow-up|124|||
94358102|NCT03901274|323093246|FG000|Overall Study|Withdrawal by Subject|0|||
94358103|NCT03901274|323093247|FG001|Overall Study|Withdrawal by Subject|6|||
94358104|NCT05570604|323093248|FG000|Overall Study|Lost to Follow-up|1|||
94358105|NCT05570604|323093249|FG001|Overall Study|Lost to Follow-up|5|||
94358106|NCT05570604|323093248|FG000|Overall Study|Illness|2|||
94358107|NCT05570604|323093249|FG001|Overall Study|Illness|2|||
94358108|NCT04527380|323093252|FG000|Overall Study|Lack of Efficacy|0|||
94358109|NCT04527380|323093253|FG001|Overall Study|Lack of Efficacy|1|||
94358110|NCT04527380|323093252|FG000|Overall Study|Withdrawal by Subject|1|||
94358111|NCT04527380|323093253|FG001|Overall Study|Withdrawal by Subject|0|||
94358112|NCT04479358|323093254|FG000|Overall Study|Withdrawal by Subject|0|||
94358113|NCT04479358|323093255|FG001|Overall Study|Withdrawal by Subject|0|||
94358114|NCT04479358|323093256|FG002|Overall Study|Withdrawal by Subject|1|||
94358115|NCT04479358|323093257|FG003|Overall Study|Withdrawal by Subject|0|||
94358116|NCT04479358|323093258|FG004|Overall Study|Withdrawal by Subject|0|||
94358117|NCT04479358|323093259|FG005|Overall Study|Withdrawal by Subject|1|||
94358118|NCT05048875|323093260|FG000|Overall Study|Withdrawal by Subject|1|||
94358119|NCT05048875|323093261|FG001|Overall Study|Withdrawal by Subject|0|||
94358120|NCT05048875|323093262|FG002|Overall Study|Withdrawal by Subject|0|||
94358121|NCT05048875|323093263|FG003|Overall Study|Withdrawal by Subject|0|||
94358122|NCT05048875|323093264|FG004|Overall Study|Withdrawal by Subject|0|||
94358123|NCT05048875|323093265|FG005|Overall Study|Withdrawal by Subject|0|||
94358124|NCT05048875|323093266|FG006|Overall Study|Withdrawal by Subject|0|||
94358125|NCT05048875|323093267|FG007|Overall Study|Withdrawal by Subject|0|||
94358126|NCT05048875|323093260|FG000|Overall Study|Adverse Event|0|||
94358127|NCT05048875|323093261|FG001|Overall Study|Adverse Event|0|||
94358128|NCT05048875|323093262|FG002|Overall Study|Adverse Event|0|||
94358129|NCT05048875|323093263|FG003|Overall Study|Adverse Event|1|||
94358130|NCT05048875|323093264|FG004|Overall Study|Adverse Event|0|||
94358131|NCT05048875|323093265|FG005|Overall Study|Adverse Event|0|||
94358132|NCT05048875|323093266|FG006|Overall Study|Adverse Event|0|||
94358133|NCT05048875|323093267|FG007|Overall Study|Adverse Event|0|||
94358134|NCT02255422|323093271|FG000|Overall Study|Withdrawal by Subject|0|||
94358135|NCT02255422|323093272|FG001|Overall Study|Withdrawal by Subject|0|||
94358136|NCT02255422|323093273|FG002|Overall Study|Withdrawal by Subject|0|||
94358137|NCT02255422|323093274|FG003|Overall Study|Withdrawal by Subject|0|||
94358138|NCT02255422|323093275|FG004|Overall Study|Withdrawal by Subject|0|||
94358139|NCT02255422|323093276|FG005|Overall Study|Withdrawal by Subject|0|||
94358140|NCT02255422|323093277|FG006|Overall Study|Withdrawal by Subject|2|||
94358141|NCT02255422|323093271|FG000|Overall Study|Lost to Follow-up|0|||
94358142|NCT02255422|323093272|FG001|Overall Study|Lost to Follow-up|0|||
94358143|NCT02255422|323093273|FG002|Overall Study|Lost to Follow-up|1|||
94358144|NCT02255422|323093274|FG003|Overall Study|Lost to Follow-up|0|||
94358145|NCT02255422|323093275|FG004|Overall Study|Lost to Follow-up|0|||
94358146|NCT02255422|323093276|FG005|Overall Study|Lost to Follow-up|0|||
94358147|NCT02255422|323093277|FG006|Overall Study|Lost to Follow-up|0|||
94358148|NCT01802281|323093278|FG000|Overall Study|Death|1|||
94358149|NCT01802281|323093279|FG001|Overall Study|Death|2|||
94358150|NCT01802281|323093278|FG000|Overall Study|Withdrawal by Subject|2|||
94358151|NCT01802281|323093279|FG001|Overall Study|Withdrawal by Subject|1|||
94358152|NCT01802281|323093278|FG000|Overall Study|Ineligible|5|||
94608223|NCT02642029|324030825|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
94608224|NCT02642029|324030826|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
94608225|NCT02642029|324030827|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
94608226|NCT02642029|324030828|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
94608227|NCT02642029|324030829|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
94608228|NCT02642029|324030830|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
94608229|NCT02642029|324030825|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
94661686|NCT00558285|324215806|FG002|Overall Study|Subject withdrew consent|1|||
94358153|NCT01802281|323093279|FG001|Overall Study|Ineligible|3|||
94358154|NCT03282123|323093280|FG000|Overall Study|Withdrawal by Subject|5|||
94358155|NCT05643573|323093281|FG000|Overall Study|Adverse Event|117|||
94608230|NCT02642029|324030826|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
94608231|NCT02642029|324030827|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
94608232|NCT02642029|324030828|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
94608233|NCT02642029|324030829|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
94608234|NCT02642029|324030830|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
94608235|NCT02642029|324030825|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
94608236|NCT02642029|324030826|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
94608237|NCT02642029|324030827|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
94608238|NCT02642029|324030828|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
94608239|NCT02642029|324030829|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
94608240|NCT02642029|324030830|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
94608241|NCT02642029|324030825|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
94608242|NCT02642029|324030826|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
94608243|NCT02642029|324030827|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
94608244|NCT02642029|324030828|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
94608245|NCT02642029|324030829|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
94608246|NCT02642029|324030830|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
94608247|NCT02642029|324030825|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
94608248|NCT02642029|324030826|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
94608249|NCT02642029|324030827|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
94608250|NCT02642029|324030828|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
94608251|NCT02642029|324030829|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
94608252|NCT02642029|324030830|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
94608253|NCT02477839|324030831|FG000|Overall Study|Adverse Event|0|||
94608254|NCT02477839|324030832|FG001|Overall Study|Adverse Event|1|||
94608255|NCT02477839|324030831|FG000|Overall Study|Protocol Violation|0|||
94608256|NCT02477839|324030832|FG001|Overall Study|Protocol Violation|2|||
94608257|NCT02477839|324030831|FG000|Overall Study|Withdrawal by Subject|3|||
94608258|NCT02477839|324030832|FG001|Overall Study|Withdrawal by Subject|3|||
94608259|NCT02477839|324030831|FG000|Overall Study|Participant had PGS during V6|0|||
94608260|NCT02477839|324030832|FG001|Overall Study|Participant had PGS during V6|1|||
94608261|NCT02477839|324030831|FG000|Overall Study|Parents decided to stop medication|0|||
94608262|NCT02477839|324030832|FG001|Overall Study|Parents decided to stop medication|1|||
94608263|NCT02477839|324030831|FG000|Overall Study|Lack of tolerability|0|||
94608264|NCT02477839|324030832|FG001|Overall Study|Lack of tolerability|1|||
94608265|NCT02477839|324030831|FG000|Overall Study|Exclusion criterion|0|||
94608266|NCT02477839|324030832|FG001|Overall Study|Exclusion criterion|1|||
94608267|NCT01439568|324030839|FG000|Overall Study|Lost to Follow-up|1|||
94608268|NCT01439568|324030840|FG001|Overall Study|Lost to Follow-up|0|||
94608269|NCT01439568|324030839|FG000|Overall Study|Withdrawal by Subject|2|||
94608270|NCT01439568|324030840|FG001|Overall Study|Withdrawal by Subject|2|||
94608271|NCT03845543|324030841|FG000|Overall Study|Death|25|||
94608272|NCT03845543|324030841|FG000|Overall Study|Withdrawal by Subject|2|||
94608273|NCT03845543|324030841|FG000|Overall Study|Lost to Follow-up|12|||
94608274|NCT03845543|324030841|FG000|Overall Study|Adverse Event|17|||
94608275|NCT02456103|324030842|FG000|Overall Study|Study Closure|207|||
94608276|NCT02456103|324030842|FG000|Overall Study|Physician Decision|1|||
94608277|NCT02456103|324030842|FG000|Overall Study|Required prohibited medications|5|||
94608278|NCT02456103|324030842|FG000|Overall Study|Protocol Violation|1|||
94608279|NCT02456103|324030842|FG000|Overall Study|Adverse Event|5|||
94608280|NCT02456103|324030842|FG000|Overall Study|Abnormal Laboratory Value|2|||
94608281|NCT02456103|324030842|FG000|Overall Study|Lost to Follow-up|1|||
94608282|NCT02456103|324030842|FG000|Overall Study|Withdrawal by Subject|24|||
94608283|NCT02448810|324030847|FG000|Overall Study|Adverse Event|0|||
94608284|NCT02448810|324030848|FG001|Overall Study|Adverse Event|0|||
94608285|NCT02448810|324030849|FG002|Overall Study|Adverse Event|1|||
94608286|NCT02448810|324030850|FG003|Overall Study|Adverse Event|0|||
94608287|NCT02448810|324030851|FG004|Overall Study|Adverse Event|0|||
94608288|NCT02448810|324030852|FG005|Overall Study|Adverse Event|0|||
94608289|NCT02448810|324030853|FG006|Overall Study|Adverse Event|0|||
94608290|NCT02448810|324030854|FG007|Overall Study|Adverse Event|0|||
94608291|NCT02448810|324030847|FG000|Overall Study|Withdrawal by Subject|0|||
94608292|NCT02448810|324030848|FG001|Overall Study|Withdrawal by Subject|0|||
94608293|NCT02448810|324030849|FG002|Overall Study|Withdrawal by Subject|1|||
94608294|NCT02448810|324030850|FG003|Overall Study|Withdrawal by Subject|0|||
94608295|NCT02448810|324030851|FG004|Overall Study|Withdrawal by Subject|3|||
94608296|NCT02448810|324030852|FG005|Overall Study|Withdrawal by Subject|5|||
94608297|NCT02448810|324030853|FG006|Overall Study|Withdrawal by Subject|0|||
94608298|NCT02448810|324030854|FG007|Overall Study|Withdrawal by Subject|2|||
94608299|NCT02448810|324030847|FG000|Overall Study|Other (study terminated by sponsor)|0|||
94608300|NCT02448810|324030848|FG001|Overall Study|Other (study terminated by sponsor)|0|||
94608301|NCT02448810|324030849|FG002|Overall Study|Other (study terminated by sponsor)|0|||
94608302|NCT02448810|324030850|FG003|Overall Study|Other (study terminated by sponsor)|0|||
94608303|NCT02448810|324030851|FG004|Overall Study|Other (study terminated by sponsor)|4|||
94608304|NCT02448810|324030852|FG005|Overall Study|Other (study terminated by sponsor)|2|||
94608305|NCT02448810|324030853|FG006|Overall Study|Other (study terminated by sponsor)|2|||
94608306|NCT02448810|324030854|FG007|Overall Study|Other (study terminated by sponsor)|1|||
94608307|NCT02448810|324030847|FG000|Overall Study|Death|1|||
94608308|NCT02448810|324030848|FG001|Overall Study|Death|0|||
94608309|NCT02448810|324030849|FG002|Overall Study|Death|1|||
94608310|NCT02448810|324030850|FG003|Overall Study|Death|0|||
94608311|NCT02448810|324030851|FG004|Overall Study|Death|1|||
94608312|NCT02448810|324030852|FG005|Overall Study|Death|0|||
94608313|NCT02448810|324030853|FG006|Overall Study|Death|0|||
94608314|NCT02448810|324030854|FG007|Overall Study|Death|0|||
94608315|NCT02448810|324030847|FG000|Overall Study|Other (Progressive disease)|2|||
94608316|NCT02448810|324030848|FG001|Overall Study|Other (Progressive disease)|2|||
94608317|NCT02448810|324030849|FG002|Overall Study|Other (Progressive disease)|0|||
94608318|NCT02448810|324030850|FG003|Overall Study|Other (Progressive disease)|3|||
94608319|NCT02448810|324030851|FG004|Overall Study|Other (Progressive disease)|23|||
94608320|NCT02448810|324030852|FG005|Overall Study|Other (Progressive disease)|9|||
94608321|NCT02448810|324030853|FG006|Overall Study|Other (Progressive disease)|14|||
94608322|NCT02448810|324030854|FG007|Overall Study|Other (Progressive disease)|5|||
94608323|NCT02448810|324030847|FG000|Overall Study|Lost to Follow-up|0|||
94608324|NCT02448810|324030848|FG001|Overall Study|Lost to Follow-up|1|||
94608325|NCT02448810|324030849|FG002|Overall Study|Lost to Follow-up|0|||
94608326|NCT02448810|324030850|FG003|Overall Study|Lost to Follow-up|0|||
94608327|NCT02448810|324030851|FG004|Overall Study|Lost to Follow-up|0|||
94608328|NCT02448810|324030852|FG005|Overall Study|Lost to Follow-up|0|||
94608329|NCT02448810|324030853|FG006|Overall Study|Lost to Follow-up|0|||
94608330|NCT02448810|324030854|FG007|Overall Study|Lost to Follow-up|0|||
94608331|NCT02448810|324030847|FG000|Overall Study|Other (unspecified)|0|||
94608332|NCT02448810|324030848|FG001|Overall Study|Other (unspecified)|0|||
94608333|NCT02448810|324030849|FG002|Overall Study|Other (unspecified)|0|||
94608334|NCT02448810|324030850|FG003|Overall Study|Other (unspecified)|0|||
94608335|NCT02448810|324030851|FG004|Overall Study|Other (unspecified)|0|||
94608336|NCT02448810|324030852|FG005|Overall Study|Other (unspecified)|0|||
94608337|NCT02448810|324030853|FG006|Overall Study|Other (unspecified)|2|||
94608338|NCT02448810|324030854|FG007|Overall Study|Other (unspecified)|0|||
94608339|NCT00568685|324030859|FG000|Overall Study|Adverse Event|2|||
94608340|NCT00568685|324030860|FG001|Overall Study|Adverse Event|3|||
94608341|NCT00568685|324030861|FG002|Overall Study|Adverse Event|3|||
94608342|NCT00568685|324030859|FG000|Overall Study|Withdrawal by Subject|7|||
94608343|NCT00568685|324030860|FG001|Overall Study|Withdrawal by Subject|2|||
94608344|NCT00568685|324030861|FG002|Overall Study|Withdrawal by Subject|2|||
94608345|NCT00568685|324030859|FG000|Overall Study|Protocol Violation|1|||
94608346|NCT00568685|324030860|FG001|Overall Study|Protocol Violation|0|||
94608347|NCT00568685|324030861|FG002|Overall Study|Protocol Violation|0|||
94608348|NCT01462227|324030863|FG000|Second Assignment|Lost to Follow-up|1|||
94608349|NCT01462227|324030864|FG001|Second Assignment|Lost to Follow-up|0|||
94252742|NCT01227577|322718710|FG000|Overall Study|Withdrawal by Subject|4|||
94252743|NCT01227577|322718710|FG000|Overall Study|Lack of Efficacy|5|||
94608350|NCT01462227|324030865|FG002|Second Assignment|Lost to Follow-up|0|||
94608351|NCT01462227|324030866|FG003|Second Assignment|Lost to Follow-up|0|||
94608352|NCT01462227|324030863|FG000|Second Assignment|Protocol Violation|0|||
94608353|NCT01462227|324030864|FG001|Second Assignment|Protocol Violation|1|||
94608354|NCT01462227|324030865|FG002|Second Assignment|Protocol Violation|1|||
94608355|NCT01462227|324030866|FG003|Second Assignment|Protocol Violation|0|||
94608356|NCT00591266|324030870|FG000|Overall Study|Adverse Event|2|||
94608357|NCT00591266|324030871|FG001|Overall Study|Adverse Event|2|||
94608358|NCT00591266|324030872|FG002|Overall Study|Adverse Event|3|||
94608359|NCT00591266|324030870|FG000|Overall Study|Lost to Follow-up|0|||
94608360|NCT00591266|324030871|FG001|Overall Study|Lost to Follow-up|1|||
94608361|NCT00591266|324030872|FG002|Overall Study|Lost to Follow-up|0|||
94252744|NCT01227577|322718710|FG000|Overall Study|Adverse Event|17|||
94608362|NCT00591266|324030870|FG000|Overall Study|Protocol Violation|0|||
94608363|NCT00591266|324030871|FG001|Overall Study|Protocol Violation|0|||
94608364|NCT00591266|324030872|FG002|Overall Study|Protocol Violation|1|||
94608365|NCT00591266|324030870|FG000|Overall Study|Withdrawal by Subject|6|||
94608366|NCT00591266|324030871|FG001|Overall Study|Withdrawal by Subject|2|||
94608367|NCT00591266|324030872|FG002|Overall Study|Withdrawal by Subject|5|||
94608368|NCT00591266|324030870|FG000|Overall Study|Lack of Efficacy|0|||
94608369|NCT00591266|324030871|FG001|Overall Study|Lack of Efficacy|2|||
94608370|NCT00591266|324030872|FG002|Overall Study|Lack of Efficacy|0|||
94608371|NCT00591266|324030870|FG000|Overall Study|Other|1|||
94608372|NCT00591266|324030871|FG001|Overall Study|Other|4|||
94608373|NCT00591266|324030872|FG002|Overall Study|Other|5|||
94608374|NCT05298306|324030874|FG000|Overall Study|Physician Decision|0|||
94608375|NCT05298306|324030875|FG001|Overall Study|Physician Decision|0|||
94608376|NCT05298306|324030876|FG002|Overall Study|Physician Decision|0|||
94608377|NCT05298306|324030877|FG003|Overall Study|Physician Decision|1|||
94608378|NCT05298306|324030878|FG004|Overall Study|Physician Decision|0|||
94608379|NCT05298306|324030879|FG005|Overall Study|Physician Decision|0|||
94608380|NCT01697358|324030882|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
94608381|NCT01697358|324030883|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
94608382|NCT01697358|324030882|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
94608383|NCT01697358|324030883|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
94608384|NCT01697358|324030882|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
94608385|NCT01697358|324030883|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
94608386|NCT01697358|324030882|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
94608387|NCT01697358|324030883|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
94608388|NCT01697358|324030882|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
94608389|NCT01697358|324030883|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
94608390|NCT01697358|324030882|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
94608391|NCT01697358|324030883|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
94608392|NCT01697358|324030882|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
94608393|NCT01697358|324030883|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
94608394|NCT01697358|324030882|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
94608395|NCT01697358|324030883|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
94608396|NCT01697358|324030882|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
94608397|NCT01697358|324030883|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
94608398|NCT01697358|324030882|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
94608399|NCT01697358|324030883|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
94608400|NCT00620464|324030884|FG000|Overall Study|Adverse Event|15|||
94608401|NCT00620464|324030885|FG001|Overall Study|Adverse Event|17|||
94608402|NCT00620464|324030884|FG000|Overall Study|Lost to Follow-up|1|||
94608403|NCT00620464|324030885|FG001|Overall Study|Lost to Follow-up|1|||
94608404|NCT00620464|324030884|FG000|Overall Study|Planning Pregnancy|1|||
94608405|NCT00620464|324030885|FG001|Overall Study|Planning Pregnancy|4|||
94608406|NCT00620464|324030884|FG000|Overall Study|Personal|2|||
94608407|NCT00620464|324030885|FG001|Overall Study|Personal|2|||
94608408|NCT00620464|324030884|FG000|Overall Study|Used prohibited medication|1|||
94608409|NCT00620464|324030885|FG001|Overall Study|Used prohibited medication|0|||
94608410|NCT00586066|324030886|FG000|Overall Study|Lost to Follow-up|6|||
94608411|NCT00586066|324030887|FG001|Overall Study|Lost to Follow-up|3|||
94608412|NCT00586066|324030886|FG000|Overall Study|Lack of Efficacy|5|||
94608413|NCT00586066|324030887|FG001|Overall Study|Lack of Efficacy|3|||
94608414|NCT00586066|324030886|FG000|Overall Study|Adverse Event|2|||
94608415|NCT00586066|324030887|FG001|Overall Study|Adverse Event|2|||
94608416|NCT00586066|324030886|FG000|Overall Study|Physician Decision|1|||
94608417|NCT00586066|324030887|FG001|Overall Study|Physician Decision|0|||
94608418|NCT00586066|324030886|FG000|Overall Study|Withdrawal of consent|4|||
94608419|NCT00586066|324030887|FG001|Overall Study|Withdrawal of consent|2|||
94608420|NCT03139279|324030888|FG000|Overall Study|Physician Decision|2|||
94608421|NCT03139279|324030889|FG001|Overall Study|Physician Decision|0|||
94608422|NCT03139279|324030888|FG000|Overall Study|Protocol Violation|5|||
94608423|NCT03139279|324030889|FG001|Overall Study|Protocol Violation|4|||
94459310|NCT04713592|323469600|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
94608424|NCT03139279|324030888|FG000|Overall Study|Withdrawal by Subject|0|||
94608425|NCT03139279|324030889|FG001|Overall Study|Withdrawal by Subject|2|||
94608426|NCT02035475|324030901|FG000|Overall Study|Withdrawal by Subject|4|||
94608427|NCT02035475|324030901|FG000|Overall Study|Physician Decision|1|||
94608428|NCT02035475|324030901|FG000|Overall Study|Equipment Error|1|||
94608429|NCT01977937|324030902|FG000|Overall Study|Withdrawal by Subject|2|||
94608430|NCT01977937|324030903|FG001|Overall Study|Withdrawal by Subject|1|||
94608431|NCT01977937|324030902|FG000|Overall Study|Adverse Event|1|||
94608432|NCT01977937|324030903|FG001|Overall Study|Adverse Event|0|||
94608433|NCT01977937|324030902|FG000|Overall Study|Physician Decision|0|||
94608434|NCT01977937|324030903|FG001|Overall Study|Physician Decision|1|||
94608435|NCT03004443|324030904|FG000|Overall Study|Pregnancy|0|||
94608436|NCT03004443|324030905|FG001|Overall Study|Pregnancy|1|||
94608437|NCT00191646|324030906|FG000|Overall Study|Toxicity|26|||
94608438|NCT00191646|324030907|FG001|Overall Study|Toxicity|37|||
94608439|NCT00191646|324030906|FG000|Overall Study|Disease Progression|5|||
94608440|NCT00191646|324030907|FG001|Overall Study|Disease Progression|6|||
94608441|NCT00191646|324030906|FG000|Overall Study|Physician Decision|20|||
94608442|NCT00191646|324030907|FG001|Overall Study|Physician Decision|11|||
94608443|NCT00191646|324030906|FG000|Overall Study|Withdrawal by Subject|58|||
94608444|NCT00191646|324030907|FG001|Overall Study|Withdrawal by Subject|39|||
94608445|NCT00191646|324030906|FG000|Overall Study|Protocol Violation|5|||
94608446|NCT00191646|324030907|FG001|Overall Study|Protocol Violation|7|||
94608447|NCT00191646|324030906|FG000|Overall Study|Death|6|||
94608448|NCT00191646|324030907|FG001|Overall Study|Death|8|||
94608449|NCT00191646|324030906|FG000|Overall Study|Other|33|||
94608450|NCT00191646|324030907|FG001|Overall Study|Other|34|||
94608451|NCT00191646|324030906|FG000|Overall Study|Missing Data|18|||
94608452|NCT00191646|324030907|FG001|Overall Study|Missing Data|11|||
94608453|NCT01346969|324030913|FG000|Overall Study|Withdrawal by Subject|0|||
94608454|NCT01346969|324030914|FG001|Overall Study|Withdrawal by Subject|0|||
94608455|NCT01346969|324030915|FG002|Overall Study|Withdrawal by Subject|1|||
94608456|NCT01346969|324030916|FG003|Overall Study|Withdrawal by Subject|0|||
94608457|NCT01346969|324030913|FG000|Overall Study|Lost to Follow-up|1|||
94608458|NCT01346969|324030914|FG001|Overall Study|Lost to Follow-up|0|||
94608459|NCT01346969|324030915|FG002|Overall Study|Lost to Follow-up|2|||
94608460|NCT01346969|324030916|FG003|Overall Study|Lost to Follow-up|0|||
94608461|NCT01346969|324030913|FG000|Overall Study|Physician Decision|0|||
94608462|NCT01346969|324030914|FG001|Overall Study|Physician Decision|0|||
94608463|NCT01346969|324030915|FG002|Overall Study|Physician Decision|0|||
94608464|NCT01346969|324030916|FG003|Overall Study|Physician Decision|1|||
94608465|NCT01346969|324030913|FG000|Overall Study|Randomized but not treated|1|||
94608466|NCT01346969|324030914|FG001|Overall Study|Randomized but not treated|0|||
94608467|NCT01346969|324030915|FG002|Overall Study|Randomized but not treated|0|||
94608468|NCT01346969|324030916|FG003|Overall Study|Randomized but not treated|0|||
94608469|NCT00932737|324030921|FG000|Overall Study|Not treated in second episode|1|||
94608470|NCT00932737|324030922|FG001|Overall Study|Not treated in second episode|0|||
94608471|NCT00932737|324030921|FG000|Overall Study|Adverse Event|0|||
94608472|NCT00932737|324030922|FG001|Overall Study|Adverse Event|1|||
94608473|NCT05156073|324030923|FG000|Overall Study|Patient canceled appointment with PCP|1|||
94608474|NCT04399837|324030924|FG000|Overall Study|Other than listed|0|||
94608475|NCT04399837|324030925|FG001|Overall Study|Other than listed|2|||
94608476|NCT04399837|324030926|FG002|Overall Study|Other than listed|2|||
94608477|NCT04399837|324030927|FG003|Overall Study|Other than listed|3|||
94608478|NCT04399837|324030924|FG000|Overall Study|Withdrawal by Subject|1|||
94608479|NCT04399837|324030925|FG001|Overall Study|Withdrawal by Subject|2|||
94608480|NCT04399837|324030926|FG002|Overall Study|Withdrawal by Subject|1|||
94608481|NCT04399837|324030927|FG003|Overall Study|Withdrawal by Subject|1|||
94608482|NCT04176705|324030928|FG000|Overall Study|Withdrawal by Subject|4|||
94459311|NCT04713592|323469601|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
94459312|NCT04713592|323469602|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
94608483|NCT04176705|324030929|FG001|Overall Study|Withdrawal by Subject|4|||
94608484|NCT04176705|324030928|FG000|Overall Study|Death|1|||
94608485|NCT04176705|324030929|FG001|Overall Study|Death|1|||
94608486|NCT04176705|324030928|FG000|Overall Study|Lost to Follow-up|3|||
94608487|NCT04176705|324030929|FG001|Overall Study|Lost to Follow-up|3|||
94608488|NCT02484690|324030938|FG000|Overall Study|Adverse Event|1|||
94608489|NCT02484690|324030939|FG001|Overall Study|Adverse Event|3|||
94608490|NCT02484690|324030940|FG002|Overall Study|Adverse Event|0|||
94608491|NCT02484690|324030941|FG003|Overall Study|Adverse Event|0|||
94608492|NCT02484690|324030942|FG004|Overall Study|Adverse Event|5|||
94608493|NCT02484690|324030938|FG000|Overall Study|Death|0|||
94608494|NCT02484690|324030939|FG001|Overall Study|Death|0|||
94608495|NCT02484690|324030940|FG002|Overall Study|Death|0|||
94608496|NCT02484690|324030941|FG003|Overall Study|Death|0|||
94608497|NCT02484690|324030942|FG004|Overall Study|Death|1|||
94608498|NCT02484690|324030938|FG000|Overall Study|Withdrawal by Subject|1|||
94608499|NCT02484690|324030939|FG001|Overall Study|Withdrawal by Subject|3|||
94608500|NCT02484690|324030940|FG002|Overall Study|Withdrawal by Subject|1|||
94608501|NCT02484690|324030941|FG003|Overall Study|Withdrawal by Subject|2|||
94608502|NCT02484690|324030942|FG004|Overall Study|Withdrawal by Subject|0|||
94608503|NCT02484690|324030938|FG000|Overall Study|Physician Decision|2|||
94608504|NCT02484690|324030939|FG001|Overall Study|Physician Decision|0|||
94608505|NCT02484690|324030940|FG002|Overall Study|Physician Decision|1|||
94252745|NCT00852540|322718711|FG000|Overall Study|Adverse Event|10|||
94252746|NCT00852540|322718712|FG001|Overall Study|Adverse Event|3|||
94252747|NCT00852540|322718711|FG000|Overall Study|Lack of Efficacy|15|||
94252748|NCT00852540|322718712|FG001|Overall Study|Lack of Efficacy|3|||
94252749|NCT00852540|322718711|FG000|Overall Study|Protocol Violation|1|||
94252750|NCT00852540|322718712|FG001|Overall Study|Protocol Violation|2|||
94358156|NCT05643573|323093282|FG001|Overall Study|Adverse Event|90|||
94358157|NCT05643573|323093281|FG000|Overall Study|Death|53|||
94608506|NCT02484690|324030941|FG003|Overall Study|Physician Decision|0|||
94608507|NCT02484690|324030942|FG004|Overall Study|Physician Decision|0|||
94608508|NCT02484690|324030938|FG000|Overall Study|Lost to Follow-up|0|||
94608509|NCT02484690|324030939|FG001|Overall Study|Lost to Follow-up|0|||
94608510|NCT02484690|324030940|FG002|Overall Study|Lost to Follow-up|1|||
94608511|NCT02484690|324030941|FG003|Overall Study|Lost to Follow-up|0|||
94608512|NCT02484690|324030942|FG004|Overall Study|Lost to Follow-up|0|||
94608513|NCT05736224|324030945|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
94608514|NCT05430022|324030946|FG000|Overall Study|Withdrawal by Subject|4|||
94608515|NCT05430022|324030947|FG001|Overall Study|Withdrawal by Subject|4|||
94608516|NCT02719327|324030949|FG000|Overall Study|Withdrawal by Subject|11|||
94608517|NCT02719327|324030950|FG001|Overall Study|Withdrawal by Subject|8|||
94608518|NCT02445391|324030951|FG000|Overall Study|No active protocol treatment|3|||
94608519|NCT02445391|324030952|FG001|Overall Study|No active protocol treatment|0|||
94608520|NCT02445391|324030953|FG002|Overall Study|No active protocol treatment|0|||
94608521|NCT02445391|324030951|FG000|Overall Study|Adverse Event|0|||
94608522|NCT02445391|324030952|FG001|Overall Study|Adverse Event|21|||
94608523|NCT02445391|324030953|FG002|Overall Study|Adverse Event|12|||
94608524|NCT02445391|324030951|FG000|Overall Study|Alternative therapy|0|||
94608525|NCT02445391|324030952|FG001|Overall Study|Alternative therapy|0|||
94608526|NCT02445391|324030953|FG002|Overall Study|Alternative therapy|1|||
94608527|NCT02445391|324030951|FG000|Overall Study|Disease progression|0|||
94608528|NCT02445391|324030952|FG001|Overall Study|Disease progression|7|||
94608529|NCT02445391|324030953|FG002|Overall Study|Disease progression|22|||
94608530|NCT02445391|324030951|FG000|Overall Study|Complicating disease|0|||
94608531|NCT02445391|324030952|FG001|Overall Study|Complicating disease|2|||
94608532|NCT02445391|324030953|FG002|Overall Study|Complicating disease|1|||
94608533|NCT02445391|324030951|FG000|Overall Study|Withdrawal by Subject|0|||
94608534|NCT02445391|324030952|FG001|Overall Study|Withdrawal by Subject|4|||
94608535|NCT02445391|324030953|FG002|Overall Study|Withdrawal by Subject|9|||
94608536|NCT02445391|324030951|FG000|Overall Study|Financial issue|0|||
94608537|NCT02445391|324030952|FG001|Overall Study|Financial issue|0|||
94608538|NCT02445391|324030953|FG002|Overall Study|Financial issue|2|||
94608539|NCT02445391|324030951|FG000|Overall Study|Still on treatment|0|||
94608540|NCT02445391|324030952|FG001|Overall Study|Still on treatment|7|||
94608541|NCT02445391|324030953|FG002|Overall Study|Still on treatment|16|||
94608542|NCT02445391|324030951|FG000|Overall Study|Not start protocol therapy|0|||
94608543|NCT02445391|324030952|FG001|Overall Study|Not start protocol therapy|12|||
94608544|NCT02445391|324030953|FG002|Overall Study|Not start protocol therapy|9|||
94252751|NCT00852540|322718711|FG000|Overall Study|Lost to Follow-up|2|||
94358158|NCT05643573|323093282|FG001|Overall Study|Death|57|||
94358159|NCT05643573|323093281|FG000|Overall Study|Lost to Follow-up|6|||
94358160|NCT05643573|323093282|FG001|Overall Study|Lost to Follow-up|3|||
94358161|NCT05643573|323093281|FG000|Overall Study|Other|18|||
94358162|NCT05643573|323093282|FG001|Overall Study|Other|15|||
94459313|NCT04713592|323469603|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
94459314|NCT01190267|323469604|FG000|Overall Study|Adverse Event|10|||
94608545|NCT02887859|324030960|FG000|Overall Study|Ongoing|6|||
94608546|NCT02887859|324030960|FG000|Overall Study|Adverse Event|7|||
94608547|NCT02887859|324030960|FG000|Overall Study|Death|1|||
94608548|NCT02887859|324030960|FG000|Overall Study|Physician Decision|1|||
94608549|NCT05419908|324030961|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
94608550|NCT05419908|324030962|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
94608551|NCT05419908|324030961|FG000|Overall Study|Serious Adverse Event|0|||
94608552|NCT05419908|324030962|FG001|Overall Study|Serious Adverse Event|2|||
94608553|NCT05419908|324030961|FG000|Overall Study|Withdrawal by Subject|2|||
94608554|NCT05419908|324030962|FG001|Overall Study|Withdrawal by Subject|0|||
94608555|NCT05419908|324030961|FG000|Overall Study|Miscellaneous|1|||
94608556|NCT05419908|324030962|FG001|Overall Study|Miscellaneous|1|||
94252752|NCT00852540|322718712|FG001|Overall Study|Lost to Follow-up|3|||
94608557|NCT01927341|324032367|FG000|Phase 1b|Lost to Follow-up|1|||
94608558|NCT01927341|324032368|FG001|Phase 1b|Lost to Follow-up|0|||
94608559|NCT01927341|324032369|FG002|Phase 1b|Lost to Follow-up|0|||
94608560|NCT01927341|324032370|FG003|Phase 1b|Lost to Follow-up|0|||
94608561|NCT01927341|324032371|FG004|Phase 1b|Lost to Follow-up|0|||
94252753|NCT00852540|322718711|FG000|Overall Study|Investigator Discretion|2|||
94252754|NCT00852540|322718712|FG001|Overall Study|Investigator Discretion|3|||
94252755|NCT00852540|322718711|FG000|Overall Study|Withdrawal by Subject|3|||
94358163|NCT05643573|323093281|FG000|Overall Study|Outcome event|64|||
94358164|NCT05643573|323093282|FG001|Overall Study|Outcome event|36|||
94608562|NCT01927341|324032367|FG000|Phase 1b|Death|2|||
94608563|NCT01927341|324032368|FG001|Phase 1b|Death|0|||
94608564|NCT01927341|324032369|FG002|Phase 1b|Death|0|||
94608565|NCT01927341|324032370|FG003|Phase 1b|Death|0|||
94608566|NCT01927341|324032371|FG004|Phase 1b|Death|0|||
94608567|NCT01927341|324032367|FG000|Phase 1b|Follow-up completed|7|||
94608568|NCT01927341|324032368|FG001|Phase 1b|Follow-up completed|0|||
94608569|NCT01927341|324032369|FG002|Phase 1b|Follow-up completed|0|||
94608570|NCT01927341|324032370|FG003|Phase 1b|Follow-up completed|0|||
94608571|NCT01927341|324032371|FG004|Phase 1b|Follow-up completed|0|||
94608572|NCT01927341|324032367|FG000|Phase 2|Lost to Follow-up|0|||
94608573|NCT01927341|324032368|FG001|Phase 2|Lost to Follow-up|1|||
94608574|NCT01927341|324032369|FG002|Phase 2|Lost to Follow-up|0|||
94608575|NCT01927341|324032370|FG003|Phase 2|Lost to Follow-up|0|||
94608576|NCT01927341|324032371|FG004|Phase 2|Lost to Follow-up|0|||
94608577|NCT01927341|324032367|FG000|Phase 2|Participant withdrew consent|0|||
94608578|NCT01927341|324032368|FG001|Phase 2|Participant withdrew consent|2|||
94608579|NCT01927341|324032369|FG002|Phase 2|Participant withdrew consent|1|||
94608580|NCT01927341|324032370|FG003|Phase 2|Participant withdrew consent|2|||
94608581|NCT01927341|324032371|FG004|Phase 2|Participant withdrew consent|3|||
94608582|NCT01927341|324032367|FG000|Phase 2|Death|0|||
94608583|NCT01927341|324032368|FG001|Phase 2|Death|4|||
94608584|NCT01927341|324032369|FG002|Phase 2|Death|0|||
94608585|NCT01927341|324032370|FG003|Phase 2|Death|3|||
94608586|NCT01927341|324032371|FG004|Phase 2|Death|2|||
94608587|NCT01927341|324032367|FG000|Phase 2|New cancer therapy|0|||
94608588|NCT01927341|324032368|FG001|Phase 2|New cancer therapy|1|||
94608589|NCT01927341|324032369|FG002|Phase 2|New cancer therapy|0|||
94608590|NCT01927341|324032370|FG003|Phase 2|New cancer therapy|4|||
94608591|NCT01927341|324032371|FG004|Phase 2|New cancer therapy|1|||
94608592|NCT01927341|324032367|FG000|Phase 2|Disease progression|0|||
94608593|NCT01927341|324032368|FG001|Phase 2|Disease progression|1|||
94608594|NCT01927341|324032369|FG002|Phase 2|Disease progression|1|||
94608595|NCT01927341|324032370|FG003|Phase 2|Disease progression|1|||
94608596|NCT01927341|324032371|FG004|Phase 2|Disease progression|0|||
94608597|NCT01927341|324032367|FG000|Phase 2|Follow-up completed|0|||
94608598|NCT01927341|324032368|FG001|Phase 2|Follow-up completed|6|||
94608599|NCT01927341|324032369|FG002|Phase 2|Follow-up completed|3|||
94608600|NCT01927341|324032370|FG003|Phase 2|Follow-up completed|5|||
94608601|NCT01927341|324032371|FG004|Phase 2|Follow-up completed|2|||
94608602|NCT03437512|324032372|FG000|Randomized|Withdrawal by Subject|0|||
94608603|NCT03437512|324032373|FG001|Randomized|Withdrawal by Subject|2|||
94608604|NCT03437512|324032372|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
94608605|NCT03437512|324032373|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
94608606|NCT00674973|324032382|FG000|Overall Study|Insufficient Therapeutic Response|77|||
94608607|NCT00674973|324032383|FG001|Overall Study|Insufficient Therapeutic Response|72|||
94608608|NCT00674973|324032382|FG000|Overall Study|Refused Treatment|1|||
94608609|NCT00674973|324032383|FG001|Overall Study|Refused Treatment|5|||
94608610|NCT00674973|324032382|FG000|Overall Study|Failure to Return|1|||
94608611|NCT00674973|324032383|FG001|Overall Study|Failure to Return|0|||
94608612|NCT00674973|324032382|FG000|Overall Study|Adverse Event|2|||
94608613|NCT00674973|324032383|FG001|Overall Study|Adverse Event|9|||
94608614|NCT00674973|324032382|FG000|Overall Study|Death|19|||
94608615|NCT00674973|324032383|FG001|Overall Study|Death|15|||
94608616|NCT00674973|324032382|FG000|Overall Study|Protocol Violation|0|||
94608617|NCT00674973|324032383|FG001|Overall Study|Protocol Violation|1|||
94608618|NCT00122278|324032384|FG000|Overall Study|Lost to Follow-up|2|||
94459315|NCT01190267|323469605|FG001|Overall Study|Adverse Event|0|||
94608619|NCT00122278|324032385|FG001|Overall Study|Lost to Follow-up|0|||
94608620|NCT05036369|324032386|FG000|Overall Study|Run In non compliance|1|||
94608621|NCT05036369|324032387|FG001|Overall Study|Run In non compliance|2|||
94608622|NCT05036369|324032386|FG000|Overall Study|Change in eligibility criteria|0|||
94608623|NCT05036369|324032387|FG001|Overall Study|Change in eligibility criteria|1|||
94608624|NCT00697073|324032388|FG000|Overall Study|Withdrawal by Subject|2|||
94608625|NCT00697073|324032388|FG000|Overall Study|Pregnancy|1|||
94608626|NCT00697073|324032388|FG000|Overall Study|non compliance and other|6|||
94608627|NCT01795638|324032389|FG000|Overall Study|Death|0|||
94608628|NCT01795638|324032390|FG001|Overall Study|Death|3|||
94608629|NCT01795638|324032389|FG000|Overall Study|transferred to quaternary hospital|2|||
94608630|NCT01795638|324032390|FG001|Overall Study|transferred to quaternary hospital|3|||
94608631|NCT01795638|324032389|FG000|Overall Study|Protocol Violation|3|||
94608632|NCT01795638|324032390|FG001|Overall Study|Protocol Violation|0|||
94608633|NCT01795638|324032389|FG000|Overall Study|discharged from hospital|7|||
94608634|NCT01795638|324032390|FG001|Overall Study|discharged from hospital|5|||
94608635|NCT01795638|324032389|FG000|Overall Study|Withdrawal by Subject|1|||
94608636|NCT01795638|324032390|FG001|Overall Study|Withdrawal by Subject|0|||
94608637|NCT03265665|324032393|FG000|24-week Data Collection|Withdrawal by Subject|2|||
94608638|NCT03265665|324032394|FG001|24-week Data Collection|Withdrawal by Subject|2|||
94608639|NCT03265665|324032393|FG000|24-week Data Collection|Lost to Follow-up|4|||
94608640|NCT03265665|324032394|FG001|24-week Data Collection|Lost to Follow-up|5|||
94608641|NCT03265665|324032393|FG000|36-week Data Collection|Lost to Follow-up|6|||
94608642|NCT03265665|324032394|FG001|36-week Data Collection|Lost to Follow-up|8|||
94608643|NCT02180165|324032395|FG000|Overall Study|Not Treated|0|||
94608644|NCT02180165|324032396|FG001|Overall Study|Not Treated|0|||
94608645|NCT02180165|324032397|FG002|Overall Study|Not Treated|1|||
94608646|NCT02180165|324032398|FG003|Overall Study|Not Treated|0|||
94608647|NCT02180165|324032395|FG000|Overall Study|Adverse Event|7|||
94608648|NCT02180165|324032396|FG001|Overall Study|Adverse Event|0|||
94608649|NCT02180165|324032397|FG002|Overall Study|Adverse Event|18|||
94608650|NCT02180165|324032398|FG003|Overall Study|Adverse Event|3|||
94608651|NCT02180165|324032395|FG000|Overall Study|Lack of Efficacy|0|||
94608652|NCT02180165|324032396|FG001|Overall Study|Lack of Efficacy|1|||
94608653|NCT02180165|324032397|FG002|Overall Study|Lack of Efficacy|3|||
94608654|NCT02180165|324032398|FG003|Overall Study|Lack of Efficacy|2|||
94608655|NCT02180165|324032395|FG000|Overall Study|Physician Decision|1|||
94608656|NCT02180165|324032396|FG001|Overall Study|Physician Decision|0|||
94608657|NCT02180165|324032397|FG002|Overall Study|Physician Decision|5|||
94608658|NCT02180165|324032398|FG003|Overall Study|Physician Decision|0|||
94608659|NCT02180165|324032395|FG000|Overall Study|Withdrawal by Subject|3|||
94608660|NCT02180165|324032396|FG001|Overall Study|Withdrawal by Subject|0|||
94608661|NCT02180165|324032397|FG002|Overall Study|Withdrawal by Subject|2|||
94608662|NCT02180165|324032398|FG003|Overall Study|Withdrawal by Subject|1|||
94608663|NCT00580970|324032403|FG000|Pre-treatment|Non-compliance|1|||
94608664|NCT00580970|324032403|FG000|Treatment (Lovastatin)|Non-compliance|6|||
94608665|NCT00580970|324032403|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
94608666|NCT00580970|324032403|FG000|Treatment (Lovastatin)|Physician Decision|4|||
94608667|NCT00580970|324032403|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
94608668|NCT00580970|324032403|FG000|Treatment (Lovastatin)|Death|1|||
94608669|NCT01086423|324032404|FG000|Overall Study|Protocol Violation|0|||
94608670|NCT01086423|324032405|FG001|Overall Study|Protocol Violation|0|||
94608671|NCT01086423|324032406|FG002|Overall Study|Protocol Violation|1|||
94608672|NCT01086423|324032404|FG000|Overall Study|Migrated/moved from study area|2|||
94608673|NCT01086423|324032405|FG001|Overall Study|Migrated/moved from study area|0|||
94608674|NCT01086423|324032406|FG002|Overall Study|Migrated/moved from study area|4|||
94608675|NCT01086423|324032404|FG000|Overall Study|Adverse event, fatal|1|||
94608676|NCT01086423|324032405|FG001|Overall Study|Adverse event, fatal|1|||
94608677|NCT01086423|324032406|FG002|Overall Study|Adverse event, fatal|0|||
94608678|NCT01086423|324032404|FG000|Overall Study|Adverse event, non-fatal|2|||
94608679|NCT01086423|324032405|FG001|Overall Study|Adverse event, non-fatal|1|||
94608680|NCT01086423|324032406|FG002|Overall Study|Adverse event, non-fatal|0|||
94608681|NCT01086423|324032404|FG000|Overall Study|Withdrawal by Subject|5|||
94608682|NCT01086423|324032405|FG001|Overall Study|Withdrawal by Subject|1|||
94608683|NCT01086423|324032406|FG002|Overall Study|Withdrawal by Subject|3|||
94608684|NCT01086423|324032404|FG000|Overall Study|Lost to Follow-up|0|||
94608685|NCT01086423|324032405|FG001|Overall Study|Lost to Follow-up|0|||
94608686|NCT01086423|324032406|FG002|Overall Study|Lost to Follow-up|1|||
94608687|NCT02517866|324032407|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
94608688|NCT02517866|324032408|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
94608689|NCT02517866|324032409|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
94608690|NCT02517866|324032407|FG000|Overall Study|Significant Protocol Deviation|4|||
94608691|NCT02517866|324032408|FG001|Overall Study|Significant Protocol Deviation|1|||
94608692|NCT02517866|324032409|FG002|Overall Study|Significant Protocol Deviation|0|||
94608693|NCT02517866|324032407|FG000|Overall Study|Lost to Follow-up|1|||
94608694|NCT02517866|324032408|FG001|Overall Study|Lost to Follow-up|0|||
94608695|NCT02517866|324032409|FG002|Overall Study|Lost to Follow-up|0|||
94608696|NCT02517866|324032407|FG000|Overall Study|Voluntary Withdrawal|2|||
94608697|NCT02517866|324032408|FG001|Overall Study|Voluntary Withdrawal|2|||
94608698|NCT02517866|324032409|FG002|Overall Study|Voluntary Withdrawal|0|||
94608699|NCT02517866|324032407|FG000|Overall Study|Investigator Decision|2|||
94608700|NCT02517866|324032408|FG001|Overall Study|Investigator Decision|1|||
94608701|NCT02517866|324032409|FG002|Overall Study|Investigator Decision|0|||
94608702|NCT02517866|324032407|FG000|Overall Study|Reason not specified|2|||
94608703|NCT02517866|324032408|FG001|Overall Study|Reason not specified|0|||
94608704|NCT02517866|324032409|FG002|Overall Study|Reason not specified|0|||
94608705|NCT03114488|324032410|FG000|Time Period 2|Withdrawal by Subject|1|||
94608706|NCT03114488|324032411|FG001|Time Period 2|Withdrawal by Subject|3|||
94608707|NCT03711266|324032412|FG000|Overall Study|Lost to Follow-up|10|||
94608708|NCT01225887|324032413|FG000|Overall Study|Ineligible:required test not done|2|||
94608709|NCT01225887|324032413|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
94608710|NCT01225887|324032413|FG000|Overall Study|Ineligible:inadequate pathology|2|||
94608711|NCT02869438|324032414|FG000|Overall Study|Lost to Follow-up|1|||
94608712|NCT02869438|324032415|FG001|Overall Study|Lost to Follow-up|0|||
94608713|NCT02869438|324032414|FG000|Overall Study|Adverse Event|1|||
94608714|NCT02869438|324032415|FG001|Overall Study|Adverse Event|0|||
94608715|NCT02869438|324032414|FG000|Overall Study|Withdrawal by Subject|1|||
94608716|NCT02869438|324032415|FG001|Overall Study|Withdrawal by Subject|2|||
94608717|NCT01954342|324032418|FG000|Overall Study|Missing data from 13-16week study visit|0|||
94608718|NCT01954342|324032419|FG001|Overall Study|Missing data from 13-16week study visit|0|||
94608719|NCT01954342|324032420|FG002|Overall Study|Missing data from 13-16week study visit|0|||
94608720|NCT01954342|324032421|FG003|Overall Study|Missing data from 13-16week study visit|1|||
94608721|NCT01954342|324032418|FG000|Overall Study|Miscarriage|0|||
94608722|NCT01954342|324032419|FG001|Overall Study|Miscarriage|0|||
94608723|NCT01954342|324032420|FG002|Overall Study|Miscarriage|0|||
94608724|NCT01954342|324032421|FG003|Overall Study|Miscarriage|3|||
94608725|NCT01954342|324032418|FG000|Overall Study|Lost to Follow-up|0|||
94608726|NCT01954342|324032419|FG001|Overall Study|Lost to Follow-up|0|||
94608727|NCT01954342|324032420|FG002|Overall Study|Lost to Follow-up|0|||
94608728|NCT01954342|324032421|FG003|Overall Study|Lost to Follow-up|5|||
94608729|NCT01954342|324032418|FG000|Overall Study|Preterm delivery|0|||
94608730|NCT01954342|324032419|FG001|Overall Study|Preterm delivery|0|||
94608731|NCT01954342|324032420|FG002|Overall Study|Preterm delivery|0|||
94608732|NCT01954342|324032421|FG003|Overall Study|Preterm delivery|3|||
94608733|NCT01954342|324032418|FG000|Overall Study|Pre-eclampsia|0|||
94608734|NCT01954342|324032419|FG001|Overall Study|Pre-eclampsia|0|||
94608735|NCT01954342|324032420|FG002|Overall Study|Pre-eclampsia|0|||
94608736|NCT01954342|324032421|FG003|Overall Study|Pre-eclampsia|4|||
94608737|NCT01954342|324032418|FG000|Overall Study|Unreliable Data|0|||
94608738|NCT01954342|324032419|FG001|Overall Study|Unreliable Data|0|||
94608739|NCT01954342|324032420|FG002|Overall Study|Unreliable Data|0|||
94608740|NCT01954342|324032421|FG003|Overall Study|Unreliable Data|2|||
94608741|NCT01368432|324032424|FG000|Overall Study|Lost to Follow-up|0|||
94608742|NCT01368432|324032425|FG001|Overall Study|Lost to Follow-up|1|||
94608743|NCT00853073|324032426|FG000|Overall Study|Withdrawal by Subject|3|||
94608744|NCT00853073|324032427|FG001|Overall Study|Withdrawal by Subject|2|||
94608745|NCT01008150|324032428|FG000|Overall Study|did not receive study drug|1|||
94608746|NCT01008150|324032429|FG001|Overall Study|did not receive study drug|1|||
94608747|NCT01008150|324032430|FG002|Overall Study|did not receive study drug|1|||
94608748|NCT01008150|324032431|FG003|Overall Study|did not receive study drug|0|||
94608749|NCT00737438|324032435|FG000|Overall Study|Withdrawal by Subject|2|||
94608750|NCT00737438|324032435|FG000|Overall Study|Patient ineligible|1|||
94608751|NCT04950166|324032436|FG000|Overall Study|Withdrawal by Subject|1|||
94608752|NCT00470847|324032440|FG000|Overall Study|Pt still receiving treatment|1|||
94608753|NCT01104155|324032453|FG000|Overall Study|Adverse Event|15|||
94608754|NCT01104155|324032454|FG001|Overall Study|Adverse Event|8|||
94608755|NCT01104155|324032453|FG000|Overall Study|Participant choice|6|||
94608756|NCT01104155|324032454|FG001|Overall Study|Participant choice|5|||
94608757|NCT01104155|324032453|FG000|Overall Study|Withdrawal of consent|1|||
94252756|NCT00852540|322718712|FG001|Overall Study|Withdrawal by Subject|1|||
94252757|NCT00852540|322718711|FG000|Overall Study|Did Not Receive Study Drug|3|||
94252758|NCT00852540|322718712|FG001|Overall Study|Did Not Receive Study Drug|3|||
94608758|NCT01104155|324032454|FG001|Overall Study|Withdrawal of consent|1|||
94608759|NCT01104155|324032453|FG000|Overall Study|Other|3|||
94608760|NCT01104155|324032454|FG001|Overall Study|Other|4|||
94252759|NCT01639495|322718713|FG000|Overall Study|Lost to Follow-up|6|||
94608761|NCT01484132|324032455|FG000|Overall Study|Lost to Follow-up|8|||
94608762|NCT01484132|324032455|FG000|Overall Study|Difficulty with time commitment|2|||
94608763|NCT01484132|324032455|FG000|Overall Study|Ineligible|1|||
94608764|NCT01484132|324032455|FG000|Overall Study|No pre-treatment urine sample collected|1|||
94608765|NCT01484132|324032455|FG000|Overall Study|No post-treatment urine sample collected|10|||
94608766|NCT01437878|324032456|FG000|Overall Study|Withdrawal by Subject|1|||
94608767|NCT01437878|324032457|FG001|Overall Study|Withdrawal by Subject|0|||
94608768|NCT01638819|324032459|FG000|Overall Study|Lost to Follow-up|1|||
94608769|NCT01638819|324032460|FG001|Overall Study|Lost to Follow-up|0|||
94358165|NCT05643573|323093281|FG000|Overall Study|Physician Decision|33|||
94608770|NCT04209348|324032461|FG000|Overall Study|Lost to Follow-up|1|||
94608771|NCT04209348|324032462|FG001|Overall Study|Lost to Follow-up|0|||
94358166|NCT05643573|323093282|FG001|Overall Study|Physician Decision|19|||
94358167|NCT05643573|323093281|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
94358168|NCT05643573|323093282|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
94358169|NCT05643573|323093281|FG000|Overall Study|Site terminated by sponsor|10|||
94358170|NCT05643573|323093282|FG001|Overall Study|Site terminated by sponsor|10|||
94358171|NCT05643573|323093281|FG000|Overall Study|Study terminated by sponsor|1|||
94358172|NCT05643573|323093282|FG001|Overall Study|Study terminated by sponsor|0|||
94358173|NCT05643573|323093281|FG000|Overall Study|Withdrawal by Subject|178|||
94358174|NCT05643573|323093282|FG001|Overall Study|Withdrawal by Subject|130|||
94358175|NCT02161380|323093283|FG000|Overall Study|Lost to Follow-up|0|||
94358176|NCT02161380|323093284|FG001|Overall Study|Lost to Follow-up|1|||
94358177|NCT02161380|323093285|FG002|Overall Study|Lost to Follow-up|0|||
94358178|NCT02161380|323093286|FG003|Overall Study|Lost to Follow-up|0|||
94358179|NCT00985114|323093296|FG000|Overall Study|Adverse Event|1|||
94358180|NCT00985114|323093297|FG001|Overall Study|Adverse Event|0|||
94358181|NCT00985114|323093296|FG000|Overall Study|Withdrawal by Subject|0|||
94358182|NCT00985114|323093297|FG001|Overall Study|Withdrawal by Subject|2|||
94358183|NCT01302366|323094374|FG000|Overall Study|patient choice or noncompliance|5|||
94358184|NCT00509223|323094379|FG000|Overall Study|Lost to Follow-up|1|||
94358185|NCT00509223|323094380|FG001|Overall Study|Lost to Follow-up|1|||
94358186|NCT00509223|323094379|FG000|Overall Study|Adverse Event|1|||
94358187|NCT00509223|323094380|FG001|Overall Study|Adverse Event|1|||
94358188|NCT00509223|323094379|FG000|Overall Study|Withdrawal by Subject|25|||
94358189|NCT00509223|323094380|FG001|Overall Study|Withdrawal by Subject|6|||
94358190|NCT00509223|323094379|FG000|Overall Study|Including: subject change of address|5|||
94358191|NCT00509223|323094380|FG001|Overall Study|Including: subject change of address|2|||
94358192|NCT00509223|323094379|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
94608772|NCT02038452|324032463|FG000|Overall Study|Withdrawal by Subject|7|||
94608773|NCT02038452|324032464|FG001|Overall Study|Withdrawal by Subject|9|||
94608774|NCT02038452|324032463|FG000|Overall Study|Lost to Follow-up|31|||
94358193|NCT00509223|323094380|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
94358194|NCT01479777|323094381|FG000|Overall Study|Physician Decision|2|||
94358195|NCT01798056|323094386|FG000|Overall Study|Serious Adverse Event|13|||
94358196|NCT01798056|323094387|FG001|Overall Study|Serious Adverse Event|12|||
94252760|NCT01639495|322718713|FG000|Overall Study|Consented but didn't have study catheter|4|||
94252761|NCT01639495|322718713|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
94252762|NCT01639495|322718713|FG000|Overall Study|No radiofrequency energy applied|2|||
94252763|NCT04433585|322718714|FG000|Overall Study|Withdrawal by Subject|15|||
94252764|NCT04433585|322718715|FG001|Overall Study|Withdrawal by Subject|3|||
94252765|NCT04433585|322718716|FG002|Overall Study|Withdrawal by Subject|15|||
94252766|NCT04433585|322718717|FG003|Overall Study|Withdrawal by Subject|6|||
94252767|NCT04433585|322718714|FG000|Overall Study|Adverse Event|10|||
94252768|NCT04433585|322718715|FG001|Overall Study|Adverse Event|4|||
94252769|NCT04433585|322718716|FG002|Overall Study|Adverse Event|1|||
94252770|NCT04433585|322718717|FG003|Overall Study|Adverse Event|0|||
94252771|NCT04433585|322718714|FG000|Overall Study|Due to the conflict in Ukraine|2|||
94252772|NCT04433585|322718715|FG001|Overall Study|Due to the conflict in Ukraine|1|||
94252773|NCT04433585|322718716|FG002|Overall Study|Due to the conflict in Ukraine|1|||
94252774|NCT04433585|322718717|FG003|Overall Study|Due to the conflict in Ukraine|2|||
94252775|NCT04433585|322718714|FG000|Overall Study|Physician Decision|1|||
94252776|NCT04433585|322718715|FG001|Overall Study|Physician Decision|2|||
94252777|NCT04433585|322718716|FG002|Overall Study|Physician Decision|0|||
94252778|NCT04433585|322718717|FG003|Overall Study|Physician Decision|0|||
94252779|NCT04433585|322718714|FG000|Overall Study|Lost to Follow-up|1|||
94252780|NCT04433585|322718715|FG001|Overall Study|Lost to Follow-up|1|||
94358197|NCT01798056|323094386|FG000|Overall Study|Withdrawal by Subject|12|||
94358198|NCT01798056|323094387|FG001|Overall Study|Withdrawal by Subject|9|||
94252781|NCT04433585|322718716|FG002|Overall Study|Lost to Follow-up|1|||
94358199|NCT01798056|323094386|FG000|Overall Study|Migrated/moved from study area|1|||
94358200|NCT01798056|323094387|FG001|Overall Study|Migrated/moved from study area|1|||
94358201|NCT01798056|323094386|FG000|Overall Study|Lost to Follow-up|1|||
94358202|NCT01798056|323094387|FG001|Overall Study|Lost to Follow-up|1|||
94358203|NCT01798056|323094386|FG000|Overall Study|Other|0|||
94358204|NCT01798056|323094387|FG001|Overall Study|Other|2|||
94358205|NCT01013207|323094388|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
94358206|NCT05637515|323094389|FG000|Overall Study|Withdrawal by Subject|17|||
94358207|NCT05637515|323094390|FG001|Overall Study|Withdrawal by Subject|17|||
94358208|NCT01541644|323094398|FG000|Overall Study|Withdrawal by Subject|3|||
94358209|NCT02389621|323094400|FG000|Treatment Period|Withdrawal by Subject|1|||
94358210|NCT02389621|323094401|FG001|Treatment Period|Withdrawal by Subject|1|||
94358211|NCT02389621|323094400|FG000|Posttreatment Period|Adverse Event|3|||
94358212|NCT02389621|323094401|FG001|Posttreatment Period|Adverse Event|1|||
94358213|NCT02389621|323094400|FG000|Posttreatment Period|Withdrawal by Subject|3|||
94358214|NCT02389621|323094401|FG001|Posttreatment Period|Withdrawal by Subject|2|||
94358215|NCT02389621|323094400|FG000|Posttreatment Period|Lost to Follow-up|1|||
94358216|NCT02389621|323094401|FG001|Posttreatment Period|Lost to Follow-up|1|||
94358217|NCT02389621|323094400|FG000|Posttreatment Period|Other - Miscellaneous|2|||
94358218|NCT02389621|323094401|FG001|Posttreatment Period|Other - Miscellaneous|0|||
94358219|NCT02815540|323094405|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
94358220|NCT02222246|323094409|FG000|Overall Study|No Emergency Department Visits|27|||
94358221|NCT02222246|323094410|FG001|Overall Study|No Emergency Department Visits|26|||
94358222|NCT02222246|323094409|FG000|Overall Study|Physician Decision|0|||
94358223|NCT02222246|323094410|FG001|Overall Study|Physician Decision|1|||
94358224|NCT00474994|323094411|FG000|Overall Study|Patient Not treated|1|||
94358225|NCT00474994|323094411|FG000|Overall Study|Patient evaluable for toxicity only|3|||
94358226|NCT00474994|323094411|FG000|Overall Study|Patient found to be ineligible|1|||
94358227|NCT02064231|323094412|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
94358228|NCT02064231|323094413|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
94358229|NCT02064231|323094414|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
94358230|NCT02064231|323094415|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
94358231|NCT02064231|323094412|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
94358232|NCT02064231|323094413|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
94358233|NCT02064231|323094414|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
94358234|NCT02064231|323094415|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
94358235|NCT02064231|323094412|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
94459316|NCT01190267|323469604|FG000|Overall Study|Treatment Failure|8|||
94459317|NCT01190267|323469605|FG001|Overall Study|Treatment Failure|2|||
94459318|NCT01190267|323469604|FG000|Overall Study|Lost to Follow-up|2|||
94358236|NCT02064231|323094413|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
94358237|NCT02064231|323094414|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
94358238|NCT02064231|323094415|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
94358239|NCT02064231|323094412|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
94358240|NCT02064231|323094413|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
94459319|NCT01190267|323469605|FG001|Overall Study|Lost to Follow-up|0|||
94608775|NCT02038452|324032464|FG001|Overall Study|Lost to Follow-up|28|||
94252782|NCT04433585|322718717|FG003|Overall Study|Lost to Follow-up|0|||
94252783|NCT04433585|322718714|FG000|Overall Study|Lack of Efficacy|0|||
94358241|NCT02064231|323094414|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
94358242|NCT02064231|323094415|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
94358243|NCT04516291|323094416|FG000|Treatment Period (24 Weeks)|Other|1|||
94358244|NCT04516291|323094417|FG001|Treatment Period (24 Weeks)|Other|0|||
94608776|NCT02322021|324032465|FG000|Core Phase|Adverse Event|1|||
94358245|NCT04516291|323094418|FG002|Treatment Period (24 Weeks)|Other|0|||
94358246|NCT04516291|323094419|FG003|Treatment Period (24 Weeks)|Other|2|||
94358247|NCT04516291|323094420|FG004|Treatment Period (24 Weeks)|Other|2|||
94358248|NCT04516291|323094421|FG005|Treatment Period (24 Weeks)|Other|4|||
94358249|NCT04516291|323094422|FG006|Treatment Period (24 Weeks)|Other|2|||
94358250|NCT04516291|323094423|FG007|Treatment Period (24 Weeks)|Other|0|||
94358251|NCT04516291|323094416|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94358252|NCT04516291|323094417|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
94358253|NCT04516291|323094418|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
94358254|NCT04516291|323094419|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94358255|NCT04516291|323094420|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
94358256|NCT04516291|323094421|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94358257|NCT04516291|323094422|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94358258|NCT04516291|323094423|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94358259|NCT04516291|323094416|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
94358260|NCT04516291|323094417|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
94358261|NCT04516291|323094418|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
94358262|NCT04516291|323094419|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
94358263|NCT04516291|323094420|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
94358264|NCT04516291|323094421|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
94358265|NCT04516291|323094422|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
94358266|NCT04516291|323094423|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
94358267|NCT04516291|323094416|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94358268|NCT04516291|323094417|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
94358269|NCT04516291|323094418|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94358270|NCT04516291|323094419|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94358271|NCT04516291|323094420|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94358272|NCT04516291|323094421|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94358273|NCT04516291|323094422|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94358274|NCT04516291|323094423|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94358275|NCT04516291|323094416|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
94358276|NCT04516291|323094417|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
94358277|NCT04516291|323094418|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
94358278|NCT04516291|323094419|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
94358279|NCT04516291|323094420|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
94358280|NCT04516291|323094421|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
94358281|NCT04516291|323094422|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
94358282|NCT04516291|323094423|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
94358283|NCT04516291|323094416|FG000|Follow-up Period (12 Weeks)|Other|0|||
94358284|NCT04516291|323094417|FG001|Follow-up Period (12 Weeks)|Other|1|||
94358285|NCT04516291|323094418|FG002|Follow-up Period (12 Weeks)|Other|0|||
94358286|NCT04516291|323094419|FG003|Follow-up Period (12 Weeks)|Other|2|||
94358287|NCT04516291|323094420|FG004|Follow-up Period (12 Weeks)|Other|0|||
94358288|NCT04516291|323094421|FG005|Follow-up Period (12 Weeks)|Other|0|||
94358289|NCT04516291|323094422|FG006|Follow-up Period (12 Weeks)|Other|0|||
94358290|NCT04516291|323094423|FG007|Follow-up Period (12 Weeks)|Other|0|||
94358291|NCT04516291|323094416|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
94608777|NCT02322021|324032466|FG001|Core Phase|Adverse Event|3|||
94608778|NCT02322021|324032467|FG002|Core Phase|Adverse Event|4|||
94608779|NCT02322021|324032468|FG003|Core Phase|Adverse Event|2|||
94608780|NCT02322021|324032469|FG004|Core Phase|Adverse Event|0|||
94608781|NCT02322021|324032465|FG000|Core Phase|Participant Choice|4|||
94608782|NCT02322021|324032466|FG001|Core Phase|Participant Choice|5|||
94608783|NCT02322021|324032467|FG002|Core Phase|Participant Choice|4|||
94608784|NCT02322021|324032468|FG003|Core Phase|Participant Choice|2|||
94608785|NCT02322021|324032469|FG004|Core Phase|Participant Choice|0|||
94608786|NCT02322021|324032465|FG000|Core Phase|Lost to Follow-up|0|||
94608787|NCT02322021|324032466|FG001|Core Phase|Lost to Follow-up|0|||
94608788|NCT02322021|324032467|FG002|Core Phase|Lost to Follow-up|0|||
94608789|NCT02322021|324032468|FG003|Core Phase|Lost to Follow-up|1|||
94608790|NCT02322021|324032469|FG004|Core Phase|Lost to Follow-up|0|||
94608791|NCT02322021|324032465|FG000|Core Phase|Other|0|||
94608792|NCT02322021|324032466|FG001|Core Phase|Other|0|||
94608793|NCT02322021|324032467|FG002|Core Phase|Other|1|||
94608794|NCT02322021|324032468|FG003|Core Phase|Other|0|||
94608795|NCT02322021|324032469|FG004|Core Phase|Other|0|||
94608796|NCT02322021|324032465|FG000|Extension Phase|Adverse Event|0|||
94608797|NCT02322021|324032466|FG001|Extension Phase|Adverse Event|0|||
94608798|NCT02322021|324032467|FG002|Extension Phase|Adverse Event|0|||
94608799|NCT02322021|324032468|FG003|Extension Phase|Adverse Event|0|||
94608800|NCT02322021|324032469|FG004|Extension Phase|Adverse Event|3|||
94608801|NCT02322021|324032465|FG000|Extension Phase|Participant Choice|0|||
94608802|NCT02322021|324032466|FG001|Extension Phase|Participant Choice|0|||
94608803|NCT02322021|324032467|FG002|Extension Phase|Participant Choice|0|||
94608804|NCT02322021|324032468|FG003|Extension Phase|Participant Choice|0|||
94608805|NCT02322021|324032469|FG004|Extension Phase|Participant Choice|6|||
94608806|NCT02322021|324032465|FG000|Extension Phase|Other|0|||
94608807|NCT02322021|324032466|FG001|Extension Phase|Other|0|||
94608808|NCT02322021|324032467|FG002|Extension Phase|Other|0|||
94608809|NCT02322021|324032468|FG003|Extension Phase|Other|0|||
94608810|NCT02322021|324032469|FG004|Extension Phase|Other|3|||
94608811|NCT02322021|324032465|FG000|Extension Phase|Lost to Follow-up|0|||
94608812|NCT02322021|324032466|FG001|Extension Phase|Lost to Follow-up|0|||
94608813|NCT02322021|324032467|FG002|Extension Phase|Lost to Follow-up|0|||
94608814|NCT02322021|324032468|FG003|Extension Phase|Lost to Follow-up|0|||
94608815|NCT02322021|324032469|FG004|Extension Phase|Lost to Follow-up|1|||
94608816|NCT02322021|324032465|FG000|Extension Phase|Study terminated by sponsor|0|||
94608817|NCT02322021|324032466|FG001|Extension Phase|Study terminated by sponsor|0|||
94608818|NCT02322021|324032467|FG002|Extension Phase|Study terminated by sponsor|0|||
94608819|NCT02322021|324032468|FG003|Extension Phase|Study terminated by sponsor|0|||
94608820|NCT02322021|324032469|FG004|Extension Phase|Study terminated by sponsor|28|||
94608821|NCT03945266|324032476|FG000|Overall Study|Withdrawal by Subject|1|||
94608822|NCT03945266|324032477|FG001|Overall Study|Withdrawal by Subject|0|||
94608823|NCT03945266|324032476|FG000|Overall Study|Miscarriage|0|||
94252784|NCT04433585|322718715|FG001|Overall Study|Lack of Efficacy|1|||
94608824|NCT03945266|324032477|FG001|Overall Study|Miscarriage|2|||
94608825|NCT03945266|324032476|FG000|Overall Study|Lost to Follow-up|1|||
94252785|NCT04433585|322718716|FG002|Overall Study|Lack of Efficacy|1|||
94252786|NCT04433585|322718717|FG003|Overall Study|Lack of Efficacy|1|||
94252787|NCT04433585|322718714|FG000|Overall Study|Death|0|||
94252788|NCT04433585|322718715|FG001|Overall Study|Death|1|||
94608826|NCT03945266|324032477|FG001|Overall Study|Lost to Follow-up|0|||
94608827|NCT02612129|324032478|FG000|Single Dose Treatment Period|Screening Failure|1|||
94608828|NCT02612129|324032479|FG001|Single Dose Treatment Period|Screening Failure|0|||
94608829|NCT02612129|324032480|FG002|Single Dose Treatment Period|Screening Failure|0|||
94608830|NCT02612129|324032478|FG000|Continuous Treatment Period|Early Escape|0|||
94608831|NCT02612129|324032479|FG001|Continuous Treatment Period|Early Escape|2|||
94608832|NCT02612129|324032480|FG002|Continuous Treatment Period|Early Escape|0|||
94608833|NCT02612129|324032478|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
94608834|NCT02612129|324032479|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
94252789|NCT04433585|322718716|FG002|Overall Study|Death|0|||
94608835|NCT02612129|324032480|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
94608836|NCT02612129|324032478|FG000|Continuous Treatment Period|Safety Reasons|0|||
94608837|NCT02612129|324032479|FG001|Continuous Treatment Period|Safety Reasons|3|||
94608838|NCT02612129|324032480|FG002|Continuous Treatment Period|Safety Reasons|0|||
94608839|NCT02612129|324032478|FG000|Continuous Treatment Period|Death|0|||
94608840|NCT02612129|324032479|FG001|Continuous Treatment Period|Death|1|||
94608841|NCT02612129|324032480|FG002|Continuous Treatment Period|Death|0|||
94608842|NCT02612129|324032478|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
94608843|NCT02612129|324032479|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
94608844|NCT02612129|324032480|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
94608845|NCT01067976|324032481|FG000|Overall Study|Study drug never administered|20|||
94608846|NCT01067976|324032481|FG000|Overall Study|Study prematurely discontinued|2|||
94608847|NCT01554397|324032482|FG000|Overall Study|Withdrawal by Subject|1|||
94608848|NCT01554397|324032483|FG001|Overall Study|Withdrawal by Subject|0|||
94608849|NCT01554397|324032482|FG000|Overall Study|Ineligible|7|||
94608850|NCT01554397|324032483|FG001|Overall Study|Ineligible|0|||
94608851|NCT03332771|324034137|FG000|Overall Study|Adverse Event|6|||
94608852|NCT03332771|324034138|FG001|Overall Study|Adverse Event|4|||
94608853|NCT03332771|324034139|FG002|Overall Study|Adverse Event|1|||
94608854|NCT03332771|324034140|FG003|Overall Study|Adverse Event|3|||
94608855|NCT03332771|324034137|FG000|Overall Study|Poor Compliance to Protocol|0|||
94608856|NCT03332771|324034138|FG001|Overall Study|Poor Compliance to Protocol|1|||
94608857|NCT03332771|324034139|FG002|Overall Study|Poor Compliance to Protocol|0|||
94608858|NCT03332771|324034140|FG003|Overall Study|Poor Compliance to Protocol|1|||
94608859|NCT03332771|324034137|FG000|Overall Study|Lost to Follow-up|2|||
94608860|NCT03332771|324034138|FG001|Overall Study|Lost to Follow-up|2|||
94608861|NCT03332771|324034139|FG002|Overall Study|Lost to Follow-up|1|||
94608862|NCT03332771|324034140|FG003|Overall Study|Lost to Follow-up|2|||
94608863|NCT03332771|324034137|FG000|Overall Study|At the Participant's own request|20|||
94608864|NCT03332771|324034138|FG001|Overall Study|At the Participant's own request|26|||
94608865|NCT03332771|324034139|FG002|Overall Study|At the Participant's own request|14|||
94608866|NCT03332771|324034140|FG003|Overall Study|At the Participant's own request|23|||
94608867|NCT03332771|324034137|FG000|Overall Study|Reason Not Specified|6|||
94608868|NCT03332771|324034138|FG001|Overall Study|Reason Not Specified|18|||
94608869|NCT03332771|324034139|FG002|Overall Study|Reason Not Specified|16|||
94608870|NCT03332771|324034140|FG003|Overall Study|Reason Not Specified|19|||
94608871|NCT04078178|324034141|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
94608872|NCT04078178|324034142|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
94608873|NCT04078178|324034141|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
94608874|NCT04078178|324034142|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
94608875|NCT04078178|324034141|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
94608876|NCT04078178|324034142|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
94252790|NCT04433585|322718717|FG003|Overall Study|Death|0|||
94608877|NCT04078178|324034141|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
94608878|NCT04078178|324034142|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
94608879|NCT04078178|324034141|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
94608880|NCT04078178|324034142|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
94608881|NCT02247531|324034143|FG000|Overall Study|Adverse Event|3|||
94608882|NCT02247531|324034144|FG001|Overall Study|Adverse Event|4|||
94608883|NCT02247531|324034145|FG002|Overall Study|Adverse Event|9|||
94608884|NCT02247531|324034143|FG000|Overall Study|Death|8|||
94608885|NCT02247531|324034144|FG001|Overall Study|Death|9|||
94608886|NCT02247531|324034145|FG002|Overall Study|Death|5|||
94608887|NCT02247531|324034143|FG000|Overall Study|Lost to Follow-up|1|||
94608888|NCT02247531|324034144|FG001|Overall Study|Lost to Follow-up|8|||
94608889|NCT02247531|324034145|FG002|Overall Study|Lost to Follow-up|3|||
94608890|NCT02247531|324034143|FG000|Overall Study|Non-compliance|2|||
94608891|NCT02247531|324034144|FG001|Overall Study|Non-compliance|2|||
94608892|NCT02247531|324034145|FG002|Overall Study|Non-compliance|0|||
94608893|NCT02247531|324034143|FG000|Overall Study|Withdrawal by Subject|26|||
94608894|NCT02247531|324034144|FG001|Overall Study|Withdrawal by Subject|31|||
94608895|NCT02247531|324034145|FG002|Overall Study|Withdrawal by Subject|25|||
94608896|NCT02247531|324034143|FG000|Overall Study|Study Terminated by Sponsor|64|||
94608897|NCT02247531|324034144|FG001|Overall Study|Study Terminated by Sponsor|66|||
94608898|NCT02247531|324034145|FG002|Overall Study|Study Terminated by Sponsor|62|||
94608899|NCT02247531|324034143|FG000|Overall Study|Physician Decision|0|||
94608900|NCT02247531|324034144|FG001|Overall Study|Physician Decision|2|||
94608901|NCT02247531|324034145|FG002|Overall Study|Physician Decision|2|||
94608902|NCT02247531|324034143|FG000|Overall Study|Unspecified Reason|2|||
94608903|NCT02247531|324034144|FG001|Overall Study|Unspecified Reason|3|||
94608904|NCT02247531|324034145|FG002|Overall Study|Unspecified Reason|4|||
94608905|NCT01854658|324034146|FG000|Overall Study|Protocol Violation|6|||
94608906|NCT01854658|324034147|FG001|Overall Study|Protocol Violation|2|||
94608907|NCT01854658|324034148|FG002|Overall Study|Protocol Violation|2|||
94608908|NCT01854658|324034149|FG003|Overall Study|Protocol Violation|1|||
94608909|NCT01854658|324034146|FG000|Overall Study|Physician Decision|7|||
94608910|NCT01854658|324034147|FG001|Overall Study|Physician Decision|5|||
94608911|NCT01854658|324034148|FG002|Overall Study|Physician Decision|2|||
94608912|NCT01854658|324034149|FG003|Overall Study|Physician Decision|4|||
94608913|NCT01854658|324034146|FG000|Overall Study|Lost to Follow-up|8|||
94608914|NCT01854658|324034147|FG001|Overall Study|Lost to Follow-up|9|||
94608915|NCT01854658|324034148|FG002|Overall Study|Lost to Follow-up|8|||
94608916|NCT01854658|324034149|FG003|Overall Study|Lost to Follow-up|4|||
94608917|NCT01854658|324034146|FG000|Overall Study|Withdrawal by Subject|28|||
94608918|NCT01854658|324034147|FG001|Overall Study|Withdrawal by Subject|21|||
94608919|NCT01854658|324034148|FG002|Overall Study|Withdrawal by Subject|29|||
94608920|NCT01854658|324034149|FG003|Overall Study|Withdrawal by Subject|15|||
94608921|NCT01854658|324034146|FG000|Overall Study|Protocol-specified criteria|15|||
94608922|NCT01854658|324034147|FG001|Overall Study|Protocol-specified criteria|15|||
94608923|NCT01854658|324034148|FG002|Overall Study|Protocol-specified criteria|10|||
94608924|NCT01854658|324034149|FG003|Overall Study|Protocol-specified criteria|7|||
94608925|NCT01854658|324034146|FG000|Overall Study|Lack of Efficacy|3|||
94608926|NCT01854658|324034147|FG001|Overall Study|Lack of Efficacy|8|||
94608927|NCT01854658|324034148|FG002|Overall Study|Lack of Efficacy|4|||
94608928|NCT01854658|324034149|FG003|Overall Study|Lack of Efficacy|7|||
94608929|NCT01854658|324034146|FG000|Overall Study|Adverse Event|21|||
94608930|NCT01854658|324034147|FG001|Overall Study|Adverse Event|14|||
94608931|NCT01854658|324034148|FG002|Overall Study|Adverse Event|23|||
94608932|NCT01854658|324034149|FG003|Overall Study|Adverse Event|19|||
94608933|NCT01854658|324034146|FG000|Overall Study|Administrative reasons|5|||
94608934|NCT01854658|324034147|FG001|Overall Study|Administrative reasons|1|||
94608935|NCT01854658|324034148|FG002|Overall Study|Administrative reasons|2|||
94608936|NCT01854658|324034149|FG003|Overall Study|Administrative reasons|2|||
94608937|NCT01442038|324034150|FG000|Overall Study|Death|35|||
94608938|NCT01442038|324034151|FG001|Overall Study|Death|29|||
94608939|NCT01442038|324034150|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
94608940|NCT01442038|324034151|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
94608941|NCT01442038|324034150|FG000|Overall Study|Participant Withdrew Consent|137|||
94608942|NCT01442038|324034151|FG001|Overall Study|Participant Withdrew Consent|102|||
94608943|NCT01442038|324034150|FG000|Overall Study|Lost to Follow-up|37|||
94608944|NCT01442038|324034151|FG001|Overall Study|Lost to Follow-up|51|||
94608945|NCT01442038|324034150|FG000|Overall Study|Adverse Event|26|||
94608946|NCT01442038|324034151|FG001|Overall Study|Adverse Event|15|||
94608947|NCT01442038|324034150|FG000|Overall Study|Protocol Deviation|9|||
94608948|NCT01442038|324034151|FG001|Overall Study|Protocol Deviation|20|||
94608949|NCT01442038|324034150|FG000|Overall Study|Investigator's Discretion|13|||
94608950|NCT01442038|324034151|FG001|Overall Study|Investigator's Discretion|16|||
94608951|NCT01442038|324034150|FG000|Overall Study|Study Terminated By Sponsor|2|||
94608952|NCT01442038|324034151|FG001|Overall Study|Study Terminated By Sponsor|3|||
94608953|NCT02437513|324034152|FG000|Overall Study|Withdrawal by Subject|2|||
94608954|NCT03403374|324034153|FG000|Overall Study|Lost to Follow-up|1|||
94608955|NCT00736957|324034156|FG000|Overall Study|Adverse Event|43|||
94608956|NCT00736957|324034156|FG000|Overall Study|Withdrawal by Subject|49|||
94608957|NCT00736957|324034156|FG000|Overall Study|violation of eligibility criteria|2|||
94608958|NCT00736957|324034156|FG000|Overall Study|did not attend hospital appointments|1|||
94608959|NCT00736957|324034156|FG000|Overall Study|not eligible for Treatment Period I|22|||
94608960|NCT00736957|324034156|FG000|Overall Study|Physician Decision|5|||
94608961|NCT01229371|324034162|FG000|Overall Study|Withdrawal by Subject|0|||
94608962|NCT01229371|324034163|FG001|Overall Study|Withdrawal by Subject|1|||
94608963|NCT01229371|324034164|FG002|Overall Study|Withdrawal by Subject|0|||
94608964|NCT01229371|324034165|FG003|Overall Study|Withdrawal by Subject|0|||
94608965|NCT05061966|324034166|FG000|Overall Study|Lost to Follow-up|13|||
94608966|NCT05061966|324034167|FG001|Overall Study|Lost to Follow-up|13|||
94608967|NCT03793556|324034168|FG000|Overall Study|Withdrawal by Subject|12|||
94608968|NCT03793556|324034169|FG001|Overall Study|Withdrawal by Subject|1|||
94608969|NCT03793556|324034168|FG000|Overall Study|Lost to Follow-up|1|||
94608970|NCT03793556|324034169|FG001|Overall Study|Lost to Follow-up|1|||
94608971|NCT04073368|324034170|FG000|Overall Study|Adverse Event|2|||
94608972|NCT04073368|324034171|FG001|Overall Study|Adverse Event|0|||
94608973|NCT04073368|324034172|FG002|Overall Study|Adverse Event|1|||
94608974|NCT04073368|324034173|FG003|Overall Study|Adverse Event|1|||
94608975|NCT04073368|324034170|FG000|Overall Study|Withdrawal by Subject|2|||
94608976|NCT04073368|324034171|FG001|Overall Study|Withdrawal by Subject|2|||
94608977|NCT04073368|324034172|FG002|Overall Study|Withdrawal by Subject|1|||
94608978|NCT04073368|324034173|FG003|Overall Study|Withdrawal by Subject|1|||
94608979|NCT04073368|324034170|FG000|Overall Study|Lost to Follow-up|1|||
94608980|NCT04073368|324034171|FG001|Overall Study|Lost to Follow-up|1|||
94608981|NCT04073368|324034172|FG002|Overall Study|Lost to Follow-up|1|||
94608982|NCT04073368|324034173|FG003|Overall Study|Lost to Follow-up|0|||
94608983|NCT04073368|324034170|FG000|Overall Study|Protocol Violation|0|||
94608984|NCT04073368|324034171|FG001|Overall Study|Protocol Violation|1|||
94608985|NCT04073368|324034172|FG002|Overall Study|Protocol Violation|0|||
94608986|NCT04073368|324034173|FG003|Overall Study|Protocol Violation|0|||
94608987|NCT04073368|324034170|FG000|Overall Study|Subject noncompliance|7|||
94608988|NCT04073368|324034171|FG001|Overall Study|Subject noncompliance|4|||
94608989|NCT04073368|324034172|FG002|Overall Study|Subject noncompliance|0|||
94252791|NCT00194987|322718718|FG000|Overall Study|Withdrawal by Subject|0|||
94608990|NCT04073368|324034173|FG003|Overall Study|Subject noncompliance|0|||
94252792|NCT00194987|322718719|FG001|Overall Study|Withdrawal by Subject|3|||
94252793|NCT04875676|322718720|FG000|Overall Study|Lost to Follow-up|1|||
94608991|NCT02600351|324034181|FG000|Overall Study|Lack of Efficacy|3|||
94608992|NCT02600351|324034182|FG001|Overall Study|Lack of Efficacy|0|||
94608993|NCT02600351|324034183|FG002|Overall Study|Lack of Efficacy|5|||
94608994|NCT02600351|324034184|FG003|Overall Study|Lack of Efficacy|2|||
94608995|NCT02600351|324034181|FG000|Overall Study|Lost to Follow-up|1|||
94608996|NCT02600351|324034182|FG001|Overall Study|Lost to Follow-up|0|||
94608997|NCT02600351|324034183|FG002|Overall Study|Lost to Follow-up|0|||
94608998|NCT02600351|324034184|FG003|Overall Study|Lost to Follow-up|0|||
94608999|NCT02600351|324034181|FG000|Overall Study|Randomized but Not Treated|1|||
94609000|NCT02600351|324034182|FG001|Overall Study|Randomized but Not Treated|0|||
94609001|NCT02600351|324034183|FG002|Overall Study|Randomized but Not Treated|1|||
94609002|NCT02600351|324034184|FG003|Overall Study|Randomized but Not Treated|3|||
94609003|NCT00567593|324034187|FG000|Overall Study|Adverse Event|1|||
94609004|NCT00567593|324034187|FG000|Overall Study|Physician Decision|1|||
94609005|NCT01675427|324034188|FG000|Overall Study|Withdrawal by Subject|7|||
94609006|NCT01675427|324034188|FG000|Overall Study|Participant Refused Sample Collection|18|||
94609007|NCT01675427|324034188|FG000|Overall Study|Sample not Collected by Mistake|2|||
94609008|NCT01675427|324034188|FG000|Overall Study|Lost to Follow-up|5|||
94609009|NCT01675427|324034188|FG000|Overall Study|Other|2|||
94661687|NCT00558285|324215807|FG003|Overall Study|Subject withdrew consent|1|||
94252794|NCT04875676|322718721|FG001|Overall Study|Lost to Follow-up|0|||
94252795|NCT04875676|322718722|FG002|Overall Study|Lost to Follow-up|0|||
94252796|NCT02090959|322718723|FG000|Overall Study|Withdrawal by Subject|10|||
94252797|NCT02090959|322718723|FG000|Overall Study|Adverse Event|1|||
94252798|NCT02090959|322718723|FG000|Overall Study|Investigator decision|2|||
94252799|NCT02090959|322718723|FG000|Overall Study|Study termination|6|||
94358292|NCT04516291|323094417|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
94358293|NCT04516291|323094418|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
94358294|NCT04516291|323094419|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
94358295|NCT04516291|323094420|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
94609010|NCT00700570|324034192|FG000|Overall Study|Adverse Event|2|||
94609011|NCT00700570|324034193|FG001|Overall Study|Adverse Event|6|||
94609012|NCT00700570|324034192|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
94609013|NCT00700570|324034193|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
94609014|NCT00700570|324034192|FG000|Overall Study|Disease Progression|8|||
94609015|NCT00700570|324034193|FG001|Overall Study|Disease Progression|11|||
94609016|NCT00700570|324034192|FG000|Overall Study|Withdrawal by Subject|1|||
94609017|NCT00700570|324034193|FG001|Overall Study|Withdrawal by Subject|6|||
94358296|NCT04516291|323094421|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
94358297|NCT04516291|323094422|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
94609018|NCT01461980|324034197|FG000|Overall Study|Other|9|||
94609019|NCT01461980|324034198|FG001|Overall Study|Other|8|||
94609020|NCT01461980|324034199|FG002|Overall Study|Other|6|||
94609021|NCT01461980|324034197|FG000|Overall Study|Medication error|7|||
94609022|NCT01461980|324034198|FG001|Overall Study|Medication error|5|||
94609023|NCT01461980|324034199|FG002|Overall Study|Medication error|6|||
94609024|NCT01461980|324034197|FG000|Overall Study|Adverse Event|12|||
94609025|NCT01461980|324034198|FG001|Overall Study|Adverse Event|5|||
94609026|NCT01461980|324034199|FG002|Overall Study|Adverse Event|6|||
94609027|NCT01461980|324034197|FG000|Overall Study|Protocol Violation|12|||
94609028|NCT01461980|324034198|FG001|Overall Study|Protocol Violation|19|||
94609029|NCT01461980|324034199|FG002|Overall Study|Protocol Violation|16|||
94609030|NCT01461980|324034197|FG000|Overall Study|No longer meets eligibility criteria|18|||
94609031|NCT01461980|324034198|FG001|Overall Study|No longer meets eligibility criteria|9|||
94609032|NCT01461980|324034199|FG002|Overall Study|No longer meets eligibility criteria|19|||
94609033|NCT01461980|324034197|FG000|Overall Study|Lost to Follow-up|52|||
94609034|NCT01461980|324034198|FG001|Overall Study|Lost to Follow-up|53|||
94609035|NCT01461980|324034199|FG002|Overall Study|Lost to Follow-up|51|||
94609036|NCT01461980|324034197|FG000|Overall Study|No longer willing to participate|52|||
94609037|NCT01461980|324034198|FG001|Overall Study|No longer willing to participate|38|||
94609038|NCT01461980|324034199|FG002|Overall Study|No longer willing to participate|54|||
94609039|NCT01461980|324034197|FG000|Overall Study|Randomized but not vaccinated|4|||
94609040|NCT01461980|324034198|FG001|Overall Study|Randomized but not vaccinated|8|||
94609041|NCT01461980|324034199|FG002|Overall Study|Randomized but not vaccinated|7|||
94609042|NCT00267189|324034200|FG000|Overall Study|Patient withdrew consent|1|||
94609043|NCT00267189|324034201|FG001|Overall Study|Patient withdrew consent|1|||
94609044|NCT00267189|324034200|FG000|Overall Study|Death|1|||
94609045|NCT00267189|324034201|FG001|Overall Study|Death|0|||
94609046|NCT00267189|324034200|FG000|Overall Study|Missing|3|||
94609047|NCT00267189|324034201|FG001|Overall Study|Missing|0|||
94609048|NCT01147640|324034202|FG000|Overall Study|Adverse Event|2|||
94609049|NCT01147640|324034203|FG001|Overall Study|Adverse Event|0|||
94609050|NCT01147640|324034202|FG000|Overall Study|Physician Decision|1|||
94609051|NCT01147640|324034203|FG001|Overall Study|Physician Decision|0|||
94609052|NCT01147640|324034202|FG000|Overall Study|Withdrawal by Subject|1|||
94609053|NCT01147640|324034203|FG001|Overall Study|Withdrawal by Subject|0|||
94609054|NCT01147640|324034202|FG000|Overall Study|Lost to Follow-up|0|||
94609055|NCT01147640|324034203|FG001|Overall Study|Lost to Follow-up|1|||
94609056|NCT01147640|324034202|FG000|Overall Study|Didn't meet eligibility criteria|1|||
94609057|NCT01147640|324034203|FG001|Overall Study|Didn't meet eligibility criteria|0|||
94609058|NCT01938573|324034207|FG000|Overall Study|Lack of Efficacy|1|||
94609059|NCT01938573|324034208|FG001|Overall Study|Lack of Efficacy|0|||
94609060|NCT01938573|324034207|FG000|Overall Study|Operation at other hospital|1|||
94609061|NCT01938573|324034208|FG001|Overall Study|Operation at other hospital|0|||
94609062|NCT01130103|324034216|FG000|Randomized Treatment|Adverse Event|1|||
94609063|NCT01130103|324034217|FG001|Randomized Treatment|Adverse Event|1|||
94609064|NCT01130103|324034216|FG000|Randomized Treatment|Lost to Follow-up|1|||
94609065|NCT01130103|324034217|FG001|Randomized Treatment|Lost to Follow-up|0|||
94609066|NCT01130103|324034216|FG000|Randomized Treatment|Protocol Violation|3|||
94609067|NCT01130103|324034217|FG001|Randomized Treatment|Protocol Violation|2|||
94609068|NCT01130103|324034216|FG000|Randomized Treatment|Withdrawal by Subject|1|||
94609069|NCT01130103|324034217|FG001|Randomized Treatment|Withdrawal by Subject|2|||
94609070|NCT01130103|324034216|FG000|Maintenance Treatment|Lack of Efficacy|0|||
94609071|NCT01130103|324034217|FG001|Maintenance Treatment|Lack of Efficacy|1|||
94609072|NCT01130103|324034216|FG000|Maintenance Treatment|Lost to Follow-up|1|||
94609073|NCT01130103|324034217|FG001|Maintenance Treatment|Lost to Follow-up|1|||
94609074|NCT01130103|324034216|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
94609075|NCT01130103|324034217|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
94609076|NCT01916967|324034221|FG000|Overall Study|Adverse Event|0|||
94609077|NCT01916967|324034222|FG001|Overall Study|Adverse Event|0|||
94609078|NCT01916967|324034223|FG002|Overall Study|Adverse Event|2|||
94609079|NCT01916967|324034221|FG000|Overall Study|Lack of Efficacy|0|||
94661688|NCT00558285|324215808|FG004|Overall Study|Subject withdrew consent|1|||
94609080|NCT01916967|324034222|FG001|Overall Study|Lack of Efficacy|0|||
94609081|NCT01916967|324034223|FG002|Overall Study|Lack of Efficacy|6|||
94609082|NCT01916967|324034221|FG000|Overall Study|Physician Decision|0|||
94609083|NCT01916967|324034222|FG001|Overall Study|Physician Decision|0|||
94252800|NCT02090959|322718723|FG000|Overall Study|Enrolled but not treated|1|||
94252801|NCT02090959|322718723|FG000|Overall Study|Transfer for compassionate use medicine|4|||
94252802|NCT02090959|322718723|FG000|Overall Study|Move to medical need program|3|||
94252803|NCT02090959|322718723|FG000|Overall Study|Entered in to other study|34|||
94252804|NCT02090959|322718723|FG000|Overall Study|Switched to commercial supply|88|||
94252805|NCT02090959|322718723|FG000|Overall Study|Other than specified|2|||
94252806|NCT00522873|322718724|FG000|Overall Study|Adverse Event|41|||
94252807|NCT00522873|322718725|FG001|Overall Study|Adverse Event|26|||
94252808|NCT00522873|322718724|FG000|Overall Study|Withdrawal by Subject|20|||
94252809|NCT00522873|322718725|FG001|Overall Study|Withdrawal by Subject|9|||
94252810|NCT00522873|322718724|FG000|Overall Study|Protocol Violation|14|||
94252811|NCT00522873|322718725|FG001|Overall Study|Protocol Violation|4|||
94252812|NCT00522873|322718724|FG000|Overall Study|Lost to Follow-up|11|||
94252813|NCT00522873|322718725|FG001|Overall Study|Lost to Follow-up|3|||
94252814|NCT00522873|322718724|FG000|Overall Study|Personal Reasons|8|||
94252815|NCT00522873|322718725|FG001|Overall Study|Personal Reasons|1|||
94252816|NCT00522873|322718724|FG000|Overall Study|Medication Errors|1|||
94252817|NCT00522873|322718725|FG001|Overall Study|Medication Errors|1|||
94252818|NCT00522873|322718724|FG000|Overall Study|Never Received Medication|1|||
94252819|NCT00522873|322718725|FG001|Overall Study|Never Received Medication|0|||
94252820|NCT02966301|322718728|FG000|Overall Study|Death|2|||
94252821|NCT02966301|322718728|FG000|Overall Study|Withdrawal by Subject|1|||
94252822|NCT00642772|322718729|FG000|Overall Study|Lost to Follow-up|3|||
94252823|NCT00642772|322718729|FG000|Overall Study|Withdrawal by Subject|7|||
94252824|NCT00545051|322718734|FG000|Overall Study|Adverse Event|7|||
94252825|NCT00545051|322718735|FG001|Overall Study|Adverse Event|3|||
94252826|NCT00545051|322718734|FG000|Overall Study|Death|1|||
94252827|NCT00545051|322718735|FG001|Overall Study|Death|0|||
94252828|NCT00545051|322718734|FG000|Overall Study|Violation of inclusion/exclusion|0|||
94252829|NCT00545051|322718735|FG001|Overall Study|Violation of inclusion/exclusion|2|||
94252830|NCT00545051|322718734|FG000|Overall Study|Protocol Violation|1|||
94252831|NCT00545051|322718735|FG001|Overall Study|Protocol Violation|0|||
94252832|NCT00545051|322718734|FG000|Overall Study|Withdrawal by Subject|0|||
94252833|NCT00545051|322718735|FG001|Overall Study|Withdrawal by Subject|1|||
94252834|NCT00545051|322718734|FG000|Overall Study|Administrative reasons|0|||
94252835|NCT00545051|322718735|FG001|Overall Study|Administrative reasons|1|||
94252836|NCT02630693|322718736|FG000|Overall Study|No receive treatment|0|||
94252837|NCT02630693|322718737|FG001|Overall Study|No receive treatment|1|||
94252838|NCT01383499|322718740|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
94358298|NCT04516291|323094423|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
94358299|NCT04516291|323094416|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
94358300|NCT04516291|323094417|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
94609084|NCT01916967|324034223|FG002|Overall Study|Physician Decision|1|||
94609085|NCT01916967|324034221|FG000|Overall Study|Protocol Violation|0|||
94609086|NCT01916967|324034222|FG001|Overall Study|Protocol Violation|1|||
94609087|NCT01916967|324034223|FG002|Overall Study|Protocol Violation|0|||
94609088|NCT01528215|324034230|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
94609089|NCT01528215|324034231|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
94609090|NCT01528215|324034230|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
94609091|NCT01528215|324034231|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
94609092|NCT01528215|324034230|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
94609093|NCT01528215|324034231|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
94609094|NCT01528215|324034230|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
94609095|NCT01528215|324034231|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
94609096|NCT01147172|324034232|FG000|Overall Study|Withdrawal by Subject|2|||
94609097|NCT01147172|324034232|FG000|Overall Study|Lost to Follow-up|2|||
94609098|NCT02808650|324034233|FG000|Overall Study|Death|0|||
94609099|NCT02808650|324034234|FG001|Overall Study|Death|0|||
94609100|NCT02808650|324034235|FG002|Overall Study|Death|0|||
94609101|NCT02808650|324034236|FG003|Overall Study|Death|0|||
94609102|NCT02808650|324034237|FG004|Overall Study|Death|1|||
94609103|NCT02808650|324034233|FG000|Overall Study|Lack of Efficacy|5|||
94609104|NCT02808650|324034234|FG001|Overall Study|Lack of Efficacy|5|||
94609105|NCT02808650|324034235|FG002|Overall Study|Lack of Efficacy|6|||
94609106|NCT02808650|324034236|FG003|Overall Study|Lack of Efficacy|5|||
94252839|NCT01383499|322718741|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
94252840|NCT01383499|322718742|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
94252841|NCT01383499|322718743|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
94252842|NCT00918580|322718744|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
94252843|NCT00918580|322718744|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
94252844|NCT00918580|322718744|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
94252845|NCT00918580|322718744|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
94252846|NCT00918580|322718744|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
94252847|NCT00918580|322718744|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
94609107|NCT02808650|324034237|FG004|Overall Study|Lack of Efficacy|4|||
94609108|NCT02808650|324034233|FG000|Overall Study|Physician Decision|1|||
94252848|NCT00918580|322718744|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
94252849|NCT04275089|322718745|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
94252850|NCT01029652|322718752|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
94252851|NCT01029652|322718753|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
94252852|NCT01029652|322718752|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
94252853|NCT01029652|322718753|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
94252854|NCT01029652|322718752|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
94252855|NCT01029652|322718753|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
94252856|NCT01029652|322718752|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
94252857|NCT01029652|322718753|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
94252858|NCT01029652|322718752|FG000|Core Study (0-12 Weeks)|Death|0|||
94252859|NCT01029652|322718753|FG001|Core Study (0-12 Weeks)|Death|1|||
94252860|NCT01029652|322718752|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
94252861|NCT01029652|322718753|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
94252862|NCT01029652|322718752|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
94252863|NCT01029652|322718753|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
94252864|NCT01029652|322718752|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
94252865|NCT01029652|322718753|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
94252866|NCT01029652|322718752|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
94252867|NCT01029652|322718753|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
94252868|NCT01029652|322718752|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
94252869|NCT01029652|322718753|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
94252870|NCT01029652|322718752|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
94252871|NCT01029652|322718753|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
94252872|NCT01029652|322718752|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
94252873|NCT01029652|322718753|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
94252874|NCT00552240|322718754|FG000|Overall Study|Adverse Event|9|||
94252875|NCT00552240|322718755|FG001|Overall Study|Adverse Event|9|||
94252876|NCT00552240|322718754|FG000|Overall Study|Protocol Violation|1|||
94252877|NCT00552240|322718755|FG001|Overall Study|Protocol Violation|1|||
94252878|NCT00552240|322718754|FG000|Overall Study|Lost to Follow-up|5|||
94252879|NCT00552240|322718755|FG001|Overall Study|Lost to Follow-up|6|||
94252880|NCT00552240|322718754|FG000|Overall Study|Withdrawal by Subject|2|||
94252881|NCT00552240|322718755|FG001|Overall Study|Withdrawal by Subject|2|||
94252882|NCT00552240|322718754|FG000|Overall Study|Lack of Efficacy|6|||
94252883|NCT00552240|322718755|FG001|Overall Study|Lack of Efficacy|0|||
94252884|NCT00552240|322718754|FG000|Overall Study|Other|1|||
94252885|NCT00552240|322718755|FG001|Overall Study|Other|0|||
94252886|NCT02679573|322718759|FG000|Overall Study|Adverse Event|13|||
94252887|NCT02679573|322718760|FG001|Overall Study|Adverse Event|6|||
94252888|NCT02679573|322718759|FG000|Overall Study|Lack of Efficacy|12|||
94252889|NCT02679573|322718760|FG001|Overall Study|Lack of Efficacy|15|||
94252890|NCT02679573|322718759|FG000|Overall Study|Could not complete required study visits|6|||
94252891|NCT02679573|322718760|FG001|Overall Study|Could not complete required study visits|2|||
94252892|NCT02679573|322718759|FG000|Overall Study|Withdrawal by Subject|2|||
94252893|NCT02679573|322718760|FG001|Overall Study|Withdrawal by Subject|9|||
94252894|NCT02679573|322718759|FG000|Overall Study|Death|2|||
94252895|NCT02679573|322718760|FG001|Overall Study|Death|0|||
94252896|NCT02679573|322718759|FG000|Overall Study|Physician Decision|2|||
94252897|NCT02679573|322718760|FG001|Overall Study|Physician Decision|4|||
94459320|NCT01190267|323469604|FG000|Overall Study|Withdrawal by Subject|13|||
94459321|NCT01190267|323469605|FG001|Overall Study|Withdrawal by Subject|1|||
94459322|NCT01190267|323469604|FG000|Overall Study|Protocol Violation|8|||
94459323|NCT01190267|323469605|FG001|Overall Study|Protocol Violation|1|||
94459324|NCT03782298|323469606|FG000|Overall Study|Protocol Deviation|4|||
94459325|NCT00742508|323469607|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
94459326|NCT00742508|323469608|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
94459327|NCT00742508|323469607|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
94459328|NCT00742508|323469608|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
94459329|NCT00742508|323469607|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
94459330|NCT00742508|323469608|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
94459331|NCT00742508|323469607|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
94459332|NCT00742508|323469608|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
94459333|NCT00742508|323469607|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
94459334|NCT00742508|323469608|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
94459335|NCT00519428|323469624|FG000|Overall Study|Adverse Event|5|||
94459336|NCT00519428|323469625|FG001|Overall Study|Adverse Event|2|||
94459337|NCT00519428|323469626|FG002|Overall Study|Adverse Event|10|||
94459338|NCT00519428|323469624|FG000|Overall Study|Lost to Follow-up|7|||
94459339|NCT00519428|323469625|FG001|Overall Study|Lost to Follow-up|7|||
94252898|NCT02679573|322718759|FG000|Overall Study|Lost to Follow-up|0|||
94252899|NCT02679573|322718760|FG001|Overall Study|Lost to Follow-up|3|||
94459340|NCT00519428|323469626|FG002|Overall Study|Lost to Follow-up|6|||
94609109|NCT02808650|324034234|FG001|Overall Study|Physician Decision|1|||
94609110|NCT02808650|324034235|FG002|Overall Study|Physician Decision|0|||
94609111|NCT02808650|324034236|FG003|Overall Study|Physician Decision|0|||
94609112|NCT02808650|324034237|FG004|Overall Study|Physician Decision|0|||
94609113|NCT02808650|324034233|FG000|Overall Study|Withdrawal by Subject|0|||
94609114|NCT02808650|324034234|FG001|Overall Study|Withdrawal by Subject|0|||
94609115|NCT02808650|324034235|FG002|Overall Study|Withdrawal by Subject|0|||
94609116|NCT02808650|324034236|FG003|Overall Study|Withdrawal by Subject|1|||
94609117|NCT02808650|324034237|FG004|Overall Study|Withdrawal by Subject|1|||
94609118|NCT01672736|324034238|FG000|Overall Study|Available drug expired on 31 May 16|3|||
94609119|NCT00764491|324034239|FG000|Overall Study|Lost to Follow-up|35|||
94609120|NCT00764491|324034240|FG001|Overall Study|Lost to Follow-up|17|||
94609121|NCT01336569|324034241|FG000|Overall Study|Lost to Follow-up|4|||
94609122|NCT00532155|324034244|FG000|Overall Study|Adverse Event|66|||
94609123|NCT00532155|324034245|FG001|Overall Study|Adverse Event|123|||
94609124|NCT00532155|324034244|FG000|Overall Study|Lack of Efficacy|332|||
94609125|NCT00532155|324034245|FG001|Overall Study|Lack of Efficacy|255|||
94609126|NCT00532155|324034244|FG000|Overall Study|Protocol Violation|1|||
94609127|NCT00532155|324034245|FG001|Overall Study|Protocol Violation|3|||
94609128|NCT00532155|324034244|FG000|Overall Study|Lost to Follow-up|2|||
94609129|NCT00532155|324034245|FG001|Overall Study|Lost to Follow-up|0|||
94609130|NCT00532155|324034244|FG000|Overall Study|Physician Decision|16|||
94609131|NCT00532155|324034245|FG001|Overall Study|Physician Decision|15|||
94609132|NCT00532155|324034244|FG000|Overall Study|Withdrawal by Subject|23|||
94609133|NCT00532155|324034245|FG001|Overall Study|Withdrawal by Subject|44|||
94609134|NCT00532155|324034244|FG000|Overall Study|Consent withdrawn|5|||
94609135|NCT00532155|324034245|FG001|Overall Study|Consent withdrawn|7|||
94609136|NCT00532155|324034244|FG000|Overall Study|Moved|1|||
94609137|NCT00532155|324034245|FG001|Overall Study|Moved|0|||
94609138|NCT00532155|324034244|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
94609139|NCT00532155|324034245|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
94609140|NCT00532155|324034244|FG000|Overall Study|Occurence of a second cancer|0|||
94609141|NCT00532155|324034245|FG001|Overall Study|Occurence of a second cancer|1|||
94609142|NCT00532155|324034244|FG000|Overall Study|Occurence of a secondary cancer|0|||
94609143|NCT00532155|324034245|FG001|Overall Study|Occurence of a secondary cancer|1|||
94609144|NCT00532155|324034244|FG000|Overall Study|Promotor ended study|1|||
94609145|NCT00532155|324034245|FG001|Overall Study|Promotor ended study|0|||
94609146|NCT00532155|324034244|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
94609147|NCT00532155|324034245|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
94609148|NCT00532155|324034244|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
94609149|NCT00532155|324034245|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
94609150|NCT00532155|324034244|FG000|Overall Study|Study stopped|1|||
94609151|NCT00532155|324034245|FG001|Overall Study|Study stopped|0|||
94609152|NCT00532155|324034244|FG000|Overall Study|Study terminated by sponsor|1|||
94609153|NCT00532155|324034245|FG001|Overall Study|Study terminated by sponsor|0|||
94609154|NCT00532155|324034244|FG000|Overall Study|Study termination stop further treatment|4|||
94609155|NCT00532155|324034245|FG001|Overall Study|Study termination stop further treatment|0|||
94609156|NCT00532155|324034244|FG000|Overall Study|Did not receive study medication|2|||
94609157|NCT00532155|324034245|FG001|Overall Study|Did not receive study medication|6|||
94609158|NCT03911154|324034246|FG000|Overall Study|Withdrawal by Subject|1|||
94609159|NCT00973674|324034247|FG000|Overall Study|Protocol Violation|2|||
94609160|NCT00973674|324034248|FG001|Overall Study|Protocol Violation|0|||
94609161|NCT01460368|324034249|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
94609162|NCT01460368|324034250|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
94609163|NCT01460368|324034251|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
94252900|NCT01323647|322718761|FG000|Overall Study|Migrated/moved from study area|2|||
94252901|NCT01323647|322718762|FG001|Overall Study|Migrated/moved from study area|0|||
94252902|NCT01323647|322718761|FG000|Overall Study|Withdrawal by Subject|5|||
94252903|NCT01323647|322718762|FG001|Overall Study|Withdrawal by Subject|0|||
94252904|NCT01323647|322718761|FG000|Overall Study|Lost to Follow-up|2|||
94252905|NCT01323647|322718762|FG001|Overall Study|Lost to Follow-up|0|||
94252906|NCT00468104|322718766|FG000|First Intervention|Protocol Violation|2|||
94609164|NCT01460368|324034252|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
94609165|NCT01460368|324034253|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
94609166|NCT01460368|324034254|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
94252907|NCT00468104|322718767|FG001|First Intervention|Protocol Violation|1|||
94609167|NCT01460368|324034255|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
94609168|NCT01460368|324034249|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
94609169|NCT01460368|324034250|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
94609170|NCT01460368|324034251|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
94609171|NCT01460368|324034252|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
94609172|NCT01460368|324034253|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
94609173|NCT01460368|324034254|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
94459341|NCT00519428|323469624|FG000|Overall Study|Withdrawal by Subject|8|||
94252908|NCT00468104|322718766|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
94459342|NCT00519428|323469625|FG001|Overall Study|Withdrawal by Subject|3|||
94459343|NCT00519428|323469626|FG002|Overall Study|Withdrawal by Subject|7|||
94459344|NCT00519428|323469624|FG000|Overall Study|unstated|1|||
94459345|NCT00519428|323469625|FG001|Overall Study|unstated|3|||
94459346|NCT00519428|323469626|FG002|Overall Study|unstated|2|||
94459347|NCT02135107|323469627|FG000|Treatment Period|Withdrawal by Subject|11|||
94459348|NCT02135107|323469628|FG001|Treatment Period|Withdrawal by Subject|0|||
94459349|NCT02135107|323469629|FG002|Treatment Period|Withdrawal by Subject|0|||
94459350|NCT02135107|323469630|FG003|Treatment Period|Withdrawal by Subject|0|||
94459351|NCT02135107|323469627|FG000|Treatment Period|Adverse Event|5|||
94459352|NCT02135107|323469628|FG001|Treatment Period|Adverse Event|2|||
94459353|NCT02135107|323469629|FG002|Treatment Period|Adverse Event|0|||
94459354|NCT02135107|323469630|FG003|Treatment Period|Adverse Event|0|||
94459355|NCT02135107|323469627|FG000|Treatment Period|Pregnancy|1|||
94459356|NCT02135107|323469628|FG001|Treatment Period|Pregnancy|0|||
94459357|NCT02135107|323469629|FG002|Treatment Period|Pregnancy|0|||
94459358|NCT02135107|323469630|FG003|Treatment Period|Pregnancy|0|||
94459359|NCT02135107|323469627|FG000|Treatment Period|Other|115|||
94459360|NCT02135107|323469628|FG001|Treatment Period|Other|24|||
94459361|NCT02135107|323469629|FG002|Treatment Period|Other|0|||
94459362|NCT02135107|323469630|FG003|Treatment Period|Other|0|||
94459363|NCT02135107|323469627|FG000|Maintenance Therapy Period|Adverse Event|0|||
94459364|NCT02135107|323469628|FG001|Maintenance Therapy Period|Adverse Event|0|||
94459365|NCT02135107|323469629|FG002|Maintenance Therapy Period|Adverse Event|3|||
94459366|NCT02135107|323469630|FG003|Maintenance Therapy Period|Adverse Event|7|||
94459367|NCT02135107|323469627|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
94459368|NCT02135107|323469628|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
94459369|NCT02135107|323469629|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
94459370|NCT02135107|323469630|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
94459371|NCT02135107|323469627|FG000|Maintenance Therapy Period|Pregnancy|0|||
94459372|NCT02135107|323469628|FG001|Maintenance Therapy Period|Pregnancy|0|||
94459373|NCT02135107|323469629|FG002|Maintenance Therapy Period|Pregnancy|0|||
94459374|NCT02135107|323469630|FG003|Maintenance Therapy Period|Pregnancy|1|||
94459375|NCT02135107|323469627|FG000|Maintenance Therapy Period|Other|0|||
94459376|NCT02135107|323469628|FG001|Maintenance Therapy Period|Other|0|||
94459377|NCT02135107|323469629|FG002|Maintenance Therapy Period|Other|7|||
94459378|NCT02135107|323469630|FG003|Maintenance Therapy Period|Other|8|||
94609174|NCT01460368|324034255|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
94609175|NCT01460368|324034249|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
94609176|NCT01460368|324034250|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
94609177|NCT01460368|324034251|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
94609178|NCT01460368|324034252|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
94609179|NCT01460368|324034253|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
94609180|NCT01460368|324034254|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
94609181|NCT01460368|324034255|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
94609182|NCT01460368|324034249|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
94609183|NCT01460368|324034250|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
94609184|NCT01460368|324034251|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
94609185|NCT01460368|324034252|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
94609186|NCT01460368|324034253|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
94609187|NCT01460368|324034254|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
94609188|NCT01460368|324034255|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
94609189|NCT01460368|324034249|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
94609190|NCT01460368|324034250|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
94609191|NCT01460368|324034251|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
94609192|NCT01460368|324034252|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
94609193|NCT01460368|324034253|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
94609194|NCT01460368|324034254|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
94609195|NCT01460368|324034255|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
94609196|NCT00747461|324034256|FG000|Overall Study|study terminated by sponsor|5|||
94609197|NCT02047227|324034257|FG000|Overall Study|Adverse Event|2|||
94609198|NCT02047227|324034258|FG001|Overall Study|Adverse Event|4|||
94609199|NCT02047227|324034257|FG000|Overall Study|Lost to Follow-up|0|||
94609200|NCT02047227|324034258|FG001|Overall Study|Lost to Follow-up|3|||
94609201|NCT02047227|324034257|FG000|Overall Study|Protocol Violation|1|||
94609202|NCT02047227|324034258|FG001|Overall Study|Protocol Violation|0|||
94609203|NCT02047227|324034257|FG000|Overall Study|Spontaneous pregnancy|1|||
94609204|NCT02047227|324034258|FG001|Overall Study|Spontaneous pregnancy|0|||
94609205|NCT02047227|324034257|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
94609206|NCT02047227|324034258|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
94609207|NCT02047227|324034257|FG000|Overall Study|No oocytes retrieved|21|||
94609208|NCT02047227|324034258|FG001|Overall Study|No oocytes retrieved|20|||
94609209|NCT02047227|324034257|FG000|Overall Study|No fertilization|61|||
94609210|NCT02047227|324034258|FG001|Overall Study|No fertilization|51|||
94609211|NCT02047227|324034257|FG000|Overall Study|Intention to freeze all embryos|1|||
94609212|NCT02047227|324034258|FG001|Overall Study|Intention to freeze all embryos|0|||
94609213|NCT02047227|324034257|FG000|Overall Study|All embryos discarded|12|||
94609214|NCT02047227|324034258|FG001|Overall Study|All embryos discarded|11|||
94609215|NCT02047227|324034257|FG000|Overall Study|Other|10|||
94609216|NCT02047227|324034258|FG001|Overall Study|Other|9|||
94609217|NCT00299182|324034271|FG000|Overall Study|Withdrawal by Subject|0|||
94609218|NCT00299182|324034272|FG001|Overall Study|Withdrawal by Subject|0|||
94609219|NCT00299182|324034273|FG002|Overall Study|Withdrawal by Subject|1|||
94609220|NCT00299182|324034274|FG003|Overall Study|Withdrawal by Subject|0|||
94609221|NCT00299182|324034275|FG004|Overall Study|Withdrawal by Subject|1|||
94609222|NCT00299182|324034276|FG005|Overall Study|Withdrawal by Subject|2|||
94609223|NCT00299182|324034277|FG006|Overall Study|Withdrawal by Subject|0|||
94609224|NCT00299182|324034271|FG000|Overall Study|Chemotherapy Changed|0|||
94609225|NCT00299182|324034272|FG001|Overall Study|Chemotherapy Changed|0|||
94609226|NCT00299182|324034273|FG002|Overall Study|Chemotherapy Changed|1|||
94609227|NCT00299182|324034274|FG003|Overall Study|Chemotherapy Changed|0|||
94609228|NCT00299182|324034275|FG004|Overall Study|Chemotherapy Changed|1|||
94609229|NCT00299182|324034276|FG005|Overall Study|Chemotherapy Changed|0|||
94609230|NCT00299182|324034277|FG006|Overall Study|Chemotherapy Changed|1|||
94609231|NCT00299182|324034271|FG000|Overall Study|Adverse Event|0|||
94609232|NCT00299182|324034272|FG001|Overall Study|Adverse Event|0|||
94609233|NCT00299182|324034273|FG002|Overall Study|Adverse Event|0|||
94609234|NCT00299182|324034274|FG003|Overall Study|Adverse Event|0|||
94609235|NCT00299182|324034275|FG004|Overall Study|Adverse Event|0|||
94609236|NCT00299182|324034276|FG005|Overall Study|Adverse Event|1|||
94609237|NCT00299182|324034277|FG006|Overall Study|Adverse Event|0|||
94609238|NCT00299182|324034271|FG000|Overall Study|Not Eligible|0|||
94609239|NCT00299182|324034272|FG001|Overall Study|Not Eligible|0|||
94609240|NCT00299182|324034273|FG002|Overall Study|Not Eligible|0|||
94609241|NCT00299182|324034274|FG003|Overall Study|Not Eligible|0|||
94609242|NCT00299182|324034275|FG004|Overall Study|Not Eligible|1|||
94609243|NCT00299182|324034276|FG005|Overall Study|Not Eligible|0|||
94609244|NCT00299182|324034277|FG006|Overall Study|Not Eligible|0|||
94609245|NCT02713204|324034282|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
94609246|NCT02713204|324034283|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
94609247|NCT02713204|324034284|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
94609248|NCT02713204|324034285|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
94609249|NCT02713204|324034286|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
94609250|NCT02713204|324034287|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
94609251|NCT02713204|324034288|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
94609252|NCT02713204|324034289|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
94609253|NCT02713204|324034282|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
94609254|NCT02713204|324034283|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
94609255|NCT02713204|324034284|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
94609256|NCT02713204|324034285|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
94609257|NCT02713204|324034286|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
94609258|NCT02713204|324034287|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
94609259|NCT02713204|324034288|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
94609260|NCT02713204|324034289|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
94609261|NCT02713204|324034282|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
94609262|NCT02713204|324034283|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
94609263|NCT02713204|324034284|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
94609264|NCT02713204|324034285|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
94609265|NCT02713204|324034286|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
94609266|NCT02713204|324034287|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
94609267|NCT02713204|324034288|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
94609268|NCT02713204|324034289|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
94609269|NCT02713204|324034282|FG000|From Week 12 up to Week 36|Adverse Event|1|||
94609270|NCT02713204|324034283|FG001|From Week 12 up to Week 36|Adverse Event|0|||
94609271|NCT02713204|324034284|FG002|From Week 12 up to Week 36|Adverse Event|0|||
94609272|NCT02713204|324034285|FG003|From Week 12 up to Week 36|Adverse Event|1|||
94609273|NCT02713204|324034286|FG004|From Week 12 up to Week 36|Adverse Event|1|||
94609274|NCT02713204|324034287|FG005|From Week 12 up to Week 36|Adverse Event|0|||
94609275|NCT02713204|324034288|FG006|From Week 12 up to Week 36|Adverse Event|2|||
94609276|NCT02713204|324034289|FG007|From Week 12 up to Week 36|Adverse Event|1|||
94609277|NCT02713204|324034282|FG000|From Week 12 up to Week 36|Death|0|||
94609278|NCT02713204|324034283|FG001|From Week 12 up to Week 36|Death|0|||
94609279|NCT02713204|324034284|FG002|From Week 12 up to Week 36|Death|0|||
94609280|NCT02713204|324034285|FG003|From Week 12 up to Week 36|Death|1|||
94609281|NCT02713204|324034286|FG004|From Week 12 up to Week 36|Death|0|||
94609282|NCT02713204|324034287|FG005|From Week 12 up to Week 36|Death|1|||
94609283|NCT02713204|324034288|FG006|From Week 12 up to Week 36|Death|0|||
94609284|NCT02713204|324034289|FG007|From Week 12 up to Week 36|Death|3|||
94609285|NCT02713204|324034282|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
94609286|NCT02713204|324034283|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
94609287|NCT02713204|324034284|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
94609288|NCT02713204|324034285|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
94609289|NCT02713204|324034286|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
94609290|NCT02713204|324034287|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
94609291|NCT02713204|324034288|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
94609292|NCT02713204|324034289|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
94609293|NCT02713204|324034282|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
94609294|NCT02713204|324034283|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
94609295|NCT02713204|324034284|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
94609296|NCT02713204|324034285|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
94609297|NCT02713204|324034286|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
94609298|NCT02713204|324034287|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
94609299|NCT02713204|324034288|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
94609300|NCT02713204|324034289|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
94609301|NCT00936611|324034290|FG000|Overall Study|Progressive Disease|3|||
94609302|NCT00936611|324034290|FG000|Overall Study|New Systemic Therapy|22|||
94609303|NCT00936611|324034290|FG000|Overall Study|Lost to Follow-up|1|||
94609304|NCT00936611|324034290|FG000|Overall Study|Withdrawal by Subject|2|||
94609305|NCT00936611|324034290|FG000|Overall Study|Still on Follow-up|1|||
94609306|NCT00936611|324034290|FG000|Overall Study|Still on Active Therapy|7|||
94609307|NCT00936611|324034290|FG000|Overall Study|Ineligible for Study Drug|3|||
94609308|NCT01565642|324034291|FG000|Overall Study|Withdrawal by Subject|2|||
94609309|NCT01565642|324034292|FG001|Overall Study|Withdrawal by Subject|1|||
94609310|NCT01934972|324034293|FG000|Overall Study|Withdrawal by Subject|9|||
94609311|NCT01934972|324034294|FG001|Overall Study|Withdrawal by Subject|6|||
94609312|NCT02955797|324034295|FG000|Overall Study|Protocol Violation|1|||
94609313|NCT02955797|324034296|FG001|Overall Study|Protocol Violation|0|||
94609314|NCT02955797|324034297|FG002|Overall Study|Protocol Violation|0|||
94609315|NCT02955797|324034298|FG003|Overall Study|Protocol Violation|1|||
94609316|NCT02955797|324034295|FG000|Overall Study|Withdrawal by Subject|2|||
94609317|NCT02955797|324034296|FG001|Overall Study|Withdrawal by Subject|2|||
94609318|NCT02955797|324034297|FG002|Overall Study|Withdrawal by Subject|0|||
94609319|NCT02955797|324034298|FG003|Overall Study|Withdrawal by Subject|1|||
94609320|NCT02955797|324034295|FG000|Overall Study|Lost to Follow-up|0|||
94609321|NCT02955797|324034296|FG001|Overall Study|Lost to Follow-up|1|||
94609322|NCT02955797|324034297|FG002|Overall Study|Lost to Follow-up|0|||
94609323|NCT02955797|324034298|FG003|Overall Study|Lost to Follow-up|0|||
94609324|NCT02770170|324034301|FG000|Overall Study|Withdrawal by Subject|0|||
94609325|NCT02770170|324034302|FG001|Overall Study|Withdrawal by Subject|0|||
94609326|NCT02770170|324034303|FG002|Overall Study|Withdrawal by Subject|0|||
94609327|NCT02770170|324034304|FG003|Overall Study|Withdrawal by Subject|2|||
94609328|NCT02770170|324034301|FG000|Overall Study|due to pregnancy|1|||
94609329|NCT02770170|324034302|FG001|Overall Study|due to pregnancy|0|||
94609330|NCT02770170|324034303|FG002|Overall Study|due to pregnancy|0|||
94609331|NCT02770170|324034304|FG003|Overall Study|due to pregnancy|0|||
94609332|NCT02770170|324034301|FG000|Overall Study|Lack of Efficacy|2|||
94609333|NCT02770170|324034302|FG001|Overall Study|Lack of Efficacy|0|||
94609334|NCT02770170|324034303|FG002|Overall Study|Lack of Efficacy|0|||
94609335|NCT02770170|324034304|FG003|Overall Study|Lack of Efficacy|1|||
94609336|NCT02770170|324034301|FG000|Overall Study|Adverse Event|4|||
94609337|NCT02770170|324034302|FG001|Overall Study|Adverse Event|3|||
94609338|NCT02770170|324034303|FG002|Overall Study|Adverse Event|5|||
94609339|NCT02770170|324034304|FG003|Overall Study|Adverse Event|3|||
94609340|NCT02770170|324034301|FG000|Overall Study|due to disease worsening|0|||
94609341|NCT02770170|324034302|FG001|Overall Study|due to disease worsening|0|||
94609342|NCT02770170|324034303|FG002|Overall Study|due to disease worsening|0|||
94609343|NCT02770170|324034304|FG003|Overall Study|due to disease worsening|1|||
94609344|NCT00304239|324034305|FG000|Overall Study|Protocol Deviations/Violations|15|||
94609345|NCT00304239|324034306|FG001|Overall Study|Protocol Deviations/Violations|0|||
94609346|NCT00304239|324034305|FG000|Overall Study|Adverse Event|2|||
94609347|NCT00304239|324034306|FG001|Overall Study|Adverse Event|0|||
94609348|NCT01710046|324034307|FG000|Overall Study|Lost to Follow-up|1|||
94609349|NCT01710046|324034308|FG001|Overall Study|Lost to Follow-up|0|||
94609350|NCT05182125|324034311|FG000|Overall Study|Withdrawal by Subject|0|||
94609351|NCT05182125|324034312|FG001|Overall Study|Withdrawal by Subject|0|||
94609352|NCT05182125|324034313|FG002|Overall Study|Withdrawal by Subject|0|||
94609353|NCT05182125|324034314|FG003|Overall Study|Withdrawal by Subject|0|||
94609354|NCT05182125|324034315|FG004|Overall Study|Withdrawal by Subject|2|||
94609355|NCT05182125|324034316|FG005|Overall Study|Withdrawal by Subject|0|||
94609356|NCT05182125|324034311|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
94609357|NCT05182125|324034312|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
94609358|NCT05182125|324034313|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
94609359|NCT05182125|324034314|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
94609360|NCT05182125|324034315|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
94609361|NCT05182125|324034316|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
94609362|NCT05182125|324034311|FG000|Overall Study|Death|0|||
94609363|NCT05182125|324034312|FG001|Overall Study|Death|0|||
94609364|NCT05182125|324034313|FG002|Overall Study|Death|0|||
94609365|NCT05182125|324034314|FG003|Overall Study|Death|0|||
94609366|NCT05182125|324034315|FG004|Overall Study|Death|1|||
94609367|NCT05182125|324034316|FG005|Overall Study|Death|0|||
94609368|NCT05182125|324034311|FG000|Overall Study|Health Contact Follow-up|5|||
94609369|NCT05182125|324034312|FG001|Overall Study|Health Contact Follow-up|5|||
94609370|NCT05182125|324034313|FG002|Overall Study|Health Contact Follow-up|2|||
94609371|NCT05182125|324034314|FG003|Overall Study|Health Contact Follow-up|9|||
94609372|NCT05182125|324034315|FG004|Overall Study|Health Contact Follow-up|7|||
94609373|NCT05182125|324034316|FG005|Overall Study|Health Contact Follow-up|2|||
94609374|NCT01033851|324034317|FG000|Overall Study|Withdrawal by Subject|3|||
94609375|NCT01033851|324034318|FG001|Overall Study|Withdrawal by Subject|7|||
94609376|NCT04815031|324034319|FG000|Overall Study|No adverse event information (missing information)|33|||
94609377|NCT04996797|324034323|FG000|Overall Study|Adverse Event|0|||
94609378|NCT04996797|324034324|FG001|Overall Study|Adverse Event|2|||
94609379|NCT04996797|324034325|FG002|Overall Study|Adverse Event|0|||
94609380|NCT04996797|324034326|FG003|Overall Study|Adverse Event|1|||
94609381|NCT04996797|324034323|FG000|Overall Study|Lack of Efficacy|0|||
94609382|NCT04996797|324034324|FG001|Overall Study|Lack of Efficacy|2|||
94609383|NCT04996797|324034325|FG002|Overall Study|Lack of Efficacy|0|||
94609384|NCT04996797|324034326|FG003|Overall Study|Lack of Efficacy|0|||
94609385|NCT04996797|324034323|FG000|Overall Study|Prohibited Medication|0|||
94609386|NCT04996797|324034324|FG001|Overall Study|Prohibited Medication|1|||
94609387|NCT04996797|324034325|FG002|Overall Study|Prohibited Medication|0|||
94609388|NCT04996797|324034326|FG003|Overall Study|Prohibited Medication|0|||
94609389|NCT04996797|324034323|FG000|Overall Study|Ongoing|68|||
94609390|NCT04996797|324034324|FG001|Overall Study|Ongoing|60|||
94609391|NCT04996797|324034325|FG002|Overall Study|Ongoing|22|||
94609392|NCT04996797|324034326|FG003|Overall Study|Ongoing|20|||
94609393|NCT04996797|324034323|FG000|Overall Study|Withdrawal by Subject|0|||
94609394|NCT04996797|324034324|FG001|Overall Study|Withdrawal by Subject|2|||
94609395|NCT04996797|324034325|FG002|Overall Study|Withdrawal by Subject|0|||
94609396|NCT04996797|324034326|FG003|Overall Study|Withdrawal by Subject|0|||
94609397|NCT01558739|324034327|FG000|Overall Study|Adverse Event|7|||
94609398|NCT01558739|324034327|FG000|Overall Study|Withdrawal by Subject|2|||
94609399|NCT01558739|324034327|FG000|Overall Study|Death|3|||
94609400|NCT01558739|324034327|FG000|Overall Study|Disease Progression|4|||
94609401|NCT01558739|324034327|FG000|Overall Study|Protocol Violation|1|||
94609402|NCT04526509|324034330|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
94609403|NCT04526509|324034331|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
94609404|NCT04526509|324034332|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
94609405|NCT04526509|324034333|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
94609406|NCT04526509|324034334|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
94252909|NCT00468104|322718767|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
94252910|NCT00468104|322718766|FG000|First Intervention|died within 3 weeks|1|||
94252911|NCT00468104|322718767|FG001|First Intervention|died within 3 weeks|0|||
94252912|NCT00468104|322718766|FG000|First Intervention|malposition/blocked chest tube tube|2|||
94252913|NCT00468104|322718767|FG001|First Intervention|malposition/blocked chest tube tube|0|||
94252914|NCT00468104|322718766|FG000|First Intervention|large lung mass with minimal effusion|1|||
94252915|NCT00468104|322718767|FG001|First Intervention|large lung mass with minimal effusion|0|||
94252916|NCT00468104|322718766|FG000|First Intervention|associated prolonged pneumothorax|1|||
94252917|NCT00468104|322718767|FG001|First Intervention|associated prolonged pneumothorax|0|||
94252918|NCT00468104|322718766|FG000|First Intervention|trapped lung|1|||
94252919|NCT00468104|322718767|FG001|First Intervention|trapped lung|0|||
94459379|NCT02278120|323469639|FG000|Treatment Period|Progressive disease|234|||
94459380|NCT02278120|323469640|FG001|Treatment Period|Progressive disease|260|||
94459381|NCT02278120|323469639|FG000|Treatment Period|Subject/guardian decision|23|||
94459382|NCT02278120|323469640|FG001|Treatment Period|Subject/guardian decision|20|||
94252920|NCT00468104|322718766|FG000|Second Intervention|Withdrawal by Subject|5|||
94252921|NCT00468104|322718767|FG001|Second Intervention|Withdrawal by Subject|2|||
94252922|NCT00468104|322718766|FG000|Second Intervention|discarded for malposition of chest tube|0|||
94252923|NCT00468104|322718767|FG001|Second Intervention|discarded for malposition of chest tube|2|||
94252924|NCT02706899|322718768|FG000|Overall Study|Withdrawal by Subject|1|||
94252925|NCT02706899|322718769|FG001|Overall Study|Withdrawal by Subject|0|||
94252926|NCT02706899|322718768|FG000|Overall Study|Death|8|||
94252927|NCT02706899|322718769|FG001|Overall Study|Death|0|||
94252928|NCT02706899|322718768|FG000|Overall Study|Study Termination by Sponsor|4|||
94252929|NCT02706899|322718769|FG001|Overall Study|Study Termination by Sponsor|6|||
94252930|NCT01737827|322718772|FG000|Overall Study|Adverse Event|3|||
94252931|NCT01737827|322718773|FG001|Overall Study|Adverse Event|6|||
94252932|NCT01737827|322718774|FG002|Overall Study|Adverse Event|0|||
94252933|NCT01737827|322718772|FG000|Overall Study|Lost to Follow-up|0|||
94609407|NCT04526509|324034335|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
94609408|NCT04526509|324034336|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
94609409|NCT04526509|324034330|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
94609410|NCT04526509|324034331|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
94609411|NCT04526509|324034332|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
94609412|NCT04526509|324034333|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
94609413|NCT04526509|324034334|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
94609414|NCT04526509|324034335|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
94609415|NCT04526509|324034336|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
94609416|NCT04526509|324034330|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
94609417|NCT04526509|324034331|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
94609418|NCT04526509|324034332|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
94609419|NCT04526509|324034333|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
94609420|NCT04526509|324034334|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
94609421|NCT04526509|324034335|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
94609422|NCT04526509|324034336|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
94609423|NCT04526509|324034330|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
94609424|NCT04526509|324034331|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
94609425|NCT04526509|324034332|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
94609426|NCT04526509|324034333|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
94609427|NCT04526509|324034334|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
94609428|NCT04526509|324034335|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
94609429|NCT04526509|324034336|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
94609430|NCT04526509|324034330|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
94609431|NCT04526509|324034331|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
94651427|NCT02331446|324181649|FG001|Overall Study|Lost before baseline analysis|1|||
94651428|NCT02331446|324181650|FG002|Overall Study|Lost before baseline analysis|1|||
94651429|NCT02331446|324181651|FG003|Overall Study|Lost before baseline analysis|0|||
94651430|NCT04879745|324181652|FG000|Overall Study|Lost to Follow-up|4|||
94651431|NCT04879745|324181653|FG001|Overall Study|Lost to Follow-up|1|||
94651432|NCT03852316|324181655|FG000|Overall Study|Protocol Violation|1|||
94252934|NCT01737827|322718773|FG001|Overall Study|Lost to Follow-up|1|||
94252935|NCT01737827|322718774|FG002|Overall Study|Lost to Follow-up|0|||
94252936|NCT01737827|322718772|FG000|Overall Study|Physician Decision|0|||
94252937|NCT01737827|322718773|FG001|Overall Study|Physician Decision|2|||
94459383|NCT02278120|323469639|FG000|Treatment Period|Adverse Event|16|||
94252938|NCT01737827|322718774|FG002|Overall Study|Physician Decision|0|||
94252939|NCT01737827|322718772|FG000|Overall Study|Progressive Disease|5|||
94459384|NCT02278120|323469640|FG001|Treatment Period|Adverse Event|14|||
94252940|NCT01737827|322718773|FG001|Overall Study|Progressive Disease|16|||
94252941|NCT01737827|322718774|FG002|Overall Study|Progressive Disease|2|||
94459385|NCT02278120|323469639|FG000|Treatment Period|Physician Decision|14|||
94358301|NCT04516291|323094418|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
94358302|NCT04516291|323094419|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
94358303|NCT04516291|323094420|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
94358304|NCT04516291|323094421|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
94358305|NCT04516291|323094422|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
94358306|NCT04516291|323094423|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
94358307|NCT00463385|323094431|FG000|Overall Study|Other|4|||
94358308|NCT00463385|323094432|FG001|Overall Study|Other|3|||
94358309|NCT00463385|323094433|FG002|Overall Study|Other|6|||
94358310|NCT00463385|323094434|FG003|Overall Study|Other|4|||
94358311|NCT00463385|323094431|FG000|Overall Study|Adverse Event|5|||
94609432|NCT04526509|324034332|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
94609433|NCT04526509|324034333|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
94609434|NCT04526509|324034334|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
94609435|NCT04526509|324034335|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
94609436|NCT04526509|324034336|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
94609437|NCT04526509|324034330|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
94609438|NCT04526509|324034331|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
94609439|NCT04526509|324034332|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
94609440|NCT04526509|324034333|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
94609441|NCT04526509|324034334|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
94609442|NCT04526509|324034335|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
94609443|NCT04526509|324034336|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
94609444|NCT04526509|324034330|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
94609445|NCT04526509|324034331|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
94609446|NCT04526509|324034332|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
94661689|NCT00558285|324215804|FG000|Overall Study|Lost to Follow-up|1|||
94358312|NCT00463385|323094432|FG001|Overall Study|Adverse Event|8|||
94358313|NCT00463385|323094433|FG002|Overall Study|Adverse Event|4|||
94358314|NCT00463385|323094434|FG003|Overall Study|Adverse Event|2|||
94358315|NCT00463385|323094431|FG000|Overall Study|Lack of Efficacy|6|||
94358316|NCT00463385|323094432|FG001|Overall Study|Lack of Efficacy|6|||
94358317|NCT00463385|323094433|FG002|Overall Study|Lack of Efficacy|7|||
94358318|NCT00463385|323094434|FG003|Overall Study|Lack of Efficacy|9|||
94358319|NCT00463385|323094431|FG000|Overall Study|Withdrawal by Subject|3|||
94358320|NCT00463385|323094432|FG001|Overall Study|Withdrawal by Subject|3|||
94358321|NCT00463385|323094433|FG002|Overall Study|Withdrawal by Subject|3|||
94358322|NCT00463385|323094434|FG003|Overall Study|Withdrawal by Subject|4|||
94358323|NCT00463385|323094431|FG000|Overall Study|Lost to Follow-up|0|||
94358324|NCT00463385|323094432|FG001|Overall Study|Lost to Follow-up|0|||
94358325|NCT00463385|323094433|FG002|Overall Study|Lost to Follow-up|0|||
94358326|NCT00463385|323094434|FG003|Overall Study|Lost to Follow-up|1|||
94358327|NCT00463385|323094431|FG000|Overall Study|Death|2|||
94358328|NCT00463385|323094432|FG001|Overall Study|Death|1|||
94358329|NCT00463385|323094433|FG002|Overall Study|Death|2|||
94358330|NCT00463385|323094434|FG003|Overall Study|Death|0|||
94358331|NCT00463385|323094431|FG000|Overall Study|Missing|2|||
94358332|NCT00463385|323094432|FG001|Overall Study|Missing|0|||
94358333|NCT00463385|323094433|FG002|Overall Study|Missing|0|||
94358334|NCT00463385|323094434|FG003|Overall Study|Missing|2|||
94358335|NCT00463385|323094431|FG000|Overall Study|1 participant received commercial drug|0|||
94358336|NCT00463385|323094432|FG001|Overall Study|1 participant received commercial drug|1|||
94358337|NCT00463385|323094433|FG002|Overall Study|1 participant received commercial drug|0|||
94358338|NCT00463385|323094434|FG003|Overall Study|1 participant received commercial drug|0|||
94358339|NCT00447265|323094435|FG000|Overall Study|Physician Decision|1|||
94358340|NCT00447265|323094436|FG001|Overall Study|Physician Decision|0|||
94358341|NCT03472586|323094437|FG000|Overall Study|Physician Decision|6|||
94609447|NCT04526509|324034333|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
94609448|NCT04526509|324034334|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
94252942|NCT01737827|322718772|FG000|Overall Study|Study Terminated by Sponsor|0|||
94252943|NCT01737827|322718773|FG001|Overall Study|Study Terminated by Sponsor|1|||
94252944|NCT01737827|322718774|FG002|Overall Study|Study Terminated by Sponsor|0|||
94252945|NCT01737827|322718772|FG000|Overall Study|Subject/Guardian Decision|0|||
94252946|NCT01737827|322718773|FG001|Overall Study|Subject/Guardian Decision|2|||
94252947|NCT01737827|322718774|FG002|Overall Study|Subject/Guardian Decision|0|||
94252948|NCT00190749|322718778|FG000|Overall Study|Lost to Follow-up|8|||
94252949|NCT00190749|322718779|FG001|Overall Study|Lost to Follow-up|11|||
94252950|NCT00190749|322718778|FG000|Overall Study|Withdrawal by Subject|10|||
94252951|NCT00190749|322718779|FG001|Overall Study|Withdrawal by Subject|6|||
94609449|NCT04526509|324034335|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
94609450|NCT04526509|324034336|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
94609451|NCT04526509|324034330|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
94609452|NCT04526509|324034331|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
94609453|NCT04526509|324034332|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
94609454|NCT04526509|324034333|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
94609455|NCT04526509|324034334|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
94609456|NCT04526509|324034335|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
94609457|NCT04526509|324034336|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
94609458|NCT04526509|324034330|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
94609459|NCT04526509|324034331|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
94609460|NCT04526509|324034332|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
94609461|NCT04526509|324034333|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
94609462|NCT04526509|324034334|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
94609463|NCT04526509|324034335|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
94609464|NCT04526509|324034336|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
94609465|NCT04526509|324034330|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
94609466|NCT04526509|324034331|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
94609467|NCT04526509|324034332|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
94609468|NCT04526509|324034333|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
94609469|NCT04526509|324034334|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
94609470|NCT04526509|324034335|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
94609471|NCT04526509|324034336|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
94609472|NCT04526509|324034330|FG000|Enrolled|Study Terminated by Sponsor|0|||
94609473|NCT04526509|324034331|FG001|Enrolled|Study Terminated by Sponsor|0|||
94609474|NCT04526509|324034332|FG002|Enrolled|Study Terminated by Sponsor|0|||
94609475|NCT04526509|324034333|FG003|Enrolled|Study Terminated by Sponsor|0|||
94609476|NCT04526509|324034334|FG004|Enrolled|Study Terminated by Sponsor|0|||
94609477|NCT04526509|324034335|FG005|Enrolled|Study Terminated by Sponsor|0|||
94609478|NCT04526509|324034336|FG006|Enrolled|Study Terminated by Sponsor|1|||
94609479|NCT04526509|324034330|FG000|Enrolled|Death prior to lymphodepletion|0|||
94609480|NCT04526509|324034331|FG001|Enrolled|Death prior to lymphodepletion|0|||
94609481|NCT04526509|324034332|FG002|Enrolled|Death prior to lymphodepletion|0|||
94609482|NCT04526509|324034333|FG003|Enrolled|Death prior to lymphodepletion|1|||
94661690|NCT00558285|324215805|FG001|Overall Study|Lost to Follow-up|1|||
94252952|NCT00190749|322718778|FG000|Overall Study|Protocol Violation|5|||
94252953|NCT00190749|322718779|FG001|Overall Study|Protocol Violation|4|||
94252954|NCT00190749|322718778|FG000|Overall Study|Adverse Event|0|||
94252955|NCT00190749|322718779|FG001|Overall Study|Adverse Event|5|||
94358342|NCT03472586|323094437|FG000|Overall Study|Death|6|||
94609483|NCT04526509|324034334|FG004|Enrolled|Death prior to lymphodepletion|0|||
94252956|NCT00190749|322718778|FG000|Overall Study|Lack of Efficacy|2|||
94609484|NCT04526509|324034335|FG005|Enrolled|Death prior to lymphodepletion|0|||
94609485|NCT04526509|324034336|FG006|Enrolled|Death prior to lymphodepletion|0|||
94609486|NCT04526509|324034330|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
94609487|NCT04526509|324034331|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
94609488|NCT04526509|324034332|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
94609489|NCT04526509|324034333|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
94609490|NCT04526509|324034334|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
94609491|NCT04526509|324034335|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
94609492|NCT04526509|324034336|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
94609493|NCT04526509|324034330|FG000|Enrolled|Physician Decision|0|||
94609494|NCT04526509|324034331|FG001|Enrolled|Physician Decision|1|||
94609495|NCT04526509|324034332|FG002|Enrolled|Physician Decision|0|||
94609496|NCT04526509|324034333|FG003|Enrolled|Physician Decision|0|||
94609497|NCT04526509|324034334|FG004|Enrolled|Physician Decision|0|||
94609498|NCT04526509|324034335|FG005|Enrolled|Physician Decision|0|||
94609499|NCT04526509|324034336|FG006|Enrolled|Physician Decision|0|||
94609500|NCT01066000|324034337|FG000|Overall Study|Protocol Violation|4|||
94609501|NCT01066000|324034337|FG000|Overall Study|Death|3|||
94609502|NCT01066000|324034337|FG000|Overall Study|Withdrawal by Subject|1|||
94609503|NCT01066000|324034337|FG000|Overall Study|Adverse Event|1|||
94609504|NCT05136690|324034338|FG000|Period 1|Withdrawal by Subject|0|||
94609505|NCT05136690|324034339|FG001|Period 1|Withdrawal by Subject|1|||
94609506|NCT05136690|324034338|FG000|Period 2|Lost to Follow-up|0|||
94609507|NCT05136690|324034339|FG001|Period 2|Lost to Follow-up|3|||
94609508|NCT05136690|324034338|FG000|Period 2|Withdrawal by Subject|0|||
94252957|NCT00190749|322718779|FG001|Overall Study|Lack of Efficacy|3|||
94252958|NCT00190749|322718778|FG000|Overall Study|Reason Not Specified|0|||
94252959|NCT00190749|322718779|FG001|Overall Study|Reason Not Specified|2|||
94252960|NCT00190749|322718778|FG000|Overall Study|Sponsor Decision|1|||
94252961|NCT00190749|322718779|FG001|Overall Study|Sponsor Decision|0|||
94252962|NCT01090427|322718780|FG000|After Controlled Period|Death|0|||
94252963|NCT01090427|322718781|FG001|After Controlled Period|Death|0|||
94252964|NCT01090427|322718782|FG002|After Controlled Period|Death|0|||
94252965|NCT01090427|322718783|FG003|After Controlled Period|Death|0|||
94252966|NCT01090427|322718784|FG004|After Controlled Period|Death|0|||
94252967|NCT01090427|322718785|FG005|After Controlled Period|Death|1|||
94252968|NCT01090427|322718786|FG006|After Controlled Period|Death|0|||
94252969|NCT01090427|322718780|FG000|After Controlled Period|Lack of Efficacy|0|||
94252970|NCT01090427|322718781|FG001|After Controlled Period|Lack of Efficacy|0|||
94252971|NCT01090427|322718782|FG002|After Controlled Period|Lack of Efficacy|0|||
94252972|NCT01090427|322718783|FG003|After Controlled Period|Lack of Efficacy|0|||
94252973|NCT01090427|322718784|FG004|After Controlled Period|Lack of Efficacy|0|||
94252974|NCT01090427|322718785|FG005|After Controlled Period|Lack of Efficacy|3|||
94252975|NCT01090427|322718786|FG006|After Controlled Period|Lack of Efficacy|2|||
94252976|NCT01090427|322718780|FG000|After Controlled Period|Adverse Event|0|||
94252977|NCT01090427|322718781|FG001|After Controlled Period|Adverse Event|0|||
94609509|NCT05136690|324034339|FG001|Period 2|Withdrawal by Subject|1|||
94609510|NCT03061097|324035559|FG000|Overall Study|Withdrawal by Subject|0|||
94609511|NCT03061097|324035560|FG001|Overall Study|Withdrawal by Subject|3|||
94609512|NCT01614600|324035561|FG000|Overall Study|Unacceptable fit|1|||
94609513|NCT01614600|324035561|FG000|Overall Study|Discomfort|1|||
94252978|NCT01090427|322718782|FG002|After Controlled Period|Adverse Event|0|||
94252979|NCT01090427|322718783|FG003|After Controlled Period|Adverse Event|2|||
94252980|NCT01090427|322718784|FG004|After Controlled Period|Adverse Event|0|||
94252981|NCT01090427|322718785|FG005|After Controlled Period|Adverse Event|1|||
94252982|NCT01090427|322718786|FG006|After Controlled Period|Adverse Event|0|||
94252983|NCT01154010|322718787|FG000|Overall Study|Lost to Follow-up|0|||
94358343|NCT03472586|323094437|FG000|Overall Study|Adverse Event|1|||
94358344|NCT02528331|323094439|FG000|Overall Study|Withdrawal by Subject|2|||
94358345|NCT01342445|323094441|FG000|Overall Study|Experienced side effects|0|||
94358346|NCT01342445|323094442|FG001|Overall Study|Experienced side effects|2|||
94358347|NCT05299359|323094443|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
94609514|NCT01614600|324035561|FG000|Overall Study|Unable to remove lens at the end of day|1|||
94609515|NCT01614600|324035561|FG000|Overall Study|Protocol deviation|1|||
94609516|NCT02423109|324035562|FG000|Lens 1|Adverse Event|1|||
94609517|NCT02423109|324035563|FG001|Lens 1|Adverse Event|0|||
94252984|NCT01154010|322718788|FG001|Overall Study|Lost to Follow-up|1|||
94252985|NCT00985946|322718797|FG000|Overall Study|Lost to Follow-up|6|||
94358348|NCT05299359|323094444|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
94358349|NCT05299359|323094443|FG000|Main Part: Day 1 up to Day 366|Other|2|||
94609518|NCT01193660|324035564|FG000|Overall Study|Withdrawal by Subject|2|||
94252986|NCT00985946|322718797|FG000|Overall Study|Withdrawal by Subject|1|||
94252987|NCT03265938|322718798|FG000|Overall Study|Withdrawal by Subject|1|||
94252988|NCT03265938|322718798|FG000|Overall Study|Physician Decision|1|||
94609519|NCT01193660|324035565|FG001|Overall Study|Withdrawal by Subject|3|||
94609520|NCT01193660|324035566|FG002|Overall Study|Withdrawal by Subject|1|||
94609521|NCT01193660|324035564|FG000|Overall Study|Death|1|||
94609522|NCT01193660|324035565|FG001|Overall Study|Death|0|||
94609523|NCT01193660|324035566|FG002|Overall Study|Death|0|||
94609524|NCT01193660|324035564|FG000|Overall Study|Physician Decision|1|||
94609525|NCT01193660|324035565|FG001|Overall Study|Physician Decision|0|||
94609526|NCT01193660|324035566|FG002|Overall Study|Physician Decision|1|||
94609527|NCT03347188|324035567|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
94609528|NCT03347188|324035568|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
94609529|NCT03347188|324035567|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
94609530|NCT03347188|324035568|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
94609531|NCT03347188|324035567|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
94609532|NCT03347188|324035568|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
94609533|NCT03347188|324035567|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
94609534|NCT03347188|324035568|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
94609535|NCT03347188|324035567|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
94609536|NCT03347188|324035568|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
94609537|NCT03347188|324035567|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
94609538|NCT03347188|324035568|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
94609539|NCT03347188|324035567|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
94609540|NCT03347188|324035568|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
94609541|NCT03347188|324035567|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
94609542|NCT03347188|324035568|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
94609543|NCT01845818|324035569|FG000|Overall Study|Withdrawal by Subject|0|||
94609544|NCT01845818|324035570|FG001|Overall Study|Withdrawal by Subject|1|||
94609545|NCT01845818|324035569|FG000|Overall Study|Lost to Follow-up|7|||
94609546|NCT01845818|324035570|FG001|Overall Study|Lost to Follow-up|5|||
94609547|NCT01845818|324035569|FG000|Overall Study|Administrative Reasons|3|||
94609548|NCT01845818|324035570|FG001|Overall Study|Administrative Reasons|1|||
94609549|NCT01845818|324035569|FG000|Overall Study|Serious Adverse Event|1|||
94609550|NCT01845818|324035570|FG001|Overall Study|Serious Adverse Event|1|||
94609551|NCT01845818|324035569|FG000|Overall Study|Other|25|||
94609552|NCT01845818|324035570|FG001|Overall Study|Other|8|||
94609553|NCT01845818|324035569|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
94609554|NCT01845818|324035570|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
94609555|NCT01845818|324035569|FG000|Overall Study|No Follow-Up Data Available|4|||
94609556|NCT01845818|324035570|FG001|Overall Study|No Follow-Up Data Available|1|||
94609557|NCT00595465|324035571|FG000|Overall Study|Adverse Event|4|||
94661691|NCT00558285|324215806|FG002|Overall Study|Lost to Follow-up|0|||
94358350|NCT05299359|323094444|FG001|Main Part: Day 1 up to Day 366|Other|0|||
94252989|NCT03265938|322718798|FG000|Overall Study|friable mass|6|||
94252990|NCT03616977|322718799|FG000|Period 1|Physician Decision|0|||
94252991|NCT03616977|322718800|FG001|Period 1|Physician Decision|1|||
94252992|NCT03616977|322718799|FG000|Period 3|Adverse Event|1|||
94252993|NCT03616977|322718800|FG001|Period 3|Adverse Event|1|||
94252994|NCT04540887|322718803|FG000|Overall Study|Withdrawal by Subject|2|||
94252995|NCT01242800|322718804|FG000|Overall Study|Patient refusal|0|||
94252996|NCT01242800|322718805|FG001|Overall Study|Patient refusal|10|||
94252997|NCT01242800|322718804|FG000|Overall Study|Physician Decision|0|||
94252998|NCT01242800|322718805|FG001|Overall Study|Physician Decision|1|||
94252999|NCT01242800|322718804|FG000|Overall Study|Disease progression|0|||
94253000|NCT01242800|322718805|FG001|Overall Study|Disease progression|3|||
94253001|NCT01242800|322718804|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
94253002|NCT01242800|322718805|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
94253003|NCT01242800|322718804|FG000|Overall Study|Reasons not reported|0|||
94253004|NCT01242800|322718805|FG001|Overall Study|Reasons not reported|4|||
94253005|NCT00928018|322718806|FG000|Overall Study|Withdrawal by Subject|1|||
94253006|NCT00928018|322718807|FG001|Overall Study|Withdrawal by Subject|0|||
94253007|NCT02859324|322718808|FG000|Overall Study|Death|4|||
94253008|NCT02859324|322718809|FG001|Overall Study|Death|6|||
94253009|NCT02859324|322718810|FG002|Overall Study|Death|5|||
94253010|NCT02859324|322718808|FG000|Overall Study|Other reasons|3|||
94253011|NCT02859324|322718809|FG001|Overall Study|Other reasons|3|||
94253012|NCT02859324|322718810|FG002|Overall Study|Other reasons|0|||
94253013|NCT03075410|322718812|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
94253014|NCT03075410|322718813|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
94253015|NCT03075410|322718814|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
94253016|NCT03075410|322718815|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
94253017|NCT03075410|322718816|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
94253018|NCT03075410|322718817|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
94253019|NCT03075410|322718818|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
94253020|NCT03075410|322718819|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
94253021|NCT03075410|322718820|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
94253022|NCT03075410|322718812|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
94253023|NCT03075410|322718813|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
94253024|NCT03075410|322718814|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
94253025|NCT03075410|322718815|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
94253026|NCT03075410|322718816|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
94253027|NCT03075410|322718817|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
94253028|NCT03075410|322718818|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
94253029|NCT03075410|322718819|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
94253030|NCT03075410|322718820|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
94253031|NCT01427751|322718821|FG000|Overall Study|Adverse Event|18|||
94253032|NCT01427751|322718822|FG001|Overall Study|Adverse Event|2|||
94253033|NCT01427751|322718821|FG000|Overall Study|No further treatment benefit expected|5|||
94253034|NCT01427751|322718822|FG001|Overall Study|No further treatment benefit expected|1|||
94253035|NCT01427751|322718821|FG000|Overall Study|Lost to Follow-up|3|||
94253036|NCT01427751|322718822|FG001|Overall Study|Lost to Follow-up|1|||
94253037|NCT01427751|322718821|FG000|Overall Study|Withdrawal of consent|2|||
94609558|NCT00595465|324035572|FG001|Overall Study|Adverse Event|3|||
94609559|NCT00595465|324035573|FG002|Overall Study|Adverse Event|3|||
94609560|NCT00595465|324035571|FG000|Overall Study|Pregnancy|0|||
94609561|NCT00595465|324035572|FG001|Overall Study|Pregnancy|0|||
94609562|NCT00595465|324035573|FG002|Overall Study|Pregnancy|1|||
94609563|NCT00595465|324035571|FG000|Overall Study|Protocol Violation|2|||
94609564|NCT00595465|324035572|FG001|Overall Study|Protocol Violation|1|||
94609565|NCT00595465|324035573|FG002|Overall Study|Protocol Violation|0|||
94609566|NCT00595465|324035571|FG000|Overall Study|Lost to Follow-up|0|||
94253038|NCT01427751|322718822|FG001|Overall Study|Withdrawal of consent|2|||
94253039|NCT01427751|322718821|FG000|Overall Study|Protocol Violation|6|||
94253040|NCT01427751|322718822|FG001|Overall Study|Protocol Violation|4|||
94459386|NCT02278120|323469640|FG001|Treatment Period|Physician Decision|27|||
94459387|NCT02278120|323469639|FG000|Treatment Period|Death|3|||
94459388|NCT02278120|323469640|FG001|Treatment Period|Death|3|||
94253041|NCT01427751|322718821|FG000|Overall Study|Death|2|||
94253042|NCT01427751|322718822|FG001|Overall Study|Death|0|||
94253043|NCT01427751|322718821|FG000|Overall Study|Other miscellaneous reasons|6|||
94253044|NCT01427751|322718822|FG001|Overall Study|Other miscellaneous reasons|4|||
94253045|NCT01182194|322718825|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
94253046|NCT01182194|322718826|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
94253047|NCT02533570|322718832|FG000|Overall Study|Adverse Event|0|||
94459389|NCT02278120|323469639|FG000|Treatment Period|Lost to Follow-up|2|||
94609567|NCT00595465|324035572|FG001|Overall Study|Lost to Follow-up|0|||
94609568|NCT00595465|324035573|FG002|Overall Study|Lost to Follow-up|2|||
94609569|NCT00595465|324035571|FG000|Overall Study|administrative reason|0|||
94609570|NCT00595465|324035572|FG001|Overall Study|administrative reason|0|||
94459390|NCT02278120|323469640|FG001|Treatment Period|Lost to Follow-up|0|||
94459391|NCT02278120|323469639|FG000|Treatment Period|Protocol deviation|0|||
94459392|NCT02278120|323469640|FG001|Treatment Period|Protocol deviation|2|||
94609571|NCT00595465|324035573|FG002|Overall Study|administrative reason|1|||
94609572|NCT02595970|324035574|FG000|Overall Study|Withdrawal by Subject|2|||
94609573|NCT02595970|324035574|FG000|Overall Study|Physician Decision|2|||
94609574|NCT02595970|324035574|FG000|Overall Study|Protocol Violation|4|||
94609575|NCT02595970|324035574|FG000|Overall Study|Adverse Event|5|||
94609576|NCT02595970|324035574|FG000|Overall Study|Lack of Efficacy|7|||
94609577|NCT03894046|324035577|FG000|Overall Study|Protocol Violation|1|||
94609578|NCT03894046|324035578|FG001|Overall Study|Protocol Violation|0|||
94609579|NCT03894046|324035579|FG002|Overall Study|Protocol Violation|0|||
94609580|NCT03894046|324035577|FG000|Overall Study|Adverse Event|0|||
94609581|NCT03894046|324035578|FG001|Overall Study|Adverse Event|1|||
94609582|NCT03894046|324035579|FG002|Overall Study|Adverse Event|0|||
94609583|NCT03894046|324035577|FG000|Overall Study|Withdrawal by Subject|2|||
94609584|NCT03894046|324035578|FG001|Overall Study|Withdrawal by Subject|3|||
94609585|NCT03894046|324035579|FG002|Overall Study|Withdrawal by Subject|1|||
94609586|NCT03894046|324035577|FG000|Overall Study|Death|15|||
94609587|NCT03894046|324035578|FG001|Overall Study|Death|21|||
94609588|NCT03894046|324035579|FG002|Overall Study|Death|4|||
94609589|NCT03894046|324035577|FG000|Overall Study|No growth of ABC|2|||
94609590|NCT03894046|324035578|FG001|Overall Study|No growth of ABC|1|||
94609591|NCT03894046|324035579|FG002|Overall Study|No growth of ABC|0|||
94609592|NCT03894046|324035577|FG000|Overall Study|Physician Decision|1|||
94609593|NCT03894046|324035578|FG001|Overall Study|Physician Decision|1|||
94609594|NCT03894046|324035579|FG002|Overall Study|Physician Decision|1|||
94609595|NCT03894046|324035577|FG000|Overall Study|Prohibited concomitant medication|1|||
94609596|NCT03894046|324035578|FG001|Overall Study|Prohibited concomitant medication|0|||
94609597|NCT03894046|324035579|FG002|Overall Study|Prohibited concomitant medication|0|||
94609598|NCT03894046|324035577|FG000|Overall Study|Transferred to other arm/group|1|||
94609599|NCT03894046|324035578|FG001|Overall Study|Transferred to other arm/group|1|||
94609600|NCT03894046|324035579|FG002|Overall Study|Transferred to other arm/group|0|||
94609601|NCT03228420|324035580|FG000|Overall Study|Lost to Follow-up|5|||
94609602|NCT03228420|324035581|FG001|Overall Study|Lost to Follow-up|3|||
94609603|NCT03228420|324035580|FG000|Overall Study|Withdrawal by Subject|10|||
94609604|NCT03228420|324035581|FG001|Overall Study|Withdrawal by Subject|0|||
94609605|NCT03228420|324035580|FG000|Overall Study|Adverse Event|5|||
94609606|NCT03228420|324035581|FG001|Overall Study|Adverse Event|2|||
94609607|NCT01298531|324035582|FG000|Overall Study|Lack of Efficacy|0|||
94609608|NCT01298531|324035583|FG001|Overall Study|Lack of Efficacy|1|||
94609609|NCT01298531|324035582|FG000|Overall Study|Lost to Follow-up|2|||
94661692|NCT00558285|324215807|FG003|Overall Study|Lost to Follow-up|0|||
94459393|NCT02278120|323469639|FG000|Treatment Period|Study terminated as per protocol|43|||
94609610|NCT01298531|324035583|FG001|Overall Study|Lost to Follow-up|0|||
94609611|NCT01298531|324035582|FG000|Overall Study|Protocol Violation|1|||
94609612|NCT01298531|324035583|FG001|Overall Study|Protocol Violation|1|||
94609613|NCT01298531|324035582|FG000|Overall Study|Adverse Event|4|||
94253048|NCT02533570|322718833|FG001|Overall Study|Adverse Event|1|||
94661693|NCT00558285|324215808|FG004|Overall Study|Lost to Follow-up|0|||
94253049|NCT02533570|322718834|FG002|Overall Study|Adverse Event|1|||
94253050|NCT05330312|322718836|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
94253051|NCT05330312|322718837|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
94253052|NCT05330312|322718838|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
94253053|NCT05330312|322718836|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
94661694|NCT00558285|324215804|FG000|Overall Study|Administrative problems|0|||
94661695|NCT00558285|324215805|FG001|Overall Study|Administrative problems|0|||
94661696|NCT00558285|324215806|FG002|Overall Study|Administrative problems|0|||
94661697|NCT00558285|324215807|FG003|Overall Study|Administrative problems|1|||
94661698|NCT00558285|324215808|FG004|Overall Study|Administrative problems|1|||
94661699|NCT00558285|324215804|FG000|Overall Study|Protocol deviation|1|||
94661700|NCT00558285|324215805|FG001|Overall Study|Protocol deviation|1|||
94661701|NCT00558285|324215806|FG002|Overall Study|Protocol deviation|0|||
94661702|NCT00558285|324215807|FG003|Overall Study|Protocol deviation|1|||
94661703|NCT00558285|324215808|FG004|Overall Study|Protocol deviation|0|||
94661704|NCT00627705|324215809|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
94661705|NCT00627705|324215810|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
94459394|NCT02278120|323469640|FG001|Treatment Period|Study terminated as per protocol|11|||
94459395|NCT02278120|323469639|FG000|Post-treatment Efficacy Follow-up|Death|0|||
94459396|NCT02278120|323469640|FG001|Post-treatment Efficacy Follow-up|Death|1|||
94459397|NCT02278120|323469639|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
94459398|NCT02278120|323469640|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
94459399|NCT02278120|323469639|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
94661706|NCT00627705|324215809|FG000|Overall Study|Adverse Event|1|||
94661707|NCT00627705|324215810|FG001|Overall Study|Adverse Event|0|||
94661708|NCT00627705|324215809|FG000|Overall Study|Withdrawal by Subject|0|||
94661709|NCT00627705|324215810|FG001|Overall Study|Withdrawal by Subject|2|||
94661710|NCT00627705|324215809|FG000|Overall Study|Lost to Follow-up|0|||
94253054|NCT05330312|322718837|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
94253055|NCT05330312|322718838|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
94253056|NCT05330312|322718836|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
94253057|NCT05330312|322718837|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
94253058|NCT05330312|322718838|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
94253059|NCT05330312|322718836|FG000|Pivotal Investigation - Part 2|Death|1|||
94253060|NCT05330312|322718837|FG001|Pivotal Investigation - Part 2|Death|4|||
94459400|NCT02278120|323469640|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
94459401|NCT02278120|323469639|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
94253061|NCT05330312|322718838|FG002|Pivotal Investigation - Part 2|Death|0|||
94459402|NCT02278120|323469640|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
94459403|NCT02278120|323469639|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
94459404|NCT02278120|323469640|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
94459405|NCT02600845|323469643|FG000|Overall Study|Reason Not Specified|3|||
94459406|NCT02600845|323469643|FG000|Overall Study|Non-compliance with Study Procedures|10|||
94459407|NCT02600845|323469643|FG000|Overall Study|Consent Withdrawal|5|||
94459408|NCT00191282|323469644|FG000|Overall Study|Adverse Event|5|||
94459409|NCT00191282|323469645|FG001|Overall Study|Adverse Event|6|||
94459410|NCT00191282|323469644|FG000|Overall Study|Death|51|||
94609614|NCT01298531|324035583|FG001|Overall Study|Adverse Event|3|||
94609615|NCT01298531|324035582|FG000|Overall Study|Does not meet entrance criteria|0|||
94609616|NCT01298531|324035583|FG001|Overall Study|Does not meet entrance criteria|1|||
94459411|NCT00191282|323469645|FG001|Overall Study|Death|51|||
94459412|NCT00191282|323469644|FG000|Overall Study|Lack of Efficacy|11|||
94459413|NCT00191282|323469645|FG001|Overall Study|Lack of Efficacy|6|||
94459414|NCT00191282|323469644|FG000|Overall Study|Noncompliance|14|||
94459415|NCT00191282|323469645|FG001|Overall Study|Noncompliance|17|||
94609617|NCT01298531|324035582|FG000|Overall Study|Other|2|||
94609618|NCT01298531|324035583|FG001|Overall Study|Other|1|||
94609619|NCT02367131|324035584|FG000|Overall Study|Adverse Event|64|||
94609620|NCT02367131|324035584|FG000|Overall Study|No visit since the first visit|3|||
94609621|NCT02367131|324035584|FG000|Overall Study|Request by patient|53|||
94661711|NCT00627705|324215810|FG001|Overall Study|Lost to Follow-up|1|||
94661712|NCT02121847|324215811|FG000|Overall Study|Administrative Reasons|1|||
94661713|NCT02121847|324215811|FG000|Overall Study|Adverse Event|2|||
94661714|NCT01781572|324215812|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
94661715|NCT01781572|324215813|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
94661716|NCT01781572|324215814|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
94253062|NCT03316300|322718839|FG000|Overall Study|Withdrawal by Subject|3|||
94459416|NCT00191282|323469644|FG000|Overall Study|Patient moved|11|||
94459417|NCT00191282|323469645|FG001|Overall Study|Patient moved|14|||
94609622|NCT02367131|324035584|FG000|Overall Study|Improvement/remission|2|||
94609623|NCT02367131|324035584|FG000|Overall Study|No change/progressive disease|78|||
94661717|NCT01781572|324215812|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
94609624|NCT02367131|324035584|FG000|Overall Study|Other than stated above|20|||
94253063|NCT03316300|322718840|FG001|Overall Study|Withdrawal by Subject|2|||
94609625|NCT02367131|324035584|FG000|Overall Study|Not treated|2|||
94609626|NCT02572388|324035585|FG000|Overall Study|Withdrawal by Subject|1|||
94609627|NCT02572388|324035586|FG001|Overall Study|Withdrawal by Subject|1|||
94609628|NCT02572388|324035587|FG002|Overall Study|Withdrawal by Subject|2|||
94609629|NCT02572388|324035588|FG003|Overall Study|Withdrawal by Subject|2|||
94609630|NCT00810108|324035591|FG000|Overall Study|Withdrawal by Subject|1|||
94609631|NCT00810108|324035592|FG001|Overall Study|Withdrawal by Subject|0|||
94609632|NCT01051466|324035593|FG000|Overall Study|Adverse Event|1|||
94609633|NCT01051466|324035594|FG001|Overall Study|Adverse Event|0|||
94609634|NCT01051466|324035593|FG000|Overall Study|Lost to Follow-up|1|||
94609635|NCT01051466|324035594|FG001|Overall Study|Lost to Follow-up|1|||
94609636|NCT01051466|324035593|FG000|Overall Study|Withdrawal by Subject|5|||
94609637|NCT01051466|324035594|FG001|Overall Study|Withdrawal by Subject|1|||
94609638|NCT01051466|324035593|FG000|Overall Study|Entry Criteria Not Met|0|||
94609639|NCT01051466|324035594|FG001|Overall Study|Entry Criteria Not Met|3|||
94609640|NCT01051466|324035593|FG000|Overall Study|Physician Decision|1|||
94609641|NCT01051466|324035594|FG001|Overall Study|Physician Decision|0|||
94609642|NCT03589469|324035604|FG000|Overall Study|Withdrawal by Subject|8|||
94609643|NCT03589469|324035604|FG000|Overall Study|Physician Decision|20|||
94609644|NCT03589469|324035604|FG000|Overall Study|Death|97|||
94609645|NCT03589469|324035604|FG000|Overall Study|Lost to Follow-up|8|||
94609646|NCT03589469|324035604|FG000|Overall Study|Miscellaneous|1|||
94609647|NCT00331864|324035605|FG000|Overall Study|Adverse Event|30|||
94609648|NCT00331864|324035606|FG001|Overall Study|Adverse Event|1|||
94609649|NCT00331864|324035605|FG000|Overall Study|Lack of Efficacy|4|||
94609650|NCT00331864|324035606|FG001|Overall Study|Lack of Efficacy|0|||
94609651|NCT00331864|324035605|FG000|Overall Study|Protocol Violation|3|||
94609652|NCT00331864|324035606|FG001|Overall Study|Protocol Violation|0|||
94609653|NCT00331864|324035605|FG000|Overall Study|Withdrawal by Subject|10|||
94609654|NCT00331864|324035606|FG001|Overall Study|Withdrawal by Subject|0|||
94609655|NCT00331864|324035605|FG000|Overall Study|Lost to Follow-up|4|||
94609656|NCT00331864|324035606|FG001|Overall Study|Lost to Follow-up|3|||
94609657|NCT00331864|324035605|FG000|Overall Study|Administrative Problems|1|||
94609658|NCT00331864|324035606|FG001|Overall Study|Administrative Problems|0|||
94609659|NCT00331864|324035605|FG000|Overall Study|Death|6|||
94609660|NCT00331864|324035606|FG001|Overall Study|Death|0|||
94609661|NCT00137631|324035612|FG000|Overall Study|Lost to Follow-up|37|||
94609662|NCT00137631|324035613|FG001|Overall Study|Lost to Follow-up|41|||
94609663|NCT02611960|324035614|FG000|Overall Study|Adverse Event|7|||
94609664|NCT02611960|324035615|FG001|Overall Study|Adverse Event|8|||
94609665|NCT02611960|324035614|FG000|Overall Study|Death|98|||
94609666|NCT02611960|324035615|FG001|Overall Study|Death|92|||
94609667|NCT02611960|324035614|FG000|Overall Study|Withdrawal by Subject|1|||
94609668|NCT02611960|324035615|FG001|Overall Study|Withdrawal by Subject|5|||
94609669|NCT02611960|324035614|FG000|Overall Study|Sponsor Decision|11|||
94609670|NCT02611960|324035615|FG001|Overall Study|Sponsor Decision|11|||
94609671|NCT00085709|324035626|FG000|Overall Study|Adverse Event|8|||
94609672|NCT00085709|324035627|FG001|Overall Study|Adverse Event|0|||
94609673|NCT00085709|324035626|FG000|Overall Study|Death|8|||
94609674|NCT00085709|324035627|FG001|Overall Study|Death|2|||
94609675|NCT00085709|324035626|FG000|Overall Study|Refusal unrelated to adverse events|1|||
94609676|NCT00085709|324035627|FG001|Overall Study|Refusal unrelated to adverse events|2|||
94609677|NCT00085709|324035626|FG000|Overall Study|Progression|3|||
94609678|NCT00085709|324035627|FG001|Overall Study|Progression|4|||
94609679|NCT00085709|324035626|FG000|Overall Study|Not protocol specified|12|||
94609680|NCT00085709|324035627|FG001|Overall Study|Not protocol specified|22|||
94609681|NCT00085709|324035626|FG000|Overall Study|Not eligible|19|||
94609682|NCT00085709|324035627|FG001|Overall Study|Not eligible|19|||
94609683|NCT00085709|324035626|FG000|Overall Study|Withdrawal by Subject|2|||
94609684|NCT00085709|324035627|FG001|Overall Study|Withdrawal by Subject|1|||
94661718|NCT01781572|324215813|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
94253064|NCT03316300|322718839|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
94609685|NCT01539642|324035628|FG000|Overall Study|Lack of Efficacy|20|||
94609686|NCT01539642|324035629|FG001|Overall Study|Lack of Efficacy|18|||
94609687|NCT01539642|324035628|FG000|Overall Study|Patient ready for early discharge|8|||
94609688|NCT01539642|324035629|FG001|Overall Study|Patient ready for early discharge|7|||
94609689|NCT01539642|324035628|FG000|Overall Study|Adverse Event|6|||
94609690|NCT01539642|324035629|FG001|Overall Study|Adverse Event|4|||
94609691|NCT01539642|324035628|FG000|Overall Study|Withdrawal by Subject|2|||
94609692|NCT01539642|324035629|FG001|Overall Study|Withdrawal by Subject|2|||
94609693|NCT01123850|324035634|FG000|Overall Study|Slow enrollment|45|||
94609694|NCT04041375|324035637|FG000|Intervention Phase|Withdrawal by Subject|2|||
94609695|NCT04041375|324035638|FG001|Intervention Phase|Withdrawal by Subject|2|||
94609696|NCT04041375|324035637|FG000|Follow-up Phase|Death|2|||
94609697|NCT04041375|324035638|FG001|Follow-up Phase|Death|0|||
94609698|NCT04041375|324035637|FG000|Follow-up Phase|Lost to Follow-up|2|||
94609699|NCT04041375|324035638|FG001|Follow-up Phase|Lost to Follow-up|1|||
94609700|NCT04041375|324035637|FG000|Follow-up Phase|Too ill|3|||
94609701|NCT04041375|324035638|FG001|Follow-up Phase|Too ill|0|||
94609702|NCT03800173|324035639|FG000|Overall Study|Lost to Follow-up|0|||
94609703|NCT03800173|324035640|FG001|Overall Study|Lost to Follow-up|0|||
94609704|NCT03800173|324035641|FG002|Overall Study|Lost to Follow-up|0|||
94609705|NCT03800173|324035642|FG003|Overall Study|Lost to Follow-up|0|||
94609706|NCT03800173|324035643|FG004|Overall Study|Lost to Follow-up|1|||
94609707|NCT03954132|324035647|FG000|Overall Study|Adverse Event|2|||
94609708|NCT03954132|324035648|FG001|Overall Study|Adverse Event|0|||
94609709|NCT03954132|324035647|FG000|Overall Study|Patient's wish|5|||
94609710|NCT03954132|324035648|FG001|Overall Study|Patient's wish|0|||
94609711|NCT03954132|324035647|FG000|Overall Study|Lost to Follow-up|10|||
94609712|NCT03954132|324035648|FG001|Overall Study|Lost to Follow-up|0|||
94609713|NCT03954132|324035647|FG000|Overall Study|Screening failure|0|||
94609714|NCT03954132|324035648|FG001|Overall Study|Screening failure|1|||
94609715|NCT03954132|324035647|FG000|Overall Study|No registration after Visit 1|5|||
94609716|NCT03954132|324035648|FG001|Overall Study|No registration after Visit 1|2|||
94609717|NCT03954132|324035647|FG000|Overall Study|Other reason than listed|2|||
94609718|NCT03954132|324035648|FG001|Overall Study|Other reason than listed|2|||
94609719|NCT03954132|324035647|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
94609720|NCT03954132|324035648|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
94609721|NCT03954132|324035647|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
94609722|NCT03954132|324035648|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
94609723|NCT00543543|324035651|FG000|Base Study|Adverse Event|1|||
94609724|NCT00543543|324035652|FG001|Base Study|Adverse Event|11|||
94609725|NCT00543543|324035653|FG002|Base Study|Adverse Event|0|||
94609726|NCT00543543|324035654|FG003|Base Study|Adverse Event|5|||
94609727|NCT00543543|324035651|FG000|Base Study|Lost to Follow-up|12|||
94609728|NCT00543543|324035652|FG001|Base Study|Lost to Follow-up|749|||
94609729|NCT00543543|324035653|FG002|Base Study|Lost to Follow-up|9|||
94609730|NCT00543543|324035654|FG003|Base Study|Lost to Follow-up|701|||
94609731|NCT00543543|324035651|FG000|Base Study|Physician Decision|0|||
94609732|NCT00543543|324035652|FG001|Base Study|Physician Decision|4|||
94609733|NCT00543543|324035653|FG002|Base Study|Physician Decision|0|||
94609734|NCT00543543|324035654|FG003|Base Study|Physician Decision|7|||
94609735|NCT00543543|324035651|FG000|Base Study|Protocol Violation|0|||
94609736|NCT00543543|324035652|FG001|Base Study|Protocol Violation|6|||
94609737|NCT00543543|324035653|FG002|Base Study|Protocol Violation|0|||
94609738|NCT00543543|324035654|FG003|Base Study|Protocol Violation|6|||
94609739|NCT00543543|324035651|FG000|Base Study|Withdrawal by Subject|7|||
94609740|NCT00543543|324035652|FG001|Base Study|Withdrawal by Subject|482|||
94609741|NCT00543543|324035653|FG002|Base Study|Withdrawal by Subject|5|||
94609742|NCT00543543|324035654|FG003|Base Study|Withdrawal by Subject|503|||
94609743|NCT00543543|324035651|FG000|Extension Study|Adverse Event|0|||
94609744|NCT00543543|324035652|FG001|Extension Study|Adverse Event|0|||
94609745|NCT00543543|324035653|FG002|Extension Study|Adverse Event|0|||
94609746|NCT00543543|324035654|FG003|Extension Study|Adverse Event|5|||
94609747|NCT00543543|324035651|FG000|Extension Study|Lost to Follow-up|0|||
94609748|NCT00543543|324035652|FG001|Extension Study|Lost to Follow-up|0|||
94609749|NCT00543543|324035653|FG002|Extension Study|Lost to Follow-up|0|||
94609750|NCT00543543|324035654|FG003|Extension Study|Lost to Follow-up|77|||
94609751|NCT00543543|324035651|FG000|Extension Study|Physician Decision|0|||
94609752|NCT00543543|324035652|FG001|Extension Study|Physician Decision|0|||
94609753|NCT00543543|324035653|FG002|Extension Study|Physician Decision|0|||
94609754|NCT00543543|324035654|FG003|Extension Study|Physician Decision|7|||
94609755|NCT00543543|324035651|FG000|Extension Study|Pregnancy|0|||
94609756|NCT00543543|324035652|FG001|Extension Study|Pregnancy|0|||
94609757|NCT00543543|324035653|FG002|Extension Study|Pregnancy|0|||
94609758|NCT00543543|324035654|FG003|Extension Study|Pregnancy|6|||
94609759|NCT00543543|324035651|FG000|Extension Study|Protocol Violation|0|||
94609760|NCT00543543|324035652|FG001|Extension Study|Protocol Violation|0|||
94609761|NCT00543543|324035653|FG002|Extension Study|Protocol Violation|0|||
94609762|NCT00543543|324035654|FG003|Extension Study|Protocol Violation|11|||
94609763|NCT00543543|324035651|FG000|Extension Study|Withdrawal by Subject|0|||
94609764|NCT00543543|324035652|FG001|Extension Study|Withdrawal by Subject|0|||
94609765|NCT00543543|324035653|FG002|Extension Study|Withdrawal by Subject|0|||
94609766|NCT00543543|324035654|FG003|Extension Study|Withdrawal by Subject|120|||
94609767|NCT04308304|324035655|FG000|Overall Study|Withdrawal by Subject|4|||
94609768|NCT04308304|324035656|FG001|Overall Study|Withdrawal by Subject|0|||
94609769|NCT04308304|324035655|FG000|Overall Study|Protocol Violation|1|||
94609770|NCT04308304|324035656|FG001|Overall Study|Protocol Violation|0|||
94609771|NCT04128371|324035659|FG000|Overall Study|Lack of Efficacy|1|||
94609772|NCT04502979|324035663|FG000|Overall Study|Lost to Follow-up|1|||
94609773|NCT04502979|324035664|FG001|Overall Study|Lost to Follow-up|3|||
94609774|NCT04502979|324035663|FG000|Overall Study|Withdrawal by Subject|2|||
94609775|NCT04502979|324035664|FG001|Overall Study|Withdrawal by Subject|1|||
94609776|NCT02024555|324035665|FG000|Overall Study|Lost to Follow-up|1|||
94609777|NCT02024555|324035666|FG001|Overall Study|Lost to Follow-up|1|||
94609778|NCT02024555|324035665|FG000|Overall Study|Withdrawal by Subject|5|||
94609779|NCT02024555|324035666|FG001|Overall Study|Withdrawal by Subject|1|||
94459418|NCT00191282|323469644|FG000|Overall Study|Withdrawal by Subject|59|||
94459419|NCT00191282|323469645|FG001|Overall Study|Withdrawal by Subject|44|||
94459420|NCT00191282|323469644|FG000|Overall Study|Physician Decision|18|||
94253065|NCT03316300|322718840|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
94253066|NCT03316300|322718839|FG000|Overall Study|Adverse Event|1|||
94253067|NCT03316300|322718840|FG001|Overall Study|Adverse Event|0|||
94253068|NCT03316300|322718839|FG000|Overall Study|COVID-19|0|||
94459421|NCT00191282|323469645|FG001|Overall Study|Physician Decision|15|||
94459422|NCT00191282|323469644|FG000|Overall Study|Protocol entry criteria not met|14|||
94459423|NCT00191282|323469645|FG001|Overall Study|Protocol entry criteria not met|9|||
94459424|NCT00191282|323469644|FG000|Overall Study|Protocol Violation|9|||
94459425|NCT00191282|323469645|FG001|Overall Study|Protocol Violation|12|||
94459426|NCT00191282|323469644|FG000|Overall Study|Severity of outcome|2|||
94459427|NCT00191282|323469645|FG001|Overall Study|Severity of outcome|5|||
94459428|NCT00191282|323469644|FG000|Overall Study|Sponsor's decision|2|||
94459429|NCT00191282|323469645|FG001|Overall Study|Sponsor's decision|2|||
94459430|NCT00191282|323469644|FG000|Overall Study|Lost to Follow-up|24|||
94609780|NCT03104374|324035667|FG000|Overall Study|Adverse Event|7|||
94609781|NCT03104374|324035668|FG001|Overall Study|Adverse Event|6|||
94609782|NCT03104374|324035669|FG002|Overall Study|Adverse Event|12|||
94609783|NCT03104374|324035670|FG003|Overall Study|Adverse Event|15|||
94609784|NCT03104374|324035667|FG000|Overall Study|Withdrawal by Subject|18|||
94609785|NCT03104374|324035668|FG001|Overall Study|Withdrawal by Subject|10|||
94609786|NCT03104374|324035669|FG002|Overall Study|Withdrawal by Subject|10|||
94609787|NCT03104374|324035670|FG003|Overall Study|Withdrawal by Subject|17|||
94609788|NCT03104374|324035667|FG000|Overall Study|Lost to Follow-up|4|||
94459431|NCT00191282|323469645|FG001|Overall Study|Lost to Follow-up|31|||
94459432|NCT00954512|323469646|FG000|Overall Study|Withdrawal by Subject|0|||
94459433|NCT00954512|323469647|FG001|Overall Study|Withdrawal by Subject|0|||
94459434|NCT00954512|323469648|FG002|Overall Study|Withdrawal by Subject|0|||
94661719|NCT01781572|324215814|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
94661720|NCT01781572|324215812|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
94253069|NCT03316300|322718840|FG001|Overall Study|COVID-19|1|||
94609789|NCT03104374|324035668|FG001|Overall Study|Lost to Follow-up|4|||
94609790|NCT03104374|324035669|FG002|Overall Study|Lost to Follow-up|6|||
94609791|NCT03104374|324035670|FG003|Overall Study|Lost to Follow-up|8|||
94609792|NCT03104374|324035667|FG000|Overall Study|Lack of Efficacy|6|||
94609793|NCT03104374|324035668|FG001|Overall Study|Lack of Efficacy|7|||
94609794|NCT03104374|324035669|FG002|Overall Study|Lack of Efficacy|12|||
94609795|NCT03104374|324035670|FG003|Overall Study|Lack of Efficacy|6|||
94609796|NCT03104374|324035667|FG000|Overall Study|Other|2|||
94459435|NCT00954512|323469649|FG003|Overall Study|Withdrawal by Subject|0|||
94609797|NCT03104374|324035668|FG001|Overall Study|Other|2|||
94609798|NCT03104374|324035669|FG002|Overall Study|Other|4|||
94661721|NCT01781572|324215813|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
94661722|NCT01781572|324215814|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
94661723|NCT01781572|324215812|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
94661724|NCT01781572|324215813|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
94609799|NCT03104374|324035670|FG003|Overall Study|Other|7|||
94661725|NCT01781572|324215814|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
94609800|NCT00589290|324035673|FG000|Overall Study|Withdrawal by Subject|1|||
94609801|NCT04449861|324035674|FG000|Overall Study|Withdrawal by Subject|4|||
94609802|NCT04449861|324035674|FG000|Overall Study|Lost to Follow-up|5|||
94609803|NCT04449861|324035674|FG000|Overall Study|Death|112|||
94609804|NCT00976677|324035675|FG000|Overall Study|Adverse Event|1|||
94609805|NCT00976677|324035676|FG001|Overall Study|Adverse Event|0|||
94609806|NCT00976677|324035675|FG000|Overall Study|Withdrawal by Subject|0|||
94661726|NCT01781572|324215812|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
94661727|NCT01781572|324215813|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
94661728|NCT01781572|324215814|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
94253070|NCT04737187|322718841|FG000|Overall Study|Switched to marketed drug|32|||
94459436|NCT00954512|323469650|FG004|Overall Study|Withdrawal by Subject|0|||
94459437|NCT00954512|323469651|FG005|Overall Study|Withdrawal by Subject|1|||
94609807|NCT00976677|324035676|FG001|Overall Study|Withdrawal by Subject|2|||
94661729|NCT01781572|324215812|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
94459438|NCT00954512|323469646|FG000|Overall Study|Adverse Event|0|||
94459439|NCT00954512|323469647|FG001|Overall Study|Adverse Event|0|||
94661730|NCT01781572|324215813|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
94661731|NCT01781572|324215814|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
94253071|NCT04737187|322718842|FG001|Overall Study|Switched to marketed drug|4|||
94459440|NCT00954512|323469648|FG002|Overall Study|Adverse Event|0|||
94609808|NCT00976677|324035675|FG000|Overall Study|Disease progression|1|||
94609809|NCT00976677|324035676|FG001|Overall Study|Disease progression|1|||
94459441|NCT00954512|323469649|FG003|Overall Study|Adverse Event|0|||
94609810|NCT00976677|324035675|FG000|Overall Study|Trial unblinded|2|||
94609811|NCT00976677|324035676|FG001|Overall Study|Trial unblinded|2|||
94609812|NCT00976677|324035675|FG000|Overall Study|Unknown/Missing|1|||
94609813|NCT00976677|324035676|FG001|Overall Study|Unknown/Missing|0|||
94609814|NCT01555983|324035677|FG000|Overall Study|Withdrawal by Subject|1|||
94661732|NCT01781572|324215812|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
94661733|NCT01781572|324215813|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
94661734|NCT01781572|324215814|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
94661735|NCT01781572|324215812|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
94661736|NCT01781572|324215813|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
94661737|NCT01781572|324215814|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
94661738|NCT01781572|324215812|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
94661739|NCT01781572|324215813|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
94661740|NCT01781572|324215814|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
94661741|NCT01781572|324215812|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
94661742|NCT01781572|324215813|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
94661743|NCT01781572|324215814|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
94661744|NCT01781572|324215812|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
94661745|NCT01781572|324215813|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
94661746|NCT01781572|324215814|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
94661747|NCT01781572|324215812|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
94661748|NCT01781572|324215813|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
94661749|NCT01781572|324215814|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
94661750|NCT01781572|324215812|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
94661751|NCT01781572|324215813|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
94661752|NCT01781572|324215814|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
94661753|NCT01781572|324215812|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
94661754|NCT01781572|324215813|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
94661755|NCT01781572|324215814|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
94661756|NCT01781572|324215812|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
94661757|NCT01781572|324215813|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
94661758|NCT01781572|324215814|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
94661759|NCT01781572|324215812|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
94661760|NCT01781572|324215813|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
94609815|NCT01555983|324035678|FG001|Overall Study|Withdrawal by Subject|0|||
94609816|NCT01555983|324035679|FG002|Overall Study|Withdrawal by Subject|0|||
94609817|NCT01555983|324035680|FG003|Overall Study|Withdrawal by Subject|0|||
94609818|NCT01555983|324035681|FG004|Overall Study|Withdrawal by Subject|1|||
94609819|NCT01555983|324035682|FG005|Overall Study|Withdrawal by Subject|1|||
94609820|NCT06238362|324035687|FG000|Overall Study|Insufficient total sleep time|1|||
94609821|NCT06238362|324035688|FG001|Overall Study|Insufficient total sleep time|0|||
94609822|NCT06238362|324035687|FG000|Overall Study|Inadequate signal quality|1|||
94609823|NCT06238362|324035688|FG001|Overall Study|Inadequate signal quality|0|||
94609824|NCT03148275|324035690|FG000|Overall Study|Death|6|||
94609825|NCT03148275|324035690|FG000|Overall Study|Adverse Event|3|||
94609826|NCT03148275|324035690|FG000|Overall Study|Liver transplant|2|||
94609827|NCT03148275|324035690|FG000|Overall Study|Patient decision|5|||
94609828|NCT03148275|324035690|FG000|Overall Study|transition to commercial drug|1|||
94609829|NCT03148275|324035690|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
94609830|NCT01083485|324037059|FG000|Overall Study|Adverse Event|0|||
94609831|NCT01083485|324037060|FG001|Overall Study|Adverse Event|1|||
94609832|NCT01083485|324037059|FG000|Overall Study|Protocol Violation|1|||
94609833|NCT01083485|324037060|FG001|Overall Study|Protocol Violation|0|||
94609834|NCT01083485|324037059|FG000|Overall Study|Withdrawal by Subject|5|||
94609835|NCT01083485|324037060|FG001|Overall Study|Withdrawal by Subject|2|||
94609836|NCT01083485|324037059|FG000|Overall Study|Other|1|||
94609837|NCT01083485|324037060|FG001|Overall Study|Other|0|||
94661761|NCT01781572|324215814|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
94609838|NCT00537238|324037061|FG000|Overall Study|Death|1|||
94609839|NCT00537238|324037062|FG001|Overall Study|Death|2|||
94661762|NCT01781572|324215812|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
94661763|NCT01781572|324215813|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
94661764|NCT01781572|324215814|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
94358351|NCT05299359|323094443|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
94609840|NCT00537238|324037061|FG000|Overall Study|Adverse Event|31|||
94609841|NCT00537238|324037062|FG001|Overall Study|Adverse Event|22|||
94609842|NCT00537238|324037061|FG000|Overall Study|Lack of Efficacy|20|||
94609843|NCT00537238|324037062|FG001|Overall Study|Lack of Efficacy|21|||
94609844|NCT00537238|324037061|FG000|Overall Study|Lost to Follow-up|12|||
94609845|NCT00537238|324037062|FG001|Overall Study|Lost to Follow-up|8|||
94609846|NCT00537238|324037061|FG000|Overall Study|Withdrawal by Subject|51|||
94609847|NCT00537238|324037062|FG001|Overall Study|Withdrawal by Subject|47|||
94609848|NCT00537238|324037061|FG000|Overall Study|Protocol Violation|15|||
94609849|NCT00537238|324037062|FG001|Overall Study|Protocol Violation|19|||
94609850|NCT00537238|324037061|FG000|Overall Study|Does not meet entrance criteria|0|||
94609851|NCT00537238|324037062|FG001|Overall Study|Does not meet entrance criteria|2|||
94609852|NCT00537238|324037061|FG000|Overall Study|Other|44|||
94609853|NCT00537238|324037062|FG001|Overall Study|Other|52|||
94609854|NCT03906461|324037063|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
94609855|NCT03906461|324037063|FG000|Completed 12-month Follow-up|Missed Visit|6|||
94609856|NCT00426231|324037064|FG000|Overall Study|Withdrawal by Subject|9|||
94609857|NCT00426231|324037065|FG001|Overall Study|Withdrawal by Subject|12|||
94609858|NCT04447417|324037066|FG000|Overall Study|Withdrawal by Subject|1|||
94609859|NCT04447417|324037067|FG001|Overall Study|Withdrawal by Subject|0|||
94609860|NCT04447417|324037066|FG000|Overall Study|Failure to meet inclusion criteria|1|||
94609861|NCT04447417|324037067|FG001|Overall Study|Failure to meet inclusion criteria|0|||
94609862|NCT04447417|324037066|FG000|Overall Study|Lost to Follow-up|1|||
94609863|NCT04447417|324037067|FG001|Overall Study|Lost to Follow-up|0|||
94609864|NCT01858376|324037068|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
94609865|NCT03956056|324037069|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
94609866|NCT03956056|324037069|FG000|Overall Study|Lack of Efficacy|1|||
94609867|NCT01680965|324037070|FG000|Overall Study|Death|0|||
94609868|NCT01680965|324037071|FG001|Overall Study|Death|0|||
94609869|NCT01680965|324037072|FG002|Overall Study|Death|0|||
94609870|NCT01680965|324037073|FG003|Overall Study|Death|6|||
94609871|NCT00195273|324037074|FG000|Overall Study|Adverse Event|9|||
94609872|NCT00195273|324037075|FG001|Overall Study|Adverse Event|9|||
94609873|NCT00195273|324037074|FG000|Overall Study|Protocol deviation|0|||
94609874|NCT00195273|324037075|FG001|Overall Study|Protocol deviation|1|||
94609875|NCT00195273|324037074|FG000|Overall Study|Lack of Efficacy|3|||
94609876|NCT00195273|324037075|FG001|Overall Study|Lack of Efficacy|1|||
94609877|NCT00195273|324037074|FG000|Overall Study|Procedural complications|9|||
94609878|NCT00195273|324037075|FG001|Overall Study|Procedural complications|3|||
94609879|NCT01886716|324037076|FG000|Week 1|Lost to Follow-up|0|||
94609880|NCT01886716|324037077|FG001|Week 1|Lost to Follow-up|0|||
94609881|NCT01886716|324037078|FG002|Week 1|Lost to Follow-up|2|||
94609882|NCT01886716|324037079|FG003|Week 1|Lost to Follow-up|2|||
94609883|NCT01886716|324037076|FG000|Week 2|Lost to Follow-up|3|||
94609884|NCT01886716|324037077|FG001|Week 2|Lost to Follow-up|2|||
94609885|NCT01886716|324037078|FG002|Week 2|Lost to Follow-up|1|||
94609886|NCT01886716|324037079|FG003|Week 2|Lost to Follow-up|3|||
94609887|NCT01886716|324037076|FG000|Week 3|Lost to Follow-up|1|||
94609888|NCT01886716|324037077|FG001|Week 3|Lost to Follow-up|1|||
94609889|NCT01886716|324037078|FG002|Week 3|Lost to Follow-up|0|||
94609890|NCT01886716|324037079|FG003|Week 3|Lost to Follow-up|1|||
94609891|NCT00107783|324037080|FG000|Overall Study|Adverse Event|0|||
94609892|NCT00107783|324037081|FG001|Overall Study|Adverse Event|2|||
94609893|NCT00107783|324037080|FG000|Overall Study|Death|0|||
94609894|NCT00107783|324037081|FG001|Overall Study|Death|1|||
94609895|NCT00107783|324037080|FG000|Overall Study|Withdrawal by Subject|2|||
94609896|NCT00107783|324037081|FG001|Overall Study|Withdrawal by Subject|0|||
94609897|NCT00107783|324037080|FG000|Overall Study|Second hip replacement|1|||
94609898|NCT00107783|324037081|FG001|Overall Study|Second hip replacement|1|||
94609899|NCT01973569|324037082|FG000|Overall Study|Adverse Event|9|||
94609900|NCT01973569|324037083|FG001|Overall Study|Adverse Event|2|||
94609901|NCT01973569|324037084|FG002|Overall Study|Adverse Event|4|||
94609902|NCT01973569|324037082|FG000|Overall Study|Protocol Violation|2|||
94609903|NCT01973569|324037083|FG001|Overall Study|Protocol Violation|1|||
94609904|NCT01973569|324037084|FG002|Overall Study|Protocol Violation|3|||
94609905|NCT01973569|324037082|FG000|Overall Study|Withdrawal by Subject|7|||
94609906|NCT01973569|324037083|FG001|Overall Study|Withdrawal by Subject|5|||
94609907|NCT01973569|324037084|FG002|Overall Study|Withdrawal by Subject|2|||
94609908|NCT01973569|324037082|FG000|Overall Study|Invasive dental treatment|3|||
94609909|NCT01973569|324037083|FG001|Overall Study|Invasive dental treatment|5|||
94609910|NCT01973569|324037084|FG002|Overall Study|Invasive dental treatment|6|||
94609911|NCT01973569|324037082|FG000|Overall Study|Prohibited concomitant d|1|||
94609912|NCT01973569|324037083|FG001|Overall Study|Prohibited concomitant d|5|||
94609913|NCT01973569|324037084|FG002|Overall Study|Prohibited concomitant d|0|||
94609914|NCT01973569|324037082|FG000|Overall Study|Disease progression|0|||
94609915|NCT01973569|324037083|FG001|Overall Study|Disease progression|3|||
94609916|NCT01973569|324037084|FG002|Overall Study|Disease progression|0|||
94609917|NCT01973569|324037082|FG000|Overall Study|Other|1|||
94609918|NCT01973569|324037083|FG001|Overall Study|Other|1|||
94609919|NCT01973569|324037084|FG002|Overall Study|Other|0|||
94609920|NCT01973569|324037082|FG000|Overall Study|Did not receive study drug|6|||
94609921|NCT01973569|324037083|FG001|Overall Study|Did not receive study drug|3|||
94609922|NCT01973569|324037084|FG002|Overall Study|Did not receive study drug|3|||
94609923|NCT03270644|324037093|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
94609924|NCT03270644|324037093|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
94609925|NCT00191906|324037096|FG000|Study Period II|Adverse Event|0|||
94609926|NCT00191906|324037097|FG001|Study Period II|Adverse Event|1|||
94609927|NCT00191906|324037098|FG002|Study Period II|Adverse Event|0|||
94609928|NCT00191906|324037099|FG003|Study Period II|Adverse Event|0|||
94609929|NCT00191906|324037096|FG000|Study Period II|Withdrawal by Subject|0|||
94609930|NCT00191906|324037097|FG001|Study Period II|Withdrawal by Subject|3|||
94609931|NCT00191906|324037098|FG002|Study Period II|Withdrawal by Subject|0|||
94609932|NCT00191906|324037099|FG003|Study Period II|Withdrawal by Subject|0|||
94609933|NCT00191906|324037096|FG000|Study Period II|Parent/Caregiver Decision|0|||
94609934|NCT00191906|324037097|FG001|Study Period II|Parent/Caregiver Decision|1|||
94609935|NCT00191906|324037098|FG002|Study Period II|Parent/Caregiver Decision|0|||
94609936|NCT00191906|324037099|FG003|Study Period II|Parent/Caregiver Decision|0|||
94609937|NCT00191906|324037096|FG000|Study Period II|Entry Criteria Exclusion|0|||
94609938|NCT00191906|324037097|FG001|Study Period II|Entry Criteria Exclusion|0|||
94609939|NCT00191906|324037098|FG002|Study Period II|Entry Criteria Exclusion|1|||
94609940|NCT00191906|324037099|FG003|Study Period II|Entry Criteria Exclusion|0|||
94609941|NCT00191906|324037096|FG000|Study Period III|Adverse Event|1|||
94609942|NCT00191906|324037097|FG001|Study Period III|Adverse Event|0|||
94609943|NCT00191906|324037098|FG002|Study Period III|Adverse Event|0|||
94609944|NCT00191906|324037099|FG003|Study Period III|Adverse Event|0|||
94609945|NCT00191906|324037096|FG000|Study Period III|Lost to Follow-up|0|||
94609946|NCT00191906|324037097|FG001|Study Period III|Lost to Follow-up|1|||
94609947|NCT00191906|324037098|FG002|Study Period III|Lost to Follow-up|0|||
94609948|NCT00191906|324037099|FG003|Study Period III|Lost to Follow-up|0|||
94609949|NCT00191906|324037096|FG000|Study Period III|Parent/Caregiver Decision|1|||
94609950|NCT00191906|324037097|FG001|Study Period III|Parent/Caregiver Decision|0|||
94609951|NCT00191906|324037098|FG002|Study Period III|Parent/Caregiver Decision|0|||
94358352|NCT05299359|323094444|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
94609952|NCT00191906|324037099|FG003|Study Period III|Parent/Caregiver Decision|0|||
94609953|NCT00191906|324037096|FG000|Study Period III|Lack of Efficacy|3|||
94609954|NCT00191906|324037097|FG001|Study Period III|Lack of Efficacy|3|||
94609955|NCT00191906|324037098|FG002|Study Period III|Lack of Efficacy|0|||
94609956|NCT00191906|324037099|FG003|Study Period III|Lack of Efficacy|0|||
94609957|NCT00333801|324037100|FG000|Overall Study|Moved to another state|5|||
94609958|NCT00333801|324037101|FG001|Overall Study|Moved to another state|3|||
94609959|NCT00333801|324037100|FG000|Overall Study|Lost to Follow-up|2|||
94609960|NCT00333801|324037101|FG001|Overall Study|Lost to Follow-up|0|||
94609961|NCT00333801|324037100|FG000|Overall Study|Incarcerated|1|||
94609962|NCT00333801|324037101|FG001|Overall Study|Incarcerated|2|||
94609963|NCT00333801|324037100|FG000|Overall Study|Withdrawal by Subject|0|||
94609964|NCT00333801|324037101|FG001|Overall Study|Withdrawal by Subject|1|||
94609965|NCT00122109|324037102|FG000|Overall Study|Did not meet criteria|6|||
94609966|NCT00122109|324037103|FG001|Overall Study|Did not meet criteria|7|||
94609967|NCT03633617|324037104|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
94609968|NCT03633617|324037105|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
94609969|NCT03633617|324037106|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
94609970|NCT03633617|324037107|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
94609971|NCT03633617|324037108|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
94609972|NCT03633617|324037109|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
94609973|NCT03633617|324037110|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
94609974|NCT03633617|324037111|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
94609975|NCT03633617|324037112|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
94609976|NCT03633617|324037113|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
94609977|NCT03633617|324037114|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
94609978|NCT03633617|324037104|FG000|Part A|Unconfirmed early termination visit|1|||
94609979|NCT03633617|324037105|FG001|Part A|Unconfirmed early termination visit|0|||
94609980|NCT03633617|324037106|FG002|Part A|Unconfirmed early termination visit|0|||
94609981|NCT03633617|324037107|FG003|Part A|Unconfirmed early termination visit|0|||
94609982|NCT03633617|324037108|FG004|Part A|Unconfirmed early termination visit|0|||
94609983|NCT03633617|324037109|FG005|Part A|Unconfirmed early termination visit|0|||
94609984|NCT03633617|324037110|FG006|Part A|Unconfirmed early termination visit|0|||
94609985|NCT03633617|324037111|FG007|Part A|Unconfirmed early termination visit|0|||
94609986|NCT03633617|324037112|FG008|Part A|Unconfirmed early termination visit|0|||
94609987|NCT03633617|324037113|FG009|Part A|Unconfirmed early termination visit|0|||
94609988|NCT03633617|324037114|FG010|Part A|Unconfirmed early termination visit|0|||
94609989|NCT03633617|324037104|FG000|Part A|Adverse Event|0|||
94609990|NCT03633617|324037105|FG001|Part A|Adverse Event|1|||
94609991|NCT03633617|324037106|FG002|Part A|Adverse Event|0|||
94609992|NCT03633617|324037107|FG003|Part A|Adverse Event|0|||
94609993|NCT03633617|324037108|FG004|Part A|Adverse Event|0|||
94609994|NCT03633617|324037109|FG005|Part A|Adverse Event|0|||
94609995|NCT03633617|324037110|FG006|Part A|Adverse Event|0|||
94609996|NCT03633617|324037111|FG007|Part A|Adverse Event|0|||
94609997|NCT03633617|324037112|FG008|Part A|Adverse Event|0|||
94609998|NCT03633617|324037113|FG009|Part A|Adverse Event|0|||
94609999|NCT03633617|324037114|FG010|Part A|Adverse Event|0|||
94610000|NCT03633617|324037104|FG000|Part A|Pregnancy|1|||
94610001|NCT03633617|324037105|FG001|Part A|Pregnancy|0|||
94610002|NCT03633617|324037106|FG002|Part A|Pregnancy|0|||
94610003|NCT03633617|324037107|FG003|Part A|Pregnancy|0|||
94610004|NCT03633617|324037108|FG004|Part A|Pregnancy|0|||
94610005|NCT03633617|324037109|FG005|Part A|Pregnancy|0|||
94610006|NCT03633617|324037110|FG006|Part A|Pregnancy|0|||
94610007|NCT03633617|324037111|FG007|Part A|Pregnancy|0|||
94610008|NCT03633617|324037112|FG008|Part A|Pregnancy|0|||
94610009|NCT03633617|324037113|FG009|Part A|Pregnancy|0|||
94610010|NCT03633617|324037114|FG010|Part A|Pregnancy|0|||
94610011|NCT03633617|324037104|FG000|Part A|Withdrawal by Subject|0|||
94610012|NCT03633617|324037105|FG001|Part A|Withdrawal by Subject|1|||
94610013|NCT03633617|324037106|FG002|Part A|Withdrawal by Subject|0|||
94610014|NCT03633617|324037107|FG003|Part A|Withdrawal by Subject|0|||
94610015|NCT03633617|324037108|FG004|Part A|Withdrawal by Subject|0|||
94610016|NCT03633617|324037109|FG005|Part A|Withdrawal by Subject|0|||
94610017|NCT03633617|324037110|FG006|Part A|Withdrawal by Subject|0|||
94610018|NCT03633617|324037111|FG007|Part A|Withdrawal by Subject|0|||
94610019|NCT03633617|324037112|FG008|Part A|Withdrawal by Subject|0|||
94610020|NCT03633617|324037113|FG009|Part A|Withdrawal by Subject|0|||
94610021|NCT03633617|324037114|FG010|Part A|Withdrawal by Subject|0|||
94610022|NCT03633617|324037104|FG000|Part B|Adverse Event|0|||
94610023|NCT03633617|324037105|FG001|Part B|Adverse Event|0|||
94610024|NCT03633617|324037106|FG002|Part B|Adverse Event|2|||
94610025|NCT03633617|324037107|FG003|Part B|Adverse Event|2|||
94610026|NCT03633617|324037108|FG004|Part B|Adverse Event|1|||
94610027|NCT03633617|324037109|FG005|Part B|Adverse Event|0|||
94610028|NCT03633617|324037110|FG006|Part B|Adverse Event|0|||
94610029|NCT03633617|324037111|FG007|Part B|Adverse Event|0|||
94610030|NCT03633617|324037112|FG008|Part B|Adverse Event|0|||
94610031|NCT03633617|324037113|FG009|Part B|Adverse Event|0|||
94610032|NCT03633617|324037114|FG010|Part B|Adverse Event|0|||
94610033|NCT03633617|324037104|FG000|Part B|Withdrawal by Subject|0|||
94610034|NCT03633617|324037105|FG001|Part B|Withdrawal by Subject|0|||
94610035|NCT03633617|324037106|FG002|Part B|Withdrawal by Subject|1|||
94610036|NCT03633617|324037107|FG003|Part B|Withdrawal by Subject|0|||
94610037|NCT03633617|324037108|FG004|Part B|Withdrawal by Subject|2|||
94610038|NCT03633617|324037109|FG005|Part B|Withdrawal by Subject|0|||
94610039|NCT03633617|324037110|FG006|Part B|Withdrawal by Subject|0|||
94610040|NCT03633617|324037111|FG007|Part B|Withdrawal by Subject|0|||
94610041|NCT03633617|324037112|FG008|Part B|Withdrawal by Subject|0|||
94253072|NCT04737187|322718841|FG000|Overall Study|Radiological Progressive Disease|145|||
94610042|NCT03633617|324037113|FG009|Part B|Withdrawal by Subject|0|||
94610043|NCT03633617|324037114|FG010|Part B|Withdrawal by Subject|0|||
94610044|NCT03633617|324037104|FG000|Part B|Lost to Follow-up|0|||
94610045|NCT03633617|324037105|FG001|Part B|Lost to Follow-up|0|||
94610046|NCT03633617|324037106|FG002|Part B|Lost to Follow-up|0|||
94610047|NCT03633617|324037107|FG003|Part B|Lost to Follow-up|0|||
94610048|NCT03633617|324037108|FG004|Part B|Lost to Follow-up|1|||
94610049|NCT03633617|324037109|FG005|Part B|Lost to Follow-up|0|||
94610050|NCT03633617|324037110|FG006|Part B|Lost to Follow-up|0|||
94610051|NCT03633617|324037111|FG007|Part B|Lost to Follow-up|0|||
94610052|NCT03633617|324037112|FG008|Part B|Lost to Follow-up|0|||
94610053|NCT03633617|324037113|FG009|Part B|Lost to Follow-up|0|||
94610054|NCT03633617|324037114|FG010|Part B|Lost to Follow-up|0|||
94610055|NCT03633617|324037104|FG000|Part B|Physician Decision|0|||
94610056|NCT03633617|324037105|FG001|Part B|Physician Decision|0|||
94610057|NCT03633617|324037106|FG002|Part B|Physician Decision|0|||
94610058|NCT03633617|324037107|FG003|Part B|Physician Decision|0|||
94610059|NCT03633617|324037108|FG004|Part B|Physician Decision|1|||
94610060|NCT03633617|324037109|FG005|Part B|Physician Decision|0|||
94610061|NCT03633617|324037110|FG006|Part B|Physician Decision|0|||
94610062|NCT03633617|324037111|FG007|Part B|Physician Decision|0|||
94610063|NCT03633617|324037112|FG008|Part B|Physician Decision|0|||
94610064|NCT03633617|324037113|FG009|Part B|Physician Decision|0|||
94610065|NCT03633617|324037114|FG010|Part B|Physician Decision|0|||
94610066|NCT03633617|324037104|FG000|Part B|COVID-19 Restrictions|0|||
94610067|NCT03633617|324037105|FG001|Part B|COVID-19 Restrictions|0|||
94610068|NCT03633617|324037106|FG002|Part B|COVID-19 Restrictions|1|||
94610069|NCT03633617|324037107|FG003|Part B|COVID-19 Restrictions|0|||
94610070|NCT03633617|324037108|FG004|Part B|COVID-19 Restrictions|0|||
94610071|NCT03633617|324037109|FG005|Part B|COVID-19 Restrictions|0|||
94610072|NCT03633617|324037110|FG006|Part B|COVID-19 Restrictions|0|||
94610073|NCT03633617|324037111|FG007|Part B|COVID-19 Restrictions|0|||
94610074|NCT03633617|324037112|FG008|Part B|COVID-19 Restrictions|0|||
94610075|NCT03633617|324037113|FG009|Part B|COVID-19 Restrictions|0|||
94610076|NCT03633617|324037114|FG010|Part B|COVID-19 Restrictions|0|||
94610077|NCT03633617|324037104|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
94610078|NCT03633617|324037105|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
94610079|NCT03633617|324037106|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
94610080|NCT03633617|324037107|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
94610081|NCT03633617|324037108|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
94610082|NCT03633617|324037109|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
94610083|NCT03633617|324037110|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
94253073|NCT04737187|322718842|FG001|Overall Study|Radiological Progressive Disease|146|||
94253074|NCT04737187|322718841|FG000|Overall Study|Clinical Progressive Disease|20|||
94253075|NCT04737187|322718842|FG001|Overall Study|Clinical Progressive Disease|20|||
94610084|NCT03633617|324037111|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
94610085|NCT03633617|324037112|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
94610086|NCT03633617|324037113|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
94610087|NCT03633617|324037114|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
94610088|NCT03633617|324037104|FG000|Part C (& Follow-up)|Adverse Event|0|||
94610089|NCT03633617|324037105|FG001|Part C (& Follow-up)|Adverse Event|0|||
94610090|NCT03633617|324037106|FG002|Part C (& Follow-up)|Adverse Event|0|||
94610091|NCT03633617|324037107|FG003|Part C (& Follow-up)|Adverse Event|0|||
94610092|NCT03633617|324037108|FG004|Part C (& Follow-up)|Adverse Event|0|||
94610093|NCT03633617|324037109|FG005|Part C (& Follow-up)|Adverse Event|1|||
94610094|NCT03633617|324037110|FG006|Part C (& Follow-up)|Adverse Event|0|||
94610095|NCT03633617|324037111|FG007|Part C (& Follow-up)|Adverse Event|1|||
94610096|NCT03633617|324037112|FG008|Part C (& Follow-up)|Adverse Event|0|||
94661765|NCT01781572|324215812|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
94253076|NCT04737187|322718841|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
94459442|NCT00954512|323469650|FG004|Overall Study|Adverse Event|1|||
94610097|NCT03633617|324037113|FG009|Part C (& Follow-up)|Adverse Event|0|||
94610098|NCT03633617|324037114|FG010|Part C (& Follow-up)|Adverse Event|0|||
94610099|NCT03633617|324037104|FG000|Part C (& Follow-up)|Pregnancy|0|||
94610100|NCT03633617|324037105|FG001|Part C (& Follow-up)|Pregnancy|0|||
94610101|NCT03633617|324037106|FG002|Part C (& Follow-up)|Pregnancy|0|||
94610102|NCT03633617|324037107|FG003|Part C (& Follow-up)|Pregnancy|0|||
94610103|NCT03633617|324037108|FG004|Part C (& Follow-up)|Pregnancy|0|||
94610104|NCT03633617|324037109|FG005|Part C (& Follow-up)|Pregnancy|0|||
94459443|NCT00954512|323469651|FG005|Overall Study|Adverse Event|2|||
94610105|NCT03633617|324037110|FG006|Part C (& Follow-up)|Pregnancy|0|||
94610106|NCT03633617|324037111|FG007|Part C (& Follow-up)|Pregnancy|0|||
94610107|NCT03633617|324037112|FG008|Part C (& Follow-up)|Pregnancy|0|||
94610108|NCT03633617|324037113|FG009|Part C (& Follow-up)|Pregnancy|1|||
94610109|NCT03633617|324037114|FG010|Part C (& Follow-up)|Pregnancy|0|||
94610110|NCT03633617|324037104|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
94610111|NCT03633617|324037105|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
94610112|NCT03633617|324037106|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
94610113|NCT03633617|324037107|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
94610114|NCT03633617|324037108|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
94610115|NCT03633617|324037109|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
94610116|NCT03633617|324037110|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
94610117|NCT03633617|324037111|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
94610118|NCT03633617|324037112|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
94610119|NCT03633617|324037113|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
94610120|NCT03633617|324037114|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
94610121|NCT03633617|324037104|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
94610122|NCT03633617|324037105|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
94610123|NCT03633617|324037106|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
94610124|NCT03633617|324037107|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
94610125|NCT03633617|324037108|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
94610126|NCT03633617|324037109|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
94610127|NCT03633617|324037110|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
94610128|NCT03633617|324037111|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
94610129|NCT03633617|324037112|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
94610130|NCT03633617|324037113|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
94610131|NCT03633617|324037114|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
94610132|NCT03633617|324037104|FG000|Part C (& Follow-up)|Physician Decision|0|||
94610133|NCT03633617|324037105|FG001|Part C (& Follow-up)|Physician Decision|0|||
94610134|NCT03633617|324037106|FG002|Part C (& Follow-up)|Physician Decision|0|||
94610135|NCT03633617|324037107|FG003|Part C (& Follow-up)|Physician Decision|0|||
94610136|NCT03633617|324037108|FG004|Part C (& Follow-up)|Physician Decision|0|||
94610137|NCT03633617|324037109|FG005|Part C (& Follow-up)|Physician Decision|0|||
94610138|NCT03633617|324037110|FG006|Part C (& Follow-up)|Physician Decision|0|||
94610139|NCT03633617|324037111|FG007|Part C (& Follow-up)|Physician Decision|1|||
94610140|NCT03633617|324037112|FG008|Part C (& Follow-up)|Physician Decision|0|||
94610141|NCT03633617|324037113|FG009|Part C (& Follow-up)|Physician Decision|0|||
94610142|NCT03633617|324037114|FG010|Part C (& Follow-up)|Physician Decision|1|||
94610143|NCT03633617|324037104|FG000|Part C (& Follow-up)|COVID-19 related|0|||
94610144|NCT03633617|324037105|FG001|Part C (& Follow-up)|COVID-19 related|0|||
94610145|NCT03633617|324037106|FG002|Part C (& Follow-up)|COVID-19 related|0|||
94610146|NCT03633617|324037107|FG003|Part C (& Follow-up)|COVID-19 related|0|||
94610147|NCT03633617|324037108|FG004|Part C (& Follow-up)|COVID-19 related|0|||
94610148|NCT03633617|324037109|FG005|Part C (& Follow-up)|COVID-19 related|1|||
94610149|NCT03633617|324037110|FG006|Part C (& Follow-up)|COVID-19 related|0|||
94610150|NCT03633617|324037111|FG007|Part C (& Follow-up)|COVID-19 related|0|||
94610151|NCT03633617|324037112|FG008|Part C (& Follow-up)|COVID-19 related|0|||
94610152|NCT03633617|324037113|FG009|Part C (& Follow-up)|COVID-19 related|0|||
94610153|NCT03633617|324037114|FG010|Part C (& Follow-up)|COVID-19 related|0|||
94610154|NCT03633617|324037104|FG000|Part C (& Follow-up)|Protocol Violation|0|||
94610155|NCT03633617|324037105|FG001|Part C (& Follow-up)|Protocol Violation|0|||
94610156|NCT03633617|324037106|FG002|Part C (& Follow-up)|Protocol Violation|0|||
94610157|NCT03633617|324037107|FG003|Part C (& Follow-up)|Protocol Violation|0|||
94610158|NCT03633617|324037108|FG004|Part C (& Follow-up)|Protocol Violation|0|||
94610159|NCT03633617|324037109|FG005|Part C (& Follow-up)|Protocol Violation|0|||
94610160|NCT03633617|324037110|FG006|Part C (& Follow-up)|Protocol Violation|0|||
94610161|NCT03633617|324037111|FG007|Part C (& Follow-up)|Protocol Violation|0|||
94610162|NCT03633617|324037112|FG008|Part C (& Follow-up)|Protocol Violation|0|||
94610163|NCT03633617|324037113|FG009|Part C (& Follow-up)|Protocol Violation|3|||
94610164|NCT03633617|324037114|FG010|Part C (& Follow-up)|Protocol Violation|1|||
94610165|NCT03633617|324037104|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
94610166|NCT03633617|324037105|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
94610167|NCT03633617|324037106|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
94610168|NCT03633617|324037107|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
94610169|NCT03633617|324037108|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
94610170|NCT03633617|324037109|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
94610171|NCT03633617|324037110|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
94610172|NCT03633617|324037111|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
94610173|NCT03633617|324037112|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
94610174|NCT03633617|324037113|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
94610175|NCT03633617|324037114|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
94610176|NCT00100178|324037117|FG000|Overall Study|Lost to Follow-up|0|||
94610177|NCT00100178|324037118|FG001|Overall Study|Lost to Follow-up|6|||
94610178|NCT00100178|324037119|FG002|Overall Study|Lost to Follow-up|5|||
94610179|NCT00100178|324037117|FG000|Overall Study|Adverse Event|2|||
94610180|NCT00100178|324037118|FG001|Overall Study|Adverse Event|2|||
94253077|NCT04737187|322718842|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
94253078|NCT04737187|322718841|FG000|Overall Study|Adverse Event|16|||
94253079|NCT04737187|322718842|FG001|Overall Study|Adverse Event|16|||
94253080|NCT04737187|322718841|FG000|Overall Study|Physician Decision|2|||
94253081|NCT04737187|322718842|FG001|Overall Study|Physician Decision|0|||
94253082|NCT04737187|322718841|FG000|Overall Study|Withdrawal by Subject|5|||
94253083|NCT04737187|322718842|FG001|Overall Study|Withdrawal by Subject|8|||
94253084|NCT04002401|322718843|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
94253085|NCT04002401|322718843|FG000|Overall Study|Death|10|||
94253086|NCT04002401|322718843|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
94253087|NCT04002401|322718843|FG000|Overall Study|Enrolled but Never Treated|1|||
94253088|NCT04002401|322718843|FG000|Overall Study|Lost to Follow-up|1|||
94459444|NCT00954512|323469646|FG000|Overall Study|Physician Decision|0|||
94459445|NCT00954512|323469647|FG001|Overall Study|Physician Decision|1|||
94459446|NCT00954512|323469648|FG002|Overall Study|Physician Decision|0|||
94459447|NCT00954512|323469649|FG003|Overall Study|Physician Decision|1|||
94459448|NCT00954512|323469650|FG004|Overall Study|Physician Decision|0|||
94459449|NCT00954512|323469651|FG005|Overall Study|Physician Decision|0|||
94459450|NCT00954512|323469646|FG000|Overall Study|Symptomatic Deterioration|0|||
94459451|NCT00954512|323469647|FG001|Overall Study|Symptomatic Deterioration|1|||
94459452|NCT00954512|323469648|FG002|Overall Study|Symptomatic Deterioration|0|||
94459453|NCT00954512|323469649|FG003|Overall Study|Symptomatic Deterioration|0|||
94459454|NCT00954512|323469650|FG004|Overall Study|Symptomatic Deterioration|2|||
94459455|NCT00954512|323469651|FG005|Overall Study|Symptomatic Deterioration|0|||
94459456|NCT00954512|323469646|FG000|Overall Study|Progression of Disease|2|||
94459457|NCT00954512|323469647|FG001|Overall Study|Progression of Disease|1|||
94459458|NCT00954512|323469648|FG002|Overall Study|Progression of Disease|0|||
94459459|NCT00954512|323469649|FG003|Overall Study|Progression of Disease|1|||
94459460|NCT00954512|323469650|FG004|Overall Study|Progression of Disease|1|||
94459461|NCT00954512|323469651|FG005|Overall Study|Progression of Disease|1|||
94459462|NCT05397171|323469653|FG000|Overall Study|Death|2|||
94459463|NCT05397171|323469654|FG001|Overall Study|Death|3|||
94459464|NCT05397171|323469655|FG002|Overall Study|Death|3|||
94459465|NCT05397171|323469653|FG000|Overall Study|Study Terminated By Sponsor|1|||
94459466|NCT05397171|323469654|FG001|Overall Study|Study Terminated By Sponsor|2|||
94459467|NCT05397171|323469655|FG002|Overall Study|Study Terminated By Sponsor|3|||
94459468|NCT05397171|323469653|FG000|Overall Study|Withdrawal by Subject|0|||
94459469|NCT05397171|323469654|FG001|Overall Study|Withdrawal by Subject|1|||
94459470|NCT05397171|323469655|FG002|Overall Study|Withdrawal by Subject|1|||
94459471|NCT02234596|323469656|FG000|Overall Study|Participant not treated|2|||
94459472|NCT00073983|323469657|FG000|Overall Study|not evaluable|1|||
94459473|NCT04250350|323471821|FG000|Overall Study|Withdrawal by Subject|13|||
94459474|NCT04250350|323471821|FG000|Overall Study|Lost to Follow-up|8|||
94459475|NCT04250350|323471821|FG000|Overall Study|Adverse Event|5|||
94459476|NCT04250350|323471821|FG000|Overall Study|Lack of Efficacy|4|||
94459477|NCT04250350|323471821|FG000|Overall Study|Physician Decision|1|||
94459478|NCT04250350|323471821|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
94459479|NCT00688701|323471824|FG000|Overall Study|Adverse Event|1|||
94459480|NCT00688701|323471825|FG001|Overall Study|Adverse Event|0|||
94459481|NCT00688701|323471826|FG002|Overall Study|Adverse Event|5|||
94459482|NCT00688701|323471827|FG003|Overall Study|Adverse Event|3|||
94459483|NCT00688701|323471824|FG000|Overall Study|Lack of Efficacy|0|||
94459484|NCT00688701|323471825|FG001|Overall Study|Lack of Efficacy|1|||
94459485|NCT00688701|323471826|FG002|Overall Study|Lack of Efficacy|0|||
94459486|NCT00688701|323471827|FG003|Overall Study|Lack of Efficacy|0|||
94459487|NCT00688701|323471824|FG000|Overall Study|Withdrawal by Subject|3|||
94459488|NCT00688701|323471825|FG001|Overall Study|Withdrawal by Subject|3|||
94459489|NCT00688701|323471826|FG002|Overall Study|Withdrawal by Subject|4|||
94459490|NCT00688701|323471827|FG003|Overall Study|Withdrawal by Subject|8|||
94459491|NCT00688701|323471824|FG000|Overall Study|Poor compliance to protocol|0|||
94459492|NCT00688701|323471825|FG001|Overall Study|Poor compliance to protocol|1|||
94459493|NCT00688701|323471826|FG002|Overall Study|Poor compliance to protocol|1|||
94459494|NCT00688701|323471827|FG003|Overall Study|Poor compliance to protocol|0|||
94459495|NCT01806961|323471828|FG000|Overall Study|sponsor decision|16|||
94459496|NCT04434469|323471831|FG000|Overall Study|Death|2|||
94661766|NCT01781572|324215813|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
94661767|NCT01781572|324215814|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
94459497|NCT04434469|323471832|FG001|Overall Study|Death|3|||
94459498|NCT04434469|323471833|FG002|Overall Study|Death|2|||
94459499|NCT04434469|323471834|FG003|Overall Study|Death|2|||
94459500|NCT04434469|323471835|FG004|Overall Study|Death|2|||
94459501|NCT04434469|323471836|FG005|Overall Study|Death|0|||
94459502|NCT04434469|323471831|FG000|Overall Study|Lost to Follow-up|0|||
94459503|NCT04434469|323471832|FG001|Overall Study|Lost to Follow-up|0|||
94459504|NCT04434469|323471833|FG002|Overall Study|Lost to Follow-up|0|||
94661768|NCT03985423|324217632|FG000|Overall Study|Adverse Event|1|||
94253089|NCT02337751|322718844|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
94253090|NCT02337751|322718845|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
94610181|NCT00100178|324037119|FG002|Overall Study|Adverse Event|1|||
94610182|NCT00100178|324037117|FG000|Overall Study|Withdrawal by Subject|1|||
94610183|NCT00100178|324037118|FG001|Overall Study|Withdrawal by Subject|1|||
94610184|NCT00100178|324037119|FG002|Overall Study|Withdrawal by Subject|1|||
94610185|NCT00100178|324037117|FG000|Overall Study|Physician Decision|6|||
94610186|NCT00100178|324037118|FG001|Overall Study|Physician Decision|1|||
94610187|NCT00100178|324037119|FG002|Overall Study|Physician Decision|3|||
94610188|NCT03257371|324037120|FG000|Overall Study|Lost to Follow-up|1|||
94610189|NCT01050543|324037123|FG000|Overall Study|Withdrawal by Subject|0|||
94610190|NCT01050543|324037124|FG001|Overall Study|Withdrawal by Subject|2|||
94610191|NCT01050543|324037123|FG000|Overall Study|Protocol Violation|0|||
94610192|NCT01050543|324037124|FG001|Overall Study|Protocol Violation|1|||
94610193|NCT01050543|324037123|FG000|Overall Study|Administrative|4|||
94610194|NCT01050543|324037124|FG001|Overall Study|Administrative|1|||
94610195|NCT00570765|324037125|FG000|DB Phase|Withdrawal by Subject|1|||
94610196|NCT00570765|324037126|FG001|DB Phase|Withdrawal by Subject|0|||
94610197|NCT00570765|324037127|FG002|DB Phase|Withdrawal by Subject|0|||
94610198|NCT00570765|324037128|FG003|DB Phase|Withdrawal by Subject|0|||
94661769|NCT03985423|324217632|FG000|Overall Study|Death|2|||
94661770|NCT03985423|324217632|FG000|Overall Study|Physician Decision|1|||
94661771|NCT03985423|324217632|FG000|Overall Study|Withdrawal by Subject|2|||
94661772|NCT03985423|324217632|FG000|Overall Study|Lack of insurance and citizenship|1|||
94661773|NCT01054820|324217641|FG000|Overall Study|Withdrawal by Subject|2|||
94661774|NCT00467870|324217642|FG000|Overall Study|Adverse Event|13|||
94661775|NCT00467870|324217643|FG001|Overall Study|Adverse Event|9|||
94661776|NCT00467870|324217644|FG002|Overall Study|Adverse Event|1|||
94661777|NCT00467870|324217645|FG003|Overall Study|Adverse Event|15|||
94661778|NCT00467870|324217646|FG004|Overall Study|Adverse Event|15|||
94661779|NCT00467870|324217647|FG005|Overall Study|Adverse Event|1|||
94661780|NCT00467870|324217642|FG000|Overall Study|Protocol Violation|2|||
94661781|NCT00467870|324217643|FG001|Overall Study|Protocol Violation|1|||
94661782|NCT00467870|324217644|FG002|Overall Study|Protocol Violation|1|||
94661783|NCT00467870|324217645|FG003|Overall Study|Protocol Violation|2|||
94661784|NCT00467870|324217646|FG004|Overall Study|Protocol Violation|0|||
94661785|NCT00467870|324217647|FG005|Overall Study|Protocol Violation|0|||
94661786|NCT00467870|324217642|FG000|Overall Study|Withdrawal by Subject|14|||
94661787|NCT00467870|324217643|FG001|Overall Study|Withdrawal by Subject|21|||
94661788|NCT00467870|324217644|FG002|Overall Study|Withdrawal by Subject|0|||
94661789|NCT00467870|324217645|FG003|Overall Study|Withdrawal by Subject|9|||
94661790|NCT00467870|324217646|FG004|Overall Study|Withdrawal by Subject|10|||
94661791|NCT00467870|324217647|FG005|Overall Study|Withdrawal by Subject|1|||
94661792|NCT00467870|324217642|FG000|Overall Study|Lost to Follow-up|5|||
94661793|NCT00467870|324217643|FG001|Overall Study|Lost to Follow-up|3|||
94610199|NCT00570765|324037125|FG000|DB Phase|Protocol Violation|0|||
94610200|NCT00570765|324037126|FG001|DB Phase|Protocol Violation|1|||
94610201|NCT00570765|324037127|FG002|DB Phase|Protocol Violation|0|||
94661794|NCT00467870|324217644|FG002|Overall Study|Lost to Follow-up|1|||
94661795|NCT00467870|324217645|FG003|Overall Study|Lost to Follow-up|1|||
94661796|NCT00467870|324217646|FG004|Overall Study|Lost to Follow-up|3|||
94610202|NCT00570765|324037128|FG003|DB Phase|Protocol Violation|0|||
94610203|NCT00570765|324037125|FG000|DB Phase|Adverse Event|3|||
94610204|NCT00570765|324037126|FG001|DB Phase|Adverse Event|6|||
94610205|NCT00570765|324037127|FG002|DB Phase|Adverse Event|0|||
94661797|NCT00467870|324217647|FG005|Overall Study|Lost to Follow-up|0|||
94661798|NCT00467870|324217642|FG000|Overall Study|Subject Non-compliance|3|||
94661799|NCT00467870|324217643|FG001|Overall Study|Subject Non-compliance|4|||
94661800|NCT00467870|324217644|FG002|Overall Study|Subject Non-compliance|0|||
94610206|NCT00570765|324037128|FG003|DB Phase|Adverse Event|0|||
94610207|NCT00570765|324037125|FG000|DB Phase|Did Not Receive Study Drug|0|||
94610208|NCT00570765|324037126|FG001|DB Phase|Did Not Receive Study Drug|0|||
94610209|NCT00570765|324037127|FG002|DB Phase|Did Not Receive Study Drug|1|||
94610210|NCT00570765|324037128|FG003|DB Phase|Did Not Receive Study Drug|0|||
94610211|NCT00570765|324037125|FG000|LTSE Phase|Withdrawal by Subject|0|||
94610212|NCT00570765|324037126|FG001|LTSE Phase|Withdrawal by Subject|0|||
94253091|NCT02337751|322718844|FG000|Overall Study|Voluntary Withdrawal|6|||
94253092|NCT02337751|322718845|FG001|Overall Study|Voluntary Withdrawal|8|||
94253093|NCT02337751|322718844|FG000|Overall Study|Lack of Efficacy|2|||
94253094|NCT02337751|322718845|FG001|Overall Study|Lack of Efficacy|5|||
94610213|NCT00570765|324037127|FG002|LTSE Phase|Withdrawal by Subject|0|||
94610214|NCT00570765|324037128|FG003|LTSE Phase|Withdrawal by Subject|1|||
94610215|NCT00570765|324037125|FG000|LTSE Phase|Adverse Event|0|||
94610216|NCT00570765|324037126|FG001|LTSE Phase|Adverse Event|0|||
94610217|NCT00570765|324037127|FG002|LTSE Phase|Adverse Event|0|||
94610218|NCT00570765|324037128|FG003|LTSE Phase|Adverse Event|7|||
94610219|NCT00570765|324037125|FG000|LTSE Phase|Physician Decision|0|||
94610220|NCT00570765|324037126|FG001|LTSE Phase|Physician Decision|0|||
94610221|NCT00570765|324037127|FG002|LTSE Phase|Physician Decision|0|||
94610222|NCT00570765|324037128|FG003|LTSE Phase|Physician Decision|4|||
94610223|NCT01332331|324037139|FG000|Overall Study|Lost to Follow-up|0|||
94610224|NCT01332331|324037140|FG001|Overall Study|Lost to Follow-up|1|||
94610225|NCT01332331|324037139|FG000|Overall Study|Adverse Event|1|||
94610226|NCT01332331|324037140|FG001|Overall Study|Adverse Event|1|||
94610227|NCT01332331|324037139|FG000|Overall Study|Physician Decision|1|||
94610228|NCT01332331|324037140|FG001|Overall Study|Physician Decision|0|||
94610229|NCT00591344|324037141|FG000|Overall Study|Transportation issues|1|||
94610230|NCT00591344|324037142|FG001|Overall Study|Transportation issues|0|||
94610231|NCT00591344|324037141|FG000|Overall Study|Moved out of state|1|||
94610232|NCT00591344|324037142|FG001|Overall Study|Moved out of state|0|||
94610233|NCT00591344|324037141|FG000|Overall Study|Medical complications|1|||
94610234|NCT00591344|324037142|FG001|Overall Study|Medical complications|3|||
94610235|NCT00591344|324037141|FG000|Overall Study|Underwent DBS|2|||
94610236|NCT00591344|324037142|FG001|Overall Study|Underwent DBS|2|||
94610237|NCT00591344|324037141|FG000|Overall Study|Death|0|||
94610238|NCT00591344|324037142|FG001|Overall Study|Death|1|||
94610239|NCT00591344|324037141|FG000|Overall Study|Lost to Follow-up|0|||
94610240|NCT00591344|324037142|FG001|Overall Study|Lost to Follow-up|1|||
94610241|NCT00591344|324037141|FG000|Overall Study|Did not want to come off medication|0|||
94610242|NCT00591344|324037142|FG001|Overall Study|Did not want to come off medication|1|||
94610243|NCT02046733|324037147|FG000|Overall Study|never initiated 'treatment visits'|6|||
94610244|NCT02046733|324037148|FG001|Overall Study|never initiated 'treatment visits'|0|||
94610245|NCT01756053|324037150|FG000|Period 1 (10 Days)|Protocol Violation|1|||
94610246|NCT01756053|324037151|FG001|Period 1 (10 Days)|Protocol Violation|1|||
94610247|NCT01756053|324037150|FG000|Period 2 (10 Days)|Protocol Violation|0|||
94610248|NCT01756053|324037151|FG001|Period 2 (10 Days)|Protocol Violation|2|||
94610249|NCT01230710|324037152|FG000|Overall Study|Disease Progression|41|||
94610250|NCT01230710|324037152|FG000|Overall Study|Lost to Follow-up|3|||
94610251|NCT01230710|324037152|FG000|Overall Study|Death|4|||
94610252|NCT01230710|324037152|FG000|Overall Study|Withdrawal of Consent|1|||
94610253|NCT01986140|324037155|FG000|Overall Study|Withdrawal by Subject|31|||
94253095|NCT02337751|322718844|FG000|Overall Study|Investigator's Judgement|1|||
94610254|NCT01986140|324037156|FG001|Overall Study|Withdrawal by Subject|25|||
94610255|NCT01986140|324037155|FG000|Overall Study|alternative treatment|1|||
94610256|NCT01986140|324037156|FG001|Overall Study|alternative treatment|1|||
94610257|NCT01986140|324037155|FG000|Overall Study|found not eligible|3|||
94610258|NCT01986140|324037156|FG001|Overall Study|found not eligible|0|||
94610259|NCT01986140|324037155|FG000|Overall Study|Adverse Event|0|||
94610260|NCT01986140|324037156|FG001|Overall Study|Adverse Event|1|||
94610261|NCT01986140|324037155|FG000|Overall Study|progression disease|0|||
94610262|NCT01986140|324037156|FG001|Overall Study|progression disease|1|||
94610263|NCT02979197|324037159|FG000|Overall Study|Adverse Event|4|||
94610264|NCT02979197|324037160|FG001|Overall Study|Adverse Event|2|||
94610265|NCT02979197|324037161|FG002|Overall Study|Adverse Event|0|||
94610266|NCT02979197|324037159|FG000|Overall Study|Protocol Violation|0|||
94610267|NCT02979197|324037160|FG001|Overall Study|Protocol Violation|1|||
94610268|NCT02979197|324037161|FG002|Overall Study|Protocol Violation|0|||
94661801|NCT00467870|324217645|FG003|Overall Study|Subject Non-compliance|1|||
94253096|NCT02337751|322718845|FG001|Overall Study|Investigator's Judgement|0|||
94610269|NCT02979197|324037159|FG000|Overall Study|Subject unable to commit to study dates|0|||
94610270|NCT02979197|324037160|FG001|Overall Study|Subject unable to commit to study dates|1|||
94661802|NCT00467870|324217646|FG004|Overall Study|Subject Non-compliance|5|||
94253097|NCT01315353|322718848|FG000|Overall Study|Death|2|||
94610271|NCT02979197|324037161|FG002|Overall Study|Subject unable to commit to study dates|0|||
94610272|NCT03643159|324037162|FG000|Overall Study|Adverse Event|1|||
94610273|NCT03643159|324037162|FG000|Overall Study|Withdrawal by Subject|1|||
94610274|NCT02081183|324037163|FG000|Overall Study|Lost to Follow-up|0|||
94610275|NCT02081183|324037164|FG001|Overall Study|Lost to Follow-up|1|||
94610276|NCT02081183|324037163|FG000|Overall Study|Protocol Violation|1|||
94661803|NCT00467870|324217647|FG005|Overall Study|Subject Non-compliance|0|||
94661804|NCT00467870|324217642|FG000|Overall Study|Other/Unknown|8|||
94661805|NCT00467870|324217643|FG001|Overall Study|Other/Unknown|5|||
94661806|NCT00467870|324217644|FG002|Overall Study|Other/Unknown|1|||
94661807|NCT00467870|324217645|FG003|Overall Study|Other/Unknown|5|||
94661808|NCT00467870|324217646|FG004|Overall Study|Other/Unknown|4|||
94661809|NCT00467870|324217647|FG005|Overall Study|Other/Unknown|0|||
94661810|NCT02519504|324217649|FG000|Overall Study|Protocol Violation|6|||
94661811|NCT02519504|324217650|FG001|Overall Study|Protocol Violation|5|||
94661812|NCT02519504|324217649|FG000|Overall Study|Ineligible for direct testing|12|||
94661813|NCT02519504|324217650|FG001|Overall Study|Ineligible for direct testing|12|||
94661814|NCT02519504|324217649|FG000|Overall Study|Did not participate in direct testing|95|||
94661815|NCT02519504|324217650|FG001|Overall Study|Did not participate in direct testing|86|||
94661816|NCT00455195|324217653|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
94661817|NCT00455195|324217654|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
94661818|NCT00455195|324217653|FG000|Double-blind Study AGLU02704|Death|1|||
94661819|NCT00455195|324217654|FG001|Double-blind Study AGLU02704|Death|0|||
94661820|NCT00455195|324217653|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
94661821|NCT00455195|324217654|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
94661822|NCT00455195|324217653|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
94661823|NCT00455195|324217654|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
94661824|NCT02148250|324217655|FG000|Screening|Withdrawal by Subject|5|||
94661825|NCT02148250|324217656|FG001|Screening|Withdrawal by Subject|0|||
94661826|NCT02553330|324217657|FG000|Overall Study|Study Terminated by Sponsor|2|||
94661827|NCT02553330|324217658|FG001|Overall Study|Study Terminated by Sponsor|13|||
94661828|NCT02553330|324217659|FG002|Overall Study|Study Terminated by Sponsor|12|||
94661829|NCT02553330|324217657|FG000|Overall Study|Withdrawal by Subject|3|||
94661830|NCT02553330|324217658|FG001|Overall Study|Withdrawal by Subject|19|||
94661831|NCT02553330|324217659|FG002|Overall Study|Withdrawal by Subject|21|||
94661832|NCT02553330|324217657|FG000|Overall Study|Other|0|||
94661833|NCT02553330|324217658|FG001|Overall Study|Other|1|||
94661834|NCT02553330|324217659|FG002|Overall Study|Other|0|||
94661835|NCT02553330|324217657|FG000|Overall Study|Non compliance to study treatment|0|||
94661836|NCT02553330|324217658|FG001|Overall Study|Non compliance to study treatment|1|||
94661837|NCT02553330|324217659|FG002|Overall Study|Non compliance to study treatment|0|||
94661838|NCT02553330|324217657|FG000|Overall Study|Adverse Event|0|||
94661839|NCT02553330|324217658|FG001|Overall Study|Adverse Event|1|||
94610277|NCT02081183|324037164|FG001|Overall Study|Protocol Violation|0|||
94610278|NCT02081183|324037163|FG000|Overall Study|Other|3|||
94661840|NCT02553330|324217659|FG002|Overall Study|Adverse Event|0|||
94661841|NCT02553330|324217657|FG000|Overall Study|Lost to Follow-up|0|||
94661842|NCT02553330|324217658|FG001|Overall Study|Lost to Follow-up|4|||
94661843|NCT02553330|324217659|FG002|Overall Study|Lost to Follow-up|4|||
94661844|NCT02169674|324217665|FG000|Overall Study|Withdrawal by Subject|2|||
94661845|NCT02169674|324217666|FG001|Overall Study|Withdrawal by Subject|1|||
94610279|NCT02081183|324037164|FG001|Overall Study|Other|3|||
94610280|NCT00961649|324037169|FG000|Overall Study|Adverse Event|4|||
94610281|NCT00961649|324037170|FG001|Overall Study|Adverse Event|0|||
94610282|NCT00961649|324037171|FG002|Overall Study|Adverse Event|0|||
94610283|NCT00961649|324037172|FG003|Overall Study|Adverse Event|2|||
94610284|NCT00961649|324037169|FG000|Overall Study|Inadequate control of IOP|0|||
94610285|NCT00961649|324037170|FG001|Overall Study|Inadequate control of IOP|0|||
94610286|NCT00961649|324037171|FG002|Overall Study|Inadequate control of IOP|0|||
94610287|NCT00961649|324037172|FG003|Overall Study|Inadequate control of IOP|1|||
94610288|NCT00961649|324037169|FG000|Overall Study|Patient has travel plans during holidays|0|||
94610289|NCT00961649|324037170|FG001|Overall Study|Patient has travel plans during holidays|0|||
94610290|NCT00961649|324037171|FG002|Overall Study|Patient has travel plans during holidays|1|||
94610291|NCT00961649|324037172|FG003|Overall Study|Patient has travel plans during holidays|0|||
94610292|NCT00961649|324037169|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
94661846|NCT02169674|324217665|FG000|Overall Study|Seroprotected|30|||
94661847|NCT02169674|324217666|FG001|Overall Study|Seroprotected|76|||
94661848|NCT02169674|324217665|FG000|Overall Study|Lost to Follow-up|0|||
94661849|NCT02169674|324217666|FG001|Overall Study|Lost to Follow-up|1|||
94661850|NCT02370602|324217667|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
94253098|NCT01315353|322718849|FG001|Overall Study|Death|1|||
94610293|NCT00961649|324037170|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
94661851|NCT02370602|324217668|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
94661852|NCT02370602|324217669|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
94661853|NCT02370602|324217670|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
94661854|NCT02370602|324217671|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
94253099|NCT01315353|322718850|FG002|Overall Study|Death|0|||
94253100|NCT01315353|322718848|FG000|Overall Study|Withdrawal by Subject|2|||
94253101|NCT01315353|322718849|FG001|Overall Study|Withdrawal by Subject|6|||
94253102|NCT01315353|322718850|FG002|Overall Study|Withdrawal by Subject|1|||
94253103|NCT01315353|322718848|FG000|Overall Study|Lost to Follow-up|13|||
94253104|NCT01315353|322718849|FG001|Overall Study|Lost to Follow-up|6|||
94253105|NCT01315353|322718850|FG002|Overall Study|Lost to Follow-up|6|||
94253106|NCT01315353|322718848|FG000|Overall Study|Unwilling to adhere to requirements|5|||
94253107|NCT01315353|322718849|FG001|Overall Study|Unwilling to adhere to requirements|5|||
94253108|NCT01315353|322718850|FG002|Overall Study|Unwilling to adhere to requirements|4|||
94253109|NCT01315353|322718848|FG000|Overall Study|Site closing|7|||
94610294|NCT00961649|324037171|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
94610295|NCT00961649|324037172|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
94610296|NCT00961649|324037169|FG000|Overall Study|Study terminated by sponsor|4|||
94610297|NCT00961649|324037170|FG001|Overall Study|Study terminated by sponsor|4|||
94610298|NCT00961649|324037171|FG002|Overall Study|Study terminated by sponsor|4|||
94610299|NCT00961649|324037172|FG003|Overall Study|Study terminated by sponsor|1|||
94610300|NCT01528033|324037173|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
94610301|NCT01528033|324037174|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
94610302|NCT01528033|324037173|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
94610303|NCT01528033|324037174|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
94610304|NCT01528033|324037173|FG000|Primary Endpoint Assessment ITT|Death|2|||
94610305|NCT01528033|324037174|FG001|Primary Endpoint Assessment ITT|Death|2|||
94610306|NCT01528033|324037173|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
94610307|NCT01528033|324037174|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
94610308|NCT01528033|324037173|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
94610309|NCT01528033|324037174|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
94610310|NCT01528033|324037173|FG000|Follow Up|No data available|46|||
94610311|NCT01528033|324037174|FG001|Follow Up|No data available|44|||
94610312|NCT04043728|324037175|FG000|Overall Study|Lost to Follow-up|1|||
94610313|NCT04043728|324037176|FG001|Overall Study|Lost to Follow-up|2|||
94610314|NCT04043728|324037177|FG002|Overall Study|Lost to Follow-up|0|||
94610315|NCT02030938|324037178|FG000|Overall Study|Lost to Follow-up|4|||
94610316|NCT02030938|324037178|FG000|Overall Study|Withdrawal by Subject|1|||
94610317|NCT02349542|324037179|FG000|Overall Study|Withdrawal by Subject|5|||
94610318|NCT04068610|324037180|FG000|Overall Study|Death|4|||
94610319|NCT04068610|324037181|FG001|Overall Study|Death|8|||
94610320|NCT04068610|324037182|FG002|Overall Study|Death|13|||
94610321|NCT04068610|324037180|FG000|Overall Study|Lost to Follow-up|0|||
94610322|NCT04068610|324037181|FG001|Overall Study|Lost to Follow-up|2|||
94610323|NCT04068610|324037182|FG002|Overall Study|Lost to Follow-up|0|||
94610324|NCT04068610|324037180|FG000|Overall Study|Withdrawal by Subject|0|||
94610325|NCT04068610|324037181|FG001|Overall Study|Withdrawal by Subject|4|||
94610326|NCT04068610|324037182|FG002|Overall Study|Withdrawal by Subject|2|||
94610327|NCT04068610|324037180|FG000|Overall Study|Other|3|||
94610328|NCT04068610|324037181|FG001|Overall Study|Other|12|||
94610329|NCT04068610|324037182|FG002|Overall Study|Other|11|||
94610330|NCT01163266|324037183|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
94610331|NCT01163266|324037184|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
94610332|NCT01163266|324037185|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
94610333|NCT01163266|324037183|FG000|Overall Study|Lack of Efficacy|1|||
94610334|NCT01163266|324037184|FG001|Overall Study|Lack of Efficacy|3|||
94610335|NCT01163266|324037185|FG002|Overall Study|Lack of Efficacy|1|||
94610336|NCT01163266|324037183|FG000|Overall Study|Noncompliance with Study Drug|0|||
94610337|NCT01163266|324037184|FG001|Overall Study|Noncompliance with Study Drug|2|||
94610338|NCT01163266|324037185|FG002|Overall Study|Noncompliance with Study Drug|0|||
94610339|NCT01163266|324037183|FG000|Overall Study|Protocol Deviations|2|||
94610340|NCT01163266|324037184|FG001|Overall Study|Protocol Deviations|2|||
94610341|NCT01163266|324037185|FG002|Overall Study|Protocol Deviations|5|||
94610342|NCT01163266|324037183|FG000|Overall Study|Withdrawal of Consent|5|||
94253110|NCT01315353|322718849|FG001|Overall Study|Site closing|4|||
94253111|NCT01315353|322718850|FG002|Overall Study|Site closing|0|||
94253112|NCT01315353|322718848|FG000|Overall Study|Taken off study by site in error|0|||
94253113|NCT01315353|322718849|FG001|Overall Study|Taken off study by site in error|1|||
94253114|NCT01315353|322718850|FG002|Overall Study|Taken off study by site in error|0|||
94610343|NCT01163266|324037184|FG001|Overall Study|Withdrawal of Consent|7|||
94610344|NCT01163266|324037185|FG002|Overall Study|Withdrawal of Consent|3|||
94610345|NCT01163266|324037183|FG000|Overall Study|Lost to Follow-up|7|||
94610346|NCT01163266|324037184|FG001|Overall Study|Lost to Follow-up|7|||
94610347|NCT01163266|324037185|FG002|Overall Study|Lost to Follow-up|10|||
94610348|NCT01163266|324037183|FG000|Overall Study|Other|1|||
94253115|NCT01315353|322718848|FG000|Overall Study|Inadvertent randomization/assignment|0|||
94610349|NCT01163266|324037184|FG001|Overall Study|Other|1|||
94610350|NCT01163266|324037185|FG002|Overall Study|Other|2|||
94610351|NCT02586064|324037186|FG000|Overall Study|Other Obligations|6|||
94610352|NCT02586064|324037187|FG001|Overall Study|Other Obligations|6|||
94610353|NCT02586064|324037186|FG000|Overall Study|Other|3|||
94610354|NCT02586064|324037187|FG001|Overall Study|Other|7|||
94610355|NCT02586064|324037186|FG000|Overall Study|Never Started|3|||
94610356|NCT02586064|324037187|FG001|Overall Study|Never Started|3|||
94610357|NCT02586064|324037186|FG000|Overall Study|Lost Interest|1|||
94610358|NCT02586064|324037187|FG001|Overall Study|Lost Interest|4|||
94610359|NCT02586064|324037186|FG000|Overall Study|Miscellaneous Life Issues|0|||
94610360|NCT02586064|324037187|FG001|Overall Study|Miscellaneous Life Issues|5|||
94610361|NCT02586064|324037186|FG000|Overall Study|Infrequent Attendance|2|||
94610362|NCT02586064|324037187|FG001|Overall Study|Infrequent Attendance|1|||
94610363|NCT02586064|324037186|FG000|Overall Study|Timed Out|2|||
94610364|NCT02586064|324037187|FG001|Overall Study|Timed Out|0|||
94610365|NCT02586064|324037186|FG000|Overall Study|AUD relapse|0|||
94610366|NCT02586064|324037187|FG001|Overall Study|AUD relapse|2|||
94610367|NCT02586064|324037186|FG000|Overall Study|Legal Issue|1|||
94610368|NCT02586064|324037187|FG001|Overall Study|Legal Issue|0|||
94610369|NCT01414608|324037189|FG000|Overall Study|Ineligible|5|||
94610370|NCT01414608|324037190|FG001|Overall Study|Ineligible|2|||
94610371|NCT02764697|324037191|FG000|Overall Study|Lack of Efficacy|3|||
94610372|NCT01193842|324037198|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
94253116|NCT01315353|322718849|FG001|Overall Study|Inadvertent randomization/assignment|0|||
94610373|NCT01193842|324037199|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
94610374|NCT01193842|324037200|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
94610375|NCT01193842|324037201|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
94610376|NCT01193842|324037202|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
94610377|NCT01193842|324037198|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
94610378|NCT01193842|324037199|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
94610379|NCT01193842|324037200|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
94610380|NCT01193842|324037201|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
94610381|NCT01193842|324037202|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
94610382|NCT01193842|324037198|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
94610383|NCT01193842|324037199|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
94610384|NCT01193842|324037200|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
94610385|NCT01193842|324037201|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
94610386|NCT01193842|324037202|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
94610387|NCT01193842|324037198|FG000|Phase II: Randomized Groups|Death|0|||
94610388|NCT01193842|324037199|FG001|Phase II: Randomized Groups|Death|0|||
94610389|NCT01193842|324037200|FG002|Phase II: Randomized Groups|Death|0|||
94610390|NCT01193842|324037201|FG003|Phase II: Randomized Groups|Death|1|||
94610391|NCT01193842|324037202|FG004|Phase II: Randomized Groups|Death|1|||
94610392|NCT01193842|324037198|FG000|Phase II: Randomized Groups|Adverse Event|0|||
94610393|NCT01193842|324037199|FG001|Phase II: Randomized Groups|Adverse Event|0|||
94610394|NCT01193842|324037200|FG002|Phase II: Randomized Groups|Adverse Event|0|||
94610395|NCT01193842|324037201|FG003|Phase II: Randomized Groups|Adverse Event|5|||
94610396|NCT01193842|324037202|FG004|Phase II: Randomized Groups|Adverse Event|3|||
94610397|NCT01193842|324037198|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
94610398|NCT01193842|324037199|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
94610399|NCT01193842|324037200|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
94610400|NCT01193842|324037201|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
94610401|NCT01193842|324037202|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
94610402|NCT01193842|324037198|FG000|Phase II: Randomized Groups|Ineligible|0|||
94610403|NCT01193842|324037199|FG001|Phase II: Randomized Groups|Ineligible|0|||
94253117|NCT01315353|322718850|FG002|Overall Study|Inadvertent randomization/assignment|2|||
94253118|NCT03035201|322718851|FG000|Overall Study|Death|9|||
94253119|NCT03035201|322718852|FG001|Overall Study|Death|12|||
94253120|NCT03035201|322718853|FG002|Overall Study|Death|9|||
94253121|NCT03035201|322718854|FG003|Overall Study|Death|10|||
94253122|NCT03035201|322718851|FG000|Overall Study|Withdrawal by Subject|51|||
94253123|NCT03035201|322718852|FG001|Overall Study|Withdrawal by Subject|49|||
94253124|NCT03035201|322718853|FG002|Overall Study|Withdrawal by Subject|37|||
94253125|NCT03035201|322718854|FG003|Overall Study|Withdrawal by Subject|46|||
94253126|NCT03035201|322718851|FG000|Overall Study|Lost to Follow-up|67|||
94253127|NCT03035201|322718852|FG001|Overall Study|Lost to Follow-up|51|||
94253128|NCT03035201|322718853|FG002|Overall Study|Lost to Follow-up|64|||
94253129|NCT03035201|322718854|FG003|Overall Study|Lost to Follow-up|69|||
94253130|NCT03705832|322718858|FG000|Overall Study|Physician Decision|0|||
94253131|NCT03705832|322718859|FG001|Overall Study|Physician Decision|1|||
94253132|NCT03705832|322718858|FG000|Overall Study|Withdrawal by Subject|1|||
94253133|NCT03705832|322718859|FG001|Overall Study|Withdrawal by Subject|0|||
94253134|NCT01050790|322718860|FG000|Overall Study|Adverse Event|1|||
94253135|NCT03319849|322718861|FG000|Overall Study|Adverse Event|1|||
94253136|NCT03319849|322718862|FG001|Overall Study|Adverse Event|0|||
94253137|NCT03319849|322718861|FG000|Overall Study|Physician Decision|0|||
94610404|NCT01193842|324037200|FG002|Phase II: Randomized Groups|Ineligible|0|||
94610405|NCT01193842|324037201|FG003|Phase II: Randomized Groups|Ineligible|0|||
94610406|NCT01193842|324037202|FG004|Phase II: Randomized Groups|Ineligible|1|||
94610407|NCT01193842|324037198|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
94610408|NCT01193842|324037199|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
94610409|NCT01193842|324037200|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
94610410|NCT01193842|324037201|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
94610411|NCT01193842|324037202|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
94610412|NCT03698331|324037203|FG000|Overall Study|Adverse Event|2|||
94610413|NCT03698331|324037204|FG001|Overall Study|Adverse Event|3|||
94610414|NCT03698331|324037203|FG000|Overall Study|Withdrawal by Subject|1|||
94610415|NCT03698331|324037204|FG001|Overall Study|Withdrawal by Subject|1|||
94610416|NCT03698331|324037203|FG000|Overall Study|Lost to Follow-up|0|||
94253138|NCT03319849|322718862|FG001|Overall Study|Physician Decision|1|||
94253139|NCT03319849|322718861|FG000|Overall Study|Withdrawal by Subject|0|||
94253140|NCT03319849|322718862|FG001|Overall Study|Withdrawal by Subject|1|||
94253141|NCT03319849|322718861|FG000|Overall Study|COVID-19|0|||
94253142|NCT03319849|322718862|FG001|Overall Study|COVID-19|1|||
94253143|NCT03319849|322718861|FG000|Overall Study|Other|1|||
94253144|NCT03319849|322718862|FG001|Overall Study|Other|2|||
94253145|NCT03319849|322718861|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
94253146|NCT03319849|322718862|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
94610417|NCT03698331|324037204|FG001|Overall Study|Lost to Follow-up|2|||
94610418|NCT03698331|324037203|FG000|Overall Study|Non-compliance with study drug|1|||
94610419|NCT03698331|324037204|FG001|Overall Study|Non-compliance with study drug|0|||
94610420|NCT02130024|324037205|FG000|Overall Study|Adverse Event|10|||
94610421|NCT02130024|324037206|FG001|Overall Study|Adverse Event|11|||
94610422|NCT02130024|324037205|FG000|Overall Study|Death|2|||
94610423|NCT02130024|324037206|FG001|Overall Study|Death|2|||
94253147|NCT03319849|322718861|FG000|Overall Study|Lost to Follow-up|0|||
94253148|NCT03319849|322718862|FG001|Overall Study|Lost to Follow-up|2|||
94253149|NCT02401867|322720754|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
94253150|NCT02401867|322720754|FG000|Analysis|Cervical assay could not be conducted|9|||
94610424|NCT02130024|324037205|FG000|Overall Study|Lost to Follow-up|1|||
94610425|NCT02130024|324037206|FG001|Overall Study|Lost to Follow-up|1|||
94610426|NCT02130024|324037205|FG000|Overall Study|Physician Decision|1|||
94610427|NCT02130024|324037206|FG001|Overall Study|Physician Decision|3|||
94610428|NCT02130024|324037205|FG000|Overall Study|Protocol Deviation|4|||
94610429|NCT02130024|324037206|FG001|Overall Study|Protocol Deviation|0|||
94610430|NCT02130024|324037205|FG000|Overall Study|Site Administration Problems|1|||
94661855|NCT02370602|324217672|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
94661856|NCT03349710|324217673|FG000|Treatment Period|Death|0|||
94661857|NCT03349710|324217674|FG001|Treatment Period|Death|0|||
94661858|NCT03349710|324217675|FG002|Treatment Period|Death|1|||
94253151|NCT02134977|322720755|FG000|Overall Study|Protocol Deviation|102|||
94253152|NCT01773291|322720756|FG000|Overall Study|Protocol Violation|1|||
94253153|NCT01773291|322720757|FG001|Overall Study|Protocol Violation|0|||
94253154|NCT01773291|322720758|FG002|Overall Study|Protocol Violation|0|||
94253155|NCT01773291|322720756|FG000|Overall Study|Withdrawal by Subject|0|||
94610431|NCT02130024|324037206|FG001|Overall Study|Site Administration Problems|0|||
94610432|NCT02130024|324037205|FG000|Overall Study|Subject Withdrew Consent|6|||
94661859|NCT03349710|324217676|FG003|Treatment Period|Death|0|||
94661860|NCT03349710|324217673|FG000|Treatment Period|Disease Progression|0|||
94253156|NCT01773291|322720757|FG001|Overall Study|Withdrawal by Subject|0|||
94253157|NCT01773291|322720758|FG002|Overall Study|Withdrawal by Subject|1|||
94459505|NCT04434469|323471834|FG003|Overall Study|Lost to Follow-up|1|||
94661861|NCT03349710|324217674|FG001|Treatment Period|Disease Progression|2|||
94661862|NCT03349710|324217675|FG002|Treatment Period|Disease Progression|0|||
94610433|NCT02130024|324037206|FG001|Overall Study|Subject Withdrew Consent|14|||
94610434|NCT03360747|324037207|FG000|Overall Study|Voluntary Withdrawal|1|||
94610435|NCT01759511|324037209|FG000|Overall Study|Adverse Event|4|||
94610436|NCT01759511|324037209|FG000|Overall Study|Death|2|||
94610437|NCT01759511|324037209|FG000|Overall Study|Lack of Efficacy|2|||
94610438|NCT01759511|324037209|FG000|Overall Study|Physician Decision|1|||
94610439|NCT01759511|324037209|FG000|Overall Study|Progressive Disease|5|||
94610440|NCT01759511|324037209|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
94610441|NCT01759511|324037209|FG000|Overall Study|Study Terminated by Sponsor|13|||
94610442|NCT01759511|324037209|FG000|Overall Study|Withdrawal by Subject|3|||
94610443|NCT03672643|324037210|FG000|Overall Study|Adverse Event|3|||
94610444|NCT03672643|324037210|FG000|Overall Study|Death|2|||
94610445|NCT03672643|324037210|FG000|Overall Study|Withdrawal by Subject|1|||
94610446|NCT03672643|324037210|FG000|Overall Study|Progressive disease|11|||
94610447|NCT03672643|324037210|FG000|Overall Study|Global deterioration of health status|1|||
94610448|NCT03672643|324037210|FG000|Overall Study|Refused further treatment|7|||
94610449|NCT03672643|324037210|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
94610450|NCT02160782|324038786|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
94610451|NCT02160782|324038787|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
94610452|NCT02160782|324038788|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
94610453|NCT02160782|324038789|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
94610454|NCT02160782|324038790|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
94610455|NCT02160782|324038786|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
94610456|NCT02160782|324038787|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
94610457|NCT02160782|324038788|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
94610458|NCT02160782|324038789|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
94610459|NCT02160782|324038790|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
94610460|NCT02160782|324038786|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
94610461|NCT02160782|324038787|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
94610462|NCT02160782|324038788|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
94610463|NCT02160782|324038789|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
94610464|NCT02160782|324038790|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
94610465|NCT02160782|324038786|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
94610466|NCT02160782|324038787|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
94610467|NCT02160782|324038788|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
94610468|NCT02160782|324038789|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
94610469|NCT02160782|324038790|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
94610470|NCT02160782|324038786|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
94610471|NCT02160782|324038787|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
94610472|NCT02160782|324038788|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
94661863|NCT03349710|324217676|FG003|Treatment Period|Disease Progression|1|||
94661864|NCT03349710|324217673|FG000|Treatment Period|Study Drug Toxicity|1|||
94459506|NCT04434469|323471835|FG004|Overall Study|Lost to Follow-up|1|||
94661865|NCT03349710|324217674|FG001|Treatment Period|Study Drug Toxicity|0|||
94661866|NCT03349710|324217675|FG002|Treatment Period|Study Drug Toxicity|1|||
94661867|NCT03349710|324217676|FG003|Treatment Period|Study Drug Toxicity|1|||
94661868|NCT03349710|324217673|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
94661869|NCT03349710|324217674|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
94661870|NCT03349710|324217675|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
94661871|NCT03349710|324217676|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
94661872|NCT03349710|324217673|FG000|Treatment Period|admin reason by sponsor|0|||
94661873|NCT03349710|324217674|FG001|Treatment Period|admin reason by sponsor|7|||
94661874|NCT03349710|324217675|FG002|Treatment Period|admin reason by sponsor|0|||
94610473|NCT02160782|324038789|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
94610474|NCT02160782|324038790|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
94610475|NCT02160782|324038786|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
94610476|NCT02160782|324038787|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
94610477|NCT02160782|324038788|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
94610478|NCT02160782|324038789|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
94610479|NCT02160782|324038790|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
94610480|NCT02160782|324038786|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
94610481|NCT02160782|324038787|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
94610482|NCT02160782|324038788|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
94661875|NCT03349710|324217676|FG003|Treatment Period|admin reason by sponsor|19|||
94661876|NCT03349710|324217673|FG000|Treatment Period|Other Reason|2|||
94661877|NCT03349710|324217674|FG001|Treatment Period|Other Reason|0|||
94661878|NCT03349710|324217675|FG002|Treatment Period|Other Reason|2|||
94661879|NCT03349710|324217676|FG003|Treatment Period|Other Reason|1|||
94661880|NCT03349710|324217673|FG000|Treatment Period|completed|6|||
94661881|NCT03349710|324217674|FG001|Treatment Period|completed|0|||
94661882|NCT03349710|324217675|FG002|Treatment Period|completed|18|||
94661883|NCT03349710|324217676|FG003|Treatment Period|completed|1|||
94661884|NCT03349710|324217673|FG000|Treatment Period|participant request to discontinue|0|||
94661885|NCT03349710|324217674|FG001|Treatment Period|participant request to discontinue|0|||
94661886|NCT03349710|324217675|FG002|Treatment Period|participant request to discontinue|4|||
94661887|NCT03349710|324217676|FG003|Treatment Period|participant request to discontinue|0|||
94661888|NCT03349710|324217673|FG000|Treatment Period|participant withdrew consent|1|||
94661889|NCT03349710|324217674|FG001|Treatment Period|participant withdrew consent|0|||
94661890|NCT03349710|324217675|FG002|Treatment Period|participant withdrew consent|0|||
94661891|NCT03349710|324217676|FG003|Treatment Period|participant withdrew consent|0|||
94661892|NCT01666002|324217677|FG000|Overall Study|Lost to Follow-up|5|||
94661893|NCT01666002|324217678|FG001|Overall Study|Lost to Follow-up|0|||
94661894|NCT02159482|324217679|FG000|Overall Study|Withdrawal by Subject|2|||
94610483|NCT02160782|324038789|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
94610484|NCT02160782|324038790|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
94610485|NCT00451451|324038796|FG000|Overall Study|Adverse Event|11|||
94610486|NCT00451451|324038797|FG001|Overall Study|Adverse Event|21|||
94610487|NCT00451451|324038798|FG002|Overall Study|Adverse Event|26|||
94661895|NCT02159482|324217679|FG000|Overall Study|Physician Decision|3|||
94661896|NCT01233817|324217680|FG000|Overall Study|Lost to Follow-up|1|||
94661897|NCT01233817|324217680|FG000|Overall Study|Withdrawal by Subject|2|||
94661898|NCT00726752|324217681|FG000|Overall Study|Lack of Efficacy|6|||
94253158|NCT02480153|322720759|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
94253159|NCT02480153|322720760|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
94253160|NCT02480153|322720761|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
94253161|NCT02480153|322720759|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
94253162|NCT02480153|322720760|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
94253163|NCT02480153|322720761|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
94253164|NCT02480153|322720759|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
94253165|NCT02480153|322720760|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
94253166|NCT02480153|322720761|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
94610488|NCT00451451|324038799|FG003|Overall Study|Adverse Event|10|||
94610489|NCT00451451|324038796|FG000|Overall Study|Lost to Follow-up|11|||
94661899|NCT01248884|324217682|FG000|Overall Study|Withdrawal by Subject|1|||
94661900|NCT01248884|324217683|FG001|Overall Study|Withdrawal by Subject|3|||
94661901|NCT01248884|324217684|FG002|Overall Study|Withdrawal by Subject|1|||
94459507|NCT04434469|323471836|FG005|Overall Study|Lost to Follow-up|0|||
94610490|NCT00451451|324038797|FG001|Overall Study|Lost to Follow-up|9|||
94610491|NCT00451451|324038798|FG002|Overall Study|Lost to Follow-up|8|||
94610492|NCT00451451|324038799|FG003|Overall Study|Lost to Follow-up|11|||
94610493|NCT00451451|324038796|FG000|Overall Study|Consent Withdrawn|14|||
94610494|NCT00451451|324038797|FG001|Overall Study|Consent Withdrawn|9|||
94661902|NCT01248884|324217682|FG000|Overall Study|Adverse Event|1|||
94661903|NCT01248884|324217683|FG001|Overall Study|Adverse Event|0|||
94610495|NCT00451451|324038798|FG002|Overall Study|Consent Withdrawn|17|||
94610496|NCT00451451|324038799|FG003|Overall Study|Consent Withdrawn|17|||
94610497|NCT00451451|324038796|FG000|Overall Study|Investigator Decision|6|||
94610498|NCT00451451|324038797|FG001|Overall Study|Investigator Decision|2|||
94610499|NCT00451451|324038798|FG002|Overall Study|Investigator Decision|1|||
94610500|NCT00451451|324038799|FG003|Overall Study|Investigator Decision|2|||
94610501|NCT00451451|324038796|FG000|Overall Study|Subject Non-Compliance|8|||
94610502|NCT00451451|324038797|FG001|Overall Study|Subject Non-Compliance|4|||
94610503|NCT00451451|324038798|FG002|Overall Study|Subject Non-Compliance|3|||
94610504|NCT00451451|324038799|FG003|Overall Study|Subject Non-Compliance|3|||
94610505|NCT00451451|324038796|FG000|Overall Study|Death|1|||
94610506|NCT00451451|324038797|FG001|Overall Study|Death|0|||
94610507|NCT00451451|324038798|FG002|Overall Study|Death|0|||
94610508|NCT00451451|324038799|FG003|Overall Study|Death|1|||
94610509|NCT00451451|324038796|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
94610510|NCT00451451|324038797|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
94610511|NCT00451451|324038798|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
94610512|NCT00451451|324038799|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
94610513|NCT00398411|324038800|FG000|Overall Study|Death|0|||
94610514|NCT00398411|324038801|FG001|Overall Study|Death|1|||
94610515|NCT02436304|324038804|FG000|Overall Study|Lost to Follow-up|0|||
94610516|NCT02436304|324038805|FG001|Overall Study|Lost to Follow-up|1|||
94610517|NCT02436304|324038806|FG002|Overall Study|Lost to Follow-up|0|||
94610518|NCT02436304|324038804|FG000|Overall Study|Withdrawal by Subject|0|||
94610519|NCT02436304|324038805|FG001|Overall Study|Withdrawal by Subject|1|||
94610520|NCT02436304|324038806|FG002|Overall Study|Withdrawal by Subject|0|||
94610521|NCT02436304|324038804|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
94610522|NCT02436304|324038805|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
94610523|NCT02436304|324038806|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
94610524|NCT02413372|324038807|FG000|Treatment|Lost to Follow-up|0|||
94610525|NCT02413372|324038808|FG001|Treatment|Lost to Follow-up|2|||
94610526|NCT02413372|324038809|FG002|Treatment|Lost to Follow-up|1|||
94610527|NCT02413372|324038807|FG000|Treatment|Withdrawal by Subject|1|||
94610528|NCT02413372|324038808|FG001|Treatment|Withdrawal by Subject|0|||
94610529|NCT02413372|324038809|FG002|Treatment|Withdrawal by Subject|0|||
94610530|NCT02413372|324038807|FG000|Follow-up|Lost to Follow-up|1|||
94610531|NCT02413372|324038808|FG001|Follow-up|Lost to Follow-up|1|||
94610532|NCT02413372|324038809|FG002|Follow-up|Lost to Follow-up|0|||
94610533|NCT02413372|324038807|FG000|Follow-up|Subject Withdrew Consent|1|||
94610534|NCT02413372|324038808|FG001|Follow-up|Subject Withdrew Consent|0|||
94610535|NCT02413372|324038809|FG002|Follow-up|Subject Withdrew Consent|1|||
94610536|NCT02413372|324038807|FG000|Follow-up|Subject unable to return for visit|0|||
94610537|NCT02413372|324038808|FG001|Follow-up|Subject unable to return for visit|0|||
94610538|NCT02413372|324038809|FG002|Follow-up|Subject unable to return for visit|1|||
94610539|NCT02497612|324038810|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
94610540|NCT02497612|324038811|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
94610541|NCT02497612|324038812|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
94610542|NCT02497612|324038813|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
94610543|NCT02497612|324038810|FG000|Overall Study|Participant's request|2|||
94610544|NCT02497612|324038811|FG001|Overall Study|Participant's request|3|||
94610545|NCT02497612|324038812|FG002|Overall Study|Participant's request|4|||
94610546|NCT02497612|324038813|FG003|Overall Study|Participant's request|1|||
94610547|NCT02497612|324038810|FG000|Overall Study|Investigator's judgement|1|||
94610548|NCT02497612|324038811|FG001|Overall Study|Investigator's judgement|0|||
94610549|NCT02497612|324038812|FG002|Overall Study|Investigator's judgement|0|||
94610550|NCT02497612|324038813|FG003|Overall Study|Investigator's judgement|2|||
94610551|NCT02497612|324038810|FG000|Overall Study|Adverse Event|3|||
94610552|NCT02497612|324038811|FG001|Overall Study|Adverse Event|1|||
94610553|NCT02497612|324038812|FG002|Overall Study|Adverse Event|4|||
94610554|NCT02497612|324038813|FG003|Overall Study|Adverse Event|1|||
94610555|NCT02497612|324038810|FG000|Overall Study|Lost to Follow-up|1|||
94610556|NCT02497612|324038811|FG001|Overall Study|Lost to Follow-up|1|||
94610557|NCT02497612|324038812|FG002|Overall Study|Lost to Follow-up|0|||
94610558|NCT02497612|324038813|FG003|Overall Study|Lost to Follow-up|1|||
94610559|NCT02497612|324038810|FG000|Overall Study|Other unspecified|1|||
94610560|NCT02497612|324038811|FG001|Overall Study|Other unspecified|1|||
94610561|NCT02497612|324038812|FG002|Overall Study|Other unspecified|2|||
94610562|NCT02497612|324038813|FG003|Overall Study|Other unspecified|0|||
94610563|NCT02497612|324038810|FG000|Overall Study|Not eligible|1|||
94610564|NCT02497612|324038811|FG001|Overall Study|Not eligible|0|||
94610565|NCT02497612|324038812|FG002|Overall Study|Not eligible|0|||
94661904|NCT01248884|324217684|FG002|Overall Study|Adverse Event|0|||
94610566|NCT02497612|324038813|FG003|Overall Study|Not eligible|1|||
94610567|NCT00611533|324038814|FG000|First Intervention (6 Weeks)|Never started study|0|||
94610568|NCT00611533|324038815|FG001|First Intervention (6 Weeks)|Never started study|1|||
94610569|NCT00611533|324038814|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
94661905|NCT02511431|324217685|FG000|Treatment|Lost to Follow-up|0|||
94661906|NCT02511431|324217686|FG001|Treatment|Lost to Follow-up|0|||
94661907|NCT02511431|324217687|FG002|Treatment|Lost to Follow-up|1|||
94253167|NCT02480153|322720759|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
94253168|NCT02480153|322720760|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
94253169|NCT02480153|322720761|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
94253170|NCT02480153|322720759|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
94253171|NCT02480153|322720760|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
94253172|NCT02480153|322720761|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
94253173|NCT02480153|322720759|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
94253174|NCT02480153|322720760|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
94253175|NCT02480153|322720761|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
94253176|NCT02480153|322720759|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
94253177|NCT02480153|322720760|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
94253178|NCT02480153|322720761|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
94253179|NCT02480153|322720759|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
94253180|NCT02480153|322720760|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
94253181|NCT02480153|322720761|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
94253182|NCT02480153|322720759|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
94253183|NCT02480153|322720760|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
94253184|NCT02480153|322720761|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
94253185|NCT02480153|322720759|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
94253186|NCT02480153|322720760|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
94253187|NCT02480153|322720761|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
94253188|NCT02480153|322720759|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
94253189|NCT02480153|322720760|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
94253190|NCT02480153|322720761|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
94253191|NCT02480153|322720759|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
94253192|NCT02480153|322720760|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
94253193|NCT02480153|322720761|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
94253194|NCT02480153|322720759|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
94610570|NCT00611533|324038815|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
94610571|NCT00611533|324038814|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
94610572|NCT00611533|324038815|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
94610573|NCT01031381|324038824|FG000|Overall Study|Physician Decision|3|||
94610574|NCT01031381|324038824|FG000|Overall Study|Withdrawal by Subject|6|||
94610575|NCT00723398|324038825|FG000|Overall Study|Withdrawal by Subject|2|||
94610576|NCT00723398|324038826|FG001|Overall Study|Withdrawal by Subject|6|||
94610577|NCT00723398|324038827|FG002|Overall Study|Withdrawal by Subject|4|||
94610578|NCT00723398|324038828|FG003|Overall Study|Withdrawal by Subject|4|||
94610579|NCT00723398|324038829|FG004|Overall Study|Withdrawal by Subject|4|||
94610580|NCT00723398|324038825|FG000|Overall Study|Protocol Violation|2|||
94610581|NCT00723398|324038826|FG001|Overall Study|Protocol Violation|1|||
94610582|NCT00723398|324038827|FG002|Overall Study|Protocol Violation|5|||
94610583|NCT00723398|324038828|FG003|Overall Study|Protocol Violation|0|||
94610584|NCT00723398|324038829|FG004|Overall Study|Protocol Violation|0|||
94610585|NCT00723398|324038825|FG000|Overall Study|Physician Decision|2|||
94610586|NCT00723398|324038826|FG001|Overall Study|Physician Decision|2|||
94610587|NCT00723398|324038827|FG002|Overall Study|Physician Decision|5|||
94610588|NCT00723398|324038828|FG003|Overall Study|Physician Decision|0|||
94610589|NCT00723398|324038829|FG004|Overall Study|Physician Decision|1|||
94610590|NCT00723398|324038825|FG000|Overall Study|Adverse Event|0|||
94610591|NCT00723398|324038826|FG001|Overall Study|Adverse Event|5|||
94610592|NCT00723398|324038827|FG002|Overall Study|Adverse Event|3|||
94610593|NCT00723398|324038828|FG003|Overall Study|Adverse Event|1|||
94610594|NCT00723398|324038829|FG004|Overall Study|Adverse Event|4|||
94610595|NCT00723398|324038825|FG000|Overall Study|Lost to Follow-up|0|||
94610596|NCT00723398|324038826|FG001|Overall Study|Lost to Follow-up|1|||
94610597|NCT00723398|324038827|FG002|Overall Study|Lost to Follow-up|0|||
94661908|NCT02511431|324217688|FG003|Treatment|Lost to Follow-up|0|||
94661909|NCT02511431|324217689|FG004|Treatment|Lost to Follow-up|0|||
94610598|NCT00723398|324038828|FG003|Overall Study|Lost to Follow-up|0|||
94610599|NCT00723398|324038829|FG004|Overall Study|Lost to Follow-up|0|||
94610600|NCT02607930|324038838|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
94610601|NCT02607930|324038839|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
94610602|NCT02607930|324038840|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
94610603|NCT02607930|324038841|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
94610604|NCT02607930|324038838|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
94610605|NCT02607930|324038839|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
94610606|NCT02607930|324038840|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
94661910|NCT02511431|324217690|FG005|Treatment|Lost to Follow-up|1|||
94253195|NCT02480153|322720760|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
94253196|NCT02480153|322720761|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
94253197|NCT02480153|322720759|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
94253198|NCT02480153|322720760|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
94253199|NCT02480153|322720761|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
94253200|NCT02480153|322720759|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
94253201|NCT02480153|322720760|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
94253202|NCT02480153|322720761|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
94253203|NCT02480153|322720759|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
94253204|NCT02480153|322720760|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
94253205|NCT02480153|322720761|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
94253206|NCT02480153|322720759|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
94253207|NCT02480153|322720760|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
94253208|NCT02480153|322720761|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
94253209|NCT02480153|322720759|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
94253210|NCT02480153|322720760|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
94253211|NCT02480153|322720761|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
94253212|NCT00203476|322720762|FG000|Overall Study|Lost to Follow-up|1|||
94610607|NCT02607930|324038841|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
94610608|NCT02607930|324038838|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
94610609|NCT02607930|324038839|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
94610610|NCT02607930|324038840|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
94610611|NCT02607930|324038841|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
94610612|NCT02607930|324038838|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
94610613|NCT02607930|324038839|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
94610614|NCT02607930|324038840|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
94610615|NCT02607930|324038841|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
94610616|NCT02607930|324038838|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
94610617|NCT02607930|324038839|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
94610618|NCT02607930|324038840|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
94610619|NCT02607930|324038841|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
94610620|NCT02607930|324038838|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
94610621|NCT02607930|324038839|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
94610622|NCT02607930|324038840|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
94610623|NCT02607930|324038841|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
94610624|NCT02607930|324038838|FG000|Double-Blinded Treatment Phase|Death|2|||
94610625|NCT02607930|324038839|FG001|Double-Blinded Treatment Phase|Death|1|||
94610626|NCT02607930|324038840|FG002|Double-Blinded Treatment Phase|Death|0|||
94610627|NCT02607930|324038841|FG003|Double-Blinded Treatment Phase|Death|0|||
94610628|NCT02607930|324038838|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
94610629|NCT02607930|324038839|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
94610630|NCT02607930|324038840|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
94610631|NCT02607930|324038841|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
94610632|NCT02607930|324038838|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
94610633|NCT02607930|324038839|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
94610634|NCT02607930|324038840|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
94610635|NCT02607930|324038841|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
94610636|NCT02607930|324038838|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
94610637|NCT02607930|324038839|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
94610638|NCT02607930|324038840|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
94610639|NCT02607930|324038841|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
94610640|NCT02607930|324038838|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
94610641|NCT02607930|324038839|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
94610642|NCT02607930|324038840|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
94610643|NCT02607930|324038841|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
94610644|NCT02607930|324038838|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
94610645|NCT02607930|324038839|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
94610646|NCT02607930|324038840|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
94610647|NCT02607930|324038841|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
94253213|NCT00203476|322720763|FG001|Overall Study|Lost to Follow-up|0|||
94253214|NCT00203476|322720764|FG002|Overall Study|Lost to Follow-up|0|||
94253215|NCT00203476|322720762|FG000|Overall Study|Withdrawal by Subject|0|||
94253216|NCT00203476|322720763|FG001|Overall Study|Withdrawal by Subject|1|||
94253217|NCT00203476|322720764|FG002|Overall Study|Withdrawal by Subject|0|||
94253218|NCT03241225|322720765|FG000|Overall Study|Lost to Follow-up|2|||
94253219|NCT03241225|322720766|FG001|Overall Study|Lost to Follow-up|1|||
94253220|NCT03241225|322720765|FG000|Overall Study|Protocol Violation|4|||
94253221|NCT03241225|322720766|FG001|Overall Study|Protocol Violation|1|||
94661911|NCT04827212|324217698|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
94661912|NCT04827212|324217699|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
94661913|NCT04827212|324217698|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
94661914|NCT04827212|324217699|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
94253222|NCT03241225|322720765|FG000|Overall Study|Withdrawal by Subject|1|||
94253223|NCT03241225|322720766|FG001|Overall Study|Withdrawal by Subject|0|||
94253224|NCT00618982|322720773|FG000|Overall Study|Adverse Event|23|||
94253225|NCT00618982|322720773|FG000|Overall Study|Withdrawal by Subject|1|||
94253226|NCT00618982|322720773|FG000|Overall Study|Protocol Violation|1|||
94253227|NCT00618982|322720773|FG000|Overall Study|ongoing, still treated with study med.|25|||
94253228|NCT04279392|322720781|FG000|Overall Study|Physician Decision|1|||
94253229|NCT04279392|322720782|FG001|Overall Study|Physician Decision|0|||
94253230|NCT01236365|322720783|FG000|Overall Study|Lost to Follow-up|0|||
94253231|NCT01236365|322720784|FG001|Overall Study|Lost to Follow-up|2|||
94253232|NCT01236365|322720783|FG000|Overall Study|Moved Out of State|1|||
94253233|NCT01236365|322720784|FG001|Overall Study|Moved Out of State|0|||
94253234|NCT01236365|322720783|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
94253235|NCT01236365|322720784|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
94253236|NCT00558259|322720787|FG000|Overall Study|Adverse Event|50|||
94253237|NCT00558259|322720788|FG001|Overall Study|Adverse Event|81|||
94253238|NCT00558259|322720787|FG000|Overall Study|Protocol Violation|9|||
94253239|NCT00558259|322720788|FG001|Overall Study|Protocol Violation|5|||
94661915|NCT03058679|324217700|FG000|Baseline to Week 6|Lost to Follow-up|3|||
94661916|NCT03058679|324217701|FG001|Baseline to Week 6|Lost to Follow-up|2|||
94253240|NCT00558259|322720787|FG000|Overall Study|Withdrawal by Subject|12|||
94253241|NCT00558259|322720788|FG001|Overall Study|Withdrawal by Subject|13|||
94253242|NCT00156819|322720789|FG000|Overall Study|Lost to Follow-up|1|||
94253243|NCT00156819|322720790|FG001|Overall Study|Lost to Follow-up|1|||
94253244|NCT00156819|322720791|FG002|Overall Study|Lost to Follow-up|3|||
94253245|NCT02585232|322720795|FG000|Overall Study|Lost to Follow-up|8|||
94661917|NCT03058679|324217700|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
94661918|NCT03058679|324217701|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
94661919|NCT03058679|324217700|FG000|Baseline to Week 6|Adverse Event|6|||
94661920|NCT03058679|324217701|FG001|Baseline to Week 6|Adverse Event|6|||
94661921|NCT03058679|324217700|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
94661922|NCT03058679|324217701|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
94661923|NCT03058679|324217700|FG000|Baseline to Week 6|Difficulty following the diet|0|||
94661924|NCT03058679|324217701|FG001|Baseline to Week 6|Difficulty following the diet|2|||
94661925|NCT03058679|324217700|FG000|Baseline to Week 6|Physician Decision|1|||
94661926|NCT03058679|324217701|FG001|Baseline to Week 6|Physician Decision|0|||
94661927|NCT03058679|324217700|FG000|Week 6 to Week 12|Change in medication|5|||
94661928|NCT03058679|324217701|FG001|Week 6 to Week 12|Change in medication|7|||
94661929|NCT03058679|324217700|FG000|Week 6 to Week 12|Adverse Event|4|||
94661930|NCT03058679|324217701|FG001|Week 6 to Week 12|Adverse Event|3|||
94661931|NCT03058679|324217700|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
94661932|NCT03058679|324217701|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
94661933|NCT03058679|324217700|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
94661934|NCT03058679|324217701|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
94661935|NCT00784810|324217702|FG000|Overall Study|Adverse Event|32|||
94661936|NCT00784810|324217703|FG001|Overall Study|Adverse Event|20|||
94661937|NCT00784810|324217702|FG000|Overall Study|Lack of Efficacy|14|||
94661938|NCT00784810|324217703|FG001|Overall Study|Lack of Efficacy|11|||
94661939|NCT00784810|324217702|FG000|Overall Study|Withdrawal by Subject|11|||
94253246|NCT02585232|322720796|FG001|Overall Study|Lost to Follow-up|8|||
94253247|NCT02585232|322720795|FG000|Overall Study|Withdrawal by Subject|4|||
94253248|NCT02585232|322720796|FG001|Overall Study|Withdrawal by Subject|8|||
94253249|NCT04371198|322720797|FG000|Overall Study|inadequate sample|4|||
94253250|NCT00564889|322720800|FG000|Overall Study|Death|7|||
94253251|NCT00564889|322720800|FG000|Overall Study|Adverse Event|12|||
94661940|NCT00784810|324217703|FG001|Overall Study|Withdrawal by Subject|9|||
94253252|NCT00564889|322720800|FG000|Overall Study|Alternative treatment|3|||
94661941|NCT00784810|324217702|FG000|Overall Study|Administrative|5|||
94661942|NCT00784810|324217703|FG001|Overall Study|Administrative|8|||
94661943|NCT00784810|324217702|FG000|Overall Study|Lost to Follow-up|1|||
94661944|NCT00784810|324217703|FG001|Overall Study|Lost to Follow-up|1|||
94661945|NCT04000165|324217708|FG000|Overall Study|Physician Decision|1|||
94661946|NCT04000165|324217708|FG000|Overall Study|Withdrawal by Subject|1|||
94661947|NCT02528214|324217712|FG000|Overall Study|Protocol Violation|0|||
94661948|NCT02528214|324217713|FG001|Overall Study|Protocol Violation|1|||
94661949|NCT02528214|324217712|FG000|Overall Study|Adverse Event|0|||
94661950|NCT02528214|324217713|FG001|Overall Study|Adverse Event|1|||
94661951|NCT02528214|324217712|FG000|Overall Study|Other than specified above|0|||
94661952|NCT02528214|324217713|FG001|Overall Study|Other than specified above|1|||
94661953|NCT01380327|324217715|FG000|Overall Study|Lost to Follow-up|0|||
94661954|NCT01380327|324217716|FG001|Overall Study|Lost to Follow-up|1|||
94661955|NCT01380327|324217717|FG002|Overall Study|Lost to Follow-up|1|||
94661956|NCT01380327|324217715|FG000|Overall Study|Protocol Violation|3|||
94661957|NCT01380327|324217716|FG001|Overall Study|Protocol Violation|2|||
94661958|NCT01380327|324217717|FG002|Overall Study|Protocol Violation|3|||
94661959|NCT01380327|324217715|FG000|Overall Study|Withdrawal by Subject|0|||
94661960|NCT01380327|324217716|FG001|Overall Study|Withdrawal by Subject|0|||
94661961|NCT01380327|324217717|FG002|Overall Study|Withdrawal by Subject|1|||
94661962|NCT01380327|324217715|FG000|Overall Study|Housing situation precluded ability to k|0|||
94661963|NCT01380327|324217716|FG001|Overall Study|Housing situation precluded ability to k|0|||
94661964|NCT01380327|324217717|FG002|Overall Study|Housing situation precluded ability to k|1|||
94661965|NCT01380327|324217715|FG000|Overall Study|Questionable onset of epilepsy|0|||
94661966|NCT01380327|324217716|FG001|Overall Study|Questionable onset of epilepsy|0|||
94661967|NCT01380327|324217717|FG002|Overall Study|Questionable onset of epilepsy|1|||
94661968|NCT03447769|324217718|FG000|Overall Study|Progressive disease|138|||
94661969|NCT03447769|324217719|FG001|Overall Study|Progressive disease|148|||
94661970|NCT03447769|324217718|FG000|Overall Study|Study terminated by Sponsor|60|||
94661971|NCT03447769|324217719|FG001|Overall Study|Study terminated by Sponsor|44|||
94661972|NCT03447769|324217718|FG000|Overall Study|Adverse Event|34|||
94661973|NCT03447769|324217719|FG001|Overall Study|Adverse Event|31|||
94661974|NCT03447769|324217718|FG000|Overall Study|Patient decision|27|||
94661975|NCT03447769|324217719|FG001|Overall Study|Patient decision|27|||
94661976|NCT03447769|324217718|FG000|Overall Study|Protocol deviation|4|||
94661977|NCT03447769|324217719|FG001|Overall Study|Protocol deviation|6|||
94661978|NCT03447769|324217718|FG000|Overall Study|Death|2|||
94661979|NCT03447769|324217719|FG001|Overall Study|Death|7|||
94661980|NCT03447769|324217718|FG000|Overall Study|Technical problems|1|||
94661981|NCT03447769|324217719|FG001|Overall Study|Technical problems|0|||
94661982|NCT03447769|324217718|FG000|Overall Study|Lost to Follow-up|0|||
94661983|NCT03447769|324217719|FG001|Overall Study|Lost to Follow-up|1|||
94661984|NCT03447769|324217718|FG000|Overall Study|Physician Decision|13|||
94661985|NCT03447769|324217719|FG001|Overall Study|Physician Decision|5|||
94661986|NCT01435577|324217737|FG000|Overall Study|Adverse Event|10|||
94661987|NCT01435577|324217738|FG001|Overall Study|Adverse Event|0|||
94661988|NCT01435577|324217737|FG000|Overall Study|Lack of Efficacy|7|||
94253253|NCT00564889|322720800|FG000|Overall Study|Disease progression|3|||
94253254|NCT00564889|322720800|FG000|Overall Study|Other, not specified|4|||
94253255|NCT01205152|322720801|FG000|Overall Study|Death|1|||
94253256|NCT03500159|322720802|FG000|Overall Study|Study Terminated|2|||
94253257|NCT03500159|322720803|FG001|Overall Study|Study Terminated|1|||
94253258|NCT03625895|322720806|FG000|Overall Study|Protocol Violation|585|||
94253259|NCT00262951|322720807|FG000|Overall Study|Progressive disease/relapse|3|||
94253260|NCT00262951|322720807|FG000|Overall Study|Adverse Event|7|||
94253261|NCT00262951|322720807|FG000|Overall Study|Death|1|||
94253262|NCT00262951|322720807|FG000|Overall Study|Withdrawal by Subject|1|||
94253263|NCT00262951|322720807|FG000|Overall Study|Alternative treatment|3|||
94253264|NCT00262951|322720807|FG000|Overall Study|Off treatment for other disease|1|||
94253265|NCT01293487|322720809|FG000|Overall Study|Lost to Follow-up|0|||
94253266|NCT01293487|322720810|FG001|Overall Study|Lost to Follow-up|0|||
94661989|NCT01435577|324217738|FG001|Overall Study|Lack of Efficacy|51|||
94661990|NCT01435577|324217737|FG000|Overall Study|Alternative treatment started|0|||
94661991|NCT01435577|324217738|FG001|Overall Study|Alternative treatment started|1|||
94661992|NCT03585244|324217741|FG000|Overall Study|Withdrawal by Subject|15|||
94661993|NCT06281548|324217742|FG000|Overall Study|Lost to Follow-up|3|||
94661994|NCT01764945|324217743|FG000|Overall Study|Adverse Event|0|||
94661995|NCT01764945|324217744|FG001|Overall Study|Adverse Event|1|||
94661996|NCT01764945|324217745|FG002|Overall Study|Adverse Event|0|||
94661997|NCT01764945|324217746|FG003|Overall Study|Adverse Event|0|||
94661998|NCT01764945|324217747|FG004|Overall Study|Adverse Event|0|||
94661999|NCT01764945|324217748|FG005|Overall Study|Adverse Event|0|||
94662000|NCT01764945|324217749|FG006|Overall Study|Adverse Event|1|||
94662001|NCT01764945|324217750|FG007|Overall Study|Adverse Event|0|||
94662002|NCT03835533|324217753|FG000|Overall Study|Death|5|||
94662003|NCT03835533|324217754|FG001|Overall Study|Death|10|||
94662004|NCT03835533|324217755|FG002|Overall Study|Death|9|||
94662005|NCT03835533|324217753|FG000|Overall Study|Withdrawal by Subject|2|||
94253267|NCT01293487|322720811|FG002|Overall Study|Lost to Follow-up|0|||
94253268|NCT01293487|322720812|FG003|Overall Study|Lost to Follow-up|1|||
94253269|NCT01293487|322720813|FG004|Overall Study|Lost to Follow-up|0|||
94253270|NCT01293487|322720814|FG005|Overall Study|Lost to Follow-up|0|||
94253271|NCT01293487|322720815|FG006|Overall Study|Lost to Follow-up|0|||
94253272|NCT01293487|322720816|FG007|Overall Study|Lost to Follow-up|0|||
94253273|NCT01293487|322720809|FG000|Overall Study|Withdrawal by Subject|0|||
94253274|NCT01293487|322720810|FG001|Overall Study|Withdrawal by Subject|0|||
94253275|NCT01293487|322720811|FG002|Overall Study|Withdrawal by Subject|0|||
94253276|NCT01293487|322720812|FG003|Overall Study|Withdrawal by Subject|0|||
94253277|NCT01293487|322720813|FG004|Overall Study|Withdrawal by Subject|0|||
94253278|NCT01293487|322720814|FG005|Overall Study|Withdrawal by Subject|0|||
94253279|NCT01293487|322720815|FG006|Overall Study|Withdrawal by Subject|0|||
94253280|NCT01293487|322720816|FG007|Overall Study|Withdrawal by Subject|2|||
94253281|NCT02372136|322720817|FG000|Overall Study|Death|3|||
94253282|NCT02372136|322720818|FG001|Overall Study|Death|1|||
94253283|NCT01688830|322720819|FG000|Overall Study|Lost to Follow-up|0|||
94253284|NCT01688830|322720820|FG001|Overall Study|Lost to Follow-up|0|||
94253285|NCT01688830|322720821|FG002|Overall Study|Lost to Follow-up|0|||
94253286|NCT01688830|322720822|FG003|Overall Study|Lost to Follow-up|0|||
94253287|NCT01688830|322720823|FG004|Overall Study|Lost to Follow-up|0|||
94253288|NCT01688830|322720824|FG005|Overall Study|Lost to Follow-up|0|||
94610648|NCT02607930|324038838|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
94610649|NCT02607930|324038839|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
94610650|NCT02607930|324038840|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
94610651|NCT02607930|324038841|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
94610652|NCT02607930|324038838|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
94610653|NCT02607930|324038839|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
94610654|NCT02607930|324038840|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
94610655|NCT02607930|324038841|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
94610656|NCT02607930|324038838|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
94610657|NCT02607930|324038839|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
94610658|NCT02607930|324038840|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
94610659|NCT02607930|324038841|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
94610660|NCT02607930|324038838|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
94610661|NCT02607930|324038839|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
94610662|NCT02607930|324038840|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
94610663|NCT02607930|324038841|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
94610664|NCT03198078|324038842|FG000|Overall Study|Adverse Event|0|||
94610665|NCT03198078|324038843|FG001|Overall Study|Adverse Event|1|||
94610666|NCT03198078|324038844|FG002|Overall Study|Adverse Event|2|||
94610667|NCT03198078|324038842|FG000|Overall Study|Lack of Efficacy|0|||
94610668|NCT03198078|324038843|FG001|Overall Study|Lack of Efficacy|0|||
94610669|NCT03198078|324038844|FG002|Overall Study|Lack of Efficacy|3|||
94610670|NCT03198078|324038842|FG000|Overall Study|Lost to Follow-up|1|||
94610671|NCT03198078|324038843|FG001|Overall Study|Lost to Follow-up|0|||
94610672|NCT03198078|324038844|FG002|Overall Study|Lost to Follow-up|0|||
94610673|NCT03198078|324038842|FG000|Overall Study|Pregnancy|0|||
94610674|NCT03198078|324038843|FG001|Overall Study|Pregnancy|1|||
94610675|NCT03198078|324038844|FG002|Overall Study|Pregnancy|0|||
94610676|NCT03198078|324038842|FG000|Overall Study|Withdrawal by Subject|1|||
94610677|NCT03198078|324038843|FG001|Overall Study|Withdrawal by Subject|0|||
94610678|NCT03198078|324038844|FG002|Overall Study|Withdrawal by Subject|2|||
94610679|NCT03198078|324038842|FG000|Overall Study|Withdrawal by Caregiver|1|||
94610680|NCT03198078|324038843|FG001|Overall Study|Withdrawal by Caregiver|3|||
94253289|NCT01688830|322720825|FG006|Overall Study|Lost to Follow-up|0|||
94253290|NCT01688830|322720826|FG007|Overall Study|Lost to Follow-up|0|||
94253291|NCT01688830|322720827|FG008|Overall Study|Lost to Follow-up|0|||
94253292|NCT01688830|322720828|FG009|Overall Study|Lost to Follow-up|0|||
94610681|NCT03198078|324038844|FG002|Overall Study|Withdrawal by Caregiver|5|||
94610682|NCT01676727|324038845|FG000|Overall Study|Death|18|||
94610683|NCT01676727|324038845|FG000|Overall Study|Withdrawal by Subject|6|||
94610684|NCT01676727|324038845|FG000|Overall Study|Screening failure|5|||
94610685|NCT01676727|324038845|FG000|Overall Study|Not willing to attend 1-year visit|2|||
94610686|NCT01676727|324038845|FG000|Overall Study|Valve explanted|1|||
94610687|NCT01578330|324038846|FG000|Overall Study|Adverse Event|2|||
94610688|NCT01578330|324038846|FG000|Overall Study|Protocol Violation|5|||
94610689|NCT01134731|324038847|FG000|Overall Study|Adverse Event|3|||
94610690|NCT01134731|324038848|FG001|Overall Study|Adverse Event|2|||
94610691|NCT01134731|324038849|FG002|Overall Study|Adverse Event|1|||
94610692|NCT01134731|324038847|FG000|Overall Study|Physician Decision|2|||
94610693|NCT01134731|324038848|FG001|Overall Study|Physician Decision|2|||
94610694|NCT01134731|324038849|FG002|Overall Study|Physician Decision|2|||
94610695|NCT01134731|324038847|FG000|Overall Study|Lack of Efficacy|0|||
94610696|NCT01134731|324038848|FG001|Overall Study|Lack of Efficacy|0|||
94253293|NCT01688830|322720829|FG010|Overall Study|Lost to Follow-up|1|||
94253294|NCT01688830|322720830|FG011|Overall Study|Lost to Follow-up|0|||
94662006|NCT03835533|324217754|FG001|Overall Study|Withdrawal by Subject|2|||
94662007|NCT03835533|324217755|FG002|Overall Study|Withdrawal by Subject|2|||
94662008|NCT03835533|324217753|FG000|Overall Study|Lost to Follow-up|1|||
94662009|NCT03835533|324217754|FG001|Overall Study|Lost to Follow-up|0|||
94662010|NCT03835533|324217755|FG002|Overall Study|Lost to Follow-up|0|||
94662011|NCT03867734|324217758|FG000|Overall Study|Lost to Follow-up|2|||
94662012|NCT03165045|324217760|FG000|Visit 1|No registration after visit 1|9|||
94662013|NCT03165045|324217760|FG000|Visit 1|No treatment documented|10|||
94662014|NCT03165045|324217760|FG000|Visit 1|No visit 1|10|||
94662015|NCT03165045|324217760|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
94662016|NCT03165045|324217760|FG000|Visit 2|No available total CCQ score at all|29|||
94662017|NCT03165045|324217760|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
94662018|NCT00355082|324217761|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
94662019|NCT00355082|324217762|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
94662020|NCT00355082|324217763|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
94662021|NCT00355082|324217761|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
94662022|NCT00355082|324217762|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
94662023|NCT00355082|324217763|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
94662024|NCT00355082|324217761|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
94662025|NCT00355082|324217762|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
94662026|NCT00355082|324217763|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
94662027|NCT00355082|324217761|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
94662028|NCT00355082|324217762|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
94662029|NCT00355082|324217763|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
94662030|NCT00355082|324217761|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
94662031|NCT00355082|324217762|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
94662032|NCT00355082|324217763|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
94662033|NCT00355082|324217761|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
94662034|NCT00355082|324217762|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
94662035|NCT00355082|324217763|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
94662036|NCT00355082|324217761|FG000|Continuation Phase|Adverse Event|2|||
94662037|NCT00355082|324217762|FG001|Continuation Phase|Adverse Event|0|||
94662038|NCT00355082|324217763|FG002|Continuation Phase|Adverse Event|1|||
94662039|NCT00355082|324217761|FG000|Continuation Phase|Lost to Follow-up|2|||
94662040|NCT00355082|324217762|FG001|Continuation Phase|Lost to Follow-up|0|||
94662041|NCT00355082|324217763|FG002|Continuation Phase|Lost to Follow-up|1|||
94662042|NCT00355082|324217761|FG000|Continuation Phase|Protocol Violation|1|||
94662043|NCT00355082|324217762|FG001|Continuation Phase|Protocol Violation|0|||
94662044|NCT00355082|324217763|FG002|Continuation Phase|Protocol Violation|1|||
94662045|NCT00355082|324217761|FG000|Continuation Phase|Withdrawal by Subject|4|||
94662046|NCT00355082|324217762|FG001|Continuation Phase|Withdrawal by Subject|0|||
94662047|NCT00355082|324217763|FG002|Continuation Phase|Withdrawal by Subject|0|||
94662048|NCT00355082|324217761|FG000|Continuation Phase|Lack of Efficacy|5|||
94662049|NCT00355082|324217762|FG001|Continuation Phase|Lack of Efficacy|0|||
94662050|NCT00355082|324217763|FG002|Continuation Phase|Lack of Efficacy|0|||
94662051|NCT00355082|324217761|FG000|Continuation Phase|Site Closed by Sponsor|8|||
94662052|NCT00355082|324217762|FG001|Continuation Phase|Site Closed by Sponsor|0|||
94662053|NCT00355082|324217763|FG002|Continuation Phase|Site Closed by Sponsor|0|||
94662054|NCT00355082|324217761|FG000|Continuation Phase|Scheduling Error|1|||
94662055|NCT00355082|324217762|FG001|Continuation Phase|Scheduling Error|0|||
94662056|NCT00355082|324217763|FG002|Continuation Phase|Scheduling Error|0|||
94662057|NCT00355082|324217761|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
94662058|NCT00355082|324217762|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
94662059|NCT00355082|324217763|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
94662060|NCT03325712|324217764|FG000|Overall Study|Protocol Violation|0|||
94662061|NCT03325712|324217765|FG001|Overall Study|Protocol Violation|0|||
94662062|NCT03325712|324217766|FG002|Overall Study|Protocol Violation|0|||
94662063|NCT03325712|324217767|FG003|Overall Study|Protocol Violation|0|||
94662064|NCT03325712|324217768|FG004|Overall Study|Protocol Violation|1|||
94662065|NCT03325712|324217769|FG005|Overall Study|Protocol Violation|0|||
94662066|NCT03325712|324217770|FG006|Overall Study|Protocol Violation|0|||
94662067|NCT03325712|324217771|FG007|Overall Study|Protocol Violation|0|||
94662068|NCT03325712|324217764|FG000|Overall Study|Adverse Event|0|||
94662069|NCT03325712|324217765|FG001|Overall Study|Adverse Event|0|||
94662070|NCT03325712|324217766|FG002|Overall Study|Adverse Event|0|||
94662071|NCT03325712|324217767|FG003|Overall Study|Adverse Event|0|||
94662072|NCT03325712|324217768|FG004|Overall Study|Adverse Event|1|||
94662073|NCT03325712|324217769|FG005|Overall Study|Adverse Event|0|||
94662074|NCT03325712|324217770|FG006|Overall Study|Adverse Event|0|||
94662075|NCT03325712|324217771|FG007|Overall Study|Adverse Event|0|||
94610697|NCT01134731|324038849|FG002|Overall Study|Lack of Efficacy|1|||
94610698|NCT01134731|324038847|FG000|Overall Study|Withdrawal by Subject|3|||
94610699|NCT01134731|324038848|FG001|Overall Study|Withdrawal by Subject|3|||
94610700|NCT01134731|324038849|FG002|Overall Study|Withdrawal by Subject|1|||
94610701|NCT01134731|324038847|FG000|Overall Study|Lost to Follow-up|5|||
94610702|NCT01134731|324038848|FG001|Overall Study|Lost to Follow-up|4|||
94610703|NCT01134731|324038849|FG002|Overall Study|Lost to Follow-up|3|||
94610704|NCT02124161|324038852|FG000|Overall Study|Other unspecified|0|||
94610705|NCT02124161|324038853|FG001|Overall Study|Other unspecified|1|||
94610706|NCT02124161|324038852|FG000|Overall Study|Death|1|||
94610707|NCT02124161|324038853|FG001|Overall Study|Death|0|||
94610708|NCT02124161|324038852|FG000|Overall Study|Protocol Violation|2|||
94610709|NCT02124161|324038853|FG001|Overall Study|Protocol Violation|1|||
94610710|NCT02124161|324038852|FG000|Overall Study|Withdrawal by Subject|1|||
94610711|NCT02124161|324038853|FG001|Overall Study|Withdrawal by Subject|2|||
94610712|NCT02124161|324038852|FG000|Overall Study|Adverse Event|2|||
94610713|NCT02124161|324038853|FG001|Overall Study|Adverse Event|0|||
94610714|NCT02124161|324038852|FG000|Overall Study|Does not meet entrance criteria|2|||
94610715|NCT02124161|324038853|FG001|Overall Study|Does not meet entrance criteria|3|||
94610716|NCT02124161|324038852|FG000|Overall Study|No longer meets eligibility criteria|5|||
94610717|NCT02124161|324038853|FG001|Overall Study|No longer meets eligibility criteria|4|||
94610718|NCT02124161|324038852|FG000|Overall Study|Lost to Follow-up|3|||
94610719|NCT02124161|324038853|FG001|Overall Study|Lost to Follow-up|4|||
94610720|NCT03387683|324038854|FG000|Overall Study|In receipt of disallowed medication|1|||
94610721|NCT03387683|324038855|FG001|Overall Study|In receipt of disallowed medication|0|||
94610722|NCT03387683|324038854|FG000|Overall Study|Did not receive treatment|1|||
94610723|NCT03387683|324038855|FG001|Overall Study|Did not receive treatment|0|||
94610724|NCT00437320|324038859|FG000|Overall Study|Participant request|2|||
94610725|NCT00437320|324038860|FG001|Overall Study|Participant request|1|||
94610726|NCT00437320|324038861|FG002|Overall Study|Participant request|4|||
94610727|NCT01739309|324038862|FG000|Overall Study|Adverse Event|1|||
94610728|NCT01739309|324038862|FG000|Overall Study|Withdrawal by Subject|1|||
94610729|NCT05447897|324038863|FG000|Overall Study|Did not participate in survey|2|||
94610730|NCT04289623|324038864|FG000|Wave 1 Emails|Email was not delivered|268|||
94610731|NCT04289623|324038865|FG001|Wave 1 Emails|Email was not delivered|257|||
94610732|NCT04289623|324038866|FG002|Wave 1 Emails|Email was not delivered|0|||
94610733|NCT04289623|324038867|FG003|Wave 1 Emails|Email was not delivered|0|||
94610734|NCT04289623|324038868|FG004|Wave 1 Emails|Email was not delivered|0|||
94610735|NCT04289623|324038869|FG005|Wave 1 Emails|Email was not delivered|0|||
94610736|NCT03080454|324038870|FG000|Baseline|Adverse Event|2|||
94610737|NCT03080454|324038870|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
94610738|NCT03080454|324038870|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
94610739|NCT01649804|324038871|FG000|Overall Study|Administrative/Other|8|||
94610740|NCT00694707|324038872|FG000|Overall Study|Did Not Receive Treatment|0|||
94610741|NCT00694707|324038873|FG001|Overall Study|Did Not Receive Treatment|0|||
94610742|NCT00694707|324038874|FG002|Overall Study|Did Not Receive Treatment|1|||
94610743|NCT00694707|324038875|FG003|Overall Study|Did Not Receive Treatment|1|||
94610744|NCT00694707|324038876|FG004|Overall Study|Did Not Receive Treatment|1|||
94610745|NCT00694707|324038872|FG000|Overall Study|Adverse Event|22|||
94610746|NCT00694707|324038873|FG001|Overall Study|Adverse Event|14|||
94610747|NCT00694707|324038874|FG002|Overall Study|Adverse Event|8|||
94610748|NCT00694707|324038875|FG003|Overall Study|Adverse Event|12|||
94610749|NCT00694707|324038876|FG004|Overall Study|Adverse Event|13|||
94610750|NCT00694707|324038872|FG000|Overall Study|Insufficient Therapeutic Response|33|||
94610751|NCT00694707|324038873|FG001|Overall Study|Insufficient Therapeutic Response|18|||
94610752|NCT00694707|324038874|FG002|Overall Study|Insufficient Therapeutic Response|17|||
94610753|NCT00694707|324038875|FG003|Overall Study|Insufficient Therapeutic Response|15|||
94610754|NCT00694707|324038876|FG004|Overall Study|Insufficient Therapeutic Response|10|||
94610755|NCT00694707|324038872|FG000|Overall Study|Protocol Violation|1|||
94253295|NCT01688830|322720831|FG012|Overall Study|Lost to Follow-up|0|||
94253296|NCT01688830|322720832|FG013|Overall Study|Lost to Follow-up|0|||
94253297|NCT01688830|322720833|FG014|Overall Study|Lost to Follow-up|0|||
94610756|NCT00694707|324038873|FG001|Overall Study|Protocol Violation|2|||
94610757|NCT00694707|324038874|FG002|Overall Study|Protocol Violation|1|||
94610758|NCT00694707|324038875|FG003|Overall Study|Protocol Violation|3|||
94610759|NCT00694707|324038876|FG004|Overall Study|Protocol Violation|1|||
94610760|NCT00694707|324038872|FG000|Overall Study|Withdrawal of Consent|14|||
94610761|NCT00694707|324038873|FG001|Overall Study|Withdrawal of Consent|18|||
94610762|NCT00694707|324038874|FG002|Overall Study|Withdrawal of Consent|22|||
94610763|NCT00694707|324038875|FG003|Overall Study|Withdrawal of Consent|16|||
94610764|NCT00694707|324038876|FG004|Overall Study|Withdrawal of Consent|15|||
94610765|NCT00694707|324038872|FG000|Overall Study|Lost to Follow-up|0|||
94610766|NCT00694707|324038873|FG001|Overall Study|Lost to Follow-up|1|||
94610767|NCT00694707|324038874|FG002|Overall Study|Lost to Follow-up|2|||
94610768|NCT00694707|324038875|FG003|Overall Study|Lost to Follow-up|0|||
94610769|NCT00694707|324038876|FG004|Overall Study|Lost to Follow-up|0|||
94610770|NCT00694707|324038872|FG000|Overall Study|Jeopardizing Parole Status|1|||
94610771|NCT00694707|324038873|FG001|Overall Study|Jeopardizing Parole Status|0|||
94610772|NCT00694707|324038874|FG002|Overall Study|Jeopardizing Parole Status|0|||
94610773|NCT00694707|324038875|FG003|Overall Study|Jeopardizing Parole Status|0|||
94610774|NCT00694707|324038876|FG004|Overall Study|Jeopardizing Parole Status|0|||
94610775|NCT00694707|324038872|FG000|Overall Study|Death in the Family|1|||
94610776|NCT00694707|324038873|FG001|Overall Study|Death in the Family|0|||
94610777|NCT00694707|324038874|FG002|Overall Study|Death in the Family|0|||
94610778|NCT00694707|324038875|FG003|Overall Study|Death in the Family|0|||
94610779|NCT00694707|324038876|FG004|Overall Study|Death in the Family|0|||
94610780|NCT00694707|324038872|FG000|Overall Study|Arrest by Police|0|||
94610781|NCT00694707|324038873|FG001|Overall Study|Arrest by Police|1|||
94610782|NCT00694707|324038874|FG002|Overall Study|Arrest by Police|0|||
94610783|NCT00694707|324038875|FG003|Overall Study|Arrest by Police|0|||
94610784|NCT00694707|324038876|FG004|Overall Study|Arrest by Police|0|||
94610785|NCT00694707|324038872|FG000|Overall Study|Administrative Reasons|0|||
94610786|NCT00694707|324038873|FG001|Overall Study|Administrative Reasons|1|||
94610787|NCT00694707|324038874|FG002|Overall Study|Administrative Reasons|0|||
94610788|NCT00694707|324038875|FG003|Overall Study|Administrative Reasons|2|||
94610789|NCT00694707|324038876|FG004|Overall Study|Administrative Reasons|0|||
94610790|NCT00694707|324038872|FG000|Overall Study|Notification of Past Head Injury|0|||
94610791|NCT00694707|324038873|FG001|Overall Study|Notification of Past Head Injury|0|||
94610792|NCT00694707|324038874|FG002|Overall Study|Notification of Past Head Injury|0|||
94610793|NCT00694707|324038875|FG003|Overall Study|Notification of Past Head Injury|1|||
94610794|NCT00694707|324038876|FG004|Overall Study|Notification of Past Head Injury|0|||
94610795|NCT03605212|324038888|FG000|Treatment Period|Adverse Event|1|||
94610796|NCT03605212|324038889|FG001|Treatment Period|Adverse Event|0|||
94610797|NCT03605212|324038890|FG002|Treatment Period|Adverse Event|0|||
94610798|NCT03605212|324038891|FG003|Treatment Period|Adverse Event|0|||
94610799|NCT03605212|324038892|FG004|Treatment Period|Adverse Event|0|||
94610800|NCT03605212|324038888|FG000|Treatment Period|Physician Decision|0|||
94610801|NCT03605212|324038889|FG001|Treatment Period|Physician Decision|0|||
94610802|NCT03605212|324038890|FG002|Treatment Period|Physician Decision|0|||
94610803|NCT03605212|324038891|FG003|Treatment Period|Physician Decision|0|||
94610804|NCT03605212|324038892|FG004|Treatment Period|Physician Decision|1|||
94610805|NCT01013350|324038897|FG000|Overall Study|Lost to Follow-up|15|||
94610806|NCT01013350|324038898|FG001|Overall Study|Lost to Follow-up|95|||
94610807|NCT01013350|324038897|FG000|Overall Study|Adverse Event|0|||
94610808|NCT01013350|324038898|FG001|Overall Study|Adverse Event|1|||
94610809|NCT01013350|324038897|FG000|Overall Study|Physician Decision|4|||
94610810|NCT01013350|324038898|FG001|Overall Study|Physician Decision|20|||
94610811|NCT01013350|324038897|FG000|Overall Study|Withdrawal by Subject|15|||
94610812|NCT01013350|324038898|FG001|Overall Study|Withdrawal by Subject|38|||
94610813|NCT01013350|324038897|FG000|Overall Study|Death|3|||
94610814|NCT01013350|324038898|FG001|Overall Study|Death|5|||
94610815|NCT01013350|324038897|FG000|Overall Study|Participant entered interventional study|0|||
94610816|NCT01013350|324038898|FG001|Overall Study|Participant entered interventional study|8|||
94610817|NCT01013350|324038897|FG000|Overall Study|Other|1|||
94610818|NCT01013350|324038898|FG001|Overall Study|Other|25|||
94610819|NCT05394350|324038903|FG000|Overall Study|Death|2|||
94610820|NCT05394350|324038904|FG001|Overall Study|Death|2|||
94610821|NCT05394350|324038905|FG002|Overall Study|Death|4|||
94610822|NCT05394350|324038906|FG003|Overall Study|Death|0|||
94610823|NCT05394350|324038907|FG004|Overall Study|Death|1|||
94610824|NCT05394350|324038908|FG005|Overall Study|Death|0|||
94610825|NCT05394350|324038903|FG000|Overall Study|Study terminated by sponsor|1|||
94610826|NCT05394350|324038904|FG001|Overall Study|Study terminated by sponsor|1|||
94610827|NCT05394350|324038905|FG002|Overall Study|Study terminated by sponsor|7|||
94610828|NCT05394350|324038906|FG003|Overall Study|Study terminated by sponsor|3|||
94610829|NCT05394350|324038907|FG004|Overall Study|Study terminated by sponsor|2|||
94610830|NCT05394350|324038908|FG005|Overall Study|Study terminated by sponsor|4|||
94610831|NCT00237185|324038909|FG000|Core|Adverse Event|3|||
94610832|NCT00237185|324038910|FG001|Core|Adverse Event|4|||
94610833|NCT00237185|324038909|FG000|Core|Abnormal laboratory value|0|||
94610834|NCT00237185|324038910|FG001|Core|Abnormal laboratory value|4|||
94610835|NCT00237185|324038909|FG000|Core|Abnormal test procedure results|1|||
94610836|NCT00237185|324038910|FG001|Core|Abnormal test procedure results|0|||
94610837|NCT00237185|324038909|FG000|Core|Lack of Efficacy|30|||
94610838|NCT00237185|324038910|FG001|Core|Lack of Efficacy|23|||
94610839|NCT00237185|324038909|FG000|Core|Protocol Violation|1|||
94610840|NCT00237185|324038910|FG001|Core|Protocol Violation|1|||
94610841|NCT00237185|324038909|FG000|Core|Withdrawal by Subject|4|||
94610842|NCT00237185|324038910|FG001|Core|Withdrawal by Subject|4|||
94610843|NCT00237185|324038909|FG000|Core|Administrative problems|0|||
94610844|NCT00237185|324038910|FG001|Core|Administrative problems|1|||
94610845|NCT00237185|324038909|FG000|Core|Death|4|||
94610846|NCT00237185|324038910|FG001|Core|Death|0|||
94610847|NCT00237185|324038909|FG000|Core|Determined ineligible post randomization|1|||
94610848|NCT00237185|324038910|FG001|Core|Determined ineligible post randomization|0|||
94662076|NCT01664078|324217772|FG000|Overall Study|Death|9|||
94662077|NCT01664078|324217772|FG000|Overall Study|Withdrawal by Subject|4|||
94662078|NCT01664078|324217772|FG000|Overall Study|Lost to Follow-up|2|||
94662079|NCT01664078|324217772|FG000|Overall Study|missed 5 year visit|1|||
94662080|NCT01664078|324217772|FG000|Overall Study|Other|53|||
94662081|NCT01898195|324217773|FG000|Smoking Abstinence|Did not have good measurements|35|||
94662082|NCT01898195|324217774|FG001|Smoking Abstinence|Did not have good measurements|38|||
94662083|NCT01898195|324217775|FG002|Smoking Abstinence|Did not have good measurements|36|||
94662084|NCT02663128|324217776|FG000|Period 2|Physician Decision|0|||
94662085|NCT02663128|324217777|FG001|Period 2|Physician Decision|0|||
94662086|NCT02663128|324217778|FG002|Period 2|Physician Decision|0|||
94662087|NCT02663128|324217779|FG003|Period 2|Physician Decision|0|||
94662088|NCT02663128|324217780|FG004|Period 2|Physician Decision|1|||
94662089|NCT02663128|324217781|FG005|Period 2|Physician Decision|0|||
94662090|NCT01358526|324217782|FG000|Open-label Titration Period|Adverse Event|95|||
94662091|NCT01358526|324217783|FG001|Open-label Titration Period|Adverse Event|0|||
94662092|NCT01358526|324217784|FG002|Open-label Titration Period|Adverse Event|0|||
94610849|NCT00237185|324038909|FG000|Extension|Adverse Event|1|||
94610850|NCT00237185|324038910|FG001|Extension|Adverse Event|0|||
94610851|NCT00237185|324038909|FG000|Extension|Abnormal laboratory value|0|||
94610852|NCT00237185|324038910|FG001|Extension|Abnormal laboratory value|1|||
94610853|NCT00237185|324038909|FG000|Extension|Lack of Efficacy|9|||
94610854|NCT00237185|324038910|FG001|Extension|Lack of Efficacy|14|||
94610855|NCT00237185|324038909|FG000|Extension|Condition no longer required study drug|0|||
94610856|NCT00237185|324038910|FG001|Extension|Condition no longer required study drug|1|||
94358353|NCT05299359|323094443|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
94610857|NCT00237185|324038909|FG000|Extension|Withdrawal by Subject|3|||
94610858|NCT00237185|324038910|FG001|Extension|Withdrawal by Subject|2|||
94610859|NCT00237185|324038909|FG000|Extension|Lost to Follow-up|1|||
94610860|NCT00237185|324038910|FG001|Extension|Lost to Follow-up|0|||
94610861|NCT00237185|324038909|FG000|Extension|Administrative problems|1|||
94610862|NCT00237185|324038910|FG001|Extension|Administrative problems|0|||
94610863|NCT00237185|324038909|FG000|Extension|Death|1|||
94610864|NCT00237185|324038910|FG001|Extension|Death|1|||
94610865|NCT05055128|324038911|FG000|Overall Study|Adverse Event|0|||
94662093|NCT01358526|324217782|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
94662094|NCT01358526|324217783|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
94662095|NCT01358526|324217784|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
94662096|NCT01358526|324217782|FG000|Open-label Titration Period|Lost to Follow-up|25|||
94662097|NCT01358526|324217783|FG001|Open-label Titration Period|Lost to Follow-up|0|||
94662098|NCT01358526|324217784|FG002|Open-label Titration Period|Lost to Follow-up|0|||
94610866|NCT05055128|324038912|FG001|Overall Study|Adverse Event|0|||
94610867|NCT05055128|324038913|FG002|Overall Study|Adverse Event|0|||
94610868|NCT05055128|324038914|FG003|Overall Study|Adverse Event|1|||
94610869|NCT05055128|324038915|FG004|Overall Study|Adverse Event|1|||
94662099|NCT01358526|324217782|FG000|Open-label Titration Period|Lack of Efficacy|107|||
94662100|NCT01358526|324217783|FG001|Open-label Titration Period|Lack of Efficacy|0|||
94662101|NCT01358526|324217784|FG002|Open-label Titration Period|Lack of Efficacy|0|||
94610870|NCT05055128|324038911|FG000|Overall Study|Protocol Violation|0|||
94610871|NCT05055128|324038912|FG001|Overall Study|Protocol Violation|0|||
94253298|NCT01688830|322720834|FG015|Overall Study|Lost to Follow-up|0|||
94253299|NCT01688830|322720835|FG016|Overall Study|Lost to Follow-up|0|||
94253300|NCT01688830|322720836|FG017|Overall Study|Lost to Follow-up|0|||
94253301|NCT01688830|322720837|FG018|Overall Study|Lost to Follow-up|0|||
94253302|NCT01688830|322720838|FG019|Overall Study|Lost to Follow-up|0|||
94610872|NCT05055128|324038913|FG002|Overall Study|Protocol Violation|0|||
94610873|NCT05055128|324038914|FG003|Overall Study|Protocol Violation|1|||
94610874|NCT05055128|324038915|FG004|Overall Study|Protocol Violation|0|||
94610875|NCT05055128|324038911|FG000|Overall Study|Withdrawal by Subject|5|||
94610876|NCT05055128|324038912|FG001|Overall Study|Withdrawal by Subject|2|||
94610877|NCT05055128|324038913|FG002|Overall Study|Withdrawal by Subject|2|||
94610878|NCT05055128|324038914|FG003|Overall Study|Withdrawal by Subject|4|||
94610879|NCT05055128|324038915|FG004|Overall Study|Withdrawal by Subject|2|||
94610880|NCT05055128|324038911|FG000|Overall Study|Randomized By Mistake|0|||
94610881|NCT05055128|324038912|FG001|Overall Study|Randomized By Mistake|1|||
94610882|NCT05055128|324038913|FG002|Overall Study|Randomized By Mistake|0|||
94610883|NCT05055128|324038914|FG003|Overall Study|Randomized By Mistake|0|||
94610884|NCT05055128|324038915|FG004|Overall Study|Randomized By Mistake|0|||
94610885|NCT05055128|324038911|FG000|Overall Study|Other|1|||
94610886|NCT05055128|324038912|FG001|Overall Study|Other|0|||
94610887|NCT05055128|324038913|FG002|Overall Study|Other|0|||
94610888|NCT05055128|324038914|FG003|Overall Study|Other|0|||
94610889|NCT05055128|324038915|FG004|Overall Study|Other|0|||
94610890|NCT01385371|324038916|FG000|Overall Study|Adverse Event|54|||
94610891|NCT01385371|324038917|FG001|Overall Study|Adverse Event|19|||
94610892|NCT01385371|324038916|FG000|Overall Study|Lost to Follow-up|16|||
94610893|NCT01385371|324038917|FG001|Overall Study|Lost to Follow-up|16|||
94610894|NCT01385371|324038916|FG000|Overall Study|Withdrawal by Subject|52|||
94610895|NCT01385371|324038917|FG001|Overall Study|Withdrawal by Subject|39|||
94610896|NCT01385371|324038916|FG000|Overall Study|Protocol Violation|25|||
94610897|NCT01385371|324038917|FG001|Overall Study|Protocol Violation|21|||
94610898|NCT01385371|324038916|FG000|Overall Study|Administrative|2|||
94610899|NCT01385371|324038917|FG001|Overall Study|Administrative|2|||
94610900|NCT03452228|324038919|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
94610901|NCT03452228|324038920|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
94610902|NCT03452228|324038921|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
94610903|NCT03452228|324038919|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
94610904|NCT03452228|324038920|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
94610905|NCT03452228|324038921|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
94610906|NCT03452228|324038919|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
94610907|NCT03452228|324038920|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
94610908|NCT03452228|324038921|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
94610909|NCT03452228|324038919|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
94610910|NCT03452228|324038920|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
94610911|NCT03452228|324038921|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
94610912|NCT01281137|324038922|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
94610913|NCT01281137|324038923|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
94610914|NCT01281137|324038922|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
94662102|NCT01358526|324217782|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
94662103|NCT01358526|324217783|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
94662104|NCT01358526|324217784|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
94253303|NCT01688830|322720839|FG020|Overall Study|Lost to Follow-up|0|||
94253304|NCT00710021|322720841|FG000|Overall Study|Lost to Follow-up|1|||
94253305|NCT00710021|322720842|FG001|Overall Study|Lost to Follow-up|0|||
94253306|NCT00710021|322720843|FG002|Overall Study|Lost to Follow-up|0|||
94253307|NCT00710021|322720841|FG000|Overall Study|Subject's Decision|0|||
94253308|NCT00710021|322720842|FG001|Overall Study|Subject's Decision|1|||
94253309|NCT00710021|322720843|FG002|Overall Study|Subject's Decision|0|||
94253310|NCT00710021|322720841|FG000|Overall Study|Subject misrandomized|0|||
94253311|NCT00710021|322720842|FG001|Overall Study|Subject misrandomized|1|||
94253312|NCT00710021|322720843|FG002|Overall Study|Subject misrandomized|1|||
94253313|NCT00710021|322720841|FG000|Overall Study|Physician Decision|0|||
94253314|NCT00710021|322720842|FG001|Overall Study|Physician Decision|1|||
94253315|NCT00710021|322720843|FG002|Overall Study|Physician Decision|0|||
94253316|NCT02457559|322720844|FG000|Overall Study|Progressive Disease|1|||
94253317|NCT02457559|322720845|FG001|Overall Study|Progressive Disease|2|||
94253318|NCT02457559|322720846|FG002|Overall Study|Progressive Disease|3|||
94253319|NCT02457559|322720847|FG003|Overall Study|Progressive Disease|0|||
94253320|NCT02457559|322720848|FG004|Overall Study|Progressive Disease|0|||
94253321|NCT02457559|322720849|FG005|Overall Study|Progressive Disease|2|||
94253322|NCT02457559|322720850|FG006|Overall Study|Progressive Disease|1|||
94253323|NCT02457559|322720851|FG007|Overall Study|Progressive Disease|0|||
94253324|NCT02457559|322720852|FG008|Overall Study|Progressive Disease|1|||
94253325|NCT02457559|322720853|FG009|Overall Study|Progressive Disease|1|||
94253326|NCT02457559|322720854|FG010|Overall Study|Progressive Disease|1|||
94253327|NCT02457559|322720844|FG000|Overall Study|Investigator's Discretion|0|||
94253328|NCT02457559|322720845|FG001|Overall Study|Investigator's Discretion|0|||
94253329|NCT02457559|322720846|FG002|Overall Study|Investigator's Discretion|2|||
94253330|NCT02457559|322720847|FG003|Overall Study|Investigator's Discretion|0|||
94253331|NCT02457559|322720848|FG004|Overall Study|Investigator's Discretion|1|||
94253332|NCT02457559|322720849|FG005|Overall Study|Investigator's Discretion|0|||
94253333|NCT02457559|322720850|FG006|Overall Study|Investigator's Discretion|1|||
94253334|NCT02457559|322720851|FG007|Overall Study|Investigator's Discretion|0|||
94253335|NCT02457559|322720852|FG008|Overall Study|Investigator's Discretion|1|||
94253336|NCT02457559|322720853|FG009|Overall Study|Investigator's Discretion|0|||
94253337|NCT02457559|322720854|FG010|Overall Study|Investigator's Discretion|1|||
94253338|NCT02457559|322720844|FG000|Overall Study|Adverse Event|0|||
94253339|NCT02457559|322720845|FG001|Overall Study|Adverse Event|1|||
94253340|NCT02457559|322720846|FG002|Overall Study|Adverse Event|2|||
94253341|NCT02457559|322720847|FG003|Overall Study|Adverse Event|0|||
94253342|NCT02457559|322720848|FG004|Overall Study|Adverse Event|0|||
94253343|NCT02457559|322720849|FG005|Overall Study|Adverse Event|0|||
94253344|NCT02457559|322720850|FG006|Overall Study|Adverse Event|0|||
94253345|NCT02457559|322720851|FG007|Overall Study|Adverse Event|0|||
94253346|NCT02457559|322720852|FG008|Overall Study|Adverse Event|0|||
94253347|NCT02457559|322720853|FG009|Overall Study|Adverse Event|0|||
94253348|NCT02457559|322720854|FG010|Overall Study|Adverse Event|0|||
94253349|NCT02457559|322720844|FG000|Overall Study|Reason not Specified|1|||
94253350|NCT02457559|322720845|FG001|Overall Study|Reason not Specified|0|||
94253351|NCT02457559|322720846|FG002|Overall Study|Reason not Specified|0|||
94253352|NCT02457559|322720847|FG003|Overall Study|Reason not Specified|0|||
94253353|NCT02457559|322720848|FG004|Overall Study|Reason not Specified|0|||
94253354|NCT02457559|322720849|FG005|Overall Study|Reason not Specified|0|||
94459508|NCT04434469|323471831|FG000|Overall Study|Study terminated by sponsor|1|||
94459509|NCT04434469|323471832|FG001|Overall Study|Study terminated by sponsor|1|||
94610915|NCT01281137|324038923|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
94610916|NCT01281137|324038922|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
94610917|NCT01281137|324038923|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
94253355|NCT02457559|322720850|FG006|Overall Study|Reason not Specified|0|||
94459510|NCT04434469|323471833|FG002|Overall Study|Study terminated by sponsor|1|||
94253356|NCT02457559|322720851|FG007|Overall Study|Reason not Specified|0|||
94253357|NCT02457559|322720852|FG008|Overall Study|Reason not Specified|0|||
94253358|NCT02457559|322720853|FG009|Overall Study|Reason not Specified|2|||
94253359|NCT02457559|322720854|FG010|Overall Study|Reason not Specified|0|||
94253360|NCT02457559|322720844|FG000|Overall Study|Death|0|||
94253361|NCT02457559|322720845|FG001|Overall Study|Death|0|||
94253362|NCT02457559|322720846|FG002|Overall Study|Death|0|||
94253363|NCT02457559|322720847|FG003|Overall Study|Death|0|||
94610918|NCT01281137|324038922|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
94610919|NCT01281137|324038923|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
94610920|NCT01281137|324038922|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
94610921|NCT01281137|324038923|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
94610922|NCT03386474|324038933|FG000|Overall Study|Death|1|||
94610923|NCT03386474|324038934|FG001|Overall Study|Death|0|||
94662105|NCT01358526|324217782|FG000|Open-label Titration Period|Administrative|8|||
94662106|NCT01358526|324217783|FG001|Open-label Titration Period|Administrative|0|||
94662107|NCT01358526|324217784|FG002|Open-label Titration Period|Administrative|0|||
94662108|NCT01358526|324217782|FG000|Open-label Titration Period|Did not qualify|178|||
94662109|NCT01358526|324217783|FG001|Open-label Titration Period|Did not qualify|0|||
94662110|NCT01358526|324217784|FG002|Open-label Titration Period|Did not qualify|0|||
94662111|NCT01358526|324217782|FG000|Double-blind Phase|Adverse Event|0|||
94662112|NCT01358526|324217783|FG001|Double-blind Phase|Adverse Event|24|||
94662113|NCT01358526|324217784|FG002|Double-blind Phase|Adverse Event|23|||
94662114|NCT01358526|324217782|FG000|Double-blind Phase|Withdrawal by Subject|0|||
94662115|NCT01358526|324217783|FG001|Double-blind Phase|Withdrawal by Subject|10|||
94662116|NCT01358526|324217784|FG002|Double-blind Phase|Withdrawal by Subject|8|||
94662117|NCT01358526|324217782|FG000|Double-blind Phase|Lost to Follow-up|0|||
94662118|NCT01358526|324217783|FG001|Double-blind Phase|Lost to Follow-up|4|||
94662119|NCT01358526|324217784|FG002|Double-blind Phase|Lost to Follow-up|1|||
94662120|NCT01358526|324217782|FG000|Double-blind Phase|Lack of Efficacy|0|||
94662121|NCT01358526|324217783|FG001|Double-blind Phase|Lack of Efficacy|31|||
94662122|NCT01358526|324217784|FG002|Double-blind Phase|Lack of Efficacy|73|||
94662123|NCT01358526|324217782|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
94662124|NCT01358526|324217783|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
94662125|NCT01358526|324217784|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
94662126|NCT01358526|324217782|FG000|Double-blind Phase|Administrative|0|||
94662127|NCT01358526|324217783|FG001|Double-blind Phase|Administrative|6|||
94662128|NCT01358526|324217784|FG002|Double-blind Phase|Administrative|10|||
94662129|NCT01617629|324217785|FG000|Overall Study|Death|2|||
94662130|NCT01617629|324217785|FG000|Overall Study|Investigator's Clinical Judgement|1|||
94662131|NCT01617629|324217785|FG000|Overall Study|Reason Not Specified|1|||
94662132|NCT01617629|324217785|FG000|Overall Study|Participant Withdrew Consent|2|||
94662133|NCT04558346|324217788|FG000|Overall Study|Withdrawal by Subject|2|||
94662134|NCT04558346|324217789|FG001|Overall Study|Withdrawal by Subject|0|||
94662135|NCT04558346|324217788|FG000|Overall Study|Lost to Follow-up|0|||
94662136|NCT04558346|324217789|FG001|Overall Study|Lost to Follow-up|1|||
94662137|NCT04558346|324217788|FG000|Overall Study|Adverse Event|0|||
94662138|NCT04558346|324217789|FG001|Overall Study|Adverse Event|1|||
94662139|NCT03832946|324217790|FG000|Overall Study|Adverse Event|3|||
94662140|NCT03832946|324217791|FG001|Overall Study|Adverse Event|1|||
94662141|NCT03832946|324217790|FG000|Overall Study|Lost to Follow-up|1|||
94662142|NCT03832946|324217791|FG001|Overall Study|Lost to Follow-up|0|||
94662143|NCT03832946|324217790|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
94662144|NCT03832946|324217791|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
94662145|NCT03832946|324217790|FG000|Overall Study|Lack of Efficacy|1|||
94662146|NCT03832946|324217791|FG001|Overall Study|Lack of Efficacy|0|||
94662147|NCT03832946|324217790|FG000|Overall Study|Withdrawal by Subject|12|||
94662148|NCT03832946|324217791|FG001|Overall Study|Withdrawal by Subject|9|||
94662149|NCT00724971|324217792|FG000|Overall Study|Adverse Event|5|||
94662150|NCT00724971|324217792|FG000|Overall Study|Withdrawal by Subject|1|||
94662151|NCT01344460|324217793|FG000|Overall Study|Withdrawal by Subject|1|||
94662152|NCT01344460|324217793|FG000|Overall Study|Lost to Follow-up|2|||
94662153|NCT02838017|324217794|FG000|Overall Study|Lost to Follow-up|14|||
94662154|NCT02838017|324217795|FG001|Overall Study|Lost to Follow-up|11|||
94662155|NCT02276482|324217798|FG000|Overall Study|Adverse Event|1|||
94662156|NCT02276482|324217799|FG001|Overall Study|Adverse Event|0|||
94662157|NCT02276482|324217798|FG000|Overall Study|Withdrawal by Subject|1|||
94662158|NCT02276482|324217799|FG001|Overall Study|Withdrawal by Subject|0|||
94662159|NCT02276482|324217798|FG000|Overall Study|Gram-negative infection|1|||
94662160|NCT02276482|324217799|FG001|Overall Study|Gram-negative infection|0|||
94662161|NCT02276482|324217798|FG000|Overall Study|Reason not specified|0|||
94662162|NCT02276482|324217799|FG001|Overall Study|Reason not specified|1|||
94662163|NCT01218646|324217803|FG000|Overall Study|Adverse Event|0|||
94662164|NCT01218646|324217804|FG001|Overall Study|Adverse Event|0|||
94662165|NCT01218646|324217805|FG002|Overall Study|Adverse Event|1|||
94662166|NCT01218646|324217806|FG003|Overall Study|Adverse Event|0|||
94662167|NCT01218646|324217803|FG000|Overall Study|Lost to Follow-up|1|||
94662168|NCT01218646|324217804|FG001|Overall Study|Lost to Follow-up|0|||
94662169|NCT01218646|324217805|FG002|Overall Study|Lost to Follow-up|0|||
94610924|NCT03386474|324038933|FG000|Overall Study|Adverse Event|0|||
94610925|NCT03386474|324038934|FG001|Overall Study|Adverse Event|1|||
94610926|NCT02282358|324038935|FG000|Overall Study|Nonevaluable|1|||
94610927|NCT02436681|324038938|FG000|Overall Study|Lost to Follow-up|10|||
94610928|NCT02436681|324038938|FG000|Overall Study|Withdrawal by Subject|2|||
94610929|NCT02436681|324038938|FG000|Overall Study|Death|2|||
94610930|NCT04122534|324038939|FG000|Overall Study|Lost to Follow-up|4|||
94610931|NCT02959983|324038949|FG000|Overall Study|Protocol Violation|0|||
94610932|NCT02959983|324038950|FG001|Overall Study|Protocol Violation|1|||
94610933|NCT02959983|324038949|FG000|Overall Study|Lack of Efficacy|0|||
94610934|NCT02959983|324038950|FG001|Overall Study|Lack of Efficacy|1|||
94610935|NCT02959983|324038949|FG000|Overall Study|Lost to Follow-up|12|||
94610936|NCT02959983|324038950|FG001|Overall Study|Lost to Follow-up|9|||
94610937|NCT02959983|324038949|FG000|Overall Study|Other|1|||
94610938|NCT02959983|324038950|FG001|Overall Study|Other|1|||
94610939|NCT02959983|324038949|FG000|Overall Study|Physician Decision|1|||
94610940|NCT02959983|324038950|FG001|Overall Study|Physician Decision|0|||
94610941|NCT02959983|324038949|FG000|Overall Study|Adverse Event|5|||
94610942|NCT02959983|324038950|FG001|Overall Study|Adverse Event|1|||
94610943|NCT02959983|324038949|FG000|Overall Study|Withdrawal by Subject|7|||
94610944|NCT02959983|324038950|FG001|Overall Study|Withdrawal by Subject|12|||
94610945|NCT03439657|324038951|FG000|Overall Study|Adverse Event|2|||
94610946|NCT03439657|324038952|FG001|Overall Study|Adverse Event|3|||
94610947|NCT03439657|324038951|FG000|Overall Study|Lost to Follow-up|1|||
94610948|NCT03439657|324038952|FG001|Overall Study|Lost to Follow-up|0|||
94610949|NCT03439657|324038951|FG000|Overall Study|Protocol Violation|1|||
94610950|NCT03439657|324038952|FG001|Overall Study|Protocol Violation|1|||
94610951|NCT03439657|324038951|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
94610952|NCT03439657|324038952|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
94610953|NCT01686828|324038953|FG000|Overall Study|Physician Decision|1|||
94662170|NCT01218646|324217806|FG003|Overall Study|Lost to Follow-up|0|||
94662171|NCT01218646|324217803|FG000|Overall Study|Protocol Violation|0|||
94662172|NCT01218646|324217804|FG001|Overall Study|Protocol Violation|0|||
94662173|NCT01218646|324217805|FG002|Overall Study|Protocol Violation|1|||
94662174|NCT01218646|324217806|FG003|Overall Study|Protocol Violation|1|||
94662175|NCT04602624|324217807|FG000|Overall Study|Protocol Deviation|1|||
94610954|NCT01686828|324038954|FG001|Overall Study|Physician Decision|0|||
94610955|NCT01686828|324038955|FG002|Overall Study|Physician Decision|0|||
94610956|NCT01686828|324038956|FG003|Overall Study|Physician Decision|0|||
94610957|NCT01686828|324038953|FG000|Overall Study|New Job|0|||
94662176|NCT04602624|324217807|FG000|Overall Study|Withdrawal by Participant|1|||
94662177|NCT03156023|324217808|FG000|Overall Study|Withdrawal by Subject|1|||
94610958|NCT01686828|324038954|FG001|Overall Study|New Job|1|||
94610959|NCT01686828|324038955|FG002|Overall Study|New Job|0|||
94610960|NCT01686828|324038956|FG003|Overall Study|New Job|0|||
94662178|NCT03156023|324217809|FG001|Overall Study|Withdrawal by Subject|0|||
94662179|NCT03156023|324217810|FG002|Overall Study|Withdrawal by Subject|2|||
94662180|NCT03156023|324217811|FG003|Overall Study|Withdrawal by Subject|1|||
94662181|NCT03156023|324217812|FG004|Overall Study|Withdrawal by Subject|1|||
94610961|NCT01686828|324038953|FG000|Overall Study|Weight Loss|0|||
94610962|NCT01686828|324038954|FG001|Overall Study|Weight Loss|0|||
94610963|NCT01686828|324038955|FG002|Overall Study|Weight Loss|1|||
94253364|NCT02457559|322720848|FG004|Overall Study|Death|0|||
94253365|NCT02457559|322720849|FG005|Overall Study|Death|0|||
94253366|NCT02457559|322720850|FG006|Overall Study|Death|0|||
94253367|NCT02457559|322720851|FG007|Overall Study|Death|0|||
94253368|NCT02457559|322720852|FG008|Overall Study|Death|1|||
94253369|NCT02457559|322720853|FG009|Overall Study|Death|1|||
94253370|NCT02457559|322720854|FG010|Overall Study|Death|0|||
94253371|NCT03169101|322720859|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
94253372|NCT03169101|322720860|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
94253373|NCT03169101|322720861|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
94253374|NCT03169101|322720862|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
94610964|NCT01686828|324038956|FG003|Overall Study|Weight Loss|0|||
94662182|NCT03156023|324217808|FG000|Overall Study|Lost to Follow-up|0|||
94662183|NCT03156023|324217809|FG001|Overall Study|Lost to Follow-up|0|||
94662184|NCT03156023|324217810|FG002|Overall Study|Lost to Follow-up|0|||
94662185|NCT03156023|324217811|FG003|Overall Study|Lost to Follow-up|0|||
94662186|NCT03156023|324217812|FG004|Overall Study|Lost to Follow-up|1|||
94662187|NCT03120624|324217815|FG000|Overall Study|Withdrawal by Subject|0|||
94662188|NCT03120624|324217816|FG001|Overall Study|Withdrawal by Subject|1|||
94662189|NCT03120624|324217817|FG002|Overall Study|Withdrawal by Subject|0|||
94662190|NCT03120624|324217818|FG003|Overall Study|Withdrawal by Subject|0|||
94662191|NCT03120624|324217819|FG004|Overall Study|Withdrawal by Subject|0|||
94662192|NCT03120624|324217820|FG005|Overall Study|Withdrawal by Subject|0|||
94662193|NCT03120624|324217821|FG006|Overall Study|Withdrawal by Subject|0|||
94610965|NCT00891462|324040526|FG000|Overall Study|Withdrawal by Subject|9|||
94610966|NCT00891462|324040527|FG001|Overall Study|Withdrawal by Subject|6|||
94610967|NCT00891462|324040528|FG002|Overall Study|Withdrawal by Subject|7|||
94610968|NCT00891462|324040526|FG000|Overall Study|Adverse Event|7|||
94610969|NCT00891462|324040527|FG001|Overall Study|Adverse Event|8|||
94610970|NCT00891462|324040528|FG002|Overall Study|Adverse Event|7|||
94610971|NCT00891462|324040526|FG000|Overall Study|Lack of Efficacy|10|||
94610972|NCT00891462|324040527|FG001|Overall Study|Lack of Efficacy|5|||
94610973|NCT00891462|324040528|FG002|Overall Study|Lack of Efficacy|1|||
94610974|NCT00891462|324040526|FG000|Overall Study|COPD exacerbation|7|||
94610975|NCT00891462|324040527|FG001|Overall Study|COPD exacerbation|4|||
94610976|NCT00891462|324040528|FG002|Overall Study|COPD exacerbation|1|||
94610977|NCT00891462|324040526|FG000|Overall Study|Other Reason|2|||
94610978|NCT00891462|324040527|FG001|Overall Study|Other Reason|5|||
94610979|NCT00891462|324040528|FG002|Overall Study|Other Reason|3|||
94610980|NCT00891462|324040526|FG000|Overall Study|Protocol Violation|2|||
94610981|NCT00891462|324040527|FG001|Overall Study|Protocol Violation|1|||
94610982|NCT00891462|324040528|FG002|Overall Study|Protocol Violation|3|||
94610983|NCT00891462|324040526|FG000|Overall Study|Inclusion/exclusion criteria|0|||
94610984|NCT00891462|324040527|FG001|Overall Study|Inclusion/exclusion criteria|2|||
94610985|NCT00891462|324040528|FG002|Overall Study|Inclusion/exclusion criteria|2|||
94610986|NCT00891462|324040526|FG000|Overall Study|Lost to Follow-up|0|||
94610987|NCT00891462|324040527|FG001|Overall Study|Lost to Follow-up|2|||
94610988|NCT00891462|324040528|FG002|Overall Study|Lost to Follow-up|0|||
94610989|NCT03911713|324040529|FG000|Overall Study|Lost to Follow-up|0|||
94610990|NCT03911713|324040530|FG001|Overall Study|Lost to Follow-up|2|||
94610991|NCT03911713|324040531|FG002|Overall Study|Lost to Follow-up|0|||
94610992|NCT03911713|324040532|FG003|Overall Study|Lost to Follow-up|0|||
94610993|NCT03911713|324040533|FG004|Overall Study|Lost to Follow-up|0|||
94610994|NCT03911713|324040529|FG000|Overall Study|Other|0|||
94610995|NCT03911713|324040530|FG001|Overall Study|Other|0|||
94610996|NCT03911713|324040531|FG002|Overall Study|Other|0|||
94610997|NCT03911713|324040532|FG003|Overall Study|Other|1|||
94610998|NCT03911713|324040533|FG004|Overall Study|Other|0|||
94610999|NCT03911713|324040529|FG000|Overall Study|Randomized, Never Dosed|1|||
94611000|NCT03911713|324040530|FG001|Overall Study|Randomized, Never Dosed|0|||
94662194|NCT03120624|324217822|FG007|Overall Study|Withdrawal by Subject|0|||
94253375|NCT00178126|322720863|FG000|Overall Study|Lost to Follow-up|21|||
94611001|NCT03911713|324040531|FG002|Overall Study|Randomized, Never Dosed|0|||
94662195|NCT04368429|324219785|FG000|Overall Study|Adverse Event|1|||
94662196|NCT04368429|324219786|FG001|Overall Study|Adverse Event|0|||
94253376|NCT00178126|322720864|FG001|Overall Study|Lost to Follow-up|21|||
94253377|NCT00178126|322720863|FG000|Overall Study|did not receive intervention|4|||
94253378|NCT00178126|322720864|FG001|Overall Study|did not receive intervention|6|||
94253379|NCT02641496|322720865|FG000|Overall Study|Lost to Follow-up|13|||
94253380|NCT02641496|322720866|FG001|Overall Study|Lost to Follow-up|12|||
94253381|NCT02641496|322720865|FG000|Overall Study|Withdrawal by Subject|1|||
94611002|NCT03911713|324040532|FG003|Overall Study|Randomized, Never Dosed|1|||
94611003|NCT03911713|324040533|FG004|Overall Study|Randomized, Never Dosed|0|||
94611004|NCT01871142|324040535|FG000|Overall Study|Adverse Event|1|||
94611005|NCT01409434|324040536|FG000|Overall Study|Protocol Violation|4|||
94611006|NCT00293215|324040537|FG000|Overall Study|Progressive disease|3|||
94611007|NCT00293215|324040538|FG001|Overall Study|Progressive disease|1|||
94611008|NCT00293215|324040537|FG000|Overall Study|Adverse Event|2|||
94611009|NCT00293215|324040538|FG001|Overall Study|Adverse Event|2|||
94611010|NCT00785928|324040543|FG000|Treatment Phase|Adverse Event|1|||
94662197|NCT01438411|324219787|FG000|Overall Study|Adverse Event|8|||
94662198|NCT01438411|324219787|FG000|Overall Study|Lost to Follow-up|1|||
94662199|NCT01438411|324219787|FG000|Overall Study|Lack of Efficacy|1|||
94662200|NCT01438411|324219787|FG000|Overall Study|Withdrawal by Subject|3|||
94662201|NCT00618514|324219788|FG000|Overall Study|Lost to Follow-up|11|||
94662202|NCT00618514|324219789|FG001|Overall Study|Lost to Follow-up|12|||
94662203|NCT00618514|324219790|FG002|Overall Study|Lost to Follow-up|4|||
94662204|NCT03320070|324219793|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
94662205|NCT03320070|324219794|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
94662206|NCT03320070|324219793|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
94662207|NCT03320070|324219794|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
94662208|NCT03320070|324219793|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
94662209|NCT03320070|324219794|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
94662210|NCT03320070|324219793|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
94662211|NCT03320070|324219794|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
94662212|NCT03320070|324219793|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
94662213|NCT03320070|324219794|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
94662214|NCT03320070|324219793|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
94662215|NCT03320070|324219794|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
94662216|NCT02053350|324219795|FG000|Overall Study|Withdrawal by Subject|1|||
94662217|NCT02053350|324219795|FG000|Overall Study|Adverse Event|4|||
94662218|NCT00317772|324219799|FG000|Overall Study|Adverse Event|0|||
94662219|NCT00317772|324219800|FG001|Overall Study|Adverse Event|0|||
94662220|NCT00317772|324219801|FG002|Overall Study|Adverse Event|0|||
94662221|NCT00317772|324219802|FG003|Overall Study|Adverse Event|2|||
94662222|NCT00317772|324219799|FG000|Overall Study|Disease Progression|2|||
94662223|NCT00317772|324219800|FG001|Overall Study|Disease Progression|2|||
94662224|NCT00317772|324219801|FG002|Overall Study|Disease Progression|1|||
94662225|NCT00317772|324219802|FG003|Overall Study|Disease Progression|7|||
94662226|NCT00987467|324219810|FG000|Overall Study|Lost to Follow-up|2|||
94662227|NCT00996996|324219814|FG000|Overall Study|Progressive Disease|10|||
94662228|NCT00996996|324219814|FG000|Overall Study|Non-compliance|8|||
94662229|NCT00996996|324219814|FG000|Overall Study|Lost to Follow-up|9|||
94662230|NCT00996996|324219814|FG000|Overall Study|Death|5|||
94662231|NCT00996996|324219814|FG000|Overall Study|Did Not Receive Study Medications|1|||
94662232|NCT02348216|324219817|FG000|Overall Study|Death|5|||
94662233|NCT02348216|324219818|FG001|Overall Study|Death|53|||
94662234|NCT02348216|324219819|FG002|Overall Study|Death|11|||
94662235|NCT02348216|324219820|FG003|Overall Study|Death|20|||
94662236|NCT02348216|324219821|FG004|Overall Study|Death|16|||
94662237|NCT02348216|324219822|FG005|Overall Study|Death|32|||
94662238|NCT02348216|324219823|FG006|Overall Study|Death|17|||
94662239|NCT02348216|324219817|FG000|Overall Study|Full consent withdrawal|0|||
94662240|NCT02348216|324219818|FG001|Overall Study|Full consent withdrawal|0|||
94662241|NCT02348216|324219819|FG002|Overall Study|Full consent withdrawal|0|||
94662242|NCT02348216|324219820|FG003|Overall Study|Full consent withdrawal|1|||
94662243|NCT02348216|324219821|FG004|Overall Study|Full consent withdrawal|3|||
94662244|NCT02348216|324219822|FG005|Overall Study|Full consent withdrawal|0|||
94662245|NCT02348216|324219823|FG006|Overall Study|Full consent withdrawal|3|||
94662246|NCT02348216|324219817|FG000|Overall Study|Lost to Follow-up|0|||
94662247|NCT02348216|324219818|FG001|Overall Study|Lost to Follow-up|5|||
94662248|NCT02348216|324219819|FG002|Overall Study|Lost to Follow-up|2|||
94662249|NCT02348216|324219820|FG003|Overall Study|Lost to Follow-up|0|||
94662250|NCT02348216|324219821|FG004|Overall Study|Lost to Follow-up|1|||
94662251|NCT02348216|324219822|FG005|Overall Study|Lost to Follow-up|1|||
94662252|NCT02348216|324219823|FG006|Overall Study|Lost to Follow-up|1|||
94662253|NCT02348216|324219817|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
94662254|NCT02348216|324219818|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
94662255|NCT02348216|324219819|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
94662256|NCT02348216|324219820|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
94662257|NCT02348216|324219821|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
94662258|NCT02348216|324219822|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
94662259|NCT02348216|324219823|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
94662260|NCT02348216|324219817|FG000|Overall Study|Reason not specified|2|||
94662261|NCT02348216|324219818|FG001|Overall Study|Reason not specified|19|||
94662262|NCT02348216|324219819|FG002|Overall Study|Reason not specified|11|||
94662263|NCT02348216|324219820|FG003|Overall Study|Reason not specified|17|||
94662264|NCT02348216|324219821|FG004|Overall Study|Reason not specified|21|||
94662265|NCT02348216|324219822|FG005|Overall Study|Reason not specified|17|||
94662266|NCT02348216|324219823|FG006|Overall Study|Reason not specified|19|||
94662267|NCT02647658|324219824|FG000|Overall Study|Consent refusal|15|||
94662268|NCT02647658|324219825|FG001|Overall Study|Consent refusal|24|||
94662269|NCT01055639|324219826|FG000|Overall Study|Adverse Event|0|||
94662270|NCT01055639|324219827|FG001|Overall Study|Adverse Event|1|||
94662271|NCT01055639|324219826|FG000|Overall Study|Lack of Efficacy|0|||
94253382|NCT02641496|322720866|FG001|Overall Study|Withdrawal by Subject|0|||
94253383|NCT01204398|322720867|FG000|Overall Study|Adverse Event|1|||
94253384|NCT00585195|322720870|FG000|Overall Study|Adverse Event|0|||
94253385|NCT00585195|322720871|FG001|Overall Study|Adverse Event|0|||
94253386|NCT00585195|322720872|FG002|Overall Study|Adverse Event|0|||
94253387|NCT00585195|322720873|FG003|Overall Study|Adverse Event|0|||
94253388|NCT00585195|322720874|FG004|Overall Study|Adverse Event|2|||
94253389|NCT00585195|322720875|FG005|Overall Study|Adverse Event|1|||
94253390|NCT00585195|322720876|FG006|Overall Study|Adverse Event|0|||
94253391|NCT00585195|322720877|FG007|Overall Study|Adverse Event|1|||
94253392|NCT00585195|322720878|FG008|Overall Study|Adverse Event|0|||
94253393|NCT00585195|322720879|FG009|Overall Study|Adverse Event|0|||
94253394|NCT00585195|322720880|FG010|Overall Study|Adverse Event|3|||
94253395|NCT00585195|322720881|FG011|Overall Study|Adverse Event|0|||
94611011|NCT00785928|324040544|FG001|Treatment Phase|Adverse Event|1|||
94611012|NCT00785928|324040545|FG002|Treatment Phase|Adverse Event|2|||
94611013|NCT00785928|324040546|FG003|Treatment Phase|Adverse Event|0|||
94611014|NCT00785928|324040547|FG004|Treatment Phase|Adverse Event|0|||
94611015|NCT00785928|324040548|FG005|Treatment Phase|Adverse Event|0|||
94611016|NCT00785928|324040549|FG006|Treatment Phase|Adverse Event|2|||
94611017|NCT00785928|324040543|FG000|Treatment Phase|Inadequate Response|0|||
94611018|NCT00785928|324040544|FG001|Treatment Phase|Inadequate Response|1|||
94611019|NCT00785928|324040545|FG002|Treatment Phase|Inadequate Response|0|||
94611020|NCT00785928|324040546|FG003|Treatment Phase|Inadequate Response|0|||
94611021|NCT00785928|324040547|FG004|Treatment Phase|Inadequate Response|0|||
94611022|NCT00785928|324040548|FG005|Treatment Phase|Inadequate Response|0|||
94611023|NCT00785928|324040549|FG006|Treatment Phase|Inadequate Response|0|||
94611024|NCT00785928|324040543|FG000|Treatment Phase|Lack of Efficacy|0|||
94611025|NCT00785928|324040544|FG001|Treatment Phase|Lack of Efficacy|1|||
94611026|NCT00785928|324040545|FG002|Treatment Phase|Lack of Efficacy|1|||
94611027|NCT00785928|324040546|FG003|Treatment Phase|Lack of Efficacy|0|||
94611028|NCT00785928|324040547|FG004|Treatment Phase|Lack of Efficacy|0|||
94611029|NCT00785928|324040548|FG005|Treatment Phase|Lack of Efficacy|0|||
94611030|NCT00785928|324040549|FG006|Treatment Phase|Lack of Efficacy|0|||
94611031|NCT00785928|324040543|FG000|Treatment Phase|Physician Decision|0|||
94611032|NCT00785928|324040544|FG001|Treatment Phase|Physician Decision|0|||
94611033|NCT00785928|324040545|FG002|Treatment Phase|Physician Decision|0|||
94611034|NCT00785928|324040546|FG003|Treatment Phase|Physician Decision|0|||
94611035|NCT00785928|324040547|FG004|Treatment Phase|Physician Decision|1|||
94611036|NCT00785928|324040548|FG005|Treatment Phase|Physician Decision|0|||
94611037|NCT00785928|324040549|FG006|Treatment Phase|Physician Decision|0|||
94611038|NCT00785928|324040543|FG000|Treatment Phase|Sponsor Decision|1|||
94611039|NCT00785928|324040544|FG001|Treatment Phase|Sponsor Decision|0|||
94611040|NCT00785928|324040545|FG002|Treatment Phase|Sponsor Decision|0|||
94611041|NCT00785928|324040546|FG003|Treatment Phase|Sponsor Decision|0|||
94611042|NCT00785928|324040547|FG004|Treatment Phase|Sponsor Decision|0|||
94611043|NCT00785928|324040548|FG005|Treatment Phase|Sponsor Decision|0|||
94611044|NCT00785928|324040549|FG006|Treatment Phase|Sponsor Decision|1|||
94611045|NCT00785928|324040543|FG000|Treatment Phase|Withdrawal by Subject|1|||
94611046|NCT00785928|324040544|FG001|Treatment Phase|Withdrawal by Subject|2|||
94611047|NCT00785928|324040545|FG002|Treatment Phase|Withdrawal by Subject|0|||
94611048|NCT00785928|324040546|FG003|Treatment Phase|Withdrawal by Subject|0|||
94611049|NCT00785928|324040547|FG004|Treatment Phase|Withdrawal by Subject|1|||
94611050|NCT00785928|324040548|FG005|Treatment Phase|Withdrawal by Subject|0|||
94611051|NCT00785928|324040549|FG006|Treatment Phase|Withdrawal by Subject|0|||
94611052|NCT04587271|324040555|FG000|Overall Study|Lost to Follow-up|2|||
94611053|NCT04587271|324040556|FG001|Overall Study|Lost to Follow-up|2|||
94611054|NCT04587271|324040557|FG002|Overall Study|Lost to Follow-up|0|||
94611055|NCT04587271|324040558|FG003|Overall Study|Lost to Follow-up|2|||
94611056|NCT04587271|324040559|FG004|Overall Study|Lost to Follow-up|2|||
94611057|NCT04587271|324040560|FG005|Overall Study|Lost to Follow-up|0|||
94611058|NCT04587271|324040555|FG000|Overall Study|Caregiver brought child to visits|0|||
94253396|NCT00585195|322720882|FG012|Overall Study|Adverse Event|8|||
94253397|NCT00585195|322720883|FG013|Overall Study|Adverse Event|6|||
94253398|NCT00585195|322720884|FG014|Overall Study|Adverse Event|4|||
94253399|NCT00585195|322720885|FG015|Overall Study|Adverse Event|1|||
94253400|NCT00585195|322720886|FG016|Overall Study|Adverse Event|14|||
94253401|NCT00585195|322720887|FG017|Overall Study|Adverse Event|9|||
94358354|NCT05299359|323094444|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
94611059|NCT04587271|324040556|FG001|Overall Study|Caregiver brought child to visits|0|||
94611060|NCT04587271|324040557|FG002|Overall Study|Caregiver brought child to visits|0|||
94611061|NCT04587271|324040558|FG003|Overall Study|Caregiver brought child to visits|1|||
94611062|NCT04587271|324040559|FG004|Overall Study|Caregiver brought child to visits|0|||
94611063|NCT04587271|324040560|FG005|Overall Study|Caregiver brought child to visits|0|||
94611064|NCT05246397|324040563|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
94611065|NCT00902668|324040564|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
94611066|NCT05021081|324040565|FG000|Phase 2|Subject enrolled in error|1|||
94611067|NCT05021081|324040566|FG001|Phase 2|Subject enrolled in error|1|||
94253402|NCT00585195|322720888|FG018|Overall Study|Adverse Event|2|||
94611068|NCT05021081|324040567|FG002|Phase 2|Subject enrolled in error|0|||
94611069|NCT02122458|324040568|FG000|Overall Study|Withdrawal by Subject|0|||
94611070|NCT02122458|324040569|FG001|Overall Study|Withdrawal by Subject|0|||
94611071|NCT02122458|324040570|FG002|Overall Study|Withdrawal by Subject|0|||
94611072|NCT02122458|324040571|FG003|Overall Study|Withdrawal by Subject|4|||
94611073|NCT02122458|324040572|FG004|Overall Study|Withdrawal by Subject|4|||
94611074|NCT02122458|324040573|FG005|Overall Study|Withdrawal by Subject|4|||
94611075|NCT02122458|324040574|FG006|Overall Study|Withdrawal by Subject|0|||
94611076|NCT02122458|324040568|FG000|Overall Study|Lost to Follow-up|1|||
94611077|NCT02122458|324040569|FG001|Overall Study|Lost to Follow-up|3|||
94611078|NCT02122458|324040570|FG002|Overall Study|Lost to Follow-up|0|||
94611079|NCT02122458|324040571|FG003|Overall Study|Lost to Follow-up|7|||
94611080|NCT02122458|324040572|FG004|Overall Study|Lost to Follow-up|5|||
94611081|NCT02122458|324040573|FG005|Overall Study|Lost to Follow-up|15|||
94611082|NCT02122458|324040574|FG006|Overall Study|Lost to Follow-up|1|||
94611083|NCT02122458|324040568|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
94611084|NCT02122458|324040569|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
94611085|NCT02122458|324040570|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
94611086|NCT02122458|324040571|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
94611087|NCT02122458|324040572|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
94611088|NCT02122458|324040573|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
94611089|NCT02122458|324040574|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
94253403|NCT00585195|322720889|FG019|Overall Study|Adverse Event|3|||
94253404|NCT00585195|322720890|FG020|Overall Study|Adverse Event|1|||
94253405|NCT00585195|322720870|FG000|Overall Study|Progressive Disease|2|||
94253406|NCT00585195|322720871|FG001|Overall Study|Progressive Disease|2|||
94253407|NCT00585195|322720872|FG002|Overall Study|Progressive Disease|5|||
94611090|NCT02122458|324040568|FG000|Overall Study|Adverse Event|1|||
94611091|NCT02122458|324040569|FG001|Overall Study|Adverse Event|0|||
94611092|NCT02122458|324040570|FG002|Overall Study|Adverse Event|0|||
94611093|NCT02122458|324040571|FG003|Overall Study|Adverse Event|0|||
94611094|NCT02122458|324040572|FG004|Overall Study|Adverse Event|0|||
94611095|NCT02122458|324040573|FG005|Overall Study|Adverse Event|0|||
94611096|NCT02122458|324040574|FG006|Overall Study|Adverse Event|0|||
94611097|NCT02122458|324040568|FG000|Overall Study|Experimental Error|0|||
94611098|NCT02122458|324040569|FG001|Overall Study|Experimental Error|0|||
94611099|NCT02122458|324040570|FG002|Overall Study|Experimental Error|0|||
94611100|NCT02122458|324040571|FG003|Overall Study|Experimental Error|0|||
94611101|NCT02122458|324040572|FG004|Overall Study|Experimental Error|3|||
94611102|NCT02122458|324040573|FG005|Overall Study|Experimental Error|0|||
94611103|NCT02122458|324040574|FG006|Overall Study|Experimental Error|0|||
94253408|NCT00585195|322720873|FG003|Overall Study|Progressive Disease|4|||
94611104|NCT02122458|324040568|FG000|Overall Study|Deployed or Moved|0|||
94611105|NCT02122458|324040569|FG001|Overall Study|Deployed or Moved|0|||
94611106|NCT02122458|324040570|FG002|Overall Study|Deployed or Moved|0|||
94611107|NCT02122458|324040571|FG003|Overall Study|Deployed or Moved|0|||
94611108|NCT02122458|324040572|FG004|Overall Study|Deployed or Moved|1|||
94611109|NCT02122458|324040573|FG005|Overall Study|Deployed or Moved|0|||
94662272|NCT01055639|324219827|FG001|Overall Study|Lack of Efficacy|1|||
94662273|NCT01055639|324219826|FG000|Overall Study|Lost to Follow-up|8|||
94662274|NCT01055639|324219827|FG001|Overall Study|Lost to Follow-up|11|||
94662275|NCT01055639|324219826|FG000|Overall Study|Protocol Violation|5|||
94662276|NCT01055639|324219827|FG001|Overall Study|Protocol Violation|5|||
94662277|NCT01055639|324219826|FG000|Overall Study|Withdrawal by Subject|8|||
94662278|NCT01055639|324219827|FG001|Overall Study|Withdrawal by Subject|11|||
94662279|NCT02460991|324219835|FG000|Overall Study|Withdrawal by Subject|0|||
94662280|NCT02460991|324219836|FG001|Overall Study|Withdrawal by Subject|2|||
94662281|NCT00856856|324219841|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
94662282|NCT00856856|324219841|FG000|4-year Clinical Follow-up|Missed visit|1|||
94662283|NCT03073603|324219843|FG000|Overall Study|Noncompliance|3|||
94662284|NCT03073603|324219844|FG001|Overall Study|Noncompliance|1|||
94662285|NCT03073603|324219843|FG000|Overall Study|Adverse Event|5|||
94662286|NCT03073603|324219844|FG001|Overall Study|Adverse Event|3|||
94662287|NCT03073603|324219843|FG000|Overall Study|Physician Decision|1|||
94662288|NCT03073603|324219844|FG001|Overall Study|Physician Decision|2|||
94662289|NCT03073603|324219843|FG000|Overall Study|Required treatment not allowed by protocol|1|||
94662290|NCT03073603|324219844|FG001|Overall Study|Required treatment not allowed by protocol|0|||
94662291|NCT03073603|324219843|FG000|Overall Study|Financial or insurance-related|8|||
94662292|NCT03073603|324219844|FG001|Overall Study|Financial or insurance-related|0|||
94662293|NCT03073603|324219843|FG000|Overall Study|Withdrawal by Subject|0|||
94662294|NCT03073603|324219844|FG001|Overall Study|Withdrawal by Subject|1|||
94662295|NCT03073603|324219843|FG000|Overall Study|Discontinued DMT|4|||
94662296|NCT03073603|324219844|FG001|Overall Study|Discontinued DMT|0|||
94662297|NCT03073603|324219843|FG000|Overall Study|Restarted DMT|0|||
94662298|NCT03073603|324219844|FG001|Overall Study|Restarted DMT|1|||
94662299|NCT02473952|324219847|FG000|Overall Study|Adverse Event|2|||
94662300|NCT02473952|324219848|FG001|Overall Study|Adverse Event|2|||
94662301|NCT02473952|324219847|FG000|Overall Study|Withdrawal by Subject|0|||
94662302|NCT02473952|324219848|FG001|Overall Study|Withdrawal by Subject|6|||
94662303|NCT00823719|324219849|FG000|Overall Study|Adverse Event|1|||
94662304|NCT00823719|324219850|FG001|Overall Study|Adverse Event|2|||
94662305|NCT00823719|324219849|FG000|Overall Study|Physician Decision|1|||
94662306|NCT00823719|324219850|FG001|Overall Study|Physician Decision|4|||
94662307|NCT00823719|324219849|FG000|Overall Study|Withdrawal by Subject|0|||
94662308|NCT00823719|324219850|FG001|Overall Study|Withdrawal by Subject|1|||
94662309|NCT00823719|324219849|FG000|Overall Study|Disease Progression|4|||
94662310|NCT00823719|324219850|FG001|Overall Study|Disease Progression|4|||
94662311|NCT02117570|324219853|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
94662312|NCT02117570|324219854|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
94662313|NCT02117570|324219855|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
94662314|NCT02117570|324219853|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
94662315|NCT02117570|324219854|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
94662316|NCT02117570|324219855|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
94662317|NCT02117570|324219853|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
94662318|NCT02117570|324219854|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
94662319|NCT02117570|324219855|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
94662320|NCT02117570|324219853|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
94662321|NCT02117570|324219854|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
94662322|NCT02117570|324219855|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
94358355|NCT05299359|323094443|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
94358356|NCT05299359|323094444|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
94662323|NCT02117570|324219853|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
94662324|NCT02117570|324219854|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
94662325|NCT02117570|324219855|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
94662326|NCT02117570|324219853|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
94662327|NCT02117570|324219854|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
94662328|NCT02117570|324219855|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
94662329|NCT02117570|324219853|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
94662330|NCT02117570|324219854|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
94611110|NCT02122458|324040574|FG006|Overall Study|Deployed or Moved|0|||
94611111|NCT02122458|324040568|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
94611112|NCT02122458|324040569|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
94611113|NCT02122458|324040570|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
94611114|NCT02122458|324040571|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
94611115|NCT02122458|324040572|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
94611116|NCT02122458|324040573|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
94611117|NCT02122458|324040574|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
94611118|NCT02122458|324040568|FG000|Overall Study|Noncompliance|0|||
94611119|NCT02122458|324040569|FG001|Overall Study|Noncompliance|1|||
94611120|NCT02122458|324040570|FG002|Overall Study|Noncompliance|0|||
94611121|NCT02122458|324040571|FG003|Overall Study|Noncompliance|0|||
94611122|NCT02122458|324040572|FG004|Overall Study|Noncompliance|0|||
94611123|NCT02122458|324040573|FG005|Overall Study|Noncompliance|0|||
94611124|NCT02122458|324040574|FG006|Overall Study|Noncompliance|0|||
94611125|NCT00412542|324040575|FG000|Overall Study|Withdrawal by Subject|0|||
94611126|NCT00412542|324040576|FG001|Overall Study|Withdrawal by Subject|2|||
94611127|NCT00412542|324040575|FG000|Overall Study|Not Eligible|0|||
94611128|NCT00412542|324040576|FG001|Overall Study|Not Eligible|1|||
94611129|NCT03161093|324040579|FG000|Overall Study|Protocol Violation|11|||
94611130|NCT03161093|324040580|FG001|Overall Study|Protocol Violation|14|||
94611131|NCT03161093|324040581|FG002|Overall Study|Protocol Violation|6|||
94611132|NCT03161093|324040582|FG003|Overall Study|Protocol Violation|13|||
94611133|NCT03161093|324040583|FG004|Overall Study|Protocol Violation|1|||
94611134|NCT03161093|324040584|FG005|Overall Study|Protocol Violation|0|||
94611135|NCT03161093|324040579|FG000|Overall Study|Adverse Event|5|||
94611136|NCT03161093|324040580|FG001|Overall Study|Adverse Event|21|||
94611137|NCT03161093|324040581|FG002|Overall Study|Adverse Event|16|||
94611138|NCT03161093|324040582|FG003|Overall Study|Adverse Event|35|||
94611139|NCT03161093|324040583|FG004|Overall Study|Adverse Event|2|||
94611140|NCT03161093|324040584|FG005|Overall Study|Adverse Event|1|||
94611141|NCT03161093|324040579|FG000|Overall Study|Lack of Efficacy|9|||
94611142|NCT03161093|324040580|FG001|Overall Study|Lack of Efficacy|13|||
94611143|NCT03161093|324040581|FG002|Overall Study|Lack of Efficacy|9|||
94611144|NCT03161093|324040582|FG003|Overall Study|Lack of Efficacy|24|||
94611145|NCT03161093|324040583|FG004|Overall Study|Lack of Efficacy|4|||
94611146|NCT03161093|324040584|FG005|Overall Study|Lack of Efficacy|1|||
94611147|NCT03161093|324040579|FG000|Overall Study|Physician Decision|0|||
94611148|NCT03161093|324040580|FG001|Overall Study|Physician Decision|1|||
94611149|NCT03161093|324040581|FG002|Overall Study|Physician Decision|0|||
94611150|NCT03161093|324040582|FG003|Overall Study|Physician Decision|2|||
94611151|NCT03161093|324040583|FG004|Overall Study|Physician Decision|17|||
94611152|NCT03161093|324040584|FG005|Overall Study|Physician Decision|15|||
94611153|NCT03161093|324040579|FG000|Overall Study|Withdrawal by Subject|24|||
94611154|NCT03161093|324040580|FG001|Overall Study|Withdrawal by Subject|73|||
94611155|NCT03161093|324040581|FG002|Overall Study|Withdrawal by Subject|44|||
94611156|NCT03161093|324040582|FG003|Overall Study|Withdrawal by Subject|97|||
94611157|NCT03161093|324040583|FG004|Overall Study|Withdrawal by Subject|11|||
94611158|NCT03161093|324040584|FG005|Overall Study|Withdrawal by Subject|10|||
94611159|NCT03161093|324040579|FG000|Overall Study|Lost to Follow-up|3|||
94611160|NCT03161093|324040580|FG001|Overall Study|Lost to Follow-up|12|||
94611161|NCT03161093|324040581|FG002|Overall Study|Lost to Follow-up|4|||
94611162|NCT03161093|324040582|FG003|Overall Study|Lost to Follow-up|7|||
94611163|NCT03161093|324040583|FG004|Overall Study|Lost to Follow-up|8|||
94611164|NCT03161093|324040584|FG005|Overall Study|Lost to Follow-up|13|||
94611165|NCT03161093|324040579|FG000|Overall Study|Death|3|||
94611166|NCT03161093|324040580|FG001|Overall Study|Death|9|||
94611167|NCT03161093|324040581|FG002|Overall Study|Death|7|||
94253409|NCT00585195|322720874|FG004|Overall Study|Progressive Disease|6|||
94253410|NCT00585195|322720875|FG005|Overall Study|Progressive Disease|4|||
94253411|NCT00585195|322720876|FG006|Overall Study|Progressive Disease|6|||
94611168|NCT03161093|324040582|FG003|Overall Study|Death|9|||
94611169|NCT03161093|324040583|FG004|Overall Study|Death|0|||
94611170|NCT03161093|324040584|FG005|Overall Study|Death|0|||
94611171|NCT03161093|324040579|FG000|Overall Study|Unknown - Not reported|0|||
94611172|NCT03161093|324040580|FG001|Overall Study|Unknown - Not reported|1|||
94611173|NCT03161093|324040581|FG002|Overall Study|Unknown - Not reported|0|||
94611174|NCT03161093|324040582|FG003|Overall Study|Unknown - Not reported|0|||
94611175|NCT03161093|324040583|FG004|Overall Study|Unknown - Not reported|0|||
94611176|NCT03161093|324040584|FG005|Overall Study|Unknown - Not reported|1|||
94611177|NCT02787551|324040585|FG000|Core Period: 26 Weeks|Adverse Event|10|||
94611178|NCT02787551|324040586|FG001|Core Period: 26 Weeks|Adverse Event|0|||
94611179|NCT02787551|324040585|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
94611180|NCT02787551|324040586|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
94611181|NCT02787551|324040585|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
94611182|NCT02787551|324040586|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
94611183|NCT02787551|324040585|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
94611184|NCT02787551|324040586|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
94662331|NCT02117570|324219855|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
94662332|NCT00922428|324219858|FG000|Overall Study|retrospective/extremely implausible data|2|||
94662333|NCT00922428|324219858|FG000|Overall Study|no medication use or questionable use|13|||
94662334|NCT03701555|324219860|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
94662335|NCT03701555|324219861|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
94662336|NCT03701555|324219862|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
94662337|NCT03701555|324219863|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
94662338|NCT03701555|324219864|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
94662339|NCT03701555|324219865|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
94662340|NCT03701555|324219866|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
94662341|NCT03701555|324219867|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
94253412|NCT00585195|322720877|FG007|Overall Study|Progressive Disease|3|||
94253413|NCT00585195|322720878|FG008|Overall Study|Progressive Disease|0|||
94253414|NCT00585195|322720879|FG009|Overall Study|Progressive Disease|5|||
94662342|NCT03701555|324219868|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
94662343|NCT03701555|324219869|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
94662344|NCT03701555|324219870|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
94662345|NCT03701555|324219871|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
94662346|NCT03701555|324219872|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
94662347|NCT03701555|324219873|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
94662348|NCT03701555|324219874|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
94662349|NCT03701555|324219875|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
94662350|NCT03701555|324219876|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
94662351|NCT03701555|324219877|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
94662352|NCT03701555|324219878|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
94662353|NCT03701555|324219879|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
94662354|NCT03701555|324219880|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
94662355|NCT03701555|324219881|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
94253415|NCT00585195|322720880|FG010|Overall Study|Progressive Disease|2|||
94253416|NCT00585195|322720881|FG011|Overall Study|Progressive Disease|25|||
94662356|NCT03701555|324219882|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
94662357|NCT03701555|324219883|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
94662358|NCT03701555|324219884|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
94662359|NCT03701555|324219885|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
94662360|NCT03701555|324219886|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
94662361|NCT03701555|324219887|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
94611185|NCT02787551|324040585|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
94611186|NCT02787551|324040586|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
94611187|NCT02787551|324040585|FG000|Core Period: 26 Weeks|Other than specified|3|||
94611188|NCT02787551|324040586|FG001|Core Period: 26 Weeks|Other than specified|1|||
94611189|NCT02787551|324040585|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
94611190|NCT02787551|324040586|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
94611191|NCT02787551|324040585|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
94611192|NCT02787551|324040586|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
94611193|NCT02787551|324040585|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
94611194|NCT02787551|324040586|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
94611195|NCT04093414|324040588|FG000|3 Month Follow up|Physician Decision|0|||
94611196|NCT04093414|324040589|FG001|3 Month Follow up|Physician Decision|1|||
94611197|NCT04093414|324040588|FG000|6month Follow up|Physician Decision|1|||
94611198|NCT04093414|324040589|FG001|6month Follow up|Physician Decision|3|||
94611199|NCT00464269|324040590|FG000|Overall Study|Lack of Efficacy|1|||
94611200|NCT00464269|324040591|FG001|Overall Study|Lack of Efficacy|0|||
94611201|NCT00464269|324040592|FG002|Overall Study|Lack of Efficacy|0|||
94611202|NCT00464269|324040593|FG003|Overall Study|Lack of Efficacy|0|||
94611203|NCT00464269|324040590|FG000|Overall Study|Lost to Follow-up|0|||
94611204|NCT00464269|324040591|FG001|Overall Study|Lost to Follow-up|4|||
94611205|NCT00464269|324040592|FG002|Overall Study|Lost to Follow-up|0|||
94611206|NCT00464269|324040593|FG003|Overall Study|Lost to Follow-up|1|||
94611207|NCT00464269|324040590|FG000|Overall Study|Withdrawal by Subject|0|||
94611208|NCT00464269|324040591|FG001|Overall Study|Withdrawal by Subject|2|||
94611209|NCT00464269|324040592|FG002|Overall Study|Withdrawal by Subject|1|||
94611210|NCT00464269|324040593|FG003|Overall Study|Withdrawal by Subject|1|||
94611211|NCT00464269|324040590|FG000|Overall Study|Other reason|3|||
94611212|NCT00464269|324040591|FG001|Overall Study|Other reason|3|||
94611213|NCT00464269|324040592|FG002|Overall Study|Other reason|1|||
94611214|NCT00464269|324040593|FG003|Overall Study|Other reason|1|||
94611215|NCT00464269|324040590|FG000|Overall Study|AE, serious fatal|0|||
94611216|NCT00464269|324040591|FG001|Overall Study|AE, serious fatal|0|||
94611217|NCT00464269|324040592|FG002|Overall Study|AE, serious fatal|1|||
94611218|NCT00464269|324040593|FG003|Overall Study|AE, serious fatal|1|||
94611219|NCT00464269|324040590|FG000|Overall Study|SAE, non-fatal|0|||
94611220|NCT00464269|324040591|FG001|Overall Study|SAE, non-fatal|0|||
94611221|NCT00464269|324040592|FG002|Overall Study|SAE, non-fatal|0|||
94611222|NCT00464269|324040593|FG003|Overall Study|SAE, non-fatal|1|||
94611223|NCT00464269|324040590|FG000|Overall Study|AE, non-serious non-fatal|2|||
94611224|NCT00464269|324040591|FG001|Overall Study|AE, non-serious non-fatal|8|||
94611225|NCT00464269|324040592|FG002|Overall Study|AE, non-serious non-fatal|3|||
94611226|NCT00464269|324040593|FG003|Overall Study|AE, non-serious non-fatal|4|||
94611227|NCT00464269|324040590|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
94611228|NCT00464269|324040591|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
94611229|NCT00464269|324040592|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
94611230|NCT00464269|324040593|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
94611231|NCT01032174|324040598|FG000|Overall Study|Adverse Event|0|||
94611232|NCT01032174|324040599|FG001|Overall Study|Adverse Event|1|||
94611233|NCT01811225|324040602|FG000|Treatment Period 1|Adverse Event|2|||
94611234|NCT01811225|324040603|FG001|Treatment Period 1|Adverse Event|3|||
94611235|NCT01811225|324040602|FG000|Treatment Period 1|Lost to Follow-up|12|||
94611236|NCT01811225|324040603|FG001|Treatment Period 1|Lost to Follow-up|8|||
94611237|NCT01811225|324040602|FG000|Treatment Period 1|transporation|1|||
94611238|NCT01811225|324040603|FG001|Treatment Period 1|transporation|0|||
94611239|NCT01811225|324040602|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
94611240|NCT01811225|324040603|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
94611241|NCT01811225|324040602|FG000|Treatment Period 2|Lost to Follow-up|1|||
94611242|NCT01811225|324040603|FG001|Treatment Period 2|Lost to Follow-up|2|||
94611243|NCT01811225|324040602|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
94611244|NCT01811225|324040603|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
94611245|NCT00968864|324040604|FG000|Overall Study|Protocol exception/ not evaluable|1|||
94611246|NCT01967173|324040605|FG000|Overall Study|Lost to Follow-up|5|||
94611247|NCT01967173|324040606|FG001|Overall Study|Lost to Follow-up|3|||
94611248|NCT01967173|324040607|FG002|Overall Study|Lost to Follow-up|2|||
94611249|NCT01967173|324040608|FG003|Overall Study|Lost to Follow-up|4|||
94611250|NCT01967173|324040609|FG004|Overall Study|Lost to Follow-up|8|||
94611251|NCT01967173|324040610|FG005|Overall Study|Lost to Follow-up|12|||
94611252|NCT01967173|324040611|FG006|Overall Study|Lost to Follow-up|6|||
94611253|NCT01967173|324040612|FG007|Overall Study|Lost to Follow-up|8|||
94611254|NCT01967173|324040605|FG000|Overall Study|Physician Decision|2|||
94611255|NCT01967173|324040606|FG001|Overall Study|Physician Decision|0|||
94611256|NCT01967173|324040607|FG002|Overall Study|Physician Decision|2|||
94611257|NCT01967173|324040608|FG003|Overall Study|Physician Decision|1|||
94611258|NCT01967173|324040609|FG004|Overall Study|Physician Decision|1|||
94611259|NCT01967173|324040610|FG005|Overall Study|Physician Decision|1|||
94611260|NCT01967173|324040611|FG006|Overall Study|Physician Decision|1|||
94611261|NCT01967173|324040612|FG007|Overall Study|Physician Decision|0|||
94611262|NCT01967173|324040605|FG000|Overall Study|Lack of Efficacy|2|||
94611263|NCT01967173|324040606|FG001|Overall Study|Lack of Efficacy|0|||
94611264|NCT01967173|324040607|FG002|Overall Study|Lack of Efficacy|2|||
94611265|NCT01967173|324040608|FG003|Overall Study|Lack of Efficacy|2|||
94611266|NCT01967173|324040609|FG004|Overall Study|Lack of Efficacy|0|||
94611267|NCT01967173|324040610|FG005|Overall Study|Lack of Efficacy|1|||
94611268|NCT01967173|324040611|FG006|Overall Study|Lack of Efficacy|0|||
94611269|NCT01967173|324040612|FG007|Overall Study|Lack of Efficacy|2|||
94611270|NCT01967173|324040605|FG000|Overall Study|Pregnancy|0|||
94611271|NCT01967173|324040606|FG001|Overall Study|Pregnancy|0|||
94611272|NCT01967173|324040607|FG002|Overall Study|Pregnancy|0|||
94611273|NCT01967173|324040608|FG003|Overall Study|Pregnancy|0|||
94611274|NCT01967173|324040609|FG004|Overall Study|Pregnancy|0|||
94611275|NCT01967173|324040610|FG005|Overall Study|Pregnancy|0|||
94611276|NCT01967173|324040611|FG006|Overall Study|Pregnancy|1|||
94611277|NCT01967173|324040612|FG007|Overall Study|Pregnancy|1|||
94611278|NCT01967173|324040605|FG000|Overall Study|Adverse Event|0|||
94611279|NCT01967173|324040606|FG001|Overall Study|Adverse Event|0|||
94611280|NCT01967173|324040607|FG002|Overall Study|Adverse Event|0|||
94611281|NCT01967173|324040608|FG003|Overall Study|Adverse Event|0|||
94611282|NCT01967173|324040609|FG004|Overall Study|Adverse Event|0|||
94611283|NCT01967173|324040610|FG005|Overall Study|Adverse Event|0|||
94611284|NCT01967173|324040611|FG006|Overall Study|Adverse Event|0|||
94611285|NCT01967173|324040612|FG007|Overall Study|Adverse Event|1|||
94611286|NCT01967173|324040605|FG000|Overall Study|Withdrawal by Subject|15|||
94611287|NCT01967173|324040606|FG001|Overall Study|Withdrawal by Subject|14|||
94611288|NCT01967173|324040607|FG002|Overall Study|Withdrawal by Subject|10|||
94611289|NCT01967173|324040608|FG003|Overall Study|Withdrawal by Subject|7|||
94611290|NCT01967173|324040609|FG004|Overall Study|Withdrawal by Subject|8|||
94611291|NCT01967173|324040610|FG005|Overall Study|Withdrawal by Subject|9|||
94611292|NCT01967173|324040611|FG006|Overall Study|Withdrawal by Subject|10|||
94611293|NCT01967173|324040612|FG007|Overall Study|Withdrawal by Subject|12|||
94611294|NCT00423514|324040613|FG000|Overall Study|Ineligible|1|||
94611295|NCT00423514|324040614|FG001|Overall Study|Ineligible|0|||
94611296|NCT00484094|324040615|FG000|Overall Study|Discontinued|39|||
94611297|NCT00484094|324040615|FG000|Overall Study|Other|3|||
94611298|NCT00590135|324040619|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
94611299|NCT02906332|324040628|FG000|Overall Study|Withdrawal by Subject|1|||
94611300|NCT02949700|324040629|FG000|Phase I|Withdrawal by Subject|1|||
94611301|NCT02949700|324040630|FG001|Phase I|Withdrawal by Subject|1|||
94611302|NCT02949700|324040631|FG002|Phase I|Withdrawal by Subject|0|||
94611303|NCT02949700|324040632|FG003|Phase I|Withdrawal by Subject|0|||
94611304|NCT02949700|324040629|FG000|Phase I|Protocol Violation|1|||
94611305|NCT02949700|324040630|FG001|Phase I|Protocol Violation|0|||
94611306|NCT02949700|324040631|FG002|Phase I|Protocol Violation|0|||
94611307|NCT02949700|324040632|FG003|Phase I|Protocol Violation|0|||
94611308|NCT02949700|324040629|FG000|Phase II|Withdrawal by Subject|0|||
94611309|NCT02949700|324040630|FG001|Phase II|Withdrawal by Subject|0|||
94611310|NCT02949700|324040631|FG002|Phase II|Withdrawal by Subject|0|||
94611311|NCT02949700|324040632|FG003|Phase II|Withdrawal by Subject|2|||
94611312|NCT02949700|324040629|FG000|Phase II|Protocol Violation|0|||
94611313|NCT02949700|324040630|FG001|Phase II|Protocol Violation|0|||
94611314|NCT02949700|324040631|FG002|Phase II|Protocol Violation|1|||
94611315|NCT02949700|324040632|FG003|Phase II|Protocol Violation|3|||
94611316|NCT00913380|324040633|FG000|Clinical Outcomes|Lost to Follow-up|6|||
94611317|NCT00913380|324040634|FG001|Clinical Outcomes|Lost to Follow-up|6|||
94611318|NCT02187744|324040635|FG000|Study|Participant refused further follow-up|1|||
94611319|NCT02187744|324040636|FG001|Study|Participant refused further follow-up|0|||
94611320|NCT02187744|324040635|FG000|Study|Other|2|||
94611321|NCT02187744|324040636|FG001|Study|Other|1|||
94611322|NCT02187744|324040635|FG000|Study|Lost to Follow-up|0|||
94611323|NCT02187744|324040636|FG001|Study|Lost to Follow-up|2|||
94611324|NCT02187744|324040635|FG000|Study|Related adverse event, not serious|0|||
94611325|NCT02187744|324040636|FG001|Study|Related adverse event, not serious|2|||
94611326|NCT02187744|324040635|FG000|Study|Death|1|||
94611327|NCT02187744|324040636|FG001|Study|Death|0|||
94611328|NCT02187744|324040635|FG000|Study|Related adverse event, serious non-fatal|0|||
94611329|NCT02187744|324040636|FG001|Study|Related adverse event, serious non-fatal|1|||
94611330|NCT02187744|324040635|FG000|Treatment|Death|1|||
94611331|NCT02187744|324040636|FG001|Treatment|Death|0|||
94611332|NCT02187744|324040635|FG000|Treatment|Related adverse event, serious non-fatal|0|||
94611333|NCT02187744|324040636|FG001|Treatment|Related adverse event, serious non-fatal|1|||
94611334|NCT02187744|324040635|FG000|Treatment|Related adverse event, not serious|0|||
94611335|NCT02187744|324040636|FG001|Treatment|Related adverse event, not serious|2|||
94611336|NCT02187744|324040635|FG000|Treatment|Lost to Follow-up|0|||
94611337|NCT02187744|324040636|FG001|Treatment|Lost to Follow-up|1|||
94611338|NCT02187744|324040635|FG000|Treatment|Other|2|||
94611339|NCT02187744|324040636|FG001|Treatment|Other|0|||
94611340|NCT02187744|324040635|FG000|Treatment|Participant refused continued treatment|1|||
94611341|NCT02187744|324040636|FG001|Treatment|Participant refused continued treatment|1|||
94611342|NCT00165984|324040637|FG000|Overall Study|Death|15|||
94611343|NCT03331250|324040642|FG000|Overall Study|Withdrawal by Subject|1|||
94611344|NCT04478266|324040643|FG000|Overall Study|Adverse Event|20|||
94611345|NCT04478266|324040644|FG001|Overall Study|Adverse Event|21|||
94611346|NCT04478266|324040643|FG000|Overall Study|Progressive disease|146|||
94611347|NCT04478266|324040644|FG001|Overall Study|Progressive disease|168|||
94611348|NCT04478266|324040643|FG000|Overall Study|Poor compliance to protocol|1|||
94611349|NCT04478266|324040644|FG001|Overall Study|Poor compliance to protocol|0|||
94611350|NCT04478266|324040643|FG000|Overall Study|Withdrawal by Subject|19|||
94611351|NCT04478266|324040644|FG001|Overall Study|Withdrawal by Subject|16|||
94611352|NCT04478266|324040643|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
94611353|NCT04478266|324040644|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
94253417|NCT00585195|322720882|FG012|Overall Study|Progressive Disease|29|||
94253418|NCT00585195|322720883|FG013|Overall Study|Progressive Disease|26|||
94611354|NCT04478266|324040643|FG000|Overall Study|Study terminated by sponsor|33|||
94611355|NCT04478266|324040644|FG001|Overall Study|Study terminated by sponsor|35|||
94611356|NCT04478266|324040643|FG000|Overall Study|Other: unspecified|5|||
94611357|NCT04478266|324040644|FG001|Overall Study|Other: unspecified|7|||
94611358|NCT04478266|324040643|FG000|Overall Study|Randomized but not treated|1|||
94611359|NCT04478266|324040644|FG001|Overall Study|Randomized but not treated|1|||
94611360|NCT00761631|324040645|FG000|Overall Study|Parent/legal guardian request|8|||
94611361|NCT00761631|324040646|FG001|Overall Study|Parent/legal guardian request|3|||
94611362|NCT00761631|324040647|FG002|Overall Study|Parent/legal guardian request|8|||
94611363|NCT00761631|324040648|FG003|Overall Study|Parent/legal guardian request|0|||
94611364|NCT00761631|324040649|FG004|Overall Study|Parent/legal guardian request|5|||
94611365|NCT00761631|324040650|FG005|Overall Study|Parent/legal guardian request|0|||
94611366|NCT00761631|324040645|FG000|Overall Study|Lost to Follow-up|2|||
94611367|NCT00761631|324040646|FG001|Overall Study|Lost to Follow-up|4|||
94611368|NCT00761631|324040647|FG002|Overall Study|Lost to Follow-up|7|||
94611369|NCT00761631|324040648|FG003|Overall Study|Lost to Follow-up|1|||
94611370|NCT00761631|324040649|FG004|Overall Study|Lost to Follow-up|6|||
94611371|NCT00761631|324040650|FG005|Overall Study|Lost to Follow-up|1|||
94611372|NCT00761631|324040645|FG000|Overall Study|Protocol Violation|2|||
94611373|NCT00761631|324040646|FG001|Overall Study|Protocol Violation|0|||
94611374|NCT00761631|324040647|FG002|Overall Study|Protocol Violation|0|||
94611375|NCT00761631|324040648|FG003|Overall Study|Protocol Violation|1|||
94611376|NCT00761631|324040649|FG004|Overall Study|Protocol Violation|5|||
94662362|NCT03701555|324219888|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
94662363|NCT03701555|324219889|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
94662364|NCT03701555|324219890|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
94611377|NCT00761631|324040650|FG005|Overall Study|Protocol Violation|1|||
94662365|NCT03701555|324219891|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
94611378|NCT00761631|324040645|FG000|Overall Study|Randomized, not treated|1|||
94611379|NCT00761631|324040646|FG001|Overall Study|Randomized, not treated|0|||
94611380|NCT00761631|324040647|FG002|Overall Study|Randomized, not treated|0|||
94611381|NCT00761631|324040648|FG003|Overall Study|Randomized, not treated|0|||
94611382|NCT00761631|324040649|FG004|Overall Study|Randomized, not treated|0|||
94662366|NCT03701555|324219892|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
94253419|NCT00585195|322720884|FG014|Overall Study|Progressive Disease|21|||
94253420|NCT00585195|322720885|FG015|Overall Study|Progressive Disease|12|||
94253421|NCT00585195|322720886|FG016|Overall Study|Progressive Disease|94|||
94253422|NCT00585195|322720887|FG017|Overall Study|Progressive Disease|42|||
94253423|NCT00585195|322720888|FG018|Overall Study|Progressive Disease|4|||
94253424|NCT00585195|322720889|FG019|Overall Study|Progressive Disease|9|||
94253425|NCT00585195|322720890|FG020|Overall Study|Progressive Disease|8|||
94253426|NCT00585195|322720870|FG000|Overall Study|Withdrawal by Subject|1|||
94253427|NCT00585195|322720871|FG001|Overall Study|Withdrawal by Subject|1|||
94253428|NCT00585195|322720872|FG002|Overall Study|Withdrawal by Subject|2|||
94253429|NCT00585195|322720873|FG003|Overall Study|Withdrawal by Subject|2|||
94253430|NCT00585195|322720874|FG004|Overall Study|Withdrawal by Subject|0|||
94253431|NCT00585195|322720875|FG005|Overall Study|Withdrawal by Subject|0|||
94253432|NCT00585195|322720876|FG006|Overall Study|Withdrawal by Subject|0|||
94253433|NCT00585195|322720877|FG007|Overall Study|Withdrawal by Subject|1|||
94253434|NCT00585195|322720878|FG008|Overall Study|Withdrawal by Subject|0|||
94253435|NCT00585195|322720879|FG009|Overall Study|Withdrawal by Subject|0|||
94253436|NCT00585195|322720880|FG010|Overall Study|Withdrawal by Subject|3|||
94253437|NCT00585195|322720881|FG011|Overall Study|Withdrawal by Subject|8|||
94253438|NCT00585195|322720882|FG012|Overall Study|Withdrawal by Subject|15|||
94253439|NCT00585195|322720883|FG013|Overall Study|Withdrawal by Subject|0|||
94253440|NCT00585195|322720884|FG014|Overall Study|Withdrawal by Subject|3|||
94253441|NCT00585195|322720885|FG015|Overall Study|Withdrawal by Subject|0|||
94253442|NCT00585195|322720886|FG016|Overall Study|Withdrawal by Subject|7|||
94253443|NCT00585195|322720887|FG017|Overall Study|Withdrawal by Subject|1|||
94253444|NCT00585195|322720888|FG018|Overall Study|Withdrawal by Subject|2|||
94253445|NCT00585195|322720889|FG019|Overall Study|Withdrawal by Subject|2|||
94253446|NCT00585195|322720890|FG020|Overall Study|Withdrawal by Subject|0|||
94253447|NCT00585195|322720870|FG000|Overall Study|Other|0|||
94253448|NCT00585195|322720871|FG001|Overall Study|Other|1|||
94253449|NCT00585195|322720872|FG002|Overall Study|Other|1|||
94253450|NCT00585195|322720873|FG003|Overall Study|Other|1|||
94253451|NCT00585195|322720874|FG004|Overall Study|Other|0|||
94253452|NCT00585195|322720875|FG005|Overall Study|Other|1|||
94253453|NCT00585195|322720876|FG006|Overall Study|Other|0|||
94253454|NCT00585195|322720877|FG007|Overall Study|Other|0|||
94253455|NCT00585195|322720878|FG008|Overall Study|Other|2|||
94253456|NCT00585195|322720879|FG009|Overall Study|Other|1|||
94611383|NCT00761631|324040650|FG005|Overall Study|Randomized, not treated|0|||
94611384|NCT00761631|324040645|FG000|Overall Study|Failed to return|1|||
94611385|NCT00761631|324040646|FG001|Overall Study|Failed to return|0|||
94611386|NCT00761631|324040647|FG002|Overall Study|Failed to return|1|||
94611387|NCT00761631|324040648|FG003|Overall Study|Failed to return|1|||
94611388|NCT00761631|324040649|FG004|Overall Study|Failed to return|5|||
94611389|NCT00761631|324040650|FG005|Overall Study|Failed to return|2|||
94611390|NCT00761631|324040645|FG000|Overall Study|Physician Decision|1|||
94611391|NCT00761631|324040646|FG001|Overall Study|Physician Decision|0|||
94611392|NCT00761631|324040647|FG002|Overall Study|Physician Decision|0|||
94611393|NCT00761631|324040648|FG003|Overall Study|Physician Decision|0|||
94611394|NCT00761631|324040649|FG004|Overall Study|Physician Decision|0|||
94611395|NCT00761631|324040650|FG005|Overall Study|Physician Decision|0|||
94611396|NCT00761631|324040645|FG000|Overall Study|Other|0|||
94611397|NCT00761631|324040646|FG001|Overall Study|Other|0|||
94611398|NCT00761631|324040647|FG002|Overall Study|Other|0|||
94611399|NCT00761631|324040648|FG003|Overall Study|Other|0|||
94611400|NCT00761631|324040649|FG004|Overall Study|Other|1|||
94611401|NCT00761631|324040650|FG005|Overall Study|Other|1|||
94611402|NCT00289016|324040653|FG000|Overall Study|Disease Progression|29|||
94611403|NCT00289016|324040653|FG000|Overall Study|Death|2|||
94611404|NCT00289016|324040653|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
94611405|NCT00289016|324040653|FG000|Overall Study|Withdrawal by Subject|2|||
94253457|NCT00585195|322720880|FG010|Overall Study|Other|0|||
94253458|NCT00585195|322720881|FG011|Overall Study|Other|19|||
94253459|NCT00585195|322720882|FG012|Overall Study|Other|24|||
94253460|NCT00585195|322720883|FG013|Overall Study|Other|7|||
94253461|NCT00585195|322720884|FG014|Overall Study|Other|11|||
94253462|NCT00585195|322720885|FG015|Overall Study|Other|3|||
94253463|NCT00585195|322720886|FG016|Overall Study|Other|28|||
94253464|NCT00585195|322720887|FG017|Overall Study|Other|12|||
94253465|NCT00585195|322720888|FG018|Overall Study|Other|10|||
94253466|NCT00585195|322720889|FG019|Overall Study|Other|4|||
94611406|NCT00289016|324040653|FG000|Overall Study|Adverse Event|1|||
94611407|NCT00289016|324040653|FG000|Overall Study|Other|1|||
94611408|NCT01187433|324040654|FG000|Overall Study|Protocol Violation|6|||
94611409|NCT01187433|324040655|FG001|Overall Study|Protocol Violation|2|||
94611410|NCT01187433|324040654|FG000|Overall Study|Withdrawal by Subject|5|||
94611411|NCT01187433|324040655|FG001|Overall Study|Withdrawal by Subject|2|||
94253467|NCT00585195|322720890|FG020|Overall Study|Other|2|||
94253468|NCT00585195|322720870|FG000|Overall Study|Randomized not treated|0|||
94253469|NCT00585195|322720871|FG001|Overall Study|Randomized not treated|0|||
94253470|NCT00585195|322720872|FG002|Overall Study|Randomized not treated|1|||
94253471|NCT00585195|322720873|FG003|Overall Study|Randomized not treated|0|||
94253472|NCT00585195|322720874|FG004|Overall Study|Randomized not treated|1|||
94253473|NCT00585195|322720875|FG005|Overall Study|Randomized not treated|0|||
94253474|NCT00585195|322720876|FG006|Overall Study|Randomized not treated|1|||
94253475|NCT00585195|322720877|FG007|Overall Study|Randomized not treated|0|||
94253476|NCT00585195|322720878|FG008|Overall Study|Randomized not treated|0|||
94253477|NCT00585195|322720879|FG009|Overall Study|Randomized not treated|0|||
94253478|NCT00585195|322720880|FG010|Overall Study|Randomized not treated|2|||
94253479|NCT00585195|322720881|FG011|Overall Study|Randomized not treated|0|||
94253480|NCT00585195|322720882|FG012|Overall Study|Randomized not treated|0|||
94253481|NCT00585195|322720883|FG013|Overall Study|Randomized not treated|0|||
94253482|NCT00585195|322720884|FG014|Overall Study|Randomized not treated|0|||
94253483|NCT00585195|322720885|FG015|Overall Study|Randomized not treated|1|||
94253484|NCT00585195|322720886|FG016|Overall Study|Randomized not treated|0|||
94253485|NCT00585195|322720887|FG017|Overall Study|Randomized not treated|1|||
94253486|NCT00585195|322720888|FG018|Overall Study|Randomized not treated|3|||
94253487|NCT00585195|322720889|FG019|Overall Study|Randomized not treated|0|||
94253488|NCT00585195|322720890|FG020|Overall Study|Randomized not treated|2|||
94253489|NCT00585195|322720870|FG000|Overall Study|Death|0|||
94253490|NCT00585195|322720871|FG001|Overall Study|Death|0|||
94253491|NCT00585195|322720872|FG002|Overall Study|Death|0|||
94253492|NCT00585195|322720873|FG003|Overall Study|Death|0|||
94253493|NCT00585195|322720874|FG004|Overall Study|Death|0|||
94253494|NCT00585195|322720875|FG005|Overall Study|Death|0|||
94253495|NCT00585195|322720876|FG006|Overall Study|Death|0|||
94253496|NCT00585195|322720877|FG007|Overall Study|Death|0|||
94253497|NCT00585195|322720878|FG008|Overall Study|Death|1|||
94253498|NCT00585195|322720879|FG009|Overall Study|Death|0|||
94253499|NCT00585195|322720880|FG010|Overall Study|Death|1|||
94253500|NCT00585195|322720881|FG011|Overall Study|Death|1|||
94253501|NCT00585195|322720882|FG012|Overall Study|Death|7|||
94253502|NCT00585195|322720883|FG013|Overall Study|Death|2|||
94253503|NCT00585195|322720884|FG014|Overall Study|Death|8|||
94611412|NCT01736124|324040656|FG000|Post-intervention Assessment|Death|2|||
94611413|NCT01736124|324040657|FG001|Post-intervention Assessment|Death|2|||
94611414|NCT01736124|324040656|FG000|Post-intervention Assessment|lost computer access|1|||
94611415|NCT01736124|324040657|FG001|Post-intervention Assessment|lost computer access|1|||
94611416|NCT01736124|324040656|FG000|Post-intervention Assessment|Moved away|3|||
94611417|NCT01736124|324040657|FG001|Post-intervention Assessment|Moved away|1|||
94611418|NCT01736124|324040656|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
94611419|NCT01736124|324040657|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
94611420|NCT01736124|324040656|FG000|Post-intervention Assessment|Illness|3|||
94611421|NCT01736124|324040657|FG001|Post-intervention Assessment|Illness|2|||
94611422|NCT01736124|324040656|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
94611423|NCT01736124|324040657|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
94611424|NCT01736124|324040656|FG000|Post-intervention Assessment|Temporarily away|3|||
94611425|NCT01736124|324040657|FG001|Post-intervention Assessment|Temporarily away|1|||
94611426|NCT01736124|324040656|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
94611427|NCT01736124|324040657|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
94611428|NCT01736124|324040656|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
94611429|NCT01736124|324040657|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
94611430|NCT01736124|324040656|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
94611431|NCT01736124|324040657|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
94611432|NCT01736124|324040656|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
94611433|NCT01736124|324040657|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
94611434|NCT01736124|324040656|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
94611435|NCT01736124|324040657|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
94611436|NCT01736124|324040656|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
94611437|NCT01736124|324040657|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
94611438|NCT01736124|324040656|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
94611439|NCT01736124|324040657|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
94611440|NCT01736124|324040656|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
94611441|NCT01736124|324040657|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
94611442|NCT01736124|324040656|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
94253504|NCT00585195|322720885|FG015|Overall Study|Death|2|||
94253505|NCT00585195|322720886|FG016|Overall Study|Death|11|||
94253506|NCT00585195|322720887|FG017|Overall Study|Death|0|||
94253507|NCT00585195|322720888|FG018|Overall Study|Death|0|||
94253508|NCT00585195|322720889|FG019|Overall Study|Death|0|||
94253509|NCT00585195|322720890|FG020|Overall Study|Death|1|||
94611443|NCT01736124|324040657|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
94611444|NCT01790932|324040658|FG000|Overall Study|Disease Progression|41|||
94611445|NCT01790932|324040658|FG000|Overall Study|Adverse Event|7|||
94611446|NCT01790932|324040658|FG000|Overall Study|Physician Decision|1|||
94253510|NCT00585195|322720870|FG000|Overall Study|Lost to Follow-up|0|||
94253511|NCT00585195|322720871|FG001|Overall Study|Lost to Follow-up|0|||
94358357|NCT05299359|323094443|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
94358358|NCT05299359|323094444|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
94358359|NCT05299359|323094443|FG000|Extension Part: Day 1 to Day 366|Other|0|||
94358360|NCT05299359|323094444|FG001|Extension Part: Day 1 to Day 366|Other|1|||
94358361|NCT04359758|323094447|FG000|Overall Study|Protocol Violation|3|||
94611447|NCT01790932|324040658|FG000|Overall Study|Withdrawal by Subject|1|||
94611448|NCT03553927|324040659|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
94611449|NCT03553927|324040660|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
94611450|NCT03553927|324040659|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
94611451|NCT03553927|324040660|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
94611452|NCT04223973|324040661|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
94611453|NCT04223973|324040662|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
94611454|NCT04223973|324040661|FG000|Overall Study|Adverse Event|4|||
94611455|NCT04223973|324040662|FG001|Overall Study|Adverse Event|0|||
94611456|NCT04223973|324040661|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
94611457|NCT04223973|324040662|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
94611458|NCT04223973|324040661|FG000|Overall Study|Physician Decision|1|||
94611459|NCT04223973|324040662|FG001|Overall Study|Physician Decision|1|||
94611460|NCT04223973|324040661|FG000|Overall Study|Withdrawal by Subject|0|||
94611461|NCT04223973|324040662|FG001|Overall Study|Withdrawal by Subject|1|||
94611462|NCT02423772|324040664|FG000|Overall Study|Lost to Follow-up|3|||
94611463|NCT02423772|324040665|FG001|Overall Study|Lost to Follow-up|3|||
94611464|NCT02423772|324040664|FG000|Overall Study|Did not begin intervention|2|||
94611465|NCT02423772|324040665|FG001|Overall Study|Did not begin intervention|5|||
94611466|NCT00678080|324040666|FG000|Overall Study|Physician Decision|2|||
94611467|NCT00678080|324040667|FG001|Overall Study|Physician Decision|0|||
94611468|NCT00678080|324040666|FG000|Overall Study|Lost to Follow-up|1|||
94611469|NCT00678080|324040667|FG001|Overall Study|Lost to Follow-up|0|||
94611470|NCT00678080|324040666|FG000|Overall Study|Withdrawal by Subject|0|||
94611471|NCT00678080|324040667|FG001|Overall Study|Withdrawal by Subject|1|||
94611472|NCT05274165|324040669|FG000|Overall Study|Withdrawal by Subject|3|||
94611473|NCT05274165|324040670|FG001|Overall Study|Withdrawal by Subject|3|||
94611474|NCT04916769|324040671|FG000|Period 1|Physician Decision|0|||
94611475|NCT04916769|324040672|FG001|Period 1|Physician Decision|0|||
94611476|NCT04916769|324040673|FG002|Period 1|Physician Decision|0|||
94611477|NCT04916769|324040674|FG003|Period 1|Physician Decision|0|||
94611478|NCT04916769|324040675|FG004|Period 1|Physician Decision|0|||
94611479|NCT04916769|324040676|FG005|Period 1|Physician Decision|1|||
94611480|NCT04916769|324040671|FG000|Period 2|Physician Decision|0|||
94611481|NCT04916769|324040672|FG001|Period 2|Physician Decision|1|||
94611482|NCT04916769|324040673|FG002|Period 2|Physician Decision|0|||
94611483|NCT04916769|324040674|FG003|Period 2|Physician Decision|0|||
94611484|NCT04916769|324040675|FG004|Period 2|Physician Decision|0|||
94611485|NCT04916769|324040676|FG005|Period 2|Physician Decision|0|||
94611486|NCT02557295|324040689|FG000|Overall Study|Withdrawal by Subject|9|||
94611487|NCT02557295|324040690|FG001|Overall Study|Withdrawal by Subject|2|||
94611488|NCT02557295|324040691|FG002|Overall Study|Withdrawal by Subject|4|||
94611489|NCT02557295|324040692|FG003|Overall Study|Withdrawal by Subject|0|||
94611490|NCT02557295|324040693|FG004|Overall Study|Withdrawal by Subject|0|||
94611491|NCT02557295|324040694|FG005|Overall Study|Withdrawal by Subject|0|||
94611492|NCT02557295|324040695|FG006|Overall Study|Withdrawal by Subject|15|||
94611493|NCT02557295|324040696|FG007|Overall Study|Withdrawal by Subject|1|||
94611494|NCT02557295|324040697|FG008|Overall Study|Withdrawal by Subject|3|||
94611495|NCT02557295|324040689|FG000|Overall Study|Disease Progression|0|||
94611496|NCT02557295|324040690|FG001|Overall Study|Disease Progression|0|||
94611497|NCT02557295|324040691|FG002|Overall Study|Disease Progression|0|||
94611498|NCT02557295|324040692|FG003|Overall Study|Disease Progression|0|||
94611499|NCT02557295|324040693|FG004|Overall Study|Disease Progression|0|||
94611500|NCT02557295|324040694|FG005|Overall Study|Disease Progression|0|||
94611501|NCT02557295|324040695|FG006|Overall Study|Disease Progression|1|||
94611502|NCT02557295|324040696|FG007|Overall Study|Disease Progression|0|||
94611503|NCT02557295|324040697|FG008|Overall Study|Disease Progression|0|||
94611504|NCT02557295|324040689|FG000|Overall Study|Lack of Efficacy|24|||
94611505|NCT02557295|324040690|FG001|Overall Study|Lack of Efficacy|1|||
94611506|NCT02557295|324040691|FG002|Overall Study|Lack of Efficacy|3|||
94611507|NCT02557295|324040692|FG003|Overall Study|Lack of Efficacy|0|||
94611508|NCT02557295|324040693|FG004|Overall Study|Lack of Efficacy|0|||
94611509|NCT02557295|324040694|FG005|Overall Study|Lack of Efficacy|0|||
94611510|NCT02557295|324040695|FG006|Overall Study|Lack of Efficacy|12|||
94611511|NCT02557295|324040696|FG007|Overall Study|Lack of Efficacy|1|||
94611512|NCT02557295|324040697|FG008|Overall Study|Lack of Efficacy|0|||
94611513|NCT02557295|324040689|FG000|Overall Study|Adverse Event|16|||
94611514|NCT02557295|324040690|FG001|Overall Study|Adverse Event|2|||
94611515|NCT02557295|324040691|FG002|Overall Study|Adverse Event|3|||
94611516|NCT02557295|324040692|FG003|Overall Study|Adverse Event|0|||
94611517|NCT02557295|324040693|FG004|Overall Study|Adverse Event|0|||
94611518|NCT02557295|324040694|FG005|Overall Study|Adverse Event|0|||
94611519|NCT02557295|324040695|FG006|Overall Study|Adverse Event|2|||
94611520|NCT02557295|324040696|FG007|Overall Study|Adverse Event|1|||
94611521|NCT02557295|324040697|FG008|Overall Study|Adverse Event|1|||
94611522|NCT02557295|324040689|FG000|Overall Study|Lost to Follow-up|4|||
94611523|NCT02557295|324040690|FG001|Overall Study|Lost to Follow-up|0|||
94611524|NCT02557295|324040691|FG002|Overall Study|Lost to Follow-up|0|||
94611525|NCT02557295|324040692|FG003|Overall Study|Lost to Follow-up|0|||
94611526|NCT02557295|324040693|FG004|Overall Study|Lost to Follow-up|0|||
94611527|NCT02557295|324040694|FG005|Overall Study|Lost to Follow-up|0|||
94611528|NCT02557295|324040695|FG006|Overall Study|Lost to Follow-up|9|||
94611529|NCT02557295|324040696|FG007|Overall Study|Lost to Follow-up|0|||
94611530|NCT02557295|324040697|FG008|Overall Study|Lost to Follow-up|0|||
94611531|NCT02557295|324040689|FG000|Overall Study|Study Close|54|||
94611532|NCT02557295|324040690|FG001|Overall Study|Study Close|3|||
94611533|NCT02557295|324040691|FG002|Overall Study|Study Close|5|||
94611534|NCT02557295|324040692|FG003|Overall Study|Study Close|3|||
94611535|NCT02557295|324040693|FG004|Overall Study|Study Close|0|||
94611536|NCT02557295|324040694|FG005|Overall Study|Study Close|0|||
94611537|NCT02557295|324040695|FG006|Overall Study|Study Close|37|||
94611538|NCT02557295|324040696|FG007|Overall Study|Study Close|3|||
94611539|NCT02557295|324040697|FG008|Overall Study|Study Close|19|||
94611540|NCT02557295|324040689|FG000|Overall Study|except for study close|4|||
94611541|NCT02557295|324040690|FG001|Overall Study|except for study close|0|||
94611542|NCT02557295|324040691|FG002|Overall Study|except for study close|0|||
94611543|NCT02557295|324040692|FG003|Overall Study|except for study close|0|||
94611544|NCT02557295|324040693|FG004|Overall Study|except for study close|0|||
94611545|NCT02557295|324040694|FG005|Overall Study|except for study close|0|||
94611546|NCT02557295|324040695|FG006|Overall Study|except for study close|5|||
94611547|NCT02557295|324040696|FG007|Overall Study|except for study close|1|||
94611548|NCT02557295|324040697|FG008|Overall Study|except for study close|0|||
94611549|NCT03001882|324040699|FG000|Overall Study|Death|1|||
94611550|NCT03001882|324040700|FG001|Overall Study|Death|0|||
94611551|NCT03001882|324040701|FG002|Overall Study|Death|0|||
94611552|NCT03001882|324040702|FG003|Overall Study|Death|3|||
94611553|NCT03001882|324040699|FG000|Overall Study|Participant withdrew consent|0|||
94611554|NCT03001882|324040700|FG001|Overall Study|Participant withdrew consent|1|||
94611555|NCT03001882|324040701|FG002|Overall Study|Participant withdrew consent|0|||
94611556|NCT03001882|324040702|FG003|Overall Study|Participant withdrew consent|5|||
94611557|NCT03001882|324040699|FG000|Overall Study|Other reasons|1|||
94611558|NCT03001882|324040700|FG001|Overall Study|Other reasons|2|||
94611559|NCT03001882|324040701|FG002|Overall Study|Other reasons|0|||
94611560|NCT03001882|324040702|FG003|Overall Study|Other reasons|5|||
94611561|NCT03001882|324040699|FG000|Overall Study|Administrative reason by sponsor|0|||
94611562|NCT03001882|324040700|FG001|Overall Study|Administrative reason by sponsor|0|||
94611563|NCT03001882|324040701|FG002|Overall Study|Administrative reason by sponsor|0|||
94611564|NCT03001882|324040702|FG003|Overall Study|Administrative reason by sponsor|1|||
94611565|NCT03001882|324040699|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
94611566|NCT03001882|324040700|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
94611567|NCT03001882|324040701|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
94611568|NCT03001882|324040702|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
94611569|NCT03001882|324040699|FG000|Overall Study|Not reported|0|||
94611570|NCT03001882|324040700|FG001|Overall Study|Not reported|0|||
94611571|NCT03001882|324040701|FG002|Overall Study|Not reported|0|||
94611572|NCT03001882|324040702|FG003|Overall Study|Not reported|6|||
94611573|NCT03001882|324040699|FG000|Overall Study|Maximum clinical benefit|2|||
94611574|NCT03001882|324040700|FG001|Overall Study|Maximum clinical benefit|3|||
94611575|NCT03001882|324040701|FG002|Overall Study|Maximum clinical benefit|0|||
94611576|NCT03001882|324040702|FG003|Overall Study|Maximum clinical benefit|10|||
94611577|NCT03001882|324040699|FG000|Overall Study|AE unrelated to study drug|3|||
94611578|NCT03001882|324040700|FG001|Overall Study|AE unrelated to study drug|3|||
94611579|NCT03001882|324040701|FG002|Overall Study|AE unrelated to study drug|0|||
94611580|NCT03001882|324040702|FG003|Overall Study|AE unrelated to study drug|11|||
94611581|NCT03001882|324040699|FG000|Overall Study|Study Drug Toxicity|8|||
94611582|NCT03001882|324040700|FG001|Overall Study|Study Drug Toxicity|5|||
94358362|NCT04359758|323094448|FG001|Overall Study|Protocol Violation|2|||
94358363|NCT04626947|323094449|FG000|Overall Study|Study terminated|14|||
94358364|NCT04365387|323094460|FG000|Overall Study|Adverse Event|4|||
94662367|NCT03701555|324219893|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
94662368|NCT03701555|324219894|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
94662369|NCT03701555|324219895|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
94662370|NCT03701555|324219860|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
94662371|NCT03701555|324219861|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
94662372|NCT03701555|324219862|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
94662373|NCT03701555|324219863|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
94662374|NCT03701555|324219864|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
94662375|NCT03701555|324219865|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
94662376|NCT03701555|324219866|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
94662377|NCT03701555|324219867|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
94662378|NCT03701555|324219868|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
94662379|NCT03701555|324219869|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
94662380|NCT03701555|324219870|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
94662381|NCT03701555|324219871|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
94662382|NCT03701555|324219872|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
94662383|NCT03701555|324219873|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
94662384|NCT03701555|324219874|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
94662385|NCT03701555|324219875|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
94662386|NCT03701555|324219876|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
94662387|NCT03701555|324219877|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
94662388|NCT03701555|324219878|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
94662389|NCT03701555|324219879|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
94662390|NCT03701555|324219880|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
94662391|NCT03701555|324219881|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
94662392|NCT03701555|324219882|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
94662393|NCT03701555|324219883|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
94662394|NCT03701555|324219884|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
94662395|NCT03701555|324219885|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
94662396|NCT03701555|324219886|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
94662397|NCT03701555|324219887|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
94662398|NCT03701555|324219888|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
94662399|NCT03701555|324219889|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
94662400|NCT03701555|324219890|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
94662401|NCT03701555|324219891|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
94662402|NCT03701555|324219892|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
94662403|NCT03701555|324219893|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
94662404|NCT03701555|324219894|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
94662405|NCT03701555|324219895|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
94662406|NCT03701555|324219860|FG000|Part 2 (Day 1)|Other|0|||
94662407|NCT03701555|324219861|FG001|Part 2 (Day 1)|Other|0|||
94662408|NCT03701555|324219862|FG002|Part 2 (Day 1)|Other|0|||
94662409|NCT03701555|324219863|FG003|Part 2 (Day 1)|Other|0|||
94662410|NCT03701555|324219864|FG004|Part 2 (Day 1)|Other|0|||
94662411|NCT03701555|324219865|FG005|Part 2 (Day 1)|Other|0|||
94662412|NCT03701555|324219866|FG006|Part 2 (Day 1)|Other|0|||
94358365|NCT04365387|323094461|FG001|Overall Study|Adverse Event|2|||
94358366|NCT04365387|323094460|FG000|Overall Study|Participants request|14|||
94358367|NCT04365387|323094461|FG001|Overall Study|Participants request|14|||
94662413|NCT03701555|324219867|FG007|Part 2 (Day 1)|Other|0|||
94662414|NCT03701555|324219868|FG008|Part 2 (Day 1)|Other|0|||
94662415|NCT03701555|324219869|FG009|Part 2 (Day 1)|Other|0|||
94358368|NCT04365387|323094460|FG000|Overall Study|Lost to Follow-up|8|||
94358369|NCT04365387|323094461|FG001|Overall Study|Lost to Follow-up|5|||
94662416|NCT03701555|324219870|FG010|Part 2 (Day 1)|Other|3|||
94358370|NCT04365387|323094460|FG000|Overall Study|Protocol deviation|3|||
94358371|NCT04365387|323094461|FG001|Overall Study|Protocol deviation|4|||
94662417|NCT03701555|324219871|FG011|Part 2 (Day 1)|Other|1|||
94662418|NCT03701555|324219872|FG012|Part 2 (Day 1)|Other|0|||
94662419|NCT03701555|324219873|FG013|Part 2 (Day 1)|Other|1|||
94662420|NCT03701555|324219874|FG014|Part 2 (Day 1)|Other|0|||
94662421|NCT03701555|324219875|FG015|Part 2 (Day 1)|Other|2|||
94253512|NCT00585195|322720872|FG002|Overall Study|Lost to Follow-up|0|||
94253513|NCT00585195|322720873|FG003|Overall Study|Lost to Follow-up|0|||
94253514|NCT00585195|322720874|FG004|Overall Study|Lost to Follow-up|0|||
94253515|NCT00585195|322720875|FG005|Overall Study|Lost to Follow-up|0|||
94253516|NCT00585195|322720876|FG006|Overall Study|Lost to Follow-up|0|||
94253517|NCT00585195|322720877|FG007|Overall Study|Lost to Follow-up|0|||
94253518|NCT00585195|322720878|FG008|Overall Study|Lost to Follow-up|0|||
94253519|NCT00585195|322720879|FG009|Overall Study|Lost to Follow-up|0|||
94253520|NCT00585195|322720880|FG010|Overall Study|Lost to Follow-up|0|||
94253521|NCT00585195|322720881|FG011|Overall Study|Lost to Follow-up|0|||
94253522|NCT00585195|322720882|FG012|Overall Study|Lost to Follow-up|1|||
94253523|NCT00585195|322720883|FG013|Overall Study|Lost to Follow-up|0|||
94253524|NCT00585195|322720884|FG014|Overall Study|Lost to Follow-up|0|||
94253525|NCT00585195|322720885|FG015|Overall Study|Lost to Follow-up|0|||
94253526|NCT00585195|322720886|FG016|Overall Study|Lost to Follow-up|0|||
94253527|NCT00585195|322720887|FG017|Overall Study|Lost to Follow-up|2|||
94253528|NCT00585195|322720888|FG018|Overall Study|Lost to Follow-up|0|||
94253529|NCT00585195|322720889|FG019|Overall Study|Lost to Follow-up|0|||
94253530|NCT00585195|322720890|FG020|Overall Study|Lost to Follow-up|0|||
94253531|NCT00585195|322720870|FG000|Overall Study|Site Terminated by Sponsor|0|||
94253532|NCT00585195|322720871|FG001|Overall Study|Site Terminated by Sponsor|0|||
94253533|NCT00585195|322720872|FG002|Overall Study|Site Terminated by Sponsor|0|||
94662422|NCT03701555|324219876|FG016|Part 2 (Day 1)|Other|2|||
94662423|NCT03701555|324219877|FG017|Part 2 (Day 1)|Other|0|||
94662424|NCT03701555|324219878|FG018|Part 2 (Day 1)|Other|0|||
94662425|NCT03701555|324219879|FG019|Part 2 (Day 1)|Other|0|||
94662426|NCT03701555|324219880|FG020|Part 2 (Day 1)|Other|0|||
94253534|NCT00585195|322720873|FG003|Overall Study|Site Terminated by Sponsor|0|||
94253535|NCT00585195|322720874|FG004|Overall Study|Site Terminated by Sponsor|0|||
94253536|NCT00585195|322720875|FG005|Overall Study|Site Terminated by Sponsor|0|||
94253537|NCT00585195|322720876|FG006|Overall Study|Site Terminated by Sponsor|0|||
94253538|NCT00585195|322720877|FG007|Overall Study|Site Terminated by Sponsor|0|||
94253539|NCT00585195|322720878|FG008|Overall Study|Site Terminated by Sponsor|0|||
94253540|NCT00585195|322720879|FG009|Overall Study|Site Terminated by Sponsor|0|||
94253541|NCT00585195|322720880|FG010|Overall Study|Site Terminated by Sponsor|0|||
94253542|NCT00585195|322720881|FG011|Overall Study|Site Terminated by Sponsor|0|||
94253543|NCT00585195|322720882|FG012|Overall Study|Site Terminated by Sponsor|1|||
94253544|NCT00585195|322720883|FG013|Overall Study|Site Terminated by Sponsor|0|||
94253545|NCT00585195|322720884|FG014|Overall Study|Site Terminated by Sponsor|0|||
94253546|NCT00585195|322720885|FG015|Overall Study|Site Terminated by Sponsor|0|||
94611583|NCT03001882|324040701|FG002|Overall Study|Study Drug Toxicity|0|||
94611584|NCT03001882|324040702|FG003|Overall Study|Study Drug Toxicity|37|||
94611585|NCT03001882|324040699|FG000|Overall Study|Disease progression|16|||
94611586|NCT03001882|324040700|FG001|Overall Study|Disease progression|14|||
94611587|NCT03001882|324040701|FG002|Overall Study|Disease progression|1|||
94611588|NCT03001882|324040702|FG003|Overall Study|Disease progression|90|||
94611589|NCT01386008|324040703|FG000|Overall Study|exited w/o incident /study discontinued|17|||
94611590|NCT01386008|324040703|FG000|Overall Study|Adverse Event|3|||
94611591|NCT00566111|324040704|FG000|Overall Study|Adverse Event|0|||
94611592|NCT00566111|324040705|FG001|Overall Study|Adverse Event|2|||
94611593|NCT05268055|324040706|FG000|Overall Study|Lost to Follow-up|68|||
94611594|NCT05268055|324040707|FG001|Overall Study|Lost to Follow-up|68|||
94611595|NCT05268055|324040706|FG000|Overall Study|Withdrawal by Subject|12|||
94611596|NCT05268055|324040707|FG001|Overall Study|Withdrawal by Subject|8|||
94611597|NCT02925923|324042674|FG000|Overall Study|blood samples hemolyzed|0|||
94611598|NCT02925923|324042675|FG001|Overall Study|blood samples hemolyzed|2|||
94611599|NCT00851630|324042676|FG000|Overall Study|Death|2|||
94662427|NCT03701555|324219881|FG021|Part 2 (Day 1)|Other|0|||
94662428|NCT03701555|324219882|FG022|Part 2 (Day 1)|Other|0|||
94662429|NCT03701555|324219883|FG023|Part 2 (Day 1)|Other|0|||
94253547|NCT00585195|322720886|FG016|Overall Study|Site Terminated by Sponsor|0|||
94253548|NCT00585195|322720887|FG017|Overall Study|Site Terminated by Sponsor|0|||
94253549|NCT00585195|322720888|FG018|Overall Study|Site Terminated by Sponsor|0|||
94253550|NCT00585195|322720889|FG019|Overall Study|Site Terminated by Sponsor|0|||
94253551|NCT00585195|322720890|FG020|Overall Study|Site Terminated by Sponsor|0|||
94253552|NCT00585195|322720870|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
94253553|NCT00585195|322720871|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
94358372|NCT04365387|323094460|FG000|Overall Study|Participant compliance with visit schedule|1|||
94358373|NCT04365387|323094461|FG001|Overall Study|Participant compliance with visit schedule|0|||
94253554|NCT00585195|322720872|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
94253555|NCT00585195|322720873|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
94611600|NCT00851630|324042677|FG001|Overall Study|Death|1|||
94611601|NCT00851630|324042676|FG000|Overall Study|Clinical failure|0|||
94611602|NCT00851630|324042677|FG001|Overall Study|Clinical failure|1|||
94611603|NCT02186873|324042684|FG000|Overall Study|Adverse Event|1|||
94611604|NCT02186873|324042685|FG001|Overall Study|Adverse Event|3|||
94662430|NCT03701555|324219884|FG024|Part 2 (Day 1)|Other|0|||
94662431|NCT03701555|324219885|FG025|Part 2 (Day 1)|Other|0|||
94662432|NCT03701555|324219886|FG026|Part 2 (Day 1)|Other|0|||
94459511|NCT04434469|323471834|FG003|Overall Study|Study terminated by sponsor|2|||
94611605|NCT02186873|324042684|FG000|Overall Study|Lack of Efficacy|0|||
94611606|NCT02186873|324042685|FG001|Overall Study|Lack of Efficacy|1|||
94611607|NCT02186873|324042684|FG000|Overall Study|Lost to Follow-up|1|||
94611608|NCT02186873|324042685|FG001|Overall Study|Lost to Follow-up|2|||
94611609|NCT02186873|324042684|FG000|Overall Study|Withdrawal by Subject|7|||
94611610|NCT02186873|324042685|FG001|Overall Study|Withdrawal by Subject|2|||
94611611|NCT04879225|324042686|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
94611612|NCT04879225|324042686|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
94611613|NCT02360995|324042691|FG000|Overall Study|Lost to Follow-up|2|||
94611614|NCT02360995|324042692|FG001|Overall Study|Lost to Follow-up|0|||
94611615|NCT02360995|324042693|FG002|Overall Study|Lost to Follow-up|2|||
94611616|NCT02360995|324042691|FG000|Overall Study|Withdrawal by Subject|0|||
94611617|NCT02360995|324042692|FG001|Overall Study|Withdrawal by Subject|1|||
94611618|NCT02360995|324042693|FG002|Overall Study|Withdrawal by Subject|0|||
94611619|NCT01824342|324042696|FG000|Overall Study|Withdrawal by Subject|0|||
94611620|NCT01824342|324042697|FG001|Overall Study|Withdrawal by Subject|3|||
94459512|NCT04434469|323471835|FG004|Overall Study|Study terminated by sponsor|3|||
94611621|NCT01824342|324042696|FG000|Overall Study|Adverse Event|1|||
94611622|NCT01824342|324042697|FG001|Overall Study|Adverse Event|1|||
94459513|NCT04434469|323471836|FG005|Overall Study|Study terminated by sponsor|3|||
94611623|NCT01824342|324042696|FG000|Overall Study|Disease Progression|1|||
94611624|NCT01824342|324042697|FG001|Overall Study|Disease Progression|1|||
94611625|NCT01824342|324042696|FG000|Overall Study|Physician Decision|5|||
94611626|NCT01824342|324042697|FG001|Overall Study|Physician Decision|0|||
94611627|NCT01824342|324042696|FG000|Overall Study|Death|2|||
94611628|NCT01824342|324042697|FG001|Overall Study|Death|0|||
94611629|NCT00369122|324042702|FG000|Overall Study|Ineligible|10|||
94611630|NCT00369122|324042702|FG000|Overall Study|No protocol treatment|1|||
94611631|NCT00004635|324042705|FG000|Period One|refused|2|||
94611632|NCT00004635|324042706|FG001|Period One|refused|1|||
94611633|NCT00004635|324042705|FG000|Period One|Withdrawal by Subject|1|||
94611634|NCT00004635|324042706|FG001|Period One|Withdrawal by Subject|1|||
94611635|NCT00004635|324042705|FG000|Period One|Protocol Violation|1|||
94611636|NCT00004635|324042706|FG001|Period One|Protocol Violation|0|||
94611637|NCT00004635|324042705|FG000|Period One|PSA did not go <5 ng/mL|1|||
94611638|NCT00004635|324042706|FG001|Period One|PSA did not go <5 ng/mL|0|||
94611639|NCT00004635|324042705|FG000|Period One|second malignancy|1|||
94611640|NCT00004635|324042706|FG001|Period One|second malignancy|0|||
94611641|NCT00004635|324042705|FG000|Period One|progressed|0|||
94611642|NCT00004635|324042706|FG001|Period One|progressed|2|||
94253556|NCT00585195|322720874|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
94253557|NCT00585195|322720875|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
94611643|NCT00004635|324042705|FG000|Period One|health problem|0|||
94611644|NCT00004635|324042706|FG001|Period One|health problem|1|||
94611645|NCT00004635|324042705|FG000|Period One|discrepancy in data entry|0|||
94611646|NCT00004635|324042706|FG001|Period One|discrepancy in data entry|1|||
94611647|NCT00004635|324042705|FG000|Period Two|progression|2|||
94253558|NCT00585195|322720876|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
94253559|NCT00585195|322720877|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
94253560|NCT00585195|322720878|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
94253561|NCT00585195|322720879|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
94253562|NCT00585195|322720880|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
94253563|NCT00585195|322720881|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
94253564|NCT00585195|322720882|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
94253565|NCT00585195|322720883|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
94253566|NCT00585195|322720884|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
94253567|NCT00585195|322720885|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
94253568|NCT00585195|322720886|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
94253569|NCT00585195|322720887|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
94253570|NCT00585195|322720888|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
94253571|NCT00585195|322720889|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
94253572|NCT00585195|322720890|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
94253573|NCT02796560|322720892|FG000|Overall Study|Adverse Event|2|||
94253574|NCT02796560|322720893|FG001|Overall Study|Adverse Event|0|||
94253575|NCT02796560|322720892|FG000|Overall Study|Withdrawal by Subject|2|||
94611648|NCT00004635|324042706|FG001|Period Two|progression|3|||
94611649|NCT00004635|324042705|FG000|Period Two|Adverse Event|1|||
94611650|NCT00004635|324042706|FG001|Period Two|Adverse Event|0|||
94611651|NCT00004635|324042705|FG000|Period Two|refused|0|||
94611652|NCT00004635|324042706|FG001|Period Two|refused|2|||
94611653|NCT00004635|324042705|FG000|Period Two|health problem|1|||
94611654|NCT00004635|324042706|FG001|Period Two|health problem|1|||
94611655|NCT00004635|324042705|FG000|Period Two|travel issues|0|||
94611656|NCT00004635|324042706|FG001|Period Two|travel issues|1|||
94611657|NCT00004635|324042705|FG000|Period Two|secondary malignancy|1|||
94611658|NCT00004635|324042706|FG001|Period Two|secondary malignancy|1|||
94611659|NCT00004635|324042705|FG000|Period Two|Lost to Follow-up|1|||
94611660|NCT00004635|324042706|FG001|Period Two|Lost to Follow-up|0|||
94611661|NCT00004635|324042705|FG000|Period Two|discrepancy in data entry|0|||
94611662|NCT00004635|324042706|FG001|Period Two|discrepancy in data entry|1|||
94611663|NCT00809354|324042707|FG000|Overall Study|Adverse Event|32|||
94611664|NCT00809354|324042708|FG001|Overall Study|Adverse Event|45|||
94611665|NCT00809354|324042709|FG002|Overall Study|Adverse Event|37|||
94611666|NCT00809354|324042710|FG003|Overall Study|Adverse Event|53|||
94611667|NCT00809354|324042711|FG004|Overall Study|Adverse Event|26|||
94611668|NCT00809354|324042712|FG005|Overall Study|Adverse Event|33|||
94611669|NCT00809354|324042713|FG006|Overall Study|Adverse Event|44|||
94611670|NCT00809354|324042714|FG007|Overall Study|Adverse Event|40|||
94611671|NCT00809354|324042715|FG008|Overall Study|Adverse Event|46|||
94611672|NCT00809354|324042716|FG009|Overall Study|Adverse Event|26|||
94611673|NCT00809354|324042707|FG000|Overall Study|Lack of Efficacy|23|||
94611674|NCT00809354|324042708|FG001|Overall Study|Lack of Efficacy|23|||
94611675|NCT00809354|324042709|FG002|Overall Study|Lack of Efficacy|22|||
94611676|NCT00809354|324042710|FG003|Overall Study|Lack of Efficacy|15|||
94611677|NCT00809354|324042711|FG004|Overall Study|Lack of Efficacy|40|||
94253576|NCT02796560|322720893|FG001|Overall Study|Withdrawal by Subject|2|||
94253577|NCT00423930|322720895|FG000|Overall Study|Withdrawal by Subject|2|||
94253578|NCT02390245|322720901|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
94253579|NCT02390245|322720902|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
94253580|NCT02390245|322720903|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
94253581|NCT02390245|322720901|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
94611678|NCT00809354|324042712|FG005|Overall Study|Lack of Efficacy|19|||
94611679|NCT00809354|324042713|FG006|Overall Study|Lack of Efficacy|21|||
94611680|NCT00809354|324042714|FG007|Overall Study|Lack of Efficacy|15|||
94611681|NCT00809354|324042715|FG008|Overall Study|Lack of Efficacy|18|||
94611682|NCT00809354|324042716|FG009|Overall Study|Lack of Efficacy|38|||
94611683|NCT00809354|324042707|FG000|Overall Study|Lost to Follow-up|10|||
94611684|NCT00809354|324042708|FG001|Overall Study|Lost to Follow-up|11|||
94611685|NCT00809354|324042709|FG002|Overall Study|Lost to Follow-up|8|||
94611686|NCT00809354|324042710|FG003|Overall Study|Lost to Follow-up|13|||
94611687|NCT00809354|324042711|FG004|Overall Study|Lost to Follow-up|6|||
94611688|NCT00809354|324042712|FG005|Overall Study|Lost to Follow-up|2|||
94662433|NCT03701555|324219887|FG027|Part 2 (Day 1)|Other|0|||
94662434|NCT03701555|324219888|FG028|Part 2 (Day 1)|Other|0|||
94662435|NCT03701555|324219889|FG029|Part 2 (Day 1)|Other|0|||
94662436|NCT03701555|324219890|FG030|Part 2 (Day 1)|Other|0|||
94662437|NCT03701555|324219891|FG031|Part 2 (Day 1)|Other|0|||
94662438|NCT03701555|324219892|FG032|Part 2 (Day 1)|Other|0|||
94662439|NCT03701555|324219893|FG033|Part 2 (Day 1)|Other|0|||
94662440|NCT03701555|324219894|FG034|Part 2 (Day 1)|Other|0|||
94662441|NCT03701555|324219895|FG035|Part 2 (Day 1)|Other|0|||
94662442|NCT03701555|324219860|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
94662443|NCT03701555|324219861|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
94662444|NCT03701555|324219862|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
94662445|NCT03701555|324219863|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
94662446|NCT03701555|324219864|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
94662447|NCT03701555|324219865|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
94253582|NCT02390245|322720902|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
94662448|NCT03701555|324219866|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
94662449|NCT03701555|324219867|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
94662450|NCT03701555|324219868|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
94662451|NCT03701555|324219869|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
94662452|NCT03701555|324219870|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
94662453|NCT03701555|324219871|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
94662454|NCT03701555|324219872|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
94662455|NCT03701555|324219873|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
94662456|NCT03701555|324219874|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
94662457|NCT03701555|324219875|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
94662458|NCT03701555|324219876|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
94662459|NCT03701555|324219877|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
94662460|NCT03701555|324219878|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
94662461|NCT03701555|324219879|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
94662462|NCT03701555|324219880|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
94662463|NCT03701555|324219881|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
94662464|NCT03701555|324219882|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
94662465|NCT03701555|324219883|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
94662466|NCT03701555|324219884|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
94459514|NCT04434469|323471831|FG000|Overall Study|Withdrawal by Subject|0|||
94459515|NCT04434469|323471832|FG001|Overall Study|Withdrawal by Subject|0|||
94459516|NCT04434469|323471833|FG002|Overall Study|Withdrawal by Subject|1|||
94459517|NCT04434469|323471834|FG003|Overall Study|Withdrawal by Subject|0|||
94459518|NCT04434469|323471835|FG004|Overall Study|Withdrawal by Subject|0|||
94459519|NCT04434469|323471836|FG005|Overall Study|Withdrawal by Subject|0|||
94662467|NCT03701555|324219885|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
94662468|NCT03701555|324219886|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
94662469|NCT03701555|324219887|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
94662470|NCT03701555|324219888|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
94662471|NCT03701555|324219889|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
94662472|NCT03701555|324219890|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
94662473|NCT03701555|324219891|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
94662474|NCT03701555|324219892|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
94662475|NCT03701555|324219893|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
94662476|NCT03701555|324219894|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
94459520|NCT04934189|323471837|FG000|Overall Study|Lost to Follow-up|4|||
94459521|NCT04934189|323471837|FG000|Overall Study|Withdrawal by Subject|17|||
94459522|NCT03692325|323471844|FG000|Overall Study|Adverse Event|2|||
94459523|NCT03692325|323471844|FG000|Overall Study|Progression/Recurrence|2|||
94459524|NCT01286168|323471845|FG000|Overall Study|Withdrawal by Subject|1|||
94459525|NCT01286168|323471845|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
94459526|NCT00425061|323471848|FG000|Overall Study|Adverse Event|1|||
94459527|NCT00425061|323471849|FG001|Overall Study|Adverse Event|0|||
94459528|NCT00425061|323471850|FG002|Overall Study|Adverse Event|0|||
94662477|NCT03701555|324219895|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
94662478|NCT03701555|324219860|FG000|Part 3 (Day 1)|Subject Decision|0|||
94662479|NCT03701555|324219861|FG001|Part 3 (Day 1)|Subject Decision|0|||
94662480|NCT03701555|324219862|FG002|Part 3 (Day 1)|Subject Decision|0|||
94662481|NCT03701555|324219863|FG003|Part 3 (Day 1)|Subject Decision|0|||
94662482|NCT03701555|324219864|FG004|Part 3 (Day 1)|Subject Decision|0|||
94662483|NCT03701555|324219865|FG005|Part 3 (Day 1)|Subject Decision|0|||
94662484|NCT03701555|324219866|FG006|Part 3 (Day 1)|Subject Decision|0|||
94253583|NCT02390245|322720903|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
94459529|NCT00425061|323471851|FG003|Overall Study|Adverse Event|2|||
94459530|NCT00425061|323471852|FG004|Overall Study|Adverse Event|2|||
94459531|NCT00425061|323471853|FG005|Overall Study|Adverse Event|0|||
94459532|NCT00425061|323471854|FG006|Overall Study|Adverse Event|0|||
94459533|NCT00425061|323471848|FG000|Overall Study|Lost to Follow-up|0|||
94459534|NCT00425061|323471849|FG001|Overall Study|Lost to Follow-up|1|||
94459535|NCT00425061|323471850|FG002|Overall Study|Lost to Follow-up|0|||
94459536|NCT00425061|323471851|FG003|Overall Study|Lost to Follow-up|0|||
94459537|NCT00425061|323471852|FG004|Overall Study|Lost to Follow-up|0|||
94459538|NCT00425061|323471853|FG005|Overall Study|Lost to Follow-up|0|||
94662485|NCT03701555|324219867|FG007|Part 3 (Day 1)|Subject Decision|0|||
94662486|NCT03701555|324219868|FG008|Part 3 (Day 1)|Subject Decision|0|||
94459539|NCT00425061|323471854|FG006|Overall Study|Lost to Follow-up|0|||
94459540|NCT00425061|323471848|FG000|Overall Study|Protocol Violation|1|||
94459541|NCT00425061|323471849|FG001|Overall Study|Protocol Violation|0|||
94662487|NCT03701555|324219869|FG009|Part 3 (Day 1)|Subject Decision|0|||
94611689|NCT00809354|324042713|FG006|Overall Study|Lost to Follow-up|0|||
94611690|NCT00809354|324042714|FG007|Overall Study|Lost to Follow-up|5|||
94611691|NCT00809354|324042715|FG008|Overall Study|Lost to Follow-up|4|||
94611692|NCT00809354|324042716|FG009|Overall Study|Lost to Follow-up|0|||
94611693|NCT00809354|324042707|FG000|Overall Study|Protocol Violation|7|||
94611694|NCT00809354|324042708|FG001|Overall Study|Protocol Violation|14|||
94611695|NCT00809354|324042709|FG002|Overall Study|Protocol Violation|14|||
94611696|NCT00809354|324042710|FG003|Overall Study|Protocol Violation|12|||
94611697|NCT00809354|324042711|FG004|Overall Study|Protocol Violation|14|||
94611698|NCT00809354|324042712|FG005|Overall Study|Protocol Violation|6|||
94611699|NCT00809354|324042713|FG006|Overall Study|Protocol Violation|4|||
94611700|NCT00809354|324042714|FG007|Overall Study|Protocol Violation|6|||
94611701|NCT00809354|324042715|FG008|Overall Study|Protocol Violation|9|||
94611702|NCT00809354|324042716|FG009|Overall Study|Protocol Violation|3|||
94611703|NCT00809354|324042707|FG000|Overall Study|Withdrawal by Subject|32|||
94611704|NCT00809354|324042708|FG001|Overall Study|Withdrawal by Subject|27|||
94611705|NCT00809354|324042709|FG002|Overall Study|Withdrawal by Subject|31|||
94611706|NCT00809354|324042710|FG003|Overall Study|Withdrawal by Subject|33|||
94611707|NCT00809354|324042711|FG004|Overall Study|Withdrawal by Subject|34|||
94611708|NCT00809354|324042712|FG005|Overall Study|Withdrawal by Subject|29|||
94611709|NCT00809354|324042713|FG006|Overall Study|Withdrawal by Subject|27|||
94611710|NCT00809354|324042714|FG007|Overall Study|Withdrawal by Subject|19|||
94611711|NCT00809354|324042715|FG008|Overall Study|Withdrawal by Subject|18|||
94662488|NCT03701555|324219870|FG010|Part 3 (Day 1)|Subject Decision|0|||
94662489|NCT03701555|324219871|FG011|Part 3 (Day 1)|Subject Decision|0|||
94253584|NCT00924027|322720904|FG000|Overall Study|Lost to Further Follow-Up|4|||
94253585|NCT00924027|322720905|FG001|Overall Study|Lost to Further Follow-Up|0|||
94253586|NCT00924027|322720906|FG002|Overall Study|Lost to Further Follow-Up|0|||
94253587|NCT00924027|322720907|FG003|Overall Study|Lost to Further Follow-Up|0|||
94253588|NCT00924027|322720904|FG000|Overall Study|Physician Decision|1|||
94253589|NCT00924027|322720905|FG001|Overall Study|Physician Decision|0|||
94253590|NCT00924027|322720906|FG002|Overall Study|Physician Decision|0|||
94253591|NCT00924027|322720907|FG003|Overall Study|Physician Decision|1|||
94253592|NCT00924027|322720904|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
94459542|NCT00425061|323471850|FG002|Overall Study|Protocol Violation|0|||
94459543|NCT00425061|323471851|FG003|Overall Study|Protocol Violation|0|||
94459544|NCT00425061|323471852|FG004|Overall Study|Protocol Violation|0|||
94459545|NCT00425061|323471853|FG005|Overall Study|Protocol Violation|0|||
94459546|NCT00425061|323471854|FG006|Overall Study|Protocol Violation|0|||
94459547|NCT00425061|323471848|FG000|Overall Study|Withdrawal by Subject|0|||
94459548|NCT00425061|323471849|FG001|Overall Study|Withdrawal by Subject|1|||
94459549|NCT00425061|323471850|FG002|Overall Study|Withdrawal by Subject|0|||
94459550|NCT00425061|323471851|FG003|Overall Study|Withdrawal by Subject|0|||
94459551|NCT00425061|323471852|FG004|Overall Study|Withdrawal by Subject|1|||
94459552|NCT00425061|323471853|FG005|Overall Study|Withdrawal by Subject|0|||
94459553|NCT00425061|323471854|FG006|Overall Study|Withdrawal by Subject|3|||
94459554|NCT00425061|323471848|FG000|Overall Study|Sponsor's request|0|||
94459555|NCT00425061|323471849|FG001|Overall Study|Sponsor's request|0|||
94459556|NCT00425061|323471850|FG002|Overall Study|Sponsor's request|0|||
94459557|NCT00425061|323471851|FG003|Overall Study|Sponsor's request|0|||
94459558|NCT00425061|323471852|FG004|Overall Study|Sponsor's request|19|||
94459559|NCT00425061|323471853|FG005|Overall Study|Sponsor's request|4|||
94459560|NCT00425061|323471854|FG006|Overall Study|Sponsor's request|15|||
94459561|NCT00425061|323471848|FG000|Overall Study|Physician Decision|0|||
94459562|NCT00425061|323471849|FG001|Overall Study|Physician Decision|0|||
94459563|NCT00425061|323471850|FG002|Overall Study|Physician Decision|0|||
94459564|NCT00425061|323471851|FG003|Overall Study|Physician Decision|0|||
94459565|NCT00425061|323471852|FG004|Overall Study|Physician Decision|1|||
94459566|NCT00425061|323471853|FG005|Overall Study|Physician Decision|0|||
94459567|NCT00425061|323471854|FG006|Overall Study|Physician Decision|0|||
94459568|NCT00425061|323471848|FG000|Overall Study|Other|0|||
94459569|NCT00425061|323471849|FG001|Overall Study|Other|0|||
94459570|NCT00425061|323471850|FG002|Overall Study|Other|0|||
94459571|NCT00425061|323471851|FG003|Overall Study|Other|0|||
94459572|NCT00425061|323471852|FG004|Overall Study|Other|3|||
94459573|NCT00425061|323471853|FG005|Overall Study|Other|0|||
94459574|NCT00425061|323471854|FG006|Overall Study|Other|1|||
94459575|NCT02031640|323471855|FG000|Screening Period|Adverse Event|1|||
94459576|NCT02031640|323471856|FG001|Screening Period|Adverse Event|0|||
94459577|NCT02031640|323471857|FG002|Screening Period|Adverse Event|0|||
94459578|NCT02031640|323471858|FG003|Screening Period|Adverse Event|0|||
94611712|NCT00809354|324042716|FG009|Overall Study|Withdrawal by Subject|20|||
94611713|NCT00809354|324042707|FG000|Overall Study|Other|10|||
94611714|NCT00809354|324042708|FG001|Overall Study|Other|2|||
94611715|NCT00809354|324042709|FG002|Overall Study|Other|7|||
94611716|NCT00809354|324042710|FG003|Overall Study|Other|10|||
94611717|NCT00809354|324042711|FG004|Overall Study|Other|5|||
94459579|NCT02031640|323471859|FG004|Screening Period|Adverse Event|0|||
94459580|NCT02031640|323471860|FG005|Screening Period|Adverse Event|0|||
94611718|NCT00809354|324042712|FG005|Overall Study|Other|3|||
94253593|NCT00924027|322720905|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
94253594|NCT00924027|322720906|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
94253595|NCT00924027|322720907|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
94253596|NCT00924027|322720904|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
94253597|NCT00924027|322720905|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
94253598|NCT00924027|322720906|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
94253599|NCT00924027|322720907|FG003|Overall Study|Withdrawal: Refused to start treatment|1|||
94253600|NCT00924027|322720904|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
94253601|NCT00924027|322720905|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
94253602|NCT00924027|322720906|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
94253603|NCT00924027|322720907|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
94253604|NCT01589237|322722515|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
94253605|NCT01589237|322722516|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
94253606|NCT01589237|322722517|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
94662490|NCT03701555|324219872|FG012|Part 3 (Day 1)|Subject Decision|0|||
94662491|NCT03701555|324219873|FG013|Part 3 (Day 1)|Subject Decision|0|||
94662492|NCT03701555|324219874|FG014|Part 3 (Day 1)|Subject Decision|0|||
94662493|NCT03701555|324219875|FG015|Part 3 (Day 1)|Subject Decision|0|||
94253607|NCT01589237|322722518|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
94253608|NCT01589237|322722515|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
94253609|NCT01589237|322722516|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
94253610|NCT01589237|322722517|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
94253611|NCT01589237|322722518|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
94253612|NCT01589237|322722515|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
94253613|NCT01589237|322722516|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
94253614|NCT01589237|322722517|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
94253615|NCT01589237|322722518|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
94253616|NCT01589237|322722515|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
94253617|NCT01589237|322722516|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
94253618|NCT01589237|322722517|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
94611719|NCT00809354|324042713|FG006|Overall Study|Other|2|||
94611720|NCT00809354|324042714|FG007|Overall Study|Other|3|||
94611721|NCT00809354|324042715|FG008|Overall Study|Other|4|||
94611722|NCT00809354|324042716|FG009|Overall Study|Other|3|||
94611723|NCT00809354|324042707|FG000|Overall Study|Study terminated by sponsor|138|||
94611724|NCT00809354|324042708|FG001|Overall Study|Study terminated by sponsor|134|||
94611725|NCT00809354|324042709|FG002|Overall Study|Study terminated by sponsor|129|||
94611726|NCT00809354|324042710|FG003|Overall Study|Study terminated by sponsor|120|||
94611727|NCT00809354|324042711|FG004|Overall Study|Study terminated by sponsor|126|||
94611728|NCT00809354|324042712|FG005|Overall Study|Study terminated by sponsor|133|||
94611729|NCT00809354|324042713|FG006|Overall Study|Study terminated by sponsor|124|||
94611730|NCT00809354|324042714|FG007|Overall Study|Study terminated by sponsor|148|||
94611731|NCT00809354|324042715|FG008|Overall Study|Study terminated by sponsor|127|||
94611732|NCT00809354|324042716|FG009|Overall Study|Study terminated by sponsor|135|||
94611733|NCT00809354|324042707|FG000|Overall Study|Withdrawn due to pregnancy|0|||
94611734|NCT00809354|324042708|FG001|Overall Study|Withdrawn due to pregnancy|1|||
94611735|NCT00809354|324042709|FG002|Overall Study|Withdrawn due to pregnancy|0|||
94611736|NCT00809354|324042710|FG003|Overall Study|Withdrawn due to pregnancy|0|||
94611737|NCT00809354|324042711|FG004|Overall Study|Withdrawn due to pregnancy|0|||
94611738|NCT00809354|324042712|FG005|Overall Study|Withdrawn due to pregnancy|0|||
94611739|NCT00809354|324042713|FG006|Overall Study|Withdrawn due to pregnancy|0|||
94611740|NCT00809354|324042714|FG007|Overall Study|Withdrawn due to pregnancy|0|||
94611741|NCT00809354|324042715|FG008|Overall Study|Withdrawn due to pregnancy|0|||
94611742|NCT00809354|324042716|FG009|Overall Study|Withdrawn due to pregnancy|0|||
94611743|NCT00809354|324042707|FG000|Overall Study|Randomized but not Treated|3|||
94611744|NCT00809354|324042708|FG001|Overall Study|Randomized but not Treated|1|||
94611745|NCT00809354|324042709|FG002|Overall Study|Randomized but not Treated|6|||
94662494|NCT03701555|324219876|FG016|Part 3 (Day 1)|Subject Decision|0|||
94662495|NCT03701555|324219877|FG017|Part 3 (Day 1)|Subject Decision|0|||
94662496|NCT03701555|324219878|FG018|Part 3 (Day 1)|Subject Decision|0|||
94253619|NCT01589237|322722518|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
94253620|NCT01672723|322722519|FG000|First Intervention|Adverse Event|3|||
94253621|NCT01672723|322722520|FG001|First Intervention|Adverse Event|0|||
94611746|NCT00809354|324042710|FG003|Overall Study|Randomized but not Treated|0|||
94611747|NCT00809354|324042711|FG004|Overall Study|Randomized but not Treated|5|||
94611748|NCT00809354|324042712|FG005|Overall Study|Randomized but not Treated|0|||
94611749|NCT00809354|324042713|FG006|Overall Study|Randomized but not Treated|1|||
94611750|NCT00809354|324042714|FG007|Overall Study|Randomized but not Treated|1|||
94611751|NCT00809354|324042715|FG008|Overall Study|Randomized but not Treated|2|||
94662497|NCT03701555|324219879|FG019|Part 3 (Day 1)|Subject Decision|0|||
94662498|NCT03701555|324219880|FG020|Part 3 (Day 1)|Subject Decision|0|||
94662499|NCT03701555|324219881|FG021|Part 3 (Day 1)|Subject Decision|0|||
94253622|NCT00910689|322722521|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
94253623|NCT00910689|322722522|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
94253624|NCT00910689|322722523|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
94253625|NCT00910689|322722524|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
94253626|NCT00910689|322722521|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
94253627|NCT00910689|322722522|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
94253628|NCT00910689|322722523|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
94253629|NCT00910689|322722524|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
94253630|NCT00910689|322722521|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
94253631|NCT00910689|322722522|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
94253632|NCT00910689|322722523|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
94253633|NCT00910689|322722524|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
94253634|NCT00910689|322722521|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
94253635|NCT00910689|322722522|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
94253636|NCT00910689|322722523|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
94253637|NCT00910689|322722524|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
94253638|NCT00910689|322722521|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
94253639|NCT00910689|322722522|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
94253640|NCT00910689|322722523|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
94253641|NCT00910689|322722524|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
94253642|NCT00910689|322722521|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
94253643|NCT00910689|322722522|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
94253644|NCT00910689|322722523|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
94253645|NCT00910689|322722524|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
94253646|NCT00910689|322722521|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
94253647|NCT00910689|322722522|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
94253648|NCT00910689|322722523|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
94253649|NCT00910689|322722524|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
94611752|NCT00809354|324042716|FG009|Overall Study|Randomized but not Treated|1|||
94611753|NCT00809354|324042707|FG000|Overall Study|Death|0|||
94611754|NCT00809354|324042708|FG001|Overall Study|Death|0|||
94611755|NCT00809354|324042709|FG002|Overall Study|Death|0|||
94611756|NCT00809354|324042710|FG003|Overall Study|Death|0|||
94611757|NCT00809354|324042711|FG004|Overall Study|Death|0|||
94611758|NCT00809354|324042712|FG005|Overall Study|Death|0|||
94611759|NCT00809354|324042713|FG006|Overall Study|Death|0|||
94611760|NCT00809354|324042714|FG007|Overall Study|Death|1|||
94611761|NCT00809354|324042715|FG008|Overall Study|Death|0|||
94611762|NCT00809354|324042716|FG009|Overall Study|Death|0|||
94611763|NCT00676338|324042718|FG000|Overall Study|Adverse Event|6|||
94611764|NCT00676338|324042719|FG001|Overall Study|Adverse Event|6|||
94611765|NCT00676338|324042720|FG002|Overall Study|Adverse Event|5|||
94611766|NCT00676338|324042721|FG003|Overall Study|Adverse Event|1|||
94611767|NCT00676338|324042718|FG000|Overall Study|Lost to Follow-up|4|||
94611768|NCT00676338|324042719|FG001|Overall Study|Lost to Follow-up|1|||
94611769|NCT00676338|324042720|FG002|Overall Study|Lost to Follow-up|3|||
94611770|NCT00676338|324042721|FG003|Overall Study|Lost to Follow-up|4|||
94611771|NCT00676338|324042718|FG000|Overall Study|Physician Decision|3|||
94611772|NCT00676338|324042719|FG001|Overall Study|Physician Decision|3|||
94611773|NCT00676338|324042720|FG002|Overall Study|Physician Decision|2|||
94611774|NCT00676338|324042721|FG003|Overall Study|Physician Decision|3|||
94611775|NCT00676338|324042718|FG000|Overall Study|Protocol Violation|5|||
94611776|NCT00676338|324042719|FG001|Overall Study|Protocol Violation|9|||
94611777|NCT00676338|324042720|FG002|Overall Study|Protocol Violation|2|||
94611778|NCT00676338|324042721|FG003|Overall Study|Protocol Violation|5|||
94611779|NCT00676338|324042718|FG000|Overall Study|Withdrawal by Subject|17|||
94611780|NCT00676338|324042719|FG001|Overall Study|Withdrawal by Subject|9|||
94611781|NCT00676338|324042720|FG002|Overall Study|Withdrawal by Subject|12|||
94611782|NCT00676338|324042721|FG003|Overall Study|Withdrawal by Subject|6|||
94611783|NCT00676338|324042718|FG000|Overall Study|Entry Criteria Not Met|0|||
94611784|NCT00676338|324042719|FG001|Overall Study|Entry Criteria Not Met|2|||
94611785|NCT00676338|324042720|FG002|Overall Study|Entry Criteria Not Met|1|||
94611786|NCT00676338|324042721|FG003|Overall Study|Entry Criteria Not Met|1|||
94253650|NCT00910689|322722521|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
94253651|NCT00910689|322722522|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
94253652|NCT00910689|322722523|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
94611787|NCT00676338|324042718|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
94611788|NCT00676338|324042719|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
94611789|NCT00676338|324042720|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
94611790|NCT00676338|324042721|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
94611791|NCT01500031|324042726|FG000|Overall Study|Death|1|||
94611792|NCT01500031|324042726|FG000|Overall Study|Withdrawal by Subject|4|||
94611793|NCT00131508|324042729|FG000|Overall Study|Disease progression|0|||
94611794|NCT00131508|324042730|FG001|Overall Study|Disease progression|2|||
94611795|NCT00131508|324042729|FG000|Overall Study|Non-Compliance|2|||
94253653|NCT00910689|322722524|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
94611796|NCT00131508|324042730|FG001|Overall Study|Non-Compliance|4|||
94611797|NCT00131508|324042729|FG000|Overall Study|Withdrawal by Subject|1|||
94611798|NCT00131508|324042730|FG001|Overall Study|Withdrawal by Subject|2|||
94611799|NCT03643575|324042731|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
94611800|NCT03643575|324042732|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
94611801|NCT03643575|324042733|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
94611802|NCT03643575|324042734|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
94611803|NCT03643575|324042735|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
94611804|NCT03643575|324042736|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
94611805|NCT03643575|324042731|FG000|Washout: 7 Days|Adverse Event|1|||
94611806|NCT03643575|324042732|FG001|Washout: 7 Days|Adverse Event|0|||
94611807|NCT03643575|324042733|FG002|Washout: 7 Days|Adverse Event|0|||
94611808|NCT03643575|324042734|FG003|Washout: 7 Days|Adverse Event|0|||
94611809|NCT03643575|324042735|FG004|Washout: 7 Days|Adverse Event|0|||
94662500|NCT03701555|324219882|FG022|Part 3 (Day 1)|Subject Decision|0|||
94662501|NCT03701555|324219883|FG023|Part 3 (Day 1)|Subject Decision|0|||
94662502|NCT03701555|324219884|FG024|Part 3 (Day 1)|Subject Decision|0|||
94662503|NCT03701555|324219885|FG025|Part 3 (Day 1)|Subject Decision|0|||
94662504|NCT03701555|324219886|FG026|Part 3 (Day 1)|Subject Decision|1|||
94662505|NCT03701555|324219887|FG027|Part 3 (Day 1)|Subject Decision|0|||
94662506|NCT03701555|324219888|FG028|Part 3 (Day 1)|Subject Decision|0|||
94662507|NCT03701555|324219889|FG029|Part 3 (Day 1)|Subject Decision|0|||
94662508|NCT03701555|324219890|FG030|Part 3 (Day 1)|Subject Decision|0|||
94662509|NCT03701555|324219891|FG031|Part 3 (Day 1)|Subject Decision|2|||
94662510|NCT03701555|324219892|FG032|Part 3 (Day 1)|Subject Decision|1|||
94662511|NCT03701555|324219893|FG033|Part 3 (Day 1)|Subject Decision|1|||
94662512|NCT03701555|324219894|FG034|Part 3 (Day 1)|Subject Decision|0|||
94662513|NCT03701555|324219895|FG035|Part 3 (Day 1)|Subject Decision|0|||
94662514|NCT03701555|324219860|FG000|Part 3 (Day 1)|Other|0|||
94662515|NCT03701555|324219861|FG001|Part 3 (Day 1)|Other|0|||
94662516|NCT03701555|324219862|FG002|Part 3 (Day 1)|Other|0|||
94662517|NCT03701555|324219863|FG003|Part 3 (Day 1)|Other|0|||
94662518|NCT03701555|324219864|FG004|Part 3 (Day 1)|Other|0|||
94662519|NCT03701555|324219865|FG005|Part 3 (Day 1)|Other|0|||
94662520|NCT03701555|324219866|FG006|Part 3 (Day 1)|Other|0|||
94662521|NCT03701555|324219867|FG007|Part 3 (Day 1)|Other|0|||
94662522|NCT03701555|324219868|FG008|Part 3 (Day 1)|Other|0|||
94662523|NCT03701555|324219869|FG009|Part 3 (Day 1)|Other|0|||
94662524|NCT03701555|324219870|FG010|Part 3 (Day 1)|Other|0|||
94662525|NCT03701555|324219871|FG011|Part 3 (Day 1)|Other|0|||
94662526|NCT03701555|324219872|FG012|Part 3 (Day 1)|Other|0|||
94662527|NCT03701555|324219873|FG013|Part 3 (Day 1)|Other|0|||
94662528|NCT03701555|324219874|FG014|Part 3 (Day 1)|Other|0|||
94662529|NCT03701555|324219875|FG015|Part 3 (Day 1)|Other|0|||
94662530|NCT03701555|324219876|FG016|Part 3 (Day 1)|Other|0|||
94662531|NCT03701555|324219877|FG017|Part 3 (Day 1)|Other|0|||
94662532|NCT03701555|324219878|FG018|Part 3 (Day 1)|Other|0|||
94662533|NCT03701555|324219879|FG019|Part 3 (Day 1)|Other|0|||
94662534|NCT03701555|324219880|FG020|Part 3 (Day 1)|Other|0|||
94662535|NCT03701555|324219881|FG021|Part 3 (Day 1)|Other|0|||
94662536|NCT03701555|324219882|FG022|Part 3 (Day 1)|Other|0|||
94662537|NCT03701555|324219883|FG023|Part 3 (Day 1)|Other|0|||
94662538|NCT03701555|324219884|FG024|Part 3 (Day 1)|Other|1|||
94662539|NCT03701555|324219885|FG025|Part 3 (Day 1)|Other|1|||
94662540|NCT03701555|324219886|FG026|Part 3 (Day 1)|Other|0|||
94662541|NCT03701555|324219887|FG027|Part 3 (Day 1)|Other|0|||
94662542|NCT03701555|324219888|FG028|Part 3 (Day 1)|Other|0|||
94662543|NCT03701555|324219889|FG029|Part 3 (Day 1)|Other|1|||
94662544|NCT03701555|324219890|FG030|Part 3 (Day 1)|Other|1|||
94662545|NCT03701555|324219891|FG031|Part 3 (Day 1)|Other|0|||
94662546|NCT03701555|324219892|FG032|Part 3 (Day 1)|Other|1|||
94662547|NCT03701555|324219893|FG033|Part 3 (Day 1)|Other|1|||
94662548|NCT03701555|324219894|FG034|Part 3 (Day 1)|Other|0|||
94611810|NCT03643575|324042736|FG005|Washout: 7 Days|Adverse Event|0|||
94611811|NCT03643575|324042731|FG000|Washout: 7 Days|Non compliance check in|0|||
94611812|NCT03643575|324042732|FG001|Washout: 7 Days|Non compliance check in|1|||
94611813|NCT03643575|324042733|FG002|Washout: 7 Days|Non compliance check in|0|||
94662549|NCT03701555|324219895|FG035|Part 3 (Day 1)|Other|0|||
94662550|NCT04757649|324219898|FG000|Overall Study|Withdrawal by Subject|1|||
94662551|NCT04757649|324219898|FG000|Overall Study|Adverse Event|1|||
94662552|NCT02696317|324219901|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
94662553|NCT02696317|324219902|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
94662554|NCT02696317|324219901|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
94662555|NCT02696317|324219902|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
94662556|NCT01343368|324219903|FG000|Overall Study|Death|1|||
94662557|NCT01343368|324219904|FG001|Overall Study|Death|0|||
94662558|NCT01343368|324219903|FG000|Overall Study|Lost to Follow-up|1|||
94662559|NCT01343368|324219904|FG001|Overall Study|Lost to Follow-up|0|||
94662560|NCT00237744|324219905|FG000|Overall Study|Withdrawal by Subject|3|||
94662561|NCT00237744|324219906|FG001|Overall Study|Withdrawal by Subject|1|||
94662562|NCT00237744|324219907|FG002|Overall Study|Withdrawal by Subject|0|||
94611814|NCT03643575|324042734|FG003|Washout: 7 Days|Non compliance check in|0|||
94611815|NCT03643575|324042735|FG004|Washout: 7 Days|Non compliance check in|0|||
94611816|NCT03643575|324042736|FG005|Washout: 7 Days|Non compliance check in|0|||
94611817|NCT01309165|324042737|FG000|Overall Study|Lost to Follow-up|4|||
94611818|NCT01309165|324042738|FG001|Overall Study|Lost to Follow-up|3|||
94611819|NCT01309165|324042737|FG000|Overall Study|Return to work|1|||
94611820|NCT01309165|324042738|FG001|Overall Study|Return to work|2|||
94611821|NCT01309165|324042737|FG000|Overall Study|Left country|0|||
94611822|NCT01309165|324042738|FG001|Overall Study|Left country|1|||
94611823|NCT01309165|324042737|FG000|Overall Study|No transportation|0|||
94611824|NCT01309165|324042738|FG001|Overall Study|No transportation|1|||
94611825|NCT01309165|324042737|FG000|Overall Study|Admitted to hospital for second stroke|1|||
94611826|NCT01309165|324042738|FG001|Overall Study|Admitted to hospital for second stroke|0|||
94611827|NCT01497275|324042739|FG000|Overall Study|Death|1|||
94611828|NCT01497275|324042739|FG000|Overall Study|Adverse Event|1|||
94611829|NCT01950169|324042740|FG000|Overall Study|Withdrawal by Subject|2|||
94611830|NCT01950169|324042741|FG001|Overall Study|Withdrawal by Subject|8|||
94611831|NCT01950169|324042742|FG002|Overall Study|Withdrawal by Subject|1|||
94611832|NCT01950169|324042740|FG000|Overall Study|Death|1|||
94611833|NCT01950169|324042741|FG001|Overall Study|Death|0|||
94611834|NCT01950169|324042742|FG002|Overall Study|Death|0|||
94611835|NCT00875979|324042745|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
94611836|NCT00875979|324042746|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
94611837|NCT00875979|324042745|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
94611838|NCT00875979|324042746|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
94611839|NCT00875979|324042745|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
94611840|NCT00875979|324042746|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
94611841|NCT00875979|324042745|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
94611842|NCT00875979|324042746|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
94611843|NCT00875979|324042745|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
94611844|NCT00875979|324042746|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
94611845|NCT00875979|324042745|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
94611846|NCT00875979|324042746|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
94611847|NCT00875979|324042745|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
94611848|NCT00875979|324042746|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
94662563|NCT03305016|324219908|FG000|Overall Study|Withdrawal by Subject|2|||
94662564|NCT02844946|324219909|FG000|Overall Study|Lost to Follow-up|7|||
94662565|NCT02844946|324219910|FG001|Overall Study|Lost to Follow-up|0|||
94662566|NCT02079805|324219911|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
94662567|NCT02079805|324219912|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
94662568|NCT02079805|324219911|FG000|Overall Study|Voluntary Withdrawal|0|||
94662569|NCT02079805|324219912|FG001|Overall Study|Voluntary Withdrawal|1|||
94662570|NCT03879798|324219913|FG000|Overall Study|Adverse Event|0|||
94662571|NCT03879798|324219914|FG001|Overall Study|Adverse Event|0|||
94662572|NCT03879798|324219915|FG002|Overall Study|Adverse Event|0|||
94662573|NCT03879798|324219916|FG003|Overall Study|Adverse Event|0|||
94662574|NCT03879798|324219917|FG004|Overall Study|Adverse Event|0|||
94662575|NCT03879798|324219918|FG005|Overall Study|Adverse Event|1|||
94662576|NCT03879798|324219913|FG000|Overall Study|Lack of Efficacy|0|||
94662577|NCT03879798|324219914|FG001|Overall Study|Lack of Efficacy|0|||
94662578|NCT03879798|324219915|FG002|Overall Study|Lack of Efficacy|0|||
94662579|NCT03879798|324219916|FG003|Overall Study|Lack of Efficacy|0|||
94662580|NCT03879798|324219917|FG004|Overall Study|Lack of Efficacy|0|||
94662581|NCT03879798|324219918|FG005|Overall Study|Lack of Efficacy|1|||
94662582|NCT03879798|324219913|FG000|Overall Study|Withdrawal by Subject|0|||
94662583|NCT03879798|324219914|FG001|Overall Study|Withdrawal by Subject|0|||
94662584|NCT03879798|324219915|FG002|Overall Study|Withdrawal by Subject|0|||
94662585|NCT03879798|324219916|FG003|Overall Study|Withdrawal by Subject|0|||
94662586|NCT03879798|324219917|FG004|Overall Study|Withdrawal by Subject|0|||
94662587|NCT03879798|324219918|FG005|Overall Study|Withdrawal by Subject|1|||
94662588|NCT02647359|324219922|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
94662589|NCT02647359|324219923|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
94662590|NCT02647359|324219922|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
94611849|NCT00875979|324042745|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
94611850|NCT00875979|324042746|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
94611851|NCT00875979|324042745|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
94611852|NCT00875979|324042746|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
94611853|NCT01772160|324042748|FG000|Overall Study|Death|3|||
94662591|NCT02647359|324219923|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
94662592|NCT02647359|324219922|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
94662593|NCT02647359|324219923|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
94662594|NCT02647359|324219922|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
94662595|NCT02647359|324219923|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
94662596|NCT02647359|324219922|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
94662597|NCT02647359|324219923|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
94662598|NCT02647359|324219922|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
94662599|NCT02647359|324219923|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
94662600|NCT00553267|324219926|FG000|Overall Study|Adverse Event|8|||
94662601|NCT00553267|324219927|FG001|Overall Study|Adverse Event|10|||
94662602|NCT00553267|324219928|FG002|Overall Study|Adverse Event|5|||
94662603|NCT00553267|324219926|FG000|Overall Study|Non compliant with protocol|3|||
94662604|NCT00553267|324219927|FG001|Overall Study|Non compliant with protocol|3|||
94662605|NCT00553267|324219928|FG002|Overall Study|Non compliant with protocol|2|||
94662606|NCT00553267|324219926|FG000|Overall Study|Lost to Follow-up|0|||
94662607|NCT00553267|324219927|FG001|Overall Study|Lost to Follow-up|0|||
94662608|NCT00553267|324219928|FG002|Overall Study|Lost to Follow-up|1|||
94662609|NCT00553267|324219926|FG000|Overall Study|Consent withdrawn|2|||
94662610|NCT00553267|324219927|FG001|Overall Study|Consent withdrawn|3|||
94662611|NCT00553267|324219928|FG002|Overall Study|Consent withdrawn|1|||
94662612|NCT00553267|324219926|FG000|Overall Study|Specified category|1|||
94662613|NCT00553267|324219927|FG001|Overall Study|Specified category|2|||
94662614|NCT00553267|324219928|FG002|Overall Study|Specified category|1|||
94662615|NCT01310036|324219929|FG000|Overall Study|Administrative/other|10|||
94662616|NCT01310036|324219929|FG000|Overall Study|Withdrew Consent|11|||
94662617|NCT01310036|324219929|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
94662618|NCT01310036|324219929|FG000|Overall Study|Progression of Disease|164|||
94662619|NCT01310036|324219929|FG000|Overall Study|Death|1|||
94662620|NCT01310036|324219929|FG000|Overall Study|Adverse event or intercurrent illness|12|||
94662621|NCT01175668|324219930|FG000|Overall Study|Withdrawal by Subject|2|||
94662622|NCT01175668|324219931|FG001|Overall Study|Withdrawal by Subject|0|||
94662623|NCT01568047|324219937|FG000|Overall Study|Ineligibility|1|||
94662624|NCT01568047|324219938|FG001|Overall Study|Ineligibility|0|||
94662625|NCT01568047|324219939|FG002|Overall Study|Ineligibility|0|||
94662626|NCT01568047|324219940|FG003|Overall Study|Ineligibility|0|||
94662627|NCT01568047|324219937|FG000|Overall Study|Withdrawal by Subject|0|||
94662628|NCT01568047|324219938|FG001|Overall Study|Withdrawal by Subject|1|||
94662629|NCT01568047|324219939|FG002|Overall Study|Withdrawal by Subject|0|||
94662630|NCT01568047|324219940|FG003|Overall Study|Withdrawal by Subject|0|||
94662631|NCT01568047|324219937|FG000|Overall Study|Adverse Event|0|||
94662632|NCT01568047|324219938|FG001|Overall Study|Adverse Event|0|||
94662633|NCT01568047|324219939|FG002|Overall Study|Adverse Event|1|||
94662634|NCT01568047|324219940|FG003|Overall Study|Adverse Event|1|||
94662635|NCT03359096|324219941|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
94662636|NCT03359096|324219942|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
94662637|NCT03359096|324219941|FG000|First Intervention (4 Weeks)|Death|1|||
94662638|NCT03359096|324219942|FG001|First Intervention (4 Weeks)|Death|0|||
94662639|NCT03359096|324219941|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
94662640|NCT03359096|324219942|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
94253654|NCT00910689|322722521|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
94253655|NCT00910689|322722522|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
94253656|NCT00910689|322722523|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
94662641|NCT02328326|324219945|FG000|Overall Study|Withdrawal by Subject|10|||
94662642|NCT02328326|324219946|FG001|Overall Study|Withdrawal by Subject|3|||
94662643|NCT02328326|324219945|FG000|Overall Study|Death|2|||
94662644|NCT02328326|324219946|FG001|Overall Study|Death|1|||
94662645|NCT02328326|324219945|FG000|Overall Study|Lost to Follow-up|10|||
94662646|NCT02328326|324219946|FG001|Overall Study|Lost to Follow-up|4|||
94662647|NCT00586105|324219949|FG000|Overall Study|Adverse Event|4|||
94662648|NCT00586105|324219949|FG000|Overall Study|Death|2|||
94662649|NCT00586105|324219949|FG000|Overall Study|Protocol Violation|1|||
94662650|NCT00586105|324219949|FG000|Overall Study|Withdrawal by Subject|3|||
94662651|NCT00586105|324219949|FG000|Overall Study|Disease progression|19|||
94662652|NCT00586105|324219949|FG000|Overall Study|Switched to commercial drug|9|||
94662653|NCT00586105|324219949|FG000|Overall Study|Reason not reported|1|||
94253657|NCT00910689|322722524|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
94253658|NCT00910689|322722521|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
94253659|NCT00910689|322722522|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
94358374|NCT04365387|323094460|FG000|Overall Study|Participant incarcerated|1|||
94358375|NCT04365387|323094461|FG001|Overall Study|Participant incarcerated|0|||
94611854|NCT01772160|324042748|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
94611855|NCT01772160|324042748|FG000|Overall Study|Consent withdrawal|3|||
94611856|NCT01772160|324042748|FG000|Overall Study|Migrated / moved from the study area|4|||
94611857|NCT01772160|324042748|FG000|Overall Study|Lost to Follow-up|30|||
94611858|NCT01772160|324042748|FG000|Overall Study|Other|5|||
94611859|NCT00369707|324042749|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
94611860|NCT00369707|324042749|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
94611861|NCT00369707|324042749|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
94611862|NCT00369707|324042749|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
94611863|NCT00369707|324042749|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
94611864|NCT00369707|324042749|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
94611865|NCT00369707|324042749|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
94611866|NCT00369707|324042749|FG000|Follow up for 2 Years After Treatment|Death|1|||
94611867|NCT00369707|324042749|FG000|Follow up for 2 Years After Treatment|Other|2|||
94611868|NCT02083081|324042750|FG000|Overall Study|Lost to Follow-up|31|||
94611869|NCT02083081|324042751|FG001|Overall Study|Lost to Follow-up|9|||
94611870|NCT02633501|324042752|FG000|Overall Study|Adverse Event|0|||
94611871|NCT02633501|324042753|FG001|Overall Study|Adverse Event|0|||
94611872|NCT02633501|324042754|FG002|Overall Study|Adverse Event|1|||
94611873|NCT02633501|324042755|FG003|Overall Study|Adverse Event|0|||
94611874|NCT02633501|324042756|FG004|Overall Study|Adverse Event|1|||
94611875|NCT02633501|324042757|FG005|Overall Study|Adverse Event|1|||
94611876|NCT02633501|324042752|FG000|Overall Study|Withdrawal by Subject|2|||
94611877|NCT02633501|324042753|FG001|Overall Study|Withdrawal by Subject|1|||
94662654|NCT01165281|324219957|FG000|Overall Study|Adverse Event|12|||
94253660|NCT00910689|322722523|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
94253661|NCT00910689|322722524|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
94253662|NCT00910689|322722521|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
94611878|NCT02633501|324042754|FG002|Overall Study|Withdrawal by Subject|2|||
94662655|NCT01165281|324219958|FG001|Overall Study|Adverse Event|14|||
94662656|NCT01165281|324219957|FG000|Overall Study|Death|3|||
94611879|NCT02633501|324042755|FG003|Overall Study|Withdrawal by Subject|2|||
94662657|NCT01165281|324219958|FG001|Overall Study|Death|4|||
94611880|NCT02633501|324042756|FG004|Overall Study|Withdrawal by Subject|1|||
94662658|NCT01165281|324219957|FG000|Overall Study|Lack of Efficacy|4|||
94662659|NCT01165281|324219958|FG001|Overall Study|Lack of Efficacy|1|||
94662660|NCT01165281|324219957|FG000|Overall Study|Lost to Follow-up|0|||
94662661|NCT01165281|324219958|FG001|Overall Study|Lost to Follow-up|1|||
94662662|NCT01165281|324219957|FG000|Overall Study|Physician Decision|8|||
94662663|NCT01165281|324219958|FG001|Overall Study|Physician Decision|1|||
94662664|NCT01165281|324219957|FG000|Overall Study|Protocol Violation|6|||
94662665|NCT01165281|324219958|FG001|Overall Study|Protocol Violation|5|||
94662666|NCT01165281|324219957|FG000|Overall Study|Withdrawal by Subject|8|||
94662667|NCT01165281|324219958|FG001|Overall Study|Withdrawal by Subject|7|||
94662668|NCT01165281|324219957|FG000|Overall Study|Noncompliance with Study Drug|1|||
94662669|NCT01165281|324219958|FG001|Overall Study|Noncompliance with Study Drug|4|||
94662670|NCT01165281|324219957|FG000|Overall Study|Progressive Disease|10|||
94662671|NCT01165281|324219958|FG001|Overall Study|Progressive Disease|14|||
94662672|NCT01165281|324219957|FG000|Overall Study|Other|6|||
94662673|NCT01165281|324219958|FG001|Overall Study|Other|0|||
94662674|NCT00364858|324219963|FG000|Overall Study|Adverse Event|1|||
94662675|NCT00364858|324219964|FG001|Overall Study|Adverse Event|5|||
94662676|NCT00364858|324219963|FG000|Overall Study|Withdrawal by Subject|1|||
94662677|NCT00364858|324219964|FG001|Overall Study|Withdrawal by Subject|1|||
94662678|NCT00364858|324219963|FG000|Overall Study|Pregnancy|1|||
94662679|NCT00364858|324219964|FG001|Overall Study|Pregnancy|1|||
94662680|NCT00364858|324219963|FG000|Overall Study|Clinical failure|2|||
94662681|NCT00364858|324219964|FG001|Overall Study|Clinical failure|13|||
94662682|NCT00364858|324219963|FG000|Overall Study|Discontinuation at baseline|1|||
94662683|NCT00364858|324219964|FG001|Overall Study|Discontinuation at baseline|0|||
94662684|NCT00364858|324219963|FG000|Overall Study|Non-compliant|1|||
94662685|NCT00364858|324219964|FG001|Overall Study|Non-compliant|0|||
94662686|NCT00364858|324219963|FG000|Overall Study|Return to Q2 regimen|0|||
94662687|NCT00364858|324219964|FG001|Overall Study|Return to Q2 regimen|1|||
94662688|NCT00364858|324219963|FG000|Overall Study|Clinical baseline issue|0|||
94662689|NCT00364858|324219964|FG001|Overall Study|Clinical baseline issue|1|||
94662690|NCT02730819|324219968|FG000|Overall Study|Lost to Follow-up|9|||
94662691|NCT02823145|324219969|FG000|Enrollment|Other|1|||
94662692|NCT02823145|324219970|FG001|Enrollment|Other|0|||
94662693|NCT02823145|324219969|FG000|Treatment|Adverse Event|0|||
94662694|NCT02823145|324219970|FG001|Treatment|Adverse Event|11|||
94662695|NCT02823145|324219969|FG000|Treatment|Death|0|||
94662696|NCT02823145|324219970|FG001|Treatment|Death|3|||
94662697|NCT02823145|324219969|FG000|Treatment|Family Decision|0|||
94662698|NCT02823145|324219970|FG001|Treatment|Family Decision|1|||
94662699|NCT02823145|324219969|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
94662700|NCT02823145|324219970|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
94662701|NCT02823145|324219969|FG000|Treatment|Lack of Efficacy|0|||
94662702|NCT02823145|324219970|FG001|Treatment|Lack of Efficacy|48|||
94662703|NCT02823145|324219969|FG000|Treatment|Non-Compliance With E-Diary|0|||
94662704|NCT02823145|324219970|FG001|Treatment|Non-Compliance With E-Diary|1|||
94253663|NCT00910689|322722522|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
94253664|NCT00910689|322722523|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
94459581|NCT02031640|323471855|FG000|Screening Period|Withdrawal by Subject|29|||
94662705|NCT02823145|324219969|FG000|Treatment|Physician Decision|0|||
94662706|NCT02823145|324219970|FG001|Treatment|Physician Decision|2|||
94662707|NCT02823145|324219969|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
94662708|NCT02823145|324219970|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
94662709|NCT02823145|324219969|FG000|Treatment|Subject needed to take prohibited medication|0|||
94459582|NCT02031640|323471856|FG001|Screening Period|Withdrawal by Subject|0|||
94459583|NCT02031640|323471857|FG002|Screening Period|Withdrawal by Subject|0|||
94459584|NCT02031640|323471858|FG003|Screening Period|Withdrawal by Subject|0|||
94459585|NCT02031640|323471859|FG004|Screening Period|Withdrawal by Subject|0|||
94459586|NCT02031640|323471860|FG005|Screening Period|Withdrawal by Subject|0|||
94459587|NCT02031640|323471855|FG000|Screening Period|Inclusion criteria not met|312|||
94459588|NCT02031640|323471856|FG001|Screening Period|Inclusion criteria not met|0|||
94459589|NCT02031640|323471857|FG002|Screening Period|Inclusion criteria not met|0|||
94459590|NCT02031640|323471858|FG003|Screening Period|Inclusion criteria not met|0|||
94459591|NCT02031640|323471859|FG004|Screening Period|Inclusion criteria not met|0|||
94459592|NCT02031640|323471860|FG005|Screening Period|Inclusion criteria not met|0|||
94459593|NCT02031640|323471855|FG000|Screening Period|Exclusion criteria met|30|||
94459594|NCT02031640|323471856|FG001|Screening Period|Exclusion criteria met|0|||
94459595|NCT02031640|323471857|FG002|Screening Period|Exclusion criteria met|0|||
94459596|NCT02031640|323471858|FG003|Screening Period|Exclusion criteria met|0|||
94459597|NCT02031640|323471859|FG004|Screening Period|Exclusion criteria met|0|||
94459598|NCT02031640|323471860|FG005|Screening Period|Exclusion criteria met|0|||
94459599|NCT02031640|323471855|FG000|Screening Period|Lost to Follow-up|14|||
94459600|NCT02031640|323471856|FG001|Screening Period|Lost to Follow-up|0|||
94459601|NCT02031640|323471857|FG002|Screening Period|Lost to Follow-up|0|||
94459602|NCT02031640|323471858|FG003|Screening Period|Lost to Follow-up|0|||
94459603|NCT02031640|323471859|FG004|Screening Period|Lost to Follow-up|0|||
94459604|NCT02031640|323471860|FG005|Screening Period|Lost to Follow-up|0|||
94459605|NCT02031640|323471855|FG000|Screening Period|Enrollment closed|26|||
94459606|NCT02031640|323471856|FG001|Screening Period|Enrollment closed|0|||
94459607|NCT02031640|323471857|FG002|Screening Period|Enrollment closed|0|||
94459608|NCT02031640|323471858|FG003|Screening Period|Enrollment closed|0|||
94459609|NCT02031640|323471859|FG004|Screening Period|Enrollment closed|0|||
94459610|NCT02031640|323471860|FG005|Screening Period|Enrollment closed|0|||
94459611|NCT02031640|323471855|FG000|Run-In Period|Adverse Event|4|||
94459612|NCT02031640|323471856|FG001|Run-In Period|Adverse Event|0|||
94459613|NCT02031640|323471857|FG002|Run-In Period|Adverse Event|0|||
94459614|NCT02031640|323471858|FG003|Run-In Period|Adverse Event|0|||
94459615|NCT02031640|323471859|FG004|Run-In Period|Adverse Event|0|||
94459616|NCT02031640|323471860|FG005|Run-In Period|Adverse Event|0|||
94459617|NCT02031640|323471855|FG000|Run-In Period|Withdrawal by Subject|17|||
94459618|NCT02031640|323471856|FG001|Run-In Period|Withdrawal by Subject|0|||
94459619|NCT02031640|323471857|FG002|Run-In Period|Withdrawal by Subject|0|||
94459620|NCT02031640|323471858|FG003|Run-In Period|Withdrawal by Subject|0|||
94459621|NCT02031640|323471859|FG004|Run-In Period|Withdrawal by Subject|0|||
94459622|NCT02031640|323471860|FG005|Run-In Period|Withdrawal by Subject|0|||
94459623|NCT02031640|323471855|FG000|Run-In Period|Inclusion criteria not met|38|||
94459624|NCT02031640|323471856|FG001|Run-In Period|Inclusion criteria not met|0|||
94459625|NCT02031640|323471857|FG002|Run-In Period|Inclusion criteria not met|0|||
94459626|NCT02031640|323471858|FG003|Run-In Period|Inclusion criteria not met|0|||
94459627|NCT02031640|323471859|FG004|Run-In Period|Inclusion criteria not met|0|||
94459628|NCT02031640|323471860|FG005|Run-In Period|Inclusion criteria not met|0|||
94459629|NCT02031640|323471855|FG000|Run-In Period|Exclusion criteria met|8|||
94459630|NCT02031640|323471856|FG001|Run-In Period|Exclusion criteria met|0|||
94459631|NCT02031640|323471857|FG002|Run-In Period|Exclusion criteria met|0|||
94459632|NCT02031640|323471858|FG003|Run-In Period|Exclusion criteria met|0|||
94459633|NCT02031640|323471859|FG004|Run-In Period|Exclusion criteria met|0|||
94459634|NCT02031640|323471860|FG005|Run-In Period|Exclusion criteria met|0|||
94459635|NCT02031640|323471855|FG000|Run-In Period|Randomization criteria not met|85|||
94459636|NCT02031640|323471856|FG001|Run-In Period|Randomization criteria not met|0|||
94459637|NCT02031640|323471857|FG002|Run-In Period|Randomization criteria not met|0|||
94459638|NCT02031640|323471858|FG003|Run-In Period|Randomization criteria not met|0|||
94459639|NCT02031640|323471859|FG004|Run-In Period|Randomization criteria not met|0|||
94459640|NCT02031640|323471860|FG005|Run-In Period|Randomization criteria not met|0|||
94459641|NCT02031640|323471855|FG000|Run-In Period|Various administrative reasons|17|||
94459642|NCT02031640|323471856|FG001|Run-In Period|Various administrative reasons|0|||
94459643|NCT02031640|323471857|FG002|Run-In Period|Various administrative reasons|0|||
94459644|NCT02031640|323471858|FG003|Run-In Period|Various administrative reasons|0|||
94459645|NCT02031640|323471859|FG004|Run-In Period|Various administrative reasons|0|||
94459646|NCT02031640|323471860|FG005|Run-In Period|Various administrative reasons|0|||
94358376|NCT04365387|323094460|FG000|Overall Study|Participant moved out of town (relocated)|0|||
94662710|NCT02823145|324219970|FG001|Treatment|Subject needed to take prohibited medication|1|||
94358377|NCT04365387|323094461|FG001|Overall Study|Participant moved out of town (relocated)|1|||
94358378|NCT04365387|323094460|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
94611881|NCT02633501|324042757|FG005|Overall Study|Withdrawal by Subject|3|||
94611882|NCT02633501|324042752|FG000|Overall Study|Various other reasons|0|||
94611883|NCT02633501|324042753|FG001|Overall Study|Various other reasons|2|||
94611884|NCT02633501|324042754|FG002|Overall Study|Various other reasons|4|||
94611885|NCT02633501|324042755|FG003|Overall Study|Various other reasons|1|||
94611886|NCT02633501|324042756|FG004|Overall Study|Various other reasons|7|||
94611887|NCT02633501|324042757|FG005|Overall Study|Various other reasons|11|||
94611888|NCT02633501|324042752|FG000|Overall Study|Lost to Follow-up|0|||
94611889|NCT02633501|324042753|FG001|Overall Study|Lost to Follow-up|0|||
94611890|NCT02633501|324042754|FG002|Overall Study|Lost to Follow-up|0|||
94611891|NCT02633501|324042755|FG003|Overall Study|Lost to Follow-up|1|||
94611892|NCT02633501|324042756|FG004|Overall Study|Lost to Follow-up|2|||
94611893|NCT02633501|324042757|FG005|Overall Study|Lost to Follow-up|0|||
94611894|NCT04738734|324042758|FG000|Overall Study|Withdrawal by Subject|2|||
94611895|NCT04738734|324042759|FG001|Overall Study|Withdrawal by Subject|4|||
94611896|NCT04738734|324042758|FG000|Overall Study|Lost to Follow-up|5|||
94611897|NCT04738734|324042759|FG001|Overall Study|Lost to Follow-up|2|||
94611898|NCT04738734|324042758|FG000|Overall Study|Physician Decision|0|||
94611899|NCT04738734|324042759|FG001|Overall Study|Physician Decision|1|||
94611900|NCT04738734|324042758|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
94611901|NCT04738734|324042759|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
94611902|NCT02337738|324042761|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
94611903|NCT02337738|324042762|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
94611904|NCT02337738|324042763|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
94611905|NCT02337738|324042761|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
94611906|NCT02337738|324042762|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
94611907|NCT02337738|324042763|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
94611908|NCT02337738|324042761|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
94611909|NCT02337738|324042762|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
94611910|NCT02337738|324042763|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
94611911|NCT02337738|324042761|FG000|Overall Study|Voluntary Withdrawal|10|||
94253665|NCT00910689|322722524|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
94253666|NCT00910689|322722521|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
94253667|NCT00910689|322722522|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
94253668|NCT00910689|322722523|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
94253669|NCT00910689|322722524|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
94253670|NCT00910689|322722521|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
94662711|NCT02823145|324219969|FG000|Treatment|Subject transferred to direct access programme|0|||
94662712|NCT02823145|324219970|FG001|Treatment|Subject transferred to direct access programme|1|||
94662713|NCT02823145|324219969|FG000|Treatment|Switching to commercially available drug|0|||
94662714|NCT02823145|324219970|FG001|Treatment|Switching to commercially available drug|11|||
94358379|NCT04365387|323094461|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
94358380|NCT04365387|323094460|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
94358381|NCT04365387|323094461|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
94662715|NCT02823145|324219969|FG000|Treatment|Transitioned to commercial supply of medication|0|||
94662716|NCT02823145|324219970|FG001|Treatment|Transitioned to commercial supply of medication|1|||
94662717|NCT02823145|324219969|FG000|Treatment|Withdrawal By Caregiver|0|||
94662718|NCT02823145|324219970|FG001|Treatment|Withdrawal By Caregiver|1|||
94662719|NCT02823145|324219969|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
94662720|NCT02823145|324219970|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
94662721|NCT02823145|324219969|FG000|Treatment|Withdrawal by Subject|0|||
94662722|NCT02823145|324219970|FG001|Treatment|Withdrawal by Subject|16|||
94662723|NCT02823145|324219969|FG000|Treatment|Reason unknown|0|||
94662724|NCT02823145|324219970|FG001|Treatment|Reason unknown|1|||
94662725|NCT02075593|324219976|FG000|Overall Study|Withdrawal by Subject|1|||
94662726|NCT00710424|324219977|FG000|Overall Study|Adverse Event|30|||
94662727|NCT00710424|324219978|FG001|Overall Study|Adverse Event|12|||
94662728|NCT00710424|324219977|FG000|Overall Study|Lack of Efficacy|4|||
94662729|NCT00710424|324219978|FG001|Overall Study|Lack of Efficacy|5|||
94253671|NCT00910689|322722522|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
94253672|NCT00910689|322722523|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
94253673|NCT00910689|322722524|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
94662730|NCT00710424|324219977|FG000|Overall Study|Withdrawal by Subject|5|||
94253674|NCT00910689|322722521|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
94253675|NCT00910689|322722522|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
94253676|NCT00910689|322722523|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
94662731|NCT00710424|324219978|FG001|Overall Study|Withdrawal by Subject|3|||
94253677|NCT00910689|322722524|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
94253678|NCT00910689|322722521|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
94253679|NCT00910689|322722522|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
94253680|NCT00910689|322722523|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
94253681|NCT00910689|322722524|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
94253682|NCT00910689|322722521|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
94253683|NCT00910689|322722522|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
94253684|NCT00910689|322722523|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
94253685|NCT00910689|322722524|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
94253686|NCT00910689|322722521|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
94253687|NCT00910689|322722522|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
94253688|NCT00910689|322722523|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
94253689|NCT00910689|322722524|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
94662732|NCT00710424|324219977|FG000|Overall Study|Lost to Follow-up|0|||
94662733|NCT00710424|324219978|FG001|Overall Study|Lost to Follow-up|1|||
94662734|NCT00710424|324219977|FG000|Overall Study|Refused medication, no side effects|1|||
94662735|NCT00710424|324219978|FG001|Overall Study|Refused medication, no side effects|0|||
94662736|NCT00710424|324219977|FG000|Overall Study|Non-compliance with stable analgesia|1|||
94662737|NCT00710424|324219978|FG001|Overall Study|Non-compliance with stable analgesia|0|||
94662738|NCT00710424|324219977|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
94662739|NCT00710424|324219978|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
94662740|NCT00710424|324219977|FG000|Overall Study|Subject thought medication changed|1|||
94662741|NCT00710424|324219978|FG001|Overall Study|Subject thought medication changed|0|||
94662742|NCT00710424|324219977|FG000|Overall Study|Ceased treatment due to travel|1|||
94662743|NCT00710424|324219978|FG001|Overall Study|Ceased treatment due to travel|0|||
94662744|NCT00710424|324219977|FG000|Overall Study|Subject preferred paracetamol|0|||
94662745|NCT00710424|324219978|FG001|Overall Study|Subject preferred paracetamol|1|||
94662746|NCT00710424|324219977|FG000|Overall Study|Felt good so stopped treatment|0|||
94662747|NCT00710424|324219978|FG001|Overall Study|Felt good so stopped treatment|1|||
94662748|NCT03069482|324222122|FG000|Overall Study|Lost to Follow-up|0|||
94662749|NCT03069482|324222123|FG001|Overall Study|Lost to Follow-up|1|||
94662750|NCT03069482|324222122|FG000|Overall Study|Physician Decision|1|||
94662751|NCT03069482|324222123|FG001|Overall Study|Physician Decision|0|||
94662752|NCT00724282|324222126|FG000|Overall Study|Withdrawal by Subject|3|||
94662753|NCT00724282|324222126|FG000|Overall Study|Physician Decision|1|||
94662754|NCT02395120|324222127|FG000|Overall Study|Missed follow-up dental exam|57|||
94662755|NCT02395120|324222128|FG001|Overall Study|Missed follow-up dental exam|62|||
94662756|NCT02395120|324222129|FG002|Overall Study|Missed follow-up dental exam|6|||
94662757|NCT02395120|324222130|FG003|Overall Study|Missed follow-up dental exam|6|||
94662758|NCT02395120|324222131|FG004|Overall Study|Missed follow-up dental exam|51|||
94662759|NCT04579757|324222139|FG000|Overall Study|Adverse Event|0|||
94662760|NCT04579757|324222140|FG001|Overall Study|Adverse Event|0|||
94662761|NCT04579757|324222141|FG002|Overall Study|Adverse Event|0|||
94662762|NCT04579757|324222142|FG003|Overall Study|Adverse Event|2|||
94662763|NCT04579757|324222143|FG004|Overall Study|Adverse Event|1|||
94662764|NCT04579757|324222144|FG005|Overall Study|Adverse Event|1|||
94662765|NCT04579757|324222145|FG006|Overall Study|Adverse Event|0|||
94662766|NCT04579757|324222146|FG007|Overall Study|Adverse Event|0|||
94662767|NCT04579757|324222147|FG008|Overall Study|Adverse Event|0|||
94662768|NCT04579757|324222139|FG000|Overall Study|Death|4|||
94662769|NCT04579757|324222140|FG001|Overall Study|Death|1|||
94662770|NCT04579757|324222141|FG002|Overall Study|Death|14|||
94662771|NCT04579757|324222142|FG003|Overall Study|Death|3|||
94662772|NCT04579757|324222143|FG004|Overall Study|Death|2|||
94662773|NCT04579757|324222144|FG005|Overall Study|Death|7|||
94662774|NCT04579757|324222145|FG006|Overall Study|Death|0|||
94662775|NCT04579757|324222146|FG007|Overall Study|Death|1|||
94662776|NCT04579757|324222147|FG008|Overall Study|Death|3|||
94662777|NCT04579757|324222139|FG000|Overall Study|Physician Decision|0|||
94662778|NCT04579757|324222140|FG001|Overall Study|Physician Decision|0|||
94662779|NCT04579757|324222141|FG002|Overall Study|Physician Decision|0|||
94662780|NCT04579757|324222142|FG003|Overall Study|Physician Decision|2|||
94662781|NCT04579757|324222143|FG004|Overall Study|Physician Decision|1|||
94662782|NCT04579757|324222144|FG005|Overall Study|Physician Decision|1|||
94662783|NCT04579757|324222145|FG006|Overall Study|Physician Decision|1|||
94662784|NCT04579757|324222146|FG007|Overall Study|Physician Decision|0|||
94662785|NCT04579757|324222147|FG008|Overall Study|Physician Decision|0|||
94662786|NCT04579757|324222139|FG000|Overall Study|Study Terminated By Sponsor|0|||
94253690|NCT00910689|322722521|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
94662787|NCT04579757|324222140|FG001|Overall Study|Study Terminated By Sponsor|0|||
94662788|NCT04579757|324222141|FG002|Overall Study|Study Terminated By Sponsor|0|||
94662789|NCT04579757|324222142|FG003|Overall Study|Study Terminated By Sponsor|0|||
94253691|NCT00910689|322722522|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
94253692|NCT00910689|322722523|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
94253693|NCT00910689|322722524|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
94253694|NCT00910689|322722521|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
94253695|NCT00910689|322722522|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
94253696|NCT00910689|322722523|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
94253697|NCT00910689|322722524|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
94253698|NCT00910689|322722521|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
94253699|NCT00910689|322722522|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
94253700|NCT00910689|322722523|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
94253701|NCT00910689|322722524|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
94253702|NCT00910689|322722521|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
94253703|NCT00910689|322722522|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
94253704|NCT00910689|322722523|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
94253705|NCT00910689|322722524|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
94253706|NCT01290029|322722525|FG000|Overall Study|Other|2|||
94253707|NCT00484289|322722528|FG000|Long Term Phase|Adverse Event|1|||
94253708|NCT00484289|322722529|FG001|Long Term Phase|Adverse Event|17|||
94253709|NCT00484289|322722530|FG002|Long Term Phase|Adverse Event|5|||
94253710|NCT00484289|322722528|FG000|Long Term Phase|Withdrawal by Subject|0|||
94253711|NCT00484289|322722529|FG001|Long Term Phase|Withdrawal by Subject|7|||
94253712|NCT00484289|322722530|FG002|Long Term Phase|Withdrawal by Subject|6|||
94253713|NCT00484289|322722528|FG000|Long Term Phase|Inadequate response|2|||
94253714|NCT00484289|322722529|FG001|Long Term Phase|Inadequate response|7|||
94253715|NCT00484289|322722530|FG002|Long Term Phase|Inadequate response|4|||
94253716|NCT00484289|322722528|FG000|Long Term Phase|Other Reason|0|||
94253717|NCT00484289|322722529|FG001|Long Term Phase|Other Reason|5|||
94253718|NCT00484289|322722530|FG002|Long Term Phase|Other Reason|1|||
94253719|NCT00484289|322722528|FG000|Post Marketing Phase|Adverse Event|0|||
94253720|NCT00484289|322722529|FG001|Post Marketing Phase|Adverse Event|1|||
94253721|NCT00484289|322722530|FG002|Post Marketing Phase|Adverse Event|0|||
94253722|NCT03938545|322722531|FG000|Overall Study|Lost to Follow-up|0|||
94253723|NCT03938545|322722532|FG001|Overall Study|Lost to Follow-up|0|||
94253724|NCT03938545|322722533|FG002|Overall Study|Lost to Follow-up|0|||
94253725|NCT03938545|322722534|FG003|Overall Study|Lost to Follow-up|1|||
94253726|NCT03938545|322722531|FG000|Overall Study|Non-compliance with study drug|0|||
94253727|NCT03938545|322722532|FG001|Overall Study|Non-compliance with study drug|0|||
94253728|NCT03938545|322722533|FG002|Overall Study|Non-compliance with study drug|1|||
94253729|NCT03938545|322722534|FG003|Overall Study|Non-compliance with study drug|0|||
94253730|NCT03938545|322722531|FG000|Overall Study|Pregnancy|1|||
94253731|NCT03938545|322722532|FG001|Overall Study|Pregnancy|0|||
94253732|NCT03938545|322722533|FG002|Overall Study|Pregnancy|0|||
94253733|NCT03938545|322722534|FG003|Overall Study|Pregnancy|0|||
94253734|NCT03938545|322722531|FG000|Overall Study|Study terminated by sponsor|6|||
94253735|NCT03938545|322722532|FG001|Overall Study|Study terminated by sponsor|4|||
94253736|NCT03938545|322722533|FG002|Overall Study|Study terminated by sponsor|2|||
94253737|NCT03938545|322722534|FG003|Overall Study|Study terminated by sponsor|4|||
94253738|NCT03938545|322722531|FG000|Overall Study|Withdrawal by Subject|0|||
94253739|NCT03938545|322722532|FG001|Overall Study|Withdrawal by Subject|1|||
94253740|NCT03938545|322722533|FG002|Overall Study|Withdrawal by Subject|0|||
94253741|NCT03938545|322722534|FG003|Overall Study|Withdrawal by Subject|0|||
94253742|NCT03938545|322722531|FG000|Overall Study|Adverse Event|1|||
94253743|NCT03938545|322722532|FG001|Overall Study|Adverse Event|0|||
94459647|NCT02031640|323471855|FG000|Double-blind Treatment Period|Protocol deviation|0|||
94459648|NCT02031640|323471856|FG001|Double-blind Treatment Period|Protocol deviation|2|||
94611912|NCT02337738|324042762|FG001|Overall Study|Voluntary Withdrawal|5|||
94611913|NCT02337738|324042763|FG002|Overall Study|Voluntary Withdrawal|2|||
94611914|NCT02337738|324042761|FG000|Overall Study|Lack of Efficacy|2|||
94611915|NCT02337738|324042762|FG001|Overall Study|Lack of Efficacy|4|||
94611916|NCT02337738|324042763|FG002|Overall Study|Lack of Efficacy|0|||
94611917|NCT02337738|324042761|FG000|Overall Study|Investigator's Judgment|1|||
94611918|NCT02337738|324042762|FG001|Overall Study|Investigator's Judgment|1|||
94611919|NCT02337738|324042763|FG002|Overall Study|Investigator's Judgment|3|||
94611920|NCT00702689|324042764|FG000|Overall Study|Withdrawal by Subject|4|||
94611921|NCT00702689|324042764|FG000|Overall Study|Recurrent malignancy|1|||
94253744|NCT03938545|322722533|FG002|Overall Study|Adverse Event|0|||
94253745|NCT03938545|322722534|FG003|Overall Study|Adverse Event|0|||
94253746|NCT05087979|322722535|FG000|Overall Study|Converted to general anesthesia|1|||
94253747|NCT05087979|322722536|FG001|Overall Study|Converted to general anesthesia|0|||
94253748|NCT01877837|322722537|FG000|Overall Study|Lost to Follow-up|1|||
94253749|NCT01877837|322722537|FG000|Overall Study|Ineligible|4|||
94253750|NCT02680002|322722539|FG000|Overall Study|Lost to Follow-up|5|||
94253751|NCT02680002|322722540|FG001|Overall Study|Lost to Follow-up|1|||
94253752|NCT02680002|322722541|FG002|Overall Study|Lost to Follow-up|4|||
94611922|NCT00702689|324042764|FG000|Overall Study|Adverse Event|1|||
94253753|NCT02680002|322722542|FG003|Overall Study|Lost to Follow-up|2|||
94253754|NCT02680002|322722543|FG004|Overall Study|Lost to Follow-up|0|||
94253755|NCT02680002|322722544|FG005|Overall Study|Lost to Follow-up|2|||
94253756|NCT02680002|322722539|FG000|Overall Study|Physician Decision|5|||
94253757|NCT02680002|322722540|FG001|Overall Study|Physician Decision|1|||
94253758|NCT02680002|322722541|FG002|Overall Study|Physician Decision|1|||
94253759|NCT02680002|322722542|FG003|Overall Study|Physician Decision|1|||
94253760|NCT02680002|322722543|FG004|Overall Study|Physician Decision|1|||
94253761|NCT02680002|322722544|FG005|Overall Study|Physician Decision|1|||
94253762|NCT02680002|322722539|FG000|Overall Study|Protocol Violation|1|||
94253763|NCT02680002|322722540|FG001|Overall Study|Protocol Violation|0|||
94253764|NCT02680002|322722541|FG002|Overall Study|Protocol Violation|1|||
94253765|NCT02680002|322722542|FG003|Overall Study|Protocol Violation|0|||
94253766|NCT02680002|322722543|FG004|Overall Study|Protocol Violation|1|||
94253767|NCT02680002|322722544|FG005|Overall Study|Protocol Violation|2|||
94253768|NCT02680002|322722539|FG000|Overall Study|Withdrawal by Subject|0|||
94253769|NCT02680002|322722540|FG001|Overall Study|Withdrawal by Subject|0|||
94253770|NCT02680002|322722541|FG002|Overall Study|Withdrawal by Subject|1|||
94253771|NCT02680002|322722542|FG003|Overall Study|Withdrawal by Subject|0|||
94253772|NCT02680002|322722543|FG004|Overall Study|Withdrawal by Subject|2|||
94253773|NCT02680002|322722544|FG005|Overall Study|Withdrawal by Subject|2|||
94253774|NCT02680002|322722539|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
94253775|NCT02680002|322722540|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
94253776|NCT02680002|322722541|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
94253777|NCT02680002|322722542|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
94253778|NCT02680002|322722543|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
94253779|NCT02680002|322722544|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
94253780|NCT02680002|322722539|FG000|Overall Study|Other|0|||
94253781|NCT02680002|322722540|FG001|Overall Study|Other|1|||
94253782|NCT02680002|322722541|FG002|Overall Study|Other|0|||
94253783|NCT02680002|322722542|FG003|Overall Study|Other|0|||
94253784|NCT02680002|322722543|FG004|Overall Study|Other|1|||
94253785|NCT02680002|322722544|FG005|Overall Study|Other|0|||
94253786|NCT02680002|322722539|FG000|Overall Study|Adverse Event|0|||
94253787|NCT02680002|322722540|FG001|Overall Study|Adverse Event|0|||
94253788|NCT02680002|322722541|FG002|Overall Study|Adverse Event|0|||
94253789|NCT02680002|322722542|FG003|Overall Study|Adverse Event|0|||
94253790|NCT02680002|322722543|FG004|Overall Study|Adverse Event|1|||
94253791|NCT02680002|322722544|FG005|Overall Study|Adverse Event|2|||
94253792|NCT03527173|322722546|FG000|Overall Study|Lost to Follow-up|4|||
94253793|NCT03527173|322722547|FG001|Overall Study|Lost to Follow-up|2|||
94253794|NCT03527173|322722546|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
94253795|NCT03527173|322722547|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
94253796|NCT03527173|322722546|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
94253797|NCT03527173|322722547|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
94253798|NCT03527173|322722546|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
94253799|NCT03527173|322722547|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
94253800|NCT00596427|322722548|FG000|Overall Study|Withdrawal by Subject|2|||
94611923|NCT00669396|324042767|FG000|Overall Study|Lost to Follow-up|10|||
94611924|NCT00669396|324042768|FG001|Overall Study|Lost to Follow-up|12|||
94611925|NCT01262573|324042769|FG000|Overall Study|Withdrawal by Subject|0|||
94611926|NCT01262573|324042770|FG001|Overall Study|Withdrawal by Subject|1|||
94611927|NCT04251273|324042773|FG000|Overall Study|Lost to Follow-up|331|||
94611928|NCT04251273|324042774|FG001|Overall Study|Lost to Follow-up|290|||
94611929|NCT04402060|324042775|FG000|Overall Study|Death|1|||
94611930|NCT04402060|324042776|FG001|Overall Study|Death|12|||
94611931|NCT04402060|324042777|FG002|Overall Study|Death|7|||
94611932|NCT04402060|324042775|FG000|Overall Study|Adverse Event|0|||
94611933|NCT04402060|324042776|FG001|Overall Study|Adverse Event|0|||
94611934|NCT04402060|324042777|FG002|Overall Study|Adverse Event|1|||
94611935|NCT04402060|324042775|FG000|Overall Study|Withdrawal by Subject|0|||
94611936|NCT04402060|324042776|FG001|Overall Study|Withdrawal by Subject|1|||
94611937|NCT04402060|324042777|FG002|Overall Study|Withdrawal by Subject|2|||
94611938|NCT04402060|324042775|FG000|Overall Study|Sponsor Request|0|||
94662790|NCT04579757|324222143|FG004|Overall Study|Study Terminated By Sponsor|2|||
94253801|NCT00596427|322722549|FG001|Overall Study|Withdrawal by Subject|2|||
94253802|NCT00596427|322722548|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
94253803|NCT00596427|322722549|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
94253804|NCT00596427|322722548|FG000|Overall Study|Protocol Violation|1|||
94253805|NCT00596427|322722549|FG001|Overall Study|Protocol Violation|0|||
94253806|NCT00320541|322722550|FG000|Overall Study|Adverse Event|21|||
94253807|NCT00320541|322722551|FG001|Overall Study|Adverse Event|19|||
94253808|NCT00320541|322722550|FG000|Overall Study|Protocol Violation|0|||
94253809|NCT00320541|322722551|FG001|Overall Study|Protocol Violation|1|||
94253810|NCT00320541|322722550|FG000|Overall Study|Withdrawal by Subject|12|||
94358382|NCT05770401|323094462|FG000|Overall Study|Lost to Follow-up|5|||
94611939|NCT04402060|324042776|FG001|Overall Study|Sponsor Request|2|||
94611940|NCT04402060|324042777|FG002|Overall Study|Sponsor Request|0|||
94662791|NCT04579757|324222144|FG005|Overall Study|Study Terminated By Sponsor|0|||
94662792|NCT04579757|324222145|FG006|Overall Study|Study Terminated By Sponsor|0|||
94662793|NCT04579757|324222146|FG007|Overall Study|Study Terminated By Sponsor|2|||
94662794|NCT04579757|324222147|FG008|Overall Study|Study Terminated By Sponsor|0|||
94662795|NCT04579757|324222139|FG000|Overall Study|Withdrawal by Subject|1|||
94662796|NCT04579757|324222140|FG001|Overall Study|Withdrawal by Subject|1|||
94662797|NCT04579757|324222141|FG002|Overall Study|Withdrawal by Subject|0|||
94662798|NCT04579757|324222142|FG003|Overall Study|Withdrawal by Subject|0|||
94662799|NCT04579757|324222143|FG004|Overall Study|Withdrawal by Subject|2|||
94662800|NCT04579757|324222144|FG005|Overall Study|Withdrawal by Subject|1|||
94662801|NCT04579757|324222145|FG006|Overall Study|Withdrawal by Subject|0|||
94662802|NCT04579757|324222146|FG007|Overall Study|Withdrawal by Subject|3|||
94662803|NCT04579757|324222147|FG008|Overall Study|Withdrawal by Subject|0|||
94662804|NCT04579757|324222139|FG000|Overall Study|Radiological or Clinical PD|1|||
94662805|NCT04579757|324222140|FG001|Overall Study|Radiological or Clinical PD|4|||
94662806|NCT04579757|324222141|FG002|Overall Study|Radiological or Clinical PD|1|||
94662807|NCT04579757|324222142|FG003|Overall Study|Radiological or Clinical PD|3|||
94662808|NCT04579757|324222143|FG004|Overall Study|Radiological or Clinical PD|9|||
94662809|NCT04579757|324222144|FG005|Overall Study|Radiological or Clinical PD|4|||
94662810|NCT04579757|324222145|FG006|Overall Study|Radiological or Clinical PD|2|||
94662811|NCT04579757|324222146|FG007|Overall Study|Radiological or Clinical PD|2|||
94662812|NCT04579757|324222147|FG008|Overall Study|Radiological or Clinical PD|0|||
94662813|NCT04579757|324222139|FG000|Overall Study|Start of New Therapy|0|||
94662814|NCT04579757|324222140|FG001|Overall Study|Start of New Therapy|0|||
94662815|NCT04579757|324222141|FG002|Overall Study|Start of New Therapy|0|||
94662816|NCT04579757|324222142|FG003|Overall Study|Start of New Therapy|0|||
94662817|NCT04579757|324222143|FG004|Overall Study|Start of New Therapy|2|||
94358383|NCT05770401|323094463|FG001|Overall Study|Lost to Follow-up|4|||
94358384|NCT00402298|323094464|FG000|Overall Study|Withdrawal by Subject|1|||
94358385|NCT00402298|323094465|FG001|Overall Study|Withdrawal by Subject|0|||
94662818|NCT04579757|324222144|FG005|Overall Study|Start of New Therapy|1|||
94662819|NCT04579757|324222145|FG006|Overall Study|Start of New Therapy|0|||
94662820|NCT04579757|324222146|FG007|Overall Study|Start of New Therapy|0|||
94662821|NCT04579757|324222147|FG008|Overall Study|Start of New Therapy|0|||
94662822|NCT02646423|324222150|FG000|Overall Study|Adverse Event|5|||
94662823|NCT02646423|324222151|FG001|Overall Study|Adverse Event|7|||
94662824|NCT02646423|324222150|FG000|Overall Study|Ineligible|2|||
94662825|NCT02646423|324222151|FG001|Overall Study|Ineligible|1|||
94662826|NCT00377819|324222152|FG000|Overall Study|Adverse Event|2|||
94662827|NCT00377819|324222153|FG001|Overall Study|Adverse Event|3|||
94662828|NCT00377819|324222152|FG000|Overall Study|Withdrawal by Subject|10|||
94662829|NCT00377819|324222153|FG001|Overall Study|Withdrawal by Subject|4|||
94662830|NCT00377819|324222152|FG000|Overall Study|Death|0|||
94662831|NCT00377819|324222153|FG001|Overall Study|Death|1|||
94662832|NCT00377819|324222152|FG000|Overall Study|Lost to Follow-up|0|||
94662833|NCT00377819|324222153|FG001|Overall Study|Lost to Follow-up|1|||
94662834|NCT00377819|324222152|FG000|Overall Study|Protocol Violation|1|||
94662835|NCT00377819|324222153|FG001|Overall Study|Protocol Violation|1|||
94662836|NCT03727750|324222154|FG000|Overall Study|Death|45|||
94662837|NCT03727750|324222154|FG000|Overall Study|Withdrawal by Subject|2|||
94662838|NCT03727750|324222154|FG000|Overall Study|Lost to Follow-up|1|||
94662839|NCT03727750|324222154|FG000|Overall Study|Other|1|||
94662840|NCT00321919|324222155|FG000|Overall Study|Adverse Event|17|||
94662841|NCT00321919|324222156|FG001|Overall Study|Adverse Event|10|||
94662842|NCT00321919|324222155|FG000|Overall Study|Death|21|||
94662843|NCT00321919|324222156|FG001|Overall Study|Death|17|||
94662844|NCT00321919|324222155|FG000|Overall Study|Insufficient Therapeutic Response|1|||
94662845|NCT00321919|324222156|FG001|Overall Study|Insufficient Therapeutic Response|0|||
94662846|NCT00321919|324222155|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
94611941|NCT04402060|324042775|FG000|Overall Study|Physician Decision|0|||
94611942|NCT04402060|324042776|FG001|Overall Study|Physician Decision|0|||
94611943|NCT04402060|324042777|FG002|Overall Study|Physician Decision|1|||
94611944|NCT04402060|324042775|FG000|Overall Study|Other|0|||
94611945|NCT04402060|324042776|FG001|Overall Study|Other|1|||
94611946|NCT04402060|324042777|FG002|Overall Study|Other|0|||
94611947|NCT00810693|324042778|FG000|Treatment Period|Adverse Event|8|||
94611948|NCT00810693|324042779|FG001|Treatment Period|Adverse Event|1|||
94611949|NCT00810693|324042780|FG002|Treatment Period|Adverse Event|7|||
94611950|NCT00810693|324042778|FG000|Treatment Period|Death|0|||
94611951|NCT00810693|324042779|FG001|Treatment Period|Death|1|||
94611952|NCT00810693|324042780|FG002|Treatment Period|Death|2|||
94611953|NCT00810693|324042778|FG000|Treatment Period|Lack of Efficacy|0|||
94611954|NCT00810693|324042779|FG001|Treatment Period|Lack of Efficacy|0|||
94611955|NCT00810693|324042780|FG002|Treatment Period|Lack of Efficacy|1|||
94611956|NCT00810693|324042778|FG000|Treatment Period|Lost to Follow-up|1|||
94611957|NCT00810693|324042779|FG001|Treatment Period|Lost to Follow-up|0|||
94611958|NCT00810693|324042780|FG002|Treatment Period|Lost to Follow-up|0|||
94611959|NCT00810693|324042778|FG000|Treatment Period|Non-compliance|1|||
94611960|NCT00810693|324042779|FG001|Treatment Period|Non-compliance|0|||
94611961|NCT00810693|324042780|FG002|Treatment Period|Non-compliance|0|||
94253811|NCT00320541|322722551|FG001|Overall Study|Withdrawal by Subject|16|||
94253812|NCT00320541|322722550|FG000|Overall Study|Physician Decision|9|||
94253813|NCT00320541|322722551|FG001|Overall Study|Physician Decision|13|||
94253814|NCT00320541|322722550|FG000|Overall Study|Other|3|||
94253815|NCT00320541|322722551|FG001|Overall Study|Other|4|||
94253816|NCT00320541|322722550|FG000|Overall Study|Sponsor Decision|2|||
94253817|NCT00320541|322722551|FG001|Overall Study|Sponsor Decision|1|||
94253818|NCT00320541|322722550|FG000|Overall Study|Death due to Study Disease|1|||
94253819|NCT00320541|322722551|FG001|Overall Study|Death due to Study Disease|3|||
94253820|NCT00320541|322722550|FG000|Overall Study|Death due to Adverse Event(s)|1|||
94253821|NCT00320541|322722551|FG001|Overall Study|Death due to Adverse Event(s)|0|||
94253822|NCT00320541|322722550|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
94253823|NCT00320541|322722551|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
94253824|NCT04097301|322722554|FG000|Overall Study|Death|1|||
94253825|NCT04097301|322722554|FG000|Overall Study|Withdrawal by Subject|1|||
94253826|NCT04097301|322722554|FG000|Overall Study|Screening Failure|5|||
94253827|NCT04214600|322722555|FG000|Overall Study|Lost to Follow-up|9|||
94253828|NCT04214600|322722556|FG001|Overall Study|Lost to Follow-up|14|||
94253829|NCT01635920|322722562|FG000|Overall Study|Adverse Event|1|||
94611962|NCT00810693|324042778|FG000|Treatment Period|Protocol Violation|1|||
94662847|NCT00321919|324222156|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
94253830|NCT01635920|322722563|FG001|Overall Study|Adverse Event|0|||
94253831|NCT01635920|322722562|FG000|Overall Study|Lost to Follow-up|0|||
94253832|NCT01635920|322722563|FG001|Overall Study|Lost to Follow-up|1|||
94253833|NCT01635920|322722562|FG000|Overall Study|Subject decision|2|||
94253834|NCT01635920|322722563|FG001|Overall Study|Subject decision|0|||
94253835|NCT01813929|322722564|FG000|Overall Study|Withdrawal by Subject|0|||
94253836|NCT01813929|322722565|FG001|Overall Study|Withdrawal by Subject|1|||
94253837|NCT02074553|322722566|FG000|Intervention Period 1|Family Emergency|0|||
94253838|NCT02074553|322722567|FG001|Intervention Period 1|Family Emergency|0|||
94253839|NCT02074553|322722568|FG002|Intervention Period 1|Family Emergency|0|||
94253840|NCT02074553|322722569|FG003|Intervention Period 1|Family Emergency|1|||
94253841|NCT02074553|322722570|FG004|Intervention Period 1|Family Emergency|0|||
94253842|NCT02074553|322722571|FG005|Intervention Period 1|Family Emergency|0|||
94253843|NCT02074553|322722572|FG006|Intervention Period 1|Family Emergency|0|||
94253844|NCT02074553|322722573|FG007|Intervention Period 1|Family Emergency|0|||
94253845|NCT02074553|322722566|FG000|Washout Period 1|Adverse Event|1|||
94253846|NCT02074553|322722567|FG001|Washout Period 1|Adverse Event|0|||
94253847|NCT02074553|322722568|FG002|Washout Period 1|Adverse Event|0|||
94253848|NCT02074553|322722569|FG003|Washout Period 1|Adverse Event|0|||
94253849|NCT02074553|322722570|FG004|Washout Period 1|Adverse Event|0|||
94253850|NCT02074553|322722571|FG005|Washout Period 1|Adverse Event|0|||
94611963|NCT00810693|324042779|FG001|Treatment Period|Protocol Violation|2|||
94611964|NCT00810693|324042780|FG002|Treatment Period|Protocol Violation|2|||
94611965|NCT00810693|324042778|FG000|Treatment Period|Withdrawal by Subject|6|||
94611966|NCT00810693|324042779|FG001|Treatment Period|Withdrawal by Subject|2|||
94611967|NCT00810693|324042780|FG002|Treatment Period|Withdrawal by Subject|3|||
94611968|NCT00810693|324042778|FG000|Treatment Period|Not treated|0|||
94253851|NCT02074553|322722572|FG006|Washout Period 1|Adverse Event|0|||
94253852|NCT02074553|322722573|FG007|Washout Period 1|Adverse Event|0|||
94253853|NCT02074553|322722566|FG000|Washout Period 1|Physician Decision|0|||
94253854|NCT02074553|322722567|FG001|Washout Period 1|Physician Decision|0|||
94253855|NCT02074553|322722568|FG002|Washout Period 1|Physician Decision|0|||
94253856|NCT02074553|322722569|FG003|Washout Period 1|Physician Decision|1|||
94253857|NCT02074553|322722570|FG004|Washout Period 1|Physician Decision|0|||
94253858|NCT02074553|322722571|FG005|Washout Period 1|Physician Decision|0|||
94253859|NCT02074553|322722572|FG006|Washout Period 1|Physician Decision|0|||
94253860|NCT02074553|322722573|FG007|Washout Period 1|Physician Decision|0|||
94253861|NCT02074553|322722566|FG000|Washout Period 1|Other|0|||
94253862|NCT02074553|322722567|FG001|Washout Period 1|Other|0|||
94253863|NCT02074553|322722568|FG002|Washout Period 1|Other|0|||
94253864|NCT02074553|322722569|FG003|Washout Period 1|Other|0|||
94253865|NCT02074553|322722570|FG004|Washout Period 1|Other|0|||
94253866|NCT02074553|322722571|FG005|Washout Period 1|Other|1|||
94253867|NCT02074553|322722572|FG006|Washout Period 1|Other|0|||
94253868|NCT02074553|322722573|FG007|Washout Period 1|Other|0|||
94253869|NCT02074553|322722566|FG000|Washout Period 2|Adverse Event|0|||
94253870|NCT02074553|322722567|FG001|Washout Period 2|Adverse Event|0|||
94253871|NCT02074553|322722568|FG002|Washout Period 2|Adverse Event|0|||
94253872|NCT02074553|322722569|FG003|Washout Period 2|Adverse Event|0|||
94253873|NCT02074553|322722570|FG004|Washout Period 2|Adverse Event|0|||
94611969|NCT00810693|324042779|FG001|Treatment Period|Not treated|1|||
94611970|NCT00810693|324042780|FG002|Treatment Period|Not treated|1|||
94611971|NCT00810693|324042778|FG000|Follow-up Period (FUP)|Adverse Event|3|||
94611972|NCT00810693|324042779|FG001|Follow-up Period (FUP)|Adverse Event|1|||
94611973|NCT00810693|324042780|FG002|Follow-up Period (FUP)|Adverse Event|1|||
94611974|NCT00810693|324042778|FG000|Follow-up Period (FUP)|Death|2|||
94611975|NCT00810693|324042779|FG001|Follow-up Period (FUP)|Death|0|||
94611976|NCT00810693|324042780|FG002|Follow-up Period (FUP)|Death|1|||
94611977|NCT00810693|324042778|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
94611978|NCT00810693|324042779|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
94611979|NCT00810693|324042780|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
94611980|NCT00810693|324042778|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
94611981|NCT00810693|324042779|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
94611982|NCT00810693|324042780|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
94611983|NCT00810693|324042778|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
94611984|NCT00810693|324042779|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
94611985|NCT00810693|324042780|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
94611986|NCT02507973|324042783|FG000|Overall Study|Adverse Event|1|||
94611987|NCT04295772|324042784|FG000|Overall Study|Protocol Violation|1|||
94611988|NCT04295772|324042785|FG001|Overall Study|Protocol Violation|0|||
94611989|NCT04295772|324042784|FG000|Overall Study|Ongoing for safety monitoring|14|||
94611990|NCT04295772|324042785|FG001|Overall Study|Ongoing for safety monitoring|1|||
94611991|NCT04295772|324042784|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
94611992|NCT04295772|324042785|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
94611993|NCT00467857|324042786|FG000|Overall Study|Adverse Event|1|||
94611994|NCT00467857|324042787|FG001|Overall Study|Adverse Event|0|||
94611995|NCT00467857|324042786|FG000|Overall Study|Withdrew consent|2|||
94611996|NCT00467857|324042787|FG001|Overall Study|Withdrew consent|0|||
94611997|NCT00467857|324042786|FG000|Overall Study|Death|0|||
94611998|NCT00467857|324042787|FG001|Overall Study|Death|1|||
94611999|NCT00467857|324042786|FG000|Overall Study|Discharged from court service|0|||
94612000|NCT00467857|324042787|FG001|Overall Study|Discharged from court service|1|||
94612001|NCT00467857|324042786|FG000|Overall Study|Emergency care required|0|||
94612002|NCT00467857|324042787|FG001|Overall Study|Emergency care required|1|||
94612003|NCT00467857|324042786|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
94612004|NCT00467857|324042787|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
94612005|NCT00467857|324042786|FG000|Overall Study|Discontinuation reason missing|0|||
94612006|NCT00467857|324042787|FG001|Overall Study|Discontinuation reason missing|3|||
94612007|NCT00910273|324042788|FG000|Overall Study|Lack of Efficacy|6|||
94612008|NCT00910273|324042789|FG001|Overall Study|Lack of Efficacy|9|||
94662848|NCT00321919|324222155|FG000|Overall Study|Refused Treatment|23|||
94253874|NCT02074553|322722571|FG005|Washout Period 2|Adverse Event|0|||
94253875|NCT02074553|322722572|FG006|Washout Period 2|Adverse Event|1|||
94253876|NCT02074553|322722573|FG007|Washout Period 2|Adverse Event|0|||
94253877|NCT02074553|322722566|FG000|Washout Period 2|Physician Decision|0|||
94253878|NCT02074553|322722567|FG001|Washout Period 2|Physician Decision|0|||
94612009|NCT00910273|324042788|FG000|Overall Study|Adverse Event|1|||
94612010|NCT00910273|324042789|FG001|Overall Study|Adverse Event|1|||
94612011|NCT00910273|324042788|FG000|Overall Study|Withdrawal by Subject|1|||
94612012|NCT00910273|324042789|FG001|Overall Study|Withdrawal by Subject|0|||
94612013|NCT00910273|324042788|FG000|Overall Study|Discontinuation of study by sponsor|8|||
94612014|NCT00910273|324042789|FG001|Overall Study|Discontinuation of study by sponsor|2|||
94253879|NCT02074553|322722568|FG002|Washout Period 2|Physician Decision|0|||
94253880|NCT02074553|322722569|FG003|Washout Period 2|Physician Decision|0|||
94662849|NCT00321919|324222156|FG001|Overall Study|Refused Treatment|14|||
94662850|NCT00321919|324222155|FG000|Overall Study|Other Protocol Violation|2|||
94662851|NCT00321919|324222156|FG001|Overall Study|Other Protocol Violation|3|||
94662852|NCT00321919|324222155|FG000|Overall Study|Failure to Return|3|||
94662853|NCT00321919|324222156|FG001|Overall Study|Failure to Return|1|||
94662854|NCT00321919|324222155|FG000|Overall Study|Other withdrawal reason|7|||
94662855|NCT00321919|324222156|FG001|Overall Study|Other withdrawal reason|6|||
94662856|NCT02624804|324222157|FG000|Overall Study|Screen Failure|5|||
94662857|NCT01917526|324222158|FG000|Overall Study|Protocol Violation|1|||
94662858|NCT01917526|324222159|FG001|Overall Study|Protocol Violation|1|||
94662859|NCT01517802|324222160|FG000|Overall Study|Death|1|||
94662860|NCT00760929|324222161|FG000|Overall Study|Adverse Event|2|||
94662861|NCT00760929|324222162|FG001|Overall Study|Adverse Event|0|||
94662862|NCT00760929|324222163|FG002|Overall Study|Adverse Event|6|||
94662863|NCT00760929|324222164|FG003|Overall Study|Adverse Event|10|||
94662864|NCT00760929|324222161|FG000|Overall Study|Lack of Efficacy|0|||
94662865|NCT00760929|324222162|FG001|Overall Study|Lack of Efficacy|2|||
94662866|NCT00760929|324222163|FG002|Overall Study|Lack of Efficacy|1|||
94662867|NCT00760929|324222164|FG003|Overall Study|Lack of Efficacy|0|||
94662868|NCT00760929|324222161|FG000|Overall Study|Withdrawal by Subject|1|||
94662869|NCT00760929|324222162|FG001|Overall Study|Withdrawal by Subject|0|||
94662870|NCT00760929|324222163|FG002|Overall Study|Withdrawal by Subject|9|||
94662871|NCT00760929|324222164|FG003|Overall Study|Withdrawal by Subject|1|||
94662872|NCT00760929|324222161|FG000|Overall Study|Lost to Follow-up|0|||
94662873|NCT00760929|324222162|FG001|Overall Study|Lost to Follow-up|0|||
94662874|NCT00760929|324222163|FG002|Overall Study|Lost to Follow-up|1|||
94662875|NCT00760929|324222164|FG003|Overall Study|Lost to Follow-up|0|||
94253881|NCT02074553|322722570|FG004|Washout Period 2|Physician Decision|0|||
94253882|NCT02074553|322722571|FG005|Washout Period 2|Physician Decision|1|||
94253883|NCT02074553|322722572|FG006|Washout Period 2|Physician Decision|0|||
94253884|NCT02074553|322722573|FG007|Washout Period 2|Physician Decision|0|||
94253885|NCT02074553|322722566|FG000|Washout Period 2|Lost to Follow-up|0|||
94253886|NCT02074553|322722567|FG001|Washout Period 2|Lost to Follow-up|0|||
94662876|NCT00760929|324222161|FG000|Overall Study|Progression of Disease|21|||
94253887|NCT02074553|322722568|FG002|Washout Period 2|Lost to Follow-up|1|||
94253888|NCT02074553|322722569|FG003|Washout Period 2|Lost to Follow-up|0|||
94253889|NCT02074553|322722570|FG004|Washout Period 2|Lost to Follow-up|0|||
94253890|NCT02074553|322722571|FG005|Washout Period 2|Lost to Follow-up|0|||
94253891|NCT02074553|322722572|FG006|Washout Period 2|Lost to Follow-up|0|||
94253892|NCT02074553|322722573|FG007|Washout Period 2|Lost to Follow-up|0|||
94253893|NCT02074553|322722566|FG000|Washout Period 3|Physician Decision|0|||
94253894|NCT02074553|322722567|FG001|Washout Period 3|Physician Decision|0|||
94253895|NCT02074553|322722568|FG002|Washout Period 3|Physician Decision|0|||
94253896|NCT02074553|322722569|FG003|Washout Period 3|Physician Decision|0|||
94253897|NCT02074553|322722570|FG004|Washout Period 3|Physician Decision|0|||
94253898|NCT02074553|322722571|FG005|Washout Period 3|Physician Decision|0|||
94253899|NCT02074553|322722572|FG006|Washout Period 3|Physician Decision|0|||
94253900|NCT02074553|322722573|FG007|Washout Period 3|Physician Decision|1|||
94253901|NCT01664598|322722574|FG000|Overall Study|Sponsor Decision|1|||
94253902|NCT01664598|322722574|FG000|Overall Study|Withdrawal of Informed Consent|4|||
94253903|NCT01664598|322722574|FG000|Overall Study|Adverse Event|1|||
94253904|NCT01658150|322722575|FG000|Overall Study|Withdrawal by Subject|1|||
94253905|NCT02342743|322722584|FG000|Baseline Period|Withdrawal by Subject|3|||
94253906|NCT02342743|322722584|FG000|Baseline Period|Lost to Follow-up|2|||
94253907|NCT02342743|322722584|FG000|Baseline Period|Change in prophylactic medication|3|||
94253908|NCT02342743|322722584|FG000|Baseline Period|Screening failure regarding baseline|7|||
94253909|NCT02342743|322722584|FG000|Treatment Period|Withdrawal by Subject|2|||
94253910|NCT02342743|322722584|FG000|Treatment Period|Lost to Follow-up|8|||
94253911|NCT02342743|322722584|FG000|Treatment Period|Change in prophylactic medication|1|||
94253912|NCT01656733|322722587|FG000|Overall Study|No permission to collect birth outcomes|0|||
94253913|NCT01656733|322722588|FG001|Overall Study|No permission to collect birth outcomes|1|||
94253914|NCT01656733|322722587|FG000|Overall Study|Delivery at another hospital|0|||
94253915|NCT01656733|322722588|FG001|Overall Study|Delivery at another hospital|2|||
94662877|NCT00760929|324222162|FG001|Overall Study|Progression of Disease|26|||
94662878|NCT00760929|324222163|FG002|Overall Study|Progression of Disease|38|||
94662879|NCT00760929|324222164|FG003|Overall Study|Progression of Disease|42|||
94662880|NCT00760929|324222161|FG000|Overall Study|Other|2|||
94662881|NCT00760929|324222162|FG001|Overall Study|Other|0|||
94662882|NCT00760929|324222163|FG002|Overall Study|Other|2|||
94662883|NCT00760929|324222164|FG003|Overall Study|Other|1|||
94253916|NCT01656733|322722587|FG000|Overall Study|Spontaneous abortion|0|||
94253917|NCT01656733|322722588|FG001|Overall Study|Spontaneous abortion|1|||
94253918|NCT02128542|322722589|FG000|Overall Study|Lost to Follow-up|3|||
94253919|NCT02128542|322722590|FG001|Overall Study|Lost to Follow-up|0|||
94662884|NCT00760929|324222161|FG000|Overall Study|Death|0|||
94662885|NCT00760929|324222162|FG001|Overall Study|Death|0|||
94662886|NCT00760929|324222163|FG002|Overall Study|Death|1|||
94662887|NCT00760929|324222164|FG003|Overall Study|Death|0|||
94662888|NCT00760929|324222161|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
94662889|NCT00760929|324222162|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
94662890|NCT00760929|324222163|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
94662891|NCT00760929|324222164|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
94253920|NCT02128542|322722589|FG000|Overall Study|Withdrew Consent|1|||
94253921|NCT02128542|322722590|FG001|Overall Study|Withdrew Consent|0|||
94253922|NCT02344004|322722594|FG000|Overall Study|Adverse Event|11|||
94253923|NCT02344004|322722595|FG001|Overall Study|Adverse Event|1|||
94253924|NCT02344004|322722594|FG000|Overall Study|Death|9|||
94253925|NCT02344004|322722595|FG001|Overall Study|Death|7|||
94253926|NCT02344004|322722594|FG000|Overall Study|Physician Decision|4|||
94253927|NCT02344004|322722595|FG001|Overall Study|Physician Decision|1|||
94253928|NCT02344004|322722594|FG000|Overall Study|Withdrawal by Subject|22|||
94253929|NCT02344004|322722595|FG001|Overall Study|Withdrawal by Subject|5|||
94253930|NCT02344004|322722594|FG000|Overall Study|Rescue Medication|2|||
94253931|NCT02344004|322722595|FG001|Overall Study|Rescue Medication|0|||
94253932|NCT02344004|322722594|FG000|Overall Study|Other Not Specified|12|||
94253933|NCT02344004|322722595|FG001|Overall Study|Other Not Specified|0|||
94253934|NCT02344004|322722594|FG000|Overall Study|Protocol Violation|1|||
94253935|NCT02344004|322722595|FG001|Overall Study|Protocol Violation|0|||
94253936|NCT02924064|322722596|FG000|Overall Study|Adverse Event|2|||
94253937|NCT02924064|322722597|FG001|Overall Study|Adverse Event|2|||
94253938|NCT02924064|322722596|FG000|Overall Study|Lost to Follow-up|0|||
94253939|NCT02924064|322722597|FG001|Overall Study|Lost to Follow-up|2|||
94253940|NCT02924064|322722596|FG000|Overall Study|Physician Decision|0|||
94253941|NCT02924064|322722597|FG001|Overall Study|Physician Decision|2|||
94253942|NCT02924064|322722596|FG000|Overall Study|Protocol Violation|1|||
94253943|NCT02924064|322722597|FG001|Overall Study|Protocol Violation|3|||
94253944|NCT02924064|322722596|FG000|Overall Study|Withdrawal by Subject|4|||
94253945|NCT02924064|322722597|FG001|Overall Study|Withdrawal by Subject|5|||
94253946|NCT02924064|322722596|FG000|Overall Study|Other|17|||
94253947|NCT02924064|322722597|FG001|Overall Study|Other|29|||
94253948|NCT01945060|322722598|FG000|Overall Study|Lost to follow up|1|||
94253949|NCT01945060|322722599|FG001|Overall Study|Lost to follow up|0|||
94253950|NCT01945060|322722598|FG000|Overall Study|Distress related to IV access|0|||
94253951|NCT01945060|322722599|FG001|Overall Study|Distress related to IV access|1|||
94253952|NCT01488487|322722600|FG000|Overall Study|Adverse Event|6|||
94253953|NCT01488487|322722600|FG000|Overall Study|Death|1|||
94253954|NCT01488487|322722600|FG000|Overall Study|Withdrawal by Subject|2|||
94253955|NCT05249829|322722602|FG000|Overall Study|Participant Relocation|0|||
94253956|NCT05249829|322722603|FG001|Overall Study|Participant Relocation|1|||
94253957|NCT05249829|322722604|FG002|Overall Study|Participant Relocation|2|||
94253958|NCT05249829|322722605|FG003|Overall Study|Participant Relocation|2|||
94662892|NCT02731131|324222165|FG000|Overall Study|Psychiatric Disorder|0|||
94662893|NCT02731131|324222166|FG001|Overall Study|Psychiatric Disorder|1|||
94662894|NCT02731131|324222165|FG000|Overall Study|Refused Therapy|0|||
94662895|NCT02731131|324222166|FG001|Overall Study|Refused Therapy|1|||
94253959|NCT05249829|322722602|FG000|Overall Study|Withdrawal by Subject|9|||
94253960|NCT05249829|322722603|FG001|Overall Study|Withdrawal by Subject|17|||
94253961|NCT05249829|322722604|FG002|Overall Study|Withdrawal by Subject|40|||
94253962|NCT05249829|322722605|FG003|Overall Study|Withdrawal by Subject|35|||
94253963|NCT05249829|322722602|FG000|Overall Study|Physician Decision|1|||
94253964|NCT05249829|322722603|FG001|Overall Study|Physician Decision|0|||
94253965|NCT05249829|322722604|FG002|Overall Study|Physician Decision|0|||
94253966|NCT05249829|322722605|FG003|Overall Study|Physician Decision|0|||
94253967|NCT05249829|322722602|FG000|Overall Study|Lost to Follow-up|16|||
94253968|NCT05249829|322722603|FG001|Overall Study|Lost to Follow-up|16|||
94253969|NCT05249829|322722604|FG002|Overall Study|Lost to Follow-up|57|||
94253970|NCT05249829|322722605|FG003|Overall Study|Lost to Follow-up|60|||
94253971|NCT05249829|322722602|FG000|Overall Study|Adverse Event|2|||
94253972|NCT05249829|322722603|FG001|Overall Study|Adverse Event|2|||
94253973|NCT05249829|322722604|FG002|Overall Study|Adverse Event|2|||
94253974|NCT05249829|322722605|FG003|Overall Study|Adverse Event|2|||
94612015|NCT00910273|324042788|FG000|Overall Study|Protocol Violation|1|||
94612016|NCT00910273|324042789|FG001|Overall Study|Protocol Violation|0|||
94612017|NCT00910273|324042788|FG000|Overall Study|Lost to Follow-up|1|||
94612018|NCT00910273|324042789|FG001|Overall Study|Lost to Follow-up|1|||
94612019|NCT04357782|324042790|FG000|Overall Study|Discharged from hospital|1|||
94612020|NCT04357782|324042791|FG001|Overall Study|Discharged from hospital|0|||
94253975|NCT05249829|322722602|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
94253976|NCT05249829|322722603|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
94253977|NCT05249829|322722604|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
94358386|NCT04089566|323094473|FG000|Overall Study|Death|0|||
94358387|NCT04089566|323094474|FG001|Overall Study|Death|6|||
94358388|NCT04089566|323094475|FG002|Overall Study|Death|10|||
94358389|NCT04089566|323094476|FG003|Overall Study|Death|0|||
94358390|NCT04089566|323094477|FG004|Overall Study|Death|0|||
94358391|NCT04089566|323094478|FG005|Overall Study|Death|0|||
94253978|NCT05249829|322722605|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
94253979|NCT05249829|322722602|FG000|Overall Study|Protocol Violation|2|||
94253980|NCT05249829|322722603|FG001|Overall Study|Protocol Violation|0|||
94253981|NCT05249829|322722604|FG002|Overall Study|Protocol Violation|5|||
94253982|NCT05249829|322722605|FG003|Overall Study|Protocol Violation|3|||
94253983|NCT05249829|322722602|FG000|Overall Study|Death|0|||
94253984|NCT05249829|322722603|FG001|Overall Study|Death|1|||
94253985|NCT05249829|322722604|FG002|Overall Study|Death|2|||
94253986|NCT05249829|322722605|FG003|Overall Study|Death|4|||
94253987|NCT00950950|322722608|FG000|Overall Study|Adverse Event|1|||
94253988|NCT00950950|322722609|FG001|Overall Study|Adverse Event|0|||
94253989|NCT00950950|322722608|FG000|Overall Study|Withdrawal by Subject|0|||
94253990|NCT00950950|322722609|FG001|Overall Study|Withdrawal by Subject|1|||
94253991|NCT02054520|322722615|FG000|Overall Study|Adverse Event|1|||
94253992|NCT02054520|322722616|FG001|Overall Study|Adverse Event|4|||
94253993|NCT02054520|322722617|FG002|Overall Study|Adverse Event|2|||
94253994|NCT02054520|322722618|FG003|Overall Study|Adverse Event|1|||
94253995|NCT02054520|322722619|FG004|Overall Study|Adverse Event|1|||
94358392|NCT04089566|323094473|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
94358393|NCT04089566|323094474|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
94612021|NCT04357782|324042790|FG000|Overall Study|Death|0|||
94612022|NCT04357782|324042791|FG001|Overall Study|Death|2|||
94612023|NCT00338104|324042796|FG000|Overall Study|Protocol Violation|2|||
94612024|NCT00338104|324042797|FG001|Overall Study|Protocol Violation|1|||
94662896|NCT03551938|324222167|FG000|3-Month Follow Up|Lost to Follow-up|39|||
94662897|NCT03551938|324222168|FG001|3-Month Follow Up|Lost to Follow-up|38|||
94662898|NCT03551938|324222167|FG000|6-Month Follow Up|Lost to Follow-up|46|||
94662899|NCT03551938|324222168|FG001|6-Month Follow Up|Lost to Follow-up|42|||
94662900|NCT03551938|324222167|FG000|9-Month Follow Up|Lost to Follow-up|44|||
94662901|NCT03551938|324222168|FG001|9-Month Follow Up|Lost to Follow-up|43|||
94662902|NCT00695903|324222169|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
94662903|NCT00695903|324222170|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
94662904|NCT00695903|324222169|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
94662905|NCT00695903|324222170|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
94662906|NCT00695903|324222169|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
94662907|NCT00695903|324222170|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
94662908|NCT00695903|324222169|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
94662909|NCT00695903|324222170|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
94662910|NCT00695903|324222169|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
94662911|NCT00695903|324222170|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
94662912|NCT00695903|324222169|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
94662913|NCT00695903|324222170|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
94662914|NCT00695903|324222169|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
94662915|NCT00695903|324222170|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
94662916|NCT00695903|324222169|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
94662917|NCT00695903|324222170|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
94662918|NCT00695903|324222169|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
94662919|NCT00695903|324222170|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
94662920|NCT00321854|324222171|FG000|Overall Study|Adverse Event|41|||
94662921|NCT00321854|324222172|FG001|Overall Study|Adverse Event|43|||
94662922|NCT00321854|324222171|FG000|Overall Study|Lack of Efficacy|9|||
94662923|NCT00321854|324222172|FG001|Overall Study|Lack of Efficacy|14|||
94662924|NCT00321854|324222171|FG000|Overall Study|Protocol Violation|6|||
94662925|NCT00321854|324222172|FG001|Overall Study|Protocol Violation|5|||
94662926|NCT00321854|324222171|FG000|Overall Study|Lost to Follow-up|0|||
94662927|NCT00321854|324222172|FG001|Overall Study|Lost to Follow-up|2|||
94662928|NCT00321854|324222171|FG000|Overall Study|Withdrawal by Subject|6|||
94662929|NCT00321854|324222172|FG001|Overall Study|Withdrawal by Subject|17|||
94662930|NCT00321854|324222171|FG000|Overall Study|Other|1|||
94662931|NCT00321854|324222172|FG001|Overall Study|Other|1|||
94662932|NCT04723576|324222173|FG000|Overall Study|Withdrawal by Subject|2133|||
94662933|NCT04723576|324222174|FG001|Overall Study|Withdrawal by Subject|3234|||
94662934|NCT00413153|324222175|FG000|Overall Study|Withdrawal by Subject|1|||
94662935|NCT00413153|324222176|FG001|Overall Study|Withdrawal by Subject|1|||
94662936|NCT00413153|324222175|FG000|Overall Study|Adverse Event|1|||
94662937|NCT00413153|324222176|FG001|Overall Study|Adverse Event|0|||
94662938|NCT00574080|324222177|FG000|Overall Study|Death|10|||
94662939|NCT00574080|324222178|FG001|Overall Study|Death|10|||
94662940|NCT02828111|324222185|FG000|Overall Study|Withdrawal by Subject|0|||
94662941|NCT02828111|324222186|FG001|Overall Study|Withdrawal by Subject|0|||
94662942|NCT02828111|324222187|FG002|Overall Study|Withdrawal by Subject|2|||
94662943|NCT02828111|324222188|FG003|Overall Study|Withdrawal by Subject|0|||
94662944|NCT02828111|324222189|FG004|Overall Study|Withdrawal by Subject|0|||
94662945|NCT02828111|324222185|FG000|Overall Study|Lost to Follow-up|0|||
94662946|NCT02828111|324222186|FG001|Overall Study|Lost to Follow-up|0|||
94662947|NCT02828111|324222187|FG002|Overall Study|Lost to Follow-up|0|||
94662948|NCT02828111|324222188|FG003|Overall Study|Lost to Follow-up|1|||
94662949|NCT02828111|324222189|FG004|Overall Study|Lost to Follow-up|1|||
94662950|NCT00971048|324222190|FG000|Overall Study|Protocol Violation|1|||
94662951|NCT00971048|324222191|FG001|Overall Study|Protocol Violation|2|||
94662952|NCT00971048|324222192|FG002|Overall Study|Protocol Violation|0|||
94662953|NCT00971048|324222193|FG003|Overall Study|Protocol Violation|1|||
94662954|NCT00971048|324222190|FG000|Overall Study|Adverse Event|0|||
94662955|NCT00971048|324222191|FG001|Overall Study|Adverse Event|0|||
94662956|NCT00971048|324222192|FG002|Overall Study|Adverse Event|1|||
94662957|NCT00971048|324222193|FG003|Overall Study|Adverse Event|0|||
94662958|NCT00971048|324222190|FG000|Overall Study|Physician Decision|0|||
94662959|NCT00971048|324222191|FG001|Overall Study|Physician Decision|0|||
94662960|NCT00971048|324222192|FG002|Overall Study|Physician Decision|0|||
94662961|NCT00971048|324222193|FG003|Overall Study|Physician Decision|1|||
94662962|NCT01127178|324222194|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
94662963|NCT01127178|324222195|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
94662964|NCT01127178|324222194|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
94662965|NCT01127178|324222195|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
94662966|NCT01127178|324222194|FG000|Dose Escalation: Treatment Phase|Other|2|||
94662967|NCT01127178|324222195|FG001|Dose Escalation: Treatment Phase|Other|0|||
94662968|NCT01127178|324222194|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
94662969|NCT01127178|324222195|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
94662970|NCT01127178|324222194|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
94662971|NCT01127178|324222195|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
94662972|NCT01127178|324222194|FG000|Dose Escalation: Extension Phase|Other|1|||
94662973|NCT01127178|324222195|FG001|Dose Escalation: Extension Phase|Other|0|||
94662974|NCT01343407|324222196|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
94662975|NCT01343407|324222197|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
94662976|NCT01343407|324222198|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
94662977|NCT01343407|324222199|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
94662978|NCT01343407|324222200|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
94662979|NCT01343407|324222201|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
94662980|NCT01343407|324222196|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
94662981|NCT01343407|324222197|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
94662982|NCT01343407|324222198|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
94662983|NCT01343407|324222199|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
94662984|NCT01343407|324222200|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
94662985|NCT01343407|324222201|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
94662986|NCT03579563|324222202|FG000|Overall Study|Lost to Follow-up|0|||
94662987|NCT03579563|324222203|FG001|Overall Study|Lost to Follow-up|0|||
94662988|NCT03579563|324222204|FG002|Overall Study|Lost to Follow-up|0|||
94662989|NCT03579563|324222205|FG003|Overall Study|Lost to Follow-up|0|||
94662990|NCT03579563|324222206|FG004|Overall Study|Lost to Follow-up|1|||
94662991|NCT03579563|324222207|FG005|Overall Study|Lost to Follow-up|0|||
94662992|NCT03579563|324222202|FG000|Overall Study|Lack of Efficacy|1|||
94662993|NCT03579563|324222203|FG001|Overall Study|Lack of Efficacy|1|||
94662994|NCT03579563|324222204|FG002|Overall Study|Lack of Efficacy|4|||
94662995|NCT03579563|324222205|FG003|Overall Study|Lack of Efficacy|1|||
94662996|NCT03579563|324222206|FG004|Overall Study|Lack of Efficacy|2|||
94662997|NCT03579563|324222207|FG005|Overall Study|Lack of Efficacy|3|||
94253996|NCT02054520|322722620|FG005|Overall Study|Adverse Event|0|||
94662998|NCT03579563|324222202|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
94253997|NCT02054520|322722615|FG000|Overall Study|Lack of Efficacy|7|||
94253998|NCT02054520|322722616|FG001|Overall Study|Lack of Efficacy|0|||
94253999|NCT02054520|322722617|FG002|Overall Study|Lack of Efficacy|2|||
94254000|NCT02054520|322722618|FG003|Overall Study|Lack of Efficacy|1|||
94254001|NCT02054520|322722619|FG004|Overall Study|Lack of Efficacy|3|||
94254002|NCT02054520|322722620|FG005|Overall Study|Lack of Efficacy|2|||
94254003|NCT02054520|322722615|FG000|Overall Study|Withdrawal by Subject|1|||
94254004|NCT02054520|322722616|FG001|Overall Study|Withdrawal by Subject|0|||
94254005|NCT02054520|322722617|FG002|Overall Study|Withdrawal by Subject|0|||
94254006|NCT02054520|322722618|FG003|Overall Study|Withdrawal by Subject|2|||
94254007|NCT02054520|322722619|FG004|Overall Study|Withdrawal by Subject|1|||
94254008|NCT02054520|322722620|FG005|Overall Study|Withdrawal by Subject|0|||
94254009|NCT02054520|322722615|FG000|Overall Study|Physician Decision|0|||
94254010|NCT02054520|322722616|FG001|Overall Study|Physician Decision|1|||
94254011|NCT02054520|322722617|FG002|Overall Study|Physician Decision|0|||
94358394|NCT04089566|323094475|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
94254012|NCT02054520|322722618|FG003|Overall Study|Physician Decision|1|||
94254013|NCT02054520|322722619|FG004|Overall Study|Physician Decision|0|||
94254014|NCT02054520|322722620|FG005|Overall Study|Physician Decision|1|||
94254015|NCT02054520|322722615|FG000|Overall Study|Study terminated by Sponsor|0|||
94254016|NCT02054520|322722616|FG001|Overall Study|Study terminated by Sponsor|0|||
94358395|NCT04089566|323094476|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
94358396|NCT04089566|323094477|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
94358397|NCT04089566|323094478|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
94358398|NCT04089566|323094473|FG000|Overall Study|Reason not Specified|0|||
94358399|NCT04089566|323094474|FG001|Overall Study|Reason not Specified|4|||
94358400|NCT04089566|323094475|FG002|Overall Study|Reason not Specified|4|||
94358401|NCT04089566|323094476|FG003|Overall Study|Reason not Specified|1|||
94358402|NCT04089566|323094477|FG004|Overall Study|Reason not Specified|0|||
94358403|NCT04089566|323094478|FG005|Overall Study|Reason not Specified|0|||
94358404|NCT05403502|323094481|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
94358405|NCT05403502|323094481|FG000|Humalog Lead-In Period|Physician Decision|2|||
94358406|NCT05403502|323094481|FG000|Humalog Lead-In Period|Protocol Violation|1|||
94358407|NCT05403502|323094481|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
94358408|NCT05403502|323094481|FG000|Lyumjev Treatment Period|Physician Decision|2|||
94358409|NCT02756182|323094482|FG000|Overall Study|StudyTechnical Difficulties|4|||
94358410|NCT00449761|323096411|FG000|Overall Study|Disease progression|12|||
94358411|NCT00449761|323096411|FG000|Overall Study|Death|5|||
94358412|NCT00449761|323096411|FG000|Overall Study|New cancer therapy|1|||
94358413|NCT00761761|323096412|FG000|Overall Study|Lost to Follow-up|3|||
94358414|NCT00761761|323096413|FG001|Overall Study|Lost to Follow-up|1|||
94358415|NCT00761761|323096412|FG000|Overall Study|Withdrawal by Subject|3|||
94358416|NCT00761761|323096413|FG001|Overall Study|Withdrawal by Subject|0|||
94358417|NCT00536991|323096415|FG000|Overall Study|Withdrawal by Subject|10|||
94358418|NCT00536991|323096415|FG000|Overall Study|Physician Decision|1|||
94358419|NCT00536991|323096415|FG000|Overall Study|patient ineligible|2|||
94358420|NCT02204449|323096419|FG000|Overall Study|Lost to Follow-up|7|||
94358421|NCT02204449|323096420|FG001|Overall Study|Lost to Follow-up|9|||
94358422|NCT02204449|323096419|FG000|Overall Study|Death|0|||
94358423|NCT02204449|323096420|FG001|Overall Study|Death|1|||
94358424|NCT02204449|323096419|FG000|Overall Study|Withdrawal by Subject|0|||
94358425|NCT02204449|323096420|FG001|Overall Study|Withdrawal by Subject|1|||
94358426|NCT00503035|323096421|FG000|Overall Study|Lost to Follow-up|2|||
94358427|NCT00503035|323096421|FG000|Overall Study|Physician Decision|3|||
94358428|NCT00503035|323096421|FG000|Overall Study|Ineligible|15|||
94358429|NCT05064436|323096425|FG000|Overall Study|Other Reasons|1|||
94358430|NCT05064436|323096426|FG001|Overall Study|Other Reasons|0|||
94358431|NCT01711736|323096427|FG000|Overall Study|Lost to Follow-up|4|||
94358432|NCT01711736|323096428|FG001|Overall Study|Lost to Follow-up|1|||
94358433|NCT01711736|323096427|FG000|Overall Study|Withdrawal by Subject|6|||
94358434|NCT01711736|323096428|FG001|Overall Study|Withdrawal by Subject|6|||
94358435|NCT01711736|323096427|FG000|Overall Study|Migrated/moved from study area|2|||
94358436|NCT01711736|323096428|FG001|Overall Study|Migrated/moved from study area|1|||
94358437|NCT05993299|323096429|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
94358438|NCT05993299|323096429|FG000|Overall Study|Ongoing|4|||
94358439|NCT03110107|323096430|FG000|Treatment Period|Disease Progression|3|||
94358440|NCT03110107|323096431|FG001|Treatment Period|Disease Progression|9|||
94358441|NCT03110107|323096432|FG002|Treatment Period|Disease Progression|8|||
94358442|NCT03110107|323096433|FG003|Treatment Period|Disease Progression|11|||
94358443|NCT03110107|323096434|FG004|Treatment Period|Disease Progression|8|||
94358444|NCT03110107|323096435|FG005|Treatment Period|Disease Progression|4|||
94358445|NCT03110107|323096436|FG006|Treatment Period|Disease Progression|6|||
94358446|NCT03110107|323096437|FG007|Treatment Period|Disease Progression|7|||
94358447|NCT03110107|323096438|FG008|Treatment Period|Disease Progression|2|||
94358448|NCT03110107|323096439|FG009|Treatment Period|Disease Progression|10|||
94358449|NCT03110107|323096440|FG010|Treatment Period|Disease Progression|5|||
94358450|NCT03110107|323096441|FG011|Treatment Period|Disease Progression|2|||
94358451|NCT03110107|323096442|FG012|Treatment Period|Disease Progression|0|||
94358452|NCT03110107|323096443|FG013|Treatment Period|Disease Progression|5|||
94358453|NCT03110107|323096444|FG014|Treatment Period|Disease Progression|14|||
94358454|NCT03110107|323096445|FG015|Treatment Period|Disease Progression|14|||
94358455|NCT03110107|323096446|FG016|Treatment Period|Disease Progression|4|||
94358456|NCT03110107|323096447|FG017|Treatment Period|Disease Progression|3|||
94358457|NCT03110107|323096448|FG018|Treatment Period|Disease Progression|16|||
94358458|NCT03110107|323096449|FG019|Treatment Period|Disease Progression|14|||
94358459|NCT03110107|323096450|FG020|Treatment Period|Disease Progression|12|||
94358460|NCT03110107|323096451|FG021|Treatment Period|Disease Progression|16|||
94358461|NCT03110107|323096452|FG022|Treatment Period|Disease Progression|18|||
94358462|NCT03110107|323096453|FG023|Treatment Period|Disease Progression|13|||
94358463|NCT03110107|323096454|FG024|Treatment Period|Disease Progression|16|||
94358464|NCT03110107|323096455|FG025|Treatment Period|Disease Progression|31|||
94358465|NCT03110107|323096430|FG000|Treatment Period|Study drug toxicity|1|||
94358466|NCT03110107|323096431|FG001|Treatment Period|Study drug toxicity|0|||
94358467|NCT03110107|323096432|FG002|Treatment Period|Study drug toxicity|1|||
94358468|NCT03110107|323096433|FG003|Treatment Period|Study drug toxicity|2|||
94459649|NCT02031640|323471857|FG002|Double-blind Treatment Period|Protocol deviation|0|||
94459650|NCT02031640|323471858|FG003|Double-blind Treatment Period|Protocol deviation|1|||
94459651|NCT02031640|323471859|FG004|Double-blind Treatment Period|Protocol deviation|3|||
94459652|NCT02031640|323471860|FG005|Double-blind Treatment Period|Protocol deviation|1|||
94459653|NCT02031640|323471855|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
94459654|NCT02031640|323471856|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
94459655|NCT02031640|323471857|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
94459656|NCT02031640|323471858|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
94459657|NCT02031640|323471859|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
94459658|NCT02031640|323471860|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
94459659|NCT02031640|323471855|FG000|Double-blind Treatment Period|Non-compliance|0|||
94459660|NCT02031640|323471856|FG001|Double-blind Treatment Period|Non-compliance|1|||
94459661|NCT02031640|323471857|FG002|Double-blind Treatment Period|Non-compliance|0|||
94459662|NCT02031640|323471858|FG003|Double-blind Treatment Period|Non-compliance|1|||
94459663|NCT02031640|323471859|FG004|Double-blind Treatment Period|Non-compliance|1|||
94459664|NCT02031640|323471860|FG005|Double-blind Treatment Period|Non-compliance|0|||
94459665|NCT02031640|323471855|FG000|Double-blind Treatment Period|Adverse Event|0|||
94459666|NCT02031640|323471856|FG001|Double-blind Treatment Period|Adverse Event|0|||
94459667|NCT02031640|323471857|FG002|Double-blind Treatment Period|Adverse Event|0|||
94459668|NCT02031640|323471858|FG003|Double-blind Treatment Period|Adverse Event|2|||
94459669|NCT02031640|323471859|FG004|Double-blind Treatment Period|Adverse Event|0|||
94459670|NCT02031640|323471860|FG005|Double-blind Treatment Period|Adverse Event|0|||
94459671|NCT02031640|323471855|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
94459672|NCT02031640|323471856|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
94459673|NCT02031640|323471857|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
94459674|NCT02031640|323471858|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
94459675|NCT02031640|323471859|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
94459676|NCT02031640|323471860|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
94459677|NCT02031640|323471855|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
94459678|NCT02031640|323471856|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
94459679|NCT02031640|323471857|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
94459680|NCT02031640|323471858|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
94459681|NCT02031640|323471859|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
94459682|NCT02031640|323471860|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
94459683|NCT03085238|323471861|FG000|Overall Study|Adverse Event|2|||
94459684|NCT03085238|323471861|FG000|Overall Study|Death|2|||
94459685|NCT02738879|323471862|FG000|Overall Study|Adverse Event|1|||
94459686|NCT02738879|323471863|FG001|Overall Study|Adverse Event|1|||
94459687|NCT02738879|323471862|FG000|Overall Study|Death|0|||
94459688|NCT02738879|323471863|FG001|Overall Study|Death|2|||
94459689|NCT02738879|323471862|FG000|Overall Study|Lost to Follow-up|1|||
94459690|NCT02738879|323471863|FG001|Overall Study|Lost to Follow-up|5|||
94459691|NCT02738879|323471862|FG000|Overall Study|Protocol Violation|1|||
94459692|NCT02738879|323471863|FG001|Overall Study|Protocol Violation|3|||
94459693|NCT02738879|323471862|FG000|Overall Study|Physician Decision|3|||
94459694|NCT02738879|323471863|FG001|Overall Study|Physician Decision|4|||
94459695|NCT02738879|323471862|FG000|Overall Study|Pregnancy|0|||
94459696|NCT02738879|323471863|FG001|Overall Study|Pregnancy|1|||
94459697|NCT02738879|323471862|FG000|Overall Study|Screen Failure|1|||
94459698|NCT02738879|323471863|FG001|Overall Study|Screen Failure|2|||
94459699|NCT02738879|323471862|FG000|Overall Study|Site Discontinued Study Participation|1|||
94459700|NCT02738879|323471863|FG001|Overall Study|Site Discontinued Study Participation|0|||
94459701|NCT02738879|323471862|FG000|Overall Study|Withdrawal by Subject|5|||
94459702|NCT02738879|323471863|FG001|Overall Study|Withdrawal by Subject|7|||
94459703|NCT02256982|323471865|FG000|Overall Study|Disease Progression|0|||
94459704|NCT02256982|323471866|FG001|Overall Study|Disease Progression|1|||
94459705|NCT04964544|323471871|FG000|Overall Study|Screen failure or other uncategorised|10|||
94459706|NCT04964544|323471871|FG000|Overall Study|Physician Decision|4|||
94459707|NCT04964544|323471871|FG000|Overall Study|Lost to Follow-up|9|||
94459708|NCT04964544|323471871|FG000|Overall Study|Withdrawal by Subject|18|||
94459709|NCT04964544|323471871|FG000|Overall Study|Death|1|||
94459710|NCT01044290|323471876|FG000|Follow-up 1|Death|3|||
94459711|NCT01044290|323471877|FG001|Follow-up 1|Death|3|||
94459712|NCT01044290|323471878|FG002|Follow-up 1|Death|1|||
94459713|NCT01044290|323471876|FG000|Follow-up 1|Withdrawal by Subject|2|||
94459714|NCT01044290|323471877|FG001|Follow-up 1|Withdrawal by Subject|2|||
94459715|NCT01044290|323471878|FG002|Follow-up 1|Withdrawal by Subject|0|||
94459716|NCT01044290|323471876|FG000|Follow-Up 2|Death|0|||
94459717|NCT01044290|323471877|FG001|Follow-Up 2|Death|1|||
94459718|NCT01044290|323471878|FG002|Follow-Up 2|Death|1|||
94459719|NCT01044290|323471876|FG000|Follow-Up 2|Withdrawal by Subject|0|||
94459720|NCT01044290|323471877|FG001|Follow-Up 2|Withdrawal by Subject|1|||
94459721|NCT01044290|323471878|FG002|Follow-Up 2|Withdrawal by Subject|1|||
94459722|NCT04323306|323471879|FG000|Overall Study|Physician Decision|1|||
94459723|NCT04323306|323471880|FG001|Overall Study|Physician Decision|0|||
94254017|NCT02054520|322722617|FG002|Overall Study|Study terminated by Sponsor|2|||
94254018|NCT02054520|322722618|FG003|Overall Study|Study terminated by Sponsor|1|||
94254019|NCT02054520|322722619|FG004|Overall Study|Study terminated by Sponsor|0|||
94254020|NCT02054520|322722620|FG005|Overall Study|Study terminated by Sponsor|0|||
94254021|NCT02318797|322722623|FG000|Overall Study|Death|3|||
94254022|NCT02318797|322722624|FG001|Overall Study|Death|6|||
94254023|NCT02318797|322722623|FG000|Overall Study|Lost to Follow-up|85|||
94254024|NCT02318797|322722624|FG001|Overall Study|Lost to Follow-up|96|||
94254025|NCT00511472|322722625|FG000|Overall Study|Clinical Adverse Event|1|||
94254026|NCT00511472|322722626|FG001|Overall Study|Clinical Adverse Event|2|||
94254027|NCT00511472|322722625|FG000|Overall Study|Laboratory Adverse Event|0|||
94254028|NCT00511472|322722626|FG001|Overall Study|Laboratory Adverse Event|2|||
94254029|NCT00511472|322722625|FG000|Overall Study|Not reported|2|||
94254030|NCT00511472|322722626|FG001|Overall Study|Not reported|2|||
94254031|NCT02709096|322722627|FG000|Overall Study|non-compliance|1|||
94254032|NCT02709096|322722628|FG001|Overall Study|non-compliance|1|||
94254033|NCT02471833|322722630|FG000|Overall Study|Lost to Follow-up|1|||
94254034|NCT02471833|322722631|FG001|Overall Study|Lost to Follow-up|0|||
94254035|NCT02471833|322722632|FG002|Overall Study|Lost to Follow-up|0|||
94254036|NCT02471833|322722630|FG000|Overall Study|Withdrawal by Subject|2|||
94254037|NCT02471833|322722631|FG001|Overall Study|Withdrawal by Subject|1|||
94254038|NCT02471833|322722632|FG002|Overall Study|Withdrawal by Subject|5|||
94254039|NCT01536015|322722635|FG000|Overall Study|Adverse Event|1|||
94254040|NCT01536015|322722636|FG001|Overall Study|Adverse Event|4|||
94254041|NCT01536015|322722635|FG000|Overall Study|Lost to Follow-up|0|||
94254042|NCT01536015|322722636|FG001|Overall Study|Lost to Follow-up|1|||
94254043|NCT01536015|322722635|FG000|Overall Study|Inclusion Criterion not met|2|||
94254044|NCT01536015|322722636|FG001|Overall Study|Inclusion Criterion not met|0|||
94254045|NCT01536015|322722635|FG000|Overall Study|Study closure|5|||
94612025|NCT00338104|324042798|FG002|Overall Study|Protocol Violation|3|||
94612026|NCT00657358|324042799|FG000|Overall Study|Lack of Efficacy|6|||
94612027|NCT00621959|324042800|FG000|Overall Study|Adverse Event|4|||
94612028|NCT00621959|324042801|FG001|Overall Study|Adverse Event|2|||
94612029|NCT00621959|324042800|FG000|Overall Study|Lack of Efficacy|1|||
94254046|NCT01536015|322722636|FG001|Overall Study|Study closure|5|||
94254047|NCT00998335|322722637|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
94254048|NCT00998335|322722638|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
94254049|NCT02447172|322722639|FG000|Overall Study|Adverse Event|11|||
94612030|NCT00621959|324042801|FG001|Overall Study|Lack of Efficacy|1|||
94254050|NCT02447172|322722640|FG001|Overall Study|Adverse Event|8|||
94254051|NCT02447172|322722641|FG002|Overall Study|Adverse Event|7|||
94612031|NCT00621959|324042800|FG000|Overall Study|Lost to Follow-up|0|||
94459724|NCT04323306|323471881|FG002|Overall Study|Physician Decision|0|||
94459725|NCT04323306|323471882|FG003|Overall Study|Physician Decision|0|||
94459726|NCT04323306|323471883|FG004|Overall Study|Physician Decision|0|||
94459727|NCT04323306|323471884|FG005|Overall Study|Physician Decision|0|||
94459728|NCT04323306|323471885|FG006|Overall Study|Physician Decision|0|||
94459729|NCT04323306|323471886|FG007|Overall Study|Physician Decision|0|||
94459730|NCT04323306|323471887|FG008|Overall Study|Physician Decision|0|||
94459731|NCT04323306|323471879|FG000|Overall Study|Withdrawal by Subject|0|||
94459732|NCT04323306|323471880|FG001|Overall Study|Withdrawal by Subject|0|||
94459733|NCT04323306|323471881|FG002|Overall Study|Withdrawal by Subject|0|||
94459734|NCT04323306|323471882|FG003|Overall Study|Withdrawal by Subject|0|||
94459735|NCT04323306|323471883|FG004|Overall Study|Withdrawal by Subject|0|||
94459736|NCT04323306|323471884|FG005|Overall Study|Withdrawal by Subject|1|||
94459737|NCT04323306|323471885|FG006|Overall Study|Withdrawal by Subject|3|||
94459738|NCT04323306|323471886|FG007|Overall Study|Withdrawal by Subject|0|||
94459739|NCT04323306|323471887|FG008|Overall Study|Withdrawal by Subject|1|||
94459740|NCT00759785|323471888|FG000|Overall Study|Participant sample not evaluable|11|||
94459741|NCT00759785|323471889|FG001|Overall Study|Participant sample not evaluable|2|||
94459742|NCT00759785|323471888|FG000|Overall Study|Participant sample lost|0|||
94459743|NCT00759785|323471889|FG001|Overall Study|Participant sample lost|1|||
94459744|NCT00759785|323471888|FG000|Overall Study|Protocol Violation|1|||
94459745|NCT00759785|323471889|FG001|Overall Study|Protocol Violation|0|||
94459746|NCT00759785|323471888|FG000|Overall Study|Physician Decision|0|||
94459747|NCT00759785|323471889|FG001|Overall Study|Physician Decision|1|||
94459748|NCT00759785|323471888|FG000|Overall Study|Withdrawal by Subject|0|||
94459749|NCT00759785|323471889|FG001|Overall Study|Withdrawal by Subject|1|||
94459750|NCT00089778|323471890|FG000|Overall Study|Protocol Violation|0|||
94459751|NCT00089778|323471891|FG001|Overall Study|Protocol Violation|0|||
94459752|NCT00089778|323471892|FG002|Overall Study|Protocol Violation|1|||
94459753|NCT02677038|323471895|FG000|Overall Study|Physician Decision|1|||
94459754|NCT02677038|323471895|FG000|Overall Study|Withdrawal by Subject|1|||
94459755|NCT01646021|323471897|FG000|Overall Study|Death|77|||
94459756|NCT01646021|323471898|FG001|Overall Study|Death|83|||
94459757|NCT01646021|323471897|FG000|Overall Study|Study Terminated by Sponsor|50|||
94459758|NCT01646021|323471898|FG001|Overall Study|Study Terminated by Sponsor|41|||
94459759|NCT01646021|323471897|FG000|Overall Study|Lost to Follow-up|2|||
94459760|NCT01646021|323471898|FG001|Overall Study|Lost to Follow-up|2|||
94459761|NCT01646021|323471897|FG000|Overall Study|Withdrawal by Subject|10|||
94459762|NCT01646021|323471898|FG001|Overall Study|Withdrawal by Subject|15|||
94459763|NCT03671564|323471899|FG000|Overall Study|Progressive Disease|3|||
94459764|NCT03671564|323471900|FG001|Overall Study|Progressive Disease|5|||
94459765|NCT03671564|323471901|FG002|Overall Study|Progressive Disease|3|||
94459766|NCT03671564|323471899|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
94459767|NCT03671564|323471900|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
94459768|NCT03671564|323471901|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
94459769|NCT03671564|323471899|FG000|Overall Study|Withdrawal by Subject|1|||
94459770|NCT03671564|323471900|FG001|Overall Study|Withdrawal by Subject|1|||
94459771|NCT03671564|323471901|FG002|Overall Study|Withdrawal by Subject|0|||
94459772|NCT04521621|323471902|FG000|Overall Study|Death|17|||
94459773|NCT04521621|323471903|FG001|Overall Study|Death|8|||
94459774|NCT04521621|323471904|FG002|Overall Study|Death|8|||
94459775|NCT04521621|323471905|FG003|Overall Study|Death|5|||
94459776|NCT04521621|323471906|FG004|Overall Study|Death|2|||
94459777|NCT04521621|323471907|FG005|Overall Study|Death|7|||
94459778|NCT04521621|323471908|FG006|Overall Study|Death|0|||
94459779|NCT04521621|323471909|FG007|Overall Study|Death|0|||
94459780|NCT04521621|323471902|FG000|Overall Study|Study Terminated by Sponsor|4|||
94459781|NCT04521621|323471903|FG001|Overall Study|Study Terminated by Sponsor|6|||
94459782|NCT04521621|323471904|FG002|Overall Study|Study Terminated by Sponsor|8|||
94459783|NCT04521621|323471905|FG003|Overall Study|Study Terminated by Sponsor|0|||
94459784|NCT04521621|323471906|FG004|Overall Study|Study Terminated by Sponsor|1|||
94459785|NCT04521621|323471907|FG005|Overall Study|Study Terminated by Sponsor|7|||
94459786|NCT04521621|323471908|FG006|Overall Study|Study Terminated by Sponsor|0|||
94459787|NCT04521621|323471909|FG007|Overall Study|Study Terminated by Sponsor|0|||
94459788|NCT04521621|323471902|FG000|Overall Study|Withdrawal by Subject|0|||
94459789|NCT04521621|323471903|FG001|Overall Study|Withdrawal by Subject|0|||
94459790|NCT04521621|323471904|FG002|Overall Study|Withdrawal by Subject|1|||
94612032|NCT00621959|324042801|FG001|Overall Study|Lost to Follow-up|2|||
94254052|NCT02447172|322722639|FG000|Overall Study|Death|3|||
94254053|NCT02447172|322722640|FG001|Overall Study|Death|1|||
94254054|NCT02447172|322722641|FG002|Overall Study|Death|0|||
94254055|NCT02447172|322722639|FG000|Overall Study|Protocol Violation|2|||
94254056|NCT02447172|322722640|FG001|Overall Study|Protocol Violation|1|||
94254057|NCT02447172|322722641|FG002|Overall Study|Protocol Violation|2|||
94254058|NCT02447172|322722639|FG000|Overall Study|Lost to Follow-up|7|||
94254059|NCT02447172|322722640|FG001|Overall Study|Lost to Follow-up|4|||
94254060|NCT02447172|322722641|FG002|Overall Study|Lost to Follow-up|4|||
94254061|NCT02447172|322722639|FG000|Overall Study|Withdrawal by Subject|5|||
94254062|NCT02447172|322722640|FG001|Overall Study|Withdrawal by Subject|1|||
94254063|NCT02447172|322722641|FG002|Overall Study|Withdrawal by Subject|3|||
94254064|NCT02447172|322722639|FG000|Overall Study|protocol specific treatment unrelated|3|||
94254065|NCT02447172|322722640|FG001|Overall Study|protocol specific treatment unrelated|0|||
94254066|NCT02447172|322722641|FG002|Overall Study|protocol specific treatment unrelated|2|||
94254067|NCT00421707|322722644|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
94612033|NCT00621959|324042800|FG000|Overall Study|Withdrawal by Subject|1|||
94612034|NCT00621959|324042801|FG001|Overall Study|Withdrawal by Subject|1|||
94612035|NCT00621959|324042800|FG000|Overall Study|Other|1|||
94612036|NCT00621959|324042801|FG001|Overall Study|Other|3|||
94612037|NCT00302107|324042808|FG000|Overall Study|Lost to Follow-up|6|||
94612038|NCT00302107|324042809|FG001|Overall Study|Lost to Follow-up|5|||
94612039|NCT00302107|324042808|FG000|Overall Study|Protocol Violation|1|||
94612040|NCT00302107|324042809|FG001|Overall Study|Protocol Violation|0|||
94612041|NCT00302107|324042808|FG000|Overall Study|Relocation|0|||
94612042|NCT00302107|324042809|FG001|Overall Study|Relocation|1|||
94612043|NCT00302107|324042808|FG000|Overall Study|Withdrawal by Subject|0|||
94612044|NCT00302107|324042809|FG001|Overall Study|Withdrawal by Subject|3|||
94612045|NCT00302107|324042808|FG000|Overall Study|Adverse Event|1|||
94612046|NCT00302107|324042809|FG001|Overall Study|Adverse Event|0|||
94612047|NCT02202837|324045005|FG000|Overall Study|Enbrel treatment discontinued|36|||
94612048|NCT02202837|324045006|FG001|Overall Study|Enbrel treatment discontinued|4|||
94612049|NCT02202837|324045005|FG000|Overall Study|Other|10|||
94612050|NCT02202837|324045006|FG001|Overall Study|Other|0|||
94612051|NCT02202837|324045005|FG000|Overall Study|Lost to Follow-up|7|||
94612052|NCT02202837|324045006|FG001|Overall Study|Lost to Follow-up|1|||
94612053|NCT01364649|324045007|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
94612054|NCT01364649|324045008|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
94612055|NCT01364649|324045007|FG000|Overall Study|Lack of Efficacy|6|||
94612056|NCT01364649|324045008|FG001|Overall Study|Lack of Efficacy|0|||
94612057|NCT01364649|324045007|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
94612058|NCT01364649|324045008|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
94612059|NCT01364649|324045007|FG000|Overall Study|Protocol Deviations|4|||
94612060|NCT01364649|324045008|FG001|Overall Study|Protocol Deviations|8|||
94612061|NCT01364649|324045007|FG000|Overall Study|Withdrawal of Consent|9|||
94612062|NCT01364649|324045008|FG001|Overall Study|Withdrawal of Consent|7|||
94612063|NCT01364649|324045007|FG000|Overall Study|Lost to Follow-up|12|||
94612064|NCT01364649|324045008|FG001|Overall Study|Lost to Follow-up|13|||
94612065|NCT01364649|324045007|FG000|Overall Study|Other|4|||
94612066|NCT01364649|324045008|FG001|Overall Study|Other|1|||
94612067|NCT00091442|324045012|FG000|Overall Study|Progressive Disease|220|||
94612068|NCT00091442|324045013|FG001|Overall Study|Progressive Disease|189|||
94254068|NCT00421707|322722645|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
94358469|NCT03110107|323096434|FG004|Treatment Period|Study drug toxicity|0|||
94612069|NCT00091442|324045012|FG000|Overall Study|Physician Decision|61|||
94612070|NCT00091442|324045013|FG001|Overall Study|Physician Decision|58|||
94254069|NCT00421707|322722644|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
94358470|NCT03110107|323096435|FG005|Treatment Period|Study drug toxicity|3|||
94358471|NCT03110107|323096436|FG006|Treatment Period|Study drug toxicity|1|||
94358472|NCT03110107|323096437|FG007|Treatment Period|Study drug toxicity|1|||
94358473|NCT03110107|323096438|FG008|Treatment Period|Study drug toxicity|3|||
94358474|NCT03110107|323096439|FG009|Treatment Period|Study drug toxicity|2|||
94358475|NCT03110107|323096440|FG010|Treatment Period|Study drug toxicity|0|||
94358476|NCT03110107|323096441|FG011|Treatment Period|Study drug toxicity|2|||
94358477|NCT03110107|323096442|FG012|Treatment Period|Study drug toxicity|0|||
94358478|NCT03110107|323096443|FG013|Treatment Period|Study drug toxicity|0|||
94358479|NCT03110107|323096444|FG014|Treatment Period|Study drug toxicity|2|||
94358480|NCT03110107|323096445|FG015|Treatment Period|Study drug toxicity|3|||
94612071|NCT00091442|324045012|FG000|Overall Study|Withdrawal by Subject|38|||
94612072|NCT00091442|324045013|FG001|Overall Study|Withdrawal by Subject|46|||
94612073|NCT00091442|324045012|FG000|Overall Study|Adverse Event|29|||
94612074|NCT00091442|324045013|FG001|Overall Study|Adverse Event|48|||
94612075|NCT00091442|324045012|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
94612076|NCT00091442|324045013|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
94612077|NCT00091442|324045012|FG000|Overall Study|Death|9|||
94612078|NCT00091442|324045013|FG001|Overall Study|Death|7|||
94612079|NCT00091442|324045012|FG000|Overall Study|Lost to Follow-up|1|||
94612080|NCT00091442|324045013|FG001|Overall Study|Lost to Follow-up|3|||
94612081|NCT00091442|324045012|FG000|Overall Study|Other|2|||
94612082|NCT00091442|324045013|FG001|Overall Study|Other|6|||
94612083|NCT05095454|324045016|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
94612084|NCT05095454|324045017|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
94612085|NCT03626168|324045020|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
94612086|NCT03626168|324045021|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
94612087|NCT03626168|324045020|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
94612088|NCT03626168|324045021|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
94612089|NCT03626168|324045020|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
94612090|NCT03626168|324045021|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
94612091|NCT00986830|324045022|FG000|Overall Study|Death|1|||
94612092|NCT00986830|324045022|FG000|Overall Study|Lost to Follow-up|1|||
94612093|NCT00986830|324045022|FG000|Overall Study|Lack of Efficacy|1|||
94612094|NCT00986830|324045022|FG000|Overall Study|Unable to access sinus with device|5|||
94612095|NCT01495975|324045023|FG000|Overall Study|Lost to Follow-up|1|||
94612096|NCT01495975|324045024|FG001|Overall Study|Lost to Follow-up|0|||
94612097|NCT00808483|324045027|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
94612098|NCT00808483|324045028|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
94612099|NCT00808483|324045027|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
94612100|NCT00808483|324045028|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
94612101|NCT00808483|324045027|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
94612102|NCT00808483|324045028|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
94612103|NCT04553679|324045029|FG000|Overall Study|Withdrawal by Subject|2|||
94612104|NCT04553679|324045030|FG001|Overall Study|Withdrawal by Subject|0|||
94612105|NCT04553679|324045029|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
94612106|NCT04553679|324045030|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
94612107|NCT01453725|324045031|FG000|Overall Study|Adverse Event|3|||
94612108|NCT01453725|324045032|FG001|Overall Study|Adverse Event|3|||
94612109|NCT01453725|324045031|FG000|Overall Study|Lost to Follow-up|4|||
94612110|NCT01453725|324045032|FG001|Overall Study|Lost to Follow-up|0|||
94612111|NCT01453725|324045031|FG000|Overall Study|Non-compliance With Protocol|1|||
94612112|NCT01453725|324045032|FG001|Overall Study|Non-compliance With Protocol|2|||
94612113|NCT01453725|324045031|FG000|Overall Study|Protocol Violation|1|||
94612114|NCT01453725|324045032|FG001|Overall Study|Protocol Violation|0|||
94612115|NCT01453725|324045031|FG000|Overall Study|Withdrawal by Subject|2|||
94612116|NCT01453725|324045032|FG001|Overall Study|Withdrawal by Subject|3|||
94612117|NCT01453725|324045031|FG000|Overall Study|Pregnancy Wish|0|||
94612118|NCT01453725|324045032|FG001|Overall Study|Pregnancy Wish|2|||
94612119|NCT01453725|324045031|FG000|Overall Study|Pregnancy|1|||
94612120|NCT01453725|324045032|FG001|Overall Study|Pregnancy|0|||
94612121|NCT01453725|324045031|FG000|Overall Study|Physician Decision|1|||
94612122|NCT01453725|324045032|FG001|Overall Study|Physician Decision|1|||
94612123|NCT00850070|324045033|FG000|Overall Study|Lack of Efficacy|1|||
94254070|NCT00421707|322722645|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
94254071|NCT00421707|322722644|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
94254072|NCT00421707|322722645|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
94254073|NCT00421707|322722644|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
94254074|NCT00421707|322722645|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
94254075|NCT00421707|322722644|FG000|Period 2: Washout|Adverse Event|1|||
94254076|NCT00421707|322722645|FG001|Period 2: Washout|Adverse Event|1|||
94254077|NCT00421707|322722644|FG000|Period 2: Washout|Withdrawal by Subject|0|||
94254078|NCT00421707|322722645|FG001|Period 2: Washout|Withdrawal by Subject|1|||
94254079|NCT00421707|322722644|FG000|Period 2: Washout|Lost to Follow-up|0|||
94254080|NCT00421707|322722645|FG001|Period 2: Washout|Lost to Follow-up|1|||
94254081|NCT00421707|322722644|FG000|Period 2: Washout|Other: Pregnancy|0|||
94254082|NCT00421707|322722645|FG001|Period 2: Washout|Other: Pregnancy|1|||
94254083|NCT00421707|322722644|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
94254084|NCT00421707|322722645|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
94254085|NCT00421707|322722644|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
94254086|NCT00421707|322722645|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
94254087|NCT00421707|322722644|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
94254088|NCT00421707|322722645|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
94254089|NCT03261700|322722646|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
94254090|NCT03261700|322722647|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
94254091|NCT00983931|322722648|FG000|14 Day Washout Period|Physician Decision|1|||
94254092|NCT00600886|322722649|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
94254093|NCT00600886|322722650|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
94254094|NCT00600886|322722649|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
94254095|NCT00600886|322722650|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
94254096|NCT00600886|322722649|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
94254097|NCT00600886|322722650|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
94254098|NCT00600886|322722649|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
94254099|NCT00600886|322722650|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
94358481|NCT03110107|323096446|FG016|Treatment Period|Study drug toxicity|3|||
94612124|NCT00850070|324045034|FG001|Overall Study|Lack of Efficacy|1|||
94612125|NCT00850070|324045033|FG000|Overall Study|Adverse Event|2|||
94612126|NCT00850070|324045034|FG001|Overall Study|Adverse Event|0|||
94612127|NCT04810481|324045037|FG000|Overall Study|Disqualified data sets|10|||
94612128|NCT04810481|324045038|FG001|Overall Study|Disqualified data sets|28|||
94612129|NCT01254292|324045042|FG000|Comparative Phase|Adverse Event|25|||
94612130|NCT01254292|324045043|FG001|Comparative Phase|Adverse Event|25|||
94612131|NCT01254292|324045042|FG000|Comparative Phase|Lost to Follow-up|3|||
94612132|NCT01254292|324045043|FG001|Comparative Phase|Lost to Follow-up|21|||
94662999|NCT03579563|324222203|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
94663000|NCT03579563|324222204|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
94663001|NCT03579563|324222205|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
94663002|NCT03579563|324222206|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
94663003|NCT03579563|324222207|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
94663004|NCT03579563|324222202|FG000|Overall Study|Time/distance concern|0|||
94663005|NCT03579563|324222203|FG001|Overall Study|Time/distance concern|0|||
94663006|NCT03579563|324222204|FG002|Overall Study|Time/distance concern|1|||
94663007|NCT03579563|324222205|FG003|Overall Study|Time/distance concern|0|||
94663008|NCT03579563|324222206|FG004|Overall Study|Time/distance concern|0|||
94663009|NCT03579563|324222207|FG005|Overall Study|Time/distance concern|1|||
94663010|NCT03579563|324222202|FG000|Overall Study|COVID shutdown|2|||
94663011|NCT03579563|324222203|FG001|Overall Study|COVID shutdown|3|||
94663012|NCT03579563|324222204|FG002|Overall Study|COVID shutdown|4|||
94663013|NCT03579563|324222205|FG003|Overall Study|COVID shutdown|3|||
94663014|NCT03579563|324222206|FG004|Overall Study|COVID shutdown|1|||
94663015|NCT03579563|324222207|FG005|Overall Study|COVID shutdown|2|||
94663016|NCT03579563|324222202|FG000|Overall Study|Protocol administration error|1|||
94663017|NCT03579563|324222203|FG001|Overall Study|Protocol administration error|0|||
94663018|NCT03579563|324222204|FG002|Overall Study|Protocol administration error|1|||
94663019|NCT03579563|324222205|FG003|Overall Study|Protocol administration error|0|||
94663020|NCT03579563|324222206|FG004|Overall Study|Protocol administration error|1|||
94663021|NCT03579563|324222207|FG005|Overall Study|Protocol administration error|5|||
94663022|NCT03625570|324222208|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
94663023|NCT03625570|324222209|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
94663024|NCT03625570|324222208|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
94663025|NCT03625570|324222209|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
94663026|NCT03625570|324222208|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
94663027|NCT03625570|324222209|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
94663028|NCT03264989|324222210|FG000|Overall Study|Lost to Follow-up|1|||
94663029|NCT03264989|324222211|FG001|Overall Study|Lost to Follow-up|0|||
94663030|NCT03264989|324222210|FG000|Overall Study|New Therapy for study Indication|1|||
94663031|NCT03264989|324222211|FG001|Overall Study|New Therapy for study Indication|0|||
94663032|NCT03264989|324222210|FG000|Overall Study|Protocol Violation|0|||
94663033|NCT03264989|324222211|FG001|Overall Study|Protocol Violation|1|||
94663034|NCT03264989|324222210|FG000|Overall Study|Patient decision|13|||
94663035|NCT03264989|324222211|FG001|Overall Study|Patient decision|0|||
94663036|NCT03264989|324222210|FG000|Overall Study|Physician Decision|6|||
94663037|NCT03264989|324222211|FG001|Overall Study|Physician Decision|4|||
94663038|NCT03264989|324222210|FG000|Overall Study|Adverse Event|2|||
94663039|NCT03264989|324222211|FG001|Overall Study|Adverse Event|1|||
94663040|NCT03264989|324222210|FG000|Overall Study|Death|1|||
94663041|NCT03264989|324222211|FG001|Overall Study|Death|1|||
94663042|NCT03264989|324222210|FG000|Overall Study|Pregnancy|2|||
94663043|NCT03264989|324222211|FG001|Overall Study|Pregnancy|0|||
94663044|NCT03264989|324222210|FG000|Overall Study|End of Study|19|||
94663045|NCT03264989|324222211|FG001|Overall Study|End of Study|5|||
94663046|NCT02937545|324222213|FG000|Overall Study|Withdrawal by Subject|1|||
94663047|NCT02937545|324222214|FG001|Overall Study|Withdrawal by Subject|2|||
94663048|NCT02937545|324222215|FG002|Overall Study|Withdrawal by Subject|6|||
94663049|NCT02937545|324222216|FG003|Overall Study|Withdrawal by Subject|7|||
94663050|NCT02937545|324222213|FG000|Overall Study|Lost to Follow-up|1|||
94663051|NCT02937545|324222214|FG001|Overall Study|Lost to Follow-up|0|||
94663052|NCT02937545|324222215|FG002|Overall Study|Lost to Follow-up|0|||
94663053|NCT02937545|324222216|FG003|Overall Study|Lost to Follow-up|0|||
94663054|NCT02504294|324222222|FG000|Overall Study|Adverse Event|15|||
94663055|NCT02504294|324222223|FG001|Overall Study|Adverse Event|12|||
94663056|NCT02504294|324222222|FG000|Overall Study|Withdrawal by Subject|7|||
94663057|NCT02504294|324222223|FG001|Overall Study|Withdrawal by Subject|1|||
94663058|NCT02504294|324222222|FG000|Overall Study|Protocol Violation|27|||
94663059|NCT02504294|324222223|FG001|Overall Study|Protocol Violation|26|||
94663060|NCT02504294|324222222|FG000|Overall Study|Physician Decision|1|||
94663061|NCT02504294|324222223|FG001|Overall Study|Physician Decision|2|||
94663062|NCT02504294|324222222|FG000|Overall Study|Lost to Follow-up|6|||
94663063|NCT02504294|324222223|FG001|Overall Study|Lost to Follow-up|7|||
94663064|NCT00833989|324222228|FG000|Overall Study|Physician Decision|0|||
94663065|NCT00833989|324222229|FG001|Overall Study|Physician Decision|0|||
94663066|NCT00833989|324222230|FG002|Overall Study|Physician Decision|0|||
94663067|NCT00833989|324222231|FG003|Overall Study|Physician Decision|1|||
94663068|NCT00833989|324222228|FG000|Overall Study|Withdrawal by Subject|3|||
94663069|NCT00833989|324222229|FG001|Overall Study|Withdrawal by Subject|0|||
94663070|NCT00833989|324222230|FG002|Overall Study|Withdrawal by Subject|1|||
94663071|NCT00833989|324222231|FG003|Overall Study|Withdrawal by Subject|1|||
94663072|NCT01949480|324222234|FG000|Overall Study|Physician Decision|5|||
94663073|NCT01949480|324222235|FG001|Overall Study|Physician Decision|8|||
94663074|NCT03998618|324222242|FG000|Overall Study|Death|7|||
94663075|NCT03998618|324222243|FG001|Overall Study|Death|11|||
94663076|NCT03998618|324222242|FG000|Overall Study|hospice enrollment|3|||
94663077|NCT03998618|324222243|FG001|Overall Study|hospice enrollment|3|||
94663078|NCT03998618|324222242|FG000|Overall Study|Not feeling well/health problems|3|||
94663079|NCT03998618|324222243|FG001|Overall Study|Not feeling well/health problems|5|||
94663080|NCT03998618|324222242|FG000|Overall Study|Lost to Follow-up|6|||
94663081|NCT03998618|324222243|FG001|Overall Study|Lost to Follow-up|6|||
94663082|NCT03998618|324222242|FG000|Overall Study|Withdrawal by Subject|0|||
94663083|NCT03998618|324222243|FG001|Overall Study|Withdrawal by Subject|4|||
94663084|NCT01910129|324222246|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
94663085|NCT01910129|324222247|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
94663086|NCT01910129|324222248|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
94663087|NCT01910129|324222246|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
94663088|NCT01910129|324222247|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
94663089|NCT01910129|324222248|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
94663090|NCT00214136|324222250|FG000|Overall Study|Death|5|||
94663091|NCT00965523|324222251|FG000|Study 221|Progressive Disease|4|||
94663092|NCT00965523|324222251|FG000|Study 221|Physician Decision|3|||
94663093|NCT00965523|324222251|FG000|Study 224|Progressive Disease|5|||
94663094|NCT00965523|324222251|FG000|Study 224|Physician Decision|1|||
94663095|NCT02310750|324222254|FG000|HP Period 1|Lost to Follow-up|0|||
94663096|NCT02310750|324222255|FG001|HP Period 1|Lost to Follow-up|0|||
94663097|NCT02310750|324222256|FG002|HP Period 1|Lost to Follow-up|0|||
94663098|NCT02310750|324222257|FG003|HP Period 1|Lost to Follow-up|0|||
94663099|NCT02310750|324222258|FG004|HP Period 1|Lost to Follow-up|0|||
94663100|NCT02310750|324222259|FG005|HP Period 1|Lost to Follow-up|0|||
94663101|NCT02310750|324222260|FG006|HP Period 1|Lost to Follow-up|1|||
94663102|NCT02310750|324222261|FG007|HP Period 1|Lost to Follow-up|0|||
94663103|NCT02310750|324222262|FG008|HP Period 1|Lost to Follow-up|0|||
94663104|NCT02310750|324222263|FG009|HP Period 1|Lost to Follow-up|0|||
94663105|NCT02310750|324222264|FG010|HP Period 1|Lost to Follow-up|0|||
94663106|NCT02310750|324222265|FG011|HP Period 1|Lost to Follow-up|0|||
94663107|NCT02310750|324222266|FG012|HP Period 1|Lost to Follow-up|0|||
94663108|NCT02310750|324222267|FG013|HP Period 1|Lost to Follow-up|0|||
94663109|NCT02310750|324222268|FG014|HP Period 1|Lost to Follow-up|0|||
94663110|NCT02310750|324222269|FG015|HP Period 1|Lost to Follow-up|0|||
94663111|NCT02310750|324222254|FG000|HP Period 1|Withdrawal by Subject|1|||
94663112|NCT02310750|324222255|FG001|HP Period 1|Withdrawal by Subject|0|||
94663113|NCT02310750|324222256|FG002|HP Period 1|Withdrawal by Subject|0|||
94663114|NCT02310750|324222257|FG003|HP Period 1|Withdrawal by Subject|1|||
94663115|NCT02310750|324222258|FG004|HP Period 1|Withdrawal by Subject|0|||
94663116|NCT02310750|324222259|FG005|HP Period 1|Withdrawal by Subject|0|||
94663117|NCT02310750|324222260|FG006|HP Period 1|Withdrawal by Subject|0|||
94663118|NCT02310750|324222261|FG007|HP Period 1|Withdrawal by Subject|0|||
94663119|NCT02310750|324222262|FG008|HP Period 1|Withdrawal by Subject|0|||
94663120|NCT02310750|324222263|FG009|HP Period 1|Withdrawal by Subject|0|||
94663121|NCT02310750|324222264|FG010|HP Period 1|Withdrawal by Subject|0|||
94663122|NCT02310750|324222265|FG011|HP Period 1|Withdrawal by Subject|0|||
94663123|NCT02310750|324222266|FG012|HP Period 1|Withdrawal by Subject|0|||
94663124|NCT02310750|324222267|FG013|HP Period 1|Withdrawal by Subject|0|||
94663125|NCT02310750|324222268|FG014|HP Period 1|Withdrawal by Subject|0|||
94663126|NCT02310750|324222269|FG015|HP Period 1|Withdrawal by Subject|0|||
94663127|NCT02310750|324222254|FG000|HP Washout 1|Lost to Follow-up|0|||
94663128|NCT02310750|324222255|FG001|HP Washout 1|Lost to Follow-up|0|||
94663129|NCT02310750|324222256|FG002|HP Washout 1|Lost to Follow-up|1|||
94663130|NCT02310750|324222257|FG003|HP Washout 1|Lost to Follow-up|1|||
94663131|NCT02310750|324222258|FG004|HP Washout 1|Lost to Follow-up|2|||
94663132|NCT02310750|324222259|FG005|HP Washout 1|Lost to Follow-up|2|||
94663133|NCT02310750|324222260|FG006|HP Washout 1|Lost to Follow-up|3|||
94663134|NCT02310750|324222261|FG007|HP Washout 1|Lost to Follow-up|0|||
94663135|NCT02310750|324222262|FG008|HP Washout 1|Lost to Follow-up|0|||
94663136|NCT02310750|324222263|FG009|HP Washout 1|Lost to Follow-up|0|||
94663137|NCT02310750|324222264|FG010|HP Washout 1|Lost to Follow-up|0|||
94663138|NCT02310750|324222265|FG011|HP Washout 1|Lost to Follow-up|0|||
94663139|NCT02310750|324222266|FG012|HP Washout 1|Lost to Follow-up|0|||
94663140|NCT02310750|324222267|FG013|HP Washout 1|Lost to Follow-up|0|||
94663141|NCT02310750|324222268|FG014|HP Washout 1|Lost to Follow-up|0|||
94663142|NCT02310750|324222269|FG015|HP Washout 1|Lost to Follow-up|0|||
94663143|NCT02310750|324222254|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
94663144|NCT02310750|324222255|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
94663145|NCT02310750|324222256|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
94358482|NCT03110107|323096447|FG017|Treatment Period|Study drug toxicity|3|||
94358483|NCT03110107|323096448|FG018|Treatment Period|Study drug toxicity|1|||
94358484|NCT03110107|323096449|FG019|Treatment Period|Study drug toxicity|2|||
94612133|NCT01254292|324045042|FG000|Comparative Phase|Pregnancy|2|||
94612134|NCT01254292|324045043|FG001|Comparative Phase|Pregnancy|6|||
94612135|NCT01254292|324045042|FG000|Comparative Phase|Withdrawal by Subject|20|||
94612136|NCT01254292|324045043|FG001|Comparative Phase|Withdrawal by Subject|21|||
94612137|NCT01254292|324045042|FG000|Comparative Phase|Protocol Violation|1|||
94612138|NCT01254292|324045043|FG001|Comparative Phase|Protocol Violation|2|||
94612139|NCT01254292|324045042|FG000|Comparative Phase|Wish for pregnancy|4|||
94612140|NCT01254292|324045043|FG001|Comparative Phase|Wish for pregnancy|6|||
94612141|NCT01254292|324045042|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
94612142|NCT01254292|324045043|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
94612143|NCT01254292|324045042|FG000|LCS12 Extension Phase|Adverse Event|9|||
94612144|NCT01254292|324045043|FG001|LCS12 Extension Phase|Adverse Event|0|||
94612145|NCT01254292|324045042|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
94612146|NCT01254292|324045043|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
94612147|NCT01254292|324045042|FG000|LCS12 Extension Phase|Other unknown|4|||
94612148|NCT01254292|324045043|FG001|LCS12 Extension Phase|Other unknown|0|||
94612149|NCT01254292|324045042|FG000|LCS12 Extension Phase|Pregnancy|2|||
94612150|NCT01254292|324045043|FG001|LCS12 Extension Phase|Pregnancy|0|||
94612151|NCT01254292|324045042|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
94612152|NCT01254292|324045043|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
94612153|NCT00285818|324045044|FG000|Overall Study|Withdrawal by Subject|3|||
94612154|NCT00285818|324045045|FG001|Overall Study|Withdrawal by Subject|2|||
94612155|NCT00285818|324045044|FG000|Overall Study|Lost to Follow-up|1|||
94612156|NCT00285818|324045045|FG001|Overall Study|Lost to Follow-up|0|||
94612157|NCT04674644|324045049|FG000|Overall Study|with missing data|37|||
94612158|NCT00199875|324045050|FG000|Overall Study|Withdrawal by Subject|0|||
94612159|NCT00199875|324045051|FG001|Overall Study|Withdrawal by Subject|0|||
94612160|NCT00199875|324045052|FG002|Overall Study|Withdrawal by Subject|0|||
94612161|NCT00199875|324045053|FG003|Overall Study|Withdrawal by Subject|0|||
94612162|NCT00199875|324045054|FG004|Overall Study|Withdrawal by Subject|1|||
94612163|NCT01024231|324045055|FG000|Overall Study|Other Reasons|1|||
94612164|NCT01024231|324045056|FG001|Overall Study|Other Reasons|2|||
94612165|NCT01024231|324045057|FG002|Overall Study|Other Reasons|0|||
94612166|NCT01024231|324045058|FG003|Overall Study|Other Reasons|0|||
94612167|NCT01024231|324045059|FG004|Overall Study|Other Reasons|2|||
94612168|NCT01024231|324045060|FG005|Overall Study|Other Reasons|0|||
94612169|NCT01024231|324045061|FG006|Overall Study|Other Reasons|1|||
94612170|NCT01024231|324045055|FG000|Overall Study|Maximum Clinical Benefit|1|||
94612171|NCT01024231|324045056|FG001|Overall Study|Maximum Clinical Benefit|2|||
94612172|NCT01024231|324045057|FG002|Overall Study|Maximum Clinical Benefit|0|||
94612173|NCT01024231|324045058|FG003|Overall Study|Maximum Clinical Benefit|1|||
94612174|NCT01024231|324045059|FG004|Overall Study|Maximum Clinical Benefit|1|||
94612175|NCT01024231|324045060|FG005|Overall Study|Maximum Clinical Benefit|0|||
94612176|NCT01024231|324045061|FG006|Overall Study|Maximum Clinical Benefit|0|||
94612177|NCT01024231|324045055|FG000|Overall Study|Disease Progression|3|||
94612178|NCT01024231|324045056|FG001|Overall Study|Disease Progression|1|||
94612179|NCT01024231|324045057|FG002|Overall Study|Disease Progression|3|||
94612180|NCT01024231|324045058|FG003|Overall Study|Disease Progression|0|||
94612181|NCT01024231|324045059|FG004|Overall Study|Disease Progression|4|||
94612182|NCT01024231|324045060|FG005|Overall Study|Disease Progression|11|||
94612183|NCT01024231|324045061|FG006|Overall Study|Disease Progression|6|||
94612184|NCT01024231|324045055|FG000|Overall Study|AE unrelated to Study Drug|0|||
94612185|NCT01024231|324045056|FG001|Overall Study|AE unrelated to Study Drug|1|||
94612186|NCT01024231|324045057|FG002|Overall Study|AE unrelated to Study Drug|0|||
94612187|NCT01024231|324045058|FG003|Overall Study|AE unrelated to Study Drug|0|||
94612188|NCT01024231|324045059|FG004|Overall Study|AE unrelated to Study Drug|0|||
94612189|NCT01024231|324045060|FG005|Overall Study|AE unrelated to Study Drug|0|||
94612190|NCT01024231|324045061|FG006|Overall Study|AE unrelated to Study Drug|0|||
94612191|NCT01024231|324045055|FG000|Overall Study|No longer meets criteria|0|||
94612192|NCT01024231|324045056|FG001|Overall Study|No longer meets criteria|0|||
94612193|NCT01024231|324045057|FG002|Overall Study|No longer meets criteria|0|||
94612194|NCT01024231|324045058|FG003|Overall Study|No longer meets criteria|0|||
94612195|NCT01024231|324045059|FG004|Overall Study|No longer meets criteria|1|||
94612196|NCT01024231|324045060|FG005|Overall Study|No longer meets criteria|0|||
94612197|NCT01024231|324045061|FG006|Overall Study|No longer meets criteria|1|||
94612198|NCT01024231|324045055|FG000|Overall Study|Study Drug Toxicity|1|||
94612199|NCT01024231|324045056|FG001|Overall Study|Study Drug Toxicity|6|||
94612200|NCT01024231|324045057|FG002|Overall Study|Study Drug Toxicity|6|||
94612201|NCT01024231|324045058|FG003|Overall Study|Study Drug Toxicity|4|||
94612202|NCT01024231|324045059|FG004|Overall Study|Study Drug Toxicity|2|||
94612203|NCT01024231|324045060|FG005|Overall Study|Study Drug Toxicity|0|||
94612204|NCT01024231|324045061|FG006|Overall Study|Study Drug Toxicity|7|||
94254100|NCT00600886|322722649|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
94254101|NCT00600886|322722650|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
94254102|NCT00600886|322722649|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
94254103|NCT00600886|322722650|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
94254104|NCT00600886|322722649|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
94254105|NCT00600886|322722650|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
94254106|NCT00600886|322722649|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
94254107|NCT00600886|322722650|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
94612205|NCT01024231|324045055|FG000|Overall Study|Death|6|||
94612206|NCT01024231|324045056|FG001|Overall Study|Death|2|||
94612207|NCT01024231|324045057|FG002|Overall Study|Death|1|||
94612208|NCT01024231|324045058|FG003|Overall Study|Death|0|||
94612209|NCT01024231|324045059|FG004|Overall Study|Death|4|||
94612210|NCT01024231|324045060|FG005|Overall Study|Death|3|||
94612211|NCT01024231|324045061|FG006|Overall Study|Death|5|||
94612212|NCT01024231|324045055|FG000|Overall Study|Lost to Follow-up|0|||
94612213|NCT01024231|324045056|FG001|Overall Study|Lost to Follow-up|0|||
94612214|NCT01024231|324045057|FG002|Overall Study|Lost to Follow-up|0|||
94612215|NCT01024231|324045058|FG003|Overall Study|Lost to Follow-up|0|||
94612216|NCT01024231|324045059|FG004|Overall Study|Lost to Follow-up|0|||
94612217|NCT01024231|324045060|FG005|Overall Study|Lost to Follow-up|0|||
94612218|NCT01024231|324045061|FG006|Overall Study|Lost to Follow-up|1|||
94612219|NCT01024231|324045055|FG000|Overall Study|Withdrew Consent|0|||
94612220|NCT01024231|324045056|FG001|Overall Study|Withdrew Consent|1|||
94612221|NCT01024231|324045057|FG002|Overall Study|Withdrew Consent|0|||
94612222|NCT01024231|324045058|FG003|Overall Study|Withdrew Consent|0|||
94612223|NCT01024231|324045059|FG004|Overall Study|Withdrew Consent|0|||
94612224|NCT01024231|324045060|FG005|Overall Study|Withdrew Consent|0|||
94612225|NCT01024231|324045061|FG006|Overall Study|Withdrew Consent|0|||
94612226|NCT01024231|324045055|FG000|Overall Study|Continuing on Treatment|0|||
94612227|NCT01024231|324045056|FG001|Overall Study|Continuing on Treatment|0|||
94612228|NCT01024231|324045057|FG002|Overall Study|Continuing on Treatment|0|||
94612229|NCT01024231|324045058|FG003|Overall Study|Continuing on Treatment|0|||
94612230|NCT01024231|324045059|FG004|Overall Study|Continuing on Treatment|3|||
94612231|NCT01024231|324045060|FG005|Overall Study|Continuing on Treatment|2|||
94612232|NCT01024231|324045061|FG006|Overall Study|Continuing on Treatment|0|||
94612233|NCT03277690|324045062|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
94612234|NCT03277690|324045063|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
94612235|NCT03277690|324045062|FG000|Dose Titration and Maintenance|Physician Decision|1|||
94612236|NCT03277690|324045063|FG001|Dose Titration and Maintenance|Physician Decision|0|||
94612237|NCT03277690|324045062|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
94612238|NCT03277690|324045063|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
94612239|NCT03277690|324045062|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
94254108|NCT00600886|322722649|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
94254109|NCT00600886|322722650|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
94254110|NCT00600886|322722649|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
94254111|NCT00600886|322722650|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
94254112|NCT00600886|322722649|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
94254113|NCT00600886|322722650|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
94254114|NCT00600886|322722649|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
94254115|NCT00600886|322722650|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
94254116|NCT00600886|322722649|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
94254117|NCT00600886|322722650|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
94254118|NCT00600886|322722649|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
94254119|NCT00600886|322722650|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
94254120|NCT00600886|322722649|FG000|Extension - Same Treatment (FAS)|Death|1|||
94254121|NCT00600886|322722650|FG001|Extension - Same Treatment (FAS)|Death|1|||
94254122|NCT00600886|322722649|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
94254123|NCT00600886|322722650|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
94254124|NCT00600886|322722649|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
94254125|NCT00600886|322722650|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
94254126|NCT00600886|322722649|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
94254127|NCT00600886|322722650|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
94254128|NCT00600886|322722649|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
94254129|NCT00600886|322722650|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
94254130|NCT00600886|322722649|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
94254131|NCT00600886|322722650|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
94254132|NCT00600886|322722649|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
94254133|NCT00600886|322722650|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
94254134|NCT00600886|322722649|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
94254135|NCT00600886|322722650|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
94254136|NCT00600886|322722649|FG000|Extension - After Crossover (CAS)|Death|1|||
94254137|NCT00600886|322722650|FG001|Extension - After Crossover (CAS)|Death|0|||
94254138|NCT00055601|322724313|FG000|Overall Study|Protocol Violation|1|||
94254139|NCT00055601|322724314|FG001|Overall Study|Protocol Violation|1|||
94254140|NCT00055601|322724313|FG000|Overall Study|No protocol treatment received|1|||
94254141|NCT00055601|322724314|FG001|Overall Study|No protocol treatment received|1|||
94254142|NCT01022268|322724315|FG000|Overall Study|Withdrawal by Subject|1|||
94254143|NCT01022268|322724316|FG001|Overall Study|Withdrawal by Subject|0|||
94254144|NCT01022268|322724315|FG000|Overall Study|Withdrawal by Subject|1|||
94254145|NCT01022268|322724316|FG001|Overall Study|Withdrawal by Subject|0|||
94254146|NCT02502097|322724317|FG000|Period 1|Adverse Event|0|||
94254147|NCT02502097|322724318|FG001|Period 1|Adverse Event|0|||
94254148|NCT02502097|322724319|FG002|Period 1|Adverse Event|1|||
94254149|NCT02502097|322724320|FG003|Period 1|Adverse Event|0|||
94254150|NCT02502097|322724317|FG000|Wash Out Period|Adverse Event|0|||
94254151|NCT02502097|322724318|FG001|Wash Out Period|Adverse Event|1|||
94254152|NCT02502097|322724319|FG002|Wash Out Period|Adverse Event|1|||
94254153|NCT02502097|322724320|FG003|Wash Out Period|Adverse Event|1|||
94254154|NCT02502097|322724317|FG000|Period 2|Adverse Event|0|||
94254155|NCT02502097|322724318|FG001|Period 2|Adverse Event|0|||
94254156|NCT02502097|322724319|FG002|Period 2|Adverse Event|1|||
94254157|NCT02502097|322724320|FG003|Period 2|Adverse Event|0|||
94254158|NCT00896051|322724322|FG000|Overall Study|Adverse Event|2|||
94254159|NCT00896051|322724323|FG001|Overall Study|Adverse Event|1|||
94254160|NCT00896051|322724322|FG000|Overall Study|Lost to Follow-up|3|||
94254161|NCT00896051|322724323|FG001|Overall Study|Lost to Follow-up|2|||
94254162|NCT00896051|322724322|FG000|Overall Study|Withdrawal by Subject|3|||
94254163|NCT00896051|322724323|FG001|Overall Study|Withdrawal by Subject|2|||
94254164|NCT00896051|322724322|FG000|Overall Study|Subject noncompliant|1|||
94254165|NCT00896051|322724323|FG001|Overall Study|Subject noncompliant|3|||
94254166|NCT00896051|322724322|FG000|Overall Study|Other|1|||
94254167|NCT00896051|322724323|FG001|Overall Study|Other|1|||
94612240|NCT03277690|324045063|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
94612241|NCT03277690|324045062|FG000|Dose Titration and Maintenance|Adverse Event|15|||
94612242|NCT03277690|324045063|FG001|Dose Titration and Maintenance|Adverse Event|0|||
94612243|NCT03277690|324045062|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
94612244|NCT03277690|324045063|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
94612245|NCT03277690|324045062|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
94612246|NCT03277690|324045063|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
94612247|NCT01691898|324045064|FG000|Overall Study|Death|34|||
94612248|NCT01691898|324045065|FG001|Overall Study|Death|32|||
94612249|NCT01691898|324045066|FG002|Overall Study|Death|6|||
94612250|NCT01691898|324045067|FG003|Overall Study|Death|3|||
94612251|NCT01691898|324045068|FG004|Overall Study|Death|8|||
94612252|NCT01691898|324045069|FG005|Overall Study|Death|31|||
94612253|NCT01691898|324045064|FG000|Overall Study|Adverse Event|0|||
94459791|NCT04521621|323471905|FG003|Overall Study|Withdrawal by Subject|1|||
94663146|NCT02310750|324222257|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
94663147|NCT02310750|324222258|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
94663148|NCT02310750|324222259|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
94663149|NCT02310750|324222260|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
94663150|NCT02310750|324222261|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
94663151|NCT02310750|324222262|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
94663152|NCT02310750|324222263|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
94663153|NCT02310750|324222264|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
94459792|NCT04521621|323471906|FG004|Overall Study|Withdrawal by Subject|0|||
94663154|NCT02310750|324222265|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
94254168|NCT00701779|322724326|FG000|Overall Study|Adverse Event|6|||
94254169|NCT00701779|322724326|FG000|Overall Study|Lost to Follow-up|1|||
94254170|NCT00701779|322724326|FG000|Overall Study|Withdrawal by Subject|2|||
94254171|NCT04187989|322724327|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
94254172|NCT04187989|322724328|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
94254173|NCT04187989|322724327|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
94254174|NCT04187989|322724328|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
94254175|NCT00092495|322724329|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
94254176|NCT00092495|322724330|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
94254177|NCT00092495|322724331|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
94254178|NCT00092495|322724332|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
94254179|NCT00092495|322724333|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
94254180|NCT00092495|322724329|FG000|Base Study Vaccination Period|Extended|0|||
94254181|NCT00092495|322724330|FG001|Base Study Vaccination Period|Extended|0|||
94254182|NCT00092495|322724331|FG002|Base Study Vaccination Period|Extended|0|||
94254183|NCT00092495|322724332|FG003|Base Study Vaccination Period|Extended|1|||
94254184|NCT00092495|322724333|FG004|Base Study Vaccination Period|Extended|0|||
94254185|NCT00092495|322724329|FG000|Base Study Vaccination Period|*Clinical AE|1|||
94254186|NCT00092495|322724330|FG001|Base Study Vaccination Period|*Clinical AE|0|||
94254187|NCT00092495|322724331|FG002|Base Study Vaccination Period|*Clinical AE|1|||
94254188|NCT00092495|322724332|FG003|Base Study Vaccination Period|*Clinical AE|2|||
94254189|NCT00092495|322724333|FG004|Base Study Vaccination Period|*Clinical AE|0|||
94254190|NCT00092495|322724329|FG000|Base Study Vaccination Period|*Other reasons|1|||
94254191|NCT00092495|322724330|FG001|Base Study Vaccination Period|*Other reasons|0|||
94254192|NCT00092495|322724331|FG002|Base Study Vaccination Period|*Other reasons|0|||
94254193|NCT00092495|322724332|FG003|Base Study Vaccination Period|*Other reasons|1|||
94254194|NCT00092495|322724333|FG004|Base Study Vaccination Period|*Other reasons|0|||
94254195|NCT00092495|322724329|FG000|Base Study Vaccination Period|*Pregnancy|0|||
94254196|NCT00092495|322724330|FG001|Base Study Vaccination Period|*Pregnancy|2|||
94254197|NCT00092495|322724331|FG002|Base Study Vaccination Period|*Pregnancy|5|||
94254198|NCT00092495|322724332|FG003|Base Study Vaccination Period|*Pregnancy|7|||
94254199|NCT00092495|322724333|FG004|Base Study Vaccination Period|*Pregnancy|0|||
94254200|NCT00092495|322724329|FG000|Base Study Vaccination Period|Adverse Event|1|||
94254201|NCT00092495|322724330|FG001|Base Study Vaccination Period|Adverse Event|0|||
94254202|NCT00092495|322724331|FG002|Base Study Vaccination Period|Adverse Event|0|||
94254203|NCT00092495|322724332|FG003|Base Study Vaccination Period|Adverse Event|3|||
94254204|NCT00092495|322724333|FG004|Base Study Vaccination Period|Adverse Event|0|||
94254205|NCT00092495|322724329|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
94254206|NCT00092495|322724330|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
94254207|NCT00092495|322724331|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
94254208|NCT00092495|322724332|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
94254209|NCT00092495|322724333|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
94254210|NCT00092495|322724329|FG000|Base Study Vaccination Period|Moved|3|||
94254211|NCT00092495|322724330|FG001|Base Study Vaccination Period|Moved|1|||
94254212|NCT00092495|322724331|FG002|Base Study Vaccination Period|Moved|2|||
94254213|NCT00092495|322724332|FG003|Base Study Vaccination Period|Moved|2|||
94254214|NCT00092495|322724333|FG004|Base Study Vaccination Period|Moved|0|||
94254215|NCT00092495|322724329|FG000|Base Study Vaccination Period|Other|1|||
94254216|NCT00092495|322724330|FG001|Base Study Vaccination Period|Other|1|||
94254217|NCT00092495|322724331|FG002|Base Study Vaccination Period|Other|0|||
94254218|NCT00092495|322724332|FG003|Base Study Vaccination Period|Other|2|||
94254219|NCT00092495|322724333|FG004|Base Study Vaccination Period|Other|0|||
94254220|NCT00092495|322724329|FG000|Base Study Vaccination Period|Pregnancy|2|||
94254221|NCT00092495|322724330|FG001|Base Study Vaccination Period|Pregnancy|0|||
94612254|NCT01691898|324045065|FG001|Overall Study|Adverse Event|1|||
94612255|NCT01691898|324045066|FG002|Overall Study|Adverse Event|0|||
94612256|NCT01691898|324045067|FG003|Overall Study|Adverse Event|1|||
94612257|NCT01691898|324045068|FG004|Overall Study|Adverse Event|1|||
94612258|NCT01691898|324045069|FG005|Overall Study|Adverse Event|0|||
94612259|NCT01691898|324045064|FG000|Overall Study|Progression of Disease|1|||
94612260|NCT01691898|324045065|FG001|Overall Study|Progression of Disease|2|||
94612261|NCT01691898|324045066|FG002|Overall Study|Progression of Disease|1|||
94612262|NCT01691898|324045067|FG003|Overall Study|Progression of Disease|0|||
94612263|NCT01691898|324045068|FG004|Overall Study|Progression of Disease|0|||
94254222|NCT00092495|322724331|FG002|Base Study Vaccination Period|Pregnancy|0|||
94254223|NCT00092495|322724332|FG003|Base Study Vaccination Period|Pregnancy|0|||
94254224|NCT00092495|322724333|FG004|Base Study Vaccination Period|Pregnancy|0|||
94254225|NCT00092495|322724329|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
94612264|NCT01691898|324045069|FG005|Overall Study|Progression of Disease|1|||
94612265|NCT01691898|324045064|FG000|Overall Study|Lost to Follow-up|3|||
94612266|NCT01691898|324045065|FG001|Overall Study|Lost to Follow-up|1|||
94612267|NCT01691898|324045066|FG002|Overall Study|Lost to Follow-up|0|||
94612268|NCT01691898|324045067|FG003|Overall Study|Lost to Follow-up|0|||
94254226|NCT00092495|322724330|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
94254227|NCT00092495|322724331|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
94254228|NCT00092495|322724332|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
94254229|NCT00092495|322724333|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
94254230|NCT00092495|322724329|FG000|Base Study Vaccination Period|Protocol Violation|1|||
94254231|NCT00092495|322724330|FG001|Base Study Vaccination Period|Protocol Violation|0|||
94254232|NCT00092495|322724331|FG002|Base Study Vaccination Period|Protocol Violation|0|||
94254233|NCT00092495|322724332|FG003|Base Study Vaccination Period|Protocol Violation|0|||
94254234|NCT00092495|322724333|FG004|Base Study Vaccination Period|Protocol Violation|0|||
94254235|NCT00092495|322724329|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
94254236|NCT00092495|322724330|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
94254237|NCT00092495|322724331|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
94254238|NCT00092495|322724332|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
94254239|NCT00092495|322724333|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
94254240|NCT00092495|322724329|FG000|Base Study Follow-up Period|Extended|0|||
94254241|NCT00092495|322724330|FG001|Base Study Follow-up Period|Extended|0|||
94254242|NCT00092495|322724331|FG002|Base Study Follow-up Period|Extended|1|||
94254243|NCT00092495|322724332|FG003|Base Study Follow-up Period|Extended|2|||
94254244|NCT00092495|322724333|FG004|Base Study Follow-up Period|Extended|0|||
94254245|NCT00092495|322724329|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
94254246|NCT00092495|322724330|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
94254247|NCT00092495|322724331|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
94254248|NCT00092495|322724332|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
94254249|NCT00092495|322724333|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
94254250|NCT00092495|322724329|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
94254251|NCT00092495|322724330|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
94254252|NCT00092495|322724331|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
94254253|NCT00092495|322724332|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
94254254|NCT00092495|322724333|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
94254255|NCT03103763|322724338|FG000|Overall Study|Death|15|||
94254256|NCT03103763|322724339|FG001|Overall Study|Death|5|||
94254257|NCT03103763|322724340|FG002|Overall Study|Death|5|||
94254258|NCT03103763|322724338|FG000|Overall Study|Withdrawal by Subject|0|||
94254259|NCT03103763|322724339|FG001|Overall Study|Withdrawal by Subject|3|||
94254260|NCT03103763|322724340|FG002|Overall Study|Withdrawal by Subject|2|||
94254261|NCT00938470|322724341|FG000|Overall Study|Disease Progression|3|||
94254262|NCT00938470|322724342|FG001|Overall Study|Disease Progression|0|||
94254263|NCT00938470|322724341|FG000|Overall Study|Alternate Treatment|1|||
94254264|NCT00938470|322724342|FG001|Overall Study|Alternate Treatment|0|||
94663155|NCT02310750|324222266|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
94663156|NCT02310750|324222267|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
94663157|NCT02310750|324222268|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
94663158|NCT02310750|324222269|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
94663159|NCT02310750|324222254|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
94663160|NCT02310750|324222255|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
94663161|NCT02310750|324222256|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
94663162|NCT02310750|324222257|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
94663163|NCT02310750|324222258|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
94663164|NCT02310750|324222259|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
94663165|NCT02310750|324222260|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
94663166|NCT02310750|324222261|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
94663167|NCT02310750|324222262|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
94663168|NCT02310750|324222263|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
94663169|NCT02310750|324222264|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
94663170|NCT02310750|324222265|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
94663171|NCT02310750|324222266|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
94663172|NCT02310750|324222267|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
94663173|NCT02310750|324222268|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
94663174|NCT02310750|324222269|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
94663175|NCT02310750|324222254|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
94663176|NCT02310750|324222255|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
94459793|NCT04521621|323471907|FG005|Overall Study|Withdrawal by Subject|0|||
94663177|NCT02310750|324222256|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
94663178|NCT02310750|324222257|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
94254265|NCT00938470|322724341|FG000|Overall Study|Death|3|||
94254266|NCT00938470|322724342|FG001|Overall Study|Death|2|||
94254267|NCT00938470|322724341|FG000|Overall Study|Other Reason|0|||
94254268|NCT00938470|322724342|FG001|Overall Study|Other Reason|1|||
94254269|NCT00717067|322724343|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
94254270|NCT00717067|322724344|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
94254271|NCT00717067|322724345|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
94254272|NCT00717067|322724346|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
94254273|NCT00717067|322724347|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
94254274|NCT01874431|322724349|FG000|Overall Study|Physician Decision|0|||
94254275|NCT01874431|322724350|FG001|Overall Study|Physician Decision|0|||
94254276|NCT01874431|322724351|FG002|Overall Study|Physician Decision|1|||
94612269|NCT01691898|324045068|FG004|Overall Study|Lost to Follow-up|1|||
94612270|NCT01691898|324045069|FG005|Overall Study|Lost to Follow-up|0|||
94612271|NCT01691898|324045064|FG000|Overall Study|Withdrawal by Subject|9|||
94612272|NCT01691898|324045065|FG001|Overall Study|Withdrawal by Subject|8|||
94254277|NCT01874431|322724352|FG003|Overall Study|Physician Decision|0|||
94254278|NCT01874431|322724353|FG004|Overall Study|Physician Decision|0|||
94254279|NCT01874431|322724354|FG005|Overall Study|Physician Decision|0|||
94254280|NCT01874431|322724355|FG006|Overall Study|Physician Decision|0|||
94254281|NCT01874431|322724356|FG007|Overall Study|Physician Decision|0|||
94254282|NCT01874431|322724349|FG000|Overall Study|Adverse Event|5|||
94254283|NCT01874431|322724350|FG001|Overall Study|Adverse Event|4|||
94254284|NCT01874431|322724351|FG002|Overall Study|Adverse Event|6|||
94254285|NCT01874431|322724352|FG003|Overall Study|Adverse Event|5|||
94254286|NCT01874431|322724353|FG004|Overall Study|Adverse Event|2|||
94254287|NCT01874431|322724354|FG005|Overall Study|Adverse Event|8|||
94254288|NCT01874431|322724355|FG006|Overall Study|Adverse Event|2|||
94254289|NCT01874431|322724356|FG007|Overall Study|Adverse Event|3|||
94254290|NCT01874431|322724349|FG000|Overall Study|Protocol Violation|1|||
94254291|NCT01874431|322724350|FG001|Overall Study|Protocol Violation|1|||
94254292|NCT01874431|322724351|FG002|Overall Study|Protocol Violation|1|||
94254293|NCT01874431|322724352|FG003|Overall Study|Protocol Violation|0|||
94254294|NCT01874431|322724353|FG004|Overall Study|Protocol Violation|3|||
94254295|NCT01874431|322724354|FG005|Overall Study|Protocol Violation|2|||
94254296|NCT01874431|322724355|FG006|Overall Study|Protocol Violation|1|||
94254297|NCT01874431|322724356|FG007|Overall Study|Protocol Violation|1|||
94254298|NCT01874431|322724349|FG000|Overall Study|Non-compliance|0|||
94254299|NCT01874431|322724350|FG001|Overall Study|Non-compliance|0|||
94254300|NCT01874431|322724351|FG002|Overall Study|Non-compliance|0|||
94254301|NCT01874431|322724352|FG003|Overall Study|Non-compliance|0|||
94254302|NCT01874431|322724353|FG004|Overall Study|Non-compliance|1|||
94254303|NCT01874431|322724354|FG005|Overall Study|Non-compliance|0|||
94254304|NCT01874431|322724355|FG006|Overall Study|Non-compliance|1|||
94254305|NCT01874431|322724356|FG007|Overall Study|Non-compliance|0|||
94254306|NCT01874431|322724349|FG000|Overall Study|Logistical difficulties|0|||
94254307|NCT01874431|322724350|FG001|Overall Study|Logistical difficulties|0|||
94254308|NCT01874431|322724351|FG002|Overall Study|Logistical difficulties|0|||
94254309|NCT01874431|322724352|FG003|Overall Study|Logistical difficulties|0|||
94254310|NCT01874431|322724353|FG004|Overall Study|Logistical difficulties|0|||
94254311|NCT01874431|322724354|FG005|Overall Study|Logistical difficulties|0|||
94254312|NCT01874431|322724355|FG006|Overall Study|Logistical difficulties|1|||
94254313|NCT01874431|322724356|FG007|Overall Study|Logistical difficulties|0|||
94254314|NCT01874431|322724349|FG000|Overall Study|Withdrawal by Subject|0|||
94254315|NCT01874431|322724350|FG001|Overall Study|Withdrawal by Subject|0|||
94254316|NCT01874431|322724351|FG002|Overall Study|Withdrawal by Subject|1|||
94254317|NCT01874431|322724352|FG003|Overall Study|Withdrawal by Subject|2|||
94254318|NCT01874431|322724353|FG004|Overall Study|Withdrawal by Subject|1|||
94254319|NCT01874431|322724354|FG005|Overall Study|Withdrawal by Subject|1|||
94254320|NCT01874431|322724355|FG006|Overall Study|Withdrawal by Subject|3|||
94254321|NCT01874431|322724356|FG007|Overall Study|Withdrawal by Subject|0|||
94254322|NCT01874431|322724349|FG000|Overall Study|Sponsor decision|0|||
94254323|NCT01874431|322724350|FG001|Overall Study|Sponsor decision|0|||
94254324|NCT01874431|322724351|FG002|Overall Study|Sponsor decision|0|||
94612273|NCT01691898|324045066|FG002|Overall Study|Withdrawal by Subject|2|||
94612274|NCT01691898|324045067|FG003|Overall Study|Withdrawal by Subject|1|||
94612275|NCT01691898|324045068|FG004|Overall Study|Withdrawal by Subject|3|||
94612276|NCT01691898|324045069|FG005|Overall Study|Withdrawal by Subject|3|||
94612277|NCT01691898|324045064|FG000|Overall Study|Non-Compliance|0|||
94612278|NCT01691898|324045065|FG001|Overall Study|Non-Compliance|0|||
94612279|NCT01691898|324045066|FG002|Overall Study|Non-Compliance|0|||
94612280|NCT01691898|324045067|FG003|Overall Study|Non-Compliance|0|||
94459794|NCT04521621|323471908|FG006|Overall Study|Withdrawal by Subject|0|||
94612281|NCT01691898|324045068|FG004|Overall Study|Non-Compliance|1|||
94254325|NCT01874431|322724352|FG003|Overall Study|Sponsor decision|0|||
94254326|NCT01874431|322724353|FG004|Overall Study|Sponsor decision|1|||
94254327|NCT01874431|322724354|FG005|Overall Study|Sponsor decision|0|||
94254328|NCT01874431|322724355|FG006|Overall Study|Sponsor decision|0|||
94254329|NCT01874431|322724356|FG007|Overall Study|Sponsor decision|0|||
94254330|NCT01874431|322724349|FG000|Overall Study|Lost to Follow-up|0|||
94254331|NCT01874431|322724350|FG001|Overall Study|Lost to Follow-up|0|||
94254332|NCT01874431|322724351|FG002|Overall Study|Lost to Follow-up|1|||
94254333|NCT01874431|322724352|FG003|Overall Study|Lost to Follow-up|0|||
94254334|NCT01874431|322724353|FG004|Overall Study|Lost to Follow-up|0|||
94254335|NCT01874431|322724354|FG005|Overall Study|Lost to Follow-up|0|||
94612282|NCT01691898|324045069|FG005|Overall Study|Non-Compliance|0|||
94612283|NCT00747812|324045070|FG000|Overall Study|Research Site Staff Relocation|5|||
94612284|NCT00747812|324045071|FG001|Overall Study|Research Site Staff Relocation|3|||
94612285|NCT02019277|324045072|FG000|Overall Study|Withdrawal by Subject|3|||
94612286|NCT02019277|324045072|FG000|Overall Study|Death|7|||
94612287|NCT02019277|324045072|FG000|Overall Study|Did no Cooperate|1|||
94612288|NCT02019277|324045072|FG000|Overall Study|Adverse Event|1|||
94612289|NCT01268150|324045074|FG000|Treatment Phase|Progression of disease|18|||
94612290|NCT01268150|324045074|FG000|Treatment Phase|Adverse Event|3|||
94612291|NCT01268150|324045074|FG000|Treatment Phase|Withdrawal by Subject|3|||
94612292|NCT01268150|324045074|FG000|Treatment Phase|Other|4|||
94612293|NCT01268150|324045074|FG000|Extension Phase|Adverse Event|3|||
94612294|NCT01268150|324045074|FG000|Extension Phase|Disease progression|18|||
94612295|NCT01268150|324045074|FG000|Extension Phase|Other|6|||
94612296|NCT00395733|324045075|FG000|Period 2|Withdrawal by Subject|1|||
94612297|NCT00395733|324045076|FG001|Period 2|Withdrawal by Subject|2|||
94612298|NCT00395733|324045075|FG000|Period 2|Protocol Violation|0|||
94612299|NCT00395733|324045076|FG001|Period 2|Protocol Violation|1|||
94612300|NCT00395733|324045075|FG000|Period 2|Adverse Event|0|||
94612301|NCT00395733|324045076|FG001|Period 2|Adverse Event|2|||
94612302|NCT00395733|324045075|FG000|Period 2|Technical problems|1|||
94612303|NCT00395733|324045076|FG001|Period 2|Technical problems|0|||
94612304|NCT03799211|324045081|FG000|Overall Study|Lost to Follow-up|2|||
94612305|NCT03799211|324045082|FG001|Overall Study|Lost to Follow-up|13|||
94612306|NCT03799211|324045081|FG000|Overall Study|Withdrawal by Subject|2|||
94612307|NCT03799211|324045082|FG001|Overall Study|Withdrawal by Subject|0|||
94612308|NCT02435147|324045083|FG000|Overall Study|non-evaluable DXA scan|11|||
94612309|NCT01069627|324045084|FG000|Overall Study|Disease progression|7|||
94612310|NCT01069627|324045084|FG000|Overall Study|Adverse Event|12|||
94612311|NCT01069627|324045084|FG000|Overall Study|Protocol Violation|1|||
94612312|NCT02939079|324045085|FG000|Overall Study|Adverse Event|2|||
94612313|NCT02939079|324045086|FG001|Overall Study|Adverse Event|1|||
94612314|NCT02939079|324045085|FG000|Overall Study|Lost to Follow-up|0|||
94612315|NCT02939079|324045086|FG001|Overall Study|Lost to Follow-up|2|||
94612316|NCT02939079|324045085|FG000|Overall Study|Protocol Violation|1|||
94612317|NCT02939079|324045086|FG001|Overall Study|Protocol Violation|0|||
94612318|NCT02939079|324045085|FG000|Overall Study|Withdrawal by Subject|0|||
94612319|NCT02939079|324045086|FG001|Overall Study|Withdrawal by Subject|1|||
94612320|NCT02939079|324045085|FG000|Overall Study|relapse during the study|1|||
94612321|NCT02939079|324045086|FG001|Overall Study|relapse during the study|1|||
94612322|NCT02963935|324045087|FG000|Overall Study|Adverse Event|12|||
94612323|NCT02963935|324045088|FG001|Overall Study|Adverse Event|6|||
94612324|NCT02963935|324045087|FG000|Overall Study|Protocol Violation|2|||
94612325|NCT02963935|324045088|FG001|Overall Study|Protocol Violation|1|||
94612326|NCT02963935|324045087|FG000|Overall Study|Lack of Efficacy|0|||
94612327|NCT02963935|324045088|FG001|Overall Study|Lack of Efficacy|2|||
94612328|NCT02963935|324045087|FG000|Overall Study|Lost to Follow-up|1|||
94612329|NCT02963935|324045088|FG001|Overall Study|Lost to Follow-up|6|||
94612330|NCT02963935|324045087|FG000|Overall Study|Unclassified|13|||
94612331|NCT02963935|324045088|FG001|Overall Study|Unclassified|22|||
94612332|NCT02853344|324045089|FG000|Overall Study|Lost to Follow-up|1|||
94612333|NCT02853344|324045090|FG001|Overall Study|Lost to Follow-up|1|||
94612334|NCT02853344|324045089|FG000|Overall Study|Withdrawal by Subject|2|||
94612335|NCT02853344|324045090|FG001|Overall Study|Withdrawal by Subject|4|||
94612336|NCT02853344|324045089|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
94612337|NCT02853344|324045090|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
94612338|NCT02853344|324045089|FG000|Overall Study|Death|70|||
94612339|NCT02853344|324045090|FG001|Overall Study|Death|112|||
94612340|NCT03082261|324045091|FG000|Overall Study|Death|4|||
94612341|NCT03082261|324045091|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
94612342|NCT03082261|324045091|FG000|Overall Study|Insurance denial|1|||
94612343|NCT03082261|324045091|FG000|Overall Study|Peripheral lead added|1|||
94612344|NCT03082261|324045091|FG000|Overall Study|Withdrawal by Subject|40|||
94612345|NCT03082261|324045091|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
94612346|NCT03082261|324045091|FG000|Overall Study|Subject implanted with device other than study device|1|||
94612347|NCT03082261|324045091|FG000|Overall Study|Lost to Follow-up|14|||
94612348|NCT03082261|324045091|FG000|Overall Study|Subject moved to a different state|1|||
94612349|NCT03082261|324045091|FG000|Overall Study|Subject non-compliance|2|||
94612350|NCT03082261|324045091|FG000|Overall Study|Subject participation terminated by investigator|9|||
94612351|NCT03082261|324045091|FG000|Overall Study|Subject participation terminated by sponsor|4|||
94612352|NCT03082261|324045091|FG000|Overall Study|System explant|19|||
94612353|NCT03082261|324045091|FG000|Overall Study|Unable to place lead(s)|2|||
94612354|NCT03082261|324045091|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
94254336|NCT01874431|322724355|FG006|Overall Study|Lost to Follow-up|0|||
94254337|NCT01874431|322724356|FG007|Overall Study|Lost to Follow-up|0|||
94254338|NCT00738582|322724357|FG000|Combination Therapy|Completed Combination Therapy|1|||
94254339|NCT00738582|322724358|FG001|Combination Therapy|Completed Combination Therapy|0|||
94254340|NCT00738582|322724357|FG000|Combination Therapy|Physician Decision|1|||
94254341|NCT00738582|322724358|FG001|Combination Therapy|Physician Decision|0|||
94254342|NCT00738582|322724357|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
94254343|NCT00738582|322724358|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
94254344|NCT00738582|322724357|FG000|Combination Therapy|Other|5|||
94254345|NCT00738582|322724358|FG001|Combination Therapy|Other|0|||
94254346|NCT00738582|322724357|FG000|Combination Therapy|Adverse Event|16|||
94254347|NCT00738582|322724358|FG001|Combination Therapy|Adverse Event|0|||
94254348|NCT00738582|322724357|FG000|Combination Therapy|Progressive Disease|9|||
94254349|NCT00738582|322724358|FG001|Combination Therapy|Progressive Disease|0|||
94254350|NCT00738582|322724357|FG000|Maintenance Therapy|Other|0|||
94254351|NCT00738582|322724358|FG001|Maintenance Therapy|Other|2|||
94254352|NCT00738582|322724357|FG000|Maintenance Therapy|Adverse Event|0|||
94663179|NCT02310750|324222258|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
94663180|NCT02310750|324222259|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
94663181|NCT02310750|324222260|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
94663182|NCT02310750|324222261|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
94663183|NCT02310750|324222262|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
94663184|NCT02310750|324222263|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
94663185|NCT02310750|324222264|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
94663186|NCT02310750|324222265|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
94663187|NCT02310750|324222266|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
94663188|NCT02310750|324222267|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
94663189|NCT02310750|324222268|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
94663190|NCT02310750|324222269|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
94663191|NCT02310750|324222254|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
94663192|NCT02310750|324222255|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
94663193|NCT02310750|324222256|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
94663194|NCT02310750|324222257|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
94663195|NCT02310750|324222258|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
94663196|NCT02310750|324222259|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
94663197|NCT02310750|324222260|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
94663198|NCT02310750|324222261|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
94663199|NCT02310750|324222262|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
94663200|NCT02310750|324222263|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
94663201|NCT02310750|324222264|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
94663202|NCT02310750|324222265|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
94663203|NCT02310750|324222266|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
94663204|NCT02310750|324222267|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
94612355|NCT04545554|324045092|FG000|Overall Study|Withdrawal by Subject|0|||
94612356|NCT04545554|324045093|FG001|Overall Study|Withdrawal by Subject|0|||
94612357|NCT04545554|324045094|FG002|Overall Study|Withdrawal by Subject|0|||
94612358|NCT04545554|324045095|FG003|Overall Study|Withdrawal by Subject|1|||
94612359|NCT04545554|324045096|FG004|Overall Study|Withdrawal by Subject|0|||
94612360|NCT04545554|324045097|FG005|Overall Study|Withdrawal by Subject|0|||
94612361|NCT02149875|324045098|FG000|Overall Study|Lost to Follow-up|3|||
94612362|NCT02149875|324045099|FG001|Overall Study|Lost to Follow-up|4|||
94612363|NCT02149875|324045100|FG002|Overall Study|Lost to Follow-up|5|||
94612364|NCT02149875|324045098|FG000|Overall Study|Withdrawal by Subject|3|||
94612365|NCT02149875|324045099|FG001|Overall Study|Withdrawal by Subject|2|||
94612366|NCT02149875|324045100|FG002|Overall Study|Withdrawal by Subject|2|||
94612367|NCT02149875|324045098|FG000|Overall Study|Physician Decision|1|||
94612368|NCT02149875|324045099|FG001|Overall Study|Physician Decision|2|||
94612369|NCT02149875|324045100|FG002|Overall Study|Physician Decision|2|||
94612370|NCT02639546|324045101|FG000|Overall Study|Death|2|||
94612371|NCT02639546|324045102|FG001|Overall Study|Death|2|||
94612372|NCT02639546|324045103|FG002|Overall Study|Death|1|||
94612373|NCT02639546|324045104|FG003|Overall Study|Death|2|||
94612374|NCT02639546|324045105|FG004|Overall Study|Death|2|||
94612375|NCT02639546|324045106|FG005|Overall Study|Death|2|||
94612376|NCT02639546|324045107|FG006|Overall Study|Death|0|||
94663205|NCT02310750|324222268|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
94663206|NCT02310750|324222269|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
94663207|NCT02310750|324222254|FG000|HP Washout 2|Lost to Follow-up|0|||
94663208|NCT02310750|324222255|FG001|HP Washout 2|Lost to Follow-up|0|||
94358485|NCT03110107|323096450|FG020|Treatment Period|Study drug toxicity|2|||
94612377|NCT02639546|324045108|FG007|Overall Study|Death|0|||
94254353|NCT00738582|322724358|FG001|Maintenance Therapy|Adverse Event|6|||
94612378|NCT02639546|324045101|FG000|Overall Study|Lost to Follow-up|0|||
94663209|NCT02310750|324222256|FG002|HP Washout 2|Lost to Follow-up|0|||
94663210|NCT02310750|324222257|FG003|HP Washout 2|Lost to Follow-up|0|||
94663211|NCT02310750|324222258|FG004|HP Washout 2|Lost to Follow-up|1|||
94663212|NCT02310750|324222259|FG005|HP Washout 2|Lost to Follow-up|0|||
94663213|NCT02310750|324222260|FG006|HP Washout 2|Lost to Follow-up|7|||
94663214|NCT02310750|324222261|FG007|HP Washout 2|Lost to Follow-up|0|||
94663215|NCT02310750|324222262|FG008|HP Washout 2|Lost to Follow-up|0|||
94663216|NCT02310750|324222263|FG009|HP Washout 2|Lost to Follow-up|0|||
94663217|NCT02310750|324222264|FG010|HP Washout 2|Lost to Follow-up|0|||
94663218|NCT02310750|324222265|FG011|HP Washout 2|Lost to Follow-up|0|||
94663219|NCT02310750|324222266|FG012|HP Washout 2|Lost to Follow-up|0|||
94663220|NCT02310750|324222267|FG013|HP Washout 2|Lost to Follow-up|0|||
94663221|NCT02310750|324222268|FG014|HP Washout 2|Lost to Follow-up|0|||
94663222|NCT02310750|324222269|FG015|HP Washout 2|Lost to Follow-up|0|||
94663223|NCT00936858|324222273|FG000|Overall Study|Death|3|||
94663224|NCT00936858|324222273|FG000|Overall Study|Progression|29|||
94663225|NCT00936858|324222273|FG000|Overall Study|Withdrawal by Subject|5|||
94612379|NCT02639546|324045102|FG001|Overall Study|Lost to Follow-up|0|||
94612380|NCT02639546|324045103|FG002|Overall Study|Lost to Follow-up|1|||
94612381|NCT02639546|324045104|FG003|Overall Study|Lost to Follow-up|0|||
94612382|NCT02639546|324045105|FG004|Overall Study|Lost to Follow-up|1|||
94612383|NCT02639546|324045106|FG005|Overall Study|Lost to Follow-up|1|||
94663226|NCT00936858|324222273|FG000|Overall Study|Adverse Event|1|||
94663227|NCT00936858|324222273|FG000|Overall Study|Physician Decision|7|||
94612384|NCT02639546|324045107|FG006|Overall Study|Lost to Follow-up|0|||
94612385|NCT02639546|324045108|FG007|Overall Study|Lost to Follow-up|1|||
94612386|NCT02639546|324045101|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
94612387|NCT02639546|324045102|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
94612388|NCT02639546|324045103|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
94612389|NCT02639546|324045104|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
94612390|NCT02639546|324045105|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
94612391|NCT02639546|324045106|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
94612392|NCT02639546|324045107|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
94612393|NCT02639546|324045108|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
94612394|NCT02639546|324045101|FG000|Overall Study|Study Terminated By Sponsor|0|||
94612395|NCT02639546|324045102|FG001|Overall Study|Study Terminated By Sponsor|2|||
94663228|NCT00936858|324222273|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
94663229|NCT00936858|324222273|FG000|Overall Study|Lost to Follow-up|1|||
94663230|NCT02265237|324222274|FG000|As Treated (Overall Study)|Adverse Event|1|||
94663231|NCT02265237|324222275|FG001|As Treated (Overall Study)|Adverse Event|1|||
94663232|NCT02265237|324222276|FG002|As Treated (Overall Study)|Adverse Event|0|||
94663233|NCT02265237|324222277|FG003|As Treated (Overall Study)|Adverse Event|0|||
94663234|NCT02265237|324222274|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
94663235|NCT02265237|324222275|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
94663236|NCT02265237|324222276|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
94663237|NCT02265237|324222277|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
94663238|NCT02265237|324222274|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
94663239|NCT02265237|324222275|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
94663240|NCT02265237|324222276|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
94663241|NCT02265237|324222277|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
94663242|NCT02265237|324222274|FG000|As Treated (Overall Study)|Other|2|||
94663243|NCT02265237|324222275|FG001|As Treated (Overall Study)|Other|0|||
94663244|NCT02265237|324222276|FG002|As Treated (Overall Study)|Other|3|||
94663245|NCT02265237|324222277|FG003|As Treated (Overall Study)|Other|1|||
94663246|NCT00435370|324222288|FG000|Overall Study|Adverse Event|8|||
94663247|NCT00435370|324222289|FG001|Overall Study|Adverse Event|8|||
94663248|NCT00435370|324222288|FG000|Overall Study|Withdrawal by Subject|10|||
94663249|NCT00435370|324222289|FG001|Overall Study|Withdrawal by Subject|10|||
94663250|NCT00435370|324222288|FG000|Overall Study|Antipsychotic medication changed|4|||
94663251|NCT00435370|324222289|FG001|Overall Study|Antipsychotic medication changed|2|||
94612396|NCT02639546|324045103|FG002|Overall Study|Study Terminated By Sponsor|3|||
94663252|NCT03943095|324222290|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
94663253|NCT03943095|324222291|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
94663254|NCT03943095|324222290|FG000|Overall Study|Withdrawal by Subject|1|||
94663255|NCT03943095|324222291|FG001|Overall Study|Withdrawal by Subject|0|||
94663256|NCT01660906|324222292|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
94663257|NCT03478891|324222293|FG000|Overall Study|Enrolled, but product never administered|0|||
94663258|NCT03478891|324222294|FG001|Overall Study|Enrolled, but product never administered|0|||
94663259|NCT03478891|324222295|FG002|Overall Study|Enrolled, but product never administered|1|||
94663260|NCT03478891|324222293|FG000|Overall Study|Moved from area|0|||
94358486|NCT03110107|323096451|FG021|Treatment Period|Study drug toxicity|0|||
94358487|NCT03110107|323096452|FG022|Treatment Period|Study drug toxicity|2|||
94358488|NCT03110107|323096453|FG023|Treatment Period|Study drug toxicity|6|||
94358489|NCT03110107|323096454|FG024|Treatment Period|Study drug toxicity|7|||
94358490|NCT03110107|323096455|FG025|Treatment Period|Study drug toxicity|6|||
94358491|NCT03110107|323096430|FG000|Treatment Period|Death|0|||
94358492|NCT03110107|323096431|FG001|Treatment Period|Death|0|||
94358493|NCT03110107|323096432|FG002|Treatment Period|Death|0|||
94358494|NCT03110107|323096433|FG003|Treatment Period|Death|0|||
94358495|NCT03110107|323096434|FG004|Treatment Period|Death|0|||
94358496|NCT03110107|323096435|FG005|Treatment Period|Death|0|||
94358497|NCT03110107|323096436|FG006|Treatment Period|Death|0|||
94358498|NCT03110107|323096437|FG007|Treatment Period|Death|0|||
94663261|NCT03478891|324222294|FG001|Overall Study|Moved from area|0|||
94663262|NCT03478891|324222295|FG002|Overall Study|Moved from area|1|||
94663263|NCT03478891|324222293|FG000|Overall Study|Lost to Follow-up|1|||
94663264|NCT03478891|324222294|FG001|Overall Study|Lost to Follow-up|0|||
94663265|NCT03478891|324222295|FG002|Overall Study|Lost to Follow-up|1|||
94663266|NCT04177758|324222296|FG000|Overall Study|Lost to Follow-up|19|||
94663267|NCT04177758|324222297|FG001|Overall Study|Lost to Follow-up|11|||
94663268|NCT02535065|324222301|FG000|Overall Study|Death|13|||
94663269|NCT02535065|324222301|FG000|Overall Study|Lost to Follow-up|1|||
94358499|NCT03110107|323096438|FG008|Treatment Period|Death|0|||
94358500|NCT03110107|323096439|FG009|Treatment Period|Death|0|||
94358501|NCT03110107|323096440|FG010|Treatment Period|Death|0|||
94358502|NCT03110107|323096441|FG011|Treatment Period|Death|0|||
94358503|NCT03110107|323096442|FG012|Treatment Period|Death|1|||
94358504|NCT03110107|323096443|FG013|Treatment Period|Death|0|||
94358505|NCT03110107|323096444|FG014|Treatment Period|Death|0|||
94358506|NCT03110107|323096445|FG015|Treatment Period|Death|0|||
94358507|NCT03110107|323096446|FG016|Treatment Period|Death|0|||
94358508|NCT03110107|323096447|FG017|Treatment Period|Death|0|||
94358509|NCT03110107|323096448|FG018|Treatment Period|Death|0|||
94358510|NCT03110107|323096449|FG019|Treatment Period|Death|0|||
94358511|NCT03110107|323096450|FG020|Treatment Period|Death|0|||
94358512|NCT03110107|323096451|FG021|Treatment Period|Death|0|||
94358513|NCT03110107|323096452|FG022|Treatment Period|Death|0|||
94358514|NCT03110107|323096453|FG023|Treatment Period|Death|0|||
94663270|NCT02535065|324222301|FG000|Overall Study|Withdrawal by Subject|6|||
94663271|NCT01128413|324222303|FG000|Overall Study|Withdrawal by Subject|1|||
94663272|NCT01128413|324222304|FG001|Overall Study|Withdrawal by Subject|0|||
94663273|NCT01128413|324222303|FG000|Overall Study|NICOM Monitor Problems|2|||
94663274|NCT01128413|324222304|FG001|Overall Study|NICOM Monitor Problems|1|||
94663275|NCT01128413|324222303|FG000|Overall Study|Pt made DNR|1|||
94663276|NCT01128413|324222304|FG001|Overall Study|Pt made DNR|0|||
94663277|NCT00791765|324224614|FG000|Weeks 1 to 12|Adverse Event|0|||
94663278|NCT00791765|324224615|FG001|Weeks 1 to 12|Adverse Event|1|||
94663279|NCT00791765|324224614|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
94663280|NCT00791765|324224615|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
94663281|NCT00791765|324224614|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
94663282|NCT00791765|324224615|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
94663283|NCT00791765|324224614|FG000|Weeks 1 to 12|Physician Decision|1|||
94358515|NCT03110107|323096454|FG024|Treatment Period|Death|0|||
94358516|NCT03110107|323096455|FG025|Treatment Period|Death|0|||
94358517|NCT03110107|323096430|FG000|Treatment Period|Adverse Event|0|||
94358518|NCT03110107|323096431|FG001|Treatment Period|Adverse Event|0|||
94358519|NCT03110107|323096432|FG002|Treatment Period|Adverse Event|1|||
94358520|NCT03110107|323096433|FG003|Treatment Period|Adverse Event|0|||
94358521|NCT03110107|323096434|FG004|Treatment Period|Adverse Event|0|||
94358522|NCT03110107|323096435|FG005|Treatment Period|Adverse Event|2|||
94358523|NCT03110107|323096436|FG006|Treatment Period|Adverse Event|0|||
94358524|NCT03110107|323096437|FG007|Treatment Period|Adverse Event|2|||
94358525|NCT03110107|323096438|FG008|Treatment Period|Adverse Event|0|||
94358526|NCT03110107|323096439|FG009|Treatment Period|Adverse Event|1|||
94358527|NCT03110107|323096440|FG010|Treatment Period|Adverse Event|0|||
94612397|NCT02639546|324045104|FG003|Overall Study|Study Terminated By Sponsor|4|||
94612398|NCT02639546|324045105|FG004|Overall Study|Study Terminated By Sponsor|4|||
94612399|NCT02639546|324045106|FG005|Overall Study|Study Terminated By Sponsor|3|||
94612400|NCT02639546|324045107|FG006|Overall Study|Study Terminated By Sponsor|3|||
94612401|NCT02639546|324045108|FG007|Overall Study|Study Terminated By Sponsor|9|||
94612402|NCT02639546|324045101|FG000|Overall Study|Withdrawal by Subject|2|||
94612403|NCT02639546|324045102|FG001|Overall Study|Withdrawal by Subject|2|||
94612404|NCT02639546|324045103|FG002|Overall Study|Withdrawal by Subject|1|||
94612405|NCT02639546|324045104|FG003|Overall Study|Withdrawal by Subject|0|||
94612406|NCT02639546|324045105|FG004|Overall Study|Withdrawal by Subject|0|||
94612407|NCT02639546|324045106|FG005|Overall Study|Withdrawal by Subject|1|||
94663284|NCT00791765|324224615|FG001|Weeks 1 to 12|Physician Decision|0|||
94663285|NCT00791765|324224614|FG000|Weeks 1 to 12|Disease progression|3|||
94663286|NCT00791765|324224615|FG001|Weeks 1 to 12|Disease progression|0|||
94663287|NCT00791765|324224614|FG000|Weeks 1 to 12|Ineligibility determined|0|||
94663288|NCT00791765|324224615|FG001|Weeks 1 to 12|Ineligibility determined|3|||
94663289|NCT00791765|324224614|FG000|Weeks 13 to 24|Protocol deviation|2|||
94663290|NCT00791765|324224615|FG001|Weeks 13 to 24|Protocol deviation|0|||
94663291|NCT00791765|324224614|FG000|Weeks 13 to 24|Adverse Event|0|||
94663292|NCT00791765|324224615|FG001|Weeks 13 to 24|Adverse Event|3|||
94663293|NCT00791765|324224614|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
94663294|NCT00791765|324224615|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
94663295|NCT00791765|324224614|FG000|Weeks 13 to 24|Disease progression|0|||
94663296|NCT00791765|324224615|FG001|Weeks 13 to 24|Disease progression|1|||
94663297|NCT00791765|324224614|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
94663298|NCT00791765|324224615|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
94663299|NCT00791765|324224614|FG000|Weeks 13 to 24|Other|0|||
94663300|NCT00791765|324224615|FG001|Weeks 13 to 24|Other|1|||
94663301|NCT01159691|324224619|FG000|Overall Study|Lost to Follow-up|2|||
94663302|NCT01159691|324224619|FG000|Overall Study|Unknown reasons|1|||
94663303|NCT01159691|324224619|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
94663304|NCT01159691|324224619|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
94663305|NCT01159691|324224619|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
94663306|NCT01159691|324224619|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
94663307|NCT01159691|324224619|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
94663308|NCT01159691|324224619|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
94663309|NCT05732454|324224620|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
94663310|NCT05732454|324224621|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
94663311|NCT05732454|324224620|FG000|Part 1: DB Period|Adverse Event|1|||
94663312|NCT05732454|324224621|FG001|Part 1: DB Period|Adverse Event|0|||
94663313|NCT05732454|324224620|FG000|Part 1: DB Period|Lost to Follow-up|1|||
94663314|NCT05732454|324224621|FG001|Part 1: DB Period|Lost to Follow-up|0|||
94663315|NCT05732454|324224620|FG000|Part 1: DB Period|Protocol Violation|0|||
94663316|NCT05732454|324224621|FG001|Part 1: DB Period|Protocol Violation|1|||
94663317|NCT05732454|324224620|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
94663318|NCT05732454|324224621|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
94663319|NCT05732454|324224620|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
94663320|NCT05732454|324224621|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
94663321|NCT05732454|324224620|FG000|Part 1: OLE Period|Adverse Event|0|||
94663322|NCT05732454|324224621|FG001|Part 1: OLE Period|Adverse Event|1|||
94663323|NCT05732454|324224620|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
94663324|NCT05732454|324224621|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
94663325|NCT00071487|324224622|FG000|52-Week Double-Blind Period|Adverse Event|5|||
94663326|NCT00071487|324224623|FG001|52-Week Double-Blind Period|Adverse Event|8|||
94663327|NCT00071487|324224624|FG002|52-Week Double-Blind Period|Adverse Event|4|||
94663328|NCT00071487|324224625|FG003|52-Week Double-Blind Period|Adverse Event|8|||
94358528|NCT03110107|323096441|FG011|Treatment Period|Adverse Event|0|||
94358529|NCT03110107|323096442|FG012|Treatment Period|Adverse Event|0|||
94358530|NCT03110107|323096443|FG013|Treatment Period|Adverse Event|0|||
94358531|NCT03110107|323096444|FG014|Treatment Period|Adverse Event|0|||
94358532|NCT03110107|323096445|FG015|Treatment Period|Adverse Event|2|||
94612408|NCT02639546|324045107|FG006|Overall Study|Withdrawal by Subject|2|||
94663329|NCT00071487|324224622|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
94663330|NCT00071487|324224623|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
94663331|NCT00071487|324224624|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
94663332|NCT00071487|324224625|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
94663333|NCT00071487|324224622|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
94663334|NCT00071487|324224623|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
94663335|NCT00071487|324224624|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
94358533|NCT03110107|323096446|FG016|Treatment Period|Adverse Event|0|||
94612409|NCT02639546|324045108|FG007|Overall Study|Withdrawal by Subject|1|||
94612410|NCT01297920|324045109|FG000|Overall Study|Adverse Event|42|||
94612411|NCT01297920|324045110|FG001|Overall Study|Adverse Event|10|||
94612412|NCT01297920|324045111|FG002|Overall Study|Adverse Event|38|||
94612413|NCT01297920|324045109|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
94663336|NCT00071487|324224625|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
94663337|NCT00071487|324224622|FG000|52-Week Double-Blind Period|Physician Decision|1|||
94663338|NCT00071487|324224623|FG001|52-Week Double-Blind Period|Physician Decision|0|||
94663339|NCT00071487|324224624|FG002|52-Week Double-Blind Period|Physician Decision|0|||
94663340|NCT00071487|324224625|FG003|52-Week Double-Blind Period|Physician Decision|0|||
94663341|NCT00071487|324224622|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
94663342|NCT00071487|324224623|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
94663343|NCT00071487|324224624|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
94663344|NCT00071487|324224625|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
94663345|NCT00071487|324224622|FG000|52-Week Double-Blind Period|Pregnancy|0|||
94663346|NCT00071487|324224623|FG001|52-Week Double-Blind Period|Pregnancy|1|||
94663347|NCT00071487|324224624|FG002|52-Week Double-Blind Period|Pregnancy|0|||
94663348|NCT00071487|324224625|FG003|52-Week Double-Blind Period|Pregnancy|0|||
94663349|NCT00071487|324224622|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
94663350|NCT00071487|324224623|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
94663351|NCT00071487|324224624|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
94663352|NCT00071487|324224625|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
94663353|NCT00071487|324224622|FG000|52-Week Double-Blind Period|Death|0|||
94663354|NCT00071487|324224623|FG001|52-Week Double-Blind Period|Death|1|||
94663355|NCT00071487|324224624|FG002|52-Week Double-Blind Period|Death|0|||
94663356|NCT00071487|324224625|FG003|52-Week Double-Blind Period|Death|0|||
94663357|NCT00071487|324224622|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
94663358|NCT00071487|324224623|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
94663359|NCT00071487|324224624|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
94663360|NCT00071487|324224625|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
94663361|NCT00071487|324224622|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
94663362|NCT00071487|324224623|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
94663363|NCT00071487|324224624|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
94663364|NCT00071487|324224625|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
94663365|NCT00071487|324224622|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
94663366|NCT00071487|324224623|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
94663367|NCT00071487|324224624|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
94663368|NCT00071487|324224625|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
94663369|NCT00071487|324224622|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
94663370|NCT00071487|324224623|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
94663371|NCT00071487|324224624|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
94663372|NCT00071487|324224625|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
94663373|NCT00071487|324224622|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
94663374|NCT00071487|324224623|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
94663375|NCT00071487|324224624|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
94663376|NCT00071487|324224625|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
94663377|NCT00071487|324224622|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
94663378|NCT00071487|324224623|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
94663379|NCT00071487|324224624|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
94663380|NCT00071487|324224625|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
94663381|NCT00071487|324224622|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
94663382|NCT00071487|324224623|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
94663383|NCT00071487|324224624|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
94663384|NCT00071487|324224625|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
94663385|NCT00352365|324224626|FG000|Induction Therapy|Adverse Event|7|||
94663386|NCT00352365|324224626|FG000|Induction Therapy|Progression/Relapse|8|||
94663387|NCT00352365|324224626|FG000|Induction Therapy|Death|7|||
94663388|NCT00352365|324224626|FG000|Induction Therapy|Not protocol specified|1|||
94663389|NCT00352365|324224626|FG000|Induction Therapy|Not eligible|3|||
94663390|NCT00352365|324224626|FG000|Induction Therapy|Death before starting protocol therapy|1|||
94663391|NCT00352365|324224626|FG000|Maintenance Therapy|Progression/Relapse|3|||
94663392|NCT00352365|324224626|FG000|Maintenance Therapy|Death|2|||
94663393|NCT00352365|324224626|FG000|Maintenance Therapy|Not protocol specified|3|||
94663394|NCT00352365|324224626|FG000|Maintenance Therapy|Not eligible|4|||
94663395|NCT04743908|324224627|FG000|Overall Study|Death|1|||
94663396|NCT04743908|324224628|FG001|Overall Study|Death|0|||
94663397|NCT04743908|324224627|FG000|Overall Study|Lost to Follow-up|181|||
94663398|NCT04743908|324224628|FG001|Overall Study|Lost to Follow-up|180|||
94663399|NCT04743908|324224627|FG000|Overall Study|Withdrawal by Subject|1|||
94663400|NCT04743908|324224628|FG001|Overall Study|Withdrawal by Subject|2|||
94663401|NCT02261363|324224632|FG000|Overall Study|Lost to Follow-up|21|||
94663402|NCT02590354|324224633|FG000|Phase 1|Active hepatitis B or C infection|1|||
94663403|NCT02590354|324224633|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
94663404|NCT02590354|324224633|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
94663405|NCT02590354|324224633|FG000|Phase 1|Subject does not want to participate|20|||
94663406|NCT02590354|324224633|FG000|Phase 1|Lost to Follow-up|1|||
94663407|NCT02590354|324224633|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
94459795|NCT04521621|323471909|FG007|Overall Study|Withdrawal by Subject|0|||
94358534|NCT03110107|323096447|FG017|Treatment Period|Adverse Event|1|||
94358535|NCT03110107|323096448|FG018|Treatment Period|Adverse Event|2|||
94358536|NCT03110107|323096449|FG019|Treatment Period|Adverse Event|1|||
94358537|NCT03110107|323096450|FG020|Treatment Period|Adverse Event|4|||
94612414|NCT01297920|324045110|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
94612415|NCT01297920|324045111|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
94612416|NCT01297920|324045109|FG000|Overall Study|Noncompliance|1|||
94358538|NCT03110107|323096451|FG021|Treatment Period|Adverse Event|2|||
94612417|NCT01297920|324045110|FG001|Overall Study|Noncompliance|0|||
94358539|NCT03110107|323096452|FG022|Treatment Period|Adverse Event|2|||
94663408|NCT00434057|324224634|FG000|Overall Study|Withdrawal by Subject|1|||
94663409|NCT01369342|324224635|FG000|Overall Study|Withdrawal by Subject|7|||
94663410|NCT01369342|324224636|FG001|Overall Study|Withdrawal by Subject|7|||
94663411|NCT01369342|324224637|FG002|Overall Study|Withdrawal by Subject|2|||
94663412|NCT01369342|324224635|FG000|Overall Study|Lost to Follow-up|5|||
94663413|NCT01369342|324224636|FG001|Overall Study|Lost to Follow-up|2|||
94663414|NCT01369342|324224637|FG002|Overall Study|Lost to Follow-up|1|||
94663415|NCT01369342|324224635|FG000|Overall Study|Not Treated|1|||
94663416|NCT01369342|324224636|FG001|Overall Study|Not Treated|0|||
94663417|NCT01369342|324224637|FG002|Overall Study|Not Treated|0|||
94663418|NCT04137380|324224644|FG000|Overall Study|Physician Decision|0|||
94663419|NCT04137380|324224645|FG001|Overall Study|Physician Decision|0|||
94663420|NCT04137380|324224646|FG002|Overall Study|Physician Decision|0|||
94663421|NCT04137380|324224647|FG003|Overall Study|Physician Decision|1|||
94663422|NCT04137380|324224648|FG004|Overall Study|Physician Decision|0|||
94663423|NCT04137380|324224649|FG005|Overall Study|Physician Decision|0|||
94663424|NCT04137380|324224650|FG006|Overall Study|Physician Decision|0|||
94663425|NCT01221597|324224651|FG000|Overall Study|Adverse Event|4|||
94663426|NCT01221597|324224652|FG001|Overall Study|Adverse Event|1|||
94663427|NCT01221597|324224651|FG000|Overall Study|Withdrawal by Subject|20|||
94663428|NCT01221597|324224652|FG001|Overall Study|Withdrawal by Subject|6|||
94663429|NCT01221597|324224651|FG000|Overall Study|Lost to Follow-up|6|||
94663430|NCT01221597|324224652|FG001|Overall Study|Lost to Follow-up|5|||
94663431|NCT01221597|324224651|FG000|Overall Study|Protocol Violation|1|||
94663432|NCT01221597|324224652|FG001|Overall Study|Protocol Violation|0|||
94663433|NCT01221597|324224651|FG000|Overall Study|Other|3|||
94663434|NCT01221597|324224652|FG001|Overall Study|Other|4|||
94663435|NCT01221597|324224651|FG000|Overall Study|Death|2|||
94663436|NCT01221597|324224652|FG001|Overall Study|Death|0|||
94663437|NCT00407537|324224653|FG000|Overall Study|Death|5|||
94663438|NCT00407537|324224654|FG001|Overall Study|Death|2|||
94663439|NCT00407537|324224653|FG000|Overall Study|Adverse Event|36|||
94663440|NCT00407537|324224654|FG001|Overall Study|Adverse Event|0|||
94663441|NCT00407537|324224653|FG000|Overall Study|Lost to Follow-up|12|||
94663442|NCT00407537|324224654|FG001|Overall Study|Lost to Follow-up|19|||
94663443|NCT00407537|324224653|FG000|Overall Study|Other|6|||
94663444|NCT00407537|324224654|FG001|Overall Study|Other|7|||
94663445|NCT00407537|324224653|FG000|Overall Study|Withdrawal by Subject|34|||
94663446|NCT00407537|324224654|FG001|Overall Study|Withdrawal by Subject|16|||
94663447|NCT02864082|324224655|FG000|Overall Study|Adverse Event|1|||
94663448|NCT02864082|324224656|FG001|Overall Study|Adverse Event|1|||
94663449|NCT02864082|324224655|FG000|Overall Study|Lost to Follow-up|0|||
94663450|NCT02864082|324224656|FG001|Overall Study|Lost to Follow-up|1|||
94663451|NCT02864082|324224655|FG000|Overall Study|Withdrawal by Subject|2|||
94663452|NCT02864082|324224656|FG001|Overall Study|Withdrawal by Subject|2|||
94663453|NCT03759873|324224657|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
94663454|NCT03759873|324224658|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
94663455|NCT03759873|324224659|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
94663456|NCT03759873|324224660|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
94663457|NCT03759873|324224657|FG000|Overall Study|Moved outside eligible area|0|||
94663458|NCT03759873|324224658|FG001|Overall Study|Moved outside eligible area|2|||
94663459|NCT03759873|324224659|FG002|Overall Study|Moved outside eligible area|0|||
94663460|NCT03759873|324224660|FG003|Overall Study|Moved outside eligible area|0|||
94663461|NCT03759873|324224657|FG000|Overall Study|Withdrawal by Subject|0|||
94663462|NCT03759873|324224658|FG001|Overall Study|Withdrawal by Subject|0|||
94663463|NCT03759873|324224659|FG002|Overall Study|Withdrawal by Subject|1|||
94663464|NCT03759873|324224660|FG003|Overall Study|Withdrawal by Subject|0|||
94663465|NCT03950739|324224661|FG000|Treatment Phase|Adverse Event|2|||
94663466|NCT03950739|324224661|FG000|Optional Extension Phase|Death|1|||
94663467|NCT03950739|324224661|FG000|Optional Extension Phase|Progressive Disease|5|||
94663468|NCT03950739|324224661|FG000|Optional Extension Phase|Adverse Event|7|||
94663469|NCT03950739|324224661|FG000|Optional Extension Phase|Lost to Follow-up|2|||
94663470|NCT03950739|324224661|FG000|Optional Extension Phase|Site Closure|2|||
94663471|NCT03950739|324224661|FG000|Optional Extension Phase|Pregnancy|1|||
94663472|NCT01715805|324224664|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
94663473|NCT01715805|324224665|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
94663474|NCT01715805|324224666|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
94358540|NCT03110107|323096453|FG023|Treatment Period|Adverse Event|2|||
94358541|NCT03110107|323096454|FG024|Treatment Period|Adverse Event|2|||
94358542|NCT03110107|323096455|FG025|Treatment Period|Adverse Event|4|||
94358543|NCT03110107|323096430|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
94358544|NCT03110107|323096431|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
94358545|NCT03110107|323096432|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
94358546|NCT03110107|323096433|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
94358547|NCT03110107|323096434|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
94358548|NCT03110107|323096435|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
94358549|NCT03110107|323096436|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
94358550|NCT03110107|323096437|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
94358551|NCT03110107|323096438|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
94358552|NCT03110107|323096439|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
94612418|NCT01297920|324045111|FG002|Overall Study|Noncompliance|0|||
94612419|NCT01297920|324045109|FG000|Overall Study|Protocol Violation|1|||
94612420|NCT01297920|324045110|FG001|Overall Study|Protocol Violation|3|||
94612421|NCT01297920|324045111|FG002|Overall Study|Protocol Violation|0|||
94612422|NCT01297920|324045109|FG000|Overall Study|Inadequate Control of IOP|7|||
94612423|NCT01297920|324045110|FG001|Overall Study|Inadequate Control of IOP|9|||
94612424|NCT01297920|324045111|FG002|Overall Study|Inadequate Control of IOP|17|||
94612425|NCT01297920|324045109|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
94612426|NCT01297920|324045110|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
94612427|NCT01297920|324045111|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
94612428|NCT01903031|324045119|FG000|Overall Study|Not Able to Attend Clinic|1|||
94612429|NCT01903031|324045120|FG001|Overall Study|Not Able to Attend Clinic|1|||
94612430|NCT01903031|324045121|FG002|Overall Study|Not Able to Attend Clinic|0|||
94612431|NCT01903031|324045119|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
94612432|NCT01903031|324045120|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
94612433|NCT01903031|324045121|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
94612434|NCT01903031|324045119|FG000|Overall Study|Adverse Event|0|||
94612435|NCT01903031|324045120|FG001|Overall Study|Adverse Event|1|||
94612436|NCT01903031|324045121|FG002|Overall Study|Adverse Event|0|||
94612437|NCT01903031|324045119|FG000|Overall Study|Withdrawal by Subject|0|||
94612438|NCT01903031|324045120|FG001|Overall Study|Withdrawal by Subject|1|||
94612439|NCT01903031|324045121|FG002|Overall Study|Withdrawal by Subject|1|||
94612440|NCT01903031|324045119|FG000|Overall Study|Protocol Violation|0|||
94612441|NCT01903031|324045120|FG001|Overall Study|Protocol Violation|0|||
94612442|NCT01903031|324045121|FG002|Overall Study|Protocol Violation|2|||
94612443|NCT01903031|324045119|FG000|Overall Study|Lost to Follow-up|0|||
94612444|NCT01903031|324045120|FG001|Overall Study|Lost to Follow-up|0|||
94612445|NCT01903031|324045121|FG002|Overall Study|Lost to Follow-up|1|||
94612446|NCT01903031|324045119|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
94612447|NCT01903031|324045120|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
94612448|NCT01903031|324045121|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
94612449|NCT03000569|324045122|FG000|Overall Study|Withdrawal by Subject|1|||
94612450|NCT03000569|324045123|FG001|Overall Study|Withdrawal by Subject|0|||
94612451|NCT02298023|324045126|FG000|Overall Study|Withdrawal by Subject|1|||
94612452|NCT02298023|324045127|FG001|Overall Study|Withdrawal by Subject|0|||
94612453|NCT02298023|324045128|FG002|Overall Study|Withdrawal by Subject|0|||
94612454|NCT02840721|324045129|FG000|Treatment Period|Adverse Event|1|||
94612455|NCT02840721|324045129|FG000|Follow-Up|Lack of Efficacy|1|||
94612456|NCT02840721|324045129|FG000|Follow-Up|Withdrawal by Subject|4|||
94612457|NCT02840721|324045129|FG000|Follow-Up|Withdrawal of Consent|2|||
94612458|NCT03307785|324045130|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
94612459|NCT03307785|324045131|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
94612460|NCT03307785|324045132|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
94612461|NCT03307785|324045133|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
94612462|NCT03307785|324045134|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
94612463|NCT03307785|324045135|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
94612464|NCT03307785|324045136|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
94612465|NCT03307785|324045137|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
94612466|NCT03307785|324045138|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
94612467|NCT03307785|324045139|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
94612468|NCT03307785|324045140|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
94612469|NCT03307785|324045130|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
94612470|NCT03307785|324045131|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
94612471|NCT03307785|324045132|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
94612472|NCT03307785|324045133|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
94612473|NCT03307785|324045134|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
94612474|NCT03307785|324045135|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
94612475|NCT03307785|324045136|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
94612476|NCT03307785|324045137|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
94612477|NCT03307785|324045138|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
94612478|NCT03307785|324045139|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
94663475|NCT01715805|324224667|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
94663476|NCT01715805|324224664|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
94663477|NCT01715805|324224665|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
94663478|NCT01715805|324224666|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
94663479|NCT01715805|324224667|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
94663480|NCT01715805|324224664|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
94663481|NCT01715805|324224665|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
94663482|NCT01715805|324224666|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
94663483|NCT01715805|324224667|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
94663484|NCT01715805|324224664|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
94663485|NCT01715805|324224665|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
94663486|NCT01715805|324224666|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
94663487|NCT01715805|324224667|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
94663488|NCT01715805|324224664|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
94663489|NCT01715805|324224665|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
94663490|NCT01715805|324224666|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
94663491|NCT01715805|324224667|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
94663492|NCT01715805|324224664|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
94663493|NCT01715805|324224665|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
94663494|NCT01715805|324224666|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
94663495|NCT01715805|324224667|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
94663496|NCT01715805|324224664|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
94663497|NCT01715805|324224665|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
94663498|NCT01715805|324224666|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
94663499|NCT01715805|324224667|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
94663500|NCT01715805|324224664|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
94663501|NCT01715805|324224665|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
94663502|NCT01715805|324224666|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
94663503|NCT01715805|324224667|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
94663504|NCT01715805|324224664|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
94663505|NCT01715805|324224665|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
94663506|NCT01715805|324224666|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
94663507|NCT01715805|324224667|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
94663508|NCT01715805|324224664|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
94663509|NCT01715805|324224665|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
94663510|NCT01715805|324224666|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
94663511|NCT01715805|324224667|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
94663512|NCT01715805|324224664|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
94663513|NCT01715805|324224665|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
94663514|NCT01715805|324224666|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
94663515|NCT01715805|324224667|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
94663516|NCT01715805|324224664|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
94663517|NCT01715805|324224665|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
94663518|NCT01715805|324224666|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
94663519|NCT01715805|324224667|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
94663520|NCT01715805|324224664|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
94663521|NCT01715805|324224665|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
94663522|NCT01715805|324224666|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
94663523|NCT01715805|324224667|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
94663524|NCT01715805|324224664|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
94663525|NCT01715805|324224665|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
94663526|NCT01715805|324224666|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
94663527|NCT01715805|324224667|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
94663528|NCT00782340|324224668|FG000|Open Label Titration|Adverse Event|12|||
94663529|NCT00782340|324224669|FG001|Open Label Titration|Adverse Event|0|||
94663530|NCT00782340|324224670|FG002|Open Label Titration|Adverse Event|0|||
94663531|NCT00782340|324224668|FG000|Open Label Titration|Treatment failure|50|||
94663532|NCT00782340|324224669|FG001|Open Label Titration|Treatment failure|0|||
94663533|NCT00782340|324224670|FG002|Open Label Titration|Treatment failure|0|||
94663534|NCT00782340|324224668|FG000|Open Label Titration|Protocol Violation|5|||
94663535|NCT00782340|324224669|FG001|Open Label Titration|Protocol Violation|0|||
94663536|NCT00782340|324224670|FG002|Open Label Titration|Protocol Violation|0|||
94663537|NCT00782340|324224668|FG000|Open Label Titration|Withdrawal by Subject|5|||
94663538|NCT00782340|324224669|FG001|Open Label Titration|Withdrawal by Subject|0|||
94663539|NCT00782340|324224670|FG002|Open Label Titration|Withdrawal by Subject|0|||
94663540|NCT00782340|324224668|FG000|Open Label Titration|Enrollment capped|16|||
94612479|NCT03307785|324045140|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
94459796|NCT04521621|323471902|FG000|Overall Study|Allocated in error without study intervention|1|||
94459797|NCT04521621|323471903|FG001|Overall Study|Allocated in error without study intervention|0|||
94459798|NCT04521621|323471904|FG002|Overall Study|Allocated in error without study intervention|0|||
94459799|NCT04521621|323471905|FG003|Overall Study|Allocated in error without study intervention|0|||
94459800|NCT04521621|323471906|FG004|Overall Study|Allocated in error without study intervention|0|||
94459801|NCT04521621|323471907|FG005|Overall Study|Allocated in error without study intervention|0|||
94459802|NCT04521621|323471908|FG006|Overall Study|Allocated in error without study intervention|0|||
94459803|NCT04521621|323471909|FG007|Overall Study|Allocated in error without study intervention|0|||
94459804|NCT01282164|323471915|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
94459805|NCT01282164|323471916|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
94459806|NCT02777970|323471917|FG000|Overall Study|Lost to Follow-up|0|||
94459807|NCT02777970|323471918|FG001|Overall Study|Lost to Follow-up|1|||
94459808|NCT02777970|323471919|FG002|Overall Study|Lost to Follow-up|0|||
94459809|NCT02777970|323471917|FG000|Overall Study|Protocol Violation|1|||
94459810|NCT02777970|323471918|FG001|Overall Study|Protocol Violation|0|||
94459811|NCT02777970|323471919|FG002|Overall Study|Protocol Violation|0|||
94459812|NCT02347891|323471920|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
94459813|NCT02347891|323471921|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
94459814|NCT02347891|323471920|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
94459815|NCT02347891|323471921|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
94459816|NCT02541669|323471922|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
94459817|NCT02541669|323471923|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
94459818|NCT02541669|323471924|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
94459819|NCT02541669|323471925|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
94612480|NCT03307785|324045130|FG000|Part A: Up to 28.5 Months|Death|4|||
94612481|NCT03307785|324045131|FG001|Part A: Up to 28.5 Months|Death|4|||
94612482|NCT03307785|324045132|FG002|Part A: Up to 28.5 Months|Death|0|||
94612483|NCT03307785|324045133|FG003|Part A: Up to 28.5 Months|Death|0|||
94612484|NCT03307785|324045134|FG004|Part A: Up to 28.5 Months|Death|0|||
94612485|NCT03307785|324045135|FG005|Part A: Up to 28.5 Months|Death|0|||
94612486|NCT03307785|324045136|FG006|Part A: Up to 28.5 Months|Death|0|||
94612487|NCT03307785|324045137|FG007|Part A: Up to 28.5 Months|Death|0|||
94612488|NCT03307785|324045138|FG008|Part A: Up to 28.5 Months|Death|0|||
94612489|NCT03307785|324045139|FG009|Part A: Up to 28.5 Months|Death|0|||
94612490|NCT03307785|324045140|FG010|Part A: Up to 28.5 Months|Death|0|||
94612491|NCT03307785|324045130|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
94612492|NCT03307785|324045131|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
94612493|NCT03307785|324045132|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
94612494|NCT03307785|324045133|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
94612495|NCT03307785|324045134|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
94612496|NCT03307785|324045135|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
94612497|NCT03307785|324045136|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
94612498|NCT03307785|324045137|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
94612499|NCT03307785|324045138|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
94612500|NCT03307785|324045139|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
94612501|NCT03307785|324045140|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
94612502|NCT03307785|324045130|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
94612503|NCT03307785|324045131|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
94612504|NCT03307785|324045132|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
94612505|NCT03307785|324045133|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
94612506|NCT03307785|324045134|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
94612507|NCT03307785|324045135|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
94612508|NCT03307785|324045136|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
94612509|NCT03307785|324045137|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
94612510|NCT03307785|324045138|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
94612511|NCT03307785|324045139|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
94612512|NCT03307785|324045140|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
94612513|NCT03307785|324045130|FG000|Part B: Up to Approx. 66 Months|Death|0|||
94612514|NCT03307785|324045131|FG001|Part B: Up to Approx. 66 Months|Death|0|||
94612515|NCT03307785|324045132|FG002|Part B: Up to Approx. 66 Months|Death|7|||
94612516|NCT03307785|324045133|FG003|Part B: Up to Approx. 66 Months|Death|0|||
94612517|NCT03307785|324045134|FG004|Part B: Up to Approx. 66 Months|Death|0|||
94612518|NCT03307785|324045135|FG005|Part B: Up to Approx. 66 Months|Death|0|||
94612519|NCT03307785|324045136|FG006|Part B: Up to Approx. 66 Months|Death|0|||
94612520|NCT03307785|324045137|FG007|Part B: Up to Approx. 66 Months|Death|0|||
94612521|NCT03307785|324045138|FG008|Part B: Up to Approx. 66 Months|Death|0|||
94612522|NCT03307785|324045139|FG009|Part B: Up to Approx. 66 Months|Death|0|||
94612523|NCT03307785|324045140|FG010|Part B: Up to Approx. 66 Months|Death|0|||
94663541|NCT00782340|324224669|FG001|Open Label Titration|Enrollment capped|0|||
94663542|NCT00782340|324224670|FG002|Open Label Titration|Enrollment capped|0|||
94663543|NCT00782340|324224668|FG000|Open Label Titration|Did not meet responder criteria|2|||
94663544|NCT00782340|324224669|FG001|Open Label Titration|Did not meet responder criteria|0|||
94663545|NCT00782340|324224670|FG002|Open Label Titration|Did not meet responder criteria|0|||
94663546|NCT00782340|324224668|FG000|Open Label Titration|Lost to Follow-up|5|||
94663547|NCT00782340|324224669|FG001|Open Label Titration|Lost to Follow-up|0|||
94663548|NCT00782340|324224670|FG002|Open Label Titration|Lost to Follow-up|0|||
94663549|NCT00782340|324224668|FG000|Open Label Titration|Randomized in error|6|||
94663550|NCT00782340|324224669|FG001|Open Label Titration|Randomized in error|0|||
94663551|NCT00782340|324224670|FG002|Open Label Titration|Randomized in error|0|||
94663552|NCT00709722|324224671|FG000|Overall Study|Adverse Event|1|||
94663553|NCT02043782|324224672|FG000|Period 1|Adverse Event|0|||
94663554|NCT02043782|324224673|FG001|Period 1|Adverse Event|0|||
94663555|NCT02043782|324224674|FG002|Period 1|Adverse Event|1|||
94663556|NCT02043782|324224675|FG003|Period 1|Adverse Event|0|||
94663557|NCT02043782|324224676|FG004|Period 1|Adverse Event|0|||
94663558|NCT02043782|324224677|FG005|Period 1|Adverse Event|0|||
94663559|NCT04667117|324224678|FG000|Investigational Period|Lost to Follow-up|0|||
94663560|NCT04667117|324224679|FG001|Investigational Period|Lost to Follow-up|0|||
94663561|NCT04667117|324224680|FG002|Investigational Period|Lost to Follow-up|1|||
94663562|NCT04667117|324224678|FG000|Investigational Period|Protocol Deviation|0|||
94663563|NCT04667117|324224679|FG001|Investigational Period|Protocol Deviation|1|||
94663564|NCT04667117|324224680|FG002|Investigational Period|Protocol Deviation|0|||
94663565|NCT04667117|324224678|FG000|Extension Period|Lost to Follow-up|1|||
94663566|NCT04667117|324224679|FG001|Extension Period|Lost to Follow-up|0|||
94663567|NCT04667117|324224680|FG002|Extension Period|Lost to Follow-up|0|||
94663568|NCT04818346|324224681|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
94663569|NCT04818346|324224682|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
94663570|NCT04818346|324224683|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
94663571|NCT04818346|324224684|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
94663572|NCT04818346|324224681|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
94663573|NCT04818346|324224682|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
94663574|NCT04818346|324224683|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
94663575|NCT04818346|324224684|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
94663576|NCT04818346|324224681|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
94663577|NCT04818346|324224682|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
94663578|NCT04818346|324224683|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
94663579|NCT04818346|324224684|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
94663580|NCT04818346|324224681|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
94663581|NCT04818346|324224682|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
94663582|NCT04818346|324224683|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
94663583|NCT04818346|324224684|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
94663584|NCT04818346|324224681|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
94663585|NCT04818346|324224682|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
94663586|NCT04818346|324224683|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
94663587|NCT04818346|324224684|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
94663588|NCT04818346|324224681|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
94663589|NCT04818346|324224682|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
94663590|NCT04818346|324224683|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
94663591|NCT04818346|324224684|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
94663592|NCT04818346|324224681|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
94663593|NCT04818346|324224682|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
94663594|NCT04818346|324224683|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
94663595|NCT04818346|324224684|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
94663596|NCT04818346|324224681|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
94663597|NCT04818346|324224682|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
94663598|NCT04818346|324224683|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
94663599|NCT04818346|324224684|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
94663600|NCT04818346|324224681|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
94663601|NCT04818346|324224682|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
94663602|NCT04818346|324224683|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
94663603|NCT04818346|324224684|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
94663604|NCT04818346|324224681|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
94663605|NCT04818346|324224682|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
94663606|NCT04818346|324224683|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
94663607|NCT04818346|324224684|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
94663608|NCT04818346|324224681|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
94663609|NCT04818346|324224682|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
94663610|NCT04818346|324224683|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
94663611|NCT04818346|324224684|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
94663612|NCT04818346|324224681|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
94663613|NCT04818346|324224682|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
94663614|NCT04818346|324224683|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
94663615|NCT04818346|324224684|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
94663616|NCT04818346|324224681|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
94663617|NCT04818346|324224682|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
94663618|NCT04818346|324224683|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
94663619|NCT04818346|324224684|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
94663620|NCT04818346|324224681|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
94663621|NCT04818346|324224682|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
94663622|NCT04818346|324224683|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
94663623|NCT04818346|324224684|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
94663624|NCT04818346|324224681|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
94663625|NCT04818346|324224682|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
94663626|NCT04818346|324224683|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
94663627|NCT04818346|324224684|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
94663628|NCT00874029|324224685|FG000|Overall Study|Withdrawal by Subject|10|||
94663629|NCT00874029|324224685|FG000|Overall Study|Pregnancy|4|||
94663630|NCT00874029|324224685|FG000|Overall Study|Physician Decision|1|||
94663631|NCT00874029|324224685|FG000|Overall Study|Adverse Event|1|||
94663632|NCT00874029|324224685|FG000|Overall Study|Lost to Follow-up|5|||
94663633|NCT01953926|324224687|FG000|Overall Study|Withdrawal by Subject|23|||
94663634|NCT01953926|324224688|FG001|Overall Study|Withdrawal by Subject|3|||
94663635|NCT01953926|324224689|FG002|Overall Study|Withdrawal by Subject|3|||
94663636|NCT01953926|324224690|FG003|Overall Study|Withdrawal by Subject|5|||
94663637|NCT01953926|324224691|FG004|Overall Study|Withdrawal by Subject|6|||
94663638|NCT01953926|324224692|FG005|Overall Study|Withdrawal by Subject|0|||
94663639|NCT01953926|324224693|FG006|Overall Study|Withdrawal by Subject|1|||
94663640|NCT01953926|324224687|FG000|Overall Study|Physician Decision|1|||
94663641|NCT01953926|324224688|FG001|Overall Study|Physician Decision|0|||
94663642|NCT01953926|324224689|FG002|Overall Study|Physician Decision|0|||
94663643|NCT01953926|324224690|FG003|Overall Study|Physician Decision|0|||
94663644|NCT01953926|324224691|FG004|Overall Study|Physician Decision|2|||
94663645|NCT01953926|324224692|FG005|Overall Study|Physician Decision|0|||
94663646|NCT01953926|324224693|FG006|Overall Study|Physician Decision|0|||
94663647|NCT01953926|324224687|FG000|Overall Study|Lost to Follow-up|18|||
94663648|NCT01953926|324224688|FG001|Overall Study|Lost to Follow-up|3|||
94663649|NCT01953926|324224689|FG002|Overall Study|Lost to Follow-up|0|||
94612524|NCT03307785|324045130|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
94612525|NCT03307785|324045131|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
94612526|NCT03307785|324045132|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
94612527|NCT03307785|324045133|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
94612528|NCT03307785|324045134|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
94612529|NCT03307785|324045135|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
94612530|NCT03307785|324045136|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
94612531|NCT03307785|324045137|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
94612532|NCT03307785|324045138|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
94612533|NCT03307785|324045139|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
94612534|NCT03307785|324045140|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
94612535|NCT03307785|324045130|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
94612536|NCT03307785|324045131|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
94612537|NCT03307785|324045132|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
94612538|NCT03307785|324045133|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
94612539|NCT03307785|324045134|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
94612540|NCT03307785|324045135|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
94612541|NCT03307785|324045136|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
94612542|NCT03307785|324045137|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
94612543|NCT03307785|324045138|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
94612544|NCT03307785|324045139|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
94612545|NCT03307785|324045140|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
94612546|NCT03307785|324045130|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
94612547|NCT03307785|324045131|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
94612548|NCT03307785|324045132|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
94459820|NCT02541669|323471926|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
94459821|NCT00834639|323471929|FG000|Second Intervention|Physician Decision|0|||
94459822|NCT00834639|323471930|FG001|Second Intervention|Physician Decision|2|||
94459823|NCT03687372|323471931|FG000|Overall Study|Lost to Follow-up|12|||
94459824|NCT03687372|323471932|FG001|Overall Study|Lost to Follow-up|21|||
94459825|NCT03687372|323471931|FG000|Overall Study|Withdrawal by Subject|4|||
94459826|NCT03687372|323471932|FG001|Overall Study|Withdrawal by Subject|17|||
94459827|NCT03687372|323471931|FG000|Overall Study|Investigator Decision|1|||
94459828|NCT03687372|323471932|FG001|Overall Study|Investigator Decision|1|||
94459829|NCT01084668|323471933|FG000|Overall Study|Lack of Efficacy|5|||
94459830|NCT01084668|323471933|FG000|Overall Study|Withdrawal by Subject|2|||
94459831|NCT01084668|323471933|FG000|Overall Study|Pregnancy|1|||
94612549|NCT03307785|324045133|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
94459832|NCT01084668|323471933|FG000|Overall Study|Non-compliance|1|||
94459833|NCT01097421|323471935|FG000|Overall Study|Adverse Event|8|||
94612550|NCT03307785|324045134|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
94612551|NCT03307785|324045135|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
94612552|NCT03307785|324045136|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
94612553|NCT03307785|324045137|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
94612554|NCT03307785|324045138|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
94612555|NCT03307785|324045139|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
94612556|NCT03307785|324045140|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
94612557|NCT03307785|324045130|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
94612558|NCT03307785|324045131|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
94612559|NCT03307785|324045132|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
94612560|NCT03307785|324045133|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
94612561|NCT03307785|324045134|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
94612562|NCT03307785|324045135|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
94612563|NCT03307785|324045136|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
94612564|NCT03307785|324045137|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
94612565|NCT03307785|324045138|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
94612566|NCT03307785|324045139|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
94612567|NCT03307785|324045140|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
94612568|NCT03307785|324045130|FG000|Part C: Up to Approx. 60 Months|Death|0|||
94612569|NCT03307785|324045131|FG001|Part C: Up to Approx. 60 Months|Death|0|||
94612570|NCT03307785|324045132|FG002|Part C: Up to Approx. 60 Months|Death|0|||
94612571|NCT03307785|324045133|FG003|Part C: Up to Approx. 60 Months|Death|2|||
94612572|NCT03307785|324045134|FG004|Part C: Up to Approx. 60 Months|Death|5|||
94612573|NCT03307785|324045135|FG005|Part C: Up to Approx. 60 Months|Death|0|||
94612574|NCT03307785|324045136|FG006|Part C: Up to Approx. 60 Months|Death|0|||
94612575|NCT03307785|324045137|FG007|Part C: Up to Approx. 60 Months|Death|0|||
94612576|NCT03307785|324045138|FG008|Part C: Up to Approx. 60 Months|Death|0|||
94612577|NCT03307785|324045139|FG009|Part C: Up to Approx. 60 Months|Death|0|||
94612578|NCT03307785|324045140|FG010|Part C: Up to Approx. 60 Months|Death|0|||
94612579|NCT03307785|324045130|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
94612580|NCT03307785|324045131|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
94612581|NCT03307785|324045132|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
94612582|NCT03307785|324045133|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
94612583|NCT03307785|324045134|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
94612584|NCT03307785|324045135|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
94612585|NCT03307785|324045136|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
94612586|NCT03307785|324045137|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
94612587|NCT03307785|324045138|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
94612588|NCT03307785|324045139|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
94612589|NCT03307785|324045140|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
94612590|NCT03307785|324045130|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
94612591|NCT03307785|324045131|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
94612592|NCT03307785|324045132|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
94612593|NCT03307785|324045133|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
94612594|NCT03307785|324045134|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
94612595|NCT03307785|324045135|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
94612596|NCT03307785|324045136|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
94612597|NCT03307785|324045137|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
94612598|NCT03307785|324045138|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
94612599|NCT03307785|324045139|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
94612600|NCT03307785|324045140|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
94612601|NCT03307785|324045130|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
94612602|NCT03307785|324045131|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
94612603|NCT03307785|324045132|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
94663650|NCT01953926|324224690|FG003|Overall Study|Lost to Follow-up|5|||
94663651|NCT01953926|324224691|FG004|Overall Study|Lost to Follow-up|3|||
94663652|NCT01953926|324224692|FG005|Overall Study|Lost to Follow-up|0|||
94663653|NCT01953926|324224693|FG006|Overall Study|Lost to Follow-up|0|||
94663654|NCT01953926|324224687|FG000|Overall Study|Protocol Violation|1|||
94663655|NCT01953926|324224688|FG001|Overall Study|Protocol Violation|0|||
94663656|NCT01953926|324224689|FG002|Overall Study|Protocol Violation|0|||
94663657|NCT01953926|324224690|FG003|Overall Study|Protocol Violation|0|||
94663658|NCT01953926|324224691|FG004|Overall Study|Protocol Violation|0|||
94663659|NCT01953926|324224692|FG005|Overall Study|Protocol Violation|0|||
94663660|NCT01953926|324224693|FG006|Overall Study|Protocol Violation|0|||
94663661|NCT01953926|324224687|FG000|Overall Study|Other, Disease progression|2|||
94663662|NCT01953926|324224688|FG001|Overall Study|Other, Disease progression|1|||
94663663|NCT01953926|324224689|FG002|Overall Study|Other, Disease progression|0|||
94663664|NCT01953926|324224690|FG003|Overall Study|Other, Disease progression|0|||
94663665|NCT01953926|324224691|FG004|Overall Study|Other, Disease progression|1|||
94663666|NCT01953926|324224692|FG005|Overall Study|Other, Disease progression|0|||
94663667|NCT01953926|324224693|FG006|Overall Study|Other, Disease progression|0|||
94663668|NCT01953926|324224687|FG000|Overall Study|Discontinuation of study by sponsor|41|||
94663669|NCT01953926|324224688|FG001|Overall Study|Discontinuation of study by sponsor|7|||
94663670|NCT01953926|324224689|FG002|Overall Study|Discontinuation of study by sponsor|5|||
94663671|NCT01953926|324224690|FG003|Overall Study|Discontinuation of study by sponsor|12|||
94663672|NCT01953926|324224691|FG004|Overall Study|Discontinuation of study by sponsor|46|||
94663673|NCT01953926|324224692|FG005|Overall Study|Discontinuation of study by sponsor|5|||
94663674|NCT01953926|324224693|FG006|Overall Study|Discontinuation of study by sponsor|6|||
94663675|NCT01953926|324224687|FG000|Overall Study|Not Treated|1|||
94663676|NCT01953926|324224688|FG001|Overall Study|Not Treated|0|||
94663677|NCT01953926|324224689|FG002|Overall Study|Not Treated|1|||
94663678|NCT01953926|324224690|FG003|Overall Study|Not Treated|0|||
94663679|NCT01953926|324224691|FG004|Overall Study|Not Treated|0|||
94663680|NCT01953926|324224692|FG005|Overall Study|Not Treated|0|||
94663681|NCT01953926|324224693|FG006|Overall Study|Not Treated|0|||
94663682|NCT02372396|324224694|FG000|Overall Study|Lost to Follow-up|7|||
94663683|NCT02372396|324224695|FG001|Overall Study|Lost to Follow-up|9|||
94663684|NCT02415400|324224696|FG000|Overall Study|Adverse Event|0|||
94663685|NCT02415400|324224697|FG001|Overall Study|Adverse Event|1|||
94663686|NCT02415400|324224698|FG002|Overall Study|Adverse Event|1|||
94663687|NCT02415400|324224699|FG003|Overall Study|Adverse Event|2|||
94663688|NCT02415400|324224696|FG000|Overall Study|Participant request to stop therapy|4|||
94663689|NCT02415400|324224697|FG001|Overall Study|Participant request to stop therapy|3|||
94663690|NCT02415400|324224698|FG002|Overall Study|Participant request to stop therapy|8|||
94663691|NCT02415400|324224699|FG003|Overall Study|Participant request to stop therapy|6|||
94663692|NCT02415400|324224696|FG000|Overall Study|Participant withdrew consent|14|||
94663693|NCT02415400|324224697|FG001|Overall Study|Participant withdrew consent|12|||
94663694|NCT02415400|324224698|FG002|Overall Study|Participant withdrew consent|30|||
94663695|NCT02415400|324224699|FG003|Overall Study|Participant withdrew consent|21|||
94663696|NCT02415400|324224696|FG000|Overall Study|Death|39|||
94663697|NCT02415400|324224697|FG001|Overall Study|Death|41|||
94663698|NCT02415400|324224698|FG002|Overall Study|Death|35|||
94663699|NCT02415400|324224699|FG003|Overall Study|Death|42|||
94663700|NCT02415400|324224696|FG000|Overall Study|Lost to Follow-up|3|||
94663701|NCT02415400|324224697|FG001|Overall Study|Lost to Follow-up|3|||
94663702|NCT02415400|324224698|FG002|Overall Study|Lost to Follow-up|2|||
94663703|NCT02415400|324224699|FG003|Overall Study|Lost to Follow-up|5|||
94663704|NCT02415400|324224696|FG000|Overall Study|Poor/Non-Compliance|0|||
94663705|NCT02415400|324224697|FG001|Overall Study|Poor/Non-Compliance|1|||
94663706|NCT02415400|324224698|FG002|Overall Study|Poor/Non-Compliance|3|||
94663707|NCT02415400|324224699|FG003|Overall Study|Poor/Non-Compliance|4|||
94612604|NCT03307785|324045133|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
94612605|NCT03307785|324045134|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
94612606|NCT03307785|324045135|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
94612607|NCT03307785|324045136|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
94612608|NCT03307785|324045137|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
94612609|NCT03307785|324045138|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
94612610|NCT03307785|324045139|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
94663708|NCT02415400|324224696|FG000|Overall Study|Participant no longer meets criteria|2|||
94663709|NCT02415400|324224697|FG001|Overall Study|Participant no longer meets criteria|0|||
94612611|NCT03307785|324045140|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
94663710|NCT02415400|324224698|FG002|Overall Study|Participant no longer meets criteria|0|||
94459834|NCT01097421|323471935|FG000|Overall Study|Protocol Violation|2|||
94663711|NCT02415400|324224699|FG003|Overall Study|Participant no longer meets criteria|1|||
94663712|NCT02415400|324224696|FG000|Overall Study|Participant doesn't answer phone|1|||
94663713|NCT02415400|324224697|FG001|Overall Study|Participant doesn't answer phone|0|||
94612612|NCT03307785|324045130|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
94663714|NCT02415400|324224698|FG002|Overall Study|Participant doesn't answer phone|0|||
94663715|NCT02415400|324224699|FG003|Overall Study|Participant doesn't answer phone|0|||
94663716|NCT02415400|324224696|FG000|Overall Study|Participant wanted home visits|1|||
94663717|NCT02415400|324224697|FG001|Overall Study|Participant wanted home visits|0|||
94663718|NCT02415400|324224698|FG002|Overall Study|Participant wanted home visits|0|||
94663719|NCT02415400|324224699|FG003|Overall Study|Participant wanted home visits|0|||
94663720|NCT02415400|324224696|FG000|Overall Study|Randomized in error|2|||
94663721|NCT02415400|324224697|FG001|Overall Study|Randomized in error|0|||
94663722|NCT02415400|324224698|FG002|Overall Study|Randomized in error|0|||
94663723|NCT02415400|324224699|FG003|Overall Study|Randomized in error|0|||
94663724|NCT02415400|324224696|FG000|Overall Study|No study drug on site|0|||
94663725|NCT02415400|324224697|FG001|Overall Study|No study drug on site|1|||
94663726|NCT02415400|324224698|FG002|Overall Study|No study drug on site|0|||
94663727|NCT02415400|324224699|FG003|Overall Study|No study drug on site|0|||
94663728|NCT02415400|324224696|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
94663729|NCT02415400|324224697|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
94663730|NCT02415400|324224698|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
94663731|NCT02415400|324224699|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
94663732|NCT02415400|324224696|FG000|Overall Study|Coagulation values cannot be set|0|||
94663733|NCT02415400|324224697|FG001|Overall Study|Coagulation values cannot be set|0|||
94663734|NCT02415400|324224698|FG002|Overall Study|Coagulation values cannot be set|1|||
94663735|NCT02415400|324224699|FG003|Overall Study|Coagulation values cannot be set|0|||
94663736|NCT02415400|324224696|FG000|Overall Study|State regulations prevent participation|0|||
94663737|NCT02415400|324224697|FG001|Overall Study|State regulations prevent participation|0|||
94663738|NCT02415400|324224698|FG002|Overall Study|State regulations prevent participation|1|||
94663739|NCT02415400|324224699|FG003|Overall Study|State regulations prevent participation|0|||
94663740|NCT02415400|324224696|FG000|Overall Study|Poor treatment monitoring|0|||
94663741|NCT02415400|324224697|FG001|Overall Study|Poor treatment monitoring|0|||
94663742|NCT02415400|324224698|FG002|Overall Study|Poor treatment monitoring|1|||
94663743|NCT02415400|324224699|FG003|Overall Study|Poor treatment monitoring|0|||
94663744|NCT02415400|324224696|FG000|Overall Study|Participant in jail|0|||
94663745|NCT02415400|324224697|FG001|Overall Study|Participant in jail|0|||
94663746|NCT02415400|324224698|FG002|Overall Study|Participant in jail|1|||
94663747|NCT02415400|324224699|FG003|Overall Study|Participant in jail|0|||
94663748|NCT02415400|324224696|FG000|Overall Study|Investigator decision|0|||
94663749|NCT02415400|324224697|FG001|Overall Study|Investigator decision|0|||
94663750|NCT02415400|324224698|FG002|Overall Study|Investigator decision|1|||
94663751|NCT02415400|324224699|FG003|Overall Study|Investigator decision|1|||
94663752|NCT02415400|324224696|FG000|Overall Study|Site closure; participant won't transfer|0|||
94663753|NCT02415400|324224697|FG001|Overall Study|Site closure; participant won't transfer|0|||
94663754|NCT02415400|324224698|FG002|Overall Study|Site closure; participant won't transfer|0|||
94663755|NCT02415400|324224699|FG003|Overall Study|Site closure; participant won't transfer|1|||
94663756|NCT01226745|324224700|FG000|Overall Study|Did not complete schedule of assessments|8|||
94663757|NCT01226745|324224701|FG001|Overall Study|Did not complete schedule of assessments|3|||
94663758|NCT01226745|324224702|FG002|Overall Study|Did not complete schedule of assessments|6|||
94663759|NCT01226745|324224703|FG003|Overall Study|Did not complete schedule of assessments|0|||
94663760|NCT01226745|324224704|FG004|Overall Study|Did not complete schedule of assessments|0|||
94663761|NCT01226745|324224705|FG005|Overall Study|Did not complete schedule of assessments|1|||
94663762|NCT01226745|324224700|FG000|Overall Study|Lost to Follow-up|2|||
94663763|NCT01226745|324224701|FG001|Overall Study|Lost to Follow-up|6|||
94663764|NCT01226745|324224702|FG002|Overall Study|Lost to Follow-up|6|||
94663765|NCT01226745|324224703|FG003|Overall Study|Lost to Follow-up|1|||
94663766|NCT01226745|324224704|FG004|Overall Study|Lost to Follow-up|1|||
94663767|NCT01226745|324224705|FG005|Overall Study|Lost to Follow-up|2|||
94663768|NCT01226745|324224700|FG000|Overall Study|Death|1|||
94663769|NCT01226745|324224701|FG001|Overall Study|Death|0|||
94663770|NCT01226745|324224702|FG002|Overall Study|Death|0|||
94663771|NCT01226745|324224703|FG003|Overall Study|Death|0|||
94663772|NCT01226745|324224704|FG004|Overall Study|Death|0|||
94663773|NCT01226745|324224705|FG005|Overall Study|Death|1|||
94663774|NCT01226745|324224700|FG000|Overall Study|Other|6|||
94663775|NCT01226745|324224701|FG001|Overall Study|Other|7|||
94663776|NCT01226745|324224702|FG002|Overall Study|Other|8|||
94663777|NCT01226745|324224703|FG003|Overall Study|Other|4|||
94663778|NCT01226745|324224704|FG004|Overall Study|Other|3|||
94663779|NCT01226745|324224705|FG005|Overall Study|Other|1|||
94663780|NCT02363738|324224708|FG000|Overall Study|Adverse Event|5|||
94663781|NCT02363738|324224709|FG001|Overall Study|Adverse Event|2|||
94663782|NCT02363738|324224708|FG000|Overall Study|Lack of Efficacy|1|||
94663783|NCT02363738|324224709|FG001|Overall Study|Lack of Efficacy|2|||
94663784|NCT02363738|324224708|FG000|Overall Study|Lost to Follow-up|2|||
94663785|NCT02363738|324224709|FG001|Overall Study|Lost to Follow-up|1|||
94663786|NCT02105948|324224714|FG000|Overall Study|Adverse Event|10|||
94663787|NCT02105948|324224715|FG001|Overall Study|Adverse Event|7|||
94663788|NCT02105948|324224716|FG002|Overall Study|Adverse Event|11|||
94663789|NCT02105948|324224717|FG003|Overall Study|Adverse Event|11|||
94663790|NCT02105948|324224714|FG000|Overall Study|Lack of Efficacy|0|||
94663791|NCT02105948|324224715|FG001|Overall Study|Lack of Efficacy|1|||
94663792|NCT02105948|324224716|FG002|Overall Study|Lack of Efficacy|3|||
94663793|NCT02105948|324224717|FG003|Overall Study|Lack of Efficacy|2|||
94663794|NCT02105948|324224714|FG000|Overall Study|Lost to Follow-up|0|||
94663795|NCT02105948|324224715|FG001|Overall Study|Lost to Follow-up|0|||
94663796|NCT02105948|324224716|FG002|Overall Study|Lost to Follow-up|2|||
94663797|NCT02105948|324224717|FG003|Overall Study|Lost to Follow-up|1|||
94663798|NCT02105948|324224714|FG000|Overall Study|Physician Decision|2|||
94663799|NCT02105948|324224715|FG001|Overall Study|Physician Decision|2|||
94663800|NCT02105948|324224716|FG002|Overall Study|Physician Decision|2|||
94663801|NCT02105948|324224717|FG003|Overall Study|Physician Decision|2|||
94663802|NCT02105948|324224714|FG000|Overall Study|Withdrawal by Subject|15|||
94663803|NCT02105948|324224715|FG001|Overall Study|Withdrawal by Subject|10|||
94663804|NCT02105948|324224716|FG002|Overall Study|Withdrawal by Subject|10|||
94663805|NCT02105948|324224717|FG003|Overall Study|Withdrawal by Subject|11|||
94663806|NCT02232893|324224719|FG000|Overall Study|Withdrawal by Subject|4|||
94663807|NCT02232893|324224720|FG001|Overall Study|Withdrawal by Subject|1|||
94663808|NCT02232893|324224719|FG000|Overall Study|Adverse Event|0|||
94663809|NCT02232893|324224720|FG001|Overall Study|Adverse Event|1|||
94663810|NCT02232893|324224719|FG000|Overall Study|Sponsor request early termination|0|||
94663811|NCT02232893|324224720|FG001|Overall Study|Sponsor request early termination|1|||
94663812|NCT02232893|324224719|FG000|Overall Study|Developed exclusion criteria|0|||
94663813|NCT02232893|324224720|FG001|Overall Study|Developed exclusion criteria|1|||
94663814|NCT02232893|324224719|FG000|Overall Study|Other|0|||
94663815|NCT02232893|324224720|FG001|Overall Study|Other|3|||
94663816|NCT03550313|324224722|FG000|Overall Study|Adverse Event|0|||
94663817|NCT03550313|324224723|FG001|Overall Study|Adverse Event|1|||
94663818|NCT03550313|324224724|FG002|Overall Study|Adverse Event|0|||
94663819|NCT03550313|324224722|FG000|Overall Study|Lost to Follow-up|5|||
94663820|NCT03550313|324224723|FG001|Overall Study|Lost to Follow-up|7|||
94663821|NCT03550313|324224724|FG002|Overall Study|Lost to Follow-up|12|||
94663822|NCT03550313|324224722|FG000|Overall Study|Study terminated by sponsor|44|||
94663823|NCT03550313|324224723|FG001|Overall Study|Study terminated by sponsor|37|||
94663824|NCT03550313|324224724|FG002|Overall Study|Study terminated by sponsor|48|||
94663825|NCT03550313|324224722|FG000|Overall Study|No longer met eligibility criteria|3|||
94663826|NCT03550313|324224723|FG001|Overall Study|No longer met eligibility criteria|5|||
94663827|NCT03550313|324224724|FG002|Overall Study|No longer met eligibility criteria|6|||
94663828|NCT03550313|324224722|FG000|Overall Study|Withdrawal by parent/guardian|20|||
94663829|NCT03550313|324224723|FG001|Overall Study|Withdrawal by parent/guardian|18|||
94663830|NCT03550313|324224724|FG002|Overall Study|Withdrawal by parent/guardian|26|||
94663831|NCT03550313|324224722|FG000|Overall Study|Other|4|||
94663832|NCT03550313|324224723|FG001|Overall Study|Other|2|||
94663833|NCT03550313|324224724|FG002|Overall Study|Other|2|||
94663834|NCT03550313|324224722|FG000|Overall Study|Randomized but not vaccinated|3|||
94663835|NCT03550313|324224723|FG001|Overall Study|Randomized but not vaccinated|23|||
94663836|NCT03550313|324224724|FG002|Overall Study|Randomized but not vaccinated|2|||
94663837|NCT03550313|324224722|FG000|Overall Study|Sites terminated due to quality issues|18|||
94663838|NCT03550313|324224723|FG001|Overall Study|Sites terminated due to quality issues|17|||
94663839|NCT03550313|324224724|FG002|Overall Study|Sites terminated due to quality issues|18|||
94663840|NCT00380068|324224726|FG000|Overall Study|Adverse Event|40|||
94663841|NCT00380068|324224726|FG000|Overall Study|Withdrawal by Subject|10|||
94663842|NCT00380068|324224726|FG000|Overall Study|Not compliant|6|||
94663843|NCT00380068|324224726|FG000|Overall Study|Lost to Follow-up|1|||
94663844|NCT00380068|324224726|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
94663845|NCT00380068|324224726|FG000|Overall Study|Lung transplant|3|||
94663846|NCT00380068|324224726|FG000|Overall Study|Physician Decision|2|||
94663847|NCT00380068|324224726|FG000|Overall Study|Partipant moved away|1|||
94663848|NCT00380068|324224726|FG000|Overall Study|Lack of Efficacy|5|||
94663849|NCT01297062|324224727|FG000|Overall Study|Adverse Event|2|||
94663850|NCT01297062|324224728|FG001|Overall Study|Adverse Event|0|||
94663851|NCT01297062|324224729|FG002|Overall Study|Adverse Event|1|||
94663852|NCT01297062|324224730|FG003|Overall Study|Adverse Event|0|||
94663853|NCT01297062|324224731|FG004|Overall Study|Adverse Event|0|||
94663854|NCT01297062|324224732|FG005|Overall Study|Adverse Event|0|||
94663855|NCT01297062|324224733|FG006|Overall Study|Adverse Event|0|||
94663856|NCT01297062|324224727|FG000|Overall Study|Physician Decision|1|||
94459835|NCT01097421|323471935|FG000|Overall Study|Lost to Follow-up|1|||
94663857|NCT01297062|324224728|FG001|Overall Study|Physician Decision|0|||
94459836|NCT01097421|323471935|FG000|Overall Study|Withdrawal by Subject|3|||
94663858|NCT01297062|324224729|FG002|Overall Study|Physician Decision|1|||
94663859|NCT01297062|324224730|FG003|Overall Study|Physician Decision|0|||
94663860|NCT01297062|324224731|FG004|Overall Study|Physician Decision|0|||
94663861|NCT01297062|324224732|FG005|Overall Study|Physician Decision|0|||
94663862|NCT01297062|324224733|FG006|Overall Study|Physician Decision|6|||
94663863|NCT01297062|324224727|FG000|Overall Study|Protocol Violation|0|||
94663864|NCT01297062|324224728|FG001|Overall Study|Protocol Violation|0|||
94663865|NCT01297062|324224729|FG002|Overall Study|Protocol Violation|0|||
94663866|NCT01297062|324224730|FG003|Overall Study|Protocol Violation|0|||
94612613|NCT03307785|324045131|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
94612614|NCT03307785|324045132|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
94612615|NCT03307785|324045133|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
94612616|NCT03307785|324045134|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
94612617|NCT03307785|324045135|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
94612618|NCT03307785|324045136|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
94612619|NCT03307785|324045137|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
94612620|NCT03307785|324045138|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
94612621|NCT03307785|324045139|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
94612622|NCT03307785|324045140|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
94612623|NCT03307785|324045130|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
94612624|NCT03307785|324045131|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
94612625|NCT03307785|324045132|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
94612626|NCT03307785|324045133|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
94612627|NCT03307785|324045134|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
94612628|NCT03307785|324045135|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
94612629|NCT03307785|324045136|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
94612630|NCT03307785|324045137|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
94612631|NCT03307785|324045138|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
94612632|NCT03307785|324045139|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
94612633|NCT03307785|324045140|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
94612634|NCT03307785|324045130|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
94612635|NCT03307785|324045131|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
94612636|NCT03307785|324045132|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
94612637|NCT03307785|324045133|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
94612638|NCT03307785|324045134|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
94612639|NCT03307785|324045135|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
94612640|NCT03307785|324045136|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
94612641|NCT03307785|324045137|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
94612642|NCT03307785|324045138|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
94612643|NCT03307785|324045139|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
94612644|NCT03307785|324045140|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
94612645|NCT03307785|324045130|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
94612646|NCT03307785|324045131|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
94612647|NCT03307785|324045132|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
94612648|NCT03307785|324045133|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
94612649|NCT03307785|324045134|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
94612650|NCT03307785|324045135|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
94612651|NCT03307785|324045136|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
94612652|NCT03307785|324045137|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
94612653|NCT03307785|324045138|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
94612654|NCT03307785|324045139|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
94612655|NCT03307785|324045140|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
94612656|NCT03307785|324045130|FG000|Part E: Up to 4.4 Months|Death|0|||
94612657|NCT03307785|324045131|FG001|Part E: Up to 4.4 Months|Death|0|||
94612658|NCT03307785|324045132|FG002|Part E: Up to 4.4 Months|Death|0|||
94612659|NCT03307785|324045133|FG003|Part E: Up to 4.4 Months|Death|0|||
94612660|NCT03307785|324045134|FG004|Part E: Up to 4.4 Months|Death|0|||
94612661|NCT03307785|324045135|FG005|Part E: Up to 4.4 Months|Death|0|||
94612662|NCT03307785|324045136|FG006|Part E: Up to 4.4 Months|Death|1|||
94612663|NCT03307785|324045137|FG007|Part E: Up to 4.4 Months|Death|0|||
94612664|NCT03307785|324045138|FG008|Part E: Up to 4.4 Months|Death|0|||
94612665|NCT03307785|324045139|FG009|Part E: Up to 4.4 Months|Death|0|||
94612666|NCT03307785|324045140|FG010|Part E: Up to 4.4 Months|Death|0|||
94612667|NCT03307785|324045130|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
94612668|NCT03307785|324045131|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
94612669|NCT03307785|324045132|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
94612670|NCT03307785|324045133|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
94612671|NCT03307785|324045134|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
94612672|NCT03307785|324045135|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
94612673|NCT03307785|324045136|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
94612674|NCT03307785|324045137|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
94612675|NCT03307785|324045138|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
94612676|NCT03307785|324045139|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
94612677|NCT03307785|324045140|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
94663867|NCT01297062|324224731|FG004|Overall Study|Protocol Violation|1|||
94612678|NCT03307785|324045130|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
94612679|NCT03307785|324045131|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
94612680|NCT03307785|324045132|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
94612681|NCT03307785|324045133|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
94612682|NCT03307785|324045134|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
94612683|NCT03307785|324045135|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
94612684|NCT03307785|324045136|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
94612685|NCT03307785|324045137|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
94612686|NCT03307785|324045138|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
94612687|NCT03307785|324045139|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
94612688|NCT03307785|324045140|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
94612689|NCT00447005|324045142|FG000|Overall Study|Adverse Event|1|||
94612690|NCT00447005|324045142|FG000|Overall Study|Lack of Efficacy|11|||
94612691|NCT03730012|324045151|FG000|Overall Study|Adverse Event|0|||
94612692|NCT03730012|324045152|FG001|Overall Study|Adverse Event|1|||
94612693|NCT03730012|324045151|FG000|Overall Study|Lack of Efficacy|1|||
94612694|NCT03730012|324045152|FG001|Overall Study|Lack of Efficacy|5|||
94612695|NCT03730012|324045151|FG000|Overall Study|Withdrawal by Subject|0|||
94612696|NCT03730012|324045152|FG001|Overall Study|Withdrawal by Subject|1|||
94612697|NCT03730012|324045151|FG000|Overall Study|Miscellaneous|2|||
94612698|NCT03730012|324045152|FG001|Overall Study|Miscellaneous|1|||
94612699|NCT05147428|324045153|FG000|Overall Study|Removed prior to mailing|289|||
94612700|NCT05147428|324045154|FG001|Overall Study|Removed prior to mailing|306|||
94612701|NCT05147428|324045155|FG002|Overall Study|Removed prior to mailing|270|||
94612702|NCT05147428|324045153|FG000|Overall Study|Died or disenrolled during blackout period|239|||
94612703|NCT05147428|324045154|FG001|Overall Study|Died or disenrolled during blackout period|278|||
94612704|NCT05147428|324045155|FG002|Overall Study|Died or disenrolled during blackout period|273|||
94612705|NCT01897714|324047810|FG000|Phase I (Dose Escalation)|Disease progression|3|||
94612706|NCT01897714|324047811|FG001|Phase I (Dose Escalation)|Disease progression|5|||
94612707|NCT01897714|324047812|FG002|Phase I (Dose Escalation)|Disease progression|1|||
94612708|NCT01897714|324047813|FG003|Phase I (Dose Escalation)|Disease progression|3|||
94612709|NCT01897714|324047814|FG004|Phase I (Dose Escalation)|Disease progression|0|||
94612710|NCT01897714|324047815|FG005|Phase I (Dose Escalation)|Disease progression|0|||
94612711|NCT01897714|324047810|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
94612712|NCT01897714|324047811|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
94612713|NCT01897714|324047812|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
94612714|NCT01897714|324047813|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
94612715|NCT01897714|324047814|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
94612716|NCT01897714|324047815|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
94612717|NCT01897714|324047810|FG000|Phase I (Dose Escalation)|Other|0|||
94612718|NCT01897714|324047811|FG001|Phase I (Dose Escalation)|Other|1|||
94612719|NCT01897714|324047812|FG002|Phase I (Dose Escalation)|Other|0|||
94612720|NCT01897714|324047813|FG003|Phase I (Dose Escalation)|Other|0|||
94612721|NCT01897714|324047814|FG004|Phase I (Dose Escalation)|Other|0|||
94612722|NCT01897714|324047815|FG005|Phase I (Dose Escalation)|Other|0|||
94612723|NCT01897714|324047810|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
94612724|NCT01897714|324047811|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
94612725|NCT01897714|324047812|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
94612726|NCT01897714|324047813|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
94612727|NCT01897714|324047814|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
94612728|NCT01897714|324047815|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
94612729|NCT01897714|324047810|FG000|Phase II (MTD)|Lost to Follow-up|0|||
94612730|NCT01897714|324047811|FG001|Phase II (MTD)|Lost to Follow-up|0|||
94612731|NCT01897714|324047812|FG002|Phase II (MTD)|Lost to Follow-up|0|||
94612732|NCT01897714|324047813|FG003|Phase II (MTD)|Lost to Follow-up|0|||
94612733|NCT01897714|324047814|FG004|Phase II (MTD)|Lost to Follow-up|1|||
94612734|NCT01897714|324047815|FG005|Phase II (MTD)|Lost to Follow-up|0|||
94612735|NCT01897714|324047810|FG000|Phase II (MTD)|Death|0|||
94612736|NCT01897714|324047811|FG001|Phase II (MTD)|Death|0|||
94612737|NCT01897714|324047812|FG002|Phase II (MTD)|Death|0|||
94612738|NCT01897714|324047813|FG003|Phase II (MTD)|Death|0|||
94612739|NCT01897714|324047814|FG004|Phase II (MTD)|Death|25|||
94612740|NCT01897714|324047815|FG005|Phase II (MTD)|Death|10|||
94612741|NCT01897714|324047810|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
94612742|NCT01897714|324047811|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
94663868|NCT01297062|324224732|FG005|Overall Study|Protocol Violation|0|||
94612743|NCT01897714|324047812|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
94612744|NCT01897714|324047813|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
94612745|NCT01897714|324047814|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
94612746|NCT01897714|324047815|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
94612747|NCT01897714|324047810|FG000|Phase II (MTD)|Other|0|||
94612748|NCT01897714|324047811|FG001|Phase II (MTD)|Other|0|||
94612749|NCT01897714|324047812|FG002|Phase II (MTD)|Other|0|||
94612750|NCT01897714|324047813|FG003|Phase II (MTD)|Other|0|||
94612751|NCT01897714|324047814|FG004|Phase II (MTD)|Other|3|||
94612752|NCT01897714|324047815|FG005|Phase II (MTD)|Other|0|||
94663869|NCT01297062|324224733|FG006|Overall Study|Protocol Violation|0|||
94663870|NCT01297062|324224727|FG000|Overall Study|Subject Decision|1|||
94663871|NCT01297062|324224728|FG001|Overall Study|Subject Decision|1|||
94663872|NCT01297062|324224729|FG002|Overall Study|Subject Decision|0|||
94663873|NCT01297062|324224730|FG003|Overall Study|Subject Decision|1|||
94663874|NCT01297062|324224731|FG004|Overall Study|Subject Decision|1|||
94663875|NCT01297062|324224732|FG005|Overall Study|Subject Decision|1|||
94663876|NCT01297062|324224733|FG006|Overall Study|Subject Decision|2|||
94663877|NCT01458574|324224734|FG000|Overall Study|Adverse Event|5|||
94663878|NCT01458574|324224735|FG001|Overall Study|Adverse Event|9|||
94663879|NCT01458574|324224736|FG002|Overall Study|Adverse Event|7|||
94663880|NCT01458574|324224734|FG000|Overall Study|Lack of Efficacy|70|||
94663881|NCT01458574|324224735|FG001|Overall Study|Lack of Efficacy|53|||
94663882|NCT01458574|324224736|FG002|Overall Study|Lack of Efficacy|132|||
94663883|NCT01458574|324224734|FG000|Overall Study|Lost to Follow-up|3|||
94663884|NCT01458574|324224735|FG001|Overall Study|Lost to Follow-up|2|||
94612753|NCT00423722|324047816|FG000|Overall Study|Death|4|||
94612754|NCT00423722|324047817|FG001|Overall Study|Death|4|||
94612755|NCT00423722|324047816|FG000|Overall Study|Declined to participate|2|||
94612756|NCT00423722|324047817|FG001|Overall Study|Declined to participate|3|||
94612757|NCT00423722|324047816|FG000|Overall Study|Unable to complete questionnaires|4|||
94612758|NCT00423722|324047817|FG001|Overall Study|Unable to complete questionnaires|4|||
94612759|NCT00423722|324047816|FG000|Overall Study|Withdrawal by Subject|4|||
94612760|NCT00423722|324047817|FG001|Overall Study|Withdrawal by Subject|2|||
94612761|NCT00518687|324047820|FG000|Overall Study|Adverse Event|201|||
94612762|NCT00518687|324047821|FG001|Overall Study|Adverse Event|177|||
94612763|NCT00518687|324047820|FG000|Overall Study|Lost to Follow-up|144|||
94612764|NCT00518687|324047821|FG001|Overall Study|Lost to Follow-up|155|||
94612765|NCT00518687|324047820|FG000|Overall Study|Physician Decision|42|||
94612766|NCT00518687|324047821|FG001|Overall Study|Physician Decision|48|||
94612767|NCT00518687|324047820|FG000|Overall Study|Progressive disease|2|||
94612768|NCT00518687|324047821|FG001|Overall Study|Progressive disease|2|||
94612769|NCT00518687|324047820|FG000|Overall Study|Protocol Violation|8|||
94612770|NCT00518687|324047821|FG001|Overall Study|Protocol Violation|10|||
94612771|NCT00518687|324047820|FG000|Overall Study|Study terminated by sponsor|930|||
94612772|NCT00518687|324047821|FG001|Overall Study|Study terminated by sponsor|918|||
94612773|NCT00518687|324047820|FG000|Overall Study|Withdrawal by Subject|110|||
94612774|NCT00518687|324047821|FG001|Overall Study|Withdrawal by Subject|110|||
94612775|NCT00392015|324047822|FG000|Overall Study|Lost to Follow-up|2|||
94612776|NCT00392015|324047823|FG001|Overall Study|Lost to Follow-up|0|||
94612777|NCT00392015|324047824|FG002|Overall Study|Lost to Follow-up|2|||
94612778|NCT00392015|324047825|FG003|Overall Study|Lost to Follow-up|1|||
94612779|NCT00392015|324047826|FG004|Overall Study|Lost to Follow-up|1|||
94612780|NCT00392015|324047827|FG005|Overall Study|Lost to Follow-up|0|||
94612781|NCT00392015|324047822|FG000|Overall Study|Withdrawal by Subject|0|||
94612782|NCT00392015|324047823|FG001|Overall Study|Withdrawal by Subject|0|||
94612783|NCT00392015|324047824|FG002|Overall Study|Withdrawal by Subject|2|||
94612784|NCT00392015|324047825|FG003|Overall Study|Withdrawal by Subject|0|||
94612785|NCT00392015|324047826|FG004|Overall Study|Withdrawal by Subject|0|||
94612786|NCT00392015|324047827|FG005|Overall Study|Withdrawal by Subject|0|||
94612787|NCT00392015|324047822|FG000|Overall Study|Adverse Event|0|||
94612788|NCT00392015|324047823|FG001|Overall Study|Adverse Event|0|||
94612789|NCT00392015|324047824|FG002|Overall Study|Adverse Event|0|||
94612790|NCT00392015|324047825|FG003|Overall Study|Adverse Event|0|||
94612791|NCT00392015|324047826|FG004|Overall Study|Adverse Event|1|||
94612792|NCT00392015|324047827|FG005|Overall Study|Adverse Event|0|||
94612793|NCT00392015|324047822|FG000|Overall Study|Previous trial recipient|0|||
94612794|NCT00392015|324047823|FG001|Overall Study|Previous trial recipient|0|||
94612795|NCT00392015|324047824|FG002|Overall Study|Previous trial recipient|0|||
94612796|NCT00392015|324047825|FG003|Overall Study|Previous trial recipient|0|||
94612797|NCT00392015|324047826|FG004|Overall Study|Previous trial recipient|1|||
94612798|NCT00392015|324047827|FG005|Overall Study|Previous trial recipient|0|||
94612799|NCT02598960|324047828|FG000|Treatment Period|Disease Progression|4|||
94612800|NCT02598960|324047829|FG001|Treatment Period|Disease Progression|4|||
94612801|NCT02598960|324047830|FG002|Treatment Period|Disease Progression|4|||
94612802|NCT02598960|324047831|FG003|Treatment Period|Disease Progression|6|||
94612803|NCT02598960|324047832|FG004|Treatment Period|Disease Progression|8|||
94612804|NCT02598960|324047833|FG005|Treatment Period|Disease Progression|2|||
94612805|NCT02598960|324047834|FG006|Treatment Period|Disease Progression|2|||
94612806|NCT02598960|324047835|FG007|Treatment Period|Disease Progression|3|||
94612807|NCT02598960|324047836|FG008|Treatment Period|Disease Progression|7|||
94612808|NCT02598960|324047837|FG009|Treatment Period|Disease Progression|9|||
94612809|NCT02598960|324047838|FG010|Treatment Period|Disease Progression|7|||
94663885|NCT01458574|324224736|FG002|Overall Study|Lost to Follow-up|1|||
94663886|NCT01458574|324224734|FG000|Overall Study|Pregnancy|1|||
94663887|NCT01458574|324224735|FG001|Overall Study|Pregnancy|1|||
94663888|NCT01458574|324224736|FG002|Overall Study|Pregnancy|0|||
94663889|NCT01458574|324224734|FG000|Overall Study|Protocol Violation|0|||
94663890|NCT01458574|324224735|FG001|Overall Study|Protocol Violation|1|||
94612810|NCT02598960|324047839|FG011|Treatment Period|Disease Progression|143|||
94612811|NCT02598960|324047840|FG012|Treatment Period|Disease Progression|23|||
94612812|NCT02598960|324047828|FG000|Treatment Period|Study drug toxicity|0|||
94612813|NCT02598960|324047829|FG001|Treatment Period|Study drug toxicity|0|||
94612814|NCT02598960|324047830|FG002|Treatment Period|Study drug toxicity|0|||
94612815|NCT02598960|324047831|FG003|Treatment Period|Study drug toxicity|0|||
94612816|NCT02598960|324047832|FG004|Treatment Period|Study drug toxicity|0|||
94612817|NCT02598960|324047833|FG005|Treatment Period|Study drug toxicity|0|||
94612818|NCT02598960|324047834|FG006|Treatment Period|Study drug toxicity|0|||
94612819|NCT02598960|324047835|FG007|Treatment Period|Study drug toxicity|0|||
94612820|NCT02598960|324047836|FG008|Treatment Period|Study drug toxicity|0|||
94612821|NCT02598960|324047837|FG009|Treatment Period|Study drug toxicity|1|||
94663891|NCT01458574|324224736|FG002|Overall Study|Protocol Violation|0|||
94663892|NCT01458574|324224734|FG000|Overall Study|Withdrawal by Subject|6|||
94663893|NCT01458574|324224735|FG001|Overall Study|Withdrawal by Subject|3|||
94663894|NCT01458574|324224736|FG002|Overall Study|Withdrawal by Subject|5|||
94663895|NCT01458574|324224734|FG000|Overall Study|Other|2|||
94663896|NCT01458574|324224735|FG001|Overall Study|Other|1|||
94663897|NCT01458574|324224736|FG002|Overall Study|Other|0|||
94663898|NCT01458574|324224734|FG000|Overall Study|Randomized but not treated|0|||
94663899|NCT01458574|324224735|FG001|Overall Study|Randomized but not treated|1|||
94663900|NCT01458574|324224736|FG002|Overall Study|Randomized but not treated|0|||
94663901|NCT01682837|324224737|FG000|Baseline|Withdrawal by Subject|5|||
94663902|NCT01365494|324224738|FG000|Overall Study|Adverse Event|1|||
94663903|NCT01365494|324224739|FG001|Overall Study|Adverse Event|0|||
94663904|NCT01365494|324224738|FG000|Overall Study|Withdrawal by Subject|0|||
94663905|NCT01365494|324224739|FG001|Overall Study|Withdrawal by Subject|1|||
94663906|NCT01365494|324224738|FG000|Overall Study|Lost to Follow-up|1|||
94663907|NCT01365494|324224739|FG001|Overall Study|Lost to Follow-up|2|||
94663908|NCT04782323|324224740|FG000|Overall Study|Death|1|||
94663909|NCT04782323|324224741|FG001|Overall Study|Death|0|||
94663910|NCT04782323|324224742|FG002|Overall Study|Death|0|||
94663911|NCT04782323|324224743|FG003|Overall Study|Death|0|||
94663912|NCT04782323|324224744|FG004|Overall Study|Death|1|||
94663913|NCT04782323|324224745|FG005|Overall Study|Death|1|||
94663914|NCT04782323|324224746|FG006|Overall Study|Death|1|||
94663915|NCT04782323|324224747|FG007|Overall Study|Death|0|||
94663916|NCT04782323|324224740|FG000|Overall Study|Withdrawal by Subject|0|||
94663917|NCT04782323|324224741|FG001|Overall Study|Withdrawal by Subject|0|||
94663918|NCT04782323|324224742|FG002|Overall Study|Withdrawal by Subject|1|||
94663919|NCT04782323|324224743|FG003|Overall Study|Withdrawal by Subject|0|||
94663920|NCT04782323|324224744|FG004|Overall Study|Withdrawal by Subject|0|||
94663921|NCT04782323|324224745|FG005|Overall Study|Withdrawal by Subject|1|||
94663922|NCT04782323|324224746|FG006|Overall Study|Withdrawal by Subject|0|||
94663923|NCT04782323|324224747|FG007|Overall Study|Withdrawal by Subject|1|||
94663924|NCT04782323|324224740|FG000|Overall Study|Lost to Follow-up|0|||
94663925|NCT04782323|324224741|FG001|Overall Study|Lost to Follow-up|1|||
94663926|NCT04782323|324224742|FG002|Overall Study|Lost to Follow-up|1|||
94663927|NCT04782323|324224743|FG003|Overall Study|Lost to Follow-up|0|||
94663928|NCT04782323|324224744|FG004|Overall Study|Lost to Follow-up|0|||
94663929|NCT04782323|324224745|FG005|Overall Study|Lost to Follow-up|1|||
94663930|NCT04782323|324224746|FG006|Overall Study|Lost to Follow-up|1|||
94663931|NCT04782323|324224747|FG007|Overall Study|Lost to Follow-up|2|||
94663932|NCT04782323|324224740|FG000|Overall Study|randomization in error|1|||
94663933|NCT04782323|324224741|FG001|Overall Study|randomization in error|0|||
94663934|NCT04782323|324224742|FG002|Overall Study|randomization in error|0|||
94663935|NCT04782323|324224743|FG003|Overall Study|randomization in error|0|||
94663936|NCT04782323|324224744|FG004|Overall Study|randomization in error|0|||
94663937|NCT04782323|324224745|FG005|Overall Study|randomization in error|0|||
94663938|NCT04782323|324224746|FG006|Overall Study|randomization in error|0|||
94663939|NCT04782323|324224747|FG007|Overall Study|randomization in error|0|||
94663940|NCT03346759|324224751|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
94663941|NCT03346759|324224752|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
94663942|NCT03346759|324224751|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
94663943|NCT03346759|324224752|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
94663944|NCT03346759|324224751|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
94663945|NCT03346759|324224752|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
94663946|NCT01965834|324224753|FG000|Overall Study|Lack of Efficacy|4|||
94663947|NCT02005471|324224754|FG000|Main Study|Adverse Event|0|||
94663948|NCT02005471|324224755|FG001|Main Study|Adverse Event|1|||
94663949|NCT02005471|324224756|FG002|Main Study|Adverse Event|0|||
94663950|NCT02005471|324224757|FG003|Main Study|Adverse Event|0|||
94663951|NCT02005471|324224754|FG000|Main Study|Death|83|||
94663952|NCT02005471|324224755|FG001|Main Study|Death|52|||
94663953|NCT02005471|324224756|FG002|Main Study|Death|0|||
94663954|NCT02005471|324224757|FG003|Main Study|Death|0|||
94663955|NCT02005471|324224754|FG000|Main Study|Lost to Follow-up|4|||
94459837|NCT00655733|323471936|FG000|Overall Study|Lost to Follow-up|2|||
94663956|NCT02005471|324224755|FG001|Main Study|Lost to Follow-up|5|||
94663957|NCT02005471|324224756|FG002|Main Study|Lost to Follow-up|0|||
94663958|NCT02005471|324224757|FG003|Main Study|Lost to Follow-up|0|||
94663959|NCT02005471|324224754|FG000|Main Study|Physician Decision|3|||
94663960|NCT02005471|324224755|FG001|Main Study|Physician Decision|1|||
94663961|NCT02005471|324224756|FG002|Main Study|Physician Decision|0|||
94663962|NCT02005471|324224757|FG003|Main Study|Physician Decision|0|||
94663963|NCT02005471|324224754|FG000|Main Study|Withdrawal by Subject|26|||
94663964|NCT02005471|324224755|FG001|Main Study|Withdrawal by Subject|11|||
94663965|NCT02005471|324224756|FG002|Main Study|Withdrawal by Subject|0|||
94663966|NCT02005471|324224757|FG003|Main Study|Withdrawal by Subject|0|||
94663967|NCT02005471|324224754|FG000|Main Study|Reason not Specified|0|||
94663968|NCT02005471|324224755|FG001|Main Study|Reason not Specified|6|||
94663969|NCT02005471|324224756|FG002|Main Study|Reason not Specified|0|||
94663970|NCT02005471|324224757|FG003|Main Study|Reason not Specified|0|||
94663971|NCT02005471|324224754|FG000|Main Study|Randomized but not Dosed|8|||
94663972|NCT02005471|324224755|FG001|Main Study|Randomized but not Dosed|0|||
94663973|NCT02005471|324224756|FG002|Main Study|Randomized but not Dosed|0|||
94663974|NCT02005471|324224757|FG003|Main Study|Randomized but not Dosed|0|||
94663975|NCT02005471|324224754|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
94663976|NCT02005471|324224755|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
94663977|NCT02005471|324224756|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
94663978|NCT02005471|324224757|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
94663979|NCT02005471|324224754|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
94663980|NCT02005471|324224755|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
94663981|NCT02005471|324224756|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
94663982|NCT02005471|324224757|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
94663983|NCT02005471|324224754|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
94663984|NCT02005471|324224755|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
94663985|NCT02005471|324224756|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
94663986|NCT02005471|324224757|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
94663987|NCT03674177|324224760|FG000|Overall Study|Lost to Follow-up|2|||
94663988|NCT03674177|324224761|FG001|Overall Study|Lost to Follow-up|1|||
94663989|NCT03674177|324224762|FG002|Overall Study|Lost to Follow-up|0|||
94663990|NCT03674177|324224763|FG003|Overall Study|Lost to Follow-up|2|||
94663991|NCT03387852|324224764|FG000|Overall Study|Adverse event (AE)|3|||
94663992|NCT03387852|324224765|FG001|Overall Study|Adverse event (AE)|0|||
94663993|NCT03387852|324224766|FG002|Overall Study|Adverse event (AE)|2|||
94663994|NCT03387852|324224767|FG003|Overall Study|Adverse event (AE)|0|||
94663995|NCT03387852|324224764|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
94663996|NCT03387852|324224765|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
94663997|NCT03387852|324224766|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
94663998|NCT03387852|324224767|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
94663999|NCT03387852|324224764|FG000|Overall Study|Withdrawal by participant|1|||
94664000|NCT03387852|324224765|FG001|Overall Study|Withdrawal by participant|1|||
94664001|NCT03387852|324224766|FG002|Overall Study|Withdrawal by participant|3|||
94664002|NCT03387852|324224767|FG003|Overall Study|Withdrawal by participant|2|||
94664003|NCT03387852|324224764|FG000|Overall Study|Other- Unspecified|1|||
94664004|NCT03387852|324224765|FG001|Overall Study|Other- Unspecified|1|||
94664005|NCT03387852|324224766|FG002|Overall Study|Other- Unspecified|2|||
94664006|NCT03387852|324224767|FG003|Overall Study|Other- Unspecified|1|||
94664007|NCT03387852|324224764|FG000|Overall Study|Poor compliance to protocol|0|||
94664008|NCT03387852|324224765|FG001|Overall Study|Poor compliance to protocol|0|||
94664009|NCT03387852|324224766|FG002|Overall Study|Poor compliance to protocol|0|||
94459838|NCT00655733|323471937|FG001|Overall Study|Lost to Follow-up|2|||
94459839|NCT00655733|323471936|FG000|Overall Study|Adverse Event|2|||
94612822|NCT02598960|324047838|FG010|Treatment Period|Study drug toxicity|0|||
94612823|NCT02598960|324047839|FG011|Treatment Period|Study drug toxicity|3|||
94612824|NCT02598960|324047840|FG012|Treatment Period|Study drug toxicity|0|||
94612825|NCT02598960|324047828|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
94612826|NCT02598960|324047829|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
94612827|NCT02598960|324047830|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
94612828|NCT02598960|324047831|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
94612829|NCT02598960|324047832|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
94612830|NCT02598960|324047833|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
94612831|NCT02598960|324047834|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
94612832|NCT02598960|324047835|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
94612833|NCT02598960|324047836|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
94612834|NCT02598960|324047837|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
94612835|NCT02598960|324047838|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
94612836|NCT02598960|324047839|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
94612837|NCT02598960|324047840|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
94612838|NCT02598960|324047828|FG000|Treatment Period|participant request to discontinue|0|||
94612839|NCT02598960|324047829|FG001|Treatment Period|participant request to discontinue|1|||
94612840|NCT02598960|324047830|FG002|Treatment Period|participant request to discontinue|0|||
94612841|NCT02598960|324047831|FG003|Treatment Period|participant request to discontinue|0|||
94664010|NCT03387852|324224767|FG003|Overall Study|Poor compliance to protocol|1|||
94664011|NCT03387852|324224764|FG000|Overall Study|Randomized and not treated|0|||
94664012|NCT03387852|324224765|FG001|Overall Study|Randomized and not treated|0|||
94664013|NCT03387852|324224766|FG002|Overall Study|Randomized and not treated|0|||
94612842|NCT02598960|324047832|FG004|Treatment Period|participant request to discontinue|1|||
94664014|NCT03387852|324224767|FG003|Overall Study|Randomized and not treated|1|||
94664015|NCT02763384|324224771|FG000|Overall Study|Physician Decision|1|||
94664016|NCT02763384|324224771|FG000|Overall Study|Rapid decline - went on hospice|1|||
94612843|NCT02598960|324047833|FG005|Treatment Period|participant request to discontinue|0|||
94664017|NCT02493127|324224772|FG000|Overall Study|Lost to Follow-up|1|||
94664018|NCT02493127|324224773|FG001|Overall Study|Lost to Follow-up|1|||
94664019|NCT00714168|324224774|FG000|Overall Study|Pregnancy|5|||
94664020|NCT00714168|324224775|FG001|Overall Study|Pregnancy|4|||
94664021|NCT00714168|324224774|FG000|Overall Study|Lost to Follow-up|32|||
94664022|NCT00714168|324224775|FG001|Overall Study|Lost to Follow-up|50|||
94664023|NCT00714168|324224774|FG000|Overall Study|Relocation|4|||
94664024|NCT00714168|324224775|FG001|Overall Study|Relocation|3|||
94664025|NCT00714168|324224774|FG000|Overall Study|Non-study medical condition|3|||
94664026|NCT00714168|324224775|FG001|Overall Study|Non-study medical condition|2|||
94664027|NCT03034577|324224777|FG000|Overall Study|Withdrawal by Subject|6|||
94664028|NCT03034577|324224778|FG001|Overall Study|Withdrawal by Subject|9|||
94664029|NCT03034577|324224777|FG000|Overall Study|Lost to Follow-up|25|||
94664030|NCT03034577|324224778|FG001|Overall Study|Lost to Follow-up|26|||
94664031|NCT01174342|324224779|FG000|Overall Study|Conversion to cesarean section|4|||
94664032|NCT01410448|324224780|FG000|Overall Study|No conversion to everolimus|0|||
94664033|NCT01410448|324224781|FG001|Overall Study|No conversion to everolimus|24|||
94664034|NCT01410448|324224780|FG000|Overall Study|Graft loss|4|||
94664035|NCT01410448|324224781|FG001|Overall Study|Graft loss|1|||
94664036|NCT01410448|324224780|FG000|Overall Study|Administrative issues|2|||
94664037|NCT01410448|324224781|FG001|Overall Study|Administrative issues|1|||
94664038|NCT01410448|324224780|FG000|Overall Study|Lost to Follow-up|1|||
94664039|NCT01410448|324224781|FG001|Overall Study|Lost to Follow-up|0|||
94664040|NCT01410448|324224780|FG000|Overall Study|Withdrawal by Subject|3|||
94664041|NCT01410448|324224781|FG001|Overall Study|Withdrawal by Subject|2|||
94664042|NCT01410448|324224780|FG000|Overall Study|Protocol Violation|0|||
94664043|NCT01410448|324224781|FG001|Overall Study|Protocol Violation|4|||
94664044|NCT01410448|324224780|FG000|Overall Study|Death|2|||
94664045|NCT01410448|324224781|FG001|Overall Study|Death|3|||
94664046|NCT01308580|324224782|FG000|Overall Study|Lost to Follow-up|12|||
94664047|NCT01308580|324224783|FG001|Overall Study|Lost to Follow-up|7|||
94664048|NCT03826667|324224786|FG000|Overall Study|Protocol deviation|21|||
94664049|NCT04764396|324224787|FG000|Overall Study|Physician Decision|1|||
94664050|NCT04764396|324224788|FG001|Overall Study|Physician Decision|0|||
94664051|NCT02653482|324224791|FG000|Overall Study|Death|1|||
94664052|NCT02653482|324224792|FG001|Overall Study|Death|1|||
94664053|NCT01218438|324224795|FG000|Epoch 1|Physician Decision|2|||
94664054|NCT01218438|324224795|FG000|Epoch 1|Adverse Event|1|||
94664055|NCT01218438|324224795|FG000|Epoch 3|Withdrawal by Subject|3|||
94664056|NCT01218438|324224795|FG000|Epoch 3|Adverse Event|1|||
94664057|NCT01218438|324224795|FG000|Epoch 4|Physician Decision|1|||
94664058|NCT01218438|324224795|FG000|Epoch 4|Withdrawal by Subject|2|||
94664059|NCT05132699|324224797|FG000|Overall Study|Withdrawal by Subject|3|||
94664060|NCT05132699|324224798|FG001|Overall Study|Withdrawal by Subject|0|||
94664061|NCT02010060|324224799|FG000|Overall Study|Lost to Follow-up|1|||
94664062|NCT02010060|324224800|FG001|Overall Study|Lost to Follow-up|2|||
94664063|NCT02010060|324224801|FG002|Overall Study|Lost to Follow-up|2|||
94664064|NCT02010060|324224799|FG000|Overall Study|Injury|0|||
94664065|NCT02010060|324224800|FG001|Overall Study|Injury|1|||
94664066|NCT02010060|324224801|FG002|Overall Study|Injury|0|||
94664067|NCT04827576|324227006|FG000|Overall Study|Death|5|||
94664068|NCT04827576|324227007|FG001|Overall Study|Death|17|||
94664069|NCT04827576|324227008|FG002|Overall Study|Death|17|||
94664070|NCT04827576|324227009|FG003|Overall Study|Death|32|||
94664071|NCT04827576|324227006|FG000|Overall Study|Study Terminated by Sponsor|2|||
94664072|NCT04827576|324227007|FG001|Overall Study|Study Terminated by Sponsor|9|||
94664073|NCT04827576|324227008|FG002|Overall Study|Study Terminated by Sponsor|7|||
94664074|NCT04827576|324227009|FG003|Overall Study|Study Terminated by Sponsor|5|||
94664075|NCT04827576|324227006|FG000|Overall Study|Investigator's Discretion|1|||
94664076|NCT04827576|324227007|FG001|Overall Study|Investigator's Discretion|0|||
94664077|NCT04827576|324227008|FG002|Overall Study|Investigator's Discretion|2|||
94664078|NCT04827576|324227009|FG003|Overall Study|Investigator's Discretion|5|||
94664079|NCT04827576|324227006|FG000|Overall Study|Withdrew Consent|0|||
94664080|NCT04827576|324227007|FG001|Overall Study|Withdrew Consent|3|||
94664081|NCT04827576|324227008|FG002|Overall Study|Withdrew Consent|0|||
94664082|NCT04827576|324227009|FG003|Overall Study|Withdrew Consent|0|||
94664083|NCT04827576|324227006|FG000|Overall Study|Lost to Follow-up|1|||
94664084|NCT04827576|324227007|FG001|Overall Study|Lost to Follow-up|0|||
94664085|NCT04827576|324227008|FG002|Overall Study|Lost to Follow-up|0|||
94664086|NCT04827576|324227009|FG003|Overall Study|Lost to Follow-up|0|||
94664087|NCT01261611|324227011|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
94358553|NCT03110107|323096440|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
94664088|NCT01261611|324227012|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
94664089|NCT01261611|324227013|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
94664090|NCT01261611|324227011|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
94664091|NCT01261611|324227012|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
94664092|NCT01261611|324227013|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
94664093|NCT01261611|324227011|FG000|Treatment Cycle 1|Adverse Event|0|||
94664094|NCT01261611|324227012|FG001|Treatment Cycle 1|Adverse Event|1|||
94664095|NCT01261611|324227013|FG002|Treatment Cycle 1|Adverse Event|0|||
94358554|NCT03110107|323096441|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
94358555|NCT03110107|323096442|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
94358556|NCT03110107|323096443|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
94358557|NCT03110107|323096444|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
94358558|NCT03110107|323096445|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
94358559|NCT03110107|323096446|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
94358560|NCT03110107|323096447|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
94358561|NCT03110107|323096448|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
94358562|NCT03110107|323096449|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
94358563|NCT03110107|323096450|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
94358564|NCT03110107|323096451|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
94358565|NCT03110107|323096452|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
94358566|NCT03110107|323096453|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
94358567|NCT03110107|323096454|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
94358568|NCT03110107|323096455|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
94358569|NCT03110107|323096430|FG000|Treatment Period|Participant withdrew consent|0|||
94358570|NCT03110107|323096431|FG001|Treatment Period|Participant withdrew consent|0|||
94358571|NCT03110107|323096432|FG002|Treatment Period|Participant withdrew consent|1|||
94358572|NCT03110107|323096433|FG003|Treatment Period|Participant withdrew consent|0|||
94358573|NCT03110107|323096434|FG004|Treatment Period|Participant withdrew consent|4|||
94358574|NCT03110107|323096435|FG005|Treatment Period|Participant withdrew consent|3|||
94358575|NCT03110107|323096436|FG006|Treatment Period|Participant withdrew consent|0|||
94358576|NCT03110107|323096437|FG007|Treatment Period|Participant withdrew consent|0|||
94358577|NCT03110107|323096438|FG008|Treatment Period|Participant withdrew consent|0|||
94358578|NCT03110107|323096439|FG009|Treatment Period|Participant withdrew consent|1|||
94358579|NCT03110107|323096440|FG010|Treatment Period|Participant withdrew consent|0|||
94358580|NCT03110107|323096441|FG011|Treatment Period|Participant withdrew consent|0|||
94358581|NCT03110107|323096442|FG012|Treatment Period|Participant withdrew consent|0|||
94358582|NCT03110107|323096443|FG013|Treatment Period|Participant withdrew consent|0|||
94358583|NCT03110107|323096444|FG014|Treatment Period|Participant withdrew consent|0|||
94612844|NCT02598960|324047834|FG006|Treatment Period|participant request to discontinue|0|||
94612845|NCT02598960|324047835|FG007|Treatment Period|participant request to discontinue|0|||
94612846|NCT02598960|324047836|FG008|Treatment Period|participant request to discontinue|0|||
94612847|NCT02598960|324047837|FG009|Treatment Period|participant request to discontinue|0|||
94612848|NCT02598960|324047838|FG010|Treatment Period|participant request to discontinue|1|||
94612849|NCT02598960|324047839|FG011|Treatment Period|participant request to discontinue|4|||
94358584|NCT03110107|323096445|FG015|Treatment Period|Participant withdrew consent|0|||
94358585|NCT03110107|323096446|FG016|Treatment Period|Participant withdrew consent|0|||
94358586|NCT03110107|323096447|FG017|Treatment Period|Participant withdrew consent|0|||
94358587|NCT03110107|323096448|FG018|Treatment Period|Participant withdrew consent|0|||
94358588|NCT03110107|323096449|FG019|Treatment Period|Participant withdrew consent|1|||
94358589|NCT03110107|323096450|FG020|Treatment Period|Participant withdrew consent|0|||
94358590|NCT03110107|323096451|FG021|Treatment Period|Participant withdrew consent|2|||
94358591|NCT03110107|323096452|FG022|Treatment Period|Participant withdrew consent|0|||
94358592|NCT03110107|323096453|FG023|Treatment Period|Participant withdrew consent|0|||
94358593|NCT03110107|323096454|FG024|Treatment Period|Participant withdrew consent|0|||
94358594|NCT03110107|323096455|FG025|Treatment Period|Participant withdrew consent|2|||
94358595|NCT03110107|323096430|FG000|Treatment Period|Participants no longer meets study criteria|0|||
94358596|NCT03110107|323096431|FG001|Treatment Period|Participants no longer meets study criteria|0|||
94358597|NCT03110107|323096432|FG002|Treatment Period|Participants no longer meets study criteria|0|||
94358598|NCT03110107|323096433|FG003|Treatment Period|Participants no longer meets study criteria|0|||
94358599|NCT03110107|323096434|FG004|Treatment Period|Participants no longer meets study criteria|0|||
94612850|NCT02598960|324047840|FG012|Treatment Period|participant request to discontinue|0|||
94612851|NCT02598960|324047828|FG000|Treatment Period|participant withdrew consent|0|||
94612852|NCT02598960|324047829|FG001|Treatment Period|participant withdrew consent|0|||
94358600|NCT03110107|323096435|FG005|Treatment Period|Participants no longer meets study criteria|0|||
94358601|NCT03110107|323096436|FG006|Treatment Period|Participants no longer meets study criteria|0|||
94358602|NCT03110107|323096437|FG007|Treatment Period|Participants no longer meets study criteria|0|||
94358603|NCT03110107|323096438|FG008|Treatment Period|Participants no longer meets study criteria|0|||
94358604|NCT03110107|323096439|FG009|Treatment Period|Participants no longer meets study criteria|0|||
94358605|NCT03110107|323096440|FG010|Treatment Period|Participants no longer meets study criteria|0|||
94358606|NCT03110107|323096441|FG011|Treatment Period|Participants no longer meets study criteria|0|||
94358607|NCT03110107|323096442|FG012|Treatment Period|Participants no longer meets study criteria|0|||
94664096|NCT01261611|324227011|FG000|Treatment Cycle 1|Protocol Violation|0|||
94664097|NCT01261611|324227012|FG001|Treatment Cycle 1|Protocol Violation|0|||
94664098|NCT01261611|324227013|FG002|Treatment Cycle 1|Protocol Violation|2|||
94664099|NCT01261611|324227011|FG000|Treatment Cycle 2|Completed study|4|||
94612853|NCT02598960|324047830|FG002|Treatment Period|participant withdrew consent|0|||
94612854|NCT02598960|324047831|FG003|Treatment Period|participant withdrew consent|0|||
94612855|NCT02598960|324047832|FG004|Treatment Period|participant withdrew consent|0|||
94612856|NCT02598960|324047833|FG005|Treatment Period|participant withdrew consent|0|||
94612857|NCT02598960|324047834|FG006|Treatment Period|participant withdrew consent|0|||
94612858|NCT02598960|324047835|FG007|Treatment Period|participant withdrew consent|0|||
94612859|NCT02598960|324047836|FG008|Treatment Period|participant withdrew consent|0|||
94612860|NCT02598960|324047837|FG009|Treatment Period|participant withdrew consent|0|||
94612861|NCT02598960|324047838|FG010|Treatment Period|participant withdrew consent|0|||
94612862|NCT02598960|324047839|FG011|Treatment Period|participant withdrew consent|3|||
94612863|NCT02598960|324047840|FG012|Treatment Period|participant withdrew consent|0|||
94612864|NCT02598960|324047828|FG000|Treatment Period|No longer meets study criteria|0|||
94612865|NCT02598960|324047829|FG001|Treatment Period|No longer meets study criteria|0|||
94612866|NCT02598960|324047830|FG002|Treatment Period|No longer meets study criteria|0|||
94612867|NCT02598960|324047831|FG003|Treatment Period|No longer meets study criteria|0|||
94612868|NCT02598960|324047832|FG004|Treatment Period|No longer meets study criteria|0|||
94612869|NCT02598960|324047833|FG005|Treatment Period|No longer meets study criteria|0|||
94612870|NCT02598960|324047834|FG006|Treatment Period|No longer meets study criteria|0|||
94612871|NCT02598960|324047835|FG007|Treatment Period|No longer meets study criteria|0|||
94612872|NCT02598960|324047836|FG008|Treatment Period|No longer meets study criteria|0|||
94612873|NCT02598960|324047837|FG009|Treatment Period|No longer meets study criteria|0|||
94612874|NCT02598960|324047838|FG010|Treatment Period|No longer meets study criteria|0|||
94612875|NCT02598960|324047839|FG011|Treatment Period|No longer meets study criteria|1|||
94612876|NCT02598960|324047840|FG012|Treatment Period|No longer meets study criteria|0|||
94612877|NCT02598960|324047828|FG000|Treatment Period|Other Reasons|0|||
94664100|NCT01261611|324227012|FG001|Treatment Cycle 2|Completed study|0|||
94612878|NCT02598960|324047829|FG001|Treatment Period|Other Reasons|0|||
94612879|NCT02598960|324047830|FG002|Treatment Period|Other Reasons|0|||
94612880|NCT02598960|324047831|FG003|Treatment Period|Other Reasons|0|||
94612881|NCT02598960|324047832|FG004|Treatment Period|Other Reasons|0|||
94612882|NCT02598960|324047833|FG005|Treatment Period|Other Reasons|0|||
94612883|NCT02598960|324047834|FG006|Treatment Period|Other Reasons|0|||
94612884|NCT02598960|324047835|FG007|Treatment Period|Other Reasons|0|||
94612885|NCT02598960|324047836|FG008|Treatment Period|Other Reasons|0|||
94612886|NCT02598960|324047837|FG009|Treatment Period|Other Reasons|0|||
94612887|NCT02598960|324047838|FG010|Treatment Period|Other Reasons|0|||
94612888|NCT02598960|324047839|FG011|Treatment Period|Other Reasons|0|||
94612889|NCT02598960|324047840|FG012|Treatment Period|Other Reasons|1|||
94612890|NCT02598960|324047828|FG000|Participants Entering Follow Up Period|Death|1|||
94612891|NCT02598960|324047829|FG001|Participants Entering Follow Up Period|Death|0|||
94612892|NCT02598960|324047830|FG002|Participants Entering Follow Up Period|Death|0|||
94612893|NCT02598960|324047831|FG003|Participants Entering Follow Up Period|Death|0|||
94612894|NCT02598960|324047832|FG004|Participants Entering Follow Up Period|Death|0|||
94612895|NCT02598960|324047833|FG005|Participants Entering Follow Up Period|Death|0|||
94612896|NCT02598960|324047834|FG006|Participants Entering Follow Up Period|Death|0|||
94612897|NCT02598960|324047835|FG007|Participants Entering Follow Up Period|Death|0|||
94612898|NCT02598960|324047836|FG008|Participants Entering Follow Up Period|Death|0|||
94664101|NCT01261611|324227013|FG002|Treatment Cycle 2|Completed study|0|||
94664102|NCT01261611|324227011|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
94664103|NCT01261611|324227012|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
94664104|NCT01261611|324227013|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
94664105|NCT01261611|324227011|FG000|Treatment Cycle 2|Adverse Event|1|||
94664106|NCT01261611|324227012|FG001|Treatment Cycle 2|Adverse Event|0|||
94664107|NCT01261611|324227013|FG002|Treatment Cycle 2|Adverse Event|0|||
94664108|NCT01261611|324227011|FG000|Treatment Cycle 2|Protocol Violation|2|||
94358608|NCT03110107|323096443|FG013|Treatment Period|Participants no longer meets study criteria|0|||
94612899|NCT02598960|324047837|FG009|Participants Entering Follow Up Period|Death|1|||
94612900|NCT02598960|324047838|FG010|Participants Entering Follow Up Period|Death|0|||
94612901|NCT02598960|324047839|FG011|Participants Entering Follow Up Period|Death|11|||
94612902|NCT02598960|324047840|FG012|Participants Entering Follow Up Period|Death|2|||
94612903|NCT02598960|324047828|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
94612904|NCT02598960|324047829|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
94612905|NCT02598960|324047830|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
94612906|NCT02598960|324047831|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
94612907|NCT02598960|324047832|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
94612908|NCT02598960|324047833|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
94612909|NCT02598960|324047834|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
94612910|NCT02598960|324047835|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
94612911|NCT02598960|324047836|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
94612912|NCT02598960|324047837|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
94612913|NCT02598960|324047838|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
94612914|NCT02598960|324047839|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
94612915|NCT02598960|324047840|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
94612916|NCT02598960|324047828|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
94612917|NCT02598960|324047829|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
94612918|NCT02598960|324047830|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
94612919|NCT02598960|324047831|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
94612920|NCT02598960|324047832|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
94612921|NCT02598960|324047833|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
94612922|NCT02598960|324047834|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
94612923|NCT02598960|324047835|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
94612924|NCT02598960|324047836|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
94612925|NCT02598960|324047837|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
94612926|NCT02598960|324047838|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
94612927|NCT02598960|324047839|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
94612928|NCT02598960|324047840|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
94612929|NCT02598960|324047828|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
94612930|NCT02598960|324047829|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
94612931|NCT02598960|324047830|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
94612932|NCT02598960|324047831|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
94612933|NCT02598960|324047832|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
94612934|NCT02598960|324047833|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
94612935|NCT02598960|324047834|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
94612936|NCT02598960|324047835|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
94612937|NCT02598960|324047836|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
94664109|NCT01261611|324227012|FG001|Treatment Cycle 2|Protocol Violation|0|||
94664110|NCT01261611|324227013|FG002|Treatment Cycle 2|Protocol Violation|0|||
94664111|NCT01261611|324227011|FG000|Treatment Cycle 2|Not otherwise specified|2|||
94664112|NCT01261611|324227012|FG001|Treatment Cycle 2|Not otherwise specified|0|||
94664113|NCT01261611|324227013|FG002|Treatment Cycle 2|Not otherwise specified|0|||
94664114|NCT01261611|324227011|FG000|Treatment Cycle 3|Completed study|24|||
94664115|NCT01261611|324227012|FG001|Treatment Cycle 3|Completed study|0|||
94664116|NCT01261611|324227013|FG002|Treatment Cycle 3|Completed study|0|||
94664117|NCT01261611|324227011|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
94664118|NCT01261611|324227012|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
94664119|NCT01261611|324227013|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
94664120|NCT01261611|324227011|FG000|Treatment Cycle 3|Adverse Event|1|||
94664121|NCT01261611|324227012|FG001|Treatment Cycle 3|Adverse Event|0|||
94664122|NCT01261611|324227013|FG002|Treatment Cycle 3|Adverse Event|0|||
94664123|NCT01261611|324227011|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
94664124|NCT01261611|324227012|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
94664125|NCT01261611|324227013|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
94664126|NCT01261611|324227011|FG000|Treatment Cycle 4|Completed study|87|||
94664127|NCT01261611|324227012|FG001|Treatment Cycle 4|Completed study|0|||
94664128|NCT01261611|324227013|FG002|Treatment Cycle 4|Completed study|0|||
94664129|NCT01261611|324227011|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
94664130|NCT01261611|324227012|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
94664131|NCT01261611|324227013|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
94664132|NCT01261611|324227011|FG000|Treatment Cycle 4|Adverse Event|1|||
94664133|NCT01261611|324227012|FG001|Treatment Cycle 4|Adverse Event|0|||
94664134|NCT01261611|324227013|FG002|Treatment Cycle 4|Adverse Event|0|||
94664135|NCT01261611|324227011|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
94664136|NCT01261611|324227012|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
94664137|NCT01261611|324227013|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
94664138|NCT01261611|324227011|FG000|Treatment Cycle 4|Not otherwise specified|3|||
94664139|NCT01261611|324227012|FG001|Treatment Cycle 4|Not otherwise specified|0|||
94664140|NCT01261611|324227013|FG002|Treatment Cycle 4|Not otherwise specified|0|||
94664141|NCT01261611|324227011|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
94664142|NCT01261611|324227012|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
94664143|NCT01261611|324227013|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
94664144|NCT01261611|324227011|FG000|Treatment Cycle 5|Adverse Event|1|||
94664145|NCT01261611|324227012|FG001|Treatment Cycle 5|Adverse Event|0|||
94664146|NCT01261611|324227013|FG002|Treatment Cycle 5|Adverse Event|0|||
94664147|NCT01261611|324227011|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
94664148|NCT01261611|324227012|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
94664149|NCT01261611|324227013|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
94664150|NCT02527798|324227014|FG000|Overall Study|Physician Decision|1|||
94664151|NCT02527798|324227015|FG001|Overall Study|Physician Decision|0|||
94664152|NCT02527798|324227016|FG002|Overall Study|Physician Decision|1|||
94664153|NCT02527798|324227017|FG003|Overall Study|Physician Decision|1|||
94664154|NCT02527798|324227018|FG004|Overall Study|Physician Decision|0|||
94664155|NCT02527798|324227019|FG005|Overall Study|Physician Decision|0|||
94664156|NCT02527798|324227014|FG000|Overall Study|Death|0|||
94664157|NCT02527798|324227015|FG001|Overall Study|Death|0|||
94664158|NCT02527798|324227016|FG002|Overall Study|Death|1|||
94664159|NCT02527798|324227017|FG003|Overall Study|Death|0|||
94664160|NCT02527798|324227018|FG004|Overall Study|Death|0|||
94459840|NCT00655733|323471937|FG001|Overall Study|Adverse Event|2|||
94612938|NCT02598960|324047837|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
94612939|NCT02598960|324047838|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
94612940|NCT02598960|324047839|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
94612941|NCT02598960|324047840|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
94612942|NCT02598960|324047828|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
94612943|NCT02598960|324047829|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
94612944|NCT02598960|324047830|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
94612945|NCT02598960|324047831|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
94612946|NCT02598960|324047832|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
94612947|NCT02598960|324047833|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
94612948|NCT02598960|324047834|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
94612949|NCT02598960|324047835|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
94612950|NCT02598960|324047836|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
94612951|NCT02598960|324047837|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
94612952|NCT02598960|324047838|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
94612953|NCT02598960|324047839|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
94612954|NCT02598960|324047840|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
94612955|NCT03693300|324047842|FG000|Overall Study|Withdrawal by Subject|6|||
94612956|NCT03693300|324047843|FG001|Overall Study|Withdrawal by Subject|0|||
94612957|NCT03693300|324047842|FG000|Overall Study|Death|50|||
94612958|NCT03693300|324047843|FG001|Overall Study|Death|2|||
94612959|NCT03693300|324047842|FG000|Overall Study|Lost to Follow-up|2|||
94612960|NCT03693300|324047843|FG001|Overall Study|Lost to Follow-up|0|||
94612961|NCT00150709|324047844|FG000|Overall Study|Protocol Violation|7|||
94612962|NCT00150709|324047845|FG001|Overall Study|Protocol Violation|8|||
94612963|NCT00150709|324047846|FG002|Overall Study|Protocol Violation|3|||
94612964|NCT00150709|324047847|FG003|Overall Study|Protocol Violation|1|||
94612965|NCT00150709|324047844|FG000|Overall Study|Adverse Event|8|||
94612966|NCT00150709|324047845|FG001|Overall Study|Adverse Event|2|||
94612967|NCT00150709|324047846|FG002|Overall Study|Adverse Event|2|||
94612968|NCT00150709|324047847|FG003|Overall Study|Adverse Event|3|||
94612969|NCT00150709|324047844|FG000|Overall Study|Lack of Efficacy|6|||
94612970|NCT00150709|324047845|FG001|Overall Study|Lack of Efficacy|11|||
94612971|NCT00150709|324047846|FG002|Overall Study|Lack of Efficacy|9|||
94612972|NCT00150709|324047847|FG003|Overall Study|Lack of Efficacy|0|||
94612973|NCT00150709|324047844|FG000|Overall Study|Withdrawal by Subject|7|||
94612974|NCT00150709|324047845|FG001|Overall Study|Withdrawal by Subject|10|||
94612975|NCT00150709|324047846|FG002|Overall Study|Withdrawal by Subject|5|||
94612976|NCT00150709|324047847|FG003|Overall Study|Withdrawal by Subject|0|||
94612977|NCT00150709|324047844|FG000|Overall Study|Lost to Follow-up|3|||
94612978|NCT00150709|324047845|FG001|Overall Study|Lost to Follow-up|2|||
94612979|NCT00150709|324047846|FG002|Overall Study|Lost to Follow-up|0|||
94612980|NCT00150709|324047847|FG003|Overall Study|Lost to Follow-up|0|||
94612981|NCT00150709|324047844|FG000|Overall Study|Sponsor decision|0|||
94612982|NCT00150709|324047845|FG001|Overall Study|Sponsor decision|0|||
94612983|NCT00150709|324047846|FG002|Overall Study|Sponsor decision|0|||
94612984|NCT00150709|324047847|FG003|Overall Study|Sponsor decision|1|||
94612985|NCT00150709|324047844|FG000|Overall Study|Site/Investigator discontinued the study|5|||
94612986|NCT00150709|324047845|FG001|Overall Study|Site/Investigator discontinued the study|5|||
94612987|NCT00150709|324047846|FG002|Overall Study|Site/Investigator discontinued the study|2|||
94612988|NCT00150709|324047847|FG003|Overall Study|Site/Investigator discontinued the study|0|||
94612989|NCT00150709|324047844|FG000|Overall Study|Decision of parent(s)|1|||
94612990|NCT00150709|324047845|FG001|Overall Study|Decision of parent(s)|2|||
94612991|NCT00150709|324047846|FG002|Overall Study|Decision of parent(s)|0|||
94612992|NCT00150709|324047847|FG003|Overall Study|Decision of parent(s)|0|||
94612993|NCT00150709|324047844|FG000|Overall Study|Decision of parent(s) and investigator|3|||
94612994|NCT00150709|324047845|FG001|Overall Study|Decision of parent(s) and investigator|0|||
94612995|NCT00150709|324047846|FG002|Overall Study|Decision of parent(s) and investigator|0|||
94612996|NCT00150709|324047847|FG003|Overall Study|Decision of parent(s) and investigator|0|||
94612997|NCT00150709|324047844|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
94664161|NCT02527798|324227019|FG005|Overall Study|Death|0|||
94664162|NCT02527798|324227014|FG000|Overall Study|Withdrawal by Subject|0|||
94612998|NCT00150709|324047845|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
94612999|NCT00150709|324047846|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
94613000|NCT00150709|324047847|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
94664163|NCT02527798|324227015|FG001|Overall Study|Withdrawal by Subject|1|||
94664164|NCT02527798|324227016|FG002|Overall Study|Withdrawal by Subject|2|||
94664165|NCT02527798|324227017|FG003|Overall Study|Withdrawal by Subject|0|||
94664166|NCT02527798|324227018|FG004|Overall Study|Withdrawal by Subject|0|||
94664167|NCT02527798|324227019|FG005|Overall Study|Withdrawal by Subject|0|||
94459841|NCT00655733|323471936|FG000|Overall Study|Withdrawal by Subject|3|||
94459842|NCT00655733|323471937|FG001|Overall Study|Withdrawal by Subject|3|||
94459843|NCT00655733|323471936|FG000|Overall Study|Physician Decision|0|||
94459844|NCT00655733|323471937|FG001|Overall Study|Physician Decision|1|||
94459845|NCT03640481|323471938|FG000|Overall Study|Death|14|||
94459846|NCT03640481|323471939|FG001|Overall Study|Death|14|||
94459847|NCT03640481|323471940|FG002|Overall Study|Death|0|||
94459848|NCT03640481|323471941|FG003|Overall Study|Death|0|||
94459849|NCT03640481|323471938|FG000|Overall Study|Lost to Follow-up|2|||
94459850|NCT03640481|323471939|FG001|Overall Study|Lost to Follow-up|0|||
94459851|NCT03640481|323471940|FG002|Overall Study|Lost to Follow-up|0|||
94459852|NCT03640481|323471941|FG003|Overall Study|Lost to Follow-up|0|||
94459853|NCT03640481|323471938|FG000|Overall Study|Site terminated by sponsor|1|||
94459854|NCT03640481|323471939|FG001|Overall Study|Site terminated by sponsor|3|||
94459855|NCT03640481|323471940|FG002|Overall Study|Site terminated by sponsor|0|||
94459856|NCT03640481|323471941|FG003|Overall Study|Site terminated by sponsor|0|||
94459857|NCT03640481|323471938|FG000|Overall Study|Study terminated by sponsor|29|||
94459858|NCT03640481|323471939|FG001|Overall Study|Study terminated by sponsor|42|||
94459859|NCT03640481|323471940|FG002|Overall Study|Study terminated by sponsor|1|||
94459860|NCT03640481|323471941|FG003|Overall Study|Study terminated by sponsor|0|||
94459861|NCT03640481|323471938|FG000|Overall Study|Withdrawal by Subject|5|||
94459862|NCT03640481|323471939|FG001|Overall Study|Withdrawal by Subject|4|||
94459863|NCT03640481|323471940|FG002|Overall Study|Withdrawal by Subject|0|||
94459864|NCT03640481|323471941|FG003|Overall Study|Withdrawal by Subject|1|||
94459865|NCT03640481|323471938|FG000|Overall Study|Other|26|||
94459866|NCT03640481|323471939|FG001|Overall Study|Other|12|||
94459867|NCT03640481|323471940|FG002|Overall Study|Other|1|||
94459868|NCT03640481|323471941|FG003|Overall Study|Other|0|||
94459869|NCT03640481|323471938|FG000|Overall Study|Randomized, but not treated|1|||
94459870|NCT03640481|323471939|FG001|Overall Study|Randomized, but not treated|3|||
94459871|NCT03640481|323471940|FG002|Overall Study|Randomized, but not treated|0|||
94459872|NCT03640481|323471941|FG003|Overall Study|Randomized, but not treated|0|||
94459873|NCT01252563|323471943|FG000|Overall Study|Contract Deviation|41|||
94459874|NCT01252563|323471943|FG000|Overall Study|Centralized Registration Deviation|30|||
94459875|NCT01252563|323471943|FG000|Overall Study|Lost to Follow-up|161|||
94459876|NCT01252563|323471943|FG000|Overall Study|No visit after first day of treatment|194|||
94459877|NCT01252563|323471943|FG000|Overall Study|No drug administration|6|||
94459878|NCT05036668|323471952|FG000|Overall Study|lost to follow Up|0|||
94459879|NCT05036668|323471953|FG001|Overall Study|lost to follow Up|0|||
94459880|NCT05036668|323471954|FG002|Overall Study|lost to follow Up|1|||
94459881|NCT00387010|323471956|FG000|Dose Titration Period|Adverse Event|12|||
94459882|NCT00387010|323471956|FG000|Dose Titration Period|Lack of Efficacy|5|||
94459883|NCT00387010|323471956|FG000|Dose Titration Period|Withdrawal by Subject|3|||
94459884|NCT00387010|323471956|FG000|Dose Titration Period|Protocol Violation|1|||
94459885|NCT00387010|323471956|FG000|Dose Titration Period|Lost to Follow-up|2|||
94459886|NCT00387010|323471956|FG000|Dose Titration Period|Noncompliance with study medication|8|||
94459887|NCT00387010|323471956|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
94459888|NCT00387010|323471956|FG000|Treatment Period|Adverse Event|4|||
94459889|NCT00387010|323471956|FG000|Treatment Period|Withdrawal by Subject|1|||
94664168|NCT02527798|324227014|FG000|Overall Study|Reason undisclosed|1|||
94664169|NCT02527798|324227015|FG001|Overall Study|Reason undisclosed|0|||
94664170|NCT02527798|324227016|FG002|Overall Study|Reason undisclosed|1|||
94664171|NCT02527798|324227017|FG003|Overall Study|Reason undisclosed|0|||
94664172|NCT02527798|324227018|FG004|Overall Study|Reason undisclosed|0|||
94664173|NCT02527798|324227019|FG005|Overall Study|Reason undisclosed|0|||
94664174|NCT02527798|324227014|FG000|Overall Study|Did not receive intervention|1|||
94664175|NCT02527798|324227015|FG001|Overall Study|Did not receive intervention|1|||
94664176|NCT02527798|324227016|FG002|Overall Study|Did not receive intervention|0|||
94664177|NCT02527798|324227017|FG003|Overall Study|Did not receive intervention|0|||
94664178|NCT02527798|324227018|FG004|Overall Study|Did not receive intervention|0|||
94664179|NCT02527798|324227019|FG005|Overall Study|Did not receive intervention|0|||
94664180|NCT00074282|324227024|FG000|Step 1|Adverse Event|32|||
94664181|NCT00074282|324227025|FG001|Step 1|Adverse Event|0|||
94664182|NCT00074282|324227026|FG002|Step 1|Adverse Event|0|||
94664183|NCT00074282|324227024|FG000|Step 1|Death|6|||
94664184|NCT00074282|324227025|FG001|Step 1|Death|0|||
94664185|NCT00074282|324227026|FG002|Step 1|Death|0|||
94664186|NCT00074282|324227024|FG000|Step 1|Withdrawal by Subject|7|||
94664187|NCT00074282|324227025|FG001|Step 1|Withdrawal by Subject|0|||
94664188|NCT00074282|324227026|FG002|Step 1|Withdrawal by Subject|0|||
94664189|NCT00074282|324227024|FG000|Step 1|Disease progression|2|||
94664190|NCT00074282|324227025|FG001|Step 1|Disease progression|0|||
94664191|NCT00074282|324227026|FG002|Step 1|Disease progression|0|||
94664192|NCT00074282|324227024|FG000|Step 1|Alternative therapy|2|||
94664193|NCT00074282|324227025|FG001|Step 1|Alternative therapy|0|||
94664194|NCT00074282|324227026|FG002|Step 1|Alternative therapy|0|||
94664195|NCT00074282|324227024|FG000|Step 1|Other complicating disease|2|||
94664196|NCT00074282|324227025|FG001|Step 1|Other complicating disease|0|||
94664197|NCT00074282|324227026|FG002|Step 1|Other complicating disease|0|||
94664198|NCT00074282|324227024|FG000|Step 1|Physician Decision|1|||
94664199|NCT00074282|324227025|FG001|Step 1|Physician Decision|0|||
94664200|NCT00074282|324227026|FG002|Step 1|Physician Decision|0|||
94664201|NCT00074282|324227024|FG000|Step 1|Ineligible|4|||
94664202|NCT00074282|324227025|FG001|Step 1|Ineligible|0|||
94664203|NCT00074282|324227026|FG002|Step 1|Ineligible|0|||
94664204|NCT00074282|324227024|FG000|Step 1|Never started treatment|2|||
94664205|NCT00074282|324227025|FG001|Step 1|Never started treatment|0|||
94664206|NCT00074282|324227026|FG002|Step 1|Never started treatment|0|||
94664207|NCT00074282|324227024|FG000|Step 2|Adverse Event|0|||
94664208|NCT00074282|324227025|FG001|Step 2|Adverse Event|2|||
94664209|NCT00074282|324227026|FG002|Step 2|Adverse Event|12|||
94664210|NCT00074282|324227024|FG000|Step 2|Disease progression|0|||
94664211|NCT00074282|324227025|FG001|Step 2|Disease progression|0|||
94664212|NCT00074282|324227026|FG002|Step 2|Disease progression|5|||
94664213|NCT00074282|324227024|FG000|Step 2|Death|0|||
94664214|NCT00074282|324227025|FG001|Step 2|Death|0|||
94664215|NCT00074282|324227026|FG002|Step 2|Death|3|||
94664216|NCT00074282|324227024|FG000|Step 2|Withdrawal by Subject|0|||
94664217|NCT00074282|324227025|FG001|Step 2|Withdrawal by Subject|0|||
94664218|NCT00074282|324227026|FG002|Step 2|Withdrawal by Subject|2|||
94664219|NCT00074282|324227024|FG000|Step 2|Physician Decision|0|||
94664220|NCT00074282|324227025|FG001|Step 2|Physician Decision|0|||
94664221|NCT00074282|324227026|FG002|Step 2|Physician Decision|1|||
94664222|NCT00074282|324227024|FG000|Step 2|Ineligible|0|||
94664223|NCT00074282|324227025|FG001|Step 2|Ineligible|0|||
94664224|NCT00074282|324227026|FG002|Step 2|Ineligible|1|||
94664225|NCT01682460|324227028|FG000|Overall Study|Withdrawal by Subject|2|||
94664226|NCT01682460|324227028|FG000|Overall Study|Did not meet inclusion criteria|2|||
94664227|NCT00920426|324227029|FG000|ITZ111451|Adverse Event|1|||
94664228|NCT00920426|324227030|FG001|ITZ111451|Adverse Event|0|||
94664229|NCT00920426|324227031|FG002|ITZ111451|Adverse Event|0|||
94664230|NCT00920426|324227032|FG003|ITZ111451|Adverse Event|0|||
94358609|NCT03110107|323096444|FG014|Treatment Period|Participants no longer meets study criteria|0|||
94664231|NCT01808690|324227035|FG000|Overall Study|Withdrawal by Subject|1|||
94664232|NCT01808690|324227036|FG001|Overall Study|Withdrawal by Subject|2|||
94664233|NCT00489970|324227037|FG000|Persistence Year 9|Lost to Follow-up|2|||
94664234|NCT00489970|324227038|FG001|Persistence Year 9|Lost to Follow-up|2|||
94664235|NCT00489970|324227039|FG002|Persistence Year 9|Lost to Follow-up|3|||
94664236|NCT00489970|324227037|FG000|Persistence Year 9|Other|1|||
94664237|NCT00489970|324227038|FG001|Persistence Year 9|Other|0|||
94664238|NCT00489970|324227039|FG002|Persistence Year 9|Other|2|||
94664239|NCT02891187|324227040|FG000|Overall Study|Lost to Follow-up|1|||
94664240|NCT02891187|324227041|FG001|Overall Study|Lost to Follow-up|2|||
94664241|NCT03836053|324227042|FG000|Overall Study|Protocol-specified criteria|0|||
94664242|NCT03836053|324227043|FG001|Overall Study|Protocol-specified criteria|2|||
94664243|NCT03836053|324227044|FG002|Overall Study|Protocol-specified criteria|1|||
94664244|NCT03836053|324227042|FG000|Overall Study|Death|1|||
94664245|NCT03836053|324227043|FG001|Overall Study|Death|6|||
94664246|NCT03836053|324227044|FG002|Overall Study|Death|4|||
94664247|NCT03836053|324227042|FG000|Overall Study|Withdrawal of consent from study|0|||
94613001|NCT00150709|324047844|FG000|Overall Study|Investigator decision|1|||
94613002|NCT00150709|324047845|FG001|Overall Study|Investigator decision|0|||
94613003|NCT00150709|324047846|FG002|Overall Study|Investigator decision|0|||
94613004|NCT00150709|324047847|FG003|Overall Study|Investigator decision|1|||
94613005|NCT00150709|324047844|FG000|Overall Study|Subject relocated|2|||
94613006|NCT00150709|324047845|FG001|Overall Study|Subject relocated|2|||
94613007|NCT00150709|324047846|FG002|Overall Study|Subject relocated|1|||
94613008|NCT00150709|324047847|FG003|Overall Study|Subject relocated|0|||
94613009|NCT00150709|324047844|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
94613010|NCT00150709|324047845|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
94613011|NCT00150709|324047846|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
94613012|NCT00150709|324047847|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
94664248|NCT03836053|324227043|FG001|Overall Study|Withdrawal of consent from study|0|||
94664249|NCT03836053|324227044|FG002|Overall Study|Withdrawal of consent from study|1|||
94664250|NCT03836053|324227042|FG000|Overall Study|Decision by sponsor|0|||
94664251|NCT03836053|324227043|FG001|Overall Study|Decision by sponsor|2|||
94664252|NCT03836053|324227044|FG002|Overall Study|Decision by sponsor|4|||
94664253|NCT04546581|324227047|FG000|Overall Study|Adverse Event|9|||
94664254|NCT04546581|324227048|FG001|Overall Study|Adverse Event|3|||
94664255|NCT04546581|324227047|FG000|Overall Study|Physician Decision|0|||
94664256|NCT04546581|324227048|FG001|Overall Study|Physician Decision|1|||
94664257|NCT04546581|324227047|FG000|Overall Study|Protocol Violation|1|||
94664258|NCT04546581|324227048|FG001|Overall Study|Protocol Violation|2|||
94664259|NCT04546581|324227047|FG000|Overall Study|Withdrawal by Subject|3|||
94664260|NCT04546581|324227048|FG001|Overall Study|Withdrawal by Subject|7|||
94664261|NCT02492100|324227049|FG000|Overall Study|Death|1|||
94664262|NCT00902304|324227050|FG000|Overall Study|Adverse Event|4|||
94664263|NCT00902304|324227051|FG001|Overall Study|Adverse Event|10|||
94664264|NCT00902304|324227052|FG002|Overall Study|Adverse Event|25|||
94664265|NCT00902304|324227050|FG000|Overall Study|Investigator discretion|3|||
94664266|NCT00902304|324227051|FG001|Overall Study|Investigator discretion|5|||
94664267|NCT00902304|324227052|FG002|Overall Study|Investigator discretion|13|||
94664268|NCT00902304|324227050|FG000|Overall Study|Lost to Follow-up|7|||
94664269|NCT00902304|324227051|FG001|Overall Study|Lost to Follow-up|7|||
94664270|NCT00902304|324227052|FG002|Overall Study|Lost to Follow-up|7|||
94664271|NCT00902304|324227050|FG000|Overall Study|Protocol Violation|9|||
94664272|NCT00902304|324227051|FG001|Overall Study|Protocol Violation|18|||
94664273|NCT00902304|324227052|FG002|Overall Study|Protocol Violation|20|||
94664274|NCT00902304|324227050|FG000|Overall Study|Withdrawal by Subject|32|||
94664275|NCT00902304|324227051|FG001|Overall Study|Withdrawal by Subject|22|||
94664276|NCT00902304|324227052|FG002|Overall Study|Withdrawal by Subject|43|||
94664277|NCT00902304|324227050|FG000|Overall Study|includes pregnancy|3|||
94664278|NCT00902304|324227051|FG001|Overall Study|includes pregnancy|9|||
94664279|NCT00902304|324227052|FG002|Overall Study|includes pregnancy|2|||
94664280|NCT02508311|324227055|FG000|Overall Study|Withdrawal by Subject|1|||
94664281|NCT02508311|324227056|FG001|Overall Study|Withdrawal by Subject|0|||
94664282|NCT04955639|324227059|FG000|Overall Study|Withdrawal by Subject|2|||
94664283|NCT04955639|324227060|FG001|Overall Study|Withdrawal by Subject|2|||
94664284|NCT04955639|324227059|FG000|Overall Study|Week 26 survey not completed|2|||
94664285|NCT04955639|324227060|FG001|Overall Study|Week 26 survey not completed|2|||
94613013|NCT00150709|324047844|FG000|Overall Study|Convenience|0|||
94664286|NCT02097472|324227061|FG000|Received Vaccination 2|Adverse Event|0|||
94664287|NCT02097472|324227062|FG001|Received Vaccination 2|Adverse Event|0|||
94664288|NCT02097472|324227063|FG002|Received Vaccination 2|Adverse Event|0|||
94664289|NCT02097472|324227064|FG003|Received Vaccination 2|Adverse Event|0|||
94664290|NCT02097472|324227065|FG004|Received Vaccination 2|Adverse Event|0|||
94664291|NCT02097472|324227066|FG005|Received Vaccination 2|Adverse Event|0|||
94664292|NCT02097472|324227067|FG006|Received Vaccination 2|Adverse Event|1|||
94664293|NCT02097472|324227068|FG007|Received Vaccination 2|Adverse Event|0|||
94664294|NCT04969250|324227071|FG000|Overall Study|Protocol Violation|0|||
94664295|NCT04969250|324227072|FG001|Overall Study|Protocol Violation|2|||
94664296|NCT04969250|324227073|FG002|Overall Study|Protocol Violation|3|||
94664297|NCT04969250|324227074|FG003|Overall Study|Protocol Violation|8|||
94664298|NCT04969250|324227071|FG000|Overall Study|Withdrawal by Subject|0|||
94664299|NCT04969250|324227072|FG001|Overall Study|Withdrawal by Subject|1|||
94664300|NCT04969250|324227073|FG002|Overall Study|Withdrawal by Subject|0|||
94664301|NCT04969250|324227074|FG003|Overall Study|Withdrawal by Subject|0|||
94664302|NCT03834779|324227075|FG000|Overall Study|Death|1|||
94613014|NCT00150709|324047845|FG001|Overall Study|Convenience|1|||
94664303|NCT03834779|324227076|FG001|Overall Study|Death|2|||
94613015|NCT00150709|324047846|FG002|Overall Study|Convenience|0|||
94613016|NCT00150709|324047847|FG003|Overall Study|Convenience|0|||
94613017|NCT00150709|324047844|FG000|Overall Study|Subject entered new drug study|0|||
94613018|NCT00150709|324047845|FG001|Overall Study|Subject entered new drug study|1|||
94613019|NCT00150709|324047846|FG002|Overall Study|Subject entered new drug study|0|||
94613020|NCT00150709|324047847|FG003|Overall Study|Subject entered new drug study|0|||
94613021|NCT00150709|324047844|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
94613022|NCT00150709|324047845|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
94613023|NCT00150709|324047846|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
94613024|NCT00150709|324047847|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
94613025|NCT00150709|324047844|FG000|Overall Study|Lack of ease of swallowing|0|||
94613026|NCT00150709|324047845|FG001|Overall Study|Lack of ease of swallowing|1|||
94613027|NCT00150709|324047846|FG002|Overall Study|Lack of ease of swallowing|0|||
94613028|NCT00150709|324047847|FG003|Overall Study|Lack of ease of swallowing|0|||
94613029|NCT01846104|324047848|FG000|Overall Study|Withdrawal by Subject|1|||
94613030|NCT02349061|324047852|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
94613031|NCT02349061|324047853|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
94613032|NCT02349061|324047854|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
94613033|NCT02349061|324047852|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
94664304|NCT03834779|324227075|FG000|Overall Study|Lost to Follow-up|6|||
94664305|NCT03834779|324227076|FG001|Overall Study|Lost to Follow-up|4|||
94664306|NCT04139317|324227077|FG000|Overall Study|Adverse Event|10|||
94664307|NCT04139317|324227078|FG001|Overall Study|Adverse Event|2|||
94664308|NCT04139317|324227077|FG000|Overall Study|Death|6|||
94664309|NCT04139317|324227078|FG001|Overall Study|Death|4|||
94664310|NCT04139317|324227077|FG000|Overall Study|Lost to Follow-up|1|||
94664311|NCT04139317|324227078|FG001|Overall Study|Lost to Follow-up|0|||
94664312|NCT04139317|324227077|FG000|Overall Study|Physician Decision|3|||
94664313|NCT04139317|324227078|FG001|Overall Study|Physician Decision|1|||
94664314|NCT04139317|324227077|FG000|Overall Study|Progressive Disease|19|||
94664315|NCT04139317|324227078|FG001|Overall Study|Progressive Disease|9|||
94664316|NCT04139317|324227077|FG000|Overall Study|Subject Decision|2|||
94664317|NCT04139317|324227078|FG001|Overall Study|Subject Decision|2|||
94664318|NCT03595904|324227084|FG000|Overall Study|Protocol Violation|3|||
94664319|NCT03595904|324227085|FG001|Overall Study|Protocol Violation|1|||
94664320|NCT03595904|324227084|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
94664321|NCT03595904|324227085|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
94664322|NCT03595904|324227084|FG000|Overall Study|Insurance complications|1|||
94664323|NCT03595904|324227085|FG001|Overall Study|Insurance complications|0|||
94664324|NCT03595904|324227084|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
94664325|NCT03595904|324227085|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
94664326|NCT01618838|324227086|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
94664327|NCT01939028|324227087|FG000|Overall Study|Withdrawal by Subject|5|||
94664328|NCT01939028|324227087|FG000|Overall Study|Physician Decision|7|||
94664329|NCT00700401|324227092|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
94664330|NCT00700401|324227092|FG000|Overall Study|Adverse Event|5|||
94664331|NCT00700401|324227092|FG000|Overall Study|Refused Treatment|2|||
94358610|NCT03110107|323096445|FG015|Treatment Period|Participants no longer meets study criteria|0|||
94358611|NCT03110107|323096446|FG016|Treatment Period|Participants no longer meets study criteria|0|||
94613034|NCT02349061|324047853|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
94613035|NCT02349061|324047854|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
94613036|NCT02349061|324047852|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
94613037|NCT02349061|324047853|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
94613038|NCT02349061|324047854|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
94613039|NCT02349061|324047852|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
94613040|NCT02349061|324047853|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
94613041|NCT02349061|324047854|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
94613042|NCT02349061|324047852|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
94613043|NCT02349061|324047853|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
94613044|NCT02349061|324047854|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
94613045|NCT02349061|324047852|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
94613046|NCT02349061|324047853|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
94613047|NCT02349061|324047854|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
94613048|NCT02349061|324047852|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
94613049|NCT02349061|324047853|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
94613050|NCT02349061|324047854|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
94613051|NCT02349061|324047852|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
94613052|NCT02349061|324047853|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
94613053|NCT02349061|324047854|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
94613054|NCT02349061|324047852|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
94613055|NCT02349061|324047853|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
94613056|NCT02349061|324047854|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
94613057|NCT02349061|324047852|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
94613058|NCT02349061|324047853|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
94613059|NCT02349061|324047854|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
94613060|NCT02349061|324047852|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
94613061|NCT02349061|324047853|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
94664332|NCT00700401|324227092|FG000|Overall Study|Lost to Follow-up|1|||
94664333|NCT00700401|324227092|FG000|Overall Study|Treatment never started|1|||
94664334|NCT00700401|324227092|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
94613062|NCT02349061|324047854|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
94613063|NCT02349061|324047852|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
94613064|NCT02349061|324047853|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
94613065|NCT02349061|324047854|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
94613066|NCT02349061|324047852|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
94664335|NCT00700401|324227092|FG000|Overall Study|Withdrawal by Subject|2|||
94664336|NCT03273946|324227093|FG000|Overall Study|Withdrawal by Subject|5|||
94664337|NCT03273946|324227093|FG000|Overall Study|Unwillingness of the guardian|1|||
94664338|NCT03273946|324227093|FG000|Overall Study|Participant refused to use the drug|2|||
94664339|NCT03273946|324227093|FG000|Overall Study|Participant relative refused to use drug|1|||
94664340|NCT01650259|324227094|FG000|Overall Study|Improvement|105|||
94664341|NCT01650259|324227095|FG001|Overall Study|Improvement|0|||
94664342|NCT01650259|324227094|FG000|Overall Study|Adverse Event|127|||
94664343|NCT01650259|324227095|FG001|Overall Study|Adverse Event|0|||
94664344|NCT01650259|324227094|FG000|Overall Study|Lack of Efficacy|143|||
94664345|NCT01650259|324227095|FG001|Overall Study|Lack of Efficacy|0|||
94664346|NCT01650259|324227094|FG000|Overall Study|Lost to Follow-up|435|||
94664347|NCT01650259|324227095|FG001|Overall Study|Lost to Follow-up|0|||
94664348|NCT01650259|324227094|FG000|Overall Study|Patients had no visit after entry|70|||
94664349|NCT01650259|324227095|FG001|Overall Study|Patients had no visit after entry|0|||
94664350|NCT01650259|324227094|FG000|Overall Study|CRF not collected|98|||
94664351|NCT01650259|324227095|FG001|Overall Study|CRF not collected|82|||
94664352|NCT01650259|324227094|FG000|Overall Study|Not treated|1|||
94664353|NCT01650259|324227095|FG001|Overall Study|Not treated|7|||
94664354|NCT01650259|324227094|FG000|Overall Study|Other than listed|64|||
94664355|NCT01650259|324227095|FG001|Overall Study|Other than listed|146|||
94664356|NCT00092131|324227096|FG000|Treatment Period I|Adverse Event|1|||
94664357|NCT00092131|324227097|FG001|Treatment Period I|Adverse Event|0|||
94664358|NCT00092131|324227096|FG000|Treatment Period II|Adverse Event|0|||
94664359|NCT00092131|324227097|FG001|Treatment Period II|Adverse Event|1|||
94664360|NCT02576067|324227099|FG000|Overall Study|Death|0|||
94664361|NCT02576067|324227100|FG001|Overall Study|Death|1|||
94664362|NCT02576067|324227099|FG000|Overall Study|Lack of Efficacy|1|||
94664363|NCT02576067|324227100|FG001|Overall Study|Lack of Efficacy|0|||
94664364|NCT02576067|324227099|FG000|Overall Study|Lost to Follow-up|11|||
94664365|NCT02576067|324227100|FG001|Overall Study|Lost to Follow-up|0|||
94664366|NCT02576067|324227099|FG000|Overall Study|Withdrawal by Subject|11|||
94664367|NCT02576067|324227100|FG001|Overall Study|Withdrawal by Subject|2|||
94664368|NCT02576067|324227099|FG000|Overall Study|study closure of main CIRT trial)|0|||
94664369|NCT02576067|324227100|FG001|Overall Study|study closure of main CIRT trial)|8|||
94664370|NCT02576067|324227099|FG000|Overall Study|not randomized, failed run-in|7|||
94664371|NCT02576067|324227100|FG001|Overall Study|not randomized, failed run-in|0|||
94664372|NCT02576067|324227099|FG000|Overall Study|screen failure/ re-enrolled|0|||
94664373|NCT02576067|324227100|FG001|Overall Study|screen failure/ re-enrolled|25|||
94664374|NCT02576067|324227099|FG000|Overall Study|Physician Decision|4|||
94664375|NCT02576067|324227100|FG001|Overall Study|Physician Decision|0|||
94664376|NCT04323436|324227101|FG000|Overall Study|Adverse Event|7|||
94664377|NCT04323436|324227102|FG001|Overall Study|Adverse Event|0|||
94664378|NCT04323436|324227103|FG002|Overall Study|Adverse Event|0|||
94664379|NCT04323436|324227101|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
94664380|NCT04323436|324227102|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
94664381|NCT04323436|324227103|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
94613067|NCT02349061|324047853|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
94613068|NCT02349061|324047854|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
94459890|NCT00387010|323471956|FG000|Treatment Period|Noncompliance with study medication|2|||
94613069|NCT02339285|324047855|FG000|Overall Study|Withdrawal by Subject|0|||
94613070|NCT02339285|324047856|FG001|Overall Study|Withdrawal by Subject|1|||
94613071|NCT02339285|324047857|FG002|Overall Study|Withdrawal by Subject|1|||
94613072|NCT02339285|324047855|FG000|Overall Study|Lost to Follow-up|1|||
94613073|NCT02339285|324047856|FG001|Overall Study|Lost to Follow-up|1|||
94613074|NCT02339285|324047857|FG002|Overall Study|Lost to Follow-up|1|||
94613075|NCT02339285|324047855|FG000|Overall Study|Protocol Deviation|0|||
94613076|NCT02339285|324047856|FG001|Overall Study|Protocol Deviation|1|||
94613077|NCT02339285|324047857|FG002|Overall Study|Protocol Deviation|0|||
94613078|NCT01863953|324047862|FG000|Overall Study|Adverse Event|0|||
94613079|NCT01863953|324047863|FG001|Overall Study|Adverse Event|0|||
94613080|NCT01863953|324047864|FG002|Overall Study|Adverse Event|1|||
94613081|NCT00108433|324047865|FG000|Overall Study|Lack of Efficacy|1|||
94613082|NCT00108433|324047866|FG001|Overall Study|Lack of Efficacy|2|||
94613083|NCT00108433|324047865|FG000|Overall Study|Death|3|||
94613084|NCT00108433|324047866|FG001|Overall Study|Death|0|||
94613085|NCT00108433|324047865|FG000|Overall Study|Adverse Event|3|||
94613086|NCT00108433|324047866|FG001|Overall Study|Adverse Event|1|||
94613087|NCT00108433|324047865|FG000|Overall Study|Other|14|||
94613088|NCT00108433|324047866|FG001|Overall Study|Other|14|||
94613089|NCT02203071|324047867|FG000|Overall Study|Lost to Follow-up|3|||
94613090|NCT02203071|324047868|FG001|Overall Study|Lost to Follow-up|1|||
94613091|NCT04195906|324047871|FG000|Part 1|Adverse Event|3|||
94613092|NCT04195906|324047872|FG001|Part 1|Adverse Event|7|||
94613093|NCT04195906|324047871|FG000|Part 1|Withdrawal by Subject|0|||
94613094|NCT04195906|324047872|FG001|Part 1|Withdrawal by Subject|1|||
94613095|NCT04195906|324047871|FG000|Part 2|Adverse Event|1|||
94664382|NCT04323436|324227101|FG000|Overall Study|Death|1|||
94613096|NCT04195906|324047872|FG001|Part 2|Adverse Event|1|||
94664383|NCT04323436|324227102|FG001|Overall Study|Death|0|||
94613097|NCT04195906|324047871|FG000|Part 2|Withdrawal by Subject|0|||
94613098|NCT04195906|324047872|FG001|Part 2|Withdrawal by Subject|3|||
94613099|NCT04195906|324047871|FG000|Part 2|Other|1|||
94613100|NCT04195906|324047872|FG001|Part 2|Other|3|||
94613101|NCT02281773|324047875|FG000|Overall Study|Adverse Event|6|||
94613102|NCT02281773|324047876|FG001|Overall Study|Adverse Event|1|||
94664384|NCT04323436|324227103|FG002|Overall Study|Death|0|||
94664385|NCT04323436|324227101|FG000|Overall Study|Physician Decision|2|||
94664386|NCT04323436|324227102|FG001|Overall Study|Physician Decision|0|||
94664387|NCT04323436|324227103|FG002|Overall Study|Physician Decision|0|||
94664388|NCT04323436|324227101|FG000|Overall Study|Progressive disease|10|||
94664389|NCT04323436|324227102|FG001|Overall Study|Progressive disease|0|||
94664390|NCT04323436|324227103|FG002|Overall Study|Progressive disease|0|||
94664391|NCT04323436|324227101|FG000|Overall Study|Subject decision|3|||
94664392|NCT04323436|324227102|FG001|Overall Study|Subject decision|0|||
94664393|NCT04323436|324227103|FG002|Overall Study|Subject decision|0|||
94664394|NCT02372409|324227104|FG000|Overall Study|Lost to Follow-up|1|||
94664395|NCT02372409|324227105|FG001|Overall Study|Lost to Follow-up|0|||
94664396|NCT02372409|324227104|FG000|Overall Study|Disease progression|1|||
94664397|NCT02372409|324227105|FG001|Overall Study|Disease progression|1|||
94613103|NCT02281773|324047877|FG002|Overall Study|Adverse Event|4|||
94613104|NCT02281773|324047878|FG003|Overall Study|Adverse Event|8|||
94613105|NCT02281773|324047879|FG004|Overall Study|Adverse Event|9|||
94613106|NCT02281773|324047875|FG000|Overall Study|Protocol Violation|1|||
94613107|NCT02281773|324047876|FG001|Overall Study|Protocol Violation|0|||
94613108|NCT02281773|324047877|FG002|Overall Study|Protocol Violation|0|||
94613109|NCT02281773|324047878|FG003|Overall Study|Protocol Violation|2|||
94613110|NCT02281773|324047879|FG004|Overall Study|Protocol Violation|2|||
94613111|NCT02281773|324047875|FG000|Overall Study|Lost to Follow-up|2|||
94613112|NCT02281773|324047876|FG001|Overall Study|Lost to Follow-up|2|||
94613113|NCT02281773|324047877|FG002|Overall Study|Lost to Follow-up|6|||
94613114|NCT02281773|324047878|FG003|Overall Study|Lost to Follow-up|2|||
94613115|NCT02281773|324047879|FG004|Overall Study|Lost to Follow-up|10|||
94613116|NCT02281773|324047875|FG000|Overall Study|Withdrawal by Subject|2|||
94613117|NCT02281773|324047876|FG001|Overall Study|Withdrawal by Subject|8|||
94613118|NCT02281773|324047877|FG002|Overall Study|Withdrawal by Subject|6|||
94613119|NCT02281773|324047878|FG003|Overall Study|Withdrawal by Subject|6|||
94613120|NCT02281773|324047879|FG004|Overall Study|Withdrawal by Subject|8|||
94613121|NCT02281773|324047875|FG000|Overall Study|Other Reason|0|||
94664398|NCT04656847|324227107|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
94664399|NCT01196975|324227108|FG000|Overall Study|Adverse Event|2|||
94664400|NCT01196975|324227109|FG001|Overall Study|Adverse Event|2|||
94664401|NCT01196975|324227110|FG002|Overall Study|Adverse Event|0|||
94613122|NCT02281773|324047876|FG001|Overall Study|Other Reason|4|||
94613123|NCT02281773|324047877|FG002|Overall Study|Other Reason|2|||
94664402|NCT01196975|324227111|FG003|Overall Study|Adverse Event|0|||
94664403|NCT01196975|324227112|FG004|Overall Study|Adverse Event|2|||
94664404|NCT01196975|324227108|FG000|Overall Study|Withdrawal by Subject|2|||
94664405|NCT01196975|324227109|FG001|Overall Study|Withdrawal by Subject|1|||
94664406|NCT01196975|324227110|FG002|Overall Study|Withdrawal by Subject|0|||
94664407|NCT01196975|324227111|FG003|Overall Study|Withdrawal by Subject|1|||
94664408|NCT01196975|324227112|FG004|Overall Study|Withdrawal by Subject|0|||
94664409|NCT01196975|324227108|FG000|Overall Study|Lost to Follow-up|11|||
94664410|NCT01196975|324227109|FG001|Overall Study|Lost to Follow-up|6|||
94664411|NCT01196975|324227110|FG002|Overall Study|Lost to Follow-up|5|||
94664412|NCT01196975|324227111|FG003|Overall Study|Lost to Follow-up|5|||
94613124|NCT02281773|324047878|FG003|Overall Study|Other Reason|3|||
94613125|NCT02281773|324047879|FG004|Overall Study|Other Reason|1|||
94613126|NCT00371826|324047885|FG000|Core Phase (12 Months)|Adverse Event|15|||
94613127|NCT00371826|324047886|FG001|Core Phase (12 Months)|Adverse Event|4|||
94613128|NCT00371826|324047887|FG002|Core Phase (12 Months)|Adverse Event|9|||
94613129|NCT00371826|324047885|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
94664413|NCT01196975|324227112|FG004|Overall Study|Lost to Follow-up|11|||
94664414|NCT03277313|324227121|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
94664415|NCT03277313|324227122|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
94664416|NCT03277313|324227121|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
94664417|NCT03277313|324227122|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
94664418|NCT03277313|324227121|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
94664419|NCT03277313|324227122|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
94613130|NCT00371826|324047886|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
94613131|NCT00371826|324047887|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
94613132|NCT00371826|324047885|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
94613133|NCT00371826|324047886|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
94613134|NCT00371826|324047887|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
94613135|NCT00371826|324047885|FG000|Core Phase (12 Months)|Protocol Violation|1|||
94613136|NCT00371826|324047886|FG001|Core Phase (12 Months)|Protocol Violation|0|||
94613137|NCT00371826|324047887|FG002|Core Phase (12 Months)|Protocol Violation|1|||
94613138|NCT00371826|324047885|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
94664420|NCT03277313|324227121|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
94664421|NCT03277313|324227122|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
94664422|NCT03277313|324227121|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
94664423|NCT03277313|324227122|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
94664424|NCT02096900|324227127|FG000|Overall Study|Did not receive medication|3|||
94664425|NCT02096900|324227128|FG001|Overall Study|Did not receive medication|1|||
94664426|NCT02096900|324227127|FG000|Overall Study|Surgery cancelled- medication received|1|||
94459891|NCT00387010|323471956|FG000|Treatment Period|Noncompliance with study procedures|3|||
94613139|NCT00371826|324047886|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
94613140|NCT00371826|324047887|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
94613141|NCT00371826|324047885|FG000|Core Phase (12 Months)|Administrative problems|1|||
94613142|NCT00371826|324047886|FG001|Core Phase (12 Months)|Administrative problems|0|||
94613143|NCT00371826|324047887|FG002|Core Phase (12 Months)|Administrative problems|8|||
94613144|NCT00371826|324047885|FG000|Core Phase (12 Months)|Graft Loss|0|||
94613145|NCT00371826|324047886|FG001|Core Phase (12 Months)|Graft Loss|1|||
94613146|NCT00371826|324047887|FG002|Core Phase (12 Months)|Graft Loss|0|||
94613147|NCT00371826|324047885|FG000|Extension Phase (24 Months)|Adverse Event|4|||
94613148|NCT00371826|324047886|FG001|Extension Phase (24 Months)|Adverse Event|5|||
94613149|NCT00371826|324047887|FG002|Extension Phase (24 Months)|Adverse Event|0|||
94613150|NCT00371826|324047885|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
94358612|NCT03110107|323096447|FG017|Treatment Period|Participants no longer meets study criteria|0|||
94613151|NCT00371826|324047886|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
94613152|NCT00371826|324047887|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
94358613|NCT03110107|323096448|FG018|Treatment Period|Participants no longer meets study criteria|0|||
94358614|NCT03110107|323096449|FG019|Treatment Period|Participants no longer meets study criteria|0|||
94358615|NCT03110107|323096450|FG020|Treatment Period|Participants no longer meets study criteria|0|||
94613153|NCT00371826|324047885|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
94613154|NCT00371826|324047886|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
94613155|NCT00371826|324047887|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
94613156|NCT00371826|324047885|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
94613157|NCT00371826|324047886|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
94613158|NCT00371826|324047887|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
94613159|NCT00371826|324047885|FG000|Extension Phase (24 Months)|Administrative problems|0|||
94613160|NCT00371826|324047886|FG001|Extension Phase (24 Months)|Administrative problems|0|||
94613161|NCT00371826|324047887|FG002|Extension Phase (24 Months)|Administrative problems|2|||
94358616|NCT03110107|323096451|FG021|Treatment Period|Participants no longer meets study criteria|0|||
94358617|NCT03110107|323096452|FG022|Treatment Period|Participants no longer meets study criteria|0|||
94358618|NCT03110107|323096453|FG023|Treatment Period|Participants no longer meets study criteria|1|||
94358619|NCT03110107|323096454|FG024|Treatment Period|Participants no longer meets study criteria|0|||
94358620|NCT03110107|323096455|FG025|Treatment Period|Participants no longer meets study criteria|0|||
94358621|NCT03110107|323096430|FG000|Treatment Period|Other Reasons|0|||
94613162|NCT00734474|324047888|FG000|Overall Study|Entry Criteria Not Met|0|||
94664427|NCT02096900|324227128|FG001|Overall Study|Surgery cancelled- medication received|1|||
94664428|NCT00360529|324227129|FG000|Overall Study|Adverse Event|10|||
94664429|NCT00360529|324227130|FG001|Overall Study|Adverse Event|23|||
94664430|NCT00360529|324227131|FG002|Overall Study|Adverse Event|33|||
94664431|NCT00360529|324227129|FG000|Overall Study|Protocol Violation|3|||
94664432|NCT00360529|324227130|FG001|Overall Study|Protocol Violation|3|||
94664433|NCT00360529|324227131|FG002|Overall Study|Protocol Violation|11|||
94664434|NCT00360529|324227129|FG000|Overall Study|Lost to Follow-up|14|||
94664435|NCT00360529|324227130|FG001|Overall Study|Lost to Follow-up|10|||
94664436|NCT00360529|324227131|FG002|Overall Study|Lost to Follow-up|13|||
94664437|NCT00360529|324227129|FG000|Overall Study|Withdrawal by Subject|22|||
94664438|NCT00360529|324227130|FG001|Overall Study|Withdrawal by Subject|14|||
94664439|NCT00360529|324227131|FG002|Overall Study|Withdrawal by Subject|18|||
94664440|NCT00360529|324227129|FG000|Overall Study|Lack of Efficacy|8|||
94664441|NCT00360529|324227130|FG001|Overall Study|Lack of Efficacy|6|||
94613163|NCT00734474|324047889|FG001|Overall Study|Entry Criteria Not Met|0|||
94613164|NCT00734474|324047890|FG002|Overall Study|Entry Criteria Not Met|5|||
94613165|NCT00734474|324047891|FG003|Overall Study|Entry Criteria Not Met|0|||
94613166|NCT00734474|324047892|FG004|Overall Study|Entry Criteria Not Met|3|||
94613167|NCT00734474|324047893|FG005|Overall Study|Entry Criteria Not Met|1|||
94613168|NCT00734474|324047894|FG006|Overall Study|Entry Criteria Not Met|0|||
94613169|NCT00734474|324047895|FG007|Overall Study|Entry Criteria Not Met|1|||
94664442|NCT00360529|324227131|FG002|Overall Study|Lack of Efficacy|5|||
94613170|NCT00734474|324047896|FG008|Overall Study|Entry Criteria Not Met|1|||
94613171|NCT00734474|324047888|FG000|Overall Study|Lost to Follow-up|1|||
94664443|NCT00360529|324227129|FG000|Overall Study|Reason discontinued not explained above|4|||
94459892|NCT00387010|323471956|FG000|Treatment Period|Participant reported study drug stolen|1|||
94459893|NCT02291601|323471957|FG000|Abdomen|Did not qualify|333|||
94459894|NCT02291601|323471958|FG001|Abdomen|Did not qualify|54|||
94459895|NCT02291601|323471959|FG002|Abdomen|Did not qualify|339|||
94459896|NCT02291601|323471957|FG000|Groin|Did not qualify|183|||
94459897|NCT02291601|323471958|FG001|Groin|Did not qualify|30|||
94459898|NCT02291601|323471959|FG002|Groin|Did not qualify|177|||
94459899|NCT01940900|323471962|FG000|Overall Study|Physician Decision|4|||
94459900|NCT01940900|323471963|FG001|Overall Study|Physician Decision|0|||
94459901|NCT01940900|323471962|FG000|Overall Study|Adverse Event|10|||
94459902|NCT01940900|323471963|FG001|Overall Study|Adverse Event|15|||
94459903|NCT01940900|323471962|FG000|Overall Study|Withdrawal by Subject|11|||
94459904|NCT01940900|323471963|FG001|Overall Study|Withdrawal by Subject|15|||
94459905|NCT01940900|323471962|FG000|Overall Study|Lost to Follow-up|1|||
94459906|NCT01940900|323471963|FG001|Overall Study|Lost to Follow-up|0|||
94459907|NCT01940900|323471962|FG000|Overall Study|Sponsor Decision|1|||
94459908|NCT01940900|323471963|FG001|Overall Study|Sponsor Decision|0|||
94459909|NCT01940900|323471962|FG000|Overall Study|subject non-compliance|1|||
94459910|NCT01940900|323471963|FG001|Overall Study|subject non-compliance|1|||
94459911|NCT01940900|323471962|FG000|Overall Study|other|1|||
94459912|NCT01940900|323471963|FG001|Overall Study|other|0|||
94459913|NCT01582178|323471967|FG000|Overall Study|Physician Decision|6|||
94459914|NCT01582178|323471968|FG001|Overall Study|Physician Decision|5|||
94459915|NCT02375555|323471969|FG000|Induction Period|Adverse Event|7|||
94459916|NCT02375555|323471969|FG000|Induction Period|Withdrawal by Subject|2|||
94459917|NCT02375555|323471969|FG000|Induction Period|Other|1|||
94459918|NCT02375555|323471969|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
94459919|NCT02375555|323471969|FG000|Maintenance Period|Adverse Event|2|||
94459920|NCT02375555|323471969|FG000|Maintenance Period|Withdrawal by Subject|4|||
94459921|NCT02375555|323471969|FG000|Maintenance Period|Death|1|||
94459922|NCT02375555|323471969|FG000|Maintenance Period|Disease Progression|5|||
94459923|NCT02375555|323471969|FG000|Maintenance Period|Patient Non-compliance|1|||
94459924|NCT02375555|323471969|FG000|Maintenance Period|Still on maintenance|16|||
94459925|NCT02294175|323471971|FG000|Overall Study|Withdrawal by Subject|1|||
94459926|NCT02294175|323471972|FG001|Overall Study|Withdrawal by Subject|2|||
94459927|NCT02294175|323471971|FG000|Overall Study|pt taking excluded medication|3|||
94459928|NCT02294175|323471972|FG001|Overall Study|pt taking excluded medication|1|||
94459929|NCT02294175|323471971|FG000|Overall Study|Protocol Violation|1|||
94459930|NCT02294175|323471972|FG001|Overall Study|Protocol Violation|0|||
94459931|NCT02294175|323471971|FG000|Overall Study|Lost to Follow-up|0|||
94459932|NCT02294175|323471972|FG001|Overall Study|Lost to Follow-up|1|||
94459933|NCT02294175|323471971|FG000|Overall Study|wound healed|0|||
94459934|NCT02294175|323471972|FG001|Overall Study|wound healed|2|||
94459935|NCT02396420|323471977|FG000|Overall Study|Death|1|||
94459936|NCT01095978|323471978|FG000|Overall Study|Did not take Klacid SR|2|||
94459937|NCT01095978|323471978|FG000|Overall Study|Adverse Event|1|||
94459938|NCT00960986|323471979|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
94459939|NCT00960986|323471980|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
94459940|NCT00960986|323471981|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
94459941|NCT00960986|323471982|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
94459942|NCT00960986|323471979|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
94459943|NCT00960986|323471980|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
94459944|NCT00960986|323471981|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
94459945|NCT00960986|323471982|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
94459946|NCT00960986|323471979|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
94459947|NCT00960986|323471980|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
94459948|NCT00960986|323471981|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
94459949|NCT00960986|323471982|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
94459950|NCT00960986|323471979|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
94459951|NCT00960986|323471980|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
94459952|NCT00960986|323471981|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
94459953|NCT00960986|323471982|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
94613172|NCT00734474|324047889|FG001|Overall Study|Lost to Follow-up|0|||
94459954|NCT00960986|323471979|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
94459955|NCT00960986|323471980|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
94459956|NCT00960986|323471981|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
94613173|NCT00734474|324047890|FG002|Overall Study|Lost to Follow-up|13|||
94613174|NCT00734474|324047891|FG003|Overall Study|Lost to Follow-up|0|||
94613175|NCT00734474|324047892|FG004|Overall Study|Lost to Follow-up|11|||
94613176|NCT00734474|324047893|FG005|Overall Study|Lost to Follow-up|1|||
94613177|NCT00734474|324047894|FG006|Overall Study|Lost to Follow-up|0|||
94613178|NCT00734474|324047895|FG007|Overall Study|Lost to Follow-up|9|||
94613179|NCT00734474|324047896|FG008|Overall Study|Lost to Follow-up|4|||
94613180|NCT00734474|324047888|FG000|Overall Study|Withdrawal by Subject|2|||
94613181|NCT00734474|324047889|FG001|Overall Study|Withdrawal by Subject|1|||
94613182|NCT00734474|324047890|FG002|Overall Study|Withdrawal by Subject|18|||
94613183|NCT00734474|324047891|FG003|Overall Study|Withdrawal by Subject|0|||
94613184|NCT00734474|324047892|FG004|Overall Study|Withdrawal by Subject|24|||
94613185|NCT00734474|324047893|FG005|Overall Study|Withdrawal by Subject|2|||
94613186|NCT00734474|324047894|FG006|Overall Study|Withdrawal by Subject|0|||
94613187|NCT00734474|324047895|FG007|Overall Study|Withdrawal by Subject|36|||
94613188|NCT00734474|324047896|FG008|Overall Study|Withdrawal by Subject|21|||
94613189|NCT00734474|324047888|FG000|Overall Study|Physician Decision|0|||
94613190|NCT00734474|324047889|FG001|Overall Study|Physician Decision|0|||
94613191|NCT00734474|324047890|FG002|Overall Study|Physician Decision|4|||
94613192|NCT00734474|324047891|FG003|Overall Study|Physician Decision|1|||
94613193|NCT00734474|324047892|FG004|Overall Study|Physician Decision|11|||
94613194|NCT00734474|324047893|FG005|Overall Study|Physician Decision|0|||
94613195|NCT00734474|324047894|FG006|Overall Study|Physician Decision|0|||
94613196|NCT00734474|324047895|FG007|Overall Study|Physician Decision|9|||
94613197|NCT00734474|324047896|FG008|Overall Study|Physician Decision|9|||
94613198|NCT00734474|324047888|FG000|Overall Study|Adverse Event|4|||
94613199|NCT00734474|324047889|FG001|Overall Study|Adverse Event|4|||
94613200|NCT00734474|324047890|FG002|Overall Study|Adverse Event|63|||
94613201|NCT00734474|324047891|FG003|Overall Study|Adverse Event|1|||
94613202|NCT00734474|324047892|FG004|Overall Study|Adverse Event|64|||
94613203|NCT00734474|324047893|FG005|Overall Study|Adverse Event|0|||
94613204|NCT00734474|324047894|FG006|Overall Study|Adverse Event|1|||
94613205|NCT00734474|324047895|FG007|Overall Study|Adverse Event|65|||
94613206|NCT00734474|324047896|FG008|Overall Study|Adverse Event|39|||
94613207|NCT00734474|324047888|FG000|Overall Study|Protocol Violation|0|||
94613208|NCT00734474|324047889|FG001|Overall Study|Protocol Violation|0|||
94613209|NCT00734474|324047890|FG002|Overall Study|Protocol Violation|4|||
94613210|NCT00734474|324047891|FG003|Overall Study|Protocol Violation|0|||
94613211|NCT00734474|324047892|FG004|Overall Study|Protocol Violation|3|||
94613212|NCT00734474|324047893|FG005|Overall Study|Protocol Violation|0|||
94613213|NCT00734474|324047894|FG006|Overall Study|Protocol Violation|0|||
94613214|NCT00734474|324047895|FG007|Overall Study|Protocol Violation|3|||
94613215|NCT00734474|324047896|FG008|Overall Study|Protocol Violation|1|||
94613216|NCT00734474|324047888|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
94613217|NCT00734474|324047889|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
94613218|NCT00734474|324047890|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
94613219|NCT00734474|324047891|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
94613220|NCT00734474|324047892|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
94613221|NCT00734474|324047893|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
94613222|NCT00734474|324047894|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
94613223|NCT00734474|324047895|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
94613224|NCT00734474|324047896|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
94613225|NCT00734474|324047888|FG000|Overall Study|Sponsor Decision|0|||
94613226|NCT00734474|324047889|FG001|Overall Study|Sponsor Decision|0|||
94613227|NCT00734474|324047890|FG002|Overall Study|Sponsor Decision|0|||
94613228|NCT00734474|324047891|FG003|Overall Study|Sponsor Decision|0|||
94613229|NCT00734474|324047892|FG004|Overall Study|Sponsor Decision|2|||
94613230|NCT00734474|324047893|FG005|Overall Study|Sponsor Decision|0|||
94613231|NCT00734474|324047894|FG006|Overall Study|Sponsor Decision|0|||
94613232|NCT00734474|324047895|FG007|Overall Study|Sponsor Decision|0|||
94613233|NCT00734474|324047896|FG008|Overall Study|Sponsor Decision|0|||
94613234|NCT00734474|324047888|FG000|Overall Study|Death|0|||
94613235|NCT00734474|324047889|FG001|Overall Study|Death|0|||
94613236|NCT00734474|324047890|FG002|Overall Study|Death|1|||
94613237|NCT00734474|324047891|FG003|Overall Study|Death|0|||
94613238|NCT00734474|324047892|FG004|Overall Study|Death|0|||
94613239|NCT00734474|324047893|FG005|Overall Study|Death|0|||
94613240|NCT00734474|324047894|FG006|Overall Study|Death|0|||
94613241|NCT00734474|324047895|FG007|Overall Study|Death|2|||
94613242|NCT00734474|324047896|FG008|Overall Study|Death|1|||
94613243|NCT00734474|324047888|FG000|Overall Study|Lack of Efficacy|0|||
94613244|NCT00734474|324047889|FG001|Overall Study|Lack of Efficacy|0|||
94613245|NCT00734474|324047890|FG002|Overall Study|Lack of Efficacy|4|||
94613246|NCT00734474|324047891|FG003|Overall Study|Lack of Efficacy|0|||
94613247|NCT00734474|324047892|FG004|Overall Study|Lack of Efficacy|0|||
94613248|NCT00734474|324047893|FG005|Overall Study|Lack of Efficacy|0|||
94613249|NCT00734474|324047894|FG006|Overall Study|Lack of Efficacy|0|||
94613250|NCT00734474|324047895|FG007|Overall Study|Lack of Efficacy|4|||
94613251|NCT00734474|324047896|FG008|Overall Study|Lack of Efficacy|6|||
94613252|NCT02104752|324047901|FG000|Overall Study|Withdrawal by Subject|1|||
94613253|NCT02104752|324047902|FG001|Overall Study|Withdrawal by Subject|0|||
94613254|NCT02104752|324047901|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
94613255|NCT02104752|324047902|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
94613256|NCT00573183|324047903|FG000|Overall Study|Lost to Follow-up|52|||
94613257|NCT00573183|324047904|FG001|Overall Study|Lost to Follow-up|50|||
94613258|NCT00573183|324047903|FG000|Overall Study|Withdrawal by Subject|8|||
94613259|NCT00573183|324047904|FG001|Overall Study|Withdrawal by Subject|2|||
94613260|NCT00573183|324047903|FG000|Overall Study|Death|0|||
94613261|NCT00573183|324047904|FG001|Overall Study|Death|1|||
94613262|NCT00573183|324047903|FG000|Overall Study|Adverse Event|2|||
94613263|NCT00573183|324047904|FG001|Overall Study|Adverse Event|0|||
94613264|NCT00573183|324047903|FG000|Overall Study|Incarceration|5|||
94613265|NCT00573183|324047904|FG001|Overall Study|Incarceration|8|||
94613266|NCT00573183|324047903|FG000|Overall Study|Other|5|||
94613267|NCT00573183|324047904|FG001|Overall Study|Other|2|||
94613268|NCT00313300|324047907|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
94613269|NCT00313300|324047908|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
94613270|NCT00313300|324047909|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
94613271|NCT00313300|324047910|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
94613272|NCT00313300|324047911|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
94613273|NCT00313300|324047907|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
94613274|NCT00313300|324047908|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
94613275|NCT00313300|324047909|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
94613276|NCT00313300|324047910|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
94613277|NCT00313300|324047911|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
94613278|NCT00313300|324047907|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
94613279|NCT00313300|324047908|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
94613280|NCT00313300|324047909|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
94613281|NCT00313300|324047910|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
94613282|NCT00313300|324047911|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
94613283|NCT00313300|324047907|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
94613284|NCT00313300|324047908|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
94613285|NCT00313300|324047909|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
94613286|NCT00313300|324047910|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
94613287|NCT00313300|324047911|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
94664444|NCT00360529|324227130|FG001|Overall Study|Reason discontinued not explained above|9|||
94664445|NCT00360529|324227131|FG002|Overall Study|Reason discontinued not explained above|11|||
94664446|NCT03230916|324227133|FG000|Overall Study|Withdrawal by Subject|0|||
94664447|NCT03230916|324227134|FG001|Overall Study|Withdrawal by Subject|0|||
94664448|NCT03230916|324227135|FG002|Overall Study|Withdrawal by Subject|0|||
94664449|NCT03230916|324227136|FG003|Overall Study|Withdrawal by Subject|0|||
94664450|NCT03230916|324227137|FG004|Overall Study|Withdrawal by Subject|0|||
94664451|NCT03230916|324227138|FG005|Overall Study|Withdrawal by Subject|1|||
94664452|NCT03230916|324227139|FG006|Overall Study|Withdrawal by Subject|0|||
94664453|NCT03230916|324227140|FG007|Overall Study|Withdrawal by Subject|0|||
94664454|NCT03230916|324227141|FG008|Overall Study|Withdrawal by Subject|0|||
94664455|NCT03230916|324227142|FG009|Overall Study|Withdrawal by Subject|0|||
94664456|NCT03230916|324227143|FG010|Overall Study|Withdrawal by Subject|0|||
94664457|NCT00045110|324227145|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
94664458|NCT00045110|324227146|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
94664459|NCT00045110|324227147|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
94664460|NCT00045110|324227145|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
94664461|NCT00045110|324227146|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
94664462|NCT00045110|324227147|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
94664463|NCT00045110|324227145|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
94664464|NCT00045110|324227146|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
94664465|NCT00045110|324227147|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
94664466|NCT03077724|324227148|FG000|Overall Study|Lost to Follow-up|5|||
94664467|NCT03077724|324227149|FG001|Overall Study|Lost to Follow-up|1|||
94664468|NCT03077724|324227148|FG000|Overall Study|Withdrawal by Subject|3|||
94664469|NCT03077724|324227149|FG001|Overall Study|Withdrawal by Subject|1|||
94664470|NCT02899728|324227150|FG000|Overall Study|Withdrawal by Subject|1|||
94664471|NCT02899728|324227151|FG001|Overall Study|Withdrawal by Subject|1|||
94664472|NCT01962493|324227152|FG000|Overall Study|Adverse Event|1|||
94664473|NCT01962493|324227153|FG001|Overall Study|Adverse Event|2|||
94664474|NCT01962493|324227152|FG000|Overall Study|Protocol Violation|0|||
94664475|NCT01962493|324227153|FG001|Overall Study|Protocol Violation|1|||
94664476|NCT01962493|324227152|FG000|Overall Study|Withdrawal by Subject|4|||
94664477|NCT01962493|324227153|FG001|Overall Study|Withdrawal by Subject|2|||
94664478|NCT00613951|324227154|FG000|Overall Study|Adverse Event|1|||
94664479|NCT00613951|324227155|FG001|Overall Study|Adverse Event|0|||
94664480|NCT00613951|324227156|FG002|Overall Study|Adverse Event|1|||
94664481|NCT00613951|324227154|FG000|Overall Study|Lack of Efficacy|0|||
94664482|NCT00613951|324227155|FG001|Overall Study|Lack of Efficacy|1|||
94664483|NCT00613951|324227156|FG002|Overall Study|Lack of Efficacy|1|||
94664484|NCT00613951|324227154|FG000|Overall Study|Protocol Violation|1|||
94664485|NCT00613951|324227155|FG001|Overall Study|Protocol Violation|1|||
94664486|NCT00613951|324227156|FG002|Overall Study|Protocol Violation|1|||
94664487|NCT00613951|324227154|FG000|Overall Study|Unclassified|5|||
94664488|NCT00613951|324227155|FG001|Overall Study|Unclassified|3|||
94664489|NCT00613951|324227156|FG002|Overall Study|Unclassified|2|||
94664490|NCT00127608|324227161|FG000|Overall Study|VZV DNA negative|1|||
94664491|NCT05437510|324227166|FG000|Overall Study|Adverse Event|1|||
94664492|NCT05437510|324227167|FG001|Overall Study|Adverse Event|1|||
94664493|NCT05437510|324227166|FG000|Overall Study|Protocol Deviation|1|||
94664494|NCT05437510|324227167|FG001|Overall Study|Protocol Deviation|6|||
94664495|NCT05437510|324227166|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
94664496|NCT05437510|324227167|FG001|Overall Study|Withdrawal by Parent/Guardian|22|||
94664497|NCT05437510|324227166|FG000|Overall Study|Lost to Follow-up|219|||
94664498|NCT05437510|324227167|FG001|Overall Study|Lost to Follow-up|289|||
94664499|NCT05437510|324227166|FG000|Overall Study|Ongoing in the Study Extension|1387|||
94664500|NCT05437510|324227167|FG001|Overall Study|Ongoing in the Study Extension|1352|||
94664501|NCT00680407|324227168|FG000|Overall Study|Lost to Follow-up|3|||
94664502|NCT00680407|324227169|FG001|Overall Study|Lost to Follow-up|3|||
94664503|NCT00680407|324227170|FG002|Overall Study|Lost to Follow-up|1|||
94664504|NCT00680407|324227168|FG000|Overall Study|Withdrawal by Subject|5|||
94664505|NCT00680407|324227169|FG001|Overall Study|Withdrawal by Subject|2|||
94664506|NCT00680407|324227170|FG002|Overall Study|Withdrawal by Subject|2|||
94664507|NCT01292603|324229687|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
94664508|NCT01292603|324229688|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
94664509|NCT01292603|324229689|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
94664510|NCT01292603|324229690|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
94664511|NCT01292603|324229691|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
94664512|NCT01292603|324229692|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
94664513|NCT01292603|324229687|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
94664514|NCT01292603|324229688|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
94664515|NCT01292603|324229689|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
94664516|NCT01292603|324229690|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
94664517|NCT01292603|324229691|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
94664518|NCT01292603|324229692|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
94664519|NCT01292603|324229687|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
94664520|NCT01292603|324229688|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
94664521|NCT01292603|324229689|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
94664522|NCT01292603|324229690|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
94664523|NCT01292603|324229691|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
94664524|NCT01292603|324229692|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
94613288|NCT00313300|324047907|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
94613289|NCT00313300|324047908|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
94613290|NCT00313300|324047909|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
94613291|NCT00313300|324047910|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
94613292|NCT00313300|324047911|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
94613293|NCT00313300|324047907|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
94613294|NCT00313300|324047908|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
94613295|NCT00313300|324047909|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
94613296|NCT00313300|324047910|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
94613297|NCT00313300|324047911|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
94613298|NCT00313300|324047907|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
94613299|NCT00313300|324047908|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
94613300|NCT00313300|324047909|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
94613301|NCT00313300|324047910|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
94613302|NCT00313300|324047911|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
94613303|NCT00313300|324047907|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
94613304|NCT00313300|324047908|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
94613305|NCT00313300|324047909|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
94613306|NCT00313300|324047910|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
94613307|NCT00313300|324047911|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
94613308|NCT00313300|324047907|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
94613309|NCT00313300|324047908|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
94613310|NCT00313300|324047909|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
94613311|NCT00313300|324047910|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
94613312|NCT00313300|324047911|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
94613313|NCT00313300|324047907|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
94613314|NCT00313300|324047908|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
94613315|NCT00313300|324047909|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
94613316|NCT00313300|324047910|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
94613317|NCT00313300|324047911|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
94613318|NCT00313300|324047907|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
94613319|NCT00313300|324047908|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
94613320|NCT00313300|324047909|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
94613321|NCT00313300|324047910|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
94613322|NCT00313300|324047911|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
94613323|NCT00313300|324047907|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
94613324|NCT00313300|324047908|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
94613325|NCT00313300|324047909|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
94613326|NCT00313300|324047910|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
94613327|NCT00313300|324047911|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
94613328|NCT00313300|324047907|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
94613329|NCT00313300|324047908|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
94613330|NCT00313300|324047909|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
94613331|NCT00313300|324047910|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
94613332|NCT00313300|324047911|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
94613333|NCT00313300|324047907|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
94613334|NCT00313300|324047908|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
94613335|NCT00313300|324047909|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
94664525|NCT01292603|324229687|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
94664526|NCT01292603|324229688|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
94613336|NCT00313300|324047910|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
94613337|NCT00313300|324047911|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
94613338|NCT00313300|324047907|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
94613339|NCT00313300|324047908|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
94613340|NCT00313300|324047909|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
94613341|NCT00313300|324047910|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
94613342|NCT00313300|324047911|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
94613343|NCT00313300|324047907|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
94613344|NCT00313300|324047908|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
94613345|NCT00313300|324047909|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
94613346|NCT00313300|324047910|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
94613347|NCT00313300|324047911|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
94613348|NCT00313300|324047907|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
94613349|NCT00313300|324047908|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
94613350|NCT00313300|324047909|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
94613351|NCT00313300|324047910|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
94613352|NCT00313300|324047911|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
94613353|NCT00313300|324047907|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
94613354|NCT00313300|324047908|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
94613355|NCT00313300|324047909|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
94613356|NCT00313300|324047910|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
94664527|NCT01292603|324229689|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
94664528|NCT01292603|324229690|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
94664529|NCT01292603|324229691|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
94664530|NCT01292603|324229692|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
94664531|NCT01292603|324229687|FG000|Part 1: Regular Follow-Up Period|Death|3|||
94664532|NCT01292603|324229688|FG001|Part 1: Regular Follow-Up Period|Death|1|||
94664533|NCT01292603|324229689|FG002|Part 1: Regular Follow-Up Period|Death|3|||
94664534|NCT01292603|324229690|FG003|Part 1: Regular Follow-Up Period|Death|1|||
94664535|NCT01292603|324229691|FG004|Part 1: Regular Follow-Up Period|Death|0|||
94664536|NCT01292603|324229692|FG005|Part 1: Regular Follow-Up Period|Death|0|||
94664537|NCT01292603|324229687|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
94664538|NCT01292603|324229688|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
94664539|NCT01292603|324229689|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
94664540|NCT01292603|324229690|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
94664541|NCT01292603|324229691|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
94664542|NCT01292603|324229692|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
94664543|NCT01292603|324229687|FG000|Part 2: Dose Confirmation Period|Death|0|||
94664544|NCT01292603|324229688|FG001|Part 2: Dose Confirmation Period|Death|0|||
94664545|NCT01292603|324229689|FG002|Part 2: Dose Confirmation Period|Death|0|||
94664546|NCT01292603|324229690|FG003|Part 2: Dose Confirmation Period|Death|0|||
94664547|NCT01292603|324229691|FG004|Part 2: Dose Confirmation Period|Death|1|||
94664548|NCT01292603|324229692|FG005|Part 2: Dose Confirmation Period|Death|0|||
94664549|NCT01292603|324229687|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
94664550|NCT01292603|324229688|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
94664551|NCT01292603|324229689|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
94664552|NCT01292603|324229690|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
94664553|NCT01292603|324229691|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
94664554|NCT01292603|324229692|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
94664555|NCT01292603|324229687|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
94664556|NCT01292603|324229688|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
94664557|NCT01292603|324229689|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
94664558|NCT01292603|324229690|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
94664559|NCT01292603|324229691|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
94664560|NCT01292603|324229692|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
94664561|NCT01292603|324229687|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
94664562|NCT01292603|324229688|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
94664563|NCT01292603|324229689|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
94613357|NCT00313300|324047911|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
94664564|NCT01292603|324229690|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
94664565|NCT01292603|324229691|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
94664566|NCT01292603|324229692|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
94459957|NCT00960986|323471982|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
94459958|NCT00960986|323471979|FG000|Period 3 (7-week Therapy Period)|Death|0|||
94459959|NCT00960986|323471980|FG001|Period 3 (7-week Therapy Period)|Death|0|||
94459960|NCT00960986|323471981|FG002|Period 3 (7-week Therapy Period)|Death|1|||
94613358|NCT00313300|324047907|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
94613359|NCT00313300|324047908|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
94613360|NCT00313300|324047909|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
94613361|NCT00313300|324047910|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
94613362|NCT00313300|324047911|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
94613363|NCT00313300|324047907|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
94613364|NCT00313300|324047908|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
94613365|NCT00313300|324047909|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
94613366|NCT00313300|324047910|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
94613367|NCT00313300|324047911|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
94613368|NCT00313300|324047907|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
94613369|NCT00313300|324047908|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
94613370|NCT00313300|324047909|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
94613371|NCT00313300|324047910|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
94613372|NCT00313300|324047911|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
94613373|NCT00428792|324047912|FG000|Overall Study|Lack of Efficacy|1|||
94613374|NCT00428792|324047913|FG001|Overall Study|Lack of Efficacy|3|||
94613375|NCT00428792|324047912|FG000|Overall Study|Lost to Follow-up|0|||
94613376|NCT00428792|324047913|FG001|Overall Study|Lost to Follow-up|1|||
94613377|NCT01856907|324047915|FG000|Overall Study|Pregnancy|0|||
94613378|NCT01856907|324047916|FG001|Overall Study|Pregnancy|1|||
94613379|NCT01856907|324047917|FG002|Overall Study|Pregnancy|0|||
94613380|NCT01856907|324047915|FG000|Overall Study|Pregnancy|0|||
94613381|NCT01856907|324047916|FG001|Overall Study|Pregnancy|1|||
94613382|NCT01856907|324047917|FG002|Overall Study|Pregnancy|0|||
94613383|NCT01856907|324047915|FG000|Overall Study|Withdrawal by Subject|0|||
94613384|NCT01856907|324047916|FG001|Overall Study|Withdrawal by Subject|1|||
94613385|NCT01856907|324047917|FG002|Overall Study|Withdrawal by Subject|0|||
94613386|NCT01604408|324047918|FG000|Treatment Period 1|Protocol Violation|0|||
94613387|NCT01604408|324047919|FG001|Treatment Period 1|Protocol Violation|1|||
94613388|NCT01604408|324047918|FG000|Treatment Period 2|Withdrawal by Subject|1|||
94613389|NCT01604408|324047919|FG001|Treatment Period 2|Withdrawal by Subject|1|||
94613390|NCT01604408|324047918|FG000|Treatment Period 2|Protocol Violation|1|||
94613391|NCT01604408|324047919|FG001|Treatment Period 2|Protocol Violation|0|||
94613392|NCT01604408|324047918|FG000|Treatment Period 2|Adverse Event|0|||
94613393|NCT01604408|324047919|FG001|Treatment Period 2|Adverse Event|1|||
94613394|NCT01604408|324047918|FG000|Treatment Period 3|Protocol Violation|1|||
94613395|NCT01604408|324047919|FG001|Treatment Period 3|Protocol Violation|1|||
94613396|NCT01604408|324047918|FG000|Treatment Period 3|Adverse Event|0|||
94613397|NCT01604408|324047919|FG001|Treatment Period 3|Adverse Event|3|||
94613398|NCT01604408|324047918|FG000|Treatment Period 3|Withdrawal by Subject|3|||
94613399|NCT01604408|324047919|FG001|Treatment Period 3|Withdrawal by Subject|1|||
94613400|NCT01604408|324047918|FG000|Treatment Period 3|Sponsor Decision|1|||
94613401|NCT01604408|324047919|FG001|Treatment Period 3|Sponsor Decision|0|||
94613402|NCT01604408|324047918|FG000|Treatment Period 4|Death|1|||
94613403|NCT01604408|324047919|FG001|Treatment Period 4|Death|0|||
94459961|NCT00960986|323471982|FG003|Period 3 (7-week Therapy Period)|Death|0|||
94613404|NCT01604408|324047918|FG000|Treatment Period 4|Withdrawal by Subject|2|||
94613405|NCT01604408|324047919|FG001|Treatment Period 4|Withdrawal by Subject|1|||
94613406|NCT01604408|324047918|FG000|Treatment Period 4|Adverse Event|0|||
94613407|NCT01604408|324047919|FG001|Treatment Period 4|Adverse Event|1|||
94613408|NCT01604408|324047918|FG000|Treatment Period 5|Adverse Event|4|||
94613409|NCT01604408|324047919|FG001|Treatment Period 5|Adverse Event|0|||
94613410|NCT01604408|324047918|FG000|Treatment Period 6|Lost to Follow-up|0|||
94613411|NCT01604408|324047919|FG001|Treatment Period 6|Lost to Follow-up|1|||
94613412|NCT01604408|324047918|FG000|Treatment Period 6|Adverse Event|2|||
94613413|NCT01604408|324047919|FG001|Treatment Period 6|Adverse Event|0|||
94613414|NCT01604408|324047918|FG000|Treatment Period 6|Sponsor decision|0|||
94613415|NCT01604408|324047919|FG001|Treatment Period 6|Sponsor decision|1|||
94613416|NCT01604408|324047918|FG000|Observation Period|Adverse Event|1|||
94613417|NCT01604408|324047919|FG001|Observation Period|Adverse Event|1|||
94613418|NCT01604408|324047918|FG000|Observation Period|Withdrawal by Subject|0|||
94613419|NCT01604408|324047919|FG001|Observation Period|Withdrawal by Subject|2|||
94613420|NCT00917501|324047920|FG000|Overall Study|Lost to Follow-up|4|||
94613421|NCT00917501|324047921|FG001|Overall Study|Lost to Follow-up|1|||
94613422|NCT00917501|324047920|FG000|Overall Study|Withdrawal by Subject|3|||
94613423|NCT00917501|324047921|FG001|Overall Study|Withdrawal by Subject|1|||
94613424|NCT00917501|324047920|FG000|Overall Study|Lack of Efficacy|1|||
94613425|NCT00917501|324047921|FG001|Overall Study|Lack of Efficacy|2|||
94613426|NCT00917501|324047920|FG000|Overall Study|trouble swollowing capsules|0|||
94613427|NCT00917501|324047921|FG001|Overall Study|trouble swollowing capsules|1|||
94613428|NCT00075218|324047922|FG000|Double-Blind Treatment|Adverse Event|23|||
94613429|NCT00075218|324047923|FG001|Double-Blind Treatment|Adverse Event|4|||
94613430|NCT00075218|324047924|FG002|Double-Blind Treatment|Adverse Event|0|||
94613431|NCT00075218|324047922|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
94613432|NCT00075218|324047923|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
94613433|NCT00075218|324047924|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
94613434|NCT00075218|324047922|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
94613435|NCT00075218|324047923|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
94664567|NCT01292603|324229687|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
94664568|NCT01292603|324229688|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
94459962|NCT00960986|323471979|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
94613436|NCT00075218|324047924|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
94613437|NCT00075218|324047922|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
94613438|NCT00075218|324047923|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
94613439|NCT00075218|324047924|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
94613440|NCT00075218|324047922|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
94613441|NCT00075218|324047923|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
94664569|NCT01292603|324229689|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
94613442|NCT00075218|324047924|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
94664570|NCT01292603|324229690|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
94664571|NCT01292603|324229691|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
94613443|NCT00075218|324047922|FG000|Double-Blind Treatment|No study medication taken|2|||
94613444|NCT00075218|324047923|FG001|Double-Blind Treatment|No study medication taken|0|||
94613445|NCT00075218|324047924|FG002|Double-Blind Treatment|No study medication taken|0|||
94613446|NCT00075218|324047922|FG000|Open-Label Treatment|Lack of Efficacy|0|||
94613447|NCT00075218|324047923|FG001|Open-Label Treatment|Lack of Efficacy|0|||
94613448|NCT00075218|324047924|FG002|Open-Label Treatment|Lack of Efficacy|174|||
94613449|NCT00075218|324047922|FG000|Open-Label Treatment|Adverse Event|0|||
94613450|NCT00075218|324047923|FG001|Open-Label Treatment|Adverse Event|0|||
94664572|NCT01292603|324229692|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
94664573|NCT01292603|324229687|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
94664574|NCT01292603|324229688|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
94664575|NCT01292603|324229689|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
94664576|NCT01292603|324229690|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
94664577|NCT01292603|324229691|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
94664578|NCT01292603|324229692|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
94664579|NCT01292603|324229687|FG000|Part 2: Regular Follow-Up|Death|0|||
94664580|NCT01292603|324229688|FG001|Part 2: Regular Follow-Up|Death|0|||
94664581|NCT01292603|324229689|FG002|Part 2: Regular Follow-Up|Death|0|||
94664582|NCT01292603|324229690|FG003|Part 2: Regular Follow-Up|Death|0|||
94664583|NCT01292603|324229691|FG004|Part 2: Regular Follow-Up|Death|6|||
94664584|NCT01292603|324229692|FG005|Part 2: Regular Follow-Up|Death|3|||
94664585|NCT01292603|324229687|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
94664586|NCT01292603|324229688|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
94664587|NCT01292603|324229689|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
94664588|NCT01292603|324229690|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
94664589|NCT01292603|324229691|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
94664590|NCT01292603|324229692|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
94664591|NCT01292603|324229687|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
94664592|NCT01292603|324229688|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
94664593|NCT01292603|324229689|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
94664594|NCT01292603|324229690|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
94664595|NCT01292603|324229691|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
94664596|NCT01292603|324229692|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
94664597|NCT01292603|324229687|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
94664598|NCT01292603|324229688|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
94613451|NCT00075218|324047924|FG002|Open-Label Treatment|Adverse Event|51|||
94613452|NCT00075218|324047922|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
94613453|NCT00075218|324047923|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
94613454|NCT00075218|324047924|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
94664599|NCT01292603|324229689|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
94664600|NCT01292603|324229690|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
94664601|NCT01292603|324229691|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
94613455|NCT00075218|324047922|FG000|Open-Label Treatment|Decision of Sponsor|0|||
94613456|NCT00075218|324047923|FG001|Open-Label Treatment|Decision of Sponsor|0|||
94613457|NCT00075218|324047924|FG002|Open-Label Treatment|Decision of Sponsor|8|||
94613458|NCT00075218|324047922|FG000|Open-Label Treatment|Protocol Violation|0|||
94613459|NCT00075218|324047923|FG001|Open-Label Treatment|Protocol Violation|0|||
94613460|NCT00075218|324047924|FG002|Open-Label Treatment|Protocol Violation|1|||
94613461|NCT00075218|324047922|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
94613462|NCT00075218|324047923|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
94613463|NCT00075218|324047924|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
94613464|NCT03342963|324047927|FG000|Overall Study|Adverse Event|1|||
94613465|NCT03342963|324047928|FG001|Overall Study|Adverse Event|2|||
94613466|NCT03342963|324047929|FG002|Overall Study|Adverse Event|0|||
94613467|NCT03342963|324047930|FG003|Overall Study|Adverse Event|0|||
94613468|NCT03342963|324047927|FG000|Overall Study|Withdrawal by Subject|1|||
94613469|NCT03342963|324047928|FG001|Overall Study|Withdrawal by Subject|0|||
94664602|NCT01292603|324229692|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
94613470|NCT03342963|324047929|FG002|Overall Study|Withdrawal by Subject|0|||
94664603|NCT01292603|324229687|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
94664604|NCT01292603|324229688|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
94664605|NCT01292603|324229689|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
94664606|NCT01292603|324229690|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
94613471|NCT03342963|324047930|FG003|Overall Study|Withdrawal by Subject|0|||
94613472|NCT00722423|324047933|FG000|Overall Study|Protocol Violation|0|||
94613473|NCT00722423|324047934|FG001|Overall Study|Protocol Violation|1|||
94613474|NCT00333840|324047935|FG000|First-line Treatment Period|Adverse Event|38|||
94613475|NCT00333840|324047936|FG001|First-line Treatment Period|Adverse Event|37|||
94613476|NCT00333840|324047937|FG002|First-line Treatment Period|Adverse Event|0|||
94613477|NCT00333840|324047938|FG003|First-line Treatment Period|Adverse Event|0|||
94613478|NCT00333840|324047935|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
94613479|NCT00333840|324047936|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
94613480|NCT00333840|324047937|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
94613481|NCT00333840|324047938|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
94613482|NCT00333840|324047935|FG000|First-line Treatment Period|Abnormal procedure|2|||
94613483|NCT00333840|324047936|FG001|First-line Treatment Period|Abnormal procedure|0|||
94613484|NCT00333840|324047937|FG002|First-line Treatment Period|Abnormal procedure|0|||
94613485|NCT00333840|324047938|FG003|First-line Treatment Period|Abnormal procedure|0|||
94613486|NCT00333840|324047935|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
94613487|NCT00333840|324047936|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
94613488|NCT00333840|324047937|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
94613489|NCT00333840|324047938|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
94613490|NCT00333840|324047935|FG000|First-line Treatment Period|No longer required study drug|21|||
94613491|NCT00333840|324047936|FG001|First-line Treatment Period|No longer required study drug|8|||
94613492|NCT00333840|324047937|FG002|First-line Treatment Period|No longer required study drug|0|||
94613493|NCT00333840|324047938|FG003|First-line Treatment Period|No longer required study drug|0|||
94613494|NCT00333840|324047935|FG000|First-line Treatment Period|Protocol Violation|17|||
94613495|NCT00333840|324047936|FG001|First-line Treatment Period|Protocol Violation|17|||
94613496|NCT00333840|324047937|FG002|First-line Treatment Period|Protocol Violation|0|||
94613497|NCT00333840|324047938|FG003|First-line Treatment Period|Protocol Violation|0|||
94613498|NCT00333840|324047935|FG000|First-line Treatment Period|Subject withdrew consent|57|||
94613499|NCT00333840|324047936|FG001|First-line Treatment Period|Subject withdrew consent|77|||
94613500|NCT00333840|324047937|FG002|First-line Treatment Period|Subject withdrew consent|0|||
94613501|NCT00333840|324047938|FG003|First-line Treatment Period|Subject withdrew consent|0|||
94613502|NCT00333840|324047935|FG000|First-line Treatment Period|Lost to Follow-up|15|||
94613503|NCT00333840|324047936|FG001|First-line Treatment Period|Lost to Follow-up|6|||
94613504|NCT00333840|324047937|FG002|First-line Treatment Period|Lost to Follow-up|0|||
94613505|NCT00333840|324047938|FG003|First-line Treatment Period|Lost to Follow-up|0|||
94613506|NCT00333840|324047935|FG000|First-line Treatment Period|Administrative problems|12|||
94613507|NCT00333840|324047936|FG001|First-line Treatment Period|Administrative problems|6|||
94613508|NCT00333840|324047937|FG002|First-line Treatment Period|Administrative problems|0|||
94613509|NCT00333840|324047938|FG003|First-line Treatment Period|Administrative problems|0|||
94613510|NCT00333840|324047935|FG000|First-line Treatment Period|Death|19|||
94613511|NCT00333840|324047936|FG001|First-line Treatment Period|Death|2|||
94613512|NCT00333840|324047937|FG002|First-line Treatment Period|Death|0|||
94613513|NCT00333840|324047938|FG003|First-line Treatment Period|Death|0|||
94613514|NCT00333840|324047935|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
94613515|NCT00333840|324047936|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
94613516|NCT00333840|324047937|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
94613517|NCT00333840|324047938|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
94613518|NCT00333840|324047935|FG000|Second-line Treatment Period|Adverse Event|0|||
94613519|NCT00333840|324047936|FG001|Second-line Treatment Period|Adverse Event|0|||
94613520|NCT00333840|324047937|FG002|Second-line Treatment Period|Adverse Event|3|||
94613521|NCT00333840|324047938|FG003|Second-line Treatment Period|Adverse Event|34|||
94613522|NCT00333840|324047935|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
94613523|NCT00333840|324047936|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
94613524|NCT00333840|324047937|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
94613525|NCT00333840|324047938|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
94664607|NCT01292603|324229691|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
94664608|NCT01292603|324229692|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
94664609|NCT01292603|324229687|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
94664610|NCT01292603|324229688|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
94664611|NCT01292603|324229689|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
94613526|NCT00333840|324047935|FG000|Second-line Treatment Period|Abnormal procedure|0|||
94613527|NCT00333840|324047936|FG001|Second-line Treatment Period|Abnormal procedure|0|||
94613528|NCT00333840|324047937|FG002|Second-line Treatment Period|Abnormal procedure|0|||
94613529|NCT00333840|324047938|FG003|Second-line Treatment Period|Abnormal procedure|1|||
94613530|NCT00333840|324047935|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
94664612|NCT01292603|324229690|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
94664613|NCT01292603|324229691|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
94664614|NCT01292603|324229692|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
94358622|NCT03110107|323096431|FG001|Treatment Period|Other Reasons|0|||
94358623|NCT03110107|323096432|FG002|Treatment Period|Other Reasons|1|||
94358624|NCT03110107|323096433|FG003|Treatment Period|Other Reasons|1|||
94358625|NCT03110107|323096434|FG004|Treatment Period|Other Reasons|0|||
94613531|NCT00333840|324047936|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
94613532|NCT00333840|324047937|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
94613533|NCT00333840|324047938|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
94613534|NCT00333840|324047935|FG000|Second-line Treatment Period|No longer required study drug|0|||
94613535|NCT00333840|324047936|FG001|Second-line Treatment Period|No longer required study drug|0|||
94613536|NCT00333840|324047937|FG002|Second-line Treatment Period|No longer required study drug|1|||
94613537|NCT00333840|324047938|FG003|Second-line Treatment Period|No longer required study drug|14|||
94613538|NCT00333840|324047935|FG000|Second-line Treatment Period|Protocol Violation|0|||
94613539|NCT00333840|324047936|FG001|Second-line Treatment Period|Protocol Violation|0|||
94613540|NCT00333840|324047937|FG002|Second-line Treatment Period|Protocol Violation|1|||
94613541|NCT00333840|324047938|FG003|Second-line Treatment Period|Protocol Violation|10|||
94613542|NCT00333840|324047935|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
94613543|NCT00333840|324047936|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
94613544|NCT00333840|324047937|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
94613545|NCT00333840|324047938|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
94613546|NCT00333840|324047935|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
94613547|NCT00333840|324047936|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
94613548|NCT00333840|324047937|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
94613549|NCT00333840|324047938|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
94613550|NCT00333840|324047935|FG000|Second-line Treatment Period|Administrative problems|0|||
94613551|NCT00333840|324047936|FG001|Second-line Treatment Period|Administrative problems|0|||
94613552|NCT00333840|324047937|FG002|Second-line Treatment Period|Administrative problems|0|||
94613553|NCT00333840|324047938|FG003|Second-line Treatment Period|Administrative problems|7|||
94613554|NCT00333840|324047935|FG000|Second-line Treatment Period|Death|0|||
94613555|NCT00333840|324047936|FG001|Second-line Treatment Period|Death|0|||
94613556|NCT00333840|324047937|FG002|Second-line Treatment Period|Death|0|||
94613557|NCT00333840|324047938|FG003|Second-line Treatment Period|Death|9|||
94613558|NCT02357979|324047939|FG000|Overall Study|Lost to Follow-up|5|||
94613559|NCT02357979|324047940|FG001|Overall Study|Lost to Follow-up|5|||
94613560|NCT00839852|324047943|FG000|Overall Study|Adverse Event|10|||
94613561|NCT00839852|324047943|FG000|Overall Study|Insufficient Therapeutic Response|3|||
94613562|NCT00839852|324047943|FG000|Overall Study|Protocol Violation|9|||
94613563|NCT00839852|324047943|FG000|Overall Study|Withdrawal of Consent|16|||
94613564|NCT00839852|324047943|FG000|Overall Study|Lost to Follow-up|7|||
94613565|NCT00839852|324047943|FG000|Overall Study|Lack of Compliance While in Jail|1|||
94613566|NCT00839852|324047943|FG000|Overall Study|Pregnancy|1|||
94613567|NCT02478372|324047946|FG000|Overall Study|Protocol Violation|12|||
94613568|NCT02478372|324047947|FG001|Overall Study|Protocol Violation|8|||
94613569|NCT02478372|324047946|FG000|Overall Study|Lost to Follow-up|1|||
94613570|NCT02478372|324047947|FG001|Overall Study|Lost to Follow-up|4|||
94613571|NCT02478372|324047946|FG000|Overall Study|Death|0|||
94613572|NCT02478372|324047947|FG001|Overall Study|Death|2|||
94613573|NCT00116428|324047948|FG000|Overall Study|Withdrawal by Subject|2|||
94613574|NCT00116428|324047949|FG001|Overall Study|Withdrawal by Subject|5|||
94613575|NCT00116428|324047948|FG000|Overall Study|Did not meet inclusion criteria|1|||
94613576|NCT00116428|324047949|FG001|Overall Study|Did not meet inclusion criteria|0|||
94613577|NCT00386607|324047950|FG000|Core|Adverse Event|40|||
94613578|NCT00386607|324047951|FG001|Core|Adverse Event|0|||
94613579|NCT00386607|324047950|FG000|Core|Abnormal laboratory value(s)|3|||
94613580|NCT00386607|324047951|FG001|Core|Abnormal laboratory value(s)|0|||
94613581|NCT00386607|324047950|FG000|Core|Unsatisfactory therapeutic effect|23|||
94613582|NCT00386607|324047951|FG001|Core|Unsatisfactory therapeutic effect|0|||
94613583|NCT00386607|324047950|FG000|Core|Condition no longer requires study drug|4|||
94613584|NCT00386607|324047951|FG001|Core|Condition no longer requires study drug|0|||
94613585|NCT00386607|324047950|FG000|Core|Patient withdrew consent|15|||
94613586|NCT00386607|324047951|FG001|Core|Patient withdrew consent|0|||
94613587|NCT00386607|324047950|FG000|Core|Lost to Follow-up|23|||
94613588|NCT00386607|324047951|FG001|Core|Lost to Follow-up|0|||
94613589|NCT00386607|324047950|FG000|Core|Administrative problems|1|||
94613590|NCT00386607|324047951|FG001|Core|Administrative problems|0|||
94613591|NCT00386607|324047950|FG000|Core|Protocol Deviation|6|||
94613592|NCT00386607|324047951|FG001|Core|Protocol Deviation|0|||
94613593|NCT00386607|324047950|FG000|Extension|Adverse Event|0|||
94613594|NCT00386607|324047951|FG001|Extension|Adverse Event|6|||
94613595|NCT00386607|324047950|FG000|Extension|Abnormal laboratory value(s)|0|||
94613596|NCT00386607|324047951|FG001|Extension|Abnormal laboratory value(s)|1|||
94358626|NCT03110107|323096435|FG005|Treatment Period|Other Reasons|1|||
94613597|NCT00386607|324047950|FG000|Extension|Administrative problems|0|||
94613598|NCT00386607|324047951|FG001|Extension|Administrative problems|1|||
94358627|NCT03110107|323096436|FG006|Treatment Period|Other Reasons|0|||
94358628|NCT03110107|323096437|FG007|Treatment Period|Other Reasons|0|||
94358629|NCT03110107|323096438|FG008|Treatment Period|Other Reasons|0|||
94613599|NCT00386607|324047950|FG000|Extension|Lost to Follow-up|0|||
94613600|NCT00386607|324047951|FG001|Extension|Lost to Follow-up|3|||
94613601|NCT00386607|324047950|FG000|Extension|Patient withdrew consent|0|||
94613602|NCT00386607|324047951|FG001|Extension|Patient withdrew consent|5|||
94613603|NCT00386607|324047950|FG000|Extension|Unsatisfactory therapeutic effect|0|||
94613604|NCT00386607|324047951|FG001|Extension|Unsatisfactory therapeutic effect|1|||
94613605|NCT02805972|324047963|FG000|Washout Period|Lost to Follow-up|3|||
94613606|NCT02805972|324047964|FG001|Washout Period|Lost to Follow-up|0|||
94613607|NCT00331422|324047965|FG000|Overall Study|Did not receive entire study regimen|5|||
94613608|NCT02155881|324047966|FG000|Overall Study|Withdrawal by Subject|0|||
94613609|NCT02155881|324047967|FG001|Overall Study|Withdrawal by Subject|2|||
94613610|NCT02155881|324047966|FG000|Overall Study|Inappropriately randomized|2|||
94613611|NCT02155881|324047967|FG001|Overall Study|Inappropriately randomized|2|||
94613612|NCT00066729|324047968|FG000|Overall Study|Lost to Follow-up|1|||
94613613|NCT00066729|324047968|FG000|Overall Study|Disease progression|1|||
94613614|NCT00516074|324047971|FG000|Overall Study|Adverse Event|0|||
94613615|NCT00516074|324047972|FG001|Overall Study|Adverse Event|1|||
94613616|NCT00516074|324047971|FG000|Overall Study|Subject Decision|4|||
94613617|NCT00516074|324047972|FG001|Overall Study|Subject Decision|2|||
94613618|NCT00516074|324047971|FG000|Overall Study|Loss of Glucose Control|2|||
94613619|NCT00516074|324047972|FG001|Overall Study|Loss of Glucose Control|0|||
94613620|NCT00633750|324047974|FG000|Overall Study|Adverse Event|2|||
94613621|NCT00633750|324047974|FG000|Overall Study|Withdrawal by Subject|3|||
94613622|NCT02215096|324047975|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
94613623|NCT02215096|324047976|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
94613624|NCT02215096|324047977|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
94613625|NCT02215096|324047978|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
94613626|NCT02215096|324047979|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
94613627|NCT02215096|324047975|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
94613628|NCT02215096|324047976|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
94613629|NCT02215096|324047977|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
94613630|NCT02215096|324047978|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
94613631|NCT02215096|324047979|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
94613632|NCT02215096|324047975|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
94613633|NCT02215096|324047976|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
94613634|NCT02215096|324047977|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
94613635|NCT02215096|324047978|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
94613636|NCT02215096|324047979|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
94613637|NCT02215096|324047975|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
94613638|NCT02215096|324047976|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
94613639|NCT02215096|324047977|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
94613640|NCT02215096|324047978|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
94613641|NCT02215096|324047979|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
94613642|NCT03841448|324047980|FG000|Double-blind Treatment (DBT) Period|Death|1|||
94613643|NCT03841448|324047981|FG001|Double-blind Treatment (DBT) Period|Death|1|||
94613644|NCT03841448|324047982|FG002|Double-blind Treatment (DBT) Period|Death|0|||
94613645|NCT03841448|324047983|FG003|Double-blind Treatment (DBT) Period|Death|0|||
94613646|NCT03841448|324047980|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
94613647|NCT03841448|324047981|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
94613648|NCT03841448|324047982|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
94613649|NCT03841448|324047983|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
94613650|NCT03841448|324047980|FG000|Open-Label Extension (OLE) Period|Death|0|||
94613651|NCT03841448|324047981|FG001|Open-Label Extension (OLE) Period|Death|0|||
94613652|NCT03841448|324047982|FG002|Open-Label Extension (OLE) Period|Death|0|||
94613653|NCT03841448|324047983|FG003|Open-Label Extension (OLE) Period|Death|1|||
94613654|NCT03841448|324047980|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
94613655|NCT03841448|324047981|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
94613656|NCT03841448|324047982|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
94613657|NCT03841448|324047983|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
94613658|NCT03841448|324047980|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
94358630|NCT03110107|323096439|FG009|Treatment Period|Other Reasons|0|||
94358631|NCT03110107|323096440|FG010|Treatment Period|Other Reasons|0|||
94358632|NCT03110107|323096441|FG011|Treatment Period|Other Reasons|0|||
94613659|NCT03841448|324047981|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
94613660|NCT03841448|324047982|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
94613661|NCT03841448|324047983|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
94358633|NCT03110107|323096442|FG012|Treatment Period|Other Reasons|0|||
94358634|NCT03110107|323096443|FG013|Treatment Period|Other Reasons|0|||
94358635|NCT03110107|323096444|FG014|Treatment Period|Other Reasons|0|||
94358636|NCT03110107|323096445|FG015|Treatment Period|Other Reasons|0|||
94358637|NCT03110107|323096446|FG016|Treatment Period|Other Reasons|0|||
94358638|NCT03110107|323096447|FG017|Treatment Period|Other Reasons|0|||
94358639|NCT03110107|323096448|FG018|Treatment Period|Other Reasons|0|||
94358640|NCT03110107|323096449|FG019|Treatment Period|Other Reasons|0|||
94358641|NCT03110107|323096450|FG020|Treatment Period|Other Reasons|0|||
94358642|NCT03110107|323096451|FG021|Treatment Period|Other Reasons|0|||
94358643|NCT03110107|323096452|FG022|Treatment Period|Other Reasons|0|||
94358644|NCT03110107|323096453|FG023|Treatment Period|Other Reasons|0|||
94358645|NCT03110107|323096454|FG024|Treatment Period|Other Reasons|1|||
94459963|NCT00960986|323471980|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
94664615|NCT01292603|324229687|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
94664616|NCT01292603|324229688|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
94664617|NCT01292603|324229689|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
94664618|NCT01292603|324229690|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
94664619|NCT01292603|324229691|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
94664620|NCT01292603|324229692|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
94664621|NCT01292603|324229687|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
94664622|NCT01292603|324229688|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
94664623|NCT01292603|324229689|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
94664624|NCT01292603|324229690|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
94664625|NCT01292603|324229691|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
94664626|NCT01292603|324229692|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
94664627|NCT01292603|324229687|FG000|Overall Survival Status|Death|3|||
94664628|NCT01292603|324229688|FG001|Overall Survival Status|Death|1|||
94664629|NCT01292603|324229689|FG002|Overall Survival Status|Death|3|||
94664630|NCT01292603|324229690|FG003|Overall Survival Status|Death|1|||
94664631|NCT01292603|324229691|FG004|Overall Survival Status|Death|16|||
94664632|NCT01292603|324229692|FG005|Overall Survival Status|Death|10|||
94664633|NCT01432366|324229693|FG000|Overall Study|Non-Responder|7|||
94664634|NCT01432366|324229693|FG000|Overall Study|Adverse Event|8|||
94664635|NCT01432366|324229693|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
94664636|NCT01432366|324229693|FG000|Overall Study|Pregnancy|1|||
94664637|NCT01432366|324229693|FG000|Overall Study|Lost to Follow-up|13|||
94664638|NCT01432366|324229693|FG000|Overall Study|Lack of Efficacy|1|||
94664639|NCT01432366|324229693|FG000|Overall Study|Site Closed|20|||
94664640|NCT01432366|324229693|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
94664641|NCT01432366|324229693|FG000|Overall Study|Other|14|||
94664642|NCT03870763|324229694|FG000|Overall Study|Study terminated by sponsor|0|||
94664643|NCT03870763|324229695|FG001|Overall Study|Study terminated by sponsor|2|||
94664644|NCT03870763|324229696|FG002|Overall Study|Study terminated by sponsor|0|||
94664645|NCT03870763|324229694|FG000|Overall Study|Withdrawal by Subject|0|||
94664646|NCT03870763|324229695|FG001|Overall Study|Withdrawal by Subject|1|||
94664647|NCT03870763|324229696|FG002|Overall Study|Withdrawal by Subject|0|||
94664648|NCT03870763|324229694|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
94664649|NCT03870763|324229695|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
94664650|NCT03870763|324229696|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
94664651|NCT00674986|324229700|FG000|Overall Study|Adverse Event|2|||
94664652|NCT00674986|324229701|FG001|Overall Study|Adverse Event|1|||
94664653|NCT00674986|324229700|FG000|Overall Study|Subject withdrew consent|12|||
94664654|NCT00674986|324229701|FG001|Overall Study|Subject withdrew consent|19|||
94664655|NCT00674986|324229700|FG000|Overall Study|Lost to Follow-up|25|||
94664656|NCT00674986|324229701|FG001|Overall Study|Lost to Follow-up|53|||
94664657|NCT00674986|324229700|FG000|Overall Study|Other reasons|4|||
94664658|NCT00674986|324229701|FG001|Overall Study|Other reasons|8|||
94459964|NCT00960986|323471981|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
94459965|NCT00960986|323471982|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
94664659|NCT00377234|324229707|FG000|Overall Study|Adverse Event|14|||
94664660|NCT00377234|324229708|FG001|Overall Study|Adverse Event|17|||
94664661|NCT00377234|324229707|FG000|Overall Study|Withdrawal by Subject|11|||
94664662|NCT00377234|324229708|FG001|Overall Study|Withdrawal by Subject|9|||
94664663|NCT00377234|324229707|FG000|Overall Study|Lost to Follow-up|4|||
94358646|NCT03110107|323096455|FG025|Treatment Period|Other Reasons|0|||
94358647|NCT03985982|323096456|FG000|Double-Blind Phase|Lost to Follow-up|4|||
94459966|NCT00960986|323471979|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
94664664|NCT00377234|324229708|FG001|Overall Study|Lost to Follow-up|2|||
94664665|NCT00377234|324229707|FG000|Overall Study|Administrative|2|||
94664666|NCT00377234|324229708|FG001|Overall Study|Administrative|1|||
94664667|NCT00377234|324229707|FG000|Overall Study|Not assigned|3|||
94664668|NCT00377234|324229708|FG001|Overall Study|Not assigned|2|||
94664669|NCT01912612|324229709|FG000|Overall Study|Adverse Event|4|||
94664670|NCT01912612|324229710|FG001|Overall Study|Adverse Event|0|||
94664671|NCT01912612|324229711|FG002|Overall Study|Adverse Event|0|||
94459967|NCT00960986|323471980|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
94459968|NCT00960986|323471981|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
94459969|NCT00960986|323471982|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
94664672|NCT01912612|324229709|FG000|Overall Study|Withdrew consent|1|||
94664673|NCT01912612|324229710|FG001|Overall Study|Withdrew consent|0|||
94664674|NCT01912612|324229711|FG002|Overall Study|Withdrew consent|0|||
94664675|NCT01912612|324229709|FG000|Overall Study|Study design change|0|||
94664676|NCT01912612|324229710|FG001|Overall Study|Study design change|0|||
94664677|NCT01912612|324229711|FG002|Overall Study|Study design change|3|||
94664678|NCT01585103|324229712|FG000|Overall Study|Unable to swallow Cytosponge|6|||
94664679|NCT01349569|324229713|FG000|Overall Study|Lack of Efficacy|4|||
94459970|NCT00960986|323471979|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
94459971|NCT00960986|323471980|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
94613662|NCT03841448|324047980|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
94613663|NCT03841448|324047981|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
94613664|NCT03841448|324047982|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
94613665|NCT03841448|324047983|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
94613666|NCT03181893|324047984|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
94613667|NCT03181893|324047985|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
94613668|NCT03181893|324047986|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
94664680|NCT03581305|324229714|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
94664681|NCT03581305|324229715|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
94664682|NCT03581305|324229714|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
94664683|NCT03581305|324229715|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
94664684|NCT03581305|324229714|FG000|Serotonergic Study|Withdrawal by Subject|5|||
94664685|NCT03581305|324229715|FG001|Serotonergic Study|Withdrawal by Subject|1|||
94664686|NCT02280044|324229720|FG000|Overall Study|Planned alternate|0|||
94664687|NCT02280044|324229721|FG001|Overall Study|Planned alternate|2|||
94664688|NCT02367911|324229724|FG000|Overall Study|Withdrawal by Subject|3|||
94664689|NCT02367911|324229725|FG001|Overall Study|Withdrawal by Subject|2|||
94664690|NCT02367911|324229724|FG000|Overall Study|Lost to Follow-up|2|||
94613669|NCT03181893|324047987|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
94664691|NCT02367911|324229725|FG001|Overall Study|Lost to Follow-up|2|||
94664692|NCT02105116|324229727|FG000|Overall Study|not eligible for step 2 of trial|5|||
94664693|NCT02105116|324229727|FG000|Overall Study|Death|1|||
94664694|NCT01490632|324229728|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
94664695|NCT01490632|324229729|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
94664696|NCT01490632|324229730|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
94664697|NCT01490632|324229731|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
94664698|NCT01490632|324229732|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
94664699|NCT01490632|324229733|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
94664700|NCT01490632|324229734|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
94664701|NCT01490632|324229735|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
94664702|NCT01490632|324229736|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
94664703|NCT01490632|324229737|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
94664704|NCT01490632|324229738|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
94664705|NCT01490632|324229739|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
94358648|NCT03985982|323096457|FG001|Double-Blind Phase|Lost to Follow-up|3|||
94613670|NCT03181893|324047988|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
94613671|NCT03181893|324047989|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
94613672|NCT03181893|324047990|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
94613673|NCT03181893|324047991|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
94613674|NCT03181893|324047992|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
94613675|NCT03181893|324047993|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
94613676|NCT03181893|324047994|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
94613677|NCT03181893|324047984|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
94613678|NCT03181893|324047985|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
94613679|NCT03181893|324047986|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
94613680|NCT03181893|324047987|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
94613681|NCT03181893|324047988|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
94613682|NCT03181893|324047989|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
94613683|NCT03181893|324047990|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
94613684|NCT03181893|324047991|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
94613685|NCT03181893|324047992|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
94613686|NCT03181893|324047993|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
94613687|NCT03181893|324047994|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
94613688|NCT03181893|324047984|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
94613689|NCT03181893|324047985|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
94613690|NCT03181893|324047986|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
94613691|NCT03181893|324047987|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
94613692|NCT03181893|324047988|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
94613693|NCT03181893|324047989|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
94613694|NCT03181893|324047990|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
94613695|NCT03181893|324047991|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
94613696|NCT03181893|324047992|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
94613697|NCT03181893|324047993|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
94613698|NCT03181893|324047994|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
94613699|NCT03181893|324047984|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
94613700|NCT03181893|324047985|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
94613701|NCT03181893|324047986|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
94613702|NCT03181893|324047987|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
94613703|NCT03181893|324047988|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
94613704|NCT03181893|324047989|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
94613705|NCT03181893|324047990|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
94664706|NCT01490632|324229740|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
94358649|NCT03985982|323096458|FG002|Double-Blind Phase|Lost to Follow-up|0|||
94358650|NCT03985982|323096456|FG000|Double-Blind Phase|Physician Decision|1|||
94358651|NCT03985982|323096457|FG001|Double-Blind Phase|Physician Decision|0|||
94358652|NCT03985982|323096458|FG002|Double-Blind Phase|Physician Decision|0|||
94358653|NCT03985982|323096456|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
94358654|NCT03985982|323096457|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
94358655|NCT03985982|323096458|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
94358656|NCT03985982|323096456|FG000|Double-Blind Phase|COVID-19|1|||
94358657|NCT03985982|323096457|FG001|Double-Blind Phase|COVID-19|0|||
94358658|NCT03985982|323096458|FG002|Double-Blind Phase|COVID-19|0|||
94358659|NCT03985982|323096456|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
94358660|NCT03985982|323096457|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
94358661|NCT03985982|323096458|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
94358662|NCT03985982|323096456|FG000|Open-Label Phase|Lost to Follow-up|0|||
94358663|NCT03985982|323096457|FG001|Open-Label Phase|Lost to Follow-up|0|||
94358664|NCT03985982|323096458|FG002|Open-Label Phase|Lost to Follow-up|13|||
94664707|NCT01490632|324229741|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
94664708|NCT01490632|324229742|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
94664709|NCT01490632|324229743|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
94664710|NCT01490632|324229744|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
94664711|NCT01490632|324229745|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
94664712|NCT01490632|324229746|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
94664713|NCT01490632|324229747|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
94664714|NCT01490632|324229728|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
94664715|NCT01490632|324229729|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
94664716|NCT01490632|324229730|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
94664717|NCT01490632|324229731|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
94664718|NCT01490632|324229732|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
94664719|NCT01490632|324229733|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
94664720|NCT01490632|324229734|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
94664721|NCT01490632|324229735|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
94664722|NCT01490632|324229736|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
94664723|NCT01490632|324229737|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
94664724|NCT01490632|324229738|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
94664725|NCT01490632|324229739|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
94664726|NCT01490632|324229740|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
94664727|NCT01490632|324229741|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
94664728|NCT01490632|324229742|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
94664729|NCT01490632|324229743|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
94613706|NCT03181893|324047991|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
94613707|NCT03181893|324047992|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
94613708|NCT03181893|324047993|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
94613709|NCT03181893|324047994|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
94613710|NCT03181893|324047984|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
94613711|NCT03181893|324047985|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
94613712|NCT03181893|324047986|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
94613713|NCT03181893|324047987|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
94613714|NCT03181893|324047988|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
94613715|NCT03181893|324047989|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
94613716|NCT03181893|324047990|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
94613717|NCT03181893|324047991|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
94613718|NCT03181893|324047992|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
94613719|NCT03181893|324047993|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
94613720|NCT03181893|324047994|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
94613721|NCT02158975|324047995|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
94613722|NCT03685123|324047996|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
94613723|NCT03685123|324047997|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
94613724|NCT03685123|324047998|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
94613725|NCT03685123|324047996|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
94613726|NCT03685123|324047997|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
94613727|NCT03685123|324047998|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
94613728|NCT03685123|324047996|FG000|Weight Loss Phase|Lost to Follow-up|1|||
94613729|NCT03685123|324047997|FG001|Weight Loss Phase|Lost to Follow-up|0|||
94613730|NCT03685123|324047998|FG002|Weight Loss Phase|Lost to Follow-up|0|||
94613731|NCT03685123|324047996|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
94613732|NCT03685123|324047997|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
94613733|NCT03685123|324047998|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
94613734|NCT03685123|324047996|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
94613735|NCT03685123|324047997|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
94613736|NCT03685123|324047998|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
94613737|NCT03685123|324047996|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
94613738|NCT03685123|324047997|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
94613739|NCT03685123|324047998|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
94613740|NCT02020577|324047999|FG000|Overall Study|Progressive disease|3|||
94613741|NCT02020577|324048000|FG001|Overall Study|Progressive disease|38|||
94613742|NCT02020577|324047999|FG000|Overall Study|Other AE or clinical progression|0|||
94613743|NCT02020577|324048000|FG001|Overall Study|Other AE or clinical progression|15|||
94664730|NCT01490632|324229744|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
94664731|NCT01490632|324229745|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
94664732|NCT01490632|324229746|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
94664733|NCT01490632|324229747|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
94664734|NCT01490632|324229728|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
94664735|NCT01490632|324229729|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
94664736|NCT01490632|324229730|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
94664737|NCT01490632|324229731|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
94664738|NCT01490632|324229732|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
94664739|NCT01490632|324229733|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
94664740|NCT01490632|324229734|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
94664741|NCT01490632|324229735|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
94664742|NCT01490632|324229736|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
94664743|NCT01490632|324229737|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
94664744|NCT01490632|324229738|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
94664745|NCT01490632|324229739|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
94664746|NCT01490632|324229740|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
94664747|NCT01490632|324229741|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
94664748|NCT01490632|324229742|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
94664749|NCT01490632|324229743|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
94664750|NCT01490632|324229744|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
94664751|NCT01490632|324229745|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
94664752|NCT01490632|324229746|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
94664753|NCT01490632|324229747|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
94664754|NCT01490632|324229728|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
94664755|NCT01490632|324229729|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
94664756|NCT01490632|324229730|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
94664757|NCT01490632|324229731|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
94664758|NCT01490632|324229732|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
94664759|NCT01490632|324229733|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
94664760|NCT01490632|324229734|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
94664761|NCT01490632|324229735|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
94664762|NCT01490632|324229736|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
94664763|NCT01490632|324229737|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
94664764|NCT01490632|324229738|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
94664765|NCT01490632|324229739|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
94664766|NCT01490632|324229740|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
94664767|NCT01490632|324229741|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
94664768|NCT01490632|324229742|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
94664769|NCT01490632|324229743|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
94664770|NCT01490632|324229744|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
94664771|NCT01490632|324229745|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
94664772|NCT01490632|324229746|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
94664773|NCT01490632|324229747|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
94664774|NCT01490632|324229728|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
94664775|NCT01490632|324229729|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664776|NCT01490632|324229730|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664777|NCT01490632|324229731|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664778|NCT01490632|324229732|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664779|NCT01490632|324229733|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664780|NCT01490632|324229734|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664781|NCT01490632|324229735|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664782|NCT01490632|324229736|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664783|NCT01490632|324229737|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664784|NCT01490632|324229738|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664785|NCT01490632|324229739|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664786|NCT01490632|324229740|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664787|NCT01490632|324229741|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664788|NCT01490632|324229742|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664789|NCT01490632|324229743|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664790|NCT01490632|324229744|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664791|NCT01490632|324229745|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664792|NCT01490632|324229746|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664793|NCT01490632|324229747|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
94664794|NCT01490632|324229728|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
94664795|NCT01490632|324229729|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
94664796|NCT01490632|324229730|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
94664797|NCT01490632|324229731|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
94664798|NCT01490632|324229732|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
94664799|NCT01490632|324229733|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
94664800|NCT01490632|324229734|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
94664801|NCT01490632|324229735|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
94664802|NCT01490632|324229736|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
94664803|NCT01490632|324229737|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
94664804|NCT01490632|324229738|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
94613744|NCT02020577|324047999|FG000|Overall Study|Withdrawal by Subject|0|||
94613745|NCT02020577|324048000|FG001|Overall Study|Withdrawal by Subject|1|||
94613746|NCT02020577|324047999|FG000|Overall Study|Other than stated above|0|||
94613747|NCT02020577|324048000|FG001|Overall Study|Other than stated above|1|||
94613748|NCT01752985|324048001|FG000|Treatment Period|Subject request to discontinue treatment|1|||
94613749|NCT01752985|324048002|FG001|Treatment Period|Subject request to discontinue treatment|0|||
94613750|NCT01752985|324048003|FG002|Treatment Period|Subject request to discontinue treatment|1|||
94613751|NCT01752985|324048001|FG000|Treatment Period|Subject no longer meets study criteria|0|||
94613752|NCT01752985|324048002|FG001|Treatment Period|Subject no longer meets study criteria|1|||
94613753|NCT01752985|324048003|FG002|Treatment Period|Subject no longer meets study criteria|1|||
94613754|NCT01752985|324048001|FG000|Treatment Period|Adverse Event|2|||
94613755|NCT01752985|324048002|FG001|Treatment Period|Adverse Event|1|||
94613756|NCT01752985|324048003|FG002|Treatment Period|Adverse Event|2|||
94613757|NCT01752985|324048001|FG000|Treatment Period|Withdrawal by Subject|1|||
94613758|NCT01752985|324048002|FG001|Treatment Period|Withdrawal by Subject|1|||
94613759|NCT01752985|324048003|FG002|Treatment Period|Withdrawal by Subject|0|||
94613760|NCT01752985|324048001|FG000|Treatment Period|Lost to Follow-up|0|||
94613761|NCT01752985|324048002|FG001|Treatment Period|Lost to Follow-up|0|||
94613762|NCT01752985|324048003|FG002|Treatment Period|Lost to Follow-up|1|||
94613763|NCT01758523|324048004|FG000|Overall Study|Adverse Event|2|||
94613764|NCT01758523|324048005|FG001|Overall Study|Adverse Event|1|||
94613765|NCT01758523|324048004|FG000|Overall Study|Lack of Efficacy|4|||
94613766|NCT01758523|324048005|FG001|Overall Study|Lack of Efficacy|2|||
94613767|NCT01758523|324048004|FG000|Overall Study|Lost to Follow-up|3|||
94613768|NCT01758523|324048005|FG001|Overall Study|Lost to Follow-up|4|||
94613769|NCT01758523|324048004|FG000|Overall Study|Withdrawal by Subject|12|||
94613770|NCT01758523|324048005|FG001|Overall Study|Withdrawal by Subject|7|||
94613771|NCT04729621|324048006|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
94613772|NCT04729621|324048007|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
94613773|NCT04729621|324048008|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
94613774|NCT04729621|324048009|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
94613775|NCT04729621|324048010|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
94613776|NCT04729621|324048006|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
94613777|NCT04729621|324048007|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
94613778|NCT04729621|324048008|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
94613779|NCT04729621|324048009|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
94613780|NCT04729621|324048010|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
94613781|NCT04729621|324048006|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
94613782|NCT04729621|324048007|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
94613783|NCT04729621|324048008|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
94613784|NCT04729621|324048009|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
94613785|NCT04729621|324048010|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
94613786|NCT04729621|324048006|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
94613787|NCT04729621|324048007|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
94613788|NCT04729621|324048008|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
94613789|NCT04729621|324048009|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
94613790|NCT04729621|324048010|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
94613791|NCT04729621|324048006|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
94613792|NCT04729621|324048007|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
94613793|NCT04729621|324048008|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
94613794|NCT04729621|324048009|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
94613795|NCT04729621|324048010|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
94613796|NCT04729621|324048006|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
94613797|NCT04729621|324048007|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
94613798|NCT04729621|324048008|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
94613799|NCT04729621|324048009|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
94613800|NCT04729621|324048010|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
94613801|NCT00347360|324048014|FG000|Overall Study|Adverse Event|1|||
94613802|NCT00347360|324048015|FG001|Overall Study|Adverse Event|2|||
94613803|NCT00347360|324048016|FG002|Overall Study|Adverse Event|0|||
94613804|NCT00347360|324048017|FG003|Overall Study|Adverse Event|4|||
94613805|NCT00347360|324048018|FG004|Overall Study|Adverse Event|1|||
94613806|NCT00347360|324048019|FG005|Overall Study|Adverse Event|2|||
94613807|NCT00347360|324048020|FG006|Overall Study|Adverse Event|2|||
94613808|NCT00347360|324048021|FG007|Overall Study|Adverse Event|0|||
94613809|NCT00347360|324048022|FG008|Overall Study|Adverse Event|2|||
94613810|NCT00347360|324048023|FG009|Overall Study|Adverse Event|3|||
94613811|NCT00347360|324048024|FG010|Overall Study|Adverse Event|3|||
94613812|NCT00347360|324048025|FG011|Overall Study|Adverse Event|1|||
94613813|NCT00347360|324048026|FG012|Overall Study|Adverse Event|3|||
94664805|NCT01490632|324229739|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
94664806|NCT01490632|324229740|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
94664807|NCT01490632|324229741|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
94664808|NCT01490632|324229742|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
94664809|NCT01490632|324229743|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
94664810|NCT01490632|324229744|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
94664811|NCT01490632|324229745|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
94664812|NCT01490632|324229746|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
94664813|NCT01490632|324229747|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
94664814|NCT01490632|324229728|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94664815|NCT01490632|324229729|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94664816|NCT01490632|324229730|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94664817|NCT01490632|324229731|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94664818|NCT01490632|324229732|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
94664819|NCT01490632|324229733|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94664820|NCT01490632|324229734|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94613814|NCT00347360|324048027|FG013|Overall Study|Adverse Event|2|||
94613815|NCT00347360|324048028|FG014|Overall Study|Adverse Event|2|||
94613816|NCT00347360|324048014|FG000|Overall Study|Lost to Follow-up|0|||
94613817|NCT00347360|324048015|FG001|Overall Study|Lost to Follow-up|0|||
94613818|NCT00347360|324048016|FG002|Overall Study|Lost to Follow-up|0|||
94613819|NCT00347360|324048017|FG003|Overall Study|Lost to Follow-up|2|||
94613820|NCT00347360|324048018|FG004|Overall Study|Lost to Follow-up|1|||
94613821|NCT00347360|324048019|FG005|Overall Study|Lost to Follow-up|1|||
94613822|NCT00347360|324048020|FG006|Overall Study|Lost to Follow-up|0|||
94613823|NCT00347360|324048021|FG007|Overall Study|Lost to Follow-up|1|||
94613824|NCT00347360|324048022|FG008|Overall Study|Lost to Follow-up|1|||
94613825|NCT00347360|324048023|FG009|Overall Study|Lost to Follow-up|2|||
94613826|NCT00347360|324048024|FG010|Overall Study|Lost to Follow-up|0|||
94613827|NCT00347360|324048025|FG011|Overall Study|Lost to Follow-up|0|||
94613828|NCT00347360|324048026|FG012|Overall Study|Lost to Follow-up|1|||
94613829|NCT00347360|324048027|FG013|Overall Study|Lost to Follow-up|0|||
94613830|NCT00347360|324048028|FG014|Overall Study|Lost to Follow-up|0|||
94613831|NCT00347360|324048014|FG000|Overall Study|Protocol Violation|2|||
94613832|NCT00347360|324048015|FG001|Overall Study|Protocol Violation|3|||
94613833|NCT00347360|324048016|FG002|Overall Study|Protocol Violation|1|||
94613834|NCT00347360|324048017|FG003|Overall Study|Protocol Violation|2|||
94613835|NCT00347360|324048018|FG004|Overall Study|Protocol Violation|1|||
94613836|NCT00347360|324048019|FG005|Overall Study|Protocol Violation|2|||
94613837|NCT00347360|324048020|FG006|Overall Study|Protocol Violation|0|||
94613838|NCT00347360|324048021|FG007|Overall Study|Protocol Violation|0|||
94613839|NCT00347360|324048022|FG008|Overall Study|Protocol Violation|1|||
94613840|NCT00347360|324048023|FG009|Overall Study|Protocol Violation|2|||
94613841|NCT00347360|324048024|FG010|Overall Study|Protocol Violation|0|||
94613842|NCT00347360|324048025|FG011|Overall Study|Protocol Violation|0|||
94613843|NCT00347360|324048026|FG012|Overall Study|Protocol Violation|0|||
94613844|NCT00347360|324048027|FG013|Overall Study|Protocol Violation|1|||
94613845|NCT00347360|324048028|FG014|Overall Study|Protocol Violation|0|||
94613846|NCT00347360|324048014|FG000|Overall Study|Withdrawal by Subject|0|||
94613847|NCT00347360|324048015|FG001|Overall Study|Withdrawal by Subject|1|||
94613848|NCT00347360|324048016|FG002|Overall Study|Withdrawal by Subject|2|||
94613849|NCT00347360|324048017|FG003|Overall Study|Withdrawal by Subject|4|||
94613850|NCT00347360|324048018|FG004|Overall Study|Withdrawal by Subject|1|||
94613851|NCT00347360|324048019|FG005|Overall Study|Withdrawal by Subject|2|||
94613852|NCT00347360|324048020|FG006|Overall Study|Withdrawal by Subject|1|||
94613853|NCT00347360|324048021|FG007|Overall Study|Withdrawal by Subject|1|||
94613854|NCT00347360|324048022|FG008|Overall Study|Withdrawal by Subject|1|||
94613855|NCT00347360|324048023|FG009|Overall Study|Withdrawal by Subject|1|||
94613856|NCT00347360|324048024|FG010|Overall Study|Withdrawal by Subject|0|||
94613857|NCT00347360|324048025|FG011|Overall Study|Withdrawal by Subject|3|||
94613858|NCT00347360|324048026|FG012|Overall Study|Withdrawal by Subject|4|||
94613859|NCT00347360|324048027|FG013|Overall Study|Withdrawal by Subject|2|||
94613860|NCT00347360|324048028|FG014|Overall Study|Withdrawal by Subject|1|||
94613861|NCT00347360|324048014|FG000|Overall Study|Lack of Efficacy|1|||
94613862|NCT00347360|324048015|FG001|Overall Study|Lack of Efficacy|1|||
94613863|NCT00347360|324048016|FG002|Overall Study|Lack of Efficacy|3|||
94613864|NCT00347360|324048017|FG003|Overall Study|Lack of Efficacy|1|||
94613865|NCT00347360|324048018|FG004|Overall Study|Lack of Efficacy|0|||
94613866|NCT00347360|324048019|FG005|Overall Study|Lack of Efficacy|1|||
94613867|NCT00347360|324048020|FG006|Overall Study|Lack of Efficacy|0|||
94613868|NCT00347360|324048021|FG007|Overall Study|Lack of Efficacy|1|||
94613869|NCT00347360|324048022|FG008|Overall Study|Lack of Efficacy|1|||
94613870|NCT00347360|324048023|FG009|Overall Study|Lack of Efficacy|0|||
94613871|NCT00347360|324048024|FG010|Overall Study|Lack of Efficacy|0|||
94613872|NCT00347360|324048025|FG011|Overall Study|Lack of Efficacy|0|||
94613873|NCT00347360|324048026|FG012|Overall Study|Lack of Efficacy|0|||
94613874|NCT00347360|324048027|FG013|Overall Study|Lack of Efficacy|0|||
94613875|NCT00347360|324048028|FG014|Overall Study|Lack of Efficacy|0|||
94613876|NCT00347360|324048014|FG000|Overall Study|Reason not listed/blank|1|||
94613877|NCT00347360|324048015|FG001|Overall Study|Reason not listed/blank|0|||
94613878|NCT00347360|324048016|FG002|Overall Study|Reason not listed/blank|0|||
94613879|NCT00347360|324048017|FG003|Overall Study|Reason not listed/blank|0|||
94613880|NCT00347360|324048018|FG004|Overall Study|Reason not listed/blank|0|||
94613881|NCT00347360|324048019|FG005|Overall Study|Reason not listed/blank|0|||
94613882|NCT00347360|324048020|FG006|Overall Study|Reason not listed/blank|1|||
94613883|NCT00347360|324048021|FG007|Overall Study|Reason not listed/blank|0|||
94613884|NCT00347360|324048022|FG008|Overall Study|Reason not listed/blank|0|||
94613885|NCT00347360|324048023|FG009|Overall Study|Reason not listed/blank|0|||
94613886|NCT00347360|324048024|FG010|Overall Study|Reason not listed/blank|0|||
94613887|NCT00347360|324048025|FG011|Overall Study|Reason not listed/blank|0|||
94613888|NCT00347360|324048026|FG012|Overall Study|Reason not listed/blank|0|||
94613889|NCT00347360|324048027|FG013|Overall Study|Reason not listed/blank|1|||
94613890|NCT00347360|324048028|FG014|Overall Study|Reason not listed/blank|0|||
94613891|NCT00347360|324048014|FG000|Overall Study|Per sponsors instruction|0|||
94613892|NCT00347360|324048015|FG001|Overall Study|Per sponsors instruction|1|||
94613893|NCT00347360|324048016|FG002|Overall Study|Per sponsors instruction|0|||
94613894|NCT00347360|324048017|FG003|Overall Study|Per sponsors instruction|0|||
94613895|NCT00347360|324048018|FG004|Overall Study|Per sponsors instruction|0|||
94613896|NCT00347360|324048019|FG005|Overall Study|Per sponsors instruction|0|||
94613897|NCT00347360|324048020|FG006|Overall Study|Per sponsors instruction|0|||
94613898|NCT00347360|324048021|FG007|Overall Study|Per sponsors instruction|0|||
94613899|NCT00347360|324048022|FG008|Overall Study|Per sponsors instruction|0|||
94613900|NCT00347360|324048023|FG009|Overall Study|Per sponsors instruction|0|||
94613901|NCT00347360|324048024|FG010|Overall Study|Per sponsors instruction|0|||
94613902|NCT00347360|324048025|FG011|Overall Study|Per sponsors instruction|0|||
94613903|NCT00347360|324048026|FG012|Overall Study|Per sponsors instruction|0|||
94613904|NCT00347360|324048027|FG013|Overall Study|Per sponsors instruction|0|||
94613905|NCT00347360|324048028|FG014|Overall Study|Per sponsors instruction|0|||
94613906|NCT00347360|324048014|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
94613907|NCT00347360|324048015|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
94613908|NCT00347360|324048016|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
94613909|NCT00347360|324048017|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
94613910|NCT00347360|324048018|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
94613911|NCT00347360|324048019|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
94664821|NCT01490632|324229735|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94664822|NCT01490632|324229736|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94664823|NCT01490632|324229737|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94664824|NCT01490632|324229738|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94664825|NCT01490632|324229739|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94664826|NCT01490632|324229740|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94664827|NCT01490632|324229741|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94664828|NCT01490632|324229742|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94664829|NCT01490632|324229743|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94664830|NCT01490632|324229744|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94664831|NCT01490632|324229745|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94664832|NCT01490632|324229746|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94664833|NCT01490632|324229747|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
94664834|NCT01490632|324229728|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
94664835|NCT01490632|324229729|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
94664836|NCT01490632|324229730|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
94664837|NCT01490632|324229731|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
94664838|NCT01490632|324229732|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
94664839|NCT01490632|324229733|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
94664840|NCT01490632|324229734|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
94664841|NCT01490632|324229735|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
94664842|NCT01490632|324229736|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
94664843|NCT01490632|324229737|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
94664844|NCT01490632|324229738|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
94664845|NCT01490632|324229739|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
94664846|NCT01490632|324229740|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
94664847|NCT01490632|324229741|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
94664848|NCT01490632|324229742|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
94664849|NCT01490632|324229743|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
94664850|NCT01490632|324229744|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
94664851|NCT01490632|324229745|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
94664852|NCT01490632|324229746|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
94664853|NCT01490632|324229747|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
94664854|NCT01490632|324229728|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
94664855|NCT01490632|324229729|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
94664856|NCT01490632|324229730|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
94664857|NCT01490632|324229731|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
94664858|NCT01490632|324229732|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
94664859|NCT01490632|324229733|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
94664860|NCT01490632|324229734|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
94664861|NCT01490632|324229735|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
94664862|NCT01490632|324229736|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
94664863|NCT01490632|324229737|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
94664864|NCT01490632|324229738|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
94664865|NCT01490632|324229739|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
94664866|NCT01490632|324229740|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
94664867|NCT01490632|324229741|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
94664868|NCT01490632|324229742|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
94664869|NCT01490632|324229743|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
94664870|NCT01490632|324229744|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
94664871|NCT01490632|324229745|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
94664872|NCT01490632|324229746|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
94664873|NCT01490632|324229747|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
94664874|NCT01490632|324229728|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
94664875|NCT01490632|324229729|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
94664876|NCT01490632|324229730|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
94664877|NCT01490632|324229731|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
94664878|NCT01490632|324229732|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
94664879|NCT01490632|324229733|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
94664880|NCT01490632|324229734|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
94664881|NCT01490632|324229735|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
94664882|NCT01490632|324229736|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
94664883|NCT01490632|324229737|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
94664884|NCT01490632|324229738|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
94664885|NCT01490632|324229739|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
94664886|NCT01490632|324229740|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
94664887|NCT01490632|324229741|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
94664888|NCT01490632|324229742|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
94664889|NCT01490632|324229743|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
94664890|NCT01490632|324229744|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
94664891|NCT01490632|324229745|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
94664892|NCT01490632|324229746|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
94664893|NCT01490632|324229747|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
94664894|NCT01490632|324229728|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
94664895|NCT01490632|324229729|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
94664896|NCT01490632|324229730|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
94664897|NCT01490632|324229731|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
94664898|NCT01490632|324229732|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
94664899|NCT01490632|324229733|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
94664900|NCT01490632|324229734|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
94664901|NCT01490632|324229735|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
94664902|NCT01490632|324229736|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
94664903|NCT01490632|324229737|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
94358665|NCT03985982|323096456|FG000|Open-Label Phase|Physician Decision|0|||
94358666|NCT03985982|323096457|FG001|Open-Label Phase|Physician Decision|0|||
94358667|NCT03985982|323096458|FG002|Open-Label Phase|Physician Decision|2|||
94358668|NCT03985982|323096456|FG000|Open-Label Phase|Withdrawal by Subject|0|||
94358669|NCT03985982|323096457|FG001|Open-Label Phase|Withdrawal by Subject|0|||
94358670|NCT03985982|323096458|FG002|Open-Label Phase|Withdrawal by Subject|11|||
94358671|NCT04780776|323096463|FG000|Titration Week 1-5|Lost to Follow-up|2|||
94358672|NCT04780776|323096464|FG001|Titration Week 1-5|Lost to Follow-up|8|||
94358673|NCT04780776|323096463|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
94358674|NCT04780776|323096464|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
94358675|NCT04780776|323096463|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
94358676|NCT04780776|323096464|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
94358677|NCT02356159|323096465|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
94358678|NCT02356159|323096466|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
94358679|NCT02356159|323096467|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
94664904|NCT01490632|324229738|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
94664905|NCT01490632|324229739|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
94664906|NCT01490632|324229740|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
94664907|NCT01490632|324229741|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
94664908|NCT01490632|324229742|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
94664909|NCT01490632|324229743|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
94664910|NCT01490632|324229744|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
94664911|NCT01490632|324229745|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
94664912|NCT01490632|324229746|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
94664913|NCT01490632|324229747|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
94664914|NCT01490632|324229728|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664915|NCT01490632|324229729|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664916|NCT01490632|324229730|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664917|NCT01490632|324229731|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664918|NCT01490632|324229732|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664919|NCT01490632|324229733|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
94664920|NCT01490632|324229734|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664921|NCT01490632|324229735|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664922|NCT01490632|324229736|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664923|NCT01490632|324229737|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664924|NCT01490632|324229738|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664925|NCT01490632|324229739|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664926|NCT01490632|324229740|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664927|NCT01490632|324229741|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664928|NCT01490632|324229742|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664929|NCT01490632|324229743|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664930|NCT01490632|324229744|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664931|NCT01490632|324229745|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664932|NCT01490632|324229746|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664933|NCT01490632|324229747|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
94664934|NCT01490632|324229728|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
94664935|NCT01490632|324229729|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
94664936|NCT01490632|324229730|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
94664937|NCT01490632|324229731|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
94664938|NCT01490632|324229732|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
94664939|NCT01490632|324229733|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
94664940|NCT01490632|324229734|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
94664941|NCT01490632|324229735|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
94664942|NCT01490632|324229736|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
94664943|NCT01490632|324229737|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
94613912|NCT00347360|324048020|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
94613913|NCT00347360|324048021|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
94613914|NCT00347360|324048022|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
94613915|NCT00347360|324048023|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
94613916|NCT00347360|324048024|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
94613917|NCT00347360|324048025|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
94613918|NCT00347360|324048026|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
94613919|NCT00347360|324048027|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
94613920|NCT00347360|324048028|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
94613921|NCT00347360|324048014|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
94613922|NCT00347360|324048015|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
94613923|NCT00347360|324048016|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
94613924|NCT00347360|324048017|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
94613925|NCT00347360|324048018|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
94613926|NCT00347360|324048019|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
94613927|NCT00347360|324048020|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
94613928|NCT00347360|324048021|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
94613929|NCT00347360|324048022|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
94613930|NCT00347360|324048023|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
94613931|NCT00347360|324048024|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
94613932|NCT00347360|324048025|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
94613933|NCT00347360|324048026|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
94613934|NCT00347360|324048027|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
94613935|NCT00347360|324048028|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
94613936|NCT00347360|324048014|FG000|Overall Study|Abnormal lab values|0|||
94613937|NCT00347360|324048015|FG001|Overall Study|Abnormal lab values|0|||
94613938|NCT00347360|324048016|FG002|Overall Study|Abnormal lab values|0|||
94613939|NCT00347360|324048017|FG003|Overall Study|Abnormal lab values|0|||
94613940|NCT00347360|324048018|FG004|Overall Study|Abnormal lab values|0|||
94613941|NCT00347360|324048019|FG005|Overall Study|Abnormal lab values|0|||
94613942|NCT00347360|324048020|FG006|Overall Study|Abnormal lab values|1|||
94613943|NCT00347360|324048021|FG007|Overall Study|Abnormal lab values|0|||
94613944|NCT00347360|324048022|FG008|Overall Study|Abnormal lab values|0|||
94613945|NCT00347360|324048023|FG009|Overall Study|Abnormal lab values|0|||
94613946|NCT00347360|324048024|FG010|Overall Study|Abnormal lab values|0|||
94613947|NCT00347360|324048025|FG011|Overall Study|Abnormal lab values|0|||
94613948|NCT00347360|324048026|FG012|Overall Study|Abnormal lab values|0|||
94613949|NCT00347360|324048027|FG013|Overall Study|Abnormal lab values|0|||
94613950|NCT00347360|324048028|FG014|Overall Study|Abnormal lab values|0|||
94613951|NCT00347360|324048014|FG000|Overall Study|PI recommended early withdrawal|0|||
94613952|NCT00347360|324048015|FG001|Overall Study|PI recommended early withdrawal|0|||
94613953|NCT00347360|324048016|FG002|Overall Study|PI recommended early withdrawal|0|||
94613954|NCT00347360|324048017|FG003|Overall Study|PI recommended early withdrawal|0|||
94613955|NCT00347360|324048018|FG004|Overall Study|PI recommended early withdrawal|0|||
94613956|NCT00347360|324048019|FG005|Overall Study|PI recommended early withdrawal|0|||
94613957|NCT00347360|324048020|FG006|Overall Study|PI recommended early withdrawal|0|||
94613958|NCT00347360|324048021|FG007|Overall Study|PI recommended early withdrawal|0|||
94613959|NCT00347360|324048022|FG008|Overall Study|PI recommended early withdrawal|0|||
94613960|NCT00347360|324048023|FG009|Overall Study|PI recommended early withdrawal|1|||
94613961|NCT00347360|324048024|FG010|Overall Study|PI recommended early withdrawal|0|||
94613962|NCT00347360|324048025|FG011|Overall Study|PI recommended early withdrawal|0|||
94613963|NCT00347360|324048026|FG012|Overall Study|PI recommended early withdrawal|0|||
94613964|NCT00347360|324048027|FG013|Overall Study|PI recommended early withdrawal|0|||
94613965|NCT00347360|324048028|FG014|Overall Study|PI recommended early withdrawal|0|||
94613966|NCT00347360|324048014|FG000|Overall Study|Did not meet criteria before ABPM|0|||
94613967|NCT00347360|324048015|FG001|Overall Study|Did not meet criteria before ABPM|0|||
94613968|NCT00347360|324048016|FG002|Overall Study|Did not meet criteria before ABPM|0|||
94613969|NCT00347360|324048017|FG003|Overall Study|Did not meet criteria before ABPM|0|||
94613970|NCT00347360|324048018|FG004|Overall Study|Did not meet criteria before ABPM|0|||
94613971|NCT00347360|324048019|FG005|Overall Study|Did not meet criteria before ABPM|0|||
94613972|NCT00347360|324048020|FG006|Overall Study|Did not meet criteria before ABPM|0|||
94613973|NCT00347360|324048021|FG007|Overall Study|Did not meet criteria before ABPM|0|||
94613974|NCT00347360|324048022|FG008|Overall Study|Did not meet criteria before ABPM|0|||
94613975|NCT00347360|324048023|FG009|Overall Study|Did not meet criteria before ABPM|0|||
94613976|NCT00347360|324048024|FG010|Overall Study|Did not meet criteria before ABPM|1|||
94613977|NCT00347360|324048025|FG011|Overall Study|Did not meet criteria before ABPM|0|||
94613978|NCT00347360|324048026|FG012|Overall Study|Did not meet criteria before ABPM|0|||
94613979|NCT00347360|324048027|FG013|Overall Study|Did not meet criteria before ABPM|0|||
94613980|NCT00347360|324048028|FG014|Overall Study|Did not meet criteria before ABPM|0|||
94613981|NCT00347360|324048014|FG000|Overall Study|Randomized in error|0|||
94613982|NCT00347360|324048015|FG001|Overall Study|Randomized in error|0|||
94613983|NCT00347360|324048016|FG002|Overall Study|Randomized in error|0|||
94613984|NCT00347360|324048017|FG003|Overall Study|Randomized in error|0|||
94613985|NCT00347360|324048018|FG004|Overall Study|Randomized in error|0|||
94613986|NCT00347360|324048019|FG005|Overall Study|Randomized in error|0|||
94613987|NCT00347360|324048020|FG006|Overall Study|Randomized in error|0|||
94613988|NCT00347360|324048021|FG007|Overall Study|Randomized in error|0|||
94613989|NCT00347360|324048022|FG008|Overall Study|Randomized in error|0|||
94613990|NCT00347360|324048023|FG009|Overall Study|Randomized in error|0|||
94613991|NCT00347360|324048024|FG010|Overall Study|Randomized in error|0|||
94613992|NCT00347360|324048025|FG011|Overall Study|Randomized in error|1|||
94613993|NCT00347360|324048026|FG012|Overall Study|Randomized in error|0|||
94613994|NCT00347360|324048027|FG013|Overall Study|Randomized in error|0|||
94613995|NCT00347360|324048028|FG014|Overall Study|Randomized in error|0|||
94613996|NCT00347360|324048014|FG000|Overall Study|Failed inclusion criteria #4|0|||
94613997|NCT00347360|324048015|FG001|Overall Study|Failed inclusion criteria #4|0|||
94613998|NCT00347360|324048016|FG002|Overall Study|Failed inclusion criteria #4|0|||
94613999|NCT00347360|324048017|FG003|Overall Study|Failed inclusion criteria #4|0|||
94614000|NCT00347360|324048018|FG004|Overall Study|Failed inclusion criteria #4|0|||
94614001|NCT00347360|324048019|FG005|Overall Study|Failed inclusion criteria #4|0|||
94614002|NCT00347360|324048020|FG006|Overall Study|Failed inclusion criteria #4|0|||
94614003|NCT00347360|324048021|FG007|Overall Study|Failed inclusion criteria #4|0|||
94614004|NCT00347360|324048022|FG008|Overall Study|Failed inclusion criteria #4|0|||
94614005|NCT00347360|324048023|FG009|Overall Study|Failed inclusion criteria #4|0|||
94614006|NCT00347360|324048024|FG010|Overall Study|Failed inclusion criteria #4|0|||
94614007|NCT00347360|324048025|FG011|Overall Study|Failed inclusion criteria #4|1|||
94614008|NCT00347360|324048026|FG012|Overall Study|Failed inclusion criteria #4|0|||
94614009|NCT00347360|324048027|FG013|Overall Study|Failed inclusion criteria #4|0|||
94614010|NCT00347360|324048028|FG014|Overall Study|Failed inclusion criteria #4|0|||
94614011|NCT00347360|324048014|FG000|Overall Study|Prolonged duration between visits|0|||
94614012|NCT00347360|324048015|FG001|Overall Study|Prolonged duration between visits|0|||
94614013|NCT00347360|324048016|FG002|Overall Study|Prolonged duration between visits|0|||
94614014|NCT00347360|324048017|FG003|Overall Study|Prolonged duration between visits|0|||
94614015|NCT00347360|324048018|FG004|Overall Study|Prolonged duration between visits|0|||
94614016|NCT00347360|324048019|FG005|Overall Study|Prolonged duration between visits|0|||
94614017|NCT00347360|324048020|FG006|Overall Study|Prolonged duration between visits|0|||
94614018|NCT00347360|324048021|FG007|Overall Study|Prolonged duration between visits|0|||
94614019|NCT00347360|324048022|FG008|Overall Study|Prolonged duration between visits|0|||
94614020|NCT00347360|324048023|FG009|Overall Study|Prolonged duration between visits|0|||
94614021|NCT00347360|324048024|FG010|Overall Study|Prolonged duration between visits|0|||
94614022|NCT00347360|324048025|FG011|Overall Study|Prolonged duration between visits|0|||
94614023|NCT00347360|324048026|FG012|Overall Study|Prolonged duration between visits|1|||
94614024|NCT00347360|324048027|FG013|Overall Study|Prolonged duration between visits|0|||
94614025|NCT00347360|324048028|FG014|Overall Study|Prolonged duration between visits|0|||
94614026|NCT00347360|324048014|FG000|Overall Study|Subject left town, ran out of study drug|0|||
94614027|NCT00347360|324048015|FG001|Overall Study|Subject left town, ran out of study drug|0|||
94614028|NCT00347360|324048016|FG002|Overall Study|Subject left town, ran out of study drug|0|||
94614029|NCT00347360|324048017|FG003|Overall Study|Subject left town, ran out of study drug|0|||
94614030|NCT00347360|324048018|FG004|Overall Study|Subject left town, ran out of study drug|0|||
94614031|NCT00347360|324048019|FG005|Overall Study|Subject left town, ran out of study drug|0|||
94614032|NCT00347360|324048020|FG006|Overall Study|Subject left town, ran out of study drug|0|||
94614033|NCT00347360|324048021|FG007|Overall Study|Subject left town, ran out of study drug|0|||
94614034|NCT00347360|324048022|FG008|Overall Study|Subject left town, ran out of study drug|0|||
94614035|NCT00347360|324048023|FG009|Overall Study|Subject left town, ran out of study drug|0|||
94614036|NCT00347360|324048024|FG010|Overall Study|Subject left town, ran out of study drug|0|||
94614037|NCT00347360|324048025|FG011|Overall Study|Subject left town, ran out of study drug|0|||
94614038|NCT00347360|324048026|FG012|Overall Study|Subject left town, ran out of study drug|0|||
94614039|NCT00347360|324048027|FG013|Overall Study|Subject left town, ran out of study drug|1|||
94358680|NCT02356159|323096468|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
94614040|NCT00347360|324048028|FG014|Overall Study|Subject left town, ran out of study drug|0|||
94614041|NCT00347360|324048014|FG000|Overall Study|Subject refuse to sign updated consent|0|||
94459972|NCT00960986|323471981|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
94459973|NCT00960986|323471982|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
94459974|NCT00960986|323471979|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
94459975|NCT00960986|323471980|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
94459976|NCT00960986|323471981|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
94459977|NCT00960986|323471982|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
94459978|NCT04413552|323471983|FG000|Overall Study|Adverse Event|0|||
94459979|NCT04413552|323471984|FG001|Overall Study|Adverse Event|0|||
94459980|NCT04413552|323471985|FG002|Overall Study|Adverse Event|0|||
94459981|NCT04413552|323471986|FG003|Overall Study|Adverse Event|0|||
94459982|NCT04413552|323471987|FG004|Overall Study|Adverse Event|0|||
94459983|NCT04413552|323471988|FG005|Overall Study|Adverse Event|0|||
94459984|NCT04413552|323471989|FG006|Overall Study|Adverse Event|1|||
94459985|NCT04413552|323471990|FG007|Overall Study|Adverse Event|0|||
94459986|NCT04413552|323471991|FG008|Overall Study|Adverse Event|0|||
94459987|NCT04413552|323471992|FG009|Overall Study|Adverse Event|0|||
94459988|NCT04464720|323471993|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
94459989|NCT05723328|323471994|FG000|Overall Study|Investigator's Decision|5|||
94459990|NCT05723328|323471995|FG001|Overall Study|Investigator's Decision|2|||
94459991|NCT03205761|323473606|FG000|Overall Study|Withdrawal by Subject|1|||
94459992|NCT03205761|323473606|FG000|Overall Study|Progressive Disease|10|||
94459993|NCT00636194|323473607|FG000|Overall Study|Study related symptoms and complaints|1|||
94459994|NCT00636194|323473608|FG001|Overall Study|Study related symptoms and complaints|0|||
94459995|NCT00636194|323473607|FG000|Overall Study|Protocol Violation|2|||
94459996|NCT00636194|323473608|FG001|Overall Study|Protocol Violation|0|||
94459997|NCT01632150|323473610|FG000|Overall Study|Disease progression|27|||
94459998|NCT01632150|323473610|FG000|Overall Study|Study drug toxicity|1|||
94459999|NCT01632150|323473610|FG000|Overall Study|Unrelated adverse event|7|||
94460000|NCT01632150|323473610|FG000|Overall Study|Withdrawal by Subject|2|||
94460001|NCT01632150|323473610|FG000|Overall Study|Patient underwent autologous transplant|1|||
94460002|NCT01632150|323473610|FG000|Overall Study|Moved to compassionate program|2|||
94460003|NCT02086448|323473614|FG000|Overall Study|Withdrawal by Subject|1|||
94460004|NCT02086448|323473615|FG001|Overall Study|Withdrawal by Subject|0|||
94460005|NCT02086448|323473616|FG002|Overall Study|Withdrawal by Subject|0|||
94460006|NCT02086448|323473617|FG003|Overall Study|Withdrawal by Subject|2|||
94460007|NCT04594941|323473618|FG000|Overall Study|Other|0|||
94460008|NCT04594941|323473619|FG001|Overall Study|Other|3|||
94460009|NCT04594941|323473620|FG002|Overall Study|Other|1|||
94460010|NCT04594941|323473621|FG003|Overall Study|Other|0|||
94460011|NCT01877551|323473624|FG000|Overall Study|Physician Decision|0|||
94614042|NCT00347360|324048015|FG001|Overall Study|Subject refuse to sign updated consent|0|||
94614043|NCT00347360|324048016|FG002|Overall Study|Subject refuse to sign updated consent|0|||
94614044|NCT00347360|324048017|FG003|Overall Study|Subject refuse to sign updated consent|0|||
94614045|NCT00347360|324048018|FG004|Overall Study|Subject refuse to sign updated consent|0|||
94614046|NCT00347360|324048019|FG005|Overall Study|Subject refuse to sign updated consent|0|||
94614047|NCT00347360|324048020|FG006|Overall Study|Subject refuse to sign updated consent|0|||
94614048|NCT00347360|324048021|FG007|Overall Study|Subject refuse to sign updated consent|0|||
94614049|NCT00347360|324048022|FG008|Overall Study|Subject refuse to sign updated consent|0|||
94614050|NCT00347360|324048023|FG009|Overall Study|Subject refuse to sign updated consent|0|||
94460012|NCT01877551|323473625|FG001|Overall Study|Physician Decision|1|||
94460013|NCT05139303|323473626|FG000|Overall Study|Lost to Follow-up|3|||
94460014|NCT05139303|323473627|FG001|Overall Study|Lost to Follow-up|0|||
94460015|NCT05139303|323473626|FG000|Overall Study|Adverse Event|1|||
94460016|NCT05139303|323473627|FG001|Overall Study|Adverse Event|0|||
94460017|NCT01938430|323473628|FG000|Overall Study|Randomized but Not Treated|0|||
94460018|NCT01938430|323473629|FG001|Overall Study|Randomized but Not Treated|0|||
94460019|NCT01938430|323473630|FG002|Overall Study|Randomized but Not Treated|0|||
94460020|NCT01938430|323473631|FG003|Overall Study|Randomized but Not Treated|0|||
94460021|NCT01938430|323473632|FG004|Overall Study|Randomized but Not Treated|0|||
94460022|NCT01938430|323473633|FG005|Overall Study|Randomized but Not Treated|0|||
94460023|NCT01938430|323473634|FG006|Overall Study|Randomized but Not Treated|0|||
94460024|NCT01938430|323473635|FG007|Overall Study|Randomized but Not Treated|0|||
94460025|NCT01938430|323473636|FG008|Overall Study|Randomized but Not Treated|0|||
94460026|NCT01938430|323473637|FG009|Overall Study|Randomized but Not Treated|0|||
94460027|NCT01938430|323473638|FG010|Overall Study|Randomized but Not Treated|1|||
94460028|NCT01938430|323473639|FG011|Overall Study|Randomized but Not Treated|0|||
94614051|NCT00347360|324048024|FG010|Overall Study|Subject refuse to sign updated consent|0|||
94614052|NCT00347360|324048025|FG011|Overall Study|Subject refuse to sign updated consent|0|||
94614053|NCT00347360|324048026|FG012|Overall Study|Subject refuse to sign updated consent|0|||
94614054|NCT00347360|324048027|FG013|Overall Study|Subject refuse to sign updated consent|0|||
94614055|NCT00347360|324048028|FG014|Overall Study|Subject refuse to sign updated consent|1|||
94614056|NCT00347360|324048014|FG000|Overall Study|Visits conflicted with new job|0|||
94614057|NCT00347360|324048015|FG001|Overall Study|Visits conflicted with new job|0|||
94614058|NCT00347360|324048016|FG002|Overall Study|Visits conflicted with new job|0|||
94614059|NCT00347360|324048017|FG003|Overall Study|Visits conflicted with new job|0|||
94614060|NCT00347360|324048018|FG004|Overall Study|Visits conflicted with new job|0|||
94614061|NCT00347360|324048019|FG005|Overall Study|Visits conflicted with new job|0|||
94614062|NCT00347360|324048020|FG006|Overall Study|Visits conflicted with new job|1|||
94614063|NCT00347360|324048021|FG007|Overall Study|Visits conflicted with new job|0|||
94614064|NCT00347360|324048022|FG008|Overall Study|Visits conflicted with new job|0|||
94614065|NCT00347360|324048023|FG009|Overall Study|Visits conflicted with new job|0|||
94614066|NCT00347360|324048024|FG010|Overall Study|Visits conflicted with new job|0|||
94614067|NCT00347360|324048025|FG011|Overall Study|Visits conflicted with new job|0|||
94614068|NCT00347360|324048026|FG012|Overall Study|Visits conflicted with new job|0|||
94614069|NCT00347360|324048027|FG013|Overall Study|Visits conflicted with new job|0|||
94614070|NCT00347360|324048028|FG014|Overall Study|Visits conflicted with new job|0|||
94614071|NCT00181155|324048031|FG000|Overall Study|Physician Decision|1|||
94614072|NCT00181155|324048032|FG001|Overall Study|Physician Decision|0|||
94614073|NCT00181155|324048031|FG000|Overall Study|Withdrawal by Subject|1|||
94614074|NCT00181155|324048032|FG001|Overall Study|Withdrawal by Subject|0|||
94614075|NCT01788228|324048033|FG000|Overall Study|Migrated/moved from study area|1|||
94614076|NCT01788228|324048034|FG001|Overall Study|Migrated/moved from study area|0|||
94614077|NCT01972568|324048035|FG000|Overall Study|Other events|3|||
94614078|NCT01972568|324048036|FG001|Overall Study|Other events|0|||
94614079|NCT01972568|324048037|FG002|Overall Study|Other events|0|||
94614080|NCT01972568|324048035|FG000|Overall Study|Lack of Efficacy|0|||
94614081|NCT01972568|324048036|FG001|Overall Study|Lack of Efficacy|1|||
94614082|NCT01972568|324048037|FG002|Overall Study|Lack of Efficacy|2|||
94614083|NCT01972568|324048035|FG000|Overall Study|Protocol Violation|1|||
94614084|NCT01972568|324048036|FG001|Overall Study|Protocol Violation|2|||
94614085|NCT01972568|324048037|FG002|Overall Study|Protocol Violation|2|||
94614086|NCT01972568|324048035|FG000|Overall Study|Withdrawal by Subject|6|||
94614087|NCT01972568|324048036|FG001|Overall Study|Withdrawal by Subject|3|||
94614088|NCT01972568|324048037|FG002|Overall Study|Withdrawal by Subject|7|||
94614089|NCT01972568|324048035|FG000|Overall Study|Lost to Follow-up|1|||
94614090|NCT01972568|324048036|FG001|Overall Study|Lost to Follow-up|0|||
94614091|NCT01972568|324048037|FG002|Overall Study|Lost to Follow-up|0|||
94614092|NCT01972568|324048035|FG000|Overall Study|Adverse Event|5|||
94614093|NCT01972568|324048036|FG001|Overall Study|Adverse Event|6|||
94460029|NCT01938430|323473640|FG012|Overall Study|Randomized but Not Treated|0|||
94460030|NCT01938430|323473641|FG013|Overall Study|Randomized but Not Treated|1|||
94460031|NCT01938430|323473628|FG000|Overall Study|Adverse Event|0|||
94614094|NCT01972568|324048037|FG002|Overall Study|Adverse Event|5|||
94614095|NCT00257608|324050058|FG000|Chemotherapy Phase|Adverse Event|138|||
94614096|NCT00257608|324050059|FG001|Chemotherapy Phase|Adverse Event|0|||
94614097|NCT00257608|324050060|FG002|Chemotherapy Phase|Adverse Event|0|||
94614098|NCT00257608|324050058|FG000|Chemotherapy Phase|Disease progression|139|||
94614099|NCT00257608|324050059|FG001|Chemotherapy Phase|Disease progression|0|||
94614100|NCT00257608|324050060|FG002|Chemotherapy Phase|Disease progression|0|||
94614101|NCT00257608|324050058|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
94614102|NCT00257608|324050059|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
94614103|NCT00257608|324050060|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
94460032|NCT01938430|323473629|FG001|Overall Study|Adverse Event|0|||
94460033|NCT01938430|323473630|FG002|Overall Study|Adverse Event|0|||
94614104|NCT00257608|324050058|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
94460034|NCT01938430|323473631|FG003|Overall Study|Adverse Event|0|||
94460035|NCT01938430|323473632|FG004|Overall Study|Adverse Event|0|||
94460036|NCT01938430|323473633|FG005|Overall Study|Adverse Event|0|||
94460037|NCT01938430|323473634|FG006|Overall Study|Adverse Event|1|||
94460038|NCT01938430|323473635|FG007|Overall Study|Adverse Event|0|||
94460039|NCT01938430|323473636|FG008|Overall Study|Adverse Event|0|||
94460040|NCT01938430|323473637|FG009|Overall Study|Adverse Event|0|||
94460041|NCT01938430|323473638|FG010|Overall Study|Adverse Event|0|||
94460042|NCT01938430|323473639|FG011|Overall Study|Adverse Event|0|||
94460043|NCT01938430|323473640|FG012|Overall Study|Adverse Event|0|||
94460044|NCT01938430|323473641|FG013|Overall Study|Adverse Event|0|||
94460045|NCT01938430|323473628|FG000|Overall Study|Death|1|||
94460046|NCT01938430|323473629|FG001|Overall Study|Death|2|||
94460047|NCT01938430|323473630|FG002|Overall Study|Death|2|||
94460048|NCT01938430|323473631|FG003|Overall Study|Death|1|||
94460049|NCT01938430|323473632|FG004|Overall Study|Death|0|||
94460050|NCT01938430|323473633|FG005|Overall Study|Death|0|||
94460051|NCT01938430|323473634|FG006|Overall Study|Death|1|||
94460052|NCT01938430|323473635|FG007|Overall Study|Death|1|||
94460053|NCT01938430|323473636|FG008|Overall Study|Death|2|||
94460054|NCT01938430|323473637|FG009|Overall Study|Death|3|||
94460055|NCT01938430|323473638|FG010|Overall Study|Death|0|||
94460056|NCT01938430|323473639|FG011|Overall Study|Death|0|||
94460057|NCT01938430|323473640|FG012|Overall Study|Death|0|||
94460058|NCT01938430|323473641|FG013|Overall Study|Death|0|||
94460059|NCT01938430|323473628|FG000|Overall Study|Investigator's Discretion|0|||
94460060|NCT01938430|323473629|FG001|Overall Study|Investigator's Discretion|0|||
94460061|NCT01938430|323473630|FG002|Overall Study|Investigator's Discretion|1|||
94460062|NCT01938430|323473631|FG003|Overall Study|Investigator's Discretion|0|||
94460063|NCT01938430|323473632|FG004|Overall Study|Investigator's Discretion|0|||
94460064|NCT01938430|323473633|FG005|Overall Study|Investigator's Discretion|0|||
94460065|NCT01938430|323473634|FG006|Overall Study|Investigator's Discretion|0|||
94460066|NCT01938430|323473635|FG007|Overall Study|Investigator's Discretion|0|||
94460067|NCT01938430|323473636|FG008|Overall Study|Investigator's Discretion|0|||
94460068|NCT01938430|323473637|FG009|Overall Study|Investigator's Discretion|0|||
94460069|NCT01938430|323473638|FG010|Overall Study|Investigator's Discretion|0|||
94460070|NCT01938430|323473639|FG011|Overall Study|Investigator's Discretion|0|||
94460071|NCT01938430|323473640|FG012|Overall Study|Investigator's Discretion|0|||
94460072|NCT01938430|323473641|FG013|Overall Study|Investigator's Discretion|0|||
94460073|NCT01938430|323473628|FG000|Overall Study|Lack of Efficacy|3|||
94460074|NCT01938430|323473629|FG001|Overall Study|Lack of Efficacy|1|||
94460075|NCT01938430|323473630|FG002|Overall Study|Lack of Efficacy|1|||
94460076|NCT01938430|323473631|FG003|Overall Study|Lack of Efficacy|1|||
94460077|NCT01938430|323473632|FG004|Overall Study|Lack of Efficacy|0|||
94460078|NCT01938430|323473633|FG005|Overall Study|Lack of Efficacy|0|||
94460079|NCT01938430|323473634|FG006|Overall Study|Lack of Efficacy|0|||
94460080|NCT01938430|323473635|FG007|Overall Study|Lack of Efficacy|0|||
94460081|NCT01938430|323473636|FG008|Overall Study|Lack of Efficacy|1|||
94460082|NCT01938430|323473637|FG009|Overall Study|Lack of Efficacy|0|||
94460083|NCT01938430|323473638|FG010|Overall Study|Lack of Efficacy|2|||
94460084|NCT01938430|323473639|FG011|Overall Study|Lack of Efficacy|1|||
94460085|NCT01938430|323473640|FG012|Overall Study|Lack of Efficacy|0|||
94460086|NCT01938430|323473641|FG013|Overall Study|Lack of Efficacy|0|||
94664944|NCT01490632|324229738|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
94664945|NCT01490632|324229739|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
94460087|NCT01938430|323473628|FG000|Overall Study|Lost to Follow-up|0|||
94460088|NCT01938430|323473629|FG001|Overall Study|Lost to Follow-up|0|||
94460089|NCT01938430|323473630|FG002|Overall Study|Lost to Follow-up|1|||
94460090|NCT01938430|323473631|FG003|Overall Study|Lost to Follow-up|0|||
94460091|NCT01938430|323473632|FG004|Overall Study|Lost to Follow-up|0|||
94460092|NCT01938430|323473633|FG005|Overall Study|Lost to Follow-up|1|||
94460093|NCT01938430|323473634|FG006|Overall Study|Lost to Follow-up|0|||
94460094|NCT01938430|323473635|FG007|Overall Study|Lost to Follow-up|0|||
94460095|NCT01938430|323473636|FG008|Overall Study|Lost to Follow-up|0|||
94460096|NCT01938430|323473637|FG009|Overall Study|Lost to Follow-up|0|||
94460097|NCT01938430|323473638|FG010|Overall Study|Lost to Follow-up|0|||
94460098|NCT01938430|323473639|FG011|Overall Study|Lost to Follow-up|0|||
94664946|NCT01490632|324229740|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
94460099|NCT01938430|323473640|FG012|Overall Study|Lost to Follow-up|0|||
94460100|NCT01938430|323473641|FG013|Overall Study|Lost to Follow-up|0|||
94460101|NCT01938430|323473628|FG000|Overall Study|Withdrew Consent|0|||
94460102|NCT01938430|323473629|FG001|Overall Study|Withdrew Consent|0|||
94460103|NCT01938430|323473630|FG002|Overall Study|Withdrew Consent|0|||
94460104|NCT01938430|323473631|FG003|Overall Study|Withdrew Consent|0|||
94460105|NCT01938430|323473632|FG004|Overall Study|Withdrew Consent|0|||
94460106|NCT01938430|323473633|FG005|Overall Study|Withdrew Consent|0|||
94460107|NCT01938430|323473634|FG006|Overall Study|Withdrew Consent|0|||
94460108|NCT01938430|323473635|FG007|Overall Study|Withdrew Consent|0|||
94460109|NCT01938430|323473636|FG008|Overall Study|Withdrew Consent|1|||
94460110|NCT01938430|323473637|FG009|Overall Study|Withdrew Consent|0|||
94614105|NCT00257608|324050059|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
94614106|NCT00257608|324050060|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
94614107|NCT00257608|324050058|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
94614108|NCT00257608|324050059|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
94614109|NCT00257608|324050060|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
94614110|NCT00257608|324050058|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
94614111|NCT00257608|324050059|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
94614112|NCT00257608|324050060|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
94614113|NCT00257608|324050058|FG000|Chemotherapy Phase|Physician Decision|28|||
94614114|NCT00257608|324050059|FG001|Chemotherapy Phase|Physician Decision|0|||
94614115|NCT00257608|324050060|FG002|Chemotherapy Phase|Physician Decision|0|||
94614116|NCT00257608|324050058|FG000|Post Chemotherapy Phase|Adverse Event|0|||
94614117|NCT00257608|324050059|FG001|Post Chemotherapy Phase|Adverse Event|34|||
94614118|NCT00257608|324050060|FG002|Post Chemotherapy Phase|Adverse Event|38|||
94614119|NCT00257608|324050058|FG000|Post Chemotherapy Phase|Disease progression|0|||
94614120|NCT00257608|324050059|FG001|Post Chemotherapy Phase|Disease progression|204|||
94614121|NCT00257608|324050060|FG002|Post Chemotherapy Phase|Disease progression|168|||
94614122|NCT00257608|324050058|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
94614123|NCT00257608|324050059|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
94614124|NCT00257608|324050060|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
94614125|NCT00257608|324050058|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
94614126|NCT00257608|324050059|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
94614127|NCT00257608|324050060|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
94614128|NCT00257608|324050058|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
94614129|NCT00257608|324050059|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
94614130|NCT00257608|324050060|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
94614131|NCT00257608|324050058|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
94614132|NCT00257608|324050059|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
94614133|NCT00257608|324050060|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
94614134|NCT00257608|324050058|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
94614135|NCT00257608|324050059|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
94614136|NCT00257608|324050060|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
94614137|NCT00257608|324050058|FG000|Post Chemotherapy Phase|Physician Decision|0|||
94614138|NCT00257608|324050059|FG001|Post Chemotherapy Phase|Physician Decision|8|||
94614139|NCT00257608|324050060|FG002|Post Chemotherapy Phase|Physician Decision|11|||
94614140|NCT00257608|324050058|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
94614141|NCT00257608|324050059|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
94614142|NCT00257608|324050060|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
94614143|NCT00257608|324050058|FG000|Post Chemotherapy Phase|Not treated|0|||
94614144|NCT00257608|324050059|FG001|Post Chemotherapy Phase|Not treated|4|||
94614145|NCT00257608|324050060|FG002|Post Chemotherapy Phase|Not treated|7|||
94614146|NCT01397162|324050062|FG000|Overall Study|Adverse Event|4|||
94614147|NCT01397162|324050063|FG001|Overall Study|Adverse Event|0|||
94614148|NCT01397162|324050064|FG002|Overall Study|Adverse Event|0|||
94614149|NCT01397162|324050065|FG003|Overall Study|Adverse Event|0|||
94614150|NCT01397162|324050066|FG004|Overall Study|Adverse Event|0|||
94614151|NCT01397162|324050062|FG000|Overall Study|Not yet defined|3|||
94614152|NCT01397162|324050063|FG001|Overall Study|Not yet defined|4|||
94614153|NCT01397162|324050064|FG002|Overall Study|Not yet defined|3|||
94614154|NCT01397162|324050065|FG003|Overall Study|Not yet defined|5|||
94614155|NCT01397162|324050066|FG004|Overall Study|Not yet defined|3|||
94614156|NCT00401531|324050067|FG000|Overall Study|Adverse Event|2|||
94614157|NCT00401531|324050068|FG001|Overall Study|Adverse Event|0|||
94614158|NCT00401531|324050067|FG000|Overall Study|Protocol Violation|3|||
94614159|NCT00401531|324050068|FG001|Overall Study|Protocol Violation|7|||
94614160|NCT00401531|324050067|FG000|Overall Study|Lost to Follow-up|1|||
94614161|NCT00401531|324050068|FG001|Overall Study|Lost to Follow-up|1|||
94614162|NCT00401531|324050067|FG000|Overall Study|Withdrawal by Subject|3|||
94614163|NCT00401531|324050068|FG001|Overall Study|Withdrawal by Subject|2|||
94614164|NCT04806503|324050069|FG000|Overall Study|Lost to Follow-up|0|||
94614165|NCT04806503|324050070|FG001|Overall Study|Lost to Follow-up|0|||
94614166|NCT04806503|324050071|FG002|Overall Study|Lost to Follow-up|1|||
94358681|NCT02356159|323096469|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
94614167|NCT04806503|324050072|FG003|Overall Study|Lost to Follow-up|0|||
94614168|NCT04806503|324050073|FG004|Overall Study|Lost to Follow-up|0|||
94614169|NCT04806503|324050069|FG000|Overall Study|Withdrawal by Subject|1|||
94614170|NCT04806503|324050070|FG001|Overall Study|Withdrawal by Subject|0|||
94614171|NCT04806503|324050071|FG002|Overall Study|Withdrawal by Subject|1|||
94460111|NCT01938430|323473638|FG010|Overall Study|Withdrew Consent|0|||
94614172|NCT04806503|324050072|FG003|Overall Study|Withdrawal by Subject|1|||
94614173|NCT04806503|324050073|FG004|Overall Study|Withdrawal by Subject|1|||
94614174|NCT04806503|324050069|FG000|Overall Study|Adverse Event|1|||
94614175|NCT04806503|324050070|FG001|Overall Study|Adverse Event|1|||
94614176|NCT04806503|324050071|FG002|Overall Study|Adverse Event|0|||
94614177|NCT04806503|324050072|FG003|Overall Study|Adverse Event|1|||
94614178|NCT04806503|324050073|FG004|Overall Study|Adverse Event|0|||
94614179|NCT02468232|324050076|FG000|Core Part of Study|Adverse Event|0|||
94614180|NCT02468232|324050077|FG001|Core Part of Study|Adverse Event|1|||
94614181|NCT02468232|324050078|FG002|Core Part of Study|Adverse Event|0|||
94614182|NCT02468232|324050079|FG003|Core Part of Study|Adverse Event|0|||
94614183|NCT02468232|324050076|FG000|Core Part of Study|Death|20|||
94614184|NCT02468232|324050077|FG001|Core Part of Study|Death|17|||
94614185|NCT02468232|324050078|FG002|Core Part of Study|Death|0|||
94614186|NCT02468232|324050079|FG003|Core Part of Study|Death|0|||
94614187|NCT02468232|324050076|FG000|Core Part of Study|Technical Problems|1|||
94614188|NCT02468232|324050077|FG001|Core Part of Study|Technical Problems|1|||
94614189|NCT02468232|324050078|FG002|Core Part of Study|Technical Problems|0|||
94614190|NCT02468232|324050079|FG003|Core Part of Study|Technical Problems|0|||
94614191|NCT02468232|324050076|FG000|OLE Part of Study|Adverse Event|0|||
94614192|NCT02468232|324050077|FG001|OLE Part of Study|Adverse Event|0|||
94614193|NCT02468232|324050078|FG002|OLE Part of Study|Adverse Event|4|||
94614194|NCT02468232|324050079|FG003|OLE Part of Study|Adverse Event|5|||
94614195|NCT02468232|324050076|FG000|OLE Part of Study|Death|0|||
94614196|NCT02468232|324050077|FG001|OLE Part of Study|Death|0|||
94614197|NCT02468232|324050078|FG002|OLE Part of Study|Death|4|||
94614198|NCT02468232|324050079|FG003|OLE Part of Study|Death|2|||
94614199|NCT02468232|324050076|FG000|OLE Part of Study|Physician Decision|0|||
94614200|NCT02468232|324050077|FG001|OLE Part of Study|Physician Decision|0|||
94614201|NCT02468232|324050078|FG002|OLE Part of Study|Physician Decision|4|||
94614202|NCT02468232|324050079|FG003|OLE Part of Study|Physician Decision|0|||
94614203|NCT02468232|324050076|FG000|OLE Part of Study|Subject/Guardian decision|0|||
94614204|NCT02468232|324050077|FG001|OLE Part of Study|Subject/Guardian decision|0|||
94614205|NCT02468232|324050078|FG002|OLE Part of Study|Subject/Guardian decision|2|||
94614206|NCT02468232|324050079|FG003|OLE Part of Study|Subject/Guardian decision|5|||
94614207|NCT02764333|324050080|FG000|Overall Study|Ineligible|1|||
94614208|NCT04622306|324050081|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
94614209|NCT04622306|324050082|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
94614210|NCT04622306|324050083|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
94614211|NCT04622306|324050084|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
94614212|NCT04622306|324050085|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
94614213|NCT04622306|324050086|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
94614214|NCT04622306|324050081|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
94614215|NCT04622306|324050082|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
94614216|NCT04622306|324050083|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
94614217|NCT04622306|324050084|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
94614218|NCT04622306|324050085|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
94614219|NCT04622306|324050086|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
94614220|NCT00617851|324050087|FG000|Overall Study|Death|0|||
94614221|NCT00617851|324050088|FG001|Overall Study|Death|0|||
94614222|NCT00617851|324050089|FG002|Overall Study|Death|0|||
94614223|NCT00617851|324050090|FG003|Overall Study|Death|1|||
94614224|NCT00617851|324050087|FG000|Overall Study|Withdrawal by Subject|14|||
94614225|NCT00617851|324050088|FG001|Overall Study|Withdrawal by Subject|7|||
94614226|NCT00617851|324050089|FG002|Overall Study|Withdrawal by Subject|12|||
94614227|NCT00617851|324050090|FG003|Overall Study|Withdrawal by Subject|4|||
94614228|NCT00617851|324050087|FG000|Overall Study|Lost to Follow-up|27|||
94460112|NCT01938430|323473639|FG011|Overall Study|Withdrew Consent|0|||
94614229|NCT00617851|324050088|FG001|Overall Study|Lost to Follow-up|29|||
94614230|NCT00617851|324050089|FG002|Overall Study|Lost to Follow-up|31|||
94460113|NCT01938430|323473640|FG012|Overall Study|Withdrew Consent|0|||
94460114|NCT01938430|323473641|FG013|Overall Study|Withdrew Consent|0|||
94460115|NCT02111785|323473642|FG000|Overall Study|Death|0|||
94460116|NCT02111785|323473643|FG001|Overall Study|Death|1|||
94460117|NCT02111785|323473644|FG002|Overall Study|Death|0|||
94460118|NCT02111785|323473645|FG003|Overall Study|Death|0|||
94460119|NCT00348790|323473646|FG000|Completed Treatment|Withdrawal by Subject|4|||
94460120|NCT00348790|323473646|FG000|Completed Treatment|Disease progression|14|||
94460121|NCT00348790|323473646|FG000|Completed Treatment|Adverse Event|4|||
94460122|NCT00348790|323473646|FG000|Completed Treatment|Required surgery|2|||
94460123|NCT00348790|323473646|FG000|Completed Treatment|Unable to travel to study site|1|||
94460124|NCT00177307|323473649|FG000|Overall Study|Withdrawal by Subject|1|||
94460125|NCT01967706|323473659|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
94460126|NCT01967706|323473660|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
94460127|NCT01967706|323473661|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
94460128|NCT01967706|323473662|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
94460129|NCT04739722|323473669|FG000|Overall Study|Lost to Follow-up|5301|||
94460130|NCT04739722|323473669|FG000|Overall Study|Withdrawal by Subject|42|||
94460131|NCT04739722|323473669|FG000|Overall Study|Non Average-risk|1157|||
94460132|NCT00725608|323473673|FG000|Overall Study|Lost to Follow-up|60|||
94460133|NCT00725608|323473673|FG000|Overall Study|Adverse Event|14|||
94460134|NCT00725608|323473673|FG000|Overall Study|Individual reasons|86|||
94460135|NCT00725608|323473673|FG000|Overall Study|Other|7|||
94460136|NCT00614120|323473674|FG000|Overall Study|Adverse Event|9|||
94460137|NCT00614120|323473675|FG001|Overall Study|Adverse Event|22|||
94460138|NCT00614120|323473676|FG002|Overall Study|Adverse Event|30|||
94460139|NCT00614120|323473677|FG003|Overall Study|Adverse Event|3|||
94460140|NCT00614120|323473674|FG000|Overall Study|Lack of Efficacy|3|||
94614231|NCT00617851|324050090|FG003|Overall Study|Lost to Follow-up|19|||
94614232|NCT00617851|324050087|FG000|Overall Study|Inappropriate Enrollment|5|||
94614233|NCT00617851|324050088|FG001|Overall Study|Inappropriate Enrollment|4|||
94614234|NCT00617851|324050089|FG002|Overall Study|Inappropriate Enrollment|1|||
94614235|NCT00617851|324050090|FG003|Overall Study|Inappropriate Enrollment|1|||
94614236|NCT00617851|324050087|FG000|Overall Study|Unable to classify|1|||
94614237|NCT00617851|324050088|FG001|Overall Study|Unable to classify|0|||
94614238|NCT00617851|324050089|FG002|Overall Study|Unable to classify|1|||
94614239|NCT00617851|324050090|FG003|Overall Study|Unable to classify|0|||
94614240|NCT01200524|324050093|FG000|Overall Study|Withdrawal by Subject|1|||
94614241|NCT01200524|324050094|FG001|Overall Study|Withdrawal by Subject|1|||
94614242|NCT01200524|324050095|FG002|Overall Study|Withdrawal by Subject|3|||
94614243|NCT01200524|324050093|FG000|Overall Study|Adverse Event|1|||
94614244|NCT01200524|324050094|FG001|Overall Study|Adverse Event|0|||
94614245|NCT01200524|324050095|FG002|Overall Study|Adverse Event|0|||
94614246|NCT01200524|324050093|FG000|Overall Study|Non availability of study nurse|0|||
94614247|NCT01200524|324050094|FG001|Overall Study|Non availability of study nurse|0|||
94614248|NCT01200524|324050095|FG002|Overall Study|Non availability of study nurse|1|||
94614249|NCT01914757|324050110|FG000|Overall Study|Severe non-compliance to protocol|3|||
94614250|NCT01914757|324050111|FG001|Overall Study|Severe non-compliance to protocol|1|||
94614251|NCT01914757|324050112|FG002|Overall Study|Severe non-compliance to protocol|2|||
94614252|NCT01914757|324050110|FG000|Overall Study|Lost to Follow-up|5|||
94614253|NCT01914757|324050111|FG001|Overall Study|Lost to Follow-up|8|||
94614254|NCT01914757|324050112|FG002|Overall Study|Lost to Follow-up|6|||
94614255|NCT01914757|324050110|FG000|Overall Study|Withdrawal by Subject|15|||
94614256|NCT01914757|324050111|FG001|Overall Study|Withdrawal by Subject|27|||
94614257|NCT01914757|324050112|FG002|Overall Study|Withdrawal by Subject|19|||
94614258|NCT01914757|324050110|FG000|Overall Study|Death|2|||
94614259|NCT01914757|324050111|FG001|Overall Study|Death|2|||
94614260|NCT01914757|324050112|FG002|Overall Study|Death|1|||
94460141|NCT00614120|323473675|FG001|Overall Study|Lack of Efficacy|3|||
94460142|NCT00614120|323473676|FG002|Overall Study|Lack of Efficacy|2|||
94614261|NCT01914757|324050110|FG000|Overall Study|Adverse Event|4|||
94614262|NCT01914757|324050111|FG001|Overall Study|Adverse Event|3|||
94614263|NCT01914757|324050112|FG002|Overall Study|Adverse Event|4|||
94614264|NCT01914757|324050110|FG000|Overall Study|Study specific withdrawal criteria|0|||
94614265|NCT01914757|324050111|FG001|Overall Study|Study specific withdrawal criteria|1|||
94614266|NCT01914757|324050112|FG002|Overall Study|Study specific withdrawal criteria|0|||
94614267|NCT01914757|324050110|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
94614268|NCT01914757|324050111|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
94460143|NCT00614120|323473677|FG003|Overall Study|Lack of Efficacy|2|||
94460144|NCT00614120|323473674|FG000|Overall Study|Protocol Violation|2|||
94460145|NCT00614120|323473675|FG001|Overall Study|Protocol Violation|5|||
94460146|NCT00614120|323473676|FG002|Overall Study|Protocol Violation|3|||
94460147|NCT00614120|323473677|FG003|Overall Study|Protocol Violation|1|||
94460148|NCT00614120|323473674|FG000|Overall Study|Withdrawal criteria|1|||
94460149|NCT00614120|323473675|FG001|Overall Study|Withdrawal criteria|0|||
94460150|NCT00614120|323473676|FG002|Overall Study|Withdrawal criteria|0|||
94460151|NCT00614120|323473677|FG003|Overall Study|Withdrawal criteria|0|||
94460152|NCT00614120|323473674|FG000|Overall Study|Withdrawal by Subject|9|||
94460153|NCT00614120|323473675|FG001|Overall Study|Withdrawal by Subject|10|||
94460154|NCT00614120|323473676|FG002|Overall Study|Withdrawal by Subject|16|||
94460155|NCT00614120|323473677|FG003|Overall Study|Withdrawal by Subject|3|||
94460156|NCT00614120|323473674|FG000|Overall Study|Did not meet trial criteria|0|||
94460157|NCT00614120|323473675|FG001|Overall Study|Did not meet trial criteria|1|||
94460158|NCT00614120|323473676|FG002|Overall Study|Did not meet trial criteria|1|||
94460159|NCT00614120|323473677|FG003|Overall Study|Did not meet trial criteria|1|||
94460160|NCT00614120|323473674|FG000|Overall Study|hCG positive (not pregnant)|0|||
94460161|NCT00614120|323473675|FG001|Overall Study|hCG positive (not pregnant)|0|||
94460162|NCT00614120|323473676|FG002|Overall Study|hCG positive (not pregnant)|1|||
94460163|NCT00614120|323473677|FG003|Overall Study|hCG positive (not pregnant)|0|||
94460164|NCT00614120|323473674|FG000|Overall Study|Hypoglycaemia|0|||
94460165|NCT00614120|323473675|FG001|Overall Study|Hypoglycaemia|0|||
94460166|NCT00614120|323473676|FG002|Overall Study|Hypoglycaemia|0|||
94460167|NCT00614120|323473677|FG003|Overall Study|Hypoglycaemia|1|||
94460168|NCT00614120|323473674|FG000|Overall Study|Lack of trial product|3|||
94460169|NCT00614120|323473675|FG001|Overall Study|Lack of trial product|3|||
94460170|NCT00614120|323473676|FG002|Overall Study|Lack of trial product|2|||
94460171|NCT00614120|323473677|FG003|Overall Study|Lack of trial product|0|||
94460172|NCT00614120|323473674|FG000|Overall Study|Late syphilis, latent|1|||
94460173|NCT00614120|323473675|FG001|Overall Study|Late syphilis, latent|0|||
94460174|NCT00614120|323473676|FG002|Overall Study|Late syphilis, latent|0|||
94460175|NCT00614120|323473677|FG003|Overall Study|Late syphilis, latent|0|||
94460176|NCT00614120|323473674|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
94460177|NCT00614120|323473675|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
94460178|NCT00614120|323473676|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
94460179|NCT00614120|323473677|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
94460180|NCT00614120|323473674|FG000|Overall Study|Lost to Follow-up|1|||
94460181|NCT00614120|323473675|FG001|Overall Study|Lost to Follow-up|2|||
94460182|NCT00614120|323473676|FG002|Overall Study|Lost to Follow-up|3|||
94460183|NCT00614120|323473677|FG003|Overall Study|Lost to Follow-up|4|||
94460184|NCT03047720|323473678|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
94460185|NCT03047720|323473679|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
94460186|NCT03409107|323473680|FG000|Overall Study|Withdrawal by Subject|4|||
94460187|NCT03409107|323473681|FG001|Overall Study|Withdrawal by Subject|2|||
94460188|NCT03409107|323473680|FG000|Overall Study|Physician Decision|1|||
94460189|NCT03409107|323473681|FG001|Overall Study|Physician Decision|0|||
94460190|NCT03409107|323473680|FG000|Overall Study|Lost to Follow-up|7|||
94460191|NCT03409107|323473681|FG001|Overall Study|Lost to Follow-up|2|||
94460192|NCT03409107|323473680|FG000|Overall Study|Adverse Event|5|||
94460193|NCT03409107|323473681|FG001|Overall Study|Adverse Event|3|||
94460194|NCT05129137|323473687|FG000|Second Period|Adverse Event|1|||
94460195|NCT05129137|323473688|FG001|Second Period|Adverse Event|0|||
94460196|NCT05129137|323473689|FG002|Second Period|Adverse Event|0|||
94460197|NCT05129137|323473690|FG003|Second Period|Adverse Event|0|||
94460198|NCT05129137|323473687|FG000|Second Period|Protocol Violation|0|||
94358682|NCT02356159|323096470|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
94358683|NCT05450198|323096474|FG000|Overall Study|Withdrawal by Subject|1|||
94358684|NCT05450198|323096475|FG001|Overall Study|Withdrawal by Subject|1|||
94358685|NCT05450198|323096476|FG002|Overall Study|Withdrawal by Subject|2|||
94358686|NCT05450198|323096477|FG003|Overall Study|Withdrawal by Subject|0|||
94358687|NCT05450198|323096474|FG000|Overall Study|Lost to Follow-up|1|||
94358688|NCT05450198|323096475|FG001|Overall Study|Lost to Follow-up|0|||
94358689|NCT05450198|323096476|FG002|Overall Study|Lost to Follow-up|2|||
94358690|NCT05450198|323096477|FG003|Overall Study|Lost to Follow-up|1|||
94358691|NCT01243762|323096479|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
94358692|NCT01243762|323096480|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
94358693|NCT01243762|323096481|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
94358694|NCT01243762|323096482|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
94358695|NCT01243762|323096483|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
94358696|NCT01243762|323096484|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
94358697|NCT01243762|323096485|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
94358698|NCT01243762|323096479|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
94460199|NCT05129137|323473688|FG001|Second Period|Protocol Violation|0|||
94460200|NCT05129137|323473689|FG002|Second Period|Protocol Violation|0|||
94460201|NCT05129137|323473690|FG003|Second Period|Protocol Violation|1|||
94460202|NCT05129137|323473687|FG000|Third Period|Protocol Violation|0|||
94460203|NCT05129137|323473688|FG001|Third Period|Protocol Violation|0|||
94460204|NCT05129137|323473689|FG002|Third Period|Protocol Violation|0|||
94460205|NCT05129137|323473690|FG003|Third Period|Protocol Violation|1|||
94358699|NCT01243762|323096480|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
94358700|NCT01243762|323096481|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
94358701|NCT01243762|323096482|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
94358702|NCT01243762|323096483|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
94358703|NCT01243762|323096484|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
94358704|NCT01243762|323096485|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
94358705|NCT01243762|323096479|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
94358706|NCT01243762|323096480|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
94358707|NCT01243762|323096481|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
94358708|NCT01243762|323096482|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
94358709|NCT01243762|323096483|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
94358710|NCT01243762|323096484|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
94358711|NCT01243762|323096485|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
94358712|NCT01243762|323096479|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
94358713|NCT01243762|323096480|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
94460206|NCT05129137|323473687|FG000|Forth Period|Protocol Violation|0|||
94460207|NCT05129137|323473688|FG001|Forth Period|Protocol Violation|1|||
94460208|NCT05129137|323473689|FG002|Forth Period|Protocol Violation|0|||
94460209|NCT05129137|323473690|FG003|Forth Period|Protocol Violation|0|||
94460210|NCT05129137|323473687|FG000|Forth Period|Withdrawal by Subject|0|||
94460211|NCT05129137|323473688|FG001|Forth Period|Withdrawal by Subject|0|||
94460212|NCT05129137|323473689|FG002|Forth Period|Withdrawal by Subject|1|||
94460213|NCT05129137|323473690|FG003|Forth Period|Withdrawal by Subject|0|||
94460214|NCT01104246|323473691|FG000|Overall Study|Withdrawal by Subject|1|||
94460215|NCT01104246|323473691|FG000|Overall Study|did not meet inclusion criteria|4|||
94460216|NCT05178641|323473692|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
94460217|NCT05178641|323473693|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
94460218|NCT05178641|323473692|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
94460219|NCT05178641|323473693|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
94460220|NCT01083186|323473695|FG000|Overall Study|Lost to Follow-up|48|||
94460221|NCT01083186|323473695|FG000|Overall Study|Consent Withdrawal|7|||
94460222|NCT01083186|323473695|FG000|Overall Study|Death|3|||
94460223|NCT01083186|323473695|FG000|Overall Study|Adverse Event|3|||
94460224|NCT01083186|323473695|FG000|Overall Study|Lack of Efficacy|2|||
94460225|NCT01083186|323473695|FG000|Overall Study|Hemodialysis Initiation|28|||
94460226|NCT01083186|323473695|FG000|Overall Study|Administrative Reasons|2|||
94460227|NCT01083186|323473695|FG000|Overall Study|Non-compliance to Study Treatment|1|||
94460228|NCT00108485|323473699|FG000|Overall Study|Withdrawal by Subject|3|||
94460229|NCT00108485|323473700|FG001|Overall Study|Withdrawal by Subject|0|||
94460230|NCT00108485|323473699|FG000|Overall Study|Lost to Follow-up|0|||
94460231|NCT00108485|323473700|FG001|Overall Study|Lost to Follow-up|2|||
94460232|NCT00878969|323473703|FG000|Overall Study|Physician Decision|5|||
94460233|NCT00878969|323473704|FG001|Overall Study|Physician Decision|3|||
94460234|NCT00878969|323473705|FG002|Overall Study|Physician Decision|2|||
94460235|NCT00878969|323473703|FG000|Overall Study|Withdrawal by Subject|1|||
94460236|NCT00878969|323473704|FG001|Overall Study|Withdrawal by Subject|6|||
94460237|NCT00878969|323473705|FG002|Overall Study|Withdrawal by Subject|3|||
94460238|NCT00878969|323473703|FG000|Overall Study|kidney transplant|2|||
94460239|NCT00878969|323473704|FG001|Overall Study|kidney transplant|3|||
94460240|NCT00878969|323473705|FG002|Overall Study|kidney transplant|2|||
94460241|NCT00878969|323473703|FG000|Overall Study|Adverse Event|3|||
94460242|NCT00878969|323473704|FG001|Overall Study|Adverse Event|1|||
94460243|NCT00878969|323473705|FG002|Overall Study|Adverse Event|2|||
94460244|NCT00878969|323473703|FG000|Overall Study|Lost to Follow-up|2|||
94460245|NCT00878969|323473704|FG001|Overall Study|Lost to Follow-up|1|||
94460246|NCT00878969|323473705|FG002|Overall Study|Lost to Follow-up|0|||
94460247|NCT00878969|323473703|FG000|Overall Study|Protocol Violation|2|||
94460248|NCT00878969|323473704|FG001|Overall Study|Protocol Violation|0|||
94460249|NCT00878969|323473705|FG002|Overall Study|Protocol Violation|0|||
94460250|NCT00878969|323473703|FG000|Overall Study|Death|0|||
94460251|NCT00878969|323473704|FG001|Overall Study|Death|0|||
94460252|NCT00878969|323473705|FG002|Overall Study|Death|2|||
94460253|NCT00878969|323473703|FG000|Overall Study|Pregnancy|0|||
94664947|NCT01490632|324229741|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
94460254|NCT00878969|323473704|FG001|Overall Study|Pregnancy|1|||
94460255|NCT00878969|323473705|FG002|Overall Study|Pregnancy|0|||
94460256|NCT01041976|323473712|FG000|Overall Study|Withdrawal by Subject|3|||
94460257|NCT01041976|323473713|FG001|Overall Study|Withdrawal by Subject|0|||
94460258|NCT01041976|323473712|FG000|Overall Study|Incarceration|2|||
94460259|NCT01041976|323473713|FG001|Overall Study|Incarceration|0|||
94358714|NCT01243762|323096481|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
94460260|NCT01041976|323473712|FG000|Overall Study|Death|0|||
94460261|NCT01041976|323473713|FG001|Overall Study|Death|4|||
94460262|NCT00189306|323473714|FG000|Treatment Period|Withdrawal by Subject|2|||
94460263|NCT00189306|323473714|FG000|Treatment Period|Adverse Event|2|||
94664948|NCT01490632|324229742|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
94664949|NCT01490632|324229743|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
94664950|NCT01490632|324229744|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
94614269|NCT01914757|324050112|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
94614270|NCT01914757|324050110|FG000|Overall Study|Other reasons|5|||
94614271|NCT01914757|324050111|FG001|Overall Study|Other reasons|9|||
94614272|NCT01914757|324050112|FG002|Overall Study|Other reasons|4|||
94614273|NCT01868503|324050113|FG000|Overall Study|Withdrawal by Subject|1|||
94614274|NCT01868503|324050113|FG000|Overall Study|Protocol Violation|1|||
94614275|NCT02651467|324050114|FG000|Overall Study|Withdrawal by Subject|0|||
94614276|NCT02651467|324050115|FG001|Overall Study|Withdrawal by Subject|0|||
94614277|NCT02651467|324050116|FG002|Overall Study|Withdrawal by Subject|2|||
94614278|NCT02651467|324050114|FG000|Overall Study|Other (Not specified)|1|||
94614279|NCT02651467|324050115|FG001|Overall Study|Other (Not specified)|0|||
94614280|NCT02651467|324050116|FG002|Overall Study|Other (Not specified)|2|||
94614281|NCT00408629|324050117|FG000|Overall Study|Adverse Event|13|||
94614282|NCT00408629|324050118|FG001|Overall Study|Adverse Event|27|||
94614283|NCT00408629|324050117|FG000|Overall Study|Withdrawal by Subject|8|||
94614284|NCT00408629|324050118|FG001|Overall Study|Withdrawal by Subject|4|||
94614285|NCT00408629|324050117|FG000|Overall Study|Lost to Follow-up|1|||
94614286|NCT00408629|324050118|FG001|Overall Study|Lost to Follow-up|1|||
94614287|NCT00408629|324050117|FG000|Overall Study|Lack of Efficacy|63|||
94614288|NCT00408629|324050118|FG001|Overall Study|Lack of Efficacy|73|||
94614289|NCT00408629|324050117|FG000|Overall Study|Protocol Violation|1|||
94614290|NCT00408629|324050118|FG001|Overall Study|Protocol Violation|5|||
94614291|NCT00408629|324050117|FG000|Overall Study|Miscellaneous|11|||
94614292|NCT00408629|324050118|FG001|Overall Study|Miscellaneous|15|||
94614293|NCT02024529|324050125|FG000|Overall Study|Withdrawal by Subject|11|||
94614294|NCT02024529|324050126|FG001|Overall Study|Withdrawal by Subject|21|||
94614295|NCT02024529|324050125|FG000|Overall Study|Lost to Follow-up|2|||
94614296|NCT02024529|324050126|FG001|Overall Study|Lost to Follow-up|4|||
94614297|NCT00354614|324050127|FG000|Overall Study|Lack of Efficacy|28|||
94614298|NCT04171765|324050128|FG000|Overall Study|Adverse Event|2|||
94614299|NCT04171765|324050129|FG001|Overall Study|Adverse Event|0|||
94614300|NCT04171765|324050130|FG002|Overall Study|Adverse Event|1|||
94614301|NCT04171765|324050131|FG003|Overall Study|Adverse Event|0|||
94614302|NCT04171765|324050128|FG000|Overall Study|Lost to Follow-up|0|||
94614303|NCT04171765|324050129|FG001|Overall Study|Lost to Follow-up|2|||
94614304|NCT04171765|324050130|FG002|Overall Study|Lost to Follow-up|2|||
94614305|NCT04171765|324050131|FG003|Overall Study|Lost to Follow-up|2|||
94614306|NCT04171765|324050128|FG000|Overall Study|Week 58 visit missed|0|||
94614307|NCT04171765|324050129|FG001|Overall Study|Week 58 visit missed|0|||
94614308|NCT04171765|324050130|FG002|Overall Study|Week 58 visit missed|1|||
94614309|NCT04171765|324050131|FG003|Overall Study|Week 58 visit missed|0|||
94614310|NCT04171765|324050128|FG000|Overall Study|Study terminated by sponsor|2|||
94614311|NCT04171765|324050129|FG001|Overall Study|Study terminated by sponsor|0|||
94614312|NCT04171765|324050130|FG002|Overall Study|Study terminated by sponsor|0|||
94614313|NCT04171765|324050131|FG003|Overall Study|Study terminated by sponsor|0|||
94614314|NCT04171765|324050128|FG000|Overall Study|Withdrawal by Subject|1|||
94614315|NCT04171765|324050129|FG001|Overall Study|Withdrawal by Subject|0|||
94614316|NCT04171765|324050130|FG002|Overall Study|Withdrawal by Subject|0|||
94614317|NCT04171765|324050131|FG003|Overall Study|Withdrawal by Subject|3|||
94614318|NCT01890746|324050132|FG000|Overall Study|Death|39|||
94614319|NCT01890746|324050133|FG001|Overall Study|Death|30|||
94614320|NCT01890746|324050132|FG000|Overall Study|Adverse Event|1|||
94614321|NCT01890746|324050133|FG001|Overall Study|Adverse Event|0|||
94614322|NCT01890746|324050132|FG000|Overall Study|Lost to Follow-up|4|||
94664951|NCT01490632|324229745|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
94614323|NCT01890746|324050133|FG001|Overall Study|Lost to Follow-up|1|||
94614324|NCT01890746|324050132|FG000|Overall Study|Physician Decision|3|||
94614325|NCT01890746|324050133|FG001|Overall Study|Physician Decision|2|||
94614326|NCT01890746|324050132|FG000|Overall Study|Withdrawal by Subject|5|||
94614327|NCT01890746|324050133|FG001|Overall Study|Withdrawal by Subject|8|||
94614328|NCT01823146|324050134|FG000|Overall Study|Withdrawal by Subject|0|||
94614329|NCT01823146|324050135|FG001|Overall Study|Withdrawal by Subject|1|||
94614330|NCT01823146|324050134|FG000|Overall Study|Lost to Follow-up|2|||
94614331|NCT01823146|324050135|FG001|Overall Study|Lost to Follow-up|1|||
94614332|NCT00491764|324050136|FG000|Overall Study|Adverse Event|1|||
94614333|NCT00491764|324050137|FG001|Overall Study|Adverse Event|2|||
94614334|NCT00491764|324050138|FG002|Overall Study|Adverse Event|4|||
94614335|NCT00491764|324050139|FG003|Overall Study|Adverse Event|4|||
94614336|NCT00491764|324050140|FG004|Overall Study|Adverse Event|0|||
94614337|NCT00491764|324050141|FG005|Overall Study|Adverse Event|1|||
94614338|NCT00491764|324050136|FG000|Overall Study|Lost to Follow-up|0|||
94614339|NCT00491764|324050137|FG001|Overall Study|Lost to Follow-up|1|||
94614340|NCT00491764|324050138|FG002|Overall Study|Lost to Follow-up|0|||
94614341|NCT00491764|324050139|FG003|Overall Study|Lost to Follow-up|1|||
94614342|NCT00491764|324050140|FG004|Overall Study|Lost to Follow-up|0|||
94614343|NCT00491764|324050141|FG005|Overall Study|Lost to Follow-up|3|||
94614344|NCT00491764|324050136|FG000|Overall Study|Withdrawal by Subject|2|||
94614345|NCT00491764|324050137|FG001|Overall Study|Withdrawal by Subject|3|||
94614346|NCT00491764|324050138|FG002|Overall Study|Withdrawal by Subject|1|||
94614347|NCT00491764|324050139|FG003|Overall Study|Withdrawal by Subject|2|||
94614348|NCT00491764|324050140|FG004|Overall Study|Withdrawal by Subject|2|||
94614349|NCT00491764|324050141|FG005|Overall Study|Withdrawal by Subject|4|||
94614350|NCT00491764|324050136|FG000|Overall Study|Non Compliance with the Protocol|1|||
94614351|NCT00491764|324050137|FG001|Overall Study|Non Compliance with the Protocol|0|||
94614352|NCT00491764|324050138|FG002|Overall Study|Non Compliance with the Protocol|0|||
94614353|NCT00491764|324050139|FG003|Overall Study|Non Compliance with the Protocol|0|||
94614354|NCT00491764|324050140|FG004|Overall Study|Non Compliance with the Protocol|0|||
94614355|NCT00491764|324050141|FG005|Overall Study|Non Compliance with the Protocol|0|||
94614356|NCT00491764|324050136|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
94614357|NCT00491764|324050137|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
94614358|NCT00491764|324050138|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
94614359|NCT00491764|324050139|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
94614360|NCT00491764|324050140|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
94614361|NCT00491764|324050141|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
94614362|NCT00491764|324050136|FG000|Overall Study|Administrative|1|||
94614363|NCT00491764|324050137|FG001|Overall Study|Administrative|0|||
94614364|NCT00491764|324050138|FG002|Overall Study|Administrative|2|||
94614365|NCT00491764|324050139|FG003|Overall Study|Administrative|1|||
94614366|NCT00491764|324050140|FG004|Overall Study|Administrative|0|||
94614367|NCT00491764|324050141|FG005|Overall Study|Administrative|0|||
94614368|NCT00697788|324050142|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
94614369|NCT00697788|324050143|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
94614370|NCT00697788|324050144|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
94614371|NCT00697788|324050145|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
94614372|NCT00697788|324050146|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
94614373|NCT00697788|324050147|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
94614374|NCT00697788|324050148|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
94614375|NCT00697788|324050149|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
94614376|NCT00697788|324050142|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
94614377|NCT00697788|324050143|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
94614378|NCT00697788|324050144|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
94614379|NCT00697788|324050145|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
94614380|NCT00697788|324050146|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
94614381|NCT00697788|324050147|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
94614382|NCT00697788|324050148|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
94614383|NCT00697788|324050149|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
94614384|NCT02833350|324050150|FG000|Overall Study|Adverse Event|0|||
94614385|NCT02833350|324050151|FG001|Overall Study|Adverse Event|3|||
94614386|NCT02833350|324050152|FG002|Overall Study|Adverse Event|4|||
94614387|NCT02833350|324050153|FG003|Overall Study|Adverse Event|4|||
94614388|NCT02833350|324050154|FG004|Overall Study|Adverse Event|1|||
94614389|NCT02833350|324050155|FG005|Overall Study|Adverse Event|0|||
94614390|NCT02833350|324050156|FG006|Overall Study|Adverse Event|1|||
94614391|NCT02833350|324050150|FG000|Overall Study|Death|0|||
94614392|NCT02833350|324050151|FG001|Overall Study|Death|0|||
94614393|NCT02833350|324050152|FG002|Overall Study|Death|1|||
94614394|NCT02833350|324050153|FG003|Overall Study|Death|0|||
94614395|NCT02833350|324050154|FG004|Overall Study|Death|0|||
94614396|NCT02833350|324050155|FG005|Overall Study|Death|0|||
94614397|NCT02833350|324050156|FG006|Overall Study|Death|0|||
94614398|NCT02833350|324050150|FG000|Overall Study|Lack of Efficacy|0|||
94614399|NCT02833350|324050151|FG001|Overall Study|Lack of Efficacy|2|||
94614400|NCT02833350|324050152|FG002|Overall Study|Lack of Efficacy|1|||
94614401|NCT02833350|324050153|FG003|Overall Study|Lack of Efficacy|4|||
94614402|NCT02833350|324050154|FG004|Overall Study|Lack of Efficacy|0|||
94614403|NCT02833350|324050155|FG005|Overall Study|Lack of Efficacy|1|||
94614404|NCT02833350|324050156|FG006|Overall Study|Lack of Efficacy|1|||
94614405|NCT02833350|324050150|FG000|Overall Study|Lost to Follow-up|0|||
94614406|NCT02833350|324050151|FG001|Overall Study|Lost to Follow-up|1|||
94614407|NCT02833350|324050152|FG002|Overall Study|Lost to Follow-up|0|||
94614408|NCT02833350|324050153|FG003|Overall Study|Lost to Follow-up|0|||
94614409|NCT02833350|324050154|FG004|Overall Study|Lost to Follow-up|0|||
94614410|NCT02833350|324050155|FG005|Overall Study|Lost to Follow-up|0|||
94614411|NCT02833350|324050156|FG006|Overall Study|Lost to Follow-up|1|||
94614412|NCT02833350|324050150|FG000|Overall Study|Withdrawal by Subject|3|||
94614413|NCT02833350|324050151|FG001|Overall Study|Withdrawal by Subject|3|||
94614414|NCT02833350|324050152|FG002|Overall Study|Withdrawal by Subject|2|||
94614415|NCT02833350|324050153|FG003|Overall Study|Withdrawal by Subject|0|||
94614416|NCT02833350|324050154|FG004|Overall Study|Withdrawal by Subject|2|||
94614417|NCT02833350|324050155|FG005|Overall Study|Withdrawal by Subject|0|||
94614418|NCT02833350|324050156|FG006|Overall Study|Withdrawal by Subject|2|||
94614419|NCT01788046|324050157|FG000|Overall Study|Withdrawal by Subject|12|||
94614420|NCT01788046|324050158|FG001|Overall Study|Withdrawal by Subject|12|||
94614421|NCT01788046|324050157|FG000|Overall Study|Lost to Follow-up|12|||
94614422|NCT01788046|324050158|FG001|Overall Study|Lost to Follow-up|19|||
94614423|NCT01788046|324050157|FG000|Overall Study|Death|7|||
94614424|NCT01788046|324050158|FG001|Overall Study|Death|5|||
94614425|NCT01788046|324050157|FG000|Overall Study|Protocol Specified Criteria|25|||
94614426|NCT01788046|324050158|FG001|Overall Study|Protocol Specified Criteria|1|||
94614427|NCT02635776|324050169|FG000|Overall Study|Physician Decision|1|||
94614428|NCT02635776|324050170|FG001|Overall Study|Physician Decision|0|||
94614429|NCT02635776|324050169|FG000|Overall Study|Adverse Event|51|||
94614430|NCT02635776|324050170|FG001|Overall Study|Adverse Event|3|||
94614431|NCT02635776|324050169|FG000|Overall Study|Withdrawal by Subject|41|||
94614432|NCT02635776|324050170|FG001|Overall Study|Withdrawal by Subject|7|||
94614433|NCT02635776|324050169|FG000|Overall Study|Lost to Follow-up|4|||
94614434|NCT02635776|324050170|FG001|Overall Study|Lost to Follow-up|0|||
94614435|NCT02635776|324050169|FG000|Overall Study|Other reasons|5|||
94614436|NCT02635776|324050170|FG001|Overall Study|Other reasons|1|||
94614437|NCT03896165|324050176|FG000|Overall Study|Withdrawal by Subject|2|||
94614438|NCT03540030|324050179|FG000|Overall Study|Withdrawal by Subject|2|||
94614439|NCT03540030|324050180|FG001|Overall Study|Withdrawal by Subject|1|||
94614440|NCT03540030|324050179|FG000|Overall Study|screen fail|7|||
94614441|NCT03540030|324050180|FG001|Overall Study|screen fail|1|||
94614442|NCT03540030|324050179|FG000|Overall Study|never had surgery after signing consent|9|||
94614443|NCT03540030|324050180|FG001|Overall Study|never had surgery after signing consent|1|||
94614444|NCT03666624|324050181|FG000|Overall Study|participant grieving over recent death of parent|1|||
94614445|NCT03666624|324050182|FG001|Overall Study|participant grieving over recent death of parent|0|||
94614446|NCT00569270|324050190|FG000|Period: First Intervention|Protocol Violation|0|||
94614447|NCT00569270|324050191|FG001|Period: First Intervention|Protocol Violation|1|||
94614448|NCT00492531|324050192|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
94614449|NCT00492531|324050193|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
94614450|NCT00397215|324050197|FG000|Month 0 (Day 0)|Adverse Event|0|||
94614451|NCT00397215|324050198|FG001|Month 0 (Day 0)|Adverse Event|1|||
94614452|NCT00397215|324050199|FG002|Month 0 (Day 0)|Adverse Event|0|||
94614453|NCT00397215|324050200|FG003|Month 0 (Day 0)|Adverse Event|0|||
94614454|NCT00397215|324050197|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
94614455|NCT00397215|324050198|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
94614456|NCT00397215|324050199|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
94614457|NCT00397215|324050200|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
94614458|NCT00397215|324050197|FG000|Month 0 (Day 0)|Other|4|||
94614459|NCT00397215|324050198|FG001|Month 0 (Day 0)|Other|1|||
94614460|NCT00397215|324050199|FG002|Month 0 (Day 0)|Other|3|||
94614461|NCT00397215|324050200|FG003|Month 0 (Day 0)|Other|3|||
94614462|NCT00397215|324050197|FG000|Month 6 (Day 180)|Adverse Event|0|||
94614463|NCT00397215|324050198|FG001|Month 6 (Day 180)|Adverse Event|3|||
94614464|NCT00397215|324050199|FG002|Month 6 (Day 180)|Adverse Event|2|||
94614465|NCT00397215|324050200|FG003|Month 6 (Day 180)|Adverse Event|0|||
94460264|NCT00189306|323473714|FG000|Treatment Period|Protocol Violation|1|||
94460265|NCT00189306|323473714|FG000|Posttreatment Period|Death|1|||
94460266|NCT00189306|323473714|FG000|Posttreatment Period|Withdrawal by Subject|2|||
94460267|NCT00189306|323473714|FG000|Posttreatment Period|Noncompliance|1|||
94614466|NCT00397215|324050197|FG000|Month 6 (Day 180)|Other|2|||
94614467|NCT00397215|324050198|FG001|Month 6 (Day 180)|Other|0|||
94614468|NCT00397215|324050199|FG002|Month 6 (Day 180)|Other|3|||
94614469|NCT00397215|324050200|FG003|Month 6 (Day 180)|Other|0|||
94614470|NCT02128932|324050201|FG000|Overall Study|Withdrawal by Subject|11|||
94614471|NCT02128932|324050202|FG001|Overall Study|Withdrawal by Subject|7|||
94614472|NCT02128932|324050203|FG002|Overall Study|Withdrawal by Subject|8|||
94614473|NCT02128932|324050201|FG000|Overall Study|Death|2|||
94614474|NCT02128932|324050202|FG001|Overall Study|Death|0|||
94614475|NCT02128932|324050203|FG002|Overall Study|Death|2|||
94614476|NCT02128932|324050201|FG000|Overall Study|Lost to Follow-up|2|||
94614477|NCT02128932|324050202|FG001|Overall Study|Lost to Follow-up|1|||
94614478|NCT02128932|324050203|FG002|Overall Study|Lost to Follow-up|1|||
94614479|NCT02128932|324050201|FG000|Overall Study|No reason for withdrawal|12|||
94460268|NCT00189306|323473714|FG000|Posttreatment Period|Target lesion excised|1|||
94614480|NCT02128932|324050202|FG001|Overall Study|No reason for withdrawal|11|||
94614481|NCT02128932|324050203|FG002|Overall Study|No reason for withdrawal|7|||
94614482|NCT01361568|324050204|FG000|Overall Study|Adverse Event|0|||
94614483|NCT01361568|324050205|FG001|Overall Study|Adverse Event|0|||
94614484|NCT01361568|324050206|FG002|Overall Study|Adverse Event|0|||
94614485|NCT01361568|324050207|FG003|Overall Study|Adverse Event|0|||
94614486|NCT01361568|324050208|FG004|Overall Study|Adverse Event|1|||
94614487|NCT01361568|324050209|FG005|Overall Study|Adverse Event|0|||
94614488|NCT01361568|324050204|FG000|Overall Study|Physician Decision|0|||
94614489|NCT01361568|324050205|FG001|Overall Study|Physician Decision|0|||
94614490|NCT01361568|324050206|FG002|Overall Study|Physician Decision|0|||
94614491|NCT01361568|324050207|FG003|Overall Study|Physician Decision|0|||
94614492|NCT01361568|324050208|FG004|Overall Study|Physician Decision|0|||
94614493|NCT01361568|324050209|FG005|Overall Study|Physician Decision|1|||
94614494|NCT01361568|324050204|FG000|Overall Study|Withdrawal by Subject|2|||
94614495|NCT01361568|324050205|FG001|Overall Study|Withdrawal by Subject|1|||
94614496|NCT01361568|324050206|FG002|Overall Study|Withdrawal by Subject|0|||
94614497|NCT01361568|324050207|FG003|Overall Study|Withdrawal by Subject|0|||
94614498|NCT01361568|324050208|FG004|Overall Study|Withdrawal by Subject|0|||
94614499|NCT01361568|324050209|FG005|Overall Study|Withdrawal by Subject|1|||
94614500|NCT01254630|324050210|FG000|Overall Study|Adverse Event|36|||
94614501|NCT01254630|324050211|FG001|Overall Study|Adverse Event|15|||
94614502|NCT01254630|324050212|FG002|Overall Study|Adverse Event|40|||
94614503|NCT01254630|324050213|FG003|Overall Study|Adverse Event|8|||
94614504|NCT01254630|324050210|FG000|Overall Study|Death|461|||
94614505|NCT01254630|324050211|FG001|Overall Study|Death|151|||
94614506|NCT01254630|324050212|FG002|Overall Study|Death|478|||
94614507|NCT01254630|324050213|FG003|Overall Study|Death|139|||
94614508|NCT01254630|324050210|FG000|Overall Study|Lost to Follow-up|80|||
94614509|NCT01254630|324050211|FG001|Overall Study|Lost to Follow-up|26|||
94614510|NCT01254630|324050212|FG002|Overall Study|Lost to Follow-up|89|||
94614511|NCT01254630|324050213|FG003|Overall Study|Lost to Follow-up|32|||
94614512|NCT01254630|324050210|FG000|Overall Study|Physician Decision|24|||
94614513|NCT01254630|324050211|FG001|Overall Study|Physician Decision|8|||
94614514|NCT01254630|324050212|FG002|Overall Study|Physician Decision|16|||
94614515|NCT01254630|324050213|FG003|Overall Study|Physician Decision|7|||
94614516|NCT01254630|324050210|FG000|Overall Study|Withdrawal by Subject|201|||
94614517|NCT01254630|324050211|FG001|Overall Study|Withdrawal by Subject|94|||
94614518|NCT01254630|324050212|FG002|Overall Study|Withdrawal by Subject|188|||
94614519|NCT01254630|324050213|FG003|Overall Study|Withdrawal by Subject|89|||
94614520|NCT01254630|324050210|FG000|Overall Study|Study terminated by sponsor|0|||
94614521|NCT01254630|324050211|FG001|Overall Study|Study terminated by sponsor|994|||
94614522|NCT01254630|324050212|FG002|Overall Study|Study terminated by sponsor|0|||
94614523|NCT01254630|324050213|FG003|Overall Study|Study terminated by sponsor|1010|||
94614524|NCT01254630|324050210|FG000|Overall Study|Status not recorded|0|||
94614525|NCT01254630|324050211|FG001|Overall Study|Status not recorded|0|||
94614526|NCT01254630|324050212|FG002|Overall Study|Status not recorded|1|||
94614527|NCT01254630|324050213|FG003|Overall Study|Status not recorded|0|||
94614528|NCT02663908|324050215|FG000|Overall Study|Withdrawal by Subject|8|||
94614529|NCT02663908|324050216|FG001|Overall Study|Withdrawal by Subject|5|||
94614530|NCT02663908|324050215|FG000|Overall Study|Lost to Follow-up|1|||
94614531|NCT02663908|324050216|FG001|Overall Study|Lost to Follow-up|5|||
94614532|NCT02663908|324050215|FG000|Overall Study|Adverse Event|13|||
94614533|NCT02663908|324050216|FG001|Overall Study|Adverse Event|11|||
94614534|NCT02663908|324050215|FG000|Overall Study|Protocol Violation|1|||
94614535|NCT02663908|324050216|FG001|Overall Study|Protocol Violation|2|||
94614536|NCT02663908|324050215|FG000|Overall Study|Lack of therapeutic response|2|||
94614537|NCT02663908|324050216|FG001|Overall Study|Lack of therapeutic response|0|||
94614538|NCT02663908|324050215|FG000|Overall Study|COVID-19|1|||
94614539|NCT02663908|324050216|FG001|Overall Study|COVID-19|0|||
94614540|NCT02663908|324050215|FG000|Overall Study|Site closed|1|||
94614541|NCT02663908|324050216|FG001|Overall Study|Site closed|0|||
94614542|NCT02663908|324050215|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
94614543|NCT02663908|324050216|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
94614544|NCT02663908|324050215|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
94614545|NCT02663908|324050216|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
94664952|NCT01490632|324229746|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
94664953|NCT01490632|324229747|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
94614546|NCT02663908|324050215|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
94614547|NCT02663908|324050216|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
94614548|NCT02663908|324050215|FG000|Overall Study|Death|1|||
94614549|NCT02663908|324050216|FG001|Overall Study|Death|0|||
94688669|NCT00363896|324315567|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
94460269|NCT00189306|323473714|FG000|Posttreatment Period|Protocol Violation|1|||
94460270|NCT00189306|323473714|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
94460271|NCT00189306|323473714|FG000|Posttreatment Period|Local skin reaction/sign|1|||
94460272|NCT00189306|323473714|FG000|Long-Term Follow-up|Adverse Event|2|||
94460273|NCT00189306|323473714|FG000|Long-Term Follow-up|Death|4|||
94460274|NCT00189306|323473714|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
94460275|NCT00189306|323473714|FG000|Long-Term Follow-up|Intercurrent disease|2|||
94460276|NCT00189306|323473714|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
94460277|NCT00189306|323473714|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
94460278|NCT02017912|323473715|FG000|Overall Study|Withdrawal by Subject|2|||
94460279|NCT02017912|323473716|FG001|Overall Study|Withdrawal by Subject|1|||
94460280|NCT02017912|323473715|FG000|Overall Study|miscellaneous|1|||
94460281|NCT02017912|323473716|FG001|Overall Study|miscellaneous|1|||
94460282|NCT01322035|323473717|FG000|Overall Study|Lost to Follow-up|8|||
94460283|NCT01322035|323473718|FG001|Overall Study|Lost to Follow-up|3|||
94460284|NCT00535847|323473719|FG000|Overall Study|Adverse Event|5|||
94460285|NCT00535847|323473720|FG001|Overall Study|Adverse Event|3|||
94460286|NCT00535847|323473721|FG002|Overall Study|Adverse Event|2|||
94460287|NCT00535847|323473719|FG000|Overall Study|Non compliance|1|||
94460288|NCT00535847|323473720|FG001|Overall Study|Non compliance|1|||
94460289|NCT00535847|323473721|FG002|Overall Study|Non compliance|0|||
94460290|NCT00535847|323473719|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
94460291|NCT00535847|323473720|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
94460292|NCT00535847|323473721|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
94460293|NCT04569968|323473722|FG000|Overall Study|Lost to Follow-up|2|||
94460294|NCT04569968|323473723|FG001|Overall Study|Lost to Follow-up|5|||
94460295|NCT04569968|323473722|FG000|Overall Study|Story of head and/or neck surgery|2|||
94460296|NCT04569968|323473723|FG001|Overall Study|Story of head and/or neck surgery|2|||
94460297|NCT04569968|323473722|FG000|Overall Study|Time of stroke onset|8|||
94460298|NCT04569968|323473723|FG001|Overall Study|Time of stroke onset|7|||
94460299|NCT04569968|323473722|FG000|Overall Study|Type of strokr|12|||
94460300|NCT04569968|323473723|FG001|Overall Study|Type of strokr|8|||
94460301|NCT04569968|323473722|FG000|Overall Study|Cooperation|8|||
94460302|NCT04569968|323473723|FG001|Overall Study|Cooperation|8|||
94460303|NCT04569968|323473722|FG000|Overall Study|Age interval|17|||
94460304|NCT04569968|323473723|FG001|Overall Study|Age interval|6|||
94460305|NCT04569968|323473722|FG000|Overall Study|Denial of participation to the study|0|||
94460306|NCT04569968|323473723|FG001|Overall Study|Denial of participation to the study|3|||
94460307|NCT04569968|323473722|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
94460308|NCT04569968|323473723|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
94460309|NCT04569968|323473722|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
94460310|NCT04569968|323473723|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
94460311|NCT04569968|323473722|FG000|Overall Study|Quarantine|1|||
94460312|NCT04569968|323473723|FG001|Overall Study|Quarantine|0|||
94460313|NCT04569968|323473722|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
94460314|NCT04569968|323473723|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
94460315|NCT04569968|323473722|FG000|Overall Study|Repetitive stroke|8|||
94460316|NCT04569968|323473723|FG001|Overall Study|Repetitive stroke|0|||
94460317|NCT04569968|323473722|FG000|Overall Study|Insufficient mastication|1|||
94460318|NCT04569968|323473723|FG001|Overall Study|Insufficient mastication|0|||
94460319|NCT04569968|323473722|FG000|Overall Study|Infection|1|||
94460320|NCT04569968|323473723|FG001|Overall Study|Infection|0|||
94460321|NCT00727844|323473724|FG000|Initial Randomization|Physician Decision|2|||
94460322|NCT00727844|323473725|FG001|Initial Randomization|Physician Decision|0|||
94460323|NCT00727844|323473726|FG002|Initial Randomization|Physician Decision|0|||
94460324|NCT00727844|323473727|FG003|Initial Randomization|Physician Decision|0|||
94460325|NCT00732758|323473728|FG000|Overall Study|Lost to Follow-up|8|||
94460326|NCT00732758|323473729|FG001|Overall Study|Lost to Follow-up|16|||
94460327|NCT05007041|323473730|FG000|Overall Study|Missing Diary Entries|0|||
94460328|NCT05007041|323473731|FG001|Overall Study|Missing Diary Entries|1|||
94460329|NCT01552915|323473732|FG000|Overall Study|Adverse Event|3|||
94460330|NCT01552915|323473733|FG001|Overall Study|Adverse Event|14|||
94460331|NCT01552915|323473734|FG002|Overall Study|Adverse Event|3|||
94460332|NCT01552915|323473732|FG000|Overall Study|Lost to Follow-up|4|||
94460333|NCT01552915|323473733|FG001|Overall Study|Lost to Follow-up|6|||
94460334|NCT01552915|323473734|FG002|Overall Study|Lost to Follow-up|5|||
94460335|NCT01552915|323473732|FG000|Overall Study|Withdrawal by Subject|6|||
94460336|NCT01552915|323473733|FG001|Overall Study|Withdrawal by Subject|4|||
94460337|NCT01552915|323473734|FG002|Overall Study|Withdrawal by Subject|5|||
94460338|NCT01552915|323473732|FG000|Overall Study|Protocol Violation|0|||
94460339|NCT01552915|323473733|FG001|Overall Study|Protocol Violation|4|||
94460340|NCT01552915|323473734|FG002|Overall Study|Protocol Violation|4|||
94460341|NCT01552915|323473732|FG000|Overall Study|Lack of Efficacy|8|||
94460342|NCT01552915|323473733|FG001|Overall Study|Lack of Efficacy|1|||
94460343|NCT01552915|323473734|FG002|Overall Study|Lack of Efficacy|4|||
94460344|NCT01552915|323473732|FG000|Overall Study|Other|2|||
94460345|NCT01552915|323473733|FG001|Overall Study|Other|0|||
94460346|NCT01552915|323473734|FG002|Overall Study|Other|6|||
94460347|NCT02288091|323473737|FG000|Overall Study|Lost to Follow-up|1|||
94460348|NCT02288091|323473737|FG000|Overall Study|Screen fail|7|||
94460349|NCT00658775|323473738|FG000|Overall Study|Adverse Event|4|||
94460350|NCT00658775|323473739|FG001|Overall Study|Adverse Event|6|||
94460351|NCT00658775|323473738|FG000|Overall Study|Lost to Follow-up|17|||
94460352|NCT00658775|323473739|FG001|Overall Study|Lost to Follow-up|18|||
94460353|NCT00658775|323473738|FG000|Overall Study|Withdrawal by Subject|6|||
94460354|NCT00658775|323473739|FG001|Overall Study|Withdrawal by Subject|4|||
94460355|NCT00658775|323473738|FG000|Overall Study|Withdrawal of consent|8|||
94460356|NCT00658775|323473739|FG001|Overall Study|Withdrawal of consent|7|||
94460357|NCT00658775|323473738|FG000|Overall Study|Other|7|||
94460358|NCT00658775|323473739|FG001|Overall Study|Other|8|||
94460359|NCT00965341|323473742|FG000|Overall Study|Withdrew consent|1|||
94460360|NCT00965341|323473743|FG001|Overall Study|Withdrew consent|5|||
94460361|NCT00965341|323473742|FG000|Overall Study|Lost to Follow-up|1|||
94460362|NCT00965341|323473743|FG001|Overall Study|Lost to Follow-up|0|||
94460363|NCT00965341|323473742|FG000|Overall Study|Transportation issues|4|||
94460364|NCT00965341|323473743|FG001|Overall Study|Transportation issues|3|||
94460365|NCT01901653|323473746|FG000|Overall Study|Death|2|||
94460366|NCT01901653|323473747|FG001|Overall Study|Death|1|||
94460367|NCT01901653|323473748|FG002|Overall Study|Death|8|||
94460368|NCT01901653|323473749|FG003|Overall Study|Death|3|||
94460369|NCT01901653|323473750|FG004|Overall Study|Death|2|||
94460370|NCT01901653|323473751|FG005|Overall Study|Death|2|||
94614550|NCT02663908|324050215|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
94614551|NCT02663908|324050216|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
94614552|NCT02663908|324050215|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
94614553|NCT02663908|324050216|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
94614554|NCT02572401|324050217|FG000|Overall Study|Lost to Follow-up|5|||
94614555|NCT02572401|324050218|FG001|Overall Study|Lost to Follow-up|8|||
94614556|NCT02572401|324050219|FG002|Overall Study|Lost to Follow-up|9|||
94614557|NCT02572401|324050220|FG003|Overall Study|Lost to Follow-up|9|||
94614558|NCT02572401|324050217|FG000|Overall Study|Death|0|||
94614559|NCT02572401|324050218|FG001|Overall Study|Death|0|||
94614560|NCT02572401|324050219|FG002|Overall Study|Death|0|||
94614561|NCT02572401|324050220|FG003|Overall Study|Death|1|||
94614562|NCT00370071|324050221|FG000|Overall Study|Withdrawal by Subject|2|||
94614563|NCT03344796|324050225|FG000|Overall Study|Lost to Follow-up|0|||
94614564|NCT03344796|324050226|FG001|Overall Study|Lost to Follow-up|0|||
94614565|NCT03344796|324050227|FG002|Overall Study|Lost to Follow-up|0|||
94614566|NCT03344796|324050228|FG003|Overall Study|Lost to Follow-up|0|||
94614567|NCT03344796|324050229|FG004|Overall Study|Lost to Follow-up|0|||
94614568|NCT03344796|324050230|FG005|Overall Study|Lost to Follow-up|2|||
94614569|NCT00450255|324050233|FG000|Overall Study|Prior RFA ablation of liver|1|||
94614570|NCT01402011|324050241|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
94614571|NCT01402011|324050242|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
94614572|NCT01402011|324050243|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
94614573|NCT01402011|324050241|FG000|Active Treatment Period|Withdrawal by Subject|1|||
94614574|NCT01402011|324050242|FG001|Active Treatment Period|Withdrawal by Subject|3|||
94614575|NCT01402011|324050243|FG002|Active Treatment Period|Withdrawal by Subject|0|||
94614576|NCT01402011|324050241|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
94460371|NCT01901653|323473752|FG006|Overall Study|Death|6|||
94460372|NCT01901653|323473753|FG007|Overall Study|Death|9|||
94460373|NCT01901653|323473754|FG008|Overall Study|Death|1|||
94460374|NCT01901653|323473755|FG009|Overall Study|Death|16|||
94460375|NCT01901653|323473756|FG010|Overall Study|Death|2|||
94614577|NCT01402011|324050242|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
94614578|NCT01402011|324050243|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
94614579|NCT00242216|324050244|FG000|Overall Study|Lost to Follow-up|12|||
94614580|NCT00242216|324050245|FG001|Overall Study|Lost to Follow-up|17|||
94460376|NCT01901653|323473757|FG011|Overall Study|Death|15|||
94460377|NCT01901653|323473758|FG012|Overall Study|Death|4|||
94460378|NCT01901653|323473746|FG000|Overall Study|Lost to Follow-up|1|||
94460379|NCT01901653|323473747|FG001|Overall Study|Lost to Follow-up|0|||
94460380|NCT01901653|323473748|FG002|Overall Study|Lost to Follow-up|2|||
94460381|NCT01901653|323473749|FG003|Overall Study|Lost to Follow-up|0|||
94460382|NCT01901653|323473750|FG004|Overall Study|Lost to Follow-up|0|||
94460383|NCT01901653|323473751|FG005|Overall Study|Lost to Follow-up|1|||
94460384|NCT01901653|323473752|FG006|Overall Study|Lost to Follow-up|0|||
94460385|NCT01901653|323473753|FG007|Overall Study|Lost to Follow-up|1|||
94460386|NCT01901653|323473754|FG008|Overall Study|Lost to Follow-up|0|||
94460387|NCT01901653|323473755|FG009|Overall Study|Lost to Follow-up|0|||
94460388|NCT01901653|323473756|FG010|Overall Study|Lost to Follow-up|0|||
94460389|NCT01901653|323473757|FG011|Overall Study|Lost to Follow-up|0|||
94460390|NCT01901653|323473758|FG012|Overall Study|Lost to Follow-up|0|||
94460391|NCT01901653|323473746|FG000|Overall Study|Withdrawal by Subject|0|||
94460392|NCT01901653|323473747|FG001|Overall Study|Withdrawal by Subject|0|||
94460393|NCT01901653|323473748|FG002|Overall Study|Withdrawal by Subject|0|||
94460394|NCT01901653|323473749|FG003|Overall Study|Withdrawal by Subject|0|||
94460395|NCT01901653|323473750|FG004|Overall Study|Withdrawal by Subject|0|||
94460396|NCT01901653|323473751|FG005|Overall Study|Withdrawal by Subject|0|||
94460397|NCT01901653|323473752|FG006|Overall Study|Withdrawal by Subject|1|||
94460398|NCT01901653|323473753|FG007|Overall Study|Withdrawal by Subject|0|||
94460399|NCT01901653|323473754|FG008|Overall Study|Withdrawal by Subject|0|||
94460400|NCT01901653|323473755|FG009|Overall Study|Withdrawal by Subject|0|||
94460401|NCT01901653|323473756|FG010|Overall Study|Withdrawal by Subject|0|||
94460402|NCT01901653|323473757|FG011|Overall Study|Withdrawal by Subject|0|||
94460403|NCT01901653|323473758|FG012|Overall Study|Withdrawal by Subject|0|||
94460404|NCT01901653|323473746|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
94460405|NCT01901653|323473747|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
94460406|NCT01901653|323473748|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
94614581|NCT00242216|324050244|FG000|Overall Study|Death|4|||
94614582|NCT00242216|324050245|FG001|Overall Study|Death|2|||
94614583|NCT00242216|324050244|FG000|Overall Study|Lack of Efficacy|1|||
94614584|NCT00242216|324050245|FG001|Overall Study|Lack of Efficacy|2|||
94614585|NCT00242216|324050244|FG000|Overall Study|no medicaiton dispensed|1|||
94614586|NCT00242216|324050245|FG001|Overall Study|no medicaiton dispensed|1|||
94614587|NCT03487549|324050248|FG000|Overall Study|Protocol Violation|0|||
94614588|NCT03487549|324050249|FG001|Overall Study|Protocol Violation|1|||
94614589|NCT03487549|324050248|FG000|Overall Study|Lost to Follow-up|2|||
94614590|NCT03487549|324050249|FG001|Overall Study|Lost to Follow-up|1|||
94614591|NCT03487549|324050248|FG000|Overall Study|Withdrawal by Subject|2|||
94614592|NCT03487549|324050249|FG001|Overall Study|Withdrawal by Subject|0|||
94614593|NCT02900976|324050250|FG000|Overall Study|Adverse Event|0|||
94460407|NCT01901653|323473749|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
94460408|NCT01901653|323473750|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
94460409|NCT01901653|323473751|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
94460410|NCT01901653|323473752|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
94460411|NCT01901653|323473753|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
94460412|NCT01901653|323473754|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
94460413|NCT01901653|323473755|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
94460414|NCT01901653|323473756|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
94460415|NCT01901653|323473757|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
94460416|NCT01901653|323473758|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
94460417|NCT03721835|323473767|FG000|Overall Study|Participant not able to return|1|||
94460418|NCT03721835|323473767|FG000|Overall Study|Lost to Follow-up|1|||
94460419|NCT03721835|323473767|FG000|Overall Study|Revision of the components of the study device|2|||
94460420|NCT03721835|323473767|FG000|Overall Study|Sponsor terminated study|6|||
94460421|NCT03721835|323473767|FG000|Overall Study|Death|1|||
94460422|NCT03721835|323473767|FG000|Overall Study|Sponsor decision|1|||
94460423|NCT02100670|323473768|FG000|Overall Study|Adverse Event|10|||
94460424|NCT02100670|323473769|FG001|Overall Study|Adverse Event|3|||
94460425|NCT02100670|323473770|FG002|Overall Study|Adverse Event|3|||
94460426|NCT02100670|323473771|FG003|Overall Study|Adverse Event|0|||
94460427|NCT02100670|323473768|FG000|Overall Study|Lost to Follow-up|1|||
94460428|NCT02100670|323473769|FG001|Overall Study|Lost to Follow-up|0|||
94614594|NCT02900976|324050251|FG001|Overall Study|Adverse Event|1|||
94614595|NCT02900976|324050250|FG000|Overall Study|Physician Decision|0|||
94614596|NCT02900976|324050251|FG001|Overall Study|Physician Decision|2|||
94460429|NCT02100670|323473770|FG002|Overall Study|Lost to Follow-up|0|||
94460430|NCT02100670|323473771|FG003|Overall Study|Lost to Follow-up|0|||
94460431|NCT02100670|323473768|FG000|Overall Study|Protocol Violation|0|||
94460432|NCT02100670|323473769|FG001|Overall Study|Protocol Violation|1|||
94460433|NCT02100670|323473770|FG002|Overall Study|Protocol Violation|0|||
94614597|NCT02900976|324050250|FG000|Overall Study|Progressive disease|0|||
94614598|NCT02900976|324050251|FG001|Overall Study|Progressive disease|6|||
94614599|NCT02171065|324051705|FG000|Overall Study|Withdrawal by Subject|1|||
94614600|NCT02171065|324051706|FG001|Overall Study|Withdrawal by Subject|0|||
94614601|NCT02171065|324051707|FG002|Overall Study|Withdrawal by Subject|0|||
94614602|NCT02171065|324051705|FG000|Overall Study|Lost to Follow-up|0|||
94614603|NCT02171065|324051706|FG001|Overall Study|Lost to Follow-up|0|||
94614604|NCT02171065|324051707|FG002|Overall Study|Lost to Follow-up|1|||
94614605|NCT00531934|324051708|FG000|Overall Study|Adverse Event|4|||
94614606|NCT00531934|324051709|FG001|Overall Study|Adverse Event|8|||
94614607|NCT00531934|324051708|FG000|Overall Study|Progression|52|||
94614608|NCT00531934|324051709|FG001|Overall Study|Progression|42|||
94614609|NCT00531934|324051708|FG000|Overall Study|Death|7|||
94614610|NCT00531934|324051709|FG001|Overall Study|Death|10|||
94614611|NCT00531934|324051708|FG000|Overall Study|Withdrawal by Subject|1|||
94614612|NCT00531934|324051709|FG001|Overall Study|Withdrawal by Subject|1|||
94614613|NCT00531934|324051708|FG000|Overall Study|Other|2|||
94614614|NCT00531934|324051709|FG001|Overall Study|Other|2|||
94614615|NCT00282412|324051713|FG000|Overall Study|Death|2|||
94614616|NCT01507298|324051714|FG000|Overall Study|Protocol Violation|0|||
94614617|NCT01507298|324051715|FG001|Overall Study|Protocol Violation|6|||
94614618|NCT00385762|324051716|FG000|Overall Study|Adverse Event|1|||
94614619|NCT00385762|324051716|FG000|Overall Study|Lost to Follow-up|1|||
94614620|NCT01797731|324051720|FG000|Overall Study|Didn't have proper radiographs required|3|||
94614621|NCT01797731|324051721|FG001|Overall Study|Didn't have proper radiographs required|3|||
94614622|NCT02248701|324051726|FG000|Overall Study|Withdrawal by Subject|2|||
94614623|NCT02248701|324051727|FG001|Overall Study|Withdrawal by Subject|1|||
94614624|NCT02248701|324051726|FG000|Overall Study|Physician Decision|0|||
94614625|NCT02248701|324051727|FG001|Overall Study|Physician Decision|1|||
94614626|NCT02248701|324051726|FG000|Overall Study|Adverse Event|1|||
94614627|NCT02248701|324051727|FG001|Overall Study|Adverse Event|0|||
94614628|NCT02248701|324051726|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
94614629|NCT02248701|324051727|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
94614630|NCT05085730|324051728|FG000|Overall Study|Withdrawal by Subject|4|||
94614631|NCT05085730|324051728|FG000|Overall Study|Physician Decision|1|||
94614632|NCT02038881|324051729|FG000|Overall Study|Withdrawal by Subject|0|||
94614633|NCT02038881|324051730|FG001|Overall Study|Withdrawal by Subject|0|||
94614634|NCT02038881|324051731|FG002|Overall Study|Withdrawal by Subject|1|||
94614635|NCT02038881|324051729|FG000|Overall Study|Lost to Follow-up|2|||
94614636|NCT02038881|324051730|FG001|Overall Study|Lost to Follow-up|0|||
94614637|NCT02038881|324051731|FG002|Overall Study|Lost to Follow-up|0|||
94614638|NCT02038881|324051729|FG000|Overall Study|incarcerated|1|||
94614639|NCT02038881|324051730|FG001|Overall Study|incarcerated|0|||
94614640|NCT02038881|324051731|FG002|Overall Study|incarcerated|0|||
94614641|NCT00880542|324051735|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
94614642|NCT00880542|324051735|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
94614643|NCT00880542|324051735|FG000|REP: Surgical Resection|progressive disease|1|||
94614644|NCT05047770|324051736|FG000|Overall Study|Withdrawal by Subject|15|||
94614645|NCT05047770|324051737|FG001|Overall Study|Withdrawal by Subject|10|||
94614646|NCT05047770|324051738|FG002|Overall Study|Withdrawal by Subject|6|||
94614647|NCT05047770|324051739|FG003|Overall Study|Withdrawal by Subject|12|||
94614648|NCT05047770|324051736|FG000|Overall Study|Lost to Follow-up|7|||
94614649|NCT05047770|324051737|FG001|Overall Study|Lost to Follow-up|5|||
94614650|NCT05047770|324051738|FG002|Overall Study|Lost to Follow-up|12|||
94614651|NCT05047770|324051739|FG003|Overall Study|Lost to Follow-up|13|||
94614652|NCT05047770|324051736|FG000|Overall Study|Other|1|||
94614653|NCT05047770|324051737|FG001|Overall Study|Other|0|||
94614654|NCT05047770|324051738|FG002|Overall Study|Other|1|||
94460434|NCT02100670|323473771|FG003|Overall Study|Protocol Violation|1|||
94614655|NCT05047770|324051739|FG003|Overall Study|Other|0|||
94614656|NCT03758443|324051740|FG000|Induction Period|Adverse Event|2|||
94614657|NCT03758443|324051741|FG001|Induction Period|Adverse Event|4|||
94614658|NCT03758443|324051742|FG002|Induction Period|Adverse Event|2|||
94614659|NCT03758443|324051743|FG003|Induction Period|Adverse Event|3|||
94614660|NCT03758443|324051740|FG000|Induction Period|Physician Decision|1|||
94614661|NCT03758443|324051741|FG001|Induction Period|Physician Decision|1|||
94614662|NCT03758443|324051742|FG002|Induction Period|Physician Decision|3|||
94614663|NCT03758443|324051743|FG003|Induction Period|Physician Decision|0|||
94614664|NCT03758443|324051740|FG000|Induction Period|Protocol Violation|0|||
94614665|NCT03758443|324051741|FG001|Induction Period|Protocol Violation|0|||
94614666|NCT03758443|324051742|FG002|Induction Period|Protocol Violation|0|||
94614667|NCT03758443|324051743|FG003|Induction Period|Protocol Violation|1|||
94614668|NCT03758443|324051740|FG000|Induction Period|Withdrawal by Subject|3|||
94614669|NCT03758443|324051741|FG001|Induction Period|Withdrawal by Subject|2|||
94614670|NCT03758443|324051742|FG002|Induction Period|Withdrawal by Subject|2|||
94614671|NCT03758443|324051743|FG003|Induction Period|Withdrawal by Subject|4|||
94614672|NCT03758443|324051740|FG000|Extended Induction Period|Adverse Event|1|||
94614673|NCT03758443|324051741|FG001|Extended Induction Period|Adverse Event|1|||
94614674|NCT03758443|324051742|FG002|Extended Induction Period|Adverse Event|0|||
94614675|NCT03758443|324051743|FG003|Extended Induction Period|Adverse Event|1|||
94614676|NCT03758443|324051740|FG000|Extended Induction Period|Lost to Follow-up|1|||
94614677|NCT03758443|324051741|FG001|Extended Induction Period|Lost to Follow-up|0|||
94614678|NCT03758443|324051742|FG002|Extended Induction Period|Lost to Follow-up|0|||
94614679|NCT03758443|324051743|FG003|Extended Induction Period|Lost to Follow-up|0|||
94614680|NCT03758443|324051740|FG000|Extended Induction Period|Physician Decision|2|||
94614681|NCT03758443|324051741|FG001|Extended Induction Period|Physician Decision|1|||
94614682|NCT03758443|324051742|FG002|Extended Induction Period|Physician Decision|2|||
94614683|NCT03758443|324051743|FG003|Extended Induction Period|Physician Decision|2|||
94614684|NCT03758443|324051740|FG000|Extended Induction Period|Protocol Violation|0|||
94614685|NCT03758443|324051741|FG001|Extended Induction Period|Protocol Violation|0|||
94614686|NCT03758443|324051742|FG002|Extended Induction Period|Protocol Violation|0|||
94614687|NCT03758443|324051743|FG003|Extended Induction Period|Protocol Violation|1|||
94614688|NCT03758443|324051740|FG000|Extended Induction Period|Withdrawal by Subject|8|||
94614689|NCT03758443|324051741|FG001|Extended Induction Period|Withdrawal by Subject|1|||
94614690|NCT03758443|324051742|FG002|Extended Induction Period|Withdrawal by Subject|7|||
94614691|NCT03758443|324051743|FG003|Extended Induction Period|Withdrawal by Subject|3|||
94614692|NCT03758443|324051740|FG000|Extended Induction Period|Miscellaneous|1|||
94614693|NCT03758443|324051741|FG001|Extended Induction Period|Miscellaneous|0|||
94614694|NCT03758443|324051742|FG002|Extended Induction Period|Miscellaneous|0|||
94614695|NCT03758443|324051743|FG003|Extended Induction Period|Miscellaneous|0|||
94614696|NCT03758443|324051740|FG000|Maintenance Period|Adverse Event|1|||
94614697|NCT03758443|324051741|FG001|Maintenance Period|Adverse Event|2|||
94614698|NCT03758443|324051742|FG002|Maintenance Period|Adverse Event|0|||
94614699|NCT03758443|324051743|FG003|Maintenance Period|Adverse Event|0|||
94614700|NCT03758443|324051740|FG000|Maintenance Period|Lost to Follow-up|0|||
94614701|NCT03758443|324051741|FG001|Maintenance Period|Lost to Follow-up|0|||
94614702|NCT03758443|324051742|FG002|Maintenance Period|Lost to Follow-up|0|||
94614703|NCT03758443|324051743|FG003|Maintenance Period|Lost to Follow-up|1|||
94614704|NCT03758443|324051740|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
94614705|NCT03758443|324051741|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
94614706|NCT03758443|324051742|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
94614707|NCT03758443|324051743|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
94614708|NCT03758443|324051740|FG000|Maintenance Period|Protocol Violation|0|||
94614709|NCT03758443|324051741|FG001|Maintenance Period|Protocol Violation|1|||
94614710|NCT03758443|324051742|FG002|Maintenance Period|Protocol Violation|0|||
94614711|NCT03758443|324051743|FG003|Maintenance Period|Protocol Violation|0|||
94614712|NCT03758443|324051740|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
94614713|NCT03758443|324051741|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
94614714|NCT03758443|324051742|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
94614715|NCT03758443|324051743|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
94614716|NCT03758443|324051740|FG000|Maintenance Period|Withdrawal by Subject|1|||
94614717|NCT03758443|324051741|FG001|Maintenance Period|Withdrawal by Subject|0|||
94614718|NCT03758443|324051742|FG002|Maintenance Period|Withdrawal by Subject|1|||
94614719|NCT03758443|324051743|FG003|Maintenance Period|Withdrawal by Subject|1|||
94614720|NCT03758443|324051740|FG000|Maintenance Period|Miscellaneous|0|||
94614721|NCT03758443|324051741|FG001|Maintenance Period|Miscellaneous|0|||
94614722|NCT03758443|324051742|FG002|Maintenance Period|Miscellaneous|1|||
94614723|NCT03758443|324051743|FG003|Maintenance Period|Miscellaneous|0|||
94614724|NCT01436396|324051744|FG000|Overall Study|Protocol Violation|7|||
94614725|NCT01436396|324051745|FG001|Overall Study|Protocol Violation|5|||
94460435|NCT02100670|323473768|FG000|Overall Study|Withdrawal of Consent|0|||
94460436|NCT02100670|323473769|FG001|Overall Study|Withdrawal of Consent|1|||
94460437|NCT02100670|323473770|FG002|Overall Study|Withdrawal of Consent|1|||
94460438|NCT02100670|323473771|FG003|Overall Study|Withdrawal of Consent|0|||
94460439|NCT02100670|323473768|FG000|Overall Study|No swelling no pain|1|||
94460440|NCT02100670|323473769|FG001|Overall Study|No swelling no pain|0|||
94460441|NCT02100670|323473770|FG002|Overall Study|No swelling no pain|0|||
94460442|NCT02100670|323473771|FG003|Overall Study|No swelling no pain|0|||
94460443|NCT02100670|323473768|FG000|Overall Study|Poor Efficacy|0|||
94460444|NCT02100670|323473769|FG001|Overall Study|Poor Efficacy|1|||
94460445|NCT02100670|323473770|FG002|Overall Study|Poor Efficacy|0|||
94460446|NCT02100670|323473771|FG003|Overall Study|Poor Efficacy|0|||
94460447|NCT02100670|323473768|FG000|Overall Study|Physician Decision|0|||
94460448|NCT02100670|323473769|FG001|Overall Study|Physician Decision|1|||
94460449|NCT02100670|323473770|FG002|Overall Study|Physician Decision|0|||
94460450|NCT02100670|323473771|FG003|Overall Study|Physician Decision|0|||
94460451|NCT02100670|323473768|FG000|Overall Study|Withdrawal by Subject|1|||
94460452|NCT02100670|323473769|FG001|Overall Study|Withdrawal by Subject|0|||
94460453|NCT02100670|323473770|FG002|Overall Study|Withdrawal by Subject|0|||
94460454|NCT02100670|323473771|FG003|Overall Study|Withdrawal by Subject|0|||
94460455|NCT00197002|323475344|FG000|Overall Study|Adverse Event|0|||
94460456|NCT00197002|323475345|FG001|Overall Study|Adverse Event|1|||
94460457|NCT00197002|323475346|FG002|Overall Study|Adverse Event|0|||
94460458|NCT00197002|323475344|FG000|Overall Study|Protocol Violation|1|||
94460459|NCT00197002|323475345|FG001|Overall Study|Protocol Violation|0|||
94460460|NCT00197002|323475346|FG002|Overall Study|Protocol Violation|2|||
94460461|NCT00197002|323475344|FG000|Overall Study|Withdrawal by Subject|9|||
94460462|NCT00197002|323475345|FG001|Overall Study|Withdrawal by Subject|5|||
94460463|NCT00197002|323475346|FG002|Overall Study|Withdrawal by Subject|7|||
94460464|NCT00197002|323475344|FG000|Overall Study|Migrated/moved from study area|3|||
94460465|NCT00197002|323475345|FG001|Overall Study|Migrated/moved from study area|5|||
94460466|NCT00197002|323475346|FG002|Overall Study|Migrated/moved from study area|1|||
94460467|NCT00197002|323475344|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
94460468|NCT00197002|323475345|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
94460469|NCT00197002|323475346|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
94460470|NCT00197002|323475344|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
94460471|NCT00197002|323475345|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
94460472|NCT00197002|323475346|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
94460473|NCT00197002|323475344|FG000|Overall Study|Others|3|||
94460474|NCT00197002|323475345|FG001|Overall Study|Others|1|||
94460475|NCT00197002|323475346|FG002|Overall Study|Others|1|||
94460476|NCT00784550|323475347|FG000|Overall Study|Adverse Event|12|||
94460477|NCT00784550|323475348|FG001|Overall Study|Adverse Event|10|||
94460478|NCT00784550|323475347|FG000|Overall Study|Lack of Efficacy|0|||
94460479|NCT00784550|323475348|FG001|Overall Study|Lack of Efficacy|1|||
94460480|NCT00784550|323475347|FG000|Overall Study|Protocol Violation|10|||
94460481|NCT00784550|323475348|FG001|Overall Study|Protocol Violation|10|||
94460482|NCT00784550|323475347|FG000|Overall Study|Lost to Follow-up|8|||
94460483|NCT00784550|323475348|FG001|Overall Study|Lost to Follow-up|5|||
94460484|NCT00784550|323475347|FG000|Overall Study|Physician Decision|2|||
94460485|NCT00784550|323475348|FG001|Overall Study|Physician Decision|3|||
94460486|NCT00784550|323475347|FG000|Overall Study|Withdrawal by Subject|4|||
94460487|NCT00784550|323475348|FG001|Overall Study|Withdrawal by Subject|13|||
94460488|NCT02163226|323475358|FG000|Overall Study|Death|2|||
94460489|NCT02163226|323475359|FG001|Overall Study|Death|1|||
94460490|NCT02163226|323475358|FG000|Overall Study|Withdrawal by Subject|5|||
94460491|NCT02163226|323475359|FG001|Overall Study|Withdrawal by Subject|2|||
94460492|NCT02163226|323475358|FG000|Overall Study|Returned home, local radiotherapy|3|||
94460493|NCT02163226|323475359|FG001|Overall Study|Returned home, local radiotherapy|0|||
94460494|NCT02163226|323475358|FG000|Overall Study|Repeat imaging showed no disease|2|||
94460495|NCT02163226|323475359|FG001|Overall Study|Repeat imaging showed no disease|0|||
94460496|NCT02163226|323475358|FG000|Overall Study|Incomplete radiotherapy|3|||
94460497|NCT02163226|323475359|FG001|Overall Study|Incomplete radiotherapy|0|||
94460498|NCT02163226|323475358|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
94460499|NCT02163226|323475359|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
94460500|NCT02163226|323475358|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
94460501|NCT02163226|323475359|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
94460502|NCT02163226|323475358|FG000|Overall Study|ineligible|0|||
94460503|NCT02163226|323475359|FG001|Overall Study|ineligible|3|||
94460504|NCT04166591|323475360|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
94460505|NCT04166591|323475361|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
94460506|NCT04166591|323475362|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
94614726|NCT01436396|324051744|FG000|Overall Study|Adverse Event|1|||
94614727|NCT01436396|324051745|FG001|Overall Study|Adverse Event|2|||
94614728|NCT01436396|324051744|FG000|Overall Study|Withdrawal by Subject|19|||
94614729|NCT01436396|324051745|FG001|Overall Study|Withdrawal by Subject|29|||
94614730|NCT01436396|324051744|FG000|Overall Study|Serious adverse event|2|||
94614731|NCT01436396|324051745|FG001|Overall Study|Serious adverse event|3|||
94614732|NCT01436396|324051744|FG000|Overall Study|Lost to Follow-up|3|||
94614733|NCT01436396|324051745|FG001|Overall Study|Lost to Follow-up|3|||
94614734|NCT01522248|324051748|FG000|Overall Study|Lost to Follow-up|1|||
94614735|NCT01522248|324051749|FG001|Overall Study|Lost to Follow-up|0|||
94614736|NCT01708161|324051757|FG000|Overall Study|Adverse Event|1|||
94614737|NCT01708161|324051758|FG001|Overall Study|Adverse Event|3|||
94614738|NCT01708161|324051759|FG002|Overall Study|Adverse Event|4|||
94614739|NCT01708161|324051760|FG003|Overall Study|Adverse Event|2|||
94614740|NCT01708161|324051761|FG004|Overall Study|Adverse Event|3|||
94614741|NCT01708161|324051762|FG005|Overall Study|Adverse Event|0|||
94614742|NCT01708161|324051757|FG000|Overall Study|Death|0|||
94614743|NCT01708161|324051758|FG001|Overall Study|Death|0|||
94614744|NCT01708161|324051759|FG002|Overall Study|Death|0|||
94614745|NCT01708161|324051760|FG003|Overall Study|Death|1|||
94614746|NCT01708161|324051761|FG004|Overall Study|Death|0|||
94614747|NCT01708161|324051762|FG005|Overall Study|Death|1|||
94614748|NCT01708161|324051757|FG000|Overall Study|Withdrawal by Subject|0|||
94614749|NCT01708161|324051758|FG001|Overall Study|Withdrawal by Subject|1|||
94614750|NCT01708161|324051759|FG002|Overall Study|Withdrawal by Subject|1|||
94614751|NCT01708161|324051760|FG003|Overall Study|Withdrawal by Subject|0|||
94614752|NCT01708161|324051761|FG004|Overall Study|Withdrawal by Subject|0|||
94614753|NCT01708161|324051762|FG005|Overall Study|Withdrawal by Subject|0|||
94614754|NCT01708161|324051757|FG000|Overall Study|Administrative problems|0|||
94614755|NCT01708161|324051758|FG001|Overall Study|Administrative problems|1|||
94614756|NCT01708161|324051759|FG002|Overall Study|Administrative problems|0|||
94614757|NCT01708161|324051760|FG003|Overall Study|Administrative problems|0|||
94614758|NCT01708161|324051761|FG004|Overall Study|Administrative problems|0|||
94614759|NCT01708161|324051762|FG005|Overall Study|Administrative problems|0|||
94614760|NCT01708161|324051757|FG000|Overall Study|Disease progression|3|||
94614761|NCT01708161|324051758|FG001|Overall Study|Disease progression|5|||
94614762|NCT01708161|324051759|FG002|Overall Study|Disease progression|5|||
94614763|NCT01708161|324051760|FG003|Overall Study|Disease progression|13|||
94614764|NCT01708161|324051761|FG004|Overall Study|Disease progression|3|||
94614765|NCT01708161|324051762|FG005|Overall Study|Disease progression|0|||
94614766|NCT00406354|324051768|FG000|All Randomized Patients|Protocol Violation|0|||
94614767|NCT00406354|324051769|FG001|All Randomized Patients|Protocol Violation|0|||
94614768|NCT00406354|324051770|FG002|All Randomized Patients|Protocol Violation|1|||
94614769|NCT00406354|324051768|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
94614770|NCT00406354|324051769|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
94614771|NCT00406354|324051770|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
94614772|NCT00406354|324051768|FG000|All Randomized and Treated Patients|Adverse Event|6|||
94614773|NCT00406354|324051769|FG001|All Randomized and Treated Patients|Adverse Event|2|||
94614774|NCT00406354|324051770|FG002|All Randomized and Treated Patients|Adverse Event|1|||
94614775|NCT00406354|324051768|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
94614776|NCT00406354|324051769|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
94614777|NCT00406354|324051770|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
94614778|NCT00406354|324051768|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
94614779|NCT00406354|324051769|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
94614780|NCT00406354|324051770|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
94614781|NCT00406354|324051768|FG000|All Randomized and Treated Patients|Physician Decision|0|||
94614782|NCT00406354|324051769|FG001|All Randomized and Treated Patients|Physician Decision|0|||
94614783|NCT00406354|324051770|FG002|All Randomized and Treated Patients|Physician Decision|1|||
94614784|NCT02913612|324051771|FG000|Overall Study|Lost to Follow-up|6|||
94614785|NCT02913612|324051772|FG001|Overall Study|Lost to Follow-up|5|||
94614786|NCT02913612|324051773|FG002|Overall Study|Lost to Follow-up|2|||
94614787|NCT02913612|324051774|FG003|Overall Study|Lost to Follow-up|0|||
94460507|NCT04166591|323475363|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
94460508|NCT04166591|323475360|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
94460509|NCT04166591|323475361|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
94460510|NCT04166591|323475362|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
94460511|NCT04166591|323475363|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
94460512|NCT02487771|323475371|FG000|Overall Study|Lost to Follow-up|2|||
94460513|NCT02487771|323475372|FG001|Overall Study|Lost to Follow-up|3|||
94460514|NCT02487771|323475371|FG000|Overall Study|Moved out of area|5|||
94460515|NCT02487771|323475372|FG001|Overall Study|Moved out of area|6|||
94460516|NCT02487771|323475371|FG000|Overall Study|Withdrawal by Subject|3|||
94460517|NCT02487771|323475372|FG001|Overall Study|Withdrawal by Subject|5|||
94460518|NCT00401544|323475378|FG000|Overall Study|Adverse Event|5|||
94460519|NCT00401544|323475379|FG001|Overall Study|Adverse Event|1|||
94460520|NCT00401544|323475380|FG002|Overall Study|Adverse Event|1|||
94460521|NCT00401544|323475381|FG003|Overall Study|Adverse Event|1|||
94460522|NCT00401544|323475378|FG000|Overall Study|Death|3|||
94460523|NCT00401544|323475379|FG001|Overall Study|Death|6|||
94460524|NCT00401544|323475380|FG002|Overall Study|Death|2|||
94460525|NCT00401544|323475381|FG003|Overall Study|Death|5|||
94460526|NCT00401544|323475378|FG000|Overall Study|Lost to Follow-up|2|||
94460527|NCT00401544|323475379|FG001|Overall Study|Lost to Follow-up|0|||
94460528|NCT00401544|323475380|FG002|Overall Study|Lost to Follow-up|1|||
94460529|NCT00401544|323475381|FG003|Overall Study|Lost to Follow-up|1|||
94460530|NCT00401544|323475378|FG000|Overall Study|Withdrawal by Subject|7|||
94460531|NCT00401544|323475379|FG001|Overall Study|Withdrawal by Subject|6|||
94460532|NCT00401544|323475380|FG002|Overall Study|Withdrawal by Subject|6|||
94460533|NCT00401544|323475381|FG003|Overall Study|Withdrawal by Subject|5|||
94460534|NCT00401544|323475378|FG000|Overall Study|Physician Decision|1|||
94460535|NCT00401544|323475379|FG001|Overall Study|Physician Decision|3|||
94460536|NCT00401544|323475380|FG002|Overall Study|Physician Decision|0|||
94460537|NCT00401544|323475381|FG003|Overall Study|Physician Decision|0|||
94460538|NCT00401544|323475378|FG000|Overall Study|Ineligibility determined|0|||
94460539|NCT00401544|323475379|FG001|Overall Study|Ineligibility determined|1|||
94460540|NCT00401544|323475380|FG002|Overall Study|Ineligibility determined|0|||
94460541|NCT00401544|323475381|FG003|Overall Study|Ineligibility determined|2|||
94460542|NCT00401544|323475378|FG000|Overall Study|Disease progression|0|||
94460543|NCT00401544|323475379|FG001|Overall Study|Disease progression|1|||
94460544|NCT00401544|323475380|FG002|Overall Study|Disease progression|0|||
94460545|NCT00401544|323475381|FG003|Overall Study|Disease progression|0|||
94460546|NCT00401544|323475378|FG000|Overall Study|Other|0|||
94460547|NCT00401544|323475379|FG001|Overall Study|Other|0|||
94460548|NCT00401544|323475380|FG002|Overall Study|Other|2|||
94460549|NCT00401544|323475381|FG003|Overall Study|Other|2|||
94460550|NCT01871402|323475386|FG000|Overall Study|Lost to Follow-up|1|||
94460551|NCT01871402|323475387|FG001|Overall Study|Lost to Follow-up|0|||
94460552|NCT01871402|323475386|FG000|Overall Study|Withdrawal by Subject|0|||
94460553|NCT01871402|323475387|FG001|Overall Study|Withdrawal by Subject|2|||
94460554|NCT01871402|323475386|FG000|Overall Study|Non-compliance|0|||
94460555|NCT01871402|323475387|FG001|Overall Study|Non-compliance|1|||
94460556|NCT01279070|323475390|FG000|Overall Study|Withdrawal by Subject|2|||
94460557|NCT01279070|323475391|FG001|Overall Study|Withdrawal by Subject|3|||
94460558|NCT01279070|323475390|FG000|Overall Study|Acute exacerbation|3|||
94460559|NCT01279070|323475391|FG001|Overall Study|Acute exacerbation|1|||
94460560|NCT01613222|323475392|FG000|Overall Study|Physician Decision|1|||
94460561|NCT01613222|323475392|FG000|Overall Study|Unable to place arterial line|1|||
94460562|NCT01613222|323475392|FG000|Overall Study|Reused disposable sensors|10|||
94460563|NCT00308087|323475393|FG000|Overall Study|Progressive Disease|19|||
94460564|NCT00308087|323475394|FG001|Overall Study|Progressive Disease|21|||
94460565|NCT00308087|323475393|FG000|Overall Study|Study Closure|11|||
94664954|NCT01490632|324229728|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
94664955|NCT01490632|324229729|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
94664956|NCT01490632|324229730|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
94460566|NCT00308087|323475394|FG001|Overall Study|Study Closure|12|||
94460567|NCT00308087|323475393|FG000|Overall Study|Withdrawal by Subject|2|||
94460568|NCT00308087|323475394|FG001|Overall Study|Withdrawal by Subject|1|||
94460569|NCT00308087|323475393|FG000|Overall Study|Other|4|||
94460570|NCT00308087|323475394|FG001|Overall Study|Other|3|||
94460571|NCT01899742|323475395|FG000|Overall Study|Adverse Event|5|||
94460572|NCT01899742|323475396|FG001|Overall Study|Adverse Event|4|||
94460573|NCT01899742|323475395|FG000|Overall Study|Lack of Efficacy|1|||
94460574|NCT01899742|323475396|FG001|Overall Study|Lack of Efficacy|5|||
94460575|NCT01899742|323475395|FG000|Overall Study|Protocol Violation|2|||
94460576|NCT01899742|323475396|FG001|Overall Study|Protocol Violation|2|||
94460577|NCT01899742|323475395|FG000|Overall Study|Withdrawal by Subject|9|||
94460578|NCT01899742|323475396|FG001|Overall Study|Withdrawal by Subject|5|||
94460579|NCT00738881|323475397|FG000|Overall Study|Withdrawal by Subject|0|||
94460580|NCT00738881|323475398|FG001|Overall Study|Withdrawal by Subject|2|||
94664957|NCT01490632|324229731|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
94664958|NCT01490632|324229732|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
94664959|NCT01490632|324229733|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
94664960|NCT01490632|324229734|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
94664961|NCT01490632|324229735|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
94664962|NCT01490632|324229736|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
94664963|NCT01490632|324229737|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
94664964|NCT01490632|324229738|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
94664965|NCT01490632|324229739|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
94664966|NCT01490632|324229740|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
94614788|NCT02913612|324051771|FG000|Overall Study|Physician Decision|1|||
94614789|NCT02913612|324051772|FG001|Overall Study|Physician Decision|4|||
94614790|NCT02913612|324051773|FG002|Overall Study|Physician Decision|1|||
94614791|NCT02913612|324051774|FG003|Overall Study|Physician Decision|0|||
94614792|NCT02913612|324051771|FG000|Overall Study|Withdrawal by Subject|2|||
94614793|NCT02913612|324051772|FG001|Overall Study|Withdrawal by Subject|4|||
94614794|NCT02913612|324051773|FG002|Overall Study|Withdrawal by Subject|0|||
94614795|NCT02913612|324051774|FG003|Overall Study|Withdrawal by Subject|0|||
94614796|NCT02913612|324051771|FG000|Overall Study|Hemangioma resolved|1|||
94614797|NCT02913612|324051772|FG001|Overall Study|Hemangioma resolved|0|||
94614798|NCT02913612|324051773|FG002|Overall Study|Hemangioma resolved|0|||
94614799|NCT02913612|324051774|FG003|Overall Study|Hemangioma resolved|0|||
94614800|NCT02913612|324051771|FG000|Overall Study|Local IRB decision|1|||
94614801|NCT02913612|324051772|FG001|Overall Study|Local IRB decision|0|||
94614802|NCT02913612|324051773|FG002|Overall Study|Local IRB decision|0|||
94614803|NCT02913612|324051774|FG003|Overall Study|Local IRB decision|0|||
94614804|NCT02913612|324051771|FG000|Overall Study|Study drug non-compliance|1|||
94614805|NCT02913612|324051772|FG001|Overall Study|Study drug non-compliance|1|||
94614806|NCT02913612|324051773|FG002|Overall Study|Study drug non-compliance|0|||
94614807|NCT02913612|324051774|FG003|Overall Study|Study drug non-compliance|0|||
94614808|NCT02913612|324051771|FG000|Overall Study|Insurance issues|0|||
94614809|NCT02913612|324051772|FG001|Overall Study|Insurance issues|1|||
94614810|NCT02913612|324051773|FG002|Overall Study|Insurance issues|0|||
94614811|NCT02913612|324051774|FG003|Overall Study|Insurance issues|0|||
94614812|NCT02913612|324051771|FG000|Overall Study|Needed to treat second hemangioma|0|||
94614813|NCT02913612|324051772|FG001|Overall Study|Needed to treat second hemangioma|1|||
94614814|NCT02913612|324051773|FG002|Overall Study|Needed to treat second hemangioma|0|||
94614815|NCT02913612|324051774|FG003|Overall Study|Needed to treat second hemangioma|0|||
94614816|NCT02913612|324051771|FG000|Overall Study|Study completion criteria not met|0|||
94614817|NCT02913612|324051772|FG001|Overall Study|Study completion criteria not met|1|||
94614818|NCT02913612|324051773|FG002|Overall Study|Study completion criteria not met|0|||
94614819|NCT02913612|324051774|FG003|Overall Study|Study completion criteria not met|0|||
94614820|NCT02913612|324051771|FG000|Overall Study|Ineligible|0|||
94614821|NCT02913612|324051772|FG001|Overall Study|Ineligible|1|||
94614822|NCT02913612|324051773|FG002|Overall Study|Ineligible|0|||
94614823|NCT02913612|324051774|FG003|Overall Study|Ineligible|0|||
94614824|NCT00071396|324051775|FG000|Overall Study|Withdrawal by Subject|1|||
94614825|NCT00071396|324051775|FG000|Overall Study|Physician Decision|2|||
94614826|NCT01206166|324051778|FG000|Overall Study|No evaluable data|2|||
94614827|NCT01206166|324051779|FG001|Overall Study|No evaluable data|3|||
94614828|NCT02345226|324051780|FG000|Double-Blind Phase|Adverse Event|5|||
94614829|NCT02345226|324051781|FG001|Double-Blind Phase|Adverse Event|6|||
94614830|NCT02345226|324051780|FG000|Double-Blind Phase|Death|3|||
94614831|NCT02345226|324051781|FG001|Double-Blind Phase|Death|0|||
94614832|NCT02345226|324051780|FG000|Double-Blind Phase|Pregnancy|0|||
94614833|NCT02345226|324051781|FG001|Double-Blind Phase|Pregnancy|1|||
94614834|NCT02345226|324051780|FG000|Double-Blind Phase|Lack of Efficacy|1|||
94614835|NCT02345226|324051781|FG001|Double-Blind Phase|Lack of Efficacy|0|||
94614836|NCT02345226|324051780|FG000|Double-Blind Phase|Investigator's Discretion|4|||
94614837|NCT02345226|324051781|FG001|Double-Blind Phase|Investigator's Discretion|3|||
94614838|NCT02345226|324051780|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
94614839|NCT02345226|324051781|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
94614840|NCT02345226|324051780|FG000|Double-Blind Phase|Withdrew Consent|41|||
94614841|NCT02345226|324051781|FG001|Double-Blind Phase|Withdrew Consent|39|||
94614842|NCT02345226|324051780|FG000|Double-Blind Phase|Lost to Follow-up|12|||
94614843|NCT02345226|324051781|FG001|Double-Blind Phase|Lost to Follow-up|16|||
94614844|NCT02345226|324051780|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
94614845|NCT02345226|324051781|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
94614846|NCT02345226|324051780|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
94614847|NCT02345226|324051781|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
94614848|NCT01927627|324051789|FG000|Overall Study|Adverse Event|3|||
94614849|NCT01927627|324051789|FG000|Overall Study|Lack of Efficacy|1|||
94614850|NCT01927627|324051789|FG000|Overall Study|Financial Concerns|1|||
94614851|NCT03608254|324051792|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
94614852|NCT03608254|324051792|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
94614853|NCT00579098|324051795|FG000|Overall Study|Lost to Follow-up|2|||
94614854|NCT00579098|324051796|FG001|Overall Study|Lost to Follow-up|0|||
94614855|NCT00579098|324051795|FG000|Overall Study|Adverse Event|2|||
94614856|NCT00579098|324051796|FG001|Overall Study|Adverse Event|3|||
94614857|NCT00579098|324051795|FG000|Overall Study|Withdrawal by Subject|2|||
94614858|NCT00579098|324051796|FG001|Overall Study|Withdrawal by Subject|3|||
94614859|NCT00579098|324051795|FG000|Overall Study|AF returned after ablation|3|||
94614860|NCT00579098|324051796|FG001|Overall Study|AF returned after ablation|2|||
94614861|NCT03021304|324051798|FG000|Overall Study|Lack of Efficacy|1|||
94614862|NCT00810355|324051799|FG000|Overall Study|Lost to Follow-up|13|||
94614863|NCT00810355|324051800|FG001|Overall Study|Lost to Follow-up|17|||
94614864|NCT00810355|324051801|FG002|Overall Study|Lost to Follow-up|11|||
94614865|NCT00810355|324051799|FG000|Overall Study|Withdrawal by Subject|1|||
94614866|NCT00810355|324051800|FG001|Overall Study|Withdrawal by Subject|0|||
94614867|NCT00810355|324051801|FG002|Overall Study|Withdrawal by Subject|0|||
94614868|NCT04154930|324051804|FG000|Overall Study|Withdrawal by Subject|15|||
94614869|NCT04154930|324051805|FG001|Overall Study|Withdrawal by Subject|6|||
94614870|NCT04154930|324051804|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
94614871|NCT04154930|324051805|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
94614872|NCT04154930|324051804|FG000|Overall Study|Lost to Follow-up|14|||
94614873|NCT04154930|324051805|FG001|Overall Study|Lost to Follow-up|6|||
94614874|NCT04154930|324051804|FG000|Overall Study|Other|6|||
94614875|NCT04154930|324051805|FG001|Overall Study|Other|0|||
94688670|NCT00363896|324315566|FG000|Overall Study|Other|1|||
94460581|NCT04186806|323475399|FG000|Period 1: 7 Days|Adverse Event|1|||
94358715|NCT01243762|323096482|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
94358716|NCT01243762|323096483|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
94358717|NCT01243762|323096484|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
94358718|NCT01243762|323096485|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
94358719|NCT01243762|323096479|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
94358720|NCT01243762|323096480|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
94358721|NCT01243762|323096481|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
94614876|NCT00400764|324051806|FG000|Phase Ib|Adverse Event|1|||
94614877|NCT00400764|324051807|FG001|Phase Ib|Adverse Event|0|||
94614878|NCT00400764|324051808|FG002|Phase Ib|Adverse Event|0|||
94614879|NCT00400764|324051809|FG003|Phase Ib|Adverse Event|0|||
94614880|NCT00400764|324051810|FG004|Phase Ib|Adverse Event|0|||
94614881|NCT00400764|324051806|FG000|Phase Ib|Death|1|||
94614882|NCT00400764|324051807|FG001|Phase Ib|Death|0|||
94614883|NCT00400764|324051808|FG002|Phase Ib|Death|0|||
94614884|NCT00400764|324051809|FG003|Phase Ib|Death|0|||
94614885|NCT00400764|324051810|FG004|Phase Ib|Death|0|||
94614886|NCT00400764|324051806|FG000|Phase Ib|Disease Progression|4|||
94614887|NCT00400764|324051807|FG001|Phase Ib|Disease Progression|4|||
94614888|NCT00400764|324051808|FG002|Phase Ib|Disease Progression|0|||
94614889|NCT00400764|324051809|FG003|Phase Ib|Disease Progression|0|||
94614890|NCT00400764|324051810|FG004|Phase Ib|Disease Progression|0|||
94614891|NCT00400764|324051806|FG000|Phase II|Death|0|||
94614892|NCT00400764|324051807|FG001|Phase II|Death|0|||
94614893|NCT00400764|324051808|FG002|Phase II|Death|1|||
94614894|NCT00400764|324051809|FG003|Phase II|Death|2|||
94614895|NCT00400764|324051810|FG004|Phase II|Death|0|||
94614896|NCT00400764|324051806|FG000|Phase II|Lost to Follow-up|0|||
94614897|NCT00400764|324051807|FG001|Phase II|Lost to Follow-up|0|||
94614898|NCT00400764|324051808|FG002|Phase II|Lost to Follow-up|1|||
94614899|NCT00400764|324051809|FG003|Phase II|Lost to Follow-up|0|||
94614900|NCT00400764|324051810|FG004|Phase II|Lost to Follow-up|0|||
94614901|NCT00400764|324051806|FG000|Phase II|Physician Decision|0|||
94614902|NCT00400764|324051807|FG001|Phase II|Physician Decision|0|||
94614903|NCT00400764|324051808|FG002|Phase II|Physician Decision|1|||
94614904|NCT00400764|324051809|FG003|Phase II|Physician Decision|1|||
94614905|NCT00400764|324051810|FG004|Phase II|Physician Decision|0|||
94614906|NCT00400764|324051806|FG000|Phase II|Sponsor's decision to terminate|0|||
94614907|NCT00400764|324051807|FG001|Phase II|Sponsor's decision to terminate|0|||
94614908|NCT00400764|324051808|FG002|Phase II|Sponsor's decision to terminate|18|||
94614909|NCT00400764|324051809|FG003|Phase II|Sponsor's decision to terminate|22|||
94614910|NCT00400764|324051810|FG004|Phase II|Sponsor's decision to terminate|11|||
94614911|NCT00400764|324051806|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
94614912|NCT00400764|324051807|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
94614913|NCT00400764|324051808|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
94614914|NCT00400764|324051809|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
94614915|NCT00400764|324051810|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
94614916|NCT00400764|324051806|FG000|Phase II|Withdrawal by Subject|0|||
94358722|NCT01243762|323096482|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
94358723|NCT01243762|323096483|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
94358724|NCT01243762|323096484|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
94358725|NCT01243762|323096485|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
94358726|NCT01243762|323096479|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
94358727|NCT01243762|323096480|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
94358728|NCT01243762|323096481|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
94358729|NCT01243762|323096482|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
94358730|NCT01243762|323096483|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
94358731|NCT01243762|323096484|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
94358732|NCT01243762|323096485|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
94358733|NCT01243762|323096479|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
94358734|NCT01243762|323096480|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
94358735|NCT01243762|323096481|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
94358736|NCT01243762|323096482|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
94358737|NCT01243762|323096483|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
94358738|NCT01243762|323096484|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
94358739|NCT01243762|323096485|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
94358740|NCT01243762|323096479|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
94460582|NCT04186806|323475400|FG001|Period 1: 7 Days|Adverse Event|0|||
94614917|NCT00400764|324051807|FG001|Phase II|Withdrawal by Subject|0|||
94614918|NCT00400764|324051808|FG002|Phase II|Withdrawal by Subject|1|||
94614919|NCT00400764|324051809|FG003|Phase II|Withdrawal by Subject|1|||
94614920|NCT00400764|324051810|FG004|Phase II|Withdrawal by Subject|0|||
94614921|NCT02628938|324051811|FG000|Overall Study|Did not attend the follow up recall|2|||
94614922|NCT02628938|324051812|FG001|Overall Study|Did not attend the follow up recall|2|||
94614923|NCT02628938|324051813|FG002|Overall Study|Did not attend the follow up recall|1|||
94614924|NCT02628938|324051811|FG000|Overall Study|Failure to comply with the instructions|3|||
94614925|NCT02628938|324051812|FG001|Overall Study|Failure to comply with the instructions|0|||
94614926|NCT02628938|324051813|FG002|Overall Study|Failure to comply with the instructions|3|||
94614927|NCT00586625|324051814|FG000|Overall Study|Adverse Event|6|||
94614928|NCT00586625|324051815|FG001|Overall Study|Adverse Event|6|||
94614929|NCT00586625|324051814|FG000|Overall Study|Protocol Violation|3|||
94614930|NCT00586625|324051815|FG001|Overall Study|Protocol Violation|0|||
94614931|NCT00586625|324051814|FG000|Overall Study|Withdrawal by Subject|32|||
94614932|NCT00586625|324051815|FG001|Overall Study|Withdrawal by Subject|10|||
94614933|NCT00586625|324051814|FG000|Overall Study|Subject non-compliance|0|||
94614934|NCT00586625|324051815|FG001|Overall Study|Subject non-compliance|1|||
94614935|NCT00586625|324051814|FG000|Overall Study|Subject unable to return for visit|2|||
94614936|NCT00586625|324051815|FG001|Overall Study|Subject unable to return for visit|0|||
94614937|NCT02058693|324051816|FG000|Phase 1|Withdrawal by Subject|3|||
94614938|NCT02058693|324051817|FG001|Phase 1|Withdrawal by Subject|2|||
94614939|NCT02058693|324051816|FG000|Phase 1|Adverse Event|0|||
94614940|NCT02058693|324051817|FG001|Phase 1|Adverse Event|1|||
94614941|NCT02058693|324051816|FG000|Phase 1|Lack of Efficacy|1|||
94614942|NCT02058693|324051817|FG001|Phase 1|Lack of Efficacy|0|||
94614943|NCT02058693|324051816|FG000|Phase 1|Physician Decision|1|||
94614944|NCT02058693|324051817|FG001|Phase 1|Physician Decision|1|||
94614945|NCT02058693|324051816|FG000|Phase 2|Withdrawal by Subject|0|||
94614946|NCT02058693|324051817|FG001|Phase 2|Withdrawal by Subject|2|||
94614947|NCT02728596|324051818|FG000|Overall Study|Refusal unrelated to adverse event|3|||
94614948|NCT02728596|324051819|FG001|Overall Study|Refusal unrelated to adverse event|6|||
94614949|NCT02728596|324051820|FG002|Overall Study|Refusal unrelated to adverse event|7|||
94614950|NCT02728596|324051821|FG003|Overall Study|Refusal unrelated to adverse event|7|||
94614951|NCT02728596|324051818|FG000|Overall Study|Death|44|||
94614952|NCT02728596|324051819|FG001|Overall Study|Death|42|||
94614953|NCT02728596|324051820|FG002|Overall Study|Death|123|||
94614954|NCT02728596|324051821|FG003|Overall Study|Death|68|||
94614955|NCT03113916|324051823|FG000|Overall Study|Withdrawal by Subject|9|||
94614956|NCT03113916|324051824|FG001|Overall Study|Withdrawal by Subject|7|||
94614957|NCT03113916|324051823|FG000|Overall Study|Pregnancy|1|||
94614958|NCT03113916|324051824|FG001|Overall Study|Pregnancy|3|||
94614959|NCT03113916|324051823|FG000|Overall Study|Lost to Follow-up|1|||
94614960|NCT03113916|324051824|FG001|Overall Study|Lost to Follow-up|2|||
94614961|NCT00241358|324051825|FG000|Overall Study|Determined to be not ineligible|0|||
94614962|NCT00241358|324051826|FG001|Overall Study|Determined to be not ineligible|1|||
94614963|NCT00241358|324051827|FG002|Overall Study|Determined to be not ineligible|1|||
94614964|NCT01999868|324051834|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
94614965|NCT01999868|324051835|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
94614966|NCT01999868|324051836|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
94614967|NCT01999868|324051834|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
94614968|NCT01999868|324051835|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
94614969|NCT01999868|324051836|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
94614970|NCT01999868|324051834|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
94614971|NCT01999868|324051835|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
94614972|NCT01999868|324051836|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
94614973|NCT01999868|324051834|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
94614974|NCT01999868|324051835|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
94614975|NCT01999868|324051836|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
94614976|NCT01999868|324051834|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
94614977|NCT01999868|324051835|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
94614978|NCT01999868|324051836|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
94614979|NCT01999868|324051834|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
94614980|NCT01999868|324051835|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
94614981|NCT01999868|324051836|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
94460583|NCT01185509|323475403|FG000|Overall Study|Progression/Relapse|9|||
94358741|NCT01243762|323096480|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
94358742|NCT01243762|323096481|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
94358743|NCT01243762|323096482|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
94358744|NCT01243762|323096483|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
94358745|NCT01243762|323096484|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
94358746|NCT01243762|323096485|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
94358747|NCT00003526|323096486|FG000|Overall Study|Not evaluable|6|||
94358748|NCT04196023|323096489|FG000|Overall Study|Withdrawal by Subject|0|||
94358749|NCT04196023|323096490|FG001|Overall Study|Withdrawal by Subject|1|||
94358750|NCT04196023|323096489|FG000|Overall Study|Adverse Event|3|||
94358751|NCT04196023|323096490|FG001|Overall Study|Adverse Event|1|||
94358752|NCT04196023|323096489|FG000|Overall Study|Lost to Follow-up|0|||
94358753|NCT04196023|323096490|FG001|Overall Study|Lost to Follow-up|1|||
94358754|NCT03605758|323096498|FG000|Overall Study|Lost to Follow-up|2|||
94358755|NCT03605758|323096499|FG001|Overall Study|Lost to Follow-up|1|||
94358756|NCT03605758|323096498|FG000|Overall Study|Illness|0|||
94358757|NCT03605758|323096499|FG001|Overall Study|Illness|1|||
94358758|NCT03605758|323096498|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
94358759|NCT03605758|323096499|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
94358760|NCT04753606|323096500|FG000|Overall Study|Adverse Event|1|||
94358761|NCT04753606|323096501|FG001|Overall Study|Adverse Event|0|||
94358762|NCT04753606|323096502|FG002|Overall Study|Adverse Event|0|||
94358763|NCT03099096|323096503|FG000|Overall Study|Adverse Event|1|||
94358764|NCT03099096|323096503|FG000|Overall Study|Physician Decision|1|||
94358765|NCT00489411|323096504|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
94358766|NCT00489411|323096505|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
94358767|NCT00489411|323096504|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
94365658|NCT01788163|323124745|FG006|Overall Study|Withdrawal by Subject|0|||
94365659|NCT01788163|323124746|FG007|Overall Study|Withdrawal by Subject|0|||
94365660|NCT01788163|323124747|FG008|Overall Study|Withdrawal by Subject|1|||
94365661|NCT00545441|323124748|FG000|Overall Study|Fistula draining at 6 months|2|||
94365662|NCT00545441|323124749|FG001|Overall Study|Fistula draining at 6 months|4|||
94365663|NCT00545441|323124748|FG000|Overall Study|Lost to Follow-up|9|||
94365664|NCT00545441|323124749|FG001|Overall Study|Lost to Follow-up|5|||
94365665|NCT00545441|323124748|FG000|Overall Study|Technical failure|0|||
94365666|NCT00545441|323124749|FG001|Overall Study|Technical failure|1|||
94365667|NCT00545441|323124748|FG000|Overall Study|Withdrawal by Subject|1|||
94365668|NCT00545441|323124749|FG001|Overall Study|Withdrawal by Subject|1|||
94365669|NCT00545441|323124748|FG000|Overall Study|Persistence or recurrence of fistula|5|||
94365670|NCT00545441|323124749|FG001|Overall Study|Persistence or recurrence of fistula|2|||
94365671|NCT00545441|323124748|FG000|Overall Study|Patients were not treated|1|||
94365672|NCT00545441|323124749|FG001|Overall Study|Patients were not treated|3|||
94365673|NCT03526679|323124750|FG000|Overall Study|still under treatment|2|||
94365674|NCT05553600|323124751|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
94365675|NCT05553600|323124752|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
94365676|NCT05553600|323124753|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
94365677|NCT05553600|323124754|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
94365678|NCT05553600|323124751|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
94365679|NCT05553600|323124752|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
94365680|NCT05553600|323124753|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
94365681|NCT05553600|323124754|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
94365682|NCT05553600|323124751|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
94365683|NCT05553600|323124752|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
94365684|NCT05553600|323124753|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
94365685|NCT05553600|323124754|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
94365686|NCT05553600|323124751|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
94365687|NCT05553600|323124752|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
94365688|NCT05553600|323124753|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
94365689|NCT05553600|323124754|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
94365690|NCT05553600|323124751|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
94365691|NCT05553600|323124752|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
94365692|NCT05553600|323124753|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
94365693|NCT05553600|323124754|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
94365694|NCT05553600|323124751|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
94460584|NCT01185509|323475404|FG001|Overall Study|Progression/Relapse|15|||
94460585|NCT01185509|323475403|FG000|Overall Study|Physician Decision|2|||
94460586|NCT01185509|323475404|FG001|Overall Study|Physician Decision|2|||
94460587|NCT01185509|323475403|FG000|Overall Study|Withdrawal by Subject|0|||
94460588|NCT01185509|323475404|FG001|Overall Study|Withdrawal by Subject|1|||
94460589|NCT01185509|323475403|FG000|Overall Study|Death|0|||
94460590|NCT01185509|323475404|FG001|Overall Study|Death|1|||
94460591|NCT01185509|323475403|FG000|Overall Study|Intercurrent Illness|0|||
94460592|NCT01185509|323475404|FG001|Overall Study|Intercurrent Illness|1|||
94460593|NCT00278148|323475409|FG000|Phase II - Expansion Phase|Disease progression|0|||
94460594|NCT00278148|323475410|FG001|Phase II - Expansion Phase|Disease progression|0|||
94460595|NCT00278148|323475411|FG002|Phase II - Expansion Phase|Disease progression|4|||
94460596|NCT00278148|323475409|FG000|Phase II - Expansion Phase|Adverse Event|0|||
94460597|NCT00278148|323475410|FG001|Phase II - Expansion Phase|Adverse Event|0|||
94460598|NCT00278148|323475411|FG002|Phase II - Expansion Phase|Adverse Event|2|||
94460599|NCT02035748|323475412|FG000|Overall Study|Adverse Event|5|||
94614982|NCT01999868|324051834|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
94614983|NCT01999868|324051835|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
94614984|NCT01999868|324051836|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
94614985|NCT01999868|324051834|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
94614986|NCT01999868|324051835|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
94614987|NCT01999868|324051836|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
94614988|NCT01999868|324051834|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
94614989|NCT01999868|324051835|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
94614990|NCT01999868|324051836|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
94614991|NCT01999868|324051834|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
94614992|NCT01999868|324051835|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
94614993|NCT01999868|324051836|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
94614994|NCT01999868|324051834|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
94614995|NCT01999868|324051835|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
94614996|NCT01999868|324051836|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
94614997|NCT01999868|324051834|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
94614998|NCT01999868|324051835|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
94614999|NCT01999868|324051836|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
94615000|NCT01999868|324051834|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
94615001|NCT01999868|324051835|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
94615002|NCT01999868|324051836|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
94615003|NCT01999868|324051834|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
94615004|NCT01999868|324051835|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
94615005|NCT01999868|324051836|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
94615006|NCT01999868|324051834|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
94615007|NCT01999868|324051835|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
94615008|NCT01999868|324051836|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
94615009|NCT01696071|324051839|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
94615010|NCT01696071|324051840|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
94615011|NCT00316719|324053308|FG000|Overall Study|Adverse Event|0|||
94615012|NCT00316719|324053309|FG001|Overall Study|Adverse Event|6|||
94615013|NCT00316719|324053308|FG000|Overall Study|Consent withdrawn|2|||
94615014|NCT00316719|324053309|FG001|Overall Study|Consent withdrawn|0|||
94615015|NCT02742441|324053312|FG000|Overall Study|Lost to Follow-up|4|||
94615016|NCT02742441|324053313|FG001|Overall Study|Lost to Follow-up|4|||
94615017|NCT02742441|324053312|FG000|Overall Study|Withdrawal by Subject|2|||
94460600|NCT02035748|323475412|FG000|Overall Study|Death|3|||
94460601|NCT02035748|323475412|FG000|Overall Study|Lost to Follow-up|2|||
94460602|NCT02035748|323475412|FG000|Overall Study|Physician Decision|3|||
94460603|NCT02035748|323475412|FG000|Overall Study|Withdrawal by Subject|6|||
94460604|NCT02035748|323475412|FG000|Overall Study|Progressive Disease|1|||
94460605|NCT02407457|323475413|FG000|1 Month|Death|3|||
94460606|NCT02407457|323475414|FG001|1 Month|Death|0|||
94460607|NCT02407457|323475413|FG000|1 Month|Lost to Follow-up|1|||
94460608|NCT02407457|323475414|FG001|1 Month|Lost to Follow-up|1|||
94460609|NCT02407457|323475413|FG000|1 Month|missed visit|2|||
94615018|NCT02742441|324053313|FG001|Overall Study|Withdrawal by Subject|2|||
94615019|NCT02742441|324053312|FG000|Overall Study|Adverse Event|0|||
94615020|NCT02742441|324053313|FG001|Overall Study|Adverse Event|2|||
94615021|NCT02008318|324053317|FG000|Overall Study|Adverse Event|4|||
94615022|NCT02008318|324053318|FG001|Overall Study|Adverse Event|0|||
94615023|NCT02008318|324053317|FG000|Overall Study|Physician Decision|2|||
94615024|NCT02008318|324053318|FG001|Overall Study|Physician Decision|0|||
94615025|NCT02008318|324053317|FG000|Overall Study|Progressive Disease|2|||
94615026|NCT02008318|324053318|FG001|Overall Study|Progressive Disease|0|||
94615027|NCT02008318|324053317|FG000|Overall Study|Protocol Violation|1|||
94615028|NCT02008318|324053318|FG001|Overall Study|Protocol Violation|1|||
94615029|NCT02008318|324053317|FG000|Overall Study|Withdrawal by Subject|3|||
94615030|NCT02008318|324053318|FG001|Overall Study|Withdrawal by Subject|0|||
94615031|NCT01313858|324053320|FG000|Overall Study|Premature Treatment Termination|251|||
94615032|NCT01313858|324053321|FG001|Overall Study|Premature Treatment Termination|219|||
94615033|NCT01313858|324053322|FG002|Overall Study|Premature Treatment Termination|191|||
94615034|NCT01313858|324053320|FG000|Overall Study|Lost to Follow-up|35|||
94615035|NCT01313858|324053321|FG001|Overall Study|Lost to Follow-up|51|||
94615036|NCT01313858|324053322|FG002|Overall Study|Lost to Follow-up|47|||
94615037|NCT02336373|324053323|FG000|Overall Study|Protocol closed early|4|||
94615038|NCT02336373|324053323|FG000|Overall Study|Physician Decision|14|||
94615039|NCT00246753|324053327|FG000|Overall Study|Withdrawal by Subject|2|||
94615040|NCT00246753|324053327|FG000|Overall Study|Physician Decision|2|||
94615041|NCT00246753|324053327|FG000|Overall Study|Adverse Event|2|||
94615042|NCT00246753|324053327|FG000|Overall Study|Unacceptable toxicity|2|||
94615043|NCT01816074|324053328|FG000|Phase 1|Time commitment issues|0|||
94615044|NCT01816074|324053329|FG001|Phase 1|Time commitment issues|0|||
94615045|NCT01816074|324053330|FG002|Phase 1|Time commitment issues|1|||
94615046|NCT01816074|324053331|FG003|Phase 1|Time commitment issues|0|||
94615047|NCT01816074|324053328|FG000|Phase 2|Time commitment Issues|0|||
94615048|NCT01816074|324053329|FG001|Phase 2|Time commitment Issues|2|||
94615049|NCT01816074|324053330|FG002|Phase 2|Time commitment Issues|0|||
94615050|NCT01816074|324053331|FG003|Phase 2|Time commitment Issues|0|||
94615051|NCT01816074|324053328|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
94615052|NCT01816074|324053329|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
94615053|NCT01816074|324053330|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
94615054|NCT01816074|324053331|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
94615055|NCT01816074|324053328|FG000|Phase 2|Physician Decision|0|||
94615056|NCT01816074|324053329|FG001|Phase 2|Physician Decision|0|||
94615057|NCT01816074|324053330|FG002|Phase 2|Physician Decision|0|||
94615058|NCT01816074|324053331|FG003|Phase 2|Physician Decision|1|||
94615059|NCT01816074|324053328|FG000|Phase 2|Withdrawal by Subject|1|||
94615060|NCT01816074|324053329|FG001|Phase 2|Withdrawal by Subject|0|||
94615061|NCT01816074|324053330|FG002|Phase 2|Withdrawal by Subject|0|||
94615062|NCT01816074|324053331|FG003|Phase 2|Withdrawal by Subject|0|||
94615063|NCT02478632|324053332|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
94615064|NCT02478632|324053333|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
94615065|NCT02478632|324053332|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
94615066|NCT02478632|324053333|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
94615067|NCT02478632|324053332|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
94615068|NCT02478632|324053333|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
94615069|NCT00864721|324053334|FG000|Overall Study|Patient request|11|||
94615070|NCT00864721|324053334|FG000|Overall Study|Hospitalized|1|||
94615071|NCT00864721|324053334|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
94615072|NCT00864721|324053334|FG000|Overall Study|Adverse Event|21|||
94615073|NCT00615108|324053335|FG000|Overall Study|Adverse Event|122|||
94615074|NCT00615108|324053335|FG000|Overall Study|Other|370|||
94615075|NCT00615108|324053335|FG000|Overall Study|Lost to Follow-up|15|||
94615076|NCT00631696|324053340|FG000|Overall Study|Entered, not randomized to treatment|1|||
94615077|NCT00631696|324053341|FG001|Overall Study|Entered, not randomized to treatment|1|||
94615078|NCT00631696|324053340|FG000|Overall Study|Discontinued after database release date|1|||
94615079|NCT00631696|324053341|FG001|Overall Study|Discontinued after database release date|0|||
94615080|NCT00631696|324053340|FG000|Overall Study|Follow up after database release date|1|||
94615081|NCT00631696|324053341|FG001|Overall Study|Follow up after database release date|0|||
94615082|NCT00631696|324053340|FG000|Overall Study|Lost to Follow-up|7|||
94615083|NCT00631696|324053341|FG001|Overall Study|Lost to Follow-up|10|||
94460610|NCT02407457|323475414|FG001|1 Month|missed visit|5|||
94615084|NCT00631696|324053340|FG000|Overall Study|Withdrawal by Subject|2|||
94615085|NCT00631696|324053341|FG001|Overall Study|Withdrawal by Subject|9|||
94615086|NCT00631696|324053340|FG000|Overall Study|Other|8|||
94615087|NCT00631696|324053341|FG001|Overall Study|Other|8|||
94615088|NCT00631696|324053340|FG000|Overall Study|Protocol Violation|9|||
94615089|NCT00631696|324053341|FG001|Overall Study|Protocol Violation|9|||
94615090|NCT00631696|324053340|FG000|Overall Study|Study terminated by sponsor|3|||
94615091|NCT00631696|324053341|FG001|Overall Study|Study terminated by sponsor|3|||
94615092|NCT00631696|324053340|FG000|Overall Study|Adverse Event|5|||
94615093|NCT00631696|324053341|FG001|Overall Study|Adverse Event|0|||
94615094|NCT01426438|324053342|FG000|Overall Study|Lost to Follow-up|1|||
94615095|NCT01426438|324053343|FG001|Overall Study|Lost to Follow-up|3|||
94615096|NCT01426438|324053342|FG000|Overall Study|Off study Treatment|9|||
94615097|NCT01426438|324053343|FG001|Overall Study|Off study Treatment|3|||
94615098|NCT01426438|324053342|FG000|Overall Study|Poor scan quality|3|||
94615099|NCT01426438|324053343|FG001|Overall Study|Poor scan quality|2|||
94615100|NCT01426438|324053342|FG000|Overall Study|Missed Scan|2|||
94615101|NCT01426438|324053343|FG001|Overall Study|Missed Scan|2|||
94615102|NCT01601132|324053344|FG000|Overall Study|Patient withdrew consent|1|||
94615103|NCT01601132|324053344|FG000|Overall Study|Protocol deviation|1|||
94615104|NCT02110238|324053345|FG000|12 Week Pivotal Phase|Adverse Event|3|||
94615105|NCT02110238|324053346|FG001|12 Week Pivotal Phase|Adverse Event|0|||
94615106|NCT02110238|324053345|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
94615107|NCT02110238|324053346|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
94615108|NCT02110238|324053345|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
94615109|NCT02110238|324053346|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
94615110|NCT02110238|324053345|FG000|12 Week Pivotal Phase|Physician Decision|0|||
94615111|NCT02110238|324053346|FG001|12 Week Pivotal Phase|Physician Decision|2|||
94615112|NCT02110238|324053345|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
94615113|NCT02110238|324053346|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
94615114|NCT02110238|324053345|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
94615115|NCT02110238|324053346|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
94615116|NCT02110238|324053345|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
94615117|NCT02110238|324053346|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
94615118|NCT02110238|324053345|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
94615119|NCT02110238|324053346|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
94615120|NCT02110238|324053345|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
94615121|NCT02110238|324053346|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
94615122|NCT02110238|324053345|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
94615123|NCT02110238|324053346|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
94615124|NCT02110238|324053345|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
94615125|NCT02110238|324053346|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
94615126|NCT02601027|324053351|FG000|Registration to Surgery|Withdrawal by Subject|20|||
94615127|NCT02601027|324053352|FG001|Registration to Surgery|Withdrawal by Subject|10|||
94365695|NCT05553600|323124752|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
94615128|NCT01393301|324053355|FG000|Overall Study|Lost to Follow-up|5|||
94615129|NCT01393301|324053356|FG001|Overall Study|Lost to Follow-up|3|||
94615130|NCT01393301|324053355|FG000|Overall Study|Withdrawal by Subject|2|||
94615131|NCT01393301|324053356|FG001|Overall Study|Withdrawal by Subject|0|||
94615132|NCT01393301|324053355|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
94615133|NCT01393301|324053356|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
94615134|NCT02758171|324053357|FG000|Wash-out|Withdrawal by Subject|1|||
94615135|NCT02758171|324053358|FG001|Wash-out|Withdrawal by Subject|0|||
94615136|NCT02758171|324053357|FG000|Wash-out|Other reason|1|||
94615137|NCT02758171|324053358|FG001|Wash-out|Other reason|0|||
94615138|NCT01999114|324053359|FG000|Overall Study|Adverse Event|8|||
94615139|NCT01999114|324053360|FG001|Overall Study|Adverse Event|7|||
94615140|NCT01999114|324053361|FG002|Overall Study|Adverse Event|2|||
94615141|NCT01999114|324053362|FG003|Overall Study|Adverse Event|2|||
94615142|NCT01999114|324053363|FG004|Overall Study|Adverse Event|1|||
94615143|NCT01999114|324053359|FG000|Overall Study|Withdrawal by Subject|0|||
94615144|NCT01999114|324053360|FG001|Overall Study|Withdrawal by Subject|0|||
94615145|NCT01999114|324053361|FG002|Overall Study|Withdrawal by Subject|1|||
94615146|NCT01999114|324053362|FG003|Overall Study|Withdrawal by Subject|0|||
94615147|NCT01999114|324053363|FG004|Overall Study|Withdrawal by Subject|1|||
94615148|NCT01999114|324053359|FG000|Overall Study|Lost to Follow-up|0|||
94615149|NCT01999114|324053360|FG001|Overall Study|Lost to Follow-up|0|||
94615150|NCT01999114|324053361|FG002|Overall Study|Lost to Follow-up|1|||
94615151|NCT01999114|324053362|FG003|Overall Study|Lost to Follow-up|0|||
94615152|NCT01999114|324053363|FG004|Overall Study|Lost to Follow-up|0|||
94615153|NCT01999114|324053359|FG000|Overall Study|Administrative|0|||
94615154|NCT01999114|324053360|FG001|Overall Study|Administrative|0|||
94615155|NCT01999114|324053361|FG002|Overall Study|Administrative|1|||
94615156|NCT01999114|324053362|FG003|Overall Study|Administrative|1|||
94615157|NCT01999114|324053363|FG004|Overall Study|Administrative|2|||
94615158|NCT03840174|324053364|FG000|Overall Study|Withdrawal by Subject|1|||
94615159|NCT03840174|324053365|FG001|Overall Study|Withdrawal by Subject|0|||
94615160|NCT03840174|324053366|FG002|Overall Study|Withdrawal by Subject|0|||
94615161|NCT03840174|324053367|FG003|Overall Study|Withdrawal by Subject|0|||
94615162|NCT01330030|324053370|FG000|Overall Study|Lost to Follow-up|16|||
94615163|NCT01330030|324053371|FG001|Overall Study|Lost to Follow-up|17|||
94615164|NCT02410551|324053372|FG000|Overall Study|Adverse Event|1|||
94615165|NCT02410551|324053372|FG000|Overall Study|Withdrawal by Subject|1|||
94615166|NCT02410551|324053372|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
94615167|NCT01419626|324053373|FG000|Overall Study|Protocol Violation|3|||
94615168|NCT01419626|324053374|FG001|Overall Study|Protocol Violation|2|||
94615169|NCT01419626|324053375|FG002|Overall Study|Protocol Violation|2|||
94615170|NCT01419626|324053373|FG000|Overall Study|Withdrawal by Subject|1|||
94615171|NCT01419626|324053374|FG001|Overall Study|Withdrawal by Subject|0|||
94615172|NCT01419626|324053375|FG002|Overall Study|Withdrawal by Subject|0|||
94615173|NCT01419626|324053373|FG000|Overall Study|Lost to Follow-up|0|||
94615174|NCT01419626|324053374|FG001|Overall Study|Lost to Follow-up|1|||
94615175|NCT01419626|324053375|FG002|Overall Study|Lost to Follow-up|1|||
94615176|NCT00074984|324053376|FG000|Overall Study|Death|1|||
94615177|NCT00074984|324053377|FG001|Overall Study|Death|2|||
94615178|NCT00074984|324053376|FG000|Overall Study|Withdrawal by Subject|2|||
94615179|NCT00074984|324053377|FG001|Overall Study|Withdrawal by Subject|3|||
94615180|NCT00074984|324053376|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
94615181|NCT00074984|324053377|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
94615182|NCT02191137|324053378|FG000|Treatment|Death|4|||
94615183|NCT02191137|324053378|FG000|Treatment|Withdrawal by Subject|3|||
94615184|NCT02191137|324053378|FG000|Treatment|Adverse Event|2|||
94615185|NCT02191137|324053378|FG000|Treatment|Other|1|||
94615186|NCT02191137|324053378|FG000|Follow-up|Lost to Follow-up|2|||
94615187|NCT02191137|324053378|FG000|Follow-up|Ongoing/unknown|2|||
94615188|NCT02191137|324053378|FG000|Follow-up|Adverse Event|1|||
94615189|NCT02404220|324053379|FG000|Overall Study|Adverse Event|0|||
94615190|NCT02404220|324053380|FG001|Overall Study|Adverse Event|0|||
94615191|NCT02404220|324053381|FG002|Overall Study|Adverse Event|1|||
94615192|NCT02404220|324053382|FG003|Overall Study|Adverse Event|0|||
94615193|NCT02404220|324053379|FG000|Overall Study|Death|5|||
94615194|NCT02404220|324053380|FG001|Overall Study|Death|5|||
94615195|NCT02404220|324053381|FG002|Overall Study|Death|3|||
94615196|NCT02404220|324053382|FG003|Overall Study|Death|8|||
94615197|NCT02404220|324053379|FG000|Overall Study|Progressive Disease|0|||
94615198|NCT02404220|324053380|FG001|Overall Study|Progressive Disease|0|||
94615199|NCT02404220|324053381|FG002|Overall Study|Progressive Disease|1|||
94615200|NCT02404220|324053382|FG003|Overall Study|Progressive Disease|1|||
94615201|NCT02404220|324053379|FG000|Overall Study|Study Terminated by Sponsor|0|||
94615202|NCT02404220|324053380|FG001|Overall Study|Study Terminated by Sponsor|0|||
94615203|NCT02404220|324053381|FG002|Overall Study|Study Terminated by Sponsor|2|||
94615204|NCT02404220|324053382|FG003|Overall Study|Study Terminated by Sponsor|1|||
94615205|NCT02404220|324053379|FG000|Overall Study|Withdrawal by Subject|0|||
94615206|NCT02404220|324053380|FG001|Overall Study|Withdrawal by Subject|1|||
94688671|NCT00363896|324315567|FG001|Overall Study|Other|2|||
94460611|NCT02407457|323475413|FG000|6-Month|Death|2|||
94460612|NCT02407457|323475414|FG001|6-Month|Death|8|||
94460613|NCT02407457|323475413|FG000|6-Month|Lost to Follow-up|2|||
94460614|NCT02407457|323475414|FG001|6-Month|Lost to Follow-up|2|||
94460615|NCT02407457|323475413|FG000|6-Month|missed visit|16|||
94460616|NCT02407457|323475414|FG001|6-Month|missed visit|14|||
94460617|NCT02407457|323475413|FG000|6-Month|Open Repair|0|||
94460618|NCT02407457|323475414|FG001|6-Month|Open Repair|1|||
94460619|NCT02407457|323475413|FG000|1 Year|Death|6|||
94460620|NCT02407457|323475414|FG001|1 Year|Death|11|||
94460621|NCT02407457|323475413|FG000|1 Year|Lost to Follow-up|3|||
94460622|NCT02407457|323475414|FG001|1 Year|Lost to Follow-up|2|||
94460623|NCT02407457|323475413|FG000|1 Year|Missed Visit|24|||
94460624|NCT02407457|323475414|FG001|1 Year|Missed Visit|14|||
94460625|NCT02407457|323475413|FG000|1 Year|Open Repair|0|||
94460626|NCT02407457|323475414|FG001|1 Year|Open Repair|1|||
94460627|NCT02407457|323475413|FG000|2-year|Death|14|||
94460628|NCT02407457|323475414|FG001|2-year|Death|8|||
94460629|NCT02407457|323475413|FG000|2-year|Lost to Follow-up|7|||
94460630|NCT02407457|323475414|FG001|2-year|Lost to Follow-up|10|||
94460631|NCT02407457|323475413|FG000|2-year|Missed Visit|13|||
94460632|NCT02407457|323475414|FG001|2-year|Missed Visit|15|||
94460633|NCT02407457|323475413|FG000|2-year|Open Repair|0|||
94460634|NCT02407457|323475414|FG001|2-year|Open Repair|2|||
94460635|NCT02407457|323475413|FG000|3-year|Death|11|||
94460636|NCT02407457|323475414|FG001|3-year|Death|10|||
94460637|NCT02407457|323475413|FG000|3-year|Lost to Follow-up|9|||
94460638|NCT02407457|323475414|FG001|3-year|Lost to Follow-up|10|||
94460639|NCT02407457|323475413|FG000|3-year|Missed Visit|19|||
94460640|NCT02407457|323475414|FG001|3-year|Missed Visit|16|||
94460641|NCT02407457|323475413|FG000|4-year|Death|18|||
94460642|NCT02407457|323475414|FG001|4-year|Death|10|||
94664967|NCT01490632|324229741|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
94460643|NCT02407457|323475413|FG000|4-year|Lost to Follow-up|10|||
94460644|NCT02407457|323475414|FG001|4-year|Lost to Follow-up|12|||
94460645|NCT02407457|323475413|FG000|4-year|Missed Visit|18|||
94460646|NCT02407457|323475414|FG001|4-year|Missed Visit|16|||
94460647|NCT02407457|323475413|FG000|5-year|Death|10|||
94460648|NCT02407457|323475414|FG001|5-year|Death|3|||
94460649|NCT02407457|323475413|FG000|5-year|Lost to Follow-up|22|||
94460650|NCT02407457|323475414|FG001|5-year|Lost to Follow-up|13|||
94460651|NCT02407457|323475413|FG000|5-year|Missed Visit|9|||
94615207|NCT02404220|324053381|FG002|Overall Study|Withdrawal by Subject|0|||
94615208|NCT02404220|324053382|FG003|Overall Study|Withdrawal by Subject|0|||
94615209|NCT02404220|324053379|FG000|Overall Study|Enrolled but Never Treated|0|||
94615210|NCT02404220|324053380|FG001|Overall Study|Enrolled but Never Treated|2|||
94615211|NCT02404220|324053381|FG002|Overall Study|Enrolled but Never Treated|0|||
94615212|NCT02404220|324053382|FG003|Overall Study|Enrolled but Never Treated|0|||
94615213|NCT00413244|324053385|FG000|Overall Study|Withdrawal by Subject|10|||
94615214|NCT00413244|324053386|FG001|Overall Study|Withdrawal by Subject|1|||
94615215|NCT03725852|324053387|FG000|Overall Study|Death|1|||
94615216|NCT03725852|324053388|FG001|Overall Study|Death|0|||
94615217|NCT03725852|324053387|FG000|Overall Study|Withdrawal by Subject|1|||
94615218|NCT03725852|324053388|FG001|Overall Study|Withdrawal by Subject|0|||
94615219|NCT03725852|324053387|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
94615220|NCT03725852|324053388|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
94615221|NCT02264639|324053389|FG000|Overall Study|Death (after completing single-dose phase)|1|||
94615222|NCT02264639|324053390|FG001|Overall Study|Death (after completing single-dose phase)|0|||
94615223|NCT02264639|324053391|FG002|Overall Study|Death (after completing single-dose phase)|0|||
94615224|NCT02264639|324053392|FG003|Overall Study|Death (after completing single-dose phase)|0|||
94615225|NCT02264639|324053393|FG004|Overall Study|Death (after completing single-dose phase)|0|||
94615226|NCT02264639|324053389|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
94615227|NCT02264639|324053390|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
94615228|NCT02264639|324053391|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
94615229|NCT02264639|324053392|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
94615230|NCT02264639|324053393|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
94615231|NCT02264639|324053389|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
94615232|NCT02264639|324053390|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
94615233|NCT02264639|324053391|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
94615234|NCT02264639|324053392|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
94615235|NCT02264639|324053393|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
94615236|NCT02264639|324053389|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
94615237|NCT02264639|324053390|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
94615238|NCT02264639|324053391|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
94615239|NCT02264639|324053392|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
94615240|NCT02264639|324053393|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
94615241|NCT01609231|324053397|FG000|Overall Study|Adverse Event|1|||
94615242|NCT01609231|324053398|FG001|Overall Study|Adverse Event|3|||
94615243|NCT01609231|324053397|FG000|Overall Study|Physician Decision|1|||
94615244|NCT01609231|324053398|FG001|Overall Study|Physician Decision|0|||
94615245|NCT01609231|324053397|FG000|Overall Study|Withdrawal by Subject|1|||
94615246|NCT01609231|324053398|FG001|Overall Study|Withdrawal by Subject|0|||
94615247|NCT00471146|324053399|FG000|Overall Study|Adverse Event|32|||
94615248|NCT00471146|324053400|FG001|Overall Study|Adverse Event|33|||
94615249|NCT00471146|324053399|FG000|Overall Study|Withdrawal by Subject|14|||
94615250|NCT00471146|324053400|FG001|Overall Study|Withdrawal by Subject|11|||
94615251|NCT00471146|324053399|FG000|Overall Study|Death|11|||
94358768|NCT00489411|323096505|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
94615252|NCT00471146|324053400|FG001|Overall Study|Death|12|||
94615253|NCT00471146|324053399|FG000|Overall Study|Lost to Follow-up|4|||
94615254|NCT00471146|324053400|FG001|Overall Study|Lost to Follow-up|2|||
94615255|NCT00471146|324053399|FG000|Overall Study|Protocol Violation|2|||
94615256|NCT00471146|324053400|FG001|Overall Study|Protocol Violation|2|||
94615257|NCT00471146|324053399|FG000|Overall Study|Objective progression or relapse|84|||
94358769|NCT00489411|323096504|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
94358770|NCT00489411|323096505|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
94358771|NCT00489411|323096504|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
94358772|NCT00489411|323096505|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
94358773|NCT00489411|323096504|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
94358774|NCT00489411|323096505|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
94358775|NCT00998166|323096506|FG000|Overall Study|Early Study Termination|8|||
94358776|NCT01283009|323096509|FG000|Overall Study|Death|83|||
94358777|NCT01283009|323096510|FG001|Overall Study|Death|78|||
94358778|NCT01283009|323096509|FG000|Overall Study|Study ended early|23|||
94358779|NCT01283009|323096510|FG001|Overall Study|Study ended early|26|||
94615258|NCT00471146|324053400|FG001|Overall Study|Objective progression or relapse|87|||
94615259|NCT00471146|324053399|FG000|Overall Study|Global deterioration of health status|12|||
94615260|NCT00471146|324053400|FG001|Overall Study|Global deterioration of health status|14|||
94615261|NCT00471146|324053399|FG000|Overall Study|Randomized but not treated|9|||
94615262|NCT00471146|324053400|FG001|Overall Study|Randomized but not treated|8|||
94615263|NCT00471146|324053399|FG000|Overall Study|Other|4|||
94615264|NCT00471146|324053400|FG001|Overall Study|Other|5|||
94615265|NCT00753766|324053401|FG000|Overall Study|Physician Decision|1|||
94615266|NCT00753766|324053402|FG001|Overall Study|Physician Decision|0|||
94615267|NCT00494299|324053407|FG000|Overall Study|Adverse Event|93|||
94615268|NCT00494299|324053408|FG001|Overall Study|Adverse Event|13|||
94615269|NCT00494299|324053407|FG000|Overall Study|Lost to Follow-up|1|||
94615270|NCT00494299|324053408|FG001|Overall Study|Lost to Follow-up|0|||
94615271|NCT00494299|324053407|FG000|Overall Study|Physician Decision|0|||
94615272|NCT00494299|324053408|FG001|Overall Study|Physician Decision|2|||
94615273|NCT00494299|324053407|FG000|Overall Study|Protocol Violation|1|||
94615274|NCT00494299|324053408|FG001|Overall Study|Protocol Violation|2|||
94615275|NCT00494299|324053407|FG000|Overall Study|Withdrawal by Subject|8|||
94615276|NCT00494299|324053408|FG001|Overall Study|Withdrawal by Subject|3|||
94615277|NCT00494299|324053407|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
94358780|NCT01283009|323096509|FG000|Overall Study|Withdrawal by Subject|10|||
94358781|NCT01283009|323096510|FG001|Overall Study|Withdrawal by Subject|8|||
94358782|NCT01283009|323096509|FG000|Overall Study|Physician Decision|1|||
94358783|NCT01283009|323096510|FG001|Overall Study|Physician Decision|1|||
94358784|NCT01283009|323096509|FG000|Overall Study|Lost to Follow-up|1|||
94358785|NCT01283009|323096510|FG001|Overall Study|Lost to Follow-up|0|||
94460652|NCT02407457|323475414|FG001|5-year|Missed Visit|1|||
94460653|NCT02122770|323475415|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
94460654|NCT02122770|323475416|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
94460655|NCT02122770|323475417|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
94460656|NCT02122770|323475418|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
94460657|NCT02122770|323475419|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
94460658|NCT02122770|323475420|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
94460659|NCT02122770|323475415|FG000|Part A: Drug-drug Interaction 2|Other|0|||
94460660|NCT02122770|323475416|FG001|Part A: Drug-drug Interaction 2|Other|0|||
94460661|NCT02122770|323475417|FG002|Part A: Drug-drug Interaction 2|Other|1|||
94460662|NCT02122770|323475418|FG003|Part A: Drug-drug Interaction 2|Other|0|||
94460663|NCT02122770|323475419|FG004|Part A: Drug-drug Interaction 2|Other|0|||
94460664|NCT02122770|323475420|FG005|Part A: Drug-drug Interaction 2|Other|0|||
94460665|NCT02122770|323475415|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
94460666|NCT02122770|323475416|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
94615278|NCT00494299|324053408|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
94615279|NCT00494299|324053407|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
94615280|NCT00494299|324053408|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
94358786|NCT01283009|323096509|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
94358787|NCT01283009|323096510|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
94358788|NCT03841331|323096513|FG000|Overall Study|Withdrawal by Subject|4|||
94358789|NCT03841331|323096514|FG001|Overall Study|Withdrawal by Subject|9|||
94358790|NCT03841331|323096513|FG000|Overall Study|Lost to Follow-up|5|||
94358791|NCT03841331|323096514|FG001|Overall Study|Lost to Follow-up|1|||
94358792|NCT02743117|323096515|FG000|Overall Study|Lost to Follow-up|0|||
94358793|NCT02743117|323096516|FG001|Overall Study|Lost to Follow-up|1|||
94358794|NCT02743117|323096515|FG000|Overall Study|Other|1|||
94358795|NCT02743117|323096516|FG001|Overall Study|Other|0|||
94358796|NCT01207219|323096517|FG000|Overall Study|changed diagnosis during study period|5|||
94358797|NCT01207219|323096518|FG001|Overall Study|changed diagnosis during study period|3|||
94358798|NCT01207219|323096519|FG002|Overall Study|changed diagnosis during study period|1|||
94358799|NCT01207219|323096517|FG000|Overall Study|Lost to Follow-up|6|||
94358800|NCT01207219|323096518|FG001|Overall Study|Lost to Follow-up|8|||
94358801|NCT01207219|323096519|FG002|Overall Study|Lost to Follow-up|6|||
94358802|NCT04115488|323096525|FG000|Overall Study|Adverse Event|8|||
94358803|NCT04115488|323096526|FG001|Overall Study|Adverse Event|4|||
94358804|NCT04115488|323096525|FG000|Overall Study|Withdrawal by Subject|3|||
94358805|NCT04115488|323096526|FG001|Overall Study|Withdrawal by Subject|6|||
94358806|NCT04115488|323096525|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
94358807|NCT04115488|323096526|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
94358808|NCT04115488|323096525|FG000|Overall Study|Patient 's location change|1|||
94358809|NCT04115488|323096526|FG001|Overall Study|Patient 's location change|0|||
94358810|NCT04115488|323096525|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
94358811|NCT04115488|323096526|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
94358812|NCT02146365|323096529|FG000|Overall Study|Lost to Follow-up|2|||
94358813|NCT02146365|323096530|FG001|Overall Study|Lost to Follow-up|1|||
94358814|NCT02146365|323096531|FG002|Overall Study|Lost to Follow-up|3|||
94460667|NCT02122770|323475417|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
94460668|NCT02122770|323475418|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
94615281|NCT00494299|324053407|FG000|Overall Study|Site Closed by Sponsor|6|||
94615282|NCT00494299|324053408|FG001|Overall Study|Site Closed by Sponsor|0|||
94615283|NCT00494299|324053407|FG000|Overall Study|Protocol Driven Decision Point|11|||
94615284|NCT00494299|324053408|FG001|Overall Study|Protocol Driven Decision Point|22|||
94615285|NCT02761733|324053411|FG000|Overall Study|Death|3|||
94615286|NCT02761733|324053412|FG001|Overall Study|Death|5|||
94615287|NCT02761733|324053413|FG002|Overall Study|Death|1|||
94615288|NCT02761733|324053414|FG003|Overall Study|Death|1|||
94615289|NCT02761733|324053411|FG000|Overall Study|Lost to Follow-up|6|||
94615290|NCT02761733|324053412|FG001|Overall Study|Lost to Follow-up|7|||
94615291|NCT02761733|324053413|FG002|Overall Study|Lost to Follow-up|0|||
94615292|NCT02761733|324053414|FG003|Overall Study|Lost to Follow-up|3|||
94615293|NCT02761733|324053411|FG000|Overall Study|Physician Decision|4|||
94615294|NCT02761733|324053412|FG001|Overall Study|Physician Decision|0|||
94615295|NCT02761733|324053413|FG002|Overall Study|Physician Decision|0|||
94615296|NCT02761733|324053414|FG003|Overall Study|Physician Decision|0|||
94615297|NCT02761733|324053411|FG000|Overall Study|Withdrawal by Subject|2|||
94615298|NCT02761733|324053412|FG001|Overall Study|Withdrawal by Subject|0|||
94615299|NCT02761733|324053413|FG002|Overall Study|Withdrawal by Subject|0|||
94615300|NCT02761733|324053414|FG003|Overall Study|Withdrawal by Subject|0|||
94615301|NCT02761733|324053411|FG000|Overall Study|Discharged from Study Site|10|||
94615302|NCT02761733|324053412|FG001|Overall Study|Discharged from Study Site|9|||
94615303|NCT02761733|324053413|FG002|Overall Study|Discharged from Study Site|25|||
94615304|NCT02761733|324053414|FG003|Overall Study|Discharged from Study Site|11|||
94615305|NCT02761733|324053411|FG000|Overall Study|Cognitive Impairment|5|||
94615306|NCT02761733|324053412|FG001|Overall Study|Cognitive Impairment|0|||
94615307|NCT02761733|324053413|FG002|Overall Study|Cognitive Impairment|1|||
94615308|NCT02761733|324053414|FG003|Overall Study|Cognitive Impairment|0|||
94615309|NCT01986907|324053415|FG000|Overall Study|Adverse Event|11|||
94615310|NCT01986907|324053415|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
94615311|NCT01986907|324053415|FG000|Overall Study|Protocol Violation|4|||
94615312|NCT01986907|324053415|FG000|Overall Study|Withdrawal by Subject|76|||
94615313|NCT01986907|324053415|FG000|Overall Study|Lost to Follow-up|38|||
94615314|NCT01986907|324053415|FG000|Overall Study|Death|9|||
94615315|NCT03212690|324053416|FG000|Overall Study|Protocol Violation|1|||
94615316|NCT01313312|324053421|FG000|Overall Study|Adverse Event|5|||
94615317|NCT01313312|324053421|FG000|Overall Study|Withdrawal by Subject|18|||
94615318|NCT01313312|324053421|FG000|Overall Study|Lack of Efficacy|3|||
94615319|NCT01313312|324053421|FG000|Overall Study|Investigator Decision|1|||
94615320|NCT01313312|324053421|FG000|Overall Study|Observational Phase|1|||
94615321|NCT01313312|324053421|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
94615322|NCT01313312|324053421|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
94615323|NCT00474760|324053422|FG000|Overall Study|Death|0|||
94615324|NCT00474760|324053423|FG001|Overall Study|Death|0|||
94615325|NCT00474760|324053424|FG002|Overall Study|Death|0|||
94615326|NCT00474760|324053425|FG003|Overall Study|Death|0|||
94615327|NCT00474760|324053426|FG004|Overall Study|Death|2|||
94615328|NCT00474760|324053427|FG005|Overall Study|Death|0|||
94615329|NCT00474760|324053428|FG006|Overall Study|Death|0|||
94615330|NCT00474760|324053422|FG000|Overall Study|Adverse Event|0|||
94615331|NCT00474760|324053423|FG001|Overall Study|Adverse Event|0|||
94615332|NCT00474760|324053424|FG002|Overall Study|Adverse Event|0|||
94615333|NCT00474760|324053425|FG003|Overall Study|Adverse Event|0|||
94615334|NCT00474760|324053426|FG004|Overall Study|Adverse Event|1|||
94615335|NCT00474760|324053427|FG005|Overall Study|Adverse Event|7|||
94615336|NCT00474760|324053428|FG006|Overall Study|Adverse Event|0|||
94460669|NCT02122770|323475419|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
94460670|NCT02122770|323475420|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
94615337|NCT00474760|324053422|FG000|Overall Study|Laboratory abnormality|0|||
94615338|NCT00474760|324053423|FG001|Overall Study|Laboratory abnormality|0|||
94615339|NCT00474760|324053424|FG002|Overall Study|Laboratory abnormality|0|||
94615340|NCT00474760|324053425|FG003|Overall Study|Laboratory abnormality|0|||
94615341|NCT00474760|324053426|FG004|Overall Study|Laboratory abnormality|0|||
94615342|NCT00474760|324053427|FG005|Overall Study|Laboratory abnormality|1|||
94615343|NCT00474760|324053428|FG006|Overall Study|Laboratory abnormality|0|||
94615344|NCT00474760|324053422|FG000|Overall Study|Withdrawal by Subject|0|||
94615345|NCT00474760|324053423|FG001|Overall Study|Withdrawal by Subject|0|||
94460671|NCT02122770|323475415|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
94615346|NCT00474760|324053424|FG002|Overall Study|Withdrawal by Subject|0|||
94615347|NCT00474760|324053425|FG003|Overall Study|Withdrawal by Subject|1|||
94615348|NCT00474760|324053426|FG004|Overall Study|Withdrawal by Subject|0|||
94615349|NCT00474760|324053427|FG005|Overall Study|Withdrawal by Subject|1|||
94615350|NCT00474760|324053428|FG006|Overall Study|Withdrawal by Subject|1|||
94615351|NCT00474760|324053422|FG000|Overall Study|Other|0|||
94615352|NCT00474760|324053423|FG001|Overall Study|Other|1|||
94615353|NCT00474760|324053424|FG002|Overall Study|Other|0|||
94460672|NCT02122770|323475416|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
94460673|NCT02122770|323475417|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
94460674|NCT02122770|323475418|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
94460675|NCT02122770|323475419|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
94460676|NCT02122770|323475420|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
94460677|NCT02122770|323475415|FG000|Part B: Standard of Care|Adverse Event|0|||
94460678|NCT02122770|323475416|FG001|Part B: Standard of Care|Adverse Event|0|||
94460679|NCT02122770|323475417|FG002|Part B: Standard of Care|Adverse Event|0|||
94460680|NCT02122770|323475418|FG003|Part B: Standard of Care|Adverse Event|0|||
94460681|NCT02122770|323475419|FG004|Part B: Standard of Care|Adverse Event|4|||
94460682|NCT02122770|323475420|FG005|Part B: Standard of Care|Adverse Event|1|||
94460683|NCT02122770|323475415|FG000|Part B: Standard of Care|Other|0|||
94460684|NCT02122770|323475416|FG001|Part B: Standard of Care|Other|0|||
94460685|NCT02122770|323475417|FG002|Part B: Standard of Care|Other|0|||
94460686|NCT02122770|323475418|FG003|Part B: Standard of Care|Other|0|||
94460687|NCT02122770|323475419|FG004|Part B: Standard of Care|Other|0|||
94460688|NCT02122770|323475420|FG005|Part B: Standard of Care|Other|2|||
94460689|NCT02122770|323475415|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
94460690|NCT02122770|323475416|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
94460691|NCT02122770|323475417|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
94460692|NCT02122770|323475418|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
94460693|NCT02122770|323475419|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
94460694|NCT02122770|323475420|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
94460695|NCT02122770|323475415|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
94460696|NCT02122770|323475416|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
94460697|NCT02122770|323475417|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
94460698|NCT02122770|323475418|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
94460699|NCT02122770|323475419|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
94460700|NCT02122770|323475420|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
94460701|NCT02122770|323475415|FG000|Part B: Standard of Care|Progressive Disease|0|||
94460702|NCT02122770|323475416|FG001|Part B: Standard of Care|Progressive Disease|0|||
94460703|NCT02122770|323475417|FG002|Part B: Standard of Care|Progressive Disease|0|||
94460704|NCT02122770|323475418|FG003|Part B: Standard of Care|Progressive Disease|0|||
94460705|NCT02122770|323475419|FG004|Part B: Standard of Care|Progressive Disease|10|||
94460706|NCT02122770|323475420|FG005|Part B: Standard of Care|Progressive Disease|8|||
94460707|NCT01740128|323475421|FG000|Overall Study|Pregnancy|0|||
94460708|NCT01740128|323475422|FG001|Overall Study|Pregnancy|1|||
94460709|NCT01740128|323475421|FG000|Overall Study|Protocol Violation|1|||
94460710|NCT01740128|323475422|FG001|Overall Study|Protocol Violation|2|||
94460711|NCT01740128|323475421|FG000|Overall Study|Lost to Follow-up|2|||
94460712|NCT01740128|323475422|FG001|Overall Study|Lost to Follow-up|2|||
94460713|NCT01740128|323475421|FG000|Overall Study|Withdrawal by Subject|1|||
94460714|NCT01740128|323475422|FG001|Overall Study|Withdrawal by Subject|0|||
94460715|NCT01740128|323475421|FG000|Overall Study|Insufficient protocol compliance|2|||
94460716|NCT01740128|323475422|FG001|Overall Study|Insufficient protocol compliance|2|||
94460717|NCT02658734|323475423|FG000|Overall Study|Adverse Event|2|||
94460718|NCT02658734|323475423|FG000|Overall Study|Death|4|||
94460719|NCT02658734|323475423|FG000|Overall Study|Lost to Follow-up|7|||
94460720|NCT02658734|323475423|FG000|Overall Study|Withdrawal of Consent|16|||
94460721|NCT02658734|323475423|FG000|Overall Study|Disease Progression|28|||
94460722|NCT02447497|323475425|FG000|Overall Study|Did not meet treatment day baseline.|6|||
94460723|NCT02447497|323475426|FG001|Overall Study|Did not meet treatment day baseline.|5|||
94460724|NCT02447497|323475427|FG002|Overall Study|Did not meet treatment day baseline.|2|||
94460725|NCT02447497|323475428|FG003|Overall Study|Did not meet treatment day baseline.|2|||
94460726|NCT02447497|323475425|FG000|Overall Study|Dressing was compromised|0|||
94460727|NCT02447497|323475426|FG001|Overall Study|Dressing was compromised|1|||
94460728|NCT02447497|323475427|FG002|Overall Study|Dressing was compromised|0|||
94460729|NCT02447497|323475428|FG003|Overall Study|Dressing was compromised|0|||
94460730|NCT04017832|323475444|FG000|Overall Study|Withdrawal by Subject|13|||
94460731|NCT04017832|323475445|FG001|Overall Study|Withdrawal by Subject|12|||
94460732|NCT04017832|323475446|FG002|Overall Study|Withdrawal by Subject|21|||
94460733|NCT04017832|323475447|FG003|Overall Study|Withdrawal by Subject|7|||
94460734|NCT04017832|323475444|FG000|Overall Study|Lost to Follow-up|0|||
94460735|NCT04017832|323475445|FG001|Overall Study|Lost to Follow-up|3|||
94460736|NCT04017832|323475446|FG002|Overall Study|Lost to Follow-up|3|||
94460737|NCT04017832|323475447|FG003|Overall Study|Lost to Follow-up|1|||
94460738|NCT04017832|323475444|FG000|Overall Study|Physician Decision|1|||
94460739|NCT04017832|323475445|FG001|Overall Study|Physician Decision|1|||
94460740|NCT04017832|323475446|FG002|Overall Study|Physician Decision|1|||
94460741|NCT04017832|323475447|FG003|Overall Study|Physician Decision|1|||
94460742|NCT04017832|323475444|FG000|Overall Study|Death|2|||
94460743|NCT04017832|323475445|FG001|Overall Study|Death|2|||
94460744|NCT04017832|323475446|FG002|Overall Study|Death|1|||
94460745|NCT04017832|323475447|FG003|Overall Study|Death|0|||
94460746|NCT02344290|323475448|FG000|Overall Study|Withdrawal by Subject|315|||
94460747|NCT02344290|323475449|FG001|Overall Study|Withdrawal by Subject|324|||
94460748|NCT02344290|323475448|FG000|Overall Study|Lost to Follow-up|258|||
94460749|NCT02344290|323475449|FG001|Overall Study|Lost to Follow-up|249|||
94460750|NCT02344290|323475448|FG000|Overall Study|Unable to get to clinic|69|||
94460751|NCT02344290|323475449|FG001|Overall Study|Unable to get to clinic|60|||
94460752|NCT02344290|323475448|FG000|Overall Study|Physician Decision|25|||
94460753|NCT02344290|323475449|FG001|Overall Study|Physician Decision|25|||
94460754|NCT02344290|323475448|FG000|Overall Study|Site Closure|15|||
94460755|NCT02344290|323475449|FG001|Overall Study|Site Closure|19|||
94460756|NCT02344290|323475448|FG000|Overall Study|Other|5|||
94460757|NCT02344290|323475449|FG001|Overall Study|Other|3|||
94460758|NCT02484651|323475450|FG000|Overall Study|Patients' data files were corrupted.|1|||
94460759|NCT02484651|323475451|FG001|Overall Study|Patients' data files were corrupted.|1|||
94460760|NCT02484651|323475450|FG000|Overall Study|BIS monitoring failed.|1|||
94460761|NCT02484651|323475451|FG001|Overall Study|BIS monitoring failed.|1|||
94460762|NCT02484651|323475450|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
94460763|NCT02484651|323475451|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
94460764|NCT04696354|323475462|FG000|Overall Study|Study termination|6|||
94460765|NCT04696354|323475463|FG001|Overall Study|Study termination|6|||
94460766|NCT04545567|323475464|FG000|Overall Study|tested positive for SARS-co-V2|1|||
94460767|NCT04545567|323475465|FG001|Overall Study|tested positive for SARS-co-V2|1|||
94460768|NCT04545567|323475464|FG000|Overall Study|Withdrawal by Subject|0|||
94460769|NCT04545567|323475465|FG001|Overall Study|Withdrawal by Subject|1|||
94460770|NCT01966068|323475468|FG000|Overall Study|Withdrawal by Subject|57|||
94460771|NCT01966068|323475468|FG000|Overall Study|Lost to Follow-up|81|||
94460772|NCT01077739|323475470|FG000|Overall Study|Premature withdrawal|1|||
94460773|NCT01077739|323475471|FG001|Overall Study|Premature withdrawal|3|||
94460774|NCT01077739|323475470|FG000|Overall Study|Withdrawal by Subject|1|||
94460775|NCT01077739|323475471|FG001|Overall Study|Withdrawal by Subject|0|||
94460776|NCT01077739|323475470|FG000|Overall Study|Death|0|||
94460777|NCT01077739|323475471|FG001|Overall Study|Death|3|||
94460778|NCT01077739|323475470|FG000|Overall Study|Unacceptable toxicity|1|||
94460779|NCT01077739|323475471|FG001|Overall Study|Unacceptable toxicity|2|||
94460780|NCT01077739|323475470|FG000|Overall Study|Other|2|||
94460781|NCT01077739|323475471|FG001|Overall Study|Other|2|||
94460782|NCT01790828|323475472|FG000|Overall Study|Other|34|||
94460783|NCT00877071|323475473|FG000|Overall Study|disease progression|2|||
94460784|NCT02548351|323475474|FG000|Overall Study|Withdrawal by Subject|149|||
94460785|NCT02548351|323475475|FG001|Overall Study|Withdrawal by Subject|154|||
94460786|NCT02548351|323475476|FG002|Overall Study|Withdrawal by Subject|152|||
94460787|NCT02548351|323475474|FG000|Overall Study|Death|11|||
94460788|NCT02548351|323475475|FG001|Overall Study|Death|15|||
94460789|NCT02548351|323475476|FG002|Overall Study|Death|12|||
94460790|NCT02548351|323475474|FG000|Overall Study|Adverse Event|22|||
94615354|NCT00474760|324053425|FG003|Overall Study|Other|0|||
94460791|NCT02548351|323475475|FG001|Overall Study|Adverse Event|56|||
94460792|NCT02548351|323475476|FG002|Overall Study|Adverse Event|36|||
94460793|NCT02548351|323475474|FG000|Overall Study|Study Terminated by Sponsor|549|||
94615355|NCT00474760|324053426|FG004|Overall Study|Other|1|||
94615356|NCT00474760|324053427|FG005|Overall Study|Other|0|||
94615357|NCT00474760|324053428|FG006|Overall Study|Other|0|||
94615358|NCT00474760|324053422|FG000|Overall Study|Progressive disease|3|||
94615359|NCT00474760|324053423|FG001|Overall Study|Progressive disease|2|||
94615360|NCT00474760|324053424|FG002|Overall Study|Progressive disease|3|||
94615361|NCT00474760|324053425|FG003|Overall Study|Progressive disease|2|||
94615362|NCT00474760|324053426|FG004|Overall Study|Progressive disease|8|||
94615363|NCT00474760|324053427|FG005|Overall Study|Progressive disease|20|||
94615364|NCT00474760|324053428|FG006|Overall Study|Progressive disease|7|||
94615365|NCT00474760|324053422|FG000|Overall Study|Terminated by sponsor|0|||
94615366|NCT00474760|324053423|FG001|Overall Study|Terminated by sponsor|0|||
94615367|NCT00474760|324053424|FG002|Overall Study|Terminated by sponsor|0|||
94615368|NCT00474760|324053425|FG003|Overall Study|Terminated by sponsor|0|||
94615369|NCT00474760|324053426|FG004|Overall Study|Terminated by sponsor|0|||
94615370|NCT00474760|324053427|FG005|Overall Study|Terminated by sponsor|0|||
94615371|NCT00474760|324053428|FG006|Overall Study|Terminated by sponsor|2|||
94615372|NCT02846324|324053429|FG000|Overall Study|Other|1|||
94615373|NCT02846324|324053430|FG001|Overall Study|Other|0|||
94615374|NCT02846324|324053431|FG002|Overall Study|Other|0|||
94688672|NCT01913639|324315568|FG000|Overall Study|Not Eligible|3|||
94460794|NCT02548351|323475475|FG001|Overall Study|Study Terminated by Sponsor|509|||
94615375|NCT02846324|324053432|FG003|Overall Study|Other|0|||
94615376|NCT02846324|324053429|FG000|Overall Study|Withdrawal by Subject|1|||
94615377|NCT02846324|324053430|FG001|Overall Study|Withdrawal by Subject|0|||
94615378|NCT02846324|324053431|FG002|Overall Study|Withdrawal by Subject|4|||
94615379|NCT02846324|324053432|FG003|Overall Study|Withdrawal by Subject|0|||
94615380|NCT00066365|324053439|FG000|Overall Study|Adverse Event|1|||
94615381|NCT00066365|324053440|FG001|Overall Study|Adverse Event|0|||
94615382|NCT00066365|324053439|FG000|Overall Study|Lack of Efficacy|15|||
94615383|NCT00066365|324053440|FG001|Overall Study|Lack of Efficacy|12|||
94615384|NCT00066365|324053439|FG000|Overall Study|Physician Decision|1|||
94615385|NCT00066365|324053440|FG001|Overall Study|Physician Decision|0|||
94615386|NCT00066365|324053439|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
94615387|NCT00066365|324053440|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
94615388|NCT00066365|324053439|FG000|Overall Study|Ineligible|4|||
94615389|NCT00066365|324053440|FG001|Overall Study|Ineligible|2|||
94615390|NCT03576495|324053441|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
94615391|NCT03576495|324053442|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
94615392|NCT00660673|324053443|FG000|Overall Study|Adverse Event|84|||
94615393|NCT00660673|324053443|FG000|Overall Study|Lack of Efficacy|7|||
94615394|NCT00660673|324053443|FG000|Overall Study|Withdrawal by Subject|22|||
94615395|NCT00660673|324053443|FG000|Overall Study|Administrative|2|||
94615396|NCT00660673|324053443|FG000|Overall Study|Protocol Violation|2|||
94615397|NCT01786148|324053444|FG000|Overall Study|Lost to Follow-up|21|||
94615398|NCT01786148|324053445|FG001|Overall Study|Lost to Follow-up|13|||
94615399|NCT01786148|324053444|FG000|Overall Study|Death|0|||
94615400|NCT01786148|324053445|FG001|Overall Study|Death|1|||
94615401|NCT01786148|324053444|FG000|Overall Study|Withdrawal by Subject|0|||
94615402|NCT01786148|324053445|FG001|Overall Study|Withdrawal by Subject|7|||
94615403|NCT01786148|324053444|FG000|Overall Study|Incarceration|1|||
94615404|NCT01786148|324053445|FG001|Overall Study|Incarceration|1|||
94615405|NCT03780543|324053446|FG000|Overall Study|Adverse Event|1|||
94615406|NCT03780543|324053447|FG001|Overall Study|Adverse Event|0|||
94615407|NCT03780543|324053448|FG002|Overall Study|Adverse Event|2|||
94615408|NCT03780543|324053446|FG000|Overall Study|Lost to Follow-up|2|||
94615409|NCT03780543|324053447|FG001|Overall Study|Lost to Follow-up|0|||
94615410|NCT03780543|324053448|FG002|Overall Study|Lost to Follow-up|1|||
94615411|NCT03780543|324053446|FG000|Overall Study|Study terminated by Sponsor|8|||
94615412|NCT03780543|324053447|FG001|Overall Study|Study terminated by Sponsor|7|||
94615413|NCT03780543|324053448|FG002|Overall Study|Study terminated by Sponsor|13|||
94615414|NCT03780543|324053446|FG000|Overall Study|Withdrawal by Subject|1|||
94615415|NCT03780543|324053447|FG001|Overall Study|Withdrawal by Subject|8|||
94615416|NCT03780543|324053448|FG002|Overall Study|Withdrawal by Subject|1|||
94615417|NCT03780543|324053446|FG000|Overall Study|Noncompliance with study drug|1|||
94615418|NCT03780543|324053447|FG001|Overall Study|Noncompliance with study drug|0|||
94615419|NCT03780543|324053448|FG002|Overall Study|Noncompliance with study drug|0|||
94615420|NCT04032652|324053453|FG000|Overall Study|The study was terminated and the PI has|1|||
94615421|NCT04032652|324053454|FG001|Overall Study|The study was terminated and the PI has|1|||
94615422|NCT03308786|324053456|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
94615423|NCT01441180|324053457|FG000|Overall Study|Lost to Follow-up|1|||
94615424|NCT01441180|324053458|FG001|Overall Study|Lost to Follow-up|1|||
94615425|NCT01441180|324053459|FG002|Overall Study|Lost to Follow-up|1|||
94615426|NCT01441180|324053457|FG000|Overall Study|Discontinued|0|||
94615427|NCT01441180|324053458|FG001|Overall Study|Discontinued|0|||
94615428|NCT01441180|324053459|FG002|Overall Study|Discontinued|2|||
94615429|NCT03673046|324055209|FG000|Overall Study|Adverse Event|1|||
94615430|NCT03673046|324055210|FG001|Overall Study|Adverse Event|1|||
94615431|NCT03673046|324055209|FG000|Overall Study|Withdrawal by Subject|8|||
94615432|NCT03673046|324055210|FG001|Overall Study|Withdrawal by Subject|2|||
94615433|NCT03817879|324055211|FG000|Overall Study|Drop out|5|||
94615434|NCT03817879|324055212|FG001|Overall Study|Drop out|12|||
94615435|NCT03817879|324055211|FG000|Overall Study|Withdrawal by Subject|0|||
94615436|NCT03817879|324055212|FG001|Overall Study|Withdrawal by Subject|1|||
94615437|NCT01896050|324055215|FG000|Overall Study|Adverse Event|37|||
94615438|NCT01896050|324055216|FG001|Overall Study|Adverse Event|2|||
94615439|NCT01896050|324055215|FG000|Overall Study|Death|1|||
94615440|NCT01896050|324055216|FG001|Overall Study|Death|0|||
94615441|NCT00825682|324055217|FG000|Overall Study|personal reasons/ inconvenience|13|||
94615442|NCT00825682|324055218|FG001|Overall Study|personal reasons/ inconvenience|5|||
94615443|NCT00866788|324055219|FG000|Overall Study|Adverse Event|0|||
94615444|NCT00866788|324055220|FG001|Overall Study|Adverse Event|2|||
94615445|NCT00866788|324055221|FG002|Overall Study|Adverse Event|0|||
94615446|NCT00866788|324055222|FG003|Overall Study|Adverse Event|1|||
94615447|NCT00866788|324055219|FG000|Overall Study|Lost to Follow-up|1|||
94615448|NCT00866788|324055220|FG001|Overall Study|Lost to Follow-up|1|||
94615449|NCT00866788|324055221|FG002|Overall Study|Lost to Follow-up|0|||
94615450|NCT00866788|324055222|FG003|Overall Study|Lost to Follow-up|2|||
94460795|NCT02548351|323475476|FG002|Overall Study|Study Terminated by Sponsor|528|||
94460796|NCT02548351|323475474|FG000|Overall Study|Site Closure|14|||
94460797|NCT02548351|323475475|FG001|Overall Study|Site Closure|5|||
94460798|NCT02548351|323475476|FG002|Overall Study|Site Closure|7|||
94460799|NCT02548351|323475474|FG000|Overall Study|Non-compliance with Study Drug|4|||
94460800|NCT02548351|323475475|FG001|Overall Study|Non-compliance with Study Drug|2|||
94460801|NCT02548351|323475476|FG002|Overall Study|Non-compliance with Study Drug|0|||
94460802|NCT02548351|323475474|FG000|Overall Study|Protocol Violation|2|||
94460803|NCT02548351|323475475|FG001|Overall Study|Protocol Violation|1|||
94460804|NCT02548351|323475476|FG002|Overall Study|Protocol Violation|2|||
94460805|NCT02548351|323475474|FG000|Overall Study|Physician Decision|11|||
94460806|NCT02548351|323475475|FG001|Overall Study|Physician Decision|18|||
94460807|NCT02548351|323475476|FG002|Overall Study|Physician Decision|11|||
94460808|NCT02548351|323475474|FG000|Overall Study|Lost to Follow-up|43|||
94460809|NCT02548351|323475475|FG001|Overall Study|Lost to Follow-up|50|||
94460810|NCT02548351|323475476|FG002|Overall Study|Lost to Follow-up|57|||
94460811|NCT02548351|323475474|FG000|Overall Study|Other|19|||
94460812|NCT02548351|323475475|FG001|Overall Study|Other|16|||
94460813|NCT02548351|323475476|FG002|Overall Study|Other|20|||
94664968|NCT01490632|324229742|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
94664969|NCT01490632|324229743|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
94664970|NCT01490632|324229744|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
94664971|NCT01490632|324229745|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
94664972|NCT01490632|324229746|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
94664973|NCT01490632|324229747|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
94688673|NCT00630058|324315570|FG000|Overall Study|Adverse Event|1|||
94358815|NCT02146365|323096532|FG003|Overall Study|Lost to Follow-up|3|||
94358816|NCT02146365|323096533|FG004|Overall Study|Lost to Follow-up|1|||
94358817|NCT02146365|323096534|FG005|Overall Study|Lost to Follow-up|1|||
94358818|NCT02146365|323096535|FG006|Overall Study|Lost to Follow-up|0|||
94358819|NCT02146365|323096536|FG007|Overall Study|Lost to Follow-up|1|||
94358820|NCT02146365|323096529|FG000|Overall Study|Withdrawal by Subject|1|||
94358821|NCT02146365|323096530|FG001|Overall Study|Withdrawal by Subject|2|||
94358822|NCT02146365|323096531|FG002|Overall Study|Withdrawal by Subject|1|||
94358823|NCT02146365|323096532|FG003|Overall Study|Withdrawal by Subject|5|||
94358824|NCT02146365|323096533|FG004|Overall Study|Withdrawal by Subject|1|||
94358825|NCT02146365|323096534|FG005|Overall Study|Withdrawal by Subject|0|||
94358826|NCT02146365|323096535|FG006|Overall Study|Withdrawal by Subject|0|||
94358827|NCT02146365|323096536|FG007|Overall Study|Withdrawal by Subject|0|||
94358828|NCT02146365|323096529|FG000|Overall Study|Unable to Comply with Protocol|0|||
94358829|NCT02146365|323096530|FG001|Overall Study|Unable to Comply with Protocol|1|||
94358830|NCT02146365|323096531|FG002|Overall Study|Unable to Comply with Protocol|1|||
94358831|NCT02146365|323096532|FG003|Overall Study|Unable to Comply with Protocol|0|||
94358832|NCT02146365|323096533|FG004|Overall Study|Unable to Comply with Protocol|0|||
94358833|NCT02146365|323096534|FG005|Overall Study|Unable to Comply with Protocol|0|||
94358834|NCT02146365|323096535|FG006|Overall Study|Unable to Comply with Protocol|0|||
94358835|NCT02146365|323096536|FG007|Overall Study|Unable to Comply with Protocol|0|||
94358836|NCT02146365|323096529|FG000|Overall Study|Other|1|||
94358837|NCT02146365|323096530|FG001|Overall Study|Other|0|||
94358838|NCT02146365|323096531|FG002|Overall Study|Other|2|||
94358839|NCT02146365|323096532|FG003|Overall Study|Other|1|||
94358840|NCT02146365|323096533|FG004|Overall Study|Other|0|||
94358841|NCT02146365|323096534|FG005|Overall Study|Other|0|||
94358842|NCT02146365|323096535|FG006|Overall Study|Other|0|||
94358843|NCT02146365|323096536|FG007|Overall Study|Other|0|||
94358844|NCT00975000|323096538|FG000|Overall Study|Other|1|||
94358845|NCT00975000|323096539|FG001|Overall Study|Other|0|||
94358846|NCT00975000|323096538|FG000|Overall Study|Adverse Event|1|||
94358847|NCT00975000|323096539|FG001|Overall Study|Adverse Event|1|||
94358848|NCT00975000|323096538|FG000|Overall Study|Withdrawal by Subject|2|||
94358849|NCT00975000|323096539|FG001|Overall Study|Withdrawal by Subject|2|||
94358850|NCT00975000|323096538|FG000|Overall Study|Lost to Follow-up|0|||
94358851|NCT00975000|323096539|FG001|Overall Study|Lost to Follow-up|1|||
94358852|NCT00975000|323096538|FG000|Overall Study|Protocol-specified Criteria|1|||
94358853|NCT00975000|323096539|FG001|Overall Study|Protocol-specified Criteria|0|||
94358854|NCT00975000|323096538|FG000|Overall Study|Non-compliance|0|||
94358855|NCT00975000|323096539|FG001|Overall Study|Non-compliance|1|||
94358856|NCT01977482|323096540|FG000|Overall Study|Adverse Event|0|||
94358857|NCT01977482|323096541|FG001|Overall Study|Adverse Event|1|||
94358858|NCT01977482|323096542|FG002|Overall Study|Adverse Event|1|||
94358859|NCT01977482|323096543|FG003|Overall Study|Adverse Event|0|||
94358860|NCT01977482|323096544|FG004|Overall Study|Adverse Event|2|||
94358861|NCT01977482|323096545|FG005|Overall Study|Adverse Event|0|||
94358862|NCT01977482|323096540|FG000|Overall Study|Lost to Follow-up|1|||
94358863|NCT01977482|323096541|FG001|Overall Study|Lost to Follow-up|0|||
94358864|NCT01977482|323096542|FG002|Overall Study|Lost to Follow-up|0|||
94460814|NCT02548351|323475474|FG000|Overall Study|Missing|1|||
94358865|NCT01977482|323096543|FG003|Overall Study|Lost to Follow-up|0|||
94358866|NCT01977482|323096544|FG004|Overall Study|Lost to Follow-up|0|||
94358867|NCT01977482|323096545|FG005|Overall Study|Lost to Follow-up|0|||
94358868|NCT01977482|323096540|FG000|Overall Study|Physician Decision|0|||
94358869|NCT01977482|323096541|FG001|Overall Study|Physician Decision|1|||
94615451|NCT00866788|324055219|FG000|Overall Study|Withdrawal by Subject|2|||
94615452|NCT00866788|324055220|FG001|Overall Study|Withdrawal by Subject|1|||
94615453|NCT00866788|324055221|FG002|Overall Study|Withdrawal by Subject|0|||
94615454|NCT00866788|324055222|FG003|Overall Study|Withdrawal by Subject|1|||
94615455|NCT00866788|324055219|FG000|Overall Study|Pregnancy|0|||
94615456|NCT00866788|324055220|FG001|Overall Study|Pregnancy|1|||
94615457|NCT00866788|324055221|FG002|Overall Study|Pregnancy|0|||
94615458|NCT00866788|324055222|FG003|Overall Study|Pregnancy|0|||
94615459|NCT00866788|324055219|FG000|Overall Study|Disease progression|3|||
94615460|NCT00866788|324055220|FG001|Overall Study|Disease progression|1|||
94615461|NCT00866788|324055221|FG002|Overall Study|Disease progression|1|||
94615462|NCT00866788|324055222|FG003|Overall Study|Disease progression|0|||
94615463|NCT00866788|324055219|FG000|Overall Study|Physician Decision|0|||
94615464|NCT00866788|324055220|FG001|Overall Study|Physician Decision|0|||
94615465|NCT00866788|324055221|FG002|Overall Study|Physician Decision|1|||
94615466|NCT00866788|324055222|FG003|Overall Study|Physician Decision|1|||
94615467|NCT02975336|324055224|FG000|DBPC (52 Weeks)|Adverse Event|16|||
94615468|NCT02975336|324055225|FG001|DBPC (52 Weeks)|Adverse Event|17|||
94615469|NCT02975336|324055226|FG002|DBPC (52 Weeks)|Adverse Event|13|||
94615470|NCT02975336|324055227|FG003|DBPC (52 Weeks)|Adverse Event|18|||
94615471|NCT02975336|324055228|FG004|DBPC (52 Weeks)|Adverse Event|0|||
94615472|NCT02975336|324055229|FG005|DBPC (52 Weeks)|Adverse Event|0|||
94615473|NCT02975336|324055230|FG006|DBPC (52 Weeks)|Adverse Event|0|||
94615474|NCT02975336|324055231|FG007|DBPC (52 Weeks)|Adverse Event|0|||
94615475|NCT02975336|324055224|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
94615476|NCT02975336|324055225|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
94615477|NCT02975336|324055226|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
94615478|NCT02975336|324055227|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
94615479|NCT02975336|324055228|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
94615480|NCT02975336|324055229|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
94615481|NCT02975336|324055230|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
94615482|NCT02975336|324055231|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
94615483|NCT02975336|324055224|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
94615484|NCT02975336|324055225|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
94615485|NCT02975336|324055226|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
94615486|NCT02975336|324055227|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
94615487|NCT02975336|324055228|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
94615488|NCT02975336|324055229|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
94615489|NCT02975336|324055230|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
94615490|NCT02975336|324055231|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
94615491|NCT02975336|324055224|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
94615492|NCT02975336|324055225|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
94615493|NCT02975336|324055226|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
94615494|NCT02975336|324055227|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
94615495|NCT02975336|324055228|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
94615496|NCT02975336|324055229|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
94615497|NCT02975336|324055230|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
94615498|NCT02975336|324055231|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
94615499|NCT02975336|324055224|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
94615500|NCT02975336|324055225|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
94615501|NCT02975336|324055226|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
94615502|NCT02975336|324055227|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
94615503|NCT02975336|324055228|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
94615504|NCT02975336|324055229|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
94615505|NCT02975336|324055230|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
94358870|NCT01977482|323096542|FG002|Overall Study|Physician Decision|0|||
94358871|NCT01977482|323096543|FG003|Overall Study|Physician Decision|0|||
94615506|NCT02975336|324055231|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
94615507|NCT02975336|324055224|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
94615508|NCT02975336|324055225|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
94615509|NCT02975336|324055226|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
94615510|NCT02975336|324055227|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
94615511|NCT02975336|324055228|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
94615512|NCT02975336|324055229|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
94615513|NCT02975336|324055230|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
94615514|NCT02975336|324055231|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
94615515|NCT02975336|324055224|FG000|LTE (104 Weeks)|Adverse Event|0|||
94615516|NCT02975336|324055225|FG001|LTE (104 Weeks)|Adverse Event|0|||
94615517|NCT02975336|324055226|FG002|LTE (104 Weeks)|Adverse Event|0|||
94615518|NCT02975336|324055227|FG003|LTE (104 Weeks)|Adverse Event|0|||
94664974|NCT01490632|324229728|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
94358872|NCT01977482|323096544|FG004|Overall Study|Physician Decision|0|||
94615519|NCT02975336|324055228|FG004|LTE (104 Weeks)|Adverse Event|7|||
94664975|NCT01490632|324229729|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
94664976|NCT01490632|324229730|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
94664977|NCT01490632|324229731|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
94664978|NCT01490632|324229732|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
94664979|NCT01490632|324229733|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
94664980|NCT01490632|324229734|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
94664981|NCT01490632|324229735|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
94664982|NCT01490632|324229736|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
94664983|NCT01490632|324229737|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
94664984|NCT01490632|324229738|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
94664985|NCT01490632|324229739|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
94664986|NCT01490632|324229740|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
94664987|NCT01490632|324229741|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
94664988|NCT01490632|324229742|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
94664989|NCT01490632|324229743|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
94664990|NCT01490632|324229744|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
94664991|NCT01490632|324229745|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
94664992|NCT01490632|324229746|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
94664993|NCT01490632|324229747|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
94664994|NCT01490632|324229728|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94664995|NCT01490632|324229729|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94664996|NCT01490632|324229730|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94664997|NCT01490632|324229731|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94664998|NCT01490632|324229732|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94664999|NCT01490632|324229733|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94665000|NCT01490632|324229734|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94665001|NCT01490632|324229735|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94665002|NCT01490632|324229736|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94665003|NCT01490632|324229737|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94665004|NCT01490632|324229738|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94665005|NCT01490632|324229739|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94665006|NCT01490632|324229740|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94358873|NCT01977482|323096545|FG005|Overall Study|Physician Decision|0|||
94358874|NCT01977482|323096540|FG000|Overall Study|Protocol Violation|0|||
94358875|NCT01977482|323096541|FG001|Overall Study|Protocol Violation|0|||
94358876|NCT01977482|323096542|FG002|Overall Study|Protocol Violation|1|||
94358877|NCT01977482|323096543|FG003|Overall Study|Protocol Violation|0|||
94358878|NCT01977482|323096544|FG004|Overall Study|Protocol Violation|0|||
94358879|NCT01977482|323096545|FG005|Overall Study|Protocol Violation|0|||
94358880|NCT01977482|323096540|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
94358881|NCT01977482|323096541|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
94358882|NCT01977482|323096542|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
94358883|NCT01977482|323096543|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
94358884|NCT01977482|323096544|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
94358885|NCT01977482|323096545|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
94358886|NCT01977482|323096540|FG000|Overall Study|Withdrawal by Subject|2|||
94358887|NCT01977482|323096541|FG001|Overall Study|Withdrawal by Subject|4|||
94358888|NCT01977482|323096542|FG002|Overall Study|Withdrawal by Subject|1|||
94358889|NCT01977482|323096543|FG003|Overall Study|Withdrawal by Subject|3|||
94358890|NCT01977482|323096544|FG004|Overall Study|Withdrawal by Subject|1|||
94358891|NCT01977482|323096545|FG005|Overall Study|Withdrawal by Subject|5|||
94365696|NCT05553600|323124753|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
94365697|NCT05553600|323124754|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
94365698|NCT05553600|323124751|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
94365699|NCT05553600|323124752|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
94365700|NCT05553600|323124753|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
94365701|NCT05553600|323124754|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
94365702|NCT05553600|323124751|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
94365703|NCT05553600|323124752|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
94365704|NCT05553600|323124753|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
94365705|NCT05553600|323124754|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
94365706|NCT05553600|323124751|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
94365707|NCT05553600|323124752|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
94365708|NCT05553600|323124753|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
94365709|NCT05553600|323124754|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
94365710|NCT05553600|323124751|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
94365711|NCT05553600|323124752|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
94365712|NCT05553600|323124753|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
94615520|NCT02975336|324055229|FG005|LTE (104 Weeks)|Adverse Event|4|||
94615521|NCT02975336|324055230|FG006|LTE (104 Weeks)|Adverse Event|2|||
94615522|NCT02975336|324055231|FG007|LTE (104 Weeks)|Adverse Event|0|||
94615523|NCT02975336|324055224|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
94615524|NCT02975336|324055225|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
94615525|NCT02975336|324055226|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
94615526|NCT02975336|324055227|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
94615527|NCT02975336|324055228|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
94615528|NCT02975336|324055229|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
94615529|NCT02975336|324055230|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
94615530|NCT02975336|324055231|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
94615531|NCT02975336|324055224|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
94615532|NCT02975336|324055225|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
94615533|NCT02975336|324055226|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
94615534|NCT02975336|324055227|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
94615535|NCT02975336|324055228|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
94615536|NCT02975336|324055229|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
94615537|NCT02975336|324055230|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
94615538|NCT02975336|324055231|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
94615539|NCT02975336|324055224|FG000|LTE (104 Weeks)|Other|0|||
94615540|NCT02975336|324055225|FG001|LTE (104 Weeks)|Other|0|||
94615541|NCT02975336|324055226|FG002|LTE (104 Weeks)|Other|0|||
94615542|NCT02975336|324055227|FG003|LTE (104 Weeks)|Other|0|||
94615543|NCT02975336|324055228|FG004|LTE (104 Weeks)|Other|55|||
94615544|NCT02975336|324055229|FG005|LTE (104 Weeks)|Other|63|||
94615545|NCT02975336|324055230|FG006|LTE (104 Weeks)|Other|76|||
94615546|NCT02975336|324055231|FG007|LTE (104 Weeks)|Other|72|||
94615547|NCT05439941|324055233|FG000|Overall Study|Lack of Efficacy|8|||
94615548|NCT05439941|324055234|FG001|Overall Study|Lack of Efficacy|5|||
94615549|NCT05439941|324055235|FG002|Overall Study|Lack of Efficacy|3|||
94615550|NCT05439941|324055233|FG000|Overall Study|Treatment Failure|0|||
94615551|NCT05439941|324055234|FG001|Overall Study|Treatment Failure|1|||
94615552|NCT05439941|324055235|FG002|Overall Study|Treatment Failure|0|||
94615553|NCT05439941|324055233|FG000|Overall Study|Adverse Event|1|||
94615554|NCT05439941|324055234|FG001|Overall Study|Adverse Event|3|||
94615555|NCT05439941|324055235|FG002|Overall Study|Adverse Event|0|||
94615556|NCT05439941|324055233|FG000|Overall Study|Adverse Event - Parent Study|1|||
94615557|NCT05439941|324055234|FG001|Overall Study|Adverse Event - Parent Study|0|||
94615558|NCT05439941|324055235|FG002|Overall Study|Adverse Event - Parent Study|0|||
94615559|NCT05439941|324055233|FG000|Overall Study|Pregnancy|1|||
94615560|NCT05439941|324055234|FG001|Overall Study|Pregnancy|0|||
94615561|NCT05439941|324055235|FG002|Overall Study|Pregnancy|0|||
94615562|NCT05439941|324055233|FG000|Overall Study|Withdrawal by Subject|9|||
94615563|NCT05439941|324055234|FG001|Overall Study|Withdrawal by Subject|6|||
94615564|NCT05439941|324055235|FG002|Overall Study|Withdrawal by Subject|10|||
94615565|NCT05439941|324055233|FG000|Overall Study|Non-Compliance|1|||
94615566|NCT05439941|324055234|FG001|Overall Study|Non-Compliance|1|||
94615567|NCT05439941|324055235|FG002|Overall Study|Non-Compliance|1|||
94615568|NCT05439941|324055233|FG000|Overall Study|Lost to Follow-up|2|||
94615569|NCT05439941|324055234|FG001|Overall Study|Lost to Follow-up|2|||
94615570|NCT05439941|324055235|FG002|Overall Study|Lost to Follow-up|0|||
94615571|NCT05439941|324055233|FG000|Overall Study|Physician Decision|1|||
94615572|NCT05439941|324055234|FG001|Overall Study|Physician Decision|0|||
94615573|NCT05439941|324055235|FG002|Overall Study|Physician Decision|0|||
94615574|NCT05439941|324055233|FG000|Overall Study|Trial Termination by Sponsor|78|||
94615575|NCT05439941|324055234|FG001|Overall Study|Trial Termination by Sponsor|83|||
94615576|NCT05439941|324055235|FG002|Overall Study|Trial Termination by Sponsor|65|||
94615577|NCT05439941|324055233|FG000|Overall Study|Other than Reasons Listed|2|||
94615578|NCT05439941|324055234|FG001|Overall Study|Other than Reasons Listed|1|||
94615579|NCT05439941|324055235|FG002|Overall Study|Other than Reasons Listed|0|||
94615580|NCT02422303|324055236|FG000|Overall Study|Lost to Follow-up|1|||
94615581|NCT02422303|324055237|FG001|Overall Study|Lost to Follow-up|1|||
94615582|NCT00434954|324055238|FG000|Overall Study|Adverse Event|17|||
94615583|NCT00434954|324055239|FG001|Overall Study|Adverse Event|2|||
94615584|NCT00434954|324055238|FG000|Overall Study|Entry criteria not met|14|||
94615585|NCT00434954|324055239|FG001|Overall Study|Entry criteria not met|16|||
94615586|NCT00434954|324055238|FG000|Overall Study|Lost to Follow-up|0|||
94615587|NCT00434954|324055239|FG001|Overall Study|Lost to Follow-up|1|||
94615588|NCT00434954|324055238|FG000|Overall Study|Physician Decision|6|||
94615589|NCT00434954|324055239|FG001|Overall Study|Physician Decision|3|||
94615590|NCT00434954|324055238|FG000|Overall Study|Protocol Violation|36|||
94615591|NCT00434954|324055239|FG001|Overall Study|Protocol Violation|27|||
94615592|NCT00434954|324055238|FG000|Overall Study|Sponsor decision|1|||
94615593|NCT00434954|324055239|FG001|Overall Study|Sponsor decision|0|||
94615594|NCT00434954|324055238|FG000|Overall Study|Subject decision|8|||
94615595|NCT00434954|324055239|FG001|Overall Study|Subject decision|22|||
94615596|NCT01303861|324055240|FG000|Overall Study|Lost to Follow-up|34|||
94615597|NCT01303861|324055241|FG001|Overall Study|Lost to Follow-up|14|||
94460815|NCT02548351|323475475|FG001|Overall Study|Missing|1|||
94460816|NCT02548351|323475476|FG002|Overall Study|Missing|0|||
94460817|NCT00721279|323475477|FG000|Overall Study|Lack of Efficacy|6|||
94460818|NCT00721279|323475478|FG001|Overall Study|Lack of Efficacy|3|||
94460819|NCT00721279|323475477|FG000|Overall Study|Tolerability insufficient|5|||
94460820|NCT00721279|323475478|FG001|Overall Study|Tolerability insufficient|2|||
94460821|NCT00721279|323475477|FG000|Overall Study|Withdrawal by Subject|13|||
94460822|NCT00721279|323475478|FG001|Overall Study|Withdrawal by Subject|3|||
94460823|NCT00721279|323475477|FG000|Overall Study|Other|12|||
94460824|NCT00721279|323475478|FG001|Overall Study|Other|16|||
94460825|NCT03839459|323476747|FG000|Overall Study|Withdrawal by Subject|2|||
94460826|NCT03839459|323476747|FG000|Overall Study|progression of disease|3|||
94460827|NCT01668966|323476753|FG000|Overall Study|Withdrawal by Subject|1|||
94460828|NCT01668966|323476753|FG000|Overall Study|Death|1|||
94460829|NCT01668966|323476753|FG000|Overall Study|Not treated|2|||
94460830|NCT04045132|323476754|FG000|Overall Study|Lost to Follow-up|3|||
94460831|NCT04045132|323476755|FG001|Overall Study|Lost to Follow-up|6|||
94460832|NCT00546117|323476756|FG000|Overall Study|Withdrawal by Subject|3|||
94460833|NCT00546117|323476757|FG001|Overall Study|Withdrawal by Subject|0|||
94460834|NCT00546117|323476756|FG000|Overall Study|Inability to schedule follow-up visit|1|||
94460835|NCT00546117|323476757|FG001|Overall Study|Inability to schedule follow-up visit|0|||
94460836|NCT04599933|323476758|FG000|Overall Study|Adverse Event|4|||
94460837|NCT04599933|323476759|FG001|Overall Study|Adverse Event|1|||
94460838|NCT04599933|323476758|FG000|Overall Study|Withdrawal by Subject|4|||
94460839|NCT04599933|323476759|FG001|Overall Study|Withdrawal by Subject|2|||
94460840|NCT04599933|323476758|FG000|Overall Study|Lost to Follow-up|0|||
94460841|NCT04599933|323476759|FG001|Overall Study|Lost to Follow-up|1|||
94460842|NCT04599933|323476758|FG000|Overall Study|Physician Decision|0|||
94460843|NCT04599933|323476759|FG001|Overall Study|Physician Decision|1|||
94460844|NCT04599933|323476758|FG000|Overall Study|Screen Failure|1|||
94460845|NCT04599933|323476759|FG001|Overall Study|Screen Failure|2|||
94460846|NCT02143791|323476766|FG000|Enrolled|Withdrawal by Subject|4|||
94460847|NCT02143791|323476766|FG000|Trial Stimulation|Lack of Efficacy|21|||
94460848|NCT02143791|323476766|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
94460849|NCT02143791|323476766|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
94460850|NCT02143791|323476766|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
94460851|NCT02143791|323476766|FG000|Any Programming (3-6 Months)|Missing Data|1|||
94460852|NCT02143791|323476766|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
94460853|NCT04984278|323476773|FG000|Period 1|Withdrawal by Subject|1|||
94460854|NCT04984278|323476774|FG001|Period 1|Withdrawal by Subject|0|||
94460855|NCT04984278|323476773|FG000|Period 1|Other|0|||
94460856|NCT04984278|323476774|FG001|Period 1|Other|1|||
94460857|NCT04984278|323476773|FG000|Period 2|Adverse Event|1|||
94460858|NCT04984278|323476774|FG001|Period 2|Adverse Event|0|||
94460859|NCT04984278|323476773|FG000|Period 2|Other|0|||
94358892|NCT00518531|323097992|FG000|Treatment Period 1|Adverse Event|5|||
94358893|NCT00518531|323097993|FG001|Treatment Period 1|Adverse Event|0|||
94358894|NCT00518531|323097992|FG000|Treatment Period 1|Lost to Follow-up|5|||
94358895|NCT00518531|323097993|FG001|Treatment Period 1|Lost to Follow-up|3|||
94358896|NCT00518531|323097992|FG000|Treatment Period 1|Physician Decision|1|||
94358897|NCT00518531|323097993|FG001|Treatment Period 1|Physician Decision|0|||
94358898|NCT00518531|323097992|FG000|Treatment Period 1|Protocol Violation|2|||
94358899|NCT00518531|323097993|FG001|Treatment Period 1|Protocol Violation|0|||
94358900|NCT00518531|323097992|FG000|Treatment Period 1|Withdrawal by Subject|4|||
94358901|NCT00518531|323097993|FG001|Treatment Period 1|Withdrawal by Subject|6|||
94358902|NCT00518531|323097992|FG000|Treatment Period 1|Early crossover|1|||
94358903|NCT00518531|323097993|FG001|Treatment Period 1|Early crossover|3|||
94358904|NCT00518531|323097992|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94358905|NCT00518531|323097993|FG001|Treatment Period 2|Withdrawal by Subject|8|||
94358906|NCT00518531|323097992|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
94358907|NCT00518531|323097993|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
94358908|NCT00518531|323097992|FG000|Treatment Period 2|Adverse Event|1|||
94358909|NCT00518531|323097993|FG001|Treatment Period 2|Adverse Event|7|||
94358910|NCT00518531|323097992|FG000|Treatment Period 2|Protocol-specified criteria|0|||
94358911|NCT00518531|323097993|FG001|Treatment Period 2|Protocol-specified criteria|1|||
94358912|NCT00518531|323097992|FG000|Treatment Period 2|Non-compliance|1|||
94358913|NCT00518531|323097993|FG001|Treatment Period 2|Non-compliance|2|||
94358914|NCT04621227|323097994|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
94358915|NCT04621227|323097994|FG000|Period 3 (29 Days)|Adverse Event|1|||
94358916|NCT04621227|323097994|FG000|Period 8 (2 Days)|Adverse Event|1|||
94358917|NCT01366846|323097995|FG000|Overall Study|Withdrawal by Subject|2|||
94460860|NCT04984278|323476774|FG001|Period 2|Other|1|||
94460861|NCT05845567|323476775|FG000|Overall Study|Withdrawal by Subject|1|||
94460862|NCT03535740|323476776|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
94460863|NCT03535740|323476776|FG000|Overall Study|Death|34|||
94460864|NCT03535740|323476776|FG000|Overall Study|Lost to Follow-up|1|||
94460865|NCT03535740|323476776|FG000|Overall Study|Withdrawal by Subject|13|||
94615598|NCT01303861|324055242|FG002|Overall Study|Lost to Follow-up|27|||
94615599|NCT01303861|324055243|FG003|Overall Study|Lost to Follow-up|31|||
94615600|NCT01303861|324055240|FG000|Overall Study|Lack of Efficacy|3|||
94615601|NCT01303861|324055241|FG001|Overall Study|Lack of Efficacy|2|||
94615602|NCT01303861|324055242|FG002|Overall Study|Lack of Efficacy|1|||
94615603|NCT01303861|324055243|FG003|Overall Study|Lack of Efficacy|0|||
94615604|NCT01303861|324055240|FG000|Overall Study|Withdrawal by Subject|16|||
94615605|NCT01303861|324055241|FG001|Overall Study|Withdrawal by Subject|8|||
94615606|NCT01303861|324055242|FG002|Overall Study|Withdrawal by Subject|8|||
94615607|NCT01303861|324055243|FG003|Overall Study|Withdrawal by Subject|23|||
94615608|NCT01303861|324055240|FG000|Overall Study|Adverse Event|4|||
94615609|NCT01303861|324055241|FG001|Overall Study|Adverse Event|1|||
94615610|NCT01303861|324055242|FG002|Overall Study|Adverse Event|0|||
94615611|NCT01303861|324055243|FG003|Overall Study|Adverse Event|5|||
94615612|NCT01303861|324055240|FG000|Overall Study|Pregnancy|1|||
94615613|NCT01303861|324055241|FG001|Overall Study|Pregnancy|0|||
94615614|NCT01303861|324055242|FG002|Overall Study|Pregnancy|0|||
94615615|NCT01303861|324055243|FG003|Overall Study|Pregnancy|0|||
94615616|NCT00573937|324055244|FG000|Overall Study|Study Terminated|0|||
94615617|NCT00573937|324055245|FG001|Overall Study|Study Terminated|1|||
94615618|NCT02476201|324055246|FG000|Overall Study|Unable to program MPP|9|||
94615619|NCT02476201|324055246|FG000|Overall Study|Study echo not performed|5|||
94615620|NCT02476201|324055246|FG000|Overall Study|Adverse Event|4|||
94615621|NCT02476201|324055246|FG000|Overall Study|Death|2|||
94615622|NCT02476201|324055246|FG000|Overall Study|Lost to Follow-up|2|||
94615623|NCT02476201|324055246|FG000|Overall Study|MPP programmed to OFF|2|||
94615624|NCT02476201|324055246|FG000|Overall Study|Withdrawal by Subject|1|||
94615625|NCT02476201|324055246|FG000|Overall Study|Unsuccessful implant|1|||
94615626|NCT03650556|324055247|FG000|Overall Study|Death|2|||
94615627|NCT03650556|324055247|FG000|Overall Study|Withdrawal by Subject|20|||
94615628|NCT03650556|324055247|FG000|Overall Study|Physician Decision|2|||
94615629|NCT03650556|324055247|FG000|Overall Study|Lost to Follow-up|8|||
94615630|NCT03650556|324055247|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
94615631|NCT03650556|324055247|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
94615632|NCT00691301|324055250|FG000|Overall Study|Adverse Event|10|||
94615633|NCT00691301|324055250|FG000|Overall Study|Death|2|||
94615634|NCT00691301|324055250|FG000|Overall Study|Lack of Efficacy|32|||
94615635|NCT00691301|324055250|FG000|Overall Study|Withdrawal by Subject|4|||
94615636|NCT00691301|324055250|FG000|Overall Study|Concurrent illness|2|||
94615637|NCT00691301|324055250|FG000|Overall Study|other reason|3|||
94615638|NCT00691301|324055250|FG000|Overall Study|Did not initiate study treatment|1|||
94615639|NCT04638660|324055252|FG000|Overall Study|Withdrawal by Subject|2|||
94615640|NCT04638660|324055253|FG001|Overall Study|Withdrawal by Subject|0|||
94615641|NCT04638660|324055252|FG000|Overall Study|Lost to Follow-up|1|||
94615642|NCT04638660|324055253|FG001|Overall Study|Lost to Follow-up|0|||
94615643|NCT03917459|324055254|FG000|Overall Study|Adverse Event|1|||
94615644|NCT03917459|324055255|FG001|Overall Study|Adverse Event|0|||
94615645|NCT03917459|324055254|FG000|Overall Study|Withdrawal by Subject|0|||
94615646|NCT03917459|324055255|FG001|Overall Study|Withdrawal by Subject|1|||
94615647|NCT00736944|324055256|FG000|Induction|Death|1|||
94615648|NCT00736944|324055256|FG000|Definitive Treatment|Physician Decision|1|||
94615649|NCT05350410|324055257|FG000|Overall Study|Withdrawal by Subject|1|||
94615650|NCT01189604|324055260|FG000|Overall Study|Impossible to visit|0|||
94615651|NCT01189604|324055261|FG001|Overall Study|Impossible to visit|0|||
94615652|NCT01189604|324055262|FG002|Overall Study|Impossible to visit|0|||
94615653|NCT01189604|324055263|FG003|Overall Study|Impossible to visit|0|||
94615654|NCT01189604|324055264|FG004|Overall Study|Impossible to visit|0|||
94615655|NCT01189604|324055265|FG005|Overall Study|Impossible to visit|1|||
94615656|NCT01189604|324055266|FG006|Overall Study|Impossible to visit|0|||
94615657|NCT01189604|324055260|FG000|Overall Study|Adverse Event|0|||
94615658|NCT01189604|324055261|FG001|Overall Study|Adverse Event|1|||
94615659|NCT01189604|324055262|FG002|Overall Study|Adverse Event|0|||
94615660|NCT01189604|324055263|FG003|Overall Study|Adverse Event|0|||
94615661|NCT01189604|324055264|FG004|Overall Study|Adverse Event|2|||
94615662|NCT01189604|324055265|FG005|Overall Study|Adverse Event|0|||
94615663|NCT01189604|324055266|FG006|Overall Study|Adverse Event|1|||
94615664|NCT01189604|324055260|FG000|Overall Study|Withdrawal by Subject|1|||
94615665|NCT01189604|324055261|FG001|Overall Study|Withdrawal by Subject|0|||
94615666|NCT01189604|324055262|FG002|Overall Study|Withdrawal by Subject|0|||
94615667|NCT01189604|324055263|FG003|Overall Study|Withdrawal by Subject|0|||
94615668|NCT01189604|324055264|FG004|Overall Study|Withdrawal by Subject|0|||
94615669|NCT01189604|324055265|FG005|Overall Study|Withdrawal by Subject|0|||
94615670|NCT01189604|324055266|FG006|Overall Study|Withdrawal by Subject|0|||
94615671|NCT01146912|324055267|FG000|Overall Study|Already received influenza vaccination|817|||
94460866|NCT03419598|323476780|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
94460867|NCT00380081|323476781|FG000|Overall Study|Withdrawal by Subject|0|||
94460868|NCT00380081|323476782|FG001|Overall Study|Withdrawal by Subject|0|||
94460869|NCT00380081|323476783|FG002|Overall Study|Withdrawal by Subject|0|||
94460870|NCT00380081|323476784|FG003|Overall Study|Withdrawal by Subject|0|||
94460871|NCT00380081|323476785|FG004|Overall Study|Withdrawal by Subject|1|||
94460872|NCT00380081|323476786|FG005|Overall Study|Withdrawal by Subject|0|||
94460873|NCT00380081|323476781|FG000|Overall Study|Family Emergency|0|||
94460874|NCT00380081|323476782|FG001|Overall Study|Family Emergency|0|||
94460875|NCT00380081|323476783|FG002|Overall Study|Family Emergency|0|||
94460876|NCT00380081|323476784|FG003|Overall Study|Family Emergency|0|||
94460877|NCT00380081|323476785|FG004|Overall Study|Family Emergency|0|||
94460878|NCT00380081|323476786|FG005|Overall Study|Family Emergency|1|||
94460879|NCT01546168|323476789|FG000|Overall Study|Lost to Follow-up|1|||
94460880|NCT01546168|323476790|FG001|Overall Study|Lost to Follow-up|0|||
94460881|NCT01546168|323476789|FG000|Overall Study|Withdrawal by Subject|1|||
94460882|NCT01546168|323476790|FG001|Overall Study|Withdrawal by Subject|0|||
94460883|NCT01546168|323476789|FG000|Overall Study|ineligible after signing consent|2|||
94460884|NCT01546168|323476790|FG001|Overall Study|ineligible after signing consent|0|||
94460885|NCT00558896|323476791|FG000|Overall Study|Adverse Event|1|||
94460886|NCT00558896|323476792|FG001|Overall Study|Adverse Event|1|||
94460887|NCT00558896|323476793|FG002|Overall Study|Adverse Event|1|||
94460888|NCT00558896|323476794|FG003|Overall Study|Adverse Event|3|||
94460889|NCT00558896|323476795|FG004|Overall Study|Adverse Event|4|||
94460890|NCT00558896|323476796|FG005|Overall Study|Adverse Event|10|||
94460891|NCT00558896|323476797|FG006|Overall Study|Adverse Event|3|||
94460892|NCT00558896|323476791|FG000|Overall Study|Death|3|||
94460893|NCT00558896|323476792|FG001|Overall Study|Death|0|||
94460894|NCT00558896|323476793|FG002|Overall Study|Death|2|||
94460895|NCT00558896|323476794|FG003|Overall Study|Death|3|||
94460896|NCT00558896|323476795|FG004|Overall Study|Death|2|||
94460897|NCT00558896|323476796|FG005|Overall Study|Death|2|||
94460898|NCT00558896|323476797|FG006|Overall Study|Death|6|||
94460899|NCT00558896|323476791|FG000|Overall Study|Withdrawal by Subject|2|||
94460900|NCT00558896|323476792|FG001|Overall Study|Withdrawal by Subject|1|||
94460901|NCT00558896|323476793|FG002|Overall Study|Withdrawal by Subject|1|||
94460902|NCT00558896|323476794|FG003|Overall Study|Withdrawal by Subject|1|||
94460903|NCT00558896|323476795|FG004|Overall Study|Withdrawal by Subject|1|||
94460904|NCT00558896|323476796|FG005|Overall Study|Withdrawal by Subject|5|||
94460905|NCT00558896|323476797|FG006|Overall Study|Withdrawal by Subject|5|||
94460906|NCT00558896|323476791|FG000|Overall Study|Alternative Treatment|2|||
94460907|NCT00558896|323476792|FG001|Overall Study|Alternative Treatment|2|||
94460908|NCT00558896|323476793|FG002|Overall Study|Alternative Treatment|0|||
94665007|NCT01490632|324229741|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
94460909|NCT00558896|323476794|FG003|Overall Study|Alternative Treatment|2|||
94665008|NCT01490632|324229742|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94665009|NCT01490632|324229743|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94665010|NCT01490632|324229744|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94665011|NCT01490632|324229745|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94665012|NCT01490632|324229746|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94665013|NCT01490632|324229747|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
94665014|NCT01490632|324229728|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
94665015|NCT01490632|324229729|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
94460910|NCT00558896|323476795|FG004|Overall Study|Alternative Treatment|6|||
94460911|NCT00558896|323476796|FG005|Overall Study|Alternative Treatment|7|||
94460912|NCT00558896|323476797|FG006|Overall Study|Alternative Treatment|1|||
94460913|NCT00558896|323476791|FG000|Overall Study|Physician discretion|3|||
94460914|NCT00558896|323476792|FG001|Overall Study|Physician discretion|2|||
94460915|NCT00558896|323476793|FG002|Overall Study|Physician discretion|1|||
94460916|NCT00558896|323476794|FG003|Overall Study|Physician discretion|2|||
94460917|NCT00558896|323476795|FG004|Overall Study|Physician discretion|1|||
94460918|NCT00558896|323476796|FG005|Overall Study|Physician discretion|3|||
94460919|NCT00558896|323476797|FG006|Overall Study|Physician discretion|3|||
94665016|NCT01490632|324229730|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
94460920|NCT00558896|323476791|FG000|Overall Study|Continues on treatment|10|||
94460921|NCT00558896|323476792|FG001|Overall Study|Continues on treatment|1|||
94460922|NCT00558896|323476793|FG002|Overall Study|Continues on treatment|0|||
94460923|NCT00558896|323476794|FG003|Overall Study|Continues on treatment|1|||
94460924|NCT00558896|323476795|FG004|Overall Study|Continues on treatment|9|||
94460925|NCT00558896|323476796|FG005|Overall Study|Continues on treatment|25|||
94665017|NCT01490632|324229731|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
94460926|NCT00558896|323476797|FG006|Overall Study|Continues on treatment|6|||
94460927|NCT03054064|323476800|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
94460928|NCT03054064|323476800|FG000|Overall Study|Investigator Decision|2|||
94460929|NCT03054064|323476800|FG000|Overall Study|Bladder Issue|1|||
94460930|NCT03054064|323476800|FG000|Overall Study|High Blood Pressure|1|||
94460931|NCT03054064|323476800|FG000|Overall Study|Change in Status|1|||
94460932|NCT06137703|323476801|FG000|Overall Study|Other|0|||
94460933|NCT06137703|323476802|FG001|Overall Study|Other|1|||
94460934|NCT06137703|323476803|FG002|Overall Study|Other|0|||
94460935|NCT06137703|323476804|FG003|Overall Study|Other|0|||
94460936|NCT06137703|323476801|FG000|Overall Study|Adverse Event|0|||
94460937|NCT06137703|323476802|FG001|Overall Study|Adverse Event|0|||
94460938|NCT06137703|323476803|FG002|Overall Study|Adverse Event|1|||
94460939|NCT06137703|323476804|FG003|Overall Study|Adverse Event|0|||
94460940|NCT03787303|323476805|FG000|Overall Study|Death|1|||
94460941|NCT03787303|323476805|FG000|Overall Study|Premature Termination of Study|1|||
94460942|NCT01801280|323476810|FG000|Period 1|Withdrawal by Subject|0|||
94460943|NCT01801280|323476811|FG001|Period 1|Withdrawal by Subject|1|||
94460944|NCT01801280|323476812|FG002|Period 1|Withdrawal by Subject|0|||
94460945|NCT01801280|323476813|FG003|Period 1|Withdrawal by Subject|0|||
94460946|NCT01801280|323476810|FG000|Period 2|Withdrawal by Subject|1|||
94460947|NCT01801280|323476811|FG001|Period 2|Withdrawal by Subject|0|||
94460948|NCT01801280|323476812|FG002|Period 2|Withdrawal by Subject|0|||
94460949|NCT01801280|323476813|FG003|Period 2|Withdrawal by Subject|0|||
94460950|NCT01801280|323476810|FG000|Period 4|Protocol Violation|0|||
94460951|NCT01801280|323476811|FG001|Period 4|Protocol Violation|0|||
94460952|NCT01801280|323476812|FG002|Period 4|Protocol Violation|1|||
94460953|NCT01801280|323476813|FG003|Period 4|Protocol Violation|0|||
94460954|NCT03589326|323476814|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
94460955|NCT03589326|323476815|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
94460956|NCT03589326|323476814|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
94460957|NCT03589326|323476815|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
94460958|NCT03589326|323476814|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
94460959|NCT03589326|323476815|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
94460960|NCT03589326|323476814|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
94460961|NCT03589326|323476815|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
94460962|NCT03589326|323476814|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
94460963|NCT03589326|323476815|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
94460964|NCT00435487|323476817|FG000|Overall Study|Death|3|||
94460965|NCT00435487|323476818|FG001|Overall Study|Death|4|||
94460966|NCT00435487|323476817|FG000|Overall Study|Adverse Event|0|||
94460967|NCT00435487|323476818|FG001|Overall Study|Adverse Event|3|||
94460968|NCT00435487|323476817|FG000|Overall Study|Lost to Follow-up|2|||
94460969|NCT00435487|323476818|FG001|Overall Study|Lost to Follow-up|2|||
94460970|NCT00435487|323476817|FG000|Overall Study|Other|5|||
94460971|NCT00435487|323476818|FG001|Overall Study|Other|2|||
94460972|NCT00435487|323476817|FG000|Overall Study|Withdrawal by Subject|2|||
94460973|NCT00435487|323476818|FG001|Overall Study|Withdrawal by Subject|1|||
94460974|NCT00435487|323476817|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
94460975|NCT00435487|323476818|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
94460976|NCT00435487|323476817|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
94665018|NCT01490632|324229732|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
94665019|NCT01490632|324229733|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
94665020|NCT01490632|324229734|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
94665021|NCT01490632|324229735|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
94665022|NCT01490632|324229736|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
94665023|NCT01490632|324229737|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
94665024|NCT01490632|324229738|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
94665025|NCT01490632|324229739|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
94665026|NCT01490632|324229740|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
94460977|NCT00435487|323476818|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
94460978|NCT01866657|323476821|FG000|Overall Study|Surgery canceled|2|||
94460979|NCT01866657|323476822|FG001|Overall Study|Surgery canceled|0|||
94665027|NCT01490632|324229741|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
94665028|NCT01490632|324229742|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
94665029|NCT01490632|324229743|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
94688674|NCT00630058|324315571|FG001|Overall Study|Adverse Event|1|||
94460980|NCT03301844|323476823|FG000|Overall Study|suspected colon cancer|1|||
94460981|NCT03301844|323476824|FG001|Overall Study|suspected colon cancer|1|||
94460982|NCT04021121|323476825|FG000|Overall Study|Death|3|||
94460983|NCT04021121|323476826|FG001|Overall Study|Death|3|||
94460984|NCT04021121|323476827|FG002|Overall Study|Death|5|||
94460985|NCT04021121|323476828|FG003|Overall Study|Death|4|||
94460986|NCT02029989|323476832|FG000|Overall Study|Withdrawal by Subject|1|||
94460987|NCT02029989|323476833|FG001|Overall Study|Withdrawal by Subject|0|||
94460988|NCT02029989|323476832|FG000|Overall Study|Withdrawal: Fear of needles|1|||
94460989|NCT02029989|323476833|FG001|Overall Study|Withdrawal: Fear of needles|0|||
94460990|NCT02029989|323476832|FG000|Overall Study|Change of location|2|||
94460991|NCT02029989|323476833|FG001|Overall Study|Change of location|3|||
94460992|NCT02029989|323476832|FG000|Overall Study|Physician Decision|2|||
94460993|NCT02029989|323476833|FG001|Overall Study|Physician Decision|0|||
94460994|NCT02029989|323476832|FG000|Overall Study|Lost to Follow-up|9|||
94460995|NCT02029989|323476833|FG001|Overall Study|Lost to Follow-up|7|||
94460996|NCT02029989|323476832|FG000|Overall Study|Death|0|||
94460997|NCT02029989|323476833|FG001|Overall Study|Death|1|||
94460998|NCT02029989|323476832|FG000|Overall Study|Protocol Violation|1|||
94460999|NCT02029989|323476833|FG001|Overall Study|Protocol Violation|0|||
94461000|NCT04351373|323476834|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
94461001|NCT04601103|323476837|FG000|Overall Study|Needed crown & cleaning|0|||
94461002|NCT04601103|323476838|FG001|Overall Study|Needed crown & cleaning|0|||
94461003|NCT04601103|323476839|FG002|Overall Study|Needed crown & cleaning|1|||
94461004|NCT04601103|323476837|FG000|Overall Study|study was terminated|18|||
94461005|NCT04601103|323476838|FG001|Overall Study|study was terminated|18|||
94461006|NCT04601103|323476839|FG002|Overall Study|study was terminated|16|||
94461007|NCT00520481|323476845|FG000|Overall Study|Adverse Event|4|||
94461008|NCT00520481|323476846|FG001|Overall Study|Adverse Event|1|||
94461009|NCT00520481|323476845|FG000|Overall Study|Withdrawal by Subject|3|||
94461010|NCT00520481|323476846|FG001|Overall Study|Withdrawal by Subject|0|||
94461011|NCT00471718|323476847|FG000|Overall Study|Adverse Event|3|||
94461012|NCT00471718|323476847|FG000|Overall Study|other complicating disease|1|||
94461013|NCT00471718|323476847|FG000|Overall Study|disease progression|22|||
94461014|NCT00471718|323476847|FG000|Overall Study|Withdrawal by Subject|1|||
94461015|NCT02225366|323476848|FG000|Overall Study|Lack of Efficacy|1|||
94461016|NCT02225366|323476849|FG001|Overall Study|Lack of Efficacy|0|||
94461017|NCT00948506|323476853|FG000|Overall Study|Withdrawal by Subject|3|||
94665030|NCT01490632|324229744|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
94665031|NCT01490632|324229745|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
94665032|NCT01490632|324229746|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
94665033|NCT01490632|324229747|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
94461018|NCT00948506|323476854|FG001|Overall Study|Withdrawal by Subject|1|||
94461019|NCT01744184|323476856|FG000|Overall Study|Adverse Event|1|||
94461020|NCT01744184|323476857|FG001|Overall Study|Adverse Event|0|||
94461021|NCT01744184|323476856|FG000|Overall Study|Withdrawal by Subject|0|||
94461022|NCT01744184|323476857|FG001|Overall Study|Withdrawal by Subject|1|||
94461023|NCT02419612|323476858|FG000|Short-term Treatment Period|Adverse Event|1|||
94461024|NCT02419612|323476859|FG001|Short-term Treatment Period|Adverse Event|1|||
94461025|NCT02419612|323476858|FG000|Short-term Treatment Period|Death|0|||
94461026|NCT02419612|323476859|FG001|Short-term Treatment Period|Death|2|||
94461027|NCT02419612|323476858|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
94461028|NCT02419612|323476859|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
94461029|NCT02419612|323476858|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
94665034|NCT01490632|324229728|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
94665035|NCT01490632|324229729|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
94665036|NCT01490632|324229730|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
94665037|NCT01490632|324229731|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
94665038|NCT01490632|324229732|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
94665039|NCT01490632|324229733|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
94665040|NCT01490632|324229734|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
94665041|NCT01490632|324229735|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
94665042|NCT01490632|324229736|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
94665043|NCT01490632|324229737|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
94665044|NCT01490632|324229738|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
94665045|NCT01490632|324229739|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
94665046|NCT01490632|324229740|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
94665047|NCT01490632|324229741|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
94665048|NCT01490632|324229742|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
94665049|NCT01490632|324229743|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
94461030|NCT02419612|323476859|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
94461031|NCT02419612|323476858|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
94461032|NCT02419612|323476859|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
94665050|NCT01490632|324229744|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
94461033|NCT02419612|323476858|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
94461034|NCT02419612|323476859|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
94461035|NCT02419612|323476858|FG000|Short-term Treatment Period|Worsening of liver function|0|||
94461036|NCT02419612|323476859|FG001|Short-term Treatment Period|Worsening of liver function|1|||
94665051|NCT01490632|324229745|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
94461037|NCT02419612|323476858|FG000|Short-term Treatment Period|Subject moved out of state|0|||
94461038|NCT02419612|323476859|FG001|Short-term Treatment Period|Subject moved out of state|1|||
94461039|NCT02419612|323476858|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
94461040|NCT02419612|323476859|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
94461041|NCT02419612|323476858|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
94461042|NCT02419612|323476859|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
94665052|NCT01490632|324229746|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
94665053|NCT01490632|324229747|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
94665054|NCT01490632|324229728|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
94665055|NCT01490632|324229729|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
94665056|NCT01490632|324229730|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
94665057|NCT01490632|324229731|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
94665058|NCT01490632|324229732|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
94665059|NCT01490632|324229733|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
94665060|NCT01490632|324229734|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
94665061|NCT01490632|324229735|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
94665062|NCT01490632|324229736|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
94665063|NCT01490632|324229737|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
94665064|NCT01490632|324229738|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
94665065|NCT01490632|324229739|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
94665066|NCT01490632|324229740|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
94665067|NCT01490632|324229741|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
94665068|NCT01490632|324229742|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
94665069|NCT01490632|324229743|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
94665070|NCT01490632|324229744|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
94665071|NCT01490632|324229745|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
94665072|NCT01490632|324229746|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
94665073|NCT01490632|324229747|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
94665074|NCT01490632|324229728|FG000|Part D: Re-Treatment Period|Death|0|||
94665075|NCT01490632|324229729|FG001|Part D: Re-Treatment Period|Death|0|||
94665076|NCT01490632|324229730|FG002|Part D: Re-Treatment Period|Death|0|||
94665077|NCT01490632|324229731|FG003|Part D: Re-Treatment Period|Death|0|||
94461043|NCT02419612|323476858|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
94461044|NCT02419612|323476859|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
94665078|NCT01490632|324229732|FG004|Part D: Re-Treatment Period|Death|0|||
94665079|NCT01490632|324229733|FG005|Part D: Re-Treatment Period|Death|0|||
94665080|NCT01490632|324229734|FG006|Part D: Re-Treatment Period|Death|0|||
94665081|NCT01490632|324229735|FG007|Part D: Re-Treatment Period|Death|0|||
94665082|NCT01490632|324229736|FG008|Part D: Re-Treatment Period|Death|0|||
94665083|NCT01490632|324229737|FG009|Part D: Re-Treatment Period|Death|0|||
94665084|NCT01490632|324229738|FG010|Part D: Re-Treatment Period|Death|0|||
94665085|NCT01490632|324229739|FG011|Part D: Re-Treatment Period|Death|0|||
94665086|NCT01490632|324229740|FG012|Part D: Re-Treatment Period|Death|0|||
94665087|NCT01490632|324229741|FG013|Part D: Re-Treatment Period|Death|0|||
94665088|NCT01490632|324229742|FG014|Part D: Re-Treatment Period|Death|0|||
94665089|NCT01490632|324229743|FG015|Part D: Re-Treatment Period|Death|0|||
94665090|NCT01490632|324229744|FG016|Part D: Re-Treatment Period|Death|0|||
94665091|NCT01490632|324229745|FG017|Part D: Re-Treatment Period|Death|0|||
94665092|NCT01490632|324229746|FG018|Part D: Re-Treatment Period|Death|1|||
94665093|NCT01490632|324229747|FG019|Part D: Re-Treatment Period|Death|0|||
94665094|NCT01490632|324229728|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
94665095|NCT01490632|324229729|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
94665096|NCT01490632|324229730|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
94665097|NCT01490632|324229731|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
94665098|NCT01490632|324229732|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
94665099|NCT01490632|324229733|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
94665100|NCT01490632|324229734|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
94665101|NCT01490632|324229735|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
94615672|NCT01146912|324055268|FG001|Overall Study|Already received influenza vaccination|822|||
94615673|NCT01146912|324055269|FG002|Overall Study|Already received influenza vaccination|13|||
94615674|NCT01146912|324055270|FG003|Overall Study|Already received influenza vaccination|15|||
94615675|NCT01146912|324055271|FG004|Overall Study|Already received influenza vaccination|41|||
94615676|NCT01146912|324055272|FG005|Overall Study|Already received influenza vaccination|61|||
94615677|NCT01146912|324055273|FG006|Overall Study|Already received influenza vaccination|56|||
94615678|NCT01146912|324055274|FG007|Overall Study|Already received influenza vaccination|0|||
94615679|NCT01146912|324055267|FG000|Overall Study|< 14 weeks gestational age|0|||
94615680|NCT01146912|324055268|FG001|Overall Study|< 14 weeks gestational age|0|||
94615681|NCT01146912|324055269|FG002|Overall Study|< 14 weeks gestational age|3|||
94615682|NCT01146912|324055270|FG003|Overall Study|< 14 weeks gestational age|2|||
94615683|NCT01146912|324055271|FG004|Overall Study|< 14 weeks gestational age|0|||
94615684|NCT01146912|324055272|FG005|Overall Study|< 14 weeks gestational age|0|||
94615685|NCT01146912|324055273|FG006|Overall Study|< 14 weeks gestational age|0|||
94615686|NCT01146912|324055274|FG007|Overall Study|< 14 weeks gestational age|0|||
94615687|NCT01146912|324055267|FG000|Overall Study|Duplicate patient|0|||
94615688|NCT01146912|324055268|FG001|Overall Study|Duplicate patient|0|||
94615689|NCT01146912|324055269|FG002|Overall Study|Duplicate patient|1|||
94615690|NCT01146912|324055270|FG003|Overall Study|Duplicate patient|0|||
94615691|NCT01146912|324055271|FG004|Overall Study|Duplicate patient|0|||
94615692|NCT01146912|324055272|FG005|Overall Study|Duplicate patient|0|||
94615693|NCT01146912|324055273|FG006|Overall Study|Duplicate patient|0|||
94615694|NCT01146912|324055274|FG007|Overall Study|Duplicate patient|0|||
94615695|NCT02609828|324055275|FG000|Overall Study|Adverse Event|8|||
94615696|NCT02609828|324055276|FG001|Overall Study|Adverse Event|1|||
94615697|NCT02609828|324055277|FG002|Overall Study|Adverse Event|0|||
94615698|NCT02609828|324055278|FG003|Overall Study|Adverse Event|6|||
94615699|NCT02609828|324055275|FG000|Overall Study|Death|15|||
94615700|NCT02609828|324055276|FG001|Overall Study|Death|1|||
94615701|NCT02609828|324055277|FG002|Overall Study|Death|1|||
94615702|NCT02609828|324055278|FG003|Overall Study|Death|19|||
94615703|NCT02609828|324055275|FG000|Overall Study|Insufficient clinical response|2|||
94615704|NCT02609828|324055276|FG001|Overall Study|Insufficient clinical response|1|||
94615705|NCT02609828|324055277|FG002|Overall Study|Insufficient clinical response|0|||
94615706|NCT02609828|324055278|FG003|Overall Study|Insufficient clinical response|0|||
94615707|NCT02609828|324055275|FG000|Overall Study|Lost to Follow-up|0|||
94615708|NCT02609828|324055276|FG001|Overall Study|Lost to Follow-up|0|||
94615709|NCT02609828|324055277|FG002|Overall Study|Lost to Follow-up|0|||
94615710|NCT02609828|324055278|FG003|Overall Study|Lost to Follow-up|1|||
94615711|NCT02609828|324055275|FG000|Overall Study|Protocol Violation|2|||
94615712|NCT02609828|324055276|FG001|Overall Study|Protocol Violation|0|||
94615713|NCT02609828|324055277|FG002|Overall Study|Protocol Violation|0|||
94615714|NCT02609828|324055278|FG003|Overall Study|Protocol Violation|1|||
94615715|NCT02609828|324055275|FG000|Overall Study|Withdrawal by Subject|12|||
94615716|NCT02609828|324055276|FG001|Overall Study|Withdrawal by Subject|1|||
94615717|NCT02609828|324055277|FG002|Overall Study|Withdrawal by Subject|0|||
94615718|NCT02609828|324055278|FG003|Overall Study|Withdrawal by Subject|10|||
94615719|NCT02609828|324055275|FG000|Overall Study|Other|3|||
94615720|NCT02609828|324055276|FG001|Overall Study|Other|0|||
94615721|NCT02609828|324055277|FG002|Overall Study|Other|0|||
94615722|NCT02609828|324055278|FG003|Overall Study|Other|6|||
94615723|NCT02609828|324055275|FG000|Overall Study|Randomized but not treated|1|||
94615724|NCT02609828|324055276|FG001|Overall Study|Randomized but not treated|0|||
94615725|NCT02609828|324055277|FG002|Overall Study|Randomized but not treated|0|||
94665102|NCT01490632|324229736|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
94665103|NCT01490632|324229737|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
94615726|NCT02609828|324055278|FG003|Overall Study|Randomized but not treated|0|||
94615727|NCT01145625|324055279|FG000|Overall Study|Lost to Follow-up|8|||
94615728|NCT01145625|324055280|FG001|Overall Study|Lost to Follow-up|9|||
94615729|NCT01145625|324055279|FG000|Overall Study|Adverse Event|6|||
94665104|NCT01490632|324229738|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
94665105|NCT01490632|324229739|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
94665106|NCT01490632|324229740|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
94665107|NCT01490632|324229741|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
94665108|NCT01490632|324229742|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
94615730|NCT01145625|324055280|FG001|Overall Study|Adverse Event|4|||
94615731|NCT01145625|324055279|FG000|Overall Study|Protocol Violation|3|||
94615732|NCT01145625|324055280|FG001|Overall Study|Protocol Violation|1|||
94615733|NCT01145625|324055279|FG000|Overall Study|Withdrawal by Subject|7|||
94615734|NCT01145625|324055280|FG001|Overall Study|Withdrawal by Subject|16|||
94615735|NCT01145625|324055279|FG000|Overall Study|Pregnancy|0|||
94615736|NCT01145625|324055280|FG001|Overall Study|Pregnancy|1|||
94615737|NCT00845858|324055281|FG000|Overall Study|Withdrawal by Subject|5|||
94615738|NCT00845858|324055282|FG001|Overall Study|Withdrawal by Subject|1|||
94615739|NCT00845858|324055283|FG002|Overall Study|Withdrawal by Subject|1|||
94615740|NCT00845858|324055281|FG000|Overall Study|Adverse Event|3|||
94615741|NCT00845858|324055282|FG001|Overall Study|Adverse Event|8|||
94461045|NCT02419612|323476858|FG000|Long-term Treatment Period|Death|0|||
94461046|NCT02419612|323476859|FG001|Long-term Treatment Period|Death|1|||
94461047|NCT02419612|323476858|FG000|Long-term Treatment Period|Adverse Event|0|||
94615742|NCT00845858|324055283|FG002|Overall Study|Adverse Event|4|||
94615743|NCT00845858|324055281|FG000|Overall Study|Protocol Violation|0|||
94615744|NCT00845858|324055282|FG001|Overall Study|Protocol Violation|0|||
94615745|NCT00845858|324055283|FG002|Overall Study|Protocol Violation|1|||
94615746|NCT00845858|324055281|FG000|Overall Study|not eligible|0|||
94615747|NCT00845858|324055282|FG001|Overall Study|not eligible|3|||
94615748|NCT00845858|324055283|FG002|Overall Study|not eligible|2|||
94615749|NCT03945214|324055284|FG000|Overall Study|Lost to Follow-up|3|||
94615750|NCT03945214|324055285|FG001|Overall Study|Lost to Follow-up|4|||
94615751|NCT03945214|324055286|FG002|Overall Study|Lost to Follow-up|7|||
94615752|NCT03945214|324055287|FG003|Overall Study|Lost to Follow-up|4|||
94615753|NCT00216476|324055288|FG000|Overall Study|Withdrawal by Subject|59|||
94615754|NCT00216476|324055289|FG001|Overall Study|Withdrawal by Subject|72|||
94615755|NCT00216476|324055290|FG002|Overall Study|Withdrawal by Subject|9|||
94461048|NCT02419612|323476859|FG001|Long-term Treatment Period|Adverse Event|5|||
94615756|NCT00216476|324055288|FG000|Overall Study|Lost to Follow-up|10|||
94615757|NCT00216476|324055289|FG001|Overall Study|Lost to Follow-up|9|||
94615758|NCT00216476|324055290|FG002|Overall Study|Lost to Follow-up|1|||
94615759|NCT00216476|324055288|FG000|Overall Study|Adverse Event|6|||
94615760|NCT00216476|324055289|FG001|Overall Study|Adverse Event|10|||
94615761|NCT00216476|324055290|FG002|Overall Study|Adverse Event|1|||
94615762|NCT00216476|324055288|FG000|Overall Study|Lack of Efficacy|4|||
94615763|NCT00216476|324055289|FG001|Overall Study|Lack of Efficacy|3|||
94615764|NCT00216476|324055290|FG002|Overall Study|Lack of Efficacy|0|||
94615765|NCT00216476|324055288|FG000|Overall Study|Death|2|||
94615766|NCT00216476|324055289|FG001|Overall Study|Death|0|||
94615767|NCT00216476|324055290|FG002|Overall Study|Death|0|||
94615768|NCT00216476|324055288|FG000|Overall Study|Pregnancy|0|||
94615769|NCT00216476|324055289|FG001|Overall Study|Pregnancy|1|||
94615770|NCT00216476|324055290|FG002|Overall Study|Pregnancy|1|||
94615771|NCT00216476|324055288|FG000|Overall Study|Other|0|||
94615772|NCT00216476|324055289|FG001|Overall Study|Other|0|||
94615773|NCT00216476|324055290|FG002|Overall Study|Other|1|||
94615774|NCT00216476|324055288|FG000|Overall Study|Refuses Injection|11|||
94615775|NCT00216476|324055289|FG001|Overall Study|Refuses Injection|0|||
94615776|NCT00216476|324055290|FG002|Overall Study|Refuses Injection|0|||
94665109|NCT01490632|324229743|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
94461049|NCT02419612|323476858|FG000|Long-term Treatment Period|Other|4|||
94615777|NCT00216476|324055288|FG000|Overall Study|No Further Need for Treatment|3|||
94615778|NCT00216476|324055289|FG001|Overall Study|No Further Need for Treatment|4|||
94615779|NCT00216476|324055290|FG002|Overall Study|No Further Need for Treatment|1|||
94615780|NCT00216476|324055288|FG000|Overall Study|Non-compliance|0|||
94615781|NCT00216476|324055289|FG001|Overall Study|Non-compliance|4|||
94615782|NCT00216476|324055290|FG002|Overall Study|Non-compliance|1|||
94615783|NCT00216476|324055288|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
94615784|NCT00216476|324055289|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
94615785|NCT00216476|324055290|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
94615786|NCT00216476|324055288|FG000|Overall Study|Administrative Reasons|1|||
94615787|NCT00216476|324055289|FG001|Overall Study|Administrative Reasons|1|||
94615788|NCT00216476|324055290|FG002|Overall Study|Administrative Reasons|0|||
94665110|NCT01490632|324229744|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
94461050|NCT02419612|323476859|FG001|Long-term Treatment Period|Other|4|||
94615789|NCT00216476|324055288|FG000|Overall Study|Protocol Deviation|5|||
94615790|NCT00216476|324055289|FG001|Overall Study|Protocol Deviation|1|||
94615791|NCT00216476|324055290|FG002|Overall Study|Protocol Deviation|0|||
94615792|NCT00216476|324055288|FG000|Overall Study|Patient Moved|2|||
94615793|NCT00216476|324055289|FG001|Overall Study|Patient Moved|2|||
94615794|NCT00216476|324055290|FG002|Overall Study|Patient Moved|0|||
94615795|NCT01952145|324055293|FG000|Overall Study|Protocol Violation|2|||
94615796|NCT01952145|324055294|FG001|Overall Study|Protocol Violation|1|||
94615797|NCT01952145|324055293|FG000|Overall Study|Death|0|||
94615798|NCT01952145|324055294|FG001|Overall Study|Death|1|||
94615799|NCT01952145|324055293|FG000|Overall Study|Adverse Event|9|||
94615800|NCT01952145|324055294|FG001|Overall Study|Adverse Event|0|||
94615801|NCT01952145|324055293|FG000|Overall Study|Withdrawal Criteria|16|||
94615802|NCT01952145|324055294|FG001|Overall Study|Withdrawal Criteria|11|||
94615803|NCT01952145|324055293|FG000|Overall Study|Unclassified|1|||
94615804|NCT01952145|324055294|FG001|Overall Study|Unclassified|1|||
94615805|NCT03719586|324055295|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
94615806|NCT03719586|324055296|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
94615807|NCT03719586|324055297|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
94615808|NCT03719586|324055298|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
94615809|NCT00696800|324055299|FG000|Overall Study|Adverse Event|16|||
94615810|NCT00696800|324055300|FG001|Overall Study|Adverse Event|3|||
94615811|NCT00696800|324055299|FG000|Overall Study|Insufficient compliance with medication|2|||
94615812|NCT00696800|324055300|FG001|Overall Study|Insufficient compliance with medication|1|||
94615813|NCT00696800|324055299|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
94615814|NCT00696800|324055300|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
94615815|NCT00696800|324055299|FG000|Overall Study|Insufficient ovarian response|4|||
94615816|NCT00696800|324055300|FG001|Overall Study|Insufficient ovarian response|1|||
94615817|NCT00696800|324055299|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
94615818|NCT00696800|324055300|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
94615819|NCT00696800|324055299|FG000|Overall Study|Too high ovarian response|6|||
94615820|NCT00696800|324055300|FG001|Overall Study|Too high ovarian response|1|||
94615821|NCT00696800|324055299|FG000|Overall Study|No/too few/bad quality oocytes|4|||
94615822|NCT00696800|324055300|FG001|Overall Study|No/too few/bad quality oocytes|3|||
94615823|NCT00696800|324055299|FG000|Overall Study|No/abnormal fertilization|11|||
94615824|NCT00696800|324055300|FG001|Overall Study|No/abnormal fertilization|13|||
94615825|NCT00696800|324055299|FG000|Overall Study|No/too few/bad quality embryos|24|||
94615826|NCT00696800|324055300|FG001|Overall Study|No/too few/bad quality embryos|18|||
94615827|NCT00696800|324055299|FG000|Overall Study|Other Reasons|5|||
94615828|NCT00696800|324055300|FG001|Overall Study|Other Reasons|3|||
94615829|NCT00696800|324055299|FG000|Overall Study|Not treated|1|||
94615830|NCT00696800|324055300|FG001|Overall Study|Not treated|2|||
94615831|NCT00538291|324055301|FG000|Overall Study|Adverse Event|2|||
94615832|NCT00538291|324055301|FG000|Overall Study|Withdrawal by Subject|1|||
94615833|NCT01696695|324055302|FG000|Overall Study|Disease progression|373|||
94615834|NCT01696695|324055302|FG000|Overall Study|Death|29|||
94615835|NCT01696695|324055302|FG000|Overall Study|Adverse Event|74|||
94615836|NCT01696695|324055302|FG000|Overall Study|Withdrawal by Subject|92|||
94615837|NCT01696695|324055302|FG000|Overall Study|Lost to Follow-up|48|||
94615838|NCT01696695|324055302|FG000|Overall Study|Other|74|||
94615839|NCT01696695|324055302|FG000|Overall Study|Major Protocol Violation|192|||
94615840|NCT01904058|324055303|FG000|Overall Study|Adverse Event|2|||
94615841|NCT01904058|324055304|FG001|Overall Study|Adverse Event|0|||
94615842|NCT01904058|324055305|FG002|Overall Study|Adverse Event|0|||
94615843|NCT01904058|324055306|FG003|Overall Study|Adverse Event|0|||
94615844|NCT01904058|324055303|FG000|Overall Study|Withdrawal by Subject|1|||
94615845|NCT01904058|324055304|FG001|Overall Study|Withdrawal by Subject|0|||
94615846|NCT01904058|324055305|FG002|Overall Study|Withdrawal by Subject|1|||
94615847|NCT01904058|324055306|FG003|Overall Study|Withdrawal by Subject|0|||
94615848|NCT01904058|324055303|FG000|Overall Study|Pregnancy|0|||
94615849|NCT01904058|324055304|FG001|Overall Study|Pregnancy|0|||
94615850|NCT01904058|324055305|FG002|Overall Study|Pregnancy|0|||
94615851|NCT01904058|324055306|FG003|Overall Study|Pregnancy|1|||
94615852|NCT03096483|324055307|FG000|Overall Study|Withdrawal by site|1|||
94615853|NCT01622231|324055308|FG000|Overall Study|Physician Decision|1|||
94615854|NCT01622231|324055308|FG000|Overall Study|Withdrawal by Subject|1|||
94615855|NCT01058655|324055310|FG000|Overall Study|Withdrawal by Subject|1|||
94615856|NCT01058655|324055311|FG001|Overall Study|Withdrawal by Subject|0|||
94615857|NCT01058655|324055312|FG002|Overall Study|Withdrawal by Subject|3|||
94615858|NCT01058655|324055313|FG003|Overall Study|Withdrawal by Subject|4|||
94615859|NCT01058655|324055310|FG000|Overall Study|Prolonged Treatment Delay|0|||
94615860|NCT01058655|324055311|FG001|Overall Study|Prolonged Treatment Delay|0|||
94615861|NCT01058655|324055312|FG002|Overall Study|Prolonged Treatment Delay|0|||
94615862|NCT01058655|324055313|FG003|Overall Study|Prolonged Treatment Delay|2|||
94615863|NCT01058655|324055310|FG000|Overall Study|Symptomatic Deterioration|0|||
94615864|NCT01058655|324055311|FG001|Overall Study|Symptomatic Deterioration|0|||
94665111|NCT01490632|324229745|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
94665112|NCT01490632|324229746|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
94615865|NCT01058655|324055312|FG002|Overall Study|Symptomatic Deterioration|0|||
94615866|NCT01058655|324055313|FG003|Overall Study|Symptomatic Deterioration|1|||
94615867|NCT01058655|324055310|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
94615868|NCT01058655|324055311|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
94615869|NCT01058655|324055312|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
94665113|NCT01490632|324229747|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
94665114|NCT01490632|324229728|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665115|NCT01490632|324229729|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665116|NCT01490632|324229730|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665117|NCT01490632|324229731|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665118|NCT01490632|324229732|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665119|NCT01490632|324229733|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665120|NCT01490632|324229734|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665121|NCT01490632|324229735|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665122|NCT01490632|324229736|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665123|NCT01490632|324229737|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665124|NCT01490632|324229738|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665125|NCT01490632|324229739|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665126|NCT01490632|324229740|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665127|NCT01490632|324229741|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665128|NCT01490632|324229742|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665129|NCT01490632|324229743|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665130|NCT01490632|324229744|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665131|NCT01490632|324229745|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665132|NCT01490632|324229746|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
94665133|NCT01490632|324229747|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
94665134|NCT01490632|324229728|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
94665135|NCT01490632|324229729|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
94665136|NCT01490632|324229730|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
94665137|NCT01490632|324229731|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
94665138|NCT01490632|324229732|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
94665139|NCT01490632|324229733|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
94665140|NCT01490632|324229734|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
94665141|NCT01490632|324229735|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
94665142|NCT01490632|324229736|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
94665143|NCT01490632|324229737|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
94665144|NCT01490632|324229738|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
94665145|NCT01490632|324229739|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
94665146|NCT01490632|324229740|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
94665147|NCT01490632|324229741|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
94665148|NCT01490632|324229742|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
94665149|NCT01490632|324229743|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
94665150|NCT01490632|324229744|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
94665151|NCT01490632|324229745|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
94665152|NCT01490632|324229746|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
94665153|NCT01490632|324229747|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
94615870|NCT01058655|324055313|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
94615871|NCT01058655|324055310|FG000|Overall Study|Death|0|||
94615872|NCT01058655|324055311|FG001|Overall Study|Death|1|||
94615873|NCT01058655|324055312|FG002|Overall Study|Death|1|||
94615874|NCT01058655|324055313|FG003|Overall Study|Death|0|||
94615875|NCT01058655|324055310|FG000|Overall Study|Disease Progression|1|||
94615876|NCT01058655|324055311|FG001|Overall Study|Disease Progression|2|||
94615877|NCT01058655|324055312|FG002|Overall Study|Disease Progression|4|||
94615878|NCT01058655|324055313|FG003|Overall Study|Disease Progression|24|||
94615879|NCT01058655|324055310|FG000|Overall Study|Other|0|||
94615880|NCT01058655|324055311|FG001|Overall Study|Other|0|||
94615881|NCT01058655|324055312|FG002|Overall Study|Other|0|||
94615882|NCT01058655|324055313|FG003|Overall Study|Other|4|||
94615883|NCT01719783|324055316|FG000|Dose 2|Physician Decision|1|||
94615884|NCT01719783|324055317|FG001|Dose 2|Physician Decision|0|||
94615885|NCT04889222|324055320|FG000|Overall Study|Did not meet eligibility criteria|8|||
94615886|NCT04889222|324055320|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
94615887|NCT04889222|324055320|FG000|Overall Study|Did not proceed due to time constraints|5|||
94615888|NCT01180647|324055321|FG000|Overall Study|Lost to Follow-up|5|||
94615889|NCT01180647|324055322|FG001|Overall Study|Lost to Follow-up|6|||
94615890|NCT00113087|324055329|FG000|Overall Study|Death or Transplant|14|||
94615891|NCT00113087|324055330|FG001|Overall Study|Death or Transplant|16|||
94615892|NCT00113087|324055329|FG000|Overall Study|Family or MD withdrew subject|10|||
94615893|NCT00113087|324055330|FG001|Overall Study|Family or MD withdrew subject|5|||
94615894|NCT02716805|324055332|FG000|Overall Study|Progressive disease|2|||
94615895|NCT02716805|324055333|FG001|Overall Study|Progressive disease|0|||
94665154|NCT01490632|324229728|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
94665155|NCT01490632|324229729|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
94615896|NCT02716805|324055334|FG002|Overall Study|Progressive disease|0|||
94615897|NCT02716805|324055335|FG003|Overall Study|Progressive disease|0|||
94615898|NCT00788073|324055337|FG000|STX209 Then Placebo|Adverse Event|1|||
94615899|NCT00788073|324055338|FG001|STX209 Then Placebo|Adverse Event|0|||
94615900|NCT00788073|324055337|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
94665156|NCT01490632|324229730|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
94665157|NCT01490632|324229731|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
94665158|NCT01490632|324229732|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
94665159|NCT01490632|324229733|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
94665160|NCT01490632|324229734|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
94665161|NCT01490632|324229735|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
94665162|NCT01490632|324229736|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
94665163|NCT01490632|324229737|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
94665164|NCT01490632|324229738|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
94665165|NCT01490632|324229739|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
94665166|NCT01490632|324229740|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
94665167|NCT01490632|324229741|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
94665168|NCT01490632|324229742|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
94665169|NCT01490632|324229743|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
94665170|NCT01490632|324229744|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
94665171|NCT01490632|324229745|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
94665172|NCT01490632|324229746|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
94665173|NCT01490632|324229747|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
94665174|NCT01490632|324229728|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
94665175|NCT01490632|324229729|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
94665176|NCT01490632|324229730|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
94665177|NCT01490632|324229731|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
94665178|NCT01490632|324229732|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
94665179|NCT01490632|324229733|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
94665180|NCT01490632|324229734|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
94665181|NCT01490632|324229735|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
94665182|NCT01490632|324229736|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
94665183|NCT01490632|324229737|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
94665184|NCT01490632|324229738|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
94665185|NCT01490632|324229739|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
94665186|NCT01490632|324229740|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
94665187|NCT01490632|324229741|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
94665188|NCT01490632|324229742|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
94665189|NCT01490632|324229743|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
94665190|NCT01490632|324229744|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
94665191|NCT01490632|324229745|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
94665192|NCT01490632|324229746|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
94665193|NCT01490632|324229747|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
94665194|NCT05706506|324229752|FG000|Overall Study|Adverse Event|1|||
94665195|NCT05706506|324229752|FG000|Overall Study|Withdrawal by Subject|4|||
94665196|NCT05706506|324229752|FG000|Overall Study|Lost to Follow-up|2|||
94665197|NCT05706506|324229752|FG000|Overall Study|Inadvertent Enrolment|12|||
94665198|NCT05706506|324229752|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
94665199|NCT05706506|324229752|FG000|Overall Study|Participant Moved Out of State|1|||
94665200|NCT02349295|324229758|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
94665201|NCT02349295|324229759|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
94665202|NCT02349295|324229760|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
94665203|NCT02349295|324229761|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
94665204|NCT02349295|324229762|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
94665205|NCT02349295|324229763|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
94665206|NCT02349295|324229764|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
94665207|NCT02349295|324229765|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
94665208|NCT02349295|324229766|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
94665209|NCT02349295|324229767|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
94665210|NCT02349295|324229768|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
94665211|NCT02349295|324229769|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
94665212|NCT02349295|324229770|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
94665213|NCT02349295|324229771|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
94665214|NCT02349295|324229758|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
94665215|NCT02349295|324229759|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
94665216|NCT02349295|324229760|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
94665217|NCT02349295|324229761|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
94665218|NCT02349295|324229762|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
94665219|NCT02349295|324229763|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
94665220|NCT02349295|324229764|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
94665221|NCT02349295|324229765|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
94665222|NCT02349295|324229766|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
94665223|NCT02349295|324229767|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
94665224|NCT02349295|324229768|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
94615901|NCT00788073|324055338|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
94615902|NCT00788073|324055337|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
94615903|NCT00788073|324055338|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
94615904|NCT00788073|324055337|FG000|STX209 Then Placebo|unable to return due to travel|0|||
94615905|NCT00788073|324055338|FG001|STX209 Then Placebo|unable to return due to travel|1|||
94615906|NCT00788073|324055337|FG000|Placebo Then STX209|Adverse Event|2|||
94615907|NCT00788073|324055338|FG001|Placebo Then STX209|Adverse Event|0|||
94615908|NCT00788073|324055337|FG000|Placebo Then STX209|Protocol Violation|0|||
94615909|NCT00788073|324055338|FG001|Placebo Then STX209|Protocol Violation|1|||
94615910|NCT03208127|324055339|FG000|Overall Study|Death|1|||
94615911|NCT00239590|324055340|FG000|Randomized|Lost to Follow-up|0|||
94615912|NCT00239590|324055341|FG001|Randomized|Lost to Follow-up|1|||
94615913|NCT00239590|324055340|FG000|Randomized|Withdrawal by Subject|0|||
94615914|NCT00239590|324055341|FG001|Randomized|Withdrawal by Subject|1|||
94615915|NCT00239590|324055340|FG000|Completed Study Protocol|Adverse Event|1|||
94615916|NCT00239590|324055341|FG001|Completed Study Protocol|Adverse Event|1|||
94615917|NCT00239590|324055340|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
94615918|NCT00239590|324055341|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
94615919|NCT01893203|324055342|FG000|Overall Study|Withdrawal by Subject|1|||
94615920|NCT00722800|324055343|FG000|Overall Study|Withdrawal by Subject|1|||
94615921|NCT00722800|324055344|FG001|Overall Study|Withdrawal by Subject|0|||
94615922|NCT00722800|324055343|FG000|Overall Study|Physician Decision|1|||
94615923|NCT00722800|324055344|FG001|Overall Study|Physician Decision|0|||
94615924|NCT01449539|324055351|FG000|Overall Study|Withdrawal by Subject|3|||
94615925|NCT01449539|324055351|FG000|Overall Study|Toxicity not study related|1|||
94615926|NCT00806351|324055356|FG000|Overall Study|Death|5|||
94615927|NCT00806351|324055357|FG001|Overall Study|Death|4|||
94615928|NCT02206048|324056974|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
94615929|NCT01644565|324056977|FG000|Overall Study|Undisclosed Medical History|1|||
94615930|NCT01644565|324056978|FG001|Overall Study|Undisclosed Medical History|0|||
94615931|NCT01644565|324056979|FG002|Overall Study|Undisclosed Medical History|0|||
94615932|NCT01644565|324056980|FG003|Overall Study|Undisclosed Medical History|0|||
94615933|NCT01644565|324056981|FG004|Overall Study|Undisclosed Medical History|0|||
94615934|NCT01644565|324056982|FG005|Overall Study|Undisclosed Medical History|0|||
94615935|NCT01644565|324056983|FG006|Overall Study|Undisclosed Medical History|0|||
94615936|NCT01644565|324056984|FG007|Overall Study|Undisclosed Medical History|0|||
94615937|NCT01644565|324056985|FG008|Overall Study|Undisclosed Medical History|0|||
94615938|NCT01644565|324056977|FG000|Overall Study|Lost to Follow-up|0|||
94615939|NCT01644565|324056978|FG001|Overall Study|Lost to Follow-up|0|||
94615940|NCT01644565|324056979|FG002|Overall Study|Lost to Follow-up|0|||
94615941|NCT01644565|324056980|FG003|Overall Study|Lost to Follow-up|1|||
94615942|NCT01644565|324056981|FG004|Overall Study|Lost to Follow-up|0|||
94615943|NCT01644565|324056982|FG005|Overall Study|Lost to Follow-up|0|||
94615944|NCT01644565|324056983|FG006|Overall Study|Lost to Follow-up|0|||
94615945|NCT01644565|324056984|FG007|Overall Study|Lost to Follow-up|2|||
94615946|NCT01644565|324056985|FG008|Overall Study|Lost to Follow-up|0|||
94615947|NCT01644565|324056977|FG000|Overall Study|Family emergency|0|||
94615948|NCT01644565|324056978|FG001|Overall Study|Family emergency|0|||
94615949|NCT01644565|324056979|FG002|Overall Study|Family emergency|0|||
94615950|NCT01644565|324056980|FG003|Overall Study|Family emergency|0|||
94615951|NCT01644565|324056981|FG004|Overall Study|Family emergency|1|||
94615952|NCT01644565|324056982|FG005|Overall Study|Family emergency|0|||
94615953|NCT01644565|324056983|FG006|Overall Study|Family emergency|0|||
94615954|NCT01644565|324056984|FG007|Overall Study|Family emergency|0|||
94615955|NCT01644565|324056985|FG008|Overall Study|Family emergency|0|||
94615956|NCT01644565|324056977|FG000|Overall Study|Relocation|0|||
94615957|NCT01644565|324056978|FG001|Overall Study|Relocation|0|||
94615958|NCT01644565|324056979|FG002|Overall Study|Relocation|0|||
94615959|NCT01644565|324056980|FG003|Overall Study|Relocation|0|||
94615960|NCT01644565|324056981|FG004|Overall Study|Relocation|0|||
94615961|NCT01644565|324056982|FG005|Overall Study|Relocation|0|||
94615962|NCT01644565|324056983|FG006|Overall Study|Relocation|0|||
94615963|NCT01644565|324056984|FG007|Overall Study|Relocation|0|||
94615964|NCT01644565|324056985|FG008|Overall Study|Relocation|1|||
94615965|NCT00231842|324056988|FG000|Overall Study|Withdrawal by Subject|3|||
94615966|NCT00231842|324056988|FG000|Overall Study|Did not complete the last 3 cycle|8|||
94615967|NCT02899299|324056989|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
94615968|NCT02899299|324056990|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
94615969|NCT02899299|324056989|FG000|Pre-treatment|Participant withdrew consent|1|||
94615970|NCT02899299|324056990|FG001|Pre-treatment|Participant withdrew consent|11|||
94615971|NCT02899299|324056989|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
94615972|NCT02899299|324056990|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
94615973|NCT02899299|324056989|FG000|Pre-treatment|Not reported|0|||
94615974|NCT02899299|324056990|FG001|Pre-treatment|Not reported|1|||
94615975|NCT02899299|324056989|FG000|Treatment|Disease Progression|182|||
94615976|NCT02899299|324056990|FG001|Treatment|Disease Progression|43|||
94615977|NCT02899299|324056989|FG000|Treatment|Study Drug Toxicity|60|||
94615978|NCT02899299|324056990|FG001|Treatment|Study Drug Toxicity|24|||
94615979|NCT02899299|324056989|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
94615980|NCT02899299|324056990|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
94615981|NCT02899299|324056989|FG000|Treatment|Participant request to discontinue Study treatment|4|||
94615982|NCT02899299|324056990|FG001|Treatment|Participant request to discontinue Study treatment|10|||
94615983|NCT02899299|324056989|FG000|Treatment|Participant withdrew consent|6|||
94615984|NCT02899299|324056990|FG001|Treatment|Participant withdrew consent|3|||
94615985|NCT02899299|324056989|FG000|Treatment|Lost to Follow-up|0|||
94615986|NCT02899299|324056990|FG001|Treatment|Lost to Follow-up|2|||
94615987|NCT02899299|324056989|FG000|Treatment|Maximum Clinical Benefit|11|||
94615988|NCT02899299|324056990|FG001|Treatment|Maximum Clinical Benefit|2|||
94615989|NCT02899299|324056989|FG000|Treatment|Poor/Non-compliance|1|||
94615990|NCT02899299|324056990|FG001|Treatment|Poor/Non-compliance|0|||
94615991|NCT02899299|324056989|FG000|Treatment|Participant no longer meets Study criteria|4|||
94615992|NCT02899299|324056990|FG001|Treatment|Participant no longer meets Study criteria|0|||
94615993|NCT02899299|324056989|FG000|Treatment|Administrative reason by Sponsor|2|||
94615994|NCT02899299|324056990|FG001|Treatment|Administrative reason by Sponsor|0|||
94615995|NCT02899299|324056989|FG000|Treatment|Other reasons|12|||
94615996|NCT02899299|324056990|FG001|Treatment|Other reasons|2|||
94615997|NCT02899299|324056989|FG000|Treatment|Not reported|7|||
94615998|NCT02899299|324056990|FG001|Treatment|Not reported|0|||
94615999|NCT01392443|324056991|FG000|Overall Study|Disease progression|30|||
94616000|NCT01392443|324056991|FG000|Overall Study|Adverse Event|24|||
94616001|NCT01392443|324056991|FG000|Overall Study|Death|7|||
94616002|NCT01392443|324056991|FG000|Overall Study|Withdrawal by Subject|5|||
94616003|NCT01392443|324056991|FG000|Overall Study|Lost to Follow-up|1|||
94616004|NCT01392443|324056991|FG000|Overall Study|Protocol Violation|1|||
94616005|NCT02570074|324056992|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
94616006|NCT02570074|324056993|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
94616007|NCT01977794|324056996|FG000|Overall Study|Adverse Event|2|||
94616008|NCT01977794|324056997|FG001|Overall Study|Adverse Event|2|||
94616009|NCT01977794|324056996|FG000|Overall Study|Lost to Follow-up|2|||
94616010|NCT01977794|324056997|FG001|Overall Study|Lost to Follow-up|1|||
94616011|NCT01977794|324056996|FG000|Overall Study|Protocol Violation|1|||
94616012|NCT01977794|324056997|FG001|Overall Study|Protocol Violation|0|||
94616013|NCT01977794|324056996|FG000|Overall Study|Death|1|||
94616014|NCT01977794|324056997|FG001|Overall Study|Death|1|||
94616015|NCT01977794|324056996|FG000|Overall Study|Withdrew consent|2|||
94616016|NCT01977794|324056997|FG001|Overall Study|Withdrew consent|1|||
94616017|NCT01977794|324056996|FG000|Overall Study|Other|0|||
94616018|NCT01977794|324056997|FG001|Overall Study|Other|1|||
94616019|NCT00639678|324056998|FG000|Overall Study|Withdrawal by Subject|3|||
94616020|NCT00639678|324056999|FG001|Overall Study|Withdrawal by Subject|0|||
94616021|NCT00639678|324057000|FG002|Overall Study|Withdrawal by Subject|4|||
94616022|NCT00639678|324057001|FG003|Overall Study|Withdrawal by Subject|0|||
94616023|NCT00639678|324056998|FG000|Overall Study|Lost to Follow-up|1|||
94616024|NCT00639678|324056999|FG001|Overall Study|Lost to Follow-up|0|||
94616025|NCT00639678|324057000|FG002|Overall Study|Lost to Follow-up|6|||
94616026|NCT00639678|324057001|FG003|Overall Study|Lost to Follow-up|0|||
94616027|NCT00639678|324056998|FG000|Overall Study|Adverse Event|0|||
94616028|NCT00639678|324056999|FG001|Overall Study|Adverse Event|1|||
94616029|NCT00639678|324057000|FG002|Overall Study|Adverse Event|0|||
94616030|NCT00639678|324057001|FG003|Overall Study|Adverse Event|0|||
94616031|NCT00639678|324056998|FG000|Overall Study|Lack of Compliance|0|||
94616032|NCT00639678|324056999|FG001|Overall Study|Lack of Compliance|0|||
94616033|NCT00639678|324057000|FG002|Overall Study|Lack of Compliance|1|||
94616034|NCT00639678|324057001|FG003|Overall Study|Lack of Compliance|0|||
94616035|NCT03228433|324057031|FG000|Overall Study|Lost to Follow-up|1|||
94616036|NCT03228433|324057032|FG001|Overall Study|Lost to Follow-up|0|||
94616037|NCT03228433|324057033|FG002|Overall Study|Lost to Follow-up|0|||
94616038|NCT03228433|324057034|FG003|Overall Study|Lost to Follow-up|0|||
94616039|NCT03228433|324057035|FG004|Overall Study|Lost to Follow-up|0|||
94616040|NCT03228433|324057036|FG005|Overall Study|Lost to Follow-up|0|||
94616041|NCT03228433|324057031|FG000|Overall Study|Positive alcohol test|0|||
94616042|NCT03228433|324057032|FG001|Overall Study|Positive alcohol test|0|||
94616043|NCT03228433|324057033|FG002|Overall Study|Positive alcohol test|0|||
94616044|NCT03228433|324057034|FG003|Overall Study|Positive alcohol test|1|||
94616045|NCT03228433|324057035|FG004|Overall Study|Positive alcohol test|0|||
94616046|NCT03228433|324057036|FG005|Overall Study|Positive alcohol test|0|||
94616047|NCT01773733|324057037|FG000|Overall Study|Adverse Event|3286|||
94616048|NCT01773733|324057038|FG001|Overall Study|Adverse Event|540|||
94616049|NCT01773733|324057037|FG000|Overall Study|Pregnancy|28|||
94616050|NCT01773733|324057038|FG001|Overall Study|Pregnancy|0|||
94616051|NCT01773733|324057037|FG000|Overall Study|Other different categories of not compl|55415|||
94616052|NCT01773733|324057038|FG001|Overall Study|Other different categories of not compl|7781|||
94616053|NCT01031706|324057039|FG000|Overall Study|Adverse Event|1|||
94616054|NCT01031706|324057040|FG001|Overall Study|Adverse Event|0|||
94616055|NCT01031706|324057039|FG000|Overall Study|Withdrawal by Subject|1|||
94616056|NCT01031706|324057040|FG001|Overall Study|Withdrawal by Subject|1|||
94616057|NCT01030536|324057047|FG000|Overall Study|Withdrawal by Subject|0|||
94616058|NCT01030536|324057048|FG001|Overall Study|Withdrawal by Subject|0|||
94616059|NCT01030536|324057049|FG002|Overall Study|Withdrawal by Subject|1|||
94616060|NCT01030536|324057050|FG003|Overall Study|Withdrawal by Subject|0|||
94616061|NCT01030536|324057051|FG004|Overall Study|Withdrawal by Subject|0|||
94616062|NCT01030536|324057047|FG000|Overall Study|undefined|1|||
94616063|NCT01030536|324057048|FG001|Overall Study|undefined|0|||
94616064|NCT01030536|324057049|FG002|Overall Study|undefined|1|||
94616065|NCT01030536|324057050|FG003|Overall Study|undefined|1|||
94616066|NCT01030536|324057051|FG004|Overall Study|undefined|0|||
94616067|NCT01030536|324057047|FG000|Overall Study|Adverse Event|0|||
94616068|NCT01030536|324057048|FG001|Overall Study|Adverse Event|3|||
94616069|NCT01030536|324057049|FG002|Overall Study|Adverse Event|1|||
94616070|NCT01030536|324057050|FG003|Overall Study|Adverse Event|0|||
94616071|NCT01030536|324057051|FG004|Overall Study|Adverse Event|1|||
94616072|NCT01030536|324057047|FG000|Overall Study|Progressive disease|6|||
94616073|NCT01030536|324057048|FG001|Overall Study|Progressive disease|2|||
94616074|NCT01030536|324057049|FG002|Overall Study|Progressive disease|3|||
94616075|NCT01030536|324057050|FG003|Overall Study|Progressive disease|2|||
94616076|NCT01030536|324057051|FG004|Overall Study|Progressive disease|0|||
94616077|NCT01030536|324057047|FG000|Overall Study|Death|0|||
94616078|NCT01030536|324057048|FG001|Overall Study|Death|1|||
94616079|NCT01030536|324057049|FG002|Overall Study|Death|0|||
94616080|NCT01030536|324057050|FG003|Overall Study|Death|0|||
94616081|NCT01030536|324057051|FG004|Overall Study|Death|0|||
94616082|NCT01365052|324057052|FG000|Overall Study|Adverse Event|4|||
94616083|NCT01365052|324057053|FG001|Overall Study|Adverse Event|4|||
94616084|NCT02980783|324057054|FG000|Overall Study|Lost to Follow-up|1|||
94616085|NCT00178633|324057056|FG000|Overall Study|Lost to Follow-up|6|||
94616086|NCT00762385|324057059|FG000|First Intervention|Lens Issue|1|||
94616087|NCT00762385|324057060|FG001|First Intervention|Lens Issue|1|||
94616088|NCT00762385|324057059|FG000|First Intervention|Lost to Follow-up|0|||
94616089|NCT00762385|324057060|FG001|First Intervention|Lost to Follow-up|2|||
94616090|NCT00762385|324057059|FG000|First Intervention|Ineligible|1|||
94616091|NCT00762385|324057060|FG001|First Intervention|Ineligible|0|||
94616092|NCT00762385|324057059|FG000|First Intervention|Protocol Violation|0|||
94616093|NCT00762385|324057060|FG001|First Intervention|Protocol Violation|1|||
94616094|NCT00762385|324057059|FG000|Second Intervention|Protocol Violation|3|||
94616095|NCT00762385|324057060|FG001|Second Intervention|Protocol Violation|3|||
94616096|NCT03570697|324057063|FG000|Overall Study|Lost to Follow-up|0|||
94616097|NCT03570697|324057064|FG001|Overall Study|Lost to Follow-up|1|||
94616098|NCT03570697|324057063|FG000|Overall Study|Death|2|||
94616099|NCT03570697|324057064|FG001|Overall Study|Death|0|||
94616100|NCT03570697|324057063|FG000|Overall Study|Withdrawal by Subject|4|||
94616101|NCT03570697|324057064|FG001|Overall Study|Withdrawal by Subject|2|||
94616102|NCT01065597|324057066|FG000|Overall Study|Adverse Event|1|||
94616103|NCT01453361|324057067|FG000|Overall Study|Disease Progression|6|||
94616104|NCT01453361|324057067|FG000|Overall Study|Screen-Failures|10|||
94616105|NCT01781975|324057069|FG000|Overall Study|Death|1|||
94616106|NCT01781975|324057070|FG001|Overall Study|Death|0|||
94616107|NCT01781975|324057069|FG000|Overall Study|Withdrawal by Subject|1|||
94616108|NCT01781975|324057070|FG001|Overall Study|Withdrawal by Subject|1|||
94616109|NCT03469934|324057071|FG000|Overall Study|Withdrawal by Subject|0|||
94616110|NCT03469934|324057072|FG001|Overall Study|Withdrawal by Subject|1|||
94616111|NCT00932126|324057078|FG000|Overall Study|Adverse Event|0|||
94616112|NCT00932126|324057079|FG001|Overall Study|Adverse Event|0|||
94616113|NCT00932126|324057080|FG002|Overall Study|Adverse Event|0|||
94616114|NCT00932126|324057081|FG003|Overall Study|Adverse Event|0|||
94616115|NCT00932126|324057082|FG004|Overall Study|Adverse Event|0|||
94616116|NCT00932126|324057083|FG005|Overall Study|Adverse Event|0|||
94616117|NCT00932126|324057084|FG006|Overall Study|Adverse Event|1|||
94616118|NCT00932126|324057085|FG007|Overall Study|Adverse Event|2|||
94616119|NCT00932126|324057078|FG000|Overall Study|Protocol Violation|0|||
94616120|NCT00932126|324057079|FG001|Overall Study|Protocol Violation|0|||
94616121|NCT00932126|324057080|FG002|Overall Study|Protocol Violation|0|||
94616122|NCT00932126|324057081|FG003|Overall Study|Protocol Violation|0|||
94616123|NCT00932126|324057082|FG004|Overall Study|Protocol Violation|1|||
94616124|NCT00932126|324057083|FG005|Overall Study|Protocol Violation|0|||
94616125|NCT00932126|324057084|FG006|Overall Study|Protocol Violation|0|||
94616126|NCT00932126|324057085|FG007|Overall Study|Protocol Violation|0|||
94616127|NCT00932126|324057078|FG000|Overall Study|Withdrawal by Subject|0|||
94616128|NCT00932126|324057079|FG001|Overall Study|Withdrawal by Subject|0|||
94616129|NCT00932126|324057080|FG002|Overall Study|Withdrawal by Subject|1|||
94665225|NCT02349295|324229769|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
94665226|NCT02349295|324229770|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
94665227|NCT02349295|324229771|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
94665228|NCT02349295|324229758|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
94665229|NCT02349295|324229759|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
94665230|NCT02349295|324229760|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
94665231|NCT02349295|324229761|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
94665232|NCT02349295|324229762|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
94665233|NCT02349295|324229763|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
94665234|NCT02349295|324229764|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
94665235|NCT02349295|324229765|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
94665236|NCT02349295|324229766|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
94665237|NCT02349295|324229767|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
94665238|NCT02349295|324229768|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
94665239|NCT02349295|324229769|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
94665240|NCT02349295|324229770|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
94665241|NCT02349295|324229771|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
94665242|NCT02349295|324229758|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
94665243|NCT02349295|324229759|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
94665244|NCT02349295|324229760|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
94665245|NCT02349295|324229761|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
94665246|NCT02349295|324229762|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
94665247|NCT02349295|324229763|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
94665248|NCT02349295|324229764|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
94665249|NCT02349295|324229765|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
94665250|NCT02349295|324229766|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
94665251|NCT02349295|324229767|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
94665252|NCT02349295|324229768|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
94665253|NCT02349295|324229769|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
94665254|NCT02349295|324229770|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
94665255|NCT02349295|324229771|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
94665256|NCT02349295|324229758|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
94665257|NCT02349295|324229759|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
94665258|NCT02349295|324229760|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
94665259|NCT02349295|324229761|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
94665260|NCT02349295|324229762|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
94665261|NCT02349295|324229763|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
94665262|NCT02349295|324229764|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
94665263|NCT02349295|324229765|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
94665264|NCT02349295|324229766|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
94665265|NCT02349295|324229767|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
94665266|NCT02349295|324229768|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
94665267|NCT02349295|324229769|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
94665268|NCT02349295|324229770|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
94665269|NCT02349295|324229771|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
94665270|NCT02349295|324229758|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
94665271|NCT02349295|324229759|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
94665272|NCT02349295|324229760|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
94665273|NCT02349295|324229761|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
94665274|NCT02349295|324229762|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
94665275|NCT02349295|324229763|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
94665276|NCT02349295|324229764|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
94665277|NCT02349295|324229765|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
94665278|NCT02349295|324229766|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
94665279|NCT02349295|324229767|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
94665280|NCT02349295|324229768|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
94665281|NCT02349295|324229769|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
94461051|NCT02419612|323476858|FG000|Long-term Treatment Period|Subject Decision|2|||
94461052|NCT02419612|323476859|FG001|Long-term Treatment Period|Subject Decision|4|||
94461053|NCT02419612|323476858|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
94665282|NCT02349295|324229770|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
94665283|NCT02349295|324229771|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
94665284|NCT02349295|324229758|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
94665285|NCT02349295|324229759|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
94665286|NCT02349295|324229760|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
94665287|NCT02349295|324229761|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
94461054|NCT02419612|323476859|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
94461055|NCT02091986|323476860|FG000|Overall Study|7 rand in error 1 patient decision|2|||
94616130|NCT00932126|324057081|FG003|Overall Study|Withdrawal by Subject|0|||
94616131|NCT00932126|324057082|FG004|Overall Study|Withdrawal by Subject|0|||
94616132|NCT00932126|324057083|FG005|Overall Study|Withdrawal by Subject|0|||
94616133|NCT00932126|324057084|FG006|Overall Study|Withdrawal by Subject|0|||
94616134|NCT00932126|324057085|FG007|Overall Study|Withdrawal by Subject|1|||
94616135|NCT00932126|324057078|FG000|Overall Study|Objective progression or relapse|3|||
94616136|NCT00932126|324057079|FG001|Overall Study|Objective progression or relapse|3|||
94616137|NCT00932126|324057080|FG002|Overall Study|Objective progression or relapse|2|||
94616138|NCT00932126|324057081|FG003|Overall Study|Objective progression or relapse|3|||
94616139|NCT00932126|324057082|FG004|Overall Study|Objective progression or relapse|3|||
94616140|NCT00932126|324057083|FG005|Overall Study|Objective progression or relapse|3|||
94616141|NCT00932126|324057084|FG006|Overall Study|Objective progression or relapse|3|||
94616142|NCT00932126|324057085|FG007|Overall Study|Objective progression or relapse|5|||
94616143|NCT00932126|324057078|FG000|Overall Study|Other|0|||
94616144|NCT00932126|324057079|FG001|Overall Study|Other|0|||
94616145|NCT00932126|324057080|FG002|Overall Study|Other|0|||
94616146|NCT00932126|324057081|FG003|Overall Study|Other|0|||
94616147|NCT00932126|324057082|FG004|Overall Study|Other|1|||
94616148|NCT00932126|324057083|FG005|Overall Study|Other|0|||
94616149|NCT00932126|324057084|FG006|Overall Study|Other|1|||
94616150|NCT00932126|324057085|FG007|Overall Study|Other|2|||
94616151|NCT02121522|324057094|FG000|Overall Study|Adverse Event|1|||
94616152|NCT01254331|324057096|FG000|Initial Phase|Adverse Event|3|||
94616153|NCT01254331|324057096|FG000|Initial Phase|Withdrawal by Subject|1|||
94616154|NCT01254331|324057096|FG000|Initial Phase|Pregnancy|1|||
94616155|NCT01254331|324057096|FG000|Extension Phase|Lack of Efficacy|1|||
94616156|NCT01254331|324057096|FG000|Extension Phase|Lost to Follow-up|3|||
94616157|NCT00843856|324057097|FG000|Overall Study|Lost to Follow-up|1|||
94616158|NCT00843856|324057098|FG001|Overall Study|Lost to Follow-up|2|||
94616159|NCT02925117|324057101|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
94616160|NCT02925117|324057102|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
94616161|NCT02925117|324057103|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
94616162|NCT02925117|324057104|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
94616163|NCT02925117|324057105|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
94616164|NCT02925117|324057106|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
94616165|NCT02925117|324057107|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
94616166|NCT02925117|324057108|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
94616167|NCT02925117|324057109|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
94616168|NCT02925117|324057110|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
94616169|NCT02925117|324057111|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
94616170|NCT02925117|324057112|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
94616171|NCT02925117|324057101|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
94616172|NCT02925117|324057102|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
94616173|NCT02925117|324057103|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
94616174|NCT02925117|324057104|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
94616175|NCT02925117|324057105|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
94616176|NCT02925117|324057106|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
94616177|NCT02925117|324057107|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
94616178|NCT02925117|324057108|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
94616179|NCT02925117|324057109|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
94616180|NCT02925117|324057110|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
94616181|NCT02925117|324057111|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
94616182|NCT02925117|324057112|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
94616183|NCT02925117|324057101|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
94616184|NCT02925117|324057102|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
94616185|NCT02925117|324057103|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
94616186|NCT02925117|324057104|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
94616187|NCT02925117|324057105|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
94616188|NCT02925117|324057106|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
94616189|NCT02925117|324057107|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
94616190|NCT02925117|324057108|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
94616191|NCT02925117|324057109|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
94616192|NCT02925117|324057110|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
94665288|NCT02349295|324229762|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
94665289|NCT02349295|324229763|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
94665290|NCT02349295|324229764|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
94665291|NCT02349295|324229765|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
94665292|NCT02349295|324229766|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
94665293|NCT02349295|324229767|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
94665294|NCT02349295|324229768|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
94665295|NCT02349295|324229769|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
94665296|NCT02349295|324229770|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
94665297|NCT02349295|324229771|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
94665298|NCT02349295|324229758|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
94665299|NCT02349295|324229759|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
94665300|NCT02349295|324229760|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
94665301|NCT02349295|324229761|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
94665302|NCT02349295|324229762|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
94665303|NCT02349295|324229763|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
94665304|NCT02349295|324229764|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
94461056|NCT02091986|323476861|FG001|Overall Study|7 rand in error 1 patient decision|3|||
94461057|NCT02091986|323476862|FG002|Overall Study|7 rand in error 1 patient decision|3|||
94616193|NCT02925117|324057111|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
94616194|NCT02925117|324057112|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
94616195|NCT02925117|324057101|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
94616196|NCT02925117|324057102|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
94616197|NCT02925117|324057103|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
94616198|NCT02925117|324057104|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
94616199|NCT02925117|324057105|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
94616200|NCT02925117|324057106|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
94616201|NCT02925117|324057107|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
94616202|NCT02925117|324057108|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
94616203|NCT02925117|324057109|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
94616204|NCT02925117|324057110|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
94616205|NCT02925117|324057111|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
94616206|NCT02925117|324057112|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
94616207|NCT02925117|324057101|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
94616208|NCT02925117|324057102|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
94616209|NCT02925117|324057103|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
94616210|NCT02925117|324057104|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
94616211|NCT02925117|324057105|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
94616212|NCT02925117|324057106|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
94616213|NCT02925117|324057107|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
94616214|NCT02925117|324057108|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
94616215|NCT02925117|324057109|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
94616216|NCT02925117|324057110|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
94616217|NCT02925117|324057111|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
94616218|NCT02925117|324057112|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
94616219|NCT02925117|324057101|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
94616220|NCT02925117|324057102|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
94616221|NCT02925117|324057103|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
94616222|NCT02925117|324057104|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
94616223|NCT02925117|324057105|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
94616224|NCT02925117|324057106|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
94616225|NCT02925117|324057107|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
94616226|NCT02925117|324057108|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
94616227|NCT02925117|324057109|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
94616228|NCT02925117|324057110|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
94616229|NCT02925117|324057111|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
94616230|NCT02925117|324057112|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
94616231|NCT02925117|324057101|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
94616232|NCT02925117|324057102|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
94616233|NCT02925117|324057103|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
94616234|NCT02925117|324057104|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
94665305|NCT02349295|324229765|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
94616235|NCT02925117|324057105|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
94616236|NCT02925117|324057106|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
94616237|NCT02925117|324057107|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
94616238|NCT02925117|324057108|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
94616239|NCT02925117|324057109|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
94616240|NCT02925117|324057110|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
94616241|NCT02925117|324057111|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
94616242|NCT02925117|324057112|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
94616243|NCT02925117|324057101|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
94616244|NCT02925117|324057102|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
94665306|NCT02349295|324229766|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
94665307|NCT02349295|324229767|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
94665308|NCT02349295|324229768|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
94665309|NCT02349295|324229769|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
94665310|NCT02349295|324229770|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
94665311|NCT02349295|324229771|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
94665312|NCT02349295|324229758|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
94665313|NCT02349295|324229759|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
94665314|NCT02349295|324229760|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
94665315|NCT02349295|324229761|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
94665316|NCT02349295|324229762|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
94665317|NCT02349295|324229763|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
94665318|NCT02349295|324229764|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
94665319|NCT02349295|324229765|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
94665320|NCT02349295|324229766|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
94665321|NCT02349295|324229767|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
94665322|NCT02349295|324229768|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
94665323|NCT02349295|324229769|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
94665324|NCT02349295|324229770|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
94665325|NCT02349295|324229771|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
94665326|NCT02349295|324229758|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
94665327|NCT02349295|324229759|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
94665328|NCT02349295|324229760|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
94665329|NCT02349295|324229761|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
94665330|NCT02349295|324229762|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
94665331|NCT02349295|324229763|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
94665332|NCT02349295|324229764|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
94665333|NCT02349295|324229765|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
94665334|NCT02349295|324229766|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
94665335|NCT02349295|324229767|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
94665336|NCT02349295|324229768|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
94665337|NCT02349295|324229769|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
94665338|NCT02349295|324229770|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
94665339|NCT02349295|324229771|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
94665340|NCT02349295|324229758|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
94665341|NCT02349295|324229759|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
94665342|NCT02349295|324229760|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
94665343|NCT02349295|324229761|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
94665344|NCT02349295|324229762|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
94665345|NCT02349295|324229763|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
94665346|NCT02349295|324229764|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
94665347|NCT02349295|324229765|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
94665348|NCT02349295|324229766|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
94665349|NCT02349295|324229767|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
94665350|NCT02349295|324229768|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
94665351|NCT02349295|324229769|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
94665352|NCT02349295|324229770|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
94665353|NCT02349295|324229771|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
94665354|NCT02349295|324229758|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
94665355|NCT02349295|324229759|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
94665356|NCT02349295|324229760|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
94665357|NCT02349295|324229761|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
94665358|NCT02349295|324229762|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
94665359|NCT02349295|324229763|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
94665360|NCT02349295|324229764|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
94665361|NCT02349295|324229765|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
94665362|NCT02349295|324229766|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
94665363|NCT02349295|324229767|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
94665364|NCT02349295|324229768|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
94665365|NCT02349295|324229769|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
94665366|NCT02349295|324229770|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
94665367|NCT02349295|324229771|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
94665368|NCT02349295|324229758|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
94665369|NCT02349295|324229759|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
94461058|NCT02091986|323476860|FG000|Overall Study|Lost to Follow-up|1|||
94461059|NCT02091986|323476861|FG001|Overall Study|Lost to Follow-up|0|||
94616245|NCT02925117|324057103|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
94616246|NCT02925117|324057104|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
94616247|NCT02925117|324057105|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
94616248|NCT02925117|324057106|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
94616249|NCT02925117|324057107|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
94616250|NCT02925117|324057108|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
94616251|NCT02925117|324057109|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
94616252|NCT02925117|324057110|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
94616253|NCT02925117|324057111|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
94616254|NCT02925117|324057112|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
94616255|NCT03546062|324057115|FG000|Overall Study|Adverse Event|6|||
94616256|NCT03546062|324057116|FG001|Overall Study|Adverse Event|5|||
94616257|NCT03546062|324057117|FG002|Overall Study|Adverse Event|8|||
94616258|NCT00508755|324057118|FG000|Overall Study|Withdrawal by Subject|1|||
94616259|NCT01768286|324057119|FG000|Overall Study|Randomized But Not Treated|0|||
94616260|NCT01768286|324057120|FG001|Overall Study|Randomized But Not Treated|0|||
94616261|NCT01768286|324057121|FG002|Overall Study|Randomized But Not Treated|1|||
94616262|NCT01768286|324057122|FG003|Overall Study|Randomized But Not Treated|0|||
94616263|NCT01768286|324057119|FG000|Overall Study|Lack of Efficacy|7|||
94616264|NCT01768286|324057120|FG001|Overall Study|Lack of Efficacy|4|||
94616265|NCT01768286|324057121|FG002|Overall Study|Lack of Efficacy|0|||
94616266|NCT01768286|324057122|FG003|Overall Study|Lack of Efficacy|1|||
94616267|NCT01768286|324057119|FG000|Overall Study|Withdrew Consent|0|||
94616268|NCT01768286|324057120|FG001|Overall Study|Withdrew Consent|0|||
94616269|NCT01768286|324057121|FG002|Overall Study|Withdrew Consent|1|||
94616270|NCT01768286|324057122|FG003|Overall Study|Withdrew Consent|0|||
94616271|NCT03113071|324057123|FG000|Overall Study|Withdrawal by Subject|1|||
94616272|NCT03113071|324057124|FG001|Overall Study|Withdrawal by Subject|0|||
94616273|NCT02004522|324057125|FG000|Overall Study|Adverse Event|55|||
94616274|NCT02004522|324057126|FG001|Overall Study|Adverse Event|6|||
94616275|NCT02004522|324057125|FG000|Overall Study|Withdrawal by Subject|13|||
94616276|NCT02004522|324057126|FG001|Overall Study|Withdrawal by Subject|7|||
94616277|NCT02004522|324057125|FG000|Overall Study|Death|12|||
94616278|NCT02004522|324057126|FG001|Overall Study|Death|3|||
94616279|NCT02004522|324057125|FG000|Overall Study|Physician Decision|3|||
94616280|NCT02004522|324057126|FG001|Overall Study|Physician Decision|4|||
94616281|NCT02004522|324057125|FG000|Overall Study|Protocol Violation|1|||
94616282|NCT02004522|324057126|FG001|Overall Study|Protocol Violation|0|||
94616283|NCT02004522|324057125|FG000|Overall Study|Other is reason listed by PI|4|||
94616284|NCT02004522|324057126|FG001|Overall Study|Other is reason listed by PI|1|||
94616285|NCT02004522|324057125|FG000|Overall Study|Never Dosed|2|||
94616286|NCT02004522|324057126|FG001|Overall Study|Never Dosed|4|||
94616287|NCT02004522|324057125|FG000|Overall Study|Disease Progression|35|||
94616288|NCT02004522|324057126|FG001|Overall Study|Disease Progression|31|||
94616289|NCT02004522|324057125|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
94616290|NCT02004522|324057126|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
94616291|NCT02229383|324057128|FG000|Overall Study|Adverse Event|7|||
94616292|NCT02229383|324057129|FG001|Overall Study|Adverse Event|4|||
94616293|NCT02229383|324057128|FG000|Overall Study|Death|0|||
94616294|NCT02229383|324057129|FG001|Overall Study|Death|1|||
94616295|NCT02229383|324057128|FG000|Overall Study|Lost to Follow-up|5|||
94616296|NCT02229383|324057129|FG001|Overall Study|Lost to Follow-up|3|||
94616297|NCT02229383|324057128|FG000|Overall Study|Withdrawal by Subject|4|||
94616298|NCT02229383|324057129|FG001|Overall Study|Withdrawal by Subject|6|||
94616299|NCT02229383|324057128|FG000|Overall Study|Did not receive treatment|1|||
94616300|NCT02229383|324057129|FG001|Overall Study|Did not receive treatment|0|||
94616301|NCT02229383|324057128|FG000|Overall Study|Other|3|||
94461060|NCT02091986|323476862|FG002|Overall Study|Lost to Follow-up|0|||
94616302|NCT02229383|324057129|FG001|Overall Study|Other|8|||
94616303|NCT00437983|324057131|FG000|Overall Study|Adverse Event|6|||
94616304|NCT00437983|324057132|FG001|Overall Study|Adverse Event|6|||
94616305|NCT00437983|324057131|FG000|Overall Study|Protocol Violation|2|||
94616306|NCT00437983|324057132|FG001|Overall Study|Protocol Violation|1|||
94616307|NCT00437983|324057131|FG000|Overall Study|Withdrawal by Subject|5|||
94616308|NCT00437983|324057132|FG001|Overall Study|Withdrawal by Subject|6|||
94616309|NCT01999179|324057133|FG000|Overall Study|Adverse Event|1|||
94616310|NCT01999179|324057133|FG000|Overall Study|Lost to Follow-up|1|||
94616311|NCT01999179|324057133|FG000|Overall Study|Change in Therapy|3|||
94616312|NCT01999179|324057133|FG000|Overall Study|New catheter|2|||
94616313|NCT02564796|324057134|FG000|Overall Study|Physician Decision|2|||
94616314|NCT02564796|324057135|FG001|Overall Study|Physician Decision|2|||
94616315|NCT03583697|324057136|FG000|Overall Study|Withdrawal by Subject|0|||
94616316|NCT03583697|324057137|FG001|Overall Study|Withdrawal by Subject|0|||
94616317|NCT03583697|324057138|FG002|Overall Study|Withdrawal by Subject|1|||
94616318|NCT03583697|324057136|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
94616319|NCT03583697|324057137|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
94616320|NCT03583697|324057138|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
94616321|NCT00566995|324057145|FG000|Overall Study|Toxicity|4|||
94616322|NCT00566995|324057145|FG000|Overall Study|Withdrew consent|3|||
94616323|NCT02468674|324058912|FG000|Overall Study|Adverse Event|0|||
94616324|NCT02468674|324058913|FG001|Overall Study|Adverse Event|0|||
94616325|NCT02468674|324058914|FG002|Overall Study|Adverse Event|0|||
94616326|NCT02468674|324058915|FG003|Overall Study|Adverse Event|1|||
94616327|NCT02468674|324058916|FG004|Overall Study|Adverse Event|0|||
94616328|NCT02468674|324058917|FG005|Overall Study|Adverse Event|1|||
94616329|NCT02468674|324058918|FG006|Overall Study|Adverse Event|0|||
94616330|NCT02468674|324058919|FG007|Overall Study|Adverse Event|0|||
94616331|NCT02468674|324058920|FG008|Overall Study|Adverse Event|0|||
94616332|NCT02468674|324058912|FG000|Overall Study|Lost to Follow-up|1|||
94616333|NCT02468674|324058913|FG001|Overall Study|Lost to Follow-up|0|||
94616334|NCT02468674|324058914|FG002|Overall Study|Lost to Follow-up|0|||
94616335|NCT02468674|324058915|FG003|Overall Study|Lost to Follow-up|0|||
94616336|NCT02468674|324058916|FG004|Overall Study|Lost to Follow-up|0|||
94616337|NCT02468674|324058917|FG005|Overall Study|Lost to Follow-up|0|||
94616338|NCT02468674|324058918|FG006|Overall Study|Lost to Follow-up|0|||
94616339|NCT02468674|324058919|FG007|Overall Study|Lost to Follow-up|1|||
94616340|NCT02468674|324058920|FG008|Overall Study|Lost to Follow-up|1|||
94616341|NCT02468674|324058912|FG000|Overall Study|Physician Decision|0|||
94616342|NCT02468674|324058913|FG001|Overall Study|Physician Decision|0|||
94616343|NCT02468674|324058914|FG002|Overall Study|Physician Decision|0|||
94616344|NCT02468674|324058915|FG003|Overall Study|Physician Decision|0|||
94616345|NCT02468674|324058916|FG004|Overall Study|Physician Decision|0|||
94616346|NCT02468674|324058917|FG005|Overall Study|Physician Decision|0|||
94616347|NCT02468674|324058918|FG006|Overall Study|Physician Decision|1|||
94616348|NCT02468674|324058919|FG007|Overall Study|Physician Decision|0|||
94616349|NCT02468674|324058920|FG008|Overall Study|Physician Decision|0|||
94616350|NCT02468674|324058912|FG000|Overall Study|Patient/Guardian Decision|0|||
94616351|NCT02468674|324058913|FG001|Overall Study|Patient/Guardian Decision|0|||
94616352|NCT02468674|324058914|FG002|Overall Study|Patient/Guardian Decision|0|||
94616353|NCT02468674|324058915|FG003|Overall Study|Patient/Guardian Decision|0|||
94616354|NCT02468674|324058916|FG004|Overall Study|Patient/Guardian Decision|1|||
94616355|NCT02468674|324058917|FG005|Overall Study|Patient/Guardian Decision|0|||
94616356|NCT02468674|324058918|FG006|Overall Study|Patient/Guardian Decision|0|||
94616357|NCT02468674|324058919|FG007|Overall Study|Patient/Guardian Decision|2|||
94616358|NCT02468674|324058920|FG008|Overall Study|Patient/Guardian Decision|1|||
94616359|NCT02468674|324058912|FG000|Overall Study|Protocol Deviation|0|||
94616360|NCT02468674|324058913|FG001|Overall Study|Protocol Deviation|0|||
94616361|NCT02468674|324058914|FG002|Overall Study|Protocol Deviation|0|||
94616362|NCT02468674|324058915|FG003|Overall Study|Protocol Deviation|0|||
94616363|NCT02468674|324058916|FG004|Overall Study|Protocol Deviation|0|||
94616364|NCT02468674|324058917|FG005|Overall Study|Protocol Deviation|0|||
94616365|NCT02468674|324058918|FG006|Overall Study|Protocol Deviation|0|||
94616366|NCT02468674|324058919|FG007|Overall Study|Protocol Deviation|1|||
94616367|NCT02468674|324058920|FG008|Overall Study|Protocol Deviation|1|||
94616368|NCT01034631|324058922|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
94616369|NCT01034631|324058923|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
94616370|NCT01034631|324058924|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
94616371|NCT01034631|324058922|FG000|Phase II|Not Evaluable per protocol|0|||
94616372|NCT01034631|324058923|FG001|Phase II|Not Evaluable per protocol|0|||
94616373|NCT01034631|324058924|FG002|Phase II|Not Evaluable per protocol|2|||
94616374|NCT01034631|324058922|FG000|Phase II|Determined Ineligible per protocol|0|||
94616375|NCT01034631|324058923|FG001|Phase II|Determined Ineligible per protocol|1|||
94616376|NCT01034631|324058924|FG002|Phase II|Determined Ineligible per protocol|0|||
94616377|NCT00354744|324058925|FG000|Overall Study|Adverse Event|2|||
94616378|NCT00354744|324058925|FG000|Overall Study|Death|2|||
94616379|NCT00354744|324058925|FG000|Overall Study|Lack of Efficacy|11|||
94616380|NCT00354744|324058925|FG000|Overall Study|Lost to Follow-up|2|||
94616381|NCT00354744|324058925|FG000|Overall Study|Physician Decision|11|||
94616382|NCT00354744|324058925|FG000|Overall Study|Withdrawal by Subject|14|||
94616383|NCT00983437|324058926|FG000|Overall Study|Adverse Event|9|||
94616384|NCT00983437|324058926|FG000|Overall Study|Lack of Efficacy|1|||
94616385|NCT00983437|324058926|FG000|Overall Study|Withdrawal by Subject|8|||
94616386|NCT00983437|324058926|FG000|Overall Study|Noncompliance to Study Procedures|1|||
94616387|NCT00983437|324058926|FG000|Overall Study|Lost to Follow-up|2|||
94616388|NCT00983437|324058926|FG000|Overall Study|Other Reason|26|||
94616389|NCT01890473|324058927|FG000|Overall Study|Lost to Follow-up|1|||
94616390|NCT01890473|324058928|FG001|Overall Study|Lost to Follow-up|0|||
94616391|NCT01890473|324058927|FG000|Overall Study|Poor/non-compliance|1|||
94665370|NCT02349295|324229760|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
94665371|NCT02349295|324229761|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
94665372|NCT02349295|324229762|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
94665373|NCT02349295|324229763|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
94665374|NCT02349295|324229764|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
94665375|NCT02349295|324229765|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
94665376|NCT02349295|324229766|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
94665377|NCT02349295|324229767|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
94665378|NCT02349295|324229768|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
94665379|NCT02349295|324229769|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
94665380|NCT02349295|324229770|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
94665381|NCT02349295|324229771|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
94665382|NCT02349295|324229758|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
94665383|NCT02349295|324229759|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
94665384|NCT02349295|324229760|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
94665385|NCT02349295|324229761|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
94665386|NCT02349295|324229762|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
94665387|NCT02349295|324229763|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
94665388|NCT02349295|324229764|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
94665389|NCT02349295|324229765|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
94665390|NCT02349295|324229766|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
94665391|NCT02349295|324229767|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
94665392|NCT02349295|324229768|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
94665393|NCT02349295|324229769|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
94665394|NCT02349295|324229770|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
94665395|NCT02349295|324229771|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
94665396|NCT02349295|324229758|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
94616392|NCT01890473|324058928|FG001|Overall Study|Poor/non-compliance|0|||
94665397|NCT02349295|324229759|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
94665398|NCT02349295|324229760|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
94665399|NCT02349295|324229761|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
94665400|NCT02349295|324229762|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
94665401|NCT02349295|324229763|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
94665402|NCT02349295|324229764|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
94665403|NCT02349295|324229765|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
94665404|NCT02349295|324229766|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
94665405|NCT02349295|324229767|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
94665406|NCT02349295|324229768|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
94665407|NCT02349295|324229769|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
94665408|NCT02349295|324229770|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
94665409|NCT02349295|324229771|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
94461061|NCT02091986|323476860|FG000|Overall Study|Withdrawal by Subject|4|||
94461062|NCT02091986|323476861|FG001|Overall Study|Withdrawal by Subject|8|||
94616393|NCT03166735|324058929|FG000|Overall Study|Not Treated|1|||
94616394|NCT03166735|324058930|FG001|Overall Study|Not Treated|0|||
94616395|NCT03166735|324058931|FG002|Overall Study|Not Treated|0|||
94616396|NCT03166735|324058932|FG003|Overall Study|Not Treated|0|||
94616397|NCT03166735|324058933|FG004|Overall Study|Not Treated|0|||
94616398|NCT03166735|324058929|FG000|Overall Study|follow-up not completed as planned|0|||
94616399|NCT03166735|324058930|FG001|Overall Study|follow-up not completed as planned|1|||
94616400|NCT03166735|324058931|FG002|Overall Study|follow-up not completed as planned|1|||
94616401|NCT03166735|324058932|FG003|Overall Study|follow-up not completed as planned|0|||
94616402|NCT03166735|324058933|FG004|Overall Study|follow-up not completed as planned|1|||
94616403|NCT03166735|324058929|FG000|Overall Study|Withdrawal by Subject|0|||
94616404|NCT03166735|324058930|FG001|Overall Study|Withdrawal by Subject|0|||
94616405|NCT03166735|324058931|FG002|Overall Study|Withdrawal by Subject|1|||
94616406|NCT03166735|324058932|FG003|Overall Study|Withdrawal by Subject|1|||
94616407|NCT03166735|324058933|FG004|Overall Study|Withdrawal by Subject|2|||
94616408|NCT03166735|324058929|FG000|Overall Study|Lost to Follow-up|0|||
94616409|NCT03166735|324058930|FG001|Overall Study|Lost to Follow-up|2|||
94616410|NCT03166735|324058931|FG002|Overall Study|Lost to Follow-up|1|||
94616411|NCT03166735|324058932|FG003|Overall Study|Lost to Follow-up|0|||
94665410|NCT02349295|324229758|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
94665411|NCT02349295|324229759|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
94665412|NCT02349295|324229760|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
94665413|NCT02349295|324229761|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
94665414|NCT02349295|324229762|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
94665415|NCT02349295|324229763|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
94665416|NCT02349295|324229764|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
94616412|NCT03166735|324058933|FG004|Overall Study|Lost to Follow-up|1|||
94616413|NCT03689530|324058940|FG000|Overall Study|Withdrawal by Subject|53|||
94616414|NCT03689530|324058941|FG001|Overall Study|Withdrawal by Subject|16|||
94616415|NCT00850343|324058942|FG000|Overall Study|Withdrawal by Subject|11|||
94616416|NCT00850343|324058943|FG001|Overall Study|Withdrawal by Subject|0|||
94616417|NCT00850343|324058944|FG002|Overall Study|Withdrawal by Subject|3|||
94616418|NCT00850343|324058945|FG003|Overall Study|Withdrawal by Subject|2|||
94616419|NCT00850343|324058942|FG000|Overall Study|Adverse Event|15|||
94616420|NCT00850343|324058943|FG001|Overall Study|Adverse Event|2|||
94616421|NCT00850343|324058944|FG002|Overall Study|Adverse Event|6|||
94616422|NCT00850343|324058945|FG003|Overall Study|Adverse Event|6|||
94616423|NCT00850343|324058942|FG000|Overall Study|Pregnancy|0|||
94616424|NCT00850343|324058943|FG001|Overall Study|Pregnancy|0|||
94616425|NCT00850343|324058944|FG002|Overall Study|Pregnancy|0|||
94616426|NCT00850343|324058945|FG003|Overall Study|Pregnancy|1|||
94665417|NCT02349295|324229765|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
94665418|NCT02349295|324229766|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
94665419|NCT02349295|324229767|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
94665420|NCT02349295|324229768|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
94665421|NCT02349295|324229769|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
94665422|NCT02349295|324229770|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
94665423|NCT02349295|324229771|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
94665424|NCT02349295|324229758|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
94665425|NCT02349295|324229759|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
94665426|NCT02349295|324229760|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
94665427|NCT02349295|324229761|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
94665428|NCT02349295|324229762|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
94665429|NCT02349295|324229763|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
94665430|NCT02349295|324229764|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
94665431|NCT02349295|324229765|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
94665432|NCT02349295|324229766|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
94665433|NCT02349295|324229767|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
94665434|NCT02349295|324229768|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
94665435|NCT02349295|324229769|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
94665436|NCT02349295|324229770|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
94665437|NCT02349295|324229771|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
94665438|NCT02349295|324229758|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
94665439|NCT02349295|324229759|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
94665440|NCT02349295|324229760|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
94665441|NCT02349295|324229761|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
94665442|NCT02349295|324229762|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
94665443|NCT02349295|324229763|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
94665444|NCT02349295|324229764|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
94665445|NCT02349295|324229765|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
94665446|NCT02349295|324229766|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
94665447|NCT02349295|324229767|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
94616427|NCT00850343|324058942|FG000|Overall Study|Lack of Efficacy|17|||
94616428|NCT00850343|324058943|FG001|Overall Study|Lack of Efficacy|0|||
94616429|NCT00850343|324058944|FG002|Overall Study|Lack of Efficacy|3|||
94616430|NCT00850343|324058945|FG003|Overall Study|Lack of Efficacy|2|||
94616431|NCT00850343|324058942|FG000|Overall Study|Non-compliance with Study Procedures|1|||
94616432|NCT00850343|324058943|FG001|Overall Study|Non-compliance with Study Procedures|0|||
94616433|NCT00850343|324058944|FG002|Overall Study|Non-compliance with Study Procedures|1|||
94616434|NCT00850343|324058945|FG003|Overall Study|Non-compliance with Study Procedures|1|||
94616435|NCT00850343|324058942|FG000|Overall Study|Physician Decision|2|||
94616436|NCT00850343|324058943|FG001|Overall Study|Physician Decision|1|||
94616437|NCT00850343|324058944|FG002|Overall Study|Physician Decision|1|||
94616438|NCT00850343|324058945|FG003|Overall Study|Physician Decision|1|||
94358918|NCT01366846|323097996|FG001|Overall Study|Withdrawal by Subject|0|||
94616439|NCT01926015|324058947|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94616440|NCT01926015|324058948|FG001|Overall Study|Withdrawal by parent/guardian|1|||
94616441|NCT01926015|324058947|FG000|Overall Study|Randomized not treated|2|||
94616442|NCT01926015|324058948|FG001|Overall Study|Randomized not treated|0|||
94616443|NCT01626456|324058949|FG000|Overall Study|Withdrawal by Subject|21|||
94616444|NCT01626456|324058950|FG001|Overall Study|Withdrawal by Subject|46|||
94616445|NCT01626456|324058949|FG000|Overall Study|Adverse Event|2|||
94616446|NCT01626456|324058950|FG001|Overall Study|Adverse Event|27|||
94616447|NCT01626456|324058949|FG000|Overall Study|Lost to Follow-up|2|||
94616448|NCT01626456|324058950|FG001|Overall Study|Lost to Follow-up|27|||
94616449|NCT01626456|324058949|FG000|Overall Study|Lack of Efficacy|6|||
94616450|NCT01626456|324058950|FG001|Overall Study|Lack of Efficacy|7|||
94616451|NCT01626456|324058949|FG000|Overall Study|Physician Decision|1|||
94616452|NCT01626456|324058950|FG001|Overall Study|Physician Decision|4|||
94616453|NCT01626456|324058949|FG000|Overall Study|Protocol Violation|1|||
94616454|NCT01626456|324058950|FG001|Overall Study|Protocol Violation|1|||
94616455|NCT01626456|324058949|FG000|Overall Study|Site Closure|2|||
94665448|NCT02349295|324229768|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
94665449|NCT02349295|324229769|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
94665450|NCT02349295|324229770|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
94665451|NCT02349295|324229771|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
94665452|NCT03912259|324229772|FG000|Overall Study|Adverse Event (AE)|2|||
94665453|NCT03912259|324229773|FG001|Overall Study|Adverse Event (AE)|4|||
94665454|NCT03912259|324229772|FG000|Overall Study|Lack of Efficacy|4|||
94665455|NCT03912259|324229773|FG001|Overall Study|Lack of Efficacy|1|||
94665456|NCT03912259|324229772|FG000|Overall Study|Withdrawal by Subject|11|||
94665457|NCT03912259|324229773|FG001|Overall Study|Withdrawal by Subject|1|||
94665458|NCT01259713|324229774|FG000|Overall Study|Adverse Event|54|||
94665459|NCT01259713|324229775|FG001|Overall Study|Adverse Event|23|||
94665460|NCT01259713|324229774|FG000|Overall Study|Death Not Related to IFI|8|||
94665461|NCT01259713|324229775|FG001|Overall Study|Death Not Related to IFI|1|||
94665462|NCT01259713|324229774|FG000|Overall Study|Investigators Discretion|14|||
94665463|NCT01259713|324229775|FG001|Overall Study|Investigators Discretion|6|||
94665464|NCT01259713|324229774|FG000|Overall Study|Lack of Efficacy|2|||
94665465|NCT01259713|324229775|FG001|Overall Study|Lack of Efficacy|0|||
94665466|NCT01259713|324229774|FG000|Overall Study|Protocol Violation|5|||
94665467|NCT01259713|324229775|FG001|Overall Study|Protocol Violation|4|||
94665468|NCT01259713|324229774|FG000|Overall Study|Subject Withdrew Consent|12|||
94665469|NCT01259713|324229775|FG001|Overall Study|Subject Withdrew Consent|7|||
94665470|NCT02091726|324229778|FG000|Overall Study|Lost to Follow-up|6|||
94665471|NCT06111742|324229785|FG000|Overall Study|Did not receive intervention|1|||
94665472|NCT06111742|324229786|FG001|Overall Study|Did not receive intervention|0|||
94665473|NCT06111742|324229787|FG002|Overall Study|Did not receive intervention|0|||
94665474|NCT06111742|324229785|FG000|Overall Study|Withdrawal by Subject|2|||
94665475|NCT06111742|324229786|FG001|Overall Study|Withdrawal by Subject|0|||
94665476|NCT06111742|324229787|FG002|Overall Study|Withdrawal by Subject|0|||
94665477|NCT02605954|324229794|FG000|Overall Study|Adverse Event|5|||
94665478|NCT02605954|324229795|FG001|Overall Study|Adverse Event|1|||
94665479|NCT02605954|324229794|FG000|Overall Study|Investigator's Discretion|1|||
94665480|NCT02605954|324229795|FG001|Overall Study|Investigator's Discretion|0|||
94665481|NCT02605954|324229794|FG000|Overall Study|Non-Compliance with Study Drug|1|||
94665482|NCT02605954|324229795|FG001|Overall Study|Non-Compliance with Study Drug|0|||
94665483|NCT02605954|324229794|FG000|Overall Study|Withdrew Consent|2|||
94665484|NCT02605954|324229795|FG001|Overall Study|Withdrew Consent|2|||
94665485|NCT02605954|324229794|FG000|Overall Study|Lost to Follow-up|3|||
94665486|NCT02605954|324229795|FG001|Overall Study|Lost to Follow-up|0|||
94665487|NCT02605954|324229794|FG000|Overall Study|Randomized but not treated|0|||
94665488|NCT02605954|324229795|FG001|Overall Study|Randomized but not treated|1|||
94665489|NCT03555396|324229796|FG000|Overall Study|Death|3|||
94665490|NCT03555396|324229797|FG001|Overall Study|Death|1|||
94665491|NCT03555396|324229796|FG000|Overall Study|Lost to Follow-up|0|||
94665492|NCT03555396|324229797|FG001|Overall Study|Lost to Follow-up|2|||
94665493|NCT02347761|324229799|FG000|All Collected|Death|1|||
94616456|NCT01626456|324058950|FG001|Overall Study|Site Closure|3|||
94616457|NCT01626456|324058949|FG000|Overall Study|Incarceration|0|||
94616458|NCT01626456|324058950|FG001|Overall Study|Incarceration|2|||
94616459|NCT00713323|324058951|FG000|Overall Study|Adverse Event|75|||
94665494|NCT02347761|324229800|FG001|All Collected|Death|0|||
94665495|NCT02347761|324229801|FG002|All Collected|Death|0|||
94665496|NCT02347761|324229799|FG000|All Collected|Lost to Follow-up|3|||
94665497|NCT02347761|324229800|FG001|All Collected|Lost to Follow-up|2|||
94665498|NCT02347761|324229801|FG002|All Collected|Lost to Follow-up|3|||
94665499|NCT02347761|324229799|FG000|All Collected|Withdrawal by Subject|11|||
94665500|NCT02347761|324229800|FG001|All Collected|Withdrawal by Subject|11|||
94616460|NCT00713323|324058951|FG000|Overall Study|Withdrawal by Subject|15|||
94616461|NCT00713323|324058951|FG000|Overall Study|Lost to Follow-up|11|||
94616462|NCT00713323|324058951|FG000|Overall Study|Lack of Efficacy|36|||
94665501|NCT02347761|324229801|FG002|All Collected|Withdrawal by Subject|22|||
94665502|NCT02347761|324229799|FG000|All Collected|invetigator disretion|2|||
94616463|NCT00713323|324058951|FG000|Overall Study|Low creatine clearance at screening|1|||
94665503|NCT02347761|324229800|FG001|All Collected|invetigator disretion|0|||
94616464|NCT00713323|324058951|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
94616465|NCT00713323|324058951|FG000|Overall Study|Surgery cured allodynic pain|1|||
94616466|NCT00713323|324058951|FG000|Overall Study|Pain free|1|||
94616467|NCT00713323|324058951|FG000|Overall Study|Non-compliance|1|||
94616468|NCT00713323|324058951|FG000|Overall Study|Pain resolved|1|||
94616469|NCT00713323|324058951|FG000|Overall Study|Subject travelling to USA|1|||
94616470|NCT00713323|324058951|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
94616471|NCT00713323|324058951|FG000|Overall Study|Treatment that may interact with Sativex|1|||
94616472|NCT04015336|324058952|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
94616473|NCT00002651|324058956|FG000|Induction|Adverse Event|44|||
94616474|NCT00002651|324058957|FG001|Induction|Adverse Event|0|||
94616475|NCT00002651|324058958|FG002|Induction|Adverse Event|0|||
94616476|NCT00002651|324058956|FG000|Induction|Refusal unrelated to adverse event|50|||
94616477|NCT00002651|324058957|FG001|Induction|Refusal unrelated to adverse event|0|||
94616478|NCT00002651|324058958|FG002|Induction|Refusal unrelated to adverse event|0|||
94616479|NCT00002651|324058956|FG000|Induction|Progression/relapse|274|||
94616480|NCT00002651|324058957|FG001|Induction|Progression/relapse|0|||
94616481|NCT00002651|324058958|FG002|Induction|Progression/relapse|0|||
94616482|NCT00002651|324058956|FG000|Induction|Death|62|||
94616483|NCT00002651|324058957|FG001|Induction|Death|0|||
94616484|NCT00002651|324058958|FG002|Induction|Death|0|||
94616485|NCT00002651|324058956|FG000|Induction|Other|823|||
94616486|NCT00002651|324058957|FG001|Induction|Other|0|||
94616487|NCT00002651|324058958|FG002|Induction|Other|0|||
94616488|NCT00002651|324058956|FG000|Induction|not eligible|90|||
94616489|NCT00002651|324058957|FG001|Induction|not eligible|0|||
94616490|NCT00002651|324058958|FG002|Induction|not eligible|0|||
94616491|NCT00002651|324058956|FG000|Consolidation and Randomization|Adverse Event|0|||
94616492|NCT00002651|324058957|FG001|Consolidation and Randomization|Adverse Event|36|||
94616493|NCT00002651|324058958|FG002|Consolidation and Randomization|Adverse Event|14|||
94616494|NCT00002651|324058956|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
94616495|NCT00002651|324058957|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
94616496|NCT00002651|324058958|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
94616497|NCT00002651|324058956|FG000|Consolidation and Randomization|Progression/relapse|0|||
94616498|NCT00002651|324058957|FG001|Consolidation and Randomization|Progression/relapse|295|||
94616499|NCT00002651|324058958|FG002|Consolidation and Randomization|Progression/relapse|298|||
94616500|NCT00002651|324058956|FG000|Consolidation and Randomization|Death|0|||
94616501|NCT00002651|324058957|FG001|Consolidation and Randomization|Death|38|||
94616502|NCT00002651|324058958|FG002|Consolidation and Randomization|Death|48|||
94616503|NCT00002651|324058956|FG000|Consolidation and Randomization|Other|0|||
94616504|NCT00002651|324058957|FG001|Consolidation and Randomization|Other|314|||
94616505|NCT00002651|324058958|FG002|Consolidation and Randomization|Other|313|||
94616506|NCT00002651|324058956|FG000|Consolidation and Randomization|not eligible|0|||
94616507|NCT00002651|324058957|FG001|Consolidation and Randomization|not eligible|102|||
94616508|NCT00002651|324058958|FG002|Consolidation and Randomization|not eligible|112|||
94616509|NCT01705730|324058967|FG000|Overall Study|Lack of Efficacy|1|||
94616510|NCT01705730|324058967|FG000|Overall Study|Adverse Event|3|||
94616511|NCT01705730|324058967|FG000|Overall Study|Lost to Follow-up|1|||
94616512|NCT01705730|324058967|FG000|Overall Study|Reason not Specified|4|||
94616513|NCT00705289|324058968|FG000|Overall Study|Subject or treating physician's choice|131|||
94616514|NCT02527161|324058971|FG000|Overall Study|Failed MRI|52|||
94616515|NCT02527161|324058971|FG000|Overall Study|Withdrawal by Subject|19|||
94616516|NCT02527161|324058971|FG000|Overall Study|Delay in or unfit for surgery|16|||
94616517|NCT02527161|324058971|FG000|Overall Study|MRI contraindication|6|||
94616518|NCT02527161|324058971|FG000|Overall Study|Consent violation|4|||
94616519|NCT02527161|324058971|FG000|Overall Study|Only Recruited to Part A|27|||
94616520|NCT02527161|324058971|FG000|Overall Study|Physician Decision|1|||
94616521|NCT02527161|324058971|FG000|Overall Study|Adverse Event|1|||
94616522|NCT02527161|324058971|FG000|Overall Study|Lost to Follow-up|6|||
94616523|NCT02202980|324058974|FG000|Overall Study|Lack of Efficacy|1|||
94616524|NCT02202980|324058975|FG001|Overall Study|Lack of Efficacy|0|||
94616525|NCT02202980|324058976|FG002|Overall Study|Lack of Efficacy|7|||
94665504|NCT02347761|324229801|FG002|All Collected|invetigator disretion|0|||
94616526|NCT02202980|324058977|FG003|Overall Study|Lack of Efficacy|0|||
94616527|NCT02202980|324058978|FG004|Overall Study|Lack of Efficacy|3|||
94616528|NCT02202980|324058979|FG005|Overall Study|Lack of Efficacy|1|||
94616529|NCT02202980|324058980|FG006|Overall Study|Lack of Efficacy|11|||
94616530|NCT02202980|324058981|FG007|Overall Study|Lack of Efficacy|2|||
94616531|NCT02202980|324058982|FG008|Overall Study|Lack of Efficacy|2|||
94616532|NCT02202980|324058983|FG009|Overall Study|Lack of Efficacy|0|||
94616533|NCT02202980|324058984|FG010|Overall Study|Lack of Efficacy|0|||
94616534|NCT02202980|324058985|FG011|Overall Study|Lack of Efficacy|3|||
94616535|NCT02202980|324058986|FG012|Overall Study|Lack of Efficacy|10|||
94616536|NCT02202980|324058987|FG013|Overall Study|Lack of Efficacy|0|||
94616537|NCT02202980|324058974|FG000|Overall Study|Protocol Violation|0|||
94665505|NCT02347761|324229799|FG000|All Collected|instillation site pain|0|||
94665506|NCT02347761|324229800|FG001|All Collected|instillation site pain|0|||
94665507|NCT02347761|324229801|FG002|All Collected|instillation site pain|1|||
94665508|NCT02347761|324229799|FG000|All Collected|exacerbation of COPD|0|||
94665509|NCT02347761|324229800|FG001|All Collected|exacerbation of COPD|0|||
94665510|NCT02347761|324229801|FG002|All Collected|exacerbation of COPD|1|||
94665511|NCT02347761|324229799|FG000|All Collected|moved/travel|0|||
94665512|NCT02347761|324229800|FG001|All Collected|moved/travel|1|||
94665513|NCT02347761|324229801|FG002|All Collected|moved/travel|0|||
94665514|NCT02347761|324229799|FG000|On Study Treatment|Lack of Efficacy|2|||
94665515|NCT02347761|324229800|FG001|On Study Treatment|Lack of Efficacy|3|||
94665516|NCT02347761|324229801|FG002|On Study Treatment|Lack of Efficacy|4|||
94665517|NCT02347761|324229799|FG000|On Study Treatment|non-compliance with study medication|0|||
94665518|NCT02347761|324229800|FG001|On Study Treatment|non-compliance with study medication|0|||
94665519|NCT02347761|324229801|FG002|On Study Treatment|non-compliance with study medication|2|||
94616538|NCT02202980|324058975|FG001|Overall Study|Protocol Violation|0|||
94616539|NCT02202980|324058976|FG002|Overall Study|Protocol Violation|0|||
94616540|NCT02202980|324058977|FG003|Overall Study|Protocol Violation|3|||
94616541|NCT02202980|324058978|FG004|Overall Study|Protocol Violation|3|||
94616542|NCT02202980|324058979|FG005|Overall Study|Protocol Violation|0|||
94616543|NCT02202980|324058980|FG006|Overall Study|Protocol Violation|0|||
94616544|NCT02202980|324058981|FG007|Overall Study|Protocol Violation|0|||
94616545|NCT02202980|324058982|FG008|Overall Study|Protocol Violation|0|||
94616546|NCT02202980|324058983|FG009|Overall Study|Protocol Violation|0|||
94616547|NCT02202980|324058984|FG010|Overall Study|Protocol Violation|0|||
94616548|NCT02202980|324058985|FG011|Overall Study|Protocol Violation|0|||
94616549|NCT02202980|324058986|FG012|Overall Study|Protocol Violation|0|||
94616550|NCT02202980|324058987|FG013|Overall Study|Protocol Violation|0|||
94616551|NCT02202980|324058974|FG000|Overall Study|Lost to Follow-up|0|||
94616552|NCT02202980|324058975|FG001|Overall Study|Lost to Follow-up|1|||
94616553|NCT02202980|324058976|FG002|Overall Study|Lost to Follow-up|1|||
94616554|NCT02202980|324058977|FG003|Overall Study|Lost to Follow-up|1|||
94616555|NCT02202980|324058978|FG004|Overall Study|Lost to Follow-up|0|||
94616556|NCT02202980|324058979|FG005|Overall Study|Lost to Follow-up|0|||
94616557|NCT02202980|324058980|FG006|Overall Study|Lost to Follow-up|0|||
94616558|NCT02202980|324058981|FG007|Overall Study|Lost to Follow-up|1|||
94616559|NCT02202980|324058982|FG008|Overall Study|Lost to Follow-up|1|||
94616560|NCT02202980|324058983|FG009|Overall Study|Lost to Follow-up|0|||
94616561|NCT02202980|324058984|FG010|Overall Study|Lost to Follow-up|0|||
94616562|NCT02202980|324058985|FG011|Overall Study|Lost to Follow-up|0|||
94616563|NCT02202980|324058986|FG012|Overall Study|Lost to Follow-up|1|||
94616564|NCT02202980|324058987|FG013|Overall Study|Lost to Follow-up|0|||
94616565|NCT02202980|324058974|FG000|Overall Study|Withdrew Consent|0|||
94616566|NCT02202980|324058975|FG001|Overall Study|Withdrew Consent|1|||
94616567|NCT02202980|324058976|FG002|Overall Study|Withdrew Consent|2|||
94616568|NCT02202980|324058977|FG003|Overall Study|Withdrew Consent|0|||
94616569|NCT02202980|324058978|FG004|Overall Study|Withdrew Consent|0|||
94616570|NCT02202980|324058979|FG005|Overall Study|Withdrew Consent|0|||
94616571|NCT02202980|324058980|FG006|Overall Study|Withdrew Consent|0|||
94616572|NCT02202980|324058981|FG007|Overall Study|Withdrew Consent|0|||
94616573|NCT02202980|324058982|FG008|Overall Study|Withdrew Consent|1|||
94616574|NCT02202980|324058983|FG009|Overall Study|Withdrew Consent|0|||
94616575|NCT02202980|324058984|FG010|Overall Study|Withdrew Consent|0|||
94616576|NCT02202980|324058985|FG011|Overall Study|Withdrew Consent|0|||
94616577|NCT02202980|324058986|FG012|Overall Study|Withdrew Consent|0|||
94616578|NCT02202980|324058987|FG013|Overall Study|Withdrew Consent|0|||
94616579|NCT02747875|324058988|FG000|Overall Study|Physician Decision|1|||
94616580|NCT02747875|324058989|FG001|Overall Study|Physician Decision|0|||
94616581|NCT02747875|324058988|FG000|Overall Study|Adverse Event|0|||
94616582|NCT02747875|324058989|FG001|Overall Study|Adverse Event|1|||
94665520|NCT02347761|324229799|FG000|On Study Treatment|Withdrawal by Subject|7|||
94616583|NCT02590003|324058990|FG000|Overall Study|Death|1|||
94665521|NCT02347761|324229800|FG001|On Study Treatment|Withdrawal by Subject|3|||
94665522|NCT02347761|324229801|FG002|On Study Treatment|Withdrawal by Subject|5|||
94665523|NCT02347761|324229799|FG000|On Study Treatment|move/travel|2|||
94461063|NCT02091986|323476862|FG002|Overall Study|Withdrawal by Subject|3|||
94616584|NCT02590003|324058991|FG001|Overall Study|Death|2|||
94616585|NCT03173313|324058994|FG000|Overall Study|Lost to Follow-up|2|||
94616586|NCT03173313|324058995|FG001|Overall Study|Lost to Follow-up|3|||
94616587|NCT03173313|324058994|FG000|Overall Study|Withdrawal by Subject|0|||
94616588|NCT03173313|324058995|FG001|Overall Study|Withdrawal by Subject|1|||
94616589|NCT03173313|324058994|FG000|Overall Study|Death|5|||
94616590|NCT03173313|324058995|FG001|Overall Study|Death|0|||
94616591|NCT03173313|324058994|FG000|Overall Study|Physician Decision|1|||
94616592|NCT03173313|324058995|FG001|Overall Study|Physician Decision|0|||
94616593|NCT03173313|324058994|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
94616594|NCT03173313|324058995|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
94665524|NCT02347761|324229800|FG001|On Study Treatment|move/travel|6|||
94665525|NCT02347761|324229801|FG002|On Study Treatment|move/travel|5|||
94616595|NCT03173313|324058994|FG000|Overall Study|Bone Fracture|1|||
94665526|NCT02347761|324229799|FG000|On Study Treatment|dissastisfaction with device|2|||
94665527|NCT02347761|324229800|FG001|On Study Treatment|dissastisfaction with device|1|||
94665528|NCT02347761|324229801|FG002|On Study Treatment|dissastisfaction with device|4|||
94665529|NCT02347761|324229799|FG000|On Study Treatment|Lost to Follow-up|2|||
94665530|NCT02347761|324229800|FG001|On Study Treatment|Lost to Follow-up|1|||
94665531|NCT02347761|324229801|FG002|On Study Treatment|Lost to Follow-up|1|||
94665532|NCT02347761|324229799|FG000|On Study Treatment|investigator discretion|2|||
94665533|NCT02347761|324229800|FG001|On Study Treatment|investigator discretion|0|||
94665534|NCT02347761|324229801|FG002|On Study Treatment|investigator discretion|0|||
94665535|NCT02347761|324229799|FG000|On Study Treatment|durg not working|0|||
94665536|NCT02347761|324229800|FG001|On Study Treatment|durg not working|1|||
94665537|NCT02347761|324229801|FG002|On Study Treatment|durg not working|1|||
94665538|NCT02347761|324229799|FG000|On Study Treatment|Adverse Event|10|||
94665539|NCT02347761|324229800|FG001|On Study Treatment|Adverse Event|8|||
94665540|NCT02347761|324229801|FG002|On Study Treatment|Adverse Event|20|||
94665541|NCT05046795|324229802|FG000|Overall Study|Adverse Event|13|||
94665542|NCT05046795|324229803|FG001|Overall Study|Adverse Event|15|||
94665543|NCT05046795|324229802|FG000|Overall Study|Withdrawal by Subject|4|||
94665544|NCT05046795|324229803|FG001|Overall Study|Withdrawal by Subject|7|||
94665545|NCT05046795|324229802|FG000|Overall Study|Physician Decision|1|||
94665546|NCT05046795|324229803|FG001|Overall Study|Physician Decision|2|||
94665547|NCT05046795|324229802|FG000|Overall Study|Protocol Violation|1|||
94665548|NCT05046795|324229803|FG001|Overall Study|Protocol Violation|2|||
94665549|NCT05046795|324229802|FG000|Overall Study|Death|1|||
94665550|NCT05046795|324229803|FG001|Overall Study|Death|0|||
94665551|NCT05046795|324229802|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
94665552|NCT05046795|324229803|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
94665553|NCT05585307|324229804|FG000|Overall Study|Lost to Follow-up|0|||
94665554|NCT05585307|324229805|FG001|Overall Study|Lost to Follow-up|0|||
94665555|NCT05585307|324229806|FG002|Overall Study|Lost to Follow-up|0|||
94665556|NCT05585307|324229807|FG003|Overall Study|Lost to Follow-up|0|||
94665557|NCT05585307|324229808|FG004|Overall Study|Lost to Follow-up|0|||
94665558|NCT05585307|324229809|FG005|Overall Study|Lost to Follow-up|0|||
94665559|NCT05585307|324229810|FG006|Overall Study|Lost to Follow-up|1|||
94665560|NCT05585307|324229811|FG007|Overall Study|Lost to Follow-up|0|||
94665561|NCT06027216|324229814|FG000|Overall Study|Did not qualify|8|||
94665562|NCT04009291|324229815|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
94665563|NCT04009291|324229816|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
94665564|NCT04009291|324229817|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
94665565|NCT04009291|324229818|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
94665566|NCT04009291|324229819|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
94665567|NCT04009291|324229815|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
94665568|NCT04009291|324229816|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
94665569|NCT04009291|324229817|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
94665570|NCT04009291|324229818|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
94665571|NCT04009291|324229819|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
94665572|NCT01362140|324229820|FG000|Overall Study|Noncompliance|1|||
94665573|NCT01362140|324229821|FG001|Overall Study|Noncompliance|0|||
94665574|NCT01362140|324229820|FG000|Overall Study|Adverse Event|2|||
94665575|NCT01362140|324229821|FG001|Overall Study|Adverse Event|2|||
94665576|NCT01362140|324229820|FG000|Overall Study|Withdrawal by Subject|3|||
94665577|NCT01362140|324229821|FG001|Overall Study|Withdrawal by Subject|3|||
94665578|NCT01362140|324229820|FG000|Overall Study|Administrative Decision|0|||
94665579|NCT01362140|324229821|FG001|Overall Study|Administrative Decision|1|||
94665580|NCT01362140|324229820|FG000|Overall Study|Death|2|||
94665581|NCT01362140|324229821|FG001|Overall Study|Death|1|||
94665582|NCT01362140|324229820|FG000|Overall Study|Other|1|||
94665583|NCT01362140|324229821|FG001|Overall Study|Other|1|||
94665584|NCT01362140|324229820|FG000|Overall Study|Protocol-specified Criteria|1|||
94665585|NCT01362140|324229821|FG001|Overall Study|Protocol-specified Criteria|2|||
94665586|NCT01362140|324229820|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
94665587|NCT01362140|324229821|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
94665588|NCT00492284|324229822|FG000|Overall Study|Adverse Event|0|||
94254354|NCT00738582|322724357|FG000|Maintenance Therapy|Progressive Disease|0|||
94665589|NCT00492284|324229823|FG001|Overall Study|Adverse Event|1|||
94665590|NCT00492284|324229824|FG002|Overall Study|Adverse Event|1|||
94665591|NCT00492284|324229825|FG003|Overall Study|Adverse Event|2|||
94665592|NCT00492284|324229822|FG000|Overall Study|Lost to Follow-up|0|||
94665593|NCT00492284|324229823|FG001|Overall Study|Lost to Follow-up|0|||
94665594|NCT00492284|324229824|FG002|Overall Study|Lost to Follow-up|3|||
94665595|NCT00492284|324229825|FG003|Overall Study|Lost to Follow-up|1|||
94665596|NCT00492284|324229822|FG000|Overall Study|Death|0|||
94665597|NCT00492284|324229823|FG001|Overall Study|Death|3|||
94665598|NCT00492284|324229824|FG002|Overall Study|Death|2|||
94665599|NCT00492284|324229825|FG003|Overall Study|Death|5|||
94665600|NCT00492284|324229822|FG000|Overall Study|Withdrawal by Subject|1|||
94665601|NCT00492284|324229823|FG001|Overall Study|Withdrawal by Subject|0|||
94665602|NCT00492284|324229824|FG002|Overall Study|Withdrawal by Subject|0|||
94665603|NCT00492284|324229825|FG003|Overall Study|Withdrawal by Subject|2|||
94665604|NCT02959437|324229826|FG000|Overall Study|Death|33|||
94665605|NCT02959437|324229827|FG001|Overall Study|Death|3|||
94665606|NCT02959437|324229828|FG002|Overall Study|Death|0|||
94665607|NCT02959437|324229829|FG003|Overall Study|Death|0|||
94665608|NCT02959437|324229826|FG000|Overall Study|Lost to Follow-up|3|||
94665609|NCT02959437|324229827|FG001|Overall Study|Lost to Follow-up|1|||
94665610|NCT02959437|324229828|FG002|Overall Study|Lost to Follow-up|0|||
94665611|NCT02959437|324229829|FG003|Overall Study|Lost to Follow-up|0|||
94665612|NCT02959437|324229826|FG000|Overall Study|Withdrawal by Subject|11|||
94665613|NCT02959437|324229827|FG001|Overall Study|Withdrawal by Subject|3|||
94665614|NCT02959437|324229828|FG002|Overall Study|Withdrawal by Subject|0|||
94665615|NCT02959437|324229829|FG003|Overall Study|Withdrawal by Subject|0|||
94665616|NCT02959437|324229826|FG000|Overall Study|Progressive Disease|9|||
94665617|NCT02959437|324229827|FG001|Overall Study|Progressive Disease|1|||
94665618|NCT02959437|324229828|FG002|Overall Study|Progressive Disease|0|||
94665619|NCT02959437|324229829|FG003|Overall Study|Progressive Disease|0|||
94665620|NCT02959437|324229826|FG000|Overall Study|Study Terminated by Sponsor|4|||
94665621|NCT02959437|324229827|FG001|Overall Study|Study Terminated by Sponsor|0|||
94665622|NCT02959437|324229828|FG002|Overall Study|Study Terminated by Sponsor|0|||
94665623|NCT02959437|324229829|FG003|Overall Study|Study Terminated by Sponsor|0|||
94665624|NCT02959437|324229826|FG000|Overall Study|Other Unspecified|2|||
94665625|NCT02959437|324229827|FG001|Overall Study|Other Unspecified|0|||
94665626|NCT02959437|324229828|FG002|Overall Study|Other Unspecified|0|||
94616596|NCT03173313|324058995|FG001|Overall Study|Bone Fracture|0|||
94616597|NCT02589405|324059009|FG000|Overall Study|Adverse Event|3|||
94616598|NCT02589405|324059009|FG000|Overall Study|Withdrawal by Subject|1|||
94616599|NCT00939640|324059014|FG000|Overall Study|Physician Decision|1|||
94616600|NCT04203797|324059015|FG000|Overall Study|Adverse Event|1|||
94616601|NCT04203797|324059016|FG001|Overall Study|Adverse Event|0|||
94616602|NCT04203797|324059015|FG000|Overall Study|Did not complete End of Study follow-up|1|||
94616603|NCT04203797|324059016|FG001|Overall Study|Did not complete End of Study follow-up|0|||
94616604|NCT02362269|324059021|FG000|Overall Study|Moved|1|||
94616605|NCT02362269|324059022|FG001|Overall Study|Moved|0|||
94616606|NCT02362269|324059021|FG000|Overall Study|Lost to Follow-up|0|||
94616607|NCT02362269|324059022|FG001|Overall Study|Lost to Follow-up|6|||
94616608|NCT00892047|324059023|FG000|Overall Study|Adverse Event|2|||
94616609|NCT00892047|324059024|FG001|Overall Study|Adverse Event|2|||
94616610|NCT00892047|324059023|FG000|Overall Study|subject burden|2|||
94616611|NCT00892047|324059024|FG001|Overall Study|subject burden|3|||
94616612|NCT00892047|324059023|FG000|Overall Study|Lack of Efficacy|0|||
94616613|NCT00892047|324059024|FG001|Overall Study|Lack of Efficacy|2|||
94616614|NCT05306977|324059025|FG000|Overall Study|Withdrawal by Subject|1|||
94616615|NCT00287365|324059026|FG000|Overall Study|sample not acquired|13|||
94616616|NCT01235689|324059027|FG000|Overall Study|Adverse Event|12|||
94665627|NCT02959437|324229829|FG003|Overall Study|Other Unspecified|0|||
94665628|NCT03150056|324229835|FG000|Overall Study|Withdrawal by Subject|0|||
94665629|NCT03150056|324229836|FG001|Overall Study|Withdrawal by Subject|0|||
94665630|NCT03150056|324229837|FG002|Overall Study|Withdrawal by Subject|0|||
94665631|NCT03150056|324229838|FG003|Overall Study|Withdrawal by Subject|0|||
94665632|NCT03150056|324229839|FG004|Overall Study|Withdrawal by Subject|0|||
94665633|NCT03150056|324229840|FG005|Overall Study|Withdrawal by Subject|2|||
94665634|NCT03150056|324229835|FG000|Overall Study|Study terminated by Sponsor|1|||
94665635|NCT03150056|324229836|FG001|Overall Study|Study terminated by Sponsor|3|||
94665636|NCT03150056|324229837|FG002|Overall Study|Study terminated by Sponsor|1|||
94665637|NCT03150056|324229838|FG003|Overall Study|Study terminated by Sponsor|1|||
94665638|NCT03150056|324229839|FG004|Overall Study|Study terminated by Sponsor|5|||
94665639|NCT03150056|324229840|FG005|Overall Study|Study terminated by Sponsor|6|||
94665640|NCT03150056|324229835|FG000|Overall Study|Death|9|||
94616617|NCT01235689|324059028|FG001|Overall Study|Adverse Event|16|||
94616618|NCT01235689|324059027|FG000|Overall Study|Lack of Efficacy|12|||
94616619|NCT01235689|324059028|FG001|Overall Study|Lack of Efficacy|5|||
94616620|NCT01235689|324059027|FG000|Overall Study|Withdrawal by Subject|3|||
94616621|NCT01235689|324059028|FG001|Overall Study|Withdrawal by Subject|4|||
94616622|NCT01235689|324059027|FG000|Overall Study|Lost to Follow-up|1|||
94616623|NCT01235689|324059028|FG001|Overall Study|Lost to Follow-up|2|||
94616624|NCT01235689|324059027|FG000|Overall Study|Miscellaneous|1|||
94616625|NCT01235689|324059028|FG001|Overall Study|Miscellaneous|5|||
94616626|NCT01443078|324059029|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
94665641|NCT03150056|324229836|FG001|Overall Study|Death|2|||
94665642|NCT03150056|324229837|FG002|Overall Study|Death|2|||
94665643|NCT03150056|324229838|FG003|Overall Study|Death|7|||
94665644|NCT03150056|324229839|FG004|Overall Study|Death|8|||
94665645|NCT03150056|324229840|FG005|Overall Study|Death|10|||
94665646|NCT02952924|324229841|FG000|Overall Study|Protocol Violation|0|||
94665647|NCT02952924|324229842|FG001|Overall Study|Protocol Violation|0|||
94665648|NCT02952924|324229843|FG002|Overall Study|Protocol Violation|0|||
94665649|NCT02952924|324229844|FG003|Overall Study|Protocol Violation|0|||
94665650|NCT02952924|324229845|FG004|Overall Study|Protocol Violation|0|||
94665651|NCT02952924|324229846|FG005|Overall Study|Protocol Violation|0|||
94665652|NCT02952924|324229847|FG006|Overall Study|Protocol Violation|0|||
94665653|NCT02952924|324229848|FG007|Overall Study|Protocol Violation|0|||
94665654|NCT02952924|324229849|FG008|Overall Study|Protocol Violation|0|||
94665655|NCT02952924|324229850|FG009|Overall Study|Protocol Violation|0|||
94665656|NCT02952924|324229851|FG010|Overall Study|Protocol Violation|0|||
94665657|NCT02952924|324229852|FG011|Overall Study|Protocol Violation|0|||
94665658|NCT02952924|324229853|FG012|Overall Study|Protocol Violation|0|||
94665659|NCT02952924|324229854|FG013|Overall Study|Protocol Violation|0|||
94665660|NCT02952924|324229855|FG014|Overall Study|Protocol Violation|0|||
94665661|NCT02952924|324229856|FG015|Overall Study|Protocol Violation|0|||
94665662|NCT02952924|324229857|FG016|Overall Study|Protocol Violation|0|||
94665663|NCT02952924|324229858|FG017|Overall Study|Protocol Violation|0|||
94665664|NCT02952924|324229859|FG018|Overall Study|Protocol Violation|0|||
94665665|NCT02952924|324229860|FG019|Overall Study|Protocol Violation|1|||
94665666|NCT02952924|324229861|FG020|Overall Study|Protocol Violation|0|||
94665667|NCT02952924|324229862|FG021|Overall Study|Protocol Violation|0|||
94665668|NCT02952924|324229841|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
94665669|NCT02952924|324229842|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
94665670|NCT02952924|324229843|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
94665671|NCT02952924|324229844|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
94665672|NCT02952924|324229845|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
94665673|NCT02952924|324229846|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
94665674|NCT02952924|324229847|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
94665675|NCT02952924|324229848|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
94665676|NCT02952924|324229849|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
94665677|NCT02952924|324229850|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
94665678|NCT02952924|324229851|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
94665679|NCT02952924|324229852|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
94665680|NCT02952924|324229853|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
94665681|NCT02952924|324229854|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
94665682|NCT02952924|324229855|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
94665683|NCT02952924|324229856|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
94665684|NCT02952924|324229857|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
94665685|NCT02952924|324229858|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
94665686|NCT02952924|324229859|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
94665687|NCT02952924|324229860|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
94665688|NCT02952924|324229861|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
94665689|NCT02952924|324229862|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
94665690|NCT02952924|324229841|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665691|NCT02952924|324229842|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665692|NCT02952924|324229843|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665693|NCT02952924|324229844|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665694|NCT02952924|324229845|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665695|NCT02952924|324229846|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665696|NCT02952924|324229847|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665697|NCT02952924|324229848|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665698|NCT02952924|324229849|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665699|NCT02952924|324229850|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665700|NCT02952924|324229851|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665701|NCT02952924|324229852|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665702|NCT02952924|324229853|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665703|NCT02952924|324229854|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665704|NCT02952924|324229855|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665705|NCT02952924|324229856|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665706|NCT02952924|324229857|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665707|NCT02952924|324229858|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665708|NCT02952924|324229859|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665709|NCT02952924|324229860|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665710|NCT02952924|324229861|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
94665711|NCT02952924|324229862|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
94665712|NCT02952924|324229841|FG000|Overall Study|Noncompliance with study drug|0|||
94665713|NCT02952924|324229842|FG001|Overall Study|Noncompliance with study drug|0|||
94665714|NCT02952924|324229843|FG002|Overall Study|Noncompliance with study drug|0|||
94616627|NCT01443078|324059029|FG000|Overall Study|Withdrawal by Subject|1|||
94616628|NCT01443078|324059029|FG000|Overall Study|Patient had brain mets|1|||
94616629|NCT00415168|324059030|FG000|Overall Study|Death|26|||
94616630|NCT00415168|324059030|FG000|Overall Study|Lost to Follow-up|3|||
94616631|NCT00415168|324059030|FG000|Overall Study|Physician Decision|13|||
94616632|NCT00415168|324059030|FG000|Overall Study|Sponsor Decision|4|||
94616633|NCT00415168|324059030|FG000|Overall Study|Withdrawal by Subject|6|||
94616634|NCT03822182|324059031|FG000|Overall Study|Protocol Violation|0|||
94616635|NCT03822182|324059032|FG001|Overall Study|Protocol Violation|1|||
94616636|NCT03822182|324059033|FG002|Overall Study|Protocol Violation|1|||
94616637|NCT02106975|324059038|FG000|Overall Study|Death|25|||
94616638|NCT02106975|324059039|FG001|Overall Study|Death|39|||
94616639|NCT02130297|324059043|FG000|Overall Study|Lost to Follow-up|4|||
94616640|NCT00306189|324059044|FG000|Overall Study|Physician Decision|0|||
94616641|NCT00306189|324059045|FG001|Overall Study|Physician Decision|0|||
94616642|NCT00306189|324059046|FG002|Overall Study|Physician Decision|0|||
94616643|NCT00306189|324059047|FG003|Overall Study|Physician Decision|1|||
94616644|NCT00306189|324059044|FG000|Overall Study|Adverse Event|3|||
94616645|NCT00306189|324059045|FG001|Overall Study|Adverse Event|3|||
94616646|NCT00306189|324059046|FG002|Overall Study|Adverse Event|2|||
94616647|NCT00306189|324059047|FG003|Overall Study|Adverse Event|2|||
94616648|NCT00306189|324059044|FG000|Overall Study|Withdrawal by Subject|4|||
94616649|NCT00306189|324059045|FG001|Overall Study|Withdrawal by Subject|2|||
94616650|NCT00306189|324059046|FG002|Overall Study|Withdrawal by Subject|8|||
94616651|NCT00306189|324059047|FG003|Overall Study|Withdrawal by Subject|1|||
94616652|NCT00306189|324059044|FG000|Overall Study|Ineligibility determined|1|||
94616653|NCT00306189|324059045|FG001|Overall Study|Ineligibility determined|1|||
94616654|NCT00306189|324059046|FG002|Overall Study|Ineligibility determined|1|||
94616655|NCT00306189|324059047|FG003|Overall Study|Ineligibility determined|1|||
94616656|NCT00306189|324059044|FG000|Overall Study|Other|1|||
94616657|NCT00306189|324059045|FG001|Overall Study|Other|0|||
94616658|NCT00306189|324059046|FG002|Overall Study|Other|0|||
94616659|NCT00306189|324059047|FG003|Overall Study|Other|0|||
94616660|NCT02059408|324059048|FG000|Overall Study|Did not get tested|0|||
94616661|NCT02059408|324059049|FG001|Overall Study|Did not get tested|330|||
94616662|NCT02059408|324059050|FG002|Overall Study|Did not get tested|358|||
94616663|NCT01548287|324059051|FG000|Screening|No reason provided|0|||
94616664|NCT01548287|324059052|FG001|Screening|No reason provided|0|||
94616665|NCT01548287|324059053|FG002|Screening|No reason provided|0|||
94616666|NCT01548287|324059054|FG003|Screening|No reason provided|0|||
94616667|NCT01548287|324059055|FG004|Screening|No reason provided|9|||
94616668|NCT01548287|324059051|FG000|Screening|Did not meet eligibility criteria|0|||
94616669|NCT01548287|324059052|FG001|Screening|Did not meet eligibility criteria|0|||
94616670|NCT01548287|324059053|FG002|Screening|Did not meet eligibility criteria|0|||
94616671|NCT01548287|324059054|FG003|Screening|Did not meet eligibility criteria|0|||
94616672|NCT01548287|324059055|FG004|Screening|Did not meet eligibility criteria|74|||
94616673|NCT01548287|324059051|FG000|Randomized Period|Did not meet inclusion criteria|0|||
94616674|NCT01548287|324059052|FG001|Randomized Period|Did not meet inclusion criteria|0|||
94616675|NCT01548287|324059053|FG002|Randomized Period|Did not meet inclusion criteria|2|||
94616676|NCT01548287|324059054|FG003|Randomized Period|Did not meet inclusion criteria|0|||
94616677|NCT01548287|324059055|FG004|Randomized Period|Did not meet inclusion criteria|0|||
94616678|NCT01548287|324059051|FG000|Randomized Period|Adverse Event|0|||
94616679|NCT01548287|324059052|FG001|Randomized Period|Adverse Event|2|||
94616680|NCT01548287|324059053|FG002|Randomized Period|Adverse Event|5|||
94616681|NCT01548287|324059054|FG003|Randomized Period|Adverse Event|0|||
94616682|NCT01548287|324059055|FG004|Randomized Period|Adverse Event|0|||
94616683|NCT02993757|324059056|FG000|Overall Study|Non compliance with the protocol|155|||
94616684|NCT02993757|324059057|FG001|Overall Study|Non compliance with the protocol|170|||
94616685|NCT02993757|324059056|FG000|Overall Study|Lost to Follow-up|1|||
94616686|NCT02993757|324059057|FG001|Overall Study|Lost to Follow-up|0|||
94616687|NCT02993757|324059056|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
94616688|NCT02993757|324059057|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
94616689|NCT02762578|324059060|FG000|Overall Study|Adverse Event|1|||
94616690|NCT02762578|324059061|FG001|Overall Study|Adverse Event|6|||
94665715|NCT02952924|324229844|FG003|Overall Study|Noncompliance with study drug|0|||
94616691|NCT02762578|324059060|FG000|Overall Study|Protocol Violation|4|||
94616692|NCT02762578|324059061|FG001|Overall Study|Protocol Violation|2|||
94616693|NCT02762578|324059060|FG000|Overall Study|Withdrawal by Subject|4|||
94616694|NCT02762578|324059061|FG001|Overall Study|Withdrawal by Subject|2|||
94616695|NCT02762578|324059060|FG000|Overall Study|Unclassified|6|||
94616696|NCT02762578|324059061|FG001|Overall Study|Unclassified|0|||
94616697|NCT01090492|324059062|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
94616698|NCT01090492|324059063|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
94616699|NCT01090492|324059064|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
94616700|NCT01090492|324059065|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
94616701|NCT01090492|324059066|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
94616702|NCT01090492|324059067|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
94616703|NCT01090492|324059068|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
94616704|NCT01090492|324059069|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
94616705|NCT01090492|324059062|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
94616706|NCT01090492|324059063|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
94616707|NCT01090492|324059064|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
94616708|NCT01090492|324059065|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
94616709|NCT01090492|324059066|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
94616710|NCT01090492|324059067|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
94616711|NCT01090492|324059068|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
94616712|NCT01090492|324059069|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
94616713|NCT01090492|324059062|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
94616714|NCT01090492|324059063|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
94616715|NCT01090492|324059064|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
94616716|NCT01090492|324059065|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
94616717|NCT01090492|324059066|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
94616718|NCT01090492|324059067|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
94616719|NCT01090492|324059068|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
94616720|NCT01090492|324059069|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
94616721|NCT01090492|324059062|FG000|First Intervention Period (4 Weeks)|Other|0|||
94616722|NCT01090492|324059063|FG001|First Intervention Period (4 Weeks)|Other|0|||
94616723|NCT01090492|324059064|FG002|First Intervention Period (4 Weeks)|Other|1|||
94616724|NCT01090492|324059065|FG003|First Intervention Period (4 Weeks)|Other|1|||
94616725|NCT01090492|324059066|FG004|First Intervention Period (4 Weeks)|Other|2|||
94616726|NCT01090492|324059067|FG005|First Intervention Period (4 Weeks)|Other|0|||
94616727|NCT01090492|324059068|FG006|First Intervention Period (4 Weeks)|Other|0|||
94616728|NCT01090492|324059069|FG007|First Intervention Period (4 Weeks)|Other|0|||
94616729|NCT01090492|324059062|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
94616730|NCT01090492|324059063|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
94616731|NCT01090492|324059064|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
94616732|NCT01090492|324059065|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
94616733|NCT01090492|324059066|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
94616734|NCT01090492|324059067|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
94616735|NCT01090492|324059068|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
94616736|NCT01090492|324059069|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
94616737|NCT01090492|324059062|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
94616738|NCT01090492|324059063|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
94616739|NCT01090492|324059064|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
94616740|NCT01090492|324059065|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
94616741|NCT01090492|324059066|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
94616742|NCT01090492|324059067|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
94616743|NCT01090492|324059068|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
94616744|NCT01090492|324059069|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
94616745|NCT01090492|324059062|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
94616746|NCT01090492|324059063|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
94616747|NCT01090492|324059064|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
94616748|NCT01090492|324059065|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
94616749|NCT01090492|324059066|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
94616750|NCT01090492|324059067|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
94616751|NCT01090492|324059068|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
94616752|NCT01090492|324059069|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
94616753|NCT01090492|324059062|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
94616754|NCT01090492|324059063|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
94616755|NCT01090492|324059064|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
94616756|NCT01090492|324059065|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
94616757|NCT01090492|324059066|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
94616758|NCT01090492|324059067|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
94358919|NCT01366846|323097997|FG002|Overall Study|Withdrawal by Subject|0|||
94616759|NCT01090492|324059068|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
94616760|NCT01090492|324059069|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
94616761|NCT01090492|324059062|FG000|Second Intervention Period (4 Weeks)|Other|0|||
94616762|NCT01090492|324059063|FG001|Second Intervention Period (4 Weeks)|Other|1|||
94616763|NCT01090492|324059064|FG002|Second Intervention Period (4 Weeks)|Other|1|||
94616764|NCT01090492|324059065|FG003|Second Intervention Period (4 Weeks)|Other|0|||
94616765|NCT01090492|324059066|FG004|Second Intervention Period (4 Weeks)|Other|0|||
94616766|NCT01090492|324059067|FG005|Second Intervention Period (4 Weeks)|Other|0|||
94616767|NCT01090492|324059068|FG006|Second Intervention Period (4 Weeks)|Other|0|||
94616768|NCT01090492|324059069|FG007|Second Intervention Period (4 Weeks)|Other|0|||
94358920|NCT01366846|323097998|FG003|Overall Study|Withdrawal by Subject|0|||
94358921|NCT01366846|323097995|FG000|Overall Study|Communication Difficulties|1|||
94358922|NCT01366846|323097996|FG001|Overall Study|Communication Difficulties|4|||
94616769|NCT01090492|324059062|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
94616770|NCT01090492|324059063|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
94616771|NCT01090492|324059064|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
94616772|NCT01090492|324059065|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
94616773|NCT01090492|324059066|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
94616774|NCT01090492|324059067|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
94616775|NCT01090492|324059068|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
94616776|NCT01090492|324059069|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
94616777|NCT01090492|324059062|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
94616778|NCT01090492|324059063|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
94616779|NCT01090492|324059064|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
94616780|NCT01090492|324059065|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
94616781|NCT01090492|324059066|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
94616782|NCT01090492|324059067|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
94616783|NCT01090492|324059068|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
94616784|NCT01090492|324059069|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
94616785|NCT00945893|324059071|FG000|Overall Study|Lost to Follow-up|2|||
94616786|NCT00945893|324059072|FG001|Overall Study|Lost to Follow-up|8|||
94616787|NCT00945893|324059071|FG000|Overall Study|Withdrawal of consent|1|||
94616788|NCT00945893|324059072|FG001|Overall Study|Withdrawal of consent|2|||
94616789|NCT02083965|324059073|FG000|Treatment Period|Other|1|||
94616790|NCT02083965|324059074|FG001|Treatment Period|Other|0|||
94616791|NCT01602120|324059075|FG000|Overall Study|Adverse Event|3|||
94616792|NCT01602120|324059076|FG001|Overall Study|Adverse Event|6|||
94616793|NCT01602120|324059077|FG002|Overall Study|Adverse Event|0|||
94616794|NCT01602120|324059078|FG003|Overall Study|Adverse Event|2|||
94616795|NCT01602120|324059075|FG000|Overall Study|Death|0|||
94616796|NCT01602120|324059076|FG001|Overall Study|Death|4|||
94616797|NCT01602120|324059077|FG002|Overall Study|Death|0|||
94616798|NCT01602120|324059078|FG003|Overall Study|Death|0|||
94616799|NCT01602120|324059075|FG000|Overall Study|Lost to Follow-up|0|||
94616800|NCT01602120|324059076|FG001|Overall Study|Lost to Follow-up|1|||
94616801|NCT01602120|324059077|FG002|Overall Study|Lost to Follow-up|0|||
94616802|NCT01602120|324059078|FG003|Overall Study|Lost to Follow-up|1|||
94616803|NCT01602120|324059075|FG000|Overall Study|Protocol Violation|1|||
94616804|NCT01602120|324059076|FG001|Overall Study|Protocol Violation|1|||
94616805|NCT01602120|324059077|FG002|Overall Study|Protocol Violation|0|||
94616806|NCT01602120|324059078|FG003|Overall Study|Protocol Violation|0|||
94616807|NCT01602120|324059075|FG000|Overall Study|Non-compliance|0|||
94616808|NCT01602120|324059076|FG001|Overall Study|Non-compliance|3|||
94616809|NCT01602120|324059077|FG002|Overall Study|Non-compliance|0|||
94616810|NCT01602120|324059078|FG003|Overall Study|Non-compliance|1|||
94616811|NCT01602120|324059075|FG000|Overall Study|Withdrawal by Subject|8|||
94616812|NCT01602120|324059076|FG001|Overall Study|Withdrawal by Subject|17|||
94616813|NCT01602120|324059077|FG002|Overall Study|Withdrawal by Subject|0|||
94616814|NCT01602120|324059078|FG003|Overall Study|Withdrawal by Subject|3|||
94616815|NCT01602120|324059075|FG000|Overall Study|Study Terminated by Sponsor|12|||
94616816|NCT01602120|324059076|FG001|Overall Study|Study Terminated by Sponsor|24|||
94616817|NCT01602120|324059077|FG002|Overall Study|Study Terminated by Sponsor|17|||
94616818|NCT01602120|324059078|FG003|Overall Study|Study Terminated by Sponsor|44|||
94616819|NCT01602120|324059075|FG000|Overall Study|Physician Decision|2|||
94616820|NCT01602120|324059076|FG001|Overall Study|Physician Decision|3|||
94616821|NCT01602120|324059077|FG002|Overall Study|Physician Decision|0|||
94616822|NCT01602120|324059078|FG003|Overall Study|Physician Decision|0|||
94616823|NCT01602120|324059075|FG000|Overall Study|Unspecified Reason|3|||
94616824|NCT01602120|324059076|FG001|Overall Study|Unspecified Reason|1|||
94616825|NCT01602120|324059077|FG002|Overall Study|Unspecified Reason|0|||
94616826|NCT01602120|324059078|FG003|Overall Study|Unspecified Reason|2|||
94616827|NCT01787331|324059081|FG000|Overall Study|Physician Decision|1|||
94616828|NCT01787331|324059081|FG000|Overall Study|Withdrawal by Subject|1|||
94616829|NCT01681472|324059082|FG000|Overall Study|Adverse Event|0|||
94616830|NCT01681472|324059083|FG001|Overall Study|Adverse Event|1|||
94358923|NCT01366846|323097997|FG002|Overall Study|Communication Difficulties|0|||
94358924|NCT01366846|323097998|FG003|Overall Study|Communication Difficulties|1|||
94616831|NCT01681472|324059084|FG002|Overall Study|Adverse Event|0|||
94616832|NCT01681472|324059085|FG003|Overall Study|Adverse Event|0|||
94616833|NCT00319501|324059086|FG000|Double-blind Period|Withdrawal by Subject|0|||
94616834|NCT00319501|324059087|FG001|Double-blind Period|Withdrawal by Subject|3|||
94616835|NCT00319501|324059086|FG000|Double-blind Period|Sponsor Request|1|||
94616836|NCT00319501|324059087|FG001|Double-blind Period|Sponsor Request|0|||
94616837|NCT00319501|324059086|FG000|Double-blind Period|Did not receive treatment|42|||
94616838|NCT00319501|324059087|FG001|Double-blind Period|Did not receive treatment|29|||
94616839|NCT00319501|324059086|FG000|Open-label Period|Adverse Event|5|||
94616840|NCT00319501|324059087|FG001|Open-label Period|Adverse Event|0|||
94616841|NCT00319501|324059086|FG000|Open-label Period|Protocol Violation|6|||
94616842|NCT00319501|324059087|FG001|Open-label Period|Protocol Violation|0|||
94616843|NCT00319501|324059086|FG000|Open-label Period|Withdrawal by Subject|38|||
94616844|NCT00319501|324059087|FG001|Open-label Period|Withdrawal by Subject|0|||
94616845|NCT00319501|324059086|FG000|Open-label Period|Principal Investigator decision|6|||
94616846|NCT00319501|324059087|FG001|Open-label Period|Principal Investigator decision|0|||
94616847|NCT00319501|324059086|FG000|Open-label Period|Sponsor request|12|||
94616848|NCT00319501|324059087|FG001|Open-label Period|Sponsor request|0|||
94616849|NCT00319501|324059086|FG000|Open-label Period|Lost to Follow-up|5|||
94616850|NCT00319501|324059087|FG001|Open-label Period|Lost to Follow-up|0|||
94616851|NCT00319501|324059086|FG000|Open-label Period|Did not receive treatment|33|||
94616852|NCT00319501|324059087|FG001|Open-label Period|Did not receive treatment|0|||
94616853|NCT00319501|324059086|FG000|Open-label Period|Other|11|||
94616854|NCT00319501|324059087|FG001|Open-label Period|Other|0|||
94616855|NCT00319501|324059086|FG000|Open-label Extension Period|Adverse Event|2|||
94616856|NCT00319501|324059087|FG001|Open-label Extension Period|Adverse Event|0|||
94616857|NCT00319501|324059086|FG000|Open-label Extension Period|Did not receive treatment|18|||
94616858|NCT00319501|324059087|FG001|Open-label Extension Period|Did not receive treatment|0|||
94616859|NCT00319501|324059086|FG000|Open-label Extension Period|Other|1|||
94616860|NCT00319501|324059087|FG001|Open-label Extension Period|Other|0|||
94616861|NCT00319501|324059086|FG000|Open-label Extension Period|Principal investigator decision|2|||
94616862|NCT00319501|324059087|FG001|Open-label Extension Period|Principal investigator decision|0|||
94616863|NCT00319501|324059086|FG000|Open-label Extension Period|Sponsor request|26|||
94616864|NCT00319501|324059087|FG001|Open-label Extension Period|Sponsor request|0|||
94358925|NCT01366846|323097995|FG000|Overall Study|Scheduling Conflicts|0|||
94358926|NCT01366846|323097996|FG001|Overall Study|Scheduling Conflicts|0|||
94616865|NCT00319501|324059086|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
94616866|NCT00319501|324059087|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
94616867|NCT04057365|324059088|FG000|Overall Study|Withdrawal by Subject|2|||
94616868|NCT04057365|324059089|FG001|Overall Study|Withdrawal by Subject|0|||
94616869|NCT00717093|324060842|FG000|Overall Study|Adverse Event|19|||
94616870|NCT00717093|324060843|FG001|Overall Study|Adverse Event|9|||
94616871|NCT00717093|324060842|FG000|Overall Study|Lack of Efficacy|3|||
94616872|NCT00717093|324060843|FG001|Overall Study|Lack of Efficacy|13|||
94616873|NCT00717093|324060842|FG000|Overall Study|Lost to Follow-up|9|||
94616874|NCT00717093|324060843|FG001|Overall Study|Lost to Follow-up|6|||
94616875|NCT00717093|324060842|FG000|Overall Study|Withdrawal by Subject|12|||
94616876|NCT00717093|324060843|FG001|Overall Study|Withdrawal by Subject|19|||
94616877|NCT00717093|324060842|FG000|Overall Study|Other|0|||
94616878|NCT00717093|324060843|FG001|Overall Study|Other|1|||
94616879|NCT00717093|324060842|FG000|Overall Study|Randomized but not treated|1|||
94616880|NCT00717093|324060843|FG001|Overall Study|Randomized but not treated|0|||
94616881|NCT01560403|324060844|FG000|Overall Study|Lost to Follow-up|0|||
94616882|NCT01560403|324060845|FG001|Overall Study|Lost to Follow-up|1|||
94616883|NCT01193530|324060850|FG000|Overall Study|Withdrawal by Subject|2|||
94616884|NCT01193530|324060851|FG001|Overall Study|Withdrawal by Subject|2|||
94616885|NCT01193530|324060850|FG000|Overall Study|Began Contraindicated Therapy|1|||
94616886|NCT01193530|324060851|FG001|Overall Study|Began Contraindicated Therapy|0|||
94616887|NCT01193530|324060850|FG000|Overall Study|Lost Light Box|0|||
94616888|NCT01193530|324060851|FG001|Overall Study|Lost Light Box|1|||
94616889|NCT01193530|324060850|FG000|Overall Study|Returned home - out of state|0|||
94616890|NCT01193530|324060851|FG001|Overall Study|Returned home - out of state|1|||
94616891|NCT01193530|324060850|FG000|Overall Study|Non-Compliance|0|||
94616892|NCT01193530|324060851|FG001|Overall Study|Non-Compliance|1|||
94616893|NCT01020981|324060852|FG000|Overall Study|Did not return mailed survey|74|||
94616894|NCT01020981|324060853|FG001|Overall Study|Did not return mailed survey|58|||
94616895|NCT01020981|324060852|FG000|Overall Study|Survey returned undeliverable|8|||
94616896|NCT01020981|324060853|FG001|Overall Study|Survey returned undeliverable|32|||
94616897|NCT01020981|324060852|FG000|Overall Study|Participant declined to complete survey|2|||
94616898|NCT01020981|324060853|FG001|Overall Study|Participant declined to complete survey|0|||
94616899|NCT04678661|324060856|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
94616900|NCT04678661|324060857|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
94616901|NCT04678661|324060856|FG000|Overall Study|Protocol Violation|2|||
94616902|NCT04678661|324060857|FG001|Overall Study|Protocol Violation|0|||
94616903|NCT04678661|324060856|FG000|Overall Study|Withdrawal by Subject|1|||
94665716|NCT02952924|324229845|FG004|Overall Study|Noncompliance with study drug|0|||
94665717|NCT02952924|324229846|FG005|Overall Study|Noncompliance with study drug|0|||
94665718|NCT02952924|324229847|FG006|Overall Study|Noncompliance with study drug|0|||
94665719|NCT02952924|324229848|FG007|Overall Study|Noncompliance with study drug|0|||
94665720|NCT02952924|324229849|FG008|Overall Study|Noncompliance with study drug|0|||
94665721|NCT02952924|324229850|FG009|Overall Study|Noncompliance with study drug|0|||
94665722|NCT02952924|324229851|FG010|Overall Study|Noncompliance with study drug|0|||
94665723|NCT02952924|324229852|FG011|Overall Study|Noncompliance with study drug|0|||
94665724|NCT02952924|324229853|FG012|Overall Study|Noncompliance with study drug|0|||
94665725|NCT02952924|324229854|FG013|Overall Study|Noncompliance with study drug|0|||
94665726|NCT02952924|324229855|FG014|Overall Study|Noncompliance with study drug|0|||
94665727|NCT02952924|324229856|FG015|Overall Study|Noncompliance with study drug|0|||
94665728|NCT02952924|324229857|FG016|Overall Study|Noncompliance with study drug|0|||
94665729|NCT02952924|324229858|FG017|Overall Study|Noncompliance with study drug|0|||
94665730|NCT02952924|324229859|FG018|Overall Study|Noncompliance with study drug|0|||
94665731|NCT02952924|324229860|FG019|Overall Study|Noncompliance with study drug|0|||
94665732|NCT02952924|324229861|FG020|Overall Study|Noncompliance with study drug|0|||
94665733|NCT02952924|324229862|FG021|Overall Study|Noncompliance with study drug|1|||
94665734|NCT00295750|324229877|FG000|Overall Study|Adverse Event|19|||
94665735|NCT00295750|324229878|FG001|Overall Study|Adverse Event|15|||
94665736|NCT00295750|324229879|FG002|Overall Study|Adverse Event|12|||
94665737|NCT00295750|324229877|FG000|Overall Study|Lack of Efficacy|1|||
94665738|NCT00295750|324229878|FG001|Overall Study|Lack of Efficacy|1|||
94665739|NCT00295750|324229879|FG002|Overall Study|Lack of Efficacy|0|||
94665740|NCT00295750|324229877|FG000|Overall Study|Lost to Follow-up|1|||
94665741|NCT00295750|324229878|FG001|Overall Study|Lost to Follow-up|4|||
94665742|NCT00295750|324229879|FG002|Overall Study|Lost to Follow-up|1|||
94665743|NCT00295750|324229877|FG000|Overall Study|Taking prohibited therapy|2|||
94665744|NCT00295750|324229878|FG001|Overall Study|Taking prohibited therapy|3|||
94665745|NCT00295750|324229879|FG002|Overall Study|Taking prohibited therapy|2|||
94665746|NCT00295750|324229877|FG000|Overall Study|Administrative errors|2|||
94665747|NCT00295750|324229878|FG001|Overall Study|Administrative errors|4|||
94665748|NCT00295750|324229879|FG002|Overall Study|Administrative errors|5|||
94665749|NCT00295750|324229877|FG000|Overall Study|Trial drug errors|1|||
94665750|NCT00295750|324229878|FG001|Overall Study|Trial drug errors|1|||
94665751|NCT00295750|324229879|FG002|Overall Study|Trial drug errors|0|||
94665752|NCT00295750|324229877|FG000|Overall Study|Disease progression|2|||
94665753|NCT00295750|324229878|FG001|Overall Study|Disease progression|1|||
94461064|NCT02091986|323476860|FG000|Overall Study|Adverse Event|0|||
94616904|NCT04678661|324060857|FG001|Overall Study|Withdrawal by Subject|0|||
94616905|NCT04678661|324060856|FG000|Overall Study|Lost to Follow-up|2|||
94616906|NCT04678661|324060857|FG001|Overall Study|Lost to Follow-up|0|||
94616907|NCT04678661|324060856|FG000|Overall Study|Death|2|||
94616908|NCT04678661|324060857|FG001|Overall Study|Death|0|||
94616909|NCT01921387|324060858|FG000|Overall Study|Adverse Event|1|||
94616910|NCT03068455|324060861|FG000|Pre-treatment Period|Disease progression|0|||
94616911|NCT03068455|324060862|FG001|Pre-treatment Period|Disease progression|1|||
94616912|NCT03068455|324060861|FG000|Pre-treatment Period|Participant withdrew consent|1|||
94616913|NCT03068455|324060862|FG001|Pre-treatment Period|Participant withdrew consent|1|||
94616914|NCT03068455|324060861|FG000|Pre-treatment Period|Poor/non-compliance|0|||
94616915|NCT03068455|324060862|FG001|Pre-treatment Period|Poor/non-compliance|1|||
94616916|NCT03068455|324060861|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
94616917|NCT03068455|324060862|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
94616918|NCT03068455|324060861|FG000|Pre-treatment Period|Not reported|2|||
94616919|NCT03068455|324060862|FG001|Pre-treatment Period|Not reported|1|||
94616920|NCT03068455|324060861|FG000|Treatment Period|Disease progression|166|||
94616921|NCT03068455|324060862|FG001|Treatment Period|Disease progression|208|||
94616922|NCT03068455|324060861|FG000|Treatment Period|Study drug toxicity|317|||
94616923|NCT03068455|324060862|FG001|Treatment Period|Study drug toxicity|104|||
94616924|NCT03068455|324060861|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
94616925|NCT03068455|324060862|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
94616926|NCT03068455|324060861|FG000|Treatment Period|Participant request to stop therapy|33|||
94616927|NCT03068455|324060862|FG001|Treatment Period|Participant request to stop therapy|20|||
94616928|NCT03068455|324060861|FG000|Treatment Period|Participant withdrew consent|5|||
94616929|NCT03068455|324060862|FG001|Treatment Period|Participant withdrew consent|10|||
94665754|NCT00295750|324229879|FG002|Overall Study|Disease progression|0|||
94665755|NCT00295750|324229877|FG000|Overall Study|Personal reasons|0|||
94665756|NCT00295750|324229878|FG001|Overall Study|Personal reasons|1|||
94665757|NCT00295750|324229879|FG002|Overall Study|Personal reasons|0|||
94665758|NCT00295750|324229877|FG000|Overall Study|Randomized but never received trial drug|4|||
94665759|NCT00295750|324229878|FG001|Overall Study|Randomized but never received trial drug|3|||
94461065|NCT02091986|323476861|FG001|Overall Study|Adverse Event|0|||
94665760|NCT00295750|324229879|FG002|Overall Study|Randomized but never received trial drug|3|||
94616930|NCT03068455|324060861|FG000|Treatment Period|Poor/non-compliance|3|||
94665761|NCT00295750|324229877|FG000|Overall Study|Withdrawal by Subject|9|||
94665762|NCT00295750|324229878|FG001|Overall Study|Withdrawal by Subject|4|||
94665763|NCT00295750|324229879|FG002|Overall Study|Withdrawal by Subject|7|||
94665764|NCT00295750|324229877|FG000|Overall Study|Protocol Violation|2|||
94665765|NCT00295750|324229878|FG001|Overall Study|Protocol Violation|4|||
94665766|NCT00295750|324229879|FG002|Overall Study|Protocol Violation|2|||
94665767|NCT01587651|324229880|FG000|Overall Study|Adverse Event|0|||
94665768|NCT01587651|324229881|FG001|Overall Study|Adverse Event|1|||
94665769|NCT01587651|324229882|FG002|Overall Study|Adverse Event|0|||
94665770|NCT01587651|324229880|FG000|Overall Study|Protocol Violation|0|||
94665771|NCT01587651|324229881|FG001|Overall Study|Protocol Violation|1|||
94665772|NCT01587651|324229882|FG002|Overall Study|Protocol Violation|1|||
94665773|NCT01587651|324229880|FG000|Overall Study|Withdrawal by Subject|0|||
94665774|NCT01587651|324229881|FG001|Overall Study|Withdrawal by Subject|1|||
94665775|NCT01587651|324229882|FG002|Overall Study|Withdrawal by Subject|0|||
94665776|NCT04403698|324229885|FG000|Overall Study|Adverse Event|1|||
94665777|NCT04403698|324229886|FG001|Overall Study|Adverse Event|1|||
94665778|NCT04403698|324229885|FG000|Overall Study|Lost to Follow-up|1|||
94665779|NCT04403698|324229886|FG001|Overall Study|Lost to Follow-up|0|||
94665780|NCT04403698|324229885|FG000|Overall Study|Protocol Violation|0|||
94665781|NCT04403698|324229886|FG001|Overall Study|Protocol Violation|1|||
94665782|NCT03152552|324229887|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
94665783|NCT03152552|324229888|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
94665784|NCT03152552|324229889|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
94665785|NCT03152552|324229890|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
94665786|NCT03152552|324229891|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
94665787|NCT03152552|324229887|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
94665788|NCT03152552|324229888|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
94665789|NCT03152552|324229889|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
94665790|NCT03152552|324229890|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
94616931|NCT03068455|324060862|FG001|Treatment Period|Poor/non-compliance|0|||
94616932|NCT03068455|324060861|FG000|Treatment Period|Participant no longer meets study criteria|1|||
94616933|NCT03068455|324060862|FG001|Treatment Period|Participant no longer meets study criteria|3|||
94616934|NCT03068455|324060861|FG000|Treatment Period|Other reasons|12|||
94616935|NCT03068455|324060862|FG001|Treatment Period|Other reasons|4|||
94616936|NCT02571777|324060865|FG000|Overall Study|Subject/guardian decision|34|||
94616937|NCT02571777|324060866|FG001|Overall Study|Subject/guardian decision|26|||
94616938|NCT02571777|324060867|FG002|Overall Study|Subject/guardian decision|26|||
94616939|NCT02571777|324060868|FG003|Overall Study|Subject/guardian decision|25|||
94616940|NCT02571777|324060869|FG004|Overall Study|Subject/guardian decision|27|||
94616941|NCT02571777|324060865|FG000|Overall Study|Protocol Deviation|2|||
94616942|NCT02571777|324060866|FG001|Overall Study|Protocol Deviation|3|||
94616943|NCT02571777|324060867|FG002|Overall Study|Protocol Deviation|4|||
94616944|NCT02571777|324060868|FG003|Overall Study|Protocol Deviation|8|||
94616945|NCT02571777|324060869|FG004|Overall Study|Protocol Deviation|4|||
94616946|NCT02571777|324060865|FG000|Overall Study|Death|1|||
94616947|NCT02571777|324060866|FG001|Overall Study|Death|1|||
94616948|NCT02571777|324060867|FG002|Overall Study|Death|4|||
94616949|NCT02571777|324060868|FG003|Overall Study|Death|0|||
94616950|NCT02571777|324060869|FG004|Overall Study|Death|0|||
94665791|NCT03152552|324229891|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
94665792|NCT03152552|324229887|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
94665793|NCT03152552|324229888|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
94665794|NCT03152552|324229889|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
94665795|NCT03152552|324229890|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
94665796|NCT03152552|324229891|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
94665797|NCT03152552|324229887|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
94665798|NCT03152552|324229888|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
94665799|NCT03152552|324229889|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
94665800|NCT03152552|324229890|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
94665801|NCT03152552|324229891|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
94461066|NCT02091986|323476862|FG002|Overall Study|Adverse Event|2|||
94461067|NCT00474045|323476863|FG000|Overall Study|Adverse Event|18|||
94461068|NCT00474045|323476864|FG001|Overall Study|Adverse Event|8|||
94461069|NCT00474045|323476863|FG000|Overall Study|Unclassified|1|||
94461070|NCT00474045|323476864|FG001|Overall Study|Unclassified|3|||
94461071|NCT00474045|323476863|FG000|Overall Study|Lack of Efficacy|0|||
94461072|NCT00474045|323476864|FG001|Overall Study|Lack of Efficacy|9|||
94461073|NCT00474045|323476863|FG000|Overall Study|Lost to Follow-up|1|||
94461074|NCT00474045|323476864|FG001|Overall Study|Lost to Follow-up|1|||
94461075|NCT00474045|323476863|FG000|Overall Study|Protocol Violation|10|||
94461076|NCT00474045|323476864|FG001|Overall Study|Protocol Violation|12|||
94461077|NCT00474045|323476863|FG000|Overall Study|Withdrawal by Subject|16|||
94616951|NCT02571777|324060865|FG000|Overall Study|Lost to Follow-up|1|||
94616952|NCT02571777|324060866|FG001|Overall Study|Lost to Follow-up|1|||
94665802|NCT03152552|324229887|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
94665803|NCT03152552|324229888|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
94665804|NCT03152552|324229889|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
94665805|NCT03152552|324229890|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
94665806|NCT03152552|324229891|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
94665807|NCT03152552|324229887|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
94665808|NCT03152552|324229888|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
94665809|NCT03152552|324229889|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
94665810|NCT03152552|324229890|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
94665811|NCT03152552|324229891|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
94665812|NCT03152552|324229887|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
94665813|NCT03152552|324229888|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
94665814|NCT03152552|324229889|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
94665815|NCT03152552|324229890|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
94665816|NCT03152552|324229891|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
94665817|NCT04899349|324229894|FG000|Overall Study|Study terminated by Sponsor|2|||
94665818|NCT04899349|324229895|FG001|Overall Study|Study terminated by Sponsor|0|||
94665819|NCT04773587|324229896|FG000|Overall Study|Lost to Follow-up|11|||
94665820|NCT04773587|324229897|FG001|Overall Study|Lost to Follow-up|3|||
94665821|NCT04773587|324229896|FG000|Overall Study|Adverse Event|6|||
94665822|NCT04773587|324229897|FG001|Overall Study|Adverse Event|3|||
94665823|NCT04773587|324229896|FG000|Overall Study|Lack of Efficacy|5|||
94665824|NCT04773587|324229897|FG001|Overall Study|Lack of Efficacy|2|||
94665825|NCT04773587|324229896|FG000|Overall Study|Withdrawal by Subject|4|||
94665826|NCT04773587|324229897|FG001|Overall Study|Withdrawal by Subject|5|||
94665827|NCT04773587|324229896|FG000|Overall Study|Noncompliance|1|||
94665828|NCT04773587|324229897|FG001|Overall Study|Noncompliance|0|||
94665829|NCT04773587|324229896|FG000|Overall Study|Protocol Violation|1|||
94665830|NCT04773587|324229897|FG001|Overall Study|Protocol Violation|0|||
94665831|NCT04773587|324229896|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
94665832|NCT04773587|324229897|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
94665833|NCT01808313|324229898|FG000|Overall Study|Adverse Event|5|||
94665834|NCT01808313|324229898|FG000|Overall Study|Protocol Violation|2|||
94665835|NCT01808313|324229898|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
94665836|NCT01808313|324229898|FG000|Overall Study|Lost to Follow-up|1|||
94665837|NCT01808313|324229898|FG000|Overall Study|Physician Decision|1|||
94665838|NCT01178853|324229899|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
94665839|NCT01178853|324229900|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
94665840|NCT01178853|324229899|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
94665841|NCT01178853|324229900|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
94665842|NCT01178853|324229899|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
94665843|NCT01178853|324229900|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
94665844|NCT01178853|324229899|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
94665845|NCT01178853|324229900|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
94665846|NCT01178853|324229899|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
94358927|NCT01366846|323097997|FG002|Overall Study|Scheduling Conflicts|1|||
94358928|NCT01366846|323097998|FG003|Overall Study|Scheduling Conflicts|0|||
94358929|NCT05279807|323098001|FG000|Overall Study|Withdrawal by Subject|1|||
94616953|NCT02571777|324060867|FG002|Overall Study|Lost to Follow-up|2|||
94616954|NCT02571777|324060868|FG003|Overall Study|Lost to Follow-up|0|||
94616955|NCT02571777|324060869|FG004|Overall Study|Lost to Follow-up|1|||
94616956|NCT02571777|324060865|FG000|Overall Study|Physician Decision|1|||
94616957|NCT02571777|324060866|FG001|Overall Study|Physician Decision|7|||
94616958|NCT02571777|324060867|FG002|Overall Study|Physician Decision|5|||
94616959|NCT02571777|324060868|FG003|Overall Study|Physician Decision|2|||
94616960|NCT02571777|324060869|FG004|Overall Study|Physician Decision|4|||
94616961|NCT02571777|324060865|FG000|Overall Study|Pregnancy|0|||
94616962|NCT02571777|324060866|FG001|Overall Study|Pregnancy|0|||
94616963|NCT02571777|324060867|FG002|Overall Study|Pregnancy|0|||
94616964|NCT02571777|324060868|FG003|Overall Study|Pregnancy|2|||
94616965|NCT02571777|324060869|FG004|Overall Study|Pregnancy|0|||
94616966|NCT01876420|324060870|FG000|Overall Study|Missed 30 day visit|1|||
94616967|NCT05213481|324060880|FG000|Overall Study|Adverse Event|3|||
94665847|NCT01178853|324229900|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
94665848|NCT00839072|324229901|FG000|First Intervention Period|Withdrawal by Subject|1|||
94665849|NCT00839072|324229902|FG001|First Intervention Period|Withdrawal by Subject|0|||
94665850|NCT00839072|324229901|FG000|First Intervention Period|Adverse Event|1|||
94358930|NCT05279807|323098002|FG001|Overall Study|Withdrawal by Subject|0|||
94358931|NCT05279807|323098001|FG000|Overall Study|Adverse Event|0|||
94358932|NCT05279807|323098002|FG001|Overall Study|Adverse Event|1|||
94665851|NCT00839072|324229902|FG001|First Intervention Period|Adverse Event|1|||
94665852|NCT00839072|324229901|FG000|Second Intervention Period|Withdrawal by Subject|1|||
94616968|NCT05213481|324060880|FG000|Overall Study|Lost to Follow-up|1|||
94616969|NCT01484275|324060883|FG000|Overall Study|Study terminated by sponsor|28|||
94616970|NCT01484275|324060884|FG001|Overall Study|Study terminated by sponsor|32|||
94665853|NCT00839072|324229902|FG001|Second Intervention Period|Withdrawal by Subject|0|||
94665854|NCT03301051|324229903|FG000|Overall Study|Adverse Event|0|||
94665855|NCT03301051|324229904|FG001|Overall Study|Adverse Event|4|||
94665856|NCT03301051|324229903|FG000|Overall Study|Withdrawal by Subject|59|||
94665857|NCT03301051|324229904|FG001|Overall Study|Withdrawal by Subject|65|||
94665858|NCT03301051|324229903|FG000|Overall Study|Lost to Follow-up|263|||
94665859|NCT03301051|324229904|FG001|Overall Study|Lost to Follow-up|282|||
94616971|NCT01484275|324060883|FG000|Overall Study|Other|10|||
94616972|NCT01484275|324060884|FG001|Overall Study|Other|0|||
94616973|NCT01484275|324060883|FG000|Overall Study|Death|3|||
94616974|NCT01484275|324060884|FG001|Overall Study|Death|4|||
94616975|NCT01484275|324060883|FG000|Overall Study|Withdrawal by Subject|1|||
94616976|NCT01484275|324060884|FG001|Overall Study|Withdrawal by Subject|5|||
94616977|NCT01484275|324060883|FG000|Overall Study|Lost to Follow-up|1|||
94616978|NCT01484275|324060884|FG001|Overall Study|Lost to Follow-up|1|||
94616979|NCT00003487|324060891|FG000|Overall Study|Not evaluable|2|||
94616980|NCT00005044|324060892|FG000|Overall Study|Protocol Violation|37|||
94616981|NCT00005044|324060893|FG001|Overall Study|Protocol Violation|46|||
94616982|NCT00005044|324060892|FG000|Overall Study|Withdrawal by Subject|1|||
94616983|NCT00005044|324060893|FG001|Overall Study|Withdrawal by Subject|5|||
94616984|NCT00005044|324060892|FG000|Overall Study|No protocol treatment|0|||
94616985|NCT00005044|324060893|FG001|Overall Study|No protocol treatment|1|||
94616986|NCT03855228|324060894|FG000|Overall Study|Adverse Event|2|||
94616987|NCT03855228|324060895|FG001|Overall Study|Adverse Event|4|||
94616988|NCT03855228|324060896|FG002|Overall Study|Adverse Event|4|||
94616989|NCT03855228|324060897|FG003|Overall Study|Adverse Event|8|||
94616990|NCT03855228|324060894|FG000|Overall Study|Treatment Failure|1|||
94616991|NCT03855228|324060895|FG001|Overall Study|Treatment Failure|2|||
94616992|NCT03855228|324060896|FG002|Overall Study|Treatment Failure|1|||
94616993|NCT03855228|324060897|FG003|Overall Study|Treatment Failure|8|||
94616994|NCT03855228|324060894|FG000|Overall Study|Lost to Follow-up|0|||
94616995|NCT03855228|324060895|FG001|Overall Study|Lost to Follow-up|0|||
94616996|NCT03855228|324060896|FG002|Overall Study|Lost to Follow-up|0|||
94616997|NCT03855228|324060897|FG003|Overall Study|Lost to Follow-up|1|||
94616998|NCT03855228|324060894|FG000|Overall Study|Protocol Violation|0|||
94616999|NCT03855228|324060895|FG001|Overall Study|Protocol Violation|1|||
94617000|NCT03855228|324060896|FG002|Overall Study|Protocol Violation|2|||
94617001|NCT03855228|324060897|FG003|Overall Study|Protocol Violation|1|||
94617002|NCT03855228|324060894|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
94617003|NCT03855228|324060895|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
94617004|NCT03855228|324060896|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
94617005|NCT03855228|324060897|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
94617006|NCT00259610|324060898|FG000|Overall Study|Withdrawal by Subject|33|||
94617007|NCT00259610|324060899|FG001|Overall Study|Withdrawal by Subject|25|||
94617008|NCT00259610|324060900|FG002|Overall Study|Withdrawal by Subject|29|||
94617009|NCT00259610|324060901|FG003|Overall Study|Withdrawal by Subject|19|||
94617010|NCT00259610|324060898|FG000|Overall Study|Lost to Follow-up|19|||
94617011|NCT00259610|324060899|FG001|Overall Study|Lost to Follow-up|8|||
94617012|NCT00259610|324060900|FG002|Overall Study|Lost to Follow-up|18|||
94617013|NCT00259610|324060901|FG003|Overall Study|Lost to Follow-up|15|||
94617014|NCT00259610|324060898|FG000|Overall Study|Physician Decision|6|||
94617015|NCT00259610|324060899|FG001|Overall Study|Physician Decision|4|||
94617016|NCT00259610|324060900|FG002|Overall Study|Physician Decision|7|||
94617017|NCT00259610|324060901|FG003|Overall Study|Physician Decision|2|||
94617018|NCT00259610|324060898|FG000|Overall Study|Death|1|||
94617019|NCT00259610|324060899|FG001|Overall Study|Death|1|||
94617020|NCT00259610|324060900|FG002|Overall Study|Death|2|||
94617021|NCT00259610|324060901|FG003|Overall Study|Death|0|||
94665860|NCT03301051|324229903|FG000|Overall Study|Protocol Violation|1|||
94665861|NCT03301051|324229904|FG001|Overall Study|Protocol Violation|3|||
94665862|NCT03301051|324229903|FG000|Overall Study|Physician Decision|1|||
94665863|NCT03301051|324229904|FG001|Overall Study|Physician Decision|3|||
94665864|NCT03301051|324229903|FG000|Overall Study|Death|1|||
94665865|NCT03301051|324229904|FG001|Overall Study|Death|1|||
94665866|NCT03301051|324229903|FG000|Overall Study|Miscellaneous|8|||
94358933|NCT05279807|323098001|FG000|Overall Study|Laboratory Abnormal Results|1|||
94617022|NCT00259610|324060898|FG000|Overall Study|non medical reason|6|||
94617023|NCT00259610|324060899|FG001|Overall Study|non medical reason|2|||
94617024|NCT00259610|324060900|FG002|Overall Study|non medical reason|10|||
94617025|NCT00259610|324060901|FG003|Overall Study|non medical reason|3|||
94617026|NCT00259610|324060898|FG000|Overall Study|Adverse Event|3|||
94617027|NCT00259610|324060899|FG001|Overall Study|Adverse Event|4|||
94617028|NCT00259610|324060900|FG002|Overall Study|Adverse Event|5|||
94617029|NCT00259610|324060901|FG003|Overall Study|Adverse Event|2|||
94617030|NCT00259610|324060898|FG000|Overall Study|Serious Adverse Event|8|||
94617031|NCT00259610|324060899|FG001|Overall Study|Serious Adverse Event|2|||
94617032|NCT00259610|324060900|FG002|Overall Study|Serious Adverse Event|2|||
94665867|NCT03301051|324229904|FG001|Overall Study|Miscellaneous|4|||
94358934|NCT05279807|323098002|FG001|Overall Study|Laboratory Abnormal Results|0|||
94358935|NCT00620776|323098005|FG000|Overall Study|Did not receive treatment|3|||
94358936|NCT00620776|323098006|FG001|Overall Study|Did not receive treatment|5|||
94617033|NCT00259610|324060901|FG003|Overall Study|Serious Adverse Event|2|||
94617034|NCT04545385|324060908|FG000|Overall Study|Withdrawal by Subject|2|||
94617035|NCT04545385|324060909|FG001|Overall Study|Withdrawal by Subject|0|||
94617036|NCT04545385|324060908|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
94617037|NCT04545385|324060909|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
94617038|NCT04545385|324060908|FG000|Overall Study|Study termination|10|||
94617039|NCT04545385|324060909|FG001|Overall Study|Study termination|10|||
94617040|NCT04545385|324060908|FG000|Overall Study|Sponsor decision|2|||
94617041|NCT04545385|324060909|FG001|Overall Study|Sponsor decision|2|||
94617042|NCT04545385|324060908|FG000|Overall Study|Other than specified|1|||
94617043|NCT04545385|324060909|FG001|Overall Study|Other than specified|0|||
94617044|NCT00915278|324060910|FG000|Overall Study|Death|1|||
94617045|NCT00915278|324060911|FG001|Overall Study|Death|0|||
94617046|NCT00915278|324060912|FG002|Overall Study|Death|0|||
94617047|NCT00915278|324060913|FG003|Overall Study|Death|0|||
94617048|NCT00915278|324060914|FG004|Overall Study|Death|0|||
94617049|NCT00915278|324060915|FG005|Overall Study|Death|0|||
94617050|NCT00915278|324060910|FG000|Overall Study|Lost to Follow-up|0|||
94617051|NCT00915278|324060911|FG001|Overall Study|Lost to Follow-up|1|||
94617052|NCT00915278|324060912|FG002|Overall Study|Lost to Follow-up|0|||
94617053|NCT00915278|324060913|FG003|Overall Study|Lost to Follow-up|0|||
94617054|NCT00915278|324060914|FG004|Overall Study|Lost to Follow-up|0|||
94617055|NCT00915278|324060915|FG005|Overall Study|Lost to Follow-up|0|||
94617056|NCT00915278|324060910|FG000|Overall Study|Withdrawal by Subject|0|||
94617057|NCT00915278|324060911|FG001|Overall Study|Withdrawal by Subject|1|||
94617058|NCT00915278|324060912|FG002|Overall Study|Withdrawal by Subject|0|||
94617059|NCT00915278|324060913|FG003|Overall Study|Withdrawal by Subject|0|||
94617060|NCT00915278|324060914|FG004|Overall Study|Withdrawal by Subject|1|||
94617061|NCT00915278|324060915|FG005|Overall Study|Withdrawal by Subject|4|||
94617062|NCT00915278|324060910|FG000|Overall Study|Adverse Event|4|||
94617063|NCT00915278|324060911|FG001|Overall Study|Adverse Event|1|||
94617064|NCT00915278|324060912|FG002|Overall Study|Adverse Event|0|||
94617065|NCT00915278|324060913|FG003|Overall Study|Adverse Event|0|||
94617066|NCT00915278|324060914|FG004|Overall Study|Adverse Event|0|||
94617067|NCT00915278|324060915|FG005|Overall Study|Adverse Event|0|||
94617068|NCT00915278|324060910|FG000|Overall Study|Progressive disease/clinical progression|0|||
94617069|NCT00915278|324060911|FG001|Overall Study|Progressive disease/clinical progression|0|||
94617070|NCT00915278|324060912|FG002|Overall Study|Progressive disease/clinical progression|0|||
94617071|NCT00915278|324060913|FG003|Overall Study|Progressive disease/clinical progression|3|||
94617072|NCT00915278|324060914|FG004|Overall Study|Progressive disease/clinical progression|1|||
94617073|NCT00915278|324060915|FG005|Overall Study|Progressive disease/clinical progression|2|||
94617074|NCT00915278|324060910|FG000|Overall Study|Infusion related AEs|0|||
94617075|NCT00915278|324060911|FG001|Overall Study|Infusion related AEs|0|||
94617076|NCT00915278|324060912|FG002|Overall Study|Infusion related AEs|0|||
94617077|NCT00915278|324060913|FG003|Overall Study|Infusion related AEs|0|||
94617078|NCT00915278|324060914|FG004|Overall Study|Infusion related AEs|0|||
94617079|NCT00915278|324060915|FG005|Overall Study|Infusion related AEs|2|||
94617080|NCT00915278|324060910|FG000|Overall Study|Admission to hospice|0|||
94617081|NCT00915278|324060911|FG001|Overall Study|Admission to hospice|0|||
94617082|NCT00915278|324060912|FG002|Overall Study|Admission to hospice|1|||
94617083|NCT00915278|324060913|FG003|Overall Study|Admission to hospice|0|||
94665868|NCT03301051|324229903|FG000|Overall Study|Randomized, not vaccinated|13|||
94665869|NCT03301051|324229904|FG001|Overall Study|Randomized, not vaccinated|10|||
94617084|NCT00915278|324060914|FG004|Overall Study|Admission to hospice|0|||
94617085|NCT00915278|324060915|FG005|Overall Study|Admission to hospice|0|||
94617086|NCT02151110|324060916|FG000|Overall Study|Withdrawal by Subject|0|||
94617087|NCT02151110|324060917|FG001|Overall Study|Withdrawal by Subject|0|||
94617088|NCT02151110|324060918|FG002|Overall Study|Withdrawal by Subject|0|||
94617089|NCT02151110|324060919|FG003|Overall Study|Withdrawal by Subject|0|||
94665870|NCT00047879|324229905|FG000|Overall Study|Progressive disease|4|||
94617090|NCT02151110|324060920|FG004|Overall Study|Withdrawal by Subject|0|||
94617091|NCT02151110|324060921|FG005|Overall Study|Withdrawal by Subject|0|||
94617092|NCT02151110|324060922|FG006|Overall Study|Withdrawal by Subject|0|||
94617093|NCT02151110|324060923|FG007|Overall Study|Withdrawal by Subject|1|||
94358937|NCT00620776|323098005|FG000|Overall Study|Adverse Event|2|||
94358938|NCT00620776|323098006|FG001|Overall Study|Adverse Event|3|||
94358939|NCT00620776|323098005|FG000|Overall Study|Lack of Efficacy|2|||
94358940|NCT00620776|323098006|FG001|Overall Study|Lack of Efficacy|1|||
94358941|NCT00620776|323098005|FG000|Overall Study|Lost to Follow-up|2|||
94358942|NCT00620776|323098006|FG001|Overall Study|Lost to Follow-up|5|||
94358943|NCT00620776|323098005|FG000|Overall Study|Withdrawal by Subject|3|||
94358944|NCT00620776|323098006|FG001|Overall Study|Withdrawal by Subject|2|||
94358945|NCT03602976|323098007|FG000|Overall Study|Withdrawal by Subject|1|||
94665871|NCT00047879|324229906|FG001|Overall Study|Progressive disease|3|||
94665872|NCT02125786|324229907|FG000|Overall Study|Still in Follow-up|3|||
94665873|NCT02125786|324229907|FG000|Overall Study|Screen Failure|2|||
94665874|NCT02125786|324229907|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
94665875|NCT02125786|324229907|FG000|Overall Study|Progressive Disease|44|||
94665876|NCT02125786|324229907|FG000|Overall Study|Death|8|||
94665877|NCT01329029|324229924|FG000|Overall Study|Withdrawal by Subject|117|||
94665878|NCT01329029|324229925|FG001|Overall Study|Withdrawal by Subject|87|||
94665879|NCT01329029|324229924|FG000|Overall Study|Adverse Event|82|||
94665880|NCT01329029|324229925|FG001|Overall Study|Adverse Event|29|||
94665881|NCT01329029|324229924|FG000|Overall Study|Death|16|||
94665882|NCT01329029|324229925|FG001|Overall Study|Death|19|||
94665883|NCT01329029|324229924|FG000|Overall Study|Other|14|||
94665884|NCT01329029|324229925|FG001|Overall Study|Other|20|||
94665885|NCT01329029|324229924|FG000|Overall Study|COPD Exacerbation|11|||
94665886|NCT01329029|324229925|FG001|Overall Study|COPD Exacerbation|18|||
94665887|NCT01329029|324229924|FG000|Overall Study|Physician Decision|16|||
94665888|NCT01329029|324229925|FG001|Overall Study|Physician Decision|13|||
94665889|NCT01329029|324229924|FG000|Overall Study|Lost to Follow-up|8|||
94665890|NCT01329029|324229925|FG001|Overall Study|Lost to Follow-up|5|||
94665891|NCT01329029|324229924|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
94665892|NCT01329029|324229925|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
94665893|NCT02352948|324229926|FG000|Overall Study|Death|47|||
94665894|NCT02352948|324229927|FG001|Overall Study|Death|48|||
94665895|NCT02352948|324229928|FG002|Overall Study|Death|114|||
94665896|NCT02352948|324229929|FG003|Overall Study|Death|74|||
94665897|NCT02352948|324229930|FG004|Overall Study|Death|77|||
94665898|NCT02352948|324229931|FG005|Overall Study|Death|44|||
94665899|NCT02352948|324229926|FG000|Overall Study|Lost to Follow-up|1|||
94665900|NCT02352948|324229927|FG001|Overall Study|Lost to Follow-up|0|||
94665901|NCT02352948|324229928|FG002|Overall Study|Lost to Follow-up|2|||
94665902|NCT02352948|324229929|FG003|Overall Study|Lost to Follow-up|1|||
94665903|NCT02352948|324229930|FG004|Overall Study|Lost to Follow-up|2|||
94665904|NCT02352948|324229931|FG005|Overall Study|Lost to Follow-up|1|||
94665905|NCT02352948|324229926|FG000|Overall Study|Withdrawal by Subject|1|||
94665906|NCT02352948|324229927|FG001|Overall Study|Withdrawal by Subject|10|||
94665907|NCT02352948|324229928|FG002|Overall Study|Withdrawal by Subject|11|||
94665908|NCT02352948|324229929|FG003|Overall Study|Withdrawal by Subject|23|||
94358946|NCT03532048|323098012|FG000|Overall Study|Lost to Follow-up|12|||
94617094|NCT02151110|324060916|FG000|Overall Study|Lost to Follow-up|0|||
94617095|NCT02151110|324060917|FG001|Overall Study|Lost to Follow-up|0|||
94617096|NCT02151110|324060918|FG002|Overall Study|Lost to Follow-up|0|||
94617097|NCT02151110|324060919|FG003|Overall Study|Lost to Follow-up|0|||
94617098|NCT02151110|324060920|FG004|Overall Study|Lost to Follow-up|0|||
94617099|NCT02151110|324060921|FG005|Overall Study|Lost to Follow-up|0|||
94617100|NCT02151110|324060922|FG006|Overall Study|Lost to Follow-up|0|||
94617101|NCT02151110|324060923|FG007|Overall Study|Lost to Follow-up|2|||
94617102|NCT04528732|324060924|FG000|Overall Study|Death|1|||
94617103|NCT04528732|324060925|FG001|Overall Study|Death|0|||
94617104|NCT04528732|324060926|FG002|Overall Study|Death|1|||
94617105|NCT04528732|324060924|FG000|Overall Study|Lost to Follow-up|0|||
94617106|NCT04528732|324060925|FG001|Overall Study|Lost to Follow-up|1|||
94617107|NCT04528732|324060926|FG002|Overall Study|Lost to Follow-up|2|||
94617108|NCT01702961|324060928|FG000|Overall Study|Additional treatment|3|||
94617109|NCT01702961|324060928|FG000|Overall Study|Progressive disease|5|||
94665909|NCT02352948|324229930|FG004|Overall Study|Withdrawal by Subject|9|||
94617110|NCT01702961|324060928|FG000|Overall Study|Relapse|20|||
94665910|NCT02352948|324229931|FG005|Overall Study|Withdrawal by Subject|4|||
94665911|NCT02352948|324229926|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
94358947|NCT03532048|323098013|FG001|Overall Study|Lost to Follow-up|17|||
94358948|NCT03532048|323098012|FG000|Overall Study|Withdrawal by Subject|7|||
94665912|NCT02352948|324229927|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
94665913|NCT02352948|324229928|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
94358949|NCT03532048|323098013|FG001|Overall Study|Withdrawal by Subject|0|||
94617111|NCT01702961|324060928|FG000|Overall Study|Death|6|||
94617112|NCT01702961|324060928|FG000|Overall Study|Lost to Follow-up|2|||
94665914|NCT02352948|324229929|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
94358950|NCT00442572|323098014|FG000|Overall Study|Relapse|8|||
94617113|NCT01702961|324060928|FG000|Overall Study|Ongoing|11|||
94617114|NCT03137537|324060935|FG000|Overall Study|Adverse Event|0|||
94665915|NCT02352948|324229930|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
94665916|NCT02352948|324229931|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
94665917|NCT02352948|324229926|FG000|Overall Study|Other|0|||
94665918|NCT02352948|324229927|FG001|Overall Study|Other|0|||
94665919|NCT02352948|324229928|FG002|Overall Study|Other|2|||
94665920|NCT02352948|324229929|FG003|Overall Study|Other|0|||
94665921|NCT02352948|324229930|FG004|Overall Study|Other|0|||
94617115|NCT03137537|324060936|FG001|Overall Study|Adverse Event|1|||
94617116|NCT00672646|324060937|FG000|Overall Study|Lost to Follow-up|0|||
94617117|NCT00672646|324060938|FG001|Overall Study|Lost to Follow-up|1|||
94617118|NCT00672646|324060939|FG002|Overall Study|Lost to Follow-up|2|||
94617119|NCT00672646|324060937|FG000|Overall Study|Withdrawal by Subject|0|||
94617120|NCT00672646|324060938|FG001|Overall Study|Withdrawal by Subject|0|||
94617121|NCT00672646|324060939|FG002|Overall Study|Withdrawal by Subject|1|||
94617122|NCT00453063|324060943|FG000|Overall Study|Adverse Event|1|||
94617123|NCT00453063|324060944|FG001|Overall Study|Adverse Event|2|||
94617124|NCT00453063|324060943|FG000|Overall Study|Withdrawal by Subject|1|||
94617125|NCT00453063|324060944|FG001|Overall Study|Withdrawal by Subject|1|||
94617126|NCT00453063|324060943|FG000|Overall Study|Protocol Violation|1|||
94617127|NCT00453063|324060944|FG001|Overall Study|Protocol Violation|0|||
94617128|NCT00365508|324060946|FG000|Overall Study|Lost to Follow-up|139|||
94617129|NCT00365508|324060947|FG001|Overall Study|Lost to Follow-up|154|||
94617130|NCT00289783|324060953|FG000|Primary Phase|Adverse Event|10|||
94617131|NCT00289783|324060954|FG001|Primary Phase|Adverse Event|1|||
94617132|NCT00289783|324060953|FG000|Primary Phase|Protocol Violation|27|||
94617133|NCT00289783|324060954|FG001|Primary Phase|Protocol Violation|6|||
94617134|NCT00289783|324060953|FG000|Primary Phase|Withdrawal by Subject|93|||
94617135|NCT00289783|324060954|FG001|Primary Phase|Withdrawal by Subject|40|||
94617136|NCT00289783|324060953|FG000|Primary Phase|Lost to Follow-up|60|||
94617137|NCT00289783|324060954|FG001|Primary Phase|Lost to Follow-up|14|||
94617138|NCT00289783|324060953|FG000|Primary Phase|Migration from the study area|26|||
94617139|NCT00289783|324060954|FG001|Primary Phase|Migration from the study area|10|||
94617140|NCT00289783|324060953|FG000|Primary Phase|Other|32|||
94617141|NCT00289783|324060954|FG001|Primary Phase|Other|12|||
94617142|NCT00289783|324060953|FG000|Fourth Dose Phase|Adverse Event|1|||
94617143|NCT00289783|324060954|FG001|Fourth Dose Phase|Adverse Event|0|||
94617144|NCT00289783|324060953|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
94617145|NCT00289783|324060954|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
94617146|NCT00289783|324060953|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
94617147|NCT00289783|324060954|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
94617148|NCT00289783|324060953|FG000|Fourth Dose Phase|Migration from the study area|1|||
94617149|NCT00289783|324060954|FG001|Fourth Dose Phase|Migration from the study area|1|||
94617150|NCT00289783|324060953|FG000|Fourth Dose Phase|Other|22|||
94617151|NCT00289783|324060954|FG001|Fourth Dose Phase|Other|10|||
94617152|NCT00404235|324060955|FG000|Overall Study|Withdrawal by Subject|1|||
94617153|NCT00404235|324060956|FG001|Overall Study|Withdrawal by Subject|2|||
94617154|NCT03128411|324060959|FG000|Treatment Phase|Adverse Event|21|||
94617155|NCT03128411|324060959|FG000|Treatment Phase|Physician Decision|1|||
94617156|NCT03128411|324060959|FG000|Treatment Phase|Other|2|||
94617157|NCT03128411|324060959|FG000|Long Term Follow-up Phase|Death|2|||
94617158|NCT00594659|324060960|FG000|Overall Study|Lost to Follow-up|13|||
94617159|NCT00594659|324060961|FG001|Overall Study|Lost to Follow-up|9|||
94617160|NCT00594659|324060962|FG002|Overall Study|Lost to Follow-up|7|||
94617161|NCT03607487|324060963|FG000|Overall Study|Withdrawal by Subject|2|||
94617162|NCT03607487|324060964|FG001|Overall Study|Withdrawal by Subject|0|||
94617163|NCT03607487|324060965|FG002|Overall Study|Withdrawal by Subject|0|||
94617164|NCT03607487|324060966|FG003|Overall Study|Withdrawal by Subject|1|||
94617165|NCT00142298|324060967|FG000|Overall Study|Adverse Event|10|||
94617166|NCT00142298|324060968|FG001|Overall Study|Adverse Event|10|||
94617167|NCT00142298|324060969|FG002|Overall Study|Adverse Event|1|||
94617168|NCT00142298|324060970|FG003|Overall Study|Adverse Event|5|||
94358951|NCT00442572|323098015|FG001|Overall Study|Relapse|1|||
94358952|NCT00442572|323098014|FG000|Overall Study|Lost to Follow-up|0|||
94617169|NCT00142298|324060971|FG004|Overall Study|Adverse Event|2|||
94617170|NCT00142298|324060972|FG005|Overall Study|Adverse Event|2|||
94617171|NCT00142298|324060973|FG006|Overall Study|Adverse Event|0|||
94617172|NCT00142298|324060974|FG007|Overall Study|Adverse Event|0|||
94617173|NCT00142298|324060975|FG008|Overall Study|Adverse Event|0|||
94617174|NCT00142298|324060976|FG009|Overall Study|Adverse Event|0|||
94617175|NCT00142298|324060967|FG000|Overall Study|Clinical disease progression|1|||
94617176|NCT00142298|324060968|FG001|Overall Study|Clinical disease progression|0|||
94617177|NCT00142298|324060969|FG002|Overall Study|Clinical disease progression|0|||
94617178|NCT00142298|324060970|FG003|Overall Study|Clinical disease progression|0|||
94617179|NCT00142298|324060971|FG004|Overall Study|Clinical disease progression|0|||
94617180|NCT00142298|324060972|FG005|Overall Study|Clinical disease progression|0|||
94617181|NCT00142298|324060973|FG006|Overall Study|Clinical disease progression|0|||
94665922|NCT02352948|324229931|FG005|Overall Study|Other|0|||
94665923|NCT01669122|324229934|FG000|Period I|Lost to Follow-up|1|||
94617182|NCT00142298|324060974|FG007|Overall Study|Clinical disease progression|0|||
94665924|NCT01669122|324229934|FG000|Washout Period II|Protocol Violation|2|||
94617183|NCT00142298|324060975|FG008|Overall Study|Clinical disease progression|0|||
94665925|NCT01864564|324229935|FG000|Overall Study|Lost to Follow-up|17|||
94665926|NCT01864564|324229936|FG001|Overall Study|Lost to Follow-up|23|||
94665927|NCT01864564|324229935|FG000|Overall Study|Withdrawal by Subject|20|||
94665928|NCT01864564|324229936|FG001|Overall Study|Withdrawal by Subject|11|||
94665929|NCT01864564|324229935|FG000|Overall Study|Protocol Violation|0|||
94665930|NCT01864564|324229936|FG001|Overall Study|Protocol Violation|27|||
94665931|NCT01864564|324229935|FG000|Overall Study|not reported|0|||
94665932|NCT01864564|324229936|FG001|Overall Study|not reported|34|||
94665933|NCT00655980|324229943|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
94665934|NCT00655980|324229944|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
94665935|NCT00655980|324229945|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
94665936|NCT03972488|324229946|FG000|Overall Study|Progressive disease|42|||
94665937|NCT03972488|324229947|FG001|Overall Study|Progressive disease|44|||
94665938|NCT03972488|324229946|FG000|Overall Study|Physician Decision|13|||
94665939|NCT03972488|324229947|FG001|Overall Study|Physician Decision|7|||
94665940|NCT03972488|324229946|FG000|Overall Study|Adverse Event|8|||
94665941|NCT03972488|324229947|FG001|Overall Study|Adverse Event|1|||
94665942|NCT03972488|324229946|FG000|Overall Study|Death|4|||
94665943|NCT03972488|324229947|FG001|Overall Study|Death|4|||
94665944|NCT03972488|324229946|FG000|Overall Study|Withdrawal by Subject|3|||
94665945|NCT03972488|324229947|FG001|Overall Study|Withdrawal by Subject|4|||
94665946|NCT03972488|324229946|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
94665947|NCT03972488|324229947|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
94665948|NCT02611037|324229948|FG000|Overall Study|Withdrawal prior to treatment|2|||
94665949|NCT02611037|324229949|FG001|Overall Study|Withdrawal prior to treatment|0|||
94665950|NCT05245864|324229950|FG000|Overall Study|Withdrawal by Subject|1|||
94665951|NCT05245864|324229951|FG001|Overall Study|Withdrawal by Subject|1|||
94665952|NCT04537923|324231349|FG000|Overall Study|Adverse Event|2|||
94665953|NCT04537923|324231350|FG001|Overall Study|Adverse Event|1|||
94617184|NCT00142298|324060976|FG009|Overall Study|Clinical disease progression|0|||
94617185|NCT00142298|324060967|FG000|Overall Study|Death|1|||
94617186|NCT00142298|324060968|FG001|Overall Study|Death|1|||
94617187|NCT00142298|324060969|FG002|Overall Study|Death|1|||
94617188|NCT00142298|324060970|FG003|Overall Study|Death|0|||
94617189|NCT00142298|324060971|FG004|Overall Study|Death|0|||
94617190|NCT00142298|324060972|FG005|Overall Study|Death|6|||
94617191|NCT00142298|324060973|FG006|Overall Study|Death|0|||
94617192|NCT00142298|324060974|FG007|Overall Study|Death|0|||
94617193|NCT00142298|324060975|FG008|Overall Study|Death|0|||
94617194|NCT00142298|324060976|FG009|Overall Study|Death|0|||
94617195|NCT00142298|324060967|FG000|Overall Study|Lack of Efficacy|44|||
94617196|NCT00142298|324060968|FG001|Overall Study|Lack of Efficacy|62|||
94617197|NCT00142298|324060969|FG002|Overall Study|Lack of Efficacy|9|||
94617198|NCT00142298|324060970|FG003|Overall Study|Lack of Efficacy|12|||
94617199|NCT00142298|324060971|FG004|Overall Study|Lack of Efficacy|1|||
94617200|NCT00142298|324060972|FG005|Overall Study|Lack of Efficacy|0|||
94617201|NCT00142298|324060973|FG006|Overall Study|Lack of Efficacy|0|||
94617202|NCT00142298|324060974|FG007|Overall Study|Lack of Efficacy|1|||
94617203|NCT00142298|324060975|FG008|Overall Study|Lack of Efficacy|0|||
94617204|NCT00142298|324060976|FG009|Overall Study|Lack of Efficacy|0|||
94617205|NCT00142298|324060967|FG000|Overall Study|Non-compliance|15|||
94617206|NCT00142298|324060968|FG001|Overall Study|Non-compliance|13|||
94617207|NCT00142298|324060969|FG002|Overall Study|Non-compliance|0|||
94617208|NCT00142298|324060970|FG003|Overall Study|Non-compliance|6|||
94617209|NCT00142298|324060971|FG004|Overall Study|Non-compliance|1|||
94617210|NCT00142298|324060972|FG005|Overall Study|Non-compliance|0|||
94617211|NCT00142298|324060973|FG006|Overall Study|Non-compliance|0|||
94617212|NCT00142298|324060974|FG007|Overall Study|Non-compliance|3|||
94617213|NCT00142298|324060975|FG008|Overall Study|Non-compliance|3|||
94617214|NCT00142298|324060976|FG009|Overall Study|Non-compliance|0|||
94617215|NCT00142298|324060967|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
94617216|NCT00142298|324060968|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
94358953|NCT00442572|323098015|FG001|Overall Study|Lost to Follow-up|1|||
94617217|NCT00142298|324060969|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
94617218|NCT00142298|324060970|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
94617219|NCT00142298|324060971|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
94617220|NCT00142298|324060972|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
94617221|NCT00142298|324060973|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
94617222|NCT00142298|324060974|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
94617223|NCT00142298|324060975|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
94617224|NCT00142298|324060976|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
94665954|NCT04537923|324231351|FG002|Overall Study|Adverse Event|2|||
94665955|NCT04537923|324231352|FG003|Overall Study|Adverse Event|4|||
94665956|NCT04537923|324231349|FG000|Overall Study|Death|3|||
94358954|NCT00442572|323098014|FG000|Overall Study|Withdrawal by Subject|0|||
94665957|NCT04537923|324231350|FG001|Overall Study|Death|3|||
94665958|NCT04537923|324231351|FG002|Overall Study|Death|1|||
94665959|NCT04537923|324231352|FG003|Overall Study|Death|11|||
94665960|NCT04537923|324231349|FG000|Overall Study|Lost to Follow-up|1|||
94665961|NCT04537923|324231350|FG001|Overall Study|Lost to Follow-up|2|||
94665962|NCT04537923|324231351|FG002|Overall Study|Lost to Follow-up|1|||
94665963|NCT04537923|324231352|FG003|Overall Study|Lost to Follow-up|6|||
94665964|NCT04537923|324231349|FG000|Overall Study|Physician Decision|1|||
94665965|NCT04537923|324231350|FG001|Overall Study|Physician Decision|0|||
94665966|NCT04537923|324231351|FG002|Overall Study|Physician Decision|2|||
94665967|NCT04537923|324231352|FG003|Overall Study|Physician Decision|5|||
94665968|NCT04537923|324231349|FG000|Overall Study|Pregnancy|1|||
94617225|NCT00142298|324060967|FG000|Overall Study|Pregnancy|4|||
94617226|NCT00142298|324060968|FG001|Overall Study|Pregnancy|4|||
94617227|NCT00142298|324060969|FG002|Overall Study|Pregnancy|2|||
94617228|NCT00142298|324060970|FG003|Overall Study|Pregnancy|3|||
94617229|NCT00142298|324060971|FG004|Overall Study|Pregnancy|0|||
94617230|NCT00142298|324060972|FG005|Overall Study|Pregnancy|0|||
94617231|NCT00142298|324060973|FG006|Overall Study|Pregnancy|0|||
94665969|NCT04537923|324231350|FG001|Overall Study|Pregnancy|0|||
94665970|NCT04537923|324231351|FG002|Overall Study|Pregnancy|0|||
94665971|NCT04537923|324231352|FG003|Overall Study|Pregnancy|0|||
94665972|NCT04537923|324231349|FG000|Overall Study|Withdrawal by Subject|4|||
94665973|NCT04537923|324231350|FG001|Overall Study|Withdrawal by Subject|4|||
94665974|NCT04537923|324231351|FG002|Overall Study|Withdrawal by Subject|4|||
94665975|NCT04537923|324231352|FG003|Overall Study|Withdrawal by Subject|58|||
94665976|NCT04537923|324231349|FG000|Overall Study|Missed study visits|2|||
94665977|NCT04537923|324231350|FG001|Overall Study|Missed study visits|0|||
94665978|NCT04537923|324231351|FG002|Overall Study|Missed study visits|0|||
94665979|NCT04537923|324231352|FG003|Overall Study|Missed study visits|3|||
94665980|NCT04537923|324231349|FG000|Overall Study|Sponsor's decision|0|||
94665981|NCT04537923|324231350|FG001|Overall Study|Sponsor's decision|0|||
94665982|NCT04537923|324231351|FG002|Overall Study|Sponsor's decision|1|||
94665983|NCT04537923|324231352|FG003|Overall Study|Sponsor's decision|1|||
94665984|NCT04537923|324231349|FG000|Overall Study|Safety reasons|1|||
94665985|NCT04537923|324231350|FG001|Overall Study|Safety reasons|0|||
94665986|NCT04537923|324231351|FG002|Overall Study|Safety reasons|0|||
94665987|NCT04537923|324231352|FG003|Overall Study|Safety reasons|0|||
94665988|NCT05349617|324231355|FG000|Overall Study|Death|1|||
94665989|NCT05349617|324231356|FG001|Overall Study|Death|1|||
94665990|NCT05349617|324231355|FG000|Overall Study|Lost to Follow-up|3|||
94665991|NCT05349617|324231356|FG001|Overall Study|Lost to Follow-up|8|||
94665992|NCT05349617|324231355|FG000|Overall Study|Withdrawal by Subject|2|||
94665993|NCT05349617|324231356|FG001|Overall Study|Withdrawal by Subject|10|||
94665994|NCT03586648|324231357|FG000|Period 1|Withdrawal by Subject|0|||
94665995|NCT03586648|324231358|FG001|Period 1|Withdrawal by Subject|1|||
94665996|NCT03586648|324231357|FG000|Period 1|Lost to Follow-up|1|||
94665997|NCT03586648|324231358|FG001|Period 1|Lost to Follow-up|1|||
94665998|NCT03586648|324231357|FG000|Period 1|Adverse Event|1|||
94665999|NCT03586648|324231358|FG001|Period 1|Adverse Event|0|||
94666000|NCT03586648|324231357|FG000|Period 1|Study related symptoms or complaints|2|||
94666001|NCT03586648|324231358|FG001|Period 1|Study related symptoms or complaints|1|||
94666002|NCT03586648|324231357|FG000|Period 1|Physician Decision|0|||
94666003|NCT03586648|324231358|FG001|Period 1|Physician Decision|1|||
94666004|NCT03586648|324231357|FG000|Period 2|Adverse Event|1|||
94666005|NCT03586648|324231358|FG001|Period 2|Adverse Event|0|||
94666006|NCT02041195|324231359|FG000|Overall Study|Adverse Event|1|||
94666007|NCT02041195|324231360|FG001|Overall Study|Adverse Event|2|||
94617232|NCT00142298|324060974|FG007|Overall Study|Pregnancy|0|||
94617233|NCT00142298|324060975|FG008|Overall Study|Pregnancy|1|||
94617234|NCT00142298|324060976|FG009|Overall Study|Pregnancy|0|||
94666008|NCT02041195|324231361|FG002|Overall Study|Adverse Event|0|||
94666009|NCT02041195|324231362|FG003|Overall Study|Adverse Event|0|||
94666010|NCT02041195|324231363|FG004|Overall Study|Adverse Event|0|||
94666011|NCT02041195|324231364|FG005|Overall Study|Adverse Event|0|||
94666012|NCT02041195|324231365|FG006|Overall Study|Adverse Event|3|||
94666013|NCT02041195|324231366|FG007|Overall Study|Adverse Event|0|||
94666014|NCT02041195|324231359|FG000|Overall Study|Withdrawal by Subject|1|||
94666015|NCT02041195|324231360|FG001|Overall Study|Withdrawal by Subject|0|||
94666016|NCT02041195|324231361|FG002|Overall Study|Withdrawal by Subject|0|||
94666017|NCT02041195|324231362|FG003|Overall Study|Withdrawal by Subject|0|||
94666018|NCT02041195|324231363|FG004|Overall Study|Withdrawal by Subject|0|||
94666019|NCT02041195|324231364|FG005|Overall Study|Withdrawal by Subject|0|||
94666020|NCT02041195|324231365|FG006|Overall Study|Withdrawal by Subject|4|||
94666021|NCT02041195|324231366|FG007|Overall Study|Withdrawal by Subject|3|||
94617235|NCT00142298|324060967|FG000|Overall Study|Virologic breakthrough|19|||
94666022|NCT02041195|324231359|FG000|Overall Study|Unable to comply with study visits|0|||
94666023|NCT02041195|324231360|FG001|Overall Study|Unable to comply with study visits|1|||
94617236|NCT00142298|324060968|FG001|Overall Study|Virologic breakthrough|23|||
94666024|NCT02041195|324231361|FG002|Overall Study|Unable to comply with study visits|0|||
94666025|NCT02041195|324231362|FG003|Overall Study|Unable to comply with study visits|0|||
94666026|NCT02041195|324231363|FG004|Overall Study|Unable to comply with study visits|1|||
94666027|NCT02041195|324231364|FG005|Overall Study|Unable to comply with study visits|0|||
94666028|NCT02041195|324231365|FG006|Overall Study|Unable to comply with study visits|0|||
94666029|NCT02041195|324231366|FG007|Overall Study|Unable to comply with study visits|0|||
94666030|NCT01880424|324231368|FG000|Overall Study|Adverse Event|7|||
94666031|NCT01880424|324231369|FG001|Overall Study|Adverse Event|6|||
94666032|NCT01880424|324231368|FG000|Overall Study|Lack of Efficacy|1|||
94666033|NCT01880424|324231369|FG001|Overall Study|Lack of Efficacy|4|||
94666034|NCT01880424|324231368|FG000|Overall Study|Lost to Follow-up|3|||
94666035|NCT01880424|324231369|FG001|Overall Study|Lost to Follow-up|2|||
94666036|NCT01880424|324231368|FG000|Overall Study|Protocol Violation|11|||
94666037|NCT01880424|324231369|FG001|Overall Study|Protocol Violation|13|||
94666038|NCT01880424|324231368|FG000|Overall Study|Withdrawal by Subject|10|||
94666039|NCT01880424|324231369|FG001|Overall Study|Withdrawal by Subject|30|||
94666040|NCT01880424|324231368|FG000|Overall Study|Other|1|||
94666041|NCT01880424|324231369|FG001|Overall Study|Other|0|||
94666042|NCT01588184|324231377|FG000|Overall Study|Death|1|||
94666043|NCT01588184|324231378|FG001|Overall Study|Death|0|||
94666044|NCT01588184|324231379|FG002|Overall Study|Death|0|||
94666045|NCT01588184|324231380|FG003|Overall Study|Death|1|||
94666046|NCT01588184|324231381|FG004|Overall Study|Death|1|||
94666047|NCT01588184|324231382|FG005|Overall Study|Death|1|||
94666048|NCT01588184|324231377|FG000|Overall Study|Withdrawal by Subject|2|||
94666049|NCT01588184|324231378|FG001|Overall Study|Withdrawal by Subject|4|||
94666050|NCT01588184|324231379|FG002|Overall Study|Withdrawal by Subject|0|||
94666051|NCT01588184|324231380|FG003|Overall Study|Withdrawal by Subject|1|||
94666052|NCT01588184|324231381|FG004|Overall Study|Withdrawal by Subject|0|||
94666053|NCT01588184|324231382|FG005|Overall Study|Withdrawal by Subject|0|||
94666054|NCT01588184|324231377|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
94666055|NCT01588184|324231378|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
94666056|NCT01588184|324231379|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
94666057|NCT01588184|324231380|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
94666058|NCT01588184|324231381|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
94666059|NCT01588184|324231382|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
94666060|NCT01588184|324231377|FG000|Overall Study|multiple reasons|0|||
94666061|NCT01588184|324231378|FG001|Overall Study|multiple reasons|3|||
94666062|NCT01588184|324231379|FG002|Overall Study|multiple reasons|0|||
94666063|NCT01588184|324231380|FG003|Overall Study|multiple reasons|1|||
94666064|NCT01588184|324231381|FG004|Overall Study|multiple reasons|0|||
94666065|NCT01588184|324231382|FG005|Overall Study|multiple reasons|0|||
94666066|NCT00907153|324231383|FG000|Overall Study|Lost to Follow-up|1|||
94617237|NCT00142298|324060969|FG002|Overall Study|Virologic breakthrough|9|||
94617238|NCT00142298|324060970|FG003|Overall Study|Virologic breakthrough|7|||
94617239|NCT00142298|324060971|FG004|Overall Study|Virologic breakthrough|2|||
94617240|NCT00142298|324060972|FG005|Overall Study|Virologic breakthrough|3|||
94617241|NCT00142298|324060973|FG006|Overall Study|Virologic breakthrough|3|||
94617242|NCT00142298|324060974|FG007|Overall Study|Virologic breakthrough|0|||
94617243|NCT00142298|324060975|FG008|Overall Study|Virologic breakthrough|0|||
94617244|NCT00142298|324060976|FG009|Overall Study|Virologic breakthrough|0|||
94617245|NCT00142298|324060967|FG000|Overall Study|Other- not specified|0|||
94617246|NCT00142298|324060968|FG001|Overall Study|Other- not specified|3|||
94617247|NCT00142298|324060969|FG002|Overall Study|Other- not specified|0|||
94617248|NCT00142298|324060970|FG003|Overall Study|Other- not specified|1|||
94617249|NCT00142298|324060971|FG004|Overall Study|Other- not specified|0|||
94617250|NCT00142298|324060972|FG005|Overall Study|Other- not specified|0|||
94617251|NCT00142298|324060973|FG006|Overall Study|Other- not specified|0|||
94617252|NCT00142298|324060974|FG007|Overall Study|Other- not specified|0|||
94617253|NCT00142298|324060975|FG008|Overall Study|Other- not specified|0|||
94617254|NCT00142298|324060976|FG009|Overall Study|Other- not specified|0|||
94617255|NCT00142298|324060967|FG000|Overall Study|Lost to Follow-up|0|||
94617256|NCT00142298|324060968|FG001|Overall Study|Lost to Follow-up|0|||
94666067|NCT00907153|324231384|FG001|Overall Study|Lost to Follow-up|1|||
94666068|NCT00907153|324231383|FG000|Overall Study|Withdrawal by Subject|1|||
94666069|NCT00907153|324231384|FG001|Overall Study|Withdrawal by Subject|3|||
94617257|NCT00142298|324060969|FG002|Overall Study|Lost to Follow-up|0|||
94666070|NCT02526693|324231385|FG000|Overall Study|Physician Decision|3|||
94666071|NCT02526693|324231386|FG001|Overall Study|Physician Decision|1|||
94666072|NCT01983293|324231387|FG000|Overall Study|Withdrawal by Subject|29|||
94666073|NCT01983293|324231388|FG001|Overall Study|Withdrawal by Subject|15|||
94666074|NCT01983293|324231387|FG000|Overall Study|Missing 12-month visit|3|||
94666075|NCT01983293|324231388|FG001|Overall Study|Missing 12-month visit|3|||
94666076|NCT01983293|324231387|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
94617258|NCT00142298|324060970|FG003|Overall Study|Lost to Follow-up|0|||
94617259|NCT00142298|324060971|FG004|Overall Study|Lost to Follow-up|0|||
94617260|NCT00142298|324060972|FG005|Overall Study|Lost to Follow-up|0|||
94617261|NCT00142298|324060973|FG006|Overall Study|Lost to Follow-up|2|||
94617262|NCT00142298|324060974|FG007|Overall Study|Lost to Follow-up|0|||
94358955|NCT00442572|323098015|FG001|Overall Study|Withdrawal by Subject|1|||
94617263|NCT00142298|324060975|FG008|Overall Study|Lost to Follow-up|0|||
94617264|NCT00142298|324060976|FG009|Overall Study|Lost to Follow-up|0|||
94617265|NCT00142298|324060967|FG000|Overall Study|Treatment Failure|0|||
94617266|NCT00142298|324060968|FG001|Overall Study|Treatment Failure|0|||
94617267|NCT00142298|324060969|FG002|Overall Study|Treatment Failure|0|||
94617268|NCT00142298|324060970|FG003|Overall Study|Treatment Failure|0|||
94617269|NCT00142298|324060971|FG004|Overall Study|Treatment Failure|0|||
94617270|NCT00142298|324060972|FG005|Overall Study|Treatment Failure|2|||
94617271|NCT00142298|324060973|FG006|Overall Study|Treatment Failure|2|||
94617272|NCT00142298|324060974|FG007|Overall Study|Treatment Failure|0|||
94617273|NCT00142298|324060975|FG008|Overall Study|Treatment Failure|0|||
94617274|NCT00142298|324060976|FG009|Overall Study|Treatment Failure|0|||
94617275|NCT01466153|324060979|FG000|Overall Study|Disease Progression|2|||
94617276|NCT01466153|324060980|FG001|Overall Study|Disease Progression|2|||
94617277|NCT01466153|324060981|FG002|Overall Study|Disease Progression|0|||
94617278|NCT01466153|324060979|FG000|Overall Study|Adverse Event|14|||
94617279|NCT01466153|324060980|FG001|Overall Study|Adverse Event|13|||
94617280|NCT01466153|324060981|FG002|Overall Study|Adverse Event|17|||
94617281|NCT01466153|324060979|FG000|Overall Study|Withdrawal of Consent|2|||
94617282|NCT01466153|324060980|FG001|Overall Study|Withdrawal of Consent|0|||
94617283|NCT01466153|324060981|FG002|Overall Study|Withdrawal of Consent|0|||
94617284|NCT01466153|324060979|FG000|Overall Study|Investigator Discretion|3|||
94617285|NCT01466153|324060980|FG001|Overall Study|Investigator Discretion|2|||
94617286|NCT01466153|324060981|FG002|Overall Study|Investigator Discretion|2|||
94617287|NCT01466153|324060979|FG000|Overall Study|Randomized-Not Treated|2|||
94617288|NCT01466153|324060980|FG001|Overall Study|Randomized-Not Treated|3|||
94617289|NCT01466153|324060981|FG002|Overall Study|Randomized-Not Treated|4|||
94617290|NCT01466153|324060979|FG000|Overall Study|Other-Unspecified|6|||
94617291|NCT01466153|324060980|FG001|Overall Study|Other-Unspecified|4|||
94617292|NCT01466153|324060981|FG002|Overall Study|Other-Unspecified|2|||
94617293|NCT01785069|324060985|FG000|Overall Study|Implanted with nonstudy device|1|||
94617294|NCT01785069|324060986|FG001|Overall Study|Implanted with nonstudy device|2|||
94617295|NCT01785069|324060987|FG002|Overall Study|Implanted with nonstudy device|1|||
94617296|NCT01785069|324060988|FG003|Overall Study|Implanted with nonstudy device|0|||
94617297|NCT01785069|324060985|FG000|Overall Study|Death|0|||
94617298|NCT01785069|324060986|FG001|Overall Study|Death|0|||
94617299|NCT01785069|324060987|FG002|Overall Study|Death|2|||
94617300|NCT01785069|324060988|FG003|Overall Study|Death|0|||
94617301|NCT01785069|324060985|FG000|Overall Study|Subject choice|2|||
94617302|NCT01785069|324060986|FG001|Overall Study|Subject choice|2|||
94617303|NCT01785069|324060987|FG002|Overall Study|Subject choice|0|||
94617304|NCT01785069|324060988|FG003|Overall Study|Subject choice|1|||
94617305|NCT01785069|324060985|FG000|Overall Study|Lost to Follow-up|1|||
94617306|NCT01785069|324060986|FG001|Overall Study|Lost to Follow-up|2|||
94617307|NCT01785069|324060987|FG002|Overall Study|Lost to Follow-up|4|||
94617308|NCT01785069|324060988|FG003|Overall Study|Lost to Follow-up|1|||
94617309|NCT01785069|324060985|FG000|Overall Study|Reason not Specified|1|||
94617310|NCT01785069|324060986|FG001|Overall Study|Reason not Specified|2|||
94617311|NCT01785069|324060987|FG002|Overall Study|Reason not Specified|1|||
94617312|NCT01785069|324060988|FG003|Overall Study|Reason not Specified|4|||
94617313|NCT01785069|324060985|FG000|Overall Study|Not evaluable|7|||
94617314|NCT01785069|324060986|FG001|Overall Study|Not evaluable|4|||
94617315|NCT01785069|324060987|FG002|Overall Study|Not evaluable|5|||
94617316|NCT01785069|324060988|FG003|Overall Study|Not evaluable|8|||
94617317|NCT00300274|324060989|FG000|Overall Study|Withdrawal by Subject|12|||
94617318|NCT00300274|324060990|FG001|Overall Study|Withdrawal by Subject|3|||
94617319|NCT00300274|324060991|FG002|Overall Study|Withdrawal by Subject|14|||
94617320|NCT00300274|324060989|FG000|Overall Study|Lost to Follow-up|3|||
94617321|NCT00300274|324060990|FG001|Overall Study|Lost to Follow-up|4|||
94617322|NCT00300274|324060991|FG002|Overall Study|Lost to Follow-up|5|||
94617323|NCT00300274|324060989|FG000|Overall Study|Death|31|||
94617324|NCT00300274|324060990|FG001|Overall Study|Death|20|||
94617325|NCT00300274|324060991|FG002|Overall Study|Death|25|||
94617326|NCT00300274|324060989|FG000|Overall Study|Re-transplant|0|||
94617327|NCT00300274|324060990|FG001|Overall Study|Re-transplant|0|||
94617328|NCT00300274|324060991|FG002|Overall Study|Re-transplant|1|||
94358956|NCT01353586|323098022|FG000|Overall Study|Procedure terminated prior to ablation|3|||
94617329|NCT00660699|324060994|FG000|Overall Study|Withdrawal by Subject|2|||
94617330|NCT01133522|324061000|FG000|Overall Study|Withdrawal by Subject|0|||
94617331|NCT01133522|324061001|FG001|Overall Study|Withdrawal by Subject|1|||
94617332|NCT01133522|324061002|FG002|Overall Study|Withdrawal by Subject|0|||
94617333|NCT01133522|324061003|FG003|Overall Study|Withdrawal by Subject|1|||
94617334|NCT01133522|324061004|FG004|Overall Study|Withdrawal by Subject|0|||
94617335|NCT01133522|324061005|FG005|Overall Study|Withdrawal by Subject|0|||
94617336|NCT01133522|324061006|FG006|Overall Study|Withdrawal by Subject|0|||
94666077|NCT01983293|324231388|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
94666078|NCT01798927|324231389|FG000|Overall Study|Withdrawal by Subject|1|||
94666079|NCT00626522|324231390|FG000|Overall Study|Protocol Violation|0|||
94666080|NCT00626522|324231391|FG001|Overall Study|Protocol Violation|0|||
94666081|NCT00626522|324231392|FG002|Overall Study|Protocol Violation|0|||
94666082|NCT00626522|324231393|FG003|Overall Study|Protocol Violation|0|||
94666083|NCT00626522|324231394|FG004|Overall Study|Protocol Violation|1|||
94666084|NCT00626522|324231395|FG005|Overall Study|Protocol Violation|0|||
94666085|NCT00626522|324231390|FG000|Overall Study|Adverse Event|2|||
94666086|NCT00626522|324231391|FG001|Overall Study|Adverse Event|1|||
94666087|NCT00626522|324231392|FG002|Overall Study|Adverse Event|2|||
94666088|NCT00626522|324231393|FG003|Overall Study|Adverse Event|0|||
94666089|NCT00626522|324231394|FG004|Overall Study|Adverse Event|1|||
94666090|NCT00626522|324231395|FG005|Overall Study|Adverse Event|1|||
94666091|NCT00626522|324231390|FG000|Overall Study|Withdrawal by Subject|2|||
94666092|NCT00626522|324231391|FG001|Overall Study|Withdrawal by Subject|5|||
94666093|NCT00626522|324231392|FG002|Overall Study|Withdrawal by Subject|5|||
94666094|NCT00626522|324231393|FG003|Overall Study|Withdrawal by Subject|0|||
94666095|NCT00626522|324231394|FG004|Overall Study|Withdrawal by Subject|4|||
94666096|NCT00626522|324231395|FG005|Overall Study|Withdrawal by Subject|1|||
94666097|NCT00626522|324231390|FG000|Overall Study|COPD exacerbation|0|||
94666098|NCT00626522|324231391|FG001|Overall Study|COPD exacerbation|0|||
94666099|NCT00626522|324231392|FG002|Overall Study|COPD exacerbation|0|||
94666100|NCT00626522|324231393|FG003|Overall Study|COPD exacerbation|1|||
94666101|NCT00626522|324231394|FG004|Overall Study|COPD exacerbation|1|||
94666102|NCT00626522|324231395|FG005|Overall Study|COPD exacerbation|0|||
94666103|NCT00626522|324231390|FG000|Overall Study|Lost to Follow-up|0|||
94666104|NCT00626522|324231391|FG001|Overall Study|Lost to Follow-up|1|||
94666105|NCT00626522|324231392|FG002|Overall Study|Lost to Follow-up|0|||
94666106|NCT00626522|324231393|FG003|Overall Study|Lost to Follow-up|0|||
94666107|NCT00626522|324231394|FG004|Overall Study|Lost to Follow-up|0|||
94666108|NCT00626522|324231395|FG005|Overall Study|Lost to Follow-up|0|||
94666109|NCT00626522|324231390|FG000|Overall Study|Inconsistent reason reported|1|||
94666110|NCT00626522|324231391|FG001|Overall Study|Inconsistent reason reported|0|||
94666111|NCT00626522|324231392|FG002|Overall Study|Inconsistent reason reported|0|||
94666112|NCT00626522|324231393|FG003|Overall Study|Inconsistent reason reported|0|||
94666113|NCT00626522|324231394|FG004|Overall Study|Inconsistent reason reported|0|||
94666114|NCT00626522|324231395|FG005|Overall Study|Inconsistent reason reported|0|||
94666115|NCT00626522|324231390|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
94666116|NCT00626522|324231391|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
94666117|NCT00626522|324231392|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
94666118|NCT00626522|324231393|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
94666119|NCT00626522|324231394|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
94666120|NCT00626522|324231395|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
94666121|NCT01928719|324231396|FG000|Overall Study|Lost to Follow-up|26|||
94666122|NCT01928719|324231397|FG001|Overall Study|Lost to Follow-up|11|||
94666123|NCT01928719|324231396|FG000|Overall Study|Withdrawal by Subject|22|||
94666124|NCT01928719|324231397|FG001|Overall Study|Withdrawal by Subject|7|||
94666125|NCT01928719|324231396|FG000|Overall Study|Protocol Violation|3|||
94666126|NCT01928719|324231397|FG001|Overall Study|Protocol Violation|1|||
94666127|NCT01928719|324231396|FG000|Overall Study|Adverse Event|1|||
94666128|NCT01928719|324231397|FG001|Overall Study|Adverse Event|0|||
94666129|NCT00773968|324231400|FG000|Overall Study|Adverse Event|2|||
94666130|NCT00773968|324231400|FG000|Overall Study|Death|1|||
94666131|NCT00773968|324231400|FG000|Overall Study|Failure to Return|2|||
94666132|NCT00773968|324231400|FG000|Overall Study|Lack of Efficacy|3|||
94666133|NCT00773968|324231400|FG000|Overall Study|Protocol Violation|1|||
94666134|NCT00773968|324231400|FG000|Overall Study|Withdrawal by Subject|11|||
94666135|NCT00773968|324231400|FG000|Overall Study|Screen Failure|17|||
94666136|NCT00773968|324231400|FG000|Overall Study|Other|8|||
94666137|NCT00263666|324231401|FG000|Overall Study|Adverse Event|6|||
94666138|NCT00263666|324231402|FG001|Overall Study|Adverse Event|8|||
94666139|NCT00263666|324231401|FG000|Overall Study|Lost to Follow-up|1|||
94666140|NCT00263666|324231402|FG001|Overall Study|Lost to Follow-up|2|||
94666141|NCT00263666|324231401|FG000|Overall Study|Withdrawal by Subject|0|||
94666142|NCT00263666|324231402|FG001|Overall Study|Withdrawal by Subject|1|||
94666143|NCT00896168|324231403|FG000|Overall Study|Adverse Event|4|||
94666144|NCT00896168|324231404|FG001|Overall Study|Adverse Event|7|||
94666145|NCT00896168|324231403|FG000|Overall Study|Treatment failure|8|||
94666146|NCT00896168|324231404|FG001|Overall Study|Treatment failure|10|||
94666147|NCT00896168|324231403|FG000|Overall Study|Lost to Follow-up|1|||
94666148|NCT00896168|324231404|FG001|Overall Study|Lost to Follow-up|1|||
94666149|NCT00896168|324231403|FG000|Overall Study|Other|1|||
94666150|NCT00896168|324231404|FG001|Overall Study|Other|1|||
94666151|NCT02332720|324231410|FG000|Part A and Part B|Lost to Follow-up|1|||
94666152|NCT02332720|324231411|FG001|Part A and Part B|Lost to Follow-up|0|||
94666153|NCT02332720|324231412|FG002|Part A and Part B|Lost to Follow-up|0|||
94666154|NCT02332720|324231413|FG003|Part A and Part B|Lost to Follow-up|0|||
94617337|NCT01133522|324061007|FG007|Overall Study|Withdrawal by Subject|0|||
94617338|NCT01133522|324061008|FG008|Overall Study|Withdrawal by Subject|0|||
94617339|NCT01133522|324061009|FG009|Overall Study|Withdrawal by Subject|0|||
94617340|NCT01133522|324061000|FG000|Overall Study|Physician Decision|0|||
94617341|NCT01133522|324061001|FG001|Overall Study|Physician Decision|0|||
94617342|NCT01133522|324061002|FG002|Overall Study|Physician Decision|0|||
94617343|NCT01133522|324061003|FG003|Overall Study|Physician Decision|0|||
94617344|NCT01133522|324061004|FG004|Overall Study|Physician Decision|1|||
94617345|NCT01133522|324061005|FG005|Overall Study|Physician Decision|0|||
94617346|NCT01133522|324061006|FG006|Overall Study|Physician Decision|0|||
94617347|NCT01133522|324061007|FG007|Overall Study|Physician Decision|0|||
94617348|NCT01133522|324061008|FG008|Overall Study|Physician Decision|0|||
94617349|NCT01133522|324061009|FG009|Overall Study|Physician Decision|0|||
94617350|NCT00799383|324063104|FG000|Overall Study|Protocol Violation|1|||
94617351|NCT00799383|324063105|FG001|Overall Study|Protocol Violation|1|||
94617352|NCT00799383|324063104|FG000|Overall Study|Adverse Event|0|||
94617353|NCT00799383|324063105|FG001|Overall Study|Adverse Event|1|||
94617354|NCT00799383|324063104|FG000|Overall Study|Lost to Follow-up|1|||
94617355|NCT00799383|324063105|FG001|Overall Study|Lost to Follow-up|2|||
94617356|NCT00799383|324063104|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
94617357|NCT00799383|324063105|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
94617358|NCT00799383|324063104|FG000|Overall Study|Withdrawal by Subject|0|||
94617359|NCT00799383|324063105|FG001|Overall Study|Withdrawal by Subject|1|||
94617360|NCT00289133|324063106|FG000|Overall Study|Non-study device implanted|12|||
94617361|NCT00289133|324063107|FG001|Overall Study|Non-study device implanted|0|||
94617362|NCT00289133|324063106|FG000|Overall Study|Protocol Violation|32|||
94617363|NCT00289133|324063107|FG001|Overall Study|Protocol Violation|38|||
94617364|NCT00289133|324063106|FG000|Overall Study|Withdrawal by Subject|9|||
94666155|NCT02332720|324231414|FG004|Part A and Part B|Lost to Follow-up|0|||
94666156|NCT02332720|324231415|FG005|Part A and Part B|Lost to Follow-up|2|||
94666157|NCT02332720|324231416|FG006|Part A and Part B|Lost to Follow-up|1|||
94666158|NCT02332720|324231417|FG007|Part A and Part B|Lost to Follow-up|1|||
94666159|NCT02332720|324231418|FG008|Part A and Part B|Lost to Follow-up|0|||
94666160|NCT02332720|324231419|FG009|Part A and Part B|Lost to Follow-up|0|||
94666161|NCT02332720|324231420|FG010|Part A and Part B|Lost to Follow-up|0|||
94666162|NCT02332720|324231421|FG011|Part A and Part B|Lost to Follow-up|0|||
94666163|NCT02332720|324231422|FG012|Part A and Part B|Lost to Follow-up|0|||
94666164|NCT02332720|324231423|FG013|Part A and Part B|Lost to Follow-up|0|||
94666165|NCT02332720|324231424|FG014|Part A and Part B|Lost to Follow-up|0|||
94666166|NCT02332720|324231425|FG015|Part A and Part B|Lost to Follow-up|1|||
94666167|NCT02332720|324231426|FG016|Part A and Part B|Lost to Follow-up|0|||
94666168|NCT02332720|324231427|FG017|Part A and Part B|Lost to Follow-up|0|||
94666169|NCT02332720|324231428|FG018|Part A and Part B|Lost to Follow-up|0|||
94666170|NCT02332720|324231429|FG019|Part A and Part B|Lost to Follow-up|0|||
94666171|NCT02332720|324231430|FG020|Part A and Part B|Lost to Follow-up|0|||
94666172|NCT02332720|324231431|FG021|Part A and Part B|Lost to Follow-up|0|||
94666173|NCT02332720|324231432|FG022|Part A and Part B|Lost to Follow-up|0|||
94666174|NCT02332720|324231410|FG000|Part A and Part B|Adverse Event|0|||
94666175|NCT02332720|324231411|FG001|Part A and Part B|Adverse Event|0|||
94666176|NCT02332720|324231412|FG002|Part A and Part B|Adverse Event|0|||
94666177|NCT02332720|324231413|FG003|Part A and Part B|Adverse Event|0|||
94666178|NCT02332720|324231414|FG004|Part A and Part B|Adverse Event|0|||
94666179|NCT02332720|324231415|FG005|Part A and Part B|Adverse Event|0|||
94617365|NCT00289133|324063107|FG001|Overall Study|Withdrawal by Subject|10|||
94617366|NCT00289133|324063106|FG000|Overall Study|Death|5|||
94617367|NCT00289133|324063107|FG001|Overall Study|Death|10|||
94617368|NCT00289133|324063106|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
94617369|NCT00289133|324063107|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
94617370|NCT00289133|324063106|FG000|Overall Study|Physician Decision|41|||
94617371|NCT00289133|324063107|FG001|Overall Study|Physician Decision|45|||
94617372|NCT00289133|324063106|FG000|Overall Study|Revision|8|||
94617373|NCT00289133|324063107|FG001|Overall Study|Revision|6|||
94617374|NCT00289133|324063106|FG000|Overall Study|Lost to Follow-up|92|||
94617375|NCT00289133|324063107|FG001|Overall Study|Lost to Follow-up|115|||
94617376|NCT00533897|324063117|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
94617377|NCT00533897|324063118|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
94617378|NCT00533897|324063119|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
94617379|NCT00533897|324063120|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
94617380|NCT00533897|324063121|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
94617381|NCT00533897|324063122|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
94617382|NCT00533897|324063123|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
94617383|NCT00533897|324063124|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
94617384|NCT00533897|324063117|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
94617385|NCT00533897|324063118|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
94617386|NCT00533897|324063119|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
94617387|NCT00533897|324063120|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
94617388|NCT00533897|324063121|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
94617389|NCT00533897|324063122|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
94666180|NCT02332720|324231416|FG006|Part A and Part B|Adverse Event|0|||
94666181|NCT02332720|324231417|FG007|Part A and Part B|Adverse Event|0|||
94666182|NCT02332720|324231418|FG008|Part A and Part B|Adverse Event|0|||
94666183|NCT02332720|324231419|FG009|Part A and Part B|Adverse Event|0|||
94617390|NCT00533897|324063123|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
94617391|NCT00533897|324063124|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
94617392|NCT00533897|324063117|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
94617393|NCT00533897|324063118|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
94617394|NCT00533897|324063119|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
94617395|NCT00533897|324063120|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
94617396|NCT00533897|324063121|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
94617397|NCT00533897|324063122|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
94617398|NCT00533897|324063123|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
94617399|NCT00533897|324063124|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
94617400|NCT00533897|324063117|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
94617401|NCT00533897|324063118|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
94617402|NCT00533897|324063119|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
94617403|NCT00533897|324063120|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
94666184|NCT02332720|324231420|FG010|Part A and Part B|Adverse Event|0|||
94666185|NCT02332720|324231421|FG011|Part A and Part B|Adverse Event|0|||
94666186|NCT02332720|324231422|FG012|Part A and Part B|Adverse Event|0|||
94666187|NCT02332720|324231423|FG013|Part A and Part B|Adverse Event|0|||
94666188|NCT02332720|324231424|FG014|Part A and Part B|Adverse Event|0|||
94666189|NCT02332720|324231425|FG015|Part A and Part B|Adverse Event|0|||
94666190|NCT02332720|324231426|FG016|Part A and Part B|Adverse Event|0|||
94617404|NCT00533897|324063121|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
94617405|NCT00533897|324063122|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
94617406|NCT00533897|324063123|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
94617407|NCT00533897|324063124|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
94617408|NCT00533897|324063117|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
94617409|NCT00533897|324063118|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
94617410|NCT00533897|324063119|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
94617411|NCT00533897|324063120|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
94617412|NCT00533897|324063121|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
94617413|NCT00533897|324063122|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
94617414|NCT00533897|324063123|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
94617415|NCT00533897|324063124|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
94617416|NCT00533897|324063117|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
94617417|NCT00533897|324063118|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
94617418|NCT00533897|324063119|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
94617419|NCT00533897|324063120|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
94617420|NCT00533897|324063121|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
94617421|NCT00533897|324063122|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
94617422|NCT00533897|324063123|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
94617423|NCT00533897|324063124|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
94666191|NCT02332720|324231427|FG017|Part A and Part B|Adverse Event|1|||
94666192|NCT02332720|324231428|FG018|Part A and Part B|Adverse Event|0|||
94666193|NCT02332720|324231429|FG019|Part A and Part B|Adverse Event|0|||
94666194|NCT02332720|324231430|FG020|Part A and Part B|Adverse Event|0|||
94666195|NCT02332720|324231431|FG021|Part A and Part B|Adverse Event|0|||
94666196|NCT02332720|324231432|FG022|Part A and Part B|Adverse Event|0|||
94666197|NCT02332720|324231410|FG000|Part A and Part B|Physician Decision|0|||
94666198|NCT02332720|324231411|FG001|Part A and Part B|Physician Decision|0|||
94666199|NCT02332720|324231412|FG002|Part A and Part B|Physician Decision|0|||
94666200|NCT02332720|324231413|FG003|Part A and Part B|Physician Decision|0|||
94666201|NCT02332720|324231414|FG004|Part A and Part B|Physician Decision|0|||
94666202|NCT02332720|324231415|FG005|Part A and Part B|Physician Decision|0|||
94666203|NCT02332720|324231416|FG006|Part A and Part B|Physician Decision|0|||
94666204|NCT02332720|324231417|FG007|Part A and Part B|Physician Decision|0|||
94666205|NCT02332720|324231418|FG008|Part A and Part B|Physician Decision|0|||
94666206|NCT02332720|324231419|FG009|Part A and Part B|Physician Decision|0|||
94666207|NCT02332720|324231420|FG010|Part A and Part B|Physician Decision|0|||
94666208|NCT02332720|324231421|FG011|Part A and Part B|Physician Decision|0|||
94666209|NCT02332720|324231422|FG012|Part A and Part B|Physician Decision|0|||
94666210|NCT02332720|324231423|FG013|Part A and Part B|Physician Decision|0|||
94666211|NCT02332720|324231424|FG014|Part A and Part B|Physician Decision|0|||
94666212|NCT02332720|324231425|FG015|Part A and Part B|Physician Decision|0|||
94666213|NCT02332720|324231426|FG016|Part A and Part B|Physician Decision|0|||
94666214|NCT02332720|324231427|FG017|Part A and Part B|Physician Decision|0|||
94666215|NCT02332720|324231428|FG018|Part A and Part B|Physician Decision|1|||
94666216|NCT02332720|324231429|FG019|Part A and Part B|Physician Decision|0|||
94666217|NCT02332720|324231430|FG020|Part A and Part B|Physician Decision|0|||
94666218|NCT02332720|324231431|FG021|Part A and Part B|Physician Decision|0|||
94666219|NCT02332720|324231432|FG022|Part A and Part B|Physician Decision|0|||
94666220|NCT02332720|324231410|FG000|Part A and Part B|Withdrawal by Subject|0|||
94666221|NCT02332720|324231411|FG001|Part A and Part B|Withdrawal by Subject|0|||
94666222|NCT02332720|324231412|FG002|Part A and Part B|Withdrawal by Subject|0|||
94666223|NCT02332720|324231413|FG003|Part A and Part B|Withdrawal by Subject|0|||
94666224|NCT02332720|324231414|FG004|Part A and Part B|Withdrawal by Subject|0|||
94666225|NCT02332720|324231415|FG005|Part A and Part B|Withdrawal by Subject|1|||
94666226|NCT02332720|324231416|FG006|Part A and Part B|Withdrawal by Subject|0|||
94666227|NCT02332720|324231417|FG007|Part A and Part B|Withdrawal by Subject|0|||
94666228|NCT02332720|324231418|FG008|Part A and Part B|Withdrawal by Subject|0|||
94666229|NCT02332720|324231419|FG009|Part A and Part B|Withdrawal by Subject|0|||
94666230|NCT02332720|324231420|FG010|Part A and Part B|Withdrawal by Subject|0|||
94666231|NCT02332720|324231421|FG011|Part A and Part B|Withdrawal by Subject|0|||
94666232|NCT02332720|324231422|FG012|Part A and Part B|Withdrawal by Subject|0|||
94666233|NCT02332720|324231423|FG013|Part A and Part B|Withdrawal by Subject|0|||
94666234|NCT02332720|324231424|FG014|Part A and Part B|Withdrawal by Subject|0|||
94666235|NCT02332720|324231425|FG015|Part A and Part B|Withdrawal by Subject|0|||
94666236|NCT02332720|324231426|FG016|Part A and Part B|Withdrawal by Subject|0|||
94666237|NCT02332720|324231427|FG017|Part A and Part B|Withdrawal by Subject|0|||
94666238|NCT02332720|324231428|FG018|Part A and Part B|Withdrawal by Subject|0|||
94666239|NCT02332720|324231429|FG019|Part A and Part B|Withdrawal by Subject|1|||
94666240|NCT02332720|324231430|FG020|Part A and Part B|Withdrawal by Subject|0|||
94666241|NCT02332720|324231431|FG021|Part A and Part B|Withdrawal by Subject|0|||
94666242|NCT02332720|324231432|FG022|Part A and Part B|Withdrawal by Subject|0|||
94666243|NCT05912400|324231433|FG000|Overall Study|Lost to Follow-up|1|||
94666244|NCT05912400|324231434|FG001|Overall Study|Lost to Follow-up|0|||
94666245|NCT05912400|324231433|FG000|Overall Study|Physician Decision|6|||
94666246|NCT05912400|324231434|FG001|Overall Study|Physician Decision|0|||
94666247|NCT05912400|324231433|FG000|Overall Study|Withdrawal by Subject|1|||
94666248|NCT05912400|324231434|FG001|Overall Study|Withdrawal by Subject|0|||
94666249|NCT00838110|324231436|FG000|Overall Study|Death|0|||
94666250|NCT00838110|324231437|FG001|Overall Study|Death|0|||
94666251|NCT00838110|324231438|FG002|Overall Study|Death|1|||
94666252|NCT00838110|324231439|FG003|Overall Study|Death|2|||
94666253|NCT00838110|324231436|FG000|Overall Study|Adverse Event|11|||
94666254|NCT00838110|324231437|FG001|Overall Study|Adverse Event|10|||
94666255|NCT00838110|324231438|FG002|Overall Study|Adverse Event|8|||
94666256|NCT00838110|324231439|FG003|Overall Study|Adverse Event|7|||
94666257|NCT00838110|324231436|FG000|Overall Study|Withdrawal by Subject|5|||
94666258|NCT00838110|324231437|FG001|Overall Study|Withdrawal by Subject|6|||
94666259|NCT00838110|324231438|FG002|Overall Study|Withdrawal by Subject|3|||
94666260|NCT00838110|324231439|FG003|Overall Study|Withdrawal by Subject|4|||
94666261|NCT00838110|324231436|FG000|Overall Study|Other|3|||
94666262|NCT00838110|324231437|FG001|Overall Study|Other|3|||
94666263|NCT00838110|324231438|FG002|Overall Study|Other|3|||
94666264|NCT00838110|324231439|FG003|Overall Study|Other|2|||
94666265|NCT00838110|324231436|FG000|Overall Study|Protocol Violation|0|||
94666266|NCT00838110|324231437|FG001|Overall Study|Protocol Violation|2|||
94666267|NCT00838110|324231438|FG002|Overall Study|Protocol Violation|1|||
94666268|NCT00838110|324231439|FG003|Overall Study|Protocol Violation|1|||
94666269|NCT00838110|324231436|FG000|Overall Study|Lost to Follow-up|3|||
94358957|NCT01353586|323098023|FG001|Overall Study|Procedure terminated prior to ablation|0|||
94617424|NCT00533897|324063117|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
94617425|NCT00533897|324063118|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
94617426|NCT00533897|324063119|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
94617427|NCT00533897|324063120|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
94617428|NCT00533897|324063121|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
94617429|NCT00533897|324063122|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
94617430|NCT00533897|324063123|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
94617431|NCT00533897|324063124|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
94617432|NCT00533897|324063117|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
94617433|NCT00533897|324063118|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
94617434|NCT00533897|324063119|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
94617435|NCT00533897|324063120|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
94617436|NCT00533897|324063121|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
94617437|NCT00533897|324063122|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
94617438|NCT00533897|324063123|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
94617439|NCT00533897|324063124|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
94617440|NCT00533897|324063117|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
94617441|NCT00533897|324063118|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
94617442|NCT00533897|324063119|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
94617443|NCT00533897|324063120|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
94617444|NCT00533897|324063121|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
94617445|NCT00533897|324063122|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
94617446|NCT00533897|324063123|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
94617447|NCT00533897|324063124|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
94617448|NCT00533897|324063117|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
94617449|NCT00533897|324063118|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
94617450|NCT00533897|324063119|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
94617451|NCT00533897|324063120|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
94617452|NCT00533897|324063121|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
94617453|NCT00533897|324063122|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
94617454|NCT00533897|324063123|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
94617455|NCT00533897|324063124|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
94617456|NCT00533897|324063117|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
94617457|NCT00533897|324063118|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
94666270|NCT00838110|324231437|FG001|Overall Study|Lost to Follow-up|0|||
94666271|NCT00838110|324231438|FG002|Overall Study|Lost to Follow-up|0|||
94617458|NCT00533897|324063119|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
94617459|NCT00533897|324063120|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
94666272|NCT00838110|324231439|FG003|Overall Study|Lost to Follow-up|0|||
94666273|NCT00838110|324231436|FG000|Overall Study|Did not meet eligibility criteria|0|||
94666274|NCT00838110|324231437|FG001|Overall Study|Did not meet eligibility criteria|0|||
94666275|NCT00838110|324231438|FG002|Overall Study|Did not meet eligibility criteria|1|||
94666276|NCT00838110|324231439|FG003|Overall Study|Did not meet eligibility criteria|2|||
94617460|NCT00533897|324063121|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
94617461|NCT00533897|324063122|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
94617462|NCT00533897|324063123|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
94617463|NCT00533897|324063124|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
94617464|NCT00533897|324063117|FG000|Long Term Extension (LTE)|Death|0|||
94617465|NCT00533897|324063118|FG001|Long Term Extension (LTE)|Death|0|||
94617466|NCT00533897|324063119|FG002|Long Term Extension (LTE)|Death|0|||
94617467|NCT00533897|324063120|FG003|Long Term Extension (LTE)|Death|0|||
94617468|NCT00533897|324063121|FG004|Long Term Extension (LTE)|Death|0|||
94617469|NCT00533897|324063122|FG005|Long Term Extension (LTE)|Death|0|||
94617470|NCT00533897|324063123|FG006|Long Term Extension (LTE)|Death|1|||
94617471|NCT00533897|324063124|FG007|Long Term Extension (LTE)|Death|3|||
94617472|NCT00533897|324063117|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
94617473|NCT00533897|324063118|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
94617474|NCT00533897|324063119|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
94617475|NCT00533897|324063120|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
94617476|NCT00533897|324063121|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
94617477|NCT00533897|324063122|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
94617478|NCT00533897|324063123|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
94617479|NCT00533897|324063124|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
94617480|NCT00533897|324063117|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
94617481|NCT00533897|324063118|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
94617482|NCT00533897|324063119|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
94617483|NCT00533897|324063120|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
94617484|NCT00533897|324063121|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
94617485|NCT00533897|324063122|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
94617486|NCT00533897|324063123|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
94617487|NCT00533897|324063124|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
94617488|NCT00533897|324063117|FG000|Long Term Extension (LTE)|Adverse Event|0|||
94617489|NCT00533897|324063118|FG001|Long Term Extension (LTE)|Adverse Event|0|||
94617490|NCT00533897|324063119|FG002|Long Term Extension (LTE)|Adverse Event|0|||
94617491|NCT00533897|324063120|FG003|Long Term Extension (LTE)|Adverse Event|0|||
94617492|NCT00533897|324063121|FG004|Long Term Extension (LTE)|Adverse Event|0|||
94617493|NCT00533897|324063122|FG005|Long Term Extension (LTE)|Adverse Event|0|||
94617494|NCT00533897|324063123|FG006|Long Term Extension (LTE)|Adverse Event|2|||
94617495|NCT00533897|324063124|FG007|Long Term Extension (LTE)|Adverse Event|5|||
94617496|NCT00533897|324063117|FG000|Long Term Extension (LTE)|Pregnancy|0|||
94617497|NCT00533897|324063118|FG001|Long Term Extension (LTE)|Pregnancy|0|||
94617498|NCT00533897|324063119|FG002|Long Term Extension (LTE)|Pregnancy|0|||
94617499|NCT00533897|324063120|FG003|Long Term Extension (LTE)|Pregnancy|0|||
94617500|NCT00533897|324063121|FG004|Long Term Extension (LTE)|Pregnancy|0|||
94617501|NCT00533897|324063122|FG005|Long Term Extension (LTE)|Pregnancy|0|||
94617502|NCT00533897|324063123|FG006|Long Term Extension (LTE)|Pregnancy|0|||
94617503|NCT00533897|324063124|FG007|Long Term Extension (LTE)|Pregnancy|2|||
94617504|NCT00533897|324063117|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
94617505|NCT00533897|324063118|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
94617506|NCT00533897|324063119|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
94617507|NCT00533897|324063120|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
94617508|NCT00533897|324063121|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
94617509|NCT00533897|324063122|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
94617510|NCT00533897|324063123|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
94617511|NCT00533897|324063124|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
94617512|NCT00533897|324063117|FG000|Long Term Extension (LTE)|Other|0|||
94617513|NCT00533897|324063118|FG001|Long Term Extension (LTE)|Other|0|||
94666277|NCT00838110|324231436|FG000|Overall Study|Randomized but not treated|0|||
94666278|NCT00838110|324231437|FG001|Overall Study|Randomized but not treated|1|||
94666279|NCT00838110|324231438|FG002|Overall Study|Randomized but not treated|0|||
94666280|NCT00838110|324231439|FG003|Overall Study|Randomized but not treated|0|||
94666281|NCT01003899|324231440|FG000|Overall Study|Other Adverse Event|8|||
94666282|NCT01003899|324231440|FG000|Overall Study|Not entered|4|||
94666283|NCT01003899|324231440|FG000|Overall Study|Not treated|1|||
94666284|NCT01003899|324231440|FG000|Overall Study|Progressive disease|34|||
94666285|NCT01262651|324231441|FG000|Overall Study|Adverse Event|40|||
94617514|NCT00533897|324063119|FG002|Long Term Extension (LTE)|Other|0|||
94617515|NCT00533897|324063120|FG003|Long Term Extension (LTE)|Other|0|||
94617516|NCT00533897|324063121|FG004|Long Term Extension (LTE)|Other|0|||
94617517|NCT00533897|324063122|FG005|Long Term Extension (LTE)|Other|0|||
94617518|NCT00533897|324063123|FG006|Long Term Extension (LTE)|Other|1|||
94617519|NCT00533897|324063124|FG007|Long Term Extension (LTE)|Other|6|||
94617520|NCT01086033|324063128|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
94617521|NCT01086033|324063128|FG000|Overall Study|Lost to Follow-up|86|||
94617522|NCT01086033|324063128|FG000|Overall Study|Adverse Event|42|||
94617523|NCT01086033|324063128|FG000|Overall Study|Withdrawal by Subject|41|||
94617524|NCT01086033|324063128|FG000|Overall Study|Other|14|||
94666286|NCT01262651|324231442|FG001|Overall Study|Adverse Event|35|||
94666287|NCT01262651|324231441|FG000|Overall Study|Withdrawal by Subject|15|||
94666288|NCT01262651|324231442|FG001|Overall Study|Withdrawal by Subject|11|||
94666289|NCT01262651|324231441|FG000|Overall Study|Withdrawal by Investigator|2|||
94666290|NCT01262651|324231442|FG001|Overall Study|Withdrawal by Investigator|2|||
94666291|NCT01262651|324231441|FG000|Overall Study|Met Withdrawal Criteria|1|||
94666292|NCT01262651|324231442|FG001|Overall Study|Met Withdrawal Criteria|0|||
94666293|NCT04969783|324231443|FG000|Overall Study|Lost to Follow-up|2|||
94617525|NCT01086033|324063128|FG000|Overall Study|Other|13|||
94617526|NCT01086033|324063128|FG000|Overall Study|AE and Withdrew Consent|5|||
94617527|NCT01086033|324063128|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
94617528|NCT01086033|324063128|FG000|Overall Study|Withdrew consent and Other Reason|4|||
94617529|NCT01086033|324063128|FG000|Overall Study|AE and Lack of Efficacy|4|||
94617530|NCT01086033|324063128|FG000|Overall Study|Death|1|||
94617531|NCT01086033|324063128|FG000|Overall Study|AE and Lost to Follow-up|1|||
94617532|NCT01086033|324063128|FG000|Overall Study|AE and Other Reason|1|||
94617533|NCT01086033|324063128|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
94617534|NCT00894166|324063130|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
94617535|NCT00894166|324063131|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
94617536|NCT00894166|324063132|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
94617537|NCT00894166|324063133|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
94617538|NCT00894166|324063134|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
94617539|NCT00894166|324063135|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
94617540|NCT00894166|324063136|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
94617541|NCT00894166|324063137|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
94617542|NCT00894166|324063130|FG000|Overall Study|Death|0|||
94617543|NCT00894166|324063131|FG001|Overall Study|Death|0|||
94617544|NCT00894166|324063132|FG002|Overall Study|Death|0|||
94617545|NCT00894166|324063133|FG003|Overall Study|Death|1|||
94617546|NCT00894166|324063134|FG004|Overall Study|Death|0|||
94617547|NCT00894166|324063135|FG005|Overall Study|Death|0|||
94617548|NCT00894166|324063136|FG006|Overall Study|Death|0|||
94617549|NCT00894166|324063137|FG007|Overall Study|Death|0|||
94617550|NCT03750955|324063139|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
94617551|NCT03750955|324063140|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
94617552|NCT03750955|324063139|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
94617553|NCT03750955|324063140|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
94617554|NCT03417219|324063142|FG000|Overall Study|Lost to Follow-up|0|||
94617555|NCT03417219|324063143|FG001|Overall Study|Lost to Follow-up|3|||
94617556|NCT03345914|324063144|FG000|Overall Study|Transition to another study at week 16|80|||
94617557|NCT03345914|324063145|FG001|Overall Study|Transition to another study at week 16|86|||
94617558|NCT03345914|324063146|FG002|Overall Study|Transition to another study at week 16|78|||
94617559|NCT03345914|324063144|FG000|Overall Study|Transition to OLE during follow-up|37|||
94617560|NCT03345914|324063145|FG001|Overall Study|Transition to OLE during follow-up|33|||
94617561|NCT03345914|324063146|FG002|Overall Study|Transition to OLE during follow-up|39|||
94617562|NCT03345914|324063144|FG000|Overall Study|Physician Decision|0|||
94617563|NCT03345914|324063145|FG001|Overall Study|Physician Decision|1|||
94617564|NCT03345914|324063146|FG002|Overall Study|Physician Decision|1|||
94617565|NCT03345914|324063144|FG000|Overall Study|Withdrawal by Subject|5|||
94617566|NCT03345914|324063145|FG001|Overall Study|Withdrawal by Subject|1|||
94617567|NCT03345914|324063146|FG002|Overall Study|Withdrawal by Subject|2|||
94617568|NCT03345914|324063144|FG000|Overall Study|Other|1|||
94617569|NCT03345914|324063145|FG001|Overall Study|Other|1|||
94617570|NCT03345914|324063146|FG002|Overall Study|Other|1|||
94617571|NCT03345914|324063144|FG000|Overall Study|Ongoing|0|||
94617572|NCT03345914|324063145|FG001|Overall Study|Ongoing|0|||
94617573|NCT03345914|324063146|FG002|Overall Study|Ongoing|1|||
94617574|NCT04377620|324063148|FG000|Overall Study|Death|42|||
94617575|NCT04377620|324063149|FG001|Overall Study|Death|48|||
94617576|NCT04377620|324063150|FG002|Overall Study|Death|36|||
94617577|NCT04377620|324063148|FG000|Overall Study|Withdrawal by Subject|0|||
94666294|NCT04969783|324231444|FG001|Overall Study|Lost to Follow-up|0|||
94666295|NCT04969783|324231443|FG000|Overall Study|Withdrawal by Subject|4|||
94666296|NCT04969783|324231444|FG001|Overall Study|Withdrawal by Subject|0|||
94617578|NCT04377620|324063149|FG001|Overall Study|Withdrawal by Subject|2|||
94617579|NCT04377620|324063150|FG002|Overall Study|Withdrawal by Subject|0|||
94617580|NCT00444912|324063154|FG000|Overall Study|Death|1|||
94617581|NCT00444912|324063155|FG001|Overall Study|Death|2|||
94617582|NCT00444912|324063154|FG000|Overall Study|Lost to Follow-up|1|||
94617583|NCT00444912|324063155|FG001|Overall Study|Lost to Follow-up|0|||
94666297|NCT04969783|324231443|FG000|Overall Study|Physician Decision|6|||
94617584|NCT00444912|324063154|FG000|Overall Study|Participant Failed Mobilization|1|||
94617585|NCT00444912|324063155|FG001|Overall Study|Participant Failed Mobilization|0|||
94617586|NCT01281865|324063156|FG000|Overall Study|Adverse Event|1|||
94617587|NCT01281865|324063157|FG001|Overall Study|Adverse Event|1|||
94617588|NCT01281865|324063156|FG000|Overall Study|Withdrawal by Subject|1|||
94358958|NCT01353586|323098022|FG000|Overall Study|Never had insertion of study catheter|4|||
94666298|NCT04969783|324231444|FG001|Overall Study|Physician Decision|0|||
94666299|NCT02489500|324231445|FG000|Overall Study|Death|1|||
94461078|NCT00474045|323476864|FG001|Overall Study|Withdrawal by Subject|18|||
94461079|NCT00474045|323476863|FG000|Overall Study|Withdrawal criteria|60|||
94617589|NCT01281865|324063157|FG001|Overall Study|Withdrawal by Subject|0|||
94617590|NCT01281865|324063156|FG000|Overall Study|Lack of Efficacy|1|||
94617591|NCT01281865|324063157|FG001|Overall Study|Lack of Efficacy|0|||
94617592|NCT01606007|324063158|FG000|Overall Study|Reason 'Other' in the protocol|0|||
94617593|NCT01606007|324063159|FG001|Overall Study|Reason 'Other' in the protocol|1|||
94617594|NCT01606007|324063160|FG002|Overall Study|Reason 'Other' in the protocol|1|||
94617595|NCT01606007|324063158|FG000|Overall Study|Pregnancy|0|||
94617596|NCT01606007|324063159|FG001|Overall Study|Pregnancy|1|||
94617597|NCT01606007|324063160|FG002|Overall Study|Pregnancy|1|||
94617598|NCT01606007|324063158|FG000|Overall Study|Withdrawal by Subject|8|||
94617599|NCT01606007|324063159|FG001|Overall Study|Withdrawal by Subject|6|||
94617600|NCT01606007|324063160|FG002|Overall Study|Withdrawal by Subject|1|||
94617601|NCT01606007|324063158|FG000|Overall Study|Adverse Event|0|||
94617602|NCT01606007|324063159|FG001|Overall Study|Adverse Event|1|||
94617603|NCT01606007|324063160|FG002|Overall Study|Adverse Event|1|||
94617604|NCT01606007|324063158|FG000|Overall Study|discontinue study treatment|0|||
94617605|NCT01606007|324063159|FG001|Overall Study|discontinue study treatment|2|||
94617606|NCT01606007|324063160|FG002|Overall Study|discontinue study treatment|1|||
94617607|NCT01606007|324063158|FG000|Overall Study|Lost to Follow-up|6|||
94617608|NCT01606007|324063159|FG001|Overall Study|Lost to Follow-up|8|||
94617609|NCT01606007|324063160|FG002|Overall Study|Lost to Follow-up|5|||
94617610|NCT01606007|324063158|FG000|Overall Study|Poor/Non-compliance|1|||
94617611|NCT01606007|324063159|FG001|Overall Study|Poor/Non-compliance|0|||
94617612|NCT01606007|324063160|FG002|Overall Study|Poor/Non-compliance|0|||
94617613|NCT04138810|324063164|FG000|Overall Study|Withdrawal by Subject|0|||
94617614|NCT04138810|324063165|FG001|Overall Study|Withdrawal by Subject|1|||
94617615|NCT04138810|324063164|FG000|Overall Study|Subject cancelled surgery|1|||
94617616|NCT04138810|324063165|FG001|Overall Study|Subject cancelled surgery|0|||
94617617|NCT00493025|324063166|FG000|Overall Study|Physician Decision|19|||
94617618|NCT02905149|324063175|FG000|Overall Study|Lost to Follow-up|2|||
94617619|NCT02905149|324063176|FG001|Overall Study|Lost to Follow-up|0|||
94617620|NCT00446251|324063177|FG000|Overall Study|On-study Transplants|2|||
94617621|NCT00446251|324063177|FG000|Overall Study|Rituximab Infusion Reaction|2|||
94617622|NCT00446251|324063177|FG000|Overall Study|Lost to Follow-up|1|||
94617623|NCT01042678|324063178|FG000|Overall Study|Physician Decision|1|||
94617624|NCT01042678|324063179|FG001|Overall Study|Physician Decision|0|||
94617625|NCT01042678|324063180|FG002|Overall Study|Physician Decision|0|||
94617626|NCT01042678|324063181|FG003|Overall Study|Physician Decision|0|||
94617627|NCT01042678|324063182|FG004|Overall Study|Physician Decision|0|||
94617628|NCT01042678|324063183|FG005|Overall Study|Physician Decision|0|||
94617629|NCT04545060|324063184|FG000|Overall Study|Adverse Event|0|||
94617630|NCT04545060|324063185|FG001|Overall Study|Adverse Event|1|||
94617631|NCT04545060|324063184|FG000|Overall Study|Death|0|||
94617632|NCT04545060|324063185|FG001|Overall Study|Death|5|||
94617633|NCT04545060|324063184|FG000|Overall Study|Lost to Follow-up|10|||
94617634|NCT04545060|324063185|FG001|Overall Study|Lost to Follow-up|13|||
94617635|NCT04545060|324063184|FG000|Overall Study|Physician Decision|3|||
94617636|NCT04545060|324063185|FG001|Overall Study|Physician Decision|0|||
94617637|NCT04545060|324063184|FG000|Overall Study|Withdrawal by Subject|17|||
94617638|NCT04545060|324063185|FG001|Overall Study|Withdrawal by Subject|22|||
94617639|NCT00389597|324063186|FG000|Overall Study|Lost to Follow-up|8|||
94617640|NCT00389597|324063187|FG001|Overall Study|Lost to Follow-up|6|||
94617641|NCT00389597|324063188|FG002|Overall Study|Lost to Follow-up|4|||
94617642|NCT00389597|324063189|FG003|Overall Study|Lost to Follow-up|6|||
94617643|NCT03988088|324063190|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
94617644|NCT03988088|324063191|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
94617645|NCT03988088|324063192|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
94617646|NCT03988088|324063193|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
94461080|NCT00474045|323476864|FG001|Overall Study|Withdrawal criteria|50|||
94461081|NCT00102531|323476872|FG000|Overall Study|Adverse Event|0|||
94617647|NCT03988088|324063190|FG000|Open-Label Addendum|Lost to Follow-up|0|||
94617648|NCT03988088|324063191|FG001|Open-Label Addendum|Lost to Follow-up|0|||
94617649|NCT03988088|324063192|FG002|Open-Label Addendum|Lost to Follow-up|1|||
94617650|NCT03988088|324063193|FG003|Open-Label Addendum|Lost to Follow-up|0|||
94617651|NCT04431453|324063194|FG000|Overall Study|Withdrew Consent|0|||
94617652|NCT04431453|324063195|FG001|Overall Study|Withdrew Consent|1|||
94666300|NCT02489500|324231446|FG001|Overall Study|Death|1|||
94666301|NCT01990950|324231447|FG000|Overall Study|Death|3|||
94461082|NCT00102531|323476873|FG001|Overall Study|Adverse Event|1|||
94617653|NCT04431453|324063196|FG002|Overall Study|Withdrew Consent|0|||
94617654|NCT04431453|324063197|FG003|Overall Study|Withdrew Consent|2|||
94617655|NCT04431453|324063198|FG004|Overall Study|Withdrew Consent|0|||
94617656|NCT04431453|324063199|FG005|Overall Study|Withdrew Consent|0|||
94617657|NCT04431453|324063200|FG006|Overall Study|Withdrew Consent|0|||
94666302|NCT01990950|324231447|FG000|Overall Study|Lost to Follow-up|2|||
94666303|NCT01990950|324231447|FG000|Overall Study|Withdrawal by Subject|6|||
94666304|NCT02863926|324231448|FG000|Overall Study|Physician Decision|1|||
94666305|NCT02863926|324231449|FG001|Overall Study|Physician Decision|0|||
94666306|NCT02863926|324231448|FG000|Overall Study|Lost to Follow-up|1|||
94666307|NCT02863926|324231449|FG001|Overall Study|Lost to Follow-up|1|||
94666308|NCT03240588|324231450|FG000|Overall Study|Death|3|||
94666309|NCT03240588|324231451|FG001|Overall Study|Death|0|||
94666310|NCT03240588|324231452|FG002|Overall Study|Death|0|||
94666311|NCT03240588|324231450|FG000|Overall Study|Adverse Event|5|||
94666312|NCT03240588|324231451|FG001|Overall Study|Adverse Event|4|||
94666313|NCT03240588|324231452|FG002|Overall Study|Adverse Event|0|||
94666314|NCT03240588|324231450|FG000|Overall Study|Lost to Follow-up|9|||
94666315|NCT03240588|324231451|FG001|Overall Study|Lost to Follow-up|4|||
94666316|NCT03240588|324231452|FG002|Overall Study|Lost to Follow-up|0|||
94666317|NCT03240588|324231450|FG000|Overall Study|Physician Decision|3|||
94666318|NCT03240588|324231451|FG001|Overall Study|Physician Decision|2|||
94666319|NCT03240588|324231452|FG002|Overall Study|Physician Decision|0|||
94666320|NCT03240588|324231450|FG000|Overall Study|Did not meet eligibility criteria|0|||
94666321|NCT03240588|324231451|FG001|Overall Study|Did not meet eligibility criteria|6|||
94666322|NCT03240588|324231452|FG002|Overall Study|Did not meet eligibility criteria|0|||
94666323|NCT03240588|324231450|FG000|Overall Study|No longer meets protocol criteria|12|||
94666324|NCT03240588|324231451|FG001|Overall Study|No longer meets protocol criteria|7|||
94666325|NCT03240588|324231452|FG002|Overall Study|No longer meets protocol criteria|0|||
94666326|NCT03240588|324231450|FG000|Overall Study|Withdrawal by Subject|60|||
94666327|NCT03240588|324231451|FG001|Overall Study|Withdrawal by Subject|52|||
94666328|NCT03240588|324231452|FG002|Overall Study|Withdrawal by Subject|7|||
94666329|NCT03240588|324231450|FG000|Overall Study|Other, additional details not available.|0|||
94666330|NCT03240588|324231451|FG001|Overall Study|Other, additional details not available.|12|||
94666331|NCT03240588|324231452|FG002|Overall Study|Other, additional details not available.|1|||
94666332|NCT03240588|324231450|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
94666333|NCT03240588|324231451|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
94666334|NCT03240588|324231452|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
94666335|NCT03240588|324231450|FG000|Overall Study|Closure of study|55|||
94666336|NCT03240588|324231451|FG001|Overall Study|Closure of study|3|||
94666337|NCT03240588|324231452|FG002|Overall Study|Closure of study|0|||
94666338|NCT03240588|324231450|FG000|Overall Study|Subject non-compliance|23|||
94666339|NCT03240588|324231451|FG001|Overall Study|Subject non-compliance|2|||
94666340|NCT03240588|324231452|FG002|Overall Study|Subject non-compliance|1|||
94666341|NCT03240588|324231450|FG000|Overall Study|Device Deficiency|1|||
94666342|NCT03240588|324231451|FG001|Overall Study|Device Deficiency|0|||
94666343|NCT03240588|324231452|FG002|Overall Study|Device Deficiency|0|||
94666344|NCT03240588|324231450|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
94666345|NCT03240588|324231451|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
94666346|NCT03240588|324231452|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
94666347|NCT01914926|324231455|FG000|Overall Study|Adverse Event|1|||
94666348|NCT01914926|324231456|FG001|Overall Study|Adverse Event|0|||
94666349|NCT01914926|324231455|FG000|Overall Study|uncooperative, agitated and removed|0|||
94666350|NCT01914926|324231456|FG001|Overall Study|uncooperative, agitated and removed|1|||
94666351|NCT04717596|324231457|FG000|Overall Study|Withdrawal by Subject|4|||
94666352|NCT01659021|324231458|FG000|Main Study|Adverse Event|2|||
94666353|NCT01659021|324231459|FG001|Main Study|Adverse Event|3|||
94666354|NCT01659021|324231458|FG000|Main Study|Lost to Follow-up|1|||
94666355|NCT01659021|324231459|FG001|Main Study|Lost to Follow-up|0|||
94666356|NCT01659021|324231458|FG000|Main Study|Unknown Reasons|2|||
94666357|NCT01659021|324231459|FG001|Main Study|Unknown Reasons|1|||
94666358|NCT01659021|324231458|FG000|Main Study|Physician Decision|34|||
94666359|NCT01659021|324231459|FG001|Main Study|Physician Decision|16|||
94666360|NCT01659021|324231458|FG000|Main Study|Withdrawal by Subject|19|||
94666361|NCT01659021|324231459|FG001|Main Study|Withdrawal by Subject|16|||
94666362|NCT01659021|324231458|FG000|Main Study|Study Terminated by Sponsor|16|||
94666363|NCT01659021|324231459|FG001|Main Study|Study Terminated by Sponsor|1|||
94666364|NCT01659021|324231458|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
94666365|NCT01659021|324231459|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
94666366|NCT01659021|324231458|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
94666367|NCT01659021|324231459|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
94666368|NCT02896855|324231460|FG000|Overall Study|Death|50|||
94666369|NCT02896855|324231461|FG001|Overall Study|Death|40|||
94666370|NCT02896855|324231460|FG000|Overall Study|Lost to Follow-up|15|||
94666371|NCT02896855|324231461|FG001|Overall Study|Lost to Follow-up|9|||
94666372|NCT02896855|324231460|FG000|Overall Study|Withdrawal by Subject|7|||
94666373|NCT02896855|324231461|FG001|Overall Study|Withdrawal by Subject|4|||
94666374|NCT01296568|324231462|FG000|Continued Access Phase|Lost to Follow-up|1|||
94666375|NCT01296568|324231462|FG000|Continued Access Phase|Withdrawal by Subject|1|||
94666376|NCT01296568|324231462|FG000|Continued Access Phase|Disease Progression|1|||
94666377|NCT02479412|324231463|FG000|Overall Study|Adverse Event|0|||
94666378|NCT02479412|324231464|FG001|Overall Study|Adverse Event|0|||
94666379|NCT02479412|324231465|FG002|Overall Study|Adverse Event|1|||
94666380|NCT02479412|324231466|FG003|Overall Study|Adverse Event|0|||
94666381|NCT02479412|324231467|FG004|Overall Study|Adverse Event|0|||
94666382|NCT02479412|324231468|FG005|Overall Study|Adverse Event|0|||
94666383|NCT02479412|324231469|FG006|Overall Study|Adverse Event|0|||
94666384|NCT02479412|324231470|FG007|Overall Study|Adverse Event|0|||
94666385|NCT02479412|324231471|FG008|Overall Study|Adverse Event|0|||
94666386|NCT02479412|324231463|FG000|Overall Study|Study-specific withdrawal criteria|0|||
94666387|NCT02479412|324231464|FG001|Overall Study|Study-specific withdrawal criteria|0|||
94666388|NCT02479412|324231465|FG002|Overall Study|Study-specific withdrawal criteria|1|||
94666389|NCT02479412|324231466|FG003|Overall Study|Study-specific withdrawal criteria|1|||
94666390|NCT02479412|324231467|FG004|Overall Study|Study-specific withdrawal criteria|0|||
94666391|NCT02479412|324231468|FG005|Overall Study|Study-specific withdrawal criteria|0|||
94666392|NCT02479412|324231469|FG006|Overall Study|Study-specific withdrawal criteria|0|||
94666393|NCT02479412|324231470|FG007|Overall Study|Study-specific withdrawal criteria|1|||
94666394|NCT02479412|324231471|FG008|Overall Study|Study-specific withdrawal criteria|1|||
94666395|NCT02479412|324231463|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
94666396|NCT02479412|324231464|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
94666397|NCT02479412|324231465|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
94666398|NCT02479412|324231466|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
94666399|NCT02479412|324231467|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
94666400|NCT02479412|324231468|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
94666401|NCT02479412|324231469|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
94666402|NCT02479412|324231470|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
94666403|NCT02479412|324231471|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
94617658|NCT04431453|324063201|FG007|Overall Study|Withdrew Consent|0|||
94617659|NCT04431453|324063194|FG000|Overall Study|Death|1|||
94617660|NCT04431453|324063195|FG001|Overall Study|Death|0|||
94617661|NCT04431453|324063196|FG002|Overall Study|Death|0|||
94617662|NCT04431453|324063197|FG003|Overall Study|Death|0|||
94617663|NCT04431453|324063198|FG004|Overall Study|Death|0|||
94617664|NCT04431453|324063199|FG005|Overall Study|Death|0|||
94617665|NCT04431453|324063200|FG006|Overall Study|Death|0|||
94617666|NCT04431453|324063201|FG007|Overall Study|Death|1|||
94617667|NCT04431453|324063194|FG000|Overall Study|Lost to Follow-up|0|||
94617668|NCT04431453|324063195|FG001|Overall Study|Lost to Follow-up|0|||
94617669|NCT04431453|324063196|FG002|Overall Study|Lost to Follow-up|1|||
94617670|NCT04431453|324063197|FG003|Overall Study|Lost to Follow-up|1|||
94617671|NCT04431453|324063198|FG004|Overall Study|Lost to Follow-up|0|||
94617672|NCT04431453|324063199|FG005|Overall Study|Lost to Follow-up|0|||
94617673|NCT04431453|324063200|FG006|Overall Study|Lost to Follow-up|0|||
94617674|NCT04431453|324063201|FG007|Overall Study|Lost to Follow-up|0|||
94617675|NCT04431453|324063194|FG000|Overall Study|Enrolled but Never Treated|0|||
94617676|NCT04431453|324063195|FG001|Overall Study|Enrolled but Never Treated|0|||
94617677|NCT04431453|324063196|FG002|Overall Study|Enrolled but Never Treated|0|||
94617678|NCT04431453|324063197|FG003|Overall Study|Enrolled but Never Treated|0|||
94617679|NCT04431453|324063198|FG004|Overall Study|Enrolled but Never Treated|1|||
94617680|NCT04431453|324063199|FG005|Overall Study|Enrolled but Never Treated|0|||
94617681|NCT04431453|324063200|FG006|Overall Study|Enrolled but Never Treated|0|||
94617682|NCT04431453|324063201|FG007|Overall Study|Enrolled but Never Treated|0|||
94617683|NCT01387789|324063205|FG000|Overall Study|Adverse Event|5|||
94617684|NCT01387789|324063205|FG000|Overall Study|Lack of Efficacy|2|||
94617685|NCT01387789|324063205|FG000|Overall Study|Lost to Follow-up|1|||
94617686|NCT00957580|324063212|FG000|Overall Study|Ongoing at data cut-off|0|||
94617687|NCT00957580|324063213|FG001|Overall Study|Ongoing at data cut-off|1|||
94617688|NCT00957580|324063214|FG002|Overall Study|Ongoing at data cut-off|0|||
94617689|NCT00957580|324063212|FG000|Overall Study|Enrolled but not treated|0|||
94617690|NCT00957580|324063213|FG001|Overall Study|Enrolled but not treated|1|||
94617691|NCT00957580|324063214|FG002|Overall Study|Enrolled but not treated|0|||
94254355|NCT00738582|322724358|FG001|Maintenance Therapy|Progressive Disease|47|||
94254356|NCT00738582|322724357|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
94254357|NCT00738582|322724358|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
94254358|NCT03010176|322724363|FG000|Overall Study|Death|21|||
94461083|NCT00102531|323476872|FG000|Overall Study|Disease Progression|5|||
94617692|NCT01534962|324063215|FG000|Overall Study|Randomized but did not start treatment|2|||
94617693|NCT01534962|324063216|FG001|Overall Study|Randomized but did not start treatment|0|||
94617694|NCT01534962|324063217|FG002|Overall Study|Randomized but did not start treatment|0|||
94617695|NCT01534962|324063218|FG003|Overall Study|Randomized but did not start treatment|1|||
94617696|NCT01534962|324063215|FG000|Overall Study|Discontinued at AF recurrence|35|||
94617697|NCT01534962|324063216|FG001|Overall Study|Discontinued at AF recurrence|26|||
94254359|NCT03010176|322724364|FG001|Overall Study|Death|35|||
94617698|NCT01534962|324063217|FG002|Overall Study|Discontinued at AF recurrence|24|||
94254360|NCT03010176|322724365|FG002|Overall Study|Death|19|||
94254361|NCT03010176|322724366|FG003|Overall Study|Death|19|||
94666404|NCT02119416|324231473|FG000|Overall Study|Protocol Violation|1|||
94358959|NCT01353586|323098023|FG001|Overall Study|Never had insertion of study catheter|1|||
94358960|NCT01353586|323098022|FG000|Overall Study|Neurological exam not done|0|||
94617699|NCT01534962|324063218|FG003|Overall Study|Discontinued at AF recurrence|31|||
94617700|NCT00087607|324063219|FG000|Overall Study|Adverse Event|14|||
94617701|NCT00087607|324063220|FG001|Overall Study|Adverse Event|24|||
94617702|NCT00087607|324063219|FG000|Overall Study|Death|0|||
94617703|NCT00087607|324063220|FG001|Overall Study|Death|1|||
94617704|NCT00087607|324063219|FG000|Overall Study|Insufficient Therapeutic Response|53|||
94617705|NCT00087607|324063220|FG001|Overall Study|Insufficient Therapeutic Response|42|||
94617706|NCT00087607|324063219|FG000|Overall Study|Failure to return|21|||
94617707|NCT00087607|324063220|FG001|Overall Study|Failure to return|17|||
94617708|NCT00087607|324063219|FG000|Overall Study|Withdrew Consent|12|||
94617709|NCT00087607|324063220|FG001|Overall Study|Withdrew Consent|16|||
94617710|NCT00087607|324063219|FG000|Overall Study|Administrative|12|||
94617711|NCT00087607|324063220|FG001|Overall Study|Administrative|12|||
94617712|NCT00087607|324063219|FG000|Overall Study|Refused Treatment|5|||
94617713|NCT00087607|324063220|FG001|Overall Study|Refused Treatment|7|||
94617714|NCT00087607|324063219|FG000|Overall Study|Other Protocol Violation|5|||
94617715|NCT00087607|324063220|FG001|Overall Study|Other Protocol Violation|2|||
94617716|NCT00087607|324063219|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
94617717|NCT00087607|324063220|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
94617718|NCT04502433|324063221|FG000|Overall Study|Death|2|||
94617719|NCT04502433|324063222|FG001|Overall Study|Death|4|||
94617720|NCT04502433|324063221|FG000|Overall Study|Lost to Follow-up|1|||
94617721|NCT04502433|324063222|FG001|Overall Study|Lost to Follow-up|0|||
94617722|NCT04502433|324063221|FG000|Overall Study|Physician Decision|0|||
94617723|NCT04502433|324063222|FG001|Overall Study|Physician Decision|1|||
94617724|NCT00868608|324063223|FG000|Overall Study|Withdrawal by Subject|3|||
94617725|NCT00868608|324063224|FG001|Overall Study|Withdrawal by Subject|1|||
94617726|NCT00868608|324063225|FG002|Overall Study|Withdrawal by Subject|0|||
94617727|NCT00868608|324063223|FG000|Overall Study|Lost to Follow-up|3|||
94617728|NCT00868608|324063224|FG001|Overall Study|Lost to Follow-up|0|||
94617729|NCT00868608|324063225|FG002|Overall Study|Lost to Follow-up|1|||
94617730|NCT00868608|324063223|FG000|Overall Study|Death|16|||
94617731|NCT00868608|324063224|FG001|Overall Study|Death|2|||
94617732|NCT00868608|324063225|FG002|Overall Study|Death|4|||
94617733|NCT00868608|324063223|FG000|Overall Study|Other - Unspecified|1|||
94617734|NCT00868608|324063224|FG001|Overall Study|Other - Unspecified|0|||
94617735|NCT00868608|324063225|FG002|Overall Study|Other - Unspecified|0|||
94617736|NCT02935842|324063226|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
94617737|NCT02935842|324063227|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
94617738|NCT02935842|324063228|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
94617739|NCT02935842|324063229|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
94617740|NCT02935842|324063226|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
94617741|NCT02935842|324063227|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
94617742|NCT02935842|324063228|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
94617743|NCT02935842|324063229|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
94617744|NCT02935842|324063226|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
94617745|NCT02935842|324063227|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
94617746|NCT02935842|324063228|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
94617747|NCT02935842|324063229|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
94617748|NCT02935842|324063226|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
94617749|NCT02935842|324063227|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
94617750|NCT02935842|324063228|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
94617751|NCT02935842|324063229|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
94617752|NCT02935842|324063226|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
94617753|NCT02935842|324063227|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
94617754|NCT02935842|324063228|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
94617755|NCT02935842|324063229|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
94617756|NCT00911547|324063230|FG000|Overall Study|Adverse Event|8|||
94617757|NCT00911547|324063231|FG001|Overall Study|Adverse Event|27|||
94617758|NCT00911547|324063232|FG002|Overall Study|Adverse Event|11|||
94617759|NCT00911547|324063233|FG003|Overall Study|Adverse Event|6|||
94617760|NCT00911547|324063230|FG000|Overall Study|Lost to Follow-up|0|||
94617761|NCT00911547|324063231|FG001|Overall Study|Lost to Follow-up|0|||
94617762|NCT00911547|324063232|FG002|Overall Study|Lost to Follow-up|2|||
94666405|NCT02119416|324231474|FG001|Overall Study|Protocol Violation|1|||
94617763|NCT00911547|324063233|FG003|Overall Study|Lost to Follow-up|1|||
94617764|NCT00911547|324063230|FG000|Overall Study|Protocol Violation|0|||
94617765|NCT00911547|324063231|FG001|Overall Study|Protocol Violation|5|||
94617766|NCT00911547|324063232|FG002|Overall Study|Protocol Violation|5|||
94666406|NCT02119416|324231475|FG002|Overall Study|Protocol Violation|1|||
94617767|NCT00911547|324063233|FG003|Overall Study|Protocol Violation|1|||
94617768|NCT00911547|324063230|FG000|Overall Study|Withdrawal by Subject|3|||
94617769|NCT00911547|324063231|FG001|Overall Study|Withdrawal by Subject|10|||
94617770|NCT00911547|324063232|FG002|Overall Study|Withdrawal by Subject|4|||
94617771|NCT00911547|324063233|FG003|Overall Study|Withdrawal by Subject|8|||
94617772|NCT02405780|324063244|FG000|Period I|Adverse Event|8|||
94617773|NCT02405780|324063245|FG001|Period I|Adverse Event|0|||
94617774|NCT02405780|324063246|FG002|Period I|Adverse Event|3|||
94617775|NCT02405780|324063247|FG003|Period I|Adverse Event|7|||
94617776|NCT02405780|324063244|FG000|Period I|Medical reasons|1|||
94617777|NCT02405780|324063245|FG001|Period I|Medical reasons|1|||
94617778|NCT02405780|324063246|FG002|Period I|Medical reasons|0|||
94617779|NCT02405780|324063247|FG003|Period I|Medical reasons|1|||
94617780|NCT02405780|324063244|FG000|Period I|Screening Failure|1|||
94617781|NCT02405780|324063245|FG001|Period I|Screening Failure|0|||
94617782|NCT02405780|324063246|FG002|Period I|Screening Failure|1|||
94617783|NCT02405780|324063247|FG003|Period I|Screening Failure|0|||
94617784|NCT02405780|324063244|FG000|Period I|Withdrawal by Subject|9|||
94617785|NCT02405780|324063245|FG001|Period I|Withdrawal by Subject|1|||
94617786|NCT02405780|324063246|FG002|Period I|Withdrawal by Subject|3|||
94617787|NCT02405780|324063247|FG003|Period I|Withdrawal by Subject|4|||
94617788|NCT02405780|324063244|FG000|Period I|Non-compliance with study procedures|8|||
94617789|NCT02405780|324063245|FG001|Period I|Non-compliance with study procedures|6|||
94617790|NCT02405780|324063246|FG002|Period I|Non-compliance with study procedures|8|||
94617791|NCT02405780|324063247|FG003|Period I|Non-compliance with study procedures|11|||
94617792|NCT02405780|324063244|FG000|Period II|Adverse Event|3|||
94617793|NCT02405780|324063245|FG001|Period II|Adverse Event|5|||
94617794|NCT02405780|324063246|FG002|Period II|Adverse Event|4|||
94617795|NCT02405780|324063247|FG003|Period II|Adverse Event|11|||
94617796|NCT02405780|324063244|FG000|Period II|Medical reason|0|||
94617797|NCT02405780|324063245|FG001|Period II|Medical reason|1|||
94617798|NCT02405780|324063246|FG002|Period II|Medical reason|0|||
94617799|NCT02405780|324063247|FG003|Period II|Medical reason|0|||
94617800|NCT02405780|324063244|FG000|Period II|Pregnancy|0|||
94617801|NCT02405780|324063245|FG001|Period II|Pregnancy|0|||
94617802|NCT02405780|324063246|FG002|Period II|Pregnancy|1|||
94617803|NCT02405780|324063247|FG003|Period II|Pregnancy|0|||
94617804|NCT02405780|324063244|FG000|Period II|Withdrawal by Subject|7|||
94617805|NCT02405780|324063245|FG001|Period II|Withdrawal by Subject|4|||
94617806|NCT02405780|324063246|FG002|Period II|Withdrawal by Subject|0|||
94617807|NCT02405780|324063247|FG003|Period II|Withdrawal by Subject|3|||
94617808|NCT02405780|324063244|FG000|Period II|Non-compliance with study procedures|5|||
94617809|NCT02405780|324063245|FG001|Period II|Non-compliance with study procedures|2|||
94617810|NCT02405780|324063246|FG002|Period II|Non-compliance with study procedures|7|||
94617811|NCT02405780|324063247|FG003|Period II|Non-compliance with study procedures|4|||
94617812|NCT00674362|324063250|FG000|Double Blind|Adverse Event|6|||
94617813|NCT00674362|324063251|FG001|Double Blind|Adverse Event|6|||
94617814|NCT00674362|324063250|FG000|Double Blind|Lack of Efficacy|2|||
94617815|NCT00674362|324063251|FG001|Double Blind|Lack of Efficacy|6|||
94617816|NCT00674362|324063250|FG000|Double Blind|Loss of efficacy|0|||
94617817|NCT00674362|324063251|FG001|Double Blind|Loss of efficacy|1|||
94617818|NCT00674362|324063250|FG000|Double Blind|Withdrawal by Subject|4|||
94617819|NCT00674362|324063251|FG001|Double Blind|Withdrawal by Subject|3|||
94617820|NCT00674362|324063250|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
94617821|NCT00674362|324063251|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
94617822|NCT00674362|324063250|FG000|Double Blind|Other: Surgery|0|||
94617823|NCT00674362|324063251|FG001|Double Blind|Other: Surgery|1|||
94617824|NCT00674362|324063250|FG000|Open Label|Adverse Event|1|||
94617825|NCT00674362|324063251|FG001|Open Label|Adverse Event|0|||
94617826|NCT00674362|324063250|FG000|Open Label|Other: Subject moved to extension study|1|||
94617827|NCT00674362|324063251|FG001|Open Label|Other: Subject moved to extension study|0|||
94617828|NCT00668707|324063252|FG000|Overall Study|Cancer Recurrence|58|||
94617829|NCT00668707|324063253|FG001|Overall Study|Cancer Recurrence|58|||
94617830|NCT00668707|324063252|FG000|Overall Study|Withdrawal by Subject|117|||
94617831|NCT00668707|324063253|FG001|Overall Study|Withdrawal by Subject|100|||
94666407|NCT02119416|324231473|FG000|Overall Study|wrong pubertal stage|1|||
94666408|NCT02119416|324231474|FG001|Overall Study|wrong pubertal stage|0|||
94617832|NCT00668707|324063252|FG000|Overall Study|Lost to Follow-up|3|||
94617833|NCT00668707|324063253|FG001|Overall Study|Lost to Follow-up|6|||
94617834|NCT00668707|324063252|FG000|Overall Study|Protocol Violation|10|||
94617835|NCT00668707|324063253|FG001|Overall Study|Protocol Violation|12|||
94617836|NCT00668707|324063252|FG000|Overall Study|Death|11|||
94617837|NCT00668707|324063253|FG001|Overall Study|Death|4|||
94617838|NCT04066023|324063254|FG000|Overall Study|Adverse Event|0|||
94666409|NCT02119416|324231475|FG002|Overall Study|wrong pubertal stage|1|||
94617839|NCT04066023|324063255|FG001|Overall Study|Adverse Event|0|||
94617840|NCT04066023|324063256|FG002|Overall Study|Adverse Event|1|||
94617841|NCT04066023|324063254|FG000|Overall Study|Sponsor decision|3|||
94617842|NCT04066023|324063255|FG001|Overall Study|Sponsor decision|6|||
94617843|NCT04066023|324063256|FG002|Overall Study|Sponsor decision|2|||
94617844|NCT04066023|324063254|FG000|Overall Study|Physician Decision|0|||
94617845|NCT04066023|324063255|FG001|Overall Study|Physician Decision|0|||
94617846|NCT04066023|324063256|FG002|Overall Study|Physician Decision|1|||
94617847|NCT04066023|324063254|FG000|Overall Study|Lost to Follow-up|0|||
94617848|NCT04066023|324063255|FG001|Overall Study|Lost to Follow-up|1|||
94617849|NCT04066023|324063256|FG002|Overall Study|Lost to Follow-up|1|||
94617850|NCT04066023|324063254|FG000|Overall Study|Noncompliance|0|||
94617851|NCT04066023|324063255|FG001|Overall Study|Noncompliance|1|||
94617852|NCT04066023|324063256|FG002|Overall Study|Noncompliance|1|||
94617853|NCT00191139|324063257|FG000|Overall Study|Adverse Event|2|||
94617854|NCT00191139|324063258|FG001|Overall Study|Adverse Event|6|||
94617855|NCT00191139|324063257|FG000|Overall Study|Death|2|||
94617856|NCT00191139|324063258|FG001|Overall Study|Death|0|||
94617857|NCT00191139|324063257|FG000|Overall Study|Withdrawal by Subject|0|||
94617858|NCT00191139|324063258|FG001|Overall Study|Withdrawal by Subject|3|||
94617859|NCT00191139|324063257|FG000|Overall Study|Disease Progression|0|||
94617860|NCT00191139|324063258|FG001|Overall Study|Disease Progression|1|||
94617861|NCT00191139|324063257|FG000|Overall Study|Other|1|||
94617862|NCT00191139|324063258|FG001|Overall Study|Other|2|||
94617863|NCT00293033|324063259|FG000|Open-label Titration Period|Adverse Event|10|||
94617864|NCT00293033|324063259|FG000|Open-label Titration Period|Death|3|||
94617865|NCT00293033|324063259|FG000|Open-label Titration Period|Lack of Efficacy|5|||
94617866|NCT00293033|324063259|FG000|Open-label Titration Period|Protocol Violation|2|||
94617867|NCT00293033|324063259|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
94617868|NCT00293033|324063259|FG000|Open-label Titration Period|Noncompliance and other|27|||
94617869|NCT00293033|324063259|FG000|Double-blind Treatment Period|Adverse Event|3|||
94617870|NCT00293033|324063259|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
94617871|NCT00293033|324063259|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
94617872|NCT00293033|324063259|FG000|Double-blind Treatment Period|Noncompliance|4|||
94617873|NCT01817530|324063260|FG000|Overall Study|Exclusionary Medication Received|0|||
94617874|NCT01817530|324063261|FG001|Overall Study|Exclusionary Medication Received|0|||
94617875|NCT01817530|324063262|FG002|Overall Study|Exclusionary Medication Received|0|||
94617876|NCT01817530|324063263|FG003|Overall Study|Exclusionary Medication Received|0|||
94617877|NCT01817530|324063264|FG004|Overall Study|Exclusionary Medication Received|1|||
94617878|NCT01817530|324063265|FG005|Overall Study|Exclusionary Medication Received|0|||
94617879|NCT01817530|324063266|FG006|Overall Study|Exclusionary Medication Received|0|||
94617880|NCT01817530|324063267|FG007|Overall Study|Exclusionary Medication Received|0|||
94617881|NCT01817530|324063260|FG000|Overall Study|Adverse Event|6|||
94617882|NCT01817530|324063261|FG001|Overall Study|Adverse Event|3|||
94617883|NCT01817530|324063262|FG002|Overall Study|Adverse Event|2|||
94617884|NCT01817530|324063263|FG003|Overall Study|Adverse Event|5|||
94617885|NCT01817530|324063264|FG004|Overall Study|Adverse Event|0|||
94617886|NCT01817530|324063265|FG005|Overall Study|Adverse Event|10|||
94617887|NCT01817530|324063266|FG006|Overall Study|Adverse Event|5|||
94617888|NCT01817530|324063267|FG007|Overall Study|Adverse Event|8|||
94617889|NCT01817530|324063260|FG000|Overall Study|Subject Noncompliant|3|||
94617890|NCT01817530|324063261|FG001|Overall Study|Subject Noncompliant|1|||
94617891|NCT01817530|324063262|FG002|Overall Study|Subject Noncompliant|0|||
94617892|NCT01817530|324063263|FG003|Overall Study|Subject Noncompliant|4|||
94617893|NCT01817530|324063264|FG004|Overall Study|Subject Noncompliant|0|||
94617894|NCT01817530|324063265|FG005|Overall Study|Subject Noncompliant|1|||
94617895|NCT01817530|324063266|FG006|Overall Study|Subject Noncompliant|1|||
94617896|NCT01817530|324063267|FG007|Overall Study|Subject Noncompliant|1|||
94617897|NCT01817530|324063260|FG000|Overall Study|Lack of Efficacy|1|||
94617898|NCT01817530|324063261|FG001|Overall Study|Lack of Efficacy|0|||
94617899|NCT01817530|324063262|FG002|Overall Study|Lack of Efficacy|0|||
94617900|NCT01817530|324063263|FG003|Overall Study|Lack of Efficacy|0|||
94617901|NCT01817530|324063264|FG004|Overall Study|Lack of Efficacy|0|||
94617902|NCT01817530|324063265|FG005|Overall Study|Lack of Efficacy|1|||
94617903|NCT01817530|324063266|FG006|Overall Study|Lack of Efficacy|0|||
94617904|NCT01817530|324063267|FG007|Overall Study|Lack of Efficacy|1|||
94617905|NCT01817530|324063260|FG000|Overall Study|Pregnancy|0|||
94617906|NCT01817530|324063261|FG001|Overall Study|Pregnancy|0|||
94617907|NCT01817530|324063262|FG002|Overall Study|Pregnancy|0|||
94617908|NCT01817530|324063263|FG003|Overall Study|Pregnancy|0|||
94666410|NCT03667053|324231476|FG000|Overall Study|Withdrawal by Subject|1|||
94617909|NCT01817530|324063264|FG004|Overall Study|Pregnancy|0|||
94617910|NCT01817530|324063265|FG005|Overall Study|Pregnancy|1|||
94617911|NCT01817530|324063266|FG006|Overall Study|Pregnancy|0|||
94617912|NCT01817530|324063267|FG007|Overall Study|Pregnancy|0|||
94617913|NCT01817530|324063260|FG000|Overall Study|Other|0|||
94617914|NCT01817530|324063261|FG001|Overall Study|Other|1|||
94617915|NCT01817530|324063262|FG002|Overall Study|Other|0|||
94617916|NCT01817530|324063263|FG003|Overall Study|Other|0|||
94617917|NCT01817530|324063264|FG004|Overall Study|Other|1|||
94666411|NCT03667053|324231477|FG001|Overall Study|Withdrawal by Subject|0|||
94617918|NCT01817530|324063265|FG005|Overall Study|Other|0|||
94617919|NCT01817530|324063266|FG006|Overall Study|Other|5|||
94617920|NCT01817530|324063267|FG007|Overall Study|Other|0|||
94617921|NCT01817530|324063260|FG000|Overall Study|Surgery or Invasive Intervention|1|||
94617922|NCT01817530|324063261|FG001|Overall Study|Surgery or Invasive Intervention|0|||
94254362|NCT03010176|322724367|FG004|Overall Study|Death|14|||
94254363|NCT03010176|322724368|FG005|Overall Study|Death|0|||
94254364|NCT03010176|322724363|FG000|Overall Study|Lost to Follow-up|0|||
94254365|NCT03010176|322724364|FG001|Overall Study|Lost to Follow-up|0|||
94254366|NCT03010176|322724365|FG002|Overall Study|Lost to Follow-up|0|||
94254367|NCT03010176|322724366|FG003|Overall Study|Lost to Follow-up|0|||
94254368|NCT03010176|322724367|FG004|Overall Study|Lost to Follow-up|1|||
94254369|NCT03010176|322724368|FG005|Overall Study|Lost to Follow-up|0|||
94254370|NCT03010176|322724363|FG000|Overall Study|Physician Decision|0|||
94254371|NCT03010176|322724364|FG001|Overall Study|Physician Decision|4|||
94254372|NCT03010176|322724365|FG002|Overall Study|Physician Decision|0|||
94254373|NCT03010176|322724366|FG003|Overall Study|Physician Decision|1|||
94617923|NCT01817530|324063262|FG002|Overall Study|Surgery or Invasive Intervention|0|||
94617924|NCT01817530|324063263|FG003|Overall Study|Surgery or Invasive Intervention|0|||
94617925|NCT01817530|324063264|FG004|Overall Study|Surgery or Invasive Intervention|1|||
94617926|NCT01817530|324063265|FG005|Overall Study|Surgery or Invasive Intervention|1|||
94617927|NCT01817530|324063266|FG006|Overall Study|Surgery or Invasive Intervention|1|||
94617928|NCT01817530|324063267|FG007|Overall Study|Surgery or Invasive Intervention|0|||
94617929|NCT01817530|324063260|FG000|Overall Study|Consent Withdrawn by Subject|3|||
94617930|NCT01817530|324063261|FG001|Overall Study|Consent Withdrawn by Subject|4|||
94617931|NCT01817530|324063262|FG002|Overall Study|Consent Withdrawn by Subject|7|||
94617932|NCT01817530|324063263|FG003|Overall Study|Consent Withdrawn by Subject|3|||
94617933|NCT01817530|324063264|FG004|Overall Study|Consent Withdrawn by Subject|5|||
94617934|NCT01817530|324063265|FG005|Overall Study|Consent Withdrawn by Subject|3|||
94617935|NCT01817530|324063266|FG006|Overall Study|Consent Withdrawn by Subject|3|||
94617936|NCT01817530|324063267|FG007|Overall Study|Consent Withdrawn by Subject|10|||
94617937|NCT01817530|324063260|FG000|Overall Study|Lost to Follow-up|1|||
94617938|NCT01817530|324063261|FG001|Overall Study|Lost to Follow-up|4|||
94617939|NCT01817530|324063262|FG002|Overall Study|Lost to Follow-up|2|||
94617940|NCT01817530|324063263|FG003|Overall Study|Lost to Follow-up|1|||
94617941|NCT01817530|324063264|FG004|Overall Study|Lost to Follow-up|3|||
94617942|NCT01817530|324063265|FG005|Overall Study|Lost to Follow-up|2|||
94617943|NCT01817530|324063266|FG006|Overall Study|Lost to Follow-up|8|||
94617944|NCT01817530|324063267|FG007|Overall Study|Lost to Follow-up|4|||
94617945|NCT03846804|324063268|FG000|Overall Study|Refused blood draw|1|||
94617946|NCT03846804|324063268|FG000|Overall Study|Protocol Violation|1|||
94617947|NCT02538029|324063269|FG000|Overall Study|unable to complete cognitive assessments|1|||
94617948|NCT02538029|324063270|FG001|Overall Study|unable to complete cognitive assessments|0|||
94617949|NCT02538029|324063271|FG002|Overall Study|unable to complete cognitive assessments|1|||
94617950|NCT01064310|324063272|FG000|Period 1|Adverse Event|7|||
94617951|NCT01064310|324063273|FG001|Period 1|Adverse Event|10|||
94617952|NCT01064310|324063274|FG002|Period 1|Adverse Event|0|||
94617953|NCT01064310|324063272|FG000|Period 1|Physician Decision|1|||
94617954|NCT01064310|324063273|FG001|Period 1|Physician Decision|0|||
94617955|NCT01064310|324063274|FG002|Period 1|Physician Decision|0|||
94617956|NCT01064310|324063272|FG000|Period 1|Withdrawal by Subject|2|||
94617957|NCT01064310|324063273|FG001|Period 1|Withdrawal by Subject|2|||
94617958|NCT01064310|324063274|FG002|Period 1|Withdrawal by Subject|0|||
94617959|NCT01064310|324063272|FG000|Period 1|Lack of Efficacy|3|||
94617960|NCT01064310|324063273|FG001|Period 1|Lack of Efficacy|5|||
94617961|NCT01064310|324063274|FG002|Period 1|Lack of Efficacy|0|||
94617962|NCT01064310|324063272|FG000|Period 1|Entered Open-label Period|1|||
94617963|NCT01064310|324063273|FG001|Period 1|Entered Open-label Period|1|||
94617964|NCT01064310|324063274|FG002|Period 1|Entered Open-label Period|0|||
94254374|NCT03010176|322724367|FG004|Overall Study|Physician Decision|0|||
94254375|NCT03010176|322724368|FG005|Overall Study|Physician Decision|0|||
94254376|NCT03010176|322724363|FG000|Overall Study|Sponsor Decision|0|||
94617965|NCT01064310|324063272|FG000|Period 2|Adverse Event|2|||
94617966|NCT01064310|324063273|FG001|Period 2|Adverse Event|1|||
94617967|NCT01064310|324063274|FG002|Period 2|Adverse Event|0|||
94617968|NCT01064310|324063272|FG000|Period 2|Physician Decision|0|||
94617969|NCT01064310|324063273|FG001|Period 2|Physician Decision|1|||
94617970|NCT01064310|324063274|FG002|Period 2|Physician Decision|0|||
94254377|NCT03010176|322724364|FG001|Overall Study|Sponsor Decision|4|||
94254378|NCT03010176|322724365|FG002|Overall Study|Sponsor Decision|4|||
94254379|NCT03010176|322724366|FG003|Overall Study|Sponsor Decision|1|||
94254380|NCT03010176|322724367|FG004|Overall Study|Sponsor Decision|6|||
94254381|NCT03010176|322724368|FG005|Overall Study|Sponsor Decision|0|||
94617971|NCT01064310|324063272|FG000|Period 2|Entered Open-label Period|1|||
94617972|NCT01064310|324063273|FG001|Period 2|Entered Open-label Period|0|||
94617973|NCT01064310|324063274|FG002|Period 2|Entered Open-label Period|0|||
94617974|NCT01064310|324063272|FG000|Period 2|Lack of Efficacy|1|||
94617975|NCT01064310|324063273|FG001|Period 2|Lack of Efficacy|4|||
94254382|NCT03010176|322724363|FG000|Overall Study|Withdrawal by Subject|11|||
94254383|NCT03010176|322724364|FG001|Overall Study|Withdrawal by Subject|9|||
94617976|NCT01064310|324063274|FG002|Period 2|Lack of Efficacy|0|||
94617977|NCT01064310|324063272|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
94617978|NCT01064310|324063273|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
94254384|NCT03010176|322724365|FG002|Overall Study|Withdrawal by Subject|3|||
94254385|NCT03010176|322724366|FG003|Overall Study|Withdrawal by Subject|0|||
94254386|NCT03010176|322724367|FG004|Overall Study|Withdrawal by Subject|4|||
94254387|NCT03010176|322724368|FG005|Overall Study|Withdrawal by Subject|0|||
94254388|NCT03536143|322724369|FG000|Overall Study|Early termination, Sponsor decision|1|||
94254389|NCT00440999|322724370|FG000|Overall Study|Adverse Event|0|||
94254390|NCT00440999|322724371|FG001|Overall Study|Adverse Event|2|||
94254391|NCT00440999|322724370|FG000|Overall Study|Lack of Efficacy|6|||
94254392|NCT00440999|322724371|FG001|Overall Study|Lack of Efficacy|7|||
94254393|NCT00440999|322724370|FG000|Overall Study|Lost to Follow-up|19|||
94254394|NCT00440999|322724371|FG001|Overall Study|Lost to Follow-up|12|||
94254395|NCT00440999|322724370|FG000|Overall Study|Protocol Violation|1|||
94254396|NCT00440999|322724371|FG001|Overall Study|Protocol Violation|0|||
94254397|NCT00440999|322724370|FG000|Overall Study|Withdrawal by Subject|2|||
94254398|NCT00440999|322724371|FG001|Overall Study|Withdrawal by Subject|5|||
94254399|NCT00440999|322724370|FG000|Overall Study|Subjets missed the visit|1|||
94254400|NCT00440999|322724371|FG001|Overall Study|Subjets missed the visit|0|||
94254401|NCT00440999|322724370|FG000|Overall Study|Mixed infection at entry|1|||
94617979|NCT01064310|324063274|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
94617980|NCT01064310|324063272|FG000|Open Label Pazopinib|Adverse Event|0|||
94617981|NCT01064310|324063273|FG001|Open Label Pazopinib|Adverse Event|0|||
94617982|NCT01064310|324063274|FG002|Open Label Pazopinib|Adverse Event|12|||
94617983|NCT01064310|324063272|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
94617984|NCT01064310|324063273|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
94617985|NCT01064310|324063274|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
94617986|NCT01064310|324063272|FG000|Open Label Pazopinib|Physician Decision|0|||
94617987|NCT01064310|324063273|FG001|Open Label Pazopinib|Physician Decision|0|||
94617988|NCT01064310|324063274|FG002|Open Label Pazopinib|Physician Decision|20|||
94617989|NCT01980940|324063275|FG000|Overall Study|Protocol Violation|0|||
94617990|NCT01980940|324063276|FG001|Overall Study|Protocol Violation|0|||
94617991|NCT01980940|324063277|FG002|Overall Study|Protocol Violation|0|||
94617992|NCT01980940|324063278|FG003|Overall Study|Protocol Violation|0|||
94617993|NCT01980940|324063279|FG004|Overall Study|Protocol Violation|0|||
94617994|NCT01980940|324063280|FG005|Overall Study|Protocol Violation|2|||
94617995|NCT01980940|324063281|FG006|Overall Study|Protocol Violation|0|||
94617996|NCT01980940|324063282|FG007|Overall Study|Protocol Violation|0|||
94617997|NCT01516437|324064730|FG000|Overall Study|Reason not specified|0|||
94617998|NCT01516437|324064731|FG001|Overall Study|Reason not specified|0|||
94617999|NCT01516437|324064732|FG002|Overall Study|Reason not specified|1|||
94618000|NCT01516437|324064733|FG003|Overall Study|Reason not specified|1|||
94618001|NCT02400333|324064734|FG000|Overall Study|Withdrawal by Subject|0|||
94618002|NCT02400333|324064735|FG001|Overall Study|Withdrawal by Subject|1|||
94618003|NCT02400333|324064736|FG002|Overall Study|Withdrawal by Subject|0|||
94618004|NCT02400333|324064737|FG003|Overall Study|Withdrawal by Subject|1|||
94618005|NCT02400333|324064734|FG000|Overall Study|Protocol Violation|1|||
94618006|NCT02400333|324064735|FG001|Overall Study|Protocol Violation|0|||
94618007|NCT02400333|324064736|FG002|Overall Study|Protocol Violation|2|||
94618008|NCT02400333|324064737|FG003|Overall Study|Protocol Violation|1|||
94618009|NCT01687998|324064738|FG000|Overall Study|Withdrawal by Subject|49|||
94618010|NCT01687998|324064739|FG001|Overall Study|Withdrawal by Subject|51|||
94618011|NCT01687998|324064738|FG000|Overall Study|Known to be Alive at Study End|54|||
94618012|NCT01687998|324064739|FG001|Overall Study|Known to be Alive at Study End|62|||
94618013|NCT01687998|324064738|FG000|Overall Study|Lost to Follow-up|9|||
94618014|NCT01687998|324064739|FG001|Overall Study|Lost to Follow-up|7|||
94618015|NCT01871532|324064743|FG000|Overall Study|Withdrawal by Subject|1|||
94618016|NCT01871532|324064744|FG001|Overall Study|Withdrawal by Subject|2|||
94618017|NCT00283400|324064745|FG000|Overall Study|Withdrawal by Subject|1|||
94618018|NCT00283400|324064746|FG001|Overall Study|Withdrawal by Subject|1|||
94618019|NCT00283400|324064747|FG002|Overall Study|Withdrawal by Subject|0|||
94618020|NCT00283400|324064748|FG003|Overall Study|Withdrawal by Subject|0|||
94618021|NCT00283400|324064745|FG000|Overall Study|Death|1|||
94618022|NCT00283400|324064746|FG001|Overall Study|Death|0|||
94618023|NCT00283400|324064747|FG002|Overall Study|Death|1|||
94618024|NCT00283400|324064748|FG003|Overall Study|Death|0|||
94618025|NCT00094172|324064751|FG000|Overall Study|Adverse Event|0|||
94618026|NCT00094172|324064752|FG001|Overall Study|Adverse Event|1|||
94358961|NCT01353586|323098023|FG001|Overall Study|Neurological exam not done|1|||
94618027|NCT00094172|324064751|FG000|Overall Study|Lost to Follow-up|2|||
94618028|NCT00094172|324064752|FG001|Overall Study|Lost to Follow-up|0|||
94618029|NCT00094172|324064751|FG000|Overall Study|Protocol Violation|0|||
94618030|NCT00094172|324064752|FG001|Overall Study|Protocol Violation|1|||
94618031|NCT00094172|324064751|FG000|Overall Study|Withdrawal by Subject|10|||
94254402|NCT00440999|322724371|FG001|Overall Study|Mixed infection at entry|0|||
94254403|NCT00440999|322724370|FG000|Overall Study|P. falciparum malaria|5|||
94254404|NCT00440999|322724371|FG001|Overall Study|P. falciparum malaria|14|||
94618032|NCT00094172|324064752|FG001|Overall Study|Withdrawal by Subject|5|||
94618033|NCT00094172|324064751|FG000|Overall Study|Primary endpoint met.|1|||
94618034|NCT00094172|324064752|FG001|Overall Study|Primary endpoint met.|0|||
94358962|NCT00276458|323098024|FG000|Overall Study|Adverse Event|0|||
94358963|NCT00276458|323098025|FG001|Overall Study|Adverse Event|2|||
94358964|NCT00276458|323098024|FG000|Overall Study|Lost to Follow-up|2|||
94358965|NCT00276458|323098025|FG001|Overall Study|Lost to Follow-up|2|||
94358966|NCT00276458|323098024|FG000|Overall Study|Protocol Violation|4|||
94358967|NCT00276458|323098025|FG001|Overall Study|Protocol Violation|3|||
94358968|NCT02797951|323098026|FG000|Overall Study|Adverse Event|4|||
94358969|NCT02797951|323098026|FG000|Overall Study|Death|1|||
94358970|NCT02797951|323098026|FG000|Overall Study|Lack of Efficacy|19|||
94358971|NCT02797951|323098026|FG000|Overall Study|Lost to Follow-up|4|||
94358972|NCT02797951|323098026|FG000|Overall Study|Physician Decision|6|||
94358973|NCT02797951|323098026|FG000|Overall Study|Withdrawal by Subject|15|||
94358974|NCT00910000|323098031|FG000|Overall Study|Adverse Event|0|||
94358975|NCT00910000|323098032|FG001|Overall Study|Adverse Event|3|||
94358976|NCT00910000|323098033|FG002|Overall Study|Adverse Event|2|||
94358977|NCT00910000|323098034|FG003|Overall Study|Adverse Event|2|||
94358978|NCT00910000|323098035|FG004|Overall Study|Adverse Event|0|||
94358979|NCT00910000|323098036|FG005|Overall Study|Adverse Event|1|||
94358980|NCT00910000|323098031|FG000|Overall Study|Withdrawal by Subject|0|||
94618035|NCT00094172|324064751|FG000|Overall Study|Started other MS therapy due to disease|1|||
94618036|NCT00094172|324064752|FG001|Overall Study|Started other MS therapy due to disease|0|||
94618037|NCT00003473|324064754|FG000|Overall Study|Three patients were not evaluable.|3|||
94618038|NCT00926328|324064758|FG000|Overall Study|Lost to Follow-up|12|||
94618039|NCT00926328|324064759|FG001|Overall Study|Lost to Follow-up|14|||
94618040|NCT00726986|324064760|FG000|Induction Phase|Adverse Event|4|||
94618041|NCT00726986|324064760|FG000|Induction Phase|Withdrawal by Subject|2|||
94618042|NCT00726986|324064760|FG000|Induction Phase|Death|2|||
94618043|NCT00726986|324064760|FG000|Induction Phase|Lack of Efficacy|5|||
94618044|NCT00726986|324064760|FG000|Induction Phase|Secondary Disease|2|||
94618045|NCT00726986|324064760|FG000|Maintenance Phase|Adverse Event|1|||
94618046|NCT00726986|324064760|FG000|Maintenance Phase|Lack of Efficacy|2|||
94618047|NCT00040365|324064766|FG000|Overall Study|Death|1|||
94618048|NCT00040365|324064766|FG000|Overall Study|Progressive disease|7|||
94618049|NCT00040365|324064766|FG000|Overall Study|Lost to Follow-up|3|||
94618050|NCT00680017|324064767|FG000|Overall Study|Adverse Event|13|||
94618051|NCT00680017|324064768|FG001|Overall Study|Adverse Event|7|||
94618052|NCT00680017|324064767|FG000|Overall Study|Withdrawal by Subject|2|||
94618053|NCT00680017|324064768|FG001|Overall Study|Withdrawal by Subject|5|||
94618054|NCT00680017|324064767|FG000|Overall Study|Lost to Follow-up|2|||
94618055|NCT00680017|324064768|FG001|Overall Study|Lost to Follow-up|0|||
94618056|NCT02555683|324064769|FG000|Overall Study|Physician Decision|1|||
94618057|NCT02555683|324064770|FG001|Overall Study|Physician Decision|0|||
94618058|NCT02555683|324064771|FG002|Overall Study|Physician Decision|2|||
94618059|NCT02555683|324064769|FG000|Overall Study|Lost to Follow-up|2|||
94618060|NCT02555683|324064770|FG001|Overall Study|Lost to Follow-up|1|||
94618061|NCT02555683|324064771|FG002|Overall Study|Lost to Follow-up|2|||
94618062|NCT02555683|324064769|FG000|Overall Study|Technical Problems|1|||
94618063|NCT02555683|324064770|FG001|Overall Study|Technical Problems|1|||
94618064|NCT02555683|324064771|FG002|Overall Study|Technical Problems|0|||
94618065|NCT02555683|324064769|FG000|Overall Study|Protocol deviation|0|||
94618066|NCT02555683|324064770|FG001|Overall Study|Protocol deviation|1|||
94618067|NCT02555683|324064771|FG002|Overall Study|Protocol deviation|0|||
94618068|NCT02555683|324064769|FG000|Overall Study|Lack of Efficacy|2|||
94618069|NCT02555683|324064770|FG001|Overall Study|Lack of Efficacy|0|||
94618070|NCT02555683|324064771|FG002|Overall Study|Lack of Efficacy|0|||
94618071|NCT02555683|324064769|FG000|Overall Study|Death|0|||
94618072|NCT02555683|324064770|FG001|Overall Study|Death|1|||
94618073|NCT02555683|324064771|FG002|Overall Study|Death|2|||
94618074|NCT02555683|324064769|FG000|Overall Study|Adverse Event|1|||
94618075|NCT02555683|324064770|FG001|Overall Study|Adverse Event|0|||
94618076|NCT02555683|324064771|FG002|Overall Study|Adverse Event|1|||
94358981|NCT00910000|323098032|FG001|Overall Study|Withdrawal by Subject|0|||
94358982|NCT00910000|323098033|FG002|Overall Study|Withdrawal by Subject|1|||
94358983|NCT00910000|323098034|FG003|Overall Study|Withdrawal by Subject|0|||
94358984|NCT00910000|323098035|FG004|Overall Study|Withdrawal by Subject|1|||
94618077|NCT02555683|324064769|FG000|Overall Study|Subject/guardian decision|12|||
94618078|NCT02555683|324064770|FG001|Overall Study|Subject/guardian decision|12|||
94358985|NCT00910000|323098036|FG005|Overall Study|Withdrawal by Subject|0|||
94461084|NCT00102531|323476873|FG001|Overall Study|Disease Progression|9|||
94461085|NCT00102531|323476872|FG000|Overall Study|Physician Decision|0|||
94461086|NCT00102531|323476873|FG001|Overall Study|Physician Decision|1|||
94618079|NCT02555683|324064771|FG002|Overall Study|Subject/guardian decision|22|||
94618080|NCT02555683|324064769|FG000|Overall Study|Death post Treatment/safety period|0|||
94618081|NCT02555683|324064770|FG001|Overall Study|Death post Treatment/safety period|1|||
94358986|NCT03733301|323098037|FG000|Overall Study|Screen Fail|1|||
94358987|NCT03733301|323098038|FG001|Overall Study|Screen Fail|0|||
94358988|NCT03733301|323098039|FG002|Overall Study|Screen Fail|0|||
94358989|NCT03733301|323098037|FG000|Overall Study|Non-compliance|1|||
94358990|NCT03733301|323098038|FG001|Overall Study|Non-compliance|0|||
94618082|NCT02555683|324064771|FG002|Overall Study|Death post Treatment/safety period|0|||
94666412|NCT03667053|324231478|FG002|Overall Study|Withdrawal by Subject|0|||
94666413|NCT00476476|324231482|FG000|Overall Study|Adverse Event|2|||
94666414|NCT00476476|324231483|FG001|Overall Study|Adverse Event|7|||
94666415|NCT00476476|324231482|FG000|Overall Study|Progressive Disease|0|||
94666416|NCT00476476|324231483|FG001|Overall Study|Progressive Disease|17|||
94666417|NCT01026974|324231484|FG000|Overall Study|Withdrawal by Subject|0|||
94666418|NCT01026974|324231485|FG001|Overall Study|Withdrawal by Subject|1|||
94666419|NCT01026974|324231486|FG002|Overall Study|Withdrawal by Subject|7|||
94666420|NCT01026974|324231487|FG003|Overall Study|Withdrawal by Subject|2|||
94666421|NCT01026974|324231484|FG000|Overall Study|Lost to Follow-up|1|||
94666422|NCT01026974|324231485|FG001|Overall Study|Lost to Follow-up|1|||
94666423|NCT01026974|324231486|FG002|Overall Study|Lost to Follow-up|4|||
94666424|NCT01026974|324231487|FG003|Overall Study|Lost to Follow-up|0|||
94666425|NCT01026974|324231484|FG000|Overall Study|Adverse Event|0|||
94666426|NCT01026974|324231485|FG001|Overall Study|Adverse Event|0|||
94666427|NCT01026974|324231486|FG002|Overall Study|Adverse Event|0|||
94666428|NCT01026974|324231487|FG003|Overall Study|Adverse Event|1|||
94666429|NCT01026974|324231484|FG000|Overall Study|Inappropriate enrollment|0|||
94666430|NCT01026974|324231485|FG001|Overall Study|Inappropriate enrollment|0|||
94666431|NCT01026974|324231486|FG002|Overall Study|Inappropriate enrollment|1|||
94666432|NCT01026974|324231487|FG003|Overall Study|Inappropriate enrollment|0|||
94666433|NCT03043664|324231488|FG000|Overall Study|Lost to Follow-up|1|||
94666434|NCT03732209|324231491|FG000|Overall Study|Lost to Follow-up|4|||
94666435|NCT03732209|324231492|FG001|Overall Study|Lost to Follow-up|4|||
94666436|NCT03732209|324231491|FG000|Overall Study|Withdrawal by Subject|8|||
94666437|NCT03732209|324231492|FG001|Overall Study|Withdrawal by Subject|9|||
94666438|NCT01581281|324231495|FG000|Overall Study|Early Study Closure|15|||
94666439|NCT01581281|324231496|FG001|Overall Study|Early Study Closure|6|||
94666440|NCT01581281|324231497|FG002|Overall Study|Early Study Closure|12|||
94666441|NCT02187991|324231499|FG000|Overall Study|Adverse Event|13|||
94666442|NCT02187991|324231500|FG001|Overall Study|Adverse Event|14|||
94666443|NCT02187991|324231501|FG002|Overall Study|Adverse Event|3|||
94666444|NCT02187991|324231502|FG003|Overall Study|Adverse Event|2|||
94666445|NCT02187991|324231499|FG000|Overall Study|Withdrawal by Subject|9|||
94666446|NCT02187991|324231500|FG001|Overall Study|Withdrawal by Subject|6|||
94666447|NCT02187991|324231501|FG002|Overall Study|Withdrawal by Subject|3|||
94666448|NCT02187991|324231502|FG003|Overall Study|Withdrawal by Subject|2|||
94666449|NCT02187991|324231499|FG000|Overall Study|Physician Decision|4|||
94666450|NCT02187991|324231500|FG001|Overall Study|Physician Decision|4|||
94666451|NCT02187991|324231501|FG002|Overall Study|Physician Decision|0|||
94666452|NCT02187991|324231502|FG003|Overall Study|Physician Decision|2|||
94666453|NCT02187991|324231499|FG000|Overall Study|Other, unrelated complication|7|||
94666454|NCT02187991|324231500|FG001|Overall Study|Other, unrelated complication|1|||
94666455|NCT02187991|324231501|FG002|Overall Study|Other, unrelated complication|1|||
94666456|NCT02187991|324231502|FG003|Overall Study|Other, unrelated complication|2|||
94666457|NCT02187991|324231499|FG000|Overall Study|Death|1|||
94666458|NCT02187991|324231500|FG001|Overall Study|Death|3|||
94666459|NCT02187991|324231501|FG002|Overall Study|Death|0|||
94666460|NCT02187991|324231502|FG003|Overall Study|Death|0|||
94666461|NCT00744653|324231507|FG000|Overall Study|antineoplastic treatment|11|||
94666462|NCT00744653|324231507|FG000|Overall Study|Death|1|||
94666463|NCT00744653|324231507|FG000|Overall Study|Lost to Follow-up|1|||
94666464|NCT00744653|324231507|FG000|Overall Study|Physician Decision|3|||
94666465|NCT02277444|324231515|FG000|Overall Study|Adverse Event|10|||
94666466|NCT02277444|324231515|FG000|Overall Study|Withdrawal by Subject|3|||
94666467|NCT02277444|324231515|FG000|Overall Study|Other|1|||
94254405|NCT00440999|322724370|FG000|Overall Study|Subj left hosp without inform staff|0|||
94254406|NCT00440999|322724371|FG001|Overall Study|Subj left hosp without inform staff|1|||
94254407|NCT02292927|322724372|FG000|Overall Study|Protocol Violation|13|||
94254408|NCT02292927|322724373|FG001|Overall Study|Protocol Violation|7|||
94254409|NCT03256851|322724374|FG000|Overall Study|Withdrawal by Subject|1|||
94254410|NCT03256851|322724375|FG001|Overall Study|Withdrawal by Subject|0|||
94254411|NCT01577745|322724376|FG000|Overall Study|Withdrawal by Subject|0|||
94254412|NCT01577745|322724377|FG001|Overall Study|Withdrawal by Subject|1|||
94254413|NCT01577745|322724378|FG002|Overall Study|Withdrawal by Subject|0|||
94254414|NCT01577745|322724379|FG003|Overall Study|Withdrawal by Subject|3|||
94254415|NCT01577745|322724380|FG004|Overall Study|Withdrawal by Subject|2|||
94254416|NCT01577745|322724381|FG005|Overall Study|Withdrawal by Subject|0|||
94254417|NCT01577745|322724376|FG000|Overall Study|Death|3|||
94254418|NCT01577745|322724377|FG001|Overall Study|Death|2|||
94618083|NCT05074667|324064772|FG000|Overall Study|Death|1|||
94618084|NCT05074667|324064772|FG000|Overall Study|Withdrawal by Subject|4|||
94618085|NCT05074667|324064772|FG000|Overall Study|Lost to Follow-up|10|||
94618086|NCT00506662|324064773|FG000|Overall Study|Adverse Event|0|||
94618087|NCT00506662|324064774|FG001|Overall Study|Adverse Event|2|||
94618088|NCT00506662|324064773|FG000|Overall Study|Lack of Efficacy|1|||
94618089|NCT00506662|324064774|FG001|Overall Study|Lack of Efficacy|0|||
94618090|NCT00506662|324064773|FG000|Overall Study|Protocol Violation|2|||
94618091|NCT00506662|324064774|FG001|Overall Study|Protocol Violation|4|||
94618092|NCT00506662|324064773|FG000|Overall Study|Trial terminated|10|||
94618093|NCT00506662|324064774|FG001|Overall Study|Trial terminated|16|||
94618094|NCT00506662|324064773|FG000|Overall Study|Not recorded|4|||
94618095|NCT00506662|324064774|FG001|Overall Study|Not recorded|6|||
94618096|NCT01826604|324064775|FG000|Overall Study|Lost to Follow-up|8|||
94618097|NCT01826604|324064776|FG001|Overall Study|Lost to Follow-up|9|||
94618098|NCT00491075|324064777|FG000|Overall Study|Withdrawal by Subject|1|||
94618099|NCT00491075|324064777|FG000|Overall Study|Physician Decision|1|||
94618100|NCT01603355|324064778|FG000|Overall Study|Lack of Efficacy|2|||
94618101|NCT01397890|324064779|FG000|Overall Study|Withdrawal by Subject|7|||
94618102|NCT01397890|324064780|FG001|Overall Study|Withdrawal by Subject|11|||
94618103|NCT01397890|324064779|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
94618104|NCT01397890|324064780|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
94618105|NCT01397890|324064779|FG000|Overall Study|Death|2|||
94618106|NCT01397890|324064780|FG001|Overall Study|Death|3|||
94618107|NCT01397890|324064779|FG000|Overall Study|Lost to Follow-up|1|||
94618108|NCT01397890|324064780|FG001|Overall Study|Lost to Follow-up|4|||
94618109|NCT01397890|324064779|FG000|Overall Study|Condition under Investigation Worsened|1|||
94618110|NCT01397890|324064780|FG001|Overall Study|Condition under Investigation Worsened|3|||
94618111|NCT01397890|324064779|FG000|Overall Study|Adverse Event|1|||
94618112|NCT01397890|324064780|FG001|Overall Study|Adverse Event|2|||
94618113|NCT01397890|324064779|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
94618114|NCT01397890|324064780|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
94618115|NCT01397890|324064779|FG000|Overall Study|Others|2|||
94618116|NCT01397890|324064780|FG001|Overall Study|Others|1|||
94618117|NCT03741062|324064781|FG000|Overall Study|Protocol Violation|1|||
94618118|NCT03741062|324064782|FG001|Overall Study|Protocol Violation|0|||
94618119|NCT02100514|324064790|FG000|Treatment Period|Adverse Event|0|||
94618120|NCT02100514|324064791|FG001|Treatment Period|Adverse Event|5|||
94618121|NCT02100514|324064792|FG002|Treatment Period|Adverse Event|0|||
94618122|NCT02100514|324064793|FG003|Treatment Period|Adverse Event|0|||
94618123|NCT02100514|324064794|FG004|Treatment Period|Adverse Event|0|||
94254419|NCT01577745|322724378|FG002|Overall Study|Death|2|||
94618124|NCT02100514|324064790|FG000|Treatment Period|Death|2|||
94254420|NCT01577745|322724379|FG003|Overall Study|Death|1|||
94254421|NCT01577745|322724380|FG004|Overall Study|Death|1|||
94254422|NCT01577745|322724381|FG005|Overall Study|Death|3|||
94254423|NCT01577745|322724376|FG000|Overall Study|Physician Decision|0|||
94254424|NCT01577745|322724377|FG001|Overall Study|Physician Decision|0|||
94618125|NCT02100514|324064791|FG001|Treatment Period|Death|2|||
94618126|NCT02100514|324064792|FG002|Treatment Period|Death|0|||
94618127|NCT02100514|324064793|FG003|Treatment Period|Death|0|||
94618128|NCT02100514|324064794|FG004|Treatment Period|Death|0|||
94618129|NCT02100514|324064790|FG000|Treatment Period|Lost to Follow-up|5|||
94618130|NCT02100514|324064791|FG001|Treatment Period|Lost to Follow-up|17|||
94618131|NCT02100514|324064792|FG002|Treatment Period|Lost to Follow-up|0|||
94618132|NCT02100514|324064793|FG003|Treatment Period|Lost to Follow-up|0|||
94618133|NCT02100514|324064794|FG004|Treatment Period|Lost to Follow-up|0|||
94666468|NCT02277444|324231515|FG000|Overall Study|Enrolled and not Treated|3|||
94666469|NCT02277444|324231515|FG000|Overall Study|Ongoing|113|||
94666470|NCT00136955|324232699|FG000|Overall Study|Adverse Event|8|||
94254425|NCT01577745|322724378|FG002|Overall Study|Physician Decision|0|||
94254426|NCT01577745|322724379|FG003|Overall Study|Physician Decision|1|||
94254427|NCT01577745|322724380|FG004|Overall Study|Physician Decision|1|||
94254428|NCT01577745|322724381|FG005|Overall Study|Physician Decision|0|||
94254429|NCT01577745|322724376|FG000|Overall Study|Lost to Follow-up|0|||
94666471|NCT00136955|324232699|FG000|Overall Study|Lost to Follow-up|1|||
94254430|NCT01577745|322724377|FG001|Overall Study|Lost to Follow-up|0|||
94254431|NCT01577745|322724378|FG002|Overall Study|Lost to Follow-up|0|||
94666472|NCT00136955|324232699|FG000|Overall Study|Withdrawal by Subject|2|||
94358991|NCT03733301|323098039|FG002|Overall Study|Non-compliance|0|||
94618134|NCT02100514|324064790|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
94618135|NCT02100514|324064791|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
94618136|NCT02100514|324064792|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
94618137|NCT02100514|324064793|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
94358992|NCT03733301|323098037|FG000|Overall Study|Lack of Efficacy|2|||
94618138|NCT02100514|324064794|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
94618139|NCT02100514|324064790|FG000|Treatment Period|Protocol Violation|1|||
94618140|NCT02100514|324064791|FG001|Treatment Period|Protocol Violation|1|||
94618141|NCT02100514|324064792|FG002|Treatment Period|Protocol Violation|0|||
94618142|NCT02100514|324064793|FG003|Treatment Period|Protocol Violation|0|||
94618143|NCT02100514|324064794|FG004|Treatment Period|Protocol Violation|0|||
94618144|NCT02100514|324064790|FG000|Treatment Period|Withdrawal by Subject|12|||
94618145|NCT02100514|324064791|FG001|Treatment Period|Withdrawal by Subject|37|||
94618146|NCT02100514|324064792|FG002|Treatment Period|Withdrawal by Subject|0|||
94618147|NCT02100514|324064793|FG003|Treatment Period|Withdrawal by Subject|0|||
94618148|NCT02100514|324064794|FG004|Treatment Period|Withdrawal by Subject|0|||
94618149|NCT02100514|324064790|FG000|Treatment Period|Other|9|||
94618150|NCT02100514|324064791|FG001|Treatment Period|Other|11|||
94618151|NCT02100514|324064792|FG002|Treatment Period|Other|0|||
94618152|NCT02100514|324064793|FG003|Treatment Period|Other|0|||
94618153|NCT02100514|324064794|FG004|Treatment Period|Other|0|||
94618154|NCT02100514|324064790|FG000|Extension Period|Withdrew consent|0|||
94618155|NCT02100514|324064791|FG001|Extension Period|Withdrew consent|0|||
94618156|NCT02100514|324064792|FG002|Extension Period|Withdrew consent|2|||
94618157|NCT02100514|324064793|FG003|Extension Period|Withdrew consent|0|||
94618158|NCT02100514|324064794|FG004|Extension Period|Withdrew consent|0|||
94618159|NCT02021331|324064797|FG000|Overall Study|Adverse Event|0|||
94618160|NCT02021331|324064798|FG001|Overall Study|Adverse Event|2|||
94618161|NCT00762229|324064799|FG000|Overall Study|Lost to Follow-up|1|||
94618162|NCT00762229|324064800|FG001|Overall Study|Lost to Follow-up|1|||
94618163|NCT00762229|324064799|FG000|Overall Study|did not recveive intervention|0|||
94618164|NCT00762229|324064800|FG001|Overall Study|did not recveive intervention|1|||
94618165|NCT00885846|324064803|FG000|Overall Study|Withdrawal by Subject|2|||
94618166|NCT00885846|324064804|FG001|Overall Study|Withdrawal by Subject|5|||
94618167|NCT00885846|324064805|FG002|Overall Study|Withdrawal by Subject|2|||
94618168|NCT01081678|324064807|FG000|Overall Study|Ineligibility Determined|0|||
94618169|NCT01081678|324064808|FG001|Overall Study|Ineligibility Determined|0|||
94618170|NCT01081678|324064809|FG002|Overall Study|Ineligibility Determined|1|||
94618171|NCT01081678|324064810|FG003|Overall Study|Ineligibility Determined|1|||
94618172|NCT01081678|324064807|FG000|Overall Study|Noncompliance|3|||
94618173|NCT01081678|324064808|FG001|Overall Study|Noncompliance|4|||
94618174|NCT01081678|324064809|FG002|Overall Study|Noncompliance|5|||
94618175|NCT01081678|324064810|FG003|Overall Study|Noncompliance|2|||
94618176|NCT01081678|324064807|FG000|Overall Study|Adverse Event|2|||
94618177|NCT01081678|324064808|FG001|Overall Study|Adverse Event|1|||
94618178|NCT01081678|324064809|FG002|Overall Study|Adverse Event|2|||
94618179|NCT01081678|324064810|FG003|Overall Study|Adverse Event|2|||
94618180|NCT01081678|324064807|FG000|Overall Study|Withdrawal by Subject|15|||
94618181|NCT01081678|324064808|FG001|Overall Study|Withdrawal by Subject|7|||
94618182|NCT01081678|324064809|FG002|Overall Study|Withdrawal by Subject|17|||
94618183|NCT01081678|324064810|FG003|Overall Study|Withdrawal by Subject|14|||
94618184|NCT01081678|324064807|FG000|Overall Study|Administrative Decision|1|||
94618185|NCT01081678|324064808|FG001|Overall Study|Administrative Decision|0|||
94618186|NCT01081678|324064809|FG002|Overall Study|Administrative Decision|0|||
94618187|NCT01081678|324064810|FG003|Overall Study|Administrative Decision|1|||
94618188|NCT01081678|324064807|FG000|Overall Study|Lost to Follow-up|4|||
94618189|NCT01081678|324064808|FG001|Overall Study|Lost to Follow-up|1|||
94618190|NCT01081678|324064809|FG002|Overall Study|Lost to Follow-up|4|||
94618191|NCT01081678|324064810|FG003|Overall Study|Lost to Follow-up|3|||
94618192|NCT01081678|324064807|FG000|Overall Study|Death|2|||
94618193|NCT01081678|324064808|FG001|Overall Study|Death|2|||
94666473|NCT00136955|324232699|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
94666474|NCT01747772|324232702|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
94618194|NCT01081678|324064809|FG002|Overall Study|Death|2|||
94618195|NCT01081678|324064810|FG003|Overall Study|Death|6|||
94618196|NCT01081678|324064807|FG000|Overall Study|Other|0|||
94618197|NCT01081678|324064808|FG001|Overall Study|Other|1|||
94618198|NCT01081678|324064809|FG002|Overall Study|Other|0|||
94618199|NCT01081678|324064810|FG003|Overall Study|Other|0|||
94618200|NCT03758066|324064815|FG000|Overall Study|Lost to Follow-up|14|||
94618201|NCT03478657|324064818|FG000|Overall Study|Withdrawal by Subject|0|||
94618202|NCT03478657|324064819|FG001|Overall Study|Withdrawal by Subject|1|||
94618203|NCT01702805|324064822|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
94618204|NCT01702805|324064823|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
94618205|NCT01702805|324064822|FG000|Overall Study|Incomplete Follow-up|18|||
94618206|NCT01702805|324064823|FG001|Overall Study|Incomplete Follow-up|15|||
94618207|NCT01702805|324064822|FG000|Overall Study|Vital Status Assessment Only|40|||
94618208|NCT01702805|324064823|FG001|Overall Study|Vital Status Assessment Only|39|||
94618209|NCT01702805|324064822|FG000|Overall Study|Lost to Follow-up|5|||
94618210|NCT01702805|324064823|FG001|Overall Study|Lost to Follow-up|5|||
94618211|NCT01091974|324064824|FG000|Overall Study|Did not start intervention|3|||
94666475|NCT03750552|324232703|FG000|Overall Study|Adverse Event|5|||
94666476|NCT03750552|324232704|FG001|Overall Study|Adverse Event|1|||
94666477|NCT03750552|324232703|FG000|Overall Study|Withdrawal by Subject|1|||
94666478|NCT03750552|324232704|FG001|Overall Study|Withdrawal by Subject|1|||
94666479|NCT03750552|324232703|FG000|Overall Study|Other|2|||
94666480|NCT03750552|324232704|FG001|Overall Study|Other|0|||
94666481|NCT02062632|324232705|FG000|Overall Study|No treatment data|1|||
94666482|NCT03832010|324232707|FG000|Overall Study|Withdrawal by Subject|2|||
94666483|NCT03832010|324232708|FG001|Overall Study|Withdrawal by Subject|1|||
94666484|NCT03832010|324232709|FG002|Overall Study|Withdrawal by Subject|0|||
94666485|NCT03832010|324232707|FG000|Overall Study|Lost to Follow-up|2|||
94666486|NCT03832010|324232708|FG001|Overall Study|Lost to Follow-up|1|||
94666487|NCT03832010|324232709|FG002|Overall Study|Lost to Follow-up|1|||
94666488|NCT01944631|324232710|FG000|Overall Study|Adverse Event|1|||
94666489|NCT01944631|324232711|FG001|Overall Study|Adverse Event|0|||
94666490|NCT01944631|324232710|FG000|Overall Study|Lost to Follow-up|3|||
94666491|NCT01944631|324232711|FG001|Overall Study|Lost to Follow-up|1|||
94666492|NCT01944631|324232710|FG000|Overall Study|Withdrawal by Subject|0|||
94666493|NCT01944631|324232711|FG001|Overall Study|Withdrawal by Subject|1|||
94666494|NCT02811861|324232712|FG000|Overall Study|Radiological Disease Progression|123|||
94666495|NCT02811861|324232713|FG001|Overall Study|Radiological Disease Progression|97|||
94666496|NCT02811861|324232714|FG002|Overall Study|Radiological Disease Progression|174|||
94666497|NCT02811861|324232712|FG000|Overall Study|Clinical Disease Progression|20|||
94666498|NCT02811861|324232713|FG001|Overall Study|Clinical Disease Progression|19|||
94666499|NCT02811861|324232714|FG002|Overall Study|Clinical Disease Progression|22|||
94666500|NCT02811861|324232712|FG000|Overall Study|Adverse Event|63|||
94666501|NCT02811861|324232713|FG001|Overall Study|Adverse Event|60|||
94666502|NCT02811861|324232714|FG002|Overall Study|Adverse Event|41|||
94666503|NCT02811861|324232712|FG000|Overall Study|Lost to Follow-up|0|||
94666504|NCT02811861|324232713|FG001|Overall Study|Lost to Follow-up|0|||
94666505|NCT02811861|324232714|FG002|Overall Study|Lost to Follow-up|1|||
94666506|NCT02811861|324232712|FG000|Overall Study|Subject Choice|29|||
94666507|NCT02811861|324232713|FG001|Overall Study|Subject Choice|17|||
94666508|NCT02811861|324232714|FG002|Overall Study|Subject Choice|23|||
94666509|NCT02811861|324232712|FG000|Overall Study|Withdrawal by Subject|4|||
94666510|NCT02811861|324232713|FG001|Overall Study|Withdrawal by Subject|4|||
94666511|NCT02811861|324232714|FG002|Overall Study|Withdrawal by Subject|9|||
94666512|NCT02811861|324232712|FG000|Overall Study|Other|4|||
94666513|NCT02811861|324232713|FG001|Overall Study|Other|13|||
94666514|NCT02811861|324232714|FG002|Overall Study|Other|3|||
94666515|NCT02811861|324232712|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
94666516|NCT02811861|324232713|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
94666517|NCT02811861|324232714|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
94666518|NCT02811861|324232712|FG000|Overall Study|Randomized but not treated|2|||
94666519|NCT02811861|324232713|FG001|Overall Study|Randomized but not treated|3|||
94666520|NCT02811861|324232714|FG002|Overall Study|Randomized but not treated|17|||
94666521|NCT03822533|324232715|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
94666522|NCT03822533|324232716|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
94666523|NCT03822533|324232715|FG000|3 Month Follow-up|Lost to Follow-up|2|||
94666524|NCT03822533|324232716|FG001|3 Month Follow-up|Lost to Follow-up|2|||
94666525|NCT03822533|324232715|FG000|6 Month Follow-up|Lost to Follow-up|3|||
94666526|NCT03822533|324232716|FG001|6 Month Follow-up|Lost to Follow-up|0|||
94666527|NCT03822533|324232715|FG000|12 Month Follow-up|Lost to Follow-up|2|||
94666528|NCT03822533|324232716|FG001|12 Month Follow-up|Lost to Follow-up|3|||
94666529|NCT03822533|324232715|FG000|12 Month Follow-up|Pregnancy|0|||
94666530|NCT03822533|324232716|FG001|12 Month Follow-up|Pregnancy|1|||
94666531|NCT03822533|324232715|FG000|12 Month Follow-up|Surgery|2|||
94666532|NCT03822533|324232716|FG001|12 Month Follow-up|Surgery|0|||
94666533|NCT03822533|324232715|FG000|12 Month Follow-up|Wrong address|1|||
94666534|NCT03822533|324232716|FG001|12 Month Follow-up|Wrong address|0|||
94666535|NCT03822533|324232715|FG000|12 Month Follow-up|No symptoms|1|||
94666536|NCT03822533|324232716|FG001|12 Month Follow-up|No symptoms|0|||
94666537|NCT03822533|324232715|FG000|12 Month Follow-up|Changed primary care center|0|||
94666538|NCT03822533|324232716|FG001|12 Month Follow-up|Changed primary care center|1|||
94666539|NCT00686166|324232717|FG000|Overall Study|Adverse Event|7|||
94666540|NCT00686166|324232717|FG000|Overall Study|Withdrawal by Subject|1|||
94666541|NCT00686166|324232717|FG000|Overall Study|Progression/Relapse|1|||
94666542|NCT00686166|324232717|FG000|Overall Study|Death|1|||
94666543|NCT00686166|324232717|FG000|Overall Study|Not Protocol Specified|1|||
94666544|NCT00686166|324232717|FG000|Overall Study|Ineligible|5|||
94666545|NCT00686166|324232717|FG000|Overall Study|Did not begin protocol therapy|4|||
94666546|NCT00328510|324232718|FG000|Overall Study|Gag disorder, could not use frame|4|||
94666547|NCT00328510|324232719|FG001|Overall Study|Gag disorder, could not use frame|0|||
94666548|NCT00328510|324232718|FG000|Overall Study|Dentition problems, could not use frame|1|||
94666549|NCT00328510|324232719|FG001|Overall Study|Dentition problems, could not use frame|0|||
94666550|NCT00328510|324232718|FG000|Overall Study|Withdrawal by Subject|4|||
94666551|NCT00328510|324232719|FG001|Overall Study|Withdrawal by Subject|2|||
94254432|NCT01577745|322724379|FG003|Overall Study|Lost to Follow-up|0|||
94666552|NCT00328510|324232718|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
94666553|NCT00328510|324232719|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
94666554|NCT00328510|324232718|FG000|Overall Study|Treatment changed to a single fraction|1|||
94666555|NCT00328510|324232719|FG001|Overall Study|Treatment changed to a single fraction|1|||
94666556|NCT00360308|324232721|FG000|Overall Study|Adverse Event|15|||
94666557|NCT00360308|324232722|FG001|Overall Study|Adverse Event|14|||
94666558|NCT00360308|324232723|FG002|Overall Study|Adverse Event|25|||
94666559|NCT00360308|324232721|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
94666560|NCT00360308|324232722|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
94666561|NCT00360308|324232723|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
94666562|NCT00360308|324232721|FG000|Overall Study|Protocol Violation|2|||
94666563|NCT00360308|324232722|FG001|Overall Study|Protocol Violation|1|||
94666564|NCT00360308|324232723|FG002|Overall Study|Protocol Violation|2|||
94666565|NCT00360308|324232721|FG000|Overall Study|Withdrawal by Subject|11|||
94666566|NCT00360308|324232722|FG001|Overall Study|Withdrawal by Subject|7|||
94666567|NCT00360308|324232723|FG002|Overall Study|Withdrawal by Subject|14|||
94666568|NCT00360308|324232721|FG000|Overall Study|Lack of Efficacy|3|||
94666569|NCT00360308|324232722|FG001|Overall Study|Lack of Efficacy|0|||
94666570|NCT00360308|324232723|FG002|Overall Study|Lack of Efficacy|2|||
94666571|NCT00360308|324232721|FG000|Overall Study|Other|2|||
94666572|NCT00360308|324232722|FG001|Overall Study|Other|1|||
94666573|NCT00360308|324232723|FG002|Overall Study|Other|1|||
94666574|NCT00360308|324232721|FG000|Overall Study|Study termination by sponsor|43|||
94666575|NCT00360308|324232722|FG001|Overall Study|Study termination by sponsor|55|||
94666576|NCT00360308|324232723|FG002|Overall Study|Study termination by sponsor|44|||
94666577|NCT04786444|324232724|FG000|Overall Study|Withdrawal by Subject|4|||
94666578|NCT04786444|324232725|FG001|Overall Study|Withdrawal by Subject|7|||
94666579|NCT04786444|324232726|FG002|Overall Study|Withdrawal by Subject|2|||
94666580|NCT04786444|324232724|FG000|Overall Study|Lost to Follow-up|11|||
94666581|NCT04786444|324232725|FG001|Overall Study|Lost to Follow-up|9|||
94666582|NCT04786444|324232726|FG002|Overall Study|Lost to Follow-up|10|||
94666583|NCT04786444|324232724|FG000|Overall Study|Subject would like to become pregnant|0|||
94666584|NCT04786444|324232725|FG001|Overall Study|Subject would like to become pregnant|1|||
94254433|NCT01577745|322724380|FG004|Overall Study|Lost to Follow-up|0|||
94254434|NCT01577745|322724381|FG005|Overall Study|Lost to Follow-up|1|||
94254435|NCT01577745|322724376|FG000|Overall Study|Alternative Therapy|0|||
94618212|NCT01091974|324064825|FG001|Overall Study|Did not start intervention|1|||
94618213|NCT01091974|324064826|FG002|Overall Study|Did not start intervention|3|||
94618214|NCT01091974|324064827|FG003|Overall Study|Did not start intervention|1|||
94618215|NCT01091974|324064824|FG000|Overall Study|resumed sleep medication|0|||
94618216|NCT01091974|324064825|FG001|Overall Study|resumed sleep medication|0|||
94618217|NCT01091974|324064826|FG002|Overall Study|resumed sleep medication|1|||
94618218|NCT01091974|324064827|FG003|Overall Study|resumed sleep medication|2|||
94618219|NCT01091974|324064824|FG000|Overall Study|Withdrawal by Subject|1|||
94618220|NCT01091974|324064825|FG001|Overall Study|Withdrawal by Subject|3|||
94618221|NCT01091974|324064826|FG002|Overall Study|Withdrawal by Subject|2|||
94618222|NCT01091974|324064827|FG003|Overall Study|Withdrawal by Subject|2|||
94618223|NCT01091974|324064824|FG000|Overall Study|side-effects|1|||
94618224|NCT01091974|324064825|FG001|Overall Study|side-effects|1|||
94618225|NCT01091974|324064826|FG002|Overall Study|side-effects|0|||
94618226|NCT01091974|324064827|FG003|Overall Study|side-effects|2|||
94618227|NCT02499783|324064828|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
94618228|NCT02499783|324064829|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
94618229|NCT02499783|324064830|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
94618230|NCT02499783|324064828|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
94618231|NCT02499783|324064829|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
94254436|NCT01577745|322724377|FG001|Overall Study|Alternative Therapy|0|||
94618232|NCT02499783|324064830|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
94254437|NCT01577745|322724378|FG002|Overall Study|Alternative Therapy|0|||
94254438|NCT01577745|322724379|FG003|Overall Study|Alternative Therapy|1|||
94254439|NCT01577745|322724380|FG004|Overall Study|Alternative Therapy|1|||
94618233|NCT02499783|324064828|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
94618234|NCT02499783|324064829|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
94618235|NCT02499783|324064830|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
94666585|NCT04786444|324232726|FG002|Overall Study|Subject would like to become pregnant|0|||
94666586|NCT03461003|324232727|FG000|Overall Study|Lost to Follow-up|2|||
94254440|NCT01577745|322724381|FG005|Overall Study|Alternative Therapy|0|||
94254441|NCT01853137|322724382|FG000|Overall Study|Lost to Follow-up|4|||
94666587|NCT03461003|324232728|FG001|Overall Study|Lost to Follow-up|2|||
94666588|NCT03461003|324232727|FG000|Overall Study|Withdrawal by Subject|3|||
94461087|NCT03057054|323476875|FG000|Overall Study|Death|4|||
94666589|NCT03461003|324232728|FG001|Overall Study|Withdrawal by Subject|1|||
94666590|NCT02462876|324232729|FG000|Overall Study|Death|3|||
94254442|NCT01853137|322724383|FG001|Overall Study|Lost to Follow-up|1|||
94254443|NCT01768117|322724384|FG000|Overall Study|Lost to Follow-up|1|||
94254444|NCT01768117|322724384|FG000|Overall Study|Withdrawal by Subject|2|||
94254445|NCT01768117|322724384|FG000|Overall Study|Protocol Violation|3|||
94254446|NCT02004353|322724389|FG000|Overall Study|Voluntary participation|1334|||
94254447|NCT02951767|322724390|FG000|Overall Study|Study Terminated By Sponsor|9|||
94254448|NCT02951767|322724390|FG000|Overall Study|Withdrawal by Subject|11|||
94254449|NCT02951767|322724390|FG000|Overall Study|Death|96|||
94254450|NCT02951767|322724390|FG000|Overall Study|Lost to Follow-up|2|||
94254451|NCT02951767|322724390|FG000|Overall Study|Physician Decision|1|||
94254452|NCT00513604|322724391|FG000|Overall Study|Not treated|2|||
94254453|NCT00513604|322724392|FG001|Overall Study|Not treated|0|||
94254454|NCT00513604|322724393|FG002|Overall Study|Not treated|1|||
94254455|NCT00513604|322724394|FG003|Overall Study|Not treated|0|||
94254456|NCT00513604|322724395|FG004|Overall Study|Not treated|0|||
94254457|NCT00513604|322724391|FG000|Overall Study|Death during treatment|0|||
94254458|NCT00513604|322724392|FG001|Overall Study|Death during treatment|3|||
94254459|NCT00513604|322724393|FG002|Overall Study|Death during treatment|2|||
94254460|NCT00513604|322724394|FG003|Overall Study|Death during treatment|0|||
94254461|NCT00513604|322724395|FG004|Overall Study|Death during treatment|0|||
94254462|NCT01815138|322724398|FG000|Overall Study|Withdrawal by Subject|0|||
94254463|NCT01815138|322724399|FG001|Overall Study|Withdrawal by Subject|1|||
94254464|NCT01815138|322724398|FG000|Overall Study|Physician Decision|8|||
94254465|NCT01815138|322724399|FG001|Overall Study|Physician Decision|5|||
94254466|NCT01047293|322724401|FG000|Overall Study|DLT criteria not fulfilled|1|||
94254467|NCT01047293|322724402|FG001|Overall Study|DLT criteria not fulfilled|1|||
94254468|NCT01047293|322724403|FG002|Overall Study|DLT criteria not fulfilled|0|||
94254469|NCT01047293|322724404|FG003|Overall Study|DLT criteria not fulfilled|0|||
94254470|NCT00757783|322724407|FG000|Overall Study|Adverse Event|0|||
94618236|NCT02499783|324064828|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
94618237|NCT02499783|324064829|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
94618238|NCT02499783|324064830|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
94618239|NCT02499783|324064828|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
94618240|NCT02499783|324064829|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
94618241|NCT02499783|324064830|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
94618242|NCT02499783|324064828|FG000|DB Period: Weeks 0-8|Other|1|||
94618243|NCT02499783|324064829|FG001|DB Period: Weeks 0-8|Other|1|||
94618244|NCT02499783|324064830|FG002|DB Period: Weeks 0-8|Other|0|||
94618245|NCT02499783|324064828|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
94618246|NCT02499783|324064829|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
94618247|NCT02499783|324064830|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
94618248|NCT02499783|324064828|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
94618249|NCT02499783|324064829|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
94618250|NCT02499783|324064830|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
94618251|NCT02499783|324064828|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
94618252|NCT02499783|324064829|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
94618253|NCT02499783|324064830|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
94618254|NCT02499783|324064828|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
94618255|NCT02499783|324064829|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
94618256|NCT02499783|324064830|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
94618257|NCT01866293|324064835|FG000|Overall Study|Adverse Event|2|||
94618258|NCT01540838|324064836|FG000|Overall Study|Open nasogastric tube|9|||
94618259|NCT01540838|324064837|FG001|Overall Study|Open nasogastric tube|7|||
94618260|NCT01540838|324064836|FG000|Overall Study|Treatment doses missing|8|||
94618261|NCT01540838|324064837|FG001|Overall Study|Treatment doses missing|12|||
94618262|NCT01540838|324064836|FG000|Overall Study|Additional antibiotic treatment|1|||
94618263|NCT01540838|324064837|FG001|Overall Study|Additional antibiotic treatment|2|||
94618264|NCT01540838|324064836|FG000|Overall Study|Died before treatment initiation|1|||
94618265|NCT01540838|324064837|FG001|Overall Study|Died before treatment initiation|1|||
94618266|NCT01540838|324064836|FG000|Overall Study|Not BM. Other treatment|3|||
94618267|NCT01540838|324064837|FG001|Overall Study|Not BM. Other treatment|1|||
94618268|NCT02130570|324064838|FG000|Overall Study|Death|3|||
94618269|NCT02130570|324064839|FG001|Overall Study|Death|5|||
94618270|NCT02130570|324064838|FG000|Overall Study|Withdrawal by Subject|6|||
94618271|NCT02130570|324064839|FG001|Overall Study|Withdrawal by Subject|3|||
94618272|NCT02130570|324064838|FG000|Overall Study|Part of practice that discontinued study|0|||
94618273|NCT02130570|324064839|FG001|Overall Study|Part of practice that discontinued study|5|||
94618274|NCT00518284|324064840|FG000|Overall Study|Adverse Event|0|||
94618275|NCT00518284|324064841|FG001|Overall Study|Adverse Event|1|||
94618276|NCT00518284|324064842|FG002|Overall Study|Adverse Event|0|||
94618277|NCT00518284|324064843|FG003|Overall Study|Adverse Event|0|||
94618278|NCT00518284|324064840|FG000|Overall Study|Study Termination|0|||
94618279|NCT00518284|324064841|FG001|Overall Study|Study Termination|2|||
94618280|NCT00518284|324064842|FG002|Overall Study|Study Termination|1|||
94618281|NCT00518284|324064843|FG003|Overall Study|Study Termination|2|||
94618282|NCT04515394|324064844|FG000|Overall Study|Participant did not receive treatment|1|||
94618283|NCT03330288|324064845|FG000|Overall Study|Other reason|1|||
94618284|NCT03330288|324064846|FG001|Overall Study|Other reason|1|||
94618285|NCT03330288|324064845|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
94618286|NCT03330288|324064846|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
94618287|NCT03330288|324064845|FG000|Overall Study|Adverse Event|1|||
94618288|NCT03330288|324064846|FG001|Overall Study|Adverse Event|0|||
94618289|NCT03330288|324064845|FG000|Overall Study|Withdrawal by Subject|1|||
94618290|NCT03330288|324064846|FG001|Overall Study|Withdrawal by Subject|0|||
94618291|NCT03330288|324064845|FG000|Overall Study|Lost to Follow-up|26|||
94618292|NCT03330288|324064846|FG001|Overall Study|Lost to Follow-up|7|||
94618293|NCT00963937|324064847|FG000|Overall Study|Protocol Violation|1|||
94618294|NCT00963937|324064848|FG001|Overall Study|Protocol Violation|1|||
94618295|NCT00963937|324064849|FG002|Overall Study|Protocol Violation|0|||
94618296|NCT00963937|324064847|FG000|Overall Study|Physician Decision|18|||
94618297|NCT00963937|324064848|FG001|Overall Study|Physician Decision|10|||
94618298|NCT00963937|324064849|FG002|Overall Study|Physician Decision|4|||
94618299|NCT00619177|324064850|FG000|Overall Study|Adverse Event|18|||
94618300|NCT00619177|324064850|FG000|Overall Study|Lost to Follow-up|2|||
94618301|NCT00619177|324064850|FG000|Overall Study|Lack of Efficacy|1|||
94618302|NCT00619177|324064850|FG000|Overall Study|Missing termination information|481|||
94618303|NCT00619177|324064850|FG000|Overall Study|Not specified reasons|6|||
94618304|NCT04203498|324064855|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
94618305|NCT04203498|324064856|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
94618306|NCT04203498|324064855|FG000|Overall Study|Withdrawal of patient consent|7|||
94618307|NCT04203498|324064856|FG001|Overall Study|Withdrawal of patient consent|2|||
94618308|NCT04203498|324064855|FG000|Overall Study|Adverse Event|4|||
94618309|NCT04203498|324064856|FG001|Overall Study|Adverse Event|1|||
94618310|NCT04203498|324064855|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
94618311|NCT04203498|324064856|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
94618312|NCT04203498|324064855|FG000|Overall Study|Did not receive IMP|2|||
94618313|NCT04203498|324064856|FG001|Overall Study|Did not receive IMP|0|||
94618314|NCT01612858|324064861|FG000|Overall Study|Withdrawal by Subject|5|||
94618315|NCT01612858|324064862|FG001|Overall Study|Withdrawal by Subject|1|||
94618316|NCT00781274|324064863|FG000|Overall Study|Withdrawal by Subject|2|||
94618317|NCT01611155|324064864|FG000|Overall Study|Adverse Event|1|||
94618318|NCT01611155|324064865|FG001|Overall Study|Adverse Event|1|||
94618319|NCT01611155|324064864|FG000|Overall Study|Refused further treatment|6|||
94618320|NCT01611155|324064865|FG001|Overall Study|Refused further treatment|4|||
94618321|NCT01611155|324064864|FG000|Overall Study|Disease progression|1|||
94618322|NCT01611155|324064865|FG001|Overall Study|Disease progression|0|||
94618323|NCT01611155|324064864|FG000|Overall Study|Withdrawal by Subject|1|||
94618324|NCT01611155|324064865|FG001|Overall Study|Withdrawal by Subject|0|||
94618325|NCT01611155|324064864|FG000|Overall Study|Alternative treatment|0|||
94618326|NCT01611155|324064865|FG001|Overall Study|Alternative treatment|1|||
94618327|NCT01611155|324064864|FG000|Overall Study|Ineligible patient|0|||
94618328|NCT01611155|324064865|FG001|Overall Study|Ineligible patient|1|||
94618329|NCT02699593|324064868|FG000|Period 1|Unsatisfactory Visual Response|0|||
94618330|NCT02699593|324064869|FG001|Period 1|Unsatisfactory Visual Response|1|||
94618331|NCT02699593|324064868|FG000|Period 1|Torn Contact Len|4|||
94618332|NCT02699593|324064869|FG001|Period 1|Torn Contact Len|3|||
94618333|NCT02699593|324064868|FG000|Period 1|Protocol Violation|0|||
94618334|NCT02699593|324064869|FG001|Period 1|Protocol Violation|1|||
94618335|NCT02699593|324064868|FG000|Period 1|Withdrawal by Subject|0|||
94618336|NCT02699593|324064869|FG001|Period 1|Withdrawal by Subject|1|||
94618337|NCT02699593|324064868|FG000|Period 1|Adverse Event|1|||
94618338|NCT02699593|324064869|FG001|Period 1|Adverse Event|1|||
94618339|NCT02699593|324064868|FG000|Period 2|Adverse Event|1|||
94618340|NCT02699593|324064869|FG001|Period 2|Adverse Event|1|||
94618341|NCT02699593|324064868|FG000|Period 2|Lost Contact Lens|0|||
94618342|NCT02699593|324064869|FG001|Period 2|Lost Contact Lens|1|||
94618343|NCT02699593|324064868|FG000|Period 2|Torn Contact Lens|1|||
94618344|NCT02699593|324064869|FG001|Period 2|Torn Contact Lens|0|||
94618345|NCT00191269|324064870|FG000|Overall Study|Protocol Violation|0|||
94254471|NCT00757783|322724408|FG001|Overall Study|Adverse Event|2|||
94254472|NCT00757783|322724407|FG000|Overall Study|Lost to Follow-up|1|||
94254473|NCT00757783|322724408|FG001|Overall Study|Lost to Follow-up|1|||
94254474|NCT00757783|322724407|FG000|Overall Study|Protocol Violation|1|||
94254475|NCT00757783|322724408|FG001|Overall Study|Protocol Violation|0|||
94254476|NCT00757783|322724407|FG000|Overall Study|Withdrawal by Subject|2|||
94618346|NCT00191269|324064871|FG001|Overall Study|Protocol Violation|2|||
94618347|NCT00191269|324064870|FG000|Overall Study|Adverse Event|1|||
94618348|NCT00191269|324064871|FG001|Overall Study|Adverse Event|4|||
94254477|NCT00757783|322724408|FG001|Overall Study|Withdrawal by Subject|1|||
94618349|NCT00191269|324064870|FG000|Overall Study|Progression of Disease|4|||
94618350|NCT00191269|324064871|FG001|Overall Study|Progression of Disease|42|||
94618351|NCT00191269|324064870|FG000|Overall Study|Lack of Efficacy|1|||
94618352|NCT00191269|324064871|FG001|Overall Study|Lack of Efficacy|5|||
94618353|NCT00191269|324064870|FG000|Overall Study|Withdrawal by Subject|0|||
94666591|NCT02462876|324232729|FG000|Overall Study|Lost to Follow-up|7|||
94666592|NCT02462876|324232729|FG000|Overall Study|Surgical Bypass|9|||
94666593|NCT02462876|324232729|FG000|Overall Study|Amputation Above the Metatarsals|1|||
94666594|NCT02462876|324232729|FG000|Overall Study|36 months follow-up visit missed|1|||
94666595|NCT02462876|324232729|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
94666596|NCT02462876|324232729|FG000|Overall Study|Patient did not come back to the vascular department|1|||
94666597|NCT02462876|324232729|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
94666598|NCT02462876|324232729|FG000|Overall Study|Patient refused to come back|1|||
94666599|NCT02462876|324232729|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
94666600|NCT02462876|324232729|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
94666601|NCT01217073|324232731|FG000|Base Period|Adverse Event|1|||
94666602|NCT01217073|324232732|FG001|Base Period|Adverse Event|0|||
94666603|NCT01217073|324232733|FG002|Base Period|Adverse Event|1|||
94666604|NCT01217073|324232734|FG003|Base Period|Adverse Event|0|||
94666605|NCT01217073|324232735|FG004|Base Period|Adverse Event|4|||
94666606|NCT01217073|324232736|FG005|Base Period|Adverse Event|1|||
94666607|NCT01217073|324232737|FG006|Base Period|Adverse Event|0|||
94666608|NCT01217073|324232738|FG007|Base Period|Adverse Event|0|||
94666609|NCT01217073|324232731|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
94666610|NCT01217073|324232732|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
94666611|NCT01217073|324232733|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
94666612|NCT01217073|324232734|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
94666613|NCT01217073|324232735|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
94666614|NCT01217073|324232736|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
94666615|NCT01217073|324232737|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
94666616|NCT01217073|324232738|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
94666617|NCT01217073|324232731|FG000|Base Period|Excluded medication|0|||
94666618|NCT01217073|324232732|FG001|Base Period|Excluded medication|0|||
94666619|NCT01217073|324232733|FG002|Base Period|Excluded medication|0|||
94666620|NCT01217073|324232734|FG003|Base Period|Excluded medication|0|||
94666621|NCT01217073|324232735|FG004|Base Period|Excluded medication|1|||
94666622|NCT01217073|324232736|FG005|Base Period|Excluded medication|0|||
94666623|NCT01217073|324232737|FG006|Base Period|Excluded medication|0|||
94666624|NCT01217073|324232738|FG007|Base Period|Excluded medication|0|||
94666625|NCT01217073|324232731|FG000|Base Period|Lack of Efficacy|0|||
94666626|NCT01217073|324232732|FG001|Base Period|Lack of Efficacy|0|||
94666627|NCT01217073|324232733|FG002|Base Period|Lack of Efficacy|0|||
94666628|NCT01217073|324232734|FG003|Base Period|Lack of Efficacy|0|||
94666629|NCT01217073|324232735|FG004|Base Period|Lack of Efficacy|0|||
94666630|NCT01217073|324232736|FG005|Base Period|Lack of Efficacy|1|||
94666631|NCT01217073|324232737|FG006|Base Period|Lack of Efficacy|0|||
94666632|NCT01217073|324232738|FG007|Base Period|Lack of Efficacy|0|||
94666633|NCT01217073|324232731|FG000|Base Period|Lost to Follow-up|0|||
94666634|NCT01217073|324232732|FG001|Base Period|Lost to Follow-up|0|||
94666635|NCT01217073|324232733|FG002|Base Period|Lost to Follow-up|1|||
94666636|NCT01217073|324232734|FG003|Base Period|Lost to Follow-up|1|||
94666637|NCT01217073|324232735|FG004|Base Period|Lost to Follow-up|3|||
94666638|NCT01217073|324232736|FG005|Base Period|Lost to Follow-up|0|||
94666639|NCT01217073|324232737|FG006|Base Period|Lost to Follow-up|0|||
94666640|NCT01217073|324232738|FG007|Base Period|Lost to Follow-up|0|||
94666641|NCT01217073|324232731|FG000|Base Period|Physician Decision|0|||
94666642|NCT01217073|324232732|FG001|Base Period|Physician Decision|0|||
94666643|NCT01217073|324232733|FG002|Base Period|Physician Decision|0|||
94666644|NCT01217073|324232734|FG003|Base Period|Physician Decision|0|||
94666645|NCT01217073|324232735|FG004|Base Period|Physician Decision|1|||
94666646|NCT01217073|324232736|FG005|Base Period|Physician Decision|0|||
94666647|NCT01217073|324232737|FG006|Base Period|Physician Decision|0|||
94666648|NCT01217073|324232738|FG007|Base Period|Physician Decision|0|||
94666649|NCT01217073|324232731|FG000|Base Period|Protocol Violation|1|||
94666650|NCT01217073|324232732|FG001|Base Period|Protocol Violation|0|||
94666651|NCT01217073|324232733|FG002|Base Period|Protocol Violation|0|||
94666652|NCT01217073|324232734|FG003|Base Period|Protocol Violation|0|||
94666653|NCT01217073|324232735|FG004|Base Period|Protocol Violation|1|||
94666654|NCT01217073|324232736|FG005|Base Period|Protocol Violation|2|||
94666655|NCT01217073|324232737|FG006|Base Period|Protocol Violation|0|||
94666656|NCT01217073|324232738|FG007|Base Period|Protocol Violation|0|||
94666657|NCT01217073|324232731|FG000|Base Period|Withdrawal by Subject|4|||
94666658|NCT01217073|324232732|FG001|Base Period|Withdrawal by Subject|5|||
94666659|NCT01217073|324232733|FG002|Base Period|Withdrawal by Subject|5|||
94666660|NCT01217073|324232734|FG003|Base Period|Withdrawal by Subject|1|||
94666661|NCT01217073|324232735|FG004|Base Period|Withdrawal by Subject|5|||
94254478|NCT00757783|322724407|FG000|Overall Study|Other|1|||
94666662|NCT01217073|324232736|FG005|Base Period|Withdrawal by Subject|5|||
94666663|NCT01217073|324232737|FG006|Base Period|Withdrawal by Subject|0|||
94666664|NCT01217073|324232738|FG007|Base Period|Withdrawal by Subject|0|||
94666665|NCT01217073|324232731|FG000|Extension Period|Adverse Event|0|||
94666666|NCT01217073|324232732|FG001|Extension Period|Adverse Event|0|||
94666667|NCT01217073|324232733|FG002|Extension Period|Adverse Event|0|||
94254479|NCT00757783|322724408|FG001|Overall Study|Other|2|||
94254480|NCT02308020|322724413|FG000|Overall Study|Lost to Follow-up|1|||
94254481|NCT02308020|322724414|FG001|Overall Study|Lost to Follow-up|7|||
94254482|NCT02308020|322724415|FG002|Overall Study|Lost to Follow-up|0|||
94254483|NCT02308020|322724416|FG003|Overall Study|Lost to Follow-up|0|||
94254484|NCT02308020|322724417|FG004|Overall Study|Lost to Follow-up|1|||
94254485|NCT02308020|322724418|FG005|Overall Study|Lost to Follow-up|2|||
94254486|NCT02308020|322724413|FG000|Overall Study|Sponsor Decision|0|||
94254487|NCT02308020|322724414|FG001|Overall Study|Sponsor Decision|8|||
94254488|NCT02308020|322724415|FG002|Overall Study|Sponsor Decision|0|||
94254489|NCT02308020|322724416|FG003|Overall Study|Sponsor Decision|2|||
94254490|NCT02308020|322724417|FG004|Overall Study|Sponsor Decision|2|||
94254491|NCT02308020|322724418|FG005|Overall Study|Sponsor Decision|1|||
94254492|NCT02308020|322724413|FG000|Overall Study|Withdrawal by Subject|3|||
94254493|NCT02308020|322724414|FG001|Overall Study|Withdrawal by Subject|5|||
94254494|NCT02308020|322724415|FG002|Overall Study|Withdrawal by Subject|3|||
94254495|NCT02308020|322724416|FG003|Overall Study|Withdrawal by Subject|2|||
94254496|NCT02308020|322724417|FG004|Overall Study|Withdrawal by Subject|1|||
94254497|NCT02308020|322724418|FG005|Overall Study|Withdrawal by Subject|2|||
94254498|NCT00505284|322724419|FG000|Overall Study|Adverse Event|3|||
94254499|NCT00505284|322724420|FG001|Overall Study|Adverse Event|7|||
94254500|NCT00505284|322724421|FG002|Overall Study|Adverse Event|9|||
94254501|NCT00505284|322724422|FG003|Overall Study|Adverse Event|14|||
94254502|NCT00505284|322724423|FG004|Overall Study|Adverse Event|22|||
94254503|NCT00505284|322724419|FG000|Overall Study|Protocol Violation|0|||
94254504|NCT00505284|322724420|FG001|Overall Study|Protocol Violation|1|||
94254505|NCT00505284|322724421|FG002|Overall Study|Protocol Violation|1|||
94254506|NCT00505284|322724422|FG003|Overall Study|Protocol Violation|0|||
94254507|NCT00505284|322724423|FG004|Overall Study|Protocol Violation|0|||
94254508|NCT00505284|322724419|FG000|Overall Study|Withdrawal by Subject|2|||
94254509|NCT00505284|322724420|FG001|Overall Study|Withdrawal by Subject|6|||
94254510|NCT00505284|322724421|FG002|Overall Study|Withdrawal by Subject|1|||
94254511|NCT00505284|322724422|FG003|Overall Study|Withdrawal by Subject|0|||
94254512|NCT00505284|322724423|FG004|Overall Study|Withdrawal by Subject|6|||
94254513|NCT00505284|322724419|FG000|Overall Study|Lack of Efficacy|0|||
94254514|NCT00505284|322724420|FG001|Overall Study|Lack of Efficacy|1|||
94254515|NCT00505284|322724421|FG002|Overall Study|Lack of Efficacy|1|||
94254516|NCT00505284|322724422|FG003|Overall Study|Lack of Efficacy|1|||
94254517|NCT00505284|322724423|FG004|Overall Study|Lack of Efficacy|1|||
94254518|NCT00505284|322724419|FG000|Overall Study|Physician Decision|0|||
94254519|NCT00505284|322724420|FG001|Overall Study|Physician Decision|1|||
94254520|NCT00505284|322724421|FG002|Overall Study|Physician Decision|0|||
94254521|NCT00505284|322724422|FG003|Overall Study|Physician Decision|0|||
94254522|NCT00505284|322724423|FG004|Overall Study|Physician Decision|0|||
94254523|NCT00505284|322724419|FG000|Overall Study|Other|5|||
94254524|NCT00505284|322724420|FG001|Overall Study|Other|0|||
94254525|NCT00505284|322724421|FG002|Overall Study|Other|0|||
94254526|NCT00505284|322724422|FG003|Overall Study|Other|4|||
94254527|NCT00505284|322724423|FG004|Overall Study|Other|4|||
94254528|NCT02673515|322724426|FG000|Overall Study|Lack of motivation|2|||
94254529|NCT02673515|322724427|FG001|Overall Study|Lack of motivation|1|||
94254530|NCT00943111|322724434|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
94254531|NCT00943111|322724435|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
94254532|NCT00943111|322724436|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
94254533|NCT00943111|322724434|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
94461088|NCT03057054|323476876|FG001|Overall Study|Death|4|||
94461089|NCT03057054|323476875|FG000|Overall Study|Withdrawal by Subject|6|||
94461090|NCT03057054|323476876|FG001|Overall Study|Withdrawal by Subject|3|||
94461091|NCT03057054|323476875|FG000|Overall Study|Ineligible|1|||
94461092|NCT03057054|323476876|FG001|Overall Study|Ineligible|1|||
94461093|NCT04756154|323476877|FG000|Overall Study|Did not meet treatment day baseline|30|||
94461094|NCT04756154|323476878|FG001|Overall Study|Did not meet treatment day baseline|28|||
94461095|NCT04756154|323476879|FG002|Overall Study|Did not meet treatment day baseline|7|||
94461096|NCT04756154|323476877|FG000|Overall Study|Did not return for final sample collection|1|||
94461097|NCT04756154|323476878|FG001|Overall Study|Did not return for final sample collection|1|||
94461098|NCT04756154|323476879|FG002|Overall Study|Did not return for final sample collection|0|||
94461099|NCT00514904|323476881|FG000|Overall Study|Withdrawal by Subject|3|||
94461100|NCT00514904|323476882|FG001|Overall Study|Withdrawal by Subject|2|||
94461101|NCT00514904|323476881|FG000|Overall Study|Lost to Follow-up|21|||
94461102|NCT00514904|323476882|FG001|Overall Study|Lost to Follow-up|3|||
94461103|NCT00138073|323476883|FG000|Overall Study|lack of resources|55|||
94461104|NCT01794793|323476887|FG000|Treatment Period|Withdrawal by Subject|24|||
94618354|NCT00191269|324064871|FG001|Overall Study|Withdrawal by Subject|1|||
94254534|NCT00943111|322724435|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
94254535|NCT00943111|322724436|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
94254536|NCT00943111|322724434|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
94461105|NCT01794793|323476887|FG000|Treatment Period|Lack of Efficacy|22|||
94254537|NCT00943111|322724435|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
94254538|NCT00943111|322724436|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
94254539|NCT00943111|322724434|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
94618355|NCT00191269|324064870|FG000|Overall Study|Pathologic Aggrevation|0|||
94618356|NCT00191269|324064871|FG001|Overall Study|Pathologic Aggrevation|1|||
94618357|NCT00191269|324064870|FG000|Overall Study|Physician Decision|0|||
94618358|NCT00191269|324064871|FG001|Overall Study|Physician Decision|3|||
94618359|NCT01201785|324064872|FG000|Overall Study|Lost to Follow-up|16|||
94618360|NCT02015754|324064873|FG000|Overall Study|Disease progression|5|||
94618361|NCT02015754|324064873|FG000|Overall Study|Change in treatment modality|5|||
94618362|NCT02015754|324064873|FG000|Overall Study|Lost to Follow-up|1|||
94618363|NCT01128842|324064874|FG000|Overall Study|Adverse Event|1|||
94618364|NCT01128842|324064874|FG000|Overall Study|Disease Progression|6|||
94618365|NCT01253408|324064875|FG000|Overall Study|Adverse Event|0|||
94618366|NCT01253408|324064876|FG001|Overall Study|Adverse Event|1|||
94618367|NCT01253408|324064877|FG002|Overall Study|Adverse Event|0|||
94618368|NCT03320057|324066288|FG000|Overall Study|Lost to Follow-up|4|||
94618369|NCT03320057|324066289|FG001|Overall Study|Lost to Follow-up|17|||
94618370|NCT03320057|324066288|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
94618371|NCT03320057|324066289|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
94618372|NCT01550289|324066292|FG000|Overall Study|Protocol Violation|1|||
94618373|NCT01550289|324066293|FG001|Overall Study|Protocol Violation|0|||
94618374|NCT01550289|324066292|FG000|Overall Study|Lost to Follow-up|1|||
94618375|NCT01550289|324066293|FG001|Overall Study|Lost to Follow-up|1|||
94618376|NCT01550289|324066292|FG000|Overall Study|Withdrawal by Subject|11|||
94618377|NCT01550289|324066293|FG001|Overall Study|Withdrawal by Subject|3|||
94618378|NCT01663532|324066295|FG000|Overall Study|Lost to Follow-up|9|||
94618379|NCT01663532|324066296|FG001|Overall Study|Lost to Follow-up|10|||
94618380|NCT01663532|324066295|FG000|Overall Study|Adverse Event|7|||
94618381|NCT01663532|324066296|FG001|Overall Study|Adverse Event|13|||
94618382|NCT01663532|324066295|FG000|Overall Study|Met Withdrawal Criteria|7|||
94618383|NCT01663532|324066296|FG001|Overall Study|Met Withdrawal Criteria|6|||
94618384|NCT01663532|324066295|FG000|Overall Study|Physician Decision|1|||
94618385|NCT01663532|324066296|FG001|Overall Study|Physician Decision|1|||
94618386|NCT01663532|324066295|FG000|Overall Study|Withdrawal by Subject|35|||
94618387|NCT01663532|324066296|FG001|Overall Study|Withdrawal by Subject|17|||
94618388|NCT01663532|324066295|FG000|Overall Study|Lack of Efficacy|15|||
94618389|NCT01663532|324066296|FG001|Overall Study|Lack of Efficacy|60|||
94618390|NCT01897454|324066302|FG000|Overall Study|Withdrawal by Subject|1|||
94618391|NCT04218695|324066304|FG000|Overall Study|Adverse Event|1|||
94618392|NCT04218695|324066305|FG001|Overall Study|Adverse Event|0|||
94618393|NCT00395304|324066306|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94618394|NCT00395304|324066307|FG001|Treatment Period 1|Withdrawal by Subject|3|||
94618395|NCT00395304|324066308|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94618396|NCT00395304|324066309|FG003|Treatment Period 1|Withdrawal by Subject|2|||
94618397|NCT00395304|324066310|FG004|Treatment Period 1|Withdrawal by Subject|1|||
94618398|NCT00395304|324066311|FG005|Treatment Period 1|Withdrawal by Subject|1|||
94618399|NCT00395304|324066306|FG000|Treatment Period 1|Lost to Follow-up|1|||
94618400|NCT00395304|324066307|FG001|Treatment Period 1|Lost to Follow-up|0|||
94618401|NCT00395304|324066308|FG002|Treatment Period 1|Lost to Follow-up|0|||
94618402|NCT00395304|324066309|FG003|Treatment Period 1|Lost to Follow-up|1|||
94618403|NCT00395304|324066310|FG004|Treatment Period 1|Lost to Follow-up|0|||
94618404|NCT00395304|324066311|FG005|Treatment Period 1|Lost to Follow-up|1|||
94618405|NCT00395304|324066306|FG000|Treatment Period 1|Physician Decision|0|||
94618406|NCT00395304|324066307|FG001|Treatment Period 1|Physician Decision|1|||
94618407|NCT00395304|324066308|FG002|Treatment Period 1|Physician Decision|0|||
94618408|NCT00395304|324066309|FG003|Treatment Period 1|Physician Decision|0|||
94618409|NCT00395304|324066310|FG004|Treatment Period 1|Physician Decision|0|||
94618410|NCT00395304|324066311|FG005|Treatment Period 1|Physician Decision|0|||
94618411|NCT00395304|324066306|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94618412|NCT00395304|324066307|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94618413|NCT00395304|324066308|FG002|Treatment Period 2|Withdrawal by Subject|0|||
94618414|NCT00395304|324066309|FG003|Treatment Period 2|Withdrawal by Subject|1|||
94618415|NCT00395304|324066310|FG004|Treatment Period 2|Withdrawal by Subject|0|||
94618416|NCT00395304|324066311|FG005|Treatment Period 2|Withdrawal by Subject|2|||
94618417|NCT00395304|324066306|FG000|Treatment Period 2|Lost to Follow-up|0|||
94618418|NCT00395304|324066307|FG001|Treatment Period 2|Lost to Follow-up|3|||
94618419|NCT00395304|324066308|FG002|Treatment Period 2|Lost to Follow-up|0|||
94618420|NCT00395304|324066309|FG003|Treatment Period 2|Lost to Follow-up|0|||
94618421|NCT00395304|324066310|FG004|Treatment Period 2|Lost to Follow-up|0|||
94618422|NCT00395304|324066311|FG005|Treatment Period 2|Lost to Follow-up|0|||
94618423|NCT00395304|324066306|FG000|Treatment Period 2|Physician Decision|0|||
94618424|NCT00395304|324066307|FG001|Treatment Period 2|Physician Decision|0|||
94618425|NCT00395304|324066308|FG002|Treatment Period 2|Physician Decision|1|||
94618426|NCT00395304|324066309|FG003|Treatment Period 2|Physician Decision|0|||
94618427|NCT00395304|324066310|FG004|Treatment Period 2|Physician Decision|0|||
94618428|NCT00395304|324066311|FG005|Treatment Period 2|Physician Decision|0|||
94618429|NCT00395304|324066306|FG000|Treatment Period 2|Other|0|||
94618430|NCT00395304|324066307|FG001|Treatment Period 2|Other|1|||
94618431|NCT00395304|324066308|FG002|Treatment Period 2|Other|0|||
94618432|NCT00395304|324066309|FG003|Treatment Period 2|Other|0|||
94618433|NCT00395304|324066310|FG004|Treatment Period 2|Other|0|||
94618434|NCT00395304|324066311|FG005|Treatment Period 2|Other|0|||
94618435|NCT00395304|324066306|FG000|Treatment Period 3|Withdrawal by Subject|0|||
94618436|NCT00395304|324066307|FG001|Treatment Period 3|Withdrawal by Subject|0|||
94618437|NCT00395304|324066308|FG002|Treatment Period 3|Withdrawal by Subject|0|||
94618438|NCT00395304|324066309|FG003|Treatment Period 3|Withdrawal by Subject|1|||
94618439|NCT00395304|324066310|FG004|Treatment Period 3|Withdrawal by Subject|0|||
94618440|NCT00395304|324066311|FG005|Treatment Period 3|Withdrawal by Subject|1|||
94618441|NCT00395304|324066306|FG000|Treatment Period 3|Lost to Follow-up|1|||
94618442|NCT00395304|324066307|FG001|Treatment Period 3|Lost to Follow-up|1|||
94618443|NCT00395304|324066308|FG002|Treatment Period 3|Lost to Follow-up|0|||
94618444|NCT00395304|324066309|FG003|Treatment Period 3|Lost to Follow-up|0|||
94618445|NCT00395304|324066310|FG004|Treatment Period 3|Lost to Follow-up|0|||
94618446|NCT00395304|324066311|FG005|Treatment Period 3|Lost to Follow-up|0|||
94618447|NCT00395304|324066306|FG000|Treatment Period 3|Physician Decision|0|||
94618448|NCT00395304|324066307|FG001|Treatment Period 3|Physician Decision|1|||
94618449|NCT00395304|324066308|FG002|Treatment Period 3|Physician Decision|0|||
94618450|NCT00395304|324066309|FG003|Treatment Period 3|Physician Decision|0|||
94618451|NCT00395304|324066310|FG004|Treatment Period 3|Physician Decision|0|||
94618452|NCT00395304|324066311|FG005|Treatment Period 3|Physician Decision|0|||
94618453|NCT00395304|324066306|FG000|Treatment Period 3|Other|0|||
94618454|NCT00395304|324066307|FG001|Treatment Period 3|Other|0|||
94618455|NCT00395304|324066308|FG002|Treatment Period 3|Other|0|||
94618456|NCT00395304|324066309|FG003|Treatment Period 3|Other|1|||
94618457|NCT00395304|324066310|FG004|Treatment Period 3|Other|0|||
94618458|NCT00395304|324066311|FG005|Treatment Period 3|Other|0|||
94618459|NCT00934089|324066312|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
94618460|NCT00934089|324066313|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
94618461|NCT00934089|324066312|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
94618462|NCT00934089|324066313|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
94618463|NCT03372096|324066316|FG000|Overall Study|Study Closed|8|||
94618464|NCT03068130|324066321|FG000|Overall Study|Adverse Event|19|||
94618465|NCT03068130|324066321|FG000|Overall Study|Death|14|||
94618466|NCT03068130|324066321|FG000|Overall Study|Lost to Follow-up|4|||
94618467|NCT03068130|324066321|FG000|Overall Study|Withdrawal by Subject|26|||
94618468|NCT03068130|324066321|FG000|Overall Study|Administrative Reasons|3|||
94618469|NCT03068130|324066321|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
94618470|NCT03068130|324066321|FG000|Overall Study|Study terminated by sponsor|194|||
94618471|NCT00612040|324066322|FG000|Overall Study|Adverse Event|0|||
94618472|NCT00612040|324066323|FG001|Overall Study|Adverse Event|2|||
94618473|NCT00612040|324066324|FG002|Overall Study|Adverse Event|1|||
94618474|NCT00612040|324066322|FG000|Overall Study|Protocol Violation|1|||
94618475|NCT00612040|324066323|FG001|Overall Study|Protocol Violation|2|||
94618476|NCT00612040|324066324|FG002|Overall Study|Protocol Violation|1|||
94618477|NCT00612040|324066322|FG000|Overall Study|Lack of Efficacy|2|||
94618478|NCT00612040|324066323|FG001|Overall Study|Lack of Efficacy|1|||
94618479|NCT00612040|324066324|FG002|Overall Study|Lack of Efficacy|0|||
94618480|NCT00612040|324066322|FG000|Overall Study|Unclassified|2|||
94618481|NCT00612040|324066323|FG001|Overall Study|Unclassified|2|||
94618482|NCT00612040|324066324|FG002|Overall Study|Unclassified|5|||
94618483|NCT00827502|324066325|FG000|Overall Study|randomized but not treated|11|||
94618484|NCT00827502|324066325|FG000|Overall Study|Adverse Event|1|||
94618485|NCT00827502|324066325|FG000|Overall Study|Lost to Follow-up|4|||
94618486|NCT00827502|324066325|FG000|Overall Study|Withdrawal by Subject|5|||
94618487|NCT03019185|324066326|FG000|Overall Study|Lost to Follow-up|3|||
94618488|NCT03019185|324066327|FG001|Overall Study|Lost to Follow-up|0|||
94618489|NCT03019185|324066328|FG002|Overall Study|Lost to Follow-up|2|||
94618490|NCT03019185|324066326|FG000|Overall Study|Withdrawal by Subject|1|||
94618491|NCT03019185|324066327|FG001|Overall Study|Withdrawal by Subject|1|||
94618492|NCT03019185|324066328|FG002|Overall Study|Withdrawal by Subject|0|||
94618493|NCT03019185|324066326|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
94618494|NCT03019185|324066327|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
94618495|NCT03019185|324066328|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
94618496|NCT03019185|324066326|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
94618497|NCT03019185|324066327|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
94618498|NCT03019185|324066328|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
94618499|NCT05154578|324066329|FG000|Overall Study|Withdrawal by Subject|2|||
94618500|NCT05154578|324066330|FG001|Overall Study|Withdrawal by Subject|3|||
94618501|NCT05154578|324066331|FG002|Overall Study|Withdrawal by Subject|2|||
94618502|NCT05154578|324066332|FG003|Overall Study|Withdrawal by Subject|4|||
94618503|NCT05154578|324066333|FG004|Overall Study|Withdrawal by Subject|0|||
94618504|NCT05154578|324066329|FG000|Overall Study|Lost to Follow-up|0|||
94618505|NCT05154578|324066330|FG001|Overall Study|Lost to Follow-up|1|||
94618506|NCT05154578|324066331|FG002|Overall Study|Lost to Follow-up|0|||
94618507|NCT05154578|324066332|FG003|Overall Study|Lost to Follow-up|3|||
94618508|NCT05154578|324066333|FG004|Overall Study|Lost to Follow-up|0|||
94618509|NCT05154578|324066329|FG000|Overall Study|Adverse Event|0|||
94618510|NCT05154578|324066330|FG001|Overall Study|Adverse Event|0|||
94618511|NCT05154578|324066331|FG002|Overall Study|Adverse Event|0|||
94618512|NCT05154578|324066332|FG003|Overall Study|Adverse Event|1|||
94618513|NCT05154578|324066333|FG004|Overall Study|Adverse Event|0|||
94618514|NCT05154578|324066329|FG000|Overall Study|Relocated to another province|0|||
94618515|NCT05154578|324066330|FG001|Overall Study|Relocated to another province|0|||
94618516|NCT05154578|324066331|FG002|Overall Study|Relocated to another province|1|||
94618517|NCT05154578|324066332|FG003|Overall Study|Relocated to another province|0|||
94618518|NCT05154578|324066333|FG004|Overall Study|Relocated to another province|1|||
94618519|NCT05154578|324066329|FG000|Overall Study|Baby loss|0|||
94618520|NCT05154578|324066330|FG001|Overall Study|Baby loss|1|||
94618521|NCT05154578|324066331|FG002|Overall Study|Baby loss|0|||
94618522|NCT05154578|324066332|FG003|Overall Study|Baby loss|0|||
94618523|NCT05154578|324066333|FG004|Overall Study|Baby loss|0|||
94618524|NCT04645953|324066334|FG000|Overall Study|Lost to Follow-up|2|||
94618525|NCT04645953|324066335|FG001|Overall Study|Lost to Follow-up|1|||
94618526|NCT04645953|324066336|FG002|Overall Study|Lost to Follow-up|1|||
94618527|NCT04645953|324066334|FG000|Overall Study|Withdrawal by Subject|0|||
94618528|NCT04645953|324066335|FG001|Overall Study|Withdrawal by Subject|1|||
94618529|NCT04645953|324066336|FG002|Overall Study|Withdrawal by Subject|0|||
94618530|NCT04645953|324066334|FG000|Overall Study|Physician Decision|0|||
94618531|NCT04645953|324066335|FG001|Overall Study|Physician Decision|1|||
94666668|NCT01217073|324232734|FG003|Extension Period|Adverse Event|0|||
94666669|NCT01217073|324232735|FG004|Extension Period|Adverse Event|0|||
94666670|NCT01217073|324232736|FG005|Extension Period|Adverse Event|0|||
94461106|NCT01794793|323476887|FG000|Treatment Period|Adverse Event|17|||
94461107|NCT01794793|323476887|FG000|Treatment Period|Physician Decision|14|||
94461108|NCT01794793|323476887|FG000|Treatment Period|Lost to Follow-up|7|||
94461109|NCT01794793|323476887|FG000|Treatment Period|Death|6|||
94461110|NCT01794793|323476887|FG000|Treatment Period|Protocol Violation|5|||
94461111|NCT01794793|323476887|FG000|Treatment Period|administrative problem|3|||
94461112|NCT01794793|323476887|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
94461113|NCT01794793|323476887|FG000|Post-treatment Follow-up|Adverse Event|8|||
94461114|NCT01794793|323476887|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
94461115|NCT01794793|323476887|FG000|Post-treatment Follow-up|administrative problem|5|||
94461116|NCT01794793|323476887|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
94461117|NCT01794793|323476887|FG000|Post-treatment Follow-up|Protocol Violation|3|||
94461118|NCT05897827|323478176|FG000|Overall Study|Lost to Follow-up|33|||
94461119|NCT05897827|323478177|FG001|Overall Study|Lost to Follow-up|14|||
94461120|NCT05897827|323478176|FG000|Overall Study|Withdrawal by Subject|1|||
94461121|NCT05897827|323478177|FG001|Overall Study|Withdrawal by Subject|1|||
94461122|NCT06366087|323478178|FG000|Overall Study|Withdrawal by Subject|0|||
94461123|NCT06366087|323478179|FG001|Overall Study|Withdrawal by Subject|1|||
94461124|NCT03875092|323478180|FG000|Overall Study|Adverse Event|2|||
94461125|NCT03875092|323478181|FG001|Overall Study|Adverse Event|5|||
94461126|NCT03875092|323478180|FG000|Overall Study|Death|44|||
94461127|NCT03875092|323478181|FG001|Overall Study|Death|51|||
94461128|NCT03875092|323478180|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
94461129|NCT03875092|323478181|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
94461130|NCT00477750|323478186|FG000|Overall Study|Currently Receiving Treatment|11|||
94461131|NCT02730377|323478187|FG000|Overall Study|Other|5|||
94461132|NCT02730377|323478188|FG001|Overall Study|Other|4|||
94461133|NCT02730377|323478187|FG000|Overall Study|Death|1|||
94461134|NCT02730377|323478188|FG001|Overall Study|Death|8|||
94461135|NCT02730377|323478187|FG000|Overall Study|Inadequate glycaemic control|368|||
94461136|NCT02730377|323478188|FG001|Overall Study|Inadequate glycaemic control|473|||
94461137|NCT02730377|323478187|FG000|Overall Study|Adverse Event|79|||
94461138|NCT02730377|323478188|FG001|Overall Study|Adverse Event|41|||
94461139|NCT02730377|323478187|FG000|Overall Study|Protocol Violation|23|||
94461140|NCT02730377|323478188|FG001|Overall Study|Protocol Violation|30|||
94461141|NCT02730377|323478187|FG000|Overall Study|Lack of Efficacy|4|||
94461142|NCT02730377|323478188|FG001|Overall Study|Lack of Efficacy|13|||
94618532|NCT04645953|324066336|FG002|Overall Study|Physician Decision|0|||
94618533|NCT04645953|324066334|FG000|Overall Study|Discontinued Prior to Dosing|0|||
94618534|NCT04645953|324066335|FG001|Overall Study|Discontinued Prior to Dosing|0|||
94618535|NCT04645953|324066336|FG002|Overall Study|Discontinued Prior to Dosing|2|||
94666671|NCT01217073|324232737|FG006|Extension Period|Adverse Event|19|||
94461143|NCT02730377|323478187|FG000|Overall Study|Pregnancy|0|||
94461144|NCT02730377|323478188|FG001|Overall Study|Pregnancy|1|||
94461145|NCT02730377|323478187|FG000|Overall Study|Withdrawal by Subject|45|||
94461146|NCT02730377|323478188|FG001|Overall Study|Withdrawal by Subject|42|||
94461147|NCT02730377|323478187|FG000|Overall Study|Lost to Follow-up|25|||
94618536|NCT04613375|324066337|FG000|Overall Study|Death|198|||
94618537|NCT04613375|324066337|FG000|Overall Study|Withdrawal by Subject|3|||
94618538|NCT03355365|324066338|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
94618539|NCT03355365|324066339|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
94618540|NCT03355365|324066338|FG000|Year 1, First Intervention|Protocol Violation|1|||
94618541|NCT03355365|324066339|FG001|Year 1, First Intervention|Protocol Violation|0|||
94618542|NCT03355365|324066338|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
94618543|NCT03355365|324066339|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
94618544|NCT03355365|324066338|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
94618545|NCT03355365|324066339|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
94618546|NCT03355365|324066338|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
94618547|NCT03355365|324066339|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
94618548|NCT03355365|324066338|FG000|Year 2, Crossover Intervention|severe COVID|0|||
94618549|NCT03355365|324066339|FG001|Year 2, Crossover Intervention|severe COVID|1|||
94618550|NCT03355365|324066338|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
94618551|NCT03355365|324066339|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
94618552|NCT03948581|324066346|FG000|Overall Study|Lost to Follow-up|0|||
94618553|NCT03948581|324066347|FG001|Overall Study|Lost to Follow-up|1|||
94618554|NCT03641339|324066348|FG000|Overall Study|Physician Decision|1|||
94618555|NCT03641339|324066349|FG001|Overall Study|Physician Decision|0|||
94618556|NCT03641339|324066350|FG002|Overall Study|Physician Decision|0|||
94618557|NCT03641339|324066351|FG003|Overall Study|Physician Decision|0|||
94618558|NCT03641339|324066352|FG004|Overall Study|Physician Decision|0|||
94618559|NCT03641339|324066353|FG005|Overall Study|Physician Decision|0|||
94618560|NCT03641339|324066348|FG000|Overall Study|Withdrawal by Subject|0|||
94618561|NCT03641339|324066349|FG001|Overall Study|Withdrawal by Subject|2|||
94254540|NCT00943111|322724435|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
94254541|NCT00943111|322724436|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
94254542|NCT00943111|322724434|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
94254543|NCT00943111|322724435|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
94254544|NCT00943111|322724436|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
94254545|NCT00943111|322724434|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
94254546|NCT00943111|322724435|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
94254547|NCT00943111|322724436|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
94254548|NCT00943111|322724434|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
94254549|NCT00943111|322724435|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
94254550|NCT00943111|322724436|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
94254551|NCT00943111|322724434|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
94254552|NCT00943111|322724435|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
94254553|NCT00943111|322724436|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
94254554|NCT02640157|322724437|FG000|Overall Study|Adverse Event|2|||
94254555|NCT02640157|322724438|FG001|Overall Study|Adverse Event|2|||
94254556|NCT02640157|322724439|FG002|Overall Study|Adverse Event|1|||
94254557|NCT02640157|322724437|FG000|Overall Study|Withdrew consent|2|||
94254558|NCT02640157|322724438|FG001|Overall Study|Withdrew consent|0|||
94254559|NCT02640157|322724439|FG002|Overall Study|Withdrew consent|2|||
94254560|NCT02640157|322724437|FG000|Overall Study|Lost to Follow-up|9|||
94254561|NCT02640157|322724438|FG001|Overall Study|Lost to Follow-up|2|||
94254562|NCT02640157|322724439|FG002|Overall Study|Lost to Follow-up|7|||
94254563|NCT02640157|322724437|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
94254564|NCT02640157|322724438|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
94254565|NCT02640157|322724439|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
94254566|NCT02730598|322724440|FG000|Overall Study|Withdrawal by Subject|3|||
94254567|NCT02730598|322724441|FG001|Overall Study|Withdrawal by Subject|3|||
94254568|NCT02730598|322724440|FG000|Overall Study|Protocol Violation|0|||
94254569|NCT02730598|322724441|FG001|Overall Study|Protocol Violation|1|||
94618562|NCT03641339|324066350|FG002|Overall Study|Withdrawal by Subject|0|||
94618563|NCT03641339|324066351|FG003|Overall Study|Withdrawal by Subject|2|||
94618564|NCT03641339|324066352|FG004|Overall Study|Withdrawal by Subject|0|||
94618565|NCT03641339|324066353|FG005|Overall Study|Withdrawal by Subject|1|||
94618566|NCT01328431|324066354|FG000|Baseline|Protocol Violation|0|||
94618567|NCT01328431|324066355|FG001|Baseline|Protocol Violation|2|||
94618568|NCT01328431|324066354|FG000|1 Month (1M)|Lost to Follow-up|55|||
94618569|NCT01328431|324066355|FG001|1 Month (1M)|Lost to Follow-up|58|||
94618570|NCT01328431|324066354|FG000|3 Month (3M)|Death|2|||
94618571|NCT01328431|324066355|FG001|3 Month (3M)|Death|2|||
94618572|NCT01328431|324066354|FG000|3 Month (3M)|Lost to Follow-up|75|||
94618573|NCT01328431|324066355|FG001|3 Month (3M)|Lost to Follow-up|70|||
94618574|NCT01328431|324066354|FG000|12 Month (12M)|Death|2|||
94254570|NCT02730598|322724440|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
94254571|NCT02730598|322724441|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
94254572|NCT03756129|322724442|FG000|Overall Study|Adverse Event|1|||
94254573|NCT03756129|322724443|FG001|Overall Study|Adverse Event|1|||
94618575|NCT01328431|324066355|FG001|12 Month (12M)|Death|6|||
94618576|NCT01328431|324066354|FG000|12 Month (12M)|Lost to Follow-up|82|||
94618577|NCT01328431|324066355|FG001|12 Month (12M)|Lost to Follow-up|91|||
94618578|NCT05229406|324066357|FG000|Overall Study|Withdrawal by Subject|1|||
94618579|NCT05229406|324066358|FG001|Overall Study|Withdrawal by Subject|2|||
94254574|NCT03756129|322724444|FG002|Overall Study|Adverse Event|0|||
94254575|NCT03756129|322724445|FG003|Overall Study|Adverse Event|2|||
94254576|NCT03756129|322724446|FG004|Overall Study|Adverse Event|0|||
94254577|NCT03756129|322724447|FG005|Overall Study|Adverse Event|0|||
94254578|NCT03756129|322724442|FG000|Overall Study|Withdrawal by Subject|2|||
94254579|NCT03756129|322724443|FG001|Overall Study|Withdrawal by Subject|1|||
94254580|NCT03756129|322724444|FG002|Overall Study|Withdrawal by Subject|3|||
94254581|NCT03756129|322724445|FG003|Overall Study|Withdrawal by Subject|1|||
94254582|NCT03756129|322724446|FG004|Overall Study|Withdrawal by Subject|1|||
94254583|NCT03756129|322724447|FG005|Overall Study|Withdrawal by Subject|3|||
94254584|NCT03756129|322724442|FG000|Overall Study|Lost to Follow-up|0|||
94254585|NCT03756129|322724443|FG001|Overall Study|Lost to Follow-up|0|||
94254586|NCT03756129|322724444|FG002|Overall Study|Lost to Follow-up|0|||
94254587|NCT03756129|322724445|FG003|Overall Study|Lost to Follow-up|0|||
94254588|NCT03756129|322724446|FG004|Overall Study|Lost to Follow-up|0|||
94254589|NCT03756129|322724447|FG005|Overall Study|Lost to Follow-up|1|||
94254590|NCT03756129|322724442|FG000|Overall Study|Physician Decision|0|||
94254591|NCT03756129|322724443|FG001|Overall Study|Physician Decision|0|||
94254592|NCT03756129|322724444|FG002|Overall Study|Physician Decision|0|||
94254593|NCT03756129|322724445|FG003|Overall Study|Physician Decision|0|||
94254594|NCT03756129|322724446|FG004|Overall Study|Physician Decision|0|||
94666672|NCT01217073|324232738|FG007|Extension Period|Adverse Event|5|||
94666673|NCT01217073|324232731|FG000|Extension Period|ALT/AST|0|||
94666674|NCT01217073|324232732|FG001|Extension Period|ALT/AST|0|||
94666675|NCT01217073|324232733|FG002|Extension Period|ALT/AST|0|||
94666676|NCT01217073|324232734|FG003|Extension Period|ALT/AST|0|||
94666677|NCT01217073|324232735|FG004|Extension Period|ALT/AST|0|||
94666678|NCT01217073|324232736|FG005|Extension Period|ALT/AST|0|||
94666679|NCT01217073|324232737|FG006|Extension Period|ALT/AST|2|||
94666680|NCT01217073|324232738|FG007|Extension Period|ALT/AST|0|||
94666681|NCT01217073|324232731|FG000|Extension Period|Contraindication to study medication|0|||
94666682|NCT01217073|324232732|FG001|Extension Period|Contraindication to study medication|0|||
94666683|NCT01217073|324232733|FG002|Extension Period|Contraindication to study medication|0|||
94666684|NCT01217073|324232734|FG003|Extension Period|Contraindication to study medication|0|||
94666685|NCT01217073|324232735|FG004|Extension Period|Contraindication to study medication|0|||
94666686|NCT01217073|324232736|FG005|Extension Period|Contraindication to study medication|0|||
94666687|NCT01217073|324232737|FG006|Extension Period|Contraindication to study medication|1|||
94666688|NCT01217073|324232738|FG007|Extension Period|Contraindication to study medication|0|||
94666689|NCT01217073|324232731|FG000|Extension Period|Creatinine/eGFR|0|||
94254595|NCT03756129|322724447|FG005|Overall Study|Physician Decision|1|||
94254596|NCT03282240|322724448|FG000|Overall Study|Adverse Event|2|||
94254597|NCT03282240|322724449|FG001|Overall Study|Adverse Event|2|||
94254598|NCT03282240|322724450|FG002|Overall Study|Adverse Event|0|||
94254599|NCT03282240|322724448|FG000|Overall Study|Lost to Follow-up|3|||
94254600|NCT03282240|322724449|FG001|Overall Study|Lost to Follow-up|0|||
94254601|NCT03282240|322724450|FG002|Overall Study|Lost to Follow-up|0|||
94254602|NCT03282240|322724448|FG000|Overall Study|Protocol Deviation|4|||
94254603|NCT03282240|322724449|FG001|Overall Study|Protocol Deviation|1|||
94254604|NCT03282240|322724450|FG002|Overall Study|Protocol Deviation|2|||
94254605|NCT03282240|322724448|FG000|Overall Study|Withdrawal by Subject|1|||
94254606|NCT03282240|322724449|FG001|Overall Study|Withdrawal by Subject|0|||
94254607|NCT03282240|322724450|FG002|Overall Study|Withdrawal by Subject|1|||
94254608|NCT01675479|322724451|FG000|Overall Study|Lost to Follow-up|11|||
94254609|NCT03567434|322724456|FG000|Overall Study|Lost to Follow-up|1|||
94254610|NCT03567434|322724457|FG001|Overall Study|Lost to Follow-up|3|||
94254611|NCT00081497|322724461|FG000|Overall Study|Adverse Event|2|||
94254612|NCT00081497|322724462|FG001|Overall Study|Adverse Event|0|||
94618580|NCT01203098|324066359|FG000|Overall Study|Adverse Event|3|||
94618581|NCT01203098|324066360|FG001|Overall Study|Adverse Event|1|||
94618582|NCT01203098|324066361|FG002|Overall Study|Adverse Event|7|||
94666690|NCT01217073|324232732|FG001|Extension Period|Creatinine/eGFR|0|||
94254613|NCT00081497|322724461|FG000|Overall Study|Death|0|||
94254614|NCT00081497|322724462|FG001|Overall Study|Death|1|||
94254615|NCT00081497|322724461|FG000|Overall Study|Withdrawal by Subject|1|||
94254616|NCT00081497|322724462|FG001|Overall Study|Withdrawal by Subject|0|||
94618583|NCT01203098|324066359|FG000|Overall Study|Lost to Follow-up|0|||
94666691|NCT01217073|324232733|FG002|Extension Period|Creatinine/eGFR|0|||
94666692|NCT01217073|324232734|FG003|Extension Period|Creatinine/eGFR|0|||
94666693|NCT01217073|324232735|FG004|Extension Period|Creatinine/eGFR|0|||
94254617|NCT00081497|322724461|FG000|Overall Study|Non-compliance|0|||
94254618|NCT00081497|322724462|FG001|Overall Study|Non-compliance|1|||
94254619|NCT00345293|322724463|FG000|Overall Study|Unable to access line for sample|1|||
94254620|NCT00345293|322724464|FG001|Overall Study|Unable to access line for sample|0|||
94254621|NCT00345293|322724463|FG000|Overall Study|Withdrawal by Subject|1|||
94254622|NCT00345293|322724464|FG001|Overall Study|Withdrawal by Subject|0|||
94254623|NCT03727438|322724469|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
94254624|NCT03727438|322724470|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
94254625|NCT03727438|322724469|FG000|Intervention Period|Excluded (health)|1|||
94254626|NCT03727438|322724470|FG001|Intervention Period|Excluded (health)|0|||
94254627|NCT03727438|322724469|FG000|Intervention Period|Withdrawal by Subject|3|||
94254628|NCT03727438|322724470|FG001|Intervention Period|Withdrawal by Subject|1|||
94254629|NCT03727438|322724469|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
94254630|NCT03727438|322724470|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
94254631|NCT03727438|322724469|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
94254632|NCT03727438|322724470|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
94254633|NCT03727438|322724469|FG000|8 Week Assessment|Withdrawal by Subject|6|||
94254634|NCT03727438|322724470|FG001|8 Week Assessment|Withdrawal by Subject|1|||
94254635|NCT03727438|322724469|FG000|6 mo Assessment|did not complete assessment|10|||
94254636|NCT03727438|322724470|FG001|6 mo Assessment|did not complete assessment|11|||
94254637|NCT00686725|322726323|FG000|Overall Study|Adverse Event|1|||
94254638|NCT00686725|322726324|FG001|Overall Study|Adverse Event|1|||
94254639|NCT00686725|322726323|FG000|Overall Study|Progressive Disease|17|||
94254640|NCT00686725|322726324|FG001|Overall Study|Progressive Disease|23|||
94254641|NCT00686725|322726323|FG000|Overall Study|Lost to Follow-up|7|||
94254642|NCT00686725|322726324|FG001|Overall Study|Lost to Follow-up|5|||
94254643|NCT00686725|322726323|FG000|Overall Study|Death|6|||
94254644|NCT00686725|322726324|FG001|Overall Study|Death|3|||
94254645|NCT00686725|322726323|FG000|Overall Study|Withdrawal by Subject|13|||
94254646|NCT00686725|322726324|FG001|Overall Study|Withdrawal by Subject|4|||
94254647|NCT00686725|322726323|FG000|Overall Study|Protocol Violation|1|||
94254648|NCT00686725|322726324|FG001|Overall Study|Protocol Violation|3|||
94254649|NCT00686725|322726323|FG000|Overall Study|Other|1|||
94254650|NCT00686725|322726324|FG001|Overall Study|Other|3|||
94254651|NCT01970345|322726327|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
94254652|NCT01970345|322726328|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
94254653|NCT01970345|322726327|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
94254654|NCT01970345|322726328|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
94254655|NCT02029846|322726329|FG000|Overall Study|n=1 each arm|1|||
94254656|NCT02029846|322726330|FG001|Overall Study|n=1 each arm|1|||
94254657|NCT00822172|322726331|FG000|Overall Study|Adverse Event|10|||
94254658|NCT00822172|322726332|FG001|Overall Study|Adverse Event|12|||
94254659|NCT00822172|322726331|FG000|Overall Study|Death|1|||
94254660|NCT00822172|322726332|FG001|Overall Study|Death|0|||
94254661|NCT00822172|322726331|FG000|Overall Study|Lost to Follow-up|3|||
94254662|NCT00822172|322726332|FG001|Overall Study|Lost to Follow-up|1|||
94254663|NCT00822172|322726331|FG000|Overall Study|Withdrawal by Subject|1|||
94254664|NCT00822172|322726332|FG001|Overall Study|Withdrawal by Subject|4|||
94254665|NCT00822172|322726331|FG000|Overall Study|site closed|0|||
94254666|NCT00822172|322726332|FG001|Overall Study|site closed|1|||
94254667|NCT00822172|322726331|FG000|Overall Study|Other|0|||
94254668|NCT00822172|322726332|FG001|Overall Study|Other|1|||
94254669|NCT00448279|322726333|FG000|Overall Study|Lost to Follow-up|2|||
94254670|NCT00448279|322726334|FG001|Overall Study|Lost to Follow-up|2|||
94254671|NCT00448279|322726333|FG000|Overall Study|Adverse Event|1|||
94254672|NCT00448279|322726334|FG001|Overall Study|Adverse Event|1|||
94254673|NCT00448279|322726333|FG000|Overall Study|Disease progression|16|||
94254674|NCT00448279|322726334|FG001|Overall Study|Disease progression|18|||
94254675|NCT00448279|322726333|FG000|Overall Study|Withdrawal by Subject|4|||
94618584|NCT01203098|324066360|FG001|Overall Study|Lost to Follow-up|0|||
94618585|NCT01203098|324066361|FG002|Overall Study|Lost to Follow-up|1|||
94618586|NCT01203098|324066359|FG000|Overall Study|Physician Decision|2|||
94618587|NCT01203098|324066360|FG001|Overall Study|Physician Decision|2|||
94618588|NCT01203098|324066361|FG002|Overall Study|Physician Decision|0|||
94358993|NCT03733301|323098038|FG001|Overall Study|Lack of Efficacy|3|||
94358994|NCT03733301|323098039|FG002|Overall Study|Lack of Efficacy|0|||
94618589|NCT01203098|324066359|FG000|Overall Study|Withdrawal by Subject|1|||
94666694|NCT01217073|324232736|FG005|Extension Period|Creatinine/eGFR|0|||
94254676|NCT00448279|322726334|FG001|Overall Study|Withdrawal by Subject|3|||
94618590|NCT01203098|324066360|FG001|Overall Study|Withdrawal by Subject|1|||
94254677|NCT00448279|322726333|FG000|Overall Study|Other|6|||
94618591|NCT01203098|324066361|FG002|Overall Study|Withdrawal by Subject|3|||
94666695|NCT01217073|324232737|FG006|Extension Period|Creatinine/eGFR|11|||
94254678|NCT00448279|322726334|FG001|Overall Study|Other|4|||
94254679|NCT00448279|322726333|FG000|Overall Study|Protocol Violation|0|||
94254680|NCT00448279|322726334|FG001|Overall Study|Protocol Violation|1|||
94254681|NCT01248065|322726337|FG000|Overall Study|Lost to Follow-up|3|||
94254682|NCT01248065|322726338|FG001|Overall Study|Lost to Follow-up|5|||
94358995|NCT03733301|323098037|FG000|Overall Study|Adverse Event|0|||
94358996|NCT03733301|323098038|FG001|Overall Study|Adverse Event|1|||
94358997|NCT03733301|323098039|FG002|Overall Study|Adverse Event|3|||
94618592|NCT00621582|324066365|FG000|Overall Study|Adverse Event|7|||
94666696|NCT01217073|324232738|FG007|Extension Period|Creatinine/eGFR|1|||
94666697|NCT01217073|324232731|FG000|Extension Period|Death|0|||
94666698|NCT01217073|324232732|FG001|Extension Period|Death|0|||
94666699|NCT01217073|324232733|FG002|Extension Period|Death|0|||
94666700|NCT01217073|324232734|FG003|Extension Period|Death|0|||
94666701|NCT01217073|324232735|FG004|Extension Period|Death|0|||
94666702|NCT01217073|324232736|FG005|Extension Period|Death|0|||
94666703|NCT01217073|324232737|FG006|Extension Period|Death|1|||
94666704|NCT01217073|324232738|FG007|Extension Period|Death|0|||
94666705|NCT01217073|324232731|FG000|Extension Period|Excluded medication|0|||
94666706|NCT01217073|324232732|FG001|Extension Period|Excluded medication|0|||
94666707|NCT01217073|324232733|FG002|Extension Period|Excluded medication|0|||
94666708|NCT01217073|324232734|FG003|Extension Period|Excluded medication|0|||
94666709|NCT01217073|324232735|FG004|Extension Period|Excluded medication|0|||
94666710|NCT01217073|324232736|FG005|Extension Period|Excluded medication|0|||
94666711|NCT01217073|324232737|FG006|Extension Period|Excluded medication|2|||
94666712|NCT01217073|324232738|FG007|Extension Period|Excluded medication|0|||
94666713|NCT01217073|324232731|FG000|Extension Period|Lack of Efficacy|0|||
94666714|NCT01217073|324232732|FG001|Extension Period|Lack of Efficacy|0|||
94666715|NCT01217073|324232733|FG002|Extension Period|Lack of Efficacy|0|||
94666716|NCT01217073|324232734|FG003|Extension Period|Lack of Efficacy|0|||
94666717|NCT01217073|324232735|FG004|Extension Period|Lack of Efficacy|0|||
94666718|NCT01217073|324232736|FG005|Extension Period|Lack of Efficacy|0|||
94666719|NCT01217073|324232737|FG006|Extension Period|Lack of Efficacy|3|||
94666720|NCT01217073|324232738|FG007|Extension Period|Lack of Efficacy|0|||
94666721|NCT01217073|324232731|FG000|Extension Period|Lost to Follow-up|0|||
94666722|NCT01217073|324232732|FG001|Extension Period|Lost to Follow-up|0|||
94666723|NCT01217073|324232733|FG002|Extension Period|Lost to Follow-up|0|||
94666724|NCT01217073|324232734|FG003|Extension Period|Lost to Follow-up|0|||
94666725|NCT01217073|324232735|FG004|Extension Period|Lost to Follow-up|0|||
94666726|NCT01217073|324232736|FG005|Extension Period|Lost to Follow-up|0|||
94666727|NCT01217073|324232737|FG006|Extension Period|Lost to Follow-up|9|||
94666728|NCT01217073|324232738|FG007|Extension Period|Lost to Follow-up|1|||
94666729|NCT01217073|324232731|FG000|Extension Period|Non-compliance with study drug|0|||
94666730|NCT01217073|324232732|FG001|Extension Period|Non-compliance with study drug|0|||
94666731|NCT01217073|324232733|FG002|Extension Period|Non-compliance with study drug|0|||
94666732|NCT01217073|324232734|FG003|Extension Period|Non-compliance with study drug|0|||
94666733|NCT01217073|324232735|FG004|Extension Period|Non-compliance with study drug|0|||
94666734|NCT01217073|324232736|FG005|Extension Period|Non-compliance with study drug|0|||
94666735|NCT01217073|324232737|FG006|Extension Period|Non-compliance with study drug|0|||
94666736|NCT01217073|324232738|FG007|Extension Period|Non-compliance with study drug|1|||
94666737|NCT01217073|324232731|FG000|Extension Period|Physician Decision|0|||
94666738|NCT01217073|324232732|FG001|Extension Period|Physician Decision|0|||
94666739|NCT01217073|324232733|FG002|Extension Period|Physician Decision|0|||
94254683|NCT01248065|322726337|FG000|Overall Study|Withdrawal by Subject|14|||
94254684|NCT01248065|322726338|FG001|Overall Study|Withdrawal by Subject|11|||
94254685|NCT01248065|322726337|FG000|Overall Study|Adverse Event|3|||
94254686|NCT01248065|322726338|FG001|Overall Study|Adverse Event|0|||
94254687|NCT01248065|322726337|FG000|Overall Study|Third treatment failure event|3|||
94254688|NCT01248065|322726338|FG001|Overall Study|Third treatment failure event|1|||
94254689|NCT01248065|322726337|FG000|Overall Study|Other|3|||
94254690|NCT01248065|322726338|FG001|Overall Study|Other|5|||
94254691|NCT02781844|322726340|FG000|Treatment Period 1|Adverse Event|0|||
94254692|NCT02781844|322726341|FG001|Treatment Period 1|Adverse Event|0|||
94254693|NCT02781844|322726342|FG002|Treatment Period 1|Adverse Event|0|||
94254694|NCT02781844|322726343|FG003|Treatment Period 1|Adverse Event|0|||
94254695|NCT02781844|322726344|FG004|Treatment Period 1|Adverse Event|0|||
94254696|NCT02781844|322726345|FG005|Treatment Period 1|Adverse Event|1|||
94254697|NCT02781844|322726346|FG006|Treatment Period 1|Adverse Event|0|||
94254698|NCT02781844|322726347|FG007|Treatment Period 1|Adverse Event|0|||
94254699|NCT04256629|322726348|FG000|Overall Study|Adverse Event|0|||
94254700|NCT04256629|322726349|FG001|Overall Study|Adverse Event|0|||
94254701|NCT04256629|322726350|FG002|Overall Study|Adverse Event|0|||
94666740|NCT01217073|324232734|FG003|Extension Period|Physician Decision|0|||
94254702|NCT04256629|322726351|FG003|Overall Study|Adverse Event|0|||
94254703|NCT04256629|322726352|FG004|Overall Study|Adverse Event|0|||
94254704|NCT04256629|322726353|FG005|Overall Study|Adverse Event|1|||
94666741|NCT01217073|324232735|FG004|Extension Period|Physician Decision|0|||
94666742|NCT01217073|324232736|FG005|Extension Period|Physician Decision|0|||
94666743|NCT01217073|324232737|FG006|Extension Period|Physician Decision|4|||
94666744|NCT01217073|324232738|FG007|Extension Period|Physician Decision|1|||
94666745|NCT01217073|324232731|FG000|Extension Period|Protocol Violation|0|||
94666746|NCT01217073|324232732|FG001|Extension Period|Protocol Violation|0|||
94666747|NCT01217073|324232733|FG002|Extension Period|Protocol Violation|0|||
94666748|NCT01217073|324232734|FG003|Extension Period|Protocol Violation|0|||
94666749|NCT01217073|324232735|FG004|Extension Period|Protocol Violation|0|||
94666750|NCT01217073|324232736|FG005|Extension Period|Protocol Violation|0|||
94254705|NCT04256629|322726348|FG000|Overall Study|Protocol Violation|0|||
94254706|NCT04256629|322726349|FG001|Overall Study|Protocol Violation|1|||
94254707|NCT04256629|322726350|FG002|Overall Study|Protocol Violation|0|||
94254708|NCT04256629|322726351|FG003|Overall Study|Protocol Violation|0|||
94618593|NCT00621582|324066365|FG000|Overall Study|Protocol Violation|57|||
94618594|NCT00621582|324066365|FG000|Overall Study|Lost to Follow-up|24|||
94618595|NCT00621582|324066365|FG000|Overall Study|issues not identified by investigators|18|||
94618596|NCT01387932|324066366|FG000|Randomized and Treated|Physician Decision|3|||
94618597|NCT01387932|324066367|FG001|Randomized and Treated|Physician Decision|2|||
94618598|NCT01387932|324066366|FG000|Randomized and Treated|Withdrawal by Subject|4|||
94618599|NCT01387932|324066367|FG001|Randomized and Treated|Withdrawal by Subject|2|||
94618600|NCT01387932|324066366|FG000|Survival Follow-up|Liver Transplant|24|||
94618601|NCT01387932|324066367|FG001|Survival Follow-up|Liver Transplant|28|||
94618602|NCT01387932|324066366|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
94618603|NCT01387932|324066367|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
94618604|NCT01387932|324066366|FG000|Survival Follow-up|Withdrawal by Subject|2|||
94618605|NCT01387932|324066367|FG001|Survival Follow-up|Withdrawal by Subject|4|||
94618606|NCT01387932|324066366|FG000|Survival Follow-up|Lost to Follow-up|6|||
94618607|NCT01387932|324066367|FG001|Survival Follow-up|Lost to Follow-up|5|||
94618608|NCT01416272|324066368|FG000|Overall Study|Unacceptable distance visual acuity|2|||
94618609|NCT01416272|324066368|FG000|Overall Study|Lost to Follow-up|1|||
94618610|NCT01416272|324066368|FG000|Overall Study|Study related complaints|1|||
94618611|NCT02197520|324066371|FG000|Period 1|Withdrawal by Subject|1|||
94618612|NCT02197520|324066372|FG001|Period 1|Withdrawal by Subject|0|||
94618613|NCT02197520|324066371|FG000|Period 2|Adverse Event|0|||
94618614|NCT02197520|324066372|FG001|Period 2|Adverse Event|2|||
94618615|NCT02197520|324066371|FG000|Period 2|Withdrawal by Subject|1|||
94618616|NCT02197520|324066372|FG001|Period 2|Withdrawal by Subject|0|||
94618617|NCT00913497|324066373|FG000|Overall Study|Adverse Event|1|||
94618618|NCT00913497|324066373|FG000|Overall Study|Withdrawal by Subject|2|||
94618619|NCT00622401|324066374|FG000|Overall Study|Disease progression prior to treatment|3|||
94618620|NCT00622401|324066375|FG001|Overall Study|Disease progression prior to treatment|2|||
94618621|NCT00622401|324066376|FG002|Overall Study|Disease progression prior to treatment|0|||
94618622|NCT03386448|324066377|FG000|Overall Study|Adverse Event|0|||
94618623|NCT03386448|324066378|FG001|Overall Study|Adverse Event|2|||
94618624|NCT03338010|324066379|FG000|Overall Study|Withdrawal by Subject|14|||
94618625|NCT03338010|324066380|FG001|Overall Study|Withdrawal by Subject|8|||
94618626|NCT03338010|324066379|FG000|Overall Study|Lost to Follow-up|4|||
94618627|NCT03338010|324066380|FG001|Overall Study|Lost to Follow-up|2|||
94618628|NCT03338010|324066379|FG000|Overall Study|Adverse Event|3|||
94618629|NCT03338010|324066380|FG001|Overall Study|Adverse Event|2|||
94618630|NCT03338010|324066379|FG000|Overall Study|Physician Decision|2|||
94618631|NCT03338010|324066380|FG001|Overall Study|Physician Decision|2|||
94618632|NCT03338010|324066379|FG000|Overall Study|Non-Compliance with Study Drug|0|||
94618633|NCT03338010|324066380|FG001|Overall Study|Non-Compliance with Study Drug|3|||
94618634|NCT03338010|324066379|FG000|Overall Study|Protocol Violation|0|||
94618635|NCT03338010|324066380|FG001|Overall Study|Protocol Violation|1|||
94618636|NCT01146665|324066383|FG000|Overall Study|Withdrawal by Subject|10|||
94618637|NCT01146665|324066384|FG001|Overall Study|Withdrawal by Subject|16|||
94618638|NCT02465515|324066385|FG000|Overall Study|Investigator site closed|4|||
94618639|NCT02465515|324066386|FG001|Overall Study|Investigator site closed|5|||
94618640|NCT02465515|324066385|FG000|Overall Study|Withdrawal by Subject|74|||
94618641|NCT02465515|324066386|FG001|Overall Study|Withdrawal by Subject|43|||
94618642|NCT02465515|324066385|FG000|Overall Study|Physician Decision|8|||
94618643|NCT02465515|324066386|FG001|Overall Study|Physician Decision|12|||
94618644|NCT02465515|324066385|FG000|Overall Study|Lost to Follow-up|68|||
94618645|NCT02465515|324066386|FG001|Overall Study|Lost to Follow-up|51|||
94618646|NCT00816595|324066387|FG000|Overall Study|Withdrawal by Subject|2|||
94618647|NCT00816595|324066388|FG001|Overall Study|Withdrawal by Subject|0|||
94618648|NCT00114530|324066389|FG000|Overall Study|Death|3|||
94618649|NCT00114530|324066390|FG001|Overall Study|Death|11|||
94618650|NCT00114530|324066389|FG000|Overall Study|Lost to Follow-up|1|||
94666751|NCT01217073|324232737|FG006|Extension Period|Protocol Violation|2|||
94666752|NCT01217073|324232738|FG007|Extension Period|Protocol Violation|1|||
94254709|NCT04256629|322726352|FG004|Overall Study|Protocol Violation|0|||
94254710|NCT04256629|322726353|FG005|Overall Study|Protocol Violation|0|||
94618651|NCT00114530|324066390|FG001|Overall Study|Lost to Follow-up|1|||
94618652|NCT00114530|324066389|FG000|Overall Study|Physician Decision|1|||
94618653|NCT00114530|324066390|FG001|Overall Study|Physician Decision|1|||
94618654|NCT00114530|324066389|FG000|Overall Study|Withdrawal by Subject|2|||
94618655|NCT00114530|324066390|FG001|Overall Study|Withdrawal by Subject|6|||
94618656|NCT00114530|324066389|FG000|Overall Study|Breast Cancer|1|||
94618657|NCT00114530|324066390|FG001|Overall Study|Breast Cancer|0|||
94618658|NCT00114530|324066389|FG000|Overall Study|Subject decision after endpoint failure|0|||
94666753|NCT01217073|324232731|FG000|Extension Period|Site discontinued study participation|0|||
94618659|NCT00114530|324066390|FG001|Overall Study|Subject decision after endpoint failure|1|||
94618660|NCT00114530|324066389|FG000|Overall Study|Ineligible|1|||
94254711|NCT00321373|322726354|FG000|Overall Study|Adverse Event|0|||
94618661|NCT00114530|324066390|FG001|Overall Study|Ineligible|0|||
94618662|NCT05248867|324066395|FG000|Double-blind Period|Lost to Follow-up|0|||
94618663|NCT05248867|324066396|FG001|Double-blind Period|Lost to Follow-up|3|||
94618664|NCT05248867|324066397|FG002|Double-blind Period|Lost to Follow-up|0|||
94618665|NCT05248867|324066398|FG003|Double-blind Period|Lost to Follow-up|0|||
94618666|NCT05248867|324066399|FG004|Double-blind Period|Lost to Follow-up|0|||
94618667|NCT05248867|324066400|FG005|Double-blind Period|Lost to Follow-up|0|||
94618668|NCT05248867|324066395|FG000|Double-blind Period|Withdrawal by Subject|5|||
94618669|NCT05248867|324066396|FG001|Double-blind Period|Withdrawal by Subject|14|||
94618670|NCT05248867|324066397|FG002|Double-blind Period|Withdrawal by Subject|0|||
94618671|NCT05248867|324066398|FG003|Double-blind Period|Withdrawal by Subject|0|||
94618672|NCT05248867|324066399|FG004|Double-blind Period|Withdrawal by Subject|0|||
94618673|NCT05248867|324066400|FG005|Double-blind Period|Withdrawal by Subject|0|||
94618674|NCT05248867|324066395|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
94618675|NCT05248867|324066396|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
94618676|NCT05248867|324066397|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
94618677|NCT05248867|324066398|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
94618678|NCT05248867|324066399|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
94618679|NCT05248867|324066400|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
94618680|NCT05248867|324066395|FG000|Double-blind Period|Other, not specified|3|||
94618681|NCT05248867|324066396|FG001|Double-blind Period|Other, not specified|8|||
94618682|NCT05248867|324066397|FG002|Double-blind Period|Other, not specified|0|||
94618683|NCT05248867|324066398|FG003|Double-blind Period|Other, not specified|0|||
94618684|NCT05248867|324066399|FG004|Double-blind Period|Other, not specified|0|||
94618685|NCT05248867|324066400|FG005|Double-blind Period|Other, not specified|0|||
94618686|NCT05248867|324066395|FG000|Open-label Period|Withdrawal by Subject|0|||
94618687|NCT05248867|324066396|FG001|Open-label Period|Withdrawal by Subject|0|||
94618688|NCT05248867|324066397|FG002|Open-label Period|Withdrawal by Subject|3|||
94618689|NCT05248867|324066398|FG003|Open-label Period|Withdrawal by Subject|1|||
94618690|NCT05248867|324066399|FG004|Open-label Period|Withdrawal by Subject|7|||
94618691|NCT05248867|324066400|FG005|Open-label Period|Withdrawal by Subject|9|||
94618692|NCT05248867|324066395|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
94618693|NCT05248867|324066396|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
94618694|NCT05248867|324066397|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
94618695|NCT05248867|324066398|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
94618696|NCT05248867|324066399|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
94618697|NCT05248867|324066400|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
94618698|NCT05248867|324066395|FG000|Open-label Period|Lost to Follow-up|0|||
94618699|NCT05248867|324066396|FG001|Open-label Period|Lost to Follow-up|0|||
94618700|NCT05248867|324066397|FG002|Open-label Period|Lost to Follow-up|0|||
94618701|NCT05248867|324066398|FG003|Open-label Period|Lost to Follow-up|0|||
94618702|NCT05248867|324066399|FG004|Open-label Period|Lost to Follow-up|5|||
94618703|NCT05248867|324066400|FG005|Open-label Period|Lost to Follow-up|2|||
94618704|NCT05248867|324066395|FG000|Open-label Period|COVID-19 Infection|0|||
94618705|NCT05248867|324066396|FG001|Open-label Period|COVID-19 Infection|0|||
94618706|NCT05248867|324066397|FG002|Open-label Period|COVID-19 Infection|0|||
94618707|NCT05248867|324066398|FG003|Open-label Period|COVID-19 Infection|0|||
94618708|NCT05248867|324066399|FG004|Open-label Period|COVID-19 Infection|1|||
94618709|NCT05248867|324066400|FG005|Open-label Period|COVID-19 Infection|0|||
94618710|NCT05248867|324066395|FG000|Open-label Period|Other, not specified|0|||
94618711|NCT05248867|324066396|FG001|Open-label Period|Other, not specified|0|||
94618712|NCT05248867|324066397|FG002|Open-label Period|Other, not specified|0|||
94618713|NCT05248867|324066398|FG003|Open-label Period|Other, not specified|0|||
94618714|NCT05248867|324066399|FG004|Open-label Period|Other, not specified|4|||
94618715|NCT05248867|324066400|FG005|Open-label Period|Other, not specified|0|||
94618716|NCT00001880|324066401|FG000|Overall Study|Death|14|||
94618717|NCT00679432|324066402|FG000|Overall Study|Adverse Event|5|||
94618718|NCT00679432|324066403|FG001|Overall Study|Adverse Event|6|||
94618719|NCT00679432|324066404|FG002|Overall Study|Adverse Event|10|||
94618720|NCT00679432|324066405|FG003|Overall Study|Adverse Event|7|||
94618721|NCT00679432|324066402|FG000|Overall Study|Protocol Violation|1|||
94618722|NCT00679432|324066403|FG001|Overall Study|Protocol Violation|1|||
94618723|NCT00679432|324066404|FG002|Overall Study|Protocol Violation|2|||
94618724|NCT00679432|324066405|FG003|Overall Study|Protocol Violation|1|||
94618725|NCT00679432|324066402|FG000|Overall Study|Withdrawal by Subject|8|||
94618726|NCT00679432|324066403|FG001|Overall Study|Withdrawal by Subject|11|||
94618727|NCT00679432|324066404|FG002|Overall Study|Withdrawal by Subject|10|||
94618728|NCT00679432|324066405|FG003|Overall Study|Withdrawal by Subject|9|||
94618729|NCT00679432|324066402|FG000|Overall Study|Lost to Follow-up|1|||
94618730|NCT00679432|324066403|FG001|Overall Study|Lost to Follow-up|5|||
94618731|NCT00679432|324066404|FG002|Overall Study|Lost to Follow-up|4|||
94618732|NCT00679432|324066405|FG003|Overall Study|Lost to Follow-up|2|||
94618733|NCT00679432|324066402|FG000|Overall Study|Physician Decision|3|||
94618734|NCT00679432|324066403|FG001|Overall Study|Physician Decision|2|||
94618735|NCT00679432|324066404|FG002|Overall Study|Physician Decision|2|||
94618736|NCT00679432|324066405|FG003|Overall Study|Physician Decision|2|||
94618737|NCT00679432|324066402|FG000|Overall Study|Sponsor decision|1|||
94618738|NCT00679432|324066403|FG001|Overall Study|Sponsor decision|0|||
94618739|NCT00679432|324066404|FG002|Overall Study|Sponsor decision|0|||
94618740|NCT00679432|324066405|FG003|Overall Study|Sponsor decision|0|||
94618741|NCT00679432|324066402|FG000|Overall Study|Lack of Efficacy|13|||
94618742|NCT00679432|324066403|FG001|Overall Study|Lack of Efficacy|9|||
94618743|NCT00679432|324066404|FG002|Overall Study|Lack of Efficacy|14|||
94618744|NCT00679432|324066405|FG003|Overall Study|Lack of Efficacy|8|||
94618745|NCT00679432|324066402|FG000|Overall Study|Infectious colitis, normal histology|5|||
94618746|NCT00679432|324066403|FG001|Overall Study|Infectious colitis, normal histology|4|||
94618747|NCT00679432|324066404|FG002|Overall Study|Infectious colitis, normal histology|8|||
94618748|NCT00679432|324066405|FG003|Overall Study|Infectious colitis, normal histology|3|||
94618749|NCT00679432|324066402|FG000|Overall Study|Randomization error, return to prior Rx|0|||
94618750|NCT00679432|324066403|FG001|Overall Study|Randomization error, return to prior Rx|0|||
94618751|NCT00679432|324066404|FG002|Overall Study|Randomization error, return to prior Rx|3|||
94618752|NCT00679432|324066405|FG003|Overall Study|Randomization error, return to prior Rx|0|||
94618753|NCT02639065|324066406|FG000|Study Treatment|Disease Progression|13|||
94618754|NCT02639065|324066406|FG000|Study Treatment|Adverse Event|9|||
94618755|NCT02639065|324066406|FG000|Study Treatment|Withdrawal by Subject|1|||
94618756|NCT02639065|324066406|FG000|Follow up|Subject refused to follow up|1|||
94618757|NCT02639065|324066406|FG000|Follow up|Symptomatic Deterioration|2|||
94618758|NCT02639065|324066406|FG000|Follow up|Death|2|||
94618759|NCT02639065|324066406|FG000|Follow up|Study Terminated|1|||
94618760|NCT02639065|324066406|FG000|Follow up|Disease Progression|3|||
94618761|NCT00824720|324066407|FG000|Overall Study|failed plug insertion|3|||
94618762|NCT00824720|324066408|FG001|Overall Study|failed plug insertion|1|||
94618763|NCT00824720|324066409|FG002|Overall Study|failed plug insertion|0|||
94618764|NCT00824720|324066407|FG000|Overall Study|Protocol Violation|0|||
94618765|NCT00824720|324066408|FG001|Overall Study|Protocol Violation|0|||
94618766|NCT00824720|324066409|FG002|Overall Study|Protocol Violation|1|||
94618767|NCT00873015|324066411|FG000|Overall Study|Withdrawal by Subject|0|||
94618768|NCT00873015|324066412|FG001|Overall Study|Withdrawal by Subject|1|||
94618769|NCT00873015|324066413|FG002|Overall Study|Withdrawal by Subject|0|||
94618770|NCT00873015|324066414|FG003|Overall Study|Withdrawal by Subject|0|||
94618771|NCT00345839|324066415|FG000|Overall Study|Withdrawal by Subject|91|||
94618772|NCT00345839|324066416|FG001|Overall Study|Withdrawal by Subject|98|||
94618773|NCT00345839|324066415|FG000|Overall Study|Lost to Follow-up|58|||
94618774|NCT00345839|324066416|FG001|Overall Study|Lost to Follow-up|61|||
94618775|NCT00826943|324066422|FG000|Overall Study|Withdrawal by Subject|0|||
94618776|NCT00826943|324066423|FG001|Overall Study|Withdrawal by Subject|0|||
94618777|NCT00826943|324066424|FG002|Overall Study|Withdrawal by Subject|0|||
94618778|NCT00826943|324066425|FG003|Overall Study|Withdrawal by Subject|0|||
94618779|NCT00826943|324066426|FG004|Overall Study|Withdrawal by Subject|1|||
94618780|NCT00826943|324066427|FG005|Overall Study|Withdrawal by Subject|0|||
94618781|NCT01995825|324068070|FG000|Overall Study|Withdrawal by Subject|1|||
94618782|NCT01995825|324068071|FG001|Overall Study|Withdrawal by Subject|0|||
94618783|NCT00217620|324068076|FG000|Overall Study|Adverse Event|2|||
94618784|NCT00217620|324068076|FG000|Overall Study|Progression|31|||
94618785|NCT00217620|324068076|FG000|Overall Study|Not Protocol Specified|4|||
94618786|NCT00217620|324068076|FG000|Overall Study|Ineligible|13|||
94618787|NCT00217620|324068076|FG000|Overall Study|Never received treatment|1|||
94618788|NCT04092582|324068081|FG000|Overall Study|Death|1|||
94618789|NCT04092582|324068082|FG001|Overall Study|Death|1|||
94618790|NCT04092582|324068081|FG000|Overall Study|Withdrawal by Subject|4|||
94618791|NCT04092582|324068082|FG001|Overall Study|Withdrawal by Subject|1|||
94254712|NCT00321373|322726355|FG001|Overall Study|Adverse Event|0|||
94254713|NCT00321373|322726356|FG002|Overall Study|Adverse Event|1|||
94254714|NCT00321373|322726354|FG000|Overall Study|Lost to Follow-up|1|||
94618792|NCT04092582|324068081|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
94618793|NCT04092582|324068082|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
94618794|NCT00560105|324068085|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
94618795|NCT00560105|324068086|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
94618796|NCT02280304|324068087|FG000|Overall Study|Lost to Follow-up|7|||
94618797|NCT02280304|324068088|FG001|Overall Study|Lost to Follow-up|8|||
94618798|NCT01606800|324068089|FG000|Overall Study|Adverse Event|3|||
94618799|NCT01606800|324068090|FG001|Overall Study|Adverse Event|1|||
94618800|NCT01606800|324068089|FG000|Overall Study|Participant withdrew consent|0|||
94618801|NCT01606800|324068090|FG001|Overall Study|Participant withdrew consent|1|||
94618802|NCT01606800|324068089|FG000|Overall Study|Missing completion status|2|||
94254715|NCT00321373|322726355|FG001|Overall Study|Lost to Follow-up|0|||
94618803|NCT01606800|324068090|FG001|Overall Study|Missing completion status|0|||
94618804|NCT00042289|324068091|FG000|Overall Study|Lost to Follow-up|3|||
94618805|NCT00042289|324068092|FG001|Overall Study|Lost to Follow-up|0|||
94618806|NCT00042289|324068093|FG002|Overall Study|Lost to Follow-up|0|||
94618807|NCT00042289|324068094|FG003|Overall Study|Lost to Follow-up|1|||
94618808|NCT00042289|324068095|FG004|Overall Study|Lost to Follow-up|3|||
94618809|NCT00042289|324068096|FG005|Overall Study|Lost to Follow-up|3|||
94618810|NCT00042289|324068097|FG006|Overall Study|Lost to Follow-up|6|||
94618811|NCT00042289|324068098|FG007|Overall Study|Lost to Follow-up|1|||
94618812|NCT00042289|324068099|FG008|Overall Study|Lost to Follow-up|1|||
94618813|NCT00042289|324068100|FG009|Overall Study|Lost to Follow-up|0|||
94618814|NCT00042289|324068101|FG010|Overall Study|Lost to Follow-up|0|||
94618815|NCT00042289|324068102|FG011|Overall Study|Lost to Follow-up|0|||
94618816|NCT00042289|324068103|FG012|Overall Study|Lost to Follow-up|0|||
94618817|NCT00042289|324068104|FG013|Overall Study|Lost to Follow-up|0|||
94618818|NCT00042289|324068105|FG014|Overall Study|Lost to Follow-up|0|||
94618819|NCT00042289|324068106|FG015|Overall Study|Lost to Follow-up|1|||
94618820|NCT00042289|324068107|FG016|Overall Study|Lost to Follow-up|1|||
94618821|NCT00042289|324068108|FG017|Overall Study|Lost to Follow-up|0|||
94618822|NCT00042289|324068109|FG018|Overall Study|Lost to Follow-up|3|||
94618823|NCT00042289|324068110|FG019|Overall Study|Lost to Follow-up|2|||
94618824|NCT00042289|324068111|FG020|Overall Study|Lost to Follow-up|0|||
94618825|NCT00042289|324068112|FG021|Overall Study|Lost to Follow-up|0|||
94618826|NCT00042289|324068113|FG022|Overall Study|Lost to Follow-up|0|||
94618827|NCT00042289|324068114|FG023|Overall Study|Lost to Follow-up|0|||
94618828|NCT00042289|324068115|FG024|Overall Study|Lost to Follow-up|0|||
94618829|NCT00042289|324068116|FG025|Overall Study|Lost to Follow-up|0|||
94618830|NCT00042289|324068117|FG026|Overall Study|Lost to Follow-up|2|||
94618831|NCT00042289|324068118|FG027|Overall Study|Lost to Follow-up|2|||
94618832|NCT00042289|324068119|FG028|Overall Study|Lost to Follow-up|2|||
94618833|NCT00042289|324068120|FG029|Overall Study|Lost to Follow-up|0|||
94618834|NCT00042289|324068121|FG030|Overall Study|Lost to Follow-up|0|||
94618835|NCT00042289|324068122|FG031|Overall Study|Lost to Follow-up|2|||
94618836|NCT00042289|324068123|FG032|Overall Study|Lost to Follow-up|1|||
94618837|NCT00042289|324068124|FG033|Overall Study|Lost to Follow-up|1|||
94618838|NCT00042289|324068125|FG034|Overall Study|Lost to Follow-up|1|||
94618839|NCT00042289|324068126|FG035|Overall Study|Lost to Follow-up|2|||
94618840|NCT00042289|324068127|FG036|Overall Study|Lost to Follow-up|1|||
94618841|NCT00042289|324068128|FG037|Overall Study|Lost to Follow-up|1|||
94618842|NCT00042289|324068129|FG038|Overall Study|Lost to Follow-up|0|||
94618843|NCT00042289|324068130|FG039|Overall Study|Lost to Follow-up|5|||
94618844|NCT00042289|324068131|FG040|Overall Study|Lost to Follow-up|0|||
94618845|NCT00042289|324068132|FG041|Overall Study|Lost to Follow-up|2|||
94618846|NCT00042289|324068133|FG042|Overall Study|Lost to Follow-up|2|||
94618847|NCT00042289|324068134|FG043|Overall Study|Lost to Follow-up|0|||
94618848|NCT00042289|324068135|FG044|Overall Study|Lost to Follow-up|0|||
94618849|NCT00042289|324068136|FG045|Overall Study|Lost to Follow-up|1|||
94618850|NCT00042289|324068137|FG046|Overall Study|Lost to Follow-up|0|||
94618851|NCT00042289|324068091|FG000|Overall Study|Other reason|0|||
94618852|NCT00042289|324068092|FG001|Overall Study|Other reason|0|||
94618853|NCT00042289|324068093|FG002|Overall Study|Other reason|0|||
94618854|NCT00042289|324068094|FG003|Overall Study|Other reason|2|||
94618855|NCT00042289|324068095|FG004|Overall Study|Other reason|0|||
94461148|NCT02730377|323478188|FG001|Overall Study|Lost to Follow-up|21|||
94618856|NCT00042289|324068096|FG005|Overall Study|Other reason|0|||
94618857|NCT00042289|324068097|FG006|Overall Study|Other reason|0|||
94618858|NCT00042289|324068098|FG007|Overall Study|Other reason|0|||
94618859|NCT00042289|324068099|FG008|Overall Study|Other reason|0|||
94618860|NCT00042289|324068100|FG009|Overall Study|Other reason|0|||
94618861|NCT00042289|324068101|FG010|Overall Study|Other reason|0|||
94618862|NCT00042289|324068102|FG011|Overall Study|Other reason|0|||
94618863|NCT00042289|324068103|FG012|Overall Study|Other reason|0|||
94618864|NCT00042289|324068104|FG013|Overall Study|Other reason|0|||
94618865|NCT00042289|324068105|FG014|Overall Study|Other reason|0|||
94618866|NCT00042289|324068106|FG015|Overall Study|Other reason|0|||
94618867|NCT00042289|324068107|FG016|Overall Study|Other reason|0|||
94618868|NCT00042289|324068108|FG017|Overall Study|Other reason|0|||
94618869|NCT00042289|324068109|FG018|Overall Study|Other reason|1|||
94618870|NCT00042289|324068110|FG019|Overall Study|Other reason|0|||
94618871|NCT00042289|324068111|FG020|Overall Study|Other reason|0|||
94618872|NCT00042289|324068112|FG021|Overall Study|Other reason|0|||
94618873|NCT00042289|324068113|FG022|Overall Study|Other reason|0|||
94618874|NCT00042289|324068114|FG023|Overall Study|Other reason|1|||
94461149|NCT01869699|323478201|FG000|Overall Study|Withdrawal by Subject|1|||
94618875|NCT00042289|324068115|FG024|Overall Study|Other reason|0|||
94618876|NCT00042289|324068116|FG025|Overall Study|Other reason|0|||
94618877|NCT00042289|324068117|FG026|Overall Study|Other reason|1|||
94618878|NCT00042289|324068118|FG027|Overall Study|Other reason|0|||
94618879|NCT00042289|324068119|FG028|Overall Study|Other reason|3|||
94618880|NCT00042289|324068120|FG029|Overall Study|Other reason|0|||
94618881|NCT00042289|324068121|FG030|Overall Study|Other reason|0|||
94618882|NCT00042289|324068122|FG031|Overall Study|Other reason|1|||
94618883|NCT00042289|324068123|FG032|Overall Study|Other reason|0|||
94666754|NCT01217073|324232732|FG001|Extension Period|Site discontinued study participation|0|||
94666755|NCT01217073|324232733|FG002|Extension Period|Site discontinued study participation|0|||
94666756|NCT01217073|324232734|FG003|Extension Period|Site discontinued study participation|0|||
94666757|NCT01217073|324232735|FG004|Extension Period|Site discontinued study participation|0|||
94666758|NCT01217073|324232736|FG005|Extension Period|Site discontinued study participation|0|||
94666759|NCT01217073|324232737|FG006|Extension Period|Site discontinued study participation|7|||
94666760|NCT01217073|324232738|FG007|Extension Period|Site discontinued study participation|2|||
94666761|NCT01217073|324232731|FG000|Extension Period|Withdrawal by Subject|0|||
94666762|NCT01217073|324232732|FG001|Extension Period|Withdrawal by Subject|0|||
94666763|NCT01217073|324232733|FG002|Extension Period|Withdrawal by Subject|0|||
94666764|NCT01217073|324232734|FG003|Extension Period|Withdrawal by Subject|0|||
94666765|NCT01217073|324232735|FG004|Extension Period|Withdrawal by Subject|0|||
94666766|NCT01217073|324232736|FG005|Extension Period|Withdrawal by Subject|0|||
94666767|NCT01217073|324232737|FG006|Extension Period|Withdrawal by Subject|30|||
94666768|NCT01217073|324232738|FG007|Extension Period|Withdrawal by Subject|8|||
94666769|NCT02502266|324232739|FG000|Overall Study|Adverse Event|0|||
94666770|NCT02502266|324232740|FG001|Overall Study|Adverse Event|0|||
94666771|NCT02502266|324232741|FG002|Overall Study|Adverse Event|0|||
94666772|NCT02502266|324232742|FG003|Overall Study|Adverse Event|0|||
94666773|NCT02502266|324232743|FG004|Overall Study|Adverse Event|1|||
94666774|NCT02502266|324232744|FG005|Overall Study|Adverse Event|1|||
94666775|NCT02502266|324232745|FG006|Overall Study|Adverse Event|1|||
94666776|NCT02502266|324232739|FG000|Overall Study|Withdrawal by Subject|30|||
94666777|NCT02502266|324232740|FG001|Overall Study|Withdrawal by Subject|15|||
94666778|NCT02502266|324232741|FG002|Overall Study|Withdrawal by Subject|16|||
94666779|NCT02502266|324232742|FG003|Overall Study|Withdrawal by Subject|0|||
94666780|NCT02502266|324232743|FG004|Overall Study|Withdrawal by Subject|0|||
94666781|NCT02502266|324232744|FG005|Overall Study|Withdrawal by Subject|0|||
94666782|NCT02502266|324232745|FG006|Overall Study|Withdrawal by Subject|0|||
94666783|NCT02502266|324232739|FG000|Overall Study|Still on Treatment|0|||
94666784|NCT02502266|324232740|FG001|Overall Study|Still on Treatment|0|||
94666785|NCT02502266|324232741|FG002|Overall Study|Still on Treatment|1|||
94666786|NCT02502266|324232742|FG003|Overall Study|Still on Treatment|0|||
94666787|NCT02502266|324232743|FG004|Overall Study|Still on Treatment|0|||
94666788|NCT02502266|324232744|FG005|Overall Study|Still on Treatment|0|||
94666789|NCT02502266|324232745|FG006|Overall Study|Still on Treatment|0|||
94666790|NCT02502266|324232739|FG000|Overall Study|Other Reasons|19|||
94666791|NCT02502266|324232740|FG001|Overall Study|Other Reasons|6|||
94666792|NCT02502266|324232741|FG002|Overall Study|Other Reasons|14|||
94666793|NCT02502266|324232742|FG003|Overall Study|Other Reasons|0|||
94666794|NCT02502266|324232743|FG004|Overall Study|Other Reasons|1|||
94666795|NCT02502266|324232744|FG005|Overall Study|Other Reasons|1|||
94666796|NCT02502266|324232745|FG006|Overall Study|Other Reasons|0|||
94666797|NCT02502266|324232739|FG000|Overall Study|Arm 4 Discontinued|0|||
94666798|NCT02502266|324232740|FG001|Overall Study|Arm 4 Discontinued|0|||
94666799|NCT02502266|324232741|FG002|Overall Study|Arm 4 Discontinued|0|||
94666800|NCT02502266|324232742|FG003|Overall Study|Arm 4 Discontinued|52|||
94666801|NCT02502266|324232743|FG004|Overall Study|Arm 4 Discontinued|0|||
94666802|NCT02502266|324232744|FG005|Overall Study|Arm 4 Discontinued|0|||
94666803|NCT02502266|324232745|FG006|Overall Study|Arm 4 Discontinued|0|||
94666804|NCT02502266|324232739|FG000|Overall Study|Never treated|0|||
94666805|NCT02502266|324232740|FG001|Overall Study|Never treated|0|||
94666806|NCT02502266|324232741|FG002|Overall Study|Never treated|0|||
94666807|NCT02502266|324232742|FG003|Overall Study|Never treated|0|||
94666808|NCT02502266|324232743|FG004|Overall Study|Never treated|0|||
94666809|NCT02502266|324232744|FG005|Overall Study|Never treated|1|||
94666810|NCT02502266|324232745|FG006|Overall Study|Never treated|0|||
94666811|NCT04862143|324232746|FG000|Overall Study|Adverse Event|1|||
94666812|NCT04862143|324232746|FG000|Overall Study|Study terminated by sponsor|1|||
94254716|NCT00321373|322726356|FG002|Overall Study|Lost to Follow-up|1|||
94254717|NCT00321373|322726354|FG000|Overall Study|Withdrawal by Subject|1|||
94254718|NCT00321373|322726355|FG001|Overall Study|Withdrawal by Subject|0|||
94254719|NCT00321373|322726356|FG002|Overall Study|Withdrawal by Subject|0|||
94666813|NCT03117738|324232747|FG000|Overall Study|Withdrawal by Subject|3|||
94666814|NCT03117738|324232748|FG001|Overall Study|Withdrawal by Subject|1|||
94666815|NCT03117738|324232747|FG000|Overall Study|Lost to Follow-up|1|||
94254720|NCT00321373|322726354|FG000|Overall Study|Other|0|||
94666816|NCT03117738|324232748|FG001|Overall Study|Lost to Follow-up|4|||
94666817|NCT04420689|324232749|FG000|Overall Study|COVID-19 related hospitalization|0|||
94666818|NCT04420689|324232750|FG001|Overall Study|COVID-19 related hospitalization|0|||
94666819|NCT04420689|324232751|FG002|Overall Study|COVID-19 related hospitalization|0|||
94666820|NCT04420689|324232752|FG003|Overall Study|COVID-19 related hospitalization|0|||
94666821|NCT04420689|324232753|FG004|Overall Study|COVID-19 related hospitalization|1|||
94666822|NCT04420689|324232754|FG005|Overall Study|COVID-19 related hospitalization|0|||
94666823|NCT04420689|324232755|FG006|Overall Study|COVID-19 related hospitalization|0|||
94254721|NCT00321373|322726355|FG001|Overall Study|Other|0|||
94666824|NCT04420689|324232749|FG000|Overall Study|Physician Decision|0|||
94666825|NCT04420689|324232750|FG001|Overall Study|Physician Decision|0|||
94666826|NCT04420689|324232751|FG002|Overall Study|Physician Decision|0|||
94666827|NCT04420689|324232752|FG003|Overall Study|Physician Decision|0|||
94666828|NCT04420689|324232753|FG004|Overall Study|Physician Decision|0|||
94666829|NCT04420689|324232754|FG005|Overall Study|Physician Decision|1|||
94666830|NCT04420689|324232755|FG006|Overall Study|Physician Decision|0|||
94666831|NCT00868439|324232757|FG000|Overall Study|Adverse Event|4|||
94666832|NCT00868439|324232758|FG001|Overall Study|Adverse Event|3|||
94666833|NCT00868439|324232757|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
94666834|NCT00868439|324232758|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
94666835|NCT00868439|324232757|FG000|Overall Study|Death|0|||
94666836|NCT00868439|324232758|FG001|Overall Study|Death|1|||
94666837|NCT00868439|324232757|FG000|Overall Study|Protocol Violation|1|||
94666838|NCT00868439|324232758|FG001|Overall Study|Protocol Violation|1|||
94666839|NCT00868439|324232757|FG000|Overall Study|Physician Decision|1|||
94666840|NCT00868439|324232758|FG001|Overall Study|Physician Decision|0|||
94666841|NCT00868439|324232757|FG000|Overall Study|Withdrawal by Subject|0|||
94666842|NCT00868439|324232758|FG001|Overall Study|Withdrawal by Subject|1|||
94666843|NCT05545072|324232763|FG000|Overall Study|Lost to Follow-up|1|||
94666844|NCT05545072|324232764|FG001|Overall Study|Lost to Follow-up|0|||
94666845|NCT05545072|324232763|FG000|Overall Study|Study ended prematurely due to funding|2|||
94666846|NCT05545072|324232764|FG001|Overall Study|Study ended prematurely due to funding|2|||
94666847|NCT01933932|324232765|FG000|Overall Study|Death|173|||
94666848|NCT01933932|324232766|FG001|Overall Study|Death|163|||
94666849|NCT01933932|324232765|FG000|Overall Study|Withdrawal by Subject|11|||
94666850|NCT01933932|324232766|FG001|Overall Study|Withdrawal by Subject|14|||
94666851|NCT01933932|324232765|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
94666852|NCT01933932|324232766|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
94666853|NCT04642638|324232769|FG000|Overall Study|Withdrawal by Subject|23|||
94666854|NCT04642638|324232770|FG001|Overall Study|Withdrawal by Subject|29|||
94666855|NCT04642638|324232771|FG002|Overall Study|Withdrawal by Subject|9|||
94666856|NCT04642638|324232772|FG003|Overall Study|Withdrawal by Subject|7|||
94666857|NCT04642638|324232773|FG004|Overall Study|Withdrawal by Subject|61|||
94666858|NCT04642638|324232774|FG005|Overall Study|Withdrawal by Subject|27|||
94666859|NCT04642638|324232769|FG000|Overall Study|Lost to Follow-up|17|||
94666860|NCT04642638|324232770|FG001|Overall Study|Lost to Follow-up|18|||
94666861|NCT04642638|324232771|FG002|Overall Study|Lost to Follow-up|5|||
94666862|NCT04642638|324232772|FG003|Overall Study|Lost to Follow-up|5|||
94666863|NCT04642638|324232773|FG004|Overall Study|Lost to Follow-up|6|||
94666864|NCT04642638|324232774|FG005|Overall Study|Lost to Follow-up|3|||
94666865|NCT04642638|324232769|FG000|Overall Study|Adverse Event|0|||
94666866|NCT04642638|324232770|FG001|Overall Study|Adverse Event|0|||
94666867|NCT04642638|324232771|FG002|Overall Study|Adverse Event|1|||
94666868|NCT04642638|324232772|FG003|Overall Study|Adverse Event|0|||
94666869|NCT04642638|324232773|FG004|Overall Study|Adverse Event|10|||
94666870|NCT04642638|324232774|FG005|Overall Study|Adverse Event|3|||
94666871|NCT04642638|324232769|FG000|Overall Study|Reason Not Specified|1|||
94666872|NCT04642638|324232770|FG001|Overall Study|Reason Not Specified|4|||
94666873|NCT04642638|324232771|FG002|Overall Study|Reason Not Specified|0|||
94666874|NCT04642638|324232772|FG003|Overall Study|Reason Not Specified|0|||
94666875|NCT04642638|324232773|FG004|Overall Study|Reason Not Specified|38|||
94666876|NCT04642638|324232774|FG005|Overall Study|Reason Not Specified|16|||
94666877|NCT04642638|324232769|FG000|Overall Study|Physician Decision|0|||
94666878|NCT04642638|324232770|FG001|Overall Study|Physician Decision|0|||
94666879|NCT04642638|324232771|FG002|Overall Study|Physician Decision|0|||
94666880|NCT04642638|324232772|FG003|Overall Study|Physician Decision|0|||
94666881|NCT04642638|324232773|FG004|Overall Study|Physician Decision|2|||
94666882|NCT04642638|324232774|FG005|Overall Study|Physician Decision|1|||
94666883|NCT04642638|324232769|FG000|Overall Study|Protocol Deviation|0|||
94666884|NCT04642638|324232770|FG001|Overall Study|Protocol Deviation|0|||
94666885|NCT04642638|324232771|FG002|Overall Study|Protocol Deviation|0|||
94666886|NCT04642638|324232772|FG003|Overall Study|Protocol Deviation|0|||
94666887|NCT04642638|324232773|FG004|Overall Study|Protocol Deviation|1|||
94666888|NCT04642638|324232774|FG005|Overall Study|Protocol Deviation|3|||
94666889|NCT04642638|324232769|FG000|Overall Study|Study Terminated|0|||
94666890|NCT04642638|324232770|FG001|Overall Study|Study Terminated|0|||
94666891|NCT04642638|324232771|FG002|Overall Study|Study Terminated|0|||
94666892|NCT04642638|324232772|FG003|Overall Study|Study Terminated|0|||
94666893|NCT04642638|324232773|FG004|Overall Study|Study Terminated|484|||
94666894|NCT04642638|324232774|FG005|Overall Study|Study Terminated|250|||
94666895|NCT04642638|324232769|FG000|Overall Study|Pregnancy|0|||
94666896|NCT04642638|324232770|FG001|Overall Study|Pregnancy|0|||
94666897|NCT04642638|324232771|FG002|Overall Study|Pregnancy|0|||
94666898|NCT04642638|324232772|FG003|Overall Study|Pregnancy|0|||
94666899|NCT04642638|324232773|FG004|Overall Study|Pregnancy|1|||
94666900|NCT04642638|324232774|FG005|Overall Study|Pregnancy|0|||
94666901|NCT00511004|324232775|FG000|Overall Study|Lost to Follow-up|0|||
94666902|NCT00511004|324232776|FG001|Overall Study|Lost to Follow-up|0|||
94666903|NCT00511004|324232777|FG002|Overall Study|Lost to Follow-up|4|||
94254722|NCT00321373|322726356|FG002|Overall Study|Other|1|||
94254723|NCT01498679|322726357|FG000|Overall Study|Adverse Event|1|||
94254724|NCT01498679|322726358|FG001|Overall Study|Adverse Event|4|||
94254725|NCT01498679|322726357|FG000|Overall Study|Lack of Efficacy|72|||
94254726|NCT01498679|322726358|FG001|Overall Study|Lack of Efficacy|12|||
94618884|NCT00042289|324068124|FG033|Overall Study|Other reason|1|||
94618885|NCT00042289|324068125|FG034|Overall Study|Other reason|0|||
94618886|NCT00042289|324068126|FG035|Overall Study|Other reason|2|||
94618887|NCT00042289|324068127|FG036|Overall Study|Other reason|0|||
94618888|NCT00042289|324068128|FG037|Overall Study|Other reason|0|||
94618889|NCT00042289|324068129|FG038|Overall Study|Other reason|0|||
94618890|NCT00042289|324068130|FG039|Overall Study|Other reason|0|||
94618891|NCT00042289|324068131|FG040|Overall Study|Other reason|0|||
94618892|NCT00042289|324068132|FG041|Overall Study|Other reason|0|||
94618893|NCT00042289|324068133|FG042|Overall Study|Other reason|0|||
94618894|NCT00042289|324068134|FG043|Overall Study|Other reason|1|||
94618895|NCT00042289|324068135|FG044|Overall Study|Other reason|0|||
94618896|NCT00042289|324068136|FG045|Overall Study|Other reason|0|||
94618897|NCT00042289|324068137|FG046|Overall Study|Other reason|0|||
94618898|NCT00042289|324068091|FG000|Overall Study|Severe debilitation, unable to continue|0|||
94618899|NCT00042289|324068092|FG001|Overall Study|Severe debilitation, unable to continue|0|||
94618900|NCT00042289|324068093|FG002|Overall Study|Severe debilitation, unable to continue|0|||
94618901|NCT00042289|324068094|FG003|Overall Study|Severe debilitation, unable to continue|0|||
94618902|NCT00042289|324068095|FG004|Overall Study|Severe debilitation, unable to continue|0|||
94618903|NCT00042289|324068096|FG005|Overall Study|Severe debilitation, unable to continue|0|||
94618904|NCT00042289|324068097|FG006|Overall Study|Severe debilitation, unable to continue|0|||
94618905|NCT00042289|324068098|FG007|Overall Study|Severe debilitation, unable to continue|0|||
94618906|NCT00042289|324068099|FG008|Overall Study|Severe debilitation, unable to continue|0|||
94618907|NCT00042289|324068100|FG009|Overall Study|Severe debilitation, unable to continue|0|||
94618908|NCT00042289|324068101|FG010|Overall Study|Severe debilitation, unable to continue|0|||
94618909|NCT00042289|324068102|FG011|Overall Study|Severe debilitation, unable to continue|0|||
94618910|NCT00042289|324068103|FG012|Overall Study|Severe debilitation, unable to continue|0|||
94618911|NCT00042289|324068104|FG013|Overall Study|Severe debilitation, unable to continue|0|||
94618912|NCT00042289|324068105|FG014|Overall Study|Severe debilitation, unable to continue|0|||
94618913|NCT00042289|324068106|FG015|Overall Study|Severe debilitation, unable to continue|0|||
94618914|NCT00042289|324068107|FG016|Overall Study|Severe debilitation, unable to continue|0|||
94618915|NCT00042289|324068108|FG017|Overall Study|Severe debilitation, unable to continue|0|||
94618916|NCT00042289|324068109|FG018|Overall Study|Severe debilitation, unable to continue|0|||
94618917|NCT00042289|324068110|FG019|Overall Study|Severe debilitation, unable to continue|0|||
94618918|NCT00042289|324068111|FG020|Overall Study|Severe debilitation, unable to continue|0|||
94618919|NCT00042289|324068112|FG021|Overall Study|Severe debilitation, unable to continue|1|||
94618920|NCT00042289|324068113|FG022|Overall Study|Severe debilitation, unable to continue|0|||
94618921|NCT00042289|324068114|FG023|Overall Study|Severe debilitation, unable to continue|1|||
94618922|NCT00042289|324068115|FG024|Overall Study|Severe debilitation, unable to continue|0|||
94618923|NCT00042289|324068116|FG025|Overall Study|Severe debilitation, unable to continue|0|||
94618924|NCT00042289|324068117|FG026|Overall Study|Severe debilitation, unable to continue|0|||
94618925|NCT00042289|324068118|FG027|Overall Study|Severe debilitation, unable to continue|1|||
94618926|NCT00042289|324068119|FG028|Overall Study|Severe debilitation, unable to continue|0|||
94618927|NCT00042289|324068120|FG029|Overall Study|Severe debilitation, unable to continue|0|||
94618928|NCT00042289|324068121|FG030|Overall Study|Severe debilitation, unable to continue|0|||
94618929|NCT00042289|324068122|FG031|Overall Study|Severe debilitation, unable to continue|1|||
94618930|NCT00042289|324068123|FG032|Overall Study|Severe debilitation, unable to continue|1|||
94618931|NCT00042289|324068124|FG033|Overall Study|Severe debilitation, unable to continue|0|||
94618932|NCT00042289|324068125|FG034|Overall Study|Severe debilitation, unable to continue|0|||
94618933|NCT00042289|324068126|FG035|Overall Study|Severe debilitation, unable to continue|0|||
94618934|NCT00042289|324068127|FG036|Overall Study|Severe debilitation, unable to continue|0|||
94666904|NCT00990652|324232778|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
94254727|NCT01498679|322726357|FG000|Overall Study|Protocol Violation|4|||
94254728|NCT01498679|322726358|FG001|Overall Study|Protocol Violation|0|||
94618935|NCT00042289|324068128|FG037|Overall Study|Severe debilitation, unable to continue|0|||
94618936|NCT00042289|324068129|FG038|Overall Study|Severe debilitation, unable to continue|0|||
94618937|NCT00042289|324068130|FG039|Overall Study|Severe debilitation, unable to continue|0|||
94618938|NCT00042289|324068131|FG040|Overall Study|Severe debilitation, unable to continue|0|||
94618939|NCT00042289|324068132|FG041|Overall Study|Severe debilitation, unable to continue|0|||
94618940|NCT00042289|324068133|FG042|Overall Study|Severe debilitation, unable to continue|0|||
94666905|NCT00990652|324232778|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
94618941|NCT00042289|324068134|FG043|Overall Study|Severe debilitation, unable to continue|0|||
94618942|NCT00042289|324068135|FG044|Overall Study|Severe debilitation, unable to continue|0|||
94666906|NCT06390839|324232779|FG000|Overall Study|Ineligible|2|||
94254729|NCT01498679|322726357|FG000|Overall Study|Physician Decision|0|||
94358998|NCT03733301|323098037|FG000|Overall Study|Withdrawal by Subject|3|||
94358999|NCT03733301|323098038|FG001|Overall Study|Withdrawal by Subject|5|||
94359000|NCT03733301|323098039|FG002|Overall Study|Withdrawal by Subject|1|||
94359001|NCT04764669|323098042|FG000|Overall Study|Adverse Event|1|||
94359002|NCT04764669|323098043|FG001|Overall Study|Adverse Event|0|||
94359003|NCT04764669|323098044|FG002|Overall Study|Adverse Event|1|||
94359004|NCT04764669|323098045|FG003|Overall Study|Adverse Event|0|||
94359005|NCT04764669|323098042|FG000|Overall Study|Subject Choice|0|||
94359006|NCT04764669|323098043|FG001|Overall Study|Subject Choice|0|||
94359007|NCT04764669|323098044|FG002|Overall Study|Subject Choice|1|||
94359008|NCT04764669|323098045|FG003|Overall Study|Subject Choice|0|||
94359009|NCT04764669|323098042|FG000|Overall Study|Withdrawal by Subject|2|||
94359010|NCT04764669|323098043|FG001|Overall Study|Withdrawal by Subject|0|||
94359011|NCT04764669|323098044|FG002|Overall Study|Withdrawal by Subject|0|||
94359012|NCT04764669|323098045|FG003|Overall Study|Withdrawal by Subject|0|||
94359013|NCT04585906|323098046|FG000|Overall Study|Lost to Follow-up|8|||
94359014|NCT04585906|323098047|FG001|Overall Study|Lost to Follow-up|5|||
94359015|NCT03697109|323098048|FG000|Open-label (OL) Phase|Adverse Event|24|||
94359016|NCT03697109|323098049|FG001|Open-label (OL) Phase|Adverse Event|0|||
94359017|NCT03697109|323098050|FG002|Open-label (OL) Phase|Adverse Event|0|||
94359018|NCT03697109|323098048|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
94359019|NCT03697109|323098049|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
94359020|NCT03697109|323098050|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
94359021|NCT03697109|323098048|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
94359022|NCT03697109|323098049|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
94359023|NCT03697109|323098050|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
94359024|NCT03697109|323098048|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
94359025|NCT03697109|323098049|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
94359026|NCT03697109|323098050|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
94359027|NCT03697109|323098048|FG000|Open-label (OL) Phase|Physician Decision|2|||
94461150|NCT01869699|323478202|FG001|Overall Study|Withdrawal by Subject|0|||
94618943|NCT00042289|324068136|FG045|Overall Study|Severe debilitation, unable to continue|0|||
94618944|NCT00042289|324068137|FG046|Overall Study|Severe debilitation, unable to continue|0|||
94618945|NCT00042289|324068091|FG000|Overall Study|Site closed|0|||
94618946|NCT00042289|324068092|FG001|Overall Study|Site closed|0|||
94618947|NCT00042289|324068093|FG002|Overall Study|Site closed|0|||
94618948|NCT00042289|324068094|FG003|Overall Study|Site closed|0|||
94618949|NCT00042289|324068095|FG004|Overall Study|Site closed|0|||
94618950|NCT00042289|324068096|FG005|Overall Study|Site closed|0|||
94618951|NCT00042289|324068097|FG006|Overall Study|Site closed|0|||
94618952|NCT00042289|324068098|FG007|Overall Study|Site closed|0|||
94618953|NCT00042289|324068099|FG008|Overall Study|Site closed|0|||
94618954|NCT00042289|324068100|FG009|Overall Study|Site closed|0|||
94618955|NCT00042289|324068101|FG010|Overall Study|Site closed|0|||
94618956|NCT00042289|324068102|FG011|Overall Study|Site closed|0|||
94618957|NCT00042289|324068103|FG012|Overall Study|Site closed|0|||
94618958|NCT00042289|324068104|FG013|Overall Study|Site closed|0|||
94618959|NCT00042289|324068105|FG014|Overall Study|Site closed|0|||
94618960|NCT00042289|324068106|FG015|Overall Study|Site closed|0|||
94618961|NCT00042289|324068107|FG016|Overall Study|Site closed|0|||
94618962|NCT00042289|324068108|FG017|Overall Study|Site closed|0|||
94618963|NCT00042289|324068109|FG018|Overall Study|Site closed|0|||
94618964|NCT00042289|324068110|FG019|Overall Study|Site closed|0|||
94618965|NCT00042289|324068111|FG020|Overall Study|Site closed|0|||
94618966|NCT00042289|324068112|FG021|Overall Study|Site closed|0|||
94618967|NCT00042289|324068113|FG022|Overall Study|Site closed|0|||
94618968|NCT00042289|324068114|FG023|Overall Study|Site closed|0|||
94618969|NCT00042289|324068115|FG024|Overall Study|Site closed|0|||
94618970|NCT00042289|324068116|FG025|Overall Study|Site closed|0|||
94618971|NCT00042289|324068117|FG026|Overall Study|Site closed|0|||
94618972|NCT00042289|324068118|FG027|Overall Study|Site closed|0|||
94618973|NCT00042289|324068119|FG028|Overall Study|Site closed|0|||
94618974|NCT00042289|324068120|FG029|Overall Study|Site closed|0|||
94618975|NCT00042289|324068121|FG030|Overall Study|Site closed|0|||
94618976|NCT00042289|324068122|FG031|Overall Study|Site closed|3|||
94618977|NCT00042289|324068123|FG032|Overall Study|Site closed|0|||
94618978|NCT00042289|324068124|FG033|Overall Study|Site closed|0|||
94618979|NCT00042289|324068125|FG034|Overall Study|Site closed|0|||
94618980|NCT00042289|324068126|FG035|Overall Study|Site closed|0|||
94618981|NCT00042289|324068127|FG036|Overall Study|Site closed|1|||
94618982|NCT00042289|324068128|FG037|Overall Study|Site closed|0|||
94359028|NCT03697109|323098049|FG001|Open-label (OL) Phase|Physician Decision|0|||
94359029|NCT03697109|323098050|FG002|Open-label (OL) Phase|Physician Decision|0|||
94359030|NCT03697109|323098048|FG000|Open-label (OL) Phase|Death|2|||
94359031|NCT03697109|323098049|FG001|Open-label (OL) Phase|Death|0|||
94618983|NCT00042289|324068129|FG038|Overall Study|Site closed|0|||
94618984|NCT00042289|324068130|FG039|Overall Study|Site closed|0|||
94618985|NCT00042289|324068131|FG040|Overall Study|Site closed|0|||
94618986|NCT00042289|324068132|FG041|Overall Study|Site closed|0|||
94618987|NCT00042289|324068133|FG042|Overall Study|Site closed|1|||
94618988|NCT00042289|324068134|FG043|Overall Study|Site closed|0|||
94618989|NCT00042289|324068135|FG044|Overall Study|Site closed|0|||
94666907|NCT06390839|324232779|FG000|Overall Study|Never start protocol therapy|3|||
94618990|NCT00042289|324068136|FG045|Overall Study|Site closed|0|||
94618991|NCT00042289|324068137|FG046|Overall Study|Site closed|0|||
94618992|NCT00042289|324068091|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
94618993|NCT00042289|324068092|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
94618994|NCT00042289|324068093|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
94618995|NCT00042289|324068094|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
94618996|NCT00042289|324068095|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
94618997|NCT00042289|324068096|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
94618998|NCT00042289|324068097|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
94618999|NCT00042289|324068098|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
94619000|NCT00042289|324068099|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
94619001|NCT00042289|324068100|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
94619002|NCT00042289|324068101|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
94619003|NCT00042289|324068102|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
94619004|NCT00042289|324068103|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
94619005|NCT00042289|324068104|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
94619006|NCT00042289|324068105|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
94619007|NCT00042289|324068106|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
94619008|NCT00042289|324068107|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
94619009|NCT00042289|324068108|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
94619010|NCT00042289|324068109|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
94619011|NCT00042289|324068110|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
94619012|NCT00042289|324068111|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
94619013|NCT00042289|324068112|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
94619014|NCT00042289|324068113|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
94619015|NCT00042289|324068114|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
94619016|NCT00042289|324068115|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
94619017|NCT00042289|324068116|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
94619018|NCT00042289|324068117|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
94619019|NCT00042289|324068118|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
94619020|NCT00042289|324068119|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
94619021|NCT00042289|324068120|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
94619022|NCT00042289|324068121|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
94619023|NCT00042289|324068122|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
94619024|NCT00042289|324068123|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
94619025|NCT00042289|324068124|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
94619026|NCT00042289|324068125|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
94619027|NCT00042289|324068126|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
94619028|NCT00042289|324068127|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
94619029|NCT00042289|324068128|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
94666908|NCT06390839|324232779|FG000|Overall Study|Adverse Event|1|||
94666909|NCT06390839|324232779|FG000|Overall Study|Alternative therapy|2|||
94254730|NCT01498679|322726358|FG001|Overall Study|Physician Decision|2|||
94254731|NCT01498679|322726357|FG000|Overall Study|Withdrawal by Subject|12|||
94254732|NCT01498679|322726358|FG001|Overall Study|Withdrawal by Subject|4|||
94254733|NCT02572882|322726359|FG000|Overall Study|Withdrawal by Subject|1|||
94359032|NCT03697109|323098050|FG002|Open-label (OL) Phase|Death|0|||
94359033|NCT03697109|323098048|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
94359034|NCT03697109|323098049|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
94359035|NCT03697109|323098050|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
94359036|NCT03697109|323098048|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
94359037|NCT03697109|323098049|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
94359038|NCT03697109|323098050|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
94359039|NCT03697109|323098048|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
94359040|NCT03697109|323098049|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
94359041|NCT03697109|323098050|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
94359042|NCT00483119|323098051|FG000|Overall Study|Adverse Event|0|||
94359043|NCT00483119|323098052|FG001|Overall Study|Adverse Event|1|||
94359044|NCT00483119|323098051|FG000|Overall Study|Physician Decision|1|||
94359045|NCT00483119|323098052|FG001|Overall Study|Physician Decision|0|||
94359046|NCT03426995|323098054|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
94359047|NCT03426995|323098055|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
94359048|NCT03426995|323098056|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
94359049|NCT03426995|323098057|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
94359050|NCT03426995|323098058|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
94359051|NCT03426995|323098059|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
94359052|NCT03426995|323098060|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
94359053|NCT03426995|323098061|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
94359054|NCT03426995|323098062|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
94359055|NCT03426995|323098063|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
94359056|NCT03426995|323098064|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
94359057|NCT03426995|323098065|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
94619030|NCT00042289|324068129|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
94619031|NCT00042289|324068130|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
94359058|NCT03426995|323098066|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
94359059|NCT03426995|323098067|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
94359060|NCT03426995|323098068|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
94359061|NCT03426995|323098069|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
94359062|NCT03426995|323098070|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
94359063|NCT03426995|323098071|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
94359064|NCT03426995|323098072|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
94619032|NCT00042289|324068131|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
94619033|NCT00042289|324068132|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
94619034|NCT00042289|324068133|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
94619035|NCT00042289|324068134|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
94619036|NCT00042289|324068135|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
94619037|NCT00042289|324068136|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
94619038|NCT00042289|324068137|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
94619039|NCT00042289|324068091|FG000|Overall Study|Protocol Violation|0|||
94619040|NCT00042289|324068092|FG001|Overall Study|Protocol Violation|0|||
94619041|NCT00042289|324068093|FG002|Overall Study|Protocol Violation|0|||
94619042|NCT00042289|324068094|FG003|Overall Study|Protocol Violation|0|||
94619043|NCT00042289|324068095|FG004|Overall Study|Protocol Violation|0|||
94619044|NCT00042289|324068096|FG005|Overall Study|Protocol Violation|1|||
94619045|NCT00042289|324068097|FG006|Overall Study|Protocol Violation|0|||
94619046|NCT00042289|324068098|FG007|Overall Study|Protocol Violation|1|||
94619047|NCT00042289|324068099|FG008|Overall Study|Protocol Violation|0|||
94619048|NCT00042289|324068100|FG009|Overall Study|Protocol Violation|0|||
94619049|NCT00042289|324068101|FG010|Overall Study|Protocol Violation|0|||
94619050|NCT00042289|324068102|FG011|Overall Study|Protocol Violation|0|||
94619051|NCT00042289|324068103|FG012|Overall Study|Protocol Violation|0|||
94619052|NCT00042289|324068104|FG013|Overall Study|Protocol Violation|0|||
94619053|NCT00042289|324068105|FG014|Overall Study|Protocol Violation|0|||
94619054|NCT00042289|324068106|FG015|Overall Study|Protocol Violation|0|||
94666910|NCT06390839|324232779|FG000|Overall Study|Death|3|||
94359065|NCT03426995|323098054|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
94359066|NCT03426995|323098055|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
94359067|NCT03426995|323098056|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
94359068|NCT03426995|323098057|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
94359069|NCT03426995|323098058|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
94461151|NCT01088243|323478203|FG000|Overall Study|Adverse Event|1|||
94619055|NCT00042289|324068107|FG016|Overall Study|Protocol Violation|0|||
94619056|NCT00042289|324068108|FG017|Overall Study|Protocol Violation|0|||
94619057|NCT00042289|324068109|FG018|Overall Study|Protocol Violation|0|||
94619058|NCT00042289|324068110|FG019|Overall Study|Protocol Violation|0|||
94666911|NCT06390839|324232779|FG000|Overall Study|Disease progression|28|||
94666912|NCT06390839|324232779|FG000|Overall Study|Withdrawal by Subject|2|||
94666913|NCT06390839|324232779|FG000|Overall Study|Complicating disease|1|||
94666914|NCT06390839|324232779|FG000|Overall Study|Noncompliance|1|||
94666915|NCT01869491|324232780|FG000|Overall Study|Adverse Event|3|||
94666916|NCT01869491|324232781|FG001|Overall Study|Adverse Event|5|||
94666917|NCT01869491|324232780|FG000|Overall Study|Lack of Efficacy|0|||
94666918|NCT01869491|324232781|FG001|Overall Study|Lack of Efficacy|3|||
94666919|NCT01869491|324232780|FG000|Overall Study|Withdrawal by Subject|6|||
94666920|NCT01869491|324232781|FG001|Overall Study|Withdrawal by Subject|7|||
94666921|NCT01869491|324232780|FG000|Overall Study|Lost to Follow-up|11|||
94666922|NCT01869491|324232781|FG001|Overall Study|Lost to Follow-up|9|||
94666923|NCT01869491|324232780|FG000|Overall Study|No further need of investigational product|1|||
94666924|NCT01869491|324232781|FG001|Overall Study|No further need of investigational product|0|||
94666925|NCT02189798|324232791|FG000|Extended Use Phase|Withdrawal by Subject|0|||
94666926|NCT02189798|324232792|FG001|Extended Use Phase|Withdrawal by Subject|4|||
94666927|NCT02189798|324232791|FG000|Extended Use Phase|Physician Decision|1|||
94666928|NCT02189798|324232792|FG001|Extended Use Phase|Physician Decision|0|||
94666929|NCT02189798|324232791|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
94666930|NCT02189798|324232792|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
94666931|NCT02189798|324232791|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
94254734|NCT02572882|322726359|FG000|Overall Study|Participant received kidney transplant|1|||
94254735|NCT04447846|322726362|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
94254736|NCT00461032|322726365|FG000|Overall Study|Adverse Event|5|||
94254737|NCT00461032|322726366|FG001|Overall Study|Adverse Event|6|||
94254738|NCT00461032|322726365|FG000|Overall Study|Lack of Efficacy|5|||
94254739|NCT00461032|322726366|FG001|Overall Study|Lack of Efficacy|1|||
94254740|NCT00461032|322726365|FG000|Overall Study|Lost to Follow-up|7|||
94254741|NCT00461032|322726366|FG001|Overall Study|Lost to Follow-up|12|||
94254742|NCT00461032|322726365|FG000|Overall Study|Protocol Violation|4|||
94254743|NCT00461032|322726366|FG001|Overall Study|Protocol Violation|4|||
94254744|NCT00461032|322726365|FG000|Overall Study|Withdrawal by Subject|7|||
94254745|NCT00461032|322726366|FG001|Overall Study|Withdrawal by Subject|15|||
94254746|NCT00461032|322726365|FG000|Overall Study|Patient Moved or Relocated|2|||
94254747|NCT00461032|322726366|FG001|Overall Study|Patient Moved or Relocated|1|||
94254748|NCT00461032|322726365|FG000|Overall Study|Other|7|||
94254749|NCT00461032|322726366|FG001|Overall Study|Other|5|||
94254750|NCT00946101|322726367|FG000|Overall Study|Lost to Follow-up|2|||
94254751|NCT00946101|322726368|FG001|Overall Study|Lost to Follow-up|1|||
94254752|NCT00946101|322726367|FG000|Overall Study|Withdrawal of consent|2|||
94254753|NCT00946101|322726368|FG001|Overall Study|Withdrawal of consent|0|||
94254754|NCT00946101|322726367|FG000|Overall Study|Physician Decision|0|||
94254755|NCT00946101|322726368|FG001|Overall Study|Physician Decision|1|||
94254756|NCT02057523|322726369|FG000|Overall Study|Withdrawal by Subject|1|||
94254757|NCT02057523|322726369|FG000|Overall Study|Lack of Efficacy|1|||
94666932|NCT02189798|324232792|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
94666933|NCT02189798|324232791|FG000|Extended Use Phase|Travel Issues|2|||
94666934|NCT02189798|324232792|FG001|Extended Use Phase|Travel Issues|1|||
94666935|NCT02189798|324232791|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
94666936|NCT02189798|324232792|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
94666937|NCT01672801|324232794|FG000|Overall Study|Screen Failure|0|||
94666938|NCT01672801|324232795|FG001|Overall Study|Screen Failure|1|||
94666939|NCT01306162|324232796|FG000|Period 1|Adverse Event|0|||
94666940|NCT01306162|324232797|FG001|Period 1|Adverse Event|0|||
94666941|NCT01306162|324232798|FG002|Period 1|Adverse Event|0|||
94666942|NCT01306162|324232799|FG003|Period 1|Adverse Event|1|||
94666943|NCT01306162|324232796|FG000|Washout 1|Non-compliance to protocol|0|||
94666944|NCT01306162|324232797|FG001|Washout 1|Non-compliance to protocol|1|||
94666945|NCT01306162|324232798|FG002|Washout 1|Non-compliance to protocol|0|||
94666946|NCT01306162|324232799|FG003|Washout 1|Non-compliance to protocol|0|||
94254758|NCT01590017|322726370|FG000|Overall Study|Adverse Event|1|||
94254759|NCT01590017|322726370|FG000|Overall Study|Withdrawal by Subject|1|||
94254760|NCT01590017|322726370|FG000|Overall Study|Lack of Efficacy|1|||
94254761|NCT01590017|322726370|FG000|Overall Study|Physician Decision|1|||
94254762|NCT00158860|322726371|FG000|Overall Study|Adverse Event|3|||
94254763|NCT00158860|322726372|FG001|Overall Study|Adverse Event|6|||
94254764|NCT00158860|322726371|FG000|Overall Study|Lost to Follow-up|11|||
94254765|NCT00158860|322726372|FG001|Overall Study|Lost to Follow-up|17|||
94666947|NCT01934218|324232804|FG000|Double-blind Phase|Adverse Event|8|||
94666948|NCT01934218|324232805|FG001|Double-blind Phase|Adverse Event|8|||
94666949|NCT01934218|324232804|FG000|Double-blind Phase|Lack of Efficacy|6|||
94666950|NCT01934218|324232805|FG001|Double-blind Phase|Lack of Efficacy|7|||
94666951|NCT01934218|324232804|FG000|Double-blind Phase|Lost to Follow-up|7|||
94666952|NCT01934218|324232805|FG001|Double-blind Phase|Lost to Follow-up|14|||
94666953|NCT01934218|324232804|FG000|Double-blind Phase|Physician Decision|1|||
94254766|NCT00158860|322726371|FG000|Overall Study|Protocol Violation|8|||
94359070|NCT03426995|323098059|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
94359071|NCT03426995|323098060|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
94359072|NCT03426995|323098061|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
94359073|NCT03426995|323098062|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
94359074|NCT03426995|323098063|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
94359075|NCT03426995|323098064|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
94359076|NCT03426995|323098065|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
94359077|NCT03426995|323098066|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
94359078|NCT03426995|323098067|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
94359079|NCT03426995|323098068|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
94359080|NCT03426995|323098069|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
94359081|NCT03426995|323098070|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
94359082|NCT03426995|323098071|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
94359083|NCT03426995|323098072|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
94359084|NCT03426995|323098054|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
94359085|NCT03426995|323098055|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
94359086|NCT03426995|323098056|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
94359087|NCT03426995|323098057|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
94359088|NCT03426995|323098058|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
94359089|NCT03426995|323098059|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
94359090|NCT03426995|323098060|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
94359091|NCT03426995|323098061|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
94359092|NCT03426995|323098062|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
94359093|NCT03426995|323098063|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
94359094|NCT03426995|323098064|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
94359095|NCT03426995|323098065|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
94359096|NCT03426995|323098066|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
94359097|NCT03426995|323098067|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
94359098|NCT03426995|323098068|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
94359099|NCT03426995|323098069|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
94359100|NCT03426995|323098070|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
94359101|NCT03426995|323098071|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
94359102|NCT03426995|323098072|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
94359103|NCT03426995|323098054|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
94359104|NCT03426995|323098055|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
94359105|NCT03426995|323098056|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
94359106|NCT03426995|323098057|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
94359107|NCT03426995|323098058|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
94619059|NCT00042289|324068111|FG020|Overall Study|Protocol Violation|0|||
94619060|NCT00042289|324068112|FG021|Overall Study|Protocol Violation|0|||
94619061|NCT00042289|324068113|FG022|Overall Study|Protocol Violation|0|||
94619062|NCT00042289|324068114|FG023|Overall Study|Protocol Violation|1|||
94619063|NCT00042289|324068115|FG024|Overall Study|Protocol Violation|1|||
94619064|NCT00042289|324068116|FG025|Overall Study|Protocol Violation|0|||
94619065|NCT00042289|324068117|FG026|Overall Study|Protocol Violation|2|||
94619066|NCT00042289|324068118|FG027|Overall Study|Protocol Violation|0|||
94619067|NCT00042289|324068119|FG028|Overall Study|Protocol Violation|0|||
94619068|NCT00042289|324068120|FG029|Overall Study|Protocol Violation|0|||
94619069|NCT00042289|324068121|FG030|Overall Study|Protocol Violation|1|||
94619070|NCT00042289|324068122|FG031|Overall Study|Protocol Violation|0|||
94619071|NCT00042289|324068123|FG032|Overall Study|Protocol Violation|0|||
94619072|NCT00042289|324068124|FG033|Overall Study|Protocol Violation|0|||
94254767|NCT00158860|322726372|FG001|Overall Study|Protocol Violation|23|||
94254768|NCT00158860|322726371|FG000|Overall Study|Withdrawal by Subject|7|||
94254769|NCT00158860|322726372|FG001|Overall Study|Withdrawal by Subject|17|||
94254770|NCT00158860|322726371|FG000|Overall Study|MOVING OUT OF STATE|1|||
94254771|NCT00158860|322726372|FG001|Overall Study|MOVING OUT OF STATE|0|||
94254772|NCT00158860|322726371|FG000|Overall Study|Pregnancy|3|||
94254773|NCT00158860|322726372|FG001|Overall Study|Pregnancy|3|||
94254774|NCT00158860|322726371|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
94254775|NCT00158860|322726372|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
94254776|NCT00158860|322726371|FG000|Overall Study|SPONSOR REQUEST|0|||
94254777|NCT00158860|322726372|FG001|Overall Study|SPONSOR REQUEST|1|||
94254778|NCT00158860|322726371|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
94254779|NCT00158860|322726372|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
94254780|NCT00158860|322726371|FG000|Overall Study|Closed per sponsor|0|||
94254781|NCT00158860|322726372|FG001|Overall Study|Closed per sponsor|1|||
94254782|NCT03235284|322726373|FG000|Overall Study|Adverse Event|1|||
94254783|NCT03235284|322726374|FG001|Overall Study|Adverse Event|2|||
94254784|NCT03235284|322726375|FG002|Overall Study|Adverse Event|1|||
94254785|NCT02783768|322726379|FG000|Overall Study|Lost to Follow-up|1|||
94254786|NCT02783768|322726380|FG001|Overall Study|Lost to Follow-up|0|||
94254787|NCT01778023|322726383|FG000|Overall Study|Withdrawal by Subject|0|||
94359108|NCT03426995|323098059|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
94359109|NCT03426995|323098060|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
94359110|NCT03426995|323098061|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
94359111|NCT03426995|323098062|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
94359112|NCT03426995|323098063|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
94359113|NCT03426995|323098064|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
94359114|NCT03426995|323098065|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
94359115|NCT03426995|323098066|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
94359116|NCT03426995|323098067|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
94359117|NCT03426995|323098068|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
94359118|NCT03426995|323098069|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
94359119|NCT03426995|323098070|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
94359120|NCT03426995|323098071|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
94359121|NCT03426995|323098072|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
94359122|NCT03426995|323098054|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
94359123|NCT03426995|323098055|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
94359124|NCT03426995|323098056|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
94359125|NCT03426995|323098057|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
94359126|NCT03426995|323098058|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
94359127|NCT03426995|323098059|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
94359128|NCT03426995|323098060|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
94359129|NCT03426995|323098061|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
94359130|NCT03426995|323098062|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
94359131|NCT03426995|323098063|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
94359132|NCT03426995|323098064|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
94359133|NCT03426995|323098065|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
94359134|NCT03426995|323098066|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
94359135|NCT03426995|323098067|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
94359136|NCT03426995|323098068|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
94359137|NCT03426995|323098069|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
94359138|NCT03426995|323098070|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
94359139|NCT03426995|323098071|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
94359140|NCT03426995|323098072|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
94359141|NCT03426995|323098054|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
94359142|NCT03426995|323098055|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
94359143|NCT03426995|323098056|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
94359144|NCT03426995|323098057|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
94359145|NCT03426995|323098058|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
94359146|NCT03426995|323098059|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
94359147|NCT03426995|323098060|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
94359148|NCT03426995|323098061|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
94359149|NCT03426995|323098062|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
94359150|NCT03426995|323098063|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
94359151|NCT03426995|323098064|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
94359152|NCT03426995|323098065|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
94359153|NCT03426995|323098066|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
94359154|NCT03426995|323098067|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
94359155|NCT03426995|323098068|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
94359156|NCT03426995|323098069|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
94359157|NCT03426995|323098070|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
94359158|NCT03426995|323098071|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
94359159|NCT03426995|323098072|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
94359160|NCT03426995|323098054|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
94359161|NCT03426995|323098055|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
94359162|NCT03426995|323098056|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
94359163|NCT03426995|323098057|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
94359164|NCT03426995|323098058|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
94359165|NCT03426995|323098059|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
94359166|NCT03426995|323098060|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
94619073|NCT00042289|324068125|FG034|Overall Study|Protocol Violation|0|||
94619074|NCT00042289|324068126|FG035|Overall Study|Protocol Violation|0|||
94619075|NCT00042289|324068127|FG036|Overall Study|Protocol Violation|0|||
94359167|NCT03426995|323098061|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
94359168|NCT03426995|323098062|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
94619076|NCT00042289|324068128|FG037|Overall Study|Protocol Violation|0|||
94619077|NCT00042289|324068129|FG038|Overall Study|Protocol Violation|0|||
94619078|NCT00042289|324068130|FG039|Overall Study|Protocol Violation|0|||
94254788|NCT01778023|322726384|FG001|Overall Study|Withdrawal by Subject|3|||
94254789|NCT01411215|322726387|FG000|Overall Study|Adverse Event|1|||
94254790|NCT01411215|322726388|FG001|Overall Study|Adverse Event|2|||
94254791|NCT01411215|322726387|FG000|Overall Study|Lack of Efficacy|2|||
94254792|NCT01411215|322726388|FG001|Overall Study|Lack of Efficacy|4|||
94254793|NCT01411215|322726387|FG000|Overall Study|Lost to Follow-up|12|||
94254794|NCT01411215|322726388|FG001|Overall Study|Lost to Follow-up|18|||
94254795|NCT01411215|322726387|FG000|Overall Study|Did not meet entrance criteria|0|||
94254796|NCT01411215|322726388|FG001|Overall Study|Did not meet entrance criteria|1|||
94254797|NCT01411215|322726387|FG000|Overall Study|Study terminated by sponsor|2|||
94254798|NCT01411215|322726388|FG001|Overall Study|Study terminated by sponsor|15|||
94619079|NCT00042289|324068131|FG040|Overall Study|Protocol Violation|0|||
94619080|NCT00042289|324068132|FG041|Overall Study|Protocol Violation|1|||
94619081|NCT00042289|324068133|FG042|Overall Study|Protocol Violation|1|||
94619082|NCT00042289|324068134|FG043|Overall Study|Protocol Violation|1|||
94619083|NCT00042289|324068135|FG044|Overall Study|Protocol Violation|0|||
94619084|NCT00042289|324068136|FG045|Overall Study|Protocol Violation|0|||
94619085|NCT00042289|324068137|FG046|Overall Study|Protocol Violation|0|||
94619086|NCT00042289|324068091|FG000|Overall Study|Withdrawal by Subject|4|||
94619087|NCT00042289|324068092|FG001|Overall Study|Withdrawal by Subject|1|||
94619088|NCT00042289|324068093|FG002|Overall Study|Withdrawal by Subject|0|||
94619089|NCT00042289|324068094|FG003|Overall Study|Withdrawal by Subject|2|||
94619090|NCT00042289|324068095|FG004|Overall Study|Withdrawal by Subject|0|||
94619091|NCT00042289|324068096|FG005|Overall Study|Withdrawal by Subject|2|||
94619092|NCT00042289|324068097|FG006|Overall Study|Withdrawal by Subject|0|||
94254799|NCT01411215|322726387|FG000|Overall Study|Protocol Violation|3|||
94254800|NCT01411215|322726388|FG001|Overall Study|Protocol Violation|5|||
94254801|NCT01411215|322726387|FG000|Overall Study|Withdrawal by Subject|34|||
94619093|NCT00042289|324068098|FG007|Overall Study|Withdrawal by Subject|0|||
94619094|NCT00042289|324068099|FG008|Overall Study|Withdrawal by Subject|0|||
94619095|NCT00042289|324068100|FG009|Overall Study|Withdrawal by Subject|1|||
94619096|NCT00042289|324068101|FG010|Overall Study|Withdrawal by Subject|0|||
94619097|NCT00042289|324068102|FG011|Overall Study|Withdrawal by Subject|0|||
94619098|NCT00042289|324068103|FG012|Overall Study|Withdrawal by Subject|2|||
94619099|NCT00042289|324068104|FG013|Overall Study|Withdrawal by Subject|0|||
94619100|NCT00042289|324068105|FG014|Overall Study|Withdrawal by Subject|0|||
94619101|NCT00042289|324068106|FG015|Overall Study|Withdrawal by Subject|0|||
94619102|NCT00042289|324068107|FG016|Overall Study|Withdrawal by Subject|0|||
94619103|NCT00042289|324068108|FG017|Overall Study|Withdrawal by Subject|0|||
94619104|NCT00042289|324068109|FG018|Overall Study|Withdrawal by Subject|0|||
94619105|NCT00042289|324068110|FG019|Overall Study|Withdrawal by Subject|0|||
94619106|NCT00042289|324068111|FG020|Overall Study|Withdrawal by Subject|0|||
94619107|NCT00042289|324068112|FG021|Overall Study|Withdrawal by Subject|1|||
94619108|NCT00042289|324068113|FG022|Overall Study|Withdrawal by Subject|1|||
94619109|NCT00042289|324068114|FG023|Overall Study|Withdrawal by Subject|1|||
94619110|NCT00042289|324068115|FG024|Overall Study|Withdrawal by Subject|0|||
94619111|NCT00042289|324068116|FG025|Overall Study|Withdrawal by Subject|0|||
94619112|NCT00042289|324068117|FG026|Overall Study|Withdrawal by Subject|1|||
94619113|NCT00042289|324068118|FG027|Overall Study|Withdrawal by Subject|0|||
94619114|NCT00042289|324068119|FG028|Overall Study|Withdrawal by Subject|2|||
94619115|NCT00042289|324068120|FG029|Overall Study|Withdrawal by Subject|0|||
94619116|NCT00042289|324068121|FG030|Overall Study|Withdrawal by Subject|0|||
94619117|NCT00042289|324068122|FG031|Overall Study|Withdrawal by Subject|1|||
94619118|NCT00042289|324068123|FG032|Overall Study|Withdrawal by Subject|2|||
94619119|NCT00042289|324068124|FG033|Overall Study|Withdrawal by Subject|1|||
94619120|NCT00042289|324068125|FG034|Overall Study|Withdrawal by Subject|0|||
94619121|NCT00042289|324068126|FG035|Overall Study|Withdrawal by Subject|0|||
94666954|NCT01934218|324232805|FG001|Double-blind Phase|Physician Decision|2|||
94666955|NCT01934218|324232804|FG000|Double-blind Phase|Protocol Violation|4|||
94666956|NCT01934218|324232805|FG001|Double-blind Phase|Protocol Violation|0|||
94254802|NCT01411215|322726388|FG001|Overall Study|Withdrawal by Subject|21|||
94254803|NCT01411215|322726387|FG000|Overall Study|Other|12|||
94461152|NCT01088243|323478204|FG001|Overall Study|Adverse Event|0|||
94619122|NCT00042289|324068127|FG036|Overall Study|Withdrawal by Subject|0|||
94619123|NCT00042289|324068128|FG037|Overall Study|Withdrawal by Subject|1|||
94619124|NCT00042289|324068129|FG038|Overall Study|Withdrawal by Subject|0|||
94619125|NCT00042289|324068130|FG039|Overall Study|Withdrawal by Subject|0|||
94619126|NCT00042289|324068131|FG040|Overall Study|Withdrawal by Subject|0|||
94619127|NCT00042289|324068132|FG041|Overall Study|Withdrawal by Subject|0|||
94619128|NCT00042289|324068133|FG042|Overall Study|Withdrawal by Subject|1|||
94619129|NCT00042289|324068134|FG043|Overall Study|Withdrawal by Subject|0|||
94619130|NCT00042289|324068135|FG044|Overall Study|Withdrawal by Subject|0|||
94619131|NCT00042289|324068136|FG045|Overall Study|Withdrawal by Subject|0|||
94666957|NCT01934218|324232804|FG000|Double-blind Phase|Withdrawal by Subject|16|||
94254804|NCT01411215|322726388|FG001|Overall Study|Other|17|||
94254805|NCT01411215|322726387|FG000|Overall Study|Screen failure|0|||
94254806|NCT01411215|322726388|FG001|Overall Study|Screen failure|1|||
94619132|NCT00042289|324068137|FG046|Overall Study|Withdrawal by Subject|0|||
94619133|NCT00717197|324068138|FG000|Overall Study|Unable to purchase study drug|5|||
94619134|NCT00717197|324068138|FG000|Overall Study|Tumor Progression|1|||
94619135|NCT00717197|324068138|FG000|Overall Study|Physician Decision|1|||
94619136|NCT00982137|324068139|FG000|Overall Study|Lost to Follow-up|0|||
94619137|NCT00982137|324068140|FG001|Overall Study|Lost to Follow-up|0|||
94619138|NCT00982137|324068141|FG002|Overall Study|Lost to Follow-up|0|||
94619139|NCT00982137|324068142|FG003|Overall Study|Lost to Follow-up|1|||
94619140|NCT00982137|324068139|FG000|Overall Study|Withdrawal by Subject|0|||
94619141|NCT00982137|324068140|FG001|Overall Study|Withdrawal by Subject|1|||
94619142|NCT00982137|324068141|FG002|Overall Study|Withdrawal by Subject|0|||
94619143|NCT00982137|324068142|FG003|Overall Study|Withdrawal by Subject|0|||
94619144|NCT00443261|324068145|FG000|Overall Study|Death|1|||
94619145|NCT04019288|324068146|FG000|Overall Study|Death|1|||
94619146|NCT04019288|324068147|FG001|Overall Study|Death|0|||
94619147|NCT04019288|324068148|FG002|Overall Study|Death|0|||
94619148|NCT01945281|324068149|FG000|Overall Study|Adverse Event|1|||
94619149|NCT01945281|324068150|FG001|Overall Study|Adverse Event|0|||
94619150|NCT01945281|324068149|FG000|Overall Study|Death|3|||
94619151|NCT01945281|324068150|FG001|Overall Study|Death|3|||
94619152|NCT01945281|324068149|FG000|Overall Study|Physician Decision|1|||
94619153|NCT01945281|324068150|FG001|Overall Study|Physician Decision|1|||
94619154|NCT01945281|324068149|FG000|Overall Study|Technical Problems|1|||
94619155|NCT01945281|324068150|FG001|Overall Study|Technical Problems|0|||
94619156|NCT04401423|324068151|FG000|Overall Study|Withdrawal by Subject|3|||
94619157|NCT04401423|324068152|FG001|Overall Study|Withdrawal by Subject|1|||
94619158|NCT04401423|324068151|FG000|Overall Study|Physician Decision|2|||
94619159|NCT04401423|324068152|FG001|Overall Study|Physician Decision|1|||
94619160|NCT01546207|324068155|FG000|Overall Study|Death|1|||
94619161|NCT03094169|324068157|FG000|Overall Study|Lack of Efficacy|0|||
94619162|NCT03094169|324068158|FG001|Overall Study|Lack of Efficacy|0|||
94619163|NCT03094169|324068159|FG002|Overall Study|Lack of Efficacy|0|||
94619164|NCT03094169|324068160|FG003|Overall Study|Lack of Efficacy|0|||
94619165|NCT03094169|324068161|FG004|Overall Study|Lack of Efficacy|0|||
94619166|NCT03094169|324068162|FG005|Overall Study|Lack of Efficacy|0|||
94619167|NCT03094169|324068163|FG006|Overall Study|Lack of Efficacy|0|||
94619168|NCT03094169|324068164|FG007|Overall Study|Lack of Efficacy|21|||
94619169|NCT03094169|324068157|FG000|Overall Study|Adverse Event|0|||
94619170|NCT03094169|324068158|FG001|Overall Study|Adverse Event|0|||
94619171|NCT03094169|324068159|FG002|Overall Study|Adverse Event|0|||
94619172|NCT03094169|324068160|FG003|Overall Study|Adverse Event|0|||
94619173|NCT03094169|324068161|FG004|Overall Study|Adverse Event|0|||
94619174|NCT03094169|324068162|FG005|Overall Study|Adverse Event|0|||
94619175|NCT03094169|324068163|FG006|Overall Study|Adverse Event|0|||
94619176|NCT03094169|324068164|FG007|Overall Study|Adverse Event|2|||
94619177|NCT03094169|324068157|FG000|Overall Study|Withdrawal by Subject|0|||
94619178|NCT03094169|324068158|FG001|Overall Study|Withdrawal by Subject|0|||
94619179|NCT03094169|324068159|FG002|Overall Study|Withdrawal by Subject|0|||
94619180|NCT03094169|324068160|FG003|Overall Study|Withdrawal by Subject|0|||
94619181|NCT03094169|324068161|FG004|Overall Study|Withdrawal by Subject|0|||
94619182|NCT03094169|324068162|FG005|Overall Study|Withdrawal by Subject|0|||
94619183|NCT03094169|324068163|FG006|Overall Study|Withdrawal by Subject|1|||
94619184|NCT03094169|324068164|FG007|Overall Study|Withdrawal by Subject|1|||
94619185|NCT03094169|324068157|FG000|Overall Study|Trial Termination|0|||
94619186|NCT03094169|324068158|FG001|Overall Study|Trial Termination|0|||
94619187|NCT03094169|324068159|FG002|Overall Study|Trial Termination|0|||
94619188|NCT03094169|324068160|FG003|Overall Study|Trial Termination|0|||
94619189|NCT03094169|324068161|FG004|Overall Study|Trial Termination|0|||
94619190|NCT03094169|324068162|FG005|Overall Study|Trial Termination|0|||
94619191|NCT03094169|324068163|FG006|Overall Study|Trial Termination|0|||
94254807|NCT00848926|322726389|FG000|Treatment Period|Progressive disease|45|||
94254808|NCT00848926|322726389|FG000|Treatment Period|Adverse Event|20|||
94619192|NCT03094169|324068164|FG007|Overall Study|Trial Termination|1|||
94666958|NCT01934218|324232805|FG001|Double-blind Phase|Withdrawal by Subject|13|||
94254809|NCT00848926|322726389|FG000|Treatment Period|Physician Decision|12|||
94619193|NCT04572633|324068165|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
94619194|NCT00142935|324068168|FG000|Overall Study|Other reason|1|||
94666959|NCT01934218|324232804|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
94619195|NCT00142935|324068169|FG001|Overall Study|Other reason|1|||
94619196|NCT00142935|324068170|FG002|Overall Study|Other reason|1|||
94619197|NCT00142935|324068168|FG000|Overall Study|Lost to Follow-up|2|||
94619198|NCT00142935|324068169|FG001|Overall Study|Lost to Follow-up|5|||
94619199|NCT00142935|324068170|FG002|Overall Study|Lost to Follow-up|5|||
94619200|NCT00142935|324068168|FG000|Overall Study|Death|0|||
94461153|NCT02474589|323478205|FG000|Overall Study|Adverse Event|6|||
94619201|NCT00142935|324068169|FG001|Overall Study|Death|2|||
94619202|NCT00142935|324068170|FG002|Overall Study|Death|1|||
94619203|NCT01180985|324068171|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
94619204|NCT01180985|324068172|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
94619205|NCT03727230|324068173|FG000|Overall Study|Lost to Follow-up|12|||
94666960|NCT01934218|324232805|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
94666961|NCT01934218|324232804|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
94666962|NCT01934218|324232805|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
94666963|NCT01934218|324232804|FG000|Open-Label Phase|Adverse Event|2|||
94666964|NCT01934218|324232805|FG001|Open-Label Phase|Adverse Event|4|||
94666965|NCT01934218|324232804|FG000|Open-Label Phase|Lack of Efficacy|1|||
94666966|NCT01934218|324232805|FG001|Open-Label Phase|Lack of Efficacy|4|||
94666967|NCT01934218|324232804|FG000|Open-Label Phase|Lost to Follow-up|4|||
94666968|NCT01934218|324232805|FG001|Open-Label Phase|Lost to Follow-up|2|||
94666969|NCT01934218|324232804|FG000|Open-Label Phase|Physician Decision|1|||
94666970|NCT01934218|324232805|FG001|Open-Label Phase|Physician Decision|0|||
94666971|NCT01934218|324232804|FG000|Open-Label Phase|Protocol Violation|1|||
94666972|NCT01934218|324232805|FG001|Open-Label Phase|Protocol Violation|0|||
94666973|NCT01934218|324232804|FG000|Open-Label Phase|Withdrawal by Subject|13|||
94666974|NCT01934218|324232805|FG001|Open-Label Phase|Withdrawal by Subject|11|||
94666975|NCT01934218|324232804|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
94666976|NCT01934218|324232805|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
94666977|NCT01934218|324232804|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
94666978|NCT01934218|324232805|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
94666979|NCT04330638|324232806|FG000|Overall Study|Adverse Event|9|||
94666980|NCT04330638|324232807|FG001|Overall Study|Adverse Event|10|||
94666981|NCT04330638|324232808|FG002|Overall Study|Adverse Event|15|||
94666982|NCT04330638|324232809|FG003|Overall Study|Adverse Event|6|||
94666983|NCT04330638|324232810|FG004|Overall Study|Adverse Event|10|||
94666984|NCT04330638|324232811|FG005|Overall Study|Adverse Event|5|||
94666985|NCT04330638|324232806|FG000|Overall Study|Other|2|||
94666986|NCT04330638|324232807|FG001|Overall Study|Other|2|||
94666987|NCT04330638|324232808|FG002|Overall Study|Other|5|||
94666988|NCT04330638|324232809|FG003|Overall Study|Other|1|||
94666989|NCT04330638|324232810|FG004|Overall Study|Other|3|||
94666990|NCT04330638|324232811|FG005|Overall Study|Other|2|||
94666991|NCT04330638|324232806|FG000|Overall Study|Withdrawal by Subject|4|||
94666992|NCT04330638|324232807|FG001|Overall Study|Withdrawal by Subject|0|||
94666993|NCT04330638|324232808|FG002|Overall Study|Withdrawal by Subject|0|||
94666994|NCT04330638|324232809|FG003|Overall Study|Withdrawal by Subject|0|||
94666995|NCT04330638|324232810|FG004|Overall Study|Withdrawal by Subject|0|||
94666996|NCT04330638|324232811|FG005|Overall Study|Withdrawal by Subject|0|||
94666997|NCT04330638|324232806|FG000|Overall Study|Lost to Follow-up|3|||
94666998|NCT04330638|324232807|FG001|Overall Study|Lost to Follow-up|2|||
94666999|NCT04330638|324232808|FG002|Overall Study|Lost to Follow-up|3|||
94667000|NCT04330638|324232809|FG003|Overall Study|Lost to Follow-up|2|||
94667001|NCT04330638|324232810|FG004|Overall Study|Lost to Follow-up|3|||
94667002|NCT04330638|324232811|FG005|Overall Study|Lost to Follow-up|0|||
94667003|NCT00522275|324232812|FG000|Overall Study|Adverse Event|35|||
94667004|NCT00522275|324232812|FG000|Overall Study|Lack of Efficacy|80|||
94667005|NCT00522275|324232812|FG000|Overall Study|Subject withdrew consent|16|||
94667006|NCT00522275|324232812|FG000|Overall Study|Protocol deviation|1|||
94667007|NCT00522275|324232812|FG000|Overall Study|Unsatisfactory compliance|11|||
94667008|NCT00522275|324232812|FG000|Overall Study|Lost to Follow-up|8|||
94667009|NCT00522275|324232812|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
94667010|NCT00522275|324232812|FG000|Overall Study|Other: Subject is pregnant|2|||
94667011|NCT00522275|324232812|FG000|Overall Study|Other: Subject relocated|2|||
94667012|NCT00522275|324232812|FG000|Overall Study|Other: Subject arrested|1|||
94667013|NCT00522275|324232812|FG000|Overall Study|Other: Site / clinic closed|4|||
94667014|NCT00522275|324232812|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
94667015|NCT00522275|324232812|FG000|Overall Study|Other: Sponsor request|2|||
94667016|NCT00522275|324232812|FG000|Overall Study|Other: Subject ran out of medication|1|||
94667017|NCT00522275|324232812|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
94667018|NCT03743038|324232815|FG000|Overall Study|Physician Decision|1|||
94667019|NCT05207813|324232816|FG000|Overall Study|Lost to Follow-up|2|||
94667020|NCT02715765|324232817|FG000|Overall Study|Study Termination|3|||
94667021|NCT02715765|324232818|FG001|Overall Study|Study Termination|0|||
94667022|NCT02715765|324232819|FG002|Overall Study|Study Termination|0|||
94667023|NCT04988308|324232820|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
94667024|NCT04988308|324232821|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
94667025|NCT04988308|324232822|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
94667026|NCT04988308|324232823|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
94461154|NCT02474589|323478206|FG001|Overall Study|Adverse Event|2|||
94461155|NCT02474589|323478205|FG000|Overall Study|Lost to Follow-up|6|||
94619206|NCT00675948|324068174|FG000|Overall Study|Adverse Event|23|||
94619207|NCT00675948|324068175|FG001|Overall Study|Adverse Event|1|||
94619208|NCT00675948|324068174|FG000|Overall Study|Lack of Efficacy|3|||
94619209|NCT00675948|324068175|FG001|Overall Study|Lack of Efficacy|0|||
94619210|NCT00675948|324068174|FG000|Overall Study|Withdrawal by Subject|7|||
94619211|NCT00675948|324068175|FG001|Overall Study|Withdrawal by Subject|0|||
94619212|NCT00675948|324068174|FG000|Overall Study|Lost to Follow-up|2|||
94619213|NCT00675948|324068175|FG001|Overall Study|Lost to Follow-up|0|||
94619214|NCT00675948|324068174|FG000|Overall Study|Protocol Violation|1|||
94619215|NCT00675948|324068175|FG001|Overall Study|Protocol Violation|0|||
94619216|NCT00675948|324068174|FG000|Overall Study|Pain under control|1|||
94619217|NCT00675948|324068175|FG001|Overall Study|Pain under control|0|||
94619218|NCT00675948|324068174|FG000|Overall Study|Sponsor decision|0|||
94619219|NCT00675948|324068175|FG001|Overall Study|Sponsor decision|1|||
94619220|NCT00675948|324068174|FG000|Overall Study|Patient died|1|||
94619221|NCT00675948|324068175|FG001|Overall Study|Patient died|0|||
94619222|NCT00675948|324068174|FG000|Overall Study|Patient unable to comply with diaries|1|||
94619223|NCT00675948|324068175|FG001|Overall Study|Patient unable to comply with diaries|0|||
94619224|NCT00675948|324068174|FG000|Overall Study|Patient feels unable to take medication|0|||
94619225|NCT00675948|324068175|FG001|Overall Study|Patient feels unable to take medication|1|||
94619226|NCT00724932|324068176|FG000|Overall Study|Lost to Follow-up|1|||
94619227|NCT00724932|324068177|FG001|Overall Study|Lost to Follow-up|0|||
94619228|NCT00724932|324068176|FG000|Overall Study|Not treated|4|||
94619229|NCT00724932|324068177|FG001|Overall Study|Not treated|3|||
94619230|NCT01896102|324068178|FG000|Overall Study|Death|1|||
94619231|NCT01896102|324068178|FG000|Overall Study|Participant to receive allogenic transplant|2|||
94619232|NCT03733470|324068181|FG000|Overall Study|PI Decision|1|||
94619233|NCT03733470|324068182|FG001|Overall Study|PI Decision|1|||
94619234|NCT01786668|324068183|FG000|Overall Study|Adverse Event|0|||
94619235|NCT01786668|324068184|FG001|Overall Study|Adverse Event|1|||
94619236|NCT01786668|324068185|FG002|Overall Study|Adverse Event|1|||
94619237|NCT01786668|324068186|FG003|Overall Study|Adverse Event|2|||
94619238|NCT01786668|324068183|FG000|Overall Study|Withdrawal by Subject|0|||
94619239|NCT01786668|324068184|FG001|Overall Study|Withdrawal by Subject|0|||
94619240|NCT01786668|324068185|FG002|Overall Study|Withdrawal by Subject|3|||
94619241|NCT01786668|324068186|FG003|Overall Study|Withdrawal by Subject|1|||
94619242|NCT01786668|324068183|FG000|Overall Study|Pregnancy|0|||
94619243|NCT01786668|324068184|FG001|Overall Study|Pregnancy|0|||
94619244|NCT01786668|324068185|FG002|Overall Study|Pregnancy|0|||
94619245|NCT01786668|324068186|FG003|Overall Study|Pregnancy|1|||
94619246|NCT01786668|324068183|FG000|Overall Study|Lost to Follow-up|1|||
94619247|NCT01786668|324068184|FG001|Overall Study|Lost to Follow-up|0|||
94619248|NCT01786668|324068185|FG002|Overall Study|Lost to Follow-up|1|||
94619249|NCT01786668|324068186|FG003|Overall Study|Lost to Follow-up|0|||
94619250|NCT01007812|324068187|FG000|Period 1, One Week|Lost to Follow-up|0|||
94619251|NCT01007812|324068188|FG001|Period 1, One Week|Lost to Follow-up|1|||
94619252|NCT01007812|324068187|FG000|Period 1, One Week|Discomfort|1|||
94619253|NCT01007812|324068188|FG001|Period 1, One Week|Discomfort|0|||
94619254|NCT00555971|324068189|FG000|Overall Study|Adverse Event|1|||
94619255|NCT00555971|324068190|FG001|Overall Study|Adverse Event|1|||
94619256|NCT01849783|324068191|FG000|Overall Study|Adverse Event|5|||
94619257|NCT01849783|324068191|FG000|Overall Study|Death|2|||
94619258|NCT01849783|324068191|FG000|Overall Study|Physician Decision|1|||
94619259|NCT01849783|324068191|FG000|Overall Study|Withdrawal by Subject|1|||
94619260|NCT01849783|324068191|FG000|Overall Study|Unable to comply|2|||
94619261|NCT01849783|324068191|FG000|Overall Study|Disease progression|11|||
94667027|NCT04988308|324232824|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
94619262|NCT02693119|324068192|FG000|Open-Label Period|Withdrawal by Subject|0|||
94619263|NCT02693119|324068193|FG001|Open-Label Period|Withdrawal by Subject|1|||
94619264|NCT02571075|324068194|FG000|Overall Study|Lost to Follow-up|20|||
94619265|NCT02571075|324068195|FG001|Overall Study|Lost to Follow-up|24|||
94619266|NCT00369824|324068198|FG000|Overall Study|Adverse Event|0|||
94619267|NCT00369824|324068199|FG001|Overall Study|Adverse Event|2|||
94619268|NCT00369824|324068200|FG002|Overall Study|Adverse Event|0|||
94619269|NCT00369824|324068201|FG003|Overall Study|Adverse Event|0|||
94619270|NCT00369824|324068202|FG004|Overall Study|Adverse Event|1|||
94619271|NCT00369824|324068203|FG005|Overall Study|Adverse Event|0|||
94619272|NCT00369824|324068198|FG000|Overall Study|Protocol Violation|0|||
94619273|NCT00369824|324068199|FG001|Overall Study|Protocol Violation|1|||
94619274|NCT00369824|324068200|FG002|Overall Study|Protocol Violation|0|||
94619275|NCT00369824|324068201|FG003|Overall Study|Protocol Violation|1|||
94619276|NCT00369824|324068202|FG004|Overall Study|Protocol Violation|1|||
94619277|NCT00369824|324068203|FG005|Overall Study|Protocol Violation|0|||
94619278|NCT00369824|324068198|FG000|Overall Study|Withdrawal by Subject|9|||
94619279|NCT00369824|324068199|FG001|Overall Study|Withdrawal by Subject|5|||
94619280|NCT00369824|324068200|FG002|Overall Study|Withdrawal by Subject|5|||
94619281|NCT00369824|324068201|FG003|Overall Study|Withdrawal by Subject|4|||
94619282|NCT00369824|324068202|FG004|Overall Study|Withdrawal by Subject|6|||
94619283|NCT00369824|324068203|FG005|Overall Study|Withdrawal by Subject|2|||
94619284|NCT00369824|324068198|FG000|Overall Study|Lost to Follow-up|6|||
94619285|NCT00369824|324068199|FG001|Overall Study|Lost to Follow-up|11|||
94619286|NCT00369824|324068200|FG002|Overall Study|Lost to Follow-up|7|||
94461156|NCT02474589|323478206|FG001|Overall Study|Lost to Follow-up|1|||
94461157|NCT02474589|323478205|FG000|Overall Study|Protocol Violation|4|||
94461158|NCT02474589|323478206|FG001|Overall Study|Protocol Violation|1|||
94461159|NCT02474589|323478205|FG000|Overall Study|Withdrawal by Subject|4|||
94461160|NCT02474589|323478206|FG001|Overall Study|Withdrawal by Subject|0|||
94461161|NCT02474589|323478205|FG000|Overall Study|Inability to complete study procedures|5|||
94461162|NCT02474589|323478206|FG001|Overall Study|Inability to complete study procedures|1|||
94461163|NCT02231879|323478209|FG000|Overall Study|Adverse Event|2|||
94619287|NCT00369824|324068201|FG003|Overall Study|Lost to Follow-up|8|||
94619288|NCT00369824|324068202|FG004|Overall Study|Lost to Follow-up|9|||
94619289|NCT00369824|324068203|FG005|Overall Study|Lost to Follow-up|6|||
94619290|NCT00369824|324068198|FG000|Overall Study|Other|0|||
94619291|NCT00369824|324068199|FG001|Overall Study|Other|0|||
94619292|NCT00369824|324068200|FG002|Overall Study|Other|0|||
94619293|NCT00369824|324068201|FG003|Overall Study|Other|2|||
94619294|NCT00369824|324068202|FG004|Overall Study|Other|1|||
94619295|NCT00369824|324068203|FG005|Overall Study|Other|3|||
94619296|NCT03953820|324068204|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
94619297|NCT03953820|324068205|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
94619298|NCT03953820|324068206|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
94619299|NCT03953820|324068204|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
94619300|NCT03953820|324068205|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
94619301|NCT03953820|324068206|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
94619302|NCT02217878|324068207|FG000|Overall Study|required morphine due to chest pain|1|||
94619303|NCT02217878|324068208|FG001|Overall Study|required morphine due to chest pain|2|||
94619304|NCT02217878|324068207|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
94619305|NCT02217878|324068208|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
94619306|NCT03516812|324068209|FG000|Overall Study|Adverse Event|4|||
94254810|NCT00848926|322726389|FG000|Treatment Period|Withdrawal by Subject|7|||
94254811|NCT00848926|322726389|FG000|Follow-up Period|Lost to Follow-up|7|||
94254812|NCT00848926|322726389|FG000|Follow-up Period|Withdrawal by Subject|3|||
94254813|NCT00848926|322726389|FG000|Follow-up Period|Other|2|||
94254814|NCT00903630|322726390|FG000|Phase 2|Adverse Event|0|||
94254815|NCT00903630|322726391|FG001|Phase 2|Adverse Event|0|||
94619307|NCT03516812|324068209|FG000|Overall Study|Lack of Efficacy|2|||
94254816|NCT00903630|322726392|FG002|Phase 2|Adverse Event|1|||
94254817|NCT02752074|322726393|FG000|Overall Study|Lost to Follow-up|1|||
94254818|NCT02752074|322726394|FG001|Overall Study|Lost to Follow-up|4|||
94254819|NCT02752074|322726393|FG000|Overall Study|Death|146|||
94619308|NCT05399641|324068218|FG000|Overall Study|Adverse Event|0|||
94619309|NCT05399641|324068219|FG001|Overall Study|Adverse Event|1|||
94619310|NCT05399641|324068220|FG002|Overall Study|Adverse Event|1|||
94619311|NCT05399641|324068218|FG000|Overall Study|Lost to Follow-up|1|||
94619312|NCT05399641|324068219|FG001|Overall Study|Lost to Follow-up|2|||
94254820|NCT02752074|322726394|FG001|Overall Study|Death|129|||
94254821|NCT02752074|322726393|FG000|Overall Study|Withdrawal by Subject|9|||
94461164|NCT02231879|323478210|FG001|Overall Study|Adverse Event|1|||
94619313|NCT05399641|324068220|FG002|Overall Study|Lost to Follow-up|2|||
94619314|NCT05399641|324068218|FG000|Overall Study|Physician Decision|1|||
94619315|NCT05399641|324068219|FG001|Overall Study|Physician Decision|3|||
94619316|NCT05399641|324068220|FG002|Overall Study|Physician Decision|3|||
94619317|NCT05399641|324068218|FG000|Overall Study|Withdrawal by Subject|4|||
94619318|NCT05399641|324068219|FG001|Overall Study|Withdrawal by Subject|11|||
94619319|NCT05399641|324068220|FG002|Overall Study|Withdrawal by Subject|7|||
94619320|NCT05399641|324068218|FG000|Overall Study|Reason not defined|3|||
94619321|NCT05399641|324068219|FG001|Overall Study|Reason not defined|5|||
94619322|NCT05399641|324068220|FG002|Overall Study|Reason not defined|6|||
94619323|NCT02094677|324068221|FG000|Overall Study|Screening|3|||
94619324|NCT02094677|324068222|FG001|Overall Study|Screening|1|||
94619325|NCT00478231|324068223|FG000|Overall Study|Death|7|||
94619326|NCT00478231|324068223|FG000|Overall Study|Lack of Efficacy|47|||
94619327|NCT00478231|324068223|FG000|Overall Study|Lost to Follow-up|7|||
94619328|NCT00478231|324068223|FG000|Overall Study|Withdrawal by Subject|6|||
94619329|NCT00478231|324068223|FG000|Overall Study|Other|9|||
94619330|NCT00478231|324068223|FG000|Overall Study|Adverse Event|5|||
94619331|NCT00478231|324068223|FG000|Overall Study|Randomized, not treated|3|||
94619332|NCT00667875|324068224|FG000|Overall Study|Adverse Event|0|||
94619333|NCT00667875|324068225|FG001|Overall Study|Adverse Event|2|||
94619334|NCT00667875|324068226|FG002|Overall Study|Adverse Event|6|||
94619335|NCT00667875|324068224|FG000|Overall Study|Withdrawal by Subject|10|||
94619336|NCT00667875|324068225|FG001|Overall Study|Withdrawal by Subject|9|||
94619337|NCT00667875|324068226|FG002|Overall Study|Withdrawal by Subject|7|||
94619338|NCT02369016|324068227|FG000|Overall Study|AE associated with clinical disease progression|2|||
94619339|NCT02369016|324068228|FG001|Overall Study|AE associated with clinical disease progression|1|||
94619340|NCT02369016|324068227|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
94619341|NCT02369016|324068228|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
94619342|NCT02369016|324068227|FG000|Overall Study|Progressive disease - clinical progression|1|||
94619343|NCT02369016|324068228|FG001|Overall Study|Progressive disease - clinical progression|4|||
94619344|NCT02369016|324068227|FG000|Overall Study|withdrawal by patient|4|||
94619345|NCT02369016|324068228|FG001|Overall Study|withdrawal by patient|0|||
94619346|NCT02369016|324068227|FG000|Overall Study|Progressive disease - radiological progression|6|||
94619347|NCT02369016|324068228|FG001|Overall Study|Progressive disease - radiological progression|2|||
94619348|NCT00923156|324068231|FG000|Overall Study|Adverse Event|0|||
94619349|NCT00923156|324068232|FG001|Overall Study|Adverse Event|2|||
94619350|NCT00923156|324068233|FG002|Overall Study|Adverse Event|1|||
94619351|NCT00923156|324068231|FG000|Overall Study|Abnormal laboratory values|0|||
94619352|NCT00923156|324068232|FG001|Overall Study|Abnormal laboratory values|0|||
94619353|NCT00923156|324068233|FG002|Overall Study|Abnormal laboratory values|1|||
94619354|NCT00923156|324068231|FG000|Overall Study|Withdrawal by Subject|0|||
94619355|NCT00923156|324068232|FG001|Overall Study|Withdrawal by Subject|1|||
94619356|NCT00923156|324068233|FG002|Overall Study|Withdrawal by Subject|0|||
94619357|NCT00923156|324068231|FG000|Overall Study|Death|0|||
94619358|NCT00923156|324068232|FG001|Overall Study|Death|1|||
94619359|NCT00923156|324068233|FG002|Overall Study|Death|0|||
94619360|NCT00923156|324068231|FG000|Overall Study|Lack of Efficacy|0|||
94619361|NCT00923156|324068232|FG001|Overall Study|Lack of Efficacy|0|||
94619362|NCT00923156|324068233|FG002|Overall Study|Lack of Efficacy|1|||
94619363|NCT00939770|324068236|FG000|Overall Study|Adverse Event|1|||
94619364|NCT00939770|324068237|FG001|Overall Study|Adverse Event|1|||
94619365|NCT00939770|324068238|FG002|Overall Study|Adverse Event|0|||
94619366|NCT00939770|324068239|FG003|Overall Study|Adverse Event|0|||
94619367|NCT00939770|324068240|FG004|Overall Study|Adverse Event|6|||
94619368|NCT00939770|324068241|FG005|Overall Study|Adverse Event|2|||
94619369|NCT00939770|324068242|FG006|Overall Study|Adverse Event|1|||
94619370|NCT00939770|324068243|FG007|Overall Study|Adverse Event|1|||
94619371|NCT00939770|324068236|FG000|Overall Study|Lack of Efficacy|4|||
94619372|NCT00939770|324068237|FG001|Overall Study|Lack of Efficacy|6|||
94619373|NCT00939770|324068238|FG002|Overall Study|Lack of Efficacy|13|||
94254822|NCT02752074|322726394|FG001|Overall Study|Withdrawal by Subject|10|||
94254823|NCT00966277|322726396|FG000|Overall Study|Withdrawal by Subject|3|||
94254824|NCT00966277|322726397|FG001|Overall Study|Withdrawal by Subject|0|||
94254825|NCT00966277|322726396|FG000|Overall Study|Ineligible|1|||
94254826|NCT00966277|322726397|FG001|Overall Study|Ineligible|3|||
94254827|NCT00966277|322726396|FG000|Overall Study|Treatment Plan Changed|0|||
94254828|NCT00966277|322726397|FG001|Overall Study|Treatment Plan Changed|1|||
94254829|NCT03305731|322726401|FG000|Overall Study|Protocol Violation|1|||
94359169|NCT03426995|323098063|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
94619374|NCT00939770|324068239|FG003|Overall Study|Lack of Efficacy|9|||
94619375|NCT00939770|324068240|FG004|Overall Study|Lack of Efficacy|16|||
94619376|NCT00939770|324068241|FG005|Overall Study|Lack of Efficacy|8|||
94254830|NCT00402597|322726402|FG000|Overall Study|Death|15|||
94619377|NCT00939770|324068242|FG006|Overall Study|Lack of Efficacy|11|||
94619378|NCT00939770|324068243|FG007|Overall Study|Lack of Efficacy|1|||
94619379|NCT00939770|324068236|FG000|Overall Study|Lost to Follow-up|0|||
94619380|NCT00939770|324068237|FG001|Overall Study|Lost to Follow-up|0|||
94619381|NCT00939770|324068238|FG002|Overall Study|Lost to Follow-up|0|||
94619382|NCT00939770|324068239|FG003|Overall Study|Lost to Follow-up|0|||
94619383|NCT00939770|324068240|FG004|Overall Study|Lost to Follow-up|1|||
94619384|NCT00939770|324068241|FG005|Overall Study|Lost to Follow-up|0|||
94619385|NCT00939770|324068242|FG006|Overall Study|Lost to Follow-up|0|||
94619386|NCT00939770|324068243|FG007|Overall Study|Lost to Follow-up|0|||
94619387|NCT00939770|324068236|FG000|Overall Study|Physician Decision|0|||
94619388|NCT00939770|324068237|FG001|Overall Study|Physician Decision|0|||
94619389|NCT00939770|324068238|FG002|Overall Study|Physician Decision|2|||
94619390|NCT00939770|324068239|FG003|Overall Study|Physician Decision|0|||
94619391|NCT00939770|324068240|FG004|Overall Study|Physician Decision|7|||
94619392|NCT00939770|324068241|FG005|Overall Study|Physician Decision|1|||
94619393|NCT00939770|324068242|FG006|Overall Study|Physician Decision|0|||
94619394|NCT00939770|324068243|FG007|Overall Study|Physician Decision|6|||
94619395|NCT00939770|324068236|FG000|Overall Study|Protocol Violation|0|||
94619396|NCT00939770|324068237|FG001|Overall Study|Protocol Violation|0|||
94619397|NCT00939770|324068238|FG002|Overall Study|Protocol Violation|0|||
94619398|NCT00939770|324068239|FG003|Overall Study|Protocol Violation|0|||
94619399|NCT00939770|324068240|FG004|Overall Study|Protocol Violation|1|||
94619400|NCT00939770|324068241|FG005|Overall Study|Protocol Violation|0|||
94619401|NCT00939770|324068242|FG006|Overall Study|Protocol Violation|0|||
94619402|NCT00939770|324068243|FG007|Overall Study|Protocol Violation|0|||
94619403|NCT00939770|324068236|FG000|Overall Study|Withdrawal by Subject|0|||
94619404|NCT00939770|324068237|FG001|Overall Study|Withdrawal by Subject|1|||
94619405|NCT00939770|324068238|FG002|Overall Study|Withdrawal by Subject|5|||
94619406|NCT00939770|324068239|FG003|Overall Study|Withdrawal by Subject|2|||
94619407|NCT00939770|324068240|FG004|Overall Study|Withdrawal by Subject|6|||
94619408|NCT00939770|324068241|FG005|Overall Study|Withdrawal by Subject|0|||
94619409|NCT00939770|324068242|FG006|Overall Study|Withdrawal by Subject|2|||
94619410|NCT00939770|324068243|FG007|Overall Study|Withdrawal by Subject|2|||
94619411|NCT00751933|324068248|FG000|Overall Study|Withdrawal by Subject|0|||
94619412|NCT00751933|324068249|FG001|Overall Study|Withdrawal by Subject|1|||
94619413|NCT00751933|324068250|FG002|Overall Study|Withdrawal by Subject|0|||
94619414|NCT00751933|324068251|FG003|Overall Study|Withdrawal by Subject|0|||
94619415|NCT00751933|324068248|FG000|Overall Study|Physician Decision|0|||
94619416|NCT00751933|324068249|FG001|Overall Study|Physician Decision|0|||
94619417|NCT00751933|324068250|FG002|Overall Study|Physician Decision|1|||
94619418|NCT00751933|324068251|FG003|Overall Study|Physician Decision|1|||
94619419|NCT04094883|324068254|FG000|Overall Study|Withdrawal by Subject|1|||
94619420|NCT03298867|324068255|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
94619421|NCT03298867|324068256|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
94619422|NCT03298867|324068255|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
94619423|NCT03298867|324068256|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
94619424|NCT03298867|324068255|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
94619425|NCT03298867|324068256|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
94619426|NCT03298867|324068255|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
94619427|NCT03298867|324068256|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
94619428|NCT03298867|324068255|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
94619429|NCT03298867|324068256|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
94619430|NCT03298867|324068255|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
94619431|NCT03298867|324068256|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
94619432|NCT03298867|324068255|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
94619433|NCT03298867|324068256|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
94619434|NCT03298867|324068255|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
94619435|NCT03298867|324068256|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
94619436|NCT03298867|324068255|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
94619437|NCT03298867|324068256|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
94619438|NCT01273597|324068257|FG000|Overall Study|Adverse Event|5|||
94619439|NCT01273597|324068257|FG000|Overall Study|Underwent Kidney Transplantation|2|||
94619440|NCT01273597|324068257|FG000|Overall Study|Reason Not Reported|1|||
94619441|NCT01385566|324069390|FG000|Overall Study|Lost to Follow-up|1|||
94619442|NCT01385566|324069391|FG001|Overall Study|Lost to Follow-up|0|||
94619443|NCT01385566|324069392|FG002|Overall Study|Lost to Follow-up|0|||
94619444|NCT01385566|324069393|FG003|Overall Study|Lost to Follow-up|0|||
94619445|NCT01385566|324069394|FG004|Overall Study|Lost to Follow-up|0|||
94619446|NCT01385566|324069395|FG005|Overall Study|Lost to Follow-up|0|||
94619447|NCT01385566|324069390|FG000|Overall Study|Withdrawal by Subject|0|||
94619448|NCT01385566|324069391|FG001|Overall Study|Withdrawal by Subject|0|||
94619449|NCT01385566|324069392|FG002|Overall Study|Withdrawal by Subject|0|||
94619450|NCT01385566|324069393|FG003|Overall Study|Withdrawal by Subject|1|||
94619451|NCT01385566|324069394|FG004|Overall Study|Withdrawal by Subject|0|||
94254831|NCT00402597|322726403|FG001|Overall Study|Death|7|||
94619452|NCT01385566|324069395|FG005|Overall Study|Withdrawal by Subject|0|||
94619453|NCT03281577|324069398|FG000|Overall Study|Adverse Event|0|||
94619454|NCT03281577|324069399|FG001|Overall Study|Adverse Event|0|||
94619455|NCT03281577|324069400|FG002|Overall Study|Adverse Event|0|||
94619456|NCT03281577|324069401|FG003|Overall Study|Adverse Event|1|||
94619457|NCT03281577|324069398|FG000|Overall Study|Withdrawal by Subject|1|||
94667028|NCT04988308|324232825|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
94667029|NCT04988308|324232820|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
94667030|NCT04988308|324232821|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
94667031|NCT04988308|324232822|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
94667032|NCT04988308|324232823|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
94667033|NCT04988308|324232824|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
94667034|NCT04988308|324232825|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
94667035|NCT04988308|324232820|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
94667036|NCT04988308|324232821|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
94667037|NCT04988308|324232822|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
94667038|NCT04988308|324232823|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
94667039|NCT04988308|324232824|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
94667040|NCT04988308|324232825|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
94667041|NCT04988308|324232820|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
94667042|NCT04988308|324232821|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
94667043|NCT04988308|324232822|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
94667044|NCT04988308|324232823|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
94667045|NCT04988308|324232824|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
94667046|NCT04988308|324232825|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
94667047|NCT04988308|324232820|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
94667048|NCT04988308|324232821|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
94667049|NCT04988308|324232822|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
94667050|NCT04988308|324232823|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
94667051|NCT04988308|324232824|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
94667052|NCT04988308|324232825|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
94667053|NCT04988308|324232820|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
94667054|NCT04988308|324232821|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
94667055|NCT04988308|324232822|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
94667056|NCT04988308|324232823|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
94667057|NCT04988308|324232824|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
94667058|NCT04988308|324232825|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
94667059|NCT04988308|324232820|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
94667060|NCT04988308|324232821|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
94667061|NCT04988308|324232822|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
94667062|NCT04988308|324232823|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
94667063|NCT04988308|324232824|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
94667064|NCT04988308|324232825|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
94667065|NCT04988308|324232820|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
94667066|NCT04988308|324232821|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
94667067|NCT04988308|324232822|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
94667068|NCT04988308|324232823|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
94667069|NCT04988308|324232824|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
94667070|NCT04988308|324232825|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
94667071|NCT04988308|324232820|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
94667072|NCT04988308|324232821|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
94667073|NCT04988308|324232822|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
94667074|NCT04988308|324232823|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
94667075|NCT04988308|324232824|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
94667076|NCT04988308|324232825|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
94667077|NCT00506493|324232834|FG000|Overall Study|Death|6|||
94667078|NCT00506493|324232834|FG000|Overall Study|Withdrawal by Subject|5|||
94667079|NCT03147248|324234605|FG000|Overall Study|Adverse Event|0|||
94667080|NCT03147248|324234606|FG001|Overall Study|Adverse Event|2|||
94667081|NCT03147248|324234607|FG002|Overall Study|Adverse Event|2|||
94667082|NCT03147248|324234608|FG003|Overall Study|Adverse Event|2|||
94667083|NCT03147248|324234609|FG004|Overall Study|Adverse Event|6|||
94667084|NCT03147248|324234610|FG005|Overall Study|Adverse Event|11|||
94667085|NCT03147248|324234605|FG000|Overall Study|Disease progression|1|||
94667086|NCT03147248|324234606|FG001|Overall Study|Disease progression|0|||
94667087|NCT03147248|324234607|FG002|Overall Study|Disease progression|0|||
94667088|NCT03147248|324234608|FG003|Overall Study|Disease progression|0|||
94667089|NCT03147248|324234609|FG004|Overall Study|Disease progression|0|||
94667090|NCT03147248|324234610|FG005|Overall Study|Disease progression|2|||
94667091|NCT03147248|324234605|FG000|Overall Study|Withdrawal by Subject|0|||
94667092|NCT03147248|324234606|FG001|Overall Study|Withdrawal by Subject|0|||
94667093|NCT03147248|324234607|FG002|Overall Study|Withdrawal by Subject|0|||
94667094|NCT03147248|324234608|FG003|Overall Study|Withdrawal by Subject|0|||
94667095|NCT03147248|324234609|FG004|Overall Study|Withdrawal by Subject|12|||
94359170|NCT03426995|323098064|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
94359171|NCT03426995|323098065|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
94359172|NCT03426995|323098066|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
94359173|NCT03426995|323098067|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
94359174|NCT03426995|323098068|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
94359175|NCT03426995|323098069|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
94359176|NCT03426995|323098070|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
94359177|NCT03426995|323098071|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
94619458|NCT03281577|324069399|FG001|Overall Study|Withdrawal by Subject|0|||
94619459|NCT03281577|324069400|FG002|Overall Study|Withdrawal by Subject|0|||
94619460|NCT03281577|324069401|FG003|Overall Study|Withdrawal by Subject|0|||
94619461|NCT00115739|324069402|FG000|Overall Study|Lost to Follow-up|3|||
94619462|NCT02195583|324069406|FG000|Overall Study|Lost to Follow-up|1|||
94619463|NCT02195583|324069406|FG000|Overall Study|Withdrawal by Subject|4|||
94619464|NCT02195583|324069406|FG000|Overall Study|Adverse Event|2|||
94619465|NCT02195583|324069406|FG000|Overall Study|Other Reason|2|||
94619466|NCT01543958|324069407|FG000|Overall Study|Loss to follow-up|3|||
94619467|NCT01543958|324069407|FG000|Overall Study|ART initiation|1|||
94619468|NCT01434667|324069416|FG000|Overall Study|Lost to Follow-up|5|||
94667096|NCT03147248|324234610|FG005|Overall Study|Withdrawal by Subject|9|||
94667097|NCT03147248|324234605|FG000|Overall Study|Protocol Violation|0|||
94359178|NCT03426995|323098072|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
94359179|NCT02279888|323098073|FG000|Overall Study|Death|326|||
94359180|NCT02279888|323098073|FG000|Overall Study|Withdrawal by Subject|38|||
94619469|NCT01434667|324069417|FG001|Overall Study|Lost to Follow-up|10|||
94619470|NCT00064337|324069422|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
94619471|NCT00064337|324069422|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
94619472|NCT00064337|324069422|FG000|PBSCC or Induction/PBSCC|Progression|3|||
94667098|NCT03147248|324234606|FG001|Overall Study|Protocol Violation|0|||
94667099|NCT03147248|324234607|FG002|Overall Study|Protocol Violation|0|||
94667100|NCT03147248|324234608|FG003|Overall Study|Protocol Violation|0|||
94667101|NCT03147248|324234609|FG004|Overall Study|Protocol Violation|2|||
94667102|NCT03147248|324234610|FG005|Overall Study|Protocol Violation|0|||
94667103|NCT03147248|324234605|FG000|Overall Study|Lost to Follow-up|0|||
94667104|NCT03147248|324234606|FG001|Overall Study|Lost to Follow-up|0|||
94667105|NCT03147248|324234607|FG002|Overall Study|Lost to Follow-up|0|||
94667106|NCT03147248|324234608|FG003|Overall Study|Lost to Follow-up|0|||
94619473|NCT00064337|324069422|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
94619474|NCT00064337|324069422|FG000|PBSCC or Induction/PBSCC|Death|2|||
94619475|NCT00064337|324069422|FG000|Transplant|Adverse Event|9|||
94619476|NCT00064337|324069422|FG000|Transplant|Not protocol-specified|5|||
94619477|NCT00064337|324069422|FG000|Transplant|Death|3|||
94619478|NCT00064337|324069422|FG000|Transplant|Patient Refusal|2|||
94619479|NCT00064337|324069422|FG000|Transplant|Progression|2|||
94619480|NCT00064337|324069422|FG000|Maintenance|Adverse Event|3|||
94619481|NCT00064337|324069422|FG000|Maintenance|Progression|2|||
94619482|NCT00064337|324069422|FG000|Maintenance|On treatment at time of analysis|2|||
94619483|NCT00064337|324069422|FG000|Maintenance|Not protocol-specified|2|||
94619484|NCT00064337|324069422|FG000|Maintenance|Death|1|||
94619485|NCT02279420|324069427|FG000|Overall Study|Lost to Follow-up|23|||
94619486|NCT02835820|324069430|FG000|Overall Study|Baseline Screen Failure|0|||
94619487|NCT02835820|324069431|FG001|Overall Study|Baseline Screen Failure|3|||
94619488|NCT01706146|324069434|FG000|Overall Study|Withdrawal by Subject|1|||
94619489|NCT01706146|324069434|FG000|Overall Study|Adverse Event|3|||
94619490|NCT01706146|324069434|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
94619491|NCT03969212|324069441|FG000|Overall Study|Adverse Event|1|||
94619492|NCT03969212|324069442|FG001|Overall Study|Adverse Event|0|||
94619493|NCT03969212|324069443|FG002|Overall Study|Adverse Event|0|||
94619494|NCT03969212|324069444|FG003|Overall Study|Adverse Event|0|||
94619495|NCT03969212|324069441|FG000|Overall Study|Lost to Follow-up|2|||
94619496|NCT03969212|324069442|FG001|Overall Study|Lost to Follow-up|2|||
94619497|NCT03969212|324069443|FG002|Overall Study|Lost to Follow-up|2|||
94619498|NCT03969212|324069444|FG003|Overall Study|Lost to Follow-up|2|||
94619499|NCT03969212|324069441|FG000|Overall Study|Protocol Violation|0|||
94619500|NCT03969212|324069442|FG001|Overall Study|Protocol Violation|0|||
94619501|NCT03969212|324069443|FG002|Overall Study|Protocol Violation|0|||
94619502|NCT03969212|324069444|FG003|Overall Study|Protocol Violation|1|||
94619503|NCT03969212|324069441|FG000|Overall Study|Withdrawal by Subject|7|||
94619504|NCT03969212|324069442|FG001|Overall Study|Withdrawal by Subject|13|||
94619505|NCT03969212|324069443|FG002|Overall Study|Withdrawal by Subject|5|||
94619506|NCT03969212|324069444|FG003|Overall Study|Withdrawal by Subject|11|||
94619507|NCT03969212|324069441|FG000|Overall Study|Physician Decision|0|||
94619508|NCT03969212|324069442|FG001|Overall Study|Physician Decision|0|||
94619509|NCT03969212|324069443|FG002|Overall Study|Physician Decision|1|||
94619510|NCT03969212|324069444|FG003|Overall Study|Physician Decision|0|||
94619511|NCT03969212|324069441|FG000|Overall Study|Reason not Specified|22|||
94619512|NCT03969212|324069442|FG001|Overall Study|Reason not Specified|23|||
94619513|NCT03969212|324069443|FG002|Overall Study|Reason not Specified|28|||
94619514|NCT03969212|324069444|FG003|Overall Study|Reason not Specified|26|||
94619515|NCT05393895|324069445|FG000|Overall Study|Adverse Event|2|||
94619516|NCT05393895|324069446|FG001|Overall Study|Adverse Event|3|||
94619517|NCT05393895|324069445|FG000|Overall Study|Lost to Follow-up|4|||
94619518|NCT05393895|324069446|FG001|Overall Study|Lost to Follow-up|3|||
94619519|NCT05393895|324069445|FG000|Overall Study|Protocol Violation|1|||
94619520|NCT05393895|324069446|FG001|Overall Study|Protocol Violation|0|||
94619521|NCT05393895|324069445|FG000|Overall Study|Withdrawal by Subject|1|||
94619522|NCT05393895|324069446|FG001|Overall Study|Withdrawal by Subject|4|||
94619523|NCT00968513|324069449|FG000|Overall Study|Death|4|||
94619524|NCT00968513|324069450|FG001|Overall Study|Death|10|||
94619525|NCT00968513|324069451|FG002|Overall Study|Death|15|||
94619526|NCT05537883|324069452|FG000|Overall Study|revisional surgery|4|||
94619527|NCT05537883|324069453|FG001|Overall Study|revisional surgery|2|||
94619528|NCT05537883|324069452|FG000|Overall Study|surgeries were cancelled|0|||
94619529|NCT05537883|324069453|FG001|Overall Study|surgeries were cancelled|2|||
94619530|NCT05537883|324069452|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
94619531|NCT05537883|324069453|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
94619532|NCT01302834|324069454|FG000|Overall Study|Protocol Violation|17|||
94619533|NCT01302834|324069455|FG001|Overall Study|Protocol Violation|23|||
94619534|NCT01302834|324069454|FG000|Overall Study|HIV positive|1|||
94619535|NCT01302834|324069455|FG001|Overall Study|HIV positive|3|||
94619536|NCT04447794|324069461|FG000|Overall Study|Lost to Follow-up|2|||
94619537|NCT04447794|324069462|FG001|Overall Study|Lost to Follow-up|3|||
94619538|NCT04447794|324069463|FG002|Overall Study|Lost to Follow-up|8|||
94619539|NCT04447794|324069461|FG000|Overall Study|Withdrawal by Subject|1|||
94619540|NCT04447794|324069462|FG001|Overall Study|Withdrawal by Subject|1|||
94619541|NCT04447794|324069463|FG002|Overall Study|Withdrawal by Subject|0|||
94619542|NCT02801396|324069465|FG000|Period 1|Withdrawal by Subject|0|||
94667107|NCT03147248|324234609|FG004|Overall Study|Lost to Follow-up|2|||
94667108|NCT03147248|324234610|FG005|Overall Study|Lost to Follow-up|0|||
94667109|NCT03147248|324234605|FG000|Overall Study|Pregnancy|0|||
94667110|NCT03147248|324234606|FG001|Overall Study|Pregnancy|0|||
94667111|NCT03147248|324234607|FG002|Overall Study|Pregnancy|0|||
94667112|NCT03147248|324234608|FG003|Overall Study|Pregnancy|0|||
94667113|NCT03147248|324234609|FG004|Overall Study|Pregnancy|1|||
94667114|NCT03147248|324234610|FG005|Overall Study|Pregnancy|0|||
94667115|NCT03147248|324234605|FG000|Overall Study|Death|0|||
94667116|NCT03147248|324234606|FG001|Overall Study|Death|0|||
94667117|NCT03147248|324234607|FG002|Overall Study|Death|0|||
94667118|NCT03147248|324234608|FG003|Overall Study|Death|0|||
94667119|NCT03147248|324234609|FG004|Overall Study|Death|0|||
94667120|NCT03147248|324234610|FG005|Overall Study|Death|4|||
94667121|NCT03147248|324234605|FG000|Overall Study|Physician Decision|0|||
94667122|NCT03147248|324234606|FG001|Overall Study|Physician Decision|0|||
94667123|NCT03147248|324234607|FG002|Overall Study|Physician Decision|0|||
94667124|NCT03147248|324234608|FG003|Overall Study|Physician Decision|0|||
94667125|NCT03147248|324234609|FG004|Overall Study|Physician Decision|2|||
94667126|NCT03147248|324234610|FG005|Overall Study|Physician Decision|4|||
94667127|NCT03147248|324234605|FG000|Overall Study|Prolonged Dosing Interval|0|||
94667128|NCT03147248|324234606|FG001|Overall Study|Prolonged Dosing Interval|0|||
94667129|NCT03147248|324234607|FG002|Overall Study|Prolonged Dosing Interval|0|||
94667130|NCT03147248|324234608|FG003|Overall Study|Prolonged Dosing Interval|0|||
94667131|NCT03147248|324234609|FG004|Overall Study|Prolonged Dosing Interval|1|||
94667132|NCT03147248|324234610|FG005|Overall Study|Prolonged Dosing Interval|1|||
94667133|NCT02207816|324234611|FG000|Overall Study|Serious Adverse Event|0|||
94667134|NCT02207816|324234612|FG001|Overall Study|Serious Adverse Event|5|||
94667135|NCT02207816|324234613|FG002|Overall Study|Serious Adverse Event|2|||
94667136|NCT02207816|324234611|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
94667137|NCT02207816|324234612|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
94667138|NCT02207816|324234613|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
94667139|NCT02207816|324234611|FG000|Overall Study|Withdrawal by Subject|4|||
94667140|NCT02207816|324234612|FG001|Overall Study|Withdrawal by Subject|9|||
94667141|NCT02207816|324234613|FG002|Overall Study|Withdrawal by Subject|7|||
94667142|NCT02207816|324234611|FG000|Overall Study|Migrated/Moved From Study Area|41|||
94667143|NCT02207816|324234612|FG001|Overall Study|Migrated/Moved From Study Area|60|||
94667144|NCT02207816|324234613|FG002|Overall Study|Migrated/Moved From Study Area|51|||
94667145|NCT02207816|324234611|FG000|Overall Study|Lost to Follow-up|3|||
94667146|NCT02207816|324234612|FG001|Overall Study|Lost to Follow-up|9|||
94667147|NCT02207816|324234613|FG002|Overall Study|Lost to Follow-up|1|||
94667148|NCT02207816|324234611|FG000|Overall Study|Other|1|||
94667149|NCT02207816|324234612|FG001|Overall Study|Other|2|||
94667150|NCT02207816|324234613|FG002|Overall Study|Other|4|||
94667151|NCT04066114|324234614|FG000|Overall Study|Adverse Event|1|||
94667152|NCT04066114|324234615|FG001|Overall Study|Adverse Event|0|||
94667153|NCT04066114|324234616|FG002|Overall Study|Adverse Event|0|||
94667154|NCT04066114|324234614|FG000|Overall Study|Withdrawal by Subject|1|||
94667155|NCT04066114|324234615|FG001|Overall Study|Withdrawal by Subject|0|||
94667156|NCT04066114|324234616|FG002|Overall Study|Withdrawal by Subject|0|||
94667157|NCT04066114|324234614|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
94667158|NCT04066114|324234615|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
94667159|NCT04066114|324234616|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
94667160|NCT00254982|324234617|FG000|Overall Study|Other|2|||
94667161|NCT00254982|324234618|FG001|Overall Study|Other|1|||
94667162|NCT00254982|324234617|FG000|Overall Study|Lack of Efficacy|5|||
94667163|NCT00254982|324234618|FG001|Overall Study|Lack of Efficacy|3|||
94667164|NCT00254982|324234617|FG000|Overall Study|Lost to Follow-up|5|||
94667165|NCT00254982|324234618|FG001|Overall Study|Lost to Follow-up|3|||
94667166|NCT00254982|324234617|FG000|Overall Study|Adverse Event|18|||
94461165|NCT02231879|323478209|FG000|Overall Study|Lack of Efficacy|0|||
94667167|NCT00254982|324234618|FG001|Overall Study|Adverse Event|16|||
94667168|NCT00254982|324234617|FG000|Overall Study|Withdrawal by Subject|1|||
94667169|NCT00254982|324234618|FG001|Overall Study|Withdrawal by Subject|1|||
94667170|NCT00254982|324234617|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
94461166|NCT02231879|323478210|FG001|Overall Study|Lack of Efficacy|1|||
94667171|NCT00254982|324234618|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
94667172|NCT00254982|324234617|FG000|Overall Study|Protocol deviation|1|||
94461167|NCT00373958|323478211|FG000|Infant Series|Withdrawal by Subject|13|||
94667173|NCT00254982|324234618|FG001|Overall Study|Protocol deviation|1|||
94667174|NCT00254982|324234617|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
94667175|NCT00254982|324234618|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
94667176|NCT00254982|324234617|FG000|Overall Study|Malignancy|0|||
94461168|NCT00373958|323478212|FG001|Infant Series|Withdrawal by Subject|15|||
94667177|NCT00254982|324234618|FG001|Overall Study|Malignancy|2|||
94667178|NCT00254982|324234617|FG000|Overall Study|Opportunistic infection|1|||
94667179|NCT00254982|324234618|FG001|Overall Study|Opportunistic infection|0|||
94667180|NCT00254982|324234617|FG000|Overall Study|Abnormal liver function tests|2|||
94667181|NCT00254982|324234618|FG001|Overall Study|Abnormal liver function tests|1|||
94254832|NCT00402597|322726404|FG002|Overall Study|Death|6|||
94254833|NCT00402597|322726405|FG003|Overall Study|Death|4|||
94254834|NCT00402597|322726406|FG004|Overall Study|Death|6|||
94254835|NCT00402597|322726402|FG000|Overall Study|Adverse Event|81|||
94254836|NCT00402597|322726403|FG001|Overall Study|Adverse Event|18|||
94254837|NCT00402597|322726404|FG002|Overall Study|Adverse Event|106|||
94254838|NCT00402597|322726405|FG003|Overall Study|Adverse Event|39|||
94254839|NCT00402597|322726406|FG004|Overall Study|Adverse Event|71|||
94254840|NCT00402597|322726402|FG000|Overall Study|Lost to Follow-up|8|||
94359181|NCT02279888|323098073|FG000|Overall Study|Lost to Follow-up|21|||
94359182|NCT02279888|323098073|FG000|Overall Study|Physician Decision|62|||
94359183|NCT02279888|323098073|FG000|Overall Study|Subject Non-compliance|43|||
94359184|NCT02279888|323098073|FG000|Overall Study|Not implanted|14|||
94359185|NCT02279888|323098073|FG000|Overall Study|Visit not performed|26|||
94359186|NCT04505592|323098074|FG000|Overall Study|Death|2|||
94359187|NCT04505592|323098075|FG001|Overall Study|Death|1|||
94359188|NCT00752206|323098079|FG000|Overall Study|Disease progression|8|||
94359189|NCT00752206|323098080|FG001|Overall Study|Disease progression|11|||
94359190|NCT00752206|323098079|FG000|Overall Study|Pregnancy|1|||
94619543|NCT02801396|324069466|FG001|Period 1|Withdrawal by Subject|0|||
94619544|NCT02801396|324069467|FG002|Period 1|Withdrawal by Subject|0|||
94619545|NCT02801396|324069468|FG003|Period 1|Withdrawal by Subject|0|||
94619546|NCT02801396|324069469|FG004|Period 1|Withdrawal by Subject|1|||
94619547|NCT02801396|324069470|FG005|Period 1|Withdrawal by Subject|0|||
94619548|NCT01306942|324069471|FG000|Phase I|Adverse Event|2|||
94619549|NCT01306942|324069472|FG001|Phase I|Adverse Event|2|||
94619550|NCT01306942|324069473|FG002|Phase I|Adverse Event|0|||
94619551|NCT01306942|324069474|FG003|Phase I|Adverse Event|0|||
94619552|NCT01306942|324069471|FG000|Phase I|Physician Decision|3|||
94619553|NCT01306942|324069472|FG001|Phase I|Physician Decision|1|||
94619554|NCT01306942|324069473|FG002|Phase I|Physician Decision|0|||
94619555|NCT01306942|324069474|FG003|Phase I|Physician Decision|0|||
94619556|NCT01306942|324069471|FG000|Phase II|Adverse Event|0|||
94619557|NCT01306942|324069472|FG001|Phase II|Adverse Event|0|||
94619558|NCT01306942|324069473|FG002|Phase II|Adverse Event|0|||
94619559|NCT01306942|324069474|FG003|Phase II|Adverse Event|6|||
94619560|NCT01306942|324069471|FG000|Phase II|Physician Decision|2|||
94619561|NCT01306942|324069472|FG001|Phase II|Physician Decision|0|||
94619562|NCT01306942|324069473|FG002|Phase II|Physician Decision|0|||
94619563|NCT01306942|324069474|FG003|Phase II|Physician Decision|5|||
94619564|NCT01306942|324069471|FG000|Phase II|Withdrawal by Subject|0|||
94619565|NCT01306942|324069472|FG001|Phase II|Withdrawal by Subject|0|||
94619566|NCT01306942|324069473|FG002|Phase II|Withdrawal by Subject|0|||
94619567|NCT01306942|324069474|FG003|Phase II|Withdrawal by Subject|2|||
94619568|NCT01306942|324069471|FG000|Phase II|Death|0|||
94619569|NCT01306942|324069472|FG001|Phase II|Death|0|||
94619570|NCT01306942|324069473|FG002|Phase II|Death|0|||
94619571|NCT01306942|324069474|FG003|Phase II|Death|1|||
94619572|NCT01306942|324069471|FG000|Phase II|Not finished treatment|0|||
94619573|NCT01306942|324069472|FG001|Phase II|Not finished treatment|0|||
94619574|NCT01306942|324069473|FG002|Phase II|Not finished treatment|0|||
94619575|NCT01306942|324069474|FG003|Phase II|Not finished treatment|1|||
94619576|NCT01306942|324069471|FG000|Phase II|Protocol Violation|0|||
94619577|NCT01306942|324069472|FG001|Phase II|Protocol Violation|0|||
94619578|NCT01306942|324069473|FG002|Phase II|Protocol Violation|0|||
94619579|NCT01306942|324069474|FG003|Phase II|Protocol Violation|1|||
94619580|NCT00602797|324069480|FG000|Overall Study|Adverse Event|1|||
94619581|NCT00743483|324069481|FG000|Baseline Period|Physician Decision|1|||
94619582|NCT00743483|324069481|FG000|Treatment Period|Adverse Event|1|||
94619583|NCT02777333|324069482|FG000|Overall Study|Withdrawal by Subject|0|||
94619584|NCT02777333|324069483|FG001|Overall Study|Withdrawal by Subject|1|||
94619585|NCT02777333|324069482|FG000|Overall Study|Lost to Follow-up|0|||
94619586|NCT02777333|324069483|FG001|Overall Study|Lost to Follow-up|1|||
94359191|NCT00752206|323098080|FG001|Overall Study|Pregnancy|0|||
94359192|NCT00678652|323098081|FG000|Overall Study|Protocol Violation|2|||
94359193|NCT00678652|323098082|FG001|Overall Study|Protocol Violation|0|||
94359194|NCT00678652|323098083|FG002|Overall Study|Protocol Violation|0|||
94619587|NCT03307967|324069484|FG000|Overall Study|Lost to Follow-up|4|||
94619588|NCT03278873|324069487|FG000|Overall Study|Withdrawal by Subject|0|||
94619589|NCT03278873|324069488|FG001|Overall Study|Withdrawal by Subject|1|||
94359195|NCT00678652|323098084|FG003|Overall Study|Protocol Violation|0|||
94619590|NCT03278873|324069489|FG002|Overall Study|Withdrawal by Subject|0|||
94619591|NCT03278873|324069490|FG003|Overall Study|Withdrawal by Subject|0|||
94619592|NCT03278873|324069487|FG000|Overall Study|Sponsor's decision|0|||
94254841|NCT00402597|322726403|FG001|Overall Study|Lost to Follow-up|1|||
94254842|NCT00402597|322726404|FG002|Overall Study|Lost to Follow-up|8|||
94359196|NCT00678652|323098081|FG000|Overall Study|Pregnancy|0|||
94619593|NCT03278873|324069488|FG001|Overall Study|Sponsor's decision|1|||
94619594|NCT03278873|324069489|FG002|Overall Study|Sponsor's decision|0|||
94619595|NCT03278873|324069490|FG003|Overall Study|Sponsor's decision|0|||
94619596|NCT03278873|324069487|FG000|Overall Study|Early Termination|2|||
94619597|NCT03278873|324069488|FG001|Overall Study|Early Termination|6|||
94619598|NCT03278873|324069489|FG002|Overall Study|Early Termination|0|||
94254843|NCT00402597|322726405|FG003|Overall Study|Lost to Follow-up|2|||
94254844|NCT00402597|322726406|FG004|Overall Study|Lost to Follow-up|3|||
94254845|NCT00402597|322726402|FG000|Overall Study|Withdrawal by Subject|57|||
94254846|NCT00402597|322726403|FG001|Overall Study|Withdrawal by Subject|16|||
94254847|NCT00402597|322726404|FG002|Overall Study|Withdrawal by Subject|65|||
94254848|NCT00402597|322726405|FG003|Overall Study|Withdrawal by Subject|15|||
94254849|NCT00402597|322726406|FG004|Overall Study|Withdrawal by Subject|24|||
94254850|NCT00402597|322726402|FG000|Overall Study|reason not specified|30|||
94254851|NCT00402597|322726403|FG001|Overall Study|reason not specified|4|||
94254852|NCT00402597|322726404|FG002|Overall Study|reason not specified|27|||
94254853|NCT00402597|322726405|FG003|Overall Study|reason not specified|14|||
94254854|NCT00402597|322726406|FG004|Overall Study|reason not specified|20|||
94254855|NCT01831856|322726407|FG000|Overall Study|Adverse Event|5|||
94254856|NCT01831856|322726408|FG001|Overall Study|Adverse Event|8|||
94254857|NCT01831856|322726407|FG000|Overall Study|Lack of Efficacy|13|||
94254858|NCT01831856|322726408|FG001|Overall Study|Lack of Efficacy|11|||
94254859|NCT01831856|322726407|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
94254860|NCT01831856|322726408|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
94359197|NCT00678652|323098082|FG001|Overall Study|Pregnancy|0|||
94359198|NCT00678652|323098083|FG002|Overall Study|Pregnancy|1|||
94619599|NCT03278873|324069490|FG003|Overall Study|Early Termination|4|||
94619600|NCT03278873|324069487|FG000|Overall Study|Lost to Follow-up|0|||
94619601|NCT03278873|324069488|FG001|Overall Study|Lost to Follow-up|0|||
94619602|NCT03278873|324069489|FG002|Overall Study|Lost to Follow-up|2|||
94619603|NCT03278873|324069490|FG003|Overall Study|Lost to Follow-up|0|||
94619604|NCT03278873|324069487|FG000|Overall Study|The patient decided to withdraw via email|1|||
94619605|NCT03278873|324069488|FG001|Overall Study|The patient decided to withdraw via email|0|||
94619606|NCT03278873|324069489|FG002|Overall Study|The patient decided to withdraw via email|0|||
94619607|NCT03278873|324069490|FG003|Overall Study|The patient decided to withdraw via email|0|||
94619608|NCT03278873|324069487|FG000|Overall Study|The patient was unresponsive to contact|0|||
94619609|NCT03278873|324069488|FG001|Overall Study|The patient was unresponsive to contact|0|||
94619610|NCT03278873|324069489|FG002|Overall Study|The patient was unresponsive to contact|0|||
94619611|NCT03278873|324069490|FG003|Overall Study|The patient was unresponsive to contact|4|||
94619612|NCT03278873|324069487|FG000|Overall Study|The patient wished to participate no longer|0|||
94619613|NCT03278873|324069488|FG001|Overall Study|The patient wished to participate no longer|1|||
94619614|NCT03278873|324069489|FG002|Overall Study|The patient wished to participate no longer|0|||
94619615|NCT03278873|324069490|FG003|Overall Study|The patient wished to participate no longer|0|||
94619616|NCT03278873|324069487|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
94619617|NCT03278873|324069488|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
94619618|NCT03278873|324069489|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
94619619|NCT03278873|324069490|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
94619620|NCT05243641|324069491|FG000|Overall Study|Adverse Event|3|||
94619621|NCT05243641|324069492|FG001|Overall Study|Adverse Event|0|||
94619622|NCT05243641|324069493|FG002|Overall Study|Adverse Event|0|||
94619623|NCT05243641|324069494|FG003|Overall Study|Adverse Event|1|||
94619624|NCT05243641|324069495|FG004|Overall Study|Adverse Event|0|||
94619625|NCT05243641|324069496|FG005|Overall Study|Adverse Event|0|||
94619626|NCT05243641|324069491|FG000|Overall Study|Disease progression|4|||
94619627|NCT05243641|324069492|FG001|Overall Study|Disease progression|0|||
94619628|NCT05243641|324069493|FG002|Overall Study|Disease progression|0|||
94619629|NCT05243641|324069494|FG003|Overall Study|Disease progression|2|||
94619630|NCT05243641|324069495|FG004|Overall Study|Disease progression|0|||
94619631|NCT05243641|324069496|FG005|Overall Study|Disease progression|0|||
94619632|NCT05695209|324069497|FG000|3-months|Withdrawal by Subject|2|||
94619633|NCT05695209|324069498|FG001|3-months|Withdrawal by Subject|0|||
94619634|NCT05695209|324069497|FG000|3-months|Unable to contact for 3-month data collection|0|||
94619635|NCT05695209|324069498|FG001|3-months|Unable to contact for 3-month data collection|1|||
94359199|NCT00678652|323098084|FG003|Overall Study|Pregnancy|0|||
94619636|NCT05695209|324069497|FG000|6-months|Lost to Follow-up|1|||
94619637|NCT05695209|324069498|FG001|6-months|Lost to Follow-up|1|||
94619638|NCT04362072|324069502|FG000|Treatment|Adverse Event|1|||
94619639|NCT04362072|324069502|FG000|Treatment|Death|9|||
94619640|NCT04362072|324069502|FG000|Treatment|Physician Decision|2|||
94619641|NCT04362072|324069502|FG000|Treatment|Progressive disease|27|||
94254861|NCT05208866|322726409|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
94359200|NCT00678652|323098081|FG000|Overall Study|Relocation|1|||
94359201|NCT00678652|323098082|FG001|Overall Study|Relocation|0|||
94359202|NCT00678652|323098083|FG002|Overall Study|Relocation|0|||
94359203|NCT00678652|323098084|FG003|Overall Study|Relocation|0|||
94359204|NCT01015118|323098086|FG000|Overall Study|Protocol Violation|5|||
94359205|NCT01015118|323098087|FG001|Overall Study|Protocol Violation|6|||
94359206|NCT01015118|323098086|FG000|Overall Study|Withdrawal by Subject|103|||
94619642|NCT04362072|324069502|FG000|Treatment|Withdrawal by Subject|4|||
94619643|NCT04362072|324069502|FG000|Treatment|Global deterioration of health status|1|||
94619644|NCT04362072|324069502|FG000|Treatment|Switched to commercial Lorlatinib|13|||
94619645|NCT04362072|324069502|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
94619646|NCT04362072|324069502|FG000|Treatment|Other|3|||
94619647|NCT04362072|324069502|FG000|Follow up|Death|2|||
94619648|NCT04362072|324069502|FG000|Follow up|Other|2|||
94619649|NCT04292743|324069508|FG000|Overall Study|Physician Decision|1|||
94619650|NCT04292743|324069509|FG001|Overall Study|Physician Decision|3|||
94619651|NCT04292743|324069510|FG002|Overall Study|Physician Decision|0|||
94667182|NCT00448539|324234633|FG000|Overall Study|Medication non-compliance|4|||
94667183|NCT00448539|324234634|FG001|Overall Study|Medication non-compliance|1|||
94667184|NCT00448539|324234633|FG000|Overall Study|Protocol Violation|1|||
94667185|NCT00448539|324234634|FG001|Overall Study|Protocol Violation|0|||
94667186|NCT00448539|324234633|FG000|Overall Study|Request of the investigator or sponsor|67|||
94667187|NCT00448539|324234634|FG001|Overall Study|Request of the investigator or sponsor|54|||
94667188|NCT00448539|324234633|FG000|Overall Study|Withdrawal by Subject|20|||
94667189|NCT00448539|324234634|FG001|Overall Study|Withdrawal by Subject|24|||
94667190|NCT00448539|324234633|FG000|Overall Study|Diary non-compliance|1|||
94667191|NCT00448539|324234634|FG001|Overall Study|Diary non-compliance|0|||
94667192|NCT00448539|324234633|FG000|Overall Study|Adverse Event|9|||
94667193|NCT00448539|324234634|FG001|Overall Study|Adverse Event|26|||
94667194|NCT00448539|324234633|FG000|Overall Study|Lack of Efficacy|27|||
94667195|NCT00448539|324234634|FG001|Overall Study|Lack of Efficacy|40|||
94667196|NCT00448539|324234633|FG000|Overall Study|Miscellaneous|2|||
94667197|NCT00448539|324234634|FG001|Overall Study|Miscellaneous|1|||
94667198|NCT00448539|324234633|FG000|Overall Study|Change of meds|2|||
94667199|NCT00448539|324234634|FG001|Overall Study|Change of meds|3|||
94667200|NCT00448539|324234633|FG000|Overall Study|Lost to Follow-up|1|||
94667201|NCT00448539|324234634|FG001|Overall Study|Lost to Follow-up|3|||
94619652|NCT04292743|324069511|FG003|Overall Study|Physician Decision|0|||
94619653|NCT04292743|324069508|FG000|Overall Study|Withdrawal by Subject|0|||
94619654|NCT04292743|324069509|FG001|Overall Study|Withdrawal by Subject|5|||
94619655|NCT04292743|324069510|FG002|Overall Study|Withdrawal by Subject|0|||
94619656|NCT04292743|324069511|FG003|Overall Study|Withdrawal by Subject|0|||
94619657|NCT04292743|324069508|FG000|Overall Study|Death|0|||
94667202|NCT01816594|324234640|FG000|Overall Study|Local Progress|0|||
94667203|NCT01816594|324234641|FG001|Overall Study|Local Progress|2|||
94667204|NCT01816594|324234640|FG000|Overall Study|Adverse Event|9|||
94667205|NCT01816594|324234641|FG001|Overall Study|Adverse Event|0|||
94667206|NCT01816594|324234640|FG000|Overall Study|Withdrawal by Subject|1|||
94667207|NCT01816594|324234641|FG001|Overall Study|Withdrawal by Subject|0|||
94667208|NCT01816594|324234640|FG000|Overall Study|Physician Decision|1|||
94667209|NCT01816594|324234641|FG001|Overall Study|Physician Decision|0|||
94667210|NCT04004611|324234645|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
94667211|NCT04004611|324234646|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
94667212|NCT04004611|324234647|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
94667213|NCT04004611|324234648|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
94667214|NCT04004611|324234649|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
94667215|NCT04004611|324234650|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
94667216|NCT04004611|324234651|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
94254862|NCT00836095|322726412|FG000|Overall Study|Physician Decision|0|||
94254863|NCT00836095|322726413|FG001|Overall Study|Physician Decision|3|||
94619658|NCT04292743|324069509|FG001|Overall Study|Death|1|||
94619659|NCT04292743|324069510|FG002|Overall Study|Death|0|||
94619660|NCT04292743|324069511|FG003|Overall Study|Death|0|||
94667217|NCT04004611|324234652|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
94667218|NCT04004611|324234653|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
94667219|NCT04004611|324234645|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
94667220|NCT04004611|324234646|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
94461169|NCT00373958|323478211|FG000|Infant Series|Failed to return|8|||
94619661|NCT04292743|324069508|FG000|Overall Study|Progression of Disease|2|||
94619662|NCT04292743|324069509|FG001|Overall Study|Progression of Disease|5|||
94619663|NCT04292743|324069510|FG002|Overall Study|Progression of Disease|0|||
94619664|NCT04292743|324069511|FG003|Overall Study|Progression of Disease|0|||
94619665|NCT04292743|324069508|FG000|Overall Study|No Treatment per protocol|0|||
94619666|NCT04292743|324069509|FG001|Overall Study|No Treatment per protocol|2|||
94619667|NCT04292743|324069510|FG002|Overall Study|No Treatment per protocol|0|||
94619668|NCT04292743|324069511|FG003|Overall Study|No Treatment per protocol|0|||
94619669|NCT05996718|324070623|FG000|Overall Study|Lost to Follow-up|3|||
94619670|NCT02562235|324070624|FG000|Overall Study|Adverse Event|3|||
94619671|NCT06956170|324070625|FG000|Overall Study|Death|2|||
94619672|NCT06956170|324070626|FG001|Overall Study|Death|1|||
94619673|NCT06956170|324070625|FG000|Overall Study|Withdrawal by Subject|1|||
94619674|NCT06956170|324070626|FG001|Overall Study|Withdrawal by Subject|0|||
94619675|NCT06956170|324070625|FG000|Overall Study|Ongoing|7|||
94619676|NCT06956170|324070626|FG001|Overall Study|Ongoing|10|||
94619677|NCT02025621|324070629|FG000|Overall Study|Withdrawal by Subject|1|||
94619678|NCT02025621|324070630|FG001|Overall Study|Withdrawal by Subject|0|||
94619679|NCT02025621|324070629|FG000|Overall Study|Death|0|||
94619680|NCT02025621|324070630|FG001|Overall Study|Death|1|||
94619681|NCT02025621|324070629|FG000|Overall Study|No longer eligible|10|||
94619682|NCT02025621|324070630|FG001|Overall Study|No longer eligible|15|||
94619683|NCT02025621|324070629|FG000|Overall Study|Surgery initiated before infusion|3|||
94619684|NCT02025621|324070630|FG001|Overall Study|Surgery initiated before infusion|3|||
94619685|NCT00844831|324070632|FG000|Overall Study|Withdrawal by Subject|4|||
94619686|NCT00844831|324070632|FG000|Overall Study|Adverse Event|1|||
94667221|NCT04004611|324234647|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
94667222|NCT04004611|324234648|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
94667223|NCT04004611|324234649|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
94667224|NCT04004611|324234650|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
94667225|NCT04004611|324234651|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
94667226|NCT04004611|324234652|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
94667227|NCT04004611|324234653|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
94254864|NCT01718353|322726414|FG000|Overall Study|Lost to Follow-up|0|||
94254865|NCT01718353|322726415|FG001|Overall Study|Lost to Follow-up|1|||
94254866|NCT01718353|322726414|FG000|Overall Study|Principal Investigator's Decision|10|||
94254867|NCT01718353|322726415|FG001|Overall Study|Principal Investigator's Decision|4|||
94254868|NCT01718353|322726414|FG000|Overall Study|Randomized but not treated|2|||
94254869|NCT01718353|322726415|FG001|Overall Study|Randomized but not treated|0|||
94254870|NCT01691768|322726423|FG000|Overall Study|Death|0|||
94254871|NCT01691768|322726424|FG001|Overall Study|Death|2|||
94254872|NCT01691768|322726423|FG000|Overall Study|Lost to Follow-up|4|||
94254873|NCT01691768|322726424|FG001|Overall Study|Lost to Follow-up|3|||
94254874|NCT01691768|322726423|FG000|Overall Study|Withdrawal by Subject|10|||
94254875|NCT01691768|322726424|FG001|Overall Study|Withdrawal by Subject|9|||
94254876|NCT01691768|322726423|FG000|Overall Study|Relocated|0|||
94254877|NCT01691768|322726424|FG001|Overall Study|Relocated|1|||
94254878|NCT01691768|322726423|FG000|Overall Study|Investigator decision|1|||
94254879|NCT01691768|322726424|FG001|Overall Study|Investigator decision|1|||
94254880|NCT00819390|322726425|FG000|Overall Study|Lost to Follow-up|1|||
94254881|NCT00819390|322726426|FG001|Overall Study|Lost to Follow-up|1|||
94254882|NCT00819390|322726427|FG002|Overall Study|Lost to Follow-up|0|||
94254883|NCT00819390|322726428|FG003|Overall Study|Lost to Follow-up|0|||
94254884|NCT00819390|322726425|FG000|Overall Study|Withdrawal by Subject|2|||
94254885|NCT00819390|322726426|FG001|Overall Study|Withdrawal by Subject|0|||
94254886|NCT00819390|322726427|FG002|Overall Study|Withdrawal by Subject|0|||
94254887|NCT00819390|322726428|FG003|Overall Study|Withdrawal by Subject|0|||
94254888|NCT00819390|322726425|FG000|Overall Study|Adverse Event|0|||
94254889|NCT00819390|322726426|FG001|Overall Study|Adverse Event|0|||
94254890|NCT00819390|322726427|FG002|Overall Study|Adverse Event|1|||
94254891|NCT00819390|322726428|FG003|Overall Study|Adverse Event|0|||
94254892|NCT00906945|322726429|FG000|Overall Study|Found to be not eligible|0|||
94254893|NCT00906945|322726430|FG001|Overall Study|Found to be not eligible|0|||
94254894|NCT00906945|322726431|FG002|Overall Study|Found to be not eligible|0|||
94619687|NCT00844831|324070632|FG000|Overall Study|Physician Decision|1|||
94619688|NCT02550106|324070635|FG000|Overall Study|Adverse Event|1|||
94619689|NCT02550106|324070635|FG000|Overall Study|Lack of Efficacy|3|||
94619690|NCT02550106|324070635|FG000|Overall Study|Protocol Violation|6|||
94619691|NCT02550106|324070635|FG000|Overall Study|Withdrawal by Subject|2|||
94619692|NCT01709513|324070636|FG000|Overall Study|Randomized but not treated|0|||
94619693|NCT01709513|324070637|FG001|Overall Study|Randomized but not treated|1|||
94619694|NCT01709513|324070638|FG002|Overall Study|Randomized but not treated|0|||
94619695|NCT01709513|324070636|FG000|Overall Study|Adverse Event|16|||
94619696|NCT01709513|324070637|FG001|Overall Study|Adverse Event|31|||
94619697|NCT01709513|324070638|FG002|Overall Study|Adverse Event|23|||
94619698|NCT01709513|324070636|FG000|Overall Study|Poor compliance to protocol|2|||
94619699|NCT01709513|324070637|FG001|Overall Study|Poor compliance to protocol|0|||
94619700|NCT01709513|324070638|FG002|Overall Study|Poor compliance to protocol|0|||
94619701|NCT01709513|324070636|FG000|Overall Study|Other|3|||
94619702|NCT01709513|324070637|FG001|Overall Study|Other|11|||
94619703|NCT01709513|324070638|FG002|Overall Study|Other|7|||
94619704|NCT03797014|324070639|FG000|Overall Study|Withdrawal by Subject|1|||
94619705|NCT03797014|324070639|FG000|Overall Study|Lost to Follow-up|1|||
94619706|NCT03797014|324070639|FG000|Overall Study|Protocol Violation|1|||
94619707|NCT01970397|324070640|FG000|Overall Study|Adverse Event|0|||
94619708|NCT01970397|324070641|FG001|Overall Study|Adverse Event|1|||
94619709|NCT01970397|324070640|FG000|Overall Study|Lost to Follow-up|0|||
94619710|NCT01970397|324070641|FG001|Overall Study|Lost to Follow-up|1|||
94619711|NCT01970397|324070640|FG000|Overall Study|Personal Reasons|1|||
94619712|NCT01970397|324070641|FG001|Overall Study|Personal Reasons|2|||
94619713|NCT01970397|324070640|FG000|Overall Study|Protocol Violation|1|||
94619714|NCT01970397|324070641|FG001|Overall Study|Protocol Violation|1|||
94619715|NCT01749137|324070646|FG000|Overall Study|Adverse Event|4|||
94619716|NCT01749137|324070647|FG001|Overall Study|Adverse Event|4|||
94619717|NCT01749137|324070646|FG000|Overall Study|Lost to Follow-up|2|||
94619718|NCT01749137|324070647|FG001|Overall Study|Lost to Follow-up|3|||
94619719|NCT01749137|324070646|FG000|Overall Study|Physician Decision|1|||
94619720|NCT01749137|324070647|FG001|Overall Study|Physician Decision|0|||
94619721|NCT01749137|324070646|FG000|Overall Study|Withdrawal by Subject|8|||
94619722|NCT01749137|324070647|FG001|Overall Study|Withdrawal by Subject|4|||
94619723|NCT01947582|324070655|FG000|Overall Study|Withdrawal by Subject|1|||
94619724|NCT04160195|324070656|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
94619725|NCT04160195|324070657|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
94619726|NCT02763462|324070658|FG000|Overall Study|Protocol Violation|6|||
94619727|NCT05209360|324070659|FG000|Overall Study|Withdrawal by Subject|0|||
94619728|NCT05209360|324070660|FG001|Overall Study|Withdrawal by Subject|0|||
94619729|NCT05209360|324070661|FG002|Overall Study|Withdrawal by Subject|1|||
94619730|NCT05209360|324070662|FG003|Overall Study|Withdrawal by Subject|0|||
94619731|NCT05209360|324070663|FG004|Overall Study|Withdrawal by Subject|0|||
94619732|NCT05209360|324070664|FG005|Overall Study|Withdrawal by Subject|0|||
94619733|NCT03768414|324070673|FG000|Overall Study|Adverse Event or side effects|72|||
94619734|NCT03768414|324070674|FG001|Overall Study|Adverse Event or side effects|28|||
94619735|NCT03768414|324070673|FG000|Overall Study|Refusal unrelated to adverse event|33|||
94619736|NCT03768414|324070674|FG001|Overall Study|Refusal unrelated to adverse event|33|||
94619737|NCT03768414|324070673|FG000|Overall Study|Progression/relapse|132|||
94619738|NCT03768414|324070674|FG001|Overall Study|Progression/relapse|60|||
94619739|NCT03768414|324070673|FG000|Overall Study|Death|9|||
94619740|NCT03768414|324070674|FG001|Overall Study|Death|6|||
94619741|NCT03768414|324070673|FG000|Overall Study|Other - not protocol specified|45|||
94619742|NCT03768414|324070674|FG001|Overall Study|Other - not protocol specified|18|||
94619743|NCT03768414|324070673|FG000|Overall Study|Reason under review|3|||
94619744|NCT03768414|324070674|FG001|Overall Study|Reason under review|2|||
94619745|NCT04075266|324070675|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
94619746|NCT04075266|324070676|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
94619747|NCT04075266|324070675|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
94619748|NCT04075266|324070676|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
94619749|NCT03706079|324070677|FG000|Predecessor Study|Death|0|||
94619750|NCT03706079|324070678|FG001|Predecessor Study|Death|2|||
94619751|NCT03706079|324070679|FG002|Predecessor Study|Death|0|||
94619752|NCT03706079|324070680|FG003|Predecessor Study|Death|1|||
94619753|NCT03706079|324070681|FG004|Predecessor Study|Death|0|||
94619754|NCT03706079|324070682|FG005|Predecessor Study|Death|0|||
94619755|NCT03706079|324070677|FG000|Predecessor Study|Lost to Follow-up|5|||
94619756|NCT03706079|324070678|FG001|Predecessor Study|Lost to Follow-up|2|||
94619757|NCT03706079|324070679|FG002|Predecessor Study|Lost to Follow-up|0|||
94619758|NCT03706079|324070680|FG003|Predecessor Study|Lost to Follow-up|0|||
94619759|NCT03706079|324070681|FG004|Predecessor Study|Lost to Follow-up|1|||
94619760|NCT03706079|324070682|FG005|Predecessor Study|Lost to Follow-up|0|||
94619761|NCT03706079|324070677|FG000|Predecessor Study|Withdrawal by Subject|8|||
94619762|NCT03706079|324070678|FG001|Predecessor Study|Withdrawal by Subject|15|||
94619763|NCT03706079|324070679|FG002|Predecessor Study|Withdrawal by Subject|0|||
94619764|NCT03706079|324070680|FG003|Predecessor Study|Withdrawal by Subject|5|||
94619765|NCT03706079|324070681|FG004|Predecessor Study|Withdrawal by Subject|2|||
94619766|NCT03706079|324070682|FG005|Predecessor Study|Withdrawal by Subject|0|||
94619767|NCT03706079|324070677|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
94619768|NCT03706079|324070678|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
94359207|NCT01015118|323098087|FG001|Overall Study|Withdrawal by Subject|27|||
94359208|NCT01015118|323098086|FG000|Overall Study|Other Adverse Event (AE)|141|||
94359209|NCT01015118|323098087|FG001|Overall Study|Other Adverse Event (AE)|33|||
94359210|NCT01015118|323098086|FG000|Overall Study|Worsening or AE of underlying disease|5|||
94359211|NCT01015118|323098087|FG001|Overall Study|Worsening or AE of underlying disease|4|||
94359212|NCT01015118|323098086|FG000|Overall Study|Progressive disease|364|||
94359213|NCT01015118|323098087|FG001|Overall Study|Progressive disease|229|||
94359214|NCT01015118|323098086|FG000|Overall Study|Not treated|9|||
94359215|NCT01015118|323098087|FG001|Overall Study|Not treated|5|||
94359216|NCT01015118|323098086|FG000|Overall Study|Other than stated above|42|||
94359217|NCT01015118|323098087|FG001|Overall Study|Other than stated above|23|||
94359218|NCT00352664|323098091|FG000|Overall Study|Withdrawal by Subject|7|||
94359219|NCT00352664|323098092|FG001|Overall Study|Withdrawal by Subject|0|||
94359220|NCT05153629|323098094|FG000|Overall Study|Withdrawal by Subject|0|||
94359221|NCT05153629|323098095|FG001|Overall Study|Withdrawal by Subject|2|||
94359222|NCT03743571|323098096|FG000|Overall Study|Withdrawal by Subject|1|||
94359223|NCT03743571|323098097|FG001|Overall Study|Withdrawal by Subject|1|||
94359224|NCT03743571|323098096|FG000|Overall Study|Lost to Follow-up|1|||
94359225|NCT03743571|323098097|FG001|Overall Study|Lost to Follow-up|2|||
94359226|NCT01821391|323098098|FG000|Overall Study|Adverse Event|1|||
94359227|NCT01821391|323098099|FG001|Overall Study|Adverse Event|0|||
94359228|NCT03222856|323098110|FG000|Overall Study|Adverse Event|6|||
94359229|NCT03222856|323098110|FG000|Overall Study|Death|1|||
94359230|NCT03839693|323100227|FG000|Overall Study|Lost to Follow-up|0|||
94359231|NCT03839693|323100228|FG001|Overall Study|Lost to Follow-up|2|||
94359232|NCT03839693|323100229|FG002|Overall Study|Lost to Follow-up|2|||
94359233|NCT03839693|323100227|FG000|Overall Study|Withdrawal by Subject|1|||
94359234|NCT03839693|323100228|FG001|Overall Study|Withdrawal by Subject|0|||
94619769|NCT03706079|324070679|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
94619770|NCT03706079|324070680|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
94619771|NCT03706079|324070681|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
94619772|NCT03706079|324070682|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
94619773|NCT03706079|324070677|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
94619774|NCT03706079|324070678|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
94619775|NCT03706079|324070679|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
94619776|NCT03706079|324070680|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
94619777|NCT03706079|324070681|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
94619778|NCT03706079|324070682|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
94619779|NCT03706079|324070677|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
94619780|NCT03706079|324070678|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
94619781|NCT03706079|324070679|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
94619782|NCT03706079|324070680|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
94619783|NCT03706079|324070681|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
94619784|NCT03706079|324070682|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
94619785|NCT03706079|324070677|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
94619786|NCT03706079|324070678|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
94619787|NCT03706079|324070679|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
94619788|NCT03706079|324070680|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
94619789|NCT03706079|324070681|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
94619790|NCT03706079|324070682|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
94619791|NCT03706079|324070677|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
94619792|NCT03706079|324070678|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
94619793|NCT03706079|324070679|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
94619794|NCT03706079|324070680|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
94667228|NCT04004611|324234645|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
94667229|NCT04004611|324234646|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
94667230|NCT04004611|324234647|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
94359235|NCT03839693|323100229|FG002|Overall Study|Withdrawal by Subject|2|||
94359236|NCT03839693|323100227|FG000|Overall Study|subject moved out of the area|1|||
94359237|NCT03839693|323100228|FG001|Overall Study|subject moved out of the area|0|||
94359238|NCT03839693|323100229|FG002|Overall Study|subject moved out of the area|0|||
94359239|NCT00270205|323100238|FG000|Overall Study|Lost to Follow-up|1|||
94359240|NCT00270205|323100239|FG001|Overall Study|Lost to Follow-up|0|||
94359241|NCT00270205|323100240|FG002|Overall Study|Lost to Follow-up|0|||
94359242|NCT00270205|323100241|FG003|Overall Study|Lost to Follow-up|1|||
94359243|NCT00066573|323100245|FG000|Overall Study|Did not received protocol treatment|28|||
94667231|NCT04004611|324234648|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
94254895|NCT00906945|322726432|FG003|Overall Study|Found to be not eligible|1|||
94254896|NCT00906945|322726433|FG004|Overall Study|Found to be not eligible|1|||
94254897|NCT00906945|322726434|FG005|Overall Study|Found to be not eligible|1|||
94254898|NCT00906945|322726429|FG000|Overall Study|Physician Decision|0|||
94254899|NCT00906945|322726430|FG001|Overall Study|Physician Decision|0|||
94254900|NCT00906945|322726431|FG002|Overall Study|Physician Decision|0|||
94254901|NCT00906945|322726432|FG003|Overall Study|Physician Decision|0|||
94254902|NCT00906945|322726433|FG004|Overall Study|Physician Decision|0|||
94619795|NCT03706079|324070681|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
94619796|NCT03706079|324070682|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
94619797|NCT03706079|324070677|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
94619798|NCT03706079|324070678|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
94619799|NCT03706079|324070679|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
94619800|NCT03706079|324070680|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
94619801|NCT03706079|324070681|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
94619802|NCT03706079|324070682|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
94619803|NCT03706079|324070677|FG000|Long Term Extension (DESTINATION)|Death|8|||
94619804|NCT03706079|324070678|FG001|Long Term Extension (DESTINATION)|Death|2|||
94619805|NCT03706079|324070679|FG002|Long Term Extension (DESTINATION)|Death|2|||
94619806|NCT03706079|324070680|FG003|Long Term Extension (DESTINATION)|Death|1|||
94619807|NCT03706079|324070681|FG004|Long Term Extension (DESTINATION)|Death|0|||
94619808|NCT03706079|324070682|FG005|Long Term Extension (DESTINATION)|Death|0|||
94619809|NCT01697566|324070685|FG000|Overall Study|Withdrawal by Subject|0|||
94619810|NCT01697566|324070686|FG001|Overall Study|Withdrawal by Subject|0|||
94619811|NCT01697566|324070687|FG002|Overall Study|Withdrawal by Subject|1|||
94619812|NCT01697566|324070688|FG003|Overall Study|Withdrawal by Subject|1|||
94619813|NCT01697566|324070685|FG000|Overall Study|Final biopsy not obtained|0|||
94619814|NCT01697566|324070686|FG001|Overall Study|Final biopsy not obtained|0|||
94619815|NCT01697566|324070687|FG002|Overall Study|Final biopsy not obtained|1|||
94619816|NCT01697566|324070688|FG003|Overall Study|Final biopsy not obtained|0|||
94619817|NCT01964430|324070689|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
94619818|NCT01964430|324070690|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
94619819|NCT01964430|324070689|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
94619820|NCT01964430|324070690|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
94619821|NCT01964430|324070689|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
94619822|NCT01964430|324070690|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
94619823|NCT01964430|324070689|FG000|Treatment Period|Adverse Event|71|||
94619824|NCT01964430|324070690|FG001|Treatment Period|Adverse Event|37|||
94619825|NCT01964430|324070689|FG000|Treatment Period|Withdrawal by Subject|36|||
94619826|NCT01964430|324070690|FG001|Treatment Period|Withdrawal by Subject|27|||
94619827|NCT01964430|324070689|FG000|Treatment Period|Death|1|||
94619828|NCT01964430|324070690|FG001|Treatment Period|Death|3|||
94619829|NCT01964430|324070689|FG000|Treatment Period|Protocol Deviation|0|||
94619830|NCT01964430|324070690|FG001|Treatment Period|Protocol Deviation|1|||
94619831|NCT01964430|324070689|FG000|Treatment Period|Physician Decision|5|||
94619832|NCT01964430|324070690|FG001|Treatment Period|Physician Decision|4|||
94619833|NCT01964430|324070689|FG000|Treatment Period|Disease Relapse|28|||
94619834|NCT01964430|324070690|FG001|Treatment Period|Disease Relapse|38|||
94619835|NCT01964430|324070689|FG000|Treatment Period|Other reasons|1|||
94619836|NCT01964430|324070690|FG001|Treatment Period|Other reasons|3|||
94619837|NCT01350492|324070693|FG000|Intervention|Lost to Follow-up|2|||
94619838|NCT01350492|324070694|FG001|Intervention|Lost to Follow-up|5|||
94619839|NCT01350492|324070693|FG000|Intervention|Withdrawal by Subject|3|||
94619840|NCT01350492|324070694|FG001|Intervention|Withdrawal by Subject|1|||
94619841|NCT01350492|324070693|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
94619842|NCT01350492|324070694|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
94619843|NCT01350492|324070693|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
94619844|NCT01350492|324070694|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
94619845|NCT03087643|324070699|FG000|Overall Study|Withdrawal by Subject|2|||
94619846|NCT03087643|324070700|FG001|Overall Study|Withdrawal by Subject|4|||
94619847|NCT03087643|324070699|FG000|Overall Study|Death|2|||
94619848|NCT03087643|324070700|FG001|Overall Study|Death|2|||
94619849|NCT01217801|324070702|FG000|Period 1|Protocol Violation|1|||
94619850|NCT01217801|324070703|FG001|Period 1|Protocol Violation|1|||
94619851|NCT01217801|324070702|FG000|Period 1|Withdrawal by Subject|0|||
94619852|NCT01217801|324070703|FG001|Period 1|Withdrawal by Subject|1|||
94619853|NCT01300650|324070704|FG000|Overall Study|Adverse Event|1|||
94619854|NCT01201850|324070707|FG000|Overall Study|Tumor progression|4|||
94619855|NCT02657369|324070708|FG000|Overall Study|Death|27|||
94619856|NCT02657369|324070708|FG000|Overall Study|Study terminated by sponsor|7|||
94254903|NCT00906945|322726434|FG005|Overall Study|Physician Decision|1|||
94254904|NCT01768637|322726435|FG000|Overall Study|Lost to Follow-up|2|||
94254905|NCT01768637|322726436|FG001|Overall Study|Lost to Follow-up|7|||
94254906|NCT01768637|322726435|FG000|Overall Study|Difficult blood draw|1|||
94667232|NCT04004611|324234649|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
94667233|NCT04004611|324234650|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
94667234|NCT04004611|324234651|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
94667235|NCT04004611|324234652|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
94667236|NCT04004611|324234653|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
94667237|NCT04004611|324234645|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
94667238|NCT04004611|324234646|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
94667239|NCT04004611|324234647|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
94667240|NCT04004611|324234648|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
94667241|NCT04004611|324234649|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
94667242|NCT04004611|324234650|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
94667243|NCT04004611|324234651|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
94667244|NCT04004611|324234652|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
94667245|NCT04004611|324234653|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
94667246|NCT04004611|324234645|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
94667247|NCT04004611|324234646|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
94667248|NCT04004611|324234647|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
94667249|NCT04004611|324234648|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
94667250|NCT04004611|324234649|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
94667251|NCT04004611|324234650|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
94667252|NCT04004611|324234651|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
94667253|NCT04004611|324234652|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
94667254|NCT04004611|324234653|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
94619857|NCT02339584|324070709|FG000|Overall Study|Adverse Event|11|||
94619858|NCT02339584|324070710|FG001|Overall Study|Adverse Event|7|||
94619859|NCT02339584|324070709|FG000|Overall Study|Lack of Efficacy|0|||
94619860|NCT02339584|324070710|FG001|Overall Study|Lack of Efficacy|1|||
94619861|NCT02339584|324070709|FG000|Overall Study|Physician Decision|1|||
94619862|NCT02339584|324070710|FG001|Overall Study|Physician Decision|2|||
94619863|NCT02339584|324070709|FG000|Overall Study|Protocol Violation|1|||
94619864|NCT02339584|324070710|FG001|Overall Study|Protocol Violation|1|||
94619865|NCT02339584|324070709|FG000|Overall Study|Withdrawal by Subject|2|||
94619866|NCT02339584|324070710|FG001|Overall Study|Withdrawal by Subject|4|||
94619867|NCT00873912|324070713|FG000|Overall Study|Withdrawal by Subject|1|||
94619868|NCT00873912|324070714|FG001|Overall Study|Withdrawal by Subject|0|||
94619869|NCT00873912|324070713|FG000|Overall Study|Lost to Follow-up|2|||
94619870|NCT00873912|324070714|FG001|Overall Study|Lost to Follow-up|0|||
94619871|NCT01088997|324070717|FG000|Overall Study|Physician Decision|1|||
94619872|NCT01088997|324070718|FG001|Overall Study|Physician Decision|1|||
94619873|NCT01088997|324070717|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
94619874|NCT01088997|324070718|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
94619875|NCT01088997|324070717|FG000|Overall Study|Excluded prior to receiving drug|1|||
94619876|NCT01088997|324070718|FG001|Overall Study|Excluded prior to receiving drug|1|||
94619877|NCT02302807|324070719|FG000|Overall Study|Withdrawal by Subject|28|||
94619878|NCT02302807|324070720|FG001|Overall Study|Withdrawal by Subject|11|||
94619879|NCT02302807|324070719|FG000|Overall Study|Lost to Follow-up|4|||
94619880|NCT02302807|324070720|FG001|Overall Study|Lost to Follow-up|6|||
94667255|NCT04004611|324234645|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
94254907|NCT01768637|322726436|FG001|Overall Study|Difficult blood draw|0|||
94254908|NCT02481947|322726437|FG000|Overall Study|Withdrawal by Subject|24|||
94254909|NCT02481947|322726438|FG001|Overall Study|Withdrawal by Subject|10|||
94254910|NCT02481947|322726437|FG000|Overall Study|Lost to Follow-up|11|||
94254911|NCT02481947|322726438|FG001|Overall Study|Lost to Follow-up|5|||
94254912|NCT02481947|322726437|FG000|Overall Study|Adverse Event|6|||
94254913|NCT02481947|322726438|FG001|Overall Study|Adverse Event|11|||
94254914|NCT02481947|322726437|FG000|Overall Study|Physician Decision|4|||
94254915|NCT02481947|322726438|FG001|Overall Study|Physician Decision|5|||
94254916|NCT02481947|322726437|FG000|Overall Study|Protocol Violation|1|||
94254917|NCT02481947|322726438|FG001|Overall Study|Protocol Violation|5|||
94254918|NCT01054170|322726439|FG000|Overall Study|Protocol Violation|1|||
94254919|NCT01054170|322726440|FG001|Overall Study|Protocol Violation|0|||
94254920|NCT01054170|322726439|FG000|Overall Study|Withdrawal by Subject|3|||
94254921|NCT01054170|322726440|FG001|Overall Study|Withdrawal by Subject|2|||
94254922|NCT01054170|322726439|FG000|Overall Study|Adverse Event|0|||
94254923|NCT01054170|322726440|FG001|Overall Study|Adverse Event|4|||
94254924|NCT03814187|322726441|FG000|Overall Study|Sponsor's Administrative Decision|0|||
94254925|NCT03814187|322726442|FG001|Overall Study|Sponsor's Administrative Decision|0|||
94254926|NCT03814187|322726443|FG002|Overall Study|Sponsor's Administrative Decision|272|||
94254927|NCT03814187|322726441|FG000|Overall Study|Death|80|||
94254928|NCT03814187|322726442|FG001|Overall Study|Death|81|||
94461170|NCT00373958|323478212|FG001|Infant Series|Failed to return|13|||
94619881|NCT02302807|324070719|FG000|Overall Study|Death|397|||
94619882|NCT02302807|324070720|FG001|Overall Study|Death|385|||
94254929|NCT03814187|322726443|FG002|Overall Study|Death|4|||
94254930|NCT03814187|322726441|FG000|Overall Study|Withdrew Consent|77|||
94254931|NCT03814187|322726442|FG001|Overall Study|Withdrew Consent|78|||
94254932|NCT03814187|322726443|FG002|Overall Study|Withdrew Consent|2|||
94254933|NCT03814187|322726441|FG000|Overall Study|Lost to Follow-up|47|||
94254934|NCT03814187|322726442|FG001|Overall Study|Lost to Follow-up|52|||
94254935|NCT03814187|322726443|FG002|Overall Study|Lost to Follow-up|1|||
94254936|NCT03814187|322726441|FG000|Overall Study|Adverse Event|22|||
94254937|NCT03814187|322726442|FG001|Overall Study|Adverse Event|23|||
94254938|NCT03814187|322726443|FG002|Overall Study|Adverse Event|0|||
94254939|NCT03814187|322726441|FG000|Overall Study|Physician Decision|7|||
94619883|NCT02302807|324070719|FG000|Overall Study|Study Terminated By Sponsor|35|||
94619884|NCT02302807|324070720|FG001|Overall Study|Study Terminated By Sponsor|64|||
94619885|NCT02302807|324070719|FG000|Overall Study|Physician Decision|0|||
94619886|NCT02302807|324070720|FG001|Overall Study|Physician Decision|1|||
94619887|NCT05372419|324070722|FG000|Overall Study|Protocol Deviation|1|||
94619888|NCT05372419|324070722|FG000|Overall Study|Withdrawal by Subject|5|||
94619889|NCT05372419|324070722|FG000|Overall Study|Lost to Follow-up|7|||
94619890|NCT04698187|324070724|FG000|Overall Study|Withdrawal by Subject|7|||
94619891|NCT04698187|324070724|FG000|Overall Study|Death|21|||
94619892|NCT04698187|324070724|FG000|Overall Study|Sponsor Decision|15|||
94619893|NCT04698187|324070724|FG000|Overall Study|In-transit Disease|1|||
94619894|NCT05475236|324070725|FG000|Overall Study|Withdrawal by Subject|0|||
94619895|NCT05475236|324070726|FG001|Overall Study|Withdrawal by Subject|1|||
94619896|NCT03904043|324070727|FG000|Overall Study|Adverse Event|1|||
94619897|NCT03904043|324070728|FG001|Overall Study|Adverse Event|1|||
94619898|NCT03904043|324070727|FG000|Overall Study|Withdrawal by Subject|1|||
94619899|NCT03904043|324070728|FG001|Overall Study|Withdrawal by Subject|0|||
94619900|NCT03904043|324070727|FG000|Overall Study|Non-compliance|1|||
94619901|NCT03904043|324070728|FG001|Overall Study|Non-compliance|0|||
94619902|NCT03904043|324070727|FG000|Overall Study|Did not start treatment|1|||
94619903|NCT03904043|324070728|FG001|Overall Study|Did not start treatment|0|||
94619904|NCT04731363|324070739|FG000|Overall Study|Could not obtain samples|0|||
94619905|NCT04731363|324070740|FG001|Overall Study|Could not obtain samples|1|||
94619906|NCT04731363|324070741|FG002|Overall Study|Could not obtain samples|0|||
94619907|NCT04731363|324070742|FG003|Overall Study|Could not obtain samples|0|||
94619908|NCT04731363|324070739|FG000|Overall Study|Physician Decision|0|||
94619909|NCT04731363|324070740|FG001|Overall Study|Physician Decision|1|||
94619910|NCT04731363|324070741|FG002|Overall Study|Physician Decision|0|||
94619911|NCT04731363|324070742|FG003|Overall Study|Physician Decision|0|||
94619912|NCT02513394|324070743|FG000|Overall Study|Withdrawal by Subject|11|||
94619913|NCT02513394|324070744|FG001|Overall Study|Withdrawal by Subject|23|||
94619914|NCT02513394|324070743|FG000|Overall Study|Ineligible|1|||
94619915|NCT02513394|324070744|FG001|Overall Study|Ineligible|0|||
94619916|NCT05766423|324070745|FG000|Overall Study|Withdrawal by Subject|1|||
94619917|NCT05766423|324070746|FG001|Overall Study|Withdrawal by Subject|0|||
94619918|NCT05766423|324070745|FG000|Overall Study|Consented, not scheduled|3|||
94619919|NCT05766423|324070746|FG001|Overall Study|Consented, not scheduled|5|||
94619920|NCT05425745|324070747|FG000|Overall Study|Withdrawal of Consent|3|||
94619921|NCT05425745|324070748|FG001|Overall Study|Withdrawal of Consent|3|||
94619922|NCT05425745|324070747|FG000|Overall Study|Death|2|||
94619923|NCT05425745|324070748|FG001|Overall Study|Death|3|||
94619924|NCT05425745|324070747|FG000|Overall Study|Lost to Follow-up|1|||
94619925|NCT05425745|324070748|FG001|Overall Study|Lost to Follow-up|2|||
94619926|NCT05425745|324070747|FG000|Overall Study|Adverse Event|0|||
94619927|NCT05425745|324070748|FG001|Overall Study|Adverse Event|1|||
94619928|NCT05425745|324070747|FG000|Overall Study|Did not return for end of study visit|0|||
94619929|NCT05425745|324070748|FG001|Overall Study|Did not return for end of study visit|1|||
94619930|NCT05425745|324070747|FG000|Overall Study|End of study visit completed by phone|1|||
94619931|NCT05425745|324070748|FG001|Overall Study|End of study visit completed by phone|0|||
94619932|NCT05425745|324070747|FG000|Overall Study|Subject decision|1|||
94619933|NCT05425745|324070748|FG001|Overall Study|Subject decision|0|||
94619934|NCT00688753|324072488|FG000|Overall Study|Disease progression|55|||
94619935|NCT00688753|324072488|FG000|Overall Study|Missing|1|||
94619936|NCT00688753|324072488|FG000|Overall Study|Death|9|||
94619937|NCT00688753|324072488|FG000|Overall Study|Withdrawal by Subject|3|||
94619938|NCT00688753|324072488|FG000|Overall Study|Adverse Event|20|||
94254940|NCT03814187|322726442|FG001|Overall Study|Physician Decision|4|||
94254941|NCT03814187|322726443|FG002|Overall Study|Physician Decision|2|||
94254942|NCT03814187|322726441|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
94461171|NCT00373958|323478211|FG000|Infant Series|Lost to Follow-up|6|||
94619939|NCT00688753|324072488|FG000|Overall Study|Protocol Violation|1|||
94619940|NCT00688753|324072488|FG000|Overall Study|Lost to Follow-up|3|||
94619941|NCT01367002|324072489|FG000|Overall Study|Withdrawal by Subject|1|||
94619942|NCT01367002|324072490|FG001|Overall Study|Withdrawal by Subject|0|||
94619943|NCT01367002|324072489|FG000|Overall Study|Physician Decision|0|||
94619944|NCT01367002|324072490|FG001|Overall Study|Physician Decision|2|||
94619945|NCT01543698|324072491|FG000|Phase 1b|Disease progression|2|||
94359244|NCT00066573|323100246|FG001|Overall Study|Did not received protocol treatment|28|||
94359245|NCT01945034|323100247|FG000|Overall Study|Medication Error|0|||
94359246|NCT01945034|323100248|FG001|Overall Study|Medication Error|1|||
94359247|NCT01945034|323100249|FG002|Overall Study|Medication Error|0|||
94359248|NCT01945034|323100247|FG000|Overall Study|Withdrawal by Subject|0|||
94359249|NCT01945034|323100248|FG001|Overall Study|Withdrawal by Subject|3|||
94359250|NCT01945034|323100249|FG002|Overall Study|Withdrawal by Subject|1|||
94359251|NCT01945034|323100247|FG000|Overall Study|Other|0|||
94359252|NCT01945034|323100248|FG001|Overall Study|Other|1|||
94359253|NCT01945034|323100249|FG002|Overall Study|Other|3|||
94359254|NCT01945034|323100247|FG000|Overall Study|Lost to Follow-up|0|||
94359255|NCT01945034|323100248|FG001|Overall Study|Lost to Follow-up|0|||
94359256|NCT01945034|323100249|FG002|Overall Study|Lost to Follow-up|2|||
94359257|NCT01945034|323100247|FG000|Overall Study|Protocol Violation|1|||
94359258|NCT01945034|323100248|FG001|Overall Study|Protocol Violation|0|||
94359259|NCT01945034|323100249|FG002|Overall Study|Protocol Violation|1|||
94359260|NCT03053102|323100252|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
94359261|NCT03053102|323100252|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
94359262|NCT02147132|323100253|FG000|Overall Study|Lost to Follow-up|1|||
94359263|NCT02147132|323100254|FG001|Overall Study|Lost to Follow-up|0|||
94359264|NCT02147132|323100255|FG002|Overall Study|Lost to Follow-up|0|||
94359265|NCT02147132|323100256|FG003|Overall Study|Lost to Follow-up|0|||
94359266|NCT00822237|323100257|FG000|Dose 1 Vaccination|Not vaccinated|3|||
94359267|NCT00822237|323100258|FG001|Dose 1 Vaccination|Not vaccinated|0|||
94359268|NCT00822237|323100257|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
94359269|NCT00822237|323100258|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
94359270|NCT00822237|323100257|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
94359271|NCT00822237|323100258|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
94359272|NCT00822237|323100257|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
94359273|NCT00822237|323100258|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
94359274|NCT00822237|323100257|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
94359275|NCT00822237|323100258|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
94359276|NCT03433482|323100259|FG000|Overall Study|Lost to Follow-up|1|||
94359277|NCT03433482|323100260|FG001|Overall Study|Lost to Follow-up|0|||
94359278|NCT03433482|323100261|FG002|Overall Study|Lost to Follow-up|1|||
94359279|NCT03433482|323100262|FG003|Overall Study|Lost to Follow-up|1|||
94359280|NCT03433482|323100259|FG000|Overall Study|Withdrawal by Subject|0|||
94359281|NCT03433482|323100260|FG001|Overall Study|Withdrawal by Subject|0|||
94359282|NCT03433482|323100261|FG002|Overall Study|Withdrawal by Subject|1|||
94359283|NCT03433482|323100262|FG003|Overall Study|Withdrawal by Subject|0|||
94359284|NCT03433482|323100259|FG000|Overall Study|Unknown reason|0|||
94359285|NCT03433482|323100260|FG001|Overall Study|Unknown reason|0|||
94359286|NCT03433482|323100261|FG002|Overall Study|Unknown reason|2|||
94359287|NCT03433482|323100262|FG003|Overall Study|Unknown reason|0|||
94359288|NCT00437294|323100263|FG000|Overall Study|Adverse Event|5|||
94359289|NCT00437294|323100264|FG001|Overall Study|Adverse Event|4|||
94359290|NCT00437294|323100263|FG000|Overall Study|Death|5|||
94359291|NCT00437294|323100264|FG001|Overall Study|Death|2|||
94359292|NCT00437294|323100263|FG000|Overall Study|Physician Decision|0|||
94359293|NCT00437294|323100264|FG001|Overall Study|Physician Decision|3|||
94359294|NCT00437294|323100263|FG000|Overall Study|Withdrawal by Subject|5|||
94619946|NCT01543698|324072492|FG001|Phase 1b|Disease progression|4|||
94619947|NCT01543698|324072493|FG002|Phase 1b|Disease progression|3|||
94619948|NCT01543698|324072494|FG003|Phase 1b|Disease progression|2|||
94619949|NCT01543698|324072495|FG004|Phase 1b|Disease progression|10|||
94619950|NCT01543698|324072496|FG005|Phase 1b|Disease progression|6|||
94619951|NCT01543698|324072497|FG006|Phase 1b|Disease progression|5|||
94619952|NCT01543698|324072498|FG007|Phase 1b|Disease progression|3|||
94619953|NCT01543698|324072499|FG008|Phase 1b|Disease progression|4|||
94619954|NCT01543698|324072500|FG009|Phase 1b|Disease progression|5|||
94619955|NCT01543698|324072501|FG010|Phase 1b|Disease progression|1|||
94619956|NCT01543698|324072502|FG011|Phase 1b|Disease progression|0|||
94619957|NCT01543698|324072503|FG012|Phase 1b|Disease progression|0|||
94619958|NCT01543698|324072504|FG013|Phase 1b|Disease progression|0|||
94359295|NCT00437294|323100264|FG001|Overall Study|Withdrawal by Subject|0|||
94359296|NCT00437294|323100263|FG000|Overall Study|Progressive Disease|19|||
94359297|NCT00437294|323100264|FG001|Overall Study|Progressive Disease|23|||
94359298|NCT00437294|323100263|FG000|Overall Study|Sponsor Decision|8|||
94359299|NCT00437294|323100264|FG001|Overall Study|Sponsor Decision|9|||
94359300|NCT00437294|323100263|FG000|Overall Study|Protocol Violation|0|||
94359301|NCT00437294|323100264|FG001|Overall Study|Protocol Violation|1|||
94359302|NCT00437294|323100263|FG000|Overall Study|Entry criteria not met|1|||
94359303|NCT00437294|323100264|FG001|Overall Study|Entry criteria not met|1|||
94619959|NCT01543698|324072505|FG014|Phase 1b|Disease progression|0|||
94619960|NCT01543698|324072491|FG000|Phase 1b|Death|0|||
94619961|NCT01543698|324072492|FG001|Phase 1b|Death|0|||
94359304|NCT03323034|323100268|FG000|Overall Study|Lack of Efficacy|5|||
94359305|NCT03323034|323100269|FG001|Overall Study|Lack of Efficacy|5|||
94359306|NCT03323034|323100270|FG002|Overall Study|Lack of Efficacy|6|||
94359307|NCT03323034|323100271|FG003|Overall Study|Lack of Efficacy|5|||
94619962|NCT01543698|324072493|FG002|Phase 1b|Death|1|||
94667256|NCT04004611|324234646|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
94667257|NCT04004611|324234647|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
94667258|NCT04004611|324234648|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
94667259|NCT04004611|324234649|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
94667260|NCT04004611|324234650|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
94667261|NCT04004611|324234651|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
94667262|NCT04004611|324234652|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
94667263|NCT04004611|324234653|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
94667264|NCT00487162|324234656|FG000|Overall Study|Adverse Event|0|||
94667265|NCT00487162|324234657|FG001|Overall Study|Adverse Event|1|||
94667266|NCT00487162|324234656|FG000|Overall Study|Physician Decision|0|||
94667267|NCT00487162|324234657|FG001|Overall Study|Physician Decision|1|||
94667268|NCT00487162|324234656|FG000|Overall Study|Withdrawal by Subject|2|||
94667269|NCT00487162|324234657|FG001|Overall Study|Withdrawal by Subject|3|||
94667270|NCT00130533|324234659|FG000|Overall Study|Withdrawal by Subject|33|||
94667271|NCT00130533|324234660|FG001|Overall Study|Withdrawal by Subject|6|||
94667272|NCT00130533|324234659|FG000|Overall Study|Adverse Event|34|||
94667273|NCT00130533|324234660|FG001|Overall Study|Adverse Event|1|||
94667274|NCT00130533|324234659|FG000|Overall Study|Disease relapse|9|||
94667275|NCT00130533|324234660|FG001|Overall Study|Disease relapse|13|||
94619963|NCT01543698|324072494|FG003|Phase 1b|Death|1|||
94619964|NCT01543698|324072495|FG004|Phase 1b|Death|0|||
94619965|NCT01543698|324072496|FG005|Phase 1b|Death|0|||
94619966|NCT01543698|324072497|FG006|Phase 1b|Death|0|||
94619967|NCT01543698|324072498|FG007|Phase 1b|Death|0|||
94619968|NCT01543698|324072499|FG008|Phase 1b|Death|0|||
94619969|NCT01543698|324072500|FG009|Phase 1b|Death|0|||
94619970|NCT01543698|324072501|FG010|Phase 1b|Death|1|||
94619971|NCT01543698|324072502|FG011|Phase 1b|Death|0|||
94619972|NCT01543698|324072503|FG012|Phase 1b|Death|0|||
94619973|NCT01543698|324072504|FG013|Phase 1b|Death|0|||
94619974|NCT01543698|324072505|FG014|Phase 1b|Death|0|||
94619975|NCT01543698|324072491|FG000|Phase 1b|Withdrawal by Subject|0|||
94619976|NCT01543698|324072492|FG001|Phase 1b|Withdrawal by Subject|1|||
94619977|NCT01543698|324072493|FG002|Phase 1b|Withdrawal by Subject|0|||
94619978|NCT01543698|324072494|FG003|Phase 1b|Withdrawal by Subject|1|||
94619979|NCT01543698|324072495|FG004|Phase 1b|Withdrawal by Subject|0|||
94619980|NCT01543698|324072496|FG005|Phase 1b|Withdrawal by Subject|0|||
94619981|NCT01543698|324072497|FG006|Phase 1b|Withdrawal by Subject|1|||
94619982|NCT01543698|324072498|FG007|Phase 1b|Withdrawal by Subject|0|||
94619983|NCT01543698|324072499|FG008|Phase 1b|Withdrawal by Subject|0|||
94619984|NCT01543698|324072500|FG009|Phase 1b|Withdrawal by Subject|0|||
94619985|NCT01543698|324072501|FG010|Phase 1b|Withdrawal by Subject|0|||
94619986|NCT01543698|324072502|FG011|Phase 1b|Withdrawal by Subject|0|||
94619987|NCT01543698|324072503|FG012|Phase 1b|Withdrawal by Subject|0|||
94619988|NCT01543698|324072504|FG013|Phase 1b|Withdrawal by Subject|0|||
94667276|NCT00130533|324234659|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
94667277|NCT00130533|324234660|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
94667278|NCT00130533|324234659|FG000|Overall Study|Death|4|||
94667279|NCT00130533|324234660|FG001|Overall Study|Death|2|||
94619989|NCT01543698|324072505|FG014|Phase 1b|Withdrawal by Subject|0|||
94619990|NCT01543698|324072491|FG000|Phase 1b|Adverse Event|1|||
94619991|NCT01543698|324072492|FG001|Phase 1b|Adverse Event|0|||
94619992|NCT01543698|324072493|FG002|Phase 1b|Adverse Event|0|||
94619993|NCT01543698|324072494|FG003|Phase 1b|Adverse Event|1|||
94619994|NCT01543698|324072495|FG004|Phase 1b|Adverse Event|2|||
94619995|NCT01543698|324072496|FG005|Phase 1b|Adverse Event|2|||
94619996|NCT01543698|324072497|FG006|Phase 1b|Adverse Event|0|||
94619997|NCT01543698|324072498|FG007|Phase 1b|Adverse Event|0|||
94619998|NCT01543698|324072499|FG008|Phase 1b|Adverse Event|1|||
94619999|NCT01543698|324072500|FG009|Phase 1b|Adverse Event|1|||
94620000|NCT01543698|324072501|FG010|Phase 1b|Adverse Event|2|||
94359308|NCT03323034|323100272|FG004|Overall Study|Lack of Efficacy|5|||
94359309|NCT03323034|323100268|FG000|Overall Study|Physician Decision|0|||
94359310|NCT03323034|323100269|FG001|Overall Study|Physician Decision|0|||
94359311|NCT03323034|323100270|FG002|Overall Study|Physician Decision|0|||
94359312|NCT03323034|323100271|FG003|Overall Study|Physician Decision|0|||
94359313|NCT03323034|323100272|FG004|Overall Study|Physician Decision|1|||
94359314|NCT03323034|323100268|FG000|Overall Study|Withdrawal by Subject|1|||
94359315|NCT03323034|323100269|FG001|Overall Study|Withdrawal by Subject|1|||
94359316|NCT03323034|323100270|FG002|Overall Study|Withdrawal by Subject|0|||
94359317|NCT03323034|323100271|FG003|Overall Study|Withdrawal by Subject|1|||
94359318|NCT03323034|323100272|FG004|Overall Study|Withdrawal by Subject|0|||
94359319|NCT02646566|323100273|FG000|Overall Study|Lost to Follow-up|5|||
94359320|NCT02646566|323100274|FG001|Overall Study|Lost to Follow-up|4|||
94359321|NCT02646566|323100275|FG002|Overall Study|Lost to Follow-up|5|||
94359322|NCT02646566|323100273|FG000|Overall Study|Treatment failure|1|||
94359323|NCT02646566|323100274|FG001|Overall Study|Treatment failure|0|||
94359324|NCT02646566|323100275|FG002|Overall Study|Treatment failure|0|||
94359325|NCT04887922|323100276|FG000|1st Randomization|Decided not to have surgery|0|||
94359326|NCT04887922|323100277|FG001|1st Randomization|Decided not to have surgery|1|||
94359327|NCT04887922|323100278|FG002|1st Randomization|Decided not to have surgery|0|||
94359328|NCT04887922|323100279|FG003|1st Randomization|Decided not to have surgery|0|||
94620001|NCT01543698|324072502|FG011|Phase 1b|Adverse Event|0|||
94620002|NCT01543698|324072503|FG012|Phase 1b|Adverse Event|0|||
94620003|NCT01543698|324072504|FG013|Phase 1b|Adverse Event|0|||
94620004|NCT01543698|324072505|FG014|Phase 1b|Adverse Event|0|||
94620005|NCT01543698|324072491|FG000|Phase 1b|Administrative problems|1|||
94620006|NCT01543698|324072492|FG001|Phase 1b|Administrative problems|0|||
94620007|NCT01543698|324072493|FG002|Phase 1b|Administrative problems|0|||
94620008|NCT01543698|324072494|FG003|Phase 1b|Administrative problems|0|||
94620009|NCT01543698|324072495|FG004|Phase 1b|Administrative problems|1|||
94620010|NCT01543698|324072496|FG005|Phase 1b|Administrative problems|0|||
94620011|NCT01543698|324072497|FG006|Phase 1b|Administrative problems|0|||
94620012|NCT01543698|324072498|FG007|Phase 1b|Administrative problems|1|||
94620013|NCT01543698|324072499|FG008|Phase 1b|Administrative problems|0|||
94620014|NCT01543698|324072500|FG009|Phase 1b|Administrative problems|0|||
94620015|NCT01543698|324072501|FG010|Phase 1b|Administrative problems|2|||
94620016|NCT01543698|324072502|FG011|Phase 1b|Administrative problems|0|||
94620017|NCT01543698|324072503|FG012|Phase 1b|Administrative problems|0|||
94620018|NCT01543698|324072504|FG013|Phase 1b|Administrative problems|0|||
94620019|NCT01543698|324072505|FG014|Phase 1b|Administrative problems|0|||
94620020|NCT01543698|324072491|FG000|Phase 1b|Protocol Violation|2|||
94620021|NCT01543698|324072492|FG001|Phase 1b|Protocol Violation|0|||
94620022|NCT01543698|324072493|FG002|Phase 1b|Protocol Violation|0|||
94620023|NCT01543698|324072494|FG003|Phase 1b|Protocol Violation|0|||
94620024|NCT01543698|324072495|FG004|Phase 1b|Protocol Violation|0|||
94620025|NCT01543698|324072496|FG005|Phase 1b|Protocol Violation|0|||
94620026|NCT01543698|324072497|FG006|Phase 1b|Protocol Violation|0|||
94620027|NCT01543698|324072498|FG007|Phase 1b|Protocol Violation|0|||
94620028|NCT01543698|324072499|FG008|Phase 1b|Protocol Violation|0|||
94620029|NCT01543698|324072500|FG009|Phase 1b|Protocol Violation|0|||
94620030|NCT01543698|324072501|FG010|Phase 1b|Protocol Violation|0|||
94620031|NCT01543698|324072502|FG011|Phase 1b|Protocol Violation|0|||
94620032|NCT01543698|324072503|FG012|Phase 1b|Protocol Violation|0|||
94620033|NCT01543698|324072504|FG013|Phase 1b|Protocol Violation|0|||
94620034|NCT01543698|324072505|FG014|Phase 1b|Protocol Violation|0|||
94620035|NCT01543698|324072491|FG000|Phase 2|Protocol Violation|0|||
94620036|NCT01543698|324072492|FG001|Phase 2|Protocol Violation|0|||
94620037|NCT01543698|324072493|FG002|Phase 2|Protocol Violation|0|||
94620038|NCT01543698|324072494|FG003|Phase 2|Protocol Violation|0|||
94620039|NCT01543698|324072495|FG004|Phase 2|Protocol Violation|0|||
94620040|NCT01543698|324072496|FG005|Phase 2|Protocol Violation|0|||
94359329|NCT04887922|323100280|FG004|1st Randomization|Decided not to have surgery|0|||
94359330|NCT01855607|323100281|FG000|Overall Study|Withdrawal by Subject|1|||
94461172|NCT00373958|323478212|FG001|Infant Series|Lost to Follow-up|5|||
94620041|NCT01543698|324072497|FG006|Phase 2|Protocol Violation|0|||
94620042|NCT01543698|324072498|FG007|Phase 2|Protocol Violation|0|||
94620043|NCT01543698|324072499|FG008|Phase 2|Protocol Violation|0|||
94620044|NCT01543698|324072500|FG009|Phase 2|Protocol Violation|0|||
94620045|NCT01543698|324072501|FG010|Phase 2|Protocol Violation|0|||
94620046|NCT01543698|324072502|FG011|Phase 2|Protocol Violation|0|||
94620047|NCT01543698|324072503|FG012|Phase 2|Protocol Violation|1|||
94620048|NCT01543698|324072504|FG013|Phase 2|Protocol Violation|0|||
94359331|NCT01855607|323100281|FG000|Overall Study|Study was terminated|11|||
94359332|NCT01422876|323100283|FG000|Week 24|Lost to Follow-up|1|||
94359333|NCT01422876|323100284|FG001|Week 24|Lost to Follow-up|1|||
94359334|NCT01422876|323100285|FG002|Week 24|Lost to Follow-up|2|||
94359335|NCT01422876|323100286|FG003|Week 24|Lost to Follow-up|4|||
94620049|NCT01543698|324072505|FG014|Phase 2|Protocol Violation|0|||
94620050|NCT01543698|324072491|FG000|Phase 2|Disease progression|0|||
94359336|NCT01422876|323100287|FG004|Week 24|Lost to Follow-up|2|||
94359337|NCT01422876|323100288|FG005|Week 24|Lost to Follow-up|0|||
94359338|NCT01422876|323100289|FG006|Week 24|Lost to Follow-up|1|||
94359339|NCT01422876|323100290|FG007|Week 24|Lost to Follow-up|3|||
94359340|NCT01422876|323100291|FG008|Week 24|Lost to Follow-up|3|||
94359341|NCT01422876|323100292|FG009|Week 24|Lost to Follow-up|4|||
94359342|NCT01422876|323100283|FG000|Week 24|Consent withdrawn|5|||
94359343|NCT01422876|323100284|FG001|Week 24|Consent withdrawn|1|||
94254943|NCT03814187|322726442|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
94254944|NCT03814187|322726443|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
94254945|NCT03814187|322726441|FG000|Overall Study|Other reasons|34|||
94254946|NCT03814187|322726442|FG001|Overall Study|Other reasons|40|||
94254947|NCT03814187|322726443|FG002|Overall Study|Other reasons|2|||
94359344|NCT01422876|323100285|FG002|Week 24|Consent withdrawn|3|||
94254948|NCT01337115|322726447|FG000|Overall Study|Protocol Violation|2|||
94254949|NCT01337115|322726448|FG001|Overall Study|Protocol Violation|0|||
94254950|NCT02842827|322726450|FG000|Overall Study|Adverse Event|0|||
94254951|NCT02842827|322726451|FG001|Overall Study|Adverse Event|1|||
94254952|NCT02842827|322726452|FG002|Overall Study|Adverse Event|0|||
94254953|NCT02842827|322726453|FG003|Overall Study|Adverse Event|1|||
94359345|NCT01422876|323100286|FG003|Week 24|Consent withdrawn|4|||
94359346|NCT01422876|323100287|FG004|Week 24|Consent withdrawn|5|||
94359347|NCT01422876|323100288|FG005|Week 24|Consent withdrawn|6|||
94359348|NCT01422876|323100289|FG006|Week 24|Consent withdrawn|5|||
94359349|NCT01422876|323100290|FG007|Week 24|Consent withdrawn|4|||
94359350|NCT01422876|323100291|FG008|Week 24|Consent withdrawn|3|||
94359351|NCT01422876|323100292|FG009|Week 24|Consent withdrawn|6|||
94359352|NCT01422876|323100283|FG000|Week 24|Death|0|||
94620051|NCT01543698|324072492|FG001|Phase 2|Disease progression|0|||
94620052|NCT01543698|324072493|FG002|Phase 2|Disease progression|0|||
94620053|NCT01543698|324072494|FG003|Phase 2|Disease progression|0|||
94620054|NCT01543698|324072495|FG004|Phase 2|Disease progression|0|||
94620055|NCT01543698|324072496|FG005|Phase 2|Disease progression|0|||
94620056|NCT01543698|324072497|FG006|Phase 2|Disease progression|0|||
94620057|NCT01543698|324072498|FG007|Phase 2|Disease progression|0|||
94620058|NCT01543698|324072499|FG008|Phase 2|Disease progression|0|||
94620059|NCT01543698|324072500|FG009|Phase 2|Disease progression|0|||
94620060|NCT01543698|324072501|FG010|Phase 2|Disease progression|0|||
94620061|NCT01543698|324072502|FG011|Phase 2|Disease progression|10|||
94620062|NCT01543698|324072503|FG012|Phase 2|Disease progression|21|||
94620063|NCT01543698|324072504|FG013|Phase 2|Disease progression|30|||
94620064|NCT01543698|324072505|FG014|Phase 2|Disease progression|25|||
94620065|NCT01543698|324072491|FG000|Phase 2|Death|0|||
94620066|NCT01543698|324072492|FG001|Phase 2|Death|0|||
94620067|NCT01543698|324072493|FG002|Phase 2|Death|0|||
94620068|NCT01543698|324072494|FG003|Phase 2|Death|0|||
94620069|NCT01543698|324072495|FG004|Phase 2|Death|0|||
94620070|NCT01543698|324072496|FG005|Phase 2|Death|0|||
94620071|NCT01543698|324072497|FG006|Phase 2|Death|0|||
94620072|NCT01543698|324072498|FG007|Phase 2|Death|0|||
94620073|NCT01543698|324072499|FG008|Phase 2|Death|0|||
94620074|NCT01543698|324072500|FG009|Phase 2|Death|0|||
94620075|NCT01543698|324072501|FG010|Phase 2|Death|0|||
94620076|NCT01543698|324072502|FG011|Phase 2|Death|0|||
94620077|NCT01543698|324072503|FG012|Phase 2|Death|1|||
94620078|NCT01543698|324072504|FG013|Phase 2|Death|1|||
94620079|NCT01543698|324072505|FG014|Phase 2|Death|1|||
94620080|NCT01543698|324072491|FG000|Phase 2|Administrative problems|0|||
94620081|NCT01543698|324072492|FG001|Phase 2|Administrative problems|0|||
94620082|NCT01543698|324072493|FG002|Phase 2|Administrative problems|0|||
94620083|NCT01543698|324072494|FG003|Phase 2|Administrative problems|0|||
94620084|NCT01543698|324072495|FG004|Phase 2|Administrative problems|0|||
94620085|NCT01543698|324072496|FG005|Phase 2|Administrative problems|0|||
94620086|NCT01543698|324072497|FG006|Phase 2|Administrative problems|0|||
94620087|NCT01543698|324072498|FG007|Phase 2|Administrative problems|0|||
94620088|NCT01543698|324072499|FG008|Phase 2|Administrative problems|0|||
94620089|NCT01543698|324072500|FG009|Phase 2|Administrative problems|0|||
94620090|NCT01543698|324072501|FG010|Phase 2|Administrative problems|0|||
94620091|NCT01543698|324072502|FG011|Phase 2|Administrative problems|0|||
94620092|NCT01543698|324072503|FG012|Phase 2|Administrative problems|0|||
94620093|NCT01543698|324072504|FG013|Phase 2|Administrative problems|3|||
94620094|NCT01543698|324072505|FG014|Phase 2|Administrative problems|1|||
94620095|NCT01543698|324072491|FG000|Phase 2|Withdrawal by Subject|0|||
94620096|NCT01543698|324072492|FG001|Phase 2|Withdrawal by Subject|0|||
94620097|NCT01543698|324072493|FG002|Phase 2|Withdrawal by Subject|0|||
94620098|NCT01543698|324072494|FG003|Phase 2|Withdrawal by Subject|0|||
94620099|NCT01543698|324072495|FG004|Phase 2|Withdrawal by Subject|0|||
94620100|NCT01543698|324072496|FG005|Phase 2|Withdrawal by Subject|0|||
94620101|NCT01543698|324072497|FG006|Phase 2|Withdrawal by Subject|0|||
94620102|NCT01543698|324072498|FG007|Phase 2|Withdrawal by Subject|0|||
94620103|NCT01543698|324072499|FG008|Phase 2|Withdrawal by Subject|0|||
94620104|NCT01543698|324072500|FG009|Phase 2|Withdrawal by Subject|0|||
94620105|NCT01543698|324072501|FG010|Phase 2|Withdrawal by Subject|0|||
94620106|NCT01543698|324072502|FG011|Phase 2|Withdrawal by Subject|0|||
94620107|NCT01543698|324072503|FG012|Phase 2|Withdrawal by Subject|0|||
94620108|NCT01543698|324072504|FG013|Phase 2|Withdrawal by Subject|3|||
94620109|NCT01543698|324072505|FG014|Phase 2|Withdrawal by Subject|1|||
94620110|NCT01543698|324072491|FG000|Phase 2|Adverse Event|0|||
94620111|NCT01543698|324072492|FG001|Phase 2|Adverse Event|0|||
94620112|NCT01543698|324072493|FG002|Phase 2|Adverse Event|0|||
94620113|NCT01543698|324072494|FG003|Phase 2|Adverse Event|0|||
94620114|NCT01543698|324072495|FG004|Phase 2|Adverse Event|0|||
94620115|NCT01543698|324072496|FG005|Phase 2|Adverse Event|0|||
94620116|NCT01543698|324072497|FG006|Phase 2|Adverse Event|0|||
94620117|NCT01543698|324072498|FG007|Phase 2|Adverse Event|0|||
94620118|NCT01543698|324072499|FG008|Phase 2|Adverse Event|0|||
94620119|NCT01543698|324072500|FG009|Phase 2|Adverse Event|0|||
94620120|NCT01543698|324072501|FG010|Phase 2|Adverse Event|0|||
94620121|NCT01543698|324072502|FG011|Phase 2|Adverse Event|1|||
94620122|NCT01543698|324072503|FG012|Phase 2|Adverse Event|3|||
94620123|NCT01543698|324072504|FG013|Phase 2|Adverse Event|5|||
94620124|NCT01543698|324072505|FG014|Phase 2|Adverse Event|14|||
94620125|NCT00403234|324072510|FG000|Overall Study|Withdrawal by Subject|0|||
94620126|NCT00403234|324072511|FG001|Overall Study|Withdrawal by Subject|1|||
94620127|NCT00403234|324072512|FG002|Overall Study|Withdrawal by Subject|0|||
94620128|NCT00403234|324072513|FG003|Overall Study|Withdrawal by Subject|0|||
94620129|NCT00403234|324072510|FG000|Overall Study|Adverse Event|1|||
94620130|NCT00403234|324072511|FG001|Overall Study|Adverse Event|0|||
94620131|NCT00403234|324072512|FG002|Overall Study|Adverse Event|1|||
94620132|NCT00403234|324072513|FG003|Overall Study|Adverse Event|0|||
94620133|NCT00967668|324072515|FG000|Overall Study|Withdrawal by Subject|13|||
94620134|NCT00967668|324072516|FG001|Overall Study|Withdrawal by Subject|8|||
94620135|NCT00967668|324072517|FG002|Overall Study|Withdrawal by Subject|8|||
94620136|NCT00967668|324072515|FG000|Overall Study|Death|0|||
94620137|NCT00967668|324072516|FG001|Overall Study|Death|2|||
94620138|NCT00967668|324072517|FG002|Overall Study|Death|4|||
94620139|NCT00967668|324072515|FG000|Overall Study|Removed due to behavior|1|||
94620140|NCT00967668|324072516|FG001|Overall Study|Removed due to behavior|1|||
94620141|NCT00967668|324072517|FG002|Overall Study|Removed due to behavior|2|||
94620142|NCT00967668|324072515|FG000|Overall Study|Refused Year 2|11|||
94620143|NCT00967668|324072516|FG001|Overall Study|Refused Year 2|6|||
94620144|NCT00967668|324072517|FG002|Overall Study|Refused Year 2|4|||
94620145|NCT00967668|324072515|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
94620146|NCT00967668|324072516|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
94620147|NCT00967668|324072517|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
94620148|NCT00967668|324072515|FG000|Overall Study|Lost to Follow-up|15|||
94620149|NCT00967668|324072516|FG001|Overall Study|Lost to Follow-up|9|||
94620150|NCT00967668|324072517|FG002|Overall Study|Lost to Follow-up|16|||
94620151|NCT00967668|324072515|FG000|Overall Study|Refused 12-mo assessment|3|||
94620152|NCT00967668|324072516|FG001|Overall Study|Refused 12-mo assessment|1|||
94620153|NCT00967668|324072517|FG002|Overall Study|Refused 12-mo assessment|9|||
94620154|NCT00967668|324072515|FG000|Overall Study|Pregnancy|1|||
94620155|NCT00967668|324072516|FG001|Overall Study|Pregnancy|0|||
94620156|NCT00967668|324072517|FG002|Overall Study|Pregnancy|0|||
94620157|NCT00259649|324072523|FG000|Overall Study|Lost to Follow-up|7|||
94620158|NCT00259649|324072523|FG000|Overall Study|irregular menses|3|||
94620159|NCT00709761|324072524|FG000|Overall Study|Withdrawal by Subject|8|||
94620160|NCT00709761|324072524|FG000|Overall Study|study closed/terminated|17|||
94620161|NCT00709761|324072524|FG000|Overall Study|Lost to Follow-up|2|||
94620162|NCT02200211|324072525|FG000|Overall Study|Lost to Follow-up|7|||
94620163|NCT02200211|324072526|FG001|Overall Study|Lost to Follow-up|7|||
94620164|NCT02200211|324072527|FG002|Overall Study|Lost to Follow-up|1|||
94620165|NCT02200211|324072528|FG003|Overall Study|Lost to Follow-up|2|||
94620166|NCT02200211|324072525|FG000|Overall Study|Withdrawal by Subject|1|||
94620167|NCT02200211|324072526|FG001|Overall Study|Withdrawal by Subject|0|||
94359353|NCT01422876|323100284|FG001|Week 24|Death|1|||
94359354|NCT01422876|323100285|FG002|Week 24|Death|0|||
94620168|NCT02200211|324072527|FG002|Overall Study|Withdrawal by Subject|0|||
94620169|NCT02200211|324072528|FG003|Overall Study|Withdrawal by Subject|0|||
94359355|NCT01422876|323100286|FG003|Week 24|Death|0|||
94620170|NCT00787891|324072542|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
94620171|NCT00787891|324072543|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
94620172|NCT00787891|324072542|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
94359356|NCT01422876|323100287|FG004|Week 24|Death|0|||
94620173|NCT00787891|324072543|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
94620174|NCT00787891|324072542|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
94620175|NCT00787891|324072543|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
94620176|NCT00787891|324072542|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
94620177|NCT00787891|324072543|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
94620178|NCT00787891|324072542|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
94620179|NCT00787891|324072543|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
94620180|NCT00787891|324072542|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
94620181|NCT00787891|324072543|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
94620182|NCT00787891|324072542|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
94667280|NCT00130533|324234659|FG000|Overall Study|Protocol Violation|5|||
94667281|NCT00130533|324234660|FG001|Overall Study|Protocol Violation|1|||
94620183|NCT00787891|324072543|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
94620184|NCT00787891|324072542|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
94620185|NCT00787891|324072543|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
94620186|NCT00787891|324072542|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
94620187|NCT00787891|324072543|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
94620188|NCT00787891|324072542|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
94620189|NCT00787891|324072543|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
94620190|NCT00739674|324072544|FG000|Overall Study|Screening failures|19|||
94620191|NCT00739674|324072545|FG001|Overall Study|Screening failures|17|||
94620192|NCT00739674|324072544|FG000|Overall Study|Site 212 removal|19|||
94620193|NCT00739674|324072545|FG001|Overall Study|Site 212 removal|13|||
94620194|NCT00739674|324072544|FG000|Overall Study|No follow-up data|33|||
94620195|NCT00739674|324072545|FG001|Overall Study|No follow-up data|18|||
94620196|NCT00739674|324072544|FG000|Overall Study|Dietician consultation >30 days|1|||
94620197|NCT00739674|324072545|FG001|Overall Study|Dietician consultation >30 days|9|||
94620198|NCT00739674|324072544|FG000|Overall Study|Adverse Event|22|||
94620199|NCT00739674|324072545|FG001|Overall Study|Adverse Event|13|||
94620200|NCT00739674|324072544|FG000|Overall Study|Death|1|||
94620201|NCT00739674|324072545|FG001|Overall Study|Death|0|||
94620202|NCT00739674|324072544|FG000|Overall Study|Lack of Efficacy|1|||
94620203|NCT00739674|324072545|FG001|Overall Study|Lack of Efficacy|0|||
94620204|NCT00739674|324072544|FG000|Overall Study|Lost to Follow-up|52|||
94620205|NCT00739674|324072545|FG001|Overall Study|Lost to Follow-up|30|||
94620206|NCT00739674|324072544|FG000|Overall Study|Protocol Violation|5|||
94620207|NCT00739674|324072545|FG001|Overall Study|Protocol Violation|5|||
94620208|NCT00739674|324072544|FG000|Overall Study|Withdrawal by Subject|9|||
94620209|NCT00739674|324072545|FG001|Overall Study|Withdrawal by Subject|9|||
94620210|NCT00739674|324072544|FG000|Overall Study|Reason missing|2|||
94620211|NCT00739674|324072545|FG001|Overall Study|Reason missing|0|||
94620212|NCT00739674|324072544|FG000|Overall Study|Clinic closed|6|||
94620213|NCT00739674|324072545|FG001|Overall Study|Clinic closed|4|||
94620214|NCT00739674|324072544|FG000|Overall Study|Patient moved|3|||
94620215|NCT00739674|324072545|FG001|Overall Study|Patient moved|2|||
94620216|NCT00739674|324072544|FG000|Overall Study|Non compliant|4|||
94620217|NCT00739674|324072545|FG001|Overall Study|Non compliant|0|||
94620218|NCT00739674|324072544|FG000|Overall Study|Unable to attend visit|3|||
94620219|NCT00739674|324072545|FG001|Overall Study|Unable to attend visit|1|||
94620220|NCT00739674|324072544|FG000|Overall Study|Home monitoring off meds|1|||
94620221|NCT00739674|324072545|FG001|Overall Study|Home monitoring off meds|0|||
94620222|NCT00739674|324072544|FG000|Overall Study|Erectile dysfunction|0|||
94620223|NCT00739674|324072545|FG001|Overall Study|Erectile dysfunction|1|||
94620224|NCT02955602|324072546|FG000|Overall Study|Adverse Event|0|||
94620225|NCT02955602|324072547|FG001|Overall Study|Adverse Event|3|||
94620226|NCT02955602|324072548|FG002|Overall Study|Adverse Event|0|||
94620227|NCT02955602|324072546|FG000|Overall Study|Withdrawal of informed consent|1|||
94620228|NCT02955602|324072547|FG001|Overall Study|Withdrawal of informed consent|3|||
94620229|NCT02955602|324072548|FG002|Overall Study|Withdrawal of informed consent|2|||
94620230|NCT02955602|324072546|FG000|Overall Study|Lost to Follow-up|0|||
94620231|NCT02955602|324072547|FG001|Overall Study|Lost to Follow-up|0|||
94620232|NCT02955602|324072548|FG002|Overall Study|Lost to Follow-up|1|||
94620233|NCT02955602|324072546|FG000|Overall Study|Other|0|||
94667282|NCT00130533|324234659|FG000|Overall Study|Lost to Follow-up|1|||
94667283|NCT00130533|324234660|FG001|Overall Study|Lost to Follow-up|1|||
94667284|NCT00130533|324234659|FG000|Overall Study|Sponsor´s decision|2|||
94667285|NCT00130533|324234660|FG001|Overall Study|Sponsor´s decision|0|||
94667286|NCT00130533|324234659|FG000|Overall Study|Second Primary Malignancy|0|||
94667287|NCT00130533|324234660|FG001|Overall Study|Second Primary Malignancy|1|||
94667288|NCT00130533|324234659|FG000|Overall Study|Other|12|||
94667289|NCT00130533|324234660|FG001|Overall Study|Other|5|||
94667290|NCT00515502|324234661|FG000|Treatment Period 1|Adverse Event|0|||
94667291|NCT00515502|324234662|FG001|Treatment Period 1|Adverse Event|0|||
94620234|NCT02955602|324072547|FG001|Overall Study|Other|1|||
94620235|NCT02955602|324072548|FG002|Overall Study|Other|3|||
94620236|NCT01594281|324072549|FG000|Interventional Core Phase|Protocol Deviation|1|||
94620237|NCT01594281|324072550|FG001|Interventional Core Phase|Protocol Deviation|0|||
94667292|NCT00515502|324234663|FG002|Treatment Period 1|Adverse Event|0|||
94620238|NCT01594281|324072551|FG002|Interventional Core Phase|Protocol Deviation|0|||
94667293|NCT00515502|324234664|FG003|Treatment Period 1|Adverse Event|0|||
94667294|NCT00515502|324234665|FG004|Treatment Period 1|Adverse Event|0|||
94620239|NCT01594281|324072549|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
94620240|NCT01594281|324072550|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
94620241|NCT01594281|324072551|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
94620242|NCT01594281|324072549|FG000|Interventional Core Phase|Death|1|||
94667295|NCT00515502|324234666|FG005|Treatment Period 1|Adverse Event|0|||
94254954|NCT02842827|322726454|FG004|Overall Study|Adverse Event|0|||
94254955|NCT02842827|322726455|FG005|Overall Study|Adverse Event|1|||
94254956|NCT02842827|322726456|FG006|Overall Study|Adverse Event|0|||
94620243|NCT01594281|324072550|FG001|Interventional Core Phase|Death|1|||
94620244|NCT01594281|324072551|FG002|Interventional Core Phase|Death|2|||
94254957|NCT02842827|322726457|FG007|Overall Study|Adverse Event|0|||
94254958|NCT02842827|322726450|FG000|Overall Study|Death|1|||
94254959|NCT02842827|322726451|FG001|Overall Study|Death|0|||
94254960|NCT02842827|322726452|FG002|Overall Study|Death|2|||
94254961|NCT02842827|322726453|FG003|Overall Study|Death|3|||
94620245|NCT01594281|324072549|FG000|Interventional Core Phase|Lost to Follow-up|1|||
94620246|NCT01594281|324072550|FG001|Interventional Core Phase|Lost to Follow-up|4|||
94620247|NCT01594281|324072551|FG002|Interventional Core Phase|Lost to Follow-up|1|||
94620248|NCT01594281|324072549|FG000|Interventional Core Phase|Adverse Event|4|||
94620249|NCT01594281|324072550|FG001|Interventional Core Phase|Adverse Event|4|||
94620250|NCT01594281|324072551|FG002|Interventional Core Phase|Adverse Event|4|||
94620251|NCT01594281|324072549|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
94620252|NCT01594281|324072550|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
94620253|NCT01594281|324072551|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
94620254|NCT01594281|324072549|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
94620255|NCT01594281|324072550|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
94620256|NCT01594281|324072551|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
94620257|NCT01594281|324072549|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
94620258|NCT01594281|324072550|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
94620259|NCT01594281|324072551|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
94620260|NCT04805541|324072552|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
94620261|NCT01673867|324072559|FG000|Randomization|Adverse event unrelated to study drug|1|||
94620262|NCT01673867|324072560|FG001|Randomization|Adverse event unrelated to study drug|0|||
94620263|NCT01673867|324072559|FG000|Randomization|Participant request to discontinue study treatment|0|||
94620264|NCT01673867|324072560|FG001|Randomization|Participant request to discontinue study treatment|4|||
94620265|NCT01673867|324072559|FG000|Randomization|Withdrawal by participant|0|||
94620266|NCT01673867|324072560|FG001|Randomization|Withdrawal by participant|12|||
94620267|NCT01673867|324072559|FG000|Randomization|Lost to Follow-up|0|||
94620268|NCT01673867|324072560|FG001|Randomization|Lost to Follow-up|1|||
94620269|NCT01673867|324072559|FG000|Randomization|Participant no longer meets study criteria|4|||
94620270|NCT01673867|324072560|FG001|Randomization|Participant no longer meets study criteria|5|||
94620271|NCT01673867|324072559|FG000|Treatment|Disease Progression|208|||
94620272|NCT01673867|324072560|FG001|Treatment|Disease Progression|178|||
94620273|NCT01673867|324072559|FG000|Treatment|Study Drug Toxicity|23|||
94620274|NCT01673867|324072560|FG001|Treatment|Study Drug Toxicity|43|||
94620275|NCT01673867|324072559|FG000|Treatment|Death|2|||
94620276|NCT01673867|324072560|FG001|Treatment|Death|3|||
94620277|NCT01673867|324072559|FG000|Treatment|Adverse event unrelated to study drug|23|||
94620278|NCT01673867|324072560|FG001|Treatment|Adverse event unrelated to study drug|10|||
94620279|NCT01673867|324072559|FG000|Treatment|Participant request to discontinue study treatment|7|||
94620280|NCT01673867|324072560|FG001|Treatment|Participant request to discontinue study treatment|17|||
94620281|NCT01673867|324072559|FG000|Treatment|Withdrawal by participant|5|||
94620282|NCT01673867|324072560|FG001|Treatment|Withdrawal by participant|5|||
94620283|NCT01673867|324072559|FG000|Treatment|Maximum clinical benefit|1|||
94620284|NCT01673867|324072560|FG001|Treatment|Maximum clinical benefit|10|||
94620285|NCT01673867|324072559|FG000|Treatment|Participant no longer meets study criteria|2|||
94620286|NCT01673867|324072560|FG001|Treatment|Participant no longer meets study criteria|0|||
94620287|NCT01673867|324072559|FG000|Treatment|Administrative reason by sponsor|3|||
94620288|NCT01673867|324072560|FG001|Treatment|Administrative reason by sponsor|0|||
94620289|NCT01673867|324072559|FG000|Treatment|Other reason|11|||
94620290|NCT01673867|324072560|FG001|Treatment|Other reason|2|||
94620291|NCT01389817|324072573|FG000|Overall Study|Physician Decision|1|||
94620292|NCT01389817|324072574|FG001|Overall Study|Physician Decision|0|||
94620293|NCT01389817|324072573|FG000|Overall Study|Lost to Follow-up|1|||
94620294|NCT01389817|324072574|FG001|Overall Study|Lost to Follow-up|0|||
94620295|NCT01389817|324072573|FG000|Overall Study|Withdrawal by Subject|2|||
94620296|NCT01389817|324072574|FG001|Overall Study|Withdrawal by Subject|0|||
94620297|NCT03486223|324072575|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
94620298|NCT03486223|324072576|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
94620299|NCT00541931|324072577|FG000|Overall Study|Adverse Event|1|||
94620300|NCT00541931|324072578|FG001|Overall Study|Adverse Event|0|||
94667296|NCT00515502|324234667|FG006|Treatment Period 1|Adverse Event|1|||
94254962|NCT02842827|322726454|FG004|Overall Study|Death|2|||
94254963|NCT02842827|322726455|FG005|Overall Study|Death|1|||
94254964|NCT02842827|322726456|FG006|Overall Study|Death|0|||
94254965|NCT02842827|322726457|FG007|Overall Study|Death|4|||
94254966|NCT02842827|322726450|FG000|Overall Study|Physician Decision|1|||
94620301|NCT00541931|324072577|FG000|Overall Study|Lost to Follow-up|3|||
94620302|NCT00541931|324072578|FG001|Overall Study|Lost to Follow-up|3|||
94620303|NCT00541931|324072577|FG000|Overall Study|Withdrawal by Subject|1|||
94620304|NCT00541931|324072578|FG001|Overall Study|Withdrawal by Subject|0|||
94620305|NCT00541931|324072577|FG000|Overall Study|Transportation Issue|0|||
94620306|NCT00541931|324072578|FG001|Overall Study|Transportation Issue|1|||
94620307|NCT02587234|324072579|FG000|Overall Study|Withdrawal by Subject|1|||
94620308|NCT02587234|324072580|FG001|Overall Study|Withdrawal by Subject|1|||
94620309|NCT02587234|324072579|FG000|Overall Study|Lost to Follow-up|0|||
94620310|NCT02587234|324072580|FG001|Overall Study|Lost to Follow-up|2|||
94620311|NCT02165215|324072581|FG000|Induction Phase|Adverse Event|1|||
94620312|NCT02165215|324072582|FG001|Induction Phase|Adverse Event|0|||
94620313|NCT02165215|324072583|FG002|Induction Phase|Adverse Event|0|||
94620314|NCT02165215|324072581|FG000|Induction Phase|Withdrawal by Subject|10|||
94620315|NCT02165215|324072582|FG001|Induction Phase|Withdrawal by Subject|0|||
94620316|NCT02165215|324072583|FG002|Induction Phase|Withdrawal by Subject|0|||
94620317|NCT02165215|324072581|FG000|Induction Phase|Protocol Violation|1|||
94620318|NCT02165215|324072582|FG001|Induction Phase|Protocol Violation|0|||
94620319|NCT02165215|324072583|FG002|Induction Phase|Protocol Violation|0|||
94620320|NCT02165215|324072581|FG000|Induction Phase|Physician Decision|1|||
94620321|NCT02165215|324072582|FG001|Induction Phase|Physician Decision|0|||
94620322|NCT02165215|324072583|FG002|Induction Phase|Physician Decision|0|||
94620323|NCT02165215|324072581|FG000|Induction Phase|Lack of Efficacy|2|||
94620324|NCT02165215|324072582|FG001|Induction Phase|Lack of Efficacy|0|||
94620325|NCT02165215|324072583|FG002|Induction Phase|Lack of Efficacy|0|||
94620326|NCT02165215|324072581|FG000|Induction Phase|Non-Compliance|2|||
94620327|NCT02165215|324072582|FG001|Induction Phase|Non-Compliance|0|||
94620328|NCT02165215|324072583|FG002|Induction Phase|Non-Compliance|0|||
94620329|NCT02165215|324072581|FG000|Induction Phase|Lost to Follow-up|6|||
94620330|NCT02165215|324072582|FG001|Induction Phase|Lost to Follow-up|0|||
94667297|NCT00515502|324234668|FG007|Treatment Period 1|Adverse Event|0|||
94667298|NCT00515502|324234669|FG008|Treatment Period 1|Adverse Event|1|||
94667299|NCT00515502|324234670|FG009|Treatment Period 1|Adverse Event|0|||
94667300|NCT00515502|324234671|FG010|Treatment Period 1|Adverse Event|0|||
94667301|NCT00515502|324234672|FG011|Treatment Period 1|Adverse Event|1|||
94667302|NCT00515502|324234661|FG000|Treatment Period 2|Adverse Event|0|||
94667303|NCT00515502|324234662|FG001|Treatment Period 2|Adverse Event|1|||
94667304|NCT00515502|324234663|FG002|Treatment Period 2|Adverse Event|0|||
94667305|NCT00515502|324234664|FG003|Treatment Period 2|Adverse Event|0|||
94667306|NCT00515502|324234665|FG004|Treatment Period 2|Adverse Event|0|||
94667307|NCT00515502|324234666|FG005|Treatment Period 2|Adverse Event|0|||
94667308|NCT00515502|324234667|FG006|Treatment Period 2|Adverse Event|0|||
94667309|NCT00515502|324234668|FG007|Treatment Period 2|Adverse Event|0|||
94667310|NCT00515502|324234669|FG008|Treatment Period 2|Adverse Event|0|||
94667311|NCT00515502|324234670|FG009|Treatment Period 2|Adverse Event|0|||
94667312|NCT00515502|324234671|FG010|Treatment Period 2|Adverse Event|0|||
94667313|NCT00515502|324234672|FG011|Treatment Period 2|Adverse Event|0|||
94667314|NCT01605617|324234673|FG000|First Intervention|Adverse Event|0|||
94667315|NCT01605617|324234674|FG001|First Intervention|Adverse Event|1|||
94667316|NCT01605617|324234673|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
94667317|NCT01605617|324234674|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
94667318|NCT01613248|324234675|FG000|Overall Study|Adverse Event|0|||
94667319|NCT01613248|324234676|FG001|Overall Study|Adverse Event|0|||
94667320|NCT01613248|324234677|FG002|Overall Study|Adverse Event|0|||
94667321|NCT01613248|324234678|FG003|Overall Study|Adverse Event|1|||
94667322|NCT01613248|324234679|FG004|Overall Study|Adverse Event|0|||
94667323|NCT01613248|324234680|FG005|Overall Study|Adverse Event|0|||
94667324|NCT01613248|324234675|FG000|Overall Study|Withdrawal by Subject|3|||
94667325|NCT01613248|324234676|FG001|Overall Study|Withdrawal by Subject|2|||
94667326|NCT01613248|324234677|FG002|Overall Study|Withdrawal by Subject|2|||
94667327|NCT01613248|324234678|FG003|Overall Study|Withdrawal by Subject|5|||
94667328|NCT01613248|324234679|FG004|Overall Study|Withdrawal by Subject|0|||
94667329|NCT01613248|324234680|FG005|Overall Study|Withdrawal by Subject|1|||
94667330|NCT01613248|324234675|FG000|Overall Study|Lost to Follow-up|5|||
94667331|NCT01613248|324234676|FG001|Overall Study|Lost to Follow-up|7|||
94667332|NCT01613248|324234677|FG002|Overall Study|Lost to Follow-up|4|||
94667333|NCT01613248|324234678|FG003|Overall Study|Lost to Follow-up|8|||
94667334|NCT01613248|324234679|FG004|Overall Study|Lost to Follow-up|4|||
94667335|NCT01613248|324234680|FG005|Overall Study|Lost to Follow-up|2|||
94667336|NCT01613248|324234675|FG000|Overall Study|Study Terminated by Sponsor|4|||
94667337|NCT01613248|324234676|FG001|Overall Study|Study Terminated by Sponsor|6|||
94254967|NCT02842827|322726451|FG001|Overall Study|Physician Decision|3|||
94254968|NCT02842827|322726452|FG002|Overall Study|Physician Decision|0|||
94254969|NCT02842827|322726453|FG003|Overall Study|Physician Decision|0|||
94254970|NCT02842827|322726454|FG004|Overall Study|Physician Decision|1|||
94254971|NCT02842827|322726455|FG005|Overall Study|Physician Decision|4|||
94254972|NCT02842827|322726456|FG006|Overall Study|Physician Decision|2|||
94254973|NCT02842827|322726457|FG007|Overall Study|Physician Decision|1|||
94254974|NCT02842827|322726450|FG000|Overall Study|Protocol Defined Disease Progression|0|||
94254975|NCT02842827|322726451|FG001|Overall Study|Protocol Defined Disease Progression|0|||
94254976|NCT02842827|322726452|FG002|Overall Study|Protocol Defined Disease Progression|0|||
94254977|NCT02842827|322726453|FG003|Overall Study|Protocol Defined Disease Progression|0|||
94254978|NCT02842827|322726454|FG004|Overall Study|Protocol Defined Disease Progression|0|||
94254979|NCT02842827|322726455|FG005|Overall Study|Protocol Defined Disease Progression|1|||
94254980|NCT02842827|322726456|FG006|Overall Study|Protocol Defined Disease Progression|0|||
94254981|NCT02842827|322726457|FG007|Overall Study|Protocol Defined Disease Progression|0|||
94254982|NCT02842827|322726450|FG000|Overall Study|Participant Withdrawal of Consent|1|||
94254983|NCT02842827|322726451|FG001|Overall Study|Participant Withdrawal of Consent|2|||
94254984|NCT02842827|322726452|FG002|Overall Study|Participant Withdrawal of Consent|2|||
94254985|NCT02842827|322726453|FG003|Overall Study|Participant Withdrawal of Consent|2|||
94254986|NCT02842827|322726454|FG004|Overall Study|Participant Withdrawal of Consent|2|||
94254987|NCT02842827|322726455|FG005|Overall Study|Participant Withdrawal of Consent|1|||
94254988|NCT02842827|322726456|FG006|Overall Study|Participant Withdrawal of Consent|2|||
94254989|NCT02842827|322726457|FG007|Overall Study|Participant Withdrawal of Consent|1|||
94254990|NCT01886378|322726470|FG000|Overall Study|Adverse Event|1|||
94254991|NCT01886378|322726470|FG000|Overall Study|Withdrawal by Subject|4|||
94254992|NCT03801915|322726471|FG000|Overall Study|Screen failure|0|||
94254993|NCT03801915|322726472|FG001|Overall Study|Screen failure|0|||
94254994|NCT03801915|322726473|FG002|Overall Study|Screen failure|1|||
94254995|NCT03801915|322726471|FG000|Overall Study|Ineligible|1|||
94254996|NCT03801915|322726472|FG001|Overall Study|Ineligible|0|||
94254997|NCT03801915|322726473|FG002|Overall Study|Ineligible|0|||
94667338|NCT01613248|324234677|FG002|Overall Study|Study Terminated by Sponsor|8|||
94667339|NCT01613248|324234678|FG003|Overall Study|Study Terminated by Sponsor|8|||
94667340|NCT01613248|324234679|FG004|Overall Study|Study Terminated by Sponsor|9|||
94667341|NCT01613248|324234680|FG005|Overall Study|Study Terminated by Sponsor|11|||
94667342|NCT01613248|324234675|FG000|Overall Study|Physician Decision|8|||
94667343|NCT01613248|324234676|FG001|Overall Study|Physician Decision|8|||
94667344|NCT01613248|324234677|FG002|Overall Study|Physician Decision|9|||
94667345|NCT01613248|324234678|FG003|Overall Study|Physician Decision|4|||
94254998|NCT03801915|322726471|FG000|Overall Study|Physician Decision|2|||
94359357|NCT01422876|323100288|FG005|Week 24|Death|0|||
94667346|NCT01613248|324234679|FG004|Overall Study|Physician Decision|7|||
94667347|NCT01613248|324234680|FG005|Overall Study|Physician Decision|6|||
94667348|NCT01613248|324234675|FG000|Overall Study|Lack of Qualifying Event|9|||
94667349|NCT01613248|324234676|FG001|Overall Study|Lack of Qualifying Event|11|||
94254999|NCT03801915|322726472|FG001|Overall Study|Physician Decision|1|||
94255000|NCT03801915|322726473|FG002|Overall Study|Physician Decision|0|||
94359358|NCT01422876|323100289|FG006|Week 24|Death|0|||
94667350|NCT01613248|324234677|FG002|Overall Study|Lack of Qualifying Event|10|||
94359359|NCT01422876|323100290|FG007|Week 24|Death|0|||
94359360|NCT01422876|323100291|FG008|Week 24|Death|0|||
94620331|NCT02165215|324072583|FG002|Induction Phase|Lost to Follow-up|0|||
94620332|NCT02165215|324072581|FG000|Maintenance Phase|Withdrawal by Subject|0|||
94620333|NCT02165215|324072582|FG001|Maintenance Phase|Withdrawal by Subject|7|||
94620334|NCT02165215|324072583|FG002|Maintenance Phase|Withdrawal by Subject|3|||
94620335|NCT02165215|324072581|FG000|Maintenance Phase|Multiple reasons|0|||
94620336|NCT02165215|324072582|FG001|Maintenance Phase|Multiple reasons|2|||
94620337|NCT02165215|324072583|FG002|Maintenance Phase|Multiple reasons|1|||
94620338|NCT02165215|324072581|FG000|Maintenance Phase|Lost to Follow-up|0|||
94620339|NCT02165215|324072582|FG001|Maintenance Phase|Lost to Follow-up|2|||
94620340|NCT02165215|324072583|FG002|Maintenance Phase|Lost to Follow-up|0|||
94620341|NCT02165215|324072581|FG000|Maintenance Phase|Adverse Event|0|||
94620342|NCT02165215|324072582|FG001|Maintenance Phase|Adverse Event|1|||
94620343|NCT02165215|324072583|FG002|Maintenance Phase|Adverse Event|1|||
94620344|NCT01877265|324072585|FG000|Treatment Period 1|Sponsor Decision|0|||
94620345|NCT01877265|324072586|FG001|Treatment Period 1|Sponsor Decision|0|||
94620346|NCT01877265|324072587|FG002|Treatment Period 1|Sponsor Decision|1|||
94620347|NCT01877265|324072588|FG003|Treatment Period 1|Sponsor Decision|0|||
94620348|NCT01877265|324072589|FG004|Treatment Period 1|Sponsor Decision|0|||
94620349|NCT01877265|324072590|FG005|Treatment Period 1|Sponsor Decision|0|||
94620350|NCT01877265|324072585|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
94620351|NCT01877265|324072586|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
94620352|NCT01877265|324072587|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
94620353|NCT01877265|324072588|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
94620354|NCT01877265|324072589|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
94620355|NCT01877265|324072590|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
94620356|NCT01877265|324072585|FG000|Treatment Period 3|Lost to Follow-up|1|||
94620357|NCT01877265|324072586|FG001|Treatment Period 3|Lost to Follow-up|0|||
94620358|NCT01877265|324072587|FG002|Treatment Period 3|Lost to Follow-up|0|||
94620359|NCT01877265|324072588|FG003|Treatment Period 3|Lost to Follow-up|0|||
94620360|NCT01877265|324072589|FG004|Treatment Period 3|Lost to Follow-up|0|||
94620361|NCT01877265|324072590|FG005|Treatment Period 3|Lost to Follow-up|0|||
94620362|NCT03130257|324072591|FG000|Overall Study|Withdrawal by Subject|1|||
94620363|NCT03130257|324072592|FG001|Overall Study|Withdrawal by Subject|0|||
94620364|NCT03130257|324072593|FG002|Overall Study|Withdrawal by Subject|2|||
94620365|NCT00129272|324072596|FG000|Overall Study|Lost to Follow-up|12|||
94620366|NCT00129272|324072597|FG001|Overall Study|Lost to Follow-up|11|||
94620367|NCT00129272|324072596|FG000|Overall Study|Withdrawal by Subject|5|||
94620368|NCT00129272|324072597|FG001|Overall Study|Withdrawal by Subject|11|||
94620369|NCT02582983|324072598|FG000|Overall Study|Death|3|||
94620370|NCT02582983|324072598|FG000|Overall Study|Withdrawal by Subject|2|||
94620371|NCT02582983|324072598|FG000|Overall Study|Adverse Event|1|||
94620372|NCT00319553|324072601|FG000|Overall Study|Protocol Violation|1|||
94620373|NCT00319553|324072602|FG001|Overall Study|Protocol Violation|2|||
94620374|NCT00319553|324072601|FG000|Overall Study|Lost to Follow-up|2|||
94620375|NCT00319553|324072602|FG001|Overall Study|Lost to Follow-up|1|||
94620376|NCT00319553|324072601|FG000|Overall Study|Withdrawal by Subject|1|||
94667351|NCT01613248|324234678|FG003|Overall Study|Lack of Qualifying Event|11|||
94667352|NCT01613248|324234679|FG004|Overall Study|Lack of Qualifying Event|15|||
94667353|NCT01613248|324234680|FG005|Overall Study|Lack of Qualifying Event|18|||
94667354|NCT01613248|324234675|FG000|Overall Study|Pregnancy|0|||
94667355|NCT01613248|324234676|FG001|Overall Study|Pregnancy|0|||
94667356|NCT01613248|324234677|FG002|Overall Study|Pregnancy|0|||
94667357|NCT01613248|324234678|FG003|Overall Study|Pregnancy|1|||
94667358|NCT01613248|324234679|FG004|Overall Study|Pregnancy|0|||
94667359|NCT01613248|324234680|FG005|Overall Study|Pregnancy|0|||
94667360|NCT01491854|324234681|FG000|Overall Study|mainly due to premature termination|93|||
94667361|NCT01491854|324234681|FG000|Overall Study|Death|1|||
94667362|NCT01491854|324234681|FG000|Overall Study|Withdrawal by Subject|3|||
94620377|NCT00319553|324072602|FG001|Overall Study|Withdrawal by Subject|1|||
94620378|NCT01751178|324072603|FG000|Overall Study|Adverse Event|2|||
94620379|NCT01751178|324072604|FG001|Overall Study|Adverse Event|0|||
94620380|NCT01751178|324072605|FG002|Overall Study|Adverse Event|0|||
94620381|NCT01751178|324072603|FG000|Overall Study|Other Reason (unknown)|1|||
94620382|NCT01751178|324072604|FG001|Overall Study|Other Reason (unknown)|0|||
94667363|NCT01491854|324234681|FG000|Overall Study|Lost to Follow-up|33|||
94667364|NCT00121238|324234682|FG000|Overall Study|disease progression before intervention|1|||
94667365|NCT00121238|324234682|FG000|Overall Study|Protocol Violation|2|||
94359361|NCT01422876|323100292|FG009|Week 24|Death|0|||
94620383|NCT01751178|324072605|FG002|Overall Study|Other Reason (unknown)|2|||
94620384|NCT03478930|324072606|FG000|Overall Study|Adverse Event|0|||
94620385|NCT03478930|324072607|FG001|Overall Study|Adverse Event|1|||
94620386|NCT03478930|324072606|FG000|Overall Study|Lack of Efficacy|3|||
94620387|NCT03478930|324072607|FG001|Overall Study|Lack of Efficacy|3|||
94620388|NCT03478930|324072606|FG000|Overall Study|Withdrawal by Subject|6|||
94667366|NCT03280121|324234695|FG000|Overall Study|Physician Decision|1|||
94667367|NCT03280121|324234695|FG000|Overall Study|Lost to Follow-up|1|||
94620389|NCT03478930|324072607|FG001|Overall Study|Withdrawal by Subject|5|||
94620390|NCT00044083|324072611|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
94620391|NCT00044083|324072612|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
94620392|NCT00044083|324072611|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
94620393|NCT00044083|324072612|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
94620394|NCT00044083|324072611|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
94620395|NCT00044083|324072612|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
94620396|NCT00044083|324072611|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
94620397|NCT00044083|324072612|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
94620398|NCT00044083|324072611|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
94620399|NCT00044083|324072612|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
94620400|NCT00044083|324072611|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
94620401|NCT00044083|324072612|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
94620402|NCT00044083|324072611|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
94620403|NCT00044083|324072612|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
94620404|NCT00044083|324072611|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
94620405|NCT00044083|324072612|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
94620406|NCT00044083|324072611|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
94620407|NCT00044083|324072612|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
94620408|NCT00044083|324072611|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
94620409|NCT00044083|324072612|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
94620410|NCT00288054|324072615|FG000|Overall Study|Protocol Violation|2|||
94620411|NCT00288054|324072615|FG000|Overall Study|Lack of Efficacy|16|||
94620412|NCT00288054|324072615|FG000|Overall Study|Adverse Event|3|||
94620413|NCT00288054|324072615|FG000|Overall Study|Withdrawal by Subject|1|||
94620414|NCT00288054|324072615|FG000|Overall Study|Not protocol specified|2|||
94620415|NCT00289991|324072616|FG000|Overall Study|Death|35|||
94620416|NCT00289991|324072617|FG001|Overall Study|Death|38|||
94620417|NCT00289991|324072616|FG000|Overall Study|Adverse Event|15|||
94620418|NCT00289991|324072617|FG001|Overall Study|Adverse Event|13|||
94620419|NCT00289991|324072616|FG000|Overall Study|Failure of prophylaxis|1|||
94620420|NCT00289991|324072617|FG001|Overall Study|Failure of prophylaxis|1|||
94620421|NCT00289991|324072616|FG000|Overall Study|Fungal breakthrough infection|0|||
94620422|NCT00289991|324072617|FG001|Overall Study|Fungal breakthrough infection|1|||
94620423|NCT00289991|324072616|FG000|Overall Study|Lost to Follow-up|0|||
94620424|NCT00289991|324072617|FG001|Overall Study|Lost to Follow-up|1|||
94620425|NCT00289991|324072616|FG000|Overall Study|Withdrawal by Subject|2|||
94620426|NCT00289991|324072617|FG001|Overall Study|Withdrawal by Subject|12|||
94620427|NCT00289991|324072616|FG000|Overall Study|Other|5|||
94620428|NCT00289991|324072617|FG001|Overall Study|Other|14|||
94620429|NCT00705484|324072618|FG000|Overall Study|Adverse Event|28|||
94620430|NCT00705484|324072619|FG001|Overall Study|Adverse Event|27|||
94620431|NCT00705484|324072618|FG000|Overall Study|Lost to Follow-up|169|||
94620432|NCT00705484|324072619|FG001|Overall Study|Lost to Follow-up|250|||
94620433|NCT00705484|324072618|FG000|Overall Study|Withdrawal by Subject|96|||
94620434|NCT00705484|324072619|FG001|Overall Study|Withdrawal by Subject|72|||
94620435|NCT00705484|324072618|FG000|Overall Study|Administrative|89|||
94620436|NCT00705484|324072619|FG001|Overall Study|Administrative|59|||
94620437|NCT02197247|324072620|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
94620438|NCT02197247|324072620|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
94620439|NCT02197247|324072620|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
94359362|NCT01422876|323100283|FG000|Week 52|Lost to Follow-up|3|||
94359363|NCT01422876|323100284|FG001|Week 52|Lost to Follow-up|5|||
94461173|NCT00373958|323478211|FG000|Infant Series|Protocol Violation|3|||
94461174|NCT00373958|323478212|FG001|Infant Series|Protocol Violation|7|||
94359364|NCT01422876|323100285|FG002|Week 52|Lost to Follow-up|7|||
94359365|NCT01422876|323100286|FG003|Week 52|Lost to Follow-up|5|||
94359366|NCT01422876|323100287|FG004|Week 52|Lost to Follow-up|8|||
94359367|NCT01422876|323100288|FG005|Week 52|Lost to Follow-up|5|||
94359368|NCT01422876|323100289|FG006|Week 52|Lost to Follow-up|5|||
94620440|NCT02197247|324072620|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
94620441|NCT02197247|324072620|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
94620442|NCT02197247|324072620|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
94620443|NCT02197247|324072620|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
94620444|NCT02197247|324072620|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
94620445|NCT02296320|324072633|FG000|Overall Study|Withdrawal by Subject|4|||
94620446|NCT02296320|324072634|FG001|Overall Study|Withdrawal by Subject|0|||
94620447|NCT02296320|324072635|FG002|Overall Study|Withdrawal by Subject|2|||
94620448|NCT02296320|324072633|FG000|Overall Study|Death|24|||
94620449|NCT02296320|324072634|FG001|Overall Study|Death|3|||
94359369|NCT01422876|323100290|FG007|Week 52|Lost to Follow-up|8|||
94359370|NCT01422876|323100291|FG008|Week 52|Lost to Follow-up|7|||
94359371|NCT01422876|323100292|FG009|Week 52|Lost to Follow-up|8|||
94359372|NCT01422876|323100283|FG000|Week 52|Consent withdrawn|9|||
94359373|NCT01422876|323100284|FG001|Week 52|Consent withdrawn|4|||
94359374|NCT01422876|323100285|FG002|Week 52|Consent withdrawn|6|||
94359375|NCT01422876|323100286|FG003|Week 52|Consent withdrawn|12|||
94359376|NCT01422876|323100287|FG004|Week 52|Consent withdrawn|7|||
94359377|NCT01422876|323100288|FG005|Week 52|Consent withdrawn|12|||
94359378|NCT01422876|323100289|FG006|Week 52|Consent withdrawn|10|||
94359379|NCT01422876|323100290|FG007|Week 52|Consent withdrawn|12|||
94359380|NCT01422876|323100291|FG008|Week 52|Consent withdrawn|13|||
94359381|NCT01422876|323100292|FG009|Week 52|Consent withdrawn|9|||
94359382|NCT01422876|323100283|FG000|Week 52|Death|0|||
94620450|NCT02296320|324072635|FG002|Overall Study|Death|27|||
94620451|NCT02296320|324072633|FG000|Overall Study|Lost to Follow-up|5|||
94359383|NCT01422876|323100284|FG001|Week 52|Death|1|||
94359384|NCT01422876|323100285|FG002|Week 52|Death|0|||
94359385|NCT01422876|323100286|FG003|Week 52|Death|1|||
94620452|NCT02296320|324072634|FG001|Overall Study|Lost to Follow-up|2|||
94359386|NCT01422876|323100287|FG004|Week 52|Death|0|||
94359387|NCT01422876|323100288|FG005|Week 52|Death|0|||
94359388|NCT01422876|323100289|FG006|Week 52|Death|1|||
94359389|NCT01422876|323100290|FG007|Week 52|Death|3|||
94359390|NCT01422876|323100291|FG008|Week 52|Death|1|||
94359391|NCT01422876|323100292|FG009|Week 52|Death|0|||
94359392|NCT00054639|323100293|FG000|Overall Study|Lack of Efficacy|1|||
94359393|NCT00054639|323100293|FG000|Overall Study|Physician Decision|1|||
94359394|NCT01600755|323100294|FG000|Overall Study|Withdrawal by Subject|6|||
94359395|NCT02916056|323100303|FG000|Overall Study|Adverse Event|6|||
94359396|NCT02916056|323100303|FG000|Overall Study|Lost to Follow-up|1|||
94359397|NCT02916056|323100303|FG000|Overall Study|Other|12|||
94359398|NCT02916056|323100303|FG000|Overall Study|Protocol Violation|1|||
94359399|NCT02916056|323100303|FG000|Overall Study|Withdrawal by Subject|8|||
94359400|NCT02916056|323100303|FG000|Overall Study|Study Terminated by Sponsor|269|||
94359401|NCT00124709|323100304|FG000|Overall Study|Randomized but did not take medication|3|||
94359402|NCT00124709|323100305|FG001|Overall Study|Randomized but did not take medication|1|||
94359403|NCT00124709|323100304|FG000|Overall Study|Adverse Event|3|||
94359404|NCT00124709|323100305|FG001|Overall Study|Adverse Event|0|||
94359405|NCT00124709|323100304|FG000|Overall Study|Lack of Efficacy|5|||
94359406|NCT00124709|323100305|FG001|Overall Study|Lack of Efficacy|10|||
94359407|NCT00124709|323100304|FG000|Overall Study|Protocol Violation|3|||
94359408|NCT00124709|323100305|FG001|Overall Study|Protocol Violation|5|||
94359409|NCT00124709|323100304|FG000|Overall Study|Withdrawal by Subject|127|||
94359410|NCT00124709|323100305|FG001|Overall Study|Withdrawal by Subject|136|||
94359411|NCT00124709|323100304|FG000|Overall Study|Lost to Follow-up|114|||
94359412|NCT00124709|323100305|FG001|Overall Study|Lost to Follow-up|120|||
94359413|NCT01471197|323100306|FG000|Overall Study|Disease Progression|4|||
94359414|NCT01471197|323100307|FG001|Overall Study|Disease Progression|2|||
94359415|NCT01471197|323100306|FG000|Overall Study|Death|1|||
94359416|NCT01471197|323100307|FG001|Overall Study|Death|0|||
94359417|NCT01471197|323100306|FG000|Overall Study|Study Drug Toxicity|1|||
94359418|NCT01471197|323100307|FG001|Overall Study|Study Drug Toxicity|0|||
94359419|NCT03358407|323100308|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
94359420|NCT03358407|323100309|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
94359421|NCT03358407|323100310|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
94359422|NCT03358407|323100311|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
94359423|NCT03358407|323100312|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
94359424|NCT03358407|323100313|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
94359425|NCT03358407|323100314|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
94359426|NCT03358407|323100315|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
94359427|NCT03358407|323100316|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
94359428|NCT03358407|323100317|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
94359429|NCT03358407|323100308|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
94359430|NCT03358407|323100309|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
94359431|NCT03358407|323100310|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
94359432|NCT03358407|323100311|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
94359433|NCT03358407|323100312|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
94359434|NCT03358407|323100313|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
94359435|NCT03358407|323100314|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
94359436|NCT03358407|323100315|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
94359437|NCT03358407|323100316|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
94359438|NCT03358407|323100317|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
94359439|NCT03358407|323100308|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
94359440|NCT03358407|323100309|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
94359441|NCT03358407|323100310|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
94359442|NCT03358407|323100311|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
94359443|NCT03358407|323100312|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
94359444|NCT03358407|323100313|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
94667368|NCT03280121|324234695|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
94667369|NCT03593655|324234704|FG000|First Product Use Period|Withdrawal by Subject|1|||
94667370|NCT03593655|324234705|FG001|First Product Use Period|Withdrawal by Subject|1|||
94667371|NCT03593655|324234704|FG000|First Product Use Period|Lost to Follow-up|1|||
94667372|NCT03593655|324234705|FG001|First Product Use Period|Lost to Follow-up|3|||
94667373|NCT03593655|324234704|FG000|Second Product Use Period|Withdrawal by Subject|1|||
94667374|NCT03593655|324234705|FG001|Second Product Use Period|Withdrawal by Subject|1|||
94667375|NCT03593655|324234704|FG000|Second Product Use Period|Lost to Follow-up|1|||
94667376|NCT03593655|324234705|FG001|Second Product Use Period|Lost to Follow-up|0|||
94667377|NCT03593655|324234704|FG000|Third Product Use Period|Lost to Follow-up|1|||
94667378|NCT03593655|324234705|FG001|Third Product Use Period|Lost to Follow-up|2|||
94667379|NCT03593655|324234704|FG000|Third Product Use Period|Physician Decision|0|||
94667380|NCT03593655|324234705|FG001|Third Product Use Period|Physician Decision|1|||
94667381|NCT03593655|324234704|FG000|Third Product Use Period|Withdrawal by Subject|0|||
94667382|NCT03593655|324234705|FG001|Third Product Use Period|Withdrawal by Subject|1|||
94667383|NCT02498613|324234715|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
94667384|NCT02498613|324234716|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
94667385|NCT02498613|324234717|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
94667386|NCT02498613|324234718|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
94667387|NCT02498613|324234715|FG000|Overall Study|Withdrawal by Subject|3|||
94667388|NCT02498613|324234716|FG001|Overall Study|Withdrawal by Subject|1|||
94667389|NCT02498613|324234717|FG002|Overall Study|Withdrawal by Subject|0|||
94667390|NCT02498613|324234718|FG003|Overall Study|Withdrawal by Subject|0|||
94667391|NCT04420221|324234719|FG000|Overall Study|Withdrawal by Subject|0|||
94667392|NCT04420221|324234720|FG001|Overall Study|Withdrawal by Subject|0|||
94667393|NCT04420221|324234721|FG002|Overall Study|Withdrawal by Subject|0|||
94667394|NCT04420221|324234722|FG003|Overall Study|Withdrawal by Subject|0|||
94667395|NCT04420221|324234723|FG004|Overall Study|Withdrawal by Subject|0|||
94667396|NCT04420221|324234724|FG005|Overall Study|Withdrawal by Subject|20|||
94667397|NCT04420221|324234725|FG006|Overall Study|Withdrawal by Subject|5|||
94667398|NCT04420221|324234719|FG000|Overall Study|Other|0|||
94667399|NCT04420221|324234720|FG001|Overall Study|Other|0|||
94667400|NCT04420221|324234721|FG002|Overall Study|Other|0|||
94667401|NCT04420221|324234722|FG003|Overall Study|Other|0|||
94667402|NCT04420221|324234723|FG004|Overall Study|Other|0|||
94667403|NCT04420221|324234724|FG005|Overall Study|Other|1|||
94667404|NCT04420221|324234725|FG006|Overall Study|Other|1|||
94667405|NCT04420221|324234719|FG000|Overall Study|Lost to Follow-up|0|||
94667406|NCT04420221|324234720|FG001|Overall Study|Lost to Follow-up|0|||
94667407|NCT04420221|324234721|FG002|Overall Study|Lost to Follow-up|0|||
94667408|NCT04420221|324234722|FG003|Overall Study|Lost to Follow-up|0|||
94667409|NCT04420221|324234723|FG004|Overall Study|Lost to Follow-up|0|||
94667410|NCT04420221|324234724|FG005|Overall Study|Lost to Follow-up|3|||
94667411|NCT04420221|324234725|FG006|Overall Study|Lost to Follow-up|2|||
94667412|NCT04420221|324234719|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
94667413|NCT04420221|324234720|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
94667414|NCT04420221|324234721|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
94667415|NCT04420221|324234722|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
94667416|NCT04420221|324234723|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
94667417|NCT04420221|324234724|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
94667418|NCT04420221|324234725|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
94667419|NCT05177770|324234726|FG000|Overall Study|Death|4|||
94667420|NCT05177770|324234726|FG000|Overall Study|Withdrawal by Subject|1|||
94667421|NCT05177770|324234726|FG000|Overall Study|Adverse Event prior to dosing|1|||
94667422|NCT02085408|324234727|FG000|Step 1: Induction|Disease Progression|19|||
94667423|NCT02085408|324234728|FG001|Step 1: Induction|Disease Progression|19|||
94667424|NCT02085408|324234727|FG000|Step 1: Induction|Adverse Event|18|||
94667425|NCT02085408|324234728|FG001|Step 1: Induction|Adverse Event|17|||
94667426|NCT02085408|324234727|FG000|Step 1: Induction|Death|33|||
94667427|NCT02085408|324234728|FG001|Step 1: Induction|Death|30|||
94667428|NCT02085408|324234727|FG000|Step 1: Induction|Withdrawal by Subject|16|||
94667429|NCT02085408|324234728|FG001|Step 1: Induction|Withdrawal by Subject|8|||
94667430|NCT02085408|324234727|FG000|Step 1: Induction|Alternative Therapy|15|||
94667431|NCT02085408|324234728|FG001|Step 1: Induction|Alternative Therapy|19|||
94667432|NCT02085408|324234727|FG000|Step 1: Induction|Complicating Disease|2|||
94667433|NCT02085408|324234728|FG001|Step 1: Induction|Complicating Disease|3|||
94667434|NCT02085408|324234727|FG000|Step 1: Induction|Other|27|||
94667435|NCT02085408|324234728|FG001|Step 1: Induction|Other|39|||
94667436|NCT02085408|324234727|FG000|Step 1: Induction|Never started treatment|6|||
94667437|NCT02085408|324234728|FG001|Step 1: Induction|Never started treatment|4|||
94667438|NCT02085408|324234727|FG000|Step 2: Consolidation|Disease Progression|5|||
94667439|NCT02085408|324234728|FG001|Step 2: Consolidation|Disease Progression|20|||
94667440|NCT02085408|324234727|FG000|Step 2: Consolidation|Adverse Event|9|||
94667441|NCT02085408|324234728|FG001|Step 2: Consolidation|Adverse Event|8|||
94359445|NCT03358407|323100314|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
94359446|NCT03358407|323100315|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
94620453|NCT02296320|324072635|FG002|Overall Study|Lost to Follow-up|7|||
94620454|NCT02296320|324072633|FG000|Overall Study|Not treated|2|||
94620455|NCT02296320|324072634|FG001|Overall Study|Not treated|0|||
94620456|NCT02296320|324072635|FG002|Overall Study|Not treated|0|||
94620457|NCT02296320|324072633|FG000|Overall Study|Not - specified|0|||
94620458|NCT02296320|324072634|FG001|Overall Study|Not - specified|0|||
94620459|NCT02296320|324072635|FG002|Overall Study|Not - specified|1|||
94620460|NCT01447433|324072636|FG000|Overall Study|Lost to Follow-up|0|||
94620461|NCT01447433|324072637|FG001|Overall Study|Lost to Follow-up|2|||
94620462|NCT01447433|324072636|FG000|Overall Study|Withdrawal by Subject|3|||
94620463|NCT01447433|324072637|FG001|Overall Study|Withdrawal by Subject|3|||
94620464|NCT01447433|324072636|FG000|Overall Study|Protocol Violation|1|||
94620465|NCT01447433|324072637|FG001|Overall Study|Protocol Violation|1|||
94620466|NCT00799422|324072641|FG000|First Week of Wear|Lost to Follow-up|0|||
94620467|NCT00799422|324072642|FG001|First Week of Wear|Lost to Follow-up|0|||
94620468|NCT00799422|324072643|FG002|First Week of Wear|Lost to Follow-up|1|||
94620469|NCT00799422|324072644|FG003|First Week of Wear|Lost to Follow-up|0|||
94620470|NCT00799422|324072645|FG004|First Week of Wear|Lost to Follow-up|0|||
94620471|NCT00799422|324072646|FG005|First Week of Wear|Lost to Follow-up|0|||
94620472|NCT00799422|324072641|FG000|First Week of Wear|Adverse Event|0|||
94620473|NCT00799422|324072642|FG001|First Week of Wear|Adverse Event|0|||
94620474|NCT00799422|324072643|FG002|First Week of Wear|Adverse Event|0|||
94620475|NCT00799422|324072644|FG003|First Week of Wear|Adverse Event|1|||
94620476|NCT00799422|324072645|FG004|First Week of Wear|Adverse Event|0|||
94620477|NCT00799422|324072646|FG005|First Week of Wear|Adverse Event|0|||
94620478|NCT03035409|324072649|FG000|Overall Study|Adverse Event|5|||
94620479|NCT03035409|324072649|FG000|Overall Study|Death|2|||
94620480|NCT03035409|324072649|FG000|Overall Study|Withdrawal by Subject|2|||
94620481|NCT03035409|324072649|FG000|Overall Study|Non compliance|4|||
94667442|NCT02085408|324234727|FG000|Step 2: Consolidation|Death|4|||
94667443|NCT02085408|324234728|FG001|Step 2: Consolidation|Death|3|||
94667444|NCT02085408|324234727|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
94667445|NCT02085408|324234728|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
94667446|NCT02085408|324234727|FG000|Step 2: Consolidation|Alternative Therapy|9|||
94667447|NCT02085408|324234728|FG001|Step 2: Consolidation|Alternative Therapy|3|||
94667448|NCT02085408|324234727|FG000|Step 2: Consolidation|Complicating Disease|0|||
94667449|NCT02085408|324234728|FG001|Step 2: Consolidation|Complicating Disease|2|||
94667450|NCT02085408|324234727|FG000|Step 2: Consolidation|Other|6|||
94667451|NCT02085408|324234728|FG001|Step 2: Consolidation|Other|6|||
94667452|NCT02085408|324234727|FG000|Step 2: Consolidation|Never started treatment|4|||
94667453|NCT02085408|324234728|FG001|Step 2: Consolidation|Never started treatment|3|||
94667454|NCT02085408|324234727|FG000|Step 3: Maintenance|Disease Progression|13|||
94667455|NCT02085408|324234728|FG001|Step 3: Maintenance|Disease Progression|11|||
94667456|NCT02085408|324234727|FG000|Step 3: Maintenance|Adverse Event|2|||
94667457|NCT02085408|324234728|FG001|Step 3: Maintenance|Adverse Event|4|||
94667458|NCT02085408|324234727|FG000|Step 3: Maintenance|Death|1|||
94667459|NCT02085408|324234728|FG001|Step 3: Maintenance|Death|2|||
94667460|NCT02085408|324234727|FG000|Step 3: Maintenance|Alternative Therapy|1|||
94667461|NCT02085408|324234728|FG001|Step 3: Maintenance|Alternative Therapy|1|||
94667462|NCT02085408|324234727|FG000|Step 3: Maintenance|Complicating Disease|0|||
94667463|NCT02085408|324234728|FG001|Step 3: Maintenance|Complicating Disease|1|||
94667464|NCT02085408|324234727|FG000|Step 3: Maintenance|Other|3|||
94667465|NCT02085408|324234728|FG001|Step 3: Maintenance|Other|2|||
94667466|NCT02085408|324234727|FG000|Step 3: Maintenance|Never started treatment|5|||
94667467|NCT02085408|324234728|FG001|Step 3: Maintenance|Never started treatment|1|||
94667468|NCT01295944|324234729|FG000|Overall Study|Switched to alternative treatment|1|||
94667469|NCT01295944|324234729|FG000|Overall Study|Ineligible|9|||
94667470|NCT01295944|324234729|FG000|Overall Study|Withdrawal by Subject|1|||
94667471|NCT01295944|324234729|FG000|Overall Study|Participant chose to be treated in Peru|1|||
94667472|NCT01295944|324234729|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
94667473|NCT01295944|324234729|FG000|Overall Study|Physician Decision|1|||
94667474|NCT01295944|324234729|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
94667475|NCT01295944|324234729|FG000|Overall Study|Disease progression|4|||
94667476|NCT01295944|324234729|FG000|Overall Study|Transferred care before starting new treatment|1|||
94667477|NCT02734212|324234732|FG000|Overall Study|Lost to Follow-up|5|||
94667478|NCT02734212|324234733|FG001|Overall Study|Lost to Follow-up|10|||
94667479|NCT04053764|324234734|FG000|Overall Study|Withdrawal by Subject|6|||
94667480|NCT04053764|324234735|FG001|Overall Study|Withdrawal by Subject|2|||
94667481|NCT04053764|324234734|FG000|Overall Study|Physician Decision|2|||
94667482|NCT04053764|324234735|FG001|Overall Study|Physician Decision|1|||
94667483|NCT04053764|324234734|FG000|Overall Study|Adverse Event|1|||
94667484|NCT04053764|324234735|FG001|Overall Study|Adverse Event|0|||
94667485|NCT04053764|324234734|FG000|Overall Study|Pregnancy|1|||
94620482|NCT03035409|324072649|FG000|Overall Study|Patient was jittery|1|||
94620483|NCT03035409|324072649|FG000|Overall Study|Did not like Questionnaire|1|||
94620484|NCT03035409|324072649|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
94667486|NCT04053764|324234735|FG001|Overall Study|Pregnancy|0|||
94667487|NCT04732286|324234736|FG000|Overall Study|Progressive Disease|2|||
94667488|NCT04732286|324234736|FG000|Overall Study|Physician Decision|1|||
94667489|NCT04732286|324234736|FG000|Overall Study|Study Terminated by Sponsor|31|||
94667490|NCT04732286|324234736|FG000|Overall Study|Withdrawal by Subject|10|||
94255001|NCT04822597|322726474|FG000|Overall Study|Withdrawal by Subject|0|||
94255002|NCT04822597|322726475|FG001|Overall Study|Withdrawal by Subject|1|||
94667491|NCT04732286|324234736|FG000|Overall Study|Non-compliance With Study Drug|1|||
94667492|NCT04732286|324234736|FG000|Overall Study|Lost to Follow-up|4|||
94667493|NCT04732286|324234736|FG000|Overall Study|Death|51|||
94667494|NCT01474681|324234737|FG000|Overall Study|Death|0|||
94667495|NCT01474681|324234738|FG001|Overall Study|Death|3|||
94667496|NCT01474681|324234739|FG002|Overall Study|Death|2|||
94667497|NCT01474681|324234740|FG003|Overall Study|Death|6|||
94255003|NCT04822597|322726476|FG002|Overall Study|Withdrawal by Subject|1|||
94255004|NCT04822597|322726477|FG003|Overall Study|Withdrawal by Subject|0|||
94667498|NCT01392560|324234741|FG000|Overall Study|Adverse Event|2|||
94667499|NCT01392560|324234741|FG000|Overall Study|not entered|8|||
94667500|NCT01392560|324234741|FG000|Overall Study|discontinued during placebo run-in|2|||
94667501|NCT01302119|324234752|FG000|Overall Study|Withdrawal by Subject|30|||
94667502|NCT01302119|324234753|FG001|Overall Study|Withdrawal by Subject|20|||
94667503|NCT01302119|324234752|FG000|Overall Study|Lost to Follow-up|10|||
94667504|NCT01302119|324234753|FG001|Overall Study|Lost to Follow-up|4|||
94667505|NCT01302119|324234752|FG000|Overall Study|Adverse Event|2|||
94667506|NCT01302119|324234753|FG001|Overall Study|Adverse Event|1|||
94667507|NCT01302119|324234752|FG000|Overall Study|Non-compliance|4|||
94667508|NCT01302119|324234753|FG001|Overall Study|Non-compliance|2|||
94667509|NCT01302119|324234752|FG000|Overall Study|Non-specific|4|||
94667510|NCT01302119|324234753|FG001|Overall Study|Non-specific|1|||
94667511|NCT02298192|324234757|FG000|Overall Study|Unclassified|3|||
94667512|NCT02298192|324234758|FG001|Overall Study|Unclassified|2|||
94667513|NCT02298192|324234757|FG000|Overall Study|Withdrawal criteria|2|||
94667514|NCT02298192|324234758|FG001|Overall Study|Withdrawal criteria|0|||
94667515|NCT02298192|324234757|FG000|Overall Study|Withdrawal by Subject|6|||
94667516|NCT02298192|324234758|FG001|Overall Study|Withdrawal by Subject|1|||
94667517|NCT02298192|324234757|FG000|Overall Study|Lost to Follow-up|2|||
94667518|NCT02298192|324234758|FG001|Overall Study|Lost to Follow-up|1|||
94667519|NCT02298192|324234757|FG000|Overall Study|Adverse Event|6|||
94667520|NCT02298192|324234758|FG001|Overall Study|Adverse Event|2|||
94667521|NCT00617344|324234759|FG000|Overall Study|Serious adverse event|1|||
94667522|NCT00617344|324234760|FG001|Overall Study|Serious adverse event|0|||
94667523|NCT00617344|324234761|FG002|Overall Study|Serious adverse event|0|||
94667524|NCT00617344|324234759|FG000|Overall Study|Other Adverse Event|1|||
94667525|NCT00617344|324234760|FG001|Overall Study|Other Adverse Event|1|||
94667526|NCT00617344|324234761|FG002|Overall Study|Other Adverse Event|0|||
94667527|NCT00617344|324234759|FG000|Overall Study|Protocol Violation|10|||
94667528|NCT00617344|324234760|FG001|Overall Study|Protocol Violation|8|||
94667529|NCT00617344|324234761|FG002|Overall Study|Protocol Violation|5|||
94667530|NCT00617344|324234759|FG000|Overall Study|Lost to Follow-up|5|||
94667531|NCT00617344|324234760|FG001|Overall Study|Lost to Follow-up|4|||
94667532|NCT00617344|324234761|FG002|Overall Study|Lost to Follow-up|1|||
94667533|NCT00617344|324234759|FG000|Overall Study|Withdrawal by Subject|8|||
94667534|NCT00617344|324234760|FG001|Overall Study|Withdrawal by Subject|9|||
94667535|NCT00617344|324234761|FG002|Overall Study|Withdrawal by Subject|2|||
94667536|NCT00679939|324234766|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
94667537|NCT00679939|324234767|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
94667538|NCT00679939|324234766|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
94667539|NCT00679939|324234767|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
94667540|NCT00679939|324234766|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
94255005|NCT04822597|322726474|FG000|Overall Study|Physician Decision|0|||
94255006|NCT04822597|322726475|FG001|Overall Study|Physician Decision|0|||
94255007|NCT04822597|322726476|FG002|Overall Study|Physician Decision|1|||
94667541|NCT00679939|324234767|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
94667542|NCT00679939|324234766|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
94667543|NCT00679939|324234767|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
94667544|NCT00679939|324234766|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
94667545|NCT00679939|324234767|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
94667546|NCT00679939|324234766|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
94667547|NCT00679939|324234767|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
94667548|NCT00679939|324234766|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
94255008|NCT04822597|322726477|FG003|Overall Study|Physician Decision|1|||
94255009|NCT04822597|322726474|FG000|Overall Study|Subject withdrawn after enrollment|0|||
94255010|NCT04822597|322726475|FG001|Overall Study|Subject withdrawn after enrollment|1|||
94667549|NCT00679939|324234767|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
94667550|NCT00679939|324234766|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
94255011|NCT04822597|322726476|FG002|Overall Study|Subject withdrawn after enrollment|0|||
94667551|NCT00679939|324234767|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
94667552|NCT00679939|324234766|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
94667553|NCT00679939|324234767|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
94667554|NCT00679939|324234766|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
94667555|NCT00679939|324234767|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
94667556|NCT01453595|324234769|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
94667557|NCT01453595|324234770|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
94667558|NCT01453595|324234771|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
94667559|NCT02693665|324234772|FG000|Overall Study|Death|3|||
94667560|NCT02693665|324234773|FG001|Overall Study|Death|2|||
94667561|NCT02693665|324234772|FG000|Overall Study|Lost to Follow-up|7|||
94667562|NCT02693665|324234773|FG001|Overall Study|Lost to Follow-up|3|||
94667563|NCT02693665|324234772|FG000|Overall Study|Protocol Violation|1|||
94620485|NCT03035409|324072649|FG000|Overall Study|Did not like taking drugs|1|||
94620486|NCT02784431|324072652|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
94620487|NCT02784431|324072652|FG000|Overall Study|Early Study Termination|19|||
94620488|NCT03302234|324072655|FG000|Overall Study|Death|191|||
94620489|NCT03302234|324072656|FG001|Overall Study|Death|192|||
94620490|NCT03302234|324072655|FG000|Overall Study|Withdrawal by Subject|2|||
94620491|NCT03302234|324072656|FG001|Overall Study|Withdrawal by Subject|2|||
94620492|NCT03302234|324072655|FG000|Overall Study|Sponsor Decision|90|||
94620493|NCT03302234|324072656|FG001|Overall Study|Sponsor Decision|89|||
94620494|NCT03302234|324072655|FG000|Overall Study|Laryngeal carcinoma|0|||
94620495|NCT03302234|324072656|FG001|Overall Study|Laryngeal carcinoma|1|||
94620496|NCT03302234|324072655|FG000|Overall Study|Not Reported|1|||
94620497|NCT03302234|324072656|FG001|Overall Study|Not Reported|0|||
94620498|NCT01348165|324072657|FG000|Overall Study|Adverse Event|0|||
94620499|NCT01348165|324072658|FG001|Overall Study|Adverse Event|0|||
94620500|NCT01348165|324072659|FG002|Overall Study|Adverse Event|0|||
94620501|NCT01348165|324072660|FG003|Overall Study|Adverse Event|0|||
94620502|NCT01348165|324072661|FG004|Overall Study|Adverse Event|0|||
94620503|NCT01348165|324072662|FG005|Overall Study|Adverse Event|0|||
94620504|NCT01348165|324072663|FG006|Overall Study|Adverse Event|1|||
94620505|NCT04706091|324072664|FG000|Treatment 2|Withdrawal by Subject|1|||
94620506|NCT04706091|324072665|FG001|Treatment 2|Withdrawal by Subject|0|||
94620507|NCT03253744|324072667|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
94620508|NCT03253744|324072668|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
94620509|NCT03253744|324072669|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
94620510|NCT03253744|324072670|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
94620511|NCT03749447|324074020|FG000|Overall Study|Adverse Event|11|||
94620512|NCT03749447|324074021|FG001|Overall Study|Adverse Event|3|||
94620513|NCT03749447|324074020|FG000|Overall Study|Death|1|||
94620514|NCT03749447|324074021|FG001|Overall Study|Death|1|||
94620515|NCT03749447|324074020|FG000|Overall Study|Lost to Follow-up|2|||
94620516|NCT03749447|324074021|FG001|Overall Study|Lost to Follow-up|2|||
94620517|NCT03749447|324074020|FG000|Overall Study|Reason Not Specified|0|||
94620518|NCT03749447|324074021|FG001|Overall Study|Reason Not Specified|3|||
94620519|NCT03749447|324074020|FG000|Overall Study|Physician Decision|4|||
94620520|NCT03749447|324074021|FG001|Overall Study|Physician Decision|3|||
94620521|NCT03749447|324074020|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
94620522|NCT03749447|324074021|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
94620523|NCT03749447|324074020|FG000|Overall Study|Study Terminated By Sponsor|112|||
94620524|NCT03749447|324074021|FG001|Overall Study|Study Terminated By Sponsor|105|||
94620525|NCT03749447|324074020|FG000|Overall Study|Withdrawal by Subject|12|||
94620526|NCT03749447|324074021|FG001|Overall Study|Withdrawal by Subject|6|||
94620527|NCT03749447|324074020|FG000|Overall Study|Non-compliance With Study Drug|0|||
94620528|NCT03749447|324074021|FG001|Overall Study|Non-compliance With Study Drug|1|||
94620529|NCT00745823|324074022|FG000|Overall Study|Adverse Event|5|||
94620530|NCT00745823|324074023|FG001|Overall Study|Adverse Event|3|||
94620531|NCT00745823|324074022|FG000|Overall Study|Lack of Efficacy|20|||
94620532|NCT00745823|324074023|FG001|Overall Study|Lack of Efficacy|6|||
94620533|NCT00745823|324074022|FG000|Overall Study|Lost to Follow-up|10|||
94620534|NCT00745823|324074023|FG001|Overall Study|Lost to Follow-up|11|||
94620535|NCT00745823|324074022|FG000|Overall Study|Physician Decision|10|||
94620536|NCT00745823|324074023|FG001|Overall Study|Physician Decision|5|||
94620537|NCT00745823|324074022|FG000|Overall Study|Pregnancy|0|||
94620538|NCT00745823|324074023|FG001|Overall Study|Pregnancy|4|||
94620539|NCT00745823|324074022|FG000|Overall Study|Withdrawal by Subject|14|||
94620540|NCT00745823|324074023|FG001|Overall Study|Withdrawal by Subject|8|||
94620541|NCT00745823|324074022|FG000|Overall Study|Study Terminated by Sponsor|326|||
94620542|NCT00745823|324074023|FG001|Overall Study|Study Terminated by Sponsor|349|||
94620543|NCT04669600|324074034|FG000|Overall Study|Withdrawal by Subject|1|||
94620544|NCT04669600|324074034|FG000|Overall Study|Other|6|||
94620545|NCT03539081|324074035|FG000|Overall Study|Withdrawal by Subject|2|||
94620546|NCT03539081|324074036|FG001|Overall Study|Withdrawal by Subject|3|||
94620547|NCT03539081|324074037|FG002|Overall Study|Withdrawal by Subject|0|||
94620548|NCT03539081|324074035|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
94359447|NCT03358407|323100316|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
94620549|NCT03539081|324074036|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
94359448|NCT03358407|323100317|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
94359449|NCT03358407|323100308|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
94359450|NCT03358407|323100309|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
94620550|NCT03539081|324074037|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
94620551|NCT01819831|324074040|FG000|Overall Study|Withdrawal by Subject|1|||
94620552|NCT01513343|324074041|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
94620553|NCT01513343|324074042|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
94620554|NCT01513343|324074041|FG000|Post Data Collection|Dropped/withdrew from study|7|||
94620555|NCT01513343|324074042|FG001|Post Data Collection|Dropped/withdrew from study|1|||
94620556|NCT01513343|324074041|FG000|Post Data Collection|Lost to Follow-up|10|||
94620557|NCT01513343|324074042|FG001|Post Data Collection|Lost to Follow-up|23|||
94620558|NCT01513343|324074041|FG000|6-month Follow-up|Lost to Follow-up|28|||
94620559|NCT01513343|324074042|FG001|6-month Follow-up|Lost to Follow-up|17|||
94620560|NCT01513343|324074041|FG000|12-month Follow-up|Lost to Follow-up|10|||
94620561|NCT01513343|324074042|FG001|12-month Follow-up|Lost to Follow-up|3|||
94620562|NCT03535844|324074050|FG000|Overall Study|Withdrawal by Subject|0|||
94620563|NCT03535844|324074051|FG001|Overall Study|Withdrawal by Subject|1|||
94620564|NCT04213079|324074054|FG000|Overall Study|Lost to Follow-up|0|||
94620565|NCT04213079|324074055|FG001|Overall Study|Lost to Follow-up|2|||
94620566|NCT00119106|324074059|FG000|Overall Study|HIV infected at baseline|179|||
94620567|NCT00119106|324074060|FG001|Overall Study|HIV infected at baseline|178|||
94620568|NCT01010061|324074061|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
94620569|NCT01010061|324074062|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
94620570|NCT01010061|324074061|FG000|Overall Study|Disease Progression|2|||
94620571|NCT01010061|324074062|FG001|Overall Study|Disease Progression|8|||
94620572|NCT01010061|324074061|FG000|Overall Study|Withdrew Consent|5|||
94620573|NCT01010061|324074062|FG001|Overall Study|Withdrew Consent|1|||
94620574|NCT01010061|324074061|FG000|Overall Study|Death|3|||
94620575|NCT01010061|324074062|FG001|Overall Study|Death|6|||
94620576|NCT01010061|324074061|FG000|Overall Study|Administrative/Other|0|||
94620577|NCT01010061|324074062|FG001|Overall Study|Administrative/Other|1|||
94620578|NCT01010061|324074061|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
94620579|NCT01010061|324074062|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
94620580|NCT01010061|324074061|FG000|Overall Study|Insufficient Therapeutic Response|1|||
94620581|NCT01010061|324074062|FG001|Overall Study|Insufficient Therapeutic Response|5|||
94620582|NCT01010061|324074061|FG000|Overall Study|Violation of Selection Criteria|0|||
94620583|NCT01010061|324074062|FG001|Overall Study|Violation of Selection Criteria|1|||
94620584|NCT01010061|324074061|FG000|Overall Study|Did Not Receive Treatment|2|||
94620585|NCT01010061|324074062|FG001|Overall Study|Did Not Receive Treatment|2|||
94620586|NCT03066804|324074063|FG000|Overall Study|Physician Decision|0|||
94620587|NCT03066804|324074064|FG001|Overall Study|Physician Decision|4|||
94620588|NCT03066804|324074063|FG000|Overall Study|Death|23|||
94620589|NCT03066804|324074064|FG001|Overall Study|Death|17|||
94620590|NCT03066804|324074063|FG000|Overall Study|Withdrawal by Subject|19|||
94620591|NCT03066804|324074064|FG001|Overall Study|Withdrawal by Subject|25|||
94620592|NCT03066804|324074063|FG000|Overall Study|Lost to Follow-up|2|||
94620593|NCT03066804|324074064|FG001|Overall Study|Lost to Follow-up|0|||
94620594|NCT03066804|324074063|FG000|Overall Study|Adverse Event|2|||
94620595|NCT03066804|324074064|FG001|Overall Study|Adverse Event|3|||
94620596|NCT03066804|324074063|FG000|Overall Study|Technical problems|5|||
94620597|NCT03066804|324074064|FG001|Overall Study|Technical problems|1|||
94620598|NCT01051323|324074067|FG000|Overall Study|Discontinuation of treatment|103|||
94620599|NCT01051323|324074067|FG000|Overall Study|Transplantation|28|||
94620600|NCT01051323|324074067|FG000|Overall Study|Dialysis dependency|22|||
94620601|NCT01051323|324074067|FG000|Overall Study|Withdrawal by Subject|13|||
94620602|NCT01051323|324074067|FG000|Overall Study|Lost to Follow-up|31|||
94620603|NCT01051323|324074067|FG000|Overall Study|Death|129|||
94620604|NCT01051323|324074067|FG000|Overall Study|Hospitalization|28|||
94620605|NCT01051323|324074067|FG000|Overall Study|Other|148|||
94620606|NCT01051323|324074067|FG000|Overall Study|Missing|37|||
94620607|NCT03470441|324074070|FG000|Overall Study|Death|0|||
94620608|NCT03470441|324074071|FG001|Overall Study|Death|1|||
94620609|NCT03470441|324074072|FG002|Overall Study|Death|1|||
94620610|NCT03470441|324074073|FG003|Overall Study|Death|0|||
94620611|NCT03470441|324074070|FG000|Overall Study|Adverse Event|0|||
94620612|NCT03470441|324074071|FG001|Overall Study|Adverse Event|0|||
94620613|NCT03470441|324074072|FG002|Overall Study|Adverse Event|0|||
94620614|NCT03470441|324074073|FG003|Overall Study|Adverse Event|1|||
94620615|NCT03470441|324074070|FG000|Overall Study|Withdrawal by Subject|1|||
94620616|NCT03470441|324074071|FG001|Overall Study|Withdrawal by Subject|4|||
94620617|NCT03470441|324074072|FG002|Overall Study|Withdrawal by Subject|1|||
94620618|NCT03470441|324074073|FG003|Overall Study|Withdrawal by Subject|3|||
94667564|NCT02693665|324234773|FG001|Overall Study|Protocol Violation|0|||
94667565|NCT02693665|324234772|FG000|Overall Study|Withdrawal by Subject|2|||
94667566|NCT02693665|324234773|FG001|Overall Study|Withdrawal by Subject|0|||
94667567|NCT02693665|324234772|FG000|Overall Study|patient wanted to leave it behind|1|||
94667568|NCT02693665|324234773|FG001|Overall Study|patient wanted to leave it behind|0|||
94667569|NCT02693665|324234772|FG000|Overall Study|anxiety|1|||
94667570|NCT02693665|324234773|FG001|Overall Study|anxiety|0|||
94667571|NCT02693665|324234772|FG000|Overall Study|family issues|1|||
94667572|NCT02693665|324234773|FG001|Overall Study|family issues|0|||
94667573|NCT02693665|324234772|FG000|Overall Study|no reason given|1|||
94667574|NCT02693665|324234773|FG001|Overall Study|no reason given|0|||
94667575|NCT05239039|324234774|FG000|Overall Study|Withdrawal by Subject|0|||
94667576|NCT05239039|324234775|FG001|Overall Study|Withdrawal by Subject|1|||
94667577|NCT04439110|324234776|FG000|Overall Study|Ineligible|2|||
94667578|NCT04439110|324234776|FG000|Overall Study|Adverse Event|4|||
94667579|NCT04439110|324234776|FG000|Overall Study|Death|2|||
94667580|NCT04439110|324234776|FG000|Overall Study|Disease proression|25|||
94667581|NCT04439110|324234776|FG000|Overall Study|Withdrawal by Subject|1|||
94667582|NCT04439110|324234776|FG000|Overall Study|Alternative therapy|1|||
94667583|NCT04439110|324234776|FG000|Overall Study|Other complicating disease|1|||
94667584|NCT04439110|324234776|FG000|Overall Study|Personal reasons|1|||
94667585|NCT04439110|324234776|FG000|Overall Study|Still on treatment|1|||
94667586|NCT00936390|324234779|FG000|Overall Study|Protocol Violation|21|||
94667587|NCT00936390|324234780|FG001|Overall Study|Protocol Violation|25|||
94667588|NCT02097108|324234781|FG000|Overall Study|Adverse Event|1|||
94667589|NCT02097108|324234781|FG000|Overall Study|patient was abroad for 6 months|1|||
94667590|NCT04450264|324236488|FG000|Overall Study|Incomplete survey|13|||
94667591|NCT04450264|324236489|FG001|Overall Study|Incomplete survey|19|||
94667592|NCT00924287|324236490|FG000|Overall Study|Death|1|||
94667593|NCT02522494|324236492|FG000|Overall Study|Lost to Follow-up|6|||
94667594|NCT02522494|324236493|FG001|Overall Study|Lost to Follow-up|2|||
94667595|NCT02522494|324236492|FG000|Overall Study|Withdrawal by Subject|1|||
94667596|NCT02522494|324236493|FG001|Overall Study|Withdrawal by Subject|0|||
94667597|NCT02522494|324236492|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
94667598|NCT02522494|324236493|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
94667599|NCT02522494|324236492|FG000|Overall Study|Participant did not watch the video|1|||
94667600|NCT02522494|324236493|FG001|Overall Study|Participant did not watch the video|0|||
94667601|NCT02522494|324236492|FG000|Overall Study|Death|0|||
94667602|NCT02522494|324236493|FG001|Overall Study|Death|1|||
94667603|NCT01412944|324236494|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
94667604|NCT01412944|324236495|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
94667605|NCT01412944|324236496|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
94667606|NCT01412944|324236497|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
94667607|NCT01412944|324236498|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
94667608|NCT01412944|324236499|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
94667609|NCT01412944|324236494|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
94667610|NCT01412944|324236495|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
94667611|NCT01412944|324236496|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
94667612|NCT01412944|324236497|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
94667613|NCT01412944|324236498|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
94667614|NCT01412944|324236499|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
94667615|NCT01412944|324236494|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
94667616|NCT01412944|324236495|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
94667617|NCT01412944|324236496|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
94667618|NCT01412944|324236497|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
94667619|NCT01412944|324236498|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
94667620|NCT01412944|324236499|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
94667621|NCT01412944|324236494|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
94667622|NCT01412944|324236495|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
94667623|NCT01412944|324236496|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
94667624|NCT01412944|324236497|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
94667625|NCT01412944|324236498|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
94667626|NCT01412944|324236499|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
94667627|NCT01412944|324236494|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
94667628|NCT01412944|324236495|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
94667629|NCT01412944|324236496|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
94667630|NCT01412944|324236497|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
94667631|NCT01412944|324236498|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
94667632|NCT01412944|324236499|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
94359451|NCT03358407|323100310|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
94359452|NCT03358407|323100311|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
94359453|NCT03358407|323100312|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
94620619|NCT00370032|324074074|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
94620620|NCT00370032|324074075|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
94620621|NCT00370032|324074074|FG000|Washout Period|Withdrawal by Subject|0|||
94620622|NCT00370032|324074075|FG001|Washout Period|Withdrawal by Subject|1|||
94620623|NCT00370032|324074074|FG000|Washout Period|Lost to Follow-up|0|||
94620624|NCT00370032|324074075|FG001|Washout Period|Lost to Follow-up|1|||
94620625|NCT00370032|324074074|FG000|Washout Period|Adverse Event|1|||
94620626|NCT00370032|324074075|FG001|Washout Period|Adverse Event|0|||
94620627|NCT00370032|324074074|FG000|Follow-up Period|Withdrawal by Subject|1|||
94620628|NCT00370032|324074075|FG001|Follow-up Period|Withdrawal by Subject|0|||
94620629|NCT00801632|324074076|FG000|Overall Study|Re-transplant|1|||
94620630|NCT02256631|324074085|FG000|Overall Study|Lost to Follow-up|1|||
94620631|NCT02256631|324074086|FG001|Overall Study|Lost to Follow-up|1|||
94620632|NCT02256631|324074087|FG002|Overall Study|Lost to Follow-up|0|||
94620633|NCT02256631|324074088|FG003|Overall Study|Lost to Follow-up|2|||
94620634|NCT02256631|324074089|FG004|Overall Study|Lost to Follow-up|0|||
94620635|NCT02256631|324074090|FG005|Overall Study|Lost to Follow-up|4|||
94620636|NCT02256631|324074091|FG006|Overall Study|Lost to Follow-up|1|||
94620637|NCT02256631|324074085|FG000|Overall Study|Withdrawal by Subject|0|||
94620638|NCT02256631|324074086|FG001|Overall Study|Withdrawal by Subject|0|||
94620639|NCT02256631|324074087|FG002|Overall Study|Withdrawal by Subject|0|||
94620640|NCT02256631|324074088|FG003|Overall Study|Withdrawal by Subject|1|||
94620641|NCT02256631|324074089|FG004|Overall Study|Withdrawal by Subject|1|||
94620642|NCT02256631|324074090|FG005|Overall Study|Withdrawal by Subject|0|||
94620643|NCT02256631|324074091|FG006|Overall Study|Withdrawal by Subject|1|||
94620644|NCT02256631|324074085|FG000|Overall Study|Unable to get to clinic|0|||
94620645|NCT02256631|324074086|FG001|Overall Study|Unable to get to clinic|2|||
94620646|NCT02256631|324074087|FG002|Overall Study|Unable to get to clinic|0|||
94620647|NCT02256631|324074088|FG003|Overall Study|Unable to get to clinic|1|||
94620648|NCT02256631|324074089|FG004|Overall Study|Unable to get to clinic|0|||
94620649|NCT02256631|324074090|FG005|Overall Study|Unable to get to clinic|1|||
94620650|NCT02256631|324074091|FG006|Overall Study|Unable to get to clinic|2|||
94620651|NCT01427972|324074093|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
94620652|NCT01427972|324074094|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
94620653|NCT01427972|324074095|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
94620654|NCT01427972|324074096|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
94620655|NCT01427972|324074097|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
94620656|NCT01427972|324074098|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
94620657|NCT01427972|324074099|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
94620658|NCT01427972|324074100|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
94620659|NCT01427972|324074101|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
94620660|NCT01427972|324074102|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
94620661|NCT01427972|324074103|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
94620662|NCT01427972|324074104|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
94620663|NCT01427972|324074093|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
94620664|NCT01427972|324074094|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
94620665|NCT01427972|324074095|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
94620666|NCT01427972|324074096|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
94620667|NCT01427972|324074097|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
94620668|NCT01427972|324074098|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
94620669|NCT01427972|324074099|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
94620670|NCT01427972|324074100|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
94620671|NCT01427972|324074101|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
94620672|NCT01427972|324074102|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
94620673|NCT01427972|324074103|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
94620674|NCT01427972|324074104|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
94620675|NCT01427972|324074093|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
94620676|NCT01427972|324074094|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
94620677|NCT01427972|324074095|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
94620678|NCT01427972|324074096|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
94620679|NCT01427972|324074097|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
94620680|NCT01427972|324074098|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
94620681|NCT01427972|324074099|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
94620682|NCT01427972|324074100|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
94620683|NCT01427972|324074101|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
94620684|NCT01427972|324074102|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
94620685|NCT01427972|324074103|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
94620686|NCT01427972|324074104|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
94620687|NCT02021773|324074105|FG000|Overall Study|Adverse Event|1|||
94620688|NCT02021773|324074106|FG001|Overall Study|Adverse Event|4|||
94620689|NCT02021773|324074107|FG002|Overall Study|Adverse Event|3|||
94620690|NCT02021773|324074105|FG000|Overall Study|Lack of Efficacy|2|||
94359454|NCT03358407|323100313|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
94359455|NCT03358407|323100314|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
94359456|NCT03358407|323100315|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
94359457|NCT03358407|323100316|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
94359458|NCT03358407|323100317|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
94359459|NCT03358407|323100308|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
94359460|NCT03358407|323100309|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
94359461|NCT03358407|323100310|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
94359462|NCT03358407|323100311|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
94359463|NCT03358407|323100312|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
94359464|NCT03358407|323100313|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
94359465|NCT03358407|323100314|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
94359466|NCT03358407|323100315|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
94359467|NCT03358407|323100316|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
94359468|NCT03358407|323100317|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
94359469|NCT03358407|323100308|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
94359470|NCT03358407|323100309|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
94359471|NCT03358407|323100310|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
94359472|NCT03358407|323100311|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
94359473|NCT03358407|323100312|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
94359474|NCT03358407|323100313|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
94359475|NCT03358407|323100314|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
94359476|NCT03358407|323100315|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
94359477|NCT03358407|323100316|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
94359478|NCT03358407|323100317|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
94359479|NCT04366258|323100319|FG000|Baseline Assessments|Screen Failure|21|||
94359480|NCT04366258|323100319|FG000|Baseline Assessments|Early Termination|3|||
94359481|NCT04139642|323100321|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
94359482|NCT04139642|323100322|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
94359483|NCT03557775|323100323|FG000|Overall Study|Withdrawal by Subject|1|||
94359484|NCT03557775|323100324|FG001|Overall Study|Withdrawal by Subject|2|||
94359485|NCT03557775|323100325|FG002|Overall Study|Withdrawal by Subject|4|||
94359486|NCT03557775|323100323|FG000|Overall Study|Physician Decision|0|||
94359487|NCT03557775|323100324|FG001|Overall Study|Physician Decision|1|||
94359488|NCT03557775|323100325|FG002|Overall Study|Physician Decision|0|||
94620691|NCT02021773|324074106|FG001|Overall Study|Lack of Efficacy|2|||
94620692|NCT02021773|324074107|FG002|Overall Study|Lack of Efficacy|2|||
94620693|NCT02021773|324074105|FG000|Overall Study|Protocol Violation|2|||
94620694|NCT02021773|324074106|FG001|Overall Study|Protocol Violation|3|||
94620695|NCT02021773|324074107|FG002|Overall Study|Protocol Violation|1|||
94620696|NCT02021773|324074105|FG000|Overall Study|Withdrawal by Subject|3|||
94620697|NCT02021773|324074106|FG001|Overall Study|Withdrawal by Subject|4|||
94620698|NCT02021773|324074107|FG002|Overall Study|Withdrawal by Subject|5|||
94620699|NCT02021773|324074105|FG000|Overall Study|Lost to Follow-up|1|||
94620700|NCT02021773|324074106|FG001|Overall Study|Lost to Follow-up|3|||
94620701|NCT02021773|324074107|FG002|Overall Study|Lost to Follow-up|0|||
94620702|NCT02021773|324074105|FG000|Overall Study|Reason not specified|3|||
94620703|NCT02021773|324074106|FG001|Overall Study|Reason not specified|0|||
94620704|NCT02021773|324074107|FG002|Overall Study|Reason not specified|0|||
94620705|NCT01197560|324074108|FG000|Overall Study|Adverse Event|6|||
94620706|NCT01197560|324074109|FG001|Overall Study|Adverse Event|8|||
94620707|NCT01197560|324074108|FG000|Overall Study|Death|3|||
94620708|NCT01197560|324074109|FG001|Overall Study|Death|5|||
94620709|NCT01197560|324074108|FG000|Overall Study|Withdrawal by Subject|1|||
94620710|NCT01197560|324074109|FG001|Overall Study|Withdrawal by Subject|1|||
94620711|NCT01197560|324074108|FG000|Overall Study|Disease progression|40|||
94620712|NCT01197560|324074109|FG001|Overall Study|Disease progression|35|||
94620713|NCT01197560|324074108|FG000|Overall Study|Miscellaneous|4|||
94620714|NCT01197560|324074109|FG001|Overall Study|Miscellaneous|3|||
94620715|NCT01197560|324074108|FG000|Overall Study|Missing|0|||
94620716|NCT01197560|324074109|FG001|Overall Study|Missing|1|||
94620717|NCT01382212|324074110|FG000|Overall Study|Kidney transplant|1|||
94620718|NCT01382212|324074110|FG000|Overall Study|Withdrew consent|1|||
94620719|NCT02006719|324074111|FG000|Overall Study|Withdrawal by Subject|10|||
94620720|NCT02006719|324074112|FG001|Overall Study|Withdrawal by Subject|2|||
94667633|NCT01412944|324236494|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
94667634|NCT01412944|324236495|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
94620721|NCT02006719|324074111|FG000|Overall Study|Lost to Follow-up|5|||
94620722|NCT02006719|324074112|FG001|Overall Study|Lost to Follow-up|1|||
94620723|NCT02006719|324074111|FG000|Overall Study|Protocol Violation|2|||
94620724|NCT02006719|324074112|FG001|Overall Study|Protocol Violation|0|||
94620725|NCT02006719|324074111|FG000|Overall Study|Adverse Event|1|||
94620726|NCT02006719|324074112|FG001|Overall Study|Adverse Event|1|||
94620727|NCT02006719|324074111|FG000|Overall Study|Other/Unknown|0|||
94620728|NCT02006719|324074112|FG001|Overall Study|Other/Unknown|1|||
94620729|NCT00228384|324074113|FG000|Overall Study|Death|9|||
94620730|NCT00228384|324074114|FG001|Overall Study|Death|3|||
94620731|NCT00228384|324074113|FG000|Overall Study|Lost to Follow-up|6|||
94620732|NCT00228384|324074114|FG001|Overall Study|Lost to Follow-up|10|||
94620733|NCT00228384|324074113|FG000|Overall Study|Surgical Intervention (bypass)|5|||
94620734|NCT00228384|324074114|FG001|Overall Study|Surgical Intervention (bypass)|5|||
94620735|NCT00228384|324074113|FG000|Overall Study|Withdrawal by Subject|9|||
94620736|NCT00228384|324074114|FG001|Overall Study|Withdrawal by Subject|10|||
94620737|NCT00228384|324074113|FG000|Overall Study|Physician Decision|0|||
94620738|NCT00228384|324074114|FG001|Overall Study|Physician Decision|1|||
94667635|NCT01412944|324236496|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
94667636|NCT01412944|324236497|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
94667637|NCT01412944|324236498|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
94667638|NCT01412944|324236499|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
94667639|NCT01412944|324236494|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
94667640|NCT01412944|324236495|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
94667641|NCT01412944|324236496|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
94667642|NCT01412944|324236497|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
94667643|NCT01412944|324236498|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
94667644|NCT01412944|324236499|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
94667645|NCT01412944|324236494|FG000|Entire: IV + Maintenance|Adverse Event|0|||
94667646|NCT01412944|324236495|FG001|Entire: IV + Maintenance|Adverse Event|0|||
94667647|NCT01412944|324236496|FG002|Entire: IV + Maintenance|Adverse Event|0|||
94667648|NCT01412944|324236497|FG003|Entire: IV + Maintenance|Adverse Event|0|||
94667649|NCT01412944|324236498|FG004|Entire: IV + Maintenance|Adverse Event|1|||
94667650|NCT01412944|324236499|FG005|Entire: IV + Maintenance|Adverse Event|0|||
94667651|NCT01412944|324236494|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
94667652|NCT01412944|324236495|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
94667653|NCT01412944|324236496|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
94667654|NCT01412944|324236497|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
94667655|NCT01412944|324236498|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
94667656|NCT01412944|324236499|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
94667657|NCT01412944|324236494|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
94667658|NCT01412944|324236495|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
94667659|NCT01412944|324236496|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
94667660|NCT01412944|324236497|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
94667661|NCT01412944|324236498|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
94667662|NCT01412944|324236499|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
94667663|NCT01412944|324236494|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
94667664|NCT01412944|324236495|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
94667665|NCT01412944|324236496|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
94667666|NCT01412944|324236497|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
94667667|NCT01412944|324236498|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
94667668|NCT01412944|324236499|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
94667669|NCT01412944|324236494|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
94667670|NCT01412944|324236495|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
94667671|NCT01412944|324236496|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
94667672|NCT01412944|324236497|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
94667673|NCT01412944|324236498|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
94667674|NCT01412944|324236499|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
94667675|NCT01412944|324236494|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
94667676|NCT01412944|324236495|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
94667677|NCT01412944|324236496|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
94667678|NCT01412944|324236497|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
94667679|NCT01412944|324236498|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
94667680|NCT01412944|324236499|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
94667681|NCT01412944|324236494|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
94667682|NCT01412944|324236495|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
94667683|NCT01412944|324236496|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
94620739|NCT01084083|324074115|FG000|Overall Study|Adverse Event|5|||
94620740|NCT01084083|324074115|FG000|Overall Study|Death|1|||
94620741|NCT01084083|324074115|FG000|Overall Study|Withdrawal by Subject|2|||
94620742|NCT01084083|324074115|FG000|Overall Study|Complicating disease|1|||
94620743|NCT01084083|324074115|FG000|Overall Study|Other|2|||
94620744|NCT01084083|324074115|FG000|Overall Study|Never started assigned therapy|1|||
94620745|NCT01737697|324074117|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
94620746|NCT01737697|324074118|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
94620747|NCT01737697|324074119|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
94667684|NCT01412944|324236497|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
94667685|NCT01412944|324236498|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
94667686|NCT01412944|324236499|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
94667687|NCT01412944|324236494|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
94667688|NCT01412944|324236495|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
94667689|NCT01412944|324236496|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
94667690|NCT01412944|324236497|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
94667691|NCT01412944|324236498|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
94667692|NCT01412944|324236499|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
94667693|NCT01412944|324236494|FG000|Entire: IV + Maintenance|Adverse Event|0|||
94667694|NCT01412944|324236495|FG001|Entire: IV + Maintenance|Adverse Event|1|||
94667695|NCT01412944|324236496|FG002|Entire: IV + Maintenance|Adverse Event|0|||
94667696|NCT01412944|324236497|FG003|Entire: IV + Maintenance|Adverse Event|0|||
94667697|NCT01412944|324236498|FG004|Entire: IV + Maintenance|Adverse Event|0|||
94667698|NCT01412944|324236499|FG005|Entire: IV + Maintenance|Adverse Event|0|||
94667699|NCT02216123|324236500|FG000|Overall Study|Lost to Follow-up|4|||
94667700|NCT02216123|324236501|FG001|Overall Study|Lost to Follow-up|2|||
94667701|NCT02216123|324236500|FG000|Overall Study|Withdrawal by Subject|2|||
94667702|NCT02216123|324236501|FG001|Overall Study|Withdrawal by Subject|0|||
94667703|NCT02239679|324236505|FG000|Overall Study|Lost to Follow-up|1|||
94667704|NCT02239679|324236506|FG001|Overall Study|Lost to Follow-up|0|||
94667705|NCT02239679|324236507|FG002|Overall Study|Lost to Follow-up|0|||
94667706|NCT02239679|324236505|FG000|Overall Study|Withdrawal by Subject|2|||
94667707|NCT02239679|324236506|FG001|Overall Study|Withdrawal by Subject|3|||
94667708|NCT02239679|324236507|FG002|Overall Study|Withdrawal by Subject|1|||
94667709|NCT03166618|324236508|FG000|Overall Study|Study was Terminated|0|||
94667710|NCT03166618|324236509|FG001|Overall Study|Study was Terminated|1|||
94667711|NCT01292928|324236516|FG000|Overall Study|Death|8|||
94667712|NCT01292928|324236516|FG000|Overall Study|Withdrawal by Subject|8|||
94667713|NCT01292928|324236516|FG000|Overall Study|Lost to Follow-up|6|||
94667714|NCT01292928|324236516|FG000|Overall Study|Physician Decision|2|||
94667715|NCT01059565|324236517|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
94667716|NCT01059565|324236518|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
94667717|NCT01059565|324236517|FG000|24-Week Randomized Phase|Adverse Event|5|||
94667718|NCT01059565|324236518|FG001|24-Week Randomized Phase|Adverse Event|0|||
94667719|NCT01059565|324236517|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
94667720|NCT01059565|324236518|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
94667721|NCT01059565|324236517|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
94667722|NCT01059565|324236518|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
94667723|NCT01059565|324236517|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
94667724|NCT01059565|324236518|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
94667725|NCT01059565|324236517|FG000|24-Week Open-Label Phase|Adverse Event|2|||
94667726|NCT01059565|324236518|FG001|24-Week Open-Label Phase|Adverse Event|0|||
94667727|NCT01059565|324236517|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
94620748|NCT01737697|324074120|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
94620749|NCT01737697|324074121|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
94620750|NCT01737697|324074122|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
94620751|NCT01737697|324074123|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
94620752|NCT01737697|324074124|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
94620753|NCT01737697|324074125|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
94620754|NCT01737697|324074126|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
94620755|NCT01737697|324074127|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
94620756|NCT01737697|324074128|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
94620757|NCT01737697|324074129|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
94620758|NCT01737697|324074130|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
94620759|NCT01737697|324074131|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
94620760|NCT01737697|324074117|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
94620761|NCT01737697|324074118|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
94667728|NCT01059565|324236518|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
94667729|NCT01059565|324236517|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
94667730|NCT01059565|324236518|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
94667731|NCT01059565|324236517|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
94620762|NCT01737697|324074119|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
94620763|NCT01737697|324074120|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
94620764|NCT01737697|324074121|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
94667732|NCT01059565|324236518|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
94667733|NCT01059565|324236517|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
94667734|NCT01059565|324236518|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
94667735|NCT01059565|324236517|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
94620765|NCT01737697|324074122|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
94667736|NCT01059565|324236518|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
94461175|NCT00373958|323478211|FG000|Infant Series|Lost Kaiser coverage|4|||
94620766|NCT01737697|324074123|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
94620767|NCT01737697|324074124|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
94620768|NCT01737697|324074125|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
94620769|NCT01737697|324074126|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
94620770|NCT01737697|324074127|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
94620771|NCT01737697|324074128|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
94620772|NCT01737697|324074129|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
94620773|NCT01737697|324074130|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
94620774|NCT01737697|324074131|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
94620775|NCT01737697|324074117|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
94620776|NCT01737697|324074118|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
94620777|NCT01737697|324074119|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
94620778|NCT01737697|324074120|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
94620779|NCT01737697|324074121|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
94620780|NCT01737697|324074122|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
94620781|NCT01737697|324074123|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
94620782|NCT01737697|324074124|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
94620783|NCT01737697|324074125|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
94620784|NCT01737697|324074126|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
94620785|NCT01737697|324074127|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
94620786|NCT01737697|324074128|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
94620787|NCT01737697|324074129|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
94620788|NCT01737697|324074130|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
94620789|NCT01737697|324074131|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
94620790|NCT01737697|324074117|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
94620791|NCT01737697|324074118|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
94620792|NCT01737697|324074119|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
94620793|NCT01737697|324074120|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
94620794|NCT01737697|324074121|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
94620795|NCT01737697|324074122|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
94620796|NCT01737697|324074123|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
94620797|NCT01737697|324074124|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
94620798|NCT01737697|324074125|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
94620799|NCT01737697|324074126|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
94620800|NCT01737697|324074127|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
94620801|NCT01737697|324074128|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
94620802|NCT01737697|324074129|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
94620803|NCT01737697|324074130|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
94620804|NCT01737697|324074131|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
94620805|NCT01737697|324074117|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
94620806|NCT01737697|324074118|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
94620807|NCT01737697|324074119|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
94620808|NCT01737697|324074120|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
94620809|NCT01737697|324074121|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
94620810|NCT01737697|324074122|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
94620811|NCT01737697|324074123|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
94620812|NCT01737697|324074124|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
94620813|NCT01737697|324074125|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
94620814|NCT01737697|324074126|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
94620815|NCT01737697|324074127|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
94620816|NCT01737697|324074128|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
94620817|NCT01737697|324074129|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
94620818|NCT01737697|324074130|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
94620819|NCT01737697|324074131|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
94620820|NCT01737697|324074117|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
94620821|NCT01737697|324074118|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
94620822|NCT01737697|324074119|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
94620823|NCT01737697|324074120|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
94620824|NCT01737697|324074121|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
94620825|NCT01737697|324074122|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
94620826|NCT01737697|324074123|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
94620827|NCT01737697|324074124|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
94620828|NCT01737697|324074125|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
94620829|NCT01737697|324074126|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
94620830|NCT01737697|324074127|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
94620831|NCT01737697|324074128|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
94620832|NCT01737697|324074129|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
94620833|NCT01737697|324074130|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
94620834|NCT01737697|324074131|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
94620835|NCT01737697|324074117|FG000|Subacute Phase|Adverse Event|0|||
94620836|NCT01737697|324074118|FG001|Subacute Phase|Adverse Event|0|||
94620837|NCT01737697|324074119|FG002|Subacute Phase|Adverse Event|0|||
94620838|NCT01737697|324074120|FG003|Subacute Phase|Adverse Event|0|||
94620839|NCT01737697|324074121|FG004|Subacute Phase|Adverse Event|0|||
94620840|NCT01737697|324074122|FG005|Subacute Phase|Adverse Event|1|||
94620841|NCT01737697|324074123|FG006|Subacute Phase|Adverse Event|1|||
94620842|NCT01737697|324074124|FG007|Subacute Phase|Adverse Event|1|||
94620843|NCT01737697|324074125|FG008|Subacute Phase|Adverse Event|1|||
94620844|NCT01737697|324074126|FG009|Subacute Phase|Adverse Event|1|||
94620845|NCT01737697|324074127|FG010|Subacute Phase|Adverse Event|4|||
94620846|NCT01737697|324074128|FG011|Subacute Phase|Adverse Event|1|||
94620847|NCT01737697|324074129|FG012|Subacute Phase|Adverse Event|1|||
94620848|NCT01737697|324074130|FG013|Subacute Phase|Adverse Event|0|||
94620849|NCT01737697|324074131|FG014|Subacute Phase|Adverse Event|0|||
94620850|NCT01737697|324074117|FG000|Subacute Phase|Withdrawal by Subject|0|||
94620851|NCT01737697|324074118|FG001|Subacute Phase|Withdrawal by Subject|0|||
94620852|NCT01737697|324074119|FG002|Subacute Phase|Withdrawal by Subject|0|||
94620853|NCT01737697|324074120|FG003|Subacute Phase|Withdrawal by Subject|0|||
94620854|NCT01737697|324074121|FG004|Subacute Phase|Withdrawal by Subject|0|||
94620855|NCT01737697|324074122|FG005|Subacute Phase|Withdrawal by Subject|1|||
94620856|NCT01737697|324074123|FG006|Subacute Phase|Withdrawal by Subject|0|||
94620857|NCT01737697|324074124|FG007|Subacute Phase|Withdrawal by Subject|2|||
94620858|NCT01737697|324074125|FG008|Subacute Phase|Withdrawal by Subject|0|||
94620859|NCT01737697|324074126|FG009|Subacute Phase|Withdrawal by Subject|1|||
94620860|NCT01737697|324074127|FG010|Subacute Phase|Withdrawal by Subject|0|||
94620861|NCT01737697|324074128|FG011|Subacute Phase|Withdrawal by Subject|1|||
94620862|NCT01737697|324074129|FG012|Subacute Phase|Withdrawal by Subject|1|||
94620863|NCT01737697|324074130|FG013|Subacute Phase|Withdrawal by Subject|1|||
94620864|NCT01737697|324074131|FG014|Subacute Phase|Withdrawal by Subject|0|||
94620865|NCT01737697|324074117|FG000|Subacute Phase|Lost to Follow-up|0|||
94620866|NCT01737697|324074118|FG001|Subacute Phase|Lost to Follow-up|0|||
94620867|NCT01737697|324074119|FG002|Subacute Phase|Lost to Follow-up|0|||
94620868|NCT01737697|324074120|FG003|Subacute Phase|Lost to Follow-up|0|||
94620869|NCT01737697|324074121|FG004|Subacute Phase|Lost to Follow-up|0|||
94620870|NCT01737697|324074122|FG005|Subacute Phase|Lost to Follow-up|0|||
94620871|NCT01737697|324074123|FG006|Subacute Phase|Lost to Follow-up|0|||
94620872|NCT01737697|324074124|FG007|Subacute Phase|Lost to Follow-up|0|||
94620873|NCT01737697|324074125|FG008|Subacute Phase|Lost to Follow-up|0|||
94620874|NCT01737697|324074126|FG009|Subacute Phase|Lost to Follow-up|0|||
94620875|NCT01737697|324074127|FG010|Subacute Phase|Lost to Follow-up|0|||
94620876|NCT01737697|324074128|FG011|Subacute Phase|Lost to Follow-up|0|||
94620877|NCT01737697|324074129|FG012|Subacute Phase|Lost to Follow-up|0|||
94620878|NCT01737697|324074130|FG013|Subacute Phase|Lost to Follow-up|0|||
94620879|NCT01737697|324074131|FG014|Subacute Phase|Lost to Follow-up|1|||
94620880|NCT01737697|324074117|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
94620881|NCT01737697|324074118|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
94620882|NCT01737697|324074119|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
94620883|NCT01737697|324074120|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
94620884|NCT01737697|324074121|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
94620885|NCT01737697|324074122|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
94620886|NCT01737697|324074123|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
94620887|NCT01737697|324074124|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
94620888|NCT01737697|324074125|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
94620889|NCT01737697|324074126|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
94620890|NCT01737697|324074127|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
94620891|NCT01737697|324074128|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
94620892|NCT01737697|324074129|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
94620893|NCT01737697|324074130|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
94620894|NCT01737697|324074131|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
94620895|NCT01737697|324074117|FG000|Subacute Phase|Protocol Violation|0|||
94620896|NCT01737697|324074118|FG001|Subacute Phase|Protocol Violation|0|||
94620897|NCT01737697|324074119|FG002|Subacute Phase|Protocol Violation|0|||
94620898|NCT01737697|324074120|FG003|Subacute Phase|Protocol Violation|0|||
94620899|NCT01737697|324074121|FG004|Subacute Phase|Protocol Violation|0|||
94620900|NCT01737697|324074122|FG005|Subacute Phase|Protocol Violation|1|||
94620901|NCT01737697|324074123|FG006|Subacute Phase|Protocol Violation|0|||
94620902|NCT01737697|324074124|FG007|Subacute Phase|Protocol Violation|0|||
94620903|NCT01737697|324074125|FG008|Subacute Phase|Protocol Violation|0|||
94620904|NCT01737697|324074126|FG009|Subacute Phase|Protocol Violation|0|||
94620905|NCT01737697|324074127|FG010|Subacute Phase|Protocol Violation|1|||
94620906|NCT01737697|324074128|FG011|Subacute Phase|Protocol Violation|0|||
94620907|NCT01737697|324074129|FG012|Subacute Phase|Protocol Violation|0|||
94620908|NCT01737697|324074130|FG013|Subacute Phase|Protocol Violation|0|||
94620909|NCT01737697|324074131|FG014|Subacute Phase|Protocol Violation|0|||
94620910|NCT01737697|324074117|FG000|Subacute Phase|Physician Decision|0|||
94620911|NCT01737697|324074118|FG001|Subacute Phase|Physician Decision|0|||
94620912|NCT01737697|324074119|FG002|Subacute Phase|Physician Decision|0|||
94620913|NCT01737697|324074120|FG003|Subacute Phase|Physician Decision|0|||
94620914|NCT01737697|324074121|FG004|Subacute Phase|Physician Decision|0|||
94620915|NCT01737697|324074122|FG005|Subacute Phase|Physician Decision|0|||
94620916|NCT01737697|324074123|FG006|Subacute Phase|Physician Decision|0|||
94620917|NCT01737697|324074124|FG007|Subacute Phase|Physician Decision|0|||
94620918|NCT01737697|324074125|FG008|Subacute Phase|Physician Decision|1|||
94620919|NCT01737697|324074126|FG009|Subacute Phase|Physician Decision|0|||
94620920|NCT01737697|324074127|FG010|Subacute Phase|Physician Decision|0|||
94620921|NCT01737697|324074128|FG011|Subacute Phase|Physician Decision|0|||
94620922|NCT01737697|324074129|FG012|Subacute Phase|Physician Decision|0|||
94620923|NCT01737697|324074130|FG013|Subacute Phase|Physician Decision|0|||
94620924|NCT01737697|324074131|FG014|Subacute Phase|Physician Decision|0|||
94620925|NCT01737697|324074117|FG000|Subacute Phase|Death|0|||
94620926|NCT01737697|324074118|FG001|Subacute Phase|Death|0|||
94620927|NCT01737697|324074119|FG002|Subacute Phase|Death|0|||
94620928|NCT01737697|324074120|FG003|Subacute Phase|Death|0|||
94620929|NCT01737697|324074121|FG004|Subacute Phase|Death|0|||
94620930|NCT01737697|324074122|FG005|Subacute Phase|Death|0|||
94620931|NCT01737697|324074123|FG006|Subacute Phase|Death|0|||
94620932|NCT01737697|324074124|FG007|Subacute Phase|Death|0|||
94620933|NCT01737697|324074125|FG008|Subacute Phase|Death|0|||
94620934|NCT01737697|324074126|FG009|Subacute Phase|Death|0|||
94620935|NCT01737697|324074127|FG010|Subacute Phase|Death|1|||
94620936|NCT01737697|324074128|FG011|Subacute Phase|Death|0|||
94620937|NCT01737697|324074129|FG012|Subacute Phase|Death|0|||
94620938|NCT01737697|324074130|FG013|Subacute Phase|Death|0|||
94620939|NCT01737697|324074131|FG014|Subacute Phase|Death|0|||
94620940|NCT04404361|324074135|FG000|Overall Study|Death|12|||
94620941|NCT04404361|324074136|FG001|Overall Study|Death|12|||
94620942|NCT04404361|324074135|FG000|Overall Study|Withdrawal by Subject|13|||
94620943|NCT04404361|324074136|FG001|Overall Study|Withdrawal by Subject|5|||
94620944|NCT04404361|324074135|FG000|Overall Study|Lost to Follow-up|6|||
94620945|NCT04404361|324074136|FG001|Overall Study|Lost to Follow-up|3|||
94620946|NCT04404361|324074135|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
94620947|NCT04404361|324074136|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
94620948|NCT02144012|324074139|FG000|Overall Study|Adverse Event|1|||
94620949|NCT02144012|324074140|FG001|Overall Study|Adverse Event|0|||
94620950|NCT02144012|324074139|FG000|Overall Study|Death|1|||
94620951|NCT02144012|324074140|FG001|Overall Study|Death|0|||
94620952|NCT02144012|324074139|FG000|Overall Study|Withdrawal by Subject|11|||
94620953|NCT02144012|324074140|FG001|Overall Study|Withdrawal by Subject|3|||
94620954|NCT02144012|324074139|FG000|Overall Study|Study Terminated by Sponsor|18|||
94620955|NCT02144012|324074140|FG001|Overall Study|Study Terminated by Sponsor|12|||
94620956|NCT02144012|324074139|FG000|Overall Study|Other|3|||
94620957|NCT02144012|324074140|FG001|Overall Study|Other|0|||
94620958|NCT03329573|324074141|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
94620959|NCT03329573|324074142|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
94620960|NCT03329573|324074143|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
94620961|NCT03329573|324074144|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
94620962|NCT03329573|324074141|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
94620963|NCT03329573|324074142|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
94620964|NCT03329573|324074143|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
94620965|NCT03329573|324074144|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
94620966|NCT03329573|324074141|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
94620967|NCT03329573|324074142|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
94620968|NCT03329573|324074143|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
94620969|NCT03329573|324074144|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
94620970|NCT03329573|324074141|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
94620971|NCT03329573|324074142|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
94620972|NCT03329573|324074143|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
94620973|NCT03329573|324074144|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
94620974|NCT00837811|324074147|FG000|Overall Study|Adverse Event|4|||
94620975|NCT00837811|324074148|FG001|Overall Study|Adverse Event|6|||
94620976|NCT00837811|324074149|FG002|Overall Study|Adverse Event|0|||
94620977|NCT00837811|324074147|FG000|Overall Study|Death|1|||
94620978|NCT00837811|324074148|FG001|Overall Study|Death|1|||
94620979|NCT00837811|324074149|FG002|Overall Study|Death|0|||
94620980|NCT00837811|324074147|FG000|Overall Study|Lack of Efficacy|0|||
94620981|NCT00837811|324074148|FG001|Overall Study|Lack of Efficacy|11|||
94620982|NCT00837811|324074149|FG002|Overall Study|Lack of Efficacy|0|||
94620983|NCT00837811|324074147|FG000|Overall Study|Lost to Follow-up|1|||
94620984|NCT00837811|324074148|FG001|Overall Study|Lost to Follow-up|3|||
94620985|NCT00837811|324074149|FG002|Overall Study|Lost to Follow-up|0|||
94620986|NCT00837811|324074147|FG000|Overall Study|Physician Decision|0|||
94620987|NCT00837811|324074148|FG001|Overall Study|Physician Decision|2|||
94620988|NCT00837811|324074149|FG002|Overall Study|Physician Decision|1|||
94620989|NCT00837811|324074147|FG000|Overall Study|Withdrawal by Subject|1|||
94620990|NCT00837811|324074148|FG001|Overall Study|Withdrawal by Subject|9|||
94667737|NCT03263429|324236522|FG000|Overall Study|Withdrawal by Subject|0|||
94667738|NCT03263429|324236523|FG001|Overall Study|Withdrawal by Subject|1|||
94667739|NCT03263429|324236524|FG002|Overall Study|Withdrawal by Subject|0|||
94667740|NCT03263429|324236522|FG000|Overall Study|Follow-Up Period Completed|0|||
94667741|NCT03263429|324236523|FG001|Overall Study|Follow-Up Period Completed|2|||
94667742|NCT03263429|324236524|FG002|Overall Study|Follow-Up Period Completed|0|||
94667743|NCT03263429|324236522|FG000|Overall Study|Death|3|||
94620991|NCT00837811|324074149|FG002|Overall Study|Withdrawal by Subject|0|||
94620992|NCT00837811|324074147|FG000|Overall Study|Sponsor Decision|0|||
94620993|NCT00837811|324074148|FG001|Overall Study|Sponsor Decision|2|||
94620994|NCT00837811|324074149|FG002|Overall Study|Sponsor Decision|0|||
94620995|NCT02801331|324074150|FG000|Overall Study|Transferred to another hospital|8|||
94620996|NCT02801331|324074151|FG001|Overall Study|Transferred to another hospital|7|||
94620997|NCT02801331|324074150|FG000|Overall Study|Withdrawal by Subject|0|||
94620998|NCT02801331|324074151|FG001|Overall Study|Withdrawal by Subject|4|||
94620999|NCT02801331|324074150|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
94621000|NCT02801331|324074151|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
94621001|NCT03305575|324075630|FG000|Overall Study|Physician Decision|1|||
94621002|NCT03305575|324075631|FG001|Overall Study|Physician Decision|0|||
94621003|NCT04115839|324075634|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
94621004|NCT04115839|324075635|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
94621005|NCT04115839|324075636|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
94621006|NCT04115839|324075637|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
94621007|NCT04115839|324075638|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
94621008|NCT04115839|324075639|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
94621009|NCT04115839|324075640|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
94621010|NCT04115839|324075634|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
94621011|NCT04115839|324075635|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
94621012|NCT04115839|324075636|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
94621013|NCT04115839|324075637|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
94621014|NCT04115839|324075638|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
94621015|NCT04115839|324075639|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
94621016|NCT04115839|324075640|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
94621017|NCT04115839|324075634|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
94621018|NCT04115839|324075635|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
94621019|NCT04115839|324075636|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
94621020|NCT04115839|324075637|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
94621021|NCT04115839|324075638|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
94621022|NCT04115839|324075639|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
94621023|NCT04115839|324075640|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
94621024|NCT04115839|324075634|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
94621025|NCT04115839|324075635|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
94621026|NCT04115839|324075636|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
94621027|NCT04115839|324075637|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
94621028|NCT04115839|324075638|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
94621029|NCT04115839|324075639|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
94621030|NCT04115839|324075640|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
94621031|NCT04115839|324075634|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
94621032|NCT04115839|324075635|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
94621033|NCT04115839|324075636|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
94621034|NCT04115839|324075637|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
94621035|NCT04115839|324075638|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
94621036|NCT04115839|324075639|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
94667744|NCT03263429|324236523|FG001|Overall Study|Death|5|||
94667745|NCT03263429|324236524|FG002|Overall Study|Death|16|||
94667746|NCT03263429|324236522|FG000|Overall Study|Participant unable to return|0|||
94667747|NCT03263429|324236523|FG001|Overall Study|Participant unable to return|0|||
94667748|NCT03263429|324236524|FG002|Overall Study|Participant unable to return|1|||
94667749|NCT03263429|324236522|FG000|Overall Study|Study Closed|0|||
94667750|NCT03263429|324236523|FG001|Overall Study|Study Closed|0|||
94667751|NCT03263429|324236524|FG002|Overall Study|Study Closed|1|||
94667752|NCT03647501|324236525|FG000|Overall Study|Lost to Follow-up|1|||
94621037|NCT04115839|324075640|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
94621038|NCT04115839|324075634|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
94621039|NCT04115839|324075635|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
94621040|NCT04115839|324075636|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
94621041|NCT04115839|324075637|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
94621042|NCT04115839|324075638|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
94667753|NCT03647501|324236526|FG001|Overall Study|Lost to Follow-up|1|||
94667754|NCT03647501|324236525|FG000|Overall Study|Withdrawal by Subject|0|||
94667755|NCT03647501|324236526|FG001|Overall Study|Withdrawal by Subject|1|||
94667756|NCT02015676|324236532|FG000|Overall Study|Adverse Event|2|||
94667757|NCT02015676|324236533|FG001|Overall Study|Adverse Event|18|||
94667758|NCT02015676|324236534|FG002|Overall Study|Adverse Event|0|||
94667759|NCT02015676|324236532|FG000|Overall Study|Lack of Efficacy|2|||
94667760|NCT02015676|324236533|FG001|Overall Study|Lack of Efficacy|4|||
94667761|NCT02015676|324236534|FG002|Overall Study|Lack of Efficacy|0|||
94667762|NCT02015676|324236532|FG000|Overall Study|Protocol Violation|1|||
94461176|NCT00373958|323478212|FG001|Infant Series|Lost Kaiser coverage|0|||
94461177|NCT00373958|323478211|FG000|Infant Series|Child relocated|1|||
94667763|NCT02015676|324236533|FG001|Overall Study|Protocol Violation|0|||
94667764|NCT02015676|324236534|FG002|Overall Study|Protocol Violation|0|||
94667765|NCT02015676|324236532|FG000|Overall Study|Withdrawal by Subject|1|||
94667766|NCT02015676|324236533|FG001|Overall Study|Withdrawal by Subject|7|||
94667767|NCT02015676|324236534|FG002|Overall Study|Withdrawal by Subject|1|||
94667768|NCT02015676|324236532|FG000|Overall Study|Administrative reasons|0|||
94667769|NCT02015676|324236533|FG001|Overall Study|Administrative reasons|3|||
94667770|NCT02015676|324236534|FG002|Overall Study|Administrative reasons|1|||
94667771|NCT02015676|324236532|FG000|Overall Study|Death|0|||
94667772|NCT02015676|324236533|FG001|Overall Study|Death|1|||
94667773|NCT02015676|324236534|FG002|Overall Study|Death|0|||
94667774|NCT02015676|324236532|FG000|Overall Study|Disease progression|3|||
94667775|NCT02015676|324236533|FG001|Overall Study|Disease progression|1|||
94667776|NCT02015676|324236534|FG002|Overall Study|Disease progression|1|||
94667777|NCT00325468|324236537|FG000|Overall Study|Adverse Event|1|||
94667778|NCT00325468|324236538|FG001|Overall Study|Adverse Event|1|||
94667779|NCT00325468|324236539|FG002|Overall Study|Adverse Event|0|||
94667780|NCT00325468|324236540|FG003|Overall Study|Adverse Event|5|||
94667781|NCT00325468|324236541|FG004|Overall Study|Adverse Event|1|||
94667782|NCT00325468|324236537|FG000|Overall Study|Death|2|||
94667783|NCT00325468|324236538|FG001|Overall Study|Death|0|||
94667784|NCT00325468|324236539|FG002|Overall Study|Death|2|||
94667785|NCT00325468|324236540|FG003|Overall Study|Death|4|||
94667786|NCT00325468|324236541|FG004|Overall Study|Death|0|||
94667787|NCT00325468|324236537|FG000|Overall Study|Lost to Follow-up|0|||
94667788|NCT00325468|324236538|FG001|Overall Study|Lost to Follow-up|0|||
94667789|NCT00325468|324236539|FG002|Overall Study|Lost to Follow-up|1|||
94667790|NCT00325468|324236540|FG003|Overall Study|Lost to Follow-up|2|||
94667791|NCT00325468|324236541|FG004|Overall Study|Lost to Follow-up|2|||
94667792|NCT00325468|324236537|FG000|Overall Study|Physician Decision|1|||
94667793|NCT00325468|324236538|FG001|Overall Study|Physician Decision|1|||
94667794|NCT00325468|324236539|FG002|Overall Study|Physician Decision|0|||
94667795|NCT00325468|324236540|FG003|Overall Study|Physician Decision|1|||
94667796|NCT00325468|324236541|FG004|Overall Study|Physician Decision|0|||
94667797|NCT00325468|324236537|FG000|Overall Study|Withdrawal by Subject|3|||
94667798|NCT00325468|324236538|FG001|Overall Study|Withdrawal by Subject|1|||
94667799|NCT00325468|324236539|FG002|Overall Study|Withdrawal by Subject|0|||
94667800|NCT00325468|324236540|FG003|Overall Study|Withdrawal by Subject|14|||
94667801|NCT00325468|324236541|FG004|Overall Study|Withdrawal by Subject|4|||
94667802|NCT00325468|324236537|FG000|Overall Study|site closure etc|4|||
94667803|NCT00325468|324236538|FG001|Overall Study|site closure etc|2|||
94667804|NCT00325468|324236539|FG002|Overall Study|site closure etc|1|||
94667805|NCT00325468|324236540|FG003|Overall Study|site closure etc|8|||
94667806|NCT00325468|324236541|FG004|Overall Study|site closure etc|1|||
94667807|NCT00224874|324236542|FG000|Overall Study|Withdrawal by Subject|0|||
94667808|NCT00224874|324236543|FG001|Overall Study|Withdrawal by Subject|0|||
94667809|NCT00224874|324236544|FG002|Overall Study|Withdrawal by Subject|1|||
94667810|NCT00224874|324236545|FG003|Overall Study|Withdrawal by Subject|0|||
94667811|NCT03526250|324236548|FG000|Overall Study|Adverse Event|4|||
94667812|NCT03526250|324236548|FG000|Overall Study|Progressive Disease|16|||
94667813|NCT03526250|324236548|FG000|Overall Study|No Treatment|3|||
94667814|NCT01556438|324236551|FG000|Overall Study|Adverse Event|4|||
94667815|NCT01556438|324236552|FG001|Overall Study|Adverse Event|2|||
94667816|NCT01556438|324236551|FG000|Overall Study|Sponsor Decision|0|||
94667817|NCT01556438|324236552|FG001|Overall Study|Sponsor Decision|2|||
94667818|NCT01556438|324236551|FG000|Overall Study|Progressive Disease|0|||
94667819|NCT01556438|324236552|FG001|Overall Study|Progressive Disease|6|||
94667820|NCT01556438|324236551|FG000|Overall Study|Death|0|||
94667821|NCT01556438|324236552|FG001|Overall Study|Death|1|||
94461178|NCT00373958|323478212|FG001|Infant Series|Child relocated|0|||
94667822|NCT04575467|324236555|FG000|Overall Study|Adverse Event|0|||
94667823|NCT04575467|324236556|FG001|Overall Study|Adverse Event|1|||
94667824|NCT04575467|324236557|FG002|Overall Study|Adverse Event|0|||
94667825|NCT04575467|324236558|FG003|Overall Study|Adverse Event|0|||
94667826|NCT02384954|324236559|FG000|Phase 1|Progressive Disease|2|||
94667827|NCT02384954|324236560|FG001|Phase 1|Progressive Disease|0|||
94461179|NCT00373958|323478211|FG000|Infant Series|Consent was not received|1|||
94667828|NCT02384954|324236561|FG002|Phase 1|Progressive Disease|1|||
94667829|NCT02384954|324236562|FG003|Phase 1|Progressive Disease|1|||
94667830|NCT02384954|324236563|FG004|Phase 1|Progressive Disease|0|||
94667831|NCT02384954|324236564|FG005|Phase 1|Progressive Disease|0|||
94667832|NCT02384954|324236565|FG006|Phase 1|Progressive Disease|0|||
94667833|NCT02384954|324236566|FG007|Phase 1|Progressive Disease|0|||
94667834|NCT02384954|324236567|FG008|Phase 1|Progressive Disease|0|||
94667835|NCT02384954|324236559|FG000|Phase 1|Adverse Event|0|||
94667836|NCT02384954|324236560|FG001|Phase 1|Adverse Event|0|||
94667837|NCT02384954|324236561|FG002|Phase 1|Adverse Event|1|||
94667838|NCT02384954|324236562|FG003|Phase 1|Adverse Event|0|||
94667839|NCT02384954|324236563|FG004|Phase 1|Adverse Event|0|||
94667840|NCT02384954|324236564|FG005|Phase 1|Adverse Event|0|||
94667841|NCT02384954|324236565|FG006|Phase 1|Adverse Event|0|||
94667842|NCT02384954|324236566|FG007|Phase 1|Adverse Event|0|||
94667843|NCT02384954|324236567|FG008|Phase 1|Adverse Event|0|||
94621043|NCT04115839|324075639|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
94621044|NCT04115839|324075640|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
94621045|NCT00297830|324075641|FG000|6 Month Visit|Death|1|||
94621046|NCT00297830|324075642|FG001|6 Month Visit|Death|0|||
94621047|NCT00297830|324075643|FG002|6 Month Visit|Death|2|||
94621048|NCT00297830|324075641|FG000|6 Month Visit|Withdrawal by Subject|2|||
94621049|NCT00297830|324075642|FG001|6 Month Visit|Withdrawal by Subject|1|||
94621050|NCT00297830|324075643|FG002|6 Month Visit|Withdrawal by Subject|1|||
94621051|NCT00297830|324075641|FG000|6 Month Visit|Adverse Event|0|||
94621052|NCT00297830|324075642|FG001|6 Month Visit|Adverse Event|1|||
94621053|NCT00297830|324075643|FG002|6 Month Visit|Adverse Event|0|||
94621054|NCT00297830|324075641|FG000|12 Month Visit|Lost to Follow-up|1|||
94621055|NCT00297830|324075642|FG001|12 Month Visit|Lost to Follow-up|0|||
94621056|NCT00297830|324075643|FG002|12 Month Visit|Lost to Follow-up|0|||
94621057|NCT00297830|324075641|FG000|12 Month Visit|Adverse Event|0|||
94621058|NCT00297830|324075642|FG001|12 Month Visit|Adverse Event|3|||
94621059|NCT00297830|324075643|FG002|12 Month Visit|Adverse Event|0|||
94621060|NCT00297830|324075641|FG000|12 Month Visit|Withdrawal by Subject|0|||
94621061|NCT00297830|324075642|FG001|12 Month Visit|Withdrawal by Subject|3|||
94621062|NCT00297830|324075643|FG002|12 Month Visit|Withdrawal by Subject|0|||
94621063|NCT00590720|324075644|FG000|Overall Study|Lost to Follow-up|1|||
94621064|NCT00590720|324075645|FG001|Overall Study|Lost to Follow-up|0|||
94621065|NCT00590720|324075644|FG000|Overall Study|Withdrawal by Subject|0|||
94621066|NCT00590720|324075645|FG001|Overall Study|Withdrawal by Subject|1|||
94621067|NCT01001377|324075649|FG000|Overall Study|Ineligibility determined|2|||
94621068|NCT01001377|324075650|FG001|Overall Study|Ineligibility determined|0|||
94621069|NCT01001377|324075649|FG000|Overall Study|Withdrawal by Subject|19|||
94621070|NCT01001377|324075650|FG001|Overall Study|Withdrawal by Subject|20|||
94621071|NCT01001377|324075649|FG000|Overall Study|Lost to Follow-up|14|||
94621072|NCT01001377|324075650|FG001|Overall Study|Lost to Follow-up|17|||
94621073|NCT01001377|324075649|FG000|Overall Study|Death|391|||
94621074|NCT01001377|324075650|FG001|Overall Study|Death|384|||
94621075|NCT03039283|324075656|FG000|Overall Study|Protocol Violation|2|||
94621076|NCT01056653|324075657|FG000|Overall Study|Lost to Follow-up|0|||
94621077|NCT01056653|324075658|FG001|Overall Study|Lost to Follow-up|0|||
94621078|NCT01056653|324075659|FG002|Overall Study|Lost to Follow-up|2|||
94621079|NCT00261807|324075661|FG000|Overall Study|Lost to Follow-up|2|||
94621080|NCT00261807|324075661|FG000|Overall Study|Adverse Event|2|||
94621081|NCT00261807|324075661|FG000|Overall Study|Death|1|||
94621082|NCT00261807|324075661|FG000|Overall Study|Protocol Violation|2|||
94621083|NCT04930965|324075663|FG000|Overall Study|Lost to Follow-up|7|||
94621084|NCT04930965|324075664|FG001|Overall Study|Lost to Follow-up|5|||
94667844|NCT02384954|324236559|FG000|Phase 2|Progressive Disease|0|||
94667845|NCT02384954|324236560|FG001|Phase 2|Progressive Disease|0|||
94667846|NCT02384954|324236561|FG002|Phase 2|Progressive Disease|0|||
94667847|NCT02384954|324236562|FG003|Phase 2|Progressive Disease|0|||
94667848|NCT02384954|324236563|FG004|Phase 2|Progressive Disease|0|||
94621085|NCT01488370|324075667|FG000|Overall Study|Protocol Violation|0|||
94621086|NCT01488370|324075668|FG001|Overall Study|Protocol Violation|1|||
94621087|NCT01488370|324075669|FG002|Overall Study|Protocol Violation|1|||
94621088|NCT04390191|324075670|FG000|Overall Study|Withdrawal by Subject|1|||
94621089|NCT04390191|324075671|FG001|Overall Study|Withdrawal by Subject|0|||
94621090|NCT02794883|324075672|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
94621091|NCT02794883|324075673|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
94621092|NCT02794883|324075674|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
94621093|NCT02794883|324075672|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
94621094|NCT02794883|324075673|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
94667849|NCT02384954|324236564|FG005|Phase 2|Progressive Disease|0|||
94621095|NCT02794883|324075674|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
94621096|NCT02794883|324075672|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
94621097|NCT02794883|324075673|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
94621098|NCT02794883|324075674|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
94621099|NCT02794883|324075672|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
94667850|NCT02384954|324236565|FG006|Phase 2|Progressive Disease|0|||
94621100|NCT02794883|324075673|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
94621101|NCT02794883|324075674|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
94667851|NCT02384954|324236566|FG007|Phase 2|Progressive Disease|1|||
94667852|NCT02384954|324236567|FG008|Phase 2|Progressive Disease|2|||
94667853|NCT02384954|324236559|FG000|Phase 2|Adverse Event|0|||
94667854|NCT02384954|324236560|FG001|Phase 2|Adverse Event|0|||
94667855|NCT02384954|324236561|FG002|Phase 2|Adverse Event|0|||
94667856|NCT02384954|324236562|FG003|Phase 2|Adverse Event|0|||
94667857|NCT02384954|324236563|FG004|Phase 2|Adverse Event|0|||
94667858|NCT02384954|324236564|FG005|Phase 2|Adverse Event|0|||
94667859|NCT02384954|324236565|FG006|Phase 2|Adverse Event|0|||
94667860|NCT02384954|324236566|FG007|Phase 2|Adverse Event|1|||
94667861|NCT02384954|324236567|FG008|Phase 2|Adverse Event|1|||
94667862|NCT02384954|324236559|FG000|Phase 2|Failure to meet continuation criteria|0|||
94667863|NCT02384954|324236560|FG001|Phase 2|Failure to meet continuation criteria|0|||
94667864|NCT02384954|324236561|FG002|Phase 2|Failure to meet continuation criteria|0|||
94667865|NCT02384954|324236562|FG003|Phase 2|Failure to meet continuation criteria|0|||
94667866|NCT02384954|324236563|FG004|Phase 2|Failure to meet continuation criteria|0|||
94667867|NCT02384954|324236564|FG005|Phase 2|Failure to meet continuation criteria|0|||
94667868|NCT02384954|324236565|FG006|Phase 2|Failure to meet continuation criteria|0|||
94667869|NCT02384954|324236566|FG007|Phase 2|Failure to meet continuation criteria|1|||
94667870|NCT02384954|324236567|FG008|Phase 2|Failure to meet continuation criteria|0|||
94667871|NCT00319098|324236570|FG000|Overall Study|Serious adverse event|3|||
94667872|NCT00319098|324236571|FG001|Overall Study|Serious adverse event|0|||
94667873|NCT00319098|324236570|FG000|Overall Study|Adverse Event|20|||
94667874|NCT00319098|324236571|FG001|Overall Study|Adverse Event|1|||
94667875|NCT00319098|324236570|FG000|Overall Study|Withdrawal by Subject|37|||
94667876|NCT00319098|324236571|FG001|Overall Study|Withdrawal by Subject|8|||
94667877|NCT00319098|324236570|FG000|Overall Study|Migrated/moved from study area|2|||
94667878|NCT00319098|324236571|FG001|Overall Study|Migrated/moved from study area|1|||
94667879|NCT00319098|324236570|FG000|Overall Study|Lost to Follow-up|37|||
94667880|NCT00319098|324236571|FG001|Overall Study|Lost to Follow-up|13|||
94667881|NCT00319098|324236570|FG000|Overall Study|Others|33|||
94667882|NCT00319098|324236571|FG001|Overall Study|Others|8|||
94667883|NCT00319098|324236570|FG000|Overall Study|Protocol Violation|3|||
94667884|NCT00319098|324236571|FG001|Overall Study|Protocol Violation|1|||
94667885|NCT02293538|324236572|FG000|Overall Study|Adverse Event|0|||
94667886|NCT02293538|324236573|FG001|Overall Study|Adverse Event|1|||
94667887|NCT02293538|324236572|FG000|Overall Study|Lost to Follow-up|1|||
94667888|NCT02293538|324236573|FG001|Overall Study|Lost to Follow-up|0|||
94667889|NCT02293538|324236572|FG000|Overall Study|Withdrawal by Subject|0|||
94667890|NCT02293538|324236573|FG001|Overall Study|Withdrawal by Subject|1|||
94667891|NCT00695669|324236578|FG000|Overall Study|Adverse Event|0|||
94667892|NCT00695669|324236579|FG001|Overall Study|Adverse Event|0|||
94667893|NCT00695669|324236580|FG002|Overall Study|Adverse Event|2|||
94667894|NCT00695669|324236581|FG003|Overall Study|Adverse Event|0|||
94667895|NCT00695669|324236578|FG000|Overall Study|Lost to Follow-up|4|||
94667896|NCT00695669|324236579|FG001|Overall Study|Lost to Follow-up|4|||
94667897|NCT00695669|324236580|FG002|Overall Study|Lost to Follow-up|1|||
94667898|NCT00695669|324236581|FG003|Overall Study|Lost to Follow-up|4|||
94667899|NCT00622167|324236582|FG000|Overall Study|Did not meet angiographic criteria|20|||
94667900|NCT00843167|324236583|FG000|Treatment Period|Adverse Event|1|||
94667901|NCT00843167|324236584|FG001|Treatment Period|Adverse Event|5|||
94667902|NCT00843167|324236583|FG000|Treatment Period|Withdrawal by Subject|2|||
94667903|NCT00843167|324236584|FG001|Treatment Period|Withdrawal by Subject|3|||
94667904|NCT03336619|324236585|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
94667905|NCT03336619|324236586|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
94667906|NCT03336619|324236585|FG000|Overall Study|Withdrawal by Subject|17|||
94667907|NCT03336619|324236586|FG001|Overall Study|Withdrawal by Subject|16|||
94667908|NCT03336619|324236585|FG000|Overall Study|Adverse Event|2|||
94667909|NCT03336619|324236586|FG001|Overall Study|Adverse Event|5|||
94667910|NCT03336619|324236585|FG000|Overall Study|Physician Decision|3|||
94667911|NCT03336619|324236586|FG001|Overall Study|Physician Decision|0|||
94667912|NCT01300546|324236587|FG000|Overall Study|Withdrawal by Subject|1|||
94667913|NCT01300546|324236588|FG001|Overall Study|Withdrawal by Subject|0|||
94667914|NCT01300546|324236587|FG000|Overall Study|Lost to Follow-up|0|||
94667915|NCT01300546|324236588|FG001|Overall Study|Lost to Follow-up|2|||
94667916|NCT01300546|324236587|FG000|Overall Study|Lack of Efficacy|0|||
94667917|NCT01300546|324236588|FG001|Overall Study|Lack of Efficacy|3|||
94667918|NCT01300546|324236587|FG000|Overall Study|Adverse Event|0|||
94667919|NCT01300546|324236588|FG001|Overall Study|Adverse Event|1|||
94667920|NCT02012491|324236591|FG000|Overall Study|Lost to Follow-up|1|||
94667921|NCT02012491|324236592|FG001|Overall Study|Lost to Follow-up|0|||
94667922|NCT02012491|324236591|FG000|Overall Study|Protocol Violation|0|||
94667923|NCT02012491|324236592|FG001|Overall Study|Protocol Violation|1|||
94667924|NCT02012491|324236591|FG000|Overall Study|Withdrawal by Subject|1|||
94667925|NCT02012491|324236592|FG001|Overall Study|Withdrawal by Subject|0|||
94667926|NCT05608629|324236593|FG000|Overall Study|Lost to Follow-up|2|||
94667927|NCT02962908|324236597|FG000|Overall Study|Lost to Follow-up|0|||
94667928|NCT02962908|324236598|FG001|Overall Study|Lost to Follow-up|3|||
94667929|NCT02962908|324236599|FG002|Overall Study|Lost to Follow-up|0|||
94621102|NCT02794883|324075672|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
94621103|NCT02794883|324075673|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
94621104|NCT02794883|324075674|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
94667930|NCT02962908|324236600|FG003|Overall Study|Lost to Follow-up|1|||
94667931|NCT02962908|324236597|FG000|Overall Study|Withdrawal by Subject|0|||
94667932|NCT02962908|324236598|FG001|Overall Study|Withdrawal by Subject|3|||
94667933|NCT02962908|324236599|FG002|Overall Study|Withdrawal by Subject|0|||
94667934|NCT02962908|324236600|FG003|Overall Study|Withdrawal by Subject|2|||
94667935|NCT02962908|324236597|FG000|Overall Study|Protocol Violation|0|||
94667936|NCT02962908|324236598|FG001|Overall Study|Protocol Violation|1|||
94667937|NCT02962908|324236599|FG002|Overall Study|Protocol Violation|0|||
94667938|NCT02962908|324236600|FG003|Overall Study|Protocol Violation|0|||
94667939|NCT02962908|324236597|FG000|Overall Study|Physician Decision|0|||
94667940|NCT02962908|324236598|FG001|Overall Study|Physician Decision|1|||
94667941|NCT02962908|324236599|FG002|Overall Study|Physician Decision|0|||
94667942|NCT02962908|324236600|FG003|Overall Study|Physician Decision|0|||
94667943|NCT01261338|324236601|FG000|Overall Study|Withdrawal by Subject|3|||
94667944|NCT01261338|324236602|FG001|Overall Study|Withdrawal by Subject|2|||
94667945|NCT02269670|324236603|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
94667946|NCT00722761|324236604|FG000|Overall Study|Lost to Follow-up|1|||
94667947|NCT00722761|324236605|FG001|Overall Study|Lost to Follow-up|4|||
94667948|NCT00722761|324236604|FG000|Overall Study|Withdrawal by Subject|5|||
94667949|NCT00722761|324236605|FG001|Overall Study|Withdrawal by Subject|2|||
94667950|NCT01389973|324236606|FG000|Overall Study|Lost to Follow-up|1|||
94667951|NCT01389973|324236606|FG000|Overall Study|Trial Stopped by Sponsor|9|||
94667952|NCT01389973|324236606|FG000|Overall Study|Other|10|||
94667953|NCT04304833|324236608|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
94667954|NCT04304833|324236609|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
94667955|NCT03776136|324236610|FG000|Overall Study|Death|85|||
94667956|NCT03776136|324236610|FG000|Overall Study|Withdrawal by Subject|3|||
94667957|NCT03776136|324236610|FG000|Overall Study|Sponsor Decision|15|||
94667958|NCT03456700|324236611|FG000|Overall Study|Withdrawal by Subject|1|||
94667959|NCT05540522|324236612|FG000|Overall Study|Adverse Event|1|||
94621105|NCT02794883|324075672|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
94621106|NCT02794883|324075673|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
94621107|NCT02794883|324075674|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
94621108|NCT02794883|324075672|FG000|Follow-up Period (up to 2 Years)|Death|12|||
94667960|NCT05540522|324236613|FG001|Overall Study|Adverse Event|0|||
94667961|NCT05540522|324236614|FG002|Overall Study|Adverse Event|2|||
94667962|NCT05540522|324236615|FG003|Overall Study|Adverse Event|5|||
94667963|NCT05540522|324236612|FG000|Overall Study|Lost to Follow-up|487|||
94621109|NCT02794883|324075673|FG001|Follow-up Period (up to 2 Years)|Death|10|||
94621110|NCT02794883|324075674|FG002|Follow-up Period (up to 2 Years)|Death|10|||
94621111|NCT01471171|324075675|FG000|Treatment Period 1|Adverse Event|4|||
94621112|NCT01471171|324075676|FG001|Treatment Period 1|Adverse Event|1|||
94621113|NCT01471171|324075675|FG000|Treatment Period 2|Adverse Event|1|||
94621114|NCT01471171|324075676|FG001|Treatment Period 2|Adverse Event|0|||
94621115|NCT03978832|324075677|FG000|Overall Study|Adverse Event|1|||
94621116|NCT03978832|324075677|FG000|Overall Study|Lost to Follow-up|1|||
94621117|NCT03978832|324075677|FG000|Overall Study|Withdrawal by Subject|6|||
94667964|NCT05540522|324236613|FG001|Overall Study|Lost to Follow-up|427|||
94667965|NCT05540522|324236614|FG002|Overall Study|Lost to Follow-up|146|||
94667966|NCT05540522|324236615|FG003|Overall Study|Lost to Follow-up|166|||
94667967|NCT05540522|324236612|FG000|Overall Study|Physician Decision|11|||
94667968|NCT05540522|324236613|FG001|Overall Study|Physician Decision|19|||
94667969|NCT05540522|324236614|FG002|Overall Study|Physician Decision|8|||
94667970|NCT05540522|324236615|FG003|Overall Study|Physician Decision|13|||
94667971|NCT05540522|324236612|FG000|Overall Study|Pregnancy|1|||
94667972|NCT05540522|324236613|FG001|Overall Study|Pregnancy|0|||
94667973|NCT05540522|324236614|FG002|Overall Study|Pregnancy|0|||
94667974|NCT05540522|324236615|FG003|Overall Study|Pregnancy|0|||
94667975|NCT05540522|324236612|FG000|Overall Study|Protocol Violation|3|||
94667976|NCT05540522|324236613|FG001|Overall Study|Protocol Violation|1|||
94667977|NCT05540522|324236614|FG002|Overall Study|Protocol Violation|9|||
94621118|NCT03978832|324075677|FG000|Overall Study|Physician Decision|2|||
94621119|NCT03978832|324075677|FG000|Overall Study|did not pass screening criteria|44|||
94667978|NCT05540522|324236615|FG003|Overall Study|Protocol Violation|7|||
94667979|NCT05540522|324236612|FG000|Overall Study|Withdrawal by Subject|168|||
94667980|NCT05540522|324236613|FG001|Overall Study|Withdrawal by Subject|134|||
94667981|NCT05540522|324236614|FG002|Overall Study|Withdrawal by Subject|331|||
94667982|NCT05540522|324236615|FG003|Overall Study|Withdrawal by Subject|322|||
94667983|NCT05540522|324236612|FG000|Overall Study|Death|7|||
94667984|NCT05540522|324236613|FG001|Overall Study|Death|9|||
94667985|NCT05540522|324236614|FG002|Overall Study|Death|49|||
94667986|NCT05540522|324236615|FG003|Overall Study|Death|46|||
94667987|NCT05540522|324236612|FG000|Overall Study|Not vaccinated|34|||
94667988|NCT05540522|324236613|FG001|Overall Study|Not vaccinated|53|||
94667989|NCT05540522|324236614|FG002|Overall Study|Not vaccinated|57|||
94621120|NCT02864498|324075682|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
94621121|NCT02864498|324075683|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
94621122|NCT02864498|324075684|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
94621123|NCT02864498|324075682|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
94621124|NCT02864498|324075683|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
94621125|NCT02864498|324075684|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
94621126|NCT02864498|324075682|FG000|Overall Study|Investigator Discretion|0|||
94621127|NCT02864498|324075683|FG001|Overall Study|Investigator Discretion|2|||
94621128|NCT02864498|324075684|FG002|Overall Study|Investigator Discretion|1|||
94621129|NCT02864498|324075682|FG000|Overall Study|Lost to Follow-up|8|||
94621130|NCT02864498|324075683|FG001|Overall Study|Lost to Follow-up|6|||
94621131|NCT02864498|324075684|FG002|Overall Study|Lost to Follow-up|3|||
94621132|NCT02864498|324075682|FG000|Overall Study|Lack of Efficacy|5|||
94621133|NCT02864498|324075683|FG001|Overall Study|Lack of Efficacy|3|||
94621134|NCT02864498|324075684|FG002|Overall Study|Lack of Efficacy|3|||
94621135|NCT02864498|324075682|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
94621136|NCT02864498|324075683|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
94621137|NCT02864498|324075684|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
94621138|NCT02864498|324075682|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
94621139|NCT02864498|324075683|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
94621140|NCT02864498|324075684|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
94621141|NCT02864498|324075682|FG000|Overall Study|Subject moved out of the country.|0|||
94621142|NCT02864498|324075683|FG001|Overall Study|Subject moved out of the country.|0|||
94621143|NCT02864498|324075684|FG002|Overall Study|Subject moved out of the country.|1|||
94621144|NCT04189081|324075685|FG000|Overall Study|Lost to Follow-up|1|||
94621145|NCT04189081|324075686|FG001|Overall Study|Lost to Follow-up|0|||
94621146|NCT04189081|324075687|FG002|Overall Study|Lost to Follow-up|0|||
94621147|NCT04189081|324075685|FG000|Overall Study|Withdrawal by Subject|0|||
94621148|NCT04189081|324075686|FG001|Overall Study|Withdrawal by Subject|0|||
94621149|NCT04189081|324075687|FG002|Overall Study|Withdrawal by Subject|1|||
94621150|NCT01812174|324075688|FG000|Overall Study|Death|1|||
94621151|NCT01812174|324075689|FG001|Overall Study|Death|0|||
94621152|NCT01812174|324075688|FG000|Overall Study|Protocol Violation|2|||
94621153|NCT01812174|324075689|FG001|Overall Study|Protocol Violation|0|||
94621154|NCT00730132|324075691|FG000|Overall Study|Protocol Violation|154|||
94621155|NCT00730132|324075691|FG000|Overall Study|Death|1|||
94621156|NCT00329238|324075692|FG000|Overall Study|Adverse Event|147|||
94621157|NCT00329238|324075693|FG001|Overall Study|Adverse Event|129|||
94621158|NCT00329238|324075692|FG000|Overall Study|Protocol Violation|23|||
94621159|NCT00329238|324075693|FG001|Overall Study|Protocol Violation|34|||
94667990|NCT05540522|324236615|FG003|Overall Study|Not vaccinated|50|||
94667991|NCT05540522|324236612|FG000|Overall Study|No longer meets eligibility criteria|0|||
94667992|NCT05540522|324236613|FG001|Overall Study|No longer meets eligibility criteria|0|||
94667993|NCT05540522|324236614|FG002|Overall Study|No longer meets eligibility criteria|3|||
94667994|NCT05540522|324236615|FG003|Overall Study|No longer meets eligibility criteria|2|||
94667995|NCT05540522|324236612|FG000|Overall Study|Other (Unspecified)|8|||
94667996|NCT05540522|324236613|FG001|Overall Study|Other (Unspecified)|10|||
94667997|NCT05540522|324236614|FG002|Overall Study|Other (Unspecified)|4|||
94667998|NCT05540522|324236615|FG003|Overall Study|Other (Unspecified)|2|||
94667999|NCT04348604|324236618|FG000|Week 8|Withdrawal by Subject|1|||
94668000|NCT04348604|324236619|FG001|Week 8|Withdrawal by Subject|1|||
94668001|NCT04348604|324236618|FG000|Week 8|Lost to Follow-up|1|||
94668002|NCT04348604|324236619|FG001|Week 8|Lost to Follow-up|2|||
94668003|NCT04348604|324236618|FG000|Week 8|Suspended|0|||
94668004|NCT04348604|324236619|FG001|Week 8|Suspended|1|||
94668005|NCT04348604|324236618|FG000|Week 12|Lost to Follow-up|1|||
94668006|NCT04348604|324236619|FG001|Week 12|Lost to Follow-up|2|||
94668007|NCT04348604|324236618|FG000|Week 12|Withdrawal by Subject|1|||
94668008|NCT04348604|324236619|FG001|Week 12|Withdrawal by Subject|0|||
94668009|NCT04348604|324236618|FG000|Week 24|Lost to Follow-up|2|||
94668010|NCT04348604|324236619|FG001|Week 24|Lost to Follow-up|1|||
94668011|NCT02459574|324236620|FG000|Overall Study|Withdrawal by Subject|6|||
94668012|NCT02459574|324236621|FG001|Overall Study|Withdrawal by Subject|6|||
94668013|NCT02459574|324236622|FG002|Overall Study|Withdrawal by Subject|2|||
94621160|NCT00329238|324075692|FG000|Overall Study|Lost to Follow-up|2|||
94621161|NCT00329238|324075693|FG001|Overall Study|Lost to Follow-up|6|||
94621162|NCT00329238|324075692|FG000|Overall Study|Withdrawal by Subject|64|||
94668014|NCT02459574|324236620|FG000|Overall Study|Lost to Follow-up|1|||
94668015|NCT02459574|324236621|FG001|Overall Study|Lost to Follow-up|1|||
94621163|NCT00329238|324075693|FG001|Overall Study|Withdrawal by Subject|58|||
94668016|NCT02459574|324236622|FG002|Overall Study|Lost to Follow-up|0|||
94668017|NCT02459574|324236620|FG000|Overall Study|Death|0|||
94668018|NCT02459574|324236621|FG001|Overall Study|Death|1|||
94668019|NCT02459574|324236622|FG002|Overall Study|Death|0|||
94668020|NCT01877408|324238491|FG000|Overall Study|Lost to Follow-up|0|||
94359489|NCT02319642|323100332|FG000|Overall Study|Adverse Event|2|||
94668021|NCT01877408|324238492|FG001|Overall Study|Lost to Follow-up|2|||
94668022|NCT01625897|324238493|FG000|Overall Study|Adverse Event|27|||
94668023|NCT01625897|324238494|FG001|Overall Study|Adverse Event|10|||
94668024|NCT01625897|324238493|FG000|Overall Study|Physician Decision|0|||
94668025|NCT01625897|324238494|FG001|Overall Study|Physician Decision|1|||
94668026|NCT01625897|324238493|FG000|Overall Study|Withdrawal by Subject|25|||
94668027|NCT01625897|324238494|FG001|Overall Study|Withdrawal by Subject|3|||
94668028|NCT00156065|324238496|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
94668029|NCT00156065|324238497|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
94668030|NCT00156065|324238498|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
94668031|NCT00156065|324238496|FG000|Overall Study|Adverse Event|8|||
94668032|NCT00156065|324238497|FG001|Overall Study|Adverse Event|11|||
94668033|NCT00156065|324238498|FG002|Overall Study|Adverse Event|4|||
94668034|NCT00156065|324238496|FG000|Overall Study|Lack of Efficacy|2|||
94668035|NCT00156065|324238497|FG001|Overall Study|Lack of Efficacy|9|||
94668036|NCT00156065|324238498|FG002|Overall Study|Lack of Efficacy|3|||
94668037|NCT00156065|324238496|FG000|Overall Study|Withdrawal by Subject|13|||
94668038|NCT00156065|324238497|FG001|Overall Study|Withdrawal by Subject|26|||
94668039|NCT00156065|324238498|FG002|Overall Study|Withdrawal by Subject|16|||
94668040|NCT00156065|324238496|FG000|Overall Study|Lost to Follow-up|5|||
94621164|NCT00329238|324075692|FG000|Overall Study|Other reason (not specified)|40|||
94621165|NCT00329238|324075693|FG001|Overall Study|Other reason (not specified)|54|||
94621166|NCT05379231|324075694|FG000|Home Visit|Withdrawal by Subject|2|||
94621167|NCT05379231|324075694|FG000|In-lab Visit|Withdrawal by Subject|2|||
94621168|NCT05466682|324075698|FG000|Overall Study|Withdrawal by Subject|0|||
94621169|NCT05466682|324075699|FG001|Overall Study|Withdrawal by Subject|2|||
94621170|NCT05466682|324075698|FG000|Overall Study|Lost to Follow-up|2|||
94621171|NCT05466682|324075699|FG001|Overall Study|Lost to Follow-up|1|||
94621172|NCT00205881|324075700|FG000|Overall Study|Withdrawal by Subject|16|||
94621173|NCT01658072|324075701|FG000|Overall Study|Protocol Violation|4|||
94621174|NCT01658072|324075702|FG001|Overall Study|Protocol Violation|2|||
94621175|NCT03208244|324075703|FG000|Overall Study|Death|1|||
94621176|NCT01874054|324075705|FG000|Overall Study|Withdrawal by Subject|3|||
94621177|NCT01874054|324075705|FG000|Overall Study|Study Termination by Sponsor|42|||
94621178|NCT01874054|324075705|FG000|Overall Study|Lost to Follow-up|5|||
94621179|NCT01874054|324075705|FG000|Overall Study|Death|5|||
94621180|NCT00702923|324075706|FG000|Overall Study|Adverse Event|1|||
94621181|NCT01546883|324075715|FG000|Overall Study|Withdrawal by Subject|3|||
94621182|NCT01546883|324075715|FG000|Overall Study|Adverse Event|4|||
94621183|NCT01546883|324075715|FG000|Overall Study|Lost to Follow-up|2|||
94621184|NCT01546883|324075715|FG000|Overall Study|early closure of study|2|||
94621185|NCT01546883|324075715|FG000|Overall Study|other unrelated illness|1|||
94621186|NCT02243696|324075716|FG000|Overall Study|Death|282|||
94621187|NCT02243696|324075716|FG000|Overall Study|Withdrawal by Subject|79|||
94621188|NCT02243696|324075716|FG000|Overall Study|Lost to Follow-up|57|||
94621189|NCT02243696|324075716|FG000|Overall Study|Subject No Longer has Study System|42|||
94621190|NCT02243696|324075716|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
94621191|NCT02243696|324075716|FG000|Overall Study|Study Terminated for EP PASSION|961|||
94621192|NCT00622284|324075717|FG000|Overall Study|Lack of Efficacy|45|||
94621193|NCT00622284|324075718|FG001|Overall Study|Lack of Efficacy|15|||
94621194|NCT00622284|324075717|FG000|Overall Study|Adverse Event|61|||
94621195|NCT00622284|324075718|FG001|Overall Study|Adverse Event|90|||
94621196|NCT00622284|324075717|FG000|Overall Study|Protocol Violation|12|||
94621197|NCT00622284|324075718|FG001|Overall Study|Protocol Violation|5|||
94621198|NCT00622284|324075717|FG000|Overall Study|Lost to Follow-up|11|||
94621199|NCT00622284|324075718|FG001|Overall Study|Lost to Follow-up|13|||
94621200|NCT00622284|324075717|FG000|Overall Study|Withdrawal by Subject|27|||
94621201|NCT00622284|324075718|FG001|Overall Study|Withdrawal by Subject|24|||
94621202|NCT00622284|324075717|FG000|Overall Study|Other reason (not specified)|33|||
94621203|NCT00622284|324075718|FG001|Overall Study|Other reason (not specified)|24|||
94668041|NCT00156065|324238497|FG001|Overall Study|Lost to Follow-up|7|||
94668042|NCT00156065|324238498|FG002|Overall Study|Lost to Follow-up|1|||
94668043|NCT00156065|324238496|FG000|Overall Study|Other|2|||
94668044|NCT00156065|324238497|FG001|Overall Study|Other|9|||
94668045|NCT00156065|324238498|FG002|Overall Study|Other|3|||
94621204|NCT00282984|324075719|FG000|Overall Study|Death|2|||
94621205|NCT00282984|324075720|FG001|Overall Study|Death|5|||
94621206|NCT00282984|324075719|FG000|Overall Study|Adverse Event|8|||
94621207|NCT00282984|324075720|FG001|Overall Study|Adverse Event|5|||
94621208|NCT00282984|324075719|FG000|Overall Study|Lack of Efficacy|0|||
94621209|NCT00282984|324075720|FG001|Overall Study|Lack of Efficacy|2|||
94668046|NCT02621931|324238499|FG000|Overall Study|Death|0|||
94621210|NCT00282984|324075719|FG000|Overall Study|Lost to Follow-up|14|||
94621211|NCT00282984|324075720|FG001|Overall Study|Lost to Follow-up|10|||
94621212|NCT00282984|324075719|FG000|Overall Study|Withdrawal by Participant|22|||
94668047|NCT02621931|324238500|FG001|Overall Study|Death|1|||
94668048|NCT02621931|324238501|FG002|Overall Study|Death|0|||
94668049|NCT02621931|324238499|FG000|Overall Study|Adverse Event|8|||
94668050|NCT02621931|324238500|FG001|Overall Study|Adverse Event|5|||
94668051|NCT02621931|324238501|FG002|Overall Study|Adverse Event|7|||
94668052|NCT02621931|324238499|FG000|Overall Study|Withdrawal by Subject|12|||
94668053|NCT02621931|324238500|FG001|Overall Study|Withdrawal by Subject|10|||
94668054|NCT02621931|324238501|FG002|Overall Study|Withdrawal by Subject|11|||
94668055|NCT02621931|324238499|FG000|Overall Study|Protocol Violation|2|||
94668056|NCT02621931|324238500|FG001|Overall Study|Protocol Violation|2|||
94668057|NCT02621931|324238501|FG002|Overall Study|Protocol Violation|2|||
94668058|NCT02621931|324238499|FG000|Overall Study|Pregnancy|2|||
94668059|NCT02621931|324238500|FG001|Overall Study|Pregnancy|0|||
94668060|NCT02621931|324238501|FG002|Overall Study|Pregnancy|0|||
94668061|NCT02621931|324238499|FG000|Overall Study|Noncompliance to study procedures|0|||
94668062|NCT02621931|324238500|FG001|Overall Study|Noncompliance to study procedures|1|||
94668063|NCT02621931|324238501|FG002|Overall Study|Noncompliance to study procedures|2|||
94668064|NCT02621931|324238499|FG000|Overall Study|Lost to Follow-up|8|||
94668065|NCT02621931|324238500|FG001|Overall Study|Lost to Follow-up|7|||
94668066|NCT02621931|324238501|FG002|Overall Study|Lost to Follow-up|10|||
94668067|NCT02621931|324238499|FG000|Overall Study|Lack of Efficacy|0|||
94668068|NCT02621931|324238500|FG001|Overall Study|Lack of Efficacy|0|||
94668069|NCT02621931|324238501|FG002|Overall Study|Lack of Efficacy|1|||
94668070|NCT02621931|324238499|FG000|Overall Study|Other|1|||
94668071|NCT02621931|324238500|FG001|Overall Study|Other|1|||
94668072|NCT02621931|324238501|FG002|Overall Study|Other|3|||
94668073|NCT01275625|324238504|FG000|Overall Study|Death|1|||
94668074|NCT01275625|324238504|FG000|Overall Study|Lack of Efficacy|2|||
94668075|NCT01275625|324238504|FG000|Overall Study|Lost to Follow-up|1|||
94668076|NCT01275625|324238504|FG000|Overall Study|Withdrawal by Subject|3|||
94668077|NCT01275625|324238504|FG000|Overall Study|Protocol Violation|1|||
94668078|NCT01275625|324238504|FG000|Overall Study|Adverse Event|4|||
94668079|NCT01275625|324238504|FG000|Overall Study|Other|1|||
94668080|NCT03422250|324238505|FG000|Intervention|Adverse Event|0|||
94668081|NCT03422250|324238506|FG001|Intervention|Adverse Event|1|||
94668082|NCT03422250|324238507|FG002|Intervention|Adverse Event|0|||
94668083|NCT03422250|324238508|FG003|Intervention|Adverse Event|1|||
94668084|NCT03422250|324238505|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
94668085|NCT03422250|324238506|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
94668086|NCT03422250|324238507|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
94668087|NCT03422250|324238508|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
94668088|NCT03422250|324238505|FG000|Follow-up|Withdrawal by Subject|0|||
94668089|NCT03422250|324238506|FG001|Follow-up|Withdrawal by Subject|0|||
94668090|NCT03422250|324238507|FG002|Follow-up|Withdrawal by Subject|0|||
94668091|NCT03422250|324238508|FG003|Follow-up|Withdrawal by Subject|1|||
94668092|NCT03422250|324238505|FG000|Follow-up|Adverse Event|0|||
94668093|NCT03422250|324238506|FG001|Follow-up|Adverse Event|0|||
94668094|NCT03422250|324238507|FG002|Follow-up|Adverse Event|0|||
94668095|NCT03422250|324238508|FG003|Follow-up|Adverse Event|1|||
94668096|NCT02388724|324238509|FG000|Overall Study|Reason not Specified|0|||
94668097|NCT02388724|324238510|FG001|Overall Study|Reason not Specified|1|||
94668098|NCT02388724|324238509|FG000|Overall Study|Major Protocol Deviation|3|||
94668099|NCT02388724|324238510|FG001|Overall Study|Major Protocol Deviation|3|||
94668100|NCT02388724|324238509|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
94668101|NCT02388724|324238510|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
94668102|NCT02388724|324238509|FG000|Overall Study|Voluntary Withdrawal|6|||
94668103|NCT02388724|324238510|FG001|Overall Study|Voluntary Withdrawal|5|||
94668104|NCT02388724|324238509|FG000|Overall Study|Randomized but not Treated|0|||
94668105|NCT02388724|324238510|FG001|Overall Study|Randomized but not Treated|2|||
94668106|NCT01549613|324238511|FG000|Overall Study|Lost to Follow-up|11|||
94668107|NCT01549613|324238512|FG001|Overall Study|Lost to Follow-up|11|||
94668108|NCT03489304|324238513|FG000|Overall Study|Lost to Follow-up|4|||
94668109|NCT03162224|324238514|FG000|Overall Study|Death|4|||
94668110|NCT03162224|324238515|FG001|Overall Study|Death|5|||
94668111|NCT03162224|324238516|FG002|Overall Study|Death|8|||
94668112|NCT03162224|324238514|FG000|Overall Study|Withdrawal by Subject|1|||
94668113|NCT03162224|324238515|FG001|Overall Study|Withdrawal by Subject|0|||
94668114|NCT03162224|324238516|FG002|Overall Study|Withdrawal by Subject|1|||
94668115|NCT03162224|324238514|FG000|Overall Study|Lost to Follow-up|0|||
94668116|NCT03162224|324238515|FG001|Overall Study|Lost to Follow-up|1|||
94668117|NCT03162224|324238516|FG002|Overall Study|Lost to Follow-up|0|||
94668118|NCT03162224|324238514|FG000|Overall Study|Other|6|||
94668119|NCT03162224|324238515|FG001|Overall Study|Other|2|||
94668120|NCT03162224|324238516|FG002|Overall Study|Other|1|||
94668121|NCT02564523|324238520|FG000|Overall Study|Withdrawal by Subject|3|||
94668122|NCT02564523|324238521|FG001|Overall Study|Withdrawal by Subject|0|||
94668123|NCT02564523|324238522|FG002|Overall Study|Withdrawal by Subject|1|||
94359490|NCT02319642|323100333|FG001|Overall Study|Adverse Event|4|||
94668124|NCT02564523|324238523|FG003|Overall Study|Withdrawal by Subject|0|||
94668125|NCT02564523|324238524|FG004|Overall Study|Withdrawal by Subject|1|||
94668126|NCT02564523|324238525|FG005|Overall Study|Withdrawal by Subject|0|||
94668127|NCT02564523|324238526|FG006|Overall Study|Withdrawal by Subject|1|||
94668128|NCT02564523|324238527|FG007|Overall Study|Withdrawal by Subject|0|||
94359491|NCT02319642|323100332|FG000|Overall Study|Lack of Efficacy|1|||
94621213|NCT00282984|324075720|FG001|Overall Study|Withdrawal by Participant|34|||
94621214|NCT00282984|324075719|FG000|Overall Study|Participant stopped study medication|2|||
94621215|NCT00282984|324075720|FG001|Overall Study|Participant stopped study medication|2|||
94621216|NCT00282984|324075719|FG000|Overall Study|Participant only allowed phone follow-up|0|||
94621217|NCT00282984|324075720|FG001|Overall Study|Participant only allowed phone follow-up|1|||
94621218|NCT00282984|324075719|FG000|Overall Study|Participant used antipsychosis meds|0|||
94621219|NCT00282984|324075720|FG001|Overall Study|Participant used antipsychosis meds|1|||
94621220|NCT00282984|324075719|FG000|Overall Study|lack of motivation|1|||
94621221|NCT00282984|324075720|FG001|Overall Study|lack of motivation|0|||
94621222|NCT00282984|324075719|FG000|Overall Study|in prison|0|||
94621223|NCT00282984|324075720|FG001|Overall Study|in prison|1|||
94621224|NCT00282984|324075719|FG000|Overall Study|Protocol Violation|2|||
94621225|NCT00282984|324075720|FG001|Overall Study|Protocol Violation|0|||
94621226|NCT00190671|324075721|FG000|Overall Study|Satisfactory Response|4|||
94621227|NCT00190671|324075722|FG001|Overall Study|Satisfactory Response|7|||
94621228|NCT00190671|324075721|FG000|Overall Study|Lack of Efficacy|19|||
94621229|NCT00190671|324075722|FG001|Overall Study|Lack of Efficacy|24|||
94621230|NCT00190671|324075721|FG000|Overall Study|Death from Study Disease|1|||
94621231|NCT00190671|324075722|FG001|Overall Study|Death from Study Disease|1|||
94621232|NCT00190671|324075721|FG000|Overall Study|Adverse Event|3|||
94621233|NCT00190671|324075722|FG001|Overall Study|Adverse Event|2|||
94621234|NCT00190671|324075721|FG000|Overall Study|Clinical Relapse|0|||
94621235|NCT00190671|324075722|FG001|Overall Study|Clinical Relapse|1|||
94621236|NCT00190671|324075721|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
94621237|NCT00190671|324075722|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
94621238|NCT00190671|324075721|FG000|Overall Study|Death from Other Causes|0|||
94621239|NCT00190671|324075722|FG001|Overall Study|Death from Other Causes|2|||
94621240|NCT00190671|324075721|FG000|Overall Study|Protocol Violation|0|||
94621241|NCT00190671|324075722|FG001|Overall Study|Protocol Violation|1|||
94621242|NCT00190671|324075721|FG000|Overall Study|Withdrawal by Subject|0|||
94621243|NCT00190671|324075722|FG001|Overall Study|Withdrawal by Subject|2|||
94621244|NCT00457301|324075723|FG000|Overall Study|Withdrawal by Subject|3|||
94621245|NCT00457301|324075724|FG001|Overall Study|Withdrawal by Subject|3|||
94621246|NCT00457301|324075723|FG000|Overall Study|Censored out of the study|15|||
94621247|NCT00457301|324075724|FG001|Overall Study|Censored out of the study|14|||
94621248|NCT00457301|324075723|FG000|Overall Study|Death|5|||
94621249|NCT00457301|324075724|FG001|Overall Study|Death|7|||
94621250|NCT03408483|324075725|FG000|Overall Study|Physician Decision|3|||
94621251|NCT03408483|324075726|FG001|Overall Study|Physician Decision|3|||
94621252|NCT03408483|324075725|FG000|Overall Study|Lost to Follow-up|3|||
94621253|NCT03408483|324075726|FG001|Overall Study|Lost to Follow-up|0|||
94621254|NCT00291577|324075728|FG000|Overall Study|Adverse Event|1|||
94621255|NCT00291577|324075728|FG000|Overall Study|Other|4|||
94621256|NCT00291577|324075728|FG000|Overall Study|Withdrawal by Subject|2|||
94621257|NCT00291577|324075728|FG000|Overall Study|Lack of Efficacy|14|||
94621258|NCT01552694|324075732|FG000|Overall Study|Lost to Follow-up|0|||
94621259|NCT01552694|324075733|FG001|Overall Study|Lost to Follow-up|1|||
94621260|NCT01552694|324075732|FG000|Overall Study|Protocol Violation|0|||
94621261|NCT01552694|324075733|FG001|Overall Study|Protocol Violation|1|||
94621262|NCT03943147|324075735|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
94621263|NCT03943147|324075736|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
94621264|NCT03943147|324075735|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
94621265|NCT03943147|324075736|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
94621266|NCT03943147|324075735|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
94621267|NCT03943147|324075736|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
94621268|NCT03943147|324075735|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
94621269|NCT03943147|324075736|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
94621270|NCT03943147|324075735|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
94621271|NCT03943147|324075736|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
94621272|NCT03943147|324075735|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
94359492|NCT02319642|323100333|FG001|Overall Study|Lack of Efficacy|1|||
94621273|NCT03943147|324075736|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
94621274|NCT01318993|324075737|FG000|Overall Study|Adverse Event|53|||
94621275|NCT01318993|324075737|FG000|Overall Study|Lack of Efficacy|121|||
94621276|NCT01318993|324075737|FG000|Overall Study|Protocol Violation|3|||
94621277|NCT01318993|324075737|FG000|Overall Study|Protocol based stopping criteria|6|||
94621278|NCT01318993|324075737|FG000|Overall Study|Study closed or terminated|174|||
94668129|NCT02564523|324238528|FG008|Overall Study|Withdrawal by Subject|0|||
94668130|NCT02564523|324238529|FG009|Overall Study|Withdrawal by Subject|0|||
94668131|NCT02564523|324238530|FG010|Overall Study|Withdrawal by Subject|1|||
94668132|NCT02564523|324238531|FG011|Overall Study|Withdrawal by Subject|0|||
94668133|NCT02564523|324238532|FG012|Overall Study|Withdrawal by Subject|1|||
94668134|NCT02564523|324238533|FG013|Overall Study|Withdrawal by Subject|0|||
94668135|NCT02564523|324238534|FG014|Overall Study|Withdrawal by Subject|0|||
94668136|NCT02564523|324238535|FG015|Overall Study|Withdrawal by Subject|0|||
94668137|NCT02564523|324238536|FG016|Overall Study|Withdrawal by Subject|0|||
94668138|NCT02564523|324238537|FG017|Overall Study|Withdrawal by Subject|0|||
94668139|NCT02564523|324238520|FG000|Overall Study|Adverse Event|0|||
94668140|NCT02564523|324238521|FG001|Overall Study|Adverse Event|0|||
94668141|NCT02564523|324238522|FG002|Overall Study|Adverse Event|0|||
94668142|NCT02564523|324238523|FG003|Overall Study|Adverse Event|0|||
94668143|NCT02564523|324238524|FG004|Overall Study|Adverse Event|0|||
94668144|NCT02564523|324238525|FG005|Overall Study|Adverse Event|0|||
94668145|NCT02564523|324238526|FG006|Overall Study|Adverse Event|0|||
94668146|NCT02564523|324238527|FG007|Overall Study|Adverse Event|0|||
94668147|NCT02564523|324238528|FG008|Overall Study|Adverse Event|0|||
94668148|NCT02564523|324238529|FG009|Overall Study|Adverse Event|0|||
94668149|NCT02564523|324238530|FG010|Overall Study|Adverse Event|0|||
94668150|NCT02564523|324238531|FG011|Overall Study|Adverse Event|0|||
94668151|NCT02564523|324238532|FG012|Overall Study|Adverse Event|0|||
94668152|NCT02564523|324238533|FG013|Overall Study|Adverse Event|0|||
94668153|NCT02564523|324238534|FG014|Overall Study|Adverse Event|0|||
94668154|NCT02564523|324238535|FG015|Overall Study|Adverse Event|0|||
94668155|NCT02564523|324238536|FG016|Overall Study|Adverse Event|0|||
94668156|NCT02564523|324238537|FG017|Overall Study|Adverse Event|1|||
94668157|NCT02564523|324238520|FG000|Overall Study|Death|0|||
94621279|NCT01318993|324075737|FG000|Overall Study|Lost to Follow-up|4|||
94621280|NCT01318993|324075737|FG000|Overall Study|Physician Decision|13|||
94621281|NCT01318993|324075737|FG000|Overall Study|Withdrawal by Subject|24|||
94621282|NCT00629707|324075738|FG000|Overall Study|Withdrawal by Subject|0|||
94621283|NCT00629707|324075739|FG001|Overall Study|Withdrawal by Subject|1|||
94621284|NCT00629707|324075738|FG000|Overall Study|Physician Decision|0|||
94621285|NCT00629707|324075739|FG001|Overall Study|Physician Decision|1|||
94621286|NCT03724032|324075740|FG000|Overall Study|Physician Decision|1|||
94621287|NCT03724032|324075741|FG001|Overall Study|Physician Decision|0|||
94621288|NCT03724032|324075742|FG002|Overall Study|Physician Decision|0|||
94621289|NCT03724032|324075740|FG000|Overall Study|Protocol Violation|2|||
94621290|NCT03724032|324075741|FG001|Overall Study|Protocol Violation|2|||
94621291|NCT03724032|324075742|FG002|Overall Study|Protocol Violation|1|||
94621292|NCT02619175|324075744|FG000|Overall Study|Withdrawal by Subject|1|||
94621293|NCT02619175|324075745|FG001|Overall Study|Withdrawal by Subject|0|||
94621294|NCT02619175|324075744|FG000|Overall Study|foot pain|1|||
94621295|NCT02619175|324075745|FG001|Overall Study|foot pain|0|||
94621296|NCT00361569|324075746|FG000|Overall Study|Protocol Violation|3|||
94621297|NCT00361569|324075747|FG001|Overall Study|Protocol Violation|2|||
94621298|NCT00361569|324075748|FG002|Overall Study|Protocol Violation|4|||
94621299|NCT00361569|324075749|FG003|Overall Study|Protocol Violation|2|||
94621300|NCT00361569|324075746|FG000|Overall Study|Withdrawal by Subject|2|||
94621301|NCT00361569|324075747|FG001|Overall Study|Withdrawal by Subject|1|||
94668158|NCT02564523|324238521|FG001|Overall Study|Death|0|||
94668159|NCT02564523|324238522|FG002|Overall Study|Death|0|||
94359493|NCT02319642|323100332|FG000|Overall Study|Withdrawal by Subject|1|||
94621302|NCT00361569|324075748|FG002|Overall Study|Withdrawal by Subject|9|||
94621303|NCT00361569|324075749|FG003|Overall Study|Withdrawal by Subject|14|||
94621304|NCT00361569|324075746|FG000|Overall Study|Adverse Event|3|||
94621305|NCT00361569|324075747|FG001|Overall Study|Adverse Event|5|||
94621306|NCT00361569|324075748|FG002|Overall Study|Adverse Event|2|||
94621307|NCT00361569|324075749|FG003|Overall Study|Adverse Event|2|||
94621308|NCT00361569|324075746|FG000|Overall Study|Lost to Follow-up|2|||
94621309|NCT00361569|324075747|FG001|Overall Study|Lost to Follow-up|3|||
94621310|NCT00361569|324075748|FG002|Overall Study|Lost to Follow-up|3|||
94621311|NCT00361569|324075749|FG003|Overall Study|Lost to Follow-up|2|||
94359494|NCT02319642|323100333|FG001|Overall Study|Withdrawal by Subject|1|||
94621312|NCT00361569|324075746|FG000|Overall Study|Not specified by investigator|2|||
94621313|NCT00361569|324075747|FG001|Overall Study|Not specified by investigator|0|||
94621314|NCT00361569|324075748|FG002|Overall Study|Not specified by investigator|0|||
94621315|NCT00361569|324075749|FG003|Overall Study|Not specified by investigator|1|||
94621316|NCT01558271|324075750|FG000|Overall Study|Adverse Event|6|||
94621317|NCT01558271|324075751|FG001|Overall Study|Adverse Event|3|||
94621318|NCT01558271|324075752|FG002|Overall Study|Adverse Event|4|||
94668160|NCT02564523|324238523|FG003|Overall Study|Death|0|||
94668161|NCT02564523|324238524|FG004|Overall Study|Death|0|||
94668162|NCT02564523|324238525|FG005|Overall Study|Death|0|||
94668163|NCT02564523|324238526|FG006|Overall Study|Death|1|||
94668164|NCT02564523|324238527|FG007|Overall Study|Death|0|||
94668165|NCT02564523|324238528|FG008|Overall Study|Death|0|||
94668166|NCT02564523|324238529|FG009|Overall Study|Death|0|||
94621319|NCT01558271|324075750|FG000|Overall Study|Lost to Follow-up|1|||
94621320|NCT01558271|324075751|FG001|Overall Study|Lost to Follow-up|0|||
94621321|NCT01558271|324075752|FG002|Overall Study|Lost to Follow-up|0|||
94621322|NCT01558271|324075750|FG000|Overall Study|Protocol Violation|1|||
94621323|NCT01558271|324075751|FG001|Overall Study|Protocol Violation|0|||
94621324|NCT01558271|324075752|FG002|Overall Study|Protocol Violation|0|||
94621325|NCT01558271|324075750|FG000|Overall Study|Withdrawal by Subject|10|||
94621326|NCT01558271|324075751|FG001|Overall Study|Withdrawal by Subject|6|||
94621327|NCT01558271|324075752|FG002|Overall Study|Withdrawal by Subject|12|||
94621328|NCT01558271|324075750|FG000|Overall Study|Physician Decision|0|||
94621329|NCT01558271|324075751|FG001|Overall Study|Physician Decision|2|||
94621330|NCT01558271|324075752|FG002|Overall Study|Physician Decision|1|||
94621331|NCT01845831|324075753|FG000|Inpatient Phase|Withdrawal by Subject|1|||
94621332|NCT01845831|324075754|FG001|Inpatient Phase|Withdrawal by Subject|1|||
94621333|NCT01845831|324075755|FG002|Inpatient Phase|Withdrawal by Subject|0|||
94621334|NCT01845831|324075756|FG003|Inpatient Phase|Withdrawal by Subject|0|||
94621335|NCT01845831|324075757|FG004|Inpatient Phase|Withdrawal by Subject|0|||
94621336|NCT02610725|324075758|FG000|Overall Study|Lost to Follow-up|197|||
94621337|NCT02610725|324075758|FG000|Overall Study|self-reported contraindication|9|||
94621338|NCT00074152|324075759|FG000|Overall Study|Death|21|||
94621339|NCT00074152|324075760|FG001|Overall Study|Death|9|||
94621340|NCT00074152|324075759|FG000|Overall Study|Lack of Efficacy|34|||
94621341|NCT00074152|324075760|FG001|Overall Study|Lack of Efficacy|24|||
94621342|NCT01063868|324075763|FG000|Overall Study|Adverse Event|9|||
94621343|NCT01063868|324075764|FG001|Overall Study|Adverse Event|7|||
94621344|NCT01063868|324075763|FG000|Overall Study|Withdrawal by Subject|3|||
94621345|NCT01063868|324075764|FG001|Overall Study|Withdrawal by Subject|1|||
94621346|NCT01063868|324075763|FG000|Overall Study|Study Terminated By Sponsor|23|||
94621347|NCT01063868|324075764|FG001|Overall Study|Study Terminated By Sponsor|4|||
94621348|NCT04212650|324075765|FG000|Overall Study|Withdrawal by Subject|1|||
94621349|NCT04212650|324075766|FG001|Overall Study|Withdrawal by Subject|0|||
94621350|NCT02166905|324075768|FG000|Overall Study|Withdrawal by Subject|1|||
94621351|NCT02166905|324075769|FG001|Overall Study|Withdrawal by Subject|0|||
94621352|NCT02166905|324075770|FG002|Overall Study|Withdrawal by Subject|0|||
94621353|NCT02166905|324075771|FG003|Overall Study|Withdrawal by Subject|0|||
94621354|NCT01918774|324078134|FG000|Overall Study|Lost prior to first CBTw session|4|||
94621355|NCT01918774|324078134|FG000|Overall Study|Lost to Follow-up|1|||
94621356|NCT02469298|324078135|FG000|Overall Study|Protocol Violation|0|||
94621357|NCT02469298|324078136|FG001|Overall Study|Protocol Violation|1|||
94621358|NCT02469298|324078137|FG002|Overall Study|Protocol Violation|1|||
94621359|NCT02469298|324078138|FG003|Overall Study|Protocol Violation|0|||
94621360|NCT02469298|324078135|FG000|Overall Study|Lost to Follow-up|1|||
94621361|NCT02469298|324078136|FG001|Overall Study|Lost to Follow-up|0|||
94621362|NCT02469298|324078137|FG002|Overall Study|Lost to Follow-up|1|||
94621363|NCT02469298|324078138|FG003|Overall Study|Lost to Follow-up|0|||
94621364|NCT02469298|324078135|FG000|Overall Study|Physician Decision|0|||
94621365|NCT02469298|324078136|FG001|Overall Study|Physician Decision|0|||
94621366|NCT02469298|324078137|FG002|Overall Study|Physician Decision|0|||
94621367|NCT02469298|324078138|FG003|Overall Study|Physician Decision|1|||
94621368|NCT02469298|324078135|FG000|Overall Study|Withdrawal by Subject|0|||
94621369|NCT02469298|324078136|FG001|Overall Study|Withdrawal by Subject|0|||
94621370|NCT02469298|324078137|FG002|Overall Study|Withdrawal by Subject|0|||
94621371|NCT02469298|324078138|FG003|Overall Study|Withdrawal by Subject|1|||
94621372|NCT00621985|324078139|FG000|Dexamethasone Admission|Adverse Event|1|||
94621373|NCT00980057|324078140|FG000|Overall Study|Death|13|||
94621374|NCT00980057|324078141|FG001|Overall Study|Death|3|||
94621375|NCT00980057|324078140|FG000|Overall Study|Adverse Event|0|||
94621376|NCT00980057|324078141|FG001|Overall Study|Adverse Event|1|||
94621377|NCT00980057|324078140|FG000|Overall Study|Physician Decision|4|||
94621378|NCT00980057|324078141|FG001|Overall Study|Physician Decision|0|||
94621379|NCT00980057|324078140|FG000|Overall Study|Lost to Follow-up|1|||
94621380|NCT00980057|324078141|FG001|Overall Study|Lost to Follow-up|0|||
94621381|NCT00980057|324078140|FG000|Overall Study|Withdrawal by Subject|1|||
94621382|NCT00980057|324078141|FG001|Overall Study|Withdrawal by Subject|1|||
94621383|NCT01508650|324078144|FG000|Overall Study|Lost to Follow-up|0|||
94621384|NCT01508650|324078145|FG001|Overall Study|Lost to Follow-up|3|||
94621385|NCT01396148|324078146|FG000|Overall Study|Patient Decision|1|||
94621386|NCT00160693|324078147|FG000|Overall Study|Adverse Event|97|||
94621387|NCT00160693|324078147|FG000|Overall Study|Lack of Efficacy|30|||
94621388|NCT00160693|324078147|FG000|Overall Study|Protocol Violation|24|||
94621389|NCT00160693|324078147|FG000|Overall Study|Lost to Follow-up|15|||
94621390|NCT00160693|324078147|FG000|Overall Study|Withdrawal by Subject|54|||
94621391|NCT00160693|324078147|FG000|Overall Study|Study terminated by sponsor|15|||
94621392|NCT03052725|324078149|FG000|Overall Study|Adverse Event|2|||
94621393|NCT03052725|324078150|FG001|Overall Study|Adverse Event|0|||
94621394|NCT03052725|324078149|FG000|Overall Study|Withdrawal by Subject|3|||
94621395|NCT03052725|324078150|FG001|Overall Study|Withdrawal by Subject|4|||
94668167|NCT02564523|324238530|FG010|Overall Study|Death|1|||
94621396|NCT03052725|324078149|FG000|Overall Study|Pregnancy|0|||
94621397|NCT03052725|324078150|FG001|Overall Study|Pregnancy|1|||
94621398|NCT03052725|324078149|FG000|Overall Study|Site closure|0|||
94621399|NCT03052725|324078150|FG001|Overall Study|Site closure|1|||
94621400|NCT03052725|324078149|FG000|Overall Study|Study terminated by sponsor|143|||
94621401|NCT03052725|324078150|FG001|Overall Study|Study terminated by sponsor|144|||
94621402|NCT01626391|324078151|FG000|Overall Study|Physician Decision|1|||
94621403|NCT01626391|324078152|FG001|Overall Study|Physician Decision|0|||
94621404|NCT01626391|324078151|FG000|Overall Study|Withdrawal by Subject|1|||
94621405|NCT01626391|324078152|FG001|Overall Study|Withdrawal by Subject|0|||
94621406|NCT00601458|324078153|FG000|Overall Study|Dosing Error|1|||
94621407|NCT00601458|324078154|FG001|Overall Study|Dosing Error|0|||
94621408|NCT00601458|324078155|FG002|Overall Study|Dosing Error|0|||
94621409|NCT00601458|324078153|FG000|Overall Study|Incomplete Data|0|||
94621410|NCT00601458|324078154|FG001|Overall Study|Incomplete Data|2|||
94621411|NCT00601458|324078155|FG002|Overall Study|Incomplete Data|0|||
94621412|NCT00601458|324078153|FG000|Overall Study|Protocol Violation|3|||
94621413|NCT00601458|324078154|FG001|Overall Study|Protocol Violation|2|||
94621414|NCT00601458|324078155|FG002|Overall Study|Protocol Violation|1|||
94621415|NCT00601458|324078153|FG000|Overall Study|Early Termination|0|||
94621416|NCT00601458|324078154|FG001|Overall Study|Early Termination|1|||
94621417|NCT00601458|324078155|FG002|Overall Study|Early Termination|1|||
94621418|NCT03982368|324078156|FG000|Overall Study|Adverse Event|6|||
94621419|NCT03982368|324078157|FG001|Overall Study|Adverse Event|4|||
94621420|NCT03982368|324078158|FG002|Overall Study|Adverse Event|3|||
94621421|NCT03982368|324078156|FG000|Overall Study|Lost to Follow-up|2|||
94621422|NCT03982368|324078157|FG001|Overall Study|Lost to Follow-up|1|||
94621423|NCT03982368|324078158|FG002|Overall Study|Lost to Follow-up|0|||
94621424|NCT03982368|324078156|FG000|Overall Study|Withdrawal by Subject|1|||
94621425|NCT03982368|324078157|FG001|Overall Study|Withdrawal by Subject|2|||
94621426|NCT03982368|324078158|FG002|Overall Study|Withdrawal by Subject|0|||
94621427|NCT03982368|324078156|FG000|Overall Study|unknow|4|||
94621428|NCT03982368|324078157|FG001|Overall Study|unknow|0|||
94621429|NCT03982368|324078158|FG002|Overall Study|unknow|2|||
94621430|NCT02099708|324078161|FG000|Overall Study|Data Not Available|30|||
94621431|NCT02099708|324078161|FG000|Overall Study|Lost to Follow-up|141|||
94621432|NCT02099708|324078161|FG000|Overall Study|Other|29|||
94621433|NCT00530946|324078184|FG000|Overall Study|Adverse Event|1|||
94621434|NCT00530946|324078185|FG001|Overall Study|Adverse Event|2|||
94621435|NCT00530946|324078186|FG002|Overall Study|Adverse Event|1|||
94621436|NCT00530946|324078187|FG003|Overall Study|Adverse Event|1|||
94621437|NCT00530946|324078184|FG000|Overall Study|Protocol Violation|0|||
94621438|NCT00530946|324078185|FG001|Overall Study|Protocol Violation|0|||
94621439|NCT00530946|324078186|FG002|Overall Study|Protocol Violation|0|||
94621440|NCT00530946|324078187|FG003|Overall Study|Protocol Violation|1|||
94621441|NCT00530946|324078184|FG000|Overall Study|Noncompliance|1|||
94621442|NCT00530946|324078185|FG001|Overall Study|Noncompliance|0|||
94621443|NCT00530946|324078186|FG002|Overall Study|Noncompliance|0|||
94621444|NCT00530946|324078187|FG003|Overall Study|Noncompliance|0|||
94621445|NCT01844518|324078199|FG000|Overall Study|Adverse Event|7|||
94621446|NCT01844518|324078200|FG001|Overall Study|Adverse Event|1|||
94621447|NCT01844518|324078199|FG000|Overall Study|Lack of Efficacy|17|||
94621448|NCT01844518|324078200|FG001|Overall Study|Lack of Efficacy|5|||
94621449|NCT01844518|324078199|FG000|Overall Study|Participant's request to discontinue|4|||
94668168|NCT02564523|324238531|FG011|Overall Study|Death|0|||
94668169|NCT02564523|324238532|FG012|Overall Study|Death|0|||
94621450|NCT01844518|324078200|FG001|Overall Study|Participant's request to discontinue|1|||
94621451|NCT01844518|324078199|FG000|Overall Study|Poor/Non-compliance|1|||
94621452|NCT01844518|324078200|FG001|Overall Study|Poor/Non-compliance|0|||
94621453|NCT01844518|324078199|FG000|Overall Study|No Longer Met Study Criteria|2|||
94621454|NCT01844518|324078200|FG001|Overall Study|No Longer Met Study Criteria|0|||
94621455|NCT01844518|324078199|FG000|Overall Study|Withdrawal by Subject|9|||
94621456|NCT01844518|324078200|FG001|Overall Study|Withdrawal by Subject|0|||
94621457|NCT01844518|324078199|FG000|Overall Study|Pregnancy|1|||
94621458|NCT01844518|324078200|FG001|Overall Study|Pregnancy|0|||
94621459|NCT00390468|324078201|FG000|Overall Study|Protocol Violation|2|||
94621460|NCT00390468|324078201|FG000|Overall Study|Lack of Efficacy|1|||
94621461|NCT04502693|324078202|FG000|Overall Study|Adverse Event|7|||
94621462|NCT04502693|324078203|FG001|Overall Study|Adverse Event|6|||
94621463|NCT04502693|324078204|FG002|Overall Study|Adverse Event|11|||
94668170|NCT02564523|324238533|FG013|Overall Study|Death|0|||
94621464|NCT04502693|324078205|FG003|Overall Study|Adverse Event|1|||
94621465|NCT04502693|324078202|FG000|Overall Study|Lost to Follow-up|32|||
94621466|NCT04502693|324078203|FG001|Overall Study|Lost to Follow-up|36|||
94621467|NCT04502693|324078204|FG002|Overall Study|Lost to Follow-up|69|||
94621468|NCT04502693|324078205|FG003|Overall Study|Lost to Follow-up|4|||
94668171|NCT02564523|324238534|FG014|Overall Study|Death|0|||
94621469|NCT04502693|324078202|FG000|Overall Study|Protocol Violation|8|||
94621470|NCT04502693|324078203|FG001|Overall Study|Protocol Violation|8|||
94668172|NCT02564523|324238535|FG015|Overall Study|Death|0|||
94621471|NCT04502693|324078204|FG002|Overall Study|Protocol Violation|16|||
94621472|NCT04502693|324078205|FG003|Overall Study|Protocol Violation|1|||
94621473|NCT04502693|324078202|FG000|Overall Study|Withdrawal by Subject|46|||
94621474|NCT04502693|324078203|FG001|Overall Study|Withdrawal by Subject|38|||
94621475|NCT04502693|324078204|FG002|Overall Study|Withdrawal by Subject|54|||
94621476|NCT04502693|324078205|FG003|Overall Study|Withdrawal by Subject|7|||
94621477|NCT04502693|324078202|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
94621478|NCT04502693|324078203|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
94621479|NCT04502693|324078204|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
94621480|NCT04502693|324078205|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
94621481|NCT04502693|324078202|FG000|Overall Study|Other|1|||
94621482|NCT04502693|324078203|FG001|Overall Study|Other|0|||
94621483|NCT04502693|324078204|FG002|Overall Study|Other|1|||
94621484|NCT04502693|324078205|FG003|Overall Study|Other|1|||
94621485|NCT01587001|324078206|FG000|Overall Study|Lost to Follow-up|2|||
94621486|NCT01587001|324078207|FG001|Overall Study|Lost to Follow-up|0|||
94621487|NCT01587001|324078206|FG000|Overall Study|Insufficient samples to complete testing|4|||
94621488|NCT01587001|324078207|FG001|Overall Study|Insufficient samples to complete testing|1|||
94621489|NCT02756013|324078210|FG000|Overall Study|Adverse Event|1|||
94621490|NCT02756013|324078210|FG000|Overall Study|Hypersensitivity|1|||
94621491|NCT03334539|324078211|FG000|Overall Study|Adverse Event|3|||
94621492|NCT03334539|324078212|FG001|Overall Study|Adverse Event|5|||
94621493|NCT03334539|324078213|FG002|Overall Study|Adverse Event|0|||
94621494|NCT03334539|324078211|FG000|Overall Study|Withdrawal by Subject|0|||
94621495|NCT03334539|324078212|FG001|Overall Study|Withdrawal by Subject|1|||
94621496|NCT03334539|324078213|FG002|Overall Study|Withdrawal by Subject|1|||
94621497|NCT03334539|324078211|FG000|Overall Study|Administrative Reasons|1|||
94621498|NCT03334539|324078212|FG001|Overall Study|Administrative Reasons|0|||
94621499|NCT03334539|324078213|FG002|Overall Study|Administrative Reasons|0|||
94621500|NCT03334539|324078211|FG000|Overall Study|Hypertension Not Controlled|0|||
94621501|NCT03334539|324078212|FG001|Overall Study|Hypertension Not Controlled|1|||
94621502|NCT03334539|324078213|FG002|Overall Study|Hypertension Not Controlled|0|||
94621503|NCT00968201|324078216|FG000|Base Study - (Period II)|Adverse Event|8|||
94621504|NCT00968201|324078217|FG001|Base Study - (Period II)|Adverse Event|0|||
94621505|NCT00968201|324078218|FG002|Base Study - (Period II)|Adverse Event|16|||
94621506|NCT00968201|324078216|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
94621507|NCT00968201|324078217|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
94621508|NCT00968201|324078218|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
94621509|NCT00968201|324078216|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
94621510|NCT00968201|324078217|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
94621511|NCT00968201|324078218|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
94621512|NCT00968201|324078216|FG000|Base Study - (Period II)|Protocol Violation|12|||
94621513|NCT00968201|324078217|FG001|Base Study - (Period II)|Protocol Violation|0|||
94621514|NCT00968201|324078218|FG002|Base Study - (Period II)|Protocol Violation|12|||
94621515|NCT00968201|324078216|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
94621516|NCT00968201|324078217|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
94621517|NCT00968201|324078218|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
94621518|NCT00968201|324078216|FG000|Base Study - (Period II)|Site Error|0|||
94621519|NCT00968201|324078217|FG001|Base Study - (Period II)|Site Error|0|||
94621520|NCT00968201|324078218|FG002|Base Study - (Period II)|Site Error|1|||
94621521|NCT00968201|324078216|FG000|Extension Study - (Period III)|Adverse Event|0|||
94621522|NCT00968201|324078217|FG001|Extension Study - (Period III)|Adverse Event|5|||
94621523|NCT00968201|324078218|FG002|Extension Study - (Period III)|Adverse Event|22|||
94621524|NCT00968201|324078216|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
94621525|NCT00968201|324078217|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
94621526|NCT00968201|324078218|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
94621527|NCT00968201|324078216|FG000|Extension Study - (Period III)|Protocol Violation|0|||
94621528|NCT00968201|324078217|FG001|Extension Study - (Period III)|Protocol Violation|17|||
94621529|NCT00968201|324078218|FG002|Extension Study - (Period III)|Protocol Violation|14|||
94621530|NCT00968201|324078216|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
94621531|NCT00968201|324078217|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
94621532|NCT00968201|324078218|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
94621533|NCT00968201|324078216|FG000|Extension Study - (Period III)|Patient Relocated|0|||
94621534|NCT00968201|324078217|FG001|Extension Study - (Period III)|Patient Relocated|1|||
94621535|NCT00968201|324078218|FG002|Extension Study - (Period III)|Patient Relocated|1|||
94621536|NCT00968201|324078216|FG000|Extension Study - (Period III)|Noncompliance|0|||
94621537|NCT00968201|324078217|FG001|Extension Study - (Period III)|Noncompliance|0|||
94621538|NCT00968201|324078218|FG002|Extension Study - (Period III)|Noncompliance|3|||
94621539|NCT00968201|324078216|FG000|Extension Study - (Period III)|Other|0|||
94621540|NCT00968201|324078217|FG001|Extension Study - (Period III)|Other|0|||
94621541|NCT00968201|324078218|FG002|Extension Study - (Period III)|Other|2|||
94621542|NCT00968201|324078216|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
94621543|NCT00968201|324078217|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
94359495|NCT05275673|323100334|FG000|Overall Study|Study Termination by Sponsor|2|||
94359496|NCT05275673|323100335|FG001|Overall Study|Study Termination by Sponsor|3|||
94359497|NCT05275673|323100334|FG000|Overall Study|Death|1|||
94621544|NCT00968201|324078218|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
94621545|NCT03736447|324078219|FG000|Overall Study|Adverse Event|5|||
94621546|NCT03736447|324078220|FG001|Overall Study|Adverse Event|1|||
94621547|NCT03736447|324078219|FG000|Overall Study|Withdrawal by Subject|5|||
94621548|NCT03736447|324078220|FG001|Overall Study|Withdrawal by Subject|1|||
94621549|NCT03736447|324078219|FG000|Overall Study|Lost to Follow-up|1|||
94621550|NCT03736447|324078220|FG001|Overall Study|Lost to Follow-up|0|||
94621551|NCT03736447|324078219|FG000|Overall Study|Physician Decision|1|||
94621552|NCT03736447|324078220|FG001|Overall Study|Physician Decision|0|||
94621553|NCT03736447|324078219|FG000|Overall Study|Continued commitment to study treatment|3|||
94621554|NCT03736447|324078220|FG001|Overall Study|Continued commitment to study treatment|0|||
94621555|NCT03736447|324078219|FG000|Overall Study|Taste aversion to study product|0|||
94621556|NCT03736447|324078220|FG001|Overall Study|Taste aversion to study product|1|||
94621557|NCT04974697|324078224|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
94621558|NCT04974697|324078224|FG000|Overall Study|Lens discomfort|1|||
94621559|NCT04523220|324078225|FG000|Main Treatment Period|Physician Decision|1|||
94621560|NCT04523220|324078226|FG001|Main Treatment Period|Physician Decision|1|||
94621561|NCT04523220|324078227|FG002|Main Treatment Period|Physician Decision|0|||
94621562|NCT04523220|324078225|FG000|Main Treatment Period|Other|5|||
94621563|NCT04523220|324078226|FG001|Main Treatment Period|Other|2|||
94621564|NCT04523220|324078227|FG002|Main Treatment Period|Other|4|||
94621565|NCT04523220|324078225|FG000|Main Treatment Period|Subject Decision|5|||
94621566|NCT04523220|324078226|FG001|Main Treatment Period|Subject Decision|7|||
94621567|NCT04523220|324078227|FG002|Main Treatment Period|Subject Decision|3|||
94621568|NCT04523220|324078225|FG000|Main Treatment Period|Death|5|||
94621569|NCT04523220|324078226|FG001|Main Treatment Period|Death|11|||
94621570|NCT04523220|324078227|FG002|Main Treatment Period|Death|4|||
94621571|NCT04523220|324078225|FG000|Main Treatment Period|Adverse Event|11|||
94621572|NCT04523220|324078226|FG001|Main Treatment Period|Adverse Event|9|||
94621573|NCT04523220|324078227|FG002|Main Treatment Period|Adverse Event|9|||
94621574|NCT04523220|324078225|FG000|Main Treatment Period|Withdrawal by Subject|3|||
94621575|NCT04523220|324078226|FG001|Main Treatment Period|Withdrawal by Subject|3|||
94621576|NCT04523220|324078227|FG002|Main Treatment Period|Withdrawal by Subject|4|||
94621577|NCT04523220|324078225|FG000|Main Treatment Period|Study drug never adminstered|10|||
94621578|NCT04523220|324078226|FG001|Main Treatment Period|Study drug never adminstered|3|||
94621579|NCT04523220|324078227|FG002|Main Treatment Period|Study drug never adminstered|5|||
94621580|NCT04523220|324078225|FG000|Extension Treatment Period|Physician Decision|1|||
94621581|NCT04523220|324078226|FG001|Extension Treatment Period|Physician Decision|0|||
94621582|NCT04523220|324078227|FG002|Extension Treatment Period|Physician Decision|3|||
94621583|NCT04523220|324078225|FG000|Extension Treatment Period|Other|2|||
94621584|NCT04523220|324078226|FG001|Extension Treatment Period|Other|6|||
94621585|NCT04523220|324078227|FG002|Extension Treatment Period|Other|6|||
94621586|NCT04523220|324078225|FG000|Extension Treatment Period|Subject Decision|5|||
94621587|NCT04523220|324078226|FG001|Extension Treatment Period|Subject Decision|2|||
94621588|NCT04523220|324078227|FG002|Extension Treatment Period|Subject Decision|4|||
94621589|NCT04523220|324078225|FG000|Extension Treatment Period|Death|6|||
94621590|NCT04523220|324078226|FG001|Extension Treatment Period|Death|4|||
94621591|NCT04523220|324078227|FG002|Extension Treatment Period|Death|7|||
94621592|NCT04523220|324078225|FG000|Extension Treatment Period|Adverse Event|6|||
94621593|NCT04523220|324078226|FG001|Extension Treatment Period|Adverse Event|7|||
94621594|NCT04523220|324078227|FG002|Extension Treatment Period|Adverse Event|9|||
94621595|NCT04523220|324078225|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
94621596|NCT04523220|324078226|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
94621597|NCT04523220|324078227|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
94621598|NCT04523220|324078225|FG000|Extension Treatment Period|Study drug never administered|0|||
94621599|NCT04523220|324078226|FG001|Extension Treatment Period|Study drug never administered|1|||
94668173|NCT02564523|324238536|FG016|Overall Study|Death|0|||
94359498|NCT05275673|323100335|FG001|Overall Study|Death|0|||
94621600|NCT04523220|324078227|FG002|Extension Treatment Period|Study drug never administered|0|||
94621601|NCT00571948|324078228|FG000|Overall Study|Lost to Follow-up|2|||
94621602|NCT00571948|324078229|FG001|Overall Study|Lost to Follow-up|0|||
94621603|NCT00571948|324078228|FG000|Overall Study|Withdrawal by Subject|1|||
94621604|NCT00571948|324078229|FG001|Overall Study|Withdrawal by Subject|2|||
94621605|NCT00571948|324078228|FG000|Overall Study|Protocol Violation|3|||
94621606|NCT00571948|324078229|FG001|Overall Study|Protocol Violation|3|||
94359499|NCT05275673|323100334|FG000|Overall Study|Withdrawal by Subject|1|||
94621607|NCT00571948|324078228|FG000|Overall Study|infant refused study meal|3|||
94621608|NCT00571948|324078229|FG001|Overall Study|infant refused study meal|4|||
94621609|NCT00571948|324078228|FG000|Overall Study|Parent were afraid of blood colection|2|||
94621610|NCT00571948|324078229|FG001|Overall Study|Parent were afraid of blood colection|5|||
94621611|NCT00481078|324078230|FG000|Overall Study|Progression of disease|11|||
94621612|NCT00481078|324078231|FG001|Overall Study|Progression of disease|11|||
94621613|NCT00481078|324078230|FG000|Overall Study|Adverse Event|15|||
94621614|NCT00481078|324078231|FG001|Overall Study|Adverse Event|3|||
94621615|NCT00481078|324078230|FG000|Overall Study|Death|5|||
94621616|NCT00481078|324078231|FG001|Overall Study|Death|3|||
94621617|NCT00481078|324078230|FG000|Overall Study|Intercurrent illness|1|||
94621618|NCT00481078|324078231|FG001|Overall Study|Intercurrent illness|0|||
94621619|NCT00481078|324078230|FG000|Overall Study|Withdrawal by Subject|7|||
94621620|NCT00481078|324078231|FG001|Overall Study|Withdrawal by Subject|1|||
94621621|NCT00481078|324078230|FG000|Overall Study|Information not available|1|||
94621622|NCT00481078|324078231|FG001|Overall Study|Information not available|0|||
94621623|NCT00481078|324078230|FG000|Overall Study|Received other treatment|2|||
94621624|NCT00481078|324078231|FG001|Overall Study|Received other treatment|1|||
94621625|NCT00481078|324078230|FG000|Overall Study|Brain metastasis|0|||
94621626|NCT00481078|324078231|FG001|Overall Study|Brain metastasis|1|||
94621627|NCT02010775|324078233|FG000|Overall Study|Adverse Event|0|||
94621628|NCT02010775|324078234|FG001|Overall Study|Adverse Event|0|||
94621629|NCT02010775|324078235|FG002|Overall Study|Adverse Event|0|||
94621630|NCT02010775|324078236|FG003|Overall Study|Adverse Event|0|||
94621631|NCT02010775|324078237|FG004|Overall Study|Adverse Event|1|||
94621632|NCT02010775|324078233|FG000|Overall Study|Pregnancy|0|||
94621633|NCT02010775|324078234|FG001|Overall Study|Pregnancy|0|||
94621634|NCT02010775|324078235|FG002|Overall Study|Pregnancy|2|||
94621635|NCT02010775|324078236|FG003|Overall Study|Pregnancy|0|||
94621636|NCT02010775|324078237|FG004|Overall Study|Pregnancy|0|||
94621637|NCT02010775|324078233|FG000|Overall Study|Lost to Follow-up|2|||
94621638|NCT02010775|324078234|FG001|Overall Study|Lost to Follow-up|0|||
94621639|NCT02010775|324078235|FG002|Overall Study|Lost to Follow-up|0|||
94621640|NCT02010775|324078236|FG003|Overall Study|Lost to Follow-up|1|||
94621641|NCT02010775|324078237|FG004|Overall Study|Lost to Follow-up|1|||
94621642|NCT02010775|324078233|FG000|Overall Study|Personal Reasons|3|||
94621643|NCT02010775|324078234|FG001|Overall Study|Personal Reasons|3|||
94621644|NCT02010775|324078235|FG002|Overall Study|Personal Reasons|1|||
94621645|NCT02010775|324078236|FG003|Overall Study|Personal Reasons|2|||
94621646|NCT02010775|324078237|FG004|Overall Study|Personal Reasons|4|||
94621647|NCT00256750|324078238|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
94621648|NCT00256750|324078239|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
94621649|NCT00256750|324078240|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
94621650|NCT00256750|324078238|FG000|Transplanted Pre-Treatment|Other|2|||
94621651|NCT00256750|324078239|FG001|Transplanted Pre-Treatment|Other|0|||
94621652|NCT00256750|324078240|FG002|Transplanted Pre-Treatment|Other|0|||
94621653|NCT00256750|324078238|FG000|Transplanted Pre-Treatment|Death|1|||
94621654|NCT00256750|324078239|FG001|Transplanted Pre-Treatment|Death|0|||
94621655|NCT00256750|324078240|FG002|Transplanted Pre-Treatment|Death|0|||
94621656|NCT00256750|324078238|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
94621657|NCT00256750|324078239|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
94621658|NCT00256750|324078240|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
94621659|NCT00256750|324078238|FG000|Post-Transplant Treated (12 Months)|Death|3|||
94668174|NCT02564523|324238537|FG017|Overall Study|Death|0|||
94621660|NCT00256750|324078239|FG001|Post-Transplant Treated (12 Months)|Death|2|||
94621661|NCT00256750|324078240|FG002|Post-Transplant Treated (12 Months)|Death|4|||
94621662|NCT00256750|324078238|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
94621663|NCT00256750|324078239|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
94621664|NCT00256750|324078240|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
94621665|NCT00256750|324078238|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
94621666|NCT00256750|324078239|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
94621667|NCT00256750|324078240|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
94621668|NCT00256750|324078238|FG000|Post-Transplant Treated (12 Months)|Other|5|||
94621669|NCT00256750|324078239|FG001|Post-Transplant Treated (12 Months)|Other|4|||
94621670|NCT00256750|324078240|FG002|Post-Transplant Treated (12 Months)|Other|2|||
94621671|NCT00256750|324078238|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
94621672|NCT00256750|324078239|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
94621673|NCT00256750|324078240|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
94621674|NCT00256750|324078238|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
94621675|NCT00256750|324078239|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
94621676|NCT00256750|324078240|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
94621677|NCT00256750|324078238|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
94668175|NCT02564523|324238520|FG000|Overall Study|Lost to Follow-up|2|||
94668176|NCT02564523|324238521|FG001|Overall Study|Lost to Follow-up|1|||
94668177|NCT02564523|324238522|FG002|Overall Study|Lost to Follow-up|4|||
94668178|NCT02564523|324238523|FG003|Overall Study|Lost to Follow-up|0|||
94668179|NCT02564523|324238524|FG004|Overall Study|Lost to Follow-up|1|||
94668180|NCT02564523|324238525|FG005|Overall Study|Lost to Follow-up|0|||
94668181|NCT02564523|324238526|FG006|Overall Study|Lost to Follow-up|1|||
94668182|NCT02564523|324238527|FG007|Overall Study|Lost to Follow-up|0|||
94668183|NCT02564523|324238528|FG008|Overall Study|Lost to Follow-up|0|||
94668184|NCT02564523|324238529|FG009|Overall Study|Lost to Follow-up|0|||
94668185|NCT02564523|324238530|FG010|Overall Study|Lost to Follow-up|0|||
94668186|NCT02564523|324238531|FG011|Overall Study|Lost to Follow-up|1|||
94668187|NCT02564523|324238532|FG012|Overall Study|Lost to Follow-up|1|||
94668188|NCT02564523|324238533|FG013|Overall Study|Lost to Follow-up|0|||
94668189|NCT02564523|324238534|FG014|Overall Study|Lost to Follow-up|0|||
94668190|NCT02564523|324238535|FG015|Overall Study|Lost to Follow-up|0|||
94668191|NCT02564523|324238536|FG016|Overall Study|Lost to Follow-up|0|||
94668192|NCT02564523|324238537|FG017|Overall Study|Lost to Follow-up|0|||
94668193|NCT02564523|324238520|FG000|Overall Study|Physician Decision|0|||
94668194|NCT02564523|324238521|FG001|Overall Study|Physician Decision|0|||
94668195|NCT02564523|324238522|FG002|Overall Study|Physician Decision|0|||
94668196|NCT02564523|324238523|FG003|Overall Study|Physician Decision|0|||
94668197|NCT02564523|324238524|FG004|Overall Study|Physician Decision|1|||
94668198|NCT02564523|324238525|FG005|Overall Study|Physician Decision|0|||
94668199|NCT02564523|324238526|FG006|Overall Study|Physician Decision|0|||
94668200|NCT02564523|324238527|FG007|Overall Study|Physician Decision|0|||
94668201|NCT02564523|324238528|FG008|Overall Study|Physician Decision|0|||
94668202|NCT02564523|324238529|FG009|Overall Study|Physician Decision|0|||
94668203|NCT02564523|324238530|FG010|Overall Study|Physician Decision|1|||
94668204|NCT02564523|324238531|FG011|Overall Study|Physician Decision|0|||
94668205|NCT02564523|324238532|FG012|Overall Study|Physician Decision|0|||
94668206|NCT02564523|324238533|FG013|Overall Study|Physician Decision|0|||
94668207|NCT02564523|324238534|FG014|Overall Study|Physician Decision|0|||
94668208|NCT02564523|324238535|FG015|Overall Study|Physician Decision|0|||
94668209|NCT02564523|324238536|FG016|Overall Study|Physician Decision|0|||
94668210|NCT02564523|324238537|FG017|Overall Study|Physician Decision|0|||
94668211|NCT02564523|324238520|FG000|Overall Study|Protocol Violation|2|||
94668212|NCT02564523|324238521|FG001|Overall Study|Protocol Violation|2|||
94668213|NCT02564523|324238522|FG002|Overall Study|Protocol Violation|5|||
94668214|NCT02564523|324238523|FG003|Overall Study|Protocol Violation|0|||
94668215|NCT02564523|324238524|FG004|Overall Study|Protocol Violation|1|||
94668216|NCT02564523|324238525|FG005|Overall Study|Protocol Violation|0|||
94668217|NCT02564523|324238526|FG006|Overall Study|Protocol Violation|0|||
94668218|NCT02564523|324238527|FG007|Overall Study|Protocol Violation|0|||
94668219|NCT02564523|324238528|FG008|Overall Study|Protocol Violation|0|||
94668220|NCT02564523|324238529|FG009|Overall Study|Protocol Violation|0|||
94668221|NCT02564523|324238530|FG010|Overall Study|Protocol Violation|0|||
94668222|NCT02564523|324238531|FG011|Overall Study|Protocol Violation|0|||
94668223|NCT02564523|324238532|FG012|Overall Study|Protocol Violation|0|||
94668224|NCT02564523|324238533|FG013|Overall Study|Protocol Violation|0|||
94668225|NCT02564523|324238534|FG014|Overall Study|Protocol Violation|0|||
94668226|NCT02564523|324238535|FG015|Overall Study|Protocol Violation|0|||
94668227|NCT02564523|324238536|FG016|Overall Study|Protocol Violation|0|||
94668228|NCT02564523|324238537|FG017|Overall Study|Protocol Violation|0|||
94668229|NCT02564523|324238520|FG000|Overall Study|Other|3|||
94668230|NCT02564523|324238521|FG001|Overall Study|Other|0|||
94668231|NCT02564523|324238522|FG002|Overall Study|Other|0|||
94668232|NCT02564523|324238523|FG003|Overall Study|Other|1|||
94668233|NCT02564523|324238524|FG004|Overall Study|Other|0|||
94668234|NCT02564523|324238525|FG005|Overall Study|Other|0|||
94668235|NCT02564523|324238526|FG006|Overall Study|Other|0|||
94668236|NCT02564523|324238527|FG007|Overall Study|Other|0|||
94668237|NCT02564523|324238528|FG008|Overall Study|Other|0|||
94668238|NCT02564523|324238529|FG009|Overall Study|Other|0|||
94668239|NCT02564523|324238530|FG010|Overall Study|Other|0|||
94668240|NCT02564523|324238531|FG011|Overall Study|Other|0|||
94668241|NCT02564523|324238532|FG012|Overall Study|Other|0|||
94668242|NCT02564523|324238533|FG013|Overall Study|Other|0|||
94668243|NCT02564523|324238534|FG014|Overall Study|Other|0|||
94668244|NCT02564523|324238535|FG015|Overall Study|Other|0|||
94668245|NCT02564523|324238536|FG016|Overall Study|Other|0|||
94668246|NCT02564523|324238537|FG017|Overall Study|Other|0|||
94668247|NCT02103439|324238539|FG000|Overall Study|Adverse Event|0|||
94668248|NCT02103439|324238540|FG001|Overall Study|Adverse Event|2|||
94668249|NCT02103439|324238539|FG000|Overall Study|Withdrawal by Subject|3|||
94668250|NCT02103439|324238540|FG001|Overall Study|Withdrawal by Subject|1|||
94668251|NCT04447404|324238541|FG000|Overall Study|Death|2|||
94668252|NCT04447404|324238542|FG001|Overall Study|Death|0|||
94668253|NCT03905655|324238543|FG000|Overall Study|Adverse Event|1|||
94668254|NCT03905655|324238544|FG001|Overall Study|Adverse Event|0|||
94668255|NCT03905655|324238545|FG002|Overall Study|Adverse Event|1|||
94668256|NCT03905655|324238546|FG003|Overall Study|Adverse Event|1|||
94668257|NCT02566031|324238547|FG000|Overall Study|Patient/guardian decision|14|||
94621678|NCT00256750|324078239|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
94621679|NCT00256750|324078240|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
94621680|NCT00256750|324078238|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
94621681|NCT00256750|324078239|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
94621682|NCT00256750|324078240|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
94621683|NCT00256750|324078238|FG000|Post-Transplant Treated (24 Months)|Death|3|||
94621684|NCT00256750|324078239|FG001|Post-Transplant Treated (24 Months)|Death|0|||
94621685|NCT00256750|324078240|FG002|Post-Transplant Treated (24 Months)|Death|0|||
94621686|NCT00256750|324078238|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
94621687|NCT00256750|324078239|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
94621688|NCT00256750|324078240|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
94621689|NCT00256750|324078238|FG000|Post-Transplant Treated (24 Months)|Other|2|||
94621690|NCT00256750|324078239|FG001|Post-Transplant Treated (24 Months)|Other|0|||
94621691|NCT00256750|324078240|FG002|Post-Transplant Treated (24 Months)|Other|1|||
94621692|NCT00256750|324078238|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
94621693|NCT00256750|324078239|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
94621694|NCT00256750|324078240|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
94621695|NCT00256750|324078238|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
94621696|NCT00256750|324078239|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
94621697|NCT00256750|324078240|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
94621698|NCT00256750|324078238|FG000|Post-Transplant Treated (36 Months)|Death|0|||
94621699|NCT00256750|324078239|FG001|Post-Transplant Treated (36 Months)|Death|2|||
94621700|NCT00256750|324078240|FG002|Post-Transplant Treated (36 Months)|Death|1|||
94621701|NCT00256750|324078238|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
94621702|NCT00256750|324078239|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
94621703|NCT00256750|324078240|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
94621704|NCT00256750|324078238|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
94621705|NCT00256750|324078239|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
94621706|NCT00256750|324078240|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
94621707|NCT00256750|324078238|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
94621708|NCT00256750|324078239|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
94621709|NCT00256750|324078240|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
94621710|NCT00256750|324078238|FG000|Post-Transplant Treated (36 Months)|Other|0|||
94621711|NCT00256750|324078239|FG001|Post-Transplant Treated (36 Months)|Other|1|||
94621712|NCT00256750|324078240|FG002|Post-Transplant Treated (36 Months)|Other|1|||
94621713|NCT00256750|324078238|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
94621714|NCT00256750|324078239|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
94621715|NCT00256750|324078240|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
94621716|NCT00256750|324078238|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
94621717|NCT00256750|324078239|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
94621718|NCT00256750|324078240|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
94621719|NCT00256750|324078238|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
94621720|NCT00256750|324078239|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
94621721|NCT00256750|324078240|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
94621722|NCT00256750|324078238|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
94621723|NCT00256750|324078239|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
94621724|NCT00256750|324078240|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
94621725|NCT00256750|324078238|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
94621726|NCT00256750|324078239|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
94621727|NCT00256750|324078240|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
94621728|NCT00256750|324078238|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
94621729|NCT00256750|324078239|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
94621730|NCT00256750|324078240|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
94621731|NCT00256750|324078238|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
94621732|NCT00256750|324078239|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
94621733|NCT00256750|324078240|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
94621734|NCT00256750|324078238|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
94621735|NCT00256750|324078239|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
94621736|NCT00256750|324078240|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
94621737|NCT00256750|324078238|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
94621738|NCT00256750|324078239|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
94621739|NCT00256750|324078240|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
94621740|NCT03727347|324078245|FG000|Overall Study|Withdrawal by Subject|2|||
94621741|NCT03727347|324078245|FG000|Overall Study|Lost to Follow-up|1|||
94621742|NCT03547583|324078246|FG000|Overall Study|Adverse Event|16|||
94621743|NCT03547583|324078247|FG001|Overall Study|Adverse Event|11|||
94668258|NCT02566031|324238548|FG001|Overall Study|Patient/guardian decision|7|||
94668259|NCT02566031|324238547|FG000|Overall Study|Protocol deviation|2|||
94621744|NCT03547583|324078248|FG002|Overall Study|Adverse Event|10|||
94621745|NCT03547583|324078246|FG000|Overall Study|Death|11|||
94621746|NCT03547583|324078247|FG001|Overall Study|Death|7|||
94621747|NCT03547583|324078248|FG002|Overall Study|Death|4|||
94621748|NCT03547583|324078246|FG000|Overall Study|Lost to Follow-up|1|||
94621749|NCT03547583|324078247|FG001|Overall Study|Lost to Follow-up|0|||
94621750|NCT03547583|324078248|FG002|Overall Study|Lost to Follow-up|0|||
94621751|NCT03547583|324078246|FG000|Overall Study|Non-compliance with study drug|0|||
94621752|NCT03547583|324078247|FG001|Overall Study|Non-compliance with study drug|0|||
94621753|NCT03547583|324078248|FG002|Overall Study|Non-compliance with study drug|1|||
94621754|NCT03547583|324078246|FG000|Overall Study|Physician Decision|1|||
94621755|NCT03547583|324078247|FG001|Overall Study|Physician Decision|0|||
94621756|NCT03547583|324078248|FG002|Overall Study|Physician Decision|3|||
94621757|NCT03547583|324078246|FG000|Overall Study|Protocol Violation|2|||
94621758|NCT03547583|324078247|FG001|Overall Study|Protocol Violation|1|||
94621759|NCT03547583|324078248|FG002|Overall Study|Protocol Violation|1|||
94621760|NCT03547583|324078246|FG000|Overall Study|Withdrawal by Subject|12|||
94621761|NCT03547583|324078247|FG001|Overall Study|Withdrawal by Subject|19|||
94621762|NCT03547583|324078248|FG002|Overall Study|Withdrawal by Subject|10|||
94621763|NCT03547583|324078246|FG000|Overall Study|Other|2|||
94621764|NCT03547583|324078247|FG001|Overall Study|Other|2|||
94621765|NCT03547583|324078248|FG002|Overall Study|Other|3|||
94621766|NCT00211510|324078249|FG000|Overall Study|Physician Decision|3|||
94621767|NCT00211510|324078250|FG001|Overall Study|Physician Decision|1|||
94621768|NCT00211510|324078249|FG000|Overall Study|Withdrawal by Subject|3|||
94621769|NCT00211510|324078250|FG001|Overall Study|Withdrawal by Subject|1|||
94621770|NCT00382252|324078251|FG000|Overall Study|Death|4|||
94621771|NCT00382252|324078251|FG000|Overall Study|Protocol Violation|8|||
94621772|NCT00382252|324078251|FG000|Overall Study|Not treated by RFA|1|||
94621773|NCT01487200|324078252|FG000|Overall Study|Withdrawal by Subject|0|||
94621774|NCT01487200|324078253|FG001|Overall Study|Withdrawal by Subject|1|||
94621775|NCT01487200|324078254|FG002|Overall Study|Withdrawal by Subject|0|||
94621776|NCT01487200|324078255|FG003|Overall Study|Withdrawal by Subject|0|||
94621777|NCT03338998|324078260|FG000|Treatment Period|Withdrawal by Subject|1|||
94621778|NCT03338998|324078261|FG001|Treatment Period|Withdrawal by Subject|1|||
94621779|NCT03338998|324078260|FG000|Treatment Period|Adverse Event|0|||
94621780|NCT03338998|324078261|FG001|Treatment Period|Adverse Event|2|||
94621781|NCT03338998|324078260|FG000|Treatment Period|Protocol deviation|1|||
94621782|NCT03338998|324078261|FG001|Treatment Period|Protocol deviation|0|||
94621783|NCT03338998|324078260|FG000|Treatment Period|Physician Decision|2|||
94621784|NCT03338998|324078261|FG001|Treatment Period|Physician Decision|0|||
94621785|NCT03338998|324078260|FG000|Treatment Period|Subject failed swallow test|4|||
94621786|NCT03338998|324078261|FG001|Treatment Period|Subject failed swallow test|0|||
94621787|NCT03338998|324078260|FG000|Safety Follow-Up Period|Adverse Event|0|||
94621788|NCT03338998|324078261|FG001|Safety Follow-Up Period|Adverse Event|1|||
94621789|NCT03338998|324078260|FG000|Safety Follow-Up Period|Protocol deviation|1|||
94621790|NCT03338998|324078261|FG001|Safety Follow-Up Period|Protocol deviation|0|||
94621791|NCT03338998|324078260|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
94621792|NCT03338998|324078261|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
94621793|NCT03288129|324078262|FG000|Overall Study|Adverse Event|10|||
94621794|NCT03288129|324078262|FG000|Overall Study|Lost to Follow-up|3|||
94621795|NCT03288129|324078262|FG000|Overall Study|Withdrawal by Subject|3|||
94621796|NCT03288129|324078262|FG000|Overall Study|Withdrawal of consent/assent|1|||
94621797|NCT03288129|324078262|FG000|Overall Study|Other|5|||
94621798|NCT02862171|324078267|FG000|Overall Study|Death|1|||
94621799|NCT02862171|324078267|FG000|Overall Study|Lost to Follow-up|13|||
94621800|NCT02862171|324078267|FG000|Overall Study|Withdrawal by Subject|57|||
94621801|NCT02862171|324078267|FG000|Overall Study|Non-compliance|4|||
94621802|NCT02862171|324078267|FG000|Overall Study|HIV-1 seroconversion|18|||
94621803|NCT00558558|324078268|FG000|Overall Study|Unable to swallow|1|||
94621804|NCT00558558|324078268|FG000|Overall Study|Withdrawal by Subject|1|||
94621805|NCT00558558|324078268|FG000|Overall Study|Lack of Efficacy|4|||
94621806|NCT02549937|324078269|FG000|Overall Study|Death|0|||
94668260|NCT02566031|324238548|FG001|Overall Study|Protocol deviation|3|||
94621807|NCT02549937|324078270|FG001|Overall Study|Death|1|||
94621808|NCT02549937|324078271|FG002|Overall Study|Death|0|||
94621809|NCT02549937|324078272|FG003|Overall Study|Death|1|||
94621810|NCT02549937|324078273|FG004|Overall Study|Death|0|||
94621811|NCT02549937|324078274|FG005|Overall Study|Death|8|||
94621812|NCT02549937|324078275|FG006|Overall Study|Death|0|||
94621813|NCT02549937|324078276|FG007|Overall Study|Death|0|||
94621814|NCT02549937|324078277|FG008|Overall Study|Death|19|||
94621815|NCT02549937|324078269|FG000|Overall Study|No follow up required|3|||
94668261|NCT02566031|324238547|FG000|Overall Study|Adverse Event|3|||
94621816|NCT02549937|324078270|FG001|Overall Study|No follow up required|6|||
94621817|NCT02549937|324078271|FG002|Overall Study|No follow up required|3|||
94621818|NCT02549937|324078272|FG003|Overall Study|No follow up required|8|||
94621819|NCT02549937|324078273|FG004|Overall Study|No follow up required|12|||
94621820|NCT02549937|324078274|FG005|Overall Study|No follow up required|21|||
94621821|NCT02549937|324078275|FG006|Overall Study|No follow up required|9|||
94621822|NCT02549937|324078276|FG007|Overall Study|No follow up required|11|||
94621823|NCT02549937|324078277|FG008|Overall Study|No follow up required|0|||
94621824|NCT02549937|324078269|FG000|Overall Study|Other|0|||
94621825|NCT02549937|324078270|FG001|Overall Study|Other|0|||
94621826|NCT02549937|324078271|FG002|Overall Study|Other|0|||
94621827|NCT02549937|324078272|FG003|Overall Study|Other|0|||
94621828|NCT02549937|324078273|FG004|Overall Study|Other|1|||
94621829|NCT02549937|324078274|FG005|Overall Study|Other|0|||
94621830|NCT02549937|324078275|FG006|Overall Study|Other|3|||
94621831|NCT02549937|324078276|FG007|Overall Study|Other|2|||
94621832|NCT02549937|324078277|FG008|Overall Study|Other|3|||
94621833|NCT02549937|324078269|FG000|Overall Study|Lost to Follow-up|0|||
94621834|NCT02549937|324078270|FG001|Overall Study|Lost to Follow-up|0|||
94621835|NCT02549937|324078271|FG002|Overall Study|Lost to Follow-up|0|||
94621836|NCT02549937|324078272|FG003|Overall Study|Lost to Follow-up|0|||
94621837|NCT02549937|324078273|FG004|Overall Study|Lost to Follow-up|0|||
94621838|NCT02549937|324078274|FG005|Overall Study|Lost to Follow-up|0|||
94621839|NCT02549937|324078275|FG006|Overall Study|Lost to Follow-up|0|||
94621840|NCT02549937|324078276|FG007|Overall Study|Lost to Follow-up|0|||
94621841|NCT02549937|324078277|FG008|Overall Study|Lost to Follow-up|3|||
94621842|NCT02549937|324078269|FG000|Overall Study|Withdrawal by Subject|0|||
94621843|NCT02549937|324078270|FG001|Overall Study|Withdrawal by Subject|0|||
94621844|NCT02549937|324078271|FG002|Overall Study|Withdrawal by Subject|0|||
94621845|NCT02549937|324078272|FG003|Overall Study|Withdrawal by Subject|0|||
94621846|NCT02549937|324078273|FG004|Overall Study|Withdrawal by Subject|0|||
94621847|NCT02549937|324078274|FG005|Overall Study|Withdrawal by Subject|1|||
94621848|NCT02549937|324078275|FG006|Overall Study|Withdrawal by Subject|4|||
94621849|NCT02549937|324078276|FG007|Overall Study|Withdrawal by Subject|3|||
94621850|NCT02549937|324078277|FG008|Overall Study|Withdrawal by Subject|2|||
94621851|NCT02549937|324078269|FG000|Overall Study|Sponsor Decision|0|||
94621852|NCT02549937|324078270|FG001|Overall Study|Sponsor Decision|0|||
94621853|NCT02549937|324078271|FG002|Overall Study|Sponsor Decision|0|||
94621854|NCT02549937|324078272|FG003|Overall Study|Sponsor Decision|0|||
94621855|NCT02549937|324078273|FG004|Overall Study|Sponsor Decision|0|||
94621856|NCT02549937|324078274|FG005|Overall Study|Sponsor Decision|0|||
94621857|NCT02549937|324078275|FG006|Overall Study|Sponsor Decision|0|||
94621858|NCT02549937|324078276|FG007|Overall Study|Sponsor Decision|0|||
94621859|NCT02549937|324078277|FG008|Overall Study|Sponsor Decision|6|||
94621860|NCT00662012|324078278|FG000|Overall Study|Lost to Follow-up|85|||
94621861|NCT00662012|324078278|FG000|Overall Study|Death|1|||
94621862|NCT00662012|324078278|FG000|Overall Study|Withdrawal by Subject|1|||
94621863|NCT05570500|324078285|FG000|Overall Study|Lost to Follow-up|7|||
94621864|NCT05570500|324078286|FG001|Overall Study|Lost to Follow-up|5|||
94621865|NCT00317356|324078287|FG000|Overall Study|Adverse Event|0|||
94621866|NCT00317356|324078288|FG001|Overall Study|Adverse Event|0|||
94621867|NCT00317356|324078289|FG002|Overall Study|Adverse Event|1|||
94621868|NCT00317356|324078290|FG003|Overall Study|Adverse Event|0|||
94621869|NCT00317356|324078287|FG000|Overall Study|Lack of Efficacy|1|||
94621870|NCT00317356|324078288|FG001|Overall Study|Lack of Efficacy|1|||
94621871|NCT00317356|324078289|FG002|Overall Study|Lack of Efficacy|0|||
94621872|NCT00317356|324078290|FG003|Overall Study|Lack of Efficacy|3|||
94621873|NCT00317356|324078287|FG000|Overall Study|Physician Decision|0|||
94621874|NCT00317356|324078288|FG001|Overall Study|Physician Decision|1|||
94621875|NCT00317356|324078289|FG002|Overall Study|Physician Decision|0|||
94621876|NCT00317356|324078290|FG003|Overall Study|Physician Decision|0|||
94621877|NCT02612727|324078291|FG000|Overall Study|Parent request|4|||
94621878|NCT02612727|324078292|FG001|Overall Study|Parent request|1|||
94621879|NCT02612727|324078291|FG000|Overall Study|Needed treatment incompatible with PT|1|||
94668262|NCT02566031|324238548|FG001|Overall Study|Adverse Event|1|||
94668263|NCT02566031|324238547|FG000|Overall Study|Lost to Follow-up|1|||
94668264|NCT02566031|324238548|FG001|Overall Study|Lost to Follow-up|1|||
94668265|NCT03204279|324238549|FG000|Overall Study|Withdrawal by Subject|0|||
94668266|NCT03204279|324238550|FG001|Overall Study|Withdrawal by Subject|1|||
94668267|NCT02277106|324238551|FG000|Stage 2|Adverse Event|0|||
94668268|NCT02277106|324238552|FG001|Stage 2|Adverse Event|0|||
94668269|NCT02277106|324238553|FG002|Stage 2|Adverse Event|1|||
94668270|NCT01064739|324238554|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
94668271|NCT01260350|324238561|FG000|Overall Study|Lack of Efficacy|0|||
94668272|NCT01260350|324238562|FG001|Overall Study|Lack of Efficacy|0|||
94668273|NCT01260350|324238563|FG002|Overall Study|Lack of Efficacy|0|||
94668274|NCT01260350|324238564|FG003|Overall Study|Lack of Efficacy|0|||
94668275|NCT01260350|324238565|FG004|Overall Study|Lack of Efficacy|0|||
94668276|NCT01260350|324238566|FG005|Overall Study|Lack of Efficacy|0|||
94668277|NCT01260350|324238567|FG006|Overall Study|Lack of Efficacy|0|||
94668278|NCT01260350|324238568|FG007|Overall Study|Lack of Efficacy|0|||
94668279|NCT01260350|324238569|FG008|Overall Study|Lack of Efficacy|0|||
94668280|NCT01260350|324238570|FG009|Overall Study|Lack of Efficacy|0|||
94668281|NCT01260350|324238571|FG010|Overall Study|Lack of Efficacy|0|||
94668282|NCT01260350|324238572|FG011|Overall Study|Lack of Efficacy|0|||
94668283|NCT01260350|324238573|FG012|Overall Study|Lack of Efficacy|0|||
94668284|NCT01260350|324238574|FG013|Overall Study|Lack of Efficacy|0|||
94668285|NCT01260350|324238575|FG014|Overall Study|Lack of Efficacy|0|||
94668286|NCT01260350|324238576|FG015|Overall Study|Lack of Efficacy|0|||
94668287|NCT01260350|324238577|FG016|Overall Study|Lack of Efficacy|0|||
94668288|NCT01260350|324238578|FG017|Overall Study|Lack of Efficacy|1|||
94668289|NCT01260350|324238579|FG018|Overall Study|Lack of Efficacy|0|||
94668290|NCT01260350|324238580|FG019|Overall Study|Lack of Efficacy|0|||
94668291|NCT01260350|324238581|FG020|Overall Study|Lack of Efficacy|3|||
94668292|NCT01260350|324238582|FG021|Overall Study|Lack of Efficacy|0|||
94668293|NCT01260350|324238561|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668294|NCT01260350|324238562|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668295|NCT01260350|324238563|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668296|NCT01260350|324238564|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668297|NCT01260350|324238565|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668298|NCT01260350|324238566|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668299|NCT01260350|324238567|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668300|NCT01260350|324238568|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668301|NCT01260350|324238569|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
94668302|NCT01260350|324238570|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668303|NCT01260350|324238571|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668304|NCT01260350|324238572|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668305|NCT01260350|324238573|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668306|NCT01260350|324238574|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668307|NCT01260350|324238575|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668308|NCT01260350|324238576|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668309|NCT01260350|324238577|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668310|NCT01260350|324238578|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668311|NCT01260350|324238579|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668312|NCT01260350|324238580|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668313|NCT01260350|324238581|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668314|NCT01260350|324238582|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
94668315|NCT03966157|324238585|FG000|Overall Study|Physician Decision|1|||
94668316|NCT03966157|324238586|FG001|Overall Study|Physician Decision|0|||
94668317|NCT03568318|324238587|FG000|Overall Study|Adverse Event|3|||
94668318|NCT03568318|324238588|FG001|Overall Study|Adverse Event|1|||
94668319|NCT03568318|324238589|FG002|Overall Study|Adverse Event|1|||
94668320|NCT03568318|324238590|FG003|Overall Study|Adverse Event|0|||
94668321|NCT03568318|324238591|FG004|Overall Study|Adverse Event|1|||
94668322|NCT03568318|324238592|FG005|Overall Study|Adverse Event|0|||
94668323|NCT03568318|324238587|FG000|Overall Study|Withdrawal by Subject|6|||
94668324|NCT03568318|324238588|FG001|Overall Study|Withdrawal by Subject|5|||
94668325|NCT03568318|324238589|FG002|Overall Study|Withdrawal by Subject|2|||
94668326|NCT03568318|324238590|FG003|Overall Study|Withdrawal by Subject|1|||
94668327|NCT03568318|324238591|FG004|Overall Study|Withdrawal by Subject|0|||
94668328|NCT03568318|324238592|FG005|Overall Study|Withdrawal by Subject|0|||
94668329|NCT03568318|324238587|FG000|Overall Study|Lost to Follow-up|3|||
94668330|NCT03568318|324238588|FG001|Overall Study|Lost to Follow-up|2|||
94668331|NCT03568318|324238589|FG002|Overall Study|Lost to Follow-up|2|||
94668332|NCT03568318|324238590|FG003|Overall Study|Lost to Follow-up|2|||
94668333|NCT03568318|324238591|FG004|Overall Study|Lost to Follow-up|1|||
94668334|NCT03568318|324238592|FG005|Overall Study|Lost to Follow-up|0|||
94668335|NCT03568318|324238587|FG000|Overall Study|Other|3|||
94668336|NCT03568318|324238588|FG001|Overall Study|Other|1|||
94668337|NCT03568318|324238589|FG002|Overall Study|Other|3|||
94668338|NCT03568318|324238590|FG003|Overall Study|Other|0|||
94668339|NCT03568318|324238591|FG004|Overall Study|Other|0|||
94621880|NCT02612727|324078292|FG001|Overall Study|Needed treatment incompatible with PT|1|||
94621881|NCT02612727|324078291|FG000|Overall Study|Direct hyperbilirubinemia|0|||
94621882|NCT02612727|324078292|FG001|Overall Study|Direct hyperbilirubinemia|2|||
94621883|NCT01949506|324078298|FG000|Overall Study|Physician Decision|1|||
94621884|NCT05059600|324078300|FG000|Overall Study|Enrolled but not Treated|10|||
94621885|NCT00621153|324078301|FG000|Overall Study|Safety Reason|8|||
94621886|NCT00621153|324078302|FG001|Overall Study|Safety Reason|7|||
94621887|NCT00621153|324078301|FG000|Overall Study|Adverse Event|3|||
94621888|NCT00621153|324078302|FG001|Overall Study|Adverse Event|2|||
94621889|NCT00621153|324078301|FG000|Overall Study|Lost to Follow-up|5|||
94621890|NCT00621153|324078302|FG001|Overall Study|Lost to Follow-up|1|||
94621891|NCT00621153|324078301|FG000|Overall Study|Withdrawal by Subject|4|||
94621892|NCT00621153|324078302|FG001|Overall Study|Withdrawal by Subject|5|||
94621893|NCT03919799|324078305|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
94621894|NCT03919799|324078306|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
94621895|NCT03919799|324078307|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
94621896|NCT03919799|324078308|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
94359500|NCT05275673|323100335|FG001|Overall Study|Withdrawal by Subject|0|||
94621897|NCT03919799|324078309|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
94621898|NCT03919799|324078305|FG000|DB Period (28 Weeks)|Adverse Event|1|||
94621899|NCT03919799|324078306|FG001|DB Period (28 Weeks)|Adverse Event|1|||
94621900|NCT03919799|324078307|FG002|DB Period (28 Weeks)|Adverse Event|1|||
94359501|NCT04668066|323100336|FG000|Part 1: Treatment Phase|Adverse Event|0|||
94621901|NCT03919799|324078308|FG003|DB Period (28 Weeks)|Adverse Event|0|||
94621902|NCT03919799|324078309|FG004|DB Period (28 Weeks)|Adverse Event|0|||
94621903|NCT03919799|324078305|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
94621904|NCT03919799|324078306|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
94621905|NCT03919799|324078307|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
94621906|NCT03919799|324078308|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
94621907|NCT03919799|324078309|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
94621908|NCT03919799|324078305|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
94621909|NCT03919799|324078306|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
94621910|NCT03919799|324078307|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
94621911|NCT03919799|324078308|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
94621912|NCT03919799|324078309|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
94621913|NCT03919799|324078305|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
94621914|NCT03919799|324078306|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
94621915|NCT03919799|324078307|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
94621916|NCT03919799|324078308|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
94621917|NCT03919799|324078309|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
94621918|NCT02915016|324078311|FG000|Overall Study|Lost to Follow-up|4|||
94621919|NCT02915016|324078312|FG001|Overall Study|Lost to Follow-up|2|||
94621920|NCT02915016|324078313|FG002|Overall Study|Lost to Follow-up|5|||
94621921|NCT02915016|324078314|FG003|Overall Study|Lost to Follow-up|3|||
94621922|NCT02915016|324078315|FG004|Overall Study|Lost to Follow-up|5|||
94621923|NCT02915016|324078316|FG005|Overall Study|Lost to Follow-up|2|||
94621924|NCT02915016|324078317|FG006|Overall Study|Lost to Follow-up|8|||
94621925|NCT02915016|324078318|FG007|Overall Study|Lost to Follow-up|2|||
94621926|NCT02915016|324078311|FG000|Overall Study|Physician Decision|0|||
94621927|NCT02915016|324078312|FG001|Overall Study|Physician Decision|0|||
94621928|NCT02915016|324078313|FG002|Overall Study|Physician Decision|1|||
94621929|NCT02915016|324078314|FG003|Overall Study|Physician Decision|0|||
94621930|NCT02915016|324078315|FG004|Overall Study|Physician Decision|0|||
94621931|NCT02915016|324078316|FG005|Overall Study|Physician Decision|1|||
94621932|NCT02915016|324078317|FG006|Overall Study|Physician Decision|2|||
94621933|NCT02915016|324078318|FG007|Overall Study|Physician Decision|0|||
94621934|NCT02915016|324078311|FG000|Overall Study|Withdrawal by Subject|2|||
94621935|NCT02915016|324078312|FG001|Overall Study|Withdrawal by Subject|0|||
94621936|NCT02915016|324078313|FG002|Overall Study|Withdrawal by Subject|1|||
94621937|NCT02915016|324078314|FG003|Overall Study|Withdrawal by Subject|0|||
94621938|NCT02915016|324078315|FG004|Overall Study|Withdrawal by Subject|1|||
94621939|NCT02915016|324078316|FG005|Overall Study|Withdrawal by Subject|3|||
94621940|NCT02915016|324078317|FG006|Overall Study|Withdrawal by Subject|1|||
94621941|NCT02915016|324078318|FG007|Overall Study|Withdrawal by Subject|1|||
94621942|NCT02915016|324078311|FG000|Overall Study|Elected not to continue|0|||
94621943|NCT02915016|324078312|FG001|Overall Study|Elected not to continue|0|||
94621944|NCT02915016|324078313|FG002|Overall Study|Elected not to continue|0|||
94621945|NCT02915016|324078314|FG003|Overall Study|Elected not to continue|1|||
94621946|NCT02915016|324078315|FG004|Overall Study|Elected not to continue|0|||
94621947|NCT02915016|324078316|FG005|Overall Study|Elected not to continue|0|||
94621948|NCT02915016|324078317|FG006|Overall Study|Elected not to continue|1|||
94621949|NCT02915016|324078318|FG007|Overall Study|Elected not to continue|0|||
94621950|NCT02915016|324078311|FG000|Overall Study|HIV infection|1|||
94621951|NCT02915016|324078312|FG001|Overall Study|HIV infection|1|||
94621952|NCT02915016|324078313|FG002|Overall Study|HIV infection|1|||
94621953|NCT02915016|324078314|FG003|Overall Study|HIV infection|0|||
94621954|NCT02915016|324078315|FG004|Overall Study|HIV infection|1|||
94621955|NCT02915016|324078316|FG005|Overall Study|HIV infection|0|||
94621956|NCT02915016|324078317|FG006|Overall Study|HIV infection|0|||
94621957|NCT02915016|324078318|FG007|Overall Study|HIV infection|0|||
94621958|NCT02915016|324078311|FG000|Overall Study|Participant unable to adhere|0|||
94621959|NCT02915016|324078312|FG001|Overall Study|Participant unable to adhere|0|||
94621960|NCT02915016|324078313|FG002|Overall Study|Participant unable to adhere|0|||
94621961|NCT02915016|324078314|FG003|Overall Study|Participant unable to adhere|0|||
94621962|NCT02915016|324078315|FG004|Overall Study|Participant unable to adhere|0|||
94621963|NCT02915016|324078316|FG005|Overall Study|Participant unable to adhere|0|||
94621964|NCT02915016|324078317|FG006|Overall Study|Participant unable to adhere|0|||
94621965|NCT02915016|324078318|FG007|Overall Study|Participant unable to adhere|1|||
94621966|NCT02578316|324078319|FG000|Extension Phase|Progression of disease|6|||
94621967|NCT03000439|324079885|FG000|Open Label Part 1|Adverse Event|6|||
94621968|NCT03000439|324079886|FG001|Open Label Part 1|Adverse Event|0|||
94621969|NCT03000439|324079887|FG002|Open Label Part 1|Adverse Event|0|||
94621970|NCT03000439|324079888|FG003|Open Label Part 1|Adverse Event|0|||
94621971|NCT03000439|324079885|FG000|Open Label Part 1|Other|2|||
94621972|NCT03000439|324079886|FG001|Open Label Part 1|Other|0|||
94621973|NCT03000439|324079887|FG002|Open Label Part 1|Other|0|||
94621974|NCT03000439|324079888|FG003|Open Label Part 1|Other|0|||
94621975|NCT03000439|324079885|FG000|Open Label Part 1|Insufficient clinical response|16|||
94621976|NCT03000439|324079886|FG001|Open Label Part 1|Insufficient clinical response|0|||
94621977|NCT03000439|324079887|FG002|Open Label Part 1|Insufficient clinical response|0|||
94359502|NCT04668066|323100337|FG001|Part 1: Treatment Phase|Adverse Event|0|||
94359503|NCT04668066|323100338|FG002|Part 1: Treatment Phase|Adverse Event|0|||
94359504|NCT04668066|323100339|FG003|Part 1: Treatment Phase|Adverse Event|0|||
94359505|NCT04668066|323100340|FG004|Part 1: Treatment Phase|Adverse Event|0|||
94359506|NCT04668066|323100341|FG005|Part 1: Treatment Phase|Adverse Event|0|||
94359507|NCT04668066|323100342|FG006|Part 1: Treatment Phase|Adverse Event|0|||
94621978|NCT03000439|324079888|FG003|Open Label Part 1|Insufficient clinical response|0|||
94621979|NCT03000439|324079885|FG000|Open Label Part 2|Other|0|||
94621980|NCT03000439|324079886|FG001|Open Label Part 2|Other|5|||
94621981|NCT03000439|324079887|FG002|Open Label Part 2|Other|0|||
94621982|NCT03000439|324079888|FG003|Open Label Part 2|Other|0|||
94621983|NCT03000439|324079885|FG000|Open Label Part 2|Insufficient clinical response|0|||
94621984|NCT03000439|324079886|FG001|Open Label Part 2|Insufficient clinical response|12|||
94621985|NCT03000439|324079887|FG002|Open Label Part 2|Insufficient clinical response|0|||
94621986|NCT03000439|324079888|FG003|Open Label Part 2|Insufficient clinical response|0|||
94621987|NCT03000439|324079885|FG000|Double Blind Phase|Adverse Event|0|||
94621988|NCT03000439|324079886|FG001|Double Blind Phase|Adverse Event|0|||
94621989|NCT03000439|324079887|FG002|Double Blind Phase|Adverse Event|2|||
94621990|NCT03000439|324079888|FG003|Double Blind Phase|Adverse Event|1|||
94621991|NCT03000439|324079885|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
94621992|NCT03000439|324079886|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
94621993|NCT03000439|324079887|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
94621994|NCT03000439|324079888|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
94621995|NCT03000439|324079885|FG000|Double Blind Phase|Other|0|||
94621996|NCT03000439|324079886|FG001|Double Blind Phase|Other|0|||
94621997|NCT03000439|324079887|FG002|Double Blind Phase|Other|10|||
94621998|NCT03000439|324079888|FG003|Double Blind Phase|Other|11|||
94621999|NCT03000439|324079885|FG000|Double Blind Phase|Insufficient clinical response|0|||
94622000|NCT03000439|324079886|FG001|Double Blind Phase|Insufficient clinical response|0|||
94622001|NCT03000439|324079887|FG002|Double Blind Phase|Insufficient clinical response|0|||
94622002|NCT03000439|324079888|FG003|Double Blind Phase|Insufficient clinical response|2|||
94622003|NCT02954237|324079893|FG000|Overall Study|Withdrawal by Subject|25|||
94622004|NCT02954237|324079893|FG000|Overall Study|Missed visit|16|||
94622005|NCT02954237|324079893|FG000|Overall Study|Death|2|||
94622006|NCT00599924|324079894|FG000|Overall Study|Lack of Efficacy|3|||
94622007|NCT00599924|324079895|FG001|Overall Study|Lack of Efficacy|5|||
94622008|NCT00599924|324079896|FG002|Overall Study|Lack of Efficacy|1|||
94622009|NCT00599924|324079897|FG003|Overall Study|Lack of Efficacy|2|||
94622010|NCT00599924|324079898|FG004|Overall Study|Lack of Efficacy|3|||
94622011|NCT00599924|324079899|FG005|Overall Study|Lack of Efficacy|2|||
94622012|NCT00599924|324079900|FG006|Overall Study|Lack of Efficacy|0|||
94622013|NCT00599924|324079894|FG000|Overall Study|Adverse Event|0|||
94622014|NCT00599924|324079895|FG001|Overall Study|Adverse Event|0|||
94622015|NCT00599924|324079896|FG002|Overall Study|Adverse Event|0|||
94622016|NCT00599924|324079897|FG003|Overall Study|Adverse Event|2|||
94622017|NCT00599924|324079898|FG004|Overall Study|Adverse Event|0|||
94622018|NCT00599924|324079899|FG005|Overall Study|Adverse Event|0|||
94622019|NCT00599924|324079900|FG006|Overall Study|Adverse Event|2|||
94359508|NCT04668066|323100343|FG007|Part 1: Treatment Phase|Adverse Event|0|||
94359509|NCT04668066|323100344|FG008|Part 1: Treatment Phase|Adverse Event|0|||
94359510|NCT04668066|323100345|FG009|Part 1: Treatment Phase|Adverse Event|0|||
94359511|NCT04668066|323100346|FG010|Part 1: Treatment Phase|Adverse Event|0|||
94359512|NCT04668066|323100347|FG011|Part 1: Treatment Phase|Adverse Event|1|||
94622020|NCT00599924|324079894|FG000|Overall Study|Death|0|||
94622021|NCT00599924|324079895|FG001|Overall Study|Death|0|||
94622022|NCT00599924|324079896|FG002|Overall Study|Death|0|||
94622023|NCT00599924|324079897|FG003|Overall Study|Death|2|||
94622024|NCT00599924|324079898|FG004|Overall Study|Death|0|||
94622025|NCT00599924|324079899|FG005|Overall Study|Death|2|||
94622026|NCT00599924|324079900|FG006|Overall Study|Death|1|||
94622027|NCT00599924|324079894|FG000|Overall Study|Protocol Violation|0|||
94622028|NCT00599924|324079895|FG001|Overall Study|Protocol Violation|0|||
94622029|NCT00599924|324079896|FG002|Overall Study|Protocol Violation|0|||
94622030|NCT00599924|324079897|FG003|Overall Study|Protocol Violation|1|||
94622031|NCT00599924|324079898|FG004|Overall Study|Protocol Violation|0|||
94622032|NCT00599924|324079899|FG005|Overall Study|Protocol Violation|0|||
94622033|NCT00599924|324079900|FG006|Overall Study|Protocol Violation|0|||
94622034|NCT00599924|324079894|FG000|Overall Study|Withdrawal by Subject|0|||
94622035|NCT00599924|324079895|FG001|Overall Study|Withdrawal by Subject|0|||
94622036|NCT00599924|324079896|FG002|Overall Study|Withdrawal by Subject|1|||
94622037|NCT00599924|324079897|FG003|Overall Study|Withdrawal by Subject|0|||
94622038|NCT00599924|324079898|FG004|Overall Study|Withdrawal by Subject|1|||
94668340|NCT03568318|324238592|FG005|Overall Study|Other|0|||
94359513|NCT04668066|323100348|FG012|Part 1: Treatment Phase|Adverse Event|1|||
94622039|NCT00599924|324079899|FG005|Overall Study|Withdrawal by Subject|0|||
94359514|NCT04668066|323100349|FG013|Part 1: Treatment Phase|Adverse Event|0|||
94622040|NCT00599924|324079900|FG006|Overall Study|Withdrawal by Subject|0|||
94622041|NCT00599924|324079894|FG000|Overall Study|Other|0|||
94622042|NCT00599924|324079895|FG001|Overall Study|Other|0|||
94668341|NCT03568318|324238587|FG000|Overall Study|Ongoing at Time of Analysis|5|||
94668342|NCT03568318|324238588|FG001|Overall Study|Ongoing at Time of Analysis|3|||
94668343|NCT03568318|324238589|FG002|Overall Study|Ongoing at Time of Analysis|2|||
94668344|NCT03568318|324238590|FG003|Overall Study|Ongoing at Time of Analysis|1|||
94668345|NCT03568318|324238591|FG004|Overall Study|Ongoing at Time of Analysis|0|||
94668346|NCT03568318|324238592|FG005|Overall Study|Ongoing at Time of Analysis|0|||
94668347|NCT02278328|324238594|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
94668348|NCT02278328|324238595|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
94668349|NCT02278328|324238596|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
94668350|NCT02278328|324238594|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
94668351|NCT02278328|324238595|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
94668352|NCT02278328|324238596|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
94668353|NCT02278328|324238594|FG000|Neuropsych Screening|incomplete consent|0|||
94668354|NCT02278328|324238595|FG001|Neuropsych Screening|incomplete consent|0|||
94668355|NCT02278328|324238596|FG002|Neuropsych Screening|incomplete consent|2|||
94668356|NCT04307004|324238607|FG000|Randomization 1|Withdrawal by Subject|25|||
94668357|NCT04307004|324238608|FG001|Randomization 1|Withdrawal by Subject|26|||
94668358|NCT04307004|324238609|FG002|Randomization 1|Withdrawal by Subject|0|||
94668359|NCT04307004|324238610|FG003|Randomization 1|Withdrawal by Subject|0|||
94668360|NCT04307004|324238607|FG000|Randomization 2|Withdrawal by Subject|0|||
94668361|NCT04307004|324238608|FG001|Randomization 2|Withdrawal by Subject|0|||
94668362|NCT04307004|324238609|FG002|Randomization 2|Withdrawal by Subject|28|||
94668363|NCT04307004|324238610|FG003|Randomization 2|Withdrawal by Subject|23|||
94668364|NCT04969198|324238614|FG000|Overall Study|Withdrawal by Subject|20|||
94668365|NCT04969198|324238614|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
94668366|NCT04969198|324238614|FG000|Overall Study|Lost to Follow-up|20|||
94668367|NCT01640808|324238615|FG000|Overall Study|Unable to continue dynamic CT|14|||
94668368|NCT01640808|324238616|FG001|Overall Study|Unable to continue dynamic CT|4|||
94668369|NCT01640808|324238615|FG000|Overall Study|Withdrawal by Subject|12|||
94668370|NCT01640808|324238616|FG001|Overall Study|Withdrawal by Subject|4|||
94668371|NCT01640808|324238615|FG000|Overall Study|Lost to Follow-up|4|||
94668372|NCT01640808|324238616|FG001|Overall Study|Lost to Follow-up|0|||
94668373|NCT01640808|324238615|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
94622043|NCT00599924|324079896|FG002|Overall Study|Other|0|||
94622044|NCT00599924|324079897|FG003|Overall Study|Other|1|||
94622045|NCT00599924|324079898|FG004|Overall Study|Other|2|||
94622046|NCT00599924|324079899|FG005|Overall Study|Other|0|||
94622047|NCT00599924|324079900|FG006|Overall Study|Other|2|||
94622048|NCT00630396|324079901|FG000|Overall Study|Death|4|||
94622049|NCT00630396|324079901|FG000|Overall Study|Lost to Follow-up|3|||
94622050|NCT00592384|324079904|FG000|Overall Study|Withdrawal by Subject|5|||
94622051|NCT00592384|324079905|FG001|Overall Study|Withdrawal by Subject|6|||
94622052|NCT01976338|324079906|FG000|Overall Study|Physician Decision|0|||
94622053|NCT01976338|324079907|FG001|Overall Study|Physician Decision|1|||
94622054|NCT01976338|324079906|FG000|Overall Study|Lost to Follow-up|3|||
94622055|NCT01976338|324079907|FG001|Overall Study|Lost to Follow-up|0|||
94622056|NCT01976338|324079906|FG000|Overall Study|Withdrawal by Subject|5|||
94622057|NCT01976338|324079907|FG001|Overall Study|Withdrawal by Subject|2|||
94622058|NCT01976338|324079906|FG000|Overall Study|Adverse Event|5|||
94622059|NCT01976338|324079907|FG001|Overall Study|Adverse Event|1|||
94622060|NCT00777608|324079908|FG000|Overall Study|Lost to Follow-up|1|||
94622061|NCT00777608|324079909|FG001|Overall Study|Lost to Follow-up|1|||
94622062|NCT00777608|324079908|FG000|Overall Study|Withdrawal by Subject|1|||
94622063|NCT00777608|324079909|FG001|Overall Study|Withdrawal by Subject|3|||
94622064|NCT00777608|324079908|FG000|Overall Study|Protocol Violation|1|||
94668374|NCT01640808|324238616|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
94668375|NCT01640808|324238615|FG000|Overall Study|Administration of anticancer drugs|2|||
94668376|NCT01640808|324238616|FG001|Overall Study|Administration of anticancer drugs|1|||
94668377|NCT01640808|324238615|FG000|Overall Study|Physician Decision|19|||
94668378|NCT01640808|324238616|FG001|Overall Study|Physician Decision|5|||
94668379|NCT01640808|324238615|FG000|Overall Study|Randomized but not treated|4|||
94668380|NCT01640808|324238616|FG001|Overall Study|Randomized but not treated|2|||
94668381|NCT04391023|324238617|FG000|Overall Study|Withdrawal by Subject|2|||
94668382|NCT04391023|324238618|FG001|Overall Study|Withdrawal by Subject|2|||
94668383|NCT01381692|324238619|FG000|Overall Study|Adverse Event|1|||
94668384|NCT01381692|324238620|FG001|Overall Study|Adverse Event|0|||
94668385|NCT01381692|324238621|FG002|Overall Study|Adverse Event|0|||
94622065|NCT00777608|324079909|FG001|Overall Study|Protocol Violation|0|||
94668386|NCT01381692|324238622|FG003|Overall Study|Adverse Event|0|||
94668387|NCT01381692|324238623|FG004|Overall Study|Adverse Event|0|||
94622066|NCT00777608|324079908|FG000|Overall Study|Investigator Decision|1|||
94622067|NCT00777608|324079909|FG001|Overall Study|Investigator Decision|2|||
94622068|NCT02228460|324079914|FG000|Overall Study|Adverse Event|1|||
94622069|NCT02228460|324079914|FG000|Overall Study|Lost to Follow-up|1|||
94668388|NCT01381692|324238624|FG005|Overall Study|Adverse Event|0|||
94622070|NCT05683249|324079915|FG000|Overall Study|Adverse Event|3|||
94668389|NCT03695172|324238628|FG000|Overall Study|Withdrawal by Subject|1|||
94668390|NCT03695172|324238629|FG001|Overall Study|Withdrawal by Subject|1|||
94668391|NCT03695172|324238630|FG002|Overall Study|Withdrawal by Subject|0|||
94668392|NCT01572727|324238631|FG000|Overall Study|Adverse Event|43|||
94668393|NCT01572727|324238632|FG001|Overall Study|Adverse Event|15|||
94668394|NCT01572727|324238631|FG000|Overall Study|Lost to Follow-up|1|||
94668395|NCT01572727|324238632|FG001|Overall Study|Lost to Follow-up|1|||
94668396|NCT01572727|324238631|FG000|Overall Study|Physician Decision|23|||
94668397|NCT01572727|324238632|FG001|Overall Study|Physician Decision|9|||
94668398|NCT01572727|324238631|FG000|Overall Study|Progressive disease|59|||
94668399|NCT01572727|324238632|FG001|Overall Study|Progressive disease|82|||
94668400|NCT01572727|324238631|FG000|Overall Study|Protocol Violation|0|||
94668401|NCT01572727|324238632|FG001|Overall Study|Protocol Violation|1|||
94668402|NCT01572727|324238631|FG000|Overall Study|Study terminated by sponsor|61|||
94668403|NCT01572727|324238632|FG001|Overall Study|Study terminated by sponsor|83|||
94668404|NCT01572727|324238631|FG000|Overall Study|Parent/guardian decision|14|||
94668405|NCT01572727|324238632|FG001|Overall Study|Parent/guardian decision|9|||
94668406|NCT01572727|324238631|FG000|Overall Study|Death|2|||
94668407|NCT01572727|324238632|FG001|Overall Study|Death|2|||
94668408|NCT01572727|324238631|FG000|Overall Study|Untreated|4|||
94668409|NCT01572727|324238632|FG001|Overall Study|Untreated|7|||
94668410|NCT00417079|324238637|FG000|Overall Study|Disease progression|267|||
94668411|NCT00417079|324238638|FG001|Overall Study|Disease progression|180|||
94668412|NCT00417079|324238637|FG000|Overall Study|Adverse Event|32|||
94668413|NCT00417079|324238638|FG001|Overall Study|Adverse Event|67|||
94668414|NCT00417079|324238637|FG000|Overall Study|Non-compliance to protocol|0|||
94668415|NCT00417079|324238638|FG001|Overall Study|Non-compliance to protocol|1|||
94668416|NCT00417079|324238637|FG000|Overall Study|Lost to Follow-up|2|||
94668417|NCT00417079|324238638|FG001|Overall Study|Lost to Follow-up|0|||
94668418|NCT00417079|324238637|FG000|Overall Study|Withdrawal by Subject|17|||
94668419|NCT00417079|324238638|FG001|Overall Study|Withdrawal by Subject|8|||
94668420|NCT00417079|324238637|FG000|Overall Study|Not treated|6|||
94668421|NCT00417079|324238638|FG001|Overall Study|Not treated|7|||
94668422|NCT00417079|324238637|FG000|Overall Study|Screened failure|2|||
94668423|NCT00417079|324238638|FG001|Overall Study|Screened failure|1|||
94668424|NCT00417079|324238637|FG000|Overall Study|Investigator's decision|1|||
94668425|NCT00417079|324238638|FG001|Overall Study|Investigator's decision|4|||
94668426|NCT00417079|324238637|FG000|Overall Study|Non-confirmed Disease progression|1|||
94668427|NCT00417079|324238638|FG001|Overall Study|Non-confirmed Disease progression|1|||
94668428|NCT00417079|324238637|FG000|Overall Study|Clinical deterioration|1|||
94668429|NCT00417079|324238638|FG001|Overall Study|Clinical deterioration|0|||
94668430|NCT00417079|324238637|FG000|Overall Study|Screening error|2|||
94668431|NCT00417079|324238638|FG001|Overall Study|Screening error|1|||
94668432|NCT00417079|324238637|FG000|Overall Study|Withdrawal by subject's family|0|||
94668433|NCT00417079|324238638|FG001|Overall Study|Withdrawal by subject's family|1|||
94668434|NCT00417079|324238637|FG000|Overall Study|Patient unable to come to the clinic|0|||
94668435|NCT00417079|324238638|FG001|Overall Study|Patient unable to come to the clinic|1|||
94668436|NCT00417079|324238637|FG000|Overall Study|abnormal liver function tests|0|||
94668437|NCT00417079|324238638|FG001|Overall Study|abnormal liver function tests|1|||
94668438|NCT03570619|324238642|FG000|Overall Study|Adverse Event|2|||
94668439|NCT03570619|324238643|FG001|Overall Study|Adverse Event|0|||
94668440|NCT03570619|324238644|FG002|Overall Study|Adverse Event|1|||
94668441|NCT03570619|324238642|FG000|Overall Study|new diagnosis of new malignancy|1|||
94668442|NCT03570619|324238643|FG001|Overall Study|new diagnosis of new malignancy|0|||
94668443|NCT03570619|324238644|FG002|Overall Study|new diagnosis of new malignancy|0|||
94668444|NCT03570619|324238642|FG000|Overall Study|Physician Decision|1|||
94668445|NCT03570619|324238643|FG001|Overall Study|Physician Decision|1|||
94668446|NCT03570619|324238644|FG002|Overall Study|Physician Decision|0|||
94668447|NCT03570619|324238642|FG000|Overall Study|Withdrawal by Subject|0|||
94668448|NCT03570619|324238643|FG001|Overall Study|Withdrawal by Subject|2|||
94668449|NCT03570619|324238644|FG002|Overall Study|Withdrawal by Subject|0|||
94668450|NCT00802074|324238645|FG000|Overall Study|Adverse Event|1|||
94668451|NCT00802074|324238646|FG001|Overall Study|Adverse Event|1|||
94668452|NCT00802074|324238647|FG002|Overall Study|Adverse Event|1|||
94668453|NCT00802074|324238648|FG003|Overall Study|Adverse Event|0|||
94668454|NCT00802074|324238649|FG004|Overall Study|Adverse Event|0|||
94668455|NCT00802074|324238650|FG005|Overall Study|Adverse Event|0|||
94668456|NCT00802074|324238645|FG000|Overall Study|Withdrawal by Subject|1|||
94668457|NCT00802074|324238646|FG001|Overall Study|Withdrawal by Subject|0|||
94668458|NCT00802074|324238647|FG002|Overall Study|Withdrawal by Subject|0|||
94668459|NCT00802074|324238648|FG003|Overall Study|Withdrawal by Subject|0|||
94668460|NCT00802074|324238649|FG004|Overall Study|Withdrawal by Subject|0|||
94668461|NCT00802074|324238650|FG005|Overall Study|Withdrawal by Subject|0|||
94668462|NCT01371851|324238651|FG000|Overall Study|Lost to Follow-up|5|||
94668463|NCT01371851|324238652|FG001|Overall Study|Lost to Follow-up|8|||
94668464|NCT01371851|324238651|FG000|Overall Study|was arrested and put in jail|0|||
94668465|NCT01371851|324238652|FG001|Overall Study|was arrested and put in jail|1|||
94359515|NCT04668066|323100350|FG014|Part 1: Treatment Phase|Adverse Event|0|||
94622071|NCT05683249|324079916|FG001|Overall Study|Adverse Event|1|||
94359516|NCT04668066|323100351|FG015|Part 1: Treatment Phase|Adverse Event|0|||
94622072|NCT05683249|324079915|FG000|Overall Study|Lack of Efficacy|0|||
94622073|NCT05683249|324079916|FG001|Overall Study|Lack of Efficacy|2|||
94622074|NCT05683249|324079915|FG000|Overall Study|Lost to Follow-up|6|||
94622075|NCT05683249|324079916|FG001|Overall Study|Lost to Follow-up|5|||
94622076|NCT05683249|324079915|FG000|Overall Study|Non-compliance with Study Drug|2|||
94622077|NCT05683249|324079916|FG001|Overall Study|Non-compliance with Study Drug|0|||
94622078|NCT05683249|324079915|FG000|Overall Study|Protocol Violation|6|||
94622079|NCT05683249|324079916|FG001|Overall Study|Protocol Violation|3|||
94622080|NCT05683249|324079915|FG000|Overall Study|Withdrawal by Subject|9|||
94622081|NCT05683249|324079916|FG001|Overall Study|Withdrawal by Subject|8|||
94622082|NCT05683249|324079915|FG000|Overall Study|Other|0|||
94622083|NCT05683249|324079916|FG001|Overall Study|Other|2|||
94622084|NCT00730405|324079922|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
94622085|NCT00730405|324079923|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
94622086|NCT00730405|324079924|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
94622087|NCT00730405|324079925|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
94622088|NCT00730405|324079926|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
94622089|NCT00730405|324079922|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
94622090|NCT00730405|324079923|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
94622091|NCT00730405|324079924|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
94622092|NCT00730405|324079925|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
94622093|NCT00730405|324079926|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
94622094|NCT00730405|324079922|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
94622095|NCT00730405|324079923|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
94622096|NCT00730405|324079924|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
94622097|NCT00730405|324079925|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
94622098|NCT00730405|324079926|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
94622099|NCT00730405|324079922|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
94622100|NCT00730405|324079923|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
94622101|NCT00730405|324079924|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
94622102|NCT00730405|324079925|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
94622103|NCT00730405|324079926|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
94622104|NCT00730405|324079922|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
94622105|NCT00730405|324079923|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
94622106|NCT00730405|324079924|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
94622107|NCT00730405|324079925|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
94622108|NCT00730405|324079926|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
94622109|NCT00730405|324079922|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
94622110|NCT00730405|324079923|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
94622111|NCT00730405|324079924|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
94622112|NCT00730405|324079925|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
94622113|NCT00730405|324079926|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
94622114|NCT00730405|324079922|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
94622115|NCT00730405|324079923|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
94622116|NCT00730405|324079924|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
94622117|NCT00730405|324079925|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
94622118|NCT00730405|324079926|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
94622119|NCT00730405|324079922|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
94622120|NCT00730405|324079923|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
94622121|NCT00730405|324079924|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
94622122|NCT00730405|324079925|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
94622123|NCT00730405|324079926|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
94622124|NCT00730405|324079922|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
94622125|NCT00730405|324079923|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
94622126|NCT00730405|324079924|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
94622127|NCT00730405|324079925|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
94622128|NCT00730405|324079926|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
94622129|NCT00730405|324079922|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
94622130|NCT00730405|324079923|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
94622131|NCT00730405|324079924|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
94622132|NCT00730405|324079925|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
94622133|NCT00730405|324079926|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
94359517|NCT04668066|323100352|FG016|Part 1: Treatment Phase|Adverse Event|0|||
94359518|NCT04668066|323100353|FG017|Part 1: Treatment Phase|Adverse Event|0|||
94359519|NCT04668066|323100354|FG018|Part 1: Treatment Phase|Adverse Event|0|||
94359520|NCT04668066|323100336|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
94359521|NCT04668066|323100337|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
94359522|NCT04668066|323100338|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
94359523|NCT04668066|323100339|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
94359524|NCT04668066|323100340|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
94359525|NCT04668066|323100341|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
94359526|NCT04668066|323100342|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
94461180|NCT00373958|323478212|FG001|Infant Series|Consent was not received|0|||
94461181|NCT00373958|323478211|FG000|Infant Series|Adverse Event|3|||
94461182|NCT00373958|323478212|FG001|Infant Series|Adverse Event|1|||
94622134|NCT00730405|324079922|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
94622135|NCT00730405|324079923|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
94622136|NCT00730405|324079924|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
94622137|NCT00730405|324079925|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
94622138|NCT00730405|324079926|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
94622139|NCT00730405|324079922|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
94622140|NCT00730405|324079923|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
94622141|NCT00730405|324079924|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
94622142|NCT00730405|324079925|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
94622143|NCT00730405|324079926|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
94622144|NCT00730405|324079922|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
94622145|NCT00730405|324079923|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
94622146|NCT00730405|324079924|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
94622147|NCT00730405|324079925|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
94622148|NCT00730405|324079926|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
94622149|NCT00730405|324079922|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
94622150|NCT00730405|324079923|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
94622151|NCT00730405|324079924|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
94622152|NCT00730405|324079925|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
94622153|NCT00730405|324079926|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
94622154|NCT00730405|324079922|FG000|Overall Study-Treatment Phase|Change of location|0|||
94622155|NCT00730405|324079923|FG001|Overall Study-Treatment Phase|Change of location|0|||
94622156|NCT00730405|324079924|FG002|Overall Study-Treatment Phase|Change of location|0|||
94622157|NCT00730405|324079925|FG003|Overall Study-Treatment Phase|Change of location|1|||
94622158|NCT00730405|324079926|FG004|Overall Study-Treatment Phase|Change of location|0|||
94622159|NCT00730405|324079922|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
94622160|NCT00730405|324079923|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
94622161|NCT00730405|324079924|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
94622162|NCT00730405|324079925|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
94622163|NCT00730405|324079926|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
94622164|NCT00730405|324079922|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
94622165|NCT00730405|324079923|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
94622166|NCT00730405|324079924|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
94622167|NCT00730405|324079925|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
94622168|NCT00730405|324079926|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
94622169|NCT00730405|324079922|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
94622170|NCT00730405|324079923|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
94622171|NCT00730405|324079924|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
94622172|NCT00730405|324079925|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
94622173|NCT00730405|324079926|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
94622174|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
94622175|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
94622176|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
94622177|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
94622178|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
94622179|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
94622180|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
94622181|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
94622182|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
94622183|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
94622184|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
94622185|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
94668466|NCT01371851|324238651|FG000|Overall Study|non study related adverse event|1|||
94668467|NCT01371851|324238652|FG001|Overall Study|non study related adverse event|0|||
94668468|NCT01371851|324238651|FG000|Overall Study|Blood Pressure outside study parameters|2|||
94359527|NCT04668066|323100343|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
94668469|NCT01371851|324238652|FG001|Overall Study|Blood Pressure outside study parameters|0|||
94668470|NCT00833638|324238653|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
94668471|NCT00833638|324238654|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
94668472|NCT00833638|324238655|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
94668473|NCT00833638|324238653|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
94668474|NCT00833638|324238654|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
94668475|NCT00833638|324238655|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
94668476|NCT00833638|324238653|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
94668477|NCT00833638|324238654|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
94668478|NCT00833638|324238655|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
94668479|NCT00833638|324238653|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
94668480|NCT00833638|324238654|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
94668481|NCT00833638|324238655|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
94359528|NCT04668066|323100344|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
94359529|NCT04668066|323100345|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
94668482|NCT00833638|324238653|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
94668483|NCT00833638|324238654|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
94668484|NCT00833638|324238655|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
94668485|NCT00833638|324238653|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
94668486|NCT00833638|324238654|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
94668487|NCT00833638|324238655|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
94668488|NCT00833638|324238653|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
94668489|NCT00833638|324238654|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
94668490|NCT00833638|324238655|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
94668491|NCT00833638|324238653|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
94668492|NCT00833638|324238654|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
94668493|NCT00833638|324238655|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
94668494|NCT00833638|324238653|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
94668495|NCT00833638|324238654|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
94668496|NCT00833638|324238655|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
94668497|NCT01178086|324238656|FG000|Overall Study|Participant refusal|7|||
94668498|NCT01178086|324238656|FG000|Overall Study|Physician Decision|44|||
94668499|NCT01178086|324238656|FG000|Overall Study|Switch to other CLL therapy|113|||
94668500|NCT01178086|324238656|FG000|Overall Study|Death|59|||
94668501|NCT01178086|324238656|FG000|Overall Study|Other unspecified|89|||
94668502|NCT01178086|324238656|FG000|Overall Study|Excluded from EAS|20|||
94668503|NCT02137369|324238657|FG000|Overall Study|Withdrawal by Subject|3|||
94668504|NCT02137369|324238658|FG001|Overall Study|Withdrawal by Subject|2|||
94359530|NCT04668066|323100346|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
94359531|NCT04668066|323100347|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
94359532|NCT04668066|323100348|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
94359533|NCT04668066|323100349|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
94359534|NCT04668066|323100350|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
94359535|NCT04668066|323100351|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
94359536|NCT04668066|323100352|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
94359537|NCT04668066|323100353|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
94359538|NCT04668066|323100354|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
94359539|NCT04668066|323100336|FG000|Part 1: Treatment Phase|Other|0|||
94359540|NCT04668066|323100337|FG001|Part 1: Treatment Phase|Other|0|||
94359541|NCT04668066|323100338|FG002|Part 1: Treatment Phase|Other|0|||
94359542|NCT04668066|323100339|FG003|Part 1: Treatment Phase|Other|0|||
94359543|NCT04668066|323100340|FG004|Part 1: Treatment Phase|Other|0|||
94359544|NCT04668066|323100341|FG005|Part 1: Treatment Phase|Other|0|||
94359545|NCT04668066|323100342|FG006|Part 1: Treatment Phase|Other|0|||
94359546|NCT04668066|323100343|FG007|Part 1: Treatment Phase|Other|0|||
94359547|NCT04668066|323100344|FG008|Part 1: Treatment Phase|Other|0|||
94668505|NCT02137369|324238657|FG000|Overall Study|Adverse Event|2|||
94668506|NCT02137369|324238658|FG001|Overall Study|Adverse Event|0|||
94668507|NCT02137369|324238657|FG000|Overall Study|Lost to Follow-up|1|||
94668508|NCT02137369|324238658|FG001|Overall Study|Lost to Follow-up|0|||
94668509|NCT02137369|324238657|FG000|Overall Study|Moved away|2|||
94668510|NCT02137369|324238658|FG001|Overall Study|Moved away|0|||
94668511|NCT00983073|324238661|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
94668512|NCT00983073|324238661|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
94668513|NCT00983073|324238661|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
94668514|NCT00983073|324238661|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
94359548|NCT04668066|323100345|FG009|Part 1: Treatment Phase|Other|0|||
94359549|NCT04668066|323100346|FG010|Part 1: Treatment Phase|Other|0|||
94359550|NCT04668066|323100347|FG011|Part 1: Treatment Phase|Other|1|||
94359551|NCT04668066|323100348|FG012|Part 1: Treatment Phase|Other|0|||
94359552|NCT04668066|323100349|FG013|Part 1: Treatment Phase|Other|0|||
94359553|NCT04668066|323100350|FG014|Part 1: Treatment Phase|Other|0|||
94668515|NCT00983073|324238661|FG000|Titration and Optimal Dose Period|Other reason|4|||
94668516|NCT00983073|324238661|FG000|Maintenance Period|Adverse Event|5|||
94668517|NCT00983073|324238661|FG000|Maintenance Period|Withdrawal by Subject|2|||
94668518|NCT00983073|324238661|FG000|Maintenance Period|Lack of Efficacy|2|||
94668519|NCT00983073|324238661|FG000|Maintenance Period|Other Reason|7|||
94668520|NCT03543254|324238662|FG000|Overall Study|Lost to Follow-up|1|||
94668521|NCT00941330|324238663|FG000|Overall Study|Other|1|||
94668522|NCT00941330|324238664|FG001|Overall Study|Other|0|||
94668523|NCT00941330|324238663|FG000|Overall Study|Physician Decision|0|||
94668524|NCT00941330|324238664|FG001|Overall Study|Physician Decision|2|||
94668525|NCT02313428|324238665|FG000|Overall Study|Lost to Follow-up|1|||
94668526|NCT02313428|324238666|FG001|Overall Study|Lost to Follow-up|1|||
94668527|NCT05374421|324238667|FG000|Overall Study|Withdrawal by Subject|3|||
94622186|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
94622187|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
94622188|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
94622189|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Death|0|||
94622190|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Death|1|||
94622191|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Death|0|||
94668528|NCT05374421|324238668|FG001|Overall Study|Withdrawal by Subject|4|||
94668529|NCT05557942|324238669|FG000|Overall Study|Death|0|||
94668530|NCT05557942|324238670|FG001|Overall Study|Death|0|||
94668531|NCT05557942|324238671|FG002|Overall Study|Death|0|||
94668532|NCT05557942|324238672|FG003|Overall Study|Death|2|||
94668533|NCT05557942|324238673|FG004|Overall Study|Death|1|||
94668534|NCT05557942|324238674|FG005|Overall Study|Death|1|||
94668535|NCT05557942|324238669|FG000|Overall Study|Physician Decision|1|||
94668536|NCT05557942|324238670|FG001|Overall Study|Physician Decision|1|||
94668537|NCT05557942|324238671|FG002|Overall Study|Physician Decision|2|||
94668538|NCT05557942|324238672|FG003|Overall Study|Physician Decision|3|||
94668539|NCT05557942|324238673|FG004|Overall Study|Physician Decision|0|||
94668540|NCT05557942|324238674|FG005|Overall Study|Physician Decision|2|||
94668541|NCT05557942|324238669|FG000|Overall Study|Study terminated by sponsor|17|||
94668542|NCT05557942|324238670|FG001|Overall Study|Study terminated by sponsor|17|||
94668543|NCT05557942|324238671|FG002|Overall Study|Study terminated by sponsor|14|||
94668544|NCT05557942|324238672|FG003|Overall Study|Study terminated by sponsor|40|||
94668545|NCT05557942|324238673|FG004|Overall Study|Study terminated by sponsor|45|||
94668546|NCT05557942|324238674|FG005|Overall Study|Study terminated by sponsor|37|||
94668547|NCT05557942|324238669|FG000|Overall Study|Protocol Violation|0|||
94668548|NCT05557942|324238670|FG001|Overall Study|Protocol Violation|0|||
94622192|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Death|1|||
94622193|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Death|0|||
94622194|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Change of location|1|||
94622195|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Change of location|1|||
94622196|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Change of location|0|||
94622197|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Change of location|1|||
94622198|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Change of location|0|||
94622199|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
94622200|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
94622201|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
94622202|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
94622203|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
94622204|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
94622205|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
94622206|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
94622207|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
94622208|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
94622209|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
94622210|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
94622211|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
94622212|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
94622213|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
94622214|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
94622215|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
94668549|NCT05557942|324238671|FG002|Overall Study|Protocol Violation|0|||
94668550|NCT05557942|324238672|FG003|Overall Study|Protocol Violation|0|||
94668551|NCT05557942|324238673|FG004|Overall Study|Protocol Violation|0|||
94668552|NCT05557942|324238674|FG005|Overall Study|Protocol Violation|1|||
94668553|NCT05557942|324238669|FG000|Overall Study|Withdrawal by Subject|0|||
94668554|NCT05557942|324238670|FG001|Overall Study|Withdrawal by Subject|0|||
94668555|NCT05557942|324238671|FG002|Overall Study|Withdrawal by Subject|0|||
94668556|NCT05557942|324238672|FG003|Overall Study|Withdrawal by Subject|0|||
94668557|NCT05557942|324238673|FG004|Overall Study|Withdrawal by Subject|2|||
94668558|NCT05557942|324238674|FG005|Overall Study|Withdrawal by Subject|0|||
94668559|NCT04154787|324238675|FG000|Overall Study|Adverse Event|0|||
94668560|NCT04154787|324238676|FG001|Overall Study|Adverse Event|1|||
94668561|NCT04154787|324238677|FG002|Overall Study|Adverse Event|0|||
94668562|NCT04154787|324238675|FG000|Overall Study|Patient Requires Other Treatment|0|||
94668563|NCT04154787|324238676|FG001|Overall Study|Patient Requires Other Treatment|1|||
94668564|NCT04154787|324238677|FG002|Overall Study|Patient Requires Other Treatment|0|||
94668565|NCT04154787|324238675|FG000|Overall Study|Study Terminated By Sponsor|0|||
94668566|NCT04154787|324238676|FG001|Overall Study|Study Terminated By Sponsor|6|||
94668567|NCT04154787|324238677|FG002|Overall Study|Study Terminated By Sponsor|1|||
94668568|NCT04154787|324238675|FG000|Overall Study|Subject Decision|0|||
94668569|NCT04154787|324238676|FG001|Overall Study|Subject Decision|1|||
94668570|NCT04154787|324238677|FG002|Overall Study|Subject Decision|0|||
94668571|NCT04154787|324238675|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
94668572|NCT04154787|324238676|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
94668573|NCT04154787|324238677|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
94668574|NCT00251745|324238682|FG000|Overall Study|Adverse Event|7|||
94668575|NCT00251745|324238683|FG001|Overall Study|Adverse Event|9|||
94668576|NCT00251745|324238684|FG002|Overall Study|Adverse Event|11|||
94668577|NCT00251745|324238682|FG000|Overall Study|Lost to Follow-up|4|||
94668578|NCT00251745|324238683|FG001|Overall Study|Lost to Follow-up|2|||
94668579|NCT00251745|324238684|FG002|Overall Study|Lost to Follow-up|5|||
94668580|NCT00251745|324238682|FG000|Overall Study|Withdrawal by Subject|13|||
94668581|NCT00251745|324238683|FG001|Overall Study|Withdrawal by Subject|7|||
94668582|NCT00251745|324238684|FG002|Overall Study|Withdrawal by Subject|3|||
94668583|NCT00251745|324238682|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
94668584|NCT00251745|324238683|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
94668585|NCT00251745|324238684|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
94622216|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
94622217|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
94622218|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
94622219|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
94622220|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
94622221|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
94622222|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
94622223|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
94622224|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
94622225|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
94622226|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
94622227|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
94622228|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
94622229|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
94622230|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
94622231|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
94622232|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
94622233|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
94622234|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
94622235|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
94622236|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
94622237|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
94622238|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
94622239|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
94622240|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
94622241|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
94622242|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
94668586|NCT00251745|324238682|FG000|Overall Study|Lack of Efficacy|3|||
94668587|NCT00251745|324238683|FG001|Overall Study|Lack of Efficacy|0|||
94668588|NCT00251745|324238684|FG002|Overall Study|Lack of Efficacy|0|||
94668589|NCT00251745|324238682|FG000|Overall Study|Noncompliant|0|||
94668590|NCT00251745|324238683|FG001|Overall Study|Noncompliant|2|||
94622243|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
94622244|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
94622245|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
94622246|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
94622247|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
94622248|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
94622249|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Missing|0|||
94622250|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Missing|0|||
94622251|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Missing|2|||
94622252|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Missing|0|||
94622253|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Missing|0|||
94622254|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
94622255|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
94622256|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
94622257|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
94622258|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
94622259|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
94622260|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
94622261|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
94622262|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
94622263|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
94622264|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
94622265|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
94622266|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
94622267|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
94622268|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
94622269|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
94622270|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
94622271|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
94622272|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
94622273|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
94622274|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
94622275|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
94622276|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
94622277|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
94622278|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
94622279|NCT00730405|324079922|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
94622280|NCT00730405|324079923|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
94622281|NCT00730405|324079924|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
94622282|NCT00730405|324079925|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
94622283|NCT00730405|324079926|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
94622284|NCT03851705|324079930|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
94622285|NCT03851705|324079931|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
94622286|NCT03851705|324079932|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
94622287|NCT03851705|324079933|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
94622288|NCT03851705|324079930|FG000|Part 1: Double-Blind Period|Other reason|1|||
94622289|NCT03851705|324079931|FG001|Part 1: Double-Blind Period|Other reason|0|||
94622290|NCT03851705|324079932|FG002|Part 1: Double-Blind Period|Other reason|0|||
94622291|NCT03851705|324079933|FG003|Part 1: Double-Blind Period|Other reason|0|||
94622292|NCT03851705|324079930|FG000|Part 2: Open-Label Period|Other reason|0|||
94622293|NCT03851705|324079931|FG001|Part 2: Open-Label Period|Other reason|0|||
94622294|NCT03851705|324079932|FG002|Part 2: Open-Label Period|Other reason|0|||
94622295|NCT03851705|324079933|FG003|Part 2: Open-Label Period|Other reason|1|||
94622296|NCT03851705|324079930|FG000|Part 2: Open-Label Period|Death|0|||
94622297|NCT03851705|324079931|FG001|Part 2: Open-Label Period|Death|0|||
94622298|NCT03851705|324079932|FG002|Part 2: Open-Label Period|Death|3|||
94622299|NCT03851705|324079933|FG003|Part 2: Open-Label Period|Death|0|||
94622300|NCT03851705|324079930|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
94622301|NCT03851705|324079931|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
94622302|NCT03851705|324079932|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
94622303|NCT03851705|324079933|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
94622304|NCT01930123|324079934|FG000|Overall Study|Adverse Event|1|||
94668591|NCT00251745|324238684|FG002|Overall Study|Noncompliant|2|||
94668592|NCT00251745|324238682|FG000|Overall Study|Pregnancy|0|||
94668593|NCT00251745|324238683|FG001|Overall Study|Pregnancy|1|||
94668594|NCT00251745|324238684|FG002|Overall Study|Pregnancy|0|||
94668595|NCT00251745|324238682|FG000|Overall Study|Per Subject Request|0|||
94668596|NCT00251745|324238683|FG001|Overall Study|Per Subject Request|0|||
94668597|NCT00251745|324238684|FG002|Overall Study|Per Subject Request|1|||
94668598|NCT00251745|324238682|FG000|Overall Study|Per Investigator Request|1|||
94668599|NCT00251745|324238683|FG001|Overall Study|Per Investigator Request|0|||
94668600|NCT00251745|324238684|FG002|Overall Study|Per Investigator Request|0|||
94668601|NCT01738984|324240702|FG000|Overall Study|Pregnancy|4|||
94668602|NCT01738984|324240703|FG001|Overall Study|Pregnancy|0|||
94668603|NCT01738984|324240702|FG000|Overall Study|Withdrawal by Subject|1|||
94668604|NCT01738984|324240703|FG001|Overall Study|Withdrawal by Subject|0|||
94668605|NCT01738984|324240702|FG000|Overall Study|Lost to Follow-up|59|||
94668606|NCT01738984|324240703|FG001|Overall Study|Lost to Follow-up|39|||
94668607|NCT00857207|324240707|FG000|Overall Study|Withdrawal by Subject|13|||
94668608|NCT00857207|324240708|FG001|Overall Study|Withdrawal by Subject|0|||
94668609|NCT00857207|324240707|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
94668610|NCT00857207|324240708|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
94668611|NCT00857207|324240707|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
94668612|NCT00857207|324240708|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
94668613|NCT00605293|324240711|FG000|Overall Study|Death|2|||
94668614|NCT00605293|324240712|FG001|Overall Study|Death|1|||
94668615|NCT00605293|324240711|FG000|Overall Study|Insufficient Therapeutic Response|2|||
94668616|NCT00605293|324240712|FG001|Overall Study|Insufficient Therapeutic Response|0|||
94668617|NCT00605293|324240711|FG000|Overall Study|Adverse Event|1|||
94668618|NCT00605293|324240712|FG001|Overall Study|Adverse Event|0|||
94668619|NCT00605293|324240711|FG000|Overall Study|Holidays Dialysis Out|1|||
94668620|NCT00605293|324240712|FG001|Overall Study|Holidays Dialysis Out|0|||
94668621|NCT00605293|324240711|FG000|Overall Study|Blood Transfusion|7|||
94668622|NCT00605293|324240712|FG001|Overall Study|Blood Transfusion|1|||
94668623|NCT00605293|324240711|FG000|Overall Study|Renal Transplantation|3|||
94668624|NCT00605293|324240712|FG001|Overall Study|Renal Transplantation|1|||
94668625|NCT00605293|324240711|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
94668626|NCT00605293|324240712|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
94668627|NCT00605293|324240711|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
94668628|NCT00605293|324240712|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
94668629|NCT00605293|324240711|FG000|Overall Study|Principal Investigator Decision|0|||
94668630|NCT00605293|324240712|FG001|Overall Study|Principal Investigator Decision|1|||
94668631|NCT04154956|324240715|FG000|Overall Study|Death|109|||
94668632|NCT04154956|324240716|FG001|Overall Study|Death|110|||
94668633|NCT04154956|324240715|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
94668634|NCT04154956|324240716|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
94668635|NCT04154956|324240715|FG000|Overall Study|Withdrawal by Subject|1|||
94622305|NCT01930123|324079935|FG001|Overall Study|Adverse Event|0|||
94622306|NCT01930123|324079934|FG000|Overall Study|Physician Decision|21|||
94622307|NCT01930123|324079935|FG001|Overall Study|Physician Decision|8|||
94622308|NCT01930123|324079934|FG000|Overall Study|Withdrawal by Subject|1|||
94622309|NCT01930123|324079935|FG001|Overall Study|Withdrawal by Subject|0|||
94622310|NCT03095612|324079936|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
94622311|NCT03095612|324079937|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
94622312|NCT03095612|324079938|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
94668636|NCT04154956|324240716|FG001|Overall Study|Withdrawal by Subject|7|||
94622313|NCT03095612|324079939|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
94622314|NCT03095612|324079940|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
94668637|NCT04154956|324240715|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
94668638|NCT04154956|324240716|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
94668639|NCT01358968|324240717|FG000|Period 2|Adverse Event|0|||
94668640|NCT01358968|324240718|FG001|Period 2|Adverse Event|1|||
94668641|NCT01358968|324240719|FG002|Period 2|Adverse Event|0|||
94668642|NCT01358968|324240720|FG003|Period 2|Adverse Event|0|||
94668643|NCT01358968|324240717|FG000|Continued Access Phase|Progression of Disease|0|||
94668644|NCT01358968|324240718|FG001|Continued Access Phase|Progression of Disease|0|||
94668645|NCT01358968|324240719|FG002|Continued Access Phase|Progression of Disease|8|||
94668646|NCT01358968|324240720|FG003|Continued Access Phase|Progression of Disease|4|||
94622315|NCT03095612|324079941|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
94622316|NCT03095612|324079942|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
94622317|NCT00036270|324079947|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
94668647|NCT01358968|324240717|FG000|Continued Access Phase|Protocol Violation|0|||
94668648|NCT01358968|324240718|FG001|Continued Access Phase|Protocol Violation|0|||
94668649|NCT01358968|324240719|FG002|Continued Access Phase|Protocol Violation|0|||
94668650|NCT01358968|324240720|FG003|Continued Access Phase|Protocol Violation|2|||
94668651|NCT01358968|324240717|FG000|Continued Access Phase|Withdrawal by Subject|0|||
94668652|NCT01358968|324240718|FG001|Continued Access Phase|Withdrawal by Subject|0|||
94668653|NCT01358968|324240719|FG002|Continued Access Phase|Withdrawal by Subject|3|||
94668654|NCT01358968|324240720|FG003|Continued Access Phase|Withdrawal by Subject|0|||
94668655|NCT01358968|324240717|FG000|Continued Access Phase|Death|0|||
94668656|NCT01358968|324240718|FG001|Continued Access Phase|Death|0|||
94668657|NCT01358968|324240719|FG002|Continued Access Phase|Death|1|||
94668658|NCT01358968|324240720|FG003|Continued Access Phase|Death|1|||
94668659|NCT05224050|324240726|FG000|Overall Study|Withdrawal by Subject|9|||
94668660|NCT05224050|324240726|FG000|Overall Study|Lost to Follow-up|3|||
94668661|NCT01814371|324240734|FG000|Overall Study|Lost to Follow-up|30|||
94668662|NCT01814371|324240735|FG001|Overall Study|Lost to Follow-up|27|||
94668663|NCT01692782|324240736|FG000|Overall Study|Adverse Event|12|||
94668664|NCT01692782|324240737|FG001|Overall Study|Adverse Event|32|||
94668665|NCT01692782|324240738|FG002|Overall Study|Adverse Event|2|||
94668666|NCT01692782|324240736|FG000|Overall Study|Lack of Efficacy|1|||
94668667|NCT01692782|324240737|FG001|Overall Study|Lack of Efficacy|2|||
94668668|NCT01692782|324240738|FG002|Overall Study|Lack of Efficacy|0|||
94668669|NCT01692782|324240736|FG000|Overall Study|Lost to Follow-up|2|||
94668670|NCT01692782|324240737|FG001|Overall Study|Lost to Follow-up|7|||
94668671|NCT01692782|324240738|FG002|Overall Study|Lost to Follow-up|1|||
94668672|NCT01692782|324240736|FG000|Overall Study|Pregnancy|1|||
94668673|NCT01692782|324240737|FG001|Overall Study|Pregnancy|0|||
94668674|NCT01692782|324240738|FG002|Overall Study|Pregnancy|0|||
94668675|NCT01692782|324240736|FG000|Overall Study|Protocol Violation|1|||
94668676|NCT01692782|324240737|FG001|Overall Study|Protocol Violation|0|||
94668677|NCT01692782|324240738|FG002|Overall Study|Protocol Violation|2|||
94668678|NCT01692782|324240736|FG000|Overall Study|Non-complance with study drug|0|||
94668679|NCT01692782|324240737|FG001|Overall Study|Non-complance with study drug|4|||
94668680|NCT01692782|324240738|FG002|Overall Study|Non-complance with study drug|1|||
94668681|NCT01692782|324240736|FG000|Overall Study|Non-compliant with study visits|0|||
94622318|NCT00036270|324079948|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
94622319|NCT00036270|324079947|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
94622320|NCT00036270|324079948|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
94622321|NCT00036270|324079947|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
94622322|NCT00036270|324079948|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
94668682|NCT01692782|324240737|FG001|Overall Study|Non-compliant with study visits|0|||
94668683|NCT01692782|324240738|FG002|Overall Study|Non-compliant with study visits|1|||
94668684|NCT01692782|324240736|FG000|Overall Study|SAE not related to study drug|0|||
94668685|NCT01692782|324240737|FG001|Overall Study|SAE not related to study drug|1|||
94668686|NCT01692782|324240738|FG002|Overall Study|SAE not related to study drug|0|||
94668687|NCT01692782|324240736|FG000|Overall Study|Withdrawal by Subject|3|||
94668688|NCT01692782|324240737|FG001|Overall Study|Withdrawal by Subject|10|||
94668689|NCT01692782|324240738|FG002|Overall Study|Withdrawal by Subject|3|||
94668690|NCT02794285|324240739|FG000|Overall Study|Adverse Event|11|||
94668691|NCT02794285|324240740|FG001|Overall Study|Adverse Event|4|||
94668692|NCT02794285|324240741|FG002|Overall Study|Adverse Event|5|||
94668693|NCT02794285|324240742|FG003|Overall Study|Adverse Event|8|||
94668694|NCT02794285|324240739|FG000|Overall Study|Condition Under Investigation Improved|1|||
94668695|NCT02794285|324240740|FG001|Overall Study|Condition Under Investigation Improved|0|||
94668696|NCT02794285|324240741|FG002|Overall Study|Condition Under Investigation Improved|0|||
94668697|NCT02794285|324240742|FG003|Overall Study|Condition Under Investigation Improved|0|||
94668698|NCT02794285|324240739|FG000|Overall Study|Condition Under Investigation Worsened|0|||
94668699|NCT02794285|324240740|FG001|Overall Study|Condition Under Investigation Worsened|2|||
94668700|NCT02794285|324240741|FG002|Overall Study|Condition Under Investigation Worsened|1|||
94668701|NCT02794285|324240742|FG003|Overall Study|Condition Under Investigation Worsened|0|||
94668702|NCT02794285|324240739|FG000|Overall Study|Death|2|||
94668703|NCT02794285|324240740|FG001|Overall Study|Death|1|||
94668704|NCT02794285|324240741|FG002|Overall Study|Death|2|||
94668705|NCT02794285|324240742|FG003|Overall Study|Death|0|||
94668706|NCT02794285|324240739|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
94668707|NCT02794285|324240740|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
94668708|NCT02794285|324240741|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
94668709|NCT02794285|324240742|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
94668710|NCT02794285|324240739|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
94668711|NCT02794285|324240740|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
94668712|NCT02794285|324240741|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
94668713|NCT02794285|324240742|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
94668714|NCT02794285|324240739|FG000|Overall Study|Lack of Efficacy|10|||
94668715|NCT02794285|324240740|FG001|Overall Study|Lack of Efficacy|6|||
94668716|NCT02794285|324240741|FG002|Overall Study|Lack of Efficacy|3|||
94668717|NCT02794285|324240742|FG003|Overall Study|Lack of Efficacy|3|||
94668718|NCT02794285|324240739|FG000|Overall Study|Lost to Follow-up|5|||
94668719|NCT02794285|324240740|FG001|Overall Study|Lost to Follow-up|6|||
94668720|NCT02794285|324240741|FG002|Overall Study|Lost to Follow-up|3|||
94668721|NCT02794285|324240742|FG003|Overall Study|Lost to Follow-up|1|||
94668722|NCT02794285|324240739|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
94668723|NCT02794285|324240740|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
94668724|NCT02794285|324240741|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
94668725|NCT02794285|324240742|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
94668726|NCT02794285|324240739|FG000|Overall Study|Withdrawal by Subject|38|||
94668727|NCT02794285|324240740|FG001|Overall Study|Withdrawal by Subject|29|||
94668728|NCT02794285|324240741|FG002|Overall Study|Withdrawal by Subject|20|||
94668729|NCT02794285|324240742|FG003|Overall Study|Withdrawal by Subject|12|||
94668730|NCT02794285|324240739|FG000|Overall Study|Missing|1|||
94668731|NCT02794285|324240740|FG001|Overall Study|Missing|0|||
94668732|NCT02794285|324240741|FG002|Overall Study|Missing|0|||
94668733|NCT02794285|324240742|FG003|Overall Study|Missing|0|||
94668734|NCT02794285|324240739|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
94668735|NCT02794285|324240740|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
94668736|NCT02794285|324240741|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
94668737|NCT02794285|324240742|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
94668738|NCT02794285|324240739|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
94668739|NCT02794285|324240740|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
94668740|NCT02794285|324240741|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
94668741|NCT02794285|324240742|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
94668742|NCT02732938|324240743|FG000|Overall Study|Death|0|||
94622323|NCT00036270|324079947|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
94622324|NCT00036270|324079948|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
94622325|NCT00036270|324079947|FG000|Study Treatment to 5 Year Report|Other|277|||
94622326|NCT00036270|324079948|FG001|Study Treatment to 5 Year Report|Other|288|||
94622327|NCT00036270|324079947|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
94622328|NCT00036270|324079948|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
94622329|NCT00036270|324079947|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
94622330|NCT00036270|324079948|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
94622331|NCT00036270|324079947|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
94622332|NCT00036270|324079948|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
94622333|NCT00036270|324079947|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
94668743|NCT02732938|324240744|FG001|Overall Study|Death|11|||
94668744|NCT02732938|324240745|FG002|Overall Study|Death|0|||
94668745|NCT02732938|324240743|FG000|Overall Study|Randomized but did not receive treatment|0|||
94668746|NCT02732938|324240744|FG001|Overall Study|Randomized but did not receive treatment|1|||
94668747|NCT02732938|324240745|FG002|Overall Study|Randomized but did not receive treatment|0|||
94668748|NCT02732938|324240743|FG000|Overall Study|Refused further follow-up|1|||
94668749|NCT02732938|324240744|FG001|Overall Study|Refused further follow-up|0|||
94668750|NCT02732938|324240745|FG002|Overall Study|Refused further follow-up|0|||
94622334|NCT00036270|324079948|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
94622335|NCT00036270|324079947|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
94622336|NCT00036270|324079948|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
94622337|NCT00036270|324079947|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
94622338|NCT00036270|324079948|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
94622339|NCT01578187|324079949|FG000|Usability Phase|Withdrawal by Subject|1|||
94622340|NCT00496470|324079950|FG000|Overall Study|Adverse Event|8|||
94622341|NCT00496470|324079951|FG001|Overall Study|Adverse Event|10|||
94622342|NCT00496470|324079950|FG000|Overall Study|Withdrawal by Subject|5|||
94622343|NCT00496470|324079951|FG001|Overall Study|Withdrawal by Subject|12|||
94622344|NCT00496470|324079950|FG000|Overall Study|Incorrectly enrolled|13|||
94622345|NCT00496470|324079951|FG001|Overall Study|Incorrectly enrolled|5|||
94622346|NCT00496470|324079950|FG000|Overall Study|Other reason|0|||
94622347|NCT00496470|324079951|FG001|Overall Study|Other reason|2|||
94622348|NCT02591290|324079952|FG000|Overall Study|Withdrawal by Subject|2|||
94622349|NCT02516163|324079953|FG000|Overall Study|Withdrawal by Subject|1|||
94622350|NCT02516163|324079953|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
94622351|NCT02516163|324079953|FG000|Overall Study|Unfit/delay in surgery|3|||
94622352|NCT02516163|324079953|FG000|Overall Study|Use of incorrect measurement technique|5|||
94622353|NCT02516163|324079953|FG000|Overall Study|Data not recorded|2|||
94622354|NCT02516163|324079953|FG000|Overall Study|MRI contraindication exclusion|6|||
94622355|NCT01370356|324079958|FG000|Overall Study|Death|1|||
94622356|NCT01370356|324079959|FG001|Overall Study|Death|0|||
94622357|NCT01370356|324079958|FG000|Overall Study|Lack of Efficacy|6|||
94622358|NCT01370356|324079959|FG001|Overall Study|Lack of Efficacy|28|||
94622359|NCT01370356|324079958|FG000|Overall Study|Lost to Follow-up|76|||
94622360|NCT01370356|324079959|FG001|Overall Study|Lost to Follow-up|81|||
94622361|NCT01370356|324079958|FG000|Overall Study|Withdrawal by Subject|54|||
94622362|NCT01370356|324079959|FG001|Overall Study|Withdrawal by Subject|59|||
94622363|NCT01370356|324079958|FG000|Overall Study|Reason not specified|39|||
94622364|NCT01370356|324079959|FG001|Overall Study|Reason not specified|43|||
94622365|NCT01370356|324079958|FG000|Overall Study|Protocol Violation|3|||
94622366|NCT01370356|324079959|FG001|Overall Study|Protocol Violation|3|||
94622367|NCT01370356|324079958|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
94622368|NCT01370356|324079959|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
94622369|NCT01370356|324079958|FG000|Overall Study|AE Not Related to Study Drug|1|||
94622370|NCT01370356|324079959|FG001|Overall Study|AE Not Related to Study Drug|4|||
94622371|NCT02002091|324079962|FG000|Screening|Lost to Follow-up|10|||
94622372|NCT02002091|324079963|FG001|Screening|Lost to Follow-up|12|||
94622373|NCT02002091|324079962|FG000|Screening|Death|3|||
94622374|NCT02002091|324079963|FG001|Screening|Death|2|||
94622375|NCT01390649|324079964|FG000|Overall Study|Physician Decision|1|||
94622376|NCT00334958|324079967|FG000|Overall Study|Medication Noncompliance|0|||
94622377|NCT00334958|324079968|FG001|Overall Study|Medication Noncompliance|3|||
94622378|NCT00334958|324079967|FG000|Overall Study|Protocol Violation|2|||
94622379|NCT00334958|324079968|FG001|Overall Study|Protocol Violation|2|||
94622380|NCT00334958|324079967|FG000|Overall Study|Request of the investigator or sponsor|0|||
94622381|NCT00334958|324079968|FG001|Overall Study|Request of the investigator or sponsor|1|||
94622382|NCT00334958|324079967|FG000|Overall Study|Withdrawal by Subject|7|||
94622383|NCT00334958|324079968|FG001|Overall Study|Withdrawal by Subject|4|||
94622384|NCT00334958|324079967|FG000|Overall Study|Adverse Event|27|||
94622385|NCT00334958|324079968|FG001|Overall Study|Adverse Event|12|||
94622386|NCT00334958|324079967|FG000|Overall Study|Other|1|||
94622387|NCT00334958|324079968|FG001|Overall Study|Other|2|||
94622388|NCT03385564|324079969|FG000|Overall Study|Adverse Event|0|||
94622389|NCT03385564|324079970|FG001|Overall Study|Adverse Event|0|||
94622390|NCT03385564|324079971|FG002|Overall Study|Adverse Event|3|||
94622391|NCT03385564|324079972|FG003|Overall Study|Adverse Event|3|||
94622392|NCT03385564|324079969|FG000|Overall Study|Other than listed|0|||
94622393|NCT03385564|324079970|FG001|Overall Study|Other than listed|0|||
94622394|NCT03385564|324079971|FG002|Overall Study|Other than listed|0|||
94622395|NCT03385564|324079972|FG003|Overall Study|Other than listed|5|||
94622396|NCT03385564|324079969|FG000|Overall Study|Withdrawal by Subject|0|||
94622397|NCT03385564|324079970|FG001|Overall Study|Withdrawal by Subject|1|||
94622398|NCT03385564|324079971|FG002|Overall Study|Withdrawal by Subject|1|||
94622399|NCT03385564|324079972|FG003|Overall Study|Withdrawal by Subject|0|||
94622400|NCT03385564|324079969|FG000|Overall Study|Lack of Efficacy|0|||
94622401|NCT03385564|324079970|FG001|Overall Study|Lack of Efficacy|0|||
94622402|NCT03385564|324079971|FG002|Overall Study|Lack of Efficacy|0|||
94622403|NCT03385564|324079972|FG003|Overall Study|Lack of Efficacy|1|||
94622404|NCT03385564|324079969|FG000|Overall Study|Death|0|||
94622405|NCT03385564|324079970|FG001|Overall Study|Death|0|||
94622406|NCT03385564|324079971|FG002|Overall Study|Death|1|||
94622407|NCT03385564|324079972|FG003|Overall Study|Death|0|||
94622408|NCT01218243|324079973|FG000|Overall Study|Lack of Efficacy|1|||
94622409|NCT01218243|324079974|FG001|Overall Study|Lack of Efficacy|1|||
94622410|NCT01218243|324079973|FG000|Overall Study|Lost to Follow-up|3|||
94622411|NCT01218243|324079974|FG001|Overall Study|Lost to Follow-up|3|||
94622412|NCT01218243|324079973|FG000|Overall Study|Protocol Violation|5|||
94668751|NCT02732938|324240743|FG000|Overall Study|Study terminated by sponsor|3|||
94668752|NCT02732938|324240744|FG001|Overall Study|Study terminated by sponsor|6|||
94668753|NCT02732938|324240745|FG002|Overall Study|Study terminated by sponsor|0|||
94668754|NCT03252587|324240746|FG000|Overall Study|Adverse Event|3|||
94668755|NCT03252587|324240747|FG001|Overall Study|Adverse Event|8|||
94668756|NCT03252587|324240748|FG002|Overall Study|Adverse Event|6|||
94668757|NCT03252587|324240749|FG003|Overall Study|Adverse Event|12|||
94668758|NCT03252587|324240746|FG000|Overall Study|Lack of Efficacy|7|||
94668759|NCT03252587|324240747|FG001|Overall Study|Lack of Efficacy|2|||
94668760|NCT03252587|324240748|FG002|Overall Study|Lack of Efficacy|2|||
94668761|NCT03252587|324240749|FG003|Overall Study|Lack of Efficacy|4|||
94668762|NCT03252587|324240746|FG000|Overall Study|Lost to Follow-up|2|||
94668763|NCT03252587|324240747|FG001|Overall Study|Lost to Follow-up|0|||
94668764|NCT03252587|324240748|FG002|Overall Study|Lost to Follow-up|0|||
94668765|NCT03252587|324240749|FG003|Overall Study|Lost to Follow-up|2|||
94668766|NCT03252587|324240746|FG000|Overall Study|Pregnancy|2|||
94668767|NCT03252587|324240747|FG001|Overall Study|Pregnancy|1|||
94622413|NCT01218243|324079974|FG001|Overall Study|Protocol Violation|10|||
94622414|NCT02083783|324079975|FG000|Overall Study|Withdrawal by Subject|1|||
94622415|NCT02083783|324079976|FG001|Overall Study|Withdrawal by Subject|0|||
94622416|NCT03322631|324079977|FG000|Overall Study|Withdrawal by Subject|0|||
94622417|NCT03322631|324079978|FG001|Overall Study|Withdrawal by Subject|1|||
94622418|NCT03322631|324079979|FG002|Overall Study|Withdrawal by Subject|0|||
94622419|NCT03322631|324079980|FG003|Overall Study|Withdrawal by Subject|0|||
94622420|NCT03322631|324079977|FG000|Overall Study|Adverse Event|0|||
94622421|NCT03322631|324079978|FG001|Overall Study|Adverse Event|0|||
94622422|NCT03322631|324079979|FG002|Overall Study|Adverse Event|1|||
94622423|NCT03322631|324079980|FG003|Overall Study|Adverse Event|0|||
94622424|NCT02412618|324079981|FG000|Overall Study|Withdrawal by Subject|1|||
94622425|NCT02412618|324079982|FG001|Overall Study|Withdrawal by Subject|1|||
94622426|NCT02412618|324079981|FG000|Overall Study|Expulsion|1|||
94622427|NCT02412618|324079982|FG001|Overall Study|Expulsion|1|||
94622428|NCT02378961|324079983|FG000|Overall Study|Lack of Efficacy|4|||
94622429|NCT02378961|324079984|FG001|Overall Study|Lack of Efficacy|2|||
94622430|NCT02378961|324079985|FG002|Overall Study|Lack of Efficacy|0|||
94622431|NCT02378961|324079986|FG003|Overall Study|Lack of Efficacy|1|||
94622432|NCT02378961|324079983|FG000|Overall Study|Death|0|||
94622433|NCT02378961|324079984|FG001|Overall Study|Death|0|||
94622434|NCT02378961|324079985|FG002|Overall Study|Death|1|||
94622435|NCT02378961|324079986|FG003|Overall Study|Death|0|||
94622436|NCT01637272|324079987|FG000|Overall Study|Adverse Event|6|||
94622437|NCT01637272|324079987|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
94622438|NCT01637272|324079987|FG000|Overall Study|Withdrawal by Subject|3|||
94622439|NCT01637272|324079987|FG000|Overall Study|Lost to Follow-up|2|||
94622440|NCT01637272|324079987|FG000|Overall Study|completed core, did not enter ext. phase|4|||
94622441|NCT01637272|324079987|FG000|Overall Study|Administrative problems|1|||
94622442|NCT01637272|324079987|FG000|Overall Study|Protocol Violation|2|||
94622443|NCT01654536|324079992|FG000|Overall Study|Lost to Follow-up|5|||
94622444|NCT01654536|324079993|FG001|Overall Study|Lost to Follow-up|5|||
94622445|NCT01654536|324079992|FG000|Overall Study|Physician Decision|12|||
94622446|NCT01654536|324079993|FG001|Overall Study|Physician Decision|8|||
94622447|NCT01654536|324079992|FG000|Overall Study|Withdrawal by Subject|27|||
94622448|NCT01654536|324079993|FG001|Overall Study|Withdrawal by Subject|25|||
94622449|NCT02605824|324079999|FG000|Overall Study|Physician Decision|1|||
94622450|NCT02605824|324080000|FG001|Overall Study|Physician Decision|0|||
94622451|NCT02030041|324080004|FG000|Overall Study|Withdrawal by Subject|2|||
94622452|NCT02030041|324080005|FG001|Overall Study|Withdrawal by Subject|2|||
94622453|NCT02030041|324080006|FG002|Overall Study|Withdrawal by Subject|1|||
94622454|NCT05201703|324080007|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
94622455|NCT05201703|324080008|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
94622456|NCT05201703|324080007|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
94622457|NCT05201703|324080008|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
94622458|NCT00393029|324080009|FG000|Overall Study|Not treated|0|||
94622459|NCT00393029|324080010|FG001|Overall Study|Not treated|1|||
94668768|NCT03252587|324240748|FG002|Overall Study|Pregnancy|0|||
94668769|NCT03252587|324240749|FG003|Overall Study|Pregnancy|1|||
94668770|NCT03252587|324240746|FG000|Overall Study|Withdrawal by Subject|8|||
94668771|NCT03252587|324240747|FG001|Overall Study|Withdrawal by Subject|4|||
94668772|NCT03252587|324240748|FG002|Overall Study|Withdrawal by Subject|4|||
94622460|NCT04659161|324080011|FG000|Overall Study|Adverse Event|10|||
94622461|NCT04659161|324080012|FG001|Overall Study|Adverse Event|6|||
94622462|NCT04659161|324080011|FG000|Overall Study|Withdrawal by Subject|13|||
94622463|NCT04659161|324080012|FG001|Overall Study|Withdrawal by Subject|12|||
94622464|NCT04659161|324080011|FG000|Overall Study|Other|9|||
94622465|NCT04659161|324080012|FG001|Overall Study|Other|8|||
94622466|NCT01929343|324080013|FG000|Overall Study|Physician Decision|0|||
94359554|NCT04668066|323100351|FG015|Part 1: Treatment Phase|Other|0|||
94668773|NCT03252587|324240749|FG003|Overall Study|Withdrawal by Subject|4|||
94668774|NCT03252587|324240746|FG000|Overall Study|Other Reasons|2|||
94668775|NCT03252587|324240747|FG001|Overall Study|Other Reasons|5|||
94668776|NCT03252587|324240748|FG002|Overall Study|Other Reasons|5|||
94668777|NCT03252587|324240749|FG003|Overall Study|Other Reasons|4|||
94668778|NCT04052204|324240750|FG000|Overall Study|Death|1|||
94668779|NCT04052204|324240751|FG001|Overall Study|Death|0|||
94668780|NCT04052204|324240752|FG002|Overall Study|Death|0|||
94668781|NCT04052204|324240750|FG000|Overall Study|Progressive disease|1|||
94668782|NCT04052204|324240751|FG001|Overall Study|Progressive disease|0|||
94668783|NCT04052204|324240752|FG002|Overall Study|Progressive disease|0|||
94668784|NCT04052204|324240750|FG000|Overall Study|Other|1|||
94668785|NCT04052204|324240751|FG001|Overall Study|Other|0|||
94668786|NCT04052204|324240752|FG002|Overall Study|Other|0|||
94668787|NCT03927950|324240753|FG000|Overall Study|Adverse Event|9|||
94668788|NCT02384759|324240755|FG000|Overall Study|Patients not treated|3|||
94668789|NCT02384759|324240756|FG001|Overall Study|Patients not treated|2|||
94668790|NCT04794803|324240757|FG000|Overall Study|Death|1|||
94668791|NCT04794803|324240758|FG001|Overall Study|Death|3|||
94668792|NCT04794803|324240757|FG000|Overall Study|Lost to Follow-up|2|||
94668793|NCT04794803|324240758|FG001|Overall Study|Lost to Follow-up|2|||
94668794|NCT04794803|324240757|FG000|Overall Study|Withdrawal by Subject|1|||
94668795|NCT04794803|324240758|FG001|Overall Study|Withdrawal by Subject|0|||
94668796|NCT04794803|324240757|FG000|Overall Study|Physician Decision|1|||
94668797|NCT04794803|324240758|FG001|Overall Study|Physician Decision|1|||
94668798|NCT04794803|324240757|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
94668799|NCT04794803|324240758|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
94668800|NCT04794803|324240757|FG000|Overall Study|Refused to continue the treatment|1|||
94668801|NCT04794803|324240758|FG001|Overall Study|Refused to continue the treatment|0|||
94668802|NCT04794803|324240757|FG000|Overall Study|Patient admitted to ICU|0|||
94668803|NCT04794803|324240758|FG001|Overall Study|Patient admitted to ICU|1|||
94668804|NCT00338884|324240766|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
94668805|NCT00338884|324240766|FG000|Overall Study|Adverse Event|14|||
94668806|NCT00338884|324240766|FG000|Overall Study|Death|8|||
94668807|NCT00338884|324240766|FG000|Overall Study|Other|4|||
94668808|NCT00338884|324240766|FG000|Overall Study|Global Deterioration of Health Status|3|||
94668809|NCT00338884|324240766|FG000|Overall Study|Withdrawal by Subject|3|||
94668810|NCT00338884|324240766|FG000|Overall Study|Lost to Follow-up|1|||
94668811|NCT00338884|324240766|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
94668812|NCT01540851|324240768|FG000|Overall Study|Lost to Follow-up|14|||
94668813|NCT01540851|324240769|FG001|Overall Study|Lost to Follow-up|15|||
94668814|NCT01540851|324240768|FG000|Overall Study|Withdrawal by Subject|7|||
94668815|NCT01540851|324240769|FG001|Overall Study|Withdrawal by Subject|3|||
94668816|NCT05072080|324240774|FG000|Overall Study|Death|0|||
94668817|NCT05072080|324240775|FG001|Overall Study|Death|0|||
94668818|NCT05072080|324240776|FG002|Overall Study|Death|1|||
94668819|NCT05072080|324240777|FG003|Overall Study|Death|0|||
94668820|NCT05072080|324240774|FG000|Overall Study|Lost to Follow-up|65|||
94668821|NCT05072080|324240775|FG001|Overall Study|Lost to Follow-up|70|||
94668822|NCT05072080|324240776|FG002|Overall Study|Lost to Follow-up|58|||
94668823|NCT05072080|324240777|FG003|Overall Study|Lost to Follow-up|23|||
94668824|NCT05072080|324240774|FG000|Overall Study|Physician Decision|2|||
94668825|NCT05072080|324240775|FG001|Overall Study|Physician Decision|1|||
94668826|NCT05072080|324240776|FG002|Overall Study|Physician Decision|1|||
94668827|NCT05072080|324240777|FG003|Overall Study|Physician Decision|0|||
94668828|NCT05072080|324240774|FG000|Overall Study|Withdrawal by Subject|45|||
94668829|NCT05072080|324240775|FG001|Overall Study|Withdrawal by Subject|30|||
94668830|NCT05072080|324240776|FG002|Overall Study|Withdrawal by Subject|27|||
94668831|NCT05072080|324240777|FG003|Overall Study|Withdrawal by Subject|7|||
94668832|NCT05072080|324240774|FG000|Overall Study|Sponsor Decision|0|||
94668833|NCT05072080|324240775|FG001|Overall Study|Sponsor Decision|1|||
94668834|NCT05072080|324240776|FG002|Overall Study|Sponsor Decision|0|||
94668835|NCT05072080|324240777|FG003|Overall Study|Sponsor Decision|0|||
94668836|NCT05072080|324240774|FG000|Overall Study|Subject moved|1|||
94668837|NCT05072080|324240775|FG001|Overall Study|Subject moved|3|||
94668838|NCT05072080|324240776|FG002|Overall Study|Subject moved|5|||
94668839|NCT05072080|324240777|FG003|Overall Study|Subject moved|2|||
94668840|NCT05072080|324240774|FG000|Overall Study|Withdrawal by parent|0|||
94668841|NCT05072080|324240775|FG001|Overall Study|Withdrawal by parent|0|||
94668842|NCT05072080|324240776|FG002|Overall Study|Withdrawal by parent|1|||
94668843|NCT05072080|324240777|FG003|Overall Study|Withdrawal by parent|0|||
94668844|NCT05072080|324240774|FG000|Overall Study|Subject was deployed|0|||
94668845|NCT05072080|324240775|FG001|Overall Study|Subject was deployed|1|||
94668846|NCT05072080|324240776|FG002|Overall Study|Subject was deployed|0|||
94668847|NCT05072080|324240777|FG003|Overall Study|Subject was deployed|0|||
94668848|NCT05072080|324240774|FG000|Overall Study|Subject left site without receiving dose|0|||
94668849|NCT05072080|324240775|FG001|Overall Study|Subject left site without receiving dose|1|||
94668850|NCT05072080|324240776|FG002|Overall Study|Subject left site without receiving dose|0|||
94668851|NCT05072080|324240777|FG003|Overall Study|Subject left site without receiving dose|0|||
94668852|NCT05072080|324240774|FG000|Overall Study|Subject incarcerated|0|||
94668853|NCT05072080|324240775|FG001|Overall Study|Subject incarcerated|1|||
94668854|NCT05072080|324240776|FG002|Overall Study|Subject incarcerated|0|||
94668855|NCT05072080|324240777|FG003|Overall Study|Subject incarcerated|1|||
94668856|NCT05072080|324240774|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
94668857|NCT05072080|324240775|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
94622467|NCT01929343|324080014|FG001|Overall Study|Physician Decision|2|||
94622468|NCT01929343|324080015|FG002|Overall Study|Physician Decision|0|||
94622469|NCT01929343|324080013|FG000|Overall Study|Withdrawal by Subject|1|||
94622470|NCT01929343|324080014|FG001|Overall Study|Withdrawal by Subject|0|||
94622471|NCT01929343|324080015|FG002|Overall Study|Withdrawal by Subject|0|||
94622472|NCT02197130|324080018|FG000|Overall Study|Adverse Event|13|||
94622473|NCT02197130|324080019|FG001|Overall Study|Adverse Event|4|||
94622474|NCT02197130|324080020|FG002|Overall Study|Adverse Event|23|||
94622475|NCT02197130|324080018|FG000|Overall Study|Death|0|||
94622476|NCT02197130|324080019|FG001|Overall Study|Death|1|||
94622477|NCT02197130|324080020|FG002|Overall Study|Death|0|||
94622478|NCT02197130|324080018|FG000|Overall Study|Lost to Follow-up|2|||
94622479|NCT02197130|324080019|FG001|Overall Study|Lost to Follow-up|0|||
94622480|NCT02197130|324080020|FG002|Overall Study|Lost to Follow-up|1|||
94622481|NCT02197130|324080018|FG000|Overall Study|Does not meet entrance criteria|0|||
94622482|NCT02197130|324080019|FG001|Overall Study|Does not meet entrance criteria|0|||
94622483|NCT02197130|324080020|FG002|Overall Study|Does not meet entrance criteria|1|||
94622484|NCT02197130|324080018|FG000|Overall Study|Withdrawal by Subject|0|||
94622485|NCT02197130|324080019|FG001|Overall Study|Withdrawal by Subject|3|||
94622486|NCT02197130|324080020|FG002|Overall Study|Withdrawal by Subject|4|||
94622487|NCT02197130|324080018|FG000|Overall Study|Other|1|||
94622488|NCT02197130|324080019|FG001|Overall Study|Other|0|||
94622489|NCT02197130|324080020|FG002|Overall Study|Other|3|||
94622490|NCT02216591|324080026|FG000|Overall Study|Lost to Follow-up|0|||
94622491|NCT02216591|324080027|FG001|Overall Study|Lost to Follow-up|1|||
94622492|NCT00039130|324080029|FG000|Overall Study|Adverse Event|11|||
94622493|NCT00039130|324080029|FG000|Overall Study|Death|9|||
94622494|NCT00039130|324080029|FG000|Overall Study|Withdrawal by Subject|3|||
94622495|NCT00039130|324080029|FG000|Overall Study|Progression|2|||
94622496|NCT00039130|324080029|FG000|Overall Study|Subsequent treatment|2|||
94622497|NCT00039130|324080029|FG000|Overall Study|Physician Decision|3|||
94622498|NCT01446289|324080031|FG000|Overall Study|Withdrawal by Subject|1|||
94622499|NCT01446289|324080032|FG001|Overall Study|Withdrawal by Subject|0|||
94622500|NCT01446289|324080033|FG002|Overall Study|Withdrawal by Subject|1|||
94622501|NCT01446289|324080034|FG003|Overall Study|Withdrawal by Subject|0|||
94622502|NCT04600921|324080037|FG000|Overall Study|Withdrawal by Subject|3|||
94622503|NCT04600921|324080038|FG001|Overall Study|Withdrawal by Subject|5|||
94622504|NCT04600921|324080037|FG000|Overall Study|Death|0|||
94622505|NCT04600921|324080038|FG001|Overall Study|Death|1|||
94622506|NCT01218113|324081889|FG000|Overall Study|Withdrawal by Subject|1|||
94622507|NCT01218113|324081890|FG001|Overall Study|Withdrawal by Subject|0|||
94622508|NCT01218113|324081891|FG002|Overall Study|Withdrawal by Subject|1|||
94622509|NCT01218113|324081889|FG000|Overall Study|Lost to Follow-up|4|||
94622510|NCT01218113|324081890|FG001|Overall Study|Lost to Follow-up|1|||
94622511|NCT01218113|324081891|FG002|Overall Study|Lost to Follow-up|4|||
94622512|NCT01218113|324081889|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
94622513|NCT01218113|324081890|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
94622514|NCT01218113|324081891|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
94622515|NCT00126191|324081900|FG000|Overall Study|Physician Decision|0|||
94622516|NCT00126191|324081901|FG001|Overall Study|Physician Decision|1|||
94622517|NCT00126191|324081900|FG000|Overall Study|Death|0|||
94622518|NCT00126191|324081901|FG001|Overall Study|Death|1|||
94622519|NCT01898806|324081902|FG000|Overall Study|Withdrawal by Subject|2|||
94668858|NCT05072080|324240776|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
94668859|NCT05072080|324240777|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
94622520|NCT01898806|324081902|FG000|Overall Study|Physician Decision|1|||
94622521|NCT03003390|324081903|FG000|Overall Study|Physician Decision|2|||
94622522|NCT03003390|324081904|FG001|Overall Study|Physician Decision|0|||
94622523|NCT03003390|324081903|FG000|Overall Study|Parent refused intervention|2|||
94622524|NCT03003390|324081904|FG001|Overall Study|Parent refused intervention|0|||
94622525|NCT03311724|324081908|FG000|Overall Study|Physician Decision|0|||
94622526|NCT03311724|324081909|FG001|Overall Study|Physician Decision|0|||
94622527|NCT03311724|324081910|FG002|Overall Study|Physician Decision|0|||
94622528|NCT03311724|324081911|FG003|Overall Study|Physician Decision|1|||
94622529|NCT03311724|324081908|FG000|Overall Study|Protocol Violation|1|||
94622530|NCT03311724|324081909|FG001|Overall Study|Protocol Violation|0|||
94622531|NCT03311724|324081910|FG002|Overall Study|Protocol Violation|1|||
94622532|NCT03311724|324081911|FG003|Overall Study|Protocol Violation|0|||
94622533|NCT03311724|324081908|FG000|Overall Study|Withdrawal by Subject|1|||
94622534|NCT03311724|324081909|FG001|Overall Study|Withdrawal by Subject|1|||
94668860|NCT05072080|324240774|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
94668861|NCT05072080|324240775|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
94668862|NCT05072080|324240776|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
94668863|NCT05072080|324240777|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
94668864|NCT04867369|324240778|FG000|Overall Study|Withdrawal by Subject|1|||
94668865|NCT04867369|324240779|FG001|Overall Study|Withdrawal by Subject|0|||
94668866|NCT03923959|324240780|FG000|Overall Study|Death|16|||
94668867|NCT03923959|324240781|FG001|Overall Study|Death|12|||
94668868|NCT03923959|324240780|FG000|Overall Study|Lost to Follow-up|56|||
94668869|NCT03923959|324240781|FG001|Overall Study|Lost to Follow-up|56|||
94668870|NCT03923959|324240780|FG000|Overall Study|Withdrawal by Subject|1|||
94668871|NCT03923959|324240781|FG001|Overall Study|Withdrawal by Subject|1|||
94668872|NCT03923959|324240780|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
94668873|NCT03923959|324240781|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
94668874|NCT03996473|324240782|FG000|Treatment Assignment|Withdrawal by Subject|1|||
94668875|NCT03996473|324240782|FG000|Treatment Assignment|Progressive disease|6|||
94668876|NCT03996473|324240782|FG000|Treatment Assignment|Study drug never administered|1|||
94668877|NCT03996473|324240782|FG000|Active Follow-up|Death|1|||
94668878|NCT03996473|324240782|FG000|Long-term Follow-up|Death|5|||
94668879|NCT02807558|324240783|FG000|Overall Study|Consent withdrawn by participant|4|||
94668880|NCT02807558|324240784|FG001|Overall Study|Consent withdrawn by participant|0|||
94668881|NCT02807558|324240785|FG002|Overall Study|Consent withdrawn by participant|4|||
94668882|NCT02807558|324240786|FG003|Overall Study|Consent withdrawn by participant|2|||
94668883|NCT02807558|324240787|FG004|Overall Study|Consent withdrawn by participant|1|||
94668884|NCT02807558|324240788|FG005|Overall Study|Consent withdrawn by participant|0|||
94622535|NCT03311724|324081910|FG002|Overall Study|Withdrawal by Subject|0|||
94622536|NCT03311724|324081911|FG003|Overall Study|Withdrawal by Subject|0|||
94622537|NCT03311724|324081908|FG000|Overall Study|Lost to Follow-up|1|||
94622538|NCT03311724|324081909|FG001|Overall Study|Lost to Follow-up|0|||
94622539|NCT03311724|324081910|FG002|Overall Study|Lost to Follow-up|0|||
94622540|NCT03311724|324081911|FG003|Overall Study|Lost to Follow-up|0|||
94622541|NCT03311724|324081908|FG000|Overall Study|Sponsor Decision|0|||
94622542|NCT03311724|324081909|FG001|Overall Study|Sponsor Decision|0|||
94622543|NCT03311724|324081910|FG002|Overall Study|Sponsor Decision|1|||
94622544|NCT03311724|324081911|FG003|Overall Study|Sponsor Decision|0|||
94622545|NCT01433991|324081912|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
94622546|NCT01433991|324081913|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
94622547|NCT01433991|324081914|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
94622548|NCT01433991|324081915|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
94622549|NCT01433991|324081912|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
94668885|NCT02807558|324240783|FG000|Overall Study|Non-compliance with Study Drug|0|||
94668886|NCT02807558|324240784|FG001|Overall Study|Non-compliance with Study Drug|0|||
94668887|NCT02807558|324240785|FG002|Overall Study|Non-compliance with Study Drug|1|||
94668888|NCT02807558|324240786|FG003|Overall Study|Non-compliance with Study Drug|0|||
94668889|NCT02807558|324240787|FG004|Overall Study|Non-compliance with Study Drug|0|||
94668890|NCT02807558|324240788|FG005|Overall Study|Non-compliance with Study Drug|0|||
94668891|NCT02807558|324240783|FG000|Overall Study|Adverse Event|0|||
94668892|NCT02807558|324240784|FG001|Overall Study|Adverse Event|0|||
94668893|NCT02807558|324240785|FG002|Overall Study|Adverse Event|9|||
94668894|NCT02807558|324240786|FG003|Overall Study|Adverse Event|0|||
94668895|NCT02807558|324240787|FG004|Overall Study|Adverse Event|0|||
94668896|NCT02807558|324240788|FG005|Overall Study|Adverse Event|0|||
94668897|NCT02807558|324240783|FG000|Overall Study|Death|23|||
94668898|NCT02807558|324240784|FG001|Overall Study|Death|2|||
94668899|NCT02807558|324240785|FG002|Overall Study|Death|3|||
94668900|NCT02807558|324240786|FG003|Overall Study|Death|43|||
94622550|NCT01433991|324081913|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
94622551|NCT01433991|324081914|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
94622552|NCT01433991|324081915|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
94622553|NCT01433991|324081912|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
94668901|NCT02807558|324240787|FG004|Overall Study|Death|24|||
94668902|NCT02807558|324240788|FG005|Overall Study|Death|15|||
94668903|NCT02807558|324240783|FG000|Overall Study|Progressive Disease|0|||
94668904|NCT02807558|324240784|FG001|Overall Study|Progressive Disease|0|||
94668905|NCT02807558|324240785|FG002|Overall Study|Progressive Disease|1|||
94668906|NCT02807558|324240786|FG003|Overall Study|Progressive Disease|0|||
94668907|NCT02807558|324240787|FG004|Overall Study|Progressive Disease|0|||
94668908|NCT02807558|324240788|FG005|Overall Study|Progressive Disease|0|||
94668909|NCT02807558|324240783|FG000|Overall Study|Other than specified|1|||
94668910|NCT02807558|324240784|FG001|Overall Study|Other than specified|0|||
94668911|NCT02807558|324240785|FG002|Overall Study|Other than specified|2|||
94622554|NCT01433991|324081913|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
94668912|NCT02807558|324240786|FG003|Overall Study|Other than specified|0|||
94668913|NCT02807558|324240787|FG004|Overall Study|Other than specified|1|||
94622555|NCT01433991|324081914|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
94622556|NCT01433991|324081915|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
94622557|NCT01433991|324081912|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
94622558|NCT01433991|324081913|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
94622559|NCT01433991|324081914|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
94622560|NCT01433991|324081915|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
94622561|NCT01433991|324081912|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
94622562|NCT01433991|324081913|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
94622563|NCT01433991|324081914|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
94622564|NCT01433991|324081915|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
94622565|NCT01433991|324081912|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
94622566|NCT01433991|324081913|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
94622567|NCT01433991|324081914|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
94622568|NCT01433991|324081915|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
94622569|NCT01433991|324081912|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
94622570|NCT01433991|324081913|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
94622571|NCT01433991|324081914|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
94622572|NCT01433991|324081915|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
94622573|NCT00612690|324081916|FG000|Overall Study|Lost to Follow-up|72|||
94622574|NCT00612690|324081917|FG001|Overall Study|Lost to Follow-up|98|||
94622575|NCT00612690|324081916|FG000|Overall Study|Withdrawal by Subject|32|||
94622576|NCT00612690|324081917|FG001|Overall Study|Withdrawal by Subject|20|||
94622577|NCT00612690|324081916|FG000|Overall Study|Withdrawal by Site|11|||
94622578|NCT00612690|324081917|FG001|Overall Study|Withdrawal by Site|0|||
94622579|NCT01575769|324081918|FG000|Overall Study|Adverse Event|1|||
94622580|NCT01575769|324081918|FG000|Overall Study|Study terminated by sponsor|40|||
94622581|NCT02370160|324081919|FG000|Overall Study|Death|3|||
94622582|NCT02370160|324081920|FG001|Overall Study|Death|4|||
94622583|NCT02370160|324081921|FG002|Overall Study|Death|1|||
94622584|NCT04487730|324081922|FG000|Overall Study|Withdrawal by Subject|3|||
94622585|NCT04487730|324081923|FG001|Overall Study|Withdrawal by Subject|1|||
94622586|NCT04487730|324081922|FG000|Overall Study|Lost to Follow-up|0|||
94622587|NCT04487730|324081923|FG001|Overall Study|Lost to Follow-up|1|||
94622588|NCT04487730|324081922|FG000|Overall Study|Physician Decision|0|||
94622589|NCT04487730|324081923|FG001|Overall Study|Physician Decision|1|||
94622590|NCT02034110|324081926|FG000|Overall Study|Physician Decision|0|||
94622591|NCT02034110|324081927|FG001|Overall Study|Physician Decision|0|||
94622592|NCT02034110|324081928|FG002|Overall Study|Physician Decision|0|||
94622593|NCT02034110|324081929|FG003|Overall Study|Physician Decision|0|||
94622594|NCT02034110|324081930|FG004|Overall Study|Physician Decision|2|||
94622595|NCT02034110|324081931|FG005|Overall Study|Physician Decision|0|||
94622596|NCT02034110|324081932|FG006|Overall Study|Physician Decision|1|||
94622597|NCT02034110|324081933|FG007|Overall Study|Physician Decision|0|||
94622598|NCT02034110|324081926|FG000|Overall Study|Lost to Follow-up|1|||
94622599|NCT02034110|324081927|FG001|Overall Study|Lost to Follow-up|0|||
94622600|NCT02034110|324081928|FG002|Overall Study|Lost to Follow-up|0|||
94622601|NCT02034110|324081929|FG003|Overall Study|Lost to Follow-up|0|||
94622602|NCT02034110|324081930|FG004|Overall Study|Lost to Follow-up|1|||
94622603|NCT02034110|324081931|FG005|Overall Study|Lost to Follow-up|0|||
94622604|NCT02034110|324081932|FG006|Overall Study|Lost to Follow-up|1|||
94622605|NCT02034110|324081933|FG007|Overall Study|Lost to Follow-up|0|||
94622606|NCT02034110|324081926|FG000|Overall Study|Withdrawal by Subject|5|||
94622607|NCT02034110|324081927|FG001|Overall Study|Withdrawal by Subject|7|||
94622608|NCT02034110|324081928|FG002|Overall Study|Withdrawal by Subject|0|||
94622609|NCT02034110|324081929|FG003|Overall Study|Withdrawal by Subject|3|||
94622610|NCT02034110|324081930|FG004|Overall Study|Withdrawal by Subject|7|||
94622611|NCT02034110|324081931|FG005|Overall Study|Withdrawal by Subject|0|||
94622612|NCT02034110|324081932|FG006|Overall Study|Withdrawal by Subject|3|||
94622613|NCT02034110|324081933|FG007|Overall Study|Withdrawal by Subject|1|||
94622614|NCT02034110|324081926|FG000|Overall Study|Study closed by sponsor|6|||
94622615|NCT02034110|324081927|FG001|Overall Study|Study closed by sponsor|2|||
94622616|NCT02034110|324081928|FG002|Overall Study|Study closed by sponsor|0|||
94622617|NCT02034110|324081929|FG003|Overall Study|Study closed by sponsor|6|||
94622618|NCT02034110|324081930|FG004|Overall Study|Study closed by sponsor|7|||
94622619|NCT02034110|324081931|FG005|Overall Study|Study closed by sponsor|0|||
94622620|NCT02034110|324081932|FG006|Overall Study|Study closed by sponsor|42|||
94622621|NCT02034110|324081933|FG007|Overall Study|Study closed by sponsor|0|||
94622622|NCT00691015|324081940|FG000|Overall Study|Refused further treatment|1|||
94622623|NCT00790023|324081944|FG000|Overall Study|Adverse Event|2|||
94622624|NCT00790023|324081945|FG001|Overall Study|Adverse Event|1|||
94622625|NCT00790023|324081946|FG002|Overall Study|Adverse Event|4|||
94622626|NCT00790023|324081944|FG000|Overall Study|Protocol Violation|2|||
94622627|NCT00790023|324081945|FG001|Overall Study|Protocol Violation|4|||
94622628|NCT00790023|324081946|FG002|Overall Study|Protocol Violation|2|||
94622629|NCT00790023|324081944|FG000|Overall Study|Withdrawal by Subject|2|||
94622630|NCT00790023|324081945|FG001|Overall Study|Withdrawal by Subject|0|||
94622631|NCT00790023|324081946|FG002|Overall Study|Withdrawal by Subject|6|||
94622632|NCT00790023|324081944|FG000|Overall Study|Lost to Follow-up|0|||
94622633|NCT00790023|324081945|FG001|Overall Study|Lost to Follow-up|0|||
94622634|NCT00790023|324081946|FG002|Overall Study|Lost to Follow-up|1|||
94622635|NCT00790023|324081944|FG000|Overall Study|Other|5|||
94622636|NCT00790023|324081945|FG001|Overall Study|Other|5|||
94622637|NCT00790023|324081946|FG002|Overall Study|Other|8|||
94622638|NCT03633695|324081947|FG000|Overall Study|Lost to Follow-up|4|||
94622639|NCT03633695|324081948|FG001|Overall Study|Lost to Follow-up|5|||
94622640|NCT03633695|324081947|FG000|Overall Study|Discontinued|8|||
94622641|NCT03633695|324081948|FG001|Overall Study|Discontinued|4|||
94622642|NCT00187486|324081949|FG000|Overall Study|Protocol Violation|1|||
94622643|NCT02380677|324081950|FG000|Overall Study|Adverse Event|0|||
94622644|NCT02380677|324081951|FG001|Overall Study|Adverse Event|0|||
94622645|NCT02380677|324081952|FG002|Overall Study|Adverse Event|0|||
94622646|NCT02380677|324081953|FG003|Overall Study|Adverse Event|1|||
94622647|NCT02380677|324081954|FG004|Overall Study|Adverse Event|1|||
94622648|NCT02380677|324081955|FG005|Overall Study|Adverse Event|4|||
94622649|NCT02380677|324081956|FG006|Overall Study|Adverse Event|2|||
94622650|NCT02380677|324081957|FG007|Overall Study|Adverse Event|2|||
94622651|NCT02380677|324081958|FG008|Overall Study|Adverse Event|2|||
94622652|NCT02380677|324081959|FG009|Overall Study|Adverse Event|1|||
94622653|NCT02380677|324081960|FG010|Overall Study|Adverse Event|2|||
94622654|NCT02380677|324081961|FG011|Overall Study|Adverse Event|1|||
94622655|NCT02380677|324081950|FG000|Overall Study|Physician Decision|1|||
94622656|NCT02380677|324081951|FG001|Overall Study|Physician Decision|0|||
94622657|NCT02380677|324081952|FG002|Overall Study|Physician Decision|1|||
94622658|NCT02380677|324081953|FG003|Overall Study|Physician Decision|1|||
94622659|NCT02380677|324081954|FG004|Overall Study|Physician Decision|0|||
94622660|NCT02380677|324081955|FG005|Overall Study|Physician Decision|0|||
94622661|NCT02380677|324081956|FG006|Overall Study|Physician Decision|0|||
94622662|NCT02380677|324081957|FG007|Overall Study|Physician Decision|0|||
94622663|NCT02380677|324081958|FG008|Overall Study|Physician Decision|0|||
94622664|NCT02380677|324081959|FG009|Overall Study|Physician Decision|0|||
94622665|NCT02380677|324081960|FG010|Overall Study|Physician Decision|0|||
94622666|NCT02380677|324081961|FG011|Overall Study|Physician Decision|0|||
94622667|NCT02380677|324081950|FG000|Overall Study|Lack of Efficacy|0|||
94622668|NCT02380677|324081951|FG001|Overall Study|Lack of Efficacy|1|||
94622669|NCT02380677|324081952|FG002|Overall Study|Lack of Efficacy|2|||
94622670|NCT02380677|324081953|FG003|Overall Study|Lack of Efficacy|0|||
94622671|NCT02380677|324081954|FG004|Overall Study|Lack of Efficacy|4|||
94622672|NCT02380677|324081955|FG005|Overall Study|Lack of Efficacy|1|||
94622673|NCT02380677|324081956|FG006|Overall Study|Lack of Efficacy|1|||
94622674|NCT02380677|324081957|FG007|Overall Study|Lack of Efficacy|2|||
94622675|NCT02380677|324081958|FG008|Overall Study|Lack of Efficacy|2|||
94622676|NCT02380677|324081959|FG009|Overall Study|Lack of Efficacy|0|||
94622677|NCT02380677|324081960|FG010|Overall Study|Lack of Efficacy|2|||
94359555|NCT04668066|323100352|FG016|Part 1: Treatment Phase|Other|0|||
94622678|NCT02380677|324081961|FG011|Overall Study|Lack of Efficacy|1|||
94622679|NCT02380677|324081950|FG000|Overall Study|Withdrawal by Subject|0|||
94622680|NCT02380677|324081951|FG001|Overall Study|Withdrawal by Subject|0|||
94622681|NCT02380677|324081952|FG002|Overall Study|Withdrawal by Subject|0|||
94622682|NCT02380677|324081953|FG003|Overall Study|Withdrawal by Subject|0|||
94622683|NCT02380677|324081954|FG004|Overall Study|Withdrawal by Subject|0|||
94622684|NCT02380677|324081955|FG005|Overall Study|Withdrawal by Subject|0|||
94622685|NCT02380677|324081956|FG006|Overall Study|Withdrawal by Subject|0|||
94622686|NCT02380677|324081957|FG007|Overall Study|Withdrawal by Subject|0|||
94622687|NCT02380677|324081958|FG008|Overall Study|Withdrawal by Subject|0|||
94622688|NCT02380677|324081959|FG009|Overall Study|Withdrawal by Subject|1|||
94622689|NCT02380677|324081960|FG010|Overall Study|Withdrawal by Subject|0|||
94622690|NCT02380677|324081961|FG011|Overall Study|Withdrawal by Subject|3|||
94622691|NCT02380677|324081950|FG000|Overall Study|Other|0|||
94622692|NCT02380677|324081951|FG001|Overall Study|Other|0|||
94622693|NCT02380677|324081952|FG002|Overall Study|Other|0|||
94668914|NCT02807558|324240788|FG005|Overall Study|Other than specified|1|||
94622694|NCT02380677|324081953|FG003|Overall Study|Other|1|||
94622695|NCT02380677|324081954|FG004|Overall Study|Other|1|||
94622696|NCT02380677|324081955|FG005|Overall Study|Other|1|||
94622697|NCT02380677|324081956|FG006|Overall Study|Other|0|||
94622698|NCT02380677|324081957|FG007|Overall Study|Other|0|||
94622699|NCT02380677|324081958|FG008|Overall Study|Other|0|||
94622700|NCT02380677|324081959|FG009|Overall Study|Other|0|||
94622701|NCT02380677|324081960|FG010|Overall Study|Other|0|||
94622702|NCT02380677|324081961|FG011|Overall Study|Other|0|||
94622703|NCT00578812|324081965|FG000|Overall Study|Not treated|6|||
94622704|NCT00578812|324081966|FG001|Overall Study|Not treated|7|||
94622705|NCT03217175|324081967|FG000|Overall Study|Physician Decision|4|||
94622706|NCT03217175|324081968|FG001|Overall Study|Physician Decision|1|||
94622707|NCT01153347|324081972|FG000|Overall Study|Withdrawal by Subject|7|||
94622708|NCT01153347|324081973|FG001|Overall Study|Withdrawal by Subject|7|||
94668915|NCT02807558|324240783|FG000|Overall Study|Lack of Efficacy|0|||
94668916|NCT02807558|324240784|FG001|Overall Study|Lack of Efficacy|0|||
94668917|NCT02807558|324240785|FG002|Overall Study|Lack of Efficacy|9|||
94668918|NCT02807558|324240786|FG003|Overall Study|Lack of Efficacy|0|||
94668919|NCT02807558|324240787|FG004|Overall Study|Lack of Efficacy|0|||
94668920|NCT02807558|324240788|FG005|Overall Study|Lack of Efficacy|0|||
94668921|NCT06116591|324240789|FG000|Overall Study|No longer met eligibility criteria|0|||
94668922|NCT06116591|324240790|FG001|Overall Study|No longer met eligibility criteria|1|||
94668923|NCT06116591|324240789|FG000|Overall Study|Other: Change in life situation|0|||
94668924|NCT06116591|324240790|FG001|Overall Study|Other: Change in life situation|1|||
94668925|NCT03644186|324240791|FG000|Overall Study|Withdrawal by Subject|1|||
94668926|NCT03644186|324240792|FG001|Overall Study|Withdrawal by Subject|1|||
94668927|NCT01618864|324240794|FG000|Overall Study|Withdrawal by Subject|2|||
94668928|NCT01618864|324240794|FG000|Overall Study|Lost to Follow-up|2|||
94668929|NCT05553808|324240795|FG000|Overall Study|Death|25|||
94668930|NCT05553808|324240796|FG001|Overall Study|Death|62|||
94668931|NCT05553808|324240795|FG000|Overall Study|Site Closed|6|||
94668932|NCT05553808|324240796|FG001|Overall Study|Site Closed|6|||
94668933|NCT05553808|324240795|FG000|Overall Study|Lost to Follow-up|1|||
94668934|NCT05553808|324240796|FG001|Overall Study|Lost to Follow-up|0|||
94668935|NCT05553808|324240795|FG000|Overall Study|Withdrawal by Subject|3|||
94668936|NCT05553808|324240796|FG001|Overall Study|Withdrawal by Subject|2|||
94668937|NCT02273141|324240797|FG000|Overall Study|Adverse Event|0|||
94668938|NCT02273141|324240798|FG001|Overall Study|Adverse Event|1|||
94668939|NCT02273141|324240797|FG000|Overall Study|Lost to Follow-up|1|||
94668940|NCT02273141|324240798|FG001|Overall Study|Lost to Follow-up|3|||
94668941|NCT02273141|324240797|FG000|Overall Study|Withdrawal by Subject|10|||
94668942|NCT02273141|324240798|FG001|Overall Study|Withdrawal by Subject|15|||
94668943|NCT02273141|324240797|FG000|Overall Study|Various|6|||
94668944|NCT02273141|324240798|FG001|Overall Study|Various|6|||
94668945|NCT00529399|324240801|FG000|Overall Study|Lost to Follow-up|1|||
94668946|NCT00529399|324240802|FG001|Overall Study|Lost to Follow-up|0|||
94668947|NCT00529399|324240803|FG002|Overall Study|Lost to Follow-up|1|||
94668948|NCT00529399|324240801|FG000|Overall Study|Withdrawal by Subject|1|||
94668949|NCT00529399|324240802|FG001|Overall Study|Withdrawal by Subject|0|||
94668950|NCT00529399|324240803|FG002|Overall Study|Withdrawal by Subject|1|||
94668951|NCT00529399|324240801|FG000|Overall Study|Non-compliant|0|||
94668952|NCT00529399|324240802|FG001|Overall Study|Non-compliant|1|||
94668953|NCT00529399|324240803|FG002|Overall Study|Non-compliant|0|||
94668954|NCT04313881|324240814|FG000|Overall Study|Death|138|||
94668955|NCT04313881|324240815|FG001|Overall Study|Death|126|||
94668956|NCT04313881|324240814|FG000|Overall Study|Study terminated by sponsor|108|||
94668957|NCT04313881|324240815|FG001|Overall Study|Study terminated by sponsor|129|||
94668958|NCT04313881|324240814|FG000|Overall Study|Consent withdrawn|19|||
94668959|NCT04313881|324240815|FG001|Overall Study|Consent withdrawn|15|||
94668960|NCT04313881|324240814|FG000|Overall Study|Reason not Specified|3|||
94668961|NCT04313881|324240815|FG001|Overall Study|Reason not Specified|1|||
94668962|NCT00688636|324240818|FG000|Overall Study|Adverse Event|2|||
94668963|NCT00688636|324240819|FG001|Overall Study|Adverse Event|1|||
94668964|NCT01328574|324240826|FG000|Overall Study|Refused further treatment|1|||
94668965|NCT03449030|324240836|FG000|Overall Study|Withdrawal by Subject|0|||
94668966|NCT03449030|324240837|FG001|Overall Study|Withdrawal by Subject|0|||
94668967|NCT03449030|324240838|FG002|Overall Study|Withdrawal by Subject|0|||
94668968|NCT03449030|324240839|FG003|Overall Study|Withdrawal by Subject|1|||
94668969|NCT03449030|324240840|FG004|Overall Study|Withdrawal by Subject|1|||
94668970|NCT03449030|324240841|FG005|Overall Study|Withdrawal by Subject|1|||
94668971|NCT03449030|324240842|FG006|Overall Study|Withdrawal by Subject|1|||
94668972|NCT03449030|324240843|FG007|Overall Study|Withdrawal by Subject|2|||
94668973|NCT03449030|324240844|FG008|Overall Study|Withdrawal by Subject|0|||
94668974|NCT03449030|324240845|FG009|Overall Study|Withdrawal by Subject|0|||
94668975|NCT03449030|324240836|FG000|Overall Study|Symptomatic Deterioration|0|||
94668976|NCT03449030|324240837|FG001|Overall Study|Symptomatic Deterioration|1|||
94622709|NCT01153347|324081974|FG002|Overall Study|Withdrawal by Subject|7|||
94622710|NCT01153347|324081975|FG003|Overall Study|Withdrawal by Subject|7|||
94622711|NCT01153347|324081972|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
94622712|NCT01153347|324081973|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
94622713|NCT01153347|324081974|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
94622714|NCT01153347|324081975|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
94622715|NCT01153347|324081972|FG000|Overall Study|Adverse Event|3|||
94622716|NCT01153347|324081973|FG001|Overall Study|Adverse Event|9|||
94622717|NCT01153347|324081974|FG002|Overall Study|Adverse Event|21|||
94622718|NCT01153347|324081975|FG003|Overall Study|Adverse Event|7|||
94622719|NCT01153347|324081972|FG000|Overall Study|Severe non-compliance to protocol|6|||
94668977|NCT03449030|324240838|FG002|Overall Study|Symptomatic Deterioration|0|||
94668978|NCT03449030|324240839|FG003|Overall Study|Symptomatic Deterioration|0|||
94668979|NCT03449030|324240840|FG004|Overall Study|Symptomatic Deterioration|0|||
94359556|NCT04668066|323100353|FG017|Part 1: Treatment Phase|Other|0|||
94668980|NCT03449030|324240841|FG005|Overall Study|Symptomatic Deterioration|1|||
94668981|NCT03449030|324240842|FG006|Overall Study|Symptomatic Deterioration|1|||
94668982|NCT03449030|324240843|FG007|Overall Study|Symptomatic Deterioration|0|||
94668983|NCT03449030|324240844|FG008|Overall Study|Symptomatic Deterioration|2|||
94668984|NCT03449030|324240845|FG009|Overall Study|Symptomatic Deterioration|0|||
94668985|NCT03449030|324240836|FG000|Overall Study|Progressive Disease|1|||
94668986|NCT03449030|324240837|FG001|Overall Study|Progressive Disease|0|||
94668987|NCT03449030|324240838|FG002|Overall Study|Progressive Disease|1|||
94668988|NCT03449030|324240839|FG003|Overall Study|Progressive Disease|4|||
94668989|NCT03449030|324240840|FG004|Overall Study|Progressive Disease|5|||
94668990|NCT03449030|324240841|FG005|Overall Study|Progressive Disease|3|||
94668991|NCT03449030|324240842|FG006|Overall Study|Progressive Disease|0|||
94668992|NCT03449030|324240843|FG007|Overall Study|Progressive Disease|1|||
94668993|NCT03449030|324240844|FG008|Overall Study|Progressive Disease|1|||
94668994|NCT03449030|324240845|FG009|Overall Study|Progressive Disease|1|||
94668995|NCT03449030|324240836|FG000|Overall Study|Adverse Event|0|||
94668996|NCT03449030|324240837|FG001|Overall Study|Adverse Event|0|||
94668997|NCT03449030|324240838|FG002|Overall Study|Adverse Event|0|||
94668998|NCT03449030|324240839|FG003|Overall Study|Adverse Event|0|||
94622720|NCT01153347|324081973|FG001|Overall Study|Severe non-compliance to protocol|7|||
94622721|NCT01153347|324081974|FG002|Overall Study|Severe non-compliance to protocol|4|||
94622722|NCT01153347|324081975|FG003|Overall Study|Severe non-compliance to protocol|3|||
94622723|NCT01153347|324081972|FG000|Overall Study|Condition under investigation worsened|1|||
94622724|NCT01153347|324081973|FG001|Overall Study|Condition under investigation worsened|1|||
94622725|NCT01153347|324081974|FG002|Overall Study|Condition under investigation worsened|0|||
94622726|NCT01153347|324081975|FG003|Overall Study|Condition under investigation worsened|0|||
94622727|NCT01153347|324081972|FG000|Overall Study|Lack of Efficacy|2|||
94622728|NCT01153347|324081973|FG001|Overall Study|Lack of Efficacy|2|||
94622729|NCT01153347|324081974|FG002|Overall Study|Lack of Efficacy|0|||
94622730|NCT01153347|324081975|FG003|Overall Study|Lack of Efficacy|4|||
94622731|NCT01153347|324081972|FG000|Overall Study|Study-specific withdrawal criteria|4|||
94622732|NCT01153347|324081973|FG001|Overall Study|Study-specific withdrawal criteria|3|||
94622733|NCT01153347|324081974|FG002|Overall Study|Study-specific withdrawal criteria|1|||
94622734|NCT01153347|324081975|FG003|Overall Study|Study-specific withdrawal criteria|2|||
94622735|NCT01153347|324081972|FG000|Overall Study|Lost to Follow-up|4|||
94622736|NCT01153347|324081973|FG001|Overall Study|Lost to Follow-up|9|||
94622737|NCT01153347|324081974|FG002|Overall Study|Lost to Follow-up|11|||
94622738|NCT01153347|324081975|FG003|Overall Study|Lost to Follow-up|8|||
94622739|NCT01153347|324081972|FG000|Overall Study|Other|5|||
94622740|NCT01153347|324081973|FG001|Overall Study|Other|5|||
94622741|NCT01153347|324081974|FG002|Overall Study|Other|4|||
94622742|NCT01153347|324081975|FG003|Overall Study|Other|0|||
94622743|NCT01153347|324081972|FG000|Overall Study|Death|1|||
94622744|NCT01153347|324081973|FG001|Overall Study|Death|0|||
94622745|NCT01153347|324081974|FG002|Overall Study|Death|0|||
94622746|NCT01153347|324081975|FG003|Overall Study|Death|0|||
94622747|NCT05035550|324081981|FG000|Overall Study|Withdrawal by Subject|3|||
94622748|NCT05035550|324081982|FG001|Overall Study|Withdrawal by Subject|0|||
94622749|NCT00224042|324081989|FG000|Overall Study|Adverse Event|2|||
94622750|NCT00224042|324081990|FG001|Overall Study|Adverse Event|1|||
94622751|NCT00224042|324081989|FG000|Overall Study|Protocol Violation|0|||
94622752|NCT00224042|324081990|FG001|Overall Study|Protocol Violation|1|||
94622753|NCT00224042|324081989|FG000|Overall Study|Physician Decision|0|||
94622754|NCT00224042|324081990|FG001|Overall Study|Physician Decision|1|||
94622755|NCT00224042|324081989|FG000|Overall Study|Did not meet lab incusion criteria|2|||
94622756|NCT00224042|324081990|FG001|Overall Study|Did not meet lab incusion criteria|3|||
94622757|NCT00224042|324081989|FG000|Overall Study|Other|2|||
94622758|NCT00224042|324081990|FG001|Overall Study|Other|0|||
94622759|NCT00840450|324081991|FG000|Overall Study|Adverse Event|1|||
94622760|NCT00840450|324081991|FG000|Overall Study|Lack of Efficacy|2|||
94622761|NCT02495168|324081992|FG000|Overall Study|Other than Specified|18|||
94622762|NCT02495168|324081993|FG001|Overall Study|Other than Specified|22|||
94622763|NCT02495168|324081994|FG002|Overall Study|Other than Specified|5|||
94668999|NCT03449030|324240840|FG004|Overall Study|Adverse Event|0|||
94669000|NCT03449030|324240841|FG005|Overall Study|Adverse Event|2|||
94669001|NCT03449030|324240842|FG006|Overall Study|Adverse Event|0|||
94669002|NCT03449030|324240843|FG007|Overall Study|Adverse Event|0|||
94622764|NCT02495168|324081992|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
94622765|NCT02495168|324081993|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
94622766|NCT02495168|324081994|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
94622767|NCT02495168|324081992|FG000|Overall Study|Physician Decision|1|||
94622768|NCT02495168|324081993|FG001|Overall Study|Physician Decision|1|||
94622769|NCT02495168|324081994|FG002|Overall Study|Physician Decision|0|||
94622770|NCT02495168|324081992|FG000|Overall Study|Lost to Follow-up|10|||
94622771|NCT02495168|324081993|FG001|Overall Study|Lost to Follow-up|6|||
94622772|NCT02495168|324081994|FG002|Overall Study|Lost to Follow-up|1|||
94622773|NCT02495168|324081992|FG000|Overall Study|Withdrawal by Subject|1|||
94669003|NCT03449030|324240844|FG008|Overall Study|Adverse Event|0|||
94669004|NCT03449030|324240845|FG009|Overall Study|Adverse Event|0|||
94669005|NCT03449030|324240836|FG000|Overall Study|Death|0|||
94669006|NCT03449030|324240837|FG001|Overall Study|Death|0|||
94669007|NCT03449030|324240838|FG002|Overall Study|Death|0|||
94669008|NCT03449030|324240839|FG003|Overall Study|Death|0|||
94669009|NCT03449030|324240840|FG004|Overall Study|Death|1|||
94669010|NCT03449030|324240841|FG005|Overall Study|Death|0|||
94669011|NCT03449030|324240842|FG006|Overall Study|Death|0|||
94669012|NCT03449030|324240843|FG007|Overall Study|Death|0|||
94669013|NCT03449030|324240844|FG008|Overall Study|Death|0|||
94669014|NCT03449030|324240845|FG009|Overall Study|Death|0|||
94669015|NCT03282227|324240846|FG000|Overall Study|Exposure Goals Achieved|60|||
94669016|NCT03282227|324240846|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
94669017|NCT03282227|324240846|FG000|Overall Study|Adverse Event|15|||
94669018|NCT03282227|324240846|FG000|Overall Study|Lost to Follow-up|21|||
94669019|NCT03282227|324240846|FG000|Overall Study|Withdrawal by Subject|20|||
94669020|NCT03282227|324240846|FG000|Overall Study|Lack of Efficacy|12|||
94669021|NCT03282227|324240846|FG000|Overall Study|Sponsor decision|3|||
94669022|NCT03282227|324240846|FG000|Overall Study|Physician Decision|2|||
94669023|NCT03282227|324240846|FG000|Overall Study|Pregnancy|2|||
94669024|NCT03282227|324240846|FG000|Overall Study|Other|1|||
94669025|NCT02677116|324240851|FG000|Overall Study|Adverse Event|0|||
94669026|NCT02677116|324240852|FG001|Overall Study|Adverse Event|1|||
94669027|NCT02677116|324240853|FG002|Overall Study|Adverse Event|0|||
94669028|NCT02677116|324240854|FG003|Overall Study|Adverse Event|0|||
94669029|NCT02677116|324240855|FG004|Overall Study|Adverse Event|0|||
94669030|NCT02677116|324240856|FG005|Overall Study|Adverse Event|1|||
94669031|NCT02677116|324240857|FG006|Overall Study|Adverse Event|1|||
94669032|NCT02677116|324240858|FG007|Overall Study|Adverse Event|0|||
94669033|NCT02677116|324240859|FG008|Overall Study|Adverse Event|0|||
94669034|NCT02677116|324240851|FG000|Overall Study|Physician Decision|0|||
94669035|NCT02677116|324240852|FG001|Overall Study|Physician Decision|2|||
94669036|NCT02677116|324240853|FG002|Overall Study|Physician Decision|3|||
94669037|NCT02677116|324240854|FG003|Overall Study|Physician Decision|2|||
94669038|NCT02677116|324240855|FG004|Overall Study|Physician Decision|1|||
94669039|NCT02677116|324240856|FG005|Overall Study|Physician Decision|3|||
94669040|NCT02677116|324240857|FG006|Overall Study|Physician Decision|1|||
94669041|NCT02677116|324240858|FG007|Overall Study|Physician Decision|1|||
94669042|NCT02677116|324240859|FG008|Overall Study|Physician Decision|2|||
94669043|NCT02677116|324240851|FG000|Overall Study|Withdrawal by parent or guardian|2|||
94669044|NCT02677116|324240852|FG001|Overall Study|Withdrawal by parent or guardian|1|||
94669045|NCT02677116|324240853|FG002|Overall Study|Withdrawal by parent or guardian|0|||
94669046|NCT02677116|324240854|FG003|Overall Study|Withdrawal by parent or guardian|1|||
94669047|NCT02677116|324240855|FG004|Overall Study|Withdrawal by parent or guardian|0|||
94669048|NCT02677116|324240856|FG005|Overall Study|Withdrawal by parent or guardian|0|||
94669049|NCT02677116|324240857|FG006|Overall Study|Withdrawal by parent or guardian|2|||
94669050|NCT02677116|324240858|FG007|Overall Study|Withdrawal by parent or guardian|1|||
94669051|NCT02677116|324240859|FG008|Overall Study|Withdrawal by parent or guardian|0|||
94669052|NCT02677116|324240851|FG000|Overall Study|Withdrawal by Subject|1|||
94669053|NCT02677116|324240852|FG001|Overall Study|Withdrawal by Subject|0|||
94669054|NCT02677116|324240853|FG002|Overall Study|Withdrawal by Subject|0|||
94669055|NCT02677116|324240854|FG003|Overall Study|Withdrawal by Subject|0|||
94669056|NCT02677116|324240855|FG004|Overall Study|Withdrawal by Subject|0|||
94669057|NCT02677116|324240856|FG005|Overall Study|Withdrawal by Subject|0|||
94669058|NCT02677116|324240857|FG006|Overall Study|Withdrawal by Subject|0|||
94669059|NCT02677116|324240858|FG007|Overall Study|Withdrawal by Subject|0|||
94669060|NCT02677116|324240859|FG008|Overall Study|Withdrawal by Subject|0|||
94669061|NCT03182868|324240860|FG000|Overall Study|Protocol Violation|3|||
94669062|NCT03182868|324240861|FG001|Overall Study|Protocol Violation|0|||
94669063|NCT03182868|324240862|FG002|Overall Study|Protocol Violation|4|||
94669064|NCT03182868|324240863|FG003|Overall Study|Protocol Violation|1|||
94669065|NCT03182868|324240864|FG004|Overall Study|Protocol Violation|8|||
94669066|NCT00322348|324240868|FG000|Overall Study|Adverse Event|0|||
94669067|NCT00322348|324240869|FG001|Overall Study|Adverse Event|1|||
94669068|NCT00322348|324240868|FG000|Overall Study|Withdrawal by Subject|1|||
94669069|NCT00322348|324240869|FG001|Overall Study|Withdrawal by Subject|4|||
94669070|NCT00322348|324240868|FG000|Overall Study|Lost to Follow-up|1|||
94669071|NCT00322348|324240869|FG001|Overall Study|Lost to Follow-up|0|||
94669072|NCT00322348|324240868|FG000|Overall Study|Death|0|||
94669073|NCT00322348|324240869|FG001|Overall Study|Death|2|||
94669074|NCT00322348|324240868|FG000|Overall Study|Disease Progression|30|||
94669075|NCT00322348|324240869|FG001|Overall Study|Disease Progression|25|||
94669076|NCT00322348|324240868|FG000|Overall Study|Reasons not specified|5|||
94669077|NCT00322348|324240869|FG001|Overall Study|Reasons not specified|1|||
94669078|NCT02341417|324240872|FG000|Overall Study|Withdrawal by Subject|0|||
94669079|NCT02341417|324240873|FG001|Overall Study|Withdrawal by Subject|2|||
94669080|NCT02341417|324240874|FG002|Overall Study|Withdrawal by Subject|0|||
94669081|NCT02341417|324240872|FG000|Overall Study|Decision by sponsor|2|||
94669082|NCT02341417|324240873|FG001|Overall Study|Decision by sponsor|0|||
94669083|NCT02341417|324240874|FG002|Overall Study|Decision by sponsor|0|||
94669084|NCT02341417|324240872|FG000|Overall Study|Death|0|||
94669085|NCT02341417|324240873|FG001|Overall Study|Death|0|||
94669086|NCT02341417|324240874|FG002|Overall Study|Death|1|||
94669087|NCT01995461|324240886|FG000|Overall Study|Death|1|||
94669088|NCT01995461|324240886|FG000|Overall Study|Lost to Follow-up|2|||
94669089|NCT01995461|324240886|FG000|Overall Study|Withdrawal by Subject|2|||
94669090|NCT02625623|324240889|FG000|Overall Study|Participants randomized but not treated|9|||
94669091|NCT02625623|324240890|FG001|Overall Study|Participants randomized but not treated|1|||
94669092|NCT00490646|324240891|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
94669093|NCT00490646|324240892|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
94669094|NCT00490646|324240891|FG000|Overall Study|Never Treated (had an adverse event)|1|||
94669095|NCT00490646|324240892|FG001|Overall Study|Never Treated (had an adverse event)|0|||
94669096|NCT00490646|324240891|FG000|Overall Study|Never Treated (withdrew consent)|0|||
94669097|NCT00490646|324240892|FG001|Overall Study|Never Treated (withdrew consent)|1|||
94669098|NCT02626780|324240897|FG000|Overall Study|Withdrawal by Subject|3|||
94669099|NCT04918784|324242832|FG000|Overall Study|Amputation - no longer eligible|1|||
94669100|NCT04918784|324242833|FG001|Overall Study|Amputation - no longer eligible|2|||
94669101|NCT04918784|324242832|FG000|Overall Study|Death|1|||
94669102|NCT04918784|324242833|FG001|Overall Study|Death|0|||
94669103|NCT04918784|324242832|FG000|Overall Study|patient non-compliance|3|||
94669104|NCT04918784|324242833|FG001|Overall Study|patient non-compliance|1|||
94669105|NCT04918784|324242832|FG000|Overall Study|Adverse Event|1|||
94669106|NCT04918784|324242833|FG001|Overall Study|Adverse Event|0|||
94669107|NCT01258608|324242834|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
94669108|NCT01258608|324242835|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
94669109|NCT01258608|324242834|FG000|Overall Study|Clinical progression|1|||
94669110|NCT01258608|324242835|FG001|Overall Study|Clinical progression|0|||
94669111|NCT01258608|324242834|FG000|Overall Study|Sponsor decision|0|||
94669112|NCT01258608|324242835|FG001|Overall Study|Sponsor decision|1|||
94669113|NCT01258608|324242834|FG000|Overall Study|Physician Decision|6|||
94669114|NCT01258608|324242835|FG001|Overall Study|Physician Decision|1|||
94669115|NCT01258608|324242834|FG000|Overall Study|Lost to Follow-up|0|||
94669116|NCT01258608|324242835|FG001|Overall Study|Lost to Follow-up|1|||
94669117|NCT01258608|324242834|FG000|Overall Study|Lack of compliance|1|||
94669118|NCT01258608|324242835|FG001|Overall Study|Lack of compliance|0|||
94669119|NCT01258608|324242834|FG000|Overall Study|Lack of Efficacy|0|||
94669120|NCT01258608|324242835|FG001|Overall Study|Lack of Efficacy|1|||
94669121|NCT01258608|324242834|FG000|Overall Study|Adverse Event|6|||
94669122|NCT01258608|324242835|FG001|Overall Study|Adverse Event|10|||
94669123|NCT01258608|324242834|FG000|Overall Study|Withdrawal by Subject|6|||
94669124|NCT01258608|324242835|FG001|Overall Study|Withdrawal by Subject|5|||
94669125|NCT04205630|324242840|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
94669126|NCT04205630|324242840|FG000|Overall Study|Disease clinical progression|7|||
94669127|NCT04205630|324242840|FG000|Overall Study|Withdrawal by Subject|2|||
94669128|NCT04205630|324242840|FG000|Overall Study|Adverse Event|17|||
94669129|NCT04205630|324242840|FG000|Overall Study|Other|1|||
94669130|NCT02943408|324242841|FG000|Overall Study|Lost to Follow-up|7|||
94669131|NCT02943408|324242842|FG001|Overall Study|Lost to Follow-up|1|||
94669132|NCT02943408|324242841|FG000|Overall Study|Withdrawal by Subject|0|||
94669133|NCT02943408|324242842|FG001|Overall Study|Withdrawal by Subject|1|||
94669134|NCT02985866|324242847|FG000|Overall Study|Poor CGM data|1|||
94669135|NCT02985866|324242848|FG001|Overall Study|Poor CGM data|1|||
94669136|NCT02008890|324242849|FG000|Period 1|Withdrawal by Subject|7|||
94669137|NCT02008890|324242850|FG001|Period 1|Withdrawal by Subject|7|||
94669138|NCT02008890|324242851|FG002|Period 1|Withdrawal by Subject|5|||
94669139|NCT02008890|324242852|FG003|Period 1|Withdrawal by Subject|0|||
94669140|NCT02008890|324242853|FG004|Period 1|Withdrawal by Subject|0|||
94669141|NCT02008890|324242849|FG000|Period 1|Pregnancy|1|||
94669142|NCT02008890|324242850|FG001|Period 1|Pregnancy|0|||
94669143|NCT02008890|324242851|FG002|Period 1|Pregnancy|0|||
94669144|NCT02008890|324242852|FG003|Period 1|Pregnancy|0|||
94669145|NCT02008890|324242853|FG004|Period 1|Pregnancy|0|||
94669146|NCT02008890|324242849|FG000|Period 1|Physician Decision|1|||
94669147|NCT02008890|324242850|FG001|Period 1|Physician Decision|0|||
94669148|NCT02008890|324242851|FG002|Period 1|Physician Decision|1|||
94669149|NCT02008890|324242852|FG003|Period 1|Physician Decision|0|||
94669150|NCT02008890|324242853|FG004|Period 1|Physician Decision|0|||
94669151|NCT02008890|324242849|FG000|Period 1|Adverse Event|6|||
94669152|NCT02008890|324242850|FG001|Period 1|Adverse Event|8|||
94669153|NCT02008890|324242851|FG002|Period 1|Adverse Event|6|||
94669154|NCT02008890|324242852|FG003|Period 1|Adverse Event|0|||
94669155|NCT02008890|324242853|FG004|Period 1|Adverse Event|0|||
94669156|NCT02008890|324242849|FG000|Period 2|Adverse Event|12|||
94669157|NCT02008890|324242850|FG001|Period 2|Adverse Event|7|||
94669158|NCT02008890|324242851|FG002|Period 2|Adverse Event|0|||
94669159|NCT02008890|324242852|FG003|Period 2|Adverse Event|5|||
94669160|NCT02008890|324242853|FG004|Period 2|Adverse Event|5|||
94669161|NCT02008890|324242849|FG000|Period 2|Withdrawal by Subject|11|||
94669162|NCT02008890|324242850|FG001|Period 2|Withdrawal by Subject|8|||
94669163|NCT02008890|324242851|FG002|Period 2|Withdrawal by Subject|0|||
94669164|NCT02008890|324242852|FG003|Period 2|Withdrawal by Subject|7|||
94669165|NCT02008890|324242853|FG004|Period 2|Withdrawal by Subject|2|||
94669166|NCT02008890|324242849|FG000|Period 2|Physician Decision|4|||
94669167|NCT02008890|324242850|FG001|Period 2|Physician Decision|0|||
94669168|NCT02008890|324242851|FG002|Period 2|Physician Decision|0|||
94669169|NCT02008890|324242852|FG003|Period 2|Physician Decision|2|||
94669170|NCT02008890|324242853|FG004|Period 2|Physician Decision|1|||
94669171|NCT02008890|324242849|FG000|Period 2|Lost to Follow-up|0|||
94669172|NCT02008890|324242850|FG001|Period 2|Lost to Follow-up|0|||
94669173|NCT02008890|324242851|FG002|Period 2|Lost to Follow-up|1|||
94669174|NCT02008890|324242852|FG003|Period 2|Lost to Follow-up|0|||
94669175|NCT02008890|324242853|FG004|Period 2|Lost to Follow-up|0|||
94669176|NCT02008890|324242849|FG000|Extension Period|Withdrawal by Subject|3|||
94669177|NCT02008890|324242850|FG001|Extension Period|Withdrawal by Subject|2|||
94669178|NCT02008890|324242851|FG002|Extension Period|Withdrawal by Subject|0|||
94669179|NCT02008890|324242852|FG003|Extension Period|Withdrawal by Subject|4|||
94669180|NCT02008890|324242853|FG004|Extension Period|Withdrawal by Subject|2|||
94622774|NCT02495168|324081993|FG001|Overall Study|Withdrawal by Subject|4|||
94622775|NCT02495168|324081994|FG002|Overall Study|Withdrawal by Subject|2|||
94622776|NCT02495168|324081992|FG000|Overall Study|Protocol Violation|0|||
94622777|NCT02495168|324081993|FG001|Overall Study|Protocol Violation|10|||
94622778|NCT02495168|324081994|FG002|Overall Study|Protocol Violation|1|||
94622779|NCT02495168|324081992|FG000|Overall Study|Adverse Event|4|||
94622780|NCT02495168|324081993|FG001|Overall Study|Adverse Event|8|||
94622781|NCT02495168|324081994|FG002|Overall Study|Adverse Event|3|||
94622782|NCT02495168|324081992|FG000|Overall Study|Lack of Efficacy|0|||
94622783|NCT02495168|324081993|FG001|Overall Study|Lack of Efficacy|0|||
94622784|NCT02495168|324081994|FG002|Overall Study|Lack of Efficacy|3|||
94622785|NCT00133952|324081995|FG000|Overall Study|Adverse Event|1|||
94622786|NCT00133952|324081996|FG001|Overall Study|Adverse Event|2|||
94622787|NCT00133952|324081995|FG000|Overall Study|Death|3|||
94622788|NCT00133952|324081996|FG001|Overall Study|Death|2|||
94622789|NCT00133952|324081995|FG000|Overall Study|Lost to Follow-up|9|||
94622790|NCT00133952|324081996|FG001|Overall Study|Lost to Follow-up|14|||
94622791|NCT00133952|324081995|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
94622792|NCT00133952|324081996|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
94622793|NCT00133952|324081995|FG000|Overall Study|Protocol Violation|1|||
94622794|NCT00133952|324081996|FG001|Overall Study|Protocol Violation|1|||
94622795|NCT00133952|324081995|FG000|Overall Study|Withdrawal by Subject|20|||
94622796|NCT00133952|324081996|FG001|Overall Study|Withdrawal by Subject|4|||
94622797|NCT00133952|324081995|FG000|Overall Study|Physician Decision|4|||
94622798|NCT00133952|324081996|FG001|Overall Study|Physician Decision|3|||
94622799|NCT00133952|324081995|FG000|Overall Study|Sponsor Decision|0|||
94622800|NCT00133952|324081996|FG001|Overall Study|Sponsor Decision|1|||
94622801|NCT01867424|324081999|FG000|Overall Study|Patient noncompliance|2|||
94622802|NCT01867424|324082000|FG001|Overall Study|Patient noncompliance|1|||
94622803|NCT00867568|324082001|FG000|Overall Study|Lack of Efficacy|10|||
94622804|NCT00867568|324082001|FG000|Overall Study|Adverse Event|4|||
94622805|NCT00867568|324082001|FG000|Overall Study|Withdrawal by Subject|1|||
94622806|NCT03639935|324082002|FG000|Overall Study|Death|3|||
94622807|NCT03639935|324082002|FG000|Overall Study|Adverse Event|1|||
94622808|NCT03616600|324082003|FG000|Overall Study|Withdrawal by Subject|1|||
94622809|NCT03616600|324082004|FG001|Overall Study|Withdrawal by Subject|0|||
94622810|NCT05386680|324082005|FG000|Overall Study|Guardian decision|2|||
94622811|NCT01847274|324082006|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
94622812|NCT01847274|324082007|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
94622813|NCT01847274|324082008|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
94622814|NCT01847274|324082009|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
94622815|NCT01847274|324082010|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
94622816|NCT01847274|324082011|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
94622817|NCT01847274|324082012|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
94622818|NCT01847274|324082013|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
94622819|NCT01847274|324082014|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
94669181|NCT02008890|324242849|FG000|Extension Period|Lost to Follow-up|1|||
94669182|NCT02008890|324242850|FG001|Extension Period|Lost to Follow-up|0|||
94669183|NCT02008890|324242851|FG002|Extension Period|Lost to Follow-up|0|||
94669184|NCT02008890|324242852|FG003|Extension Period|Lost to Follow-up|0|||
94622820|NCT01847274|324082015|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
94622821|NCT01847274|324082016|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
94622822|NCT01847274|324082006|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
94622823|NCT01847274|324082007|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
94669185|NCT02008890|324242853|FG004|Extension Period|Lost to Follow-up|0|||
94669186|NCT02008890|324242849|FG000|Extension Period|Adverse Event|1|||
94669187|NCT02008890|324242850|FG001|Extension Period|Adverse Event|3|||
94669188|NCT02008890|324242851|FG002|Extension Period|Adverse Event|0|||
94622824|NCT01847274|324082008|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
94622825|NCT01847274|324082009|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
94622826|NCT01847274|324082010|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
94622827|NCT01847274|324082011|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
94622828|NCT01847274|324082012|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
94622829|NCT01847274|324082013|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
94622830|NCT01847274|324082014|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
94622831|NCT01847274|324082015|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
94622832|NCT01847274|324082016|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
94622833|NCT01847274|324082006|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
94622834|NCT01847274|324082007|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
94622835|NCT01847274|324082008|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
94622836|NCT01847274|324082009|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
94622837|NCT01847274|324082010|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
94622838|NCT01847274|324082011|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
94622839|NCT01847274|324082012|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
94622840|NCT01847274|324082013|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
94622841|NCT01847274|324082014|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
94622842|NCT01847274|324082015|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
94622843|NCT01847274|324082016|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
94622844|NCT01847274|324082006|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
94622845|NCT01847274|324082007|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
94622846|NCT01847274|324082008|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
94622847|NCT01847274|324082009|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
94622848|NCT01847274|324082010|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
94622849|NCT01847274|324082011|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
94669189|NCT02008890|324242852|FG003|Extension Period|Adverse Event|0|||
94669190|NCT02008890|324242853|FG004|Extension Period|Adverse Event|2|||
94669191|NCT01773070|324242860|FG000|Overall Study|Withdrawal by Subject|24|||
94669192|NCT01773070|324242860|FG000|Overall Study|Lost to Follow-up|39|||
94669193|NCT01773070|324242860|FG000|Overall Study|Other|15|||
94669194|NCT01773070|324242860|FG000|Overall Study|Death (unrelated to study procedures)|3|||
94669195|NCT02925455|324242861|FG000|Overall Study|Withdrawal by Subject|2|||
94669196|NCT02925455|324242862|FG001|Overall Study|Withdrawal by Subject|0|||
94669197|NCT00951041|324242863|FG000|Overall Study|Withdrawal by Subject|1|||
94669198|NCT00951041|324242864|FG001|Overall Study|Withdrawal by Subject|1|||
94669199|NCT00951041|324242863|FG000|Overall Study|Lost to Follow-up|1|||
94669200|NCT00951041|324242864|FG001|Overall Study|Lost to Follow-up|0|||
94669201|NCT00951041|324242863|FG000|Overall Study|Other|3|||
94669202|NCT00951041|324242864|FG001|Overall Study|Other|0|||
94669203|NCT03561090|324242867|FG000|Overall Study|Adverse Event|11|||
94669204|NCT03561090|324242868|FG001|Overall Study|Adverse Event|7|||
94669205|NCT03561090|324242867|FG000|Overall Study|Non-Compliance With Study Drug|2|||
94669206|NCT03561090|324242868|FG001|Overall Study|Non-Compliance With Study Drug|0|||
94669207|NCT03561090|324242867|FG000|Overall Study|Protocol Violation|2|||
94669208|NCT03561090|324242868|FG001|Overall Study|Protocol Violation|2|||
94669209|NCT03561090|324242867|FG000|Overall Study|Withdrawal by Subject|7|||
94669210|NCT03561090|324242868|FG001|Overall Study|Withdrawal by Subject|7|||
94669211|NCT03561090|324242867|FG000|Overall Study|Lost to Follow-up|7|||
94669212|NCT03561090|324242868|FG001|Overall Study|Lost to Follow-up|2|||
94669213|NCT03561090|324242867|FG000|Overall Study|Study Terminated by Sponsor|10|||
94669214|NCT03561090|324242868|FG001|Overall Study|Study Terminated by Sponsor|15|||
94669215|NCT03561090|324242867|FG000|Overall Study|Randomized by Mistake|1|||
94669216|NCT03561090|324242868|FG001|Overall Study|Randomized by Mistake|1|||
94669217|NCT03561090|324242867|FG000|Overall Study|Other Not Specified|0|||
94669218|NCT03561090|324242868|FG001|Overall Study|Other Not Specified|2|||
94669219|NCT00725452|324242871|FG000|Overall Study|Adverse Event|3|||
94669220|NCT00725452|324242871|FG000|Overall Study|Lack of Efficacy|2|||
94669221|NCT00725452|324242871|FG000|Overall Study|Reason not specified|1|||
94669222|NCT00725452|324242871|FG000|Overall Study|Physician Decision|1|||
94669223|NCT00725452|324242871|FG000|Overall Study|Withdrawal by Subject|3|||
94669224|NCT00725452|324242871|FG000|Overall Study|Lost to Follow-up|1|||
94669225|NCT02163733|324242872|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
94669226|NCT02163733|324242873|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
94669227|NCT02163733|324242874|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
94669228|NCT02163733|324242872|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
94669229|NCT02163733|324242873|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
94669230|NCT02163733|324242874|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
94669231|NCT02723864|324242875|FG000|Overall Study|Refused further treatment|1|||
94669232|NCT02723864|324242876|FG001|Overall Study|Refused further treatment|0|||
94669233|NCT02723864|324242877|FG002|Overall Study|Refused further treatment|0|||
94669234|NCT02723864|324242878|FG003|Overall Study|Refused further treatment|0|||
94669235|NCT02723864|324242879|FG004|Overall Study|Refused further treatment|1|||
94669236|NCT02723864|324242880|FG005|Overall Study|Refused further treatment|2|||
94669237|NCT02723864|324242881|FG006|Overall Study|Refused further treatment|0|||
94669238|NCT02723864|324242875|FG000|Overall Study|Exceed treatment hold time|0|||
94622850|NCT01847274|324082012|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
94622851|NCT01847274|324082013|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
94622852|NCT01847274|324082014|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
94622853|NCT01847274|324082015|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
94622854|NCT01847274|324082016|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
94622855|NCT01847274|324082006|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
94622856|NCT01847274|324082007|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
94622857|NCT01847274|324082008|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
94622858|NCT01847274|324082009|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
94622859|NCT01847274|324082010|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
94622860|NCT01847274|324082011|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
94622861|NCT01847274|324082012|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
94622862|NCT01847274|324082013|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
94622863|NCT01847274|324082014|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
94622864|NCT01847274|324082015|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
94622865|NCT01847274|324082016|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
94622866|NCT01847274|324082006|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
94622867|NCT01847274|324082007|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
94622868|NCT01847274|324082008|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
94622869|NCT01847274|324082009|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
94622870|NCT01847274|324082010|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
94622871|NCT01847274|324082011|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
94622872|NCT01847274|324082012|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
94622873|NCT01847274|324082013|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
94622874|NCT01847274|324082014|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
94622875|NCT01847274|324082015|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
94622876|NCT01847274|324082016|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
94622877|NCT01847274|324082006|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
94622878|NCT01847274|324082007|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
94622879|NCT01847274|324082008|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
94622880|NCT01847274|324082009|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
94622881|NCT01847274|324082010|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
94622882|NCT01847274|324082011|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
94622883|NCT01847274|324082012|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
94622884|NCT01847274|324082013|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
94622885|NCT01847274|324082014|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
94622886|NCT01847274|324082015|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
94622887|NCT01847274|324082016|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
94622888|NCT01847274|324082006|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
94622889|NCT01847274|324082007|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
94622890|NCT01847274|324082008|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
94622891|NCT01847274|324082009|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
94622892|NCT01847274|324082010|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
94622893|NCT01847274|324082011|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
94622894|NCT01847274|324082012|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
94622895|NCT01847274|324082013|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
94622896|NCT01847274|324082014|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
94622897|NCT01847274|324082015|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
94622898|NCT01847274|324082016|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
94622899|NCT01847274|324082006|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
94622900|NCT01847274|324082007|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
94622901|NCT01847274|324082008|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
94622902|NCT01847274|324082009|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
94622903|NCT01847274|324082010|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
94622904|NCT01847274|324082011|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
94622905|NCT01847274|324082012|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
94622906|NCT01847274|324082013|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
94669239|NCT02723864|324242876|FG001|Overall Study|Exceed treatment hold time|1|||
94669240|NCT02723864|324242877|FG002|Overall Study|Exceed treatment hold time|0|||
94669241|NCT02723864|324242878|FG003|Overall Study|Exceed treatment hold time|0|||
94669242|NCT02723864|324242879|FG004|Overall Study|Exceed treatment hold time|0|||
94669243|NCT02723864|324242880|FG005|Overall Study|Exceed treatment hold time|0|||
94669244|NCT02723864|324242881|FG006|Overall Study|Exceed treatment hold time|0|||
94669245|NCT02723864|324242875|FG000|Overall Study|Clinical progression|0|||
94669246|NCT02723864|324242876|FG001|Overall Study|Clinical progression|0|||
94669247|NCT02723864|324242877|FG002|Overall Study|Clinical progression|1|||
94669248|NCT02723864|324242878|FG003|Overall Study|Clinical progression|0|||
94669249|NCT02723864|324242879|FG004|Overall Study|Clinical progression|0|||
94669250|NCT02723864|324242880|FG005|Overall Study|Clinical progression|3|||
94669251|NCT02723864|324242881|FG006|Overall Study|Clinical progression|1|||
94669252|NCT02723864|324242875|FG000|Overall Study|Physician Decision|0|||
94669253|NCT02723864|324242876|FG001|Overall Study|Physician Decision|0|||
94669254|NCT02723864|324242877|FG002|Overall Study|Physician Decision|0|||
94669255|NCT02723864|324242878|FG003|Overall Study|Physician Decision|0|||
94669256|NCT02723864|324242879|FG004|Overall Study|Physician Decision|0|||
94669257|NCT02723864|324242880|FG005|Overall Study|Physician Decision|0|||
94669258|NCT02723864|324242881|FG006|Overall Study|Physician Decision|1|||
94669259|NCT02723864|324242875|FG000|Overall Study|Changes in patient condition|0|||
94669260|NCT02723864|324242876|FG001|Overall Study|Changes in patient condition|0|||
94669261|NCT02723864|324242877|FG002|Overall Study|Changes in patient condition|0|||
94669262|NCT02723864|324242878|FG003|Overall Study|Changes in patient condition|0|||
94669263|NCT02723864|324242879|FG004|Overall Study|Changes in patient condition|0|||
94669264|NCT02723864|324242880|FG005|Overall Study|Changes in patient condition|1|||
94669265|NCT02723864|324242881|FG006|Overall Study|Changes in patient condition|0|||
94669266|NCT02723864|324242875|FG000|Overall Study|Patient choice|0|||
94669267|NCT02723864|324242876|FG001|Overall Study|Patient choice|0|||
94669268|NCT02723864|324242877|FG002|Overall Study|Patient choice|0|||
94669269|NCT02723864|324242878|FG003|Overall Study|Patient choice|0|||
94669270|NCT02723864|324242879|FG004|Overall Study|Patient choice|0|||
94669271|NCT02723864|324242880|FG005|Overall Study|Patient choice|1|||
94669272|NCT02723864|324242881|FG006|Overall Study|Patient choice|0|||
94669273|NCT02723864|324242875|FG000|Overall Study|Adverse Event|0|||
94669274|NCT02723864|324242876|FG001|Overall Study|Adverse Event|0|||
94669275|NCT02723864|324242877|FG002|Overall Study|Adverse Event|0|||
94669276|NCT02723864|324242878|FG003|Overall Study|Adverse Event|0|||
94669277|NCT02723864|324242879|FG004|Overall Study|Adverse Event|0|||
94669278|NCT02723864|324242880|FG005|Overall Study|Adverse Event|1|||
94669279|NCT02723864|324242881|FG006|Overall Study|Adverse Event|0|||
94669280|NCT02723864|324242875|FG000|Overall Study|Started new treatment|0|||
94669281|NCT02723864|324242876|FG001|Overall Study|Started new treatment|0|||
94669282|NCT02723864|324242877|FG002|Overall Study|Started new treatment|0|||
94669283|NCT02723864|324242878|FG003|Overall Study|Started new treatment|0|||
94669284|NCT02723864|324242879|FG004|Overall Study|Started new treatment|0|||
94669285|NCT02723864|324242880|FG005|Overall Study|Started new treatment|1|||
94669286|NCT02723864|324242881|FG006|Overall Study|Started new treatment|0|||
94669287|NCT02723864|324242875|FG000|Overall Study|Switched to alternative treatment|0|||
94669288|NCT02723864|324242876|FG001|Overall Study|Switched to alternative treatment|0|||
94669289|NCT02723864|324242877|FG002|Overall Study|Switched to alternative treatment|0|||
94669290|NCT02723864|324242878|FG003|Overall Study|Switched to alternative treatment|0|||
94669291|NCT02723864|324242879|FG004|Overall Study|Switched to alternative treatment|0|||
94669292|NCT02723864|324242880|FG005|Overall Study|Switched to alternative treatment|1|||
94669293|NCT02723864|324242881|FG006|Overall Study|Switched to alternative treatment|0|||
94669294|NCT02723864|324242875|FG000|Overall Study|Late determination of ineligibility|0|||
94669295|NCT02723864|324242876|FG001|Overall Study|Late determination of ineligibility|0|||
94669296|NCT02723864|324242877|FG002|Overall Study|Late determination of ineligibility|0|||
94669297|NCT02723864|324242878|FG003|Overall Study|Late determination of ineligibility|0|||
94669298|NCT02723864|324242879|FG004|Overall Study|Late determination of ineligibility|0|||
94669299|NCT02723864|324242880|FG005|Overall Study|Late determination of ineligibility|1|||
94669300|NCT02723864|324242881|FG006|Overall Study|Late determination of ineligibility|0|||
94669301|NCT00713648|324242884|FG000|Overall Study|Adverse Event|1|||
94669302|NCT00713648|324242884|FG000|Overall Study|Unclassified|2|||
94669303|NCT00713648|324242884|FG000|Overall Study|According to Protocol|2|||
94669304|NCT00713648|324242884|FG000|Overall Study|Development of antibodies|3|||
94669305|NCT02047045|324242885|FG000|Baseline|Withdrawal by Subject|3|||
94669306|NCT02047045|324242886|FG001|Baseline|Withdrawal by Subject|2|||
94669307|NCT02047045|324242885|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
94669308|NCT02047045|324242886|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
94669309|NCT02047045|324242885|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
94669310|NCT02047045|324242886|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
94669311|NCT02047045|324242885|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
94669312|NCT02047045|324242886|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
94669313|NCT02047045|324242885|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
94669314|NCT02047045|324242886|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
94669315|NCT02047045|324242885|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
94669316|NCT02047045|324242886|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
94669317|NCT02047045|324242885|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
94669318|NCT02047045|324242886|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
94669319|NCT02047045|324242885|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
94669320|NCT02047045|324242886|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
94669321|NCT02047045|324242885|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
94669322|NCT02047045|324242886|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
94669323|NCT02633800|324242887|FG000|Overall Study|Death|3|||
94669324|NCT02633800|324242888|FG001|Overall Study|Death|3|||
94669325|NCT02633800|324242887|FG000|Overall Study|Reason not provided|1|||
94669326|NCT02633800|324242888|FG001|Overall Study|Reason not provided|0|||
94669327|NCT02633800|324242887|FG000|Overall Study|Radiologic(al) progression|23|||
94669328|NCT02633800|324242888|FG001|Overall Study|Radiologic(al) progression|23|||
94669329|NCT02633800|324242887|FG000|Overall Study|Clinical progression|3|||
94669330|NCT02633800|324242888|FG001|Overall Study|Clinical progression|6|||
94669331|NCT02633800|324242887|FG000|Overall Study|Study terminated by sponsor|6|||
94669332|NCT02633800|324242888|FG001|Overall Study|Study terminated by sponsor|5|||
94669333|NCT02633800|324242887|FG000|Overall Study|Adverse event, non-fatal|7|||
94669334|NCT02633800|324242888|FG001|Overall Study|Adverse event, non-fatal|2|||
94669335|NCT02633800|324242887|FG000|Overall Study|Withdrawal by Subject|0|||
94669336|NCT02633800|324242888|FG001|Overall Study|Withdrawal by Subject|3|||
94669337|NCT02633800|324242887|FG000|Overall Study|Patient Request|1|||
94669338|NCT02633800|324242888|FG001|Overall Study|Patient Request|1|||
94669339|NCT00082173|324242889|FG000|Overall Study|Withdrawal by Subject|3|||
94669340|NCT00082173|324242890|FG001|Overall Study|Withdrawal by Subject|5|||
94669341|NCT00082173|324242889|FG000|Overall Study|Lost to Follow-up|1|||
94669342|NCT00082173|324242890|FG001|Overall Study|Lost to Follow-up|0|||
94669343|NCT00082173|324242889|FG000|Overall Study|Adverse Event|1|||
94669344|NCT00082173|324242890|FG001|Overall Study|Adverse Event|0|||
94622907|NCT01847274|324082014|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
94622908|NCT01847274|324082015|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
94622909|NCT01847274|324082016|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
94622910|NCT01847274|324082006|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
94622911|NCT01847274|324082007|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
94622912|NCT01847274|324082008|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
94622913|NCT01847274|324082009|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
94622914|NCT01847274|324082010|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
94622915|NCT01847274|324082011|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
94622916|NCT01847274|324082012|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
94622917|NCT01847274|324082013|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
94622918|NCT01847274|324082014|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
94622919|NCT01847274|324082015|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
94622920|NCT01847274|324082016|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
94622921|NCT01847274|324082006|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
94622922|NCT01847274|324082007|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
94622923|NCT01847274|324082008|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
94622924|NCT01847274|324082009|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
94622925|NCT01847274|324082010|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
94622926|NCT01847274|324082011|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
94622927|NCT01847274|324082012|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
94622928|NCT01847274|324082013|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
94622929|NCT01847274|324082014|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
94622930|NCT01847274|324082015|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
94622931|NCT01847274|324082016|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
94622932|NCT01847274|324082006|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
94622933|NCT01847274|324082007|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
94622934|NCT01847274|324082008|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
94622935|NCT01847274|324082009|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
94622936|NCT01847274|324082010|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
94622937|NCT01847274|324082011|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
94622938|NCT01847274|324082012|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
94622939|NCT01847274|324082013|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
94669345|NCT00082173|324242889|FG000|Overall Study|Culture negative or resistant at baselin|5|||
94669346|NCT00082173|324242890|FG001|Overall Study|Culture negative or resistant at baselin|6|||
94669347|NCT00746590|324242891|FG000|Overall Study|Death|1|||
94669348|NCT03214367|324242892|FG000|Lead-in Period|Withdrawal by Subject|50|||
94669349|NCT03214367|324242893|FG001|Lead-in Period|Withdrawal by Subject|0|||
94669350|NCT03214367|324242894|FG002|Lead-in Period|Withdrawal by Subject|0|||
94669351|NCT03214367|324242895|FG003|Lead-in Period|Withdrawal by Subject|0|||
94669352|NCT03214367|324242896|FG004|Lead-in Period|Withdrawal by Subject|2|||
94669353|NCT03214367|324242897|FG005|Lead-in Period|Withdrawal by Subject|0|||
94669354|NCT03214367|324242898|FG006|Lead-in Period|Withdrawal by Subject|0|||
94669355|NCT03214367|324242899|FG007|Lead-in Period|Withdrawal by Subject|0|||
94669356|NCT03214367|324242892|FG000|Lead-in Period|Adverse Event|3|||
94669357|NCT03214367|324242893|FG001|Lead-in Period|Adverse Event|0|||
94669358|NCT03214367|324242894|FG002|Lead-in Period|Adverse Event|0|||
94669359|NCT03214367|324242895|FG003|Lead-in Period|Adverse Event|0|||
94669360|NCT03214367|324242896|FG004|Lead-in Period|Adverse Event|0|||
94669361|NCT03214367|324242897|FG005|Lead-in Period|Adverse Event|0|||
94669362|NCT03214367|324242898|FG006|Lead-in Period|Adverse Event|0|||
94669363|NCT03214367|324242899|FG007|Lead-in Period|Adverse Event|0|||
94622940|NCT01847274|324082014|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
94622941|NCT01847274|324082015|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
94622942|NCT01847274|324082016|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
94622943|NCT01847274|324082006|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
94622944|NCT01847274|324082007|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
94622945|NCT01847274|324082008|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
94622946|NCT01847274|324082009|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
94622947|NCT01847274|324082010|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
94622948|NCT01847274|324082011|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
94622949|NCT01847274|324082012|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
94622950|NCT01847274|324082013|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
94622951|NCT01847274|324082014|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
94622952|NCT01847274|324082015|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
94622953|NCT01847274|324082016|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
94622954|NCT01847274|324082006|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
94622955|NCT01847274|324082007|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
94622956|NCT01847274|324082008|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
94622957|NCT01847274|324082009|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
94622958|NCT01847274|324082010|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
94622959|NCT01847274|324082011|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
94622960|NCT01847274|324082012|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
94622961|NCT01847274|324082013|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
94622962|NCT01847274|324082014|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
94622963|NCT01847274|324082015|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
94622964|NCT01847274|324082016|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
94622965|NCT01847274|324082006|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
94622966|NCT01847274|324082007|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
94622967|NCT01847274|324082008|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
94622968|NCT01847274|324082009|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
94622969|NCT01847274|324082010|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
94622970|NCT01847274|324082011|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
94622971|NCT01847274|324082012|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
94622972|NCT01847274|324082013|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
94622973|NCT01847274|324082014|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
94622974|NCT01847274|324082015|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
94622975|NCT01847274|324082016|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
94622976|NCT01847274|324082006|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
94622977|NCT01847274|324082007|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
94622978|NCT01847274|324082008|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
94622979|NCT01847274|324082009|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
94622980|NCT01847274|324082010|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
94622981|NCT01847274|324082011|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
94622982|NCT01847274|324082012|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
94622983|NCT01847274|324082013|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
94622984|NCT01847274|324082014|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
94622985|NCT01847274|324082015|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
94622986|NCT01847274|324082016|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
94622987|NCT03600818|324082017|FG000|Overall Study|Adverse Event|4|||
94622988|NCT03600818|324082018|FG001|Overall Study|Adverse Event|7|||
94622989|NCT03600818|324082017|FG000|Overall Study|Lack of Efficacy|9|||
94669364|NCT03214367|324242892|FG000|Lead-in Period|Lost to Follow-up|12|||
94669365|NCT03214367|324242893|FG001|Lead-in Period|Lost to Follow-up|0|||
94669366|NCT03214367|324242894|FG002|Lead-in Period|Lost to Follow-up|0|||
94669367|NCT03214367|324242895|FG003|Lead-in Period|Lost to Follow-up|0|||
94669368|NCT03214367|324242896|FG004|Lead-in Period|Lost to Follow-up|0|||
94669369|NCT03214367|324242897|FG005|Lead-in Period|Lost to Follow-up|0|||
94669370|NCT03214367|324242898|FG006|Lead-in Period|Lost to Follow-up|0|||
94669371|NCT03214367|324242899|FG007|Lead-in Period|Lost to Follow-up|0|||
94669372|NCT03214367|324242892|FG000|Lead-in Period|Sponsor Decision|11|||
94669373|NCT03214367|324242893|FG001|Lead-in Period|Sponsor Decision|0|||
94669374|NCT03214367|324242894|FG002|Lead-in Period|Sponsor Decision|0|||
94669375|NCT03214367|324242895|FG003|Lead-in Period|Sponsor Decision|0|||
94669376|NCT03214367|324242896|FG004|Lead-in Period|Sponsor Decision|0|||
94669377|NCT03214367|324242897|FG005|Lead-in Period|Sponsor Decision|0|||
94669378|NCT03214367|324242898|FG006|Lead-in Period|Sponsor Decision|0|||
94669379|NCT03214367|324242899|FG007|Lead-in Period|Sponsor Decision|0|||
94669380|NCT03214367|324242892|FG000|Lead-in Period|Physician Decision|12|||
94669381|NCT03214367|324242893|FG001|Lead-in Period|Physician Decision|0|||
94669382|NCT03214367|324242894|FG002|Lead-in Period|Physician Decision|0|||
94669383|NCT03214367|324242895|FG003|Lead-in Period|Physician Decision|0|||
94669384|NCT03214367|324242896|FG004|Lead-in Period|Physician Decision|0|||
94669385|NCT03214367|324242897|FG005|Lead-in Period|Physician Decision|0|||
94669386|NCT03214367|324242898|FG006|Lead-in Period|Physician Decision|0|||
94669387|NCT03214367|324242899|FG007|Lead-in Period|Physician Decision|0|||
94669388|NCT03214367|324242892|FG000|Lead-in Period|Protocol Violation|5|||
94669389|NCT03214367|324242893|FG001|Lead-in Period|Protocol Violation|0|||
94669390|NCT03214367|324242894|FG002|Lead-in Period|Protocol Violation|0|||
94669391|NCT03214367|324242895|FG003|Lead-in Period|Protocol Violation|0|||
94669392|NCT03214367|324242896|FG004|Lead-in Period|Protocol Violation|0|||
94669393|NCT03214367|324242897|FG005|Lead-in Period|Protocol Violation|0|||
94669394|NCT03214367|324242898|FG006|Lead-in Period|Protocol Violation|0|||
94669395|NCT03214367|324242899|FG007|Lead-in Period|Protocol Violation|0|||
94669396|NCT03214367|324242892|FG000|Lead-in Period|Treatment Interruption|1|||
94669397|NCT03214367|324242893|FG001|Lead-in Period|Treatment Interruption|0|||
94669398|NCT03214367|324242894|FG002|Lead-in Period|Treatment Interruption|0|||
94669399|NCT03214367|324242895|FG003|Lead-in Period|Treatment Interruption|0|||
94669400|NCT03214367|324242896|FG004|Lead-in Period|Treatment Interruption|0|||
94669401|NCT03214367|324242897|FG005|Lead-in Period|Treatment Interruption|0|||
94669402|NCT03214367|324242898|FG006|Lead-in Period|Treatment Interruption|0|||
94669403|NCT03214367|324242899|FG007|Lead-in Period|Treatment Interruption|0|||
94669404|NCT03214367|324242892|FG000|Treatment Period|Adverse Event|0|||
94669405|NCT03214367|324242893|FG001|Treatment Period|Adverse Event|1|||
94669406|NCT03214367|324242894|FG002|Treatment Period|Adverse Event|4|||
94669407|NCT03214367|324242895|FG003|Treatment Period|Adverse Event|2|||
94669408|NCT03214367|324242896|FG004|Treatment Period|Adverse Event|0|||
94669409|NCT03214367|324242897|FG005|Treatment Period|Adverse Event|0|||
94669410|NCT03214367|324242898|FG006|Treatment Period|Adverse Event|0|||
94669411|NCT03214367|324242899|FG007|Treatment Period|Adverse Event|0|||
94669412|NCT03214367|324242892|FG000|Treatment Period|Death|0|||
94669413|NCT03214367|324242893|FG001|Treatment Period|Death|1|||
94669414|NCT03214367|324242894|FG002|Treatment Period|Death|1|||
94669415|NCT03214367|324242895|FG003|Treatment Period|Death|1|||
94669416|NCT03214367|324242896|FG004|Treatment Period|Death|0|||
94669417|NCT03214367|324242897|FG005|Treatment Period|Death|0|||
94669418|NCT03214367|324242898|FG006|Treatment Period|Death|0|||
94669419|NCT03214367|324242899|FG007|Treatment Period|Death|0|||
94669420|NCT03214367|324242892|FG000|Treatment Period|Lost to Follow-up|0|||
94669421|NCT03214367|324242893|FG001|Treatment Period|Lost to Follow-up|5|||
94669422|NCT03214367|324242894|FG002|Treatment Period|Lost to Follow-up|3|||
94669423|NCT03214367|324242895|FG003|Treatment Period|Lost to Follow-up|2|||
94669424|NCT03214367|324242896|FG004|Treatment Period|Lost to Follow-up|0|||
94669425|NCT03214367|324242897|FG005|Treatment Period|Lost to Follow-up|2|||
94669426|NCT03214367|324242898|FG006|Treatment Period|Lost to Follow-up|1|||
94669427|NCT03214367|324242899|FG007|Treatment Period|Lost to Follow-up|0|||
94669428|NCT03214367|324242892|FG000|Treatment Period|Sponsor Decision|0|||
94669429|NCT03214367|324242893|FG001|Treatment Period|Sponsor Decision|3|||
94669430|NCT03214367|324242894|FG002|Treatment Period|Sponsor Decision|0|||
94669431|NCT03214367|324242895|FG003|Treatment Period|Sponsor Decision|0|||
94669432|NCT03214367|324242896|FG004|Treatment Period|Sponsor Decision|0|||
94669433|NCT03214367|324242897|FG005|Treatment Period|Sponsor Decision|0|||
94669434|NCT03214367|324242898|FG006|Treatment Period|Sponsor Decision|0|||
94669435|NCT03214367|324242899|FG007|Treatment Period|Sponsor Decision|0|||
94669436|NCT03214367|324242892|FG000|Treatment Period|Physician Decision|0|||
94669437|NCT03214367|324242893|FG001|Treatment Period|Physician Decision|1|||
94669438|NCT03214367|324242894|FG002|Treatment Period|Physician Decision|2|||
94669439|NCT03214367|324242895|FG003|Treatment Period|Physician Decision|0|||
94669440|NCT03214367|324242896|FG004|Treatment Period|Physician Decision|0|||
94669441|NCT03214367|324242897|FG005|Treatment Period|Physician Decision|0|||
94669442|NCT03214367|324242898|FG006|Treatment Period|Physician Decision|0|||
94669443|NCT03214367|324242899|FG007|Treatment Period|Physician Decision|0|||
94669444|NCT03214367|324242892|FG000|Treatment Period|Protocol Violation|0|||
94669445|NCT03214367|324242893|FG001|Treatment Period|Protocol Violation|3|||
94669446|NCT03214367|324242894|FG002|Treatment Period|Protocol Violation|0|||
94669447|NCT03214367|324242895|FG003|Treatment Period|Protocol Violation|0|||
94669448|NCT03214367|324242896|FG004|Treatment Period|Protocol Violation|0|||
94669449|NCT03214367|324242897|FG005|Treatment Period|Protocol Violation|0|||
94669450|NCT03214367|324242898|FG006|Treatment Period|Protocol Violation|0|||
94669451|NCT03214367|324242899|FG007|Treatment Period|Protocol Violation|0|||
94669452|NCT03214367|324242892|FG000|Treatment Period|Withdrawal by Subject|0|||
94669453|NCT03214367|324242893|FG001|Treatment Period|Withdrawal by Subject|20|||
94669454|NCT03214367|324242894|FG002|Treatment Period|Withdrawal by Subject|23|||
94669455|NCT03214367|324242895|FG003|Treatment Period|Withdrawal by Subject|14|||
94669456|NCT03214367|324242896|FG004|Treatment Period|Withdrawal by Subject|0|||
94669457|NCT03214367|324242897|FG005|Treatment Period|Withdrawal by Subject|1|||
94669458|NCT03214367|324242898|FG006|Treatment Period|Withdrawal by Subject|1|||
94669459|NCT03214367|324242899|FG007|Treatment Period|Withdrawal by Subject|1|||
94669460|NCT03508843|324242900|FG000|Overall Study|Withdrawal by Subject|1|||
94669461|NCT03508843|324242900|FG000|Overall Study|technical difficulties|2|||
94669462|NCT00765843|324242903|FG000|Overall Study|Lost to Follow-up|1|||
94669463|NCT00765843|324242904|FG001|Overall Study|Lost to Follow-up|3|||
94669464|NCT00765843|324242905|FG002|Overall Study|Lost to Follow-up|2|||
94669465|NCT00765843|324242903|FG000|Overall Study|did not return to receive intervention|0|||
94669466|NCT00765843|324242904|FG001|Overall Study|did not return to receive intervention|1|||
94669467|NCT00765843|324242905|FG002|Overall Study|did not return to receive intervention|0|||
94669468|NCT00765843|324242903|FG000|Overall Study|Adverse Event|0|||
94669469|NCT00765843|324242904|FG001|Overall Study|Adverse Event|0|||
94669470|NCT00765843|324242905|FG002|Overall Study|Adverse Event|1|||
94669471|NCT03031938|324242910|FG000|Overall Study|Death|1|||
94669472|NCT03031938|324242911|FG001|Overall Study|Death|0|||
94669473|NCT00454051|324242912|FG000|Overall Study|Adverse Event|1|||
94669474|NCT00454051|324242913|FG001|Overall Study|Adverse Event|2|||
94669475|NCT00454051|324242912|FG000|Overall Study|Withdrawal by Subject|1|||
94669476|NCT00454051|324242913|FG001|Overall Study|Withdrawal by Subject|0|||
94669477|NCT00454051|324242912|FG000|Overall Study|Protocol Violation|1|||
94669478|NCT00454051|324242913|FG001|Overall Study|Protocol Violation|1|||
94669479|NCT01571362|324242914|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
94669480|NCT01571362|324242915|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
94669481|NCT01571362|324242916|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
94669482|NCT01571362|324242914|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
94669483|NCT01571362|324242915|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
94669484|NCT01571362|324242916|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
94669485|NCT01571362|324242914|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
94669486|NCT01571362|324242915|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
94669487|NCT01571362|324242916|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
94669488|NCT01571362|324242914|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
94669489|NCT01571362|324242915|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
94669490|NCT01571362|324242916|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
94669491|NCT01571362|324242914|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
94669492|NCT01571362|324242915|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
94669493|NCT01571362|324242916|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
94669494|NCT01571362|324242914|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
94669495|NCT01571362|324242915|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
94669496|NCT01571362|324242916|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
94669497|NCT01571362|324242914|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
94669498|NCT01571362|324242915|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
94669499|NCT01571362|324242916|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
94669500|NCT01571362|324242914|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
94669501|NCT01571362|324242915|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
94669502|NCT01571362|324242916|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
94669503|NCT01571362|324242914|FG000|Double-Blind Treatment Period|Adverse Event|0|||
94669504|NCT01571362|324242915|FG001|Double-Blind Treatment Period|Adverse Event|9|||
94669505|NCT01571362|324242916|FG002|Double-Blind Treatment Period|Adverse Event|14|||
94669506|NCT01571362|324242914|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
94669507|NCT01571362|324242915|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
94669508|NCT01571362|324242916|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
94669509|NCT01571362|324242914|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
94669510|NCT01571362|324242915|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
94669511|NCT01571362|324242916|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
94669512|NCT01571362|324242914|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
94669513|NCT01571362|324242915|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
94669514|NCT01571362|324242916|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
94669515|NCT01669629|324242917|FG000|Period 1|protocol deviation|1|||
94669516|NCT01669629|324242918|FG001|Period 1|protocol deviation|2|||
94669517|NCT01597050|324242919|FG000|Overall Study|Withdrawal by Subject|1|||
94622990|NCT03600818|324082018|FG001|Overall Study|Lack of Efficacy|4|||
94622991|NCT03600818|324082017|FG000|Overall Study|Withdrawal by Subject|4|||
94622992|NCT03600818|324082018|FG001|Overall Study|Withdrawal by Subject|3|||
94622993|NCT03600818|324082017|FG000|Overall Study|Other-unspecified|5|||
94622994|NCT03600818|324082018|FG001|Overall Study|Other-unspecified|3|||
94622995|NCT03600818|324082017|FG000|Overall Study|Randomized and not treated|0|||
94622996|NCT03600818|324082018|FG001|Overall Study|Randomized and not treated|1|||
94622997|NCT02969369|324082019|FG000|Study|Adverse Event|1|||
94622998|NCT02969369|324082020|FG001|Study|Adverse Event|6|||
94622999|NCT02969369|324082019|FG000|Study|Lack of Efficacy|0|||
94623000|NCT02969369|324082020|FG001|Study|Lack of Efficacy|1|||
94623001|NCT02969369|324082019|FG000|Study|Lost to Follow-up|0|||
94623002|NCT02969369|324082020|FG001|Study|Lost to Follow-up|1|||
94623003|NCT02969369|324082019|FG000|Study|Withdrawal by Subject|3|||
94623004|NCT02969369|324082020|FG001|Study|Withdrawal by Subject|5|||
94623005|NCT02969369|324082019|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
94623006|NCT02969369|324082020|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
94623007|NCT02969369|324082019|FG000|Double-blind Period|Adverse Event|1|||
94623008|NCT02969369|324082020|FG001|Double-blind Period|Adverse Event|5|||
94623009|NCT02969369|324082019|FG000|Double-blind Period|Lost to Follow-up|0|||
94623010|NCT02969369|324082020|FG001|Double-blind Period|Lost to Follow-up|1|||
94623011|NCT02969369|324082019|FG000|Double-blind Period|Withdrawal by Subject|2|||
94623012|NCT02969369|324082020|FG001|Double-blind Period|Withdrawal by Subject|3|||
94623013|NCT02969369|324082019|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
94623014|NCT02969369|324082020|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
94623015|NCT02969369|324082019|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
94623016|NCT02969369|324082020|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
94623017|NCT02969369|324082019|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
94623018|NCT02969369|324082020|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
94623019|NCT02969369|324082019|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
94623020|NCT02969369|324082020|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
94623021|NCT00521014|324082021|FG000|Overall Study|Inevaluable, not treated|1|||
94623022|NCT02042183|324082024|FG000|Overall Study|Physician Decision|7|||
94623023|NCT02042183|324082025|FG001|Overall Study|Physician Decision|2|||
94623024|NCT02042183|324082024|FG000|Overall Study|Lack of Efficacy|4|||
94623025|NCT02042183|324082025|FG001|Overall Study|Lack of Efficacy|3|||
94623026|NCT02042183|324082024|FG000|Overall Study|Non-compliance with Study Drug|2|||
94623027|NCT02042183|324082025|FG001|Overall Study|Non-compliance with Study Drug|3|||
94623028|NCT02042183|324082024|FG000|Overall Study|Adverse Event|17|||
94623029|NCT02042183|324082025|FG001|Overall Study|Adverse Event|6|||
94623030|NCT02042183|324082024|FG000|Overall Study|Other|3|||
94623031|NCT02042183|324082025|FG001|Overall Study|Other|3|||
94623032|NCT02042183|324082024|FG000|Overall Study|Withdrawal by Subject|21|||
94623033|NCT02042183|324082025|FG001|Overall Study|Withdrawal by Subject|16|||
94623034|NCT02042183|324082024|FG000|Overall Study|Site Terminated by Sponsor|2|||
94623035|NCT02042183|324082025|FG001|Overall Study|Site Terminated by Sponsor|1|||
94623036|NCT02042183|324082024|FG000|Overall Study|Lost to Follow-up|9|||
94623037|NCT02042183|324082025|FG001|Overall Study|Lost to Follow-up|2|||
94623038|NCT02244606|324082026|FG000|Overall Study|Adverse Event|0|||
94623039|NCT02244606|324082027|FG001|Overall Study|Adverse Event|1|||
94623040|NCT02244606|324082028|FG002|Overall Study|Adverse Event|1|||
94623041|NCT02244606|324082029|FG003|Overall Study|Adverse Event|0|||
94623042|NCT02244606|324082026|FG000|Overall Study|Lost to Follow-up|2|||
94623043|NCT02244606|324082027|FG001|Overall Study|Lost to Follow-up|2|||
94623044|NCT02244606|324082028|FG002|Overall Study|Lost to Follow-up|1|||
94623045|NCT02244606|324082029|FG003|Overall Study|Lost to Follow-up|0|||
94623046|NCT02244606|324082026|FG000|Overall Study|Protocol Violation|0|||
94623047|NCT02244606|324082027|FG001|Overall Study|Protocol Violation|0|||
94623048|NCT02244606|324082028|FG002|Overall Study|Protocol Violation|0|||
94623049|NCT02244606|324082029|FG003|Overall Study|Protocol Violation|1|||
94623050|NCT02244606|324082026|FG000|Overall Study|Withdrawal by Subject|1|||
94623051|NCT02244606|324082027|FG001|Overall Study|Withdrawal by Subject|1|||
94623052|NCT02244606|324082028|FG002|Overall Study|Withdrawal by Subject|0|||
94623053|NCT02244606|324082029|FG003|Overall Study|Withdrawal by Subject|0|||
94623054|NCT02244606|324082026|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
94623055|NCT02244606|324082027|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
94623056|NCT02244606|324082028|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
94623057|NCT02244606|324082029|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
94623058|NCT00814164|324082032|FG000|Overall Study|Progression|7|||
94669518|NCT01597050|324242920|FG001|Overall Study|Withdrawal by Subject|0|||
94669519|NCT00483184|324242921|FG000|Overall Study|Withdrawal by Subject|2|||
94669520|NCT00483184|324242922|FG001|Overall Study|Withdrawal by Subject|2|||
94669521|NCT00483184|324242923|FG002|Overall Study|Withdrawal by Subject|0|||
94669522|NCT00483184|324242921|FG000|Overall Study|Lost to Follow-up|1|||
94669523|NCT00483184|324242922|FG001|Overall Study|Lost to Follow-up|0|||
94669524|NCT00483184|324242923|FG002|Overall Study|Lost to Follow-up|0|||
94669525|NCT00483184|324242921|FG000|Overall Study|Adverse Event|1|||
94669526|NCT00483184|324242922|FG001|Overall Study|Adverse Event|2|||
94669527|NCT00483184|324242923|FG002|Overall Study|Adverse Event|2|||
94669528|NCT00483184|324242921|FG000|Overall Study|Protocol Violation|1|||
94669529|NCT00483184|324242922|FG001|Overall Study|Protocol Violation|0|||
94669530|NCT00483184|324242923|FG002|Overall Study|Protocol Violation|1|||
94669531|NCT00558428|324242924|FG000|Overall Study|Adverse Event|6|||
94669532|NCT00558428|324242925|FG001|Overall Study|Adverse Event|22|||
94669533|NCT00558428|324242926|FG002|Overall Study|Adverse Event|3|||
94669534|NCT00558428|324242927|FG003|Overall Study|Adverse Event|4|||
94669535|NCT00558428|324242924|FG000|Overall Study|Lost to Follow-up|0|||
94669536|NCT00558428|324242925|FG001|Overall Study|Lost to Follow-up|1|||
94669537|NCT00558428|324242926|FG002|Overall Study|Lost to Follow-up|0|||
94669538|NCT00558428|324242927|FG003|Overall Study|Lost to Follow-up|0|||
94669539|NCT00558428|324242924|FG000|Overall Study|Lack of Efficacy|0|||
94669540|NCT00558428|324242925|FG001|Overall Study|Lack of Efficacy|0|||
94669541|NCT00558428|324242926|FG002|Overall Study|Lack of Efficacy|1|||
94669542|NCT00558428|324242927|FG003|Overall Study|Lack of Efficacy|2|||
94669543|NCT00558428|324242924|FG000|Overall Study|Non compliant with protocol|1|||
94669544|NCT00558428|324242925|FG001|Overall Study|Non compliant with protocol|0|||
94669545|NCT00558428|324242926|FG002|Overall Study|Non compliant with protocol|0|||
94669546|NCT00558428|324242927|FG003|Overall Study|Non compliant with protocol|3|||
94669547|NCT00558428|324242924|FG000|Overall Study|Consent withdrawn|2|||
94669548|NCT00558428|324242925|FG001|Overall Study|Consent withdrawn|1|||
94669549|NCT00558428|324242926|FG002|Overall Study|Consent withdrawn|0|||
94669550|NCT00558428|324242927|FG003|Overall Study|Consent withdrawn|1|||
94669551|NCT00558428|324242924|FG000|Overall Study|Other|3|||
94669552|NCT00558428|324242925|FG001|Overall Study|Other|0|||
94669553|NCT00558428|324242926|FG002|Overall Study|Other|0|||
94669554|NCT00558428|324242927|FG003|Overall Study|Other|1|||
94669555|NCT02065336|324242928|FG000|Extension Phase|Study Terminated by Sponsor|0|||
94669556|NCT02065336|324242929|FG001|Extension Phase|Study Terminated by Sponsor|0|||
94669557|NCT02065336|324242930|FG002|Extension Phase|Study Terminated by Sponsor|0|||
94669558|NCT02065336|324242931|FG003|Extension Phase|Study Terminated by Sponsor|0|||
94669559|NCT02065336|324242932|FG004|Extension Phase|Study Terminated by Sponsor|0|||
94669560|NCT02065336|324242933|FG005|Extension Phase|Study Terminated by Sponsor|0|||
94669561|NCT02065336|324242934|FG006|Extension Phase|Study Terminated by Sponsor|0|||
94669562|NCT02065336|324242935|FG007|Extension Phase|Study Terminated by Sponsor|0|||
94669563|NCT02065336|324242936|FG008|Extension Phase|Study Terminated by Sponsor|2|||
94669564|NCT02065336|324242937|FG009|Extension Phase|Study Terminated by Sponsor|8|||
94669565|NCT01654549|324242941|FG000|Overall Study|H.pylori eradication not successful|0|||
94669566|NCT01654549|324242942|FG001|Overall Study|H.pylori eradication not successful|1|||
94669567|NCT00937924|324242943|FG000|Overall Study|Lost to Follow-up|44|||
94669568|NCT00937924|324242944|FG001|Overall Study|Lost to Follow-up|44|||
94669569|NCT00937924|324242945|FG002|Overall Study|Lost to Follow-up|41|||
94669570|NCT03853109|324242946|FG000|Overall Study|Withdrawal by Subject|0|||
94669571|NCT03853109|324242947|FG001|Overall Study|Withdrawal by Subject|0|||
94669572|NCT03853109|324242948|FG002|Overall Study|Withdrawal by Subject|1|||
94669573|NCT03853109|324242949|FG003|Overall Study|Withdrawal by Subject|2|||
94669574|NCT03853109|324242950|FG004|Overall Study|Withdrawal by Subject|1|||
94669575|NCT03853109|324242951|FG005|Overall Study|Withdrawal by Subject|4|||
94669576|NCT03853109|324242952|FG006|Overall Study|Withdrawal by Subject|5|||
94669577|NCT03853109|324242953|FG007|Overall Study|Withdrawal by Subject|3|||
94669578|NCT03853109|324242946|FG000|Overall Study|Decision by Sponsor|0|||
94669579|NCT03853109|324242947|FG001|Overall Study|Decision by Sponsor|0|||
94669580|NCT03853109|324242948|FG002|Overall Study|Decision by Sponsor|1|||
94669581|NCT03853109|324242949|FG003|Overall Study|Decision by Sponsor|0|||
94669582|NCT03853109|324242950|FG004|Overall Study|Decision by Sponsor|1|||
94359557|NCT04668066|323100354|FG018|Part 1: Treatment Phase|Other|0|||
94669583|NCT03853109|324242951|FG005|Overall Study|Decision by Sponsor|1|||
94669584|NCT03853109|324242952|FG006|Overall Study|Decision by Sponsor|10|||
94669585|NCT03853109|324242953|FG007|Overall Study|Decision by Sponsor|2|||
94669586|NCT03853109|324242946|FG000|Overall Study|Lost to Follow-up|0|||
94669587|NCT03853109|324242947|FG001|Overall Study|Lost to Follow-up|0|||
94669588|NCT03853109|324242948|FG002|Overall Study|Lost to Follow-up|0|||
94669589|NCT03853109|324242949|FG003|Overall Study|Lost to Follow-up|0|||
94669590|NCT03853109|324242950|FG004|Overall Study|Lost to Follow-up|1|||
94669591|NCT03853109|324242951|FG005|Overall Study|Lost to Follow-up|3|||
94669592|NCT03853109|324242952|FG006|Overall Study|Lost to Follow-up|0|||
94669593|NCT03853109|324242953|FG007|Overall Study|Lost to Follow-up|0|||
94669594|NCT03853109|324242946|FG000|Overall Study|Death|2|||
94669595|NCT03853109|324242947|FG001|Overall Study|Death|5|||
94669596|NCT03853109|324242948|FG002|Overall Study|Death|8|||
94669597|NCT03853109|324242949|FG003|Overall Study|Death|10|||
94669598|NCT03853109|324242950|FG004|Overall Study|Death|3|||
94669599|NCT03853109|324242951|FG005|Overall Study|Death|20|||
94669600|NCT03853109|324242952|FG006|Overall Study|Death|10|||
94623059|NCT00814164|324082032|FG000|Overall Study|not stated|7|||
94623060|NCT00814164|324082032|FG000|Overall Study|Death|5|||
94623061|NCT03132220|324082042|FG000|Overall Study|Lost to Follow-up|17|||
94623062|NCT03132220|324082043|FG001|Overall Study|Lost to Follow-up|8|||
94623063|NCT03132220|324082042|FG000|Overall Study|Withdrawal by Subject|1|||
94623064|NCT03132220|324082043|FG001|Overall Study|Withdrawal by Subject|4|||
94623065|NCT05228132|324082044|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
94623066|NCT05228132|324082044|FG000|Overall Study|Adverse Event|3|||
94623067|NCT05228132|324082044|FG000|Overall Study|Lost to Follow-up|1|||
94623068|NCT05228132|324082044|FG000|Overall Study|Arteriovenous-fistula mature|1|||
94623069|NCT01243892|324082045|FG000|Overall Study|Did not meet eligibility criteria|2|||
94623070|NCT01243892|324082046|FG001|Overall Study|Did not meet eligibility criteria|0|||
94623071|NCT02627144|324082049|FG000|Overall Study|Serious adverse event|32|||
94623072|NCT02627144|324082049|FG000|Overall Study|Cancer progression|171|||
94623073|NCT02627144|324082049|FG000|Overall Study|Death from cancer|20|||
94623074|NCT02627144|324082049|FG000|Overall Study|Death from other cause|8|||
94623075|NCT02627144|324082049|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
94623076|NCT02627144|324082049|FG000|Overall Study|Administrative reasons|65|||
94623077|NCT02627144|324082049|FG000|Overall Study|Lost to Follow-up|8|||
94623078|NCT02627144|324082049|FG000|Overall Study|Enrolled, not treated|6|||
94623079|NCT02627144|324082049|FG000|Overall Study|Other|17|||
94623080|NCT01233258|324082053|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
94623081|NCT01233258|324082054|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
94623082|NCT01233258|324082055|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
94623083|NCT01233258|324082056|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
94623084|NCT01233258|324082057|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
94623085|NCT01233258|324082058|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
94623086|NCT01233258|324082053|FG000|First Intervention (6 Months)|Protocol Violation|0|||
94623087|NCT01233258|324082054|FG001|First Intervention (6 Months)|Protocol Violation|0|||
94623088|NCT01233258|324082055|FG002|First Intervention (6 Months)|Protocol Violation|1|||
94623089|NCT01233258|324082056|FG003|First Intervention (6 Months)|Protocol Violation|0|||
94623090|NCT01233258|324082057|FG004|First Intervention (6 Months)|Protocol Violation|0|||
94623091|NCT01233258|324082058|FG005|First Intervention (6 Months)|Protocol Violation|0|||
94623092|NCT01233258|324082053|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
94623093|NCT01233258|324082054|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
94669601|NCT03853109|324242953|FG007|Overall Study|Death|5|||
94669602|NCT00727272|324242959|FG000|Washout Period A|Adverse Event|0|||
94669603|NCT00727272|324242960|FG001|Washout Period A|Adverse Event|0|||
94669604|NCT00727272|324242961|FG002|Washout Period A|Adverse Event|1|||
94669605|NCT00727272|324242959|FG000|Washout Period B|Withdrawal by Subject|0|||
94669606|NCT00727272|324242960|FG001|Washout Period B|Withdrawal by Subject|0|||
94669607|NCT00727272|324242961|FG002|Washout Period B|Withdrawal by Subject|1|||
94669608|NCT00651664|324242962|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
94669609|NCT00651664|324242963|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
94669610|NCT00651664|324242964|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
94669611|NCT00651664|324242965|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
94669612|NCT00651664|324242966|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
94669613|NCT00651664|324242967|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
94669614|NCT00651664|324242968|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
94669615|NCT00651664|324242969|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
94669616|NCT00651664|324242970|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
94669617|NCT00651664|324242971|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
94669618|NCT00651664|324242962|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
94669619|NCT00651664|324242963|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
94669620|NCT00651664|324242964|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
94669621|NCT00651664|324242965|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
94669622|NCT00651664|324242966|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
94461183|NCT00373958|323478211|FG000|Infant Series|Physician Decision|1|||
94461184|NCT00373958|323478212|FG001|Infant Series|Physician Decision|1|||
94669623|NCT00651664|324242967|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
94669624|NCT00651664|324242968|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
94669625|NCT00651664|324242969|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
94669626|NCT00651664|324242970|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
94461185|NCT00373958|323478211|FG000|Toddler Dose|Lost to Follow-up|5|||
94623094|NCT01233258|324082055|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
94623095|NCT01233258|324082056|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
94669627|NCT00651664|324242971|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
94669628|NCT00651664|324242962|FG000|Overall Study|Progressive Disease|3|||
94669629|NCT00651664|324242963|FG001|Overall Study|Progressive Disease|3|||
94669630|NCT00651664|324242964|FG002|Overall Study|Progressive Disease|3|||
94669631|NCT00651664|324242965|FG003|Overall Study|Progressive Disease|12|||
94669632|NCT00651664|324242966|FG004|Overall Study|Progressive Disease|4|||
94669633|NCT00651664|324242967|FG005|Overall Study|Progressive Disease|1|||
94669634|NCT00651664|324242968|FG006|Overall Study|Progressive Disease|3|||
94669635|NCT00651664|324242969|FG007|Overall Study|Progressive Disease|6|||
94669636|NCT00651664|324242970|FG008|Overall Study|Progressive Disease|5|||
94669637|NCT00651664|324242971|FG009|Overall Study|Progressive Disease|5|||
94669638|NCT00651664|324242962|FG000|Overall Study|Patient Declined Further Treatment|0|||
94669639|NCT00651664|324242963|FG001|Overall Study|Patient Declined Further Treatment|0|||
94669640|NCT00651664|324242964|FG002|Overall Study|Patient Declined Further Treatment|0|||
94669641|NCT00651664|324242965|FG003|Overall Study|Patient Declined Further Treatment|1|||
94669642|NCT00651664|324242966|FG004|Overall Study|Patient Declined Further Treatment|1|||
94669643|NCT00651664|324242967|FG005|Overall Study|Patient Declined Further Treatment|1|||
94669644|NCT00651664|324242968|FG006|Overall Study|Patient Declined Further Treatment|0|||
94669645|NCT00651664|324242969|FG007|Overall Study|Patient Declined Further Treatment|0|||
94669646|NCT00651664|324242970|FG008|Overall Study|Patient Declined Further Treatment|0|||
94669647|NCT00651664|324242971|FG009|Overall Study|Patient Declined Further Treatment|1|||
94669648|NCT00651664|324242962|FG000|Overall Study|Symptomatic Deterioration|0|||
94623096|NCT01233258|324082057|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
94623097|NCT01233258|324082058|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
94623098|NCT02795832|324082059|FG000|Overall Study|Adverse Event|0|||
94623099|NCT02795832|324082060|FG001|Overall Study|Adverse Event|0|||
94623100|NCT02795832|324082061|FG002|Overall Study|Adverse Event|0|||
94623101|NCT02795832|324082062|FG003|Overall Study|Adverse Event|0|||
94623102|NCT02795832|324082063|FG004|Overall Study|Adverse Event|0|||
94623103|NCT02795832|324082064|FG005|Overall Study|Adverse Event|3|||
94623104|NCT02853604|324084042|FG000|Overall Study|Withdrawal by Subject|12|||
94623105|NCT02853604|324084043|FG001|Overall Study|Withdrawal by Subject|35|||
94623106|NCT02853604|324084042|FG000|Overall Study|Lost to Follow-up|4|||
94623107|NCT02853604|324084043|FG001|Overall Study|Lost to Follow-up|8|||
94623108|NCT02853604|324084042|FG000|Overall Study|Death|1|||
94623109|NCT02853604|324084043|FG001|Overall Study|Death|5|||
94623110|NCT02853604|324084042|FG000|Overall Study|Miscellaneous|11|||
94623111|NCT02853604|324084043|FG001|Overall Study|Miscellaneous|2|||
94623112|NCT02853604|324084042|FG000|Overall Study|Progressive Disease|0|||
94623113|NCT02853604|324084043|FG001|Overall Study|Progressive Disease|2|||
94623114|NCT03766581|324084044|FG000|Randomization|Other reasons|2|||
94623115|NCT03766581|324084045|FG001|Randomization|Other reasons|1|||
94623116|NCT03766581|324084046|FG002|Randomization|Other reasons|0|||
94623117|NCT03766581|324084047|FG003|Randomization|Other reasons|1|||
94623118|NCT03766581|324084048|FG004|Randomization|Other reasons|0|||
94623119|NCT03766581|324084049|FG005|Randomization|Other reasons|0|||
94623120|NCT03766581|324084050|FG006|Randomization|Other reasons|0|||
94623121|NCT03766581|324084051|FG007|Randomization|Other reasons|0|||
94623122|NCT03766581|324084044|FG000|Randomization|Participant no longer meets study criteria|5|||
94623123|NCT03766581|324084045|FG001|Randomization|Participant no longer meets study criteria|3|||
94623124|NCT03766581|324084046|FG002|Randomization|Participant no longer meets study criteria|4|||
94623125|NCT03766581|324084047|FG003|Randomization|Participant no longer meets study criteria|0|||
94623126|NCT03766581|324084048|FG004|Randomization|Participant no longer meets study criteria|2|||
94623127|NCT03766581|324084049|FG005|Randomization|Participant no longer meets study criteria|3|||
94623128|NCT03766581|324084050|FG006|Randomization|Participant no longer meets study criteria|0|||
94623129|NCT03766581|324084051|FG007|Randomization|Participant no longer meets study criteria|1|||
94623130|NCT03766581|324084044|FG000|Randomization|Participant request to discontinue study treatment|1|||
94623131|NCT03766581|324084045|FG001|Randomization|Participant request to discontinue study treatment|0|||
94623132|NCT03766581|324084046|FG002|Randomization|Participant request to discontinue study treatment|0|||
94669649|NCT00651664|324242963|FG001|Overall Study|Symptomatic Deterioration|0|||
94669650|NCT00651664|324242964|FG002|Overall Study|Symptomatic Deterioration|0|||
94359558|NCT04668066|323100336|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
94359559|NCT04668066|323100337|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
94359560|NCT04668066|323100338|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
94623133|NCT03766581|324084047|FG003|Randomization|Participant request to discontinue study treatment|0|||
94623134|NCT03766581|324084048|FG004|Randomization|Participant request to discontinue study treatment|1|||
94669651|NCT00651664|324242965|FG003|Overall Study|Symptomatic Deterioration|1|||
94669652|NCT00651664|324242966|FG004|Overall Study|Symptomatic Deterioration|0|||
94669653|NCT00651664|324242967|FG005|Overall Study|Symptomatic Deterioration|0|||
94669654|NCT00651664|324242968|FG006|Overall Study|Symptomatic Deterioration|1|||
94623135|NCT03766581|324084049|FG005|Randomization|Participant request to discontinue study treatment|2|||
94623136|NCT03766581|324084050|FG006|Randomization|Participant request to discontinue study treatment|0|||
94623137|NCT03766581|324084051|FG007|Randomization|Participant request to discontinue study treatment|0|||
94623138|NCT03766581|324084044|FG000|Randomization|Participant withdrew consent|1|||
94669655|NCT00651664|324242969|FG007|Overall Study|Symptomatic Deterioration|0|||
94669656|NCT00651664|324242970|FG008|Overall Study|Symptomatic Deterioration|1|||
94669657|NCT00651664|324242971|FG009|Overall Study|Symptomatic Deterioration|0|||
94669658|NCT00651664|324242962|FG000|Overall Study|Reason not Specified|0|||
94669659|NCT00651664|324242963|FG001|Overall Study|Reason not Specified|0|||
94669660|NCT00651664|324242964|FG002|Overall Study|Reason not Specified|0|||
94669661|NCT00651664|324242965|FG003|Overall Study|Reason not Specified|0|||
94669662|NCT00651664|324242966|FG004|Overall Study|Reason not Specified|0|||
94669663|NCT00651664|324242967|FG005|Overall Study|Reason not Specified|0|||
94669664|NCT00651664|324242968|FG006|Overall Study|Reason not Specified|1|||
94623139|NCT03766581|324084045|FG001|Randomization|Participant withdrew consent|0|||
94623140|NCT03766581|324084046|FG002|Randomization|Participant withdrew consent|1|||
94623141|NCT03766581|324084047|FG003|Randomization|Participant withdrew consent|2|||
94623142|NCT03766581|324084048|FG004|Randomization|Participant withdrew consent|1|||
94623143|NCT03766581|324084049|FG005|Randomization|Participant withdrew consent|1|||
94623144|NCT03766581|324084050|FG006|Randomization|Participant withdrew consent|0|||
94623145|NCT03766581|324084051|FG007|Randomization|Participant withdrew consent|0|||
94623146|NCT03766581|324084044|FG000|Treatment|Adverse Event|82|||
94623147|NCT03766581|324084045|FG001|Treatment|Adverse Event|44|||
94623148|NCT03766581|324084046|FG002|Treatment|Adverse Event|47|||
94623149|NCT03766581|324084047|FG003|Treatment|Adverse Event|46|||
94623150|NCT03766581|324084048|FG004|Treatment|Adverse Event|50|||
94623151|NCT03766581|324084049|FG005|Treatment|Adverse Event|77|||
94623152|NCT03766581|324084050|FG006|Treatment|Adverse Event|5|||
94623153|NCT03766581|324084051|FG007|Treatment|Adverse Event|2|||
94623154|NCT03766581|324084044|FG000|Treatment|Participant request to discontinue treatment|34|||
94623155|NCT03766581|324084045|FG001|Treatment|Participant request to discontinue treatment|6|||
94623156|NCT03766581|324084046|FG002|Treatment|Participant request to discontinue treatment|10|||
94623157|NCT03766581|324084047|FG003|Treatment|Participant request to discontinue treatment|10|||
94623158|NCT03766581|324084048|FG004|Treatment|Participant request to discontinue treatment|14|||
94623159|NCT03766581|324084049|FG005|Treatment|Participant request to discontinue treatment|15|||
94623160|NCT03766581|324084050|FG006|Treatment|Participant request to discontinue treatment|0|||
94623161|NCT03766581|324084051|FG007|Treatment|Participant request to discontinue treatment|1|||
94623162|NCT03766581|324084044|FG000|Treatment|Participant withdrew consent|11|||
94623163|NCT03766581|324084045|FG001|Treatment|Participant withdrew consent|4|||
94623164|NCT03766581|324084046|FG002|Treatment|Participant withdrew consent|5|||
94623165|NCT03766581|324084047|FG003|Treatment|Participant withdrew consent|5|||
94623166|NCT03766581|324084048|FG004|Treatment|Participant withdrew consent|4|||
94623167|NCT03766581|324084049|FG005|Treatment|Participant withdrew consent|4|||
94623168|NCT03766581|324084050|FG006|Treatment|Participant withdrew consent|0|||
94623169|NCT03766581|324084051|FG007|Treatment|Participant withdrew consent|0|||
94623170|NCT03766581|324084044|FG000|Treatment|Death|1|||
94623171|NCT03766581|324084045|FG001|Treatment|Death|0|||
94623172|NCT03766581|324084046|FG002|Treatment|Death|0|||
94623173|NCT03766581|324084047|FG003|Treatment|Death|0|||
94623174|NCT03766581|324084048|FG004|Treatment|Death|0|||
94623175|NCT03766581|324084049|FG005|Treatment|Death|0|||
94623176|NCT03766581|324084050|FG006|Treatment|Death|0|||
94623177|NCT03766581|324084051|FG007|Treatment|Death|0|||
94623178|NCT03766581|324084044|FG000|Treatment|Lost to Follow-up|1|||
94623179|NCT03766581|324084045|FG001|Treatment|Lost to Follow-up|0|||
94623180|NCT03766581|324084046|FG002|Treatment|Lost to Follow-up|0|||
94623181|NCT03766581|324084047|FG003|Treatment|Lost to Follow-up|1|||
94623182|NCT03766581|324084048|FG004|Treatment|Lost to Follow-up|0|||
94623183|NCT03766581|324084049|FG005|Treatment|Lost to Follow-up|0|||
94623184|NCT03766581|324084050|FG006|Treatment|Lost to Follow-up|0|||
94623185|NCT03766581|324084051|FG007|Treatment|Lost to Follow-up|0|||
94623186|NCT03766581|324084044|FG000|Treatment|Poor/Non compliance|2|||
94623187|NCT03766581|324084045|FG001|Treatment|Poor/Non compliance|2|||
94623188|NCT03766581|324084046|FG002|Treatment|Poor/Non compliance|1|||
94623189|NCT03766581|324084047|FG003|Treatment|Poor/Non compliance|1|||
94669665|NCT00651664|324242969|FG007|Overall Study|Reason not Specified|0|||
94669666|NCT00651664|324242970|FG008|Overall Study|Reason not Specified|0|||
94669667|NCT00651664|324242971|FG009|Overall Study|Reason not Specified|0|||
94669668|NCT01388816|324242972|FG000|Overall Study|Adverse Event|0|||
94623190|NCT03766581|324084048|FG004|Treatment|Poor/Non compliance|1|||
94669669|NCT01388816|324242973|FG001|Overall Study|Adverse Event|2|||
94669670|NCT01388816|324242974|FG002|Overall Study|Adverse Event|0|||
94669671|NCT01388816|324242975|FG003|Overall Study|Adverse Event|0|||
94669672|NCT01388816|324242972|FG000|Overall Study|Lost to Follow-up|0|||
94669673|NCT01388816|324242973|FG001|Overall Study|Lost to Follow-up|1|||
94623191|NCT03766581|324084049|FG005|Treatment|Poor/Non compliance|1|||
94623192|NCT03766581|324084050|FG006|Treatment|Poor/Non compliance|0|||
94623193|NCT03766581|324084051|FG007|Treatment|Poor/Non compliance|0|||
94623194|NCT03766581|324084044|FG000|Treatment|Participant no longer meets study criteria|9|||
94623195|NCT03766581|324084045|FG001|Treatment|Participant no longer meets study criteria|1|||
94623196|NCT03766581|324084046|FG002|Treatment|Participant no longer meets study criteria|5|||
94669674|NCT01388816|324242974|FG002|Overall Study|Lost to Follow-up|0|||
94669675|NCT01388816|324242975|FG003|Overall Study|Lost to Follow-up|0|||
94669676|NCT01388816|324242972|FG000|Overall Study|Withdrawal by Subject|2|||
94669677|NCT01388816|324242973|FG001|Overall Study|Withdrawal by Subject|1|||
94669678|NCT01388816|324242974|FG002|Overall Study|Withdrawal by Subject|1|||
94669679|NCT01388816|324242975|FG003|Overall Study|Withdrawal by Subject|0|||
94669680|NCT01388816|324242972|FG000|Overall Study|Protocol Violation|0|||
94669681|NCT01388816|324242973|FG001|Overall Study|Protocol Violation|0|||
94669682|NCT01388816|324242974|FG002|Overall Study|Protocol Violation|2|||
94669683|NCT01388816|324242975|FG003|Overall Study|Protocol Violation|0|||
94669684|NCT02270450|324242976|FG000|Overall Study|Refusal unrelated to adverse event|3|||
94669685|NCT02270450|324242977|FG001|Overall Study|Refusal unrelated to adverse event|1|||
94669686|NCT02270450|324242978|FG002|Overall Study|Refusal unrelated to adverse event|5|||
94669687|NCT02270450|324242979|FG003|Overall Study|Refusal unrelated to adverse event|14|||
94669688|NCT02270450|324242976|FG000|Overall Study|Progression/relapse|1|||
94669689|NCT02270450|324242977|FG001|Overall Study|Progression/relapse|2|||
94669690|NCT02270450|324242978|FG002|Overall Study|Progression/relapse|4|||
94669691|NCT02270450|324242979|FG003|Overall Study|Progression/relapse|9|||
94669692|NCT02270450|324242976|FG000|Overall Study|Death|19|||
94669693|NCT02270450|324242977|FG001|Overall Study|Death|19|||
94669694|NCT02270450|324242978|FG002|Overall Study|Death|31|||
94669695|NCT02270450|324242979|FG003|Overall Study|Death|59|||
94669696|NCT02576678|324242981|FG000|Overall Study|Adverse Event|0|||
94669697|NCT02576678|324242982|FG001|Overall Study|Adverse Event|0|||
94669698|NCT02576678|324242983|FG002|Overall Study|Adverse Event|2|||
94669699|NCT02576678|324242981|FG000|Overall Study|Withdrawal by Subject|3|||
94669700|NCT02576678|324242982|FG001|Overall Study|Withdrawal by Subject|1|||
94669701|NCT02576678|324242983|FG002|Overall Study|Withdrawal by Subject|2|||
94669702|NCT02576678|324242981|FG000|Overall Study|Lost to Follow-up|0|||
94669703|NCT02576678|324242982|FG001|Overall Study|Lost to Follow-up|0|||
94669704|NCT02576678|324242983|FG002|Overall Study|Lost to Follow-up|1|||
94669705|NCT02576678|324242981|FG000|Overall Study|Miscellaneous|2|||
94669706|NCT02576678|324242982|FG001|Overall Study|Miscellaneous|0|||
94669707|NCT02576678|324242983|FG002|Overall Study|Miscellaneous|0|||
94669708|NCT02363946|324242984|FG000|Overall Study|Lost to Follow-up|0|||
94669709|NCT02363946|324242985|FG001|Overall Study|Lost to Follow-up|0|||
94669710|NCT02363946|324242986|FG002|Overall Study|Lost to Follow-up|0|||
94669711|NCT02363946|324242987|FG003|Overall Study|Lost to Follow-up|0|||
94669712|NCT02363946|324242988|FG004|Overall Study|Lost to Follow-up|0|||
94669713|NCT02363946|324242989|FG005|Overall Study|Lost to Follow-up|0|||
94669714|NCT02363946|324242990|FG006|Overall Study|Lost to Follow-up|0|||
94669715|NCT02363946|324242991|FG007|Overall Study|Lost to Follow-up|1|||
94669716|NCT02363946|324242992|FG008|Overall Study|Lost to Follow-up|0|||
94669717|NCT02363946|324242993|FG009|Overall Study|Lost to Follow-up|0|||
94669718|NCT02363946|324242994|FG010|Overall Study|Lost to Follow-up|0|||
94669719|NCT02363946|324242995|FG011|Overall Study|Lost to Follow-up|0|||
94669720|NCT02363946|324242996|FG012|Overall Study|Lost to Follow-up|0|||
94669721|NCT02199028|324242997|FG000|Week 1|Adverse Event|1|||
94669722|NCT02199028|324242998|FG001|Week 1|Adverse Event|0|||
94669723|NCT02199028|324242997|FG000|Week 3|Adverse Event|1|||
94669724|NCT02199028|324242998|FG001|Week 3|Adverse Event|0|||
94669725|NCT05045625|324242999|FG000|Overall Study|Lost to Follow-up|3|||
94669726|NCT01777854|324243000|FG000|Overall Study|Physician Decision|3|||
94669727|NCT01777854|324243001|FG001|Overall Study|Physician Decision|3|||
94669728|NCT01018394|324243002|FG000|Overall Study|Withdrawal by Subject|5|||
94669729|NCT01018394|324243003|FG001|Overall Study|Withdrawal by Subject|5|||
94669730|NCT01018394|324243002|FG000|Overall Study|Lost to Follow-up|4|||
94669731|NCT01018394|324243003|FG001|Overall Study|Lost to Follow-up|3|||
94669732|NCT00374322|324243004|FG000|Overall Study|Lost to Follow-up|92|||
94669733|NCT00374322|324243005|FG001|Overall Study|Lost to Follow-up|90|||
94669734|NCT00374322|324243004|FG000|Overall Study|Protocol Violation|8|||
94669735|NCT00374322|324243005|FG001|Overall Study|Protocol Violation|3|||
94669736|NCT00374322|324243004|FG000|Overall Study|Withdrawal by Subject|235|||
94669737|NCT00374322|324243005|FG001|Overall Study|Withdrawal by Subject|167|||
94461186|NCT00373958|323478212|FG001|Toddler Dose|Lost to Follow-up|8|||
94461187|NCT00373958|323478211|FG000|Toddler Dose|Withdrawal by Subject|2|||
94669738|NCT00374322|324243004|FG000|Overall Study|Sponsor Terminated Study|866|||
94669739|NCT00374322|324243005|FG001|Overall Study|Sponsor Terminated Study|990|||
94669740|NCT00374322|324243004|FG000|Overall Study|Physician Decision|36|||
94669741|NCT00374322|324243005|FG001|Overall Study|Physician Decision|32|||
94669742|NCT00374322|324243004|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
94669743|NCT00374322|324243005|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
94669744|NCT00374322|324243004|FG000|Overall Study|Sponsor Decision|2|||
94669745|NCT00374322|324243005|FG001|Overall Study|Sponsor Decision|3|||
94669746|NCT00374322|324243004|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
94669747|NCT00374322|324243005|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
94669748|NCT00374322|324243004|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
94669749|NCT00374322|324243005|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
94669750|NCT00374322|324243004|FG000|Overall Study|Severe Toxicity|1|||
94669751|NCT00374322|324243005|FG001|Overall Study|Severe Toxicity|0|||
94669752|NCT00374322|324243004|FG000|Overall Study|Site Closed|2|||
94669753|NCT00374322|324243005|FG001|Overall Study|Site Closed|2|||
94669754|NCT00374322|324243004|FG000|Overall Study|Participant Changed Physician|1|||
94669755|NCT00374322|324243005|FG001|Overall Study|Participant Changed Physician|0|||
94669756|NCT00374322|324243004|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
94623197|NCT03766581|324084047|FG003|Treatment|Participant no longer meets study criteria|4|||
94623198|NCT03766581|324084048|FG004|Treatment|Participant no longer meets study criteria|4|||
94623199|NCT03766581|324084049|FG005|Treatment|Participant no longer meets study criteria|4|||
94623200|NCT03766581|324084050|FG006|Treatment|Participant no longer meets study criteria|2|||
94623201|NCT03766581|324084051|FG007|Treatment|Participant no longer meets study criteria|0|||
94623202|NCT03766581|324084044|FG000|Treatment|Other reasons|13|||
94623203|NCT03766581|324084045|FG001|Treatment|Other reasons|8|||
94623204|NCT03766581|324084046|FG002|Treatment|Other reasons|3|||
94623205|NCT03766581|324084047|FG003|Treatment|Other reasons|7|||
94623206|NCT03766581|324084048|FG004|Treatment|Other reasons|3|||
94623207|NCT03766581|324084049|FG005|Treatment|Other reasons|3|||
94623208|NCT03766581|324084050|FG006|Treatment|Other reasons|0|||
94623209|NCT03766581|324084051|FG007|Treatment|Other reasons|0|||
94623210|NCT00520936|324084052|FG000|Overall Study|Physician Decision|0|||
94623211|NCT00520936|324084053|FG001|Overall Study|Physician Decision|2|||
94623212|NCT00520936|324084054|FG002|Overall Study|Physician Decision|1|||
94623213|NCT00520936|324084055|FG003|Overall Study|Physician Decision|0|||
94623214|NCT00520936|324084056|FG004|Overall Study|Physician Decision|0|||
94623215|NCT00520936|324084057|FG005|Overall Study|Physician Decision|0|||
94623216|NCT00520936|324084058|FG006|Overall Study|Physician Decision|0|||
94623217|NCT00520936|324084059|FG007|Overall Study|Physician Decision|0|||
94623218|NCT00520936|324084052|FG000|Overall Study|Withdrawal by Subject|0|||
94623219|NCT00520936|324084053|FG001|Overall Study|Withdrawal by Subject|0|||
94623220|NCT00520936|324084054|FG002|Overall Study|Withdrawal by Subject|0|||
94623221|NCT00520936|324084055|FG003|Overall Study|Withdrawal by Subject|0|||
94623222|NCT00520936|324084056|FG004|Overall Study|Withdrawal by Subject|0|||
94623223|NCT00520936|324084057|FG005|Overall Study|Withdrawal by Subject|0|||
94623224|NCT00520936|324084058|FG006|Overall Study|Withdrawal by Subject|0|||
94623225|NCT00520936|324084059|FG007|Overall Study|Withdrawal by Subject|1|||
94623226|NCT00520936|324084052|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
94623227|NCT00520936|324084053|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
94623228|NCT00520936|324084054|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
94623229|NCT00520936|324084055|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
94623230|NCT00520936|324084056|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
94623231|NCT00520936|324084057|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
94623232|NCT00520936|324084058|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
94623233|NCT00520936|324084059|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
94623234|NCT00520936|324084052|FG000|Overall Study|Death|0|||
94623235|NCT00520936|324084053|FG001|Overall Study|Death|0|||
94623236|NCT00520936|324084054|FG002|Overall Study|Death|0|||
94623237|NCT00520936|324084055|FG003|Overall Study|Death|0|||
94623238|NCT00520936|324084056|FG004|Overall Study|Death|0|||
94623239|NCT00520936|324084057|FG005|Overall Study|Death|0|||
94623240|NCT00520936|324084058|FG006|Overall Study|Death|1|||
94623241|NCT00520936|324084059|FG007|Overall Study|Death|0|||
94623242|NCT00520936|324084052|FG000|Overall Study|Protocol Violation|0|||
94623243|NCT00520936|324084053|FG001|Overall Study|Protocol Violation|1|||
94623244|NCT00520936|324084054|FG002|Overall Study|Protocol Violation|1|||
94623245|NCT00520936|324084055|FG003|Overall Study|Protocol Violation|0|||
94623246|NCT00520936|324084056|FG004|Overall Study|Protocol Violation|1|||
94623247|NCT00520936|324084057|FG005|Overall Study|Protocol Violation|0|||
94623248|NCT00520936|324084058|FG006|Overall Study|Protocol Violation|1|||
94623249|NCT00520936|324084059|FG007|Overall Study|Protocol Violation|0|||
94623250|NCT02269241|324084060|FG000|Overall Study|Lost to Follow-up|269|||
94623251|NCT02269241|324084060|FG000|Overall Study|Withdrawal by Subject|155|||
94623252|NCT02269241|324084060|FG000|Overall Study|Protocol Violation|1|||
94623253|NCT02269241|324084060|FG000|Overall Study|Physician Decision|7|||
94623254|NCT02269241|324084060|FG000|Overall Study|Pregnancy|15|||
94623255|NCT02269241|324084060|FG000|Overall Study|Wish for pregnancy|5|||
94623256|NCT02269241|324084060|FG000|Overall Study|Development of an exclusion criteria|16|||
94623257|NCT02269241|324084060|FG000|Overall Study|Adverse Event|113|||
94623258|NCT02269241|324084060|FG000|Overall Study|At the specific request of the sponsor|20|||
94669757|NCT00374322|324243005|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
94669758|NCT00374322|324243004|FG000|Overall Study|Noncompliance with Study Requirements|0|||
94623259|NCT02269241|324084060|FG000|Overall Study|Several reasons not classified|53|||
94623260|NCT02269241|324084060|FG000|Overall Study|Screening failures|546|||
94623261|NCT05275400|324084064|FG000|Treatment Period|Adverse Event|7|||
94623262|NCT05275400|324084065|FG001|Treatment Period|Adverse Event|1|||
94623263|NCT05275400|324084064|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
94623264|NCT05275400|324084065|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
94623265|NCT05275400|324084064|FG000|Treatment Period|Death|5|||
94669759|NCT00374322|324243005|FG001|Overall Study|Noncompliance with Study Requirements|1|||
94623266|NCT05275400|324084065|FG001|Treatment Period|Death|2|||
94623267|NCT05275400|324084064|FG000|Treatment Period|Protocol Violation|1|||
94623268|NCT05275400|324084065|FG001|Treatment Period|Protocol Violation|0|||
94623269|NCT05275400|324084064|FG000|Treatment Period|Physician Decision|5|||
94623270|NCT05275400|324084065|FG001|Treatment Period|Physician Decision|4|||
94623271|NCT05275400|324084064|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
94623272|NCT05275400|324084065|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
94623273|NCT05275400|324084064|FG000|Treatment Period|Withdrawal by Subject|30|||
94623274|NCT05275400|324084065|FG001|Treatment Period|Withdrawal by Subject|12|||
94623275|NCT05275400|324084064|FG000|Treatment Period|Lost to Follow-up|1|||
94623276|NCT05275400|324084065|FG001|Treatment Period|Lost to Follow-up|5|||
94623277|NCT05275400|324084064|FG000|Treatment Period|Lack of Efficacy|1|||
94623278|NCT05275400|324084065|FG001|Treatment Period|Lack of Efficacy|0|||
94623279|NCT05275400|324084064|FG000|Treatment Period|Sponsor Decision|1|||
94623280|NCT05275400|324084065|FG001|Treatment Period|Sponsor Decision|0|||
94623281|NCT05275400|324084064|FG000|Follow-Up Period|Death|2|||
94623282|NCT05275400|324084065|FG001|Follow-Up Period|Death|0|||
94623283|NCT05275400|324084064|FG000|Follow-Up Period|Protocol Violation|1|||
94623284|NCT05275400|324084065|FG001|Follow-Up Period|Protocol Violation|0|||
94623285|NCT05275400|324084064|FG000|Follow-Up Period|Withdrawal by Subject|3|||
94623286|NCT05275400|324084065|FG001|Follow-Up Period|Withdrawal by Subject|0|||
94623287|NCT06333613|324084072|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
94623288|NCT01061177|324084076|FG000|Overall Study|Adverse Event|117|||
94623289|NCT01061177|324084076|FG000|Overall Study|Withdrawal by Subject|27|||
94623290|NCT01061177|324084076|FG000|Overall Study|Disease progression|17|||
94623291|NCT01061177|324084076|FG000|Overall Study|Protocol Violation|11|||
94623292|NCT01061177|324084076|FG000|Overall Study|Lost to Follow-up|9|||
94623293|NCT01061177|324084076|FG000|Overall Study|New cancer therapy|9|||
94623294|NCT01061177|324084076|FG000|Overall Study|Abnormal laboratory values|6|||
94623295|NCT01061177|324084076|FG000|Overall Study|Abnormal test procedure results|4|||
94669760|NCT00374322|324243004|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
94669761|NCT00374322|324243005|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
94669762|NCT00374322|324243004|FG000|Overall Study|Did Not Receive Study Medication|8|||
94669763|NCT00374322|324243005|FG001|Overall Study|Did Not Receive Study Medication|6|||
94669764|NCT00234065|324243006|FG000|Overall Study|Adverse Event|268|||
94669765|NCT00234065|324243007|FG001|Overall Study|Adverse Event|166|||
94669766|NCT00234065|324243006|FG000|Overall Study|Withdrawal by Subject|73|||
94669767|NCT00234065|324243007|FG001|Overall Study|Withdrawal by Subject|56|||
94669768|NCT00234065|324243006|FG000|Overall Study|Physician Decision|23|||
94669769|NCT00234065|324243007|FG001|Overall Study|Physician Decision|22|||
94669770|NCT00234065|324243006|FG000|Overall Study|Not Classified|111|||
94669771|NCT00234065|324243007|FG001|Overall Study|Not Classified|112|||
94669772|NCT00126438|324243008|FG000|Overall Study|Withdrawal due to adverse event|1|||
94669773|NCT00126438|324243009|FG001|Overall Study|Withdrawal due to adverse event|0|||
94669774|NCT00126438|324243008|FG000|Overall Study|Lost to Follow-up|22|||
94669775|NCT00126438|324243009|FG001|Overall Study|Lost to Follow-up|0|||
94669776|NCT00126438|324243008|FG000|Overall Study|Protocol Violation|8|||
94669777|NCT00126438|324243009|FG001|Overall Study|Protocol Violation|8|||
94669778|NCT00126438|324243008|FG000|Overall Study|Withdrawal by Subject|3|||
94669779|NCT00126438|324243009|FG001|Overall Study|Withdrawal by Subject|2|||
94669780|NCT02477618|324243010|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
94669781|NCT02477618|324243011|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
94669782|NCT02477618|324243010|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
94669783|NCT02477618|324243011|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
94669784|NCT02477618|324243010|FG000|Overall Study|Adverse Event|1|||
94669785|NCT02477618|324243011|FG001|Overall Study|Adverse Event|1|||
94669786|NCT02477618|324243010|FG000|Overall Study|Transferred Away from Study Site|1|||
94669787|NCT02477618|324243011|FG001|Overall Study|Transferred Away from Study Site|0|||
94623296|NCT01061177|324084076|FG000|Overall Study|Administratie problems|4|||
94623297|NCT01061177|324084076|FG000|Overall Study|Death|4|||
94623298|NCT00299104|324084077|FG000|Treatment Period|Adverse Event|14|||
94623299|NCT00299104|324084078|FG001|Treatment Period|Adverse Event|9|||
94623300|NCT00299104|324084079|FG002|Treatment Period|Adverse Event|7|||
94623301|NCT00299104|324084077|FG000|Treatment Period|Death|1|||
94623302|NCT00299104|324084078|FG001|Treatment Period|Death|1|||
94623303|NCT00299104|324084079|FG002|Treatment Period|Death|1|||
94623304|NCT00299104|324084077|FG000|Treatment Period|Insufficient therapeutic response|34|||
94669788|NCT02477618|324243010|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
94669789|NCT02477618|324243011|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
94359561|NCT04668066|323100339|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
94359562|NCT04668066|323100340|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
94359563|NCT04668066|323100341|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
94359564|NCT04668066|323100342|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
94359565|NCT04668066|323100343|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
94359566|NCT04668066|323100344|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
94359567|NCT04668066|323100345|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
94359568|NCT04668066|323100346|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
94359569|NCT04668066|323100347|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
94623305|NCT00299104|324084078|FG001|Treatment Period|Insufficient therapeutic response|13|||
94623306|NCT00299104|324084079|FG002|Treatment Period|Insufficient therapeutic response|8|||
94623307|NCT00299104|324084077|FG000|Treatment Period|Failure to return|9|||
94623308|NCT00299104|324084078|FG001|Treatment Period|Failure to return|8|||
94623309|NCT00299104|324084079|FG002|Treatment Period|Failure to return|8|||
94623310|NCT00299104|324084077|FG000|Treatment Period|Violation of selection criteria|1|||
94359570|NCT04668066|323100348|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
94623311|NCT00299104|324084078|FG001|Treatment Period|Violation of selection criteria|2|||
94623312|NCT00299104|324084079|FG002|Treatment Period|Violation of selection criteria|0|||
94623313|NCT00299104|324084077|FG000|Treatment Period|Protocol Violation|1|||
94623314|NCT00299104|324084078|FG001|Treatment Period|Protocol Violation|1|||
94623315|NCT00299104|324084079|FG002|Treatment Period|Protocol Violation|0|||
94623316|NCT00299104|324084077|FG000|Treatment Period|Refused treatment|9|||
94623317|NCT00299104|324084078|FG001|Treatment Period|Refused treatment|2|||
94623318|NCT00299104|324084079|FG002|Treatment Period|Refused treatment|2|||
94623319|NCT00299104|324084077|FG000|Treatment Period|Withdrew consent|14|||
94623320|NCT00299104|324084078|FG001|Treatment Period|Withdrew consent|19|||
94623321|NCT00299104|324084079|FG002|Treatment Period|Withdrew consent|9|||
94623322|NCT00299104|324084077|FG000|Treatment Period|Administrative reasons|106|||
94623323|NCT00299104|324084078|FG001|Treatment Period|Administrative reasons|120|||
94623324|NCT00299104|324084079|FG002|Treatment Period|Administrative reasons|137|||
94623325|NCT00299104|324084077|FG000|Safety Follow-Up (SFU) Period|Death|3|||
94623326|NCT00299104|324084078|FG001|Safety Follow-Up (SFU) Period|Death|2|||
94623327|NCT00299104|324084079|FG002|Safety Follow-Up (SFU) Period|Death|1|||
94623328|NCT00299104|324084077|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
94623329|NCT00299104|324084078|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
94623330|NCT00299104|324084079|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
94623331|NCT00299104|324084077|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
94623332|NCT00299104|324084078|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
94623333|NCT00299104|324084079|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
94623334|NCT00299104|324084077|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
94623335|NCT00299104|324084078|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
94623336|NCT00299104|324084079|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
94623337|NCT00299104|324084077|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
94623338|NCT00299104|324084078|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
94623339|NCT00299104|324084079|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
94623340|NCT00299104|324084077|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
94623341|NCT00299104|324084078|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
94623342|NCT00299104|324084079|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
94669790|NCT00955357|324244900|FG000|Titration Phase|Adverse Event|9|||
94669791|NCT00955357|324244901|FG001|Titration Phase|Adverse Event|46|||
94669792|NCT00955357|324244900|FG000|Titration Phase|Lack of Efficacy|0|||
94669793|NCT00955357|324244901|FG001|Titration Phase|Lack of Efficacy|2|||
94359571|NCT04668066|323100349|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
94359572|NCT04668066|323100350|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
94623343|NCT00299104|324084077|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
94623344|NCT00299104|324084078|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
94669794|NCT00955357|324244900|FG000|Titration Phase|Protocol Violation|3|||
94669795|NCT00955357|324244901|FG001|Titration Phase|Protocol Violation|7|||
94669796|NCT00955357|324244900|FG000|Titration Phase|Lost to Follow-up|1|||
94669797|NCT00955357|324244901|FG001|Titration Phase|Lost to Follow-up|3|||
94669798|NCT00955357|324244900|FG000|Titration Phase|Withdrawal by Subject|3|||
94669799|NCT00955357|324244901|FG001|Titration Phase|Withdrawal by Subject|5|||
94669800|NCT00955357|324244900|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
94669801|NCT00955357|324244901|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
94669802|NCT00955357|324244900|FG000|Titration Phase|Study medication not tolerated|0|||
94669803|NCT00955357|324244901|FG001|Titration Phase|Study medication not tolerated|1|||
94669804|NCT00955357|324244900|FG000|Titration Phase|Non compliance to study procedures|0|||
94669805|NCT00955357|324244901|FG001|Titration Phase|Non compliance to study procedures|1|||
94669806|NCT00955357|324244900|FG000|Maintenance Phase|Adverse Event|3|||
94669807|NCT00955357|324244901|FG001|Maintenance Phase|Adverse Event|23|||
94669808|NCT00955357|324244900|FG000|Maintenance Phase|Lack of Efficacy|0|||
94669809|NCT00955357|324244901|FG001|Maintenance Phase|Lack of Efficacy|4|||
94669810|NCT00955357|324244900|FG000|Maintenance Phase|Protocol Violation|2|||
94669811|NCT00955357|324244901|FG001|Maintenance Phase|Protocol Violation|6|||
94669812|NCT00955357|324244900|FG000|Maintenance Phase|Lost to Follow-up|2|||
94669813|NCT00955357|324244901|FG001|Maintenance Phase|Lost to Follow-up|7|||
94669814|NCT00955357|324244900|FG000|Maintenance Phase|Withdrawal by Subject|4|||
94669815|NCT00955357|324244901|FG001|Maintenance Phase|Withdrawal by Subject|4|||
94669816|NCT00955357|324244900|FG000|Maintenance Phase|Patient moving out of area|0|||
94669817|NCT00955357|324244901|FG001|Maintenance Phase|Patient moving out of area|1|||
94669818|NCT00955357|324244900|FG000|Maintenance Phase|Non compliance to study procedures|1|||
94669819|NCT00955357|324244901|FG001|Maintenance Phase|Non compliance to study procedures|0|||
94669820|NCT00886340|324244904|FG000|Overall Study|Withdrawal by Subject|0|||
94669821|NCT00886340|324244905|FG001|Overall Study|Withdrawal by Subject|7|||
94669822|NCT02338154|324244906|FG000|Overall Study|Death|46|||
94669823|NCT02338154|324244906|FG000|Overall Study|Valve Implant Failure|17|||
94669824|NCT02338154|324244906|FG000|Overall Study|Valve Explant|11|||
94669825|NCT02338154|324244906|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
94669826|NCT02338154|324244906|FG000|Overall Study|Lost to Follow-up|8|||
94669827|NCT02338154|324244906|FG000|Overall Study|Other Reason|3|||
94669828|NCT02338154|324244906|FG000|Overall Study|Patients Without Exit Form|47|||
94669829|NCT02338154|324244906|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
94669830|NCT03224182|324244907|FG000|Overall Study|Study Drug Not Instilled|6|||
94669831|NCT03224182|324244908|FG001|Overall Study|Study Drug Not Instilled|1|||
94669832|NCT03224182|324244907|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
94669833|NCT03224182|324244908|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
94669834|NCT03224182|324244907|FG000|Overall Study|Withdrew of Consent|4|||
94669835|NCT03224182|324244908|FG001|Overall Study|Withdrew of Consent|2|||
94669836|NCT03224182|324244907|FG000|Overall Study|Investigator Decision|3|||
94669837|NCT03224182|324244908|FG001|Overall Study|Investigator Decision|1|||
94669838|NCT03224182|324244907|FG000|Overall Study|Sponsor Decision|26|||
94669839|NCT03224182|324244908|FG001|Overall Study|Sponsor Decision|12|||
94669840|NCT03224182|324244907|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
94669841|NCT03224182|324244908|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
94669842|NCT03224182|324244907|FG000|Overall Study|Lost to Follow-up|1|||
94669843|NCT03224182|324244908|FG001|Overall Study|Lost to Follow-up|0|||
94669844|NCT03224182|324244907|FG000|Overall Study|Participant Had Recurrence|11|||
94669845|NCT03224182|324244908|FG001|Overall Study|Participant Had Recurrence|5|||
94669846|NCT03224182|324244907|FG000|Overall Study|Death|0|||
94669847|NCT03224182|324244908|FG001|Overall Study|Death|1|||
94669848|NCT03224182|324244907|FG000|Overall Study|Reason not Specified|3|||
94669849|NCT03224182|324244908|FG001|Overall Study|Reason not Specified|3|||
94669850|NCT03224182|324244907|FG000|Overall Study|Other|1|||
94669851|NCT03224182|324244908|FG001|Overall Study|Other|0|||
94669852|NCT02822222|324244912|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
94669853|NCT02822222|324244913|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
94669854|NCT02481310|324244914|FG000|Follow up|Still in follow up|0|||
94669855|NCT02481310|324244915|FG001|Follow up|Still in follow up|3|||
94461188|NCT00373958|323478212|FG001|Toddler Dose|Withdrawal by Subject|2|||
94461189|NCT00373958|323478211|FG000|Toddler Dose|Failed to return|1|||
94669856|NCT02481310|324244916|FG002|Follow up|Still in follow up|0|||
94669857|NCT02120027|324244917|FG000|Overall Study|Adverse Event|4|||
94669858|NCT02120027|324244918|FG001|Overall Study|Adverse Event|5|||
94669859|NCT02120027|324244917|FG000|Overall Study|Lack of Efficacy|3|||
94669860|NCT02120027|324244918|FG001|Overall Study|Lack of Efficacy|5|||
94669861|NCT02120027|324244917|FG000|Overall Study|Lost to Follow-up|5|||
94669862|NCT02120027|324244918|FG001|Overall Study|Lost to Follow-up|13|||
94461190|NCT00373958|323478212|FG001|Toddler Dose|Failed to return|2|||
94669863|NCT02120027|324244917|FG000|Overall Study|Other|4|||
94669864|NCT02120027|324244918|FG001|Overall Study|Other|0|||
94669865|NCT02120027|324244917|FG000|Overall Study|Physician Decision|4|||
94669866|NCT02120027|324244918|FG001|Overall Study|Physician Decision|3|||
94359573|NCT04668066|323100351|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
94623345|NCT00299104|324084079|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
94623346|NCT00299104|324084077|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
94623347|NCT00299104|324084078|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
94623348|NCT00299104|324084079|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
94623349|NCT04623216|324084091|FG000|Overall Study|Death|5|||
94623350|NCT04623216|324084092|FG001|Overall Study|Death|2|||
94623351|NCT04623216|324084093|FG002|Overall Study|Death|0|||
94623352|NCT04623216|324084094|FG003|Overall Study|Death|0|||
94623353|NCT04623216|324084091|FG000|Overall Study|Terminated by Sponsor|3|||
94623354|NCT04623216|324084092|FG001|Overall Study|Terminated by Sponsor|2|||
94623355|NCT04623216|324084093|FG002|Overall Study|Terminated by Sponsor|2|||
94623356|NCT04623216|324084094|FG003|Overall Study|Terminated by Sponsor|0|||
94623357|NCT04623216|324084091|FG000|Overall Study|Physician Decision|1|||
94623358|NCT04623216|324084092|FG001|Overall Study|Physician Decision|0|||
94623359|NCT04623216|324084093|FG002|Overall Study|Physician Decision|0|||
94623360|NCT04623216|324084094|FG003|Overall Study|Physician Decision|0|||
94623361|NCT01651039|324084095|FG000|Overall Study|Non-evaluables|5|||
94623362|NCT01651039|324084095|FG000|Overall Study|Physician Decision|2|||
94623363|NCT01651039|324084095|FG000|Overall Study|Withdrawal by Subject|1|||
94623364|NCT01651039|324084095|FG000|Overall Study|Progressive Disease|22|||
94623365|NCT02059395|324084101|FG000|Overall Study|Lost to Follow-up|2|||
94623366|NCT02059395|324084102|FG001|Overall Study|Lost to Follow-up|4|||
94623367|NCT01909674|324084103|FG000|Overall Study|Withdrawal by Subject|5|||
94623368|NCT01909674|324084104|FG001|Overall Study|Withdrawal by Subject|2|||
94623369|NCT00847379|324084105|FG000|Overall Study|Study terminated by Sponsor|59|||
94623370|NCT00847379|324084106|FG001|Overall Study|Study terminated by Sponsor|57|||
94623371|NCT00847379|324084107|FG002|Overall Study|Study terminated by Sponsor|57|||
94623372|NCT00134082|324084108|FG000|Overall Study|Adverse Event|2|||
94623373|NCT00134082|324084108|FG000|Overall Study|Death|1|||
94623374|NCT00378378|324084109|FG000|Overall Study|Withdrawal by Subject|0|||
94623375|NCT00378378|324084110|FG001|Overall Study|Withdrawal by Subject|1|||
94623376|NCT00378378|324084111|FG002|Overall Study|Withdrawal by Subject|0|||
94623377|NCT00378378|324084109|FG000|Overall Study|Treatment Failure|0|||
94623378|NCT00378378|324084110|FG001|Overall Study|Treatment Failure|0|||
94623379|NCT00378378|324084111|FG002|Overall Study|Treatment Failure|1|||
94623380|NCT00378378|324084109|FG000|Overall Study|Non-compliance with protocol|0|||
94623381|NCT00378378|324084110|FG001|Overall Study|Non-compliance with protocol|0|||
94623382|NCT00378378|324084111|FG002|Overall Study|Non-compliance with protocol|1|||
94623383|NCT04270747|324084118|FG000|Through Week 16|Adverse Event|1|||
94623384|NCT04270747|324084119|FG001|Through Week 16|Adverse Event|2|||
94623385|NCT04270747|324084120|FG002|Through Week 16|Adverse Event|0|||
94623386|NCT04270747|324084118|FG000|Through Week 16|Death|0|||
94623387|NCT04270747|324084119|FG001|Through Week 16|Death|2|||
94623388|NCT04270747|324084120|FG002|Through Week 16|Death|0|||
94623389|NCT04270747|324084118|FG000|Through Week 16|Consent Withdrawn|3|||
94623390|NCT04270747|324084119|FG001|Through Week 16|Consent Withdrawn|3|||
94623391|NCT04270747|324084120|FG002|Through Week 16|Consent Withdrawn|0|||
94623392|NCT04270747|324084118|FG000|Through Week 16|Physician Decision|1|||
94623393|NCT04270747|324084119|FG001|Through Week 16|Physician Decision|1|||
94623394|NCT04270747|324084120|FG002|Through Week 16|Physician Decision|0|||
94623395|NCT04270747|324084118|FG000|Through Week 16|Lost to Follow-up|2|||
94623396|NCT04270747|324084119|FG001|Through Week 16|Lost to Follow-up|0|||
94623397|NCT04270747|324084120|FG002|Through Week 16|Lost to Follow-up|0|||
94623398|NCT04270747|324084118|FG000|Through Week 16|Protocol Violation|1|||
94623399|NCT04270747|324084119|FG001|Through Week 16|Protocol Violation|2|||
94623400|NCT04270747|324084120|FG002|Through Week 16|Protocol Violation|0|||
94623401|NCT04270747|324084118|FG000|Through Week 16|Protocol Specified Criteria|6|||
94623402|NCT04270747|324084119|FG001|Through Week 16|Protocol Specified Criteria|7|||
94623403|NCT04270747|324084120|FG002|Through Week 16|Protocol Specified Criteria|0|||
94623404|NCT04270747|324084118|FG000|Through Week 16|Miscellaneous|1|||
94623405|NCT04270747|324084119|FG001|Through Week 16|Miscellaneous|1|||
94623406|NCT04270747|324084120|FG002|Through Week 16|Miscellaneous|0|||
94623407|NCT04270747|324084118|FG000|Post Week 16|Adverse Event|7|||
94623408|NCT04270747|324084119|FG001|Post Week 16|Adverse Event|5|||
94623409|NCT04270747|324084120|FG002|Post Week 16|Adverse Event|1|||
94623410|NCT04270747|324084118|FG000|Post Week 16|Death|2|||
94623411|NCT04270747|324084119|FG001|Post Week 16|Death|0|||
94623412|NCT04270747|324084120|FG002|Post Week 16|Death|2|||
94623413|NCT04270747|324084118|FG000|Post Week 16|Consent Withdrawn|4|||
94623414|NCT04270747|324084119|FG001|Post Week 16|Consent Withdrawn|3|||
94623415|NCT04270747|324084120|FG002|Post Week 16|Consent Withdrawn|6|||
94623416|NCT04270747|324084118|FG000|Post Week 16|Physician Decision|3|||
94623417|NCT04270747|324084119|FG001|Post Week 16|Physician Decision|1|||
94623418|NCT04270747|324084120|FG002|Post Week 16|Physician Decision|1|||
94623419|NCT04270747|324084118|FG000|Post Week 16|Lost to Follow-up|2|||
94623420|NCT04270747|324084119|FG001|Post Week 16|Lost to Follow-up|1|||
94623421|NCT04270747|324084120|FG002|Post Week 16|Lost to Follow-up|0|||
94623422|NCT04270747|324084118|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
94623423|NCT04270747|324084119|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
94623424|NCT04270747|324084120|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
94623425|NCT04270747|324084118|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
94623426|NCT04270747|324084119|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
94623427|NCT04270747|324084120|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
94623428|NCT04270747|324084118|FG000|Post Week 16|Miscellaneous|1|||
94623429|NCT04270747|324084119|FG001|Post Week 16|Miscellaneous|0|||
94623430|NCT04270747|324084120|FG002|Post Week 16|Miscellaneous|1|||
94623431|NCT05025241|324084121|FG000|Screening|Failed Screening|5|||
94623432|NCT05025241|324084121|FG000|Treatment and Follow Up|Adverse Event|3|||
94623433|NCT02220205|324084122|FG000|Overall Study|Withdrawal by Subject|1|||
94623434|NCT02220205|324084123|FG001|Overall Study|Withdrawal by Subject|0|||
94623435|NCT04605484|324084124|FG000|Overall Study|Lost to Follow-up|0|||
94623436|NCT04605484|324084125|FG001|Overall Study|Lost to Follow-up|1|||
94623437|NCT04605484|324084126|FG002|Overall Study|Lost to Follow-up|1|||
94623438|NCT04605484|324084124|FG000|Overall Study|Other|0|||
94623439|NCT04605484|324084125|FG001|Overall Study|Other|1|||
94623440|NCT04605484|324084126|FG002|Overall Study|Other|0|||
94623441|NCT04171531|324084127|FG000|Overall Study|Lost to Follow-up|4|||
94623442|NCT04171531|324084128|FG001|Overall Study|Lost to Follow-up|5|||
94623443|NCT04171531|324084127|FG000|Overall Study|Consent only through 6 months|1|||
94623444|NCT04171531|324084128|FG001|Overall Study|Consent only through 6 months|1|||
94623445|NCT04171531|324084127|FG000|Overall Study|Insurance did not cover procedure|0|||
94623446|NCT04171531|324084128|FG001|Overall Study|Insurance did not cover procedure|1|||
94623447|NCT04171531|324084127|FG000|Overall Study|Physician Decision|0|||
94623448|NCT04171531|324084128|FG001|Overall Study|Physician Decision|3|||
94623449|NCT04171531|324084127|FG000|Overall Study|Withdrawal by Subject|1|||
94623450|NCT04171531|324084128|FG001|Overall Study|Withdrawal by Subject|5|||
94623451|NCT03366337|324084130|FG000|Overall Study|Lost to Follow-up|1|||
94623452|NCT03366337|324084131|FG001|Overall Study|Lost to Follow-up|0|||
94623453|NCT03366337|324084132|FG002|Overall Study|Lost to Follow-up|1|||
94623454|NCT03366337|324084133|FG003|Overall Study|Lost to Follow-up|0|||
94623455|NCT03366337|324084130|FG000|Overall Study|Withdrawal by Subject|2|||
94623456|NCT03366337|324084131|FG001|Overall Study|Withdrawal by Subject|0|||
94623457|NCT03366337|324084132|FG002|Overall Study|Withdrawal by Subject|1|||
94623458|NCT03366337|324084133|FG003|Overall Study|Withdrawal by Subject|1|||
94623459|NCT00880009|324084139|FG000|Overall Study|Study terminated by sponsor|14|||
94623460|NCT00880009|324084139|FG000|Overall Study|Withdrawal by Subject|1|||
94623461|NCT00880009|324084139|FG000|Overall Study|Protocol Violation|1|||
94623462|NCT01496612|324084141|FG000|1st Intervention|Adverse Event|1|||
94623463|NCT01496612|324084142|FG001|1st Intervention|Adverse Event|0|||
94623464|NCT01496612|324084141|FG000|1st Intervention|Withdrawal by Subject|1|||
94623465|NCT01496612|324084142|FG001|1st Intervention|Withdrawal by Subject|0|||
94623466|NCT04967443|324084143|FG000|Open Label Treatment|Death|1|||
94623467|NCT04967443|324084144|FG001|Open Label Treatment|Death|0|||
94623468|NCT04967443|324084145|FG002|Open Label Treatment|Death|0|||
94623469|NCT04967443|324084146|FG003|Open Label Treatment|Death|0|||
94623470|NCT04967443|324084147|FG004|Open Label Treatment|Death|0|||
94623471|NCT04967443|324084148|FG005|Open Label Treatment|Death|0|||
94623472|NCT04967443|324084149|FG006|Open Label Treatment|Death|0|||
94623473|NCT04967443|324084150|FG007|Open Label Treatment|Death|0|||
94623474|NCT04967443|324084143|FG000|Open Label Treatment|Lost to Follow-up|0|||
94623475|NCT04967443|324084144|FG001|Open Label Treatment|Lost to Follow-up|0|||
94623476|NCT04967443|324084145|FG002|Open Label Treatment|Lost to Follow-up|1|||
94623477|NCT04967443|324084146|FG003|Open Label Treatment|Lost to Follow-up|0|||
94623478|NCT04967443|324084147|FG004|Open Label Treatment|Lost to Follow-up|0|||
94623479|NCT04967443|324084148|FG005|Open Label Treatment|Lost to Follow-up|0|||
94623480|NCT04967443|324084149|FG006|Open Label Treatment|Lost to Follow-up|0|||
94623481|NCT04967443|324084150|FG007|Open Label Treatment|Lost to Follow-up|0|||
94623482|NCT04967443|324084143|FG000|Open Label Treatment|Withdrawal by Subject|0|||
94623483|NCT04967443|324084144|FG001|Open Label Treatment|Withdrawal by Subject|1|||
94623484|NCT04967443|324084145|FG002|Open Label Treatment|Withdrawal by Subject|0|||
94623485|NCT04967443|324084146|FG003|Open Label Treatment|Withdrawal by Subject|1|||
94623486|NCT04967443|324084147|FG004|Open Label Treatment|Withdrawal by Subject|0|||
94623487|NCT04967443|324084148|FG005|Open Label Treatment|Withdrawal by Subject|1|||
94669867|NCT02120027|324244917|FG000|Overall Study|Protocol Violation|18|||
94669868|NCT02120027|324244918|FG001|Overall Study|Protocol Violation|21|||
94669869|NCT02120027|324244917|FG000|Overall Study|Study terminated by Sponsor|45|||
94623488|NCT04967443|324084149|FG006|Open Label Treatment|Withdrawal by Subject|2|||
94623489|NCT04967443|324084150|FG007|Open Label Treatment|Withdrawal by Subject|3|||
94623490|NCT04967443|324084143|FG000|Follow-Up|Death|1|||
94623491|NCT04967443|324084144|FG001|Follow-Up|Death|0|||
94623492|NCT04967443|324084145|FG002|Follow-Up|Death|0|||
94623493|NCT04967443|324084146|FG003|Follow-Up|Death|0|||
94623494|NCT04967443|324084147|FG004|Follow-Up|Death|0|||
94623495|NCT04967443|324084148|FG005|Follow-Up|Death|0|||
94623496|NCT04967443|324084149|FG006|Follow-Up|Death|0|||
94623497|NCT04967443|324084150|FG007|Follow-Up|Death|0|||
94623498|NCT04967443|324084143|FG000|Follow-Up|Lost to Follow-up|0|||
94623499|NCT04967443|324084144|FG001|Follow-Up|Lost to Follow-up|0|||
94623500|NCT04967443|324084145|FG002|Follow-Up|Lost to Follow-up|1|||
94623501|NCT04967443|324084146|FG003|Follow-Up|Lost to Follow-up|1|||
94623502|NCT04967443|324084147|FG004|Follow-Up|Lost to Follow-up|0|||
94623503|NCT04967443|324084148|FG005|Follow-Up|Lost to Follow-up|0|||
94623504|NCT04967443|324084149|FG006|Follow-Up|Lost to Follow-up|0|||
94623505|NCT04967443|324084150|FG007|Follow-Up|Lost to Follow-up|0|||
94623506|NCT04967443|324084143|FG000|Follow-Up|Withdrawal by Subject|0|||
94623507|NCT04967443|324084144|FG001|Follow-Up|Withdrawal by Subject|1|||
94623508|NCT04967443|324084145|FG002|Follow-Up|Withdrawal by Subject|0|||
94623509|NCT04967443|324084146|FG003|Follow-Up|Withdrawal by Subject|1|||
94623510|NCT04967443|324084147|FG004|Follow-Up|Withdrawal by Subject|0|||
94669870|NCT02120027|324244918|FG001|Overall Study|Study terminated by Sponsor|47|||
94669871|NCT02120027|324244917|FG000|Overall Study|Withdrawal by Subject|33|||
94669872|NCT02120027|324244918|FG001|Overall Study|Withdrawal by Subject|25|||
94669873|NCT00643916|324244921|FG000|Overall Study|Protocol Violation|0|||
94669874|NCT00643916|324244922|FG001|Overall Study|Protocol Violation|1|||
94669875|NCT00643916|324244923|FG002|Overall Study|Protocol Violation|1|||
94669876|NCT00643916|324244924|FG003|Overall Study|Protocol Violation|1|||
94669877|NCT00643916|324244925|FG004|Overall Study|Protocol Violation|0|||
94669878|NCT00643916|324244926|FG005|Overall Study|Protocol Violation|0|||
94623511|NCT04967443|324084148|FG005|Follow-Up|Withdrawal by Subject|1|||
94669879|NCT00643916|324244921|FG000|Overall Study|Lost to Follow-up|0|||
94669880|NCT00643916|324244922|FG001|Overall Study|Lost to Follow-up|1|||
94669881|NCT00643916|324244923|FG002|Overall Study|Lost to Follow-up|0|||
94669882|NCT00643916|324244924|FG003|Overall Study|Lost to Follow-up|0|||
94669883|NCT00643916|324244925|FG004|Overall Study|Lost to Follow-up|0|||
94669884|NCT00643916|324244926|FG005|Overall Study|Lost to Follow-up|0|||
94669885|NCT00643916|324244921|FG000|Overall Study|Withdrawal by Subject|2|||
94669886|NCT00643916|324244922|FG001|Overall Study|Withdrawal by Subject|2|||
94669887|NCT00643916|324244923|FG002|Overall Study|Withdrawal by Subject|2|||
94669888|NCT00643916|324244924|FG003|Overall Study|Withdrawal by Subject|1|||
94669889|NCT00643916|324244925|FG004|Overall Study|Withdrawal by Subject|0|||
94669890|NCT00643916|324244926|FG005|Overall Study|Withdrawal by Subject|1|||
94669891|NCT00643916|324244921|FG000|Overall Study|Not Vaccinated|2|||
94669892|NCT00643916|324244922|FG001|Overall Study|Not Vaccinated|2|||
94669893|NCT00643916|324244923|FG002|Overall Study|Not Vaccinated|3|||
94669894|NCT00643916|324244924|FG003|Overall Study|Not Vaccinated|0|||
94669895|NCT00643916|324244925|FG004|Overall Study|Not Vaccinated|2|||
94669896|NCT00643916|324244926|FG005|Overall Study|Not Vaccinated|0|||
94669897|NCT00440531|324244939|FG000|Overall Study|Adverse Event|1|||
94669898|NCT00440531|324244940|FG001|Overall Study|Adverse Event|0|||
94669899|NCT00440531|324244941|FG002|Overall Study|Adverse Event|2|||
94669900|NCT00440531|324244939|FG000|Overall Study|Withdrawal by Subject|2|||
94669901|NCT00440531|324244940|FG001|Overall Study|Withdrawal by Subject|0|||
94669902|NCT00440531|324244941|FG002|Overall Study|Withdrawal by Subject|0|||
94669903|NCT00440531|324244939|FG000|Overall Study|Protocol Violation|1|||
94669904|NCT00440531|324244940|FG001|Overall Study|Protocol Violation|2|||
94669905|NCT00440531|324244941|FG002|Overall Study|Protocol Violation|0|||
94669906|NCT00440531|324244939|FG000|Overall Study|Lost to Follow-up|4|||
94669907|NCT00440531|324244940|FG001|Overall Study|Lost to Follow-up|3|||
94669908|NCT00440531|324244941|FG002|Overall Study|Lost to Follow-up|5|||
94669909|NCT00440531|324244939|FG000|Overall Study|see pre-assignment details|2|||
94669910|NCT00440531|324244940|FG001|Overall Study|see pre-assignment details|0|||
94669911|NCT00440531|324244941|FG002|Overall Study|see pre-assignment details|0|||
94669912|NCT00447057|324244942|FG000|Overall Study|Adverse Event|4|||
94623512|NCT04967443|324084149|FG006|Follow-Up|Withdrawal by Subject|2|||
94669913|NCT00447057|324244943|FG001|Overall Study|Adverse Event|10|||
94669914|NCT00447057|324244944|FG002|Overall Study|Adverse Event|0|||
94359574|NCT04668066|323100352|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
94623513|NCT04967443|324084150|FG007|Follow-Up|Withdrawal by Subject|3|||
94669915|NCT00447057|324244945|FG003|Overall Study|Adverse Event|3|||
94623514|NCT04584645|324084151|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
94623515|NCT04584645|324084152|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
94669916|NCT00447057|324244942|FG000|Overall Study|Death due to study disease|6|||
94669917|NCT00447057|324244943|FG001|Overall Study|Death due to study disease|4|||
94669918|NCT00447057|324244944|FG002|Overall Study|Death due to study disease|1|||
94669919|NCT00447057|324244945|FG003|Overall Study|Death due to study disease|1|||
94669920|NCT00447057|324244942|FG000|Overall Study|Lost to Follow-up|0|||
94669921|NCT00447057|324244943|FG001|Overall Study|Lost to Follow-up|1|||
94669922|NCT00447057|324244944|FG002|Overall Study|Lost to Follow-up|0|||
94669923|NCT00447057|324244945|FG003|Overall Study|Lost to Follow-up|0|||
94669924|NCT00447057|324244942|FG000|Overall Study|Entry criteria not met|1|||
94623516|NCT03706456|324084159|FG000|Overall Study|Adverse Event|1|||
94623517|NCT03706456|324084159|FG000|Overall Study|Lack of Efficacy|2|||
94359575|NCT04668066|323100353|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
94669925|NCT00447057|324244943|FG001|Overall Study|Entry criteria not met|1|||
94669926|NCT00447057|324244944|FG002|Overall Study|Entry criteria not met|0|||
94669927|NCT00447057|324244945|FG003|Overall Study|Entry criteria not met|0|||
94669928|NCT00447057|324244942|FG000|Overall Study|Protocol Violation|0|||
94669929|NCT00447057|324244943|FG001|Overall Study|Protocol Violation|1|||
94669930|NCT00447057|324244944|FG002|Overall Study|Protocol Violation|0|||
94669931|NCT00447057|324244945|FG003|Overall Study|Protocol Violation|0|||
94669932|NCT00447057|324244942|FG000|Overall Study|Withdrawal by Subject|4|||
94669933|NCT00447057|324244943|FG001|Overall Study|Withdrawal by Subject|5|||
94669934|NCT00447057|324244944|FG002|Overall Study|Withdrawal by Subject|1|||
94669935|NCT00447057|324244945|FG003|Overall Study|Withdrawal by Subject|1|||
94669936|NCT00447057|324244942|FG000|Overall Study|Physician Decision|9|||
94669937|NCT00447057|324244943|FG001|Overall Study|Physician Decision|6|||
94669938|NCT00447057|324244944|FG002|Overall Study|Physician Decision|3|||
94669939|NCT00447057|324244945|FG003|Overall Study|Physician Decision|1|||
94669940|NCT00447057|324244942|FG000|Overall Study|Sponsor decision|1|||
94669941|NCT00447057|324244943|FG001|Overall Study|Sponsor decision|1|||
94669942|NCT00447057|324244944|FG002|Overall Study|Sponsor decision|0|||
94669943|NCT00447057|324244945|FG003|Overall Study|Sponsor decision|0|||
94669944|NCT00447057|324244942|FG000|Overall Study|Progressive disease|58|||
94669945|NCT00447057|324244943|FG001|Overall Study|Progressive disease|43|||
94669946|NCT00447057|324244944|FG002|Overall Study|Progressive disease|13|||
94669947|NCT00447057|324244945|FG003|Overall Study|Progressive disease|18|||
94669948|NCT00447057|324244942|FG000|Overall Study|Death due to adverse event|0|||
94669949|NCT00447057|324244943|FG001|Overall Study|Death due to adverse event|0|||
94669950|NCT00447057|324244944|FG002|Overall Study|Death due to adverse event|1|||
94359576|NCT04668066|323100354|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
94359577|NCT04668066|323100336|FG000|Part 1: Follow-Up|Adverse Event|0|||
94669951|NCT00447057|324244945|FG003|Overall Study|Death due to adverse event|2|||
94669952|NCT00447057|324244942|FG000|Overall Study|Death, study drug related|0|||
94359578|NCT04668066|323100337|FG001|Part 1: Follow-Up|Adverse Event|0|||
94669953|NCT00447057|324244943|FG001|Overall Study|Death, study drug related|1|||
94669954|NCT00447057|324244944|FG002|Overall Study|Death, study drug related|0|||
94669955|NCT00447057|324244945|FG003|Overall Study|Death, study drug related|0|||
94669956|NCT01791725|324244946|FG000|Overall Study|Withdrawal by Subject|0|||
94669957|NCT01791725|324244947|FG001|Overall Study|Withdrawal by Subject|1|||
94669958|NCT01791725|324244948|FG002|Overall Study|Withdrawal by Subject|0|||
94669959|NCT00160680|324244949|FG000|Overall Study|Adverse Event|0|||
94669960|NCT00160680|324244950|FG001|Overall Study|Adverse Event|1|||
94669961|NCT00160680|324244949|FG000|Overall Study|Lack of Efficacy|2|||
94669962|NCT00160680|324244950|FG001|Overall Study|Lack of Efficacy|1|||
94669963|NCT00160680|324244949|FG000|Overall Study|Lost to Follow-up|3|||
94669964|NCT00160680|324244950|FG001|Overall Study|Lost to Follow-up|2|||
94669965|NCT00160680|324244949|FG000|Overall Study|Withdrawal by Subject|4|||
94669966|NCT00160680|324244950|FG001|Overall Study|Withdrawal by Subject|9|||
94669967|NCT01843192|324244951|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
94669968|NCT01843192|324244952|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
94669969|NCT01843192|324244953|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
94669970|NCT01471054|324244954|FG000|Overall Study|Study terminated prematurely|4|||
94669971|NCT01471054|324244955|FG001|Overall Study|Study terminated prematurely|0|||
94669972|NCT04493216|324244956|FG000|Overall Study|Study terminated by sponsor|30|||
94669973|NCT04493216|324244957|FG001|Overall Study|Study terminated by sponsor|33|||
94669974|NCT04493216|324244958|FG002|Overall Study|Study terminated by sponsor|28|||
94669975|NCT04493216|324244959|FG003|Overall Study|Study terminated by sponsor|27|||
94669976|NCT04493216|324244956|FG000|Overall Study|Withdrawal by Subject|2|||
94669977|NCT04493216|324244957|FG001|Overall Study|Withdrawal by Subject|1|||
94669978|NCT04493216|324244958|FG002|Overall Study|Withdrawal by Subject|1|||
94669979|NCT04493216|324244959|FG003|Overall Study|Withdrawal by Subject|2|||
94669980|NCT04493216|324244956|FG000|Overall Study|Protocol Violation|1|||
94669981|NCT04493216|324244957|FG001|Overall Study|Protocol Violation|2|||
94669982|NCT04493216|324244958|FG002|Overall Study|Protocol Violation|0|||
94669983|NCT04493216|324244959|FG003|Overall Study|Protocol Violation|2|||
94669984|NCT04493216|324244956|FG000|Overall Study|Physician Decision|0|||
94669985|NCT04493216|324244957|FG001|Overall Study|Physician Decision|0|||
94669986|NCT04493216|324244958|FG002|Overall Study|Physician Decision|1|||
94669987|NCT04493216|324244959|FG003|Overall Study|Physician Decision|0|||
94669988|NCT04493216|324244956|FG000|Overall Study|Lost to Follow-up|2|||
94669989|NCT04493216|324244957|FG001|Overall Study|Lost to Follow-up|1|||
94669990|NCT04493216|324244958|FG002|Overall Study|Lost to Follow-up|0|||
94669991|NCT04493216|324244959|FG003|Overall Study|Lost to Follow-up|1|||
94669992|NCT04493216|324244956|FG000|Overall Study|Adverse Event|1|||
94669993|NCT04493216|324244957|FG001|Overall Study|Adverse Event|4|||
94669994|NCT04493216|324244958|FG002|Overall Study|Adverse Event|5|||
94669995|NCT04493216|324244959|FG003|Overall Study|Adverse Event|2|||
94669996|NCT04493216|324244956|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
94669997|NCT04493216|324244957|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
94669998|NCT04493216|324244958|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
94669999|NCT04493216|324244959|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
94670000|NCT02131272|324244962|FG000|Overall Study|Withdrawal by parent|0|||
94670001|NCT02131272|324244963|FG001|Overall Study|Withdrawal by parent|1|||
94670002|NCT02131272|324244962|FG000|Overall Study|Withdrawal by Subject|0|||
94670003|NCT02131272|324244963|FG001|Overall Study|Withdrawal by Subject|1|||
94670004|NCT02131272|324244962|FG000|Overall Study|Withdrawal Criteria|1|||
94670005|NCT02131272|324244963|FG001|Overall Study|Withdrawal Criteria|0|||
94670006|NCT01786512|324244966|FG000|Overall Study|Lost to Follow-up|0|||
94670007|NCT01786512|324244967|FG001|Overall Study|Lost to Follow-up|0|||
94670008|NCT01786512|324244968|FG002|Overall Study|Lost to Follow-up|0|||
94670009|NCT01786512|324244969|FG003|Overall Study|Lost to Follow-up|0|||
94670010|NCT01786512|324244970|FG004|Overall Study|Lost to Follow-up|0|||
94670011|NCT01786512|324244971|FG005|Overall Study|Lost to Follow-up|0|||
94670012|NCT01786512|324244972|FG006|Overall Study|Lost to Follow-up|0|||
94670013|NCT01786512|324244973|FG007|Overall Study|Lost to Follow-up|0|||
94670014|NCT01786512|324244974|FG008|Overall Study|Lost to Follow-up|0|||
94670015|NCT01786512|324244975|FG009|Overall Study|Lost to Follow-up|1|||
94670016|NCT01786512|324244976|FG010|Overall Study|Lost to Follow-up|0|||
94670017|NCT01786512|324244966|FG000|Overall Study|Decision by sponsor|0|||
94670018|NCT01786512|324244967|FG001|Overall Study|Decision by sponsor|0|||
94670019|NCT01786512|324244968|FG002|Overall Study|Decision by sponsor|0|||
94359579|NCT04668066|323100338|FG002|Part 1: Follow-Up|Adverse Event|0|||
94670020|NCT01786512|324244969|FG003|Overall Study|Decision by sponsor|0|||
94670021|NCT01786512|324244970|FG004|Overall Study|Decision by sponsor|0|||
94670022|NCT01786512|324244971|FG005|Overall Study|Decision by sponsor|0|||
94670023|NCT01786512|324244972|FG006|Overall Study|Decision by sponsor|0|||
94670024|NCT01786512|324244973|FG007|Overall Study|Decision by sponsor|0|||
94670025|NCT01786512|324244974|FG008|Overall Study|Decision by sponsor|0|||
94670026|NCT01786512|324244975|FG009|Overall Study|Decision by sponsor|0|||
94670027|NCT01786512|324244976|FG010|Overall Study|Decision by sponsor|2|||
94670028|NCT01786512|324244966|FG000|Overall Study|Withdrawal by Subject|0|||
94670029|NCT01786512|324244967|FG001|Overall Study|Withdrawal by Subject|1|||
94359580|NCT04668066|323100339|FG003|Part 1: Follow-Up|Adverse Event|0|||
94670030|NCT01786512|324244968|FG002|Overall Study|Withdrawal by Subject|0|||
94670031|NCT01786512|324244969|FG003|Overall Study|Withdrawal by Subject|0|||
94670032|NCT01786512|324244970|FG004|Overall Study|Withdrawal by Subject|0|||
94670033|NCT01786512|324244971|FG005|Overall Study|Withdrawal by Subject|0|||
94670034|NCT01786512|324244972|FG006|Overall Study|Withdrawal by Subject|1|||
94670035|NCT01786512|324244973|FG007|Overall Study|Withdrawal by Subject|0|||
94670036|NCT01786512|324244974|FG008|Overall Study|Withdrawal by Subject|0|||
94670037|NCT01786512|324244975|FG009|Overall Study|Withdrawal by Subject|3|||
94670038|NCT01786512|324244976|FG010|Overall Study|Withdrawal by Subject|7|||
94670039|NCT01786512|324244966|FG000|Overall Study|Death|0|||
94670040|NCT01786512|324244967|FG001|Overall Study|Death|0|||
94670041|NCT01786512|324244968|FG002|Overall Study|Death|0|||
94670042|NCT01786512|324244969|FG003|Overall Study|Death|0|||
94670043|NCT01786512|324244970|FG004|Overall Study|Death|0|||
94670044|NCT01786512|324244971|FG005|Overall Study|Death|0|||
94670045|NCT01786512|324244972|FG006|Overall Study|Death|0|||
94670046|NCT01786512|324244973|FG007|Overall Study|Death|0|||
94670047|NCT01786512|324244974|FG008|Overall Study|Death|4|||
94670048|NCT01786512|324244975|FG009|Overall Study|Death|1|||
94670049|NCT01786512|324244976|FG010|Overall Study|Death|3|||
94670050|NCT01925950|324244977|FG000|Part 2|Withdrawal by Subject|1|||
94670051|NCT01925950|324244978|FG001|Part 2|Withdrawal by Subject|0|||
94670052|NCT03137303|324244981|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
94670053|NCT03137303|324244982|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
94670054|NCT03137303|324244981|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
94670055|NCT03137303|324244982|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
94670056|NCT03137303|324244981|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
94670057|NCT03137303|324244982|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
94670058|NCT03137303|324244981|FG000|T3: 9-month Follow-up|Death|1|||
94670059|NCT03137303|324244982|FG001|T3: 9-month Follow-up|Death|0|||
94670060|NCT03137303|324244981|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
94670061|NCT03137303|324244982|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
94670062|NCT03137303|324244981|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
94670063|NCT03137303|324244982|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
94670064|NCT03137303|324244981|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
94670065|NCT03137303|324244982|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
94670066|NCT04162769|324244983|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
94670067|NCT04162769|324244984|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
94670068|NCT04162769|324244985|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
94670069|NCT04162769|324244986|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
94670070|NCT04162769|324244983|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
94670071|NCT04162769|324244984|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
94670072|NCT04162769|324244985|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
94670073|NCT04162769|324244986|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
94670074|NCT04162769|324244983|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
94670075|NCT04162769|324244984|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
94670076|NCT04162769|324244985|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
94670077|NCT04162769|324244986|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
94670078|NCT04162769|324244983|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
94670079|NCT04162769|324244984|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
94670080|NCT04162769|324244985|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
94359581|NCT04668066|323100340|FG004|Part 1: Follow-Up|Adverse Event|0|||
94359582|NCT04668066|323100341|FG005|Part 1: Follow-Up|Adverse Event|0|||
94623518|NCT04112784|324084160|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
94623519|NCT04112784|324084160|FG000|Overall Study|Screen Failures|4|||
94623520|NCT01756898|324084161|FG000|Overall Study|Adverse Event|7|||
94623521|NCT01756898|324084162|FG001|Overall Study|Adverse Event|1|||
94623522|NCT01756898|324084163|FG002|Overall Study|Adverse Event|0|||
94623523|NCT01756898|324084164|FG003|Overall Study|Adverse Event|0|||
94623524|NCT01756898|324084161|FG000|Overall Study|Lack of Efficacy|4|||
94670081|NCT04162769|324244986|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
94670082|NCT04162769|324244983|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
94670083|NCT04162769|324244984|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
94670084|NCT04162769|324244985|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
94670085|NCT04162769|324244986|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
94670086|NCT04162769|324244983|FG000|Double-blind Treatment (12-Week)|Other|0|||
94670087|NCT04162769|324244984|FG001|Double-blind Treatment (12-Week)|Other|1|||
94670088|NCT04162769|324244985|FG002|Double-blind Treatment (12-Week)|Other|1|||
94670089|NCT04162769|324244986|FG003|Double-blind Treatment (12-Week)|Other|0|||
94670090|NCT04162769|324244983|FG000|OLE Period (52-Week)|Adverse Event|0|||
94670091|NCT04162769|324244984|FG001|OLE Period (52-Week)|Adverse Event|0|||
94670092|NCT04162769|324244985|FG002|OLE Period (52-Week)|Adverse Event|0|||
94359583|NCT04668066|323100342|FG006|Part 1: Follow-Up|Adverse Event|0|||
94359584|NCT04668066|323100343|FG007|Part 1: Follow-Up|Adverse Event|0|||
94623525|NCT01756898|324084162|FG001|Overall Study|Lack of Efficacy|7|||
94623526|NCT01756898|324084163|FG002|Overall Study|Lack of Efficacy|6|||
94623527|NCT01756898|324084164|FG003|Overall Study|Lack of Efficacy|6|||
94623528|NCT01756898|324084161|FG000|Overall Study|Lost to Follow-up|2|||
94623529|NCT01756898|324084162|FG001|Overall Study|Lost to Follow-up|4|||
94623530|NCT01756898|324084163|FG002|Overall Study|Lost to Follow-up|2|||
94623531|NCT01756898|324084164|FG003|Overall Study|Lost to Follow-up|3|||
94623532|NCT01756898|324084161|FG000|Overall Study|Protocol Violation|1|||
94623533|NCT01756898|324084162|FG001|Overall Study|Protocol Violation|2|||
94623534|NCT01756898|324084163|FG002|Overall Study|Protocol Violation|2|||
94623535|NCT01756898|324084164|FG003|Overall Study|Protocol Violation|1|||
94623536|NCT01756898|324084161|FG000|Overall Study|Withdrew Consent|5|||
94623537|NCT01756898|324084162|FG001|Overall Study|Withdrew Consent|3|||
94623538|NCT01756898|324084163|FG002|Overall Study|Withdrew Consent|5|||
94623539|NCT01756898|324084164|FG003|Overall Study|Withdrew Consent|6|||
94623540|NCT01756898|324084161|FG000|Overall Study|Other|0|||
94623541|NCT01756898|324084162|FG001|Overall Study|Other|2|||
94623542|NCT01756898|324084163|FG002|Overall Study|Other|2|||
94623543|NCT01756898|324084164|FG003|Overall Study|Other|0|||
94623544|NCT03715530|324084165|FG000|Overall Study|Lost to Follow-up|3|||
94623545|NCT03715530|324084166|FG001|Overall Study|Lost to Follow-up|1|||
94623546|NCT03715530|324084167|FG002|Overall Study|Lost to Follow-up|2|||
94623547|NCT00006237|324084168|FG000|Overall Study|Adverse Event|39|||
94623548|NCT00006237|324084169|FG001|Overall Study|Adverse Event|29|||
94623549|NCT00006237|324084168|FG000|Overall Study|Death|1|||
94623550|NCT00006237|324084169|FG001|Overall Study|Death|0|||
94623551|NCT00006237|324084168|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
94623552|NCT00006237|324084169|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
94623553|NCT00006237|324084168|FG000|Overall Study|Progression/relapse|54|||
94623554|NCT00006237|324084169|FG001|Overall Study|Progression/relapse|2|||
94623555|NCT00006237|324084168|FG000|Overall Study|Not eligible|9|||
94623556|NCT00006237|324084169|FG001|Overall Study|Not eligible|20|||
94623557|NCT00006237|324084168|FG000|Overall Study|Withdrawal by Subject|0|||
94623558|NCT00006237|324084169|FG001|Overall Study|Withdrawal by Subject|1|||
94623559|NCT00006237|324084168|FG000|Overall Study|Not protocol specified|14|||
94623560|NCT00006237|324084169|FG001|Overall Study|Not protocol specified|5|||
94623561|NCT02837783|324084174|FG000|Overall Study|Adverse Event|1|||
94623562|NCT02837783|324084175|FG001|Overall Study|Adverse Event|0|||
94623563|NCT02837783|324084174|FG000|Overall Study|Other, Not Specified|1|||
94623564|NCT02837783|324084175|FG001|Overall Study|Other, Not Specified|2|||
94623565|NCT01950741|324084178|FG000|Overall Study|Lost to Follow-up|1|||
94623566|NCT01950741|324084178|FG000|Overall Study|Death|1|||
94623567|NCT01950741|324084178|FG000|Overall Study|Withdrawal by Subject|1|||
94623568|NCT03648983|324084179|FG000|Overall Study|Study was terminated due to PI departure|95|||
94623569|NCT01858389|324084180|FG000|Overall Study|Death|1|||
94623570|NCT01858389|324084181|FG001|Overall Study|Death|3|||
94623571|NCT01858389|324084180|FG000|Overall Study|Study terminated by sponsor|0|||
94623572|NCT01858389|324084181|FG001|Overall Study|Study terminated by sponsor|2|||
94623573|NCT01858389|324084180|FG000|Overall Study|Withdrawal by Subject|0|||
94623574|NCT01858389|324084181|FG001|Overall Study|Withdrawal by Subject|1|||
94623575|NCT01858389|324084180|FG000|Overall Study|Progressive disease|10|||
94623576|NCT01858389|324084181|FG001|Overall Study|Progressive disease|11|||
94623577|NCT01858389|324084180|FG000|Overall Study|Other|2|||
94623578|NCT01858389|324084181|FG001|Overall Study|Other|4|||
94623579|NCT01858389|324084180|FG000|Overall Study|Adverse Event|3|||
94623580|NCT01858389|324084181|FG001|Overall Study|Adverse Event|1|||
94623581|NCT01858389|324084180|FG000|Overall Study|Did not receive treatment|0|||
94623582|NCT01858389|324084181|FG001|Overall Study|Did not receive treatment|3|||
94623583|NCT03572062|324084182|FG000|Overall Study|Adverse Event|0|||
94623584|NCT03572062|324084183|FG001|Overall Study|Adverse Event|0|||
94623585|NCT03572062|324084184|FG002|Overall Study|Adverse Event|0|||
94623586|NCT03572062|324084185|FG003|Overall Study|Adverse Event|0|||
94623587|NCT03572062|324084186|FG004|Overall Study|Adverse Event|0|||
94623588|NCT03572062|324084187|FG005|Overall Study|Adverse Event|0|||
94623589|NCT03572062|324084188|FG006|Overall Study|Adverse Event|0|||
94623590|NCT03572062|324084189|FG007|Overall Study|Adverse Event|0|||
94623591|NCT03572062|324084190|FG008|Overall Study|Adverse Event|1|||
94623592|NCT03572062|324084191|FG009|Overall Study|Adverse Event|3|||
94623593|NCT03572062|324084182|FG000|Overall Study|Death|0|||
94623594|NCT03572062|324084183|FG001|Overall Study|Death|0|||
94623595|NCT03572062|324084184|FG002|Overall Study|Death|0|||
94623596|NCT03572062|324084185|FG003|Overall Study|Death|0|||
94623597|NCT03572062|324084186|FG004|Overall Study|Death|0|||
94623598|NCT03572062|324084187|FG005|Overall Study|Death|1|||
94623599|NCT03572062|324084188|FG006|Overall Study|Death|0|||
94623600|NCT03572062|324084189|FG007|Overall Study|Death|0|||
94623601|NCT03572062|324084190|FG008|Overall Study|Death|0|||
94623602|NCT03572062|324084191|FG009|Overall Study|Death|0|||
94623603|NCT03572062|324084182|FG000|Overall Study|Lost to Follow-up|0|||
94623604|NCT03572062|324084183|FG001|Overall Study|Lost to Follow-up|0|||
94623605|NCT03572062|324084184|FG002|Overall Study|Lost to Follow-up|0|||
94623606|NCT03572062|324084185|FG003|Overall Study|Lost to Follow-up|0|||
94623607|NCT03572062|324084186|FG004|Overall Study|Lost to Follow-up|0|||
94623608|NCT03572062|324084187|FG005|Overall Study|Lost to Follow-up|1|||
94623609|NCT03572062|324084188|FG006|Overall Study|Lost to Follow-up|1|||
94623610|NCT03572062|324084189|FG007|Overall Study|Lost to Follow-up|0|||
94623611|NCT03572062|324084190|FG008|Overall Study|Lost to Follow-up|0|||
94623612|NCT03572062|324084191|FG009|Overall Study|Lost to Follow-up|0|||
94623613|NCT03572062|324084182|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
94623614|NCT03572062|324084183|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
94623615|NCT03572062|324084184|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
94623616|NCT03572062|324084185|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
94623617|NCT03572062|324084186|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
94623618|NCT03572062|324084187|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
94623619|NCT03572062|324084188|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
94623620|NCT03572062|324084189|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
94623621|NCT03572062|324084190|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
94623622|NCT03572062|324084191|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
94623623|NCT03572062|324084182|FG000|Overall Study|Study Terminated By Sponsor|0|||
94623624|NCT03572062|324084183|FG001|Overall Study|Study Terminated By Sponsor|0|||
94623625|NCT03572062|324084184|FG002|Overall Study|Study Terminated By Sponsor|0|||
94623626|NCT03572062|324084185|FG003|Overall Study|Study Terminated By Sponsor|0|||
94623627|NCT03572062|324084186|FG004|Overall Study|Study Terminated By Sponsor|0|||
94623628|NCT03572062|324084187|FG005|Overall Study|Study Terminated By Sponsor|0|||
94623629|NCT03572062|324084188|FG006|Overall Study|Study Terminated By Sponsor|0|||
94623630|NCT03572062|324084189|FG007|Overall Study|Study Terminated By Sponsor|0|||
94623631|NCT03572062|324084190|FG008|Overall Study|Study Terminated By Sponsor|29|||
94623632|NCT03572062|324084191|FG009|Overall Study|Study Terminated By Sponsor|27|||
94623633|NCT03572062|324084182|FG000|Overall Study|Physician Decision|0|||
94623634|NCT03572062|324084183|FG001|Overall Study|Physician Decision|0|||
94623635|NCT03572062|324084184|FG002|Overall Study|Physician Decision|0|||
94623636|NCT03572062|324084185|FG003|Overall Study|Physician Decision|0|||
94623637|NCT03572062|324084186|FG004|Overall Study|Physician Decision|0|||
94623638|NCT03572062|324084187|FG005|Overall Study|Physician Decision|0|||
94623639|NCT03572062|324084188|FG006|Overall Study|Physician Decision|0|||
94623640|NCT03572062|324084189|FG007|Overall Study|Physician Decision|0|||
94623641|NCT03572062|324084190|FG008|Overall Study|Physician Decision|1|||
94623642|NCT03572062|324084191|FG009|Overall Study|Physician Decision|0|||
94623643|NCT03572062|324084182|FG000|Overall Study|Withdrawal by Subject|0|||
94623644|NCT03572062|324084183|FG001|Overall Study|Withdrawal by Subject|0|||
94670093|NCT04162769|324244986|FG003|OLE Period (52-Week)|Adverse Event|5|||
94670094|NCT04162769|324244983|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
94670095|NCT04162769|324244984|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
94670096|NCT04162769|324244985|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
94670097|NCT04162769|324244986|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
94670098|NCT04162769|324244983|FG000|OLE Period (52-Week)|Physician Decision|0|||
94670099|NCT04162769|324244984|FG001|OLE Period (52-Week)|Physician Decision|0|||
94670100|NCT04162769|324244985|FG002|OLE Period (52-Week)|Physician Decision|0|||
94670101|NCT04162769|324244986|FG003|OLE Period (52-Week)|Physician Decision|1|||
94670102|NCT04162769|324244983|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
94670103|NCT04162769|324244984|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
94670104|NCT04162769|324244985|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
94670105|NCT04162769|324244986|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
94670106|NCT04162769|324244983|FG000|OLE Period (52-Week)|Protocol deviation|0|||
94670107|NCT04162769|324244984|FG001|OLE Period (52-Week)|Protocol deviation|0|||
94670108|NCT04162769|324244985|FG002|OLE Period (52-Week)|Protocol deviation|0|||
94670109|NCT04162769|324244986|FG003|OLE Period (52-Week)|Protocol deviation|2|||
94670110|NCT02261493|324244987|FG000|Overall Study|Noncompliance|0|||
94670111|NCT02261493|324244988|FG001|Overall Study|Noncompliance|0|||
94670112|NCT02261493|324244989|FG002|Overall Study|Noncompliance|2|||
94670113|NCT02261493|324244987|FG000|Overall Study|Physician Decision|0|||
94670114|NCT02261493|324244988|FG001|Overall Study|Physician Decision|1|||
94670115|NCT02261493|324244989|FG002|Overall Study|Physician Decision|0|||
94670116|NCT02261493|324244987|FG000|Overall Study|Undisclosed alcohol abuse|0|||
94670117|NCT02261493|324244988|FG001|Overall Study|Undisclosed alcohol abuse|1|||
94670118|NCT02261493|324244989|FG002|Overall Study|Undisclosed alcohol abuse|0|||
94670119|NCT02261493|324244987|FG000|Overall Study|Protocol Violation|1|||
94670120|NCT02261493|324244988|FG001|Overall Study|Protocol Violation|0|||
94670121|NCT02261493|324244989|FG002|Overall Study|Protocol Violation|0|||
94670122|NCT02261493|324244987|FG000|Overall Study|Personal Reasons|14|||
94670123|NCT02261493|324244988|FG001|Overall Study|Personal Reasons|14|||
94670124|NCT02261493|324244989|FG002|Overall Study|Personal Reasons|16|||
94670125|NCT02261493|324244987|FG000|Overall Study|Lost to Follow-up|14|||
94670126|NCT02261493|324244988|FG001|Overall Study|Lost to Follow-up|27|||
94670127|NCT02261493|324244989|FG002|Overall Study|Lost to Follow-up|8|||
94670128|NCT02261493|324244987|FG000|Overall Study|Pregnancy|1|||
94670129|NCT02261493|324244988|FG001|Overall Study|Pregnancy|2|||
94670130|NCT02261493|324244989|FG002|Overall Study|Pregnancy|0|||
94670131|NCT02261493|324244987|FG000|Overall Study|Lack of Efficacy|0|||
94670132|NCT02261493|324244988|FG001|Overall Study|Lack of Efficacy|1|||
94670133|NCT02261493|324244989|FG002|Overall Study|Lack of Efficacy|0|||
94670134|NCT02261493|324244987|FG000|Overall Study|Adverse Event|0|||
94670135|NCT02261493|324244988|FG001|Overall Study|Adverse Event|1|||
94670136|NCT02261493|324244989|FG002|Overall Study|Adverse Event|0|||
94670137|NCT04402866|324244992|FG000|Overall Study|Discontinued Prior to Treatment|0|||
94670138|NCT04402866|324244993|FG001|Overall Study|Discontinued Prior to Treatment|0|||
94670139|NCT04402866|324244994|FG002|Overall Study|Discontinued Prior to Treatment|0|||
94670140|NCT04402866|324244995|FG003|Overall Study|Discontinued Prior to Treatment|0|||
94670141|NCT04402866|324244996|FG004|Overall Study|Discontinued Prior to Treatment|2|||
94670142|NCT04402866|324244997|FG005|Overall Study|Discontinued Prior to Treatment|3|||
94670143|NCT04402866|324244992|FG000|Overall Study|Adverse Event|2|||
94670144|NCT04402866|324244993|FG001|Overall Study|Adverse Event|1|||
94670145|NCT04402866|324244994|FG002|Overall Study|Adverse Event|0|||
94670146|NCT04402866|324244995|FG003|Overall Study|Adverse Event|0|||
94670147|NCT04402866|324244996|FG004|Overall Study|Adverse Event|13|||
94670148|NCT04402866|324244997|FG005|Overall Study|Adverse Event|8|||
94670149|NCT04402866|324244992|FG000|Overall Study|Miscellaneous|0|||
94670150|NCT04402866|324244993|FG001|Overall Study|Miscellaneous|0|||
94670151|NCT04402866|324244994|FG002|Overall Study|Miscellaneous|1|||
94670152|NCT04402866|324244995|FG003|Overall Study|Miscellaneous|0|||
94670153|NCT04402866|324244996|FG004|Overall Study|Miscellaneous|0|||
94670154|NCT04402866|324244997|FG005|Overall Study|Miscellaneous|0|||
94670155|NCT04402866|324244992|FG000|Overall Study|Lost to Follow-up|0|||
94670156|NCT04402866|324244993|FG001|Overall Study|Lost to Follow-up|0|||
94670157|NCT04402866|324244994|FG002|Overall Study|Lost to Follow-up|0|||
94670158|NCT04402866|324244995|FG003|Overall Study|Lost to Follow-up|0|||
94670159|NCT04402866|324244996|FG004|Overall Study|Lost to Follow-up|0|||
94670160|NCT04402866|324244997|FG005|Overall Study|Lost to Follow-up|1|||
94670161|NCT04402866|324244992|FG000|Overall Study|Withdrawal by Subject|0|||
94670162|NCT04402866|324244993|FG001|Overall Study|Withdrawal by Subject|0|||
94670163|NCT04402866|324244994|FG002|Overall Study|Withdrawal by Subject|0|||
94670164|NCT04402866|324244995|FG003|Overall Study|Withdrawal by Subject|0|||
94670165|NCT04402866|324244996|FG004|Overall Study|Withdrawal by Subject|0|||
94670166|NCT04402866|324244997|FG005|Overall Study|Withdrawal by Subject|2|||
94670167|NCT03643952|324244998|FG000|Overall Study|Lack of Efficacy|1|||
94359585|NCT04668066|323100344|FG008|Part 1: Follow-Up|Adverse Event|0|||
94359586|NCT04668066|323100345|FG009|Part 1: Follow-Up|Adverse Event|0|||
94359587|NCT04668066|323100346|FG010|Part 1: Follow-Up|Adverse Event|0|||
94670168|NCT00626028|324244999|FG000|Overall Study|Adverse Event|1|||
94670169|NCT00626028|324245000|FG001|Overall Study|Adverse Event|1|||
94670170|NCT00626028|324244999|FG000|Overall Study|Device Failure|0|||
94670171|NCT00626028|324245000|FG001|Overall Study|Device Failure|1|||
94670172|NCT00626028|324244999|FG000|Overall Study|Physician Decision|2|||
94670173|NCT00626028|324245000|FG001|Overall Study|Physician Decision|1|||
94670174|NCT00626028|324244999|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
94670175|NCT00626028|324245000|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
94670176|NCT01292876|324245001|FG000|Overall Study|Physician Decision|4|||
94670177|NCT01627327|324245002|FG000|Overall Study|Adverse Event|6|||
94670178|NCT01627327|324245003|FG001|Overall Study|Adverse Event|12|||
94670179|NCT01627327|324245002|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
94670180|NCT01627327|324245003|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
94670181|NCT01627327|324245002|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
94359588|NCT04668066|323100347|FG011|Part 1: Follow-Up|Adverse Event|1|||
94359589|NCT04668066|323100348|FG012|Part 1: Follow-Up|Adverse Event|0|||
94359590|NCT04668066|323100349|FG013|Part 1: Follow-Up|Adverse Event|0|||
94670182|NCT01627327|324245003|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
94670183|NCT01627327|324245002|FG000|Overall Study|Protocol Violation|4|||
94359591|NCT04668066|323100350|FG014|Part 1: Follow-Up|Adverse Event|0|||
94670184|NCT01627327|324245003|FG001|Overall Study|Protocol Violation|10|||
94670185|NCT01627327|324245002|FG000|Overall Study|Lost to Follow-up|1|||
94359592|NCT04668066|323100351|FG015|Part 1: Follow-Up|Adverse Event|0|||
94359593|NCT04668066|323100352|FG016|Part 1: Follow-Up|Adverse Event|0|||
94670186|NCT01627327|324245003|FG001|Overall Study|Lost to Follow-up|3|||
94359594|NCT04668066|323100353|FG017|Part 1: Follow-Up|Adverse Event|0|||
94359595|NCT04668066|323100354|FG018|Part 1: Follow-Up|Adverse Event|0|||
94359596|NCT04668066|323100336|FG000|Part 1: Follow-Up|Other|0|||
94359597|NCT04668066|323100337|FG001|Part 1: Follow-Up|Other|0|||
94359598|NCT04668066|323100338|FG002|Part 1: Follow-Up|Other|0|||
94359599|NCT04668066|323100339|FG003|Part 1: Follow-Up|Other|0|||
94359600|NCT04668066|323100340|FG004|Part 1: Follow-Up|Other|0|||
94359601|NCT04668066|323100341|FG005|Part 1: Follow-Up|Other|0|||
94623645|NCT03572062|324084184|FG002|Overall Study|Withdrawal by Subject|0|||
94623646|NCT03572062|324084185|FG003|Overall Study|Withdrawal by Subject|0|||
94623647|NCT03572062|324084186|FG004|Overall Study|Withdrawal by Subject|0|||
94623648|NCT03572062|324084187|FG005|Overall Study|Withdrawal by Subject|0|||
94623649|NCT03572062|324084188|FG006|Overall Study|Withdrawal by Subject|0|||
94623650|NCT03572062|324084189|FG007|Overall Study|Withdrawal by Subject|0|||
94623651|NCT03572062|324084190|FG008|Overall Study|Withdrawal by Subject|0|||
94623652|NCT03572062|324084191|FG009|Overall Study|Withdrawal by Subject|1|||
94623653|NCT03572062|324084182|FG000|Overall Study|Randomized But Not Treated|0|||
94623654|NCT03572062|324084183|FG001|Overall Study|Randomized But Not Treated|0|||
94623655|NCT03572062|324084184|FG002|Overall Study|Randomized But Not Treated|0|||
94623656|NCT03572062|324084185|FG003|Overall Study|Randomized But Not Treated|0|||
94623657|NCT03572062|324084186|FG004|Overall Study|Randomized But Not Treated|1|||
94623658|NCT03572062|324084187|FG005|Overall Study|Randomized But Not Treated|2|||
94623659|NCT03572062|324084188|FG006|Overall Study|Randomized But Not Treated|0|||
94623660|NCT03572062|324084189|FG007|Overall Study|Randomized But Not Treated|1|||
94623661|NCT03572062|324084190|FG008|Overall Study|Randomized But Not Treated|0|||
94623662|NCT03572062|324084191|FG009|Overall Study|Randomized But Not Treated|0|||
94623663|NCT02521870|324084192|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
94623664|NCT02521870|324084193|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
94623665|NCT02521870|324084194|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
94623666|NCT02521870|324084195|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
94623667|NCT02521870|324084196|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
94623668|NCT02521870|324084197|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
94623669|NCT02521870|324084198|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
94623670|NCT02521870|324084199|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
94623671|NCT02521870|324084200|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
94623672|NCT02521870|324084201|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
94623673|NCT02521870|324084202|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
94623674|NCT02521870|324084203|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
94623675|NCT02521870|324084192|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
94623676|NCT02521870|324084193|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
94623677|NCT02521870|324084194|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
94623678|NCT02521870|324084195|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
94623679|NCT02521870|324084196|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
94623680|NCT02521870|324084197|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
94623681|NCT02521870|324084198|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
94623682|NCT02521870|324084199|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
94623683|NCT02521870|324084200|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
94623684|NCT02521870|324084201|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
94623685|NCT02521870|324084202|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
94623686|NCT02521870|324084203|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
94623687|NCT02521870|324084192|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
94623688|NCT02521870|324084193|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
94623689|NCT02521870|324084194|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
94623690|NCT02521870|324084195|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
94623691|NCT02521870|324084196|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
94623692|NCT02521870|324084197|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
94623693|NCT02521870|324084198|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
94623694|NCT02521870|324084199|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
94623695|NCT02521870|324084200|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
94623696|NCT02521870|324084201|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
94623697|NCT02521870|324084202|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
94623698|NCT02521870|324084203|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
94623699|NCT02521870|324084192|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
94623700|NCT02521870|324084193|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
94623701|NCT02521870|324084194|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
94623702|NCT02521870|324084195|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
94623703|NCT02521870|324084196|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
94623704|NCT02521870|324084197|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
94623705|NCT02521870|324084198|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
94359602|NCT04668066|323100342|FG006|Part 1: Follow-Up|Other|0|||
94359603|NCT04668066|323100343|FG007|Part 1: Follow-Up|Other|0|||
94359604|NCT04668066|323100344|FG008|Part 1: Follow-Up|Other|0|||
94359605|NCT04668066|323100345|FG009|Part 1: Follow-Up|Other|0|||
94670187|NCT01627327|324245002|FG000|Overall Study|Physician Decision|1|||
94670188|NCT01627327|324245003|FG001|Overall Study|Physician Decision|0|||
94670189|NCT01627327|324245002|FG000|Overall Study|Withdrawal by Subject|3|||
94670190|NCT01627327|324245003|FG001|Overall Study|Withdrawal by Subject|3|||
94670191|NCT02525874|324245007|FG000|Overall Study|Other|1|||
94670192|NCT02525874|324245007|FG000|Overall Study|Investigator Decision|1|||
94670193|NCT02525874|324245007|FG000|Overall Study|Consent withdrawn|22|||
94670194|NCT02525874|324245007|FG000|Overall Study|Non-compliance with study drug|3|||
94670195|NCT02525874|324245007|FG000|Overall Study|Adverse Event|17|||
94670196|NCT02525874|324245007|FG000|Overall Study|Lost to Follow-up|7|||
94670197|NCT02525874|324245007|FG000|Overall Study|Disease progression, defined by protocol|2|||
94670198|NCT02525874|324245007|FG000|Overall Study|Disease relapse|4|||
94670199|NCT02525874|324245007|FG000|Overall Study|Alternative Treatment for MS|2|||
94670200|NCT02525874|324245007|FG000|Overall Study|New lesions in Brain|1|||
94670201|NCT03945188|324245017|FG000|Overall Study|Protocol Violation|1|||
94670202|NCT03945188|324245018|FG001|Overall Study|Protocol Violation|0|||
94670203|NCT03945188|324245017|FG000|Overall Study|Disease worsening|79|||
94670204|NCT03945188|324245018|FG001|Overall Study|Disease worsening|73|||
94670205|NCT03945188|324245017|FG000|Overall Study|Physician Decision|2|||
94670206|NCT03945188|324245018|FG001|Overall Study|Physician Decision|2|||
94670207|NCT03945188|324245017|FG000|Overall Study|Lack of Efficacy|7|||
94670208|NCT03945188|324245018|FG001|Overall Study|Lack of Efficacy|4|||
94670209|NCT03945188|324245017|FG000|Overall Study|Pregnancy|2|||
94670210|NCT03945188|324245018|FG001|Overall Study|Pregnancy|0|||
94670211|NCT03945188|324245017|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
94670212|NCT03945188|324245018|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
94670213|NCT03945188|324245017|FG000|Overall Study|Adverse Event|10|||
94670214|NCT03945188|324245018|FG001|Overall Study|Adverse Event|5|||
94670215|NCT03945188|324245017|FG000|Overall Study|Other|2|||
94670216|NCT03945188|324245018|FG001|Overall Study|Other|2|||
94670217|NCT03945188|324245017|FG000|Overall Study|Lost to Follow-up|1|||
94670218|NCT03945188|324245018|FG001|Overall Study|Lost to Follow-up|2|||
94670219|NCT04530448|324245019|FG000|Overall Study|Physician Decision|3|||
94670220|NCT04530448|324245020|FG001|Overall Study|Physician Decision|0|||
94670221|NCT01618162|324245047|FG000|Overall Study|Protocol Violation|13|||
94670222|NCT01618162|324245048|FG001|Overall Study|Protocol Violation|10|||
94670223|NCT01618162|324245047|FG000|Overall Study|Adverse Event|9|||
94670224|NCT01618162|324245048|FG001|Overall Study|Adverse Event|2|||
94670225|NCT01618162|324245047|FG000|Overall Study|Withdrawal Criteria|2|||
94670226|NCT01618162|324245048|FG001|Overall Study|Withdrawal Criteria|10|||
94670227|NCT01618162|324245047|FG000|Overall Study|Unclassified|14|||
94670228|NCT01618162|324245048|FG001|Overall Study|Unclassified|13|||
94670229|NCT04124926|324245049|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
94670230|NCT04124926|324245050|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
94670231|NCT04124926|324245051|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
94670232|NCT04124926|324245052|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
94670233|NCT04124926|324245053|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
94670234|NCT04124926|324245049|FG000|Healing Phase|Protocol Violation|0|||
94670235|NCT04124926|324245050|FG001|Healing Phase|Protocol Violation|1|||
94670236|NCT04124926|324245051|FG002|Healing Phase|Protocol Violation|0|||
94670237|NCT04124926|324245052|FG003|Healing Phase|Protocol Violation|0|||
94670238|NCT04124926|324245053|FG004|Healing Phase|Protocol Violation|0|||
94670239|NCT04124926|324245049|FG000|Healing Phase|Lost to Follow-up|5|||
94670240|NCT04124926|324245050|FG001|Healing Phase|Lost to Follow-up|4|||
94670241|NCT04124926|324245051|FG002|Healing Phase|Lost to Follow-up|0|||
94670242|NCT04124926|324245052|FG003|Healing Phase|Lost to Follow-up|0|||
94670243|NCT04124926|324245053|FG004|Healing Phase|Lost to Follow-up|0|||
94670244|NCT04124926|324245049|FG000|Healing Phase|Voluntary Withdrawal|10|||
94670245|NCT04124926|324245050|FG001|Healing Phase|Voluntary Withdrawal|7|||
94670246|NCT04124926|324245051|FG002|Healing Phase|Voluntary Withdrawal|0|||
94670247|NCT04124926|324245052|FG003|Healing Phase|Voluntary Withdrawal|0|||
94670248|NCT04124926|324245053|FG004|Healing Phase|Voluntary Withdrawal|0|||
94670249|NCT04124926|324245049|FG000|Healing Phase|Withdrawal of Consent|5|||
94670250|NCT04124926|324245050|FG001|Healing Phase|Withdrawal of Consent|3|||
94670251|NCT04124926|324245051|FG002|Healing Phase|Withdrawal of Consent|0|||
94670252|NCT04124926|324245052|FG003|Healing Phase|Withdrawal of Consent|0|||
94670253|NCT04124926|324245053|FG004|Healing Phase|Withdrawal of Consent|0|||
94670254|NCT04124926|324245049|FG000|Healing Phase|Miscellaneous|8|||
94670255|NCT04124926|324245050|FG001|Healing Phase|Miscellaneous|7|||
94670256|NCT04124926|324245051|FG002|Healing Phase|Miscellaneous|0|||
94670257|NCT04124926|324245052|FG003|Healing Phase|Miscellaneous|0|||
94670258|NCT04124926|324245053|FG004|Healing Phase|Miscellaneous|0|||
94670259|NCT04124926|324245049|FG000|Healing Phase|Randomized but not Treated|0|||
94670260|NCT04124926|324245050|FG001|Healing Phase|Randomized but not Treated|3|||
94670261|NCT04124926|324245051|FG002|Healing Phase|Randomized but not Treated|0|||
94670262|NCT04124926|324245052|FG003|Healing Phase|Randomized but not Treated|0|||
94670263|NCT04124926|324245053|FG004|Healing Phase|Randomized but not Treated|0|||
94670264|NCT04124926|324245049|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
94670265|NCT04124926|324245050|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
94670266|NCT04124926|324245051|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
94670267|NCT04124926|324245052|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
94670268|NCT04124926|324245053|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
94359606|NCT04668066|323100346|FG010|Part 1: Follow-Up|Other|0|||
94359607|NCT04668066|323100347|FG011|Part 1: Follow-Up|Other|1|||
94359608|NCT04668066|323100348|FG012|Part 1: Follow-Up|Other|1|||
94359609|NCT04668066|323100349|FG013|Part 1: Follow-Up|Other|0|||
94359610|NCT04668066|323100350|FG014|Part 1: Follow-Up|Other|0|||
94359611|NCT04668066|323100351|FG015|Part 1: Follow-Up|Other|0|||
94359612|NCT04668066|323100352|FG016|Part 1: Follow-Up|Other|0|||
94359613|NCT04668066|323100353|FG017|Part 1: Follow-Up|Other|0|||
94670269|NCT04124926|324245049|FG000|Maintenance Phase|Protocol Violation|0|||
94670270|NCT04124926|324245050|FG001|Maintenance Phase|Protocol Violation|0|||
94359614|NCT04668066|323100354|FG018|Part 1: Follow-Up|Other|0|||
94359615|NCT04668066|323100336|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
94359616|NCT04668066|323100337|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
94359617|NCT04668066|323100338|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
94359618|NCT04668066|323100339|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
94359619|NCT04668066|323100340|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
94359620|NCT04668066|323100341|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
94359621|NCT04668066|323100342|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
94359622|NCT04668066|323100343|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
94359623|NCT04668066|323100344|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
94359624|NCT04668066|323100345|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
94359625|NCT04668066|323100346|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
94359626|NCT04668066|323100347|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
94359627|NCT04668066|323100348|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
94359628|NCT04668066|323100349|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
94359629|NCT04668066|323100350|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
94359630|NCT04668066|323100351|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
94359631|NCT04668066|323100352|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
94359632|NCT04668066|323100353|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
94359633|NCT04668066|323100354|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
94359634|NCT04668066|323100336|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
94623706|NCT02521870|324084199|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
94623707|NCT02521870|324084200|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
94623708|NCT02521870|324084201|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
94623709|NCT02521870|324084202|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
94623710|NCT02521870|324084203|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
94623711|NCT02521870|324084192|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
94623712|NCT02521870|324084193|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
94623713|NCT02521870|324084194|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
94623714|NCT02521870|324084195|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
94623715|NCT02521870|324084196|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
94670271|NCT04124926|324245051|FG002|Maintenance Phase|Protocol Violation|3|||
94670272|NCT04124926|324245052|FG003|Maintenance Phase|Protocol Violation|0|||
94623716|NCT02521870|324084197|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
94623717|NCT02521870|324084198|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
94670273|NCT04124926|324245053|FG004|Maintenance Phase|Protocol Violation|0|||
94670274|NCT04124926|324245049|FG000|Maintenance Phase|Lost to Follow-up|0|||
94359635|NCT04668066|323100337|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
94359636|NCT04668066|323100338|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
94359637|NCT04668066|323100339|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
94359638|NCT04668066|323100340|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
94670275|NCT04124926|324245050|FG001|Maintenance Phase|Lost to Follow-up|0|||
94670276|NCT04124926|324245051|FG002|Maintenance Phase|Lost to Follow-up|7|||
94670277|NCT04124926|324245052|FG003|Maintenance Phase|Lost to Follow-up|8|||
94670278|NCT04124926|324245053|FG004|Maintenance Phase|Lost to Follow-up|9|||
94670279|NCT04124926|324245049|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
94670280|NCT04124926|324245050|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
94670281|NCT04124926|324245051|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
94670282|NCT04124926|324245052|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
94670283|NCT04124926|324245053|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
94670284|NCT04124926|324245049|FG000|Maintenance Phase|Pregnancy|0|||
94670285|NCT04124926|324245050|FG001|Maintenance Phase|Pregnancy|0|||
94461191|NCT00373958|323478211|FG000|Toddler Dose|Protocol Violation|0|||
94461192|NCT00373958|323478212|FG001|Toddler Dose|Protocol Violation|1|||
94461193|NCT00373958|323478211|FG000|Toddler Dose|Withdrawn after infant series|22|||
94670286|NCT04124926|324245051|FG002|Maintenance Phase|Pregnancy|0|||
94670287|NCT04124926|324245052|FG003|Maintenance Phase|Pregnancy|1|||
94670288|NCT04124926|324245053|FG004|Maintenance Phase|Pregnancy|0|||
94670289|NCT04124926|324245049|FG000|Maintenance Phase|Lack of Efficacy|0|||
94670290|NCT04124926|324245050|FG001|Maintenance Phase|Lack of Efficacy|0|||
94670291|NCT04124926|324245051|FG002|Maintenance Phase|Lack of Efficacy|0|||
94670292|NCT04124926|324245052|FG003|Maintenance Phase|Lack of Efficacy|0|||
94670293|NCT04124926|324245053|FG004|Maintenance Phase|Lack of Efficacy|1|||
94670294|NCT04124926|324245049|FG000|Maintenance Phase|Withdrawal of Consent|0|||
94670295|NCT04124926|324245050|FG001|Maintenance Phase|Withdrawal of Consent|0|||
94670296|NCT04124926|324245051|FG002|Maintenance Phase|Withdrawal of Consent|5|||
94670297|NCT04124926|324245052|FG003|Maintenance Phase|Withdrawal of Consent|5|||
94670298|NCT04124926|324245053|FG004|Maintenance Phase|Withdrawal of Consent|5|||
94670299|NCT04124926|324245049|FG000|Maintenance Phase|Miscellaneous|0|||
94670300|NCT04124926|324245050|FG001|Maintenance Phase|Miscellaneous|0|||
94670301|NCT04124926|324245051|FG002|Maintenance Phase|Miscellaneous|1|||
94670302|NCT04124926|324245052|FG003|Maintenance Phase|Miscellaneous|2|||
94670303|NCT04124926|324245053|FG004|Maintenance Phase|Miscellaneous|4|||
94670304|NCT04124926|324245049|FG000|Maintenance Phase|Randomized but not Treated|0|||
94670305|NCT04124926|324245050|FG001|Maintenance Phase|Randomized but not Treated|0|||
94670306|NCT04124926|324245051|FG002|Maintenance Phase|Randomized but not Treated|2|||
94670307|NCT04124926|324245052|FG003|Maintenance Phase|Randomized but not Treated|2|||
94670308|NCT04124926|324245053|FG004|Maintenance Phase|Randomized but not Treated|0|||
94670309|NCT03321396|324245055|FG000|Overall Study|Physician Decision|1|||
94670310|NCT00423176|324245056|FG000|Overall Study|Adverse Event|4|||
94670311|NCT00423176|324245057|FG001|Overall Study|Adverse Event|6|||
94670312|NCT00423176|324245056|FG000|Overall Study|Treatment Failure|1|||
94670313|NCT00423176|324245057|FG001|Overall Study|Treatment Failure|6|||
94670314|NCT00423176|324245056|FG000|Overall Study|Lost to Follow-up|4|||
94461194|NCT00373958|323478212|FG001|Toddler Dose|Withdrawn after infant series|25|||
94461195|NCT02052596|323478213|FG000|Active Phase|Adverse Event|3|||
94670315|NCT00423176|324245057|FG001|Overall Study|Lost to Follow-up|7|||
94670316|NCT00423176|324245056|FG000|Overall Study|Withdrawal by Subject|4|||
94670317|NCT00423176|324245057|FG001|Overall Study|Withdrawal by Subject|3|||
94670318|NCT00423176|324245056|FG000|Overall Study|Protocol Violation|1|||
94670319|NCT00423176|324245057|FG001|Overall Study|Protocol Violation|3|||
94670320|NCT00423176|324245056|FG000|Overall Study|Did not meet protocol eligibility|2|||
94670321|NCT00423176|324245057|FG001|Overall Study|Did not meet protocol eligibility|4|||
94670322|NCT02013622|324245058|FG000|Overall Study|Lost to Follow-up|10|||
94670323|NCT02013622|324245058|FG000|Overall Study|Adverse Event|3|||
94670324|NCT02013622|324245058|FG000|Overall Study|Met Withdrawal Criteria|3|||
94670325|NCT02013622|324245058|FG000|Overall Study|Withdrawal by Subject|6|||
94670326|NCT02013622|324245058|FG000|Overall Study|Protocol Deviation|1|||
94670327|NCT02013622|324245058|FG000|Overall Study|Lack of Efficacy|1|||
94670328|NCT01324271|324245067|FG000|Overall Study|Lost to Follow-up|3|||
94670329|NCT01324271|324245068|FG001|Overall Study|Lost to Follow-up|0|||
94670330|NCT01324271|324245067|FG000|Overall Study|Physician Decision|1|||
94670331|NCT01324271|324245068|FG001|Overall Study|Physician Decision|0|||
94670332|NCT02701985|324245071|FG000|Overall Study|Withdrawal by Subject|1|||
94670333|NCT02701985|324245072|FG001|Overall Study|Withdrawal by Subject|1|||
94670334|NCT02701985|324245071|FG000|Overall Study|Lost to Follow-up|1|||
94670335|NCT02701985|324245072|FG001|Overall Study|Lost to Follow-up|0|||
94670336|NCT02701985|324245071|FG000|Overall Study|Death|1|||
94670337|NCT02701985|324245072|FG001|Overall Study|Death|0|||
94670338|NCT02701985|324245071|FG000|Overall Study|Adverse Event|0|||
94670339|NCT02701985|324245072|FG001|Overall Study|Adverse Event|5|||
94670340|NCT03206203|324245074|FG000|Treatment|Death|38|||
94670341|NCT03206203|324245075|FG001|Treatment|Death|26|||
94670342|NCT03206203|324245076|FG002|Treatment|Death|0|||
94670343|NCT03206203|324245074|FG000|Treatment|Withdrawal by Subject|1|||
94670344|NCT03206203|324245075|FG001|Treatment|Withdrawal by Subject|0|||
94670345|NCT03206203|324245076|FG002|Treatment|Withdrawal by Subject|0|||
94670346|NCT03206203|324245074|FG000|Treatment|Lost to Follow-up|4|||
94670347|NCT03206203|324245075|FG001|Treatment|Lost to Follow-up|0|||
94670348|NCT03206203|324245076|FG002|Treatment|Lost to Follow-up|0|||
94670349|NCT03206203|324245074|FG000|Treatment|N/A in Follow-Up|8|||
94670350|NCT03206203|324245075|FG001|Treatment|N/A in Follow-Up|1|||
94670351|NCT03206203|324245076|FG002|Treatment|N/A in Follow-Up|0|||
94670352|NCT03206203|324245074|FG000|Treatment|Disease progression|0|||
94670353|NCT03206203|324245075|FG001|Treatment|Disease progression|1|||
94670354|NCT03206203|324245076|FG002|Treatment|Disease progression|0|||
94670355|NCT03206203|324245074|FG000|Treatment|Refused follow-up|0|||
94670356|NCT03206203|324245075|FG001|Treatment|Refused follow-up|1|||
94670357|NCT03206203|324245076|FG002|Treatment|Refused follow-up|0|||
94670358|NCT03206203|324245074|FG000|Treatment|Cross over to Arm 1|0|||
94670359|NCT03206203|324245075|FG001|Treatment|Cross over to Arm 1|19|||
94670360|NCT03206203|324245076|FG002|Treatment|Cross over to Arm 1|0|||
94670361|NCT03206203|324245074|FG000|Optional Cross-Over|Death|0|||
94670362|NCT03206203|324245075|FG001|Optional Cross-Over|Death|0|||
94670363|NCT03206203|324245076|FG002|Optional Cross-Over|Death|14|||
94670364|NCT03206203|324245074|FG000|Optional Cross-Over|Refused follow-up|0|||
94670365|NCT03206203|324245075|FG001|Optional Cross-Over|Refused follow-up|0|||
94461196|NCT02052596|323478214|FG001|Active Phase|Adverse Event|2|||
94623718|NCT02521870|324084199|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
94623719|NCT02521870|324084200|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
94623720|NCT02521870|324084201|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
94623721|NCT02521870|324084202|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
94623722|NCT02521870|324084203|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
94623723|NCT02521870|324084192|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
94623724|NCT02521870|324084193|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
94670366|NCT03206203|324245076|FG002|Optional Cross-Over|Refused follow-up|2|||
94670367|NCT04393441|324245077|FG000|Overall Study|Adverse Event|0|||
94670368|NCT04393441|324245078|FG001|Overall Study|Adverse Event|3|||
94670369|NCT04393441|324245077|FG000|Overall Study|Withdrawal by Subject|5|||
94670370|NCT04393441|324245078|FG001|Overall Study|Withdrawal by Subject|7|||
94670371|NCT04393441|324245077|FG000|Overall Study|Lost to Follow-up|0|||
94670372|NCT04393441|324245078|FG001|Overall Study|Lost to Follow-up|2|||
94670373|NCT04393441|324245077|FG000|Overall Study|Protocol Deviation|2|||
94670374|NCT04393441|324245078|FG001|Overall Study|Protocol Deviation|1|||
94670375|NCT04393441|324245077|FG000|Overall Study|Reason not Specified|1|||
94623725|NCT02521870|324084194|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
94670376|NCT04393441|324245078|FG001|Overall Study|Reason not Specified|1|||
94670377|NCT03565887|324245079|FG000|Overall Study|Adverse Event|1|||
94623726|NCT02521870|324084195|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
94623727|NCT02521870|324084196|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
94670378|NCT03565887|324245080|FG001|Overall Study|Adverse Event|0|||
94670379|NCT03565887|324245079|FG000|Overall Study|Withdrawal by Subject|0|||
94670380|NCT03565887|324245080|FG001|Overall Study|Withdrawal by Subject|2|||
94670381|NCT02195986|324245081|FG000|Overall Study|Adverse Event|3|||
94670382|NCT02195986|324245082|FG001|Overall Study|Adverse Event|0|||
94670383|NCT02195986|324245083|FG002|Overall Study|Adverse Event|0|||
94670384|NCT02195986|324245081|FG000|Overall Study|Withdrawal by Subject|0|||
94670385|NCT02195986|324245082|FG001|Overall Study|Withdrawal by Subject|3|||
94670386|NCT02195986|324245083|FG002|Overall Study|Withdrawal by Subject|0|||
94670387|NCT02195986|324245081|FG000|Overall Study|Family Emergency|0|||
94670388|NCT02195986|324245082|FG001|Overall Study|Family Emergency|0|||
94670389|NCT02195986|324245083|FG002|Overall Study|Family Emergency|1|||
94670390|NCT02195986|324245081|FG000|Overall Study|Protocol Violation|0|||
94670391|NCT02195986|324245082|FG001|Overall Study|Protocol Violation|1|||
94670392|NCT02195986|324245083|FG002|Overall Study|Protocol Violation|1|||
94670393|NCT02195986|324245081|FG000|Overall Study|Non-compliance|0|||
94670394|NCT02195986|324245082|FG001|Overall Study|Non-compliance|1|||
94670395|NCT02195986|324245083|FG002|Overall Study|Non-compliance|0|||
94670396|NCT00449176|324245084|FG000|Overall Study|Withdrawal by Subject|39|||
94461197|NCT02052596|323478213|FG000|Active Phase|Lost to Follow-up|8|||
94623728|NCT02521870|324084197|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
94623729|NCT02521870|324084198|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
94623730|NCT02521870|324084199|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
94623731|NCT02521870|324084200|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
94623732|NCT02521870|324084201|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
94623733|NCT02521870|324084202|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
94623734|NCT02521870|324084203|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
94623735|NCT02521870|324084192|FG000|Phase 2: Dose Expansion|Death|0|||
94623736|NCT02521870|324084193|FG001|Phase 2: Dose Expansion|Death|0|||
94623737|NCT02521870|324084194|FG002|Phase 2: Dose Expansion|Death|0|||
94623738|NCT02521870|324084195|FG003|Phase 2: Dose Expansion|Death|0|||
94623739|NCT02521870|324084196|FG004|Phase 2: Dose Expansion|Death|1|||
94623740|NCT02521870|324084197|FG005|Phase 2: Dose Expansion|Death|1|||
94623741|NCT02521870|324084198|FG006|Phase 2: Dose Expansion|Death|3|||
94623742|NCT02521870|324084199|FG007|Phase 2: Dose Expansion|Death|1|||
94623743|NCT02521870|324084200|FG008|Phase 2: Dose Expansion|Death|1|||
94623744|NCT02521870|324084201|FG009|Phase 2: Dose Expansion|Death|5|||
94623745|NCT02521870|324084202|FG010|Phase 2: Dose Expansion|Death|2|||
94623746|NCT02521870|324084203|FG011|Phase 2: Dose Expansion|Death|2|||
94623747|NCT02521870|324084192|FG000|Phase 2: Dose Expansion|Other|0|||
94623748|NCT02521870|324084193|FG001|Phase 2: Dose Expansion|Other|0|||
94623749|NCT02521870|324084194|FG002|Phase 2: Dose Expansion|Other|0|||
94623750|NCT02521870|324084195|FG003|Phase 2: Dose Expansion|Other|0|||
94623751|NCT02521870|324084196|FG004|Phase 2: Dose Expansion|Other|10|||
94623752|NCT02521870|324084197|FG005|Phase 2: Dose Expansion|Other|3|||
94623753|NCT02521870|324084198|FG006|Phase 2: Dose Expansion|Other|2|||
94623754|NCT02521870|324084199|FG007|Phase 2: Dose Expansion|Other|0|||
94623755|NCT02521870|324084200|FG008|Phase 2: Dose Expansion|Other|10|||
94623756|NCT02521870|324084201|FG009|Phase 2: Dose Expansion|Other|5|||
94623757|NCT02521870|324084202|FG010|Phase 2: Dose Expansion|Other|1|||
94623758|NCT02521870|324084203|FG011|Phase 2: Dose Expansion|Other|7|||
94623759|NCT02521870|324084192|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
94623760|NCT02521870|324084193|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
94623761|NCT02521870|324084194|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
94623762|NCT02521870|324084195|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
94623763|NCT02521870|324084196|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
94623764|NCT02521870|324084197|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
94623765|NCT02521870|324084198|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
94623766|NCT02521870|324084199|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
94623767|NCT02521870|324084200|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
94623768|NCT02521870|324084201|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
94623769|NCT02521870|324084202|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
94623770|NCT02521870|324084203|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
94623771|NCT02521870|324084192|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
94623772|NCT02521870|324084193|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
94623773|NCT02521870|324084194|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
94623774|NCT02521870|324084195|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
94623775|NCT02521870|324084196|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
94623776|NCT02521870|324084197|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
94623777|NCT02521870|324084198|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
94461198|NCT02052596|323478214|FG001|Active Phase|Lost to Follow-up|11|||
94670397|NCT00449176|324245085|FG001|Overall Study|Withdrawal by Subject|43|||
94670398|NCT00449176|324245086|FG002|Overall Study|Withdrawal by Subject|59|||
94623778|NCT02521870|324084199|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
94623779|NCT02521870|324084200|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
94623780|NCT02521870|324084201|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
94623781|NCT02521870|324084202|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
94623782|NCT02521870|324084203|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
94623783|NCT03930797|324084206|FG000|Overall Study|Lost to Follow-up|3|||
94623784|NCT03930797|324084207|FG001|Overall Study|Lost to Follow-up|10|||
94623785|NCT03200860|324084208|FG000|Overall Study|Withdrawal by Subject|1|||
94623786|NCT03200860|324084209|FG001|Overall Study|Withdrawal by Subject|0|||
94670399|NCT00449176|324245084|FG000|Overall Study|Lost to Follow-up|13|||
94623787|NCT01744197|324084213|FG000|Overall Study|Received 1 patch|2|||
94623788|NCT01744197|324084214|FG001|Overall Study|Received 1 patch|1|||
94623789|NCT01744197|324084213|FG000|Overall Study|No patch received|2|||
94623790|NCT01744197|324084214|FG001|Overall Study|No patch received|2|||
94623791|NCT04342897|324084215|FG000|Overall Study|Death|7|||
94623792|NCT04342897|324084216|FG001|Overall Study|Death|4|||
94623793|NCT04342897|324084215|FG000|Overall Study|Lost to Follow-up|6|||
94623794|NCT04342897|324084216|FG001|Overall Study|Lost to Follow-up|6|||
94623795|NCT04342897|324084215|FG000|Overall Study|Withdrawal by Subject|1|||
94623796|NCT04342897|324084216|FG001|Overall Study|Withdrawal by Subject|2|||
94623797|NCT00753415|324084217|FG000|Part A|Disease progression|1|||
94623798|NCT00753415|324084218|FG001|Part A|Disease progression|0|||
94623799|NCT00753415|324084219|FG002|Part A|Disease progression|1|||
94623800|NCT00753415|324084220|FG003|Part A|Disease progression|2|||
94623801|NCT00753415|324084221|FG004|Part A|Disease progression|0|||
94623802|NCT00753415|324084222|FG005|Part A|Disease progression|0|||
94623803|NCT00753415|324084223|FG006|Part A|Disease progression|0|||
94623804|NCT00753415|324084224|FG007|Part A|Disease progression|0|||
94623805|NCT00753415|324084225|FG008|Part A|Disease progression|0|||
94623806|NCT00753415|324084226|FG009|Part A|Disease progression|0|||
94623807|NCT00753415|324084217|FG000|Part A|Withdrawal by Subject|0|||
94623808|NCT00753415|324084218|FG001|Part A|Withdrawal by Subject|0|||
94623809|NCT00753415|324084219|FG002|Part A|Withdrawal by Subject|1|||
94623810|NCT00753415|324084220|FG003|Part A|Withdrawal by Subject|0|||
94623811|NCT00753415|324084221|FG004|Part A|Withdrawal by Subject|0|||
94623812|NCT00753415|324084222|FG005|Part A|Withdrawal by Subject|0|||
94623813|NCT00753415|324084223|FG006|Part A|Withdrawal by Subject|0|||
94623814|NCT00753415|324084224|FG007|Part A|Withdrawal by Subject|0|||
94623815|NCT00753415|324084225|FG008|Part A|Withdrawal by Subject|0|||
94623816|NCT00753415|324084226|FG009|Part A|Withdrawal by Subject|0|||
94623817|NCT00753415|324084217|FG000|Part B|Lost to Follow-up|0|||
94623818|NCT00753415|324084218|FG001|Part B|Lost to Follow-up|0|||
94461199|NCT02052596|323478213|FG000|Active Phase|Protocol Violation|1|||
94623819|NCT00753415|324084219|FG002|Part B|Lost to Follow-up|0|||
94623820|NCT00753415|324084220|FG003|Part B|Lost to Follow-up|0|||
94670400|NCT00449176|324245085|FG001|Overall Study|Lost to Follow-up|8|||
94623821|NCT00753415|324084221|FG004|Part B|Lost to Follow-up|0|||
94623822|NCT00753415|324084222|FG005|Part B|Lost to Follow-up|0|||
94623823|NCT00753415|324084223|FG006|Part B|Lost to Follow-up|0|||
94623824|NCT00753415|324084224|FG007|Part B|Lost to Follow-up|1|||
94623825|NCT00753415|324084225|FG008|Part B|Lost to Follow-up|1|||
94623826|NCT00753415|324084226|FG009|Part B|Lost to Follow-up|0|||
94623827|NCT00753415|324084217|FG000|Part B|Disease progression|0|||
94623828|NCT00753415|324084218|FG001|Part B|Disease progression|0|||
94623829|NCT00753415|324084219|FG002|Part B|Disease progression|0|||
94623830|NCT00753415|324084220|FG003|Part B|Disease progression|0|||
94623831|NCT00753415|324084221|FG004|Part B|Disease progression|0|||
94623832|NCT00753415|324084222|FG005|Part B|Disease progression|0|||
94623833|NCT00753415|324084223|FG006|Part B|Disease progression|0|||
94623834|NCT00753415|324084224|FG007|Part B|Disease progression|0|||
94623835|NCT00753415|324084225|FG008|Part B|Disease progression|2|||
94623836|NCT00753415|324084226|FG009|Part B|Disease progression|1|||
94623837|NCT04518306|324084238|FG000|Double-Blind Period|Run in failure|0|||
94623838|NCT04518306|324084239|FG001|Double-Blind Period|Run in failure|0|||
94623839|NCT04518306|324084240|FG002|Double-Blind Period|Run in failure|1|||
94623840|NCT04518306|324084238|FG000|Double-Blind Period|Adverse Event|0|||
94623841|NCT04518306|324084239|FG001|Double-Blind Period|Adverse Event|2|||
94623842|NCT04518306|324084240|FG002|Double-Blind Period|Adverse Event|2|||
94623843|NCT04518306|324084238|FG000|Double-Blind Period|Lost to Follow-up|1|||
94623844|NCT04518306|324084239|FG001|Double-Blind Period|Lost to Follow-up|2|||
94623845|NCT04518306|324084240|FG002|Double-Blind Period|Lost to Follow-up|2|||
94623846|NCT04518306|324084238|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
94623847|NCT04518306|324084239|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
94623848|NCT04518306|324084240|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
94623849|NCT04518306|324084238|FG000|Double-Blind Period|Other|0|||
94623850|NCT04518306|324084239|FG001|Double-Blind Period|Other|2|||
94623851|NCT04518306|324084240|FG002|Double-Blind Period|Other|0|||
94623852|NCT04518306|324084238|FG000|Double-Blind Period|Missing|0|||
94623853|NCT04518306|324084239|FG001|Double-Blind Period|Missing|1|||
94623854|NCT04518306|324084240|FG002|Double-Blind Period|Missing|0|||
94623855|NCT01405456|324084241|FG000|Overall Study|Lost to Follow-up|2|||
94623856|NCT01405456|324084242|FG001|Overall Study|Lost to Follow-up|1|||
94623857|NCT01405456|324084241|FG000|Overall Study|Physician Decision|1|||
94623858|NCT01405456|324084242|FG001|Overall Study|Physician Decision|0|||
94623859|NCT01798004|324085338|FG000|Overall Study|Death|2|||
94623860|NCT01798004|324085338|FG000|Overall Study|Lack of Efficacy|8|||
94623861|NCT01798004|324085338|FG000|Overall Study|Physician Decision|25|||
94623862|NCT01798004|324085338|FG000|Overall Study|Withdrawal by Subject|4|||
94623863|NCT01798004|324085338|FG000|Overall Study|Ineligible|4|||
94623864|NCT01798004|324085338|FG000|Overall Study|Patient/parent refusal|7|||
94623865|NCT01798004|324085338|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
94623866|NCT01798004|324085338|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
94623867|NCT02385045|324085342|FG000|Overall Study|Endoscopy could not be completed|4|||
94623868|NCT04840615|324085343|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
94623869|NCT04840615|324085344|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
94623870|NCT04840615|324085345|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
94623871|NCT00307294|324085346|FG000|Overall Study|Withdrawal by Subject|1|||
94623872|NCT01664533|324085349|FG000|Overall Study|Death|42|||
94623873|NCT01664533|324085349|FG000|Overall Study|Lost to Follow-up|3|||
94623874|NCT01664533|324085349|FG000|Overall Study|Study termination|9|||
94623875|NCT01664533|324085349|FG000|Overall Study|Protocol Violation|3|||
94623876|NCT02980601|324085351|FG000|Overall Study|Lost to Follow-up|2|||
94623877|NCT02980601|324085352|FG001|Overall Study|Lost to Follow-up|2|||
94623878|NCT02980601|324085351|FG000|Overall Study|Death|0|||
94623879|NCT02980601|324085352|FG001|Overall Study|Death|1|||
94623880|NCT02980601|324085351|FG000|Overall Study|Graft loss|1|||
94623881|NCT02980601|324085352|FG001|Overall Study|Graft loss|0|||
94623882|NCT02980601|324085351|FG000|Overall Study|Failed to sign consent|2|||
94623883|NCT02980601|324085352|FG001|Overall Study|Failed to sign consent|0|||
94623884|NCT00290888|324085353|FG000|Overall Study|Physician Decision|3|||
94623885|NCT00290888|324085354|FG001|Overall Study|Physician Decision|1|||
94623886|NCT02601469|324085359|FG000|Overall Study|Enrolled in Error|1|||
94623887|NCT02601469|324085360|FG001|Overall Study|Enrolled in Error|0|||
94623888|NCT01806298|324085361|FG000|Overall Study|Adverse Event|3|||
94623889|NCT01806298|324085361|FG000|Overall Study|Protocol Non-compliance|1|||
94623890|NCT01806298|324085361|FG000|Overall Study|Withdrawal by Subject|1|||
94623891|NCT01806298|324085361|FG000|Overall Study|Other|5|||
94623892|NCT03808545|324085366|FG000|Overall Study|Withdrawal by Subject|1|||
94623893|NCT03808545|324085367|FG001|Overall Study|Withdrawal by Subject|1|||
94623894|NCT00963547|324085368|FG000|Overall Study|Adverse Event|0|||
94623895|NCT00963547|324085369|FG001|Overall Study|Adverse Event|1|||
94623896|NCT00963547|324085370|FG002|Overall Study|Adverse Event|0|||
94623897|NCT00963547|324085371|FG003|Overall Study|Adverse Event|1|||
94623898|NCT00963547|324085372|FG004|Overall Study|Adverse Event|0|||
94623899|NCT00963547|324085373|FG005|Overall Study|Adverse Event|0|||
94623900|NCT00963547|324085374|FG006|Overall Study|Adverse Event|0|||
94623901|NCT00963547|324085368|FG000|Overall Study|Physician Decision|1|||
94623902|NCT00963547|324085369|FG001|Overall Study|Physician Decision|1|||
94623903|NCT00963547|324085370|FG002|Overall Study|Physician Decision|0|||
94670401|NCT00449176|324245086|FG002|Overall Study|Lost to Follow-up|12|||
94623904|NCT00963547|324085371|FG003|Overall Study|Physician Decision|0|||
94623905|NCT00963547|324085372|FG004|Overall Study|Physician Decision|0|||
94670402|NCT00449176|324245084|FG000|Overall Study|Adverse Event|51|||
94670403|NCT00449176|324245085|FG001|Overall Study|Adverse Event|107|||
94670404|NCT00449176|324245086|FG002|Overall Study|Adverse Event|15|||
94670405|NCT00449176|324245084|FG000|Overall Study|Lack of Efficacy|13|||
94670406|NCT00449176|324245085|FG001|Overall Study|Lack of Efficacy|7|||
94670407|NCT00449176|324245086|FG002|Overall Study|Lack of Efficacy|50|||
94670408|NCT00449176|324245084|FG000|Overall Study|Study drug non-compliant|14|||
94670409|NCT00449176|324245085|FG001|Overall Study|Study drug non-compliant|11|||
94670410|NCT00449176|324245086|FG002|Overall Study|Study drug non-compliant|11|||
94670411|NCT00449176|324245084|FG000|Overall Study|all other|22|||
94670412|NCT00449176|324245085|FG001|Overall Study|all other|19|||
94670413|NCT00449176|324245086|FG002|Overall Study|all other|20|||
94670414|NCT02081846|324245087|FG000|Overall Study|Withdrawal by Subject|1|||
94670415|NCT02081846|324245088|FG001|Overall Study|Withdrawal by Subject|0|||
94670416|NCT02081846|324245087|FG000|Overall Study|invalid consent|1|||
94670417|NCT02081846|324245088|FG001|Overall Study|invalid consent|0|||
94670418|NCT01454583|324245089|FG000|1st Year|Lost to Follow-up|1057|||
94670419|NCT01454583|324245090|FG001|1st Year|Lost to Follow-up|318|||
94670420|NCT01454583|324245091|FG002|1st Year|Lost to Follow-up|180|||
94670421|NCT01454583|324245089|FG000|2nd Year|Lost to Follow-up|3965|||
94670422|NCT01454583|324245090|FG001|2nd Year|Lost to Follow-up|1049|||
94670423|NCT01454583|324245091|FG002|2nd Year|Lost to Follow-up|737|||
94670424|NCT01454583|324245089|FG000|3rd Year|Lost to Follow-up|1959|||
94670425|NCT01454583|324245090|FG001|3rd Year|Lost to Follow-up|512|||
94670426|NCT01454583|324245091|FG002|3rd Year|Lost to Follow-up|297|||
94670427|NCT02491671|324245094|FG000|Overall Study|Adverse Event|6|||
94670428|NCT02491671|324245095|FG001|Overall Study|Adverse Event|8|||
94670429|NCT02491671|324245094|FG000|Overall Study|Death|0|||
94670430|NCT02491671|324245095|FG001|Overall Study|Death|2|||
94670431|NCT02491671|324245094|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
94670432|NCT02491671|324245095|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
94670433|NCT02251990|324245096|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
94670434|NCT02251990|324245097|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
94670435|NCT02251990|324245096|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
94670436|NCT02251990|324245097|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
94670437|NCT02251990|324245096|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
94670438|NCT02251990|324245097|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
94670439|NCT02251990|324245096|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
94670440|NCT02251990|324245097|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
94670441|NCT02251990|324245096|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
94670442|NCT02251990|324245097|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
94670443|NCT02251990|324245096|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
94670444|NCT02251990|324245097|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
94670445|NCT03265600|324245098|FG000|Overall Study|Lost to Follow-up|17|||
94670446|NCT03265600|324245099|FG001|Overall Study|Lost to Follow-up|5|||
94670447|NCT03265600|324245098|FG000|Overall Study|Withdrawal by Subject|4|||
94670448|NCT03265600|324245099|FG001|Overall Study|Withdrawal by Subject|2|||
94670449|NCT03265600|324245098|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
94670450|NCT03265600|324245099|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
94670451|NCT00535730|324245100|FG000|Overall Study|Adverse Event|1|||
94670452|NCT00535730|324245101|FG001|Overall Study|Adverse Event|1|||
94670453|NCT00535730|324245100|FG000|Overall Study|Lost to Follow-up|0|||
94670454|NCT00535730|324245101|FG001|Overall Study|Lost to Follow-up|1|||
94670455|NCT00535730|324245100|FG000|Overall Study|Physician Decision|0|||
94670456|NCT00535730|324245101|FG001|Overall Study|Physician Decision|1|||
94670457|NCT00535730|324245100|FG000|Overall Study|Protocol Violation|1|||
94670458|NCT00535730|324245101|FG001|Overall Study|Protocol Violation|0|||
94670459|NCT00535730|324245100|FG000|Overall Study|Withdrawal by Subject|0|||
94670460|NCT00535730|324245101|FG001|Overall Study|Withdrawal by Subject|4|||
94670461|NCT01967732|324245102|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
94670462|NCT01967732|324245103|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
94670463|NCT01967732|324245104|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
94670464|NCT01967732|324245105|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
94670465|NCT01967732|324245102|FG000|First Intervention (Day 1)|Poor venous access|0|||
94670466|NCT01967732|324245103|FG001|First Intervention (Day 1)|Poor venous access|1|||
94670467|NCT01967732|324245104|FG002|First Intervention (Day 1)|Poor venous access|0|||
94670468|NCT01967732|324245105|FG003|First Intervention (Day 1)|Poor venous access|0|||
94670469|NCT00113568|324245107|FG000|Overall Study|Adverse Event|97|||
94670470|NCT00113568|324245107|FG000|Overall Study|Death|1|||
94670471|NCT00113568|324245107|FG000|Overall Study|Lack of Efficacy|30|||
94670472|NCT00113568|324245107|FG000|Overall Study|Lost to Follow-up|156|||
94670473|NCT00113568|324245107|FG000|Overall Study|Protocol Violation|32|||
94670474|NCT00113568|324245107|FG000|Overall Study|Withdrawal by Subject|117|||
94670475|NCT00113568|324245107|FG000|Overall Study|Other|112|||
94670476|NCT00262821|324245110|FG000|Overall Study|Ineligible - wrong stage|0|||
94670477|NCT00262821|324245111|FG001|Overall Study|Ineligible - wrong stage|3|||
94359639|NCT04668066|323100341|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
94359640|NCT04668066|323100342|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
94359641|NCT04668066|323100343|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
94359642|NCT04668066|323100344|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
94359643|NCT04668066|323100345|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
94359644|NCT04668066|323100346|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
94359645|NCT04668066|323100347|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
94359646|NCT04668066|323100348|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
94359647|NCT04668066|323100349|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
94359648|NCT04668066|323100350|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
94623906|NCT00963547|324085373|FG005|Overall Study|Physician Decision|0|||
94623907|NCT00963547|324085374|FG006|Overall Study|Physician Decision|0|||
94623908|NCT00963547|324085368|FG000|Overall Study|Progressive Disease|3|||
94623909|NCT00963547|324085369|FG001|Overall Study|Progressive Disease|8|||
94623910|NCT00963547|324085370|FG002|Overall Study|Progressive Disease|9|||
94623911|NCT00963547|324085371|FG003|Overall Study|Progressive Disease|5|||
94623912|NCT00963547|324085372|FG004|Overall Study|Progressive Disease|0|||
94623913|NCT00963547|324085373|FG005|Overall Study|Progressive Disease|0|||
94623914|NCT00963547|324085374|FG006|Overall Study|Progressive Disease|0|||
94623915|NCT00963547|324085368|FG000|Overall Study|Withdrawal by Subject|0|||
94623916|NCT00963547|324085369|FG001|Overall Study|Withdrawal by Subject|0|||
94623917|NCT00963547|324085370|FG002|Overall Study|Withdrawal by Subject|3|||
94623918|NCT00963547|324085371|FG003|Overall Study|Withdrawal by Subject|0|||
94623919|NCT00963547|324085372|FG004|Overall Study|Withdrawal by Subject|0|||
94623920|NCT00963547|324085373|FG005|Overall Study|Withdrawal by Subject|0|||
94623921|NCT00963547|324085374|FG006|Overall Study|Withdrawal by Subject|0|||
94623922|NCT00963547|324085368|FG000|Overall Study|Reason Unknown|0|||
94623923|NCT00963547|324085369|FG001|Overall Study|Reason Unknown|1|||
94623924|NCT00963547|324085370|FG002|Overall Study|Reason Unknown|0|||
94623925|NCT00963547|324085371|FG003|Overall Study|Reason Unknown|0|||
94623926|NCT00963547|324085372|FG004|Overall Study|Reason Unknown|0|||
94623927|NCT00963547|324085373|FG005|Overall Study|Reason Unknown|0|||
94623928|NCT00963547|324085374|FG006|Overall Study|Reason Unknown|0|||
94623929|NCT02161731|324085378|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
94623930|NCT02161731|324085379|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
94623931|NCT02161731|324085378|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
94623932|NCT02161731|324085379|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
94623933|NCT01408485|324085380|FG000|Overall Study|Withdrawal by Subject|21|||
94623934|NCT03292588|324085381|FG000|Overall Study|Death|1|||
94623935|NCT03292588|324085382|FG001|Overall Study|Death|0|||
94623936|NCT03292588|324085381|FG000|Overall Study|Lost to Follow-up|12|||
94623937|NCT03292588|324085382|FG001|Overall Study|Lost to Follow-up|16|||
94623938|NCT03292588|324085381|FG000|Overall Study|Physician Decision|0|||
94623939|NCT03292588|324085382|FG001|Overall Study|Physician Decision|1|||
94623940|NCT03292588|324085381|FG000|Overall Study|Withdrawal by Subject|4|||
94623941|NCT03292588|324085382|FG001|Overall Study|Withdrawal by Subject|4|||
94623942|NCT03292588|324085381|FG000|Overall Study|Move out of town|1|||
94623943|NCT03292588|324085382|FG001|Overall Study|Move out of town|0|||
94623944|NCT03292588|324085381|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
94623945|NCT03292588|324085382|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
94623946|NCT00062374|324085383|FG000|Overall Study|Not treated|12|||
94623947|NCT02151591|324085384|FG000|Overall Study|Lost to Follow-up|6|||
94623948|NCT02151591|324085385|FG001|Overall Study|Lost to Follow-up|3|||
94670478|NCT00262821|324245110|FG000|Overall Study|Ineligible - wrong cell type|2|||
94670479|NCT00262821|324245111|FG001|Overall Study|Ineligible - wrong cell type|2|||
94670480|NCT00262821|324245110|FG000|Overall Study|Ineligible - wrong primary|0|||
94670481|NCT00262821|324245111|FG001|Overall Study|Ineligible - wrong primary|1|||
94670482|NCT00262821|324245110|FG000|Overall Study|Ineligible - inadequate pathology|1|||
94670483|NCT00262821|324245111|FG001|Overall Study|Ineligible - inadequate pathology|3|||
94670484|NCT00262821|324245110|FG000|Overall Study|Ineligible - elevated creatinine|0|||
94670485|NCT00262821|324245111|FG001|Overall Study|Ineligible - elevated creatinine|2|||
94670486|NCT00262821|324245110|FG000|Overall Study|Ineligible - required test not done|1|||
94670487|NCT00262821|324245111|FG001|Overall Study|Ineligible - required test not done|4|||
94623949|NCT02193867|324085386|FG000|Overall Study|Death|2|||
94623950|NCT02193867|324085386|FG000|Overall Study|Sponsor Study Termination|2|||
94623951|NCT03716024|324085387|FG000|Overall Study|Randomized, not Treated|7|||
94623952|NCT03716024|324085388|FG001|Overall Study|Randomized, not Treated|8|||
94670488|NCT00262821|324245110|FG000|Overall Study|Inevaluable - inadequate data|0|||
94359649|NCT04668066|323100351|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
94623953|NCT03716024|324085387|FG000|Overall Study|Adverse Event|1|||
94623954|NCT03716024|324085388|FG001|Overall Study|Adverse Event|2|||
94623955|NCT03716024|324085387|FG000|Overall Study|Treatment Failure|1|||
94623956|NCT03716024|324085388|FG001|Overall Study|Treatment Failure|0|||
94623957|NCT03716024|324085387|FG000|Overall Study|Lost to Follow-up|2|||
94623958|NCT03716024|324085388|FG001|Overall Study|Lost to Follow-up|6|||
94461200|NCT02052596|323478214|FG001|Active Phase|Protocol Violation|2|||
94461201|NCT02052596|323478213|FG000|Active Phase|Withdrawal by Subject|3|||
94623959|NCT03716024|324085387|FG000|Overall Study|Withdrawal by Subject|0|||
94623960|NCT03716024|324085388|FG001|Overall Study|Withdrawal by Subject|1|||
94623961|NCT03716024|324085387|FG000|Overall Study|Missing Reason|0|||
94623962|NCT03716024|324085388|FG001|Overall Study|Missing Reason|1|||
94623963|NCT02128113|324085389|FG000|Overall Study|Withdrawal by Subject|3|||
94623964|NCT02128113|324085390|FG001|Overall Study|Withdrawal by Subject|1|||
94623965|NCT02128113|324085391|FG002|Overall Study|Withdrawal by Subject|0|||
94623966|NCT02128113|324085389|FG000|Overall Study|Protocol Violation|0|||
94623967|NCT02128113|324085390|FG001|Overall Study|Protocol Violation|1|||
94623968|NCT02128113|324085391|FG002|Overall Study|Protocol Violation|0|||
94623969|NCT02128113|324085389|FG000|Overall Study|Surgery cancelled|0|||
94623970|NCT02128113|324085390|FG001|Overall Study|Surgery cancelled|1|||
94623971|NCT02128113|324085391|FG002|Overall Study|Surgery cancelled|0|||
94623972|NCT02128113|324085389|FG000|Overall Study|Adverse Event|0|||
94623973|NCT02128113|324085390|FG001|Overall Study|Adverse Event|0|||
94623974|NCT02128113|324085391|FG002|Overall Study|Adverse Event|1|||
94623975|NCT01727297|324085393|FG000|Overall Study|Death|13|||
94623976|NCT01727297|324085394|FG001|Overall Study|Death|0|||
94623977|NCT01727297|324085393|FG000|Overall Study|Protocol Violation|1|||
94623978|NCT01727297|324085394|FG001|Overall Study|Protocol Violation|10|||
94623979|NCT01727297|324085393|FG000|Overall Study|Adverse Event|3|||
94623980|NCT01727297|324085394|FG001|Overall Study|Adverse Event|1|||
94623981|NCT01727297|324085393|FG000|Overall Study|Lost to Follow-up|11|||
94623982|NCT01727297|324085394|FG001|Overall Study|Lost to Follow-up|0|||
94623983|NCT01727297|324085393|FG000|Overall Study|Withdrawal by Subject|26|||
94623984|NCT01727297|324085394|FG001|Overall Study|Withdrawal by Subject|27|||
94623985|NCT01727297|324085393|FG000|Overall Study|Physician Decision|19|||
94623986|NCT01727297|324085394|FG001|Overall Study|Physician Decision|5|||
94623987|NCT01727297|324085393|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
94623988|NCT01727297|324085394|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
94623989|NCT01192516|324085395|FG000|Overall Study|Lost to Follow-up|7|||
94623990|NCT01192516|324085396|FG001|Overall Study|Lost to Follow-up|10|||
94623991|NCT01192516|324085397|FG002|Overall Study|Lost to Follow-up|7|||
94623992|NCT01192516|324085395|FG000|Overall Study|Withdrawal by Subject|4|||
94623993|NCT01192516|324085396|FG001|Overall Study|Withdrawal by Subject|4|||
94623994|NCT01192516|324085397|FG002|Overall Study|Withdrawal by Subject|1|||
94623995|NCT01192516|324085395|FG000|Overall Study|started new treatment|5|||
94623996|NCT01192516|324085396|FG001|Overall Study|started new treatment|1|||
94623997|NCT01192516|324085397|FG002|Overall Study|started new treatment|0|||
94623998|NCT01192516|324085395|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
94623999|NCT01192516|324085396|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
94624000|NCT01192516|324085397|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
94624001|NCT01256008|324085398|FG000|Overall Study|Lost to Follow-up|6|||
94624002|NCT01256008|324085399|FG001|Overall Study|Lost to Follow-up|4|||
94624003|NCT01256008|324085400|FG002|Overall Study|Lost to Follow-up|11|||
94624004|NCT01256008|324085398|FG000|Overall Study|Withdrawal by Subject|2|||
94624005|NCT01256008|324085399|FG001|Overall Study|Withdrawal by Subject|3|||
94624006|NCT01256008|324085400|FG002|Overall Study|Withdrawal by Subject|10|||
94624007|NCT01496807|324085403|FG000|Overall Study|Progressive Disease|21|||
94624008|NCT01496807|324085403|FG000|Overall Study|Participant preference/toxicity|8|||
94624009|NCT01496807|324085403|FG000|Overall Study|Change in diagnosis|1|||
94624010|NCT01537393|324085404|FG000|Overall Study|Exclude prior to study|32|||
94624011|NCT01537393|324085405|FG001|Overall Study|Exclude prior to study|44|||
94624012|NCT01537393|324085404|FG000|Overall Study|Death|20|||
94624013|NCT01537393|324085405|FG001|Overall Study|Death|32|||
94624014|NCT01537393|324085404|FG000|Overall Study|Withdrawal by Subject|18|||
94624015|NCT01537393|324085405|FG001|Overall Study|Withdrawal by Subject|17|||
94624016|NCT01537393|324085404|FG000|Overall Study|Lost to Follow-up|53|||
94624017|NCT01537393|324085405|FG001|Overall Study|Lost to Follow-up|48|||
94624018|NCT01537393|324085404|FG000|Overall Study|Failure - Regrafted|28|||
94624019|NCT01537393|324085405|FG001|Overall Study|Failure - Regrafted|43|||
94624020|NCT01537393|324085404|FG000|Overall Study|Failure - Not regrafted|2|||
94624021|NCT01537393|324085405|FG001|Overall Study|Failure - Not regrafted|6|||
94624022|NCT01537393|324085404|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
94624023|NCT01537393|324085405|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
94624024|NCT01217814|324085406|FG000|Overall Study|Adverse Event|1|||
94624025|NCT01217814|324085407|FG001|Overall Study|Adverse Event|1|||
94624026|NCT01217814|324085408|FG002|Overall Study|Adverse Event|0|||
94624027|NCT01217814|324085406|FG000|Overall Study|Lack of Efficacy|0|||
94624028|NCT01217814|324085407|FG001|Overall Study|Lack of Efficacy|0|||
94624029|NCT01217814|324085408|FG002|Overall Study|Lack of Efficacy|1|||
94624030|NCT01709162|324085409|FG000|Overall Study|Disease progression|3|||
94624031|NCT01709162|324085410|FG001|Overall Study|Disease progression|3|||
94670489|NCT00262821|324245111|FG001|Overall Study|Inevaluable - inadequate data|4|||
94670490|NCT01857531|324245114|FG000|Overall Study|Withdrawal by Subject|4|||
94670491|NCT00127101|324245116|FG000|Base Protocol|Adverse Event|0|||
94670492|NCT00127101|324245117|FG001|Base Protocol|Adverse Event|2|||
94670493|NCT00127101|324245118|FG002|Base Protocol|Adverse Event|1|||
94670494|NCT00127101|324245119|FG003|Base Protocol|Adverse Event|0|||
94670495|NCT00127101|324245120|FG004|Base Protocol|Adverse Event|0|||
94670496|NCT00127101|324245121|FG005|Base Protocol|Adverse Event|0|||
94670497|NCT00127101|324245116|FG000|Base Protocol|Lack of Efficacy|1|||
94670498|NCT00127101|324245117|FG001|Base Protocol|Lack of Efficacy|0|||
94670499|NCT00127101|324245118|FG002|Base Protocol|Lack of Efficacy|0|||
94670500|NCT00127101|324245119|FG003|Base Protocol|Lack of Efficacy|0|||
94670501|NCT00127101|324245120|FG004|Base Protocol|Lack of Efficacy|2|||
94670502|NCT00127101|324245121|FG005|Base Protocol|Lack of Efficacy|0|||
94670503|NCT00127101|324245116|FG000|Base Protocol|Withdrawal by Subject|1|||
94670504|NCT00127101|324245117|FG001|Base Protocol|Withdrawal by Subject|2|||
94670505|NCT00127101|324245118|FG002|Base Protocol|Withdrawal by Subject|1|||
94670506|NCT00127101|324245119|FG003|Base Protocol|Withdrawal by Subject|0|||
94670507|NCT00127101|324245120|FG004|Base Protocol|Withdrawal by Subject|0|||
94670508|NCT00127101|324245121|FG005|Base Protocol|Withdrawal by Subject|1|||
94670509|NCT00127101|324245116|FG000|Continuation Phase|Adverse Event|0|||
94670510|NCT00127101|324245117|FG001|Continuation Phase|Adverse Event|0|||
94670511|NCT00127101|324245118|FG002|Continuation Phase|Adverse Event|0|||
94670512|NCT00127101|324245119|FG003|Continuation Phase|Adverse Event|0|||
94670513|NCT00127101|324245120|FG004|Continuation Phase|Adverse Event|1|||
94670514|NCT00127101|324245121|FG005|Continuation Phase|Adverse Event|1|||
94670515|NCT00127101|324245116|FG000|Continuation Phase|Lack of Efficacy|0|||
94670516|NCT00127101|324245117|FG001|Continuation Phase|Lack of Efficacy|0|||
94670517|NCT00127101|324245118|FG002|Continuation Phase|Lack of Efficacy|0|||
94670518|NCT00127101|324245119|FG003|Continuation Phase|Lack of Efficacy|0|||
94670519|NCT00127101|324245120|FG004|Continuation Phase|Lack of Efficacy|0|||
94670520|NCT00127101|324245121|FG005|Continuation Phase|Lack of Efficacy|1|||
94670521|NCT00127101|324245116|FG000|Continuation Phase|Withdrawal by Subject|0|||
94670522|NCT00127101|324245117|FG001|Continuation Phase|Withdrawal by Subject|0|||
94670523|NCT00127101|324245118|FG002|Continuation Phase|Withdrawal by Subject|1|||
94670524|NCT00127101|324245119|FG003|Continuation Phase|Withdrawal by Subject|0|||
94670525|NCT00127101|324245120|FG004|Continuation Phase|Withdrawal by Subject|2|||
94670526|NCT00127101|324245121|FG005|Continuation Phase|Withdrawal by Subject|1|||
94670527|NCT04197713|324245124|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
94670528|NCT04197713|324245125|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
94670529|NCT03432364|324247183|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
94670530|NCT01754467|324247192|FG000|Overall Study|Lost to Follow-up|1|||
94670531|NCT00530855|324247193|FG000|Overall Study|Lack of Efficacy|20|||
94670532|NCT00530855|324247193|FG000|Overall Study|Withdrawal by Subject|30|||
94670533|NCT00530855|324247193|FG000|Overall Study|Fatal Serious AE|3|||
94670534|NCT00530855|324247193|FG000|Overall Study|Non Fatal Serious AE|7|||
94670535|NCT00530855|324247193|FG000|Overall Study|Non Fatal Non Serious AE|12|||
94670536|NCT00530855|324247193|FG000|Overall Study|Protocol Violation|3|||
94670537|NCT00530855|324247193|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
94670538|NCT00530855|324247193|FG000|Overall Study|Lost to Follow-up|9|||
94670539|NCT00530855|324247193|FG000|Overall Study|Other reason for premature termination|17|||
94670540|NCT01059175|324247194|FG000|Overall Study|Death|17|||
94670541|NCT01059175|324247195|FG001|Overall Study|Death|17|||
94670542|NCT01059175|324247194|FG000|Overall Study|Adverse Event|4|||
94670543|NCT01059175|324247195|FG001|Overall Study|Adverse Event|2|||
94670544|NCT01059175|324247194|FG000|Overall Study|Lost to Follow-up|0|||
94670545|NCT01059175|324247195|FG001|Overall Study|Lost to Follow-up|1|||
94670546|NCT02219048|324247199|FG000|Overall Study|Adverse Event|2|||
94670547|NCT02219048|324247200|FG001|Overall Study|Adverse Event|5|||
94670548|NCT02219048|324247199|FG000|Overall Study|No longer meets eligibility criteria|1|||
94670549|NCT02219048|324247200|FG001|Overall Study|No longer meets eligibility criteria|0|||
94670550|NCT02219048|324247199|FG000|Overall Study|Study terminated by sponsor|16|||
94670551|NCT02219048|324247200|FG001|Overall Study|Study terminated by sponsor|15|||
94670552|NCT02219048|324247199|FG000|Overall Study|Withdrawal by Subject|2|||
94670553|NCT02219048|324247200|FG001|Overall Study|Withdrawal by Subject|0|||
94359650|NCT04668066|323100352|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
94670554|NCT02219048|324247199|FG000|Overall Study|Other|0|||
94670555|NCT02219048|324247200|FG001|Overall Study|Other|1|||
94359651|NCT04668066|323100353|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
94670556|NCT01984684|324247201|FG000|Overall Study|Lost to Follow-up|25|||
94670557|NCT01984684|324247202|FG001|Overall Study|Lost to Follow-up|24|||
94359652|NCT04668066|323100354|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
94670558|NCT01984684|324247201|FG000|Overall Study|Adverse Event|8|||
94670559|NCT01984684|324247202|FG001|Overall Study|Adverse Event|12|||
94670560|NCT01984684|324247201|FG000|Overall Study|Withdrawal by Subject|9|||
94461202|NCT02052596|323478214|FG001|Active Phase|Withdrawal by Subject|4|||
94624032|NCT01709162|324085409|FG000|Overall Study|Study drug toxicity|2|||
94624033|NCT01709162|324085410|FG001|Overall Study|Study drug toxicity|0|||
94624034|NCT01709162|324085409|FG000|Overall Study|Administrative reason by sponsor|0|||
94624035|NCT01709162|324085410|FG001|Overall Study|Administrative reason by sponsor|1|||
94624036|NCT01709162|324085409|FG000|Overall Study|Other|1|||
94624037|NCT01709162|324085410|FG001|Overall Study|Other|0|||
94624038|NCT01709162|324085409|FG000|Overall Study|Withdrawal by Subject|0|||
94624039|NCT01709162|324085410|FG001|Overall Study|Withdrawal by Subject|1|||
94624040|NCT00729651|324085411|FG000|Overall Study|Withdrawal by Subject|5|||
94624041|NCT00729651|324085412|FG001|Overall Study|Withdrawal by Subject|6|||
94624042|NCT00729651|324085411|FG000|Overall Study|Lost to Follow-up|5|||
94624043|NCT00729651|324085412|FG001|Overall Study|Lost to Follow-up|4|||
94624044|NCT00729651|324085411|FG000|Overall Study|Protocol Violation|0|||
94624045|NCT00729651|324085412|FG001|Overall Study|Protocol Violation|1|||
94624046|NCT00729651|324085411|FG000|Overall Study|Adverse Event|7|||
94624047|NCT00729651|324085412|FG001|Overall Study|Adverse Event|3|||
94624048|NCT00729651|324085411|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
94624049|NCT00729651|324085412|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
94624050|NCT00729651|324085411|FG000|Overall Study|Subject's private reason|2|||
94624051|NCT00729651|324085412|FG001|Overall Study|Subject's private reason|0|||
94624052|NCT03310021|324085413|FG000|Overall Study|Withdrawal by Subject|0|||
94624053|NCT03310021|324085414|FG001|Overall Study|Withdrawal by Subject|0|||
94624054|NCT03310021|324085415|FG002|Overall Study|Withdrawal by Subject|0|||
94624055|NCT03310021|324085416|FG003|Overall Study|Withdrawal by Subject|0|||
94624056|NCT03310021|324085417|FG004|Overall Study|Withdrawal by Subject|0|||
94624057|NCT03310021|324085418|FG005|Overall Study|Withdrawal by Subject|0|||
94624058|NCT03310021|324085419|FG006|Overall Study|Withdrawal by Subject|1|||
94624059|NCT03310021|324085420|FG007|Overall Study|Withdrawal by Subject|0|||
94624060|NCT03310021|324085421|FG008|Overall Study|Withdrawal by Subject|0|||
94624061|NCT03310021|324085422|FG009|Overall Study|Withdrawal by Subject|0|||
94624062|NCT03310021|324085423|FG010|Overall Study|Withdrawal by Subject|0|||
94624063|NCT03310021|324085424|FG011|Overall Study|Withdrawal by Subject|0|||
94624064|NCT03310021|324085425|FG012|Overall Study|Withdrawal by Subject|0|||
94624065|NCT03310021|324085426|FG013|Overall Study|Withdrawal by Subject|0|||
94624066|NCT03310021|324085427|FG014|Overall Study|Withdrawal by Subject|0|||
94624067|NCT03310021|324085428|FG015|Overall Study|Withdrawal by Subject|0|||
94624068|NCT03310021|324085429|FG016|Overall Study|Withdrawal by Subject|0|||
94624069|NCT03310021|324085430|FG017|Overall Study|Withdrawal by Subject|0|||
94624070|NCT03310021|324085431|FG018|Overall Study|Withdrawal by Subject|0|||
94624071|NCT03310021|324085432|FG019|Overall Study|Withdrawal by Subject|0|||
94624072|NCT03310021|324085413|FG000|Overall Study|Lost to Follow-up|0|||
94624073|NCT03310021|324085414|FG001|Overall Study|Lost to Follow-up|0|||
94624074|NCT03310021|324085415|FG002|Overall Study|Lost to Follow-up|0|||
94624075|NCT03310021|324085416|FG003|Overall Study|Lost to Follow-up|0|||
94624076|NCT03310021|324085417|FG004|Overall Study|Lost to Follow-up|0|||
94624077|NCT03310021|324085418|FG005|Overall Study|Lost to Follow-up|0|||
94624078|NCT03310021|324085419|FG006|Overall Study|Lost to Follow-up|0|||
94624079|NCT03310021|324085420|FG007|Overall Study|Lost to Follow-up|0|||
94624080|NCT03310021|324085421|FG008|Overall Study|Lost to Follow-up|0|||
94624081|NCT03310021|324085422|FG009|Overall Study|Lost to Follow-up|0|||
94624082|NCT03310021|324085423|FG010|Overall Study|Lost to Follow-up|1|||
94624083|NCT03310021|324085424|FG011|Overall Study|Lost to Follow-up|0|||
94624084|NCT03310021|324085425|FG012|Overall Study|Lost to Follow-up|0|||
94624085|NCT03310021|324085426|FG013|Overall Study|Lost to Follow-up|0|||
94624086|NCT03310021|324085427|FG014|Overall Study|Lost to Follow-up|0|||
94624087|NCT03310021|324085428|FG015|Overall Study|Lost to Follow-up|0|||
94624088|NCT03310021|324085429|FG016|Overall Study|Lost to Follow-up|0|||
94624089|NCT03310021|324085430|FG017|Overall Study|Lost to Follow-up|0|||
94624090|NCT03310021|324085431|FG018|Overall Study|Lost to Follow-up|0|||
94624091|NCT03310021|324085432|FG019|Overall Study|Lost to Follow-up|0|||
94624092|NCT02925494|324085433|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
94624093|NCT02925494|324085434|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
94624094|NCT02925494|324085435|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
94624095|NCT02925494|324085436|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
94624096|NCT02925494|324085433|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
94624097|NCT02925494|324085434|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
94624098|NCT02925494|324085435|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
94624099|NCT02925494|324085436|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
94624100|NCT02925494|324085433|FG000|Post-Treatment Follow-Up Period|Other|1|||
94624101|NCT02925494|324085434|FG001|Post-Treatment Follow-Up Period|Other|4|||
94624102|NCT02925494|324085435|FG002|Post-Treatment Follow-Up Period|Other|3|||
94624103|NCT02925494|324085436|FG003|Post-Treatment Follow-Up Period|Other|6|||
94624104|NCT02925494|324085433|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
94624105|NCT02925494|324085434|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
94651433|NCT03852316|324181655|FG000|Overall Study|Withdrawal by Subject|2|||
94670561|NCT01984684|324247202|FG001|Overall Study|Withdrawal by Subject|9|||
94670562|NCT01984684|324247201|FG000|Overall Study|Lack of Efficacy|3|||
94670563|NCT01984684|324247202|FG001|Overall Study|Lack of Efficacy|6|||
94670564|NCT01984684|324247201|FG000|Overall Study|Physician Decision|4|||
94670565|NCT01984684|324247202|FG001|Overall Study|Physician Decision|2|||
94670566|NCT01984684|324247201|FG000|Overall Study|Protocol Violation|4|||
94670567|NCT01984684|324247202|FG001|Overall Study|Protocol Violation|2|||
94670568|NCT01984684|324247201|FG000|Overall Study|Death|0|||
94670569|NCT01984684|324247202|FG001|Overall Study|Death|1|||
94670570|NCT01984684|324247201|FG000|Overall Study|Noncompliance with study drug|2|||
94670571|NCT01984684|324247202|FG001|Overall Study|Noncompliance with study drug|1|||
94670572|NCT01984684|324247201|FG000|Overall Study|Subject incarcerated|1|||
94670573|NCT01984684|324247202|FG001|Overall Study|Subject incarcerated|0|||
94670574|NCT01984684|324247201|FG000|Overall Study|Study drug not available at site|1|||
94670575|NCT01984684|324247202|FG001|Overall Study|Study drug not available at site|1|||
94670576|NCT01984684|324247201|FG000|Overall Study|Subject had inadequate IV access|0|||
94670577|NCT01984684|324247202|FG001|Overall Study|Subject had inadequate IV access|1|||
94670578|NCT03152526|324247203|FG000|Overall Study|Withdrawal by Subject|0|||
94670579|NCT03152526|324247204|FG001|Overall Study|Withdrawal by Subject|1|||
94670580|NCT05130970|324247205|FG000|Overall Study|Adverse Event|1|||
94670581|NCT05130970|324247206|FG001|Overall Study|Adverse Event|1|||
94670582|NCT05130970|324247205|FG000|Overall Study|Death|0|||
94670583|NCT05130970|324247206|FG001|Overall Study|Death|1|||
94670584|NCT05130970|324247205|FG000|Overall Study|Lost to Follow-up|0|||
94670585|NCT05130970|324247206|FG001|Overall Study|Lost to Follow-up|1|||
94670586|NCT05130970|324247205|FG000|Overall Study|Physician Decision|0|||
94670587|NCT05130970|324247206|FG001|Overall Study|Physician Decision|1|||
94670588|NCT05130970|324247205|FG000|Overall Study|Withdrawal by Subject|1|||
94670589|NCT05130970|324247206|FG001|Overall Study|Withdrawal by Subject|1|||
94670590|NCT03896035|324247212|FG000|Overall Study|Lost to Follow-up|2|||
94670591|NCT03896035|324247213|FG001|Overall Study|Lost to Follow-up|6|||
94670592|NCT03896035|324247212|FG000|Overall Study|Withdrawal by Subject|0|||
94670593|NCT03896035|324247213|FG001|Overall Study|Withdrawal by Subject|1|||
94670594|NCT03896035|324247212|FG000|Overall Study|Health/family health issues during COVID|0|||
94670595|NCT03896035|324247213|FG001|Overall Study|Health/family health issues during COVID|4|||
94670596|NCT03624504|324247214|FG000|Overall Study|Unsuccessful Implant|1|||
94670597|NCT00003298|324247215|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
94670598|NCT00003298|324247215|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
94670599|NCT00003298|324247215|FG000|Surgery|Unresectable at surgery|3|||
94670600|NCT00003298|324247215|FG000|Surgery|Progression before surgery|2|||
94670601|NCT00003298|324247215|FG000|Surgery|Unevaluable and off study|2|||
94670602|NCT00003298|324247215|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
94670603|NCT00003298|324247215|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
94670604|NCT00003298|324247215|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
94670605|NCT00003298|324247215|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
94670606|NCT00003298|324247215|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
94670607|NCT00003298|324247215|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
94670608|NCT00003298|324247215|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
94670609|NCT00003298|324247215|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
94670610|NCT00003298|324247215|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
94670611|NCT00003298|324247215|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
94670612|NCT00951483|324247216|FG000|Overall Study|Physician Decision|4|||
94670613|NCT00951483|324247217|FG001|Overall Study|Physician Decision|0|||
94670614|NCT00951483|324247216|FG000|Overall Study|Withdrawal by Subject|15|||
94670615|NCT00951483|324247217|FG001|Overall Study|Withdrawal by Subject|0|||
94670616|NCT02308748|324247220|FG000|Period 1|Withdrawal by Subject|0|||
94670617|NCT02308748|324247221|FG001|Period 1|Withdrawal by Subject|0|||
94670618|NCT02308748|324247222|FG002|Period 1|Withdrawal by Subject|1|||
94670619|NCT02308748|324247223|FG003|Period 1|Withdrawal by Subject|0|||
94670620|NCT02308748|324247224|FG004|Period 1|Withdrawal by Subject|0|||
94359653|NCT04668066|323100336|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
94359654|NCT04668066|323100337|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
94359655|NCT04668066|323100338|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
94670621|NCT02308748|324247225|FG005|Period 1|Withdrawal by Subject|0|||
94670622|NCT02308748|324247226|FG006|Period 1|Withdrawal by Subject|0|||
94670623|NCT02308748|324247227|FG007|Period 1|Withdrawal by Subject|0|||
94670624|NCT02308748|324247228|FG008|Period 1|Withdrawal by Subject|0|||
94670625|NCT02308748|324247229|FG009|Period 1|Withdrawal by Subject|0|||
94670626|NCT02308748|324247220|FG000|Period 2|Adverse Event|0|||
94670627|NCT02308748|324247221|FG001|Period 2|Adverse Event|0|||
94670628|NCT02308748|324247222|FG002|Period 2|Adverse Event|0|||
94670629|NCT02308748|324247223|FG003|Period 2|Adverse Event|0|||
94670630|NCT02308748|324247224|FG004|Period 2|Adverse Event|0|||
94624106|NCT02925494|324085435|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
94624107|NCT02925494|324085436|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
94624108|NCT02925494|324085433|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
94624109|NCT02925494|324085434|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
94624110|NCT02925494|324085435|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
94624111|NCT02925494|324085436|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
94624112|NCT02925494|324085433|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
94624113|NCT02925494|324085434|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
94624114|NCT02925494|324085435|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
94624115|NCT02925494|324085436|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
94624116|NCT02925494|324085433|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
94624117|NCT02925494|324085434|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
94624118|NCT02925494|324085435|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
94624119|NCT02925494|324085436|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
94624120|NCT03129100|324085438|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
94624121|NCT03129100|324085439|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
94624122|NCT03129100|324085440|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
94624123|NCT03129100|324085441|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
94624124|NCT03129100|324085442|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
94624125|NCT03129100|324085443|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
94624126|NCT03129100|324085444|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
94624127|NCT03129100|324085445|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
94624128|NCT03129100|324085446|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
94624129|NCT03129100|324085447|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
94624130|NCT03129100|324085448|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
94624131|NCT03129100|324085449|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
94624132|NCT03129100|324085450|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
94624133|NCT03129100|324085451|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
94624134|NCT03129100|324085452|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
94624135|NCT03129100|324085453|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
94624136|NCT03129100|324085454|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
94624137|NCT03129100|324085455|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
94624138|NCT03129100|324085456|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
94624139|NCT03129100|324085457|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
94624140|NCT03129100|324085458|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
94624141|NCT03129100|324085459|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
94624142|NCT03129100|324085460|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
94624143|NCT03129100|324085461|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
94624144|NCT03129100|324085462|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
94624145|NCT03129100|324085463|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
94624146|NCT03129100|324085438|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
94624147|NCT03129100|324085439|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624148|NCT03129100|324085440|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624149|NCT03129100|324085441|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624150|NCT03129100|324085442|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624151|NCT03129100|324085443|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624152|NCT03129100|324085444|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624153|NCT03129100|324085445|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624154|NCT03129100|324085446|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624155|NCT03129100|324085447|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624156|NCT03129100|324085448|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624157|NCT03129100|324085449|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624158|NCT03129100|324085450|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624159|NCT03129100|324085451|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624160|NCT03129100|324085452|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624161|NCT03129100|324085453|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624162|NCT03129100|324085454|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624163|NCT03129100|324085455|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624164|NCT03129100|324085456|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624165|NCT03129100|324085457|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624166|NCT03129100|324085458|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624167|NCT03129100|324085459|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624168|NCT03129100|324085460|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624169|NCT03129100|324085461|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624170|NCT03129100|324085462|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624171|NCT03129100|324085463|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
94624172|NCT03129100|324085438|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
94624173|NCT03129100|324085439|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
94624174|NCT03129100|324085440|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624175|NCT03129100|324085441|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624176|NCT03129100|324085442|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624177|NCT03129100|324085443|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94670631|NCT02308748|324247225|FG005|Period 2|Adverse Event|0|||
94670632|NCT02308748|324247226|FG006|Period 2|Adverse Event|0|||
94670633|NCT02308748|324247227|FG007|Period 2|Adverse Event|1|||
94670634|NCT02308748|324247228|FG008|Period 2|Adverse Event|0|||
94461203|NCT02052596|323478213|FG000|Active Phase|Enrolled in error|1|||
94461204|NCT02052596|323478214|FG001|Active Phase|Enrolled in error|0|||
94670635|NCT02308748|324247229|FG009|Period 2|Adverse Event|0|||
94670636|NCT02308748|324247220|FG000|Period 3|Protocol Violation|0|||
94670637|NCT02308748|324247221|FG001|Period 3|Protocol Violation|0|||
94670638|NCT02308748|324247222|FG002|Period 3|Protocol Violation|0|||
94670639|NCT02308748|324247223|FG003|Period 3|Protocol Violation|0|||
94670640|NCT02308748|324247224|FG004|Period 3|Protocol Violation|0|||
94670641|NCT02308748|324247225|FG005|Period 3|Protocol Violation|0|||
94670642|NCT02308748|324247226|FG006|Period 3|Protocol Violation|0|||
94670643|NCT02308748|324247227|FG007|Period 3|Protocol Violation|0|||
94670644|NCT02308748|324247228|FG008|Period 3|Protocol Violation|0|||
94670645|NCT02308748|324247229|FG009|Period 3|Protocol Violation|1|||
94670646|NCT02308748|324247220|FG000|Period 5|Adverse Event|1|||
94670647|NCT02308748|324247221|FG001|Period 5|Adverse Event|0|||
94670648|NCT02308748|324247222|FG002|Period 5|Adverse Event|0|||
94670649|NCT02308748|324247223|FG003|Period 5|Adverse Event|0|||
94670650|NCT02308748|324247224|FG004|Period 5|Adverse Event|0|||
94670651|NCT02308748|324247225|FG005|Period 5|Adverse Event|0|||
94670652|NCT02308748|324247226|FG006|Period 5|Adverse Event|0|||
94670653|NCT02308748|324247227|FG007|Period 5|Adverse Event|0|||
94670654|NCT02308748|324247228|FG008|Period 5|Adverse Event|1|||
94670655|NCT02308748|324247229|FG009|Period 5|Adverse Event|0|||
94670656|NCT02834780|324247230|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
94670657|NCT02834780|324247231|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
94670658|NCT02834780|324247232|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
94670659|NCT02834780|324247233|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
94670660|NCT02834780|324247234|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
94670661|NCT02834780|324247235|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
94670662|NCT02834780|324247236|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
94670663|NCT02834780|324247237|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
94670664|NCT02834780|324247238|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
94670665|NCT02834780|324247239|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
94670666|NCT02834780|324247240|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
94670667|NCT02834780|324247241|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
94670668|NCT02834780|324247242|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
94670669|NCT02834780|324247230|FG000|Overall Study|Withdrawal by Subject|0|||
94670670|NCT02834780|324247231|FG001|Overall Study|Withdrawal by Subject|0|||
94670671|NCT02834780|324247232|FG002|Overall Study|Withdrawal by Subject|1|||
94670672|NCT02834780|324247233|FG003|Overall Study|Withdrawal by Subject|0|||
94670673|NCT02834780|324247234|FG004|Overall Study|Withdrawal by Subject|0|||
94670674|NCT02834780|324247235|FG005|Overall Study|Withdrawal by Subject|0|||
94670675|NCT02834780|324247236|FG006|Overall Study|Withdrawal by Subject|0|||
94670676|NCT02834780|324247237|FG007|Overall Study|Withdrawal by Subject|0|||
94670677|NCT02834780|324247238|FG008|Overall Study|Withdrawal by Subject|0|||
94670678|NCT02834780|324247239|FG009|Overall Study|Withdrawal by Subject|0|||
94670679|NCT02834780|324247240|FG010|Overall Study|Withdrawal by Subject|1|||
94670680|NCT02834780|324247241|FG011|Overall Study|Withdrawal by Subject|0|||
94670681|NCT02834780|324247242|FG012|Overall Study|Withdrawal by Subject|0|||
94670682|NCT02834780|324247230|FG000|Overall Study|Adverse Event|0|||
94670683|NCT02834780|324247231|FG001|Overall Study|Adverse Event|0|||
94670684|NCT02834780|324247232|FG002|Overall Study|Adverse Event|0|||
94670685|NCT02834780|324247233|FG003|Overall Study|Adverse Event|0|||
94670686|NCT02834780|324247234|FG004|Overall Study|Adverse Event|1|||
94670687|NCT02834780|324247235|FG005|Overall Study|Adverse Event|0|||
94670688|NCT02834780|324247236|FG006|Overall Study|Adverse Event|1|||
94670689|NCT02834780|324247237|FG007|Overall Study|Adverse Event|1|||
94670690|NCT02834780|324247238|FG008|Overall Study|Adverse Event|0|||
94670691|NCT02834780|324247239|FG009|Overall Study|Adverse Event|2|||
94670692|NCT02834780|324247240|FG010|Overall Study|Adverse Event|0|||
94670693|NCT02834780|324247241|FG011|Overall Study|Adverse Event|3|||
94670694|NCT02834780|324247242|FG012|Overall Study|Adverse Event|2|||
94670695|NCT02834780|324247230|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
94670696|NCT02834780|324247231|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
94670697|NCT02834780|324247232|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
94670698|NCT02834780|324247233|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
94670699|NCT02834780|324247234|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
94461205|NCT02052596|323478213|FG000|Active Phase|Lost due to Crohn's disease|0|||
94670700|NCT02834780|324247235|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
94670701|NCT02834780|324247236|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
94670702|NCT02834780|324247237|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
94624178|NCT03129100|324085444|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624179|NCT03129100|324085445|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624180|NCT03129100|324085446|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624181|NCT03129100|324085447|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624182|NCT03129100|324085448|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624183|NCT03129100|324085449|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624184|NCT03129100|324085450|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624185|NCT03129100|324085451|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624186|NCT03129100|324085452|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624187|NCT03129100|324085453|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624188|NCT03129100|324085454|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624189|NCT03129100|324085455|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624190|NCT03129100|324085456|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624191|NCT03129100|324085457|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624192|NCT03129100|324085458|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624193|NCT03129100|324085459|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624194|NCT03129100|324085460|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624195|NCT03129100|324085461|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624196|NCT03129100|324085462|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624197|NCT03129100|324085463|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
94624198|NCT03129100|324085438|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
94624199|NCT03129100|324085439|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
94624200|NCT03129100|324085440|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624201|NCT03129100|324085441|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624202|NCT03129100|324085442|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624203|NCT03129100|324085443|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624204|NCT03129100|324085444|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624205|NCT03129100|324085445|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624206|NCT03129100|324085446|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624207|NCT03129100|324085447|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624208|NCT03129100|324085448|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624209|NCT03129100|324085449|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624210|NCT03129100|324085450|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624211|NCT03129100|324085451|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624212|NCT03129100|324085452|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624213|NCT03129100|324085453|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624214|NCT03129100|324085454|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624215|NCT03129100|324085455|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624216|NCT03129100|324085456|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624217|NCT03129100|324085457|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624218|NCT03129100|324085458|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624219|NCT03129100|324085459|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624220|NCT03129100|324085460|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624221|NCT03129100|324085461|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624222|NCT03129100|324085462|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624223|NCT03129100|324085463|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
94624224|NCT03129100|324085438|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624225|NCT03129100|324085439|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
94670703|NCT02834780|324247238|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
94624226|NCT03129100|324085440|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624227|NCT03129100|324085441|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624228|NCT03129100|324085442|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624229|NCT03129100|324085443|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624230|NCT03129100|324085444|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624231|NCT03129100|324085445|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624232|NCT03129100|324085446|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624233|NCT03129100|324085447|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624234|NCT03129100|324085448|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624235|NCT03129100|324085449|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
94670704|NCT02834780|324247239|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
94670705|NCT02834780|324247240|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
94670706|NCT02834780|324247241|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
94670707|NCT02834780|324247242|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
94670708|NCT02834780|324247230|FG000|Overall Study|Other|1|||
94670709|NCT02834780|324247231|FG001|Overall Study|Other|0|||
94670710|NCT02834780|324247232|FG002|Overall Study|Other|1|||
94670711|NCT02834780|324247233|FG003|Overall Study|Other|2|||
94670712|NCT02834780|324247234|FG004|Overall Study|Other|0|||
94670713|NCT02834780|324247235|FG005|Overall Study|Other|0|||
94670714|NCT02834780|324247236|FG006|Overall Study|Other|0|||
94670715|NCT02834780|324247237|FG007|Overall Study|Other|0|||
94670716|NCT02834780|324247238|FG008|Overall Study|Other|0|||
94670717|NCT02834780|324247239|FG009|Overall Study|Other|0|||
94670718|NCT02834780|324247240|FG010|Overall Study|Other|0|||
94670719|NCT02834780|324247241|FG011|Overall Study|Other|0|||
94670720|NCT02834780|324247242|FG012|Overall Study|Other|1|||
94670721|NCT01994954|324247243|FG000|Overall Study|Death|1|||
94670722|NCT01994954|324247244|FG001|Overall Study|Death|0|||
94670723|NCT01994954|324247243|FG000|Overall Study|Withdrawal by Subject|9|||
94670724|NCT01994954|324247244|FG001|Overall Study|Withdrawal by Subject|14|||
94670725|NCT01994954|324247243|FG000|Overall Study|Physician Decision|2|||
94670726|NCT01994954|324247244|FG001|Overall Study|Physician Decision|2|||
94670727|NCT01994954|324247243|FG000|Overall Study|Lost to Follow-up|8|||
94670728|NCT01994954|324247244|FG001|Overall Study|Lost to Follow-up|10|||
94670729|NCT01994954|324247243|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
94670730|NCT01994954|324247244|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
94670731|NCT03342638|324247249|FG000|Overall Study|Withdrawal by Subject|1|||
94670732|NCT03342638|324247250|FG001|Overall Study|Withdrawal by Subject|0|||
94670733|NCT03342638|324247249|FG000|Overall Study|Physician Decision|0|||
94670734|NCT03342638|324247250|FG001|Overall Study|Physician Decision|1|||
94670735|NCT01881126|324247256|FG000|Overall Study|Non-compliance|1|||
94670736|NCT01881126|324247257|FG001|Overall Study|Non-compliance|1|||
94670737|NCT01881126|324247256|FG000|Overall Study|Adverse Event|0|||
94670738|NCT01881126|324247257|FG001|Overall Study|Adverse Event|1|||
94670739|NCT00765388|324247259|FG000|Period 1|Lack of Efficacy|1|||
94670740|NCT00765388|324247260|FG001|Period 1|Lack of Efficacy|2|||
94670741|NCT00765388|324247259|FG000|Period 1|Lost to Follow-up|0|||
94670742|NCT00765388|324247260|FG001|Period 1|Lost to Follow-up|1|||
94670743|NCT00765388|324247259|FG000|Period 1|Herpes Zoster|0|||
94670744|NCT00765388|324247260|FG001|Period 1|Herpes Zoster|1|||
94670745|NCT00765388|324247259|FG000|Period 1|Hip operation|0|||
94670746|NCT00765388|324247260|FG001|Period 1|Hip operation|1|||
94670747|NCT01988779|324247261|FG000|Overall Study|Withdrawal by Subject|2|||
94670748|NCT01988779|324247262|FG001|Overall Study|Withdrawal by Subject|2|||
94670749|NCT01988779|324247261|FG000|Overall Study|Protocol Violation|1|||
94670750|NCT01988779|324247262|FG001|Overall Study|Protocol Violation|0|||
94670751|NCT01090453|324247263|FG000|Overall Study|Withdrawal by Subject|1|||
94670752|NCT01090453|324247264|FG001|Overall Study|Withdrawal by Subject|2|||
94670753|NCT01090453|324247263|FG000|Overall Study|Lost to Follow-up|7|||
94670754|NCT01090453|324247264|FG001|Overall Study|Lost to Follow-up|7|||
94670755|NCT01090453|324247263|FG000|Overall Study|Non serious AEs|1|||
94670756|NCT01090453|324247264|FG001|Overall Study|Non serious AEs|0|||
94670757|NCT01090453|324247263|FG000|Overall Study|Protocol Violation|2|||
94670758|NCT01090453|324247264|FG001|Overall Study|Protocol Violation|0|||
94670759|NCT01090453|324247263|FG000|Overall Study|Other|2|||
94670760|NCT01090453|324247264|FG001|Overall Study|Other|4|||
94670761|NCT01090453|324247263|FG000|Overall Study|Eligibility Criteria|0|||
94670762|NCT01090453|324247264|FG001|Overall Study|Eligibility Criteria|1|||
94670763|NCT01041638|324247267|FG000|Overall Study|Adverse Event|4|||
94670764|NCT01041638|324247267|FG000|Overall Study|Death|1|||
94670765|NCT01041638|324247267|FG000|Overall Study|Lack of Efficacy|7|||
94670766|NCT01041638|324247267|FG000|Overall Study|Physician Decision|4|||
94670767|NCT01041638|324247267|FG000|Overall Study|Withdrawal by Subject|11|||
94670768|NCT00528775|324247268|FG000|Overall Study|Other not specified|1|||
94670769|NCT00587964|324247271|FG000|Overall Study|Withdrawal by Subject|1|||
94670770|NCT00587964|324247271|FG000|Overall Study|Lost to Follow-up|1|||
94670771|NCT00587964|324247271|FG000|Overall Study|Patient found to be ineligible|1|||
94670772|NCT00587964|324247271|FG000|Overall Study|Patient did not receive intervention|5|||
94670773|NCT00587964|324247271|FG000|Overall Study|Progression of Disease|4|||
94670774|NCT01207102|324247274|FG000|Overall Study|Withdrawal by Subject|5|||
94670775|NCT01207102|324247274|FG000|Overall Study|Adverse Event|2|||
94670776|NCT01207102|324247274|FG000|Overall Study|progression|2|||
94670777|NCT01207102|324247274|FG000|Overall Study|Withdrawal by Treating Physician|1|||
94670778|NCT00736645|324247277|FG000|Overall Study|Adverse Event|0|||
94670779|NCT00736645|324247278|FG001|Overall Study|Adverse Event|2|||
94670780|NCT00736645|324247279|FG002|Overall Study|Adverse Event|0|||
94670781|NCT00736645|324247280|FG003|Overall Study|Adverse Event|0|||
94670782|NCT00734630|324247281|FG000|Overall Study|Lack of Efficacy|4|||
94670783|NCT00734630|324247282|FG001|Overall Study|Lack of Efficacy|4|||
94670784|NCT00734630|324247281|FG000|Overall Study|Withdrawal by Subject|7|||
94670785|NCT00734630|324247282|FG001|Overall Study|Withdrawal by Subject|9|||
94670786|NCT00734630|324247281|FG000|Overall Study|Lost to Follow-up|13|||
94670787|NCT00734630|324247282|FG001|Overall Study|Lost to Follow-up|7|||
94670788|NCT00734630|324247281|FG000|Overall Study|Protocol Violation|0|||
94670789|NCT00734630|324247282|FG001|Overall Study|Protocol Violation|3|||
94624236|NCT03129100|324085450|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624237|NCT03129100|324085451|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624238|NCT03129100|324085452|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624239|NCT03129100|324085453|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624240|NCT03129100|324085454|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624241|NCT03129100|324085455|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624242|NCT03129100|324085456|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624243|NCT03129100|324085457|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624244|NCT03129100|324085458|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624245|NCT03129100|324085459|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624246|NCT03129100|324085460|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624247|NCT03129100|324085461|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624248|NCT03129100|324085462|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624249|NCT03129100|324085463|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
94624250|NCT03129100|324085438|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624251|NCT03129100|324085439|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624252|NCT03129100|324085440|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
94624253|NCT03129100|324085441|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
94624254|NCT03129100|324085442|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624255|NCT03129100|324085443|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
94624256|NCT03129100|324085444|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624257|NCT03129100|324085445|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624258|NCT03129100|324085446|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624259|NCT03129100|324085447|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624260|NCT03129100|324085448|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624261|NCT03129100|324085449|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624262|NCT03129100|324085450|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624263|NCT03129100|324085451|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624264|NCT03129100|324085452|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624265|NCT03129100|324085453|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624266|NCT03129100|324085454|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624267|NCT03129100|324085455|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624268|NCT03129100|324085456|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624269|NCT03129100|324085457|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624270|NCT03129100|324085458|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624271|NCT03129100|324085459|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624272|NCT03129100|324085460|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624273|NCT03129100|324085461|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624274|NCT03129100|324085462|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94670790|NCT00734630|324247281|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
94624275|NCT03129100|324085463|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
94624276|NCT03129100|324085438|FG000|Period2 Extension Period (Group A and B)|Death|0|||
94624277|NCT03129100|324085439|FG001|Period2 Extension Period (Group A and B)|Death|0|||
94624278|NCT03129100|324085440|FG002|Period2 Extension Period (Group A and B)|Death|1|||
94624279|NCT03129100|324085441|FG003|Period2 Extension Period (Group A and B)|Death|0|||
94624280|NCT03129100|324085442|FG004|Period2 Extension Period (Group A and B)|Death|0|||
94624281|NCT03129100|324085443|FG005|Period2 Extension Period (Group A and B)|Death|0|||
94624282|NCT03129100|324085444|FG006|Period2 Extension Period (Group A and B)|Death|0|||
94624283|NCT03129100|324085445|FG007|Period2 Extension Period (Group A and B)|Death|0|||
94624284|NCT03129100|324085446|FG008|Period2 Extension Period (Group A and B)|Death|0|||
94624285|NCT03129100|324085447|FG009|Period2 Extension Period (Group A and B)|Death|0|||
94624286|NCT03129100|324085448|FG010|Period2 Extension Period (Group A and B)|Death|0|||
94670791|NCT00734630|324247282|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
94670792|NCT00734630|324247281|FG000|Overall Study|Adverse Event|3|||
94670793|NCT00734630|324247282|FG001|Overall Study|Adverse Event|6|||
94670794|NCT00734630|324247281|FG000|Overall Study|Randomized in Error|0|||
94670795|NCT00734630|324247282|FG001|Overall Study|Randomized in Error|1|||
94624287|NCT03129100|324085449|FG011|Period2 Extension Period (Group A and B)|Death|0|||
94624288|NCT03129100|324085450|FG012|Period2 Extension Period (Group A and B)|Death|0|||
94670796|NCT00734630|324247281|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
94670797|NCT00734630|324247282|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
94670798|NCT00734630|324247281|FG000|Overall Study|Poor Compliance|1|||
94670799|NCT00734630|324247282|FG001|Overall Study|Poor Compliance|1|||
94670800|NCT01922076|324247283|FG000|Overall Study|Adverse Event|0|||
94670801|NCT01922076|324247284|FG001|Overall Study|Adverse Event|0|||
94670802|NCT01922076|324247285|FG002|Overall Study|Adverse Event|0|||
94670803|NCT01922076|324247286|FG003|Overall Study|Adverse Event|0|||
94670804|NCT01922076|324247287|FG004|Overall Study|Adverse Event|1|||
94670805|NCT01922076|324247288|FG005|Overall Study|Adverse Event|0|||
94670806|NCT01922076|324247289|FG006|Overall Study|Adverse Event|0|||
94670807|NCT01922076|324247283|FG000|Overall Study|Physician Decision|0|||
94670808|NCT01922076|324247284|FG001|Overall Study|Physician Decision|0|||
94670809|NCT01922076|324247285|FG002|Overall Study|Physician Decision|1|||
94670810|NCT01922076|324247286|FG003|Overall Study|Physician Decision|0|||
94670811|NCT01922076|324247287|FG004|Overall Study|Physician Decision|0|||
94670812|NCT01922076|324247288|FG005|Overall Study|Physician Decision|0|||
94670813|NCT01922076|324247289|FG006|Overall Study|Physician Decision|0|||
94670814|NCT01922076|324247283|FG000|Overall Study|Withdrawal by Subject|0|||
94670815|NCT01922076|324247284|FG001|Overall Study|Withdrawal by Subject|0|||
94624289|NCT03129100|324085451|FG013|Period2 Extension Period (Group A and B)|Death|0|||
94624290|NCT03129100|324085452|FG014|Period2 Extension Period (Group A and B)|Death|0|||
94624291|NCT03129100|324085453|FG015|Period2 Extension Period (Group A and B)|Death|0|||
94624292|NCT03129100|324085454|FG016|Period2 Extension Period (Group A and B)|Death|0|||
94624293|NCT03129100|324085455|FG017|Period2 Extension Period (Group A and B)|Death|0|||
94624294|NCT03129100|324085456|FG018|Period2 Extension Period (Group A and B)|Death|0|||
94624295|NCT03129100|324085457|FG019|Period2 Extension Period (Group A and B)|Death|0|||
94624296|NCT03129100|324085458|FG020|Period2 Extension Period (Group A and B)|Death|0|||
94624297|NCT03129100|324085459|FG021|Period2 Extension Period (Group A and B)|Death|0|||
94624298|NCT03129100|324085460|FG022|Period2 Extension Period (Group A and B)|Death|0|||
94624299|NCT03129100|324085461|FG023|Period2 Extension Period (Group A and B)|Death|0|||
94624300|NCT03129100|324085462|FG024|Period2 Extension Period (Group A and B)|Death|0|||
94624301|NCT03129100|324085463|FG025|Period2 Extension Period (Group A and B)|Death|0|||
94624302|NCT03129100|324085438|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624303|NCT03129100|324085439|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624304|NCT03129100|324085440|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
94624305|NCT03129100|324085441|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
94624306|NCT03129100|324085442|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
94624307|NCT03129100|324085443|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
94624308|NCT03129100|324085444|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
94624309|NCT03129100|324085445|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624310|NCT03129100|324085446|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624311|NCT03129100|324085447|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624312|NCT03129100|324085448|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624313|NCT03129100|324085449|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624314|NCT03129100|324085450|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624315|NCT03129100|324085451|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624316|NCT03129100|324085452|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624317|NCT03129100|324085453|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624318|NCT03129100|324085454|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624319|NCT03129100|324085455|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624320|NCT03129100|324085456|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624321|NCT03129100|324085457|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624322|NCT03129100|324085458|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624323|NCT03129100|324085459|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624324|NCT03129100|324085460|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624325|NCT03129100|324085461|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624326|NCT03129100|324085462|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624327|NCT03129100|324085463|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
94624328|NCT03129100|324085438|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624329|NCT03129100|324085439|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624330|NCT03129100|324085440|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
94624331|NCT03129100|324085441|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624332|NCT03129100|324085442|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624333|NCT03129100|324085443|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624334|NCT03129100|324085444|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94670816|NCT01922076|324247285|FG002|Overall Study|Withdrawal by Subject|0|||
94624335|NCT03129100|324085445|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624336|NCT03129100|324085446|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94670817|NCT01922076|324247286|FG003|Overall Study|Withdrawal by Subject|1|||
94670818|NCT01922076|324247287|FG004|Overall Study|Withdrawal by Subject|0|||
94624337|NCT03129100|324085447|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624338|NCT03129100|324085448|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624339|NCT03129100|324085449|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624340|NCT03129100|324085450|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624341|NCT03129100|324085451|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624342|NCT03129100|324085452|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624343|NCT03129100|324085453|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624344|NCT03129100|324085454|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624345|NCT03129100|324085455|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624346|NCT03129100|324085456|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624347|NCT03129100|324085457|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624348|NCT03129100|324085458|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624349|NCT03129100|324085459|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624350|NCT03129100|324085460|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624351|NCT03129100|324085461|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624352|NCT03129100|324085462|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624353|NCT03129100|324085463|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
94624354|NCT03129100|324085438|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624355|NCT03129100|324085439|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624356|NCT03129100|324085440|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
94624357|NCT03129100|324085441|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624358|NCT03129100|324085442|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624359|NCT03129100|324085443|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624360|NCT03129100|324085444|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624361|NCT03129100|324085445|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624362|NCT03129100|324085446|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624363|NCT03129100|324085447|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624364|NCT03129100|324085448|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624365|NCT03129100|324085449|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624366|NCT03129100|324085450|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624367|NCT03129100|324085451|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624368|NCT03129100|324085452|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624369|NCT03129100|324085453|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624370|NCT03129100|324085454|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624371|NCT03129100|324085455|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624372|NCT03129100|324085456|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624373|NCT03129100|324085457|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624374|NCT03129100|324085458|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624375|NCT03129100|324085459|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624376|NCT03129100|324085460|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624377|NCT03129100|324085461|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624378|NCT03129100|324085462|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624379|NCT03129100|324085463|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
94624380|NCT03129100|324085438|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94670819|NCT01922076|324247288|FG005|Overall Study|Withdrawal by Subject|1|||
94670820|NCT01922076|324247289|FG006|Overall Study|Withdrawal by Subject|1|||
94670821|NCT03240692|324247292|FG000|Overall Study|Physician Decision|1|||
94670822|NCT03240692|324247292|FG000|Overall Study|Withdrawal by Subject|1|||
94670823|NCT00683644|324247293|FG000|Overall Study|Withdrawal by Subject|4|||
94670824|NCT00683644|324247294|FG001|Overall Study|Withdrawal by Subject|2|||
94670825|NCT00683644|324247293|FG000|Overall Study|Lost to Follow-up|1|||
94670826|NCT00683644|324247294|FG001|Overall Study|Lost to Follow-up|4|||
94670827|NCT00683644|324247293|FG000|Overall Study|Adverse Event|1|||
94670828|NCT00683644|324247294|FG001|Overall Study|Adverse Event|2|||
94670829|NCT00683644|324247293|FG000|Overall Study|Low copper, other health problems,|7|||
94670830|NCT00683644|324247294|FG001|Overall Study|Low copper, other health problems,|6|||
94670831|NCT02300220|324247295|FG000|Overall Study|Lost to Follow-up|1|||
94670832|NCT02300220|324247296|FG001|Overall Study|Lost to Follow-up|2|||
94670833|NCT02300220|324247295|FG000|Overall Study|Death|1|||
94670834|NCT02300220|324247296|FG001|Overall Study|Death|1|||
94670835|NCT02300220|324247295|FG000|Overall Study|Adverse Event|1|||
94670836|NCT02300220|324247296|FG001|Overall Study|Adverse Event|1|||
94670837|NCT02300220|324247295|FG000|Overall Study|Protocol Violation|1|||
94670838|NCT02300220|324247296|FG001|Overall Study|Protocol Violation|0|||
94670839|NCT02300220|324247295|FG000|Overall Study|Withdrawal by Subject|0|||
94670840|NCT02300220|324247296|FG001|Overall Study|Withdrawal by Subject|2|||
94670841|NCT02300220|324247295|FG000|Overall Study|Did not tolerate IMP|0|||
94670842|NCT02300220|324247296|FG001|Overall Study|Did not tolerate IMP|1|||
94670843|NCT03085485|324247298|FG000|Overall Study|Death|1|||
94670844|NCT03085485|324247299|FG001|Overall Study|Death|0|||
94670845|NCT03085485|324247298|FG000|Overall Study|Lost to Follow-up|1|||
94670846|NCT03085485|324247299|FG001|Overall Study|Lost to Follow-up|0|||
94670847|NCT01022762|324247300|FG000|Overall Study|Adverse Event|3|||
94670848|NCT01022762|324247301|FG001|Overall Study|Adverse Event|1|||
94670849|NCT01022762|324247300|FG000|Overall Study|Lack of Efficacy|0|||
94670850|NCT01022762|324247301|FG001|Overall Study|Lack of Efficacy|1|||
94670851|NCT01022762|324247300|FG000|Overall Study|Protocol Violation|7|||
94670852|NCT01022762|324247301|FG001|Overall Study|Protocol Violation|6|||
94670853|NCT01022762|324247300|FG000|Overall Study|Unclassified|12|||
94670854|NCT01022762|324247301|FG001|Overall Study|Unclassified|20|||
94670855|NCT00518115|324247305|FG000|Overall Study|Adverse Event|6|||
94670856|NCT00518115|324247306|FG001|Overall Study|Adverse Event|1|||
94670857|NCT00518115|324247307|FG002|Overall Study|Adverse Event|5|||
94670858|NCT00518115|324247308|FG003|Overall Study|Adverse Event|6|||
94670859|NCT00518115|324247309|FG004|Overall Study|Adverse Event|5|||
94670860|NCT00518115|324247310|FG005|Overall Study|Adverse Event|5|||
94670861|NCT00518115|324247311|FG006|Overall Study|Adverse Event|5|||
94670862|NCT00518115|324247312|FG007|Overall Study|Adverse Event|10|||
94670863|NCT00518115|324247313|FG008|Overall Study|Adverse Event|2|||
94670864|NCT00518115|324247314|FG009|Overall Study|Adverse Event|9|||
94670865|NCT00518115|324247305|FG000|Overall Study|Lost to Follow-up|0|||
94670866|NCT00518115|324247306|FG001|Overall Study|Lost to Follow-up|0|||
94670867|NCT00518115|324247307|FG002|Overall Study|Lost to Follow-up|2|||
94670868|NCT00518115|324247308|FG003|Overall Study|Lost to Follow-up|3|||
94670869|NCT00518115|324247309|FG004|Overall Study|Lost to Follow-up|1|||
94670870|NCT00518115|324247310|FG005|Overall Study|Lost to Follow-up|3|||
94670871|NCT00518115|324247311|FG006|Overall Study|Lost to Follow-up|0|||
94670872|NCT00518115|324247312|FG007|Overall Study|Lost to Follow-up|1|||
94670873|NCT00518115|324247313|FG008|Overall Study|Lost to Follow-up|1|||
94670874|NCT00518115|324247314|FG009|Overall Study|Lost to Follow-up|1|||
94670875|NCT00518115|324247305|FG000|Overall Study|Protocol Violation|1|||
94670876|NCT00518115|324247306|FG001|Overall Study|Protocol Violation|3|||
94670877|NCT00518115|324247307|FG002|Overall Study|Protocol Violation|1|||
94670878|NCT00518115|324247308|FG003|Overall Study|Protocol Violation|0|||
94670879|NCT00518115|324247309|FG004|Overall Study|Protocol Violation|0|||
94670880|NCT00518115|324247310|FG005|Overall Study|Protocol Violation|0|||
94670881|NCT00518115|324247311|FG006|Overall Study|Protocol Violation|0|||
94670882|NCT00518115|324247312|FG007|Overall Study|Protocol Violation|0|||
94670883|NCT00518115|324247313|FG008|Overall Study|Protocol Violation|0|||
94670884|NCT00518115|324247314|FG009|Overall Study|Protocol Violation|0|||
94670885|NCT00518115|324247305|FG000|Overall Study|Withdrawal by Subject|1|||
94670886|NCT00518115|324247306|FG001|Overall Study|Withdrawal by Subject|1|||
94670887|NCT00518115|324247307|FG002|Overall Study|Withdrawal by Subject|5|||
94670888|NCT00518115|324247308|FG003|Overall Study|Withdrawal by Subject|0|||
94670889|NCT00518115|324247309|FG004|Overall Study|Withdrawal by Subject|2|||
94670890|NCT00518115|324247310|FG005|Overall Study|Withdrawal by Subject|1|||
94670891|NCT00518115|324247311|FG006|Overall Study|Withdrawal by Subject|0|||
94670892|NCT00518115|324247312|FG007|Overall Study|Withdrawal by Subject|2|||
94670893|NCT00518115|324247313|FG008|Overall Study|Withdrawal by Subject|1|||
94670894|NCT00518115|324247314|FG009|Overall Study|Withdrawal by Subject|3|||
94670895|NCT00518115|324247305|FG000|Overall Study|Lack of Efficacy|1|||
94670896|NCT00518115|324247306|FG001|Overall Study|Lack of Efficacy|0|||
94670897|NCT00518115|324247307|FG002|Overall Study|Lack of Efficacy|1|||
94670898|NCT00518115|324247308|FG003|Overall Study|Lack of Efficacy|1|||
94670899|NCT00518115|324247309|FG004|Overall Study|Lack of Efficacy|0|||
94670900|NCT00518115|324247310|FG005|Overall Study|Lack of Efficacy|0|||
94670901|NCT00518115|324247311|FG006|Overall Study|Lack of Efficacy|0|||
94670902|NCT00518115|324247312|FG007|Overall Study|Lack of Efficacy|1|||
94670903|NCT00518115|324247313|FG008|Overall Study|Lack of Efficacy|0|||
94670904|NCT00518115|324247314|FG009|Overall Study|Lack of Efficacy|0|||
94670905|NCT00518115|324247305|FG000|Overall Study|Non-Compliance|1|||
94670906|NCT00518115|324247306|FG001|Overall Study|Non-Compliance|0|||
94670907|NCT00518115|324247307|FG002|Overall Study|Non-Compliance|1|||
94670908|NCT00518115|324247308|FG003|Overall Study|Non-Compliance|0|||
94670909|NCT00518115|324247309|FG004|Overall Study|Non-Compliance|1|||
94670910|NCT00518115|324247310|FG005|Overall Study|Non-Compliance|1|||
94670911|NCT00518115|324247311|FG006|Overall Study|Non-Compliance|1|||
94670912|NCT00518115|324247312|FG007|Overall Study|Non-Compliance|1|||
94670913|NCT00518115|324247313|FG008|Overall Study|Non-Compliance|0|||
94670914|NCT00518115|324247314|FG009|Overall Study|Non-Compliance|1|||
94670915|NCT00518115|324247305|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
94670916|NCT00518115|324247306|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
94670917|NCT00518115|324247307|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
94670918|NCT00518115|324247308|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
94670919|NCT00518115|324247309|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
94670920|NCT00518115|324247310|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
94670921|NCT00518115|324247311|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
94670922|NCT00518115|324247312|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
94670923|NCT00518115|324247313|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
94670924|NCT00518115|324247314|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
94670925|NCT00518115|324247305|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
94670926|NCT00518115|324247306|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
94670927|NCT00518115|324247307|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
94670928|NCT00518115|324247308|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
94670929|NCT00518115|324247309|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
94670930|NCT00518115|324247310|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
94670931|NCT00518115|324247311|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
94670932|NCT00518115|324247312|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
94670933|NCT00518115|324247313|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
94670934|NCT00518115|324247314|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
94670935|NCT00518115|324247305|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
94670936|NCT00518115|324247306|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
94670937|NCT00518115|324247307|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
94670938|NCT00518115|324247308|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
94670939|NCT00518115|324247309|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
94670940|NCT00518115|324247310|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
94670941|NCT00518115|324247311|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
94670942|NCT00518115|324247312|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
94670943|NCT00518115|324247313|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
94670944|NCT00518115|324247314|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
94670945|NCT00518115|324247305|FG000|Overall Study|Wrong Monotherapy Administered|0|||
94670946|NCT00518115|324247306|FG001|Overall Study|Wrong Monotherapy Administered|0|||
94670947|NCT00518115|324247307|FG002|Overall Study|Wrong Monotherapy Administered|1|||
94670948|NCT00518115|324247308|FG003|Overall Study|Wrong Monotherapy Administered|0|||
94670949|NCT00518115|324247309|FG004|Overall Study|Wrong Monotherapy Administered|0|||
94670950|NCT00518115|324247310|FG005|Overall Study|Wrong Monotherapy Administered|0|||
94670951|NCT00518115|324247311|FG006|Overall Study|Wrong Monotherapy Administered|1|||
94670952|NCT00518115|324247312|FG007|Overall Study|Wrong Monotherapy Administered|0|||
94670953|NCT00518115|324247313|FG008|Overall Study|Wrong Monotherapy Administered|0|||
94670954|NCT00518115|324247314|FG009|Overall Study|Wrong Monotherapy Administered|0|||
94670955|NCT00518115|324247305|FG000|Overall Study|Violation of Exclusion Criteria|0|||
94670956|NCT00518115|324247306|FG001|Overall Study|Violation of Exclusion Criteria|0|||
94670957|NCT00518115|324247307|FG002|Overall Study|Violation of Exclusion Criteria|0|||
94670958|NCT00518115|324247308|FG003|Overall Study|Violation of Exclusion Criteria|1|||
94670959|NCT00518115|324247309|FG004|Overall Study|Violation of Exclusion Criteria|0|||
94670960|NCT00518115|324247310|FG005|Overall Study|Violation of Exclusion Criteria|0|||
94670961|NCT00518115|324247311|FG006|Overall Study|Violation of Exclusion Criteria|1|||
94670962|NCT00518115|324247312|FG007|Overall Study|Violation of Exclusion Criteria|0|||
94670963|NCT00518115|324247313|FG008|Overall Study|Violation of Exclusion Criteria|0|||
94670964|NCT00518115|324247314|FG009|Overall Study|Violation of Exclusion Criteria|0|||
94670965|NCT00518115|324247305|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
94670966|NCT00518115|324247306|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
94670967|NCT00518115|324247307|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
94670968|NCT00518115|324247308|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
94670969|NCT00518115|324247309|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
94670970|NCT00518115|324247310|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
94670971|NCT00518115|324247311|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
94670972|NCT00518115|324247312|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
94670973|NCT00518115|324247313|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
94670974|NCT00518115|324247314|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
94670975|NCT00518115|324247305|FG000|Overall Study|Withdrew Consent|0|||
94670976|NCT00518115|324247306|FG001|Overall Study|Withdrew Consent|0|||
94670977|NCT00518115|324247307|FG002|Overall Study|Withdrew Consent|0|||
94670978|NCT00518115|324247308|FG003|Overall Study|Withdrew Consent|0|||
94670979|NCT00518115|324247309|FG004|Overall Study|Withdrew Consent|0|||
94670980|NCT00518115|324247310|FG005|Overall Study|Withdrew Consent|1|||
94670981|NCT00518115|324247311|FG006|Overall Study|Withdrew Consent|0|||
94670982|NCT00518115|324247312|FG007|Overall Study|Withdrew Consent|0|||
94670983|NCT00518115|324247313|FG008|Overall Study|Withdrew Consent|0|||
94670984|NCT00518115|324247314|FG009|Overall Study|Withdrew Consent|0|||
94670985|NCT00518115|324247305|FG000|Overall Study|Moved Out of State|0|||
94670986|NCT00518115|324247306|FG001|Overall Study|Moved Out of State|0|||
94670987|NCT00518115|324247307|FG002|Overall Study|Moved Out of State|0|||
94670988|NCT00518115|324247308|FG003|Overall Study|Moved Out of State|0|||
94670989|NCT00518115|324247309|FG004|Overall Study|Moved Out of State|0|||
94670990|NCT00518115|324247310|FG005|Overall Study|Moved Out of State|0|||
94670991|NCT00518115|324247311|FG006|Overall Study|Moved Out of State|0|||
94670992|NCT00518115|324247312|FG007|Overall Study|Moved Out of State|0|||
94670993|NCT00518115|324247313|FG008|Overall Study|Moved Out of State|0|||
94670994|NCT00518115|324247314|FG009|Overall Study|Moved Out of State|1|||
94670995|NCT04891419|324247315|FG000|Overall Study|Withdrawal by Subject|4|||
94670996|NCT04891419|324247316|FG001|Overall Study|Withdrawal by Subject|0|||
94670997|NCT04891419|324247315|FG000|Overall Study|Lost to Follow-up|1|||
94670998|NCT04891419|324247316|FG001|Overall Study|Lost to Follow-up|3|||
94670999|NCT02820623|324247318|FG000|Overall Study|Withdrawal by Subject|1|||
94671000|NCT02820623|324247319|FG001|Overall Study|Withdrawal by Subject|3|||
94671001|NCT02820623|324247320|FG002|Overall Study|Withdrawal by Subject|3|||
94671002|NCT02820623|324247318|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
94671003|NCT02820623|324247319|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
94671004|NCT02820623|324247320|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
94671005|NCT02820623|324247318|FG000|Overall Study|Therapist unable to enroll clients|1|||
94461206|NCT02052596|323478214|FG001|Active Phase|Lost due to Crohn's disease|1|||
94624381|NCT03129100|324085439|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624382|NCT03129100|324085440|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
94624383|NCT03129100|324085441|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624384|NCT03129100|324085442|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624385|NCT03129100|324085443|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624386|NCT03129100|324085444|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624387|NCT03129100|324085445|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624388|NCT03129100|324085446|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624389|NCT03129100|324085447|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624390|NCT03129100|324085448|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624391|NCT03129100|324085449|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624392|NCT03129100|324085450|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624393|NCT03129100|324085451|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624394|NCT03129100|324085452|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624395|NCT03129100|324085453|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624396|NCT03129100|324085454|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624397|NCT03129100|324085455|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624398|NCT03129100|324085456|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624399|NCT03129100|324085457|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624400|NCT03129100|324085458|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624401|NCT03129100|324085459|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94671006|NCT02820623|324247319|FG001|Overall Study|Therapist unable to enroll clients|1|||
94671007|NCT02820623|324247320|FG002|Overall Study|Therapist unable to enroll clients|3|||
94671008|NCT02820623|324247318|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
94671009|NCT02820623|324247319|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
94461207|NCT02052596|323478213|FG000|Safety Phase|Adverse Event|6|||
94624402|NCT03129100|324085460|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94671010|NCT02820623|324247320|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
94671011|NCT01302847|324247321|FG000|Overall Study|Death|0|||
94671012|NCT01302847|324247322|FG001|Overall Study|Death|1|||
94671013|NCT01302847|324247323|FG002|Overall Study|Death|0|||
94671014|NCT01302847|324247324|FG003|Overall Study|Death|0|||
94671015|NCT01302847|324247325|FG004|Overall Study|Death|0|||
94671016|NCT01302847|324247326|FG005|Overall Study|Death|1|||
94671017|NCT01302847|324247327|FG006|Overall Study|Death|1|||
94671018|NCT01302847|324247328|FG007|Overall Study|Death|0|||
94671019|NCT01302847|324247321|FG000|Overall Study|Pregnancy|2|||
94671020|NCT01302847|324247322|FG001|Overall Study|Pregnancy|0|||
94671021|NCT01302847|324247323|FG002|Overall Study|Pregnancy|0|||
94671022|NCT01302847|324247324|FG003|Overall Study|Pregnancy|0|||
94671023|NCT01302847|324247325|FG004|Overall Study|Pregnancy|0|||
94671024|NCT01302847|324247326|FG005|Overall Study|Pregnancy|0|||
94671025|NCT01302847|324247327|FG006|Overall Study|Pregnancy|0|||
94671026|NCT01302847|324247328|FG007|Overall Study|Pregnancy|0|||
94671027|NCT01302847|324247321|FG000|Overall Study|Virologic failure|0|||
94671028|NCT01302847|324247322|FG001|Overall Study|Virologic failure|2|||
94624403|NCT03129100|324085461|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624404|NCT03129100|324085462|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624405|NCT03129100|324085463|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
94624406|NCT03129100|324085438|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624407|NCT03129100|324085439|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624408|NCT03129100|324085440|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624409|NCT03129100|324085441|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624410|NCT03129100|324085442|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
94624411|NCT03129100|324085443|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
94624412|NCT03129100|324085444|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
94624413|NCT03129100|324085445|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624414|NCT03129100|324085446|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624415|NCT03129100|324085447|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624416|NCT03129100|324085448|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624417|NCT03129100|324085449|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624418|NCT03129100|324085450|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624419|NCT03129100|324085451|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624420|NCT03129100|324085452|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624421|NCT03129100|324085453|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624422|NCT03129100|324085454|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624423|NCT03129100|324085455|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624424|NCT03129100|324085456|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624425|NCT03129100|324085457|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624426|NCT03129100|324085458|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624427|NCT03129100|324085459|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624428|NCT03129100|324085460|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624429|NCT03129100|324085461|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624430|NCT03129100|324085462|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624431|NCT03129100|324085463|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
94624432|NCT03129100|324085438|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624433|NCT03129100|324085439|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624434|NCT03129100|324085440|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624435|NCT03129100|324085441|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624436|NCT03129100|324085442|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624437|NCT03129100|324085443|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624438|NCT03129100|324085444|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624439|NCT03129100|324085445|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624440|NCT03129100|324085446|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624441|NCT03129100|324085447|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
94624442|NCT03129100|324085448|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624443|NCT03129100|324085449|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94671029|NCT01302847|324247323|FG002|Overall Study|Virologic failure|0|||
94671030|NCT01302847|324247324|FG003|Overall Study|Virologic failure|2|||
94671031|NCT01302847|324247325|FG004|Overall Study|Virologic failure|1|||
94671032|NCT01302847|324247326|FG005|Overall Study|Virologic failure|3|||
94671033|NCT01302847|324247327|FG006|Overall Study|Virologic failure|1|||
94671034|NCT01302847|324247328|FG007|Overall Study|Virologic failure|2|||
94624444|NCT03129100|324085450|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624445|NCT03129100|324085451|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624446|NCT03129100|324085452|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624447|NCT03129100|324085453|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624448|NCT03129100|324085454|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624449|NCT03129100|324085455|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624450|NCT03129100|324085456|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624451|NCT03129100|324085457|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624452|NCT03129100|324085458|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624453|NCT03129100|324085459|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624454|NCT03129100|324085460|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624455|NCT03129100|324085461|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624456|NCT03129100|324085462|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624457|NCT03129100|324085463|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
94624458|NCT03129100|324085438|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624459|NCT03129100|324085439|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624460|NCT03129100|324085440|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624461|NCT03129100|324085441|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624462|NCT03129100|324085442|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624463|NCT03129100|324085443|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624464|NCT03129100|324085444|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624465|NCT03129100|324085445|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624466|NCT03129100|324085446|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624467|NCT03129100|324085447|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624468|NCT03129100|324085448|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624469|NCT03129100|324085449|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
94624470|NCT03129100|324085450|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624471|NCT03129100|324085451|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624472|NCT03129100|324085452|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624473|NCT03129100|324085453|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624474|NCT03129100|324085454|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624475|NCT03129100|324085455|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624476|NCT03129100|324085456|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624477|NCT03129100|324085457|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624478|NCT03129100|324085458|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624479|NCT03129100|324085459|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624480|NCT03129100|324085460|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624481|NCT03129100|324085461|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624482|NCT03129100|324085462|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624483|NCT03129100|324085463|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
94624484|NCT03129100|324085438|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624485|NCT03129100|324085439|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624486|NCT03129100|324085440|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624487|NCT03129100|324085441|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624488|NCT03129100|324085442|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624489|NCT03129100|324085443|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624490|NCT03129100|324085444|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624491|NCT03129100|324085445|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624492|NCT03129100|324085446|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624493|NCT03129100|324085447|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624494|NCT03129100|324085448|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624495|NCT03129100|324085449|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
94624496|NCT03129100|324085450|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
94624497|NCT03129100|324085451|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
94624498|NCT03129100|324085452|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
94624499|NCT03129100|324085453|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624500|NCT03129100|324085454|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624501|NCT03129100|324085455|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624502|NCT03129100|324085456|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624503|NCT03129100|324085457|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624504|NCT03129100|324085458|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624505|NCT03129100|324085459|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624506|NCT03129100|324085460|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94671035|NCT01302847|324247321|FG000|Overall Study|Severe debilitation, unable to continue|0|||
94671036|NCT01302847|324247322|FG001|Overall Study|Severe debilitation, unable to continue|0|||
94671037|NCT01302847|324247323|FG002|Overall Study|Severe debilitation, unable to continue|0|||
94671038|NCT01302847|324247324|FG003|Overall Study|Severe debilitation, unable to continue|0|||
94671039|NCT01302847|324247325|FG004|Overall Study|Severe debilitation, unable to continue|0|||
94671040|NCT01302847|324247326|FG005|Overall Study|Severe debilitation, unable to continue|1|||
94671041|NCT01302847|324247327|FG006|Overall Study|Severe debilitation, unable to continue|1|||
94671042|NCT01302847|324247328|FG007|Overall Study|Severe debilitation, unable to continue|0|||
94624507|NCT03129100|324085461|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624508|NCT03129100|324085462|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624509|NCT03129100|324085463|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
94624510|NCT03129100|324085438|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624511|NCT03129100|324085439|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624512|NCT03129100|324085440|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624513|NCT03129100|324085441|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624514|NCT03129100|324085442|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624515|NCT03129100|324085443|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624516|NCT03129100|324085444|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624517|NCT03129100|324085445|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624518|NCT03129100|324085446|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624519|NCT03129100|324085447|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624520|NCT03129100|324085448|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624521|NCT03129100|324085449|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
94624522|NCT03129100|324085450|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624523|NCT03129100|324085451|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
94624524|NCT03129100|324085452|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
94624525|NCT03129100|324085453|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624526|NCT03129100|324085454|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624527|NCT03129100|324085455|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624528|NCT03129100|324085456|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624529|NCT03129100|324085457|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624530|NCT03129100|324085458|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624531|NCT03129100|324085459|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624532|NCT03129100|324085460|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624533|NCT03129100|324085461|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624534|NCT03129100|324085462|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624535|NCT03129100|324085463|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
94624536|NCT03129100|324085438|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624537|NCT03129100|324085439|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624538|NCT03129100|324085440|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624539|NCT03129100|324085441|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624540|NCT03129100|324085442|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624541|NCT03129100|324085443|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624542|NCT03129100|324085444|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624543|NCT03129100|324085445|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624544|NCT03129100|324085446|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624545|NCT03129100|324085447|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624546|NCT03129100|324085448|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624547|NCT03129100|324085449|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624548|NCT03129100|324085450|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624549|NCT03129100|324085451|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624550|NCT03129100|324085452|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624551|NCT03129100|324085453|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
94624552|NCT03129100|324085454|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624553|NCT03129100|324085455|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624554|NCT03129100|324085456|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624555|NCT03129100|324085457|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624556|NCT03129100|324085458|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624557|NCT03129100|324085459|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624558|NCT03129100|324085460|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624559|NCT03129100|324085461|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94671043|NCT01302847|324247321|FG000|Overall Study|Not able to get to clinic|1|||
94671044|NCT01302847|324247322|FG001|Overall Study|Not able to get to clinic|1|||
94671045|NCT01302847|324247323|FG002|Overall Study|Not able to get to clinic|0|||
94624560|NCT03129100|324085462|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624561|NCT03129100|324085463|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
94624562|NCT03129100|324085438|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624563|NCT03129100|324085439|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624564|NCT03129100|324085440|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624565|NCT03129100|324085441|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624566|NCT03129100|324085442|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624567|NCT03129100|324085443|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624568|NCT03129100|324085444|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624569|NCT03129100|324085445|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624570|NCT03129100|324085446|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624571|NCT03129100|324085447|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624572|NCT03129100|324085448|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624573|NCT03129100|324085449|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624574|NCT03129100|324085450|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
94624575|NCT03129100|324085451|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624576|NCT03129100|324085452|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
94624577|NCT03129100|324085453|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
94624578|NCT03129100|324085454|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624579|NCT03129100|324085455|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624580|NCT03129100|324085456|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624581|NCT03129100|324085457|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624582|NCT03129100|324085458|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624583|NCT03129100|324085459|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624584|NCT03129100|324085460|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624585|NCT03129100|324085461|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624586|NCT03129100|324085462|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624587|NCT03129100|324085463|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
94624588|NCT03129100|324085438|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624589|NCT03129100|324085439|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624590|NCT03129100|324085440|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624591|NCT03129100|324085441|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624592|NCT03129100|324085442|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624593|NCT03129100|324085443|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624594|NCT03129100|324085444|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624595|NCT03129100|324085445|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624596|NCT03129100|324085446|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624597|NCT03129100|324085447|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624598|NCT03129100|324085448|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624599|NCT03129100|324085449|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624600|NCT03129100|324085450|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624601|NCT03129100|324085451|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624602|NCT03129100|324085452|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624603|NCT03129100|324085453|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624604|NCT03129100|324085454|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624605|NCT03129100|324085455|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
94624606|NCT03129100|324085456|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624607|NCT03129100|324085457|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
94624608|NCT03129100|324085458|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624609|NCT03129100|324085459|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624610|NCT03129100|324085460|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624611|NCT03129100|324085461|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624612|NCT03129100|324085462|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624613|NCT03129100|324085463|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
94624614|NCT03129100|324085438|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624615|NCT03129100|324085439|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624616|NCT03129100|324085440|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624617|NCT03129100|324085441|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624618|NCT03129100|324085442|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624619|NCT03129100|324085443|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624620|NCT03129100|324085444|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624621|NCT03129100|324085445|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624622|NCT03129100|324085446|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624623|NCT03129100|324085447|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624624|NCT03129100|324085448|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624625|NCT03129100|324085449|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624626|NCT03129100|324085450|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624627|NCT03129100|324085451|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94671046|NCT01302847|324247324|FG003|Overall Study|Not able to get to clinic|0|||
94671047|NCT01302847|324247325|FG004|Overall Study|Not able to get to clinic|0|||
94671048|NCT01302847|324247326|FG005|Overall Study|Not able to get to clinic|0|||
94671049|NCT01302847|324247327|FG006|Overall Study|Not able to get to clinic|0|||
94671050|NCT01302847|324247328|FG007|Overall Study|Not able to get to clinic|0|||
94671051|NCT01302847|324247321|FG000|Overall Study|Site closing|2|||
94671052|NCT01302847|324247322|FG001|Overall Study|Site closing|2|||
94671053|NCT01302847|324247323|FG002|Overall Study|Site closing|0|||
94671054|NCT01302847|324247324|FG003|Overall Study|Site closing|0|||
94671055|NCT01302847|324247325|FG004|Overall Study|Site closing|0|||
94671056|NCT01302847|324247326|FG005|Overall Study|Site closing|0|||
94671057|NCT01302847|324247327|FG006|Overall Study|Site closing|0|||
94671058|NCT01302847|324247328|FG007|Overall Study|Site closing|0|||
94671059|NCT01302847|324247321|FG000|Overall Study|Withdrawal by Subject|1|||
94671060|NCT01302847|324247322|FG001|Overall Study|Withdrawal by Subject|0|||
94671061|NCT01302847|324247323|FG002|Overall Study|Withdrawal by Subject|0|||
94671062|NCT01302847|324247324|FG003|Overall Study|Withdrawal by Subject|0|||
94671063|NCT01302847|324247325|FG004|Overall Study|Withdrawal by Subject|1|||
94671064|NCT01302847|324247326|FG005|Overall Study|Withdrawal by Subject|0|||
94671065|NCT01302847|324247327|FG006|Overall Study|Withdrawal by Subject|0|||
94671066|NCT01302847|324247328|FG007|Overall Study|Withdrawal by Subject|1|||
94671067|NCT01302847|324247321|FG000|Overall Study|Not willing to adhere to requirements|5|||
94671068|NCT01302847|324247322|FG001|Overall Study|Not willing to adhere to requirements|0|||
94671069|NCT01302847|324247323|FG002|Overall Study|Not willing to adhere to requirements|1|||
94671070|NCT01302847|324247324|FG003|Overall Study|Not willing to adhere to requirements|0|||
94671071|NCT01302847|324247325|FG004|Overall Study|Not willing to adhere to requirements|0|||
94671072|NCT01302847|324247326|FG005|Overall Study|Not willing to adhere to requirements|0|||
94671073|NCT01302847|324247327|FG006|Overall Study|Not willing to adhere to requirements|0|||
94671074|NCT01302847|324247328|FG007|Overall Study|Not willing to adhere to requirements|2|||
94671075|NCT01302847|324247321|FG000|Overall Study|Site unable to contact participant|2|||
94671076|NCT01302847|324247322|FG001|Overall Study|Site unable to contact participant|1|||
94671077|NCT01302847|324247323|FG002|Overall Study|Site unable to contact participant|0|||
94671078|NCT01302847|324247324|FG003|Overall Study|Site unable to contact participant|0|||
94671079|NCT01302847|324247325|FG004|Overall Study|Site unable to contact participant|0|||
94671080|NCT01302847|324247326|FG005|Overall Study|Site unable to contact participant|0|||
94671081|NCT01302847|324247327|FG006|Overall Study|Site unable to contact participant|2|||
94671082|NCT01302847|324247328|FG007|Overall Study|Site unable to contact participant|0|||
94671083|NCT04302350|324247329|FG000|Overall Study|Physician Decision|1|||
94671084|NCT04302350|324247330|FG001|Overall Study|Physician Decision|1|||
94671085|NCT04302350|324247331|FG002|Overall Study|Physician Decision|2|||
94671086|NCT04302350|324247329|FG000|Overall Study|Lack of Efficacy|1|||
94671087|NCT04302350|324247330|FG001|Overall Study|Lack of Efficacy|1|||
94671088|NCT04302350|324247331|FG002|Overall Study|Lack of Efficacy|4|||
94671089|NCT04302350|324247329|FG000|Overall Study|Adverse Event|0|||
94671090|NCT04302350|324247330|FG001|Overall Study|Adverse Event|1|||
94671091|NCT04302350|324247331|FG002|Overall Study|Adverse Event|2|||
94671092|NCT00808808|324247332|FG000|Overall Study|Vaccinated; survey not completed|131|||
94671093|NCT00808808|324247333|FG001|Overall Study|Vaccinated; survey not completed|169|||
94671094|NCT00808808|324247334|FG002|Overall Study|Vaccinated; survey not completed|302|||
94671095|NCT00808808|324247332|FG000|Overall Study|Employee was not vaccinated.|2686|||
94671096|NCT00808808|324247333|FG001|Overall Study|Employee was not vaccinated.|2268|||
94671097|NCT00808808|324247334|FG002|Overall Study|Employee was not vaccinated.|2255|||
94671098|NCT03969719|324247335|FG000|Overall Study|Other reasons not specified|1|||
94671099|NCT03969719|324247336|FG001|Overall Study|Other reasons not specified|1|||
94671100|NCT03969719|324247337|FG002|Overall Study|Other reasons not specified|3|||
94671101|NCT03969719|324247335|FG000|Overall Study|Withdrawal by Subject|2|||
94671102|NCT03969719|324247336|FG001|Overall Study|Withdrawal by Subject|3|||
94671103|NCT03969719|324247337|FG002|Overall Study|Withdrawal by Subject|2|||
94671104|NCT03969719|324247335|FG000|Overall Study|Protocol Violation|1|||
94671105|NCT03969719|324247336|FG001|Overall Study|Protocol Violation|2|||
94671106|NCT03969719|324247337|FG002|Overall Study|Protocol Violation|0|||
94671107|NCT03969719|324247335|FG000|Overall Study|Adverse Event|0|||
94671108|NCT03969719|324247336|FG001|Overall Study|Adverse Event|2|||
94671109|NCT03969719|324247337|FG002|Overall Study|Adverse Event|0|||
94671110|NCT03969719|324247335|FG000|Overall Study|Lost to Follow-up|0|||
94671111|NCT03969719|324247336|FG001|Overall Study|Lost to Follow-up|1|||
94671112|NCT03969719|324247337|FG002|Overall Study|Lost to Follow-up|0|||
94671113|NCT01297959|324247338|FG000|Overall Study|Adverse Event|0|||
94671114|NCT01297959|324247339|FG001|Overall Study|Adverse Event|1|||
94671115|NCT01297959|324247338|FG000|Overall Study|Protocol Violation|2|||
94671116|NCT01297959|324247339|FG001|Overall Study|Protocol Violation|1|||
94671117|NCT01297959|324247338|FG000|Overall Study|Withdrawal by Subject|5|||
94671118|NCT01297959|324247339|FG001|Overall Study|Withdrawal by Subject|4|||
94671119|NCT01297959|324247338|FG000|Overall Study|Physician Decision|0|||
94671120|NCT01297959|324247339|FG001|Overall Study|Physician Decision|1|||
94671121|NCT01297959|324247338|FG000|Overall Study|Unrelated medical illness / complication|0|||
94671122|NCT01297959|324247339|FG001|Overall Study|Unrelated medical illness / complication|2|||
94671123|NCT01297959|324247338|FG000|Overall Study|Other|13|||
94671124|NCT01297959|324247339|FG001|Overall Study|Other|7|||
94671125|NCT01667432|324247340|FG000|Overall Study|Premature Study Termination|26|||
94671126|NCT01667432|324247340|FG000|Overall Study|Failure to Return|10|||
94671127|NCT01667432|324247340|FG000|Overall Study|Moved to Another Center|3|||
94671128|NCT01667432|324247340|FG000|Overall Study|Lost to Follow-up|3|||
94671129|NCT01667432|324247340|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
94671130|NCT01667432|324247340|FG000|Overall Study|Insufficient Therapeutic Response|4|||
94671131|NCT01667432|324247340|FG000|Overall Study|Adverse Event|1|||
94671132|NCT01667432|324247340|FG000|Overall Study|Protocol Deviation|2|||
94671133|NCT01667432|324247340|FG000|Overall Study|Principal Investigator Decision|1|||
94671134|NCT01667432|324247340|FG000|Overall Study|Reason Not Specified|2|||
94671135|NCT01667432|324247340|FG000|Overall Study|Missing Information|4|||
94671136|NCT03762473|324247341|FG000|Overall Study|Death|1|||
94671137|NCT03762473|324247342|FG001|Overall Study|Death|0|||
94671138|NCT02077166|324247352|FG000|Overall Study|Death|6|||
94671139|NCT02077166|324247353|FG001|Overall Study|Death|7|||
94671140|NCT02077166|324247354|FG002|Overall Study|Death|5|||
94671141|NCT02077166|324247355|FG003|Overall Study|Death|6|||
94671142|NCT02077166|324247356|FG004|Overall Study|Death|4|||
94671143|NCT02077166|324247357|FG005|Overall Study|Death|32|||
94671144|NCT02077166|324247358|FG006|Overall Study|Death|22|||
94671145|NCT02077166|324247352|FG000|Overall Study|Study Closure by Sponsor|3|||
94671146|NCT02077166|324247353|FG001|Overall Study|Study Closure by Sponsor|0|||
94671147|NCT02077166|324247354|FG002|Overall Study|Study Closure by Sponsor|2|||
94671148|NCT02077166|324247355|FG003|Overall Study|Study Closure by Sponsor|2|||
94671149|NCT02077166|324247356|FG004|Overall Study|Study Closure by Sponsor|2|||
94671150|NCT02077166|324247357|FG005|Overall Study|Study Closure by Sponsor|12|||
94671151|NCT02077166|324247358|FG006|Overall Study|Study Closure by Sponsor|4|||
94671152|NCT02077166|324247352|FG000|Overall Study|Lost to Follow-up|0|||
94671153|NCT02077166|324247353|FG001|Overall Study|Lost to Follow-up|0|||
94671154|NCT02077166|324247354|FG002|Overall Study|Lost to Follow-up|0|||
94671155|NCT02077166|324247355|FG003|Overall Study|Lost to Follow-up|0|||
94671156|NCT02077166|324247356|FG004|Overall Study|Lost to Follow-up|0|||
94671157|NCT02077166|324247357|FG005|Overall Study|Lost to Follow-up|1|||
94671158|NCT02077166|324247358|FG006|Overall Study|Lost to Follow-up|0|||
94671159|NCT02077166|324247352|FG000|Overall Study|Withdrawal by Subject|3|||
94671160|NCT02077166|324247353|FG001|Overall Study|Withdrawal by Subject|0|||
94671161|NCT02077166|324247354|FG002|Overall Study|Withdrawal by Subject|1|||
94671162|NCT02077166|324247355|FG003|Overall Study|Withdrawal by Subject|1|||
94671163|NCT02077166|324247356|FG004|Overall Study|Withdrawal by Subject|1|||
94671164|NCT02077166|324247357|FG005|Overall Study|Withdrawal by Subject|3|||
94671165|NCT02077166|324247358|FG006|Overall Study|Withdrawal by Subject|0|||
94671166|NCT02077166|324247352|FG000|Overall Study|Other, Not Specified|0|||
94671167|NCT02077166|324247353|FG001|Overall Study|Other, Not Specified|0|||
94671168|NCT02077166|324247354|FG002|Overall Study|Other, Not Specified|1|||
94671169|NCT02077166|324247355|FG003|Overall Study|Other, Not Specified|0|||
94671170|NCT02077166|324247356|FG004|Overall Study|Other, Not Specified|1|||
94671171|NCT02077166|324247357|FG005|Overall Study|Other, Not Specified|7|||
94671172|NCT02077166|324247358|FG006|Overall Study|Other, Not Specified|8|||
94671173|NCT00707031|324247359|FG000|Overall Study|Adverse Event|45|||
94671174|NCT00707031|324247360|FG001|Overall Study|Adverse Event|45|||
94671175|NCT00707031|324247359|FG000|Overall Study|Lack of Efficacy|19|||
94671176|NCT00707031|324247360|FG001|Overall Study|Lack of Efficacy|6|||
94671177|NCT00707031|324247359|FG000|Overall Study|Lost to Follow-up|2|||
94671178|NCT00707031|324247360|FG001|Overall Study|Lost to Follow-up|1|||
94671179|NCT00707031|324247359|FG000|Overall Study|Protocol Violation|1|||
94671180|NCT00707031|324247360|FG001|Overall Study|Protocol Violation|0|||
94671181|NCT00707031|324247359|FG000|Overall Study|Withdrawal by Subject|7|||
94671182|NCT00707031|324247360|FG001|Overall Study|Withdrawal by Subject|8|||
94671183|NCT00707031|324247359|FG000|Overall Study|Poor Compliance to Protocol|7|||
94671184|NCT00707031|324247360|FG001|Overall Study|Poor Compliance to Protocol|13|||
94671185|NCT00707031|324247359|FG000|Overall Study|Familial or Personal Reasons|12|||
94461208|NCT02052596|323478214|FG001|Safety Phase|Adverse Event|3|||
94461209|NCT02052596|323478213|FG000|Safety Phase|Lost to Follow-up|11|||
94671186|NCT00707031|324247360|FG001|Overall Study|Familial or Personal Reasons|15|||
94671187|NCT00707031|324247359|FG000|Overall Study|Serious Noncompliance|2|||
94671188|NCT00707031|324247360|FG001|Overall Study|Serious Noncompliance|3|||
94671189|NCT00707031|324247359|FG000|Overall Study|Sponsor Decision|9|||
94671190|NCT00707031|324247360|FG001|Overall Study|Sponsor Decision|8|||
94461210|NCT02052596|323478214|FG001|Safety Phase|Lost to Follow-up|18|||
94671191|NCT03519854|324247361|FG000|Overall Study|Technical Error|0|||
94671192|NCT03519854|324247362|FG001|Overall Study|Technical Error|0|||
94671193|NCT03519854|324247363|FG002|Overall Study|Technical Error|1|||
94671194|NCT03519854|324247364|FG003|Overall Study|Technical Error|0|||
94671195|NCT03519854|324247365|FG004|Overall Study|Technical Error|0|||
94671196|NCT03519854|324247366|FG005|Overall Study|Technical Error|0|||
94671197|NCT03519854|324247367|FG006|Overall Study|Technical Error|0|||
94671198|NCT03519854|324247368|FG007|Overall Study|Technical Error|0|||
94671199|NCT03519854|324247369|FG008|Overall Study|Technical Error|0|||
94671200|NCT03519854|324247370|FG009|Overall Study|Technical Error|0|||
94671201|NCT03519854|324247371|FG010|Overall Study|Technical Error|0|||
94671202|NCT03519854|324247372|FG011|Overall Study|Technical Error|0|||
94671203|NCT03519854|324247373|FG012|Overall Study|Technical Error|0|||
94671204|NCT03519854|324247374|FG013|Overall Study|Technical Error|0|||
94671205|NCT03519854|324247375|FG014|Overall Study|Technical Error|0|||
94671206|NCT03519854|324247376|FG015|Overall Study|Technical Error|0|||
94671207|NCT03519854|324247377|FG016|Overall Study|Technical Error|0|||
94671208|NCT03519854|324247378|FG017|Overall Study|Technical Error|0|||
94671209|NCT03832595|324247381|FG000|Overall Study|Death|142|||
94671210|NCT03832595|324247382|FG001|Overall Study|Death|130|||
94671211|NCT03832595|324247381|FG000|Overall Study|Medical management without dialysis|37|||
94671212|NCT03832595|324247382|FG001|Overall Study|Medical management without dialysis|1|||
94671213|NCT00818753|324247387|FG000|Overall Study|Protocol Violation|1|||
94671214|NCT00818753|324247388|FG001|Overall Study|Protocol Violation|0|||
94671215|NCT00818753|324247389|FG002|Overall Study|Protocol Violation|0|||
94671216|NCT00818753|324247387|FG000|Overall Study|Other reason (not specified)|0|||
94671217|NCT00818753|324247388|FG001|Overall Study|Other reason (not specified)|0|||
94671218|NCT00818753|324247389|FG002|Overall Study|Other reason (not specified)|1|||
94671219|NCT00818753|324247387|FG000|Overall Study|Randomised and not treated|2|||
94671220|NCT00818753|324247388|FG001|Overall Study|Randomised and not treated|0|||
94671221|NCT00818753|324247389|FG002|Overall Study|Randomised and not treated|0|||
94671222|NCT02119260|324250310|FG000|Overall Study|Adverse Event|1|||
94671223|NCT02119260|324250311|FG001|Overall Study|Adverse Event|0|||
94671224|NCT02119260|324250312|FG002|Overall Study|Adverse Event|0|||
94671225|NCT02119260|324250313|FG003|Overall Study|Adverse Event|0|||
94671226|NCT02119260|324250314|FG004|Overall Study|Adverse Event|0|||
94671227|NCT02119260|324250315|FG005|Overall Study|Adverse Event|0|||
94671228|NCT02119260|324250316|FG006|Overall Study|Adverse Event|0|||
94671229|NCT02119260|324250310|FG000|Overall Study|Withdrew consent|0|||
94671230|NCT02119260|324250311|FG001|Overall Study|Withdrew consent|1|||
94671231|NCT02119260|324250312|FG002|Overall Study|Withdrew consent|1|||
94671232|NCT02119260|324250313|FG003|Overall Study|Withdrew consent|0|||
94671233|NCT02119260|324250314|FG004|Overall Study|Withdrew consent|0|||
94671234|NCT02119260|324250315|FG005|Overall Study|Withdrew consent|0|||
94671235|NCT02119260|324250316|FG006|Overall Study|Withdrew consent|0|||
94671236|NCT00175825|324250320|FG000|Overall Study|Adverse Event|3|||
94671237|NCT00175825|324250321|FG001|Overall Study|Adverse Event|2|||
94671238|NCT00175825|324250322|FG002|Overall Study|Adverse Event|1|||
94671239|NCT00175825|324250323|FG003|Overall Study|Adverse Event|1|||
94671240|NCT00175825|324250320|FG000|Overall Study|Lost to Follow-up|1|||
94671241|NCT00175825|324250321|FG001|Overall Study|Lost to Follow-up|2|||
94671242|NCT00175825|324250322|FG002|Overall Study|Lost to Follow-up|0|||
94671243|NCT00175825|324250323|FG003|Overall Study|Lost to Follow-up|0|||
94671244|NCT00175825|324250320|FG000|Overall Study|Withdrawal by Subject|1|||
94671245|NCT00175825|324250321|FG001|Overall Study|Withdrawal by Subject|0|||
94671246|NCT00175825|324250322|FG002|Overall Study|Withdrawal by Subject|0|||
94671247|NCT00175825|324250323|FG003|Overall Study|Withdrawal by Subject|0|||
94671248|NCT00608582|324250324|FG000|Overall Study|Lost to Follow-up|2|||
94671249|NCT00608582|324250325|FG001|Overall Study|Lost to Follow-up|0|||
94671250|NCT00608582|324250324|FG000|Overall Study|No Best Response in Phase 1 located|1|||
94671251|NCT00608582|324250325|FG001|Overall Study|No Best Response in Phase 1 located|1|||
94671252|NCT00608582|324250324|FG000|Overall Study|Illicit Drug Use|1|||
94671253|NCT00608582|324250325|FG001|Overall Study|Illicit Drug Use|0|||
94671254|NCT00608582|324250324|FG000|Overall Study|Early stage Design Change|0|||
94671255|NCT00608582|324250325|FG001|Overall Study|Early stage Design Change|3|||
94671256|NCT00428090|324250326|FG000|Overall Study|Adverse Event|10|||
94671257|NCT00428090|324250327|FG001|Overall Study|Adverse Event|8|||
94671258|NCT00428090|324250328|FG002|Overall Study|Adverse Event|10|||
94671259|NCT00428090|324250329|FG003|Overall Study|Adverse Event|11|||
94671260|NCT00428090|324250326|FG000|Overall Study|Lost to Follow-up|3|||
94671261|NCT00428090|324250327|FG001|Overall Study|Lost to Follow-up|6|||
94671262|NCT00428090|324250328|FG002|Overall Study|Lost to Follow-up|1|||
94671263|NCT00428090|324250329|FG003|Overall Study|Lost to Follow-up|4|||
94671264|NCT00428090|324250326|FG000|Overall Study|Protocol Violation|3|||
94671265|NCT00428090|324250327|FG001|Overall Study|Protocol Violation|1|||
94671266|NCT00428090|324250328|FG002|Overall Study|Protocol Violation|3|||
94671267|NCT00428090|324250329|FG003|Overall Study|Protocol Violation|3|||
94671268|NCT00428090|324250326|FG000|Overall Study|Withdrawal by Subject|10|||
94671269|NCT00428090|324250327|FG001|Overall Study|Withdrawal by Subject|12|||
94671270|NCT00428090|324250328|FG002|Overall Study|Withdrawal by Subject|15|||
94671271|NCT00428090|324250329|FG003|Overall Study|Withdrawal by Subject|5|||
94671272|NCT00428090|324250326|FG000|Overall Study|Sponsor terminated study|0|||
94671273|NCT00428090|324250327|FG001|Overall Study|Sponsor terminated study|1|||
94671274|NCT00428090|324250328|FG002|Overall Study|Sponsor terminated study|0|||
94671275|NCT00428090|324250329|FG003|Overall Study|Sponsor terminated study|0|||
94671276|NCT00428090|324250326|FG000|Overall Study|Non-compliance|4|||
94671277|NCT00428090|324250327|FG001|Overall Study|Non-compliance|0|||
94671278|NCT00428090|324250328|FG002|Overall Study|Non-compliance|1|||
94671279|NCT00428090|324250329|FG003|Overall Study|Non-compliance|3|||
94671280|NCT00428090|324250326|FG000|Overall Study|Par. did not returned to visit|1|||
94671281|NCT00428090|324250327|FG001|Overall Study|Par. did not returned to visit|0|||
94671282|NCT00428090|324250328|FG002|Overall Study|Par. did not returned to visit|0|||
94671283|NCT00428090|324250329|FG003|Overall Study|Par. did not returned to visit|1|||
94671284|NCT00428090|324250326|FG000|Overall Study|Follow-Up visit not possible|1|||
94671285|NCT00428090|324250327|FG001|Overall Study|Follow-Up visit not possible|0|||
94671286|NCT00428090|324250328|FG002|Overall Study|Follow-Up visit not possible|0|||
94671287|NCT00428090|324250329|FG003|Overall Study|Follow-Up visit not possible|0|||
94671288|NCT00428090|324250326|FG000|Overall Study|Prohibited medication used for SAE|1|||
94671289|NCT00428090|324250327|FG001|Overall Study|Prohibited medication used for SAE|0|||
94671290|NCT00428090|324250328|FG002|Overall Study|Prohibited medication used for SAE|0|||
94671291|NCT00428090|324250329|FG003|Overall Study|Prohibited medication used for SAE|0|||
94671292|NCT00428090|324250326|FG000|Overall Study|Death of par.|1|||
94671293|NCT00428090|324250327|FG001|Overall Study|Death of par.|0|||
94671294|NCT00428090|324250328|FG002|Overall Study|Death of par.|1|||
94671295|NCT00428090|324250329|FG003|Overall Study|Death of par.|0|||
94671296|NCT00428090|324250326|FG000|Overall Study|Visit 7 exceed the visit window|0|||
94671297|NCT00428090|324250327|FG001|Overall Study|Visit 7 exceed the visit window|1|||
94671298|NCT00428090|324250328|FG002|Overall Study|Visit 7 exceed the visit window|0|||
94671299|NCT00428090|324250329|FG003|Overall Study|Visit 7 exceed the visit window|0|||
94671300|NCT00428090|324250326|FG000|Overall Study|Medical monitor terminated par.|0|||
94671301|NCT00428090|324250327|FG001|Overall Study|Medical monitor terminated par.|1|||
94671302|NCT00428090|324250328|FG002|Overall Study|Medical monitor terminated par.|0|||
94671303|NCT00428090|324250329|FG003|Overall Study|Medical monitor terminated par.|0|||
94671304|NCT00428090|324250326|FG000|Overall Study|Mental status of par. was|0|||
94671305|NCT00428090|324250327|FG001|Overall Study|Mental status of par. was|1|||
94671306|NCT00428090|324250328|FG002|Overall Study|Mental status of par. was|0|||
94671307|NCT00428090|324250329|FG003|Overall Study|Mental status of par. was|0|||
94671308|NCT00428090|324250326|FG000|Overall Study|Worsening of AD|0|||
94671309|NCT00428090|324250327|FG001|Overall Study|Worsening of AD|0|||
94671310|NCT00428090|324250328|FG002|Overall Study|Worsening of AD|1|||
94671311|NCT00428090|324250329|FG003|Overall Study|Worsening of AD|0|||
94671312|NCT00428090|324250326|FG000|Overall Study|Excluded for concerning QTc value|0|||
94671313|NCT00428090|324250327|FG001|Overall Study|Excluded for concerning QTc value|0|||
94671314|NCT00428090|324250328|FG002|Overall Study|Excluded for concerning QTc value|1|||
94671315|NCT00428090|324250329|FG003|Overall Study|Excluded for concerning QTc value|0|||
94671316|NCT00428090|324250326|FG000|Overall Study|Insufficient AD documentation|0|||
94671317|NCT00428090|324250327|FG001|Overall Study|Insufficient AD documentation|0|||
94671318|NCT00428090|324250328|FG002|Overall Study|Insufficient AD documentation|1|||
94671319|NCT00428090|324250329|FG003|Overall Study|Insufficient AD documentation|0|||
94671320|NCT00428090|324250326|FG000|Overall Study|High MMSE scores|0|||
94671321|NCT00428090|324250327|FG001|Overall Study|High MMSE scores|0|||
94671322|NCT00428090|324250328|FG002|Overall Study|High MMSE scores|1|||
94671323|NCT00428090|324250329|FG003|Overall Study|High MMSE scores|0|||
94671324|NCT00428090|324250326|FG000|Overall Study|Deterioration of cognitive status|0|||
94671325|NCT00428090|324250327|FG001|Overall Study|Deterioration of cognitive status|0|||
94671326|NCT00428090|324250328|FG002|Overall Study|Deterioration of cognitive status|1|||
94671327|NCT00428090|324250329|FG003|Overall Study|Deterioration of cognitive status|0|||
94671328|NCT00428090|324250326|FG000|Overall Study|Serious adverse event|0|||
94671329|NCT00428090|324250327|FG001|Overall Study|Serious adverse event|0|||
94671330|NCT00428090|324250328|FG002|Overall Study|Serious adverse event|1|||
94671331|NCT00428090|324250329|FG003|Overall Study|Serious adverse event|0|||
94671332|NCT00428090|324250326|FG000|Overall Study|Excluded for heart insufficiency|0|||
94671333|NCT00428090|324250327|FG001|Overall Study|Excluded for heart insufficiency|0|||
94671334|NCT00428090|324250328|FG002|Overall Study|Excluded for heart insufficiency|1|||
94671335|NCT00428090|324250329|FG003|Overall Study|Excluded for heart insufficiency|0|||
94671336|NCT00428090|324250326|FG000|Overall Study|Raised Creatinine Value|0|||
94671337|NCT00428090|324250327|FG001|Overall Study|Raised Creatinine Value|0|||
94671338|NCT00428090|324250328|FG002|Overall Study|Raised Creatinine Value|0|||
94671339|NCT00428090|324250329|FG003|Overall Study|Raised Creatinine Value|1|||
94671340|NCT03393000|324250332|FG000|Overall Study|Death|11|||
94671341|NCT03393000|324250332|FG000|Overall Study|Withdrawal by Subject|2|||
94671342|NCT03393000|324250332|FG000|Overall Study|Physician Decision|1|||
94671343|NCT02181803|324250333|FG000|Overall Study|Withdrawal by Subject|0|||
94671344|NCT02181803|324250334|FG001|Overall Study|Withdrawal by Subject|2|||
94671345|NCT02181803|324250335|FG002|Overall Study|Withdrawal by Subject|0|||
94671346|NCT02181803|324250336|FG003|Overall Study|Withdrawal by Subject|0|||
94671347|NCT02181803|324250337|FG004|Overall Study|Withdrawal by Subject|0|||
94461211|NCT02052596|323478213|FG000|Safety Phase|Protocol Violation|1|||
94671348|NCT02181803|324250338|FG005|Overall Study|Withdrawal by Subject|0|||
94671349|NCT02181803|324250339|FG006|Overall Study|Withdrawal by Subject|0|||
94671350|NCT02181803|324250340|FG007|Overall Study|Withdrawal by Subject|0|||
94671351|NCT02181803|324250341|FG008|Overall Study|Withdrawal by Subject|0|||
94671352|NCT02181803|324250333|FG000|Overall Study|Physician Decision|0|||
94671353|NCT02181803|324250334|FG001|Overall Study|Physician Decision|0|||
94671354|NCT02181803|324250335|FG002|Overall Study|Physician Decision|0|||
94671355|NCT02181803|324250336|FG003|Overall Study|Physician Decision|1|||
94671356|NCT02181803|324250337|FG004|Overall Study|Physician Decision|0|||
94671357|NCT02181803|324250338|FG005|Overall Study|Physician Decision|0|||
94671358|NCT02181803|324250339|FG006|Overall Study|Physician Decision|0|||
94671359|NCT02181803|324250340|FG007|Overall Study|Physician Decision|1|||
94671360|NCT02181803|324250341|FG008|Overall Study|Physician Decision|0|||
94671361|NCT02181803|324250333|FG000|Overall Study|Adverse Event|0|||
94671362|NCT02181803|324250334|FG001|Overall Study|Adverse Event|2|||
94671363|NCT02181803|324250335|FG002|Overall Study|Adverse Event|0|||
94671364|NCT02181803|324250336|FG003|Overall Study|Adverse Event|1|||
94671365|NCT02181803|324250337|FG004|Overall Study|Adverse Event|0|||
94671366|NCT02181803|324250338|FG005|Overall Study|Adverse Event|0|||
94671367|NCT02181803|324250339|FG006|Overall Study|Adverse Event|1|||
94671368|NCT02181803|324250340|FG007|Overall Study|Adverse Event|0|||
94671369|NCT02181803|324250341|FG008|Overall Study|Adverse Event|0|||
94671370|NCT01514448|324250342|FG000|Overall Study|Death|7|||
94671371|NCT01514448|324250343|FG001|Overall Study|Death|8|||
94671372|NCT01514448|324250342|FG000|Overall Study|Withdrawal by Subject|2|||
94671373|NCT01514448|324250343|FG001|Overall Study|Withdrawal by Subject|0|||
94671374|NCT01514448|324250342|FG000|Overall Study|Lost to Follow-up|2|||
94671375|NCT01514448|324250343|FG001|Overall Study|Lost to Follow-up|0|||
94671376|NCT01514448|324250342|FG000|Overall Study|New Cancer Therapy|1|||
94671377|NCT01514448|324250343|FG001|Overall Study|New Cancer Therapy|0|||
94671378|NCT02314624|324250347|FG000|Overall Study|No participating patient|16|||
94671379|NCT02314624|324250348|FG001|Overall Study|No participating patient|13|||
94671380|NCT02314624|324250347|FG000|Overall Study|Participant withdrew|7|||
94671381|NCT02314624|324250348|FG001|Overall Study|Participant withdrew|2|||
94671382|NCT02314624|324250347|FG000|Overall Study|Lost to Follow-up|2|||
94671383|NCT02314624|324250348|FG001|Overall Study|Lost to Follow-up|5|||
94671384|NCT02314624|324250347|FG000|Overall Study|Dropped/Excluded by PI|6|||
94671385|NCT02314624|324250348|FG001|Overall Study|Dropped/Excluded by PI|6|||
94671386|NCT03151005|324250351|FG000|Overall Study|Lost to Follow-up|5|||
94671387|NCT03151005|324250352|FG001|Overall Study|Lost to Follow-up|5|||
94671388|NCT00464815|324250353|FG000|Overall Study|Withdrawal by Subject|6|||
94671389|NCT00464815|324250354|FG001|Overall Study|Withdrawal by Subject|3|||
94671390|NCT02633137|324250359|FG000|Overall Study|Adverse Event|1|||
94671391|NCT02633137|324250359|FG000|Overall Study|Lack of Efficacy|2|||
94671392|NCT02633137|324250359|FG000|Overall Study|Withdrawal by Subject|1|||
94671393|NCT05554237|324250360|FG000|Part 2 (7 Days)|Adverse Event|0|||
94671394|NCT05554237|324250361|FG001|Part 2 (7 Days)|Adverse Event|0|||
94671395|NCT05554237|324250362|FG002|Part 2 (7 Days)|Adverse Event|0|||
94671396|NCT05554237|324250363|FG003|Part 2 (7 Days)|Adverse Event|0|||
94671397|NCT05554237|324250364|FG004|Part 2 (7 Days)|Adverse Event|2|||
94671398|NCT05554237|324250365|FG005|Part 2 (7 Days)|Adverse Event|0|||
94671399|NCT05554237|324250366|FG006|Part 2 (7 Days)|Adverse Event|0|||
94671400|NCT05554237|324250367|FG007|Part 2 (7 Days)|Adverse Event|0|||
94671401|NCT05554237|324250368|FG008|Part 2 (7 Days)|Adverse Event|0|||
94671402|NCT05554237|324250369|FG009|Part 2 (7 Days)|Adverse Event|1|||
94671403|NCT05554237|324250370|FG010|Part 2 (7 Days)|Adverse Event|0|||
94671404|NCT05554237|324250371|FG011|Part 2 (7 Days)|Adverse Event|0|||
94671405|NCT05554237|324250372|FG012|Part 2 (7 Days)|Adverse Event|1|||
94671406|NCT05554237|324250373|FG013|Part 2 (7 Days)|Adverse Event|0|||
94671407|NCT01972841|324250374|FG000|Overall Study|Randomized but Never Received Treatment|2|||
94671408|NCT01972841|324250375|FG001|Overall Study|Randomized but Never Received Treatment|5|||
94671409|NCT01972841|324250376|FG002|Overall Study|Randomized but Never Received Treatment|4|||
94671410|NCT01972841|324250377|FG003|Overall Study|Randomized but Never Received Treatment|2|||
94671411|NCT01972841|324250378|FG004|Overall Study|Randomized but Never Received Treatment|6|||
94671412|NCT01972841|324250379|FG005|Overall Study|Randomized but Never Received Treatment|13|||
94671413|NCT01972841|324250374|FG000|Overall Study|Adverse Event|13|||
94671414|NCT01972841|324250375|FG001|Overall Study|Adverse Event|8|||
94671415|NCT01972841|324250376|FG002|Overall Study|Adverse Event|12|||
94671416|NCT01972841|324250377|FG003|Overall Study|Adverse Event|9|||
94671417|NCT01972841|324250378|FG004|Overall Study|Adverse Event|21|||
94671418|NCT01972841|324250379|FG005|Overall Study|Adverse Event|26|||
94461212|NCT02052596|323478214|FG001|Safety Phase|Protocol Violation|2|||
94671419|NCT01972841|324250374|FG000|Overall Study|Lack of Efficacy|1|||
94671420|NCT01972841|324250375|FG001|Overall Study|Lack of Efficacy|0|||
94671421|NCT01972841|324250376|FG002|Overall Study|Lack of Efficacy|0|||
94671422|NCT01972841|324250377|FG003|Overall Study|Lack of Efficacy|2|||
94671423|NCT01972841|324250378|FG004|Overall Study|Lack of Efficacy|4|||
94671424|NCT01972841|324250379|FG005|Overall Study|Lack of Efficacy|1|||
94671425|NCT01972841|324250374|FG000|Overall Study|Lost to Follow-up|4|||
94671426|NCT01972841|324250375|FG001|Overall Study|Lost to Follow-up|2|||
94671427|NCT01972841|324250376|FG002|Overall Study|Lost to Follow-up|4|||
94671428|NCT01972841|324250377|FG003|Overall Study|Lost to Follow-up|2|||
94671429|NCT01972841|324250378|FG004|Overall Study|Lost to Follow-up|9|||
94671430|NCT01972841|324250379|FG005|Overall Study|Lost to Follow-up|3|||
94671431|NCT01972841|324250374|FG000|Overall Study|Protocol Violation|2|||
94671432|NCT01972841|324250375|FG001|Overall Study|Protocol Violation|2|||
94671433|NCT01972841|324250376|FG002|Overall Study|Protocol Violation|3|||
94671434|NCT01972841|324250377|FG003|Overall Study|Protocol Violation|5|||
94671435|NCT01972841|324250378|FG004|Overall Study|Protocol Violation|9|||
94671436|NCT01972841|324250379|FG005|Overall Study|Protocol Violation|4|||
94671437|NCT01972841|324250374|FG000|Overall Study|Withdrawal by participants|21|||
94671438|NCT01972841|324250375|FG001|Overall Study|Withdrawal by participants|27|||
94671439|NCT01972841|324250376|FG002|Overall Study|Withdrawal by participants|23|||
94671440|NCT01972841|324250377|FG003|Overall Study|Withdrawal by participants|16|||
94671441|NCT01972841|324250378|FG004|Overall Study|Withdrawal by participants|33|||
94671442|NCT01972841|324250379|FG005|Overall Study|Withdrawal by participants|34|||
94671443|NCT01972841|324250374|FG000|Overall Study|Miscellaneous|0|||
94671444|NCT01972841|324250375|FG001|Overall Study|Miscellaneous|0|||
94671445|NCT01972841|324250376|FG002|Overall Study|Miscellaneous|4|||
94671446|NCT01972841|324250377|FG003|Overall Study|Miscellaneous|1|||
94671447|NCT01972841|324250378|FG004|Overall Study|Miscellaneous|0|||
94671448|NCT01972841|324250379|FG005|Overall Study|Miscellaneous|4|||
94671449|NCT01972841|324250374|FG000|Overall Study|Did not have end of treatment page|0|||
94671450|NCT01972841|324250375|FG001|Overall Study|Did not have end of treatment page|0|||
94671451|NCT01972841|324250376|FG002|Overall Study|Did not have end of treatment page|0|||
94671452|NCT01972841|324250377|FG003|Overall Study|Did not have end of treatment page|0|||
94671453|NCT01972841|324250378|FG004|Overall Study|Did not have end of treatment page|1|||
94671454|NCT01972841|324250379|FG005|Overall Study|Did not have end of treatment page|0|||
94671455|NCT04435366|324250380|FG000|Year 1 (12 Months)|Adverse Event|3|||
94671456|NCT04435366|324250381|FG001|Year 1 (12 Months)|Adverse Event|0|||
94671457|NCT04435366|324250382|FG002|Year 1 (12 Months)|Adverse Event|2|||
94671458|NCT04435366|324250380|FG000|Year 1 (12 Months)|Death|2|||
94624628|NCT03129100|324085452|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624629|NCT03129100|324085453|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624630|NCT03129100|324085454|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624631|NCT03129100|324085455|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624632|NCT03129100|324085456|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624633|NCT03129100|324085457|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624634|NCT03129100|324085458|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
94624635|NCT03129100|324085459|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624636|NCT03129100|324085460|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624637|NCT03129100|324085461|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624638|NCT03129100|324085462|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624639|NCT03129100|324085463|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
94624640|NCT03129100|324085438|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
94624641|NCT03129100|324085439|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
94624642|NCT03129100|324085440|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
94624643|NCT03129100|324085441|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
94624644|NCT03129100|324085442|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
94624645|NCT03129100|324085443|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
94624646|NCT03129100|324085444|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
94624647|NCT03129100|324085445|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
94671459|NCT04435366|324250381|FG001|Year 1 (12 Months)|Death|0|||
94671460|NCT04435366|324250382|FG002|Year 1 (12 Months)|Death|1|||
94671461|NCT04435366|324250380|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
94671462|NCT04435366|324250381|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
94671463|NCT04435366|324250382|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
94671464|NCT04435366|324250380|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
94671465|NCT04435366|324250381|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
94671466|NCT04435366|324250382|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
94671467|NCT04435366|324250380|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
94671468|NCT04435366|324250381|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
94671469|NCT04435366|324250382|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
94671470|NCT04435366|324250380|FG000|Year 1 (12 Months)|Not treated|0|||
94671471|NCT04435366|324250381|FG001|Year 1 (12 Months)|Not treated|0|||
94671472|NCT04435366|324250382|FG002|Year 1 (12 Months)|Not treated|1|||
94671473|NCT04435366|324250380|FG000|Year 2 (12 Months)|Death|1|||
94671474|NCT04435366|324250381|FG001|Year 2 (12 Months)|Death|4|||
94671475|NCT04435366|324250382|FG002|Year 2 (12 Months)|Death|6|||
94671476|NCT04435366|324250380|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
94671477|NCT04435366|324250381|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
94671478|NCT04435366|324250382|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
94671479|NCT04435366|324250380|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
94671480|NCT04435366|324250381|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
94671481|NCT04435366|324250382|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
94624648|NCT03129100|324085446|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
94624649|NCT03129100|324085447|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
94624650|NCT03129100|324085448|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
94624651|NCT03129100|324085449|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
94624652|NCT03129100|324085450|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
94624653|NCT03129100|324085451|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
94624654|NCT03129100|324085452|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
94624655|NCT03129100|324085453|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
94624656|NCT03129100|324085454|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
94624657|NCT03129100|324085455|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
94624658|NCT03129100|324085456|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
94624659|NCT03129100|324085457|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
94624660|NCT03129100|324085458|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
94624661|NCT03129100|324085459|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
94624662|NCT03129100|324085460|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
94624663|NCT03129100|324085461|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
94624664|NCT03129100|324085462|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
94624665|NCT03129100|324085463|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
94624666|NCT03129100|324085438|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624667|NCT03129100|324085439|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624668|NCT03129100|324085440|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624669|NCT03129100|324085441|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624670|NCT03129100|324085442|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624671|NCT03129100|324085443|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624672|NCT03129100|324085444|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624673|NCT03129100|324085445|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624674|NCT03129100|324085446|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624675|NCT03129100|324085447|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624676|NCT03129100|324085448|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624677|NCT03129100|324085449|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624678|NCT03129100|324085450|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624679|NCT03129100|324085451|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624680|NCT03129100|324085452|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624681|NCT03129100|324085453|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624682|NCT03129100|324085454|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624683|NCT03129100|324085455|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624684|NCT03129100|324085456|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624685|NCT03129100|324085457|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624686|NCT03129100|324085458|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
94624687|NCT03129100|324085459|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624688|NCT03129100|324085460|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624689|NCT03129100|324085461|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624690|NCT03129100|324085462|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624691|NCT03129100|324085463|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
94624692|NCT03129100|324085438|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
94624693|NCT03129100|324085439|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
94624694|NCT03129100|324085440|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
94624695|NCT03129100|324085441|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
94624696|NCT03129100|324085442|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
94624697|NCT03129100|324085443|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
94624698|NCT03129100|324085444|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
94624699|NCT03129100|324085445|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
94624700|NCT03129100|324085446|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
94671482|NCT04435366|324250380|FG000|Year 2 (12 Months)|Adverse Event|2|||
94671483|NCT04435366|324250381|FG001|Year 2 (12 Months)|Adverse Event|1|||
94624701|NCT03129100|324085447|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
94624702|NCT03129100|324085448|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
94624703|NCT03129100|324085449|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
94624704|NCT03129100|324085450|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
94624705|NCT03129100|324085451|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
94624706|NCT03129100|324085452|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
94624707|NCT03129100|324085453|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
94624708|NCT03129100|324085454|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
94624709|NCT03129100|324085455|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
94624710|NCT03129100|324085456|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
94624711|NCT03129100|324085457|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
94624712|NCT03129100|324085458|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
94624713|NCT03129100|324085459|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
94624714|NCT03129100|324085460|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
94624715|NCT03129100|324085461|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
94624716|NCT03129100|324085462|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
94624717|NCT03129100|324085463|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
94671484|NCT04435366|324250382|FG002|Year 2 (12 Months)|Adverse Event|6|||
94671485|NCT03575325|324250383|FG000|Overall Study|Death|1|||
94671486|NCT05711641|324250384|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
94671487|NCT05711641|324250385|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
94671488|NCT05711641|324250384|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
94671489|NCT05711641|324250385|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
94671490|NCT02192502|324250386|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
94671491|NCT02192502|324250387|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
94624718|NCT03129100|324085438|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624719|NCT03129100|324085439|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624720|NCT03129100|324085440|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624721|NCT03129100|324085441|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624722|NCT03129100|324085442|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624723|NCT03129100|324085443|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624724|NCT03129100|324085444|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624725|NCT03129100|324085445|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624726|NCT03129100|324085446|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624727|NCT03129100|324085447|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624728|NCT03129100|324085448|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624729|NCT03129100|324085449|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624730|NCT03129100|324085450|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624731|NCT03129100|324085451|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624732|NCT03129100|324085452|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624733|NCT03129100|324085453|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624734|NCT03129100|324085454|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624735|NCT03129100|324085455|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624736|NCT03129100|324085456|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624737|NCT03129100|324085457|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624738|NCT03129100|324085458|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624739|NCT03129100|324085459|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624740|NCT03129100|324085460|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624741|NCT03129100|324085461|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
94624742|NCT03129100|324085462|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
94624743|NCT03129100|324085463|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
94624744|NCT03129100|324085438|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624745|NCT03129100|324085439|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624746|NCT03129100|324085440|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624747|NCT03129100|324085441|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624748|NCT03129100|324085442|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624749|NCT03129100|324085443|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624750|NCT03129100|324085444|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624751|NCT03129100|324085445|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624752|NCT03129100|324085446|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624753|NCT03129100|324085447|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624754|NCT03129100|324085448|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624755|NCT03129100|324085449|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624756|NCT03129100|324085450|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624757|NCT03129100|324085451|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624758|NCT03129100|324085452|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624759|NCT03129100|324085453|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624760|NCT03129100|324085454|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624761|NCT03129100|324085455|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624762|NCT03129100|324085456|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624763|NCT03129100|324085457|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624764|NCT03129100|324085458|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624765|NCT03129100|324085459|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624766|NCT03129100|324085460|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
94624767|NCT03129100|324085461|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
94624768|NCT03129100|324085462|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
94624769|NCT03129100|324085463|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
94624770|NCT03129100|324085438|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624771|NCT03129100|324085439|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624772|NCT03129100|324085440|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94671492|NCT02192502|324250386|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
94671493|NCT02192502|324250387|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
94671494|NCT02192502|324250386|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
94671495|NCT02192502|324250387|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
94671496|NCT02862457|324250388|FG000|Overall Study|Death|1|||
94671497|NCT02862457|324250389|FG001|Overall Study|Death|3|||
94671498|NCT02862457|324250390|FG002|Overall Study|Death|2|||
94671499|NCT02862457|324250391|FG003|Overall Study|Death|3|||
94671500|NCT02862457|324250392|FG004|Overall Study|Death|0|||
94671501|NCT02862457|324250393|FG005|Overall Study|Death|2|||
94671502|NCT02862457|324250394|FG006|Overall Study|Death|1|||
94671503|NCT02862457|324250388|FG000|Overall Study|Lost to Follow-up|1|||
94671504|NCT02862457|324250389|FG001|Overall Study|Lost to Follow-up|0|||
94671505|NCT02862457|324250390|FG002|Overall Study|Lost to Follow-up|0|||
94671506|NCT02862457|324250391|FG003|Overall Study|Lost to Follow-up|1|||
94671507|NCT02862457|324250392|FG004|Overall Study|Lost to Follow-up|0|||
94671508|NCT02862457|324250393|FG005|Overall Study|Lost to Follow-up|0|||
94671509|NCT02862457|324250394|FG006|Overall Study|Lost to Follow-up|0|||
94671510|NCT02862457|324250388|FG000|Overall Study|Withdrawal by Subject|0|||
94671511|NCT02862457|324250389|FG001|Overall Study|Withdrawal by Subject|0|||
94671512|NCT02862457|324250390|FG002|Overall Study|Withdrawal by Subject|1|||
94671513|NCT02862457|324250391|FG003|Overall Study|Withdrawal by Subject|0|||
94671514|NCT02862457|324250392|FG004|Overall Study|Withdrawal by Subject|0|||
94671515|NCT02862457|324250393|FG005|Overall Study|Withdrawal by Subject|1|||
94671516|NCT02862457|324250394|FG006|Overall Study|Withdrawal by Subject|0|||
94671517|NCT00743366|324250398|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
94671518|NCT00743366|324250399|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
94671519|NCT01483924|324250400|FG000|Overall Study|Withdrawal by Subject|2|||
94671520|NCT01483924|324250401|FG001|Overall Study|Withdrawal by Subject|0|||
94671521|NCT01483924|324250402|FG002|Overall Study|Withdrawal by Subject|0|||
94671522|NCT01483924|324250403|FG003|Overall Study|Withdrawal by Subject|1|||
94671523|NCT01483924|324250404|FG004|Overall Study|Withdrawal by Subject|1|||
94671524|NCT01483924|324250400|FG000|Overall Study|Adverse Event|0|||
94671525|NCT01483924|324250401|FG001|Overall Study|Adverse Event|0|||
94671526|NCT01483924|324250402|FG002|Overall Study|Adverse Event|1|||
94671527|NCT01483924|324250403|FG003|Overall Study|Adverse Event|1|||
94671528|NCT01483924|324250404|FG004|Overall Study|Adverse Event|0|||
94671529|NCT01483924|324250400|FG000|Overall Study|Non-compliance|0|||
94671530|NCT01483924|324250401|FG001|Overall Study|Non-compliance|0|||
94671531|NCT01483924|324250402|FG002|Overall Study|Non-compliance|0|||
94671532|NCT01483924|324250403|FG003|Overall Study|Non-compliance|1|||
94671533|NCT01483924|324250404|FG004|Overall Study|Non-compliance|1|||
94671534|NCT01483924|324250400|FG000|Overall Study|Sponsor concern over ECG result|0|||
94671535|NCT01483924|324250401|FG001|Overall Study|Sponsor concern over ECG result|0|||
94671536|NCT01483924|324250402|FG002|Overall Study|Sponsor concern over ECG result|0|||
94671537|NCT01483924|324250403|FG003|Overall Study|Sponsor concern over ECG result|1|||
94671538|NCT01483924|324250404|FG004|Overall Study|Sponsor concern over ECG result|0|||
94671539|NCT00335322|324250405|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
94671540|NCT00335322|324250406|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
94671541|NCT00335322|324250407|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
94671542|NCT03364751|324250410|FG000|Overall Study|Withdrawal by Subject|1|||
94671543|NCT03364751|324250411|FG001|Overall Study|Withdrawal by Subject|0|||
94671544|NCT03364751|324250412|FG002|Overall Study|Withdrawal by Subject|0|||
94671545|NCT03364751|324250413|FG003|Overall Study|Withdrawal by Subject|0|||
94671546|NCT03364751|324250410|FG000|Overall Study|Lost to Follow-up|0|||
94671547|NCT03364751|324250411|FG001|Overall Study|Lost to Follow-up|1|||
94671548|NCT03364751|324250412|FG002|Overall Study|Lost to Follow-up|0|||
94671549|NCT03364751|324250413|FG003|Overall Study|Lost to Follow-up|0|||
94671550|NCT03178266|324250416|FG000|Overall Study|Death|0|||
94671551|NCT03178266|324250417|FG001|Overall Study|Death|1|||
94671552|NCT03178266|324250416|FG000|Overall Study|Disont. Early|0|||
94671553|NCT03178266|324250417|FG001|Overall Study|Disont. Early|1|||
94671554|NCT03178266|324250416|FG000|Overall Study|Withdrawal by Subject|0|||
94671555|NCT03178266|324250417|FG001|Overall Study|Withdrawal by Subject|2|||
94671556|NCT04435665|324250428|FG000|Overall Study|Lost to Follow-up|0|||
94671557|NCT04435665|324250429|FG001|Overall Study|Lost to Follow-up|0|||
94671558|NCT04435665|324250430|FG002|Overall Study|Lost to Follow-up|0|||
94671559|NCT04435665|324250431|FG003|Overall Study|Lost to Follow-up|1|||
94671560|NCT04672941|324250432|FG000|Overall Study|Investigator decision|1|||
94671561|NCT04672941|324250432|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
94671562|NCT04672941|324250432|FG000|Overall Study|COVID-19 related but no adverse event|1|||
94671563|NCT04672941|324250432|FG000|Overall Study|Adverse Event|2|||
94671564|NCT04672941|324250432|FG000|Overall Study|Lost to Follow-up|2|||
94671565|NCT02275065|324250442|FG000|Overall Study|Randomized but not treated|1|||
94671566|NCT02275065|324250443|FG001|Overall Study|Randomized but not treated|0|||
94671567|NCT02275065|324250444|FG002|Overall Study|Randomized but not treated|1|||
94671568|NCT02275065|324250445|FG003|Overall Study|Randomized but not treated|1|||
94671569|NCT02275065|324250446|FG004|Overall Study|Randomized but not treated|0|||
94671570|NCT00989287|324250447|FG000|Overall Study|Adverse Event|1|||
94671571|NCT00989287|324250448|FG001|Overall Study|Adverse Event|0|||
94671572|NCT00989287|324250447|FG000|Overall Study|Lost to Follow-up|0|||
94671573|NCT00989287|324250448|FG001|Overall Study|Lost to Follow-up|1|||
94671574|NCT00729833|324250449|FG000|Overall Study|Death|5|||
94671575|NCT00729833|324250450|FG001|Overall Study|Death|1|||
94671576|NCT00729833|324250451|FG002|Overall Study|Death|3|||
94671577|NCT00729833|324250452|FG003|Overall Study|Death|5|||
94671578|NCT00729833|324250449|FG000|Overall Study|Study Terminated by Sponsor|0|||
94671579|NCT00729833|324250450|FG001|Overall Study|Study Terminated by Sponsor|0|||
94671580|NCT00729833|324250451|FG002|Overall Study|Study Terminated by Sponsor|1|||
94671581|NCT00729833|324250452|FG003|Overall Study|Study Terminated by Sponsor|0|||
94671582|NCT00729833|324250449|FG000|Overall Study|Lost to Follow-up|1|||
94671583|NCT00729833|324250450|FG001|Overall Study|Lost to Follow-up|0|||
94671584|NCT00729833|324250451|FG002|Overall Study|Lost to Follow-up|0|||
94671585|NCT00729833|324250452|FG003|Overall Study|Lost to Follow-up|0|||
94671586|NCT00729833|324250449|FG000|Overall Study|Withdrawal by Subject|3|||
94671587|NCT00729833|324250450|FG001|Overall Study|Withdrawal by Subject|1|||
94671588|NCT00729833|324250451|FG002|Overall Study|Withdrawal by Subject|3|||
94671589|NCT00729833|324250452|FG003|Overall Study|Withdrawal by Subject|0|||
94671590|NCT00729833|324250449|FG000|Overall Study|Unspecified Reasons|11|||
94671591|NCT00729833|324250450|FG001|Overall Study|Unspecified Reasons|5|||
94671592|NCT00729833|324250451|FG002|Overall Study|Unspecified Reasons|5|||
94671593|NCT00729833|324250452|FG003|Overall Study|Unspecified Reasons|1|||
94671594|NCT00295022|324250454|FG000|Overall Study|Adverse Event|1|||
94671595|NCT00295022|324250455|FG001|Overall Study|Adverse Event|1|||
94671596|NCT00295022|324250456|FG002|Overall Study|Adverse Event|2|||
94671597|NCT00295022|324250454|FG000|Overall Study|Lost to Follow-up|0|||
94671598|NCT00295022|324250455|FG001|Overall Study|Lost to Follow-up|0|||
94671599|NCT00295022|324250456|FG002|Overall Study|Lost to Follow-up|1|||
94671600|NCT00295022|324250454|FG000|Overall Study|Withdrawal by Subject|0|||
94671601|NCT00295022|324250455|FG001|Overall Study|Withdrawal by Subject|0|||
94671602|NCT00295022|324250456|FG002|Overall Study|Withdrawal by Subject|2|||
94671603|NCT04123067|324250457|FG000|Overall Study|Lost to Follow-up|0|||
94671604|NCT04123067|324250458|FG001|Overall Study|Lost to Follow-up|1|||
94671605|NCT01775904|324250459|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
94671606|NCT01775904|324250459|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
94671607|NCT04084314|324250460|FG000|Overall Study|Subject/guardian decision|91|||
94671608|NCT04084314|324250460|FG000|Overall Study|Adverse Event|24|||
94671609|NCT04084314|324250460|FG000|Overall Study|Lost to Follow-up|19|||
94671610|NCT04084314|324250460|FG000|Overall Study|New therapy for study indication|9|||
94671611|NCT04084314|324250460|FG000|Overall Study|Pregnancy|9|||
94671612|NCT04084314|324250460|FG000|Overall Study|Withdrawal of informed consent|8|||
94671613|NCT04084314|324250460|FG000|Overall Study|Physician Decision|4|||
94671614|NCT04084314|324250460|FG000|Overall Study|Protocol Deviation|3|||
94671615|NCT00827918|324250461|FG000|Overall Study|Adverse Event|4|||
94671616|NCT00827918|324250462|FG001|Overall Study|Adverse Event|0|||
94671617|NCT00827918|324250463|FG002|Overall Study|Adverse Event|0|||
94671618|NCT00827918|324250461|FG000|Overall Study|Lack of Efficacy|16|||
94671619|NCT00827918|324250462|FG001|Overall Study|Lack of Efficacy|4|||
94671620|NCT00827918|324250463|FG002|Overall Study|Lack of Efficacy|15|||
94671621|NCT00827918|324250461|FG000|Overall Study|Physician Decision|1|||
94671622|NCT00827918|324250462|FG001|Overall Study|Physician Decision|0|||
94671623|NCT00827918|324250463|FG002|Overall Study|Physician Decision|0|||
94671624|NCT00827918|324250461|FG000|Overall Study|Pregnancy|0|||
94671625|NCT00827918|324250462|FG001|Overall Study|Pregnancy|1|||
94671626|NCT00827918|324250463|FG002|Overall Study|Pregnancy|0|||
94671627|NCT00827918|324250461|FG000|Overall Study|Progressive Disease|1|||
94671628|NCT00827918|324250462|FG001|Overall Study|Progressive Disease|1|||
94671629|NCT00827918|324250463|FG002|Overall Study|Progressive Disease|0|||
94671630|NCT00827918|324250461|FG000|Overall Study|Protocol Violation|0|||
94671631|NCT00827918|324250462|FG001|Overall Study|Protocol Violation|1|||
94671632|NCT00827918|324250463|FG002|Overall Study|Protocol Violation|0|||
94671633|NCT00827918|324250461|FG000|Overall Study|Withdrawal by Subject|6|||
94671634|NCT00827918|324250462|FG001|Overall Study|Withdrawal by Subject|2|||
94671635|NCT00827918|324250463|FG002|Overall Study|Withdrawal by Subject|6|||
94671636|NCT02291614|324250464|FG000|Overall Study|Lost to Follow-up|0|||
94671637|NCT02291614|324250465|FG001|Overall Study|Lost to Follow-up|0|||
94671638|NCT02291614|324250466|FG002|Overall Study|Lost to Follow-up|0|||
94671639|NCT02291614|324250467|FG003|Overall Study|Lost to Follow-up|0|||
94671640|NCT02291614|324250468|FG004|Overall Study|Lost to Follow-up|0|||
94671641|NCT02291614|324250469|FG005|Overall Study|Lost to Follow-up|0|||
94671642|NCT02291614|324250470|FG006|Overall Study|Lost to Follow-up|0|||
94671643|NCT02291614|324250471|FG007|Overall Study|Lost to Follow-up|1|||
94671644|NCT02291614|324250472|FG008|Overall Study|Lost to Follow-up|0|||
94671645|NCT02291614|324250473|FG009|Overall Study|Lost to Follow-up|0|||
94671646|NCT02291614|324250474|FG010|Overall Study|Lost to Follow-up|0|||
94671647|NCT02291614|324250464|FG000|Overall Study|Withdrawal by Subject|0|||
94671648|NCT02291614|324250465|FG001|Overall Study|Withdrawal by Subject|1|||
94671649|NCT02291614|324250466|FG002|Overall Study|Withdrawal by Subject|0|||
94671650|NCT02291614|324250467|FG003|Overall Study|Withdrawal by Subject|0|||
94624773|NCT03129100|324085441|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624774|NCT03129100|324085442|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624775|NCT03129100|324085443|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624776|NCT03129100|324085444|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624777|NCT03129100|324085445|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624778|NCT03129100|324085446|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624779|NCT03129100|324085447|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624780|NCT03129100|324085448|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624781|NCT03129100|324085449|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624782|NCT03129100|324085450|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624783|NCT03129100|324085451|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624784|NCT03129100|324085452|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624785|NCT03129100|324085453|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624786|NCT03129100|324085454|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624787|NCT03129100|324085455|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624788|NCT03129100|324085456|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624789|NCT03129100|324085457|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624790|NCT03129100|324085458|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624791|NCT03129100|324085459|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624792|NCT03129100|324085460|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624793|NCT03129100|324085461|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624794|NCT03129100|324085462|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
94624795|NCT03129100|324085463|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
94624796|NCT03129100|324085438|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624797|NCT03129100|324085439|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624798|NCT03129100|324085440|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624799|NCT03129100|324085441|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624800|NCT03129100|324085442|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624801|NCT03129100|324085443|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624802|NCT03129100|324085444|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624803|NCT03129100|324085445|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624804|NCT03129100|324085446|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624805|NCT03129100|324085447|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624806|NCT03129100|324085448|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624807|NCT03129100|324085449|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624808|NCT03129100|324085450|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624809|NCT03129100|324085451|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624810|NCT03129100|324085452|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624811|NCT03129100|324085453|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624812|NCT03129100|324085454|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624813|NCT03129100|324085455|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624814|NCT03129100|324085456|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624815|NCT03129100|324085457|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624816|NCT03129100|324085458|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624817|NCT03129100|324085459|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624818|NCT03129100|324085460|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624819|NCT03129100|324085461|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624820|NCT03129100|324085462|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
94624821|NCT03129100|324085463|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
94624822|NCT03129100|324085438|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
94624823|NCT03129100|324085439|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
94624824|NCT03129100|324085440|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
94624825|NCT03129100|324085441|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
94624826|NCT03129100|324085442|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
94624827|NCT03129100|324085443|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
94624828|NCT03129100|324085444|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
94624829|NCT03129100|324085445|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
94624830|NCT03129100|324085446|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
94624831|NCT03129100|324085447|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
94624832|NCT03129100|324085448|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
94624833|NCT03129100|324085449|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
94624834|NCT03129100|324085450|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
94461213|NCT02052596|323478213|FG000|Safety Phase|Withdrawal by Subject|8|||
94624835|NCT03129100|324085451|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
94624836|NCT03129100|324085452|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
94461214|NCT02052596|323478214|FG001|Safety Phase|Withdrawal by Subject|11|||
94624837|NCT03129100|324085453|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
94624838|NCT03129100|324085454|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
94624839|NCT03129100|324085455|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
94624840|NCT03129100|324085456|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
94624841|NCT03129100|324085457|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
94624842|NCT03129100|324085458|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
94624843|NCT03129100|324085459|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
94624844|NCT03129100|324085460|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
94624845|NCT03129100|324085461|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
94624846|NCT03129100|324085462|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
94624847|NCT03129100|324085463|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
94624848|NCT00221403|324085468|FG000|Overall Study|Protocol Violation|1|||
94624849|NCT00221403|324085469|FG001|Overall Study|Protocol Violation|0|||
94624850|NCT00221403|324085470|FG002|Overall Study|Protocol Violation|0|||
94624851|NCT00221403|324085468|FG000|Overall Study|Physician Decision|1|||
94624852|NCT00221403|324085469|FG001|Overall Study|Physician Decision|0|||
94624853|NCT00221403|324085470|FG002|Overall Study|Physician Decision|0|||
94624854|NCT00221403|324085468|FG000|Overall Study|Withdrawal by Subject|0|||
94624855|NCT00221403|324085469|FG001|Overall Study|Withdrawal by Subject|3|||
94624856|NCT00221403|324085470|FG002|Overall Study|Withdrawal by Subject|0|||
94624857|NCT00221403|324085468|FG000|Overall Study|Lack of Efficacy|0|||
94624858|NCT00221403|324085469|FG001|Overall Study|Lack of Efficacy|1|||
94624859|NCT00221403|324085470|FG002|Overall Study|Lack of Efficacy|0|||
94624860|NCT00221403|324085468|FG000|Overall Study|Adverse Event|0|||
94624861|NCT00221403|324085469|FG001|Overall Study|Adverse Event|1|||
94624862|NCT00221403|324085470|FG002|Overall Study|Adverse Event|0|||
94624863|NCT00843024|324085472|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
94624864|NCT00843024|324085473|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
94624865|NCT00843024|324085474|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
94624866|NCT00843024|324085475|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
94624867|NCT00843024|324085476|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
94624868|NCT00843024|324085477|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
94624869|NCT00843024|324085472|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
94624870|NCT00843024|324085473|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
94624871|NCT00843024|324085474|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
94624872|NCT00843024|324085475|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
94624873|NCT00843024|324085476|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
94624874|NCT00843024|324085477|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
94624875|NCT00843024|324085472|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
94624876|NCT00843024|324085473|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
94624877|NCT00843024|324085474|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
94624878|NCT00843024|324085475|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
94624879|NCT00843024|324085476|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
94624880|NCT00843024|324085477|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
94624881|NCT00843024|324085472|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
94624882|NCT00843024|324085473|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
94624883|NCT00843024|324085474|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
94624884|NCT00843024|324085475|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
94624885|NCT00843024|324085476|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
94624886|NCT00843024|324085477|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
94624887|NCT00843024|324085472|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
94624888|NCT00843024|324085473|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
94624889|NCT00843024|324085474|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
94624890|NCT00843024|324085475|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
94624891|NCT00843024|324085476|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
94624892|NCT00843024|324085477|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
94624893|NCT00843024|324085472|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
94624894|NCT00843024|324085473|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
94624895|NCT00843024|324085474|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
94624896|NCT00843024|324085475|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
94624897|NCT00843024|324085476|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
94624898|NCT00843024|324085477|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
94624899|NCT00843024|324085472|FG000|Single-blind Placebo Run-In Phase|Other|0|||
94624900|NCT00843024|324085473|FG001|Single-blind Placebo Run-In Phase|Other|1|||
94624901|NCT00843024|324085474|FG002|Single-blind Placebo Run-In Phase|Other|0|||
94624902|NCT00843024|324085475|FG003|Single-blind Placebo Run-In Phase|Other|0|||
94624903|NCT00843024|324085476|FG004|Single-blind Placebo Run-In Phase|Other|0|||
94671651|NCT02291614|324250468|FG004|Overall Study|Withdrawal by Subject|0|||
94461215|NCT02052596|323478213|FG000|Safety Phase|Enrolled in error|1|||
94624904|NCT00843024|324085477|FG005|Single-blind Placebo Run-In Phase|Other|0|||
94624905|NCT00843024|324085472|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
94624906|NCT00843024|324085473|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
94624907|NCT00843024|324085474|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
94624908|NCT00843024|324085475|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
94624909|NCT00843024|324085476|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
94624910|NCT00843024|324085477|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
94624911|NCT00843024|324085472|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
94624912|NCT00843024|324085473|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
94624913|NCT00843024|324085474|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
94624914|NCT00843024|324085475|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
94624915|NCT00843024|324085476|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
94624916|NCT00843024|324085477|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
94624917|NCT00843024|324085472|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
94671652|NCT02291614|324250469|FG005|Overall Study|Withdrawal by Subject|0|||
94671653|NCT02291614|324250470|FG006|Overall Study|Withdrawal by Subject|0|||
94671654|NCT02291614|324250471|FG007|Overall Study|Withdrawal by Subject|0|||
94671655|NCT02291614|324250472|FG008|Overall Study|Withdrawal by Subject|0|||
94671656|NCT02291614|324250473|FG009|Overall Study|Withdrawal by Subject|2|||
94671657|NCT02291614|324250474|FG010|Overall Study|Withdrawal by Subject|2|||
94671658|NCT02291614|324250464|FG000|Overall Study|Decision by sponsor|0|||
94671659|NCT02291614|324250465|FG001|Overall Study|Decision by sponsor|0|||
94671660|NCT02291614|324250466|FG002|Overall Study|Decision by sponsor|0|||
94671661|NCT02291614|324250467|FG003|Overall Study|Decision by sponsor|1|||
94671662|NCT02291614|324250468|FG004|Overall Study|Decision by sponsor|0|||
94671663|NCT02291614|324250469|FG005|Overall Study|Decision by sponsor|0|||
94671664|NCT02291614|324250470|FG006|Overall Study|Decision by sponsor|0|||
94671665|NCT02291614|324250471|FG007|Overall Study|Decision by sponsor|0|||
94671666|NCT02291614|324250472|FG008|Overall Study|Decision by sponsor|0|||
94671667|NCT02291614|324250473|FG009|Overall Study|Decision by sponsor|0|||
94671668|NCT02291614|324250474|FG010|Overall Study|Decision by sponsor|0|||
94671669|NCT02291614|324250464|FG000|Overall Study|Death|0|||
94671670|NCT02291614|324250465|FG001|Overall Study|Death|0|||
94671671|NCT02291614|324250466|FG002|Overall Study|Death|1|||
94671672|NCT02291614|324250467|FG003|Overall Study|Death|0|||
94671673|NCT02291614|324250468|FG004|Overall Study|Death|1|||
94624918|NCT00843024|324085473|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
94624919|NCT00843024|324085474|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
94624920|NCT00843024|324085475|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
94624921|NCT00843024|324085476|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
94624922|NCT00843024|324085477|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
94624923|NCT00843024|324085472|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
94624924|NCT00843024|324085473|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
94624925|NCT00843024|324085474|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
94624926|NCT00843024|324085475|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
94624927|NCT00843024|324085476|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
94624928|NCT00843024|324085477|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
94624929|NCT00843024|324085472|FG000|Double-blind Treatment Phase|Physician Decision|0|||
94624930|NCT00843024|324085473|FG001|Double-blind Treatment Phase|Physician Decision|0|||
94624931|NCT00843024|324085474|FG002|Double-blind Treatment Phase|Physician Decision|0|||
94624932|NCT00843024|324085475|FG003|Double-blind Treatment Phase|Physician Decision|3|||
94624933|NCT00843024|324085476|FG004|Double-blind Treatment Phase|Physician Decision|1|||
94624934|NCT00843024|324085477|FG005|Double-blind Treatment Phase|Physician Decision|1|||
94624935|NCT00843024|324085472|FG000|Double-blind Treatment Phase|Adverse Event|0|||
94624936|NCT00843024|324085473|FG001|Double-blind Treatment Phase|Adverse Event|0|||
94624937|NCT00843024|324085474|FG002|Double-blind Treatment Phase|Adverse Event|0|||
94624938|NCT00843024|324085475|FG003|Double-blind Treatment Phase|Adverse Event|0|||
94624939|NCT00843024|324085476|FG004|Double-blind Treatment Phase|Adverse Event|1|||
94624940|NCT00843024|324085477|FG005|Double-blind Treatment Phase|Adverse Event|1|||
94624941|NCT00843024|324085472|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
94624942|NCT00843024|324085473|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
94624943|NCT00843024|324085474|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
94624944|NCT00843024|324085475|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
94624945|NCT00843024|324085476|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
94624946|NCT00843024|324085477|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
94624947|NCT03667924|324085480|FG000|Baseline Completed|Lost to Follow-up|0|||
94624948|NCT03667924|324085481|FG001|Baseline Completed|Lost to Follow-up|2|||
94671674|NCT02291614|324250469|FG005|Overall Study|Death|1|||
94671675|NCT02291614|324250470|FG006|Overall Study|Death|1|||
94671676|NCT02291614|324250471|FG007|Overall Study|Death|0|||
94624949|NCT03667924|324085482|FG002|Baseline Completed|Lost to Follow-up|0|||
94624950|NCT03667924|324085480|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
94671677|NCT02291614|324250472|FG008|Overall Study|Death|0|||
94671678|NCT02291614|324250473|FG009|Overall Study|Death|0|||
94671679|NCT02291614|324250474|FG010|Overall Study|Death|0|||
94359656|NCT04668066|323100339|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
94359657|NCT04668066|323100340|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
94359658|NCT04668066|323100341|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
94359659|NCT04668066|323100342|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
94624951|NCT03667924|324085481|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
94624952|NCT03667924|324085482|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
94624953|NCT03667924|324085480|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
94624954|NCT03667924|324085481|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
94624955|NCT03667924|324085482|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
94624956|NCT03667924|324085480|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
94624957|NCT03667924|324085481|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
94624958|NCT03667924|324085482|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
94624959|NCT03667924|324085480|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
94624960|NCT03667924|324085481|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
94624961|NCT03667924|324085482|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
94624962|NCT03667924|324085480|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
94624963|NCT03667924|324085481|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
94624964|NCT03667924|324085482|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
94624965|NCT03667924|324085480|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
94624966|NCT03667924|324085481|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
94624967|NCT03667924|324085482|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
94624968|NCT01325584|324085483|FG000|Overall Study|Death|1|||
94624969|NCT02617628|324085484|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
94624970|NCT02617628|324085485|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
94624971|NCT04484142|324085486|FG000|Overall Study|Adverse Event|13|||
94624972|NCT04484142|324085486|FG000|Overall Study|Progressive Disease|87|||
94624973|NCT04484142|324085486|FG000|Overall Study|Clinical Progression|10|||
94624974|NCT04484142|324085486|FG000|Overall Study|Withdrawal by Subject|6|||
94624975|NCT04484142|324085486|FG000|Overall Study|Physician Decision|1|||
94624976|NCT01713686|324086724|FG000|Overall Study|Lost to Follow-up|9|||
94624977|NCT01713686|324086724|FG000|Overall Study|Withdrawal by Subject|6|||
94624978|NCT03187197|324086727|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
94624979|NCT03187197|324086728|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
94624980|NCT03187197|324086729|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
94624981|NCT03187197|324086727|FG000|Overall Study|Withdrawal by Subject|8|||
94624982|NCT03187197|324086728|FG001|Overall Study|Withdrawal by Subject|63|||
94624983|NCT03187197|324086729|FG002|Overall Study|Withdrawal by Subject|4|||
94624984|NCT03187197|324086727|FG000|Overall Study|Lost to Follow-up|1|||
94624985|NCT03187197|324086728|FG001|Overall Study|Lost to Follow-up|60|||
94624986|NCT03187197|324086729|FG002|Overall Study|Lost to Follow-up|7|||
94624987|NCT03187197|324086727|FG000|Overall Study|Adverse Event|6|||
94624988|NCT03187197|324086728|FG001|Overall Study|Adverse Event|29|||
94624989|NCT03187197|324086729|FG002|Overall Study|Adverse Event|0|||
94624990|NCT03187197|324086727|FG000|Overall Study|Death|0|||
94624991|NCT03187197|324086728|FG001|Overall Study|Death|11|||
94624992|NCT03187197|324086729|FG002|Overall Study|Death|0|||
94624993|NCT03187197|324086727|FG000|Overall Study|Administrative problem|1|||
94624994|NCT03187197|324086728|FG001|Overall Study|Administrative problem|1|||
94624995|NCT03187197|324086729|FG002|Overall Study|Administrative problem|0|||
94624996|NCT03187197|324086727|FG000|Overall Study|Reason not listed|2|||
94624997|NCT03187197|324086728|FG001|Overall Study|Reason not listed|54|||
94624998|NCT03187197|324086729|FG002|Overall Study|Reason not listed|1|||
94624999|NCT03187197|324086727|FG000|Overall Study|Missing|1|||
94625000|NCT03187197|324086728|FG001|Overall Study|Missing|32|||
94625001|NCT03187197|324086729|FG002|Overall Study|Missing|3|||
94625002|NCT03187197|324086727|FG000|Overall Study|Status missing|2|||
94625003|NCT03187197|324086728|FG001|Overall Study|Status missing|33|||
94625004|NCT03187197|324086729|FG002|Overall Study|Status missing|3|||
94625005|NCT03187197|324086727|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
94625006|NCT03187197|324086728|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
94625007|NCT03187197|324086729|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
94625008|NCT02323113|324086730|FG000|Overall Study|Adverse Event|3|||
94625009|NCT02323113|324086731|FG001|Overall Study|Adverse Event|3|||
94625010|NCT02323113|324086732|FG002|Overall Study|Adverse Event|2|||
94625011|NCT02323113|324086733|FG003|Overall Study|Adverse Event|5|||
94359660|NCT04668066|323100343|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
94625012|NCT02323113|324086734|FG004|Overall Study|Adverse Event|8|||
94625013|NCT02323113|324086735|FG005|Overall Study|Adverse Event|3|||
94625014|NCT02323113|324086736|FG006|Overall Study|Adverse Event|6|||
94625015|NCT02323113|324086737|FG007|Overall Study|Adverse Event|0|||
94625016|NCT02323113|324086730|FG000|Overall Study|Progressive Disease|0|||
94461216|NCT02052596|323478214|FG001|Safety Phase|Enrolled in error|0|||
94625017|NCT02323113|324086731|FG001|Overall Study|Progressive Disease|1|||
94625018|NCT02323113|324086732|FG002|Overall Study|Progressive Disease|1|||
94625019|NCT02323113|324086733|FG003|Overall Study|Progressive Disease|0|||
94625020|NCT02323113|324086734|FG004|Overall Study|Progressive Disease|0|||
94625021|NCT02323113|324086735|FG005|Overall Study|Progressive Disease|3|||
94625022|NCT02323113|324086736|FG006|Overall Study|Progressive Disease|0|||
94625023|NCT02323113|324086737|FG007|Overall Study|Progressive Disease|0|||
94625024|NCT02323113|324086730|FG000|Overall Study|Symptomatic Deterioration|0|||
94625025|NCT02323113|324086731|FG001|Overall Study|Symptomatic Deterioration|0|||
94625026|NCT02323113|324086732|FG002|Overall Study|Symptomatic Deterioration|1|||
94625027|NCT02323113|324086733|FG003|Overall Study|Symptomatic Deterioration|0|||
94625028|NCT02323113|324086734|FG004|Overall Study|Symptomatic Deterioration|1|||
94625029|NCT02323113|324086735|FG005|Overall Study|Symptomatic Deterioration|0|||
94625030|NCT02323113|324086736|FG006|Overall Study|Symptomatic Deterioration|0|||
94625031|NCT02323113|324086737|FG007|Overall Study|Symptomatic Deterioration|0|||
94625032|NCT02323113|324086730|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
94625033|NCT02323113|324086731|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
94625034|NCT02323113|324086732|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
94625035|NCT02323113|324086733|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
94625036|NCT02323113|324086734|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
94625037|NCT02323113|324086735|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
94625038|NCT02323113|324086736|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
94625039|NCT02323113|324086737|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
94625040|NCT02323113|324086730|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
94625041|NCT02323113|324086731|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
94625042|NCT02323113|324086732|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
94625043|NCT02323113|324086733|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
94625044|NCT02323113|324086734|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
94625045|NCT02323113|324086735|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
94625046|NCT02323113|324086736|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
94625047|NCT02323113|324086737|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
94625048|NCT00381485|324086741|FG000|Open-Label Run-In Period|Adverse Event|9|||
94625049|NCT00381485|324086742|FG001|Open-Label Run-In Period|Adverse Event|0|||
94625050|NCT00381485|324086743|FG002|Open-Label Run-In Period|Adverse Event|0|||
94625051|NCT00381485|324086744|FG003|Open-Label Run-In Period|Adverse Event|0|||
94625052|NCT00381485|324086741|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
94625053|NCT00381485|324086742|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
94625054|NCT00381485|324086743|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
94625055|NCT00381485|324086744|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
94625056|NCT00381485|324086741|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
94625057|NCT00381485|324086742|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
94625058|NCT00381485|324086743|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
94625059|NCT00381485|324086744|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
94625060|NCT00381485|324086741|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
94625061|NCT00381485|324086742|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
94625062|NCT00381485|324086743|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
94625063|NCT00381485|324086744|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
94625064|NCT00381485|324086741|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
94625065|NCT00381485|324086742|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
94625066|NCT00381485|324086743|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
94625067|NCT00381485|324086744|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
94625068|NCT00381485|324086741|FG000|Open-Label Run-In Period|Treatment failure|1|||
94625069|NCT00381485|324086742|FG001|Open-Label Run-In Period|Treatment failure|0|||
94625070|NCT00381485|324086743|FG002|Open-Label Run-In Period|Treatment failure|0|||
94625071|NCT00381485|324086744|FG003|Open-Label Run-In Period|Treatment failure|0|||
94625072|NCT00381485|324086741|FG000|Double-Blind Treatment Period|Adverse Event|0|||
94625073|NCT00381485|324086742|FG001|Double-Blind Treatment Period|Adverse Event|2|||
94625074|NCT00381485|324086743|FG002|Double-Blind Treatment Period|Adverse Event|2|||
94625075|NCT00381485|324086744|FG003|Double-Blind Treatment Period|Adverse Event|5|||
94625076|NCT00381485|324086741|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
94625077|NCT00381485|324086742|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
94625078|NCT00381485|324086743|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
94625079|NCT00381485|324086744|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
94625080|NCT00381485|324086741|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
94625081|NCT00381485|324086742|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
94625082|NCT00381485|324086743|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
94625083|NCT00381485|324086744|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
94625084|NCT00381485|324086741|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
94625085|NCT00381485|324086742|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
94625086|NCT00381485|324086743|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
94625087|NCT00381485|324086744|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
94625088|NCT00381485|324086741|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
94625089|NCT00381485|324086742|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
94625090|NCT00381485|324086743|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
94625091|NCT00381485|324086744|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
94625092|NCT00381485|324086741|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
94625093|NCT00381485|324086742|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
94625094|NCT00381485|324086743|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
94625095|NCT00381485|324086744|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
94625096|NCT00381485|324086741|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
94625097|NCT00381485|324086742|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
94625098|NCT00381485|324086743|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
94625099|NCT00381485|324086744|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
94625100|NCT00381485|324086741|FG000|Double-Blind Treatment Period|Administrative|0|||
94625101|NCT00381485|324086742|FG001|Double-Blind Treatment Period|Administrative|1|||
94625102|NCT00381485|324086743|FG002|Double-Blind Treatment Period|Administrative|0|||
94625103|NCT00381485|324086744|FG003|Double-Blind Treatment Period|Administrative|1|||
94625104|NCT01235351|324086745|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
94625105|NCT01235351|324086746|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
94625106|NCT01648101|324086748|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
94625107|NCT01648101|324086749|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
94625108|NCT01648101|324086750|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
94625109|NCT01648101|324086748|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
94625110|NCT01648101|324086749|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
94625111|NCT01648101|324086750|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
94625112|NCT01648101|324086748|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
94625113|NCT01648101|324086749|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
94625114|NCT01648101|324086750|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
94625115|NCT01648101|324086748|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
94625116|NCT01648101|324086749|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
94625117|NCT01648101|324086750|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
94625118|NCT01648101|324086748|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
94625119|NCT01648101|324086749|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
94625120|NCT01648101|324086750|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
94625121|NCT01648101|324086748|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
94625122|NCT01648101|324086749|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
94625123|NCT01648101|324086750|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
94625124|NCT01648101|324086748|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
94625125|NCT01648101|324086749|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
94625126|NCT01648101|324086750|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
94625127|NCT01648101|324086748|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
94625128|NCT01648101|324086749|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
94625129|NCT01648101|324086750|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
94625130|NCT01648101|324086748|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
94625131|NCT01648101|324086749|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
94625132|NCT01648101|324086750|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
94625133|NCT01648101|324086748|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
94625134|NCT01648101|324086749|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
94625135|NCT01648101|324086750|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
94625136|NCT01648101|324086748|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
94625137|NCT01648101|324086749|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
94625138|NCT01648101|324086750|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
94625139|NCT01581931|324086763|FG000|Washout|Adverse Event|0|||
94625140|NCT01581931|324086764|FG001|Washout|Adverse Event|1|||
94625141|NCT00907777|324086765|FG000|Overall Study|Withdrawal by Subject|0|||
94625142|NCT00907777|324086766|FG001|Overall Study|Withdrawal by Subject|1|||
94625143|NCT03156543|324086767|FG000|Overall Study|Withdrawal by Subject|1|||
94625144|NCT03156543|324086768|FG001|Overall Study|Withdrawal by Subject|0|||
94671680|NCT01565707|324250477|FG000|Overall Study|Adverse Event|1|||
94671681|NCT01565707|324250478|FG001|Overall Study|Adverse Event|6|||
94625145|NCT01473836|324086769|FG000|Overall Study|Adverse Event|4|||
94625146|NCT01473836|324086769|FG000|Overall Study|Lack of Efficacy|1|||
94625147|NCT01473836|324086769|FG000|Overall Study|Does not meet entrance criteria|1|||
94671682|NCT01565707|324250479|FG002|Overall Study|Adverse Event|2|||
94671683|NCT01565707|324250480|FG003|Overall Study|Adverse Event|1|||
94625148|NCT03291808|324086770|FG000|Overall Study|Lost to Follow-up|6|||
94625149|NCT03291808|324086770|FG000|Overall Study|Research burden|4|||
94625150|NCT02674529|324086775|FG000|Overall Study|Lost to Follow-up|1|||
94625151|NCT02674529|324086776|FG001|Overall Study|Lost to Follow-up|2|||
94625152|NCT02674529|324086775|FG000|Overall Study|Withdrawal by Subject|2|||
94625153|NCT02674529|324086776|FG001|Overall Study|Withdrawal by Subject|1|||
94625154|NCT02674529|324086775|FG000|Overall Study|Physician Decision|0|||
94625155|NCT02674529|324086776|FG001|Overall Study|Physician Decision|1|||
94625156|NCT02674529|324086775|FG000|Overall Study|Protocol Violation|0|||
94625157|NCT02674529|324086776|FG001|Overall Study|Protocol Violation|1|||
94625158|NCT02891850|324086777|FG000|Overall Study|Adverse Event|3|||
94625159|NCT02891850|324086778|FG001|Overall Study|Adverse Event|0|||
94625160|NCT02891850|324086777|FG000|Overall Study|Death|0|||
94625161|NCT02891850|324086778|FG001|Overall Study|Death|4|||
94625162|NCT02891850|324086777|FG000|Overall Study|Physician Decision|1|||
94625163|NCT02891850|324086778|FG001|Overall Study|Physician Decision|0|||
94625164|NCT02891850|324086777|FG000|Overall Study|Pregnancy|1|||
94625165|NCT02891850|324086778|FG001|Overall Study|Pregnancy|0|||
94625166|NCT02891850|324086777|FG000|Overall Study|Withdrawal by Subject|2|||
94625167|NCT02891850|324086778|FG001|Overall Study|Withdrawal by Subject|3|||
94625168|NCT01892293|324086783|FG000|Overall Study|Apheresed but not treated|4|||
94625169|NCT00674700|324086784|FG000|Year 1|Adverse Event|17|||
94625170|NCT00674700|324086785|FG001|Year 1|Adverse Event|20|||
94625171|NCT00674700|324086786|FG002|Year 1|Adverse Event|5|||
94625172|NCT00674700|324086784|FG000|Year 1|Withdrawal by Subject|7|||
94625173|NCT00674700|324086785|FG001|Year 1|Withdrawal by Subject|7|||
94625174|NCT00674700|324086786|FG002|Year 1|Withdrawal by Subject|6|||
94625175|NCT00674700|324086784|FG000|Year 1|Any other reason not above-mentioned|7|||
94625176|NCT00674700|324086785|FG001|Year 1|Any other reason not above-mentioned|7|||
94625177|NCT00674700|324086786|FG002|Year 1|Any other reason not above-mentioned|6|||
94625178|NCT00674700|324086784|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
94625179|NCT00674700|324086785|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
94625180|NCT00674700|324086786|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
94625181|NCT00674700|324086784|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
94625182|NCT00674700|324086785|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
94625183|NCT00674700|324086786|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
94625184|NCT00674700|324086784|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
94625185|NCT00674700|324086785|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
94625186|NCT00674700|324086786|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
94625187|NCT02871297|324086791|FG000|Overall Study|Adverse Event|34|||
94625188|NCT02871297|324086791|FG000|Overall Study|Lack of Efficacy|10|||
94625189|NCT02871297|324086791|FG000|Overall Study|Non-compliance with study drug|15|||
94625190|NCT02871297|324086791|FG000|Overall Study|Protocol Violation|3|||
94625191|NCT02871297|324086791|FG000|Overall Study|Withdrawal by Subject|20|||
94625192|NCT02871297|324086791|FG000|Overall Study|Lost to Follow-up|13|||
94625193|NCT02871297|324086791|FG000|Overall Study|Rolled over to 13546A|2|||
94625194|NCT02871297|324086791|FG000|Overall Study|Other than specified|39|||
94625195|NCT02966028|324086792|FG000|Overall Study|Adverse Event|7|||
94625196|NCT02966028|324086793|FG001|Overall Study|Adverse Event|13|||
94625197|NCT02966028|324086794|FG002|Overall Study|Adverse Event|10|||
94625198|NCT02966028|324086792|FG000|Overall Study|Physician Decision|1|||
94625199|NCT02966028|324086793|FG001|Overall Study|Physician Decision|0|||
94625200|NCT02966028|324086794|FG002|Overall Study|Physician Decision|2|||
94625201|NCT02966028|324086792|FG000|Overall Study|Withdrawal by Subject|7|||
94625202|NCT02966028|324086793|FG001|Overall Study|Withdrawal by Subject|5|||
94625203|NCT02966028|324086794|FG002|Overall Study|Withdrawal by Subject|5|||
94625204|NCT02966028|324086792|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
94625205|NCT02966028|324086793|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
94625206|NCT02966028|324086794|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
94625207|NCT00056316|324086797|FG000|Overall Study|Withdrawal by Subject|2|||
94625208|NCT00056316|324086798|FG001|Overall Study|Withdrawal by Subject|2|||
94625209|NCT00056316|324086797|FG000|Overall Study|Death/NH placement of pt|1|||
94625210|NCT00056316|324086798|FG001|Overall Study|Death/NH placement of pt|1|||
94625211|NCT04980040|324086799|FG000|Overall Study|Violated the Inclusion Criteria|260|||
94625212|NCT04980040|324086799|FG000|Overall Study|Violated the Administration & Dosage|225|||
94625213|NCT04980040|324086799|FG000|Overall Study|Lost to Safety-Follow-up|4|||
94625214|NCT04980040|324086799|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
94625215|NCT02820753|324086800|FG000|2 Month|Withdrawal by Subject|3|||
94625216|NCT02820753|324086801|FG001|2 Month|Withdrawal by Subject|3|||
94625217|NCT02820753|324086800|FG000|2 Month|Lost to Follow-up|24|||
94461217|NCT02052596|323478213|FG000|Safety Phase|Lost due to Crohn's disease|0|||
94625218|NCT02820753|324086801|FG001|2 Month|Lost to Follow-up|26|||
94625219|NCT02820753|324086800|FG000|2 Month|Stopped per NIH Hold|51|||
94625220|NCT02820753|324086801|FG001|2 Month|Stopped per NIH Hold|13|||
94625221|NCT02820753|324086800|FG000|6 Month|Withdrawal by Subject|2|||
94625222|NCT02820753|324086801|FG001|6 Month|Withdrawal by Subject|2|||
94625223|NCT02820753|324086800|FG000|6 Month|Lost to Follow-up|20|||
94625224|NCT02820753|324086801|FG001|6 Month|Lost to Follow-up|27|||
94625225|NCT02820753|324086800|FG000|6 Month|Stopped per NIH Hold|81|||
94625226|NCT02820753|324086801|FG001|6 Month|Stopped per NIH Hold|81|||
94625227|NCT02820753|324086800|FG000|6 Month|Death|0|||
94625228|NCT02820753|324086801|FG001|6 Month|Death|1|||
94625229|NCT01397084|324086802|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
94625230|NCT01397084|324086802|FG000|Overall Study|Protocol Violation|2|||
94625231|NCT01397084|324086802|FG000|Overall Study|Adverse Event|2|||
94625232|NCT01397084|324086802|FG000|Overall Study|Withdrawal by Subject|1|||
94625233|NCT01397084|324086802|FG000|Overall Study|Lost to Follow-up|1|||
94625234|NCT01397084|324086802|FG000|Overall Study|Used other proton pump inhibitor|1|||
94625235|NCT00004978|324086803|FG000|Overall Study|Death|107|||
94625236|NCT00004978|324086804|FG001|Overall Study|Death|116|||
94625237|NCT00004978|324086803|FG000|Overall Study|Lost to Follow-up|101|||
94625238|NCT00004978|324086804|FG001|Overall Study|Lost to Follow-up|108|||
94625239|NCT00004978|324086803|FG000|Overall Study|Withdrawal by Subject|17|||
94625240|NCT00004978|324086804|FG001|Overall Study|Withdrawal by Subject|26|||
94625241|NCT00004978|324086803|FG000|Overall Study|site closure - not in analysis cohort|19|||
94625242|NCT00004978|324086804|FG001|Overall Study|site closure - not in analysis cohort|20|||
94625243|NCT03761277|324086805|FG000|Enrollment to Implant|Screen Failure|17|||
94625244|NCT03761277|324086805|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
94625245|NCT03761277|324086805|FG000|Enrollment to Implant|Physician Decision|2|||
94625246|NCT03761277|324086805|FG000|Enrollment to Implant|Site Closure|3|||
94625247|NCT03761277|324086805|FG000|Enrollment to Implant|Sponsor Request|2|||
94625248|NCT03761277|324086805|FG000|Post-Implant to 6 Months|Adverse Event|2|||
94625249|NCT03761277|324086805|FG000|Post-Implant to 6 Months|Death|1|||
94625250|NCT03761277|324086805|FG000|Post-Implant to 6 Months|Site Closure|2|||
94625251|NCT03761277|324086805|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
94625252|NCT03761277|324086805|FG000|6 Months to 12 Months|Physician Decision|2|||
94625253|NCT03761277|324086805|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
94625254|NCT01652703|324086806|FG000|Overall Study|Withdrawal by Subject|0|||
94625255|NCT01652703|324086807|FG001|Overall Study|Withdrawal by Subject|1|||
94625256|NCT01652703|324086808|FG002|Overall Study|Withdrawal by Subject|3|||
94625257|NCT01652703|324086809|FG003|Overall Study|Withdrawal by Subject|1|||
94625258|NCT01652703|324086810|FG004|Overall Study|Withdrawal by Subject|0|||
94625259|NCT01652703|324086811|FG005|Overall Study|Withdrawal by Subject|1|||
94625260|NCT01652703|324086806|FG000|Overall Study|Other|0|||
94625261|NCT01652703|324086807|FG001|Overall Study|Other|0|||
94625262|NCT01652703|324086808|FG002|Overall Study|Other|0|||
94625263|NCT01652703|324086809|FG003|Overall Study|Other|1|||
94625264|NCT01652703|324086810|FG004|Overall Study|Other|1|||
94625265|NCT01652703|324086811|FG005|Overall Study|Other|1|||
94625266|NCT00684593|324086817|FG000|Overall Study|Adverse Event|0|||
94625267|NCT00684593|324086818|FG001|Overall Study|Adverse Event|2|||
94625268|NCT02270957|324086828|FG000|Overall Study|Lack of Efficacy|2|||
94625269|NCT02270957|324086829|FG001|Overall Study|Lack of Efficacy|4|||
94625270|NCT02270957|324086828|FG000|Overall Study|Adverse Event|2|||
94625271|NCT02270957|324086829|FG001|Overall Study|Adverse Event|0|||
94625272|NCT04343261|324086830|FG000|Overall Study|Adverse Event|1|||
94625273|NCT04343261|324086830|FG000|Overall Study|received inadequate amount of antibodies|7|||
94625274|NCT01539538|324086832|FG000|Overall Study|Adverse Event|13|||
94625275|NCT01539538|324086833|FG001|Overall Study|Adverse Event|18|||
94625276|NCT01539538|324086832|FG000|Overall Study|Lack of Efficacy|13|||
94625277|NCT01539538|324086833|FG001|Overall Study|Lack of Efficacy|16|||
94625278|NCT01539538|324086832|FG000|Overall Study|Withdrawal by Subject|2|||
94625279|NCT01539538|324086833|FG001|Overall Study|Withdrawal by Subject|3|||
94625280|NCT01539538|324086832|FG000|Overall Study|PCA no longer required or PCA problem|3|||
94359661|NCT04668066|323100344|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
94359662|NCT04668066|323100345|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
94359663|NCT04668066|323100346|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
94359664|NCT04668066|323100347|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
94359665|NCT04668066|323100348|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
94359666|NCT04668066|323100349|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
94359667|NCT04668066|323100350|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
94359668|NCT04668066|323100351|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
94359669|NCT04668066|323100352|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
94359670|NCT04668066|323100353|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
94359671|NCT04668066|323100354|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
94359672|NCT04668066|323100336|FG000|Part 2: Treatment Phase|Other|0|||
94359673|NCT04668066|323100337|FG001|Part 2: Treatment Phase|Other|0|||
94359674|NCT04668066|323100338|FG002|Part 2: Treatment Phase|Other|0|||
94359675|NCT04668066|323100339|FG003|Part 2: Treatment Phase|Other|0|||
94359676|NCT04668066|323100340|FG004|Part 2: Treatment Phase|Other|0|||
94359677|NCT04668066|323100341|FG005|Part 2: Treatment Phase|Other|0|||
94359678|NCT04668066|323100342|FG006|Part 2: Treatment Phase|Other|0|||
94359679|NCT04668066|323100343|FG007|Part 2: Treatment Phase|Other|0|||
94359680|NCT04668066|323100344|FG008|Part 2: Treatment Phase|Other|0|||
94359681|NCT04668066|323100345|FG009|Part 2: Treatment Phase|Other|0|||
94359682|NCT04668066|323100346|FG010|Part 2: Treatment Phase|Other|0|||
94359683|NCT04668066|323100347|FG011|Part 2: Treatment Phase|Other|0|||
94359684|NCT04668066|323100348|FG012|Part 2: Treatment Phase|Other|0|||
94359685|NCT04668066|323100349|FG013|Part 2: Treatment Phase|Other|0|||
94359686|NCT04668066|323100350|FG014|Part 2: Treatment Phase|Other|0|||
94359687|NCT04668066|323100351|FG015|Part 2: Treatment Phase|Other|0|||
94359688|NCT04668066|323100352|FG016|Part 2: Treatment Phase|Other|0|||
94359689|NCT04668066|323100353|FG017|Part 2: Treatment Phase|Other|0|||
94359690|NCT04668066|323100354|FG018|Part 2: Treatment Phase|Other|1|||
94359691|NCT04668066|323100336|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
94625281|NCT01539538|324086833|FG001|Overall Study|PCA no longer required or PCA problem|7|||
94625282|NCT03782792|324086837|FG000|Overall Study|Patient left the country|0|||
94625283|NCT03782792|324086838|FG001|Overall Study|Patient left the country|1|||
94625284|NCT03782792|324086837|FG000|Overall Study|Withdrawal by Subject|1|||
94359692|NCT04668066|323100337|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
94625285|NCT03782792|324086838|FG001|Overall Study|Withdrawal by Subject|2|||
94625286|NCT02321800|324086842|FG000|Overall Study|Withdrawal by Subject|3|||
94625287|NCT02321800|324086843|FG001|Overall Study|Withdrawal by Subject|3|||
94625288|NCT02321800|324086842|FG000|Overall Study|Death|1|||
94625289|NCT02321800|324086843|FG001|Overall Study|Death|0|||
94625290|NCT02321800|324086842|FG000|Overall Study|Protocol Violation|1|||
94625291|NCT02321800|324086843|FG001|Overall Study|Protocol Violation|0|||
94625292|NCT02321800|324086842|FG000|Overall Study|Lost to Follow-up|10|||
94625293|NCT02321800|324086843|FG001|Overall Study|Lost to Follow-up|4|||
94625294|NCT02321800|324086842|FG000|Overall Study|Adverse Event|2|||
94625295|NCT02321800|324086843|FG001|Overall Study|Adverse Event|3|||
94625296|NCT02321800|324086842|FG000|Overall Study|Other, Miscellaneous|3|||
94625297|NCT02321800|324086843|FG001|Overall Study|Other, Miscellaneous|1|||
94625298|NCT03845985|324086849|FG000|Overall Study|Lost to Follow-up|2|||
94625299|NCT03845985|324086850|FG001|Overall Study|Lost to Follow-up|1|||
94625300|NCT03845985|324086849|FG000|Overall Study|Physician Decision|1|||
94625301|NCT03845985|324086850|FG001|Overall Study|Physician Decision|0|||
94625302|NCT03845985|324086849|FG000|Overall Study|Withdrawal by Subject|4|||
94625303|NCT03845985|324086850|FG001|Overall Study|Withdrawal by Subject|1|||
94625304|NCT01962896|324086852|FG000|Overall Study|Lack of Efficacy|4|||
94625305|NCT01866930|324086853|FG000|Treatment Period|Other|1|||
94625306|NCT01866930|324086854|FG001|Treatment Period|Other|0|||
94625307|NCT01866930|324086853|FG000|Treatment Period|Death|0|||
94625308|NCT01866930|324086854|FG001|Treatment Period|Death|2|||
94625309|NCT01866930|324086853|FG000|Treatment Period|Poor/non compliance|0|||
94625310|NCT01866930|324086854|FG001|Treatment Period|Poor/non compliance|2|||
94625311|NCT01866930|324086853|FG000|Treatment Period|No longer meets study criteria|0|||
94625312|NCT01866930|324086854|FG001|Treatment Period|No longer meets study criteria|1|||
94625313|NCT01866930|324086853|FG000|Treatment Period|Withdrawal by Subject|2|||
94625314|NCT01866930|324086854|FG001|Treatment Period|Withdrawal by Subject|8|||
94625315|NCT01866930|324086853|FG000|Treatment Period|Lack of Efficacy|1|||
94625316|NCT01866930|324086854|FG001|Treatment Period|Lack of Efficacy|9|||
94625317|NCT01866930|324086853|FG000|Treatment Period|Adverse Event|4|||
94625318|NCT01866930|324086854|FG001|Treatment Period|Adverse Event|12|||
94625319|NCT01866930|324086853|FG000|Treatment Period|Lost to Follow-up|1|||
94625320|NCT01866930|324086854|FG001|Treatment Period|Lost to Follow-up|1|||
94359693|NCT04668066|323100338|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
94359694|NCT04668066|323100339|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
94359695|NCT04668066|323100340|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
94359696|NCT04668066|323100341|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
94359697|NCT04668066|323100342|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
94359698|NCT04668066|323100343|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
94359699|NCT04668066|323100344|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
94359700|NCT04668066|323100345|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
94359701|NCT04668066|323100346|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
94359702|NCT04668066|323100347|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
94359703|NCT04668066|323100348|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
94359704|NCT04668066|323100349|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
94359705|NCT04668066|323100350|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
94359706|NCT04668066|323100351|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
94359707|NCT04668066|323100352|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
94625321|NCT01866930|324086853|FG000|Follow-up Period|Lost to Follow-up|1|||
94625322|NCT01866930|324086854|FG001|Follow-up Period|Lost to Follow-up|1|||
94625323|NCT01866930|324086853|FG000|Follow-up Period|Other|1|||
94625324|NCT01866930|324086854|FG001|Follow-up Period|Other|5|||
94625325|NCT01866930|324086853|FG000|Follow-up Period|No longer required per protocol|1|||
94625326|NCT01866930|324086854|FG001|Follow-up Period|No longer required per protocol|0|||
94625327|NCT01866930|324086853|FG000|Follow-up Period|Withdrawal by Subject|3|||
94625328|NCT01866930|324086854|FG001|Follow-up Period|Withdrawal by Subject|3|||
94625329|NCT00279305|324086857|FG000|Overall Study|Pregnancy|1|||
94625330|NCT00279305|324086858|FG001|Overall Study|Pregnancy|0|||
94625331|NCT00279305|324086857|FG000|Overall Study|Withdrawal by Subject|2|||
94625332|NCT00279305|324086858|FG001|Overall Study|Withdrawal by Subject|0|||
94625333|NCT00279305|324086857|FG000|Overall Study|Dificulting establishing IV|1|||
94625334|NCT00279305|324086858|FG001|Overall Study|Dificulting establishing IV|0|||
94625335|NCT00279305|324086857|FG000|Overall Study|FDA Safety Alert|4|||
94625336|NCT00279305|324086858|FG001|Overall Study|FDA Safety Alert|1|||
94625337|NCT00458211|324086860|FG000|Overall Study|Lack of Efficacy|12|||
94625338|NCT00458211|324086860|FG000|Overall Study|Withdrawal by Subject|2|||
94625339|NCT00458211|324086860|FG000|Overall Study|Protocol Violation|2|||
94625340|NCT03918447|324086863|FG000|Overall Study|Death|1|||
94625341|NCT03918447|324086864|FG001|Overall Study|Death|0|||
94625342|NCT03918447|324086863|FG000|Overall Study|Lost to Follow-up|13|||
94625343|NCT03918447|324086864|FG001|Overall Study|Lost to Follow-up|6|||
94625344|NCT03918447|324086863|FG000|Overall Study|Withdrawal by Subject|19|||
94625345|NCT03918447|324086864|FG001|Overall Study|Withdrawal by Subject|17|||
94625346|NCT03918447|324086863|FG000|Overall Study|Study Terminated by Sponsor|195|||
94625347|NCT03918447|324086864|FG001|Overall Study|Study Terminated by Sponsor|197|||
94625348|NCT03918447|324086863|FG000|Overall Study|Reason not Specified|0|||
94625349|NCT03918447|324086864|FG001|Overall Study|Reason not Specified|1|||
94625350|NCT05355805|324086865|FG000|Overall Study|Lost to Follow-up|6|||
94625351|NCT05355805|324086866|FG001|Overall Study|Lost to Follow-up|11|||
94625352|NCT05355805|324086867|FG002|Overall Study|Lost to Follow-up|10|||
94625353|NCT05355805|324086868|FG003|Overall Study|Lost to Follow-up|6|||
94625354|NCT05355805|324086865|FG000|Overall Study|Decision by Sponsor|0|||
94625355|NCT05355805|324086866|FG001|Overall Study|Decision by Sponsor|0|||
94625356|NCT05355805|324086867|FG002|Overall Study|Decision by Sponsor|1|||
94625357|NCT05355805|324086868|FG003|Overall Study|Decision by Sponsor|0|||
94625358|NCT05355805|324086865|FG000|Overall Study|Withdrawal by Subject|7|||
94625359|NCT05355805|324086866|FG001|Overall Study|Withdrawal by Subject|14|||
94625360|NCT05355805|324086867|FG002|Overall Study|Withdrawal by Subject|15|||
94625361|NCT05355805|324086868|FG003|Overall Study|Withdrawal by Subject|13|||
94625362|NCT00884312|324088486|FG000|Overall Study|Non-fatal Progressive Disease|0|||
94625363|NCT00884312|324088487|FG001|Overall Study|Non-fatal Progressive Disease|8|||
94625364|NCT00884312|324088486|FG000|Overall Study|Fatal Progressive Disease|0|||
94625365|NCT00884312|324088487|FG001|Overall Study|Fatal Progressive Disease|1|||
94625366|NCT00884312|324088486|FG000|Overall Study|Non-fatal Adverse Event|1|||
94625367|NCT00884312|324088487|FG001|Overall Study|Non-fatal Adverse Event|0|||
94625368|NCT00884312|324088486|FG000|Overall Study|Fatal Adverse Event|1|||
94625369|NCT00884312|324088487|FG001|Overall Study|Fatal Adverse Event|4|||
94625370|NCT00884312|324088486|FG000|Overall Study|Withdrawal by Subject|0|||
94625371|NCT00884312|324088487|FG001|Overall Study|Withdrawal by Subject|6|||
94625372|NCT00884312|324088486|FG000|Overall Study|Physician Decision|0|||
94625373|NCT00884312|324088487|FG001|Overall Study|Physician Decision|1|||
94359708|NCT04668066|323100353|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
94359709|NCT04668066|323100354|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
94625374|NCT00884312|324088486|FG000|Overall Study|Other|0|||
94625375|NCT00884312|324088487|FG001|Overall Study|Other|4|||
94625376|NCT00884312|324088486|FG000|Overall Study|Did Not Receive Study Drug|0|||
94625377|NCT00884312|324088487|FG001|Overall Study|Did Not Receive Study Drug|1|||
94625378|NCT02585960|324088488|FG000|PK/Safety Assessment Period|Physician Decision|0|||
94625379|NCT02585960|324088489|FG001|PK/Safety Assessment Period|Physician Decision|1|||
94625380|NCT02585960|324088490|FG002|PK/Safety Assessment Period|Physician Decision|0|||
94625381|NCT02585960|324088488|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
94625382|NCT02585960|324088489|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
94625383|NCT02585960|324088490|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
94625384|NCT02585960|324088488|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
94359710|NCT01886105|323100355|FG000|Overall Study|Lack of Efficacy|3|||
94359711|NCT01891669|323100356|FG000|Overall Study|Death|0|||
94359712|NCT01891669|323100357|FG001|Overall Study|Death|0|||
94359713|NCT01891669|323100358|FG002|Overall Study|Death|0|||
94359714|NCT01891669|323100359|FG003|Overall Study|Death|0|||
94359715|NCT01891669|323100360|FG004|Overall Study|Death|0|||
94359716|NCT01891669|323100361|FG005|Overall Study|Death|0|||
94359717|NCT01891669|323100362|FG006|Overall Study|Death|0|||
94359718|NCT01891669|323100363|FG007|Overall Study|Death|1|||
94359719|NCT01891669|323100364|FG008|Overall Study|Death|0|||
94359720|NCT01891669|323100365|FG009|Overall Study|Death|1|||
94359721|NCT01891669|323100356|FG000|Overall Study|Withdrawal by Subject|1|||
94359722|NCT01891669|323100357|FG001|Overall Study|Withdrawal by Subject|1|||
94359723|NCT01891669|323100358|FG002|Overall Study|Withdrawal by Subject|0|||
94359724|NCT01891669|323100359|FG003|Overall Study|Withdrawal by Subject|0|||
94359725|NCT01891669|323100360|FG004|Overall Study|Withdrawal by Subject|0|||
94359726|NCT01891669|323100361|FG005|Overall Study|Withdrawal by Subject|0|||
94359727|NCT01891669|323100362|FG006|Overall Study|Withdrawal by Subject|1|||
94461218|NCT02052596|323478214|FG001|Safety Phase|Lost due to Crohn's disease|1|||
94461219|NCT02850016|323478215|FG000|Overall Study|Withdrawal by Subject|1|||
94461220|NCT02850016|323478216|FG001|Overall Study|Withdrawal by Subject|2|||
94461221|NCT03536949|323478217|FG000|Overall Study|Adverse Event|4|||
94625385|NCT02585960|324088489|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
94625386|NCT02585960|324088490|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
94625387|NCT02585960|324088488|FG000|PK/Safety Assessment Period|Other|4|||
94625388|NCT02585960|324088489|FG001|PK/Safety Assessment Period|Other|4|||
94625389|NCT02585960|324088490|FG002|PK/Safety Assessment Period|Other|0|||
94625390|NCT02585960|324088488|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
94625391|NCT02585960|324088489|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
94625392|NCT02585960|324088490|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
94625393|NCT02585960|324088488|FG000|PK/Safety Assessment Period|Screen Failure|0|||
94625394|NCT02585960|324088489|FG001|PK/Safety Assessment Period|Screen Failure|0|||
94625395|NCT02585960|324088490|FG002|PK/Safety Assessment Period|Screen Failure|1|||
94625396|NCT02585960|324088488|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
94625397|NCT02585960|324088489|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
94625398|NCT02585960|324088490|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
94625399|NCT02585960|324088488|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
94625400|NCT02585960|324088489|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
94625401|NCT02585960|324088490|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
94625402|NCT02509156|324088491|FG000|Randomized Phase|Death|1|||
94625403|NCT02509156|324088492|FG001|Randomized Phase|Death|0|||
94625404|NCT02509156|324088491|FG000|Randomized Phase|Withdrawal by Subject|1|||
94625405|NCT02509156|324088492|FG001|Randomized Phase|Withdrawal by Subject|1|||
94625406|NCT03266107|324088493|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
94625407|NCT03266107|324088493|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
94625408|NCT03266107|324088493|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
94625409|NCT03266107|324088493|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
94625410|NCT01191801|324088494|FG000|Overall Study|Death|36|||
94625411|NCT01191801|324088495|FG001|Overall Study|Death|12|||
94625412|NCT01191801|324088494|FG000|Overall Study|Lack of Efficacy|176|||
94625413|NCT01191801|324088495|FG001|Overall Study|Lack of Efficacy|258|||
94625414|NCT01191801|324088494|FG000|Overall Study|Adverse Event|9|||
94625415|NCT01191801|324088495|FG001|Overall Study|Adverse Event|8|||
94625416|NCT01191801|324088494|FG000|Overall Study|Protocol Violation|2|||
94625417|NCT01191801|324088495|FG001|Overall Study|Protocol Violation|4|||
94625418|NCT01191801|324088494|FG000|Overall Study|Physician Decision|47|||
94625419|NCT01191801|324088495|FG001|Overall Study|Physician Decision|24|||
94625420|NCT01191801|324088494|FG000|Overall Study|Withdrawal by Subject|1|||
94625421|NCT01191801|324088495|FG001|Overall Study|Withdrawal by Subject|4|||
94625422|NCT01191801|324088494|FG000|Overall Study|Not Provided|45|||
94625423|NCT01191801|324088495|FG001|Overall Study|Not Provided|27|||
94625424|NCT00003479|324088496|FG000|Overall Study|Not evaluable|3|||
94625425|NCT00587054|324088499|FG000|Overall Study|Patient not treated|9|||
94625426|NCT03648541|324088500|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
94625427|NCT03648541|324088501|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
94625428|NCT03648541|324088500|FG000|Re-induction Period Only|Lack of Efficacy|7|||
94625429|NCT03648541|324088501|FG001|Re-induction Period Only|Lack of Efficacy|0|||
94625430|NCT03648541|324088500|FG000|Maintenance Period Only|Missing|0|||
94625431|NCT03648541|324088501|FG001|Maintenance Period Only|Missing|1|||
94625432|NCT03648541|324088500|FG000|Maintenance Period Only|Other not listed below|0|||
94625433|NCT03648541|324088501|FG001|Maintenance Period Only|Other not listed below|4|||
94625434|NCT03648541|324088500|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
94625435|NCT03648541|324088501|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
94359728|NCT01891669|323100363|FG007|Overall Study|Withdrawal by Subject|2|||
94359729|NCT01891669|323100364|FG008|Overall Study|Withdrawal by Subject|1|||
94359730|NCT01891669|323100365|FG009|Overall Study|Withdrawal by Subject|1|||
94359731|NCT01891669|323100356|FG000|Overall Study|Other|1|||
94359732|NCT01891669|323100357|FG001|Overall Study|Other|0|||
94359733|NCT01891669|323100358|FG002|Overall Study|Other|0|||
94359734|NCT01891669|323100359|FG003|Overall Study|Other|0|||
94359735|NCT01891669|323100360|FG004|Overall Study|Other|0|||
94359736|NCT01891669|323100361|FG005|Overall Study|Other|0|||
94359737|NCT01891669|323100362|FG006|Overall Study|Other|0|||
94359738|NCT01891669|323100363|FG007|Overall Study|Other|1|||
94359739|NCT01891669|323100364|FG008|Overall Study|Other|0|||
94359740|NCT01891669|323100365|FG009|Overall Study|Other|0|||
94359741|NCT02388906|323100370|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
94359742|NCT02388906|323100371|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
94359743|NCT02388906|323100370|FG000|Treatment Period|Disease progression|121|||
94359744|NCT02388906|323100371|FG001|Treatment Period|Disease progression|100|||
94359745|NCT02388906|323100370|FG000|Treatment Period|Study drug toxicity|41|||
94359746|NCT02388906|323100371|FG001|Treatment Period|Study drug toxicity|208|||
94359747|NCT02388906|323100370|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
94359748|NCT02388906|323100371|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
94359749|NCT02388906|323100370|FG000|Treatment Period|Participant request to stop treatment|5|||
94359750|NCT02388906|323100371|FG001|Treatment Period|Participant request to stop treatment|9|||
94359751|NCT02388906|323100370|FG000|Treatment Period|Participant withdrew consent|2|||
94359752|NCT02388906|323100371|FG001|Treatment Period|Participant withdrew consent|3|||
94359753|NCT02388906|323100370|FG000|Treatment Period|Poor/non-compliance|0|||
94359754|NCT02388906|323100371|FG001|Treatment Period|Poor/non-compliance|1|||
94359755|NCT02388906|323100370|FG000|Treatment Period|Participant no longer meets study criteria|0|||
94359756|NCT02388906|323100371|FG001|Treatment Period|Participant no longer meets study criteria|1|||
94359757|NCT02388906|323100370|FG000|Treatment Period|Other reasons|3|||
94359758|NCT02388906|323100371|FG001|Treatment Period|Other reasons|3|||
94359759|NCT00965562|323100374|FG000|Overall Study|Lost to Follow-up|1|||
94359760|NCT00965562|323100375|FG001|Overall Study|Lost to Follow-up|2|||
94359761|NCT00965562|323100376|FG002|Overall Study|Lost to Follow-up|3|||
94359762|NCT00965562|323100374|FG000|Overall Study|Withdrawal by Subject|2|||
94359763|NCT00965562|323100375|FG001|Overall Study|Withdrawal by Subject|2|||
94359764|NCT00965562|323100376|FG002|Overall Study|Withdrawal by Subject|0|||
94359765|NCT01195662|323100381|FG000|Double Blind Treatment Period|Adverse Event|4|||
94359766|NCT01195662|323100382|FG001|Double Blind Treatment Period|Adverse Event|1|||
94359767|NCT01195662|323100383|FG002|Double Blind Treatment Period|Adverse Event|2|||
94359768|NCT01195662|323100381|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
94359769|NCT01195662|323100382|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
94359770|NCT01195662|323100383|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
94359771|NCT01195662|323100381|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
94359772|NCT01195662|323100382|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
94359773|NCT01195662|323100383|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
94359774|NCT01195662|323100381|FG000|Double Blind Treatment Period|Administrative reason|2|||
94359775|NCT01195662|323100382|FG001|Double Blind Treatment Period|Administrative reason|1|||
94359776|NCT01195662|323100383|FG002|Double Blind Treatment Period|Administrative reason|1|||
94359777|NCT01195662|323100381|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
94359778|NCT01195662|323100382|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
94359779|NCT01195662|323100383|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
94359780|NCT01195662|323100381|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
94359781|NCT01195662|323100382|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
94359782|NCT01195662|323100383|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
94359783|NCT01195662|323100381|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
94359784|NCT01195662|323100382|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
94359785|NCT01195662|323100383|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
94359786|NCT01195662|323100381|FG000|Double Blind Treatment Period|Non-specified|3|||
94359787|NCT01195662|323100382|FG001|Double Blind Treatment Period|Non-specified|0|||
94625436|NCT03648541|324088500|FG000|Maintenance Period Only|Protocol Violation|0|||
94625437|NCT03648541|324088501|FG001|Maintenance Period Only|Protocol Violation|1|||
94625438|NCT03648541|324088500|FG000|Maintenance Period Only|Lack of Efficacy|0|||
94625439|NCT03648541|324088501|FG001|Maintenance Period Only|Lack of Efficacy|18|||
94625440|NCT03648541|324088500|FG000|Maintenance Period Only|Adverse Event|0|||
94625441|NCT03648541|324088501|FG001|Maintenance Period Only|Adverse Event|4|||
94625442|NCT03648541|324088500|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
94625443|NCT03648541|324088501|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
94625444|NCT02849678|324088504|FG000|Overall Study|Protocol Violation|3|||
94625445|NCT02849678|324088505|FG001|Overall Study|Protocol Violation|6|||
94359788|NCT01195662|323100383|FG002|Double Blind Treatment Period|Non-specified|0|||
94359789|NCT01195662|323100381|FG000|Double Blind Treatment Period|Missing disposition information|0|||
94359790|NCT01195662|323100382|FG001|Double Blind Treatment Period|Missing disposition information|1|||
94359791|NCT01195662|323100383|FG002|Double Blind Treatment Period|Missing disposition information|1|||
94359792|NCT01195662|323100381|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
94359793|NCT01195662|323100382|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
94359794|NCT01195662|323100383|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
94359795|NCT01195662|323100381|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
94359796|NCT01195662|323100382|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
94359797|NCT01195662|323100383|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
94359798|NCT01329562|323100384|FG000|Overall Study|Protocol Violation|5|||
94359799|NCT01329562|323100385|FG001|Overall Study|Protocol Violation|3|||
94359800|NCT01329562|323100384|FG000|Overall Study|Lost to Follow-up|1|||
94359801|NCT01329562|323100385|FG001|Overall Study|Lost to Follow-up|1|||
94359802|NCT01329562|323100384|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
94359803|NCT01329562|323100385|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
94359804|NCT01329562|323100384|FG000|Overall Study|Physician Decision|0|||
94359805|NCT01329562|323100385|FG001|Overall Study|Physician Decision|1|||
94359806|NCT03179462|323100389|FG000|Overall Study|screening failure|1|||
94359807|NCT03179462|323100390|FG001|Overall Study|screening failure|2|||
94359808|NCT03179462|323100391|FG002|Overall Study|screening failure|0|||
94359809|NCT01250418|323100392|FG000|Overall Study|monitor data failure|1|||
94359810|NCT01250418|323100393|FG001|Overall Study|monitor data failure|1|||
94359811|NCT01761565|323100394|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
94359812|NCT00816166|323100395|FG000|Overall Study|Lost to Follow-up|6|||
94359813|NCT00816166|323100396|FG001|Overall Study|Lost to Follow-up|10|||
94359814|NCT00816166|323100395|FG000|Overall Study|Death|4|||
94359815|NCT00816166|323100396|FG001|Overall Study|Death|2|||
94359816|NCT05182840|323100398|FG000|Run-in Period|Not treated|0|||
94359817|NCT05182840|323100399|FG001|Run-in Period|Not treated|1|||
94359818|NCT05182840|323100400|FG002|Run-in Period|Not treated|0|||
94359819|NCT05182840|323100401|FG003|Run-in Period|Not treated|0|||
94359820|NCT05182840|323100402|FG004|Run-in Period|Not treated|0|||
94359821|NCT05182840|323100403|FG005|Run-in Period|Not treated|0|||
94359822|NCT05182840|323100404|FG006|Run-in Period|Not treated|0|||
94359823|NCT05182840|323100405|FG007|Run-in Period|Not treated|0|||
94359824|NCT05182840|323100406|FG008|Run-in Period|Not treated|0|||
94359825|NCT05182840|323100407|FG009|Run-in Period|Not treated|0|||
94359826|NCT05182840|323100398|FG000|Run-in Period|Other reason but not sponsor termination|14|||
94359827|NCT05182840|323100399|FG001|Run-in Period|Other reason but not sponsor termination|18|||
94359828|NCT05182840|323100400|FG002|Run-in Period|Other reason but not sponsor termination|0|||
94359829|NCT05182840|323100401|FG003|Run-in Period|Other reason but not sponsor termination|0|||
94359830|NCT05182840|323100402|FG004|Run-in Period|Other reason but not sponsor termination|0|||
94359831|NCT05182840|323100403|FG005|Run-in Period|Other reason but not sponsor termination|0|||
94359832|NCT05182840|323100404|FG006|Run-in Period|Other reason but not sponsor termination|0|||
94359833|NCT05182840|323100405|FG007|Run-in Period|Other reason but not sponsor termination|0|||
94359834|NCT05182840|323100406|FG008|Run-in Period|Other reason but not sponsor termination|0|||
94359835|NCT05182840|323100407|FG009|Run-in Period|Other reason but not sponsor termination|0|||
94359836|NCT05182840|323100398|FG000|Run-in Period|No reason available|2|||
94359837|NCT05182840|323100399|FG001|Run-in Period|No reason available|2|||
94359838|NCT05182840|323100400|FG002|Run-in Period|No reason available|0|||
94359839|NCT05182840|323100401|FG003|Run-in Period|No reason available|0|||
94359840|NCT05182840|323100402|FG004|Run-in Period|No reason available|0|||
94359841|NCT05182840|323100403|FG005|Run-in Period|No reason available|0|||
94359842|NCT05182840|323100404|FG006|Run-in Period|No reason available|0|||
94625446|NCT00003499|324088506|FG000|Overall Study|Not evaluable|8|||
94625447|NCT00407797|324088509|FG000|Overall Study|Lost to Follow-up|2|||
94625448|NCT00407797|324088509|FG000|Overall Study|Adverse Event|6|||
94625449|NCT00407797|324088509|FG000|Overall Study|Other|7|||
94625450|NCT00407797|324088509|FG000|Overall Study|Withdrawal by Subject|3|||
94625451|NCT00851747|324088511|FG000|Overall Study|Physician Decision|6|||
94625452|NCT00851747|324088512|FG001|Overall Study|Physician Decision|6|||
94625453|NCT00851747|324088513|FG002|Overall Study|Physician Decision|6|||
94625454|NCT02340975|324088514|FG000|Overall Study|Death|6|||
94625455|NCT02340975|324088515|FG001|Overall Study|Death|23|||
94625456|NCT02340975|324088516|FG002|Overall Study|Death|21|||
94625457|NCT02340975|324088517|FG003|Overall Study|Death|7|||
94625458|NCT02340975|324088518|FG004|Overall Study|Death|21|||
94625459|NCT02340975|324088519|FG005|Overall Study|Death|13|||
94625460|NCT02340975|324088514|FG000|Overall Study|Lost to Follow-up|0|||
94625461|NCT02340975|324088515|FG001|Overall Study|Lost to Follow-up|0|||
94359843|NCT05182840|323100405|FG007|Run-in Period|No reason available|0|||
94359844|NCT05182840|323100406|FG008|Run-in Period|No reason available|0|||
94359845|NCT05182840|323100407|FG009|Run-in Period|No reason available|0|||
94359846|NCT05182840|323100398|FG000|Run-in Period|Burden of study procedures|2|||
94359847|NCT05182840|323100399|FG001|Run-in Period|Burden of study procedures|2|||
94359848|NCT05182840|323100400|FG002|Run-in Period|Burden of study procedures|0|||
94359849|NCT05182840|323100401|FG003|Run-in Period|Burden of study procedures|0|||
94359850|NCT05182840|323100402|FG004|Run-in Period|Burden of study procedures|0|||
94359851|NCT05182840|323100403|FG005|Run-in Period|Burden of study procedures|0|||
94625462|NCT02340975|324088516|FG002|Overall Study|Lost to Follow-up|0|||
94671684|NCT01565707|324250477|FG000|Overall Study|Lost to Follow-up|1|||
94671685|NCT01565707|324250478|FG001|Overall Study|Lost to Follow-up|0|||
94671686|NCT01565707|324250479|FG002|Overall Study|Lost to Follow-up|0|||
94671687|NCT01565707|324250480|FG003|Overall Study|Lost to Follow-up|0|||
94671688|NCT01565707|324250477|FG000|Overall Study|Protocol Violation|1|||
94671689|NCT01565707|324250478|FG001|Overall Study|Protocol Violation|0|||
94671690|NCT01565707|324250479|FG002|Overall Study|Protocol Violation|0|||
94671691|NCT01565707|324250480|FG003|Overall Study|Protocol Violation|1|||
94671692|NCT01565707|324250477|FG000|Overall Study|Withdrawal by Subject|3|||
94671693|NCT01565707|324250478|FG001|Overall Study|Withdrawal by Subject|1|||
94671694|NCT01565707|324250479|FG002|Overall Study|Withdrawal by Subject|1|||
94671695|NCT01565707|324250480|FG003|Overall Study|Withdrawal by Subject|1|||
94671696|NCT01565707|324250477|FG000|Overall Study|Randomized but not evaluable|2|||
94671697|NCT01565707|324250478|FG001|Overall Study|Randomized but not evaluable|0|||
94671698|NCT01565707|324250479|FG002|Overall Study|Randomized but not evaluable|0|||
94671699|NCT01565707|324250480|FG003|Overall Study|Randomized but not evaluable|0|||
94671700|NCT01565707|324250477|FG000|Overall Study|Miscellaneous|1|||
94671701|NCT01565707|324250478|FG001|Overall Study|Miscellaneous|1|||
94671702|NCT01565707|324250479|FG002|Overall Study|Miscellaneous|0|||
94671703|NCT01565707|324250480|FG003|Overall Study|Miscellaneous|2|||
94671704|NCT01400503|324250482|FG000|Overall Study|Withdrawal by Subject|1|||
94671705|NCT01400503|324250482|FG000|Overall Study|Study Terminated by Sponsor|58|||
94671706|NCT01400503|324250482|FG000|Overall Study|Other|1|||
94671707|NCT00058123|324250485|FG000|Overall Study|Wrong histology|9|||
94671708|NCT00058123|324250485|FG000|Overall Study|Received >3 prior treatments|1|||
94671709|NCT02130193|324250486|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
94671710|NCT02130193|324250487|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
94671711|NCT02130193|324250488|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
94671712|NCT02130193|324250486|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
94671713|NCT02130193|324250487|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
94671714|NCT02130193|324250488|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
94671715|NCT02130193|324250486|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
94671716|NCT02130193|324250487|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
94671717|NCT02130193|324250488|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
94671718|NCT02130193|324250486|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
94671719|NCT02130193|324250487|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
94671720|NCT02130193|324250488|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
94671721|NCT01212770|324250489|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
94671722|NCT01212770|324250490|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
94671723|NCT01212770|324250491|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
94671724|NCT01212770|324250492|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
94671725|NCT01212770|324250493|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
94671726|NCT01212770|324250494|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
94671727|NCT01212770|324250495|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
94671728|NCT01212770|324250496|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
94671729|NCT01212770|324250497|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
94671730|NCT01212770|324250489|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
94671731|NCT01212770|324250490|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
94671732|NCT01212770|324250491|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
94671733|NCT01212770|324250492|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
94671734|NCT01212770|324250493|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
94671735|NCT01212770|324250494|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
94671736|NCT01212770|324250495|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
94671737|NCT01212770|324250496|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
94671738|NCT01212770|324250497|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
94671739|NCT01212770|324250489|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
94671740|NCT01212770|324250490|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
94671741|NCT01212770|324250491|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
94671742|NCT01212770|324250492|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
94671743|NCT01212770|324250493|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
94671744|NCT01212770|324250494|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
94671745|NCT01212770|324250495|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
94671746|NCT01212770|324250496|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
94359852|NCT05182840|323100404|FG006|Run-in Period|Burden of study procedures|0|||
94359853|NCT05182840|323100405|FG007|Run-in Period|Burden of study procedures|0|||
94359854|NCT05182840|323100406|FG008|Run-in Period|Burden of study procedures|0|||
94359855|NCT05182840|323100407|FG009|Run-in Period|Burden of study procedures|0|||
94359856|NCT05182840|323100398|FG000|Run-in Period|Change of residence|1|||
94359857|NCT05182840|323100399|FG001|Run-in Period|Change of residence|0|||
94359858|NCT05182840|323100400|FG002|Run-in Period|Change of residence|0|||
94359859|NCT05182840|323100401|FG003|Run-in Period|Change of residence|0|||
94359860|NCT05182840|323100402|FG004|Run-in Period|Change of residence|0|||
94359861|NCT05182840|323100403|FG005|Run-in Period|Change of residence|0|||
94359862|NCT05182840|323100404|FG006|Run-in Period|Change of residence|0|||
94359863|NCT05182840|323100405|FG007|Run-in Period|Change of residence|0|||
94359864|NCT05182840|323100406|FG008|Run-in Period|Change of residence|0|||
94359865|NCT05182840|323100407|FG009|Run-in Period|Change of residence|0|||
94625463|NCT02340975|324088517|FG003|Overall Study|Lost to Follow-up|0|||
94625464|NCT02340975|324088518|FG004|Overall Study|Lost to Follow-up|2|||
94625465|NCT02340975|324088519|FG005|Overall Study|Lost to Follow-up|0|||
94625466|NCT02340975|324088514|FG000|Overall Study|Withdrawal by Subject|0|||
94625467|NCT02340975|324088515|FG001|Overall Study|Withdrawal by Subject|0|||
94625468|NCT02340975|324088516|FG002|Overall Study|Withdrawal by Subject|3|||
94625469|NCT02340975|324088517|FG003|Overall Study|Withdrawal by Subject|3|||
94625470|NCT02340975|324088518|FG004|Overall Study|Withdrawal by Subject|2|||
94625471|NCT02340975|324088519|FG005|Overall Study|Withdrawal by Subject|0|||
94625472|NCT02340975|324088514|FG000|Overall Study|Other|0|||
94625473|NCT02340975|324088515|FG001|Overall Study|Other|4|||
94625474|NCT02340975|324088516|FG002|Overall Study|Other|0|||
94625475|NCT02340975|324088517|FG003|Overall Study|Other|2|||
94625476|NCT02340975|324088518|FG004|Overall Study|Other|0|||
94625477|NCT02340975|324088519|FG005|Overall Study|Other|6|||
94625478|NCT00982878|324088523|FG000|Overall Study|Physician Decision|1|||
94625479|NCT01169493|324088524|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
94625480|NCT01169493|324088525|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
94625481|NCT01169493|324088526|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
94625482|NCT01169493|324088527|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
94625483|NCT01169493|324088528|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
94625484|NCT01169493|324088529|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
94625485|NCT01169493|324088524|FG000|Period 3 (6 Months)|Adverse Event|0|||
94625486|NCT01169493|324088525|FG001|Period 3 (6 Months)|Adverse Event|1|||
94625487|NCT01169493|324088526|FG002|Period 3 (6 Months)|Adverse Event|0|||
94625488|NCT01169493|324088527|FG003|Period 3 (6 Months)|Adverse Event|0|||
94625489|NCT01169493|324088528|FG004|Period 3 (6 Months)|Adverse Event|0|||
94625490|NCT01169493|324088529|FG005|Period 3 (6 Months)|Adverse Event|0|||
94625491|NCT01169493|324088524|FG000|Period 3 (6 Months)|Physician Decision|0|||
94625492|NCT01169493|324088525|FG001|Period 3 (6 Months)|Physician Decision|1|||
94625493|NCT01169493|324088526|FG002|Period 3 (6 Months)|Physician Decision|1|||
94625494|NCT01169493|324088527|FG003|Period 3 (6 Months)|Physician Decision|0|||
94625495|NCT01169493|324088528|FG004|Period 3 (6 Months)|Physician Decision|0|||
94625496|NCT01169493|324088529|FG005|Period 3 (6 Months)|Physician Decision|0|||
94625497|NCT01985867|324088533|FG000|Overall Study|Lost to Follow-up|3|||
94625498|NCT01985867|324088534|FG001|Overall Study|Lost to Follow-up|4|||
94625499|NCT01985867|324088533|FG000|Overall Study|Adverse Event|3|||
94625500|NCT01985867|324088534|FG001|Overall Study|Adverse Event|2|||
94625501|NCT01985867|324088533|FG000|Overall Study|Lack of Efficacy|1|||
94625502|NCT01985867|324088534|FG001|Overall Study|Lack of Efficacy|0|||
94625503|NCT01442675|324088535|FG000|Overall Study|Protocol Violation|6|||
94625504|NCT01442675|324088535|FG000|Overall Study|Lost to Follow-up|2|||
94625505|NCT01442675|324088535|FG000|Overall Study|Withdrawal by Subject|4|||
94625506|NCT00160251|324088537|FG000|Prior to Amendment 2|Adverse Event|2|||
94625507|NCT00160251|324088538|FG001|Prior to Amendment 2|Adverse Event|1|||
94625508|NCT00160251|324088539|FG002|Prior to Amendment 2|Adverse Event|3|||
94625509|NCT00160251|324088540|FG003|Prior to Amendment 2|Adverse Event|1|||
94625510|NCT00160251|324088541|FG004|Prior to Amendment 2|Adverse Event|1|||
94625511|NCT00160251|324088542|FG005|Prior to Amendment 2|Adverse Event|1|||
94625512|NCT00160251|324088543|FG006|Prior to Amendment 2|Adverse Event|1|||
94625513|NCT00160251|324088544|FG007|Prior to Amendment 2|Adverse Event|0|||
94625514|NCT00160251|324088537|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
94625515|NCT00160251|324088538|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
94625516|NCT00160251|324088539|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
94625517|NCT00160251|324088540|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
94625518|NCT00160251|324088541|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
94625519|NCT00160251|324088542|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
94625520|NCT00160251|324088543|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
94625521|NCT00160251|324088544|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
94625522|NCT00160251|324088537|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
94625523|NCT00160251|324088538|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
94625524|NCT00160251|324088539|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
94625525|NCT00160251|324088540|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
94625526|NCT00160251|324088541|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
94359866|NCT05182840|323100398|FG000|Run-in Period|Adverse Event|5|||
94359867|NCT05182840|323100399|FG001|Run-in Period|Adverse Event|5|||
94359868|NCT05182840|323100400|FG002|Run-in Period|Adverse Event|0|||
94625527|NCT00160251|324088542|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
94625528|NCT00160251|324088543|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
94625529|NCT00160251|324088544|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
94671747|NCT01212770|324250497|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
94671748|NCT01212770|324250489|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
94671749|NCT01212770|324250490|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94671750|NCT01212770|324250491|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
94671751|NCT01212770|324250492|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94671752|NCT01212770|324250493|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94671753|NCT01212770|324250494|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94671754|NCT01212770|324250495|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94671755|NCT01212770|324250496|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94671756|NCT01212770|324250497|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94671757|NCT01212770|324250489|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94671758|NCT01212770|324250490|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94671759|NCT01212770|324250491|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
94671760|NCT01212770|324250492|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94671761|NCT01212770|324250493|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94671762|NCT01212770|324250494|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94461222|NCT03536949|323478218|FG001|Overall Study|Adverse Event|0|||
94625530|NCT00160251|324088537|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
94625531|NCT00160251|324088538|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
94625532|NCT00160251|324088539|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
94625533|NCT00160251|324088540|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
94625534|NCT00160251|324088541|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
94625535|NCT00160251|324088542|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
94625536|NCT00160251|324088543|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
94625537|NCT00160251|324088544|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
94625538|NCT00160251|324088537|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
94625539|NCT00160251|324088538|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
94625540|NCT00160251|324088539|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
94625541|NCT00160251|324088540|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
94625542|NCT00160251|324088541|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
94625543|NCT00160251|324088542|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
94625544|NCT00160251|324088543|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
94625545|NCT00160251|324088544|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
94625546|NCT00160251|324088537|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
94625547|NCT00160251|324088538|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
94625548|NCT00160251|324088539|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
94625549|NCT00160251|324088540|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
94625550|NCT00160251|324088541|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
94625551|NCT00160251|324088542|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
94625552|NCT00160251|324088543|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
94625553|NCT00160251|324088544|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
94625554|NCT00160251|324088537|FG000|Post-amendment 2|Adverse Event|0|||
94625555|NCT00160251|324088538|FG001|Post-amendment 2|Adverse Event|0|||
94625556|NCT00160251|324088539|FG002|Post-amendment 2|Adverse Event|0|||
94625557|NCT00160251|324088540|FG003|Post-amendment 2|Adverse Event|0|||
94625558|NCT00160251|324088541|FG004|Post-amendment 2|Adverse Event|0|||
94625559|NCT00160251|324088542|FG005|Post-amendment 2|Adverse Event|0|||
94625560|NCT00160251|324088543|FG006|Post-amendment 2|Adverse Event|0|||
94625561|NCT00160251|324088544|FG007|Post-amendment 2|Adverse Event|20|||
94625562|NCT00160251|324088537|FG000|Post-amendment 2|Lack of Efficacy|0|||
94625563|NCT00160251|324088538|FG001|Post-amendment 2|Lack of Efficacy|0|||
94625564|NCT00160251|324088539|FG002|Post-amendment 2|Lack of Efficacy|0|||
94625565|NCT00160251|324088540|FG003|Post-amendment 2|Lack of Efficacy|0|||
94625566|NCT00160251|324088541|FG004|Post-amendment 2|Lack of Efficacy|0|||
94625567|NCT00160251|324088542|FG005|Post-amendment 2|Lack of Efficacy|0|||
94625568|NCT00160251|324088543|FG006|Post-amendment 2|Lack of Efficacy|0|||
94625569|NCT00160251|324088544|FG007|Post-amendment 2|Lack of Efficacy|24|||
94625570|NCT00160251|324088537|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
94625571|NCT00160251|324088538|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
94625572|NCT00160251|324088539|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
94625573|NCT00160251|324088540|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
94625574|NCT00160251|324088541|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
94625575|NCT00160251|324088542|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
94625576|NCT00160251|324088543|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
94625577|NCT00160251|324088544|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
94625578|NCT02859454|324088547|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
94625579|NCT00459953|324088548|FG000|Overall Study|not analyzed-household member in study|1|||
94625580|NCT00459953|324088549|FG001|Overall Study|not analyzed-household member in study|1|||
94625581|NCT02289417|324088554|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
94625582|NCT02289417|324088555|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
94359869|NCT05182840|323100401|FG003|Run-in Period|Adverse Event|0|||
94359870|NCT05182840|323100402|FG004|Run-in Period|Adverse Event|0|||
94359871|NCT05182840|323100403|FG005|Run-in Period|Adverse Event|0|||
94359872|NCT05182840|323100404|FG006|Run-in Period|Adverse Event|0|||
94359873|NCT05182840|323100405|FG007|Run-in Period|Adverse Event|0|||
94359874|NCT05182840|323100406|FG008|Run-in Period|Adverse Event|0|||
94359875|NCT05182840|323100407|FG009|Run-in Period|Adverse Event|0|||
94359876|NCT05182840|323100398|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
94359877|NCT05182840|323100399|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
94359878|NCT05182840|323100400|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
94359879|NCT05182840|323100401|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
94359880|NCT05182840|323100402|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
94365713|NCT05553600|323124754|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
94625583|NCT02289417|324088556|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
94625584|NCT02289417|324088557|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
94625585|NCT02289417|324088558|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
94625586|NCT02289417|324088559|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
94625587|NCT02289417|324088560|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
94625588|NCT02289417|324088561|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
94625589|NCT02289417|324088562|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
94625590|NCT02289417|324088554|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
94625591|NCT02289417|324088555|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
94625592|NCT02289417|324088556|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
94625593|NCT02289417|324088557|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
94625594|NCT02289417|324088558|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
94625595|NCT02289417|324088559|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
94625596|NCT02289417|324088560|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
94625597|NCT02289417|324088561|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
94625598|NCT02289417|324088562|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
94625599|NCT02289417|324088554|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
94625600|NCT02289417|324088555|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
94625601|NCT02289417|324088556|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
94625602|NCT02289417|324088557|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
94625603|NCT02289417|324088558|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
94625604|NCT02289417|324088559|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
94625605|NCT02289417|324088560|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
94625606|NCT02289417|324088561|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
94625607|NCT02289417|324088562|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
94625608|NCT02289417|324088554|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
94625609|NCT02289417|324088555|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
94625610|NCT02289417|324088556|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
94625611|NCT02289417|324088557|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
94625612|NCT02289417|324088558|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
94625613|NCT02289417|324088559|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
94625614|NCT02289417|324088560|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
94625615|NCT02289417|324088561|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
94625616|NCT02289417|324088562|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
94625617|NCT02289417|324088554|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
94625618|NCT02289417|324088555|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
94625619|NCT02289417|324088556|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
94625620|NCT02289417|324088557|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
94625621|NCT02289417|324088558|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
94625622|NCT02289417|324088559|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
94625623|NCT02289417|324088560|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
94625624|NCT02289417|324088561|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
94625625|NCT02289417|324088562|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
94625626|NCT02289417|324088554|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
94625627|NCT02289417|324088555|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
94625628|NCT02289417|324088556|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
94625629|NCT02289417|324088557|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
94625630|NCT02289417|324088558|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
94625631|NCT02289417|324088559|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
94625632|NCT02289417|324088560|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
94625633|NCT02289417|324088561|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
94625634|NCT02289417|324088562|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
94625635|NCT02289417|324088554|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
94625636|NCT02289417|324088555|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
94625637|NCT02289417|324088556|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
94625638|NCT02289417|324088557|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
94625639|NCT02289417|324088558|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
94625640|NCT02289417|324088559|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
94625641|NCT02289417|324088560|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
94625642|NCT02289417|324088561|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
94625643|NCT02289417|324088562|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
94625644|NCT02289417|324088554|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
94625645|NCT02289417|324088555|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
94625646|NCT02289417|324088556|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
94625647|NCT02289417|324088557|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
94625648|NCT02289417|324088558|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
94625649|NCT02289417|324088559|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
94625650|NCT02289417|324088560|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
94625651|NCT02289417|324088561|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
94625652|NCT02289417|324088562|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
94625653|NCT02289417|324088554|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
94625654|NCT02289417|324088555|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
94625655|NCT02289417|324088556|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
94625656|NCT02289417|324088557|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
94625657|NCT02289417|324088558|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
94625658|NCT02289417|324088559|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
94625659|NCT02289417|324088560|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
94625660|NCT02289417|324088561|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
94625661|NCT02289417|324088562|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
94625662|NCT02289417|324088554|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
94625663|NCT02289417|324088555|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
94625664|NCT02289417|324088556|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
94625665|NCT02289417|324088557|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
94625666|NCT02289417|324088558|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
94625667|NCT02289417|324088559|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
94625668|NCT02289417|324088560|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
94625669|NCT02289417|324088561|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
94625670|NCT02289417|324088562|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
94625671|NCT02289417|324088554|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
94625672|NCT02289417|324088555|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
94625673|NCT02289417|324088556|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
94625674|NCT02289417|324088557|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
94625675|NCT02289417|324088558|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
94625676|NCT02289417|324088559|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
94625677|NCT02289417|324088560|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
94625678|NCT02289417|324088561|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
94625679|NCT02289417|324088562|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
94625680|NCT02289417|324088554|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
94625681|NCT02289417|324088555|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
94625682|NCT02289417|324088556|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
94625683|NCT02289417|324088557|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
94625684|NCT02289417|324088558|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
94625685|NCT02289417|324088559|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
94625686|NCT02289417|324088560|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
94625687|NCT02289417|324088561|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
94625688|NCT02289417|324088562|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
94625689|NCT02289417|324088554|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
94625690|NCT02289417|324088555|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
94625691|NCT02289417|324088556|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
94625692|NCT02289417|324088557|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
94625693|NCT02289417|324088558|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
94625694|NCT02289417|324088559|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
94625695|NCT02289417|324088560|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
94625696|NCT02289417|324088561|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
94625697|NCT02289417|324088562|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
94625698|NCT02289417|324088554|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
94625699|NCT02289417|324088555|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
94625700|NCT02289417|324088556|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
94625701|NCT02289417|324088557|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
94625702|NCT02289417|324088558|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
94625703|NCT02289417|324088559|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
94671763|NCT01212770|324250495|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94671764|NCT01212770|324250496|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94671765|NCT01212770|324250497|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94671766|NCT01212770|324250489|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
94671767|NCT01212770|324250490|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
94671768|NCT01212770|324250491|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
94671769|NCT01212770|324250492|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
94671770|NCT01212770|324250493|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
94671771|NCT01212770|324250494|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
94671772|NCT01212770|324250495|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
94671773|NCT01212770|324250496|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
94671774|NCT01212770|324250497|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
94671775|NCT01212770|324250489|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
94671776|NCT01212770|324250490|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
94671777|NCT01212770|324250491|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
94671778|NCT01212770|324250492|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
94671779|NCT01212770|324250493|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
94671780|NCT01212770|324250494|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
94671781|NCT01212770|324250495|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
94671782|NCT01212770|324250496|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
94671783|NCT01212770|324250497|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
94671784|NCT01212770|324250489|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
94671785|NCT01212770|324250490|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
94671786|NCT01212770|324250491|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
94671787|NCT01212770|324250492|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
94671788|NCT01212770|324250493|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
94671789|NCT01212770|324250494|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
94671790|NCT01212770|324250495|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
94671791|NCT01212770|324250496|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
94671792|NCT01212770|324250497|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
94359881|NCT05182840|323100403|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
94671793|NCT01212770|324250489|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
94671794|NCT01212770|324250490|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
94671795|NCT01212770|324250491|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
94671796|NCT01212770|324250492|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
94671797|NCT01212770|324250493|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
94671798|NCT01212770|324250494|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
94671799|NCT01212770|324250495|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
94671800|NCT01212770|324250496|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
94671801|NCT01212770|324250497|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
94671802|NCT01212770|324250489|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
94671803|NCT01212770|324250490|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
94671804|NCT01212770|324250491|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
94671805|NCT01212770|324250492|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
94671806|NCT01212770|324250493|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
94671807|NCT01212770|324250494|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
94671808|NCT01212770|324250495|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
94671809|NCT01212770|324250496|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
94671810|NCT01212770|324250497|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
94671811|NCT01212770|324250489|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
94671812|NCT01212770|324250490|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
94359882|NCT05182840|323100404|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
94625704|NCT02289417|324088560|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
94625705|NCT02289417|324088561|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
94625706|NCT02289417|324088562|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
94625707|NCT02725710|324088565|FG000|Overall Study|Lost to Follow-up|1|||
94625708|NCT02725710|324088566|FG001|Overall Study|Lost to Follow-up|0|||
94625709|NCT01666782|324088567|FG000|Overall Study|Received 2 doses of vaccine|0|||
94625710|NCT01666782|324088568|FG001|Overall Study|Received 2 doses of vaccine|1|||
94625711|NCT01666782|324088567|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
94625712|NCT01666782|324088568|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
94625713|NCT02695329|324088569|FG000|Overall Study|Adverse Event|1|||
94625714|NCT02695329|324088570|FG001|Overall Study|Adverse Event|0|||
94625715|NCT02695329|324088569|FG000|Overall Study|Poor X-ray quality for measurement|4|||
94625716|NCT02695329|324088570|FG001|Overall Study|Poor X-ray quality for measurement|5|||
94461223|NCT03536949|323478217|FG000|Overall Study|Lost to Follow-up|2|||
94625717|NCT01032837|324088571|FG000|Overall Study|Adverse event/internal illness|0|||
94625718|NCT01032837|324088572|FG001|Overall Study|Adverse event/internal illness|1|||
94625719|NCT01032837|324088573|FG002|Overall Study|Adverse event/internal illness|0|||
94625720|NCT01032837|324088574|FG003|Overall Study|Adverse event/internal illness|1|||
94625721|NCT01032837|324088571|FG000|Overall Study|Withdrew consent|0|||
94625722|NCT01032837|324088572|FG001|Overall Study|Withdrew consent|2|||
94625723|NCT01032837|324088573|FG002|Overall Study|Withdrew consent|0|||
94625724|NCT01032837|324088574|FG003|Overall Study|Withdrew consent|1|||
94625725|NCT01032837|324088571|FG000|Overall Study|Failed to return|0|||
94625726|NCT01032837|324088572|FG001|Overall Study|Failed to return|0|||
94625727|NCT01032837|324088573|FG002|Overall Study|Failed to return|1|||
94625728|NCT01032837|324088574|FG003|Overall Study|Failed to return|0|||
94625729|NCT01032837|324088571|FG000|Overall Study|Refused treatment|0|||
94625730|NCT01032837|324088572|FG001|Overall Study|Refused treatment|0|||
94625731|NCT01032837|324088573|FG002|Overall Study|Refused treatment|0|||
94625732|NCT01032837|324088574|FG003|Overall Study|Refused treatment|1|||
94625733|NCT01782222|324088575|FG000|Overall Study|Adverse Event|4|||
94625734|NCT01782222|324088576|FG001|Overall Study|Adverse Event|5|||
94625735|NCT01782222|324088577|FG002|Overall Study|Adverse Event|3|||
94625736|NCT01782222|324088575|FG000|Overall Study|Lack of Efficacy|2|||
94625737|NCT01782222|324088576|FG001|Overall Study|Lack of Efficacy|1|||
94625738|NCT01782222|324088577|FG002|Overall Study|Lack of Efficacy|0|||
94625739|NCT01782222|324088575|FG000|Overall Study|Protocol Violation|1|||
94625740|NCT01782222|324088576|FG001|Overall Study|Protocol Violation|0|||
94625741|NCT01782222|324088577|FG002|Overall Study|Protocol Violation|0|||
94625742|NCT01782222|324088575|FG000|Overall Study|Withdrawal by Subject|1|||
94625743|NCT01782222|324088576|FG001|Overall Study|Withdrawal by Subject|4|||
94625744|NCT01782222|324088577|FG002|Overall Study|Withdrawal by Subject|1|||
94625745|NCT01782222|324088575|FG000|Overall Study|Moved to other state|0|||
94625746|NCT01782222|324088576|FG001|Overall Study|Moved to other state|1|||
94625747|NCT01782222|324088577|FG002|Overall Study|Moved to other state|0|||
94625748|NCT02439138|324088578|FG000|Overall Study|Adverse Event|1|||
94625749|NCT02439138|324088578|FG000|Overall Study|PI decision to terminate the study|2|||
94625750|NCT02615145|324088579|FG000|Overall Study|Did Not Start Treatment|0|||
94625751|NCT02615145|324088580|FG001|Overall Study|Did Not Start Treatment|0|||
94625752|NCT02615145|324088581|FG002|Overall Study|Did Not Start Treatment|1|||
94625753|NCT02615145|324088582|FG003|Overall Study|Did Not Start Treatment|1|||
94625754|NCT02615145|324088579|FG000|Overall Study|Failure to Return|20|||
94625755|NCT02615145|324088580|FG001|Overall Study|Failure to Return|10|||
94625756|NCT02615145|324088581|FG002|Overall Study|Failure to Return|7|||
94625757|NCT02615145|324088582|FG003|Overall Study|Failure to Return|0|||
94625758|NCT02615145|324088579|FG000|Overall Study|Death|2|||
94625759|NCT02615145|324088580|FG001|Overall Study|Death|3|||
94625760|NCT02615145|324088581|FG002|Overall Study|Death|0|||
94625761|NCT02615145|324088582|FG003|Overall Study|Death|0|||
94625762|NCT02615145|324088579|FG000|Overall Study|Other, Not Specified|5|||
94625763|NCT02615145|324088580|FG001|Overall Study|Other, Not Specified|2|||
94625764|NCT02615145|324088581|FG002|Overall Study|Other, Not Specified|0|||
94625765|NCT02615145|324088582|FG003|Overall Study|Other, Not Specified|0|||
94625766|NCT01594762|324088583|FG000|Overall Study|Withdrawal by Subject|1|||
94625767|NCT01594762|324088584|FG001|Overall Study|Withdrawal by Subject|0|||
94625768|NCT01594762|324088583|FG000|Overall Study|Lost to Follow-up|10|||
94625769|NCT01594762|324088584|FG001|Overall Study|Lost to Follow-up|10|||
94671813|NCT01212770|324250491|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
94671814|NCT01212770|324250492|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
94671815|NCT01212770|324250493|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
94671816|NCT01212770|324250494|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
94671817|NCT01212770|324250495|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
94671818|NCT01212770|324250496|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
94671819|NCT01212770|324250497|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
94671820|NCT01212770|324250489|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
94461224|NCT03536949|323478218|FG001|Overall Study|Lost to Follow-up|1|||
94461225|NCT03536949|323478217|FG000|Overall Study|Withdrawal by Subject|6|||
94461226|NCT03536949|323478218|FG001|Overall Study|Withdrawal by Subject|0|||
94461227|NCT03536949|323478217|FG000|Overall Study|Non-compliance|2|||
94461228|NCT03536949|323478218|FG001|Overall Study|Non-compliance|1|||
94461229|NCT00705718|323478219|FG000|Overall Study|Death|6|||
94359883|NCT05182840|323100405|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
94359884|NCT05182840|323100406|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
94359885|NCT05182840|323100407|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
94359886|NCT05182840|323100398|FG000|Treatment Period|Reason missing|0|||
94359887|NCT05182840|323100399|FG001|Treatment Period|Reason missing|0|||
94359888|NCT05182840|323100400|FG002|Treatment Period|Reason missing|1|||
94359889|NCT05182840|323100401|FG003|Treatment Period|Reason missing|0|||
94359890|NCT05182840|323100402|FG004|Treatment Period|Reason missing|0|||
94359891|NCT05182840|323100403|FG005|Treatment Period|Reason missing|0|||
94359892|NCT05182840|323100404|FG006|Treatment Period|Reason missing|0|||
94359893|NCT05182840|323100405|FG007|Treatment Period|Reason missing|0|||
94359894|NCT05182840|323100406|FG008|Treatment Period|Reason missing|0|||
94359895|NCT05182840|323100407|FG009|Treatment Period|Reason missing|0|||
94359896|NCT05182840|323100398|FG000|Treatment Period|Other but not sponsor termination|0|||
94359897|NCT05182840|323100399|FG001|Treatment Period|Other but not sponsor termination|0|||
94359898|NCT05182840|323100400|FG002|Treatment Period|Other but not sponsor termination|8|||
94359899|NCT05182840|323100401|FG003|Treatment Period|Other but not sponsor termination|6|||
94359900|NCT05182840|323100402|FG004|Treatment Period|Other but not sponsor termination|6|||
94359901|NCT05182840|323100403|FG005|Treatment Period|Other but not sponsor termination|7|||
94359902|NCT05182840|323100404|FG006|Treatment Period|Other but not sponsor termination|5|||
94359903|NCT05182840|323100405|FG007|Treatment Period|Other but not sponsor termination|8|||
94359904|NCT05182840|323100406|FG008|Treatment Period|Other but not sponsor termination|7|||
94359905|NCT05182840|323100407|FG009|Treatment Period|Other but not sponsor termination|2|||
94359906|NCT05182840|323100398|FG000|Treatment Period|Protocol deviation|0|||
94359907|NCT05182840|323100399|FG001|Treatment Period|Protocol deviation|0|||
94359908|NCT05182840|323100400|FG002|Treatment Period|Protocol deviation|0|||
94359909|NCT05182840|323100401|FG003|Treatment Period|Protocol deviation|0|||
94359910|NCT05182840|323100402|FG004|Treatment Period|Protocol deviation|0|||
94359911|NCT05182840|323100403|FG005|Treatment Period|Protocol deviation|0|||
94359912|NCT05182840|323100404|FG006|Treatment Period|Protocol deviation|0|||
94359913|NCT05182840|323100405|FG007|Treatment Period|Protocol deviation|0|||
94359914|NCT05182840|323100406|FG008|Treatment Period|Protocol deviation|1|||
94359915|NCT05182840|323100407|FG009|Treatment Period|Protocol deviation|0|||
94359916|NCT05182840|323100398|FG000|Treatment Period|No reason available|0|||
94359917|NCT05182840|323100399|FG001|Treatment Period|No reason available|0|||
94359918|NCT05182840|323100400|FG002|Treatment Period|No reason available|0|||
94359919|NCT05182840|323100401|FG003|Treatment Period|No reason available|1|||
94359920|NCT05182840|323100402|FG004|Treatment Period|No reason available|0|||
94359921|NCT05182840|323100403|FG005|Treatment Period|No reason available|2|||
94359922|NCT05182840|323100404|FG006|Treatment Period|No reason available|0|||
94359923|NCT05182840|323100405|FG007|Treatment Period|No reason available|1|||
94359924|NCT05182840|323100406|FG008|Treatment Period|No reason available|0|||
94359925|NCT05182840|323100407|FG009|Treatment Period|No reason available|0|||
94359926|NCT05182840|323100398|FG000|Treatment Period|Burden of study procedures|0|||
94359927|NCT05182840|323100399|FG001|Treatment Period|Burden of study procedures|0|||
94359928|NCT05182840|323100400|FG002|Treatment Period|Burden of study procedures|0|||
94359929|NCT05182840|323100401|FG003|Treatment Period|Burden of study procedures|0|||
94359930|NCT05182840|323100402|FG004|Treatment Period|Burden of study procedures|1|||
94359931|NCT05182840|323100403|FG005|Treatment Period|Burden of study procedures|0|||
94359932|NCT05182840|323100404|FG006|Treatment Period|Burden of study procedures|0|||
94359933|NCT05182840|323100405|FG007|Treatment Period|Burden of study procedures|0|||
94359934|NCT05182840|323100406|FG008|Treatment Period|Burden of study procedures|0|||
94359935|NCT05182840|323100407|FG009|Treatment Period|Burden of study procedures|0|||
94359936|NCT05182840|323100398|FG000|Treatment Period|Change of residence|0|||
94359937|NCT05182840|323100399|FG001|Treatment Period|Change of residence|0|||
94359938|NCT05182840|323100400|FG002|Treatment Period|Change of residence|0|||
94359939|NCT05182840|323100401|FG003|Treatment Period|Change of residence|0|||
94359940|NCT05182840|323100402|FG004|Treatment Period|Change of residence|0|||
94359941|NCT05182840|323100403|FG005|Treatment Period|Change of residence|1|||
94359942|NCT05182840|323100404|FG006|Treatment Period|Change of residence|0|||
94359943|NCT05182840|323100405|FG007|Treatment Period|Change of residence|0|||
94359944|NCT05182840|323100406|FG008|Treatment Period|Change of residence|0|||
94359945|NCT05182840|323100407|FG009|Treatment Period|Change of residence|0|||
94359946|NCT05182840|323100398|FG000|Treatment Period|Adverse Event|0|||
94359947|NCT05182840|323100399|FG001|Treatment Period|Adverse Event|0|||
94359948|NCT05182840|323100400|FG002|Treatment Period|Adverse Event|4|||
94359949|NCT05182840|323100401|FG003|Treatment Period|Adverse Event|16|||
94359950|NCT05182840|323100402|FG004|Treatment Period|Adverse Event|12|||
94359951|NCT05182840|323100403|FG005|Treatment Period|Adverse Event|6|||
94359952|NCT05182840|323100404|FG006|Treatment Period|Adverse Event|4|||
94359953|NCT05182840|323100405|FG007|Treatment Period|Adverse Event|8|||
94671821|NCT01212770|324250490|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
94671822|NCT01212770|324250491|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
94671823|NCT01212770|324250492|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
94671824|NCT01212770|324250493|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
94671825|NCT01212770|324250494|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
94671826|NCT01212770|324250495|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
94671827|NCT01212770|324250496|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
94671828|NCT01212770|324250497|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
94671829|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
94671830|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
94671831|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
94671832|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
94671833|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
94671834|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
94671835|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
94671836|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
94625770|NCT01846416|324088585|FG000|Treatment Phase|Death|2|||
94625771|NCT01846416|324088586|FG001|Treatment Phase|Death|9|||
94625772|NCT01846416|324088587|FG002|Treatment Phase|Death|1|||
94625773|NCT01846416|324088585|FG000|Treatment Phase|Withdrawal by Subject|2|||
94625774|NCT01846416|324088586|FG001|Treatment Phase|Withdrawal by Subject|4|||
94625775|NCT01846416|324088587|FG002|Treatment Phase|Withdrawal by Subject|2|||
94625776|NCT01846416|324088585|FG000|Treatment Phase|Other|1|||
94625777|NCT01846416|324088586|FG001|Treatment Phase|Other|5|||
94625778|NCT01846416|324088587|FG002|Treatment Phase|Other|1|||
94625779|NCT01846416|324088585|FG000|Treatment Phase|Physician Decision|1|||
94625780|NCT01846416|324088586|FG001|Treatment Phase|Physician Decision|2|||
94625781|NCT01846416|324088587|FG002|Treatment Phase|Physician Decision|0|||
94625782|NCT01846416|324088585|FG000|Treatment Phase|Adverse Event|3|||
94625783|NCT01846416|324088586|FG001|Treatment Phase|Adverse Event|4|||
94625784|NCT01846416|324088587|FG002|Treatment Phase|Adverse Event|0|||
94625785|NCT01846416|324088585|FG000|Treatment Phase|Non-compliance|0|||
94625786|NCT01846416|324088586|FG001|Treatment Phase|Non-compliance|2|||
94625787|NCT01846416|324088587|FG002|Treatment Phase|Non-compliance|0|||
94625788|NCT01846416|324088585|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
94625789|NCT01846416|324088586|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
94625790|NCT01846416|324088587|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
94625791|NCT01846416|324088585|FG000|Treatment Phase|Progressive Disease|21|||
94625792|NCT01846416|324088586|FG001|Treatment Phase|Progressive Disease|63|||
94625793|NCT01846416|324088587|FG002|Treatment Phase|Progressive Disease|9|||
94625794|NCT01846416|324088585|FG000|Survival Follow-up|Death|21|||
94625795|NCT01846416|324088586|FG001|Survival Follow-up|Death|62|||
94625796|NCT01846416|324088587|FG002|Survival Follow-up|Death|9|||
94625797|NCT01846416|324088585|FG000|Survival Follow-up|Lost to Follow-up|0|||
94625798|NCT01846416|324088586|FG001|Survival Follow-up|Lost to Follow-up|2|||
94625799|NCT01846416|324088587|FG002|Survival Follow-up|Lost to Follow-up|2|||
94625800|NCT01846416|324088585|FG000|Survival Follow-up|Withdrawal by Subject|2|||
94625801|NCT01846416|324088586|FG001|Survival Follow-up|Withdrawal by Subject|7|||
94625802|NCT01846416|324088587|FG002|Survival Follow-up|Withdrawal by Subject|0|||
94625803|NCT01846416|324088585|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
94625804|NCT01846416|324088586|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
94625805|NCT01846416|324088587|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
94625806|NCT01846416|324088585|FG000|Survival Follow-up|Other|3|||
94625807|NCT01846416|324088586|FG001|Survival Follow-up|Other|1|||
94671837|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
94671838|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
94625808|NCT01846416|324088587|FG002|Survival Follow-up|Other|1|||
94625809|NCT00833794|324088588|FG000|Open-label Phase|Adverse Event|225|||
94625810|NCT00833794|324088589|FG001|Open-label Phase|Adverse Event|0|||
94671839|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
94671840|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
94671841|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
94625811|NCT00833794|324088588|FG000|Open-label Phase|Lack of Efficacy|28|||
94625812|NCT00833794|324088589|FG001|Open-label Phase|Lack of Efficacy|0|||
94625813|NCT00833794|324088588|FG000|Open-label Phase|Withdrawal by Subject|48|||
94625814|NCT00833794|324088589|FG001|Open-label Phase|Withdrawal by Subject|0|||
94625815|NCT00833794|324088588|FG000|Open-label Phase|Physician Decision|20|||
94625816|NCT00833794|324088589|FG001|Open-label Phase|Physician Decision|0|||
94625817|NCT00833794|324088588|FG000|Open-label Phase|Administrative reason|1|||
94625818|NCT00833794|324088589|FG001|Open-label Phase|Administrative reason|0|||
94625819|NCT00833794|324088588|FG000|Open-label Phase|Protocol Violation|47|||
94671842|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
94625820|NCT00833794|324088589|FG001|Open-label Phase|Protocol Violation|0|||
94625821|NCT00833794|324088588|FG000|Open-label Phase|Did not complete wash-out period|12|||
94625822|NCT00833794|324088589|FG001|Open-label Phase|Did not complete wash-out period|0|||
94359954|NCT05182840|323100406|FG008|Treatment Period|Adverse Event|16|||
94359955|NCT05182840|323100407|FG009|Treatment Period|Adverse Event|5|||
94359956|NCT05182840|323100398|FG000|Treatment Period|Not treated with study drug|0|||
94359957|NCT05182840|323100399|FG001|Treatment Period|Not treated with study drug|0|||
94359958|NCT05182840|323100400|FG002|Treatment Period|Not treated with study drug|0|||
94359959|NCT05182840|323100401|FG003|Treatment Period|Not treated with study drug|1|||
94359960|NCT05182840|323100402|FG004|Treatment Period|Not treated with study drug|0|||
94359961|NCT05182840|323100403|FG005|Treatment Period|Not treated with study drug|0|||
94359962|NCT05182840|323100404|FG006|Treatment Period|Not treated with study drug|1|||
94359963|NCT05182840|323100405|FG007|Treatment Period|Not treated with study drug|1|||
94359964|NCT05182840|323100406|FG008|Treatment Period|Not treated with study drug|0|||
94359965|NCT05182840|323100407|FG009|Treatment Period|Not treated with study drug|0|||
94359966|NCT04342390|323100409|FG000|Overall Study|Lost to Follow-up|3|||
94359967|NCT04342390|323100410|FG001|Overall Study|Lost to Follow-up|0|||
94359968|NCT04768881|323100413|FG000|Overall Study|Completed Study Follow-up|0|||
94359969|NCT04768881|323100414|FG001|Overall Study|Completed Study Follow-up|2|||
94359970|NCT04768881|323100413|FG000|Overall Study|Death|3|||
94359971|NCT04768881|323100414|FG001|Overall Study|Death|2|||
94625823|NCT00833794|324088588|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
94625824|NCT00833794|324088589|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
94625825|NCT00833794|324088588|FG000|Double-blind Phase|Adverse Event|44|||
94625826|NCT00833794|324088589|FG001|Double-blind Phase|Adverse Event|11|||
94625827|NCT00833794|324088588|FG000|Double-blind Phase|Lack of Efficacy|34|||
94625828|NCT00833794|324088589|FG001|Double-blind Phase|Lack of Efficacy|22|||
94625829|NCT00833794|324088588|FG000|Double-blind Phase|Withdrawal by Subject|23|||
94625830|NCT00833794|324088589|FG001|Double-blind Phase|Withdrawal by Subject|6|||
94625831|NCT00833794|324088588|FG000|Double-blind Phase|Physician Decision|4|||
94625832|NCT00833794|324088589|FG001|Double-blind Phase|Physician Decision|7|||
94625833|NCT00833794|324088588|FG000|Double-blind Phase|Administrative reason|1|||
94625834|NCT00833794|324088589|FG001|Double-blind Phase|Administrative reason|3|||
94625835|NCT02007109|324088593|FG000|Overall Study|Diary not returned or excluded|102|||
94625836|NCT02007109|324088593|FG000|Overall Study|Excluded - Age<7yo|9|||
94625837|NCT00496054|324088594|FG000|Overall Study|Adverse Event|1|||
94625838|NCT00496054|324088594|FG000|Overall Study|Lost to Follow-up|7|||
94625839|NCT02207244|324088595|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
94625840|NCT02207244|324088596|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
94625841|NCT02207244|324088597|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
94625842|NCT02207244|324088598|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
94625843|NCT02207244|324088599|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
94625844|NCT02207244|324088600|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
94625845|NCT02207244|324088601|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
94625846|NCT02207244|324088602|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
94625847|NCT02207244|324088603|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
94625848|NCT02207244|324088604|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
94625849|NCT02207244|324088605|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
94625850|NCT02207244|324088595|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
94625851|NCT02207244|324088596|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
94625852|NCT02207244|324088597|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
94625853|NCT02207244|324088598|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
94625854|NCT02207244|324088599|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
94625855|NCT02207244|324088600|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
94625856|NCT02207244|324088601|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
94625857|NCT02207244|324088602|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
94625858|NCT02207244|324088603|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
94625859|NCT02207244|324088604|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
94359972|NCT04768881|323100413|FG000|Overall Study|Study Terminated by Sponsor|2|||
94359973|NCT04768881|323100414|FG001|Overall Study|Study Terminated by Sponsor|2|||
94359974|NCT04768881|323100413|FG000|Overall Study|Withdrawal by Subject|2|||
94625860|NCT02207244|324088605|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
94625861|NCT02207244|324088595|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
94625862|NCT02207244|324088596|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
94625863|NCT02207244|324088597|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
94625864|NCT02207244|324088598|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
94625865|NCT02207244|324088599|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
94625866|NCT02207244|324088600|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
94625867|NCT02207244|324088601|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
94359975|NCT04768881|323100414|FG001|Overall Study|Withdrawal by Subject|0|||
94359976|NCT04768881|323100413|FG000|Overall Study|Other|2|||
94359977|NCT04768881|323100414|FG001|Overall Study|Other|0|||
94359978|NCT00828009|323100422|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
94359979|NCT00828009|323100422|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
94359980|NCT00828009|323100422|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
94359981|NCT00828009|323100422|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
94359982|NCT00828009|323100422|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
94359983|NCT00828009|323100422|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
94359984|NCT00828009|323100422|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
94359985|NCT00828009|323100422|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
94671843|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
94359986|NCT00828009|323100422|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
94671844|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
94671845|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
94671846|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
94671847|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
94671848|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
94671849|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
94671850|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
94671851|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
94671852|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
94671853|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
94671854|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
94359987|NCT00828009|323100422|FG000|Step 2 - Maintenance Therapy|Death|1|||
94359988|NCT00828009|323100422|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
94359989|NCT00828009|323100422|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
94359990|NCT00828009|323100422|FG000|Step 2 - Maintenance Therapy|Other|1|||
94359991|NCT01298661|323100427|FG000|Overall Study|Withdrawal by Subject|2|||
94359992|NCT01298661|323100428|FG001|Overall Study|Withdrawal by Subject|0|||
94359993|NCT01298661|323100429|FG002|Overall Study|Withdrawal by Subject|2|||
94359994|NCT01361308|323101746|FG000|Overall Study|Withdrawal by Subject|9|||
94359995|NCT01361308|323101747|FG001|Overall Study|Withdrawal by Subject|13|||
94359996|NCT01361308|323101746|FG000|Overall Study|Physician Decision|3|||
94359997|NCT01361308|323101747|FG001|Overall Study|Physician Decision|3|||
94359998|NCT01361308|323101746|FG000|Overall Study|Lack of Efficacy|2|||
94359999|NCT01361308|323101747|FG001|Overall Study|Lack of Efficacy|0|||
94360000|NCT01361308|323101746|FG000|Overall Study|Protocol Violation|1|||
94360001|NCT01361308|323101747|FG001|Overall Study|Protocol Violation|0|||
94360002|NCT01361308|323101746|FG000|Overall Study|Lost to Follow-up|5|||
94360003|NCT01361308|323101747|FG001|Overall Study|Lost to Follow-up|4|||
94360004|NCT01361308|323101746|FG000|Overall Study|Adverse Event|8|||
94360005|NCT01361308|323101747|FG001|Overall Study|Adverse Event|4|||
94360006|NCT01361308|323101746|FG000|Overall Study|Eligibility Criteria Not Met|2|||
94360007|NCT01361308|323101747|FG001|Overall Study|Eligibility Criteria Not Met|3|||
94360008|NCT01361308|323101746|FG000|Overall Study|Failed C-SSRS|5|||
94360009|NCT01361308|323101747|FG001|Overall Study|Failed C-SSRS|2|||
94360010|NCT01361308|323101746|FG000|Overall Study|Other|0|||
94360011|NCT01361308|323101747|FG001|Overall Study|Other|1|||
94360012|NCT02087865|323101749|FG000|Overall Study|Withdrawal by Subject|6|||
94671855|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
94671856|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
94360013|NCT02087865|323101750|FG001|Overall Study|Withdrawal by Subject|0|||
94360014|NCT02087865|323101751|FG002|Overall Study|Withdrawal by Subject|1|||
94360015|NCT02087865|323101749|FG000|Overall Study|Lost to Follow-up|0|||
94360016|NCT02087865|323101750|FG001|Overall Study|Lost to Follow-up|0|||
94671857|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
94671858|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
94671859|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
94360017|NCT02087865|323101751|FG002|Overall Study|Lost to Follow-up|1|||
94360018|NCT02087865|323101749|FG000|Overall Study|Drug Non-compliance|0|||
94360019|NCT02087865|323101750|FG001|Overall Study|Drug Non-compliance|2|||
94360020|NCT02087865|323101751|FG002|Overall Study|Drug Non-compliance|0|||
94360021|NCT02087865|323101749|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
94461230|NCT00705718|323478220|FG001|Overall Study|Death|6|||
94461231|NCT00705718|323478219|FG000|Overall Study|Not due for Visit|0|||
94461232|NCT00705718|323478220|FG001|Overall Study|Not due for Visit|12|||
94671860|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
94360022|NCT02087865|323101750|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
94461233|NCT00705718|323478219|FG000|Overall Study|Follow up not done|1|||
94360023|NCT02087865|323101751|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
94360024|NCT01339273|323101756|FG000|Overall Study|Lost to Follow-up|8|||
94360025|NCT01339273|323101757|FG001|Overall Study|Lost to Follow-up|8|||
94360026|NCT00344968|323101760|FG000|Overall Study|Adverse Event|5|||
94360027|NCT00344968|323101761|FG001|Overall Study|Adverse Event|4|||
94360028|NCT00344968|323101762|FG002|Overall Study|Adverse Event|15|||
94625868|NCT02207244|324088602|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
94625869|NCT02207244|324088603|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
94625870|NCT02207244|324088604|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
94625871|NCT02207244|324088605|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
94625872|NCT02207244|324088595|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
94625873|NCT02207244|324088596|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
94625874|NCT02207244|324088597|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
94625875|NCT02207244|324088598|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
94625876|NCT02207244|324088599|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
94625877|NCT02207244|324088600|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
94625878|NCT02207244|324088601|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
94625879|NCT02207244|324088602|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
94625880|NCT02207244|324088603|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
94625881|NCT02207244|324088604|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
94625882|NCT02207244|324088605|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
94625883|NCT02207244|324088595|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
94625884|NCT02207244|324088596|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
94625885|NCT02207244|324088597|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
94625886|NCT02207244|324088598|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
94625887|NCT02207244|324088599|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
94625888|NCT02207244|324088600|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
94625889|NCT02207244|324088601|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
94625890|NCT02207244|324088602|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
94625891|NCT02207244|324088603|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
94625892|NCT02207244|324088604|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
94625893|NCT02207244|324088605|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
94625894|NCT02207244|324088595|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
94625895|NCT02207244|324088596|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
94625896|NCT02207244|324088597|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
94625897|NCT02207244|324088598|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
94625898|NCT02207244|324088599|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
94625899|NCT02207244|324088600|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
94625900|NCT02207244|324088601|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
94625901|NCT02207244|324088602|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
94625902|NCT02207244|324088603|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
94625903|NCT02207244|324088604|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
94625904|NCT02207244|324088605|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
94625905|NCT02207244|324088595|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
94625906|NCT02207244|324088596|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
94625907|NCT02207244|324088597|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
94625908|NCT02207244|324088598|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
94625909|NCT02207244|324088599|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
94625910|NCT02207244|324088600|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
94625911|NCT02207244|324088601|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
94625912|NCT02207244|324088602|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
94625913|NCT02207244|324088603|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
94625914|NCT02207244|324088604|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
94625915|NCT02207244|324088605|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
94625916|NCT02207244|324088595|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
94625917|NCT02207244|324088596|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
94625918|NCT02207244|324088597|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
94671861|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
94671862|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
94671863|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
94671864|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
94671865|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
94671866|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
94671867|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
94671868|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
94671869|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
94671870|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
94671871|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
94671872|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
94671873|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
94671874|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
94671875|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
94671876|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
94671877|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
94671878|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
94671879|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
94671880|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
94671881|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
94671882|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
94671883|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
94671884|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
94671885|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
94671886|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
94671887|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
94671888|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
94671889|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
94671890|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
94671891|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
94671892|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
94671893|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
94671894|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
94671895|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
94671896|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
94671897|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
94671898|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
94671899|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
94671900|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
94671901|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
94671902|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
94671903|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
94671904|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
94671905|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
94671906|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
94671907|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
94671908|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
94671909|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
94671910|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
94671911|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
94671912|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
94671913|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
94671914|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
94671915|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
94671916|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
94671917|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
94671918|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
94671919|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
94671920|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
94461234|NCT00705718|323478220|FG001|Overall Study|Follow up not done|4|||
94461235|NCT02954653|323478223|FG000|Overall Study|Death|3|||
94461236|NCT02954653|323478224|FG001|Overall Study|Death|1|||
94671921|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
94671922|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
94671923|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
94671924|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
94671925|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
94671926|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
94671927|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
94671928|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
94671929|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
94671930|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
94671931|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
94671932|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
94671933|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
94671934|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
94671935|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
94671936|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
94671937|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
94671938|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
94671939|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
94671940|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
94671941|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
94671942|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
94671943|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
94671944|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
94671945|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
94671946|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
94671947|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
94671948|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
94671949|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
94671950|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
94671951|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
94671952|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
94671953|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
94671954|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
94671955|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
94671956|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
94671957|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
94671958|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
94671959|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
94671960|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
94671961|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
94671962|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
94671963|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
94671964|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
94671965|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
94671966|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
94671967|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
94671968|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
94671969|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
94671970|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
94671971|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
94671972|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
94671973|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
94671974|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
94671975|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
94671976|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
94671977|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
94671978|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
94671979|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
94671980|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
94671981|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
94671982|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
94671983|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
94671984|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
94671985|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
94671986|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
94671987|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
94671988|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
94671989|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
94671990|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
94671991|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
94671992|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
94671993|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
94671994|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
94671995|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
94671996|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
94671997|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
94671998|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
94671999|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
94672000|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
94672001|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
94672002|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
94672003|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
94672004|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
94672005|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
94672006|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
94672007|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
94672008|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
94672009|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
94672010|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
94672011|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
94672012|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
94672013|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
94672014|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
94672015|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
94672016|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
94625919|NCT02207244|324088598|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
94625920|NCT02207244|324088599|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
94625921|NCT02207244|324088600|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
94625922|NCT02207244|324088601|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
94625923|NCT02207244|324088602|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
94625924|NCT02207244|324088603|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
94625925|NCT02207244|324088604|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
94625926|NCT02207244|324088605|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
94625927|NCT02207244|324088595|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
94625928|NCT02207244|324088596|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
94625929|NCT02207244|324088597|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
94625930|NCT02207244|324088598|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
94625931|NCT02207244|324088599|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
94625932|NCT02207244|324088600|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
94625933|NCT02207244|324088601|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
94625934|NCT02207244|324088602|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
94625935|NCT02207244|324088603|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
94625936|NCT02207244|324088604|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
94625937|NCT02207244|324088605|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
94625938|NCT02207244|324088595|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
94625939|NCT02207244|324088596|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
94625940|NCT02207244|324088597|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
94625941|NCT02207244|324088598|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
94625942|NCT02207244|324088599|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
94625943|NCT02207244|324088600|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
94625944|NCT02207244|324088601|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
94625945|NCT02207244|324088602|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
94625946|NCT02207244|324088603|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
94625947|NCT02207244|324088604|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
94625948|NCT02207244|324088605|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
94625949|NCT02207244|324088595|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
94625950|NCT02207244|324088596|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
94625951|NCT02207244|324088597|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
94625952|NCT02207244|324088598|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
94625953|NCT02207244|324088599|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
94625954|NCT02207244|324088600|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
94625955|NCT02207244|324088601|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
94625956|NCT02207244|324088602|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
94625957|NCT02207244|324088603|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
94625958|NCT02207244|324088604|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
94625959|NCT02207244|324088605|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
94625960|NCT02207244|324088595|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
94625961|NCT02207244|324088596|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
94672017|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
94672018|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
94625962|NCT02207244|324088597|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
94625963|NCT02207244|324088598|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
94625964|NCT02207244|324088599|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
94625965|NCT02207244|324088600|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
94625966|NCT02207244|324088601|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
94625967|NCT02207244|324088602|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
94625968|NCT02207244|324088603|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
94625969|NCT02207244|324088604|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
94625970|NCT02207244|324088605|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
94625971|NCT02207244|324088595|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
94625972|NCT02207244|324088596|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
94625973|NCT02207244|324088597|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
94625974|NCT02207244|324088598|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
94625975|NCT02207244|324088599|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
94625976|NCT02207244|324088600|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
94625977|NCT02207244|324088601|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
94625978|NCT02207244|324088602|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
94625979|NCT02207244|324088603|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
94625980|NCT02207244|324088604|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
94625981|NCT02207244|324088605|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
94625982|NCT02207244|324088595|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
94625983|NCT02207244|324088596|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
94625984|NCT02207244|324088597|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
94625985|NCT02207244|324088598|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
94625986|NCT02207244|324088599|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
94625987|NCT02207244|324088600|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
94625988|NCT02207244|324088601|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
94625989|NCT02207244|324088602|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
94625990|NCT02207244|324088603|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
94625991|NCT02207244|324088604|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
94625992|NCT02207244|324088605|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
94625993|NCT02207244|324088595|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
94625994|NCT02207244|324088596|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
94625995|NCT02207244|324088597|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
94625996|NCT02207244|324088598|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
94625997|NCT02207244|324088599|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
94625998|NCT02207244|324088600|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
94625999|NCT02207244|324088601|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
94626000|NCT02207244|324088602|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
94626001|NCT02207244|324088603|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
94626002|NCT02207244|324088604|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
94626003|NCT02207244|324088605|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
94626004|NCT02207244|324088595|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
94626005|NCT02207244|324088596|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
94626006|NCT02207244|324088597|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
94626007|NCT02207244|324088598|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
94626008|NCT02207244|324088599|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
94626009|NCT02207244|324088600|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
94626010|NCT02207244|324088601|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
94626011|NCT02207244|324088602|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
94626012|NCT02207244|324088603|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
94626013|NCT02207244|324088604|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
94626014|NCT02207244|324088605|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
94626015|NCT02207244|324088595|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
94626016|NCT02207244|324088596|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
94626017|NCT02207244|324088597|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
94626018|NCT02207244|324088598|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
94626019|NCT02207244|324088599|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
94626020|NCT02207244|324088600|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
94626021|NCT02207244|324088601|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
94626022|NCT02207244|324088602|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
94626023|NCT02207244|324088603|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
94672019|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
94672020|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
94626024|NCT02207244|324088604|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
94672021|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
94461237|NCT02954653|323478225|FG002|Overall Study|Death|0|||
94672022|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
94672023|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
94672024|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
94672025|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
94672026|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
94672027|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
94672028|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
94672029|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
94672030|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
94672031|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
94672032|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
94672033|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
94672034|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
94672035|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
94672036|NCT01212770|324250489|FG000|Long-term Safety Phase (Year 5)|Death|0|||
94672037|NCT01212770|324250490|FG001|Long-term Safety Phase (Year 5)|Death|0|||
94672038|NCT01212770|324250491|FG002|Long-term Safety Phase (Year 5)|Death|0|||
94672039|NCT01212770|324250492|FG003|Long-term Safety Phase (Year 5)|Death|0|||
94672040|NCT01212770|324250493|FG004|Long-term Safety Phase (Year 5)|Death|0|||
94672041|NCT01212770|324250494|FG005|Long-term Safety Phase (Year 5)|Death|0|||
94672042|NCT01212770|324250495|FG006|Long-term Safety Phase (Year 5)|Death|0|||
94672043|NCT01212770|324250496|FG007|Long-term Safety Phase (Year 5)|Death|1|||
94672044|NCT01212770|324250497|FG008|Long-term Safety Phase (Year 5)|Death|0|||
94672045|NCT00829387|324250500|FG000|Overall Study|Withdrawal by Subject|2|||
94672046|NCT00829387|324250501|FG001|Overall Study|Withdrawal by Subject|3|||
94672047|NCT00829387|324250500|FG000|Overall Study|Disqualified by PI|1|||
94672048|NCT00829387|324250501|FG001|Overall Study|Disqualified by PI|0|||
94672049|NCT02693743|324250507|FG000|Overall Study|Physician Decision|1|||
94672050|NCT02693743|324250508|FG001|Overall Study|Physician Decision|0|||
94672051|NCT02858895|324250511|FG000|Overall Study|Disease progression|31|||
94672052|NCT02858895|324250511|FG000|Overall Study|Death|2|||
94672053|NCT02858895|324250511|FG000|Overall Study|Adverse Event|1|||
94672054|NCT02858895|324250511|FG000|Overall Study|Withdrawal by Subject|3|||
94672055|NCT02858895|324250511|FG000|Overall Study|hospice,|1|||
94672056|NCT02858895|324250511|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
94672057|NCT04508699|324250520|FG000|Overall Study|Lack of Efficacy|2|||
94672058|NCT04508699|324250521|FG001|Overall Study|Lack of Efficacy|15|||
94672059|NCT04508699|324250520|FG000|Overall Study|Withdrawal by Subject|0|||
94672060|NCT04508699|324250521|FG001|Overall Study|Withdrawal by Subject|2|||
94672061|NCT01475136|324250522|FG000|Overall Study|Sponsor Decision|0|||
94672062|NCT01475136|324250523|FG001|Overall Study|Sponsor Decision|1|||
94672063|NCT01475136|324250524|FG002|Overall Study|Sponsor Decision|0|||
94672064|NCT01475136|324250525|FG003|Overall Study|Sponsor Decision|0|||
94672065|NCT01475136|324250522|FG000|Overall Study|Entry Criteria Not Met|0|||
94672066|NCT01475136|324250523|FG001|Overall Study|Entry Criteria Not Met|2|||
94672067|NCT01475136|324250524|FG002|Overall Study|Entry Criteria Not Met|3|||
94672068|NCT01475136|324250525|FG003|Overall Study|Entry Criteria Not Met|1|||
94672069|NCT01475136|324250522|FG000|Overall Study|Withdrawal by Subject|0|||
94672070|NCT01475136|324250523|FG001|Overall Study|Withdrawal by Subject|0|||
94672071|NCT01475136|324250524|FG002|Overall Study|Withdrawal by Subject|0|||
94672072|NCT01475136|324250525|FG003|Overall Study|Withdrawal by Subject|2|||
94672073|NCT01475136|324250522|FG000|Overall Study|Adverse Event|1|||
94672074|NCT01475136|324250523|FG001|Overall Study|Adverse Event|0|||
94672075|NCT01475136|324250524|FG002|Overall Study|Adverse Event|0|||
94672076|NCT01475136|324250525|FG003|Overall Study|Adverse Event|1|||
94672077|NCT01475136|324250522|FG000|Overall Study|Death|0|||
94672078|NCT01475136|324250523|FG001|Overall Study|Death|0|||
94672079|NCT01475136|324250524|FG002|Overall Study|Death|0|||
94672080|NCT01475136|324250525|FG003|Overall Study|Death|1|||
94672081|NCT02160314|324251799|FG000|Overall Study|Adverse Event|0|||
94672082|NCT02160314|324251800|FG001|Overall Study|Adverse Event|6|||
94672083|NCT02160314|324251799|FG000|Overall Study|Protocol Violation|0|||
94672084|NCT02160314|324251800|FG001|Overall Study|Protocol Violation|4|||
94672085|NCT02160314|324251799|FG000|Overall Study|Withdrawal by Subject|1|||
94360029|NCT00344968|323101760|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
94672086|NCT02160314|324251800|FG001|Overall Study|Withdrawal by Subject|2|||
94672087|NCT02160314|324251799|FG000|Overall Study|Lost to Follow-up|0|||
94672088|NCT02160314|324251800|FG001|Overall Study|Lost to Follow-up|1|||
94672089|NCT02057874|324251802|FG000|Overall Study|participant did not return for scan|1|||
94672090|NCT02586025|324251806|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
94672091|NCT02586025|324251807|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
94672092|NCT02586025|324251806|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
94672093|NCT02586025|324251807|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
94672094|NCT02586025|324251806|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
94672095|NCT02586025|324251807|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
94626025|NCT02207244|324088605|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
94626026|NCT02207244|324088595|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
94626027|NCT02207244|324088596|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
94626028|NCT02207244|324088597|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
94626029|NCT02207244|324088598|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
94626030|NCT02207244|324088599|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
94626031|NCT02207244|324088600|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
94626032|NCT02207244|324088601|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
94626033|NCT02207244|324088602|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
94626034|NCT02207244|324088603|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
94626035|NCT02207244|324088604|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
94626036|NCT02207244|324088605|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
94626037|NCT02207244|324088595|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
94626038|NCT02207244|324088596|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
94626039|NCT02207244|324088597|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
94626040|NCT02207244|324088598|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
94626041|NCT02207244|324088599|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
94626042|NCT02207244|324088600|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
94626043|NCT02207244|324088601|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
94626044|NCT02207244|324088602|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
94626045|NCT02207244|324088603|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
94626046|NCT02207244|324088604|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
94626047|NCT02207244|324088605|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
94626048|NCT02207244|324088595|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
94626049|NCT02207244|324088596|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
94626050|NCT02207244|324088597|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
94626051|NCT02207244|324088598|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
94626052|NCT02207244|324088599|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
94626053|NCT02207244|324088600|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
94626054|NCT02207244|324088601|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
94626055|NCT02207244|324088602|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
94626056|NCT02207244|324088603|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
94626057|NCT02207244|324088604|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
94626058|NCT02207244|324088605|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
94626059|NCT02207244|324088595|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
94626060|NCT02207244|324088596|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
94626061|NCT02207244|324088597|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
94626062|NCT02207244|324088598|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
94626063|NCT02207244|324088599|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
94626064|NCT02207244|324088600|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
94626065|NCT02207244|324088601|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
94626066|NCT02207244|324088602|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
94626067|NCT02207244|324088603|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
94626068|NCT02207244|324088604|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
94626069|NCT02207244|324088605|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
94626070|NCT02207244|324088595|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
94626071|NCT02207244|324088596|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
94626072|NCT02207244|324088597|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
94626073|NCT02207244|324088598|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
94626074|NCT02207244|324088599|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
94626075|NCT02207244|324088600|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
94626076|NCT02207244|324088601|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
94626077|NCT02207244|324088602|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
94626078|NCT02207244|324088603|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
94626079|NCT02207244|324088604|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
94626080|NCT02207244|324088605|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
94626081|NCT02207244|324088595|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
94626082|NCT02207244|324088596|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
94626083|NCT02207244|324088597|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
94626084|NCT02207244|324088598|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
94672096|NCT02586025|324251806|FG000|Neoadjuvant Treatment|Death|1|||
94672097|NCT02586025|324251807|FG001|Neoadjuvant Treatment|Death|0|||
94360030|NCT00344968|323101761|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
94360031|NCT00344968|323101762|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
94360032|NCT00344968|323101760|FG000|Overall Study|Protocol Violation|2|||
94360033|NCT00344968|323101761|FG001|Overall Study|Protocol Violation|2|||
94360034|NCT00344968|323101762|FG002|Overall Study|Protocol Violation|5|||
94626085|NCT02207244|324088599|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
94626086|NCT02207244|324088600|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
94626087|NCT02207244|324088601|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
94626088|NCT02207244|324088602|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
94626089|NCT02207244|324088603|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
94626090|NCT02207244|324088604|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
94626091|NCT02207244|324088605|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
94626092|NCT02207244|324088595|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
94626093|NCT02207244|324088596|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
94626094|NCT02207244|324088597|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
94626095|NCT02207244|324088598|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
94626096|NCT02207244|324088599|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
94626097|NCT02207244|324088600|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
94626098|NCT02207244|324088601|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
94626099|NCT02207244|324088602|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
94626100|NCT02207244|324088603|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
94626101|NCT02207244|324088604|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
94626102|NCT02207244|324088605|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
94626103|NCT02207244|324088595|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
94626104|NCT02207244|324088596|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
94626105|NCT02207244|324088597|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
94626106|NCT02207244|324088598|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
94626107|NCT02207244|324088599|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
94626108|NCT02207244|324088600|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
94626109|NCT02207244|324088601|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
94626110|NCT02207244|324088602|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
94626111|NCT02207244|324088603|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
94626112|NCT02207244|324088604|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
94626113|NCT02207244|324088605|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
94626114|NCT02207244|324088595|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
94626115|NCT02207244|324088596|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
94626116|NCT02207244|324088597|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
94626117|NCT02207244|324088598|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
94626118|NCT02207244|324088599|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
94626119|NCT02207244|324088600|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
94626120|NCT02207244|324088601|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
94626121|NCT02207244|324088602|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
94626122|NCT02207244|324088603|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
94626123|NCT02207244|324088604|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
94626124|NCT02207244|324088605|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
94626125|NCT02207244|324088595|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
94626126|NCT02207244|324088596|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
94626127|NCT02207244|324088597|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
94626128|NCT02207244|324088598|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
94626129|NCT02207244|324088599|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
94626130|NCT02207244|324088600|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
94626131|NCT02207244|324088601|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
94626132|NCT02207244|324088602|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
94626133|NCT02207244|324088603|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
94626134|NCT02207244|324088604|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
94626135|NCT02207244|324088605|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
94626136|NCT02207244|324088595|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
94626137|NCT02207244|324088596|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
94626138|NCT02207244|324088597|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
94626139|NCT02207244|324088598|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
94626140|NCT02207244|324088599|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
94360035|NCT00344968|323101760|FG000|Overall Study|Withdrawal by Subject|14|||
94360036|NCT00344968|323101761|FG001|Overall Study|Withdrawal by Subject|31|||
94626141|NCT02207244|324088600|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
94626142|NCT02207244|324088601|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
94626143|NCT02207244|324088602|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
94626144|NCT02207244|324088603|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
94626145|NCT02207244|324088604|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
94626146|NCT02207244|324088605|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
94360037|NCT00344968|323101762|FG002|Overall Study|Withdrawal by Subject|27|||
94672098|NCT02586025|324251806|FG000|Neoadjuvant Treatment|Adverse Event|1|||
94672099|NCT02586025|324251807|FG001|Neoadjuvant Treatment|Adverse Event|0|||
94672100|NCT02586025|324251806|FG000|Neoadjuvant Treatment|Physician Decision|2|||
94672101|NCT02586025|324251807|FG001|Neoadjuvant Treatment|Physician Decision|1|||
94672102|NCT02586025|324251806|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
94672103|NCT02586025|324251807|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
94672104|NCT02586025|324251806|FG000|Adjuvant Treatment|Recurrent Disease|4|||
94672105|NCT02586025|324251807|FG001|Adjuvant Treatment|Recurrent Disease|5|||
94672106|NCT02586025|324251806|FG000|Adjuvant Treatment|Physician Decision|0|||
94672107|NCT02586025|324251807|FG001|Adjuvant Treatment|Physician Decision|1|||
94672108|NCT02586025|324251806|FG000|Adjuvant Treatment|Pregnancy|1|||
94672109|NCT02586025|324251807|FG001|Adjuvant Treatment|Pregnancy|0|||
94672110|NCT02586025|324251806|FG000|Treatment-Free Follow-Up|Death|11|||
94672111|NCT02586025|324251807|FG001|Treatment-Free Follow-Up|Death|11|||
94672112|NCT02586025|324251806|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
94672113|NCT02586025|324251807|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
94672114|NCT02586025|324251806|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
94672115|NCT02586025|324251807|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
94672116|NCT02586025|324251806|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
94672117|NCT02586025|324251807|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
94672118|NCT02586025|324251806|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
94672119|NCT02586025|324251807|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
94672120|NCT02030015|324251808|FG000|Overall Study|Withdrawal by Subject|3|||
94672121|NCT02030015|324251808|FG000|Overall Study|Death|13|||
94672122|NCT03014674|324251809|FG000|Overall Study|Withdrawal by Subject|1|||
94672123|NCT03014674|324251810|FG001|Overall Study|Withdrawal by Subject|0|||
94672124|NCT03014674|324251811|FG002|Overall Study|Withdrawal by Subject|0|||
94672125|NCT03284788|324251813|FG000|Overall Study|Withdrawal by Subject|2|||
94672126|NCT00381940|324251817|FG000|Overall Study|Lack of Efficacy|3|||
94672127|NCT00381940|324251817|FG000|Overall Study|Protocol Violation|1|||
94672128|NCT00381940|324251817|FG000|Overall Study|Ineligible|1|||
94672129|NCT02450331|324251819|FG000|Overall Study|Death|162|||
94672130|NCT02450331|324251820|FG001|Overall Study|Death|171|||
94672131|NCT02450331|324251819|FG000|Overall Study|Lost to Follow-up|14|||
94672132|NCT02450331|324251820|FG001|Overall Study|Lost to Follow-up|12|||
94672133|NCT02450331|324251819|FG000|Overall Study|Withdrawal by Subject|55|||
94672134|NCT02450331|324251820|FG001|Overall Study|Withdrawal by Subject|44|||
94672135|NCT02450331|324251819|FG000|Overall Study|Non-specified other|1|||
94672136|NCT02450331|324251820|FG001|Overall Study|Non-specified other|1|||
94672137|NCT01615328|324251821|FG000|Overall Study|Lost to Follow-up|3|||
94672138|NCT01615328|324251822|FG001|Overall Study|Lost to Follow-up|5|||
94672139|NCT04465357|324251824|FG000|Overall Study|Adverse Event|2|||
94672140|NCT04465357|324251824|FG000|Overall Study|Lack of Efficacy|1|||
94672141|NCT04465357|324251824|FG000|Overall Study|Lost to Follow-up|2|||
94672142|NCT04465357|324251824|FG000|Overall Study|Withdrawal by Subject|6|||
94672143|NCT04465357|324251824|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
94672144|NCT01970462|324251828|FG000|Overall Study|Lost to Follow-up|0|||
94672145|NCT01970462|324251829|FG001|Overall Study|Lost to Follow-up|2|||
94672146|NCT00754338|324251830|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
94672147|NCT00754338|324251831|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
94672148|NCT00754338|324251832|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
94672149|NCT00754338|324251833|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
94672150|NCT00754338|324251830|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
94672151|NCT00754338|324251831|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
94672152|NCT00754338|324251832|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
94672153|NCT00754338|324251833|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
94672154|NCT00831779|324251834|FG000|Overall Study|Lost to Follow-up|1|||
94672155|NCT00831779|324251835|FG001|Overall Study|Lost to Follow-up|0|||
94672156|NCT00831779|324251834|FG000|Overall Study|No longer met criteria|0|||
94672157|NCT00831779|324251835|FG001|Overall Study|No longer met criteria|1|||
94672158|NCT04528069|324251836|FG000|Overall Study|Adverse Event|1|||
94672159|NCT04528069|324251836|FG000|Overall Study|Lost to Follow-up|1|||
94672160|NCT04528069|324251836|FG000|Overall Study|Patient Unable to Come|1|||
94672161|NCT04528069|324251836|FG000|Overall Study|Patient Unable to Attend|1|||
94672162|NCT01433354|324251837|FG000|Overall Study|Adverse Event|6|||
94672163|NCT01433354|324251837|FG000|Overall Study|Lost to Follow-up|1|||
94672164|NCT01433354|324251837|FG000|Overall Study|Administrative problems|90|||
94672165|NCT01433354|324251837|FG000|Overall Study|Protocol Violation|2|||
94672166|NCT01433354|324251837|FG000|Overall Study|Lack of Efficacy|17|||
94672167|NCT01433354|324251837|FG000|Overall Study|Subject Withdrew Consent|3|||
94672168|NCT00911534|324251839|FG000|Overall Study|Adverse Event|4|||
94672169|NCT00911534|324251840|FG001|Overall Study|Adverse Event|4|||
94672170|NCT00911534|324251839|FG000|Overall Study|Lost to Follow-up|2|||
94672171|NCT00911534|324251840|FG001|Overall Study|Lost to Follow-up|4|||
94672172|NCT00911534|324251839|FG000|Overall Study|Withdrawal by Subject|2|||
94672173|NCT00911534|324251840|FG001|Overall Study|Withdrawal by Subject|1|||
94626147|NCT02207244|324088595|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
94626148|NCT02207244|324088596|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
94626149|NCT02207244|324088597|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
94626150|NCT02207244|324088598|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
94626151|NCT02207244|324088599|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
94626152|NCT02207244|324088600|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
94626153|NCT02207244|324088601|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
94626154|NCT02207244|324088602|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
94626155|NCT02207244|324088603|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
94626156|NCT02207244|324088604|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
94626157|NCT02207244|324088605|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
94626158|NCT01269463|324088608|FG000|First Intervention|Withdrawal by Subject|1|||
94626159|NCT01269463|324088609|FG001|First Intervention|Withdrawal by Subject|0|||
94626160|NCT01269463|324088608|FG000|First Intervention|Adverse Event|1|||
94626161|NCT01269463|324088609|FG001|First Intervention|Adverse Event|0|||
94626162|NCT01269463|324088608|FG000|First Intervention|Lack of Efficacy|0|||
94626163|NCT01269463|324088609|FG001|First Intervention|Lack of Efficacy|1|||
94626164|NCT01269463|324088608|FG000|First Intervention|Physician Decision|0|||
94626165|NCT01269463|324088609|FG001|First Intervention|Physician Decision|1|||
94626166|NCT04051008|324088610|FG000|Overall Study|Withdrawal by Subject|2|||
94626167|NCT04051008|324088611|FG001|Overall Study|Withdrawal by Subject|0|||
94626168|NCT04051008|324088612|FG002|Overall Study|Withdrawal by Subject|1|||
94626169|NCT01835587|324088613|FG000|Overall Study|Disease Recurrence or Relapse|0|||
94626170|NCT01835587|324088614|FG001|Overall Study|Disease Recurrence or Relapse|3|||
94626171|NCT01835587|324088615|FG002|Overall Study|Disease Recurrence or Relapse|0|||
94626172|NCT01835587|324088616|FG003|Overall Study|Disease Recurrence or Relapse|3|||
94626173|NCT01835587|324088613|FG000|Overall Study|Withdrawal by Subject|2|||
94626174|NCT01835587|324088614|FG001|Overall Study|Withdrawal by Subject|0|||
94626175|NCT01835587|324088615|FG002|Overall Study|Withdrawal by Subject|0|||
94626176|NCT01835587|324088616|FG003|Overall Study|Withdrawal by Subject|3|||
94626177|NCT01835587|324088613|FG000|Overall Study|Adverse Event|0|||
94626178|NCT01835587|324088614|FG001|Overall Study|Adverse Event|0|||
94626179|NCT01835587|324088615|FG002|Overall Study|Adverse Event|2|||
94626180|NCT01835587|324088616|FG003|Overall Study|Adverse Event|2|||
94626181|NCT01835587|324088613|FG000|Overall Study|Death|0|||
94626182|NCT01835587|324088614|FG001|Overall Study|Death|0|||
94626183|NCT01835587|324088615|FG002|Overall Study|Death|0|||
94626184|NCT01835587|324088616|FG003|Overall Study|Death|1|||
94626185|NCT01835587|324088613|FG000|Overall Study|Miscellaneous|0|||
94626186|NCT01835587|324088614|FG001|Overall Study|Miscellaneous|1|||
94626187|NCT01835587|324088615|FG002|Overall Study|Miscellaneous|0|||
94626188|NCT01835587|324088616|FG003|Overall Study|Miscellaneous|0|||
94626189|NCT00838578|324088617|FG000|Overall Study|Protocol Violation|2|||
94626190|NCT02142959|324088618|FG000|Overall Study|Adverse Event|1|||
94626191|NCT02142959|324088619|FG001|Overall Study|Adverse Event|0|||
94626192|NCT02142959|324088620|FG002|Overall Study|Adverse Event|0|||
94626193|NCT02142959|324088618|FG000|Overall Study|Death|0|||
94626194|NCT02142959|324088619|FG001|Overall Study|Death|1|||
94626195|NCT02142959|324088620|FG002|Overall Study|Death|0|||
94626196|NCT02142959|324088618|FG000|Overall Study|Withdrawal by Subject|3|||
94626197|NCT02142959|324088619|FG001|Overall Study|Withdrawal by Subject|1|||
94626198|NCT02142959|324088620|FG002|Overall Study|Withdrawal by Subject|3|||
94626199|NCT02142959|324088618|FG000|Overall Study|Administrative Reasons|1|||
94626200|NCT02142959|324088619|FG001|Overall Study|Administrative Reasons|0|||
94626201|NCT02142959|324088620|FG002|Overall Study|Administrative Reasons|1|||
94626202|NCT02142959|324088618|FG000|Overall Study|Missing|0|||
94626203|NCT02142959|324088619|FG001|Overall Study|Missing|1|||
94672174|NCT00911534|324251839|FG000|Overall Study|Lack of Efficacy|4|||
94672175|NCT00911534|324251840|FG001|Overall Study|Lack of Efficacy|1|||
94626204|NCT02142959|324088620|FG002|Overall Study|Missing|0|||
94626205|NCT02142959|324088618|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
94626206|NCT02142959|324088619|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
94626207|NCT02142959|324088620|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
94626208|NCT02142959|324088618|FG000|Overall Study|Patient didn't complete end of study visit|0|||
94626209|NCT02142959|324088619|FG001|Overall Study|Patient didn't complete end of study visit|0|||
94626210|NCT02142959|324088620|FG002|Overall Study|Patient didn't complete end of study visit|1|||
94626211|NCT03031678|324088621|FG000|Overall Study|Study closed prior to completion|1|||
94626212|NCT00439244|324088622|FG000|Overall Study|Adverse Event|5|||
94626213|NCT00439244|324088623|FG001|Overall Study|Adverse Event|2|||
94626214|NCT00439244|324088624|FG002|Overall Study|Adverse Event|3|||
94626215|NCT00439244|324088622|FG000|Overall Study|Withdrawal by Subject|3|||
94626216|NCT00439244|324088623|FG001|Overall Study|Withdrawal by Subject|1|||
94626217|NCT00439244|324088624|FG002|Overall Study|Withdrawal by Subject|2|||
94626218|NCT00439244|324088622|FG000|Overall Study|Lost to Follow-up|2|||
94672176|NCT00911534|324251839|FG000|Overall Study|Withdrawal of consent|1|||
94672177|NCT00911534|324251840|FG001|Overall Study|Withdrawal of consent|4|||
94672178|NCT00911534|324251839|FG000|Overall Study|Other|2|||
94672179|NCT00911534|324251840|FG001|Overall Study|Other|2|||
94672180|NCT01970982|324251841|FG000|Overall Study|Withdrawal by Subject|0|||
94672181|NCT01970982|324251842|FG001|Overall Study|Withdrawal by Subject|0|||
94672182|NCT01970982|324251843|FG002|Overall Study|Withdrawal by Subject|2|||
94672183|NCT02395042|324251844|FG000|Treatment 1 Period|Adverse Event|1|||
94672184|NCT02395042|324251845|FG001|Treatment 1 Period|Adverse Event|3|||
94672185|NCT02395042|324251846|FG002|Treatment 1 Period|Adverse Event|1|||
94672186|NCT02395042|324251844|FG000|Treatment 1 Period|Lack of Efficacy|1|||
94672187|NCT02395042|324251845|FG001|Treatment 1 Period|Lack of Efficacy|1|||
94672188|NCT02395042|324251846|FG002|Treatment 1 Period|Lack of Efficacy|0|||
94672189|NCT02395042|324251844|FG000|Treatment 1 Period|Lost to Follow-up|1|||
94672190|NCT02395042|324251845|FG001|Treatment 1 Period|Lost to Follow-up|0|||
94672191|NCT02395042|324251846|FG002|Treatment 1 Period|Lost to Follow-up|0|||
94672192|NCT02395042|324251844|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
94672193|NCT02395042|324251845|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
94672194|NCT02395042|324251846|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
94672195|NCT02395042|324251844|FG000|Treatment 2 Period|Lack of Efficacy|1|||
94672196|NCT02395042|324251845|FG001|Treatment 2 Period|Lack of Efficacy|1|||
94672197|NCT02395042|324251846|FG002|Treatment 2 Period|Lack of Efficacy|0|||
94672198|NCT01270347|324251847|FG000|Core Phase|Adverse Event|1|||
94672199|NCT01270347|324251848|FG001|Core Phase|Adverse Event|6|||
94672200|NCT01270347|324251847|FG000|Core Phase|Withdrawal by Subject|1|||
94672201|NCT01270347|324251848|FG001|Core Phase|Withdrawal by Subject|2|||
94672202|NCT01270347|324251847|FG000|Core Phase|Lost to Follow-up|0|||
94672203|NCT01270347|324251848|FG001|Core Phase|Lost to Follow-up|1|||
94672204|NCT01270347|324251847|FG000|Core Phase|Miscellaneous|8|||
94672205|NCT01270347|324251848|FG001|Core Phase|Miscellaneous|14|||
94672206|NCT01270347|324251847|FG000|Extension Phase|Adverse Event|1|||
94672207|NCT01270347|324251848|FG001|Extension Phase|Adverse Event|3|||
94672208|NCT01270347|324251847|FG000|Extension Phase|Withdrawal by Subject|3|||
94672209|NCT01270347|324251848|FG001|Extension Phase|Withdrawal by Subject|4|||
94672210|NCT01270347|324251847|FG000|Extension Phase|Miscellaneous|2|||
94672211|NCT01270347|324251848|FG001|Extension Phase|Miscellaneous|2|||
94672212|NCT00715429|324251849|FG000|Overall Study|Did not complete the study diary|0|||
94672213|NCT00715429|324251850|FG001|Overall Study|Did not complete the study diary|1|||
94672214|NCT03492281|324251851|FG000|Overall Study|Withdrawal by Subject|21|||
94672215|NCT03492281|324251852|FG001|Overall Study|Withdrawal by Subject|14|||
94672216|NCT03492281|324251853|FG002|Overall Study|Withdrawal by Subject|13|||
94672217|NCT03492281|324251851|FG000|Overall Study|Lost to Follow-up|14|||
94672218|NCT03492281|324251852|FG001|Overall Study|Lost to Follow-up|15|||
94672219|NCT03492281|324251853|FG002|Overall Study|Lost to Follow-up|10|||
94672220|NCT03492281|324251851|FG000|Overall Study|Adverse Event|6|||
94626219|NCT00439244|324088623|FG001|Overall Study|Lost to Follow-up|1|||
94626220|NCT00439244|324088624|FG002|Overall Study|Lost to Follow-up|2|||
94626221|NCT00439244|324088622|FG000|Overall Study|Death|0|||
94626222|NCT00439244|324088623|FG001|Overall Study|Death|1|||
94626223|NCT00439244|324088624|FG002|Overall Study|Death|0|||
94626224|NCT00439244|324088622|FG000|Overall Study|Protocol Violation|0|||
94626225|NCT00439244|324088623|FG001|Overall Study|Protocol Violation|1|||
94626226|NCT00439244|324088624|FG002|Overall Study|Protocol Violation|0|||
94626227|NCT00439244|324088622|FG000|Overall Study|Administrative problems|1|||
94626228|NCT00439244|324088623|FG001|Overall Study|Administrative problems|0|||
94626229|NCT00439244|324088624|FG002|Overall Study|Administrative problems|0|||
94626230|NCT00887978|324088625|FG000|Overall Study|Adverse Event|18|||
94626231|NCT00887978|324088626|FG001|Overall Study|Adverse Event|5|||
94626232|NCT00887978|324088625|FG000|Overall Study|Clinical Worsening|4|||
94626233|NCT00887978|324088626|FG001|Overall Study|Clinical Worsening|4|||
94626234|NCT00887978|324088625|FG000|Overall Study|Death|2|||
94626235|NCT00887978|324088626|FG001|Overall Study|Death|3|||
94672221|NCT03492281|324251852|FG001|Overall Study|Adverse Event|8|||
94672222|NCT03492281|324251853|FG002|Overall Study|Adverse Event|13|||
94672223|NCT03492281|324251851|FG000|Overall Study|Lack of Efficacy|3|||
94672224|NCT03492281|324251852|FG001|Overall Study|Lack of Efficacy|0|||
94626236|NCT00887978|324088625|FG000|Overall Study|Withdrawal by Subject|1|||
94626237|NCT00887978|324088626|FG001|Overall Study|Withdrawal by Subject|2|||
94626238|NCT00887978|324088625|FG000|Overall Study|Lost to Follow-up|0|||
94626239|NCT00887978|324088626|FG001|Overall Study|Lost to Follow-up|1|||
94672225|NCT03492281|324251853|FG002|Overall Study|Lack of Efficacy|1|||
94672226|NCT03492281|324251851|FG000|Overall Study|Physician Decision|1|||
94672227|NCT03492281|324251852|FG001|Overall Study|Physician Decision|0|||
94672228|NCT03492281|324251853|FG002|Overall Study|Physician Decision|3|||
94626240|NCT04702997|324088633|FG000|Overall Study|Withdrawal by Subject|1|||
94626241|NCT04702997|324088634|FG001|Overall Study|Withdrawal by Subject|1|||
94626242|NCT03278613|324088635|FG000|Overall Study|Lost to Follow-up|3|||
94672229|NCT03492281|324251851|FG000|Overall Study|Protocol Violation|0|||
94672230|NCT03492281|324251852|FG001|Overall Study|Protocol Violation|2|||
94672231|NCT03492281|324251853|FG002|Overall Study|Protocol Violation|1|||
94672232|NCT03492281|324251851|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
94672233|NCT03492281|324251852|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
94672234|NCT03492281|324251853|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
94672235|NCT03492281|324251851|FG000|Overall Study|Death|0|||
94672236|NCT03492281|324251852|FG001|Overall Study|Death|0|||
94672237|NCT03492281|324251853|FG002|Overall Study|Death|1|||
94672238|NCT03492281|324251851|FG000|Overall Study|Captured as Other in Database|8|||
94672239|NCT03492281|324251852|FG001|Overall Study|Captured as Other in Database|6|||
94672240|NCT03492281|324251853|FG002|Overall Study|Captured as Other in Database|3|||
94672241|NCT01152580|324251855|FG000|Overall Study|Withdrawal by Subject|0|||
94672242|NCT01152580|324251856|FG001|Overall Study|Withdrawal by Subject|1|||
94672243|NCT01596582|324251865|FG000|Overall Study|Deemed ineligible after study visit|3|||
94672244|NCT01596582|324251866|FG001|Overall Study|Deemed ineligible after study visit|6|||
94672245|NCT01596582|324251865|FG000|Overall Study|Missing all outcome data|1|||
94672246|NCT01596582|324251866|FG001|Overall Study|Missing all outcome data|1|||
94672247|NCT01292239|324251871|FG000|Overall Study|Other|1|||
94672248|NCT01292239|324251872|FG001|Overall Study|Other|1|||
94672249|NCT01292239|324251871|FG000|Overall Study|Withdrawal by Subject|3|||
94672250|NCT01292239|324251872|FG001|Overall Study|Withdrawal by Subject|6|||
94672251|NCT04072159|324251873|FG000|Overall Study|Lost to Follow-up|6|||
94672252|NCT04072159|324251874|FG001|Overall Study|Lost to Follow-up|6|||
94672253|NCT04072159|324251873|FG000|Overall Study|Withdrawal by Subject|2|||
94672254|NCT04072159|324251874|FG001|Overall Study|Withdrawal by Subject|0|||
94672255|NCT00419263|324251876|FG000|Overall Study|Lost to Follow-up|2|||
94672256|NCT00419263|324251877|FG001|Overall Study|Lost to Follow-up|1|||
94672257|NCT00419263|324251878|FG002|Overall Study|Lost to Follow-up|1|||
94672258|NCT00419263|324251876|FG000|Overall Study|Randomized in Error, Not Treated|1|||
94672259|NCT00419263|324251877|FG001|Overall Study|Randomized in Error, Not Treated|1|||
94672260|NCT00419263|324251878|FG002|Overall Study|Randomized in Error, Not Treated|0|||
94672261|NCT00419263|324251876|FG000|Overall Study|Adverse Event|0|||
94672262|NCT00419263|324251877|FG001|Overall Study|Adverse Event|0|||
94672263|NCT00419263|324251878|FG002|Overall Study|Adverse Event|1|||
94672264|NCT00419263|324251876|FG000|Overall Study|Withdrawal by Subject|0|||
94672265|NCT00419263|324251877|FG001|Overall Study|Withdrawal by Subject|0|||
94672266|NCT00419263|324251878|FG002|Overall Study|Withdrawal by Subject|1|||
94672267|NCT00377403|324251879|FG000|Overall Study|Unable to contact for telephone intervie|4|||
94672268|NCT00377403|324251880|FG001|Overall Study|Unable to contact for telephone intervie|7|||
94672269|NCT00765674|324251881|FG000|Overall Study|Adverse Event|7|||
94672270|NCT00765674|324251882|FG001|Overall Study|Adverse Event|2|||
94672271|NCT00765674|324251883|FG002|Overall Study|Adverse Event|8|||
94672272|NCT00765674|324251884|FG003|Overall Study|Adverse Event|11|||
94672273|NCT00765674|324251881|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
94672274|NCT00765674|324251882|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
94672275|NCT00765674|324251883|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
94672276|NCT00765674|324251884|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
94672277|NCT00765674|324251881|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
94672278|NCT00765674|324251882|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
94672279|NCT00765674|324251883|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
94672280|NCT00765674|324251884|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
94672281|NCT00765674|324251881|FG000|Overall Study|Lack of Efficacy|2|||
94672282|NCT00765674|324251882|FG001|Overall Study|Lack of Efficacy|3|||
94672283|NCT00765674|324251883|FG002|Overall Study|Lack of Efficacy|1|||
94672284|NCT00765674|324251884|FG003|Overall Study|Lack of Efficacy|2|||
94672285|NCT00765674|324251881|FG000|Overall Study|Protocol Violation|2|||
94672286|NCT00765674|324251882|FG001|Overall Study|Protocol Violation|0|||
94672287|NCT00765674|324251883|FG002|Overall Study|Protocol Violation|1|||
94672288|NCT00765674|324251884|FG003|Overall Study|Protocol Violation|0|||
94672289|NCT00765674|324251881|FG000|Overall Study|Withdrawal by Subject|5|||
94672290|NCT00765674|324251882|FG001|Overall Study|Withdrawal by Subject|7|||
94672291|NCT00765674|324251883|FG002|Overall Study|Withdrawal by Subject|3|||
94672292|NCT00765674|324251884|FG003|Overall Study|Withdrawal by Subject|8|||
94672293|NCT00765674|324251881|FG000|Overall Study|Lost to Follow-up|4|||
94672294|NCT00765674|324251882|FG001|Overall Study|Lost to Follow-up|6|||
94672295|NCT00765674|324251883|FG002|Overall Study|Lost to Follow-up|2|||
94672296|NCT00765674|324251884|FG003|Overall Study|Lost to Follow-up|1|||
94672297|NCT00765674|324251881|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
94672298|NCT00765674|324251882|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
94672299|NCT00765674|324251883|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
94672300|NCT00765674|324251884|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
94360038|NCT00344968|323101760|FG000|Overall Study|Lost to Follow-up|24|||
94672301|NCT01813474|324251885|FG000|Overall Study|Withdrawal by Subject|0|||
94672302|NCT01813474|324251886|FG001|Overall Study|Withdrawal by Subject|0|||
94672303|NCT01813474|324251887|FG002|Overall Study|Withdrawal by Subject|1|||
94672304|NCT01813474|324251885|FG000|Overall Study|Adverse Event|1|||
94672305|NCT01813474|324251886|FG001|Overall Study|Adverse Event|1|||
94672306|NCT01813474|324251887|FG002|Overall Study|Adverse Event|0|||
94672307|NCT01813474|324251885|FG000|Overall Study|Lack of Efficacy|2|||
94672308|NCT01813474|324251886|FG001|Overall Study|Lack of Efficacy|6|||
94672309|NCT01813474|324251887|FG002|Overall Study|Lack of Efficacy|9|||
94672310|NCT01813474|324251885|FG000|Overall Study|Death|0|||
94672311|NCT01813474|324251886|FG001|Overall Study|Death|0|||
94672312|NCT01813474|324251887|FG002|Overall Study|Death|1|||
94672313|NCT03015402|324251888|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
94672314|NCT03015402|324251889|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
94672315|NCT03015402|324251888|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
94672316|NCT03015402|324251889|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
94360039|NCT00344968|323101761|FG001|Overall Study|Lost to Follow-up|37|||
94360040|NCT00344968|323101762|FG002|Overall Study|Lost to Follow-up|37|||
94360041|NCT00344968|323101760|FG000|Overall Study|Death|11|||
94360042|NCT00344968|323101761|FG001|Overall Study|Death|27|||
94672317|NCT03213158|324251894|FG000|Overall Study|Withdrawal by Subject|1|||
94672318|NCT03213158|324251894|FG000|Overall Study|Physician Decision|2|||
94672319|NCT01569438|324251898|FG000|Overall Study|Lack of Efficacy|1|||
94672320|NCT01569438|324251899|FG001|Overall Study|Lack of Efficacy|2|||
94672321|NCT01569438|324251898|FG000|Overall Study|Withdrawal by Subject|0|||
94672322|NCT01569438|324251899|FG001|Overall Study|Withdrawal by Subject|3|||
94672323|NCT01569438|324251898|FG000|Overall Study|Adverse Event|2|||
94672324|NCT01569438|324251899|FG001|Overall Study|Adverse Event|15|||
94672325|NCT01569438|324251898|FG000|Overall Study|Protocol Violation|2|||
94672326|NCT01569438|324251899|FG001|Overall Study|Protocol Violation|0|||
94672327|NCT01569438|324251898|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
94672328|NCT01569438|324251899|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
94672329|NCT01569438|324251898|FG000|Overall Study|Sponsor/Physician decision|1|||
94672330|NCT01569438|324251899|FG001|Overall Study|Sponsor/Physician decision|1|||
94672331|NCT01569438|324251898|FG000|Overall Study|Unable to adhere to study schedule|0|||
94672332|NCT01569438|324251899|FG001|Overall Study|Unable to adhere to study schedule|1|||
94672333|NCT01936857|324251900|FG000|Overall Study|Sent to prison or 06 center|11|||
94672334|NCT01936857|324251901|FG001|Overall Study|Sent to prison or 06 center|12|||
94672335|NCT01936857|324251900|FG000|Overall Study|Lost to Follow-up|10|||
94672336|NCT01936857|324251901|FG001|Overall Study|Lost to Follow-up|7|||
94672337|NCT01936857|324251900|FG000|Overall Study|Death|7|||
94672338|NCT01936857|324251901|FG001|Overall Study|Death|3|||
94672339|NCT01936857|324251900|FG000|Overall Study|Moved|2|||
94672340|NCT01936857|324251901|FG001|Overall Study|Moved|1|||
94672341|NCT01936857|324251900|FG000|Overall Study|Withdrawal by Subject|1|||
94672342|NCT01936857|324251901|FG001|Overall Study|Withdrawal by Subject|0|||
94672343|NCT01936857|324251900|FG000|Overall Study|Side effect of medication|1|||
94672344|NCT01936857|324251901|FG001|Overall Study|Side effect of medication|0|||
94672345|NCT01936857|324251900|FG000|Overall Study|Other|2|||
94672346|NCT01936857|324251901|FG001|Overall Study|Other|2|||
94672347|NCT03792126|324251909|FG000|Overall Study|Adverse Event|1|||
94672348|NCT03792126|324251910|FG001|Overall Study|Adverse Event|2|||
94672349|NCT03792126|324251909|FG000|Overall Study|Death|0|||
94672350|NCT03792126|324251910|FG001|Overall Study|Death|1|||
94626243|NCT03278613|324088636|FG001|Overall Study|Lost to Follow-up|1|||
94626244|NCT05255068|324090081|FG000|Overall Study|Lost to Follow-up|0|||
94626245|NCT05255068|324090082|FG001|Overall Study|Lost to Follow-up|1|||
94626246|NCT00540514|324090093|FG000|Overall Study|Still on treatment|3|||
94626247|NCT00540514|324090094|FG001|Overall Study|Still on treatment|0|||
94626248|NCT00540514|324090093|FG000|Overall Study|Unacceptable Toxicity|61|||
94626249|NCT00540514|324090094|FG001|Overall Study|Unacceptable Toxicity|62|||
94626250|NCT00540514|324090093|FG000|Overall Study|Adverse Event|20|||
94626251|NCT00540514|324090094|FG001|Overall Study|Adverse Event|24|||
94626252|NCT00540514|324090093|FG000|Overall Study|Physician Decision|86|||
94626253|NCT00540514|324090094|FG001|Overall Study|Physician Decision|99|||
94626254|NCT00540514|324090093|FG000|Overall Study|Protocol Deviation|3|||
94626255|NCT00540514|324090094|FG001|Overall Study|Protocol Deviation|4|||
94672351|NCT03792126|324251909|FG000|Overall Study|Lost to Follow-up|1|||
94672352|NCT03792126|324251910|FG001|Overall Study|Lost to Follow-up|0|||
94672353|NCT03792126|324251909|FG000|Overall Study|Withdrawal by Subject|0|||
94360043|NCT00344968|323101762|FG002|Overall Study|Death|31|||
94360044|NCT00344968|323101760|FG000|Overall Study|Other|0|||
94626256|NCT00540514|324090093|FG000|Overall Study|Lost to Follow-up|1|||
94626257|NCT00540514|324090094|FG001|Overall Study|Lost to Follow-up|1|||
94626258|NCT00540514|324090093|FG000|Overall Study|Withdrawal by Subject|65|||
94626259|NCT00540514|324090094|FG001|Overall Study|Withdrawal by Subject|67|||
94626260|NCT00540514|324090093|FG000|Overall Study|Excluded prior to treatment|7|||
94360045|NCT00344968|323101761|FG001|Overall Study|Other|1|||
94360046|NCT00344968|323101762|FG002|Overall Study|Other|0|||
94672354|NCT03792126|324251910|FG001|Overall Study|Withdrawal by Subject|1|||
94672355|NCT03792126|324251909|FG000|Overall Study|COVID-19 Restrictions|1|||
94672356|NCT03792126|324251910|FG001|Overall Study|COVID-19 Restrictions|3|||
94672357|NCT03792126|324251909|FG000|Overall Study|Symptoms resolved|0|||
94672358|NCT03792126|324251910|FG001|Overall Study|Symptoms resolved|3|||
94360047|NCT01656850|323101763|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
94672359|NCT01515748|324251931|FG000|Overall Study|Withdrawal by Subject|32|||
94672360|NCT01515748|324251932|FG001|Overall Study|Withdrawal by Subject|41|||
94672361|NCT01515748|324251931|FG000|Overall Study|Lost to Follow-up|2|||
94672362|NCT01515748|324251932|FG001|Overall Study|Lost to Follow-up|4|||
94672363|NCT01515748|324251931|FG000|Overall Study|Other than specified above|5|||
94672364|NCT01515748|324251932|FG001|Overall Study|Other than specified above|10|||
94672365|NCT02276222|324251933|FG000|Overall Study|Adverse Event|62|||
94672366|NCT02276222|324251934|FG001|Overall Study|Adverse Event|11|||
94672367|NCT02276222|324251933|FG000|Overall Study|Death|3|||
94672368|NCT02276222|324251934|FG001|Overall Study|Death|4|||
94672369|NCT02276222|324251933|FG000|Overall Study|Lack of Efficacy|13|||
94672370|NCT02276222|324251934|FG001|Overall Study|Lack of Efficacy|3|||
94672371|NCT02276222|324251933|FG000|Overall Study|Protocol Violation|3|||
94672372|NCT02276222|324251934|FG001|Overall Study|Protocol Violation|2|||
94672373|NCT02276222|324251933|FG000|Overall Study|Withdrawal by Subject|79|||
94672374|NCT02276222|324251934|FG001|Overall Study|Withdrawal by Subject|33|||
94672375|NCT02276222|324251933|FG000|Overall Study|non compliance with study medication|6|||
94672376|NCT02276222|324251934|FG001|Overall Study|non compliance with study medication|2|||
94672377|NCT02276222|324251933|FG000|Overall Study|sponsor decision|0|||
94672378|NCT02276222|324251934|FG001|Overall Study|sponsor decision|3|||
94672379|NCT02276222|324251933|FG000|Overall Study|Lost to Follow-up|15|||
94672380|NCT02276222|324251934|FG001|Overall Study|Lost to Follow-up|5|||
94672381|NCT02276222|324251933|FG000|Overall Study|Physician Decision|2|||
94672382|NCT02276222|324251934|FG001|Overall Study|Physician Decision|1|||
94672383|NCT02276222|324251933|FG000|Overall Study|sheduling conflict|1|||
94672384|NCT02276222|324251934|FG001|Overall Study|sheduling conflict|0|||
94672385|NCT02276222|324251933|FG000|Overall Study|subject withdrew after randomization|1|||
94672386|NCT02276222|324251934|FG001|Overall Study|subject withdrew after randomization|0|||
94672387|NCT00725296|324251935|FG000|Overall Study|Adverse Event|11|||
94672388|NCT00725296|324251935|FG000|Overall Study|Lack of Efficacy|7|||
94672389|NCT00725296|324251935|FG000|Overall Study|Withdrawal by Subject|3|||
94672390|NCT00725296|324251935|FG000|Overall Study|Non-Compliance|2|||
94672391|NCT00725296|324251935|FG000|Overall Study|Lost to Follow-up|1|||
94672392|NCT00725296|324251935|FG000|Overall Study|Other|38|||
94672393|NCT03657277|324251936|FG000|Overall Study|Physician Decision|2|||
94672394|NCT03657277|324251936|FG000|Overall Study|Lost to Follow-up|1|||
94672395|NCT03657277|324251936|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
94672396|NCT04866017|324251938|FG000|Overall Study|Study Terminated by Sponsor|13|||
94672397|NCT04866017|324251939|FG001|Overall Study|Study Terminated by Sponsor|14|||
94672398|NCT04866017|324251940|FG002|Overall Study|Study Terminated by Sponsor|13|||
94672399|NCT04866017|324251938|FG000|Overall Study|Death|8|||
94672400|NCT04866017|324251939|FG001|Overall Study|Death|4|||
94672401|NCT04866017|324251940|FG002|Overall Study|Death|8|||
94672402|NCT04866017|324251938|FG000|Overall Study|Withdrawal by Subject|1|||
94672403|NCT04866017|324251939|FG001|Overall Study|Withdrawal by Subject|0|||
94672404|NCT04866017|324251940|FG002|Overall Study|Withdrawal by Subject|1|||
94672405|NCT04866017|324251938|FG000|Overall Study|Physician Decision|0|||
94672406|NCT04866017|324251939|FG001|Overall Study|Physician Decision|1|||
94672407|NCT04866017|324251940|FG002|Overall Study|Physician Decision|0|||
94672408|NCT04981678|324251941|FG000|Overall Study|Lost to Follow-up|0|||
94672409|NCT04981678|324251942|FG001|Overall Study|Lost to Follow-up|1|||
94672410|NCT00844857|324253582|FG000|Overall Study|Adverse Event|24|||
94672411|NCT00844857|324253583|FG001|Overall Study|Adverse Event|5|||
94672412|NCT00844857|324253582|FG000|Overall Study|Sponsor Decision|1|||
94672413|NCT00844857|324253583|FG001|Overall Study|Sponsor Decision|1|||
94672414|NCT00844857|324253582|FG000|Overall Study|Physician Decision|2|||
94672415|NCT00844857|324253583|FG001|Overall Study|Physician Decision|0|||
94672416|NCT00844857|324253582|FG000|Overall Study|Parent/Caregiver Decision|6|||
94672417|NCT00844857|324253583|FG001|Overall Study|Parent/Caregiver Decision|2|||
94672418|NCT00844857|324253582|FG000|Overall Study|Withdrawal by Subject|8|||
94672419|NCT00844857|324253583|FG001|Overall Study|Withdrawal by Subject|7|||
94672420|NCT00844857|324253582|FG000|Overall Study|Protocol Violation|6|||
94672421|NCT00844857|324253583|FG001|Overall Study|Protocol Violation|0|||
94672422|NCT00844857|324253582|FG000|Overall Study|Lack of Efficacy|5|||
94672423|NCT00844857|324253583|FG001|Overall Study|Lack of Efficacy|5|||
94672424|NCT00844857|324253582|FG000|Overall Study|Clinical Relapse|0|||
94672425|NCT00844857|324253583|FG001|Overall Study|Clinical Relapse|1|||
94672426|NCT00844857|324253582|FG000|Overall Study|Entry Criteria Not Met|0|||
94672427|NCT00844857|324253583|FG001|Overall Study|Entry Criteria Not Met|1|||
94672428|NCT00844857|324253582|FG000|Overall Study|Lost to Follow-up|2|||
94672429|NCT00844857|324253583|FG001|Overall Study|Lost to Follow-up|3|||
94672430|NCT00844857|324253582|FG000|Overall Study|Did Not Take Study Drug|3|||
94672431|NCT00844857|324253583|FG001|Overall Study|Did Not Take Study Drug|1|||
94360048|NCT01656850|323101764|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
94360049|NCT00968539|323101765|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
94360050|NCT00968539|323101766|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
94360051|NCT00938392|323101767|FG000|Overall Study|Adverse Event|0|||
94360052|NCT00938392|323101768|FG001|Overall Study|Adverse Event|1|||
94360053|NCT00938392|323101767|FG000|Overall Study|Withdrawal by Subject|0|||
94360054|NCT00938392|323101768|FG001|Overall Study|Withdrawal by Subject|1|||
94360055|NCT00938392|323101767|FG000|Overall Study|Lost to Follow-up|2|||
94360056|NCT00938392|323101768|FG001|Overall Study|Lost to Follow-up|2|||
94360057|NCT00122954|323101771|FG000|Overall Study|Withdrawal by Subject|2|||
94360058|NCT00122954|323101772|FG001|Overall Study|Withdrawal by Subject|2|||
94360059|NCT00122954|323101771|FG000|Overall Study|Protocol Violation|0|||
94360060|NCT00122954|323101772|FG001|Overall Study|Protocol Violation|1|||
94360061|NCT00558831|323101775|FG000|Overall Study|Lost to Follow-up|1|||
94360062|NCT05604521|323101778|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
94360063|NCT05604521|323101779|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
94360064|NCT05604521|323101778|FG000|Overall Study|Adverse Event|1|||
94360065|NCT05604521|323101779|FG001|Overall Study|Adverse Event|0|||
94360066|NCT03526549|323101781|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
94360067|NCT03526549|323101782|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
94360068|NCT03526549|323101781|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
94360069|NCT03526549|323101782|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
94360070|NCT03526549|323101781|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
94360071|NCT03526549|323101782|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
94360072|NCT03526549|323101781|FG000|Open-label Phase|Adverse Event|4|||
94360073|NCT03526549|323101782|FG001|Open-label Phase|Adverse Event|0|||
94360074|NCT03526549|323101781|FG000|Open-label Phase|Withdrawal by Subject|54|||
94360075|NCT03526549|323101782|FG001|Open-label Phase|Withdrawal by Subject|0|||
94360076|NCT03526549|323101781|FG000|Open-label Phase|Lost to Follow-up|35|||
94360077|NCT03526549|323101782|FG001|Open-label Phase|Lost to Follow-up|0|||
94360078|NCT03526549|323101781|FG000|Open-label Phase|Other than Specified|5|||
94360079|NCT03526549|323101782|FG001|Open-label Phase|Other than Specified|0|||
94360080|NCT00593385|323101783|FG000|Overall Study|Death|14|||
94360081|NCT00593385|323101783|FG000|Overall Study|Lost to Follow-up|17|||
94360082|NCT00593385|323101783|FG000|Overall Study|Withdrawal by Subject|9|||
94360083|NCT00848965|323101784|FG000|Overall Study|Adverse Event|1|||
94360084|NCT00848965|323101784|FG000|Overall Study|Withdrawal by Subject|1|||
94360085|NCT00348348|323101785|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
94360086|NCT00348348|323101786|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
94360087|NCT00348348|323101785|FG000|Overall Study|Lack of Efficacy|1|||
94360088|NCT00348348|323101786|FG001|Overall Study|Lack of Efficacy|1|||
94360089|NCT00348348|323101785|FG000|Overall Study|Lost to Follow-up|8|||
94461238|NCT02954653|323478226|FG003|Overall Study|Death|0|||
94461239|NCT02954653|323478227|FG004|Overall Study|Death|0|||
94461240|NCT02954653|323478228|FG005|Overall Study|Death|0|||
94626261|NCT00540514|324090094|FG001|Overall Study|Excluded prior to treatment|7|||
94626262|NCT00540514|324090093|FG000|Overall Study|Paclitaxel not available|0|||
94626263|NCT00540514|324090094|FG001|Overall Study|Paclitaxel not available|2|||
94626264|NCT02501473|324090095|FG000|Overall Study|Study Terminated|2|||
94626265|NCT02501473|324090096|FG001|Overall Study|Study Terminated|3|||
94626266|NCT02501473|324090097|FG002|Overall Study|Study Terminated|7|||
94626267|NCT02501473|324090098|FG003|Overall Study|Study Terminated|9|||
94626268|NCT02501473|324090099|FG004|Overall Study|Study Terminated|2|||
94626269|NCT02501473|324090100|FG005|Overall Study|Study Terminated|10|||
94626270|NCT02501473|324090101|FG006|Overall Study|Study Terminated|1|||
94626271|NCT02501473|324090102|FG007|Overall Study|Study Terminated|0|||
94626272|NCT02501473|324090095|FG000|Overall Study|Withdrawal by Subject|0|||
94626273|NCT02501473|324090096|FG001|Overall Study|Withdrawal by Subject|0|||
94626274|NCT02501473|324090097|FG002|Overall Study|Withdrawal by Subject|3|||
94626275|NCT02501473|324090098|FG003|Overall Study|Withdrawal by Subject|3|||
94626276|NCT02501473|324090099|FG004|Overall Study|Withdrawal by Subject|2|||
94360090|NCT00348348|323101786|FG001|Overall Study|Lost to Follow-up|10|||
94360091|NCT00348348|323101785|FG000|Overall Study|Withdrawal by Subject|4|||
94360092|NCT00348348|323101786|FG001|Overall Study|Withdrawal by Subject|1|||
94360093|NCT00348348|323101785|FG000|Overall Study|Other|7|||
94360094|NCT00348348|323101786|FG001|Overall Study|Other|4|||
94360095|NCT00348348|323101785|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
94360096|NCT00348348|323101786|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
94360097|NCT00348348|323101785|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
94360098|NCT00348348|323101786|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
94360099|NCT00348348|323101785|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
94360100|NCT00348348|323101786|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
94461241|NCT02954653|323478229|FG006|Overall Study|Death|0|||
94626277|NCT02501473|324090100|FG005|Overall Study|Withdrawal by Subject|2|||
94626278|NCT02501473|324090101|FG006|Overall Study|Withdrawal by Subject|0|||
94626279|NCT02501473|324090102|FG007|Overall Study|Withdrawal by Subject|0|||
94626280|NCT02501473|324090095|FG000|Overall Study|Death|0|||
94626281|NCT02501473|324090096|FG001|Overall Study|Death|0|||
94626282|NCT02501473|324090097|FG002|Overall Study|Death|1|||
94626283|NCT02501473|324090098|FG003|Overall Study|Death|1|||
94626284|NCT02501473|324090099|FG004|Overall Study|Death|0|||
94626285|NCT02501473|324090100|FG005|Overall Study|Death|1|||
94626286|NCT02501473|324090101|FG006|Overall Study|Death|0|||
94626287|NCT02501473|324090102|FG007|Overall Study|Death|0|||
94626288|NCT02501473|324090095|FG000|Overall Study|Lost to Follow-up|1|||
94626289|NCT02501473|324090096|FG001|Overall Study|Lost to Follow-up|0|||
94626290|NCT02501473|324090097|FG002|Overall Study|Lost to Follow-up|1|||
94626291|NCT02501473|324090098|FG003|Overall Study|Lost to Follow-up|0|||
94626292|NCT02501473|324090099|FG004|Overall Study|Lost to Follow-up|0|||
94626293|NCT02501473|324090100|FG005|Overall Study|Lost to Follow-up|1|||
94626294|NCT02501473|324090101|FG006|Overall Study|Lost to Follow-up|0|||
94626295|NCT02501473|324090102|FG007|Overall Study|Lost to Follow-up|0|||
94626296|NCT02501473|324090095|FG000|Overall Study|Reason not specified|0|||
94626297|NCT02501473|324090096|FG001|Overall Study|Reason not specified|0|||
94626298|NCT02501473|324090097|FG002|Overall Study|Reason not specified|1|||
94626299|NCT02501473|324090098|FG003|Overall Study|Reason not specified|1|||
94626300|NCT02501473|324090099|FG004|Overall Study|Reason not specified|0|||
94626301|NCT02501473|324090100|FG005|Overall Study|Reason not specified|0|||
94626302|NCT02501473|324090101|FG006|Overall Study|Reason not specified|0|||
94626303|NCT02501473|324090102|FG007|Overall Study|Reason not specified|0|||
94626304|NCT02324569|324090104|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
94626305|NCT02324569|324090105|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
94626306|NCT02324569|324090104|FG000|Overall Study|Voluntary Withdrawal|3|||
94626307|NCT02324569|324090105|FG001|Overall Study|Voluntary Withdrawal|6|||
94626308|NCT02324569|324090104|FG000|Overall Study|Lack of Efficacy|2|||
94626309|NCT02324569|324090105|FG001|Overall Study|Lack of Efficacy|3|||
94626310|NCT02324569|324090104|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
94626311|NCT02324569|324090105|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
94461242|NCT02954653|323478230|FG007|Overall Study|Death|0|||
94626312|NCT02324569|324090104|FG000|Overall Study|Inconvenient Schedule|2|||
94626313|NCT02324569|324090105|FG001|Overall Study|Inconvenient Schedule|0|||
94626314|NCT00911820|324090108|FG000|Overall Study|RECIST progression|12|||
94626315|NCT00911820|324090109|FG001|Overall Study|RECIST progression|8|||
94672432|NCT00844857|324253582|FG000|Overall Study|Good Clinical Practice Violations|21|||
94672433|NCT00844857|324253583|FG001|Overall Study|Good Clinical Practice Violations|11|||
94672434|NCT00570674|324253584|FG000|Overall Study|Withdrawal by Subject|0|||
94672435|NCT00570674|324253585|FG001|Overall Study|Withdrawal by Subject|0|||
94672436|NCT00570674|324253586|FG002|Overall Study|Withdrawal by Subject|1|||
94672437|NCT00570674|324253587|FG003|Overall Study|Withdrawal by Subject|0|||
94672438|NCT00570674|324253588|FG004|Overall Study|Withdrawal by Subject|0|||
94672439|NCT00570674|324253589|FG005|Overall Study|Withdrawal by Subject|0|||
94672440|NCT00570674|324253590|FG006|Overall Study|Withdrawal by Subject|0|||
94672441|NCT01621126|324253592|FG000|Overall Study|Physician Decision|6|||
94672442|NCT01949311|324253593|FG000|Overall Study|Lost to Follow-up|73|||
94672443|NCT01949311|324253593|FG000|Overall Study|Terminated by Sponsor|708|||
94672444|NCT01949311|324253593|FG000|Overall Study|Withdrawal by Subject|375|||
94672445|NCT01949311|324253593|FG000|Overall Study|Lack of Efficacy|50|||
94672446|NCT01949311|324253593|FG000|Overall Study|Protocol Deviation|34|||
94672447|NCT01949311|324253593|FG000|Overall Study|Pregnancy|20|||
94672448|NCT01949311|324253593|FG000|Overall Study|Physician Decision|9|||
94672449|NCT01949311|324253593|FG000|Overall Study|Other|4|||
94672450|NCT01949311|324253593|FG000|Overall Study|Adverse Event|107|||
94672451|NCT00833560|324253594|FG000|Overall Study|Toxicity|13|||
94672452|NCT00833560|324253594|FG000|Overall Study|Adverse Event|11|||
94672453|NCT00833560|324253594|FG000|Overall Study|Protocol Violation|6|||
94672454|NCT00833560|324253594|FG000|Overall Study|Lack of Efficacy|4|||
94672455|NCT00833560|324253594|FG000|Overall Study|Death|2|||
94672456|NCT00833560|324253594|FG000|Overall Study|Pregression of other disease|1|||
94672457|NCT00833560|324253594|FG000|Overall Study|Other|5|||
94672458|NCT00999466|324253596|FG000|Main Part|Withdrawal by Subject|0|||
94672459|NCT00999466|324253597|FG001|Main Part|Withdrawal by Subject|0|||
94672460|NCT00999466|324253598|FG002|Main Part|Withdrawal by Subject|2|||
94672461|NCT00999466|324253596|FG000|Main Part|Adverse Event|0|||
94672462|NCT00999466|324253597|FG001|Main Part|Adverse Event|4|||
94672463|NCT00999466|324253598|FG002|Main Part|Adverse Event|2|||
94672464|NCT03318523|324253599|FG000|PC Period: Up to Year 1|Adverse Event|1|||
94672465|NCT03318523|324253600|FG001|PC Period: Up to Year 1|Adverse Event|0|||
94672466|NCT03318523|324253601|FG002|PC Period: Up to Year 1|Adverse Event|2|||
94672467|NCT03318523|324253602|FG003|PC Period: Up to Year 1|Adverse Event|0|||
94672468|NCT03318523|324253603|FG004|PC Period: Up to Year 1|Adverse Event|0|||
94672469|NCT03318523|324253604|FG005|PC Period: Up to Year 1|Adverse Event|0|||
94672470|NCT03318523|324253605|FG006|PC Period: Up to Year 1|Adverse Event|0|||
94672471|NCT03318523|324253606|FG007|PC Period: Up to Year 1|Adverse Event|0|||
94672472|NCT03318523|324253607|FG008|PC Period: Up to Year 1|Adverse Event|0|||
94672473|NCT03318523|324253608|FG009|PC Period: Up to Year 1|Adverse Event|0|||
94672474|NCT03318523|324253599|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
94672475|NCT03318523|324253600|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
94672476|NCT03318523|324253601|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
94672477|NCT03318523|324253602|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
94672478|NCT03318523|324253603|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
94672479|NCT03318523|324253604|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
94672480|NCT03318523|324253605|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
94672481|NCT03318523|324253606|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
94672482|NCT03318523|324253607|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
94672483|NCT03318523|324253608|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
94672484|NCT03318523|324253599|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
94672485|NCT03318523|324253600|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
94672486|NCT03318523|324253601|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
94672487|NCT03318523|324253602|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
94672488|NCT03318523|324253603|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
94672489|NCT03318523|324253604|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
94672490|NCT03318523|324253605|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
94672491|NCT03318523|324253606|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
94672492|NCT03318523|324253607|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
94672493|NCT03318523|324253608|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
94672494|NCT03318523|324253599|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
94672495|NCT03318523|324253600|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
94672496|NCT03318523|324253601|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
94672497|NCT03318523|324253602|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
94672498|NCT03318523|324253603|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
94672499|NCT03318523|324253604|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
94672500|NCT03318523|324253605|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
94672501|NCT03318523|324253606|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
94672502|NCT03318523|324253607|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
94672503|NCT03318523|324253608|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
94672504|NCT03318523|324253599|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
94672505|NCT03318523|324253600|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
94626316|NCT00911820|324090108|FG000|Overall Study|Adverse Event|8|||
94626317|NCT00911820|324090109|FG001|Overall Study|Adverse Event|8|||
94626318|NCT00911820|324090108|FG000|Overall Study|Clinical Progression|7|||
94626319|NCT00911820|324090109|FG001|Overall Study|Clinical Progression|5|||
94626320|NCT00911820|324090108|FG000|Overall Study|Physician Decision|5|||
94626321|NCT00911820|324090109|FG001|Overall Study|Physician Decision|9|||
94626322|NCT00911820|324090108|FG000|Overall Study|Decline in Performance Status|4|||
94626323|NCT00911820|324090109|FG001|Overall Study|Decline in Performance Status|2|||
94626324|NCT00911820|324090108|FG000|Overall Study|Withdrawal by Subject|3|||
94626325|NCT00911820|324090109|FG001|Overall Study|Withdrawal by Subject|4|||
94626326|NCT00911820|324090108|FG000|Overall Study|Death|1|||
94626327|NCT00911820|324090109|FG001|Overall Study|Death|2|||
94626328|NCT00911820|324090108|FG000|Overall Study|Pursue surgery|1|||
94626329|NCT00911820|324090109|FG001|Overall Study|Pursue surgery|1|||
94626330|NCT00911820|324090108|FG000|Overall Study|Pursue Radiation|1|||
94626331|NCT00911820|324090109|FG001|Overall Study|Pursue Radiation|0|||
94626332|NCT00911820|324090108|FG000|Overall Study|Still on Therapy|2|||
94626333|NCT00911820|324090109|FG001|Overall Study|Still on Therapy|2|||
94626334|NCT00911820|324090108|FG000|Overall Study|Pathology Not Confirmed|1|||
94626335|NCT00911820|324090109|FG001|Overall Study|Pathology Not Confirmed|0|||
94626336|NCT00911820|324090108|FG000|Overall Study|Withdraw before Receive Treatment|0|||
94626337|NCT00911820|324090109|FG001|Overall Study|Withdraw before Receive Treatment|2|||
94626338|NCT03364023|324090110|FG000|Overall Study|Lost to Follow-up|3|||
94626339|NCT03364023|324090110|FG000|Overall Study|Death|14|||
94626340|NCT03602482|324090119|FG000|Overall Study|Withdrawal by Subject|6|||
94626341|NCT03602482|324090120|FG001|Overall Study|Withdrawal by Subject|7|||
94626342|NCT03602482|324090121|FG002|Overall Study|Withdrawal by Subject|0|||
94626343|NCT03602482|324090122|FG003|Overall Study|Withdrawal by Subject|0|||
94626344|NCT02397278|324090123|FG000|Overall Study|Withdrawal by Subject|0|||
94626345|NCT02397278|324090124|FG001|Overall Study|Withdrawal by Subject|2|||
94626346|NCT02397278|324090123|FG000|Overall Study|Deemed ineligible following surgery|1|||
94626347|NCT02397278|324090124|FG001|Overall Study|Deemed ineligible following surgery|1|||
94626348|NCT00105469|324090125|FG000|Overall Study|Adverse Event|9|||
94626349|NCT00105469|324090126|FG001|Overall Study|Adverse Event|8|||
94626350|NCT00105469|324090125|FG000|Overall Study|Protocol Violation|4|||
94626351|NCT00105469|324090126|FG001|Overall Study|Protocol Violation|0|||
94626352|NCT00105469|324090125|FG000|Overall Study|Withdrawal by Subject|2|||
94626353|NCT00105469|324090126|FG001|Overall Study|Withdrawal by Subject|3|||
94626354|NCT00105469|324090125|FG000|Overall Study|Lost to Follow-up|1|||
94626355|NCT00105469|324090126|FG001|Overall Study|Lost to Follow-up|0|||
94626356|NCT00105469|324090125|FG000|Overall Study|Lack of Efficacy|2|||
94626357|NCT00105469|324090126|FG001|Overall Study|Lack of Efficacy|0|||
94626358|NCT00105469|324090125|FG000|Overall Study|Other Reason|4|||
94626359|NCT00105469|324090126|FG001|Overall Study|Other Reason|0|||
94626360|NCT03098550|324090128|FG000|Overall Study|Disease Progression|30|||
94626361|NCT03098550|324090129|FG001|Overall Study|Disease Progression|19|||
94626362|NCT03098550|324090130|FG002|Overall Study|Disease Progression|41|||
94626363|NCT03098550|324090128|FG000|Overall Study|Study Drug Toxicity|2|||
94626364|NCT03098550|324090129|FG001|Overall Study|Study Drug Toxicity|1|||
94626365|NCT03098550|324090130|FG002|Overall Study|Study Drug Toxicity|0|||
94626366|NCT03098550|324090128|FG000|Overall Study|Death|1|||
94626367|NCT03098550|324090129|FG001|Overall Study|Death|0|||
94626368|NCT03098550|324090130|FG002|Overall Study|Death|0|||
94626369|NCT03098550|324090128|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
94626370|NCT03098550|324090129|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
94626371|NCT03098550|324090130|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
94626372|NCT03098550|324090128|FG000|Overall Study|Administrative reason by sponsor|0|||
94626373|NCT03098550|324090129|FG001|Overall Study|Administrative reason by sponsor|0|||
94626374|NCT03098550|324090130|FG002|Overall Study|Administrative reason by sponsor|1|||
94672506|NCT03318523|324253601|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
94672507|NCT03318523|324253602|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
94360101|NCT00348348|323101785|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
94626375|NCT03098550|324090128|FG000|Overall Study|Other reasons|2|||
94626376|NCT03098550|324090129|FG001|Overall Study|Other reasons|0|||
94626377|NCT03098550|324090130|FG002|Overall Study|Other reasons|0|||
94360102|NCT00348348|323101786|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
94626378|NCT01384760|324090139|FG000|Overall Study|Lost to Follow-up|0|||
94626379|NCT01384760|324090140|FG001|Overall Study|Lost to Follow-up|6|||
94626380|NCT01384760|324090139|FG000|Overall Study|Protocol Violation|16|||
94626381|NCT01384760|324090140|FG001|Overall Study|Protocol Violation|0|||
94626382|NCT02167893|324090146|FG000|Overall Study|Investigator transferred|85|||
94626383|NCT02167893|324090146|FG000|Overall Study|Investigator health reasons|10|||
94626384|NCT02167893|324090146|FG000|Overall Study|Case report forms not collected|68|||
94626385|NCT00618072|324090152|FG000|Overall Study|Lost to Follow-up|2|||
94626386|NCT00618072|324090153|FG001|Overall Study|Lost to Follow-up|0|||
94672508|NCT03318523|324253603|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
94672509|NCT03318523|324253604|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
94672510|NCT03318523|324253605|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
94672511|NCT03318523|324253606|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
94672512|NCT03318523|324253607|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
94672513|NCT03318523|324253608|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
94672514|NCT03318523|324253599|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
94672515|NCT03318523|324253600|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
94672516|NCT03318523|324253601|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
94672517|NCT03318523|324253602|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
94672518|NCT03318523|324253603|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
94672519|NCT03318523|324253604|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
94672520|NCT03318523|324253605|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
94672521|NCT03318523|324253606|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
94672522|NCT03318523|324253607|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
94672523|NCT03318523|324253608|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
94672524|NCT03318523|324253599|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
94672525|NCT03318523|324253600|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
94672526|NCT03318523|324253601|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
94672527|NCT03318523|324253602|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
94672528|NCT03318523|324253603|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
94672529|NCT03318523|324253604|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
94672530|NCT03318523|324253605|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
94672531|NCT03318523|324253606|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
94672532|NCT03318523|324253607|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
94672533|NCT03318523|324253608|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
94672534|NCT03318523|324253599|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
94672535|NCT03318523|324253600|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
94672536|NCT03318523|324253601|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
94672537|NCT03318523|324253602|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
94672538|NCT03318523|324253603|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
94672539|NCT03318523|324253604|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
94672540|NCT03318523|324253605|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
94672541|NCT03318523|324253606|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
94672542|NCT03318523|324253607|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
94672543|NCT03318523|324253608|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
94672544|NCT00828984|324253609|FG000|Overall Study|Adverse Event|2|||
94672545|NCT00828984|324253610|FG001|Overall Study|Adverse Event|3|||
94672546|NCT00828984|324253611|FG002|Overall Study|Adverse Event|0|||
94672547|NCT00828984|324253609|FG000|Overall Study|Lost to Follow-up|5|||
94672548|NCT00828984|324253610|FG001|Overall Study|Lost to Follow-up|3|||
94672549|NCT00828984|324253611|FG002|Overall Study|Lost to Follow-up|1|||
94672550|NCT00828984|324253609|FG000|Overall Study|Withdrawal by Subject|4|||
94672551|NCT00828984|324253610|FG001|Overall Study|Withdrawal by Subject|4|||
94672552|NCT00828984|324253611|FG002|Overall Study|Withdrawal by Subject|4|||
94672553|NCT00828984|324253609|FG000|Overall Study|Ineligable|1|||
94672554|NCT00828984|324253610|FG001|Overall Study|Ineligable|2|||
94672555|NCT00828984|324253611|FG002|Overall Study|Ineligable|0|||
94672556|NCT00828984|324253609|FG000|Overall Study|Medical Contraindication|0|||
94672557|NCT00828984|324253610|FG001|Overall Study|Medical Contraindication|1|||
94672558|NCT00828984|324253611|FG002|Overall Study|Medical Contraindication|0|||
94672559|NCT00828984|324253609|FG000|Overall Study|Noncompliant|1|||
94672560|NCT00828984|324253610|FG001|Overall Study|Noncompliant|2|||
94672561|NCT00828984|324253611|FG002|Overall Study|Noncompliant|3|||
94672562|NCT00828984|324253609|FG000|Overall Study|ConMed|1|||
94672563|NCT00828984|324253610|FG001|Overall Study|ConMed|1|||
94672564|NCT00828984|324253611|FG002|Overall Study|ConMed|1|||
94672565|NCT03232983|324253612|FG000|Period 1|Physician Decision|0|||
94672566|NCT03232983|324253613|FG001|Period 1|Physician Decision|0|||
94672567|NCT03232983|324253614|FG002|Period 1|Physician Decision|1|||
94672568|NCT03232983|324253615|FG003|Period 1|Physician Decision|0|||
94672569|NCT03232983|324253612|FG000|Washout Period 2|Physician Decision|0|||
94672570|NCT03232983|324253613|FG001|Washout Period 2|Physician Decision|0|||
94672571|NCT03232983|324253614|FG002|Washout Period 2|Physician Decision|1|||
94672572|NCT03232983|324253615|FG003|Washout Period 2|Physician Decision|0|||
94672573|NCT03232983|324253612|FG000|Washout Period 2|Withdrawal by Subject|0|||
94672574|NCT03232983|324253613|FG001|Washout Period 2|Withdrawal by Subject|0|||
94672575|NCT03232983|324253614|FG002|Washout Period 2|Withdrawal by Subject|0|||
94672576|NCT03232983|324253615|FG003|Washout Period 2|Withdrawal by Subject|1|||
94672577|NCT03232983|324253612|FG000|Period 4|Withdrawal by Subject|1|||
94672578|NCT03232983|324253613|FG001|Period 4|Withdrawal by Subject|0|||
94672579|NCT03232983|324253614|FG002|Period 4|Withdrawal by Subject|0|||
94672580|NCT03232983|324253615|FG003|Period 4|Withdrawal by Subject|0|||
94672581|NCT03338894|324253616|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
94672582|NCT01733732|324253617|FG000|Overall Study|Adverse Event|1|||
94672583|NCT01733732|324253618|FG001|Overall Study|Adverse Event|0|||
94672584|NCT01733732|324253617|FG000|Overall Study|Did not attend all study visits|1|||
94672585|NCT01733732|324253618|FG001|Overall Study|Did not attend all study visits|0|||
94672586|NCT02548455|324253619|FG000|Overall Study|Withdrawal by Subject|27|||
94672587|NCT02548455|324253619|FG000|Overall Study|Death|26|||
94672588|NCT02548455|324253619|FG000|Overall Study|Lost to Follow-up|14|||
94672589|NCT02548455|324253619|FG000|Overall Study|Visit not completed|173|||
94672590|NCT00815295|324253620|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
94672591|NCT00815295|324253621|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
94672592|NCT00815295|324253622|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
94672593|NCT01040260|324253624|FG000|Overall Study|Withdrawal by Subject|12|||
94672594|NCT01040260|324253625|FG001|Overall Study|Withdrawal by Subject|6|||
94672595|NCT01040260|324253624|FG000|Overall Study|Lost to Follow-up|3|||
94672596|NCT01040260|324253625|FG001|Overall Study|Lost to Follow-up|5|||
94672597|NCT00162370|324253629|FG000|Efficacy Population|Lost to Follow-up|51|||
94672598|NCT04040751|324253630|FG000|Overall Study|Withdrawal by Subject|2|||
94672599|NCT04040751|324253631|FG001|Overall Study|Withdrawal by Subject|0|||
94672600|NCT04040751|324253632|FG002|Overall Study|Withdrawal by Subject|2|||
94672601|NCT04040751|324253633|FG003|Overall Study|Withdrawal by Subject|0|||
94672602|NCT01506193|324253634|FG000|Overall Study|Protocol Violation|1|||
94672603|NCT01506193|324253635|FG001|Overall Study|Protocol Violation|0|||
94672604|NCT01506193|324253636|FG002|Overall Study|Protocol Violation|1|||
94672605|NCT01506193|324253634|FG000|Overall Study|Migrated/moved from study area|0|||
94672606|NCT01506193|324253635|FG001|Overall Study|Migrated/moved from study area|0|||
94360103|NCT00348348|323101785|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
94360104|NCT00348348|323101786|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
94360105|NCT00348348|323101785|FG000|Overall Study|Adverse event probably related to study|1|||
94360106|NCT00348348|323101786|FG001|Overall Study|Adverse event probably related to study|0|||
94360107|NCT03710824|323101787|FG000|Overall Study|Withdrawal by Subject|1|||
94360108|NCT03710824|323101787|FG000|Overall Study|Lost to Follow-up|3|||
94461243|NCT02954653|323478231|FG008|Overall Study|Death|0|||
94461244|NCT02954653|323478223|FG000|Overall Study|Randomized but did not receive treatment|1|||
94461245|NCT02954653|323478224|FG001|Overall Study|Randomized but did not receive treatment|0|||
94461246|NCT02954653|323478225|FG002|Overall Study|Randomized but did not receive treatment|0|||
94461247|NCT02954653|323478226|FG003|Overall Study|Randomized but did not receive treatment|0|||
94360109|NCT03710824|323101787|FG000|Overall Study|Adverse Event|25|||
94360110|NCT03710824|323101787|FG000|Overall Study|Treatment discontinuation|2|||
94360111|NCT01605370|323101790|FG000|Overall Study|Adverse Event|1|||
94360112|NCT01605370|323101791|FG001|Overall Study|Adverse Event|0|||
94360113|NCT00578448|323101792|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
94360114|NCT00578448|323101792|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
94360115|NCT00578448|323101792|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
94360116|NCT00578448|323101792|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
94360117|NCT01353209|323101796|FG000|Overall Study|Adverse Event|1|||
94360118|NCT01353209|323101797|FG001|Overall Study|Adverse Event|1|||
94360119|NCT01301625|323101800|FG000|Overall Study|Death|5|||
94360120|NCT01301625|323101800|FG000|Overall Study|Not Due|21|||
94360121|NCT01301625|323101800|FG000|Overall Study|Expected|8|||
94360122|NCT01301625|323101800|FG000|Overall Study|Lost to Follow-up|1|||
94360123|NCT00779857|323101801|FG000|Overall Study|Death|1|||
94360124|NCT00779857|323101801|FG000|Overall Study|Withdrawal by Subject|3|||
94360125|NCT00779857|323101801|FG000|Overall Study|Missed Visit|2|||
94360126|NCT04640168|323101802|FG000|Overall Study|Withdrawal by Subject|8|||
94360127|NCT04640168|323101803|FG001|Overall Study|Withdrawal by Subject|7|||
94360128|NCT04640168|323101802|FG000|Overall Study|Lost to Follow-up|1|||
94360129|NCT04640168|323101803|FG001|Overall Study|Lost to Follow-up|0|||
94672607|NCT01506193|324253636|FG002|Overall Study|Migrated/moved from study area|1|||
94672608|NCT01506193|324253634|FG000|Overall Study|Adverse event, non-fatal|0|||
94672609|NCT01506193|324253635|FG001|Overall Study|Adverse event, non-fatal|0|||
94672610|NCT01506193|324253636|FG002|Overall Study|Adverse event, non-fatal|1|||
94672611|NCT01506193|324253634|FG000|Overall Study|Withdrawal by Subject|5|||
94672612|NCT01506193|324253635|FG001|Overall Study|Withdrawal by Subject|1|||
94672613|NCT01506193|324253636|FG002|Overall Study|Withdrawal by Subject|8|||
94672614|NCT01506193|324253634|FG000|Overall Study|Lost to Follow-up|8|||
94672615|NCT01506193|324253635|FG001|Overall Study|Lost to Follow-up|3|||
94672616|NCT01506193|324253636|FG002|Overall Study|Lost to Follow-up|3|||
94672617|NCT00514735|324253642|FG000|Overall Study|Withdrawal by Subject|13|||
94672618|NCT00514735|324253643|FG001|Overall Study|Withdrawal by Subject|5|||
94672619|NCT00514735|324253642|FG000|Overall Study|Death|1|||
94672620|NCT00514735|324253643|FG001|Overall Study|Death|0|||
94672621|NCT00514735|324253642|FG000|Overall Study|Lost to Follow-up|0|||
94360130|NCT04640168|323101802|FG000|Overall Study|Enrolled but not treated|12|||
94360131|NCT04640168|323101803|FG001|Overall Study|Enrolled but not treated|12|||
94360132|NCT04983589|323101809|FG000|Overall Study|Withdrawal by Subject|0|||
94360133|NCT04983589|323101810|FG001|Overall Study|Withdrawal by Subject|3|||
94360134|NCT04983589|323101809|FG000|Overall Study|COVID-19 Infection|1|||
94360135|NCT04983589|323101810|FG001|Overall Study|COVID-19 Infection|0|||
94360136|NCT04983589|323101809|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
94360137|NCT04983589|323101810|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
94626387|NCT00618072|324090154|FG002|Overall Study|Lost to Follow-up|3|||
94626388|NCT00618072|324090152|FG000|Overall Study|Physician Decision|0|||
94626389|NCT00618072|324090153|FG001|Overall Study|Physician Decision|1|||
94626390|NCT00618072|324090154|FG002|Overall Study|Physician Decision|1|||
94626391|NCT01532414|324090156|FG000|Overall Study|Lost to Follow-up|3|||
94626392|NCT01532414|324090157|FG001|Overall Study|Lost to Follow-up|0|||
94626393|NCT01532414|324090158|FG002|Overall Study|Lost to Follow-up|1|||
94626394|NCT01532414|324090156|FG000|Overall Study|Withdrawal by Subject|3|||
94626395|NCT01532414|324090157|FG001|Overall Study|Withdrawal by Subject|0|||
94626396|NCT01532414|324090158|FG002|Overall Study|Withdrawal by Subject|0|||
94626397|NCT01532414|324090156|FG000|Overall Study|No V6 semen sample|0|||
94626398|NCT01532414|324090157|FG001|Overall Study|No V6 semen sample|1|||
94626399|NCT01532414|324090158|FG002|Overall Study|No V6 semen sample|0|||
94626400|NCT01532414|324090156|FG000|Overall Study|Adverse Event|0|||
94626401|NCT01532414|324090157|FG001|Overall Study|Adverse Event|1|||
94626402|NCT01532414|324090158|FG002|Overall Study|Adverse Event|1|||
94626403|NCT01532414|324090156|FG000|Overall Study|Unable to complete 24 hour PK|0|||
94626404|NCT01532414|324090157|FG001|Overall Study|Unable to complete 24 hour PK|0|||
94626405|NCT01532414|324090158|FG002|Overall Study|Unable to complete 24 hour PK|1|||
94626406|NCT01532414|324090156|FG000|Overall Study|Withdrawn by sponsor|1|||
94626407|NCT01532414|324090157|FG001|Overall Study|Withdrawn by sponsor|0|||
94626408|NCT01532414|324090158|FG002|Overall Study|Withdrawn by sponsor|0|||
94626409|NCT00903695|324090159|FG000|Overall Study|medical exclusion after 1st testing|1|||
94626410|NCT00903695|324090160|FG001|Overall Study|medical exclusion after 1st testing|0|||
94626411|NCT00903695|324090159|FG000|Overall Study|lung cancer|1|||
94626412|NCT00903695|324090160|FG001|Overall Study|lung cancer|0|||
94626413|NCT00482612|324090161|FG000|In-treatment Period|No study medication administered|0|||
94626414|NCT00482612|324090162|FG001|In-treatment Period|No study medication administered|0|||
94626415|NCT00482612|324090163|FG002|In-treatment Period|No study medication administered|1|||
94626416|NCT00482612|324090164|FG003|In-treatment Period|No study medication administered|0|||
94626417|NCT00482612|324090161|FG000|Follow-up Period|Other|4|||
94626418|NCT00482612|324090162|FG001|Follow-up Period|Other|2|||
94626419|NCT00482612|324090163|FG002|Follow-up Period|Other|1|||
94626420|NCT00482612|324090164|FG003|Follow-up Period|Other|2|||
94626421|NCT00482612|324090161|FG000|Follow-up Period|Lack of compliance|0|||
94626422|NCT00482612|324090162|FG001|Follow-up Period|Lack of compliance|0|||
94626423|NCT00482612|324090163|FG002|Follow-up Period|Lack of compliance|1|||
94626424|NCT00482612|324090164|FG003|Follow-up Period|Lack of compliance|0|||
94626425|NCT00482612|324090161|FG000|Follow-up Period|Lost to Follow-up|0|||
94626426|NCT00482612|324090162|FG001|Follow-up Period|Lost to Follow-up|4|||
94626427|NCT00482612|324090163|FG002|Follow-up Period|Lost to Follow-up|2|||
94626428|NCT00482612|324090164|FG003|Follow-up Period|Lost to Follow-up|1|||
94626429|NCT00482612|324090161|FG000|Follow-up Period|Adverse Event|4|||
94626430|NCT00482612|324090162|FG001|Follow-up Period|Adverse Event|7|||
94626431|NCT00482612|324090163|FG002|Follow-up Period|Adverse Event|9|||
94626432|NCT00482612|324090164|FG003|Follow-up Period|Adverse Event|0|||
94626433|NCT00482612|324090161|FG000|Follow-up Period|Lack of Efficacy|2|||
94626434|NCT00482612|324090162|FG001|Follow-up Period|Lack of Efficacy|0|||
94626435|NCT00482612|324090163|FG002|Follow-up Period|Lack of Efficacy|1|||
94626436|NCT00482612|324090164|FG003|Follow-up Period|Lack of Efficacy|0|||
94626437|NCT00482612|324090161|FG000|Follow-up Period|Withdrawal by Subject|3|||
94626438|NCT00482612|324090162|FG001|Follow-up Period|Withdrawal by Subject|5|||
94626439|NCT00482612|324090163|FG002|Follow-up Period|Withdrawal by Subject|7|||
94626440|NCT00482612|324090164|FG003|Follow-up Period|Withdrawal by Subject|2|||
94626441|NCT00482612|324090161|FG000|Follow-up Period|Reasons not related to trial|1|||
94626442|NCT00482612|324090162|FG001|Follow-up Period|Reasons not related to trial|0|||
94626443|NCT00482612|324090163|FG002|Follow-up Period|Reasons not related to trial|1|||
94626444|NCT00482612|324090164|FG003|Follow-up Period|Reasons not related to trial|3|||
94626445|NCT01366521|324090165|FG000|Overall Study|Adverse Event|1|||
94626446|NCT01366521|324090166|FG001|Overall Study|Adverse Event|0|||
94626447|NCT01366521|324090167|FG002|Overall Study|Adverse Event|0|||
94626448|NCT01366521|324090168|FG003|Overall Study|Adverse Event|0|||
94626449|NCT01366521|324090165|FG000|Overall Study|Protocol Violation|0|||
94626450|NCT01366521|324090166|FG001|Overall Study|Protocol Violation|0|||
94626451|NCT01366521|324090167|FG002|Overall Study|Protocol Violation|1|||
94626452|NCT01366521|324090168|FG003|Overall Study|Protocol Violation|0|||
94626453|NCT01366521|324090165|FG000|Overall Study|Physician Decision|0|||
94626454|NCT01366521|324090166|FG001|Overall Study|Physician Decision|0|||
94626455|NCT01366521|324090167|FG002|Overall Study|Physician Decision|1|||
94672622|NCT00514735|324253643|FG001|Overall Study|Lost to Follow-up|1|||
94672623|NCT00675766|324253645|FG000|Overall Study|Lost to Follow-up|6|||
94672624|NCT00675766|324253646|FG001|Overall Study|Lost to Follow-up|5|||
94672625|NCT00675766|324253647|FG002|Overall Study|Lost to Follow-up|21|||
94672626|NCT00675766|324253648|FG003|Overall Study|Lost to Follow-up|26|||
94672627|NCT00540124|324253652|FG000|Overall Study|Adverse Event|0|||
94672628|NCT00540124|324253653|FG001|Overall Study|Adverse Event|2|||
94672629|NCT00540124|324253654|FG002|Overall Study|Adverse Event|1|||
94672630|NCT00540124|324253652|FG000|Overall Study|Entry Criteria Not Met|2|||
94672631|NCT00540124|324253653|FG001|Overall Study|Entry Criteria Not Met|0|||
94672632|NCT00540124|324253654|FG002|Overall Study|Entry Criteria Not Met|0|||
94672633|NCT00540124|324253652|FG000|Overall Study|Lack of Efficacy|1|||
94672634|NCT00540124|324253653|FG001|Overall Study|Lack of Efficacy|0|||
94672635|NCT00540124|324253654|FG002|Overall Study|Lack of Efficacy|0|||
94672636|NCT00540124|324253652|FG000|Overall Study|Withdrawal by Subject|1|||
94672637|NCT00540124|324253653|FG001|Overall Study|Withdrawal by Subject|1|||
94672638|NCT00540124|324253654|FG002|Overall Study|Withdrawal by Subject|0|||
94672639|NCT01239030|324253657|FG000|Double Blind|Adverse Event|0|||
94672640|NCT01239030|324253658|FG001|Double Blind|Adverse Event|1|||
94672641|NCT01239030|324253659|FG002|Double Blind|Adverse Event|0|||
94672642|NCT01239030|324253660|FG003|Double Blind|Adverse Event|2|||
94672643|NCT01239030|324253661|FG004|Double Blind|Adverse Event|0|||
94672644|NCT01239030|324253657|FG000|Double Blind|Withdrawal by Subject|0|||
94672645|NCT01239030|324253658|FG001|Double Blind|Withdrawal by Subject|1|||
94672646|NCT01239030|324253659|FG002|Double Blind|Withdrawal by Subject|1|||
94672647|NCT01239030|324253660|FG003|Double Blind|Withdrawal by Subject|0|||
94672648|NCT01239030|324253661|FG004|Double Blind|Withdrawal by Subject|1|||
94672649|NCT01239030|324253657|FG000|Double Blind|Lost to Follow-up|1|||
94672650|NCT01239030|324253658|FG001|Double Blind|Lost to Follow-up|1|||
94672651|NCT01239030|324253659|FG002|Double Blind|Lost to Follow-up|0|||
94672652|NCT01239030|324253660|FG003|Double Blind|Lost to Follow-up|0|||
94672653|NCT01239030|324253661|FG004|Double Blind|Lost to Follow-up|0|||
94672654|NCT01239030|324253657|FG000|Double Blind|Physician Decision|0|||
94672655|NCT01239030|324253658|FG001|Double Blind|Physician Decision|1|||
94672656|NCT01239030|324253659|FG002|Double Blind|Physician Decision|0|||
94672657|NCT01239030|324253660|FG003|Double Blind|Physician Decision|0|||
94672658|NCT01239030|324253661|FG004|Double Blind|Physician Decision|0|||
94672659|NCT01239030|324253657|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
94672660|NCT01239030|324253658|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
94672661|NCT01239030|324253659|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
94672662|NCT01239030|324253660|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
94672663|NCT01239030|324253661|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
94672664|NCT01239030|324253657|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
94672665|NCT01239030|324253658|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
94672666|NCT01239030|324253659|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
94672667|NCT01239030|324253660|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
94672668|NCT01239030|324253661|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
94360138|NCT01165424|323101811|FG000|Overall Study|Clinical adverse experiences|1|||
94360139|NCT01165424|323101811|FG000|Overall Study|Laboratory adverse experiences|1|||
94360140|NCT01165424|323101811|FG000|Overall Study|Did not meet entry criteria|1|||
94360141|NCT01165424|323101811|FG000|Overall Study|Participant moved (relocated)|1|||
94626456|NCT01366521|324090168|FG003|Overall Study|Physician Decision|0|||
94626457|NCT01366521|324090165|FG000|Overall Study|Withdrawal by Subject|0|||
94626458|NCT01366521|324090166|FG001|Overall Study|Withdrawal by Subject|1|||
94626459|NCT01366521|324090167|FG002|Overall Study|Withdrawal by Subject|0|||
94626460|NCT01366521|324090168|FG003|Overall Study|Withdrawal by Subject|0|||
94626461|NCT00684307|324090169|FG000|Overall Study|Adverse Event|11|||
94626462|NCT00684307|324090170|FG001|Overall Study|Adverse Event|6|||
94626463|NCT00684307|324090171|FG002|Overall Study|Adverse Event|15|||
94626464|NCT00684307|324090172|FG003|Overall Study|Adverse Event|16|||
94626465|NCT00684307|324090173|FG004|Overall Study|Adverse Event|8|||
94626466|NCT00684307|324090169|FG000|Overall Study|Development of increasing Liver Function|0|||
94626467|NCT00684307|324090170|FG001|Overall Study|Development of increasing Liver Function|2|||
94626468|NCT00684307|324090171|FG002|Overall Study|Development of increasing Liver Function|0|||
94672669|NCT01239030|324253657|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
94672670|NCT01239030|324253658|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
94672671|NCT01239030|324253659|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
94672672|NCT01239030|324253660|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
94672673|NCT01239030|324253661|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
94672674|NCT01239030|324253657|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
94672675|NCT01239030|324253658|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
94672676|NCT01239030|324253659|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
94672677|NCT01239030|324253660|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
94672678|NCT01239030|324253661|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
94672679|NCT02114151|324253662|FG000|Overall Study|Death|1|||
94672680|NCT02114151|324253662|FG000|Overall Study|Lost to Follow-up|1|||
94672681|NCT02114151|324253662|FG000|Overall Study|Withdrawal by Subject|5|||
94672682|NCT04322682|324253664|FG000|Overall Study|Withdrawal by Subject|33|||
94672683|NCT04322682|324253665|FG001|Overall Study|Withdrawal by Subject|47|||
94672684|NCT04322682|324253664|FG000|Overall Study|Death|5|||
94672685|NCT04322682|324253665|FG001|Overall Study|Death|9|||
94672686|NCT04322682|324253664|FG000|Overall Study|Lost to Follow-up|4|||
94672687|NCT04322682|324253665|FG001|Overall Study|Lost to Follow-up|8|||
94672688|NCT04322682|324253664|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
94672689|NCT04322682|324253665|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
94672690|NCT02238379|324253666|FG000|Overall Study|Lost to Follow-up|1|||
94672691|NCT02238379|324253667|FG001|Overall Study|Lost to Follow-up|0|||
94672692|NCT00441090|324253670|FG000|Overall Study|Adverse Event|0|||
94672693|NCT00441090|324253671|FG001|Overall Study|Adverse Event|1|||
94672694|NCT00441090|324253672|FG002|Overall Study|Adverse Event|1|||
94672695|NCT00441090|324253673|FG003|Overall Study|Adverse Event|0|||
94672696|NCT00441090|324253674|FG004|Overall Study|Adverse Event|0|||
94672697|NCT00441090|324253670|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
94672698|NCT00441090|324253671|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
94672699|NCT00441090|324253672|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
94672700|NCT00441090|324253673|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
94672701|NCT00441090|324253674|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
94672702|NCT00441090|324253670|FG000|Overall Study|Withdrawal by Subject|1|||
94672703|NCT00441090|324253671|FG001|Overall Study|Withdrawal by Subject|0|||
94672704|NCT00441090|324253672|FG002|Overall Study|Withdrawal by Subject|1|||
94672705|NCT00441090|324253673|FG003|Overall Study|Withdrawal by Subject|0|||
94672706|NCT00441090|324253674|FG004|Overall Study|Withdrawal by Subject|0|||
94672707|NCT00441090|324253670|FG000|Overall Study|Lack of Efficacy|1|||
94672708|NCT00441090|324253671|FG001|Overall Study|Lack of Efficacy|0|||
94672709|NCT00441090|324253672|FG002|Overall Study|Lack of Efficacy|0|||
94672710|NCT00441090|324253673|FG003|Overall Study|Lack of Efficacy|0|||
94672711|NCT00441090|324253674|FG004|Overall Study|Lack of Efficacy|0|||
94672712|NCT01441102|324253676|FG000|Overall Study|Adverse Event|1|||
94672713|NCT01441102|324253676|FG000|Overall Study|Withdrawal by Subject|2|||
94672714|NCT00605280|324253677|FG000|Year 1|Protocol Violation|0|||
94672715|NCT00605280|324253678|FG001|Year 1|Protocol Violation|0|||
94672716|NCT00605280|324253679|FG002|Year 1|Protocol Violation|0|||
94672717|NCT00605280|324253680|FG003|Year 1|Protocol Violation|1|||
94672718|NCT00605280|324253677|FG000|Year 1|Adverse Event|3|||
94672719|NCT00605280|324253678|FG001|Year 1|Adverse Event|1|||
94672720|NCT00605280|324253679|FG002|Year 1|Adverse Event|1|||
94672721|NCT00605280|324253680|FG003|Year 1|Adverse Event|5|||
94672722|NCT00605280|324253677|FG000|Year 1|Physician Decision|7|||
94672723|NCT00605280|324253678|FG001|Year 1|Physician Decision|4|||
94672724|NCT00605280|324253679|FG002|Year 1|Physician Decision|0|||
94672725|NCT00605280|324253680|FG003|Year 1|Physician Decision|6|||
94672726|NCT00605280|324253677|FG000|Year 1|Withdrawal by Subject|2|||
94672727|NCT00605280|324253678|FG001|Year 1|Withdrawal by Subject|4|||
94672728|NCT00605280|324253679|FG002|Year 1|Withdrawal by Subject|0|||
94672729|NCT00605280|324253680|FG003|Year 1|Withdrawal by Subject|4|||
94672730|NCT00605280|324253677|FG000|Year 1|Other|2|||
94672731|NCT00605280|324253678|FG001|Year 1|Other|1|||
94672732|NCT00605280|324253679|FG002|Year 1|Other|0|||
94672733|NCT00605280|324253680|FG003|Year 1|Other|1|||
94672734|NCT00605280|324253677|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
94672735|NCT00605280|324253678|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
94672736|NCT00605280|324253679|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
94672737|NCT00605280|324253680|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
94672738|NCT00605280|324253677|FG000|Year 2|Adverse Event|4|||
94672739|NCT00605280|324253678|FG001|Year 2|Adverse Event|0|||
94672740|NCT00605280|324253679|FG002|Year 2|Adverse Event|2|||
94672741|NCT00605280|324253680|FG003|Year 2|Adverse Event|4|||
94672742|NCT00605280|324253677|FG000|Year 2|Physician Decision|11|||
94672743|NCT00605280|324253678|FG001|Year 2|Physician Decision|6|||
94672744|NCT00605280|324253679|FG002|Year 2|Physician Decision|4|||
94672745|NCT00605280|324253680|FG003|Year 2|Physician Decision|11|||
94672746|NCT00605280|324253677|FG000|Year 2|Withdrawal by Subject|4|||
94672747|NCT00605280|324253678|FG001|Year 2|Withdrawal by Subject|0|||
94672748|NCT00605280|324253679|FG002|Year 2|Withdrawal by Subject|0|||
94672749|NCT00605280|324253680|FG003|Year 2|Withdrawal by Subject|4|||
94672750|NCT00605280|324253677|FG000|Year 2|Other|1|||
94672751|NCT00605280|324253678|FG001|Year 2|Other|0|||
94672752|NCT00605280|324253679|FG002|Year 2|Other|0|||
94672753|NCT00605280|324253680|FG003|Year 2|Other|1|||
94672754|NCT00605280|324253677|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
94672755|NCT00605280|324253678|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
94672756|NCT00605280|324253679|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
94672757|NCT00605280|324253680|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
94672758|NCT00605280|324253677|FG000|Year 3 Extension|Adverse Event|2|||
94672759|NCT00605280|324253678|FG001|Year 3 Extension|Adverse Event|0|||
94672760|NCT00605280|324253679|FG002|Year 3 Extension|Adverse Event|0|||
94360142|NCT01725217|323101814|FG000|Overall Study|Withdrawal by Subject|1|||
94360143|NCT01725217|323101815|FG001|Overall Study|Withdrawal by Subject|0|||
94626469|NCT00684307|324090172|FG003|Overall Study|Development of increasing Liver Function|1|||
94626470|NCT00684307|324090173|FG004|Overall Study|Development of increasing Liver Function|0|||
94626471|NCT00684307|324090169|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
94626472|NCT00684307|324090170|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
94626473|NCT00684307|324090171|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
94626474|NCT00684307|324090172|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
94626475|NCT00684307|324090173|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
94626476|NCT00684307|324090169|FG000|Overall Study|Incorrect enrolment or randomization|4|||
94626477|NCT00684307|324090170|FG001|Overall Study|Incorrect enrolment or randomization|0|||
94626478|NCT00684307|324090171|FG002|Overall Study|Incorrect enrolment or randomization|0|||
94626479|NCT00684307|324090172|FG003|Overall Study|Incorrect enrolment or randomization|0|||
94626480|NCT00684307|324090173|FG004|Overall Study|Incorrect enrolment or randomization|0|||
94626481|NCT00684307|324090169|FG000|Overall Study|Interupted IP for more than 7 days|0|||
94626482|NCT00684307|324090170|FG001|Overall Study|Interupted IP for more than 7 days|4|||
94626483|NCT00684307|324090171|FG002|Overall Study|Interupted IP for more than 7 days|1|||
94626484|NCT00684307|324090172|FG003|Overall Study|Interupted IP for more than 7 days|3|||
94626485|NCT00684307|324090173|FG004|Overall Study|Interupted IP for more than 7 days|3|||
94626486|NCT00684307|324090169|FG000|Overall Study|Severe non compliance to protocol|1|||
94626487|NCT00684307|324090170|FG001|Overall Study|Severe non compliance to protocol|0|||
94626488|NCT00684307|324090171|FG002|Overall Study|Severe non compliance to protocol|0|||
94626489|NCT00684307|324090172|FG003|Overall Study|Severe non compliance to protocol|1|||
94626490|NCT00684307|324090173|FG004|Overall Study|Severe non compliance to protocol|2|||
94626491|NCT00684307|324090169|FG000|Overall Study|Participant not willing to continue|7|||
94626492|NCT00684307|324090170|FG001|Overall Study|Participant not willing to continue|10|||
94626493|NCT00684307|324090171|FG002|Overall Study|Participant not willing to continue|11|||
94626494|NCT00684307|324090172|FG003|Overall Study|Participant not willing to continue|5|||
94626495|NCT00684307|324090173|FG004|Overall Study|Participant not willing to continue|8|||
94626496|NCT00684307|324090169|FG000|Overall Study|Criteria from the CSR|0|||
94626497|NCT00684307|324090170|FG001|Overall Study|Criteria from the CSR|0|||
94626498|NCT00684307|324090171|FG002|Overall Study|Criteria from the CSR|1|||
94626499|NCT00684307|324090172|FG003|Overall Study|Criteria from the CSR|3|||
94626500|NCT00684307|324090173|FG004|Overall Study|Criteria from the CSR|3|||
94626501|NCT00759031|324090174|FG000|First Intervention (1 Day)|Physician Decision|1|||
94626502|NCT00759031|324090175|FG001|First Intervention (1 Day)|Physician Decision|0|||
94626503|NCT00759031|324090174|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
94626504|NCT00759031|324090175|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
94626505|NCT00759031|324090174|FG000|First Intervention (1 Day)|Screening failure|1|||
94626506|NCT00759031|324090175|FG001|First Intervention (1 Day)|Screening failure|0|||
94626507|NCT02483520|324090178|FG000|Overall Study|Lost to Follow-up|3|||
94626508|NCT02483520|324090179|FG001|Overall Study|Lost to Follow-up|4|||
94626509|NCT02483520|324090178|FG000|Overall Study|Withdrawal by Subject|4|||
94626510|NCT02483520|324090179|FG001|Overall Study|Withdrawal by Subject|14|||
94626511|NCT02483520|324090178|FG000|Overall Study|Hospitalized|2|||
94626512|NCT02483520|324090179|FG001|Overall Study|Hospitalized|3|||
94626513|NCT02483520|324090178|FG000|Overall Study|Moved to LTC|2|||
94626514|NCT02483520|324090179|FG001|Overall Study|Moved to LTC|3|||
94626515|NCT02599129|324090180|FG000|Overall Study|Lack of Efficacy|2|||
94626516|NCT02599129|324090181|FG001|Overall Study|Lack of Efficacy|2|||
94626517|NCT02599129|324090180|FG000|Overall Study|Lost to Follow-up|1|||
94626518|NCT02599129|324090181|FG001|Overall Study|Lost to Follow-up|0|||
94626519|NCT02599129|324090180|FG000|Overall Study|Withdrawal by Subject|2|||
94626520|NCT02599129|324090181|FG001|Overall Study|Withdrawal by Subject|1|||
94626521|NCT01401283|324090186|FG000|Overall Study|surgery cancelled|5|||
94626522|NCT01401283|324090187|FG001|Overall Study|surgery cancelled|8|||
94626523|NCT01401283|324090186|FG000|Overall Study|preoperative arrhythmia|5|||
94626524|NCT01401283|324090187|FG001|Overall Study|preoperative arrhythmia|0|||
94626525|NCT01401283|324090186|FG000|Overall Study|no central venous access|0|||
94626526|NCT01401283|324090187|FG001|Overall Study|no central venous access|1|||
94626527|NCT01401283|324090186|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
94626528|NCT01401283|324090187|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
94626529|NCT01751867|324090188|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
94626530|NCT01751867|324090189|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
94626531|NCT01751867|324090188|FG000|Overall Study|Diease Progression|4|||
94626532|NCT01751867|324090189|FG001|Overall Study|Diease Progression|18|||
94626533|NCT01751867|324090188|FG000|Overall Study|Adverse Event|8|||
94626534|NCT01751867|324090189|FG001|Overall Study|Adverse Event|15|||
94626535|NCT01751867|324090188|FG000|Overall Study|Poor Compliance|0|||
94626536|NCT01751867|324090189|FG001|Overall Study|Poor Compliance|5|||
94626537|NCT01751867|324090188|FG000|Overall Study|Withdrawal by Subject|3|||
94626538|NCT01751867|324090189|FG001|Overall Study|Withdrawal by Subject|1|||
94672761|NCT00605280|324253680|FG003|Year 3 Extension|Adverse Event|2|||
94461248|NCT02954653|323478227|FG004|Overall Study|Randomized but did not receive treatment|0|||
94461249|NCT02954653|323478228|FG005|Overall Study|Randomized but did not receive treatment|0|||
94461250|NCT02954653|323478229|FG006|Overall Study|Randomized but did not receive treatment|0|||
94626539|NCT01751867|324090188|FG000|Overall Study|Physician Decision|4|||
94626540|NCT01751867|324090189|FG001|Overall Study|Physician Decision|7|||
94626541|NCT01751867|324090188|FG000|Overall Study|Protocol Violation|0|||
94626542|NCT01751867|324090189|FG001|Overall Study|Protocol Violation|2|||
94626543|NCT01751867|324090188|FG000|Overall Study|Death|0|||
94626544|NCT01751867|324090189|FG001|Overall Study|Death|5|||
94626545|NCT01751867|324090188|FG000|Overall Study|Other|11|||
94626546|NCT01751867|324090189|FG001|Overall Study|Other|37|||
94626547|NCT01751867|324090188|FG000|Overall Study|Randomized but not treated.|2|||
94626548|NCT01751867|324090189|FG001|Overall Study|Randomized but not treated.|1|||
94626549|NCT01806545|324090190|FG000|Overall Study|Adverse Event|2|||
94626550|NCT01806545|324090191|FG001|Overall Study|Adverse Event|3|||
94626551|NCT01806545|324090190|FG000|Overall Study|Lost to Follow-up|1|||
94626552|NCT01806545|324090191|FG001|Overall Study|Lost to Follow-up|0|||
94626553|NCT01806545|324090190|FG000|Overall Study|Withdrawal by Subject|3|||
94626554|NCT01806545|324090191|FG001|Overall Study|Withdrawal by Subject|2|||
94626555|NCT01059825|324090192|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
94626556|NCT01059825|324090193|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
94626557|NCT01059825|324090194|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
94626558|NCT01059825|324090195|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
94626559|NCT01059825|324090196|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
94626560|NCT01059825|324090197|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
94626561|NCT01059825|324090198|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
94626562|NCT01059825|324090192|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
94626563|NCT01059825|324090193|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
94626564|NCT01059825|324090194|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
94626565|NCT01059825|324090195|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
94626566|NCT01059825|324090196|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
94626567|NCT01059825|324090197|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
94626568|NCT01059825|324090198|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
94626569|NCT01059825|324090192|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
94626570|NCT01059825|324090193|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
94626571|NCT01059825|324090194|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
94626572|NCT01059825|324090195|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
94626573|NCT01059825|324090196|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
94626574|NCT01059825|324090197|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
94626575|NCT01059825|324090198|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
94626576|NCT01059825|324090192|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
94626577|NCT01059825|324090193|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
94626578|NCT01059825|324090194|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
94626579|NCT01059825|324090195|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
94626580|NCT01059825|324090196|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
94626581|NCT01059825|324090197|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
94626582|NCT01059825|324090198|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
94626583|NCT01059825|324090192|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
94626584|NCT01059825|324090193|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
94626585|NCT01059825|324090194|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
94626586|NCT01059825|324090195|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
94626587|NCT01059825|324090196|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
94626588|NCT01059825|324090197|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
94626589|NCT01059825|324090198|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
94626590|NCT01059825|324090192|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
94626591|NCT01059825|324090193|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
94626592|NCT01059825|324090194|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
94626593|NCT01059825|324090195|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
94626594|NCT01059825|324090196|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
94626595|NCT01059825|324090197|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
94626596|NCT01059825|324090198|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
94626597|NCT01059825|324090192|FG000|Treatment Period|Lost to Follow-up|2|||
94626598|NCT01059825|324090193|FG001|Treatment Period|Lost to Follow-up|1|||
94626599|NCT01059825|324090194|FG002|Treatment Period|Lost to Follow-up|0|||
94626600|NCT01059825|324090195|FG003|Treatment Period|Lost to Follow-up|1|||
94626601|NCT01059825|324090196|FG004|Treatment Period|Lost to Follow-up|2|||
94626602|NCT01059825|324090197|FG005|Treatment Period|Lost to Follow-up|0|||
94626603|NCT01059825|324090198|FG006|Treatment Period|Lost to Follow-up|0|||
94626604|NCT01059825|324090192|FG000|Treatment Period|Withdrawal by Subject|3|||
94626605|NCT01059825|324090193|FG001|Treatment Period|Withdrawal by Subject|0|||
94672762|NCT00605280|324253677|FG000|Year 3 Extension|Physician Decision|0|||
94672763|NCT00605280|324253678|FG001|Year 3 Extension|Physician Decision|0|||
94672764|NCT00605280|324253679|FG002|Year 3 Extension|Physician Decision|0|||
94672765|NCT00605280|324253680|FG003|Year 3 Extension|Physician Decision|2|||
94672766|NCT00605280|324253677|FG000|Year 3 Extension|Withdrawal by Subject|2|||
94672767|NCT00605280|324253678|FG001|Year 3 Extension|Withdrawal by Subject|0|||
94672768|NCT00605280|324253679|FG002|Year 3 Extension|Withdrawal by Subject|0|||
94672769|NCT00605280|324253680|FG003|Year 3 Extension|Withdrawal by Subject|5|||
94672770|NCT00605280|324253677|FG000|Year 3 Extension|Other|2|||
94672771|NCT00605280|324253678|FG001|Year 3 Extension|Other|0|||
94672772|NCT00605280|324253679|FG002|Year 3 Extension|Other|0|||
94672773|NCT00605280|324253680|FG003|Year 3 Extension|Other|0|||
94672774|NCT00605280|324253677|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
94672775|NCT00605280|324253678|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
94672776|NCT00605280|324253679|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
94672777|NCT00605280|324253680|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
94672778|NCT00810264|324253683|FG000|Overall Study|Lost to Follow-up|191|||
94672779|NCT00810264|324253683|FG000|Overall Study|Withdrawal by subject or physician|721|||
94672780|NCT00810264|324253683|FG000|Overall Study|Death|641|||
94672781|NCT01563536|324253691|FG000|Overall Study|Withdrawal by Subject|0|||
94672782|NCT01563536|324253692|FG001|Overall Study|Withdrawal by Subject|2|||
94672783|NCT01563536|324253691|FG000|Overall Study|Lost to Follow-up|1|||
94672784|NCT01563536|324253692|FG001|Overall Study|Lost to Follow-up|0|||
94672785|NCT01860703|324253694|FG000|Overall Study|Adverse Event|1|||
94672786|NCT01860703|324253695|FG001|Overall Study|Adverse Event|4|||
94672787|NCT01860703|324253696|FG002|Overall Study|Adverse Event|0|||
94672788|NCT01860703|324253697|FG003|Overall Study|Adverse Event|2|||
94672789|NCT01860703|324253694|FG000|Overall Study|Withdrawal by Subject|0|||
94672790|NCT01860703|324253695|FG001|Overall Study|Withdrawal by Subject|1|||
94672791|NCT01860703|324253696|FG002|Overall Study|Withdrawal by Subject|0|||
94672792|NCT01860703|324253697|FG003|Overall Study|Withdrawal by Subject|0|||
94672793|NCT01860703|324253694|FG000|Overall Study|Personal reason|1|||
94672794|NCT01860703|324253695|FG001|Overall Study|Personal reason|0|||
94672795|NCT01860703|324253696|FG002|Overall Study|Personal reason|1|||
94672796|NCT01860703|324253697|FG003|Overall Study|Personal reason|0|||
94672797|NCT01662310|324253698|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
94672798|NCT01662310|324253699|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
94672799|NCT01662310|324253700|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
94672800|NCT01662310|324253701|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
94672801|NCT01662310|324253702|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
94672802|NCT01662310|324253698|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
94672803|NCT01662310|324253699|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
94672804|NCT01662310|324253700|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
94672805|NCT01662310|324253701|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
94672806|NCT01662310|324253702|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
94672807|NCT01662310|324253698|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
94672808|NCT01662310|324253699|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
94672809|NCT01662310|324253700|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
94672810|NCT01662310|324253701|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
94672811|NCT01662310|324253702|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
94672812|NCT01662310|324253698|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
94672813|NCT01662310|324253699|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
94672814|NCT01662310|324253700|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
94672815|NCT01662310|324253701|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
94672816|NCT01662310|324253702|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
94672817|NCT01662310|324253698|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
94672818|NCT01662310|324253699|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
94672819|NCT01662310|324253700|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
94672820|NCT01662310|324253701|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
94672821|NCT01662310|324253702|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
94672822|NCT01662310|324253698|FG000|Run-In or Stabilization Phase|Other|1|||
94672823|NCT01662310|324253699|FG001|Run-In or Stabilization Phase|Other|0|||
94672824|NCT01662310|324253700|FG002|Run-In or Stabilization Phase|Other|0|||
94672825|NCT01662310|324253701|FG003|Run-In or Stabilization Phase|Other|0|||
94672826|NCT01662310|324253702|FG004|Run-In or Stabilization Phase|Other|0|||
94672827|NCT01662310|324253698|FG000|Double-Blind Phase|Adverse Event|0|||
94672828|NCT01662310|324253699|FG001|Double-Blind Phase|Adverse Event|0|||
94672829|NCT01662310|324253700|FG002|Double-Blind Phase|Adverse Event|1|||
94672830|NCT01662310|324253701|FG003|Double-Blind Phase|Adverse Event|0|||
94672831|NCT01662310|324253702|FG004|Double-Blind Phase|Adverse Event|0|||
94672832|NCT01662310|324253698|FG000|Double-Blind Phase|Lost to Follow-up|0|||
94672833|NCT01662310|324253699|FG001|Double-Blind Phase|Lost to Follow-up|3|||
94360144|NCT01725217|323101816|FG002|Overall Study|Withdrawal by Subject|0|||
94672834|NCT01662310|324253700|FG002|Double-Blind Phase|Lost to Follow-up|0|||
94672835|NCT01662310|324253701|FG003|Double-Blind Phase|Lost to Follow-up|0|||
94672836|NCT01662310|324253702|FG004|Double-Blind Phase|Lost to Follow-up|0|||
94672837|NCT01662310|324253698|FG000|Double-Blind Phase|Pregnancy|0|||
94672838|NCT01662310|324253699|FG001|Double-Blind Phase|Pregnancy|2|||
94672839|NCT01662310|324253700|FG002|Double-Blind Phase|Pregnancy|0|||
94672840|NCT01662310|324253701|FG003|Double-Blind Phase|Pregnancy|0|||
94672841|NCT01662310|324253702|FG004|Double-Blind Phase|Pregnancy|0|||
94672842|NCT01662310|324253698|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
94672843|NCT01662310|324253699|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
94672844|NCT01662310|324253700|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
94672845|NCT01662310|324253701|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
94672846|NCT01662310|324253702|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
94672847|NCT01662310|324253698|FG000|Double-Blind Phase|Other|0|||
94672848|NCT01662310|324253699|FG001|Double-Blind Phase|Other|0|||
94672849|NCT01662310|324253700|FG002|Double-Blind Phase|Other|1|||
94672850|NCT01662310|324253701|FG003|Double-Blind Phase|Other|0|||
94672851|NCT01662310|324253702|FG004|Double-Blind Phase|Other|0|||
94672852|NCT01662310|324253698|FG000|Double-Blind Phase|Randomized but not treated|0|||
94672853|NCT01662310|324253699|FG001|Double-Blind Phase|Randomized but not treated|1|||
94672854|NCT01662310|324253700|FG002|Double-Blind Phase|Randomized but not treated|0|||
94672855|NCT01662310|324253701|FG003|Double-Blind Phase|Randomized but not treated|0|||
94672856|NCT01662310|324253702|FG004|Double-Blind Phase|Randomized but not treated|0|||
94672857|NCT01662310|324253698|FG000|Open-Label Extension Phase|Adverse Event|0|||
94672858|NCT01662310|324253699|FG001|Open-Label Extension Phase|Adverse Event|0|||
94672859|NCT01662310|324253700|FG002|Open-Label Extension Phase|Adverse Event|0|||
94672860|NCT01662310|324253701|FG003|Open-Label Extension Phase|Adverse Event|3|||
94672861|NCT01662310|324253702|FG004|Open-Label Extension Phase|Adverse Event|0|||
94672862|NCT01662310|324253698|FG000|Open-Label Extension Phase|Death|0|||
94672863|NCT01662310|324253699|FG001|Open-Label Extension Phase|Death|0|||
94672864|NCT01662310|324253700|FG002|Open-Label Extension Phase|Death|0|||
94672865|NCT01662310|324253701|FG003|Open-Label Extension Phase|Death|1|||
94672866|NCT01662310|324253702|FG004|Open-Label Extension Phase|Death|0|||
94672867|NCT01662310|324253698|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
94672868|NCT01662310|324253699|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
94672869|NCT01662310|324253700|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
94672870|NCT01662310|324253701|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
94672871|NCT01662310|324253702|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
94672872|NCT01662310|324253698|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
94672873|NCT01662310|324253699|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
94672874|NCT01662310|324253700|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
94672875|NCT01662310|324253701|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
94672876|NCT01662310|324253702|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
94672877|NCT01662310|324253698|FG000|Open-Label Extension Phase|Pregnancy|0|||
94672878|NCT01662310|324253699|FG001|Open-Label Extension Phase|Pregnancy|0|||
94672879|NCT01662310|324253700|FG002|Open-Label Extension Phase|Pregnancy|0|||
94672880|NCT01662310|324253701|FG003|Open-Label Extension Phase|Pregnancy|1|||
94672881|NCT01662310|324253702|FG004|Open-Label Extension Phase|Pregnancy|0|||
94672882|NCT01662310|324253698|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
94672883|NCT01662310|324253699|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
94672884|NCT01662310|324253700|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
94672885|NCT01662310|324253701|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
94672886|NCT01662310|324253702|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
94672887|NCT02432105|324253706|FG000|Overall Study|Lost to Follow-up|1|||
94672888|NCT02432105|324253707|FG001|Overall Study|Lost to Follow-up|1|||
94672889|NCT02432105|324253708|FG002|Overall Study|Lost to Follow-up|0|||
94672890|NCT02432105|324253706|FG000|Overall Study|Withdrawal by Subject|1|||
94672891|NCT02432105|324253707|FG001|Overall Study|Withdrawal by Subject|0|||
94672892|NCT02432105|324253708|FG002|Overall Study|Withdrawal by Subject|1|||
94672893|NCT02432105|324253706|FG000|Overall Study|Culture positive for yeast|0|||
94672894|NCT02432105|324253707|FG001|Overall Study|Culture positive for yeast|1|||
94672895|NCT02432105|324253708|FG002|Overall Study|Culture positive for yeast|0|||
94461251|NCT02954653|323478230|FG007|Overall Study|Randomized but did not receive treatment|0|||
94461252|NCT02954653|323478231|FG008|Overall Study|Randomized but did not receive treatment|0|||
94461253|NCT02954653|323478223|FG000|Overall Study|Started another anti-cancer therapy|0|||
94672896|NCT02432105|324253706|FG000|Overall Study|Randomized in error|0|||
94672897|NCT02432105|324253707|FG001|Overall Study|Randomized in error|0|||
94672898|NCT02432105|324253708|FG002|Overall Study|Randomized in error|2|||
94672899|NCT00636610|324253711|FG000|Overall Study|Adverse Event|4|||
94672900|NCT00636610|324253712|FG001|Overall Study|Adverse Event|4|||
94672901|NCT00636610|324253711|FG000|Overall Study|Death|6|||
94672902|NCT00636610|324253712|FG001|Overall Study|Death|3|||
94672903|NCT00636610|324253711|FG000|Overall Study|Physician decision to withdraw patient|15|||
94672904|NCT00636610|324253712|FG001|Overall Study|Physician decision to withdraw patient|9|||
94672905|NCT00636610|324253711|FG000|Overall Study|Subject decision to withdraw|15|||
94672906|NCT00636610|324253712|FG001|Overall Study|Subject decision to withdraw|11|||
94672907|NCT00636610|324253711|FG000|Overall Study|Disease progression - radiographic|41|||
94360145|NCT00308555|323101817|FG000|Overall Study|Withdrawal by Subject|1|||
94360146|NCT00308555|323101818|FG001|Overall Study|Withdrawal by Subject|0|||
94360147|NCT00308555|323101817|FG000|Overall Study|Physician Decision|2|||
94360148|NCT00308555|323101818|FG001|Overall Study|Physician Decision|0|||
94360149|NCT02331680|323101820|FG000|Overall Study|Adverse Event|3|||
94360150|NCT02331680|323101821|FG001|Overall Study|Adverse Event|0|||
94360151|NCT02331680|323101822|FG002|Overall Study|Adverse Event|2|||
94360152|NCT02331680|323101820|FG000|Overall Study|Physician Decision|1|||
94360153|NCT02331680|323101821|FG001|Overall Study|Physician Decision|1|||
94360154|NCT02331680|323101822|FG002|Overall Study|Physician Decision|2|||
94360155|NCT02331680|323101820|FG000|Overall Study|Withdrawal by Subject|0|||
94360156|NCT02331680|323101821|FG001|Overall Study|Withdrawal by Subject|1|||
94360157|NCT02331680|323101822|FG002|Overall Study|Withdrawal by Subject|2|||
94360158|NCT02331680|323101820|FG000|Overall Study|Met withdrawal criteria|2|||
94360159|NCT02331680|323101821|FG001|Overall Study|Met withdrawal criteria|2|||
94360160|NCT02331680|323101822|FG002|Overall Study|Met withdrawal criteria|5|||
94360161|NCT02331680|323101820|FG000|Overall Study|Non-compliance with study drug|0|||
94672908|NCT00636610|324253712|FG001|Overall Study|Disease progression - radiographic|51|||
94672909|NCT00636610|324253711|FG000|Overall Study|Disease progression - clinical|8|||
94360162|NCT02331680|323101821|FG001|Overall Study|Non-compliance with study drug|0|||
94360163|NCT02331680|323101822|FG002|Overall Study|Non-compliance with study drug|1|||
94360164|NCT02331680|323101820|FG000|Overall Study|Protocol Violation|0|||
94360165|NCT02331680|323101821|FG001|Overall Study|Protocol Violation|0|||
94360166|NCT02331680|323101822|FG002|Overall Study|Protocol Violation|3|||
94360167|NCT02335411|323101823|FG000|Overall Study|Death|223|||
94360168|NCT02335411|323101824|FG001|Overall Study|Death|22|||
94360169|NCT02335411|323101825|FG002|Overall Study|Death|26|||
94461254|NCT02954653|323478224|FG001|Overall Study|Started another anti-cancer therapy|1|||
94461255|NCT02954653|323478225|FG002|Overall Study|Started another anti-cancer therapy|0|||
94672910|NCT00636610|324253712|FG001|Overall Study|Disease progression - clinical|3|||
94672911|NCT00636610|324253711|FG000|Overall Study|Reason for discontinuation not available|3|||
94672912|NCT00636610|324253712|FG001|Overall Study|Reason for discontinuation not available|2|||
94672913|NCT00671931|324253721|FG000|Overall Study|Physician Decision|1|||
94672914|NCT00671931|324253722|FG001|Overall Study|Physician Decision|0|||
94672915|NCT00671931|324253723|FG002|Overall Study|Physician Decision|0|||
94672916|NCT00671931|324253724|FG003|Overall Study|Physician Decision|2|||
94672917|NCT00671931|324253725|FG004|Overall Study|Physician Decision|1|||
94672918|NCT03355326|324253726|FG000|Overall Study|Protocol Violation|3|||
94672919|NCT03355326|324253727|FG001|Overall Study|Protocol Violation|3|||
94672920|NCT02151266|324253728|FG000|Overall Study|Lost to Follow-up|1|||
94672921|NCT02151266|324253729|FG001|Overall Study|Lost to Follow-up|4|||
94672922|NCT02151266|324253730|FG002|Overall Study|Lost to Follow-up|1|||
94672923|NCT02151266|324253728|FG000|Overall Study|Did NOT receive intervention|3|||
94672924|NCT02151266|324253729|FG001|Overall Study|Did NOT receive intervention|6|||
94672925|NCT02151266|324253730|FG002|Overall Study|Did NOT receive intervention|2|||
94672926|NCT02151266|324253728|FG000|Overall Study|Not able to exercise|4|||
94672927|NCT02151266|324253729|FG001|Overall Study|Not able to exercise|5|||
94672928|NCT02151266|324253730|FG002|Overall Study|Not able to exercise|4|||
94672929|NCT02816138|324253731|FG000|Overall Study|Adverse Event|1|||
94672930|NCT02291679|324253732|FG000|Overall Study|Adverse Event|2|||
94672931|NCT02291679|324253733|FG001|Overall Study|Adverse Event|12|||
94672932|NCT02291679|324253734|FG002|Overall Study|Adverse Event|19|||
94672933|NCT02291679|324253732|FG000|Overall Study|Protocol Violation|5|||
94672934|NCT02291679|324253733|FG001|Overall Study|Protocol Violation|1|||
94360170|NCT02335411|323101823|FG000|Overall Study|Physician Decision|3|||
94360171|NCT02335411|323101824|FG001|Overall Study|Physician Decision|0|||
94360172|NCT02335411|323101825|FG002|Overall Study|Physician Decision|0|||
94672935|NCT02291679|324253734|FG002|Overall Study|Protocol Violation|7|||
94672936|NCT02291679|324253732|FG000|Overall Study|Withdrew Consent|18|||
94672937|NCT02291679|324253733|FG001|Overall Study|Withdrew Consent|10|||
94360173|NCT02335411|323101823|FG000|Overall Study|Protocol Violation|1|||
94672938|NCT02291679|324253734|FG002|Overall Study|Withdrew Consent|15|||
94672939|NCT02291679|324253732|FG000|Overall Study|Lost to Follow-up|12|||
94672940|NCT02291679|324253733|FG001|Overall Study|Lost to Follow-up|10|||
94672941|NCT02291679|324253734|FG002|Overall Study|Lost to Follow-up|9|||
94672942|NCT02291679|324253732|FG000|Overall Study|Insufficient Therapeutic Response|5|||
94626606|NCT01059825|324090194|FG002|Treatment Period|Withdrawal by Subject|1|||
94626607|NCT01059825|324090195|FG003|Treatment Period|Withdrawal by Subject|5|||
94626608|NCT01059825|324090196|FG004|Treatment Period|Withdrawal by Subject|4|||
94626609|NCT01059825|324090197|FG005|Treatment Period|Withdrawal by Subject|1|||
94626610|NCT01059825|324090198|FG006|Treatment Period|Withdrawal by Subject|0|||
94626611|NCT01059825|324090192|FG000|Treatment Period|Other reason not specified|1|||
94626612|NCT01059825|324090193|FG001|Treatment Period|Other reason not specified|2|||
94626613|NCT01059825|324090194|FG002|Treatment Period|Other reason not specified|1|||
94626614|NCT01059825|324090195|FG003|Treatment Period|Other reason not specified|2|||
94626615|NCT01059825|324090196|FG004|Treatment Period|Other reason not specified|0|||
94626616|NCT01059825|324090197|FG005|Treatment Period|Other reason not specified|0|||
94626617|NCT01059825|324090198|FG006|Treatment Period|Other reason not specified|0|||
94626618|NCT01059825|324090192|FG000|Treatment Period|Protocol Violation|0|||
94626619|NCT01059825|324090193|FG001|Treatment Period|Protocol Violation|0|||
94626620|NCT01059825|324090194|FG002|Treatment Period|Protocol Violation|1|||
94626621|NCT01059825|324090195|FG003|Treatment Period|Protocol Violation|1|||
94626622|NCT01059825|324090196|FG004|Treatment Period|Protocol Violation|1|||
94626623|NCT01059825|324090197|FG005|Treatment Period|Protocol Violation|1|||
94626624|NCT01059825|324090198|FG006|Treatment Period|Protocol Violation|0|||
94626625|NCT01059825|324090192|FG000|Treatment Period|Adverse event related to study drug|1|||
94626626|NCT01059825|324090193|FG001|Treatment Period|Adverse event related to study drug|0|||
94626627|NCT01059825|324090194|FG002|Treatment Period|Adverse event related to study drug|1|||
94626628|NCT01059825|324090195|FG003|Treatment Period|Adverse event related to study drug|1|||
94626629|NCT01059825|324090196|FG004|Treatment Period|Adverse event related to study drug|0|||
94626630|NCT01059825|324090197|FG005|Treatment Period|Adverse event related to study drug|0|||
94626631|NCT01059825|324090198|FG006|Treatment Period|Adverse event related to study drug|0|||
94626632|NCT01059825|324090192|FG000|Treatment Period|Insufficient clinical response|3|||
94626633|NCT01059825|324090193|FG001|Treatment Period|Insufficient clinical response|0|||
94626634|NCT01059825|324090194|FG002|Treatment Period|Insufficient clinical response|0|||
94626635|NCT01059825|324090195|FG003|Treatment Period|Insufficient clinical response|0|||
94626636|NCT01059825|324090196|FG004|Treatment Period|Insufficient clinical response|0|||
94626637|NCT01059825|324090197|FG005|Treatment Period|Insufficient clinical response|0|||
94626638|NCT01059825|324090198|FG006|Treatment Period|Insufficient clinical response|0|||
94626639|NCT01059825|324090192|FG000|Treatment Period|Adverse event not related to study drug|0|||
94626640|NCT01059825|324090193|FG001|Treatment Period|Adverse event not related to study drug|1|||
94626641|NCT01059825|324090194|FG002|Treatment Period|Adverse event not related to study drug|2|||
94626642|NCT01059825|324090195|FG003|Treatment Period|Adverse event not related to study drug|1|||
94626643|NCT01059825|324090196|FG004|Treatment Period|Adverse event not related to study drug|1|||
94626644|NCT01059825|324090197|FG005|Treatment Period|Adverse event not related to study drug|1|||
94626645|NCT01059825|324090198|FG006|Treatment Period|Adverse event not related to study drug|0|||
94626646|NCT00284050|324090199|FG000|Overall Study|Adverse Event|1|||
94626647|NCT00284050|324090200|FG001|Overall Study|Adverse Event|1|||
94626648|NCT00284050|324090201|FG002|Overall Study|Adverse Event|1|||
94626649|NCT00284050|324090199|FG000|Overall Study|Lack of Efficacy|0|||
94626650|NCT00284050|324090200|FG001|Overall Study|Lack of Efficacy|1|||
94626651|NCT00284050|324090201|FG002|Overall Study|Lack of Efficacy|3|||
94626652|NCT00284050|324090199|FG000|Overall Study|Protocol Violation|0|||
94626653|NCT00284050|324090200|FG001|Overall Study|Protocol Violation|1|||
94626654|NCT00284050|324090201|FG002|Overall Study|Protocol Violation|2|||
94626655|NCT00284050|324090199|FG000|Overall Study|Withdrawal by Subject|2|||
94626656|NCT00284050|324090200|FG001|Overall Study|Withdrawal by Subject|2|||
94626657|NCT00284050|324090201|FG002|Overall Study|Withdrawal by Subject|2|||
94626658|NCT00284050|324090199|FG000|Overall Study|Lost to Follow-up|1|||
94626659|NCT00284050|324090200|FG001|Overall Study|Lost to Follow-up|0|||
94626660|NCT00284050|324090201|FG002|Overall Study|Lost to Follow-up|1|||
94626661|NCT00284050|324090199|FG000|Overall Study|Death|1|||
94626662|NCT00284050|324090200|FG001|Overall Study|Death|0|||
94626663|NCT00284050|324090201|FG002|Overall Study|Death|0|||
94626664|NCT00489541|324090208|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
94672943|NCT02291679|324253733|FG001|Overall Study|Insufficient Therapeutic Response|5|||
94672944|NCT02291679|324253734|FG002|Overall Study|Insufficient Therapeutic Response|7|||
94672945|NCT02291679|324253732|FG000|Overall Study|Other|2|||
94626665|NCT00489541|324090209|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
94672946|NCT02291679|324253733|FG001|Overall Study|Other|4|||
94672947|NCT02291679|324253734|FG002|Overall Study|Other|2|||
94626666|NCT00489541|324090208|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
94626667|NCT00489541|324090209|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
94626668|NCT00489541|324090208|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
94672948|NCT01112579|324253735|FG000|Overall Study|Missed Visit|1|||
94672949|NCT01112579|324253736|FG001|Overall Study|Missed Visit|1|||
94672950|NCT01112579|324253735|FG000|Overall Study|Death|0|||
94672951|NCT01112579|324253736|FG001|Overall Study|Death|2|||
94672952|NCT01971723|324253737|FG000|Overall Study|Withdrawal by Subject|1|||
94672953|NCT01971723|324253738|FG001|Overall Study|Withdrawal by Subject|1|||
94672954|NCT01971723|324253737|FG000|Overall Study|Protocol Violation|1|||
94672955|NCT01971723|324253738|FG001|Overall Study|Protocol Violation|2|||
94360174|NCT02335411|323101824|FG001|Overall Study|Protocol Violation|0|||
94360175|NCT02335411|323101825|FG002|Overall Study|Protocol Violation|0|||
94360176|NCT02335411|323101823|FG000|Overall Study|Withdrawal by Subject|11|||
94360177|NCT02335411|323101824|FG001|Overall Study|Withdrawal by Subject|0|||
94360178|NCT02335411|323101825|FG002|Overall Study|Withdrawal by Subject|3|||
94360179|NCT02335411|323101823|FG000|Overall Study|Sponsor Decision|12|||
94360180|NCT02335411|323101824|FG001|Overall Study|Sponsor Decision|3|||
94360181|NCT02335411|323101825|FG002|Overall Study|Sponsor Decision|2|||
94360182|NCT02335411|323101823|FG000|Overall Study|Adverse Event|9|||
94360183|NCT02335411|323101824|FG001|Overall Study|Adverse Event|0|||
94626669|NCT00489541|324090209|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
94626670|NCT00489541|324090208|FG000|12-Month Clinical Follow-up|Death|3|||
94626671|NCT00489541|324090209|FG001|12-Month Clinical Follow-up|Death|2|||
94626672|NCT00489541|324090208|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
94626673|NCT00489541|324090209|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
94626674|NCT00489541|324090208|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
94626675|NCT00489541|324090209|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
94626676|NCT05131646|324090210|FG000|Overall Study|Withdrawal by Subject|1|||
94626677|NCT05131646|324090211|FG001|Overall Study|Withdrawal by Subject|0|||
94626678|NCT05131646|324090212|FG002|Overall Study|Withdrawal by Subject|0|||
94626679|NCT02548650|324090213|FG000|Triple Therapy|Adverse Event|1|||
94626680|NCT02548650|324090214|FG001|Triple Therapy|Adverse Event|0|||
94626681|NCT02548650|324090213|FG000|Triple Therapy|Withdrawal by Subject|0|||
94626682|NCT02548650|324090214|FG001|Triple Therapy|Withdrawal by Subject|4|||
94626683|NCT02548650|324090213|FG000|Double Therapy|Adverse Event|1|||
94626684|NCT02548650|324090214|FG001|Double Therapy|Adverse Event|1|||
94626685|NCT02548650|324090213|FG000|Double Therapy|Withdrawal by Subject|0|||
94626686|NCT02548650|324090214|FG001|Double Therapy|Withdrawal by Subject|1|||
94626687|NCT01854710|324090217|FG000|Overall Study|Withdrawal by Subject|2|||
94626688|NCT01854710|324090218|FG001|Overall Study|Withdrawal by Subject|1|||
94626689|NCT01854710|324090219|FG002|Overall Study|Withdrawal by Subject|0|||
94626690|NCT01854710|324090220|FG003|Overall Study|Withdrawal by Subject|0|||
94626691|NCT01854710|324090221|FG004|Overall Study|Withdrawal by Subject|0|||
94626692|NCT01854710|324090222|FG005|Overall Study|Withdrawal by Subject|0|||
94626693|NCT01854710|324090217|FG000|Overall Study|CRI procedural error|2|||
94626694|NCT01854710|324090218|FG001|Overall Study|CRI procedural error|2|||
94626695|NCT01854710|324090219|FG002|Overall Study|CRI procedural error|2|||
94626696|NCT01854710|324090220|FG003|Overall Study|CRI procedural error|2|||
94626697|NCT01854710|324090221|FG004|Overall Study|CRI procedural error|2|||
94626698|NCT01854710|324090222|FG005|Overall Study|CRI procedural error|2|||
94626699|NCT01336764|324090223|FG000|Overall Study|Withdrawal by Subject|5|||
94626700|NCT01336764|324090224|FG001|Overall Study|Withdrawal by Subject|5|||
94626701|NCT00171730|324090226|FG000|Overall Study|Adverse Event|3|||
94626702|NCT00171730|324090226|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
94626703|NCT00171730|324090226|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
94626704|NCT00171730|324090226|FG000|Overall Study|Withdrawal by Subject|3|||
94626705|NCT02670837|324090227|FG000|Overall Study|Death|2|||
94626706|NCT02670837|324090228|FG001|Overall Study|Death|0|||
94626707|NCT02670837|324090229|FG002|Overall Study|Death|0|||
94626708|NCT01053221|324090230|FG000|Overall Study|The study was closed prematurely|5|||
94626709|NCT01053221|324090231|FG001|Overall Study|The study was closed prematurely|9|||
94626710|NCT02088047|324090232|FG000|Overall Study|Withdrawal by Subject|1|||
94626711|NCT02088047|324090233|FG001|Overall Study|Withdrawal by Subject|0|||
94626712|NCT00660309|324090234|FG000|Overall Study|Adverse Event|2|||
94626713|NCT00660309|324090235|FG001|Overall Study|Adverse Event|0|||
94626714|NCT00660309|324090234|FG000|Overall Study|Withdrawal by Subject|0|||
94626715|NCT00660309|324090235|FG001|Overall Study|Withdrawal by Subject|3|||
94672956|NCT01024608|324253740|FG000|Overall Study|Adverse Event|1|||
94672957|NCT01024608|324253741|FG001|Overall Study|Adverse Event|0|||
94672958|NCT01024608|324253740|FG000|Overall Study|Withdrawal by Subject|1|||
94360184|NCT02335411|323101825|FG002|Overall Study|Adverse Event|0|||
94360185|NCT03522506|323101827|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
94626716|NCT02573311|324090236|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
94626717|NCT02573311|324090237|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
94626718|NCT02573311|324090236|FG000|Disposition for Part 2|Physician Decision|25|||
94626719|NCT02573311|324090237|FG001|Disposition for Part 2|Physician Decision|7|||
94672959|NCT01024608|324253741|FG001|Overall Study|Withdrawal by Subject|0|||
94626720|NCT02573311|324090236|FG000|Disposition for Part 2|Adverse Event|36|||
94626721|NCT02573311|324090237|FG001|Disposition for Part 2|Adverse Event|5|||
94672960|NCT01024608|324253740|FG000|Overall Study|Lost to Follow-up|0|||
94672961|NCT01024608|324253741|FG001|Overall Study|Lost to Follow-up|1|||
94672962|NCT01024608|324253740|FG000|Overall Study|Protocol Violation|0|||
94672963|NCT01024608|324253741|FG001|Overall Study|Protocol Violation|3|||
94672964|NCT01024608|324253740|FG000|Overall Study|Never received study treatment|2|||
94672965|NCT01024608|324253741|FG001|Overall Study|Never received study treatment|0|||
94672966|NCT05338333|324253742|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
94672967|NCT05338333|324253743|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
94672968|NCT04050865|324255446|FG000|Overall Study|Adverse Event|1|||
94672969|NCT04050865|324255447|FG001|Overall Study|Adverse Event|0|||
94672970|NCT04050865|324255446|FG000|Overall Study|no insert|1|||
94672971|NCT04050865|324255447|FG001|Overall Study|no insert|0|||
94672972|NCT04050865|324255446|FG000|Overall Study|Only 1 insert|2|||
94672973|NCT04050865|324255447|FG001|Overall Study|Only 1 insert|3|||
94672974|NCT04050865|324255446|FG000|Overall Study|Physician Decision|0|||
94672975|NCT04050865|324255447|FG001|Overall Study|Physician Decision|1|||
94672976|NCT04050865|324255446|FG000|Overall Study|Withdrawal by Subject|0|||
94672977|NCT04050865|324255447|FG001|Overall Study|Withdrawal by Subject|1|||
94672978|NCT01332227|324255451|FG000|Overall Study|Adverse Event|4|||
94672979|NCT01332227|324255452|FG001|Overall Study|Adverse Event|1|||
94672980|NCT01332227|324255451|FG000|Overall Study|Withdrawal by Subject|5|||
94672981|NCT01332227|324255452|FG001|Overall Study|Withdrawal by Subject|1|||
94672982|NCT01332227|324255451|FG000|Overall Study|Lost to Follow-up|2|||
94672983|NCT01332227|324255452|FG001|Overall Study|Lost to Follow-up|0|||
94672984|NCT01332227|324255451|FG000|Overall Study|Lack of Efficacy|3|||
94672985|NCT01332227|324255452|FG001|Overall Study|Lack of Efficacy|1|||
94672986|NCT01332227|324255451|FG000|Overall Study|Poor compliance/noncompliance|1|||
94672987|NCT01332227|324255452|FG001|Overall Study|Poor compliance/noncompliance|1|||
94672988|NCT01332227|324255451|FG000|Overall Study|Patient moved from area|1|||
94672989|NCT01332227|324255452|FG001|Overall Study|Patient moved from area|0|||
94672990|NCT01332227|324255451|FG000|Overall Study|Patient began prohibited medication|0|||
94672991|NCT01332227|324255452|FG001|Overall Study|Patient began prohibited medication|1|||
94672992|NCT02173548|324255455|FG000|Overall Study|Lost to Follow-up|0|||
94672993|NCT02173548|324255456|FG001|Overall Study|Lost to Follow-up|2|||
94672994|NCT02173548|324255455|FG000|Overall Study|Withdrawal by Subject|1|||
94672995|NCT02173548|324255456|FG001|Overall Study|Withdrawal by Subject|0|||
94672996|NCT03751631|324255457|FG000|Overall Study|Withdrawal by Subject|0|||
94672997|NCT03751631|324255458|FG001|Overall Study|Withdrawal by Subject|0|||
94672998|NCT03751631|324255459|FG002|Overall Study|Withdrawal by Subject|1|||
94672999|NCT03751631|324255460|FG003|Overall Study|Withdrawal by Subject|1|||
94673000|NCT03751631|324255461|FG004|Overall Study|Withdrawal by Subject|0|||
94673001|NCT03751631|324255462|FG005|Overall Study|Withdrawal by Subject|0|||
94673002|NCT04517864|324255468|FG000|Placebo-Controlled Phase|Adverse Event|1|||
94673003|NCT04517864|324255469|FG001|Placebo-Controlled Phase|Adverse Event|0|||
94673004|NCT04517864|324255468|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
94673005|NCT04517864|324255469|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
94673006|NCT04517864|324255468|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
94673007|NCT04517864|324255469|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
94673008|NCT04517864|324255468|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
94673009|NCT04517864|324255469|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
94673010|NCT04517864|324255468|FG000|Active Therapy Extension Phase|Adverse Event|1|||
94673011|NCT04517864|324255469|FG001|Active Therapy Extension Phase|Adverse Event|0|||
94673012|NCT04517864|324255468|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
94673013|NCT04517864|324255469|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
94673014|NCT04517864|324255468|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
94673015|NCT04517864|324255469|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
94673016|NCT04517864|324255468|FG000|Active Therapy Extension Phase|Physician Decision|1|||
94673017|NCT04517864|324255469|FG001|Active Therapy Extension Phase|Physician Decision|0|||
94673018|NCT04517864|324255468|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
94673019|NCT04517864|324255469|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
94673020|NCT04517864|324255468|FG000|Active Therapy Extension Phase|44 participants in this row remained ongoing in the Active Therapy Extension Phase|20|||
94673021|NCT04517864|324255469|FG001|Active Therapy Extension Phase|44 participants in this row remained ongoing in the Active Therapy Extension Phase|24|||
94673022|NCT02690974|324255470|FG000|Overall Study|Adverse Event|16|||
94673023|NCT02690974|324255470|FG000|Overall Study|Death|9|||
94673024|NCT02690974|324255470|FG000|Overall Study|Subject/guardian decision|4|||
94673025|NCT02690974|324255470|FG000|Overall Study|Lost to Follow-up|3|||
94673026|NCT02690974|324255470|FG000|Overall Study|Withdrawal of Informed Consent|3|||
94673027|NCT02690974|324255470|FG000|Overall Study|Physician Decision|2|||
94673028|NCT02690974|324255470|FG000|Overall Study|Non-compliance with study treatment|1|||
94673029|NCT02690974|324255470|FG000|Overall Study|Protocol-defined stopping criteria|1|||
94673030|NCT02690974|324255470|FG000|Overall Study|Protocol Deviation|1|||
94673031|NCT01559844|324255474|FG000|Overall Study|Consent Withdrawn|7|||
94673032|NCT01559844|324255474|FG000|Overall Study|Death|5|||
94673033|NCT01559844|324255474|FG000|Overall Study|Efficacy Failure|10|||
94673034|NCT01559844|324255474|FG000|Overall Study|No Longer A Transplant Candidate|3|||
94673035|NCT02623322|324255475|FG000|Overall Study|Lost to Follow-up|2|||
94673036|NCT02623322|324255476|FG001|Overall Study|Lost to Follow-up|1|||
94673037|NCT02623322|324255477|FG002|Overall Study|Lost to Follow-up|0|||
94673038|NCT02052310|324255481|FG000|Overall Study|Death|64|||
94673039|NCT02052310|324255482|FG001|Overall Study|Death|54|||
94673040|NCT02052310|324255481|FG000|Overall Study|Withdrawal by Subject|37|||
94673041|NCT02052310|324255482|FG001|Overall Study|Withdrawal by Subject|49|||
94673042|NCT02052310|324255481|FG000|Overall Study|Other than specified|32|||
94673043|NCT02052310|324255482|FG001|Overall Study|Other than specified|29|||
94673044|NCT02052310|324255481|FG000|Overall Study|Adverse Event|29|||
94673045|NCT02052310|324255482|FG001|Overall Study|Adverse Event|22|||
94673046|NCT02052310|324255481|FG000|Overall Study|Kidney Transplant|23|||
94673047|NCT02052310|324255482|FG001|Overall Study|Kidney Transplant|29|||
94673048|NCT02052310|324255481|FG000|Overall Study|Physician Decision|14|||
94673049|NCT02052310|324255482|FG001|Overall Study|Physician Decision|7|||
94673050|NCT02052310|324255481|FG000|Overall Study|Lack of Efficacy|6|||
94673051|NCT02052310|324255482|FG001|Overall Study|Lack of Efficacy|1|||
94673052|NCT02052310|324255481|FG000|Overall Study|Site Terminated by Sponsor|5|||
94673053|NCT02052310|324255482|FG001|Overall Study|Site Terminated by Sponsor|13|||
94673054|NCT02052310|324255481|FG000|Overall Study|Lost to Follow-up|4|||
94673055|NCT02052310|324255482|FG001|Overall Study|Lost to Follow-up|2|||
94673056|NCT02052310|324255481|FG000|Overall Study|Protocol Violation|1|||
94673057|NCT02052310|324255482|FG001|Overall Study|Protocol Violation|6|||
94673058|NCT03813238|324255483|FG000|Overall Study|Adverse Event|0|||
94673059|NCT03813238|324255484|FG001|Overall Study|Adverse Event|6|||
94673060|NCT03813238|324255483|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94673061|NCT03813238|324255484|FG001|Overall Study|Withdrawal by parent/guardian|2|||
94673062|NCT03813238|324255483|FG000|Overall Study|Lost to Follow-up|0|||
94673063|NCT03813238|324255484|FG001|Overall Study|Lost to Follow-up|1|||
94673064|NCT03813238|324255483|FG000|Overall Study|Other than specified|1|||
94673065|NCT03813238|324255484|FG001|Overall Study|Other than specified|2|||
94673066|NCT00152464|324255485|FG000|Overall Study|Adverse Event|3|||
94673067|NCT00152464|324255486|FG001|Overall Study|Adverse Event|6|||
94673068|NCT00152464|324255485|FG000|Overall Study|Lost to Follow-up|8|||
94673069|NCT00152464|324255486|FG001|Overall Study|Lost to Follow-up|4|||
94673070|NCT00152464|324255485|FG000|Overall Study|Protocol Violation|3|||
94673071|NCT00152464|324255486|FG001|Overall Study|Protocol Violation|1|||
94673072|NCT00152464|324255485|FG000|Overall Study|Withdrawal by Subject|21|||
94673073|NCT00152464|324255486|FG001|Overall Study|Withdrawal by Subject|22|||
94673074|NCT00152464|324255485|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
94673075|NCT00152464|324255486|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
94673076|NCT00152464|324255485|FG000|Overall Study|Eczema deterioration|0|||
94673077|NCT00152464|324255486|FG001|Overall Study|Eczema deterioration|1|||
94673078|NCT00152464|324255485|FG000|Overall Study|Parent decision|1|||
94673079|NCT00152464|324255486|FG001|Overall Study|Parent decision|1|||
94673080|NCT00152464|324255485|FG000|Overall Study|Investigator decision|1|||
94673081|NCT00152464|324255486|FG001|Overall Study|Investigator decision|0|||
94673082|NCT00152464|324255485|FG000|Overall Study|Lack of Efficacy|1|||
94673083|NCT00152464|324255486|FG001|Overall Study|Lack of Efficacy|0|||
94673084|NCT00152464|324255485|FG000|Overall Study|Eczema poorly controlled|1|||
94673085|NCT00152464|324255486|FG001|Overall Study|Eczema poorly controlled|0|||
94673086|NCT00152464|324255485|FG000|Overall Study|Patient relocated|1|||
94673087|NCT00152464|324255486|FG001|Overall Study|Patient relocated|0|||
94673088|NCT03581981|324255490|FG000|Overall Study|Withdrawal by Subject|12|||
94673089|NCT03581981|324255491|FG001|Overall Study|Withdrawal by Subject|13|||
94673090|NCT03581981|324255490|FG000|Overall Study|Physician Decision|1|||
94673091|NCT03581981|324255491|FG001|Overall Study|Physician Decision|2|||
94673092|NCT03581981|324255490|FG000|Overall Study|Lost to Follow-up|0|||
94673093|NCT03581981|324255491|FG001|Overall Study|Lost to Follow-up|4|||
94673094|NCT02080871|324255492|FG000|Overall Study|Death|1|||
94673095|NCT02080871|324255492|FG000|Overall Study|Lost to Follow-up|1|||
94673096|NCT00234052|324255493|FG000|Treatment|Withdrawal by Subject|3|||
94673097|NCT00234052|324255493|FG000|Treatment|Adverse Event|5|||
94673098|NCT00234052|324255493|FG000|Treatment|Death|2|||
94673099|NCT00234052|324255493|FG000|Treatment|Progressive Disease|11|||
94673100|NCT00234052|324255493|FG000|Follow-up for 5 Years|Death|41|||
94673101|NCT00234052|324255493|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
94360186|NCT03522506|323101828|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
94360187|NCT03522506|323101829|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
94360188|NCT03522506|323101830|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
94673102|NCT00234052|324255493|FG000|Follow-up for 5 Years|Other|7|||
94673103|NCT01410474|324255494|FG000|Overall Study|Withdrawal by Subject|0|||
94673104|NCT01410474|324255495|FG001|Overall Study|Withdrawal by Subject|1|||
94673105|NCT04477187|324255496|FG000|Overall Study|Lost to Follow-up|2|||
94673106|NCT00863655|324255501|FG000|Overall Study|Protocol Violation|4|||
94673107|NCT00863655|324255502|FG001|Overall Study|Protocol Violation|0|||
94673108|NCT00863655|324255501|FG000|Overall Study|Adverse Event|52|||
94673109|NCT00863655|324255502|FG001|Overall Study|Adverse Event|8|||
94673110|NCT00863655|324255501|FG000|Overall Study|Withdrawal by Subject|47|||
94673111|NCT00863655|324255502|FG001|Overall Study|Withdrawal by Subject|7|||
94673112|NCT00863655|324255501|FG000|Overall Study|Administrative problems|1|||
94673113|NCT00863655|324255502|FG001|Overall Study|Administrative problems|0|||
94673114|NCT00863655|324255501|FG000|Overall Study|Death|7|||
94673115|NCT00863655|324255502|FG001|Overall Study|Death|1|||
94673116|NCT00863655|324255501|FG000|Overall Study|New cancer therapy|5|||
94673117|NCT00863655|324255502|FG001|Overall Study|New cancer therapy|1|||
94673118|NCT00863655|324255501|FG000|Overall Study|Disease progression|364|||
94673119|NCT00863655|324255502|FG001|Overall Study|Disease progression|221|||
94673120|NCT00863655|324255501|FG000|Overall Study|Treatment completed as per protocol|5|||
94673121|NCT00863655|324255502|FG001|Overall Study|Treatment completed as per protocol|1|||
94673122|NCT02157779|324255505|FG000|Overall Study|Logistical|9|||
94673123|NCT02157779|324255506|FG001|Overall Study|Logistical|3|||
94673124|NCT02157779|324255505|FG000|Overall Study|Stopped attending, reason unknown|11|||
94673125|NCT02157779|324255506|FG001|Overall Study|Stopped attending, reason unknown|7|||
94673126|NCT02157779|324255505|FG000|Overall Study|No response to outreach after Baseline|1|||
94673127|NCT02157779|324255506|FG001|Overall Study|No response to outreach after Baseline|1|||
94673128|NCT02157779|324255505|FG000|Overall Study|Moved|1|||
94673129|NCT02157779|324255506|FG001|Overall Study|Moved|0|||
94673130|NCT02157779|324255505|FG000|Overall Study|Medical|1|||
94673131|NCT02157779|324255506|FG001|Overall Study|Medical|0|||
94673132|NCT02157779|324255505|FG000|Overall Study|Legal issue|1|||
94673133|NCT02157779|324255506|FG001|Overall Study|Legal issue|0|||
94673134|NCT00917579|324255507|FG000|Washout >= 2 Weeks|Adverse Event|1|||
94673135|NCT00917579|324255508|FG001|Washout >= 2 Weeks|Adverse Event|0|||
94673136|NCT00917579|324255507|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
94673137|NCT00917579|324255508|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
94673138|NCT05763628|324255509|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
94673139|NCT05763628|324255510|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
94673140|NCT05763628|324255509|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
94673141|NCT05763628|324255510|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
94673142|NCT05763628|324255509|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
94673143|NCT05763628|324255510|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
94673144|NCT01137474|324255511|FG000|Overall Study|Adverse Event|3|||
94673145|NCT01137474|324255512|FG001|Overall Study|Adverse Event|5|||
94673146|NCT01137474|324255513|FG002|Overall Study|Adverse Event|1|||
94673147|NCT01137474|324255514|FG003|Overall Study|Adverse Event|3|||
94673148|NCT01137474|324255511|FG000|Overall Study|Withdrawal by Subject|7|||
94673149|NCT01137474|324255512|FG001|Overall Study|Withdrawal by Subject|2|||
94673150|NCT01137474|324255513|FG002|Overall Study|Withdrawal by Subject|6|||
94673151|NCT01137474|324255514|FG003|Overall Study|Withdrawal by Subject|9|||
94673152|NCT01137474|324255511|FG000|Overall Study|No longer met study criteria|6|||
94673153|NCT01137474|324255512|FG001|Overall Study|No longer met study criteria|1|||
94673154|NCT01137474|324255513|FG002|Overall Study|No longer met study criteria|0|||
94673155|NCT01137474|324255514|FG003|Overall Study|No longer met study criteria|5|||
94673156|NCT01137474|324255511|FG000|Overall Study|Lost to Follow-up|5|||
94673157|NCT01137474|324255512|FG001|Overall Study|Lost to Follow-up|1|||
94673158|NCT01137474|324255513|FG002|Overall Study|Lost to Follow-up|0|||
94673159|NCT01137474|324255514|FG003|Overall Study|Lost to Follow-up|2|||
94673160|NCT01137474|324255511|FG000|Overall Study|Lack of Efficacy|0|||
94673161|NCT01137474|324255512|FG001|Overall Study|Lack of Efficacy|0|||
94673162|NCT01137474|324255513|FG002|Overall Study|Lack of Efficacy|0|||
94673163|NCT01137474|324255514|FG003|Overall Study|Lack of Efficacy|2|||
94673164|NCT01137474|324255511|FG000|Overall Study|Other|3|||
94673165|NCT01137474|324255512|FG001|Overall Study|Other|1|||
94673166|NCT01137474|324255513|FG002|Overall Study|Other|0|||
94673167|NCT01137474|324255514|FG003|Overall Study|Other|0|||
94673168|NCT01137474|324255511|FG000|Overall Study|Pregnancy|0|||
94673169|NCT01137474|324255512|FG001|Overall Study|Pregnancy|1|||
94673170|NCT01137474|324255513|FG002|Overall Study|Pregnancy|0|||
94673171|NCT01137474|324255514|FG003|Overall Study|Pregnancy|0|||
94673172|NCT01137474|324255511|FG000|Overall Study|Administrative reason by sponsor|0|||
94673173|NCT01137474|324255512|FG001|Overall Study|Administrative reason by sponsor|1|||
94673174|NCT01137474|324255513|FG002|Overall Study|Administrative reason by sponsor|0|||
94673175|NCT01137474|324255514|FG003|Overall Study|Administrative reason by sponsor|0|||
94673176|NCT04385368|324255515|FG000|Overall Study|Death|5|||
94673177|NCT04385368|324255516|FG001|Overall Study|Death|5|||
94461256|NCT02954653|323478226|FG003|Overall Study|Started another anti-cancer therapy|0|||
94673178|NCT04385368|324255515|FG000|Overall Study|Physician Decision|3|||
94673179|NCT04385368|324255516|FG001|Overall Study|Physician Decision|0|||
94673180|NCT04385368|324255515|FG000|Overall Study|Withdrawal by Subject|4|||
94673181|NCT04385368|324255516|FG001|Overall Study|Withdrawal by Subject|3|||
94673182|NCT04495179|324255523|FG000|Overall Study|Lost to Follow-up|0|||
94673183|NCT04495179|324255524|FG001|Overall Study|Lost to Follow-up|1|||
94673184|NCT04495179|324255523|FG000|Overall Study|Withdrawal by Subject|2|||
94673185|NCT04495179|324255524|FG001|Overall Study|Withdrawal by Subject|4|||
94673186|NCT04495179|324255523|FG000|Overall Study|Study terminated by sponsor|0|||
94673187|NCT04495179|324255524|FG001|Overall Study|Study terminated by sponsor|18|||
94673188|NCT04495179|324255523|FG000|Overall Study|Death|0|||
94673189|NCT04495179|324255524|FG001|Overall Study|Death|4|||
94673190|NCT04495179|324255523|FG000|Overall Study|Adverse Event|0|||
94673191|NCT04495179|324255524|FG001|Overall Study|Adverse Event|1|||
94673192|NCT02477111|324255525|FG000|Overall Study|Death|28|||
94673193|NCT02477111|324255525|FG000|Overall Study|Withdrawal by Subject|19|||
94673194|NCT02477111|324255525|FG000|Overall Study|Lost to Follow-up|4|||
94673195|NCT00689221|324255526|FG000|Overall Study|Ongoing at cut-off date|39|||
94673196|NCT00689221|324255527|FG001|Overall Study|Ongoing at cut-off date|36|||
94673197|NCT01749982|324255528|FG000|Overall Study|Physician Decision|0|||
94673198|NCT01749982|324255529|FG001|Overall Study|Physician Decision|0|||
94673199|NCT01749982|324255530|FG002|Overall Study|Physician Decision|0|||
94673200|NCT01749982|324255531|FG003|Overall Study|Physician Decision|1|||
94673201|NCT01749982|324255528|FG000|Overall Study|Lost to Follow-up|0|||
94673202|NCT01749982|324255529|FG001|Overall Study|Lost to Follow-up|0|||
94673203|NCT01749982|324255530|FG002|Overall Study|Lost to Follow-up|0|||
94673204|NCT01749982|324255531|FG003|Overall Study|Lost to Follow-up|1|||
94673205|NCT01749982|324255528|FG000|Overall Study|Withdrawal by Subject|0|||
94673206|NCT01749982|324255529|FG001|Overall Study|Withdrawal by Subject|0|||
94673207|NCT01749982|324255530|FG002|Overall Study|Withdrawal by Subject|0|||
94673208|NCT01749982|324255531|FG003|Overall Study|Withdrawal by Subject|1|||
94673209|NCT02660827|324255532|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
94673210|NCT02660827|324255532|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
94673211|NCT02660827|324255532|FG000|From Study to End of Continued Access|Adverse Event|3|||
94673212|NCT02660827|324255532|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
94673213|NCT02660827|324255532|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
94673214|NCT02660827|324255532|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
94673215|NCT02660827|324255532|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
94673216|NCT02660827|324255532|FG000|Period 2: Continued Access Period|Adverse Event|3|||
94673217|NCT00584727|324255533|FG000|First Intervention|Discontinuation|0|||
94673218|NCT00584727|324255534|FG001|First Intervention|Discontinuation|0|||
94673219|NCT00584727|324255535|FG002|First Intervention|Discontinuation|1|||
94673220|NCT00584727|324255536|FG003|First Intervention|Discontinuation|0|||
94673221|NCT00584727|324255537|FG004|First Intervention|Discontinuation|0|||
94673222|NCT00584727|324255538|FG005|First Intervention|Discontinuation|0|||
94673223|NCT00584727|324255533|FG000|Third Intervention|Protocol Violation|0|||
94673224|NCT00584727|324255534|FG001|Third Intervention|Protocol Violation|0|||
94673225|NCT00584727|324255535|FG002|Third Intervention|Protocol Violation|1|||
94673226|NCT00584727|324255536|FG003|Third Intervention|Protocol Violation|0|||
94673227|NCT00584727|324255537|FG004|Third Intervention|Protocol Violation|4|||
94673228|NCT00584727|324255538|FG005|Third Intervention|Protocol Violation|2|||
94673229|NCT00862134|324255539|FG000|Overall Study|Death|1|||
94673230|NCT00862134|324255540|FG001|Overall Study|Death|0|||
94673231|NCT00862134|324255539|FG000|Overall Study|Physician Decision|0|||
94673232|NCT00862134|324255540|FG001|Overall Study|Physician Decision|1|||
94673233|NCT00862134|324255539|FG000|Overall Study|Withdrawal by Subject|1|||
94673234|NCT00862134|324255540|FG001|Overall Study|Withdrawal by Subject|2|||
94673235|NCT00862134|324255539|FG000|Overall Study|Sponsor terminated study|5|||
94673236|NCT00862134|324255540|FG001|Overall Study|Sponsor terminated study|7|||
94673237|NCT00862134|324255539|FG000|Overall Study|Adverse Event|2|||
94673238|NCT00862134|324255540|FG001|Overall Study|Adverse Event|2|||
94673239|NCT00862134|324255539|FG000|Overall Study|Withdrew prior to dosing|2|||
94673240|NCT00862134|324255540|FG001|Overall Study|Withdrew prior to dosing|0|||
94673241|NCT03311373|324255544|FG000|Overall Study|Adverse Event|1|||
94673242|NCT03311373|324255544|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
94673243|NCT03311373|324255544|FG000|Overall Study|Lost to Follow-up|1|||
94673244|NCT03311373|324255544|FG000|Overall Study|Physician Decision|1|||
94673245|NCT03311373|324255544|FG000|Overall Study|Withdrawal by Subject|3|||
94673246|NCT00567190|324255546|FG000|Overall Study|Death|235|||
94673247|NCT00567190|324255547|FG001|Overall Study|Death|280|||
94673248|NCT00567190|324255546|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
94360189|NCT03522506|323101827|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
94673249|NCT00567190|324255547|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
94673250|NCT00698646|324255548|FG000|Overall Study|Adverse Event|8|||
94673251|NCT00698646|324255549|FG001|Overall Study|Adverse Event|7|||
94673252|NCT00698646|324255550|FG002|Overall Study|Adverse Event|8|||
94673253|NCT00698646|324255548|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
94673254|NCT00698646|324255549|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
94673255|NCT00698646|324255550|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
94673256|NCT00698646|324255548|FG000|Overall Study|Protocol Deviation|6|||
94673257|NCT00698646|324255549|FG001|Overall Study|Protocol Deviation|2|||
94673258|NCT00698646|324255550|FG002|Overall Study|Protocol Deviation|3|||
94673259|NCT00698646|324255548|FG000|Overall Study|Withdrawal by Subject|10|||
94360190|NCT03522506|323101828|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
94626722|NCT02573311|324090236|FG000|Disposition for Part 2|Lost to Follow-up|76|||
94626723|NCT02573311|324090237|FG001|Disposition for Part 2|Lost to Follow-up|7|||
94626724|NCT02573311|324090236|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
94626725|NCT02573311|324090237|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
94626726|NCT02573311|324090236|FG000|Disposition for Part 2|Investigator decision|0|||
94626727|NCT02573311|324090237|FG001|Disposition for Part 2|Investigator decision|1|||
94626728|NCT02573311|324090236|FG000|Disposition for Part 2|Other than specified above|13|||
94626729|NCT02573311|324090237|FG001|Disposition for Part 2|Other than specified above|3|||
94626730|NCT00519831|324090243|FG000|Overall Study|Adverse Event|3|||
94626731|NCT02854631|324090244|FG000|Overall Study|Adverse Event|1|||
94626732|NCT02854631|324090245|FG001|Overall Study|Adverse Event|2|||
94626733|NCT02854631|324090244|FG000|Overall Study|Withdrew Consent|3|||
94626734|NCT02854631|324090245|FG001|Overall Study|Withdrew Consent|2|||
94626735|NCT02854631|324090244|FG000|Overall Study|Investigator's Discretion|2|||
94626736|NCT02854631|324090245|FG001|Overall Study|Investigator's Discretion|0|||
94626737|NCT02854631|324090244|FG000|Overall Study|Death|12|||
94626738|NCT02854631|324090245|FG001|Overall Study|Death|8|||
94626739|NCT02854631|324090244|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
94626740|NCT02854631|324090245|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
94626741|NCT02854631|324090244|FG000|Overall Study|Protocol Violation|0|||
94626742|NCT02854631|324090245|FG001|Overall Study|Protocol Violation|1|||
94626743|NCT02854631|324090244|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
94626744|NCT02854631|324090245|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
94626745|NCT02854631|324090244|FG000|Overall Study|Lost to Follow-up|4|||
94626746|NCT02854631|324090245|FG001|Overall Study|Lost to Follow-up|2|||
94626747|NCT01411774|324091733|FG000|Overall Study|Withdrawal by Subject|0|||
94626748|NCT01411774|324091734|FG001|Overall Study|Withdrawal by Subject|3|||
94626749|NCT02990910|324091745|FG000|Overall Study|Lack of Efficacy|6|||
94626750|NCT02990910|324091746|FG001|Overall Study|Lack of Efficacy|10|||
94626751|NCT01315678|324091751|FG000|Overall Study|Withdrawal by Subject|7|||
94626752|NCT01315678|324091752|FG001|Overall Study|Withdrawal by Subject|3|||
94626753|NCT01315678|324091751|FG000|Overall Study|Adverse Event|3|||
94626754|NCT01315678|324091752|FG001|Overall Study|Adverse Event|1|||
94626755|NCT01315678|324091751|FG000|Overall Study|Lost to Follow-up|1|||
94626756|NCT01315678|324091752|FG001|Overall Study|Lost to Follow-up|0|||
94626757|NCT01315678|324091751|FG000|Overall Study|similar reason to those listed above|3|||
94626758|NCT01315678|324091752|FG001|Overall Study|similar reason to those listed above|2|||
94626759|NCT00331682|324091756|FG000|Overall Study|Adverse Event|1|||
94626760|NCT02468414|324091761|FG000|Overall Study|Early Study Termination by Sponsor|1|||
94626761|NCT02468414|324091762|FG001|Overall Study|Early Study Termination by Sponsor|0|||
94626762|NCT02468414|324091761|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
94626763|NCT02468414|324091762|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
94626764|NCT02468414|324091761|FG000|Overall Study|Screen Failure|1|||
94626765|NCT02468414|324091762|FG001|Overall Study|Screen Failure|0|||
94626766|NCT00573469|324091763|FG000|Overall Study|Adverse Event|1|||
94626767|NCT00573469|324091764|FG001|Overall Study|Adverse Event|1|||
94626768|NCT00573469|324091765|FG002|Overall Study|Adverse Event|1|||
94626769|NCT00573469|324091763|FG000|Overall Study|Withdrawal by Subject|0|||
94626770|NCT00573469|324091764|FG001|Overall Study|Withdrawal by Subject|2|||
94626771|NCT00573469|324091765|FG002|Overall Study|Withdrawal by Subject|0|||
94626772|NCT00573469|324091763|FG000|Overall Study|Other|5|||
94626773|NCT00573469|324091764|FG001|Overall Study|Other|1|||
94626774|NCT00573469|324091765|FG002|Overall Study|Other|3|||
94626775|NCT02989194|324091766|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
94626776|NCT02989194|324091767|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
94626777|NCT02989194|324091768|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
94626778|NCT02989194|324091766|FG000|Overall Study|Lost to Follow-up|0|||
94626779|NCT02989194|324091767|FG001|Overall Study|Lost to Follow-up|1|||
94626780|NCT02989194|324091768|FG002|Overall Study|Lost to Follow-up|0|||
94626781|NCT02989194|324091766|FG000|Overall Study|Withdrawal by Subject|0|||
94626782|NCT02989194|324091767|FG001|Overall Study|Withdrawal by Subject|1|||
94626783|NCT02989194|324091768|FG002|Overall Study|Withdrawal by Subject|0|||
94626784|NCT02670083|324091774|FG000|Overall Study|Adverse Event|16|||
94626785|NCT02670083|324091775|FG001|Overall Study|Adverse Event|13|||
94626786|NCT02670083|324091774|FG000|Overall Study|Death|4|||
94626787|NCT02670083|324091775|FG001|Overall Study|Death|6|||
94626788|NCT02670083|324091774|FG000|Overall Study|Lost to Follow-up|2|||
94626789|NCT02670083|324091775|FG001|Overall Study|Lost to Follow-up|2|||
94626790|NCT02670083|324091774|FG000|Overall Study|Multiple Reasons|9|||
94626791|NCT02670083|324091775|FG001|Overall Study|Multiple Reasons|9|||
94626792|NCT02670083|324091774|FG000|Overall Study|Physician Decision|0|||
94626793|NCT02670083|324091775|FG001|Overall Study|Physician Decision|2|||
94626794|NCT02670083|324091774|FG000|Overall Study|Study Terminated By Sponsor|257|||
94626795|NCT02670083|324091775|FG001|Overall Study|Study Terminated By Sponsor|254|||
94626796|NCT02670083|324091774|FG000|Overall Study|Symptomatic Deterioration|0|||
94626797|NCT02670083|324091775|FG001|Overall Study|Symptomatic Deterioration|2|||
94626798|NCT02670083|324091774|FG000|Overall Study|Withdrawal by Subject|32|||
94626799|NCT02670083|324091775|FG001|Overall Study|Withdrawal by Subject|31|||
94626800|NCT02670083|324091774|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94626801|NCT02670083|324091775|FG001|Overall Study|Non-Compliance With Study Drug|0|||
94626802|NCT02014597|324091776|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
94626803|NCT02014597|324091777|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
94626804|NCT02155608|324091778|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
94626805|NCT02155608|324091779|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
94626806|NCT02155608|324091778|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
94626807|NCT02155608|324091779|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
94626808|NCT03555591|324091780|FG000|Overall Study|Protocol Violation|77|||
94626809|NCT01549860|324091781|FG000|Overall Study|Withdrawal by Subject|1|||
94626810|NCT01549860|324091782|FG001|Overall Study|Withdrawal by Subject|0|||
94626811|NCT01549860|324091781|FG000|Overall Study|Physician Decision|1|||
94626812|NCT01549860|324091782|FG001|Overall Study|Physician Decision|1|||
94626813|NCT00660023|324091784|FG000|Overall Study|Adverse Event|2|||
94626814|NCT00660023|324091784|FG000|Overall Study|Death|8|||
94626815|NCT00660023|324091784|FG000|Overall Study|Blood Transfusion|5|||
94626816|NCT00660023|324091784|FG000|Overall Study|Renal Transplantation|3|||
94626817|NCT00660023|324091784|FG000|Overall Study|Withdrawal by Subject|1|||
94626818|NCT00660023|324091784|FG000|Overall Study|Missed Pregnancy Test|1|||
94626819|NCT00660023|324091784|FG000|Overall Study|Other Screening Failure|9|||
94626820|NCT02430311|324091785|FG000|Part A|Adverse Event|0|||
94626821|NCT02430311|324091786|FG001|Part A|Adverse Event|1|||
94626822|NCT02430311|324091785|FG000|Part A|Withdrawal by Subject|1|||
94626823|NCT02430311|324091786|FG001|Part A|Withdrawal by Subject|0|||
94626824|NCT02430311|324091785|FG000|Part B|Meet study-specific withdrawal criteria|6|||
94626825|NCT02430311|324091786|FG001|Part B|Meet study-specific withdrawal criteria|6|||
94626826|NCT02430311|324091785|FG000|Part B|Withdrawal by Subject|2|||
94626827|NCT02430311|324091786|FG001|Part B|Withdrawal by Subject|2|||
94626828|NCT02430311|324091785|FG000|Part B|Adverse Event|1|||
94626829|NCT02430311|324091786|FG001|Part B|Adverse Event|0|||
94673260|NCT00698646|324255549|FG001|Overall Study|Withdrawal by Subject|11|||
94673261|NCT00698646|324255550|FG002|Overall Study|Withdrawal by Subject|8|||
94673262|NCT00698646|324255548|FG000|Overall Study|Lost to Follow-up|0|||
94673263|NCT00698646|324255549|FG001|Overall Study|Lost to Follow-up|0|||
94673264|NCT00698646|324255550|FG002|Overall Study|Lost to Follow-up|2|||
94673265|NCT00698646|324255548|FG000|Overall Study|Administrative problems|1|||
94673266|NCT00698646|324255549|FG001|Overall Study|Administrative problems|0|||
94673267|NCT00698646|324255550|FG002|Overall Study|Administrative problems|1|||
94673268|NCT02495025|324255551|FG000|Overall Study|Lost to Follow-up|21|||
94673269|NCT02495025|324255552|FG001|Overall Study|Lost to Follow-up|14|||
94673270|NCT02495025|324255551|FG000|Overall Study|Withdrawal by Subject|5|||
94673271|NCT02495025|324255552|FG001|Overall Study|Withdrawal by Subject|0|||
94673272|NCT00313820|324255553|FG000|Assigned to Treatment|Other|1|||
94673273|NCT00313820|324255554|FG001|Assigned to Treatment|Other|0|||
94673274|NCT00313820|324255553|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
94673275|NCT00313820|324255554|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
94673276|NCT00313820|324255553|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
94673277|NCT00313820|324255554|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
94673278|NCT00313820|324255553|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
94673279|NCT00313820|324255554|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
94673280|NCT00313820|324255553|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
94673281|NCT00313820|324255554|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
94673282|NCT00313820|324255553|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
94673283|NCT00313820|324255554|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
94673284|NCT02747238|324255555|FG000|Overall Study|Lack of Efficacy|0|||
94673285|NCT02747238|324255556|FG001|Overall Study|Lack of Efficacy|1|||
94673286|NCT02747238|324255555|FG000|Overall Study|Data lost|3|||
94673287|NCT02747238|324255556|FG001|Overall Study|Data lost|5|||
94673288|NCT02085252|324255557|FG000|Overall Study|Withdrawal of Consent|1|||
94673289|NCT02085252|324255558|FG001|Overall Study|Withdrawal of Consent|0|||
94673290|NCT02085252|324255557|FG000|Overall Study|Adverse Event|0|||
94673291|NCT02085252|324255558|FG001|Overall Study|Adverse Event|1|||
94673292|NCT02085252|324255557|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
94673293|NCT02085252|324255558|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
94673294|NCT02085252|324255557|FG000|Overall Study|Reason Not Specified|0|||
94673295|NCT02085252|324255558|FG001|Overall Study|Reason Not Specified|1|||
94673296|NCT02085252|324255557|FG000|Overall Study|Reason Unknown|0|||
94673297|NCT02085252|324255558|FG001|Overall Study|Reason Unknown|1|||
94673298|NCT00951275|324255559|FG000|Overall Study|Administrative Reason|1|||
94673299|NCT00951275|324255559|FG000|Overall Study|Adverse Event|7|||
94673300|NCT00951275|324255559|FG000|Overall Study|Withdrawal by Subject|4|||
94673301|NCT00951275|324255559|FG000|Overall Study|Protocol Violation|1|||
94673302|NCT01169675|324255560|FG000|Overall Study|Progressive disease|13|||
94673303|NCT01169675|324255561|FG001|Overall Study|Progressive disease|2|||
94673304|NCT01169675|324255562|FG002|Overall Study|Progressive disease|5|||
94673305|NCT01169675|324255563|FG003|Overall Study|Progressive disease|15|||
94673306|NCT01169675|324255564|FG004|Overall Study|Progressive disease|1|||
94673307|NCT01169675|324255560|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
94673308|NCT01169675|324255561|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94673309|NCT01169675|324255562|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94673310|NCT01169675|324255563|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94673311|NCT01169675|324255564|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
94673312|NCT01169675|324255560|FG000|Overall Study|Adverse Event|5|||
94673313|NCT01169675|324255561|FG001|Overall Study|Adverse Event|1|||
94673314|NCT01169675|324255562|FG002|Overall Study|Adverse Event|2|||
94673315|NCT01169675|324255563|FG003|Overall Study|Adverse Event|0|||
94673316|NCT01169675|324255564|FG004|Overall Study|Adverse Event|0|||
94673317|NCT01169675|324255560|FG000|Overall Study|Withdrawal by Subject|1|||
94673318|NCT01169675|324255561|FG001|Overall Study|Withdrawal by Subject|0|||
94673319|NCT01169675|324255562|FG002|Overall Study|Withdrawal by Subject|0|||
94673320|NCT01169675|324255563|FG003|Overall Study|Withdrawal by Subject|1|||
94673321|NCT01169675|324255564|FG004|Overall Study|Withdrawal by Subject|2|||
94673322|NCT01169675|324255560|FG000|Overall Study|Other Reason Not Defined Above|0|||
94673323|NCT01169675|324255561|FG001|Overall Study|Other Reason Not Defined Above|0|||
94673324|NCT01169675|324255562|FG002|Overall Study|Other Reason Not Defined Above|0|||
94673325|NCT01169675|324255563|FG003|Overall Study|Other Reason Not Defined Above|1|||
94673326|NCT01169675|324255564|FG004|Overall Study|Other Reason Not Defined Above|1|||
94673327|NCT04839965|324255565|FG000|Overall Study|Death|6|||
94673328|NCT04839965|324255566|FG001|Overall Study|Death|6|||
94673329|NCT04839965|324255565|FG000|Overall Study|Lost to Follow-up|1|||
94673330|NCT04839965|324255566|FG001|Overall Study|Lost to Follow-up|0|||
94673331|NCT00981084|324255567|FG000|Post Intervention (Data Analysis)|poor effort|1|||
94673332|NCT00981084|324255568|FG001|Post Intervention (Data Analysis)|poor effort|1|||
94461257|NCT02954653|323478227|FG004|Overall Study|Started another anti-cancer therapy|0|||
94673333|NCT00981084|324255567|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
94673334|NCT00981084|324255568|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
94673335|NCT03645759|324255569|FG000|Overall Study|Lost to Follow-up|3|||
94673336|NCT03645759|324255570|FG001|Overall Study|Lost to Follow-up|2|||
94673337|NCT01951625|324255575|FG000|Treatment Period|Protocol Violation|2|||
94673338|NCT01951625|324255576|FG001|Treatment Period|Protocol Violation|0|||
94673339|NCT01951625|324255577|FG002|Treatment Period|Protocol Violation|1|||
94673340|NCT01951625|324255578|FG003|Treatment Period|Protocol Violation|3|||
94673341|NCT01951625|324255579|FG004|Treatment Period|Protocol Violation|2|||
94673342|NCT01951625|324255575|FG000|Treatment Period|Physician Decision|0|||
94673343|NCT01951625|324255576|FG001|Treatment Period|Physician Decision|0|||
94673344|NCT01951625|324255577|FG002|Treatment Period|Physician Decision|0|||
94673345|NCT01951625|324255578|FG003|Treatment Period|Physician Decision|0|||
94673346|NCT01951625|324255579|FG004|Treatment Period|Physician Decision|1|||
94673347|NCT01951625|324255575|FG000|Treatment Period|Protocol driven decision point|0|||
94673348|NCT01951625|324255576|FG001|Treatment Period|Protocol driven decision point|5|||
94673349|NCT01951625|324255577|FG002|Treatment Period|Protocol driven decision point|0|||
94673350|NCT01951625|324255578|FG003|Treatment Period|Protocol driven decision point|2|||
94673351|NCT01951625|324255579|FG004|Treatment Period|Protocol driven decision point|1|||
94673352|NCT01951625|324255575|FG000|Treatment Period|Non compliance with study drug|1|||
94673353|NCT01951625|324255576|FG001|Treatment Period|Non compliance with study drug|2|||
94673354|NCT01951625|324255577|FG002|Treatment Period|Non compliance with study drug|2|||
94673355|NCT01951625|324255578|FG003|Treatment Period|Non compliance with study drug|0|||
94673356|NCT01951625|324255579|FG004|Treatment Period|Non compliance with study drug|0|||
94673357|NCT01951625|324255575|FG000|Treatment Period|Death|3|||
94673358|NCT01951625|324255576|FG001|Treatment Period|Death|2|||
94673359|NCT01951625|324255577|FG002|Treatment Period|Death|2|||
94673360|NCT01951625|324255578|FG003|Treatment Period|Death|1|||
94673361|NCT01951625|324255579|FG004|Treatment Period|Death|2|||
94673362|NCT01951625|324255575|FG000|Treatment Period|Adverse Event|7|||
94673363|NCT01951625|324255576|FG001|Treatment Period|Adverse Event|10|||
94673364|NCT01951625|324255577|FG002|Treatment Period|Adverse Event|9|||
94673365|NCT01951625|324255578|FG003|Treatment Period|Adverse Event|8|||
94673366|NCT01951625|324255579|FG004|Treatment Period|Adverse Event|8|||
94673367|NCT01951625|324255575|FG000|Treatment Period|Withdrawal by Subject|5|||
94673368|NCT01951625|324255576|FG001|Treatment Period|Withdrawal by Subject|2|||
94673369|NCT01951625|324255577|FG002|Treatment Period|Withdrawal by Subject|1|||
94673370|NCT01951625|324255578|FG003|Treatment Period|Withdrawal by Subject|7|||
94673371|NCT01951625|324255579|FG004|Treatment Period|Withdrawal by Subject|3|||
94673372|NCT01951625|324255575|FG000|Treatment Period|Lost to Follow-up|1|||
94673373|NCT01951625|324255576|FG001|Treatment Period|Lost to Follow-up|0|||
94673374|NCT01951625|324255577|FG002|Treatment Period|Lost to Follow-up|0|||
94673375|NCT01951625|324255578|FG003|Treatment Period|Lost to Follow-up|1|||
94673376|NCT01951625|324255579|FG004|Treatment Period|Lost to Follow-up|0|||
94673377|NCT01951625|324255575|FG000|Follow Up Period|Non-compliance with study drug|1|||
94673378|NCT01951625|324255576|FG001|Follow Up Period|Non-compliance with study drug|0|||
94673379|NCT01951625|324255577|FG002|Follow Up Period|Non-compliance with study drug|0|||
94673380|NCT01951625|324255578|FG003|Follow Up Period|Non-compliance with study drug|0|||
94673381|NCT01951625|324255579|FG004|Follow Up Period|Non-compliance with study drug|0|||
94673382|NCT01951625|324255575|FG000|Follow Up Period|Death|1|||
94673383|NCT01951625|324255576|FG001|Follow Up Period|Death|3|||
94673384|NCT01951625|324255577|FG002|Follow Up Period|Death|2|||
94673385|NCT01951625|324255578|FG003|Follow Up Period|Death|2|||
94673386|NCT01951625|324255579|FG004|Follow Up Period|Death|1|||
94673387|NCT01951625|324255575|FG000|Follow Up Period|Logistical difficulties|1|||
94673388|NCT01951625|324255576|FG001|Follow Up Period|Logistical difficulties|2|||
94673389|NCT01951625|324255577|FG002|Follow Up Period|Logistical difficulties|0|||
94673390|NCT01951625|324255578|FG003|Follow Up Period|Logistical difficulties|0|||
94673391|NCT01951625|324255579|FG004|Follow Up Period|Logistical difficulties|0|||
94673392|NCT01951625|324255575|FG000|Follow Up Period|Adverse Event|0|||
94673393|NCT01951625|324255576|FG001|Follow Up Period|Adverse Event|3|||
94673394|NCT01951625|324255577|FG002|Follow Up Period|Adverse Event|2|||
94673395|NCT01951625|324255578|FG003|Follow Up Period|Adverse Event|3|||
94673396|NCT01951625|324255579|FG004|Follow Up Period|Adverse Event|5|||
94673397|NCT01951625|324255575|FG000|Follow Up Period|Withdrawal by Subject|4|||
94673398|NCT01951625|324255576|FG001|Follow Up Period|Withdrawal by Subject|1|||
94673399|NCT01951625|324255577|FG002|Follow Up Period|Withdrawal by Subject|0|||
94673400|NCT01951625|324255578|FG003|Follow Up Period|Withdrawal by Subject|5|||
94673401|NCT01951625|324255579|FG004|Follow Up Period|Withdrawal by Subject|3|||
94673402|NCT01951625|324255575|FG000|Follow Up Period|Lost to Follow-up|1|||
94673403|NCT01951625|324255576|FG001|Follow Up Period|Lost to Follow-up|0|||
94673404|NCT01951625|324255577|FG002|Follow Up Period|Lost to Follow-up|0|||
94673405|NCT01951625|324255578|FG003|Follow Up Period|Lost to Follow-up|1|||
94673406|NCT01951625|324255579|FG004|Follow Up Period|Lost to Follow-up|1|||
94673407|NCT03053050|324255580|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
94673408|NCT03053050|324255581|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
94673409|NCT03053050|324255582|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
94673410|NCT03053050|324255583|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
94673411|NCT03053050|324255580|FG000|Randomized Phase|Withdrew Consent|16|||
94673412|NCT03053050|324255581|FG001|Randomized Phase|Withdrew Consent|8|||
94673413|NCT03053050|324255582|FG002|Randomized Phase|Withdrew Consent|9|||
94673414|NCT03053050|324255583|FG003|Randomized Phase|Withdrew Consent|0|||
94673415|NCT03053050|324255580|FG000|Randomized Phase|Investigator's Discretion|6|||
94673416|NCT03053050|324255581|FG001|Randomized Phase|Investigator's Discretion|6|||
94673417|NCT03053050|324255582|FG002|Randomized Phase|Investigator's Discretion|3|||
94673418|NCT03053050|324255583|FG003|Randomized Phase|Investigator's Discretion|0|||
94673419|NCT03053050|324255580|FG000|Randomized Phase|Lost to Follow-up|5|||
94673420|NCT03053050|324255581|FG001|Randomized Phase|Lost to Follow-up|1|||
94673421|NCT03053050|324255582|FG002|Randomized Phase|Lost to Follow-up|1|||
94673422|NCT03053050|324255583|FG003|Randomized Phase|Lost to Follow-up|0|||
94673423|NCT03053050|324255580|FG000|Randomized Phase|Adverse Event|0|||
94673424|NCT03053050|324255581|FG001|Randomized Phase|Adverse Event|1|||
94673425|NCT03053050|324255582|FG002|Randomized Phase|Adverse Event|0|||
94673426|NCT03053050|324255583|FG003|Randomized Phase|Adverse Event|0|||
94673427|NCT03053050|324255580|FG000|Randomized Phase|Randomized but Never Treated|2|||
94673428|NCT03053050|324255581|FG001|Randomized Phase|Randomized but Never Treated|2|||
94673429|NCT03053050|324255582|FG002|Randomized Phase|Randomized but Never Treated|2|||
94673430|NCT03053050|324255583|FG003|Randomized Phase|Randomized but Never Treated|0|||
94673431|NCT03053050|324255580|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
94673432|NCT03053050|324255581|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
94673433|NCT03053050|324255582|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
94673434|NCT03053050|324255583|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
94673435|NCT03053050|324255580|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
94673436|NCT03053050|324255581|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
94673437|NCT03053050|324255582|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
94673438|NCT03053050|324255583|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
94673439|NCT03053050|324255580|FG000|Open-label Phase|Withdrew Consent|0|||
94673440|NCT03053050|324255581|FG001|Open-label Phase|Withdrew Consent|0|||
94673441|NCT03053050|324255582|FG002|Open-label Phase|Withdrew Consent|0|||
94673442|NCT03053050|324255583|FG003|Open-label Phase|Withdrew Consent|6|||
94673443|NCT03053050|324255580|FG000|Open-label Phase|Investigator's Discretion|0|||
94673444|NCT03053050|324255581|FG001|Open-label Phase|Investigator's Discretion|0|||
94673445|NCT03053050|324255582|FG002|Open-label Phase|Investigator's Discretion|0|||
94673446|NCT03053050|324255583|FG003|Open-label Phase|Investigator's Discretion|4|||
94673447|NCT03703466|324255584|FG000|Overall Study|Death|2|||
94673448|NCT03703466|324255585|FG001|Overall Study|Death|1|||
94673449|NCT03703466|324255586|FG002|Overall Study|Death|0|||
94673450|NCT03703466|324255584|FG000|Overall Study|Withdrawal by Subject|0|||
94673451|NCT03703466|324255585|FG001|Overall Study|Withdrawal by Subject|3|||
94673452|NCT03703466|324255586|FG002|Overall Study|Withdrawal by Subject|0|||
94673453|NCT03703466|324255584|FG000|Overall Study|Completed < 3 Cycles|2|||
94673454|NCT03703466|324255585|FG001|Overall Study|Completed < 3 Cycles|2|||
94673455|NCT03703466|324255586|FG002|Overall Study|Completed < 3 Cycles|2|||
94673456|NCT05073133|324255587|FG000|Overall Study|Death|2|||
94673457|NCT02412137|324255588|FG000|Overall Study|Withdrawal by Subject|2|||
94673458|NCT02412137|324255589|FG001|Overall Study|Withdrawal by Subject|0|||
94673459|NCT02412137|324255588|FG000|Overall Study|Lost to Follow-up|21|||
94673460|NCT02412137|324255589|FG001|Overall Study|Lost to Follow-up|14|||
94673461|NCT02412137|324255588|FG000|Overall Study|Physician Decision|28|||
94673462|NCT02412137|324255589|FG001|Overall Study|Physician Decision|9|||
94673463|NCT01986881|324257660|FG000|Overall Study|Death|228|||
94673464|NCT01986881|324257661|FG001|Overall Study|Death|233|||
94673465|NCT01986881|324257662|FG002|Overall Study|Death|247|||
94673466|NCT01986881|324257660|FG000|Overall Study|Lost to Follow-up|51|||
94673467|NCT01986881|324257661|FG001|Overall Study|Lost to Follow-up|44|||
94673468|NCT01986881|324257662|FG002|Overall Study|Lost to Follow-up|55|||
94673469|NCT01986881|324257660|FG000|Overall Study|Physician Decision|7|||
94673470|NCT01986881|324257661|FG001|Overall Study|Physician Decision|4|||
94673471|NCT01986881|324257662|FG002|Overall Study|Physician Decision|6|||
94673472|NCT01986881|324257660|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
94673473|NCT01986881|324257661|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
94673474|NCT01986881|324257662|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
94673475|NCT01986881|324257660|FG000|Overall Study|Withdrawal by Subject|41|||
94673476|NCT01986881|324257661|FG001|Overall Study|Withdrawal by Subject|60|||
94673477|NCT01986881|324257662|FG002|Overall Study|Withdrawal by Subject|45|||
94673478|NCT01986881|324257660|FG000|Overall Study|Subject Moved|0|||
94673479|NCT01986881|324257661|FG001|Overall Study|Subject Moved|1|||
94673480|NCT01986881|324257662|FG002|Overall Study|Subject Moved|0|||
94673481|NCT01986881|324257660|FG000|Overall Study|Other|1|||
94673482|NCT01986881|324257661|FG001|Overall Study|Other|2|||
94673483|NCT01986881|324257662|FG002|Overall Study|Other|2|||
94673484|NCT02979639|324257663|FG000|Overall Study|Withdrawal based on medical judgement|1|||
94673485|NCT02979639|324257663|FG000|Overall Study|Lost to Follow-up|8|||
94673486|NCT02979639|324257663|FG000|Overall Study|Withdrawal by Subject|3|||
94673487|NCT02979639|324257663|FG000|Overall Study|Adverse Event|2|||
94673488|NCT03597568|324257678|FG000|Overall Study|Withdrawal by Subject|1|||
94673489|NCT03597568|324257679|FG001|Overall Study|Withdrawal by Subject|1|||
94673490|NCT03597568|324257678|FG000|Overall Study|Unable to analyze vascular data|1|||
94673491|NCT03597568|324257679|FG001|Overall Study|Unable to analyze vascular data|1|||
94673492|NCT04279314|324257680|FG000|Overall Study|Adverse Event|55|||
94673493|NCT04279314|324257680|FG000|Overall Study|Withdrawal by Subject|5|||
94673494|NCT04279314|324257680|FG000|Overall Study|Lack of Efficacy|5|||
94673495|NCT04279314|324257680|FG000|Overall Study|Protocol Violation|3|||
94673496|NCT04279314|324257680|FG000|Overall Study|Other (not COVID-19 related)|2|||
94673497|NCT00499031|324257683|FG000|Overall Study|Improper pre-protocol treatment|1|||
94673498|NCT00499031|324257683|FG000|Overall Study|Required test not done|1|||
94673499|NCT00499031|324257683|FG000|Overall Study|Never treated|1|||
94673500|NCT01357616|324257684|FG000|Overall Study|Adverse Event|1|||
94673501|NCT01357616|324257685|FG001|Overall Study|Adverse Event|1|||
94673502|NCT01357616|324257684|FG000|Overall Study|Lost to Follow-up|4|||
94673503|NCT01357616|324257685|FG001|Overall Study|Lost to Follow-up|3|||
94673504|NCT01357616|324257684|FG000|Overall Study|Protocol Violation|0|||
94673505|NCT01357616|324257685|FG001|Overall Study|Protocol Violation|2|||
94673506|NCT01357616|324257684|FG000|Overall Study|Inadequate Control of IOP|1|||
94673507|NCT01357616|324257685|FG001|Overall Study|Inadequate Control of IOP|2|||
94673508|NCT01357616|324257684|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
94673509|NCT01357616|324257685|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
94673510|NCT01357616|324257684|FG000|Overall Study|Withdrawal by Subject|1|||
94673511|NCT01357616|324257685|FG001|Overall Study|Withdrawal by Subject|0|||
94673512|NCT00677833|324257686|FG000|Overall Study|Withdrawal by Subject|4|||
94673513|NCT00677833|324257687|FG001|Overall Study|Withdrawal by Subject|0|||
94673514|NCT00677833|324257688|FG002|Overall Study|Withdrawal by Subject|1|||
94673515|NCT00677833|324257689|FG003|Overall Study|Withdrawal by Subject|3|||
94673516|NCT00677833|324257686|FG000|Overall Study|Lost to Follow-up|0|||
94673517|NCT00677833|324257687|FG001|Overall Study|Lost to Follow-up|0|||
94673518|NCT00677833|324257688|FG002|Overall Study|Lost to Follow-up|1|||
94673519|NCT00677833|324257689|FG003|Overall Study|Lost to Follow-up|0|||
94673520|NCT00620750|324257690|FG000|Overall Study|Lost to Follow-up|25|||
94673521|NCT00430248|324257693|FG000|Overall Study|Adverse Event|49|||
94673522|NCT00430248|324257694|FG001|Overall Study|Adverse Event|61|||
94673523|NCT00430248|324257695|FG002|Overall Study|Adverse Event|64|||
94673524|NCT00430248|324257693|FG000|Overall Study|Protocol Violation|10|||
94673525|NCT00430248|324257694|FG001|Overall Study|Protocol Violation|2|||
94673526|NCT00430248|324257695|FG002|Overall Study|Protocol Violation|4|||
94673527|NCT00430248|324257693|FG000|Overall Study|Personal Reasons|12|||
94673528|NCT00430248|324257694|FG001|Overall Study|Personal Reasons|24|||
94673529|NCT00430248|324257695|FG002|Overall Study|Personal Reasons|9|||
94673530|NCT00430248|324257693|FG000|Overall Study|Lost to Follow-up|28|||
94673531|NCT00430248|324257694|FG001|Overall Study|Lost to Follow-up|33|||
94673532|NCT00430248|324257695|FG002|Overall Study|Lost to Follow-up|28|||
94673533|NCT00430248|324257693|FG000|Overall Study|Therapeutic Failure|1|||
94673534|NCT00430248|324257694|FG001|Overall Study|Therapeutic Failure|1|||
94673535|NCT00430248|324257695|FG002|Overall Study|Therapeutic Failure|1|||
94673536|NCT00430248|324257693|FG000|Overall Study|Withdrawal by Subject|14|||
94673537|NCT00430248|324257694|FG001|Overall Study|Withdrawal by Subject|20|||
94673538|NCT00430248|324257695|FG002|Overall Study|Withdrawal by Subject|16|||
94673539|NCT00430248|324257693|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
94673540|NCT00430248|324257694|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
94673541|NCT00430248|324257695|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
94673542|NCT00430248|324257693|FG000|Overall Study|Gout Flare|3|||
94673543|NCT00430248|324257694|FG001|Overall Study|Gout Flare|7|||
94673544|NCT00430248|324257695|FG002|Overall Study|Gout Flare|2|||
94673545|NCT00430248|324257693|FG000|Overall Study|Reason Not Specified|8|||
94673546|NCT00430248|324257694|FG001|Overall Study|Reason Not Specified|8|||
94360191|NCT03522506|323101829|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
94360192|NCT03522506|323101830|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
94360193|NCT00650806|323101831|FG000|Overall Study|Adverse Event|0|||
94673547|NCT00430248|324257695|FG002|Overall Study|Reason Not Specified|11|||
94673548|NCT02570126|324257696|FG000|Overall Study|Lost to Follow-up|2|||
94673549|NCT02570126|324257697|FG001|Overall Study|Lost to Follow-up|0|||
94673550|NCT02570126|324257696|FG000|Overall Study|Unable To Arrange Visit 3|1|||
94673551|NCT02570126|324257697|FG001|Overall Study|Unable To Arrange Visit 3|0|||
94673552|NCT02570126|324257696|FG000|Overall Study|Violation Of Procedures GSK|0|||
94673553|NCT02570126|324257697|FG001|Overall Study|Violation Of Procedures GSK|1|||
94673554|NCT02570126|324257696|FG000|Overall Study|Protocol Violation|0|||
94673555|NCT02570126|324257697|FG001|Overall Study|Protocol Violation|1|||
94673556|NCT02570126|324257696|FG000|Overall Study|Withdrawal by Subject|3|||
94673557|NCT02570126|324257697|FG001|Overall Study|Withdrawal by Subject|7|||
94360194|NCT00650806|323101832|FG001|Overall Study|Adverse Event|5|||
94673558|NCT04683926|324257700|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
94673559|NCT04683926|324257701|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
94673560|NCT04683926|324257702|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
94673561|NCT04683926|324257703|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
94673562|NCT02740049|324257704|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
94673563|NCT01256411|324257705|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
94673564|NCT01256411|324257706|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
94673565|NCT01256411|324257707|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
94673566|NCT01256411|324257708|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
94673567|NCT01256411|324257709|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
94673568|NCT01256411|324257710|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
94673569|NCT01256411|324257705|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
94673570|NCT01256411|324257706|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
94673571|NCT01256411|324257707|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
94673572|NCT01256411|324257708|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
94673573|NCT01256411|324257709|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
94673574|NCT01256411|324257710|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
94673575|NCT01256411|324257705|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
94673576|NCT01256411|324257706|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
94673577|NCT01256411|324257707|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
94673578|NCT01256411|324257708|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
94673579|NCT01256411|324257709|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
94673580|NCT01256411|324257710|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
94673581|NCT01256411|324257705|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
94673582|NCT01256411|324257706|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
94673583|NCT01256411|324257707|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
94673584|NCT01256411|324257708|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
94673585|NCT01256411|324257709|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
94673586|NCT01256411|324257710|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
94673587|NCT01256411|324257705|FG000|Extension by Maximum Treatment|Adverse Event|4|||
94673588|NCT01256411|324257706|FG001|Extension by Maximum Treatment|Adverse Event|2|||
94673589|NCT01256411|324257707|FG002|Extension by Maximum Treatment|Adverse Event|1|||
94673590|NCT01256411|324257708|FG003|Extension by Maximum Treatment|Adverse Event|0|||
94673591|NCT01256411|324257709|FG004|Extension by Maximum Treatment|Adverse Event|0|||
94673592|NCT01256411|324257710|FG005|Extension by Maximum Treatment|Adverse Event|0|||
94673593|NCT01256411|324257705|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
94673594|NCT01256411|324257706|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
94673595|NCT01256411|324257707|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
94673596|NCT01256411|324257708|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
94673597|NCT01256411|324257709|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
94673598|NCT01256411|324257710|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
94673599|NCT01256411|324257705|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
94673600|NCT01256411|324257706|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
94673601|NCT01256411|324257707|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
94673602|NCT01256411|324257708|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
94673603|NCT01256411|324257709|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
94673604|NCT01256411|324257710|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
94673605|NCT01256411|324257705|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
94673606|NCT01256411|324257706|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
94673607|NCT01256411|324257707|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
94673608|NCT01256411|324257708|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
94673609|NCT01256411|324257709|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
94673610|NCT01256411|324257710|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
94673611|NCT01256411|324257705|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
94673612|NCT01256411|324257706|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
94673613|NCT01256411|324257707|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
94673614|NCT01256411|324257708|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
94673615|NCT01256411|324257709|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
94673616|NCT01256411|324257710|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
94673617|NCT01256411|324257705|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
94673618|NCT01256411|324257706|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
94673619|NCT01256411|324257707|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
94673620|NCT01256411|324257708|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
94673621|NCT01256411|324257709|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
94673622|NCT01256411|324257710|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
94673623|NCT02316769|324257711|FG000|Overall Study|Physician Decision|1|||
94673624|NCT02316769|324257712|FG001|Overall Study|Physician Decision|0|||
94673625|NCT02316769|324257711|FG000|Overall Study|Withdrawal by Subject|1|||
94673626|NCT02316769|324257712|FG001|Overall Study|Withdrawal by Subject|0|||
94673627|NCT04570436|324257716|FG000|Overall Study|Adverse Event|0|||
94673628|NCT04570436|324257717|FG001|Overall Study|Adverse Event|0|||
94673629|NCT04570436|324257718|FG002|Overall Study|Adverse Event|1|||
94255012|NCT04822597|322726477|FG003|Overall Study|Subject withdrawn after enrollment|1|||
94255013|NCT04822597|322726474|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
94255014|NCT04822597|322726475|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
94255015|NCT04822597|322726476|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
94255016|NCT04822597|322726477|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
94255017|NCT00446992|322726478|FG000|Overall Study|Adverse Event|11|||
94255018|NCT00446992|322726478|FG000|Overall Study|Lost to Follow-up|5|||
94255019|NCT01013285|322726482|FG000|Overall Study|Death|48|||
94255020|NCT01013285|322726483|FG001|Overall Study|Death|89|||
94255021|NCT01257425|322726484|FG000|Overall Study|Lack of Efficacy|3|||
94255022|NCT01257425|322726485|FG001|Overall Study|Lack of Efficacy|3|||
94255023|NCT01257425|322726484|FG000|Overall Study|Adverse Event|1|||
94255024|NCT01257425|322726485|FG001|Overall Study|Adverse Event|1|||
94255025|NCT01257425|322726484|FG000|Overall Study|Protocol Violation|1|||
94255026|NCT01257425|322726485|FG001|Overall Study|Protocol Violation|1|||
94255027|NCT01257425|322726484|FG000|Overall Study|Withdrawal by Subject|0|||
94255028|NCT01257425|322726485|FG001|Overall Study|Withdrawal by Subject|1|||
94255029|NCT01257425|322726484|FG000|Overall Study|Death|1|||
94255030|NCT01257425|322726485|FG001|Overall Study|Death|0|||
94626830|NCT02430311|324091785|FG000|Part B|Death|1|||
94626831|NCT02430311|324091786|FG001|Part B|Death|0|||
94626832|NCT00309387|324091793|FG000|Overall Study|Death|72|||
94626833|NCT00309387|324091794|FG001|Overall Study|Death|73|||
94626834|NCT00309387|324091793|FG000|Overall Study|Lost to Follow-up|70|||
94626835|NCT00309387|324091794|FG001|Overall Study|Lost to Follow-up|86|||
94626836|NCT04532164|324091795|FG000|Overall Study|Adverse Event|1|||
94626837|NCT04532164|324091795|FG000|Overall Study|Protocol Violation|5|||
94626838|NCT04532164|324091795|FG000|Overall Study|Lost to Follow-up|1|||
94626839|NCT04532164|324091795|FG000|Overall Study|Found to be Ineligible|3|||
94626840|NCT04532164|324091795|FG000|Overall Study|Withdrawal by Subject|14|||
94626841|NCT00617773|324091802|FG000|Overall Study|Physician Decision|1|||
94626842|NCT00617773|324091802|FG000|Overall Study|Lack of compliance with the protocol|1|||
94626843|NCT00617773|324091802|FG000|Overall Study|Withdrawal by Subject|1|||
94626844|NCT00617773|324091802|FG000|Overall Study|Death|1|||
94626845|NCT00617773|324091802|FG000|Overall Study|Progressive disease|19|||
94626846|NCT00617773|324091802|FG000|Overall Study|Protocol Violation|1|||
94626847|NCT03489720|324091813|FG000|Overall Study|Withdrawal by Subject|2|||
94626848|NCT03489720|324091814|FG001|Overall Study|Withdrawal by Subject|0|||
94626849|NCT00429273|324091816|FG000|Overall Study|Lost to Follow-up|1|||
94626850|NCT00429273|324091817|FG001|Overall Study|Lost to Follow-up|2|||
94626851|NCT00429273|324091818|FG002|Overall Study|Lost to Follow-up|2|||
94626852|NCT00429273|324091816|FG000|Overall Study|Physician Decision|6|||
94626853|NCT00429273|324091817|FG001|Overall Study|Physician Decision|5|||
94626854|NCT00429273|324091818|FG002|Overall Study|Physician Decision|5|||
94626855|NCT00429273|324091816|FG000|Overall Study|Adverse Event|1|||
94626856|NCT00429273|324091817|FG001|Overall Study|Adverse Event|1|||
94626857|NCT00429273|324091818|FG002|Overall Study|Adverse Event|2|||
94626858|NCT01438957|324091819|FG000|Overall Study|Physician Decision|1|||
94626859|NCT01438957|324091820|FG001|Overall Study|Physician Decision|1|||
94626860|NCT01438957|324091821|FG002|Overall Study|Physician Decision|0|||
94626861|NCT01438957|324091822|FG003|Overall Study|Physician Decision|1|||
94626862|NCT01438957|324091823|FG004|Overall Study|Physician Decision|0|||
94626863|NCT02732119|324091833|FG000|Phase I|Adverse Event|1|||
94626864|NCT02732119|324091834|FG001|Phase I|Adverse Event|3|||
94626865|NCT02732119|324091835|FG002|Phase I|Adverse Event|1|||
94626866|NCT02732119|324091836|FG003|Phase I|Adverse Event|0|||
94626867|NCT02732119|324091837|FG004|Phase I|Adverse Event|0|||
94626868|NCT02732119|324091833|FG000|Phase I|Progressive disease|7|||
94626869|NCT02732119|324091834|FG001|Phase I|Progressive disease|3|||
94626870|NCT02732119|324091835|FG002|Phase I|Progressive disease|2|||
94626871|NCT02732119|324091836|FG003|Phase I|Progressive disease|0|||
94626872|NCT02732119|324091837|FG004|Phase I|Progressive disease|0|||
94626873|NCT02732119|324091833|FG000|Phase I|Protocol deviation|0|||
94626874|NCT02732119|324091834|FG001|Phase I|Protocol deviation|1|||
94626875|NCT02732119|324091835|FG002|Phase I|Protocol deviation|0|||
94626876|NCT02732119|324091836|FG003|Phase I|Protocol deviation|0|||
94626877|NCT02732119|324091837|FG004|Phase I|Protocol deviation|0|||
94255031|NCT05323396|322726486|FG000|Overall Study|Lost to Follow-up|1|||
94626878|NCT02732119|324091833|FG000|Phase I|Physician Decision|0|||
94626879|NCT02732119|324091834|FG001|Phase I|Physician Decision|3|||
94626880|NCT02732119|324091835|FG002|Phase I|Physician Decision|4|||
94626881|NCT02732119|324091836|FG003|Phase I|Physician Decision|0|||
94626882|NCT02732119|324091837|FG004|Phase I|Physician Decision|0|||
94626883|NCT02732119|324091833|FG000|Phase II|Adverse Event|0|||
94626884|NCT02732119|324091834|FG001|Phase II|Adverse Event|0|||
94626885|NCT02732119|324091835|FG002|Phase II|Adverse Event|0|||
94626886|NCT02732119|324091836|FG003|Phase II|Adverse Event|3|||
94673630|NCT04570436|324257719|FG003|Overall Study|Adverse Event|0|||
94673631|NCT04570436|324257720|FG004|Overall Study|Adverse Event|0|||
94673632|NCT04570436|324257721|FG005|Overall Study|Adverse Event|0|||
94673633|NCT04570436|324257722|FG006|Overall Study|Adverse Event|0|||
94673634|NCT04570436|324257723|FG007|Overall Study|Adverse Event|0|||
94673635|NCT04570436|324257724|FG008|Overall Study|Adverse Event|0|||
94626887|NCT02732119|324091837|FG004|Phase II|Adverse Event|3|||
94626888|NCT02732119|324091833|FG000|Phase II|Death|0|||
94626889|NCT02732119|324091834|FG001|Phase II|Death|0|||
94626890|NCT02732119|324091835|FG002|Phase II|Death|0|||
94626891|NCT02732119|324091836|FG003|Phase II|Death|1|||
94626892|NCT02732119|324091837|FG004|Phase II|Death|0|||
94626893|NCT02732119|324091833|FG000|Phase II|Progressive dissease|0|||
94626894|NCT02732119|324091834|FG001|Phase II|Progressive dissease|0|||
94626895|NCT02732119|324091835|FG002|Phase II|Progressive dissease|0|||
94626896|NCT02732119|324091836|FG003|Phase II|Progressive dissease|30|||
94626897|NCT02732119|324091837|FG004|Phase II|Progressive dissease|23|||
94626898|NCT02732119|324091833|FG000|Phase II|Study terminated by sponsor|0|||
94626899|NCT02732119|324091834|FG001|Phase II|Study terminated by sponsor|0|||
94626900|NCT02732119|324091835|FG002|Phase II|Study terminated by sponsor|0|||
94626901|NCT02732119|324091836|FG003|Phase II|Study terminated by sponsor|2|||
94626902|NCT02732119|324091837|FG004|Phase II|Study terminated by sponsor|2|||
94626903|NCT02732119|324091833|FG000|Phase II|Other|0|||
94626904|NCT02732119|324091834|FG001|Phase II|Other|0|||
94626905|NCT02732119|324091835|FG002|Phase II|Other|0|||
94626906|NCT02732119|324091836|FG003|Phase II|Other|2|||
94626907|NCT02732119|324091837|FG004|Phase II|Other|0|||
94626908|NCT02732119|324091833|FG000|Phase II|Physician Decision|0|||
94626909|NCT02732119|324091834|FG001|Phase II|Physician Decision|0|||
94626910|NCT02732119|324091835|FG002|Phase II|Physician Decision|0|||
94626911|NCT02732119|324091836|FG003|Phase II|Physician Decision|8|||
94626912|NCT02732119|324091837|FG004|Phase II|Physician Decision|5|||
94626913|NCT02101060|324091838|FG000|Overall Study|Adverse Event|1|||
94626914|NCT02101060|324091839|FG001|Overall Study|Adverse Event|0|||
94626915|NCT02101060|324091838|FG000|Overall Study|Withdrawal by Subject|1|||
94626916|NCT02101060|324091839|FG001|Overall Study|Withdrawal by Subject|1|||
94626917|NCT02101060|324091838|FG000|Overall Study|Lost to Follow-up|3|||
94626918|NCT02101060|324091839|FG001|Overall Study|Lost to Follow-up|3|||
94626919|NCT03020160|324091840|FG000|Overall Study|Withdrawal by Subject|1|||
94626920|NCT03020160|324091841|FG001|Overall Study|Withdrawal by Subject|0|||
94626921|NCT00964860|324091842|FG000|Overall Study|Withdrawal by Subject|0|||
94626922|NCT00964860|324091843|FG001|Overall Study|Withdrawal by Subject|1|||
94626923|NCT01513473|324091844|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
94626924|NCT01513473|324091845|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
94626925|NCT01513473|324091844|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
94626926|NCT01513473|324091845|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
94626927|NCT01513473|324091844|FG000|Main Trial (26 Weeks)|Unclassified|0|||
94626928|NCT01513473|324091845|FG001|Main Trial (26 Weeks)|Unclassified|2|||
94626929|NCT01513473|324091844|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
94626930|NCT01513473|324091845|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
94626931|NCT01513473|324091844|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
94626932|NCT01513473|324091845|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
94673636|NCT04570436|324257725|FG009|Overall Study|Adverse Event|0|||
94673637|NCT04570436|324257716|FG000|Overall Study|Physician Decision|1|||
94673638|NCT04570436|324257717|FG001|Overall Study|Physician Decision|0|||
94626933|NCT03462082|324091852|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
94626934|NCT03462082|324091853|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
94626935|NCT03462082|324091854|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
94673639|NCT04570436|324257718|FG002|Overall Study|Physician Decision|0|||
94673640|NCT04570436|324257719|FG003|Overall Study|Physician Decision|0|||
94673641|NCT04570436|324257720|FG004|Overall Study|Physician Decision|0|||
94673642|NCT04570436|324257721|FG005|Overall Study|Physician Decision|0|||
94673643|NCT04570436|324257722|FG006|Overall Study|Physician Decision|0|||
94673644|NCT04570436|324257723|FG007|Overall Study|Physician Decision|0|||
94626936|NCT03462082|324091855|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
94626937|NCT03462082|324091856|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
94626938|NCT03462082|324091857|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
94626939|NCT03462082|324091858|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
94626940|NCT03462082|324091859|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
94626941|NCT00166114|324091860|FG000|Overall Study|Protocol Violation|2|||
94626942|NCT00166114|324091861|FG001|Overall Study|Protocol Violation|1|||
94626943|NCT00166114|324091860|FG000|Overall Study|Withdrawal by Subject|10|||
94626944|NCT00166114|324091861|FG001|Overall Study|Withdrawal by Subject|4|||
94626945|NCT00166114|324091860|FG000|Overall Study|Adverse Event|2|||
94626946|NCT00166114|324091861|FG001|Overall Study|Adverse Event|1|||
94626947|NCT02709785|324091866|FG000|Overall Study|Withdrawal by Subject|1|||
94673645|NCT04570436|324257724|FG008|Overall Study|Physician Decision|0|||
94626948|NCT02709785|324091867|FG001|Overall Study|Withdrawal by Subject|2|||
94673646|NCT04570436|324257725|FG009|Overall Study|Physician Decision|0|||
94673647|NCT00594854|324257728|FG000|Overall Study|Study terminated|7|||
94673648|NCT00594854|324257729|FG001|Overall Study|Study terminated|10|||
94673649|NCT03574597|324257730|FG000|Overall Study|Withdrawal by Subject|67|||
94673650|NCT03574597|324257731|FG001|Overall Study|Withdrawal by Subject|96|||
94673651|NCT03574597|324257730|FG000|Overall Study|Lost to Follow-up|192|||
94673652|NCT03574597|324257731|FG001|Overall Study|Lost to Follow-up|188|||
94673653|NCT04212091|324257738|FG000|Overall Study|Lost to Follow-up|0|||
94673654|NCT04212091|324257739|FG001|Overall Study|Lost to Follow-up|0|||
94673655|NCT04212091|324257740|FG002|Overall Study|Lost to Follow-up|0|||
94673656|NCT04212091|324257741|FG003|Overall Study|Lost to Follow-up|0|||
94673657|NCT04212091|324257742|FG004|Overall Study|Lost to Follow-up|1|||
94673658|NCT04212091|324257743|FG005|Overall Study|Lost to Follow-up|1|||
94673659|NCT04212091|324257738|FG000|Overall Study|Participant unable to adhere to visit|0|||
94673660|NCT04212091|324257739|FG001|Overall Study|Participant unable to adhere to visit|0|||
94673661|NCT04212091|324257740|FG002|Overall Study|Participant unable to adhere to visit|0|||
94673662|NCT04212091|324257741|FG003|Overall Study|Participant unable to adhere to visit|0|||
94626949|NCT02709785|324091868|FG002|Overall Study|Withdrawal by Subject|1|||
94626950|NCT02117648|324091869|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
94626951|NCT02117648|324091869|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
94626952|NCT02117648|324091869|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
94626953|NCT02117648|324091869|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
94626954|NCT02117648|324091869|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
94626955|NCT02117648|324091869|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
94626956|NCT02117648|324091869|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
94626957|NCT02117648|324091869|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
94626958|NCT02117648|324091869|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
94626959|NCT02117648|324091869|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
94626960|NCT02117648|324091869|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
94626961|NCT01366209|324091870|FG000|Overall Study|Adverse Event|6|||
94626962|NCT01366209|324091871|FG001|Overall Study|Adverse Event|7|||
94626963|NCT01366209|324091870|FG000|Overall Study|Withdrawal by Subject|4|||
94626964|NCT01366209|324091871|FG001|Overall Study|Withdrawal by Subject|4|||
94626965|NCT01366209|324091870|FG000|Overall Study|Death|12|||
94626966|NCT01366209|324091871|FG001|Overall Study|Death|19|||
94626967|NCT01366209|324091870|FG000|Overall Study|Lung transplantation|6|||
94626968|NCT01366209|324091871|FG001|Overall Study|Lung transplantation|1|||
94626969|NCT01366209|324091870|FG000|Overall Study|Lost to Follow-up|2|||
94626970|NCT01366209|324091871|FG001|Overall Study|Lost to Follow-up|1|||
94626971|NCT01366209|324091870|FG000|Overall Study|Physician Decision|1|||
94626972|NCT01366209|324091871|FG001|Overall Study|Physician Decision|0|||
94626973|NCT01366209|324091870|FG000|Overall Study|Sponsors decision|0|||
94626974|NCT01366209|324091871|FG001|Overall Study|Sponsors decision|1|||
94626975|NCT01366209|324091870|FG000|Overall Study|Withdrew consent|4|||
94626976|NCT01366209|324091871|FG001|Overall Study|Withdrew consent|3|||
94626977|NCT01606436|324091872|FG000|Overall Study|Withdrawal by Subject|0|||
94626978|NCT01606436|324091873|FG001|Overall Study|Withdrawal by Subject|0|||
94626979|NCT01606436|324091874|FG002|Overall Study|Withdrawal by Subject|1|||
94626980|NCT01606436|324091875|FG003|Overall Study|Withdrawal by Subject|1|||
94626981|NCT01606436|324091876|FG004|Overall Study|Withdrawal by Subject|1|||
94626982|NCT01606436|324091877|FG005|Overall Study|Withdrawal by Subject|0|||
94626983|NCT01606436|324091872|FG000|Overall Study|Adverse Event|0|||
94626984|NCT01606436|324091873|FG001|Overall Study|Adverse Event|0|||
94626985|NCT01606436|324091874|FG002|Overall Study|Adverse Event|1|||
94626986|NCT01606436|324091875|FG003|Overall Study|Adverse Event|0|||
94626987|NCT01606436|324091876|FG004|Overall Study|Adverse Event|0|||
94626988|NCT01606436|324091877|FG005|Overall Study|Adverse Event|0|||
94626989|NCT01606436|324091872|FG000|Overall Study|Sponsor Decision|0|||
94626990|NCT01606436|324091873|FG001|Overall Study|Sponsor Decision|0|||
94626991|NCT01606436|324091874|FG002|Overall Study|Sponsor Decision|0|||
94626992|NCT01606436|324091875|FG003|Overall Study|Sponsor Decision|1|||
94626993|NCT01606436|324091876|FG004|Overall Study|Sponsor Decision|0|||
94626994|NCT01606436|324091877|FG005|Overall Study|Sponsor Decision|0|||
94626995|NCT01049308|324091880|FG000|Pill Counts|Withdrawal by Subject|83|||
94626996|NCT01365910|324091881|FG000|Overall Study|Withdrawal by Subject|7|||
94626997|NCT01365910|324091881|FG000|Overall Study|disease progression|18|||
94626998|NCT01365910|324091881|FG000|Overall Study|Adverse Event|3|||
94626999|NCT01365910|324091881|FG000|Overall Study|other complicating disease|1|||
94627000|NCT01365910|324091881|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
94627001|NCT00276744|324091882|FG000|PART A|Reason unknown|98|||
94627002|NCT00640601|324091889|FG000|Overall Study|Adverse Event|43|||
94627003|NCT00640601|324091889|FG000|Overall Study|Withdrawal by Subject|20|||
94627004|NCT00640601|324091889|FG000|Overall Study|Protocol Violation|6|||
94627005|NCT00640601|324091889|FG000|Overall Study|Lack of Efficacy|16|||
94627006|NCT00640601|324091889|FG000|Overall Study|Lost to Follow-up|9|||
94627007|NCT00640601|324091889|FG000|Overall Study|Physician Decision|8|||
94627008|NCT00640601|324091889|FG000|Overall Study|treatment naive, combination therapy|10|||
94627009|NCT01862874|324091890|FG000|Overall Study|Randomized not treated|1|||
94360195|NCT00650806|323101833|FG002|Overall Study|Adverse Event|3|||
94360196|NCT00650806|323101834|FG003|Overall Study|Adverse Event|4|||
94360197|NCT00650806|323101831|FG000|Overall Study|Lost to Follow-up|7|||
94360198|NCT00650806|323101832|FG001|Overall Study|Lost to Follow-up|6|||
94360199|NCT00650806|323101833|FG002|Overall Study|Lost to Follow-up|11|||
94360200|NCT00650806|323101834|FG003|Overall Study|Lost to Follow-up|10|||
94360201|NCT00650806|323101831|FG000|Overall Study|Protocol Violation|0|||
94360202|NCT00650806|323101832|FG001|Overall Study|Protocol Violation|0|||
94360203|NCT00650806|323101833|FG002|Overall Study|Protocol Violation|0|||
94360204|NCT00650806|323101834|FG003|Overall Study|Protocol Violation|1|||
94360205|NCT00650806|323101831|FG000|Overall Study|Pregnancy|0|||
94673663|NCT04212091|324257742|FG004|Overall Study|Participant unable to adhere to visit|1|||
94673664|NCT04212091|324257743|FG005|Overall Study|Participant unable to adhere to visit|0|||
94673665|NCT04575051|324257744|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
94673666|NCT04575051|324257745|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
94673667|NCT04575051|324257746|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
94673668|NCT04575051|324257747|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
94673669|NCT04575051|324257748|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
94673670|NCT04575051|324257744|FG000|Time Period 1|Missing follow up|1|||
94673671|NCT04575051|324257745|FG001|Time Period 1|Missing follow up|3|||
94673672|NCT04575051|324257746|FG002|Time Period 1|Missing follow up|1|||
94673673|NCT04575051|324257747|FG003|Time Period 1|Missing follow up|3|||
94673674|NCT04575051|324257748|FG004|Time Period 1|Missing follow up|2|||
94673675|NCT04575051|324257744|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
94673676|NCT04575051|324257745|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
94673677|NCT04575051|324257746|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
94673678|NCT04575051|324257747|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
94673679|NCT04575051|324257748|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
94673680|NCT04575051|324257744|FG000|Time Period 2|Missing follow up|1|||
94673681|NCT04575051|324257745|FG001|Time Period 2|Missing follow up|8|||
94673682|NCT04575051|324257746|FG002|Time Period 2|Missing follow up|7|||
94673683|NCT04575051|324257747|FG003|Time Period 2|Missing follow up|0|||
94673684|NCT04575051|324257748|FG004|Time Period 2|Missing follow up|1|||
94673685|NCT04575051|324257744|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
94673686|NCT04575051|324257745|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
94673687|NCT04575051|324257746|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
94673688|NCT04575051|324257747|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
94673689|NCT04575051|324257748|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
94673690|NCT04575051|324257744|FG000|Time Period 3|Missing follow up|8|||
94673691|NCT04575051|324257745|FG001|Time Period 3|Missing follow up|6|||
94673692|NCT04575051|324257746|FG002|Time Period 3|Missing follow up|4|||
94673693|NCT04575051|324257747|FG003|Time Period 3|Missing follow up|3|||
94673694|NCT04575051|324257748|FG004|Time Period 3|Missing follow up|0|||
94673695|NCT04575051|324257744|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
94673696|NCT04575051|324257745|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
94673697|NCT04575051|324257746|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
94673698|NCT04575051|324257747|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
94673699|NCT04575051|324257748|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
94673700|NCT04575051|324257744|FG000|Time Period 4|Missing follow up|17|||
94673701|NCT04575051|324257745|FG001|Time Period 4|Missing follow up|3|||
94673702|NCT04575051|324257746|FG002|Time Period 4|Missing follow up|4|||
94673703|NCT04575051|324257747|FG003|Time Period 4|Missing follow up|2|||
94673704|NCT04575051|324257748|FG004|Time Period 4|Missing follow up|1|||
94673705|NCT04575051|324257744|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
94673706|NCT04575051|324257745|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
94673707|NCT04575051|324257746|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
94673708|NCT04575051|324257747|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
94673709|NCT04575051|324257748|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
94673710|NCT04575051|324257744|FG000|Time Period 5|Missing follow up|11|||
94673711|NCT04575051|324257745|FG001|Time Period 5|Missing follow up|8|||
94673712|NCT04575051|324257746|FG002|Time Period 5|Missing follow up|12|||
94673713|NCT04575051|324257747|FG003|Time Period 5|Missing follow up|3|||
94673714|NCT04575051|324257748|FG004|Time Period 5|Missing follow up|11|||
94360206|NCT00650806|323101832|FG001|Overall Study|Pregnancy|0|||
94360207|NCT00650806|323101833|FG002|Overall Study|Pregnancy|0|||
94360208|NCT00650806|323101834|FG003|Overall Study|Pregnancy|1|||
94673715|NCT03583554|324257751|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
94673716|NCT03583554|324257752|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
94360209|NCT00650806|323101831|FG000|Overall Study|Withdrawal by Subject|7|||
94360210|NCT00650806|323101832|FG001|Overall Study|Withdrawal by Subject|5|||
94673717|NCT03583554|324257753|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
94673718|NCT01800968|324257754|FG000|Overall Study|Death|23|||
94673719|NCT01800968|324257755|FG001|Overall Study|Death|16|||
94673720|NCT01800968|324257754|FG000|Overall Study|Lost to Follow-up|5|||
94673721|NCT01800968|324257755|FG001|Overall Study|Lost to Follow-up|7|||
94673722|NCT01800968|324257754|FG000|Overall Study|Withdrawal by Subject|7|||
94673723|NCT01800968|324257755|FG001|Overall Study|Withdrawal by Subject|9|||
94673724|NCT01800968|324257754|FG000|Overall Study|Physician Decision|1|||
94673725|NCT01800968|324257755|FG001|Overall Study|Physician Decision|0|||
94673726|NCT02472964|324257756|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
94673727|NCT02472964|324257757|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
94673728|NCT02472964|324257756|FG000|Part 1 (up to Week 24)|disease progression|58|||
94673729|NCT02472964|324257757|FG001|Part 1 (up to Week 24)|disease progression|47|||
94673730|NCT02472964|324257756|FG000|Part 1 (up to Week 24)|Death|3|||
94673731|NCT02472964|324257757|FG001|Part 1 (up to Week 24)|Death|6|||
94673732|NCT02472964|324257756|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
94673733|NCT02472964|324257757|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
94673734|NCT02472964|324257756|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
94673735|NCT02472964|324257757|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
94673736|NCT02472964|324257756|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
94673737|NCT02472964|324257757|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
94673738|NCT02472964|324257756|FG000|Part 1 (up to Week 24)|Other|2|||
94673739|NCT02472964|324257757|FG001|Part 1 (up to Week 24)|Other|1|||
94673740|NCT02472964|324257756|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
94673741|NCT02472964|324257757|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
94673742|NCT02472964|324257756|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
94673743|NCT02472964|324257757|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
94673744|NCT02472964|324257756|FG000|Part 2 (Week 24-week 48)|Death|0|||
94673745|NCT02472964|324257757|FG001|Part 2 (Week 24-week 48)|Death|1|||
94673746|NCT02472964|324257756|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
94673747|NCT02472964|324257757|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
94673748|NCT02472964|324257756|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
94673749|NCT02472964|324257757|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
94673750|NCT02472964|324257756|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
94673751|NCT02472964|324257757|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
94673752|NCT02472964|324257756|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
94673753|NCT02472964|324257757|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
94673754|NCT01812655|324257758|FG000|Overall Study|Protocol Violation|1|||
94627010|NCT01862874|324091891|FG001|Overall Study|Randomized not treated|0|||
94627011|NCT01862874|324091890|FG000|Overall Study|Adverse Event|0|||
94627012|NCT01862874|324091891|FG001|Overall Study|Adverse Event|3|||
94627013|NCT01862874|324091890|FG000|Overall Study|Lost to Follow-up|26|||
94627014|NCT01862874|324091891|FG001|Overall Study|Lost to Follow-up|29|||
94627015|NCT01862874|324091890|FG000|Overall Study|Physician Decision|5|||
94627016|NCT01862874|324091891|FG001|Overall Study|Physician Decision|3|||
94627017|NCT01862874|324091890|FG000|Overall Study|Withdrawn by parent/guardian|1|||
94627018|NCT01862874|324091891|FG001|Overall Study|Withdrawn by parent/guardian|1|||
94627019|NCT01862874|324091890|FG000|Overall Study|Withdrawal by Subject|46|||
94627020|NCT01862874|324091891|FG001|Overall Study|Withdrawal by Subject|40|||
94627021|NCT01862874|324091890|FG000|Overall Study|Death|0|||
94627022|NCT01862874|324091891|FG001|Overall Study|Death|1|||
94627023|NCT03681405|324091892|FG000|Overall Study|Found to be ineligible after randomized|1|||
94627024|NCT03681405|324091893|FG001|Overall Study|Found to be ineligible after randomized|0|||
94627025|NCT00471328|324091897|FG000|Core Phase|Adverse Event|18|||
94627026|NCT00471328|324091898|FG001|Core Phase|Adverse Event|6|||
94627027|NCT00471328|324091897|FG000|Core Phase|Death|8|||
94627028|NCT00471328|324091898|FG001|Core Phase|Death|4|||
94627029|NCT00471328|324091897|FG000|Core Phase|Withdrawal by Subject|2|||
94627030|NCT00471328|324091898|FG001|Core Phase|Withdrawal by Subject|2|||
94673755|NCT01812655|324257759|FG001|Overall Study|Protocol Violation|1|||
94673756|NCT01812655|324257760|FG002|Overall Study|Protocol Violation|0|||
94673757|NCT03923933|324257761|FG000|Overall Study|Lost to Follow-up|1|||
94673758|NCT03923933|324257762|FG001|Overall Study|Lost to Follow-up|0|||
94673759|NCT03923933|324257761|FG000|Overall Study|Withdrawal by Subject|0|||
94673760|NCT03923933|324257762|FG001|Overall Study|Withdrawal by Subject|1|||
94673761|NCT01939548|324257765|FG000|Overall Study|Non compliance|0|||
94673762|NCT01939548|324257766|FG001|Overall Study|Non compliance|2|||
94673763|NCT01939548|324257767|FG002|Overall Study|Non compliance|0|||
94673764|NCT01939548|324257765|FG000|Overall Study|Study Terminated by Sponsor|17|||
94255032|NCT05323396|322726487|FG001|Overall Study|Lost to Follow-up|31|||
94627031|NCT00471328|324091897|FG000|Core Phase|Abnormal laboratory value|1|||
94627032|NCT00471328|324091898|FG001|Core Phase|Abnormal laboratory value|0|||
94627033|NCT00471328|324091897|FG000|Core Phase|Disease Progression|78|||
94627034|NCT00471328|324091898|FG001|Core Phase|Disease Progression|53|||
94627035|NCT00471328|324091897|FG000|Core Phase|Administrative Problem|0|||
94627036|NCT00471328|324091898|FG001|Core Phase|Administrative Problem|1|||
94673765|NCT01939548|324257766|FG001|Overall Study|Study Terminated by Sponsor|19|||
94673766|NCT01939548|324257767|FG002|Overall Study|Study Terminated by Sponsor|12|||
94673767|NCT01939548|324257765|FG000|Overall Study|Insufficient Clinical Response|1|||
94673768|NCT01939548|324257766|FG001|Overall Study|Insufficient Clinical Response|0|||
94673769|NCT01939548|324257767|FG002|Overall Study|Insufficient Clinical Response|0|||
94673770|NCT01939548|324257765|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
94673771|NCT01939548|324257766|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
94673772|NCT01939548|324257767|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
94673773|NCT01939548|324257765|FG000|Overall Study|Withdrawal by Subject|4|||
94673774|NCT01939548|324257766|FG001|Overall Study|Withdrawal by Subject|4|||
94673775|NCT01939548|324257767|FG002|Overall Study|Withdrawal by Subject|1|||
94673776|NCT01939548|324257765|FG000|Overall Study|Protocol Violation|7|||
94673777|NCT01939548|324257766|FG001|Overall Study|Protocol Violation|6|||
94673778|NCT01939548|324257767|FG002|Overall Study|Protocol Violation|5|||
94673779|NCT01939548|324257765|FG000|Overall Study|Lost to Follow-up|5|||
94673780|NCT01939548|324257766|FG001|Overall Study|Lost to Follow-up|5|||
94673781|NCT01939548|324257767|FG002|Overall Study|Lost to Follow-up|3|||
94673782|NCT01939548|324257765|FG000|Overall Study|Adverse Event|2|||
94673783|NCT01939548|324257766|FG001|Overall Study|Adverse Event|9|||
94673784|NCT01939548|324257767|FG002|Overall Study|Adverse Event|7|||
94673785|NCT01939548|324257765|FG000|Overall Study|Death|0|||
94673786|NCT01939548|324257766|FG001|Overall Study|Death|0|||
94673787|NCT01939548|324257767|FG002|Overall Study|Death|1|||
94673788|NCT01939548|324257765|FG000|Overall Study|Participant dropped|0|||
94673789|NCT01939548|324257766|FG001|Overall Study|Participant dropped|0|||
94673790|NCT01939548|324257767|FG002|Overall Study|Participant dropped|1|||
94673791|NCT01939548|324257765|FG000|Overall Study|Participant unwilling to continue|0|||
94673792|NCT01939548|324257766|FG001|Overall Study|Participant unwilling to continue|1|||
94673793|NCT01939548|324257767|FG002|Overall Study|Participant unwilling to continue|0|||
94673794|NCT01939548|324257765|FG000|Overall Study|Participant withdrew consent|0|||
94673795|NCT01939548|324257766|FG001|Overall Study|Participant withdrew consent|2|||
94673796|NCT01939548|324257767|FG002|Overall Study|Participant withdrew consent|0|||
94673797|NCT01939548|324257765|FG000|Overall Study|Did not complete follow-up|0|||
94673798|NCT01939548|324257766|FG001|Overall Study|Did not complete follow-up|1|||
94673799|NCT01939548|324257767|FG002|Overall Study|Did not complete follow-up|0|||
94673800|NCT04510675|324257768|FG000|Overall Study|Withdrawal by Subject|5|||
94673801|NCT02657031|324257769|FG000|Overall Study|Adverse Event|1|||
94673802|NCT02657031|324257770|FG001|Overall Study|Adverse Event|2|||
94673803|NCT04198805|324257771|FG000|Overall Study|Death|0|||
94673804|NCT04198805|324257772|FG001|Overall Study|Death|0|||
94673805|NCT04198805|324257773|FG002|Overall Study|Death|0|||
94673806|NCT04198805|324257774|FG003|Overall Study|Death|1|||
94673807|NCT04198805|324257771|FG000|Overall Study|Early Termination|8|||
94673808|NCT04198805|324257772|FG001|Overall Study|Early Termination|4|||
94673809|NCT04198805|324257773|FG002|Overall Study|Early Termination|6|||
94673810|NCT04198805|324257774|FG003|Overall Study|Early Termination|9|||
94673811|NCT01330433|324257775|FG000|Overall Study|Death|1|||
94673812|NCT01330433|324257776|FG001|Overall Study|Death|3|||
94673813|NCT01330433|324257775|FG000|Overall Study|Lost to Follow-up|1|||
94673814|NCT01330433|324257776|FG001|Overall Study|Lost to Follow-up|0|||
94673815|NCT01666808|324257777|FG000|Overall Study|Lost to Follow-up|9|||
94673816|NCT01666808|324257778|FG001|Overall Study|Lost to Follow-up|15|||
94673817|NCT01666808|324257777|FG000|Overall Study|Withdrawal by Subject|3|||
94673818|NCT01666808|324257778|FG001|Overall Study|Withdrawal by Subject|1|||
94673819|NCT01666808|324257777|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
94673820|NCT01666808|324257778|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
94673821|NCT01499082|324257779|FG000|Overall Study|Randomized but not Treated|0|||
94673822|NCT01499082|324257780|FG001|Overall Study|Randomized but not Treated|1|||
94673823|NCT01499082|324257779|FG000|Overall Study|Adverse Event|12|||
94673824|NCT01499082|324257780|FG001|Overall Study|Adverse Event|16|||
94673825|NCT01499082|324257779|FG000|Overall Study|Lack of Efficacy|1|||
94673826|NCT01499082|324257780|FG001|Overall Study|Lack of Efficacy|1|||
94673827|NCT01499082|324257779|FG000|Overall Study|Protocol Violation|6|||
94673828|NCT01499082|324257780|FG001|Overall Study|Protocol Violation|8|||
94673829|NCT01499082|324257779|FG000|Overall Study|Diverse Reasons|18|||
94673830|NCT01499082|324257780|FG001|Overall Study|Diverse Reasons|14|||
94673831|NCT01499082|324257779|FG000|Overall Study|Site Closure for Noncompliance|5|||
94673832|NCT01499082|324257780|FG001|Overall Study|Site Closure for Noncompliance|2|||
94673833|NCT01499082|324257779|FG000|Overall Study|Hypoglycemia|2|||
94673834|NCT01499082|324257780|FG001|Overall Study|Hypoglycemia|3|||
94673835|NCT01499082|324257779|FG000|Overall Study|Lost to Follow-up|1|||
94673836|NCT01499082|324257780|FG001|Overall Study|Lost to Follow-up|3|||
94673837|NCT03599349|324257781|FG000|Overall Study|Lost to Follow-up|1|||
94673838|NCT02638948|324257784|FG000|Overall Study|Withdrawal by Subject|4|||
94673839|NCT02638948|324257785|FG001|Overall Study|Withdrawal by Subject|5|||
94673840|NCT02638948|324257786|FG002|Overall Study|Withdrawal by Subject|3|||
94673841|NCT02638948|324257787|FG003|Overall Study|Withdrawal by Subject|1|||
94673842|NCT02638948|324257784|FG000|Overall Study|Administrative Reason by Sponsor|0|||
94673843|NCT02638948|324257785|FG001|Overall Study|Administrative Reason by Sponsor|1|||
94673844|NCT02638948|324257786|FG002|Overall Study|Administrative Reason by Sponsor|0|||
94627037|NCT00471328|324091897|FG000|Core Phase|Protocol Deviation|0|||
94627038|NCT00471328|324091898|FG001|Core Phase|Protocol Deviation|1|||
94627039|NCT00471328|324091897|FG000|Extension Phase|Adverse Event|3|||
94627040|NCT00471328|324091898|FG001|Extension Phase|Adverse Event|12|||
94627041|NCT00471328|324091897|FG000|Extension Phase|Withdrawal by Subject|0|||
94627042|NCT00471328|324091898|FG001|Extension Phase|Withdrawal by Subject|2|||
94627043|NCT00471328|324091897|FG000|Extension Phase|Death|1|||
94627044|NCT00471328|324091898|FG001|Extension Phase|Death|7|||
94627045|NCT00471328|324091897|FG000|Extension Phase|Protocol Deviation|3|||
94627046|NCT00471328|324091898|FG001|Extension Phase|Protocol Deviation|1|||
94627047|NCT00471328|324091897|FG000|Extension Phase|Treatment duration as per protocol|0|||
94627048|NCT00471328|324091898|FG001|Extension Phase|Treatment duration as per protocol|1|||
94627049|NCT00471328|324091897|FG000|Extension Phase|Disease Progression|32|||
94627050|NCT00471328|324091898|FG001|Extension Phase|Disease Progression|44|||
94627051|NCT00471328|324091897|FG000|Extension Phase|New cancer Therapy|1|||
94627052|NCT00471328|324091898|FG001|Extension Phase|New cancer Therapy|0|||
94627053|NCT00471328|324091897|FG000|Extension Phase|Administrative Problem|1|||
94627054|NCT00471328|324091898|FG001|Extension Phase|Administrative Problem|0|||
94627055|NCT00844896|324091899|FG000|Overall Study|Lost to Follow-up|12|||
94627056|NCT00844896|324091900|FG001|Overall Study|Lost to Follow-up|16|||
94627057|NCT00844896|324091899|FG000|Overall Study|Parents did not have time to complete|0|||
94627058|NCT00844896|324091900|FG001|Overall Study|Parents did not have time to complete|1|||
94627059|NCT02233647|324091901|FG000|Overall Study|Adverse Event|1|||
94627060|NCT00727025|324093803|FG000|Overall Study|Physician Decision|23|||
94627061|NCT01218204|324093807|FG000|Part B Washout|Adverse Event|0|||
94627062|NCT01218204|324093808|FG001|Part B Washout|Adverse Event|1|||
94627063|NCT01218204|324093809|FG002|Part B Washout|Adverse Event|0|||
94627064|NCT01218204|324093810|FG003|Part B Washout|Adverse Event|0|||
94627065|NCT01218204|324093807|FG000|Part B Washout|Lost to Follow-up|0|||
94627066|NCT01218204|324093808|FG001|Part B Washout|Lost to Follow-up|2|||
94627067|NCT01218204|324093809|FG002|Part B Washout|Lost to Follow-up|0|||
94627068|NCT01218204|324093810|FG003|Part B Washout|Lost to Follow-up|0|||
94627069|NCT01218204|324093807|FG000|Part B Washout|Physician Decision|0|||
94627070|NCT01218204|324093808|FG001|Part B Washout|Physician Decision|14|||
94627071|NCT01218204|324093809|FG002|Part B Washout|Physician Decision|0|||
94627072|NCT01218204|324093810|FG003|Part B Washout|Physician Decision|0|||
94627073|NCT01218204|324093807|FG000|Part B Washout|Withdrawal by Subject|0|||
94627074|NCT01218204|324093808|FG001|Part B Washout|Withdrawal by Subject|14|||
94627075|NCT01218204|324093809|FG002|Part B Washout|Withdrawal by Subject|0|||
94627076|NCT01218204|324093810|FG003|Part B Washout|Withdrawal by Subject|0|||
94627077|NCT01218204|324093807|FG000|Part B Washout|Reached defined stopping criteria|0|||
94627078|NCT01218204|324093808|FG001|Part B Washout|Reached defined stopping criteria|2|||
94627079|NCT01218204|324093809|FG002|Part B Washout|Reached defined stopping criteria|0|||
94627080|NCT01218204|324093810|FG003|Part B Washout|Reached defined stopping criteria|0|||
94627081|NCT01218204|324093807|FG000|Part B Washout|Did not meet continuation criteria|0|||
94627082|NCT01218204|324093808|FG001|Part B Washout|Did not meet continuation criteria|112|||
94627083|NCT01218204|324093809|FG002|Part B Washout|Did not meet continuation criteria|0|||
94627084|NCT01218204|324093810|FG003|Part B Washout|Did not meet continuation criteria|0|||
94627085|NCT01218204|324093807|FG000|Part B Run-in|Adverse Event|0|||
94627086|NCT01218204|324093808|FG001|Part B Run-in|Adverse Event|0|||
94627087|NCT01218204|324093809|FG002|Part B Run-in|Adverse Event|1|||
94627088|NCT01218204|324093810|FG003|Part B Run-in|Adverse Event|0|||
94627089|NCT01218204|324093807|FG000|Part B Run-in|Protocol Violation|0|||
94627090|NCT01218204|324093808|FG001|Part B Run-in|Protocol Violation|0|||
94627091|NCT01218204|324093809|FG002|Part B Run-in|Protocol Violation|2|||
94627092|NCT01218204|324093810|FG003|Part B Run-in|Protocol Violation|0|||
94627093|NCT01218204|324093807|FG000|Part B Run-in|Withdrawal by Subject|0|||
94627094|NCT01218204|324093808|FG001|Part B Run-in|Withdrawal by Subject|0|||
94461258|NCT02954653|323478228|FG005|Overall Study|Started another anti-cancer therapy|0|||
94627095|NCT01218204|324093809|FG002|Part B Run-in|Withdrawal by Subject|3|||
94627096|NCT01218204|324093810|FG003|Part B Run-in|Withdrawal by Subject|0|||
94627097|NCT01218204|324093807|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
94627098|NCT01218204|324093808|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
94627099|NCT01218204|324093809|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
94627100|NCT01218204|324093810|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
94627101|NCT01218204|324093807|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
94627102|NCT01218204|324093808|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
94627103|NCT01218204|324093809|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
94627104|NCT01218204|324093810|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
94627105|NCT00127660|324093811|FG000|Overall Study|Protocol Violation|3|||
94627106|NCT00127660|324093812|FG001|Overall Study|Protocol Violation|3|||
94627107|NCT00127660|324093813|FG002|Overall Study|Protocol Violation|5|||
94627108|NCT00127660|324093814|FG003|Overall Study|Protocol Violation|0|||
94627109|NCT01083576|324093815|FG000|Overall Study|Treatment Failure|6|||
94627110|NCT01083576|324093816|FG001|Overall Study|Treatment Failure|1|||
94627111|NCT02547649|324093817|FG000|Overall Study|Lost to Follow-up|3|||
94627112|NCT02547649|324093818|FG001|Overall Study|Lost to Follow-up|1|||
94627113|NCT02547649|324093819|FG002|Overall Study|Lost to Follow-up|1|||
94627114|NCT02547649|324093817|FG000|Overall Study|Not vaccinated|0|||
94627115|NCT02547649|324093818|FG001|Overall Study|Not vaccinated|0|||
94627116|NCT02547649|324093819|FG002|Overall Study|Not vaccinated|1|||
94255033|NCT05323396|322726486|FG000|Overall Study|Pregnancy|1|||
94255034|NCT05323396|322726487|FG001|Overall Study|Pregnancy|0|||
94255035|NCT02502799|322728403|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
94255036|NCT02502799|322728404|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
94255037|NCT02502799|322728405|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
94255038|NCT02502799|322728406|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
94255039|NCT02502799|322728403|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
94255040|NCT02502799|322728404|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
94255041|NCT02502799|322728405|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
94255042|NCT02502799|322728406|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
94255043|NCT02502799|322728403|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
94255044|NCT02502799|322728404|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
94255045|NCT02502799|322728405|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
94255046|NCT02502799|322728406|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
94255047|NCT02502799|322728403|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
94255048|NCT02502799|322728404|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
94255049|NCT02502799|322728405|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
94255050|NCT02502799|322728406|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
94255051|NCT02502799|322728403|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
94255052|NCT02502799|322728404|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
94255053|NCT02502799|322728405|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
94255054|NCT02502799|322728406|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
94255055|NCT00031551|322728407|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
94255056|NCT00031551|322728408|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
94255057|NCT02186223|322728415|FG000|Overall Study|Not eligible for device placement|6|||
94255058|NCT02186223|322728415|FG000|Overall Study|Unable to obtain femoral access|3|||
94255059|NCT02186223|322728415|FG000|Overall Study|Death|3|||
94255060|NCT02186223|322728415|FG000|Overall Study|Device in place less than 48 hours|9|||
94255061|NCT02079610|322728416|FG000|Overall Study|Withdrawal by Subject|1|||
94255062|NCT02079610|322728417|FG001|Overall Study|Withdrawal by Subject|1|||
94255063|NCT00250679|322728420|FG000|Overall Study|Adverse Event|12|||
94255064|NCT00250679|322728421|FG001|Overall Study|Adverse Event|15|||
94255065|NCT00250679|322728422|FG002|Overall Study|Adverse Event|16|||
94255066|NCT00250679|322728420|FG000|Overall Study|Protocol Violation|2|||
94255067|NCT00250679|322728421|FG001|Overall Study|Protocol Violation|4|||
94255068|NCT00250679|322728422|FG002|Overall Study|Protocol Violation|3|||
94255069|NCT00250679|322728420|FG000|Overall Study|Withdrawal by Subject|15|||
94255070|NCT00250679|322728421|FG001|Overall Study|Withdrawal by Subject|18|||
94255071|NCT00250679|322728422|FG002|Overall Study|Withdrawal by Subject|15|||
94255072|NCT00250679|322728420|FG000|Overall Study|Lost to Follow-up|3|||
94255073|NCT00250679|322728421|FG001|Overall Study|Lost to Follow-up|4|||
94255074|NCT00250679|322728422|FG002|Overall Study|Lost to Follow-up|2|||
94255075|NCT00250679|322728420|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
94255076|NCT00250679|322728421|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
94255077|NCT00250679|322728422|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
94255078|NCT00250679|322728420|FG000|Overall Study|Lack of Efficacy|0|||
94255079|NCT00250679|322728421|FG001|Overall Study|Lack of Efficacy|1|||
94255080|NCT00250679|322728422|FG002|Overall Study|Lack of Efficacy|3|||
94255081|NCT00250679|322728420|FG000|Overall Study|Technical Holter issues|1|||
94255082|NCT00250679|322728421|FG001|Overall Study|Technical Holter issues|0|||
94255083|NCT00250679|322728422|FG002|Overall Study|Technical Holter issues|2|||
94255084|NCT00250679|322728420|FG000|Overall Study|Moved|1|||
94255085|NCT00250679|322728421|FG001|Overall Study|Moved|1|||
94255086|NCT00250679|322728422|FG002|Overall Study|Moved|0|||
94255087|NCT00250679|322728420|FG000|Overall Study|Non-compliance|1|||
94255088|NCT00250679|322728421|FG001|Overall Study|Non-compliance|1|||
94255089|NCT00250679|322728422|FG002|Overall Study|Non-compliance|0|||
94255090|NCT00250679|322728420|FG000|Overall Study|various single events: hip surgery,diary|3|||
94255091|NCT00250679|322728421|FG001|Overall Study|various single events: hip surgery,diary|1|||
94255092|NCT00250679|322728422|FG002|Overall Study|various single events: hip surgery,diary|1|||
94255093|NCT01295034|322728424|FG000|Overall Study|Lost to Follow-up|5|||
94255094|NCT01295034|322728425|FG001|Overall Study|Lost to Follow-up|5|||
94255095|NCT00824161|322728430|FG000|Overall Study|Withdrawal by Subject|1|||
94255096|NCT00824161|322728430|FG000|Overall Study|Screen Failure|1|||
94673845|NCT02638948|324257787|FG003|Overall Study|Administrative Reason by Sponsor|4|||
94673846|NCT02638948|324257784|FG000|Overall Study|Adverse Event|0|||
94673847|NCT02638948|324257785|FG001|Overall Study|Adverse Event|0|||
94673848|NCT02638948|324257786|FG002|Overall Study|Adverse Event|1|||
94673849|NCT02638948|324257787|FG003|Overall Study|Adverse Event|1|||
94673850|NCT02638948|324257784|FG000|Overall Study|Lack of Efficacy|1|||
94673851|NCT02638948|324257785|FG001|Overall Study|Lack of Efficacy|1|||
94673852|NCT02638948|324257786|FG002|Overall Study|Lack of Efficacy|0|||
94673853|NCT02638948|324257787|FG003|Overall Study|Lack of Efficacy|0|||
94673854|NCT02638948|324257784|FG000|Overall Study|Lost to Follow-up|0|||
94673855|NCT02638948|324257785|FG001|Overall Study|Lost to Follow-up|0|||
94673856|NCT02638948|324257786|FG002|Overall Study|Lost to Follow-up|1|||
94673857|NCT02638948|324257787|FG003|Overall Study|Lost to Follow-up|1|||
94673858|NCT02638948|324257784|FG000|Overall Study|Poor/Non-Compliance|0|||
94673859|NCT02638948|324257785|FG001|Overall Study|Poor/Non-Compliance|2|||
94673860|NCT02638948|324257786|FG002|Overall Study|Poor/Non-Compliance|1|||
94673861|NCT02638948|324257787|FG003|Overall Study|Poor/Non-Compliance|0|||
94673862|NCT02638948|324257784|FG000|Overall Study|Participant no longer met study criteria|0|||
94673863|NCT02638948|324257785|FG001|Overall Study|Participant no longer met study criteria|1|||
94673864|NCT02638948|324257786|FG002|Overall Study|Participant no longer met study criteria|0|||
94673865|NCT02638948|324257787|FG003|Overall Study|Participant no longer met study criteria|0|||
94673866|NCT02638948|324257784|FG000|Overall Study|Other than specified above|4|||
94673867|NCT02638948|324257785|FG001|Overall Study|Other than specified above|1|||
94673868|NCT02638948|324257786|FG002|Overall Study|Other than specified above|1|||
94673869|NCT02638948|324257787|FG003|Overall Study|Other than specified above|1|||
94673870|NCT00696410|324257797|FG000|Overall Study|Lost to Follow-up|2|||
94673871|NCT00696410|324257798|FG001|Overall Study|Lost to Follow-up|0|||
94673872|NCT00696410|324257797|FG000|Overall Study|Withdrawal by Subject|8|||
94673873|NCT00696410|324257798|FG001|Overall Study|Withdrawal by Subject|0|||
94673874|NCT00696410|324257797|FG000|Overall Study|Physician Decision|3|||
94673875|NCT00696410|324257798|FG001|Overall Study|Physician Decision|0|||
94673876|NCT00538590|324257799|FG000|Overall Study|Death|1|||
94673877|NCT00538590|324257800|FG001|Overall Study|Death|0|||
94673878|NCT01256567|324257801|FG000|Overall Study|Withdrawal by Subject|1|||
94673879|NCT00450411|324257807|FG000|Overall Study|Protocol Violation|6|||
94673880|NCT00450411|324257807|FG000|Overall Study|No protocol treatment|2|||
94673881|NCT00344461|324257810|FG000|Overall Study|Adverse Event|6|||
94673882|NCT00344461|324257810|FG000|Overall Study|Death|1|||
94673883|NCT00344461|324257810|FG000|Overall Study|Lack of Efficacy|2|||
94673884|NCT00344461|324257810|FG000|Overall Study|Lost to Follow-up|2|||
94673885|NCT00344461|324257810|FG000|Overall Study|Physician Decision|2|||
94673886|NCT00344461|324257810|FG000|Overall Study|Protocol Violation|6|||
94673887|NCT00344461|324257810|FG000|Overall Study|Withdrawal by Subject|2|||
94673888|NCT02883062|324257811|FG000|Overall Study|Withdrawal by Subject|6|||
94673889|NCT02883062|324257812|FG001|Overall Study|Withdrawal by Subject|0|||
94673890|NCT03221387|324257816|FG000|Overall Study|Lost to Follow-up|1|||
94673891|NCT03221387|324257816|FG000|Overall Study|Lung transplant|1|||
94673892|NCT00803452|324257819|FG000|Overall Study|Adverse Event|0|||
94673893|NCT00803452|324257820|FG001|Overall Study|Adverse Event|2|||
94673894|NCT00803452|324257819|FG000|Overall Study|Lost to Follow-up|0|||
94673895|NCT00803452|324257820|FG001|Overall Study|Lost to Follow-up|3|||
94673896|NCT02048072|324257821|FG000|Overall Study|Adverse Event|3|||
94673897|NCT02048072|324257821|FG000|Overall Study|Lost to Follow-up|1|||
94673898|NCT04102579|324257822|FG000|Overall Study|Withdrawal by Subject|3|||
94673899|NCT04102579|324257823|FG001|Overall Study|Withdrawal by Subject|4|||
94673900|NCT04102579|324257822|FG000|Overall Study|Lost to Follow-up|0|||
94673901|NCT04102579|324257823|FG001|Overall Study|Lost to Follow-up|1|||
94673902|NCT04102579|324257822|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
94673903|NCT04102579|324257823|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
94673904|NCT04102579|324257822|FG000|Overall Study|Other than Specified|1|||
94673905|NCT04102579|324257823|FG001|Overall Study|Other than Specified|0|||
94673906|NCT04102579|324257822|FG000|Overall Study|Not Dosed with Study Drug|0|||
94673907|NCT04102579|324257823|FG001|Overall Study|Not Dosed with Study Drug|1|||
94673908|NCT05899686|324257824|FG000|Overall Study|Protocol Violation|1|||
94673909|NCT00572195|324257825|FG000|Overall Study|Withdrawal by Subject|50|||
94673910|NCT00572195|324257825|FG000|Overall Study|Death|9|||
94673911|NCT00572195|324257825|FG000|Overall Study|Adverse Event|4|||
94255097|NCT03271021|322728431|FG000|Overall Study|Adverse Event|3|||
94255098|NCT03271021|322728432|FG001|Overall Study|Adverse Event|2|||
94255099|NCT03271021|322728431|FG000|Overall Study|Withdrawal by Subject|36|||
94255100|NCT03271021|322728432|FG001|Overall Study|Withdrawal by Subject|53|||
94255101|NCT03271021|322728431|FG000|Overall Study|Lost to Follow-up|34|||
94255102|NCT03271021|322728432|FG001|Overall Study|Lost to Follow-up|39|||
94255103|NCT03271021|322728431|FG000|Overall Study|Protocol Violation|6|||
94255104|NCT03271021|322728432|FG001|Overall Study|Protocol Violation|4|||
94255105|NCT03271021|322728431|FG000|Overall Study|Abnormal Lab Results|1|||
94255106|NCT03271021|322728432|FG001|Overall Study|Abnormal Lab Results|0|||
94673912|NCT00572195|324257825|FG000|Overall Study|Lost to Follow-up|5|||
94627117|NCT02547649|324093817|FG000|Overall Study|Withdrawal by Subject|0|||
94627118|NCT02547649|324093818|FG001|Overall Study|Withdrawal by Subject|4|||
94627119|NCT02547649|324093819|FG002|Overall Study|Withdrawal by Subject|2|||
94627120|NCT01906008|324093827|FG000|Overall Study|Lost to Follow-up|2|||
94627121|NCT01906008|324093828|FG001|Overall Study|Lost to Follow-up|0|||
94627122|NCT01906008|324093827|FG000|Overall Study|Oxaliplatin toxicity|2|||
94627123|NCT01906008|324093828|FG001|Overall Study|Oxaliplatin toxicity|0|||
94627124|NCT01906008|324093827|FG000|Overall Study|Protocol Violation|0|||
94627125|NCT01906008|324093828|FG001|Overall Study|Protocol Violation|1|||
94627126|NCT01906008|324093827|FG000|Overall Study|Withdrawal by Subject|1|||
94627127|NCT01906008|324093828|FG001|Overall Study|Withdrawal by Subject|5|||
94627128|NCT01906008|324093827|FG000|Overall Study|Did not start study med|3|||
94627129|NCT01906008|324093828|FG001|Overall Study|Did not start study med|4|||
94627130|NCT01906008|324093827|FG000|Overall Study|Oxaliplatin stops|10|||
94627131|NCT01906008|324093828|FG001|Overall Study|Oxaliplatin stops|8|||
94627132|NCT01906008|324093827|FG000|Overall Study|Hospice|1|||
94627133|NCT01906008|324093828|FG001|Overall Study|Hospice|0|||
94627134|NCT01906008|324093827|FG000|Overall Study|Physician Decision|3|||
94627135|NCT01906008|324093828|FG001|Overall Study|Physician Decision|3|||
94627136|NCT01906008|324093827|FG000|Overall Study|Lack of compliance of study med|5|||
94627137|NCT01906008|324093828|FG001|Overall Study|Lack of compliance of study med|3|||
94627138|NCT01906008|324093827|FG000|Overall Study|Adverse Event|0|||
94627139|NCT01906008|324093828|FG001|Overall Study|Adverse Event|3|||
94627140|NCT02266225|324093833|FG000|Overall Study|Lost to Follow-up|2|||
94627141|NCT02266225|324093833|FG000|Overall Study|Death|1|||
94627142|NCT02266225|324093833|FG000|Overall Study|Withdrawal by Subject|13|||
94627143|NCT00420927|324093834|FG000|Period 1|Adverse Event|19|||
94627144|NCT00420927|324093835|FG001|Period 1|Adverse Event|15|||
94627145|NCT00420927|324093836|FG002|Period 1|Adverse Event|0|||
94627146|NCT00420927|324093837|FG003|Period 1|Adverse Event|0|||
94627147|NCT00420927|324093838|FG004|Period 1|Adverse Event|0|||
94627148|NCT00420927|324093839|FG005|Period 1|Adverse Event|0|||
94627149|NCT00420927|324093840|FG006|Period 1|Adverse Event|0|||
94627150|NCT00420927|324093834|FG000|Period 1|Withdrawal by Subject|7|||
94627151|NCT00420927|324093835|FG001|Period 1|Withdrawal by Subject|12|||
94627152|NCT00420927|324093836|FG002|Period 1|Withdrawal by Subject|0|||
94627153|NCT00420927|324093837|FG003|Period 1|Withdrawal by Subject|0|||
94627154|NCT00420927|324093838|FG004|Period 1|Withdrawal by Subject|0|||
94627155|NCT00420927|324093839|FG005|Period 1|Withdrawal by Subject|0|||
94627156|NCT00420927|324093840|FG006|Period 1|Withdrawal by Subject|0|||
94627157|NCT00420927|324093834|FG000|Period 1|Lost to Follow-up|8|||
94627158|NCT00420927|324093835|FG001|Period 1|Lost to Follow-up|6|||
94627159|NCT00420927|324093836|FG002|Period 1|Lost to Follow-up|0|||
94627160|NCT00420927|324093837|FG003|Period 1|Lost to Follow-up|0|||
94627161|NCT00420927|324093838|FG004|Period 1|Lost to Follow-up|0|||
94627162|NCT00420927|324093839|FG005|Period 1|Lost to Follow-up|0|||
94627163|NCT00420927|324093840|FG006|Period 1|Lost to Follow-up|0|||
94627164|NCT00420927|324093834|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
94627165|NCT00420927|324093835|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
94627166|NCT00420927|324093836|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
94627167|NCT00420927|324093837|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
94627168|NCT00420927|324093838|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
94627169|NCT00420927|324093839|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
94627170|NCT00420927|324093840|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
94627171|NCT00420927|324093834|FG000|Period 1|Death|2|||
94627172|NCT00420927|324093835|FG001|Period 1|Death|0|||
94627173|NCT00420927|324093836|FG002|Period 1|Death|0|||
94627174|NCT00420927|324093837|FG003|Period 1|Death|0|||
94627175|NCT00420927|324093838|FG004|Period 1|Death|0|||
94627176|NCT00420927|324093839|FG005|Period 1|Death|0|||
94627177|NCT00420927|324093840|FG006|Period 1|Death|0|||
94627178|NCT00420927|324093834|FG000|Period 1|Subject moved/relocated|0|||
94627179|NCT00420927|324093835|FG001|Period 1|Subject moved/relocated|2|||
94627180|NCT00420927|324093836|FG002|Period 1|Subject moved/relocated|0|||
94627181|NCT00420927|324093837|FG003|Period 1|Subject moved/relocated|0|||
94627182|NCT00420927|324093838|FG004|Period 1|Subject moved/relocated|0|||
94627183|NCT00420927|324093839|FG005|Period 1|Subject moved/relocated|0|||
94627184|NCT00420927|324093840|FG006|Period 1|Subject moved/relocated|0|||
94627185|NCT00420927|324093834|FG000|Period 1|Noncompliant with study drug|1|||
94627186|NCT00420927|324093835|FG001|Period 1|Noncompliant with study drug|1|||
94627187|NCT00420927|324093836|FG002|Period 1|Noncompliant with study drug|0|||
94627188|NCT00420927|324093837|FG003|Period 1|Noncompliant with study drug|0|||
94627189|NCT00420927|324093838|FG004|Period 1|Noncompliant with study drug|0|||
94627190|NCT00420927|324093839|FG005|Period 1|Noncompliant with study drug|0|||
94627191|NCT00420927|324093840|FG006|Period 1|Noncompliant with study drug|0|||
94627192|NCT00420927|324093834|FG000|Period 1|Randomization error|1|||
94627193|NCT00420927|324093835|FG001|Period 1|Randomization error|0|||
94627194|NCT00420927|324093836|FG002|Period 1|Randomization error|0|||
94627195|NCT00420927|324093837|FG003|Period 1|Randomization error|0|||
94627196|NCT00420927|324093838|FG004|Period 1|Randomization error|0|||
94627197|NCT00420927|324093839|FG005|Period 1|Randomization error|0|||
94255107|NCT03271021|322728431|FG000|Overall Study|Miscellaneous|9|||
94627198|NCT00420927|324093840|FG006|Period 1|Randomization error|0|||
94627199|NCT00420927|324093834|FG000|Period 1|Suspected tuberculosis/positive test|1|||
94627200|NCT00420927|324093835|FG001|Period 1|Suspected tuberculosis/positive test|1|||
94627201|NCT00420927|324093836|FG002|Period 1|Suspected tuberculosis/positive test|0|||
94627202|NCT00420927|324093837|FG003|Period 1|Suspected tuberculosis/positive test|0|||
94627203|NCT00420927|324093838|FG004|Period 1|Suspected tuberculosis/positive test|0|||
94627204|NCT00420927|324093839|FG005|Period 1|Suspected tuberculosis/positive test|0|||
94627205|NCT00420927|324093840|FG006|Period 1|Suspected tuberculosis/positive test|0|||
94627206|NCT00420927|324093834|FG000|Period 1|Study site closure|0|||
94627207|NCT00420927|324093835|FG001|Period 1|Study site closure|1|||
94627208|NCT00420927|324093836|FG002|Period 1|Study site closure|0|||
94627209|NCT00420927|324093837|FG003|Period 1|Study site closure|0|||
94627210|NCT00420927|324093838|FG004|Period 1|Study site closure|0|||
94627211|NCT00420927|324093839|FG005|Period 1|Study site closure|0|||
94627212|NCT00420927|324093840|FG006|Period 1|Study site closure|0|||
94627213|NCT00420927|324093834|FG000|Period 1|Subject received new diagnosis|0|||
94627214|NCT00420927|324093835|FG001|Period 1|Subject received new diagnosis|2|||
94627215|NCT00420927|324093836|FG002|Period 1|Subject received new diagnosis|0|||
94627216|NCT00420927|324093837|FG003|Period 1|Subject received new diagnosis|0|||
94627217|NCT00420927|324093838|FG004|Period 1|Subject received new diagnosis|0|||
94627218|NCT00420927|324093839|FG005|Period 1|Subject received new diagnosis|0|||
94627219|NCT00420927|324093840|FG006|Period 1|Subject received new diagnosis|0|||
94627220|NCT00420927|324093834|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
94627221|NCT00420927|324093835|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
94627222|NCT00420927|324093836|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
94627223|NCT00420927|324093837|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
94627224|NCT00420927|324093838|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
94627225|NCT00420927|324093839|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
94627226|NCT00420927|324093840|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
94627227|NCT00420927|324093834|FG000|Period 1|Failed to meet entry criteria|8|||
94627228|NCT00420927|324093835|FG001|Period 1|Failed to meet entry criteria|7|||
94627229|NCT00420927|324093836|FG002|Period 1|Failed to meet entry criteria|0|||
94627230|NCT00420927|324093837|FG003|Period 1|Failed to meet entry criteria|0|||
94627231|NCT00420927|324093838|FG004|Period 1|Failed to meet entry criteria|0|||
94627232|NCT00420927|324093839|FG005|Period 1|Failed to meet entry criteria|0|||
94627233|NCT00420927|324093840|FG006|Period 1|Failed to meet entry criteria|0|||
94627234|NCT00420927|324093834|FG000|Period 1|Took prohibited medication|1|||
94627235|NCT00420927|324093835|FG001|Period 1|Took prohibited medication|3|||
94627236|NCT00420927|324093836|FG002|Period 1|Took prohibited medication|0|||
94627237|NCT00420927|324093837|FG003|Period 1|Took prohibited medication|0|||
94627238|NCT00420927|324093838|FG004|Period 1|Took prohibited medication|0|||
94627239|NCT00420927|324093839|FG005|Period 1|Took prohibited medication|0|||
94627240|NCT00420927|324093840|FG006|Period 1|Took prohibited medication|0|||
94627241|NCT00420927|324093834|FG000|Period 2|Adverse Event|0|||
94627242|NCT00420927|324093835|FG001|Period 2|Adverse Event|0|||
94627243|NCT00420927|324093836|FG002|Period 2|Adverse Event|7|||
94627244|NCT00420927|324093837|FG003|Period 2|Adverse Event|3|||
94627245|NCT00420927|324093838|FG004|Period 2|Adverse Event|17|||
94627246|NCT00420927|324093839|FG005|Period 2|Adverse Event|6|||
94627247|NCT00420927|324093840|FG006|Period 2|Adverse Event|20|||
94627248|NCT00420927|324093834|FG000|Period 2|Withdrawal by Subject|0|||
94627249|NCT00420927|324093835|FG001|Period 2|Withdrawal by Subject|0|||
94627250|NCT00420927|324093836|FG002|Period 2|Withdrawal by Subject|1|||
94627251|NCT00420927|324093837|FG003|Period 2|Withdrawal by Subject|3|||
94627252|NCT00420927|324093838|FG004|Period 2|Withdrawal by Subject|11|||
94627253|NCT00420927|324093839|FG005|Period 2|Withdrawal by Subject|2|||
94627254|NCT00420927|324093840|FG006|Period 2|Withdrawal by Subject|12|||
94627255|NCT00420927|324093834|FG000|Period 2|Lost to Follow-up|0|||
94627256|NCT00420927|324093835|FG001|Period 2|Lost to Follow-up|0|||
94627257|NCT00420927|324093836|FG002|Period 2|Lost to Follow-up|2|||
94627258|NCT00420927|324093837|FG003|Period 2|Lost to Follow-up|2|||
94627259|NCT00420927|324093838|FG004|Period 2|Lost to Follow-up|6|||
94627260|NCT00420927|324093839|FG005|Period 2|Lost to Follow-up|3|||
94627261|NCT00420927|324093840|FG006|Period 2|Lost to Follow-up|9|||
94627262|NCT00420927|324093834|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
94627263|NCT00420927|324093835|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
94627264|NCT00420927|324093836|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
94255108|NCT03271021|322728432|FG001|Overall Study|Miscellaneous|8|||
94627265|NCT00420927|324093837|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
94627266|NCT00420927|324093838|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
94627267|NCT00420927|324093839|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
94627268|NCT00420927|324093840|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
94627269|NCT00420927|324093834|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
94627270|NCT00420927|324093835|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
94673913|NCT03360942|324257830|FG000|Overall Study|Device explanted|2|||
94673914|NCT03360942|324257830|FG000|Overall Study|Study closure|1|||
94673915|NCT03360942|324257830|FG000|Overall Study|Withdrawal by Subject|2|||
94673916|NCT03538951|324257831|FG000|Overall Study|Withdrawal by Subject|1|||
94673917|NCT03538951|324257832|FG001|Overall Study|Withdrawal by Subject|2|||
94673918|NCT00003508|324259412|FG000|Overall Study|Not evaluable|5|||
94673919|NCT01712009|324259413|FG000|Overall Study|Withdrawal by Subject|24|||
94673920|NCT01712009|324259414|FG001|Overall Study|Withdrawal by Subject|15|||
94673921|NCT01712009|324259415|FG002|Overall Study|Withdrawal by Subject|8|||
94673922|NCT01712009|324259413|FG000|Overall Study|Lost to Follow-up|2|||
94673923|NCT01712009|324259414|FG001|Overall Study|Lost to Follow-up|0|||
94673924|NCT01712009|324259415|FG002|Overall Study|Lost to Follow-up|1|||
94673925|NCT01712009|324259413|FG000|Overall Study|Decision by Sponsor|12|||
94673926|NCT01712009|324259414|FG001|Overall Study|Decision by Sponsor|14|||
94673927|NCT01712009|324259415|FG002|Overall Study|Decision by Sponsor|12|||
94673928|NCT03382782|324259419|FG000|Cohort 1|Withdrawal by Subject|11|||
94673929|NCT03382782|324259420|FG001|Cohort 1|Withdrawal by Subject|5|||
94673930|NCT03382782|324259421|FG002|Cohort 1|Withdrawal by Subject|0|||
94673931|NCT03382782|324259419|FG000|Cohort 2|Withdrawal by Subject|1|||
94673932|NCT03382782|324259420|FG001|Cohort 2|Withdrawal by Subject|1|||
94673933|NCT03382782|324259421|FG002|Cohort 2|Withdrawal by Subject|0|||
94673934|NCT03382782|324259419|FG000|Cohort 3|Withdrawal by Subject|1|||
94673935|NCT03382782|324259420|FG001|Cohort 3|Withdrawal by Subject|2|||
94673936|NCT03382782|324259421|FG002|Cohort 3|Withdrawal by Subject|0|||
94673937|NCT03409666|324259422|FG000|Overall Study|Physician Decision|0|||
94673938|NCT03409666|324259423|FG001|Overall Study|Physician Decision|1|||
94673939|NCT03409666|324259422|FG000|Overall Study|Protocol Violation|0|||
94673940|NCT03409666|324259423|FG001|Overall Study|Protocol Violation|3|||
94673941|NCT00512148|324259424|FG000|Primay Study Period|Withdrawal by Subject|1|||
94673942|NCT02001194|324259428|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
94673943|NCT02001194|324259429|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
94673944|NCT02001194|324259430|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
94673945|NCT02001194|324259431|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
94673946|NCT02001194|324259428|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
94673947|NCT02001194|324259429|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
94627271|NCT00420927|324093836|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
94627272|NCT00420927|324093837|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
94627273|NCT00420927|324093838|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
94627274|NCT00420927|324093839|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
94627275|NCT00420927|324093840|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
94627276|NCT00420927|324093834|FG000|Period 2|Subject unable to find transportation|0|||
94627277|NCT00420927|324093835|FG001|Period 2|Subject unable to find transportation|0|||
94627278|NCT00420927|324093836|FG002|Period 2|Subject unable to find transportation|0|||
94627279|NCT00420927|324093837|FG003|Period 2|Subject unable to find transportation|0|||
94627280|NCT00420927|324093838|FG004|Period 2|Subject unable to find transportation|0|||
94627281|NCT00420927|324093839|FG005|Period 2|Subject unable to find transportation|0|||
94627282|NCT00420927|324093840|FG006|Period 2|Subject unable to find transportation|1|||
94627283|NCT00420927|324093834|FG000|Period 2|Physician Decision|0|||
94627284|NCT00420927|324093835|FG001|Period 2|Physician Decision|0|||
94627285|NCT00420927|324093836|FG002|Period 2|Physician Decision|0|||
94627286|NCT00420927|324093837|FG003|Period 2|Physician Decision|0|||
94627287|NCT00420927|324093838|FG004|Period 2|Physician Decision|1|||
94627288|NCT00420927|324093839|FG005|Period 2|Physician Decision|1|||
94627289|NCT00420927|324093840|FG006|Period 2|Physician Decision|0|||
94627290|NCT00420927|324093834|FG000|Period 2|Sponsor decision|0|||
94627291|NCT00420927|324093835|FG001|Period 2|Sponsor decision|0|||
94627292|NCT00420927|324093836|FG002|Period 2|Sponsor decision|1|||
94627293|NCT00420927|324093837|FG003|Period 2|Sponsor decision|0|||
94673948|NCT02001194|324259430|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
94673949|NCT02001194|324259431|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
94673950|NCT02184611|324259439|FG000|Overall Study|Lack of Efficacy|11|||
94627294|NCT00420927|324093838|FG004|Period 2|Sponsor decision|0|||
94627295|NCT00420927|324093839|FG005|Period 2|Sponsor decision|0|||
94627296|NCT00420927|324093840|FG006|Period 2|Sponsor decision|1|||
94627297|NCT00420927|324093834|FG000|Period 2|Randomization error|0|||
94627298|NCT00420927|324093835|FG001|Period 2|Randomization error|0|||
94627299|NCT00420927|324093836|FG002|Period 2|Randomization error|0|||
94627300|NCT00420927|324093837|FG003|Period 2|Randomization error|0|||
94627301|NCT00420927|324093838|FG004|Period 2|Randomization error|1|||
94627302|NCT00420927|324093839|FG005|Period 2|Randomization error|1|||
94673951|NCT02184611|324259440|FG001|Overall Study|Lack of Efficacy|15|||
94673952|NCT02184611|324259439|FG000|Overall Study|Withdrawal by Subject|5|||
94673953|NCT02184611|324259440|FG001|Overall Study|Withdrawal by Subject|6|||
94673954|NCT02184611|324259439|FG000|Overall Study|Adverse Event|4|||
94673955|NCT02184611|324259440|FG001|Overall Study|Adverse Event|5|||
94673956|NCT02184611|324259439|FG000|Overall Study|Protocol Violation|1|||
94627303|NCT00420927|324093840|FG006|Period 2|Randomization error|0|||
94673957|NCT02184611|324259440|FG001|Overall Study|Protocol Violation|1|||
94360211|NCT00650806|323101833|FG002|Overall Study|Withdrawal by Subject|8|||
94360212|NCT00650806|323101834|FG003|Overall Study|Withdrawal by Subject|6|||
94360213|NCT00650806|323101831|FG000|Overall Study|Noncompliance with study drug regimen|1|||
94360214|NCT00650806|323101832|FG001|Overall Study|Noncompliance with study drug regimen|1|||
94627304|NCT00420927|324093834|FG000|Period 2|Noncompliant with study drug|0|||
94627305|NCT00420927|324093835|FG001|Period 2|Noncompliant with study drug|0|||
94627306|NCT00420927|324093836|FG002|Period 2|Noncompliant with study drug|0|||
94627307|NCT00420927|324093837|FG003|Period 2|Noncompliant with study drug|1|||
94627308|NCT00420927|324093838|FG004|Period 2|Noncompliant with study drug|0|||
94627309|NCT00420927|324093839|FG005|Period 2|Noncompliant with study drug|0|||
94627310|NCT00420927|324093840|FG006|Period 2|Noncompliant with study drug|2|||
94627311|NCT00420927|324093834|FG000|Period 2|Methotrexate intolerance|0|||
94627312|NCT00420927|324093835|FG001|Period 2|Methotrexate intolerance|0|||
94627313|NCT00420927|324093836|FG002|Period 2|Methotrexate intolerance|0|||
94627314|NCT00420927|324093837|FG003|Period 2|Methotrexate intolerance|0|||
94627315|NCT00420927|324093838|FG004|Period 2|Methotrexate intolerance|0|||
94627316|NCT00420927|324093839|FG005|Period 2|Methotrexate intolerance|0|||
94627317|NCT00420927|324093840|FG006|Period 2|Methotrexate intolerance|1|||
94627318|NCT00420927|324093834|FG000|Period 2|Took prohibited medication|0|||
94627319|NCT00420927|324093835|FG001|Period 2|Took prohibited medication|0|||
94627320|NCT00420927|324093836|FG002|Period 2|Took prohibited medication|0|||
94627321|NCT00420927|324093837|FG003|Period 2|Took prohibited medication|0|||
94673958|NCT02184611|324259439|FG000|Overall Study|Protocol defined stopping criteria|0|||
94360215|NCT00650806|323101833|FG002|Overall Study|Noncompliance with study drug regimen|0|||
94627322|NCT00420927|324093838|FG004|Period 2|Took prohibited medication|1|||
94627323|NCT00420927|324093839|FG005|Period 2|Took prohibited medication|0|||
94627324|NCT00420927|324093840|FG006|Period 2|Took prohibited medication|0|||
94627325|NCT02246660|324093841|FG000|Overall Study|Withdrawal by Subject|0|||
94627326|NCT02246660|324093842|FG001|Overall Study|Withdrawal by Subject|1|||
94627327|NCT02246660|324093843|FG002|Overall Study|Withdrawal by Subject|0|||
94627328|NCT02246660|324093841|FG000|Overall Study|Death|0|||
94627329|NCT02246660|324093842|FG001|Overall Study|Death|0|||
94673959|NCT02184611|324259440|FG001|Overall Study|Protocol defined stopping criteria|1|||
94673960|NCT00522301|324259441|FG000|Overall Study|Withdrawal by Subject|1|||
94673961|NCT00522301|324259441|FG000|Overall Study|Adverse Event|5|||
94673962|NCT00985725|324259448|FG000|Overall Study|Adverse Event|4|||
94673963|NCT00985725|324259449|FG001|Overall Study|Adverse Event|1|||
94673964|NCT00985725|324259448|FG000|Overall Study|Protocol Violation|1|||
94673965|NCT00985725|324259449|FG001|Overall Study|Protocol Violation|3|||
94673966|NCT00985725|324259448|FG000|Overall Study|Withdrawal by Subject|4|||
94673967|NCT00985725|324259449|FG001|Overall Study|Withdrawal by Subject|4|||
94673968|NCT00985725|324259448|FG000|Overall Study|Lost to Follow-up|1|||
94673969|NCT00985725|324259449|FG001|Overall Study|Lost to Follow-up|1|||
94360216|NCT00650806|323101834|FG003|Overall Study|Noncompliance with study drug regimen|0|||
94627330|NCT02246660|324093843|FG002|Overall Study|Death|1|||
94627331|NCT02557646|324093849|FG000|Overall Study|Adverse Event|40|||
94673970|NCT00985725|324259448|FG000|Overall Study|Lack of Efficacy|0|||
94360217|NCT00650806|323101831|FG000|Overall Study|Study terminated by sponsor|2|||
94627332|NCT02557646|324093849|FG000|Overall Study|Death|1|||
94627333|NCT02557646|324093849|FG000|Overall Study|Lack of Efficacy|186|||
94627334|NCT02557646|324093849|FG000|Overall Study|Withdrawal by Subject|18|||
94627335|NCT02557646|324093849|FG000|Overall Study|Lost to Follow-up|17|||
94627336|NCT02557646|324093849|FG000|Overall Study|Other|14|||
94627337|NCT00518986|324093854|FG000|Overall Study|Adverse Event|12|||
94627338|NCT00518986|324093855|FG001|Overall Study|Adverse Event|7|||
94627339|NCT00518986|324093854|FG000|Overall Study|Lack of Efficacy|0|||
94627340|NCT00518986|324093855|FG001|Overall Study|Lack of Efficacy|2|||
94627341|NCT00518986|324093854|FG000|Overall Study|Lost to Follow-up|3|||
94627342|NCT00518986|324093855|FG001|Overall Study|Lost to Follow-up|2|||
94627343|NCT00518986|324093854|FG000|Overall Study|Physician Decision|0|||
94627344|NCT00518986|324093855|FG001|Overall Study|Physician Decision|3|||
94627345|NCT00518986|324093854|FG000|Overall Study|Protocol Violation|5|||
94627346|NCT00518986|324093855|FG001|Overall Study|Protocol Violation|7|||
94627347|NCT00518986|324093854|FG000|Overall Study|Withdrawal by Subject|4|||
94627348|NCT00518986|324093855|FG001|Overall Study|Withdrawal by Subject|4|||
94627349|NCT00518986|324093854|FG000|Overall Study|Non-Specific|2|||
94627350|NCT00518986|324093855|FG001|Overall Study|Non-Specific|1|||
94627351|NCT04997161|324093856|FG000|Overall Study|Study terminated by sponsor|3|||
94627352|NCT01919723|324093857|FG000|Overall Study|Blood Samples Hemolyzed|2|||
94627353|NCT01919723|324093858|FG001|Overall Study|Blood Samples Hemolyzed|2|||
94627354|NCT00582166|324093859|FG000|Overall Study|Death|1|||
94627355|NCT00582166|324093859|FG000|Overall Study|Ineligible pathology|1|||
94627356|NCT00211809|324093862|FG000|Overall Study|Lack of Efficacy|1|||
94627357|NCT00211809|324093862|FG000|Overall Study|Lost to Follow-up|2|||
94627358|NCT00211809|324093862|FG000|Overall Study|Pregnancy|1|||
94627359|NCT00211809|324093862|FG000|Overall Study|side effects|2|||
94627360|NCT01417234|324093863|FG000|Overall Study|Subject non-compliant|3|||
94627361|NCT04294472|324093864|FG000|Overall Study|Adverse Event|0|||
94627362|NCT04294472|324093865|FG001|Overall Study|Adverse Event|1|||
94627363|NCT04294472|324093866|FG002|Overall Study|Adverse Event|1|||
94627364|NCT04294472|324093864|FG000|Overall Study|Randomized but not treated|0|||
94627365|NCT04294472|324093865|FG001|Overall Study|Randomized but not treated|1|||
94627366|NCT04294472|324093866|FG002|Overall Study|Randomized but not treated|1|||
94627367|NCT03944954|324093872|FG000|Overall Study|Withdrawal by Subject|22|||
94627368|NCT03944954|324093873|FG001|Overall Study|Withdrawal by Subject|4|||
94627369|NCT03944954|324093872|FG000|Overall Study|Lost to Follow-up|18|||
94627370|NCT03944954|324093873|FG001|Overall Study|Lost to Follow-up|0|||
94627371|NCT03944954|324093872|FG000|Overall Study|Failed Medical Screening|7|||
94627372|NCT03944954|324093873|FG001|Overall Study|Failed Medical Screening|0|||
94360218|NCT00650806|323101832|FG001|Overall Study|Study terminated by sponsor|3|||
94360219|NCT00650806|323101833|FG002|Overall Study|Study terminated by sponsor|5|||
94360220|NCT00650806|323101834|FG003|Overall Study|Study terminated by sponsor|4|||
94627373|NCT02268084|324093874|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
94673971|NCT00985725|324259449|FG001|Overall Study|Lack of Efficacy|1|||
94673972|NCT00985725|324259448|FG000|Overall Study|Non-compliance|1|||
94673973|NCT00985725|324259449|FG001|Overall Study|Non-compliance|2|||
94360221|NCT00650806|323101831|FG000|Overall Study|Other|1|||
94627374|NCT02268084|324093875|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
94627375|NCT02268084|324093874|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
94627376|NCT02268084|324093875|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
94627377|NCT02603419|324093876|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
94627378|NCT02603419|324093877|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
94673974|NCT00985725|324259448|FG000|Overall Study|Out-of-window visits|0|||
94673975|NCT00985725|324259449|FG001|Overall Study|Out-of-window visits|1|||
94673976|NCT04605978|324259452|FG000|Overall Study|Adverse Event|2|||
94673977|NCT04605978|324259453|FG001|Overall Study|Adverse Event|1|||
94673978|NCT04605978|324259452|FG000|Overall Study|Withdrawal nonmedical reason|1|||
94673979|NCT04605978|324259453|FG001|Overall Study|Withdrawal nonmedical reason|1|||
94673980|NCT02583425|324259454|FG000|Screening|Did not meet entry criteria|12|||
94673981|NCT02583425|324259454|FG000|Baseline|Did not meet continued criteria|5|||
94673982|NCT02583425|324259454|FG000|Treatment Period|Adverse Event|1|||
94673983|NCT01690130|324259455|FG000|Overall Study|Subject have cancelled visit.|1|||
94673984|NCT01690130|324259456|FG001|Overall Study|Subject have cancelled visit.|0|||
94673985|NCT01644734|324259457|FG000|Overall Study|Adverse Event|4|||
94673986|NCT01644734|324259457|FG000|Overall Study|Lost to Follow-up|17|||
94673987|NCT01644734|324259457|FG000|Overall Study|Reasons other than stated above|7|||
94673988|NCT01644734|324259457|FG000|Overall Study|Missing documentation|238|||
94673989|NCT02565914|324259458|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
94673990|NCT02565914|324259458|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
94673991|NCT02565914|324259458|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
94673992|NCT02565914|324259458|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
94673993|NCT02565914|324259458|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
94673994|NCT02565914|324259458|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
94673995|NCT02565914|324259458|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
94673996|NCT02565914|324259458|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
94673997|NCT02565914|324259458|FG000|Part A (Up to 96 Weeks)|Other|18|||
94673998|NCT02565914|324259458|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
94673999|NCT02565914|324259458|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
94674000|NCT02565914|324259458|FG000|Part B (Up to 96 Weeks)|Other|1|||
94674001|NCT02565914|324259458|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
94674002|NCT02565914|324259458|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
94674003|NCT02565914|324259458|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
94674004|NCT02565914|324259458|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
94674005|NCT02565914|324259458|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
94674006|NCT02565914|324259458|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
94674007|NCT02565914|324259458|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
94674008|NCT02565914|324259458|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
94674009|NCT02565914|324259458|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
94674010|NCT02565914|324259458|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
94674011|NCT02565914|324259458|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
94674012|NCT02565914|324259458|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
94674013|NCT03466086|324259471|FG000|Period 1|Sponsor decision due to study timeline|1|||
94674014|NCT03466086|324259472|FG001|Period 1|Sponsor decision due to study timeline|0|||
94674015|NCT03466086|324259471|FG000|Period 1|Withdrawal by Subject|1|||
94674016|NCT03466086|324259472|FG001|Period 1|Withdrawal by Subject|0|||
94674017|NCT00002558|324259473|FG000|Overall Study|Withdrawal by Subject|0|||
94674018|NCT00002558|324259474|FG001|Overall Study|Withdrawal by Subject|1|||
94674019|NCT01949870|324259475|FG000|Overall Study|Lack of Efficacy|2|||
94674020|NCT01949870|324259475|FG000|Overall Study|Adverse Event|1|||
94674021|NCT01949870|324259475|FG000|Overall Study|Study termination|1|||
94674022|NCT01949870|324259475|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
94674023|NCT00781391|324259480|FG000|Overall Study|never received study drug|24|||
94674024|NCT00781391|324259481|FG001|Overall Study|never received study drug|23|||
94674025|NCT00781391|324259482|FG002|Overall Study|never received study drug|32|||
94674026|NCT00781391|324259480|FG000|Overall Study|Protocol Violation|19|||
94674027|NCT00781391|324259481|FG001|Overall Study|Protocol Violation|17|||
94674028|NCT00781391|324259482|FG002|Overall Study|Protocol Violation|20|||
94627379|NCT02603419|324093878|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
94627380|NCT02603419|324093879|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
94627381|NCT02603419|324093880|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
94627382|NCT02603419|324093881|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
94627383|NCT02603419|324093876|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
94627384|NCT02603419|324093877|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
94627385|NCT02603419|324093878|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
94627386|NCT02603419|324093879|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
94627387|NCT02603419|324093880|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
94674029|NCT00781391|324259480|FG000|Overall Study|Death|789|||
94674030|NCT00781391|324259481|FG001|Overall Study|Death|730|||
94674031|NCT00781391|324259482|FG002|Overall Study|Death|706|||
94674032|NCT00781391|324259480|FG000|Overall Study|Withdrawal by Subject|47|||
94674033|NCT00781391|324259481|FG001|Overall Study|Withdrawal by Subject|37|||
94674034|NCT00781391|324259482|FG002|Overall Study|Withdrawal by Subject|25|||
94674035|NCT00781391|324259480|FG000|Overall Study|Lost to Follow-up|0|||
94674036|NCT00781391|324259481|FG001|Overall Study|Lost to Follow-up|0|||
94674037|NCT00781391|324259482|FG002|Overall Study|Lost to Follow-up|1|||
94674038|NCT00645164|324259483|FG000|Overall Study|Lost to Follow-up|2|||
94674039|NCT00645164|324259483|FG000|Overall Study|Withdrawal by Subject|4|||
94674040|NCT00645164|324259483|FG000|Overall Study|Protocol Violation|1|||
94674041|NCT01822587|324259484|FG000|Overall Study|Lost to Follow-up|7|||
94674042|NCT01822587|324259485|FG001|Overall Study|Lost to Follow-up|9|||
94674043|NCT01822587|324259486|FG002|Overall Study|Lost to Follow-up|12|||
94674044|NCT01822587|324259484|FG000|Overall Study|Physician Decision|9|||
94674045|NCT01822587|324259485|FG001|Overall Study|Physician Decision|6|||
94674046|NCT01822587|324259486|FG002|Overall Study|Physician Decision|6|||
94674047|NCT01362439|324259489|FG000|Overall Study|Adverse Event|1|||
94674048|NCT01362439|324259489|FG000|Overall Study|Lack of Efficacy|3|||
94674049|NCT01362439|324259489|FG000|Overall Study|Lost to Follow-up|2|||
94674050|NCT01362439|324259489|FG000|Overall Study|Study medication non-compliant|1|||
94674051|NCT01362439|324259489|FG000|Overall Study|Participant who withdrew consent|8|||
94674052|NCT00658567|324259490|FG000|Overall Study|Adverse Event|5|||
94674053|NCT00658567|324259491|FG001|Overall Study|Adverse Event|2|||
94674054|NCT00658567|324259492|FG002|Overall Study|Adverse Event|3|||
94674055|NCT00658567|324259490|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
94674056|NCT00658567|324259491|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
94674057|NCT00658567|324259492|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
94674058|NCT00658567|324259490|FG000|Overall Study|Physician Decision|0|||
94674059|NCT00658567|324259491|FG001|Overall Study|Physician Decision|1|||
94674060|NCT00658567|324259492|FG002|Overall Study|Physician Decision|0|||
94674061|NCT00658567|324259490|FG000|Overall Study|At Discretion of Sponsor|1|||
94674062|NCT00658567|324259491|FG001|Overall Study|At Discretion of Sponsor|1|||
94674063|NCT00658567|324259492|FG002|Overall Study|At Discretion of Sponsor|1|||
94674064|NCT00611858|324259493|FG000|Overall Study|Adverse Event|2|||
94674065|NCT00611858|324259493|FG000|Overall Study|Withdrawal by Subject|2|||
94674066|NCT04259450|324259494|FG000|Overall Study|Adverse event/ Toxicity|0|||
94674067|NCT04259450|324259495|FG001|Overall Study|Adverse event/ Toxicity|3|||
94674068|NCT04259450|324259496|FG002|Overall Study|Adverse event/ Toxicity|0|||
94674069|NCT04259450|324259497|FG003|Overall Study|Adverse event/ Toxicity|1|||
94674070|NCT04259450|324259498|FG004|Overall Study|Adverse event/ Toxicity|0|||
94674071|NCT04259450|324259499|FG005|Overall Study|Adverse event/ Toxicity|0|||
94674072|NCT04259450|324259500|FG006|Overall Study|Adverse event/ Toxicity|0|||
94674073|NCT04259450|324259501|FG007|Overall Study|Adverse event/ Toxicity|1|||
94674074|NCT04259450|324259502|FG008|Overall Study|Adverse event/ Toxicity|0|||
94674075|NCT04259450|324259503|FG009|Overall Study|Adverse event/ Toxicity|3|||
94674076|NCT04259450|324259494|FG000|Overall Study|Disease progression|2|||
94674077|NCT04259450|324259495|FG001|Overall Study|Disease progression|3|||
94674078|NCT04259450|324259496|FG002|Overall Study|Disease progression|4|||
94674079|NCT04259450|324259497|FG003|Overall Study|Disease progression|4|||
94674080|NCT04259450|324259498|FG004|Overall Study|Disease progression|6|||
94674081|NCT04259450|324259499|FG005|Overall Study|Disease progression|6|||
94674082|NCT04259450|324259500|FG006|Overall Study|Disease progression|5|||
94674083|NCT04259450|324259501|FG007|Overall Study|Disease progression|15|||
94674084|NCT04259450|324259502|FG008|Overall Study|Disease progression|6|||
94674085|NCT04259450|324259503|FG009|Overall Study|Disease progression|17|||
94674086|NCT04259450|324259494|FG000|Overall Study|Death|0|||
94674087|NCT04259450|324259495|FG001|Overall Study|Death|0|||
94674088|NCT04259450|324259496|FG002|Overall Study|Death|0|||
94674089|NCT04259450|324259497|FG003|Overall Study|Death|0|||
94674090|NCT04259450|324259498|FG004|Overall Study|Death|0|||
94674091|NCT04259450|324259499|FG005|Overall Study|Death|0|||
94674092|NCT04259450|324259500|FG006|Overall Study|Death|0|||
94674093|NCT04259450|324259501|FG007|Overall Study|Death|1|||
94674094|NCT04259450|324259502|FG008|Overall Study|Death|1|||
94674095|NCT04259450|324259503|FG009|Overall Study|Death|0|||
94674096|NCT04259450|324259494|FG000|Overall Study|Withdrawal by Subject|0|||
94674097|NCT04259450|324259495|FG001|Overall Study|Withdrawal by Subject|0|||
94674098|NCT04259450|324259496|FG002|Overall Study|Withdrawal by Subject|0|||
94674099|NCT04259450|324259497|FG003|Overall Study|Withdrawal by Subject|0|||
94674100|NCT04259450|324259498|FG004|Overall Study|Withdrawal by Subject|0|||
94674101|NCT04259450|324259499|FG005|Overall Study|Withdrawal by Subject|0|||
94674102|NCT04259450|324259500|FG006|Overall Study|Withdrawal by Subject|0|||
94674103|NCT04259450|324259501|FG007|Overall Study|Withdrawal by Subject|1|||
94674104|NCT04259450|324259502|FG008|Overall Study|Withdrawal by Subject|0|||
94674105|NCT04259450|324259503|FG009|Overall Study|Withdrawal by Subject|0|||
94674106|NCT04259450|324259494|FG000|Overall Study|Long Term Adverse Event|0|||
94674107|NCT04259450|324259495|FG001|Overall Study|Long Term Adverse Event|0|||
94674108|NCT04259450|324259496|FG002|Overall Study|Long Term Adverse Event|0|||
94360222|NCT00650806|323101832|FG001|Overall Study|Other|1|||
94674109|NCT04259450|324259497|FG003|Overall Study|Long Term Adverse Event|0|||
94674110|NCT04259450|324259498|FG004|Overall Study|Long Term Adverse Event|0|||
94674111|NCT04259450|324259499|FG005|Overall Study|Long Term Adverse Event|0|||
94674112|NCT04259450|324259500|FG006|Overall Study|Long Term Adverse Event|0|||
94674113|NCT04259450|324259501|FG007|Overall Study|Long Term Adverse Event|0|||
94627388|NCT02603419|324093881|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
94627389|NCT02603419|324093876|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
94627390|NCT02603419|324093877|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
94627391|NCT02603419|324093878|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
94627392|NCT02603419|324093879|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
94627393|NCT02603419|324093880|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
94627394|NCT02603419|324093881|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
94627395|NCT02603419|324093876|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
94627396|NCT02603419|324093877|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
94255109|NCT02518490|322728433|FG000|Overall Study|Withdrawal by Subject|1|||
94255110|NCT02518490|322728434|FG001|Overall Study|Withdrawal by Subject|1|||
94255111|NCT01774487|322728437|FG000|Overall Study|Did not tolerate taste|4|||
94255112|NCT01774487|322728438|FG001|Overall Study|Did not tolerate taste|4|||
94627397|NCT02603419|324093878|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
94627398|NCT02603419|324093879|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
94255113|NCT00346632|322728439|FG000|Overall Study|Progressive Disease|2|||
94255114|NCT00346632|322728440|FG001|Overall Study|Progressive Disease|2|||
94255115|NCT00346632|322728441|FG002|Overall Study|Progressive Disease|4|||
94255116|NCT00346632|322728442|FG003|Overall Study|Progressive Disease|3|||
94255117|NCT00346632|322728443|FG004|Overall Study|Progressive Disease|3|||
94255118|NCT00346632|322728444|FG005|Overall Study|Progressive Disease|1|||
94255119|NCT00346632|322728445|FG006|Overall Study|Progressive Disease|2|||
94255120|NCT00346632|322728446|FG007|Overall Study|Progressive Disease|2|||
94255121|NCT00346632|322728447|FG008|Overall Study|Progressive Disease|2|||
94255122|NCT00346632|322728448|FG009|Overall Study|Progressive Disease|2|||
94255123|NCT00346632|322728439|FG000|Overall Study|Adverse Event|0|||
94255124|NCT00346632|322728440|FG001|Overall Study|Adverse Event|0|||
94255125|NCT00346632|322728441|FG002|Overall Study|Adverse Event|0|||
94255126|NCT00346632|322728442|FG003|Overall Study|Adverse Event|0|||
94255127|NCT00346632|322728443|FG004|Overall Study|Adverse Event|1|||
94255128|NCT00346632|322728444|FG005|Overall Study|Adverse Event|1|||
94255129|NCT00346632|322728445|FG006|Overall Study|Adverse Event|1|||
94255130|NCT00346632|322728446|FG007|Overall Study|Adverse Event|0|||
94255131|NCT00346632|322728447|FG008|Overall Study|Adverse Event|0|||
94255132|NCT00346632|322728448|FG009|Overall Study|Adverse Event|0|||
94255133|NCT00346632|322728439|FG000|Overall Study|Death|0|||
94255134|NCT00346632|322728440|FG001|Overall Study|Death|0|||
94255135|NCT00346632|322728441|FG002|Overall Study|Death|1|||
94627399|NCT02603419|324093880|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
94627400|NCT02603419|324093881|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
94627401|NCT02603419|324093876|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
94627402|NCT02603419|324093877|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
94627403|NCT02603419|324093878|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
94627404|NCT02603419|324093879|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
94627405|NCT02603419|324093880|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
94627406|NCT02603419|324093881|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
94627407|NCT02603419|324093876|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
94627408|NCT02603419|324093877|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
94627409|NCT02603419|324093878|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
94627410|NCT02603419|324093879|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
94627411|NCT02603419|324093880|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
94627412|NCT02603419|324093881|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
94627413|NCT02603419|324093876|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
94627414|NCT02603419|324093877|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
94627415|NCT02603419|324093878|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
94627416|NCT02603419|324093879|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
94627417|NCT02603419|324093880|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
94627418|NCT02603419|324093881|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
94627419|NCT02603419|324093876|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
94627420|NCT02603419|324093877|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
94627421|NCT02603419|324093878|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
94627422|NCT02603419|324093879|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
94627423|NCT02603419|324093880|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
94627424|NCT02603419|324093881|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
94627425|NCT02603419|324093876|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
94627426|NCT02603419|324093877|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
94627427|NCT02603419|324093878|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
94627428|NCT02603419|324093879|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
94627429|NCT02603419|324093880|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
94360223|NCT00650806|323101833|FG002|Overall Study|Other|2|||
94627430|NCT02603419|324093881|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
94627431|NCT02603419|324093876|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
94627432|NCT02603419|324093877|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
94627433|NCT02603419|324093878|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
94627434|NCT02603419|324093879|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
94627435|NCT02603419|324093880|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
94627436|NCT02603419|324093881|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
94627437|NCT00040664|324093882|FG000|Overall Study|Adverse Event|12|||
94627438|NCT00040664|324093883|FG001|Overall Study|Adverse Event|3|||
94627439|NCT00040664|324093884|FG002|Overall Study|Adverse Event|2|||
94627440|NCT00040664|324093885|FG003|Overall Study|Adverse Event|7|||
94627441|NCT00040664|324093882|FG000|Overall Study|Lack of Efficacy|9|||
94627442|NCT00040664|324093883|FG001|Overall Study|Lack of Efficacy|2|||
94627443|NCT00040664|324093884|FG002|Overall Study|Lack of Efficacy|3|||
94627444|NCT00040664|324093885|FG003|Overall Study|Lack of Efficacy|4|||
94627445|NCT00040664|324093882|FG000|Overall Study|Insufficient CD4 response|1|||
94627446|NCT00040664|324093883|FG001|Overall Study|Insufficient CD4 response|0|||
94627447|NCT00040664|324093884|FG002|Overall Study|Insufficient CD4 response|1|||
94627448|NCT00040664|324093885|FG003|Overall Study|Insufficient CD4 response|0|||
94627449|NCT00040664|324093882|FG000|Overall Study|Lost to Follow-up|4|||
94627450|NCT00040664|324093883|FG001|Overall Study|Lost to Follow-up|2|||
94627451|NCT00040664|324093884|FG002|Overall Study|Lost to Follow-up|0|||
94627452|NCT00040664|324093885|FG003|Overall Study|Lost to Follow-up|2|||
94627453|NCT00040664|324093882|FG000|Overall Study|Protocol Violation|2|||
94627454|NCT00040664|324093883|FG001|Overall Study|Protocol Violation|1|||
94627455|NCT00040664|324093884|FG002|Overall Study|Protocol Violation|0|||
94627456|NCT00040664|324093885|FG003|Overall Study|Protocol Violation|1|||
94627457|NCT00040664|324093882|FG000|Overall Study|Withdrawal by Subject|7|||
94627458|NCT00040664|324093883|FG001|Overall Study|Withdrawal by Subject|0|||
94627459|NCT00040664|324093884|FG002|Overall Study|Withdrawal by Subject|3|||
94627460|NCT00040664|324093885|FG003|Overall Study|Withdrawal by Subject|4|||
94627461|NCT00040664|324093882|FG000|Overall Study|Pregnancy|3|||
94627462|NCT00040664|324093883|FG001|Overall Study|Pregnancy|0|||
94627463|NCT00040664|324093884|FG002|Overall Study|Pregnancy|0|||
94627464|NCT00040664|324093885|FG003|Overall Study|Pregnancy|3|||
94627465|NCT00040664|324093882|FG000|Overall Study|Medication adherence/compliance problems|8|||
94627466|NCT00040664|324093883|FG001|Overall Study|Medication adherence/compliance problems|2|||
94627467|NCT00040664|324093884|FG002|Overall Study|Medication adherence/compliance problems|1|||
94627468|NCT00040664|324093885|FG003|Overall Study|Medication adherence/compliance problems|5|||
94627469|NCT00040664|324093882|FG000|Overall Study|Poor taste|2|||
94627470|NCT00040664|324093883|FG001|Overall Study|Poor taste|0|||
94360224|NCT00650806|323101834|FG003|Overall Study|Other|0|||
94627471|NCT00040664|324093884|FG002|Overall Study|Poor taste|2|||
94674114|NCT04259450|324259502|FG008|Overall Study|Long Term Adverse Event|0|||
94255136|NCT00346632|322728442|FG003|Overall Study|Death|0|||
94674115|NCT04259450|324259503|FG009|Overall Study|Long Term Adverse Event|1|||
94674116|NCT02954354|324259504|FG000|Overall Study|Adverse Event|2|||
94674117|NCT02954354|324259505|FG001|Overall Study|Adverse Event|2|||
94674118|NCT02954354|324259506|FG002|Overall Study|Adverse Event|4|||
94674119|NCT02954354|324259504|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
94674120|NCT02954354|324259505|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
94674121|NCT02954354|324259506|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
94674122|NCT02954354|324259504|FG000|Overall Study|Lack of Efficacy|0|||
94255137|NCT00346632|322728443|FG004|Overall Study|Death|0|||
94255138|NCT00346632|322728444|FG005|Overall Study|Death|0|||
94255139|NCT00346632|322728445|FG006|Overall Study|Death|0|||
94674123|NCT02954354|324259505|FG001|Overall Study|Lack of Efficacy|2|||
94674124|NCT02954354|324259506|FG002|Overall Study|Lack of Efficacy|0|||
94674125|NCT02954354|324259504|FG000|Overall Study|Withdrawal by Subject|17|||
94674126|NCT02954354|324259505|FG001|Overall Study|Withdrawal by Subject|9|||
94674127|NCT02954354|324259506|FG002|Overall Study|Withdrawal by Subject|11|||
94674128|NCT02954354|324259504|FG000|Overall Study|Lost to Follow-up|12|||
94674129|NCT02954354|324259505|FG001|Overall Study|Lost to Follow-up|5|||
94674130|NCT02954354|324259506|FG002|Overall Study|Lost to Follow-up|0|||
94674131|NCT02954354|324259504|FG000|Overall Study|Miscellaneous|2|||
94674132|NCT02954354|324259505|FG001|Overall Study|Miscellaneous|2|||
94674133|NCT02954354|324259506|FG002|Overall Study|Miscellaneous|1|||
94674134|NCT02612311|324259512|FG000|Overall Study|Adverse Event|16|||
94674135|NCT02612311|324259513|FG001|Overall Study|Adverse Event|12|||
94674136|NCT02612311|324259514|FG002|Overall Study|Adverse Event|7|||
94674137|NCT02612311|324259515|FG003|Overall Study|Adverse Event|13|||
94255140|NCT00346632|322728446|FG007|Overall Study|Death|0|||
94674138|NCT02612311|324259512|FG000|Overall Study|Death|29|||
94674139|NCT02612311|324259513|FG001|Overall Study|Death|10|||
94674140|NCT02612311|324259514|FG002|Overall Study|Death|11|||
94674141|NCT02612311|324259515|FG003|Overall Study|Death|11|||
94255141|NCT00346632|322728447|FG008|Overall Study|Death|0|||
94255142|NCT00346632|322728448|FG009|Overall Study|Death|0|||
94255143|NCT00346632|322728439|FG000|Overall Study|Protocol Violation|0|||
94255144|NCT00346632|322728440|FG001|Overall Study|Protocol Violation|0|||
94255145|NCT00346632|322728441|FG002|Overall Study|Protocol Violation|0|||
94255146|NCT00346632|322728442|FG003|Overall Study|Protocol Violation|0|||
94255147|NCT00346632|322728443|FG004|Overall Study|Protocol Violation|0|||
94255148|NCT00346632|322728444|FG005|Overall Study|Protocol Violation|0|||
94255149|NCT00346632|322728445|FG006|Overall Study|Protocol Violation|1|||
94255150|NCT00346632|322728446|FG007|Overall Study|Protocol Violation|0|||
94255151|NCT00346632|322728447|FG008|Overall Study|Protocol Violation|0|||
94255152|NCT00346632|322728448|FG009|Overall Study|Protocol Violation|0|||
94674142|NCT02612311|324259512|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
94674143|NCT02612311|324259513|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
94255153|NCT00346632|322728439|FG000|Overall Study|Withdrawal by Subject|0|||
94255154|NCT00346632|322728440|FG001|Overall Study|Withdrawal by Subject|0|||
94255155|NCT00346632|322728441|FG002|Overall Study|Withdrawal by Subject|0|||
94255156|NCT00346632|322728442|FG003|Overall Study|Withdrawal by Subject|0|||
94255157|NCT00346632|322728443|FG004|Overall Study|Withdrawal by Subject|0|||
94255158|NCT00346632|322728444|FG005|Overall Study|Withdrawal by Subject|0|||
94255159|NCT00346632|322728445|FG006|Overall Study|Withdrawal by Subject|1|||
94255160|NCT00346632|322728446|FG007|Overall Study|Withdrawal by Subject|0|||
94255161|NCT00346632|322728447|FG008|Overall Study|Withdrawal by Subject|0|||
94255162|NCT00346632|322728448|FG009|Overall Study|Withdrawal by Subject|0|||
94255163|NCT00346632|322728439|FG000|Overall Study|Switched to alternative treatment|0|||
94255164|NCT00346632|322728440|FG001|Overall Study|Switched to alternative treatment|0|||
94674144|NCT02612311|324259514|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
94674145|NCT02612311|324259515|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
94255165|NCT00346632|322728441|FG002|Overall Study|Switched to alternative treatment|1|||
94360225|NCT04882085|323101835|FG000|Overall Study|Death|6|||
94674146|NCT02612311|324259512|FG000|Overall Study|Investigator's Decision|11|||
94674147|NCT02612311|324259513|FG001|Overall Study|Investigator's Decision|15|||
94674148|NCT02612311|324259514|FG002|Overall Study|Investigator's Decision|6|||
94674149|NCT02612311|324259515|FG003|Overall Study|Investigator's Decision|6|||
94255166|NCT00346632|322728442|FG003|Overall Study|Switched to alternative treatment|0|||
94255167|NCT00346632|322728443|FG004|Overall Study|Switched to alternative treatment|0|||
94255168|NCT00346632|322728444|FG005|Overall Study|Switched to alternative treatment|0|||
94255169|NCT00346632|322728445|FG006|Overall Study|Switched to alternative treatment|0|||
94255170|NCT00346632|322728446|FG007|Overall Study|Switched to alternative treatment|0|||
94255171|NCT00346632|322728447|FG008|Overall Study|Switched to alternative treatment|0|||
94255172|NCT00346632|322728448|FG009|Overall Study|Switched to alternative treatment|0|||
94255173|NCT00346632|322728439|FG000|Overall Study|Not Stated|1|||
94674150|NCT02612311|324259512|FG000|Overall Study|Lack of Efficacy|0|||
94674151|NCT02612311|324259513|FG001|Overall Study|Lack of Efficacy|0|||
94255174|NCT00346632|322728440|FG001|Overall Study|Not Stated|1|||
94255175|NCT00346632|322728441|FG002|Overall Study|Not Stated|0|||
94255176|NCT00346632|322728442|FG003|Overall Study|Not Stated|0|||
94255177|NCT00346632|322728443|FG004|Overall Study|Not Stated|0|||
94255178|NCT00346632|322728444|FG005|Overall Study|Not Stated|0|||
94255179|NCT00346632|322728445|FG006|Overall Study|Not Stated|0|||
94255180|NCT00346632|322728446|FG007|Overall Study|Not Stated|2|||
94255181|NCT00346632|322728447|FG008|Overall Study|Not Stated|2|||
94255182|NCT00346632|322728448|FG009|Overall Study|Not Stated|1|||
94255183|NCT04882995|322728449|FG000|Overall Study|Withdrawal by Subject|1|||
94255184|NCT04882995|322728450|FG001|Overall Study|Withdrawal by Subject|2|||
94255185|NCT04882995|322728449|FG000|Overall Study|Protocol Violation|4|||
94255186|NCT04882995|322728450|FG001|Overall Study|Protocol Violation|4|||
94255187|NCT04882995|322728449|FG000|Overall Study|Surgery postponed due to COVID|1|||
94255188|NCT04882995|322728450|FG001|Overall Study|Surgery postponed due to COVID|1|||
94255189|NCT00477334|322728451|FG000|Overall Study|Discontinued prior to taking study drug|106|||
94255190|NCT00477334|322728452|FG001|Overall Study|Discontinued prior to taking study drug|53|||
94255191|NCT00477334|322728451|FG000|Overall Study|Adverse Event|1|||
94255192|NCT00477334|322728452|FG001|Overall Study|Adverse Event|2|||
94255193|NCT00477334|322728451|FG000|Overall Study|Withdrawal by Subject|2|||
94255194|NCT00477334|322728452|FG001|Overall Study|Withdrawal by Subject|1|||
94255195|NCT00477334|322728451|FG000|Overall Study|Lost to Follow-up|15|||
94255196|NCT00477334|322728452|FG001|Overall Study|Lost to Follow-up|4|||
94255197|NCT00477334|322728451|FG000|Overall Study|Administrative Problems|39|||
94255198|NCT00477334|322728452|FG001|Overall Study|Administrative Problems|15|||
94255199|NCT00477334|322728451|FG000|Overall Study|Protocol Violation|7|||
94255200|NCT00477334|322728452|FG001|Overall Study|Protocol Violation|1|||
94255201|NCT03587974|322728453|FG000|Overall Study|caregiver demented, care recipient died|3|||
94255202|NCT03587974|322728454|FG001|Overall Study|caregiver demented, care recipient died|3|||
94255203|NCT03587974|322728453|FG000|Overall Study|Withdrawal by Subject|2|||
94255204|NCT03587974|322728454|FG001|Overall Study|Withdrawal by Subject|1|||
94255205|NCT00372229|322728455|FG000|Study Phase|Graft loss|0|||
94255206|NCT00372229|322728456|FG001|Study Phase|Graft loss|3|||
94255207|NCT00372229|322728455|FG000|Study Phase|Protocol Violation|3|||
94255208|NCT00372229|322728456|FG001|Study Phase|Protocol Violation|4|||
94255209|NCT00372229|322728455|FG000|Study Phase|Consent withdrawn|16|||
94255210|NCT00372229|322728456|FG001|Study Phase|Consent withdrawn|14|||
94255211|NCT00372229|322728455|FG000|Study Phase|Refused treatment/did not cooperate|3|||
94255212|NCT00372229|322728456|FG001|Study Phase|Refused treatment/did not cooperate|1|||
94255213|NCT00372229|322728455|FG000|Study Phase|Death|3|||
94255214|NCT00372229|322728456|FG001|Study Phase|Death|2|||
94255215|NCT00372229|322728455|FG000|Study Phase|Reason not specified|3|||
94255216|NCT00372229|322728456|FG001|Study Phase|Reason not specified|2|||
94255217|NCT00372229|322728455|FG000|Study Phase|Lost to Follow-up|3|||
94255218|NCT00372229|322728456|FG001|Study Phase|Lost to Follow-up|3|||
94255219|NCT00372229|322728455|FG000|Follow-Up Phase|Graft loss|8|||
94255220|NCT00372229|322728456|FG001|Follow-Up Phase|Graft loss|7|||
94255221|NCT00372229|322728455|FG000|Follow-Up Phase|Consent withdrawn|13|||
94255222|NCT00372229|322728456|FG001|Follow-Up Phase|Consent withdrawn|19|||
94255223|NCT00372229|322728455|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
94255224|NCT00372229|322728456|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
94255225|NCT00372229|322728455|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
94255226|NCT00372229|322728456|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
94627472|NCT00040664|324093885|FG003|Overall Study|Poor taste|0|||
94627473|NCT00040664|324093882|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
94627474|NCT00040664|324093883|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
94627475|NCT00040664|324093884|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
94627476|NCT00040664|324093885|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
94627477|NCT00040664|324093882|FG000|Overall Study|Change of formulation|2|||
94627478|NCT00040664|324093883|FG001|Overall Study|Change of formulation|2|||
94627479|NCT00040664|324093884|FG002|Overall Study|Change of formulation|0|||
94627480|NCT00040664|324093885|FG003|Overall Study|Change of formulation|0|||
94627481|NCT00040664|324093882|FG000|Overall Study|Non-viability of oral suspension|1|||
94627482|NCT00040664|324093883|FG001|Overall Study|Non-viability of oral suspension|0|||
94627483|NCT00040664|324093884|FG002|Overall Study|Non-viability of oral suspension|1|||
94627484|NCT00040664|324093885|FG003|Overall Study|Non-viability of oral suspension|0|||
94627485|NCT01683383|324093886|FG000|Overall Study|Infant was not transported|1|||
94627486|NCT01683383|324093887|FG001|Overall Study|Infant was not transported|0|||
94255227|NCT00372229|322728455|FG000|Follow-Up Phase|Death|9|||
94255228|NCT00372229|322728456|FG001|Follow-Up Phase|Death|12|||
94255229|NCT00372229|322728455|FG000|Follow-Up Phase|Administrative|1|||
94255230|NCT00372229|322728456|FG001|Follow-Up Phase|Administrative|0|||
94255231|NCT00372229|322728455|FG000|Follow-Up Phase|Reason not specified|2|||
94255232|NCT00372229|322728456|FG001|Follow-Up Phase|Reason not specified|3|||
94255233|NCT00372229|322728455|FG000|Follow-Up Phase|Lost to Follow-up|12|||
94255234|NCT00372229|322728456|FG001|Follow-Up Phase|Lost to Follow-up|10|||
94255235|NCT01878214|322728457|FG000|Overall Study|Withdrawal by Subject|18|||
94674152|NCT02612311|324259514|FG002|Overall Study|Lack of Efficacy|1|||
94674153|NCT02612311|324259515|FG003|Overall Study|Lack of Efficacy|1|||
94674154|NCT02612311|324259512|FG000|Overall Study|Lost to Follow-up|2|||
94674155|NCT02612311|324259513|FG001|Overall Study|Lost to Follow-up|2|||
94674156|NCT02612311|324259514|FG002|Overall Study|Lost to Follow-up|1|||
94674157|NCT02612311|324259515|FG003|Overall Study|Lost to Follow-up|2|||
94674158|NCT02612311|324259512|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
94674159|NCT02612311|324259513|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
94674160|NCT02612311|324259514|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
94674161|NCT02612311|324259515|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
94674162|NCT02612311|324259512|FG000|Overall Study|Site Terminated by Sponsor|29|||
94674163|NCT02612311|324259513|FG001|Overall Study|Site Terminated by Sponsor|12|||
94674164|NCT02612311|324259514|FG002|Overall Study|Site Terminated by Sponsor|13|||
94674165|NCT02612311|324259515|FG003|Overall Study|Site Terminated by Sponsor|5|||
94674166|NCT02612311|324259512|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
94674167|NCT02612311|324259513|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
94360226|NCT04882085|323101836|FG001|Overall Study|Death|9|||
94674168|NCT02612311|324259514|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
94674169|NCT02612311|324259515|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
94674170|NCT02612311|324259512|FG000|Overall Study|Reason Not Specified|3|||
94674171|NCT02612311|324259513|FG001|Overall Study|Reason Not Specified|7|||
94674172|NCT02612311|324259514|FG002|Overall Study|Reason Not Specified|4|||
94674173|NCT02612311|324259515|FG003|Overall Study|Reason Not Specified|5|||
94674174|NCT02612311|324259512|FG000|Overall Study|Unknown/Missing|10|||
94674175|NCT02612311|324259513|FG001|Overall Study|Unknown/Missing|13|||
94674176|NCT02612311|324259514|FG002|Overall Study|Unknown/Missing|4|||
94255236|NCT01878214|322728458|FG001|Overall Study|Withdrawal by Subject|7|||
94255237|NCT01878214|322728457|FG000|Overall Study|Death|0|||
94255238|NCT01878214|322728458|FG001|Overall Study|Death|1|||
94255239|NCT01878214|322728457|FG000|Overall Study|Lost to Follow-up|35|||
94255240|NCT01878214|322728458|FG001|Overall Study|Lost to Follow-up|36|||
94255241|NCT00495586|322728461|FG000|Overall Study|Withdrawal by Subject|4|||
94255242|NCT00495586|322728462|FG001|Overall Study|Withdrawal by Subject|4|||
94255243|NCT03038438|322728463|FG000|Overall Study|Death|3|||
94255244|NCT03038438|322728463|FG000|Overall Study|Lost to Follow-up|8|||
94255245|NCT03038438|322728463|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
94255246|NCT03038438|322728463|FG000|Overall Study|Withdrawal by Subject|5|||
94255247|NCT03038438|322728463|FG000|Overall Study|No 36-Month Follow-Up|18|||
94255248|NCT03215810|322728464|FG000|Overall Study|Still responding to nivolumab|1|||
94255249|NCT03215810|322728464|FG000|Overall Study|Insufficient TIL growth|1|||
94255250|NCT03215810|322728464|FG000|Overall Study|Decline in performance status|1|||
94255251|NCT03215810|322728464|FG000|Overall Study|Withdrawal by Subject|1|||
94255252|NCT00701220|322728467|FG000|Overall Study|Withdrawal by Subject|0|||
94255253|NCT00701220|322728468|FG001|Overall Study|Withdrawal by Subject|2|||
94255254|NCT00701220|322728467|FG000|Overall Study|Protocol Violation|2|||
94255255|NCT00701220|322728468|FG001|Overall Study|Protocol Violation|0|||
94255256|NCT02095951|322728470|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
94255257|NCT02095951|322728471|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
94255258|NCT03618823|322728472|FG000|Overall Study|Lost to Follow-up|63|||
94255259|NCT03618823|322728473|FG001|Overall Study|Lost to Follow-up|61|||
94255260|NCT02483585|322728477|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
94255261|NCT02483585|322728478|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
94255262|NCT02483585|322728477|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
94255263|NCT02483585|322728478|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
94255264|NCT02483585|322728477|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
94255265|NCT02483585|322728478|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
94255266|NCT02483585|322728477|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
94255267|NCT02483585|322728478|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
94255268|NCT02483585|322728477|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
94255269|NCT02483585|322728478|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
94255270|NCT02483585|322728477|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
94255271|NCT02483585|322728478|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
94255272|NCT02483585|322728477|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
94255273|NCT02483585|322728478|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
94255274|NCT00842985|322728480|FG000|Screening|Did not meet entrance requirements|27|||
94255275|NCT00842985|322728480|FG000|First Intervention|Withdrawal by Subject|3|||
94255276|NCT00842985|322728480|FG000|First Intervention|Protocol Violation|3|||
94674177|NCT02612311|324259515|FG003|Overall Study|Unknown/Missing|0|||
94674178|NCT02612311|324259512|FG000|Overall Study|Non-Compliance with Study|1|||
94674179|NCT02612311|324259513|FG001|Overall Study|Non-Compliance with Study|0|||
94674180|NCT02612311|324259514|FG002|Overall Study|Non-Compliance with Study|0|||
94255277|NCT00842985|322728480|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
94255278|NCT00842985|322728480|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
94255279|NCT01990560|322728483|FG000|Overall Study|Withdrawal by Subject|1|||
94674181|NCT02612311|324259515|FG003|Overall Study|Non-Compliance with Study|0|||
94255280|NCT01236339|322728489|FG000|Overall Study|Termination of study by sponsor|11|||
94255281|NCT01236339|322728490|FG001|Overall Study|Termination of study by sponsor|13|||
94255282|NCT01098097|322728491|FG000|Overall Study|Adverse Event|17|||
94255283|NCT01098097|322728491|FG000|Overall Study|Lost to Follow-up|18|||
94255284|NCT01098097|322728491|FG000|Overall Study|Status unknown|16|||
94255285|NCT01098097|322728491|FG000|Overall Study|No reason reported|31|||
94255286|NCT00394082|322728492|FG000|Overall Study|Unacceptable toxicity|15|||
94255287|NCT00394082|322728492|FG000|Overall Study|Adverse Event|4|||
94255288|NCT00394082|322728492|FG000|Overall Study|Physician Decision|4|||
94255289|NCT00394082|322728492|FG000|Overall Study|Withdrawal by Subject|2|||
94255290|NCT00394082|322728492|FG000|Overall Study|Other|1|||
94255291|NCT01502631|322728493|FG000|Overall Study|Adverse Event|5|||
94255292|NCT01502631|322728494|FG001|Overall Study|Adverse Event|8|||
94255293|NCT01502631|322728493|FG000|Overall Study|Lost to Follow-up|2|||
94255294|NCT01502631|322728494|FG001|Overall Study|Lost to Follow-up|2|||
94255295|NCT01502631|322728493|FG000|Overall Study|Participant withdrew consent|2|||
94255296|NCT01502631|322728494|FG001|Overall Study|Participant withdrew consent|4|||
94255297|NCT01502631|322728493|FG000|Overall Study|Participant non-compliant|1|||
94255298|NCT01502631|322728494|FG001|Overall Study|Participant non-compliant|0|||
94255299|NCT01502631|322728493|FG000|Overall Study|Investigator's decision|0|||
94255300|NCT01502631|322728494|FG001|Overall Study|Investigator's decision|1|||
94255301|NCT01502631|322728493|FG000|Overall Study|Other|10|||
94255302|NCT01502631|322728494|FG001|Overall Study|Other|5|||
94255303|NCT00138671|322728495|FG000|Overall Study|Death|0|||
94255304|NCT00138671|322728496|FG001|Overall Study|Death|3|||
94255305|NCT00138671|322728495|FG000|Overall Study|Adverse Event|6|||
94255306|NCT00138671|322728496|FG001|Overall Study|Adverse Event|3|||
94255307|NCT00138671|322728495|FG000|Overall Study|Lost to Follow-up|1|||
94255308|NCT00138671|322728496|FG001|Overall Study|Lost to Follow-up|2|||
94255309|NCT00138671|322728495|FG000|Overall Study|Withdrawal by Subject|3|||
94255310|NCT00138671|322728496|FG001|Overall Study|Withdrawal by Subject|5|||
94255311|NCT00138671|322728495|FG000|Overall Study|Other|3|||
94255312|NCT00138671|322728496|FG001|Overall Study|Other|3|||
94255313|NCT00395460|322728499|FG000|Overall Study|Withdrawal by Subject|1|||
94255314|NCT00395460|322728500|FG001|Overall Study|Withdrawal by Subject|0|||
94255315|NCT01952054|322728502|FG000|Overall Study|Physician Decision|1|||
94255316|NCT01498653|322728505|FG000|Overall Study|Adverse Event|2|||
94255317|NCT01498653|322728506|FG001|Overall Study|Adverse Event|2|||
94255318|NCT01498653|322728505|FG000|Overall Study|Lack of Efficacy|12|||
94255319|NCT01498653|322728506|FG001|Overall Study|Lack of Efficacy|26|||
94255320|NCT01498653|322728505|FG000|Overall Study|Protocol Violation|0|||
94255321|NCT01498653|322728506|FG001|Overall Study|Protocol Violation|4|||
94255322|NCT01498653|322728505|FG000|Overall Study|Lost to Follow-up|1|||
94255323|NCT01498653|322728506|FG001|Overall Study|Lost to Follow-up|0|||
94255324|NCT01498653|322728505|FG000|Overall Study|Physician Decision|2|||
94255325|NCT01498653|322728506|FG001|Overall Study|Physician Decision|0|||
94255326|NCT01498653|322728505|FG000|Overall Study|Withdrawal by Subject|2|||
94255327|NCT01498653|322728506|FG001|Overall Study|Withdrawal by Subject|3|||
94255328|NCT02070588|322728508|FG000|Overall Study|Withdrawal by Subject|29|||
94255329|NCT02070588|322728509|FG001|Overall Study|Withdrawal by Subject|1|||
94255330|NCT02070588|322728510|FG002|Overall Study|Withdrawal by Subject|0|||
94255331|NCT02070588|322728508|FG000|Overall Study|Writhdrawal due to early termination|9|||
94674182|NCT02782169|324259518|FG000|Overall Study|Lost to Follow-up|1|||
94674183|NCT02782169|324259519|FG001|Overall Study|Lost to Follow-up|2|||
94674184|NCT01830127|324259523|FG000|Overall Study|Adverse Event|1|||
94674185|NCT01830127|324259524|FG001|Overall Study|Adverse Event|6|||
94255332|NCT02070588|322728509|FG001|Overall Study|Writhdrawal due to early termination|0|||
94255333|NCT02070588|322728510|FG002|Overall Study|Writhdrawal due to early termination|0|||
94255334|NCT02070588|322728508|FG000|Overall Study|Adverse Event|1|||
94255335|NCT02070588|322728509|FG001|Overall Study|Adverse Event|0|||
94255336|NCT02070588|322728510|FG002|Overall Study|Adverse Event|0|||
94255337|NCT00938860|322728512|FG000|Overall Study|Adverse Event|2|||
94255338|NCT00938860|322728513|FG001|Overall Study|Adverse Event|1|||
94255339|NCT00938860|322728512|FG000|Overall Study|Abnormal laboratory values|2|||
94255340|NCT00938860|322728513|FG001|Overall Study|Abnormal laboratory values|2|||
94255341|NCT00938860|322728512|FG000|Overall Study|Withdrawal by Subject|11|||
94674186|NCT01830127|324259523|FG000|Overall Study|Lack of Efficacy|3|||
94674187|NCT01830127|324259524|FG001|Overall Study|Lack of Efficacy|0|||
94674188|NCT01830127|324259523|FG000|Overall Study|Withdrawal by Subject|1|||
94674189|NCT01830127|324259524|FG001|Overall Study|Withdrawal by Subject|1|||
94674190|NCT01830127|324259523|FG000|Overall Study|Other reason not defined above|0|||
94674191|NCT01830127|324259524|FG001|Overall Study|Other reason not defined above|2|||
94674192|NCT00553696|324259532|FG000|Overall Study|Adverse Event|2|||
94674193|NCT00553696|324259533|FG001|Overall Study|Adverse Event|4|||
94674194|NCT00553696|324259534|FG002|Overall Study|Adverse Event|0|||
94674195|NCT00553696|324259535|FG003|Overall Study|Adverse Event|1|||
94674196|NCT00553696|324259532|FG000|Overall Study|Global deterioration of health status|0|||
94674197|NCT00553696|324259533|FG001|Overall Study|Global deterioration of health status|2|||
94674198|NCT00553696|324259534|FG002|Overall Study|Global deterioration of health status|0|||
94674199|NCT00553696|324259535|FG003|Overall Study|Global deterioration of health status|0|||
94674200|NCT00553696|324259532|FG000|Overall Study|Objective progression or relapse|2|||
94674201|NCT00553696|324259533|FG001|Overall Study|Objective progression or relapse|9|||
94674202|NCT00553696|324259534|FG002|Overall Study|Objective progression or relapse|6|||
94674203|NCT00553696|324259535|FG003|Overall Study|Objective progression or relapse|0|||
94674204|NCT00553696|324259532|FG000|Overall Study|Withdrawal by Subject|0|||
94674205|NCT00553696|324259533|FG001|Overall Study|Withdrawal by Subject|1|||
94674206|NCT00553696|324259534|FG002|Overall Study|Withdrawal by Subject|0|||
94674207|NCT00553696|324259535|FG003|Overall Study|Withdrawal by Subject|0|||
94674208|NCT02925676|324259536|FG000|Overall Study|Withdrawal by Subject|1|||
94674209|NCT01951638|324259543|FG000|Treatment Period|Protocol Violation|0|||
94674210|NCT01951638|324259544|FG001|Treatment Period|Protocol Violation|0|||
94674211|NCT01951638|324259545|FG002|Treatment Period|Protocol Violation|0|||
94674212|NCT01951638|324259546|FG003|Treatment Period|Protocol Violation|2|||
94674213|NCT01951638|324259547|FG004|Treatment Period|Protocol Violation|0|||
94674214|NCT01951638|324259543|FG000|Treatment Period|Protocol-driven decision point|1|||
94674215|NCT01951638|324259544|FG001|Treatment Period|Protocol-driven decision point|3|||
94674216|NCT01951638|324259545|FG002|Treatment Period|Protocol-driven decision point|0|||
94674217|NCT01951638|324259546|FG003|Treatment Period|Protocol-driven decision point|0|||
94674218|NCT01951638|324259547|FG004|Treatment Period|Protocol-driven decision point|0|||
94674219|NCT01951638|324259543|FG000|Treatment Period|Logistical difficulties|0|||
94674220|NCT01951638|324259544|FG001|Treatment Period|Logistical difficulties|1|||
94674221|NCT01951638|324259545|FG002|Treatment Period|Logistical difficulties|1|||
94674222|NCT01951638|324259546|FG003|Treatment Period|Logistical difficulties|0|||
94674223|NCT01951638|324259547|FG004|Treatment Period|Logistical difficulties|0|||
94674224|NCT01951638|324259543|FG000|Treatment Period|Withdrawal by Subject|9|||
94674225|NCT01951638|324259544|FG001|Treatment Period|Withdrawal by Subject|6|||
94674226|NCT01951638|324259545|FG002|Treatment Period|Withdrawal by Subject|4|||
94674227|NCT01951638|324259546|FG003|Treatment Period|Withdrawal by Subject|5|||
94674228|NCT01951638|324259547|FG004|Treatment Period|Withdrawal by Subject|4|||
94674229|NCT01951638|324259543|FG000|Treatment Period|Death|0|||
94674230|NCT01951638|324259544|FG001|Treatment Period|Death|0|||
94674231|NCT01951638|324259545|FG002|Treatment Period|Death|0|||
94674232|NCT01951638|324259546|FG003|Treatment Period|Death|3|||
94674233|NCT01951638|324259547|FG004|Treatment Period|Death|1|||
94674234|NCT01951638|324259543|FG000|Treatment Period|Adverse Event|3|||
94674235|NCT01951638|324259544|FG001|Treatment Period|Adverse Event|4|||
94674236|NCT01951638|324259545|FG002|Treatment Period|Adverse Event|8|||
94674237|NCT01951638|324259546|FG003|Treatment Period|Adverse Event|6|||
94674238|NCT01951638|324259547|FG004|Treatment Period|Adverse Event|5|||
94674239|NCT01951638|324259543|FG000|Follow-up Period|Protocol Violation|0|||
94674240|NCT01951638|324259544|FG001|Follow-up Period|Protocol Violation|0|||
94674241|NCT01951638|324259545|FG002|Follow-up Period|Protocol Violation|0|||
94674242|NCT01951638|324259546|FG003|Follow-up Period|Protocol Violation|1|||
94674243|NCT01951638|324259547|FG004|Follow-up Period|Protocol Violation|0|||
94674244|NCT01951638|324259543|FG000|Follow-up Period|Logistical difficulties|0|||
94674245|NCT01951638|324259544|FG001|Follow-up Period|Logistical difficulties|2|||
94674246|NCT01951638|324259545|FG002|Follow-up Period|Logistical difficulties|0|||
94674247|NCT01951638|324259546|FG003|Follow-up Period|Logistical difficulties|0|||
94674248|NCT01951638|324259547|FG004|Follow-up Period|Logistical difficulties|1|||
94674249|NCT01951638|324259543|FG000|Follow-up Period|Withdrawal by Subject|1|||
94674250|NCT01951638|324259544|FG001|Follow-up Period|Withdrawal by Subject|5|||
94674251|NCT01951638|324259545|FG002|Follow-up Period|Withdrawal by Subject|2|||
94674252|NCT01951638|324259546|FG003|Follow-up Period|Withdrawal by Subject|1|||
94674253|NCT01951638|324259547|FG004|Follow-up Period|Withdrawal by Subject|2|||
94674254|NCT01951638|324259543|FG000|Follow-up Period|Lost to Follow-up|0|||
94255342|NCT00938860|322728513|FG001|Overall Study|Withdrawal by Subject|8|||
94255343|NCT00938860|322728512|FG000|Overall Study|Lost to Follow-up|4|||
94255344|NCT00938860|322728513|FG001|Overall Study|Lost to Follow-up|4|||
94255345|NCT00938860|322728512|FG000|Overall Study|Administration problems|2|||
94360227|NCT04882085|323101835|FG000|Overall Study|Withdrawal by Subject|0|||
94360228|NCT04882085|323101836|FG001|Overall Study|Withdrawal by Subject|3|||
94360229|NCT04882085|323101835|FG000|Overall Study|Randomized not treated|1|||
94360230|NCT04882085|323101836|FG001|Overall Study|Randomized not treated|0|||
94360231|NCT01683565|323101837|FG000|Overall Study|Lost to Follow-up|2|||
94360232|NCT01683565|323101838|FG001|Overall Study|Lost to Follow-up|0|||
94360233|NCT01683565|323101837|FG000|Overall Study|Discontinued Intervention|1|||
94255346|NCT00938860|322728513|FG001|Overall Study|Administration problems|0|||
94255347|NCT00938860|322728512|FG000|Overall Study|Death|1|||
94255348|NCT00938860|322728513|FG001|Overall Study|Death|1|||
94255349|NCT00938860|322728512|FG000|Overall Study|Protocol Violation|3|||
94255350|NCT00938860|322728513|FG001|Overall Study|Protocol Violation|1|||
94255351|NCT01477333|322728514|FG000|Overall Study|Adverse Event|1|||
94255352|NCT01477333|322728514|FG000|Overall Study|Withdrawal by Subject|1|||
94255353|NCT01477333|322728514|FG000|Overall Study|Clinical Deterioration|1|||
94255354|NCT01759368|322728525|FG000|Overall Study|Lost to Follow-up|1|||
94255355|NCT01759368|322728526|FG001|Overall Study|Lost to Follow-up|0|||
94255356|NCT01959334|322728527|FG000|Second Dose|Adverse Event|1|||
94255357|NCT01959334|322728528|FG001|Second Dose|Adverse Event|0|||
94255358|NCT01959334|322728527|FG000|Third Dose|Adverse Event|0|||
94255359|NCT01959334|322728528|FG001|Third Dose|Adverse Event|1|||
94255360|NCT02009761|322728531|FG000|Overall Study|Adverse Event|4|||
94255361|NCT01636960|322728534|FG000|Induction Phase|Adverse Event|2|||
94255362|NCT01636960|322728534|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
94255363|NCT01636960|322728534|FG000|Maintenance Phase|Adverse Event|3|||
94255364|NCT01636960|322728534|FG000|Maintenance Phase|Progressive disease|1|||
94255365|NCT00679627|322728535|FG000|Overall Study|Death|41|||
94255366|NCT00679627|322728536|FG001|Overall Study|Death|29|||
94255367|NCT00679627|322728535|FG000|Overall Study|Adverse Event|43|||
94255368|NCT00679627|322728536|FG001|Overall Study|Adverse Event|53|||
94255369|NCT00679627|322728535|FG000|Overall Study|Withdrawal by Subject|168|||
94255370|NCT00679627|322728536|FG001|Overall Study|Withdrawal by Subject|172|||
94255371|NCT00679627|322728535|FG000|Overall Study|Lost to Follow-up|22|||
94255372|NCT00679627|322728536|FG001|Overall Study|Lost to Follow-up|26|||
94255373|NCT00679627|322728535|FG000|Overall Study|Early Study Closure|425|||
94255374|NCT00679627|322728536|FG001|Overall Study|Early Study Closure|405|||
94255375|NCT01079741|322728539|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
94255376|NCT01079741|322728540|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
94255377|NCT01079741|322728541|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
94255378|NCT01079741|322728542|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
94255379|NCT01079741|322728543|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
94255380|NCT01079741|322728539|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
94255381|NCT01079741|322728540|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
94255382|NCT01079741|322728541|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
94255383|NCT01079741|322728542|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
94255384|NCT01079741|322728543|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
94255385|NCT00940108|322728544|FG000|Overall Study|Adverse Event|2|||
94360234|NCT01683565|323101838|FG001|Overall Study|Discontinued Intervention|1|||
94360235|NCT00071006|323101839|FG000|Overall Study|Lack of Efficacy|7|||
94360236|NCT00071006|323101839|FG000|Overall Study|Adverse Event|1|||
94360237|NCT00071006|323101839|FG000|Overall Study|Withdrawal by Subject|1|||
94360238|NCT00071006|323101839|FG000|Overall Study|Other|3|||
94360239|NCT01215968|323101840|FG000|Overall Study|Adverse Event|0|||
94360240|NCT01215968|323101841|FG001|Overall Study|Adverse Event|2|||
94360241|NCT01215968|323101840|FG000|Overall Study|Protocol Violation|2|||
94360242|NCT01215968|323101841|FG001|Overall Study|Protocol Violation|4|||
94360243|NCT01215968|323101840|FG000|Overall Study|Not received study drug|0|||
94360244|NCT01215968|323101841|FG001|Overall Study|Not received study drug|1|||
94360245|NCT02851069|323101843|FG000|Overall Study|Failure to Return|3|||
94360246|NCT02851069|323101843|FG000|Overall Study|Other|3|||
94360247|NCT00777920|323101847|FG000|Overall Study|Adverse Event|39|||
94627487|NCT02496611|324093890|FG000|Overall Study|Lost to Follow-up|2|||
94627488|NCT02496611|324093891|FG001|Overall Study|Lost to Follow-up|1|||
94627489|NCT02496611|324093890|FG000|Overall Study|Withdrawal by Subject|5|||
94627490|NCT02496611|324093891|FG001|Overall Study|Withdrawal by Subject|2|||
94627491|NCT03798483|324093892|FG000|Overall Study|Lost to Follow-up|2|||
94627492|NCT01918085|324093917|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
94627493|NCT01918085|324093918|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
94627494|NCT02760069|324093924|FG000|Overall Study|Withdrawal by Subject|0|||
94627495|NCT02760069|324093925|FG001|Overall Study|Withdrawal by Subject|1|||
94627496|NCT02760069|324093926|FG002|Overall Study|Withdrawal by Subject|1|||
94627497|NCT00357968|324093931|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
94627498|NCT00357968|324093932|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
94674255|NCT01951638|324259544|FG001|Follow-up Period|Lost to Follow-up|1|||
94674256|NCT01951638|324259545|FG002|Follow-up Period|Lost to Follow-up|0|||
94674257|NCT01951638|324259546|FG003|Follow-up Period|Lost to Follow-up|1|||
94674258|NCT01951638|324259547|FG004|Follow-up Period|Lost to Follow-up|0|||
94674259|NCT01951638|324259543|FG000|Follow-up Period|Death|1|||
94674260|NCT01951638|324259544|FG001|Follow-up Period|Death|0|||
94674261|NCT01951638|324259545|FG002|Follow-up Period|Death|1|||
94674262|NCT01951638|324259546|FG003|Follow-up Period|Death|4|||
94674263|NCT01951638|324259547|FG004|Follow-up Period|Death|1|||
94674264|NCT01951638|324259543|FG000|Follow-up Period|Adverse Event|0|||
94674265|NCT01951638|324259544|FG001|Follow-up Period|Adverse Event|1|||
94674266|NCT01951638|324259545|FG002|Follow-up Period|Adverse Event|2|||
94674267|NCT01951638|324259546|FG003|Follow-up Period|Adverse Event|1|||
94674268|NCT01951638|324259547|FG004|Follow-up Period|Adverse Event|1|||
94674269|NCT02365519|324259548|FG000|Randomized and Treated|Adverse Event|0|||
94674270|NCT02365519|324259549|FG001|Randomized and Treated|Adverse Event|1|||
94674271|NCT02365519|324259550|FG002|Randomized and Treated|Adverse Event|0|||
94674272|NCT02365519|324259548|FG000|Randomized and Treated|Withdrawal by Subject|0|||
94674273|NCT02365519|324259549|FG001|Randomized and Treated|Withdrawal by Subject|1|||
94674274|NCT02365519|324259550|FG002|Randomized and Treated|Withdrawal by Subject|1|||
94255386|NCT00940108|322728545|FG001|Overall Study|Adverse Event|4|||
94255387|NCT00940108|322728546|FG002|Overall Study|Adverse Event|0|||
94255388|NCT00940108|322728547|FG003|Overall Study|Adverse Event|2|||
94255389|NCT00940108|322728544|FG000|Overall Study|Withdrew Consent|2|||
94255390|NCT00940108|322728545|FG001|Overall Study|Withdrew Consent|1|||
94255391|NCT00940108|322728546|FG002|Overall Study|Withdrew Consent|0|||
94255392|NCT00940108|322728547|FG003|Overall Study|Withdrew Consent|1|||
94255393|NCT00940108|322728544|FG000|Overall Study|Dose 2 contraindicated|1|||
94255394|NCT00940108|322728545|FG001|Overall Study|Dose 2 contraindicated|1|||
94255395|NCT00940108|322728546|FG002|Overall Study|Dose 2 contraindicated|0|||
94255396|NCT00940108|322728547|FG003|Overall Study|Dose 2 contraindicated|1|||
94255397|NCT00940108|322728544|FG000|Overall Study|Declined further vaccination|0|||
94255398|NCT00940108|322728545|FG001|Overall Study|Declined further vaccination|1|||
94255399|NCT00940108|322728546|FG002|Overall Study|Declined further vaccination|3|||
94255400|NCT00940108|322728547|FG003|Overall Study|Declined further vaccination|0|||
94255401|NCT00940108|322728544|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
94255402|NCT00940108|322728545|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
94255403|NCT00940108|322728546|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
94255404|NCT00940108|322728547|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
94255405|NCT00940108|322728544|FG000|Overall Study|Viral illness after Dose 1|0|||
94255406|NCT00940108|322728545|FG001|Overall Study|Viral illness after Dose 1|1|||
94255407|NCT00940108|322728546|FG002|Overall Study|Viral illness after Dose 1|0|||
94255408|NCT00940108|322728547|FG003|Overall Study|Viral illness after Dose 1|0|||
94255409|NCT00940108|322728544|FG000|Overall Study|Diagnosed with H1N1|0|||
94461259|NCT02954653|323478229|FG006|Overall Study|Started another anti-cancer therapy|0|||
94627499|NCT00357968|324093931|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
94627500|NCT00357968|324093932|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
94627501|NCT01482884|324093940|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
94627502|NCT01482884|324093941|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
94627503|NCT01482884|324093940|FG000|Overall Study|Protocol Violation|1|||
94627504|NCT01482884|324093941|FG001|Overall Study|Protocol Violation|0|||
94627505|NCT01482884|324093940|FG000|Overall Study|Lost to Follow-up|2|||
94627506|NCT01482884|324093941|FG001|Overall Study|Lost to Follow-up|2|||
94627507|NCT01482884|324093940|FG000|Overall Study|Lack of Efficacy|0|||
94627508|NCT01482884|324093941|FG001|Overall Study|Lack of Efficacy|1|||
94627509|NCT01482884|324093940|FG000|Overall Study|Adverse Event|2|||
94627510|NCT01482884|324093941|FG001|Overall Study|Adverse Event|1|||
94627511|NCT01482884|324093940|FG000|Overall Study|Withdrawal by Subject|8|||
94627512|NCT01482884|324093941|FG001|Overall Study|Withdrawal by Subject|13|||
94627513|NCT02846779|324093955|FG000|Overall Study|Lost Enrollment|83|||
94627514|NCT02846779|324093956|FG001|Overall Study|Lost Enrollment|82|||
94627515|NCT02846779|324093957|FG002|Overall Study|Lost Enrollment|86|||
94627516|NCT02846779|324093955|FG000|Overall Study|Less than 31 days of follow-up|56|||
94627517|NCT02846779|324093956|FG001|Overall Study|Less than 31 days of follow-up|45|||
94627518|NCT02846779|324093957|FG002|Overall Study|Less than 31 days of follow-up|52|||
94627519|NCT01753856|324093958|FG000|Overall Study|Adverse Event|1|||
94627520|NCT01753856|324093959|FG001|Overall Study|Adverse Event|0|||
94674275|NCT03419364|324259552|FG000|Overall Study|Delivery due to maternal condition|2|||
94255410|NCT00940108|322728545|FG001|Overall Study|Diagnosed with H1N1|0|||
94255411|NCT00940108|322728546|FG002|Overall Study|Diagnosed with H1N1|0|||
94627521|NCT01753856|324093958|FG000|Overall Study|Withdrawal by Subject|0|||
94627522|NCT01753856|324093959|FG001|Overall Study|Withdrawal by Subject|2|||
94674276|NCT03419364|324259553|FG001|Overall Study|Delivery due to maternal condition|0|||
94255412|NCT00940108|322728547|FG003|Overall Study|Diagnosed with H1N1|1|||
94627523|NCT01753856|324093958|FG000|Overall Study|Sponsor Decision|2|||
94674277|NCT03419364|324259554|FG002|Overall Study|Delivery due to maternal condition|0|||
94674278|NCT00657618|324259555|FG000|Overall Study|Adverse Event|32|||
94674279|NCT00657618|324259555|FG000|Overall Study|Withdrawal by Subject|8|||
94674280|NCT00657618|324259555|FG000|Overall Study|negative for leishmaniasis|2|||
94674281|NCT00657618|324259555|FG000|Overall Study|didn't start due to schedule conflicts|1|||
94674282|NCT01592370|324259561|FG000|Overall Study|Disease Progression|62|||
94674283|NCT01592370|324259562|FG001|Overall Study|Disease Progression|16|||
94674284|NCT01592370|324259563|FG002|Overall Study|Disease Progression|52|||
94674285|NCT01592370|324259564|FG003|Overall Study|Disease Progression|3|||
94674286|NCT01592370|324259565|FG004|Overall Study|Disease Progression|3|||
94674287|NCT01592370|324259566|FG005|Overall Study|Disease Progression|31|||
94674288|NCT01592370|324259567|FG006|Overall Study|Disease Progression|14|||
94674289|NCT01592370|324259561|FG000|Overall Study|Study Drug Toxicity|14|||
94674290|NCT01592370|324259562|FG001|Overall Study|Study Drug Toxicity|3|||
94674291|NCT01592370|324259563|FG002|Overall Study|Study Drug Toxicity|0|||
94674292|NCT01592370|324259564|FG003|Overall Study|Study Drug Toxicity|0|||
94674293|NCT01592370|324259565|FG004|Overall Study|Study Drug Toxicity|0|||
94674294|NCT01592370|324259566|FG005|Overall Study|Study Drug Toxicity|0|||
94674295|NCT01592370|324259567|FG006|Overall Study|Study Drug Toxicity|1|||
94674296|NCT01592370|324259561|FG000|Overall Study|AE unrelated to study drug|4|||
94674297|NCT01592370|324259562|FG001|Overall Study|AE unrelated to study drug|3|||
94674298|NCT01592370|324259563|FG002|Overall Study|AE unrelated to study drug|0|||
94674299|NCT01592370|324259564|FG003|Overall Study|AE unrelated to study drug|0|||
94674300|NCT01592370|324259565|FG004|Overall Study|AE unrelated to study drug|0|||
94674301|NCT01592370|324259566|FG005|Overall Study|AE unrelated to study drug|0|||
94674302|NCT01592370|324259567|FG006|Overall Study|AE unrelated to study drug|1|||
94255413|NCT01588496|322728548|FG000|Overall Study|Withdrawal by Subject|0|||
94255414|NCT01588496|322728549|FG001|Overall Study|Withdrawal by Subject|1|||
94255415|NCT01588496|322728550|FG002|Overall Study|Withdrawal by Subject|0|||
94255416|NCT00705523|322728551|FG000|Overall Study|Lost to Follow-up|2|||
94255417|NCT00705523|322728552|FG001|Overall Study|Lost to Follow-up|3|||
94255418|NCT04217590|322728553|FG000|Overall Study|Other|1|||
94255419|NCT04217590|322728554|FG001|Overall Study|Other|1|||
94255420|NCT04217590|322728553|FG000|Overall Study|Withdrawal by Subject|3|||
94255421|NCT04217590|322728554|FG001|Overall Study|Withdrawal by Subject|1|||
94255422|NCT04217590|322728553|FG000|Overall Study|Death|0|||
94255423|NCT04217590|322728554|FG001|Overall Study|Death|1|||
94255424|NCT03353350|322728557|FG000|30-week Core Treatment Period|Protocol Violation|1|||
94255425|NCT03353350|322728558|FG001|30-week Core Treatment Period|Protocol Violation|1|||
94255426|NCT03353350|322728559|FG002|30-week Core Treatment Period|Protocol Violation|1|||
94255427|NCT03353350|322728560|FG003|30-week Core Treatment Period|Protocol Violation|0|||
94255428|NCT03353350|322728557|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
94255429|NCT03353350|322728558|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
94255430|NCT03353350|322728559|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
94255431|NCT03353350|322728560|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
94255432|NCT03353350|322728557|FG000|30-week Core Treatment Period|Adverse Event|0|||
94255433|NCT03353350|322728558|FG001|30-week Core Treatment Period|Adverse Event|4|||
94255434|NCT03353350|322728559|FG002|30-week Core Treatment Period|Adverse Event|2|||
94255435|NCT03353350|322728560|FG003|30-week Core Treatment Period|Adverse Event|3|||
94255436|NCT03353350|322728557|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
94255437|NCT03353350|322728558|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
94255438|NCT03353350|322728559|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
94255439|NCT03353350|322728560|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
94255440|NCT03353350|322728557|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
94255441|NCT03353350|322728558|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
94255442|NCT03353350|322728559|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
94255443|NCT03353350|322728560|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
94255444|NCT03353350|322728557|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
94255445|NCT03353350|322728558|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
94255446|NCT03353350|322728559|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
94255447|NCT03353350|322728560|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
94255448|NCT03353350|322728557|FG000|26-week Treatment Extension Period|Adverse Event|1|||
94255449|NCT03353350|322728558|FG001|26-week Treatment Extension Period|Adverse Event|0|||
94255450|NCT03353350|322728559|FG002|26-week Treatment Extension Period|Adverse Event|0|||
94255451|NCT03353350|322728560|FG003|26-week Treatment Extension Period|Adverse Event|1|||
94255452|NCT03353350|322728557|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
94255453|NCT03353350|322728558|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
94255454|NCT03353350|322728559|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
94255455|NCT03353350|322728560|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
94360248|NCT00777920|323101847|FG000|Overall Study|Withdrawal of Consent|4|||
94360249|NCT00777920|323101847|FG000|Overall Study|Lost to Follow-up|1|||
94674303|NCT01592370|324259561|FG000|Overall Study|Request to discontinue study treatment|5|||
94674304|NCT01592370|324259562|FG001|Overall Study|Request to discontinue study treatment|0|||
94674305|NCT01592370|324259563|FG002|Overall Study|Request to discontinue study treatment|2|||
94674306|NCT01592370|324259564|FG003|Overall Study|Request to discontinue study treatment|0|||
94674307|NCT01592370|324259565|FG004|Overall Study|Request to discontinue study treatment|1|||
94674308|NCT01592370|324259566|FG005|Overall Study|Request to discontinue study treatment|2|||
94674309|NCT01592370|324259567|FG006|Overall Study|Request to discontinue study treatment|0|||
94674310|NCT01592370|324259561|FG000|Overall Study|Withdrew consent|1|||
94674311|NCT01592370|324259562|FG001|Overall Study|Withdrew consent|2|||
94674312|NCT01592370|324259563|FG002|Overall Study|Withdrew consent|1|||
94674313|NCT01592370|324259564|FG003|Overall Study|Withdrew consent|1|||
94674314|NCT01592370|324259565|FG004|Overall Study|Withdrew consent|0|||
94674315|NCT01592370|324259566|FG005|Overall Study|Withdrew consent|0|||
94674316|NCT01592370|324259567|FG006|Overall Study|Withdrew consent|0|||
94674317|NCT01592370|324259561|FG000|Overall Study|Maximum clinical benefit|11|||
94674318|NCT01592370|324259562|FG001|Overall Study|Maximum clinical benefit|1|||
94674319|NCT01592370|324259563|FG002|Overall Study|Maximum clinical benefit|7|||
94674320|NCT01592370|324259564|FG003|Overall Study|Maximum clinical benefit|1|||
94674321|NCT01592370|324259565|FG004|Overall Study|Maximum clinical benefit|0|||
94674322|NCT01592370|324259566|FG005|Overall Study|Maximum clinical benefit|0|||
94674323|NCT01592370|324259567|FG006|Overall Study|Maximum clinical benefit|0|||
94674324|NCT01592370|324259561|FG000|Overall Study|No longer meets study criteria|1|||
94674325|NCT01592370|324259562|FG001|Overall Study|No longer meets study criteria|0|||
94674326|NCT01592370|324259563|FG002|Overall Study|No longer meets study criteria|0|||
94674327|NCT01592370|324259564|FG003|Overall Study|No longer meets study criteria|0|||
94674328|NCT01592370|324259565|FG004|Overall Study|No longer meets study criteria|0|||
94674329|NCT01592370|324259566|FG005|Overall Study|No longer meets study criteria|0|||
94674330|NCT01592370|324259567|FG006|Overall Study|No longer meets study criteria|0|||
94674331|NCT01592370|324259561|FG000|Overall Study|Other Reasons|6|||
94674332|NCT01592370|324259562|FG001|Overall Study|Other Reasons|0|||
94674333|NCT01592370|324259563|FG002|Overall Study|Other Reasons|10|||
94674334|NCT01592370|324259564|FG003|Overall Study|Other Reasons|0|||
94674335|NCT01592370|324259565|FG004|Overall Study|Other Reasons|0|||
94674336|NCT01592370|324259566|FG005|Overall Study|Other Reasons|1|||
94674337|NCT01592370|324259567|FG006|Overall Study|Other Reasons|0|||
94674340|NCT04120233|324259572|FG000|Overall Study|Adverse Event|0|||
94674341|NCT04120233|324259573|FG001|Overall Study|Adverse Event|0|||
94674342|NCT04120233|324259574|FG002|Overall Study|Adverse Event|0|||
94674343|NCT04120233|324259575|FG003|Overall Study|Adverse Event|0|||
94674344|NCT04120233|324259576|FG004|Overall Study|Adverse Event|1|||
94674345|NCT04120233|324259577|FG005|Overall Study|Adverse Event|0|||
94674346|NCT01377480|324261126|FG000|Overall Study|Protocol Violation|0|||
94255456|NCT02571049|322728561|FG000|Screening|Did not meet entry criteria|2|||
94255457|NCT02571049|322728562|FG001|Screening|Did not meet entry criteria|2|||
94255458|NCT02571049|322728561|FG000|Randomization|No migraine attack|0|||
94255459|NCT02571049|322728562|FG001|Randomization|No migraine attack|1|||
94255460|NCT02571049|322728561|FG000|Randomization|Adverse Event|0|||
94255461|NCT02571049|322728562|FG001|Randomization|Adverse Event|1|||
94255462|NCT04161495|322728563|FG000|Overall Study|Withdrawal by Subject|3|||
94255463|NCT04161495|322728564|FG001|Overall Study|Withdrawal by Subject|0|||
94255464|NCT04161495|322728563|FG000|Overall Study|Protocol Violation|1|||
94255465|NCT04161495|322728564|FG001|Overall Study|Protocol Violation|0|||
94255466|NCT04161495|322728563|FG000|Overall Study|Prohibited concomitant medication|3|||
94255467|NCT04161495|322728564|FG001|Overall Study|Prohibited concomitant medication|0|||
94255468|NCT04161495|322728563|FG000|Overall Study|Adverse Event|1|||
94255469|NCT04161495|322728564|FG001|Overall Study|Adverse Event|0|||
94255470|NCT04161495|322728563|FG000|Overall Study|Other - Unspecified|1|||
94255471|NCT04161495|322728564|FG001|Overall Study|Other - Unspecified|0|||
94255472|NCT04161495|322728563|FG000|Overall Study|Death|0|||
94255473|NCT04161495|322728564|FG001|Overall Study|Death|1|||
94255474|NCT03581825|322728567|FG000|Period 1|Lens Discomfort|1|||
94255475|NCT03581825|322728568|FG001|Period 1|Lens Discomfort|0|||
94255476|NCT03581825|322728567|FG000|Period 2|Unsatisfactory Vision to Test|0|||
94674347|NCT01377480|324261127|FG001|Overall Study|Protocol Violation|0|||
94674348|NCT01377480|324261128|FG002|Overall Study|Protocol Violation|0|||
94674349|NCT01377480|324261129|FG003|Overall Study|Protocol Violation|4|||
94674350|NCT01377480|324261126|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
94674351|NCT01377480|324261127|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
94674352|NCT01377480|324261128|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
94255477|NCT03581825|322728568|FG001|Period 2|Unsatisfactory Vision to Test|1|||
94255478|NCT03866473|322728569|FG000|Phase 1|Death|1|||
94255479|NCT03866473|322728570|FG001|Phase 1|Death|0|||
94255480|NCT03866473|322728569|FG000|Phase 2|Death|0|||
94255481|NCT03866473|322728570|FG001|Phase 2|Death|2|||
94674353|NCT01377480|324261129|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
94674354|NCT01377480|324261126|FG000|Overall Study|Withdrawal by Subject|0|||
94255482|NCT03866473|322728569|FG000|Phase 2|Dropped|1|||
94255483|NCT03866473|322728570|FG001|Phase 2|Dropped|1|||
94360250|NCT00777920|323101847|FG000|Overall Study|Investigator's discretion|1|||
94360251|NCT00777920|323101847|FG000|Overall Study|Clinical status did not improve|1|||
94627524|NCT01753856|324093959|FG001|Overall Study|Sponsor Decision|0|||
94627525|NCT00203996|324093960|FG000|Overall Study|Lost to Follow-up|0|||
94627526|NCT00203996|324093961|FG001|Overall Study|Lost to Follow-up|0|||
94627527|NCT00203996|324093962|FG002|Overall Study|Lost to Follow-up|0|||
94627528|NCT00203996|324093963|FG003|Overall Study|Lost to Follow-up|1|||
94627529|NCT00203996|324093964|FG004|Overall Study|Lost to Follow-up|0|||
94627530|NCT00203996|324093965|FG005|Overall Study|Lost to Follow-up|0|||
94627531|NCT00203996|324093966|FG006|Overall Study|Lost to Follow-up|0|||
94627532|NCT00203996|324093967|FG007|Overall Study|Lost to Follow-up|0|||
94627533|NCT00203996|324093968|FG008|Overall Study|Lost to Follow-up|0|||
94627534|NCT00203996|324093969|FG009|Overall Study|Lost to Follow-up|0|||
94627535|NCT00203996|324093960|FG000|Overall Study|Protocol Violation|0|||
94627536|NCT00203996|324093961|FG001|Overall Study|Protocol Violation|0|||
94627537|NCT00203996|324093962|FG002|Overall Study|Protocol Violation|0|||
94627538|NCT00203996|324093963|FG003|Overall Study|Protocol Violation|6|||
94627539|NCT00203996|324093964|FG004|Overall Study|Protocol Violation|1|||
94627540|NCT00203996|324093965|FG005|Overall Study|Protocol Violation|0|||
94627541|NCT00203996|324093966|FG006|Overall Study|Protocol Violation|0|||
94627542|NCT00203996|324093967|FG007|Overall Study|Protocol Violation|0|||
94627543|NCT00203996|324093968|FG008|Overall Study|Protocol Violation|0|||
94627544|NCT00203996|324093969|FG009|Overall Study|Protocol Violation|0|||
94627545|NCT00203996|324093960|FG000|Overall Study|Physician Decision|0|||
94627546|NCT00203996|324093961|FG001|Overall Study|Physician Decision|0|||
94627547|NCT00203996|324093962|FG002|Overall Study|Physician Decision|0|||
94627548|NCT00203996|324093963|FG003|Overall Study|Physician Decision|2|||
94627549|NCT00203996|324093964|FG004|Overall Study|Physician Decision|0|||
94627550|NCT00203996|324093965|FG005|Overall Study|Physician Decision|0|||
94627551|NCT00203996|324093966|FG006|Overall Study|Physician Decision|0|||
94627552|NCT00203996|324093967|FG007|Overall Study|Physician Decision|0|||
94627553|NCT00203996|324093968|FG008|Overall Study|Physician Decision|0|||
94627554|NCT00203996|324093969|FG009|Overall Study|Physician Decision|1|||
94627555|NCT00203996|324093960|FG000|Overall Study|CPAP machine malfunction|0|||
94627556|NCT00203996|324093961|FG001|Overall Study|CPAP machine malfunction|0|||
94627557|NCT00203996|324093962|FG002|Overall Study|CPAP machine malfunction|0|||
94627558|NCT00203996|324093963|FG003|Overall Study|CPAP machine malfunction|1|||
94627559|NCT00203996|324093964|FG004|Overall Study|CPAP machine malfunction|0|||
94627560|NCT00203996|324093965|FG005|Overall Study|CPAP machine malfunction|0|||
94627561|NCT00203996|324093966|FG006|Overall Study|CPAP machine malfunction|0|||
94627562|NCT00203996|324093967|FG007|Overall Study|CPAP machine malfunction|0|||
94627563|NCT00203996|324093968|FG008|Overall Study|CPAP machine malfunction|0|||
94627564|NCT00203996|324093969|FG009|Overall Study|CPAP machine malfunction|0|||
94627565|NCT00203996|324093960|FG000|Overall Study|Scheduling issue|0|||
94627566|NCT00203996|324093961|FG001|Overall Study|Scheduling issue|0|||
94627567|NCT00203996|324093962|FG002|Overall Study|Scheduling issue|0|||
94627568|NCT00203996|324093963|FG003|Overall Study|Scheduling issue|0|||
94627569|NCT00203996|324093964|FG004|Overall Study|Scheduling issue|0|||
94627570|NCT00203996|324093965|FG005|Overall Study|Scheduling issue|0|||
94627571|NCT00203996|324093966|FG006|Overall Study|Scheduling issue|0|||
94627572|NCT00203996|324093967|FG007|Overall Study|Scheduling issue|2|||
94627573|NCT00203996|324093968|FG008|Overall Study|Scheduling issue|0|||
94627574|NCT00203996|324093969|FG009|Overall Study|Scheduling issue|0|||
94627575|NCT02848651|324093970|FG000|Overall Study|Death|85|||
94627576|NCT02848651|324093970|FG000|Overall Study|Lost to Follow-up|1|||
94627577|NCT02848651|324093970|FG000|Overall Study|Non-Compliance|1|||
94627578|NCT02848651|324093970|FG000|Overall Study|Symptomatic Deterioration|1|||
94627579|NCT02848651|324093970|FG000|Overall Study|Physician Decision|4|||
94627580|NCT02848651|324093970|FG000|Overall Study|Withdrawal by Subject|14|||
94627581|NCT03064451|324093971|FG000|Overall Study|Lost to Follow-up|1|||
94627582|NCT03064451|324093971|FG000|Overall Study|Mapping Failure|4|||
94627583|NCT03064451|324093971|FG000|Overall Study|Exited prior to procedure|8|||
94627584|NCT03064451|324093971|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
94627585|NCT00850564|324093974|FG000|Overall Study|Withdrawal by Subject|2|||
94627586|NCT02310568|324095649|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
94627587|NCT02310568|324095650|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
94627588|NCT02310568|324095651|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
94627589|NCT02310568|324095652|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
94627590|NCT02310568|324095653|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
94627591|NCT02310568|324095649|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
94627592|NCT02310568|324095650|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
94627593|NCT02310568|324095651|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
94627594|NCT02310568|324095652|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
94627595|NCT02310568|324095653|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
94627596|NCT02310568|324095649|FG000|Stage 1 ( 4 Weeks)|Other|1|||
94627597|NCT02310568|324095650|FG001|Stage 1 ( 4 Weeks)|Other|1|||
94627598|NCT02310568|324095651|FG002|Stage 1 ( 4 Weeks)|Other|0|||
94627599|NCT02310568|324095652|FG003|Stage 1 ( 4 Weeks)|Other|0|||
94627600|NCT02310568|324095653|FG004|Stage 1 ( 4 Weeks)|Other|0|||
94255484|NCT03866473|322728569|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
94255485|NCT03866473|322728570|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
94255486|NCT01910181|322728582|FG000|Overall Study|Death|37|||
94255487|NCT01910181|322728582|FG000|Overall Study|Lost to Follow-up|3|||
94255488|NCT01910181|322728582|FG000|Overall Study|Study Terminated by Sponsor|6|||
94255489|NCT00153062|322730054|FG000|Overall Study|Death|360|||
94255490|NCT00153062|322730055|FG001|Overall Study|Death|352|||
94255491|NCT00153062|322730056|FG002|Overall Study|Death|369|||
94255492|NCT00153062|322730057|FG003|Overall Study|Death|365|||
94255493|NCT00153062|322730054|FG000|Overall Study|Withdrawal by Subject|14|||
94255494|NCT00153062|322730055|FG001|Overall Study|Withdrawal by Subject|30|||
94255495|NCT00153062|322730056|FG002|Overall Study|Withdrawal by Subject|27|||
94255496|NCT00153062|322730057|FG003|Overall Study|Withdrawal by Subject|28|||
94255497|NCT00153062|322730054|FG000|Overall Study|Lost to Follow-up|12|||
94255498|NCT00153062|322730055|FG001|Overall Study|Lost to Follow-up|20|||
94255499|NCT00153062|322730056|FG002|Overall Study|Lost to Follow-up|15|||
94255500|NCT00153062|322730057|FG003|Overall Study|Lost to Follow-up|16|||
94255501|NCT00153062|322730054|FG000|Overall Study|Adverse Event|0|||
94255502|NCT00153062|322730055|FG001|Overall Study|Adverse Event|1|||
94255503|NCT00153062|322730056|FG002|Overall Study|Adverse Event|1|||
94255504|NCT00153062|322730057|FG003|Overall Study|Adverse Event|0|||
94255505|NCT00153062|322730054|FG000|Overall Study|Protocol Violation|0|||
94255506|NCT00153062|322730055|FG001|Overall Study|Protocol Violation|2|||
94255507|NCT00153062|322730056|FG002|Overall Study|Protocol Violation|1|||
94255508|NCT00153062|322730057|FG003|Overall Study|Protocol Violation|1|||
94255509|NCT00153062|322730054|FG000|Overall Study|No disposition data available|1|||
94255510|NCT00153062|322730055|FG001|Overall Study|No disposition data available|1|||
94255511|NCT00153062|322730056|FG002|Overall Study|No disposition data available|1|||
94255512|NCT00153062|322730057|FG003|Overall Study|No disposition data available|1|||
94627601|NCT02310568|324095649|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
94627602|NCT02310568|324095650|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
94627603|NCT02310568|324095651|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
94627604|NCT02310568|324095652|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
94627605|NCT02310568|324095653|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
94627606|NCT02310568|324095649|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
94627607|NCT02310568|324095650|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
94627608|NCT02310568|324095651|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
94627609|NCT02310568|324095652|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
94627610|NCT02310568|324095653|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
94627611|NCT02310568|324095649|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
94627612|NCT02310568|324095650|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
94627613|NCT02310568|324095651|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
94627614|NCT02310568|324095652|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
94627615|NCT02310568|324095653|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
94627616|NCT02310568|324095649|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
94627617|NCT02310568|324095650|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
94627618|NCT02310568|324095651|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
94627619|NCT02310568|324095652|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
94627620|NCT02310568|324095653|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
94627621|NCT02310568|324095649|FG000|Stage 2 (4 Weeks)|Other|0|||
94627622|NCT02310568|324095650|FG001|Stage 2 (4 Weeks)|Other|1|||
94627623|NCT02310568|324095651|FG002|Stage 2 (4 Weeks)|Other|1|||
94627624|NCT02310568|324095652|FG003|Stage 2 (4 Weeks)|Other|0|||
94627625|NCT02310568|324095653|FG004|Stage 2 (4 Weeks)|Other|0|||
94627626|NCT02310568|324095649|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
94627627|NCT02310568|324095650|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
94627628|NCT02310568|324095651|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
94627629|NCT02310568|324095652|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
94627630|NCT02310568|324095653|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
94627631|NCT02310568|324095649|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
94627632|NCT02310568|324095650|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
94627633|NCT02310568|324095651|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
94627634|NCT02310568|324095652|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
94627635|NCT02310568|324095653|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
94627636|NCT02310568|324095649|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
94627637|NCT02310568|324095650|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
94627638|NCT02310568|324095651|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
94255513|NCT00153062|322730054|FG000|Overall Study|Other|0|||
94255514|NCT00153062|322730055|FG001|Overall Study|Other|0|||
94255515|NCT00153062|322730056|FG002|Overall Study|Other|1|||
94627639|NCT02310568|324095652|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
94627640|NCT02310568|324095653|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
94627641|NCT01338792|324095654|FG000|Overall Study|Adverse Event|2|||
94627642|NCT01338792|324095654|FG000|Overall Study|Death|1|||
94627643|NCT01338792|324095654|FG000|Overall Study|Withdrawal by Subject|1|||
94627644|NCT01224431|324095656|FG000|Overall Study|not randomized|0|||
94255516|NCT00153062|322730057|FG003|Overall Study|Other|0|||
94674355|NCT01377480|324261127|FG001|Overall Study|Withdrawal by Subject|0|||
94674356|NCT01377480|324261128|FG002|Overall Study|Withdrawal by Subject|1|||
94674357|NCT01377480|324261129|FG003|Overall Study|Withdrawal by Subject|0|||
94674358|NCT01377480|324261126|FG000|Overall Study|Serious adverse event|0|||
94674359|NCT01377480|324261127|FG001|Overall Study|Serious adverse event|0|||
94674360|NCT01377480|324261128|FG002|Overall Study|Serious adverse event|1|||
94674361|NCT01377480|324261129|FG003|Overall Study|Serious adverse event|1|||
94674362|NCT01377480|324261126|FG000|Overall Study|Other|0|||
94674363|NCT01377480|324261127|FG001|Overall Study|Other|0|||
94674364|NCT01377480|324261128|FG002|Overall Study|Other|7|||
94674365|NCT01377480|324261129|FG003|Overall Study|Other|6|||
94674366|NCT00593567|324261130|FG000|Overall Study|Adverse Event|2|||
94674367|NCT00593567|324261131|FG001|Overall Study|Adverse Event|0|||
94674368|NCT00593567|324261130|FG000|Overall Study|Physician Decision|2|||
94674369|NCT00593567|324261131|FG001|Overall Study|Physician Decision|0|||
94674370|NCT00593567|324261130|FG000|Overall Study|Protocol Violation|13|||
94674371|NCT00593567|324261131|FG001|Overall Study|Protocol Violation|7|||
94674372|NCT00593567|324261130|FG000|Overall Study|Lack of Efficacy|2|||
94674373|NCT00593567|324261131|FG001|Overall Study|Lack of Efficacy|1|||
94674374|NCT00593567|324261130|FG000|Overall Study|Withdrawal by Subject|1|||
94674375|NCT00593567|324261131|FG001|Overall Study|Withdrawal by Subject|2|||
94674376|NCT00789815|324261132|FG000|Overall Study|Protocol Violation|6|||
94674377|NCT00789815|324261133|FG001|Overall Study|Protocol Violation|1|||
94674378|NCT00789815|324261132|FG000|Overall Study|Intubation due to massive bleeding|1|||
94674379|NCT00789815|324261133|FG001|Overall Study|Intubation due to massive bleeding|0|||
94674380|NCT03576768|324261134|FG000|Overall Study|Lost to Follow-up|3|||
94674381|NCT03576768|324261135|FG001|Overall Study|Lost to Follow-up|3|||
94674382|NCT03576768|324261136|FG002|Overall Study|Lost to Follow-up|0|||
94674383|NCT03576768|324261137|FG003|Overall Study|Lost to Follow-up|0|||
94674384|NCT00289887|324261150|FG000|Overall Study|Adverse Event|3|||
94674385|NCT00289887|324261151|FG001|Overall Study|Adverse Event|3|||
94674386|NCT00289887|324261150|FG000|Overall Study|Lack of Efficacy|3|||
94674387|NCT00289887|324261151|FG001|Overall Study|Lack of Efficacy|11|||
94674388|NCT00289887|324261150|FG000|Overall Study|Lost to Follow-up|3|||
94674389|NCT00289887|324261151|FG001|Overall Study|Lost to Follow-up|3|||
94674390|NCT00289887|324261150|FG000|Overall Study|Protocol Violation|3|||
94674391|NCT00289887|324261151|FG001|Overall Study|Protocol Violation|1|||
94674392|NCT00289887|324261150|FG000|Overall Study|Withdrawal by Subject|3|||
94674393|NCT00289887|324261151|FG001|Overall Study|Withdrawal by Subject|8|||
94674394|NCT00289887|324261150|FG000|Overall Study|Other|7|||
94674395|NCT00289887|324261151|FG001|Overall Study|Other|3|||
94360252|NCT00777920|323101847|FG000|Overall Study|Other, not specified|4|||
94360253|NCT00483717|323101848|FG000|Overall Study|Protocol Violation|5|||
94360254|NCT00483717|323101849|FG001|Overall Study|Protocol Violation|7|||
94360255|NCT00483717|323101848|FG000|Overall Study|Time of dosing missing|1|||
94360256|NCT00483717|323101849|FG001|Overall Study|Time of dosing missing|1|||
94360257|NCT00483717|323101848|FG000|Overall Study|No treatment for migraine|16|||
94360258|NCT00483717|323101849|FG001|Overall Study|No treatment for migraine|13|||
94360259|NCT00483717|323101848|FG000|Overall Study|Lost to Follow-up|1|||
94360260|NCT00483717|323101849|FG001|Overall Study|Lost to Follow-up|0|||
94360261|NCT00483717|323101848|FG000|Overall Study|Withdrawal by Subject|1|||
94360262|NCT00483717|323101849|FG001|Overall Study|Withdrawal by Subject|0|||
94674396|NCT02606279|324261158|FG000|Overall Study|Lost to Follow-up|0|||
94674397|NCT02606279|324261159|FG001|Overall Study|Lost to Follow-up|1|||
94674398|NCT01666951|324261160|FG000|Overall Study|Not dosed|1|||
94674399|NCT01666951|324261161|FG001|Overall Study|Not dosed|1|||
94674400|NCT03040713|324261162|FG000|Overall Study|Positive amyloid scan|3|||
94674401|NCT00337272|324261165|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
94674402|NCT00337272|324261166|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
94674403|NCT00337272|324261165|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
94674404|NCT00337272|324261166|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
94674405|NCT00337272|324261165|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
94674406|NCT00337272|324261166|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
94255517|NCT01919814|322730058|FG000|Overall Study|Adverse Event|1|||
94255518|NCT01919814|322730059|FG001|Overall Study|Adverse Event|0|||
94255519|NCT01919814|322730058|FG000|Overall Study|Protocol Violation|1|||
94255520|NCT01919814|322730059|FG001|Overall Study|Protocol Violation|0|||
94255521|NCT01919814|322730058|FG000|Overall Study|Withdrawal by Subject|1|||
94255522|NCT01919814|322730059|FG001|Overall Study|Withdrawal by Subject|0|||
94255523|NCT02831387|322730060|FG000|Overall Study|Withdrawal by Subject|1|||
94255524|NCT02831387|322730061|FG001|Overall Study|Withdrawal by Subject|1|||
94255525|NCT02831387|322730060|FG000|Overall Study|Discontinued due to stock recovery|0|||
94255526|NCT02831387|322730061|FG001|Overall Study|Discontinued due to stock recovery|1|||
94255527|NCT01828073|322730062|FG000|Overall Study|Lost to Follow-up|1|||
94255528|NCT01828073|322730063|FG001|Overall Study|Lost to Follow-up|2|||
94255529|NCT02915302|322730064|FG000|Overall Study|Adverse Event|3|||
94255530|NCT02915302|322730065|FG001|Overall Study|Adverse Event|0|||
94360263|NCT03878108|323101850|FG000|Overall Study|Adverse Event|1|||
94360264|NCT03878108|323101851|FG001|Overall Study|Adverse Event|0|||
94255531|NCT02915302|322730064|FG000|Overall Study|Protocol Violation|20|||
94255532|NCT02915302|322730065|FG001|Overall Study|Protocol Violation|27|||
94255533|NCT02915302|322730064|FG000|Overall Study|Lost to Follow-up|19|||
94255534|NCT02915302|322730065|FG001|Overall Study|Lost to Follow-up|22|||
94255535|NCT02915302|322730064|FG000|Overall Study|Withdrawal by Subject|22|||
94255536|NCT02915302|322730065|FG001|Overall Study|Withdrawal by Subject|29|||
94255537|NCT02915302|322730064|FG000|Overall Study|Other|1|||
94255538|NCT02915302|322730065|FG001|Overall Study|Other|0|||
94255539|NCT00816400|322730066|FG000|Overall Study|Death|2|||
94255540|NCT00816400|322730067|FG001|Overall Study|Death|3|||
94255541|NCT00816400|322730068|FG002|Overall Study|Death|3|||
94255542|NCT00816400|322730069|FG003|Overall Study|Death|3|||
94255543|NCT00816400|322730070|FG004|Overall Study|Death|2|||
94255544|NCT00816400|322730071|FG005|Overall Study|Death|3|||
94255545|NCT00816400|322730072|FG006|Overall Study|Death|2|||
94360265|NCT01608321|323101852|FG000|Overall Study|Withdrawal by Subject|1|||
94360266|NCT01608321|323101853|FG001|Overall Study|Withdrawal by Subject|0|||
94360267|NCT03188991|323101854|FG000|Overall Study|Withdrawal by Subject|0|||
94360268|NCT03188991|323101855|FG001|Overall Study|Withdrawal by Subject|0|||
94360269|NCT03188991|323101856|FG002|Overall Study|Withdrawal by Subject|0|||
94360270|NCT03188991|323101857|FG003|Overall Study|Withdrawal by Subject|1|||
94360271|NCT00700115|323103712|FG000|Overall Study|Withdrawal by Subject|1|||
94360272|NCT00700115|323103713|FG001|Overall Study|Withdrawal by Subject|0|||
94360273|NCT00700115|323103712|FG000|Overall Study|Lost to Follow-up|0|||
94360274|NCT00700115|323103713|FG001|Overall Study|Lost to Follow-up|1|||
94360275|NCT02503215|323103714|FG000|Overall Study|Unable to wear compression stockings|1|||
94627645|NCT01224431|324095657|FG001|Overall Study|not randomized|4|||
94627646|NCT01224431|324095656|FG000|Overall Study|no video record|0|||
94627647|NCT01224431|324095657|FG001|Overall Study|no video record|1|||
94627648|NCT02057406|324095658|FG000|Overall Study|Physician Decision|0|||
94627649|NCT02057406|324095659|FG001|Overall Study|Physician Decision|0|||
94627650|NCT02057406|324095660|FG002|Overall Study|Physician Decision|2|||
94627651|NCT02057406|324095658|FG000|Overall Study|Withdrawal by Subject|0|||
94627652|NCT02057406|324095659|FG001|Overall Study|Withdrawal by Subject|2|||
94627653|NCT02057406|324095660|FG002|Overall Study|Withdrawal by Subject|0|||
94627654|NCT02057406|324095658|FG000|Overall Study|Lost to Follow-up|0|||
94627655|NCT02057406|324095659|FG001|Overall Study|Lost to Follow-up|0|||
94627656|NCT02057406|324095660|FG002|Overall Study|Lost to Follow-up|1|||
94627657|NCT02057406|324095658|FG000|Overall Study|Death|1|||
94627658|NCT02057406|324095659|FG001|Overall Study|Death|0|||
94627659|NCT02057406|324095660|FG002|Overall Study|Death|0|||
94627660|NCT02057406|324095658|FG000|Overall Study|Protocol Violation|0|||
94627661|NCT02057406|324095659|FG001|Overall Study|Protocol Violation|1|||
94627662|NCT02057406|324095660|FG002|Overall Study|Protocol Violation|0|||
94627663|NCT02057406|324095658|FG000|Overall Study|Patient transportation issues|0|||
94627664|NCT02057406|324095659|FG001|Overall Study|Patient transportation issues|0|||
94627665|NCT02057406|324095660|FG002|Overall Study|Patient transportation issues|1|||
94627666|NCT01342796|324095661|FG000|Overall Study|Withdrawal by Subject|2|||
94627667|NCT01342796|324095662|FG001|Overall Study|Withdrawal by Subject|0|||
94627668|NCT01342796|324095661|FG000|Overall Study|Lost to Follow-up|0|||
94627669|NCT01342796|324095662|FG001|Overall Study|Lost to Follow-up|3|||
94627670|NCT01342796|324095661|FG000|Overall Study|Inappropriate enrollment|1|||
94627671|NCT01342796|324095662|FG001|Overall Study|Inappropriate enrollment|0|||
94627672|NCT03902574|324095663|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
94627673|NCT03902574|324095664|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
94627674|NCT03902574|324095665|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
94255546|NCT00816400|322730073|FG007|Overall Study|Death|5|||
94255547|NCT00816400|322730074|FG008|Overall Study|Death|6|||
94360276|NCT02503215|323103714|FG000|Overall Study|Unable to use positive airway pressure|2|||
94360277|NCT02983305|323103719|FG000|Overall Study|incomplete data|2|||
94627675|NCT02692716|324095667|FG000|Overall Study|Lost to Follow-up|2|||
94627676|NCT02692716|324095668|FG001|Overall Study|Lost to Follow-up|5|||
94627677|NCT02692716|324095667|FG000|Overall Study|Withdrawal by Subject|3|||
94627678|NCT02692716|324095668|FG001|Overall Study|Withdrawal by Subject|1|||
94627679|NCT02899988|324095669|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
94255548|NCT00816400|322730066|FG000|Overall Study|In hospice care at the end of the study|0|||
94360278|NCT02983305|323103720|FG001|Overall Study|incomplete data|0|||
94627680|NCT02899988|324095670|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
94627681|NCT02899988|324095671|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94627682|NCT02899988|324095672|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94627683|NCT02899988|324095673|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94674407|NCT00337272|324261165|FG000|Treatment Period|Non-compliance|1|||
94255549|NCT00816400|322730067|FG001|Overall Study|In hospice care at the end of the study|0|||
94255550|NCT00816400|322730068|FG002|Overall Study|In hospice care at the end of the study|2|||
94360279|NCT00706901|323103721|FG000|Overall Study|Lost to Follow-up|2|||
94360280|NCT00706901|323103722|FG001|Overall Study|Lost to Follow-up|3|||
94674408|NCT00337272|324261166|FG001|Treatment Period|Non-compliance|1|||
94674409|NCT00337272|324261165|FG000|Treatment Period|Withdrawal by Subject|0|||
94674410|NCT00337272|324261166|FG001|Treatment Period|Withdrawal by Subject|1|||
94674411|NCT00337272|324261165|FG000|Withdrawal Period|Non-compliance|0|||
94674412|NCT00337272|324261166|FG001|Withdrawal Period|Non-compliance|1|||
94674413|NCT02366910|324261169|FG000|Overall Study|Withdrawal by Subject|2|||
94674414|NCT02366910|324261169|FG000|Overall Study|Screen Failure|3|||
94674415|NCT05159622|324261180|FG000|Overall Study|Lost to Follow-up|4|||
94674416|NCT05159622|324261181|FG001|Overall Study|Lost to Follow-up|5|||
94674417|NCT02428296|324261182|FG000|Overall Study|Adverse Event|7|||
94674418|NCT02428296|324261182|FG000|Overall Study|Withdrawal by Subject|2|||
94674419|NCT01050816|324261185|FG000|Overall Study|Lost to Follow-up|2|||
94674420|NCT01050816|324261185|FG000|Overall Study|patient's refusal|2|||
94255551|NCT00816400|322730069|FG003|Overall Study|In hospice care at the end of the study|0|||
94255552|NCT00816400|322730070|FG004|Overall Study|In hospice care at the end of the study|0|||
94255553|NCT00816400|322730071|FG005|Overall Study|In hospice care at the end of the study|0|||
94255554|NCT00816400|322730072|FG006|Overall Study|In hospice care at the end of the study|0|||
94255555|NCT00816400|322730073|FG007|Overall Study|In hospice care at the end of the study|0|||
94255556|NCT00816400|322730074|FG008|Overall Study|In hospice care at the end of the study|0|||
94255557|NCT00690443|322730079|FG000|Overall Study|Adverse Event|1|||
94255558|NCT00690443|322730080|FG001|Overall Study|Adverse Event|2|||
94255559|NCT00645801|322730081|FG000|Overall Study|unclear if patient took all the medication.|1|||
94255560|NCT00645801|322730082|FG001|Overall Study|unclear if patient took all the medication.|0|||
94255561|NCT00645801|322730081|FG000|Overall Study|Lost to Follow-up|19|||
94255562|NCT00645801|322730082|FG001|Overall Study|Lost to Follow-up|15|||
94255563|NCT00932113|322730083|FG000|Overall Study|Lost to Follow-up|1|||
94255564|NCT00932113|322730084|FG001|Overall Study|Lost to Follow-up|0|||
94255565|NCT01403610|322730087|FG000|Overall Study|Withdrawal by Subject|2|||
94255566|NCT01403610|322730088|FG001|Overall Study|Withdrawal by Subject|0|||
94255567|NCT01403610|322730089|FG002|Overall Study|Withdrawal by Subject|0|||
94255568|NCT01403610|322730090|FG003|Overall Study|Withdrawal by Subject|0|||
94255569|NCT01403610|322730087|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
94255570|NCT01403610|322730088|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
94255571|NCT01403610|322730089|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
94255572|NCT01403610|322730090|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
94255573|NCT01201317|322730091|FG000|Overall Study|Withdrawal by Subject|5|||
94255574|NCT01201317|322730092|FG001|Overall Study|Withdrawal by Subject|0|||
94255575|NCT01201317|322730093|FG002|Overall Study|Withdrawal by Subject|3|||
94255576|NCT01201317|322730091|FG000|Overall Study|Adverse Event|2|||
94255577|NCT01201317|322730092|FG001|Overall Study|Adverse Event|2|||
94255578|NCT01201317|322730093|FG002|Overall Study|Adverse Event|2|||
94255579|NCT01201317|322730091|FG000|Overall Study|Screen failure|1|||
94255580|NCT01201317|322730092|FG001|Overall Study|Screen failure|1|||
94255581|NCT01201317|322730093|FG002|Overall Study|Screen failure|0|||
94255582|NCT01201317|322730091|FG000|Overall Study|Protocol Violation|0|||
94255583|NCT01201317|322730092|FG001|Overall Study|Protocol Violation|1|||
94255584|NCT01201317|322730093|FG002|Overall Study|Protocol Violation|1|||
94255585|NCT01201317|322730091|FG000|Overall Study|Death|0|||
94255586|NCT01201317|322730092|FG001|Overall Study|Death|1|||
94255587|NCT01201317|322730093|FG002|Overall Study|Death|0|||
94255588|NCT01201317|322730091|FG000|Overall Study|Study-specific withdrawal criteria|0|||
94255589|NCT01201317|322730092|FG001|Overall Study|Study-specific withdrawal criteria|0|||
94255590|NCT01201317|322730093|FG002|Overall Study|Study-specific withdrawal criteria|1|||
94255591|NCT01201317|322730091|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
94255592|NCT01201317|322730092|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
94255593|NCT01201317|322730093|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
94255594|NCT01201317|322730091|FG000|Overall Study|Decrease in renal function|0|||
94255595|NCT01201317|322730092|FG001|Overall Study|Decrease in renal function|1|||
94255596|NCT01201317|322730093|FG002|Overall Study|Decrease in renal function|0|||
94255597|NCT01201317|322730091|FG000|Overall Study|Lack of Efficacy|1|||
94255598|NCT01201317|322730092|FG001|Overall Study|Lack of Efficacy|0|||
94674421|NCT00677352|324261186|FG000|Treatment Phase|Adverse Event|14|||
94674422|NCT00677352|324261187|FG001|Treatment Phase|Adverse Event|22|||
94674423|NCT00677352|324261186|FG000|Treatment Phase|Lack of Efficacy|2|||
94674424|NCT00677352|324261187|FG001|Treatment Phase|Lack of Efficacy|3|||
94255599|NCT01201317|322730093|FG002|Overall Study|Lack of Efficacy|0|||
94255600|NCT01201317|322730091|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
94255601|NCT01201317|322730092|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
94255602|NCT01201317|322730093|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
94255603|NCT01350336|322730094|FG000|Overall Study|Lost to Follow-up|31|||
94255604|NCT01350336|322730094|FG000|Overall Study|Withdrawal by Subject|14|||
94255605|NCT01350336|322730094|FG000|Overall Study|Physician Decision|8|||
94674425|NCT00677352|324261186|FG000|Treatment Phase|Lost to Follow-up|0|||
94674426|NCT00677352|324261187|FG001|Treatment Phase|Lost to Follow-up|1|||
94674427|NCT00677352|324261186|FG000|Treatment Phase|Withdrawal by Subject|7|||
94674428|NCT00677352|324261187|FG001|Treatment Phase|Withdrawal by Subject|7|||
94674429|NCT00677352|324261186|FG000|Treatment Phase|Physician Decision|1|||
94674430|NCT00677352|324261187|FG001|Treatment Phase|Physician Decision|0|||
94674431|NCT00677352|324261186|FG000|Treatment Phase|Pregnancy|0|||
94674432|NCT00677352|324261187|FG001|Treatment Phase|Pregnancy|1|||
94674433|NCT00677352|324261186|FG000|Treatment Phase|Protocol Violation|1|||
94674434|NCT00677352|324261187|FG001|Treatment Phase|Protocol Violation|1|||
94674435|NCT00677352|324261186|FG000|Treatment Phase|Transference or work related matter|0|||
94674436|NCT00677352|324261187|FG001|Treatment Phase|Transference or work related matter|5|||
94674437|NCT00677352|324261186|FG000|Treatment Phase|Not treated|0|||
94674438|NCT00677352|324261187|FG001|Treatment Phase|Not treated|2|||
94674439|NCT00677352|324261186|FG000|Tapering Phase|Adverse Event|1|||
94674440|NCT00677352|324261187|FG001|Tapering Phase|Adverse Event|5|||
94674441|NCT00677352|324261186|FG000|Tapering Phase|Withdrawal by Subject|5|||
94674442|NCT00677352|324261187|FG001|Tapering Phase|Withdrawal by Subject|3|||
94674443|NCT00677352|324261186|FG000|Tapering Phase|Pregnancy|0|||
94674444|NCT00677352|324261187|FG001|Tapering Phase|Pregnancy|1|||
94674445|NCT00677352|324261186|FG000|Tapering Phase|Job transfer|0|||
94674446|NCT00677352|324261187|FG001|Tapering Phase|Job transfer|1|||
94674447|NCT02123108|324261196|FG000|Overall Study|Death|2|||
94674448|NCT02123108|324261197|FG001|Overall Study|Death|3|||
94674449|NCT02274857|324261198|FG000|Overall Study|Adverse Event|1|||
94674450|NCT02274857|324261199|FG001|Overall Study|Adverse Event|0|||
94674451|NCT02274857|324261198|FG000|Overall Study|Death|1|||
94674452|NCT02274857|324261199|FG001|Overall Study|Death|2|||
94674453|NCT02274857|324261198|FG000|Overall Study|Lost to Follow-up|3|||
94674454|NCT02274857|324261199|FG001|Overall Study|Lost to Follow-up|0|||
94674455|NCT02274857|324261198|FG000|Overall Study|Physician Decision|2|||
94674456|NCT02274857|324261199|FG001|Overall Study|Physician Decision|0|||
94674457|NCT02274857|324261198|FG000|Overall Study|Trial screen failure|0|||
94674458|NCT02274857|324261199|FG001|Overall Study|Trial screen failure|2|||
94674459|NCT02274857|324261198|FG000|Overall Study|Withdrawal by Subject|11|||
94674460|NCT02274857|324261199|FG001|Overall Study|Withdrawal by Subject|2|||
94674461|NCT02274857|324261198|FG000|Overall Study|Other|2|||
94674462|NCT02274857|324261199|FG001|Overall Study|Other|0|||
94674463|NCT00677235|324261202|FG000|Overall Study|Withdrawal by Subject|1|||
94674464|NCT00677235|324261203|FG001|Overall Study|Withdrawal by Subject|1|||
94674465|NCT00677235|324261202|FG000|Overall Study|Lost to Follow-up|2|||
94674466|NCT00677235|324261203|FG001|Overall Study|Lost to Follow-up|1|||
94674467|NCT00677235|324261202|FG000|Overall Study|Death|37|||
94674468|NCT00677235|324261203|FG001|Overall Study|Death|36|||
94674469|NCT00677235|324261202|FG000|Overall Study|Adverse Experience|1|||
94674470|NCT00677235|324261203|FG001|Overall Study|Adverse Experience|0|||
94674471|NCT00708916|324261206|FG000|Overall Study|Subject Noncompliance|2|||
94674472|NCT00708916|324261206|FG000|Overall Study|Adverse Event|2|||
94674473|NCT01281644|324261210|FG000|Overall Study|Lost to Follow-up|3|||
94674474|NCT01281644|324261210|FG000|Overall Study|Withdrawal by Subject|2|||
94255606|NCT01350336|322730094|FG000|Overall Study|Death|4|||
94255607|NCT01491672|322730095|FG000|Overall Study|Lost to Follow-up|0|||
94255608|NCT01491672|322730096|FG001|Overall Study|Lost to Follow-up|4|||
94255609|NCT01491672|322730097|FG002|Overall Study|Lost to Follow-up|1|||
94255610|NCT01491672|322730095|FG000|Overall Study|Withdrawal by Subject|6|||
94255611|NCT01491672|322730096|FG001|Overall Study|Withdrawal by Subject|7|||
94255612|NCT01491672|322730097|FG002|Overall Study|Withdrawal by Subject|0|||
94255613|NCT01491672|322730095|FG000|Overall Study|Adverse Event|8|||
94255614|NCT01491672|322730096|FG001|Overall Study|Adverse Event|10|||
94255615|NCT01491672|322730097|FG002|Overall Study|Adverse Event|4|||
94674475|NCT02110901|324261211|FG000|Overall Study|Death|6|||
94674476|NCT02110901|324261212|FG001|Overall Study|Death|3|||
94674477|NCT02110901|324261211|FG000|Overall Study|Lost to Follow-up|12|||
94674478|NCT02110901|324261212|FG001|Overall Study|Lost to Follow-up|8|||
94674479|NCT02110901|324261211|FG000|Overall Study|Withdrawal by Subject|7|||
94674480|NCT02110901|324261212|FG001|Overall Study|Withdrawal by Subject|3|||
94674481|NCT02110901|324261211|FG000|Overall Study|received a kidney transplant|5|||
94674482|NCT02110901|324261212|FG001|Overall Study|received a kidney transplant|0|||
94255616|NCT01491672|322730095|FG000|Overall Study|Disease progression|42|||
94255617|NCT01491672|322730096|FG001|Overall Study|Disease progression|34|||
94255618|NCT01491672|322730097|FG002|Overall Study|Disease progression|6|||
94674483|NCT02618967|324261213|FG000|Overall Study|Lost to Follow-up|0|||
94674484|NCT02618967|324261214|FG001|Overall Study|Lost to Follow-up|0|||
94255619|NCT01491672|322730095|FG000|Overall Study|Protocol deviation|0|||
94255620|NCT01491672|322730096|FG001|Overall Study|Protocol deviation|1|||
94255621|NCT01491672|322730097|FG002|Overall Study|Protocol deviation|0|||
94674485|NCT02618967|324261215|FG002|Overall Study|Lost to Follow-up|1|||
94674486|NCT02618967|324261216|FG003|Overall Study|Lost to Follow-up|0|||
94674487|NCT02618967|324261217|FG004|Overall Study|Lost to Follow-up|2|||
94674488|NCT02618967|324261218|FG005|Overall Study|Lost to Follow-up|0|||
94674489|NCT02618967|324261219|FG006|Overall Study|Lost to Follow-up|0|||
94674490|NCT02618967|324261220|FG007|Overall Study|Lost to Follow-up|0|||
94674491|NCT02618967|324261213|FG000|Overall Study|Withdrawal by Subject|1|||
94674492|NCT02618967|324261214|FG001|Overall Study|Withdrawal by Subject|0|||
94674493|NCT02618967|324261215|FG002|Overall Study|Withdrawal by Subject|0|||
94255622|NCT01491672|322730095|FG000|Overall Study|Death|0|||
94674494|NCT02618967|324261216|FG003|Overall Study|Withdrawal by Subject|0|||
94674495|NCT02618967|324261217|FG004|Overall Study|Withdrawal by Subject|0|||
94674496|NCT02618967|324261218|FG005|Overall Study|Withdrawal by Subject|0|||
94674497|NCT02618967|324261219|FG006|Overall Study|Withdrawal by Subject|0|||
94674498|NCT02618967|324261220|FG007|Overall Study|Withdrawal by Subject|0|||
94674499|NCT01368965|324261221|FG000|Overall Study|Lost to Follow-up|12|||
94674500|NCT02061202|324261222|FG000|Overall Study|Lost to Follow-up|1|||
94674501|NCT02061202|324261223|FG001|Overall Study|Lost to Follow-up|1|||
94674502|NCT00569582|324261234|FG000|Overall Study|Withdrawal by Subject|5|||
94674503|NCT00569582|324261234|FG000|Overall Study|Death|2|||
94674504|NCT00569582|324261234|FG000|Overall Study|Adverse Event|7|||
94674505|NCT00569582|324261234|FG000|Overall Study|Subject was too ill to travel.|1|||
94674506|NCT00569582|324261234|FG000|Overall Study|Subject was non-compliant.|1|||
94674507|NCT02355743|324261235|FG000|Overall Study|Withdrawal by Subject|1|||
94674508|NCT02355743|324261235|FG000|Overall Study|Lost to Follow-up|1|||
94674509|NCT01428076|324261243|FG000|Overall Study|Adverse Event|0|||
94674510|NCT01428076|324261244|FG001|Overall Study|Adverse Event|1|||
94674511|NCT02454101|324261247|FG000|Overall Study|Adverse Event|2|||
94674512|NCT02454101|324261248|FG001|Overall Study|Adverse Event|3|||
94674513|NCT02454101|324261247|FG000|Overall Study|Lost to Follow-up|3|||
94674514|NCT02454101|324261248|FG001|Overall Study|Lost to Follow-up|4|||
94674515|NCT00045305|324261249|FG000|Overall Study|Lack of Efficacy|6|||
94674516|NCT00045305|324261249|FG000|Overall Study|Adverse Event|3|||
94674517|NCT00045305|324261249|FG000|Overall Study|Death|3|||
94674518|NCT00045305|324261249|FG000|Overall Study|site error|2|||
94674519|NCT02191267|324261250|FG000|Overall Study|Withdrawal by Subject|1|||
94674520|NCT02191267|324261251|FG001|Overall Study|Withdrawal by Subject|0|||
94674521|NCT02191267|324261252|FG002|Overall Study|Withdrawal by Subject|0|||
94674522|NCT00316082|324261253|FG000|Overall Study|Lack of Efficacy|2|||
94674523|NCT00316082|324261254|FG001|Overall Study|Lack of Efficacy|3|||
94674524|NCT00316082|324261255|FG002|Overall Study|Lack of Efficacy|3|||
94674525|NCT00316082|324261256|FG003|Overall Study|Lack of Efficacy|4|||
94674526|NCT00316082|324261257|FG004|Overall Study|Lack of Efficacy|6|||
94674527|NCT00316082|324261253|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
94674528|NCT00316082|324261254|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
94674529|NCT00316082|324261255|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
94674530|NCT00316082|324261256|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
94674531|NCT00316082|324261257|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
94255623|NCT01491672|322730096|FG001|Overall Study|Death|4|||
94255624|NCT01491672|322730097|FG002|Overall Study|Death|0|||
94255625|NCT00107120|322730098|FG000|Overall Study|Adverse Event|4|||
94255626|NCT00107120|322730099|FG001|Overall Study|Adverse Event|1|||
94255627|NCT00107120|322730098|FG000|Overall Study|Lack of Efficacy|5|||
94255628|NCT00107120|322730099|FG001|Overall Study|Lack of Efficacy|5|||
94255629|NCT00107120|322730098|FG000|Overall Study|Protocol Violation|3|||
94255630|NCT00107120|322730099|FG001|Overall Study|Protocol Violation|0|||
94255631|NCT00107120|322730098|FG000|Overall Study|Withdrawal by Subject|8|||
94255632|NCT00107120|322730099|FG001|Overall Study|Withdrawal by Subject|9|||
94255633|NCT00107120|322730098|FG000|Overall Study|Lost to Follow-up|8|||
94255634|NCT00107120|322730099|FG001|Overall Study|Lost to Follow-up|6|||
94255635|NCT00107120|322730098|FG000|Overall Study|Pregnancy|0|||
94255636|NCT00107120|322730099|FG001|Overall Study|Pregnancy|1|||
94255637|NCT00107120|322730098|FG000|Overall Study|moving away from site|1|||
94255638|NCT00107120|322730099|FG001|Overall Study|moving away from site|1|||
94255639|NCT00107120|322730098|FG000|Overall Study|death of parent|0|||
94255640|NCT00107120|322730099|FG001|Overall Study|death of parent|1|||
94674532|NCT00316082|324261253|FG000|Overall Study|Lost to Follow-up|7|||
94674533|NCT00316082|324261254|FG001|Overall Study|Lost to Follow-up|6|||
94674534|NCT00316082|324261255|FG002|Overall Study|Lost to Follow-up|7|||
94674535|NCT00316082|324261256|FG003|Overall Study|Lost to Follow-up|8|||
94674536|NCT00316082|324261257|FG004|Overall Study|Lost to Follow-up|6|||
94674537|NCT00316082|324261253|FG000|Overall Study|Poor/noncompliance|6|||
94674538|NCT00316082|324261254|FG001|Overall Study|Poor/noncompliance|1|||
94674539|NCT00316082|324261255|FG002|Overall Study|Poor/noncompliance|4|||
94674540|NCT00316082|324261256|FG003|Overall Study|Poor/noncompliance|1|||
94674541|NCT00316082|324261257|FG004|Overall Study|Poor/noncompliance|4|||
94674542|NCT00316082|324261253|FG000|Overall Study|Adverse Event|4|||
94674543|NCT00316082|324261254|FG001|Overall Study|Adverse Event|2|||
94255641|NCT00876928|322730108|FG000|Overall Study|Lost to Follow-up|2|||
94255642|NCT00876928|322730109|FG001|Overall Study|Lost to Follow-up|5|||
94674544|NCT00316082|324261255|FG002|Overall Study|Adverse Event|5|||
94674545|NCT00316082|324261256|FG003|Overall Study|Adverse Event|1|||
94674546|NCT00316082|324261257|FG004|Overall Study|Adverse Event|3|||
94674547|NCT00316082|324261253|FG000|Overall Study|Subject no longer meets study criteria|3|||
94674548|NCT00316082|324261254|FG001|Overall Study|Subject no longer meets study criteria|1|||
94674549|NCT00316082|324261255|FG002|Overall Study|Subject no longer meets study criteria|2|||
94255643|NCT00876928|322730108|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
94627684|NCT02899988|324095674|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94627685|NCT02899988|324095675|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94627686|NCT02899988|324095676|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94627687|NCT02899988|324095677|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94627688|NCT02899988|324095678|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94627689|NCT02899988|324095679|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94627690|NCT02899988|324095669|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
94627691|NCT02899988|324095670|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
94627692|NCT02899988|324095671|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
94627693|NCT02899988|324095672|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
94627694|NCT02899988|324095673|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
94627695|NCT02899988|324095674|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
94627696|NCT02899988|324095675|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
94627697|NCT02899988|324095676|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
94627698|NCT02899988|324095677|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
94627699|NCT02899988|324095678|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
94627700|NCT02899988|324095679|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
94627701|NCT02899988|324095669|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
94255644|NCT00876928|322730109|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
94255645|NCT03602066|322730114|FG000|Overall Study|Withdrawal by Subject|2|||
94255646|NCT03602066|322730115|FG001|Overall Study|Withdrawal by Subject|0|||
94255647|NCT03602066|322730114|FG000|Overall Study|Physician Decision|1|||
94255648|NCT03602066|322730115|FG001|Overall Study|Physician Decision|0|||
94255649|NCT01111474|322730116|FG000|Overall Study|Lost to Follow-up|12|||
94255650|NCT01016977|322730117|FG000|Overall Study|Lost to Follow-up|1|||
94255651|NCT01016977|322730118|FG001|Overall Study|Lost to Follow-up|0|||
94255652|NCT01016977|322730117|FG000|Overall Study|Withdrawal by Subject|2|||
94255653|NCT01016977|322730118|FG001|Overall Study|Withdrawal by Subject|2|||
94255654|NCT01143038|322730119|FG000|Overall Study|Withdrawal by Subject|4|||
94255655|NCT01143038|322730119|FG000|Overall Study|Requirement for alternative therapy|5|||
94255656|NCT01143038|322730119|FG000|Overall Study|Adverse Event|3|||
94255657|NCT01143038|322730119|FG000|Overall Study|Lost to Follow-up|2|||
94255658|NCT01143038|322730119|FG000|Overall Study|Protocol Deviation|1|||
94255659|NCT01143038|322730119|FG000|Overall Study|Death|1|||
94255660|NCT03718533|322730123|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
94255661|NCT03718533|322730123|FG000|Overall Study|Protocol deviation|1|||
94255662|NCT03718533|322730123|FG000|Overall Study|Disease progression|1|||
94255663|NCT03718533|322730123|FG000|Overall Study|Relapse|1|||
94255664|NCT03718533|322730123|FG000|Overall Study|Physician Decision|2|||
94255665|NCT03718533|322730123|FG000|Overall Study|Physician Decision and Adverse Event|1|||
94255666|NCT02038543|322730124|FG000|Overall Study|Screen Failure|0|||
94255667|NCT02038543|322730125|FG001|Overall Study|Screen Failure|0|||
94255668|NCT02038543|322730126|FG002|Overall Study|Screen Failure|0|||
94255669|NCT02038543|322730127|FG003|Overall Study|Screen Failure|1|||
94255670|NCT02038543|322730124|FG000|Overall Study|Withdrawal by Subject|0|||
94255671|NCT02038543|322730125|FG001|Overall Study|Withdrawal by Subject|0|||
94255672|NCT02038543|322730126|FG002|Overall Study|Withdrawal by Subject|0|||
94255673|NCT02038543|322730127|FG003|Overall Study|Withdrawal by Subject|1|||
94255674|NCT00093808|322730128|FG000|Overall Study|Cancel participation before receiving tx|1|||
94255675|NCT00093808|322730128|FG000|Overall Study|Protocol Violation|1|||
94255676|NCT00871780|322730129|FG000|Overall Study|Enrolled But Not Treated|6|||
94255677|NCT00871780|322730129|FG000|Overall Study|Withdrawal by Subject|9|||
94255678|NCT00871780|322730129|FG000|Overall Study|Adverse Event|6|||
94255679|NCT00871780|322730129|FG000|Overall Study|Voluntary Discontinuation|4|||
94255680|NCT00871780|322730129|FG000|Overall Study|Death|1|||
94255681|NCT00871780|322730129|FG000|Overall Study|Physician Decision|1|||
94255682|NCT00211185|322730139|FG000|Overall Study|Death|2|||
94255683|NCT00211185|322730139|FG000|Overall Study|Disease progression|7|||
94255684|NCT00211185|322730139|FG000|Overall Study|Withdrawal by Subject|6|||
94255685|NCT00211185|322730139|FG000|Overall Study|Physician Decision|5|||
94255686|NCT02208999|322730141|FG000|Overall Study|Lost to Follow-up|1|||
94627702|NCT02899988|324095670|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
94627703|NCT02899988|324095671|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
94255687|NCT00319839|322730142|FG000|Overall Study|Adverse Event|5|||
94255688|NCT00319839|322730142|FG000|Overall Study|Withdrawal by Subject|1|||
94255689|NCT01037244|322730143|FG000|Overall Study|Adverse Event|3|||
94255690|NCT01037244|322730144|FG001|Overall Study|Adverse Event|2|||
94255691|NCT01037244|322730145|FG002|Overall Study|Adverse Event|6|||
94627704|NCT02899988|324095672|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
94255692|NCT01037244|322730146|FG003|Overall Study|Adverse Event|3|||
94255693|NCT01037244|322730143|FG000|Overall Study|Lack of Efficacy|1|||
94255694|NCT01037244|322730144|FG001|Overall Study|Lack of Efficacy|1|||
94255695|NCT01037244|322730145|FG002|Overall Study|Lack of Efficacy|0|||
94255696|NCT01037244|322730146|FG003|Overall Study|Lack of Efficacy|1|||
94255697|NCT01037244|322730143|FG000|Overall Study|Lost to Follow-up|3|||
94674550|NCT00316082|324261256|FG003|Overall Study|Subject no longer meets study criteria|2|||
94360281|NCT00706901|323103723|FG002|Overall Study|Lost to Follow-up|2|||
94360282|NCT00706901|323103721|FG000|Overall Study|Withdrawal by Subject|4|||
94360283|NCT00706901|323103722|FG001|Overall Study|Withdrawal by Subject|2|||
94360284|NCT00706901|323103723|FG002|Overall Study|Withdrawal by Subject|5|||
94360285|NCT00706901|323103721|FG000|Overall Study|In Jail|1|||
94360286|NCT00706901|323103722|FG001|Overall Study|In Jail|0|||
94360287|NCT00706901|323103723|FG002|Overall Study|In Jail|1|||
94360288|NCT00706901|323103721|FG000|Overall Study|Death|1|||
94360289|NCT00706901|323103722|FG001|Overall Study|Death|0|||
94360290|NCT00706901|323103723|FG002|Overall Study|Death|0|||
94360291|NCT01319994|323103724|FG000|Overall Study|Protocol Violation|7|||
94360292|NCT01319994|323103725|FG001|Overall Study|Protocol Violation|6|||
94360293|NCT01458535|323103728|FG000|Overall Study|Other|0|||
94360294|NCT01458535|323103729|FG001|Overall Study|Other|0|||
94360295|NCT01458535|323103730|FG002|Overall Study|Other|0|||
94360296|NCT01458535|323103731|FG003|Overall Study|Other|0|||
94360297|NCT01458535|323103732|FG004|Overall Study|Other|1|||
94360298|NCT01458535|323103733|FG005|Overall Study|Other|1|||
94627705|NCT02899988|324095673|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
94627706|NCT02899988|324095674|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
94627707|NCT02899988|324095675|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
94627708|NCT02899988|324095676|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
94627709|NCT02899988|324095677|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
94627710|NCT02899988|324095678|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
94627711|NCT02899988|324095679|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
94627712|NCT02899988|324095669|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
94627713|NCT02899988|324095670|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
94627714|NCT02899988|324095671|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
94627715|NCT02899988|324095672|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
94627716|NCT02899988|324095673|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
94627717|NCT02899988|324095674|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
94627718|NCT02899988|324095675|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
94627719|NCT02899988|324095676|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
94627720|NCT02899988|324095677|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
94627721|NCT02899988|324095678|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
94627722|NCT02899988|324095679|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
94627723|NCT02899988|324095669|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
94627724|NCT02899988|324095670|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
94627725|NCT02899988|324095671|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
94627726|NCT02899988|324095672|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
94627727|NCT02899988|324095673|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
94627728|NCT02899988|324095674|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
94627729|NCT02899988|324095675|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
94627730|NCT02899988|324095676|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
94627731|NCT02899988|324095677|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
94627732|NCT02899988|324095678|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
94627733|NCT02899988|324095679|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
94627734|NCT02899988|324095669|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
94627735|NCT02899988|324095670|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
94627736|NCT02899988|324095671|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
94627737|NCT02899988|324095672|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
94627738|NCT02899988|324095673|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
94627739|NCT02899988|324095674|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
94627740|NCT02899988|324095675|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
94627741|NCT02899988|324095676|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
94627742|NCT02899988|324095677|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
94627743|NCT02899988|324095678|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
94627744|NCT02899988|324095679|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
94674551|NCT00316082|324261257|FG004|Overall Study|Subject no longer meets study criteria|1|||
94674552|NCT00316082|324261253|FG000|Overall Study|Physician Decision|1|||
94360299|NCT01458535|323103728|FG000|Overall Study|Withdrawal by Subject|0|||
94360300|NCT01458535|323103729|FG001|Overall Study|Withdrawal by Subject|0|||
94360301|NCT01458535|323103730|FG002|Overall Study|Withdrawal by Subject|2|||
94360302|NCT01458535|323103731|FG003|Overall Study|Withdrawal by Subject|0|||
94627745|NCT00617123|324095680|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
94627746|NCT00617123|324095681|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
94674553|NCT00316082|324261254|FG001|Overall Study|Physician Decision|1|||
94360303|NCT01458535|323103732|FG004|Overall Study|Withdrawal by Subject|1|||
94360304|NCT01458535|323103733|FG005|Overall Study|Withdrawal by Subject|1|||
94360305|NCT01458535|323103728|FG000|Overall Study|Lost to Follow-up|0|||
94360306|NCT01458535|323103729|FG001|Overall Study|Lost to Follow-up|2|||
94674554|NCT00316082|324261255|FG002|Overall Study|Physician Decision|2|||
94674555|NCT00316082|324261256|FG003|Overall Study|Physician Decision|1|||
94674556|NCT00316082|324261257|FG004|Overall Study|Physician Decision|1|||
94674557|NCT00316082|324261253|FG000|Overall Study|Death|0|||
94674558|NCT00316082|324261254|FG001|Overall Study|Death|0|||
94674559|NCT00316082|324261255|FG002|Overall Study|Death|1|||
94360307|NCT01458535|323103730|FG002|Overall Study|Lost to Follow-up|0|||
94360308|NCT01458535|323103731|FG003|Overall Study|Lost to Follow-up|3|||
94360309|NCT01458535|323103732|FG004|Overall Study|Lost to Follow-up|2|||
94360310|NCT01458535|323103733|FG005|Overall Study|Lost to Follow-up|2|||
94360311|NCT01458535|323103728|FG000|Overall Study|Adverse Event|0|||
94360312|NCT01458535|323103729|FG001|Overall Study|Adverse Event|0|||
94360313|NCT01458535|323103730|FG002|Overall Study|Adverse Event|0|||
94360314|NCT01458535|323103731|FG003|Overall Study|Adverse Event|1|||
94360315|NCT01458535|323103732|FG004|Overall Study|Adverse Event|0|||
94360316|NCT01458535|323103733|FG005|Overall Study|Adverse Event|0|||
94360317|NCT01300741|323103742|FG000|Overall Study|Lens deposits|1|||
94360318|NCT01300741|323103742|FG000|Overall Study|Lost to Follow-up|1|||
94674560|NCT00316082|324261256|FG003|Overall Study|Death|0|||
94674561|NCT00316082|324261257|FG004|Overall Study|Death|0|||
94674562|NCT00316082|324261253|FG000|Overall Study|Administrative reason by sponsor|0|||
94674563|NCT00316082|324261254|FG001|Overall Study|Administrative reason by sponsor|0|||
94674564|NCT00316082|324261255|FG002|Overall Study|Administrative reason by sponsor|1|||
94674565|NCT00316082|324261256|FG003|Overall Study|Administrative reason by sponsor|0|||
94674566|NCT00316082|324261257|FG004|Overall Study|Administrative reason by sponsor|0|||
94674567|NCT02216773|324261258|FG000|Overall Study|Disease progression|4|||
94674568|NCT02216773|324261259|FG001|Overall Study|Disease progression|2|||
94674569|NCT02216773|324261258|FG000|Overall Study|Insufficient FLRV|4|||
94360319|NCT01300741|323103742|FG000|Overall Study|Discomfort|1|||
94360320|NCT01473602|323103743|FG000|Overall Study|Adverse Event|1|||
94360321|NCT01473602|323103744|FG001|Overall Study|Adverse Event|2|||
94360322|NCT01473602|323103743|FG000|Overall Study|Death|0|||
94360323|NCT01473602|323103744|FG001|Overall Study|Death|1|||
94360324|NCT01473602|323103743|FG000|Overall Study|Lost to Follow-up|1|||
94360325|NCT01473602|323103744|FG001|Overall Study|Lost to Follow-up|1|||
94674570|NCT02216773|324261259|FG001|Overall Study|Insufficient FLRV|0|||
94674571|NCT02216773|324261258|FG000|Overall Study|Abandoned|4|||
94674572|NCT02216773|324261259|FG001|Overall Study|Abandoned|3|||
94674573|NCT03266770|324261260|FG000|Overall Study|Physician Decision|3|||
94674574|NCT03266770|324261260|FG000|Overall Study|Insufficient study supplies|1|||
94674575|NCT03266770|324261260|FG000|Overall Study|Adverse Event|1|||
94674576|NCT04274894|324261261|FG000|Overall Study|Adverse Event|7|||
94674577|NCT04274894|324261261|FG000|Overall Study|Withdrew consent|5|||
94674578|NCT04274894|324261261|FG000|Overall Study|Lost to Follow-up|9|||
94674579|NCT04274894|324261261|FG000|Overall Study|COVID-19 infection|1|||
94674580|NCT04274894|324261261|FG000|Overall Study|Other, not specified|20|||
94674581|NCT01693068|324261269|FG000|Randomization Period|On-study|2|||
94674582|NCT01693068|324261270|FG001|Randomization Period|On-study|5|||
94674583|NCT01693068|324261271|FG002|Randomization Period|On-study|0|||
94674584|NCT01693068|324261269|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
94674585|NCT01693068|324261270|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
94674586|NCT01693068|324261271|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
94674587|NCT02279043|324261272|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
94674588|NCT02279043|324261273|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
94674589|NCT02279043|324261274|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
94674590|NCT02279043|324261272|FG000|Overall Study|Lost to Follow-up|46|||
94674591|NCT02279043|324261273|FG001|Overall Study|Lost to Follow-up|88|||
94674592|NCT02279043|324261274|FG002|Overall Study|Lost to Follow-up|0|||
94674593|NCT01687257|324261275|FG000|Overall Study|Efficacy Failure|6|||
94674594|NCT01687257|324261276|FG001|Overall Study|Efficacy Failure|0|||
94674595|NCT01687257|324261277|FG002|Overall Study|Efficacy Failure|5|||
94674596|NCT01687257|324261275|FG000|Overall Study|Subject Withdrew Consent|1|||
94674597|NCT01687257|324261276|FG001|Overall Study|Subject Withdrew Consent|1|||
94674598|NCT01687257|324261277|FG002|Overall Study|Subject Withdrew Consent|1|||
94674599|NCT01687257|324261275|FG000|Overall Study|Adverse Event|1|||
94674600|NCT01687257|324261276|FG001|Overall Study|Adverse Event|0|||
94255698|NCT01037244|322730144|FG001|Overall Study|Lost to Follow-up|3|||
94255699|NCT01037244|322730145|FG002|Overall Study|Lost to Follow-up|4|||
94255700|NCT01037244|322730146|FG003|Overall Study|Lost to Follow-up|4|||
94255701|NCT01037244|322730143|FG000|Overall Study|Withdrawal by Subject|1|||
94255702|NCT01037244|322730144|FG001|Overall Study|Withdrawal by Subject|5|||
94255703|NCT01037244|322730145|FG002|Overall Study|Withdrawal by Subject|3|||
94255704|NCT01037244|322730146|FG003|Overall Study|Withdrawal by Subject|5|||
94255705|NCT01037244|322730143|FG000|Overall Study|Partner Withdrew Consent|2|||
94255706|NCT01037244|322730144|FG001|Overall Study|Partner Withdrew Consent|1|||
94255707|NCT01037244|322730145|FG002|Overall Study|Partner Withdrew Consent|0|||
94255708|NCT01037244|322730146|FG003|Overall Study|Partner Withdrew Consent|0|||
94255709|NCT01037244|322730143|FG000|Overall Study|Various|3|||
94255710|NCT01037244|322730144|FG001|Overall Study|Various|2|||
94360326|NCT01473602|323103743|FG000|Overall Study|Withdrawal by Subject|5|||
94360327|NCT01473602|323103744|FG001|Overall Study|Withdrawal by Subject|4|||
94360328|NCT01473602|323103743|FG000|Overall Study|Physician Decision|1|||
94360329|NCT01473602|323103744|FG001|Overall Study|Physician Decision|0|||
94360330|NCT02325414|323103745|FG000|Overall Study|Withdrawal by Subject|3|||
94360331|NCT02325414|323103746|FG001|Overall Study|Withdrawal by Subject|1|||
94360332|NCT02325414|323103745|FG000|Overall Study|Lost to Follow-up|5|||
94360333|NCT02325414|323103746|FG001|Overall Study|Lost to Follow-up|5|||
94360334|NCT00560573|323103748|FG000|Overall Study|Death|4|||
94360335|NCT00560573|323103749|FG001|Overall Study|Death|1|||
94360336|NCT00560573|323103750|FG002|Overall Study|Death|4|||
94360337|NCT00560573|323103751|FG003|Overall Study|Death|5|||
94360338|NCT00560573|323103752|FG004|Overall Study|Death|1|||
94360339|NCT00560573|323103753|FG005|Overall Study|Death|10|||
94360340|NCT00560573|323103748|FG000|Overall Study|Lost to Follow-up|0|||
94360341|NCT00560573|323103749|FG001|Overall Study|Lost to Follow-up|0|||
94360342|NCT00560573|323103750|FG002|Overall Study|Lost to Follow-up|0|||
94360343|NCT00560573|323103751|FG003|Overall Study|Lost to Follow-up|1|||
94360344|NCT00560573|323103752|FG004|Overall Study|Lost to Follow-up|1|||
94360345|NCT00560573|323103753|FG005|Overall Study|Lost to Follow-up|0|||
94360346|NCT00560573|323103748|FG000|Overall Study|Withdrawal by Subject|0|||
94360347|NCT00560573|323103749|FG001|Overall Study|Withdrawal by Subject|0|||
94360348|NCT00560573|323103750|FG002|Overall Study|Withdrawal by Subject|0|||
94360349|NCT00560573|323103751|FG003|Overall Study|Withdrawal by Subject|1|||
94360350|NCT00560573|323103752|FG004|Overall Study|Withdrawal by Subject|1|||
94360351|NCT00560573|323103753|FG005|Overall Study|Withdrawal by Subject|0|||
94627747|NCT00617123|324095680|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
94627748|NCT00617123|324095681|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
94627749|NCT00617123|324095680|FG000|Referral Screening Period|Adverse Event|0|||
94627750|NCT00617123|324095681|FG001|Referral Screening Period|Adverse Event|1|||
94627751|NCT00617123|324095680|FG000|Study Treatment Period|Withdrawal by Subject|8|||
94627752|NCT00617123|324095681|FG001|Study Treatment Period|Withdrawal by Subject|12|||
94627753|NCT00617123|324095680|FG000|Study Treatment Period|Adverse Event|7|||
94627754|NCT00617123|324095681|FG001|Study Treatment Period|Adverse Event|3|||
94627755|NCT00617123|324095680|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
94627756|NCT00617123|324095681|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
94627757|NCT00617123|324095680|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
94627758|NCT00617123|324095681|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
94627759|NCT04626297|324095682|FG000|Overall Study|Adverse Event|5|||
94627760|NCT04626297|324095683|FG001|Overall Study|Adverse Event|3|||
94627761|NCT04626297|324095682|FG000|Overall Study|Lost to Follow-up|7|||
94627762|NCT04626297|324095683|FG001|Overall Study|Lost to Follow-up|3|||
94627763|NCT04626297|324095682|FG000|Overall Study|Protocol Violation|5|||
94627764|NCT04626297|324095683|FG001|Overall Study|Protocol Violation|1|||
94627765|NCT04626297|324095682|FG000|Overall Study|Withdrawal by Subject|20|||
94627766|NCT04626297|324095683|FG001|Overall Study|Withdrawal by Subject|6|||
94627767|NCT04626297|324095682|FG000|Overall Study|Sponsor decision|2|||
94627768|NCT04626297|324095683|FG001|Overall Study|Sponsor decision|1|||
94627769|NCT02170298|324095684|FG000|Overall Study|Withdrawal by Subject|0|||
94627770|NCT02170298|324095685|FG001|Overall Study|Withdrawal by Subject|1|||
94627771|NCT02170298|324095684|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
94627772|NCT02170298|324095685|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
94627773|NCT03521934|324095686|FG000|Overall Study|Death|65|||
94627774|NCT03521934|324095687|FG001|Overall Study|Death|73|||
94627775|NCT03521934|324095686|FG000|Overall Study|Withdrawal by Subject|18|||
94627776|NCT03521934|324095687|FG001|Overall Study|Withdrawal by Subject|23|||
94627777|NCT03521934|324095686|FG000|Overall Study|Site Terminated by Sponsor|39|||
94627778|NCT03521934|324095687|FG001|Overall Study|Site Terminated by Sponsor|35|||
94627779|NCT03521934|324095686|FG000|Overall Study|Study Terminated by Sponsor|483|||
94627780|NCT03521934|324095687|FG001|Overall Study|Study Terminated by Sponsor|477|||
94627781|NCT03521934|324095686|FG000|Overall Study|Reason not Specified|3|||
94627782|NCT03521934|324095687|FG001|Overall Study|Reason not Specified|6|||
94627783|NCT00885105|324095688|FG000|Overall Study|Withdrawal by Subject|0|||
94627784|NCT00885105|324095689|FG001|Overall Study|Withdrawal by Subject|8|||
94627785|NCT00885105|324095688|FG000|Overall Study|Adverse Event|1|||
94627786|NCT00885105|324095689|FG001|Overall Study|Adverse Event|0|||
94627787|NCT00885105|324095688|FG000|Overall Study|Protocol Violation|0|||
94627788|NCT00885105|324095689|FG001|Overall Study|Protocol Violation|2|||
94627789|NCT01350414|324095690|FG000|Overall Study|Lost to Follow-up|13|||
94627790|NCT01350414|324095690|FG000|Overall Study|Withdrawal by Subject|4|||
94627791|NCT01350414|324095690|FG000|Overall Study|Physician Decision|2|||
94360352|NCT00560573|323103748|FG000|Overall Study|Other|2|||
94360353|NCT00560573|323103749|FG001|Overall Study|Other|2|||
94360354|NCT00560573|323103750|FG002|Overall Study|Other|2|||
94627792|NCT02573350|324095694|FG000|Overall Study|Lost to Follow-up|2|||
94627793|NCT02573350|324095695|FG001|Overall Study|Lost to Follow-up|1|||
94360355|NCT00560573|323103751|FG003|Overall Study|Other|3|||
94360356|NCT00560573|323103752|FG004|Overall Study|Other|3|||
94255711|NCT01037244|322730145|FG002|Overall Study|Various|1|||
94255712|NCT01037244|322730146|FG003|Overall Study|Various|1|||
94255713|NCT01324440|322730147|FG000|Overall Study|Subject moved|0|||
94255714|NCT01324440|322730148|FG001|Overall Study|Subject moved|1|||
94255715|NCT02054741|322730149|FG000|Overall Study|Protocol Violation|13|||
94255716|NCT02054741|322730150|FG001|Overall Study|Protocol Violation|2|||
94255717|NCT02054741|322730149|FG000|Overall Study|Withdrawal by Subject|10|||
94255718|NCT02054741|322730150|FG001|Overall Study|Withdrawal by Subject|5|||
94255719|NCT02054741|322730149|FG000|Overall Study|Death|94|||
94255720|NCT02054741|322730150|FG001|Overall Study|Death|90|||
94255721|NCT02054741|322730149|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
94255722|NCT02054741|322730150|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
94255723|NCT04025580|322730151|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
94255724|NCT04025580|322730152|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
94255725|NCT04025580|322730153|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
94255726|NCT02325557|322730154|FG000|Overall Study|Progressive disease|1|||
94255727|NCT02325557|322730155|FG001|Overall Study|Progressive disease|0|||
94255728|NCT02325557|322730156|FG002|Overall Study|Progressive disease|0|||
94255729|NCT02325557|322730157|FG003|Overall Study|Progressive disease|0|||
94255730|NCT02325557|322730154|FG000|Overall Study|Withdrawal by Subject|4|||
94255731|NCT02325557|322730155|FG001|Overall Study|Withdrawal by Subject|0|||
94255732|NCT02325557|322730156|FG002|Overall Study|Withdrawal by Subject|0|||
94255733|NCT02325557|322730157|FG003|Overall Study|Withdrawal by Subject|15|||
94255734|NCT02325557|322730154|FG000|Overall Study|Death|5|||
94255735|NCT02325557|322730155|FG001|Overall Study|Death|1|||
94255736|NCT02325557|322730156|FG002|Overall Study|Death|1|||
94255737|NCT02325557|322730157|FG003|Overall Study|Death|16|||
94255738|NCT02325557|322730154|FG000|Overall Study|Lost to Follow-up|0|||
94255739|NCT02325557|322730155|FG001|Overall Study|Lost to Follow-up|0|||
94255740|NCT02325557|322730156|FG002|Overall Study|Lost to Follow-up|1|||
94255741|NCT02325557|322730157|FG003|Overall Study|Lost to Follow-up|1|||
94255742|NCT02325557|322730154|FG000|Overall Study|Other|0|||
94255743|NCT02325557|322730155|FG001|Overall Study|Other|0|||
94255744|NCT02325557|322730156|FG002|Overall Study|Other|0|||
94255745|NCT02325557|322730157|FG003|Overall Study|Other|5|||
94255746|NCT01602562|322730158|FG000|Overall Study|Adverse Event|3|||
94255747|NCT01602562|322730159|FG001|Overall Study|Adverse Event|1|||
94255748|NCT01602562|322730158|FG000|Overall Study|Physician Decision|1|||
94255749|NCT01602562|322730159|FG001|Overall Study|Physician Decision|1|||
94255750|NCT01602562|322730158|FG000|Overall Study|Withdrawal by Subject|1|||
94255751|NCT01602562|322730159|FG001|Overall Study|Withdrawal by Subject|1|||
94255752|NCT03881553|322730161|FG000|Overall Study|Discharged prior to participation|1|||
94255753|NCT03881553|322730162|FG001|Overall Study|Discharged prior to participation|1|||
94255754|NCT03881553|322730163|FG002|Overall Study|Discharged prior to participation|0|||
94255755|NCT03881553|322730161|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
94264156|NCT01323621|322761851|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
94264157|NCT01323621|322761852|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
94264158|NCT01323621|322761853|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
94264159|NCT02876835|322761860|FG000|Treatment Period (51.1 Month)|Other|1|||
94264160|NCT02876835|322761861|FG001|Treatment Period (51.1 Month)|Other|0|||
94627794|NCT02573350|324095694|FG000|Overall Study|Adverse Event|3|||
94627795|NCT02573350|324095695|FG001|Overall Study|Adverse Event|4|||
94627796|NCT02573350|324095694|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
94627797|NCT02573350|324095695|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
94627798|NCT02573350|324095694|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
94627799|NCT02573350|324095695|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
94627800|NCT02573350|324095694|FG000|Overall Study|Subject withdrew consent to participate|6|||
94627801|NCT02573350|324095695|FG001|Overall Study|Subject withdrew consent to participate|1|||
94627802|NCT02573350|324095694|FG000|Overall Study|Protocol Deviation|1|||
94627803|NCT02573350|324095695|FG001|Overall Study|Protocol Deviation|1|||
94627804|NCT00743340|324095696|FG000|Overall Study|Study medication non-compliance|1|||
94627805|NCT00743340|324095696|FG000|Overall Study|Lost to Follow-up|1|||
94627806|NCT00743340|324095696|FG000|Overall Study|Withdrawal from the Study|5|||
94627807|NCT00743340|324095696|FG000|Overall Study|Protocol Violation|1|||
94627808|NCT00743340|324095696|FG000|Overall Study|Virologic failure|8|||
94627809|NCT00743340|324095696|FG000|Overall Study|Pregnancy|1|||
94627810|NCT00743340|324095696|FG000|Overall Study|Rolled over to other Gilead Study|23|||
94627811|NCT00743340|324095696|FG000|Overall Study|Participant Relocated|1|||
94627812|NCT01987505|324095699|FG000|Overall Study|Other|9|||
94627813|NCT01987505|324095699|FG000|Overall Study|Withdrawal by Subject|2|||
94627814|NCT01987505|324095699|FG000|Overall Study|Other Reason|2|||
94627815|NCT01987505|324095699|FG000|Overall Study|Lost to Follow-up|15|||
94627816|NCT01987505|324095699|FG000|Overall Study|Investigator Decision|2|||
94627817|NCT01987505|324095699|FG000|Overall Study|Death|4|||
94627818|NCT01833520|324095700|FG000|Overall Study|Lack of Efficacy|3|||
94627819|NCT01833520|324095701|FG001|Overall Study|Lack of Efficacy|3|||
94627820|NCT01833520|324095702|FG002|Overall Study|Lack of Efficacy|8|||
94627821|NCT01833520|324095703|FG003|Overall Study|Lack of Efficacy|3|||
94627822|NCT02743520|324095704|FG000|Overall Study|Withdrawal by Subject|1|||
94627823|NCT04983264|324095705|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
94627824|NCT04983264|324095706|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
94627825|NCT04983264|324095707|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
94627826|NCT04983264|324095705|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
94627827|NCT04983264|324095706|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
94627828|NCT04983264|324095707|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
94627829|NCT01124422|324095708|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
94627830|NCT01124422|324095709|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
94627831|NCT01124422|324095710|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
94627832|NCT01124422|324095708|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
94627833|NCT01124422|324095709|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
94627834|NCT01124422|324095710|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
94627835|NCT01124422|324095708|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
94627836|NCT01124422|324095709|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
94627837|NCT01124422|324095710|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
94627838|NCT01124422|324095708|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
94627839|NCT01124422|324095709|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
94627840|NCT01124422|324095710|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
94627841|NCT01124422|324095708|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
94627842|NCT01124422|324095709|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
94627843|NCT01124422|324095710|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
94627844|NCT01124422|324095708|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
94627845|NCT01124422|324095709|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
94627846|NCT01124422|324095710|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
94627847|NCT01124422|324095708|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
94627848|NCT01124422|324095709|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
94627849|NCT01124422|324095710|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
94627850|NCT01124422|324095708|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
94627851|NCT01124422|324095709|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
94627852|NCT01124422|324095710|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
94627853|NCT01124422|324095708|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
94627854|NCT01124422|324095709|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
94627855|NCT01124422|324095710|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
94627856|NCT01124422|324095708|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
94627857|NCT01124422|324095709|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
94627858|NCT01124422|324095710|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
94627859|NCT00938639|324095711|FG000|Overall Study|Moved away from study area|0|||
94255756|NCT03881553|322730162|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
94255757|NCT03881553|322730163|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
94255758|NCT01959516|322730164|FG000|Epoch 1|Adverse Event|4|||
94255759|NCT01959516|322730165|FG001|Epoch 1|Adverse Event|1|||
94255760|NCT01959516|322730164|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
94255761|NCT01959516|322730165|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
94255762|NCT01959516|322730164|FG000|Epoch 1|Subject withdrew consent|3|||
94255763|NCT01959516|322730165|FG001|Epoch 1|Subject withdrew consent|2|||
94255764|NCT01959516|322730164|FG000|Epoch 1|Administrative problems|1|||
94255765|NCT01959516|322730165|FG001|Epoch 1|Administrative problems|0|||
94255766|NCT01959516|322730164|FG000|Epoch 1|Use of prohibited treatment|1|||
94255767|NCT01959516|322730165|FG001|Epoch 1|Use of prohibited treatment|0|||
94255768|NCT01959516|322730164|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
94255769|NCT01959516|322730165|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
94255770|NCT01959516|322730164|FG000|Epoch 1|Protocol deviation|0|||
94627860|NCT00938639|324095712|FG001|Overall Study|Moved away from study area|1|||
94627861|NCT00938639|324095711|FG000|Overall Study|Lost to Follow-up|1|||
94627862|NCT00938639|324095712|FG001|Overall Study|Lost to Follow-up|2|||
94627863|NCT00938639|324095711|FG000|Overall Study|Family issues|1|||
94627864|NCT00938639|324095712|FG001|Overall Study|Family issues|1|||
94627865|NCT00938639|324095711|FG000|Overall Study|Participant noncompliance|1|||
94674601|NCT01687257|324261277|FG002|Overall Study|Adverse Event|0|||
94255771|NCT01959516|322730165|FG001|Epoch 1|Protocol deviation|1|||
94255772|NCT01959516|322730164|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
94255773|NCT01959516|322730165|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
94255774|NCT01959516|322730164|FG000|Epoch 2|Subject withdrew consent|1|||
94627866|NCT00938639|324095712|FG001|Overall Study|Participant noncompliance|0|||
94627867|NCT03454893|324095713|FG000|Overall Study|Study Terminated by the Sponsor|5|||
94627868|NCT03454893|324095713|FG000|Overall Study|Did not pass screening|4|||
94255775|NCT01959516|322730165|FG001|Epoch 2|Subject withdrew consent|0|||
94360357|NCT00560573|323103753|FG005|Overall Study|Other|3|||
94360358|NCT00560573|323103748|FG000|Overall Study|Enrolled, not treated|0|||
94360359|NCT00560573|323103749|FG001|Overall Study|Enrolled, not treated|0|||
94360360|NCT00560573|323103750|FG002|Overall Study|Enrolled, not treated|0|||
94360361|NCT00560573|323103751|FG003|Overall Study|Enrolled, not treated|0|||
94360362|NCT00560573|323103752|FG004|Overall Study|Enrolled, not treated|1|||
94360363|NCT00560573|323103753|FG005|Overall Study|Enrolled, not treated|0|||
94360364|NCT00726882|323103754|FG000|Overall Study|Withdrawal by Subject|5|||
94360365|NCT00726882|323103754|FG000|Overall Study|Lost to Follow-up|7|||
94360366|NCT00726882|323103754|FG000|Overall Study|Other|10|||
94360367|NCT03735680|323103755|FG000|Overall Study|Withdrawal by Subject|0|||
94360368|NCT03735680|323103756|FG001|Overall Study|Withdrawal by Subject|1|||
94360369|NCT03735680|323103757|FG002|Overall Study|Withdrawal by Subject|0|||
94360370|NCT03735680|323103758|FG003|Overall Study|Withdrawal by Subject|0|||
94360371|NCT03735680|323103759|FG004|Overall Study|Withdrawal by Subject|0|||
94360372|NCT03735680|323103760|FG005|Overall Study|Withdrawal by Subject|1|||
94360373|NCT03735680|323103755|FG000|Overall Study|Patient unable or unwilling to continue|0|||
94360374|NCT03735680|323103756|FG001|Overall Study|Patient unable or unwilling to continue|0|||
94360375|NCT03735680|323103757|FG002|Overall Study|Patient unable or unwilling to continue|1|||
94360376|NCT03735680|323103758|FG003|Overall Study|Patient unable or unwilling to continue|0|||
94360377|NCT03735680|323103759|FG004|Overall Study|Patient unable or unwilling to continue|0|||
94360378|NCT03735680|323103760|FG005|Overall Study|Patient unable or unwilling to continue|0|||
94360379|NCT04478994|323103761|FG000|Overall Study|Withdrawal by Subject|1|||
94360380|NCT04478994|323103762|FG001|Overall Study|Withdrawal by Subject|1|||
94360381|NCT01100073|323103763|FG000|Overall Study|Lack of Efficacy|4|||
94360382|NCT01100073|323103763|FG000|Overall Study|Insufficient Tolerability|21|||
94360383|NCT01100073|323103763|FG000|Overall Study|Withdrawal by Subject|13|||
94360384|NCT01100073|323103763|FG000|Overall Study|Lost to Follow-up|39|||
94360385|NCT01100073|323103763|FG000|Overall Study|Lack of effect + patient's wish|2|||
94360386|NCT01100073|323103763|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
94627869|NCT01484197|324095721|FG000|Treatment Period 1|Adverse Event|1|||
94627870|NCT01484197|324095722|FG001|Treatment Period 1|Adverse Event|0|||
94627871|NCT01484197|324095723|FG002|Treatment Period 1|Adverse Event|0|||
94627872|NCT01484197|324095724|FG003|Treatment Period 1|Adverse Event|0|||
94627873|NCT01484197|324095721|FG000|Treatment Period 2|Subject withdrew consent|0|||
94627874|NCT01484197|324095722|FG001|Treatment Period 2|Subject withdrew consent|0|||
94627875|NCT01484197|324095723|FG002|Treatment Period 2|Subject withdrew consent|0|||
94627876|NCT01484197|324095724|FG003|Treatment Period 2|Subject withdrew consent|1|||
94627877|NCT00553644|324095726|FG000|Overall Study|Adverse Event|17|||
94627878|NCT00553644|324095726|FG000|Overall Study|Withdrawal by Subject|4|||
94627879|NCT00553644|324095726|FG000|Overall Study|Physician Decision|1|||
94627880|NCT00553644|324095726|FG000|Overall Study|Alternative therapy|6|||
94627881|NCT01678911|324095727|FG000|Second Intervention|Lost to Follow-up|2|||
94627882|NCT01678911|324095728|FG001|Second Intervention|Lost to Follow-up|0|||
94627883|NCT02706691|324095729|FG000|Overall Study|Adverse Event|1|||
94627884|NCT01619423|324095730|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
94627885|NCT01619423|324095731|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
94627886|NCT01619423|324095732|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
94627887|NCT01619423|324095733|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
94627888|NCT03167411|324095736|FG000|Overall Study|Adverse Event|0|||
94627889|NCT03167411|324095737|FG001|Overall Study|Adverse Event|1|||
94627890|NCT01830972|324095738|FG000|Part II|Withdrawal by Subject|2|||
94627891|NCT01830972|324095739|FG001|Part II|Withdrawal by Subject|2|||
94627892|NCT01830972|324095738|FG000|Part III|Withdrawal by Subject|1|||
94627893|NCT01830972|324095739|FG001|Part III|Withdrawal by Subject|0|||
94627894|NCT01830972|324095738|FG000|Part III|Noncompliance|1|||
94627895|NCT01830972|324095739|FG001|Part III|Noncompliance|0|||
94627896|NCT01830972|324095738|FG000|Part IV|Withdrawal by Subject|2|||
94627897|NCT01830972|324095739|FG001|Part IV|Withdrawal by Subject|1|||
94627898|NCT01830972|324095738|FG000|Part IV|Non-Compliance|1|||
94627899|NCT01830972|324095739|FG001|Part IV|Non-Compliance|0|||
94627900|NCT00673465|324095740|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
94360387|NCT01100073|323103763|FG000|Overall Study|Other|8|||
94360388|NCT01100073|323103763|FG000|Overall Study|Missing|5|||
94360389|NCT02526017|323103769|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
94360390|NCT02526017|323103770|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
94360391|NCT02526017|323103771|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
94627901|NCT00673465|324095741|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
94627902|NCT00673465|324095742|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
94627903|NCT00673465|324095743|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
94627904|NCT00673465|324095744|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
94627905|NCT00673465|324095745|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
94627906|NCT00673465|324095746|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
94360392|NCT02526017|323103772|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
94674602|NCT01687257|324261275|FG000|Overall Study|Investigator's Discretion|0|||
94674603|NCT01687257|324261276|FG001|Overall Study|Investigator's Discretion|3|||
94674604|NCT01687257|324261277|FG002|Overall Study|Investigator's Discretion|0|||
94674605|NCT00490282|324261278|FG000|Overall Study|Withdrawal by Subject|3|||
94674606|NCT00977665|324261282|FG000|Overall Study|Withdrawal by Subject|1|||
94674607|NCT00977665|324261283|FG001|Overall Study|Withdrawal by Subject|3|||
94674608|NCT00977665|324261282|FG000|Overall Study|Physician Decision|2|||
94674609|NCT00977665|324261283|FG001|Overall Study|Physician Decision|1|||
94674610|NCT00977665|324261282|FG000|Overall Study|Sponsor requested withdrawal|0|||
94674611|NCT00977665|324261283|FG001|Overall Study|Sponsor requested withdrawal|1|||
94674612|NCT00977665|324261282|FG000|Overall Study|Lost to Follow-up|1|||
94674613|NCT00977665|324261283|FG001|Overall Study|Lost to Follow-up|0|||
94674614|NCT00977665|324261282|FG000|Overall Study|Death|3|||
94674615|NCT00977665|324261283|FG001|Overall Study|Death|2|||
94627907|NCT00673465|324095747|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
94627908|NCT00673465|324095748|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
94627909|NCT00673465|324095749|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
94627910|NCT00673465|324095750|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
94627911|NCT00673465|324095751|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
94627912|NCT00673465|324095740|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
94627913|NCT00673465|324095741|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
94627914|NCT00673465|324095742|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
94627915|NCT00673465|324095743|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
94627916|NCT00673465|324095744|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
94627917|NCT00673465|324095745|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
94627918|NCT00673465|324095746|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
94627919|NCT00673465|324095747|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
94627920|NCT00673465|324095748|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
94627921|NCT00673465|324095749|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
94627922|NCT00673465|324095750|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
94627923|NCT00673465|324095751|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
94627924|NCT01829191|324095752|FG000|Overall Study|Relocation|0|||
94627925|NCT01829191|324095753|FG001|Overall Study|Relocation|1|||
94627926|NCT01829191|324095752|FG000|Overall Study|Lens discomfort|0|||
94627927|NCT01829191|324095753|FG001|Overall Study|Lens discomfort|3|||
94627928|NCT01829191|324095752|FG000|Overall Study|Lens handling difficulty|1|||
94627929|NCT01829191|324095753|FG001|Overall Study|Lens handling difficulty|4|||
94627930|NCT01829191|324095752|FG000|Overall Study|Protocol Violation|4|||
94627931|NCT01829191|324095753|FG001|Overall Study|Protocol Violation|1|||
94627932|NCT01829191|324095752|FG000|Overall Study|Withdrawal by Subject|2|||
94627933|NCT01829191|324095753|FG001|Overall Study|Withdrawal by Subject|3|||
94627934|NCT01829191|324095752|FG000|Overall Study|Lost to Follow-up|0|||
94627935|NCT01829191|324095753|FG001|Overall Study|Lost to Follow-up|1|||
94627936|NCT01829191|324095752|FG000|Overall Study|Subject was fit for ortho - k|0|||
94627937|NCT01829191|324095753|FG001|Overall Study|Subject was fit for ortho - k|1|||
94674616|NCT00977665|324261282|FG000|Overall Study|Adverse Event|14|||
94674617|NCT00977665|324261283|FG001|Overall Study|Adverse Event|7|||
94674618|NCT00977665|324261282|FG000|Overall Study|Treatment failure|0|||
94627938|NCT00553514|324095754|FG000|Overall Study|Protocol deviation|0|||
94627939|NCT00553514|324095755|FG001|Overall Study|Protocol deviation|0|||
94627940|NCT00553514|324095756|FG002|Overall Study|Protocol deviation|0|||
94674619|NCT00977665|324261283|FG001|Overall Study|Treatment failure|1|||
94674620|NCT03078816|324261284|FG000|Overall Study|Withdrawal by Subject|1|||
94674621|NCT01494584|324261285|FG000|Overall Study|Study Closed/Terminated|1|||
94674622|NCT01218126|324261286|FG000|Overall Study|Adverse Event|8|||
94674623|NCT01218126|324261287|FG001|Overall Study|Adverse Event|10|||
94674624|NCT01218126|324261288|FG002|Overall Study|Adverse Event|12|||
94674625|NCT01218126|324261289|FG003|Overall Study|Adverse Event|16|||
94674626|NCT01218126|324261286|FG000|Overall Study|Lack of Efficacy|7|||
94674627|NCT01218126|324261287|FG001|Overall Study|Lack of Efficacy|2|||
94674628|NCT01218126|324261288|FG002|Overall Study|Lack of Efficacy|2|||
94674629|NCT01218126|324261289|FG003|Overall Study|Lack of Efficacy|6|||
94674630|NCT01218126|324261286|FG000|Overall Study|Protocol Violation|5|||
94674631|NCT01218126|324261287|FG001|Overall Study|Protocol Violation|2|||
94674632|NCT01218126|324261288|FG002|Overall Study|Protocol Violation|2|||
94674633|NCT01218126|324261289|FG003|Overall Study|Protocol Violation|3|||
94674634|NCT01218126|324261286|FG000|Overall Study|Protocol-defined stopping criteria|1|||
94674635|NCT01218126|324261287|FG001|Overall Study|Protocol-defined stopping criteria|1|||
94674636|NCT01218126|324261288|FG002|Overall Study|Protocol-defined stopping criteria|0|||
94674637|NCT01218126|324261289|FG003|Overall Study|Protocol-defined stopping criteria|0|||
94674638|NCT01218126|324261286|FG000|Overall Study|Lost to Follow-up|0|||
94674639|NCT01218126|324261287|FG001|Overall Study|Lost to Follow-up|0|||
94674640|NCT01218126|324261288|FG002|Overall Study|Lost to Follow-up|0|||
94674641|NCT01218126|324261289|FG003|Overall Study|Lost to Follow-up|2|||
94674642|NCT01218126|324261286|FG000|Overall Study|Physician Decision|1|||
94674643|NCT01218126|324261287|FG001|Overall Study|Physician Decision|2|||
94674644|NCT01218126|324261288|FG002|Overall Study|Physician Decision|4|||
94674645|NCT01218126|324261289|FG003|Overall Study|Physician Decision|2|||
94674646|NCT01218126|324261286|FG000|Overall Study|Withdrawal by Subject|2|||
94674647|NCT01218126|324261287|FG001|Overall Study|Withdrawal by Subject|5|||
94674648|NCT01218126|324261288|FG002|Overall Study|Withdrawal by Subject|4|||
94674649|NCT01218126|324261289|FG003|Overall Study|Withdrawal by Subject|6|||
94674650|NCT00686881|324261295|FG000|Overall Study|Withdrawal by Subject|11|||
94674651|NCT00686881|324261296|FG001|Overall Study|Withdrawal by Subject|18|||
94674652|NCT00686881|324261295|FG000|Overall Study|Lost to Follow-up|0|||
94674653|NCT00686881|324261296|FG001|Overall Study|Lost to Follow-up|1|||
94674654|NCT00686881|324261295|FG000|Overall Study|Treatment-related adverse event|10|||
94674655|NCT00686881|324261296|FG001|Overall Study|Treatment-related adverse event|9|||
94674656|NCT00686881|324261295|FG000|Overall Study|Met discontinuation criteria|5|||
94674657|NCT00686881|324261296|FG001|Overall Study|Met discontinuation criteria|0|||
94674658|NCT00686881|324261295|FG000|Overall Study|Onset of malignant tumor|11|||
94674659|NCT00686881|324261296|FG001|Overall Study|Onset of malignant tumor|11|||
94674660|NCT00686881|324261295|FG000|Overall Study|Lack of Efficacy|4|||
94674661|NCT00686881|324261296|FG001|Overall Study|Lack of Efficacy|3|||
94674662|NCT00686881|324261295|FG000|Overall Study|Physician Decision|1|||
94674663|NCT00686881|324261296|FG001|Overall Study|Physician Decision|0|||
94674664|NCT00686881|324261295|FG000|Overall Study|Circumstances of site|1|||
94674665|NCT00686881|324261296|FG001|Overall Study|Circumstances of site|1|||
94674666|NCT00686881|324261295|FG000|Overall Study|Did not meet protocol eligibility|1|||
94674667|NCT00686881|324261296|FG001|Overall Study|Did not meet protocol eligibility|0|||
94674668|NCT00686881|324261295|FG000|Overall Study|Irregular visits|1|||
94674669|NCT00686881|324261296|FG001|Overall Study|Irregular visits|0|||
94674670|NCT00686881|324261295|FG000|Overall Study|Study discontinuation|35|||
94674671|NCT00686881|324261296|FG001|Overall Study|Study discontinuation|32|||
94674672|NCT00686881|324261295|FG000|Overall Study|Never received study drug|2|||
94674673|NCT00686881|324261296|FG001|Overall Study|Never received study drug|6|||
94674674|NCT03260868|324261297|FG000|Overall Study|Poor Compliance to Protocol|0|||
94674675|NCT03260868|324261298|FG001|Overall Study|Poor Compliance to Protocol|2|||
94674676|NCT03260868|324261297|FG000|Overall Study|Study Terminated By Sponsor|2|||
94674677|NCT03260868|324261298|FG001|Overall Study|Study Terminated By Sponsor|1|||
94674678|NCT03260868|324261297|FG000|Overall Study|Other than specified above|1|||
94674679|NCT03260868|324261298|FG001|Overall Study|Other than specified above|0|||
94674680|NCT00541450|324261299|FG000|Phase A|Adverse Event|3|||
94674681|NCT00541450|324261300|FG001|Phase A|Adverse Event|0|||
94674682|NCT00541450|324261299|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
94255776|NCT01959516|322730164|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
94674683|NCT00541450|324261300|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
94674684|NCT00541450|324261299|FG000|Phase A|Hyperglycemia|0|||
94627941|NCT00553514|324095757|FG003|Overall Study|Protocol deviation|1|||
94627942|NCT00553514|324095758|FG004|Overall Study|Protocol deviation|0|||
94627943|NCT00553514|324095754|FG000|Overall Study|Lack of ovarian response|4|||
94627944|NCT00553514|324095755|FG001|Overall Study|Lack of ovarian response|5|||
94627945|NCT00553514|324095756|FG002|Overall Study|Lack of ovarian response|5|||
94627946|NCT00553514|324095757|FG003|Overall Study|Lack of ovarian response|5|||
94627947|NCT00553514|324095758|FG004|Overall Study|Lack of ovarian response|6|||
94627948|NCT00553514|324095754|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
94627949|NCT00553514|324095755|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
94627950|NCT00553514|324095756|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
94627951|NCT00553514|324095757|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
94627952|NCT00553514|324095758|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
94627953|NCT00553514|324095754|FG000|Overall Study|Risk of multiple pregnancy|0|||
94627954|NCT00553514|324095755|FG001|Overall Study|Risk of multiple pregnancy|2|||
94627955|NCT00553514|324095756|FG002|Overall Study|Risk of multiple pregnancy|0|||
94627956|NCT00553514|324095757|FG003|Overall Study|Risk of multiple pregnancy|1|||
94627957|NCT00553514|324095758|FG004|Overall Study|Risk of multiple pregnancy|0|||
94627958|NCT00553514|324095754|FG000|Overall Study|Other|1|||
94627959|NCT00553514|324095755|FG001|Overall Study|Other|1|||
94627960|NCT00553514|324095756|FG002|Overall Study|Other|0|||
94627961|NCT00553514|324095757|FG003|Overall Study|Other|0|||
94627962|NCT00553514|324095758|FG004|Overall Study|Other|1|||
94627963|NCT00023764|324095759|FG000|Overall Study|Other|1|||
94627964|NCT00023764|324095759|FG000|Overall Study|Adverse Event|4|||
94627965|NCT00023764|324095759|FG000|Overall Study|Withdrawal by Subject|1|||
94627966|NCT00023764|324095759|FG000|Overall Study|Progression of disease|6|||
94627967|NCT00023764|324095759|FG000|Overall Study|patient received other treatment|1|||
94627968|NCT00023764|324095759|FG000|Overall Study|delay in obtaining staging images|1|||
94627969|NCT00855920|324095763|FG000|Overall Study|Protocol Violation|0|||
94627970|NCT00855920|324095764|FG001|Overall Study|Protocol Violation|0|||
94627971|NCT00855920|324095765|FG002|Overall Study|Protocol Violation|2|||
94627972|NCT00855920|324095763|FG000|Overall Study|Adverse Event|2|||
94627973|NCT00855920|324095764|FG001|Overall Study|Adverse Event|1|||
94627974|NCT00855920|324095765|FG002|Overall Study|Adverse Event|1|||
94627975|NCT00855920|324095763|FG000|Overall Study|Lack of Efficacy|2|||
94627976|NCT00855920|324095764|FG001|Overall Study|Lack of Efficacy|2|||
94627977|NCT00855920|324095765|FG002|Overall Study|Lack of Efficacy|2|||
94627978|NCT00855920|324095763|FG000|Overall Study|Withdrawal by Subject|2|||
94627979|NCT00855920|324095764|FG001|Overall Study|Withdrawal by Subject|3|||
94627980|NCT00855920|324095765|FG002|Overall Study|Withdrawal by Subject|2|||
94627981|NCT00855920|324095763|FG000|Overall Study|Lost to Follow-up|1|||
94627982|NCT00855920|324095764|FG001|Overall Study|Lost to Follow-up|0|||
94627983|NCT00855920|324095765|FG002|Overall Study|Lost to Follow-up|2|||
94627984|NCT00855920|324095763|FG000|Overall Study|Death|0|||
94627985|NCT00855920|324095764|FG001|Overall Study|Death|1|||
94627986|NCT00855920|324095765|FG002|Overall Study|Death|0|||
94627987|NCT00855920|324095763|FG000|Overall Study|Decision by the sponsor|0|||
94627988|NCT00855920|324095764|FG001|Overall Study|Decision by the sponsor|1|||
94627989|NCT00855920|324095765|FG002|Overall Study|Decision by the sponsor|1|||
94627990|NCT00855920|324095763|FG000|Overall Study|Other than specified above|1|||
94627991|NCT00855920|324095764|FG001|Overall Study|Other than specified above|1|||
94627992|NCT00855920|324095765|FG002|Overall Study|Other than specified above|1|||
94627993|NCT02850965|324095766|FG000|Overall Study|Other than listed|3|||
94627994|NCT02850965|324095767|FG001|Overall Study|Other than listed|4|||
94627995|NCT02850965|324095766|FG000|Overall Study|Protocol Violation|0|||
94461260|NCT02954653|323478230|FG007|Overall Study|Started another anti-cancer therapy|0|||
94461261|NCT02954653|323478231|FG008|Overall Study|Started another anti-cancer therapy|0|||
94461262|NCT02954653|323478223|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
94461263|NCT02954653|323478224|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
94461264|NCT02954653|323478225|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
94461265|NCT02954653|323478226|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
94461266|NCT02954653|323478227|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
94627996|NCT02850965|324095767|FG001|Overall Study|Protocol Violation|2|||
94627997|NCT02850965|324095766|FG000|Overall Study|Lost to Follow-up|5|||
94627998|NCT02850965|324095767|FG001|Overall Study|Lost to Follow-up|3|||
94627999|NCT02850965|324095766|FG000|Overall Study|Lack of Efficacy|4|||
94461267|NCT02954653|323478228|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
94628000|NCT02850965|324095767|FG001|Overall Study|Lack of Efficacy|8|||
94628001|NCT02850965|324095766|FG000|Overall Study|Adverse Event|3|||
94628002|NCT02850965|324095767|FG001|Overall Study|Adverse Event|2|||
94628003|NCT02850965|324095766|FG000|Overall Study|Withdrawal by Subject|3|||
94628004|NCT02850965|324095767|FG001|Overall Study|Withdrawal by Subject|4|||
94628005|NCT02850965|324095766|FG000|Overall Study|Physician Decision|0|||
94628006|NCT02850965|324095767|FG001|Overall Study|Physician Decision|1|||
94628007|NCT02850965|324095766|FG000|Overall Study|Randomized but not treated|0|||
94461268|NCT02954653|323478229|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
94628008|NCT02850965|324095767|FG001|Overall Study|Randomized but not treated|1|||
94628009|NCT00371137|324095768|FG000|Overall Study|Adverse Event|20|||
94628010|NCT00371137|324095769|FG001|Overall Study|Adverse Event|35|||
94628011|NCT00371137|324095770|FG002|Overall Study|Adverse Event|42|||
94628012|NCT00371137|324095768|FG000|Overall Study|Withdrawal by Subject|11|||
94628013|NCT00371137|324095769|FG001|Overall Study|Withdrawal by Subject|10|||
94628014|NCT00371137|324095770|FG002|Overall Study|Withdrawal by Subject|15|||
94628015|NCT00371137|324095768|FG000|Overall Study|Lost to Follow-up|6|||
94628016|NCT00371137|324095769|FG001|Overall Study|Lost to Follow-up|3|||
94628017|NCT00371137|324095770|FG002|Overall Study|Lost to Follow-up|5|||
94628018|NCT00371137|324095768|FG000|Overall Study|Lack of Efficacy|30|||
94628019|NCT00371137|324095769|FG001|Overall Study|Lack of Efficacy|12|||
94628020|NCT00371137|324095770|FG002|Overall Study|Lack of Efficacy|13|||
94628021|NCT00371137|324095768|FG000|Overall Study|Sponsor Decision|2|||
94628022|NCT00371137|324095769|FG001|Overall Study|Sponsor Decision|1|||
94628023|NCT00371137|324095770|FG002|Overall Study|Sponsor Decision|2|||
94628024|NCT00371137|324095768|FG000|Overall Study|Physician Decision|1|||
94628025|NCT00371137|324095769|FG001|Overall Study|Physician Decision|1|||
94628026|NCT00371137|324095770|FG002|Overall Study|Physician Decision|1|||
94628027|NCT00371137|324095768|FG000|Overall Study|Protocol Violation|2|||
94628028|NCT00371137|324095769|FG001|Overall Study|Protocol Violation|1|||
94628029|NCT00371137|324095770|FG002|Overall Study|Protocol Violation|1|||
94628030|NCT03926169|324095771|FG000|Period A|Adverse Event|2|||
94628031|NCT03926169|324095772|FG001|Period A|Adverse Event|2|||
94628032|NCT03926169|324095773|FG002|Period A|Adverse Event|1|||
94628033|NCT03926169|324095771|FG000|Period A|Withdrawal by Subject|2|||
94628034|NCT03926169|324095772|FG001|Period A|Withdrawal by Subject|2|||
94628035|NCT03926169|324095773|FG002|Period A|Withdrawal by Subject|2|||
94628036|NCT03926169|324095771|FG000|Period A|Lost to Follow-up|3|||
94628037|NCT03926169|324095772|FG001|Period A|Lost to Follow-up|1|||
94628038|NCT03926169|324095773|FG002|Period A|Lost to Follow-up|0|||
94628039|NCT03926169|324095771|FG000|Period A|Lack of Efficacy|0|||
94628040|NCT03926169|324095772|FG001|Period A|Lack of Efficacy|2|||
94628041|NCT03926169|324095773|FG002|Period A|Lack of Efficacy|2|||
94628042|NCT03926169|324095771|FG000|Period A|COVID-19 Infection|0|||
94628043|NCT03926169|324095772|FG001|Period A|COVID-19 Infection|1|||
94628044|NCT03926169|324095773|FG002|Period A|COVID-19 Infection|0|||
94628045|NCT03926169|324095771|FG000|Period A|COVID-19 Logistical Restrictions|0|||
94628046|NCT03926169|324095772|FG001|Period A|COVID-19 Logistical Restrictions|2|||
94628047|NCT03926169|324095773|FG002|Period A|COVID-19 Logistical Restrictions|1|||
94628048|NCT03926169|324095771|FG000|Period A|Other, Not Specified|1|||
94628049|NCT03926169|324095772|FG001|Period A|Other, Not Specified|0|||
94628050|NCT03926169|324095773|FG002|Period A|Other, Not Specified|0|||
94628051|NCT03926169|324095771|FG000|Period B|Adverse Event|3|||
94628052|NCT03926169|324095772|FG001|Period B|Adverse Event|1|||
94628053|NCT03926169|324095773|FG002|Period B|Adverse Event|1|||
94628054|NCT03926169|324095771|FG000|Period B|Withdrawal by Subject|1|||
94628055|NCT03926169|324095772|FG001|Period B|Withdrawal by Subject|3|||
94628056|NCT03926169|324095773|FG002|Period B|Withdrawal by Subject|0|||
94628057|NCT03926169|324095771|FG000|Period B|Lack of Efficacy|3|||
94628058|NCT03926169|324095772|FG001|Period B|Lack of Efficacy|1|||
94628059|NCT03926169|324095773|FG002|Period B|Lack of Efficacy|1|||
94628060|NCT03926169|324095771|FG000|Period B|Lost to Follow-up|1|||
94628061|NCT03926169|324095772|FG001|Period B|Lost to Follow-up|1|||
94628062|NCT03926169|324095773|FG002|Period B|Lost to Follow-up|4|||
94628063|NCT03926169|324095771|FG000|Period B|Other, Not Specified|62|||
94628064|NCT03926169|324095772|FG001|Period B|Other, Not Specified|57|||
94628065|NCT03926169|324095773|FG002|Period B|Other, Not Specified|65|||
94628066|NCT04786990|324095776|FG000|Overall Study|Withdrawal by Subject|1|||
94628067|NCT04786990|324095776|FG000|Overall Study|Adverse Event|1|||
94628068|NCT04786990|324095776|FG000|Overall Study|Lost to Follow-up|1|||
94628069|NCT04786990|324095776|FG000|Overall Study|Noncompliance|1|||
94628070|NCT04786990|324095776|FG000|Overall Study|Unable to complete site visits|1|||
94628071|NCT04786990|324095776|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
94360393|NCT02526017|323103773|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
94628072|NCT02505867|324095777|FG000|Overall Study|Lack of Efficacy|6|||
94628073|NCT02505867|324095778|FG001|Overall Study|Lack of Efficacy|6|||
94628074|NCT00687323|324095789|FG000|Overall Study|Death|25|||
94628075|NCT00687323|324095789|FG000|Overall Study|Withdrawal by Subject|1|||
94360394|NCT02526017|323103774|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
94360395|NCT02526017|323103775|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
94360396|NCT02526017|323103776|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
94360397|NCT02526017|323103777|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
94360398|NCT01118949|323103787|FG000|Overall Study|Adverse Event|5|||
94360399|NCT01118949|323103787|FG000|Overall Study|Withdrawal by Subject|4|||
94360400|NCT01035229|323103788|FG000|Overall Study|Adverse Event|61|||
94628076|NCT00687323|324095789|FG000|Overall Study|Excluded from efficacy evaluations|6|||
94628077|NCT00687323|324095789|FG000|Overall Study|Screen failure|148|||
94628078|NCT03310775|324095791|FG000|Overall Study|Lost to Follow-up|2|||
94628079|NCT03310775|324095792|FG001|Overall Study|Lost to Follow-up|3|||
94628080|NCT03310775|324095791|FG000|Overall Study|aggravation of depression|0|||
94628081|NCT03310775|324095792|FG001|Overall Study|aggravation of depression|1|||
94628082|NCT00598832|324095799|FG000|Overall Study|Lack of Efficacy|3|||
94628083|NCT00598832|324095800|FG001|Overall Study|Lack of Efficacy|7|||
94628084|NCT00598832|324095799|FG000|Overall Study|Adverse Event|6|||
94628085|NCT00598832|324095800|FG001|Overall Study|Adverse Event|2|||
94628086|NCT00598832|324095799|FG000|Overall Study|Withdrawal by Subject|25|||
94628087|NCT00598832|324095800|FG001|Overall Study|Withdrawal by Subject|36|||
94628088|NCT00598832|324095799|FG000|Overall Study|Protocol Violation|0|||
94628089|NCT00598832|324095800|FG001|Overall Study|Protocol Violation|2|||
94628090|NCT00598832|324095799|FG000|Overall Study|Lost to Follow-up|24|||
94674685|NCT00541450|324261300|FG001|Phase A|Hyperglycemia|1|||
94674686|NCT00541450|324261299|FG000|Phase A|Lost to Follow-up|6|||
94674687|NCT00541450|324261300|FG001|Phase A|Lost to Follow-up|4|||
94674688|NCT00541450|324261299|FG000|Phase A|Physician Decision|2|||
94674689|NCT00541450|324261300|FG001|Phase A|Physician Decision|0|||
94674690|NCT00541450|324261299|FG000|Phase A|Protocol Violation|2|||
94674691|NCT00541450|324261300|FG001|Phase A|Protocol Violation|3|||
94674692|NCT00541450|324261299|FG000|Phase A|Withdrawal by Subject|7|||
94674693|NCT00541450|324261300|FG001|Phase A|Withdrawal by Subject|7|||
94674694|NCT00541450|324261299|FG000|Phase B|Adverse Event|6|||
94674695|NCT00541450|324261300|FG001|Phase B|Adverse Event|6|||
94255777|NCT01959516|322730165|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
94255778|NCT01078675|322730166|FG000|Overall Study|Withdrawal by Subject|7|||
94628091|NCT00598832|324095800|FG001|Overall Study|Lost to Follow-up|29|||
94628092|NCT00598832|324095799|FG000|Overall Study|Pregnancy|2|||
94628093|NCT00598832|324095800|FG001|Overall Study|Pregnancy|2|||
94674696|NCT00541450|324261299|FG000|Phase B|Hyperglycemia|10|||
94674697|NCT00541450|324261300|FG001|Phase B|Hyperglycemia|9|||
94674698|NCT00541450|324261299|FG000|Phase B|Lost to Follow-up|6|||
94674699|NCT00541450|324261300|FG001|Phase B|Lost to Follow-up|4|||
94674700|NCT00541450|324261299|FG000|Phase B|Physician Decision|4|||
94674701|NCT00541450|324261300|FG001|Phase B|Physician Decision|2|||
94674702|NCT00541450|324261299|FG000|Phase B|Pregnancy|0|||
94674703|NCT00541450|324261300|FG001|Phase B|Pregnancy|1|||
94674704|NCT00541450|324261299|FG000|Phase B|Protocol Violation|3|||
94674705|NCT00541450|324261300|FG001|Phase B|Protocol Violation|3|||
94674706|NCT00541450|324261299|FG000|Phase B|Withdrawal by Subject|8|||
94674707|NCT00541450|324261300|FG001|Phase B|Withdrawal by Subject|6|||
94674708|NCT01323530|324263108|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
94674709|NCT01323530|324263109|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
94674710|NCT01323530|324263110|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
94674711|NCT01323530|324263111|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
94674712|NCT01323530|324263112|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
94674713|NCT01323530|324263113|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
94674714|NCT01323530|324263114|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
94674715|NCT01323530|324263108|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
94674716|NCT01323530|324263109|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
94674717|NCT01323530|324263110|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
94674718|NCT01323530|324263111|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
94674719|NCT01323530|324263112|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
94674720|NCT01323530|324263113|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
94360401|NCT01035229|323103789|FG001|Overall Study|Adverse Event|14|||
94628094|NCT00598832|324095799|FG000|Overall Study|Physician Decision|1|||
94674721|NCT01323530|324263114|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
94674722|NCT01323530|324263108|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
94628095|NCT00598832|324095800|FG001|Overall Study|Physician Decision|4|||
94674723|NCT01323530|324263109|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
94674724|NCT01323530|324263110|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
94674725|NCT01323530|324263111|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
94674726|NCT01323530|324263112|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
94674727|NCT01323530|324263113|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
94674728|NCT01323530|324263114|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
94674729|NCT01323530|324263108|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
94674730|NCT01323530|324263109|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
94674731|NCT01323530|324263110|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
94674732|NCT01323530|324263111|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
94674733|NCT01323530|324263112|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
94674734|NCT01323530|324263113|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
94674735|NCT01323530|324263114|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
94674736|NCT01323530|324263108|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
94674737|NCT01323530|324263109|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
94674738|NCT01323530|324263110|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
94674739|NCT01323530|324263111|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
94674740|NCT01323530|324263112|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
94674741|NCT01323530|324263113|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
94674742|NCT01323530|324263114|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
94674743|NCT01323530|324263108|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
94674744|NCT01323530|324263109|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
94674745|NCT01323530|324263110|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
94674746|NCT01323530|324263111|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
94674747|NCT01323530|324263112|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
94674748|NCT01323530|324263113|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
94628096|NCT00598832|324095799|FG000|Overall Study|Non compliance|1|||
94628097|NCT00598832|324095800|FG001|Overall Study|Non compliance|0|||
94628098|NCT00679302|324095803|FG000|Overall Study|Lost to Follow-up|8|||
94628099|NCT00679302|324095804|FG001|Overall Study|Lost to Follow-up|4|||
94628100|NCT00646776|324095805|FG000|Overall Study|Adverse Event|1|||
94628101|NCT00646776|324095806|FG001|Overall Study|Adverse Event|9|||
94628102|NCT00646776|324095805|FG000|Overall Study|Investigator discretion|0|||
94628103|NCT00646776|324095806|FG001|Overall Study|Investigator discretion|4|||
94628104|NCT00126568|324095808|FG000|Overall Study|Death|2|||
94628105|NCT00600483|324095809|FG000|Overall Study|Lost to Follow-up|26|||
94628106|NCT00600483|324095810|FG001|Overall Study|Lost to Follow-up|47|||
94674749|NCT01323530|324263114|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
94674750|NCT01323530|324263108|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
94360402|NCT01035229|323103788|FG000|Overall Study|Withdrawal by Subject|20|||
94628107|NCT00600483|324095809|FG000|Overall Study|Randomized but not treated|10|||
94628108|NCT00600483|324095810|FG001|Overall Study|Randomized but not treated|0|||
94628109|NCT00580606|324095811|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
94674751|NCT01323530|324263109|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
94674752|NCT01323530|324263110|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
94674753|NCT01323530|324263111|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
94255779|NCT01078675|322730167|FG001|Overall Study|Withdrawal by Subject|3|||
94255780|NCT01078675|322730166|FG000|Overall Study|Protocol Violation|56|||
94255781|NCT01078675|322730167|FG001|Overall Study|Protocol Violation|0|||
94255782|NCT01078675|322730166|FG000|Overall Study|Provided in CRF for specific reasons|2|||
94255783|NCT01078675|322730167|FG001|Overall Study|Provided in CRF for specific reasons|3|||
94255784|NCT01078675|322730166|FG000|Overall Study|Adverse Event|3|||
94255785|NCT01078675|322730167|FG001|Overall Study|Adverse Event|0|||
94255786|NCT04223830|322730168|FG000|Overall Study|Lost to Follow-up|9|||
94255787|NCT04223830|322730168|FG000|Overall Study|Adverse Event|1|||
94255788|NCT00615836|322730169|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
94255789|NCT00615836|322730170|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
94255790|NCT00615836|322730171|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
94255791|NCT00615836|322730172|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
94255792|NCT00615836|322730173|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
94255793|NCT00615836|322730169|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
94255794|NCT00615836|322730170|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
94255795|NCT00615836|322730171|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
94255796|NCT00615836|322730172|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
94255797|NCT00615836|322730173|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
94255798|NCT00615836|322730169|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
94255799|NCT00615836|322730170|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
94255800|NCT00615836|322730171|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
94255801|NCT00615836|322730172|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
94255802|NCT00615836|322730173|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
94255803|NCT00615836|322730169|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
94255804|NCT00615836|322730170|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
94255805|NCT00615836|322730171|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
94255806|NCT00615836|322730172|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
94255807|NCT00615836|322730173|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
94255808|NCT00615836|322730169|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
94255809|NCT00615836|322730170|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
94255810|NCT00615836|322730171|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
94255811|NCT00615836|322730172|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
94255812|NCT00615836|322730173|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
94255813|NCT00615836|322730169|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
94255814|NCT00615836|322730170|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
94255815|NCT00615836|322730171|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
94255816|NCT00615836|322730172|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
94255817|NCT00615836|322730173|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
94255818|NCT00615836|322730169|FG000|Extension Study (FE992026 CS31)|Other|10|||
94255819|NCT00615836|322730170|FG001|Extension Study (FE992026 CS31)|Other|7|||
94255820|NCT00615836|322730171|FG002|Extension Study (FE992026 CS31)|Other|8|||
94255821|NCT00615836|322730172|FG003|Extension Study (FE992026 CS31)|Other|8|||
94255822|NCT00615836|322730173|FG004|Extension Study (FE992026 CS31)|Other|0|||
94255823|NCT00615836|322730169|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
94255824|NCT00615836|322730170|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
94255825|NCT00615836|322730171|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
94255826|NCT00615836|322730172|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
94255827|NCT00615836|322730173|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
94255828|NCT00615836|322730169|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
94255829|NCT00615836|322730170|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
94674754|NCT01323530|324263112|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
94674755|NCT01323530|324263113|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
94674756|NCT01323530|324263114|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
94674757|NCT01323530|324263108|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
94674758|NCT01323530|324263109|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
94674759|NCT01323530|324263110|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
94674760|NCT01323530|324263111|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
94674761|NCT01323530|324263112|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
94674762|NCT01323530|324263113|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
94461269|NCT02954653|323478230|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
94674763|NCT01323530|324263114|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
94674764|NCT03076970|324263115|FG000|Washout Period 2|Adverse Event|0|||
94674765|NCT03076970|324263116|FG001|Washout Period 2|Adverse Event|0|||
94674766|NCT03076970|324263117|FG002|Washout Period 2|Adverse Event|0|||
94360403|NCT01035229|323103789|FG001|Overall Study|Withdrawal by Subject|7|||
94360404|NCT01035229|323103788|FG000|Overall Study|Lost to Follow-up|1|||
94360405|NCT01035229|323103789|FG001|Overall Study|Lost to Follow-up|0|||
94360406|NCT01035229|323103788|FG000|Overall Study|Administrative problems|1|||
94360407|NCT01035229|323103789|FG001|Overall Study|Administrative problems|1|||
94360408|NCT01035229|323103788|FG000|Overall Study|Death|13|||
94360409|NCT01035229|323103789|FG001|Overall Study|Death|5|||
94360410|NCT01035229|323103788|FG000|Overall Study|New cancer therapy|2|||
94360411|NCT01035229|323103789|FG001|Overall Study|New cancer therapy|0|||
94360412|NCT01035229|323103788|FG000|Overall Study|Protocol Violation|0|||
94360413|NCT01035229|323103789|FG001|Overall Study|Protocol Violation|2|||
94360414|NCT01035229|323103788|FG000|Overall Study|Sponsor's decision to end study|3|||
94360415|NCT01035229|323103789|FG001|Overall Study|Sponsor's decision to end study|3|||
94360416|NCT01035229|323103788|FG000|Overall Study|Disease Progression|261|||
94360417|NCT01035229|323103789|FG001|Overall Study|Disease Progression|152|||
94360418|NCT04341727|323103801|FG000|Overall Study|Withdrawal by Subject|0|||
94360419|NCT04341727|323103802|FG001|Overall Study|Withdrawal by Subject|0|||
94360420|NCT04341727|323103803|FG002|Overall Study|Withdrawal by Subject|1|||
94360421|NCT04341727|323103804|FG003|Overall Study|Withdrawal by Subject|0|||
94360422|NCT04341727|323103801|FG000|Overall Study|Lost to Follow-up|0|||
94360423|NCT04341727|323103802|FG001|Overall Study|Lost to Follow-up|0|||
94360424|NCT04341727|323103803|FG002|Overall Study|Lost to Follow-up|0|||
94360425|NCT04341727|323103804|FG003|Overall Study|Lost to Follow-up|1|||
94360426|NCT00057330|323103811|FG000|Overall Study|Adverse Event|9|||
94360427|NCT00057330|323103812|FG001|Overall Study|Adverse Event|12|||
94360428|NCT00057330|323103811|FG000|Overall Study|Death|1|||
94360429|NCT00057330|323103812|FG001|Overall Study|Death|0|||
94360430|NCT00057330|323103811|FG000|Overall Study|Protocol Violation|1|||
94360431|NCT00057330|323103812|FG001|Overall Study|Protocol Violation|1|||
94360432|NCT00057330|323103811|FG000|Overall Study|Withdrawal by Subject|115|||
94360433|NCT00057330|323103812|FG001|Overall Study|Withdrawal by Subject|84|||
94360434|NCT00057330|323103811|FG000|Overall Study|Lost to Follow-up|745|||
94360435|NCT00057330|323103812|FG001|Overall Study|Lost to Follow-up|617|||
94360436|NCT00057330|323103811|FG000|Overall Study|Physician Decision|1|||
94360437|NCT00057330|323103812|FG001|Overall Study|Physician Decision|0|||
94360438|NCT00057330|323103811|FG000|Overall Study|Other|260|||
94360439|NCT00057330|323103812|FG001|Overall Study|Other|206|||
94360440|NCT03772574|323103821|FG000|Overall Study|Protocol Violation|2|||
94360441|NCT03772574|323103822|FG001|Overall Study|Protocol Violation|0|||
94360442|NCT03772574|323103823|FG002|Overall Study|Protocol Violation|0|||
94360443|NCT03772574|323103821|FG000|Overall Study|Discomfort|0|||
94360444|NCT03772574|323103822|FG001|Overall Study|Discomfort|5|||
94360445|NCT03772574|323103823|FG002|Overall Study|Discomfort|4|||
94360446|NCT03292731|323103831|FG000|Overall Study|Protocol Violation|4|||
94360447|NCT03292731|323103832|FG001|Overall Study|Protocol Violation|11|||
94360448|NCT03292731|323103833|FG002|Overall Study|Protocol Violation|1|||
94360449|NCT00471237|323103838|FG000|Overall Study|Adverse Event|6|||
94360450|NCT00471237|323103839|FG001|Overall Study|Adverse Event|5|||
94360451|NCT00471237|323103840|FG002|Overall Study|Adverse Event|4|||
94360452|NCT00471237|323103841|FG003|Overall Study|Adverse Event|8|||
94360453|NCT00471237|323103842|FG004|Overall Study|Adverse Event|7|||
94360454|NCT00471237|323103843|FG005|Overall Study|Adverse Event|5|||
94360455|NCT00471237|323103844|FG006|Overall Study|Adverse Event|0|||
94360456|NCT00471237|323103838|FG000|Overall Study|Lost to Follow-up|1|||
94360457|NCT00471237|323103839|FG001|Overall Study|Lost to Follow-up|1|||
94360458|NCT00471237|323103840|FG002|Overall Study|Lost to Follow-up|0|||
94628110|NCT00580606|324095812|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
94628111|NCT00580606|324095811|FG000|Open Label (OL)|Withdrawal by Subject|4|||
94628112|NCT00580606|324095812|FG001|Open Label (OL)|Withdrawal by Subject|6|||
94628113|NCT00580606|324095811|FG000|Open Label (OL)|Dosing Symptoms|0|||
94628114|NCT00580606|324095812|FG001|Open Label (OL)|Dosing Symptoms|1|||
94628115|NCT00580606|324095811|FG000|Open Label (OL)|Lost to Follow-up|0|||
94628116|NCT00580606|324095812|FG001|Open Label (OL)|Lost to Follow-up|1|||
94628117|NCT00580606|324095811|FG000|Open Label (OL)|Pregnancy|0|||
94628118|NCT00580606|324095812|FG001|Open Label (OL)|Pregnancy|1|||
94674767|NCT03076970|324263118|FG003|Washout Period 2|Adverse Event|0|||
94360459|NCT00471237|323103841|FG003|Overall Study|Lost to Follow-up|2|||
94360460|NCT00471237|323103842|FG004|Overall Study|Lost to Follow-up|3|||
94360461|NCT00471237|323103843|FG005|Overall Study|Lost to Follow-up|0|||
94360462|NCT00471237|323103844|FG006|Overall Study|Lost to Follow-up|0|||
94360463|NCT00471237|323103838|FG000|Overall Study|Protocol Violation|3|||
94360464|NCT00471237|323103839|FG001|Overall Study|Protocol Violation|6|||
94360465|NCT00471237|323103840|FG002|Overall Study|Protocol Violation|3|||
94360466|NCT00471237|323103841|FG003|Overall Study|Protocol Violation|2|||
94360467|NCT00471237|323103842|FG004|Overall Study|Protocol Violation|2|||
94360468|NCT00471237|323103843|FG005|Overall Study|Protocol Violation|4|||
94628119|NCT00580606|324095811|FG000|Open Label (OL)|Non-compliance|2|||
94628120|NCT00580606|324095812|FG001|Open Label (OL)|Non-compliance|0|||
94628121|NCT00580606|324095811|FG000|Open Label (OL)|Physician Decision|1|||
94628122|NCT00580606|324095812|FG001|Open Label (OL)|Physician Decision|1|||
94255830|NCT00615836|322730171|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
94255831|NCT00615836|322730172|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
94255832|NCT00615836|322730173|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
94255833|NCT00336895|322730174|FG000|Overall Study|diarrhea|1|||
94255834|NCT00336895|322730174|FG000|Overall Study|nausea and upset stomach|1|||
94255835|NCT00336895|322730174|FG000|Overall Study|Physician Decision|1|||
94255836|NCT00336895|322730174|FG000|Overall Study|screen failed|1|||
94255837|NCT01048671|322730175|FG000|Overall Study|Protocol Violation|0|||
94255838|NCT01048671|322730176|FG001|Overall Study|Protocol Violation|1|||
94255839|NCT01048671|322730177|FG002|Overall Study|Protocol Violation|1|||
94255840|NCT00899548|322730178|FG000|Overall Study|Physician Decision|3|||
94255841|NCT00609765|322730179|FG000|Overall Study|Study ended prior to 12 months|1|||
94255842|NCT01209780|322730181|FG000|Overall Study|Adverse Event|0|||
94255843|NCT01209780|322730182|FG001|Overall Study|Adverse Event|1|||
94255844|NCT01209780|322730183|FG002|Overall Study|Adverse Event|0|||
94255845|NCT01209780|322730184|FG003|Overall Study|Adverse Event|0|||
94255846|NCT01209780|322730185|FG004|Overall Study|Adverse Event|0|||
94255847|NCT01209780|322730181|FG000|Overall Study|Withdrawal by Subject|9|||
94255848|NCT01209780|322730182|FG001|Overall Study|Withdrawal by Subject|2|||
94255849|NCT01209780|322730183|FG002|Overall Study|Withdrawal by Subject|1|||
94255850|NCT01209780|322730184|FG003|Overall Study|Withdrawal by Subject|1|||
94255851|NCT01209780|322730185|FG004|Overall Study|Withdrawal by Subject|0|||
94255852|NCT01209780|322730181|FG000|Overall Study|Lost to Follow-up|17|||
94255853|NCT01209780|322730182|FG001|Overall Study|Lost to Follow-up|12|||
94255854|NCT01209780|322730183|FG002|Overall Study|Lost to Follow-up|3|||
94255855|NCT01209780|322730184|FG003|Overall Study|Lost to Follow-up|9|||
94255856|NCT01209780|322730185|FG004|Overall Study|Lost to Follow-up|4|||
94255857|NCT01209780|322730181|FG000|Overall Study|Protocol Violation|0|||
94255858|NCT01209780|322730182|FG001|Overall Study|Protocol Violation|1|||
94255859|NCT01209780|322730183|FG002|Overall Study|Protocol Violation|0|||
94255860|NCT01209780|322730184|FG003|Overall Study|Protocol Violation|0|||
94255861|NCT01209780|322730185|FG004|Overall Study|Protocol Violation|0|||
94255862|NCT01209780|322730181|FG000|Overall Study|Inappropriate enrollment|0|||
94255863|NCT01209780|322730182|FG001|Overall Study|Inappropriate enrollment|2|||
94255864|NCT01209780|322730183|FG002|Overall Study|Inappropriate enrollment|0|||
94255865|NCT01209780|322730184|FG003|Overall Study|Inappropriate enrollment|0|||
94255866|NCT01209780|322730185|FG004|Overall Study|Inappropriate enrollment|1|||
94255867|NCT01745848|322730186|FG000|Overall Study|Adverse Event|6|||
94255868|NCT00818649|322730193|FG000|Overall Study|Declining performance status|2|||
94255869|NCT00818649|322730193|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
94255870|NCT00818649|322730193|FG000|Overall Study|Adverse Event|1|||
94255871|NCT02075541|322730194|FG000|Overall Study|Serious Adverse Event|1|||
94255872|NCT02075541|322730195|FG001|Overall Study|Serious Adverse Event|4|||
94255873|NCT02075541|322730194|FG000|Overall Study|Protocol Violation|1|||
94255874|NCT02075541|322730195|FG001|Overall Study|Protocol Violation|0|||
94255875|NCT02075541|322730194|FG000|Overall Study|Withdrawal by Subject|1|||
94255876|NCT02075541|322730195|FG001|Overall Study|Withdrawal by Subject|3|||
94255877|NCT02075541|322730194|FG000|Overall Study|Sponsor study termination|0|||
94255878|NCT02075541|322730195|FG001|Overall Study|Sponsor study termination|1|||
94255879|NCT02075541|322730194|FG000|Overall Study|Other- unable to perform study procedure|1|||
94255880|NCT02075541|322730195|FG001|Overall Study|Other- unable to perform study procedure|0|||
94255881|NCT01270971|322730197|FG000|Overall Study|Withdrawal by Subject|24|||
94255882|NCT01270971|322730198|FG001|Overall Study|Withdrawal by Subject|11|||
94255883|NCT01270971|322730197|FG000|Overall Study|Lost to Follow-up|18|||
94255884|NCT01270971|322730198|FG001|Overall Study|Lost to Follow-up|5|||
94255885|NCT01270971|322730197|FG000|Overall Study|Adverse Event|1|||
94255886|NCT01270971|322730198|FG001|Overall Study|Adverse Event|2|||
94255887|NCT01270971|322730197|FG000|Overall Study|Non compliance|2|||
94255888|NCT01270971|322730198|FG001|Overall Study|Non compliance|2|||
94255889|NCT01270971|322730197|FG000|Overall Study|Non-specific|7|||
94255890|NCT01270971|322730198|FG001|Overall Study|Non-specific|3|||
94255891|NCT00400985|322730199|FG000|Overall Study|Withdrawal by Subject|5|||
94255892|NCT00400985|322730199|FG000|Overall Study|system modification|8|||
94255893|NCT00400985|322730199|FG000|Overall Study|Death|30|||
94255894|NCT00400985|322730199|FG000|Overall Study|Lost to Follow-up|9|||
94255895|NCT02003573|322730200|FG000|Overall Study|Progressive disease|2|||
94674768|NCT03076970|324263119|FG004|Washout Period 2|Adverse Event|1|||
94255896|NCT02003573|322730201|FG001|Overall Study|Progressive disease|0|||
94255897|NCT02003573|322730202|FG002|Overall Study|Progressive disease|1|||
94255898|NCT02003573|322730200|FG000|Overall Study|Other Adverse event|0|||
94255899|NCT02003573|322730201|FG001|Overall Study|Other Adverse event|1|||
94255900|NCT02003573|322730202|FG002|Overall Study|Other Adverse event|1|||
94255901|NCT02003573|322730200|FG000|Overall Study|Refuse to take trial medication|0|||
94255902|NCT02003573|322730201|FG001|Overall Study|Refuse to take trial medication|1|||
94255903|NCT02003573|322730202|FG002|Overall Study|Refuse to take trial medication|1|||
94255904|NCT02003573|322730200|FG000|Overall Study|Other than specified|1|||
94255905|NCT02003573|322730201|FG001|Overall Study|Other than specified|2|||
94628123|NCT00580606|324095811|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
94628124|NCT00580606|324095812|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
94628125|NCT03655691|324095813|FG000|Overall Study|Adverse Event|0|||
94628126|NCT03655691|324095814|FG001|Overall Study|Adverse Event|0|||
94628127|NCT03655691|324095815|FG002|Overall Study|Adverse Event|1|||
94628128|NCT03655691|324095813|FG000|Overall Study|Lost to Follow-up|1|||
94628129|NCT03655691|324095814|FG001|Overall Study|Lost to Follow-up|1|||
94628130|NCT03655691|324095815|FG002|Overall Study|Lost to Follow-up|2|||
94255906|NCT02003573|322730202|FG002|Overall Study|Other than specified|3|||
94255907|NCT02374671|322730203|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
94255908|NCT02374671|322730204|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
94255909|NCT02374671|322730205|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
94255910|NCT02374671|322730203|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
94255911|NCT02374671|322730204|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
94255912|NCT02374671|322730205|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
94255913|NCT02374671|322730203|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
94255914|NCT02374671|322730204|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
94255915|NCT02374671|322730205|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
94255916|NCT02374671|322730203|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
94255917|NCT02374671|322730204|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
94255918|NCT02374671|322730205|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
94255919|NCT02374671|322730203|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
94255920|NCT02374671|322730204|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
94255921|NCT02374671|322730205|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
94255922|NCT02988622|322730206|FG000|Overall Study|Lost to Follow-up|17|||
94255923|NCT03562247|322730207|FG000|Overall Study|Lost to Follow-up|3|||
94255924|NCT03562247|322730208|FG001|Overall Study|Lost to Follow-up|1|||
94255925|NCT03562247|322730209|FG002|Overall Study|Lost to Follow-up|1|||
94255926|NCT00971243|322730210|FG000|Double Blind Period|Adverse Event|2|||
94255927|NCT00971243|322730211|FG001|Double Blind Period|Adverse Event|3|||
94255928|NCT00971243|322730212|FG002|Double Blind Period|Adverse Event|2|||
94255929|NCT00971243|322730213|FG003|Double Blind Period|Adverse Event|2|||
94255930|NCT00971243|322730214|FG004|Double Blind Period|Adverse Event|3|||
94255931|NCT00971243|322730210|FG000|Double Blind Period|Lost to Follow-up|0|||
94255932|NCT00971243|322730211|FG001|Double Blind Period|Lost to Follow-up|1|||
94255933|NCT00971243|322730212|FG002|Double Blind Period|Lost to Follow-up|1|||
94255934|NCT00971243|322730213|FG003|Double Blind Period|Lost to Follow-up|0|||
94255935|NCT00971243|322730214|FG004|Double Blind Period|Lost to Follow-up|1|||
94255936|NCT00971243|322730210|FG000|Double Blind Period|Physician Decision|10|||
94255937|NCT00971243|322730211|FG001|Double Blind Period|Physician Decision|6|||
94255938|NCT00971243|322730212|FG002|Double Blind Period|Physician Decision|7|||
94360469|NCT00471237|323103844|FG006|Overall Study|Protocol Violation|1|||
94628131|NCT03655691|324095813|FG000|Overall Study|Protocol Violation|0|||
94628132|NCT03655691|324095814|FG001|Overall Study|Protocol Violation|1|||
94628133|NCT03655691|324095815|FG002|Overall Study|Protocol Violation|0|||
94628134|NCT03655691|324095813|FG000|Overall Study|Withdrawal by Subject|1|||
94628135|NCT03655691|324095814|FG001|Overall Study|Withdrawal by Subject|1|||
94628136|NCT03655691|324095815|FG002|Overall Study|Withdrawal by Subject|0|||
94628137|NCT01317160|324095820|FG000|Overall Study|Incorrect inclusion|1|||
94628138|NCT01317160|324095821|FG001|Overall Study|Incorrect inclusion|1|||
94628139|NCT01317160|324095820|FG000|Overall Study|Lost to Follow-up|3|||
94628140|NCT01317160|324095821|FG001|Overall Study|Lost to Follow-up|3|||
94628141|NCT01317160|324095820|FG000|Overall Study|Withdrawal by Subject|0|||
94628142|NCT01317160|324095821|FG001|Overall Study|Withdrawal by Subject|2|||
94628143|NCT01774968|324095822|FG000|Overall Study|Adverse Event|4|||
94628144|NCT01774968|324095823|FG001|Overall Study|Adverse Event|4|||
94628145|NCT01774968|324095822|FG000|Overall Study|Death|0|||
94628146|NCT01774968|324095823|FG001|Overall Study|Death|1|||
94628147|NCT01774968|324095822|FG000|Overall Study|Lost to Follow-up|1|||
94628148|NCT01774968|324095823|FG001|Overall Study|Lost to Follow-up|3|||
94628149|NCT01774968|324095822|FG000|Overall Study|Physician Decision|5|||
94628150|NCT01774968|324095823|FG001|Overall Study|Physician Decision|1|||
94628151|NCT01774968|324095822|FG000|Overall Study|Protocol Violation|14|||
94628152|NCT01774968|324095823|FG001|Overall Study|Protocol Violation|13|||
94628153|NCT01774968|324095822|FG000|Overall Study|Sponsor Decision|0|||
94628154|NCT01774968|324095823|FG001|Overall Study|Sponsor Decision|2|||
94628155|NCT01774968|324095822|FG000|Overall Study|Withdrawal by Subject|6|||
94255939|NCT00971243|322730213|FG003|Double Blind Period|Physician Decision|6|||
94255940|NCT00971243|322730214|FG004|Double Blind Period|Physician Decision|7|||
94255941|NCT00971243|322730210|FG000|Double Blind Period|Protocol Violation|2|||
94628156|NCT01774968|324095823|FG001|Overall Study|Withdrawal by Subject|11|||
94628157|NCT04221009|324097859|FG000|Overall Study|Withdrawal by Subject|4|||
94628158|NCT00793598|324097860|FG000|Overall Study|Patient Request|0|||
94628159|NCT00793598|324097861|FG001|Overall Study|Patient Request|1|||
94628160|NCT00793598|324097862|FG002|Overall Study|Patient Request|0|||
94628161|NCT00793598|324097863|FG003|Overall Study|Patient Request|0|||
94674769|NCT03076970|324263120|FG005|Washout Period 2|Adverse Event|0|||
94674770|NCT03076970|324263115|FG000|Period 3|Withdrawal by Subject|0|||
94674771|NCT03076970|324263116|FG001|Period 3|Withdrawal by Subject|0|||
94360470|NCT00471237|323103838|FG000|Overall Study|Withdrawal by Subject|8|||
94360471|NCT00471237|323103839|FG001|Overall Study|Withdrawal by Subject|6|||
94360472|NCT00471237|323103840|FG002|Overall Study|Withdrawal by Subject|5|||
94360473|NCT00471237|323103841|FG003|Overall Study|Withdrawal by Subject|8|||
94360474|NCT00471237|323103842|FG004|Overall Study|Withdrawal by Subject|7|||
94360475|NCT00471237|323103843|FG005|Overall Study|Withdrawal by Subject|4|||
94674772|NCT03076970|324263117|FG002|Period 3|Withdrawal by Subject|0|||
94674773|NCT03076970|324263118|FG003|Period 3|Withdrawal by Subject|0|||
94674774|NCT03076970|324263119|FG004|Period 3|Withdrawal by Subject|0|||
94674775|NCT03076970|324263120|FG005|Period 3|Withdrawal by Subject|1|||
94674776|NCT03076970|324263115|FG000|Period 3|Failure to meet I/E criteria|0|||
94674777|NCT03076970|324263116|FG001|Period 3|Failure to meet I/E criteria|0|||
94674778|NCT03076970|324263117|FG002|Period 3|Failure to meet I/E criteria|0|||
94674779|NCT03076970|324263118|FG003|Period 3|Failure to meet I/E criteria|0|||
94674780|NCT03076970|324263119|FG004|Period 3|Failure to meet I/E criteria|1|||
94674781|NCT03076970|324263120|FG005|Period 3|Failure to meet I/E criteria|0|||
94674782|NCT00590902|324263124|FG000|Overall Study|Death|1|||
94674783|NCT00785291|324263128|FG000|Overall Study|Never began treatment|8|||
94674784|NCT00785291|324263129|FG001|Overall Study|Never began treatment|4|||
94674785|NCT00785291|324263130|FG002|Overall Study|Never began treatment|4|||
94674786|NCT00785291|324263128|FG000|Overall Study|Adverse Event|39|||
94674787|NCT00785291|324263129|FG001|Overall Study|Adverse Event|70|||
94674788|NCT00785291|324263130|FG002|Overall Study|Adverse Event|56|||
94674789|NCT00785291|324263128|FG000|Overall Study|Death|7|||
94674790|NCT00785291|324263129|FG001|Overall Study|Death|4|||
94674791|NCT00785291|324263130|FG002|Overall Study|Death|3|||
94674792|NCT00785291|324263128|FG000|Overall Study|Withdrawal by Subject|35|||
94360476|NCT00471237|323103844|FG006|Overall Study|Withdrawal by Subject|2|||
94360477|NCT00471237|323103838|FG000|Overall Study|Sponsor terminated study|20|||
94360478|NCT00471237|323103839|FG001|Overall Study|Sponsor terminated study|23|||
94360479|NCT00471237|323103840|FG002|Overall Study|Sponsor terminated study|19|||
94360480|NCT00471237|323103841|FG003|Overall Study|Sponsor terminated study|22|||
94360481|NCT00471237|323103842|FG004|Overall Study|Sponsor terminated study|18|||
94674793|NCT00785291|324263129|FG001|Overall Study|Withdrawal by Subject|36|||
94674794|NCT00785291|324263130|FG002|Overall Study|Withdrawal by Subject|17|||
94674795|NCT00785291|324263128|FG000|Overall Study|Alternative Therapy|12|||
94674796|NCT00785291|324263129|FG001|Overall Study|Alternative Therapy|6|||
94674797|NCT00785291|324263130|FG002|Overall Study|Alternative Therapy|7|||
94674798|NCT00785291|324263128|FG000|Overall Study|Complicating illness|6|||
94674799|NCT00785291|324263129|FG001|Overall Study|Complicating illness|4|||
94674800|NCT00785291|324263130|FG002|Overall Study|Complicating illness|4|||
94674801|NCT00785291|324263128|FG000|Overall Study|Other Medical Reasons|29|||
94674802|NCT00785291|324263129|FG001|Overall Study|Other Medical Reasons|25|||
94674803|NCT00785291|324263130|FG002|Overall Study|Other Medical Reasons|15|||
94674804|NCT01111123|324263132|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
94674805|NCT01111123|324263133|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
94674806|NCT01111123|324263132|FG000|Maintenance Phase|Lost to Follow-up|0|||
94674807|NCT01111123|324263133|FG001|Maintenance Phase|Lost to Follow-up|2|||
94360482|NCT00471237|323103843|FG005|Overall Study|Sponsor terminated study|24|||
94360483|NCT00471237|323103844|FG006|Overall Study|Sponsor terminated study|0|||
94360484|NCT00471237|323103838|FG000|Overall Study|Non-compliance|0|||
94360485|NCT00471237|323103839|FG001|Overall Study|Non-compliance|1|||
94360486|NCT00471237|323103840|FG002|Overall Study|Non-compliance|0|||
94674808|NCT00119405|324263134|FG000|Overall Study|Withdrawal by Subject|1|||
94674809|NCT01735201|324263135|FG000|Overall Study|Adverse Event|1|||
94674810|NCT01735201|324263136|FG001|Overall Study|Adverse Event|1|||
94674811|NCT01735201|324263137|FG002|Overall Study|Adverse Event|0|||
94674812|NCT01735201|324263138|FG003|Overall Study|Adverse Event|1|||
94674813|NCT01735201|324263139|FG004|Overall Study|Adverse Event|1|||
94674814|NCT01735201|324263140|FG005|Overall Study|Adverse Event|3|||
94674815|NCT01735201|324263141|FG006|Overall Study|Adverse Event|2|||
94360487|NCT00471237|323103841|FG003|Overall Study|Non-compliance|1|||
94360488|NCT00471237|323103842|FG004|Overall Study|Non-compliance|0|||
94360489|NCT00471237|323103843|FG005|Overall Study|Non-compliance|0|||
94360490|NCT00471237|323103844|FG006|Overall Study|Non-compliance|0|||
94360491|NCT00471237|323103838|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
94360492|NCT00471237|323103839|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
94360493|NCT00471237|323103840|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
94360494|NCT00471237|323103841|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
94674816|NCT01735201|324263142|FG007|Overall Study|Adverse Event|1|||
94674817|NCT01735201|324263135|FG000|Overall Study|Personal Reasons|1|||
94674818|NCT01735201|324263136|FG001|Overall Study|Personal Reasons|0|||
94674819|NCT01735201|324263137|FG002|Overall Study|Personal Reasons|0|||
94674820|NCT01735201|324263138|FG003|Overall Study|Personal Reasons|0|||
94360495|NCT00471237|323103842|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
94360496|NCT00471237|323103843|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
94360497|NCT00471237|323103844|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
94360498|NCT00471237|323103838|FG000|Overall Study|Early stopping due to non-efficacy|1|||
94360499|NCT00471237|323103839|FG001|Overall Study|Early stopping due to non-efficacy|0|||
94360500|NCT00471237|323103840|FG002|Overall Study|Early stopping due to non-efficacy|0|||
94360501|NCT00471237|323103841|FG003|Overall Study|Early stopping due to non-efficacy|0|||
94360502|NCT00471237|323103842|FG004|Overall Study|Early stopping due to non-efficacy|1|||
94360503|NCT00471237|323103843|FG005|Overall Study|Early stopping due to non-efficacy|0|||
94360504|NCT00471237|323103844|FG006|Overall Study|Early stopping due to non-efficacy|0|||
94360505|NCT00471237|323103838|FG000|Overall Study|Participant planned to travel to abraod|1|||
94360506|NCT00471237|323103839|FG001|Overall Study|Participant planned to travel to abraod|0|||
94360507|NCT00471237|323103840|FG002|Overall Study|Participant planned to travel to abraod|0|||
94360508|NCT00471237|323103841|FG003|Overall Study|Participant planned to travel to abraod|0|||
94360509|NCT00471237|323103842|FG004|Overall Study|Participant planned to travel to abraod|0|||
94360510|NCT00471237|323103843|FG005|Overall Study|Participant planned to travel to abraod|1|||
94360511|NCT00471237|323103844|FG006|Overall Study|Participant planned to travel to abraod|0|||
94360512|NCT00471237|323103838|FG000|Overall Study|High parathyroid hormone|0|||
94360513|NCT00471237|323103839|FG001|Overall Study|High parathyroid hormone|0|||
94360514|NCT00471237|323103840|FG002|Overall Study|High parathyroid hormone|1|||
94360515|NCT00471237|323103841|FG003|Overall Study|High parathyroid hormone|0|||
94360516|NCT00471237|323103842|FG004|Overall Study|High parathyroid hormone|0|||
94360517|NCT00471237|323103843|FG005|Overall Study|High parathyroid hormone|0|||
94360518|NCT00471237|323103844|FG006|Overall Study|High parathyroid hormone|0|||
94360519|NCT00471237|323103838|FG000|Overall Study|Participant lost medication|0|||
94360520|NCT00471237|323103839|FG001|Overall Study|Participant lost medication|0|||
94628162|NCT00793598|324097864|FG004|Overall Study|Patient Request|0|||
94628163|NCT00793598|324097865|FG005|Overall Study|Patient Request|0|||
94628164|NCT00793598|324097866|FG006|Overall Study|Patient Request|0|||
94628165|NCT00793598|324097867|FG007|Overall Study|Patient Request|0|||
94628166|NCT00793598|324097860|FG000|Overall Study|Protocol Violation|0|||
94628167|NCT00793598|324097861|FG001|Overall Study|Protocol Violation|0|||
94628168|NCT00793598|324097862|FG002|Overall Study|Protocol Violation|0|||
94628169|NCT00793598|324097863|FG003|Overall Study|Protocol Violation|0|||
94628170|NCT00793598|324097864|FG004|Overall Study|Protocol Violation|0|||
94628171|NCT00793598|324097865|FG005|Overall Study|Protocol Violation|0|||
94628172|NCT00793598|324097866|FG006|Overall Study|Protocol Violation|0|||
94628173|NCT00793598|324097867|FG007|Overall Study|Protocol Violation|1|||
94628174|NCT00793598|324097860|FG000|Overall Study|Subject not dosed|0|||
94628175|NCT00793598|324097861|FG001|Overall Study|Subject not dosed|0|||
94628176|NCT00793598|324097862|FG002|Overall Study|Subject not dosed|0|||
94628177|NCT00793598|324097863|FG003|Overall Study|Subject not dosed|0|||
94628178|NCT00793598|324097864|FG004|Overall Study|Subject not dosed|0|||
94628179|NCT00793598|324097865|FG005|Overall Study|Subject not dosed|1|||
94628180|NCT00793598|324097866|FG006|Overall Study|Subject not dosed|0|||
94628181|NCT00793598|324097867|FG007|Overall Study|Subject not dosed|0|||
94628182|NCT01943292|324097868|FG000|Overall Study|Withdrawal by Subject|1|||
94628183|NCT01943292|324097869|FG001|Overall Study|Withdrawal by Subject|0|||
94628184|NCT01943292|324097870|FG002|Overall Study|Withdrawal by Subject|0|||
94628185|NCT00638378|324097871|FG000|Overall Study|Death|2|||
94628186|NCT00638378|324097871|FG000|Overall Study|Adverse Event|1|||
94628187|NCT00638378|324097871|FG000|Overall Study|Disease progression|15|||
94628188|NCT00638378|324097871|FG000|Overall Study|Physician Decision|4|||
94628189|NCT00842712|324097874|FG000|Safety Run-in Part|Adverse Event|0|||
94628190|NCT00842712|324097875|FG001|Safety Run-in Part|Adverse Event|1|||
94628191|NCT00842712|324097876|FG002|Safety Run-in Part|Adverse Event|0|||
94628192|NCT00842712|324097877|FG003|Safety Run-in Part|Adverse Event|0|||
94628193|NCT00842712|324097878|FG004|Safety Run-in Part|Adverse Event|0|||
94628194|NCT00842712|324097879|FG005|Safety Run-in Part|Adverse Event|0|||
94628195|NCT00842712|324097880|FG006|Safety Run-in Part|Adverse Event|0|||
94628196|NCT00842712|324097874|FG000|Safety Run-in Part|Progressive disease|3|||
94628197|NCT00842712|324097875|FG001|Safety Run-in Part|Progressive disease|1|||
94628198|NCT00842712|324097876|FG002|Safety Run-in Part|Progressive disease|0|||
94628199|NCT00842712|324097877|FG003|Safety Run-in Part|Progressive disease|1|||
94674821|NCT01735201|324263139|FG004|Overall Study|Personal Reasons|0|||
94360521|NCT00471237|323103840|FG002|Overall Study|Participant lost medication|0|||
94360522|NCT00471237|323103841|FG003|Overall Study|Participant lost medication|0|||
94360523|NCT00471237|323103842|FG004|Overall Study|Participant lost medication|1|||
94628200|NCT00842712|324097878|FG004|Safety Run-in Part|Progressive disease|0|||
94628201|NCT00842712|324097879|FG005|Safety Run-in Part|Progressive disease|0|||
94628202|NCT00842712|324097880|FG006|Safety Run-in Part|Progressive disease|0|||
94628203|NCT00842712|324097874|FG000|Randomized Part|Randomized but not treated|0|||
94628204|NCT00842712|324097875|FG001|Randomized Part|Randomized but not treated|0|||
94628205|NCT00842712|324097876|FG002|Randomized Part|Randomized but not treated|0|||
94255942|NCT00971243|322730211|FG001|Double Blind Period|Protocol Violation|0|||
94255943|NCT00971243|322730212|FG002|Double Blind Period|Protocol Violation|3|||
94255944|NCT00971243|322730213|FG003|Double Blind Period|Protocol Violation|2|||
94255945|NCT00971243|322730214|FG004|Double Blind Period|Protocol Violation|2|||
94255946|NCT00971243|322730210|FG000|Double Blind Period|Withdrawal by Subject|4|||
94255947|NCT00971243|322730211|FG001|Double Blind Period|Withdrawal by Subject|1|||
94255948|NCT00971243|322730212|FG002|Double Blind Period|Withdrawal by Subject|4|||
94255949|NCT00971243|322730213|FG003|Double Blind Period|Withdrawal by Subject|4|||
94255950|NCT00971243|322730214|FG004|Double Blind Period|Withdrawal by Subject|4|||
94255951|NCT00971243|322730210|FG000|Double Blind Period|Other reasons|1|||
94255952|NCT00971243|322730211|FG001|Double Blind Period|Other reasons|0|||
94255953|NCT00971243|322730212|FG002|Double Blind Period|Other reasons|2|||
94255954|NCT00971243|322730213|FG003|Double Blind Period|Other reasons|0|||
94255955|NCT00971243|322730214|FG004|Double Blind Period|Other reasons|1|||
94255956|NCT00971243|322730210|FG000|Open-label Period|Adverse Event|1|||
94255957|NCT00971243|322730211|FG001|Open-label Period|Adverse Event|0|||
94255958|NCT00971243|322730212|FG002|Open-label Period|Adverse Event|1|||
94255959|NCT00971243|322730213|FG003|Open-label Period|Adverse Event|1|||
94255960|NCT00971243|322730214|FG004|Open-label Period|Adverse Event|0|||
94255961|NCT00971243|322730210|FG000|Open-label Period|Physician Decision|5|||
94255962|NCT00971243|322730211|FG001|Open-label Period|Physician Decision|9|||
94255963|NCT00971243|322730212|FG002|Open-label Period|Physician Decision|3|||
94255964|NCT00971243|322730213|FG003|Open-label Period|Physician Decision|7|||
94255965|NCT00971243|322730214|FG004|Open-label Period|Physician Decision|2|||
94255966|NCT00971243|322730210|FG000|Open-label Period|Protocol Violation|1|||
94255967|NCT00971243|322730211|FG001|Open-label Period|Protocol Violation|1|||
94255968|NCT00971243|322730212|FG002|Open-label Period|Protocol Violation|1|||
94255969|NCT00971243|322730213|FG003|Open-label Period|Protocol Violation|0|||
94255970|NCT00971243|322730214|FG004|Open-label Period|Protocol Violation|1|||
94255971|NCT00971243|322730210|FG000|Open-label Period|Withdrawal by Subject|1|||
94255972|NCT00971243|322730211|FG001|Open-label Period|Withdrawal by Subject|0|||
94255973|NCT00971243|322730212|FG002|Open-label Period|Withdrawal by Subject|0|||
94255974|NCT00971243|322730213|FG003|Open-label Period|Withdrawal by Subject|2|||
94255975|NCT00971243|322730214|FG004|Open-label Period|Withdrawal by Subject|1|||
94255976|NCT00971243|322730210|FG000|Open-label Period|Other reason|0|||
94255977|NCT00971243|322730211|FG001|Open-label Period|Other reason|0|||
94628206|NCT00842712|324097877|FG003|Randomized Part|Randomized but not treated|0|||
94628207|NCT00842712|324097878|FG004|Randomized Part|Randomized but not treated|0|||
94628208|NCT00842712|324097879|FG005|Randomized Part|Randomized but not treated|1|||
94628209|NCT00842712|324097880|FG006|Randomized Part|Randomized but not treated|4|||
94628210|NCT00842712|324097874|FG000|Randomized Part|Ongoing at cut-off date|0|||
94628211|NCT00842712|324097875|FG001|Randomized Part|Ongoing at cut-off date|0|||
94628212|NCT00842712|324097876|FG002|Randomized Part|Ongoing at cut-off date|0|||
94628213|NCT00842712|324097877|FG003|Randomized Part|Ongoing at cut-off date|0|||
94628214|NCT00842712|324097878|FG004|Randomized Part|Ongoing at cut-off date|0|||
94628215|NCT00842712|324097879|FG005|Randomized Part|Ongoing at cut-off date|0|||
94628216|NCT00842712|324097880|FG006|Randomized Part|Ongoing at cut-off date|2|||
94628217|NCT00543140|324097887|FG000|Overall Study|Lost to Follow-up|33|||
94628218|NCT00543140|324097887|FG000|Overall Study|Withdrawal by Subject|13|||
94628219|NCT00543140|324097887|FG000|Overall Study|Protocol Violation|10|||
94628220|NCT00543140|324097887|FG000|Overall Study|Insufficient weight loss|10|||
94628221|NCT00543140|324097887|FG000|Overall Study|SAE leading to explant of SAGB|3|||
94628222|NCT00543140|324097887|FG000|Overall Study|Death|1|||
94628223|NCT00543140|324097887|FG000|Overall Study|Subject moved|1|||
94628224|NCT00543140|324097887|FG000|Overall Study|Conversion to different procedure|1|||
94628225|NCT03506815|324097888|FG000|Overall Study|Adverse Event|8|||
94628226|NCT03506815|324097889|FG001|Overall Study|Adverse Event|0|||
94628227|NCT03506815|324097888|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
94628228|NCT03506815|324097889|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
94628229|NCT03506815|324097888|FG000|Overall Study|Protocol Violation|1|||
94628230|NCT03506815|324097889|FG001|Overall Study|Protocol Violation|0|||
94628231|NCT03506815|324097888|FG000|Overall Study|Elective Surgery|1|||
94628232|NCT03506815|324097889|FG001|Overall Study|Elective Surgery|0|||
94628233|NCT00381095|324097893|FG000|Overall Study|Death|3|||
94628234|NCT00381095|324097894|FG001|Overall Study|Death|4|||
94628235|NCT00381095|324097893|FG000|Overall Study|Lack of Efficacy|2|||
94628236|NCT00381095|324097894|FG001|Overall Study|Lack of Efficacy|4|||
94628237|NCT00381095|324097893|FG000|Overall Study|Other|2|||
94628238|NCT00381095|324097894|FG001|Overall Study|Other|2|||
94255978|NCT00971243|322730212|FG002|Open-label Period|Other reason|0|||
94255979|NCT00971243|322730213|FG003|Open-label Period|Other reason|0|||
94255980|NCT00971243|322730214|FG004|Open-label Period|Other reason|2|||
94628239|NCT00381095|324097893|FG000|Overall Study|Protocol Violation|1|||
94628240|NCT00381095|324097894|FG001|Overall Study|Protocol Violation|1|||
94255981|NCT00770341|322730215|FG000|Overall Study|Did not meet eligibility criteria|1|||
94628241|NCT00381095|324097893|FG000|Overall Study|Withdrawal by Subject|3|||
94628242|NCT00381095|324097894|FG001|Overall Study|Withdrawal by Subject|3|||
94628243|NCT00381095|324097893|FG000|Overall Study|Adverse Event|2|||
94628244|NCT00381095|324097894|FG001|Overall Study|Adverse Event|7|||
94628245|NCT01104493|324097895|FG000|Overall Study|Lost to Follow-up|0|||
94628246|NCT01104493|324097896|FG001|Overall Study|Lost to Follow-up|2|||
94628247|NCT01029795|324097899|FG000|Overall Study|Entry Criteria Not Met|2|||
94628248|NCT01029795|324097900|FG001|Overall Study|Entry Criteria Not Met|1|||
94628249|NCT01029795|324097899|FG000|Overall Study|Physician Decision|2|||
94628250|NCT01029795|324097900|FG001|Overall Study|Physician Decision|1|||
94628251|NCT01029795|324097899|FG000|Overall Study|Sponsor Decision|11|||
94628252|NCT01029795|324097900|FG001|Overall Study|Sponsor Decision|17|||
94628253|NCT01029795|324097899|FG000|Overall Study|Withdrawal by Subject|1|||
94628254|NCT01029795|324097900|FG001|Overall Study|Withdrawal by Subject|3|||
94628255|NCT01831544|324097906|FG000|Overall Study|Death|1|||
94628256|NCT01831544|324097906|FG000|Overall Study|Still on original MVAD device|2|||
94628257|NCT02782780|324097907|FG000|Overall Study|dropped out after randomization.|7|||
94628258|NCT02782780|324097908|FG001|Overall Study|dropped out after randomization.|5|||
94628259|NCT02782780|324097907|FG000|Overall Study|Protocol Violation|0|||
94628260|NCT02782780|324097908|FG001|Overall Study|Protocol Violation|2|||
94628261|NCT03654651|324097909|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
94628262|NCT03654651|324097910|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
94628263|NCT01702454|324097911|FG000|Overall Study|Consent withdrawal|0|||
94628264|NCT01702454|324097912|FG001|Overall Study|Consent withdrawal|1|||
94628265|NCT01702454|324097911|FG000|Overall Study|Migrated/moved from study area|0|||
94628266|NCT01702454|324097912|FG001|Overall Study|Migrated/moved from study area|1|||
94628267|NCT01702454|324097911|FG000|Overall Study|Lost to Follow-up|3|||
94628268|NCT01702454|324097912|FG001|Overall Study|Lost to Follow-up|6|||
94628269|NCT02433483|324097913|FG000|Overall Study|Unacceptable toxicity|1|||
94628270|NCT02433483|324097913|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
94628271|NCT03510884|324097914|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
94628272|NCT03510884|324097915|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
94628273|NCT03510884|324097916|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
94628274|NCT03510884|324097917|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
94628275|NCT03510884|324097914|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
94628276|NCT03510884|324097915|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
94628277|NCT03510884|324097916|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
94628278|NCT03510884|324097917|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
94628279|NCT03510884|324097914|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
94628280|NCT03510884|324097915|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
94628281|NCT03510884|324097916|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
94628282|NCT03510884|324097917|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
94628283|NCT03510884|324097914|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
94628284|NCT03510884|324097915|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
94628285|NCT03510884|324097916|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
94628286|NCT03510884|324097917|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
94628287|NCT03510884|324097914|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
94628288|NCT03510884|324097915|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
94628289|NCT03510884|324097916|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
94628290|NCT03510884|324097917|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
94628291|NCT03510884|324097914|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
94628292|NCT03510884|324097915|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
94628293|NCT03510884|324097916|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
94628294|NCT03510884|324097917|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
94628295|NCT03510884|324097914|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
94628296|NCT03510884|324097915|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
94628297|NCT03510884|324097916|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
94628298|NCT03510884|324097917|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
94628299|NCT03510884|324097914|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
94628300|NCT03510884|324097915|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
94628301|NCT03510884|324097916|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
94628302|NCT03510884|324097917|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
94674822|NCT01735201|324263140|FG005|Overall Study|Personal Reasons|0|||
94674823|NCT01735201|324263141|FG006|Overall Study|Personal Reasons|0|||
94255982|NCT00770341|322730216|FG001|Overall Study|Did not meet eligibility criteria|0|||
94255983|NCT00770341|322730217|FG002|Overall Study|Did not meet eligibility criteria|0|||
94255984|NCT00770341|322730215|FG000|Overall Study|Withdrawal by Subject|0|||
94255985|NCT00770341|322730216|FG001|Overall Study|Withdrawal by Subject|1|||
94255986|NCT00770341|322730217|FG002|Overall Study|Withdrawal by Subject|0|||
94255987|NCT00770341|322730215|FG000|Overall Study|Clinical Adverse Event|3|||
94255988|NCT00770341|322730216|FG001|Overall Study|Clinical Adverse Event|1|||
94255989|NCT00770341|322730217|FG002|Overall Study|Clinical Adverse Event|2|||
94255990|NCT00770341|322730215|FG000|Overall Study|Laboratory adverse event|3|||
94255991|NCT00770341|322730216|FG001|Overall Study|Laboratory adverse event|3|||
94255992|NCT00770341|322730217|FG002|Overall Study|Laboratory adverse event|0|||
94255993|NCT00770341|322730215|FG000|Overall Study|Lack of Efficacy|3|||
94255994|NCT00770341|322730216|FG001|Overall Study|Lack of Efficacy|0|||
94255995|NCT00770341|322730217|FG002|Overall Study|Lack of Efficacy|1|||
94255996|NCT00770341|322730215|FG000|Overall Study|Other|1|||
94255997|NCT00770341|322730216|FG001|Overall Study|Other|0|||
94255998|NCT00770341|322730217|FG002|Overall Study|Other|0|||
94255999|NCT00770341|322730215|FG000|Overall Study|Not treated|1|||
94256000|NCT00770341|322730216|FG001|Overall Study|Not treated|0|||
94256001|NCT00770341|322730217|FG002|Overall Study|Not treated|0|||
94256002|NCT00960531|322730223|FG000|Overall Study|Lack of Efficacy|1|||
94256003|NCT00960531|322730224|FG001|Overall Study|Lack of Efficacy|0|||
94256004|NCT00960531|322730225|FG002|Overall Study|Lack of Efficacy|0|||
94256005|NCT00960531|322730226|FG003|Overall Study|Lack of Efficacy|0|||
94256006|NCT00960531|322730227|FG004|Overall Study|Lack of Efficacy|0|||
94256007|NCT00960531|322730228|FG005|Overall Study|Lack of Efficacy|0|||
94256008|NCT00960531|322730229|FG006|Overall Study|Lack of Efficacy|0|||
94256009|NCT00960531|322730230|FG007|Overall Study|Lack of Efficacy|0|||
94256010|NCT00960531|322730231|FG008|Overall Study|Lack of Efficacy|0|||
94256011|NCT00960531|322730232|FG009|Overall Study|Lack of Efficacy|0|||
94256012|NCT00960531|322730223|FG000|Overall Study|Withdrawal by Subject|1|||
94256013|NCT00960531|322730224|FG001|Overall Study|Withdrawal by Subject|0|||
94256014|NCT00960531|322730225|FG002|Overall Study|Withdrawal by Subject|5|||
94256015|NCT00960531|322730226|FG003|Overall Study|Withdrawal by Subject|2|||
94256016|NCT00960531|322730227|FG004|Overall Study|Withdrawal by Subject|0|||
94256017|NCT00960531|322730228|FG005|Overall Study|Withdrawal by Subject|0|||
94256018|NCT00960531|322730229|FG006|Overall Study|Withdrawal by Subject|2|||
94256019|NCT00960531|322730230|FG007|Overall Study|Withdrawal by Subject|0|||
94256020|NCT00960531|322730231|FG008|Overall Study|Withdrawal by Subject|1|||
94256021|NCT00960531|322730232|FG009|Overall Study|Withdrawal by Subject|0|||
94256022|NCT00960531|322730223|FG000|Overall Study|Caregiver Request|2|||
94256023|NCT00960531|322730224|FG001|Overall Study|Caregiver Request|0|||
94256024|NCT00960531|322730225|FG002|Overall Study|Caregiver Request|6|||
94256025|NCT00960531|322730226|FG003|Overall Study|Caregiver Request|5|||
94256026|NCT00960531|322730227|FG004|Overall Study|Caregiver Request|0|||
94256027|NCT00960531|322730228|FG005|Overall Study|Caregiver Request|2|||
94256028|NCT00960531|322730229|FG006|Overall Study|Caregiver Request|3|||
94674824|NCT01735201|324263142|FG007|Overall Study|Personal Reasons|0|||
94674825|NCT01735201|324263135|FG000|Overall Study|Protocol Violation|1|||
94256029|NCT00960531|322730230|FG007|Overall Study|Caregiver Request|1|||
94256030|NCT00960531|322730231|FG008|Overall Study|Caregiver Request|3|||
94256031|NCT00960531|322730232|FG009|Overall Study|Caregiver Request|0|||
94256032|NCT00960531|322730223|FG000|Overall Study|Investigator Request|0|||
94256033|NCT00960531|322730224|FG001|Overall Study|Investigator Request|0|||
94256034|NCT00960531|322730225|FG002|Overall Study|Investigator Request|1|||
94256035|NCT00960531|322730226|FG003|Overall Study|Investigator Request|0|||
94256036|NCT00960531|322730227|FG004|Overall Study|Investigator Request|0|||
94256037|NCT00960531|322730228|FG005|Overall Study|Investigator Request|0|||
94256038|NCT00960531|322730229|FG006|Overall Study|Investigator Request|0|||
94256039|NCT00960531|322730230|FG007|Overall Study|Investigator Request|0|||
94256040|NCT00960531|322730231|FG008|Overall Study|Investigator Request|0|||
94256041|NCT00960531|322730232|FG009|Overall Study|Investigator Request|0|||
94256042|NCT00960531|322730223|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
94674826|NCT01735201|324263136|FG001|Overall Study|Protocol Violation|0|||
94674827|NCT01735201|324263137|FG002|Overall Study|Protocol Violation|0|||
94256043|NCT00960531|322730224|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
94256044|NCT00960531|322730225|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
94256045|NCT00960531|322730226|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
94256046|NCT00960531|322730227|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
94256047|NCT00960531|322730228|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
94674828|NCT01735201|324263138|FG003|Overall Study|Protocol Violation|0|||
94674829|NCT01735201|324263139|FG004|Overall Study|Protocol Violation|0|||
94674830|NCT01735201|324263140|FG005|Overall Study|Protocol Violation|0|||
94674831|NCT01735201|324263141|FG006|Overall Study|Protocol Violation|0|||
94674832|NCT01735201|324263142|FG007|Overall Study|Protocol Violation|0|||
94674833|NCT01735201|324263135|FG000|Overall Study|Other Miscellaneous Reasons|0|||
94674834|NCT01735201|324263136|FG001|Overall Study|Other Miscellaneous Reasons|0|||
94674835|NCT01735201|324263137|FG002|Overall Study|Other Miscellaneous Reasons|0|||
94674836|NCT01735201|324263138|FG003|Overall Study|Other Miscellaneous Reasons|1|||
94674837|NCT01735201|324263139|FG004|Overall Study|Other Miscellaneous Reasons|0|||
94674838|NCT01735201|324263140|FG005|Overall Study|Other Miscellaneous Reasons|2|||
94674839|NCT01735201|324263141|FG006|Overall Study|Other Miscellaneous Reasons|1|||
94674840|NCT01735201|324263142|FG007|Overall Study|Other Miscellaneous Reasons|1|||
94674841|NCT00685945|324263143|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
94674842|NCT00939484|324263145|FG000|Overall Study|Progression/Relapse|8|||
94674843|NCT00939484|324263146|FG001|Overall Study|Progression/Relapse|20|||
94674844|NCT00939484|324263147|FG002|Overall Study|Progression/Relapse|3|||
94674845|NCT04791761|324263149|FG000|Overall Study|Lost to Follow-up|8|||
94674846|NCT04791761|324263150|FG001|Overall Study|Lost to Follow-up|6|||
94674847|NCT04791761|324263151|FG002|Overall Study|Lost to Follow-up|10|||
94674848|NCT04791761|324263149|FG000|Overall Study|Withdrawal by Subject|0|||
94256048|NCT00960531|322730229|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
94256049|NCT00960531|322730230|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
94256050|NCT00960531|322730231|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
94256051|NCT00960531|322730232|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
94256052|NCT00960531|322730223|FG000|Overall Study|Lost to Follow-up|0|||
94256053|NCT00960531|322730224|FG001|Overall Study|Lost to Follow-up|0|||
94256054|NCT00960531|322730225|FG002|Overall Study|Lost to Follow-up|1|||
94256055|NCT00960531|322730226|FG003|Overall Study|Lost to Follow-up|0|||
94256056|NCT00960531|322730227|FG004|Overall Study|Lost to Follow-up|0|||
94256057|NCT00960531|322730228|FG005|Overall Study|Lost to Follow-up|0|||
94256058|NCT00960531|322730229|FG006|Overall Study|Lost to Follow-up|1|||
94256059|NCT00960531|322730230|FG007|Overall Study|Lost to Follow-up|0|||
94256060|NCT00960531|322730231|FG008|Overall Study|Lost to Follow-up|0|||
94256061|NCT00960531|322730232|FG009|Overall Study|Lost to Follow-up|0|||
94256062|NCT00960531|322730223|FG000|Overall Study|Failed to Return|2|||
94256063|NCT00960531|322730224|FG001|Overall Study|Failed to Return|0|||
94256064|NCT00960531|322730225|FG002|Overall Study|Failed to Return|0|||
94256065|NCT00960531|322730226|FG003|Overall Study|Failed to Return|0|||
94256066|NCT00960531|322730227|FG004|Overall Study|Failed to Return|0|||
94256067|NCT00960531|322730228|FG005|Overall Study|Failed to Return|0|||
94256068|NCT00960531|322730229|FG006|Overall Study|Failed to Return|0|||
94256069|NCT00960531|322730230|FG007|Overall Study|Failed to Return|2|||
94360524|NCT00471237|323103843|FG005|Overall Study|Participant lost medication|0|||
94360525|NCT00471237|323103844|FG006|Overall Study|Participant lost medication|0|||
94674849|NCT04791761|324263150|FG001|Overall Study|Withdrawal by Subject|1|||
94674850|NCT04791761|324263151|FG002|Overall Study|Withdrawal by Subject|1|||
94674851|NCT04791761|324263149|FG000|Overall Study|Protocol Violation|0|||
94674852|NCT04791761|324263150|FG001|Overall Study|Protocol Violation|1|||
94674853|NCT04791761|324263151|FG002|Overall Study|Protocol Violation|1|||
94674854|NCT01756352|324263153|FG000|Overall Study|moved away and lost to followup|1|||
94256070|NCT00960531|322730231|FG008|Overall Study|Failed to Return|0|||
94256071|NCT00960531|322730232|FG009|Overall Study|Failed to Return|0|||
94256072|NCT00960531|322730223|FG000|Overall Study|Adverse Event (AE)|2|||
94256073|NCT00960531|322730224|FG001|Overall Study|Adverse Event (AE)|0|||
94256074|NCT00960531|322730225|FG002|Overall Study|Adverse Event (AE)|0|||
94256075|NCT00960531|322730226|FG003|Overall Study|Adverse Event (AE)|0|||
94256076|NCT00960531|322730227|FG004|Overall Study|Adverse Event (AE)|0|||
94256077|NCT00960531|322730228|FG005|Overall Study|Adverse Event (AE)|1|||
94256078|NCT00960531|322730229|FG006|Overall Study|Adverse Event (AE)|2|||
94256079|NCT00960531|322730230|FG007|Overall Study|Adverse Event (AE)|0|||
94256080|NCT00960531|322730231|FG008|Overall Study|Adverse Event (AE)|2|||
94256081|NCT00960531|322730232|FG009|Overall Study|Adverse Event (AE)|0|||
94256082|NCT00960531|322730223|FG000|Overall Study|Reason not Specified|2|||
94360526|NCT00471237|323103838|FG000|Overall Study|Administration of prohibited medicine|0|||
94360527|NCT00471237|323103839|FG001|Overall Study|Administration of prohibited medicine|0|||
94628303|NCT03510884|324097914|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
94628304|NCT03510884|324097915|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
94628305|NCT03510884|324097916|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
94628306|NCT03510884|324097917|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
94628307|NCT03510884|324097914|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
94628308|NCT03510884|324097915|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
94628309|NCT03510884|324097916|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
94628310|NCT03510884|324097917|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
94628311|NCT03824912|324097918|FG000|Overall Study|Lost to Follow-up|18|||
94628312|NCT03824912|324097919|FG001|Overall Study|Lost to Follow-up|15|||
94628313|NCT03824912|324097920|FG002|Overall Study|Lost to Follow-up|8|||
94628314|NCT03824912|324097918|FG000|Overall Study|Negative Baseline Culture Result|118|||
94628315|NCT03824912|324097919|FG001|Overall Study|Negative Baseline Culture Result|112|||
94628316|NCT03824912|324097920|FG002|Overall Study|Negative Baseline Culture Result|57|||
94628317|NCT03824912|324097918|FG000|Overall Study|Non-Compliance with Study Drug|0|||
94628318|NCT03824912|324097919|FG001|Overall Study|Non-Compliance with Study Drug|0|||
94628319|NCT03824912|324097920|FG002|Overall Study|Non-Compliance with Study Drug|1|||
94628320|NCT03824912|324097918|FG000|Overall Study|Protocol Violation|1|||
94628321|NCT03824912|324097919|FG001|Overall Study|Protocol Violation|4|||
94628322|NCT03824912|324097920|FG002|Overall Study|Protocol Violation|1|||
94628323|NCT03824912|324097918|FG000|Overall Study|Withdrawal by Subject|3|||
94628324|NCT03824912|324097919|FG001|Overall Study|Withdrawal by Subject|2|||
94628325|NCT03824912|324097920|FG002|Overall Study|Withdrawal by Subject|1|||
94628326|NCT03824912|324097918|FG000|Overall Study|Participation in another study|0|||
94628327|NCT03824912|324097919|FG001|Overall Study|Participation in another study|1|||
94628328|NCT03824912|324097920|FG002|Overall Study|Participation in another study|0|||
94628329|NCT02485301|324097921|FG000|Overall Study|Serious Adverse Events|2|||
94628330|NCT02485301|324097922|FG001|Overall Study|Serious Adverse Events|1|||
94628331|NCT02485301|324097921|FG000|Overall Study|Protocol Violation|0|||
94628332|NCT02485301|324097922|FG001|Overall Study|Protocol Violation|1|||
94628333|NCT02485301|324097921|FG000|Overall Study|Withdrawal by Subject|6|||
94628334|NCT02485301|324097922|FG001|Overall Study|Withdrawal by Subject|7|||
94628335|NCT02485301|324097921|FG000|Overall Study|Migrated/moved from study area|10|||
94628336|NCT02485301|324097922|FG001|Overall Study|Migrated/moved from study area|19|||
94628337|NCT02485301|324097921|FG000|Overall Study|Lost to Follow-up|17|||
94628338|NCT02485301|324097922|FG001|Overall Study|Lost to Follow-up|17|||
94628339|NCT02485301|324097921|FG000|Overall Study|Other|3|||
94628340|NCT02485301|324097922|FG001|Overall Study|Other|4|||
94628341|NCT02692703|324097931|FG000|Overall Study|Lost to Follow-up|1|||
94628342|NCT02692703|324097931|FG000|Overall Study|Other|1|||
94628343|NCT04118166|324097932|FG000|Overall Study|Adverse Event|1|||
94628344|NCT05048784|324097933|FG000|Period 1|Adverse Event|3|||
94628345|NCT05048784|324097934|FG001|Period 1|Adverse Event|1|||
94628346|NCT05048784|324097935|FG002|Period 1|Adverse Event|0|||
94628347|NCT05048784|324097936|FG003|Period 1|Adverse Event|0|||
94628348|NCT05048784|324097933|FG000|Period 2|Lost to Follow-up|0|||
94628349|NCT05048784|324097934|FG001|Period 2|Lost to Follow-up|1|||
94628350|NCT05048784|324097935|FG002|Period 2|Lost to Follow-up|0|||
94628351|NCT05048784|324097936|FG003|Period 2|Lost to Follow-up|0|||
94628352|NCT03519932|324097939|FG000|First Intervention|Adverse Event|1|||
94628353|NCT03519932|324097940|FG001|First Intervention|Adverse Event|3|||
94628354|NCT04016285|324097941|FG000|Overall Study|Did not progress to surgery|2|||
94628355|NCT04016285|324097942|FG001|Overall Study|Did not progress to surgery|5|||
94628356|NCT04016285|324097941|FG000|Overall Study|Failed to collect outcome data|5|||
94628357|NCT04016285|324097942|FG001|Overall Study|Failed to collect outcome data|3|||
94628358|NCT00010374|324097943|FG000|Overall Study|False positive phrenic nerve test|1|||
94628359|NCT00299975|324097944|FG000|Overall Study|Adverse Event|1|||
94628360|NCT00299975|324097945|FG001|Overall Study|Adverse Event|0|||
94628361|NCT00299975|324097946|FG002|Overall Study|Adverse Event|2|||
94628362|NCT00299975|324097944|FG000|Overall Study|Pregnancy|0|||
94628363|NCT00299975|324097945|FG001|Overall Study|Pregnancy|0|||
94628364|NCT00299975|324097946|FG002|Overall Study|Pregnancy|1|||
94628365|NCT00299975|324097944|FG000|Overall Study|Lack of Efficacy|1|||
94674855|NCT03255824|324263154|FG000|Overall Study|Under-sedation|2|||
94674856|NCT03255824|324263155|FG001|Overall Study|Under-sedation|1|||
94674857|NCT03315143|324263157|FG000|Overall Study|Death|240|||
94674858|NCT03315143|324263158|FG001|Overall Study|Death|246|||
94674859|NCT03315143|324263157|FG000|Overall Study|Withdrawal by Subject|57|||
94674860|NCT03315143|324263158|FG001|Overall Study|Withdrawal by Subject|68|||
94674861|NCT03315143|324263157|FG000|Overall Study|Site Terminated by Sponsor|256|||
94674862|NCT03315143|324263158|FG001|Overall Study|Site Terminated by Sponsor|282|||
94674863|NCT03315143|324263157|FG000|Overall Study|Study Terminated by Sponsor|4723|||
94674864|NCT03315143|324263158|FG001|Overall Study|Study Terminated by Sponsor|4664|||
94674865|NCT03315143|324263157|FG000|Overall Study|Reason not Specified|16|||
94674866|NCT03315143|324263158|FG001|Overall Study|Reason not Specified|32|||
94674867|NCT00526630|324263159|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
94674868|NCT00526630|324263160|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
94628366|NCT00299975|324097945|FG001|Overall Study|Lack of Efficacy|0|||
94628367|NCT00299975|324097946|FG002|Overall Study|Lack of Efficacy|1|||
94628368|NCT00299975|324097944|FG000|Overall Study|Lost to Follow-up|1|||
94256083|NCT00960531|322730224|FG001|Overall Study|Reason not Specified|1|||
94256084|NCT00960531|322730225|FG002|Overall Study|Reason not Specified|13|||
94256085|NCT00960531|322730226|FG003|Overall Study|Reason not Specified|1|||
94256086|NCT00960531|322730227|FG004|Overall Study|Reason not Specified|2|||
94256087|NCT00960531|322730228|FG005|Overall Study|Reason not Specified|0|||
94628369|NCT00299975|324097945|FG001|Overall Study|Lost to Follow-up|0|||
94628370|NCT00299975|324097946|FG002|Overall Study|Lost to Follow-up|0|||
94628371|NCT00299975|324097944|FG000|Overall Study|Withdrawal by Subject|0|||
94674869|NCT00526630|324263159|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
94256088|NCT00960531|322730229|FG006|Overall Study|Reason not Specified|16|||
94256089|NCT00960531|322730230|FG007|Overall Study|Reason not Specified|0|||
94256090|NCT00960531|322730231|FG008|Overall Study|Reason not Specified|8|||
94256091|NCT00960531|322730232|FG009|Overall Study|Reason not Specified|1|||
94256092|NCT00346268|322732783|FG000|Overall Study|Adverse Event|1|||
94256093|NCT00346268|322732784|FG001|Overall Study|Adverse Event|0|||
94256094|NCT00346268|322732783|FG000|Overall Study|Protocol Violation|1|||
94674870|NCT00526630|324263160|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
94674871|NCT03320018|324263161|FG000|Treatment Period|Withdrawal by Subject|1|||
94674872|NCT03320018|324263162|FG001|Treatment Period|Withdrawal by Subject|0|||
94256095|NCT00346268|322732784|FG001|Overall Study|Protocol Violation|0|||
94256096|NCT00346268|322732783|FG000|Overall Study|Participant refused|0|||
94256097|NCT00346268|322732784|FG001|Overall Study|Participant refused|3|||
94256098|NCT00409773|322732785|FG000|Overall Study|Adverse Event|3|||
94256099|NCT00409773|322732786|FG001|Overall Study|Adverse Event|4|||
94256100|NCT00409773|322732787|FG002|Overall Study|Adverse Event|4|||
94256101|NCT00409773|322732788|FG003|Overall Study|Adverse Event|2|||
94256102|NCT00409773|322732789|FG004|Overall Study|Adverse Event|6|||
94256103|NCT00409773|322732785|FG000|Overall Study|Lost to Follow-up|6|||
94256104|NCT00409773|322732786|FG001|Overall Study|Lost to Follow-up|1|||
94256105|NCT00409773|322732787|FG002|Overall Study|Lost to Follow-up|2|||
94256106|NCT00409773|322732788|FG003|Overall Study|Lost to Follow-up|3|||
94256107|NCT00409773|322732789|FG004|Overall Study|Lost to Follow-up|1|||
94256108|NCT00409773|322732785|FG000|Overall Study|Physician Decision|0|||
94256109|NCT00409773|322732786|FG001|Overall Study|Physician Decision|0|||
94256110|NCT00409773|322732787|FG002|Overall Study|Physician Decision|0|||
94256111|NCT00409773|322732788|FG003|Overall Study|Physician Decision|2|||
94256112|NCT00409773|322732789|FG004|Overall Study|Physician Decision|0|||
94256113|NCT00409773|322732785|FG000|Overall Study|Protocol Violation|0|||
94256114|NCT00409773|322732786|FG001|Overall Study|Protocol Violation|2|||
94256115|NCT00409773|322732787|FG002|Overall Study|Protocol Violation|3|||
94256116|NCT00409773|322732788|FG003|Overall Study|Protocol Violation|3|||
94256117|NCT00409773|322732789|FG004|Overall Study|Protocol Violation|1|||
94461270|NCT02954653|323478231|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
94628372|NCT00299975|324097945|FG001|Overall Study|Withdrawal by Subject|1|||
94628373|NCT00299975|324097946|FG002|Overall Study|Withdrawal by Subject|3|||
94256118|NCT00409773|322732785|FG000|Overall Study|Withdrawal by Subject|0|||
94256119|NCT00409773|322732786|FG001|Overall Study|Withdrawal by Subject|0|||
94256120|NCT00409773|322732787|FG002|Overall Study|Withdrawal by Subject|0|||
94256121|NCT00409773|322732788|FG003|Overall Study|Withdrawal by Subject|2|||
94256122|NCT00409773|322732789|FG004|Overall Study|Withdrawal by Subject|1|||
94256123|NCT00409773|322732785|FG000|Overall Study|Lack of Eligibility|0|||
94461271|NCT00250458|323478232|FG000|Overall Study|Lost to Follow-up|4|||
94628374|NCT00299975|324097944|FG000|Overall Study|Physician Decision|0|||
94256124|NCT00409773|322732786|FG001|Overall Study|Lack of Eligibility|0|||
94256125|NCT00409773|322732787|FG002|Overall Study|Lack of Eligibility|0|||
94256126|NCT00409773|322732788|FG003|Overall Study|Lack of Eligibility|0|||
94628375|NCT00299975|324097945|FG001|Overall Study|Physician Decision|0|||
94674873|NCT03320018|324263161|FG000|Day 90 Follow up|Death|0|||
94674874|NCT03320018|324263162|FG001|Day 90 Follow up|Death|1|||
94628376|NCT00299975|324097946|FG002|Overall Study|Physician Decision|1|||
94674875|NCT00549757|324263163|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
94674876|NCT00549757|324263164|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
94674877|NCT00549757|324263163|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
94674878|NCT00549757|324263164|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
94674879|NCT00549757|324263163|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
94674880|NCT00549757|324263164|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
94674881|NCT00549757|324263163|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
94674882|NCT00549757|324263164|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
94674883|NCT00549757|324263163|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
94674884|NCT00549757|324263164|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
94674885|NCT00549757|324263163|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
94674886|NCT00549757|324263164|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
94674887|NCT00549757|324263163|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
94674888|NCT00549757|324263164|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
94674889|NCT00549757|324263163|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
94674890|NCT00549757|324263164|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
94674891|NCT00549757|324263163|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
94674892|NCT00549757|324263164|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
94674893|NCT00549757|324263163|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
94674894|NCT00549757|324263164|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
94674895|NCT00549757|324263163|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
94674896|NCT00549757|324263164|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
94674897|NCT00549757|324263163|FG000|Extension Period (in Average 9 Months)|Death|143|||
94674898|NCT00549757|324263164|FG001|Extension Period (in Average 9 Months)|Death|136|||
94674899|NCT00549757|324263163|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
94461272|NCT00250458|323478233|FG001|Overall Study|Lost to Follow-up|2|||
94461273|NCT00250458|323478232|FG000|Overall Study|Protocol Violation|0|||
94628377|NCT02927431|324097947|FG000|Overall Study|Withdrawal by Subject|0|||
94628378|NCT02927431|324097948|FG001|Overall Study|Withdrawal by Subject|0|||
94628379|NCT02927431|324097949|FG002|Overall Study|Withdrawal by Subject|1|||
94628380|NCT00320411|324097950|FG000|Overall Study|No investigational product admin.|4|||
94628381|NCT00587639|324097951|FG000|Overall Study|Withdrawal by Subject|1|||
94628382|NCT00752232|324097954|FG000|Overall Study|Protocol Violation|0|||
94628383|NCT00752232|324097955|FG001|Overall Study|Protocol Violation|0|||
94628384|NCT00752232|324097956|FG002|Overall Study|Protocol Violation|0|||
94628385|NCT00752232|324097957|FG003|Overall Study|Protocol Violation|0|||
94628386|NCT00752232|324097958|FG004|Overall Study|Protocol Violation|0|||
94628387|NCT00752232|324097959|FG005|Overall Study|Protocol Violation|1|||
94628388|NCT00752232|324097960|FG006|Overall Study|Protocol Violation|0|||
94628389|NCT00752232|324097954|FG000|Overall Study|Caregiver request|2|||
94628390|NCT00752232|324097955|FG001|Overall Study|Caregiver request|0|||
94628391|NCT00752232|324097956|FG002|Overall Study|Caregiver request|0|||
94628392|NCT00752232|324097957|FG003|Overall Study|Caregiver request|0|||
94628393|NCT00752232|324097958|FG004|Overall Study|Caregiver request|1|||
94628394|NCT00752232|324097959|FG005|Overall Study|Caregiver request|0|||
94628395|NCT00752232|324097960|FG006|Overall Study|Caregiver request|0|||
94674900|NCT00549757|324263164|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
94674901|NCT00549757|324263163|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
94256127|NCT00409773|322732789|FG004|Overall Study|Lack of Eligibility|1|||
94461274|NCT00250458|323478233|FG001|Overall Study|Protocol Violation|1|||
94628396|NCT00752232|324097954|FG000|Overall Study|Investigator request|0|||
94628397|NCT00752232|324097955|FG001|Overall Study|Investigator request|0|||
94628398|NCT00752232|324097956|FG002|Overall Study|Investigator request|0|||
94628399|NCT00752232|324097957|FG003|Overall Study|Investigator request|0|||
94628400|NCT00752232|324097958|FG004|Overall Study|Investigator request|1|||
94628401|NCT00752232|324097959|FG005|Overall Study|Investigator request|0|||
94628402|NCT00752232|324097960|FG006|Overall Study|Investigator request|0|||
94628403|NCT00752232|324097954|FG000|Overall Study|Subject request|0|||
94628404|NCT00752232|324097955|FG001|Overall Study|Subject request|0|||
94628405|NCT00752232|324097956|FG002|Overall Study|Subject request|1|||
94628406|NCT00752232|324097957|FG003|Overall Study|Subject request|0|||
94628407|NCT00752232|324097958|FG004|Overall Study|Subject request|0|||
94628408|NCT00752232|324097959|FG005|Overall Study|Subject request|0|||
94628409|NCT00752232|324097960|FG006|Overall Study|Subject request|0|||
94628410|NCT00752232|324097954|FG000|Overall Study|Group home admission|0|||
94628411|NCT00752232|324097955|FG001|Overall Study|Group home admission|0|||
94628412|NCT00752232|324097956|FG002|Overall Study|Group home admission|0|||
94628413|NCT00752232|324097957|FG003|Overall Study|Group home admission|1|||
94628414|NCT00752232|324097958|FG004|Overall Study|Group home admission|0|||
94628415|NCT00752232|324097959|FG005|Overall Study|Group home admission|0|||
94628416|NCT00752232|324097960|FG006|Overall Study|Group home admission|0|||
94628417|NCT00752232|324097954|FG000|Overall Study|Caregiver could not attend the subject|0|||
94628418|NCT00752232|324097955|FG001|Overall Study|Caregiver could not attend the subject|0|||
94628419|NCT00752232|324097956|FG002|Overall Study|Caregiver could not attend the subject|0|||
94628420|NCT00752232|324097957|FG003|Overall Study|Caregiver could not attend the subject|0|||
94628421|NCT00752232|324097958|FG004|Overall Study|Caregiver could not attend the subject|1|||
94628422|NCT00752232|324097959|FG005|Overall Study|Caregiver could not attend the subject|0|||
94628423|NCT00752232|324097960|FG006|Overall Study|Caregiver could not attend the subject|0|||
94628424|NCT00555321|324097963|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
94628425|NCT00555321|324097964|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
94628426|NCT00555321|324097965|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
94628427|NCT00555321|324097966|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
94628428|NCT00555321|324097967|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
94628429|NCT00555321|324097963|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
94628430|NCT00555321|324097964|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
94628431|NCT00555321|324097965|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
94628432|NCT00555321|324097966|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
94628433|NCT00555321|324097967|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
94628434|NCT00555321|324097963|FG000|Treatment Phase up to 12-months|Death|2|||
94628435|NCT00555321|324097964|FG001|Treatment Phase up to 12-months|Death|1|||
94628436|NCT00555321|324097965|FG002|Treatment Phase up to 12-months|Death|4|||
94628437|NCT00555321|324097966|FG003|Treatment Phase up to 12-months|Death|0|||
94628438|NCT00555321|324097967|FG004|Treatment Phase up to 12-months|Death|0|||
94628439|NCT00555321|324097963|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
94628440|NCT00555321|324097964|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
94628441|NCT00555321|324097965|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
94628442|NCT00555321|324097966|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
94674902|NCT00549757|324263164|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
94256128|NCT02359877|322732790|FG000|Overall Study|Withdrawal by Subject|1|||
94256129|NCT02359877|322732791|FG001|Overall Study|Withdrawal by Subject|0|||
94628443|NCT00555321|324097967|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
94628444|NCT00555321|324097963|FG000|Treatment Phase up to 12-months|Other Reason|1|||
94628445|NCT00555321|324097964|FG001|Treatment Phase up to 12-months|Other Reason|3|||
94256130|NCT02359877|322732792|FG002|Overall Study|Withdrawal by Subject|0|||
94256131|NCT02359877|322732793|FG003|Overall Study|Withdrawal by Subject|2|||
94256132|NCT02359877|322732790|FG000|Overall Study|Adverse Event|0|||
94256133|NCT02359877|322732791|FG001|Overall Study|Adverse Event|0|||
94256134|NCT02359877|322732792|FG002|Overall Study|Adverse Event|0|||
94256135|NCT02359877|322732793|FG003|Overall Study|Adverse Event|1|||
94256136|NCT00275262|322732794|FG000|Overall Study|Adverse Event|2|||
94256137|NCT00275262|322732795|FG001|Overall Study|Adverse Event|0|||
94256138|NCT00275262|322732794|FG000|Overall Study|Disease progression|2|||
94256139|NCT00275262|322732795|FG001|Overall Study|Disease progression|5|||
94256140|NCT00275262|322732794|FG000|Overall Study|Lost to Follow-up|0|||
94256141|NCT00275262|322732795|FG001|Overall Study|Lost to Follow-up|2|||
94256142|NCT00275262|322732794|FG000|Overall Study|Protocol Violation|0|||
94256143|NCT00275262|322732795|FG001|Overall Study|Protocol Violation|2|||
94256144|NCT00275262|322732794|FG000|Overall Study|Death|1|||
94256145|NCT00275262|322732795|FG001|Overall Study|Death|0|||
94256146|NCT00275262|322732794|FG000|Overall Study|Started Chemotherapy|1|||
94256147|NCT00275262|322732795|FG001|Overall Study|Started Chemotherapy|0|||
94256148|NCT00001962|322732800|FG000|Overall Study|Lack of Efficacy|18|||
94256149|NCT00001962|322732800|FG000|Overall Study|Lack of Accrual|6|||
94628446|NCT00555321|324097965|FG002|Treatment Phase up to 12-months|Other Reason|2|||
94628447|NCT00555321|324097966|FG003|Treatment Phase up to 12-months|Other Reason|0|||
94628448|NCT00555321|324097967|FG004|Treatment Phase up to 12-months|Other Reason|0|||
94628449|NCT00555321|324097963|FG000|Treatment Phase up to 12-months|Never treated|2|||
94628450|NCT00555321|324097964|FG001|Treatment Phase up to 12-months|Never treated|3|||
94360528|NCT00471237|323103840|FG002|Overall Study|Administration of prohibited medicine|0|||
94360529|NCT00471237|323103841|FG003|Overall Study|Administration of prohibited medicine|0|||
94628451|NCT00555321|324097965|FG002|Treatment Phase up to 12-months|Never treated|1|||
94628452|NCT00555321|324097966|FG003|Treatment Phase up to 12-months|Never treated|0|||
94628453|NCT00555321|324097967|FG004|Treatment Phase up to 12-months|Never treated|4|||
94628454|NCT00555321|324097963|FG000|Long-term Extension Phase|Adverse Event|2|||
94628455|NCT00555321|324097964|FG001|Long-term Extension Phase|Adverse Event|5|||
94628456|NCT00555321|324097965|FG002|Long-term Extension Phase|Adverse Event|2|||
94628457|NCT00555321|324097966|FG003|Long-term Extension Phase|Adverse Event|1|||
94628458|NCT00555321|324097967|FG004|Long-term Extension Phase|Adverse Event|0|||
94628459|NCT00555321|324097963|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
94628460|NCT00555321|324097964|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
94256150|NCT00001962|322732800|FG000|Overall Study|Death|1|||
94256151|NCT00001962|322732800|FG000|Overall Study|Lost to Follow-up|2|||
94256152|NCT00001962|322732800|FG000|Overall Study|Adverse Event|1|||
94360530|NCT00471237|323103842|FG004|Overall Study|Administration of prohibited medicine|1|||
94628461|NCT00555321|324097965|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
94628462|NCT00555321|324097966|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
94256153|NCT01036763|322732810|FG000|Overall Study|Adverse Event|25|||
94628463|NCT00555321|324097967|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
94628464|NCT00555321|324097963|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
94628465|NCT00555321|324097964|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
94628466|NCT00555321|324097965|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
94628467|NCT00555321|324097966|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
94628468|NCT00555321|324097967|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
94628469|NCT00555321|324097963|FG000|Long-term Extension Phase|Death|2|||
94628470|NCT00555321|324097964|FG001|Long-term Extension Phase|Death|0|||
94628471|NCT00555321|324097965|FG002|Long-term Extension Phase|Death|0|||
94628472|NCT00555321|324097966|FG003|Long-term Extension Phase|Death|3|||
94628473|NCT00555321|324097967|FG004|Long-term Extension Phase|Death|0|||
94628474|NCT00555321|324097963|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
94628475|NCT00555321|324097964|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
94628476|NCT00555321|324097965|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
94628477|NCT00555321|324097966|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
94628478|NCT00555321|324097967|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
94628479|NCT00555321|324097963|FG000|Long-term Extension Phase|Other Reason|1|||
94628480|NCT00555321|324097964|FG001|Long-term Extension Phase|Other Reason|0|||
94628481|NCT00555321|324097965|FG002|Long-term Extension Phase|Other Reason|2|||
94628482|NCT00555321|324097966|FG003|Long-term Extension Phase|Other Reason|0|||
94628483|NCT00555321|324097967|FG004|Long-term Extension Phase|Other Reason|0|||
94628484|NCT02013791|324097970|FG000|Period 1|Lost to Follow-up|0|||
94628485|NCT02013791|324097971|FG001|Period 1|Lost to Follow-up|0|||
94628486|NCT02013791|324097972|FG002|Period 1|Lost to Follow-up|0|||
94628487|NCT02013791|324097973|FG003|Period 1|Lost to Follow-up|1|||
94628488|NCT02013791|324097974|FG004|Period 1|Lost to Follow-up|0|||
94628489|NCT02013791|324097975|FG005|Period 1|Lost to Follow-up|0|||
94628490|NCT02013791|324097976|FG006|Period 1|Lost to Follow-up|1|||
94256154|NCT01036763|322732810|FG000|Overall Study|Lost to Follow-up|28|||
94256155|NCT01036763|322732810|FG000|Overall Study|Other reason (not specified)|40|||
94628491|NCT02013791|324097977|FG007|Period 1|Lost to Follow-up|1|||
94628492|NCT02013791|324097978|FG008|Period 1|Lost to Follow-up|0|||
94628493|NCT02013791|324097970|FG000|Period 1|Other Miscellaneous Reasons|0|||
94628494|NCT02013791|324097971|FG001|Period 1|Other Miscellaneous Reasons|2|||
94628495|NCT02013791|324097972|FG002|Period 1|Other Miscellaneous Reasons|0|||
94628496|NCT02013791|324097973|FG003|Period 1|Other Miscellaneous Reasons|0|||
94628497|NCT02013791|324097974|FG004|Period 1|Other Miscellaneous Reasons|0|||
94628498|NCT02013791|324097975|FG005|Period 1|Other Miscellaneous Reasons|0|||
94628499|NCT02013791|324097976|FG006|Period 1|Other Miscellaneous Reasons|0|||
94628500|NCT02013791|324097977|FG007|Period 1|Other Miscellaneous Reasons|0|||
94628501|NCT02013791|324097978|FG008|Period 1|Other Miscellaneous Reasons|0|||
94628502|NCT01500694|324097979|FG000|Overall Study|Adverse Event|4|||
94628503|NCT01500694|324097980|FG001|Overall Study|Adverse Event|3|||
94628504|NCT01500694|324097979|FG000|Overall Study|Protocol Violation|0|||
94628505|NCT01500694|324097980|FG001|Overall Study|Protocol Violation|1|||
94628506|NCT01500694|324097979|FG000|Overall Study|Withdrawal by Subject|23|||
94628507|NCT01500694|324097980|FG001|Overall Study|Withdrawal by Subject|14|||
94628508|NCT01500694|324097979|FG000|Overall Study|Lost to Follow-up|2|||
94628509|NCT01500694|324097980|FG001|Overall Study|Lost to Follow-up|3|||
94628510|NCT01500694|324097979|FG000|Overall Study|Lack of Efficacy|14|||
94628511|NCT01500694|324097980|FG001|Overall Study|Lack of Efficacy|5|||
94628512|NCT01500694|324097979|FG000|Overall Study|Other|9|||
94628513|NCT01500694|324097980|FG001|Overall Study|Other|3|||
94628514|NCT01405742|324097981|FG000|Overall Study|Lost to Follow-up|1|||
94628515|NCT01405742|324097982|FG001|Overall Study|Lost to Follow-up|0|||
94628516|NCT01244425|324097983|FG000|Overall Study|Withdrawal by Subject|2|||
94628517|NCT01244425|324097984|FG001|Overall Study|Withdrawal by Subject|2|||
94628518|NCT01244425|324097983|FG000|Overall Study|Adverse Event|1|||
94628519|NCT01244425|324097984|FG001|Overall Study|Adverse Event|1|||
94628520|NCT04656691|324097985|FG000|Overall Study|Adverse Event|1|||
94628521|NCT04557371|324097987|FG000|Overall Study|Covid-19-related|0|||
94628522|NCT04557371|324097988|FG001|Overall Study|Covid-19-related|1|||
94628523|NCT04557371|324097989|FG002|Overall Study|Covid-19-related|0|||
94256156|NCT00743275|322732811|FG000|Overall Study|Protocol Violation|0|||
94256157|NCT00743275|322732812|FG001|Overall Study|Protocol Violation|1|||
94256158|NCT02594163|322732815|FG000|Treatment Period|Progressive disease|2|||
94256159|NCT02594163|322732816|FG001|Treatment Period|Progressive disease|3|||
94256160|NCT02594163|322732815|FG000|Treatment Period|Adverse Event|1|||
94256161|NCT02594163|322732816|FG001|Treatment Period|Adverse Event|5|||
94256162|NCT02594163|322732815|FG000|Treatment Period|Physician Decision|1|||
94256163|NCT02594163|322732816|FG001|Treatment Period|Physician Decision|3|||
94256164|NCT02594163|322732815|FG000|Treatment Period|Study termination by sponsor|2|||
94256165|NCT02594163|322732816|FG001|Treatment Period|Study termination by sponsor|1|||
94256166|NCT02594163|322732815|FG000|Treatment Period|Other, Non-AE|1|||
94256167|NCT02594163|322732816|FG001|Treatment Period|Other, Non-AE|0|||
94256168|NCT02594163|322732815|FG000|Follow-up Period|Withdrawal by Subject|0|||
94256169|NCT02594163|322732816|FG001|Follow-up Period|Withdrawal by Subject|1|||
94256170|NCT02594163|322732815|FG000|Follow-up Period|Study Termination by Sponsor|6|||
94256171|NCT02594163|322732816|FG001|Follow-up Period|Study Termination by Sponsor|4|||
94256172|NCT02594163|322732815|FG000|Follow-up Period|Lost to Follow-up|1|||
94256173|NCT02594163|322732816|FG001|Follow-up Period|Lost to Follow-up|0|||
94256174|NCT02594163|322732815|FG000|Follow-up Period|Death|2|||
94256175|NCT02594163|322732816|FG001|Follow-up Period|Death|5|||
94256176|NCT02594163|322732815|FG000|Follow-up Period|Adverse Event|0|||
94256177|NCT02594163|322732816|FG001|Follow-up Period|Adverse Event|1|||
94256178|NCT02594163|322732815|FG000|Follow-up Period|Progressive Disease|2|||
94256179|NCT02594163|322732816|FG001|Follow-up Period|Progressive Disease|0|||
94256180|NCT02594163|322732815|FG000|Follow-up Period|Physician Decision|0|||
94256181|NCT02594163|322732816|FG001|Follow-up Period|Physician Decision|1|||
94256182|NCT00117845|322732819|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
94256183|NCT01076192|322732822|FG000|Overall Study|Other|197|||
94256184|NCT02795429|322732823|FG000|Overall Study|Adverse Event|1|||
94256185|NCT02795429|322732824|FG001|Overall Study|Adverse Event|2|||
94256186|NCT02795429|322732825|FG002|Overall Study|Adverse Event|1|||
94256187|NCT02795429|322732826|FG003|Overall Study|Adverse Event|2|||
94628524|NCT04557371|324097987|FG000|Overall Study|Withdrawal by Subject|0|||
94628525|NCT04557371|324097988|FG001|Overall Study|Withdrawal by Subject|1|||
94628526|NCT04557371|324097989|FG002|Overall Study|Withdrawal by Subject|0|||
94628527|NCT04557371|324097987|FG000|Overall Study|Adverse Event|1|||
94628528|NCT04557371|324097988|FG001|Overall Study|Adverse Event|0|||
94628529|NCT04557371|324097989|FG002|Overall Study|Adverse Event|0|||
94256188|NCT02795429|322732827|FG004|Overall Study|Adverse Event|1|||
94256189|NCT02795429|322732823|FG000|Overall Study|Death|1|||
94256190|NCT02795429|322732824|FG001|Overall Study|Death|0|||
94256191|NCT02795429|322732825|FG002|Overall Study|Death|1|||
94360531|NCT00471237|323103843|FG005|Overall Study|Administration of prohibited medicine|0|||
94628530|NCT03694821|324097990|FG000|Overall Study|Study terminated|4|||
94628531|NCT03694821|324097991|FG001|Overall Study|Study terminated|8|||
94256192|NCT02795429|322732826|FG003|Overall Study|Death|2|||
94256193|NCT02795429|322732827|FG004|Overall Study|Death|1|||
94256194|NCT02795429|322732823|FG000|Overall Study|Physician Decision|0|||
94256195|NCT02795429|322732824|FG001|Overall Study|Physician Decision|0|||
94256196|NCT02795429|322732825|FG002|Overall Study|Physician Decision|2|||
94256197|NCT02795429|322732826|FG003|Overall Study|Physician Decision|1|||
94256198|NCT02795429|322732827|FG004|Overall Study|Physician Decision|5|||
94256199|NCT02795429|322732823|FG000|Overall Study|Progressive disease|3|||
94256200|NCT02795429|322732824|FG001|Overall Study|Progressive disease|7|||
94256201|NCT02795429|322732825|FG002|Overall Study|Progressive disease|6|||
94256202|NCT02795429|322732826|FG003|Overall Study|Progressive disease|26|||
94256203|NCT02795429|322732827|FG004|Overall Study|Progressive disease|20|||
94256204|NCT02795429|322732823|FG000|Overall Study|Subject/guardian decision|1|||
94256205|NCT02795429|322732824|FG001|Overall Study|Subject/guardian decision|1|||
94256206|NCT02795429|322732825|FG002|Overall Study|Subject/guardian decision|1|||
94256207|NCT02795429|322732826|FG003|Overall Study|Subject/guardian decision|1|||
94256208|NCT02795429|322732827|FG004|Overall Study|Subject/guardian decision|3|||
94256209|NCT03064035|322732828|FG000|Overall Study|Did not receive allocated intervention|4|||
94256210|NCT03064035|322732829|FG001|Overall Study|Did not receive allocated intervention|2|||
94256211|NCT03064035|322732828|FG000|Overall Study|Lost to Follow-up|1|||
94628532|NCT03694821|324097992|FG002|Overall Study|Study terminated|4|||
94628533|NCT00750204|324097995|FG000|Overall Study|study halted prematurely|1|||
94628534|NCT00750204|324097996|FG001|Overall Study|study halted prematurely|1|||
94628535|NCT00662363|324097997|FG000|Overall Study|Withdrawal by Subject|6|||
94628536|NCT00662363|324097998|FG001|Overall Study|Withdrawal by Subject|5|||
94628537|NCT00662363|324097997|FG000|Overall Study|Adverse Event|0|||
94628538|NCT00662363|324097998|FG001|Overall Study|Adverse Event|3|||
94628539|NCT00662363|324097997|FG000|Overall Study|Discharged early from rehab|4|||
94628540|NCT00662363|324097998|FG001|Overall Study|Discharged early from rehab|1|||
94628541|NCT00662363|324097997|FG000|Overall Study|Protocol Violation|1|||
94628542|NCT00662363|324097998|FG001|Overall Study|Protocol Violation|1|||
94628543|NCT03789318|324097999|FG000|Overall Study|Adverse Event|0|||
94628544|NCT03789318|324098000|FG001|Overall Study|Adverse Event|0|||
94628545|NCT03789318|324098001|FG002|Overall Study|Adverse Event|1|||
94628546|NCT03789318|324098002|FG003|Overall Study|Adverse Event|1|||
94628547|NCT03789318|324098003|FG004|Overall Study|Adverse Event|0|||
94628548|NCT03789318|324097999|FG000|Overall Study|Lost to Follow-up|0|||
94628549|NCT03789318|324098000|FG001|Overall Study|Lost to Follow-up|0|||
94628550|NCT03789318|324098001|FG002|Overall Study|Lost to Follow-up|1|||
94628551|NCT03789318|324098002|FG003|Overall Study|Lost to Follow-up|0|||
94628552|NCT03789318|324098003|FG004|Overall Study|Lost to Follow-up|0|||
94628553|NCT03789318|324097999|FG000|Overall Study|Withdrawal by Subject|0|||
94628554|NCT03789318|324098000|FG001|Overall Study|Withdrawal by Subject|0|||
94628555|NCT03789318|324098001|FG002|Overall Study|Withdrawal by Subject|1|||
94628556|NCT03789318|324098002|FG003|Overall Study|Withdrawal by Subject|0|||
94628557|NCT03789318|324098003|FG004|Overall Study|Withdrawal by Subject|0|||
94628558|NCT01535053|324098004|FG000|Overall Study|Ineligible|1|||
94628559|NCT01535053|324098005|FG001|Overall Study|Ineligible|2|||
94628560|NCT00512707|324098006|FG000|Overall Study|Lost to Follow-up|5|||
94628561|NCT00512707|324098007|FG001|Overall Study|Lost to Follow-up|11|||
94628562|NCT00512707|324098006|FG000|Overall Study|Developed skin irritation|2|||
94628563|NCT00512707|324098007|FG001|Overall Study|Developed skin irritation|1|||
94628564|NCT00512707|324098006|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
94628565|NCT00512707|324098007|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
94628566|NCT00512707|324098006|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
94628567|NCT00512707|324098007|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
94628568|NCT03700671|324098008|FG000|Overall Study|Lack of Efficacy|1|||
94628569|NCT03700671|324098009|FG001|Overall Study|Lack of Efficacy|2|||
94628570|NCT02879305|324098010|FG000|Overall Study|Investigator Site Closed|55|||
94628571|NCT02879305|324098011|FG001|Overall Study|Investigator Site Closed|57|||
94628572|NCT02879305|324098010|FG000|Overall Study|Withdrawal by Subject|44|||
94628573|NCT02879305|324098011|FG001|Overall Study|Withdrawal by Subject|42|||
94628574|NCT02879305|324098010|FG000|Overall Study|Lost to Follow-up|17|||
94628575|NCT02879305|324098011|FG001|Overall Study|Lost to Follow-up|12|||
94628576|NCT02879305|324098010|FG000|Overall Study|Other|1|||
94628577|NCT02879305|324098011|FG001|Overall Study|Other|0|||
94628578|NCT04203238|324100263|FG000|Overall Study|Withdrawal by Subject|1|||
94628579|NCT04203238|324100264|FG001|Overall Study|Withdrawal by Subject|1|||
94628580|NCT04203238|324100263|FG000|Overall Study|Covid-19|3|||
94628581|NCT04203238|324100264|FG001|Overall Study|Covid-19|0|||
94628582|NCT00733408|324100265|FG000|Overall Study|Adverse Event|4|||
94628583|NCT02329730|324100266|FG000|Overall Study|Protocol Violation|0|||
94628584|NCT02329730|324100267|FG001|Overall Study|Protocol Violation|0|||
94628585|NCT02329730|324100268|FG002|Overall Study|Protocol Violation|0|||
94628586|NCT02329730|324100269|FG003|Overall Study|Protocol Violation|0|||
94628587|NCT02329730|324100270|FG004|Overall Study|Protocol Violation|2|||
94674903|NCT00549757|324263163|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
94674904|NCT00549757|324263164|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
94674905|NCT01197508|324263167|FG000|Overall Study|Withdrawal by Subject|8|||
94674906|NCT01197508|324263168|FG001|Overall Study|Withdrawal by Subject|7|||
94674907|NCT01197508|324263169|FG002|Overall Study|Withdrawal by Subject|15|||
94674908|NCT01197508|324263170|FG003|Overall Study|Withdrawal by Subject|4|||
94256212|NCT03064035|322732829|FG001|Overall Study|Lost to Follow-up|1|||
94256213|NCT00706433|322732830|FG000|Overall Study|Lost to Follow-up|3|||
94256214|NCT00706433|322732831|FG001|Overall Study|Lost to Follow-up|1|||
94256215|NCT00706433|322732832|FG002|Overall Study|Lost to Follow-up|6|||
94256216|NCT00706433|322732833|FG003|Overall Study|Lost to Follow-up|0|||
94256217|NCT00706433|322732830|FG000|Overall Study|Withdrawal by Subject|1|||
94256218|NCT00706433|322732831|FG001|Overall Study|Withdrawal by Subject|2|||
94256219|NCT00706433|322732832|FG002|Overall Study|Withdrawal by Subject|3|||
94256220|NCT00706433|322732833|FG003|Overall Study|Withdrawal by Subject|1|||
94256221|NCT00706433|322732830|FG000|Overall Study|Adverse Event|0|||
94256222|NCT00706433|322732831|FG001|Overall Study|Adverse Event|0|||
94256223|NCT00706433|322732832|FG002|Overall Study|Adverse Event|1|||
94628588|NCT02329730|324100271|FG005|Overall Study|Protocol Violation|2|||
94628589|NCT02329730|324100272|FG006|Overall Study|Protocol Violation|0|||
94628590|NCT02329730|324100273|FG007|Overall Study|Protocol Violation|0|||
94628591|NCT02329730|324100274|FG008|Overall Study|Protocol Violation|0|||
94628592|NCT02329730|324100275|FG009|Overall Study|Protocol Violation|0|||
94628593|NCT02329730|324100276|FG010|Overall Study|Protocol Violation|0|||
94628594|NCT02329730|324100277|FG011|Overall Study|Protocol Violation|0|||
94628595|NCT02329730|324100266|FG000|Overall Study|Withdrawal by Subject|0|||
94628596|NCT02329730|324100267|FG001|Overall Study|Withdrawal by Subject|0|||
94256224|NCT00706433|322732833|FG003|Overall Study|Adverse Event|0|||
94360532|NCT00471237|323103844|FG006|Overall Study|Administration of prohibited medicine|0|||
94628597|NCT02329730|324100268|FG002|Overall Study|Withdrawal by Subject|0|||
94628598|NCT02329730|324100269|FG003|Overall Study|Withdrawal by Subject|0|||
94628599|NCT02329730|324100270|FG004|Overall Study|Withdrawal by Subject|1|||
94628600|NCT02329730|324100271|FG005|Overall Study|Withdrawal by Subject|0|||
94628601|NCT02329730|324100272|FG006|Overall Study|Withdrawal by Subject|1|||
94628602|NCT02329730|324100273|FG007|Overall Study|Withdrawal by Subject|1|||
94628603|NCT02329730|324100274|FG008|Overall Study|Withdrawal by Subject|1|||
94628604|NCT02329730|324100275|FG009|Overall Study|Withdrawal by Subject|1|||
94628605|NCT02329730|324100276|FG010|Overall Study|Withdrawal by Subject|0|||
94628606|NCT02329730|324100277|FG011|Overall Study|Withdrawal by Subject|0|||
94628607|NCT00996216|324100286|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
94628608|NCT00996216|324100286|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
94628609|NCT00996216|324100286|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
94628610|NCT02345850|324100287|FG000|Overall Study|Not transplanted|10|||
94628611|NCT02345850|324100288|FG001|Overall Study|Not transplanted|5|||
94628612|NCT02345850|324100289|FG002|Overall Study|Not transplanted|4|||
94628613|NCT02345850|324100287|FG000|Overall Study|Lost to Follow-up|2|||
94628614|NCT02345850|324100288|FG001|Overall Study|Lost to Follow-up|3|||
94628615|NCT02345850|324100289|FG002|Overall Study|Lost to Follow-up|2|||
94628616|NCT02345850|324100287|FG000|Overall Study|Withdrawal by Subject|1|||
94628617|NCT02345850|324100288|FG001|Overall Study|Withdrawal by Subject|0|||
94628618|NCT02345850|324100289|FG002|Overall Study|Withdrawal by Subject|0|||
94628619|NCT04160091|324100294|FG000|Overall Study|Terminated by Sponsor|7|||
94628620|NCT04160091|324100295|FG001|Overall Study|Terminated by Sponsor|3|||
94628621|NCT04160091|324100296|FG002|Overall Study|Terminated by Sponsor|5|||
94628622|NCT04160091|324100297|FG003|Overall Study|Terminated by Sponsor|2|||
94628623|NCT04160091|324100294|FG000|Overall Study|Noncompliance|0|||
94628624|NCT04160091|324100295|FG001|Overall Study|Noncompliance|0|||
94628625|NCT04160091|324100296|FG002|Overall Study|Noncompliance|0|||
94628626|NCT04160091|324100297|FG003|Overall Study|Noncompliance|1|||
94628627|NCT04160091|324100294|FG000|Overall Study|Withdrawal by Subject|0|||
94628628|NCT04160091|324100295|FG001|Overall Study|Withdrawal by Subject|0|||
94628629|NCT04160091|324100296|FG002|Overall Study|Withdrawal by Subject|0|||
94628630|NCT04160091|324100297|FG003|Overall Study|Withdrawal by Subject|1|||
94628631|NCT00464087|324100298|FG000|Overall Study|No PCI per inclusion criteria|0|||
94628632|NCT00464087|324100299|FG001|Overall Study|No PCI per inclusion criteria|0|||
94628633|NCT00464087|324100300|FG002|Overall Study|No PCI per inclusion criteria|29|||
94628634|NCT00609492|324100302|FG000|Overall Study|Withdrawal by Subject|0|||
94628635|NCT00609492|324100303|FG001|Overall Study|Withdrawal by Subject|2|||
94628636|NCT00609492|324100304|FG002|Overall Study|Withdrawal by Subject|3|||
94628637|NCT00609492|324100302|FG000|Overall Study|Lost to Follow-up|1|||
94628638|NCT00609492|324100303|FG001|Overall Study|Lost to Follow-up|1|||
94628639|NCT00609492|324100304|FG002|Overall Study|Lost to Follow-up|4|||
94628640|NCT00720434|324100305|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
94628641|NCT00720434|324100306|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
94628642|NCT00720434|324100307|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
94628643|NCT00720434|324100308|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
94628644|NCT00720434|324100305|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
94628645|NCT00720434|324100306|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
94628646|NCT00720434|324100307|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
94628647|NCT00720434|324100308|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
94628648|NCT00720434|324100305|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
94628649|NCT00720434|324100306|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
94628650|NCT00720434|324100307|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
94628651|NCT00720434|324100308|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
94628652|NCT00720434|324100305|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
94628653|NCT00720434|324100306|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
94628654|NCT00720434|324100307|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
94360533|NCT00471237|323103838|FG000|Overall Study|Participant shifted residence|0|||
94256225|NCT00706433|322732830|FG000|Overall Study|Protocol Violation|1|||
94256226|NCT00706433|322732831|FG001|Overall Study|Protocol Violation|0|||
94256227|NCT00706433|322732832|FG002|Overall Study|Protocol Violation|0|||
94256228|NCT00706433|322732833|FG003|Overall Study|Protocol Violation|0|||
94256229|NCT00706433|322732830|FG000|Overall Study|new job|0|||
94256230|NCT00706433|322732831|FG001|Overall Study|new job|0|||
94256231|NCT00706433|322732832|FG002|Overall Study|new job|0|||
94256232|NCT00706433|322732833|FG003|Overall Study|new job|1|||
94256233|NCT01174160|322732834|FG000|Overall Study|Adverse Event|1|||
94256234|NCT01174160|322732835|FG001|Overall Study|Adverse Event|0|||
94256235|NCT01174160|322732834|FG000|Overall Study|Lost to Follow-up|1|||
94256236|NCT01174160|322732835|FG001|Overall Study|Lost to Follow-up|0|||
94256237|NCT01174160|322732834|FG000|Overall Study|Physician Decision|1|||
94256238|NCT01174160|322732835|FG001|Overall Study|Physician Decision|0|||
94256239|NCT01174160|322732834|FG000|Overall Study|Protocol Violation|4|||
94256240|NCT01174160|322732835|FG001|Overall Study|Protocol Violation|6|||
94256241|NCT01174160|322732834|FG000|Overall Study|Withdrawal by Subject|1|||
94256242|NCT01174160|322732835|FG001|Overall Study|Withdrawal by Subject|0|||
94256243|NCT01347762|322732836|FG000|Overall Study|Lost to Follow-up|0|||
94256244|NCT01347762|322732837|FG001|Overall Study|Lost to Follow-up|1|||
94256245|NCT01347762|322732838|FG002|Overall Study|Lost to Follow-up|6|||
94256246|NCT01347762|322732839|FG003|Overall Study|Lost to Follow-up|5|||
94256247|NCT01347762|322732836|FG000|Overall Study|Withdrawal by Subject|4|||
94360534|NCT00471237|323103839|FG001|Overall Study|Participant shifted residence|0|||
94628655|NCT00720434|324100308|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
94628656|NCT00720434|324100305|FG000|Open-Label Period (Week 5-72)|Other|4|||
94628657|NCT00720434|324100306|FG001|Open-Label Period (Week 5-72)|Other|3|||
94628658|NCT00720434|324100307|FG002|Open-Label Period (Week 5-72)|Other|3|||
94628659|NCT00720434|324100308|FG003|Open-Label Period (Week 5-72)|Other|2|||
94628660|NCT00754624|324100309|FG000|Overall Study|Adverse Event|16|||
94628661|NCT00754624|324100309|FG000|Overall Study|Death|1|||
94628662|NCT00754624|324100309|FG000|Overall Study|Physician Decision|8|||
94628663|NCT00754624|324100309|FG000|Overall Study|Protocol Violation|1|||
94628664|NCT00754624|324100309|FG000|Overall Study|Withdrawal by Subject|28|||
94628665|NCT00754624|324100309|FG000|Overall Study|Various|12|||
94628666|NCT00754624|324100309|FG000|Overall Study|Lost to Follow-up|3|||
94628667|NCT02425046|324100310|FG000|Overall Study|Lost to Follow-up|52|||
94628668|NCT02425046|324100311|FG001|Overall Study|Lost to Follow-up|50|||
94628669|NCT02425046|324100312|FG002|Overall Study|Lost to Follow-up|56|||
94628670|NCT02425046|324100310|FG000|Overall Study|Withdrawal by Subject|16|||
94628671|NCT02425046|324100311|FG001|Overall Study|Withdrawal by Subject|12|||
94628672|NCT02425046|324100312|FG002|Overall Study|Withdrawal by Subject|0|||
94628673|NCT01599234|324100316|FG000|Overall Study|Adverse Event|9|||
94628674|NCT01599234|324100317|FG001|Overall Study|Adverse Event|5|||
94628675|NCT01599234|324100316|FG000|Overall Study|Withdrawal by Subject|2|||
94628676|NCT01599234|324100317|FG001|Overall Study|Withdrawal by Subject|1|||
94628677|NCT01599234|324100316|FG000|Overall Study|Lost to Follow-up|1|||
94628678|NCT01599234|324100317|FG001|Overall Study|Lost to Follow-up|2|||
94628679|NCT01599234|324100316|FG000|Overall Study|Lack of Efficacy|2|||
94628680|NCT01599234|324100317|FG001|Overall Study|Lack of Efficacy|4|||
94628681|NCT01599234|324100316|FG000|Overall Study|Unable to operate spray|1|||
94628682|NCT01599234|324100317|FG001|Overall Study|Unable to operate spray|0|||
94628683|NCT01599234|324100316|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
94628684|NCT01599234|324100317|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
94628685|NCT01599234|324100316|FG000|Overall Study|Death|1|||
94628686|NCT01599234|324100317|FG001|Overall Study|Death|0|||
94628687|NCT01599234|324100316|FG000|Overall Study|Patient would not stop driving|1|||
94628688|NCT01599234|324100317|FG001|Overall Study|Patient would not stop driving|0|||
94628689|NCT01599234|324100316|FG000|Overall Study|Contra-indication discovered|0|||
94628690|NCT01599234|324100317|FG001|Overall Study|Contra-indication discovered|1|||
94256248|NCT01347762|322732837|FG001|Overall Study|Withdrawal by Subject|1|||
94628691|NCT01599234|324100316|FG000|Overall Study|Pregnancy|0|||
94628692|NCT01599234|324100317|FG001|Overall Study|Pregnancy|1|||
94628693|NCT04492618|324100324|FG000|Overall Study|Withdrawal by Subject|1|||
94256249|NCT01347762|322732838|FG002|Overall Study|Withdrawal by Subject|3|||
94256250|NCT01347762|322732839|FG003|Overall Study|Withdrawal by Subject|3|||
94256251|NCT03406260|322732840|FG000|Period 1|Adverse Event|0|||
94256252|NCT03406260|322732841|FG001|Period 1|Adverse Event|0|||
94360535|NCT00471237|323103840|FG002|Overall Study|Participant shifted residence|0|||
94628694|NCT03585504|324100327|FG000|Overall Study|Lost to Follow-up|26|||
94628695|NCT03585504|324100328|FG001|Overall Study|Lost to Follow-up|29|||
94256253|NCT03406260|322732842|FG002|Period 1|Adverse Event|0|||
94256254|NCT03406260|322732843|FG003|Period 1|Adverse Event|0|||
94360536|NCT00471237|323103841|FG003|Overall Study|Participant shifted residence|0|||
94628696|NCT01414114|324100329|FG000|Overall Study|Adverse Event|2|||
94628697|NCT01414114|324100329|FG000|Overall Study|Withdrawal by Subject|1|||
94628698|NCT01414114|324100329|FG000|Overall Study|Other|2|||
94628699|NCT00460408|324100335|FG000|Overall Study|Adverse Event|1|||
94628700|NCT00460408|324100336|FG001|Overall Study|Adverse Event|0|||
94360537|NCT00471237|323103842|FG004|Overall Study|Participant shifted residence|1|||
94360538|NCT00471237|323103843|FG005|Overall Study|Participant shifted residence|0|||
94360539|NCT00471237|323103844|FG006|Overall Study|Participant shifted residence|0|||
94360540|NCT00471237|323103838|FG000|Overall Study|Participant's decision|0|||
94360541|NCT00471237|323103839|FG001|Overall Study|Participant's decision|0|||
94360542|NCT00471237|323103840|FG002|Overall Study|Participant's decision|0|||
94360543|NCT00471237|323103841|FG003|Overall Study|Participant's decision|0|||
94360544|NCT00471237|323103842|FG004|Overall Study|Participant's decision|0|||
94360545|NCT00471237|323103843|FG005|Overall Study|Participant's decision|1|||
94360546|NCT00471237|323103844|FG006|Overall Study|Participant's decision|0|||
94360547|NCT00924313|323103847|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
94360548|NCT01298362|323103848|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
94360549|NCT01298362|323103849|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
94360550|NCT01317199|323103852|FG000|Dose-escalation Phase 1|Physician Decision|5|||
94360551|NCT01317199|323103853|FG001|Dose-escalation Phase 1|Physician Decision|0|||
94360552|NCT01317199|323103854|FG002|Dose-escalation Phase 1|Physician Decision|0|||
94360553|NCT01317199|323103855|FG003|Dose-escalation Phase 1|Physician Decision|0|||
94360554|NCT01317199|323103852|FG000|Dose-escalation Phase 1|Disease progression|1|||
94360555|NCT01317199|323103853|FG001|Dose-escalation Phase 1|Disease progression|0|||
94360556|NCT01317199|323103854|FG002|Dose-escalation Phase 1|Disease progression|0|||
94360557|NCT01317199|323103855|FG003|Dose-escalation Phase 1|Disease progression|0|||
94360558|NCT01317199|323103852|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
94360559|NCT01317199|323103853|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
94360560|NCT01317199|323103854|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
94360561|NCT01317199|323103855|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
94360562|NCT01317199|323103852|FG000|Randomized Phase 2|Disease progression|0|||
94360563|NCT01317199|323103853|FG001|Randomized Phase 2|Disease progression|3|||
94360564|NCT01317199|323103854|FG002|Randomized Phase 2|Disease progression|7|||
94360565|NCT01317199|323103855|FG003|Randomized Phase 2|Disease progression|5|||
94360566|NCT01317199|323103852|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
94360567|NCT01317199|323103853|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
94360568|NCT01317199|323103854|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
94360569|NCT01317199|323103855|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
94360570|NCT01317199|323103852|FG000|Randomized Phase 2|Adverse Event|0|||
94360571|NCT01317199|323103853|FG001|Randomized Phase 2|Adverse Event|0|||
94360572|NCT01317199|323103854|FG002|Randomized Phase 2|Adverse Event|0|||
94360573|NCT01317199|323103855|FG003|Randomized Phase 2|Adverse Event|1|||
94360574|NCT01317199|323103852|FG000|Randomized Phase 2|Comorbidities|0|||
94360575|NCT01317199|323103853|FG001|Randomized Phase 2|Comorbidities|2|||
94360576|NCT01317199|323103854|FG002|Randomized Phase 2|Comorbidities|2|||
94360577|NCT01317199|323103855|FG003|Randomized Phase 2|Comorbidities|2|||
94360578|NCT01317199|323103852|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
94360579|NCT01317199|323103853|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
94360580|NCT01317199|323103854|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
94360581|NCT01317199|323103855|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
94360582|NCT01317199|323103852|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
94360583|NCT01317199|323103853|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
94360584|NCT01317199|323103854|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
94360585|NCT01317199|323103855|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
94360586|NCT01317199|323103852|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
94360587|NCT01317199|323103853|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
94360588|NCT01317199|323103854|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
94360589|NCT01317199|323103855|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
94628701|NCT00460408|324100337|FG002|Overall Study|Adverse Event|0|||
94628702|NCT00460408|324100338|FG003|Overall Study|Adverse Event|0|||
94628703|NCT00460408|324100335|FG000|Overall Study|Death|7|||
94628704|NCT00460408|324100336|FG001|Overall Study|Death|0|||
94628705|NCT00460408|324100337|FG002|Overall Study|Death|0|||
94628706|NCT00460408|324100338|FG003|Overall Study|Death|0|||
94628707|NCT00460408|324100335|FG000|Overall Study|Lost to Follow-up|11|||
94628708|NCT00460408|324100336|FG001|Overall Study|Lost to Follow-up|0|||
94628709|NCT00460408|324100337|FG002|Overall Study|Lost to Follow-up|1|||
94628710|NCT00460408|324100338|FG003|Overall Study|Lost to Follow-up|0|||
94628711|NCT00460408|324100335|FG000|Overall Study|Withdrawal by Subject|31|||
94360590|NCT01317199|323103852|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
94360591|NCT01317199|323103853|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
94360592|NCT01317199|323103854|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
94628712|NCT00460408|324100336|FG001|Overall Study|Withdrawal by Subject|0|||
94628713|NCT00460408|324100337|FG002|Overall Study|Withdrawal by Subject|0|||
94360593|NCT01317199|323103855|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
94360594|NCT02684370|323103856|FG000|Part A|Adverse Event|2|||
94628714|NCT00460408|324100338|FG003|Overall Study|Withdrawal by Subject|0|||
94628715|NCT00460408|324100335|FG000|Overall Study|Insufficient clinical response|5|||
94360595|NCT02684370|323103857|FG001|Part A|Adverse Event|0|||
94360596|NCT02684370|323103858|FG002|Part A|Adverse Event|1|||
94628716|NCT00460408|324100336|FG001|Overall Study|Insufficient clinical response|1|||
94360597|NCT02684370|323103859|FG003|Part A|Adverse Event|0|||
94360598|NCT02684370|323103860|FG004|Part A|Adverse Event|0|||
94360599|NCT02684370|323103861|FG005|Part A|Adverse Event|0|||
94360600|NCT02684370|323103856|FG000|Part A|Lost to Follow-up|1|||
94360601|NCT02684370|323103857|FG001|Part A|Lost to Follow-up|1|||
94360602|NCT02684370|323103858|FG002|Part A|Lost to Follow-up|0|||
94360603|NCT02684370|323103859|FG003|Part A|Lost to Follow-up|0|||
94360604|NCT02684370|323103860|FG004|Part A|Lost to Follow-up|0|||
94360605|NCT02684370|323103861|FG005|Part A|Lost to Follow-up|0|||
94360606|NCT02684370|323103856|FG000|Part A|Subject Withdrawal|1|||
94360607|NCT02684370|323103857|FG001|Part A|Subject Withdrawal|0|||
94360608|NCT02684370|323103858|FG002|Part A|Subject Withdrawal|3|||
94360609|NCT02684370|323103859|FG003|Part A|Subject Withdrawal|0|||
94360610|NCT02684370|323103860|FG004|Part A|Subject Withdrawal|0|||
94360611|NCT02684370|323103861|FG005|Part A|Subject Withdrawal|0|||
94360612|NCT02684370|323103856|FG000|Part A|Other|0|||
94360613|NCT02684370|323103857|FG001|Part A|Other|0|||
94360614|NCT02684370|323103858|FG002|Part A|Other|1|||
94360615|NCT02684370|323103859|FG003|Part A|Other|0|||
94360616|NCT02684370|323103860|FG004|Part A|Other|0|||
94360617|NCT02684370|323103861|FG005|Part A|Other|0|||
94360618|NCT02684370|323103856|FG000|Part B|Adverse Event|0|||
94360619|NCT02684370|323103857|FG001|Part B|Adverse Event|0|||
94360620|NCT02684370|323103858|FG002|Part B|Adverse Event|0|||
94360621|NCT02684370|323103859|FG003|Part B|Adverse Event|0|||
94628717|NCT00460408|324100337|FG002|Overall Study|Insufficient clinical response|5|||
94628718|NCT00460408|324100338|FG003|Overall Study|Insufficient clinical response|0|||
94628719|NCT00460408|324100335|FG000|Overall Study|Other|12|||
94628720|NCT00460408|324100336|FG001|Overall Study|Other|2|||
94628721|NCT00460408|324100337|FG002|Overall Study|Other|0|||
94628722|NCT00460408|324100338|FG003|Overall Study|Other|0|||
94628723|NCT00865124|324100339|FG000|Overall Study|Physician Decision|2|||
94628724|NCT00865124|324100340|FG001|Overall Study|Physician Decision|1|||
94628725|NCT00865124|324100341|FG002|Overall Study|Physician Decision|0|||
94628726|NCT00865124|324100339|FG000|Overall Study|Withdrawn consent|2|||
94628727|NCT00865124|324100340|FG001|Overall Study|Withdrawn consent|0|||
94628728|NCT00865124|324100341|FG002|Overall Study|Withdrawn consent|0|||
94628729|NCT00545168|324100348|FG000|Overall Study|Lost to Follow-up|5|||
94628730|NCT00545168|324100349|FG001|Overall Study|Lost to Follow-up|5|||
94628731|NCT00545168|324100350|FG002|Overall Study|Lost to Follow-up|5|||
94628732|NCT00545168|324100348|FG000|Overall Study|Withdrawal by Subject|9|||
94628733|NCT00545168|324100349|FG001|Overall Study|Withdrawal by Subject|0|||
94628734|NCT00545168|324100350|FG002|Overall Study|Withdrawal by Subject|13|||
94628735|NCT00545168|324100348|FG000|Overall Study|Protocol Violation|1|||
94628736|NCT00545168|324100349|FG001|Overall Study|Protocol Violation|0|||
94628737|NCT00545168|324100350|FG002|Overall Study|Protocol Violation|1|||
94628738|NCT00545168|324100348|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
94628739|NCT00545168|324100349|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
94628740|NCT00545168|324100350|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
94628741|NCT02708121|324100351|FG000|Overall Study|Withdrawn by Study Team|1|||
94628742|NCT02708121|324100352|FG001|Overall Study|Withdrawn by Study Team|1|||
94628743|NCT02708121|324100351|FG000|Overall Study|Withdrawal by Subject|0|||
94628744|NCT02708121|324100352|FG001|Overall Study|Withdrawal by Subject|4|||
94628745|NCT01749514|324100355|FG000|Overall Study|Lost to Follow-up|0|||
94628746|NCT01749514|324100356|FG001|Overall Study|Lost to Follow-up|0|||
94628747|NCT01749514|324100357|FG002|Overall Study|Lost to Follow-up|0|||
94628748|NCT01749514|324100358|FG003|Overall Study|Lost to Follow-up|0|||
94628749|NCT01749514|324100359|FG004|Overall Study|Lost to Follow-up|0|||
94628750|NCT01749514|324100360|FG005|Overall Study|Lost to Follow-up|0|||
94628751|NCT01749514|324100361|FG006|Overall Study|Lost to Follow-up|0|||
94360622|NCT02684370|323103860|FG004|Part B|Adverse Event|2|||
94360623|NCT02684370|323103861|FG005|Part B|Adverse Event|1|||
94360624|NCT02684370|323103856|FG000|Part B|Lost to Follow-up|0|||
94628752|NCT01749514|324100362|FG007|Overall Study|Lost to Follow-up|1|||
94628753|NCT01749514|324100355|FG000|Overall Study|Withdrawal by Subject|0|||
94628754|NCT01749514|324100356|FG001|Overall Study|Withdrawal by Subject|0|||
94360625|NCT02684370|323103857|FG001|Part B|Lost to Follow-up|0|||
94360626|NCT02684370|323103858|FG002|Part B|Lost to Follow-up|0|||
94360627|NCT02684370|323103859|FG003|Part B|Lost to Follow-up|1|||
94360628|NCT02684370|323103860|FG004|Part B|Lost to Follow-up|2|||
94360629|NCT02684370|323103861|FG005|Part B|Lost to Follow-up|5|||
94360630|NCT02684370|323103856|FG000|Part B|Subject Withdrawal|0|||
94360631|NCT02684370|323103857|FG001|Part B|Subject Withdrawal|0|||
94360632|NCT02684370|323103858|FG002|Part B|Subject Withdrawal|0|||
94360633|NCT02684370|323103859|FG003|Part B|Subject Withdrawal|1|||
94360634|NCT02684370|323103860|FG004|Part B|Subject Withdrawal|1|||
94360635|NCT02684370|323103861|FG005|Part B|Subject Withdrawal|2|||
94628755|NCT01749514|324100357|FG002|Overall Study|Withdrawal by Subject|0|||
94628756|NCT01749514|324100358|FG003|Overall Study|Withdrawal by Subject|0|||
94628757|NCT01749514|324100359|FG004|Overall Study|Withdrawal by Subject|0|||
94628758|NCT01749514|324100360|FG005|Overall Study|Withdrawal by Subject|1|||
94628759|NCT01749514|324100361|FG006|Overall Study|Withdrawal by Subject|0|||
94628760|NCT01749514|324100362|FG007|Overall Study|Withdrawal by Subject|1|||
94628761|NCT01749514|324100355|FG000|Overall Study|Not Reported|0|||
94628762|NCT01749514|324100356|FG001|Overall Study|Not Reported|0|||
94628763|NCT01749514|324100357|FG002|Overall Study|Not Reported|0|||
94628764|NCT01749514|324100358|FG003|Overall Study|Not Reported|0|||
94628765|NCT01749514|324100359|FG004|Overall Study|Not Reported|0|||
94628766|NCT01749514|324100360|FG005|Overall Study|Not Reported|0|||
94628767|NCT01749514|324100361|FG006|Overall Study|Not Reported|0|||
94628768|NCT01749514|324100362|FG007|Overall Study|Not Reported|5|||
94628769|NCT04649060|324100365|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
94628770|NCT04649060|324100366|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
94628771|NCT04649060|324100365|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
94628772|NCT04649060|324100366|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
94628773|NCT04649060|324100365|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
94628774|NCT04649060|324100366|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
94628775|NCT04649060|324100365|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
94628776|NCT04649060|324100366|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
94628777|NCT04649060|324100365|FG000|Arm A/Arm B Treatment|Patient Request|1|||
94628778|NCT04649060|324100366|FG001|Arm A/Arm B Treatment|Patient Request|0|||
94628779|NCT04649060|324100365|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
94628780|NCT04649060|324100366|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
94628781|NCT04649060|324100365|FG000|Arm A/Arm B Treatment|Other|1|||
94628782|NCT04649060|324100366|FG001|Arm A/Arm B Treatment|Other|0|||
94628783|NCT04649060|324100365|FG000|Crossover (Arm B)|Adverse Event|0|||
94628784|NCT04649060|324100366|FG001|Crossover (Arm B)|Adverse Event|1|||
94628785|NCT04649060|324100365|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
94628786|NCT04649060|324100366|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
94628787|NCT01402492|324100368|FG000|Overall Study|Withdrawal by Subject|17|||
94628788|NCT01402492|324100369|FG001|Overall Study|Withdrawal by Subject|11|||
94628789|NCT01402492|324100370|FG002|Overall Study|Withdrawal by Subject|11|||
94628790|NCT01402492|324100368|FG000|Overall Study|Adverse Event|2|||
94628791|NCT01402492|324100369|FG001|Overall Study|Adverse Event|3|||
94628792|NCT01402492|324100370|FG002|Overall Study|Adverse Event|4|||
94628793|NCT01402492|324100368|FG000|Overall Study|Physician Decision|0|||
94628794|NCT01402492|324100369|FG001|Overall Study|Physician Decision|3|||
94628795|NCT01402492|324100370|FG002|Overall Study|Physician Decision|0|||
94628796|NCT01402492|324100368|FG000|Overall Study|Incarcerated (N=3)|2|||
94628797|NCT01402492|324100369|FG001|Overall Study|Incarcerated (N=3)|0|||
94628798|NCT01402492|324100370|FG002|Overall Study|Incarcerated (N=3)|1|||
94628799|NCT01465997|324100377|FG000|Overall Study|Adverse Event|12|||
94628800|NCT01465997|324100378|FG001|Overall Study|Adverse Event|22|||
94628801|NCT01465997|324100377|FG000|Overall Study|Lack of Efficacy|13|||
94628802|NCT01465997|324100378|FG001|Overall Study|Lack of Efficacy|1|||
94628803|NCT01465997|324100377|FG000|Overall Study|Protocol Violation|1|||
94628804|NCT01465997|324100378|FG001|Overall Study|Protocol Violation|4|||
94628805|NCT01465997|324100377|FG000|Overall Study|Lost to Follow-up|6|||
94628806|NCT01465997|324100378|FG001|Overall Study|Lost to Follow-up|9|||
94628807|NCT01465997|324100377|FG000|Overall Study|Withdrawal by Subject|32|||
94628808|NCT01465997|324100378|FG001|Overall Study|Withdrawal by Subject|35|||
94628809|NCT01465997|324100377|FG000|Overall Study|investigator's decision|1|||
94628810|NCT01465997|324100378|FG001|Overall Study|investigator's decision|1|||
94628811|NCT01465997|324100377|FG000|Overall Study|Death|0|||
94628812|NCT01465997|324100378|FG001|Overall Study|Death|1|||
94628813|NCT01465997|324100377|FG000|Overall Study|sponsor's decision|1|||
94628814|NCT01465997|324100378|FG001|Overall Study|sponsor's decision|1|||
94628815|NCT01465997|324100377|FG000|Overall Study|subject withdrew consent|1|||
94628816|NCT01465997|324100378|FG001|Overall Study|subject withdrew consent|0|||
94628817|NCT01465997|324100377|FG000|Overall Study|local lab unblinded site|1|||
94628818|NCT01465997|324100378|FG001|Overall Study|local lab unblinded site|0|||
94628819|NCT01465997|324100377|FG000|Overall Study|withdrew before follow-up|0|||
94628820|NCT01465997|324100378|FG001|Overall Study|withdrew before follow-up|13|||
94628821|NCT01465997|324100377|FG000|Overall Study|decision by site staff|0|||
94628822|NCT01465997|324100378|FG001|Overall Study|decision by site staff|1|||
94628823|NCT01465997|324100377|FG000|Overall Study|subject left participation SP0993|0|||
94628824|NCT01465997|324100378|FG001|Overall Study|subject left participation SP0993|1|||
94628825|NCT03018704|324100379|FG000|Overall Study|Lost to Follow-up|1|||
94628826|NCT03018704|324100380|FG001|Overall Study|Lost to Follow-up|1|||
94674909|NCT01197508|324263167|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
94674910|NCT01197508|324263168|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
94256255|NCT03406260|322732844|FG004|Period 1|Adverse Event|1|||
94628827|NCT00642460|324100381|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
94628828|NCT00642460|324100382|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
94628829|NCT00642460|324100383|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
94628830|NCT00642460|324100384|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
94628831|NCT00642460|324100385|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
94628832|NCT00642460|324100386|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
94628833|NCT00642460|324100381|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
94628834|NCT00642460|324100382|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
94628835|NCT00642460|324100383|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
94628836|NCT00642460|324100384|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
94628837|NCT00642460|324100385|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
94628838|NCT00642460|324100386|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
94628839|NCT00642460|324100381|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
94628840|NCT00642460|324100382|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
94628841|NCT00642460|324100383|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
94628842|NCT00642460|324100384|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
94628843|NCT00642460|324100385|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
94628844|NCT00642460|324100386|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
94628845|NCT00642460|324100381|FG000|Part II: Open-Label Up to Week 92|Death|0|||
94628846|NCT00642460|324100382|FG001|Part II: Open-Label Up to Week 92|Death|1|||
94628847|NCT00642460|324100383|FG002|Part II: Open-Label Up to Week 92|Death|0|||
94628848|NCT00642460|324100384|FG003|Part II: Open-Label Up to Week 92|Death|2|||
94628849|NCT00642460|324100385|FG004|Part II: Open-Label Up to Week 92|Death|0|||
94628850|NCT00642460|324100386|FG005|Part II: Open-Label Up to Week 92|Death|0|||
94628851|NCT00642460|324100381|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
94628852|NCT00642460|324100382|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
94628853|NCT00642460|324100383|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
94628854|NCT00642460|324100384|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
94628855|NCT00642460|324100385|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
94628856|NCT00642460|324100386|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
94628857|NCT00642460|324100381|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
94628858|NCT00642460|324100382|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
94628859|NCT00642460|324100383|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
94628860|NCT00642460|324100384|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
94628861|NCT00642460|324100385|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
94628862|NCT00642460|324100386|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
94628863|NCT00642460|324100381|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
94628864|NCT00642460|324100382|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
94628865|NCT00642460|324100383|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
94628866|NCT00642460|324100384|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
94628867|NCT00642460|324100385|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
94628868|NCT00642460|324100386|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
94628869|NCT00642460|324100381|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
94628870|NCT00642460|324100382|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
94628871|NCT00642460|324100383|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
94674911|NCT01197508|324263169|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
94628872|NCT00642460|324100384|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
94360636|NCT00978120|323103865|FG000|Overall Study|Death|0|||
94360637|NCT00978120|323103866|FG001|Overall Study|Death|0|||
94360638|NCT00978120|323103867|FG002|Overall Study|Death|0|||
94628873|NCT00642460|324100385|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
94628874|NCT00642460|324100386|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
94628875|NCT00642460|324100381|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
94628876|NCT00642460|324100382|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
94628877|NCT00642460|324100383|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
94628878|NCT00642460|324100384|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
94628879|NCT00642460|324100385|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
94628880|NCT00642460|324100386|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
94628881|NCT00642460|324100381|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
94628882|NCT00642460|324100382|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
94628883|NCT00642460|324100383|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
94628884|NCT00642460|324100384|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
94628885|NCT00642460|324100385|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
94628886|NCT00642460|324100386|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
94628887|NCT00642460|324100381|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
94628888|NCT00642460|324100382|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
94628889|NCT00642460|324100383|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
94628890|NCT00642460|324100384|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
94628891|NCT00642460|324100385|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
94628892|NCT00642460|324100386|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
94628893|NCT00642460|324100381|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
94628894|NCT00642460|324100382|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
94628895|NCT00642460|324100383|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
94628896|NCT00642460|324100384|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
94628897|NCT00642460|324100385|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
94628898|NCT00642460|324100386|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
94628899|NCT00642460|324100381|FG000|Part III: Open-Label Up to Week 260|Other|0|||
94628900|NCT00642460|324100382|FG001|Part III: Open-Label Up to Week 260|Other|0|||
94628901|NCT00642460|324100383|FG002|Part III: Open-Label Up to Week 260|Other|0|||
94628902|NCT00642460|324100384|FG003|Part III: Open-Label Up to Week 260|Other|0|||
94628903|NCT00642460|324100385|FG004|Part III: Open-Label Up to Week 260|Other|2|||
94628904|NCT00642460|324100386|FG005|Part III: Open-Label Up to Week 260|Other|2|||
94628905|NCT00642460|324100381|FG000|Part III: Open-Label Up to Week 260|Death|0|||
94628906|NCT00642460|324100382|FG001|Part III: Open-Label Up to Week 260|Death|0|||
94628907|NCT00642460|324100383|FG002|Part III: Open-Label Up to Week 260|Death|0|||
94628908|NCT00642460|324100384|FG003|Part III: Open-Label Up to Week 260|Death|0|||
94628909|NCT00642460|324100385|FG004|Part III: Open-Label Up to Week 260|Death|0|||
94628910|NCT00642460|324100386|FG005|Part III: Open-Label Up to Week 260|Death|3|||
94628911|NCT00642460|324100381|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
94628912|NCT00642460|324100382|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
94628913|NCT00642460|324100383|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
94628914|NCT00642460|324100384|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
94628915|NCT00642460|324100385|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
94360639|NCT00978120|323103868|FG003|Overall Study|Death|1|||
94360640|NCT00978120|323103865|FG000|Overall Study|Lost to Follow-up|0|||
94360641|NCT00978120|323103866|FG001|Overall Study|Lost to Follow-up|0|||
94360642|NCT00978120|323103867|FG002|Overall Study|Lost to Follow-up|3|||
94360643|NCT00978120|323103868|FG003|Overall Study|Lost to Follow-up|0|||
94628916|NCT00642460|324100386|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
94628917|NCT00642460|324100381|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
94628918|NCT00642460|324100382|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
94628919|NCT00642460|324100383|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
94628920|NCT00642460|324100384|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
94628921|NCT00642460|324100385|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
94628922|NCT00642460|324100386|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
94628923|NCT00563381|324100391|FG000|Overall Study|Adverse Event|264|||
94628924|NCT00563381|324100392|FG001|Overall Study|Adverse Event|292|||
94628925|NCT00563381|324100391|FG000|Overall Study|Protocol Violation|66|||
94628926|NCT00563381|324100392|FG001|Overall Study|Protocol Violation|74|||
94628927|NCT00563381|324100391|FG000|Overall Study|Lost to Follow-up|7|||
94628928|NCT00563381|324100392|FG001|Overall Study|Lost to Follow-up|15|||
94628929|NCT00563381|324100391|FG000|Overall Study|Withdrawal by Subject|192|||
94628930|NCT00563381|324100392|FG001|Overall Study|Withdrawal by Subject|209|||
94628931|NCT00563381|324100391|FG000|Overall Study|Lack of Efficacy|32|||
94628932|NCT00563381|324100392|FG001|Overall Study|Lack of Efficacy|24|||
94628933|NCT00563381|324100391|FG000|Overall Study|Individual different reasons|24|||
94628934|NCT00563381|324100392|FG001|Overall Study|Individual different reasons|34|||
94628935|NCT02407704|324100394|FG000|Overall Study|Lost to Follow-up|0|||
94628936|NCT02407704|324100395|FG001|Overall Study|Lost to Follow-up|0|||
94628937|NCT02407704|324100396|FG002|Overall Study|Lost to Follow-up|0|||
94628938|NCT02407704|324100397|FG003|Overall Study|Lost to Follow-up|2|||
94628939|NCT02407704|324100394|FG000|Overall Study|Protocol Violation|0|||
94628940|NCT02407704|324100395|FG001|Overall Study|Protocol Violation|0|||
94628941|NCT02407704|324100396|FG002|Overall Study|Protocol Violation|0|||
94628942|NCT02407704|324100397|FG003|Overall Study|Protocol Violation|1|||
94628943|NCT02407704|324100394|FG000|Overall Study|Withdrawal by Subject|0|||
94628944|NCT02407704|324100395|FG001|Overall Study|Withdrawal by Subject|0|||
94628945|NCT02407704|324100396|FG002|Overall Study|Withdrawal by Subject|1|||
94628946|NCT02407704|324100397|FG003|Overall Study|Withdrawal by Subject|0|||
94628947|NCT02730455|324100398|FG000|Overall Study|Death|5|||
94628948|NCT02730455|324100399|FG001|Overall Study|Death|6|||
94628949|NCT02730455|324100400|FG002|Overall Study|Death|4|||
94628950|NCT02730455|324100398|FG000|Overall Study|Consent withdrawn|2|||
94628951|NCT02730455|324100399|FG001|Overall Study|Consent withdrawn|4|||
94628952|NCT02730455|324100400|FG002|Overall Study|Consent withdrawn|1|||
94628953|NCT02730455|324100398|FG000|Overall Study|Lost to Follow-up|3|||
94628954|NCT02730455|324100399|FG001|Overall Study|Lost to Follow-up|1|||
94628955|NCT02730455|324100400|FG002|Overall Study|Lost to Follow-up|4|||
94628956|NCT02730455|324100398|FG000|Overall Study|Other|1|||
94628957|NCT02730455|324100399|FG001|Overall Study|Other|1|||
94628958|NCT02730455|324100400|FG002|Overall Study|Other|2|||
94628959|NCT02730455|324100398|FG000|Overall Study|Other|2|||
94628960|NCT02730455|324100399|FG001|Overall Study|Other|2|||
94628961|NCT02730455|324100400|FG002|Overall Study|Other|0|||
94628962|NCT05227027|324100409|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
94628963|NCT05227027|324100410|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
94628964|NCT00996307|324100411|FG000|Overall Study|Adverse Event|0|||
94628965|NCT00996307|324100412|FG001|Overall Study|Adverse Event|1|||
94628966|NCT00996307|324100413|FG002|Overall Study|Adverse Event|0|||
94628967|NCT00996307|324100414|FG003|Overall Study|Adverse Event|0|||
94628968|NCT00996307|324100411|FG000|Overall Study|Withdrawal by Subject|3|||
94628969|NCT00996307|324100412|FG001|Overall Study|Withdrawal by Subject|2|||
94628970|NCT00996307|324100413|FG002|Overall Study|Withdrawal by Subject|5|||
94628971|NCT00996307|324100414|FG003|Overall Study|Withdrawal by Subject|5|||
94628972|NCT00996307|324100411|FG000|Overall Study|Lost to Follow-up|13|||
94628973|NCT00996307|324100412|FG001|Overall Study|Lost to Follow-up|13|||
94628974|NCT00996307|324100413|FG002|Overall Study|Lost to Follow-up|7|||
94628975|NCT00996307|324100414|FG003|Overall Study|Lost to Follow-up|15|||
94628976|NCT00996307|324100411|FG000|Overall Study|Administrative reason|0|||
94628977|NCT00996307|324100412|FG001|Overall Study|Administrative reason|1|||
94628978|NCT00996307|324100413|FG002|Overall Study|Administrative reason|0|||
94628979|NCT00996307|324100414|FG003|Overall Study|Administrative reason|0|||
94628980|NCT00996307|324100411|FG000|Overall Study|Unable to classify|4|||
94628981|NCT00996307|324100412|FG001|Overall Study|Unable to classify|0|||
94628982|NCT00996307|324100413|FG002|Overall Study|Unable to classify|2|||
94628983|NCT00996307|324100414|FG003|Overall Study|Unable to classify|1|||
94628984|NCT00573534|324100415|FG000|Overall Study|oppositional behavior|3|||
94628985|NCT00536198|324100418|FG000|Overall Study|Lost to Follow-up|15|||
94628986|NCT00536198|324100419|FG001|Overall Study|Lost to Follow-up|14|||
94256256|NCT03406260|322732845|FG005|Period 1|Adverse Event|0|||
94256257|NCT02527343|322732846|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
94256258|NCT02527343|322732847|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
94256259|NCT02527343|322732848|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
94256260|NCT02527343|322732849|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
94256261|NCT02527343|322732850|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
94628987|NCT00536198|324100418|FG000|Overall Study|Withdrawal by Subject|16|||
94628988|NCT00536198|324100419|FG001|Overall Study|Withdrawal by Subject|12|||
94628989|NCT00536198|324100418|FG000|Overall Study|Adverse Event|2|||
94628990|NCT00536198|324100419|FG001|Overall Study|Adverse Event|2|||
94256262|NCT02527343|322732851|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
94628991|NCT00536198|324100418|FG000|Overall Study|Rescue|3|||
94628992|NCT00536198|324100419|FG001|Overall Study|Rescue|9|||
94628993|NCT00536198|324100418|FG000|Overall Study|Pregnancy|1|||
94628994|NCT00536198|324100419|FG001|Overall Study|Pregnancy|1|||
94628995|NCT00536198|324100418|FG000|Overall Study|Protocol Violation|0|||
94628996|NCT00536198|324100419|FG001|Overall Study|Protocol Violation|1|||
94628997|NCT01324999|324100420|FG000|Overall Study|Adverse Event|3|||
94628998|NCT01324999|324100420|FG000|Overall Study|Withdrawal by Subject|2|||
94628999|NCT01605877|324100424|FG000|Overall Study|Withdrawal by Subject|1|||
94629000|NCT03965962|324100425|FG000|Overall Study|Adverse Event|1|||
94629001|NCT03965962|324100426|FG001|Overall Study|Adverse Event|0|||
94629002|NCT03965962|324100427|FG002|Overall Study|Adverse Event|0|||
94629003|NCT03965962|324100428|FG003|Overall Study|Adverse Event|0|||
94629004|NCT03965962|324100425|FG000|Overall Study|Protocol Violation|21|||
94629005|NCT03965962|324100426|FG001|Overall Study|Protocol Violation|4|||
94629006|NCT03965962|324100427|FG002|Overall Study|Protocol Violation|10|||
94629007|NCT03965962|324100428|FG003|Overall Study|Protocol Violation|5|||
94629008|NCT03965962|324100425|FG000|Overall Study|Lost to Follow-up|0|||
94629009|NCT03965962|324100426|FG001|Overall Study|Lost to Follow-up|1|||
94629010|NCT03965962|324100427|FG002|Overall Study|Lost to Follow-up|0|||
94629011|NCT03965962|324100428|FG003|Overall Study|Lost to Follow-up|0|||
94629012|NCT03965962|324100425|FG000|Overall Study|Withdrawal by Subject|3|||
94629013|NCT03965962|324100426|FG001|Overall Study|Withdrawal by Subject|0|||
94629014|NCT03965962|324100427|FG002|Overall Study|Withdrawal by Subject|0|||
94629015|NCT03965962|324100428|FG003|Overall Study|Withdrawal by Subject|1|||
94629016|NCT02132130|324100429|FG000|Overall Study|Lost to Follow-up|0|||
94629017|NCT02132130|324100430|FG001|Overall Study|Lost to Follow-up|2|||
94629018|NCT02132130|324100431|FG002|Overall Study|Lost to Follow-up|0|||
94629019|NCT02132130|324100432|FG003|Overall Study|Lost to Follow-up|0|||
94629020|NCT02132130|324100429|FG000|Overall Study|Withdrawal by Subject|0|||
94629021|NCT02132130|324100430|FG001|Overall Study|Withdrawal by Subject|0|||
94629022|NCT02132130|324100431|FG002|Overall Study|Withdrawal by Subject|0|||
94629023|NCT02132130|324100432|FG003|Overall Study|Withdrawal by Subject|1|||
94629024|NCT01782495|324100433|FG000|Overall Study|Adverse Event|0|||
94629025|NCT01782495|324100434|FG001|Overall Study|Adverse Event|0|||
94629026|NCT01782495|324100435|FG002|Overall Study|Adverse Event|0|||
94629027|NCT01782495|324100436|FG003|Overall Study|Adverse Event|0|||
94629028|NCT01782495|324100437|FG004|Overall Study|Adverse Event|0|||
94629029|NCT01782495|324100438|FG005|Overall Study|Adverse Event|0|||
94629030|NCT01782495|324100439|FG006|Overall Study|Adverse Event|0|||
94629031|NCT01782495|324100440|FG007|Overall Study|Adverse Event|2|||
94629032|NCT01782495|324100441|FG008|Overall Study|Adverse Event|0|||
94629033|NCT01782495|324100442|FG009|Overall Study|Adverse Event|0|||
94629034|NCT01782495|324100443|FG010|Overall Study|Adverse Event|0|||
94629035|NCT01782495|324100433|FG000|Overall Study|Withdrew Consent|0|||
94629036|NCT01782495|324100434|FG001|Overall Study|Withdrew Consent|1|||
94629037|NCT01782495|324100435|FG002|Overall Study|Withdrew Consent|0|||
94629038|NCT01782495|324100436|FG003|Overall Study|Withdrew Consent|0|||
94629039|NCT01782495|324100437|FG004|Overall Study|Withdrew Consent|0|||
94629040|NCT01782495|324100438|FG005|Overall Study|Withdrew Consent|0|||
94629041|NCT01782495|324100439|FG006|Overall Study|Withdrew Consent|0|||
94629042|NCT01782495|324100440|FG007|Overall Study|Withdrew Consent|1|||
94629043|NCT01782495|324100441|FG008|Overall Study|Withdrew Consent|0|||
94629044|NCT01782495|324100442|FG009|Overall Study|Withdrew Consent|0|||
94629045|NCT01782495|324100443|FG010|Overall Study|Withdrew Consent|0|||
94629046|NCT02260921|324100445|FG000|Overall Study|Adverse Event|1|||
94629047|NCT02260921|324100446|FG001|Overall Study|Adverse Event|0|||
94629048|NCT02260921|324100445|FG000|Overall Study|Lost to Follow-up|4|||
94629049|NCT02260921|324100446|FG001|Overall Study|Lost to Follow-up|3|||
94256263|NCT02527343|322732846|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
94629050|NCT02260921|324100445|FG000|Overall Study|Withdraw Consent|4|||
94629051|NCT02260921|324100446|FG001|Overall Study|Withdraw Consent|1|||
94629052|NCT02260921|324100445|FG000|Overall Study|Death|1|||
94629053|NCT02260921|324100446|FG001|Overall Study|Death|0|||
94629054|NCT02260921|324100445|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
94629055|NCT02260921|324100446|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
94629056|NCT00576927|324100451|FG000|Clinical Assessment|Lack of Efficacy|24|||
94629057|NCT00576927|324100451|FG000|Clinical Assessment|Death|1|||
94674912|NCT01197508|324263170|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
94256264|NCT02527343|322732847|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
94256265|NCT02527343|322732848|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
94256266|NCT02527343|322732849|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
94256267|NCT02527343|322732850|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
94256268|NCT02527343|322732851|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
94256269|NCT02527343|322732846|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
94256270|NCT02527343|322732847|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
94256271|NCT02527343|322732848|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
94256272|NCT02527343|322732849|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
94256273|NCT02527343|322732850|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
94256274|NCT02527343|322732851|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
94256275|NCT02527343|322732846|FG000|RT Period: Weeks 1 to 52|Other|4|||
94256276|NCT02527343|322732847|FG001|RT Period: Weeks 1 to 52|Other|3|||
94629058|NCT00576927|324100451|FG000|Clinical Assessment|Withdrawal by Subject|10|||
94629059|NCT00576927|324100451|FG000|Clinical Assessment|Physician Decision|1|||
94629060|NCT00576927|324100451|FG000|Baseline|Physician Decision|9|||
94629061|NCT00576927|324100451|FG000|Baseline|Medication Change by PCP of subject|1|||
94629062|NCT00576927|324100451|FG000|Baseline|Withdrawal by Subject|3|||
94629063|NCT00576927|324100451|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
94629064|NCT00576927|324100451|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
94629065|NCT00576927|324100451|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
94629066|NCT00576927|324100451|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
94629067|NCT00576927|324100451|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
94629068|NCT01850524|324100455|FG000|Overall Study|Lost to Follow-up|5|||
94629069|NCT01850524|324100456|FG001|Overall Study|Lost to Follow-up|10|||
94629070|NCT01850524|324100455|FG000|Overall Study|Withdrawal by Subject|24|||
94629071|NCT01850524|324100456|FG001|Overall Study|Withdrawal by Subject|22|||
94629072|NCT01850524|324100455|FG000|Overall Study|Reason not Specified|142|||
94629073|NCT01850524|324100456|FG001|Overall Study|Reason not Specified|141|||
94629074|NCT01905657|324100466|FG000|Overall Study|Adverse Event|23|||
94629075|NCT01905657|324100467|FG001|Overall Study|Adverse Event|17|||
94629076|NCT01905657|324100468|FG002|Overall Study|Adverse Event|18|||
94629077|NCT01905657|324100466|FG000|Overall Study|Clinical Progression|103|||
94629078|NCT01905657|324100467|FG001|Overall Study|Clinical Progression|78|||
94629079|NCT01905657|324100468|FG002|Overall Study|Clinical Progression|59|||
94629080|NCT01905657|324100466|FG000|Overall Study|Death|40|||
94629081|NCT01905657|324100467|FG001|Overall Study|Death|43|||
94629082|NCT01905657|324100468|FG002|Overall Study|Death|47|||
94629083|NCT01905657|324100466|FG000|Overall Study|Excluded Medication|13|||
94629084|NCT01905657|324100467|FG001|Overall Study|Excluded Medication|16|||
94629085|NCT01905657|324100468|FG002|Overall Study|Excluded Medication|9|||
94629086|NCT01905657|324100466|FG000|Overall Study|Lost to Follow-up|1|||
94629087|NCT01905657|324100467|FG001|Overall Study|Lost to Follow-up|2|||
94629088|NCT01905657|324100468|FG002|Overall Study|Lost to Follow-up|1|||
94629089|NCT01905657|324100466|FG000|Overall Study|Physician Decision|5|||
94629090|NCT01905657|324100467|FG001|Overall Study|Physician Decision|8|||
94629091|NCT01905657|324100468|FG002|Overall Study|Physician Decision|12|||
94629092|NCT01905657|324100466|FG000|Overall Study|Protocol Violation|2|||
94674913|NCT01197508|324263167|FG000|Overall Study|Adverse Event|10|||
94256277|NCT02527343|322732848|FG002|RT Period: Weeks 1 to 52|Other|0|||
94629093|NCT01905657|324100467|FG001|Overall Study|Protocol Violation|1|||
94629094|NCT01905657|324100468|FG002|Overall Study|Protocol Violation|1|||
94629095|NCT01905657|324100466|FG000|Overall Study|Screen Failure|0|||
94629096|NCT01905657|324100467|FG001|Overall Study|Screen Failure|1|||
94629097|NCT01905657|324100468|FG002|Overall Study|Screen Failure|0|||
94629098|NCT01905657|324100466|FG000|Overall Study|Withdrawal by Subject|15|||
94629099|NCT01905657|324100467|FG001|Overall Study|Withdrawal by Subject|21|||
94629100|NCT01905657|324100468|FG002|Overall Study|Withdrawal by Subject|53|||
94629101|NCT01905657|324100466|FG000|Overall Study|Sponsor Decision|1|||
94629102|NCT01905657|324100467|FG001|Overall Study|Sponsor Decision|0|||
94629103|NCT01905657|324100468|FG002|Overall Study|Sponsor Decision|0|||
94629104|NCT04080297|324100469|FG000|Overall Study|Adverse Event|1|||
94629105|NCT04080297|324100470|FG001|Overall Study|Adverse Event|3|||
94629106|NCT04080297|324100469|FG000|Overall Study|concurrent illness|1|||
94629107|NCT04080297|324100470|FG001|Overall Study|concurrent illness|0|||
94629108|NCT03334903|324100475|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
94629109|NCT03334903|324100476|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
94629110|NCT03334903|324100475|FG000|Overall Study|Protocol Violation|1|||
94629111|NCT03334903|324100476|FG001|Overall Study|Protocol Violation|3|||
94629112|NCT03334903|324100475|FG000|Overall Study|Surgery postponed|1|||
94629113|NCT03334903|324100476|FG001|Overall Study|Surgery postponed|0|||
94629114|NCT03334903|324100475|FG000|Overall Study|Adverse Event|1|||
94629115|NCT03334903|324100476|FG001|Overall Study|Adverse Event|1|||
94629116|NCT03334903|324100475|FG000|Overall Study|Withdrawal by Subject|0|||
94629117|NCT03334903|324100476|FG001|Overall Study|Withdrawal by Subject|1|||
94629118|NCT03032705|324100477|FG000|Overall Study|Lost to Follow-up|16|||
94629119|NCT03032705|324100478|FG001|Overall Study|Lost to Follow-up|17|||
94629120|NCT03032705|324100477|FG000|Overall Study|did not quality|6|||
94629121|NCT03032705|324100478|FG001|Overall Study|did not quality|6|||
94629122|NCT00353262|324100479|FG000|Overall Study|Adverse Event|8|||
94629123|NCT00353262|324100479|FG000|Overall Study|Withdrawal by Subject|2|||
94629124|NCT00353262|324100479|FG000|Overall Study|Insufficient Therapeutic Response|13|||
94629125|NCT00353262|324100479|FG000|Overall Study|Progression|1|||
94629126|NCT00353262|324100479|FG000|Overall Study|Surgery|4|||
94629127|NCT00353262|324100479|FG000|Overall Study|Break from Chemotherapy|1|||
94629128|NCT01955733|324102153|FG000|Period 1|Lost to Follow-up|1|||
94629129|NCT01955733|324102154|FG001|Period 1|Lost to Follow-up|0|||
94629130|NCT01955733|324102155|FG002|Period 1|Lost to Follow-up|0|||
94256278|NCT02527343|322732849|FG003|RT Period: Weeks 1 to 52|Other|0|||
94629131|NCT01955733|324102153|FG000|Period 2|Adverse Event|1|||
94629132|NCT01955733|324102154|FG001|Period 2|Adverse Event|0|||
94629133|NCT01955733|324102155|FG002|Period 2|Adverse Event|0|||
94629134|NCT01955733|324102153|FG000|Period 2|Physician Decision|0|||
94629135|NCT01955733|324102154|FG001|Period 2|Physician Decision|0|||
94629136|NCT01955733|324102155|FG002|Period 2|Physician Decision|1|||
94629137|NCT01955733|324102153|FG000|Period 2|Withdrawal by Subject|1|||
94629138|NCT01955733|324102154|FG001|Period 2|Withdrawal by Subject|3|||
94629139|NCT01955733|324102155|FG002|Period 2|Withdrawal by Subject|2|||
94629140|NCT01955733|324102153|FG000|Period 2|Study terminated by sponsor|8|||
94629141|NCT01955733|324102154|FG001|Period 2|Study terminated by sponsor|14|||
94629142|NCT01955733|324102155|FG002|Period 2|Study terminated by sponsor|16|||
94629143|NCT01955733|324102153|FG000|Period 2|Lost to Follow-up|2|||
94629144|NCT01955733|324102154|FG001|Period 2|Lost to Follow-up|0|||
94629145|NCT01955733|324102155|FG002|Period 2|Lost to Follow-up|0|||
94629146|NCT01955733|324102153|FG000|Period 2|Other not defined above|0|||
94629147|NCT01955733|324102154|FG001|Period 2|Other not defined above|2|||
94629148|NCT01955733|324102155|FG002|Period 2|Other not defined above|2|||
94629149|NCT01438424|324102157|FG000|Overall Study|Continuing treatment|29|||
94629150|NCT01438424|324102157|FG000|Overall Study|Minimal virologic response|95|||
94629151|NCT01438424|324102157|FG000|Overall Study|Not identified|55|||
94629152|NCT01438424|324102157|FG000|Overall Study|Withdrawal by Subject|104|||
94629153|NCT01438424|324102157|FG000|Overall Study|Progression of chronic hepatitis B|22|||
94674914|NCT01197508|324263168|FG001|Overall Study|Adverse Event|13|||
94256279|NCT02527343|322732850|FG004|RT Period: Weeks 1 to 52|Other|0|||
94256280|NCT02527343|322732851|FG005|RT Period: Weeks 1 to 52|Other|0|||
94256281|NCT02527343|322732846|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
94256282|NCT02527343|322732847|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
94256283|NCT02527343|322732848|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
94256284|NCT02527343|322732849|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
94256285|NCT02527343|322732850|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
94256286|NCT02527343|322732851|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
94360644|NCT00978120|323103865|FG000|Overall Study|Withdrawal by Subject|2|||
94360645|NCT00978120|323103866|FG001|Overall Study|Withdrawal by Subject|0|||
94629154|NCT01438424|324102157|FG000|Overall Study|Death|22|||
94629155|NCT01438424|324102157|FG000|Overall Study|Adverse Event|17|||
94629156|NCT01438424|324102157|FG000|Overall Study|Lost to Follow-up|17|||
94629157|NCT01438424|324102157|FG000|Overall Study|Abnormal laboratory test result|14|||
94629158|NCT01438424|324102157|FG000|Overall Study|Need for drug prohibited by protocol|14|||
94629159|NCT01438424|324102157|FG000|Overall Study|Pregnancy|7|||
94629160|NCT01438424|324102157|FG000|Overall Study|No longer met inclusion criteria|1|||
94629161|NCT01438424|324102157|FG000|Overall Study|Participant noncompliance|20|||
94629162|NCT02154490|324102163|FG000|Overall Study|No tissue submitted|23|||
94629163|NCT02154490|324102163|FG000|Overall Study|No biomarker results|167|||
94629164|NCT02154490|324102163|FG000|Overall Study|Not assigned to a sub-study|270|||
94629165|NCT02154490|324102163|FG000|Overall Study|Did not register to a sub-study|749|||
94629166|NCT02373202|324102166|FG000|Overall Study|Adverse Event|2|||
94629167|NCT02373202|324102167|FG001|Overall Study|Adverse Event|5|||
94629168|NCT02373202|324102168|FG002|Overall Study|Adverse Event|2|||
94629169|NCT02373202|324102169|FG003|Overall Study|Adverse Event|1|||
94629170|NCT02373202|324102166|FG000|Overall Study|Lack of Efficacy|0|||
94629171|NCT02373202|324102167|FG001|Overall Study|Lack of Efficacy|0|||
94629172|NCT02373202|324102168|FG002|Overall Study|Lack of Efficacy|1|||
94629173|NCT02373202|324102169|FG003|Overall Study|Lack of Efficacy|0|||
94629174|NCT02373202|324102166|FG000|Overall Study|Other|0|||
94629175|NCT02373202|324102167|FG001|Overall Study|Other|1|||
94629176|NCT02373202|324102168|FG002|Overall Study|Other|0|||
94629177|NCT02373202|324102169|FG003|Overall Study|Other|0|||
94629178|NCT00410046|324102170|FG000|Overall Study|Adverse Event|3|||
94629179|NCT00410046|324102170|FG000|Overall Study|Withdrawal by Subject|1|||
94629180|NCT00410046|324102170|FG000|Overall Study|Lost to Follow-up|1|||
94629181|NCT00848081|324102171|FG000|Overall Study|Adverse Event|6|||
94629182|NCT00848081|324102172|FG001|Overall Study|Adverse Event|7|||
94629183|NCT00848081|324102171|FG000|Overall Study|Protocol Violation|8|||
94629184|NCT00848081|324102172|FG001|Overall Study|Protocol Violation|5|||
94629185|NCT00848081|324102171|FG000|Overall Study|Lost to Follow-up|1|||
94629186|NCT00848081|324102172|FG001|Overall Study|Lost to Follow-up|0|||
94629187|NCT00848081|324102171|FG000|Overall Study|Physician Decision|0|||
94629188|NCT00848081|324102172|FG001|Overall Study|Physician Decision|3|||
94629189|NCT00848081|324102171|FG000|Overall Study|Withdrawal by Subject|5|||
94629190|NCT00848081|324102172|FG001|Overall Study|Withdrawal by Subject|3|||
94629191|NCT00856284|324102174|FG000|Overall Study|Hyperglycemic rescue|231|||
94629192|NCT00856284|324102175|FG001|Overall Study|Hyperglycemic rescue|201|||
94629193|NCT00856284|324102176|FG002|Overall Study|Hyperglycemic rescue|235|||
94629194|NCT00856284|324102174|FG000|Overall Study|Adverse Event|60|||
94629195|NCT00856284|324102175|FG001|Overall Study|Adverse Event|74|||
94629196|NCT00856284|324102176|FG002|Overall Study|Adverse Event|82|||
94629197|NCT00856284|324102174|FG000|Overall Study|Major protocol deviation|24|||
94629198|NCT00856284|324102175|FG001|Overall Study|Major protocol deviation|16|||
94629199|NCT00856284|324102176|FG002|Overall Study|Major protocol deviation|15|||
94629200|NCT00856284|324102174|FG000|Overall Study|Lost to Follow-up|20|||
94629201|NCT00856284|324102175|FG001|Overall Study|Lost to Follow-up|22|||
94629202|NCT00856284|324102176|FG002|Overall Study|Lost to Follow-up|28|||
94629203|NCT00856284|324102174|FG000|Overall Study|Voluntary withdrawal|48|||
94629204|NCT00856284|324102175|FG001|Overall Study|Voluntary withdrawal|52|||
94629205|NCT00856284|324102176|FG002|Overall Study|Voluntary withdrawal|62|||
94629206|NCT00856284|324102174|FG000|Overall Study|Pregnancy|1|||
94629207|NCT00856284|324102175|FG001|Overall Study|Pregnancy|2|||
94629208|NCT00856284|324102176|FG002|Overall Study|Pregnancy|0|||
94629209|NCT00856284|324102174|FG000|Overall Study|Investigator discretion|9|||
94629210|NCT00856284|324102175|FG001|Overall Study|Investigator discretion|8|||
94629211|NCT00856284|324102176|FG002|Overall Study|Investigator discretion|10|||
94629212|NCT00856284|324102174|FG000|Overall Study|Other|15|||
94629213|NCT00856284|324102175|FG001|Overall Study|Other|17|||
94629214|NCT00856284|324102176|FG002|Overall Study|Other|14|||
94629215|NCT00856284|324102174|FG000|Overall Study|Randomized in error|0|||
94629216|NCT00856284|324102175|FG001|Overall Study|Randomized in error|0|||
94629217|NCT00856284|324102176|FG002|Overall Study|Randomized in error|1|||
94629218|NCT03342690|324102177|FG000|Overall Study|Missing Information|9|||
94629219|NCT03342690|324102177|FG000|Overall Study|Protocol Violation|16|||
94629220|NCT02064894|324102178|FG000|Overall Study|Withdrawal by Subject|43|||
94629221|NCT02064894|324102179|FG001|Overall Study|Withdrawal by Subject|102|||
94629222|NCT02064894|324102180|FG002|Overall Study|Withdrawal by Subject|115|||
94629223|NCT00549302|324102181|FG000|Double-Blind|Death|2|||
94629224|NCT00549302|324102182|FG001|Double-Blind|Death|9|||
94674915|NCT01197508|324263169|FG002|Overall Study|Adverse Event|23|||
94674916|NCT01197508|324263170|FG003|Overall Study|Adverse Event|3|||
94674917|NCT01197508|324263167|FG000|Overall Study|Severe non-compliance to protocol|0|||
94674918|NCT01197508|324263168|FG001|Overall Study|Severe non-compliance to protocol|3|||
94674919|NCT01197508|324263169|FG002|Overall Study|Severe non-compliance to protocol|1|||
94256287|NCT02527343|322732846|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
94674920|NCT01197508|324263170|FG003|Overall Study|Severe non-compliance to protocol|3|||
94674921|NCT01197508|324263167|FG000|Overall Study|Condition under investigation worsened|1|||
94674922|NCT01197508|324263168|FG001|Overall Study|Condition under investigation worsened|1|||
94674923|NCT01197508|324263169|FG002|Overall Study|Condition under investigation worsened|1|||
94674924|NCT01197508|324263170|FG003|Overall Study|Condition under investigation worsened|1|||
94674925|NCT01197508|324263167|FG000|Overall Study|Lack of Efficacy|1|||
94674926|NCT01197508|324263168|FG001|Overall Study|Lack of Efficacy|2|||
94674927|NCT01197508|324263169|FG002|Overall Study|Lack of Efficacy|2|||
94674928|NCT01197508|324263170|FG003|Overall Study|Lack of Efficacy|1|||
94674929|NCT01197508|324263167|FG000|Overall Study|Study-specific withdrawal criteria|0|||
94674930|NCT01197508|324263168|FG001|Overall Study|Study-specific withdrawal criteria|0|||
94256288|NCT02527343|322732847|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
94256289|NCT02527343|322732848|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
94256290|NCT02527343|322732849|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
94256291|NCT02527343|322732850|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
94256292|NCT02527343|322732851|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
94256293|NCT02527343|322732846|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
94256294|NCT02527343|322732847|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
94256295|NCT02527343|322732848|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
94256296|NCT02527343|322732849|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
94256297|NCT02527343|322732850|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
94256298|NCT02527343|322732851|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
94256299|NCT02527343|322732846|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
94256300|NCT02527343|322732847|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
94256301|NCT02527343|322732848|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
94256302|NCT02527343|322732849|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
94256303|NCT02527343|322732850|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
94256304|NCT02527343|322732851|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
94256305|NCT02527343|322732846|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
94256306|NCT02527343|322732847|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
94256307|NCT02527343|322732848|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
94256308|NCT02527343|322732849|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
94256309|NCT02527343|322732850|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
94256310|NCT02527343|322732851|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
94256311|NCT02527343|322732846|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
94256312|NCT02527343|322732847|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
94256313|NCT02527343|322732848|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
94256314|NCT02527343|322732849|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
94256315|NCT02527343|322732850|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
94256316|NCT02527343|322732851|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
94256317|NCT02527343|322732846|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
94256318|NCT02527343|322732847|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
94256319|NCT02527343|322732848|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
94256320|NCT02527343|322732849|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
94256321|NCT02527343|322732850|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
94256322|NCT02527343|322732851|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
94256323|NCT02527343|322732846|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
94256324|NCT02527343|322732847|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
94256325|NCT02527343|322732848|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
94256326|NCT02527343|322732849|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
94256327|NCT02527343|322732850|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
94256328|NCT02527343|322732851|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
94674931|NCT01197508|324263169|FG002|Overall Study|Study-specific withdrawal criteria|1|||
94674932|NCT01197508|324263170|FG003|Overall Study|Study-specific withdrawal criteria|2|||
94256329|NCT02527343|322732846|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
94256330|NCT02527343|322732847|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
94256331|NCT02527343|322732848|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
94256332|NCT02527343|322732849|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
94256333|NCT02527343|322732850|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
94256334|NCT02527343|322732851|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
94256335|NCT00986674|322732852|FG000|Overall Study|Lack of Efficacy|28|||
94256336|NCT00986674|322732853|FG001|Overall Study|Lack of Efficacy|25|||
94256337|NCT00986674|322732854|FG002|Overall Study|Lack of Efficacy|23|||
94674933|NCT01197508|324263167|FG000|Overall Study|Lost to Follow-up|1|||
94674934|NCT01197508|324263168|FG001|Overall Study|Lost to Follow-up|1|||
94256338|NCT00986674|322732852|FG000|Overall Study|Adverse Event|4|||
94256339|NCT00986674|322732853|FG001|Overall Study|Adverse Event|8|||
94256340|NCT00986674|322732854|FG002|Overall Study|Adverse Event|9|||
94256341|NCT00986674|322732852|FG000|Overall Study|Death|5|||
94629225|NCT00549302|324102183|FG002|Double-Blind|Death|0|||
94629226|NCT00549302|324102181|FG000|Double-Blind|Adverse Event|3|||
94629227|NCT00549302|324102182|FG001|Double-Blind|Adverse Event|16|||
94629228|NCT00549302|324102183|FG002|Double-Blind|Adverse Event|0|||
94629229|NCT00549302|324102181|FG000|Double-Blind|Withdrawal by Subject|3|||
94629230|NCT00549302|324102182|FG001|Double-Blind|Withdrawal by Subject|8|||
94629231|NCT00549302|324102183|FG002|Double-Blind|Withdrawal by Subject|0|||
94629232|NCT00549302|324102181|FG000|Double-Blind|Investigator Decision|1|||
94629233|NCT00549302|324102182|FG001|Double-Blind|Investigator Decision|5|||
94629234|NCT00549302|324102183|FG002|Double-Blind|Investigator Decision|0|||
94629235|NCT00549302|324102181|FG000|Double-Blind|Sponsor Decision|0|||
94629236|NCT00549302|324102182|FG001|Double-Blind|Sponsor Decision|1|||
94629237|NCT00549302|324102183|FG002|Double-Blind|Sponsor Decision|0|||
94629238|NCT00549302|324102181|FG000|Double-Blind|Lost to Follow-up|1|||
94629239|NCT00549302|324102182|FG001|Double-Blind|Lost to Follow-up|2|||
94629240|NCT00549302|324102183|FG002|Double-Blind|Lost to Follow-up|0|||
94629241|NCT00549302|324102181|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
94629242|NCT00549302|324102182|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
94629243|NCT00549302|324102183|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
94629244|NCT00549302|324102181|FG000|Double-Blind|New condition or starts new therapy|0|||
94629245|NCT00549302|324102182|FG001|Double-Blind|New condition or starts new therapy|2|||
94629246|NCT00549302|324102183|FG002|Double-Blind|New condition or starts new therapy|0|||
94629247|NCT00549302|324102181|FG000|Open-Label|Adverse Event|0|||
94629248|NCT00549302|324102182|FG001|Open-Label|Adverse Event|0|||
94629249|NCT00549302|324102183|FG002|Open-Label|Adverse Event|11|||
94629250|NCT00549302|324102181|FG000|Open-Label|Death|0|||
94629251|NCT00549302|324102182|FG001|Open-Label|Death|0|||
94629252|NCT00549302|324102183|FG002|Open-Label|Death|40|||
94629253|NCT00549302|324102181|FG000|Open-Label|Investigator Decision|0|||
94629254|NCT00549302|324102182|FG001|Open-Label|Investigator Decision|0|||
94629255|NCT00549302|324102183|FG002|Open-Label|Investigator Decision|5|||
94629256|NCT00549302|324102181|FG000|Open-Label|Lost to Follow-up|0|||
94629257|NCT00549302|324102182|FG001|Open-Label|Lost to Follow-up|0|||
94629258|NCT00549302|324102183|FG002|Open-Label|Lost to Follow-up|2|||
94629259|NCT00549302|324102181|FG000|Open-Label|Other|0|||
94629260|NCT00549302|324102182|FG001|Open-Label|Other|0|||
94629261|NCT00549302|324102183|FG002|Open-Label|Other|3|||
94629262|NCT00549302|324102181|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
94629263|NCT00549302|324102182|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
94629264|NCT00549302|324102183|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
94629265|NCT00549302|324102181|FG000|Open-Label|Withdrawal by Subject|0|||
94629266|NCT00549302|324102182|FG001|Open-Label|Withdrawal by Subject|0|||
94629267|NCT00549302|324102183|FG002|Open-Label|Withdrawal by Subject|6|||
94629268|NCT00105482|324102184|FG000|Overall Study|Adverse Event|1|||
94629269|NCT00105482|324102185|FG001|Overall Study|Adverse Event|1|||
94629270|NCT00105482|324102184|FG000|Overall Study|Lost to Follow-up|26|||
94629271|NCT00105482|324102185|FG001|Overall Study|Lost to Follow-up|17|||
94629272|NCT00105482|324102184|FG000|Overall Study|Withdrawal by Subject|0|||
94629273|NCT00105482|324102185|FG001|Overall Study|Withdrawal by Subject|1|||
94629274|NCT00105482|324102184|FG000|Overall Study|Lost Interest|29|||
94629275|NCT00105482|324102185|FG001|Overall Study|Lost Interest|32|||
94629276|NCT00105482|324102184|FG000|Overall Study|Scheduling Conflict|2|||
94629277|NCT00105482|324102185|FG001|Overall Study|Scheduling Conflict|3|||
94629278|NCT00105482|324102184|FG000|Overall Study|Withdrawn by PI|1|||
94629279|NCT00105482|324102185|FG001|Overall Study|Withdrawn by PI|1|||
94629280|NCT01979016|324102199|FG000|Overall Study|Withdrawal by Subject|2|||
94629281|NCT01979016|324102200|FG001|Overall Study|Withdrawal by Subject|0|||
94629282|NCT01979016|324102199|FG000|Overall Study|Adverse Event|0|||
94629283|NCT01979016|324102200|FG001|Overall Study|Adverse Event|1|||
94629284|NCT04326231|324102202|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
94629285|NCT02005445|324102203|FG000|Overall Study|Dual study enrollment|0|||
94629286|NCT02005445|324102204|FG001|Overall Study|Dual study enrollment|1|||
94629287|NCT01314443|324102205|FG000|Overall Study|Withdrawal by Subject|2|||
94629288|NCT01314443|324102206|FG001|Overall Study|Withdrawal by Subject|1|||
94256342|NCT00986674|322732853|FG001|Overall Study|Death|0|||
94256343|NCT00986674|322732854|FG002|Overall Study|Death|4|||
94629289|NCT01314443|324102207|FG002|Overall Study|Withdrawal by Subject|1|||
94629290|NCT01314443|324102208|FG003|Overall Study|Withdrawal by Subject|1|||
94629291|NCT01314443|324102205|FG000|Overall Study|Protocol Violation|2|||
94256344|NCT00986674|322732852|FG000|Overall Study|Withdrawal by Subject|6|||
94629292|NCT01314443|324102206|FG001|Overall Study|Protocol Violation|2|||
94629293|NCT01314443|324102207|FG002|Overall Study|Protocol Violation|1|||
94629294|NCT01314443|324102208|FG003|Overall Study|Protocol Violation|1|||
94629295|NCT01111149|324102211|FG000|Overall Study|Protocol Violation|1|||
94629296|NCT01111149|324102212|FG001|Overall Study|Protocol Violation|1|||
94360646|NCT00978120|323103867|FG002|Overall Study|Withdrawal by Subject|0|||
94360647|NCT00978120|323103868|FG003|Overall Study|Withdrawal by Subject|0|||
94360648|NCT00978120|323103865|FG000|Overall Study|Moved out of state|0|||
94360649|NCT00978120|323103866|FG001|Overall Study|Moved out of state|0|||
94360650|NCT00978120|323103867|FG002|Overall Study|Moved out of state|0|||
94360651|NCT00978120|323103868|FG003|Overall Study|Moved out of state|1|||
94360652|NCT01023815|323103869|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
94360653|NCT01023815|323103870|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
94360654|NCT01023815|323103871|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
94360655|NCT01023815|323103872|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
94360656|NCT01023815|323103869|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
94360657|NCT01023815|323103870|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
94360658|NCT01023815|323103871|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
94360659|NCT01023815|323103872|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
94360660|NCT01023815|323103869|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
94360661|NCT01023815|323103870|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
94360662|NCT01023815|323103871|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
94360663|NCT01023815|323103872|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
94360664|NCT01023815|323103869|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
94360665|NCT01023815|323103870|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
94360666|NCT01023815|323103871|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
94360667|NCT01023815|323103872|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
94360668|NCT01023815|323103869|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
94360669|NCT01023815|323103870|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
94360670|NCT01023815|323103871|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
94360671|NCT01023815|323103872|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
94360672|NCT00762073|323103873|FG000|Overall Study|Lack of Efficacy|1|||
94360673|NCT00762073|323103874|FG001|Overall Study|Lack of Efficacy|1|||
94360674|NCT00762073|323103875|FG002|Overall Study|Lack of Efficacy|0|||
94360675|NCT00762073|323103876|FG003|Overall Study|Lack of Efficacy|0|||
94360676|NCT00762073|323103873|FG000|Overall Study|Adverse Event|1|||
94360677|NCT00762073|323103874|FG001|Overall Study|Adverse Event|0|||
94360678|NCT00762073|323103875|FG002|Overall Study|Adverse Event|1|||
94360679|NCT00762073|323103876|FG003|Overall Study|Adverse Event|1|||
94360680|NCT00762073|323103873|FG000|Overall Study|Significant Subject Noncompliance|0|||
94360681|NCT00762073|323103874|FG001|Overall Study|Significant Subject Noncompliance|1|||
94360682|NCT00762073|323103875|FG002|Overall Study|Significant Subject Noncompliance|0|||
94629297|NCT01111149|324102213|FG002|Overall Study|Protocol Violation|2|||
94629298|NCT01111149|324102211|FG000|Overall Study|Withdrawal by Subject|1|||
94629299|NCT01111149|324102212|FG001|Overall Study|Withdrawal by Subject|0|||
94629300|NCT01111149|324102213|FG002|Overall Study|Withdrawal by Subject|2|||
94629301|NCT00759954|324102214|FG000|Overall Study|Personal reason|1|||
94629302|NCT00759954|324102215|FG001|Overall Study|Personal reason|0|||
94629303|NCT00759954|324102214|FG000|Overall Study|Adverse Event|1|||
94629304|NCT00759954|324102215|FG001|Overall Study|Adverse Event|2|||
94629305|NCT02875860|324102217|FG000|Overall Study|Withdrawal by Subject|0|||
94629306|NCT02875860|324102218|FG001|Overall Study|Withdrawal by Subject|1|||
94629307|NCT02320149|324102219|FG000|Overall Study|Adverse Event|3|||
94629308|NCT02320149|324102220|FG001|Overall Study|Adverse Event|7|||
94629309|NCT02320149|324102219|FG000|Overall Study|Withdrawal of Consent|28|||
94629310|NCT02320149|324102220|FG001|Overall Study|Withdrawal of Consent|32|||
94629311|NCT02320149|324102219|FG000|Overall Study|Lost to Follow-up|21|||
94629312|NCT02320149|324102220|FG001|Overall Study|Lost to Follow-up|34|||
94629313|NCT02320149|324102219|FG000|Overall Study|Protocol Violation|2|||
94629314|NCT02320149|324102220|FG001|Overall Study|Protocol Violation|1|||
94629315|NCT02320149|324102219|FG000|Overall Study|Noncompliance with Study Treatment|7|||
94629316|NCT02320149|324102220|FG001|Overall Study|Noncompliance with Study Treatment|2|||
94629317|NCT02320149|324102219|FG000|Overall Study|Lack of Efficacy|0|||
94629318|NCT02320149|324102220|FG001|Overall Study|Lack of Efficacy|1|||
94629319|NCT02320149|324102219|FG000|Overall Study|Other Miscellaneous Reasons|2|||
94629320|NCT02320149|324102220|FG001|Overall Study|Other Miscellaneous Reasons|3|||
94360683|NCT00762073|323103876|FG003|Overall Study|Significant Subject Noncompliance|1|||
94360684|NCT00762073|323103873|FG000|Overall Study|Withdrawal by Subject|1|||
94360685|NCT00762073|323103874|FG001|Overall Study|Withdrawal by Subject|2|||
94629321|NCT01156311|324102221|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
94629322|NCT01156311|324102222|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
94256345|NCT00986674|322732853|FG001|Overall Study|Withdrawal by Subject|2|||
94256346|NCT00986674|322732854|FG002|Overall Study|Withdrawal by Subject|1|||
94256347|NCT00986674|322732852|FG000|Overall Study|alternative therapy|0|||
94256348|NCT00986674|322732853|FG001|Overall Study|alternative therapy|0|||
94256349|NCT00986674|322732854|FG002|Overall Study|alternative therapy|1|||
94629323|NCT01156311|324102223|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
94256350|NCT00986674|322732852|FG000|Overall Study|not start protocol therapy|4|||
94256351|NCT00986674|322732853|FG001|Overall Study|not start protocol therapy|3|||
94256352|NCT00986674|322732854|FG002|Overall Study|not start protocol therapy|1|||
94629324|NCT01156311|324102224|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
94629325|NCT01156311|324102221|FG000|2-Month Monotherapy Period|Physician Decision|0|||
94629326|NCT01156311|324102222|FG001|2-Month Monotherapy Period|Physician Decision|1|||
94629327|NCT01156311|324102223|FG002|2-Month Monotherapy Period|Physician Decision|0|||
94629328|NCT01156311|324102224|FG003|2-Month Monotherapy Period|Physician Decision|0|||
94629329|NCT01156311|324102221|FG000|2-Month Monotherapy Period|Other|1|||
94629330|NCT01156311|324102222|FG001|2-Month Monotherapy Period|Other|0|||
94629331|NCT01156311|324102223|FG002|2-Month Monotherapy Period|Other|0|||
94629332|NCT01156311|324102224|FG003|2-Month Monotherapy Period|Other|0|||
94629333|NCT01156311|324102221|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
94629334|NCT01156311|324102222|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
94629335|NCT01156311|324102223|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
94629336|NCT01156311|324102224|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
94629337|NCT01156311|324102221|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
94629338|NCT01156311|324102222|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
94629339|NCT01156311|324102223|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
94629340|NCT01156311|324102224|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
94629341|NCT01156311|324102221|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
94629342|NCT01156311|324102222|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
94629343|NCT01156311|324102223|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
94629344|NCT01156311|324102224|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
94629345|NCT01156311|324102221|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
94629346|NCT01156311|324102222|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
94629347|NCT01156311|324102223|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
94629348|NCT01156311|324102224|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
94629349|NCT01156311|324102221|FG000|6-month Add-on Therapy Period|Other|0|||
94256353|NCT00986674|322732852|FG000|Overall Study|unknown/not specify|0|||
94256354|NCT00986674|322732853|FG001|Overall Study|unknown/not specify|7|||
94256355|NCT00986674|322732854|FG002|Overall Study|unknown/not specify|9|||
94256356|NCT02216357|322732858|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
94256357|NCT02216357|322732859|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
94256358|NCT02319525|322732860|FG000|Overall Study|Withdrawal by Subject|2|||
94256359|NCT02319525|322732861|FG001|Overall Study|Withdrawal by Subject|1|||
94256360|NCT00928746|322732866|FG000|Overall Study|Adverse Event|2|||
94256361|NCT00928746|322732866|FG000|Overall Study|Protocol Violation|1|||
94256362|NCT00928746|322732866|FG000|Overall Study|Withdrawal by Subject|1|||
94256363|NCT00928746|322732866|FG000|Overall Study|Other|2|||
94256364|NCT05116046|322732867|FG000|Overall Study|Withdrawal by parent/guardian|2|||
94256365|NCT05116046|322732868|FG001|Overall Study|Withdrawal by parent/guardian|1|||
94256366|NCT05116046|322732869|FG002|Overall Study|Withdrawal by parent/guardian|1|||
94256367|NCT05116046|322732867|FG000|Overall Study|Study terminated by sponsor|14|||
94256368|NCT05116046|322732868|FG001|Overall Study|Study terminated by sponsor|16|||
94629350|NCT01156311|324102222|FG001|6-month Add-on Therapy Period|Other|0|||
94629351|NCT01156311|324102223|FG002|6-month Add-on Therapy Period|Other|1|||
94629352|NCT01156311|324102224|FG003|6-month Add-on Therapy Period|Other|2|||
94629353|NCT01750242|324102225|FG000|Overall Study|Unreadable Images|3|||
94629354|NCT02069366|324102226|FG000|Overall Study|Lost to Follow-up|0|||
94629355|NCT02069366|324102227|FG001|Overall Study|Lost to Follow-up|0|||
94629356|NCT02069366|324102228|FG002|Overall Study|Lost to Follow-up|1|||
94629357|NCT02069366|324102229|FG003|Overall Study|Lost to Follow-up|0|||
94629358|NCT02069366|324102230|FG004|Overall Study|Lost to Follow-up|0|||
94629359|NCT02069366|324102231|FG005|Overall Study|Lost to Follow-up|2|||
94629360|NCT02069366|324102226|FG000|Overall Study|Protocol Violation|0|||
94629361|NCT02069366|324102227|FG001|Overall Study|Protocol Violation|0|||
94629362|NCT02069366|324102228|FG002|Overall Study|Protocol Violation|1|||
94629363|NCT02069366|324102229|FG003|Overall Study|Protocol Violation|0|||
94629364|NCT02069366|324102230|FG004|Overall Study|Protocol Violation|0|||
94629365|NCT02069366|324102231|FG005|Overall Study|Protocol Violation|0|||
94629366|NCT02069366|324102226|FG000|Overall Study|Withdrawal by Subject|1|||
94256369|NCT05116046|322732869|FG002|Overall Study|Study terminated by sponsor|1|||
94256370|NCT01442779|322732873|FG000|Overall Study|Withdrawal by Subject|3|||
94256371|NCT01442779|322732873|FG000|Overall Study|Death|3|||
94629367|NCT02069366|324102227|FG001|Overall Study|Withdrawal by Subject|0|||
94674935|NCT01197508|324263169|FG002|Overall Study|Lost to Follow-up|2|||
94629368|NCT02069366|324102228|FG002|Overall Study|Withdrawal by Subject|1|||
94629369|NCT02069366|324102229|FG003|Overall Study|Withdrawal by Subject|2|||
94256372|NCT01442779|322732873|FG000|Overall Study|Non-compliance|1|||
94256373|NCT00551460|322732874|FG000|Overall Study|Adverse Event|1|||
94256374|NCT00551460|322732874|FG000|Overall Study|Withdrawal by Subject|1|||
94256375|NCT00551460|322732874|FG000|Overall Study|Physician Decision|1|||
94256376|NCT00551460|322732874|FG000|Overall Study|Death|7|||
94256377|NCT00551460|322732874|FG000|Overall Study|Ineligible|4|||
94256378|NCT00551460|322732874|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
94256379|NCT03426267|322732875|FG000|Overall Study|Physician Decision|1|||
94256380|NCT03426267|322732876|FG001|Overall Study|Physician Decision|4|||
94629370|NCT02069366|324102230|FG004|Overall Study|Withdrawal by Subject|0|||
94629371|NCT02069366|324102231|FG005|Overall Study|Withdrawal by Subject|0|||
94629372|NCT03033394|324102248|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
94629373|NCT03033394|324102248|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
94629374|NCT03033394|324102248|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
94629375|NCT03033394|324102248|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
94629376|NCT03033394|324102248|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
94629377|NCT01426373|324102249|FG000|Overall Study|Adverse Event|6|||
94629378|NCT01426373|324102249|FG000|Overall Study|Lost to Follow-up|14|||
94629379|NCT01426373|324102249|FG000|Overall Study|Participant Convenience|10|||
94629380|NCT01426373|324102249|FG000|Overall Study|Miscellaneous Reasons|4|||
94629381|NCT04502589|324102250|FG000|Overall Study|Physician Decision|1|||
94629382|NCT04502589|324102251|FG001|Overall Study|Physician Decision|0|||
94629383|NCT02532972|324102253|FG000|Overall Study|Withdrawal by Subject|1|||
94629384|NCT01025752|324102254|FG000|Overall Study|Lost to Follow-up|7|||
94629385|NCT01025752|324102255|FG001|Overall Study|Lost to Follow-up|10|||
94629386|NCT01025752|324102254|FG000|Overall Study|Physician Decision|1|||
94629387|NCT01025752|324102255|FG001|Overall Study|Physician Decision|3|||
94629388|NCT02788357|324102257|FG000|Overall Study|Lost to Follow-up|3|||
94629389|NCT02788357|324102258|FG001|Overall Study|Lost to Follow-up|0|||
94629390|NCT00927784|324102259|FG000|Overall Study|Death|1|||
94629391|NCT00927784|324102260|FG001|Overall Study|Death|0|||
94629392|NCT00927784|324102259|FG000|Overall Study|Withdrawal by Subject|1|||
94629393|NCT00927784|324102260|FG001|Overall Study|Withdrawal by Subject|0|||
94629394|NCT02643082|324102261|FG000|Period 1|Adverse Event|1|||
94629395|NCT02643082|324102262|FG001|Period 1|Adverse Event|0|||
94629396|NCT00881712|324102263|FG000|Overall Study|Death|1|||
94629397|NCT00881712|324102264|FG001|Overall Study|Death|0|||
94629398|NCT00881712|324102265|FG002|Overall Study|Death|0|||
94629399|NCT00881712|324102263|FG000|Overall Study|Withdrawal by Subject|1|||
94629400|NCT00881712|324102264|FG001|Overall Study|Withdrawal by Subject|0|||
94629401|NCT00881712|324102265|FG002|Overall Study|Withdrawal by Subject|0|||
94629402|NCT01927367|324102272|FG000|Overall Study|Withdrawal by Subject|7|||
94629403|NCT01927367|324102273|FG001|Overall Study|Withdrawal by Subject|4|||
94629404|NCT01927367|324102272|FG000|Overall Study|No baseline data|0|||
94629405|NCT01927367|324102273|FG001|Overall Study|No baseline data|1|||
94629406|NCT00071513|324102274|FG000|Intervention Component|Withdrawal by Subject|2|||
94629407|NCT00071513|324102275|FG001|Intervention Component|Withdrawal by Subject|3|||
94629408|NCT00071513|324102274|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
94629409|NCT00071513|324102275|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
94629410|NCT01958008|324102282|FG000|Overall Study|Worsening of disease under study|0|||
94629411|NCT01958008|324102283|FG001|Overall Study|Worsening of disease under study|0|||
94629412|NCT01958008|324102284|FG002|Overall Study|Worsening of disease under study|1|||
94629413|NCT01958008|324102285|FG003|Overall Study|Worsening of disease under study|0|||
94629414|NCT01958008|324102282|FG000|Overall Study|Other adverse event|1|||
94629415|NCT01958008|324102283|FG001|Overall Study|Other adverse event|0|||
94629416|NCT01958008|324102284|FG002|Overall Study|Other adverse event|0|||
94629417|NCT01958008|324102285|FG003|Overall Study|Other adverse event|0|||
94629418|NCT02547454|324102294|FG000|Overall Study|Due to hemodialysis|53|||
94629419|NCT02547454|324102294|FG000|Overall Study|Due to transplantation|1|||
94629420|NCT02547454|324102294|FG000|Overall Study|Due to no further need to treat|4|||
94256381|NCT03426267|322732875|FG000|Overall Study|Lost to Follow-up|1|||
94629421|NCT02547454|324102294|FG000|Overall Study|Death|38|||
94629422|NCT02547454|324102294|FG000|Overall Study|Lost to Follow-up|26|||
94629423|NCT02547454|324102294|FG000|Overall Study|Other|39|||
94629424|NCT02547454|324102294|FG000|Overall Study|No data|11|||
94629425|NCT01031069|324102300|FG000|Overall Study|Serious Adverse Event|0|||
94256382|NCT03426267|322732876|FG001|Overall Study|Lost to Follow-up|0|||
94256383|NCT03426267|322732875|FG000|Overall Study|Withdrawal by Subject|4|||
94360686|NCT00762073|323103875|FG002|Overall Study|Withdrawal by Subject|1|||
94629426|NCT01031069|324102301|FG001|Overall Study|Serious Adverse Event|1|||
94629427|NCT01031069|324102302|FG002|Overall Study|Serious Adverse Event|0|||
94629428|NCT01031069|324102303|FG003|Overall Study|Serious Adverse Event|0|||
94256384|NCT03426267|322732876|FG001|Overall Study|Withdrawal by Subject|10|||
94256385|NCT03426267|322732875|FG000|Overall Study|Protocol Violation|1|||
94360687|NCT00762073|323103876|FG003|Overall Study|Withdrawal by Subject|1|||
94629429|NCT01031069|324102300|FG000|Overall Study|Withdrawal by Subject|2|||
94629430|NCT01031069|324102301|FG001|Overall Study|Withdrawal by Subject|3|||
94629431|NCT01031069|324102302|FG002|Overall Study|Withdrawal by Subject|18|||
94629432|NCT01031069|324102303|FG003|Overall Study|Withdrawal by Subject|18|||
94629433|NCT01031069|324102300|FG000|Overall Study|Migrated/moved from study area|1|||
94629434|NCT01031069|324102301|FG001|Overall Study|Migrated/moved from study area|2|||
94629435|NCT01031069|324102302|FG002|Overall Study|Migrated/moved from study area|1|||
94629436|NCT01031069|324102303|FG003|Overall Study|Migrated/moved from study area|1|||
94629437|NCT01031069|324102300|FG000|Overall Study|Lost to Follow-up|9|||
94629438|NCT01031069|324102301|FG001|Overall Study|Lost to Follow-up|5|||
94629439|NCT01031069|324102302|FG002|Overall Study|Lost to Follow-up|21|||
94629440|NCT01031069|324102303|FG003|Overall Study|Lost to Follow-up|15|||
94629441|NCT01031069|324102300|FG000|Overall Study|Other|0|||
94629442|NCT01031069|324102301|FG001|Overall Study|Other|0|||
94629443|NCT01031069|324102302|FG002|Overall Study|Other|1|||
94629444|NCT01031069|324102303|FG003|Overall Study|Other|0|||
94629445|NCT01937559|324102305|FG000|Overall Study|Physician Decision|3|||
94629446|NCT01937559|324102306|FG001|Overall Study|Physician Decision|3|||
94629447|NCT01937559|324102307|FG002|Overall Study|Physician Decision|0|||
94629448|NCT01937559|324102305|FG000|Overall Study|Withdrawal by Subject|6|||
94629449|NCT01937559|324102306|FG001|Overall Study|Withdrawal by Subject|4|||
94629450|NCT01937559|324102307|FG002|Overall Study|Withdrawal by Subject|0|||
94629451|NCT01937559|324102305|FG000|Overall Study|screen fail|2|||
94629452|NCT01937559|324102306|FG001|Overall Study|screen fail|4|||
94629453|NCT01937559|324102307|FG002|Overall Study|screen fail|0|||
94629454|NCT02759471|324102308|FG000|Overall Study|discomfort|2|||
94256386|NCT03426267|322732876|FG001|Overall Study|Protocol Violation|3|||
94256387|NCT03426267|322732875|FG000|Overall Study|Adverse Event|9|||
94256388|NCT03426267|322732876|FG001|Overall Study|Adverse Event|27|||
94256389|NCT03426267|322732875|FG000|Overall Study|Prohibited Treatment Intake|2|||
94629455|NCT01852110|324103909|FG000|Overall Study|Adverse Event|12|||
94629456|NCT01852110|324103910|FG001|Overall Study|Adverse Event|5|||
94629457|NCT01852110|324103911|FG002|Overall Study|Adverse Event|0|||
94629458|NCT01852110|324103912|FG003|Overall Study|Adverse Event|0|||
94629459|NCT01852110|324103913|FG004|Overall Study|Adverse Event|0|||
94629460|NCT01852110|324103914|FG005|Overall Study|Adverse Event|0|||
94629461|NCT01852110|324103909|FG000|Overall Study|Lost to Follow-up|1|||
94629462|NCT01852110|324103910|FG001|Overall Study|Lost to Follow-up|3|||
94629463|NCT01852110|324103911|FG002|Overall Study|Lost to Follow-up|0|||
94629464|NCT01852110|324103912|FG003|Overall Study|Lost to Follow-up|0|||
94629465|NCT01852110|324103913|FG004|Overall Study|Lost to Follow-up|0|||
94629466|NCT01852110|324103914|FG005|Overall Study|Lost to Follow-up|0|||
94629467|NCT01852110|324103909|FG000|Overall Study|Non-compliance with Study Drug|2|||
94629468|NCT01852110|324103910|FG001|Overall Study|Non-compliance with Study Drug|1|||
94629469|NCT01852110|324103911|FG002|Overall Study|Non-compliance with Study Drug|0|||
94629470|NCT01852110|324103912|FG003|Overall Study|Non-compliance with Study Drug|0|||
94629471|NCT01852110|324103913|FG004|Overall Study|Non-compliance with Study Drug|0|||
94629472|NCT01852110|324103914|FG005|Overall Study|Non-compliance with Study Drug|0|||
94629473|NCT01852110|324103909|FG000|Overall Study|Physician Decision|1|||
94629474|NCT01852110|324103910|FG001|Overall Study|Physician Decision|0|||
94629475|NCT01852110|324103911|FG002|Overall Study|Physician Decision|0|||
94629476|NCT01852110|324103912|FG003|Overall Study|Physician Decision|0|||
94629477|NCT01852110|324103913|FG004|Overall Study|Physician Decision|0|||
94629478|NCT01852110|324103914|FG005|Overall Study|Physician Decision|0|||
94629479|NCT01852110|324103909|FG000|Overall Study|Protocol Violation|0|||
94629480|NCT01852110|324103910|FG001|Overall Study|Protocol Violation|1|||
94360688|NCT00762073|323103873|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
94360689|NCT00762073|323103874|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
94360690|NCT00762073|323103875|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
94360691|NCT00762073|323103876|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
94360692|NCT03992456|323103877|FG000|Overall Study|Withdrawal by Subject|1|||
94360693|NCT03992456|323103878|FG001|Overall Study|Withdrawal by Subject|0|||
94360694|NCT03992456|323103877|FG000|Overall Study|Disease progression|4|||
94360695|NCT03992456|323103878|FG001|Overall Study|Disease progression|5|||
94360696|NCT03992456|323103877|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
94360697|NCT03992456|323103878|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
94360698|NCT01901393|323103879|FG000|Overall Study|Adverse Event|1|||
94360699|NCT01901393|323103880|FG001|Overall Study|Adverse Event|0|||
94360700|NCT00539006|323103894|FG000|Pre-treatment|Other|0|||
94360701|NCT00539006|323103895|FG001|Pre-treatment|Other|1|||
94360702|NCT00539006|323103896|FG002|Pre-treatment|Other|0|||
94360703|NCT00539006|323103897|FG003|Pre-treatment|Other|0|||
94360704|NCT00539006|323103894|FG000|Treatment Period 1|Lost to Follow-up|0|||
94360705|NCT00539006|323103895|FG001|Treatment Period 1|Lost to Follow-up|0|||
94360706|NCT00539006|323103896|FG002|Treatment Period 1|Lost to Follow-up|1|||
94360707|NCT00539006|323103897|FG003|Treatment Period 1|Lost to Follow-up|0|||
94360708|NCT00539006|323103894|FG000|Treatment Period 1|Protocol Violation|0|||
94360709|NCT00539006|323103895|FG001|Treatment Period 1|Protocol Violation|0|||
94360710|NCT00539006|323103896|FG002|Treatment Period 1|Protocol Violation|1|||
94360711|NCT00539006|323103897|FG003|Treatment Period 1|Protocol Violation|0|||
94360712|NCT00539006|323103894|FG000|Treatment Period 1|Lack of Efficacy|0|||
94360713|NCT00539006|323103895|FG001|Treatment Period 1|Lack of Efficacy|0|||
94360714|NCT00539006|323103896|FG002|Treatment Period 1|Lack of Efficacy|0|||
94360715|NCT00539006|323103897|FG003|Treatment Period 1|Lack of Efficacy|1|||
94360716|NCT00539006|323103894|FG000|Washout|Adverse Event|2|||
94360717|NCT00539006|323103895|FG001|Washout|Adverse Event|1|||
94360718|NCT00539006|323103896|FG002|Washout|Adverse Event|0|||
94360719|NCT00539006|323103897|FG003|Washout|Adverse Event|0|||
94360720|NCT00539006|323103894|FG000|Washout|Protocol Violation|1|||
94360721|NCT00539006|323103895|FG001|Washout|Protocol Violation|1|||
94360722|NCT00539006|323103896|FG002|Washout|Protocol Violation|0|||
94360723|NCT00539006|323103897|FG003|Washout|Protocol Violation|0|||
94360724|NCT00539006|323103894|FG000|Washout|Withdrawal by Subject|0|||
94360725|NCT00539006|323103895|FG001|Washout|Withdrawal by Subject|2|||
94360726|NCT00539006|323103896|FG002|Washout|Withdrawal by Subject|0|||
94360727|NCT00539006|323103897|FG003|Washout|Withdrawal by Subject|0|||
94360728|NCT00539006|323103894|FG000|Washout|Failed to meet continuation criteria|16|||
94360729|NCT00539006|323103895|FG001|Washout|Failed to meet continuation criteria|5|||
94360730|NCT00539006|323103896|FG002|Washout|Failed to meet continuation criteria|14|||
94360731|NCT00539006|323103897|FG003|Washout|Failed to meet continuation criteria|6|||
94360732|NCT00539006|323103894|FG000|Washout|Other|1|||
94360733|NCT00539006|323103895|FG001|Washout|Other|1|||
94360734|NCT00539006|323103896|FG002|Washout|Other|2|||
94360735|NCT00539006|323103897|FG003|Washout|Other|3|||
94360736|NCT00539006|323103894|FG000|Treatment Period 2|Protocol Violation|1|||
94360737|NCT00539006|323103895|FG001|Treatment Period 2|Protocol Violation|0|||
94360738|NCT00539006|323103896|FG002|Treatment Period 2|Protocol Violation|0|||
94360739|NCT00539006|323103897|FG003|Treatment Period 2|Protocol Violation|0|||
94360740|NCT00539006|323103894|FG000|Treatment Period 2|Other|0|||
94360741|NCT00539006|323103895|FG001|Treatment Period 2|Other|1|||
94360742|NCT00539006|323103896|FG002|Treatment Period 2|Other|0|||
94629481|NCT01852110|324103911|FG002|Overall Study|Protocol Violation|0|||
94629482|NCT01852110|324103912|FG003|Overall Study|Protocol Violation|0|||
94629483|NCT01852110|324103913|FG004|Overall Study|Protocol Violation|0|||
94629484|NCT01852110|324103914|FG005|Overall Study|Protocol Violation|0|||
94629485|NCT01852110|324103909|FG000|Overall Study|Study Terminated by Sponsor|30|||
94629486|NCT01852110|324103910|FG001|Overall Study|Study Terminated by Sponsor|32|||
94629487|NCT01852110|324103911|FG002|Overall Study|Study Terminated by Sponsor|0|||
94360743|NCT00539006|323103897|FG003|Treatment Period 2|Other|0|||
94360744|NCT00320801|323103899|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
94629488|NCT01852110|324103912|FG003|Overall Study|Study Terminated by Sponsor|0|||
94360745|NCT00320801|323103900|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
94360746|NCT00320801|323103901|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
94360747|NCT00320801|323103902|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
94360748|NCT00320801|323103899|FG000|Open-label Run-in Period|Adverse Event|33|||
94360749|NCT00320801|323103900|FG001|Open-label Run-in Period|Adverse Event|0|||
94360750|NCT00320801|323103901|FG002|Open-label Run-in Period|Adverse Event|0|||
94360751|NCT00320801|323103902|FG003|Open-label Run-in Period|Adverse Event|0|||
94360752|NCT00320801|323103899|FG000|Open-label Run-in Period|Administrative|10|||
94360753|NCT00320801|323103900|FG001|Open-label Run-in Period|Administrative|0|||
94360754|NCT00320801|323103901|FG002|Open-label Run-in Period|Administrative|0|||
94360755|NCT00320801|323103902|FG003|Open-label Run-in Period|Administrative|0|||
94629489|NCT01852110|324103913|FG004|Overall Study|Study Terminated by Sponsor|0|||
94629490|NCT01852110|324103914|FG005|Overall Study|Study Terminated by Sponsor|0|||
94360756|NCT00320801|323103899|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
94360757|NCT00320801|323103900|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
94360758|NCT00320801|323103901|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
94360759|NCT00320801|323103902|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
94360760|NCT00320801|323103899|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
94360761|NCT00320801|323103900|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
94360762|NCT00320801|323103901|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
94360763|NCT00320801|323103902|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
94629491|NCT01852110|324103909|FG000|Overall Study|Withdrawal by Subject|4|||
94629492|NCT01852110|324103910|FG001|Overall Study|Withdrawal by Subject|4|||
94629493|NCT01852110|324103911|FG002|Overall Study|Withdrawal by Subject|0|||
94629494|NCT01852110|324103912|FG003|Overall Study|Withdrawal by Subject|0|||
94629495|NCT01852110|324103913|FG004|Overall Study|Withdrawal by Subject|0|||
94629496|NCT01852110|324103914|FG005|Overall Study|Withdrawal by Subject|0|||
94629497|NCT00793403|324103915|FG000|Overall Study|Other|73|||
94629498|NCT02392247|324103924|FG000|Overall Study|Withdrawal by Subject|1|||
94629499|NCT02392247|324103924|FG000|Overall Study|Surgery cancelled; no data|1|||
94629500|NCT01991067|324103925|FG000|Overall Study|Lost to Follow-up|6|||
94629501|NCT01991067|324103926|FG001|Overall Study|Lost to Follow-up|5|||
94629502|NCT01411228|324103928|FG000|Overall Study|Lost to Follow-up|0|||
94629503|NCT01411228|324103929|FG001|Overall Study|Lost to Follow-up|0|||
94629504|NCT01411228|324103930|FG002|Overall Study|Lost to Follow-up|1|||
94629505|NCT01411228|324103928|FG000|Overall Study|Withdrawal by Subject|1|||
94629506|NCT01411228|324103929|FG001|Overall Study|Withdrawal by Subject|0|||
94629507|NCT01411228|324103930|FG002|Overall Study|Withdrawal by Subject|0|||
94629508|NCT02664441|324103932|FG000|Randomization|Withdrawal by Subject|0|||
94629509|NCT02664441|324103933|FG001|Randomization|Withdrawal by Subject|1|||
94360764|NCT00320801|323103899|FG000|Open-label Run-in Period|Did not qualify|1|||
94629510|NCT02664441|324103932|FG000|36-week Randomized Trial|Adverse Event|2|||
94629511|NCT02664441|324103933|FG001|36-week Randomized Trial|Adverse Event|0|||
94629512|NCT02664441|324103932|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
94461275|NCT00250458|323478232|FG000|Overall Study|Withdrawal by Subject|4|||
94461276|NCT00250458|323478233|FG001|Overall Study|Withdrawal by Subject|2|||
94629513|NCT02664441|324103933|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
94629514|NCT02664441|324103932|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
94629515|NCT02664441|324103933|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
94629516|NCT02664441|324103932|FG000|18-week Open Label Extension|Adverse Event|1|||
94629517|NCT02664441|324103933|FG001|18-week Open Label Extension|Adverse Event|0|||
94256390|NCT03426267|322732876|FG001|Overall Study|Prohibited Treatment Intake|3|||
94256391|NCT03426267|322732875|FG000|Overall Study|Lack of Efficacy|0|||
94256392|NCT03426267|322732876|FG001|Overall Study|Lack of Efficacy|25|||
94256393|NCT03426267|322732875|FG000|Overall Study|other|3|||
94256394|NCT03426267|322732876|FG001|Overall Study|other|0|||
94256395|NCT01580969|322732877|FG000|Overall Study|Physician Decision|3|||
94256396|NCT01580969|322732878|FG001|Overall Study|Physician Decision|0|||
94256397|NCT01580969|322732879|FG002|Overall Study|Physician Decision|0|||
94256398|NCT00448123|322732880|FG000|Overall Study|Lost to Follow-up|9|||
94256399|NCT00448123|322732881|FG001|Overall Study|Lost to Follow-up|6|||
94256400|NCT00448123|322732880|FG000|Overall Study|Physician Decision|6|||
94256401|NCT00448123|322732881|FG001|Overall Study|Physician Decision|6|||
94256402|NCT01272804|322732883|FG000|Overall Study|Adverse Event|1|||
94256403|NCT01272804|322732884|FG001|Overall Study|Adverse Event|0|||
94256404|NCT01272804|322732885|FG002|Overall Study|Adverse Event|0|||
94256405|NCT01272804|322732886|FG003|Overall Study|Adverse Event|0|||
94256406|NCT01272804|322732887|FG004|Overall Study|Adverse Event|2|||
94256407|NCT01272804|322732888|FG005|Overall Study|Adverse Event|1|||
94256408|NCT01275131|322732892|FG000|Period 1|Withdrawal by Subject|1|||
94256409|NCT01275131|322732893|FG001|Period 1|Withdrawal by Subject|0|||
94256410|NCT01275131|322732894|FG002|Period 1|Withdrawal by Subject|3|||
94256411|NCT01275131|322732895|FG003|Period 1|Withdrawal by Subject|2|||
94256412|NCT01275131|322732892|FG000|Period 1|Physician Decision|1|||
94256413|NCT01275131|322732893|FG001|Period 1|Physician Decision|0|||
94256414|NCT01275131|322732894|FG002|Period 1|Physician Decision|0|||
94256415|NCT01275131|322732895|FG003|Period 1|Physician Decision|0|||
94256416|NCT01275131|322732892|FG000|Period 2 (Crossover)|Adverse Event|0|||
94256417|NCT01275131|322732893|FG001|Period 2 (Crossover)|Adverse Event|1|||
94256418|NCT01275131|322732894|FG002|Period 2 (Crossover)|Adverse Event|0|||
94256419|NCT01275131|322732895|FG003|Period 2 (Crossover)|Adverse Event|0|||
94256420|NCT01275131|322732892|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
94256421|NCT01275131|322732893|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
94256422|NCT01275131|322732894|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
94256423|NCT01275131|322732895|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
94256424|NCT00731120|322732896|FG000|Overall Study|Adverse Event|7|||
94256425|NCT00731120|322732897|FG001|Overall Study|Adverse Event|6|||
94256426|NCT00731120|322732898|FG002|Overall Study|Adverse Event|8|||
94256427|NCT00731120|322732896|FG000|Overall Study|Lack of Efficacy|4|||
94256428|NCT00731120|322732897|FG001|Overall Study|Lack of Efficacy|5|||
94256429|NCT00731120|322732898|FG002|Overall Study|Lack of Efficacy|4|||
94256430|NCT00731120|322732896|FG000|Overall Study|Noncompliance with Study Drug|3|||
94256431|NCT00731120|322732897|FG001|Overall Study|Noncompliance with Study Drug|3|||
94256432|NCT00731120|322732898|FG002|Overall Study|Noncompliance with Study Drug|1|||
94256433|NCT00731120|322732896|FG000|Overall Study|Protocol Deviations|1|||
94256434|NCT00731120|322732897|FG001|Overall Study|Protocol Deviations|6|||
94256435|NCT00731120|322732898|FG002|Overall Study|Protocol Deviations|1|||
94256436|NCT00731120|322732896|FG000|Overall Study|Withdrawal of Consent|13|||
94256437|NCT00731120|322732897|FG001|Overall Study|Withdrawal of Consent|8|||
94256438|NCT00731120|322732898|FG002|Overall Study|Withdrawal of Consent|4|||
94256439|NCT00731120|322732896|FG000|Overall Study|Lost to Follow-up|10|||
94256440|NCT00731120|322732897|FG001|Overall Study|Lost to Follow-up|15|||
94256441|NCT00731120|322732898|FG002|Overall Study|Lost to Follow-up|17|||
94256442|NCT00731120|322732896|FG000|Overall Study|Other|4|||
94256443|NCT00731120|322732897|FG001|Overall Study|Other|0|||
94256444|NCT00731120|322732898|FG002|Overall Study|Other|1|||
94256445|NCT01142596|322732904|FG000|Overall Study|Withdrawal by Subject|9|||
94256446|NCT01142596|322732905|FG001|Overall Study|Withdrawal by Subject|35|||
94256447|NCT01142596|322732904|FG000|Overall Study|Adverse Event|8|||
94256448|NCT01142596|322732905|FG001|Overall Study|Adverse Event|35|||
94256449|NCT01142596|322732904|FG000|Overall Study|Lack of Efficacy|5|||
94256450|NCT01142596|322732905|FG001|Overall Study|Lack of Efficacy|9|||
94256451|NCT01142596|322732904|FG000|Overall Study|Lost to Follow-up|2|||
94256452|NCT01142596|322732905|FG001|Overall Study|Lost to Follow-up|3|||
94256453|NCT01142596|322732904|FG000|Overall Study|Other reason (not specified)|5|||
94256454|NCT01142596|322732905|FG001|Overall Study|Other reason (not specified)|4|||
94256455|NCT03945825|322732910|FG000|Overall Study|Enrolled but treatment not administered|0|||
94256456|NCT03945825|322732911|FG001|Overall Study|Enrolled but treatment not administered|0|||
94256457|NCT03945825|322732912|FG002|Overall Study|Enrolled but treatment not administered|0|||
94256458|NCT03945825|322732913|FG003|Overall Study|Enrolled but treatment not administered|0|||
94256459|NCT03945825|322732914|FG004|Overall Study|Enrolled but treatment not administered|1|||
94256460|NCT03945825|322732915|FG005|Overall Study|Enrolled but treatment not administered|0|||
94256461|NCT03945825|322732910|FG000|Overall Study|Lost to Follow-up|1|||
94256462|NCT03945825|322732911|FG001|Overall Study|Lost to Follow-up|5|||
94256463|NCT03945825|322732912|FG002|Overall Study|Lost to Follow-up|0|||
94256464|NCT03945825|322732913|FG003|Overall Study|Lost to Follow-up|1|||
94256465|NCT03945825|322732914|FG004|Overall Study|Lost to Follow-up|2|||
94256466|NCT03945825|322732915|FG005|Overall Study|Lost to Follow-up|2|||
94256467|NCT03945825|322732910|FG000|Overall Study|Withdrawal by Subject|1|||
94256468|NCT03945825|322732911|FG001|Overall Study|Withdrawal by Subject|0|||
94256469|NCT03945825|322732912|FG002|Overall Study|Withdrawal by Subject|1|||
94256470|NCT03945825|322732913|FG003|Overall Study|Withdrawal by Subject|1|||
94256471|NCT03945825|322732914|FG004|Overall Study|Withdrawal by Subject|0|||
94256472|NCT03945825|322732915|FG005|Overall Study|Withdrawal by Subject|1|||
94256473|NCT00928447|322732916|FG000|Overall Study|Withdrawal by Subject|1|||
94256474|NCT00928447|322732916|FG000|Overall Study|Investigator's decision|1|||
94256475|NCT03333837|322732919|FG000|Overall Study|Adverse Event|2|||
94256476|NCT03333837|322732920|FG001|Overall Study|Adverse Event|1|||
94256477|NCT03333837|322732921|FG002|Overall Study|Adverse Event|1|||
94256478|NCT03333837|322732922|FG003|Overall Study|Adverse Event|1|||
94256479|NCT03333837|322732923|FG004|Overall Study|Adverse Event|0|||
94256480|NCT03333837|322732919|FG000|Overall Study|Caregiver withdrew|0|||
94256481|NCT03333837|322732920|FG001|Overall Study|Caregiver withdrew|2|||
94256482|NCT03333837|322732921|FG002|Overall Study|Caregiver withdrew|1|||
94256483|NCT03333837|322732922|FG003|Overall Study|Caregiver withdrew|0|||
94256484|NCT03333837|322732923|FG004|Overall Study|Caregiver withdrew|0|||
94256485|NCT03333837|322732919|FG000|Overall Study|Withdrawal by Subject|0|||
94256486|NCT03333837|322732920|FG001|Overall Study|Withdrawal by Subject|0|||
94256487|NCT03333837|322732921|FG002|Overall Study|Withdrawal by Subject|1|||
94256488|NCT03333837|322732922|FG003|Overall Study|Withdrawal by Subject|1|||
94256489|NCT03333837|322732923|FG004|Overall Study|Withdrawal by Subject|3|||
94256490|NCT03333837|322732919|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
94256491|NCT03333837|322732920|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
94256492|NCT03333837|322732921|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
94256493|NCT03333837|322732922|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
94256494|NCT03333837|322732923|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
94256495|NCT00985153|322732924|FG000|Overall Study|Lost to Follow-up|16|||
94256496|NCT00985153|322732925|FG001|Overall Study|Lost to Follow-up|19|||
94256497|NCT00985153|322732926|FG002|Overall Study|Lost to Follow-up|17|||
94256498|NCT00985153|322732927|FG003|Overall Study|Lost to Follow-up|20|||
94256499|NCT00985153|322732924|FG000|Overall Study|Protocol Violation|3|||
94256500|NCT00985153|322732925|FG001|Overall Study|Protocol Violation|2|||
94256501|NCT00985153|322732926|FG002|Overall Study|Protocol Violation|4|||
94256502|NCT00985153|322732927|FG003|Overall Study|Protocol Violation|3|||
94256503|NCT00985153|322732924|FG000|Overall Study|Withdrawal by Subject|6|||
94256504|NCT00985153|322732925|FG001|Overall Study|Withdrawal by Subject|11|||
94256505|NCT00985153|322732926|FG002|Overall Study|Withdrawal by Subject|11|||
94256506|NCT00985153|322732927|FG003|Overall Study|Withdrawal by Subject|10|||
94256507|NCT00985153|322732924|FG000|Overall Study|Missed One or More Bleeds|7|||
94256508|NCT00985153|322732925|FG001|Overall Study|Missed One or More Bleeds|7|||
94256509|NCT00985153|322732926|FG002|Overall Study|Missed One or More Bleeds|8|||
94256510|NCT00985153|322732927|FG003|Overall Study|Missed One or More Bleeds|10|||
94256511|NCT00985153|322732924|FG000|Overall Study|Incomplete Safety Follow-up|3|||
94256512|NCT00985153|322732925|FG001|Overall Study|Incomplete Safety Follow-up|5|||
94256513|NCT00985153|322732926|FG002|Overall Study|Incomplete Safety Follow-up|4|||
94256514|NCT00985153|322732927|FG003|Overall Study|Incomplete Safety Follow-up|4|||
94256515|NCT00511901|322732928|FG000|Overall Study|Withdrawal by Subject|1|||
94256516|NCT00511901|322732929|FG001|Overall Study|Withdrawal by Subject|3|||
94256517|NCT01281969|322732930|FG000|Overall Study|not randomized didn't meet criteria|0|||
94256518|NCT01281969|322732931|FG001|Overall Study|not randomized didn't meet criteria|0|||
94256519|NCT01281969|322732932|FG002|Overall Study|not randomized didn't meet criteria|7|||
94256520|NCT01281969|322732930|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
94256521|NCT01281969|322732931|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
94256522|NCT01281969|322732932|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
94256523|NCT01281969|322732930|FG000|Overall Study|not randomized, child consent not given|0|||
94256524|NCT01281969|322732931|FG001|Overall Study|not randomized, child consent not given|0|||
94256525|NCT01281969|322732932|FG002|Overall Study|not randomized, child consent not given|2|||
94256526|NCT01074216|322732933|FG000|Overall Study|Physician Decision|1|||
94256527|NCT01074216|322732933|FG000|Overall Study|Not Treated|12|||
94256528|NCT05056987|322732934|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
94256529|NCT05056987|322732935|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
94256530|NCT05056987|322732934|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
94256531|NCT05056987|322732935|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
94256532|NCT00368992|322732937|FG000|Overall Study|Ineligible|5|||
94256533|NCT00368992|322732937|FG000|Overall Study|Refused treatment|3|||
94360765|NCT00320801|323103900|FG001|Open-label Run-in Period|Did not qualify|0|||
94256534|NCT00368992|322732937|FG000|Overall Study|Lack of Efficacy|63|||
94256535|NCT00368992|322732937|FG000|Overall Study|Adverse Event|26|||
94256536|NCT00368992|322732937|FG000|Overall Study|Death|4|||
94256537|NCT00368992|322732937|FG000|Overall Study|Other|9|||
94256538|NCT00427895|322732940|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
94256539|NCT00427895|322732941|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
94256540|NCT00427895|322732942|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
94256541|NCT00427895|322732943|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
94256542|NCT00427895|322732944|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
94256543|NCT00427895|322732945|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
94256544|NCT00427895|322732946|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
94256545|NCT00427895|322732947|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
94360766|NCT00320801|323103901|FG002|Open-label Run-in Period|Did not qualify|0|||
94360767|NCT00320801|323103902|FG003|Open-label Run-in Period|Did not qualify|0|||
94360768|NCT00320801|323103899|FG000|Double-blind Phase|Withdrawal by Subject|0|||
94360769|NCT00320801|323103900|FG001|Double-blind Phase|Withdrawal by Subject|0|||
94360770|NCT00320801|323103901|FG002|Double-blind Phase|Withdrawal by Subject|1|||
94360771|NCT00320801|323103902|FG003|Double-blind Phase|Withdrawal by Subject|0|||
94360772|NCT00320801|323103899|FG000|Double-blind Phase|Adverse Event|0|||
94360773|NCT00320801|323103900|FG001|Double-blind Phase|Adverse Event|2|||
94360774|NCT00320801|323103901|FG002|Double-blind Phase|Adverse Event|8|||
94360775|NCT00320801|323103902|FG003|Double-blind Phase|Adverse Event|0|||
94360776|NCT00320801|323103899|FG000|Double-blind Phase|Administrative|0|||
94360777|NCT00320801|323103900|FG001|Double-blind Phase|Administrative|0|||
94360778|NCT00320801|323103901|FG002|Double-blind Phase|Administrative|4|||
94360779|NCT00320801|323103902|FG003|Double-blind Phase|Administrative|0|||
94360780|NCT00320801|323103899|FG000|Double-blind Phase|Lack of Efficacy|0|||
94360781|NCT00320801|323103900|FG001|Double-blind Phase|Lack of Efficacy|9|||
94360782|NCT00320801|323103901|FG002|Double-blind Phase|Lack of Efficacy|1|||
94360783|NCT00320801|323103902|FG003|Double-blind Phase|Lack of Efficacy|0|||
94360784|NCT00320801|323103899|FG000|Extension Phase|Withdrawal by Subject|0|||
94360785|NCT00320801|323103900|FG001|Extension Phase|Withdrawal by Subject|0|||
94360786|NCT00320801|323103901|FG002|Extension Phase|Withdrawal by Subject|0|||
94360787|NCT00320801|323103902|FG003|Extension Phase|Withdrawal by Subject|6|||
94360788|NCT00320801|323103899|FG000|Extension Phase|Adverse Event|0|||
94360789|NCT00320801|323103900|FG001|Extension Phase|Adverse Event|0|||
94360790|NCT00320801|323103901|FG002|Extension Phase|Adverse Event|0|||
94360791|NCT00320801|323103902|FG003|Extension Phase|Adverse Event|8|||
94360792|NCT00320801|323103899|FG000|Extension Phase|Administrative|0|||
94360793|NCT00320801|323103900|FG001|Extension Phase|Administrative|0|||
94360794|NCT00320801|323103901|FG002|Extension Phase|Administrative|0|||
94360795|NCT00320801|323103902|FG003|Extension Phase|Administrative|29|||
94360796|NCT00320801|323103899|FG000|Extension Phase|Lack of Efficacy|0|||
94360797|NCT00320801|323103900|FG001|Extension Phase|Lack of Efficacy|0|||
94360798|NCT00320801|323103901|FG002|Extension Phase|Lack of Efficacy|0|||
94360799|NCT00320801|323103902|FG003|Extension Phase|Lack of Efficacy|2|||
94360800|NCT00320801|323103899|FG000|Extension Phase|Lost to Follow-up|0|||
94360801|NCT00320801|323103900|FG001|Extension Phase|Lost to Follow-up|0|||
94360802|NCT00320801|323103901|FG002|Extension Phase|Lost to Follow-up|0|||
94360803|NCT00320801|323103902|FG003|Extension Phase|Lost to Follow-up|3|||
94360804|NCT00577031|323103903|FG000|Overall Study|Adverse Event|52|||
94360805|NCT00577031|323103903|FG000|Overall Study|Progression of disease|93|||
94674936|NCT01197508|324263170|FG003|Overall Study|Lost to Follow-up|0|||
94256546|NCT00427895|322732940|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
94360806|NCT00577031|323103903|FG000|Overall Study|Protocol Violation|5|||
94360807|NCT00577031|323103903|FG000|Overall Study|Participant withdrew consent|13|||
94360808|NCT00577031|323103903|FG000|Overall Study|Participant non-compliance|5|||
94360809|NCT00577031|323103903|FG000|Overall Study|Need for surgery|17|||
94360810|NCT00577031|323103903|FG000|Overall Study|Medical decision|14|||
94360811|NCT00577031|323103903|FG000|Overall Study|Death|6|||
94360812|NCT00807040|323103904|FG000|Overall Study|Death|24|||
94360813|NCT00807040|323103905|FG001|Overall Study|Death|29|||
94360814|NCT00807040|323103904|FG000|Overall Study|Withdrawal by Subject|8|||
94360815|NCT00807040|323103905|FG001|Overall Study|Withdrawal by Subject|6|||
94674937|NCT01197508|324263167|FG000|Overall Study|Other|2|||
94360816|NCT00807040|323103904|FG000|Overall Study|Lost to Follow-up|4|||
94360817|NCT00807040|323103905|FG001|Overall Study|Lost to Follow-up|6|||
94360818|NCT00890409|323103906|FG000|Overall Study|Lost to Follow-up|20|||
94360819|NCT00890409|323103907|FG001|Overall Study|Lost to Follow-up|21|||
94360820|NCT00455923|323103908|FG000|Overall Study|Pregnancy|0|||
94360821|NCT00455923|323103909|FG001|Overall Study|Pregnancy|2|||
94360822|NCT00455923|323103908|FG000|Overall Study|Other|3|||
94360823|NCT00455923|323103909|FG001|Overall Study|Other|1|||
94360824|NCT00938015|323103914|FG000|Overall Study|Death|2|||
94360825|NCT00938015|323103914|FG000|Overall Study|Lost to Follow-up|32|||
94360826|NCT00938015|323103914|FG000|Overall Study|Adverse Event|32|||
94629518|NCT02664441|324103932|FG000|18-week Open Label Extension|Physician Decision|1|||
94256547|NCT00427895|322732941|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
94256548|NCT00427895|322732942|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
94256549|NCT00427895|322732943|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
94256550|NCT00427895|322732944|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
94256551|NCT00427895|322732945|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
94256552|NCT00427895|322732946|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
94256553|NCT00427895|322732947|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
94256554|NCT00427895|322732940|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
94256555|NCT00427895|322732941|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
94256556|NCT00427895|322732942|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
94256557|NCT00427895|322732943|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
94256558|NCT00427895|322732944|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
94256559|NCT00427895|322732945|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
94256560|NCT00427895|322732946|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
94256561|NCT00427895|322732947|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
94256562|NCT00427895|322732940|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
94256563|NCT00427895|322732941|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
94256564|NCT00427895|322732942|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
94256565|NCT00427895|322732943|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
94256566|NCT00427895|322732944|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
94256567|NCT00427895|322732945|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
94256568|NCT00427895|322732946|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
94256569|NCT00427895|322732947|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
94256570|NCT00427895|322732940|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
94256571|NCT00427895|322732941|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
94256572|NCT00427895|322732942|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
94256573|NCT00427895|322732943|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
94256574|NCT00427895|322732944|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
94256575|NCT00427895|322732945|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
94256576|NCT00427895|322732946|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
94256577|NCT00427895|322732947|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
94256578|NCT00427895|322732940|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
94256579|NCT00427895|322732941|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
94256580|NCT00427895|322732942|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
94256581|NCT00427895|322732943|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
94256582|NCT00427895|322732944|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
94256583|NCT00427895|322732945|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
94256584|NCT00427895|322732946|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
94256585|NCT00427895|322732947|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
94256586|NCT00427895|322732940|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
94629519|NCT02664441|324103933|FG001|18-week Open Label Extension|Physician Decision|0|||
94629520|NCT02664441|324103932|FG000|18-week Open Label Extension|Death|1|||
94629521|NCT02664441|324103933|FG001|18-week Open Label Extension|Death|0|||
94629522|NCT02664441|324103932|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
94629523|NCT02664441|324103933|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
94629524|NCT03562481|324103934|FG000|First Intervention|Lost to Follow-up|1|||
94629525|NCT03562481|324103935|FG001|First Intervention|Lost to Follow-up|0|||
94629526|NCT05620563|324103950|FG000|Overall Study|Adverse Event|3|||
94629527|NCT05620563|324103951|FG001|Overall Study|Adverse Event|1|||
94629528|NCT05620563|324103950|FG000|Overall Study|Lost to Follow-up|0|||
94629529|NCT05620563|324103951|FG001|Overall Study|Lost to Follow-up|2|||
94629530|NCT05620563|324103950|FG000|Overall Study|Protocol Deviation|1|||
94629531|NCT05620563|324103951|FG001|Overall Study|Protocol Deviation|2|||
94629532|NCT05620563|324103950|FG000|Overall Study|Withdrawal by Subject|3|||
94629533|NCT05620563|324103951|FG001|Overall Study|Withdrawal by Subject|3|||
94629534|NCT05620563|324103950|FG000|Overall Study|Physician Decision|0|||
94629535|NCT05620563|324103951|FG001|Overall Study|Physician Decision|1|||
94629536|NCT00065507|324103952|FG000|Overall Study|Death|16|||
94629537|NCT00065507|324103953|FG001|Overall Study|Death|17|||
94629538|NCT00065507|324103952|FG000|Overall Study|Adverse Event|4|||
94629539|NCT00065507|324103953|FG001|Overall Study|Adverse Event|3|||
94256587|NCT00427895|322732941|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
94256588|NCT00427895|322732942|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
94256589|NCT00427895|322732943|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
94256590|NCT00427895|322732944|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
94256591|NCT00427895|322732945|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
94256592|NCT00427895|322732946|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
94360827|NCT00938015|323103914|FG000|Overall Study|Non-responder|52|||
94629540|NCT00065507|324103952|FG000|Overall Study|Lack of Efficacy|0|||
94629541|NCT00065507|324103953|FG001|Overall Study|Lack of Efficacy|6|||
94629542|NCT00065507|324103952|FG000|Overall Study|Poor/Non-compliance|3|||
94629543|NCT00065507|324103953|FG001|Overall Study|Poor/Non-compliance|2|||
94674938|NCT01197508|324263168|FG001|Overall Study|Other|3|||
94674939|NCT01197508|324263169|FG002|Overall Study|Other|2|||
94674940|NCT01197508|324263170|FG003|Overall Study|Other|2|||
94674941|NCT01301391|324263171|FG000|Overall Study|Death|13|||
94674942|NCT01301391|324263171|FG000|Overall Study|Lost to Follow-up|3|||
94674943|NCT01301391|324263171|FG000|Overall Study|Physician Decision|2|||
94674944|NCT01301391|324263171|FG000|Overall Study|Sponsor's decision|8|||
94674945|NCT00293267|324263175|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
94674946|NCT00293267|324263176|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
94674947|NCT00293267|324263175|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
94674948|NCT00293267|324263176|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
94674949|NCT00293267|324263175|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
94674950|NCT00293267|324263176|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
94674951|NCT00293267|324263175|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
94674952|NCT00293267|324263176|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
94360828|NCT00938015|323103914|FG000|Overall Study|Reason not related to Etanercept|29|||
94360829|NCT03186794|323103915|FG000|Overall Study|Physician Decision|2|||
94674953|NCT00293267|324263175|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
94674954|NCT00293267|324263176|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
94674955|NCT00293267|324263175|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
94674956|NCT00293267|324263176|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
94674957|NCT00293267|324263175|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
94256593|NCT00427895|322732947|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
94256594|NCT00427895|322732940|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
94256595|NCT00427895|322732941|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
94256596|NCT00427895|322732942|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
94256597|NCT00427895|322732943|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
94256598|NCT00427895|322732944|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
94256599|NCT00427895|322732945|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
94256600|NCT00427895|322732946|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
94256601|NCT00427895|322732947|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
94256602|NCT00427895|322732940|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
94256603|NCT00427895|322732941|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
94256604|NCT00427895|322732942|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
94256605|NCT00427895|322732943|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
94256606|NCT00427895|322732944|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
94256607|NCT00427895|322732945|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
94256608|NCT00427895|322732946|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
94256609|NCT00427895|322732947|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
94256610|NCT00427895|322732940|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
94256611|NCT00427895|322732941|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
94256612|NCT00427895|322732942|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
94256613|NCT00427895|322732943|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
94256614|NCT00427895|322732944|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
94256615|NCT00427895|322732945|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
94256616|NCT00427895|322732946|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
94256617|NCT00427895|322732947|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
94256618|NCT00427895|322732940|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
94256619|NCT00427895|322732941|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
94256620|NCT00427895|322732942|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
94256621|NCT00427895|322732943|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
94256622|NCT00427895|322732944|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
94256623|NCT00427895|322732945|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
94256624|NCT00427895|322732946|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
94256625|NCT00427895|322732947|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
94256626|NCT00427895|322732940|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
94256627|NCT00427895|322732941|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
94256628|NCT00427895|322732942|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
94256629|NCT00427895|322732943|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
94256630|NCT00427895|322732944|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
94256631|NCT00427895|322732945|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
94256632|NCT00427895|322732946|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
94256633|NCT00427895|322732947|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
94256634|NCT00427895|322732940|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
94256635|NCT00427895|322732941|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
94256636|NCT00427895|322732942|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
94256637|NCT00427895|322732943|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
94360830|NCT03186794|323103915|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
94360831|NCT03075826|323103916|FG000|Overall Study|Withdrawal by Subject|1|||
94360832|NCT03075826|323103916|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
94360833|NCT00903409|323103917|FG000|Overall Study|Adverse Event|11|||
94360834|NCT00903409|323103918|FG001|Overall Study|Adverse Event|9|||
94674958|NCT00293267|324263176|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
94674959|NCT00293267|324263175|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
94360835|NCT00903409|323103917|FG000|Overall Study|Non-compliance with Protocol|1|||
94360836|NCT00903409|323103918|FG001|Overall Study|Non-compliance with Protocol|1|||
94360837|NCT00903409|323103917|FG000|Overall Study|Laboratory Abnormality|2|||
94360838|NCT00903409|323103918|FG001|Overall Study|Laboratory Abnormality|0|||
94360839|NCT00903409|323103917|FG000|Overall Study|Withdrawal by Subject|8|||
94360840|NCT00903409|323103918|FG001|Overall Study|Withdrawal by Subject|8|||
94360841|NCT00903409|323103917|FG000|Overall Study|Other|2|||
94360842|NCT00903409|323103918|FG001|Overall Study|Other|3|||
94360843|NCT00903409|323103917|FG000|Overall Study|Lost to Follow-up|2|||
94360844|NCT00903409|323103918|FG001|Overall Study|Lost to Follow-up|6|||
94360845|NCT00690573|323103919|FG000|Overall Study|Lack of Efficacy|8|||
94360846|NCT00690573|323103919|FG000|Overall Study|Withdrawal by Subject|1|||
94360847|NCT00795886|323103920|FG000|Overall Study|Death|10|||
94360848|NCT05554471|323103921|FG000|Overall Study|Physician Decision|2|||
94360849|NCT05554471|323103922|FG001|Overall Study|Physician Decision|1|||
94360850|NCT05554471|323103921|FG000|Overall Study|Lost to Follow-up|2|||
94360851|NCT05554471|323103922|FG001|Overall Study|Lost to Follow-up|1|||
94360852|NCT05554471|323103921|FG000|Overall Study|Death|0|||
94360853|NCT05554471|323103922|FG001|Overall Study|Death|1|||
94360854|NCT02062385|323103923|FG000|Overall Study|Adverse Event|19|||
94360855|NCT02062385|323103924|FG001|Overall Study|Adverse Event|13|||
94360856|NCT02062385|323103925|FG002|Overall Study|Adverse Event|1|||
94360857|NCT02062385|323103926|FG003|Overall Study|Adverse Event|0|||
94360858|NCT02062385|323103923|FG000|Overall Study|Protocol Violation|1|||
94360859|NCT02062385|323103924|FG001|Overall Study|Protocol Violation|0|||
94360860|NCT02062385|323103925|FG002|Overall Study|Protocol Violation|0|||
94360861|NCT02062385|323103926|FG003|Overall Study|Protocol Violation|0|||
94360862|NCT02062385|323103923|FG000|Overall Study|Incomplete EPI by database lock|2|||
94360863|NCT02062385|323103924|FG001|Overall Study|Incomplete EPI by database lock|0|||
94360864|NCT02062385|323103925|FG002|Overall Study|Incomplete EPI by database lock|0|||
94360865|NCT02062385|323103926|FG003|Overall Study|Incomplete EPI by database lock|0|||
94360866|NCT02062385|323103923|FG000|Overall Study|Moved|10|||
94360867|NCT02062385|323103924|FG001|Overall Study|Moved|11|||
94360868|NCT02062385|323103925|FG002|Overall Study|Moved|1|||
94360869|NCT02062385|323103926|FG003|Overall Study|Moved|0|||
94360870|NCT02062385|323103923|FG000|Overall Study|Withdrawn by parent/guardian|46|||
94360871|NCT02062385|323103924|FG001|Overall Study|Withdrawn by parent/guardian|41|||
94360872|NCT02062385|323103925|FG002|Overall Study|Withdrawn by parent/guardian|9|||
94360873|NCT02062385|323103926|FG003|Overall Study|Withdrawn by parent/guardian|8|||
94360874|NCT02062385|323103923|FG000|Overall Study|Death|0|||
94360875|NCT02062385|323103924|FG001|Overall Study|Death|0|||
94360876|NCT02062385|323103925|FG002|Overall Study|Death|0|||
94360877|NCT02062385|323103926|FG003|Overall Study|Death|1|||
94360878|NCT02062385|323103923|FG000|Overall Study|Lost to Follow-up|0|||
94360879|NCT02062385|323103924|FG001|Overall Study|Lost to Follow-up|0|||
94360880|NCT02062385|323103925|FG002|Overall Study|Lost to Follow-up|1|||
94360881|NCT02062385|323103926|FG003|Overall Study|Lost to Follow-up|0|||
94360882|NCT02660489|323105443|FG000|Overall Study|Lost to Follow-up|1|||
94360883|NCT02660489|323105444|FG001|Overall Study|Lost to Follow-up|1|||
94360884|NCT02660489|323105443|FG000|Overall Study|Adverse Event|1|||
94360885|NCT02660489|323105444|FG001|Overall Study|Adverse Event|3|||
94360886|NCT02660489|323105443|FG000|Overall Study|no rhinovirus infection|4|||
94360887|NCT02660489|323105444|FG001|Overall Study|no rhinovirus infection|4|||
94360888|NCT00953017|323105445|FG000|Overall Study|DId not show up for colonoscopy|4|||
94360889|NCT00953017|323105446|FG001|Overall Study|DId not show up for colonoscopy|4|||
94360890|NCT00953017|323105447|FG002|Overall Study|DId not show up for colonoscopy|5|||
94629544|NCT00065507|324103952|FG000|Overall Study|Lost to Follow-up|3|||
94629545|NCT00065507|324103953|FG001|Overall Study|Lost to Follow-up|0|||
94629546|NCT00065507|324103952|FG000|Overall Study|Subject Withdrew Consent|2|||
94629547|NCT00065507|324103953|FG001|Overall Study|Subject Withdrew Consent|1|||
94629548|NCT00065507|324103952|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
94629549|NCT00065507|324103953|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
94629550|NCT00085631|324103954|FG000|Overall Study|Missing Data|4|||
94629551|NCT00085631|324103955|FG001|Overall Study|Missing Data|11|||
94629552|NCT00085631|324103956|FG002|Overall Study|Missing Data|7|||
94629553|NCT00411645|324103957|FG000|Overall Study|Consent Withdrawn|13|||
94629554|NCT00411645|324103958|FG001|Overall Study|Consent Withdrawn|22|||
94360891|NCT00953017|323105448|FG003|Overall Study|DId not show up for colonoscopy|4|||
94360892|NCT00953017|323105445|FG000|Overall Study|Incomplete data|1|||
94360893|NCT00953017|323105446|FG001|Overall Study|Incomplete data|1|||
94360894|NCT00953017|323105447|FG002|Overall Study|Incomplete data|0|||
94360895|NCT00953017|323105448|FG003|Overall Study|Incomplete data|0|||
94360896|NCT00953017|323105445|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
94360897|NCT00953017|323105446|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
94360898|NCT00953017|323105447|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
94360899|NCT00953017|323105448|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
94360900|NCT00953017|323105445|FG000|Overall Study|Brown stool prior to procedure|0|||
94629555|NCT00411645|324103957|FG000|Overall Study|Death|56|||
94629556|NCT00411645|324103958|FG001|Overall Study|Death|135|||
94629557|NCT00411645|324103957|FG000|Overall Study|Investigator/Sponsor Decision|10|||
94629558|NCT00411645|324103958|FG001|Overall Study|Investigator/Sponsor Decision|7|||
94629559|NCT00411645|324103957|FG000|Overall Study|Lost to Follow-up|2|||
94629560|NCT00411645|324103958|FG001|Overall Study|Lost to Follow-up|0|||
94629561|NCT00779467|324103961|FG000|Overall Study|Lack of Efficacy|11|||
94629562|NCT00779467|324103962|FG001|Overall Study|Lack of Efficacy|2|||
94629563|NCT00779467|324103963|FG002|Overall Study|Lack of Efficacy|6|||
94629564|NCT00779467|324103964|FG003|Overall Study|Lack of Efficacy|11|||
94629565|NCT00779467|324103961|FG000|Overall Study|failed inclusion criteria|3|||
94629566|NCT00779467|324103962|FG001|Overall Study|failed inclusion criteria|3|||
94629567|NCT00779467|324103963|FG002|Overall Study|failed inclusion criteria|1|||
94629568|NCT00779467|324103964|FG003|Overall Study|failed inclusion criteria|2|||
94629569|NCT00779467|324103961|FG000|Overall Study|missing data|1|||
94629570|NCT00779467|324103962|FG001|Overall Study|missing data|0|||
94629571|NCT00779467|324103963|FG002|Overall Study|missing data|1|||
94256638|NCT00427895|322732944|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
94256639|NCT00427895|322732945|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
94256640|NCT00427895|322732946|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
94629572|NCT00779467|324103964|FG003|Overall Study|missing data|4|||
94629573|NCT00779467|324103961|FG000|Overall Study|technical issue|0|||
94629574|NCT00779467|324103962|FG001|Overall Study|technical issue|0|||
94256641|NCT00427895|322732947|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
94256642|NCT00427895|322732940|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
94256643|NCT00427895|322732941|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
94256644|NCT00427895|322732942|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
94256645|NCT00427895|322732943|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
94256646|NCT00427895|322732944|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
94256647|NCT00427895|322732945|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
94256648|NCT00427895|322732946|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
94256649|NCT00427895|322732947|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
94256650|NCT00427895|322732940|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
94256651|NCT00427895|322732941|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
94256652|NCT00427895|322732942|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
94256653|NCT00427895|322732943|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
94256654|NCT00427895|322732944|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
94256655|NCT00427895|322732945|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
94256656|NCT00427895|322732946|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
94256657|NCT00427895|322732947|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
94256658|NCT00427895|322732940|FG000|Vax 1/Year 1 Follow-up|Death|1|||
94256659|NCT00427895|322732941|FG001|Vax 1/Year 1 Follow-up|Death|0|||
94256660|NCT00427895|322732942|FG002|Vax 1/Year 1 Follow-up|Death|0|||
94256661|NCT00427895|322732943|FG003|Vax 1/Year 1 Follow-up|Death|0|||
94256662|NCT00427895|322732944|FG004|Vax 1/Year 1 Follow-up|Death|0|||
94256663|NCT00427895|322732945|FG005|Vax 1/Year 1 Follow-up|Death|0|||
94256664|NCT00427895|322732946|FG006|Vax 1/Year 1 Follow-up|Death|0|||
94256665|NCT00427895|322732947|FG007|Vax 1/Year 1 Follow-up|Death|0|||
94256666|NCT00427895|322732940|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
94256667|NCT00427895|322732941|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
94256668|NCT00427895|322732942|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
94256669|NCT00427895|322732943|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
94256670|NCT00427895|322732944|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
94256671|NCT00427895|322732945|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
94256672|NCT00427895|322732946|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
94256673|NCT00427895|322732947|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
94256674|NCT00427895|322732940|FG000|Vax 1/Year 1 Follow-up|Other|0|||
94256675|NCT00427895|322732941|FG001|Vax 1/Year 1 Follow-up|Other|0|||
94256676|NCT00427895|322732942|FG002|Vax 1/Year 1 Follow-up|Other|0|||
94256677|NCT00427895|322732943|FG003|Vax 1/Year 1 Follow-up|Other|2|||
94256678|NCT00427895|322732944|FG004|Vax 1/Year 1 Follow-up|Other|0|||
94256679|NCT00427895|322732945|FG005|Vax 1/Year 1 Follow-up|Other|0|||
94256680|NCT00427895|322732946|FG006|Vax 1/Year 1 Follow-up|Other|0|||
94256681|NCT00427895|322732947|FG007|Vax 1/Year 1 Follow-up|Other|0|||
94256682|NCT00427895|322732940|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
94256683|NCT00427895|322732941|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
94256684|NCT00427895|322732942|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
94256685|NCT00427895|322732943|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
94256686|NCT00427895|322732944|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
94256687|NCT00427895|322732945|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
94256688|NCT00427895|322732946|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
94256689|NCT00427895|322732947|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
94629575|NCT00779467|324103963|FG002|Overall Study|technical issue|2|||
94629576|NCT00779467|324103964|FG003|Overall Study|technical issue|1|||
94629577|NCT00779467|324103961|FG000|Overall Study|unavailable research staff|0|||
94629578|NCT00779467|324103962|FG001|Overall Study|unavailable research staff|0|||
94629579|NCT00779467|324103963|FG002|Overall Study|unavailable research staff|0|||
94629580|NCT00779467|324103964|FG003|Overall Study|unavailable research staff|1|||
94629581|NCT01402544|324103966|FG000|Overall Study|Withdrawal by Subject|6|||
94629582|NCT01442493|324103967|FG000|Overall Study|withdrawn from study|3|||
94629583|NCT01442493|324103968|FG001|Overall Study|withdrawn from study|2|||
94629584|NCT04876274|324103971|FG000|Overall Study|Lost to Follow-up|9|||
94629585|NCT04876274|324103972|FG001|Overall Study|Lost to Follow-up|12|||
94629586|NCT03070782|324103973|FG000|Overall Study|Adverse Event|3|||
94629587|NCT03070782|324103974|FG001|Overall Study|Adverse Event|0|||
94629588|NCT03070782|324103975|FG002|Overall Study|Adverse Event|3|||
94629589|NCT03070782|324103976|FG003|Overall Study|Adverse Event|1|||
94629590|NCT03070782|324103977|FG004|Overall Study|Adverse Event|6|||
94629591|NCT03070782|324103978|FG005|Overall Study|Adverse Event|2|||
94629592|NCT03070782|324103973|FG000|Overall Study|Withdrawal by Subject|2|||
94629593|NCT03070782|324103974|FG001|Overall Study|Withdrawal by Subject|1|||
94629594|NCT03070782|324103975|FG002|Overall Study|Withdrawal by Subject|1|||
94629595|NCT03070782|324103976|FG003|Overall Study|Withdrawal by Subject|0|||
94629596|NCT03070782|324103977|FG004|Overall Study|Withdrawal by Subject|4|||
94629597|NCT03070782|324103978|FG005|Overall Study|Withdrawal by Subject|3|||
94629598|NCT03070782|324103973|FG000|Overall Study|Reason Not Specified|2|||
94629599|NCT03070782|324103974|FG001|Overall Study|Reason Not Specified|0|||
94629600|NCT03070782|324103975|FG002|Overall Study|Reason Not Specified|0|||
94629601|NCT03070782|324103976|FG003|Overall Study|Reason Not Specified|1|||
94629602|NCT03070782|324103977|FG004|Overall Study|Reason Not Specified|2|||
94629603|NCT03070782|324103978|FG005|Overall Study|Reason Not Specified|1|||
94629604|NCT03070782|324103973|FG000|Overall Study|Ineligibility|0|||
94629605|NCT03070782|324103974|FG001|Overall Study|Ineligibility|0|||
94629606|NCT03070782|324103975|FG002|Overall Study|Ineligibility|0|||
94629607|NCT03070782|324103976|FG003|Overall Study|Ineligibility|1|||
94629608|NCT03070782|324103977|FG004|Overall Study|Ineligibility|0|||
94629609|NCT03070782|324103978|FG005|Overall Study|Ineligibility|1|||
94629610|NCT03070782|324103973|FG000|Overall Study|Pregnancy|0|||
94256690|NCT00723021|322732950|FG000|Intervention Period 4|Adverse Event|0|||
94629611|NCT03070782|324103974|FG001|Overall Study|Pregnancy|0|||
94629612|NCT03070782|324103975|FG002|Overall Study|Pregnancy|0|||
94629613|NCT03070782|324103976|FG003|Overall Study|Pregnancy|1|||
94629614|NCT03070782|324103977|FG004|Overall Study|Pregnancy|0|||
94629615|NCT03070782|324103978|FG005|Overall Study|Pregnancy|0|||
94629616|NCT03070782|324103973|FG000|Overall Study|Investigator Judgement|0|||
94629617|NCT03070782|324103974|FG001|Overall Study|Investigator Judgement|0|||
94629618|NCT03070782|324103975|FG002|Overall Study|Investigator Judgement|0|||
94629619|NCT03070782|324103976|FG003|Overall Study|Investigator Judgement|1|||
94629620|NCT03070782|324103977|FG004|Overall Study|Investigator Judgement|0|||
94629621|NCT03070782|324103978|FG005|Overall Study|Investigator Judgement|0|||
94629622|NCT01986985|324103979|FG000|Overall Study|Withdrawal by Subject|4|||
94629623|NCT01986985|324103979|FG000|Overall Study|Scan not completed due to malfunction|3|||
94629624|NCT01948050|324103981|FG000|Overall Study|Withdrawal by Subject|0|||
94629625|NCT01948050|324103982|FG001|Overall Study|Withdrawal by Subject|1|||
94629626|NCT02288559|324103983|FG000|Overall Study|Adverse Event|1|||
94629627|NCT02288559|324103984|FG001|Overall Study|Adverse Event|1|||
94629628|NCT02288559|324103985|FG002|Overall Study|Adverse Event|5|||
94629629|NCT02288559|324103986|FG003|Overall Study|Adverse Event|0|||
94629630|NCT02288559|324103983|FG000|Overall Study|Death|0|||
94629631|NCT02288559|324103984|FG001|Overall Study|Death|0|||
94629632|NCT02288559|324103985|FG002|Overall Study|Death|1|||
94629633|NCT02288559|324103986|FG003|Overall Study|Death|0|||
94629634|NCT02288559|324103983|FG000|Overall Study|Lost to Follow-up|0|||
94629635|NCT02288559|324103984|FG001|Overall Study|Lost to Follow-up|0|||
94629636|NCT02288559|324103985|FG002|Overall Study|Lost to Follow-up|0|||
94629637|NCT02288559|324103986|FG003|Overall Study|Lost to Follow-up|1|||
94629638|NCT02288559|324103983|FG000|Overall Study|Withdrawal by Subject|0|||
94629639|NCT02288559|324103984|FG001|Overall Study|Withdrawal by Subject|0|||
94629640|NCT02288559|324103985|FG002|Overall Study|Withdrawal by Subject|2|||
94629641|NCT02288559|324103986|FG003|Overall Study|Withdrawal by Subject|1|||
94674960|NCT00293267|324263176|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
94674961|NCT00293267|324263175|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
94674962|NCT00293267|324263176|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
94674963|NCT00293267|324263175|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
94674964|NCT00293267|324263176|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
94256691|NCT00723021|322732951|FG001|Intervention Period 4|Adverse Event|0|||
94629642|NCT02288559|324103983|FG000|Overall Study|Reason Not Specified|0|||
94629643|NCT02288559|324103984|FG001|Overall Study|Reason Not Specified|0|||
94629644|NCT02288559|324103985|FG002|Overall Study|Reason Not Specified|3|||
94629645|NCT02288559|324103986|FG003|Overall Study|Reason Not Specified|0|||
94629646|NCT03303079|324103987|FG000|Overall Study|Adverse Event|0|||
94256692|NCT00723021|322732952|FG002|Intervention Period 4|Adverse Event|0|||
94256693|NCT00723021|322732953|FG003|Intervention Period 4|Adverse Event|0|||
94256694|NCT00723021|322732954|FG004|Intervention Period 4|Adverse Event|1|||
94256695|NCT00467285|322732955|FG000|Overall Study|Lost to Follow-up|4|||
94256696|NCT00467285|322732956|FG001|Overall Study|Lost to Follow-up|4|||
94256697|NCT02910739|322732957|FG000|Overall Study|Adverse Event|1|||
94256698|NCT02910739|322732958|FG001|Overall Study|Adverse Event|0|||
94256699|NCT02910739|322732959|FG002|Overall Study|Adverse Event|0|||
94256700|NCT02910739|322732960|FG003|Overall Study|Adverse Event|0|||
94256701|NCT02656823|322732961|FG000|Overall Study|Adverse Event|3|||
94256702|NCT02656823|322732961|FG000|Overall Study|Lost to Follow-up|2|||
94256703|NCT01340651|322732963|FG000|Overall Study|Adverse Event|3|||
94256704|NCT01340651|322732963|FG000|Overall Study|Consent Withdrawn|2|||
94629647|NCT03303079|324103988|FG001|Overall Study|Adverse Event|1|||
94629648|NCT03303079|324103989|FG002|Overall Study|Adverse Event|3|||
94674965|NCT00293267|324263175|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
94256705|NCT01340651|322732963|FG000|Overall Study|Commercial Supply per Sponsor|12|||
94256706|NCT01009580|322732964|FG000|Overall Study|Adverse Event|4|||
94256707|NCT01009580|322732965|FG001|Overall Study|Adverse Event|4|||
94629649|NCT03303079|324103987|FG000|Overall Study|Protocol Violation|5|||
94629650|NCT03303079|324103988|FG001|Overall Study|Protocol Violation|4|||
94629651|NCT03303079|324103989|FG002|Overall Study|Protocol Violation|7|||
94629652|NCT03303079|324103987|FG000|Overall Study|Withdrawal by Subject|2|||
94629653|NCT03303079|324103988|FG001|Overall Study|Withdrawal by Subject|4|||
94629654|NCT03303079|324103989|FG002|Overall Study|Withdrawal by Subject|2|||
94629655|NCT03303079|324103987|FG000|Overall Study|Other than specified|0|||
94629656|NCT03303079|324103988|FG001|Overall Study|Other than specified|2|||
94629657|NCT03303079|324103989|FG002|Overall Study|Other than specified|0|||
94629658|NCT02551731|324103996|FG000|Overall Study|Withdrawal by Subject|2|||
94629659|NCT01961323|324103997|FG000|Overall Study|Withdrawal by Subject|7|||
94629660|NCT01961323|324103997|FG000|Overall Study|Lost to Follow-up|8|||
94629661|NCT01961323|324103997|FG000|Overall Study|screen failure|34|||
94629662|NCT02746874|324103998|FG000|Overall Study|Withdrawal by Subject|0|||
94674966|NCT00293267|324263176|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
94256708|NCT01009580|322732964|FG000|Overall Study|Lack of Efficacy|0|||
94256709|NCT01009580|322732965|FG001|Overall Study|Lack of Efficacy|1|||
94256710|NCT01009580|322732964|FG000|Overall Study|Protocol Violation|2|||
94256711|NCT01009580|322732965|FG001|Overall Study|Protocol Violation|3|||
94256712|NCT01009580|322732964|FG000|Overall Study|Withdrawal Criteria|4|||
94256713|NCT01009580|322732965|FG001|Overall Study|Withdrawal Criteria|6|||
94256714|NCT01009580|322732964|FG000|Overall Study|Unclassified|17|||
94256715|NCT01009580|322732965|FG001|Overall Study|Unclassified|21|||
94256716|NCT03226275|322732966|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
94256717|NCT03226275|322732967|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
94256718|NCT03226275|322732968|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
94256719|NCT03226275|322732969|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
94256720|NCT03226275|322732966|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
94256721|NCT03226275|322732967|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
94256722|NCT03226275|322732968|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
94256723|NCT03226275|322732969|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
94256724|NCT01614197|322734417|FG000|Overall Study|Withdrawal by Subject|0|||
94256725|NCT01614197|322734418|FG001|Overall Study|Withdrawal by Subject|1|||
94256726|NCT01614197|322734419|FG002|Overall Study|Withdrawal by Subject|0|||
94256727|NCT01614197|322734420|FG003|Overall Study|Withdrawal by Subject|0|||
94256728|NCT03646656|322734421|FG000|Overall Study|Lost to Follow-up|1|||
94256729|NCT03646656|322734422|FG001|Overall Study|Lost to Follow-up|0|||
94256730|NCT03646656|322734421|FG000|Overall Study|Withdrawal by Subject|2|||
94256731|NCT03646656|322734422|FG001|Overall Study|Withdrawal by Subject|0|||
94256732|NCT02336178|322734423|FG000|Overall Study|Lost to Follow-up|1|||
94256733|NCT02336178|322734423|FG000|Overall Study|Protocol Violation|1|||
94256734|NCT02336178|322734423|FG000|Overall Study|Withdrawal by Subject|1|||
94256735|NCT02336178|322734423|FG000|Overall Study|Other|1|||
94256736|NCT02647866|322734424|FG000|Overall Study|Adverse Event|0|||
94256737|NCT02647866|322734425|FG001|Overall Study|Adverse Event|0|||
94256738|NCT02647866|322734426|FG002|Overall Study|Adverse Event|2|||
94256739|NCT02647866|322734427|FG003|Overall Study|Adverse Event|2|||
94256740|NCT02647866|322734428|FG004|Overall Study|Adverse Event|1|||
94256741|NCT02647866|322734424|FG000|Overall Study|Disease Worsening|3|||
94256742|NCT02647866|322734425|FG001|Overall Study|Disease Worsening|1|||
94256743|NCT02647866|322734426|FG002|Overall Study|Disease Worsening|0|||
94256744|NCT02647866|322734427|FG003|Overall Study|Disease Worsening|0|||
94256745|NCT02647866|322734428|FG004|Overall Study|Disease Worsening|1|||
94256746|NCT02647866|322734424|FG000|Overall Study|Withdrawal by Subject|1|||
94256747|NCT02647866|322734425|FG001|Overall Study|Withdrawal by Subject|1|||
94256748|NCT02647866|322734426|FG002|Overall Study|Withdrawal by Subject|2|||
94256749|NCT02647866|322734427|FG003|Overall Study|Withdrawal by Subject|4|||
94256750|NCT02647866|322734428|FG004|Overall Study|Withdrawal by Subject|4|||
94256751|NCT02647866|322734424|FG000|Overall Study|Physician Decision|0|||
94256752|NCT02647866|322734425|FG001|Overall Study|Physician Decision|1|||
94256753|NCT02647866|322734426|FG002|Overall Study|Physician Decision|1|||
94256754|NCT02647866|322734427|FG003|Overall Study|Physician Decision|0|||
94256755|NCT02647866|322734428|FG004|Overall Study|Physician Decision|2|||
94256756|NCT02647866|322734424|FG000|Overall Study|Death|0|||
94256757|NCT02647866|322734425|FG001|Overall Study|Death|1|||
94256758|NCT02647866|322734426|FG002|Overall Study|Death|0|||
94256759|NCT02647866|322734427|FG003|Overall Study|Death|0|||
94256760|NCT02647866|322734428|FG004|Overall Study|Death|0|||
94256761|NCT02647866|322734424|FG000|Overall Study|Subject moved to different country|1|||
94256762|NCT02647866|322734425|FG001|Overall Study|Subject moved to different country|0|||
94256763|NCT02647866|322734426|FG002|Overall Study|Subject moved to different country|0|||
94256764|NCT02647866|322734427|FG003|Overall Study|Subject moved to different country|0|||
94256765|NCT02647866|322734428|FG004|Overall Study|Subject moved to different country|0|||
94256766|NCT00825916|322734432|FG000|Overall Study|Lost to Follow-up|4|||
94256767|NCT00825916|322734433|FG001|Overall Study|Lost to Follow-up|2|||
94256768|NCT00825916|322734434|FG002|Overall Study|Lost to Follow-up|1|||
94256769|NCT00687973|322734440|FG000|Overall Study|Adverse Event|18|||
94256770|NCT00687973|322734441|FG001|Overall Study|Adverse Event|28|||
94256771|NCT00687973|322734440|FG000|Overall Study|Lack of Efficacy|2|||
94256772|NCT00687973|322734441|FG001|Overall Study|Lack of Efficacy|3|||
94256773|NCT00687973|322734440|FG000|Overall Study|Protocol Violation|1|||
94256774|NCT00687973|322734441|FG001|Overall Study|Protocol Violation|2|||
94256775|NCT00687973|322734440|FG000|Overall Study|Administrative Reasons|0|||
94256776|NCT00687973|322734441|FG001|Overall Study|Administrative Reasons|2|||
94256777|NCT00687973|322734440|FG000|Overall Study|Withdrawal by Subject|3|||
94256778|NCT00687973|322734441|FG001|Overall Study|Withdrawal by Subject|3|||
94256779|NCT02578862|322734442|FG000|Overall Study|Withdrawal by Subject|0|||
94256780|NCT02578862|322734443|FG001|Overall Study|Withdrawal by Subject|1|||
94256781|NCT02578862|322734442|FG000|Overall Study|Unplanned unilateral procedure|0|||
94256782|NCT02578862|322734443|FG001|Overall Study|Unplanned unilateral procedure|1|||
94256783|NCT01001832|322734452|FG000|Short-term Period|Adverse Event|2|||
94256784|NCT01001832|322734453|FG001|Short-term Period|Adverse Event|3|||
94360901|NCT00953017|323105446|FG001|Overall Study|Brown stool prior to procedure|0|||
94360902|NCT00953017|323105447|FG002|Overall Study|Brown stool prior to procedure|1|||
94360903|NCT00953017|323105448|FG003|Overall Study|Brown stool prior to procedure|0|||
94360904|NCT01519635|323105449|FG000|Overall Study|Withdrawal by Subject|0|||
94360905|NCT01519635|323105450|FG001|Overall Study|Withdrawal by Subject|1|||
94360906|NCT01519635|323105449|FG000|Overall Study|No possibility to put a catheter|1|||
94360907|NCT01519635|323105450|FG001|Overall Study|No possibility to put a catheter|2|||
94360908|NCT04633434|323105451|FG000|Overall Study|Lost to Follow-up|32|||
94360909|NCT04633434|323105452|FG001|Overall Study|Lost to Follow-up|32|||
94360910|NCT04888377|323105453|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
94360911|NCT04888377|323105454|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
94360912|NCT04888377|323105453|FG000|Overall Study|Physician Decision|6|||
94360913|NCT04888377|323105454|FG001|Overall Study|Physician Decision|6|||
94360914|NCT04888377|323105453|FG000|Overall Study|Withdrawal by Subject|7|||
94360915|NCT04888377|323105454|FG001|Overall Study|Withdrawal by Subject|3|||
94360916|NCT04242264|323105455|FG000|Overall Study|Lost to Follow-up|2|||
94360917|NCT04242264|323105456|FG001|Overall Study|Lost to Follow-up|2|||
94360918|NCT04242264|323105457|FG002|Overall Study|Lost to Follow-up|1|||
94360919|NCT04242264|323105458|FG003|Overall Study|Lost to Follow-up|1|||
94360920|NCT04242264|323105455|FG000|Overall Study|Withdrawal by Subject|1|||
94360921|NCT04242264|323105456|FG001|Overall Study|Withdrawal by Subject|0|||
94360922|NCT04242264|323105457|FG002|Overall Study|Withdrawal by Subject|0|||
94360923|NCT04242264|323105458|FG003|Overall Study|Withdrawal by Subject|0|||
94360924|NCT03586427|323105459|FG000|Overall Study|Lost to Follow-up|0|||
94360925|NCT03586427|323105460|FG001|Overall Study|Lost to Follow-up|3|||
94360926|NCT03586427|323105461|FG002|Overall Study|Lost to Follow-up|1|||
94360927|NCT03586427|323105462|FG003|Overall Study|Lost to Follow-up|3|||
94360928|NCT03586427|323105463|FG004|Overall Study|Lost to Follow-up|3|||
94360929|NCT03586427|323105459|FG000|Overall Study|Withdrawal by Subject|0|||
94360930|NCT03586427|323105460|FG001|Overall Study|Withdrawal by Subject|1|||
94360931|NCT03586427|323105461|FG002|Overall Study|Withdrawal by Subject|2|||
94360932|NCT03586427|323105462|FG003|Overall Study|Withdrawal by Subject|1|||
94360933|NCT03586427|323105463|FG004|Overall Study|Withdrawal by Subject|1|||
94360934|NCT03586427|323105459|FG000|Overall Study|Adverse Event|0|||
94360935|NCT03586427|323105460|FG001|Overall Study|Adverse Event|0|||
94360936|NCT03586427|323105461|FG002|Overall Study|Adverse Event|1|||
94360937|NCT03586427|323105462|FG003|Overall Study|Adverse Event|0|||
94360938|NCT03586427|323105463|FG004|Overall Study|Adverse Event|0|||
94360939|NCT03586427|323105459|FG000|Overall Study|Protocol Violation|0|||
94360940|NCT03586427|323105460|FG001|Overall Study|Protocol Violation|0|||
94360941|NCT03586427|323105461|FG002|Overall Study|Protocol Violation|1|||
94360942|NCT03586427|323105462|FG003|Overall Study|Protocol Violation|0|||
94360943|NCT03586427|323105463|FG004|Overall Study|Protocol Violation|1|||
94360944|NCT03586427|323105459|FG000|Overall Study|Noncompliance with study drug|0|||
94360945|NCT03586427|323105460|FG001|Overall Study|Noncompliance with study drug|0|||
94360946|NCT03586427|323105461|FG002|Overall Study|Noncompliance with study drug|1|||
94360947|NCT03586427|323105462|FG003|Overall Study|Noncompliance with study drug|0|||
94360948|NCT03586427|323105463|FG004|Overall Study|Noncompliance with study drug|0|||
94360949|NCT00494234|323105464|FG000|Overall Study|Withdrawal by Subject|1|||
94360950|NCT00494234|323105465|FG001|Overall Study|Withdrawal by Subject|0|||
94629663|NCT02746874|324103999|FG001|Overall Study|Withdrawal by Subject|1|||
94629664|NCT02746874|324103998|FG000|Overall Study|Surgery Date Changed|0|||
94629665|NCT02746874|324103999|FG001|Overall Study|Surgery Date Changed|2|||
94629666|NCT01881776|324104000|FG000|Overall Study|Lost to Follow-up|1|||
94629667|NCT01881776|324104001|FG001|Overall Study|Lost to Follow-up|2|||
94629668|NCT01881776|324104002|FG002|Overall Study|Lost to Follow-up|1|||
94629669|NCT01881776|324104000|FG000|Overall Study|Protocol Violation|0|||
94629670|NCT01881776|324104001|FG001|Overall Study|Protocol Violation|2|||
94629671|NCT01881776|324104002|FG002|Overall Study|Protocol Violation|1|||
94629672|NCT00674661|324104008|FG000|Overall Study|Other|5|||
94629673|NCT00674661|324104009|FG001|Overall Study|Other|7|||
94629674|NCT00674661|324104008|FG000|Overall Study|Lost to Follow-up|6|||
94629675|NCT00674661|324104009|FG001|Overall Study|Lost to Follow-up|3|||
94629676|NCT00674661|324104008|FG000|Overall Study|Withdrawal by Subject|0|||
94629677|NCT00674661|324104009|FG001|Overall Study|Withdrawal by Subject|5|||
94360951|NCT00494234|323105464|FG000|Overall Study|Disease progression|11|||
94360952|NCT00494234|323105465|FG001|Overall Study|Disease progression|8|||
94360953|NCT00494234|323105464|FG000|Overall Study|Death|2|||
94360954|NCT00494234|323105465|FG001|Overall Study|Death|1|||
94360955|NCT03193996|323105466|FG000|Overall Study|Withdrawal by Subject|4|||
94360956|NCT03193996|323105466|FG000|Overall Study|Lost to Follow-up|4|||
94360957|NCT03193996|323105466|FG000|Overall Study|Physician Decision|2|||
94360958|NCT03193996|323105466|FG000|Overall Study|Pregnancy|1|||
94360959|NCT03193996|323105466|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
94360960|NCT03193996|323105466|FG000|Overall Study|Complicating disease|1|||
94360961|NCT00423137|323105467|FG000|Overall Study|Lost to Follow-up|0|||
94360962|NCT00423137|323105468|FG001|Overall Study|Lost to Follow-up|0|||
94674967|NCT00293267|324263175|FG000|Extension - Double-Blind Week 49-156|Death|3|||
94674968|NCT00293267|324263176|FG001|Extension - Double-Blind Week 49-156|Death|0|||
94674969|NCT00293267|324263175|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
94674970|NCT00293267|324263176|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
94674971|NCT00293267|324263175|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
94674972|NCT00293267|324263176|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
94674973|NCT00293267|324263175|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
94674974|NCT00293267|324263176|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
94674975|NCT00293267|324263175|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
94674976|NCT00293267|324263176|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
94674977|NCT00293267|324263175|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
94674978|NCT00293267|324263176|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
94674979|NCT00293267|324263175|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
94674980|NCT00293267|324263176|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
94674981|NCT00293267|324263175|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
94674982|NCT00293267|324263176|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
94674983|NCT00293267|324263175|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
94674984|NCT00293267|324263176|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
94674985|NCT00293267|324263175|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
94674986|NCT00293267|324263176|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
94674987|NCT00293267|324263175|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
94674988|NCT00293267|324263176|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
94674989|NCT00293267|324263175|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
94674990|NCT00293267|324263176|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
94674991|NCT00293267|324263175|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
94674992|NCT00293267|324263176|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
94674993|NCT00293267|324263175|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
94674994|NCT00293267|324263176|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
94674995|NCT00293267|324263175|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
94674996|NCT00293267|324263176|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
94674997|NCT00293267|324263175|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
94674998|NCT00293267|324263176|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
94674999|NCT00293267|324263175|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
94675000|NCT00293267|324263176|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
94675001|NCT00238433|324263178|FG000|Overall Study|Screen failure|1|||
94675002|NCT00238433|324263178|FG000|Overall Study|Lost to Follow-up|1|||
94675003|NCT00238433|324263178|FG000|Overall Study|Death|1|||
94675004|NCT01896869|324263179|FG000|Overall Study|Withdrawal by Subject|0|||
94675005|NCT01896869|324263180|FG001|Overall Study|Withdrawal by Subject|6|||
94675006|NCT01896869|324263179|FG000|Overall Study|Lost to Follow-up|1|||
94256785|NCT01001832|322734452|FG000|Long-term Period|Adverse Event|2|||
94256786|NCT01001832|322734453|FG001|Long-term Period|Adverse Event|1|||
94256787|NCT01001832|322734452|FG000|Long-term Period|Withdrawal by Subject|1|||
94256788|NCT01001832|322734453|FG001|Long-term Period|Withdrawal by Subject|0|||
94256789|NCT01001832|322734452|FG000|Long-term Period|Lack of Efficacy|0|||
94256790|NCT01001832|322734453|FG001|Long-term Period|Lack of Efficacy|2|||
94256791|NCT01001832|322734452|FG000|Long-term Period|Other|1|||
94256792|NCT01001832|322734453|FG001|Long-term Period|Other|2|||
94256793|NCT01001832|322734452|FG000|Follow-up Period|Withdrawal by Subject|1|||
94256794|NCT01001832|322734453|FG001|Follow-up Period|Withdrawal by Subject|0|||
94256795|NCT01001832|322734452|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
94675007|NCT01896869|324263180|FG001|Overall Study|Lost to Follow-up|0|||
94675008|NCT02054806|324263181|FG000|Overall Study|Sponsor Decision|31|||
94675009|NCT02054806|324263181|FG000|Overall Study|Withdrawal by Subject|43|||
94675010|NCT02054806|324263181|FG000|Overall Study|Protocol Violation|2|||
94675011|NCT02054806|324263181|FG000|Overall Study|Lost to Follow-up|10|||
94675012|NCT02054806|324263181|FG000|Overall Study|Death|391|||
94675013|NCT01132326|324263182|FG000|Overall Study|Lack of Efficacy|25|||
94675014|NCT01132326|324263182|FG000|Overall Study|Adverse Event|37|||
94675015|NCT01132326|324263182|FG000|Overall Study|Protocol Violation|1|||
94675016|NCT01132326|324263182|FG000|Overall Study|Lost to Follow-up|16|||
94675017|NCT01132326|324263182|FG000|Overall Study|Withdrawal by Subject|40|||
94675018|NCT01132326|324263182|FG000|Overall Study|Physician Decision|10|||
94256796|NCT01001832|322734453|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
94256797|NCT01001832|322734452|FG000|Follow-up Period|Other|2|||
94256798|NCT01001832|322734453|FG001|Follow-up Period|Other|1|||
94256799|NCT00051363|322734455|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
94256800|NCT00051363|322734456|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
94256801|NCT00051363|322734455|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
94256802|NCT00051363|322734456|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
94360963|NCT00423137|323105469|FG002|Overall Study|Lost to Follow-up|1|||
94675019|NCT01132326|324263182|FG000|Overall Study|Study Termination|80|||
94675020|NCT01132326|324263182|FG000|Overall Study|Declining Health|1|||
94675021|NCT01132326|324263182|FG000|Overall Study|Pregnancy|1|||
94256803|NCT00051363|322734455|FG000|Overall Study|Death|2|||
94256804|NCT00051363|322734456|FG001|Overall Study|Death|2|||
94256805|NCT00051363|322734455|FG000|Overall Study|Excluded Pre-Randomization|2|||
94675022|NCT01132326|324263182|FG000|Overall Study|Caregiver Withdrew Consent|1|||
94675023|NCT01132326|324263182|FG000|Overall Study|Death|5|||
94675024|NCT01132326|324263182|FG000|Overall Study|Subject Unable to Come To Visits|1|||
94256806|NCT00051363|322734456|FG001|Overall Study|Excluded Pre-Randomization|5|||
94256807|NCT00807235|322734457|FG000|Overall Study|Adverse Event|1|||
94256808|NCT00807235|322734458|FG001|Overall Study|Adverse Event|0|||
94256809|NCT01012713|322734459|FG000|Overall Study|Lack of Efficacy|3|||
94256810|NCT00561951|322734461|FG000|Overall Study|Adverse Event|11|||
94256811|NCT00561951|322734462|FG001|Overall Study|Adverse Event|14|||
94256812|NCT00561951|322734463|FG002|Overall Study|Adverse Event|14|||
94256813|NCT00561951|322734461|FG000|Overall Study|Lack of Efficacy|5|||
94256814|NCT00561951|322734462|FG001|Overall Study|Lack of Efficacy|3|||
94256815|NCT00561951|322734463|FG002|Overall Study|Lack of Efficacy|2|||
94256816|NCT00561951|322734461|FG000|Overall Study|Lost to Follow-up|1|||
94256817|NCT00561951|322734462|FG001|Overall Study|Lost to Follow-up|1|||
94256818|NCT00561951|322734463|FG002|Overall Study|Lost to Follow-up|0|||
94256819|NCT00561951|322734461|FG000|Overall Study|Withdrawal by Subject|10|||
94256820|NCT00561951|322734462|FG001|Overall Study|Withdrawal by Subject|9|||
94256821|NCT00561951|322734463|FG002|Overall Study|Withdrawal by Subject|10|||
94256822|NCT00561951|322734461|FG000|Overall Study|Protocol Violation|4|||
94256823|NCT00561951|322734462|FG001|Overall Study|Protocol Violation|3|||
94256824|NCT00561951|322734463|FG002|Overall Study|Protocol Violation|4|||
94256825|NCT00561951|322734461|FG000|Overall Study|Physician Decision|1|||
94256826|NCT00561951|322734462|FG001|Overall Study|Physician Decision|0|||
94256827|NCT00561951|322734463|FG002|Overall Study|Physician Decision|0|||
94256828|NCT00561951|322734461|FG000|Overall Study|Pregnancy|0|||
94256829|NCT00561951|322734462|FG001|Overall Study|Pregnancy|1|||
94629678|NCT01741701|324104010|FG000|Overall Study|Adverse Event|5|||
94629679|NCT01741701|324104011|FG001|Overall Study|Adverse Event|1|||
94629680|NCT01741701|324104010|FG000|Overall Study|Withdrawal by Subject|0|||
94629681|NCT01741701|324104011|FG001|Overall Study|Withdrawal by Subject|1|||
94629682|NCT03049280|324104012|FG000|Overall Study|Physician Decision|1|||
94629683|NCT03552198|324104013|FG000|Overall Study|Lost to Follow-up|42|||
94629684|NCT03552198|324104014|FG001|Overall Study|Lost to Follow-up|48|||
94629685|NCT03552198|324104015|FG002|Overall Study|Lost to Follow-up|15|||
94629686|NCT03552198|324104016|FG003|Overall Study|Lost to Follow-up|19|||
94629687|NCT03552198|324104013|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
94629688|NCT03552198|324104014|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
94629689|NCT03552198|324104015|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
94629690|NCT03552198|324104016|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
94629691|NCT03552198|324104013|FG000|Overall Study|Did not receive air alerts|1|||
94629692|NCT03552198|324104014|FG001|Overall Study|Did not receive air alerts|0|||
94629693|NCT03552198|324104015|FG002|Overall Study|Did not receive air alerts|0|||
94629694|NCT03552198|324104016|FG003|Overall Study|Did not receive air alerts|1|||
94629695|NCT03060629|324104020|FG000|Overall Study|Death|4|||
94629696|NCT03060629|324104021|FG001|Overall Study|Death|5|||
94629697|NCT03060629|324104020|FG000|Overall Study|Withdrawal by Subject|50|||
94629698|NCT03060629|324104021|FG001|Overall Study|Withdrawal by Subject|35|||
94629699|NCT03060629|324104020|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
94629700|NCT03060629|324104021|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
94629701|NCT03060629|324104020|FG000|Overall Study|Participant Relocate|15|||
94629702|NCT03060629|324104021|FG001|Overall Study|Participant Relocate|15|||
94629703|NCT03060629|324104020|FG000|Overall Study|Unable to Contact Participant|34|||
94629704|NCT03060629|324104021|FG001|Overall Study|Unable to Contact Participant|23|||
94629705|NCT03060629|324104020|FG000|Overall Study|Investigator Decision|7|||
94629706|NCT03060629|324104021|FG001|Overall Study|Investigator Decision|7|||
94629707|NCT03060629|324104020|FG000|Overall Study|Study Terminated by Sponsor|1100|||
94629708|NCT03060629|324104021|FG001|Overall Study|Study Terminated by Sponsor|1123|||
94629709|NCT03060629|324104020|FG000|Overall Study|Other|4|||
94629710|NCT03060629|324104021|FG001|Overall Study|Other|4|||
94629711|NCT01691781|324104028|FG000|Overall Study|Withdrawal by Subject|4|||
94629712|NCT01691781|324104029|FG001|Overall Study|Withdrawal by Subject|3|||
94629713|NCT01691781|324104028|FG000|Overall Study|Physician Decision|1|||
94629714|NCT01691781|324104029|FG001|Overall Study|Physician Decision|1|||
94629715|NCT01691781|324104028|FG000|Overall Study|Protocol Violation|2|||
94629716|NCT01691781|324104029|FG001|Overall Study|Protocol Violation|2|||
94629717|NCT01691781|324104028|FG000|Overall Study|Adverse Event|0|||
94629718|NCT01691781|324104029|FG001|Overall Study|Adverse Event|1|||
94629719|NCT01714635|324104030|FG000|Overall Study|Discontinued|1|||
94629720|NCT01714635|324104031|FG001|Overall Study|Discontinued|0|||
94629721|NCT01714635|324104032|FG002|Overall Study|Discontinued|2|||
94256830|NCT00561951|322734463|FG002|Overall Study|Pregnancy|0|||
94256831|NCT00561951|322734461|FG000|Overall Study|Meet Withdrawal Criterion|0|||
94256832|NCT00561951|322734462|FG001|Overall Study|Meet Withdrawal Criterion|1|||
94629722|NCT01714635|324104030|FG000|Overall Study|Missed 6-month exam|1|||
94629723|NCT01714635|324104031|FG001|Overall Study|Missed 6-month exam|0|||
94629724|NCT01714635|324104032|FG002|Overall Study|Missed 6-month exam|0|||
94629725|NCT03978520|324104033|FG000|Overall Study|Adverse Event|2|||
94629726|NCT03978520|324104034|FG001|Overall Study|Adverse Event|5|||
94629727|NCT03978520|324104035|FG002|Overall Study|Adverse Event|3|||
94256833|NCT00561951|322734463|FG002|Overall Study|Meet Withdrawal Criterion|1|||
94256834|NCT00561951|322734461|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
94256835|NCT00561951|322734462|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
94256836|NCT00561951|322734463|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
94256837|NCT01596621|322734464|FG000|Overall Study|Death|4|||
94256838|NCT01596621|322734464|FG000|Overall Study|Withdrawal by Subject|9|||
94256839|NCT01596621|322734464|FG000|Overall Study|Disease Progression|49|||
94256840|NCT01596621|322734464|FG000|Overall Study|Lost to Follow-up|3|||
94256841|NCT01596621|322734464|FG000|Overall Study|Other than specified|13|||
94256842|NCT04508023|322734465|FG000|Overall Study|Withdrawal by Subject|1|||
94256843|NCT04508023|322734466|FG001|Overall Study|Withdrawal by Subject|2|||
94256844|NCT01668667|322734472|FG000|Overall Study|Adverse Event|3|||
94256845|NCT01668667|322734473|FG001|Overall Study|Adverse Event|6|||
94256846|NCT01668667|322734474|FG002|Overall Study|Adverse Event|4|||
94256847|NCT01668667|322734475|FG003|Overall Study|Adverse Event|4|||
94256848|NCT01668667|322734472|FG000|Overall Study|Lack of Efficacy|3|||
94256849|NCT01668667|322734473|FG001|Overall Study|Lack of Efficacy|2|||
94256850|NCT01668667|322734474|FG002|Overall Study|Lack of Efficacy|2|||
94256851|NCT01668667|322734475|FG003|Overall Study|Lack of Efficacy|3|||
94629728|NCT03978520|324104036|FG003|Overall Study|Adverse Event|5|||
94629729|NCT03978520|324104037|FG004|Overall Study|Adverse Event|6|||
94629730|NCT03978520|324104033|FG000|Overall Study|Withdrawal by Subject|10|||
94629731|NCT03978520|324104034|FG001|Overall Study|Withdrawal by Subject|4|||
94629732|NCT03978520|324104035|FG002|Overall Study|Withdrawal by Subject|5|||
94629733|NCT03978520|324104036|FG003|Overall Study|Withdrawal by Subject|6|||
94629734|NCT03978520|324104037|FG004|Overall Study|Withdrawal by Subject|5|||
94629735|NCT03978520|324104033|FG000|Overall Study|Lost to Follow-up|2|||
94360964|NCT00423137|323105470|FG003|Overall Study|Lost to Follow-up|0|||
94360965|NCT00423137|323105467|FG000|Overall Study|Protocol Violation|0|||
94360966|NCT00423137|323105468|FG001|Overall Study|Protocol Violation|0|||
94360967|NCT00423137|323105469|FG002|Overall Study|Protocol Violation|0|||
94360968|NCT00423137|323105470|FG003|Overall Study|Protocol Violation|1|||
94360969|NCT00423137|323105467|FG000|Overall Study|Adverse Event Study disease worse|1|||
94360970|NCT00423137|323105468|FG001|Overall Study|Adverse Event Study disease worse|0|||
94360971|NCT00423137|323105469|FG002|Overall Study|Adverse Event Study disease worse|3|||
94360972|NCT00423137|323105470|FG003|Overall Study|Adverse Event Study disease worse|1|||
94360973|NCT00423137|323105467|FG000|Overall Study|Adverse Event Other|0|||
94360974|NCT00423137|323105468|FG001|Overall Study|Adverse Event Other|0|||
94360975|NCT00423137|323105469|FG002|Overall Study|Adverse Event Other|2|||
94360976|NCT00423137|323105470|FG003|Overall Study|Adverse Event Other|0|||
94360977|NCT02116309|323105471|FG000|Overall Study|Lost to Follow-up|0|||
94360978|NCT02116309|323105472|FG001|Overall Study|Lost to Follow-up|1|||
94360979|NCT02329834|323105473|FG000|Overall Study|Physician Decision|1|||
94360980|NCT02329834|323105474|FG001|Overall Study|Physician Decision|0|||
94360981|NCT01976104|323105475|FG000|Overall Study|Adverse Event|0|||
94360982|NCT01976104|323105476|FG001|Overall Study|Adverse Event|0|||
94360983|NCT01976104|323105477|FG002|Overall Study|Adverse Event|1|||
94360984|NCT01976104|323105478|FG003|Overall Study|Adverse Event|0|||
94360985|NCT01976104|323105475|FG000|Overall Study|Lost to Follow-up|3|||
94360986|NCT01976104|323105476|FG001|Overall Study|Lost to Follow-up|0|||
94360987|NCT01976104|323105477|FG002|Overall Study|Lost to Follow-up|1|||
94360988|NCT01976104|323105478|FG003|Overall Study|Lost to Follow-up|1|||
94360989|NCT01976104|323105475|FG000|Overall Study|Subject Choice|0|||
94360990|NCT01976104|323105476|FG001|Overall Study|Subject Choice|1|||
94360991|NCT01976104|323105477|FG002|Overall Study|Subject Choice|0|||
94256852|NCT01668667|322734472|FG000|Overall Study|Protocol Violation|6|||
94256853|NCT01668667|322734473|FG001|Overall Study|Protocol Violation|10|||
94256854|NCT01668667|322734474|FG002|Overall Study|Protocol Violation|12|||
94360992|NCT01976104|323105478|FG003|Overall Study|Subject Choice|1|||
94629736|NCT03978520|324104034|FG001|Overall Study|Lost to Follow-up|2|||
94629737|NCT03978520|324104035|FG002|Overall Study|Lost to Follow-up|2|||
94256855|NCT01668667|322734475|FG003|Overall Study|Protocol Violation|5|||
94256856|NCT01668667|322734472|FG000|Overall Study|Lost to Follow-up|9|||
94256857|NCT01668667|322734473|FG001|Overall Study|Lost to Follow-up|4|||
94256858|NCT01668667|322734474|FG002|Overall Study|Lost to Follow-up|7|||
94256859|NCT01668667|322734475|FG003|Overall Study|Lost to Follow-up|6|||
94256860|NCT01668667|322734472|FG000|Overall Study|Physician Decision|3|||
94256861|NCT01668667|322734473|FG001|Overall Study|Physician Decision|0|||
94256862|NCT01668667|322734474|FG002|Overall Study|Physician Decision|1|||
94256863|NCT01668667|322734475|FG003|Overall Study|Physician Decision|0|||
94256864|NCT01668667|322734472|FG000|Overall Study|Withdrawal by Subject|7|||
94256865|NCT01668667|322734473|FG001|Overall Study|Withdrawal by Subject|4|||
94256866|NCT01668667|322734474|FG002|Overall Study|Withdrawal by Subject|5|||
94256867|NCT01668667|322734475|FG003|Overall Study|Withdrawal by Subject|5|||
94256868|NCT03110185|322734476|FG000|Overall Study|Death|0|||
94256869|NCT03110185|322734477|FG001|Overall Study|Death|1|||
94256870|NCT03110185|322734476|FG000|Overall Study|Withdrawal by Subject|2|||
94256871|NCT03110185|322734477|FG001|Overall Study|Withdrawal by Subject|7|||
94256872|NCT03110185|322734476|FG000|Overall Study|Time Constraints|0|||
94256873|NCT03110185|322734477|FG001|Overall Study|Time Constraints|6|||
94256874|NCT03110185|322734476|FG000|Overall Study|Conflict with care|5|||
94256875|NCT03110185|322734477|FG001|Overall Study|Conflict with care|12|||
94256876|NCT03110185|322734476|FG000|Overall Study|Protocol Violation|1|||
94256877|NCT03110185|322734477|FG001|Overall Study|Protocol Violation|4|||
94256878|NCT03110185|322734476|FG000|Overall Study|MRI Incompatible|2|||
94256879|NCT03110185|322734477|FG001|Overall Study|MRI Incompatible|0|||
94256880|NCT03110185|322734476|FG000|Overall Study|Patient Refusal|0|||
94256881|NCT03110185|322734477|FG001|Overall Study|Patient Refusal|1|||
94256882|NCT01201265|322734478|FG000|Overall Study|Death|14|||
94256883|NCT01201265|322734478|FG000|Overall Study|Insufficient Therapeutic Response|3|||
94256884|NCT01201265|322734478|FG000|Overall Study|Lost to Follow-up|10|||
94256885|NCT01201265|322734478|FG000|Overall Study|Withdrawal by Subject|7|||
94256886|NCT01201265|322734478|FG000|Overall Study|Disease Progression|4|||
94256887|NCT01759407|322734481|FG000|Overall Study|Protocol Violation|0|||
94256888|NCT01759407|322734482|FG001|Overall Study|Protocol Violation|2|||
94256889|NCT01013597|322734483|FG000|Overall Study|Withdrawal by Subject|1|||
94256890|NCT02513745|322734484|FG000|Overall Study|Criteria at time of surgery not met.|3|||
94256891|NCT02513745|322734485|FG001|Overall Study|Criteria at time of surgery not met.|3|||
94360993|NCT01976104|323105475|FG000|Overall Study|Withdrawal by Subject|3|||
94360994|NCT01976104|323105476|FG001|Overall Study|Withdrawal by Subject|0|||
94360995|NCT01976104|323105477|FG002|Overall Study|Withdrawal by Subject|0|||
94360996|NCT01976104|323105478|FG003|Overall Study|Withdrawal by Subject|1|||
94360997|NCT01976104|323105475|FG000|Overall Study|Other|0|||
94360998|NCT01976104|323105476|FG001|Overall Study|Other|1|||
94360999|NCT01976104|323105477|FG002|Overall Study|Other|0|||
94361000|NCT01976104|323105478|FG003|Overall Study|Other|0|||
94629738|NCT03978520|324104036|FG003|Overall Study|Lost to Follow-up|0|||
94361001|NCT01068418|323105481|FG000|Overall Study|Physician Decision|12|||
94361002|NCT04964960|323105489|FG000|Overall Study|Withdrawal by Subject|1|||
94361003|NCT04409509|323105490|FG000|Overall Study|Failure to meet randomization requirement|1|||
94361004|NCT04409509|323105491|FG001|Overall Study|Failure to meet randomization requirement|0|||
94361005|NCT04409509|323105490|FG000|Overall Study|Adverse Event|0|||
94361006|NCT04409509|323105491|FG001|Overall Study|Adverse Event|1|||
94361007|NCT04409509|323105490|FG000|Overall Study|Death|11|||
94361008|NCT04409509|323105491|FG001|Overall Study|Death|10|||
94361009|NCT04409509|323105490|FG000|Overall Study|Non-compliance with study drug|0|||
94361010|NCT04409509|323105491|FG001|Overall Study|Non-compliance with study drug|1|||
94361011|NCT04409509|323105490|FG000|Overall Study|Lost to Follow-up|0|||
94361012|NCT04409509|323105491|FG001|Overall Study|Lost to Follow-up|3|||
94361013|NCT04409509|323105490|FG000|Overall Study|Withdrawal by Subject|0|||
94361014|NCT04409509|323105491|FG001|Overall Study|Withdrawal by Subject|3|||
94361015|NCT04409509|323105490|FG000|Overall Study|Randomized by mistake|0|||
94361016|NCT04409509|323105491|FG001|Overall Study|Randomized by mistake|1|||
94361017|NCT04409509|323105490|FG000|Overall Study|Other|1|||
94361018|NCT04409509|323105491|FG001|Overall Study|Other|1|||
94629739|NCT03978520|324104037|FG004|Overall Study|Lost to Follow-up|1|||
94629740|NCT03978520|324104033|FG000|Overall Study|COVID-19 infection|0|||
94629741|NCT03978520|324104034|FG001|Overall Study|COVID-19 infection|1|||
94629742|NCT03978520|324104035|FG002|Overall Study|COVID-19 infection|0|||
94256892|NCT01209143|322734486|FG000|Overall Study|Adverse Event|2|||
94256893|NCT01209143|322734487|FG001|Overall Study|Adverse Event|1|||
94256894|NCT01209143|322734486|FG000|Overall Study|Death|0|||
94256895|NCT01209143|322734487|FG001|Overall Study|Death|1|||
94256896|NCT01209143|322734486|FG000|Overall Study|Physician Decision|3|||
94256897|NCT01209143|322734487|FG001|Overall Study|Physician Decision|1|||
94256898|NCT01209143|322734486|FG000|Overall Study|Lost to Follow-up|1|||
94256899|NCT01209143|322734487|FG001|Overall Study|Lost to Follow-up|0|||
94256900|NCT01209143|322734486|FG000|Overall Study|Withdrawal by Subject|2|||
94256901|NCT01209143|322734487|FG001|Overall Study|Withdrawal by Subject|1|||
94256902|NCT01209143|322734486|FG000|Overall Study|Disease progression|11|||
94256903|NCT01209143|322734487|FG001|Overall Study|Disease progression|16|||
94256904|NCT01145755|322734488|FG000|Overall Study|Adverse Event|2|||
94256905|NCT01145755|322734489|FG001|Overall Study|Adverse Event|4|||
94256906|NCT01145755|322734490|FG002|Overall Study|Adverse Event|2|||
94256907|NCT01145755|322734488|FG000|Overall Study|Withdrawal by Subject|2|||
94256908|NCT01145755|322734489|FG001|Overall Study|Withdrawal by Subject|2|||
94256909|NCT01145755|322734490|FG002|Overall Study|Withdrawal by Subject|2|||
94256910|NCT01145755|322734488|FG000|Overall Study|Lost to Follow-up|2|||
94256911|NCT01145755|322734489|FG001|Overall Study|Lost to Follow-up|3|||
94256912|NCT01145755|322734490|FG002|Overall Study|Lost to Follow-up|1|||
94256913|NCT01145755|322734488|FG000|Overall Study|Protocol Violation|0|||
94256914|NCT01145755|322734489|FG001|Overall Study|Protocol Violation|3|||
94256915|NCT01145755|322734490|FG002|Overall Study|Protocol Violation|1|||
94256916|NCT01145755|322734488|FG000|Overall Study|Study Closure|14|||
94256917|NCT01145755|322734489|FG001|Overall Study|Study Closure|14|||
94256918|NCT01145755|322734490|FG002|Overall Study|Study Closure|17|||
94256919|NCT01145755|322734488|FG000|Overall Study|Lack of Efficacy|0|||
94256920|NCT01145755|322734489|FG001|Overall Study|Lack of Efficacy|1|||
94256921|NCT01145755|322734490|FG002|Overall Study|Lack of Efficacy|0|||
94256922|NCT01145755|322734488|FG000|Overall Study|Patient could not swollow medication|0|||
94256923|NCT01145755|322734489|FG001|Overall Study|Patient could not swollow medication|0|||
94256924|NCT01145755|322734490|FG002|Overall Study|Patient could not swollow medication|1|||
94256925|NCT01145755|322734488|FG000|Overall Study|Withdrawal by Subject|0|||
94256926|NCT01145755|322734489|FG001|Overall Study|Withdrawal by Subject|0|||
94256927|NCT01145755|322734490|FG002|Overall Study|Withdrawal by Subject|1|||
94256928|NCT01145755|322734488|FG000|Overall Study|Positive urine ethanol|0|||
94256929|NCT01145755|322734489|FG001|Overall Study|Positive urine ethanol|1|||
94256930|NCT01145755|322734490|FG002|Overall Study|Positive urine ethanol|0|||
94256931|NCT02739360|322734500|FG000|Overall Study|Adverse Event|1|||
94256932|NCT02739360|322734500|FG000|Overall Study|Study terminated by Sponsor|2|||
94256933|NCT05543187|322734505|FG000|Overall Study|Ongoing|3|||
94256934|NCT05543187|322734506|FG001|Overall Study|Ongoing|2|||
94256935|NCT00883051|322734507|FG000|Overall Study|Lost to Follow-up|0|||
94256936|NCT00883051|322734508|FG001|Overall Study|Lost to Follow-up|0|||
94256937|NCT00883051|322734509|FG002|Overall Study|Lost to Follow-up|0|||
94256938|NCT00883051|322734510|FG003|Overall Study|Lost to Follow-up|0|||
94256939|NCT00883051|322734511|FG004|Overall Study|Lost to Follow-up|1|||
94256940|NCT00883051|322734507|FG000|Overall Study|Did not use study medication|24|||
94361019|NCT01418365|323105495|FG000|First Intervention|Withdrawal by Subject|0|||
94256941|NCT00883051|322734508|FG001|Overall Study|Did not use study medication|22|||
94361020|NCT01418365|323105496|FG001|First Intervention|Withdrawal by Subject|1|||
94361021|NCT01418365|323105495|FG000|First Intervention|Non-compliance|1|||
94361022|NCT01418365|323105496|FG001|First Intervention|Non-compliance|0|||
94361023|NCT01418365|323105495|FG000|Second Intervention|Withdrawal by Subject|0|||
94629743|NCT03978520|324104036|FG003|Overall Study|COVID-19 infection|0|||
94629744|NCT03978520|324104037|FG004|Overall Study|COVID-19 infection|0|||
94629745|NCT03978520|324104033|FG000|Overall Study|Other, not specified|9|||
94629746|NCT03978520|324104034|FG001|Overall Study|Other, not specified|4|||
94256942|NCT00883051|322734509|FG002|Overall Study|Did not use study medication|29|||
94256943|NCT00883051|322734510|FG003|Overall Study|Did not use study medication|29|||
94256944|NCT00883051|322734511|FG004|Overall Study|Did not use study medication|17|||
94256945|NCT03604523|322734514|FG000|Overall Study|Physician Decision|1|||
94256946|NCT03604523|322734515|FG001|Overall Study|Physician Decision|0|||
94256947|NCT04675151|322734518|FG000|Overall Study|Protocol Violation|1|||
94256948|NCT04675151|322734519|FG001|Overall Study|Protocol Violation|0|||
94256949|NCT04675151|322734520|FG002|Overall Study|Protocol Violation|0|||
94256950|NCT04675151|322734521|FG003|Overall Study|Protocol Violation|1|||
94256951|NCT02684357|322734522|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
94256952|NCT02684357|322734523|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
94256953|NCT02684357|322734524|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
94256954|NCT02684357|322734525|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
94256955|NCT02684357|322734526|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
94256956|NCT02684357|322734527|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
94256957|NCT02684357|322734522|FG000|Part A|Lost to Follow-up|0|||
94256958|NCT02684357|322734523|FG001|Part A|Lost to Follow-up|2|||
94629747|NCT03978520|324104035|FG002|Overall Study|Other, not specified|1|||
94629748|NCT03978520|324104036|FG003|Overall Study|Other, not specified|1|||
94629749|NCT03978520|324104037|FG004|Overall Study|Other, not specified|2|||
94629750|NCT03978520|324104033|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
94629751|NCT03978520|324104034|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
94629752|NCT03978520|324104035|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
94629753|NCT03978520|324104036|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
94629754|NCT03978520|324104037|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
94629755|NCT00230607|324104038|FG000|Overall Study|Other|3|||
94629756|NCT03672747|324104039|FG000|Overall Study|Lost to Follow-up|1|||
94629757|NCT03672747|324104040|FG001|Overall Study|Lost to Follow-up|1|||
94629758|NCT03672747|324104041|FG002|Overall Study|Lost to Follow-up|2|||
94629759|NCT03672747|324104042|FG003|Overall Study|Lost to Follow-up|2|||
94629760|NCT03672747|324104043|FG004|Overall Study|Lost to Follow-up|2|||
94629761|NCT03672747|324104044|FG005|Overall Study|Lost to Follow-up|1|||
94629762|NCT02634320|324104049|FG000|Overall Study|Adverse Event|2|||
94629763|NCT02634320|324104049|FG000|Overall Study|Lost to Follow-up|3|||
94629764|NCT02634320|324104049|FG000|Overall Study|Moved out of area|2|||
94629765|NCT02634320|324104049|FG000|Overall Study|Out of window for study visits|1|||
94629766|NCT02634320|324104049|FG000|Overall Study|Protocol Violation|1|||
94629767|NCT02634320|324104049|FG000|Overall Study|Withdrawal by Subject|5|||
94629768|NCT02634320|324104049|FG000|Overall Study|Lack of Efficacy|2|||
94629769|NCT02622321|324104050|FG000|Overall Study|Withdrawal by Subject|2|||
94629770|NCT02622321|324104051|FG001|Overall Study|Withdrawal by Subject|0|||
94629771|NCT02622321|324104052|FG002|Overall Study|Withdrawal by Subject|0|||
94629772|NCT02622321|324104053|FG003|Overall Study|Withdrawal by Subject|0|||
94629773|NCT02622321|324104050|FG000|Overall Study|Death|0|||
94629774|NCT02622321|324104051|FG001|Overall Study|Death|0|||
94629775|NCT02622321|324104052|FG002|Overall Study|Death|1|||
94629776|NCT02622321|324104053|FG003|Overall Study|Death|0|||
94629777|NCT02622321|324104050|FG000|Overall Study|Physician Decision|1|||
94629778|NCT02622321|324104051|FG001|Overall Study|Physician Decision|0|||
94629779|NCT02622321|324104052|FG002|Overall Study|Physician Decision|0|||
94629780|NCT02622321|324104053|FG003|Overall Study|Physician Decision|0|||
94629781|NCT00965718|324104054|FG000|Overall Study|Withdrawal by Subject|4|||
94629782|NCT03036072|324104057|FG000|Overall Study|Death|0|||
94629783|NCT03036072|324104058|FG001|Overall Study|Death|1|||
94629784|NCT03036072|324104057|FG000|Overall Study|Withdrawal by Subject|0|||
94629785|NCT03036072|324104058|FG001|Overall Study|Withdrawal by Subject|1|||
94629786|NCT03036072|324104057|FG000|Overall Study|Physician Decision|0|||
94629787|NCT03036072|324104058|FG001|Overall Study|Physician Decision|1|||
94629788|NCT00477971|324104059|FG000|Overall Study|Disease progression|6|||
94629789|NCT00477971|324104060|FG001|Overall Study|Disease progression|0|||
94256959|NCT02684357|322734524|FG002|Part A|Lost to Follow-up|2|||
94256960|NCT02684357|322734525|FG003|Part A|Lost to Follow-up|0|||
94256961|NCT02684357|322734526|FG004|Part A|Lost to Follow-up|0|||
94256962|NCT02684357|322734527|FG005|Part A|Lost to Follow-up|0|||
94256963|NCT02684357|322734522|FG000|Part A|Withdrawal by Subject|3|||
94256964|NCT02684357|322734523|FG001|Part A|Withdrawal by Subject|0|||
94256965|NCT02684357|322734524|FG002|Part A|Withdrawal by Subject|0|||
94256966|NCT02684357|322734525|FG003|Part A|Withdrawal by Subject|0|||
94629790|NCT00477971|324104059|FG000|Overall Study|Withdrawal by Subject|3|||
94629791|NCT00477971|324104060|FG001|Overall Study|Withdrawal by Subject|1|||
94629792|NCT00477971|324104059|FG000|Overall Study|Adverse Event|3|||
94629793|NCT00477971|324104060|FG001|Overall Study|Adverse Event|0|||
94629794|NCT00477971|324104059|FG000|Overall Study|Death|2|||
94629795|NCT00477971|324104060|FG001|Overall Study|Death|4|||
94629796|NCT00477971|324104059|FG000|Overall Study|Alternative treatment|3|||
94629797|NCT00477971|324104060|FG001|Overall Study|Alternative treatment|1|||
94629798|NCT01386554|324104061|FG000|Overall Study|Lost to Follow-up|0|||
94361024|NCT01418365|323105496|FG001|Second Intervention|Withdrawal by Subject|1|||
94361025|NCT00111007|323105497|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
94361026|NCT00111007|323105498|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
94361027|NCT00111007|323105497|FG000|Double-blind (DB) Treatment|Death|5|||
94361028|NCT00111007|323105498|FG001|Double-blind (DB) Treatment|Death|2|||
94361029|NCT00111007|323105497|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
94361030|NCT00111007|323105498|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
94361031|NCT00111007|323105497|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
94361032|NCT00111007|323105498|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
94361033|NCT00111007|323105497|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
94361034|NCT00111007|323105498|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
94361035|NCT00111007|323105497|FG000|Double-blind (DB) Treatment|Relapse|1|||
94361036|NCT00111007|323105498|FG001|Double-blind (DB) Treatment|Relapse|0|||
94361037|NCT00111007|323105497|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
94361038|NCT00111007|323105498|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
94361039|NCT00111007|323105497|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
94361040|NCT00111007|323105498|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
94361041|NCT00111007|323105497|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
94361042|NCT00111007|323105498|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
94361043|NCT00111007|323105497|FG000|Active Follow-up|Adverse Event|1|||
94361044|NCT00111007|323105498|FG001|Active Follow-up|Adverse Event|0|||
94361045|NCT00111007|323105497|FG000|Active Follow-up|Death|2|||
94629799|NCT01386554|324104062|FG001|Overall Study|Lost to Follow-up|0|||
94629800|NCT01386554|324104063|FG002|Overall Study|Lost to Follow-up|1|||
94629801|NCT01386554|324104061|FG000|Overall Study|Adverse Event|2|||
94629802|NCT01386554|324104062|FG001|Overall Study|Adverse Event|5|||
94629803|NCT01386554|324104063|FG002|Overall Study|Adverse Event|2|||
94629804|NCT01386554|324104061|FG000|Overall Study|Progressive disease|1|||
94629805|NCT01386554|324104062|FG001|Overall Study|Progressive disease|2|||
94629806|NCT01386554|324104063|FG002|Overall Study|Progressive disease|2|||
94629807|NCT01386554|324104061|FG000|Overall Study|Administration of live vaccines|0|||
94629808|NCT01386554|324104062|FG001|Overall Study|Administration of live vaccines|1|||
94629809|NCT01386554|324104063|FG002|Overall Study|Administration of live vaccines|0|||
94629810|NCT01386554|324104061|FG000|Overall Study|Investigator discretion|0|||
94629811|NCT01386554|324104062|FG001|Overall Study|Investigator discretion|0|||
94629812|NCT01386554|324104063|FG002|Overall Study|Investigator discretion|1|||
94629813|NCT01386554|324104061|FG000|Overall Study|Reason not collected|0|||
94629814|NCT01386554|324104062|FG001|Overall Study|Reason not collected|1|||
94629815|NCT01386554|324104063|FG002|Overall Study|Reason not collected|0|||
94629816|NCT01134783|324105948|FG000|Overall Study|Pregnancy|16|||
94629817|NCT01134783|324105949|FG001|Overall Study|Pregnancy|8|||
94361046|NCT00111007|323105498|FG001|Active Follow-up|Death|0|||
94361047|NCT00111007|323105497|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
94361048|NCT00111007|323105498|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
94361049|NCT00111007|323105497|FG000|Long Term Follow-up|Death|34|||
94361050|NCT00111007|323105498|FG001|Long Term Follow-up|Death|39|||
94629818|NCT01134783|324105948|FG000|Overall Study|Withdrawal by Subject|15|||
94629819|NCT01134783|324105949|FG001|Overall Study|Withdrawal by Subject|9|||
94629820|NCT01134783|324105948|FG000|Overall Study|Lost to Follow-up|5|||
94629821|NCT01134783|324105949|FG001|Overall Study|Lost to Follow-up|20|||
94629822|NCT04232124|324105952|FG000|Overall Study|Lost to Follow-up|3|||
94629823|NCT02961751|324105953|FG000|Overall Study|Lost to Follow-up|11|||
94629824|NCT02961751|324105953|FG000|Overall Study|Physician Decision|2|||
94629825|NCT02961751|324105953|FG000|Overall Study|Not Eligible at Enrollment|1|||
94675025|NCT00952367|324263183|FG000|Overall Study|Withdrawal by Subject|2|||
94675026|NCT00952367|324263183|FG000|Overall Study|Noncoordination|1|||
94256967|NCT02684357|322734526|FG004|Part A|Withdrawal by Subject|0|||
94256968|NCT02684357|322734527|FG005|Part A|Withdrawal by Subject|0|||
94256969|NCT02684357|322734522|FG000|Part A|Other|0|||
94256970|NCT02684357|322734523|FG001|Part A|Other|1|||
94256971|NCT02684357|322734524|FG002|Part A|Other|0|||
94256972|NCT02684357|322734525|FG003|Part A|Other|0|||
94256973|NCT02684357|322734526|FG004|Part A|Other|0|||
94256974|NCT02684357|322734527|FG005|Part A|Other|0|||
94256975|NCT02684357|322734522|FG000|Part B|Adverse Event (Other)|0|||
94256976|NCT02684357|322734523|FG001|Part B|Adverse Event (Other)|0|||
94256977|NCT02684357|322734524|FG002|Part B|Adverse Event (Other)|0|||
94256978|NCT02684357|322734525|FG003|Part B|Adverse Event (Other)|1|||
94256979|NCT02684357|322734526|FG004|Part B|Adverse Event (Other)|1|||
94256980|NCT02684357|322734527|FG005|Part B|Adverse Event (Other)|1|||
94256981|NCT02684357|322734522|FG000|Part B|Lost to Follow-up|0|||
94256982|NCT02684357|322734523|FG001|Part B|Lost to Follow-up|0|||
94256983|NCT02684357|322734524|FG002|Part B|Lost to Follow-up|0|||
94256984|NCT02684357|322734525|FG003|Part B|Lost to Follow-up|1|||
94256985|NCT02684357|322734526|FG004|Part B|Lost to Follow-up|1|||
94256986|NCT02684357|322734527|FG005|Part B|Lost to Follow-up|7|||
94256987|NCT02684357|322734522|FG000|Part B|Withdrawal by Subject|0|||
94256988|NCT02684357|322734523|FG001|Part B|Withdrawal by Subject|0|||
94256989|NCT02684357|322734524|FG002|Part B|Withdrawal by Subject|0|||
94256990|NCT02684357|322734525|FG003|Part B|Withdrawal by Subject|0|||
94256991|NCT02684357|322734526|FG004|Part B|Withdrawal by Subject|2|||
94256992|NCT02684357|322734527|FG005|Part B|Withdrawal by Subject|4|||
94256993|NCT02684357|322734522|FG000|Part B|Other|0|||
94256994|NCT02684357|322734523|FG001|Part B|Other|0|||
94256995|NCT02684357|322734524|FG002|Part B|Other|0|||
94256996|NCT02684357|322734525|FG003|Part B|Other|1|||
94256997|NCT02684357|322734526|FG004|Part B|Other|0|||
94256998|NCT02684357|322734527|FG005|Part B|Other|1|||
94256999|NCT01658826|322734541|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
94257000|NCT01658826|322734542|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
94257001|NCT01658826|322734541|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
94257002|NCT01658826|322734542|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
94257003|NCT01658826|322734541|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
94257004|NCT01658826|322734542|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
94257005|NCT01658826|322734541|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
94257006|NCT01658826|322734542|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
94257007|NCT01658826|322734541|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
94257008|NCT01658826|322734542|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
94257009|NCT01658826|322734541|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
94257010|NCT01658826|322734542|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
94257011|NCT01658826|322734541|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
94257012|NCT01658826|322734542|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
94257013|NCT01658826|322734541|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
94257014|NCT01658826|322734542|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
94257015|NCT01658826|322734541|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
94257016|NCT01658826|322734542|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
94257017|NCT01696942|322734543|FG000|Overall Study|Withdrawal by Subject|1|||
94257018|NCT01696942|322734544|FG001|Overall Study|Withdrawal by Subject|0|||
94257019|NCT01696942|322734543|FG000|Overall Study|Protocol Violation|1|||
94257020|NCT01696942|322734544|FG001|Overall Study|Protocol Violation|2|||
94257021|NCT01696942|322734543|FG000|Overall Study|screen failure|0|||
94257022|NCT01696942|322734544|FG001|Overall Study|screen failure|1|||
94257023|NCT02881957|322734545|FG000|Overall Study|Comfort care|0|||
94675027|NCT00952367|324263183|FG000|Overall Study|Protocol Violation|3|||
94257024|NCT02881957|322734546|FG001|Overall Study|Comfort care|1|||
94257025|NCT02881957|322734545|FG000|Overall Study|Concurrent trial enrollment|0|||
94257026|NCT02881957|322734546|FG001|Overall Study|Concurrent trial enrollment|1|||
94257027|NCT02881957|322734545|FG000|Overall Study|Discharged within 48 hours|0|||
94257028|NCT02881957|322734546|FG001|Overall Study|Discharged within 48 hours|1|||
94257029|NCT02881957|322734545|FG000|Overall Study|Withdrawal by Subject|2|||
94257030|NCT02881957|322734546|FG001|Overall Study|Withdrawal by Subject|1|||
94257031|NCT02881957|322734545|FG000|Overall Study|Protocol Violation|1|||
94257032|NCT02881957|322734546|FG001|Overall Study|Protocol Violation|0|||
94257033|NCT00658684|322734547|FG000|Overall Study|Adverse Event|10|||
94257034|NCT00658684|322734548|FG001|Overall Study|Adverse Event|8|||
94257035|NCT00658684|322734549|FG002|Overall Study|Adverse Event|2|||
94257036|NCT00658684|322734550|FG003|Overall Study|Adverse Event|0|||
94675028|NCT02230956|324263187|FG000|Overall Study|Adverse Event|1|||
94257037|NCT00658684|322734547|FG000|Overall Study|Withdrawal by Subject|6|||
94361051|NCT00111007|323105497|FG000|Long Term Follow-up|Lost to Follow-up|1|||
94361052|NCT00111007|323105498|FG001|Long Term Follow-up|Lost to Follow-up|1|||
94361053|NCT00111007|323105497|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
94361054|NCT00111007|323105498|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
94361055|NCT00111007|323105497|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
94361056|NCT00111007|323105498|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
94361057|NCT00111007|323105497|FG000|Long Term Follow-up|Missing|10|||
94361058|NCT00111007|323105498|FG001|Long Term Follow-up|Missing|3|||
94361059|NCT03480243|323105500|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
94361060|NCT03480243|323105500|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
94361061|NCT03409328|323105501|FG000|Overall Study|Lost to Follow-up|6|||
94361062|NCT03409328|323105502|FG001|Overall Study|Lost to Follow-up|3|||
94361063|NCT03930615|323105503|FG000|Overall Study|Death|9|||
94361064|NCT03930615|323105504|FG001|Overall Study|Death|3|||
94361065|NCT03930615|323105503|FG000|Overall Study|Lost to Follow-up|1|||
94361066|NCT03930615|323105504|FG001|Overall Study|Lost to Follow-up|2|||
94361067|NCT03930615|323105503|FG000|Overall Study|Physician Decision|3|||
94361068|NCT03930615|323105504|FG001|Overall Study|Physician Decision|4|||
94361069|NCT03930615|323105503|FG000|Overall Study|Withdrawal by Subject|13|||
94361070|NCT03930615|323105504|FG001|Overall Study|Withdrawal by Subject|2|||
94361071|NCT03930615|323105503|FG000|Overall Study|Not treated|1|||
94361072|NCT03930615|323105504|FG001|Overall Study|Not treated|1|||
94361073|NCT04611152|323105505|FG000|Overall Study|Adverse Event|9|||
94361074|NCT04611152|323105506|FG001|Overall Study|Adverse Event|8|||
94361075|NCT04611152|323105505|FG000|Overall Study|Non-compliance with study schedule|1|||
94361076|NCT04611152|323105506|FG001|Overall Study|Non-compliance with study schedule|3|||
94361077|NCT04611152|323105505|FG000|Overall Study|Withdrawal by Subject|5|||
94361078|NCT04611152|323105506|FG001|Overall Study|Withdrawal by Subject|6|||
94361079|NCT04611152|323105505|FG000|Overall Study|Lost to Follow-up|11|||
94361080|NCT04611152|323105506|FG001|Overall Study|Lost to Follow-up|2|||
94361081|NCT04456998|323105511|FG000|Overall Study|Adverse Event|0|||
94361082|NCT04456998|323105512|FG001|Overall Study|Adverse Event|4|||
94361083|NCT04456998|323105511|FG000|Overall Study|Protocol Deviation|0|||
94361084|NCT04456998|323105512|FG001|Overall Study|Protocol Deviation|1|||
94361085|NCT04456998|323105511|FG000|Overall Study|Withdrawal by Subject|0|||
94361086|NCT04456998|323105512|FG001|Overall Study|Withdrawal by Subject|1|||
94361087|NCT00956813|323105513|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
94361088|NCT00956813|323105514|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
94361089|NCT00956813|323105513|FG000|Flaxseed and Placebo|Ineligible|3|||
94361090|NCT00956813|323105514|FG001|Flaxseed and Placebo|Ineligible|1|||
94361091|NCT00002540|323105520|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
94361092|NCT00002540|323105521|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
94361093|NCT00002540|323105520|FG000|Overall Study|Died Before Randomization|2|||
94361094|NCT00002540|323105521|FG001|Overall Study|Died Before Randomization|6|||
94361095|NCT00002540|323105520|FG000|Overall Study|Died Before ASU (Control)|202|||
94361096|NCT00002540|323105521|FG001|Overall Study|Died Before ASU (Control)|0|||
94361097|NCT00002540|323105520|FG000|Overall Study|Refused ASU (Control)|597|||
94361098|NCT00002540|323105521|FG001|Overall Study|Refused ASU (Control)|0|||
94361099|NCT00002540|323105520|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
94361100|NCT00002540|323105521|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
94361101|NCT03917654|323105522|FG000|Year 1|Withdrawal by Subject|1|||
94361102|NCT03917654|323105523|FG001|Year 1|Withdrawal by Subject|0|||
94629826|NCT02961751|324105953|FG000|Overall Study|Protocol Violation|1|||
94361103|NCT03917654|323105524|FG002|Year 1|Withdrawal by Subject|0|||
94361104|NCT03917654|323105525|FG003|Year 1|Withdrawal by Subject|0|||
94361105|NCT03917654|323105526|FG004|Year 1|Withdrawal by Subject|0|||
94629827|NCT00664742|324105954|FG000|Overall Study|Withdrawn due to adverse events|3|||
94629828|NCT00664742|324105954|FG000|Overall Study|Withdrawal by Subject|31|||
94629829|NCT00664742|324105954|FG000|Overall Study|Lost to Follow-up|92|||
94629830|NCT02064868|324105955|FG000|Overall Study|Lost to Follow-up|14|||
94629831|NCT02064868|324105956|FG001|Overall Study|Lost to Follow-up|8|||
94629832|NCT02064868|324105955|FG000|Overall Study|Physician Decision|1|||
94629833|NCT02064868|324105956|FG001|Overall Study|Physician Decision|0|||
94629834|NCT02064868|324105955|FG000|Overall Study|Withdrawal by Subject|14|||
94629835|NCT02064868|324105956|FG001|Overall Study|Withdrawal by Subject|3|||
94629836|NCT02064868|324105955|FG000|Overall Study|Technical Problems or Missing|5|||
94629837|NCT02064868|324105956|FG001|Overall Study|Technical Problems or Missing|2|||
94629838|NCT00931762|324105957|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
94629839|NCT00931762|324105957|FG000|Overall Study|Administrative Problems|5|||
94629840|NCT00931762|324105957|FG000|Overall Study|Death|1|||
94461277|NCT00250458|323478232|FG000|Overall Study|Lack of Migraine Attack|20|||
94461278|NCT00250458|323478233|FG001|Overall Study|Lack of Migraine Attack|9|||
94461279|NCT00250458|323478232|FG000|Overall Study|Qualifying migraine but did not treat|3|||
94461280|NCT00250458|323478233|FG001|Overall Study|Qualifying migraine but did not treat|3|||
94461281|NCT00250458|323478232|FG000|Overall Study|Other|1|||
94461282|NCT00250458|323478233|FG001|Overall Study|Other|0|||
94461283|NCT04329091|323478237|FG000|Overall Study|Physician Decision|5|||
94461284|NCT00723190|323478244|FG000|Overall Study|Withdrawal by Subject|45|||
94461285|NCT00723190|323478244|FG000|Overall Study|Lost to Follow-up|37|||
94461286|NCT00723190|323478244|FG000|Overall Study|Adverse Event|18|||
94461287|NCT00723190|323478244|FG000|Overall Study|Lack of Efficacy|16|||
94461288|NCT00723190|323478244|FG000|Overall Study|Protocol Violation|15|||
94461289|NCT00723190|323478244|FG000|Overall Study|Other-Premature Discontinuation|9|||
94461290|NCT00723190|323478244|FG000|Overall Study|Other-Not included in safety population|2|||
94461291|NCT01258075|323478246|FG000|Overall Study|Adverse Event|8|||
94461292|NCT01258075|323478247|FG001|Overall Study|Adverse Event|3|||
94461293|NCT01258075|323478246|FG000|Overall Study|Lost to Follow-up|11|||
94461294|NCT01258075|323478247|FG001|Overall Study|Lost to Follow-up|6|||
94461295|NCT01258075|323478246|FG000|Overall Study|Withdrawal by Subject|10|||
94461296|NCT01258075|323478247|FG001|Overall Study|Withdrawal by Subject|7|||
94461297|NCT01258075|323478246|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
94461298|NCT01258075|323478247|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
94461299|NCT01258075|323478246|FG000|Overall Study|Other|12|||
94461300|NCT01258075|323478247|FG001|Overall Study|Other|5|||
94461301|NCT04416737|323478249|FG000|Week 1 (First Injection)|Physician Decision|0|||
94461302|NCT04416737|323478250|FG001|Week 1 (First Injection)|Physician Decision|1|||
94461303|NCT04489381|323478251|FG000|Overall Study|Lost to Follow-up|2|||
94461304|NCT04489381|323478252|FG001|Overall Study|Lost to Follow-up|3|||
94461305|NCT04489381|323478251|FG000|Overall Study|Withdrawal by Subject|1|||
94461306|NCT04489381|323478252|FG001|Overall Study|Withdrawal by Subject|0|||
94461307|NCT00574249|323478255|FG000|Overall Study|Adverse Event|6|||
94461308|NCT00574249|323478256|FG001|Overall Study|Adverse Event|18|||
94461309|NCT00574249|323478255|FG000|Overall Study|Lack of Efficacy|5|||
94461310|NCT00574249|323478256|FG001|Overall Study|Lack of Efficacy|3|||
94461311|NCT00574249|323478255|FG000|Overall Study|Lost to Follow-up|4|||
94461312|NCT00574249|323478256|FG001|Overall Study|Lost to Follow-up|3|||
94461313|NCT00574249|323478255|FG000|Overall Study|Protocol Violation|5|||
94461314|NCT00574249|323478256|FG001|Overall Study|Protocol Violation|2|||
94461315|NCT00574249|323478255|FG000|Overall Study|History of carcinoma|1|||
94461316|NCT00574249|323478256|FG001|Overall Study|History of carcinoma|0|||
94461317|NCT00574249|323478255|FG000|Overall Study|Withdrawal by Subject|3|||
94461318|NCT00574249|323478256|FG001|Overall Study|Withdrawal by Subject|0|||
94461319|NCT00574249|323478255|FG000|Overall Study|Physician Decision|1|||
94461320|NCT00574249|323478256|FG001|Overall Study|Physician Decision|0|||
94461321|NCT00574249|323478255|FG000|Overall Study|Pregnancy|1|||
94461322|NCT00574249|323478256|FG001|Overall Study|Pregnancy|0|||
94461323|NCT00574249|323478255|FG000|Overall Study|Excluded by company|0|||
94461324|NCT00574249|323478256|FG001|Overall Study|Excluded by company|1|||
94461325|NCT00574249|323478255|FG000|Overall Study|PPD test taken twice|0|||
94461326|NCT00574249|323478256|FG001|Overall Study|PPD test taken twice|1|||
94461327|NCT03197870|323478258|FG000|Overall Study|Adverse Event|9|||
94461328|NCT03197870|323478259|FG001|Overall Study|Adverse Event|4|||
94461329|NCT03197870|323478260|FG002|Overall Study|Adverse Event|6|||
94461330|NCT03197870|323478258|FG000|Overall Study|Withdrawal by Subject|2|||
94629841|NCT00931762|324105957|FG000|Overall Study|Disease Progression|3|||
94629842|NCT00931762|324105957|FG000|Overall Study|Adverse Event (s)|11|||
94629843|NCT00931762|324105957|FG000|Overall Study|Subject withdrew consent|13|||
94461331|NCT03197870|323478259|FG001|Overall Study|Withdrawal by Subject|3|||
94461332|NCT03197870|323478260|FG002|Overall Study|Withdrawal by Subject|0|||
94461333|NCT03197870|323478258|FG000|Overall Study|Lost to Follow-up|2|||
94461334|NCT03197870|323478259|FG001|Overall Study|Lost to Follow-up|2|||
94461335|NCT03197870|323478260|FG002|Overall Study|Lost to Follow-up|0|||
94461336|NCT03197870|323478258|FG000|Overall Study|data not available|1|||
94461337|NCT03197870|323478259|FG001|Overall Study|data not available|1|||
94461338|NCT03197870|323478260|FG002|Overall Study|data not available|0|||
94461339|NCT02783729|323478261|FG000|Overall Study|Lack of Efficacy|1|||
94629844|NCT01413191|324105958|FG000|Overall Study|Lost to Follow-up|5|||
94361106|NCT03917654|323105527|FG005|Year 1|Withdrawal by Subject|1|||
94361107|NCT03917654|323105528|FG006|Year 1|Withdrawal by Subject|6|||
94361108|NCT03917654|323105529|FG007|Year 1|Withdrawal by Subject|2|||
94361109|NCT03917654|323105530|FG008|Year 1|Withdrawal by Subject|5|||
94361110|NCT03917654|323105531|FG009|Year 1|Withdrawal by Subject|3|||
94361111|NCT03917654|323105532|FG010|Year 1|Withdrawal by Subject|1|||
94361112|NCT03917654|323105533|FG011|Year 1|Withdrawal by Subject|0|||
94361113|NCT03917654|323105522|FG000|Year 1|Travel|0|||
94361114|NCT03917654|323105523|FG001|Year 1|Travel|1|||
94361115|NCT03917654|323105524|FG002|Year 1|Travel|1|||
94361116|NCT03917654|323105525|FG003|Year 1|Travel|0|||
94361117|NCT03917654|323105526|FG004|Year 1|Travel|4|||
94361118|NCT03917654|323105527|FG005|Year 1|Travel|4|||
94361119|NCT03917654|323105528|FG006|Year 1|Travel|10|||
94361120|NCT03917654|323105529|FG007|Year 1|Travel|8|||
94361121|NCT03917654|323105530|FG008|Year 1|Travel|2|||
94361122|NCT03917654|323105531|FG009|Year 1|Travel|5|||
94361123|NCT03917654|323105532|FG010|Year 1|Travel|3|||
94361124|NCT03917654|323105533|FG011|Year 1|Travel|3|||
94361125|NCT03917654|323105522|FG000|Year 1|Subject moved away from site|0|||
94361126|NCT03917654|323105523|FG001|Year 1|Subject moved away from site|1|||
94361127|NCT03917654|323105524|FG002|Year 1|Subject moved away from site|0|||
94361128|NCT03917654|323105525|FG003|Year 1|Subject moved away from site|0|||
94361129|NCT03917654|323105526|FG004|Year 1|Subject moved away from site|0|||
94361130|NCT03917654|323105527|FG005|Year 1|Subject moved away from site|0|||
94361131|NCT03917654|323105528|FG006|Year 1|Subject moved away from site|1|||
94361132|NCT03917654|323105529|FG007|Year 1|Subject moved away from site|2|||
94361133|NCT03917654|323105530|FG008|Year 1|Subject moved away from site|1|||
94361134|NCT03917654|323105531|FG009|Year 1|Subject moved away from site|0|||
94629845|NCT01413191|324105958|FG000|Overall Study|Disease Progression|5|||
94629846|NCT01413191|324105958|FG000|Overall Study|Death|1|||
94629847|NCT01327885|324105967|FG000|Overall Study|Disease progression-according to RECIST|173|||
94629848|NCT01327885|324105968|FG001|Overall Study|Disease progression-according to RECIST|165|||
94629849|NCT01327885|324105967|FG000|Overall Study|Clinical progression|24|||
94629850|NCT01327885|324105968|FG001|Overall Study|Clinical progression|27|||
94629851|NCT01327885|324105967|FG000|Overall Study|Adverse Event|14|||
94629852|NCT01327885|324105968|FG001|Overall Study|Adverse Event|10|||
94629853|NCT01327885|324105967|FG000|Overall Study|Subject choice|5|||
94629854|NCT01327885|324105968|FG001|Overall Study|Subject choice|10|||
94629855|NCT01327885|324105967|FG000|Overall Study|Other|8|||
94629856|NCT01327885|324105968|FG001|Overall Study|Other|6|||
94629857|NCT01327885|324105967|FG000|Overall Study|Withdrawal of consent from study|3|||
94629858|NCT01327885|324105968|FG001|Overall Study|Withdrawal of consent from study|4|||
94629859|NCT01327885|324105967|FG000|Overall Study|Not treated|1|||
94629860|NCT01327885|324105968|FG001|Overall Study|Not treated|1|||
94629861|NCT01327885|324105967|FG000|Overall Study|Administrative decision|0|||
94629862|NCT01327885|324105968|FG001|Overall Study|Administrative decision|1|||
94629863|NCT02564042|324105972|FG000|Overall Study|Adverse Event|4|||
94629864|NCT02564042|324105973|FG001|Overall Study|Adverse Event|4|||
94629865|NCT02564042|324105974|FG002|Overall Study|Adverse Event|3|||
94629866|NCT02564042|324105975|FG003|Overall Study|Adverse Event|0|||
94629867|NCT02564042|324105976|FG004|Overall Study|Adverse Event|0|||
94629868|NCT02564042|324105977|FG005|Overall Study|Adverse Event|1|||
94629869|NCT02564042|324105972|FG000|Overall Study|Lost to Follow-up|1|||
94629870|NCT02564042|324105973|FG001|Overall Study|Lost to Follow-up|1|||
94629871|NCT02564042|324105974|FG002|Overall Study|Lost to Follow-up|1|||
94629872|NCT02564042|324105975|FG003|Overall Study|Lost to Follow-up|0|||
94629873|NCT02564042|324105976|FG004|Overall Study|Lost to Follow-up|1|||
94629874|NCT02564042|324105977|FG005|Overall Study|Lost to Follow-up|1|||
94361135|NCT03917654|323105532|FG010|Year 1|Subject moved away from site|0|||
94361136|NCT03917654|323105533|FG011|Year 1|Subject moved away from site|3|||
94629875|NCT02564042|324105972|FG000|Overall Study|Physician Decision|1|||
94629876|NCT02564042|324105973|FG001|Overall Study|Physician Decision|0|||
94629877|NCT02564042|324105974|FG002|Overall Study|Physician Decision|0|||
94629878|NCT02564042|324105975|FG003|Overall Study|Physician Decision|1|||
94361137|NCT03917654|323105522|FG000|Year 1|Spouse/Family member request|0|||
94361138|NCT03917654|323105523|FG001|Year 1|Spouse/Family member request|0|||
94629879|NCT02564042|324105976|FG004|Overall Study|Physician Decision|0|||
94629880|NCT02564042|324105977|FG005|Overall Study|Physician Decision|0|||
94629881|NCT02564042|324105972|FG000|Overall Study|Withdrawal by Subject|5|||
94629882|NCT02564042|324105973|FG001|Overall Study|Withdrawal by Subject|3|||
94629883|NCT02564042|324105974|FG002|Overall Study|Withdrawal by Subject|2|||
94629884|NCT02564042|324105975|FG003|Overall Study|Withdrawal by Subject|2|||
94629885|NCT02564042|324105976|FG004|Overall Study|Withdrawal by Subject|10|||
94361139|NCT03917654|323105524|FG002|Year 1|Spouse/Family member request|1|||
94361140|NCT03917654|323105525|FG003|Year 1|Spouse/Family member request|0|||
94361141|NCT03917654|323105526|FG004|Year 1|Spouse/Family member request|1|||
94361142|NCT03917654|323105527|FG005|Year 1|Spouse/Family member request|0|||
94361143|NCT03917654|323105528|FG006|Year 1|Spouse/Family member request|0|||
94629886|NCT02564042|324105977|FG005|Overall Study|Withdrawal by Subject|12|||
94629887|NCT04273217|324105978|FG000|Overall Study|Lost to Follow-up|0|||
94629888|NCT04273217|324105979|FG001|Overall Study|Lost to Follow-up|0|||
94629889|NCT04273217|324105980|FG002|Overall Study|Lost to Follow-up|0|||
94629890|NCT04273217|324105981|FG003|Overall Study|Lost to Follow-up|0|||
94629891|NCT04273217|324105982|FG004|Overall Study|Lost to Follow-up|0|||
94629892|NCT04273217|324105983|FG005|Overall Study|Lost to Follow-up|1|||
94629893|NCT04273217|324105978|FG000|Overall Study|Participant non-compliance|0|||
94629894|NCT04273217|324105979|FG001|Overall Study|Participant non-compliance|0|||
94629895|NCT04273217|324105980|FG002|Overall Study|Participant non-compliance|0|||
94629896|NCT04273217|324105981|FG003|Overall Study|Participant non-compliance|0|||
94629897|NCT04273217|324105982|FG004|Overall Study|Participant non-compliance|1|||
94629898|NCT04273217|324105983|FG005|Overall Study|Participant non-compliance|0|||
94629899|NCT04273217|324105978|FG000|Overall Study|Positive urine drug screen|1|||
94629900|NCT04273217|324105979|FG001|Overall Study|Positive urine drug screen|0|||
94629901|NCT04273217|324105980|FG002|Overall Study|Positive urine drug screen|1|||
94629902|NCT04273217|324105981|FG003|Overall Study|Positive urine drug screen|0|||
94629903|NCT04273217|324105982|FG004|Overall Study|Positive urine drug screen|0|||
94629904|NCT04273217|324105983|FG005|Overall Study|Positive urine drug screen|1|||
94629905|NCT00644995|324105984|FG000|Overall Study|Lost to Follow-up|1|||
94629906|NCT00644995|324105985|FG001|Overall Study|Lost to Follow-up|4|||
94629907|NCT00644995|324105984|FG000|Overall Study|Refused|1|||
94629908|NCT00644995|324105985|FG001|Overall Study|Refused|0|||
94629909|NCT01425281|324105986|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
94629910|NCT01425281|324105987|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
94629911|NCT01425281|324105986|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
94629912|NCT01425281|324105987|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
94629913|NCT01425281|324105986|FG000|At 180-day Clinical Follow-up|Death|0|||
94629914|NCT01425281|324105987|FG001|At 180-day Clinical Follow-up|Death|1|||
94629915|NCT01425281|324105986|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
94629916|NCT01425281|324105987|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
94629917|NCT01425281|324105986|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
94629918|NCT01425281|324105987|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
94629919|NCT01425281|324105986|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
94257038|NCT00658684|322734548|FG001|Overall Study|Withdrawal by Subject|4|||
94257039|NCT00658684|322734549|FG002|Overall Study|Withdrawal by Subject|1|||
94257040|NCT00658684|322734550|FG003|Overall Study|Withdrawal by Subject|1|||
94257041|NCT00658684|322734547|FG000|Overall Study|Lack of Efficacy|1|||
94257042|NCT00658684|322734548|FG001|Overall Study|Lack of Efficacy|1|||
94257043|NCT00658684|322734549|FG002|Overall Study|Lack of Efficacy|0|||
94257044|NCT00658684|322734550|FG003|Overall Study|Lack of Efficacy|0|||
94257045|NCT00658684|322734547|FG000|Overall Study|Protocol Violation|1|||
94257046|NCT00658684|322734548|FG001|Overall Study|Protocol Violation|1|||
94257047|NCT00658684|322734549|FG002|Overall Study|Protocol Violation|0|||
94257048|NCT00658684|322734550|FG003|Overall Study|Protocol Violation|0|||
94257049|NCT00658684|322734547|FG000|Overall Study|Pregnancy|1|||
94257050|NCT00658684|322734548|FG001|Overall Study|Pregnancy|1|||
94257051|NCT00658684|322734549|FG002|Overall Study|Pregnancy|0|||
94257052|NCT00658684|322734550|FG003|Overall Study|Pregnancy|0|||
94257053|NCT00688103|322734551|FG000|Overall Study|Adverse Event|4|||
94257054|NCT00688103|322734552|FG001|Overall Study|Adverse Event|1|||
94257055|NCT00688103|322734551|FG000|Overall Study|Lack of Efficacy|11|||
94257056|NCT00688103|322734552|FG001|Overall Study|Lack of Efficacy|1|||
94257057|NCT00688103|322734551|FG000|Overall Study|Withdrawal by Subject|4|||
94257058|NCT00688103|322734552|FG001|Overall Study|Withdrawal by Subject|2|||
94257059|NCT00688103|322734551|FG000|Overall Study|complex reasons|11|||
94257060|NCT00688103|322734552|FG001|Overall Study|complex reasons|9|||
94257061|NCT00252733|322736332|FG000|Overall Study|Withdrawal by Subject|73|||
94257062|NCT00252733|322736333|FG001|Overall Study|Withdrawal by Subject|67|||
94257063|NCT00252733|322736332|FG000|Overall Study|Death|7|||
94257064|NCT00252733|322736333|FG001|Overall Study|Death|5|||
94257065|NCT00252733|322736332|FG000|Overall Study|Lost to Follow-up|12|||
94257066|NCT00252733|322736333|FG001|Overall Study|Lost to Follow-up|6|||
94257067|NCT00252733|322736332|FG000|Overall Study|Multiple Reasons|14|||
94257068|NCT00252733|322736333|FG001|Overall Study|Multiple Reasons|14|||
94257069|NCT00601419|322736336|FG000|Overall Study|Lost to Follow-up|3|||
94629920|NCT01425281|324105987|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
94629921|NCT01425281|324105986|FG000|At 2-year Clinical Follow-up|Death|2|||
94257070|NCT00601419|322736336|FG000|Overall Study|Missed Visits|1|||
94257071|NCT02935452|322736337|FG000|Overall Study|work and life commintment|3|||
94257072|NCT02935452|322736338|FG001|Overall Study|work and life commintment|1|||
94629922|NCT01425281|324105987|FG001|At 2-year Clinical Follow-up|Death|0|||
94629923|NCT01425281|324105986|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
94629924|NCT01425281|324105987|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
94629925|NCT01425281|324105986|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
94675029|NCT02230956|324263188|FG001|Overall Study|Adverse Event|1|||
94257073|NCT04281004|322736339|FG000|Overall Study|Physician Decision|1|||
94257074|NCT04281004|322736340|FG001|Overall Study|Physician Decision|0|||
94361144|NCT03917654|323105529|FG007|Year 1|Spouse/Family member request|2|||
94361145|NCT03917654|323105530|FG008|Year 1|Spouse/Family member request|0|||
94361146|NCT03917654|323105531|FG009|Year 1|Spouse/Family member request|0|||
94361147|NCT03917654|323105532|FG010|Year 1|Spouse/Family member request|0|||
94361148|NCT03917654|323105533|FG011|Year 1|Spouse/Family member request|1|||
94361149|NCT03917654|323105522|FG000|Year 1|Death|0|||
94361150|NCT03917654|323105523|FG001|Year 1|Death|0|||
94361151|NCT03917654|323105524|FG002|Year 1|Death|0|||
94361152|NCT03917654|323105525|FG003|Year 1|Death|0|||
94629926|NCT01425281|324105987|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
94629927|NCT01425281|324105986|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
94629928|NCT01425281|324105987|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
94629929|NCT01425281|324105986|FG000|At 3-year Clinical Follow-up|Death|2|||
94629930|NCT01425281|324105987|FG001|At 3-year Clinical Follow-up|Death|3|||
94629931|NCT01425281|324105986|FG000|At 4-year Clinical Follow-up|Death|7|||
94629932|NCT01425281|324105987|FG001|At 4-year Clinical Follow-up|Death|3|||
94629933|NCT01425281|324105986|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
94257075|NCT03645057|322736346|FG000|Randomization to Baseline|Lost to Follow-up|1|||
94257076|NCT03645057|322736347|FG001|Randomization to Baseline|Lost to Follow-up|0|||
94257077|NCT03645057|322736348|FG002|Randomization to Baseline|Lost to Follow-up|1|||
94257078|NCT03645057|322736349|FG003|Randomization to Baseline|Lost to Follow-up|0|||
94257079|NCT03645057|322736346|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
94257080|NCT03645057|322736347|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
94257081|NCT03645057|322736348|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
94257082|NCT03645057|322736349|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
94257083|NCT03645057|322736346|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
94257084|NCT03645057|322736347|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
94257085|NCT03645057|322736348|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
94257086|NCT03645057|322736349|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
94257087|NCT03645057|322736346|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
94257088|NCT03645057|322736347|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
94257089|NCT03645057|322736348|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
94257090|NCT03645057|322736349|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
94257091|NCT01873495|322736350|FG000|Overall Study|Withdrawal by Subject|1|||
94257092|NCT01873495|322736350|FG000|Overall Study|Physician Decision|3|||
94257093|NCT01873495|322736350|FG000|Overall Study|Adverse Event|1|||
94257094|NCT01873495|322736350|FG000|Overall Study|Removed for Transplantation|1|||
94257095|NCT01873495|322736350|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
94257096|NCT01689337|322736351|FG000|Overall Study|Study Discontinuation|1|||
94257097|NCT03907410|322736353|FG000|Overall Study|Lost to Follow-up|4|||
94257098|NCT03907410|322736354|FG001|Overall Study|Lost to Follow-up|1|||
94257099|NCT03907410|322736355|FG002|Overall Study|Lost to Follow-up|1|||
94257100|NCT03907410|322736353|FG000|Overall Study|Lost to follow-up and research burden|0|||
94257101|NCT03907410|322736354|FG001|Overall Study|Lost to follow-up and research burden|0|||
94257102|NCT03907410|322736355|FG002|Overall Study|Lost to follow-up and research burden|1|||
94257103|NCT00762970|322736356|FG000|Overall Study|Withdrawal by Subject|7|||
94257104|NCT00762970|322736357|FG001|Overall Study|Withdrawal by Subject|4|||
94257105|NCT00762970|322736358|FG002|Overall Study|Withdrawal by Subject|0|||
94257106|NCT00762970|322736356|FG000|Overall Study|Protocol Violation|3|||
94257107|NCT00762970|322736357|FG001|Overall Study|Protocol Violation|1|||
94257108|NCT00762970|322736358|FG002|Overall Study|Protocol Violation|1|||
94257109|NCT00762970|322736356|FG000|Overall Study|Lost to Follow-up|1|||
94257110|NCT00762970|322736357|FG001|Overall Study|Lost to Follow-up|2|||
94257111|NCT00762970|322736358|FG002|Overall Study|Lost to Follow-up|0|||
94257112|NCT00762970|322736356|FG000|Overall Study|Difficulty of handling lens|1|||
94257113|NCT00762970|322736357|FG001|Overall Study|Difficulty of handling lens|2|||
94257114|NCT00762970|322736358|FG002|Overall Study|Difficulty of handling lens|0|||
94257115|NCT00666679|322736359|FG000|First Intervention|Lost to Follow-up|1|||
94257116|NCT00666679|322736360|FG001|First Intervention|Lost to Follow-up|0|||
94257117|NCT00666679|322736359|FG000|First Intervention|Protocol Violation|1|||
94257118|NCT00666679|322736360|FG001|First Intervention|Protocol Violation|0|||
94257119|NCT00666679|322736359|FG000|First Intervention|Withdrawal by Subject|1|||
94257120|NCT00666679|322736360|FG001|First Intervention|Withdrawal by Subject|0|||
94361153|NCT03917654|323105526|FG004|Year 1|Death|0|||
94361154|NCT03917654|323105527|FG005|Year 1|Death|0|||
94361155|NCT03917654|323105528|FG006|Year 1|Death|0|||
94361156|NCT03917654|323105529|FG007|Year 1|Death|0|||
94629934|NCT01425281|324105987|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
94361157|NCT03917654|323105530|FG008|Year 1|Death|1|||
94629935|NCT01425281|324105986|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
94629936|NCT01425281|324105987|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
94629937|NCT01425281|324105986|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
94629938|NCT01425281|324105987|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
94629939|NCT01425281|324105986|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
94629940|NCT01425281|324105987|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
94361158|NCT03917654|323105531|FG009|Year 1|Death|1|||
94675030|NCT02230956|324263189|FG002|Overall Study|Adverse Event|0|||
94675031|NCT02230956|324263187|FG000|Overall Study|Lack of Efficacy|1|||
94675032|NCT02230956|324263188|FG001|Overall Study|Lack of Efficacy|1|||
94675033|NCT02230956|324263189|FG002|Overall Study|Lack of Efficacy|1|||
94675034|NCT02230956|324263187|FG000|Overall Study|Lost to Follow-up|1|||
94675035|NCT02230956|324263188|FG001|Overall Study|Lost to Follow-up|1|||
94675036|NCT02230956|324263189|FG002|Overall Study|Lost to Follow-up|2|||
94675037|NCT02230956|324263187|FG000|Overall Study|Personal Reasons|2|||
94361159|NCT03917654|323105532|FG010|Year 1|Death|0|||
94675038|NCT02230956|324263188|FG001|Overall Study|Personal Reasons|1|||
94361160|NCT03917654|323105533|FG011|Year 1|Death|0|||
94361161|NCT03917654|323105522|FG000|Year 1|Lost to Follow-up|0|||
94361162|NCT03917654|323105523|FG001|Year 1|Lost to Follow-up|0|||
94361163|NCT03917654|323105524|FG002|Year 1|Lost to Follow-up|0|||
94361164|NCT03917654|323105525|FG003|Year 1|Lost to Follow-up|0|||
94361165|NCT03917654|323105526|FG004|Year 1|Lost to Follow-up|0|||
94361166|NCT03917654|323105527|FG005|Year 1|Lost to Follow-up|0|||
94361167|NCT03917654|323105528|FG006|Year 1|Lost to Follow-up|2|||
94361168|NCT03917654|323105529|FG007|Year 1|Lost to Follow-up|0|||
94361169|NCT03917654|323105530|FG008|Year 1|Lost to Follow-up|0|||
94361170|NCT03917654|323105531|FG009|Year 1|Lost to Follow-up|0|||
94361171|NCT03917654|323105532|FG010|Year 1|Lost to Follow-up|0|||
94361172|NCT03917654|323105533|FG011|Year 1|Lost to Follow-up|0|||
94361173|NCT03917654|323105522|FG000|Year 1|Missed visits|0|||
94361174|NCT03917654|323105523|FG001|Year 1|Missed visits|0|||
94361175|NCT03917654|323105524|FG002|Year 1|Missed visits|0|||
94361176|NCT03917654|323105525|FG003|Year 1|Missed visits|0|||
94361177|NCT03917654|323105526|FG004|Year 1|Missed visits|0|||
94361178|NCT03917654|323105527|FG005|Year 1|Missed visits|0|||
94361179|NCT03917654|323105528|FG006|Year 1|Missed visits|0|||
94361180|NCT03917654|323105529|FG007|Year 1|Missed visits|0|||
94361181|NCT03917654|323105530|FG008|Year 1|Missed visits|0|||
94361182|NCT03917654|323105531|FG009|Year 1|Missed visits|0|||
94361183|NCT03917654|323105532|FG010|Year 1|Missed visits|1|||
94361184|NCT03917654|323105533|FG011|Year 1|Missed visits|1|||
94361185|NCT03917654|323105522|FG000|Year 1|Pregnancy|0|||
94361186|NCT03917654|323105523|FG001|Year 1|Pregnancy|0|||
94361187|NCT03917654|323105524|FG002|Year 1|Pregnancy|0|||
94361188|NCT03917654|323105525|FG003|Year 1|Pregnancy|0|||
94361189|NCT03917654|323105526|FG004|Year 1|Pregnancy|0|||
94361190|NCT03917654|323105527|FG005|Year 1|Pregnancy|0|||
94361191|NCT03917654|323105528|FG006|Year 1|Pregnancy|0|||
94361192|NCT03917654|323105529|FG007|Year 1|Pregnancy|1|||
94361193|NCT03917654|323105530|FG008|Year 1|Pregnancy|0|||
94361194|NCT03917654|323105531|FG009|Year 1|Pregnancy|1|||
94361195|NCT03917654|323105532|FG010|Year 1|Pregnancy|0|||
94361196|NCT03917654|323105533|FG011|Year 1|Pregnancy|0|||
94361197|NCT03917654|323105522|FG000|Year 2|Travel|1|||
94361198|NCT03917654|323105523|FG001|Year 2|Travel|0|||
94361199|NCT03917654|323105524|FG002|Year 2|Travel|0|||
94361200|NCT03917654|323105525|FG003|Year 2|Travel|0|||
94361201|NCT03917654|323105526|FG004|Year 2|Travel|1|||
94361202|NCT03917654|323105527|FG005|Year 2|Travel|1|||
94361203|NCT03917654|323105528|FG006|Year 2|Travel|2|||
94361204|NCT03917654|323105529|FG007|Year 2|Travel|1|||
94675039|NCT02230956|324263189|FG002|Overall Study|Personal Reasons|1|||
94675040|NCT02230956|324263187|FG000|Overall Study|Protocol Violation|0|||
94675041|NCT02230956|324263188|FG001|Overall Study|Protocol Violation|1|||
94675042|NCT02230956|324263189|FG002|Overall Study|Protocol Violation|1|||
94675043|NCT02230956|324263187|FG000|Overall Study|Other Miscellaneous Reason|0|||
94675044|NCT02230956|324263188|FG001|Overall Study|Other Miscellaneous Reason|1|||
94675045|NCT02230956|324263189|FG002|Overall Study|Other Miscellaneous Reason|2|||
94361205|NCT03917654|323105530|FG008|Year 2|Travel|0|||
94361206|NCT03917654|323105531|FG009|Year 2|Travel|1|||
94361207|NCT03917654|323105532|FG010|Year 2|Travel|0|||
94361208|NCT03917654|323105533|FG011|Year 2|Travel|1|||
94361209|NCT03917654|323105522|FG000|Year 2|Married|1|||
94361210|NCT03917654|323105523|FG001|Year 2|Married|0|||
94361211|NCT03917654|323105524|FG002|Year 2|Married|0|||
94361212|NCT03917654|323105525|FG003|Year 2|Married|0|||
94361213|NCT03917654|323105526|FG004|Year 2|Married|0|||
94675046|NCT04535947|324263190|FG000|Overall Study|Adverse Event|1|||
94675047|NCT04535947|324263191|FG001|Overall Study|Adverse Event|4|||
94675048|NCT04535947|324263190|FG000|Overall Study|Other reasons not specified|2|||
94675049|NCT04535947|324263191|FG001|Overall Study|Other reasons not specified|0|||
94361214|NCT03917654|323105527|FG005|Year 2|Married|0|||
94361215|NCT03917654|323105528|FG006|Year 2|Married|1|||
94361216|NCT03917654|323105529|FG007|Year 2|Married|1|||
94361217|NCT03917654|323105530|FG008|Year 2|Married|0|||
94361218|NCT03917654|323105531|FG009|Year 2|Married|0|||
94361219|NCT03917654|323105532|FG010|Year 2|Married|0|||
94361220|NCT03917654|323105533|FG011|Year 2|Married|0|||
94361221|NCT03917654|323105522|FG000|Year 2|Subject moved away from site|1|||
94361222|NCT03917654|323105523|FG001|Year 2|Subject moved away from site|0|||
94361223|NCT03917654|323105524|FG002|Year 2|Subject moved away from site|0|||
94361224|NCT03917654|323105525|FG003|Year 2|Subject moved away from site|0|||
94461340|NCT02783729|323478262|FG001|Overall Study|Lack of Efficacy|0|||
94461341|NCT02783729|323478263|FG002|Overall Study|Lack of Efficacy|0|||
94461342|NCT02783729|323478264|FG003|Overall Study|Lack of Efficacy|0|||
94461343|NCT02783729|323478261|FG000|Overall Study|Adverse Event|2|||
94461344|NCT02783729|323478262|FG001|Overall Study|Adverse Event|6|||
94461345|NCT02783729|323478263|FG002|Overall Study|Adverse Event|2|||
94461346|NCT02783729|323478264|FG003|Overall Study|Adverse Event|3|||
94461347|NCT02783729|323478261|FG000|Overall Study|Other|1|||
94461348|NCT02783729|323478262|FG001|Overall Study|Other|6|||
94461349|NCT02783729|323478263|FG002|Overall Study|Other|2|||
94461350|NCT02783729|323478264|FG003|Overall Study|Other|3|||
94461351|NCT02783729|323478261|FG000|Overall Study|Withdrawal by Subject|2|||
94461352|NCT02783729|323478262|FG001|Overall Study|Withdrawal by Subject|3|||
94461353|NCT02783729|323478263|FG002|Overall Study|Withdrawal by Subject|1|||
94461354|NCT02783729|323478264|FG003|Overall Study|Withdrawal by Subject|2|||
94461355|NCT02783729|323478261|FG000|Overall Study|Participant's choice|2|||
94461356|NCT02783729|323478262|FG001|Overall Study|Participant's choice|1|||
94461357|NCT02783729|323478263|FG002|Overall Study|Participant's choice|2|||
94461358|NCT02783729|323478264|FG003|Overall Study|Participant's choice|1|||
94461359|NCT02783729|323478261|FG000|Overall Study|Lost to Follow-up|2|||
94461360|NCT02783729|323478262|FG001|Overall Study|Lost to Follow-up|1|||
94461361|NCT02783729|323478263|FG002|Overall Study|Lost to Follow-up|1|||
94461362|NCT02783729|323478264|FG003|Overall Study|Lost to Follow-up|0|||
94461363|NCT02693171|323478265|FG000|Overall Study|Adverse Event|1|||
94629941|NCT01425281|324105986|FG000|At 5-year Clinical Follow-up|Death|2|||
94629942|NCT01425281|324105987|FG001|At 5-year Clinical Follow-up|Death|0|||
94629943|NCT01425281|324105986|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
94629944|NCT01425281|324105987|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
94629945|NCT01425281|324105986|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
94629946|NCT01425281|324105987|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
94629947|NCT01425281|324105986|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
94629948|NCT01425281|324105987|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
94629949|NCT02051608|324105990|FG000|Part 1: Double Blind Treatment|Death|3|||
94629950|NCT02051608|324105991|FG001|Part 1: Double Blind Treatment|Death|3|||
94629951|NCT02051608|324105992|FG002|Part 1: Double Blind Treatment|Death|0|||
94629952|NCT02051608|324105993|FG003|Part 1: Double Blind Treatment|Death|0|||
94629953|NCT02051608|324105990|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
94629954|NCT02051608|324105991|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
94629955|NCT02051608|324105992|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
94629956|NCT02051608|324105993|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
94629957|NCT02051608|324105990|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
94629958|NCT02051608|324105991|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
94629959|NCT02051608|324105992|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
94629960|NCT02051608|324105993|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
94629961|NCT02051608|324105990|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
94629962|NCT02051608|324105991|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
94629963|NCT02051608|324105992|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
94629964|NCT02051608|324105993|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
94629965|NCT02051608|324105990|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
94629966|NCT02051608|324105991|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
94629967|NCT02051608|324105992|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
94629968|NCT02051608|324105993|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
94629969|NCT02051608|324105990|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
94629970|NCT02051608|324105991|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
94629971|NCT02051608|324105992|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
94629972|NCT02051608|324105993|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
94629973|NCT02051608|324105990|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
94629974|NCT02051608|324105991|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
94629975|NCT02051608|324105992|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
94629976|NCT02051608|324105993|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
94629977|NCT02051608|324105990|FG000|Part 1: Double Blind Treatment|Other|6|||
94629978|NCT02051608|324105991|FG001|Part 1: Double Blind Treatment|Other|3|||
94461364|NCT02693171|323478265|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
94461365|NCT04050124|323478266|FG000|Overall Study|Death|1|||
94461366|NCT04050124|323478267|FG001|Overall Study|Death|0|||
94461367|NCT03045276|323478268|FG000|Intervention Phase|Withdrawal by Subject|7|||
94461368|NCT03045276|323478269|FG001|Intervention Phase|Withdrawal by Subject|2|||
94629979|NCT02051608|324105992|FG002|Part 1: Double Blind Treatment|Other|0|||
94629980|NCT02051608|324105993|FG003|Part 1: Double Blind Treatment|Other|0|||
94461369|NCT03045276|323478270|FG002|Intervention Phase|Withdrawal by Subject|3|||
94461370|NCT03045276|323478271|FG003|Intervention Phase|Withdrawal by Subject|7|||
94461371|NCT03045276|323478268|FG000|Intervention Phase|Developed exclusionary criteria|3|||
94629981|NCT02051608|324105990|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
94257121|NCT00666679|322736359|FG000|First Intervention|Randomized did not start treatment|1|||
94257122|NCT00666679|322736360|FG001|First Intervention|Randomized did not start treatment|1|||
94257123|NCT00666679|322736359|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
94257124|NCT00666679|322736360|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
94257125|NCT00666679|322736359|FG000|Washout Period of 1 Week|Protocol Violation|0|||
94257126|NCT00666679|322736360|FG001|Washout Period of 1 Week|Protocol Violation|1|||
94257127|NCT00666679|322736359|FG000|Second Intervention|Adverse Event|1|||
94257128|NCT00666679|322736360|FG001|Second Intervention|Adverse Event|0|||
94257129|NCT00666679|322736359|FG000|Second Intervention|Death|0|||
94257130|NCT00666679|322736360|FG001|Second Intervention|Death|1|||
94257131|NCT03486457|322736361|FG000|Up to Month 3|Adverse Event|2|||
94257132|NCT03486457|322736362|FG001|Up to Month 3|Adverse Event|5|||
94257133|NCT03486457|322736361|FG000|Up to Month 3|Lack of Efficacy|1|||
94257134|NCT03486457|322736362|FG001|Up to Month 3|Lack of Efficacy|0|||
94257135|NCT03486457|322736361|FG000|Up to Month 3|Withdrawal by Subject|1|||
94257136|NCT03486457|322736362|FG001|Up to Month 3|Withdrawal by Subject|0|||
94257137|NCT03486457|322736361|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
94257138|NCT03486457|322736362|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
94257139|NCT03486457|322736361|FG000|Up to Month 3|Other|1|||
94257140|NCT03486457|322736362|FG001|Up to Month 3|Other|0|||
94257141|NCT03486457|322736361|FG000|Month 3 to Month 6|Adverse Event|2|||
94257142|NCT03486457|322736362|FG001|Month 3 to Month 6|Adverse Event|0|||
94257143|NCT03486457|322736361|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
94257144|NCT03486457|322736362|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
94257145|NCT03486457|322736361|FG000|Month 3 to Month 6|Pregnancy|0|||
94257146|NCT03486457|322736362|FG001|Month 3 to Month 6|Pregnancy|1|||
94257147|NCT03486457|322736361|FG000|Month 3 to Month 6|Other|1|||
94257148|NCT03486457|322736362|FG001|Month 3 to Month 6|Other|0|||
94257149|NCT00655863|322736364|FG000|Overall Study|Lost to Follow-up|0|||
94257150|NCT00655863|322736365|FG001|Overall Study|Lost to Follow-up|0|||
94257151|NCT00655863|322736366|FG002|Overall Study|Lost to Follow-up|1|||
94257152|NCT03451162|322736367|FG000|Overall Study|Lost to Follow-up|1|||
94257153|NCT03451162|322736368|FG001|Overall Study|Lost to Follow-up|0|||
94257154|NCT03451162|322736369|FG002|Overall Study|Lost to Follow-up|0|||
94257155|NCT03451162|322736370|FG003|Overall Study|Lost to Follow-up|0|||
94257156|NCT03451162|322736371|FG004|Overall Study|Lost to Follow-up|0|||
94257157|NCT03451162|322736367|FG000|Overall Study|Physician Decision|0|||
94257158|NCT03451162|322736368|FG001|Overall Study|Physician Decision|1|||
94257159|NCT03451162|322736369|FG002|Overall Study|Physician Decision|0|||
94257160|NCT03451162|322736370|FG003|Overall Study|Physician Decision|0|||
94257161|NCT03451162|322736371|FG004|Overall Study|Physician Decision|0|||
94361225|NCT03917654|323105526|FG004|Year 2|Subject moved away from site|1|||
94361226|NCT03917654|323105527|FG005|Year 2|Subject moved away from site|0|||
94361227|NCT03917654|323105528|FG006|Year 2|Subject moved away from site|2|||
94361228|NCT03917654|323105529|FG007|Year 2|Subject moved away from site|3|||
94629982|NCT02051608|324105991|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
94629983|NCT02051608|324105992|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
94629984|NCT02051608|324105993|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
94629985|NCT02051608|324105990|FG000|Part 2: Open-label Extension|Adverse Event|0|||
94629986|NCT02051608|324105991|FG001|Part 2: Open-label Extension|Adverse Event|0|||
94629987|NCT02051608|324105992|FG002|Part 2: Open-label Extension|Adverse Event|6|||
94629988|NCT02051608|324105993|FG003|Part 2: Open-label Extension|Adverse Event|8|||
94361229|NCT03917654|323105530|FG008|Year 2|Subject moved away from site|0|||
94361230|NCT03917654|323105531|FG009|Year 2|Subject moved away from site|2|||
94361231|NCT03917654|323105532|FG010|Year 2|Subject moved away from site|0|||
94361232|NCT03917654|323105533|FG011|Year 2|Subject moved away from site|1|||
94361233|NCT03917654|323105522|FG000|Year 2|Year 2 Screening failure|0|||
94361234|NCT03917654|323105523|FG001|Year 2|Year 2 Screening failure|1|||
94361235|NCT03917654|323105524|FG002|Year 2|Year 2 Screening failure|0|||
94361236|NCT03917654|323105525|FG003|Year 2|Year 2 Screening failure|0|||
94361237|NCT03917654|323105526|FG004|Year 2|Year 2 Screening failure|2|||
94361238|NCT03917654|323105527|FG005|Year 2|Year 2 Screening failure|0|||
94361239|NCT03917654|323105528|FG006|Year 2|Year 2 Screening failure|4|||
94629989|NCT02051608|324105990|FG000|Part 2: Open-label Extension|Death|0|||
94629990|NCT02051608|324105991|FG001|Part 2: Open-label Extension|Death|0|||
94257162|NCT03451162|322736367|FG000|Overall Study|Withdrawal by Subject|1|||
94257163|NCT03451162|322736368|FG001|Overall Study|Withdrawal by Subject|1|||
94361240|NCT03917654|323105529|FG007|Year 2|Year 2 Screening failure|3|||
94361241|NCT03917654|323105530|FG008|Year 2|Year 2 Screening failure|10|||
94361242|NCT03917654|323105531|FG009|Year 2|Year 2 Screening failure|2|||
94629991|NCT02051608|324105992|FG002|Part 2: Open-label Extension|Death|7|||
94629992|NCT02051608|324105993|FG003|Part 2: Open-label Extension|Death|4|||
94257164|NCT03451162|322736369|FG002|Overall Study|Withdrawal by Subject|0|||
94257165|NCT03451162|322736370|FG003|Overall Study|Withdrawal by Subject|0|||
94257166|NCT03451162|322736371|FG004|Overall Study|Withdrawal by Subject|0|||
94361243|NCT03917654|323105532|FG010|Year 2|Year 2 Screening failure|1|||
94629993|NCT02051608|324105990|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
94361244|NCT03917654|323105533|FG011|Year 2|Year 2 Screening failure|1|||
94361245|NCT03917654|323105522|FG000|Year 2|Death|0|||
94361246|NCT03917654|323105523|FG001|Year 2|Death|0|||
94361247|NCT03917654|323105524|FG002|Year 2|Death|0|||
94361248|NCT03917654|323105525|FG003|Year 2|Death|0|||
94361249|NCT03917654|323105526|FG004|Year 2|Death|0|||
94361250|NCT03917654|323105527|FG005|Year 2|Death|1|||
94361251|NCT03917654|323105528|FG006|Year 2|Death|0|||
94629994|NCT02051608|324105991|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
94629995|NCT02051608|324105992|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
94629996|NCT02051608|324105993|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
94629997|NCT02051608|324105990|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
94629998|NCT02051608|324105991|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
94629999|NCT02051608|324105992|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
94630000|NCT02051608|324105993|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
94630001|NCT02051608|324105990|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
94630002|NCT02051608|324105991|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
94630003|NCT02051608|324105992|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
94630004|NCT02051608|324105993|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
94630005|NCT02051608|324105990|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
94630006|NCT02051608|324105991|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
94630007|NCT02051608|324105992|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
94630008|NCT02051608|324105993|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
94630009|NCT02051608|324105990|FG000|Part 2: Open-label Extension|Physician Decision|0|||
94630010|NCT02051608|324105991|FG001|Part 2: Open-label Extension|Physician Decision|0|||
94630011|NCT02051608|324105992|FG002|Part 2: Open-label Extension|Physician Decision|8|||
94630012|NCT02051608|324105993|FG003|Part 2: Open-label Extension|Physician Decision|5|||
94630013|NCT02051608|324105990|FG000|Part 2: Open-label Extension|Other|0|||
94630014|NCT02051608|324105991|FG001|Part 2: Open-label Extension|Other|0|||
94630015|NCT02051608|324105992|FG002|Part 2: Open-label Extension|Other|9|||
94630016|NCT02051608|324105993|FG003|Part 2: Open-label Extension|Other|9|||
94630017|NCT00449540|324105998|FG000|Pretreatment Phase|No migraine experienced|66|||
94630018|NCT00449540|324105999|FG001|Pretreatment Phase|No migraine experienced|0|||
94630019|NCT00449540|324106000|FG002|Pretreatment Phase|No migraine experienced|0|||
94630020|NCT00449540|324105998|FG000|Treatment Phase|did not experience or treat migraine|0|||
94630021|NCT00449540|324105999|FG001|Treatment Phase|did not experience or treat migraine|20|||
94630022|NCT00449540|324106000|FG002|Treatment Phase|did not experience or treat migraine|17|||
94630023|NCT00487747|324106006|FG000|Overall Study|Adverse Event|1|||
94630024|NCT00487747|324106006|FG000|Overall Study|Lost to Follow-up|9|||
94630025|NCT00487747|324106006|FG000|Overall Study|Lack of Efficacy|1|||
94630026|NCT02036294|324106028|FG000|Overall Study|Death|7|||
94630027|NCT02036294|324106029|FG001|Overall Study|Death|8|||
94630028|NCT02036294|324106028|FG000|Overall Study|Withdrawal by Subject|2|||
94630029|NCT02036294|324106029|FG001|Overall Study|Withdrawal by Subject|3|||
94630030|NCT01980992|324106030|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
94630031|NCT01980992|324106031|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
94630032|NCT01980992|324106030|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
94630033|NCT01980992|324106031|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
94630034|NCT01980992|324106030|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
94630035|NCT01980992|324106031|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
94630036|NCT01980992|324106030|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
94630037|NCT01980992|324106031|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
94630038|NCT01980992|324106030|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
94675050|NCT04535947|324263190|FG000|Overall Study|Withdrawal by Subject|1|||
94361252|NCT03917654|323105529|FG007|Year 2|Death|0|||
94361253|NCT03917654|323105530|FG008|Year 2|Death|1|||
94361254|NCT03917654|323105531|FG009|Year 2|Death|1|||
94361255|NCT03917654|323105532|FG010|Year 2|Death|0|||
94257167|NCT03658668|322736372|FG000|Overall Study|Time Commitment|1|||
94257168|NCT03658668|322736373|FG001|Overall Study|Time Commitment|1|||
94257169|NCT01128738|322736375|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
94257170|NCT01128738|322736376|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
94257171|NCT01128738|322736375|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
94257172|NCT01128738|322736376|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
94257173|NCT01128738|322736375|FG000|Second TP|Lost to Follow-up|0|||
94257174|NCT01128738|322736376|FG001|Second TP|Lost to Follow-up|1|||
94257175|NCT01128738|322736375|FG000|Second TP|Withdrawal by Subject|0|||
94675051|NCT04535947|324263191|FG001|Overall Study|Withdrawal by Subject|1|||
94675052|NCT00763958|324263193|FG000|Overall Study|did not meet final criteria|4|||
94675053|NCT00763958|324263194|FG001|Overall Study|did not meet final criteria|4|||
94675054|NCT00763958|324263193|FG000|Overall Study|Lost to Follow-up|10|||
94675055|NCT00763958|324263194|FG001|Overall Study|Lost to Follow-up|2|||
94675056|NCT00763958|324263193|FG000|Overall Study|Believed they were receiving placebo|0|||
94675057|NCT00763958|324263194|FG001|Overall Study|Believed they were receiving placebo|5|||
94675058|NCT00929162|324263195|FG000|Overall Study|Adverse Event|8|||
94675059|NCT00929162|324263196|FG001|Overall Study|Adverse Event|5|||
94675060|NCT00929162|324263195|FG000|Overall Study|Withdrawal by Subject|3|||
94675061|NCT00929162|324263196|FG001|Overall Study|Withdrawal by Subject|1|||
94675062|NCT00929162|324263195|FG000|Overall Study|Protocol Violation|32|||
94675063|NCT00929162|324263196|FG001|Overall Study|Protocol Violation|30|||
94675064|NCT00929162|324263195|FG000|Overall Study|Other termination reason|5|||
94675065|NCT00929162|324263196|FG001|Overall Study|Other termination reason|6|||
94675066|NCT03802123|324263197|FG000|Overall Study|Withdrawal by Subject|3|||
94675067|NCT03802123|324263197|FG000|Overall Study|Physician Decision|1|||
94675068|NCT03802123|324263197|FG000|Overall Study|Subject moved to hospice care|1|||
94675069|NCT03802123|324263197|FG000|Overall Study|technician error|1|||
94675070|NCT03802123|324263197|FG000|Overall Study|Death|3|||
94675071|NCT01274182|324263198|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
94675072|NCT01274182|324263199|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
94675073|NCT01274182|324263200|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
94675074|NCT01274182|324263198|FG000|Overall Study|Adverse Event|4|||
94675075|NCT01274182|324263199|FG001|Overall Study|Adverse Event|5|||
94675076|NCT01274182|324263200|FG002|Overall Study|Adverse Event|3|||
94675077|NCT01274182|324263198|FG000|Overall Study|Withdrawal by Subject|5|||
94675078|NCT01274182|324263199|FG001|Overall Study|Withdrawal by Subject|5|||
94675079|NCT01274182|324263200|FG002|Overall Study|Withdrawal by Subject|3|||
94675080|NCT01274182|324263198|FG000|Overall Study|Lost to Follow-up|2|||
94675081|NCT01274182|324263199|FG001|Overall Study|Lost to Follow-up|3|||
94675082|NCT01274182|324263200|FG002|Overall Study|Lost to Follow-up|1|||
94675083|NCT01274182|324263198|FG000|Overall Study|Protocol Violation|3|||
94675084|NCT01274182|324263199|FG001|Overall Study|Protocol Violation|2|||
94675085|NCT01274182|324263200|FG002|Overall Study|Protocol Violation|0|||
94675086|NCT01274182|324263198|FG000|Overall Study|Death|1|||
94257176|NCT01128738|322736376|FG001|Second TP|Withdrawal by Subject|2|||
94257177|NCT00455325|322736377|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
94257178|NCT00455325|322736378|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
94257179|NCT00455325|322736379|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
94257180|NCT00455325|322736380|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
94675087|NCT01274182|324263199|FG001|Overall Study|Death|0|||
94675088|NCT01274182|324263200|FG002|Overall Study|Death|1|||
94675089|NCT02355002|324263201|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
94675090|NCT02355002|324263202|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
94257181|NCT00455325|322736377|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
94257182|NCT00455325|322736378|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
94257183|NCT00455325|322736379|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
94257184|NCT00455325|322736380|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
94257185|NCT00455325|322736377|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
94257186|NCT00455325|322736378|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
94675091|NCT02355002|324263201|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
94675092|NCT02355002|324263202|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
94257187|NCT00455325|322736379|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
94257188|NCT00455325|322736380|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
94361256|NCT03917654|323105533|FG011|Year 2|Death|0|||
94361257|NCT03917654|323105522|FG000|Year 2|Withdrawal by Subject|0|||
94675093|NCT02355002|324263201|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
94675094|NCT02355002|324263202|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
94361258|NCT03917654|323105523|FG001|Year 2|Withdrawal by Subject|0|||
94361259|NCT03917654|323105524|FG002|Year 2|Withdrawal by Subject|0|||
94361260|NCT03917654|323105525|FG003|Year 2|Withdrawal by Subject|0|||
94675095|NCT02355002|324263201|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
94675096|NCT02355002|324263202|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
94675097|NCT02355002|324263201|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
94630039|NCT01980992|324106031|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
94630040|NCT01980992|324106030|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
94630041|NCT01980992|324106031|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
94630042|NCT02651922|324106032|FG000|Overall Study|due to exclusion criteria|2|||
94630043|NCT01276353|324106033|FG000|Double-blind|Adverse Event|2|||
94630044|NCT01276353|324106034|FG001|Double-blind|Adverse Event|0|||
94630045|NCT01276353|324106033|FG000|Double-blind|Withdrawal by Subject|1|||
94630046|NCT01276353|324106034|FG001|Double-blind|Withdrawal by Subject|0|||
94630047|NCT01276353|324106033|FG000|Extension|Adverse Event|2|||
94630048|NCT01276353|324106034|FG001|Extension|Adverse Event|5|||
94630049|NCT01276353|324106033|FG000|Extension|Withdrawal by Subject|1|||
94630050|NCT01276353|324106034|FG001|Extension|Withdrawal by Subject|2|||
94630051|NCT01276353|324106033|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
94630052|NCT01276353|324106034|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
94630053|NCT01276353|324106033|FG000|Extension|Physician Decision|1|||
94630054|NCT01276353|324106034|FG001|Extension|Physician Decision|0|||
94630055|NCT01276353|324106033|FG000|Extension|Prohibited concomitant medications|0|||
94630056|NCT01276353|324106034|FG001|Extension|Prohibited concomitant medications|1|||
94630057|NCT04952402|324106036|FG000|Overall Study|Lost to Follow-up|1|||
94630058|NCT04952402|324106037|FG001|Overall Study|Lost to Follow-up|3|||
94630059|NCT04952402|324106036|FG000|Overall Study|Lack Of Venous Access|0|||
94630060|NCT04952402|324106037|FG001|Overall Study|Lack Of Venous Access|1|||
94361261|NCT03917654|323105526|FG004|Year 2|Withdrawal by Subject|0|||
94361262|NCT03917654|323105527|FG005|Year 2|Withdrawal by Subject|0|||
94361263|NCT03917654|323105528|FG006|Year 2|Withdrawal by Subject|3|||
94361264|NCT03917654|323105529|FG007|Year 2|Withdrawal by Subject|0|||
94361265|NCT03917654|323105530|FG008|Year 2|Withdrawal by Subject|2|||
94361266|NCT03917654|323105531|FG009|Year 2|Withdrawal by Subject|5|||
94361267|NCT03917654|323105532|FG010|Year 2|Withdrawal by Subject|0|||
94361268|NCT03917654|323105533|FG011|Year 2|Withdrawal by Subject|0|||
94361269|NCT03917654|323105522|FG000|Year 2|Spouse/family member request|0|||
94361270|NCT03917654|323105523|FG001|Year 2|Spouse/family member request|0|||
94361271|NCT03917654|323105524|FG002|Year 2|Spouse/family member request|0|||
94361272|NCT03917654|323105525|FG003|Year 2|Spouse/family member request|0|||
94361273|NCT03917654|323105526|FG004|Year 2|Spouse/family member request|0|||
94361274|NCT03917654|323105527|FG005|Year 2|Spouse/family member request|0|||
94361275|NCT03917654|323105528|FG006|Year 2|Spouse/family member request|1|||
94361276|NCT03917654|323105529|FG007|Year 2|Spouse/family member request|0|||
94361277|NCT03917654|323105530|FG008|Year 2|Spouse/family member request|0|||
94361278|NCT03917654|323105531|FG009|Year 2|Spouse/family member request|0|||
94361279|NCT03917654|323105532|FG010|Year 2|Spouse/family member request|0|||
94361280|NCT03917654|323105533|FG011|Year 2|Spouse/family member request|0|||
94361281|NCT03917654|323105522|FG000|Year 2|Lost to Follow-up|0|||
94361282|NCT03917654|323105523|FG001|Year 2|Lost to Follow-up|0|||
94361283|NCT03917654|323105524|FG002|Year 2|Lost to Follow-up|0|||
94361284|NCT03917654|323105525|FG003|Year 2|Lost to Follow-up|0|||
94361285|NCT03917654|323105526|FG004|Year 2|Lost to Follow-up|0|||
94361286|NCT03917654|323105527|FG005|Year 2|Lost to Follow-up|0|||
94361287|NCT03917654|323105528|FG006|Year 2|Lost to Follow-up|1|||
94361288|NCT03917654|323105529|FG007|Year 2|Lost to Follow-up|0|||
94361289|NCT03917654|323105530|FG008|Year 2|Lost to Follow-up|1|||
94361290|NCT03917654|323105531|FG009|Year 2|Lost to Follow-up|0|||
94630061|NCT03402386|324106040|FG000|Overall Study|Adverse Event|3|||
94630062|NCT03402386|324106040|FG000|Overall Study|Physician Decision|1|||
94630063|NCT03402386|324106040|FG000|Overall Study|Difficult to control Hb|2|||
94675098|NCT02355002|324263202|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
94361291|NCT03917654|323105532|FG010|Year 2|Lost to Follow-up|0|||
94361292|NCT03917654|323105533|FG011|Year 2|Lost to Follow-up|1|||
94675099|NCT02355002|324263201|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
94675100|NCT02355002|324263202|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
94675101|NCT02355002|324263201|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
94675102|NCT02355002|324263202|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
94675103|NCT02657317|324263203|FG000|Overall Study|Withdrawal by Subject|2|||
94675104|NCT02657317|324263204|FG001|Overall Study|Withdrawal by Subject|0|||
94675105|NCT02657317|324263203|FG000|Overall Study|Lost to Follow-up|3|||
94675106|NCT02657317|324263204|FG001|Overall Study|Lost to Follow-up|3|||
94675107|NCT02753595|324263207|FG000|Overall Study|Sponsor termination|2|||
94675108|NCT02753595|324263208|FG001|Overall Study|Sponsor termination|2|||
94675109|NCT01328080|324263209|FG000|Overall Study|Lost to Follow-up|5|||
94675110|NCT03649230|324263215|FG000|Overall Study|Adverse Event|12|||
94675111|NCT03649230|324263215|FG000|Overall Study|Death|8|||
94257189|NCT00455325|322736377|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
94257190|NCT00455325|322736378|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
94257191|NCT00455325|322736379|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
94257192|NCT00455325|322736380|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
94257193|NCT00455325|322736377|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
94257194|NCT00455325|322736378|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
94257195|NCT00455325|322736379|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
94257196|NCT00455325|322736380|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
94257197|NCT00455325|322736377|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
94257198|NCT00455325|322736378|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
94257199|NCT00455325|322736379|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
94257200|NCT00455325|322736380|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
94257201|NCT00455325|322736377|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
94257202|NCT00455325|322736378|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
94257203|NCT00455325|322736379|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
94257204|NCT00455325|322736380|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
94257205|NCT01178671|322736381|FG000|Overall Study|Adverse Event|4|||
94257206|NCT01178671|322736382|FG001|Overall Study|Adverse Event|6|||
94257207|NCT01178671|322736381|FG000|Overall Study|Protocol Violation|1|||
94257208|NCT01178671|322736382|FG001|Overall Study|Protocol Violation|1|||
94257209|NCT01178671|322736381|FG000|Overall Study|Lack of Efficacy|0|||
94257210|NCT01178671|322736382|FG001|Overall Study|Lack of Efficacy|1|||
94257211|NCT01178671|322736381|FG000|Overall Study|Lost to Follow-up|3|||
94257212|NCT01178671|322736382|FG001|Overall Study|Lost to Follow-up|1|||
94257213|NCT01178671|322736381|FG000|Overall Study|Physician Decision|4|||
94257214|NCT01178671|322736382|FG001|Overall Study|Physician Decision|6|||
94257215|NCT02745392|322736386|FG000|Overall Study|Lost to Follow-up|0|||
94257216|NCT02745392|322736387|FG001|Overall Study|Lost to Follow-up|1|||
94257217|NCT02745392|322736388|FG002|Overall Study|Lost to Follow-up|0|||
94257218|NCT02745392|322736389|FG003|Overall Study|Lost to Follow-up|0|||
94257219|NCT00892723|322736390|FG000|Overall Study|Lost to Follow-up|1|||
94257220|NCT00892723|322736391|FG001|Overall Study|Lost to Follow-up|3|||
94257221|NCT00892723|322736392|FG002|Overall Study|Lost to Follow-up|1|||
94257222|NCT00892723|322736390|FG000|Overall Study|Withdrawal by Subject|1|||
94257223|NCT00892723|322736391|FG001|Overall Study|Withdrawal by Subject|1|||
94257224|NCT00892723|322736392|FG002|Overall Study|Withdrawal by Subject|1|||
94257225|NCT00150969|322736393|FG000|24 Month Main Study|Adverse Event|3|||
94257226|NCT00150969|322736394|FG001|24 Month Main Study|Adverse Event|4|||
94257227|NCT00150969|322736393|FG000|24 Month Main Study|Death|1|||
94257228|NCT00150969|322736394|FG001|24 Month Main Study|Death|1|||
94257229|NCT00150969|322736393|FG000|24 Month Main Study|Lack of Efficacy|1|||
94257230|NCT00150969|322736394|FG001|24 Month Main Study|Lack of Efficacy|8|||
94257231|NCT00150969|322736393|FG000|24 Month Main Study|Lost to Follow-up|3|||
94257232|NCT00150969|322736394|FG001|24 Month Main Study|Lost to Follow-up|2|||
94257233|NCT00150969|322736393|FG000|24 Month Main Study|Protocol Violation|4|||
94257234|NCT00150969|322736394|FG001|24 Month Main Study|Protocol Violation|2|||
94257235|NCT00150969|322736393|FG000|24 Month Main Study|Withdrawal by Subject|7|||
94257236|NCT00150969|322736394|FG001|24 Month Main Study|Withdrawal by Subject|4|||
94257237|NCT00150969|322736393|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
94257238|NCT00150969|322736394|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
94257239|NCT00150969|322736393|FG000|24-48 Month Extension|Lack of Efficacy|0|||
94257240|NCT00150969|322736394|FG001|24-48 Month Extension|Lack of Efficacy|1|||
94257241|NCT00150969|322736393|FG000|24-48 Month Extension|Adverse Event|1|||
94675112|NCT03649230|324263215|FG000|Overall Study|Withdrawal by Subject|6|||
94675113|NCT03649230|324263215|FG000|Overall Study|Physician Decision|5|||
94675114|NCT03649230|324263215|FG000|Overall Study|Disease progression|5|||
94257242|NCT00150969|322736394|FG001|24-48 Month Extension|Adverse Event|3|||
94257243|NCT00150969|322736393|FG000|24-48 Month Extension|Other Reason|81|||
94257244|NCT00150969|322736394|FG001|24-48 Month Extension|Other Reason|91|||
94257245|NCT01313689|322736395|FG000|24-Week Randomization 1|Adverse Event|10|||
94361293|NCT03917654|323105522|FG000|Year 2|Adverse Event|0|||
94630064|NCT01896531|324106043|FG000|Overall Study|Death|57|||
94630065|NCT01896531|324106044|FG001|Overall Study|Death|59|||
94630066|NCT01896531|324106043|FG000|Overall Study|Lost to Follow-up|3|||
94630067|NCT01896531|324106044|FG001|Overall Study|Lost to Follow-up|0|||
94257246|NCT01313689|322736396|FG001|24-Week Randomization 1|Adverse Event|5|||
94257247|NCT01313689|322736397|FG002|24-Week Randomization 1|Adverse Event|0|||
94257248|NCT01313689|322736398|FG003|24-Week Randomization 1|Adverse Event|0|||
94257249|NCT01313689|322736399|FG004|24-Week Randomization 1|Adverse Event|0|||
94257250|NCT01313689|322736395|FG000|24-Week Randomization 1|Physician Decision|4|||
94257251|NCT01313689|322736396|FG001|24-Week Randomization 1|Physician Decision|5|||
94257252|NCT01313689|322736397|FG002|24-Week Randomization 1|Physician Decision|0|||
94257253|NCT01313689|322736398|FG003|24-Week Randomization 1|Physician Decision|0|||
94257254|NCT01313689|322736399|FG004|24-Week Randomization 1|Physician Decision|0|||
94257255|NCT01313689|322736395|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
94257256|NCT01313689|322736396|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
94257257|NCT01313689|322736397|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
94257258|NCT01313689|322736398|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
94257259|NCT01313689|322736399|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
94257260|NCT01313689|322736395|FG000|24-Week Randomization 2|Adverse Event|0|||
94257261|NCT01313689|322736396|FG001|24-Week Randomization 2|Adverse Event|0|||
94257262|NCT01313689|322736397|FG002|24-Week Randomization 2|Adverse Event|2|||
94257263|NCT01313689|322736398|FG003|24-Week Randomization 2|Adverse Event|0|||
94257264|NCT01313689|322736399|FG004|24-Week Randomization 2|Adverse Event|8|||
94257265|NCT01313689|322736395|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
94257266|NCT01313689|322736396|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
94257267|NCT01313689|322736397|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
94257268|NCT01313689|322736398|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
94257269|NCT01313689|322736399|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
94257270|NCT01313689|322736395|FG000|24-Week Randomization 2|Physician Decision|0|||
94257271|NCT01313689|322736396|FG001|24-Week Randomization 2|Physician Decision|0|||
94257272|NCT01313689|322736397|FG002|24-Week Randomization 2|Physician Decision|0|||
94257273|NCT01313689|322736398|FG003|24-Week Randomization 2|Physician Decision|0|||
94257274|NCT01313689|322736399|FG004|24-Week Randomization 2|Physician Decision|4|||
94257275|NCT02294227|322736400|FG000|Overall Study|Death|0|||
94257276|NCT02294227|322736401|FG001|Overall Study|Death|0|||
94257277|NCT02294227|322736402|FG002|Overall Study|Death|1|||
94257278|NCT02294227|322736400|FG000|Overall Study|Subject/Guardian Decision|6|||
94257279|NCT02294227|322736401|FG001|Overall Study|Subject/Guardian Decision|3|||
94257280|NCT02294227|322736402|FG002|Overall Study|Subject/Guardian Decision|7|||
94257281|NCT02294227|322736400|FG000|Overall Study|Physician Decision|1|||
94257282|NCT02294227|322736401|FG001|Overall Study|Physician Decision|2|||
94257283|NCT02294227|322736402|FG002|Overall Study|Physician Decision|1|||
94257284|NCT02294227|322736400|FG000|Overall Study|Lost to Follow-up|1|||
94257285|NCT02294227|322736401|FG001|Overall Study|Lost to Follow-up|0|||
94257286|NCT02294227|322736402|FG002|Overall Study|Lost to Follow-up|0|||
94257287|NCT02294227|322736400|FG000|Overall Study|Lack of Efficacy|11|||
94257288|NCT02294227|322736401|FG001|Overall Study|Lack of Efficacy|12|||
94257289|NCT02294227|322736402|FG002|Overall Study|Lack of Efficacy|8|||
94257290|NCT02294227|322736400|FG000|Overall Study|Adverse Event|6|||
94257291|NCT02294227|322736401|FG001|Overall Study|Adverse Event|8|||
94257292|NCT02294227|322736402|FG002|Overall Study|Adverse Event|2|||
94257293|NCT01007448|322736404|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
94257294|NCT01007448|322736405|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
94257295|NCT01007448|322736404|FG000|Overall Study|Staph Skin Infection Flare|1|||
94257296|NCT01007448|322736405|FG001|Overall Study|Staph Skin Infection Flare|0|||
94257297|NCT01007448|322736404|FG000|Overall Study|Participant Leaving the Country|1|||
94257298|NCT01007448|322736405|FG001|Overall Study|Participant Leaving the Country|0|||
94257299|NCT01007448|322736404|FG000|Overall Study|Participant Given Prohibited Medication|1|||
94257300|NCT01007448|322736405|FG001|Overall Study|Participant Given Prohibited Medication|0|||
94257301|NCT01007448|322736404|FG000|Overall Study|Progressive Disease|1|||
94257302|NCT01007448|322736405|FG001|Overall Study|Progressive Disease|2|||
94257303|NCT01007448|322736404|FG000|Overall Study|Lack of Efficacy|2|||
94257304|NCT01007448|322736405|FG001|Overall Study|Lack of Efficacy|0|||
94257305|NCT01007448|322736404|FG000|Overall Study|Withdrawal by Subject|2|||
94257306|NCT01007448|322736405|FG001|Overall Study|Withdrawal by Subject|3|||
94257307|NCT01007448|322736404|FG000|Overall Study|Adverse Event|1|||
94257308|NCT01007448|322736405|FG001|Overall Study|Adverse Event|4|||
94257309|NCT00887432|322736406|FG000|Overall Study|Start Excluded Therapy|3|||
94257310|NCT00887432|322736407|FG001|Overall Study|Start Excluded Therapy|0|||
94257311|NCT00887432|322736406|FG000|Overall Study|Did not complete treatment|6|||
94257312|NCT00887432|322736407|FG001|Overall Study|Did not complete treatment|8|||
94257313|NCT00887432|322736406|FG000|Overall Study|Protocol Violation|2|||
94257314|NCT00887432|322736407|FG001|Overall Study|Protocol Violation|3|||
94257315|NCT00887432|322736406|FG000|Overall Study|Withdrawal by Subject|3|||
94257316|NCT00887432|322736407|FG001|Overall Study|Withdrawal by Subject|2|||
94257317|NCT00887432|322736406|FG000|Overall Study|Lost to Follow-up|1|||
94257318|NCT00887432|322736407|FG001|Overall Study|Lost to Follow-up|0|||
94257319|NCT00887432|322736406|FG000|Overall Study|No reason provided|0|||
94257320|NCT00887432|322736407|FG001|Overall Study|No reason provided|1|||
94675115|NCT03649230|324263215|FG000|Overall Study|Switched to non-HEC|5|||
94675116|NCT03649230|324263215|FG000|Overall Study|Chemotherapy discontinued|4|||
94675117|NCT03649230|324263215|FG000|Overall Study|Received only 3 HEC cycles|4|||
94675118|NCT03649230|324263215|FG000|Overall Study|Screen Failure|3|||
94675119|NCT03649230|324263215|FG000|Overall Study|Patient stopped treatment|2|||
94675120|NCT03649230|324263215|FG000|Overall Study|Protocol Violation|1|||
94675121|NCT03649230|324263215|FG000|Overall Study|Non-compliance|1|||
94675122|NCT03649230|324263215|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
94675123|NCT03685591|324263221|FG000|Overall Study|Global Deterioration of Health Status|0|||
94675124|NCT03685591|324263222|FG001|Overall Study|Global Deterioration of Health Status|0|||
94675125|NCT03685591|324263223|FG002|Overall Study|Global Deterioration of Health Status|0|||
94675126|NCT03685591|324263224|FG003|Overall Study|Global Deterioration of Health Status|1|||
94675127|NCT03685591|324263225|FG004|Overall Study|Global Deterioration of Health Status|2|||
94675128|NCT03685591|324263226|FG005|Overall Study|Global Deterioration of Health Status|4|||
94675129|NCT03685591|324263227|FG006|Overall Study|Global Deterioration of Health Status|1|||
94675130|NCT03685591|324263228|FG007|Overall Study|Global Deterioration of Health Status|1|||
94675131|NCT03685591|324263229|FG008|Overall Study|Global Deterioration of Health Status|0|||
94675132|NCT03685591|324263221|FG000|Overall Study|Progressive Disease|1|||
94675133|NCT03685591|324263222|FG001|Overall Study|Progressive Disease|1|||
94675134|NCT03685591|324263223|FG002|Overall Study|Progressive Disease|0|||
94675135|NCT03685591|324263224|FG003|Overall Study|Progressive Disease|3|||
94675136|NCT03685591|324263225|FG004|Overall Study|Progressive Disease|5|||
94675137|NCT03685591|324263226|FG005|Overall Study|Progressive Disease|4|||
94675138|NCT03685591|324263227|FG006|Overall Study|Progressive Disease|3|||
94675139|NCT03685591|324263228|FG007|Overall Study|Progressive Disease|2|||
94675140|NCT03685591|324263229|FG008|Overall Study|Progressive Disease|1|||
94675141|NCT03685591|324263221|FG000|Overall Study|Other|0|||
94675142|NCT03685591|324263222|FG001|Overall Study|Other|0|||
94675143|NCT03685591|324263223|FG002|Overall Study|Other|1|||
94675144|NCT03685591|324263224|FG003|Overall Study|Other|0|||
94675145|NCT03685591|324263225|FG004|Overall Study|Other|2|||
94675146|NCT03685591|324263226|FG005|Overall Study|Other|3|||
94257321|NCT02121834|322736408|FG000|Overall Study|Protocol Violation|0|||
94257322|NCT02121834|322736409|FG001|Overall Study|Protocol Violation|1|||
94257323|NCT02121834|322736410|FG002|Overall Study|Protocol Violation|0|||
94257324|NCT02121834|322736411|FG003|Overall Study|Protocol Violation|0|||
94257325|NCT02121834|322736412|FG004|Overall Study|Protocol Violation|0|||
94257326|NCT02121834|322736413|FG005|Overall Study|Protocol Violation|0|||
94257327|NCT02121834|322736414|FG006|Overall Study|Protocol Violation|0|||
94257328|NCT02121834|322736408|FG000|Overall Study|Withdrawal by Subject|0|||
94257329|NCT02121834|322736409|FG001|Overall Study|Withdrawal by Subject|1|||
94257330|NCT02121834|322736410|FG002|Overall Study|Withdrawal by Subject|1|||
94257331|NCT02121834|322736411|FG003|Overall Study|Withdrawal by Subject|0|||
94257332|NCT02121834|322736412|FG004|Overall Study|Withdrawal by Subject|0|||
94257333|NCT02121834|322736413|FG005|Overall Study|Withdrawal by Subject|0|||
94257334|NCT02121834|322736414|FG006|Overall Study|Withdrawal by Subject|0|||
94257335|NCT02121834|322736408|FG000|Overall Study|Lost to Follow-up|0|||
94257336|NCT02121834|322736409|FG001|Overall Study|Lost to Follow-up|0|||
94257337|NCT02121834|322736410|FG002|Overall Study|Lost to Follow-up|1|||
94257338|NCT02121834|322736411|FG003|Overall Study|Lost to Follow-up|0|||
94257339|NCT02121834|322736412|FG004|Overall Study|Lost to Follow-up|0|||
94257340|NCT02121834|322736413|FG005|Overall Study|Lost to Follow-up|0|||
94257341|NCT02121834|322736414|FG006|Overall Study|Lost to Follow-up|0|||
94257342|NCT00343252|322736416|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
94257343|NCT00343252|322736417|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
94257344|NCT00343252|322736416|FG000|6 Months (All Treated Participants)|Death|0|||
94257345|NCT00343252|322736417|FG001|6 Months (All Treated Participants)|Death|2|||
94257346|NCT00343252|322736416|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
94257347|NCT00343252|322736417|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
94257348|NCT00343252|322736416|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
94257349|NCT00343252|322736417|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
94257350|NCT00343252|322736416|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
94257351|NCT00343252|322736417|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
94257352|NCT00343252|322736416|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
94257353|NCT00343252|322736417|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
94257354|NCT00343252|322736416|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
94257355|NCT00343252|322736417|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
94257356|NCT00343252|322736416|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
94257357|NCT00343252|322736417|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
94257358|NCT00343252|322736416|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
94675147|NCT03685591|324263227|FG006|Overall Study|Other|0|||
94675148|NCT03685591|324263228|FG007|Overall Study|Other|0|||
94675149|NCT03685591|324263229|FG008|Overall Study|Other|0|||
94675150|NCT03685591|324263221|FG000|Overall Study|Withdrawal by Subject|0|||
94675151|NCT03685591|324263222|FG001|Overall Study|Withdrawal by Subject|0|||
94675152|NCT03685591|324263223|FG002|Overall Study|Withdrawal by Subject|0|||
94675153|NCT03685591|324263224|FG003|Overall Study|Withdrawal by Subject|0|||
94675154|NCT03685591|324263225|FG004|Overall Study|Withdrawal by Subject|3|||
94675155|NCT03685591|324263226|FG005|Overall Study|Withdrawal by Subject|2|||
94675156|NCT03685591|324263227|FG006|Overall Study|Withdrawal by Subject|0|||
94675157|NCT03685591|324263228|FG007|Overall Study|Withdrawal by Subject|0|||
94675158|NCT03685591|324263229|FG008|Overall Study|Withdrawal by Subject|1|||
94675159|NCT03685591|324263221|FG000|Overall Study|Adverse Event|0|||
94675160|NCT03685591|324263222|FG001|Overall Study|Adverse Event|0|||
94675161|NCT03685591|324263223|FG002|Overall Study|Adverse Event|0|||
94675162|NCT03685591|324263224|FG003|Overall Study|Adverse Event|1|||
94675163|NCT03685591|324263225|FG004|Overall Study|Adverse Event|1|||
94675164|NCT03685591|324263226|FG005|Overall Study|Adverse Event|4|||
94675165|NCT03685591|324263227|FG006|Overall Study|Adverse Event|0|||
94675166|NCT03685591|324263228|FG007|Overall Study|Adverse Event|1|||
94675167|NCT03685591|324263229|FG008|Overall Study|Adverse Event|1|||
94675168|NCT00500903|324263232|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
94675169|NCT00500903|324263233|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
94675170|NCT00500903|324263234|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
94675171|NCT00500903|324263232|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
94675172|NCT00500903|324263233|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
94675173|NCT00500903|324263234|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
94675174|NCT00500903|324263232|FG000|Overall Study|Progressive Disease|41|||
94675175|NCT00500903|324263233|FG001|Overall Study|Progressive Disease|2|||
94257359|NCT00343252|322736417|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
94257360|NCT00343252|322736416|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
94257361|NCT00343252|322736417|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
94257362|NCT00343252|322736416|FG000|12 Months (All Treated Participants)|Death|3|||
94257363|NCT00343252|322736417|FG001|12 Months (All Treated Participants)|Death|3|||
94257364|NCT00343252|322736416|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
94257365|NCT00343252|322736417|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
94257366|NCT00343252|322736416|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
94257367|NCT00343252|322736417|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
94257368|NCT00343252|322736416|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
94257369|NCT00343252|322736417|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
94257370|NCT00343252|322736416|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
94257371|NCT00343252|322736417|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
94257372|NCT00343252|322736416|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
94257373|NCT00343252|322736417|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
94257374|NCT00343252|322736416|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
94257375|NCT00343252|322736417|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
94257376|NCT00343252|322736416|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
94257377|NCT00343252|322736417|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
94257378|NCT00343252|322736416|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
94257379|NCT00343252|322736417|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
94257380|NCT00343252|322736416|FG000|18 Months (All Treated Participants)|Death|4|||
94257381|NCT00343252|322736417|FG001|18 Months (All Treated Participants)|Death|5|||
94257382|NCT00343252|322736416|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
94257383|NCT00343252|322736417|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
94257384|NCT00343252|322736416|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
94257385|NCT00343252|322736417|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
94257386|NCT00343252|322736416|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
94257387|NCT00343252|322736417|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
94257388|NCT00343252|322736416|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
94257389|NCT00343252|322736417|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
94257390|NCT00343252|322736416|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
94257391|NCT00343252|322736417|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
94257392|NCT00343252|322736416|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
94257393|NCT00343252|322736417|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
94257394|NCT00343252|322736416|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
94257395|NCT00343252|322736417|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
94257396|NCT02019927|322736418|FG000|Overall Study|Lost to Follow-up|2|||
94257397|NCT02019927|322736419|FG001|Overall Study|Lost to Follow-up|4|||
94257398|NCT02019927|322736420|FG002|Overall Study|Lost to Follow-up|1|||
94257399|NCT02019927|322736421|FG003|Overall Study|Lost to Follow-up|2|||
94461372|NCT03045276|323478269|FG001|Intervention Phase|Developed exclusionary criteria|3|||
94461373|NCT03045276|323478270|FG002|Intervention Phase|Developed exclusionary criteria|0|||
94461374|NCT03045276|323478271|FG003|Intervention Phase|Developed exclusionary criteria|0|||
94675176|NCT00500903|324263234|FG002|Overall Study|Progressive Disease|15|||
94675177|NCT00500903|324263232|FG000|Overall Study|Patient Declined Further Treatment|0|||
94675178|NCT00500903|324263233|FG001|Overall Study|Patient Declined Further Treatment|0|||
94675179|NCT00500903|324263234|FG002|Overall Study|Patient Declined Further Treatment|3|||
94675180|NCT00500903|324263232|FG000|Overall Study|Symptomatic Deterioration|2|||
94675181|NCT00500903|324263233|FG001|Overall Study|Symptomatic Deterioration|0|||
94675182|NCT00500903|324263234|FG002|Overall Study|Symptomatic Deterioration|0|||
94675183|NCT00500903|324263232|FG000|Overall Study|Reason Not Specified|10|||
94675184|NCT00500903|324263233|FG001|Overall Study|Reason Not Specified|0|||
94675185|NCT00500903|324263234|FG002|Overall Study|Reason Not Specified|2|||
94675186|NCT00279201|324263236|FG000|Initiation|Death|1|||
94675187|NCT00279201|324263237|FG001|Initiation|Death|5|||
94257400|NCT02019927|322736422|FG004|Overall Study|Lost to Follow-up|3|||
94257401|NCT02019927|322736423|FG005|Overall Study|Lost to Follow-up|1|||
94257402|NCT01054846|322736426|FG000|Overall Study|Lost to Follow-up|76|||
94257403|NCT01054846|322736427|FG001|Overall Study|Lost to Follow-up|17|||
94257404|NCT02434939|322736428|FG000|Overall Study|Lack of Efficacy|34|||
94257405|NCT02434939|322736429|FG001|Overall Study|Lack of Efficacy|48|||
94257406|NCT02434939|322736428|FG000|Overall Study|Withdrawal by Subject|3|||
94257407|NCT02434939|322736429|FG001|Overall Study|Withdrawal by Subject|0|||
94257408|NCT02434939|322736428|FG000|Overall Study|Adverse Event|0|||
94257409|NCT02434939|322736429|FG001|Overall Study|Adverse Event|1|||
94257410|NCT00069238|322736433|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
94257411|NCT00069238|322736434|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
94257412|NCT00069238|322736435|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
94257413|NCT00069238|322736433|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
94257414|NCT00069238|322736434|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
94257415|NCT00069238|322736435|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
94257416|NCT00069238|322736433|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
94257417|NCT00069238|322736434|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
94257418|NCT00069238|322736435|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
94257419|NCT01551212|322736436|FG000|Overall Study|Graft loss/Retransplantation|0|||
94257420|NCT01551212|322736437|FG001|Overall Study|Graft loss/Retransplantation|1|||
94257421|NCT01551212|322736436|FG000|Overall Study|Administrative problems|1|||
94257422|NCT01551212|322736437|FG001|Overall Study|Administrative problems|2|||
94257423|NCT01551212|322736436|FG000|Overall Study|Lost to Follow-up|0|||
94257424|NCT01551212|322736437|FG001|Overall Study|Lost to Follow-up|1|||
94257425|NCT01551212|322736436|FG000|Overall Study|Protocol Violation|0|||
94257426|NCT01551212|322736437|FG001|Overall Study|Protocol Violation|1|||
94257427|NCT01551212|322736436|FG000|Overall Study|Withdrawal by Subject|0|||
94257428|NCT01551212|322736437|FG001|Overall Study|Withdrawal by Subject|7|||
94257429|NCT01551212|322736436|FG000|Overall Study|Death|2|||
94257430|NCT01551212|322736437|FG001|Overall Study|Death|4|||
94257431|NCT01551212|322736436|FG000|Overall Study|Never Received Study Treatment|2|||
94257432|NCT01551212|322736437|FG001|Overall Study|Never Received Study Treatment|4|||
94257433|NCT00388154|322736440|FG000|Overall Study|Withdrawal by Subject|1|||
94257434|NCT01723254|322736441|FG000|Overall Study|Conflict with work schedule|0|||
94257435|NCT01723254|322736442|FG001|Overall Study|Conflict with work schedule|0|||
94257436|NCT01723254|322736443|FG002|Overall Study|Conflict with work schedule|0|||
94257437|NCT01723254|322736444|FG003|Overall Study|Conflict with work schedule|0|||
94257438|NCT01723254|322736445|FG004|Overall Study|Conflict with work schedule|0|||
94257439|NCT01723254|322736446|FG005|Overall Study|Conflict with work schedule|0|||
94257440|NCT01723254|322736447|FG006|Overall Study|Conflict with work schedule|0|||
94257441|NCT01723254|322736448|FG007|Overall Study|Conflict with work schedule|1|||
94257442|NCT01723254|322736441|FG000|Overall Study|Personal issues|0|||
94257443|NCT01723254|322736442|FG001|Overall Study|Personal issues|0|||
94257444|NCT01723254|322736443|FG002|Overall Study|Personal issues|0|||
94257445|NCT01723254|322736444|FG003|Overall Study|Personal issues|0|||
94257446|NCT01723254|322736445|FG004|Overall Study|Personal issues|0|||
94257447|NCT01723254|322736446|FG005|Overall Study|Personal issues|1|||
94257448|NCT01723254|322736447|FG006|Overall Study|Personal issues|0|||
94257449|NCT01723254|322736448|FG007|Overall Study|Personal issues|0|||
94257450|NCT01723254|322736441|FG000|Overall Study|No longer have time to participate|0|||
94257451|NCT01723254|322736442|FG001|Overall Study|No longer have time to participate|0|||
94257452|NCT01723254|322736443|FG002|Overall Study|No longer have time to participate|0|||
94257453|NCT01723254|322736444|FG003|Overall Study|No longer have time to participate|1|||
94257454|NCT01723254|322736445|FG004|Overall Study|No longer have time to participate|0|||
94257455|NCT01723254|322736446|FG005|Overall Study|No longer have time to participate|0|||
94257456|NCT01723254|322736447|FG006|Overall Study|No longer have time to participate|0|||
94257457|NCT01723254|322736448|FG007|Overall Study|No longer have time to participate|0|||
94257458|NCT01723254|322736441|FG000|Overall Study|Move/Left to another country/city|0|||
94257459|NCT01723254|322736442|FG001|Overall Study|Move/Left to another country/city|0|||
94675188|NCT00279201|324263238|FG002|Initiation|Death|0|||
94675189|NCT00279201|324263239|FG003|Initiation|Death|0|||
94257460|NCT01723254|322736443|FG002|Overall Study|Move/Left to another country/city|2|||
94257461|NCT01723254|322736444|FG003|Overall Study|Move/Left to another country/city|1|||
94257462|NCT01723254|322736445|FG004|Overall Study|Move/Left to another country/city|1|||
94257463|NCT01723254|322736446|FG005|Overall Study|Move/Left to another country/city|0|||
94257464|NCT01723254|322736447|FG006|Overall Study|Move/Left to another country/city|0|||
94257465|NCT01723254|322736448|FG007|Overall Study|Move/Left to another country/city|0|||
94257466|NCT01723254|322736441|FG000|Overall Study|Protocol Violation|0|||
94257467|NCT01723254|322736442|FG001|Overall Study|Protocol Violation|1|||
94257468|NCT01723254|322736443|FG002|Overall Study|Protocol Violation|0|||
94257469|NCT01723254|322736444|FG003|Overall Study|Protocol Violation|0|||
94257470|NCT01723254|322736445|FG004|Overall Study|Protocol Violation|0|||
94257471|NCT01723254|322736446|FG005|Overall Study|Protocol Violation|0|||
94257472|NCT01723254|322736447|FG006|Overall Study|Protocol Violation|0|||
94361294|NCT03917654|323105523|FG001|Year 2|Adverse Event|0|||
94257473|NCT01723254|322736448|FG007|Overall Study|Protocol Violation|0|||
94257474|NCT01723254|322736441|FG000|Overall Study|Withdrawal by Subject|1|||
94257475|NCT01723254|322736442|FG001|Overall Study|Withdrawal by Subject|2|||
94361295|NCT03917654|323105524|FG002|Year 2|Adverse Event|0|||
94257476|NCT01723254|322736443|FG002|Overall Study|Withdrawal by Subject|1|||
94257477|NCT01723254|322736444|FG003|Overall Study|Withdrawal by Subject|0|||
94257478|NCT01723254|322736445|FG004|Overall Study|Withdrawal by Subject|1|||
94257479|NCT01723254|322736446|FG005|Overall Study|Withdrawal by Subject|1|||
94257480|NCT01723254|322736447|FG006|Overall Study|Withdrawal by Subject|1|||
94257481|NCT01723254|322736448|FG007|Overall Study|Withdrawal by Subject|2|||
94257482|NCT03737474|322736449|FG000|Overall Study|Adverse Event|18|||
94257483|NCT03737474|322736450|FG001|Overall Study|Adverse Event|48|||
94257484|NCT03737474|322736449|FG000|Overall Study|Lack of Efficacy|1|||
94257485|NCT03737474|322736450|FG001|Overall Study|Lack of Efficacy|3|||
94257486|NCT03737474|322736449|FG000|Overall Study|Protocol Violation|0|||
94257487|NCT03737474|322736450|FG001|Overall Study|Protocol Violation|8|||
94257488|NCT03737474|322736449|FG000|Overall Study|Withdrawal by Subject|5|||
94257489|NCT03737474|322736450|FG001|Overall Study|Withdrawal by Subject|20|||
94257490|NCT03737474|322736449|FG000|Overall Study|Non-compliance With Study Drug|0|||
94257491|NCT03737474|322736450|FG001|Overall Study|Non-compliance With Study Drug|1|||
94257492|NCT03737474|322736449|FG000|Overall Study|Physician Decision|1|||
94257493|NCT03737474|322736450|FG001|Overall Study|Physician Decision|4|||
94257494|NCT02678247|322736451|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
94257495|NCT02678247|322736452|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
94257496|NCT02678247|322736451|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
94257497|NCT02678247|322736452|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
94257498|NCT02678247|322736451|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
94257499|NCT02678247|322736452|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
94257500|NCT02678247|322736451|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
94257501|NCT02678247|322736452|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
94257502|NCT02678247|322736451|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
94257503|NCT02678247|322736452|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
94257504|NCT02678247|322736451|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
94257505|NCT02678247|322736452|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
94257506|NCT00753272|322736453|FG000|Overall Study|Adverse Event|878|||
94257507|NCT00753272|322736454|FG001|Overall Study|Adverse Event|869|||
94257508|NCT00753272|322736453|FG000|Overall Study|Protocol Violation|28|||
94257509|NCT00753272|322736454|FG001|Overall Study|Protocol Violation|46|||
94257510|NCT00753272|322736453|FG000|Overall Study|Withdrawal by Subject|2481|||
94257511|NCT00753272|322736454|FG001|Overall Study|Withdrawal by Subject|2407|||
94257512|NCT00753272|322736453|FG000|Overall Study|Lost to Follow-up|491|||
94257513|NCT00753272|322736454|FG001|Overall Study|Lost to Follow-up|497|||
94257514|NCT00753272|322736453|FG000|Overall Study|Other|1104|||
94257515|NCT00753272|322736454|FG001|Overall Study|Other|1088|||
94257516|NCT02146326|322736455|FG000|Overall Study|Lost to Follow-up|3|||
94257517|NCT02146326|322736456|FG001|Overall Study|Lost to Follow-up|3|||
94257518|NCT02146326|322736457|FG002|Overall Study|Lost to Follow-up|11|||
94257519|NCT02146326|322736458|FG003|Overall Study|Lost to Follow-up|19|||
94257520|NCT02146326|322736455|FG000|Overall Study|Withdrawal by Subject|2|||
94257521|NCT02146326|322736456|FG001|Overall Study|Withdrawal by Subject|1|||
94257522|NCT02146326|322736457|FG002|Overall Study|Withdrawal by Subject|15|||
94257523|NCT02146326|322736458|FG003|Overall Study|Withdrawal by Subject|11|||
94257524|NCT02146326|322736455|FG000|Overall Study|Separated from mental health center|23|||
94257525|NCT02146326|322736456|FG001|Overall Study|Separated from mental health center|33|||
94257526|NCT02146326|322736457|FG002|Overall Study|Separated from mental health center|0|||
94257527|NCT02146326|322736458|FG003|Overall Study|Separated from mental health center|0|||
94257528|NCT02146326|322736455|FG000|Overall Study|Incarcerated|0|||
94257529|NCT02146326|322736456|FG001|Overall Study|Incarcerated|0|||
94257530|NCT02146326|322736457|FG002|Overall Study|Incarcerated|3|||
94257531|NCT02146326|322736458|FG003|Overall Study|Incarcerated|8|||
94257532|NCT02146326|322736455|FG000|Overall Study|Death|0|||
94257533|NCT02146326|322736456|FG001|Overall Study|Death|0|||
94257534|NCT02146326|322736457|FG002|Overall Study|Death|4|||
94257535|NCT02146326|322736458|FG003|Overall Study|Death|4|||
94257536|NCT02146326|322736455|FG000|Overall Study|Unable to complete interview|0|||
94630068|NCT01896531|324106043|FG000|Overall Study|Non-compliance|0|||
94630069|NCT01896531|324106044|FG001|Overall Study|Non-compliance|1|||
94630070|NCT01896531|324106043|FG000|Overall Study|Study Ended by Sponsor|7|||
94630071|NCT01896531|324106044|FG001|Overall Study|Study Ended by Sponsor|20|||
94630072|NCT01896531|324106043|FG000|Overall Study|Withdrawal by Subject|3|||
94630073|NCT01896531|324106044|FG001|Overall Study|Withdrawal by Subject|2|||
94257537|NCT02146326|322736456|FG001|Overall Study|Unable to complete interview|0|||
94257538|NCT02146326|322736457|FG002|Overall Study|Unable to complete interview|10|||
94257539|NCT02146326|322736458|FG003|Overall Study|Unable to complete interview|6|||
94257540|NCT00777946|322736459|FG000|Overall Study|Adverse Event|11|||
94257541|NCT00777946|322736460|FG001|Overall Study|Adverse Event|1|||
94257542|NCT00777946|322736461|FG002|Overall Study|Adverse Event|3|||
94257543|NCT00777946|322736459|FG000|Overall Study|Lack of Efficacy|0|||
94257544|NCT00777946|322736460|FG001|Overall Study|Lack of Efficacy|0|||
94630074|NCT01896531|324106043|FG000|Overall Study|Death Prior to Treatment|1|||
94630075|NCT01896531|324106044|FG001|Overall Study|Death Prior to Treatment|0|||
94630076|NCT01574326|324106045|FG000|Overall Study|Randomized but not treated|0|||
94630077|NCT01574326|324106046|FG001|Overall Study|Randomized but not treated|1|||
94630078|NCT01574326|324106045|FG000|Overall Study|Withdrawal by Participant|2|||
94630079|NCT01574326|324106046|FG001|Overall Study|Withdrawal by Participant|4|||
94257545|NCT00777946|322736461|FG002|Overall Study|Lack of Efficacy|9|||
94257546|NCT00777946|322736459|FG000|Overall Study|Condition no longer required study drug|1|||
94257547|NCT00777946|322736460|FG001|Overall Study|Condition no longer required study drug|0|||
94257548|NCT00777946|322736461|FG002|Overall Study|Condition no longer required study drug|0|||
94257549|NCT00777946|322736459|FG000|Overall Study|Patient withdrew consent|3|||
94257550|NCT00777946|322736460|FG001|Overall Study|Patient withdrew consent|2|||
94257551|NCT00777946|322736461|FG002|Overall Study|Patient withdrew consent|3|||
94257552|NCT00777946|322736459|FG000|Overall Study|Lost to Follow-up|3|||
94257553|NCT00777946|322736460|FG001|Overall Study|Lost to Follow-up|1|||
94257554|NCT00777946|322736461|FG002|Overall Study|Lost to Follow-up|0|||
94257555|NCT00777946|322736459|FG000|Overall Study|Protocol deviation|2|||
94257556|NCT00777946|322736460|FG001|Overall Study|Protocol deviation|1|||
94257557|NCT00777946|322736461|FG002|Overall Study|Protocol deviation|1|||
94257558|NCT00777946|322736459|FG000|Overall Study|Randomized in error|1|||
94257559|NCT00777946|322736460|FG001|Overall Study|Randomized in error|1|||
94257560|NCT00777946|322736461|FG002|Overall Study|Randomized in error|0|||
94257561|NCT01598311|322736465|FG000|Overall Study|Physician Decision|4|||
94257562|NCT01598311|322736466|FG001|Overall Study|Physician Decision|5|||
94257563|NCT01598311|322736465|FG000|Overall Study|Adverse Event|9|||
94257564|NCT01598311|322736466|FG001|Overall Study|Adverse Event|13|||
94257565|NCT01598311|322736465|FG000|Overall Study|Lost to Follow-up|7|||
94257566|NCT01598311|322736466|FG001|Overall Study|Lost to Follow-up|12|||
94257567|NCT01598311|322736465|FG000|Overall Study|Withdrawal by Subject|9|||
94257568|NCT01598311|322736466|FG001|Overall Study|Withdrawal by Subject|13|||
94257569|NCT01598311|322736465|FG000|Overall Study|No reason provided.|0|||
94257570|NCT01598311|322736466|FG001|Overall Study|No reason provided.|5|||
94257571|NCT01598311|322736465|FG000|Overall Study|Randomized but never treated|8|||
94257572|NCT01598311|322736466|FG001|Overall Study|Randomized but never treated|5|||
94257573|NCT01598311|322736465|FG000|Overall Study|Treated but no confirmed CDAD|9|||
94257574|NCT01598311|322736466|FG001|Overall Study|Treated but no confirmed CDAD|8|||
94257575|NCT01598311|322736465|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
94257576|NCT01598311|322736466|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
94257577|NCT01313117|322736470|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
94257578|NCT01313117|322736470|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
94257579|NCT01912456|322737953|FG000|Period 1|Physician Decision|0|||
94257580|NCT01912456|322737954|FG001|Period 1|Physician Decision|0|||
94257581|NCT01912456|322737955|FG002|Period 1|Physician Decision|1|||
94257582|NCT01912456|322737956|FG003|Period 1|Physician Decision|0|||
94257583|NCT01912456|322737953|FG000|Period 1|non-compliance|1|||
94257584|NCT01912456|322737954|FG001|Period 1|non-compliance|0|||
94257585|NCT01912456|322737955|FG002|Period 1|non-compliance|0|||
94257586|NCT01912456|322737956|FG003|Period 1|non-compliance|1|||
94257587|NCT01912456|322737953|FG000|Period 1|Adverse Event|1|||
94257588|NCT01912456|322737954|FG001|Period 1|Adverse Event|0|||
94630080|NCT01574326|324106045|FG000|Overall Study|Physician Decision|5|||
94630081|NCT01574326|324106046|FG001|Overall Study|Physician Decision|3|||
94630082|NCT01574326|324106045|FG000|Overall Study|Adverse Event|1|||
94630083|NCT01574326|324106046|FG001|Overall Study|Adverse Event|3|||
94630084|NCT01574326|324106045|FG000|Overall Study|Other: Mainly kidney transplant|8|||
94630085|NCT01574326|324106046|FG001|Overall Study|Other: Mainly kidney transplant|8|||
94630086|NCT01195415|324106047|FG000|Overall Study|No repeat biopsy due to progression|2|||
94630087|NCT02485574|324106052|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
94630088|NCT01018186|324106057|FG000|2-week Run-in Period|Protocol Violation|1|||
94630089|NCT01018186|324106058|FG001|2-week Run-in Period|Protocol Violation|0|||
94630090|NCT01018186|324106059|FG002|2-week Run-in Period|Protocol Violation|0|||
94257589|NCT01912456|322737955|FG002|Period 1|Adverse Event|0|||
94257590|NCT01912456|322737956|FG003|Period 1|Adverse Event|1|||
94257591|NCT01912456|322737953|FG000|Period 1|Withdrawal by Subject|0|||
94257592|NCT01912456|322737954|FG001|Period 1|Withdrawal by Subject|1|||
94257593|NCT01912456|322737955|FG002|Period 1|Withdrawal by Subject|1|||
94257594|NCT01912456|322737956|FG003|Period 1|Withdrawal by Subject|1|||
94257595|NCT01912456|322737953|FG000|Period 2|Lack of Efficacy|0|||
94361296|NCT03917654|323105525|FG003|Year 2|Adverse Event|0|||
94675190|NCT00279201|324263240|FG004|Initiation|Death|0|||
94257596|NCT01912456|322737954|FG001|Period 2|Lack of Efficacy|2|||
94257597|NCT01912456|322737955|FG002|Period 2|Lack of Efficacy|0|||
94257598|NCT01912456|322737956|FG003|Period 2|Lack of Efficacy|0|||
94257599|NCT01912456|322737953|FG000|Period 2|Adverse Event|0|||
94257600|NCT01912456|322737954|FG001|Period 2|Adverse Event|0|||
94257601|NCT01912456|322737955|FG002|Period 2|Adverse Event|0|||
94257602|NCT01912456|322737956|FG003|Period 2|Adverse Event|1|||
94257603|NCT01201343|322737957|FG000|Overall Study|Adverse Event|6|||
94630091|NCT01018186|324106060|FG003|2-week Run-in Period|Protocol Violation|0|||
94675191|NCT00279201|324263241|FG005|Initiation|Death|0|||
94675192|NCT00279201|324263236|FG000|Initiation|Adverse Event|6|||
94675193|NCT00279201|324263237|FG001|Initiation|Adverse Event|15|||
94675194|NCT00279201|324263238|FG002|Initiation|Adverse Event|0|||
94675195|NCT00279201|324263239|FG003|Initiation|Adverse Event|0|||
94675196|NCT00279201|324263240|FG004|Initiation|Adverse Event|0|||
94675197|NCT00279201|324263241|FG005|Initiation|Adverse Event|0|||
94675198|NCT00279201|324263236|FG000|Initiation|Lost to Follow-up|42|||
94675199|NCT00279201|324263237|FG001|Initiation|Lost to Follow-up|41|||
94675200|NCT00279201|324263238|FG002|Initiation|Lost to Follow-up|0|||
94675201|NCT00279201|324263239|FG003|Initiation|Lost to Follow-up|0|||
94675202|NCT00279201|324263240|FG004|Initiation|Lost to Follow-up|0|||
94675203|NCT00279201|324263241|FG005|Initiation|Lost to Follow-up|0|||
94675204|NCT00279201|324263236|FG000|Initiation|Entry Criteria Exclusion|7|||
94675205|NCT00279201|324263237|FG001|Initiation|Entry Criteria Exclusion|9|||
94675206|NCT00279201|324263238|FG002|Initiation|Entry Criteria Exclusion|0|||
94675207|NCT00279201|324263239|FG003|Initiation|Entry Criteria Exclusion|0|||
94675208|NCT00279201|324263240|FG004|Initiation|Entry Criteria Exclusion|0|||
94675209|NCT00279201|324263241|FG005|Initiation|Entry Criteria Exclusion|0|||
94675210|NCT00279201|324263236|FG000|Initiation|Protocol Violation|9|||
94675211|NCT00279201|324263237|FG001|Initiation|Protocol Violation|10|||
94675212|NCT00279201|324263238|FG002|Initiation|Protocol Violation|0|||
94675213|NCT00279201|324263239|FG003|Initiation|Protocol Violation|0|||
94675214|NCT00279201|324263240|FG004|Initiation|Protocol Violation|0|||
94675215|NCT00279201|324263241|FG005|Initiation|Protocol Violation|0|||
94675216|NCT00279201|324263236|FG000|Initiation|Withdrawal by Subject|35|||
94675217|NCT00279201|324263237|FG001|Initiation|Withdrawal by Subject|41|||
94675218|NCT00279201|324263238|FG002|Initiation|Withdrawal by Subject|0|||
94675219|NCT00279201|324263239|FG003|Initiation|Withdrawal by Subject|0|||
94675220|NCT00279201|324263240|FG004|Initiation|Withdrawal by Subject|0|||
94675221|NCT00279201|324263241|FG005|Initiation|Withdrawal by Subject|0|||
94675222|NCT00279201|324263236|FG000|Initiation|Physician Decision|15|||
94675223|NCT00279201|324263237|FG001|Initiation|Physician Decision|18|||
94675224|NCT00279201|324263238|FG002|Initiation|Physician Decision|0|||
94675225|NCT00279201|324263239|FG003|Initiation|Physician Decision|0|||
94675226|NCT00279201|324263240|FG004|Initiation|Physician Decision|0|||
94675227|NCT00279201|324263241|FG005|Initiation|Physician Decision|0|||
94675228|NCT00279201|324263236|FG000|Initiation|Sponsor Decision|13|||
94675229|NCT00279201|324263237|FG001|Initiation|Sponsor Decision|5|||
94675230|NCT00279201|324263238|FG002|Initiation|Sponsor Decision|0|||
94675231|NCT00279201|324263239|FG003|Initiation|Sponsor Decision|0|||
94675232|NCT00279201|324263240|FG004|Initiation|Sponsor Decision|0|||
94675233|NCT00279201|324263241|FG005|Initiation|Sponsor Decision|0|||
94675234|NCT00279201|324263236|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
94675235|NCT00279201|324263237|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
94675236|NCT00279201|324263238|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
94675237|NCT00279201|324263239|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
94675238|NCT00279201|324263240|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
94675239|NCT00279201|324263241|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
94675240|NCT00279201|324263236|FG000|Maintenance|Lack of Efficacy|32|||
94675241|NCT00279201|324263237|FG001|Maintenance|Lack of Efficacy|30|||
94675242|NCT00279201|324263238|FG002|Maintenance|Lack of Efficacy|0|||
94675243|NCT00279201|324263239|FG003|Maintenance|Lack of Efficacy|0|||
94675244|NCT00279201|324263240|FG004|Maintenance|Lack of Efficacy|0|||
94675245|NCT00279201|324263241|FG005|Maintenance|Lack of Efficacy|0|||
94675246|NCT00279201|324263236|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
94675247|NCT00279201|324263237|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
94675248|NCT00279201|324263238|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
94675249|NCT00279201|324263239|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
94675250|NCT00279201|324263240|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
94675251|NCT00279201|324263241|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
94675252|NCT00279201|324263236|FG000|Maintenance|Adverse Event|4|||
94675253|NCT00279201|324263237|FG001|Maintenance|Adverse Event|4|||
94361297|NCT03917654|323105526|FG004|Year 2|Adverse Event|0|||
94361298|NCT03917654|323105527|FG005|Year 2|Adverse Event|0|||
94675254|NCT00279201|324263238|FG002|Maintenance|Adverse Event|0|||
94675255|NCT00279201|324263239|FG003|Maintenance|Adverse Event|0|||
94675256|NCT00279201|324263240|FG004|Maintenance|Adverse Event|0|||
94675257|NCT00279201|324263241|FG005|Maintenance|Adverse Event|0|||
94675258|NCT00279201|324263236|FG000|Maintenance|Death|4|||
94675259|NCT00279201|324263237|FG001|Maintenance|Death|4|||
94675260|NCT00279201|324263238|FG002|Maintenance|Death|0|||
94675261|NCT00279201|324263239|FG003|Maintenance|Death|0|||
94675262|NCT00279201|324263240|FG004|Maintenance|Death|0|||
94630092|NCT01018186|324106057|FG000|2-week Run-in Period|Lost to Follow-up|2|||
94630093|NCT01018186|324106058|FG001|2-week Run-in Period|Lost to Follow-up|0|||
94630094|NCT01018186|324106059|FG002|2-week Run-in Period|Lost to Follow-up|0|||
94630095|NCT01018186|324106060|FG003|2-week Run-in Period|Lost to Follow-up|0|||
94630096|NCT01018186|324106057|FG000|2-week Run-in Period|Physician Decision|3|||
94630097|NCT01018186|324106058|FG001|2-week Run-in Period|Physician Decision|0|||
94630098|NCT01018186|324106059|FG002|2-week Run-in Period|Physician Decision|0|||
94630099|NCT01018186|324106060|FG003|2-week Run-in Period|Physician Decision|0|||
94630100|NCT01018186|324106057|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
94630101|NCT01018186|324106058|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
94630102|NCT01018186|324106059|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
94630103|NCT01018186|324106060|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
94630104|NCT01018186|324106057|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
94630105|NCT01018186|324106058|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
94630106|NCT01018186|324106059|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
94630107|NCT01018186|324106060|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
94630108|NCT01018186|324106057|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
94630109|NCT01018186|324106058|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
94630110|NCT01018186|324106059|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
94630111|NCT01018186|324106060|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
94630112|NCT01018186|324106057|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
94630113|NCT01018186|324106058|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
94630114|NCT01018186|324106059|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
94630115|NCT01018186|324106060|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
94630116|NCT01018186|324106057|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
94630117|NCT01018186|324106058|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
94630118|NCT01018186|324106059|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
94630119|NCT01018186|324106060|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
94630120|NCT01018186|324106057|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
94630121|NCT01018186|324106058|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
94630122|NCT01018186|324106059|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
94630123|NCT01018186|324106060|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
94630124|NCT01018186|324106057|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
94630125|NCT01018186|324106058|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
94630126|NCT01018186|324106059|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
94630127|NCT01018186|324106060|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
94630128|NCT01018186|324106057|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
94630129|NCT01018186|324106058|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
94630130|NCT01018186|324106059|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
94630131|NCT01018186|324106060|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
94630132|NCT01018186|324106057|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
94630133|NCT01018186|324106058|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
94630134|NCT01018186|324106059|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
94630135|NCT01018186|324106060|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
94630136|NCT03334448|324106061|FG000|Washout|Personal Reason|0|||
94675263|NCT00279201|324263241|FG005|Maintenance|Death|0|||
94675264|NCT00279201|324263236|FG000|Maintenance|Lost to Follow-up|17|||
94361299|NCT03917654|323105528|FG006|Year 2|Adverse Event|0|||
94630137|NCT03334448|324106062|FG001|Washout|Personal Reason|1|||
94630138|NCT03334448|324106063|FG002|Washout|Personal Reason|0|||
94630139|NCT03334448|324106064|FG003|Washout|Personal Reason|0|||
94630140|NCT03334448|324106061|FG000|Washout|Protocol Violation|0|||
94361300|NCT03917654|323105529|FG007|Year 2|Adverse Event|0|||
94630141|NCT03334448|324106062|FG001|Washout|Protocol Violation|0|||
94630142|NCT03334448|324106063|FG002|Washout|Protocol Violation|0|||
94630143|NCT03334448|324106064|FG003|Washout|Protocol Violation|1|||
94630144|NCT01922089|324106065|FG000|Overall Study|Adverse Event|18|||
94630145|NCT01922089|324106066|FG001|Overall Study|Adverse Event|13|||
94630146|NCT01922089|324106065|FG000|Overall Study|Protocol Deviation|10|||
94630147|NCT01922089|324106066|FG001|Overall Study|Protocol Deviation|7|||
94630148|NCT01922089|324106065|FG000|Overall Study|Withdrawal by Subject|3|||
94630149|NCT01922089|324106066|FG001|Overall Study|Withdrawal by Subject|4|||
94630150|NCT01922089|324106065|FG000|Overall Study|administrative problems|4|||
94630151|NCT01922089|324106066|FG001|Overall Study|administrative problems|1|||
94630152|NCT01922089|324106065|FG000|Overall Study|Physician Decision|2|||
94257604|NCT01201343|322737957|FG000|Overall Study|Withdrawal by Subject|5|||
94257605|NCT01201343|322737957|FG000|Overall Study|Lost to Follow-up|2|||
94257606|NCT01201343|322737957|FG000|Overall Study|Lack of Efficacy|2|||
94257607|NCT01201343|322737957|FG000|Overall Study|Participant wrongly included in trial|1|||
94257608|NCT01201343|322737957|FG000|Overall Study|Randomized, not treated|3|||
94257609|NCT01177722|322737958|FG000|Overall Study|Serious Adverse Event|0|||
94257610|NCT01177722|322737959|FG001|Overall Study|Serious Adverse Event|0|||
94257611|NCT01177722|322737960|FG002|Overall Study|Serious Adverse Event|1|||
94257612|NCT01177722|322737961|FG003|Overall Study|Serious Adverse Event|0|||
94630153|NCT01922089|324106066|FG001|Overall Study|Physician Decision|3|||
94630154|NCT01922089|324106065|FG000|Overall Study|Death|2|||
94630155|NCT01922089|324106066|FG001|Overall Study|Death|1|||
94630156|NCT01922089|324106065|FG000|Overall Study|Lost to Follow-up|0|||
94630157|NCT01922089|324106066|FG001|Overall Study|Lost to Follow-up|1|||
94630158|NCT00001723|324106068|FG000|Overall Study|Lack of Efficacy|6|||
94630159|NCT00001723|324106069|FG001|Overall Study|Lack of Efficacy|7|||
94630160|NCT00001723|324106068|FG000|Overall Study|Lack of family interest|4|||
94630161|NCT00001723|324106069|FG001|Overall Study|Lack of family interest|5|||
94630162|NCT00001723|324106068|FG000|Overall Study|Lost to Follow-up|2|||
94630163|NCT00001723|324106069|FG001|Overall Study|Lost to Follow-up|2|||
94630164|NCT00001723|324106068|FG000|Overall Study|medication intolerance|1|||
94630165|NCT00001723|324106069|FG001|Overall Study|medication intolerance|2|||
94630166|NCT00241280|324106072|FG000|Overall Study|Adverse Event|2|||
94630167|NCT00241280|324106073|FG001|Overall Study|Adverse Event|6|||
94630168|NCT00241280|324106072|FG000|Overall Study|Discomfort|11|||
94630169|NCT00241280|324106073|FG001|Overall Study|Discomfort|16|||
94630170|NCT00241280|324106072|FG000|Overall Study|Pregnancy|1|||
94630171|NCT00241280|324106073|FG001|Overall Study|Pregnancy|5|||
94630172|NCT00241280|324106072|FG000|Overall Study|Lost to Follow-up|5|||
94630173|NCT00241280|324106073|FG001|Overall Study|Lost to Follow-up|8|||
94630174|NCT00241280|324106072|FG000|Overall Study|Withdrawal by Subject|7|||
94630175|NCT00241280|324106073|FG001|Overall Study|Withdrawal by Subject|4|||
94630176|NCT00241280|324106072|FG000|Overall Study|Protocol Violation|4|||
94630177|NCT00241280|324106073|FG001|Overall Study|Protocol Violation|10|||
94630178|NCT00241280|324106072|FG000|Overall Study|Relocation|4|||
94630179|NCT00241280|324106073|FG001|Overall Study|Relocation|4|||
94630180|NCT00241280|324106072|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
94630181|NCT00241280|324106073|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
94630182|NCT00241280|324106072|FG000|Overall Study|Unsatisfactory Visual Response|1|||
94630183|NCT00241280|324106073|FG001|Overall Study|Unsatisfactory Visual Response|1|||
94630184|NCT00241280|324106072|FG000|Overall Study|Diabetic|1|||
94361301|NCT03917654|323105530|FG008|Year 2|Adverse Event|0|||
94630185|NCT00241280|324106073|FG001|Overall Study|Diabetic|0|||
94630186|NCT00241280|324106072|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
94630187|NCT00241280|324106073|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
94630188|NCT00241280|324106072|FG000|Overall Study|Dispensed incorrect test article|1|||
94630189|NCT00241280|324106073|FG001|Overall Study|Dispensed incorrect test article|2|||
94257613|NCT01177722|322737958|FG000|Overall Study|Protocol Violation|0|||
94630190|NCT00241280|324106072|FG000|Overall Study|Unacceptable Fit|0|||
94630191|NCT00241280|324106073|FG001|Overall Study|Unacceptable Fit|1|||
94630192|NCT00241280|324106072|FG000|Overall Study|Scheduling Conflict|0|||
94630193|NCT00241280|324106073|FG001|Overall Study|Scheduling Conflict|2|||
94630194|NCT00241280|324106072|FG000|Overall Study|History of Ocular Surgery|0|||
94630195|NCT00241280|324106073|FG001|Overall Study|History of Ocular Surgery|1|||
94630196|NCT00241280|324106072|FG000|Overall Study|Coating on Lens|1|||
94630197|NCT00241280|324106073|FG001|Overall Study|Coating on Lens|0|||
94630198|NCT00241280|324106072|FG000|Overall Study|Excessive Dryness|0|||
94630199|NCT00241280|324106073|FG001|Overall Study|Excessive Dryness|1|||
94630200|NCT03547687|324106074|FG000|Overall Study|Withdrawal by Subject|1|||
94630201|NCT03547687|324106074|FG000|Overall Study|Death|1|||
94630202|NCT00368355|324106075|FG000|Overall Study|Adverse Event|1|||
94630203|NCT00368355|324106076|FG001|Overall Study|Adverse Event|0|||
94630204|NCT00368355|324106075|FG000|Overall Study|Death|2|||
94630205|NCT00368355|324106076|FG001|Overall Study|Death|4|||
94630206|NCT00368355|324106075|FG000|Overall Study|Relapse|6|||
94630207|NCT00368355|324106076|FG001|Overall Study|Relapse|10|||
94630208|NCT00368355|324106075|FG000|Overall Study|Subsequent transplant|0|||
94630209|NCT00368355|324106076|FG001|Overall Study|Subsequent transplant|3|||
94630210|NCT00368355|324106075|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
94630211|NCT00368355|324106076|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
94630212|NCT02743871|324106077|FG000|Overall Study|Lost to Follow-up|0|||
94630213|NCT02743871|324106078|FG001|Overall Study|Lost to Follow-up|0|||
94630214|NCT02743871|324106079|FG002|Overall Study|Lost to Follow-up|0|||
94630215|NCT02743871|324106080|FG003|Overall Study|Lost to Follow-up|1|||
94630216|NCT02743871|324106081|FG004|Overall Study|Lost to Follow-up|0|||
94630217|NCT02743871|324106082|FG005|Overall Study|Lost to Follow-up|0|||
94630218|NCT02743871|324106083|FG006|Overall Study|Lost to Follow-up|1|||
94630219|NCT02743871|324106084|FG007|Overall Study|Lost to Follow-up|0|||
94630220|NCT02743871|324106085|FG008|Overall Study|Lost to Follow-up|0|||
94630221|NCT02743871|324106086|FG009|Overall Study|Lost to Follow-up|0|||
94630222|NCT02743871|324106087|FG010|Overall Study|Lost to Follow-up|0|||
94630223|NCT02743871|324106088|FG011|Overall Study|Lost to Follow-up|2|||
94630224|NCT02743871|324106089|FG012|Overall Study|Lost to Follow-up|0|||
94630225|NCT02743871|324106090|FG013|Overall Study|Lost to Follow-up|0|||
94630226|NCT02743871|324106077|FG000|Overall Study|Withdrawal by Subject|0|||
94630227|NCT02743871|324106078|FG001|Overall Study|Withdrawal by Subject|0|||
94630228|NCT02743871|324106079|FG002|Overall Study|Withdrawal by Subject|0|||
94630229|NCT02743871|324106080|FG003|Overall Study|Withdrawal by Subject|0|||
94630230|NCT02743871|324106081|FG004|Overall Study|Withdrawal by Subject|0|||
94630231|NCT02743871|324106082|FG005|Overall Study|Withdrawal by Subject|0|||
94630232|NCT02743871|324106083|FG006|Overall Study|Withdrawal by Subject|0|||
94630233|NCT02743871|324106084|FG007|Overall Study|Withdrawal by Subject|0|||
94630234|NCT02743871|324106085|FG008|Overall Study|Withdrawal by Subject|0|||
94630235|NCT02743871|324106086|FG009|Overall Study|Withdrawal by Subject|0|||
94630236|NCT02743871|324106087|FG010|Overall Study|Withdrawal by Subject|1|||
94630237|NCT02743871|324106088|FG011|Overall Study|Withdrawal by Subject|0|||
94630238|NCT02743871|324106089|FG012|Overall Study|Withdrawal by Subject|12|||
94630239|NCT02743871|324106090|FG013|Overall Study|Withdrawal by Subject|6|||
94630240|NCT02743871|324106077|FG000|Overall Study|Adverse Event|1|||
94630241|NCT02743871|324106078|FG001|Overall Study|Adverse Event|0|||
94630242|NCT02743871|324106079|FG002|Overall Study|Adverse Event|0|||
94630243|NCT02743871|324106080|FG003|Overall Study|Adverse Event|0|||
94630244|NCT02743871|324106081|FG004|Overall Study|Adverse Event|0|||
94630245|NCT02743871|324106082|FG005|Overall Study|Adverse Event|0|||
94630246|NCT02743871|324106083|FG006|Overall Study|Adverse Event|0|||
94630247|NCT02743871|324106084|FG007|Overall Study|Adverse Event|0|||
94630248|NCT02743871|324106085|FG008|Overall Study|Adverse Event|0|||
94461375|NCT03045276|323478268|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
94461376|NCT03045276|323478269|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
94630249|NCT02743871|324106086|FG009|Overall Study|Adverse Event|0|||
94630250|NCT02743871|324106087|FG010|Overall Study|Adverse Event|0|||
94630251|NCT02743871|324106088|FG011|Overall Study|Adverse Event|0|||
94630252|NCT02743871|324106089|FG012|Overall Study|Adverse Event|0|||
94630253|NCT02743871|324106090|FG013|Overall Study|Adverse Event|0|||
94630254|NCT02743871|324106077|FG000|Overall Study|Other|0|||
94630255|NCT02743871|324106078|FG001|Overall Study|Other|0|||
94630256|NCT02743871|324106079|FG002|Overall Study|Other|0|||
94630257|NCT02743871|324106080|FG003|Overall Study|Other|0|||
94630258|NCT02743871|324106081|FG004|Overall Study|Other|0|||
94630259|NCT02743871|324106082|FG005|Overall Study|Other|0|||
94630260|NCT02743871|324106083|FG006|Overall Study|Other|0|||
94630261|NCT02743871|324106084|FG007|Overall Study|Other|0|||
94630262|NCT02743871|324106085|FG008|Overall Study|Other|0|||
94630263|NCT02743871|324106086|FG009|Overall Study|Other|0|||
94630264|NCT02743871|324106087|FG010|Overall Study|Other|0|||
94630265|NCT02743871|324106088|FG011|Overall Study|Other|1|||
94630266|NCT02743871|324106089|FG012|Overall Study|Other|1|||
94630267|NCT02743871|324106090|FG013|Overall Study|Other|1|||
94630268|NCT02743871|324106077|FG000|Overall Study|Protocol Violation|0|||
94630269|NCT02743871|324106078|FG001|Overall Study|Protocol Violation|0|||
94630270|NCT02743871|324106079|FG002|Overall Study|Protocol Violation|0|||
94675265|NCT00279201|324263237|FG001|Maintenance|Lost to Follow-up|13|||
94630271|NCT02743871|324106080|FG003|Overall Study|Protocol Violation|0|||
94630272|NCT02743871|324106081|FG004|Overall Study|Protocol Violation|0|||
94630273|NCT02743871|324106082|FG005|Overall Study|Protocol Violation|0|||
94630274|NCT02743871|324106083|FG006|Overall Study|Protocol Violation|0|||
94630275|NCT02743871|324106084|FG007|Overall Study|Protocol Violation|0|||
94630276|NCT02743871|324106085|FG008|Overall Study|Protocol Violation|0|||
94630277|NCT02743871|324106086|FG009|Overall Study|Protocol Violation|0|||
94630278|NCT02743871|324106087|FG010|Overall Study|Protocol Violation|0|||
94630279|NCT02743871|324106088|FG011|Overall Study|Protocol Violation|0|||
94630280|NCT02743871|324106089|FG012|Overall Study|Protocol Violation|2|||
94630281|NCT02743871|324106090|FG013|Overall Study|Protocol Violation|0|||
94630282|NCT03171415|324106093|FG000|Overall Study|Lost to Follow-up|0|||
94630283|NCT03171415|324106094|FG001|Overall Study|Lost to Follow-up|0|||
94630284|NCT03171415|324106095|FG002|Overall Study|Lost to Follow-up|0|||
94630285|NCT03171415|324106096|FG003|Overall Study|Lost to Follow-up|0|||
94630286|NCT03171415|324106097|FG004|Overall Study|Lost to Follow-up|2|||
94630287|NCT01059799|324106099|FG000|Overall Study|Adverse Event|2|||
94630288|NCT01059799|324106100|FG001|Overall Study|Adverse Event|3|||
94630289|NCT01059799|324106099|FG000|Overall Study|Lack of Efficacy|1|||
94630290|NCT01059799|324106100|FG001|Overall Study|Lack of Efficacy|0|||
94630291|NCT01059799|324106099|FG000|Overall Study|Protocol Violation|3|||
94630292|NCT01059799|324106100|FG001|Overall Study|Protocol Violation|2|||
94630293|NCT01059799|324106099|FG000|Overall Study|Withdrawal criteria|13|||
94630294|NCT01059799|324106100|FG001|Overall Study|Withdrawal criteria|2|||
94630295|NCT01059799|324106099|FG000|Overall Study|Other|12|||
94630296|NCT01059799|324106100|FG001|Overall Study|Other|3|||
94630297|NCT02671422|324106108|FG000|Overall Study|Lost to Follow-up|1|||
94630298|NCT02671422|324106108|FG000|Overall Study|Adverse Event|68|||
94257614|NCT01177722|322737959|FG001|Overall Study|Protocol Violation|0|||
94257615|NCT01177722|322737960|FG002|Overall Study|Protocol Violation|1|||
94257616|NCT01177722|322737961|FG003|Overall Study|Protocol Violation|0|||
94257617|NCT01177722|322737958|FG000|Overall Study|Lost to Follow-up|3|||
94257618|NCT01177722|322737959|FG001|Overall Study|Lost to Follow-up|4|||
94257619|NCT01177722|322737960|FG002|Overall Study|Lost to Follow-up|3|||
94257620|NCT01177722|322737961|FG003|Overall Study|Lost to Follow-up|1|||
94257621|NCT01177722|322737958|FG000|Overall Study|Withdrawal by Subject|10|||
94257622|NCT01177722|322737959|FG001|Overall Study|Withdrawal by Subject|6|||
94257623|NCT01177722|322737960|FG002|Overall Study|Withdrawal by Subject|4|||
94257624|NCT01177722|322737961|FG003|Overall Study|Withdrawal by Subject|6|||
94257625|NCT01222507|322737962|FG000|Overall Study|Physician Decision|1|||
94257626|NCT01222507|322737962|FG000|Overall Study|Withdrawal by Subject|1|||
94257627|NCT01650246|322737963|FG000|Overall Study|Adverse Event|23|||
94257628|NCT01650246|322737963|FG000|Overall Study|Protocol Violation|5|||
94257629|NCT01650246|322737963|FG000|Overall Study|Sponsor terminated study|53|||
94257630|NCT01650246|322737963|FG000|Overall Study|Lost to Follow-up|5|||
94257631|NCT01650246|322737963|FG000|Overall Study|Withdrawal by Subject|26|||
94257632|NCT01650246|322737963|FG000|Overall Study|Death|1|||
94257633|NCT01650246|322737963|FG000|Overall Study|Lack of Efficacy|30|||
94257634|NCT00971932|322737965|FG000|Overall Study|Withdrawal by Subject|1|||
94257635|NCT00971932|322737965|FG000|Overall Study|Investigator's decision|2|||
94257636|NCT00971932|322737965|FG000|Overall Study|Ongoing|4|||
94257637|NCT01217957|322737966|FG000|Phase 1|Withdrawal by Patient|1|||
94257638|NCT01217957|322737967|FG001|Phase 1|Withdrawal by Patient|0|||
94257639|NCT01217957|322737968|FG002|Phase 1|Withdrawal by Patient|1|||
94257640|NCT01217957|322737969|FG003|Phase 1|Withdrawal by Patient|1|||
94257641|NCT01217957|322737970|FG004|Phase 1|Withdrawal by Patient|0|||
94257642|NCT01217957|322737966|FG000|Phase 2|Withdrawal by Patient|0|||
94630299|NCT02671422|324106108|FG000|Overall Study|Lack of Efficacy|1|||
94630300|NCT02671422|324106108|FG000|Overall Study|Lost to Follow-up|4|||
94630301|NCT02671422|324106108|FG000|Overall Study|Withdrawal by Subject|7|||
94630302|NCT02671422|324106108|FG000|Overall Study|Progressive Disease|156|||
94630303|NCT02671422|324106108|FG000|Overall Study|Worsening of Disease|4|||
94630304|NCT02671422|324106108|FG000|Overall Study|Sponsor decision|5|||
94630305|NCT02671422|324106108|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
94257643|NCT01217957|322737967|FG001|Phase 2|Withdrawal by Patient|0|||
94257644|NCT01217957|322737968|FG002|Phase 2|Withdrawal by Patient|0|||
94257645|NCT01217957|322737969|FG003|Phase 2|Withdrawal by Patient|0|||
94630306|NCT02671422|324106108|FG000|Overall Study|Not treated with Vargatef®|3|||
94630307|NCT02671422|324106108|FG000|Overall Study|Other not defined above|3|||
94630308|NCT02744391|324106110|FG000|Overall Study|Lost to Follow-up|9|||
94630309|NCT02744391|324106110|FG000|Overall Study|Physician Decision|2|||
94630310|NCT02744391|324106110|FG000|Overall Study|Withdrawal by Subject|3|||
94630311|NCT02700815|324107807|FG000|Overall Study|Adverse Event|0|||
94257646|NCT01217957|322737970|FG004|Phase 2|Withdrawal by Patient|1|||
94257647|NCT01640054|322737971|FG000|Overall Study|Study-specific disc criteria|1|||
94257648|NCT01640054|322737971|FG000|Overall Study|Lack of Efficacy|3|||
94257649|NCT01640054|322737971|FG000|Overall Study|Adverse Event|2|||
94257650|NCT05220254|322737972|FG000|Overall Study|Withdrawal by Subject|4|||
94257651|NCT05220254|322737972|FG000|Overall Study|Removed due to ineligibility|1|||
94630312|NCT02700815|324107808|FG001|Overall Study|Adverse Event|6|||
94630313|NCT02700815|324107809|FG002|Overall Study|Adverse Event|2|||
94630314|NCT02700815|324107810|FG003|Overall Study|Adverse Event|3|||
94630315|NCT02700815|324107807|FG000|Overall Study|Lack of Efficacy|0|||
94630316|NCT02700815|324107808|FG001|Overall Study|Lack of Efficacy|0|||
94257652|NCT05220254|322737972|FG000|Overall Study|Lost to Follow-up|7|||
94257653|NCT01620255|322737978|FG000|Overall Study|Withdrawal by Subject|4|||
94257654|NCT01620255|322737979|FG001|Overall Study|Withdrawal by Subject|1|||
94257655|NCT01620255|322737980|FG002|Overall Study|Withdrawal by Subject|1|||
94257656|NCT01620255|322737981|FG003|Overall Study|Withdrawal by Subject|2|||
94257657|NCT01620255|322737982|FG004|Overall Study|Withdrawal by Subject|4|||
94257658|NCT01620255|322737978|FG000|Overall Study|Participant underwent fecal transplant|0|||
94257659|NCT01620255|322737979|FG001|Overall Study|Participant underwent fecal transplant|0|||
94257660|NCT01620255|322737980|FG002|Overall Study|Participant underwent fecal transplant|1|||
94257661|NCT01620255|322737981|FG003|Overall Study|Participant underwent fecal transplant|0|||
94257662|NCT01620255|322737982|FG004|Overall Study|Participant underwent fecal transplant|0|||
94257663|NCT01620255|322737978|FG000|Overall Study|Non-compliance|0|||
94257664|NCT01620255|322737979|FG001|Overall Study|Non-compliance|1|||
94257665|NCT01620255|322737980|FG002|Overall Study|Non-compliance|0|||
94257666|NCT01620255|322737981|FG003|Overall Study|Non-compliance|0|||
94257667|NCT01620255|322737982|FG004|Overall Study|Non-compliance|0|||
94257668|NCT01620255|322737978|FG000|Overall Study|Adverse Event|0|||
94257669|NCT01620255|322737979|FG001|Overall Study|Adverse Event|4|||
94257670|NCT01620255|322737980|FG002|Overall Study|Adverse Event|0|||
94257671|NCT01620255|322737981|FG003|Overall Study|Adverse Event|1|||
94257672|NCT01620255|322737982|FG004|Overall Study|Adverse Event|1|||
94257673|NCT01620255|322737978|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
94257674|NCT01620255|322737979|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
94257675|NCT01620255|322737980|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
94257676|NCT01620255|322737981|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
94257677|NCT01620255|322737982|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
94257678|NCT01716117|322737983|FG000|Overall Study|Death|5|||
94257679|NCT01716117|322737984|FG001|Overall Study|Death|2|||
94257680|NCT01716117|322737983|FG000|Overall Study|Withdrawal by Subject|2|||
94257681|NCT01716117|322737984|FG001|Overall Study|Withdrawal by Subject|0|||
94257682|NCT01557283|322737985|FG000|Overall Study|Lost to Follow-up|7|||
94257683|NCT01557283|322737985|FG000|Overall Study|Non-responder|19|||
94257684|NCT01557283|322737985|FG000|Overall Study|Adverse Event|7|||
94257685|NCT01557283|322737985|FG000|Overall Study|Lack of Efficacy|1|||
94257686|NCT01557283|322737985|FG000|Overall Study|Non-compliance|1|||
94257687|NCT01557283|322737985|FG000|Overall Study|Withdrawal by Subject|1|||
94257688|NCT01557283|322737985|FG000|Overall Study|Participant's weight too high for dose|1|||
94257689|NCT01557283|322737985|FG000|Overall Study|Worsening of psoriasis|1|||
94257690|NCT01557283|322737985|FG000|Overall Study|Other|6|||
94257691|NCT01765192|322737986|FG000|Treatment Period 1|Adverse Event|0|||
94257692|NCT01765192|322737987|FG001|Treatment Period 1|Adverse Event|1|||
94257693|NCT01765192|322737986|FG000|Washout Period|Voluntary Withdrawal|1|||
94257694|NCT01765192|322737987|FG001|Washout Period|Voluntary Withdrawal|1|||
94257695|NCT01765192|322737986|FG000|Washout Period|Reason not specified|1|||
94257696|NCT01765192|322737987|FG001|Washout Period|Reason not specified|0|||
94257697|NCT01765192|322737986|FG000|Treatment Period 2|Reason not specified|0|||
94257698|NCT01765192|322737987|FG001|Treatment Period 2|Reason not specified|2|||
94257699|NCT01765192|322737986|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
94257700|NCT01765192|322737987|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
94257701|NCT02080221|322737994|FG000|Overall Study|Withdrawal by Subject|1|||
94257702|NCT02080221|322737994|FG000|Overall Study|Clinical Progression of Disease|1|||
94257703|NCT01386788|322737997|FG000|Overall Study|Lost to Follow-up|2|||
94257704|NCT03310268|322738000|FG000|Overall Study|(Not specified)|1|||
94257705|NCT03310268|322738001|FG001|Overall Study|(Not specified)|5|||
94257706|NCT03310268|322738002|FG002|Overall Study|(Not specified)|0|||
94257707|NCT02808143|322738005|FG000|Maintenance Phase|Disease recurrence|1|||
94257708|NCT02808143|322738006|FG001|Maintenance Phase|Disease recurrence|3|||
94257709|NCT02808143|322738005|FG000|Maintenance Phase|Disease progression|1|||
94257710|NCT02808143|322738006|FG001|Maintenance Phase|Disease progression|2|||
94257711|NCT02808143|322738005|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
94257712|NCT02808143|322738006|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
94257713|NCT02808143|322738005|FG000|Survival Follow-Up|Disease recurrence|0|||
94257714|NCT02808143|322738006|FG001|Survival Follow-Up|Disease recurrence|2|||
94257715|NCT02808143|322738005|FG000|Survival Follow-Up|Adverse Event|0|||
94257716|NCT02808143|322738006|FG001|Survival Follow-Up|Adverse Event|1|||
94257717|NCT02808143|322738005|FG000|Survival Follow-Up|Death|1|||
94257718|NCT02808143|322738006|FG001|Survival Follow-Up|Death|0|||
94630317|NCT02700815|324107809|FG002|Overall Study|Lack of Efficacy|1|||
94630318|NCT02700815|324107810|FG003|Overall Study|Lack of Efficacy|2|||
94630319|NCT02700815|324107807|FG000|Overall Study|Lost to Follow-up|1|||
94630320|NCT02700815|324107808|FG001|Overall Study|Lost to Follow-up|0|||
94630321|NCT02700815|324107809|FG002|Overall Study|Lost to Follow-up|0|||
94630322|NCT02700815|324107810|FG003|Overall Study|Lost to Follow-up|1|||
94630323|NCT02700815|324107807|FG000|Overall Study|Refusal to continue medication|0|||
94257719|NCT01155375|322738007|FG000|Overall Study|Adverse Event|1|||
94630324|NCT02700815|324107808|FG001|Overall Study|Refusal to continue medication|1|||
94675266|NCT00279201|324263238|FG002|Maintenance|Lost to Follow-up|0|||
94675267|NCT00279201|324263239|FG003|Maintenance|Lost to Follow-up|0|||
94675268|NCT00279201|324263240|FG004|Maintenance|Lost to Follow-up|0|||
94675269|NCT00279201|324263241|FG005|Maintenance|Lost to Follow-up|0|||
94675270|NCT00279201|324263236|FG000|Maintenance|Entry Criteria Exclusion|1|||
94257720|NCT01155375|322738008|FG001|Overall Study|Adverse Event|0|||
94257721|NCT01480674|322738009|FG000|Overall Study|Death|23|||
94257722|NCT01480674|322738009|FG000|Overall Study|Lost to Follow-up|2|||
94257723|NCT01480674|322738009|FG000|Overall Study|visit not done|10|||
94257724|NCT04754477|322738010|FG000|Overall Study|Withdrawal by Subject|1|||
94257725|NCT01313637|322738011|FG000|Overall Study|Adverse Event|17|||
94257726|NCT01313637|322738012|FG001|Overall Study|Adverse Event|24|||
94257727|NCT01313637|322738013|FG002|Overall Study|Adverse Event|25|||
94257728|NCT01313637|322738014|FG003|Overall Study|Adverse Event|18|||
94257729|NCT01313637|322738011|FG000|Overall Study|Lack of Efficacy|44|||
94257730|NCT01313637|322738012|FG001|Overall Study|Lack of Efficacy|38|||
94257731|NCT01313637|322738013|FG002|Overall Study|Lack of Efficacy|37|||
94257732|NCT01313637|322738014|FG003|Overall Study|Lack of Efficacy|24|||
94257733|NCT01313637|322738011|FG000|Overall Study|Protocol Violation|4|||
94257734|NCT01313637|322738012|FG001|Overall Study|Protocol Violation|3|||
94257735|NCT01313637|322738013|FG002|Overall Study|Protocol Violation|11|||
94257736|NCT01313637|322738014|FG003|Overall Study|Protocol Violation|5|||
94257737|NCT01313637|322738011|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
94257738|NCT01313637|322738012|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
94257739|NCT01313637|322738013|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
94257740|NCT01313637|322738014|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
94257741|NCT01313637|322738011|FG000|Overall Study|Lost to Follow-up|0|||
94257742|NCT01313637|322738012|FG001|Overall Study|Lost to Follow-up|2|||
94257743|NCT01313637|322738013|FG002|Overall Study|Lost to Follow-up|1|||
94257744|NCT01313637|322738014|FG003|Overall Study|Lost to Follow-up|3|||
94257745|NCT01313637|322738011|FG000|Overall Study|Withdrawal by Subject|11|||
94257746|NCT01313637|322738012|FG001|Overall Study|Withdrawal by Subject|13|||
94675271|NCT00279201|324263237|FG001|Maintenance|Entry Criteria Exclusion|4|||
94675272|NCT00279201|324263238|FG002|Maintenance|Entry Criteria Exclusion|0|||
94675273|NCT00279201|324263239|FG003|Maintenance|Entry Criteria Exclusion|0|||
94675274|NCT00279201|324263240|FG004|Maintenance|Entry Criteria Exclusion|0|||
94675275|NCT00279201|324263241|FG005|Maintenance|Entry Criteria Exclusion|0|||
94675276|NCT00279201|324263236|FG000|Maintenance|Protocol Violation|16|||
94675277|NCT00279201|324263237|FG001|Maintenance|Protocol Violation|24|||
94675278|NCT00279201|324263238|FG002|Maintenance|Protocol Violation|0|||
94675279|NCT00279201|324263239|FG003|Maintenance|Protocol Violation|0|||
94675280|NCT00279201|324263240|FG004|Maintenance|Protocol Violation|0|||
94675281|NCT00279201|324263241|FG005|Maintenance|Protocol Violation|0|||
94675282|NCT00279201|324263236|FG000|Maintenance|Withdrawal by Subject|18|||
94675283|NCT00279201|324263237|FG001|Maintenance|Withdrawal by Subject|18|||
94675284|NCT00279201|324263238|FG002|Maintenance|Withdrawal by Subject|0|||
94675285|NCT00279201|324263239|FG003|Maintenance|Withdrawal by Subject|0|||
94675286|NCT00279201|324263240|FG004|Maintenance|Withdrawal by Subject|0|||
94675287|NCT00279201|324263241|FG005|Maintenance|Withdrawal by Subject|0|||
94675288|NCT00279201|324263236|FG000|Maintenance|Physician Decision|9|||
94675289|NCT00279201|324263237|FG001|Maintenance|Physician Decision|9|||
94675290|NCT00279201|324263238|FG002|Maintenance|Physician Decision|0|||
94675291|NCT00279201|324263239|FG003|Maintenance|Physician Decision|0|||
94675292|NCT00279201|324263240|FG004|Maintenance|Physician Decision|0|||
94675293|NCT00279201|324263241|FG005|Maintenance|Physician Decision|0|||
94675294|NCT00279201|324263236|FG000|Maintenance|Sponsor Decision|4|||
94675295|NCT00279201|324263237|FG001|Maintenance|Sponsor Decision|0|||
94675296|NCT00279201|324263238|FG002|Maintenance|Sponsor Decision|0|||
94675297|NCT00279201|324263239|FG003|Maintenance|Sponsor Decision|0|||
94675298|NCT00279201|324263240|FG004|Maintenance|Sponsor Decision|0|||
94675299|NCT00279201|324263241|FG005|Maintenance|Sponsor Decision|0|||
94675300|NCT00279201|324263236|FG000|Maintenance|HbA1c>7.5%|123|||
94675301|NCT00279201|324263237|FG001|Maintenance|HbA1c>7.5%|126|||
94361302|NCT03917654|323105531|FG009|Year 2|Adverse Event|1|||
94361303|NCT03917654|323105532|FG010|Year 2|Adverse Event|0|||
94675302|NCT00279201|324263238|FG002|Maintenance|HbA1c>7.5%|0|||
94257747|NCT01313637|322738013|FG002|Overall Study|Withdrawal by Subject|18|||
94257748|NCT01313637|322738014|FG003|Overall Study|Withdrawal by Subject|15|||
94257749|NCT01136772|322738017|FG000|Overall Study|Adverse Event|15|||
94257750|NCT01136772|322738018|FG001|Overall Study|Adverse Event|14|||
94257751|NCT01136772|322738017|FG000|Overall Study|Lack of Efficacy|42|||
94361304|NCT03917654|323105533|FG011|Year 2|Adverse Event|0|||
94675303|NCT00279201|324263239|FG003|Maintenance|HbA1c>7.5%|0|||
94257752|NCT01136772|322738018|FG001|Overall Study|Lack of Efficacy|39|||
94675304|NCT00279201|324263240|FG004|Maintenance|HbA1c>7.5%|0|||
94675305|NCT00279201|324263241|FG005|Maintenance|HbA1c>7.5%|0|||
94257753|NCT01136772|322738017|FG000|Overall Study|Administrative|14|||
94257754|NCT01136772|322738018|FG001|Overall Study|Administrative|12|||
94675306|NCT00279201|324263236|FG000|Intensification Addendum|Withdrawal by Subject|0|||
94675307|NCT00279201|324263237|FG001|Intensification Addendum|Withdrawal by Subject|0|||
94361305|NCT00905437|323105534|FG000|Overall Study|Adverse Event|3|||
94361306|NCT00905437|323105535|FG001|Overall Study|Adverse Event|2|||
94361307|NCT00905437|323105534|FG000|Overall Study|Lost to Follow-up|0|||
94361308|NCT00905437|323105535|FG001|Overall Study|Lost to Follow-up|1|||
94361309|NCT00905437|323105534|FG000|Overall Study|Withdrawal by Subject|0|||
94361310|NCT00905437|323105535|FG001|Overall Study|Withdrawal by Subject|1|||
94361311|NCT00905437|323105534|FG000|Overall Study|Other|5|||
94361312|NCT00905437|323105535|FG001|Overall Study|Other|6|||
94361313|NCT01381068|323105542|FG000|Overall Study|Death|1|||
94361314|NCT01381068|323105543|FG001|Overall Study|Death|0|||
94361315|NCT01071278|323105544|FG000|Overall Study|Premature Discontinuation|254|||
94361316|NCT01071278|323105544|FG000|Overall Study|Completion Status Unknown|459|||
94361317|NCT02268214|323105550|FG000|Overall Study|Subject no longer meets study criteria|0|||
94361318|NCT02268214|323105551|FG001|Overall Study|Subject no longer meets study criteria|2|||
94361319|NCT02268214|323105552|FG002|Overall Study|Subject no longer meets study criteria|0|||
94361320|NCT02268214|323105550|FG000|Overall Study|Pregnancy|2|||
94361321|NCT02268214|323105551|FG001|Overall Study|Pregnancy|2|||
94361322|NCT02268214|323105552|FG002|Overall Study|Pregnancy|1|||
94361323|NCT02268214|323105550|FG000|Overall Study|Lost to Follow-up|3|||
94361324|NCT02268214|323105551|FG001|Overall Study|Lost to Follow-up|3|||
94361325|NCT02268214|323105552|FG002|Overall Study|Lost to Follow-up|4|||
94361326|NCT02268214|323105550|FG000|Overall Study|Lack of Efficacy|1|||
94361327|NCT02268214|323105551|FG001|Overall Study|Lack of Efficacy|0|||
94361328|NCT02268214|323105552|FG002|Overall Study|Lack of Efficacy|2|||
94361329|NCT02268214|323105550|FG000|Overall Study|Adverse Event|11|||
94361330|NCT02268214|323105551|FG001|Overall Study|Adverse Event|14|||
94361331|NCT02268214|323105552|FG002|Overall Study|Adverse Event|9|||
94361332|NCT02268214|323105550|FG000|Overall Study|Withdrawal by Subject|4|||
94361333|NCT02268214|323105551|FG001|Overall Study|Withdrawal by Subject|5|||
94361334|NCT02268214|323105552|FG002|Overall Study|Withdrawal by Subject|10|||
94361335|NCT02268214|323105550|FG000|Overall Study|Subject request to discontinue treatment|10|||
94361336|NCT02268214|323105551|FG001|Overall Study|Subject request to discontinue treatment|8|||
94361337|NCT02268214|323105552|FG002|Overall Study|Subject request to discontinue treatment|6|||
94361338|NCT02268214|323105550|FG000|Overall Study|Poor/non-compliance|2|||
94361339|NCT02268214|323105551|FG001|Overall Study|Poor/non-compliance|1|||
94630325|NCT02700815|324107809|FG002|Overall Study|Refusal to continue medication|0|||
94630326|NCT02700815|324107810|FG003|Overall Study|Refusal to continue medication|1|||
94630327|NCT02700815|324107807|FG000|Overall Study|Withdrawal by Subject|0|||
94630328|NCT02700815|324107808|FG001|Overall Study|Withdrawal by Subject|0|||
94630329|NCT02700815|324107809|FG002|Overall Study|Withdrawal by Subject|1|||
94630330|NCT02700815|324107810|FG003|Overall Study|Withdrawal by Subject|0|||
94630331|NCT00524368|324107811|FG000|Overall Study|Adverse Event|10|||
94630332|NCT00524368|324107812|FG001|Overall Study|Adverse Event|12|||
94630333|NCT00524368|324107811|FG000|Overall Study|Lost to Follow-up|9|||
94630334|NCT00524368|324107812|FG001|Overall Study|Lost to Follow-up|13|||
94630335|NCT00524368|324107811|FG000|Overall Study|Withdrawal by Subject|4|||
94630336|NCT00524368|324107812|FG001|Overall Study|Withdrawal by Subject|5|||
94630337|NCT00524368|324107811|FG000|Overall Study|Non-compliant|8|||
94630338|NCT00524368|324107812|FG001|Overall Study|Non-compliant|9|||
94630339|NCT00524368|324107811|FG000|Overall Study|Reached a Virologic Endpoint|3|||
94630340|NCT00524368|324107812|FG001|Overall Study|Reached a Virologic Endpoint|2|||
94630341|NCT00524368|324107811|FG000|Overall Study|Sponsor's Decision|2|||
94630342|NCT00524368|324107812|FG001|Overall Study|Sponsor's Decision|0|||
94630343|NCT00524368|324107811|FG000|Overall Study|Ineligible to Continue the study|2|||
94630344|NCT00524368|324107812|FG001|Overall Study|Ineligible to Continue the study|5|||
94630345|NCT00524368|324107811|FG000|Overall Study|Other|3|||
94630346|NCT00524368|324107812|FG001|Overall Study|Other|2|||
94630347|NCT01752907|324107818|FG000|Overall Study|Withdrawal by Subject|4|||
94630348|NCT01752907|324107819|FG001|Overall Study|Withdrawal by Subject|10|||
94630349|NCT01752907|324107818|FG000|Overall Study|Lost to Follow-up|2|||
94630350|NCT01752907|324107819|FG001|Overall Study|Lost to Follow-up|1|||
94361340|NCT02268214|323105552|FG002|Overall Study|Poor/non-compliance|2|||
94361341|NCT02268214|323105550|FG000|Overall Study|Other reasons|7|||
94630351|NCT01752907|324107818|FG000|Overall Study|Decision by Sponsor|6|||
94361342|NCT02268214|323105551|FG001|Overall Study|Other reasons|3|||
94630352|NCT01752907|324107819|FG001|Overall Study|Decision by Sponsor|9|||
94361343|NCT02268214|323105552|FG002|Overall Study|Other reasons|3|||
94361344|NCT02268214|323105550|FG000|Overall Study|Not entering long-term period|2|||
94361345|NCT02268214|323105551|FG001|Overall Study|Not entering long-term period|3|||
94630353|NCT03045328|324107820|FG000|Overall Study|Withdrawal by Subject|2|||
94630354|NCT04271605|324107821|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
94630355|NCT00157950|324107824|FG000|Overall Study|Death|1|||
94630356|NCT00157950|324107825|FG001|Overall Study|Death|0|||
94630357|NCT00589914|324107838|FG000|Overall Study|Adverse Event|19|||
94630358|NCT00589914|324107839|FG001|Overall Study|Adverse Event|10|||
94630359|NCT00589914|324107838|FG000|Overall Study|Death|2|||
94257755|NCT01136772|322738017|FG000|Overall Study|Withdrawal by Subject|33|||
94257756|NCT01136772|322738018|FG001|Overall Study|Withdrawal by Subject|36|||
94257757|NCT01136772|322738017|FG000|Overall Study|Did not receive injection|10|||
94257758|NCT01136772|322738018|FG001|Overall Study|Did not receive injection|7|||
94257759|NCT01136772|322738017|FG000|Overall Study|Did not follow up after first injection|2|||
94257760|NCT01136772|322738018|FG001|Overall Study|Did not follow up after first injection|2|||
94257761|NCT01127139|322738019|FG000|Overall Study|Adverse Event|40|||
94257762|NCT01127139|322738019|FG000|Overall Study|Incompliance|12|||
94257763|NCT01127139|322738019|FG000|Overall Study|Lack of Efficacy|4|||
94257764|NCT01127139|322738019|FG000|Overall Study|Reason not specified|1|||
94257765|NCT03421431|322738020|FG000|Overall Study|Adverse Event|2|||
94257766|NCT03421431|322738021|FG001|Overall Study|Adverse Event|1|||
94257767|NCT03421431|322738022|FG002|Overall Study|Adverse Event|12|||
94257768|NCT03421431|322738020|FG000|Overall Study|Lost to Follow-up|1|||
94257769|NCT03421431|322738021|FG001|Overall Study|Lost to Follow-up|1|||
94257770|NCT03421431|322738022|FG002|Overall Study|Lost to Follow-up|1|||
94257771|NCT03421431|322738020|FG000|Overall Study|Withdrawal by Subject|3|||
94257772|NCT03421431|322738021|FG001|Overall Study|Withdrawal by Subject|2|||
94257773|NCT03421431|322738022|FG002|Overall Study|Withdrawal by Subject|1|||
94257774|NCT03421431|322738020|FG000|Overall Study|Protocol Violation|0|||
94257775|NCT03421431|322738021|FG001|Overall Study|Protocol Violation|1|||
94257776|NCT03421431|322738022|FG002|Overall Study|Protocol Violation|0|||
94257777|NCT03421431|322738020|FG000|Overall Study|Participant met Stopping Rules|0|||
94257778|NCT03421431|322738021|FG001|Overall Study|Participant met Stopping Rules|1|||
94257779|NCT03421431|322738022|FG002|Overall Study|Participant met Stopping Rules|0|||
94257780|NCT00235326|322738023|FG000|Overall Study|Lost to Follow-up|746|||
94257781|NCT00235326|322738024|FG001|Overall Study|Lost to Follow-up|1400|||
94257782|NCT04964414|322738026|FG000|Overall Study|Lost to Follow-up|10|||
94257783|NCT04964414|322738027|FG001|Overall Study|Lost to Follow-up|8|||
94257784|NCT04964414|322738026|FG000|Overall Study|Withdrawal by Subject|1|||
94257785|NCT04964414|322738027|FG001|Overall Study|Withdrawal by Subject|1|||
94257786|NCT01790126|322738028|FG000|Overall Study|PSA Progression|12|||
94257787|NCT01790126|322738029|FG001|Overall Study|PSA Progression|16|||
94257788|NCT01790126|322738030|FG002|Overall Study|PSA Progression|16|||
94257789|NCT01790126|322738028|FG000|Overall Study|Other|5|||
94257790|NCT01790126|322738029|FG001|Overall Study|Other|4|||
94257791|NCT01790126|322738030|FG002|Overall Study|Other|8|||
94257792|NCT01790126|322738028|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
94257793|NCT01790126|322738029|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
94257794|NCT01790126|322738030|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
94257795|NCT01790126|322738028|FG000|Overall Study|Withdrawal by Physician|1|||
94257796|NCT01790126|322738029|FG001|Overall Study|Withdrawal by Physician|1|||
94257797|NCT01790126|322738030|FG002|Overall Study|Withdrawal by Physician|2|||
94257798|NCT01790126|322738028|FG000|Overall Study|Withdrawal by Subject|3|||
94257799|NCT01790126|322738029|FG001|Overall Study|Withdrawal by Subject|1|||
94257800|NCT01790126|322738030|FG002|Overall Study|Withdrawal by Subject|2|||
94257801|NCT01790126|322738028|FG000|Overall Study|Lost to Follow-up|1|||
94257802|NCT01790126|322738029|FG001|Overall Study|Lost to Follow-up|0|||
94257803|NCT01790126|322738030|FG002|Overall Study|Lost to Follow-up|1|||
94257804|NCT01790126|322738028|FG000|Overall Study|Adverse Event|0|||
94257805|NCT01790126|322738029|FG001|Overall Study|Adverse Event|2|||
94257806|NCT01790126|322738030|FG002|Overall Study|Adverse Event|0|||
94257807|NCT01790126|322738028|FG000|Overall Study|Death|2|||
94257808|NCT01790126|322738029|FG001|Overall Study|Death|0|||
94257809|NCT01790126|322738030|FG002|Overall Study|Death|0|||
94257810|NCT01790126|322738028|FG000|Overall Study|Radiographic Progression|3|||
94257811|NCT01790126|322738029|FG001|Overall Study|Radiographic Progression|1|||
94257812|NCT01790126|322738030|FG002|Overall Study|Radiographic Progression|0|||
94257813|NCT00195507|322738031|FG000|Overall Study|Adverse Event|24|||
94257814|NCT00195507|322738032|FG001|Overall Study|Adverse Event|13|||
94257815|NCT00195507|322738031|FG000|Overall Study|Death|0|||
94257816|NCT00195507|322738032|FG001|Overall Study|Death|1|||
94257817|NCT00195507|322738031|FG000|Overall Study|Failed to Return|4|||
94257818|NCT00195507|322738032|FG001|Overall Study|Failed to Return|3|||
94257819|NCT00195507|322738031|FG000|Overall Study|Physician Decision|1|||
94257820|NCT00195507|322738032|FG001|Overall Study|Physician Decision|2|||
94257821|NCT00195507|322738031|FG000|Overall Study|Lost to Follow-up|3|||
94257822|NCT00195507|322738032|FG001|Overall Study|Lost to Follow-up|2|||
94257823|NCT00195507|322738031|FG000|Overall Study|Protocol Violation|5|||
94257824|NCT00195507|322738032|FG001|Overall Study|Protocol Violation|4|||
94257825|NCT00195507|322738031|FG000|Overall Study|Lack of Efficacy|40|||
94257826|NCT00195507|322738032|FG001|Overall Study|Lack of Efficacy|67|||
94257827|NCT00195507|322738031|FG000|Overall Study|Withdrawal by Subject|16|||
94257828|NCT00195507|322738032|FG001|Overall Study|Withdrawal by Subject|23|||
94257829|NCT00195507|322738031|FG000|Overall Study|Protocol Deviation|6|||
94257830|NCT00195507|322738032|FG001|Overall Study|Protocol Deviation|3|||
94257831|NCT01211197|322738033|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
94257832|NCT01211197|322738034|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
94630360|NCT00589914|324107839|FG001|Overall Study|Death|0|||
94630361|NCT00589914|324107838|FG000|Overall Study|Lack of Efficacy|40|||
94630362|NCT00589914|324107839|FG001|Overall Study|Lack of Efficacy|43|||
94630363|NCT00589914|324107838|FG000|Overall Study|Lost to Follow-up|11|||
94630364|NCT00589914|324107839|FG001|Overall Study|Lost to Follow-up|18|||
94630365|NCT00589914|324107838|FG000|Overall Study|Pregnancy|1|||
94630366|NCT00589914|324107839|FG001|Overall Study|Pregnancy|0|||
94630367|NCT00589914|324107838|FG000|Overall Study|Withdrawal by Subject|55|||
94630368|NCT00589914|324107839|FG001|Overall Study|Withdrawal by Subject|49|||
94630369|NCT00589914|324107838|FG000|Overall Study|Other|22|||
94630370|NCT00589914|324107839|FG001|Overall Study|Other|17|||
94630371|NCT02489344|324107840|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
94630372|NCT02489344|324107840|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
94630373|NCT02489344|324107840|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
94630374|NCT02489344|324107840|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
94630375|NCT03315208|324107846|FG000|Overall Study|Lost to Follow-up|11|||
94630376|NCT03315208|324107847|FG001|Overall Study|Lost to Follow-up|6|||
94630377|NCT03315208|324107846|FG000|Overall Study|Withdrawal by Subject|2|||
94630378|NCT03315208|324107847|FG001|Overall Study|Withdrawal by Subject|0|||
94630379|NCT00022633|324107850|FG000|Overall Study|Adverse Event|11|||
94630380|NCT00022633|324107851|FG001|Overall Study|Adverse Event|1|||
94630381|NCT00022633|324107850|FG000|Overall Study|Refusal unrelated to adverse event|1|||
94630382|NCT00022633|324107851|FG001|Overall Study|Refusal unrelated to adverse event|0|||
94630383|NCT00022633|324107850|FG000|Overall Study|Progression/relapse|9|||
94675308|NCT00279201|324263238|FG002|Intensification Addendum|Withdrawal by Subject|12|||
94675309|NCT00279201|324263239|FG003|Intensification Addendum|Withdrawal by Subject|14|||
94675310|NCT00279201|324263240|FG004|Intensification Addendum|Withdrawal by Subject|9|||
94675311|NCT00279201|324263241|FG005|Intensification Addendum|Withdrawal by Subject|18|||
94675312|NCT00279201|324263236|FG000|Intensification Addendum|Lost to Follow-up|0|||
94675313|NCT00279201|324263237|FG001|Intensification Addendum|Lost to Follow-up|0|||
94675314|NCT00279201|324263238|FG002|Intensification Addendum|Lost to Follow-up|4|||
94675315|NCT00279201|324263239|FG003|Intensification Addendum|Lost to Follow-up|6|||
94675316|NCT00279201|324263240|FG004|Intensification Addendum|Lost to Follow-up|7|||
94675317|NCT00279201|324263241|FG005|Intensification Addendum|Lost to Follow-up|7|||
94675318|NCT00279201|324263236|FG000|Intensification Addendum|Protocol Violation|0|||
94675319|NCT00279201|324263237|FG001|Intensification Addendum|Protocol Violation|0|||
94675320|NCT00279201|324263238|FG002|Intensification Addendum|Protocol Violation|2|||
94675321|NCT00279201|324263239|FG003|Intensification Addendum|Protocol Violation|2|||
94675322|NCT00279201|324263240|FG004|Intensification Addendum|Protocol Violation|6|||
94630384|NCT00022633|324107851|FG001|Overall Study|Progression/relapse|2|||
94630385|NCT00022633|324107850|FG000|Overall Study|Death|4|||
94630386|NCT00022633|324107851|FG001|Overall Study|Death|0|||
94630387|NCT00022633|324107850|FG000|Overall Study|Other - not protocol specified|3|||
94630388|NCT00022633|324107851|FG001|Overall Study|Other - not protocol specified|2|||
94630389|NCT00022633|324107850|FG000|Overall Study|Ineligible|4|||
94675323|NCT00279201|324263241|FG005|Intensification Addendum|Protocol Violation|6|||
94675324|NCT00279201|324263236|FG000|Intensification Addendum|Adverse Event|0|||
94675325|NCT00279201|324263237|FG001|Intensification Addendum|Adverse Event|0|||
94675326|NCT00279201|324263238|FG002|Intensification Addendum|Adverse Event|0|||
94675327|NCT00279201|324263239|FG003|Intensification Addendum|Adverse Event|4|||
94675328|NCT00279201|324263240|FG004|Intensification Addendum|Adverse Event|1|||
94675329|NCT00279201|324263241|FG005|Intensification Addendum|Adverse Event|3|||
94675330|NCT00279201|324263236|FG000|Intensification Addendum|Physician Decision|0|||
94675331|NCT00279201|324263237|FG001|Intensification Addendum|Physician Decision|0|||
94257833|NCT01211197|322738035|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
94257834|NCT01211197|322738036|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
94257835|NCT01211197|322738037|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
94257836|NCT01211197|322738038|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
94257837|NCT01211197|322738033|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
94257838|NCT01211197|322738034|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
94257839|NCT01211197|322738035|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
94257840|NCT01211197|322738036|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
94257841|NCT01211197|322738037|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
94257842|NCT01211197|322738038|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
94257843|NCT02168842|322738041|FG000|Overall Study|Withdrawal by Subject|5|||
94257844|NCT02168842|322738042|FG001|Overall Study|Withdrawal by Subject|3|||
94257845|NCT02168842|322738041|FG000|Overall Study|Lost to Follow-up|0|||
94257846|NCT02168842|322738042|FG001|Overall Study|Lost to Follow-up|2|||
94257847|NCT02168842|322738041|FG000|Overall Study|Death|2|||
94257848|NCT02168842|322738042|FG001|Overall Study|Death|1|||
94257849|NCT02168842|322738041|FG000|Overall Study|Physician Decision|1|||
94257850|NCT02168842|322738042|FG001|Overall Study|Physician Decision|2|||
94257851|NCT02027623|322738048|FG000|Overall Study|Lost to Follow-up|3|||
94257852|NCT02027623|322738049|FG001|Overall Study|Lost to Follow-up|3|||
94257853|NCT02027623|322738048|FG000|Overall Study|Withdrawal by Subject|6|||
94630390|NCT00022633|324107851|FG001|Overall Study|Ineligible|0|||
94630391|NCT01907815|324107858|FG000|Overall Study|Withdrawal by Subject|1|||
94630392|NCT01907815|324107859|FG001|Overall Study|Withdrawal by Subject|0|||
94630393|NCT01285310|324107860|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
94630394|NCT01285310|324107861|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
94630395|NCT01285310|324107862|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
94630396|NCT01285310|324107863|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
94630397|NCT01285310|324107864|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
94630398|NCT01285310|324107860|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
94630399|NCT01285310|324107861|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
94630400|NCT01285310|324107862|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
94630401|NCT01285310|324107863|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
94630402|NCT01285310|324107864|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
94630403|NCT01285310|324107860|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
94630404|NCT01285310|324107861|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
94630405|NCT01285310|324107862|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
94630406|NCT01285310|324107863|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
94630407|NCT01285310|324107864|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
94630408|NCT01285310|324107860|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
94630409|NCT01285310|324107861|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
94630410|NCT01285310|324107862|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
94630411|NCT01285310|324107863|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
94630412|NCT01285310|324107864|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
94630413|NCT01285310|324107860|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
94630414|NCT01285310|324107861|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
94630415|NCT01285310|324107862|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
94630416|NCT01285310|324107863|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
94630417|NCT01285310|324107864|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
94630418|NCT01285310|324107860|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
94630419|NCT01285310|324107861|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
94630420|NCT01285310|324107862|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
94630421|NCT01285310|324107863|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
94630422|NCT01285310|324107864|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
94630423|NCT01285310|324107860|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
94630424|NCT01285310|324107861|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
94630425|NCT01285310|324107862|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
94630426|NCT01285310|324107863|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
94630427|NCT01285310|324107864|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
94630428|NCT01285310|324107860|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
94630429|NCT01285310|324107861|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
94630430|NCT01285310|324107862|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
94630431|NCT01285310|324107863|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
94630432|NCT01285310|324107864|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
94630433|NCT01285310|324107860|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
94630434|NCT01285310|324107861|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
94630435|NCT01285310|324107862|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
94630436|NCT01285310|324107863|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
94630437|NCT01285310|324107864|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
94630438|NCT01285310|324107860|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
94630439|NCT01285310|324107861|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
94630440|NCT01285310|324107862|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
94630441|NCT01285310|324107863|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
94630442|NCT01285310|324107864|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
94630443|NCT01285310|324107860|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
94630444|NCT01285310|324107861|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
94630445|NCT01285310|324107862|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
94630446|NCT01285310|324107863|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
94630447|NCT01285310|324107864|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
94630448|NCT01285310|324107860|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
94630449|NCT01285310|324107861|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
94361346|NCT02268214|323105552|FG002|Overall Study|Not entering long-term period|5|||
94361347|NCT04066894|323105554|FG000|Overall Study|Lack of Efficacy|1|||
94361348|NCT04066894|323105554|FG000|Overall Study|Screen Failure|1|||
94361349|NCT00633217|323105566|FG000|Overall Study|Adverse Event|5|||
94361350|NCT00633217|323105567|FG001|Overall Study|Adverse Event|9|||
94361351|NCT00633217|323105566|FG000|Overall Study|Lack of Efficacy|0|||
94361352|NCT00633217|323105567|FG001|Overall Study|Lack of Efficacy|2|||
94361353|NCT00633217|323105566|FG000|Overall Study|Protocol Violation|3|||
94361354|NCT00633217|323105567|FG001|Overall Study|Protocol Violation|7|||
94361355|NCT00633217|323105566|FG000|Overall Study|Lost to Follow-up|2|||
94361356|NCT00633217|323105567|FG001|Overall Study|Lost to Follow-up|2|||
94361357|NCT00633217|323105566|FG000|Overall Study|Investigator Discretion|2|||
94361358|NCT00633217|323105567|FG001|Overall Study|Investigator Discretion|0|||
94361359|NCT00633217|323105566|FG000|Overall Study|Withdrew Consent|3|||
94361360|NCT00633217|323105567|FG001|Overall Study|Withdrew Consent|3|||
94630450|NCT01285310|324107862|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
94630451|NCT01285310|324107863|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
94630452|NCT01285310|324107864|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
94630453|NCT01996982|324107865|FG000|Overall Study|PI/team left institution|7|||
94630454|NCT00137046|324107866|FG000|Overall Study|Death|2|||
94630455|NCT00137046|324107867|FG001|Overall Study|Death|1|||
94630456|NCT00137046|324107866|FG000|Overall Study|Adverse Event|16|||
94630457|NCT00137046|324107867|FG001|Overall Study|Adverse Event|5|||
94630458|NCT00137046|324107866|FG000|Overall Study|Laboratory Abnormality|2|||
94630459|NCT00137046|324107867|FG001|Overall Study|Laboratory Abnormality|0|||
94630460|NCT00137046|324107866|FG000|Overall Study|Lack of Efficacy|13|||
94630461|NCT00137046|324107867|FG001|Overall Study|Lack of Efficacy|1|||
94630462|NCT00137046|324107866|FG000|Overall Study|Lost to Follow-up|8|||
94630463|NCT00137046|324107867|FG001|Overall Study|Lost to Follow-up|24|||
94630464|NCT00137046|324107866|FG000|Overall Study|Other|23|||
94630465|NCT00137046|324107867|FG001|Overall Study|Other|19|||
94630466|NCT00137046|324107866|FG000|Overall Study|Withdrawal by Subject|33|||
94630467|NCT00137046|324107867|FG001|Overall Study|Withdrawal by Subject|42|||
94630468|NCT00137046|324107866|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
94630469|NCT00137046|324107867|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
94630470|NCT00137046|324107866|FG000|Overall Study|Withdrew prior to study treatment|1|||
94630471|NCT00137046|324107867|FG001|Overall Study|Withdrew prior to study treatment|1|||
94630472|NCT00811473|324107870|FG000|Overall Study|Adverse Event|3|||
94630473|NCT00811473|324107871|FG001|Overall Study|Adverse Event|12|||
94630474|NCT00811473|324107870|FG000|Overall Study|Lost to Follow-up|5|||
94630475|NCT00811473|324107871|FG001|Overall Study|Lost to Follow-up|1|||
94630476|NCT00811473|324107870|FG000|Overall Study|Withdrawal by Subject|2|||
94630477|NCT00811473|324107871|FG001|Overall Study|Withdrawal by Subject|4|||
94630478|NCT00811473|324107870|FG000|Overall Study|Severe non-compliance to protocol|2|||
94630479|NCT00811473|324107871|FG001|Overall Study|Severe non-compliance to protocol|4|||
94630480|NCT00811473|324107870|FG000|Overall Study|Lack of therapeutic response|4|||
94630481|NCT00811473|324107871|FG001|Overall Study|Lack of therapeutic response|1|||
94630482|NCT00811473|324107870|FG000|Overall Study|Condition under investigation worsened|1|||
94630483|NCT00811473|324107871|FG001|Overall Study|Condition under investigation worsened|3|||
94630484|NCT00811473|324107870|FG000|Overall Study|Other 2|4|||
94630485|NCT00811473|324107871|FG001|Overall Study|Other 2|1|||
94630486|NCT00811473|324107870|FG000|Overall Study|Incorrect Enrollment|1|||
94630487|NCT00811473|324107871|FG001|Overall Study|Incorrect Enrollment|0|||
94630488|NCT00811473|324107870|FG000|Overall Study|Safety Reasons|1|||
94630489|NCT00811473|324107871|FG001|Overall Study|Safety Reasons|0|||
94630490|NCT00110149|324107872|FG000|Overall Study|Physician Decision|3|||
94630491|NCT00667368|324107875|FG000|Overall Study|Lost to Follow-up|176|||
94630492|NCT00667368|324107876|FG001|Overall Study|Lost to Follow-up|155|||
94630493|NCT00667368|324107875|FG000|Overall Study|Discontinued early|24|||
94630494|NCT00667368|324107876|FG001|Overall Study|Discontinued early|17|||
94630495|NCT00191789|324107880|FG000|Overall Study|Adverse Event|5|||
94630496|NCT00191789|324107880|FG000|Overall Study|Patient: Satisfactory Response|5|||
94630497|NCT00191789|324107880|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
94630498|NCT00191789|324107880|FG000|Overall Study|Withdrawal by Subject|4|||
94675332|NCT00279201|324263238|FG002|Intensification Addendum|Physician Decision|4|||
94630499|NCT00191789|324107880|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
94630500|NCT00191789|324107880|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
94630501|NCT00191789|324107880|FG000|Overall Study|Death - Not Study-Drug Related|1|||
94630502|NCT03235154|324107883|FG000|Overall Study|Withdrawal by Subject|1|||
94630503|NCT03235154|324107883|FG000|Overall Study|Adverse Event|1|||
94361361|NCT01283282|323105568|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
94361362|NCT01283282|323105569|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
94361363|NCT01283282|323105568|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
94361364|NCT01283282|323105569|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
94361365|NCT01283282|323105568|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
94630504|NCT03235154|324107883|FG000|Overall Study|Lost to Follow-up|2|||
94361366|NCT01283282|323105569|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
94361367|NCT00594568|323107280|FG000|Initial Treatment|Adverse Event|51|||
94361368|NCT00594568|323107281|FG001|Initial Treatment|Adverse Event|121|||
94361369|NCT00594568|323107282|FG002|Initial Treatment|Adverse Event|144|||
94361370|NCT00594568|323107280|FG000|Initial Treatment|Death|6|||
94361371|NCT00594568|323107281|FG001|Initial Treatment|Death|11|||
94361372|NCT00594568|323107282|FG002|Initial Treatment|Death|15|||
94361373|NCT00594568|323107280|FG000|Initial Treatment|Lost to Follow-up|4|||
94361374|NCT00594568|323107281|FG001|Initial Treatment|Lost to Follow-up|1|||
94361375|NCT00594568|323107282|FG002|Initial Treatment|Lost to Follow-up|4|||
94361376|NCT00594568|323107280|FG000|Initial Treatment|Physician Decision|3|||
94361377|NCT00594568|323107281|FG001|Initial Treatment|Physician Decision|2|||
94361378|NCT00594568|323107282|FG002|Initial Treatment|Physician Decision|4|||
94361379|NCT00594568|323107280|FG000|Initial Treatment|Protocol Violation|2|||
94361380|NCT00594568|323107281|FG001|Initial Treatment|Protocol Violation|2|||
94361381|NCT00594568|323107282|FG002|Initial Treatment|Protocol Violation|5|||
94630505|NCT01867021|324107889|FG000|Overall Study|Adverse Event|0|||
94630506|NCT01867021|324107890|FG001|Overall Study|Adverse Event|1|||
94630507|NCT01867021|324107889|FG000|Overall Study|Not Eligible|0|||
94630508|NCT01867021|324107890|FG001|Overall Study|Not Eligible|1|||
94630509|NCT01867021|324107889|FG000|Overall Study|Death|1|||
94630510|NCT01867021|324107890|FG001|Overall Study|Death|0|||
94257854|NCT02027623|322738049|FG001|Overall Study|Withdrawal by Subject|9|||
94257855|NCT00406653|322738051|FG000|Induction Period|Adverse Event|1|||
94257856|NCT00406653|322738052|FG001|Induction Period|Adverse Event|10|||
94257857|NCT00406653|322738053|FG002|Induction Period|Adverse Event|4|||
94257858|NCT00406653|322738054|FG003|Induction Period|Adverse Event|11|||
94257859|NCT00406653|322738055|FG004|Induction Period|Adverse Event|0|||
94257860|NCT00406653|322738056|FG005|Induction Period|Adverse Event|0|||
94257861|NCT00406653|322738057|FG006|Induction Period|Adverse Event|0|||
94257862|NCT00406653|322738051|FG000|Induction Period|Lack of Efficacy|11|||
94257863|NCT00406653|322738052|FG001|Induction Period|Lack of Efficacy|14|||
94257864|NCT00406653|322738053|FG002|Induction Period|Lack of Efficacy|8|||
94361382|NCT00594568|323107280|FG000|Initial Treatment|Withdrawal by Subject|25|||
94257865|NCT00406653|322738054|FG003|Induction Period|Lack of Efficacy|10|||
94257866|NCT00406653|322738055|FG004|Induction Period|Lack of Efficacy|0|||
94630511|NCT01867021|324107889|FG000|Overall Study|Lost to Follow-up|0|||
94630512|NCT01867021|324107890|FG001|Overall Study|Lost to Follow-up|2|||
94361383|NCT00594568|323107281|FG001|Initial Treatment|Withdrawal by Subject|31|||
94361384|NCT00594568|323107282|FG002|Initial Treatment|Withdrawal by Subject|46|||
94257867|NCT00406653|322738056|FG005|Induction Period|Lack of Efficacy|0|||
94361385|NCT00594568|323107280|FG000|Initial Treatment|Sponsor decision|193|||
94630513|NCT01867021|324107889|FG000|Overall Study|Withdrawal by Subject|1|||
94630514|NCT01867021|324107890|FG001|Overall Study|Withdrawal by Subject|6|||
94630515|NCT02860169|324107892|FG000|Part A|Withdrawal by Subject|1|||
94630516|NCT02860169|324107892|FG000|Part A|Other (Screening failure)|6|||
94630517|NCT02860169|324107892|FG000|Part A|Other (Survey not completed)|3|||
94630518|NCT02860169|324107892|FG000|Part A|Other (did not completed consent)|1|||
94630519|NCT02860169|324107892|FG000|Part B|Other (Screening failure)|10|||
94630520|NCT02860169|324107892|FG000|Part B|Withdrawal by Subject|1|||
94630521|NCT02860169|324107892|FG000|Part C|Other (Screening failure)|1|||
94630522|NCT03198234|324107893|FG000|Overall Study|Relapse of primary disease|0|||
94630523|NCT03198234|324107894|FG001|Overall Study|Relapse of primary disease|1|||
94630524|NCT03198234|324107895|FG002|Overall Study|Relapse of primary disease|0|||
94630525|NCT01648205|324107898|FG000|Placebo|Pregnancy|1|||
94630526|NCT01648205|324107898|FG000|Placebo|Withdrawal by Subject|1|||
94630527|NCT01648205|324107898|FG000|Placebo|Protocol Violation|2|||
94630528|NCT01648205|324107898|FG000|Ranolazine|Death|1|||
94630529|NCT01648205|324107898|FG000|Ranolazine|Withdrawal by Subject|1|||
94630530|NCT01648205|324107898|FG000|Ranolazine|Protocol Violation|3|||
94630531|NCT03428360|324107900|FG000|Overall Study|Informed consent withdrawn|5|||
94630532|NCT03428360|324107900|FG000|Overall Study|Withdrawal by Subject|4|||
94630533|NCT03428360|324107900|FG000|Overall Study|Lost to Follow-up|5|||
94630534|NCT03428360|324107900|FG000|Overall Study|Physician Decision|2|||
94630535|NCT03428360|324107900|FG000|Overall Study|Informed consent withdrawn|5|||
94630536|NCT03428360|324107900|FG000|Overall Study|Study terminated by sponsor|10|||
94630537|NCT03428360|324107900|FG000|Overall Study|Non-compliant with study|1|||
94630538|NCT03428360|324107900|FG000|Overall Study|Non-compliant with study drug|3|||
94630539|NCT03428360|324107900|FG000|Overall Study|Death|3|||
94630540|NCT03428360|324107900|FG000|Overall Study|Adverse Event|1|||
94630541|NCT03428360|324107900|FG000|Overall Study|Not on antiepileptic drug|1|||
94630542|NCT01634360|324107901|FG000|Overall Study|Adverse Event|10|||
94630543|NCT01634360|324107902|FG001|Overall Study|Adverse Event|34|||
94630544|NCT01634360|324107901|FG000|Overall Study|subject withdrew consent|13|||
94630545|NCT01634360|324107902|FG001|Overall Study|subject withdrew consent|23|||
94630546|NCT01634360|324107901|FG000|Overall Study|Protocol Violation|1|||
94630547|NCT01634360|324107902|FG001|Overall Study|Protocol Violation|1|||
94630548|NCT01634360|324107901|FG000|Overall Study|Lack of Efficacy|4|||
94630549|NCT01634360|324107902|FG001|Overall Study|Lack of Efficacy|14|||
94630550|NCT01634360|324107901|FG000|Overall Study|Other|3|||
94630551|NCT01634360|324107902|FG001|Overall Study|Other|20|||
94630552|NCT01634360|324107901|FG000|Overall Study|Study termination by sponsor|18|||
94630553|NCT01634360|324107902|FG001|Overall Study|Study termination by sponsor|44|||
94630554|NCT01414855|324107903|FG000|Overall Study|Death|17|||
94630555|NCT01414855|324107903|FG000|Overall Study|Lost to Follow-up|5|||
94630556|NCT01414855|324107903|FG000|Overall Study|Withdrawal by Subject|7|||
94630557|NCT03266094|324107909|FG000|Overall Study|Lost to Follow-up|1|||
94630558|NCT03266094|324107909|FG000|Overall Study|Withdrawal by Subject|1|||
94630559|NCT00459108|324107912|FG000|Overall Study|Withdrawal by Subject|5|||
94630560|NCT00459108|324107912|FG000|Overall Study|Adverse Event|3|||
94630561|NCT00459108|324107912|FG000|Overall Study|Death|2|||
94630562|NCT00459108|324107912|FG000|Overall Study|Progression|1|||
94630563|NCT00897104|324107918|FG000|Overall Study|Lost to Follow-up|12|||
94630564|NCT00897104|324107919|FG001|Overall Study|Lost to Follow-up|17|||
94630565|NCT00897104|324107920|FG002|Overall Study|Lost to Follow-up|2|||
94630566|NCT00897104|324107918|FG000|Overall Study|Pregnancy|0|||
94630567|NCT00897104|324107919|FG001|Overall Study|Pregnancy|1|||
94630568|NCT00897104|324107920|FG002|Overall Study|Pregnancy|0|||
94630569|NCT00897104|324107918|FG000|Overall Study|Protocol Violation|0|||
94630570|NCT00897104|324107919|FG001|Overall Study|Protocol Violation|1|||
94630571|NCT00897104|324107920|FG002|Overall Study|Protocol Violation|0|||
94630572|NCT00897104|324107918|FG000|Overall Study|Withdrawal by Subject|23|||
94630573|NCT00897104|324107919|FG001|Overall Study|Withdrawal by Subject|27|||
94675333|NCT00279201|324263239|FG003|Intensification Addendum|Physician Decision|1|||
94675334|NCT00279201|324263240|FG004|Intensification Addendum|Physician Decision|3|||
94675335|NCT00279201|324263241|FG005|Intensification Addendum|Physician Decision|2|||
94630574|NCT00897104|324107920|FG002|Overall Study|Withdrawal by Subject|3|||
94630575|NCT00897104|324107918|FG000|Overall Study|Abnormal Prestudy Labs|2|||
94630576|NCT00897104|324107919|FG001|Overall Study|Abnormal Prestudy Labs|0|||
94630577|NCT00897104|324107920|FG002|Overall Study|Abnormal Prestudy Labs|0|||
94630578|NCT00897104|324107918|FG000|Overall Study|Abnormal Baseline ECG|2|||
94630579|NCT00897104|324107919|FG001|Overall Study|Abnormal Baseline ECG|2|||
94630580|NCT00897104|324107920|FG002|Overall Study|Abnormal Baseline ECG|0|||
94630581|NCT00897104|324107918|FG000|Overall Study|Need for Concom. Med.|0|||
94630582|NCT00897104|324107919|FG001|Overall Study|Need for Concom. Med.|1|||
94630583|NCT00897104|324107920|FG002|Overall Study|Need for Concom. Med.|1|||
94630584|NCT00897104|324107918|FG000|Overall Study|Lack of Migraine Attack|20|||
94630585|NCT00897104|324107919|FG001|Overall Study|Lack of Migraine Attack|22|||
94630586|NCT00897104|324107920|FG002|Overall Study|Lack of Migraine Attack|1|||
94630587|NCT00897104|324107918|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
94675336|NCT00279201|324263236|FG000|Intensification Addendum|Sponsor Decision|0|||
94675337|NCT00279201|324263237|FG001|Intensification Addendum|Sponsor Decision|0|||
94257868|NCT00406653|322738057|FG006|Induction Period|Lack of Efficacy|0|||
94257869|NCT00406653|322738051|FG000|Induction Period|Lost to Follow-up|0|||
94257870|NCT00406653|322738052|FG001|Induction Period|Lost to Follow-up|2|||
94257871|NCT00406653|322738053|FG002|Induction Period|Lost to Follow-up|0|||
94257872|NCT00406653|322738054|FG003|Induction Period|Lost to Follow-up|0|||
94257873|NCT00406653|322738055|FG004|Induction Period|Lost to Follow-up|0|||
94257874|NCT00406653|322738056|FG005|Induction Period|Lost to Follow-up|0|||
94257875|NCT00406653|322738057|FG006|Induction Period|Lost to Follow-up|0|||
94257876|NCT00406653|322738051|FG000|Induction Period|Withdrawal of Consent|2|||
94257877|NCT00406653|322738052|FG001|Induction Period|Withdrawal of Consent|5|||
94257878|NCT00406653|322738053|FG002|Induction Period|Withdrawal of Consent|1|||
94257879|NCT00406653|322738054|FG003|Induction Period|Withdrawal of Consent|2|||
94257880|NCT00406653|322738055|FG004|Induction Period|Withdrawal of Consent|0|||
94257881|NCT00406653|322738056|FG005|Induction Period|Withdrawal of Consent|0|||
94257882|NCT00406653|322738057|FG006|Induction Period|Withdrawal of Consent|0|||
94257883|NCT00406653|322738051|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
94257884|NCT00406653|322738052|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
94257885|NCT00406653|322738053|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
94257886|NCT00406653|322738054|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
94257887|NCT00406653|322738055|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
94257888|NCT00406653|322738056|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
94257889|NCT00406653|322738057|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
94257890|NCT00406653|322738051|FG000|Induction Period|Pregnancy|1|||
94257891|NCT00406653|322738052|FG001|Induction Period|Pregnancy|0|||
94257892|NCT00406653|322738053|FG002|Induction Period|Pregnancy|0|||
94257893|NCT00406653|322738054|FG003|Induction Period|Pregnancy|0|||
94257894|NCT00406653|322738055|FG004|Induction Period|Pregnancy|0|||
94257895|NCT00406653|322738056|FG005|Induction Period|Pregnancy|0|||
94257896|NCT00406653|322738057|FG006|Induction Period|Pregnancy|0|||
94257897|NCT00406653|322738051|FG000|Induction Period|Declined participation but followup done|0|||
94257898|NCT00406653|322738052|FG001|Induction Period|Declined participation but followup done|2|||
94257899|NCT00406653|322738053|FG002|Induction Period|Declined participation but followup done|1|||
94257900|NCT00406653|322738054|FG003|Induction Period|Declined participation but followup done|1|||
94257901|NCT00406653|322738055|FG004|Induction Period|Declined participation but followup done|0|||
94257902|NCT00406653|322738056|FG005|Induction Period|Declined participation but followup done|0|||
94257903|NCT00406653|322738057|FG006|Induction Period|Declined participation but followup done|0|||
94257904|NCT00406653|322738051|FG000|Induction Period|Given prohibited drug|0|||
94257905|NCT00406653|322738052|FG001|Induction Period|Given prohibited drug|1|||
94257906|NCT00406653|322738053|FG002|Induction Period|Given prohibited drug|2|||
94257907|NCT00406653|322738054|FG003|Induction Period|Given prohibited drug|0|||
94257908|NCT00406653|322738055|FG004|Induction Period|Given prohibited drug|0|||
94257909|NCT00406653|322738056|FG005|Induction Period|Given prohibited drug|0|||
94257910|NCT00406653|322738057|FG006|Induction Period|Given prohibited drug|0|||
94257911|NCT00406653|322738051|FG000|Induction Period|Incarcerated|0|||
94257912|NCT00406653|322738052|FG001|Induction Period|Incarcerated|0|||
94257913|NCT00406653|322738053|FG002|Induction Period|Incarcerated|1|||
94257914|NCT00406653|322738054|FG003|Induction Period|Incarcerated|0|||
94257915|NCT00406653|322738055|FG004|Induction Period|Incarcerated|0|||
94257916|NCT00406653|322738056|FG005|Induction Period|Incarcerated|0|||
94257917|NCT00406653|322738057|FG006|Induction Period|Incarcerated|0|||
94257918|NCT00406653|322738051|FG000|Induction Period|Patient relocated|0|||
94257919|NCT00406653|322738052|FG001|Induction Period|Patient relocated|0|||
94257920|NCT00406653|322738053|FG002|Induction Period|Patient relocated|1|||
94257921|NCT00406653|322738054|FG003|Induction Period|Patient relocated|0|||
94257922|NCT00406653|322738055|FG004|Induction Period|Patient relocated|0|||
94257923|NCT00406653|322738056|FG005|Induction Period|Patient relocated|0|||
94257924|NCT00406653|322738057|FG006|Induction Period|Patient relocated|0|||
94257925|NCT00406653|322738051|FG000|Maintenance Period|Adverse Event|0|||
94257926|NCT00406653|322738052|FG001|Maintenance Period|Adverse Event|0|||
94257927|NCT00406653|322738053|FG002|Maintenance Period|Adverse Event|0|||
94257928|NCT00406653|322738054|FG003|Maintenance Period|Adverse Event|0|||
94257929|NCT00406653|322738055|FG004|Maintenance Period|Adverse Event|1|||
94257930|NCT00406653|322738056|FG005|Maintenance Period|Adverse Event|1|||
94257931|NCT00406653|322738057|FG006|Maintenance Period|Adverse Event|0|||
94257932|NCT00406653|322738051|FG000|Maintenance Period|Lack of Efficacy|0|||
94257933|NCT00406653|322738052|FG001|Maintenance Period|Lack of Efficacy|0|||
94257934|NCT00406653|322738053|FG002|Maintenance Period|Lack of Efficacy|0|||
94257935|NCT00406653|322738054|FG003|Maintenance Period|Lack of Efficacy|0|||
94257936|NCT00406653|322738055|FG004|Maintenance Period|Lack of Efficacy|20|||
94257937|NCT00406653|322738056|FG005|Maintenance Period|Lack of Efficacy|26|||
94257938|NCT00406653|322738057|FG006|Maintenance Period|Lack of Efficacy|0|||
94257939|NCT00406653|322738051|FG000|Maintenance Period|Lost to Follow-up|0|||
94257940|NCT00406653|322738052|FG001|Maintenance Period|Lost to Follow-up|0|||
94361386|NCT00594568|323107281|FG001|Initial Treatment|Sponsor decision|142|||
94361387|NCT00594568|323107282|FG002|Initial Treatment|Sponsor decision|147|||
94361388|NCT00594568|323107280|FG000|Initial Treatment|Caregiver decision|21|||
94361389|NCT00594568|323107281|FG001|Initial Treatment|Caregiver decision|36|||
94361390|NCT00594568|323107282|FG002|Initial Treatment|Caregiver decision|36|||
94361391|NCT00594568|323107280|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
94361392|NCT00594568|323107281|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
94361393|NCT00594568|323107282|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
94361394|NCT00594568|323107280|FG000|Initial Treatment|Entry criteria exclusion|0|||
94361395|NCT00594568|323107281|FG001|Initial Treatment|Entry criteria exclusion|1|||
94361396|NCT00594568|323107282|FG002|Initial Treatment|Entry criteria exclusion|1|||
94361397|NCT00594568|323107280|FG000|Delayed Start|Death|0|||
94361398|NCT00594568|323107281|FG001|Delayed Start|Death|0|||
94361399|NCT00594568|323107282|FG002|Delayed Start|Death|1|||
94361400|NCT00594568|323107280|FG000|Delayed Start|Adverse Event|12|||
94361401|NCT00594568|323107281|FG001|Delayed Start|Adverse Event|2|||
94361402|NCT00594568|323107282|FG002|Delayed Start|Adverse Event|2|||
94361403|NCT00594568|323107280|FG000|Delayed Start|Withdrawal by Subject|4|||
94361404|NCT00594568|323107281|FG001|Delayed Start|Withdrawal by Subject|3|||
94361405|NCT00594568|323107282|FG002|Delayed Start|Withdrawal by Subject|0|||
94361406|NCT00594568|323107280|FG000|Delayed Start|Physician Decision|0|||
94361407|NCT00594568|323107281|FG001|Delayed Start|Physician Decision|0|||
94361408|NCT00594568|323107282|FG002|Delayed Start|Physician Decision|1|||
94361409|NCT00594568|323107280|FG000|Delayed Start|Lost to Follow-up|0|||
94361410|NCT00594568|323107281|FG001|Delayed Start|Lost to Follow-up|0|||
94361411|NCT00594568|323107282|FG002|Delayed Start|Lost to Follow-up|1|||
94361412|NCT00594568|323107280|FG000|Delayed Start|Caregiver Decision|5|||
94361413|NCT00594568|323107281|FG001|Delayed Start|Caregiver Decision|6|||
94361414|NCT00594568|323107282|FG002|Delayed Start|Caregiver Decision|2|||
94361415|NCT00594568|323107280|FG000|Delayed Start|Sponsor Decision|77|||
94361416|NCT00594568|323107281|FG001|Delayed Start|Sponsor Decision|66|||
94361417|NCT00594568|323107282|FG002|Delayed Start|Sponsor Decision|59|||
94361418|NCT00594568|323107280|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
94361419|NCT00594568|323107281|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
94361420|NCT00594568|323107282|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
94361421|NCT00594568|323107280|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
94361422|NCT00594568|323107281|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
94361423|NCT00594568|323107282|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
94361424|NCT00594568|323107280|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
94361425|NCT00594568|323107281|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
94361426|NCT00594568|323107282|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
94361427|NCT00594568|323107280|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
94361428|NCT00594568|323107281|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
94361429|NCT00594568|323107282|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
94361430|NCT00594568|323107280|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
94361431|NCT00594568|323107281|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
94361432|NCT00594568|323107282|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
94361433|NCT00594568|323107280|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
94361434|NCT00594568|323107281|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
94361435|NCT00594568|323107282|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
94361436|NCT00326118|323107283|FG000|Active Phase|Withdrawal by Subject|4|||
94361437|NCT00326118|323107284|FG001|Active Phase|Withdrawal by Subject|1|||
94361438|NCT03255226|323107290|FG000|Overall Study|Adverse Event|2|||
94361439|NCT03255226|323107290|FG000|Overall Study|Physician Decision|3|||
94361440|NCT03255226|323107290|FG000|Overall Study|Withdrawal by Subject|1|||
94361441|NCT03255226|323107290|FG000|Overall Study|Serum or blood sodium increased|4|||
94361442|NCT03255226|323107290|FG000|Overall Study|Serum or blood potassium increased|4|||
94361443|NCT00602927|323107291|FG000|Period 1: 13 Days|Protocol Violation|2|||
94361444|NCT00602927|323107292|FG001|Period 1: 13 Days|Protocol Violation|4|||
94361445|NCT00602927|323107291|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
94361446|NCT00602927|323107292|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
94361447|NCT00602927|323107291|FG000|Period 1: 13 Days|Time|1|||
94361448|NCT00602927|323107292|FG001|Period 1: 13 Days|Time|0|||
94361449|NCT00602927|323107291|FG000|Period 1: 13 Days|Claustrophobia|0|||
94361450|NCT00602927|323107292|FG001|Period 1: 13 Days|Claustrophobia|1|||
94361451|NCT00602927|323107291|FG000|Period 2: 14 Days|Protocol Violation|0|||
94630588|NCT00897104|324107919|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
94361452|NCT00602927|323107292|FG001|Period 2: 14 Days|Protocol Violation|2|||
94361453|NCT00602927|323107291|FG000|Period 3: 13 Days|Protocol Violation|0|||
94361454|NCT00602927|323107292|FG001|Period 3: 13 Days|Protocol Violation|1|||
94361455|NCT00602927|323107291|FG000|Period 3: 13 Days|MRI data quality|2|||
94361456|NCT00602927|323107292|FG001|Period 3: 13 Days|MRI data quality|2|||
94361457|NCT05378269|323107293|FG000|Overall Study|Protocol Violation|1|||
94361458|NCT05378269|323107294|FG001|Overall Study|Protocol Violation|0|||
94630589|NCT00897104|324107920|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
94630590|NCT00897104|324107918|FG000|Overall Study|Other|3|||
94630591|NCT00897104|324107919|FG001|Overall Study|Other|0|||
94630592|NCT00897104|324107920|FG002|Overall Study|Other|0|||
94630593|NCT00897104|324107918|FG000|Overall Study|Protocol Violation|1|||
94630594|NCT00897104|324107919|FG001|Overall Study|Protocol Violation|0|||
94630595|NCT00897104|324107920|FG002|Overall Study|Protocol Violation|0|||
94630596|NCT00897104|324107918|FG000|Overall Study|Withdrawal by Subject|0|||
94630597|NCT00897104|324107919|FG001|Overall Study|Withdrawal by Subject|0|||
94630598|NCT00897104|324107920|FG002|Overall Study|Withdrawal by Subject|1|||
94630599|NCT00434330|324107921|FG000|Overall Study|Adverse Event|0|||
94630600|NCT00434330|324107922|FG001|Overall Study|Adverse Event|0|||
94630601|NCT00434330|324107923|FG002|Overall Study|Adverse Event|1|||
94630602|NCT00434330|324107924|FG003|Overall Study|Adverse Event|0|||
94630603|NCT00434330|324107925|FG004|Overall Study|Adverse Event|0|||
94630604|NCT00434330|324107926|FG005|Overall Study|Adverse Event|0|||
94630605|NCT00434330|324107921|FG000|Overall Study|Death|1|||
94630606|NCT00434330|324107922|FG001|Overall Study|Death|0|||
94630607|NCT00434330|324107923|FG002|Overall Study|Death|0|||
94630608|NCT00434330|324107924|FG003|Overall Study|Death|0|||
94630609|NCT00434330|324107925|FG004|Overall Study|Death|1|||
94630610|NCT00434330|324107926|FG005|Overall Study|Death|1|||
94630611|NCT00434330|324107921|FG000|Overall Study|Withdrawal by Subject|0|||
94630612|NCT00434330|324107922|FG001|Overall Study|Withdrawal by Subject|0|||
94630613|NCT00434330|324107923|FG002|Overall Study|Withdrawal by Subject|1|||
94630614|NCT00434330|324107924|FG003|Overall Study|Withdrawal by Subject|1|||
94630615|NCT00434330|324107925|FG004|Overall Study|Withdrawal by Subject|0|||
94630616|NCT00434330|324107926|FG005|Overall Study|Withdrawal by Subject|0|||
94630617|NCT00434330|324107921|FG000|Overall Study|Renal transplant|0|||
94630618|NCT00434330|324107922|FG001|Overall Study|Renal transplant|0|||
94630619|NCT00434330|324107923|FG002|Overall Study|Renal transplant|0|||
94630620|NCT00434330|324107924|FG003|Overall Study|Renal transplant|1|||
94630621|NCT00434330|324107925|FG004|Overall Study|Renal transplant|0|||
94630622|NCT00434330|324107926|FG005|Overall Study|Renal transplant|0|||
94630623|NCT00434330|324107921|FG000|Overall Study|Subject Not Compliant With Study|0|||
94630624|NCT00434330|324107922|FG001|Overall Study|Subject Not Compliant With Study|0|||
94630625|NCT00434330|324107923|FG002|Overall Study|Subject Not Compliant With Study|1|||
94630626|NCT00434330|324107924|FG003|Overall Study|Subject Not Compliant With Study|0|||
94630627|NCT00434330|324107925|FG004|Overall Study|Subject Not Compliant With Study|0|||
94630628|NCT00434330|324107926|FG005|Overall Study|Subject Not Compliant With Study|0|||
94630629|NCT01705652|324107928|FG000|Overall Study|Adverse Event|1|||
94630630|NCT01705652|324107929|FG001|Overall Study|Adverse Event|0|||
94630631|NCT01705652|324107928|FG000|Overall Study|Withdrawal by Subject|1|||
94630632|NCT01705652|324107929|FG001|Overall Study|Withdrawal by Subject|2|||
94630633|NCT01705652|324107928|FG000|Overall Study|non-compliance|1|||
94630634|NCT01705652|324107929|FG001|Overall Study|non-compliance|1|||
94630635|NCT01962207|324107930|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
94630636|NCT01962207|324107931|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
94630637|NCT01962207|324107932|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
94630638|NCT01962207|324107933|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
94630639|NCT01962207|324107930|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
94630640|NCT01962207|324107931|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
94630641|NCT01962207|324107932|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
94257941|NCT00406653|322738053|FG002|Maintenance Period|Lost to Follow-up|0|||
94630642|NCT01962207|324107933|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
94630643|NCT01962207|324107930|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
94630644|NCT01962207|324107931|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
94630645|NCT01962207|324107932|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
94630646|NCT01962207|324107933|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
94630647|NCT01962207|324107930|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
94630648|NCT01962207|324107931|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
94630649|NCT01962207|324107932|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
94630650|NCT01962207|324107933|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
94630651|NCT01962207|324107930|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
94361459|NCT05378269|323107295|FG002|Overall Study|Protocol Violation|2|||
94361460|NCT05378269|323107296|FG003|Overall Study|Protocol Violation|0|||
94361461|NCT05378269|323107297|FG004|Overall Study|Protocol Violation|0|||
94361462|NCT00685763|323107300|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
94361463|NCT00685763|323107300|FG000|Overall Study|Protocol Violation|1|||
94361464|NCT01741259|323107301|FG000|Overall Study|Protocol Violation|6|||
94361465|NCT01741259|323107302|FG001|Overall Study|Protocol Violation|4|||
94630652|NCT01962207|324107931|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
94257942|NCT00406653|322738054|FG003|Maintenance Period|Lost to Follow-up|0|||
94257943|NCT00406653|322738055|FG004|Maintenance Period|Lost to Follow-up|2|||
94257944|NCT00406653|322738056|FG005|Maintenance Period|Lost to Follow-up|1|||
94257945|NCT00406653|322738057|FG006|Maintenance Period|Lost to Follow-up|0|||
94257946|NCT00406653|322738051|FG000|Maintenance Period|Withdrawal of Consent|0|||
94257947|NCT00406653|322738052|FG001|Maintenance Period|Withdrawal of Consent|0|||
94257948|NCT00406653|322738053|FG002|Maintenance Period|Withdrawal of Consent|0|||
94257949|NCT00406653|322738054|FG003|Maintenance Period|Withdrawal of Consent|0|||
94257950|NCT00406653|322738055|FG004|Maintenance Period|Withdrawal of Consent|2|||
94257951|NCT00406653|322738056|FG005|Maintenance Period|Withdrawal of Consent|0|||
94257952|NCT00406653|322738057|FG006|Maintenance Period|Withdrawal of Consent|0|||
94257953|NCT00406653|322738051|FG000|Maintenance Period|Pregnancy|0|||
94361466|NCT01741259|323107301|FG000|Overall Study|Withdrawal by Subject|0|||
94361467|NCT01741259|323107302|FG001|Overall Study|Withdrawal by Subject|2|||
94630653|NCT01962207|324107932|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
94630654|NCT01962207|324107933|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
94630655|NCT01962207|324107930|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
94630656|NCT01962207|324107931|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
94630657|NCT01962207|324107932|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
94630658|NCT01962207|324107933|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
94630659|NCT04772755|324107934|FG000|Overall Study|Withdrawal by Subject|1|||
94630660|NCT04772755|324107935|FG001|Overall Study|Withdrawal by Subject|0|||
94630661|NCT04772755|324107934|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
94630662|NCT04772755|324107935|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
94630663|NCT01428453|324107941|FG000|Overall Study|Adverse Event|2|||
94630664|NCT01428453|324107942|FG001|Overall Study|Adverse Event|7|||
94630665|NCT01428453|324107941|FG000|Overall Study|Protocol Violation|1|||
94630666|NCT01428453|324107942|FG001|Overall Study|Protocol Violation|0|||
94630667|NCT01428453|324107941|FG000|Overall Study|Lost to Follow-up|0|||
94257954|NCT00406653|322738052|FG001|Maintenance Period|Pregnancy|0|||
94257955|NCT00406653|322738053|FG002|Maintenance Period|Pregnancy|0|||
94257956|NCT00406653|322738054|FG003|Maintenance Period|Pregnancy|0|||
94257957|NCT00406653|322738055|FG004|Maintenance Period|Pregnancy|0|||
94257958|NCT00406653|322738056|FG005|Maintenance Period|Pregnancy|1|||
94257959|NCT00406653|322738057|FG006|Maintenance Period|Pregnancy|0|||
94257960|NCT00406653|322738051|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
94257961|NCT00406653|322738052|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
94257962|NCT00406653|322738053|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
94257963|NCT00406653|322738054|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
94257964|NCT00406653|322738055|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
94257965|NCT00406653|322738056|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
94257966|NCT00406653|322738057|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
94257967|NCT00406653|322738051|FG000|Maintenance Period|Error in disease score evaluation|0|||
94257968|NCT00406653|322738052|FG001|Maintenance Period|Error in disease score evaluation|0|||
94257969|NCT00406653|322738053|FG002|Maintenance Period|Error in disease score evaluation|0|||
94257970|NCT00406653|322738054|FG003|Maintenance Period|Error in disease score evaluation|0|||
94257971|NCT00406653|322738055|FG004|Maintenance Period|Error in disease score evaluation|1|||
94257972|NCT00406653|322738056|FG005|Maintenance Period|Error in disease score evaluation|0|||
94257973|NCT00406653|322738057|FG006|Maintenance Period|Error in disease score evaluation|0|||
94257974|NCT00406653|322738051|FG000|Open-Label Period|Death|0|||
94257975|NCT00406653|322738052|FG001|Open-Label Period|Death|0|||
94257976|NCT00406653|322738053|FG002|Open-Label Period|Death|0|||
94257977|NCT00406653|322738054|FG003|Open-Label Period|Death|0|||
94257978|NCT00406653|322738055|FG004|Open-Label Period|Death|0|||
94257979|NCT00406653|322738056|FG005|Open-Label Period|Death|0|||
94257980|NCT00406653|322738057|FG006|Open-Label Period|Death|1|||
94257981|NCT00406653|322738051|FG000|Open-Label Period|Adverse Event|0|||
94257982|NCT00406653|322738052|FG001|Open-Label Period|Adverse Event|0|||
94257983|NCT00406653|322738053|FG002|Open-Label Period|Adverse Event|0|||
94257984|NCT00406653|322738054|FG003|Open-Label Period|Adverse Event|0|||
94257985|NCT00406653|322738055|FG004|Open-Label Period|Adverse Event|0|||
94257986|NCT00406653|322738056|FG005|Open-Label Period|Adverse Event|0|||
94257987|NCT00406653|322738057|FG006|Open-Label Period|Adverse Event|18|||
94257988|NCT00406653|322738051|FG000|Open-Label Period|Lack of Efficacy|0|||
94257989|NCT00406653|322738052|FG001|Open-Label Period|Lack of Efficacy|0|||
94257990|NCT00406653|322738053|FG002|Open-Label Period|Lack of Efficacy|0|||
94257991|NCT00406653|322738054|FG003|Open-Label Period|Lack of Efficacy|0|||
94257992|NCT00406653|322738055|FG004|Open-Label Period|Lack of Efficacy|0|||
94257993|NCT00406653|322738056|FG005|Open-Label Period|Lack of Efficacy|0|||
94257994|NCT00406653|322738057|FG006|Open-Label Period|Lack of Efficacy|160|||
94257995|NCT00406653|322738051|FG000|Open-Label Period|Lost to Follow-up|0|||
94257996|NCT00406653|322738052|FG001|Open-Label Period|Lost to Follow-up|0|||
94257997|NCT00406653|322738053|FG002|Open-Label Period|Lost to Follow-up|0|||
94257998|NCT00406653|322738054|FG003|Open-Label Period|Lost to Follow-up|0|||
94257999|NCT00406653|322738055|FG004|Open-Label Period|Lost to Follow-up|0|||
94258000|NCT00406653|322738056|FG005|Open-Label Period|Lost to Follow-up|0|||
94258001|NCT00406653|322738057|FG006|Open-Label Period|Lost to Follow-up|6|||
94258002|NCT00406653|322738051|FG000|Open-Label Period|Withdrawal of Consent|0|||
94258003|NCT00406653|322738052|FG001|Open-Label Period|Withdrawal of Consent|0|||
94258004|NCT00406653|322738053|FG002|Open-Label Period|Withdrawal of Consent|0|||
94258005|NCT00406653|322738054|FG003|Open-Label Period|Withdrawal of Consent|0|||
94630668|NCT01428453|324107942|FG001|Overall Study|Lost to Follow-up|1|||
94258006|NCT00406653|322738055|FG004|Open-Label Period|Withdrawal of Consent|0|||
94258007|NCT00406653|322738056|FG005|Open-Label Period|Withdrawal of Consent|0|||
94258008|NCT00406653|322738057|FG006|Open-Label Period|Withdrawal of Consent|11|||
94258009|NCT00406653|322738051|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
94258010|NCT00406653|322738052|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
94258011|NCT00406653|322738053|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
94258012|NCT00406653|322738054|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
94258013|NCT00406653|322738055|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
94258014|NCT00406653|322738056|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
94258015|NCT00406653|322738057|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
94258016|NCT00406653|322738051|FG000|Open-Label Period|Pregnancy|0|||
94258017|NCT00406653|322738052|FG001|Open-Label Period|Pregnancy|0|||
94258018|NCT00406653|322738053|FG002|Open-Label Period|Pregnancy|0|||
94258019|NCT00406653|322738054|FG003|Open-Label Period|Pregnancy|0|||
94258020|NCT00406653|322738055|FG004|Open-Label Period|Pregnancy|0|||
94258021|NCT00406653|322738056|FG005|Open-Label Period|Pregnancy|0|||
94258022|NCT00406653|322738057|FG006|Open-Label Period|Pregnancy|2|||
94258023|NCT00406653|322738051|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
94258024|NCT00406653|322738052|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
94258025|NCT00406653|322738053|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
94258026|NCT00406653|322738054|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
94258027|NCT00406653|322738055|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
94258028|NCT00406653|322738056|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
94258029|NCT00406653|322738057|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
94258030|NCT00406653|322738051|FG000|Open-Label Period|Declined participation but followup done|0|||
94258031|NCT00406653|322738052|FG001|Open-Label Period|Declined participation but followup done|0|||
94258032|NCT00406653|322738053|FG002|Open-Label Period|Declined participation but followup done|0|||
94258033|NCT00406653|322738054|FG003|Open-Label Period|Declined participation but followup done|0|||
94630669|NCT01428453|324107941|FG000|Overall Study|Withdrawal by Subject|3|||
94630670|NCT01428453|324107942|FG001|Overall Study|Withdrawal by Subject|1|||
94630671|NCT02663674|324107943|FG000|Overall Study|Lost to Follow-up|5|||
94630672|NCT02663674|324107944|FG001|Overall Study|Lost to Follow-up|4|||
94630673|NCT02663674|324107943|FG000|Overall Study|Withdrawal by Subject|1|||
94630674|NCT02663674|324107944|FG001|Overall Study|Withdrawal by Subject|4|||
94630675|NCT02663674|324107943|FG000|Overall Study|Physician Decision|1|||
94630676|NCT02663674|324107944|FG001|Overall Study|Physician Decision|1|||
94630677|NCT02663674|324107943|FG000|Overall Study|Other Event (Health Related)|0|||
94630678|NCT02663674|324107944|FG001|Overall Study|Other Event (Health Related)|1|||
94630679|NCT02239978|324109772|FG000|Overall Study|Withdrawal by Subject|2|||
94630680|NCT02239978|324109773|FG001|Overall Study|Withdrawal by Subject|0|||
94630681|NCT03138889|324109774|FG000|Overall Study|Withdrawal by Subject|5|||
94630682|NCT03138889|324109775|FG001|Overall Study|Withdrawal by Subject|5|||
94630683|NCT03138889|324109776|FG002|Overall Study|Withdrawal by Subject|0|||
94630684|NCT03138889|324109777|FG003|Overall Study|Withdrawal by Subject|2|||
94630685|NCT03138889|324109778|FG004|Overall Study|Withdrawal by Subject|1|||
94630686|NCT03138889|324109779|FG005|Overall Study|Withdrawal by Subject|3|||
94630687|NCT03138889|324109780|FG006|Overall Study|Withdrawal by Subject|0|||
94630688|NCT03138889|324109781|FG007|Overall Study|Withdrawal by Subject|1|||
94630689|NCT01356966|324109782|FG000|Overall Study|Withdrawal by Subject|1|||
94630690|NCT01356966|324109783|FG001|Overall Study|Withdrawal by Subject|2|||
94630691|NCT01356966|324109782|FG000|Overall Study|Physician Decision|1|||
94630692|NCT01356966|324109783|FG001|Overall Study|Physician Decision|0|||
94630693|NCT01349790|324109784|FG000|Overall Study|Investigator Judgement|3|||
94630694|NCT01349790|324109784|FG000|Overall Study|Death|2|||
94630695|NCT01349790|324109784|FG000|Overall Study|Withdrawal by Patient|2|||
94630696|NCT01349790|324109784|FG000|Overall Study|Adverse Event|1|||
94630697|NCT01349790|324109784|FG000|Overall Study|Lost to Follow-up|1|||
94630698|NCT02743806|324109785|FG000|Overall Study|Adverse Event|9|||
94258034|NCT00406653|322738055|FG004|Open-Label Period|Declined participation but followup done|0|||
94258035|NCT00406653|322738056|FG005|Open-Label Period|Declined participation but followup done|0|||
94258036|NCT00406653|322738057|FG006|Open-Label Period|Declined participation but followup done|8|||
94630699|NCT02743806|324109785|FG000|Overall Study|Lost to Follow-up|8|||
94630700|NCT02743806|324109785|FG000|Overall Study|Voluntary Withdrawal|54|||
94630701|NCT02743806|324109785|FG000|Overall Study|Study Termination|65|||
94630702|NCT02743806|324109785|FG000|Overall Study|Pregnancy|6|||
94630703|NCT02743806|324109785|FG000|Overall Study|No Longer Clinically Benefiting|27|||
94630704|NCT02743806|324109785|FG000|Overall Study|Reason Not Specified|12|||
94630705|NCT01475331|324109786|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
94630706|NCT01475331|324109787|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
94630707|NCT01475331|324109786|FG000|Overall Study|excessive main duct communication|1|||
94630708|NCT01475331|324109787|FG001|Overall Study|excessive main duct communication|1|||
94630709|NCT01475331|324109786|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
94258037|NCT00406653|322738051|FG000|Open-Label Period|Discontinued by Sponsor|0|||
94258038|NCT00406653|322738052|FG001|Open-Label Period|Discontinued by Sponsor|0|||
94258039|NCT00406653|322738053|FG002|Open-Label Period|Discontinued by Sponsor|0|||
94258040|NCT00406653|322738054|FG003|Open-Label Period|Discontinued by Sponsor|0|||
94258041|NCT00406653|322738055|FG004|Open-Label Period|Discontinued by Sponsor|0|||
94258042|NCT00406653|322738056|FG005|Open-Label Period|Discontinued by Sponsor|0|||
94258043|NCT00406653|322738057|FG006|Open-Label Period|Discontinued by Sponsor|1|||
94258044|NCT00406653|322738051|FG000|Open-Label Period|Refused followup|0|||
94258045|NCT00406653|322738052|FG001|Open-Label Period|Refused followup|0|||
94258046|NCT00406653|322738053|FG002|Open-Label Period|Refused followup|0|||
94258047|NCT00406653|322738054|FG003|Open-Label Period|Refused followup|0|||
94258048|NCT00406653|322738055|FG004|Open-Label Period|Refused followup|0|||
94258049|NCT00406653|322738056|FG005|Open-Label Period|Refused followup|0|||
94258050|NCT00406653|322738057|FG006|Open-Label Period|Refused followup|1|||
94258051|NCT03513588|322738058|FG000|Overall Study|Lost to Follow-up|0|||
94258052|NCT03513588|322738059|FG001|Overall Study|Lost to Follow-up|1|||
94258053|NCT03513588|322738060|FG002|Overall Study|Lost to Follow-up|1|||
94258054|NCT03513588|322738058|FG000|Overall Study|Study dosing paused by sponsor|1|||
94258055|NCT03513588|322738059|FG001|Overall Study|Study dosing paused by sponsor|1|||
94258056|NCT03513588|322738060|FG002|Overall Study|Study dosing paused by sponsor|0|||
94258057|NCT03513588|322738058|FG000|Overall Study|Death|0|||
94630710|NCT01475331|324109787|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
94630711|NCT01475331|324109786|FG000|Overall Study|Sign of malignancy during the procedure|2|||
94630712|NCT01475331|324109787|FG001|Overall Study|Sign of malignancy during the procedure|0|||
94630713|NCT01475331|324109786|FG000|Overall Study|cyst found to be prohibitively small|0|||
94630714|NCT01475331|324109787|FG001|Overall Study|cyst found to be prohibitively small|1|||
94630715|NCT02085785|324109792|FG000|Overall Study|Withdrawal by Subject|2|||
94630716|NCT02085785|324109793|FG001|Overall Study|Withdrawal by Subject|1|||
94630717|NCT02085785|324109792|FG000|Overall Study|Lost to Follow-up|0|||
94630718|NCT02085785|324109793|FG001|Overall Study|Lost to Follow-up|1|||
94630719|NCT01988103|324109794|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
94630720|NCT01988103|324109795|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
94630721|NCT01988103|324109796|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
94630722|NCT01988103|324109797|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
94630723|NCT01988103|324109798|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
94630724|NCT01988103|324109794|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
94630725|NCT01988103|324109795|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
94630726|NCT01988103|324109796|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
94630727|NCT01988103|324109797|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
94630728|NCT01988103|324109798|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
94630729|NCT01988103|324109794|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
94630730|NCT01988103|324109795|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
94630731|NCT01988103|324109796|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
94630732|NCT01988103|324109797|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
94630733|NCT01988103|324109798|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
94630734|NCT01988103|324109794|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
94630735|NCT01988103|324109795|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
94630736|NCT01988103|324109796|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
94630737|NCT01988103|324109797|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
94630738|NCT01988103|324109798|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
94630739|NCT01988103|324109794|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
94630740|NCT01988103|324109795|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
94630741|NCT01988103|324109796|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
94630742|NCT01988103|324109797|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
94630743|NCT01988103|324109798|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
94630744|NCT01988103|324109794|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
94630745|NCT01988103|324109795|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
94630746|NCT01988103|324109796|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
94630747|NCT01988103|324109797|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
94675338|NCT00279201|324263238|FG002|Intensification Addendum|Sponsor Decision|0|||
94675339|NCT00279201|324263239|FG003|Intensification Addendum|Sponsor Decision|0|||
94258058|NCT03513588|322738059|FG001|Overall Study|Death|0|||
94258059|NCT03513588|322738060|FG002|Overall Study|Death|1|||
94258060|NCT02076178|322738061|FG000|Oral Phase|Adverse Event|0|||
94258061|NCT02076178|322738062|FG001|Oral Phase|Adverse Event|7|||
94258062|NCT02076178|322738061|FG000|Oral Phase|Withdrawal by Subject|0|||
94258063|NCT02076178|322738062|FG001|Oral Phase|Withdrawal by Subject|4|||
94258064|NCT02076178|322738061|FG000|Oral Phase|Physician Decision|0|||
94630748|NCT01988103|324109798|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
94258065|NCT02076178|322738062|FG001|Oral Phase|Physician Decision|1|||
94258066|NCT02076178|322738061|FG000|Injection Phase|Protocol defined stopping criteria|1|||
94258067|NCT02076178|322738062|FG001|Injection Phase|Protocol defined stopping criteria|0|||
94258068|NCT02076178|322738061|FG000|Injection Phase|Withdrawal by Subject|0|||
94258069|NCT02076178|322738062|FG001|Injection Phase|Withdrawal by Subject|3|||
94258070|NCT02076178|322738061|FG000|Injection Phase|Physician Decision|0|||
94258071|NCT02076178|322738062|FG001|Injection Phase|Physician Decision|3|||
94258072|NCT02076178|322738061|FG000|Injection Phase|Lost to Follow-up|0|||
94258073|NCT02076178|322738062|FG001|Injection Phase|Lost to Follow-up|1|||
94258074|NCT02893930|322738063|FG000|Overall Study|Adverse Event|3|||
94258075|NCT02893930|322738063|FG000|Overall Study|Death|1|||
94258076|NCT02893930|322738063|FG000|Overall Study|Disease progression|5|||
94258077|NCT02893930|322738063|FG000|Overall Study|Withdrawal by Subject|2|||
94258078|NCT02893930|322738063|FG000|Overall Study|Physician Decision|1|||
94258079|NCT02893930|322738063|FG000|Overall Study|Ineligible|1|||
94258080|NCT03021954|322738064|FG000|Overall Study|Lost to Follow-up|10|||
94258081|NCT03021954|322738065|FG001|Overall Study|Lost to Follow-up|43|||
94258082|NCT03021954|322738064|FG000|Overall Study|Subjects had avulsion trauma|4|||
94258083|NCT03021954|322738065|FG001|Overall Study|Subjects had avulsion trauma|1|||
94258084|NCT00412971|322738068|FG000|Overall Study|Lost to Follow-up|17|||
94258085|NCT00412971|322738069|FG001|Overall Study|Lost to Follow-up|9|||
94258086|NCT00412971|322738068|FG000|Overall Study|Protocol Violation|13|||
94630749|NCT01988103|324109794|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
94630750|NCT01988103|324109795|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
94630751|NCT01988103|324109796|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
94630752|NCT01988103|324109797|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
94630753|NCT01988103|324109798|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
94630754|NCT02289898|324109799|FG000|Overall Study|Death|5|||
94630755|NCT02289898|324109800|FG001|Overall Study|Death|4|||
94630756|NCT02289898|324109801|FG002|Overall Study|Death|3|||
94630757|NCT02289898|324109799|FG000|Overall Study|Physician Decision|2|||
94630758|NCT02289898|324109800|FG001|Overall Study|Physician Decision|5|||
94630759|NCT02289898|324109801|FG002|Overall Study|Physician Decision|2|||
94630760|NCT02289898|324109799|FG000|Overall Study|Withdrawal by Subject|0|||
94630761|NCT02289898|324109800|FG001|Overall Study|Withdrawal by Subject|4|||
94630762|NCT02289898|324109801|FG002|Overall Study|Withdrawal by Subject|1|||
94630763|NCT02289898|324109799|FG000|Overall Study|Adverse Event|3|||
94630764|NCT02289898|324109800|FG001|Overall Study|Adverse Event|5|||
94630765|NCT02289898|324109801|FG002|Overall Study|Adverse Event|5|||
94630766|NCT02289898|324109799|FG000|Overall Study|Disease progression|34|||
94630767|NCT02289898|324109800|FG001|Overall Study|Disease progression|28|||
94630768|NCT02289898|324109801|FG002|Overall Study|Disease progression|34|||
94630769|NCT02289898|324109799|FG000|Overall Study|Use of another anticancer therapy|0|||
94630770|NCT02289898|324109800|FG001|Overall Study|Use of another anticancer therapy|0|||
94630771|NCT02289898|324109801|FG002|Overall Study|Use of another anticancer therapy|1|||
94630772|NCT02289898|324109799|FG000|Overall Study|Other|8|||
94630773|NCT02289898|324109800|FG001|Overall Study|Other|7|||
94630774|NCT02289898|324109801|FG002|Overall Study|Other|10|||
94630775|NCT02254486|324109802|FG000|Overall Study|Adverse Event|1|||
94630776|NCT02254486|324109803|FG001|Overall Study|Adverse Event|1|||
94258087|NCT00412971|322738069|FG001|Overall Study|Protocol Violation|1|||
94258088|NCT02668185|322738080|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
94258089|NCT02668185|322738081|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
94630777|NCT02254486|324109802|FG000|Overall Study|Lack of Efficacy|1|||
94630778|NCT02254486|324109803|FG001|Overall Study|Lack of Efficacy|0|||
94630779|NCT02254486|324109802|FG000|Overall Study|Lost to Follow-up|2|||
94630780|NCT02254486|324109803|FG001|Overall Study|Lost to Follow-up|4|||
94630781|NCT02254486|324109802|FG000|Overall Study|Protocol Violation|1|||
94361468|NCT00564486|323107304|FG000|Overall Study|Adverse Event|0|||
94361469|NCT00564486|323107305|FG001|Overall Study|Adverse Event|1|||
94361470|NCT00564486|323107306|FG002|Overall Study|Adverse Event|0|||
94361471|NCT00564486|323107307|FG003|Overall Study|Adverse Event|0|||
94361472|NCT00564486|323107304|FG000|Overall Study|Withdrawal by Subject|4|||
94361473|NCT00564486|323107305|FG001|Overall Study|Withdrawal by Subject|0|||
94361474|NCT00564486|323107306|FG002|Overall Study|Withdrawal by Subject|0|||
94361475|NCT00564486|323107307|FG003|Overall Study|Withdrawal by Subject|5|||
94361476|NCT00564486|323107304|FG000|Overall Study|Subject refused to have blood drawn|0|||
94361477|NCT00564486|323107305|FG001|Overall Study|Subject refused to have blood drawn|0|||
94361478|NCT00564486|323107306|FG002|Overall Study|Subject refused to have blood drawn|1|||
94361479|NCT00564486|323107307|FG003|Overall Study|Subject refused to have blood drawn|0|||
94361480|NCT00564486|323107304|FG000|Overall Study|Lost to Follow-up|3|||
94361481|NCT00564486|323107305|FG001|Overall Study|Lost to Follow-up|0|||
94361482|NCT00564486|323107306|FG002|Overall Study|Lost to Follow-up|2|||
94361483|NCT00564486|323107307|FG003|Overall Study|Lost to Follow-up|2|||
94361484|NCT00684645|323107308|FG000|Overall Study|Death|2|||
94361485|NCT00684645|323107308|FG000|Overall Study|Progressive disease|67|||
94361486|NCT00684645|323107308|FG000|Overall Study|Adverse Event|27|||
94361487|NCT00684645|323107308|FG000|Overall Study|Lost to Follow-up|3|||
94361488|NCT00684645|323107308|FG000|Overall Study|Other|15|||
94361489|NCT03746080|323107309|FG000|Overall Study|In follow up|2|||
94361490|NCT03746080|323107309|FG000|Overall Study|Death|15|||
94630782|NCT02254486|324109803|FG001|Overall Study|Protocol Violation|2|||
94630783|NCT02254486|324109802|FG000|Overall Study|Withdrawal by Subject|17|||
94630784|NCT02254486|324109803|FG001|Overall Study|Withdrawal by Subject|15|||
94630785|NCT02254486|324109802|FG000|Overall Study|GFR<60mL/min|16|||
94630786|NCT02254486|324109803|FG001|Overall Study|GFR<60mL/min|21|||
94630787|NCT02254486|324109802|FG000|Overall Study|Various|12|||
94630788|NCT02254486|324109803|FG001|Overall Study|Various|12|||
94630789|NCT04166435|324109804|FG000|Overall Study|2 patients ineligible for response|2|||
94630790|NCT00267046|324109805|FG000|Overall Study|Disease progression|4|||
94630791|NCT00267046|324109806|FG001|Overall Study|Disease progression|2|||
94630792|NCT00267046|324109805|FG000|Overall Study|Chemotoxicity|2|||
94630793|NCT00267046|324109806|FG001|Overall Study|Chemotoxicity|0|||
94630794|NCT00267046|324109805|FG000|Overall Study|Open-label palifermin|2|||
94630795|NCT00267046|324109806|FG001|Overall Study|Open-label palifermin|7|||
94630796|NCT00267046|324109805|FG000|Overall Study|Surgery|3|||
94630797|NCT00267046|324109806|FG001|Overall Study|Surgery|1|||
94630798|NCT00267046|324109805|FG000|Overall Study|Withdrawal by Subject|1|||
94630799|NCT00267046|324109806|FG001|Overall Study|Withdrawal by Subject|0|||
94630800|NCT00267046|324109805|FG000|Overall Study|Radiation|0|||
94630801|NCT00267046|324109806|FG001|Overall Study|Radiation|1|||
94630802|NCT01601626|324109807|FG000|Overall Study|Death|1|||
94630803|NCT01601626|324109808|FG001|Overall Study|Death|1|||
94630804|NCT01601626|324109809|FG002|Overall Study|Death|1|||
94630805|NCT01601626|324109807|FG000|Overall Study|Lost to Follow-up|1|||
94630806|NCT01601626|324109808|FG001|Overall Study|Lost to Follow-up|2|||
94630807|NCT01601626|324109809|FG002|Overall Study|Lost to Follow-up|0|||
94630808|NCT01601626|324109807|FG000|Overall Study|Unable to Get to Clinic|0|||
94630809|NCT01601626|324109808|FG001|Overall Study|Unable to Get to Clinic|1|||
94630810|NCT01601626|324109809|FG002|Overall Study|Unable to Get to Clinic|0|||
94630811|NCT01601626|324109807|FG000|Overall Study|Withdrawal by Subject|0|||
94630812|NCT01601626|324109808|FG001|Overall Study|Withdrawal by Subject|1|||
94630813|NCT01601626|324109809|FG002|Overall Study|Withdrawal by Subject|1|||
94630814|NCT01601626|324109807|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
94630815|NCT01601626|324109808|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
94630816|NCT01601626|324109809|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
94630817|NCT02598076|324109812|FG000|Overall Study|Lost to Follow-up|2|||
94361491|NCT01473589|323107310|FG000|Overall Study|Adverse Event|1|||
94361492|NCT01473589|323107311|FG001|Overall Study|Adverse Event|1|||
94361493|NCT01473589|323107310|FG000|Overall Study|Death|2|||
94361494|NCT01473589|323107311|FG001|Overall Study|Death|0|||
94361495|NCT01473589|323107310|FG000|Overall Study|Lost to Follow-up|2|||
94630818|NCT02598076|324109813|FG001|Overall Study|Lost to Follow-up|3|||
94630819|NCT01946425|324109814|FG000|Overall Study|Protocol Violation|1|||
94630820|NCT01946425|324109815|FG001|Overall Study|Protocol Violation|0|||
94630821|NCT01946425|324109814|FG000|Overall Study|Withdrawal by Subject|1|||
94630822|NCT01946425|324109815|FG001|Overall Study|Withdrawal by Subject|0|||
94630823|NCT03274440|324109816|FG000|Overall Study|Time commitment too great|1|||
94630824|NCT03274440|324109817|FG001|Overall Study|Time commitment too great|0|||
94630825|NCT03274440|324109818|FG002|Overall Study|Time commitment too great|0|||
94630826|NCT03274440|324109819|FG003|Overall Study|Time commitment too great|1|||
94630827|NCT03274440|324109820|FG004|Overall Study|Time commitment too great|0|||
94630828|NCT03274440|324109821|FG005|Overall Study|Time commitment too great|0|||
94361496|NCT01473589|323107311|FG001|Overall Study|Lost to Follow-up|2|||
94630829|NCT01828281|324109823|FG000|Overall Study|Withdrawal by Subject|1|||
94630830|NCT01828281|324109824|FG001|Overall Study|Withdrawal by Subject|0|||
94630831|NCT01291173|324109825|FG000|Overall Study|Adverse Event|0|||
94630832|NCT01291173|324109826|FG001|Overall Study|Adverse Event|3|||
94258090|NCT02668185|322738080|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
94258091|NCT02668185|322738081|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
94258092|NCT02668185|322738080|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
94258093|NCT02668185|322738081|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
94258094|NCT02668185|322738080|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
94258095|NCT02668185|322738081|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
94258096|NCT04526197|322738084|FG000|Period 1|Adverse Event|0|||
94258097|NCT04526197|322738085|FG001|Period 1|Adverse Event|1|||
94258098|NCT04526197|322738084|FG000|Period 1|Withdrawal by Subject|1|||
94258099|NCT04526197|322738085|FG001|Period 1|Withdrawal by Subject|0|||
94258100|NCT04526197|322738084|FG000|Period 2|Adverse Event|0|||
94258101|NCT04526197|322738085|FG001|Period 2|Adverse Event|1|||
94258102|NCT04526197|322738084|FG000|Period 2|Withdrawal by Subject|0|||
94258103|NCT04526197|322738085|FG001|Period 2|Withdrawal by Subject|1|||
94258104|NCT02092220|322738086|FG000|Period 1|Unrelated Illness|0|||
94258105|NCT02092220|322738087|FG001|Period 1|Unrelated Illness|2|||
94258106|NCT02092220|322738086|FG000|Period 2|Severe Hypoglycaemia|1|||
94258107|NCT02092220|322738087|FG001|Period 2|Severe Hypoglycaemia|0|||
94258108|NCT02092220|322738086|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
94258109|NCT02092220|322738087|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
94258110|NCT03707925|322738088|FG000|Overall Study|Inevaluable|1|||
94258111|NCT00688181|322738089|FG000|Overall Study|Lost to Follow-up|17|||
94258112|NCT00688181|322738089|FG000|Overall Study|Unknown Reason|4|||
94258113|NCT00688181|322738089|FG000|Overall Study|Non-clinical Reason|2|||
94258114|NCT01119001|322738090|FG000|Overall Study|Withdrawal by Subject|2|||
94258115|NCT00633061|322738091|FG000|Overall Study|Study closed|86|||
94258116|NCT00633061|322738092|FG001|Overall Study|Study closed|0|||
94258117|NCT00607022|322738093|FG000|Overall Study|Withdrawal by Subject|1|||
94258118|NCT00607022|322738094|FG001|Overall Study|Withdrawal by Subject|0|||
94258119|NCT00607022|322738095|FG002|Overall Study|Withdrawal by Subject|0|||
94258120|NCT01411839|322738096|FG000|Overall Study|Lost to Follow-up|4|||
94258121|NCT01411839|322738097|FG001|Overall Study|Lost to Follow-up|3|||
94258122|NCT01012739|322738098|FG000|Treatment Period 1|Adverse Event|0|||
94258123|NCT01012739|322738099|FG001|Treatment Period 1|Adverse Event|0|||
94258124|NCT01012739|322738100|FG002|Treatment Period 1|Adverse Event|0|||
94258125|NCT01012739|322738101|FG003|Treatment Period 1|Adverse Event|1|||
94258126|NCT01012739|322738098|FG000|Treatment Period 2|Abnormal test procedure results|0|||
94258127|NCT01012739|322738099|FG001|Treatment Period 2|Abnormal test procedure results|0|||
94258128|NCT01012739|322738100|FG002|Treatment Period 2|Abnormal test procedure results|0|||
94258129|NCT01012739|322738101|FG003|Treatment Period 2|Abnormal test procedure results|1|||
94258130|NCT01328717|322740398|FG000|Overall Study|Adverse Event|1|||
94258131|NCT01440374|322740399|FG000|Part 1: Open-label Phase|Adverse Event|5|||
94258132|NCT01440374|322740400|FG001|Part 1: Open-label Phase|Adverse Event|0|||
94258133|NCT01440374|322740401|FG002|Part 1: Open-label Phase|Adverse Event|0|||
94258134|NCT01440374|322740402|FG003|Part 1: Open-label Phase|Adverse Event|0|||
94258135|NCT01440374|322740399|FG000|Part 1: Open-label Phase|Physician Decision|1|||
94258136|NCT01440374|322740400|FG001|Part 1: Open-label Phase|Physician Decision|0|||
94258137|NCT01440374|322740401|FG002|Part 1: Open-label Phase|Physician Decision|0|||
94258138|NCT01440374|322740402|FG003|Part 1: Open-label Phase|Physician Decision|0|||
94258139|NCT01440374|322740399|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
94258140|NCT01440374|322740400|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
94258141|NCT01440374|322740401|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
94258142|NCT01440374|322740402|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
94258143|NCT01440374|322740399|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
94258144|NCT01440374|322740400|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
94258145|NCT01440374|322740401|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
94630833|NCT01291173|324109827|FG002|Overall Study|Adverse Event|1|||
94630834|NCT01291173|324109828|FG003|Overall Study|Adverse Event|3|||
94258146|NCT01440374|322740402|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
94258147|NCT01440374|322740399|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
94258148|NCT01440374|322740400|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
94258149|NCT01440374|322740401|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
94258150|NCT01440374|322740402|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
94258151|NCT01440374|322740399|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
94258152|NCT01440374|322740400|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
94258153|NCT01440374|322740401|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
94258154|NCT01440374|322740402|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
94258155|NCT01440374|322740399|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
94258156|NCT01440374|322740400|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
94258157|NCT01440374|322740401|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
94630835|NCT01291173|324109825|FG000|Overall Study|Protocol Violation|7|||
94630836|NCT01291173|324109826|FG001|Overall Study|Protocol Violation|2|||
94630837|NCT01291173|324109827|FG002|Overall Study|Protocol Violation|2|||
94675340|NCT00279201|324263240|FG004|Intensification Addendum|Sponsor Decision|1|||
94675341|NCT00279201|324263241|FG005|Intensification Addendum|Sponsor Decision|1|||
94675342|NCT00279201|324263236|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
94675343|NCT00279201|324263237|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
94675344|NCT00279201|324263238|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
94675345|NCT00279201|324263239|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
94675346|NCT00279201|324263240|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
94675347|NCT00279201|324263241|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
94675348|NCT00279201|324263236|FG000|Intensification Addendum|Lack of Efficacy|0|||
94675349|NCT00279201|324263237|FG001|Intensification Addendum|Lack of Efficacy|0|||
94675350|NCT00279201|324263238|FG002|Intensification Addendum|Lack of Efficacy|0|||
94675351|NCT00279201|324263239|FG003|Intensification Addendum|Lack of Efficacy|1|||
94675352|NCT00279201|324263240|FG004|Intensification Addendum|Lack of Efficacy|1|||
94675353|NCT00279201|324263241|FG005|Intensification Addendum|Lack of Efficacy|0|||
94675354|NCT00279201|324263236|FG000|Intensification Addendum|Death|0|||
94675355|NCT00279201|324263237|FG001|Intensification Addendum|Death|0|||
94675356|NCT00279201|324263238|FG002|Intensification Addendum|Death|0|||
94675357|NCT00279201|324263239|FG003|Intensification Addendum|Death|0|||
94675358|NCT00279201|324263240|FG004|Intensification Addendum|Death|1|||
94675359|NCT00279201|324263241|FG005|Intensification Addendum|Death|0|||
94675360|NCT00265889|324263242|FG000|Overall Study|Physician Decision|1|||
94675361|NCT00265889|324263242|FG000|Overall Study|Protocol Violation|1|||
94675362|NCT00265889|324263242|FG000|Overall Study|Insurance denied the request|3|||
94675363|NCT02355028|324263247|FG000|Overall Study|Adverse Event|2|||
94675364|NCT02355028|324263248|FG001|Overall Study|Adverse Event|0|||
94675365|NCT02355028|324263247|FG000|Overall Study|Withdrawal by Subject|1|||
94675366|NCT02355028|324263248|FG001|Overall Study|Withdrawal by Subject|1|||
94258158|NCT01440374|322740402|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
94258159|NCT01440374|322740399|FG000|Part 2; Double-blind Phase|Not treated|0|||
94258160|NCT01440374|322740400|FG001|Part 2; Double-blind Phase|Not treated|0|||
94258161|NCT01440374|322740401|FG002|Part 2; Double-blind Phase|Not treated|1|||
94258162|NCT01440374|322740402|FG003|Part 2; Double-blind Phase|Not treated|0|||
94258163|NCT01440374|322740399|FG000|Part 3: Extension|Withdrawal by Subject|0|||
94258164|NCT01440374|322740400|FG001|Part 3: Extension|Withdrawal by Subject|0|||
94258165|NCT01440374|322740401|FG002|Part 3: Extension|Withdrawal by Subject|0|||
94258166|NCT01440374|322740402|FG003|Part 3: Extension|Withdrawal by Subject|5|||
94258167|NCT01440374|322740399|FG000|Part 3: Extension|Adverse Event|0|||
94258168|NCT01440374|322740400|FG001|Part 3: Extension|Adverse Event|0|||
94258169|NCT01440374|322740401|FG002|Part 3: Extension|Adverse Event|0|||
94258170|NCT01440374|322740402|FG003|Part 3: Extension|Adverse Event|13|||
94258171|NCT01440374|322740399|FG000|Part 3: Extension|Physician Decision|0|||
94258172|NCT01440374|322740400|FG001|Part 3: Extension|Physician Decision|0|||
94675367|NCT02355028|324263247|FG000|Overall Study|Deemed ineligible after randomization|8|||
94675368|NCT02355028|324263248|FG001|Overall Study|Deemed ineligible after randomization|4|||
94675369|NCT00542880|324263249|FG000|Period 1|Eligibility criteria not fulfilled|2|||
94675370|NCT00542880|324263250|FG001|Period 1|Eligibility criteria not fulfilled|6|||
94675371|NCT00542880|324263249|FG000|Period 1|Adverse Event|2|||
94675372|NCT00542880|324263250|FG001|Period 1|Adverse Event|2|||
94675373|NCT00542880|324263249|FG000|Period 1|Development of study-specific criteria|1|||
94675374|NCT00542880|324263250|FG001|Period 1|Development of study-specific criteria|2|||
94675375|NCT00542880|324263249|FG000|Period 1|Withdrawal by Subject|1|||
94675376|NCT00542880|324263250|FG001|Period 1|Withdrawal by Subject|1|||
94675377|NCT00542880|324263249|FG000|Period 1|Protocol Violation|0|||
94675378|NCT00542880|324263250|FG001|Period 1|Protocol Violation|1|||
94675379|NCT00542880|324263249|FG000|Period 2|Adverse Event|5|||
94675380|NCT00542880|324263250|FG001|Period 2|Adverse Event|7|||
94675381|NCT00542880|324263249|FG000|Period 2|Eligibility not fulfilled|0|||
94675382|NCT00542880|324263250|FG001|Period 2|Eligibility not fulfilled|1|||
94675383|NCT00542880|324263249|FG000|Period 2|Discontinuation criteria|2|||
94675384|NCT00542880|324263250|FG001|Period 2|Discontinuation criteria|0|||
94675385|NCT00542880|324263249|FG000|Period 2|Severe non-compliance|0|||
94675386|NCT00542880|324263250|FG001|Period 2|Severe non-compliance|1|||
94675387|NCT00542880|324263249|FG000|Period 2|Other|0|||
94675388|NCT00542880|324263250|FG001|Period 2|Other|1|||
94258173|NCT01440374|322740401|FG002|Part 3: Extension|Physician Decision|0|||
94258174|NCT01440374|322740402|FG003|Part 3: Extension|Physician Decision|14|||
94258175|NCT00171704|322740403|FG000|Overall Study|Adverse Event|24|||
94258176|NCT00171704|322740404|FG001|Overall Study|Adverse Event|33|||
94258177|NCT00171704|322740403|FG000|Overall Study|Disease Progression|14|||
94258178|NCT00171704|322740404|FG001|Overall Study|Disease Progression|9|||
94258179|NCT00171704|322740403|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
94675389|NCT00542880|324263249|FG000|Period 3|Adverse Event|0|||
94675390|NCT00542880|324263250|FG001|Period 3|Adverse Event|2|||
94675391|NCT00558064|324263251|FG000|Overall Study|Adverse Event|3|||
94361497|NCT01473589|323107310|FG000|Overall Study|Protocol Violation|1|||
94675392|NCT00558064|324263252|FG001|Overall Study|Adverse Event|2|||
94675393|NCT00558064|324263251|FG000|Overall Study|Lack of Efficacy|0|||
94675394|NCT00558064|324263252|FG001|Overall Study|Lack of Efficacy|1|||
94361498|NCT01473589|323107311|FG001|Overall Study|Protocol Violation|0|||
94361499|NCT01473589|323107310|FG000|Overall Study|Withdrawal by Subject|5|||
94361500|NCT01473589|323107311|FG001|Overall Study|Withdrawal by Subject|11|||
94361501|NCT01473589|323107310|FG000|Overall Study|Physician Decision|0|||
94361502|NCT01473589|323107311|FG001|Overall Study|Physician Decision|1|||
94361503|NCT01473589|323107310|FG000|Overall Study|Entry criteria not met|0|||
94361504|NCT01473589|323107311|FG001|Overall Study|Entry criteria not met|1|||
94361505|NCT01976663|323107317|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
94361506|NCT01976663|323107317|FG000|Overall Study|Personal Reasons|6|||
94361507|NCT01976663|323107317|FG000|Overall Study|Withdrawal by Subject|4|||
94361508|NCT01976663|323107317|FG000|Overall Study|Screen Failure|3|||
94361509|NCT01976663|323107317|FG000|Overall Study|Adverse Event|2|||
94361510|NCT01976663|323107317|FG000|Overall Study|Lost to Follow-up|3|||
94361511|NCT03722849|323107318|FG000|Overall Study|Withdrawal by Subject|1|||
94361512|NCT03722849|323107319|FG001|Overall Study|Withdrawal by Subject|1|||
94361513|NCT03446157|323107324|FG000|Overall Study|Death|11|||
94361514|NCT03446157|323107325|FG001|Overall Study|Death|9|||
94361515|NCT03446157|323107324|FG000|Overall Study|Lost to Follow-up|0|||
94361516|NCT03446157|323107325|FG001|Overall Study|Lost to Follow-up|1|||
94361517|NCT03446157|323107324|FG000|Overall Study|Withdrawal by Subject|2|||
94361518|NCT03446157|323107325|FG001|Overall Study|Withdrawal by Subject|1|||
94361519|NCT03237325|323107328|FG000|Overall Study|Lost to Follow-up|3|||
94361520|NCT03237325|323107329|FG001|Overall Study|Lost to Follow-up|5|||
94361521|NCT03237325|323107328|FG000|Overall Study|Physician Decision|2|||
94361522|NCT03237325|323107329|FG001|Overall Study|Physician Decision|4|||
94361523|NCT03237325|323107328|FG000|Overall Study|Withdrawal by Subject|9|||
94361524|NCT03237325|323107329|FG001|Overall Study|Withdrawal by Subject|12|||
94361525|NCT03237325|323107328|FG000|Overall Study|Noncompliance with Study Procedures|1|||
94361526|NCT03237325|323107329|FG001|Overall Study|Noncompliance with Study Procedures|1|||
94361527|NCT03237325|323107328|FG000|Overall Study|Termination by Sponsor|0|||
94361528|NCT03237325|323107329|FG001|Overall Study|Termination by Sponsor|1|||
94361529|NCT03237325|323107328|FG000|Overall Study|Reason other than described|0|||
94361530|NCT03237325|323107329|FG001|Overall Study|Reason other than described|2|||
94361531|NCT04221373|323107331|FG000|Overall Study|Physician Decision|4|||
94361532|NCT04221373|323107332|FG001|Overall Study|Physician Decision|0|||
94361533|NCT00627094|323107335|FG000|Overall Study|Adverse Event|8|||
94361534|NCT00627094|323107336|FG001|Overall Study|Adverse Event|7|||
94361535|NCT00627094|323107335|FG000|Overall Study|Lost to Follow-up|1|||
94361536|NCT00627094|323107336|FG001|Overall Study|Lost to Follow-up|0|||
94361537|NCT00627094|323107335|FG000|Overall Study|Withdrawal by Subject|1|||
94361538|NCT00627094|323107336|FG001|Overall Study|Withdrawal by Subject|1|||
94361539|NCT00627094|323107335|FG000|Overall Study|ulcer healed|1|||
94361540|NCT00627094|323107336|FG001|Overall Study|ulcer healed|7|||
94361541|NCT00627094|323107335|FG000|Overall Study|Other reason|1|||
94361542|NCT00627094|323107336|FG001|Overall Study|Other reason|0|||
94361543|NCT00183170|323107337|FG000|First Intervention|Did not complete study|1|||
94361544|NCT00183170|323107338|FG001|First Intervention|Did not complete study|0|||
94361545|NCT00183170|323107337|FG000|First Intervention|Did not meet targeted BrAC|1|||
94361546|NCT00183170|323107338|FG001|First Intervention|Did not meet targeted BrAC|0|||
94361547|NCT00183170|323107337|FG000|Washout 1 Week|Did not complete study|6|||
94361548|NCT00183170|323107338|FG001|Washout 1 Week|Did not complete study|8|||
94361549|NCT00183170|323107337|FG000|Second Intervention|Did not complete study|1|||
94361550|NCT00183170|323107338|FG001|Second Intervention|Did not complete study|0|||
94361551|NCT00183170|323107337|FG000|Second Intervention|Did not meet targeted BrAC|0|||
94361552|NCT00183170|323107338|FG001|Second Intervention|Did not meet targeted BrAC|2|||
94361553|NCT00585468|323107339|FG000|First Intervention|Withdrawal by Subject|1|||
94361554|NCT00585468|323107340|FG001|First Intervention|Withdrawal by Subject|1|||
94361555|NCT03205046|323107341|FG000|Overall Study|Death|10|||
94361556|NCT03205046|323107342|FG001|Overall Study|Death|6|||
94361557|NCT03205046|323107341|FG000|Overall Study|Withdrawal by Subject|1|||
94361558|NCT03205046|323107342|FG001|Overall Study|Withdrawal by Subject|2|||
94361559|NCT03205046|323107341|FG000|Overall Study|Lost to Follow-up|0|||
94361560|NCT03205046|323107342|FG001|Overall Study|Lost to Follow-up|1|||
94675395|NCT00558064|324263251|FG000|Overall Study|Protocol Violation|1|||
94361561|NCT03205046|323107341|FG000|Overall Study|Study terminated by sponsor|2|||
94361562|NCT03205046|323107342|FG001|Overall Study|Study terminated by sponsor|1|||
94361563|NCT03253809|323107343|FG000|Overall Study|Unable to obtain study related data|14|||
94361564|NCT02181673|323107346|FG000|Up to Week 24|Adverse Event|2|||
94361565|NCT02181673|323107347|FG001|Up to Week 24|Adverse Event|0|||
94361566|NCT02181673|323107348|FG002|Up to Week 24|Adverse Event|3|||
94361567|NCT02181673|323107346|FG000|Up to Week 24|Death|1|||
94361568|NCT02181673|323107347|FG001|Up to Week 24|Death|0|||
94361569|NCT02181673|323107348|FG002|Up to Week 24|Death|0|||
94361570|NCT02181673|323107346|FG000|Up to Week 24|Lack of Efficacy|1|||
94361571|NCT02181673|323107347|FG001|Up to Week 24|Lack of Efficacy|0|||
94675396|NCT00558064|324263252|FG001|Overall Study|Protocol Violation|0|||
94675397|NCT00558064|324263251|FG000|Overall Study|Lost to Follow-up|0|||
94258180|NCT00171704|322740404|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
94258181|NCT00171704|322740403|FG000|Overall Study|Administrative Problems|2|||
94258182|NCT00171704|322740404|FG001|Overall Study|Administrative Problems|1|||
94258183|NCT00171704|322740403|FG000|Overall Study|Death|2|||
94258184|NCT00171704|322740404|FG001|Overall Study|Death|2|||
94258185|NCT00171704|322740403|FG000|Overall Study|Withdrawal by Subject|1|||
94258186|NCT00171704|322740404|FG001|Overall Study|Withdrawal by Subject|3|||
94258187|NCT00171704|322740403|FG000|Overall Study|Protocol Violation|0|||
94258188|NCT00171704|322740404|FG001|Overall Study|Protocol Violation|1|||
94258189|NCT03057977|322740405|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
94258190|NCT03057977|322740406|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
94258191|NCT03057977|322740405|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
94258192|NCT03057977|322740406|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
94258193|NCT03057977|322740405|FG000|Discontinuation From Treatment|Protocol Violation|6|||
94258194|NCT03057977|322740406|FG001|Discontinuation From Treatment|Protocol Violation|5|||
94258195|NCT03057977|322740405|FG000|Discontinuation From Treatment|Not treated|4|||
94258196|NCT03057977|322740406|FG001|Discontinuation From Treatment|Not treated|0|||
94258197|NCT03057977|322740405|FG000|Discontinuation From Treatment|Adverse Event|343|||
94258198|NCT03057977|322740406|FG001|Discontinuation From Treatment|Adverse Event|337|||
94258199|NCT03057977|322740405|FG000|Discontinuation From Treatment|Reason Unknown|0|||
94258200|NCT03057977|322740406|FG001|Discontinuation From Treatment|Reason Unknown|1|||
94258201|NCT03057977|322740405|FG000|Discontinuation From Treatment|Personal Reasons|1|||
94258202|NCT03057977|322740406|FG001|Discontinuation From Treatment|Personal Reasons|1|||
94258203|NCT03057977|322740405|FG000|Discontinuation From Treatment|Unblinded medication|1|||
94258204|NCT03057977|322740406|FG001|Discontinuation From Treatment|Unblinded medication|0|||
94258205|NCT03057977|322740405|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
94258206|NCT03057977|322740406|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
94258207|NCT03057977|322740405|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
94258208|NCT03057977|322740406|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
94258209|NCT03057977|322740405|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
94258210|NCT03057977|322740406|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
94258211|NCT03057977|322740405|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
94258212|NCT03057977|322740406|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
94258213|NCT03057977|322740405|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
94258214|NCT03057977|322740406|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
94258215|NCT03057977|322740405|FG000|Discontinuation From Treatment|Not attending study visit|3|||
94258216|NCT03057977|322740406|FG001|Discontinuation From Treatment|Not attending study visit|10|||
94258217|NCT03057977|322740405|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
94258218|NCT03057977|322740406|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
94258219|NCT03057977|322740405|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
94258220|NCT03057977|322740406|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
94258221|NCT03057977|322740405|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
94258222|NCT03057977|322740406|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
94675398|NCT00558064|324263252|FG001|Overall Study|Lost to Follow-up|1|||
94675399|NCT00558064|324263251|FG000|Overall Study|Withdrawal by Subject|0|||
94675400|NCT00558064|324263252|FG001|Overall Study|Withdrawal by Subject|1|||
94675401|NCT00558064|324263251|FG000|Overall Study|No visit within allowance period|1|||
94675402|NCT00558064|324263252|FG001|Overall Study|No visit within allowance period|0|||
94675403|NCT02027402|324263254|FG000|Overall Study|Withdrawal by Subject|4|||
94258223|NCT03057977|322740405|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
94258224|NCT03057977|322740406|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
94258225|NCT03057977|322740405|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
94258226|NCT03057977|322740406|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
94258227|NCT00953407|322740407|FG000|Overall Study|Failed inclusion criteria|1|||
94258228|NCT00953407|322740408|FG001|Overall Study|Failed inclusion criteria|1|||
94258229|NCT00953407|322740409|FG002|Overall Study|Failed inclusion criteria|1|||
94258230|NCT00953407|322740410|FG003|Overall Study|Failed inclusion criteria|1|||
94258231|NCT00953407|322740411|FG004|Overall Study|Failed inclusion criteria|1|||
94258232|NCT00953407|322740407|FG000|Overall Study|Lost to Follow-up|0|||
94258233|NCT00953407|322740408|FG001|Overall Study|Lost to Follow-up|0|||
94258234|NCT00953407|322740409|FG002|Overall Study|Lost to Follow-up|0|||
94258235|NCT00953407|322740410|FG003|Overall Study|Lost to Follow-up|1|||
94258236|NCT00953407|322740411|FG004|Overall Study|Lost to Follow-up|0|||
94258237|NCT00081770|322740412|FG000|Overall Study|Adverse Event|130|||
94258238|NCT00081770|322740413|FG001|Overall Study|Adverse Event|98|||
94258239|NCT00081770|322740414|FG002|Overall Study|Adverse Event|136|||
94258240|NCT00081770|322740412|FG000|Overall Study|Lack of Efficacy|262|||
94258241|NCT00081770|322740413|FG001|Overall Study|Lack of Efficacy|357|||
94258242|NCT00081770|322740414|FG002|Overall Study|Lack of Efficacy|211|||
94258243|NCT00081770|322740412|FG000|Overall Study|Lost to Follow-up|45|||
94258244|NCT00081770|322740413|FG001|Overall Study|Lost to Follow-up|34|||
94258245|NCT00081770|322740414|FG002|Overall Study|Lost to Follow-up|45|||
94258246|NCT00081770|322740412|FG000|Overall Study|Protocol Violation|15|||
94258247|NCT00081770|322740413|FG001|Overall Study|Protocol Violation|10|||
94258248|NCT00081770|322740414|FG002|Overall Study|Protocol Violation|10|||
94258249|NCT00081770|322740412|FG000|Overall Study|Withdrawal by Subject|45|||
94258250|NCT00081770|322740413|FG001|Overall Study|Withdrawal by Subject|40|||
94258251|NCT00081770|322740414|FG002|Overall Study|Withdrawal by Subject|42|||
94258252|NCT00081770|322740412|FG000|Overall Study|Did not meet protocol eligibility|2|||
94258253|NCT00081770|322740413|FG001|Overall Study|Did not meet protocol eligibility|0|||
94258254|NCT00081770|322740414|FG002|Overall Study|Did not meet protocol eligibility|3|||
94258255|NCT00081770|322740412|FG000|Overall Study|Administrative|1|||
94258256|NCT00081770|322740413|FG001|Overall Study|Administrative|0|||
94258257|NCT00081770|322740414|FG002|Overall Study|Administrative|1|||
94258258|NCT00081770|322740412|FG000|Overall Study|Other|2|||
94258259|NCT00081770|322740413|FG001|Overall Study|Other|7|||
94258260|NCT00081770|322740414|FG002|Overall Study|Other|8|||
94258261|NCT03435497|322740415|FG000|Overall Study|Lost to Follow-up|1|||
94258262|NCT03435497|322740416|FG001|Overall Study|Lost to Follow-up|0|||
94258263|NCT03435497|322740415|FG000|Overall Study|Death|1|||
94258264|NCT03435497|322740416|FG001|Overall Study|Death|0|||
94258265|NCT03435497|322740415|FG000|Overall Study|Withdrawal by Subject|0|||
94258266|NCT03435497|322740416|FG001|Overall Study|Withdrawal by Subject|4|||
94258267|NCT03435497|322740415|FG000|Overall Study|Wrong survey administered|0|||
94258268|NCT03435497|322740416|FG001|Overall Study|Wrong survey administered|2|||
94258269|NCT03628898|322740418|FG000|Overall Study|Device deficiency|1|||
94258270|NCT03442985|322740419|FG000|Overall Study|Sponsor Request|55|||
94258271|NCT03442985|322740420|FG001|Overall Study|Sponsor Request|60|||
94258272|NCT03442985|322740421|FG002|Overall Study|Sponsor Request|54|||
94258273|NCT03442985|322740419|FG000|Overall Study|Lost to Follow-up|5|||
94258274|NCT03442985|322740420|FG001|Overall Study|Lost to Follow-up|2|||
94675404|NCT02027402|324263255|FG001|Overall Study|Withdrawal by Subject|1|||
94675405|NCT00982930|324263256|FG000|Overall Study|Adverse Event|1|||
94675406|NCT00982930|324263256|FG000|Overall Study|Withdrawal by Subject|1|||
94675407|NCT00982930|324263256|FG000|Overall Study|Administrative Problems|2|||
94675408|NCT01648270|324263257|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
94258275|NCT03442985|322740421|FG002|Overall Study|Lost to Follow-up|7|||
94258276|NCT03442985|322740419|FG000|Overall Study|Withdrawal by Subject|2|||
94258277|NCT03442985|322740420|FG001|Overall Study|Withdrawal by Subject|3|||
94258278|NCT03442985|322740421|FG002|Overall Study|Withdrawal by Subject|4|||
94258279|NCT03442985|322740419|FG000|Overall Study|Adverse Event|0|||
94258280|NCT03442985|322740420|FG001|Overall Study|Adverse Event|1|||
94258281|NCT03442985|322740421|FG002|Overall Study|Adverse Event|0|||
94258282|NCT00288509|322740422|FG000|Treatment Cycle 1|Adverse Event|1|||
94258283|NCT00288509|322740422|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
94258284|NCT00288509|322740422|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
94258285|NCT00288509|322740422|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
94258286|NCT00288509|322740422|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
94258287|NCT00288509|322740422|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
94258288|NCT00288509|322740422|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
94258289|NCT00288509|322740422|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
94361572|NCT02181673|323107348|FG002|Up to Week 24|Lack of Efficacy|0|||
94361573|NCT02181673|323107346|FG000|Up to Week 24|Lost to Follow-up|1|||
94361574|NCT02181673|323107347|FG001|Up to Week 24|Lost to Follow-up|0|||
94361575|NCT02181673|323107348|FG002|Up to Week 24|Lost to Follow-up|0|||
94361576|NCT02181673|323107346|FG000|Up to Week 24|Physician Decision|0|||
94361577|NCT02181673|323107347|FG001|Up to Week 24|Physician Decision|0|||
94361578|NCT02181673|323107348|FG002|Up to Week 24|Physician Decision|3|||
94361579|NCT02181673|323107346|FG000|Up to Week 24|Withdrawal by Subject|10|||
94361580|NCT02181673|323107347|FG001|Up to Week 24|Withdrawal by Subject|0|||
94361581|NCT02181673|323107348|FG002|Up to Week 24|Withdrawal by Subject|1|||
94361582|NCT02181673|323107346|FG000|Up to Week 24|Other|2|||
94361583|NCT02181673|323107347|FG001|Up to Week 24|Other|0|||
94361584|NCT02181673|323107348|FG002|Up to Week 24|Other|3|||
94361585|NCT02181673|323107346|FG000|Up to Week 24|Randomized not Treated|0|||
94361586|NCT02181673|323107347|FG001|Up to Week 24|Randomized not Treated|0|||
94361587|NCT02181673|323107348|FG002|Up to Week 24|Randomized not Treated|1|||
94361588|NCT02181673|323107346|FG000|Week 24-Week 60|Adverse Event|0|||
94361589|NCT02181673|323107347|FG001|Week 24-Week 60|Adverse Event|4|||
94361590|NCT02181673|323107348|FG002|Week 24-Week 60|Adverse Event|10|||
94361591|NCT02181673|323107346|FG000|Week 24-Week 60|Other|0|||
94361592|NCT02181673|323107347|FG001|Week 24-Week 60|Other|2|||
94361593|NCT02181673|323107348|FG002|Week 24-Week 60|Other|1|||
94361594|NCT02181673|323107346|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
94361595|NCT02181673|323107347|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
94361596|NCT02181673|323107348|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
94361597|NCT02181673|323107346|FG000|Week 24-Week 60|Pregnancy|0|||
94361598|NCT02181673|323107347|FG001|Week 24-Week 60|Pregnancy|0|||
94361599|NCT02181673|323107348|FG002|Week 24-Week 60|Pregnancy|1|||
94361600|NCT02181673|323107346|FG000|Week 24-Week 60|Lack of Efficacy|0|||
94361601|NCT02181673|323107347|FG001|Week 24-Week 60|Lack of Efficacy|0|||
94361602|NCT02181673|323107348|FG002|Week 24-Week 60|Lack of Efficacy|1|||
94361603|NCT02181673|323107346|FG000|Week 24-Week 60|Lost to Follow-up|0|||
94361604|NCT02181673|323107347|FG001|Week 24-Week 60|Lost to Follow-up|0|||
94361605|NCT02181673|323107348|FG002|Week 24-Week 60|Lost to Follow-up|1|||
94361606|NCT02181673|323107346|FG000|Week 24-Week 60|Physician Decision|0|||
94361607|NCT02181673|323107347|FG001|Week 24-Week 60|Physician Decision|0|||
94361608|NCT02181673|323107348|FG002|Week 24-Week 60|Physician Decision|1|||
94630838|NCT01291173|324109828|FG003|Overall Study|Protocol Violation|5|||
94630839|NCT01291173|324109825|FG000|Overall Study|Withdrawal by Subject|6|||
94630840|NCT01291173|324109826|FG001|Overall Study|Withdrawal by Subject|4|||
94630841|NCT01291173|324109827|FG002|Overall Study|Withdrawal by Subject|4|||
94630842|NCT01291173|324109828|FG003|Overall Study|Withdrawal by Subject|2|||
94630843|NCT01291173|324109825|FG000|Overall Study|Lost to Follow-up|4|||
94630844|NCT01291173|324109826|FG001|Overall Study|Lost to Follow-up|6|||
94630845|NCT01291173|324109827|FG002|Overall Study|Lost to Follow-up|3|||
94630846|NCT01291173|324109828|FG003|Overall Study|Lost to Follow-up|2|||
94630847|NCT01291173|324109825|FG000|Overall Study|Unable to meet visit schedule|0|||
94630848|NCT01291173|324109826|FG001|Overall Study|Unable to meet visit schedule|0|||
94630849|NCT01291173|324109827|FG002|Overall Study|Unable to meet visit schedule|1|||
94630850|NCT01291173|324109828|FG003|Overall Study|Unable to meet visit schedule|0|||
94630851|NCT01291173|324109825|FG000|Overall Study|Lack of compliance|0|||
94630852|NCT01291173|324109826|FG001|Overall Study|Lack of compliance|0|||
94630853|NCT01291173|324109827|FG002|Overall Study|Lack of compliance|0|||
94630854|NCT01291173|324109828|FG003|Overall Study|Lack of compliance|1|||
94630855|NCT01291173|324109825|FG000|Overall Study|Subject was unblinded|0|||
94630856|NCT01291173|324109826|FG001|Overall Study|Subject was unblinded|0|||
94630857|NCT01291173|324109827|FG002|Overall Study|Subject was unblinded|1|||
94630858|NCT01291173|324109828|FG003|Overall Study|Subject was unblinded|0|||
94630859|NCT01291173|324109825|FG000|Overall Study|Excluded therapy|0|||
94361609|NCT03155269|323107349|FG000|Overall Study|Withdrawal by Subject|4|||
94361610|NCT03155269|323107350|FG001|Overall Study|Withdrawal by Subject|5|||
94361611|NCT03155269|323107349|FG000|Overall Study|Lost to Follow-up|1|||
94361612|NCT03155269|323107350|FG001|Overall Study|Lost to Follow-up|2|||
94361613|NCT00433771|323107351|FG000|Overall Study|screen fail|14|||
94361614|NCT00433771|323107351|FG000|Overall Study|Treated and later found to be ineligible|2|||
94630860|NCT01291173|324109826|FG001|Overall Study|Excluded therapy|0|||
94630861|NCT01291173|324109827|FG002|Overall Study|Excluded therapy|1|||
94630862|NCT01291173|324109828|FG003|Overall Study|Excluded therapy|0|||
94630863|NCT00390858|324109829|FG000|Overall Study|Adverse Event|6|||
94630864|NCT00390858|324109830|FG001|Overall Study|Adverse Event|2|||
94630865|NCT00390858|324109829|FG000|Overall Study|Lack of Efficacy|0|||
94361615|NCT00433771|323107351|FG000|Overall Study|Death|2|||
94361616|NCT00433771|323107351|FG000|Overall Study|Failure to deploy stent|1|||
94361617|NCT00138658|323107352|FG000|Overall Study|Adverse Event|23|||
94361618|NCT00138658|323107352|FG000|Overall Study|Death|1|||
94361619|NCT00138658|323107352|FG000|Overall Study|Disease Progression|21|||
94361620|NCT00138658|323107352|FG000|Overall Study|Physician Decision|11|||
94361621|NCT00138658|323107352|FG000|Overall Study|Withdrawal by Subject|5|||
94361622|NCT04637815|323107353|FG000|Overall Study|Death|1|||
94675409|NCT02170025|324263258|FG000|Overall Study|Adverse Event|2|||
94675410|NCT02170025|324263259|FG001|Overall Study|Adverse Event|0|||
94675411|NCT01338025|324263260|FG000|Overall Study|Unexpected closure of study|10|||
94675412|NCT01338025|324263261|FG001|Overall Study|Unexpected closure of study|9|||
94258290|NCT00288509|322740422|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
94675413|NCT01338025|324263260|FG000|Overall Study|Withdrawal by Subject|0|||
94675414|NCT01338025|324263261|FG001|Overall Study|Withdrawal by Subject|2|||
94675415|NCT01338025|324263260|FG000|Overall Study|Found ineligible after starting|1|||
94675416|NCT01338025|324263261|FG001|Overall Study|Found ineligible after starting|0|||
94675417|NCT01553318|324265367|FG000|Overall Study|Protocol Violation|3|||
94675418|NCT01553318|324265368|FG001|Overall Study|Protocol Violation|2|||
94675419|NCT01266850|324265372|FG000|Overall Study|Lost to Follow-up|19|||
94675420|NCT01266850|324265373|FG001|Overall Study|Lost to Follow-up|19|||
94675421|NCT01266850|324265374|FG002|Overall Study|Lost to Follow-up|13|||
94675422|NCT01266850|324265375|FG003|Overall Study|Lost to Follow-up|13|||
94675423|NCT01266850|324265376|FG004|Overall Study|Lost to Follow-up|12|||
94675424|NCT01266850|324265372|FG000|Overall Study|Withdrawal by Subject|8|||
94675425|NCT01266850|324265373|FG001|Overall Study|Withdrawal by Subject|9|||
94675426|NCT01266850|324265374|FG002|Overall Study|Withdrawal by Subject|6|||
94675427|NCT01266850|324265375|FG003|Overall Study|Withdrawal by Subject|9|||
94258291|NCT00288509|322740422|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
94258292|NCT00288509|322740422|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
94258293|NCT00288509|322740422|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
94258294|NCT00288509|322740422|FG000|Treatment Cycle 4|Physician Decision|4|||
94258295|NCT00288509|322740422|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
94258296|NCT02986334|322740427|FG000|Overall Study|Withdrawal by Subject|0|||
94258297|NCT02986334|322740428|FG001|Overall Study|Withdrawal by Subject|1|||
94258298|NCT02986334|322740429|FG002|Overall Study|Withdrawal by Subject|2|||
94258299|NCT02986334|322740427|FG000|Overall Study|Lost to Follow-up|1|||
94258300|NCT02986334|322740428|FG001|Overall Study|Lost to Follow-up|2|||
94258301|NCT02986334|322740429|FG002|Overall Study|Lost to Follow-up|1|||
94258302|NCT02986334|322740427|FG000|Overall Study|Adverse Event|0|||
94258303|NCT02986334|322740428|FG001|Overall Study|Adverse Event|2|||
94258304|NCT02986334|322740429|FG002|Overall Study|Adverse Event|1|||
94258305|NCT02986334|322740427|FG000|Overall Study|non compliance in phone ratings|2|||
94258306|NCT02986334|322740428|FG001|Overall Study|non compliance in phone ratings|1|||
94258307|NCT02986334|322740429|FG002|Overall Study|non compliance in phone ratings|2|||
94258308|NCT02986334|322740427|FG000|Overall Study|undisclosed comorbidities|0|||
94258309|NCT02986334|322740428|FG001|Overall Study|undisclosed comorbidities|1|||
94258310|NCT02986334|322740429|FG002|Overall Study|undisclosed comorbidities|1|||
94258311|NCT00120406|322740432|FG000|Overall Study|Death|9|||
94258312|NCT00120406|322740433|FG001|Overall Study|Death|4|||
94258313|NCT00120406|322740432|FG000|Overall Study|Withdrawal by Subject|5|||
94258314|NCT00120406|322740433|FG001|Overall Study|Withdrawal by Subject|7|||
94258315|NCT00120406|322740432|FG000|Overall Study|Lost to Follow-up|5|||
94258316|NCT00120406|322740433|FG001|Overall Study|Lost to Follow-up|2|||
94675428|NCT01266850|324265376|FG004|Overall Study|Withdrawal by Subject|12|||
94258317|NCT00120406|322740432|FG000|Overall Study|received non-study stent|0|||
94258318|NCT00120406|322740433|FG001|Overall Study|received non-study stent|2|||
94258319|NCT00120406|322740432|FG000|Overall Study|patient moved but has not withdrawn|0|||
94258320|NCT00120406|322740433|FG001|Overall Study|patient moved but has not withdrawn|1|||
94258321|NCT02544217|322740437|FG000|Overall Study|Withdrawal by Subject|1|||
94675429|NCT01266850|324265372|FG000|Overall Study|Physician Decision|3|||
94258322|NCT02544217|322740438|FG001|Overall Study|Withdrawal by Subject|1|||
94258323|NCT02544217|322740439|FG002|Overall Study|Withdrawal by Subject|0|||
94675430|NCT01266850|324265373|FG001|Overall Study|Physician Decision|6|||
94675431|NCT01266850|324265374|FG002|Overall Study|Physician Decision|4|||
94675432|NCT01266850|324265375|FG003|Overall Study|Physician Decision|4|||
94675433|NCT01266850|324265376|FG004|Overall Study|Physician Decision|3|||
94675434|NCT01266850|324265372|FG000|Overall Study|Protocol Violation|0|||
94258324|NCT02544217|322740440|FG003|Overall Study|Withdrawal by Subject|0|||
94258325|NCT02544217|322740441|FG004|Overall Study|Withdrawal by Subject|0|||
94675435|NCT01266850|324265373|FG001|Overall Study|Protocol Violation|1|||
94675436|NCT01266850|324265374|FG002|Overall Study|Protocol Violation|0|||
94675437|NCT01266850|324265375|FG003|Overall Study|Protocol Violation|1|||
94675438|NCT01266850|324265376|FG004|Overall Study|Protocol Violation|2|||
94675439|NCT01266850|324265372|FG000|Overall Study|Adverse Event|0|||
94675440|NCT01266850|324265373|FG001|Overall Study|Adverse Event|0|||
94675441|NCT01266850|324265374|FG002|Overall Study|Adverse Event|0|||
94675442|NCT01266850|324265375|FG003|Overall Study|Adverse Event|0|||
94675443|NCT01266850|324265376|FG004|Overall Study|Adverse Event|1|||
94675444|NCT01266850|324265372|FG000|Overall Study|Site Closure|0|||
94675445|NCT01266850|324265373|FG001|Overall Study|Site Closure|1|||
94675446|NCT01266850|324265374|FG002|Overall Study|Site Closure|1|||
94675447|NCT01266850|324265375|FG003|Overall Study|Site Closure|1|||
94675448|NCT01266850|324265376|FG004|Overall Study|Site Closure|0|||
94675449|NCT04128293|324265377|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
94675450|NCT04128293|324265378|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
94675451|NCT04128293|324265379|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
94675452|NCT04128293|324265380|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
94675453|NCT00224770|324265381|FG000|Overall Study|Lost to Follow-up|4|||
94675454|NCT00224770|324265382|FG001|Overall Study|Lost to Follow-up|2|||
94675455|NCT00224770|324265383|FG002|Overall Study|Lost to Follow-up|0|||
94675456|NCT00437645|324265390|FG000|Overall Study|Adverse Event|15|||
94675457|NCT00437645|324265391|FG001|Overall Study|Adverse Event|84|||
94675458|NCT00437645|324265390|FG000|Overall Study|Withdrawal by Subject|10|||
94675459|NCT00437645|324265391|FG001|Overall Study|Withdrawal by Subject|22|||
94675460|NCT00437645|324265390|FG000|Overall Study|Protocol Violation|3|||
94258326|NCT02544217|322740442|FG005|Overall Study|Withdrawal by Subject|0|||
94258327|NCT04964388|322740445|FG000|Overall Study|Lost to Follow-up|3|||
94258328|NCT04964388|322740446|FG001|Overall Study|Lost to Follow-up|2|||
94258329|NCT04335812|322740447|FG000|Overall Study|Withdrawal by Subject|1|||
94258330|NCT04335812|322740448|FG001|Overall Study|Withdrawal by Subject|3|||
94258331|NCT04335812|322740447|FG000|Overall Study|Lost to Follow-up|12|||
94258332|NCT04335812|322740448|FG001|Overall Study|Lost to Follow-up|12|||
94258333|NCT04335812|322740447|FG000|Overall Study|Did not engage in the intervention|22|||
94258334|NCT04335812|322740448|FG001|Overall Study|Did not engage in the intervention|18|||
94258335|NCT02175004|322740449|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
94258336|NCT02175004|322740450|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
94258337|NCT02175004|322740449|FG000|Overall Study|Investigator Judgment|1|||
94258338|NCT02175004|322740450|FG001|Overall Study|Investigator Judgment|4|||
94258339|NCT02175004|322740449|FG000|Overall Study|Voluntary Withdrawal|6|||
94258340|NCT02175004|322740450|FG001|Overall Study|Voluntary Withdrawal|19|||
94258341|NCT02175004|322740449|FG000|Overall Study|Liver Transplant|1|||
94258342|NCT02175004|322740450|FG001|Overall Study|Liver Transplant|0|||
94258343|NCT02175004|322740449|FG000|Overall Study|Disease Progression|1|||
94258344|NCT02175004|322740450|FG001|Overall Study|Disease Progression|0|||
94258345|NCT02175004|322740449|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
94258346|NCT02175004|322740450|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
94258347|NCT00221195|322740451|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
94258348|NCT00221195|322740452|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
94258349|NCT00221195|322740451|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
94258350|NCT00221195|322740452|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
94258351|NCT00221195|322740451|FG000|Washout Period (Months 7-9)|Death|0|||
94258352|NCT00221195|322740452|FG001|Washout Period (Months 7-9)|Death|1|||
94258353|NCT00221195|322740451|FG000|Therapy 2 (Months 10-15)|Death|1|||
94675461|NCT00437645|324265391|FG001|Overall Study|Protocol Violation|3|||
94675462|NCT00437645|324265390|FG000|Overall Study|Lost to Follow-up|2|||
94258354|NCT00221195|322740452|FG001|Therapy 2 (Months 10-15)|Death|0|||
94675463|NCT00437645|324265391|FG001|Overall Study|Lost to Follow-up|3|||
94675464|NCT00437645|324265390|FG000|Overall Study|Administrative problems|2|||
94675465|NCT00437645|324265391|FG001|Overall Study|Administrative problems|1|||
94675466|NCT00437645|324265390|FG000|Overall Study|Lack of Efficacy|2|||
94675467|NCT00437645|324265391|FG001|Overall Study|Lack of Efficacy|1|||
94675468|NCT00437645|324265390|FG000|Overall Study|Condition no longer requires study drug|1|||
94258355|NCT00221195|322740451|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
94258356|NCT00221195|322740452|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
94258357|NCT00881608|322740453|FG000|Overall Study|Study prematurely terminated|11|||
94258358|NCT03214094|322740454|FG000|Overall Study|Case Report Forms Uncollected|14|||
94675469|NCT00437645|324265391|FG001|Overall Study|Condition no longer requires study drug|1|||
94675470|NCT01783418|324265400|FG000|Overall Study|Withdrawal by Subject|1|||
94675471|NCT01783418|324265401|FG001|Overall Study|Withdrawal by Subject|0|||
94675472|NCT00415610|324265403|FG000|Overall Study|Death|3|||
94675473|NCT00415610|324265404|FG001|Overall Study|Death|2|||
94675474|NCT00415610|324265405|FG002|Overall Study|Death|5|||
94675475|NCT01699022|324265408|FG000|Overall Study|Early discontinuation from the study|3|||
94675476|NCT03286751|324265410|FG000|Washout Period 1|Withdrawal by Subject|0|||
94675477|NCT03286751|324265411|FG001|Washout Period 1|Withdrawal by Subject|0|||
94675478|NCT03286751|324265412|FG002|Washout Period 1|Withdrawal by Subject|0|||
94675479|NCT03286751|324265413|FG003|Washout Period 1|Withdrawal by Subject|0|||
94675480|NCT03286751|324265414|FG004|Washout Period 1|Withdrawal by Subject|1|||
94675481|NCT03286751|324265415|FG005|Washout Period 1|Withdrawal by Subject|0|||
94675482|NCT03286751|324265410|FG000|Washout Period 2|Personal Reasons|0|||
94675483|NCT03286751|324265411|FG001|Washout Period 2|Personal Reasons|1|||
94675484|NCT03286751|324265412|FG002|Washout Period 2|Personal Reasons|0|||
94675485|NCT03286751|324265413|FG003|Washout Period 2|Personal Reasons|0|||
94258359|NCT03214094|322740454|FG000|Overall Study|Protocol Deviation|46|||
94258360|NCT01607554|322740460|FG000|Overall Study|Disease progression|2|||
94258361|NCT00795951|322740461|FG000|Overall Study|Lost to Follow-up|1|||
94258362|NCT00795951|322740461|FG000|Overall Study|Withdrawal by Subject|1|||
94258363|NCT01180998|322740462|FG000|Overall Study|Poor Vision|0|||
94258364|NCT01180998|322740463|FG001|Overall Study|Poor Vision|2|||
94258365|NCT01180998|322740464|FG002|Overall Study|Poor Vision|2|||
94258366|NCT01180998|322740462|FG000|Overall Study|Lost to Follow-up|0|||
94258367|NCT01180998|322740463|FG001|Overall Study|Lost to Follow-up|0|||
94258368|NCT01180998|322740464|FG002|Overall Study|Lost to Follow-up|1|||
94258369|NCT01180998|322740462|FG000|Overall Study|Protocol Violation|1|||
94258370|NCT01180998|322740463|FG001|Overall Study|Protocol Violation|2|||
94258371|NCT01180998|322740464|FG002|Overall Study|Protocol Violation|0|||
94258372|NCT01180998|322740462|FG000|Overall Study|Withdrawal by Subject|0|||
94258373|NCT01180998|322740463|FG001|Overall Study|Withdrawal by Subject|0|||
94258374|NCT01180998|322740464|FG002|Overall Study|Withdrawal by Subject|1|||
94258375|NCT01180998|322740462|FG000|Overall Study|Poor comfort|3|||
94258376|NCT01180998|322740463|FG001|Overall Study|Poor comfort|0|||
94258377|NCT01180998|322740464|FG002|Overall Study|Poor comfort|4|||
94258378|NCT01180998|322740462|FG000|Overall Study|Poor lens handling|0|||
94258379|NCT01180998|322740463|FG001|Overall Study|Poor lens handling|0|||
94258380|NCT01180998|322740464|FG002|Overall Study|Poor lens handling|2|||
94258381|NCT00655486|322740465|FG000|Overall Study|Adverse Event|10|||
94258382|NCT00655486|322740465|FG000|Overall Study|Lack of Efficacy|8|||
94258383|NCT00655486|322740465|FG000|Overall Study|Withdrawal by Subject|4|||
94258384|NCT00655486|322740465|FG000|Overall Study|Protocol Violation|1|||
94258385|NCT00655486|322740465|FG000|Overall Study|Unsatisfactory compliance|2|||
94258386|NCT00655486|322740465|FG000|Overall Study|Other: Pregnancy|1|||
94258387|NCT00655486|322740465|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
94258388|NCT00655486|322740465|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
94258389|NCT00712673|322740466|FG000|Overall Study|Adverse Event|3|||
94258390|NCT00712673|322740467|FG001|Overall Study|Adverse Event|3|||
94258391|NCT00712673|322740468|FG002|Overall Study|Adverse Event|21|||
94258392|NCT00712673|322740469|FG003|Overall Study|Adverse Event|26|||
94258393|NCT00712673|322740466|FG000|Overall Study|Lack of Efficacy|2|||
94258394|NCT00712673|322740467|FG001|Overall Study|Lack of Efficacy|8|||
94258395|NCT00712673|322740468|FG002|Overall Study|Lack of Efficacy|8|||
94258396|NCT00712673|322740469|FG003|Overall Study|Lack of Efficacy|6|||
94258397|NCT00712673|322740466|FG000|Overall Study|Poor Compliance to Protocol|3|||
94258398|NCT00712673|322740467|FG001|Overall Study|Poor Compliance to Protocol|3|||
94675486|NCT03286751|324265414|FG004|Washout Period 2|Personal Reasons|0|||
94675487|NCT03286751|324265415|FG005|Washout Period 2|Personal Reasons|0|||
94675488|NCT03286751|324265410|FG000|Washout Period 5|Adverse Event|0|||
94675489|NCT03286751|324265411|FG001|Washout Period 5|Adverse Event|0|||
94675490|NCT03286751|324265412|FG002|Washout Period 5|Adverse Event|0|||
94675491|NCT03286751|324265413|FG003|Washout Period 5|Adverse Event|0|||
94675492|NCT03286751|324265414|FG004|Washout Period 5|Adverse Event|1|||
94675493|NCT03286751|324265415|FG005|Washout Period 5|Adverse Event|0|||
94675494|NCT01662063|324265416|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
94675495|NCT01662063|324265417|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
94675496|NCT01662063|324265418|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
94258399|NCT00712673|322740468|FG002|Overall Study|Poor Compliance to Protocol|4|||
94258400|NCT00712673|322740469|FG003|Overall Study|Poor Compliance to Protocol|16|||
94258401|NCT00712673|322740466|FG000|Overall Study|Lost to Follow-up|1|||
94361623|NCT04637815|323107354|FG001|Overall Study|Death|0|||
94675497|NCT01662063|324265416|FG000|Overall Study|Lack of Efficacy|1|||
94258402|NCT00712673|322740467|FG001|Overall Study|Lost to Follow-up|0|||
94258403|NCT00712673|322740468|FG002|Overall Study|Lost to Follow-up|2|||
94258404|NCT00712673|322740469|FG003|Overall Study|Lost to Follow-up|0|||
94258405|NCT00712673|322740466|FG000|Overall Study|Withdrawal by Subject|6|||
94258406|NCT00712673|322740467|FG001|Overall Study|Withdrawal by Subject|7|||
94258407|NCT00712673|322740468|FG002|Overall Study|Withdrawal by Subject|15|||
94258408|NCT00712673|322740469|FG003|Overall Study|Withdrawal by Subject|20|||
94258409|NCT00712673|322740466|FG000|Overall Study|Familial and Personal Reasons|5|||
94461377|NCT03045276|323478270|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
94461378|NCT03045276|323478271|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
94461379|NCT03045276|323478268|FG000|Follow-Up Phase|Lost to Follow-up|0|||
94461380|NCT03045276|323478269|FG001|Follow-Up Phase|Lost to Follow-up|1|||
94461381|NCT03045276|323478270|FG002|Follow-Up Phase|Lost to Follow-up|0|||
94461382|NCT03045276|323478271|FG003|Follow-Up Phase|Lost to Follow-up|1|||
94461383|NCT03045276|323478268|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
94461384|NCT03045276|323478269|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
94461385|NCT03045276|323478270|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
94461386|NCT03045276|323478271|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
94461387|NCT00347919|323478272|FG000|Overall Study|Lost to Follow-up|11|||
94461388|NCT00347919|323478273|FG001|Overall Study|Lost to Follow-up|13|||
94461389|NCT00347919|323478274|FG002|Overall Study|Lost to Follow-up|0|||
94461390|NCT00347919|323478272|FG000|Overall Study|Withdrawal by Subject|6|||
94461391|NCT00347919|323478273|FG001|Overall Study|Withdrawal by Subject|8|||
94461392|NCT00347919|323478274|FG002|Overall Study|Withdrawal by Subject|0|||
94461393|NCT00347919|323478272|FG000|Overall Study|Physician Decision|1|||
94461394|NCT00347919|323478273|FG001|Overall Study|Physician Decision|1|||
94461395|NCT00347919|323478274|FG002|Overall Study|Physician Decision|0|||
94461396|NCT00347919|323478272|FG000|Overall Study|Sponsor terminated study|15|||
94461397|NCT00347919|323478273|FG001|Overall Study|Sponsor terminated study|10|||
94461398|NCT00347919|323478274|FG002|Overall Study|Sponsor terminated study|16|||
94461399|NCT00347919|323478272|FG000|Overall Study|Death|35|||
94461400|NCT00347919|323478273|FG001|Overall Study|Death|42|||
94461401|NCT00347919|323478274|FG002|Overall Study|Death|19|||
94461402|NCT00347919|323478272|FG000|Overall Study|Par. Started Other Treatment|1|||
94461403|NCT00347919|323478273|FG001|Overall Study|Par. Started Other Treatment|1|||
94461404|NCT00347919|323478274|FG002|Overall Study|Par. Started Other Treatment|1|||
94461405|NCT00347919|323478272|FG000|Overall Study|Missing|2|||
94461406|NCT00347919|323478273|FG001|Overall Study|Missing|1|||
94461407|NCT00347919|323478274|FG002|Overall Study|Missing|2|||
94461408|NCT03379753|323478275|FG000|Overall Study|Withdrawal by Subject|2|||
94461409|NCT03379753|323478276|FG001|Overall Study|Withdrawal by Subject|1|||
94461410|NCT03379753|323478275|FG000|Overall Study|not having correct procedure|1|||
94461411|NCT03379753|323478276|FG001|Overall Study|not having correct procedure|2|||
94461412|NCT03379753|323478275|FG000|Overall Study|No primary outcome|12|||
94461413|NCT03379753|323478276|FG001|Overall Study|No primary outcome|22|||
94461414|NCT01032239|323478277|FG000|Overall Study|Lost to Follow-up|3|||
94461415|NCT01032239|323478278|FG001|Overall Study|Lost to Follow-up|2|||
94461416|NCT01032239|323478277|FG000|Overall Study|Withdrawal by Subject|2|||
94461417|NCT01032239|323478278|FG001|Overall Study|Withdrawal by Subject|3|||
94461418|NCT01032239|323478277|FG000|Overall Study|Death|1|||
94461419|NCT01032239|323478278|FG001|Overall Study|Death|0|||
94461420|NCT01032239|323478277|FG000|Overall Study|Protocol Violation|1|||
94461421|NCT01032239|323478278|FG001|Overall Study|Protocol Violation|0|||
94461422|NCT01446237|323478279|FG000|Overall Study|Adverse Event|1|||
94461423|NCT01446237|323478279|FG000|Overall Study|Lost to Follow-up|2|||
94461424|NCT01446237|323478279|FG000|Overall Study|Withdrawal by Subject|7|||
94461425|NCT03627416|323478280|FG000|Overall Study|Adverse Event|0|||
94461426|NCT03627416|323478281|FG001|Overall Study|Adverse Event|1|||
94461427|NCT04972968|323478282|FG000|Overall Study|Adverse Event|3|||
94461428|NCT04972968|323478283|FG001|Overall Study|Adverse Event|1|||
94461429|NCT04972968|323478284|FG002|Overall Study|Adverse Event|1|||
94461430|NCT04972968|323478285|FG003|Overall Study|Adverse Event|7|||
94461431|NCT04972968|323478282|FG000|Overall Study|Lack of Efficacy|2|||
94461432|NCT04972968|323478283|FG001|Overall Study|Lack of Efficacy|1|||
94630866|NCT00390858|324109830|FG001|Overall Study|Lack of Efficacy|1|||
94630867|NCT00390858|324109829|FG000|Overall Study|Withdrawal by Subject|3|||
94630868|NCT00390858|324109830|FG001|Overall Study|Withdrawal by Subject|4|||
94630869|NCT00142584|324109831|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
94461433|NCT04972968|323478284|FG002|Overall Study|Lack of Efficacy|0|||
94461434|NCT04972968|323478285|FG003|Overall Study|Lack of Efficacy|0|||
94461435|NCT04972968|323478282|FG000|Overall Study|Withdrawal by Subject|7|||
94461436|NCT04972968|323478283|FG001|Overall Study|Withdrawal by Subject|4|||
94461437|NCT04972968|323478284|FG002|Overall Study|Withdrawal by Subject|3|||
94461438|NCT04972968|323478285|FG003|Overall Study|Withdrawal by Subject|2|||
94630870|NCT00142584|324109832|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
94258410|NCT00712673|322740467|FG001|Overall Study|Familial and Personal Reasons|0|||
94461439|NCT04972968|323478282|FG000|Overall Study|Study Terminated by Sponsor|25|||
94461440|NCT04972968|323478283|FG001|Overall Study|Study Terminated by Sponsor|28|||
94461441|NCT04972968|323478284|FG002|Overall Study|Study Terminated by Sponsor|32|||
94461442|NCT04972968|323478285|FG003|Overall Study|Study Terminated by Sponsor|27|||
94461443|NCT04972968|323478282|FG000|Overall Study|Other|1|||
94630871|NCT00142584|324109831|FG000|Overall Study|Withdrawal by Subject|30|||
94461444|NCT04972968|323478283|FG001|Overall Study|Other|0|||
94461445|NCT04972968|323478284|FG002|Overall Study|Other|1|||
94461446|NCT04972968|323478285|FG003|Overall Study|Other|1|||
94461447|NCT00808639|323478287|FG000|Overall Study|Disease progression before surgery.|1|||
94461448|NCT03197324|323478288|FG000|Overall Study|Adverse Event|0|||
94461449|NCT03197324|323478289|FG001|Overall Study|Adverse Event|1|||
94461450|NCT03589976|323478290|FG000|Overall Study|Death|5|||
94461451|NCT03589976|323478291|FG001|Overall Study|Death|1|||
94461452|NCT03589976|323478290|FG000|Overall Study|Adverse Event|5|||
94461453|NCT03589976|323478291|FG001|Overall Study|Adverse Event|1|||
94461454|NCT03589976|323478290|FG000|Overall Study|Withdrawal by Subject|4|||
94461455|NCT03589976|323478291|FG001|Overall Study|Withdrawal by Subject|1|||
94461456|NCT03589976|323478290|FG000|Overall Study|Lost to Follow-up|1|||
94461457|NCT03589976|323478291|FG001|Overall Study|Lost to Follow-up|0|||
94461458|NCT03589976|323478290|FG000|Overall Study|Other|4|||
94461459|NCT03589976|323478291|FG001|Overall Study|Other|3|||
94461460|NCT04778059|323478296|FG000|Overall Study|Death|2|||
94461461|NCT04778059|323478297|FG001|Overall Study|Death|2|||
94461462|NCT04778059|323478298|FG002|Overall Study|Death|1|||
94461463|NCT04778059|323478299|FG003|Overall Study|Death|1|||
94461464|NCT04778059|323478300|FG004|Overall Study|Death|1|||
94461465|NCT04778059|323478296|FG000|Overall Study|Lost to Follow-up|0|||
94461466|NCT04778059|323478297|FG001|Overall Study|Lost to Follow-up|0|||
94461467|NCT04778059|323478298|FG002|Overall Study|Lost to Follow-up|0|||
94461468|NCT04778059|323478299|FG003|Overall Study|Lost to Follow-up|0|||
94461469|NCT04778059|323478300|FG004|Overall Study|Lost to Follow-up|1|||
94461470|NCT04778059|323478296|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
94461471|NCT04778059|323478297|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
94461472|NCT04778059|323478298|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
94461473|NCT04778059|323478299|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
94461474|NCT04778059|323478300|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
94461475|NCT01328548|323478304|FG000|Overall Study|Death|3|||
94461476|NCT01328548|323478305|FG001|Overall Study|Death|0|||
94461477|NCT01328548|323478304|FG000|Overall Study|Protocol Violation|1|||
94461478|NCT01328548|323478305|FG001|Overall Study|Protocol Violation|0|||
94461479|NCT04852679|323478306|FG000|Main Intervention Period|Withdrawal by Subject|3|||
94461480|NCT04852679|323478306|FG000|Main Intervention Period|Adverse Event|1|||
94461481|NCT04852679|323478306|FG000|Main Intervention Period|Progressive Disease|16|||
94461482|NCT04852679|323478306|FG000|Main Intervention Period|Refused study visit|1|||
94461483|NCT04852679|323478306|FG000|Independent Injection Period|Missed study visit|1|||
94461484|NCT03800836|323478307|FG000|Overall Study|Other|2|||
94461485|NCT03800836|323478308|FG001|Overall Study|Other|1|||
94461486|NCT03800836|323478309|FG002|Overall Study|Other|0|||
94461487|NCT03800836|323478310|FG003|Overall Study|Other|2|||
94461488|NCT03800836|323478311|FG004|Overall Study|Other|0|||
94461489|NCT03800836|323478312|FG005|Overall Study|Other|1|||
94461490|NCT03800836|323478307|FG000|Overall Study|Lost to Follow-up|2|||
94461491|NCT03800836|323478308|FG001|Overall Study|Lost to Follow-up|0|||
94461492|NCT03800836|323478309|FG002|Overall Study|Lost to Follow-up|1|||
94461493|NCT03800836|323478310|FG003|Overall Study|Lost to Follow-up|1|||
94461494|NCT03800836|323478311|FG004|Overall Study|Lost to Follow-up|3|||
94461495|NCT03800836|323478312|FG005|Overall Study|Lost to Follow-up|0|||
94461496|NCT03800836|323478307|FG000|Overall Study|Withdrawal by Subject|1|||
94461497|NCT03800836|323478308|FG001|Overall Study|Withdrawal by Subject|0|||
94461498|NCT03800836|323478309|FG002|Overall Study|Withdrawal by Subject|0|||
94461499|NCT03800836|323478310|FG003|Overall Study|Withdrawal by Subject|0|||
94461500|NCT03800836|323478311|FG004|Overall Study|Withdrawal by Subject|0|||
94461501|NCT03800836|323478312|FG005|Overall Study|Withdrawal by Subject|0|||
94461502|NCT03800836|323478307|FG000|Overall Study|Physician Decision|31|||
94461503|NCT03800836|323478308|FG001|Overall Study|Physician Decision|3|||
94461504|NCT03800836|323478309|FG002|Overall Study|Physician Decision|6|||
94461505|NCT03800836|323478310|FG003|Overall Study|Physician Decision|4|||
94461506|NCT03800836|323478311|FG004|Overall Study|Physician Decision|4|||
94461507|NCT03800836|323478312|FG005|Overall Study|Physician Decision|5|||
94461508|NCT03800836|323478307|FG000|Overall Study|Death|34|||
94630872|NCT00142584|324109832|FG001|Overall Study|Withdrawal by Subject|16|||
94630873|NCT00142584|324109831|FG000|Overall Study|Lost to Follow-up|22|||
94630874|NCT00142584|324109832|FG001|Overall Study|Lost to Follow-up|12|||
94630875|NCT00142584|324109831|FG000|Overall Study|Adverse Event|14|||
94461509|NCT03800836|323478308|FG001|Overall Study|Death|16|||
94461510|NCT03800836|323478309|FG002|Overall Study|Death|5|||
94461511|NCT03800836|323478310|FG003|Overall Study|Death|5|||
94461512|NCT03800836|323478311|FG004|Overall Study|Death|10|||
94461513|NCT03800836|323478312|FG005|Overall Study|Death|0|||
94461514|NCT03800836|323478307|FG000|Overall Study|Symptomatic Deterioration|1|||
94461515|NCT03800836|323478308|FG001|Overall Study|Symptomatic Deterioration|0|||
94461516|NCT03800836|323478309|FG002|Overall Study|Symptomatic Deterioration|1|||
94630876|NCT00142584|324109832|FG001|Overall Study|Adverse Event|5|||
94461517|NCT03800836|323478310|FG003|Overall Study|Symptomatic Deterioration|0|||
94461518|NCT03800836|323478311|FG004|Overall Study|Symptomatic Deterioration|0|||
94630877|NCT00142584|324109831|FG000|Overall Study|Protocol Violation|4|||
94461519|NCT03800836|323478312|FG005|Overall Study|Symptomatic Deterioration|0|||
94461520|NCT01944670|323479511|FG000|Overall Study|Lost to Follow-up|2|||
94461521|NCT02908672|323479514|FG000|Overall Study|Death|112|||
94461522|NCT02908672|323479515|FG001|Overall Study|Death|93|||
94461523|NCT02908672|323479514|FG000|Overall Study|Lost to Follow-up|3|||
94461524|NCT02908672|323479515|FG001|Overall Study|Lost to Follow-up|3|||
94461525|NCT02908672|323479514|FG000|Overall Study|Other|2|||
94461526|NCT02908672|323479515|FG001|Overall Study|Other|0|||
94461527|NCT02908672|323479514|FG000|Overall Study|Protocol Violation|1|||
94461528|NCT02908672|323479515|FG001|Overall Study|Protocol Violation|1|||
94461529|NCT02908672|323479514|FG000|Overall Study|Withdrawal by Subject|13|||
94461530|NCT02908672|323479515|FG001|Overall Study|Withdrawal by Subject|18|||
94461531|NCT02908672|323479514|FG000|Overall Study|Study is ongoing|124|||
94461532|NCT02908672|323479515|FG001|Overall Study|Study is ongoing|141|||
94461533|NCT02908672|323479514|FG000|Overall Study|Discontinued the study during run-in|3|||
94461534|NCT02908672|323479515|FG001|Overall Study|Discontinued the study during run-in|0|||
94461535|NCT05896527|323479521|FG000|Overall Study|Withdrawal by Subject|11|||
94461536|NCT05896527|323479522|FG001|Overall Study|Withdrawal by Subject|10|||
94461537|NCT05896527|323479523|FG002|Overall Study|Withdrawal by Subject|4|||
94461538|NCT05896527|323479524|FG003|Overall Study|Withdrawal by Subject|3|||
94461539|NCT05896527|323479525|FG004|Overall Study|Withdrawal by Subject|2|||
94461540|NCT05896527|323479521|FG000|Overall Study|Lost to Follow-up|0|||
94461541|NCT05896527|323479522|FG001|Overall Study|Lost to Follow-up|2|||
94461542|NCT05896527|323479523|FG002|Overall Study|Lost to Follow-up|2|||
94461543|NCT05896527|323479524|FG003|Overall Study|Lost to Follow-up|2|||
94461544|NCT05896527|323479525|FG004|Overall Study|Lost to Follow-up|1|||
94461545|NCT05896527|323479521|FG000|Overall Study|Significant protocol noncompliance|0|||
94461546|NCT05896527|323479522|FG001|Overall Study|Significant protocol noncompliance|1|||
94461547|NCT05896527|323479523|FG002|Overall Study|Significant protocol noncompliance|0|||
94461548|NCT05896527|323479524|FG003|Overall Study|Significant protocol noncompliance|0|||
94461549|NCT05896527|323479525|FG004|Overall Study|Significant protocol noncompliance|0|||
94675498|NCT01662063|324265417|FG001|Overall Study|Lack of Efficacy|6|||
94675499|NCT01662063|324265418|FG002|Overall Study|Lack of Efficacy|0|||
94675500|NCT01662063|324265416|FG000|Overall Study|Lost to Follow-up|0|||
94675501|NCT01662063|324265417|FG001|Overall Study|Lost to Follow-up|4|||
94461550|NCT05896527|323479521|FG000|Overall Study|Eligibility criteria not met|1|||
94461551|NCT05896527|323479522|FG001|Overall Study|Eligibility criteria not met|0|||
94461552|NCT05896527|323479523|FG002|Overall Study|Eligibility criteria not met|0|||
94461553|NCT05896527|323479524|FG003|Overall Study|Eligibility criteria not met|0|||
94461554|NCT05896527|323479525|FG004|Overall Study|Eligibility criteria not met|0|||
94461555|NCT05896527|323479521|FG000|Overall Study|Sponsor's decision|0|||
94461556|NCT05896527|323479522|FG001|Overall Study|Sponsor's decision|0|||
94461557|NCT05896527|323479523|FG002|Overall Study|Sponsor's decision|0|||
94630878|NCT00142584|324109832|FG001|Overall Study|Protocol Violation|7|||
94630879|NCT00142584|324109831|FG000|Overall Study|Treatment Failure|2|||
94630880|NCT00142584|324109832|FG001|Overall Study|Treatment Failure|0|||
94630881|NCT00558025|324109835|FG000|Overall Study|Adverse Event|1|||
94630882|NCT00558025|324109836|FG001|Overall Study|Adverse Event|1|||
94630883|NCT00558025|324109835|FG000|Overall Study|Withdrawal by Subject|2|||
94630884|NCT00558025|324109836|FG001|Overall Study|Withdrawal by Subject|2|||
94630885|NCT00558025|324109835|FG000|Overall Study|Protocol Violation|1|||
94630886|NCT00558025|324109836|FG001|Overall Study|Protocol Violation|0|||
94630887|NCT01506479|324109837|FG000|Overall Study|Lost to Follow-up|1|||
94630888|NCT01506479|324109838|FG001|Overall Study|Lost to Follow-up|2|||
94630889|NCT01506479|324109839|FG002|Overall Study|Lost to Follow-up|2|||
94630890|NCT01506479|324109837|FG000|Overall Study|Withdrawal by Subject|1|||
94630891|NCT01506479|324109838|FG001|Overall Study|Withdrawal by Subject|2|||
94630892|NCT01506479|324109839|FG002|Overall Study|Withdrawal by Subject|1|||
94630893|NCT01506479|324109837|FG000|Overall Study|Missing assessment|1|||
94630894|NCT01506479|324109838|FG001|Overall Study|Missing assessment|0|||
94630895|NCT01506479|324109839|FG002|Overall Study|Missing assessment|0|||
94675502|NCT01662063|324265418|FG002|Overall Study|Lost to Follow-up|0|||
94675503|NCT01662063|324265416|FG000|Overall Study|Protocol Violation|1|||
94675504|NCT01662063|324265417|FG001|Overall Study|Protocol Violation|0|||
94461558|NCT05896527|323479524|FG003|Overall Study|Sponsor's decision|1|||
94461559|NCT05896527|323479525|FG004|Overall Study|Sponsor's decision|0|||
94461560|NCT05896527|323479521|FG000|Overall Study|Investigator's decision|0|||
94461561|NCT05896527|323479522|FG001|Overall Study|Investigator's decision|1|||
94461562|NCT05896527|323479523|FG002|Overall Study|Investigator's decision|0|||
94461563|NCT05896527|323479524|FG003|Overall Study|Investigator's decision|0|||
94461564|NCT05896527|323479525|FG004|Overall Study|Investigator's decision|0|||
94630896|NCT01506479|324109837|FG000|Overall Study|Adverse Event|0|||
94630897|NCT01506479|324109838|FG001|Overall Study|Adverse Event|1|||
94630898|NCT01506479|324109839|FG002|Overall Study|Adverse Event|0|||
94630899|NCT02205814|324109840|FG000|Overall Study|Lost to Follow-up|0|||
94630900|NCT02205814|324109841|FG001|Overall Study|Lost to Follow-up|0|||
94630901|NCT02205814|324109842|FG002|Overall Study|Lost to Follow-up|0|||
94630902|NCT02205814|324109843|FG003|Overall Study|Lost to Follow-up|1|||
94461565|NCT05896527|323479521|FG000|Overall Study|Pregnancy of his partner|0|||
94461566|NCT05896527|323479522|FG001|Overall Study|Pregnancy of his partner|0|||
94461567|NCT05896527|323479523|FG002|Overall Study|Pregnancy of his partner|0|||
94461568|NCT05896527|323479524|FG003|Overall Study|Pregnancy of his partner|1|||
94461569|NCT05896527|323479525|FG004|Overall Study|Pregnancy of his partner|0|||
94461570|NCT02659514|323479527|FG000|Overall Study|Adverse Event|3|||
94461571|NCT02659514|323479528|FG001|Overall Study|Adverse Event|12|||
94461572|NCT02659514|323479527|FG000|Overall Study|Disease Progression|23|||
94461573|NCT02659514|323479528|FG001|Overall Study|Disease Progression|13|||
94461574|NCT02659514|323479527|FG000|Overall Study|Withdrawal by Subject|0|||
94461575|NCT02659514|323479528|FG001|Overall Study|Withdrawal by Subject|4|||
94461576|NCT02659514|323479527|FG000|Overall Study|Lost to Follow-up|0|||
94461577|NCT02659514|323479528|FG001|Overall Study|Lost to Follow-up|1|||
94461578|NCT02659514|323479527|FG000|Overall Study|Death|6|||
94461579|NCT02659514|323479528|FG001|Overall Study|Death|1|||
94461580|NCT02659514|323479527|FG000|Overall Study|Reason Unspecified|0|||
94461581|NCT02659514|323479528|FG001|Overall Study|Reason Unspecified|3|||
94461582|NCT01661933|323479529|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
94461583|NCT01661933|323479529|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
94461584|NCT01968707|323479530|FG000|Overall Study|Did not meet treatment day baseline|49|||
94461585|NCT01968707|323479531|FG001|Overall Study|Did not meet treatment day baseline|12|||
94461586|NCT01968707|323479532|FG002|Overall Study|Did not meet treatment day baseline|41|||
94461587|NCT01968707|323479533|FG003|Overall Study|Did not meet treatment day baseline|44|||
94461588|NCT01968707|323479534|FG004|Overall Study|Did not meet treatment day baseline|36|||
94461589|NCT01968707|323479535|FG005|Overall Study|Did not meet treatment day baseline|11|||
94461590|NCT01968707|323479536|FG006|Overall Study|Did not meet treatment day baseline|34|||
94461591|NCT01968707|323479537|FG007|Overall Study|Did not meet treatment day baseline|35|||
94461592|NCT01565668|323479543|FG000|Overall Study|Death|2|||
94461593|NCT01565668|323479544|FG001|Overall Study|Death|1|||
94461594|NCT01565668|323479543|FG000|Overall Study|Lack of Efficacy|4|||
94461595|NCT01565668|323479544|FG001|Overall Study|Lack of Efficacy|2|||
94461596|NCT01565668|323479543|FG000|Overall Study|Participant went on Hospice Care|1|||
94461597|NCT01565668|323479544|FG001|Overall Study|Participant went on Hospice Care|0|||
94461598|NCT01565668|323479543|FG000|Overall Study|Adverse Event|6|||
94461599|NCT01565668|323479544|FG001|Overall Study|Adverse Event|1|||
94461600|NCT01565668|323479543|FG000|Overall Study|Randomized, but never received drug|0|||
94461601|NCT01565668|323479544|FG001|Overall Study|Randomized, but never received drug|2|||
94461602|NCT01565668|323479543|FG000|Overall Study|Progressive disease|13|||
94461603|NCT01565668|323479544|FG001|Overall Study|Progressive disease|14|||
94461604|NCT01565668|323479543|FG000|Overall Study|Withdrawal by Subject|1|||
94461605|NCT01565668|323479544|FG001|Overall Study|Withdrawal by Subject|3|||
94461606|NCT01565668|323479543|FG000|Overall Study|HSCT Transplant|11|||
94461607|NCT01565668|323479544|FG001|Overall Study|HSCT Transplant|15|||
94461608|NCT04258254|323479559|FG000|Overall Study|Withdrawal by Subject|0|||
94461609|NCT04258254|323479560|FG001|Overall Study|Withdrawal by Subject|1|||
94461610|NCT04258254|323479561|FG002|Overall Study|Withdrawal by Subject|0|||
94461611|NCT03729570|323479562|FG000|Overall Study|Lost to Follow-up|16|||
94461612|NCT03729570|323479563|FG001|Overall Study|Lost to Follow-up|20|||
94461613|NCT03729570|323479562|FG000|Overall Study|Seroconversion|5|||
94461614|NCT03729570|323479563|FG001|Overall Study|Seroconversion|0|||
94461615|NCT03729570|323479562|FG000|Overall Study|Moved out of the city|1|||
94461616|NCT03729570|323479563|FG001|Overall Study|Moved out of the city|0|||
94461617|NCT03729570|323479562|FG000|Overall Study|Time Conflict|1|||
94630903|NCT02205814|324109840|FG000|Overall Study|Lack of Efficacy|1|||
94461618|NCT03729570|323479563|FG001|Overall Study|Time Conflict|0|||
94461619|NCT03729570|323479562|FG000|Overall Study|Time Commitment|2|||
94461620|NCT03729570|323479563|FG001|Overall Study|Time Commitment|0|||
94461621|NCT03729570|323479562|FG000|Overall Study|Bad Experience|0|||
94461622|NCT03729570|323479563|FG001|Overall Study|Bad Experience|1|||
94461623|NCT03729570|323479562|FG000|Overall Study|No reason provided|2|||
94461624|NCT03729570|323479563|FG001|Overall Study|No reason provided|1|||
94461625|NCT03729570|323479562|FG000|Overall Study|Family Conflict|0|||
94461626|NCT03729570|323479563|FG001|Overall Study|Family Conflict|1|||
94461627|NCT03729570|323479562|FG000|Overall Study|Did not want to continue taking medications|0|||
94461628|NCT03729570|323479563|FG001|Overall Study|Did not want to continue taking medications|1|||
94461629|NCT03729570|323479562|FG000|Overall Study|Found another PrEP provider|1|||
94461630|NCT03729570|323479563|FG001|Overall Study|Found another PrEP provider|0|||
94461631|NCT03729570|323479562|FG000|Overall Study|Did not enjoy being in the control group|0|||
94461632|NCT03729570|323479563|FG001|Overall Study|Did not enjoy being in the control group|1|||
94461633|NCT01701193|323479564|FG000|Overall Study|Withdrawal by Subject|2|||
94461634|NCT01701193|323479565|FG001|Overall Study|Withdrawal by Subject|2|||
94461635|NCT01701193|323479566|FG002|Overall Study|Withdrawal by Subject|1|||
94461636|NCT01701193|323479567|FG003|Overall Study|Withdrawal by Subject|2|||
94461637|NCT01701193|323479564|FG000|Overall Study|Adverse Event|1|||
94461638|NCT01701193|323479565|FG001|Overall Study|Adverse Event|0|||
94461639|NCT01701193|323479566|FG002|Overall Study|Adverse Event|0|||
94461640|NCT01701193|323479567|FG003|Overall Study|Adverse Event|0|||
94675505|NCT01662063|324265418|FG002|Overall Study|Protocol Violation|0|||
94675506|NCT01662063|324265416|FG000|Overall Study|Withdrawal by Subject|2|||
94675507|NCT01662063|324265417|FG001|Overall Study|Withdrawal by Subject|4|||
94675508|NCT01662063|324265418|FG002|Overall Study|Withdrawal by Subject|1|||
94675509|NCT01662063|324265416|FG000|Overall Study|Physician Decision|0|||
94675510|NCT01662063|324265417|FG001|Overall Study|Physician Decision|2|||
94675511|NCT01662063|324265418|FG002|Overall Study|Physician Decision|0|||
94675512|NCT01662063|324265416|FG000|Overall Study|Other|0|||
94675513|NCT01662063|324265417|FG001|Overall Study|Other|1|||
94675514|NCT01662063|324265418|FG002|Overall Study|Other|0|||
94675515|NCT04044456|324265420|FG000|Overall Study|Lost to Follow-up|4|||
94675516|NCT04044456|324265421|FG001|Overall Study|Lost to Follow-up|1|||
94675517|NCT04044456|324265420|FG000|Overall Study|Withdrawal by Subject|1|||
94675518|NCT04044456|324265421|FG001|Overall Study|Withdrawal by Subject|0|||
94675519|NCT01972529|324265422|FG000|Overall Study|Adverse Event|0|||
94675520|NCT01972529|324265423|FG001|Overall Study|Adverse Event|1|||
94675521|NCT01972529|324265424|FG002|Overall Study|Adverse Event|0|||
94675522|NCT01972529|324265425|FG003|Overall Study|Adverse Event|0|||
94675523|NCT01972529|324265422|FG000|Overall Study|Lost to Follow-up|1|||
94675524|NCT01972529|324265423|FG001|Overall Study|Lost to Follow-up|0|||
94675525|NCT01972529|324265424|FG002|Overall Study|Lost to Follow-up|0|||
94675526|NCT01972529|324265425|FG003|Overall Study|Lost to Follow-up|0|||
94675527|NCT01972529|324265422|FG000|Overall Study|Participant Choice|0|||
94675528|NCT01972529|324265423|FG001|Overall Study|Participant Choice|1|||
94675529|NCT01972529|324265424|FG002|Overall Study|Participant Choice|0|||
94675530|NCT01972529|324265425|FG003|Overall Study|Participant Choice|0|||
94675531|NCT01972529|324265422|FG000|Overall Study|Withdrawl of Consent|1|||
94675532|NCT01972529|324265423|FG001|Overall Study|Withdrawl of Consent|2|||
94675533|NCT01972529|324265424|FG002|Overall Study|Withdrawl of Consent|0|||
94675534|NCT01972529|324265425|FG003|Overall Study|Withdrawl of Consent|1|||
94675535|NCT01972529|324265422|FG000|Overall Study|Other|0|||
94675536|NCT01972529|324265423|FG001|Overall Study|Other|0|||
94675537|NCT01972529|324265424|FG002|Overall Study|Other|0|||
94675538|NCT01972529|324265425|FG003|Overall Study|Other|2|||
94461641|NCT02062944|323479568|FG000|Overall Study|Lost to Follow-up|1|||
94461642|NCT02062944|323479568|FG000|Overall Study|New hemotological disorder identified|1|||
94461643|NCT02062944|323479568|FG000|Overall Study|Uncontrolled Hypertension|1|||
94461644|NCT02062944|323479568|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
94461645|NCT01459718|323479572|FG000|Overall Study|Physician Decision|1|||
94461646|NCT01459718|323479572|FG000|Overall Study|Lost to Follow-up|1|||
94461647|NCT01459718|323479572|FG000|Overall Study|Adverse Event|1|||
94461648|NCT01472757|323479573|FG000|Overall Study|Withdrawal by Subject|1|||
94461649|NCT01472757|323479574|FG001|Overall Study|Withdrawal by Subject|2|||
94461650|NCT01472757|323479575|FG002|Overall Study|Withdrawal by Subject|2|||
94461651|NCT01472757|323479576|FG003|Overall Study|Withdrawal by Subject|0|||
94461652|NCT01472757|323479573|FG000|Overall Study|Asthma exacerbation|4|||
94461653|NCT01472757|323479574|FG001|Overall Study|Asthma exacerbation|1|||
94461654|NCT01472757|323479575|FG002|Overall Study|Asthma exacerbation|2|||
94461655|NCT01472757|323479576|FG003|Overall Study|Asthma exacerbation|1|||
94461656|NCT01472757|323479573|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
94461657|NCT01472757|323479574|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
94461658|NCT01472757|323479575|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
94461659|NCT01472757|323479576|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
94461660|NCT01472757|323479573|FG000|Overall Study|Protocol Violation|3|||
94461661|NCT01472757|323479574|FG001|Overall Study|Protocol Violation|2|||
94461662|NCT01472757|323479575|FG002|Overall Study|Protocol Violation|4|||
94675539|NCT01972529|324265422|FG000|Overall Study|Not treated|0|||
94675540|NCT01972529|324265423|FG001|Overall Study|Not treated|1|||
94675541|NCT01972529|324265424|FG002|Overall Study|Not treated|2|||
94675542|NCT01972529|324265425|FG003|Overall Study|Not treated|1|||
94675543|NCT02436330|324265428|FG000|Cohort 1|Lost to Follow-up|5|||
94675544|NCT02436330|324265429|FG001|Cohort 1|Lost to Follow-up|2|||
94675545|NCT02436330|324265428|FG000|Cohort 1|Withdrawal by Subject|0|||
94675546|NCT02436330|324265429|FG001|Cohort 1|Withdrawal by Subject|1|||
94461663|NCT01472757|323479576|FG003|Overall Study|Protocol Violation|4|||
94461664|NCT01472757|323479573|FG000|Overall Study|Other reasons|1|||
94461665|NCT01472757|323479574|FG001|Overall Study|Other reasons|0|||
94461666|NCT01472757|323479575|FG002|Overall Study|Other reasons|2|||
94461667|NCT01472757|323479576|FG003|Overall Study|Other reasons|2|||
94461668|NCT00985959|323479579|FG000|Overall Study|Adverse Event|0|||
94461669|NCT00985959|323479580|FG001|Overall Study|Adverse Event|0|||
94675547|NCT02436330|324265428|FG000|Cohort 2|Lost to Follow-up|2|||
94675548|NCT02436330|324265429|FG001|Cohort 2|Lost to Follow-up|0|||
94461670|NCT00985959|323479581|FG002|Overall Study|Adverse Event|19|||
94675549|NCT02436330|324265428|FG000|Cohort 2|Withdrawal by Subject|2|||
94675550|NCT02436330|324265429|FG001|Cohort 2|Withdrawal by Subject|3|||
94675551|NCT02436330|324265428|FG000|Cohort 3|Lost to Follow-up|1|||
94675552|NCT02436330|324265429|FG001|Cohort 3|Lost to Follow-up|0|||
94675553|NCT02436330|324265428|FG000|Cohort 3|Withdrawal by Subject|4|||
94675554|NCT02436330|324265429|FG001|Cohort 3|Withdrawal by Subject|0|||
94675555|NCT02436330|324265428|FG000|Cohort 4|Lost to Follow-up|1|||
94675556|NCT02436330|324265429|FG001|Cohort 4|Lost to Follow-up|0|||
94675557|NCT02436330|324265428|FG000|Cohort 4|Withdrawal by Subject|1|||
94675558|NCT02436330|324265429|FG001|Cohort 4|Withdrawal by Subject|0|||
94675559|NCT02436330|324265428|FG000|Cohort 5|Lost to Follow-up|3|||
94675560|NCT02436330|324265429|FG001|Cohort 5|Lost to Follow-up|2|||
94675561|NCT02436330|324265428|FG000|Cohort 5|Withdrawal by Subject|3|||
94675562|NCT02436330|324265429|FG001|Cohort 5|Withdrawal by Subject|2|||
94675563|NCT02436330|324265428|FG000|Cohort 6|Lost to Follow-up|2|||
94675564|NCT02436330|324265429|FG001|Cohort 6|Lost to Follow-up|0|||
94675565|NCT02436330|324265428|FG000|Cohort 6|Withdrawal by Subject|1|||
94675566|NCT02436330|324265429|FG001|Cohort 6|Withdrawal by Subject|1|||
94675567|NCT04721925|324265430|FG000|2-Month Assessment|Lost to Follow-up|5|||
94675568|NCT04721925|324265431|FG001|2-Month Assessment|Lost to Follow-up|3|||
94675569|NCT04721925|324265430|FG000|4-Month Assessment|Lost to Follow-up|3|||
94675570|NCT04721925|324265431|FG001|4-Month Assessment|Lost to Follow-up|6|||
94675571|NCT01113502|324265435|FG000|Overall Study|Withdrawal by Subject|1|||
94675572|NCT01113502|324265436|FG001|Overall Study|Withdrawal by Subject|0|||
94675573|NCT01113502|324265437|FG002|Overall Study|Withdrawal by Subject|1|||
94675574|NCT01113502|324265438|FG003|Overall Study|Withdrawal by Subject|1|||
94675575|NCT01113502|324265439|FG004|Overall Study|Withdrawal by Subject|0|||
94675576|NCT01113502|324265435|FG000|Overall Study|Adverse Event|0|||
94675577|NCT01113502|324265436|FG001|Overall Study|Adverse Event|0|||
94675578|NCT01113502|324265437|FG002|Overall Study|Adverse Event|3|||
94675579|NCT01113502|324265438|FG003|Overall Study|Adverse Event|2|||
94675580|NCT01113502|324265439|FG004|Overall Study|Adverse Event|0|||
94361624|NCT04637815|323107353|FG000|Overall Study|Lost to Follow-up|5|||
94361625|NCT04637815|323107354|FG001|Overall Study|Lost to Follow-up|2|||
94361626|NCT00943826|323107356|FG000|Concurrent Phase|Adverse Event|50|||
94361627|NCT00943826|323107357|FG001|Concurrent Phase|Adverse Event|27|||
94630904|NCT02205814|324109841|FG001|Overall Study|Lack of Efficacy|0|||
94630905|NCT02205814|324109842|FG002|Overall Study|Lack of Efficacy|1|||
94630906|NCT02205814|324109843|FG003|Overall Study|Lack of Efficacy|1|||
94630907|NCT02205814|324109840|FG000|Overall Study|Physician Decision|0|||
94630908|NCT02205814|324109841|FG001|Overall Study|Physician Decision|0|||
94630909|NCT02205814|324109842|FG002|Overall Study|Physician Decision|1|||
94630910|NCT02205814|324109843|FG003|Overall Study|Physician Decision|0|||
94630911|NCT02205814|324109840|FG000|Overall Study|Protocol Violation|1|||
94630912|NCT02205814|324109841|FG001|Overall Study|Protocol Violation|0|||
94630913|NCT02205814|324109842|FG002|Overall Study|Protocol Violation|0|||
94630914|NCT02205814|324109843|FG003|Overall Study|Protocol Violation|1|||
94361628|NCT00943826|323107356|FG000|Concurrent Phase|Withdrew consent|3|||
94630915|NCT02205814|324109840|FG000|Overall Study|Withdrawal by Subject|0|||
94675581|NCT00118716|324265441|FG000|Overall Study|Adverse Event|2|||
94461671|NCT00985959|323479579|FG000|Overall Study|Withdrawal by Subject|0|||
94361629|NCT00943826|323107357|FG001|Concurrent Phase|Withdrew consent|7|||
94361630|NCT00943826|323107356|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
94361631|NCT00943826|323107357|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
94361632|NCT00943826|323107356|FG000|Concurrent Phase|Administrative reasons|2|||
94361633|NCT00943826|323107357|FG001|Concurrent Phase|Administrative reasons|1|||
94361634|NCT00943826|323107356|FG000|Concurrent Phase|Protocol Violation|1|||
94361635|NCT00943826|323107357|FG001|Concurrent Phase|Protocol Violation|0|||
94361636|NCT00943826|323107356|FG000|Maintenance Phase|Adverse Event|31|||
94361637|NCT00943826|323107357|FG001|Maintenance Phase|Adverse Event|30|||
94361638|NCT00943826|323107356|FG000|Maintenance Phase|Withdrew consent|2|||
94361639|NCT00943826|323107357|FG001|Maintenance Phase|Withdrew consent|4|||
94361640|NCT00943826|323107356|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
94361641|NCT00943826|323107357|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
94361642|NCT00943826|323107356|FG000|Maintenance Phase|Administrative reasons|4|||
94361643|NCT00943826|323107357|FG001|Maintenance Phase|Administrative reasons|1|||
94361644|NCT00943826|323107356|FG000|Maintenance Phase|Failure to return|0|||
94361645|NCT00943826|323107357|FG001|Maintenance Phase|Failure to return|1|||
94361646|NCT00943826|323107356|FG000|Monotherapy Phase|Adverse Event|42|||
94361647|NCT00943826|323107357|FG001|Monotherapy Phase|Adverse Event|5|||
94361648|NCT00943826|323107356|FG000|Monotherapy Phase|Administrative reasons|11|||
94361649|NCT00943826|323107357|FG001|Monotherapy Phase|Administrative reasons|5|||
94361650|NCT00943826|323107356|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
94361651|NCT00943826|323107357|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
94361652|NCT00943826|323107356|FG000|Monotherapy Phase|Withdrew Consent|2|||
94361653|NCT00943826|323107357|FG001|Monotherapy Phase|Withdrew Consent|3|||
94361654|NCT00943826|323107356|FG000|Monotherapy Phase|Failure to return|2|||
94361655|NCT00943826|323107357|FG001|Monotherapy Phase|Failure to return|1|||
94361656|NCT00943826|323107356|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
94361657|NCT00943826|323107357|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
94361658|NCT00943826|323107356|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
94361659|NCT00943826|323107357|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
94361660|NCT00943826|323107356|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
94361661|NCT00943826|323107357|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
94361662|NCT00943826|323107356|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
94361663|NCT00943826|323107357|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
94361664|NCT00491322|323107358|FG000|Overall Study|Protocol Violation|1|||
94361665|NCT00491322|323107359|FG001|Overall Study|Protocol Violation|0|||
94361666|NCT00491322|323107358|FG000|Overall Study|Pregnancy|0|||
94361667|NCT00491322|323107359|FG001|Overall Study|Pregnancy|1|||
94361668|NCT02886494|323107361|FG000|Overall Study|Adverse Event|1|||
94361669|NCT02886494|323107362|FG001|Overall Study|Adverse Event|0|||
94361670|NCT02886494|323107361|FG000|Overall Study|Withdrawal by Subject|12|||
94361671|NCT02886494|323107362|FG001|Overall Study|Withdrawal by Subject|3|||
94361672|NCT02886494|323107361|FG000|Overall Study|Protocol Violation|4|||
94361673|NCT02886494|323107362|FG001|Overall Study|Protocol Violation|1|||
94361674|NCT00625846|323107363|FG000|Overall Study|Withdrawal by Subject|2|||
94361675|NCT00625846|323107364|FG001|Overall Study|Withdrawal by Subject|0|||
94361676|NCT00625846|323107365|FG002|Overall Study|Withdrawal by Subject|1|||
94361677|NCT00625846|323107366|FG003|Overall Study|Withdrawal by Subject|2|||
94361678|NCT00877799|323107369|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
94361679|NCT00877799|323107370|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
94361680|NCT00877799|323107371|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
94361681|NCT00877799|323107372|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
94361682|NCT00877799|323107373|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
94361683|NCT00877799|323107369|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
94361684|NCT00877799|323107370|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
94361685|NCT00877799|323107371|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
94361686|NCT00877799|323107372|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
94361687|NCT00877799|323107373|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
94361688|NCT00877799|323107369|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
94361689|NCT00877799|323107370|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
94361690|NCT00877799|323107371|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
94361691|NCT00877799|323107372|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
94361692|NCT00877799|323107373|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
94361693|NCT00877799|323107369|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
94361694|NCT00877799|323107370|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
94361695|NCT00877799|323107371|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
94461672|NCT00985959|323479580|FG001|Overall Study|Withdrawal by Subject|0|||
94461673|NCT00985959|323479581|FG002|Overall Study|Withdrawal by Subject|8|||
94461674|NCT00985959|323479579|FG000|Overall Study|Progressive disease|1|||
94630916|NCT02205814|324109841|FG001|Overall Study|Withdrawal by Subject|1|||
94630917|NCT02205814|324109842|FG002|Overall Study|Withdrawal by Subject|2|||
94630918|NCT02205814|324109843|FG003|Overall Study|Withdrawal by Subject|1|||
94258411|NCT00712673|322740468|FG002|Overall Study|Familial and Personal Reasons|5|||
94258412|NCT00712673|322740469|FG003|Overall Study|Familial and Personal Reasons|2|||
94258413|NCT00712673|322740466|FG000|Overall Study|Investigator's Decision|1|||
94258414|NCT00712673|322740467|FG001|Overall Study|Investigator's Decision|0|||
94258415|NCT00712673|322740468|FG002|Overall Study|Investigator's Decision|0|||
94258416|NCT00712673|322740469|FG003|Overall Study|Investigator's Decision|0|||
94258417|NCT00712673|322740466|FG000|Overall Study|Protocol Violation|0|||
94258418|NCT00712673|322740467|FG001|Overall Study|Protocol Violation|0|||
94258419|NCT00712673|322740468|FG002|Overall Study|Protocol Violation|2|||
94258420|NCT00712673|322740469|FG003|Overall Study|Protocol Violation|0|||
94258421|NCT02768870|322740470|FG000|Overall Study|Death|1|||
94258422|NCT02768870|322740470|FG000|Overall Study|Reoperation|6|||
94258423|NCT02768870|322740470|FG000|Overall Study|Lost to Follow-up|1|||
94258424|NCT02768870|322740470|FG000|Overall Study|Exit|4|||
94258425|NCT02963610|322740471|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
94258426|NCT04634825|322740472|FG000|Overall Study|Death|10|||
94258427|NCT04634825|322740473|FG001|Overall Study|Death|3|||
94258428|NCT04634825|322740472|FG000|Overall Study|Lost to Follow-up|1|||
94258429|NCT04634825|322740473|FG001|Overall Study|Lost to Follow-up|0|||
94258430|NCT04634825|322740472|FG000|Overall Study|Study terminated by sponsor|35|||
94258431|NCT04634825|322740473|FG001|Overall Study|Study terminated by sponsor|11|||
94258432|NCT04634825|322740472|FG000|Overall Study|Withdrawal by Subject|2|||
94258433|NCT04634825|322740473|FG001|Overall Study|Withdrawal by Subject|0|||
94258434|NCT01100034|322740476|FG000|Overall Study|Lost to Follow-up|11|||
94258435|NCT01100034|322740476|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
94361696|NCT00877799|323107372|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
94361697|NCT00877799|323107373|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
94361698|NCT00877799|323107369|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
94361699|NCT00877799|323107370|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
94361700|NCT00877799|323107371|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
94361701|NCT00877799|323107372|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
94361702|NCT00877799|323107373|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
94361703|NCT04512976|323107374|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
94361704|NCT04512976|323107375|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
94361705|NCT04512976|323107376|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
94361706|NCT04512976|323107377|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
94361707|NCT04512976|323107378|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
94361708|NCT04512976|323107379|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
94361709|NCT00538473|323107380|FG000|Overall Study|Adverse Event|1|||
94361710|NCT00538473|323107381|FG001|Overall Study|Adverse Event|0|||
94361711|NCT00806416|323107387|FG000|Period 1 - Part I|Adverse Event|0|||
94361712|NCT00806416|323107388|FG001|Period 1 - Part I|Adverse Event|1|||
94361713|NCT00806416|323107389|FG002|Period 1 - Part I|Adverse Event|0|||
94361714|NCT00806416|323107390|FG003|Period 1 - Part I|Adverse Event|0|||
94361715|NCT00806416|323107387|FG000|Period 1 - Part I|Lost to Follow-up|0|||
94361716|NCT00806416|323107388|FG001|Period 1 - Part I|Lost to Follow-up|2|||
94361717|NCT00806416|323107389|FG002|Period 1 - Part I|Lost to Follow-up|0|||
94361718|NCT00806416|323107390|FG003|Period 1 - Part I|Lost to Follow-up|0|||
94361719|NCT00806416|323107387|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
94361720|NCT00806416|323107388|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
94361721|NCT00806416|323107389|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
94361722|NCT00806416|323107390|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
94361723|NCT00806416|323107387|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
94361724|NCT00806416|323107388|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
94361725|NCT00806416|323107389|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
94361726|NCT00806416|323107390|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
94361727|NCT00244881|323107393|FG000|Overall Study|Withdrawal by Subject|3|||
94361728|NCT03359473|323107394|FG000|Overall Study|Adverse Event|0|||
94361729|NCT03359473|323107395|FG001|Overall Study|Adverse Event|2|||
94361730|NCT03359473|323107396|FG002|Overall Study|Adverse Event|5|||
94361731|NCT03359473|323107397|FG003|Overall Study|Adverse Event|3|||
94361732|NCT03359473|323107394|FG000|Overall Study|Lost to Follow-up|0|||
94361733|NCT03359473|323107395|FG001|Overall Study|Lost to Follow-up|1|||
94361734|NCT03359473|323107396|FG002|Overall Study|Lost to Follow-up|0|||
94361735|NCT03359473|323107397|FG003|Overall Study|Lost to Follow-up|0|||
94258436|NCT01100034|322740476|FG000|Overall Study|Withdrawal by Subject|4|||
94258437|NCT01100034|322740476|FG000|Overall Study|Sponsor decision|21|||
94258438|NCT01100034|322740476|FG000|Overall Study|Participated in another clinical trial|1|||
94258439|NCT01100034|322740476|FG000|Overall Study|Participants moved to another hospital|4|||
94258440|NCT01100034|322740476|FG000|Overall Study|Site closed due to non-responsiveness|1|||
94361736|NCT03359473|323107394|FG000|Overall Study|Physician Decision|0|||
94361737|NCT03359473|323107395|FG001|Overall Study|Physician Decision|1|||
94361738|NCT03359473|323107396|FG002|Overall Study|Physician Decision|0|||
94361739|NCT03359473|323107397|FG003|Overall Study|Physician Decision|1|||
94361740|NCT03359473|323107394|FG000|Overall Study|Withdrawal by Subject|1|||
94361741|NCT03359473|323107395|FG001|Overall Study|Withdrawal by Subject|2|||
94361742|NCT03359473|323107396|FG002|Overall Study|Withdrawal by Subject|1|||
94361743|NCT03359473|323107397|FG003|Overall Study|Withdrawal by Subject|0|||
94361744|NCT03359473|323107394|FG000|Overall Study|Protocol-defined stopping criteria|1|||
94361745|NCT03359473|323107395|FG001|Overall Study|Protocol-defined stopping criteria|0|||
94361746|NCT03359473|323107396|FG002|Overall Study|Protocol-defined stopping criteria|0|||
94361747|NCT03359473|323107397|FG003|Overall Study|Protocol-defined stopping criteria|1|||
94361748|NCT01265875|323107398|FG000|Overall Study|Uncooperative/unreliable|1|||
94361749|NCT02325739|323107399|FG000|Phase I Part|Adverse Event|1|||
94361750|NCT02325739|323107400|FG001|Phase I Part|Adverse Event|0|||
94361751|NCT02325739|323107401|FG002|Phase I Part|Adverse Event|1|||
94361752|NCT02325739|323107402|FG003|Phase I Part|Adverse Event|2|||
94361753|NCT02325739|323107403|FG004|Phase I Part|Adverse Event|3|||
94361754|NCT02325739|323107404|FG005|Phase I Part|Adverse Event|1|||
94361755|NCT02325739|323107405|FG006|Phase I Part|Adverse Event|0|||
94361756|NCT02325739|323107406|FG007|Phase I Part|Adverse Event|2|||
94361757|NCT02325739|323107407|FG008|Phase I Part|Adverse Event|0|||
94361758|NCT02325739|323107408|FG009|Phase I Part|Adverse Event|0|||
94361759|NCT02325739|323107409|FG010|Phase I Part|Adverse Event|0|||
94361760|NCT02325739|323107399|FG000|Phase I Part|Progressive disease|9|||
94361761|NCT02325739|323107400|FG001|Phase I Part|Progressive disease|6|||
94361762|NCT02325739|323107401|FG002|Phase I Part|Progressive disease|3|||
94361763|NCT02325739|323107402|FG003|Phase I Part|Progressive disease|23|||
94361764|NCT02325739|323107403|FG004|Phase I Part|Progressive disease|14|||
94361765|NCT02325739|323107404|FG005|Phase I Part|Progressive disease|6|||
94361766|NCT02325739|323107405|FG006|Phase I Part|Progressive disease|6|||
94361767|NCT02325739|323107406|FG007|Phase I Part|Progressive disease|3|||
94361768|NCT02325739|323107407|FG008|Phase I Part|Progressive disease|0|||
94361769|NCT02325739|323107408|FG009|Phase I Part|Progressive disease|0|||
94361770|NCT02325739|323107409|FG010|Phase I Part|Progressive disease|0|||
94361771|NCT02325739|323107399|FG000|Phase I Part|Subject/guardian decision|1|||
94361772|NCT02325739|323107400|FG001|Phase I Part|Subject/guardian decision|0|||
94361773|NCT02325739|323107401|FG002|Phase I Part|Subject/guardian decision|1|||
94361774|NCT02325739|323107402|FG003|Phase I Part|Subject/guardian decision|1|||
94361775|NCT02325739|323107403|FG004|Phase I Part|Subject/guardian decision|0|||
94361776|NCT02325739|323107404|FG005|Phase I Part|Subject/guardian decision|0|||
94361777|NCT02325739|323107405|FG006|Phase I Part|Subject/guardian decision|0|||
94361778|NCT02325739|323107406|FG007|Phase I Part|Subject/guardian decision|1|||
94361779|NCT02325739|323107407|FG008|Phase I Part|Subject/guardian decision|0|||
94361780|NCT02325739|323107408|FG009|Phase I Part|Subject/guardian decision|0|||
94361781|NCT02325739|323107409|FG010|Phase I Part|Subject/guardian decision|0|||
94361782|NCT02325739|323107399|FG000|Phase I Part|Death|0|||
94361783|NCT02325739|323107400|FG001|Phase I Part|Death|0|||
94361784|NCT02325739|323107401|FG002|Phase I Part|Death|0|||
94630919|NCT02205814|324109840|FG000|Overall Study|not compliant with study procedures|0|||
94630920|NCT02205814|324109841|FG001|Overall Study|not compliant with study procedures|0|||
94630921|NCT02205814|324109842|FG002|Overall Study|not compliant with study procedures|1|||
94630922|NCT02205814|324109843|FG003|Overall Study|not compliant with study procedures|0|||
94630923|NCT00726661|324109846|FG000|Overall Study|Lost to Follow-up|36|||
94630924|NCT00726661|324109847|FG001|Overall Study|Lost to Follow-up|11|||
94630925|NCT00726661|324109846|FG000|Overall Study|Withdrawal by Subject|17|||
94675582|NCT00118716|324265442|FG001|Overall Study|Adverse Event|7|||
94361785|NCT02325739|323107402|FG003|Phase I Part|Death|0|||
94361786|NCT02325739|323107403|FG004|Phase I Part|Death|2|||
94361787|NCT02325739|323107404|FG005|Phase I Part|Death|0|||
94361788|NCT02325739|323107405|FG006|Phase I Part|Death|0|||
94361789|NCT02325739|323107406|FG007|Phase I Part|Death|0|||
94630926|NCT00726661|324109847|FG001|Overall Study|Withdrawal by Subject|13|||
94630927|NCT00726661|324109846|FG000|Overall Study|Trial terminated by sponsor|214|||
94630928|NCT00726661|324109847|FG001|Overall Study|Trial terminated by sponsor|187|||
94675583|NCT00118716|324265441|FG000|Overall Study|Protocol Violation|5|||
94675584|NCT00118716|324265442|FG001|Overall Study|Protocol Violation|4|||
94361790|NCT02325739|323107407|FG008|Phase I Part|Death|0|||
94461675|NCT00985959|323479580|FG001|Overall Study|Progressive disease|2|||
94675585|NCT00118716|324265441|FG000|Overall Study|Withdrawal by Subject|0|||
94630929|NCT00726661|324109846|FG000|Overall Study|Death|475|||
94361791|NCT02325739|323107408|FG009|Phase I Part|Death|0|||
94361792|NCT02325739|323107409|FG010|Phase I Part|Death|0|||
94361793|NCT02325739|323107399|FG000|Phase II Part|Adverse Event|0|||
94361794|NCT02325739|323107400|FG001|Phase II Part|Adverse Event|0|||
94361795|NCT02325739|323107401|FG002|Phase II Part|Adverse Event|0|||
94361796|NCT02325739|323107402|FG003|Phase II Part|Adverse Event|0|||
94361797|NCT02325739|323107403|FG004|Phase II Part|Adverse Event|0|||
94361798|NCT02325739|323107404|FG005|Phase II Part|Adverse Event|0|||
94630930|NCT00726661|324109847|FG001|Overall Study|Death|159|||
94630931|NCT00726661|324109846|FG000|Overall Study|Physician Decision|25|||
94630932|NCT00726661|324109847|FG001|Overall Study|Physician Decision|13|||
94630933|NCT00726661|324109846|FG000|Overall Study|Other|47|||
94630934|NCT00726661|324109847|FG001|Overall Study|Other|35|||
94630935|NCT02659631|324109850|FG000|Overall Study|Lost to Follow-up|0|||
94630936|NCT02659631|324109851|FG001|Overall Study|Lost to Follow-up|0|||
94630937|NCT02659631|324109852|FG002|Overall Study|Lost to Follow-up|2|||
94630938|NCT02659631|324109853|FG003|Overall Study|Lost to Follow-up|0|||
94630939|NCT02659631|324109854|FG004|Overall Study|Lost to Follow-up|0|||
94630940|NCT02659631|324109855|FG005|Overall Study|Lost to Follow-up|1|||
94630941|NCT02659631|324109856|FG006|Overall Study|Lost to Follow-up|0|||
94630942|NCT02659631|324109857|FG007|Overall Study|Lost to Follow-up|0|||
94630943|NCT02659631|324109858|FG008|Overall Study|Lost to Follow-up|0|||
94630944|NCT02659631|324109859|FG009|Overall Study|Lost to Follow-up|0|||
94630945|NCT02659631|324109850|FG000|Overall Study|Withdrawal prior to treatment|0|||
94630946|NCT02659631|324109851|FG001|Overall Study|Withdrawal prior to treatment|0|||
94630947|NCT02659631|324109852|FG002|Overall Study|Withdrawal prior to treatment|0|||
94630948|NCT02659631|324109853|FG003|Overall Study|Withdrawal prior to treatment|0|||
94630949|NCT02659631|324109854|FG004|Overall Study|Withdrawal prior to treatment|1|||
94630950|NCT02659631|324109855|FG005|Overall Study|Withdrawal prior to treatment|0|||
94630951|NCT02659631|324109856|FG006|Overall Study|Withdrawal prior to treatment|0|||
94630952|NCT02659631|324109857|FG007|Overall Study|Withdrawal prior to treatment|0|||
94630953|NCT02659631|324109858|FG008|Overall Study|Withdrawal prior to treatment|0|||
94630954|NCT02659631|324109859|FG009|Overall Study|Withdrawal prior to treatment|0|||
94630955|NCT02659631|324109850|FG000|Overall Study|Participant refused further follow-up|0|||
94630956|NCT02659631|324109851|FG001|Overall Study|Participant refused further follow-up|0|||
94630957|NCT02659631|324109852|FG002|Overall Study|Participant refused further follow-up|0|||
94630958|NCT02659631|324109853|FG003|Overall Study|Participant refused further follow-up|1|||
94630959|NCT02659631|324109854|FG004|Overall Study|Participant refused further follow-up|0|||
94630960|NCT02659631|324109855|FG005|Overall Study|Participant refused further follow-up|0|||
94630961|NCT02659631|324109856|FG006|Overall Study|Participant refused further follow-up|0|||
94630962|NCT02659631|324109857|FG007|Overall Study|Participant refused further follow-up|0|||
94630963|NCT02659631|324109858|FG008|Overall Study|Participant refused further follow-up|1|||
94630964|NCT02659631|324109859|FG009|Overall Study|Participant refused further follow-up|0|||
94630965|NCT02659631|324109850|FG000|Overall Study|Death (follow-up phase)|1|||
94630966|NCT02659631|324109851|FG001|Overall Study|Death (follow-up phase)|2|||
94630967|NCT02659631|324109852|FG002|Overall Study|Death (follow-up phase)|1|||
94630968|NCT02659631|324109853|FG003|Overall Study|Death (follow-up phase)|1|||
94630969|NCT02659631|324109854|FG004|Overall Study|Death (follow-up phase)|3|||
94630970|NCT02659631|324109855|FG005|Overall Study|Death (follow-up phase)|2|||
94630971|NCT02659631|324109856|FG006|Overall Study|Death (follow-up phase)|0|||
94630972|NCT02659631|324109857|FG007|Overall Study|Death (follow-up phase)|3|||
94675586|NCT00118716|324265442|FG001|Overall Study|Withdrawal by Subject|1|||
94361799|NCT02325739|323107405|FG006|Phase II Part|Adverse Event|0|||
94361800|NCT02325739|323107406|FG007|Phase II Part|Adverse Event|0|||
94361801|NCT02325739|323107407|FG008|Phase II Part|Adverse Event|4|||
94630973|NCT02659631|324109858|FG008|Overall Study|Death (follow-up phase)|1|||
94361802|NCT02325739|323107408|FG009|Phase II Part|Adverse Event|5|||
94630974|NCT02659631|324109859|FG009|Overall Study|Death (follow-up phase)|0|||
94630975|NCT02659631|324109850|FG000|Overall Study|Death (treatment phase)|0|||
94630976|NCT02659631|324109851|FG001|Overall Study|Death (treatment phase)|0|||
94630977|NCT02659631|324109852|FG002|Overall Study|Death (treatment phase)|0|||
94630978|NCT02659631|324109853|FG003|Overall Study|Death (treatment phase)|0|||
94630979|NCT02659631|324109854|FG004|Overall Study|Death (treatment phase)|1|||
94675587|NCT00118716|324265441|FG000|Overall Study|Exacerbation|2|||
94361803|NCT02325739|323107409|FG010|Phase II Part|Adverse Event|1|||
94361804|NCT02325739|323107399|FG000|Phase II Part|Physician Decision|0|||
94361805|NCT02325739|323107400|FG001|Phase II Part|Physician Decision|0|||
94361806|NCT02325739|323107401|FG002|Phase II Part|Physician Decision|0|||
94361807|NCT02325739|323107402|FG003|Phase II Part|Physician Decision|0|||
94361808|NCT02325739|323107403|FG004|Phase II Part|Physician Decision|0|||
94361809|NCT02325739|323107404|FG005|Phase II Part|Physician Decision|0|||
94361810|NCT02325739|323107405|FG006|Phase II Part|Physician Decision|0|||
94361811|NCT02325739|323107406|FG007|Phase II Part|Physician Decision|0|||
94361812|NCT02325739|323107407|FG008|Phase II Part|Physician Decision|0|||
94361813|NCT02325739|323107408|FG009|Phase II Part|Physician Decision|1|||
94361814|NCT02325739|323107409|FG010|Phase II Part|Physician Decision|0|||
94361815|NCT02325739|323107399|FG000|Phase II Part|Progressive disease|0|||
94630980|NCT02659631|324109855|FG005|Overall Study|Death (treatment phase)|0|||
94630981|NCT02659631|324109856|FG006|Overall Study|Death (treatment phase)|1|||
94361816|NCT02325739|323107400|FG001|Phase II Part|Progressive disease|0|||
94361817|NCT02325739|323107401|FG002|Phase II Part|Progressive disease|0|||
94361818|NCT02325739|323107402|FG003|Phase II Part|Progressive disease|0|||
94361819|NCT02325739|323107403|FG004|Phase II Part|Progressive disease|0|||
94361820|NCT02325739|323107404|FG005|Phase II Part|Progressive disease|0|||
94361821|NCT02325739|323107405|FG006|Phase II Part|Progressive disease|0|||
94361822|NCT02325739|323107406|FG007|Phase II Part|Progressive disease|0|||
94361823|NCT02325739|323107407|FG008|Phase II Part|Progressive disease|22|||
94361824|NCT02325739|323107408|FG009|Phase II Part|Progressive disease|29|||
94361825|NCT02325739|323107409|FG010|Phase II Part|Progressive disease|18|||
94361826|NCT02325739|323107399|FG000|Phase II Part|Subject/guardian decision|0|||
94361827|NCT02325739|323107400|FG001|Phase II Part|Subject/guardian decision|0|||
94361828|NCT02325739|323107401|FG002|Phase II Part|Subject/guardian decision|0|||
94361829|NCT02325739|323107402|FG003|Phase II Part|Subject/guardian decision|0|||
94361830|NCT02325739|323107403|FG004|Phase II Part|Subject/guardian decision|0|||
94361831|NCT02325739|323107404|FG005|Phase II Part|Subject/guardian decision|0|||
94361832|NCT02325739|323107405|FG006|Phase II Part|Subject/guardian decision|0|||
94361833|NCT02325739|323107406|FG007|Phase II Part|Subject/guardian decision|0|||
94361834|NCT02325739|323107407|FG008|Phase II Part|Subject/guardian decision|4|||
94361835|NCT02325739|323107408|FG009|Phase II Part|Subject/guardian decision|1|||
94361836|NCT02325739|323107409|FG010|Phase II Part|Subject/guardian decision|1|||
94361837|NCT00227591|323107410|FG000|Overall Study|Withdrawal by Subject|1|||
94361838|NCT00077766|323107411|FG000|Overall Study|Adverse Event|1|||
94361839|NCT00077766|323107412|FG001|Overall Study|Adverse Event|1|||
94361840|NCT00077766|323107411|FG000|Overall Study|Withdrawal by Subject|4|||
94361841|NCT00077766|323107412|FG001|Overall Study|Withdrawal by Subject|3|||
94361842|NCT00077766|323107411|FG000|Overall Study|Death|12|||
94361843|NCT00077766|323107412|FG001|Overall Study|Death|10|||
94361844|NCT00077766|323107411|FG000|Overall Study|Lost to Follow-up|2|||
94361845|NCT00077766|323107412|FG001|Overall Study|Lost to Follow-up|0|||
94630982|NCT02659631|324109857|FG007|Overall Study|Death (treatment phase)|0|||
94630983|NCT02659631|324109858|FG008|Overall Study|Death (treatment phase)|0|||
94630984|NCT02659631|324109859|FG009|Overall Study|Death (treatment phase)|0|||
94361846|NCT00077766|323107411|FG000|Overall Study|Protocol Violation|1|||
94361847|NCT00077766|323107412|FG001|Overall Study|Protocol Violation|0|||
94630985|NCT00005937|324109860|FG000|Overall Study|Lack of Efficacy|5|||
94630986|NCT01288469|324109861|FG000|Overall Study|Adverse Event|4|||
94361848|NCT00077766|323107411|FG000|Overall Study|Kidney Transplantation|9|||
94361849|NCT00077766|323107412|FG001|Overall Study|Kidney Transplantation|5|||
94361850|NCT00077766|323107411|FG000|Overall Study|Transplantation|5|||
94630987|NCT01288469|324109862|FG001|Overall Study|Adverse Event|1|||
94630988|NCT01288469|324109863|FG002|Overall Study|Adverse Event|1|||
94630989|NCT01288469|324109861|FG000|Overall Study|Poor compliance to protocol|0|||
94630990|NCT01288469|324109862|FG001|Overall Study|Poor compliance to protocol|1|||
94630991|NCT01288469|324109863|FG002|Overall Study|Poor compliance to protocol|0|||
94630992|NCT01288469|324109861|FG000|Overall Study|Participant Moved|1|||
94630993|NCT01288469|324109862|FG001|Overall Study|Participant Moved|0|||
94630994|NCT01288469|324109863|FG002|Overall Study|Participant Moved|0|||
94630995|NCT01288469|324109861|FG000|Overall Study|Consent withdrawn by subject|1|||
94630996|NCT01288469|324109862|FG001|Overall Study|Consent withdrawn by subject|1|||
94630997|NCT01288469|324109863|FG002|Overall Study|Consent withdrawn by subject|1|||
94630998|NCT01288469|324109861|FG000|Overall Study|Exclusion criteria finally met|1|||
94630999|NCT01288469|324109862|FG001|Overall Study|Exclusion criteria finally met|0|||
94631000|NCT01288469|324109863|FG002|Overall Study|Exclusion criteria finally met|0|||
94631001|NCT00255047|324109864|FG000|Overall Study|Serious Adverse Events|2|||
94631002|NCT00255047|324109865|FG001|Overall Study|Serious Adverse Events|1|||
94631003|NCT00255047|324109866|FG002|Overall Study|Serious Adverse Events|2|||
94631004|NCT00255047|324109867|FG003|Overall Study|Serious Adverse Events|1|||
94631005|NCT00255047|324109864|FG000|Overall Study|Adverse Event|0|||
94631006|NCT00255047|324109865|FG001|Overall Study|Adverse Event|3|||
94631007|NCT00255047|324109866|FG002|Overall Study|Adverse Event|2|||
94631008|NCT00255047|324109867|FG003|Overall Study|Adverse Event|1|||
94631009|NCT00255047|324109864|FG000|Overall Study|Protocol Violation|13|||
94631010|NCT00255047|324109865|FG001|Overall Study|Protocol Violation|13|||
94631011|NCT00255047|324109866|FG002|Overall Study|Protocol Violation|16|||
94631012|NCT00255047|324109867|FG003|Overall Study|Protocol Violation|20|||
94631013|NCT00255047|324109864|FG000|Overall Study|Lost to Follow-up|9|||
94631014|NCT00255047|324109865|FG001|Overall Study|Lost to Follow-up|8|||
94631015|NCT00255047|324109866|FG002|Overall Study|Lost to Follow-up|5|||
94631016|NCT00255047|324109867|FG003|Overall Study|Lost to Follow-up|6|||
94631017|NCT00255047|324109864|FG000|Overall Study|Withdrawal by Subject|24|||
94631018|NCT00255047|324109865|FG001|Overall Study|Withdrawal by Subject|23|||
94631019|NCT00255047|324109866|FG002|Overall Study|Withdrawal by Subject|25|||
94631020|NCT00255047|324109867|FG003|Overall Study|Withdrawal by Subject|18|||
94631021|NCT02452398|324109868|FG000|Overall Study|Adverse Event|1|||
94631022|NCT02452398|324109868|FG000|Overall Study|Lost to Follow-up|28|||
94631023|NCT02452398|324109868|FG000|Overall Study|Physician Decision|2|||
94631024|NCT02452398|324109868|FG000|Overall Study|Withdrawal by Subject|6|||
94631025|NCT02452398|324109868|FG000|Overall Study|Moved away|4|||
94631026|NCT01957644|324109872|FG000|Overall Study|Adverse Event|4|||
94631027|NCT01957644|324109873|FG001|Overall Study|Adverse Event|2|||
94631028|NCT01957644|324109874|FG002|Overall Study|Adverse Event|0|||
94631029|NCT01957644|324109875|FG003|Overall Study|Adverse Event|0|||
94631030|NCT01957644|324109876|FG004|Overall Study|Adverse Event|1|||
94631031|NCT01957644|324109872|FG000|Overall Study|Progressive disease / relapse|0|||
94631032|NCT01957644|324109873|FG001|Overall Study|Progressive disease / relapse|1|||
94631033|NCT01957644|324109874|FG002|Overall Study|Progressive disease / relapse|0|||
94631034|NCT01957644|324109875|FG003|Overall Study|Progressive disease / relapse|1|||
94631035|NCT01957644|324109876|FG004|Overall Study|Progressive disease / relapse|0|||
94631036|NCT01957644|324109872|FG000|Overall Study|Other reason|1|||
94631037|NCT01957644|324109873|FG001|Overall Study|Other reason|2|||
94631038|NCT01957644|324109874|FG002|Overall Study|Other reason|1|||
94258441|NCT01259726|322740477|FG000|Overall Study|Death|1|||
94258442|NCT01259726|322740478|FG001|Overall Study|Death|0|||
94631039|NCT01957644|324109875|FG003|Overall Study|Other reason|1|||
94631040|NCT01957644|324109876|FG004|Overall Study|Other reason|0|||
94631041|NCT01957644|324109872|FG000|Overall Study|Withdrawal by Subject|1|||
94631042|NCT01957644|324109873|FG001|Overall Study|Withdrawal by Subject|0|||
94675588|NCT00118716|324265442|FG001|Overall Study|Exacerbation|2|||
94675589|NCT00118716|324265441|FG000|Overall Study|Discontinued by sponsor|1|||
94675590|NCT00118716|324265442|FG001|Overall Study|Discontinued by sponsor|1|||
94675591|NCT00118716|324265441|FG000|Overall Study|Non-compliance|1|||
94675592|NCT00118716|324265442|FG001|Overall Study|Non-compliance|3|||
94675593|NCT00118716|324265441|FG000|Overall Study|misrandomized|1|||
94675594|NCT00118716|324265442|FG001|Overall Study|misrandomized|1|||
94675595|NCT00118716|324265441|FG000|Overall Study|Expired drug use|1|||
94675596|NCT00118716|324265442|FG001|Overall Study|Expired drug use|2|||
94675597|NCT00118716|324265441|FG000|Overall Study|Investigator discretion|0|||
94675598|NCT00118716|324265442|FG001|Overall Study|Investigator discretion|1|||
94675599|NCT00952822|324265443|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
94675600|NCT00952822|324265444|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
94675601|NCT00952822|324265445|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
94675602|NCT00952822|324265446|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
94675603|NCT00952822|324265443|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
94675604|NCT00952822|324265444|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
94675605|NCT00952822|324265445|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
94675606|NCT00952822|324265446|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
94675607|NCT04860518|324265450|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
94675608|NCT04860518|324265451|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
94675609|NCT02831257|324265453|FG000|Overall Study|Lack of Efficacy|3|||
94675610|NCT02831257|324265453|FG000|Overall Study|Adverse Event|2|||
94675611|NCT02831257|324265453|FG000|Overall Study|Physician Decision|1|||
94675612|NCT02831257|324265453|FG000|Overall Study|Withdrawal by Subject|6|||
94675613|NCT01844284|324265454|FG000|Overall Study|Lost to Follow-up|12|||
94675614|NCT01844284|324265455|FG001|Overall Study|Lost to Follow-up|7|||
94675615|NCT01820559|324265456|FG000|Overall Study|Adverse Event|4|||
94675616|NCT01820559|324265457|FG001|Overall Study|Adverse Event|6|||
94675617|NCT01820559|324265458|FG002|Overall Study|Adverse Event|13|||
94675618|NCT01820559|324265456|FG000|Overall Study|Withdrawal by Subject|1|||
94675619|NCT01820559|324265457|FG001|Overall Study|Withdrawal by Subject|2|||
94675620|NCT01820559|324265458|FG002|Overall Study|Withdrawal by Subject|5|||
94675621|NCT01820559|324265456|FG000|Overall Study|Protocol Violation|2|||
94675622|NCT01820559|324265457|FG001|Overall Study|Protocol Violation|1|||
94675623|NCT01820559|324265458|FG002|Overall Study|Protocol Violation|3|||
94675624|NCT01820559|324265456|FG000|Overall Study|Subject's non-compliance|1|||
94675625|NCT01820559|324265457|FG001|Overall Study|Subject's non-compliance|0|||
94675626|NCT01820559|324265458|FG002|Overall Study|Subject's non-compliance|2|||
94675627|NCT01820559|324265456|FG000|Overall Study|Lost to Follow-up|3|||
94675628|NCT01820559|324265457|FG001|Overall Study|Lost to Follow-up|2|||
94675629|NCT01820559|324265458|FG002|Overall Study|Lost to Follow-up|2|||
94675630|NCT01820559|324265456|FG000|Overall Study|At sponsor request|0|||
94675631|NCT01820559|324265457|FG001|Overall Study|At sponsor request|0|||
94675632|NCT01820559|324265458|FG002|Overall Study|At sponsor request|1|||
94675633|NCT01820559|324265456|FG000|Overall Study|Lack of Efficacy|3|||
94675634|NCT01820559|324265457|FG001|Overall Study|Lack of Efficacy|2|||
94675635|NCT01820559|324265458|FG002|Overall Study|Lack of Efficacy|3|||
94258443|NCT01259726|322740479|FG002|Overall Study|Death|0|||
94258444|NCT01259726|322740480|FG003|Overall Study|Death|0|||
94258445|NCT01259726|322740477|FG000|Overall Study|Physician Decision|2|||
94258446|NCT01259726|322740478|FG001|Overall Study|Physician Decision|0|||
94258447|NCT01259726|322740479|FG002|Overall Study|Physician Decision|1|||
94258448|NCT01259726|322740480|FG003|Overall Study|Physician Decision|1|||
94258449|NCT01259726|322740477|FG000|Overall Study|Withdrawal by Subject|1|||
94631043|NCT01957644|324109874|FG002|Overall Study|Withdrawal by Subject|0|||
94631044|NCT01957644|324109875|FG003|Overall Study|Withdrawal by Subject|0|||
94631045|NCT01957644|324109876|FG004|Overall Study|Withdrawal by Subject|0|||
94631046|NCT01957644|324109872|FG000|Overall Study|Protocol Violation|0|||
94631047|NCT01957644|324109873|FG001|Overall Study|Protocol Violation|1|||
94631048|NCT01957644|324109874|FG002|Overall Study|Protocol Violation|0|||
94675636|NCT02755597|324265459|FG000|Overall Study|Withdrew consent|27|||
94675637|NCT02755597|324265460|FG001|Overall Study|Withdrew consent|11|||
94631049|NCT01957644|324109875|FG003|Overall Study|Protocol Violation|0|||
94675638|NCT02755597|324265459|FG000|Overall Study|Lost to Follow-up|1|||
94675639|NCT02755597|324265460|FG001|Overall Study|Lost to Follow-up|0|||
94675640|NCT02755597|324265459|FG000|Overall Study|Death|78|||
94258450|NCT01259726|322740478|FG001|Overall Study|Withdrawal by Subject|3|||
94631050|NCT01957644|324109876|FG004|Overall Study|Protocol Violation|0|||
94675641|NCT02755597|324265460|FG001|Overall Study|Death|36|||
94258451|NCT01259726|322740479|FG002|Overall Study|Withdrawal by Subject|2|||
94258452|NCT01259726|322740480|FG003|Overall Study|Withdrawal by Subject|1|||
94675642|NCT02755597|324265459|FG000|Overall Study|Study terminated by Sponsor|67|||
94258453|NCT01259726|322740477|FG000|Overall Study|Lost to Follow-up|1|||
94258454|NCT01259726|322740478|FG001|Overall Study|Lost to Follow-up|1|||
94631051|NCT04044716|324109877|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
94675643|NCT02755597|324265460|FG001|Overall Study|Study terminated by Sponsor|47|||
94631052|NCT04044716|324109878|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
94631053|NCT04044716|324109879|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
94631054|NCT04044716|324109877|FG000|Overall Study|Lost to Follow-up|2|||
94631055|NCT04044716|324109878|FG001|Overall Study|Lost to Follow-up|3|||
94631056|NCT04044716|324109879|FG002|Overall Study|Lost to Follow-up|0|||
94631057|NCT00732615|324109880|FG000|Overall Study|Withdrawal by Subject|3|||
94631058|NCT00732615|324109881|FG001|Overall Study|Withdrawal by Subject|1|||
94631059|NCT00732615|324109880|FG000|Overall Study|Lost to Follow-up|0|||
94631060|NCT00732615|324109881|FG001|Overall Study|Lost to Follow-up|1|||
94631061|NCT00732615|324109880|FG000|Overall Study|Adverse Event|0|||
94631062|NCT00732615|324109881|FG001|Overall Study|Adverse Event|2|||
94631063|NCT00732615|324109880|FG000|Overall Study|Physician Decision|3|||
94631064|NCT00732615|324109881|FG001|Overall Study|Physician Decision|0|||
94631065|NCT00732615|324109880|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
94631066|NCT00732615|324109881|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
94631067|NCT00737282|324109882|FG000|Overall Study|Study prematurely terminated|175|||
94631068|NCT02049957|324109885|FG000|Overall Study|Progressive Disease|5|||
94631069|NCT02049957|324109886|FG001|Overall Study|Progressive Disease|4|||
94631070|NCT02049957|324109887|FG002|Overall Study|Progressive Disease|2|||
94631071|NCT02049957|324109888|FG003|Overall Study|Progressive Disease|2|||
94631072|NCT02049957|324109889|FG004|Overall Study|Progressive Disease|6|||
94631073|NCT02049957|324109890|FG005|Overall Study|Progressive Disease|35|||
94631074|NCT02049957|324109891|FG006|Overall Study|Progressive Disease|7|||
94631075|NCT02049957|324109892|FG007|Overall Study|Progressive Disease|26|||
94631076|NCT02049957|324109893|FG008|Overall Study|Progressive Disease|6|||
94631077|NCT02049957|324109885|FG000|Overall Study|Adverse Event|1|||
94631078|NCT02049957|324109886|FG001|Overall Study|Adverse Event|1|||
94631079|NCT02049957|324109887|FG002|Overall Study|Adverse Event|1|||
94631080|NCT02049957|324109888|FG003|Overall Study|Adverse Event|0|||
94631081|NCT02049957|324109889|FG004|Overall Study|Adverse Event|0|||
94631082|NCT02049957|324109890|FG005|Overall Study|Adverse Event|5|||
94631083|NCT02049957|324109891|FG006|Overall Study|Adverse Event|0|||
94631084|NCT02049957|324109892|FG007|Overall Study|Adverse Event|6|||
94631085|NCT02049957|324109893|FG008|Overall Study|Adverse Event|1|||
94631086|NCT02049957|324109885|FG000|Overall Study|Study Terminated by Sponsor|0|||
94631087|NCT02049957|324109886|FG001|Overall Study|Study Terminated by Sponsor|1|||
94258455|NCT01259726|322740479|FG002|Overall Study|Lost to Follow-up|1|||
94258456|NCT01259726|322740480|FG003|Overall Study|Lost to Follow-up|3|||
94258457|NCT01978262|322740481|FG000|Overall Study|Withdrawal by Subject|9|||
94258458|NCT01978262|322740481|FG000|Overall Study|Lost to Follow-up|2|||
94258459|NCT00908232|322740487|FG000|Cycle 1 to 4|Death|5|||
94258460|NCT00908232|322740488|FG001|Cycle 1 to 4|Death|0|||
94258461|NCT00908232|322740489|FG002|Cycle 1 to 4|Death|0|||
94258462|NCT00908232|322740490|FG003|Cycle 1 to 4|Death|0|||
94258463|NCT00908232|322740487|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
94258464|NCT00908232|322740488|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
94258465|NCT00908232|322740489|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
94258466|NCT00908232|322740490|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
94258467|NCT00908232|322740487|FG000|Cycle 1 to 4|Progressive Disease|6|||
94258468|NCT00908232|322740488|FG001|Cycle 1 to 4|Progressive Disease|0|||
94258469|NCT00908232|322740489|FG002|Cycle 1 to 4|Progressive Disease|0|||
94258470|NCT00908232|322740490|FG003|Cycle 1 to 4|Progressive Disease|0|||
94258471|NCT00908232|322740487|FG000|Cycle 1 to 4|Adverse Event|12|||
94258472|NCT00908232|322740488|FG001|Cycle 1 to 4|Adverse Event|0|||
94258473|NCT00908232|322740489|FG002|Cycle 1 to 4|Adverse Event|0|||
94258474|NCT00908232|322740490|FG003|Cycle 1 to 4|Adverse Event|0|||
94258475|NCT00908232|322740487|FG000|Cycle 1 to 4|Other|1|||
94258476|NCT00908232|322740488|FG001|Cycle 1 to 4|Other|0|||
94258477|NCT00908232|322740489|FG002|Cycle 1 to 4|Other|0|||
94258478|NCT00908232|322740490|FG003|Cycle 1 to 4|Other|0|||
94258479|NCT00908232|322740487|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
94258480|NCT00908232|322740488|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
94258481|NCT00908232|322740489|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
94258482|NCT00908232|322740490|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
94258483|NCT00908232|322740487|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
94258484|NCT00908232|322740488|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
94258485|NCT00908232|322740489|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
94258486|NCT00908232|322740490|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
94258487|NCT00908232|322740487|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
94258488|NCT00908232|322740488|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
94258489|NCT00908232|322740489|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
94258490|NCT00908232|322740490|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
94258491|NCT00908232|322740487|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
94631088|NCT02049957|324109887|FG002|Overall Study|Study Terminated by Sponsor|0|||
94631089|NCT02049957|324109888|FG003|Overall Study|Study Terminated by Sponsor|0|||
94258492|NCT00908232|322740488|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
94258493|NCT00908232|322740489|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
94258494|NCT00908232|322740490|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
94258495|NCT00908232|322740487|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
94258496|NCT00908232|322740488|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
94258497|NCT00908232|322740489|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
94258498|NCT00908232|322740490|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
94258499|NCT00908232|322740487|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
94258500|NCT00908232|322740488|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
94258501|NCT00908232|322740489|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
94258502|NCT00908232|322740490|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
94258503|NCT00908232|322740487|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
94258504|NCT00908232|322740488|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
94258505|NCT00908232|322740489|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
94258506|NCT00908232|322740490|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
94258507|NCT00908232|322740487|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
94258508|NCT00908232|322740488|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
94258509|NCT00908232|322740489|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
94258510|NCT00908232|322740490|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
94258511|NCT02435966|322740491|FG000|Overall Study|Withdrawal by Subject|0|||
94258512|NCT02435966|322740492|FG001|Overall Study|Withdrawal by Subject|1|||
94258513|NCT02435966|322740493|FG002|Overall Study|Withdrawal by Subject|0|||
94258514|NCT04620811|322740494|FG000|Overall Study|Withdrawal by Subject|18|||
94258515|NCT04620811|322740495|FG001|Overall Study|Withdrawal by Subject|15|||
94258516|NCT04620811|322740494|FG000|Overall Study|Adverse Event|6|||
94258517|NCT04620811|322740495|FG001|Overall Study|Adverse Event|11|||
94258518|NCT04620811|322740494|FG000|Overall Study|Lost to Follow-up|4|||
94258519|NCT04620811|322740495|FG001|Overall Study|Lost to Follow-up|8|||
94258520|NCT04620811|322740494|FG000|Overall Study|Physician Decision|1|||
94258521|NCT04620811|322740495|FG001|Overall Study|Physician Decision|4|||
94258522|NCT04620811|322740494|FG000|Overall Study|Sponsor Decision|0|||
94258523|NCT04620811|322740495|FG001|Overall Study|Sponsor Decision|1|||
94258524|NCT04620811|322740494|FG000|Overall Study|Elevation of ALT or AST|1|||
94258525|NCT04620811|322740495|FG001|Overall Study|Elevation of ALT or AST|0|||
94258526|NCT04620811|322740494|FG000|Overall Study|Other|3|||
94258527|NCT04620811|322740495|FG001|Overall Study|Other|5|||
94258528|NCT04079803|322740502|FG000|Overall Study|Withdrawal by Subject|0|||
94258529|NCT04079803|322740503|FG001|Overall Study|Withdrawal by Subject|0|||
94258530|NCT04079803|322740504|FG002|Overall Study|Withdrawal by Subject|1|||
94258531|NCT03370471|322740508|FG000|Overall Study|Withdrawal by Subject|6|||
94258532|NCT03370471|322740509|FG001|Overall Study|Withdrawal by Subject|1|||
94258533|NCT03370471|322740508|FG000|Overall Study|Unable to access veins for blood draw|0|||
94258534|NCT03370471|322740509|FG001|Overall Study|Unable to access veins for blood draw|1|||
94258535|NCT03370471|322740508|FG000|Overall Study|Screen fail|1|||
94258536|NCT03370471|322740509|FG001|Overall Study|Screen fail|0|||
94258537|NCT01765179|322740510|FG000|Overall Study|Adverse Event|3|||
94258538|NCT01765179|322740510|FG000|Overall Study|Lost to Follow-up|5|||
94258539|NCT01765179|322740510|FG000|Overall Study|Non-compliance with study drug|2|||
94258540|NCT01765179|322740510|FG000|Overall Study|Protocol Violation|1|||
94258541|NCT01765179|322740510|FG000|Overall Study|Withdrawal by Subject|8|||
94258542|NCT01765179|322740510|FG000|Overall Study|Hematocrit >54%|3|||
94258543|NCT01765179|322740510|FG000|Overall Study|prohibited med|1|||
94258544|NCT01765179|322740510|FG000|Overall Study|Out of country unable to finish study|1|||
94258545|NCT01765179|322740510|FG000|Overall Study|lack of venous access|1|||
94258546|NCT01765179|322740510|FG000|Overall Study|work conflict|1|||
94258547|NCT01765179|322740510|FG000|Overall Study|Ca elevated 10.6|1|||
94258548|NCT00564018|322740511|FG000|Overall Study|Withdrawal by Subject|2|||
94258549|NCT00564018|322740512|FG001|Overall Study|Withdrawal by Subject|3|||
94258550|NCT00564018|322740513|FG002|Overall Study|Withdrawal by Subject|1|||
94258551|NCT03267940|322740514|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
94258552|NCT03267940|322740515|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
94258553|NCT03267940|322740516|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
94258554|NCT03267940|322740517|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
94258555|NCT03267940|322740518|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
94258556|NCT03267940|322740519|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
94258557|NCT03267940|322740514|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
94258558|NCT03267940|322740515|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
94258559|NCT03267940|322740516|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
94258560|NCT03267940|322740517|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
94258561|NCT03267940|322740518|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
94258562|NCT03267940|322740519|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
94258563|NCT03267940|322740514|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
94258564|NCT03267940|322740515|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
94258565|NCT03267940|322740516|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
94258566|NCT03267940|322740517|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
94258567|NCT03267940|322740518|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
94258568|NCT03267940|322740519|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
94258569|NCT03267940|322740514|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
94258570|NCT03267940|322740515|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
94258571|NCT03267940|322740516|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
94258572|NCT03267940|322740517|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
94258573|NCT03267940|322740518|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
94258574|NCT03267940|322740519|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
94258575|NCT03267940|322740514|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
94258576|NCT03267940|322740515|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
94258577|NCT03267940|322740516|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
94258578|NCT03267940|322740517|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
94258579|NCT03267940|322740518|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
94258580|NCT03267940|322740519|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
94258581|NCT03267940|322740514|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
94258582|NCT03267940|322740515|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
94258583|NCT03267940|322740516|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
94258584|NCT03267940|322740517|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
94258585|NCT03267940|322740518|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
94258586|NCT03267940|322740519|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
94258587|NCT03267940|322740514|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
94258588|NCT03267940|322740515|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
94258589|NCT03267940|322740516|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
94258590|NCT03267940|322740517|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
94258591|NCT03267940|322740518|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
94258592|NCT03267940|322740519|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
94258593|NCT03267940|322740514|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
94258594|NCT03267940|322740515|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
94461676|NCT00985959|323479581|FG002|Overall Study|Progressive disease|8|||
94461677|NCT00985959|323479579|FG000|Overall Study|Unrecovered toxicity|0|||
94631090|NCT02049957|324109889|FG004|Overall Study|Study Terminated by Sponsor|0|||
94631091|NCT02049957|324109890|FG005|Overall Study|Study Terminated by Sponsor|0|||
94631092|NCT02049957|324109891|FG006|Overall Study|Study Terminated by Sponsor|1|||
94631093|NCT02049957|324109892|FG007|Overall Study|Study Terminated by Sponsor|0|||
94631094|NCT02049957|324109893|FG008|Overall Study|Study Terminated by Sponsor|0|||
94631095|NCT02049957|324109885|FG000|Overall Study|Withdrawal by Subject|0|||
94631096|NCT02049957|324109886|FG001|Overall Study|Withdrawal by Subject|0|||
94631097|NCT02049957|324109887|FG002|Overall Study|Withdrawal by Subject|0|||
94631098|NCT02049957|324109888|FG003|Overall Study|Withdrawal by Subject|1|||
94631099|NCT02049957|324109889|FG004|Overall Study|Withdrawal by Subject|0|||
94631100|NCT02049957|324109890|FG005|Overall Study|Withdrawal by Subject|2|||
94631101|NCT02049957|324109891|FG006|Overall Study|Withdrawal by Subject|0|||
94631102|NCT02049957|324109892|FG007|Overall Study|Withdrawal by Subject|3|||
94631103|NCT02049957|324109893|FG008|Overall Study|Withdrawal by Subject|1|||
94631104|NCT02049957|324109885|FG000|Overall Study|Physician Decision|0|||
94631105|NCT02049957|324109886|FG001|Overall Study|Physician Decision|0|||
94631106|NCT02049957|324109887|FG002|Overall Study|Physician Decision|0|||
94631107|NCT02049957|324109888|FG003|Overall Study|Physician Decision|0|||
94631108|NCT02049957|324109889|FG004|Overall Study|Physician Decision|0|||
94631109|NCT02049957|324109890|FG005|Overall Study|Physician Decision|1|||
94631110|NCT02049957|324109891|FG006|Overall Study|Physician Decision|0|||
94631111|NCT02049957|324109892|FG007|Overall Study|Physician Decision|0|||
94631112|NCT02049957|324109893|FG008|Overall Study|Physician Decision|0|||
94631113|NCT01414075|324109894|FG000|Overall Study|Adverse Event|1|||
94631114|NCT01414075|324109895|FG001|Overall Study|Adverse Event|0|||
94631115|NCT01414075|324109896|FG002|Overall Study|Adverse Event|1|||
94631116|NCT01414075|324109897|FG003|Overall Study|Adverse Event|0|||
94631117|NCT01414075|324109894|FG000|Overall Study|Death|1|||
94631118|NCT01414075|324109895|FG001|Overall Study|Death|0|||
94631119|NCT01414075|324109896|FG002|Overall Study|Death|0|||
94631120|NCT01414075|324109897|FG003|Overall Study|Death|1|||
94631121|NCT01414075|324109894|FG000|Overall Study|Withdrawal by Subject|0|||
94631122|NCT01414075|324109895|FG001|Overall Study|Withdrawal by Subject|0|||
94631123|NCT01414075|324109896|FG002|Overall Study|Withdrawal by Subject|0|||
94631124|NCT01414075|324109897|FG003|Overall Study|Withdrawal by Subject|1|||
94631125|NCT01414075|324109894|FG000|Overall Study|Other than specified|1|||
94631126|NCT01414075|324109895|FG001|Overall Study|Other than specified|0|||
94361851|NCT00077766|323107412|FG001|Overall Study|Transplantation|1|||
94361852|NCT00077766|323107411|FG000|Overall Study|Investigators Discretion|1|||
94361853|NCT00077766|323107412|FG001|Overall Study|Investigators Discretion|0|||
94361854|NCT00077766|323107411|FG000|Overall Study|Participant's decision|1|||
94361855|NCT00077766|323107412|FG001|Overall Study|Participant's decision|0|||
94361856|NCT00077766|323107411|FG000|Overall Study|Dialysis Discontinued|1|||
94361857|NCT00077766|323107412|FG001|Overall Study|Dialysis Discontinued|0|||
94361858|NCT00077766|323107411|FG000|Overall Study|Dialysis|0|||
94361859|NCT00077766|323107412|FG001|Overall Study|Dialysis|1|||
94631127|NCT01414075|324109896|FG002|Overall Study|Other than specified|1|||
94631128|NCT01414075|324109897|FG003|Overall Study|Other than specified|0|||
94631129|NCT02170051|324109901|FG000|Overall Study|Withdrawal by Subject|10|||
94631130|NCT02170051|324109902|FG001|Overall Study|Withdrawal by Subject|10|||
94361860|NCT00077766|323107411|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
94361861|NCT00077766|323107412|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
94361862|NCT00077766|323107411|FG000|Overall Study|Started Nocturnal Dialysis|0|||
94361863|NCT00077766|323107412|FG001|Overall Study|Started Nocturnal Dialysis|1|||
94361864|NCT00077766|323107411|FG000|Overall Study|Stop Dialysis|0|||
94361865|NCT00077766|323107412|FG001|Overall Study|Stop Dialysis|1|||
94361866|NCT00077766|323107411|FG000|Overall Study|Participants Vacation|2|||
94361867|NCT00077766|323107412|FG001|Overall Study|Participants Vacation|1|||
94361868|NCT02341482|323107413|FG000|Overall Study|Adverse Event|1|||
94361869|NCT01876901|323107414|FG000|Overall Study|Protocol Violation|10|||
94361870|NCT01876901|323107415|FG001|Overall Study|Protocol Violation|2|||
94361871|NCT01876901|323107414|FG000|Overall Study|No or other surgical intervention|7|||
94361872|NCT01876901|323107415|FG001|Overall Study|No or other surgical intervention|5|||
94361873|NCT03843775|323107423|FG000|Overall Study|Adverse Event|1|||
94361874|NCT03843775|323107424|FG001|Overall Study|Adverse Event|1|||
94361875|NCT03843775|323107423|FG000|Overall Study|Lack of Efficacy|2|||
94361876|NCT03843775|323107424|FG001|Overall Study|Lack of Efficacy|6|||
94361877|NCT03843775|323107423|FG000|Overall Study|Withdrawal by Subject|0|||
94361878|NCT03843775|323107424|FG001|Overall Study|Withdrawal by Subject|1|||
94258595|NCT03267940|322740516|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
94258596|NCT03267940|322740517|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
94258597|NCT03267940|322740518|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
94258598|NCT03267940|322740519|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
94258599|NCT03267940|322740514|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
94258600|NCT03267940|322740515|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
94258601|NCT03267940|322740516|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
94258602|NCT03267940|322740517|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
94258603|NCT03267940|322740518|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
94258604|NCT03267940|322740519|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
94258605|NCT03343301|322740520|FG000|Overall Study|Withdrawal by Subject|1|||
94258606|NCT03343301|322740521|FG001|Overall Study|Withdrawal by Subject|1|||
94258607|NCT03343301|322740520|FG000|Overall Study|Death|0|||
94361879|NCT04150107|323107427|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
94361880|NCT04150107|323107428|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
94361881|NCT04150107|323107427|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
94361882|NCT04150107|323107428|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
94361883|NCT00440193|323107429|FG000|Treatment Period|Adverse Event|74|||
94361884|NCT00440193|323107430|FG001|Treatment Period|Adverse Event|67|||
94361885|NCT00440193|323107429|FG000|Treatment Period|Death|19|||
94361886|NCT00440193|323107430|FG001|Treatment Period|Death|22|||
94631131|NCT02170051|324109901|FG000|Overall Study|Lost to Follow-up|1|||
94631132|NCT02170051|324109902|FG001|Overall Study|Lost to Follow-up|3|||
94631133|NCT04868890|324109905|FG000|Overall Study|Death|2|||
94631134|NCT04868890|324109906|FG001|Overall Study|Death|1|||
94631135|NCT04868890|324109905|FG000|Overall Study|Withdrawal by Subject|1|||
94631136|NCT04868890|324109906|FG001|Overall Study|Withdrawal by Subject|5|||
94631137|NCT01013701|324109909|FG000|Overall Study|study prematurely terminated|7|||
94631138|NCT01338493|324109912|FG000|Enrolled|Withdrawal by Subject|1|||
94631139|NCT01338493|324109912|FG000|Enrolled|Patient not implanted|4|||
94631140|NCT01338493|324109912|FG000|Discharge|Death|1|||
94631141|NCT01338493|324109912|FG000|Discharge|Missed visit|1|||
94631142|NCT01338493|324109912|FG000|6 Months Follow up|Lost to Follow-up|11|||
94631143|NCT01338493|324109912|FG000|6 Months Follow up|Missed visit|8|||
94631144|NCT01338493|324109912|FG000|12 Months Follow up|Lost to Follow-up|9|||
94631145|NCT01614067|324109913|FG000|Overall Study|Pregnancy|1|||
94258608|NCT03343301|322740521|FG001|Overall Study|Death|2|||
94361887|NCT00440193|323107429|FG000|Treatment Period|Lack of Efficacy|0|||
94631146|NCT01614067|324109914|FG001|Overall Study|Pregnancy|0|||
94631147|NCT01614067|324109913|FG000|Overall Study|Physician Decision|6|||
94258609|NCT03343301|322740520|FG000|Overall Study|Other|0|||
94258610|NCT03343301|322740521|FG001|Overall Study|Other|6|||
94258611|NCT03343301|322740520|FG000|Overall Study|Missing|2|||
94361888|NCT00440193|323107430|FG001|Treatment Period|Lack of Efficacy|1|||
94258612|NCT03343301|322740521|FG001|Overall Study|Missing|0|||
94258613|NCT01585987|322740522|FG000|Randomized|Withdrawal by Subject|0|||
94258614|NCT01585987|322740523|FG001|Randomized|Withdrawal by Subject|4|||
94258615|NCT01585987|322740522|FG000|Randomized|No longer met criteria|0|||
94258616|NCT01585987|322740523|FG001|Randomized|No longer met criteria|2|||
94258617|NCT01585987|322740522|FG000|Treated|Disease Progression|39|||
94258618|NCT01585987|322740523|FG001|Treated|Disease Progression|36|||
94258619|NCT01585987|322740522|FG000|Treated|Study Drug Toxicity|9|||
94258620|NCT01585987|322740523|FG001|Treated|Study Drug Toxicity|5|||
94258621|NCT01585987|322740522|FG000|Treated|Adverse Event|3|||
94258622|NCT01585987|322740523|FG001|Treated|Adverse Event|0|||
94258623|NCT01585987|322740522|FG000|Treated|Withdrawal by Subject|1|||
94258624|NCT01585987|322740523|FG001|Treated|Withdrawal by Subject|2|||
94258625|NCT01585987|322740522|FG000|Treated|Death|1|||
94258626|NCT01585987|322740523|FG001|Treated|Death|0|||
94258627|NCT01585987|322740522|FG000|Treated|Lost to Follow-up|0|||
94258628|NCT01585987|322740523|FG001|Treated|Lost to Follow-up|1|||
94258629|NCT01585987|322740522|FG000|Treated|Maximum Clinical Benefit|0|||
94258630|NCT01585987|322740523|FG001|Treated|Maximum Clinical Benefit|1|||
94258631|NCT01585987|322740522|FG000|Treated|Non-Specified|1|||
94258632|NCT01585987|322740523|FG001|Treated|Non-Specified|2|||
94258633|NCT01585987|322740522|FG000|Treated|Subject Request|0|||
94258634|NCT01585987|322740523|FG001|Treated|Subject Request|1|||
94258635|NCT01585987|322740522|FG000|Treated|Poor/Non-Compliance|0|||
94258636|NCT01585987|322740523|FG001|Treated|Poor/Non-Compliance|1|||
94258637|NCT01163916|322740529|FG000|Overall Study|Withdrawal by Subject|2|||
94258638|NCT01163916|322740530|FG001|Overall Study|Withdrawal by Subject|0|||
94258639|NCT01163916|322740531|FG002|Overall Study|Withdrawal by Subject|2|||
94258640|NCT01163916|322740529|FG000|Overall Study|Adverse Event|2|||
94258641|NCT01163916|322740530|FG001|Overall Study|Adverse Event|0|||
94258642|NCT01163916|322740531|FG002|Overall Study|Adverse Event|1|||
94258643|NCT01163916|322740529|FG000|Overall Study|Lack of Efficacy|2|||
94258644|NCT01163916|322740530|FG001|Overall Study|Lack of Efficacy|0|||
94258645|NCT01163916|322740531|FG002|Overall Study|Lack of Efficacy|1|||
94258646|NCT01163916|322740529|FG000|Overall Study|Other|24|||
94258647|NCT01163916|322740530|FG001|Overall Study|Other|4|||
94258648|NCT01163916|322740531|FG002|Overall Study|Other|16|||
94258649|NCT03170154|322740532|FG000|Overall Study|Lost to Follow-up|4|||
94258650|NCT03170154|322740532|FG000|Overall Study|Death|2|||
94258651|NCT03170154|322740532|FG000|Overall Study|Withdrawal by Subject|2|||
94258652|NCT02279862|322740533|FG000|Overall Study|Study drug toxicity|3|||
94258653|NCT02279862|322740534|FG001|Overall Study|Study drug toxicity|6|||
94258654|NCT02279862|322740533|FG000|Overall Study|No longer meets criteria|0|||
94258655|NCT02279862|322740534|FG001|Overall Study|No longer meets criteria|1|||
94258656|NCT02279862|322740533|FG000|Overall Study|Administrative reason by sponsor|0|||
94631148|NCT01614067|324109914|FG001|Overall Study|Physician Decision|5|||
94631149|NCT01614067|324109913|FG000|Overall Study|Withdrawal by Subject|0|||
94631150|NCT01614067|324109914|FG001|Overall Study|Withdrawal by Subject|1|||
94631151|NCT01614067|324109913|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
94631152|NCT01614067|324109914|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
94631153|NCT00847704|324109915|FG000|Overall Study|Withdrawal by Subject|1|||
94631154|NCT02289079|324109916|FG000|Overall Study|Physician Decision|2|||
94631155|NCT02289079|324109917|FG001|Overall Study|Physician Decision|0|||
94631156|NCT02289079|324109916|FG000|Overall Study|Lost to Follow-up|0|||
94631157|NCT02289079|324109917|FG001|Overall Study|Lost to Follow-up|1|||
94631158|NCT02111850|324109918|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
94631159|NCT02111850|324109919|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
94631160|NCT02111850|324109920|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
94631161|NCT02111850|324109921|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
94631162|NCT02111850|324109922|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
94631163|NCT02111850|324109923|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
94631164|NCT02111850|324109924|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
94631165|NCT02111850|324109925|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
94631166|NCT02111850|324109926|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
94651434|NCT03852316|324181655|FG000|Overall Study|Enrolled but Device not Utilized|1|||
94258657|NCT02279862|322740534|FG001|Overall Study|Administrative reason by sponsor|1|||
94258658|NCT02279862|322740533|FG000|Overall Study|Disease progression|5|||
94258659|NCT02279862|322740534|FG001|Overall Study|Disease progression|2|||
94258660|NCT02279862|322740533|FG000|Overall Study|Study closed by sponsor|16|||
94258661|NCT02279862|322740534|FG001|Overall Study|Study closed by sponsor|13|||
94258662|NCT02279862|322740533|FG000|Overall Study|Other|1|||
94258663|NCT02279862|322740534|FG001|Overall Study|Other|2|||
94258664|NCT02279862|322740533|FG000|Overall Study|Withdrawal by Subject|1|||
94258665|NCT02279862|322740534|FG001|Overall Study|Withdrawal by Subject|0|||
94258666|NCT05266586|322740535|FG000|Overall Study|Adverse Event|2|||
94258667|NCT05266586|322740536|FG001|Overall Study|Adverse Event|2|||
94258668|NCT05266586|322740537|FG002|Overall Study|Adverse Event|1|||
94361889|NCT00440193|323107429|FG000|Treatment Period|Lost to Follow-up|12|||
94361890|NCT00440193|323107430|FG001|Treatment Period|Lost to Follow-up|18|||
94361891|NCT00440193|323107429|FG000|Treatment Period|Physician Decision|3|||
94361892|NCT00440193|323107430|FG001|Treatment Period|Physician Decision|6|||
94361893|NCT00440193|323107429|FG000|Treatment Period|Protocol Violation|16|||
94361894|NCT00440193|323107430|FG001|Treatment Period|Protocol Violation|19|||
94361895|NCT00440193|323107429|FG000|Treatment Period|Withdrawal by Subject|36|||
94361896|NCT00440193|323107430|FG001|Treatment Period|Withdrawal by Subject|77|||
94361897|NCT00440193|323107429|FG000|Treatment Period|Clinical endpoint reached|28|||
94361898|NCT00440193|323107430|FG001|Treatment Period|Clinical endpoint reached|25|||
94361899|NCT00440193|323107429|FG000|Treatment Period|Study terminated by sponsor|102|||
94361900|NCT00440193|323107430|FG001|Treatment Period|Study terminated by sponsor|94|||
94361901|NCT00440193|323107429|FG000|Treatment Period|Protocol driven decision point|2|||
94361902|NCT00440193|323107430|FG001|Treatment Period|Protocol driven decision point|2|||
94361903|NCT00440193|323107429|FG000|Treatment Period|Switch to commercial drug|0|||
94361904|NCT00440193|323107430|FG001|Treatment Period|Switch to commercial drug|2|||
94361905|NCT00440193|323107429|FG000|Treatment Period|Technical problems|1|||
94361906|NCT00440193|323107430|FG001|Treatment Period|Technical problems|1|||
94361907|NCT00440193|323107429|FG000|Treatment Period|Participant convenience|5|||
94361908|NCT00440193|323107430|FG001|Treatment Period|Participant convenience|2|||
94361909|NCT00440193|323107429|FG000|Treatment Period|Participant did not receive treatment|7|||
94361910|NCT00440193|323107430|FG001|Treatment Period|Participant did not receive treatment|13|||
94361911|NCT00440193|323107429|FG000|Treatment Period|Site closed by investigator|0|||
94361912|NCT00440193|323107430|FG001|Treatment Period|Site closed by investigator|2|||
94361913|NCT00440193|323107429|FG000|Observational Period|Adverse Event|2|||
94361914|NCT00440193|323107430|FG001|Observational Period|Adverse Event|2|||
94361915|NCT00440193|323107429|FG000|Observational Period|Death|15|||
94361916|NCT00440193|323107430|FG001|Observational Period|Death|20|||
94361917|NCT00440193|323107429|FG000|Observational Period|Lost to Follow-up|12|||
94361918|NCT00440193|323107430|FG001|Observational Period|Lost to Follow-up|8|||
94361919|NCT00440193|323107429|FG000|Observational Period|Protocol Violation|1|||
94361920|NCT00440193|323107430|FG001|Observational Period|Protocol Violation|0|||
94361921|NCT00440193|323107429|FG000|Observational Period|Withdrawal by Subject|11|||
94361922|NCT00440193|323107430|FG001|Observational Period|Withdrawal by Subject|8|||
94361923|NCT00440193|323107429|FG000|Observational Period|Physician Decision|1|||
94361924|NCT00440193|323107430|FG001|Observational Period|Physician Decision|0|||
94361925|NCT00440193|323107429|FG000|Observational Period|Clinical endpoint reached|1|||
94361926|NCT00440193|323107430|FG001|Observational Period|Clinical endpoint reached|0|||
94361927|NCT00440193|323107429|FG000|Observational Period|Participant convenience|2|||
94361928|NCT00440193|323107430|FG001|Observational Period|Participant convenience|0|||
94361929|NCT00563706|323108759|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
94361930|NCT00563706|323108760|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
94361931|NCT00563706|323108761|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
94361932|NCT00563706|323108762|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
94361933|NCT00563706|323108763|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
94361934|NCT00563706|323108764|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
94361935|NCT00563706|323108765|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
94631167|NCT02111850|324109927|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
94631168|NCT02111850|324109928|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
94631169|NCT02998840|324109931|FG000|Overall Study|Lost to Follow-up|1|||
94631170|NCT02998840|324109932|FG001|Overall Study|Lost to Follow-up|1|||
94631171|NCT02998840|324109933|FG002|Overall Study|Lost to Follow-up|2|||
94631172|NCT02998840|324109934|FG003|Overall Study|Lost to Follow-up|3|||
94361936|NCT00563706|323108766|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
94361937|NCT00563706|323108767|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
94361938|NCT00563706|323108759|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
94631173|NCT02998840|324109931|FG000|Overall Study|Withdrawal by Subject|1|||
94631174|NCT02998840|324109932|FG001|Overall Study|Withdrawal by Subject|1|||
94631175|NCT02998840|324109933|FG002|Overall Study|Withdrawal by Subject|0|||
94631176|NCT02998840|324109934|FG003|Overall Study|Withdrawal by Subject|1|||
94631177|NCT02998840|324109931|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
94631178|NCT02998840|324109932|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
94631179|NCT02998840|324109933|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
94631180|NCT02998840|324109934|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
94361939|NCT00563706|323108760|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
94361940|NCT00563706|323108761|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
94361941|NCT00563706|323108762|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
94361942|NCT00563706|323108763|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
94461678|NCT00985959|323479580|FG001|Overall Study|Unrecovered toxicity|0|||
94631181|NCT03915496|324109935|FG000|Overall Study|Adverse Event|2|||
94258669|NCT05266586|322740535|FG000|Overall Study|Withdrawal by Subject|1|||
94258670|NCT05266586|322740536|FG001|Overall Study|Withdrawal by Subject|0|||
94258671|NCT05266586|322740537|FG002|Overall Study|Withdrawal by Subject|1|||
94258672|NCT05266586|322740535|FG000|Overall Study|Non-compliance with study drug|0|||
94258673|NCT05266586|322740536|FG001|Overall Study|Non-compliance with study drug|1|||
94258674|NCT05266586|322740537|FG002|Overall Study|Non-compliance with study drug|0|||
94258675|NCT05266586|322740535|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
94258676|NCT05266586|322740536|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
94258677|NCT05266586|322740537|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
94258678|NCT02225353|322740538|FG000|Overall Study|Lost to Follow-up|0|||
94258679|NCT02225353|322740539|FG001|Overall Study|Lost to Follow-up|1|||
94258680|NCT02225353|322740540|FG002|Overall Study|Lost to Follow-up|3|||
94258681|NCT02225353|322740538|FG000|Overall Study|Protocol Violation|4|||
94258682|NCT02225353|322740539|FG001|Overall Study|Protocol Violation|5|||
94258683|NCT02225353|322740540|FG002|Overall Study|Protocol Violation|12|||
94258684|NCT03254485|322740541|FG000|Overall Study|Adverse Event|3|||
94258685|NCT03254485|322740542|FG001|Overall Study|Adverse Event|0|||
94258686|NCT03254485|322740543|FG002|Overall Study|Adverse Event|0|||
94258687|NCT03254485|322740544|FG003|Overall Study|Adverse Event|6|||
94258688|NCT03254485|322740541|FG000|Overall Study|Protocol Violation|6|||
94258689|NCT03254485|322740542|FG001|Overall Study|Protocol Violation|0|||
94258690|NCT03254485|322740543|FG002|Overall Study|Protocol Violation|0|||
94258691|NCT03254485|322740544|FG003|Overall Study|Protocol Violation|2|||
94258692|NCT03254485|322740541|FG000|Overall Study|Withdrawal by Subject|1|||
94258693|NCT03254485|322740542|FG001|Overall Study|Withdrawal by Subject|0|||
94258694|NCT03254485|322740543|FG002|Overall Study|Withdrawal by Subject|0|||
94258695|NCT03254485|322740544|FG003|Overall Study|Withdrawal by Subject|4|||
94258696|NCT03254485|322740541|FG000|Overall Study|Death|0|||
94258697|NCT03254485|322740542|FG001|Overall Study|Death|0|||
94258698|NCT03254485|322740543|FG002|Overall Study|Death|0|||
94258699|NCT03254485|322740544|FG003|Overall Study|Death|1|||
94258700|NCT03254485|322740541|FG000|Overall Study|Lost to Follow-up|1|||
94258701|NCT03254485|322740542|FG001|Overall Study|Lost to Follow-up|0|||
94258702|NCT03254485|322740543|FG002|Overall Study|Lost to Follow-up|0|||
94258703|NCT03254485|322740544|FG003|Overall Study|Lost to Follow-up|0|||
94258704|NCT03254485|322740541|FG000|Overall Study|Other|1|||
94258705|NCT03254485|322740542|FG001|Overall Study|Other|0|||
94258706|NCT03254485|322740543|FG002|Overall Study|Other|0|||
94258707|NCT03254485|322740544|FG003|Overall Study|Other|2|||
94258708|NCT01079130|322740547|FG000|Overall Study|Adverse Event|1|||
94258709|NCT01079130|322740548|FG001|Overall Study|Adverse Event|1|||
94258710|NCT01079130|322740549|FG002|Overall Study|Adverse Event|0|||
94258711|NCT01079130|322740550|FG003|Overall Study|Adverse Event|1|||
94258712|NCT01079130|322740551|FG004|Overall Study|Adverse Event|5|||
94258713|NCT01079130|322740552|FG005|Overall Study|Adverse Event|1|||
94258714|NCT01079130|322740547|FG000|Overall Study|Administrative problems|1|||
94258715|NCT01079130|322740548|FG001|Overall Study|Administrative problems|3|||
94258716|NCT01079130|322740549|FG002|Overall Study|Administrative problems|0|||
94258717|NCT01079130|322740550|FG003|Overall Study|Administrative problems|0|||
94258718|NCT01079130|322740551|FG004|Overall Study|Administrative problems|0|||
94258719|NCT01079130|322740552|FG005|Overall Study|Administrative problems|1|||
94258720|NCT01079130|322740547|FG000|Overall Study|Withdrawal by Subject|0|||
94258721|NCT01079130|322740548|FG001|Overall Study|Withdrawal by Subject|1|||
94258722|NCT01079130|322740549|FG002|Overall Study|Withdrawal by Subject|0|||
94258723|NCT01079130|322740550|FG003|Overall Study|Withdrawal by Subject|0|||
94258724|NCT01079130|322740551|FG004|Overall Study|Withdrawal by Subject|1|||
94258725|NCT01079130|322740552|FG005|Overall Study|Withdrawal by Subject|3|||
94258726|NCT01079130|322740547|FG000|Overall Study|Protocol deviation|0|||
94258727|NCT01079130|322740548|FG001|Overall Study|Protocol deviation|2|||
94258728|NCT01079130|322740549|FG002|Overall Study|Protocol deviation|1|||
94258729|NCT01079130|322740550|FG003|Overall Study|Protocol deviation|2|||
94258730|NCT01079130|322740551|FG004|Overall Study|Protocol deviation|0|||
94258731|NCT01079130|322740552|FG005|Overall Study|Protocol deviation|0|||
94258732|NCT01079130|322740547|FG000|Overall Study|Abnormal test procedure result(s)|0|||
94258733|NCT01079130|322740548|FG001|Overall Study|Abnormal test procedure result(s)|0|||
94258734|NCT01079130|322740549|FG002|Overall Study|Abnormal test procedure result(s)|0|||
94258735|NCT01079130|322740550|FG003|Overall Study|Abnormal test procedure result(s)|0|||
94258736|NCT01079130|322740551|FG004|Overall Study|Abnormal test procedure result(s)|1|||
94258737|NCT01079130|322740552|FG005|Overall Study|Abnormal test procedure result(s)|0|||
94258738|NCT01079130|322740547|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94258739|NCT01079130|322740548|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94258740|NCT01079130|322740549|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
94258741|NCT01079130|322740550|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
94258742|NCT01079130|322740551|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
94258743|NCT01079130|322740552|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
94258744|NCT01079130|322740547|FG000|Overall Study|Lost to Follow-up|0|||
94258745|NCT01079130|322740548|FG001|Overall Study|Lost to Follow-up|0|||
94631182|NCT03915496|324109936|FG001|Overall Study|Adverse Event|1|||
94631183|NCT03915496|324109937|FG002|Overall Study|Adverse Event|2|||
94631184|NCT02480114|324109938|FG000|Overall Study|Not completing surveys|3|||
94631185|NCT02480114|324109939|FG001|Overall Study|Not completing surveys|2|||
94631186|NCT02480114|324109938|FG000|Overall Study|Withdrawal by Subject|2|||
94631187|NCT02480114|324109939|FG001|Overall Study|Withdrawal by Subject|4|||
94631188|NCT02480114|324109938|FG000|Overall Study|Disease progression|3|||
94631189|NCT02480114|324109939|FG001|Overall Study|Disease progression|0|||
94631190|NCT02480114|324109938|FG000|Overall Study|Improper completion of survey|1|||
94631191|NCT02480114|324109939|FG001|Overall Study|Improper completion of survey|1|||
94631192|NCT02480114|324109938|FG000|Overall Study|Not eligible|0|||
94258746|NCT01079130|322740549|FG002|Overall Study|Lost to Follow-up|0|||
94258747|NCT01079130|322740550|FG003|Overall Study|Lost to Follow-up|0|||
94258748|NCT01079130|322740551|FG004|Overall Study|Lost to Follow-up|1|||
94258749|NCT01079130|322740552|FG005|Overall Study|Lost to Follow-up|0|||
94258750|NCT03442114|322740557|FG000|Overall Study|Lost to Follow-up|13|||
94258751|NCT03442114|322740558|FG001|Overall Study|Lost to Follow-up|13|||
94258752|NCT03442114|322740557|FG000|Overall Study|Physician Decision|2|||
94258753|NCT03442114|322740558|FG001|Overall Study|Physician Decision|2|||
94258754|NCT03442114|322740557|FG000|Overall Study|Protocol Violation|0|||
94258755|NCT03442114|322740558|FG001|Overall Study|Protocol Violation|2|||
94258756|NCT03442114|322740557|FG000|Overall Study|Withdrawal by Subject|1|||
94258757|NCT03442114|322740558|FG001|Overall Study|Withdrawal by Subject|3|||
94258758|NCT03442114|322740557|FG000|Overall Study|Guardianship Change|0|||
94258759|NCT03442114|322740558|FG001|Overall Study|Guardianship Change|1|||
94258760|NCT02903368|322740559|FG000|Part 1|Adverse Event|3|||
94258761|NCT02903368|322740560|FG001|Part 1|Adverse Event|0|||
94258762|NCT02903368|322740561|FG002|Part 1|Adverse Event|0|||
94258763|NCT02903368|322740562|FG003|Part 1|Adverse Event|0|||
94258764|NCT02903368|322740559|FG000|Part 1|Withdrawal by Subject|1|||
94258765|NCT02903368|322740560|FG001|Part 1|Withdrawal by Subject|0|||
94258766|NCT02903368|322740561|FG002|Part 1|Withdrawal by Subject|0|||
94258767|NCT02903368|322740562|FG003|Part 1|Withdrawal by Subject|0|||
94258768|NCT02903368|322740559|FG000|Part 2|Adverse Event|0|||
94258769|NCT02903368|322740560|FG001|Part 2|Adverse Event|0|||
94258770|NCT02903368|322740561|FG002|Part 2|Adverse Event|5|||
94258771|NCT02903368|322740562|FG003|Part 2|Adverse Event|0|||
94258772|NCT02903368|322740559|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
94258773|NCT02903368|322740560|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
94258774|NCT02903368|322740561|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
94258775|NCT02903368|322740562|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
94258776|NCT02903368|322740559|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
94258777|NCT02903368|322740560|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
94258778|NCT02903368|322740561|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
94258779|NCT02903368|322740562|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
94258780|NCT02903368|322740559|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
94258781|NCT02903368|322740560|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
94258782|NCT02903368|322740561|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
94258783|NCT02903368|322740562|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
94258784|NCT02901041|322742224|FG000|Overall Study|Withdrawal by PI|4|||
94258785|NCT02901041|322742225|FG001|Overall Study|Withdrawal by PI|8|||
94258786|NCT02901041|322742224|FG000|Overall Study|Withdrawal by Subject|7|||
94258787|NCT02901041|322742225|FG001|Overall Study|Withdrawal by Subject|3|||
94258788|NCT03818204|322742226|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
94258789|NCT03818204|322742227|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
94258790|NCT03818204|322742228|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
94258791|NCT03818204|322742229|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
94258792|NCT03818204|322742230|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
94258793|NCT03818204|322742231|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
94258794|NCT03818204|322742232|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
94258795|NCT03818204|322742233|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
94258796|NCT03818204|322742234|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
94258797|NCT03818204|322742235|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
94258798|NCT03818204|322742236|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
94258799|NCT03818204|322742237|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
94258800|NCT03818204|322742238|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
94258801|NCT03818204|322742239|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
94631193|NCT02480114|324109939|FG001|Overall Study|Not eligible|1|||
94631194|NCT02554812|324109940|FG000|Overall Study|Adverse Event|2|||
94631195|NCT02554812|324109941|FG001|Overall Study|Adverse Event|5|||
94631196|NCT02554812|324109942|FG002|Overall Study|Adverse Event|3|||
94361943|NCT00563706|323108764|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
94361944|NCT00563706|323108765|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
94361945|NCT00563706|323108766|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
94361946|NCT00563706|323108767|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
94461679|NCT00985959|323479581|FG002|Overall Study|Unrecovered toxicity|7|||
94461680|NCT00985959|323479579|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
94461681|NCT00985959|323479580|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
94461682|NCT00985959|323479581|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
94361947|NCT00563706|323108759|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
94361948|NCT00563706|323108760|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
94361949|NCT00563706|323108761|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
94361950|NCT00563706|323108762|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
94361951|NCT00563706|323108763|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
94361952|NCT00563706|323108764|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
94361953|NCT00563706|323108765|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
94361954|NCT00563706|323108766|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
94361955|NCT00563706|323108767|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
94361956|NCT00563706|323108759|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
94361957|NCT00563706|323108760|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
94361958|NCT00563706|323108761|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
94361959|NCT00563706|323108762|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
94361960|NCT00563706|323108763|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
94361961|NCT00563706|323108764|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
94361962|NCT00563706|323108765|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
94361963|NCT00563706|323108766|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
94361964|NCT00563706|323108767|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
94361965|NCT00563706|323108759|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
94361966|NCT00563706|323108760|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
94361967|NCT00563706|323108761|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
94361968|NCT00563706|323108762|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
94361969|NCT00563706|323108763|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
94361970|NCT00563706|323108764|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
94361971|NCT00563706|323108765|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
94361972|NCT00563706|323108766|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
94361973|NCT00563706|323108767|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
94361974|NCT01646268|323108768|FG000|Overall Study|Adverse Event|6|||
94361975|NCT01646268|323108769|FG001|Overall Study|Adverse Event|7|||
94361976|NCT01646268|323108768|FG000|Overall Study|Lack of Efficacy|1|||
94361977|NCT01646268|323108769|FG001|Overall Study|Lack of Efficacy|3|||
94361978|NCT01646268|323108768|FG000|Overall Study|Protocol Violation|0|||
94361979|NCT01646268|323108769|FG001|Overall Study|Protocol Violation|1|||
94361980|NCT01646268|323108768|FG000|Overall Study|Withdrawal by Subject|2|||
94361981|NCT01646268|323108769|FG001|Overall Study|Withdrawal by Subject|5|||
94361982|NCT01646268|323108768|FG000|Overall Study|Other|2|||
94361983|NCT01646268|323108769|FG001|Overall Study|Other|0|||
94361984|NCT00347776|323108773|FG000|1.5 Month Follow-up|Death|2|||
94361985|NCT00347776|323108774|FG001|1.5 Month Follow-up|Death|0|||
94361986|NCT00347776|323108775|FG002|1.5 Month Follow-up|Death|0|||
94361987|NCT00347776|323108773|FG000|1.5 Month Follow-up|reached the endpoint|12|||
94361988|NCT00347776|323108774|FG001|1.5 Month Follow-up|reached the endpoint|8|||
94361989|NCT00347776|323108775|FG002|1.5 Month Follow-up|reached the endpoint|12|||
94361990|NCT00347776|323108773|FG000|6 Month Follow-up|Death|2|||
94361991|NCT00347776|323108774|FG001|6 Month Follow-up|Death|1|||
94361992|NCT00347776|323108775|FG002|6 Month Follow-up|Death|3|||
94361993|NCT00347776|323108773|FG000|6 Month Follow-up|reached endpont|20|||
94361994|NCT00347776|323108774|FG001|6 Month Follow-up|reached endpont|12|||
94361995|NCT00347776|323108775|FG002|6 Month Follow-up|reached endpont|15|||
94361996|NCT00347776|323108773|FG000|12 Month Follow-up|Lost to Follow-up|7|||
94361997|NCT00347776|323108774|FG001|12 Month Follow-up|Lost to Follow-up|6|||
94361998|NCT00347776|323108775|FG002|12 Month Follow-up|Lost to Follow-up|6|||
94361999|NCT00347776|323108773|FG000|12 Month Follow-up|Death|3|||
94362000|NCT00347776|323108774|FG001|12 Month Follow-up|Death|4|||
94461683|NCT00985959|323479579|FG000|Overall Study|Complete response observed over 2 cycles|0|||
94461684|NCT00985959|323479580|FG001|Overall Study|Complete response observed over 2 cycles|1|||
94461685|NCT00985959|323479581|FG002|Overall Study|Complete response observed over 2 cycles|4|||
94461686|NCT00985959|323479579|FG000|Overall Study|Other|0|||
94461687|NCT00985959|323479580|FG001|Overall Study|Other|0|||
94631197|NCT02554812|324109943|FG003|Overall Study|Adverse Event|0|||
94362001|NCT00347776|323108775|FG002|12 Month Follow-up|Death|4|||
94362002|NCT00347776|323108773|FG000|12 Month Follow-up|Reached endpoint|13|||
94461688|NCT00985959|323479581|FG002|Overall Study|Other|11|||
94258802|NCT03818204|322742240|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
94258803|NCT03818204|322742241|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
94258804|NCT03818204|322742242|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
94258805|NCT03818204|322742243|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
94258806|NCT03818204|322742244|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
94258807|NCT03818204|322742226|FG000|Overall Study|Physician Decision|0|||
94258808|NCT03818204|322742227|FG001|Overall Study|Physician Decision|0|||
94258809|NCT03818204|322742228|FG002|Overall Study|Physician Decision|0|||
94258810|NCT03818204|322742229|FG003|Overall Study|Physician Decision|0|||
94258811|NCT03818204|322742230|FG004|Overall Study|Physician Decision|0|||
94258812|NCT03818204|322742231|FG005|Overall Study|Physician Decision|0|||
94258813|NCT03818204|322742232|FG006|Overall Study|Physician Decision|0|||
94258814|NCT03818204|322742233|FG007|Overall Study|Physician Decision|0|||
94258815|NCT03818204|322742234|FG008|Overall Study|Physician Decision|0|||
94258816|NCT03818204|322742235|FG009|Overall Study|Physician Decision|0|||
94258817|NCT03818204|322742236|FG010|Overall Study|Physician Decision|0|||
94258818|NCT03818204|322742237|FG011|Overall Study|Physician Decision|0|||
94258819|NCT03818204|322742238|FG012|Overall Study|Physician Decision|0|||
94258820|NCT03818204|322742239|FG013|Overall Study|Physician Decision|0|||
94258821|NCT03818204|322742240|FG014|Overall Study|Physician Decision|1|||
94258822|NCT03818204|322742241|FG015|Overall Study|Physician Decision|0|||
94258823|NCT03818204|322742242|FG016|Overall Study|Physician Decision|0|||
94258824|NCT03818204|322742243|FG017|Overall Study|Physician Decision|0|||
94258825|NCT03818204|322742244|FG018|Overall Study|Physician Decision|0|||
94258826|NCT03864146|322742250|FG000|Overall Study|Lost to Follow-up|14|||
94258827|NCT03864146|322742251|FG001|Overall Study|Lost to Follow-up|23|||
94258828|NCT03864146|322742250|FG000|Overall Study|Withdrawal by Subject|3|||
94258829|NCT03864146|322742251|FG001|Overall Study|Withdrawal by Subject|2|||
94258830|NCT01933113|322742259|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
94258831|NCT00879762|322742260|FG000|Overall Study|Lost to Follow-up|3|||
94258832|NCT00879762|322742261|FG001|Overall Study|Lost to Follow-up|1|||
94258833|NCT04981366|322742262|FG000|Overall Study|Withdrawal by Subject|5|||
94258834|NCT04981366|322742263|FG001|Overall Study|Withdrawal by Subject|4|||
94258835|NCT04981366|322742264|FG002|Overall Study|Withdrawal by Subject|8|||
94461689|NCT01043705|323479585|FG000|Overall Study|Death|28|||
94461690|NCT01043705|323479586|FG001|Overall Study|Death|60|||
94461691|NCT01043705|323479587|FG002|Overall Study|Death|26|||
94461692|NCT01043705|323479585|FG000|Overall Study|Lost to Follow-up|27|||
94461693|NCT01043705|323479586|FG001|Overall Study|Lost to Follow-up|12|||
94461694|NCT01043705|323479587|FG002|Overall Study|Lost to Follow-up|0|||
94461695|NCT01043705|323479585|FG000|Overall Study|Multiple Reasons|4|||
94461696|NCT01043705|323479586|FG001|Overall Study|Multiple Reasons|7|||
94461697|NCT01043705|323479587|FG002|Overall Study|Multiple Reasons|0|||
94461698|NCT01043705|323479585|FG000|Overall Study|Protocol Violation|2|||
94461699|NCT01043705|323479586|FG001|Overall Study|Protocol Violation|1|||
94461700|NCT01043705|323479587|FG002|Overall Study|Protocol Violation|0|||
94461701|NCT01043705|323479585|FG000|Overall Study|Withdrawal by Subject|8|||
94258836|NCT04981366|322742262|FG000|Overall Study|Health issues unrelated to the trial|1|||
94258837|NCT04981366|322742263|FG001|Overall Study|Health issues unrelated to the trial|2|||
94258838|NCT04981366|322742264|FG002|Overall Study|Health issues unrelated to the trial|0|||
94258839|NCT01676909|322742265|FG000|Overall Study|Withdrawal by Subject|3|||
94258840|NCT01676909|322742266|FG001|Overall Study|Withdrawal by Subject|5|||
94258841|NCT01676909|322742265|FG000|Overall Study|Lost to Follow-up|15|||
94258842|NCT01676909|322742266|FG001|Overall Study|Lost to Follow-up|9|||
94258843|NCT00162032|322742272|FG000|Overall Study|Lost to Follow-up|4|||
94258844|NCT00162032|322742273|FG001|Overall Study|Lost to Follow-up|2|||
94258845|NCT00162032|322742272|FG000|Overall Study|Reason not specified|1|||
94258846|NCT00162032|322742273|FG001|Overall Study|Reason not specified|0|||
94258847|NCT04661878|322742274|FG000|Overall Study|Lost to Follow-up|6|||
94258848|NCT04661878|322742275|FG001|Overall Study|Lost to Follow-up|5|||
94258849|NCT03437278|322742278|FG000|Overall Study|Adverse Event|0|||
94258850|NCT03437278|322742279|FG001|Overall Study|Adverse Event|0|||
94258851|NCT03437278|322742280|FG002|Overall Study|Adverse Event|1|||
94258852|NCT03437278|322742278|FG000|Overall Study|Progressive disease|1|||
94258853|NCT03437278|322742279|FG001|Overall Study|Progressive disease|0|||
94258854|NCT03437278|322742280|FG002|Overall Study|Progressive disease|0|||
94258855|NCT03437278|322742278|FG000|Overall Study|Physician Decision|1|||
94258856|NCT03437278|322742279|FG001|Overall Study|Physician Decision|0|||
94258857|NCT03437278|322742280|FG002|Overall Study|Physician Decision|1|||
94258858|NCT02683941|322742281|FG000|Double-blind Phase|Adverse Event|0|||
94258859|NCT02683941|322742282|FG001|Double-blind Phase|Adverse Event|1|||
94258860|NCT02683941|322742281|FG000|Double-blind Phase|Withdrawal by Subject|4|||
94258861|NCT02683941|322742282|FG001|Double-blind Phase|Withdrawal by Subject|2|||
94258862|NCT02683941|322742281|FG000|Double-blind Phase|Lost to Follow-up|1|||
94258863|NCT02683941|322742282|FG001|Double-blind Phase|Lost to Follow-up|0|||
94461702|NCT01043705|323479586|FG001|Overall Study|Withdrawal by Subject|6|||
94461703|NCT01043705|323479587|FG002|Overall Study|Withdrawal by Subject|0|||
94461704|NCT01043705|323479585|FG000|Overall Study|Site Closure|8|||
94675644|NCT02755597|324265459|FG000|Overall Study|Other, not specified|20|||
94675645|NCT02755597|324265460|FG001|Overall Study|Other, not specified|3|||
94675646|NCT02755597|324265459|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
94675647|NCT02755597|324265460|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
94675648|NCT03205371|324265461|FG000|Overall Study|Withdrawal by Subject|4|||
94258864|NCT02683941|322742281|FG000|Double-blind Phase|Disease Progression|5|||
94258865|NCT02683941|322742282|FG001|Double-blind Phase|Disease Progression|2|||
94258866|NCT02683941|322742281|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
94258867|NCT02683941|322742282|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
94258868|NCT02683941|322742281|FG000|Open-label Treatment Phase|Disease Progression|1|||
94258869|NCT02683941|322742282|FG001|Open-label Treatment Phase|Disease Progression|2|||
94258870|NCT02683941|322742281|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
94258871|NCT02683941|322742282|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
94258872|NCT02683941|322742281|FG000|Open-label Treatment Phase|Other|1|||
94258873|NCT02683941|322742282|FG001|Open-label Treatment Phase|Other|0|||
94258874|NCT02683941|322742281|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
94258875|NCT02683941|322742282|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
94258876|NCT02683941|322742281|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
94258877|NCT02683941|322742282|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
94258878|NCT02683941|322742281|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
94258879|NCT02683941|322742282|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
94258880|NCT02683941|322742281|FG000|Open-label Follow-up Phase|Other|8|||
94258881|NCT02683941|322742282|FG001|Open-label Follow-up Phase|Other|1|||
94258882|NCT02446886|322742283|FG000|Overall Study|Adverse Event|1|||
94258883|NCT02446886|322742284|FG001|Overall Study|Adverse Event|3|||
94258884|NCT02446886|322742283|FG000|Overall Study|Withdrawal by Subject|1|||
94258885|NCT02446886|322742284|FG001|Overall Study|Withdrawal by Subject|1|||
94258886|NCT00926211|322742287|FG000|Overall Study|Lost to Follow-up|1|||
94258887|NCT00392327|322742288|FG000|Overall Study|Death|1|||
94258888|NCT00392327|322742289|FG001|Overall Study|Death|0|||
94258889|NCT00392327|322742290|FG002|Overall Study|Death|1|||
94258890|NCT00392327|322742291|FG003|Overall Study|Death|0|||
94258891|NCT00392327|322742292|FG004|Overall Study|Death|0|||
94258892|NCT00392327|322742293|FG005|Overall Study|Death|0|||
94258893|NCT00392327|322742294|FG006|Overall Study|Death|0|||
94258894|NCT00392327|322742295|FG007|Overall Study|Death|0|||
94258895|NCT00392327|322742288|FG000|Overall Study|Lack of Efficacy|8|||
94258896|NCT00392327|322742289|FG001|Overall Study|Lack of Efficacy|8|||
94258897|NCT00392327|322742290|FG002|Overall Study|Lack of Efficacy|9|||
94258898|NCT00392327|322742291|FG003|Overall Study|Lack of Efficacy|6|||
94258899|NCT00392327|322742292|FG004|Overall Study|Lack of Efficacy|3|||
94258900|NCT00392327|322742293|FG005|Overall Study|Lack of Efficacy|3|||
94258901|NCT00392327|322742294|FG006|Overall Study|Lack of Efficacy|3|||
94258902|NCT00392327|322742295|FG007|Overall Study|Lack of Efficacy|3|||
94258903|NCT00392327|322742288|FG000|Overall Study|Physician Decision|3|||
94258904|NCT00392327|322742289|FG001|Overall Study|Physician Decision|5|||
94258905|NCT00392327|322742290|FG002|Overall Study|Physician Decision|2|||
94258906|NCT00392327|322742291|FG003|Overall Study|Physician Decision|2|||
94258907|NCT00392327|322742292|FG004|Overall Study|Physician Decision|0|||
94258908|NCT00392327|322742293|FG005|Overall Study|Physician Decision|1|||
94258909|NCT00392327|322742294|FG006|Overall Study|Physician Decision|5|||
94258910|NCT00392327|322742295|FG007|Overall Study|Physician Decision|3|||
94258911|NCT00392327|322742288|FG000|Overall Study|Protocol Violation|0|||
94258912|NCT00392327|322742289|FG001|Overall Study|Protocol Violation|0|||
94258913|NCT00392327|322742290|FG002|Overall Study|Protocol Violation|1|||
94362003|NCT00347776|323108774|FG001|12 Month Follow-up|Reached endpoint|6|||
94258914|NCT00392327|322742291|FG003|Overall Study|Protocol Violation|0|||
94258915|NCT00392327|322742292|FG004|Overall Study|Protocol Violation|0|||
94258916|NCT00392327|322742293|FG005|Overall Study|Protocol Violation|0|||
94258917|NCT00392327|322742294|FG006|Overall Study|Protocol Violation|0|||
94258918|NCT00392327|322742295|FG007|Overall Study|Protocol Violation|0|||
94258919|NCT00392327|322742288|FG000|Overall Study|Withdrawal by Subject|3|||
94362004|NCT00347776|323108775|FG002|12 Month Follow-up|Reached endpoint|9|||
94675649|NCT03205371|324265462|FG001|Overall Study|Withdrawal by Subject|1|||
94675650|NCT03205371|324265463|FG002|Overall Study|Withdrawal by Subject|0|||
94258920|NCT00392327|322742289|FG001|Overall Study|Withdrawal by Subject|2|||
94258921|NCT00392327|322742290|FG002|Overall Study|Withdrawal by Subject|4|||
94258922|NCT00392327|322742291|FG003|Overall Study|Withdrawal by Subject|6|||
94675651|NCT03205371|324265464|FG003|Overall Study|Withdrawal by Subject|0|||
94675652|NCT03205371|324265465|FG004|Overall Study|Withdrawal by Subject|0|||
94675653|NCT03205371|324265466|FG005|Overall Study|Withdrawal by Subject|0|||
94675654|NCT03205371|324265467|FG006|Overall Study|Withdrawal by Subject|4|||
94675655|NCT03205371|324265468|FG007|Overall Study|Withdrawal by Subject|0|||
94675656|NCT03205371|324265469|FG008|Overall Study|Withdrawal by Subject|2|||
94675657|NCT03205371|324265470|FG009|Overall Study|Withdrawal by Subject|0|||
94675658|NCT03205371|324265471|FG010|Overall Study|Withdrawal by Subject|0|||
94675659|NCT03205371|324265472|FG011|Overall Study|Withdrawal by Subject|1|||
94675660|NCT03205371|324265461|FG000|Overall Study|Lost to Follow-up|0|||
94675661|NCT03205371|324265462|FG001|Overall Study|Lost to Follow-up|0|||
94675662|NCT03205371|324265463|FG002|Overall Study|Lost to Follow-up|0|||
94675663|NCT03205371|324265464|FG003|Overall Study|Lost to Follow-up|0|||
94675664|NCT03205371|324265465|FG004|Overall Study|Lost to Follow-up|0|||
94675665|NCT03205371|324265466|FG005|Overall Study|Lost to Follow-up|0|||
94675666|NCT03205371|324265467|FG006|Overall Study|Lost to Follow-up|5|||
94675667|NCT03205371|324265468|FG007|Overall Study|Lost to Follow-up|2|||
94675668|NCT03205371|324265469|FG008|Overall Study|Lost to Follow-up|3|||
94675669|NCT03205371|324265470|FG009|Overall Study|Lost to Follow-up|0|||
94675670|NCT03205371|324265471|FG010|Overall Study|Lost to Follow-up|0|||
94675671|NCT03205371|324265472|FG011|Overall Study|Lost to Follow-up|0|||
94675672|NCT03205371|324265461|FG000|Overall Study|Protocol Violation|0|||
94675673|NCT03205371|324265462|FG001|Overall Study|Protocol Violation|0|||
94675674|NCT03205371|324265463|FG002|Overall Study|Protocol Violation|0|||
94675675|NCT03205371|324265464|FG003|Overall Study|Protocol Violation|0|||
94675676|NCT03205371|324265465|FG004|Overall Study|Protocol Violation|0|||
94675677|NCT03205371|324265466|FG005|Overall Study|Protocol Violation|0|||
94675678|NCT03205371|324265467|FG006|Overall Study|Protocol Violation|1|||
94675679|NCT03205371|324265468|FG007|Overall Study|Protocol Violation|0|||
94675680|NCT03205371|324265469|FG008|Overall Study|Protocol Violation|0|||
94362005|NCT03099265|323108776|FG000|Overall Study|Adverse Event|1|||
94362006|NCT00396318|323108779|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
94362007|NCT00290511|323108780|FG000|Overall Study|Adverse Event|1|||
94631198|NCT02554812|324109944|FG004|Overall Study|Adverse Event|5|||
94631199|NCT02554812|324109945|FG005|Overall Study|Adverse Event|0|||
94631200|NCT02554812|324109946|FG006|Overall Study|Adverse Event|1|||
94631201|NCT02554812|324109947|FG007|Overall Study|Adverse Event|6|||
94631202|NCT02554812|324109948|FG008|Overall Study|Adverse Event|2|||
94631203|NCT02554812|324109949|FG009|Overall Study|Adverse Event|2|||
94631204|NCT02554812|324109950|FG010|Overall Study|Adverse Event|1|||
94631205|NCT02554812|324109951|FG011|Overall Study|Adverse Event|2|||
94675681|NCT03205371|324265470|FG009|Overall Study|Protocol Violation|0|||
94675682|NCT03205371|324265471|FG010|Overall Study|Protocol Violation|0|||
94631206|NCT02554812|324109952|FG012|Overall Study|Adverse Event|0|||
94675683|NCT03205371|324265472|FG011|Overall Study|Protocol Violation|0|||
94675684|NCT03205371|324265461|FG000|Overall Study|Adverse Event|0|||
94675685|NCT03205371|324265462|FG001|Overall Study|Adverse Event|0|||
94675686|NCT03205371|324265463|FG002|Overall Study|Adverse Event|0|||
94675687|NCT03205371|324265464|FG003|Overall Study|Adverse Event|0|||
94258923|NCT00392327|322742292|FG004|Overall Study|Withdrawal by Subject|0|||
94258924|NCT00392327|322742293|FG005|Overall Study|Withdrawal by Subject|1|||
94258925|NCT00392327|322742294|FG006|Overall Study|Withdrawal by Subject|1|||
94258926|NCT00392327|322742295|FG007|Overall Study|Withdrawal by Subject|5|||
94258927|NCT00392327|322742288|FG000|Overall Study|Ineligible|0|||
94258928|NCT00392327|322742289|FG001|Overall Study|Ineligible|4|||
94258929|NCT00392327|322742290|FG002|Overall Study|Ineligible|3|||
94631207|NCT02554812|324109953|FG013|Overall Study|Adverse Event|3|||
94631208|NCT02554812|324109954|FG014|Overall Study|Adverse Event|2|||
94631209|NCT02554812|324109955|FG015|Overall Study|Adverse Event|1|||
94631210|NCT02554812|324109956|FG016|Overall Study|Adverse Event|0|||
94631211|NCT02554812|324109957|FG017|Overall Study|Adverse Event|1|||
94631212|NCT02554812|324109958|FG018|Overall Study|Adverse Event|0|||
94631213|NCT02554812|324109959|FG019|Overall Study|Adverse Event|0|||
94631214|NCT02554812|324109960|FG020|Overall Study|Adverse Event|0|||
94631215|NCT02554812|324109961|FG021|Overall Study|Adverse Event|2|||
94631216|NCT02554812|324109962|FG022|Overall Study|Adverse Event|1|||
94631217|NCT02554812|324109963|FG023|Overall Study|Adverse Event|1|||
94631218|NCT02554812|324109964|FG024|Overall Study|Adverse Event|1|||
94631219|NCT02554812|324109965|FG025|Overall Study|Adverse Event|2|||
94631220|NCT02554812|324109966|FG026|Overall Study|Adverse Event|1|||
94631221|NCT02554812|324109940|FG000|Overall Study|Death|1|||
94631222|NCT02554812|324109941|FG001|Overall Study|Death|2|||
94631223|NCT02554812|324109942|FG002|Overall Study|Death|2|||
94631224|NCT02554812|324109943|FG003|Overall Study|Death|2|||
94631225|NCT02554812|324109944|FG004|Overall Study|Death|0|||
94631226|NCT02554812|324109945|FG005|Overall Study|Death|1|||
94631227|NCT02554812|324109946|FG006|Overall Study|Death|1|||
94675688|NCT03205371|324265465|FG004|Overall Study|Adverse Event|0|||
94631228|NCT02554812|324109947|FG007|Overall Study|Death|1|||
94631229|NCT02554812|324109948|FG008|Overall Study|Death|0|||
94258930|NCT00392327|322742291|FG003|Overall Study|Ineligible|2|||
94631230|NCT02554812|324109949|FG009|Overall Study|Death|0|||
94631231|NCT02554812|324109950|FG010|Overall Study|Death|0|||
94631232|NCT02554812|324109951|FG011|Overall Study|Death|0|||
94631233|NCT02554812|324109952|FG012|Overall Study|Death|0|||
94631234|NCT02554812|324109953|FG013|Overall Study|Death|0|||
94631235|NCT02554812|324109954|FG014|Overall Study|Death|1|||
94631236|NCT02554812|324109955|FG015|Overall Study|Death|1|||
94631237|NCT02554812|324109956|FG016|Overall Study|Death|1|||
94631238|NCT02554812|324109957|FG017|Overall Study|Death|0|||
94258931|NCT00392327|322742292|FG004|Overall Study|Ineligible|0|||
94258932|NCT00392327|322742293|FG005|Overall Study|Ineligible|0|||
94258933|NCT00392327|322742294|FG006|Overall Study|Ineligible|0|||
94258934|NCT00392327|322742295|FG007|Overall Study|Ineligible|0|||
94258935|NCT02409368|322742299|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
94258936|NCT02409368|322742300|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
94631239|NCT02554812|324109958|FG018|Overall Study|Death|1|||
94631240|NCT02554812|324109959|FG019|Overall Study|Death|2|||
94631241|NCT02554812|324109960|FG020|Overall Study|Death|0|||
94631242|NCT02554812|324109961|FG021|Overall Study|Death|1|||
94631243|NCT02554812|324109962|FG022|Overall Study|Death|1|||
94258937|NCT02409368|322742301|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
94258938|NCT02409368|322742302|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
94258939|NCT02409368|322742299|FG000|ECOG Reclassification|Death|1|||
94258940|NCT02409368|322742300|FG001|ECOG Reclassification|Death|5|||
94258941|NCT02409368|322742301|FG002|ECOG Reclassification|Death|0|||
94631244|NCT02554812|324109963|FG023|Overall Study|Death|0|||
94631245|NCT02554812|324109964|FG024|Overall Study|Death|0|||
94631246|NCT02554812|324109965|FG025|Overall Study|Death|0|||
94631247|NCT02554812|324109966|FG026|Overall Study|Death|0|||
94631248|NCT02554812|324109940|FG000|Overall Study|Lost to Follow-up|0|||
94631249|NCT02554812|324109941|FG001|Overall Study|Lost to Follow-up|1|||
94631250|NCT02554812|324109942|FG002|Overall Study|Lost to Follow-up|0|||
94258942|NCT02409368|322742302|FG003|ECOG Reclassification|Death|0|||
94258943|NCT02409368|322742299|FG000|ECOG Reclassification|Disease Progression|113|||
94258944|NCT02409368|322742300|FG001|ECOG Reclassification|Disease Progression|382|||
94258945|NCT02409368|322742301|FG002|ECOG Reclassification|Disease Progression|70|||
94631251|NCT02554812|324109943|FG003|Overall Study|Lost to Follow-up|0|||
94631252|NCT02554812|324109944|FG004|Overall Study|Lost to Follow-up|0|||
94258946|NCT02409368|322742302|FG003|ECOG Reclassification|Disease Progression|1|||
94631253|NCT02554812|324109945|FG005|Overall Study|Lost to Follow-up|0|||
94631254|NCT02554812|324109946|FG006|Overall Study|Lost to Follow-up|0|||
94675689|NCT03205371|324265466|FG005|Overall Study|Adverse Event|0|||
94675690|NCT03205371|324265467|FG006|Overall Study|Adverse Event|0|||
94675691|NCT03205371|324265468|FG007|Overall Study|Adverse Event|1|||
94675692|NCT03205371|324265469|FG008|Overall Study|Adverse Event|0|||
94675693|NCT03205371|324265470|FG009|Overall Study|Adverse Event|0|||
94675694|NCT03205371|324265471|FG010|Overall Study|Adverse Event|0|||
94675695|NCT03205371|324265472|FG011|Overall Study|Adverse Event|0|||
94675696|NCT02835339|324265482|FG000|Overall Study|Did not receive allocated intervention|13|||
94258947|NCT02409368|322742299|FG000|ECOG Reclassification|Lost to Follow-up|1|||
94258948|NCT02409368|322742300|FG001|ECOG Reclassification|Lost to Follow-up|5|||
94258949|NCT02409368|322742301|FG002|ECOG Reclassification|Lost to Follow-up|0|||
94258950|NCT02409368|322742302|FG003|ECOG Reclassification|Lost to Follow-up|0|||
94258951|NCT02409368|322742299|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
94258952|NCT02409368|322742300|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
94258953|NCT02409368|322742301|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
94258954|NCT02409368|322742302|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
94258955|NCT02409368|322742299|FG000|ECOG Reclassification|Poor/non-compliance|0|||
94258956|NCT02409368|322742300|FG001|ECOG Reclassification|Poor/non-compliance|3|||
94258957|NCT02409368|322742301|FG002|ECOG Reclassification|Poor/non-compliance|2|||
94258958|NCT02409368|322742302|FG003|ECOG Reclassification|Poor/non-compliance|0|||
94258959|NCT02409368|322742299|FG000|ECOG Reclassification|Study drug toxicity|17|||
94258960|NCT02409368|322742300|FG001|ECOG Reclassification|Study drug toxicity|42|||
94258961|NCT02409368|322742301|FG002|ECOG Reclassification|Study drug toxicity|7|||
94258962|NCT02409368|322742302|FG003|ECOG Reclassification|Study drug toxicity|0|||
94258963|NCT02409368|322742299|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
94258964|NCT02409368|322742300|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
94258965|NCT02409368|322742301|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
94258966|NCT02409368|322742302|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
94258967|NCT02409368|322742299|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
94258968|NCT02409368|322742300|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
94258969|NCT02409368|322742301|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
94258970|NCT02409368|322742302|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
94258971|NCT02409368|322742299|FG000|ECOG Reclassification|Participant withdrew consent|2|||
94258972|NCT02409368|322742300|FG001|ECOG Reclassification|Participant withdrew consent|3|||
94258973|NCT02409368|322742301|FG002|ECOG Reclassification|Participant withdrew consent|4|||
94258974|NCT02409368|322742302|FG003|ECOG Reclassification|Participant withdrew consent|0|||
94258975|NCT02409368|322742299|FG000|ECOG Reclassification|Other Reasons|5|||
94258976|NCT02409368|322742300|FG001|ECOG Reclassification|Other Reasons|26|||
94258977|NCT02409368|322742301|FG002|ECOG Reclassification|Other Reasons|2|||
94258978|NCT02409368|322742302|FG003|ECOG Reclassification|Other Reasons|0|||
94258979|NCT02409368|322742299|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
94258980|NCT02409368|322742300|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
94258981|NCT02409368|322742301|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
94258982|NCT02409368|322742302|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
94258983|NCT01296347|322742303|FG000|Allocation|Withdrawal by Subject|1|||
94258984|NCT01296347|322742304|FG001|Allocation|Withdrawal by Subject|2|||
94258985|NCT01296347|322742303|FG000|Allocation|Lack of Efficacy|1|||
94258986|NCT01296347|322742304|FG001|Allocation|Lack of Efficacy|2|||
94258987|NCT01296347|322742303|FG000|Allocation|not received infusion|1|||
94258988|NCT01296347|322742304|FG001|Allocation|not received infusion|0|||
94461705|NCT01043705|323479586|FG001|Overall Study|Site Closure|0|||
94675697|NCT02835339|324265483|FG001|Overall Study|Did not receive allocated intervention|16|||
94675698|NCT01077544|324265484|FG000|Overall Study|New Cancer Therapy|3|||
94258989|NCT01296347|322742303|FG000|6 Week Follow up|Death|0|||
94258990|NCT01296347|322742304|FG001|6 Week Follow up|Death|1|||
94258991|NCT01296347|322742303|FG000|3 Month Follow up|Death|1|||
94258992|NCT01296347|322742304|FG001|3 Month Follow up|Death|0|||
94258993|NCT01296347|322742303|FG000|3 Month Follow up|Lost to Follow-up|0|||
94675699|NCT01077544|324265485|FG001|Overall Study|New Cancer Therapy|3|||
94675700|NCT01077544|324265484|FG000|Overall Study|Adverse Event|0|||
94362008|NCT00290511|323108780|FG000|Overall Study|Death|1|||
94675701|NCT01077544|324265485|FG001|Overall Study|Adverse Event|1|||
94675702|NCT01077544|324265484|FG000|Overall Study|Disease Progression|0|||
94675703|NCT01077544|324265485|FG001|Overall Study|Disease Progression|1|||
94362009|NCT00290511|323108780|FG000|Overall Study|Physician Decision|1|||
94362010|NCT00290511|323108780|FG000|Overall Study|Withdrawal by Subject|1|||
94362011|NCT01728376|323108781|FG000|Overall Study|Adverse Event|1|||
94362012|NCT01728376|323108782|FG001|Overall Study|Adverse Event|1|||
94362013|NCT01728376|323108783|FG002|Overall Study|Adverse Event|1|||
94362014|NCT01728376|323108784|FG003|Overall Study|Adverse Event|1|||
94362015|NCT01728376|323108785|FG004|Overall Study|Adverse Event|1|||
94362016|NCT01728376|323108786|FG005|Overall Study|Adverse Event|0|||
94362017|NCT01728376|323108781|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
94362018|NCT01728376|323108782|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
94362019|NCT01728376|323108783|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
94362020|NCT01728376|323108784|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
94362021|NCT01728376|323108785|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
94362022|NCT01728376|323108786|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
94362023|NCT01728376|323108781|FG000|Overall Study|No relevant bacteria|2|||
94362024|NCT01728376|323108782|FG001|Overall Study|No relevant bacteria|0|||
94362025|NCT01728376|323108783|FG002|Overall Study|No relevant bacteria|0|||
94362026|NCT01728376|323108784|FG003|Overall Study|No relevant bacteria|0|||
94362027|NCT01728376|323108785|FG004|Overall Study|No relevant bacteria|1|||
94362028|NCT01728376|323108786|FG005|Overall Study|No relevant bacteria|1|||
94362029|NCT01728376|323108781|FG000|Overall Study|Did not receive treatment|0|||
94362030|NCT01728376|323108782|FG001|Overall Study|Did not receive treatment|1|||
94362031|NCT01728376|323108783|FG002|Overall Study|Did not receive treatment|0|||
94362032|NCT01728376|323108784|FG003|Overall Study|Did not receive treatment|0|||
94362033|NCT01728376|323108785|FG004|Overall Study|Did not receive treatment|0|||
94362034|NCT01728376|323108786|FG005|Overall Study|Did not receive treatment|0|||
94362035|NCT01728376|323108781|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
94362036|NCT01728376|323108782|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
94362037|NCT01728376|323108783|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
94362038|NCT01728376|323108784|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
94362039|NCT01728376|323108785|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
94362040|NCT01728376|323108786|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
94362041|NCT03862807|323108791|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
94362042|NCT01160770|323108797|FG000|Overall Study|Adverse Event|10|||
94362043|NCT01160770|323108797|FG000|Overall Study|Protocol Violation|2|||
94362044|NCT01160770|323108797|FG000|Overall Study|Subject/parent/caregiver request|33|||
94362045|NCT01160770|323108797|FG000|Overall Study|Physician Decision|1|||
94362046|NCT01160770|323108797|FG000|Overall Study|Lost to Follow-up|7|||
94362047|NCT01160770|323108797|FG000|Overall Study|Study termination or sponsor request|1|||
94362048|NCT01160770|323108797|FG000|Overall Study|Death|9|||
94362049|NCT01160770|323108797|FG000|Overall Study|Lack of Efficacy|15|||
94362050|NCT01160770|323108797|FG000|Overall Study|Other Reasons|1|||
94362051|NCT01513759|323108798|FG000|Overall Study|Protocol Violation|4|||
94362052|NCT01513759|323108798|FG000|Overall Study|Death during catheter placement|1|||
94362053|NCT05981365|323108802|FG000|Period 1|Adverse Event|1|||
94362054|NCT05981365|323108803|FG001|Period 1|Adverse Event|0|||
94362055|NCT00297882|323108804|FG000|Day 14|Lack of Efficacy|12|||
94362056|NCT00297882|323108805|FG001|Day 14|Lack of Efficacy|49|||
94362057|NCT00297882|323108804|FG000|Day 28|Lost to Follow-up|13|||
94362058|NCT00297882|323108805|FG001|Day 28|Lost to Follow-up|23|||
94362059|NCT00297882|323108804|FG000|Day 28|Lack of Efficacy|3|||
94362060|NCT00297882|323108805|FG001|Day 28|Lack of Efficacy|0|||
94362061|NCT01012609|323108807|FG000|Overall Study|Withdrawal by Subject|1|||
94362062|NCT01012609|323108808|FG001|Overall Study|Withdrawal by Subject|1|||
94362063|NCT01453296|323108809|FG000|Treatment Period 1|Adverse Event|0|||
94362064|NCT01453296|323108810|FG001|Treatment Period 1|Adverse Event|1|||
94362065|NCT01453296|323108809|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
94675704|NCT04252742|324265494|FG000|Overall Study|Decision by sponsor|0|||
94675705|NCT04252742|324265495|FG001|Overall Study|Decision by sponsor|2|||
94362066|NCT01453296|323108810|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
94362067|NCT01453296|323108809|FG000|Treatment Period 2|Adverse Event|1|||
94362068|NCT01453296|323108810|FG001|Treatment Period 2|Adverse Event|0|||
94362069|NCT01453296|323108809|FG000|Treatment Period 2|Withdrawal by Subject|1|||
94362070|NCT01453296|323108810|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94362071|NCT00924820|323108816|FG000|Overall Study|Death|2|||
94362072|NCT00924820|323108816|FG000|Overall Study|Ineligible, Screen Failure|5|||
94362073|NCT03901352|323108819|FG000|Double-blind Phase|Adverse Event|6|||
94362074|NCT03901352|323108820|FG001|Double-blind Phase|Adverse Event|4|||
94362075|NCT03901352|323108819|FG000|Double-blind Phase|Death|1|||
94362076|NCT03901352|323108820|FG001|Double-blind Phase|Death|0|||
94675706|NCT04252742|324265494|FG000|Overall Study|Withdrawal by Subject|15|||
94362077|NCT03901352|323108819|FG000|Double-blind Phase|Lack of Efficacy|0|||
94258994|NCT01296347|322742304|FG001|3 Month Follow up|Lost to Follow-up|1|||
94258995|NCT01296347|322742303|FG000|6 Month Follow up|Death|2|||
94258996|NCT01296347|322742304|FG001|6 Month Follow up|Death|1|||
94258997|NCT01296347|322742303|FG000|6 Month Follow up|Lost to Follow-up|0|||
94258998|NCT01296347|322742304|FG001|6 Month Follow up|Lost to Follow-up|1|||
94258999|NCT01296347|322742303|FG000|12 Month Follow up|Lost to Follow-up|3|||
94259000|NCT01296347|322742304|FG001|12 Month Follow up|Lost to Follow-up|1|||
94259001|NCT01296347|322742303|FG000|12 Month Follow up|Death|1|||
94259002|NCT01296347|322742304|FG001|12 Month Follow up|Death|1|||
94259003|NCT01296347|322742303|FG000|12 Month Follow up|Withdrawal by Subject|0|||
94259004|NCT01296347|322742304|FG001|12 Month Follow up|Withdrawal by Subject|1|||
94259005|NCT01948908|322742305|FG000|Overall Study|Protocol Violation|1|||
94259006|NCT01948908|322742306|FG001|Overall Study|Protocol Violation|0|||
94259007|NCT01948908|322742307|FG002|Overall Study|Protocol Violation|2|||
94259008|NCT02240693|322742308|FG000|Overall Study|Adverse Event|0|||
94259009|NCT02240693|322742309|FG001|Overall Study|Adverse Event|0|||
94259010|NCT02240693|322742310|FG002|Overall Study|Adverse Event|0|||
94259011|NCT02240693|322742311|FG003|Overall Study|Adverse Event|0|||
94259012|NCT02240693|322742312|FG004|Overall Study|Adverse Event|1|||
94259013|NCT02240693|322742308|FG000|Overall Study|Withdrawal by Subject|0|||
94259014|NCT02240693|322742309|FG001|Overall Study|Withdrawal by Subject|0|||
94259015|NCT02240693|322742310|FG002|Overall Study|Withdrawal by Subject|2|||
94259016|NCT02240693|322742311|FG003|Overall Study|Withdrawal by Subject|1|||
94259017|NCT02240693|322742312|FG004|Overall Study|Withdrawal by Subject|0|||
94259018|NCT02240693|322742308|FG000|Overall Study|Other than specified|0|||
94259019|NCT02240693|322742309|FG001|Overall Study|Other than specified|0|||
94259020|NCT02240693|322742310|FG002|Overall Study|Other than specified|2|||
94259021|NCT02240693|322742311|FG003|Overall Study|Other than specified|0|||
94259022|NCT02240693|322742312|FG004|Overall Study|Other than specified|0|||
94259023|NCT02041520|322742313|FG000|Overall Study|Adverse Event|2|||
94259024|NCT02041520|322742314|FG001|Overall Study|Adverse Event|1|||
94259025|NCT02041520|322742313|FG000|Overall Study|Withdrawal by Subject|3|||
94259026|NCT02041520|322742314|FG001|Overall Study|Withdrawal by Subject|4|||
94259027|NCT02041520|322742313|FG000|Overall Study|Protocol Violation|1|||
94259028|NCT02041520|322742314|FG001|Overall Study|Protocol Violation|0|||
94259029|NCT02041520|322742313|FG000|Overall Study|Lost to Follow-up|0|||
94259030|NCT02041520|322742314|FG001|Overall Study|Lost to Follow-up|1|||
94259031|NCT02041520|322742313|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
94259032|NCT02041520|322742314|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
94259033|NCT00413972|322742315|FG000|Overall Study|Adverse Event|2|||
94259034|NCT00413972|322742316|FG001|Overall Study|Adverse Event|1|||
94259035|NCT00413972|322742317|FG002|Overall Study|Adverse Event|0|||
94259036|NCT00413972|322742318|FG003|Overall Study|Adverse Event|0|||
94259037|NCT00413972|322742315|FG000|Overall Study|Lost to Follow-up|1|||
94259038|NCT00413972|322742316|FG001|Overall Study|Lost to Follow-up|2|||
94259039|NCT00413972|322742317|FG002|Overall Study|Lost to Follow-up|1|||
94259040|NCT00413972|322742318|FG003|Overall Study|Lost to Follow-up|0|||
94259041|NCT00413972|322742315|FG000|Overall Study|Withdrawal by Subject|4|||
94259042|NCT00413972|322742316|FG001|Overall Study|Withdrawal by Subject|5|||
94259043|NCT00413972|322742317|FG002|Overall Study|Withdrawal by Subject|7|||
94259044|NCT00413972|322742318|FG003|Overall Study|Withdrawal by Subject|2|||
94259045|NCT00413972|322742315|FG000|Overall Study|Protocol Violation|0|||
94259046|NCT00413972|322742316|FG001|Overall Study|Protocol Violation|0|||
94259047|NCT00413972|322742317|FG002|Overall Study|Protocol Violation|2|||
94259048|NCT00413972|322742318|FG003|Overall Study|Protocol Violation|0|||
94259049|NCT00413972|322742315|FG000|Overall Study|Other|0|||
94259050|NCT00413972|322742316|FG001|Overall Study|Other|0|||
94259051|NCT00413972|322742317|FG002|Overall Study|Other|0|||
94362078|NCT03901352|323108820|FG001|Double-blind Phase|Lack of Efficacy|1|||
94362079|NCT03901352|323108819|FG000|Double-blind Phase|Protocol Violation|0|||
94259052|NCT00413972|322742318|FG003|Overall Study|Other|1|||
94362080|NCT03901352|323108820|FG001|Double-blind Phase|Protocol Violation|1|||
94259053|NCT01898923|322742319|FG000|Overall Study|Lack of Efficacy|5|||
94259054|NCT01898923|322742320|FG001|Overall Study|Lack of Efficacy|6|||
94259055|NCT01898923|322742319|FG000|Overall Study|Adverse Event|3|||
94259056|NCT01898923|322742320|FG001|Overall Study|Adverse Event|1|||
94259057|NCT01898923|322742319|FG000|Overall Study|Lost to Follow-up|0|||
94259058|NCT01898923|322742320|FG001|Overall Study|Lost to Follow-up|1|||
94259059|NCT01898923|322742319|FG000|Overall Study|Withdrawal by Subject|4|||
94259060|NCT01898923|322742320|FG001|Overall Study|Withdrawal by Subject|7|||
94259061|NCT01898923|322742319|FG000|Overall Study|Physician Decision|3|||
94259062|NCT01898923|322742320|FG001|Overall Study|Physician Decision|4|||
94259063|NCT01898923|322742319|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
94259064|NCT01898923|322742320|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
94259065|NCT01116882|322742321|FG000|30-day|Lost to Follow-up|50|||
94461706|NCT01043705|323479587|FG002|Overall Study|Site Closure|0|||
94259066|NCT01116882|322742322|FG001|30-day|Lost to Follow-up|21|||
94362081|NCT03901352|323108819|FG000|Double-blind Phase|Withdrawal by Subject|10|||
94362082|NCT03901352|323108820|FG001|Double-blind Phase|Withdrawal by Subject|8|||
94362083|NCT03901352|323108819|FG000|Open-label Extension Phase|Adverse Event|24|||
94362084|NCT03901352|323108820|FG001|Open-label Extension Phase|Adverse Event|0|||
94362085|NCT03901352|323108819|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
94362086|NCT03901352|323108820|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
94362087|NCT03901352|323108819|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
94362088|NCT03901352|323108820|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
94362089|NCT03901352|323108819|FG000|Open-label Extension Phase|Other|1|||
94362090|NCT03901352|323108820|FG001|Open-label Extension Phase|Other|0|||
94362091|NCT02940392|323108823|FG000|Overall Study|Lost to Follow-up|3|||
94362092|NCT02940392|323108823|FG000|Overall Study|Retreatment|3|||
94362093|NCT02940392|323108823|FG000|Overall Study|Death|2|||
94362094|NCT02871921|323108827|FG000|Overall Study|Withdrawal by Subject|34|||
94362095|NCT02871921|323108828|FG001|Overall Study|Withdrawal by Subject|27|||
94362096|NCT02871921|323108829|FG002|Overall Study|Withdrawal by Subject|27|||
94362097|NCT02871921|323108830|FG003|Overall Study|Withdrawal by Subject|30|||
94362098|NCT03919669|323108831|FG000|Overall Study|Withdrawal by Subject|1|||
94362099|NCT03919669|323108832|FG001|Overall Study|Withdrawal by Subject|0|||
94461707|NCT01043705|323479585|FG000|Overall Study|Subsequent Procedure|9|||
94461708|NCT01043705|323479586|FG001|Overall Study|Subsequent Procedure|24|||
94631255|NCT02554812|324109947|FG007|Overall Study|Lost to Follow-up|0|||
94631256|NCT02554812|324109948|FG008|Overall Study|Lost to Follow-up|0|||
94631257|NCT02554812|324109949|FG009|Overall Study|Lost to Follow-up|0|||
94631258|NCT02554812|324109950|FG010|Overall Study|Lost to Follow-up|0|||
94631259|NCT02554812|324109951|FG011|Overall Study|Lost to Follow-up|0|||
94631260|NCT02554812|324109952|FG012|Overall Study|Lost to Follow-up|0|||
94631261|NCT02554812|324109953|FG013|Overall Study|Lost to Follow-up|0|||
94631262|NCT02554812|324109954|FG014|Overall Study|Lost to Follow-up|0|||
94631263|NCT02554812|324109955|FG015|Overall Study|Lost to Follow-up|0|||
94631264|NCT02554812|324109956|FG016|Overall Study|Lost to Follow-up|0|||
94631265|NCT02554812|324109957|FG017|Overall Study|Lost to Follow-up|0|||
94631266|NCT02554812|324109958|FG018|Overall Study|Lost to Follow-up|0|||
94631267|NCT02554812|324109959|FG019|Overall Study|Lost to Follow-up|0|||
94631268|NCT02554812|324109960|FG020|Overall Study|Lost to Follow-up|0|||
94631269|NCT02554812|324109961|FG021|Overall Study|Lost to Follow-up|0|||
94631270|NCT02554812|324109962|FG022|Overall Study|Lost to Follow-up|0|||
94631271|NCT02554812|324109963|FG023|Overall Study|Lost to Follow-up|0|||
94631272|NCT02554812|324109964|FG024|Overall Study|Lost to Follow-up|0|||
94461709|NCT01043705|323479587|FG002|Overall Study|Subsequent Procedure|29|||
94362100|NCT03919669|323108833|FG002|Overall Study|Withdrawal by Subject|0|||
94362101|NCT01067339|323108834|FG000|Overall Study|Withdrawal by Subject|6|||
94362102|NCT01067339|323108835|FG001|Overall Study|Withdrawal by Subject|5|||
94362103|NCT02353572|323108836|FG000|Overall Study|Withdrawal by Subject|1|||
94631273|NCT02554812|324109965|FG025|Overall Study|Lost to Follow-up|0|||
94631274|NCT02554812|324109966|FG026|Overall Study|Lost to Follow-up|0|||
94631275|NCT02554812|324109940|FG000|Overall Study|Global deterioration of health status|4|||
94631276|NCT02554812|324109941|FG001|Overall Study|Global deterioration of health status|3|||
94631277|NCT02554812|324109942|FG002|Overall Study|Global deterioration of health status|3|||
94631278|NCT02554812|324109943|FG003|Overall Study|Global deterioration of health status|2|||
94631279|NCT02554812|324109944|FG004|Overall Study|Global deterioration of health status|5|||
94631280|NCT02554812|324109945|FG005|Overall Study|Global deterioration of health status|0|||
94631281|NCT02554812|324109946|FG006|Overall Study|Global deterioration of health status|2|||
94631282|NCT02554812|324109947|FG007|Overall Study|Global deterioration of health status|1|||
94631283|NCT02554812|324109948|FG008|Overall Study|Global deterioration of health status|1|||
94631284|NCT02554812|324109949|FG009|Overall Study|Global deterioration of health status|1|||
94631285|NCT02554812|324109950|FG010|Overall Study|Global deterioration of health status|2|||
94631286|NCT02554812|324109951|FG011|Overall Study|Global deterioration of health status|1|||
94631287|NCT02554812|324109952|FG012|Overall Study|Global deterioration of health status|0|||
94631288|NCT02554812|324109953|FG013|Overall Study|Global deterioration of health status|0|||
94631289|NCT02554812|324109954|FG014|Overall Study|Global deterioration of health status|0|||
94259067|NCT01116882|322742321|FG000|30-day|Withdrawal by Subject|2|||
94259068|NCT01116882|322742322|FG001|30-day|Withdrawal by Subject|4|||
94259069|NCT01116882|322742321|FG000|30-day|Other Reasons|16|||
94259070|NCT01116882|322742322|FG001|30-day|Other Reasons|6|||
94259071|NCT01116882|322742321|FG000|12-month|Lost to Follow-up|111|||
94259072|NCT01116882|322742322|FG001|12-month|Lost to Follow-up|42|||
94259073|NCT01116882|322742321|FG000|12-month|Other Reasons|151|||
94259074|NCT01116882|322742322|FG001|12-month|Other Reasons|49|||
94259075|NCT01116882|322742321|FG000|12-month|Withdrawal by Subject|5|||
94259076|NCT01116882|322742322|FG001|12-month|Withdrawal by Subject|8|||
94259077|NCT01777269|322742323|FG000|Overall Study|Adverse Event|24|||
94259078|NCT01777269|322742324|FG001|Overall Study|Adverse Event|33|||
94259079|NCT01777269|322742323|FG000|Overall Study|Lack of Efficacy|8|||
94259080|NCT01777269|322742324|FG001|Overall Study|Lack of Efficacy|10|||
94259081|NCT01777269|322742323|FG000|Overall Study|Protocol Violation|4|||
94259082|NCT01777269|322742324|FG001|Overall Study|Protocol Violation|4|||
94259083|NCT01777269|322742323|FG000|Overall Study|Participants reached stopping criteria|1|||
94259084|NCT01777269|322742324|FG001|Overall Study|Participants reached stopping criteria|1|||
94259085|NCT01777269|322742323|FG000|Overall Study|Lost to Follow-up|4|||
94259086|NCT01777269|322742324|FG001|Overall Study|Lost to Follow-up|0|||
94259087|NCT01777269|322742323|FG000|Overall Study|Physician Decision|5|||
94259088|NCT01777269|322742324|FG001|Overall Study|Physician Decision|2|||
94259089|NCT01777269|322742323|FG000|Overall Study|Withdrawal by Subject|9|||
94259090|NCT01777269|322742324|FG001|Overall Study|Withdrawal by Subject|9|||
94259091|NCT00504881|322742325|FG000|Overall Study|Lack of Efficacy|1|||
94259092|NCT00504881|322742326|FG001|Overall Study|Lack of Efficacy|5|||
94259093|NCT00504881|322742325|FG000|Overall Study|Lost to Follow-up|0|||
94259094|NCT00504881|322742326|FG001|Overall Study|Lost to Follow-up|2|||
94259095|NCT00504881|322742325|FG000|Overall Study|Withdrawal by Subject|1|||
94259096|NCT00504881|322742326|FG001|Overall Study|Withdrawal by Subject|4|||
94259097|NCT00504881|322742325|FG000|Overall Study|Non-Compliance|1|||
94259098|NCT00504881|322742326|FG001|Overall Study|Non-Compliance|0|||
94259099|NCT00504881|322742325|FG000|Overall Study|No Birth Control|0|||
94259100|NCT00504881|322742326|FG001|Overall Study|No Birth Control|1|||
94259101|NCT00504881|322742325|FG000|Overall Study|Safety Visit not performed|0|||
94259102|NCT00504881|322742326|FG001|Overall Study|Safety Visit not performed|1|||
94259103|NCT00504881|322742325|FG000|Overall Study|AE, serious fatal|0|||
94259104|NCT00504881|322742326|FG001|Overall Study|AE, serious fatal|1|||
94259105|NCT00504881|322742325|FG000|Overall Study|SAE, non-fatal|2|||
94259106|NCT00504881|322742326|FG001|Overall Study|SAE, non-fatal|6|||
94259107|NCT00504881|322742325|FG000|Overall Study|AE, non-serious non-fatal|4|||
94259108|NCT00504881|322742326|FG001|Overall Study|AE, non-serious non-fatal|14|||
94259109|NCT00504881|322742325|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
94259110|NCT00504881|322742326|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
94259111|NCT00504881|322742325|FG000|Overall Study|AE of unknown type|1|||
94259112|NCT00504881|322742326|FG001|Overall Study|AE of unknown type|0|||
94631290|NCT02554812|324109955|FG015|Overall Study|Global deterioration of health status|1|||
94631291|NCT02554812|324109956|FG016|Overall Study|Global deterioration of health status|0|||
94631292|NCT02554812|324109957|FG017|Overall Study|Global deterioration of health status|0|||
94259113|NCT01030198|322742330|FG000|Overall Study|Could not measure efficacy accurately|0|||
94259114|NCT01030198|322742331|FG001|Overall Study|Could not measure efficacy accurately|7|||
94259115|NCT02370043|322742332|FG000|Overall Study|Withdrawal by Subject|0|||
94259116|NCT02370043|322742333|FG001|Overall Study|Withdrawal by Subject|0|||
94259117|NCT02370043|322742334|FG002|Overall Study|Withdrawal by Subject|0|||
94259118|NCT02370043|322742335|FG003|Overall Study|Withdrawal by Subject|0|||
94259119|NCT02370043|322742336|FG004|Overall Study|Withdrawal by Subject|1|||
94259120|NCT02370043|322742337|FG005|Overall Study|Withdrawal by Subject|1|||
94259121|NCT01231516|322742338|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
94259122|NCT01231516|322742339|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
94362104|NCT02353572|323108836|FG000|Overall Study|Study terminated|2|||
94675707|NCT04252742|324265495|FG001|Overall Study|Withdrawal by Subject|9|||
94675708|NCT04252742|324265494|FG000|Overall Study|Lost to Follow-up|0|||
94259123|NCT01231516|322742338|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
94631293|NCT02554812|324109958|FG018|Overall Study|Global deterioration of health status|0|||
94631294|NCT02554812|324109959|FG019|Overall Study|Global deterioration of health status|0|||
94631295|NCT02554812|324109960|FG020|Overall Study|Global deterioration of health status|0|||
94631296|NCT02554812|324109961|FG021|Overall Study|Global deterioration of health status|0|||
94631297|NCT02554812|324109962|FG022|Overall Study|Global deterioration of health status|0|||
94631298|NCT02554812|324109963|FG023|Overall Study|Global deterioration of health status|0|||
94631299|NCT02554812|324109964|FG024|Overall Study|Global deterioration of health status|0|||
94631300|NCT02554812|324109965|FG025|Overall Study|Global deterioration of health status|0|||
94631301|NCT02554812|324109966|FG026|Overall Study|Global deterioration of health status|0|||
94631302|NCT02554812|324109940|FG000|Overall Study|Progressive disease|20|||
94631303|NCT02554812|324109941|FG001|Overall Study|Progressive disease|16|||
94631304|NCT02554812|324109942|FG002|Overall Study|Progressive disease|19|||
94631305|NCT02554812|324109943|FG003|Overall Study|Progressive disease|18|||
94631306|NCT02554812|324109944|FG004|Overall Study|Progressive disease|21|||
94631307|NCT02554812|324109945|FG005|Overall Study|Progressive disease|15|||
94631308|NCT02554812|324109946|FG006|Overall Study|Progressive disease|6|||
94631309|NCT02554812|324109947|FG007|Overall Study|Progressive disease|13|||
94631310|NCT02554812|324109948|FG008|Overall Study|Progressive disease|6|||
94631311|NCT02554812|324109949|FG009|Overall Study|Progressive disease|6|||
94631312|NCT02554812|324109950|FG010|Overall Study|Progressive disease|8|||
94631313|NCT02554812|324109951|FG011|Overall Study|Progressive disease|8|||
94631314|NCT02554812|324109952|FG012|Overall Study|Progressive disease|6|||
94631315|NCT02554812|324109953|FG013|Overall Study|Progressive disease|10|||
94631316|NCT02554812|324109954|FG014|Overall Study|Progressive disease|20|||
94631317|NCT02554812|324109955|FG015|Overall Study|Progressive disease|6|||
94631318|NCT02554812|324109956|FG016|Overall Study|Progressive disease|3|||
94675709|NCT04252742|324265495|FG001|Overall Study|Lost to Follow-up|1|||
94259124|NCT01231516|322742339|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
94259125|NCT01231516|322742338|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
94259126|NCT01231516|322742339|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
94259127|NCT01231516|322742338|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
94259128|NCT01231516|322742339|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
94259129|NCT01231516|322742338|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
94259130|NCT01231516|322742339|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
94259131|NCT01231516|322742338|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
94259132|NCT01231516|322742339|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
94259133|NCT01231516|322742338|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
94259134|NCT01231516|322742339|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
94259135|NCT01231516|322742338|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
94259136|NCT01231516|322742339|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
94259137|NCT01231516|322742338|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
94259138|NCT01231516|322742339|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
94259139|NCT01231516|322742338|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
94259140|NCT01231516|322742339|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
94259141|NCT01231516|322742338|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
94259142|NCT01231516|322742339|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
94259143|NCT01231516|322742338|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
94259144|NCT01231516|322742339|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
94259145|NCT01231516|322742338|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
94259146|NCT01231516|322742339|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
94259147|NCT01231516|322742338|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
94259148|NCT01231516|322742339|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
94259149|NCT01231516|322742338|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
94259150|NCT01231516|322742339|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
94631319|NCT02554812|324109957|FG017|Overall Study|Progressive disease|3|||
94631320|NCT02554812|324109958|FG018|Overall Study|Progressive disease|11|||
94631321|NCT02554812|324109959|FG019|Overall Study|Progressive disease|7|||
94631322|NCT02554812|324109960|FG020|Overall Study|Progressive disease|11|||
94631323|NCT02554812|324109961|FG021|Overall Study|Progressive disease|6|||
94631324|NCT02554812|324109962|FG022|Overall Study|Progressive disease|9|||
94631325|NCT02554812|324109963|FG023|Overall Study|Progressive disease|9|||
94631326|NCT02554812|324109964|FG024|Overall Study|Progressive disease|4|||
94631327|NCT02554812|324109965|FG025|Overall Study|Progressive disease|5|||
94631328|NCT02554812|324109966|FG026|Overall Study|Progressive disease|5|||
94631329|NCT02554812|324109940|FG000|Overall Study|Other|0|||
94631330|NCT02554812|324109941|FG001|Overall Study|Other|0|||
94675710|NCT04085328|324265505|FG000|Overall Study|Witihdrew Consent|16|||
94259151|NCT01231516|322742338|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
94259152|NCT01231516|322742339|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
94259153|NCT00026208|322742340|FG000|Overall Study|Complications of auto accident|1|||
94259154|NCT00026208|322742341|FG001|Overall Study|Complications of auto accident|0|||
94259155|NCT04908189|322742342|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
94259156|NCT04908189|322742343|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
94259157|NCT04908189|322742344|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
94259158|NCT04908189|322742342|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
94259159|NCT04908189|322742343|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
94259160|NCT04908189|322742344|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
94259161|NCT04908189|322742342|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
94259162|NCT04908189|322742343|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
94259163|NCT04908189|322742344|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
94259164|NCT04908189|322742342|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
94259165|NCT04908189|322742343|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
94259166|NCT04908189|322742344|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
94259167|NCT04908189|322742342|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
94259168|NCT04908189|322742343|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
94259169|NCT04908189|322742344|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
94259170|NCT04908189|322742342|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
94259171|NCT04908189|322742343|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
94259172|NCT04908189|322742344|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
94259173|NCT04908189|322742342|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
94259174|NCT04908189|322742343|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
94259175|NCT04908189|322742344|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
94259176|NCT04908189|322742342|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
94259177|NCT04908189|322742343|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
94259178|NCT04908189|322742344|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
94259179|NCT04908189|322742342|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
94259180|NCT04908189|322742343|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
94259181|NCT04908189|322742344|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
94259182|NCT04908189|322742342|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
94259183|NCT04908189|322742343|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
94259184|NCT04908189|322742344|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
94259185|NCT04908189|322742342|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
94259186|NCT04908189|322742343|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
94259187|NCT04908189|322742344|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
94259188|NCT04908189|322742342|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
94259189|NCT04908189|322742343|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
94259190|NCT04908189|322742344|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
94259191|NCT05245097|322742345|FG000|Overall Study|Adverse Event|13|||
94259192|NCT05245097|322742346|FG001|Overall Study|Adverse Event|2|||
94259193|NCT05245097|322742345|FG000|Overall Study|Protocol Violation|8|||
94259194|NCT05245097|322742346|FG001|Overall Study|Protocol Violation|6|||
94259195|NCT05245097|322742345|FG000|Overall Study|Withdrawal by Subject|18|||
94259196|NCT05245097|322742346|FG001|Overall Study|Withdrawal by Subject|0|||
94259197|NCT05245097|322742345|FG000|Overall Study|Death|6|||
94259198|NCT05245097|322742346|FG001|Overall Study|Death|7|||
94259199|NCT05245097|322742345|FG000|Overall Study|Physician Decision|6|||
94259200|NCT05245097|322742346|FG001|Overall Study|Physician Decision|0|||
94259201|NCT05245097|322742345|FG000|Overall Study|Relocation|4|||
94259202|NCT05245097|322742346|FG001|Overall Study|Relocation|3|||
94259203|NCT00810394|322742351|FG000|Overall Study|Withdrawal by Subject|3|||
94259204|NCT01853982|322742352|FG000|Overall Study|Withdrawal by Subject|1|||
94259205|NCT01853982|322742353|FG001|Overall Study|Withdrawal by Subject|0|||
94259206|NCT01853982|322742352|FG000|Overall Study|Death|1|||
94259207|NCT01853982|322742353|FG001|Overall Study|Death|0|||
94259208|NCT01853982|322742352|FG000|Overall Study|Lost to Follow-up|0|||
94259209|NCT01853982|322742353|FG001|Overall Study|Lost to Follow-up|1|||
94259210|NCT03330847|322742359|FG000|Overall Study|Patients ongoing study|62|||
94259211|NCT03330847|322742360|FG001|Overall Study|Patients ongoing study|65|||
94259212|NCT03330847|322742361|FG002|Overall Study|Patients ongoing study|15|||
94631331|NCT02554812|324109942|FG002|Overall Study|Other|2|||
94259213|NCT05269355|322742363|FG000|Overall Study|Progressive Disease|104|||
94259214|NCT05269355|322742364|FG001|Overall Study|Progressive Disease|68|||
94259215|NCT05269355|322742363|FG000|Overall Study|Study Terminated by Sponsor|87|||
94259216|NCT05269355|322742364|FG001|Overall Study|Study Terminated by Sponsor|29|||
94259217|NCT05269355|322742363|FG000|Overall Study|Adverse Event|15|||
94631332|NCT02554812|324109943|FG003|Overall Study|Other|3|||
94461710|NCT01043705|323479585|FG000|Overall Study|Adverse Event|0|||
94631333|NCT02554812|324109944|FG004|Overall Study|Other|2|||
94631334|NCT02554812|324109945|FG005|Overall Study|Other|1|||
94631335|NCT02554812|324109946|FG006|Overall Study|Other|0|||
94631336|NCT02554812|324109947|FG007|Overall Study|Other|0|||
94631337|NCT02554812|324109948|FG008|Overall Study|Other|1|||
94631338|NCT02554812|324109949|FG009|Overall Study|Other|1|||
94631339|NCT02554812|324109950|FG010|Overall Study|Other|0|||
94631340|NCT02554812|324109951|FG011|Overall Study|Other|0|||
94631341|NCT02554812|324109952|FG012|Overall Study|Other|1|||
94631342|NCT02554812|324109953|FG013|Overall Study|Other|0|||
94631343|NCT02554812|324109954|FG014|Overall Study|Other|1|||
94631344|NCT02554812|324109955|FG015|Overall Study|Other|0|||
94631345|NCT02554812|324109956|FG016|Overall Study|Other|0|||
94631346|NCT02554812|324109957|FG017|Overall Study|Other|0|||
94631347|NCT02554812|324109958|FG018|Overall Study|Other|0|||
94631348|NCT02554812|324109959|FG019|Overall Study|Other|0|||
94631349|NCT02554812|324109960|FG020|Overall Study|Other|0|||
94631350|NCT02554812|324109961|FG021|Overall Study|Other|2|||
94631351|NCT02554812|324109962|FG022|Overall Study|Other|0|||
94631352|NCT02554812|324109963|FG023|Overall Study|Other|0|||
94631353|NCT02554812|324109964|FG024|Overall Study|Other|0|||
94631354|NCT02554812|324109965|FG025|Overall Study|Other|0|||
94631355|NCT02554812|324109966|FG026|Overall Study|Other|0|||
94631356|NCT02554812|324109940|FG000|Overall Study|Withdrawal by Subject|1|||
94631357|NCT02554812|324109941|FG001|Overall Study|Withdrawal by Subject|0|||
94631358|NCT02554812|324109942|FG002|Overall Study|Withdrawal by Subject|0|||
94631359|NCT02554812|324109943|FG003|Overall Study|Withdrawal by Subject|2|||
94631360|NCT02554812|324109944|FG004|Overall Study|Withdrawal by Subject|2|||
94631361|NCT02554812|324109945|FG005|Overall Study|Withdrawal by Subject|3|||
94631362|NCT02554812|324109946|FG006|Overall Study|Withdrawal by Subject|0|||
94631363|NCT02554812|324109947|FG007|Overall Study|Withdrawal by Subject|0|||
94631364|NCT02554812|324109948|FG008|Overall Study|Withdrawal by Subject|1|||
94631365|NCT02554812|324109949|FG009|Overall Study|Withdrawal by Subject|1|||
94631366|NCT02554812|324109950|FG010|Overall Study|Withdrawal by Subject|0|||
94631367|NCT02554812|324109951|FG011|Overall Study|Withdrawal by Subject|1|||
94631368|NCT02554812|324109952|FG012|Overall Study|Withdrawal by Subject|1|||
94631369|NCT02554812|324109953|FG013|Overall Study|Withdrawal by Subject|1|||
94631370|NCT02554812|324109954|FG014|Overall Study|Withdrawal by Subject|1|||
94631371|NCT02554812|324109955|FG015|Overall Study|Withdrawal by Subject|1|||
94631372|NCT02554812|324109956|FG016|Overall Study|Withdrawal by Subject|3|||
94631373|NCT02554812|324109957|FG017|Overall Study|Withdrawal by Subject|1|||
94631374|NCT02554812|324109958|FG018|Overall Study|Withdrawal by Subject|0|||
94631375|NCT02554812|324109959|FG019|Overall Study|Withdrawal by Subject|2|||
94631376|NCT02554812|324109960|FG020|Overall Study|Withdrawal by Subject|0|||
94631377|NCT02554812|324109961|FG021|Overall Study|Withdrawal by Subject|1|||
94631378|NCT02554812|324109962|FG022|Overall Study|Withdrawal by Subject|0|||
94631379|NCT02554812|324109963|FG023|Overall Study|Withdrawal by Subject|1|||
94631380|NCT02554812|324109964|FG024|Overall Study|Withdrawal by Subject|0|||
94631381|NCT02554812|324109965|FG025|Overall Study|Withdrawal by Subject|0|||
94631382|NCT02554812|324109966|FG026|Overall Study|Withdrawal by Subject|1|||
94631383|NCT02554812|324109940|FG000|Overall Study|Physician Decision|1|||
94631384|NCT02554812|324109941|FG001|Overall Study|Physician Decision|0|||
94461711|NCT01043705|323479586|FG001|Overall Study|Adverse Event|2|||
94631385|NCT02554812|324109942|FG002|Overall Study|Physician Decision|0|||
94631386|NCT02554812|324109943|FG003|Overall Study|Physician Decision|1|||
94631387|NCT02554812|324109944|FG004|Overall Study|Physician Decision|0|||
94631388|NCT02554812|324109945|FG005|Overall Study|Physician Decision|1|||
94631389|NCT02554812|324109946|FG006|Overall Study|Physician Decision|0|||
94631390|NCT02554812|324109947|FG007|Overall Study|Physician Decision|0|||
94631391|NCT02554812|324109948|FG008|Overall Study|Physician Decision|0|||
94631392|NCT02554812|324109949|FG009|Overall Study|Physician Decision|0|||
94631393|NCT02554812|324109950|FG010|Overall Study|Physician Decision|1|||
94259218|NCT05269355|322742364|FG001|Overall Study|Adverse Event|8|||
94259219|NCT05269355|322742363|FG000|Overall Study|Withdrawal by Subject|18|||
94259220|NCT05269355|322742364|FG001|Overall Study|Withdrawal by Subject|5|||
94259221|NCT05269355|322742363|FG000|Overall Study|Physician Decision|6|||
94259222|NCT05269355|322742364|FG001|Overall Study|Physician Decision|4|||
94259223|NCT05269355|322742363|FG000|Overall Study|Death|3|||
94259224|NCT05269355|322742364|FG001|Overall Study|Death|5|||
94259225|NCT05269355|322742363|FG000|Overall Study|Other Than Specified|5|||
94259226|NCT05269355|322742364|FG001|Overall Study|Other Than Specified|1|||
94259227|NCT05269355|322742363|FG000|Overall Study|Randomized But Not Treated|1|||
94259228|NCT05269355|322742364|FG001|Overall Study|Randomized But Not Treated|0|||
94259229|NCT01065454|322742365|FG000|Treatment|Adverse Event|7|||
94259230|NCT01065454|322742366|FG001|Treatment|Adverse Event|4|||
94259231|NCT01065454|322742367|FG002|Treatment|Adverse Event|3|||
94259232|NCT01065454|322742368|FG003|Treatment|Adverse Event|6|||
94259233|NCT01065454|322742365|FG000|Treatment|Death|1|||
94259234|NCT01065454|322742366|FG001|Treatment|Death|0|||
94259235|NCT01065454|322742367|FG002|Treatment|Death|0|||
94259236|NCT01065454|322742368|FG003|Treatment|Death|0|||
94259237|NCT01065454|322742365|FG000|Treatment|Non-compliance|1|||
94259238|NCT01065454|322742366|FG001|Treatment|Non-compliance|0|||
94259239|NCT01065454|322742367|FG002|Treatment|Non-compliance|0|||
94259240|NCT01065454|322742368|FG003|Treatment|Non-compliance|1|||
94259241|NCT01065454|322742365|FG000|Treatment|Protocol Decision|0|||
94259242|NCT01065454|322742366|FG001|Treatment|Protocol Decision|0|||
94259243|NCT01065454|322742367|FG002|Treatment|Protocol Decision|3|||
94259244|NCT01065454|322742368|FG003|Treatment|Protocol Decision|2|||
94259245|NCT01065454|322742365|FG000|Treatment|Protocol Violation|1|||
94259246|NCT01065454|322742366|FG001|Treatment|Protocol Violation|0|||
94259247|NCT01065454|322742367|FG002|Treatment|Protocol Violation|1|||
94259248|NCT01065454|322742368|FG003|Treatment|Protocol Violation|0|||
94259249|NCT01065454|322742365|FG000|Treatment|Withdrawal by Subject|3|||
94259250|NCT01065454|322742366|FG001|Treatment|Withdrawal by Subject|1|||
94259251|NCT01065454|322742367|FG002|Treatment|Withdrawal by Subject|2|||
94259252|NCT01065454|322742368|FG003|Treatment|Withdrawal by Subject|3|||
94259253|NCT01065454|322742365|FG000|Follow up|Adverse Event|1|||
94259254|NCT01065454|322742366|FG001|Follow up|Adverse Event|0|||
94259255|NCT01065454|322742367|FG002|Follow up|Adverse Event|0|||
94259256|NCT01065454|322742368|FG003|Follow up|Adverse Event|1|||
94259257|NCT01065454|322742365|FG000|Follow up|Death|0|||
94259258|NCT01065454|322742366|FG001|Follow up|Death|1|||
94259259|NCT01065454|322742367|FG002|Follow up|Death|1|||
94259260|NCT01065454|322742368|FG003|Follow up|Death|0|||
94259261|NCT01065454|322742365|FG000|Follow up|Lost to Follow-up|0|||
94259262|NCT01065454|322742366|FG001|Follow up|Lost to Follow-up|0|||
94259263|NCT01065454|322742367|FG002|Follow up|Lost to Follow-up|0|||
94259264|NCT01065454|322742368|FG003|Follow up|Lost to Follow-up|1|||
94259265|NCT01065454|322742365|FG000|Follow up|Progressive disease|0|||
94259266|NCT01065454|322742366|FG001|Follow up|Progressive disease|0|||
94259267|NCT01065454|322742367|FG002|Follow up|Progressive disease|0|||
94259268|NCT01065454|322742368|FG003|Follow up|Progressive disease|1|||
94259269|NCT01065454|322742365|FG000|Follow up|Withdrawal by Subject|1|||
94259270|NCT01065454|322742366|FG001|Follow up|Withdrawal by Subject|1|||
94259271|NCT01065454|322742367|FG002|Follow up|Withdrawal by Subject|1|||
94259272|NCT01065454|322742368|FG003|Follow up|Withdrawal by Subject|0|||
94259273|NCT01065454|322742365|FG000|Follow up|study ongoing|37|||
94259274|NCT01065454|322742366|FG001|Follow up|study ongoing|22|||
94259275|NCT01065454|322742367|FG002|Follow up|study ongoing|15|||
94259276|NCT01065454|322742368|FG003|Follow up|study ongoing|41|||
94259277|NCT04646005|322742369|FG000|Overall Study|Adverse Event|1|||
94259278|NCT04646005|322742369|FG000|Overall Study|Progressive Disease|71|||
94259279|NCT04646005|322742369|FG000|Overall Study|Death|20|||
94259280|NCT04646005|322742369|FG000|Overall Study|Withdrawal by Subject|12|||
94259281|NCT04646005|322742369|FG000|Overall Study|Sponsor Request|9|||
94259282|NCT03440320|322743858|FG000|Overall Study|Withdrawal by Subject|0|||
94259283|NCT03440320|322743859|FG001|Overall Study|Withdrawal by Subject|1|||
94259284|NCT02647320|322743862|FG000|Overall Study|Adverse Event|0|||
94631394|NCT02554812|324109951|FG011|Overall Study|Physician Decision|0|||
94631395|NCT02554812|324109952|FG012|Overall Study|Physician Decision|0|||
94631396|NCT02554812|324109953|FG013|Overall Study|Physician Decision|0|||
94631397|NCT02554812|324109954|FG014|Overall Study|Physician Decision|0|||
94631398|NCT02554812|324109955|FG015|Overall Study|Physician Decision|0|||
94259285|NCT02647320|322743863|FG001|Overall Study|Adverse Event|1|||
94259286|NCT02647320|322743864|FG002|Overall Study|Adverse Event|3|||
94259287|NCT02647320|322743865|FG003|Overall Study|Adverse Event|2|||
94259288|NCT02647320|322743866|FG004|Overall Study|Adverse Event|1|||
94259289|NCT02647320|322743862|FG000|Overall Study|Protocol Violation|0|||
94259290|NCT02647320|322743863|FG001|Overall Study|Protocol Violation|0|||
94259291|NCT02647320|322743864|FG002|Overall Study|Protocol Violation|3|||
94259292|NCT02647320|322743865|FG003|Overall Study|Protocol Violation|0|||
94259293|NCT02647320|322743866|FG004|Overall Study|Protocol Violation|0|||
94362105|NCT01610284|323108838|FG000|Randomization Phase|Adverse Event|1|||
94362106|NCT01610284|323108839|FG001|Randomization Phase|Adverse Event|0|||
94259294|NCT02647320|322743862|FG000|Overall Study|Withdrawal by Subject|7|||
94259295|NCT02647320|322743863|FG001|Overall Study|Withdrawal by Subject|4|||
94259296|NCT02647320|322743864|FG002|Overall Study|Withdrawal by Subject|2|||
94259297|NCT02647320|322743865|FG003|Overall Study|Withdrawal by Subject|2|||
94259298|NCT02647320|322743866|FG004|Overall Study|Withdrawal by Subject|7|||
94259299|NCT02647320|322743862|FG000|Overall Study|Persistent hyperglycemia|0|||
94259300|NCT02647320|322743863|FG001|Overall Study|Persistent hyperglycemia|1|||
94259301|NCT02647320|322743864|FG002|Overall Study|Persistent hyperglycemia|1|||
94259302|NCT02647320|322743865|FG003|Overall Study|Persistent hyperglycemia|1|||
94259303|NCT02647320|322743866|FG004|Overall Study|Persistent hyperglycemia|1|||
94259304|NCT02647320|322743862|FG000|Overall Study|Study terminated by sponsor|1|||
94259305|NCT02647320|322743863|FG001|Overall Study|Study terminated by sponsor|1|||
94259306|NCT02647320|322743864|FG002|Overall Study|Study terminated by sponsor|1|||
94259307|NCT02647320|322743865|FG003|Overall Study|Study terminated by sponsor|1|||
94259308|NCT02647320|322743866|FG004|Overall Study|Study terminated by sponsor|2|||
94259309|NCT02647320|322743862|FG000|Overall Study|Reason not provided|0|||
94259310|NCT02647320|322743863|FG001|Overall Study|Reason not provided|0|||
94259311|NCT02647320|322743864|FG002|Overall Study|Reason not provided|1|||
94259312|NCT02647320|322743865|FG003|Overall Study|Reason not provided|0|||
94259313|NCT02647320|322743866|FG004|Overall Study|Reason not provided|2|||
94259314|NCT02647320|322743862|FG000|Overall Study|Lost to Follow-up|1|||
94259315|NCT02647320|322743863|FG001|Overall Study|Lost to Follow-up|1|||
94259316|NCT02647320|322743864|FG002|Overall Study|Lost to Follow-up|0|||
94259317|NCT02647320|322743865|FG003|Overall Study|Lost to Follow-up|0|||
94259318|NCT02647320|322743866|FG004|Overall Study|Lost to Follow-up|0|||
94259319|NCT02647320|322743862|FG000|Overall Study|Develop anemia|1|||
94259320|NCT02647320|322743863|FG001|Overall Study|Develop anemia|0|||
94259321|NCT02647320|322743864|FG002|Overall Study|Develop anemia|0|||
94259322|NCT02647320|322743865|FG003|Overall Study|Develop anemia|0|||
94259323|NCT02647320|322743866|FG004|Overall Study|Develop anemia|0|||
94259324|NCT02647320|322743862|FG000|Overall Study|Lack of Efficacy|0|||
94259325|NCT02647320|322743863|FG001|Overall Study|Lack of Efficacy|0|||
94259326|NCT02647320|322743864|FG002|Overall Study|Lack of Efficacy|0|||
94259327|NCT02647320|322743865|FG003|Overall Study|Lack of Efficacy|1|||
94259328|NCT02647320|322743866|FG004|Overall Study|Lack of Efficacy|0|||
94259329|NCT02647320|322743862|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
94259330|NCT02647320|322743863|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
94259331|NCT02647320|322743864|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
94461712|NCT01043705|323479587|FG002|Overall Study|Adverse Event|0|||
94259332|NCT02647320|322743865|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
94259333|NCT02647320|322743866|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
94259334|NCT00792805|322743867|FG000|Overall Study|Adverse Event|12|||
94259335|NCT00792805|322743868|FG001|Overall Study|Adverse Event|10|||
94259336|NCT00792805|322743869|FG002|Overall Study|Adverse Event|10|||
94259337|NCT00792805|322743867|FG000|Overall Study|Subject withdrew consent|5|||
94259338|NCT00792805|322743868|FG001|Overall Study|Subject withdrew consent|6|||
94259339|NCT00792805|322743869|FG002|Overall Study|Subject withdrew consent|5|||
94259340|NCT00792805|322743867|FG000|Overall Study|Administrative problems|2|||
94259341|NCT00792805|322743868|FG001|Overall Study|Administrative problems|0|||
94259342|NCT00792805|322743869|FG002|Overall Study|Administrative problems|4|||
94259343|NCT00792805|322743867|FG000|Overall Study|Abnormal test procedure result(s)|1|||
94259344|NCT00792805|322743868|FG001|Overall Study|Abnormal test procedure result(s)|2|||
94259345|NCT00792805|322743869|FG002|Overall Study|Abnormal test procedure result(s)|0|||
94259346|NCT00792805|322743867|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94259347|NCT00792805|322743868|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
94259348|NCT00792805|322743869|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
94259349|NCT00792805|322743867|FG000|Overall Study|Lost to Follow-up|1|||
94259350|NCT00792805|322743868|FG001|Overall Study|Lost to Follow-up|1|||
94259351|NCT00792805|322743869|FG002|Overall Study|Lost to Follow-up|6|||
94259352|NCT00792805|322743867|FG000|Overall Study|Abnormal laboratory value(s)|0|||
94259353|NCT00792805|322743868|FG001|Overall Study|Abnormal laboratory value(s)|0|||
94259354|NCT00792805|322743869|FG002|Overall Study|Abnormal laboratory value(s)|1|||
94259355|NCT00792805|322743867|FG000|Overall Study|Protocol deviation|0|||
94259356|NCT00792805|322743868|FG001|Overall Study|Protocol deviation|1|||
94259357|NCT00792805|322743869|FG002|Overall Study|Protocol deviation|1|||
94259358|NCT04796896|322743870|FG000|Overall Study|Adverse Event|1|||
94259359|NCT04796896|322743871|FG001|Overall Study|Adverse Event|0|||
94259360|NCT04796896|322743872|FG002|Overall Study|Adverse Event|0|||
94259361|NCT04796896|322743873|FG003|Overall Study|Adverse Event|0|||
94259362|NCT04796896|322743874|FG004|Overall Study|Adverse Event|0|||
94259363|NCT04796896|322743875|FG005|Overall Study|Adverse Event|1|||
94259364|NCT04796896|322743876|FG006|Overall Study|Adverse Event|1|||
94259365|NCT04796896|322743877|FG007|Overall Study|Adverse Event|0|||
94259366|NCT04796896|322743878|FG008|Overall Study|Adverse Event|1|||
94259367|NCT04796896|322743879|FG009|Overall Study|Adverse Event|1|||
94259368|NCT04796896|322743880|FG010|Overall Study|Adverse Event|1|||
94259369|NCT04796896|322743881|FG011|Overall Study|Adverse Event|0|||
94259370|NCT04796896|322743870|FG000|Overall Study|Lost to Follow-up|24|||
94259371|NCT04796896|322743871|FG001|Overall Study|Lost to Follow-up|15|||
94259372|NCT04796896|322743872|FG002|Overall Study|Lost to Follow-up|6|||
94259373|NCT04796896|322743873|FG003|Overall Study|Lost to Follow-up|4|||
94259374|NCT04796896|322743874|FG004|Overall Study|Lost to Follow-up|21|||
94259375|NCT04796896|322743875|FG005|Overall Study|Lost to Follow-up|55|||
94259376|NCT04796896|322743876|FG006|Overall Study|Lost to Follow-up|237|||
94259377|NCT04796896|322743877|FG007|Overall Study|Lost to Follow-up|52|||
94259378|NCT04796896|322743878|FG008|Overall Study|Lost to Follow-up|221|||
94259379|NCT04796896|322743879|FG009|Overall Study|Lost to Follow-up|43|||
94259380|NCT04796896|322743880|FG010|Overall Study|Lost to Follow-up|142|||
94259381|NCT04796896|322743881|FG011|Overall Study|Lost to Follow-up|18|||
94259382|NCT04796896|322743870|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
94259383|NCT04796896|322743871|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
94259384|NCT04796896|322743872|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
94259385|NCT04796896|322743873|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
94259386|NCT04796896|322743874|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
94259387|NCT04796896|322743875|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
94259388|NCT04796896|322743876|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
94259389|NCT04796896|322743877|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
94259390|NCT04796896|322743878|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
94259391|NCT04796896|322743879|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
94461713|NCT01043705|323479585|FG000|Overall Study|Screen Fail|21|||
94461714|NCT01043705|323479586|FG001|Overall Study|Screen Fail|0|||
94259392|NCT04796896|322743880|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
94259393|NCT04796896|322743881|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
94259394|NCT04796896|322743870|FG000|Overall Study|Physician Decision|1|||
94259395|NCT04796896|322743871|FG001|Overall Study|Physician Decision|0|||
94259396|NCT04796896|322743872|FG002|Overall Study|Physician Decision|0|||
94259397|NCT04796896|322743873|FG003|Overall Study|Physician Decision|0|||
94259398|NCT04796896|322743874|FG004|Overall Study|Physician Decision|0|||
94259399|NCT04796896|322743875|FG005|Overall Study|Physician Decision|3|||
94259400|NCT04796896|322743876|FG006|Overall Study|Physician Decision|18|||
94259401|NCT04796896|322743877|FG007|Overall Study|Physician Decision|1|||
94259402|NCT04796896|322743878|FG008|Overall Study|Physician Decision|7|||
94461715|NCT01043705|323479587|FG002|Overall Study|Screen Fail|0|||
94461716|NCT01043705|323479585|FG000|Overall Study|Other|0|||
94631399|NCT02554812|324109956|FG016|Overall Study|Physician Decision|1|||
94631400|NCT02554812|324109957|FG017|Overall Study|Physician Decision|1|||
94631401|NCT02554812|324109958|FG018|Overall Study|Physician Decision|0|||
94631402|NCT02554812|324109959|FG019|Overall Study|Physician Decision|1|||
94631403|NCT02554812|324109960|FG020|Overall Study|Physician Decision|1|||
94631404|NCT02554812|324109961|FG021|Overall Study|Physician Decision|0|||
94631405|NCT02554812|324109962|FG022|Overall Study|Physician Decision|1|||
94631406|NCT02554812|324109963|FG023|Overall Study|Physician Decision|0|||
94631407|NCT02554812|324109964|FG024|Overall Study|Physician Decision|0|||
94631408|NCT02554812|324109965|FG025|Overall Study|Physician Decision|0|||
94631409|NCT02554812|324109966|FG026|Overall Study|Physician Decision|0|||
94631410|NCT02554812|324109940|FG000|Overall Study|Study terminated by sponsor|0|||
94631411|NCT02554812|324109941|FG001|Overall Study|Study terminated by sponsor|0|||
94631412|NCT02554812|324109942|FG002|Overall Study|Study terminated by sponsor|0|||
94631413|NCT02554812|324109943|FG003|Overall Study|Study terminated by sponsor|0|||
94631414|NCT02554812|324109944|FG004|Overall Study|Study terminated by sponsor|0|||
94631415|NCT02554812|324109945|FG005|Overall Study|Study terminated by sponsor|0|||
94631416|NCT02554812|324109946|FG006|Overall Study|Study terminated by sponsor|0|||
94631417|NCT02554812|324109947|FG007|Overall Study|Study terminated by sponsor|0|||
94631418|NCT02554812|324109948|FG008|Overall Study|Study terminated by sponsor|0|||
94631419|NCT02554812|324109949|FG009|Overall Study|Study terminated by sponsor|0|||
94631420|NCT02554812|324109950|FG010|Overall Study|Study terminated by sponsor|0|||
94631421|NCT02554812|324109951|FG011|Overall Study|Study terminated by sponsor|0|||
94631422|NCT02554812|324109952|FG012|Overall Study|Study terminated by sponsor|0|||
94631423|NCT02554812|324109953|FG013|Overall Study|Study terminated by sponsor|0|||
94631424|NCT02554812|324109954|FG014|Overall Study|Study terminated by sponsor|0|||
94631425|NCT02554812|324109955|FG015|Overall Study|Study terminated by sponsor|0|||
94631426|NCT02554812|324109956|FG016|Overall Study|Study terminated by sponsor|0|||
94631427|NCT02554812|324109957|FG017|Overall Study|Study terminated by sponsor|0|||
94631428|NCT02554812|324109958|FG018|Overall Study|Study terminated by sponsor|0|||
94631429|NCT02554812|324109959|FG019|Overall Study|Study terminated by sponsor|0|||
94631430|NCT02554812|324109960|FG020|Overall Study|Study terminated by sponsor|0|||
94631431|NCT02554812|324109961|FG021|Overall Study|Study terminated by sponsor|0|||
94631432|NCT02554812|324109962|FG022|Overall Study|Study terminated by sponsor|0|||
94631433|NCT02554812|324109963|FG023|Overall Study|Study terminated by sponsor|0|||
94631434|NCT02554812|324109964|FG024|Overall Study|Study terminated by sponsor|1|||
94631435|NCT02554812|324109965|FG025|Overall Study|Study terminated by sponsor|0|||
94631436|NCT02554812|324109966|FG026|Overall Study|Study terminated by sponsor|0|||
94631437|NCT02554812|324109940|FG000|Overall Study|No longer meets eligibility criteria|0|||
94631438|NCT02554812|324109941|FG001|Overall Study|No longer meets eligibility criteria|1|||
94631439|NCT02554812|324109942|FG002|Overall Study|No longer meets eligibility criteria|0|||
94631440|NCT02554812|324109943|FG003|Overall Study|No longer meets eligibility criteria|0|||
94631441|NCT02554812|324109944|FG004|Overall Study|No longer meets eligibility criteria|0|||
94631442|NCT02554812|324109945|FG005|Overall Study|No longer meets eligibility criteria|0|||
94631443|NCT02554812|324109946|FG006|Overall Study|No longer meets eligibility criteria|0|||
94631444|NCT02554812|324109947|FG007|Overall Study|No longer meets eligibility criteria|0|||
94631445|NCT02554812|324109948|FG008|Overall Study|No longer meets eligibility criteria|0|||
94631446|NCT02554812|324109949|FG009|Overall Study|No longer meets eligibility criteria|0|||
94631447|NCT02554812|324109950|FG010|Overall Study|No longer meets eligibility criteria|0|||
94631448|NCT02554812|324109951|FG011|Overall Study|No longer meets eligibility criteria|0|||
94631449|NCT02554812|324109952|FG012|Overall Study|No longer meets eligibility criteria|0|||
94631450|NCT02554812|324109953|FG013|Overall Study|No longer meets eligibility criteria|0|||
94631451|NCT02554812|324109954|FG014|Overall Study|No longer meets eligibility criteria|0|||
94631452|NCT02554812|324109955|FG015|Overall Study|No longer meets eligibility criteria|0|||
94631453|NCT02554812|324109956|FG016|Overall Study|No longer meets eligibility criteria|0|||
94631454|NCT02554812|324109957|FG017|Overall Study|No longer meets eligibility criteria|0|||
94631455|NCT02554812|324109958|FG018|Overall Study|No longer meets eligibility criteria|0|||
94631456|NCT02554812|324109959|FG019|Overall Study|No longer meets eligibility criteria|0|||
94631457|NCT02554812|324109960|FG020|Overall Study|No longer meets eligibility criteria|0|||
94631458|NCT02554812|324109961|FG021|Overall Study|No longer meets eligibility criteria|0|||
94631459|NCT02554812|324109962|FG022|Overall Study|No longer meets eligibility criteria|0|||
94631460|NCT02554812|324109963|FG023|Overall Study|No longer meets eligibility criteria|0|||
94631461|NCT02554812|324109964|FG024|Overall Study|No longer meets eligibility criteria|0|||
94631462|NCT02554812|324109965|FG025|Overall Study|No longer meets eligibility criteria|0|||
94631463|NCT02554812|324109966|FG026|Overall Study|No longer meets eligibility criteria|0|||
94651435|NCT03603964|324181656|FG000|Overall Study|Death|9|||
94259403|NCT04796896|322743879|FG009|Overall Study|Physician Decision|0|||
94259404|NCT04796896|322743880|FG010|Overall Study|Physician Decision|5|||
94259405|NCT04796896|322743881|FG011|Overall Study|Physician Decision|0|||
94259406|NCT04796896|322743870|FG000|Overall Study|Withdrawal by Subject|36|||
94259407|NCT04796896|322743871|FG001|Overall Study|Withdrawal by Subject|31|||
94259408|NCT04796896|322743872|FG002|Overall Study|Withdrawal by Subject|11|||
94259409|NCT04796896|322743873|FG003|Overall Study|Withdrawal by Subject|8|||
94259410|NCT04796896|322743874|FG004|Overall Study|Withdrawal by Subject|16|||
94259411|NCT04796896|322743875|FG005|Overall Study|Withdrawal by Subject|162|||
94259412|NCT04796896|322743876|FG006|Overall Study|Withdrawal by Subject|299|||
94259413|NCT04796896|322743877|FG007|Overall Study|Withdrawal by Subject|149|||
94631464|NCT00224055|324112446|FG000|Overall Study|Adverse Event|9|||
94631465|NCT00224055|324112447|FG001|Overall Study|Adverse Event|3|||
94631466|NCT00224055|324112446|FG000|Overall Study|Lost to Follow-up|1|||
94631467|NCT00224055|324112447|FG001|Overall Study|Lost to Follow-up|2|||
94631468|NCT00224055|324112446|FG000|Overall Study|Protocol Violation|1|||
94631469|NCT00224055|324112447|FG001|Overall Study|Protocol Violation|1|||
94631470|NCT00224055|324112446|FG000|Overall Study|Inclusion Violation|3|||
94631471|NCT00224055|324112447|FG001|Overall Study|Inclusion Violation|6|||
94631472|NCT00224055|324112446|FG000|Overall Study|Withdrawal by Subject|0|||
94631473|NCT00224055|324112447|FG001|Overall Study|Withdrawal by Subject|2|||
94631474|NCT00224055|324112446|FG000|Overall Study|Other|1|||
94631475|NCT00224055|324112447|FG001|Overall Study|Other|0|||
94631476|NCT00418314|324112450|FG000|Overall Study|Withdrawal by Subject|1|||
94631477|NCT00418314|324112451|FG001|Overall Study|Withdrawal by Subject|2|||
94631478|NCT03182829|324112452|FG000|Overall Study|Protocol Violation|12|||
94631479|NCT03182829|324112453|FG001|Overall Study|Protocol Violation|12|||
94631480|NCT03182829|324112452|FG000|Overall Study|Other|4|||
94631481|NCT03182829|324112453|FG001|Overall Study|Other|3|||
94631482|NCT00715078|324112454|FG000|Overall Study|Death|29|||
94631483|NCT00715078|324112455|FG001|Overall Study|Death|36|||
94631484|NCT00715078|324112456|FG002|Overall Study|Death|36|||
94631485|NCT00715078|324112454|FG000|Overall Study|Withdrawal by Subject|1|||
94631486|NCT00715078|324112455|FG001|Overall Study|Withdrawal by Subject|0|||
94631487|NCT00715078|324112456|FG002|Overall Study|Withdrawal by Subject|1|||
94631488|NCT00715078|324112454|FG000|Overall Study|Unable to start due to disease prog.|0|||
94631489|NCT00715078|324112455|FG001|Overall Study|Unable to start due to disease prog.|0|||
94631490|NCT00715078|324112456|FG002|Overall Study|Unable to start due to disease prog.|1|||
94631491|NCT02511184|324112457|FG000|Overall Study|Death|1|||
94631492|NCT02511184|324112458|FG001|Overall Study|Death|0|||
94631493|NCT02511184|324112457|FG000|Overall Study|Lost to Follow-up|0|||
94631494|NCT02511184|324112458|FG001|Overall Study|Lost to Follow-up|1|||
94631495|NCT02511184|324112457|FG000|Overall Study|Study terminated by sponsor|1|||
94631496|NCT02511184|324112458|FG001|Overall Study|Study terminated by sponsor|5|||
94259414|NCT04796896|322743878|FG008|Overall Study|Withdrawal by Subject|303|||
94259415|NCT04796896|322743879|FG009|Overall Study|Withdrawal by Subject|94|||
94259416|NCT04796896|322743880|FG010|Overall Study|Withdrawal by Subject|192|||
94259417|NCT04796896|322743881|FG011|Overall Study|Withdrawal by Subject|16|||
94631497|NCT02511184|324112457|FG000|Overall Study|Withdrawal by Subject|0|||
94631498|NCT02511184|324112458|FG001|Overall Study|Withdrawal by Subject|1|||
94631499|NCT02904512|324112459|FG000|Overall Study|Withdrawal by Subject|1|||
94631500|NCT02904512|324112460|FG001|Overall Study|Withdrawal by Subject|0|||
94631501|NCT02904512|324112459|FG000|Overall Study|Transferred to ICU|1|||
94631502|NCT02904512|324112460|FG001|Overall Study|Transferred to ICU|0|||
94631503|NCT02904512|324112459|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
94631504|NCT02904512|324112460|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
94631505|NCT00386776|324112461|FG000|Overall Study|Withdrawal by Subject|8|||
94631506|NCT00588848|324112462|FG000|Overall Study|Physician Decision|0|||
94631507|NCT00588848|324112463|FG001|Overall Study|Physician Decision|3|||
94631508|NCT00293254|324112464|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
94259418|NCT04796896|322743870|FG000|Overall Study|Other Than Specified|6|||
94631509|NCT00293254|324112465|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
94631510|NCT00293254|324112464|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
94631511|NCT00293254|324112465|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
94631512|NCT00293254|324112464|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
94631513|NCT00293254|324112465|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
94259419|NCT04796896|322743871|FG001|Overall Study|Other Than Specified|5|||
94259420|NCT04796896|322743872|FG002|Overall Study|Other Than Specified|3|||
94631514|NCT00293254|324112464|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
94631515|NCT00293254|324112465|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
94631516|NCT00293254|324112464|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
94631517|NCT00293254|324112465|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
94631518|NCT00293254|324112464|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
94631519|NCT00293254|324112465|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
94631520|NCT00293254|324112464|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
94259421|NCT04796896|322743873|FG003|Overall Study|Other Than Specified|2|||
94259422|NCT04796896|322743874|FG004|Overall Study|Other Than Specified|6|||
94259423|NCT04796896|322743875|FG005|Overall Study|Other Than Specified|31|||
94259424|NCT04796896|322743876|FG006|Overall Study|Other Than Specified|86|||
94259425|NCT04796896|322743877|FG007|Overall Study|Other Than Specified|66|||
94259426|NCT04796896|322743878|FG008|Overall Study|Other Than Specified|388|||
94259427|NCT04796896|322743879|FG009|Overall Study|Other Than Specified|48|||
94259428|NCT04796896|322743880|FG010|Overall Study|Other Than Specified|258|||
94259429|NCT04796896|322743881|FG011|Overall Study|Other Than Specified|4|||
94259430|NCT04796896|322743870|FG000|Overall Study|Protocol Deviation|0|||
94259431|NCT04796896|322743871|FG001|Overall Study|Protocol Deviation|0|||
94259432|NCT04796896|322743872|FG002|Overall Study|Protocol Deviation|0|||
94259433|NCT04796896|322743873|FG003|Overall Study|Protocol Deviation|1|||
94259434|NCT04796896|322743874|FG004|Overall Study|Protocol Deviation|1|||
94259435|NCT04796896|322743875|FG005|Overall Study|Protocol Deviation|2|||
94259436|NCT04796896|322743876|FG006|Overall Study|Protocol Deviation|2|||
94259437|NCT04796896|322743877|FG007|Overall Study|Protocol Deviation|2|||
94259438|NCT04796896|322743878|FG008|Overall Study|Protocol Deviation|2|||
94259439|NCT04796896|322743879|FG009|Overall Study|Protocol Deviation|1|||
94259440|NCT04796896|322743880|FG010|Overall Study|Protocol Deviation|0|||
94259441|NCT04796896|322743881|FG011|Overall Study|Protocol Deviation|0|||
94259442|NCT04796896|322743870|FG000|Overall Study|Missing|0|||
94259443|NCT04796896|322743871|FG001|Overall Study|Missing|0|||
94259444|NCT04796896|322743872|FG002|Overall Study|Missing|0|||
94259445|NCT04796896|322743873|FG003|Overall Study|Missing|0|||
94259446|NCT04796896|322743874|FG004|Overall Study|Missing|0|||
94259447|NCT04796896|322743875|FG005|Overall Study|Missing|0|||
94259448|NCT04796896|322743876|FG006|Overall Study|Missing|2|||
94259449|NCT04796896|322743877|FG007|Overall Study|Missing|1|||
94259450|NCT04796896|322743878|FG008|Overall Study|Missing|2|||
94259451|NCT04796896|322743879|FG009|Overall Study|Missing|1|||
94259452|NCT04796896|322743880|FG010|Overall Study|Missing|1|||
94259453|NCT04796896|322743881|FG011|Overall Study|Missing|0|||
94259454|NCT04796896|322743870|FG000|Overall Study|Death|0|||
94259455|NCT04796896|322743871|FG001|Overall Study|Death|0|||
94259456|NCT04796896|322743872|FG002|Overall Study|Death|0|||
94259457|NCT04796896|322743873|FG003|Overall Study|Death|0|||
94259458|NCT04796896|322743874|FG004|Overall Study|Death|0|||
94259459|NCT04796896|322743875|FG005|Overall Study|Death|0|||
94259460|NCT04796896|322743876|FG006|Overall Study|Death|0|||
94259461|NCT04796896|322743877|FG007|Overall Study|Death|0|||
94259462|NCT04796896|322743878|FG008|Overall Study|Death|1|||
94259463|NCT04796896|322743879|FG009|Overall Study|Death|0|||
94259464|NCT04796896|322743880|FG010|Overall Study|Death|0|||
94259465|NCT04796896|322743881|FG011|Overall Study|Death|0|||
94259466|NCT03249714|322743886|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
94259467|NCT03249714|322743887|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
94259468|NCT03249714|322743886|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
94259469|NCT03249714|322743887|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
94259470|NCT03249714|322743886|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
94259471|NCT03249714|322743887|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
94259472|NCT03249714|322743886|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
94259473|NCT03249714|322743887|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
94259474|NCT00887250|322743888|FG000|Overall Study|Adverse Event|3|||
94259475|NCT00887250|322743889|FG001|Overall Study|Adverse Event|0|||
94259476|NCT00887250|322743890|FG002|Overall Study|Adverse Event|7|||
94259477|NCT00887250|322743888|FG000|Overall Study|Lack of Efficacy|9|||
94259478|NCT00887250|322743889|FG001|Overall Study|Lack of Efficacy|6|||
94259479|NCT00887250|322743890|FG002|Overall Study|Lack of Efficacy|1|||
94259480|NCT00887250|322743888|FG000|Overall Study|Lost to Follow-up|2|||
94259481|NCT00887250|322743889|FG001|Overall Study|Lost to Follow-up|3|||
94259482|NCT00887250|322743890|FG002|Overall Study|Lost to Follow-up|1|||
94259483|NCT00887250|322743888|FG000|Overall Study|Protocol Violation|2|||
94362107|NCT01610284|323108838|FG000|Randomization Phase|Physician Decision|1|||
94651436|NCT03603964|324181656|FG000|Overall Study|Withdrawal by participant|7|||
94259484|NCT00887250|322743889|FG001|Overall Study|Protocol Violation|2|||
94259485|NCT00887250|322743890|FG002|Overall Study|Protocol Violation|1|||
94259486|NCT00887250|322743888|FG000|Overall Study|Withdrawal by Subject|2|||
94259487|NCT00887250|322743889|FG001|Overall Study|Withdrawal by Subject|1|||
94259488|NCT00887250|322743890|FG002|Overall Study|Withdrawal by Subject|2|||
94259489|NCT00887250|322743888|FG000|Overall Study|Patient uncooperative|0|||
94259490|NCT00887250|322743889|FG001|Overall Study|Patient uncooperative|0|||
94259491|NCT00887250|322743890|FG002|Overall Study|Patient uncooperative|1|||
94259492|NCT02960854|322743891|FG000|Overall Study|Not Disclosed|2|||
94259493|NCT02960854|322743892|FG001|Overall Study|Not Disclosed|2|||
94259494|NCT02960854|322743891|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
94259495|NCT02960854|322743892|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
94259496|NCT02960854|322743891|FG000|Overall Study|Subject Withdrew Consent|0|||
94362108|NCT01610284|323108839|FG001|Randomization Phase|Physician Decision|1|||
94259497|NCT02960854|322743892|FG001|Overall Study|Subject Withdrew Consent|1|||
94259498|NCT02960854|322743891|FG000|Overall Study|Death|4|||
94259499|NCT02960854|322743892|FG001|Overall Study|Death|6|||
94259500|NCT04218084|322743893|FG000|Overall Study|Adverse Event|7|||
94259501|NCT04218084|322743894|FG001|Overall Study|Adverse Event|2|||
94259502|NCT04218084|322743893|FG000|Overall Study|Withdrawal of Consent|4|||
94259503|NCT04218084|322743894|FG001|Overall Study|Withdrawal of Consent|5|||
94259504|NCT04218084|322743893|FG000|Overall Study|Physician Decision|1|||
94259505|NCT04218084|322743894|FG001|Overall Study|Physician Decision|1|||
94259506|NCT04218084|322743893|FG000|Overall Study|Lost to Follow-up|1|||
94259507|NCT04218084|322743894|FG001|Overall Study|Lost to Follow-up|1|||
94259508|NCT04218084|322743893|FG000|Overall Study|Non-compliance with study drug|1|||
94259509|NCT04218084|322743894|FG001|Overall Study|Non-compliance with study drug|1|||
94259510|NCT04218084|322743893|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
94259511|NCT04218084|322743894|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
94259512|NCT04218084|322743893|FG000|Overall Study|Other|0|||
94259513|NCT04218084|322743894|FG001|Overall Study|Other|1|||
94259514|NCT04218084|322743893|FG000|Overall Study|Ongoing at data cut-off date|62|||
94259515|NCT04218084|322743894|FG001|Overall Study|Ongoing at data cut-off date|58|||
94259516|NCT04745026|322743895|FG000|Overall Study|Physician Decision|1|||
94259517|NCT04745026|322743896|FG001|Overall Study|Physician Decision|0|||
94259518|NCT04745026|322743895|FG000|Overall Study|Adverse Event|2|||
94259519|NCT04745026|322743896|FG001|Overall Study|Adverse Event|2|||
94259520|NCT04745026|322743895|FG000|Overall Study|Protocol Violation|1|||
94259521|NCT04745026|322743896|FG001|Overall Study|Protocol Violation|3|||
94259522|NCT04745026|322743895|FG000|Overall Study|Lost to Follow-up|4|||
94259523|NCT04745026|322743896|FG001|Overall Study|Lost to Follow-up|3|||
94259524|NCT04745026|322743895|FG000|Overall Study|Withdrawal by Subject|5|||
94259525|NCT04745026|322743896|FG001|Overall Study|Withdrawal by Subject|5|||
94259526|NCT03840486|322743900|FG000|Overall Study|Withdrawal by Subject|0|||
94259527|NCT03840486|322743901|FG001|Overall Study|Withdrawal by Subject|1|||
94259528|NCT03840486|322743902|FG002|Overall Study|Withdrawal by Subject|0|||
94259529|NCT03840486|322743903|FG003|Overall Study|Withdrawal by Subject|0|||
94259530|NCT03840486|322743904|FG004|Overall Study|Withdrawal by Subject|0|||
94259531|NCT03840486|322743905|FG005|Overall Study|Withdrawal by Subject|0|||
94259532|NCT03840486|322743906|FG006|Overall Study|Withdrawal by Subject|0|||
94259533|NCT03840486|322743907|FG007|Overall Study|Withdrawal by Subject|0|||
94259534|NCT03840486|322743908|FG008|Overall Study|Withdrawal by Subject|0|||
94259535|NCT03840486|322743909|FG009|Overall Study|Withdrawal by Subject|0|||
94259536|NCT03840486|322743910|FG010|Overall Study|Withdrawal by Subject|0|||
94259537|NCT03840486|322743911|FG011|Overall Study|Withdrawal by Subject|0|||
94259538|NCT05041101|322743912|FG000|Overall Study|Adverse Event|1|||
94259539|NCT05041101|322743913|FG001|Overall Study|Adverse Event|0|||
94259540|NCT05041101|322743914|FG002|Overall Study|Adverse Event|0|||
94259541|NCT05041101|322743912|FG000|Overall Study|Diease Progression|5|||
94259542|NCT05041101|322743913|FG001|Overall Study|Diease Progression|0|||
94259543|NCT05041101|322743914|FG002|Overall Study|Diease Progression|0|||
94259544|NCT04426851|322743915|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
94259545|NCT04426851|322743916|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
94259546|NCT04426851|322743915|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
94259547|NCT04426851|322743916|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
94259548|NCT03401229|322743919|FG000|Overall Study|Lost to Follow-up|2|||
94259549|NCT03401229|322743920|FG001|Overall Study|Lost to Follow-up|1|||
94259550|NCT03401229|322743919|FG000|Overall Study|Other|1|||
94259551|NCT03401229|322743920|FG001|Overall Study|Other|3|||
94259552|NCT03401229|322743919|FG000|Overall Study|Adverse Event|8|||
94259553|NCT03401229|322743920|FG001|Overall Study|Adverse Event|6|||
94259554|NCT03401229|322743919|FG000|Overall Study|Withdrawal by Subject|29|||
94259555|NCT03401229|322743920|FG001|Overall Study|Withdrawal by Subject|26|||
94631521|NCT00293254|324112465|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
94631522|NCT00293254|324112464|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
94631523|NCT00293254|324112465|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
94631524|NCT00293254|324112464|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
94631525|NCT00293254|324112465|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
94259556|NCT03401229|322743919|FG000|Overall Study|COVID-19|0|||
94259557|NCT03401229|322743920|FG001|Overall Study|COVID-19|1|||
94259558|NCT03575143|322743921|FG000|Overall Study|Lost to Follow-up|0|||
94259559|NCT03575143|322743922|FG001|Overall Study|Lost to Follow-up|0|||
94259560|NCT03575143|322743923|FG002|Overall Study|Lost to Follow-up|4|||
94259561|NCT03575143|322743921|FG000|Overall Study|Withdrawal by Subject|0|||
94259562|NCT03575143|322743922|FG001|Overall Study|Withdrawal by Subject|0|||
94259563|NCT03575143|322743923|FG002|Overall Study|Withdrawal by Subject|5|||
94259564|NCT03575143|322743921|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
94259565|NCT03575143|322743922|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
94259566|NCT03575143|322743923|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
94259567|NCT01287065|322743924|FG000|Treatment Period 1|Adverse Event|0|||
94259568|NCT01287065|322743925|FG001|Treatment Period 1|Adverse Event|0|||
94259569|NCT01287065|322743926|FG002|Treatment Period 1|Adverse Event|0|||
94259570|NCT01287065|322743927|FG003|Treatment Period 1|Adverse Event|0|||
94259571|NCT01287065|322743928|FG004|Treatment Period 1|Adverse Event|1|||
94259572|NCT01287065|322743929|FG005|Treatment Period 1|Adverse Event|0|||
94259573|NCT01287065|322743924|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94259574|NCT01287065|322743925|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94259575|NCT01287065|322743926|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94259576|NCT01287065|322743927|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94259577|NCT01287065|322743928|FG004|Treatment Period 1|Withdrawal by Subject|0|||
94259578|NCT01287065|322743929|FG005|Treatment Period 1|Withdrawal by Subject|1|||
94259579|NCT02875977|322743930|FG000|Overall Study|Lost to Follow-up|42|||
94259580|NCT02875977|322743931|FG001|Overall Study|Lost to Follow-up|29|||
94259581|NCT00141726|322743935|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
94259582|NCT03285178|322743936|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
94259583|NCT03285178|322743937|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
94259584|NCT03285178|322743938|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
94259585|NCT03285178|322743939|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
94631526|NCT00293254|324112464|FG000|Extension - Double-Blind Week 49-156|Death|4|||
94631527|NCT00293254|324112465|FG001|Extension - Double-Blind Week 49-156|Death|1|||
94631528|NCT00293254|324112464|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
94631529|NCT00293254|324112465|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
94631530|NCT00293254|324112464|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
94631531|NCT00293254|324112465|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
94631532|NCT00293254|324112464|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
94631533|NCT00293254|324112465|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
94631534|NCT00293254|324112464|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
94631535|NCT00293254|324112465|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
94631536|NCT00293254|324112464|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
94631537|NCT00293254|324112465|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
94631538|NCT00293254|324112464|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
94631539|NCT00293254|324112465|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
94631540|NCT00293254|324112464|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
94631541|NCT00293254|324112465|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
94631542|NCT00293254|324112464|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
94631543|NCT00293254|324112465|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
94631544|NCT00293254|324112464|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
94631545|NCT00293254|324112465|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
94631546|NCT00293254|324112464|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
94631547|NCT00293254|324112465|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
94631548|NCT00293254|324112464|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
94631549|NCT00293254|324112465|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
94631550|NCT00293254|324112464|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
94631551|NCT00293254|324112465|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
94631552|NCT00293254|324112464|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
94631553|NCT00293254|324112465|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
94631554|NCT00293254|324112464|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
94631555|NCT00293254|324112465|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
94631556|NCT00293254|324112464|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
94631557|NCT00293254|324112465|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
94631558|NCT00293254|324112464|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
94631559|NCT00293254|324112465|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
94631560|NCT00293254|324112464|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
94631561|NCT00293254|324112465|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
94631562|NCT00232817|324112472|FG000|Overall Study|Protocol Violation|2|||
94631563|NCT00232817|324112473|FG001|Overall Study|Protocol Violation|1|||
94631564|NCT00799487|324112474|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
94631565|NCT00799487|324112475|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
94631566|NCT00799487|324112476|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
94631567|NCT00799487|324112474|FG000|Dose Adjustment Period|Adverse Event|2|||
94362109|NCT01610284|323108838|FG000|Randomization Phase|Death|0|||
94362110|NCT01610284|323108839|FG001|Randomization Phase|Death|1|||
94362111|NCT01610284|323108838|FG000|Treatment Phase|Adverse Event|80|||
94362112|NCT01610284|323108839|FG001|Treatment Phase|Adverse Event|12|||
94362113|NCT01610284|323108838|FG000|Treatment Phase|Lost to Follow-up|1|||
94631568|NCT00799487|324112475|FG001|Dose Adjustment Period|Adverse Event|0|||
94631569|NCT00799487|324112476|FG002|Dose Adjustment Period|Adverse Event|0|||
94259586|NCT03285178|322743940|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
94259587|NCT03285178|322743941|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
94259588|NCT03285178|322743942|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
94631570|NCT00799487|324112474|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
94631571|NCT00799487|324112475|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
94631572|NCT00799487|324112476|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
94631573|NCT00799487|324112474|FG000|Dose Adjustment Period|Investigator Discretion|2|||
94631574|NCT00799487|324112475|FG001|Dose Adjustment Period|Investigator Discretion|0|||
94631575|NCT00799487|324112476|FG002|Dose Adjustment Period|Investigator Discretion|0|||
94631576|NCT00799487|324112474|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
94631577|NCT00799487|324112475|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
94631578|NCT00799487|324112476|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
94631579|NCT00799487|324112474|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
94631580|NCT00799487|324112475|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
94259589|NCT03285178|322743936|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
94259590|NCT03285178|322743937|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
94259591|NCT03285178|322743938|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
94259592|NCT03285178|322743939|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
94259593|NCT03285178|322743940|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
94259594|NCT03285178|322743941|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
94259595|NCT03285178|322743942|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
94259596|NCT03285178|322743936|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
94259597|NCT03285178|322743937|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
94259598|NCT03285178|322743938|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
94259599|NCT03285178|322743939|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
94259600|NCT03285178|322743940|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
94259601|NCT03285178|322743941|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
94259602|NCT03285178|322743942|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
94259603|NCT03285178|322743936|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
94259604|NCT03285178|322743937|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
94259605|NCT03285178|322743938|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
94259606|NCT03285178|322743939|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
94259607|NCT03285178|322743940|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
94259608|NCT03285178|322743941|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
94259609|NCT03285178|322743942|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
94259610|NCT03285178|322743936|FG000|Single-Blind Run-In Period|Physician Decision|2|||
94259611|NCT03285178|322743937|FG001|Single-Blind Run-In Period|Physician Decision|0|||
94259612|NCT03285178|322743938|FG002|Single-Blind Run-In Period|Physician Decision|0|||
94259613|NCT03285178|322743939|FG003|Single-Blind Run-In Period|Physician Decision|0|||
94259614|NCT03285178|322743940|FG004|Single-Blind Run-In Period|Physician Decision|0|||
94259615|NCT03285178|322743941|FG005|Single-Blind Run-In Period|Physician Decision|0|||
94259616|NCT03285178|322743942|FG006|Single-Blind Run-In Period|Physician Decision|0|||
94259617|NCT03285178|322743936|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
94259618|NCT03285178|322743937|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
94259619|NCT03285178|322743938|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
94259620|NCT03285178|322743939|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
94259621|NCT03285178|322743940|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
94259622|NCT03285178|322743941|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
94259623|NCT03285178|322743942|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
94259624|NCT03285178|322743936|FG000|Double-Blind Treatment Period|Adverse Event|0|||
94259625|NCT03285178|322743937|FG001|Double-Blind Treatment Period|Adverse Event|0|||
94259626|NCT03285178|322743938|FG002|Double-Blind Treatment Period|Adverse Event|0|||
94259627|NCT03285178|322743939|FG003|Double-Blind Treatment Period|Adverse Event|0|||
94259628|NCT03285178|322743940|FG004|Double-Blind Treatment Period|Adverse Event|0|||
94259629|NCT03285178|322743941|FG005|Double-Blind Treatment Period|Adverse Event|0|||
94259630|NCT03285178|322743942|FG006|Double-Blind Treatment Period|Adverse Event|2|||
94259631|NCT03285178|322743936|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
94259632|NCT03285178|322743937|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
94259633|NCT03285178|322743938|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
94259634|NCT03285178|322743939|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
94259635|NCT03285178|322743940|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
94631581|NCT00799487|324112476|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
94631582|NCT00799487|324112474|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
94362114|NCT01610284|323108839|FG001|Treatment Phase|Lost to Follow-up|0|||
94362115|NCT01610284|323108838|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
94362116|NCT01610284|323108839|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
94362117|NCT01610284|323108838|FG000|Treatment Phase|Physician Decision|27|||
94362118|NCT01610284|323108839|FG001|Treatment Phase|Physician Decision|24|||
94362119|NCT01610284|323108838|FG000|Treatment Phase|Progressive Disease|377|||
94362120|NCT01610284|323108839|FG001|Treatment Phase|Progressive Disease|486|||
94362121|NCT01610284|323108838|FG000|Treatment Phase|Protocol Deviation|2|||
94362122|NCT01610284|323108839|FG001|Treatment Phase|Protocol Deviation|3|||
94362123|NCT01610284|323108838|FG000|Treatment Phase|Study terminated by Sponsor|18|||
94362124|NCT01610284|323108839|FG001|Treatment Phase|Study terminated by Sponsor|15|||
94362125|NCT01610284|323108838|FG000|Treatment Phase|Subject/Guardian Decision|55|||
94362126|NCT01610284|323108839|FG001|Treatment Phase|Subject/Guardian Decision|23|||
94362127|NCT01610284|323108838|FG000|Treatment Phase|Death|6|||
94362128|NCT01610284|323108839|FG001|Treatment Phase|Death|5|||
94362129|NCT01610284|323108838|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
94362130|NCT01610284|323108839|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
94362131|NCT01610284|323108838|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
94362132|NCT01610284|323108839|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
94362133|NCT01610284|323108838|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
94362134|NCT01610284|323108839|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
94362135|NCT01610284|323108838|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
94362136|NCT01610284|323108839|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
94362137|NCT01610284|323108838|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
94362138|NCT01610284|323108839|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
94362139|NCT01610284|323108838|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
94362140|NCT01610284|323108839|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
94362141|NCT01157065|323108840|FG000|Overall Study|Death|0|||
94362142|NCT01157065|323108841|FG001|Overall Study|Death|1|||
94362143|NCT02057549|323108842|FG000|Overall Study|Lost to Follow-up|1|||
94362144|NCT02057549|323108843|FG001|Overall Study|Lost to Follow-up|0|||
94362145|NCT02057549|323108842|FG000|Overall Study|Physician Decision|1|||
94362146|NCT02057549|323108843|FG001|Overall Study|Physician Decision|0|||
94362147|NCT02057549|323108842|FG000|Overall Study|Withdrawal by Subject|1|||
94362148|NCT02057549|323108843|FG001|Overall Study|Withdrawal by Subject|0|||
94631583|NCT00799487|324112475|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
94631584|NCT00799487|324112476|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
94631585|NCT00799487|324112474|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
94631586|NCT00799487|324112475|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
94631587|NCT00799487|324112476|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
94631588|NCT00799487|324112474|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
94631589|NCT00799487|324112475|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
94631590|NCT00799487|324112476|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
94631591|NCT00799487|324112474|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
94631592|NCT00799487|324112475|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
94631593|NCT00799487|324112476|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
94631594|NCT00799487|324112474|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
94631595|NCT00799487|324112475|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
94631596|NCT00799487|324112476|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
94631597|NCT00799487|324112474|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
94631598|NCT00799487|324112475|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
94631599|NCT00799487|324112476|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
94631600|NCT03263442|324112477|FG000|Inpatient Phase|Death|1|||
94631601|NCT03263442|324112478|FG001|Inpatient Phase|Death|0|||
94631602|NCT03263442|324112477|FG000|Inpatient Phase|Withdrawal by Subject|1|||
94631603|NCT03263442|324112478|FG001|Inpatient Phase|Withdrawal by Subject|0|||
94631604|NCT03263442|324112477|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
94631605|NCT03263442|324112478|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
94675711|NCT04085328|324265506|FG001|Overall Study|Witihdrew Consent|16|||
94675712|NCT04085328|324265505|FG000|Overall Study|Adverse Event|8|||
94675713|NCT04085328|324265506|FG001|Overall Study|Adverse Event|7|||
94675714|NCT04085328|324265505|FG000|Overall Study|Lost to Follow-up|7|||
94675715|NCT04085328|324265506|FG001|Overall Study|Lost to Follow-up|2|||
94362149|NCT00530621|323108846|FG000|Overall Study|Adverse Event|11|||
94362150|NCT00530621|323108847|FG001|Overall Study|Adverse Event|8|||
94362151|NCT00530621|323108846|FG000|Overall Study|Physician Decision|2|||
94362152|NCT00530621|323108847|FG001|Overall Study|Physician Decision|4|||
94362153|NCT00530621|323108846|FG000|Overall Study|Progressive Disease (PD)|47|||
94362154|NCT00530621|323108847|FG001|Overall Study|Progressive Disease (PD)|40|||
94362155|NCT00530621|323108846|FG000|Overall Study|Sponsor Decision|12|||
94362156|NCT00530621|323108847|FG001|Overall Study|Sponsor Decision|15|||
94362157|NCT00530621|323108846|FG000|Overall Study|Subject Decision|4|||
94631606|NCT03263442|324112477|FG000|1-month Follow-Up|Lost to Follow-up|1|||
94631607|NCT03263442|324112478|FG001|1-month Follow-Up|Lost to Follow-up|0|||
94631608|NCT03263442|324112477|FG000|3-month Follow-Up|Lost to Follow-up|1|||
94631609|NCT03263442|324112478|FG001|3-month Follow-Up|Lost to Follow-up|3|||
94631610|NCT03263442|324112477|FG000|6-month Follow-Up|Lost to Follow-up|2|||
94631611|NCT03263442|324112478|FG001|6-month Follow-Up|Lost to Follow-up|2|||
94631612|NCT03518073|324112479|FG000|Overall Study|Adverse Event|2|||
94631613|NCT03518073|324112480|FG001|Overall Study|Adverse Event|4|||
94631614|NCT03518073|324112481|FG002|Overall Study|Adverse Event|2|||
94631615|NCT03518073|324112479|FG000|Overall Study|Death|2|||
94631616|NCT03518073|324112480|FG001|Overall Study|Death|1|||
94259636|NCT03285178|322743941|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
94631617|NCT03518073|324112481|FG002|Overall Study|Death|3|||
94631618|NCT03518073|324112479|FG000|Overall Study|Lost to Follow-up|1|||
94631619|NCT03518073|324112480|FG001|Overall Study|Lost to Follow-up|0|||
94631620|NCT03518073|324112481|FG002|Overall Study|Lost to Follow-up|1|||
94631621|NCT03518073|324112479|FG000|Overall Study|Physician Decision|5|||
94631622|NCT03518073|324112480|FG001|Overall Study|Physician Decision|0|||
94631623|NCT03518073|324112481|FG002|Overall Study|Physician Decision|2|||
94631624|NCT03518073|324112479|FG000|Overall Study|Progressive disease|1|||
94631625|NCT03518073|324112480|FG001|Overall Study|Progressive disease|1|||
94631626|NCT03518073|324112481|FG002|Overall Study|Progressive disease|1|||
94631627|NCT03518073|324112479|FG000|Overall Study|Protocol Violation|1|||
94631628|NCT03518073|324112480|FG001|Overall Study|Protocol Violation|0|||
94631629|NCT03518073|324112481|FG002|Overall Study|Protocol Violation|0|||
94631630|NCT03518073|324112479|FG000|Overall Study|Withdrawal by Subject|30|||
94631631|NCT03518073|324112480|FG001|Overall Study|Withdrawal by Subject|34|||
94631632|NCT03518073|324112481|FG002|Overall Study|Withdrawal by Subject|29|||
94631633|NCT03518073|324112479|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
94631634|NCT03518073|324112480|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
94631635|NCT03518073|324112481|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
94631636|NCT03518073|324112479|FG000|Overall Study|Covid-19|1|||
94631637|NCT03518073|324112480|FG001|Overall Study|Covid-19|2|||
94631638|NCT03518073|324112481|FG002|Overall Study|Covid-19|1|||
94631639|NCT02169739|324112483|FG000|Overall Study|Lost to Follow-up|0|||
94631640|NCT02169739|324112484|FG001|Overall Study|Lost to Follow-up|4|||
94631641|NCT01484873|324112485|FG000|Overall Study|Withdrawal by Subject|2|||
94631642|NCT00100815|324112486|FG000|Overall Study|Progression|24|||
94631643|NCT00100815|324112486|FG000|Overall Study|Adverse Event|18|||
94631644|NCT00100815|324112486|FG000|Overall Study|Death|4|||
94631645|NCT00100815|324112486|FG000|Overall Study|Other|3|||
94631646|NCT01549392|324112488|FG000|Overall Study|Withdrawal by Subject|1|||
94631647|NCT01549392|324112489|FG001|Overall Study|Withdrawal by Subject|0|||
94631648|NCT01525550|324112491|FG000|Overall Study|Lost to Follow-up|8|||
94631649|NCT01525550|324112492|FG001|Overall Study|Lost to Follow-up|2|||
94631650|NCT01525550|324112491|FG000|Overall Study|Death|19|||
94631651|NCT01525550|324112492|FG001|Overall Study|Death|28|||
94631652|NCT01525550|324112491|FG000|Overall Study|Other|0|||
94631653|NCT01525550|324112492|FG001|Overall Study|Other|4|||
94631654|NCT01525550|324112491|FG000|Overall Study|Sponsor's Decision|30|||
94631655|NCT01525550|324112492|FG001|Overall Study|Sponsor's Decision|11|||
94631656|NCT01525550|324112491|FG000|Overall Study|Withdrawal by Subject|4|||
94631657|NCT01525550|324112492|FG001|Overall Study|Withdrawal by Subject|0|||
94631658|NCT03480750|324112493|FG000|Overall Study|Withdrawal by Subject|0|||
94631659|NCT03480750|324112494|FG001|Overall Study|Withdrawal by Subject|1|||
94631660|NCT03480750|324112495|FG002|Overall Study|Withdrawal by Subject|0|||
94259637|NCT03285178|322743942|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
94259638|NCT03285178|322743936|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
94259639|NCT03285178|322743937|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
94259640|NCT03285178|322743938|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
94259641|NCT03285178|322743939|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
94259642|NCT03285178|322743940|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
94259643|NCT03285178|322743941|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
94259644|NCT03285178|322743942|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
94362158|NCT00530621|323108847|FG001|Overall Study|Subject Decision|7|||
94631661|NCT03480750|324112496|FG003|Overall Study|Withdrawal by Subject|0|||
94631662|NCT03480750|324112497|FG004|Overall Study|Withdrawal by Subject|0|||
94631663|NCT03480750|324112498|FG005|Overall Study|Withdrawal by Subject|0|||
94631664|NCT03480750|324112493|FG000|Overall Study|The interruption in Trientine shippment|0|||
94631665|NCT03480750|324112494|FG001|Overall Study|The interruption in Trientine shippment|0|||
94631666|NCT03480750|324112495|FG002|Overall Study|The interruption in Trientine shippment|0|||
94631667|NCT03480750|324112496|FG003|Overall Study|The interruption in Trientine shippment|0|||
94631668|NCT03480750|324112497|FG004|Overall Study|The interruption in Trientine shippment|0|||
94631669|NCT03480750|324112498|FG005|Overall Study|The interruption in Trientine shippment|1|||
94631670|NCT01103284|324112500|FG000|Overall Study|Death|2|||
94259645|NCT03285178|322743936|FG000|Double-Blind Treatment Period|COVID-19|0|||
94631671|NCT01103284|324112501|FG001|Overall Study|Death|0|||
94631672|NCT01103284|324112500|FG000|Overall Study|Lost to Follow-up|9|||
94631673|NCT01103284|324112501|FG001|Overall Study|Lost to Follow-up|10|||
94631674|NCT01103284|324112500|FG000|Overall Study|Pregnancy|3|||
94631675|NCT01103284|324112501|FG001|Overall Study|Pregnancy|1|||
94631676|NCT01103284|324112500|FG000|Overall Study|Protocol Violation|12|||
94631677|NCT01103284|324112501|FG001|Overall Study|Protocol Violation|5|||
94631678|NCT01103284|324112500|FG000|Overall Study|Adverse Event|0|||
94631679|NCT01103284|324112501|FG001|Overall Study|Adverse Event|5|||
94631680|NCT01103284|324112500|FG000|Overall Study|Withdrawal by Subject|14|||
94631681|NCT01103284|324112501|FG001|Overall Study|Withdrawal by Subject|18|||
94631682|NCT01103284|324112500|FG000|Overall Study|Dermal Hypersensitivity|0|||
94631683|NCT01103284|324112501|FG001|Overall Study|Dermal Hypersensitivity|1|||
94631684|NCT01103284|324112500|FG000|Overall Study|Termination by the Sponsor|0|||
94631685|NCT01103284|324112501|FG001|Overall Study|Termination by the Sponsor|1|||
94631686|NCT01103284|324112500|FG000|Overall Study|Not described|2|||
94631687|NCT01103284|324112501|FG001|Overall Study|Not described|1|||
94631688|NCT01103284|324112500|FG000|Overall Study|Missing CRF entries for study completion|0|||
94631689|NCT01103284|324112501|FG001|Overall Study|Missing CRF entries for study completion|2|||
94631690|NCT03227029|324112507|FG000|Overall Study|Child Wheezed (no treatment)|0|||
94631691|NCT03227029|324112508|FG001|Overall Study|Child Wheezed (no treatment)|1|||
94631692|NCT03227029|324112509|FG002|Overall Study|Child Wheezed (no treatment)|0|||
94631693|NCT03227029|324112507|FG000|Overall Study|No post RSV season visit due to COVID|3|||
94631694|NCT03227029|324112508|FG001|Overall Study|No post RSV season visit due to COVID|3|||
94631695|NCT03227029|324112509|FG002|Overall Study|No post RSV season visit due to COVID|2|||
94631696|NCT03227029|324112507|FG000|Overall Study|Not able to get to clinic|0|||
94631697|NCT03227029|324112508|FG001|Overall Study|Not able to get to clinic|0|||
94631698|NCT03227029|324112509|FG002|Overall Study|Not able to get to clinic|1|||
94631699|NCT03227029|324112507|FG000|Overall Study|Withdrawal by Subject|1|||
94631700|NCT03227029|324112508|FG001|Overall Study|Withdrawal by Subject|0|||
94631701|NCT03227029|324112509|FG002|Overall Study|Withdrawal by Subject|0|||
94631702|NCT03227029|324112507|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
94631703|NCT03227029|324112508|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
94631704|NCT03227029|324112509|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
94631705|NCT01074450|324112510|FG000|First Intervention|Emesis in Dosing Interval|0|||
94631706|NCT01074450|324112511|FG001|First Intervention|Emesis in Dosing Interval|2|||
94631707|NCT01074450|324112510|FG000|Second Intervention|Protocol Violation|1|||
94631708|NCT01074450|324112511|FG001|Second Intervention|Protocol Violation|0|||
94631709|NCT01074450|324112510|FG000|Second Intervention|Physician Decision|0|||
94631710|NCT01074450|324112511|FG001|Second Intervention|Physician Decision|1|||
94631711|NCT03414424|324112512|FG000|Overall Study|Screened out after consent|0|||
94631712|NCT03414424|324112513|FG001|Overall Study|Screened out after consent|2|||
94631713|NCT03414424|324112512|FG000|Overall Study|Lost to Follow-up|0|||
94631714|NCT03414424|324112513|FG001|Overall Study|Lost to Follow-up|1|||
94631715|NCT03042533|324112514|FG000|Overall Study|MD left program|1|||
94631716|NCT03042533|324112515|FG001|Overall Study|MD left program|4|||
94631717|NCT03042533|324112516|FG002|Overall Study|MD left program|1|||
94631718|NCT03527966|324112517|FG000|Overall Study|Lost to Follow-up|3|||
94631719|NCT03527966|324112518|FG001|Overall Study|Lost to Follow-up|0|||
94631720|NCT01949051|324112519|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
94631721|NCT01949051|324112520|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
94631722|NCT01949051|324112521|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
94631723|NCT01949051|324112522|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
94631724|NCT01949051|324112523|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
94631725|NCT01949051|324112524|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
94631726|NCT01949051|324112519|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
94631727|NCT01949051|324112520|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
94631728|NCT01949051|324112521|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
94631729|NCT01949051|324112522|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
94631730|NCT01949051|324112523|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
94631731|NCT01949051|324112524|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
94631732|NCT01949051|324112519|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
94631733|NCT01949051|324112520|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
94631734|NCT01949051|324112521|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
94259646|NCT03285178|322743937|FG001|Double-Blind Treatment Period|COVID-19|0|||
94631735|NCT01949051|324112522|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
94631736|NCT01949051|324112523|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
94259647|NCT03285178|322743938|FG002|Double-Blind Treatment Period|COVID-19|1|||
94631737|NCT01949051|324112524|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
94631738|NCT01949051|324112519|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
94631739|NCT01949051|324112520|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
94631740|NCT01949051|324112521|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
94675716|NCT04085328|324265505|FG000|Overall Study|Physician Decision|0|||
94675717|NCT04085328|324265506|FG001|Overall Study|Physician Decision|1|||
94675718|NCT04085328|324265505|FG000|Overall Study|Pregnancy|0|||
94675719|NCT04085328|324265506|FG001|Overall Study|Pregnancy|1|||
94675720|NCT04085328|324265505|FG000|Overall Study|Reasons Related to COVID-19|5|||
94675721|NCT04085328|324265506|FG001|Overall Study|Reasons Related to COVID-19|8|||
94675722|NCT04085328|324265505|FG000|Overall Study|Did not meet inclusion criteria|1|||
94675723|NCT04085328|324265506|FG001|Overall Study|Did not meet inclusion criteria|1|||
94675724|NCT04085328|324265505|FG000|Overall Study|Early termination|1|||
94675725|NCT04085328|324265506|FG001|Overall Study|Early termination|0|||
94675726|NCT02975973|324265507|FG000|Overall Study|Adverse Event|1|||
94675727|NCT02975973|324265508|FG001|Overall Study|Adverse Event|1|||
94675728|NCT02975973|324265509|FG002|Overall Study|Adverse Event|1|||
94675729|NCT02975973|324265510|FG003|Overall Study|Adverse Event|0|||
94675730|NCT00771810|324265511|FG000|Overall Study|Adverse Event|3|||
94675731|NCT00771810|324265512|FG001|Overall Study|Adverse Event|0|||
94675732|NCT00771810|324265513|FG002|Overall Study|Adverse Event|2|||
94675733|NCT00771810|324265511|FG000|Overall Study|Lost to Follow-up|0|||
94675734|NCT00771810|324265512|FG001|Overall Study|Lost to Follow-up|0|||
94675735|NCT00771810|324265513|FG002|Overall Study|Lost to Follow-up|1|||
94675736|NCT00771810|324265511|FG000|Overall Study|Physician Decision|1|||
94675737|NCT00771810|324265512|FG001|Overall Study|Physician Decision|2|||
94675738|NCT00771810|324265513|FG002|Overall Study|Physician Decision|2|||
94675739|NCT00771810|324265511|FG000|Overall Study|Protocol Violation|0|||
94675740|NCT00771810|324265512|FG001|Overall Study|Protocol Violation|1|||
94675741|NCT00771810|324265513|FG002|Overall Study|Protocol Violation|1|||
94675742|NCT00771810|324265511|FG000|Overall Study|Withdrawal by Subject|1|||
94675743|NCT00771810|324265512|FG001|Overall Study|Withdrawal by Subject|2|||
94675744|NCT00771810|324265513|FG002|Overall Study|Withdrawal by Subject|0|||
94675745|NCT00771810|324265511|FG000|Overall Study|Other|0|||
94675746|NCT00771810|324265512|FG001|Overall Study|Other|0|||
94259648|NCT03285178|322743939|FG003|Double-Blind Treatment Period|COVID-19|0|||
94259649|NCT03285178|322743940|FG004|Double-Blind Treatment Period|COVID-19|0|||
94259650|NCT03285178|322743941|FG005|Double-Blind Treatment Period|COVID-19|0|||
94259651|NCT03285178|322743942|FG006|Double-Blind Treatment Period|COVID-19|0|||
94259652|NCT01388790|322743943|FG000|Overall Study|Ongoing at data cut-off date|8|||
94259653|NCT01324323|322743944|FG000|Overall Study|Withdrawal by Subject|1|||
94259654|NCT00973362|322743945|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
94259655|NCT00973362|322743946|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
94259656|NCT00973362|322743945|FG000|Baseline Evaluation|No colposcopy visit|62|||
94259657|NCT00973362|322743946|FG001|Baseline Evaluation|No colposcopy visit|0|||
94259658|NCT00973362|322743945|FG000|Baseline Evaluation|Inevaluable|686|||
94259659|NCT00973362|322743946|FG001|Baseline Evaluation|Inevaluable|223|||
94259660|NCT00973362|322743945|FG000|3-Year Follow-up|Lost to Follow-up|17|||
94259661|NCT00973362|322743946|FG001|3-Year Follow-up|Lost to Follow-up|0|||
94259662|NCT00887679|322743949|FG000|Overall Study|Withdrawal by Subject|1|||
94259663|NCT00887679|322743949|FG000|Overall Study|Lost to Follow-up|4|||
94259664|NCT00887679|322743949|FG000|Overall Study|Physician Decision|5|||
94259665|NCT02260882|322743950|FG000|Overall Study|Protocol Violation|0|||
94259666|NCT02260882|322743951|FG001|Overall Study|Protocol Violation|1|||
94259667|NCT04781387|322743955|FG000|Overall Study|Withdrawal by Subject|1|||
94259668|NCT04781387|322743956|FG001|Overall Study|Withdrawal by Subject|0|||
94259669|NCT04781387|322743957|FG002|Overall Study|Withdrawal by Subject|1|||
94259670|NCT04781387|322743955|FG000|Overall Study|Lost to Follow-up|1|||
94259671|NCT04781387|322743956|FG001|Overall Study|Lost to Follow-up|0|||
94259672|NCT04781387|322743957|FG002|Overall Study|Lost to Follow-up|0|||
94259673|NCT01740323|322743958|FG000|Overall Study|Adverse Event|1|||
94259674|NCT01740323|322743959|FG001|Overall Study|Adverse Event|0|||
94259675|NCT01740323|322743958|FG000|Overall Study|Randomized but did not take study drug|1|||
94259676|NCT01740323|322743959|FG001|Overall Study|Randomized but did not take study drug|0|||
94259677|NCT02196714|322743960|FG000|Overall Study|Protocol Violation|0|||
94259678|NCT02196714|322743961|FG001|Overall Study|Protocol Violation|0|||
94259679|NCT02196714|322743962|FG002|Overall Study|Protocol Violation|1|||
94259680|NCT02196714|322743963|FG003|Overall Study|Protocol Violation|0|||
94259681|NCT01211522|322743969|FG000|Overall Study|Withdrawal by Subject|3|||
94259682|NCT01211522|322743970|FG001|Overall Study|Withdrawal by Subject|7|||
94259683|NCT01211522|322743971|FG002|Overall Study|Withdrawal by Subject|5|||
94259684|NCT00372385|322743972|FG000|Overall Study|Adverse Event|6|||
94259685|NCT00372385|322743973|FG001|Overall Study|Adverse Event|11|||
94259686|NCT00372385|322743974|FG002|Overall Study|Adverse Event|9|||
94259687|NCT00372385|322743975|FG003|Overall Study|Adverse Event|7|||
94675747|NCT00771810|324265513|FG002|Overall Study|Other|1|||
94675748|NCT02515279|324265516|FG000|Overall Study|Adverse Event|7|||
94675749|NCT02515279|324265516|FG000|Overall Study|Lack of Efficacy|31|||
94675750|NCT02515279|324265516|FG000|Overall Study|Lost to Follow-up|9|||
94675751|NCT02515279|324265516|FG000|Overall Study|Withdrawal by Subject|18|||
94675752|NCT02515279|324265516|FG000|Overall Study|End-of-treatment visit not attended|17|||
94675753|NCT02515279|324265516|FG000|Overall Study|Other|22|||
94259688|NCT00372385|322743972|FG000|Overall Study|Noncompliance|0|||
94259689|NCT00372385|322743973|FG001|Overall Study|Noncompliance|1|||
94259690|NCT00372385|322743974|FG002|Overall Study|Noncompliance|1|||
94259691|NCT00372385|322743975|FG003|Overall Study|Noncompliance|1|||
94259692|NCT00372385|322743972|FG000|Overall Study|Physician Decision|1|||
94259693|NCT00372385|322743973|FG001|Overall Study|Physician Decision|0|||
94259694|NCT00372385|322743974|FG002|Overall Study|Physician Decision|0|||
94259695|NCT00372385|322743975|FG003|Overall Study|Physician Decision|0|||
94259696|NCT00372385|322743972|FG000|Overall Study|Lost to Follow-up|2|||
94259697|NCT00372385|322743973|FG001|Overall Study|Lost to Follow-up|0|||
94259698|NCT00372385|322743974|FG002|Overall Study|Lost to Follow-up|0|||
94259699|NCT00372385|322743975|FG003|Overall Study|Lost to Follow-up|0|||
94259700|NCT00372385|322743972|FG000|Overall Study|Withdrawal by Subject|2|||
94259701|NCT00372385|322743973|FG001|Overall Study|Withdrawal by Subject|1|||
94259702|NCT00372385|322743974|FG002|Overall Study|Withdrawal by Subject|0|||
94259703|NCT00372385|322743975|FG003|Overall Study|Withdrawal by Subject|0|||
94259704|NCT00372385|322743972|FG000|Overall Study|Refusal of Treatment|3|||
94259705|NCT00372385|322743973|FG001|Overall Study|Refusal of Treatment|6|||
94259706|NCT00372385|322743974|FG002|Overall Study|Refusal of Treatment|0|||
94259707|NCT00372385|322743975|FG003|Overall Study|Refusal of Treatment|0|||
94259708|NCT00372385|322743972|FG000|Overall Study|No Response|1|||
94259709|NCT00372385|322743973|FG001|Overall Study|No Response|1|||
94259710|NCT00372385|322743974|FG002|Overall Study|No Response|0|||
94259711|NCT00372385|322743975|FG003|Overall Study|No Response|0|||
94259712|NCT00372385|322743972|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
94259713|NCT00372385|322743973|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
94259714|NCT00372385|322743974|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
94259715|NCT00372385|322743975|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
94259716|NCT00372385|322743972|FG000|Overall Study|Virologic Stopping Rule|17|||
94259717|NCT00372385|322743973|FG001|Overall Study|Virologic Stopping Rule|0|||
94259718|NCT00372385|322743974|FG002|Overall Study|Virologic Stopping Rule|0|||
94259719|NCT00372385|322743975|FG003|Overall Study|Virologic Stopping Rule|0|||
94259720|NCT01139658|322743976|FG000|Overall Study|Adverse Event|10|||
94259721|NCT01139658|322743977|FG001|Overall Study|Adverse Event|27|||
94259722|NCT01139658|322743976|FG000|Overall Study|Lack of Efficacy|15|||
94259723|NCT01139658|322743977|FG001|Overall Study|Lack of Efficacy|7|||
94259724|NCT01139658|322743976|FG000|Overall Study|Withdrawal by Subject|2|||
94259725|NCT01139658|322743977|FG001|Overall Study|Withdrawal by Subject|4|||
94259726|NCT01139658|322743976|FG000|Overall Study|No documentation of treatment|1|||
94259727|NCT01139658|322743977|FG001|Overall Study|No documentation of treatment|0|||
94259728|NCT01139658|322743976|FG000|Overall Study|Other|28|||
94259729|NCT01139658|322743977|FG001|Overall Study|Other|75|||
94259730|NCT01193920|322743978|FG000|Overall Study|Withdrawal by Subject|1|||
94259731|NCT01193920|322743979|FG001|Overall Study|Withdrawal by Subject|0|||
94259732|NCT01193920|322743980|FG002|Overall Study|Withdrawal by Subject|5|||
94259733|NCT01193920|322743981|FG003|Overall Study|Withdrawal by Subject|1|||
94259734|NCT01193920|322743982|FG004|Overall Study|Withdrawal by Subject|3|||
94259735|NCT01193920|322743983|FG005|Overall Study|Withdrawal by Subject|1|||
94259736|NCT01193920|322743984|FG006|Overall Study|Withdrawal by Subject|3|||
94259737|NCT01193920|322743985|FG007|Overall Study|Withdrawal by Subject|0|||
94259738|NCT01193920|322743986|FG008|Overall Study|Withdrawal by Subject|1|||
94259739|NCT01193920|322743987|FG009|Overall Study|Withdrawal by Subject|0|||
94259740|NCT01193920|322743978|FG000|Overall Study|Lost to Follow-up|1|||
94259741|NCT01193920|322743979|FG001|Overall Study|Lost to Follow-up|0|||
94259742|NCT01193920|322743980|FG002|Overall Study|Lost to Follow-up|1|||
94259743|NCT01193920|322743981|FG003|Overall Study|Lost to Follow-up|1|||
94259744|NCT01193920|322743982|FG004|Overall Study|Lost to Follow-up|3|||
94259745|NCT01193920|322743983|FG005|Overall Study|Lost to Follow-up|3|||
94259746|NCT01193920|322743984|FG006|Overall Study|Lost to Follow-up|1|||
94259747|NCT01193920|322743985|FG007|Overall Study|Lost to Follow-up|0|||
94259748|NCT01193920|322743986|FG008|Overall Study|Lost to Follow-up|2|||
94259749|NCT01193920|322743987|FG009|Overall Study|Lost to Follow-up|3|||
94259750|NCT01193920|322743978|FG000|Overall Study|Protocol Violation|1|||
94259751|NCT01193920|322743979|FG001|Overall Study|Protocol Violation|0|||
94259752|NCT01193920|322743980|FG002|Overall Study|Protocol Violation|0|||
94259753|NCT01193920|322743981|FG003|Overall Study|Protocol Violation|0|||
94259754|NCT01193920|322743982|FG004|Overall Study|Protocol Violation|0|||
94259755|NCT01193920|322743983|FG005|Overall Study|Protocol Violation|0|||
94259756|NCT01193920|322743984|FG006|Overall Study|Protocol Violation|0|||
94259757|NCT01193920|322743985|FG007|Overall Study|Protocol Violation|0|||
94259758|NCT01193920|322743986|FG008|Overall Study|Protocol Violation|0|||
94259759|NCT01193920|322743987|FG009|Overall Study|Protocol Violation|0|||
94259760|NCT01193920|322743978|FG000|Overall Study|Death|0|||
94259761|NCT01193920|322743979|FG001|Overall Study|Death|0|||
94259762|NCT01193920|322743980|FG002|Overall Study|Death|0|||
94259763|NCT01193920|322743981|FG003|Overall Study|Death|1|||
94631741|NCT01949051|324112522|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
94259764|NCT01193920|322743982|FG004|Overall Study|Death|0|||
94259765|NCT01193920|322743983|FG005|Overall Study|Death|0|||
94631742|NCT01949051|324112523|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
94631743|NCT01949051|324112524|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
94631744|NCT01949051|324112519|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
94631745|NCT01949051|324112520|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
94362159|NCT00530621|323108846|FG000|Overall Study|Death|3|||
94631746|NCT01949051|324112521|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
94675754|NCT00504426|324265518|FG000|Overall Study|Adverse Event|0|||
94362160|NCT00530621|323108847|FG001|Overall Study|Death|6|||
94259766|NCT01193920|322743984|FG006|Overall Study|Death|2|||
94259767|NCT01193920|322743985|FG007|Overall Study|Death|3|||
94259768|NCT01193920|322743986|FG008|Overall Study|Death|2|||
94259769|NCT01193920|322743987|FG009|Overall Study|Death|4|||
94259770|NCT01193920|322743978|FG000|Overall Study|Unable to classify|0|||
94259771|NCT01193920|322743979|FG001|Overall Study|Unable to classify|0|||
94259772|NCT01193920|322743980|FG002|Overall Study|Unable to classify|0|||
94259773|NCT01193920|322743981|FG003|Overall Study|Unable to classify|1|||
94259774|NCT01193920|322743982|FG004|Overall Study|Unable to classify|0|||
94259775|NCT01193920|322743983|FG005|Overall Study|Unable to classify|0|||
94259776|NCT01193920|322743984|FG006|Overall Study|Unable to classify|0|||
94259777|NCT01193920|322743985|FG007|Overall Study|Unable to classify|1|||
94259778|NCT01193920|322743986|FG008|Overall Study|Unable to classify|0|||
94259779|NCT01193920|322743987|FG009|Overall Study|Unable to classify|0|||
94259780|NCT00494481|322743988|FG000|Overall Study|Condition under investigation worsened|11|||
94259781|NCT00494481|322743989|FG001|Overall Study|Condition under investigation worsened|13|||
94259782|NCT00494481|322743988|FG000|Overall Study|Adverse Event|15|||
94259783|NCT00494481|322743989|FG001|Overall Study|Adverse Event|11|||
94259784|NCT00494481|322743988|FG000|Overall Study|Other|1|||
94259785|NCT00494481|322743989|FG001|Overall Study|Other|0|||
94259786|NCT00494481|322743988|FG000|Overall Study|Never received IP|2|||
94259787|NCT00494481|322743989|FG001|Overall Study|Never received IP|0|||
94259788|NCT00332189|322743990|FG000|Overall Study|Adverse Event|3|||
94259789|NCT00332189|322743990|FG000|Overall Study|Uncooperative/Noncompliant|3|||
94259790|NCT00332189|322743990|FG000|Overall Study|Withdrawal by Subject|9|||
94259791|NCT00332189|322743990|FG000|Overall Study|Lack of Efficacy|4|||
94259792|NCT00332189|322743990|FG000|Overall Study|Moved out of country|2|||
94259793|NCT06132425|322743995|FG000|Overall Study|Withdrawal by Subject|3|||
94259794|NCT06132425|322743996|FG001|Overall Study|Withdrawal by Subject|0|||
94259795|NCT06132425|322743995|FG000|Overall Study|Did not follow study instructions|0|||
94259796|NCT06132425|322743996|FG001|Overall Study|Did not follow study instructions|2|||
94259797|NCT06132425|322743995|FG000|Overall Study|Lost to Follow-up|3|||
94259798|NCT06132425|322743996|FG001|Overall Study|Lost to Follow-up|5|||
94259799|NCT05461794|322744003|FG000|Overall Study|Withdrawal by Subject|1|||
94259800|NCT05461794|322744004|FG001|Overall Study|Withdrawal by Subject|1|||
94259801|NCT05461794|322744005|FG002|Overall Study|Withdrawal by Subject|3|||
94259802|NCT05461794|322744003|FG000|Overall Study|Study Terminated By Sponsor|18|||
94259803|NCT05461794|322744004|FG001|Overall Study|Study Terminated By Sponsor|13|||
94259804|NCT05461794|322744005|FG002|Overall Study|Study Terminated By Sponsor|16|||
94259805|NCT05461794|322744003|FG000|Overall Study|Death|20|||
94259806|NCT05461794|322744004|FG001|Overall Study|Death|5|||
94259807|NCT05461794|322744005|FG002|Overall Study|Death|19|||
94259808|NCT02677896|322744006|FG000|Double Blind Period (up to 35 Months)|Death|117|||
94259809|NCT02677896|322744007|FG001|Double Blind Period (up to 35 Months)|Death|197|||
94259810|NCT02677896|322744006|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
94259811|NCT02677896|322744007|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
94259812|NCT02677896|322744006|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
94259813|NCT02677896|322744007|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
94259814|NCT02677896|322744006|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
94259815|NCT02677896|322744007|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
94259816|NCT02677896|322744006|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
94259817|NCT02677896|322744007|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
94259818|NCT02677896|322744006|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
94259819|NCT02677896|322744007|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
94259820|NCT02677896|322744006|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
94259821|NCT02677896|322744007|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
94259822|NCT02677896|322744006|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
94259823|NCT02677896|322744007|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
94259824|NCT02677896|322744006|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
94259825|NCT02677896|322744007|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
94259826|NCT02677896|322744006|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
94259827|NCT02677896|322744007|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
94259828|NCT02677896|322744006|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
94259829|NCT02677896|322744007|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
94259830|NCT02677896|322744006|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
94259831|NCT02677896|322744007|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
94259832|NCT02677896|322744006|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
94259833|NCT02677896|322744007|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
94259834|NCT02677896|322744006|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
94259835|NCT02677896|322744007|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
94259836|NCT02521493|322744008|FG000|Overall Study|Death|3|||
94259837|NCT02521493|322744009|FG001|Overall Study|Death|4|||
94259838|NCT02521493|322744010|FG002|Overall Study|Death|1|||
94631747|NCT01949051|324112522|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
94631748|NCT01949051|324112523|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
94631749|NCT01949051|324112524|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
94631750|NCT00006903|324112528|FG000|Overall Study|Still receiving treatment|0|||
94631751|NCT00006903|324112529|FG001|Overall Study|Still receiving treatment|0|||
94631752|NCT00006903|324112530|FG002|Overall Study|Still receiving treatment|1|||
94631753|NCT00006903|324112528|FG000|Overall Study|Refused further treatment|0|||
94631754|NCT00006903|324112529|FG001|Overall Study|Refused further treatment|2|||
94631755|NCT00006903|324112530|FG002|Overall Study|Refused further treatment|1|||
94631756|NCT00006903|324112528|FG000|Overall Study|Adverse Event|0|||
94631757|NCT00006903|324112529|FG001|Overall Study|Adverse Event|0|||
94631758|NCT00006903|324112530|FG002|Overall Study|Adverse Event|1|||
94631759|NCT00006903|324112528|FG000|Overall Study|Death|0|||
94631760|NCT00006903|324112529|FG001|Overall Study|Death|1|||
94631761|NCT00006903|324112530|FG002|Overall Study|Death|0|||
94631762|NCT00006903|324112528|FG000|Overall Study|Patient never treated|0|||
94631763|NCT00006903|324112529|FG001|Overall Study|Patient never treated|0|||
94631764|NCT00006903|324112530|FG002|Overall Study|Patient never treated|1|||
94631765|NCT00006903|324112528|FG000|Overall Study|Ineligible|10|||
94631766|NCT00006903|324112529|FG001|Overall Study|Ineligible|1|||
94631767|NCT00006903|324112530|FG002|Overall Study|Ineligible|2|||
94631768|NCT00372112|324112531|FG000|Overall Study|Adverse Event|0|||
94631769|NCT00372112|324112532|FG001|Overall Study|Adverse Event|1|||
94631770|NCT00372112|324112533|FG002|Overall Study|Adverse Event|1|||
94631771|NCT00372112|324112534|FG003|Overall Study|Adverse Event|1|||
94631772|NCT00372112|324112531|FG000|Overall Study|Withdrawal by Subject|0|||
94631773|NCT00372112|324112532|FG001|Overall Study|Withdrawal by Subject|0|||
94259839|NCT02521493|322744008|FG000|Overall Study|Physician Decision|19|||
94259840|NCT02521493|322744009|FG001|Overall Study|Physician Decision|1|||
94631774|NCT00372112|324112533|FG002|Overall Study|Withdrawal by Subject|2|||
94631775|NCT00372112|324112534|FG003|Overall Study|Withdrawal by Subject|1|||
94259841|NCT02521493|322744010|FG002|Overall Study|Physician Decision|2|||
94259842|NCT02521493|322744008|FG000|Overall Study|Withdrawal by Subject|3|||
94259843|NCT02521493|322744009|FG001|Overall Study|Withdrawal by Subject|0|||
94259844|NCT02521493|322744010|FG002|Overall Study|Withdrawal by Subject|0|||
94362161|NCT00530621|323108846|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
94362162|NCT00530621|323108847|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
94362163|NCT02596009|323108848|FG000|Overall Study|Administrative problems|0|||
94631776|NCT00372112|324112531|FG000|Overall Study|Exacerbation|0|||
94259845|NCT02521493|322744008|FG000|Overall Study|Ineligible|0|||
94259846|NCT02521493|322744009|FG001|Overall Study|Ineligible|1|||
94259847|NCT02521493|322744010|FG002|Overall Study|Ineligible|0|||
94259848|NCT02521493|322744008|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
94259849|NCT02521493|322744009|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
94259850|NCT02521493|322744010|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
94259851|NCT02521493|322744008|FG000|Overall Study|No MRD result|0|||
94259852|NCT02521493|322744009|FG001|Overall Study|No MRD result|0|||
94259853|NCT02521493|322744010|FG002|Overall Study|No MRD result|4|||
94259854|NCT05066724|322744011|FG000|Overall Study|Adverse Event|1|||
94259855|NCT05066724|322744011|FG000|Overall Study|Non-Compliance With Study Drug|5|||
94259856|NCT05066724|322744011|FG000|Overall Study|Withdrawal by Subject|6|||
94259857|NCT05066724|322744011|FG000|Overall Study|Physician Decision|2|||
94259858|NCT04821869|322744012|FG000|Overall Study|Adverse Event|4|||
94259859|NCT04821869|322744012|FG000|Overall Study|Withdrawal by Subject|2|||
94259860|NCT04821869|322744012|FG000|Overall Study|Did not meet FEV1 criteria|1|||
94259861|NCT03444324|322744013|FG000|Overall Study|Withdrawal by Subject|0|||
94259862|NCT03444324|322744014|FG001|Overall Study|Withdrawal by Subject|1|||
94259863|NCT03444324|322744013|FG000|Overall Study|Lost to Follow-up|4|||
94259864|NCT03444324|322744014|FG001|Overall Study|Lost to Follow-up|2|||
94259865|NCT03444324|322744013|FG000|Overall Study|Protocol Violation|0|||
94259866|NCT03444324|322744014|FG001|Overall Study|Protocol Violation|1|||
94259867|NCT03444324|322744013|FG000|Overall Study|Lack of Trial Compliance|1|||
94259868|NCT03444324|322744014|FG001|Overall Study|Lack of Trial Compliance|1|||
94259869|NCT03444324|322744013|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
94259870|NCT03444324|322744014|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
94259871|NCT04223856|322744015|FG000|Overall Study|Progressive disease|153|||
94259872|NCT04223856|322744016|FG001|Overall Study|Progressive disease|73|||
94259873|NCT04223856|322744015|FG000|Overall Study|Adverse Event|97|||
94631777|NCT00372112|324112532|FG001|Overall Study|Exacerbation|0|||
94631778|NCT00372112|324112533|FG002|Overall Study|Exacerbation|0|||
94631779|NCT00372112|324112534|FG003|Overall Study|Exacerbation|1|||
94631780|NCT00372112|324112531|FG000|Overall Study|PR >240 at Visit 3|0|||
94631781|NCT00372112|324112532|FG001|Overall Study|PR >240 at Visit 3|0|||
94631782|NCT00372112|324112533|FG002|Overall Study|PR >240 at Visit 3|0|||
94631783|NCT00372112|324112534|FG003|Overall Study|PR >240 at Visit 3|1|||
94631784|NCT00372112|324112531|FG000|Overall Study|Hepatitis B|1|||
94631785|NCT00372112|324112532|FG001|Overall Study|Hepatitis B|0|||
94631786|NCT00372112|324112533|FG002|Overall Study|Hepatitis B|0|||
94631787|NCT00372112|324112534|FG003|Overall Study|Hepatitis B|0|||
94631788|NCT00372112|324112531|FG000|Overall Study|Other-protocol violation|0|||
94631789|NCT00372112|324112532|FG001|Overall Study|Other-protocol violation|0|||
94631790|NCT00372112|324112533|FG002|Overall Study|Other-protocol violation|1|||
94631791|NCT00372112|324112534|FG003|Overall Study|Other-protocol violation|0|||
94631792|NCT00356369|324112535|FG000|Active Phase|Withdrawal by Subject|2|||
94631793|NCT00356369|324112536|FG001|Active Phase|Withdrawal by Subject|1|||
94631794|NCT00533845|324112559|FG000|Overall Study|Physician Decision|1|||
94631795|NCT00533845|324112560|FG001|Overall Study|Physician Decision|0|||
94631796|NCT02377466|324112561|FG000|Overall Study|Other: Randomized and not treated|0|||
94631797|NCT02377466|324112562|FG001|Overall Study|Other: Randomized and not treated|2|||
94259874|NCT04223856|322744016|FG001|Overall Study|Adverse Event|62|||
94259875|NCT04223856|322744015|FG000|Overall Study|Physician Decision|9|||
94259876|NCT04223856|322744016|FG001|Overall Study|Physician Decision|28|||
94259877|NCT04223856|322744015|FG000|Overall Study|Withdrawal by Subject|22|||
94362164|NCT02596009|323108849|FG001|Overall Study|Administrative problems|1|||
94362165|NCT02596009|323108850|FG002|Overall Study|Administrative problems|0|||
94362166|NCT02596009|323108851|FG003|Overall Study|Administrative problems|0|||
94259878|NCT04223856|322744016|FG001|Overall Study|Withdrawal by Subject|24|||
94259879|NCT04223856|322744015|FG000|Overall Study|Other|7|||
94259880|NCT04223856|322744016|FG001|Overall Study|Other|2|||
94631798|NCT03566823|324112566|FG000|Overall Study|Lack of Efficacy|0|||
94631799|NCT03566823|324112567|FG001|Overall Study|Lack of Efficacy|1|||
94631800|NCT03566823|324112568|FG002|Overall Study|Lack of Efficacy|0|||
94631801|NCT03566823|324112566|FG000|Overall Study|Withdrawal by Subject|1|||
94631802|NCT03566823|324112567|FG001|Overall Study|Withdrawal by Subject|2|||
94631803|NCT03566823|324112568|FG002|Overall Study|Withdrawal by Subject|0|||
94259881|NCT04223856|322744015|FG000|Overall Study|Randomized but not treated|2|||
94362167|NCT02596009|323108852|FG004|Overall Study|Administrative problems|0|||
94631804|NCT03566823|324112566|FG000|Overall Study|Adverse Event|1|||
94631805|NCT03566823|324112567|FG001|Overall Study|Adverse Event|0|||
94631806|NCT03566823|324112568|FG002|Overall Study|Adverse Event|2|||
94631807|NCT02326025|324112574|FG000|Overall Study|Adverse Event|3|||
94631808|NCT02326025|324112575|FG001|Overall Study|Adverse Event|0|||
94631809|NCT02326025|324112574|FG000|Overall Study|Physician Decision|1|||
94631810|NCT02326025|324112575|FG001|Overall Study|Physician Decision|2|||
94631811|NCT02326025|324112574|FG000|Overall Study|Physician and Participant Decision|1|||
94631812|NCT02326025|324112575|FG001|Overall Study|Physician and Participant Decision|0|||
94631813|NCT02326025|324112574|FG000|Overall Study|Withdrawal by Subject|0|||
94631814|NCT02326025|324112575|FG001|Overall Study|Withdrawal by Subject|2|||
94631815|NCT02326025|324112574|FG000|Overall Study|Protocol Violation|0|||
94631816|NCT02326025|324112575|FG001|Overall Study|Protocol Violation|1|||
94631817|NCT00467259|324112578|FG000|Overall Study|Adverse Event|24|||
94631818|NCT00467259|324112579|FG001|Overall Study|Adverse Event|90|||
94259882|NCT04223856|322744016|FG001|Overall Study|Randomized but not treated|11|||
94259883|NCT04223856|322744015|FG000|Overall Study|On-treatment|144|||
94259884|NCT04223856|322744016|FG001|Overall Study|On-treatment|0|||
94259885|NCT06515483|322744017|FG000|Overall Study|Subject withdraw due to family issues|1|||
94259886|NCT06515483|322744018|FG001|Overall Study|Subject withdraw due to family issues|0|||
94259887|NCT02164383|322745466|FG000|Overall Study|Lost to Follow-up|1|||
94259888|NCT02164383|322745467|FG001|Overall Study|Lost to Follow-up|0|||
94259889|NCT02141984|322745471|FG000|Overall Study|Lack of Efficacy|2|||
94259890|NCT01060540|322745472|FG000|Overall Study|Withdrawal by Subject|10|||
94259891|NCT01060540|322745473|FG001|Overall Study|Withdrawal by Subject|20|||
94259892|NCT01060540|322745472|FG000|Overall Study|Lost to Follow-up|52|||
94259893|NCT01060540|322745473|FG001|Overall Study|Lost to Follow-up|43|||
94259894|NCT01060540|322745472|FG000|Overall Study|Death|2|||
94259895|NCT01060540|322745473|FG001|Overall Study|Death|1|||
94259896|NCT01060540|322745472|FG000|Overall Study|Physician Decision|0|||
94259897|NCT01060540|322745473|FG001|Overall Study|Physician Decision|1|||
94259898|NCT00975507|322745474|FG000|Overall Study|Adverse Event|1|||
94259899|NCT00975507|322745475|FG001|Overall Study|Adverse Event|0|||
94259900|NCT00975507|322745474|FG000|Overall Study|Lost to Follow-up|7|||
94259901|NCT00975507|322745475|FG001|Overall Study|Lost to Follow-up|1|||
94259902|NCT00975507|322745474|FG000|Overall Study|Protocol Violation|2|||
94259903|NCT00975507|322745475|FG001|Overall Study|Protocol Violation|0|||
94259904|NCT00975507|322745474|FG000|Overall Study|Withdrawal by Subject|10|||
94259905|NCT00975507|322745475|FG001|Overall Study|Withdrawal by Subject|3|||
94259906|NCT02824263|322745476|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
94259907|NCT02824263|322745477|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
94259908|NCT02824263|322745476|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
94259909|NCT02824263|322745477|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
94259910|NCT05580588|322745478|FG000|Overall Study|Lack of Efficacy|12|||
94259911|NCT04442737|322745481|FG000|Overall Study|Lost to Follow-up|1|||
94259912|NCT04442737|322745482|FG001|Overall Study|Lost to Follow-up|3|||
94259913|NCT04442737|322745481|FG000|Overall Study|Withdrawal by Subject|3|||
94259914|NCT04442737|322745482|FG001|Overall Study|Withdrawal by Subject|2|||
94259915|NCT04442737|322745481|FG000|Overall Study|Adverse Event|3|||
94259916|NCT04442737|322745482|FG001|Overall Study|Adverse Event|2|||
94259917|NCT04442737|322745481|FG000|Overall Study|Death|0|||
94259918|NCT04442737|322745482|FG001|Overall Study|Death|1|||
94259919|NCT04442737|322745481|FG000|Overall Study|Protocol Violation|0|||
94259920|NCT04442737|322745482|FG001|Overall Study|Protocol Violation|2|||
94259921|NCT04442737|322745481|FG000|Overall Study|Other|1|||
94259922|NCT04442737|322745482|FG001|Overall Study|Other|1|||
94259923|NCT00744523|322745483|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
94259924|NCT00744523|322745484|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
94259925|NCT01139021|322745485|FG000|Overall Study|Adverse Event|0|||
94362168|NCT02596009|323108853|FG005|Overall Study|Administrative problems|0|||
94631819|NCT00467259|324112578|FG000|Overall Study|Protocol Violation|1|||
94675755|NCT00504426|324265519|FG001|Overall Study|Adverse Event|0|||
94675756|NCT00504426|324265520|FG002|Overall Study|Adverse Event|2|||
94259926|NCT01139021|322745486|FG001|Overall Study|Adverse Event|0|||
94259927|NCT01139021|322745487|FG002|Overall Study|Adverse Event|0|||
94259928|NCT01139021|322745488|FG003|Overall Study|Adverse Event|0|||
94259929|NCT01139021|322745489|FG004|Overall Study|Adverse Event|1|||
94259930|NCT01139021|322745490|FG005|Overall Study|Adverse Event|0|||
94259931|NCT01139021|322745485|FG000|Overall Study|Lost to Follow-up|0|||
94259932|NCT01139021|322745486|FG001|Overall Study|Lost to Follow-up|0|||
94259933|NCT01139021|322745487|FG002|Overall Study|Lost to Follow-up|0|||
94259934|NCT01139021|322745488|FG003|Overall Study|Lost to Follow-up|0|||
94362169|NCT00518011|323108854|FG000|Overall Study|Death|1|||
94631820|NCT00467259|324112579|FG001|Overall Study|Protocol Violation|7|||
94631821|NCT00467259|324112578|FG000|Overall Study|Withdrawal by Subject|34|||
94259935|NCT01139021|322745489|FG004|Overall Study|Lost to Follow-up|2|||
94631822|NCT00467259|324112579|FG001|Overall Study|Withdrawal by Subject|108|||
94259936|NCT01139021|322745490|FG005|Overall Study|Lost to Follow-up|0|||
94259937|NCT01139021|322745485|FG000|Overall Study|Protocol Violation|1|||
94259938|NCT01139021|322745486|FG001|Overall Study|Protocol Violation|0|||
94675757|NCT00504426|324265521|FG003|Overall Study|Adverse Event|0|||
94631823|NCT00467259|324112578|FG000|Overall Study|Physician Decision|0|||
94631824|NCT00467259|324112579|FG001|Overall Study|Physician Decision|2|||
94631825|NCT00467259|324112578|FG000|Overall Study|Lost to Follow-up|14|||
94631826|NCT00467259|324112579|FG001|Overall Study|Lost to Follow-up|34|||
94631827|NCT00467259|324112578|FG000|Overall Study|Site Closed|2|||
94631828|NCT00467259|324112579|FG001|Overall Study|Site Closed|1|||
94631829|NCT01129960|324112582|FG000|Overall Study|Withdrawal by Subject|3|||
94631830|NCT01129960|324112583|FG001|Overall Study|Withdrawal by Subject|0|||
94631831|NCT01129960|324112584|FG002|Overall Study|Withdrawal by Subject|3|||
94631832|NCT01129960|324112585|FG003|Overall Study|Withdrawal by Subject|2|||
94631833|NCT01129960|324112582|FG000|Overall Study|Lack of Efficacy|1|||
94631834|NCT01129960|324112583|FG001|Overall Study|Lack of Efficacy|1|||
94631835|NCT01129960|324112584|FG002|Overall Study|Lack of Efficacy|1|||
94631836|NCT01129960|324112585|FG003|Overall Study|Lack of Efficacy|1|||
94631837|NCT01129960|324112582|FG000|Overall Study|Adverse Event|23|||
94631838|NCT01129960|324112583|FG001|Overall Study|Adverse Event|16|||
94631839|NCT01129960|324112584|FG002|Overall Study|Adverse Event|16|||
94631840|NCT01129960|324112585|FG003|Overall Study|Adverse Event|7|||
94631841|NCT01129960|324112582|FG000|Overall Study|Protocol Violation|1|||
94631842|NCT01129960|324112583|FG001|Overall Study|Protocol Violation|2|||
94631843|NCT01129960|324112584|FG002|Overall Study|Protocol Violation|3|||
94631844|NCT01129960|324112585|FG003|Overall Study|Protocol Violation|0|||
94631845|NCT01129960|324112582|FG000|Overall Study|Lost to Follow-up|0|||
94631846|NCT01129960|324112583|FG001|Overall Study|Lost to Follow-up|2|||
94631847|NCT01129960|324112584|FG002|Overall Study|Lost to Follow-up|3|||
94631848|NCT01129960|324112585|FG003|Overall Study|Lost to Follow-up|3|||
94631849|NCT01129960|324112582|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
94631850|NCT01129960|324112583|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
94631851|NCT01129960|324112584|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
94631852|NCT01129960|324112585|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
94631853|NCT01129960|324112582|FG000|Overall Study|Physician Decision|1|||
94631854|NCT01129960|324112583|FG001|Overall Study|Physician Decision|0|||
94631855|NCT01129960|324112584|FG002|Overall Study|Physician Decision|0|||
94631856|NCT01129960|324112585|FG003|Overall Study|Physician Decision|0|||
94631857|NCT01129960|324112582|FG000|Overall Study|Pregnancy|1|||
94631858|NCT01129960|324112583|FG001|Overall Study|Pregnancy|0|||
94631859|NCT01129960|324112584|FG002|Overall Study|Pregnancy|0|||
94631860|NCT01129960|324112585|FG003|Overall Study|Pregnancy|0|||
94631861|NCT00165776|324112586|FG000|Overall Study|Lack of Efficacy|0|||
94631862|NCT00165776|324112587|FG001|Overall Study|Lack of Efficacy|0|||
94631863|NCT00165776|324112588|FG002|Overall Study|Lack of Efficacy|0|||
94631864|NCT00165776|324112589|FG003|Overall Study|Lack of Efficacy|1|||
94631865|NCT00165776|324112586|FG000|Overall Study|Withdrawal by Subject|4|||
94631866|NCT00165776|324112587|FG001|Overall Study|Withdrawal by Subject|1|||
94631867|NCT00165776|324112588|FG002|Overall Study|Withdrawal by Subject|2|||
94675758|NCT00504426|324265518|FG000|Overall Study|Protocol Violation|1|||
94631868|NCT00165776|324112589|FG003|Overall Study|Withdrawal by Subject|0|||
94631869|NCT00165776|324112586|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
94675759|NCT00504426|324265519|FG001|Overall Study|Protocol Violation|1|||
94675760|NCT00504426|324265520|FG002|Overall Study|Protocol Violation|2|||
94675761|NCT00504426|324265521|FG003|Overall Study|Protocol Violation|0|||
94675762|NCT00504426|324265518|FG000|Overall Study|Withdrawal by Subject|2|||
94675763|NCT00504426|324265519|FG001|Overall Study|Withdrawal by Subject|0|||
94675764|NCT00504426|324265520|FG002|Overall Study|Withdrawal by Subject|0|||
94675765|NCT00504426|324265521|FG003|Overall Study|Withdrawal by Subject|0|||
94675766|NCT04843930|324265522|FG000|Randomization|Withdrawal by Subject|6|||
94675767|NCT04843930|324265523|FG001|Randomization|Withdrawal by Subject|6|||
94675768|NCT04843930|324265524|FG002|Randomization|Withdrawal by Subject|0|||
94675769|NCT04843930|324265525|FG003|Randomization|Withdrawal by Subject|0|||
94675770|NCT04843930|324265522|FG000|Week 6 Assessment|Adverse Event|3|||
94675771|NCT04843930|324265523|FG001|Week 6 Assessment|Adverse Event|0|||
94675772|NCT04843930|324265524|FG002|Week 6 Assessment|Adverse Event|0|||
94675773|NCT04843930|324265525|FG003|Week 6 Assessment|Adverse Event|0|||
94675774|NCT04843930|324265522|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
94675775|NCT04843930|324265523|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
94675776|NCT04843930|324265524|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
94675777|NCT04843930|324265525|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
94675778|NCT04843930|324265522|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
94675779|NCT04843930|324265523|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
94675780|NCT04843930|324265524|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
94259939|NCT01139021|322745487|FG002|Overall Study|Protocol Violation|0|||
94631870|NCT00165776|324112587|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
94631871|NCT00165776|324112588|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
94631872|NCT00165776|324112589|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
94631873|NCT01340898|324112590|FG000|Primary Phase|Serious Adverse Events|0|||
94631874|NCT01340898|324112591|FG001|Primary Phase|Serious Adverse Events|0|||
94631875|NCT01340898|324112592|FG002|Primary Phase|Serious Adverse Events|1|||
94631876|NCT01340898|324112590|FG000|Primary Phase|Withdrawal by Subject|8|||
94631877|NCT01340898|324112591|FG001|Primary Phase|Withdrawal by Subject|7|||
94631878|NCT01340898|324112592|FG002|Primary Phase|Withdrawal by Subject|5|||
94631879|NCT01340898|324112590|FG000|Primary Phase|Migrated/moved from study area|4|||
94631880|NCT01340898|324112591|FG001|Primary Phase|Migrated/moved from study area|1|||
94631881|NCT01340898|324112592|FG002|Primary Phase|Migrated/moved from study area|0|||
94631882|NCT01340898|324112590|FG000|Primary Phase|Lost to Follow-up|4|||
94631883|NCT01340898|324112591|FG001|Primary Phase|Lost to Follow-up|1|||
94631884|NCT01340898|324112592|FG002|Primary Phase|Lost to Follow-up|0|||
94631885|NCT01340898|324112590|FG000|Booster Phase|Withdrawal by Subject|3|||
94631886|NCT01340898|324112591|FG001|Booster Phase|Withdrawal by Subject|0|||
94631887|NCT01340898|324112592|FG002|Booster Phase|Withdrawal by Subject|4|||
94631888|NCT01340898|324112590|FG000|Booster Phase|Migrated/moved from study area|3|||
94631889|NCT01340898|324112591|FG001|Booster Phase|Migrated/moved from study area|0|||
94631890|NCT01340898|324112592|FG002|Booster Phase|Migrated/moved from study area|0|||
94631891|NCT01340898|324112590|FG000|Booster Phase|Lost to Follow-up|4|||
94675781|NCT04843930|324265525|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
94675782|NCT02778100|324265537|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
94675783|NCT02778100|324265538|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
94675784|NCT01298999|324265541|FG000|Overall Study|Physician Decision|0|||
94631892|NCT01340898|324112591|FG001|Booster Phase|Lost to Follow-up|2|||
94631893|NCT01340898|324112592|FG002|Booster Phase|Lost to Follow-up|3|||
94631894|NCT04900220|324112593|FG000|Overall Study|Lost to Follow-up|1|||
94631895|NCT04900220|324112594|FG001|Overall Study|Lost to Follow-up|1|||
94631896|NCT02028065|324112597|FG000|Randomization Through Start Treatment|Not treated|1|||
94631897|NCT02028065|324112598|FG001|Randomization Through Start Treatment|Not treated|3|||
94631898|NCT02028065|324112599|FG002|Randomization Through Start Treatment|Not treated|3|||
94631899|NCT02028065|324112597|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
94631900|NCT02028065|324112598|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
94631901|NCT02028065|324112599|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
94631902|NCT02028065|324112597|FG000|Treatment Through Study Completion|Physician Decision|1|||
94631903|NCT02028065|324112598|FG001|Treatment Through Study Completion|Physician Decision|0|||
94631904|NCT02028065|324112599|FG002|Treatment Through Study Completion|Physician Decision|0|||
94631905|NCT02028065|324112597|FG000|Treatment Through Study Completion|Protocol Violation|1|||
94631906|NCT02028065|324112598|FG001|Treatment Through Study Completion|Protocol Violation|4|||
94631907|NCT02028065|324112599|FG002|Treatment Through Study Completion|Protocol Violation|0|||
94631908|NCT02028065|324112597|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
94631909|NCT02028065|324112598|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
94631910|NCT02028065|324112599|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
94631911|NCT02028065|324112597|FG000|Treatment Through Study Completion|Adverse Event|3|||
94631912|NCT02028065|324112598|FG001|Treatment Through Study Completion|Adverse Event|3|||
94631913|NCT02028065|324112599|FG002|Treatment Through Study Completion|Adverse Event|5|||
94631914|NCT04851314|324112600|FG000|Overall Study|Unable to complete research set-up procedures|0|||
94631915|NCT04851314|324112601|FG001|Overall Study|Unable to complete research set-up procedures|2|||
94631916|NCT04851314|324112600|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
94631917|NCT04851314|324112601|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
94631918|NCT00877383|324112602|FG000|Overall Study|Adverse Event|13|||
94631919|NCT00877383|324112603|FG001|Overall Study|Adverse Event|14|||
94631920|NCT00877383|324112602|FG000|Overall Study|Lost to Follow-up|5|||
94675785|NCT01298999|324265542|FG001|Overall Study|Physician Decision|1|||
94675786|NCT01298999|324265541|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
94259940|NCT01139021|322745488|FG003|Overall Study|Protocol Violation|0|||
94259941|NCT01139021|322745489|FG004|Overall Study|Protocol Violation|2|||
94259942|NCT01139021|322745490|FG005|Overall Study|Protocol Violation|0|||
94675787|NCT01298999|324265542|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
94675788|NCT02686034|324265545|FG000|Run-In Period 1|Eligibility|12|||
94675789|NCT02686034|324265546|FG001|Run-In Period 1|Eligibility|10|||
94675790|NCT02686034|324265545|FG000|Run-In Period 1|Withdrawal by Subject|4|||
94675791|NCT02686034|324265546|FG001|Run-In Period 1|Withdrawal by Subject|3|||
94675792|NCT02686034|324265545|FG000|Run-In Period 1|Lost to Follow-up|4|||
94675793|NCT02686034|324265546|FG001|Run-In Period 1|Lost to Follow-up|4|||
94675794|NCT02686034|324265545|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
94675795|NCT02686034|324265546|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
94675796|NCT02686034|324265545|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
94631921|NCT00877383|324112603|FG001|Overall Study|Lost to Follow-up|3|||
94675797|NCT02686034|324265546|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
94675798|NCT02686034|324265545|FG000|Randomized Controlled Period 2|Adverse Event|0|||
94675799|NCT02686034|324265546|FG001|Randomized Controlled Period 2|Adverse Event|2|||
94675800|NCT02686034|324265545|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
94675801|NCT02686034|324265546|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
94675802|NCT02686034|324265545|FG000|Open Label Period 3|Lost to Follow-up|0|||
94675803|NCT02686034|324265546|FG001|Open Label Period 3|Lost to Follow-up|1|||
94675804|NCT01489189|324265547|FG000|Overall Study|Withdrawal by Subject|20|||
94675805|NCT01489189|324265548|FG001|Overall Study|Withdrawal by Subject|23|||
94675806|NCT01489189|324265547|FG000|Overall Study|Death|10|||
94675807|NCT01489189|324265548|FG001|Overall Study|Death|8|||
94675808|NCT01489189|324265547|FG000|Overall Study|Missed Visit|1|||
94675809|NCT01489189|324265548|FG001|Overall Study|Missed Visit|4|||
94675810|NCT04225988|324265549|FG000|Overall Study|Withdrawal by Subject|2|||
94675811|NCT04225988|324265550|FG001|Overall Study|Withdrawal by Subject|0|||
94259943|NCT01139021|322745485|FG000|Overall Study|Withdrawal by Subject|0|||
94259944|NCT01139021|322745486|FG001|Overall Study|Withdrawal by Subject|0|||
94259945|NCT01139021|322745487|FG002|Overall Study|Withdrawal by Subject|0|||
94631922|NCT00877383|324112602|FG000|Overall Study|Subject withdrew consent|3|||
94631923|NCT00877383|324112603|FG001|Overall Study|Subject withdrew consent|12|||
94631924|NCT00877383|324112602|FG000|Overall Study|Subject no longer requires study drug|2|||
94631925|NCT00877383|324112603|FG001|Overall Study|Subject no longer requires study drug|0|||
94631926|NCT00877383|324112602|FG000|Overall Study|Administrative problems|2|||
94631927|NCT00877383|324112603|FG001|Overall Study|Administrative problems|0|||
94631928|NCT00877383|324112602|FG000|Overall Study|Protocol deviation|2|||
94631929|NCT00877383|324112603|FG001|Overall Study|Protocol deviation|6|||
94631930|NCT00877383|324112602|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94631931|NCT00877383|324112603|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94631932|NCT00877383|324112602|FG000|Overall Study|Death|1|||
94675812|NCT01337674|324267002|FG000|Treatment Period 1|Adverse Event|0|||
94675813|NCT01337674|324267003|FG001|Treatment Period 1|Adverse Event|1|||
94675814|NCT01337674|324267004|FG002|Treatment Period 1|Adverse Event|0|||
94259946|NCT01139021|322745488|FG003|Overall Study|Withdrawal by Subject|1|||
94631933|NCT00877383|324112603|FG001|Overall Study|Death|2|||
94631934|NCT00867009|324112604|FG000|Induction Period|Nonserious Adverse Event|5|||
94631935|NCT00867009|324112604|FG000|Induction Period|Serious Adverse Event|10|||
94631936|NCT00867009|324112604|FG000|Induction Period|Death due to serious adverse event|6|||
94675815|NCT01337674|324267005|FG003|Treatment Period 1|Adverse Event|0|||
94675816|NCT01337674|324267002|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
94675817|NCT01337674|324267003|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
94259947|NCT01139021|322745489|FG004|Overall Study|Withdrawal by Subject|4|||
94259948|NCT01139021|322745490|FG005|Overall Study|Withdrawal by Subject|0|||
94259949|NCT03603028|322745491|FG000|Overall Study|Withdrawal by Subject|1|||
94259950|NCT05333224|322745492|FG000|Overall Study - Infants|Lost to Follow-up|1|||
94259951|NCT05333224|322745493|FG001|Overall Study - Infants|Lost to Follow-up|1|||
94259952|NCT01774110|322745494|FG000|Overall Study|Lost to Follow-up|7|||
94259953|NCT04507126|322745498|FG000|Overall Study|Withdrawal by Subject|1|||
94259954|NCT04507126|322745498|FG000|Overall Study|Protocol Violation|2|||
94259955|NCT04507126|322745498|FG000|Overall Study|Physician Decision|1|||
94259956|NCT02699983|322745500|FG000|Overall Study|Withdrawal by Subject|1|||
94259957|NCT02699983|322745501|FG001|Overall Study|Withdrawal by Subject|0|||
94259958|NCT01249274|322745502|FG000|Overall Study|Lost to Follow-up|3|||
94259959|NCT01249274|322745503|FG001|Overall Study|Lost to Follow-up|4|||
94259960|NCT01249274|322745502|FG000|Overall Study|Received inpatient substance treatment|1|||
94259961|NCT01249274|322745503|FG001|Overall Study|Received inpatient substance treatment|2|||
94259962|NCT02604433|322745510|FG000|Overall Study|Withdrawal by Subject|37|||
94259963|NCT02604433|322745511|FG001|Overall Study|Withdrawal by Subject|16|||
94259964|NCT02604433|322745510|FG000|Overall Study|Adverse Event|4|||
94259965|NCT02604433|322745511|FG001|Overall Study|Adverse Event|0|||
94259966|NCT02604433|322745510|FG000|Overall Study|Other reasons|3|||
94259967|NCT02604433|322745511|FG001|Overall Study|Other reasons|5|||
94259968|NCT02604433|322745510|FG000|Overall Study|Death|4|||
94259969|NCT02604433|322745511|FG001|Overall Study|Death|1|||
94259970|NCT02604433|322745510|FG000|Overall Study|Transition to Rollover Protocol|169|||
94259971|NCT02604433|322745511|FG001|Overall Study|Transition to Rollover Protocol|82|||
94259972|NCT02604433|322745510|FG000|Overall Study|Physician Decision|1|||
94259973|NCT02604433|322745511|FG001|Overall Study|Physician Decision|1|||
94259974|NCT02604433|322745510|FG000|Overall Study|Lack of Efficacy|0|||
94259975|NCT02604433|322745511|FG001|Overall Study|Lack of Efficacy|1|||
94259976|NCT01128894|322745519|FG000|Overall Study|Adverse Event|31|||
94259977|NCT01128894|322745520|FG001|Overall Study|Adverse Event|41|||
94259978|NCT01128894|322745519|FG000|Overall Study|Protocol Violation|2|||
94259979|NCT01128894|322745520|FG001|Overall Study|Protocol Violation|1|||
94631937|NCT00867009|324112604|FG000|Induction Period|Death due to Study Disease|4|||
94631938|NCT00867009|324112604|FG000|Induction Period|Protocol Violation|1|||
94631939|NCT00867009|324112604|FG000|Induction Period|Withdrawal by Subject|8|||
94631940|NCT00867009|324112604|FG000|Induction Period|Physician Decision|3|||
94631941|NCT00867009|324112604|FG000|Induction Period|Progressive Disease (PD)|25|||
94631942|NCT00867009|324112604|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
94631943|NCT03128892|324112605|FG000|Overall Study|Withdrawal by Subject|2|||
94631944|NCT03128892|324112605|FG000|Overall Study|Physician Decision|1|||
94631945|NCT02999854|324112613|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
94631946|NCT02999854|324112614|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
94631947|NCT02999854|324112613|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
94631948|NCT02999854|324112614|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
94631949|NCT02999854|324112613|FG000|Active Study Phase (up to 18 Months)|Death|7|||
94631950|NCT02999854|324112614|FG001|Active Study Phase (up to 18 Months)|Death|5|||
94631951|NCT02999854|324112613|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
94631952|NCT02999854|324112614|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
94631953|NCT02999854|324112613|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
94631954|NCT02999854|324112614|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
94631955|NCT02999854|324112613|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
94631956|NCT02999854|324112614|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
94631957|NCT02999854|324112613|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
94631958|NCT02999854|324112614|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
94631959|NCT02999854|324112613|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
94631960|NCT02999854|324112614|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
94631961|NCT01339429|324112615|FG000|Overall Study|Withdrawal by Subject|1|||
94631962|NCT01339429|324112615|FG000|Overall Study|Physician Decision|3|||
94631963|NCT04140292|324112616|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
94631964|NCT04140292|324112617|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
94631965|NCT00459667|324112618|FG000|Overall Study|Adverse Event|9|||
94259980|NCT01128894|322745519|FG000|Overall Study|Noncompliance|4|||
94259981|NCT01128894|322745520|FG001|Overall Study|Noncompliance|5|||
94259982|NCT01128894|322745519|FG000|Overall Study|Lost to Follow-up|8|||
94259983|NCT01128894|322745520|FG001|Overall Study|Lost to Follow-up|8|||
94259984|NCT01128894|322745519|FG000|Overall Study|Withdrawal by Subject|10|||
94362170|NCT00518011|323108855|FG001|Overall Study|Death|1|||
94259985|NCT01128894|322745520|FG001|Overall Study|Withdrawal by Subject|12|||
94259986|NCT01128894|322745519|FG000|Overall Study|Physician Decision|2|||
94259987|NCT01128894|322745520|FG001|Overall Study|Physician Decision|1|||
94259988|NCT01128894|322745519|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
94362171|NCT00518011|323108854|FG000|Overall Study|Adverse Event|2|||
94631966|NCT00459667|324112619|FG001|Overall Study|Adverse Event|12|||
94631967|NCT00459667|324112620|FG002|Overall Study|Adverse Event|8|||
94631968|NCT00459667|324112618|FG000|Overall Study|Lost to Follow-up|5|||
94631969|NCT00459667|324112619|FG001|Overall Study|Lost to Follow-up|9|||
94631970|NCT00459667|324112620|FG002|Overall Study|Lost to Follow-up|3|||
94631971|NCT00459667|324112618|FG000|Overall Study|Pregnancy|1|||
94631972|NCT00459667|324112619|FG001|Overall Study|Pregnancy|1|||
94631973|NCT00459667|324112620|FG002|Overall Study|Pregnancy|1|||
94631974|NCT00459667|324112618|FG000|Overall Study|Protocol Violation|1|||
94631975|NCT00459667|324112619|FG001|Overall Study|Protocol Violation|0|||
94631976|NCT00459667|324112620|FG002|Overall Study|Protocol Violation|0|||
94631977|NCT00459667|324112618|FG000|Overall Study|Withdrawal by Subject|3|||
94631978|NCT00459667|324112619|FG001|Overall Study|Withdrawal by Subject|5|||
94631979|NCT00459667|324112620|FG002|Overall Study|Withdrawal by Subject|5|||
94631980|NCT00459667|324112618|FG000|Overall Study|Other disease modifying treatment|1|||
94631981|NCT00459667|324112619|FG001|Overall Study|Other disease modifying treatment|2|||
94631982|NCT00459667|324112620|FG002|Overall Study|Other disease modifying treatment|1|||
94631983|NCT00459667|324112618|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
94631984|NCT00459667|324112619|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
94631985|NCT00459667|324112620|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
94631986|NCT00459667|324112618|FG000|Overall Study|No treatment administered|6|||
94631987|NCT00459667|324112619|FG001|Overall Study|No treatment administered|3|||
94259989|NCT01128894|322745520|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
94259990|NCT02349451|322745522|FG000|Overall Study|Withdrawal by Subject|0|||
94259991|NCT02349451|322745523|FG001|Overall Study|Withdrawal by Subject|1|||
94259992|NCT02349451|322745524|FG002|Overall Study|Withdrawal by Subject|2|||
94259993|NCT02349451|322745525|FG003|Overall Study|Withdrawal by Subject|1|||
94259994|NCT00261846|322745526|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
94259995|NCT00261846|322745527|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
94259996|NCT00261846|322745528|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
94259997|NCT00261846|322745529|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
94259998|NCT00261846|322745530|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
94259999|NCT00261846|322745531|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
94260000|NCT00261846|322745532|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
94260001|NCT00261846|322745533|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
94260002|NCT00261846|322745534|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
94260003|NCT00261846|322745535|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
94260004|NCT00261846|322745536|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
94260005|NCT00261846|322745537|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
94260006|NCT00261846|322745526|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
94260007|NCT00261846|322745527|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
94362172|NCT00518011|323108855|FG001|Overall Study|Adverse Event|3|||
94631988|NCT00459667|324112620|FG002|Overall Study|No treatment administered|1|||
94631989|NCT00396591|324112621|FG000|Overall Study|Disease Progression|13|||
94631990|NCT00396591|324112621|FG000|Overall Study|Adverse Event|2|||
94631991|NCT00396591|324112621|FG000|Overall Study|Participant request|1|||
94631992|NCT03406104|324112622|FG000|Overall Study|Lost to Follow-up|2|||
94631993|NCT03406104|324112622|FG000|Overall Study|Withdrawal by Subject|2|||
94631994|NCT03406104|324112622|FG000|Overall Study|due to Covid patient did not want to travel|1|||
94631995|NCT03406104|324112622|FG000|Overall Study|Death|2|||
94631996|NCT03241342|324112623|FG000|Overall Study|Adverse Event|5|||
94675818|NCT01337674|324267004|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
94675819|NCT01337674|324267005|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
94675820|NCT01337674|324267002|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94675821|NCT01337674|324267003|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94675822|NCT01337674|324267004|FG002|Treatment Period 2|Withdrawal by Subject|1|||
94675823|NCT01337674|324267005|FG003|Treatment Period 2|Withdrawal by Subject|0|||
94675824|NCT01345630|324267006|FG000|Overall Study|Adverse Event|22|||
94675825|NCT01345630|324267007|FG001|Overall Study|Adverse Event|23|||
94675826|NCT01345630|324267006|FG000|Overall Study|Lost to Follow-up|17|||
94675827|NCT01345630|324267007|FG001|Overall Study|Lost to Follow-up|16|||
94260008|NCT00261846|322745528|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
94260009|NCT00261846|322745529|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
94260010|NCT00261846|322745530|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
94260011|NCT00261846|322745531|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
94260012|NCT00261846|322745532|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
94260013|NCT00261846|322745533|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
94260014|NCT00261846|322745534|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
94675828|NCT01345630|324267006|FG000|Overall Study|Protocol Violation|4|||
94675829|NCT01345630|324267007|FG001|Overall Study|Protocol Violation|1|||
94675830|NCT01345630|324267006|FG000|Overall Study|Medication error without associated AE|0|||
94675831|NCT01345630|324267007|FG001|Overall Study|Medication error without associated AE|1|||
94675832|NCT01345630|324267006|FG000|Overall Study|Study terminated by sponsor|254|||
94675833|NCT01345630|324267007|FG001|Overall Study|Study terminated by sponsor|285|||
94362173|NCT00518011|323108854|FG000|Overall Study|Disease Progression|2|||
94675834|NCT01345630|324267006|FG000|Overall Study|Other reasons|6|||
94675835|NCT01345630|324267007|FG001|Overall Study|Other reasons|8|||
94675836|NCT01345630|324267006|FG000|Overall Study|Withdrawn due to pregnancy|1|||
94260015|NCT00261846|322745535|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
94631997|NCT03241342|324112624|FG001|Overall Study|Adverse Event|8|||
94631998|NCT03241342|324112625|FG002|Overall Study|Adverse Event|4|||
94631999|NCT03241342|324112623|FG000|Overall Study|Lack of Efficacy|0|||
94632000|NCT03241342|324112624|FG001|Overall Study|Lack of Efficacy|0|||
94632001|NCT03241342|324112625|FG002|Overall Study|Lack of Efficacy|1|||
94632002|NCT03241342|324112623|FG000|Overall Study|noncompliance with study drug|2|||
94632003|NCT03241342|324112624|FG001|Overall Study|noncompliance with study drug|1|||
94632004|NCT03241342|324112625|FG002|Overall Study|noncompliance with study drug|1|||
94632005|NCT03241342|324112623|FG000|Overall Study|sponsor decision|0|||
94632006|NCT03241342|324112624|FG001|Overall Study|sponsor decision|1|||
94632007|NCT03241342|324112625|FG002|Overall Study|sponsor decision|2|||
94632008|NCT03241342|324112623|FG000|Overall Study|not reported|15|||
94632009|NCT03241342|324112624|FG001|Overall Study|not reported|21|||
94632010|NCT03241342|324112625|FG002|Overall Study|not reported|19|||
94632011|NCT00556712|324112626|FG000|Overall Study|Adverse Event|7|||
94632012|NCT00556712|324112627|FG001|Overall Study|Adverse Event|19|||
94632013|NCT00556712|324112626|FG000|Overall Study|Death|5|||
94632014|NCT00556712|324112627|FG001|Overall Study|Death|10|||
94632015|NCT00556712|324112626|FG000|Overall Study|Progressive Disease|383|||
94632016|NCT00556712|324112627|FG001|Overall Study|Progressive Disease|320|||
94632017|NCT00556712|324112626|FG000|Overall Study|Protocol Violation|3|||
94632018|NCT00556712|324112627|FG001|Overall Study|Protocol Violation|2|||
94632019|NCT00556712|324112626|FG000|Overall Study|Refused Treatment|17|||
94632020|NCT00556712|324112627|FG001|Overall Study|Refused Treatment|16|||
94632021|NCT00556712|324112626|FG000|Overall Study|Failure to Return|2|||
94632022|NCT00556712|324112627|FG001|Overall Study|Failure to Return|3|||
94632023|NCT00556712|324112626|FG000|Overall Study|Other|2|||
94632024|NCT00556712|324112627|FG001|Overall Study|Other|2|||
94632025|NCT00556712|324112626|FG000|Overall Study|Ongoing at Data Cutoff|32|||
94632026|NCT00556712|324112627|FG001|Overall Study|Ongoing at Data Cutoff|66|||
94632027|NCT00680043|324112629|FG000|Overall Study|Withdrawal by Subject|1|||
94632028|NCT00680043|324112630|FG001|Overall Study|Withdrawal by Subject|0|||
94632029|NCT00680043|324112631|FG002|Overall Study|Withdrawal by Subject|0|||
94632030|NCT00680043|324112629|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
94260016|NCT00261846|322745536|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
94260017|NCT00261846|322745537|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
94260018|NCT00261846|322745526|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
94260019|NCT00261846|322745527|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
94260020|NCT00261846|322745528|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
94260021|NCT00261846|322745529|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
94260022|NCT00261846|322745530|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
94260023|NCT00261846|322745531|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
94260024|NCT00261846|322745532|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
94260025|NCT00261846|322745533|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
94260026|NCT00261846|322745534|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
94260027|NCT00261846|322745535|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
94260028|NCT00261846|322745536|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
94260029|NCT00261846|322745537|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
94260030|NCT00261846|322745526|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
94260031|NCT00261846|322745527|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
94260032|NCT00261846|322745528|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
94260033|NCT00261846|322745529|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
94260034|NCT00261846|322745530|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
94260035|NCT00261846|322745531|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
94260036|NCT00261846|322745532|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
94260037|NCT00261846|322745533|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
94260038|NCT00261846|322745534|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
94632031|NCT00680043|324112630|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
94260039|NCT00261846|322745535|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
94260040|NCT00261846|322745536|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
94362174|NCT00518011|323108855|FG001|Overall Study|Disease Progression|2|||
94362175|NCT00518011|323108854|FG000|Overall Study|Other Reasons|3|||
94632032|NCT00680043|324112631|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
94632033|NCT00680043|324112629|FG000|Overall Study|Renal Transplant|1|||
94632034|NCT00680043|324112630|FG001|Overall Study|Renal Transplant|0|||
94632035|NCT00680043|324112631|FG002|Overall Study|Renal Transplant|4|||
94632036|NCT00513474|324112633|FG000|Overall Study|Death|6|||
94632037|NCT00513474|324112634|FG001|Overall Study|Death|9|||
94632038|NCT00513474|324112633|FG000|Overall Study|Participant Withdrew Consent|1|||
94632039|NCT00513474|324112634|FG001|Overall Study|Participant Withdrew Consent|0|||
94632040|NCT02953314|324112637|FG000|Overall Study|Adverse Event|0|||
94632041|NCT02953314|324112638|FG001|Overall Study|Adverse Event|1|||
94632042|NCT02953314|324112637|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
94632043|NCT02953314|324112638|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
94632044|NCT02045797|324112639|FG000|Overall Study|Adverse Event|3|||
94632045|NCT02045797|324112640|FG001|Overall Study|Adverse Event|1|||
94632046|NCT02045797|324112641|FG002|Overall Study|Adverse Event|0|||
94632047|NCT02045797|324112639|FG000|Overall Study|Lack of Efficacy|1|||
94632048|NCT02045797|324112640|FG001|Overall Study|Lack of Efficacy|0|||
94632049|NCT02045797|324112641|FG002|Overall Study|Lack of Efficacy|0|||
94632050|NCT02045797|324112639|FG000|Overall Study|Lost to Follow-up|2|||
94632051|NCT02045797|324112640|FG001|Overall Study|Lost to Follow-up|3|||
94632052|NCT02045797|324112641|FG002|Overall Study|Lost to Follow-up|1|||
94632053|NCT02045797|324112639|FG000|Overall Study|Physician Decision|0|||
94632054|NCT02045797|324112640|FG001|Overall Study|Physician Decision|1|||
94632055|NCT02045797|324112641|FG002|Overall Study|Physician Decision|0|||
94632056|NCT02045797|324112639|FG000|Overall Study|Withdrawal by Subject|1|||
94632057|NCT02045797|324112640|FG001|Overall Study|Withdrawal by Subject|2|||
94632058|NCT02045797|324112641|FG002|Overall Study|Withdrawal by Subject|0|||
94632059|NCT02200445|324112642|FG000|Overall Study|Lack of Efficacy|1|||
94632060|NCT02200445|324112643|FG001|Overall Study|Lack of Efficacy|2|||
94632061|NCT02200445|324112644|FG002|Overall Study|Lack of Efficacy|2|||
94632062|NCT02200445|324112642|FG000|Overall Study|Adverse Event|0|||
94632063|NCT02200445|324112643|FG001|Overall Study|Adverse Event|2|||
94632064|NCT02200445|324112644|FG002|Overall Study|Adverse Event|0|||
94632065|NCT02927080|324114916|FG000|Overall Study|Withdrawal by Subject|0|||
94632066|NCT02927080|324114917|FG001|Overall Study|Withdrawal by Subject|0|||
94632067|NCT02927080|324114918|FG002|Overall Study|Withdrawal by Subject|0|||
94632068|NCT02927080|324114919|FG003|Overall Study|Withdrawal by Subject|0|||
94632069|NCT02927080|324114920|FG004|Overall Study|Withdrawal by Subject|1|||
94632070|NCT02927080|324114921|FG005|Overall Study|Withdrawal by Subject|0|||
94632071|NCT02927080|324114922|FG006|Overall Study|Withdrawal by Subject|1|||
94632072|NCT02927080|324114923|FG007|Overall Study|Withdrawal by Subject|1|||
94632073|NCT02927080|324114924|FG008|Overall Study|Withdrawal by Subject|0|||
94632074|NCT02927080|324114925|FG009|Overall Study|Withdrawal by Subject|2|||
94632075|NCT02927080|324114916|FG000|Overall Study|Willingness to comply with protocol|0|||
94632076|NCT02927080|324114917|FG001|Overall Study|Willingness to comply with protocol|0|||
94632077|NCT02927080|324114918|FG002|Overall Study|Willingness to comply with protocol|0|||
94632078|NCT02927080|324114919|FG003|Overall Study|Willingness to comply with protocol|0|||
94632079|NCT02927080|324114920|FG004|Overall Study|Willingness to comply with protocol|0|||
94632080|NCT02927080|324114921|FG005|Overall Study|Willingness to comply with protocol|0|||
94632081|NCT02927080|324114922|FG006|Overall Study|Willingness to comply with protocol|0|||
94632082|NCT02927080|324114923|FG007|Overall Study|Willingness to comply with protocol|0|||
94632083|NCT02927080|324114924|FG008|Overall Study|Willingness to comply with protocol|0|||
94632084|NCT02927080|324114925|FG009|Overall Study|Willingness to comply with protocol|1|||
94632085|NCT02927080|324114916|FG000|Overall Study|Study terminated by Sponsor|0|||
94632086|NCT02927080|324114917|FG001|Overall Study|Study terminated by Sponsor|0|||
94632087|NCT02927080|324114918|FG002|Overall Study|Study terminated by Sponsor|0|||
94632088|NCT02927080|324114919|FG003|Overall Study|Study terminated by Sponsor|0|||
94632089|NCT02927080|324114920|FG004|Overall Study|Study terminated by Sponsor|0|||
94632090|NCT02927080|324114921|FG005|Overall Study|Study terminated by Sponsor|0|||
94632091|NCT02927080|324114922|FG006|Overall Study|Study terminated by Sponsor|6|||
94632092|NCT02927080|324114923|FG007|Overall Study|Study terminated by Sponsor|7|||
94632093|NCT02927080|324114924|FG008|Overall Study|Study terminated by Sponsor|2|||
94632094|NCT02927080|324114925|FG009|Overall Study|Study terminated by Sponsor|3|||
94632095|NCT02927080|324114916|FG000|Overall Study|Adverse Event|0|||
94632096|NCT02927080|324114917|FG001|Overall Study|Adverse Event|1|||
94632097|NCT02927080|324114918|FG002|Overall Study|Adverse Event|0|||
94632098|NCT02927080|324114919|FG003|Overall Study|Adverse Event|0|||
94632099|NCT02927080|324114920|FG004|Overall Study|Adverse Event|0|||
94632100|NCT02927080|324114921|FG005|Overall Study|Adverse Event|0|||
94632101|NCT02927080|324114922|FG006|Overall Study|Adverse Event|0|||
94632102|NCT02927080|324114923|FG007|Overall Study|Adverse Event|1|||
94632103|NCT02927080|324114924|FG008|Overall Study|Adverse Event|0|||
94632104|NCT02927080|324114925|FG009|Overall Study|Adverse Event|1|||
94632105|NCT02927080|324114916|FG000|Overall Study|Other|0|||
94632106|NCT02927080|324114917|FG001|Overall Study|Other|0|||
94632107|NCT02927080|324114918|FG002|Overall Study|Other|0|||
94632108|NCT02927080|324114919|FG003|Overall Study|Other|0|||
94632109|NCT02927080|324114920|FG004|Overall Study|Other|0|||
94632110|NCT02927080|324114921|FG005|Overall Study|Other|0|||
94632111|NCT02927080|324114922|FG006|Overall Study|Other|1|||
94632112|NCT02927080|324114923|FG007|Overall Study|Other|0|||
94632113|NCT02927080|324114924|FG008|Overall Study|Other|1|||
94632114|NCT02927080|324114925|FG009|Overall Study|Other|0|||
94632115|NCT03909295|324114935|FG000|Overall Study|Adverse Event|2|||
94632116|NCT03909295|324114935|FG000|Overall Study|Study terminated by sponsor|50|||
94632117|NCT01199289|324114937|FG000|Overall Study|Ineligibility determined|2|||
94632118|NCT01199289|324114938|FG001|Overall Study|Ineligibility determined|1|||
94632119|NCT01199289|324114939|FG002|Overall Study|Ineligibility determined|0|||
94632120|NCT01199289|324114940|FG003|Overall Study|Ineligibility determined|0|||
94632121|NCT01199289|324114937|FG000|Overall Study|Protocol Violation|1|||
94632122|NCT01199289|324114938|FG001|Overall Study|Protocol Violation|0|||
94632123|NCT01199289|324114939|FG002|Overall Study|Protocol Violation|0|||
94632124|NCT01199289|324114940|FG003|Overall Study|Protocol Violation|1|||
94632125|NCT01199289|324114937|FG000|Overall Study|Noncompliance|1|||
94632126|NCT01199289|324114938|FG001|Overall Study|Noncompliance|0|||
94632127|NCT01199289|324114939|FG002|Overall Study|Noncompliance|2|||
94632128|NCT01199289|324114940|FG003|Overall Study|Noncompliance|0|||
94632129|NCT01199289|324114937|FG000|Overall Study|Adverse Event|0|||
94632130|NCT01199289|324114938|FG001|Overall Study|Adverse Event|3|||
94632131|NCT01199289|324114939|FG002|Overall Study|Adverse Event|1|||
94632132|NCT01199289|324114940|FG003|Overall Study|Adverse Event|4|||
94632133|NCT01199289|324114937|FG000|Overall Study|Full consent withdrawn|2|||
94632134|NCT01199289|324114938|FG001|Overall Study|Full consent withdrawn|2|||
94675837|NCT01345630|324267007|FG001|Overall Study|Withdrawn due to pregnancy|2|||
94632135|NCT01199289|324114939|FG002|Overall Study|Full consent withdrawn|2|||
94632136|NCT01199289|324114940|FG003|Overall Study|Full consent withdrawn|3|||
94632137|NCT01199289|324114937|FG000|Overall Study|Administrative decision|0|||
94632138|NCT01199289|324114938|FG001|Overall Study|Administrative decision|0|||
94632139|NCT01199289|324114939|FG002|Overall Study|Administrative decision|0|||
94632140|NCT01199289|324114940|FG003|Overall Study|Administrative decision|1|||
94632141|NCT01199289|324114937|FG000|Overall Study|Lost to Follow-up|0|||
94632142|NCT01199289|324114938|FG001|Overall Study|Lost to Follow-up|0|||
94632143|NCT01199289|324114939|FG002|Overall Study|Lost to Follow-up|0|||
94632144|NCT01199289|324114940|FG003|Overall Study|Lost to Follow-up|1|||
94632145|NCT01199289|324114937|FG000|Overall Study|Protocol-specified criteria|3|||
94632146|NCT01199289|324114938|FG001|Overall Study|Protocol-specified criteria|0|||
94632147|NCT01199289|324114939|FG002|Overall Study|Protocol-specified criteria|0|||
94632148|NCT01199289|324114940|FG003|Overall Study|Protocol-specified criteria|1|||
94632149|NCT01199289|324114937|FG000|Overall Study|Pregnancy|0|||
94632150|NCT01199289|324114938|FG001|Overall Study|Pregnancy|1|||
94632151|NCT01199289|324114939|FG002|Overall Study|Pregnancy|0|||
94632152|NCT01199289|324114940|FG003|Overall Study|Pregnancy|1|||
94632153|NCT02141282|324114944|FG000|Overall Study|Adverse event, not related to progression|8|||
94632154|NCT02141282|324114945|FG001|Overall Study|Adverse event, not related to progression|1|||
94632155|NCT02141282|324114946|FG002|Overall Study|Adverse event, not related to progression|3|||
94632156|NCT02141282|324114947|FG003|Overall Study|Adverse event, not related to progression|1|||
94632157|NCT02141282|324114944|FG000|Overall Study|Adverse event, related to progression|1|||
94632158|NCT02141282|324114945|FG001|Overall Study|Adverse event, related to progression|0|||
94632159|NCT02141282|324114946|FG002|Overall Study|Adverse event, related to progression|2|||
94632160|NCT02141282|324114947|FG003|Overall Study|Adverse event, related to progression|0|||
94632161|NCT02141282|324114944|FG000|Overall Study|COVID-19 infection|1|||
94632162|NCT02141282|324114945|FG001|Overall Study|COVID-19 infection|0|||
94632163|NCT02141282|324114946|FG002|Overall Study|COVID-19 infection|0|||
94632164|NCT02141282|324114947|FG003|Overall Study|COVID-19 infection|0|||
94632165|NCT02141282|324114944|FG000|Overall Study|Lost to Follow-up|0|||
94632166|NCT02141282|324114945|FG001|Overall Study|Lost to Follow-up|0|||
94362176|NCT00518011|323108855|FG001|Overall Study|Other Reasons|2|||
94362177|NCT00518011|323108854|FG000|Overall Study|Withdrawal by Subject|1|||
94362178|NCT00518011|323108855|FG001|Overall Study|Withdrawal by Subject|0|||
94632167|NCT02141282|324114946|FG002|Overall Study|Lost to Follow-up|4|||
94632168|NCT02141282|324114947|FG003|Overall Study|Lost to Follow-up|2|||
94632169|NCT02141282|324114944|FG000|Overall Study|Other, not specified|14|||
94632170|NCT02141282|324114945|FG001|Overall Study|Other, not specified|11|||
94632171|NCT02141282|324114946|FG002|Overall Study|Other, not specified|23|||
94632172|NCT02141282|324114947|FG003|Overall Study|Other, not specified|9|||
94461717|NCT01043705|323479586|FG001|Overall Study|Other|19|||
94362179|NCT01525407|323108856|FG000|Overall Study|Change in recipient treatment plan|2|||
94362180|NCT01525407|323108857|FG001|Overall Study|Change in recipient treatment plan|2|||
94362181|NCT01525407|323108856|FG000|Overall Study|Withdrawal by Subject|0|||
94362182|NCT01525407|323108857|FG001|Overall Study|Withdrawal by Subject|1|||
94362183|NCT01525407|323108856|FG000|Overall Study|Transplant was delayed|0|||
94632173|NCT02141282|324114944|FG000|Overall Study|Progressive disease, Richter's|4|||
94632174|NCT02141282|324114945|FG001|Overall Study|Progressive disease, Richter's|1|||
94632175|NCT02141282|324114946|FG002|Overall Study|Progressive disease, Richter's|1|||
94632176|NCT02141282|324114947|FG003|Overall Study|Progressive disease, Richter's|1|||
94632177|NCT02141282|324114944|FG000|Overall Study|Progressive disease per protocol|12|||
94632178|NCT02141282|324114945|FG001|Overall Study|Progressive disease per protocol|7|||
94632179|NCT02141282|324114946|FG002|Overall Study|Progressive disease per protocol|9|||
94632180|NCT02141282|324114947|FG003|Overall Study|Progressive disease per protocol|2|||
94632181|NCT02141282|324114944|FG000|Overall Study|Stem cell transplant|1|||
94632182|NCT02141282|324114945|FG001|Overall Study|Stem cell transplant|0|||
94632183|NCT02141282|324114946|FG002|Overall Study|Stem cell transplant|1|||
94632184|NCT02141282|324114947|FG003|Overall Study|Stem cell transplant|0|||
94632185|NCT02141282|324114944|FG000|Overall Study|Study terminated by Sponsor|0|||
94632186|NCT02141282|324114945|FG001|Overall Study|Study terminated by Sponsor|1|||
94632187|NCT02141282|324114946|FG002|Overall Study|Study terminated by Sponsor|0|||
94632188|NCT02141282|324114947|FG003|Overall Study|Study terminated by Sponsor|0|||
94632189|NCT02141282|324114944|FG000|Overall Study|Subject non-compliance|0|||
94632190|NCT02141282|324114945|FG001|Overall Study|Subject non-compliance|0|||
94632191|NCT02141282|324114946|FG002|Overall Study|Subject non-compliance|1|||
94632192|NCT02141282|324114947|FG003|Overall Study|Subject non-compliance|0|||
94632193|NCT02141282|324114944|FG000|Overall Study|Withdrew consent|2|||
94632194|NCT02141282|324114945|FG001|Overall Study|Withdrew consent|0|||
94632195|NCT02141282|324114946|FG002|Overall Study|Withdrew consent|4|||
94632196|NCT02141282|324114947|FG003|Overall Study|Withdrew consent|0|||
94632197|NCT03312933|324114948|FG000|Overall Study|Protocol Violation|15|||
94632198|NCT03312933|324114948|FG000|Overall Study|Lost to Follow-up|36|||
94632199|NCT03312933|324114948|FG000|Overall Study|Withdrawal by Subject|3|||
94632200|NCT02068443|324114949|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
94632201|NCT02068443|324114950|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
94632202|NCT02068443|324114951|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
94632203|NCT02068443|324114949|FG000|Overall Study|Voluntary Withdrawal|4|||
94632204|NCT02068443|324114950|FG001|Overall Study|Voluntary Withdrawal|0|||
94632205|NCT02068443|324114951|FG002|Overall Study|Voluntary Withdrawal|1|||
94260041|NCT00261846|322745537|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
94260042|NCT00261846|322745526|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
94260043|NCT00261846|322745527|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
94260044|NCT00261846|322745528|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
94260045|NCT00261846|322745529|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
94260046|NCT00261846|322745530|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
94260047|NCT00261846|322745531|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
94260048|NCT00261846|322745532|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
94260049|NCT00261846|322745533|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
94260050|NCT00261846|322745534|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
94260051|NCT00261846|322745535|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
94260052|NCT00261846|322745536|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
94260053|NCT00261846|322745537|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
94260054|NCT00261846|322745526|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
94260055|NCT00261846|322745527|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
94260056|NCT00261846|322745528|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
94260057|NCT00261846|322745529|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
94260058|NCT00261846|322745530|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
94260059|NCT00261846|322745531|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
94260060|NCT00261846|322745532|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
94260061|NCT00261846|322745533|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
94260062|NCT00261846|322745534|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
94260063|NCT00261846|322745535|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
94260064|NCT00261846|322745536|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
94632206|NCT02068443|324114949|FG000|Overall Study|Lack of Efficacy|2|||
94632207|NCT02068443|324114950|FG001|Overall Study|Lack of Efficacy|1|||
94260065|NCT00261846|322745537|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
94260066|NCT00261846|322745526|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
94260067|NCT00261846|322745527|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
94260068|NCT00261846|322745528|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
94260069|NCT00261846|322745529|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
94260070|NCT00261846|322745530|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
94260071|NCT00261846|322745531|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
94632208|NCT02068443|324114951|FG002|Overall Study|Lack of Efficacy|0|||
94632209|NCT02068443|324114949|FG000|Overall Study|Other Reason Not Specified|1|||
94260072|NCT00261846|322745532|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
94260073|NCT00261846|322745533|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
94362184|NCT01525407|323108857|FG001|Overall Study|Transplant was delayed|1|||
94362185|NCT01525407|323108856|FG000|Overall Study|Delay in Transplant|1|||
94362186|NCT01525407|323108857|FG001|Overall Study|Delay in Transplant|0|||
94362187|NCT02998645|323108858|FG000|Treatment Period 1|Adverse Event|6|||
94362188|NCT02998645|323108858|FG000|Treatment Period 1|Death|5|||
94362189|NCT02998645|323108858|FG000|Treatment Period 1|Technical Problems|4|||
94362190|NCT02998645|323108858|FG000|Treatment Period 1|Lack of Efficacy|2|||
94362191|NCT02998645|323108858|FG000|Treatment Period 1|Progressive disease|1|||
94362192|NCT02998645|323108858|FG000|Treatment Period 1|Subject/guardian decision|1|||
94362193|NCT02998645|323108858|FG000|Treatment Period 2|Lack of Efficacy|5|||
94362194|NCT02998645|323108858|FG000|Treatment Period 2|Adverse Event|2|||
94362195|NCT02998645|323108858|FG000|Treatment Period 2|Progressive disease|2|||
94362196|NCT02998645|323108858|FG000|Treatment Period 2|Physician Decision|1|||
94362197|NCT03644927|323108864|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
94362198|NCT03644927|323108865|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
94362199|NCT03078192|323108869|FG000|Overall Study|Withdrawal by Subject|2|||
94362200|NCT03078192|323108870|FG001|Overall Study|Withdrawal by Subject|1|||
94362201|NCT03078192|323108869|FG000|Overall Study|screen failure|0|||
94362202|NCT03078192|323108870|FG001|Overall Study|screen failure|3|||
94362203|NCT02873195|323108871|FG000|Overall Study|Ineligible|5|||
94362204|NCT02873195|323108872|FG001|Overall Study|Ineligible|0|||
94362205|NCT02184988|323108873|FG000|Overall Study|Pregnancy|2|||
94362206|NCT02184988|323108873|FG000|Overall Study|Adverse Event|2|||
94362207|NCT02184988|323108873|FG000|Overall Study|moving away/travelling/unable to complet|6|||
94362208|NCT02184988|323108873|FG000|Overall Study|work scheduling issues|4|||
94362209|NCT02184988|323108873|FG000|Overall Study|various other reasons|9|||
94362210|NCT02184988|323108873|FG000|Overall Study|Lost to Follow-up|32|||
94362211|NCT00752895|323108875|FG000|Overall Study|Withdrawal by Subject|8|||
94362212|NCT00752895|323108876|FG001|Overall Study|Withdrawal by Subject|3|||
94362213|NCT00096031|323108877|FG000|Overall Study|Adverse Event|3|||
94362214|NCT00096031|323108877|FG000|Overall Study|Lack of Efficacy|42|||
94362215|NCT00096031|323108877|FG000|Overall Study|Death|4|||
94362216|NCT00096031|323108877|FG000|Overall Study|Withdrawal by Subject|1|||
94362217|NCT00096031|323108877|FG000|Overall Study|Ineligible|8|||
94362218|NCT00096031|323108877|FG000|Overall Study|Not protocol specified|5|||
94362219|NCT04822701|323108878|FG000|Overall Study|Not treated|2|||
94362220|NCT04822701|323108879|FG001|Overall Study|Not treated|0|||
94362221|NCT04822701|323108878|FG000|Overall Study|Lost to Follow-up|1|||
94362222|NCT04822701|323108879|FG001|Overall Study|Lost to Follow-up|0|||
94362223|NCT04822701|323108878|FG000|Overall Study|Withdrawal by Subject|1|||
94362224|NCT04822701|323108879|FG001|Overall Study|Withdrawal by Subject|0|||
94362225|NCT01340794|323110626|FG000|Overall Study|Withdrawal by Subject|0|||
94362226|NCT01340794|323110627|FG001|Overall Study|Withdrawal by Subject|1|||
94362227|NCT00457249|323110631|FG000|Overall Study|Lost to Follow-up|3|||
94362228|NCT00457249|323110632|FG001|Overall Study|Lost to Follow-up|0|||
94362229|NCT00457249|323110631|FG000|Overall Study|Protocol Violation|4|||
94362230|NCT00457249|323110632|FG001|Overall Study|Protocol Violation|1|||
94362231|NCT00457249|323110631|FG000|Overall Study|Withdrawal by Subject|3|||
94362232|NCT00457249|323110632|FG001|Overall Study|Withdrawal by Subject|1|||
94362233|NCT00457249|323110631|FG000|Overall Study|Serious Adverse Events|2|||
94362234|NCT00457249|323110632|FG001|Overall Study|Serious Adverse Events|0|||
94362235|NCT00648739|323110633|FG000|Overall Study|Adverse Event|1|||
94362236|NCT00648739|323110634|FG001|Overall Study|Adverse Event|0|||
94362237|NCT00648739|323110635|FG002|Overall Study|Adverse Event|1|||
94362238|NCT00648739|323110636|FG003|Overall Study|Adverse Event|2|||
94362239|NCT00648739|323110637|FG004|Overall Study|Adverse Event|1|||
94362240|NCT00648739|323110638|FG005|Overall Study|Adverse Event|0|||
94362241|NCT00648739|323110639|FG006|Overall Study|Adverse Event|0|||
94362242|NCT00648739|323110633|FG000|Overall Study|Withdrawal by Subject|1|||
94362243|NCT00648739|323110634|FG001|Overall Study|Withdrawal by Subject|0|||
94362244|NCT00648739|323110635|FG002|Overall Study|Withdrawal by Subject|1|||
94362245|NCT00648739|323110636|FG003|Overall Study|Withdrawal by Subject|0|||
94362246|NCT00648739|323110637|FG004|Overall Study|Withdrawal by Subject|0|||
94362247|NCT00648739|323110638|FG005|Overall Study|Withdrawal by Subject|2|||
94362248|NCT00648739|323110639|FG006|Overall Study|Withdrawal by Subject|0|||
94362249|NCT00648739|323110633|FG000|Overall Study|Lack of Efficacy|0|||
94632210|NCT02068443|324114950|FG001|Overall Study|Other Reason Not Specified|0|||
94632211|NCT02068443|324114951|FG002|Overall Study|Other Reason Not Specified|0|||
94632212|NCT01986855|324114953|FG000|Overall Study|Adverse Event|1|||
94632213|NCT01986855|324114954|FG001|Overall Study|Adverse Event|0|||
94362250|NCT00648739|323110634|FG001|Overall Study|Lack of Efficacy|0|||
94362251|NCT00648739|323110635|FG002|Overall Study|Lack of Efficacy|0|||
94362252|NCT00648739|323110636|FG003|Overall Study|Lack of Efficacy|0|||
94362253|NCT00648739|323110637|FG004|Overall Study|Lack of Efficacy|1|||
94362254|NCT00648739|323110638|FG005|Overall Study|Lack of Efficacy|2|||
94362255|NCT00648739|323110639|FG006|Overall Study|Lack of Efficacy|0|||
94362256|NCT00648739|323110633|FG000|Overall Study|Investigator Considered it Advisable|0|||
94362257|NCT00648739|323110634|FG001|Overall Study|Investigator Considered it Advisable|0|||
94362258|NCT00648739|323110635|FG002|Overall Study|Investigator Considered it Advisable|0|||
94362259|NCT00648739|323110636|FG003|Overall Study|Investigator Considered it Advisable|0|||
94362260|NCT00648739|323110637|FG004|Overall Study|Investigator Considered it Advisable|0|||
94362261|NCT00648739|323110638|FG005|Overall Study|Investigator Considered it Advisable|1|||
94362262|NCT00648739|323110639|FG006|Overall Study|Investigator Considered it Advisable|1|||
94362263|NCT00648739|323110633|FG000|Overall Study|Death|0|||
94362264|NCT00648739|323110634|FG001|Overall Study|Death|1|||
94362265|NCT00648739|323110635|FG002|Overall Study|Death|0|||
94362266|NCT00648739|323110636|FG003|Overall Study|Death|0|||
94362267|NCT00648739|323110637|FG004|Overall Study|Death|0|||
94362268|NCT00648739|323110638|FG005|Overall Study|Death|0|||
94362269|NCT00648739|323110639|FG006|Overall Study|Death|0|||
94362270|NCT00648739|323110633|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
94362271|NCT00648739|323110634|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
94362272|NCT00648739|323110635|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
94362273|NCT00648739|323110636|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
94362274|NCT00648739|323110637|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
94362275|NCT00648739|323110638|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
94362276|NCT00648739|323110639|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
94362277|NCT00648739|323110633|FG000|Overall Study|Follow-up Visits Not Completed|0|||
94362278|NCT00648739|323110634|FG001|Overall Study|Follow-up Visits Not Completed|1|||
94632214|NCT01986855|324114955|FG002|Overall Study|Adverse Event|0|||
94632215|NCT01986855|324114953|FG000|Overall Study|Death|3|||
94632216|NCT01986855|324114954|FG001|Overall Study|Death|4|||
94632217|NCT01986855|324114955|FG002|Overall Study|Death|4|||
94632218|NCT01986855|324114953|FG000|Overall Study|Lost to Follow-up|2|||
94632219|NCT01986855|324114954|FG001|Overall Study|Lost to Follow-up|1|||
94632220|NCT01986855|324114955|FG002|Overall Study|Lost to Follow-up|0|||
94632221|NCT01986855|324114953|FG000|Overall Study|Screen Failure|0|||
94632222|NCT01986855|324114954|FG001|Overall Study|Screen Failure|1|||
94632223|NCT01986855|324114955|FG002|Overall Study|Screen Failure|0|||
94632224|NCT01986855|324114953|FG000|Overall Study|Participant Moved|0|||
94632225|NCT01986855|324114954|FG001|Overall Study|Participant Moved|0|||
94632226|NCT01986855|324114955|FG002|Overall Study|Participant Moved|2|||
94632227|NCT01986855|324114953|FG000|Overall Study|Withdrawal by Subject|7|||
94632228|NCT01986855|324114954|FG001|Overall Study|Withdrawal by Subject|8|||
94632229|NCT01986855|324114955|FG002|Overall Study|Withdrawal by Subject|5|||
94632230|NCT02825992|324114956|FG000|Overall Study|Withdrawal by Subject|4|||
94632231|NCT02825992|324114956|FG000|Overall Study|Lost to Follow-up|2|||
94632232|NCT02825992|324114956|FG000|Overall Study|Procedure terminated|2|||
94632233|NCT01320085|324114960|FG000|Overall Study|Disease Progression|26|||
94632234|NCT01320085|324114961|FG001|Overall Study|Disease Progression|93|||
94632235|NCT01320085|324114962|FG002|Overall Study|Disease Progression|17|||
94632236|NCT01320085|324114960|FG000|Overall Study|Adverse Event|12|||
94632237|NCT01320085|324114961|FG001|Overall Study|Adverse Event|20|||
94632238|NCT01320085|324114962|FG002|Overall Study|Adverse Event|5|||
94632239|NCT01320085|324114960|FG000|Overall Study|Withdrawal by Subject|2|||
94632240|NCT01320085|324114961|FG001|Overall Study|Withdrawal by Subject|4|||
94632241|NCT01320085|324114962|FG002|Overall Study|Withdrawal by Subject|1|||
94632242|NCT01320085|324114960|FG000|Overall Study|Protocol Deviation|1|||
94632243|NCT01320085|324114961|FG001|Overall Study|Protocol Deviation|0|||
94632244|NCT01320085|324114962|FG002|Overall Study|Protocol Deviation|1|||
94632245|NCT01320085|324114960|FG000|Overall Study|Administrative problems|0|||
94632246|NCT01320085|324114961|FG001|Overall Study|Administrative problems|0|||
94632247|NCT01320085|324114962|FG002|Overall Study|Administrative problems|1|||
94632248|NCT00710710|324114963|FG000|Overall Study|Consent withdrawn|2|||
94632249|NCT00710710|324114964|FG001|Overall Study|Consent withdrawn|2|||
94632250|NCT00710710|324114963|FG000|Overall Study|Protocol Violation|0|||
94632251|NCT00710710|324114964|FG001|Overall Study|Protocol Violation|1|||
94632252|NCT00710710|324114963|FG000|Overall Study|Adverse Event|3|||
94632253|NCT00710710|324114964|FG001|Overall Study|Adverse Event|3|||
94632254|NCT00710710|324114963|FG000|Overall Study|Progressive disease|40|||
94632255|NCT00710710|324114964|FG001|Overall Study|Progressive disease|38|||
94632256|NCT02041286|324114971|FG000|Overall Study|Adverse Event|1|||
94632257|NCT02282020|324114972|FG000|Overall Study|Objective Disease Progression|128|||
94632258|NCT02282020|324114973|FG001|Overall Study|Objective Disease Progression|30|||
94632259|NCT02282020|324114972|FG000|Overall Study|Adverse Event|18|||
94675838|NCT01345630|324267006|FG000|Overall Study|No longer willing to participate|9|||
94675839|NCT01345630|324267007|FG001|Overall Study|No longer willing to participate|12|||
94675840|NCT01345630|324267006|FG000|Overall Study|Insufficient clinical response|48|||
94675841|NCT01345630|324267007|FG001|Overall Study|Insufficient clinical response|11|||
94362279|NCT00648739|323110635|FG002|Overall Study|Follow-up Visits Not Completed|0|||
94362280|NCT00648739|323110636|FG003|Overall Study|Follow-up Visits Not Completed|0|||
94362281|NCT00648739|323110637|FG004|Overall Study|Follow-up Visits Not Completed|0|||
94632260|NCT02282020|324114973|FG001|Overall Study|Adverse Event|15|||
94632261|NCT02282020|324114972|FG000|Overall Study|Withdrawal by Subject|7|||
94632262|NCT02282020|324114973|FG001|Overall Study|Withdrawal by Subject|10|||
94632263|NCT02282020|324114972|FG000|Overall Study|Miscellaneous|5|||
94632264|NCT02282020|324114973|FG001|Overall Study|Miscellaneous|19|||
94632265|NCT02282020|324114972|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
94632266|NCT02282020|324114973|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
94632267|NCT02282020|324114972|FG000|Overall Study|Developed Discontinuation Criteria|0|||
94632268|NCT02282020|324114973|FG001|Overall Study|Developed Discontinuation Criteria|2|||
94632269|NCT02282020|324114972|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
94632270|NCT02282020|324114973|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
94632271|NCT01500629|324114974|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
94632272|NCT01500629|324114975|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
94632273|NCT01963403|324114976|FG000|Overall Study|Lost to Follow-up|2|||
94632274|NCT01963403|324114977|FG001|Overall Study|Lost to Follow-up|3|||
94632275|NCT01963403|324114976|FG000|Overall Study|Implant removal|0|||
94632276|NCT01963403|324114977|FG001|Overall Study|Implant removal|1|||
94632277|NCT00531050|324114978|FG000|Part 1: Period 1|Adverse Event|0|||
94632278|NCT00531050|324114979|FG001|Part 1: Period 1|Adverse Event|1|||
94632279|NCT00531050|324114980|FG002|Part 1: Period 1|Adverse Event|0|||
94632280|NCT00531050|324114981|FG003|Part 1: Period 1|Adverse Event|0|||
94632281|NCT00531050|324114982|FG004|Part 1: Period 1|Adverse Event|0|||
94632282|NCT00531050|324114983|FG005|Part 1: Period 1|Adverse Event|0|||
94632283|NCT00531050|324114978|FG000|Part 1: Period 1|Protocol Deviation|0|||
94632284|NCT00531050|324114979|FG001|Part 1: Period 1|Protocol Deviation|0|||
94632285|NCT00531050|324114980|FG002|Part 1: Period 1|Protocol Deviation|0|||
94632286|NCT00531050|324114981|FG003|Part 1: Period 1|Protocol Deviation|1|||
94632287|NCT00531050|324114982|FG004|Part 1: Period 1|Protocol Deviation|0|||
94632288|NCT00531050|324114983|FG005|Part 1: Period 1|Protocol Deviation|0|||
94632289|NCT00531050|324114978|FG000|Part 1: Period 3|Adverse Event|1|||
94632290|NCT00531050|324114979|FG001|Part 1: Period 3|Adverse Event|0|||
94632291|NCT00531050|324114980|FG002|Part 1: Period 3|Adverse Event|0|||
94632292|NCT00531050|324114981|FG003|Part 1: Period 3|Adverse Event|0|||
94632293|NCT00531050|324114982|FG004|Part 1: Period 3|Adverse Event|0|||
94632294|NCT00531050|324114983|FG005|Part 1: Period 3|Adverse Event|0|||
94632295|NCT00531050|324114978|FG000|Part 2: Period 1|Adverse Event|0|||
94632296|NCT00531050|324114979|FG001|Part 2: Period 1|Adverse Event|0|||
94632297|NCT00531050|324114980|FG002|Part 2: Period 1|Adverse Event|0|||
94632298|NCT00531050|324114981|FG003|Part 2: Period 1|Adverse Event|0|||
94632299|NCT00531050|324114982|FG004|Part 2: Period 1|Adverse Event|0|||
94632300|NCT00531050|324114983|FG005|Part 2: Period 1|Adverse Event|1|||
94632301|NCT00531050|324114978|FG000|Part 2: Period 3|Abnormal test procedure|1|||
94632302|NCT00531050|324114979|FG001|Part 2: Period 3|Abnormal test procedure|0|||
94632303|NCT00531050|324114980|FG002|Part 2: Period 3|Abnormal test procedure|0|||
94632304|NCT00531050|324114981|FG003|Part 2: Period 3|Abnormal test procedure|0|||
94632305|NCT00531050|324114982|FG004|Part 2: Period 3|Abnormal test procedure|0|||
94632306|NCT00531050|324114983|FG005|Part 2: Period 3|Abnormal test procedure|1|||
94632307|NCT02233309|324114985|FG000|Overall Study|Physician Decision|5|||
94632308|NCT04481750|324114989|FG000|Period 1 (Fasted)|Adverse Event|0|||
94632309|NCT04481750|324114990|FG001|Period 1 (Fasted)|Adverse Event|0|||
94632310|NCT04481750|324114991|FG002|Period 1 (Fasted)|Adverse Event|1|||
94632311|NCT04481750|324114992|FG003|Period 1 (Fasted)|Adverse Event|0|||
94632312|NCT04481750|324114993|FG004|Period 1 (Fasted)|Adverse Event|0|||
94632313|NCT04481750|324114994|FG005|Period 1 (Fasted)|Adverse Event|0|||
94461718|NCT01043705|323479587|FG002|Overall Study|Other|25|||
94632314|NCT04481750|324114995|FG006|Period 1 (Fasted)|Adverse Event|0|||
94632315|NCT04481750|324114996|FG007|Period 1 (Fasted)|Adverse Event|0|||
94632316|NCT04481750|324114997|FG008|Period 1 (Fasted)|Adverse Event|0|||
94632317|NCT04481750|324114998|FG009|Period 1 (Fasted)|Adverse Event|0|||
94632318|NCT04481750|324114999|FG010|Period 1 (Fasted)|Adverse Event|0|||
94632319|NCT00475176|324115000|FG000|Overall Study|Adverse Event|2|||
94675842|NCT02543658|324267008|FG000|Overall Study|Lack of Efficacy|0|||
94632320|NCT00475176|324115000|FG000|Overall Study|Withdrawal by Subject|1|||
94675843|NCT02543658|324267009|FG001|Overall Study|Lack of Efficacy|4|||
94675844|NCT01203930|324267015|FG000|Overall Study|Disease Progression|0|||
94675845|NCT01203930|324267016|FG001|Overall Study|Disease Progression|4|||
94675846|NCT01203930|324267015|FG000|Overall Study|Death|3|||
94675847|NCT01203930|324267016|FG001|Overall Study|Death|1|||
94675848|NCT01203930|324267015|FG000|Overall Study|Withdrew Consent|1|||
94675849|NCT01203930|324267016|FG001|Overall Study|Withdrew Consent|10|||
94675850|NCT01203930|324267015|FG000|Overall Study|Investigator Request|0|||
94675851|NCT01203930|324267016|FG001|Overall Study|Investigator Request|8|||
94675852|NCT01203930|324267015|FG000|Overall Study|Study Terminated by Sponsor|0|||
94675853|NCT01203930|324267016|FG001|Overall Study|Study Terminated by Sponsor|12|||
94675854|NCT01203930|324267015|FG000|Overall Study|Poor tolerance of study drug|0|||
94675855|NCT01203930|324267016|FG001|Overall Study|Poor tolerance of study drug|1|||
94675856|NCT01203930|324267015|FG000|Overall Study|Adverse Event|17|||
94675857|NCT01203930|324267016|FG001|Overall Study|Adverse Event|5|||
94675858|NCT02178059|324267017|FG000|Washout|Physician Decision|1|||
94675859|NCT02178059|324267018|FG001|Washout|Physician Decision|0|||
94675860|NCT03092375|324267022|FG000|Overall Study|Lack of Efficacy|0|||
94675861|NCT03092375|324267023|FG001|Overall Study|Lack of Efficacy|1|||
94675862|NCT03092375|324267024|FG002|Overall Study|Lack of Efficacy|1|||
94675863|NCT03092375|324267025|FG003|Overall Study|Lack of Efficacy|0|||
94675864|NCT00662857|324267027|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
94675865|NCT00662857|324267028|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
94675866|NCT00662857|324267027|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
94675867|NCT00662857|324267028|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
94675868|NCT00662857|324267027|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
94675869|NCT00662857|324267028|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
94675870|NCT02127372|324267029|FG000|Overall Study|Withdrawal by Subject|1|||
94675871|NCT02127372|324267030|FG001|Overall Study|Withdrawal by Subject|0|||
94675872|NCT00514943|324267031|FG000|Stage 1|Progressive disease|4|||
94675873|NCT00514943|324267032|FG001|Stage 1|Progressive disease|8|||
94675874|NCT00514943|324267031|FG000|Stage 1|Other Adverse Event|16|||
94675875|NCT00514943|324267032|FG001|Stage 1|Other Adverse Event|6|||
94675876|NCT00514943|324267031|FG000|Stage 1|Not treated|1|||
94675877|NCT00514943|324267032|FG001|Stage 1|Not treated|2|||
94675878|NCT00514943|324267031|FG000|Stage 1|Patient refused to continue study meds|8|||
94675879|NCT00514943|324267032|FG001|Stage 1|Patient refused to continue study meds|3|||
94675880|NCT00514943|324267031|FG000|Stage 1|Other than stated above|1|||
94675881|NCT00514943|324267032|FG001|Stage 1|Other than stated above|7|||
94675882|NCT00514943|324267031|FG000|Stage 2|Progressive disease|27|||
94675883|NCT00514943|324267032|FG001|Stage 2|Progressive disease|24|||
94675884|NCT00514943|324267031|FG000|Stage 2|Other Adverse Event|3|||
94675885|NCT00514943|324267032|FG001|Stage 2|Other Adverse Event|10|||
94675886|NCT00514943|324267031|FG000|Stage 2|Patient refused to continue study meds|2|||
94675887|NCT00514943|324267032|FG001|Stage 2|Patient refused to continue study meds|0|||
94675888|NCT00514943|324267031|FG000|Stage 2|Other than stated above|0|||
94675889|NCT00514943|324267032|FG001|Stage 2|Other than stated above|2|||
94675890|NCT02459262|324267033|FG000|Overall Study|Withdrawal by Subject|0|||
94675891|NCT02459262|324267034|FG001|Overall Study|Withdrawal by Subject|0|||
94675892|NCT02459262|324267035|FG002|Overall Study|Withdrawal by Subject|0|||
94675893|NCT02459262|324267036|FG003|Overall Study|Withdrawal by Subject|0|||
94675894|NCT02459262|324267037|FG004|Overall Study|Withdrawal by Subject|0|||
94675895|NCT02459262|324267038|FG005|Overall Study|Withdrawal by Subject|0|||
94675896|NCT02459262|324267039|FG006|Overall Study|Withdrawal by Subject|0|||
94675897|NCT02459262|324267040|FG007|Overall Study|Withdrawal by Subject|0|||
94675898|NCT02459262|324267041|FG008|Overall Study|Withdrawal by Subject|0|||
94675899|NCT02459262|324267042|FG009|Overall Study|Withdrawal by Subject|1|||
94675900|NCT02459262|324267043|FG010|Overall Study|Withdrawal by Subject|0|||
94675901|NCT02641392|324267044|FG000|Overall Study|Lost to Follow-up|0|||
94675902|NCT02641392|324267045|FG001|Overall Study|Lost to Follow-up|0|||
94675903|NCT02641392|324267046|FG002|Overall Study|Lost to Follow-up|2|||
94675904|NCT02641392|324267044|FG000|Overall Study|Withdrawal by Subject|0|||
94675905|NCT02641392|324267045|FG001|Overall Study|Withdrawal by Subject|0|||
94675906|NCT02641392|324267046|FG002|Overall Study|Withdrawal by Subject|17|||
94675907|NCT02641392|324267044|FG000|Overall Study|Adverse Event|0|||
94675908|NCT02641392|324267045|FG001|Overall Study|Adverse Event|1|||
94675909|NCT02641392|324267046|FG002|Overall Study|Adverse Event|25|||
94675910|NCT02641392|324267044|FG000|Overall Study|Study Terminated by Sponsor|4|||
94675911|NCT02641392|324267045|FG001|Overall Study|Study Terminated by Sponsor|12|||
94675912|NCT02641392|324267046|FG002|Overall Study|Study Terminated by Sponsor|144|||
94675913|NCT02641392|324267044|FG000|Overall Study|Lack of Efficacy|0|||
94675914|NCT02641392|324267045|FG001|Overall Study|Lack of Efficacy|0|||
94675915|NCT02641392|324267046|FG002|Overall Study|Lack of Efficacy|101|||
94675916|NCT02641392|324267044|FG000|Overall Study|Miscellaneous|0|||
94675917|NCT02641392|324267045|FG001|Overall Study|Miscellaneous|0|||
94675918|NCT02641392|324267046|FG002|Overall Study|Miscellaneous|3|||
94675919|NCT02641392|324267044|FG000|Overall Study|Death|0|||
94675920|NCT02641392|324267045|FG001|Overall Study|Death|0|||
94675921|NCT02641392|324267046|FG002|Overall Study|Death|1|||
94675922|NCT00420199|324267047|FG000|Overall Study|Participant no longer met study criteria|1|||
94675923|NCT00420199|324267048|FG001|Overall Study|Participant no longer met study criteria|0|||
94675924|NCT04020341|324267050|FG000|Overall Study|Adverse Event|8|||
94675925|NCT04020341|324267051|FG001|Overall Study|Adverse Event|6|||
94675926|NCT04020341|324267050|FG000|Overall Study|Lost to Follow-up|8|||
94675927|NCT04020341|324267051|FG001|Overall Study|Lost to Follow-up|2|||
94675928|NCT04020341|324267050|FG000|Overall Study|Withdrawal by Subject|16|||
94675929|NCT04020341|324267051|FG001|Overall Study|Withdrawal by Subject|16|||
94675930|NCT04020341|324267050|FG000|Overall Study|Participant not able to swallow the tablet|1|||
94675931|NCT04020341|324267051|FG001|Overall Study|Participant not able to swallow the tablet|0|||
94675932|NCT04020341|324267050|FG000|Overall Study|Physician Decision|0|||
94675933|NCT04020341|324267051|FG001|Overall Study|Physician Decision|2|||
94675934|NCT04020341|324267050|FG000|Overall Study|Protocol Deviation|0|||
94675935|NCT04020341|324267051|FG001|Overall Study|Protocol Deviation|2|||
94675936|NCT02182973|324267052|FG000|Overall Study|Withdrawal by Subject|3|||
94675937|NCT02182973|324267053|FG001|Overall Study|Withdrawal by Subject|0|||
94675938|NCT01235546|324267054|FG000|Overall Study|Staff error, medication not administered|1|||
94362282|NCT00648739|323110638|FG005|Overall Study|Follow-up Visits Not Completed|0|||
94362283|NCT00648739|323110639|FG006|Overall Study|Follow-up Visits Not Completed|0|||
94362284|NCT00698009|323110647|FG000|Overall Study|Withdrawal by Subject|1|||
94632321|NCT00475176|324115000|FG000|Overall Study|Protocol Violation|1|||
94632322|NCT01463878|324115004|FG000|Overall Study|no longer met criteria for tube feed|2|||
94632323|NCT01463878|324115005|FG001|Overall Study|no longer met criteria for tube feed|2|||
94632324|NCT02436889|324115006|FG000|Overall Study|No improvement in symptoms|1|||
94632325|NCT02436889|324115007|FG001|Overall Study|No improvement in symptoms|0|||
94632326|NCT02436889|324115006|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
94632327|NCT02436889|324115007|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
94632328|NCT01585428|324115008|FG000|Overall Study|Death during treatment|1|||
94362285|NCT03387423|323110651|FG000|Overall Study|Lost to Follow-up|16|||
94362286|NCT03387423|323110652|FG001|Overall Study|Lost to Follow-up|12|||
94632329|NCT01585428|324115009|FG001|Overall Study|Death during treatment|0|||
94632330|NCT01084174|324115010|FG000|Overall Study|gastrointestinal symptoms|1|||
94632331|NCT01084174|324115011|FG001|Overall Study|gastrointestinal symptoms|1|||
94632332|NCT01084174|324115010|FG000|Overall Study|Eosinophilic esophagitis|0|||
94632333|NCT01084174|324115011|FG001|Overall Study|Eosinophilic esophagitis|1|||
94632334|NCT01084174|324115010|FG000|Overall Study|Anaphylaxis|0|||
94632335|NCT01084174|324115011|FG001|Overall Study|Anaphylaxis|1|||
94632336|NCT01084174|324115010|FG000|Overall Study|Participant noncompliance|0|||
94632337|NCT01084174|324115011|FG001|Overall Study|Participant noncompliance|1|||
94632338|NCT00708162|324115013|FG000|Randomized Phase|Randomized but Not Treated|7|||
94632339|NCT00708162|324115014|FG001|Randomized Phase|Randomized but Not Treated|5|||
94632340|NCT00708162|324115013|FG000|Randomized Phase|Participant Noncompliance|40|||
94632341|NCT00708162|324115014|FG001|Randomized Phase|Participant Noncompliance|32|||
94632342|NCT00708162|324115013|FG000|Randomized Phase|Lost to Follow-up|34|||
94632343|NCT00708162|324115014|FG001|Randomized Phase|Lost to Follow-up|34|||
94632344|NCT00708162|324115013|FG000|Randomized Phase|Withdrew Consent|31|||
94632345|NCT00708162|324115014|FG001|Randomized Phase|Withdrew Consent|22|||
94632346|NCT00708162|324115013|FG000|Randomized Phase|Lack of Efficacy|14|||
94632347|NCT00708162|324115014|FG001|Randomized Phase|Lack of Efficacy|19|||
94675939|NCT01235546|324267055|FG001|Overall Study|Staff error, medication not administered|0|||
94362287|NCT03387423|323110653|FG002|Overall Study|Lost to Follow-up|1|||
94362288|NCT03387423|323110654|FG003|Overall Study|Lost to Follow-up|0|||
94362289|NCT03387423|323110651|FG000|Overall Study|Other|0|||
94632348|NCT00708162|324115013|FG000|Randomized Phase|Protocol Violation|10|||
94632349|NCT00708162|324115014|FG001|Randomized Phase|Protocol Violation|11|||
94632350|NCT00708162|324115013|FG000|Randomized Phase|Adverse Event|8|||
94632351|NCT00708162|324115014|FG001|Randomized Phase|Adverse Event|12|||
94632352|NCT00708162|324115013|FG000|Randomized Phase|Investigator's Discretion|7|||
94675940|NCT01235546|324267054|FG000|Overall Study|Protocol Violation|1|||
94675941|NCT01235546|324267055|FG001|Overall Study|Protocol Violation|1|||
94675942|NCT01123382|324267056|FG000|Overall Study|Withdrawal by Subject|1|||
94675943|NCT01123382|324267057|FG001|Overall Study|Withdrawal by Subject|4|||
94362290|NCT03387423|323110652|FG001|Overall Study|Other|3|||
94632353|NCT00708162|324115014|FG001|Randomized Phase|Investigator's Discretion|10|||
94632354|NCT00708162|324115013|FG000|Randomized Phase|Death|2|||
94632355|NCT00708162|324115014|FG001|Randomized Phase|Death|9|||
94632356|NCT00708162|324115013|FG000|Randomized Phase|Pregnancy|3|||
94632357|NCT00708162|324115014|FG001|Randomized Phase|Pregnancy|0|||
94632358|NCT00708162|324115013|FG000|Open-Label Phase|Lost to Follow-up|10|||
94632359|NCT00708162|324115014|FG001|Open-Label Phase|Lost to Follow-up|8|||
94632360|NCT00708162|324115013|FG000|Open-Label Phase|Withdrew Consent|12|||
94632361|NCT00708162|324115014|FG001|Open-Label Phase|Withdrew Consent|6|||
94632362|NCT00708162|324115013|FG000|Open-Label Phase|Participant Noncompliance|7|||
94632363|NCT00708162|324115014|FG001|Open-Label Phase|Participant Noncompliance|7|||
94632364|NCT00708162|324115013|FG000|Open-Label Phase|Lack of Efficacy|7|||
94632365|NCT00708162|324115014|FG001|Open-Label Phase|Lack of Efficacy|4|||
94632366|NCT00708162|324115013|FG000|Open-Label Phase|Investigator's Discretion|3|||
94632367|NCT00708162|324115014|FG001|Open-Label Phase|Investigator's Discretion|2|||
94632368|NCT00708162|324115013|FG000|Open-Label Phase|Death|3|||
94632369|NCT00708162|324115014|FG001|Open-Label Phase|Death|1|||
94632370|NCT00708162|324115013|FG000|Open-Label Phase|Adverse Event|1|||
94632371|NCT00708162|324115014|FG001|Open-Label Phase|Adverse Event|2|||
94632372|NCT00708162|324115013|FG000|Open-Label Phase|Other|1|||
94632373|NCT00708162|324115014|FG001|Open-Label Phase|Other|0|||
94632374|NCT00503009|324115015|FG000|Overall Study|Protocol Violation|1|||
94632375|NCT00503009|324115016|FG001|Overall Study|Protocol Violation|0|||
94632376|NCT00503009|324115017|FG002|Overall Study|Protocol Violation|1|||
94632377|NCT00503009|324115015|FG000|Overall Study|Withdrawal by Subject|0|||
94632378|NCT00503009|324115016|FG001|Overall Study|Withdrawal by Subject|1|||
94632379|NCT00503009|324115017|FG002|Overall Study|Withdrawal by Subject|1|||
94632380|NCT00503009|324115015|FG000|Overall Study|Physician Decision|0|||
94632381|NCT00503009|324115016|FG001|Overall Study|Physician Decision|1|||
94632382|NCT00503009|324115017|FG002|Overall Study|Physician Decision|1|||
94632383|NCT01349803|324115018|FG000|Overall Study|Adverse Event|0|||
94632384|NCT01349803|324115019|FG001|Overall Study|Adverse Event|0|||
94632385|NCT01349803|324115020|FG002|Overall Study|Adverse Event|0|||
94632386|NCT01349803|324115021|FG003|Overall Study|Adverse Event|2|||
94632387|NCT01349803|324115018|FG000|Overall Study|Withdrawal by Subject|1|||
94632388|NCT01349803|324115019|FG001|Overall Study|Withdrawal by Subject|0|||
94632389|NCT01349803|324115020|FG002|Overall Study|Withdrawal by Subject|0|||
94632390|NCT01349803|324115021|FG003|Overall Study|Withdrawal by Subject|0|||
94632391|NCT01349803|324115018|FG000|Overall Study|Protocol-specified criteria|0|||
94632392|NCT01349803|324115019|FG001|Overall Study|Protocol-specified criteria|1|||
94632393|NCT01349803|324115020|FG002|Overall Study|Protocol-specified criteria|3|||
94632394|NCT01349803|324115021|FG003|Overall Study|Protocol-specified criteria|0|||
94632395|NCT00227903|324115022|FG000|Overall Study|Withdrawal by Subject|2|||
94632396|NCT00227903|324115023|FG001|Overall Study|Withdrawal by Subject|5|||
94632397|NCT00227903|324115022|FG000|Overall Study|Subject moved out of area|1|||
94632398|NCT00227903|324115023|FG001|Overall Study|Subject moved out of area|2|||
94632399|NCT00227903|324115022|FG000|Overall Study|Lost to Follow-up|1|||
94632400|NCT00227903|324115023|FG001|Overall Study|Lost to Follow-up|3|||
94632401|NCT00227903|324115022|FG000|Overall Study|Miscarriage|1|||
94632402|NCT00227903|324115023|FG001|Overall Study|Miscarriage|0|||
94632403|NCT02514447|324115024|FG000|Overall Study|Withdrawal by Subject|3|||
94632404|NCT02514447|324115025|FG001|Overall Study|Withdrawal by Subject|1|||
94632405|NCT02514447|324115026|FG002|Overall Study|Withdrawal by Subject|1|||
94632406|NCT02514447|324115027|FG003|Overall Study|Withdrawal by Subject|0|||
94632407|NCT02514447|324115028|FG004|Overall Study|Withdrawal by Subject|0|||
94632408|NCT02514447|324115029|FG005|Overall Study|Withdrawal by Subject|0|||
94632409|NCT02514447|324115030|FG006|Overall Study|Withdrawal by Subject|0|||
94632410|NCT02514447|324115031|FG007|Overall Study|Withdrawal by Subject|1|||
94632411|NCT02514447|324115032|FG008|Overall Study|Withdrawal by Subject|1|||
94632412|NCT02514447|324115024|FG000|Overall Study|Death|24|||
94632413|NCT02514447|324115025|FG001|Overall Study|Death|28|||
94632414|NCT02514447|324115026|FG002|Overall Study|Death|29|||
94632415|NCT02514447|324115027|FG003|Overall Study|Death|0|||
94632416|NCT02514447|324115028|FG004|Overall Study|Death|3|||
94632417|NCT02514447|324115029|FG005|Overall Study|Death|4|||
94632418|NCT02514447|324115030|FG006|Overall Study|Death|8|||
94632419|NCT02514447|324115031|FG007|Overall Study|Death|6|||
94632420|NCT02514447|324115032|FG008|Overall Study|Death|5|||
94632421|NCT02514447|324115024|FG000|Overall Study|Lost to Follow-up|1|||
94632422|NCT02514447|324115025|FG001|Overall Study|Lost to Follow-up|0|||
94632423|NCT02514447|324115026|FG002|Overall Study|Lost to Follow-up|0|||
94632424|NCT02514447|324115027|FG003|Overall Study|Lost to Follow-up|0|||
94632425|NCT02514447|324115028|FG004|Overall Study|Lost to Follow-up|0|||
94632426|NCT02514447|324115029|FG005|Overall Study|Lost to Follow-up|0|||
94632427|NCT02514447|324115030|FG006|Overall Study|Lost to Follow-up|0|||
94632428|NCT02514447|324115031|FG007|Overall Study|Lost to Follow-up|0|||
94632429|NCT02514447|324115032|FG008|Overall Study|Lost to Follow-up|1|||
94632430|NCT02514447|324115024|FG000|Overall Study|Sponsor Termination of Study|0|||
94632431|NCT02514447|324115025|FG001|Overall Study|Sponsor Termination of Study|1|||
94632432|NCT02514447|324115026|FG002|Overall Study|Sponsor Termination of Study|1|||
94632433|NCT02514447|324115027|FG003|Overall Study|Sponsor Termination of Study|0|||
94632434|NCT02514447|324115028|FG004|Overall Study|Sponsor Termination of Study|0|||
94632435|NCT02514447|324115029|FG005|Overall Study|Sponsor Termination of Study|0|||
94632436|NCT02514447|324115030|FG006|Overall Study|Sponsor Termination of Study|0|||
94632437|NCT02514447|324115031|FG007|Overall Study|Sponsor Termination of Study|0|||
94632438|NCT02514447|324115032|FG008|Overall Study|Sponsor Termination of Study|0|||
94632439|NCT02514447|324115024|FG000|Overall Study|Study completion per Investigator|1|||
94632440|NCT02514447|324115025|FG001|Overall Study|Study completion per Investigator|0|||
94632441|NCT02514447|324115026|FG002|Overall Study|Study completion per Investigator|1|||
94632442|NCT02514447|324115027|FG003|Overall Study|Study completion per Investigator|2|||
94632443|NCT02514447|324115028|FG004|Overall Study|Study completion per Investigator|0|||
94632444|NCT02514447|324115029|FG005|Overall Study|Study completion per Investigator|0|||
94632445|NCT02514447|324115030|FG006|Overall Study|Study completion per Investigator|0|||
94632446|NCT02514447|324115031|FG007|Overall Study|Study completion per Investigator|0|||
94632447|NCT02514447|324115032|FG008|Overall Study|Study completion per Investigator|1|||
94632448|NCT02289690|324115033|FG000|Overall Study|Adverse Event Related to Progression|0|||
94632449|NCT02289690|324115034|FG001|Overall Study|Adverse Event Related to Progression|1|||
94632450|NCT02289690|324115035|FG002|Overall Study|Adverse Event Related to Progression|1|||
94632451|NCT02289690|324115036|FG003|Overall Study|Adverse Event Related to Progression|0|||
94632452|NCT02289690|324115037|FG004|Overall Study|Adverse Event Related to Progression|1|||
94632453|NCT02289690|324115038|FG005|Overall Study|Adverse Event Related to Progression|0|||
94632454|NCT02289690|324115039|FG006|Overall Study|Adverse Event Related to Progression|1|||
94632455|NCT02289690|324115040|FG007|Overall Study|Adverse Event Related to Progression|0|||
94632456|NCT02289690|324115041|FG008|Overall Study|Adverse Event Related to Progression|0|||
94632457|NCT02289690|324115042|FG009|Overall Study|Adverse Event Related to Progression|0|||
94632458|NCT02289690|324115033|FG000|Overall Study|Withdrawal by Subject|1|||
94632459|NCT02289690|324115034|FG001|Overall Study|Withdrawal by Subject|0|||
94632460|NCT02289690|324115035|FG002|Overall Study|Withdrawal by Subject|0|||
94632461|NCT02289690|324115036|FG003|Overall Study|Withdrawal by Subject|0|||
94632462|NCT02289690|324115037|FG004|Overall Study|Withdrawal by Subject|1|||
94632463|NCT02289690|324115038|FG005|Overall Study|Withdrawal by Subject|1|||
94632464|NCT02289690|324115039|FG006|Overall Study|Withdrawal by Subject|0|||
94632465|NCT02289690|324115040|FG007|Overall Study|Withdrawal by Subject|0|||
94632466|NCT02289690|324115041|FG008|Overall Study|Withdrawal by Subject|4|||
94632467|NCT02289690|324115042|FG009|Overall Study|Withdrawal by Subject|2|||
94632468|NCT02289690|324115033|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
94632469|NCT02289690|324115034|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
94632470|NCT02289690|324115035|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
94632471|NCT02289690|324115036|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
94632472|NCT02289690|324115037|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
94632473|NCT02289690|324115038|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
94632474|NCT02289690|324115039|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
94632475|NCT02289690|324115040|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
94632476|NCT02289690|324115041|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
94632477|NCT02289690|324115042|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
94632478|NCT02289690|324115033|FG000|Overall Study|Lost to Follow-up|0|||
94632479|NCT02289690|324115034|FG001|Overall Study|Lost to Follow-up|0|||
94632480|NCT02289690|324115035|FG002|Overall Study|Lost to Follow-up|0|||
94632481|NCT02289690|324115036|FG003|Overall Study|Lost to Follow-up|0|||
94632482|NCT02289690|324115037|FG004|Overall Study|Lost to Follow-up|0|||
94632483|NCT02289690|324115038|FG005|Overall Study|Lost to Follow-up|0|||
94632484|NCT02289690|324115039|FG006|Overall Study|Lost to Follow-up|0|||
94632485|NCT02289690|324115040|FG007|Overall Study|Lost to Follow-up|1|||
94632486|NCT02289690|324115041|FG008|Overall Study|Lost to Follow-up|0|||
94632487|NCT02289690|324115042|FG009|Overall Study|Lost to Follow-up|2|||
94632488|NCT02289690|324115033|FG000|Overall Study|Death|0|||
94632489|NCT02289690|324115034|FG001|Overall Study|Death|0|||
94632490|NCT02289690|324115035|FG002|Overall Study|Death|0|||
94632491|NCT02289690|324115036|FG003|Overall Study|Death|0|||
94632492|NCT02289690|324115037|FG004|Overall Study|Death|0|||
94632493|NCT02289690|324115038|FG005|Overall Study|Death|0|||
94632494|NCT02289690|324115039|FG006|Overall Study|Death|0|||
94461719|NCT02612610|323479588|FG000|Overall Study|Withdrawal by Subject|1|||
94632495|NCT02289690|324115040|FG007|Overall Study|Death|49|||
94632496|NCT02289690|324115041|FG008|Overall Study|Death|45|||
94632497|NCT02289690|324115042|FG009|Overall Study|Death|41|||
94675944|NCT01123382|324267056|FG000|Overall Study|Lost to Follow-up|1|||
94675945|NCT01123382|324267057|FG001|Overall Study|Lost to Follow-up|2|||
94675946|NCT01591382|324267059|FG000|Overall Study|Discharged Prior to Study Completion|2|||
94675947|NCT01591382|324267060|FG001|Overall Study|Discharged Prior to Study Completion|1|||
94675948|NCT01591382|324267059|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
94675949|NCT01591382|324267060|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
94675950|NCT00716092|324267061|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
94675951|NCT00716092|324267062|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
94675952|NCT00716092|324267063|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
94675953|NCT00330174|324267065|FG000|Overall Study|Withdrawal by Subject|7|||
94675954|NCT00330174|324267066|FG001|Overall Study|Withdrawal by Subject|7|||
94675955|NCT00330174|324267065|FG000|Overall Study|Lost to Follow-up|4|||
94675956|NCT00330174|324267066|FG001|Overall Study|Lost to Follow-up|1|||
94675957|NCT00330174|324267065|FG000|Overall Study|Clinical deterioration|1|||
94675958|NCT00330174|324267066|FG001|Overall Study|Clinical deterioration|2|||
94675959|NCT00330174|324267065|FG000|Overall Study|Excessive missed visits|3|||
94675960|NCT00330174|324267066|FG001|Overall Study|Excessive missed visits|8|||
94675961|NCT00330174|324267065|FG000|Overall Study|Miscellaneous reasons|7|||
94675962|NCT00330174|324267066|FG001|Overall Study|Miscellaneous reasons|1|||
94675963|NCT02403180|324267067|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
94675964|NCT02403180|324267068|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
94675965|NCT02403180|324267067|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
94675966|NCT02403180|324267068|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
94675967|NCT00166296|324267081|FG000|Overall Study|Withdrawal by Subject|1|||
94260074|NCT00261846|322745534|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
94260075|NCT00261846|322745535|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
94632498|NCT02289690|324115033|FG000|Overall Study|Sponsor Discontinued Study|0|||
94632499|NCT02289690|324115034|FG001|Overall Study|Sponsor Discontinued Study|0|||
94632500|NCT02289690|324115035|FG002|Overall Study|Sponsor Discontinued Study|0|||
94632501|NCT02289690|324115036|FG003|Overall Study|Sponsor Discontinued Study|0|||
94632502|NCT02289690|324115037|FG004|Overall Study|Sponsor Discontinued Study|0|||
94632503|NCT02289690|324115038|FG005|Overall Study|Sponsor Discontinued Study|0|||
94632504|NCT02289690|324115039|FG006|Overall Study|Sponsor Discontinued Study|0|||
94632505|NCT02289690|324115040|FG007|Overall Study|Sponsor Discontinued Study|9|||
94632506|NCT02289690|324115041|FG008|Overall Study|Sponsor Discontinued Study|7|||
94632507|NCT02289690|324115042|FG009|Overall Study|Sponsor Discontinued Study|15|||
94632508|NCT02289690|324115033|FG000|Overall Study|Other|0|||
94632509|NCT02289690|324115034|FG001|Overall Study|Other|0|||
94632510|NCT02289690|324115035|FG002|Overall Study|Other|0|||
94632511|NCT02289690|324115036|FG003|Overall Study|Other|1|||
94632512|NCT02289690|324115037|FG004|Overall Study|Other|1|||
94632513|NCT02289690|324115038|FG005|Overall Study|Other|0|||
94632514|NCT02289690|324115039|FG006|Overall Study|Other|1|||
94632515|NCT02289690|324115040|FG007|Overall Study|Other|2|||
94632516|NCT02289690|324115041|FG008|Overall Study|Other|3|||
94632517|NCT02289690|324115042|FG009|Overall Study|Other|1|||
94632518|NCT01244906|324115043|FG000|Overall Study|Death|2|||
94632519|NCT01244906|324115043|FG000|Overall Study|Progression of disease post treatment|6|||
94632520|NCT00723892|324115044|FG000|Overall Study|Participant not tracked|33|||
94632521|NCT00723892|324115045|FG001|Overall Study|Participant not tracked|35|||
94632522|NCT00723892|324115044|FG000|Overall Study|Virological criterion|24|||
94632523|NCT00723892|324115045|FG001|Overall Study|Virological criterion|9|||
94632524|NCT00723892|324115044|FG000|Overall Study|Withdrawal by Subject|6|||
94632525|NCT00723892|324115045|FG001|Overall Study|Withdrawal by Subject|9|||
94632526|NCT00723892|324115044|FG000|Overall Study|End planned|11|||
94632527|NCT00723892|324115045|FG001|Overall Study|End planned|7|||
94632528|NCT00723892|324115044|FG000|Overall Study|Bad tolerance|5|||
94632529|NCT00723892|324115045|FG001|Overall Study|Bad tolerance|5|||
94632530|NCT00723892|324115044|FG000|Overall Study|Multiple reasons|17|||
94632531|NCT00723892|324115045|FG001|Overall Study|Multiple reasons|12|||
94632532|NCT00723892|324115044|FG000|Overall Study|Other|6|||
94632533|NCT00723892|324115045|FG001|Overall Study|Other|3|||
94632534|NCT00723892|324115044|FG000|Overall Study|Study end|1|||
94632535|NCT00723892|324115045|FG001|Overall Study|Study end|3|||
94632536|NCT00723892|324115044|FG000|Overall Study|Weight loss|1|||
94632537|NCT00723892|324115045|FG001|Overall Study|Weight loss|3|||
94632538|NCT00723892|324115044|FG000|Overall Study|Alcohol abuse|0|||
94632539|NCT00723892|324115045|FG001|Overall Study|Alcohol abuse|1|||
94632540|NCT00723892|324115044|FG000|Overall Study|Intercurrent infection|2|||
94675968|NCT00166296|324267082|FG001|Overall Study|Withdrawal by Subject|3|||
94675969|NCT00166296|324267081|FG000|Overall Study|Adverse Event|2|||
94675970|NCT00166296|324267082|FG001|Overall Study|Adverse Event|4|||
94632541|NCT00723892|324115045|FG001|Overall Study|Intercurrent infection|0|||
94675971|NCT00166296|324267081|FG000|Overall Study|Lost to Follow-up|4|||
94675972|NCT00166296|324267082|FG001|Overall Study|Lost to Follow-up|2|||
94675973|NCT03172702|324267085|FG000|Overall Study|Adverse Event|9|||
94632542|NCT00723892|324115044|FG000|Overall Study|Drug addiction|1|||
94632543|NCT00723892|324115045|FG001|Overall Study|Drug addiction|0|||
94632544|NCT03247530|324115050|FG000|Overall Study|Withdrawal by caregiver|19|||
94632545|NCT03247530|324115051|FG001|Overall Study|Withdrawal by caregiver|8|||
94632546|NCT03247530|324115052|FG002|Overall Study|Withdrawal by caregiver|10|||
94632547|NCT03247530|324115050|FG000|Overall Study|Lost to Follow-up|3|||
94632548|NCT03247530|324115051|FG001|Overall Study|Lost to Follow-up|9|||
94632549|NCT03247530|324115052|FG002|Overall Study|Lost to Follow-up|6|||
94632550|NCT03247530|324115050|FG000|Overall Study|Adverse Event|2|||
94632551|NCT03247530|324115051|FG001|Overall Study|Adverse Event|5|||
94632552|NCT03247530|324115052|FG002|Overall Study|Adverse Event|2|||
94632553|NCT03247530|324115050|FG000|Overall Study|Failure to follow procedure|1|||
94632554|NCT03247530|324115051|FG001|Overall Study|Failure to follow procedure|1|||
94632555|NCT03247530|324115052|FG002|Overall Study|Failure to follow procedure|1|||
94632556|NCT03247530|324115050|FG000|Overall Study|Withdrawal by Subject|1|||
94632557|NCT03247530|324115051|FG001|Overall Study|Withdrawal by Subject|1|||
94632558|NCT03247530|324115052|FG002|Overall Study|Withdrawal by Subject|0|||
94632559|NCT03247530|324115050|FG000|Overall Study|Study medication misuse|0|||
94632560|NCT03247530|324115051|FG001|Overall Study|Study medication misuse|1|||
94632561|NCT03247530|324115052|FG002|Overall Study|Study medication misuse|0|||
94632562|NCT03247530|324115050|FG000|Overall Study|Other, multiple categories|1|||
94632563|NCT03247530|324115051|FG001|Overall Study|Other, multiple categories|3|||
94632564|NCT03247530|324115052|FG002|Overall Study|Other, multiple categories|1|||
94632565|NCT00546637|324115053|FG000|Overall Study|Adverse Event|46|||
94632566|NCT00546637|324115054|FG001|Overall Study|Adverse Event|20|||
94632567|NCT00546637|324115053|FG000|Overall Study|Lack of Efficacy|5|||
94632568|NCT00546637|324115054|FG001|Overall Study|Lack of Efficacy|5|||
94632569|NCT00546637|324115053|FG000|Overall Study|Lost to Follow-up|2|||
94632570|NCT00546637|324115054|FG001|Overall Study|Lost to Follow-up|2|||
94632571|NCT00546637|324115053|FG000|Overall Study|Other|10|||
94632572|NCT00546637|324115054|FG001|Overall Study|Other|12|||
94632573|NCT00546637|324115053|FG000|Overall Study|Withdrawal by Subject|7|||
94632574|NCT00546637|324115054|FG001|Overall Study|Withdrawal by Subject|9|||
94632575|NCT00546637|324115053|FG000|Overall Study|Randomized, but not treated|3|||
94632576|NCT00546637|324115054|FG001|Overall Study|Randomized, but not treated|1|||
94632577|NCT01113801|324115057|FG000|Overall Study|Adverse Event|4|||
94632578|NCT01113801|324115058|FG001|Overall Study|Adverse Event|0|||
94632579|NCT01113801|324115059|FG002|Overall Study|Adverse Event|2|||
94632580|NCT01113801|324115060|FG003|Overall Study|Adverse Event|6|||
94632581|NCT01113801|324115057|FG000|Overall Study|Death|4|||
94632582|NCT01113801|324115058|FG001|Overall Study|Death|5|||
94632583|NCT01113801|324115059|FG002|Overall Study|Death|3|||
94632584|NCT01113801|324115060|FG003|Overall Study|Death|4|||
94632585|NCT01113801|324115057|FG000|Overall Study|Protocol Violation|0|||
94632586|NCT01113801|324115058|FG001|Overall Study|Protocol Violation|1|||
94632587|NCT01113801|324115059|FG002|Overall Study|Protocol Violation|0|||
94632588|NCT01113801|324115060|FG003|Overall Study|Protocol Violation|0|||
94632589|NCT01113801|324115057|FG000|Overall Study|Withdrawal by Subject|9|||
94632590|NCT01113801|324115058|FG001|Overall Study|Withdrawal by Subject|7|||
94632591|NCT01113801|324115059|FG002|Overall Study|Withdrawal by Subject|7|||
94632592|NCT01113801|324115060|FG003|Overall Study|Withdrawal by Subject|8|||
94632593|NCT01113801|324115057|FG000|Overall Study|Physician Decision|2|||
94632594|NCT01113801|324115058|FG001|Overall Study|Physician Decision|2|||
94632595|NCT01113801|324115059|FG002|Overall Study|Physician Decision|3|||
94632596|NCT01113801|324115060|FG003|Overall Study|Physician Decision|3|||
94632597|NCT01113801|324115057|FG000|Overall Study|Sponsor Decision|15|||
94632598|NCT01113801|324115058|FG001|Overall Study|Sponsor Decision|21|||
94675974|NCT03172702|324267085|FG000|Overall Study|Death|2|||
94632599|NCT01113801|324115059|FG002|Overall Study|Sponsor Decision|20|||
94632600|NCT01113801|324115060|FG003|Overall Study|Sponsor Decision|15|||
94632601|NCT01113801|324115057|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
94632602|NCT01113801|324115058|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
94632603|NCT01113801|324115059|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
94632604|NCT01113801|324115060|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
94632605|NCT00276159|324115063|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
94632606|NCT00333866|324115064|FG000|Overall Study|Adverse Event|23|||
94632607|NCT00333866|324115065|FG001|Overall Study|Adverse Event|37|||
94632608|NCT00333866|324115066|FG002|Overall Study|Adverse Event|38|||
94632609|NCT00333866|324115067|FG003|Overall Study|Adverse Event|47|||
94632610|NCT00333866|324115064|FG000|Overall Study|Other|3|||
94632611|NCT00333866|324115065|FG001|Overall Study|Other|2|||
94675975|NCT03172702|324267085|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
94675976|NCT03172702|324267085|FG000|Overall Study|Withdrawal by Subject|5|||
94362291|NCT03387423|323110653|FG002|Overall Study|Other|0|||
94362292|NCT03387423|323110654|FG003|Overall Study|Other|0|||
94632612|NCT00333866|324115066|FG002|Overall Study|Other|2|||
94632613|NCT00333866|324115067|FG003|Overall Study|Other|2|||
94632614|NCT00333866|324115064|FG000|Overall Study|Lack of Efficacy|8|||
94632615|NCT00333866|324115065|FG001|Overall Study|Lack of Efficacy|6|||
94632616|NCT00333866|324115066|FG002|Overall Study|Lack of Efficacy|3|||
94632617|NCT00333866|324115067|FG003|Overall Study|Lack of Efficacy|5|||
94632618|NCT00333866|324115064|FG000|Overall Study|Lost to Follow-up|1|||
94632619|NCT00333866|324115065|FG001|Overall Study|Lost to Follow-up|2|||
94632620|NCT00333866|324115066|FG002|Overall Study|Lost to Follow-up|2|||
94632621|NCT00333866|324115067|FG003|Overall Study|Lost to Follow-up|2|||
94632622|NCT00333866|324115064|FG000|Overall Study|Withdrawal by Subject|8|||
94632623|NCT00333866|324115065|FG001|Overall Study|Withdrawal by Subject|14|||
94632624|NCT00333866|324115066|FG002|Overall Study|Withdrawal by Subject|4|||
94632625|NCT00333866|324115067|FG003|Overall Study|Withdrawal by Subject|9|||
94632626|NCT00333866|324115064|FG000|Overall Study|Randomized but not Treated|5|||
94632627|NCT00333866|324115065|FG001|Overall Study|Randomized but not Treated|3|||
94632628|NCT00333866|324115066|FG002|Overall Study|Randomized but not Treated|2|||
94632629|NCT00333866|324115067|FG003|Overall Study|Randomized but not Treated|1|||
94632630|NCT02710045|324115068|FG000|Overall Study|Death|1|||
94632631|NCT02710045|324115069|FG001|Overall Study|Death|2|||
94632632|NCT02710045|324115070|FG002|Overall Study|Death|0|||
94632633|NCT02710045|324115068|FG000|Overall Study|Withdrawal by Subject|6|||
94632634|NCT02710045|324115069|FG001|Overall Study|Withdrawal by Subject|6|||
94632635|NCT02710045|324115070|FG002|Overall Study|Withdrawal by Subject|2|||
94632636|NCT02710045|324115068|FG000|Overall Study|Protocol Violation|1|||
94632637|NCT02710045|324115069|FG001|Overall Study|Protocol Violation|2|||
94632638|NCT02710045|324115070|FG002|Overall Study|Protocol Violation|3|||
94632639|NCT02710045|324115068|FG000|Overall Study|Lost to Follow-up|3|||
94632640|NCT02710045|324115069|FG001|Overall Study|Lost to Follow-up|6|||
94632641|NCT02710045|324115070|FG002|Overall Study|Lost to Follow-up|7|||
94675977|NCT03172702|324267085|FG000|Overall Study|Other|2|||
94675978|NCT00701038|324267090|FG000|Overall Study|study amended pilot group of patients|4|||
94632642|NCT02710045|324115068|FG000|Overall Study|Physician Decision|0|||
94632643|NCT02710045|324115069|FG001|Overall Study|Physician Decision|0|||
94632644|NCT02710045|324115070|FG002|Overall Study|Physician Decision|1|||
94632645|NCT02710045|324115068|FG000|Overall Study|Poor Attendance|0|||
94632646|NCT02710045|324115069|FG001|Overall Study|Poor Attendance|1|||
94632647|NCT02710045|324115070|FG002|Overall Study|Poor Attendance|0|||
94632648|NCT02426892|324115071|FG000|Overall Study|Adverse Event|2|||
94632649|NCT02426892|324115071|FG000|Overall Study|Lack of Efficacy|17|||
94632650|NCT02426892|324115071|FG000|Overall Study|Withdrawal by Subject|1|||
94632651|NCT01359449|324115072|FG000|Overall Study|Lost to Follow-up|1|||
94632652|NCT01359449|324115073|FG001|Overall Study|Lost to Follow-up|0|||
94632653|NCT01359449|324115072|FG000|Overall Study|Protocol Violation|0|||
94632654|NCT01359449|324115073|FG001|Overall Study|Protocol Violation|2|||
94632655|NCT01359449|324115072|FG000|Overall Study|Withdrawal by Subject|3|||
94632656|NCT01359449|324115073|FG001|Overall Study|Withdrawal by Subject|2|||
94632657|NCT02393547|324115074|FG000|Overall Study|Adverse Event|2|||
94632658|NCT02393547|324115074|FG000|Overall Study|Withdrawal by Subject|3|||
94632659|NCT02393547|324115074|FG000|Overall Study|Lost to Follow-up|1|||
94632660|NCT00429104|324115075|FG000|Overall Study|Protocol Violation|1|||
94632661|NCT02707991|324115076|FG000|Overall Study|Protocol Violation|1|||
94632662|NCT02707991|324115077|FG001|Overall Study|Protocol Violation|0|||
94632663|NCT02707991|324115076|FG000|Overall Study|Became ineligible|0|||
94632664|NCT02707991|324115077|FG001|Overall Study|Became ineligible|1|||
94632665|NCT00514540|324115078|FG000|First-Line Chemo|Withdrawal by Subject|1|||
94632666|NCT00514540|324115078|FG000|First-Line Chemo|Protocol Violation|7|||
94632667|NCT00514540|324115078|FG000|Second-Line|Physician/Patient Decision|31|||
94632668|NCT01214629|324115079|FG000|Overall Study|Progressive Disease|1|||
94632669|NCT01214629|324115080|FG001|Overall Study|Progressive Disease|1|||
94632670|NCT01214629|324115081|FG002|Overall Study|Progressive Disease|0|||
94632671|NCT01214629|324115082|FG003|Overall Study|Progressive Disease|1|||
94632672|NCT01214629|324115083|FG004|Overall Study|Progressive Disease|2|||
94632673|NCT01214629|324115084|FG005|Overall Study|Progressive Disease|3|||
94632674|NCT01214629|324115085|FG006|Overall Study|Progressive Disease|1|||
94632675|NCT01214629|324115086|FG007|Overall Study|Progressive Disease|1|||
94632676|NCT01214629|324115087|FG008|Overall Study|Progressive Disease|1|||
94632677|NCT01214629|324115088|FG009|Overall Study|Progressive Disease|5|||
94632678|NCT01214629|324115089|FG010|Overall Study|Progressive Disease|1|||
94632679|NCT01214629|324115079|FG000|Overall Study|Adverse Event|0|||
94632680|NCT01214629|324115080|FG001|Overall Study|Adverse Event|0|||
94632681|NCT01214629|324115081|FG002|Overall Study|Adverse Event|0|||
94632682|NCT01214629|324115082|FG003|Overall Study|Adverse Event|1|||
94632683|NCT01214629|324115083|FG004|Overall Study|Adverse Event|0|||
94632684|NCT01214629|324115084|FG005|Overall Study|Adverse Event|1|||
94632685|NCT01214629|324115085|FG006|Overall Study|Adverse Event|0|||
94632686|NCT01214629|324115086|FG007|Overall Study|Adverse Event|0|||
94632687|NCT01214629|324115087|FG008|Overall Study|Adverse Event|0|||
94632688|NCT01214629|324115088|FG009|Overall Study|Adverse Event|1|||
94632689|NCT01214629|324115089|FG010|Overall Study|Adverse Event|0|||
94632690|NCT01214629|324115079|FG000|Overall Study|Physician Decision|0|||
94632691|NCT01214629|324115080|FG001|Overall Study|Physician Decision|0|||
94632692|NCT01214629|324115081|FG002|Overall Study|Physician Decision|0|||
94632693|NCT01214629|324115082|FG003|Overall Study|Physician Decision|0|||
94632694|NCT01214629|324115083|FG004|Overall Study|Physician Decision|0|||
94632695|NCT01214629|324115084|FG005|Overall Study|Physician Decision|0|||
94632696|NCT01214629|324115085|FG006|Overall Study|Physician Decision|0|||
94675979|NCT00701038|324267091|FG001|Overall Study|study amended pilot group of patients|4|||
94675980|NCT05099926|324267094|FG000|Overall Study|Lost to Follow-up|1|||
94675981|NCT02953938|324267095|FG000|Overall Study|Adverse Event|0|||
94675982|NCT02953938|324267096|FG001|Overall Study|Adverse Event|1|||
94675983|NCT02953938|324267095|FG000|Overall Study|Withdrawal by Subject|1|||
94675984|NCT02953938|324267096|FG001|Overall Study|Withdrawal by Subject|1|||
94675985|NCT02342886|324267097|FG000|Overall Study|Treatment non-compliance|1|||
94675986|NCT02342886|324267098|FG001|Overall Study|Treatment non-compliance|0|||
94675987|NCT02342886|324267099|FG002|Overall Study|Treatment non-compliance|0|||
94675988|NCT02342886|324267100|FG003|Overall Study|Treatment non-compliance|1|||
94675989|NCT02342886|324267101|FG004|Overall Study|Treatment non-compliance|0|||
94675990|NCT02342886|324267097|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
94675991|NCT02342886|324267098|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
94675992|NCT02342886|324267099|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
94675993|NCT02342886|324267100|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
94675994|NCT02342886|324267101|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
94675995|NCT02342886|324267097|FG000|Overall Study|Adverse event/specific toxicity|4|||
94675996|NCT02342886|324267098|FG001|Overall Study|Adverse event/specific toxicity|3|||
94675997|NCT02342886|324267099|FG002|Overall Study|Adverse event/specific toxicity|11|||
94675998|NCT02342886|324267100|FG003|Overall Study|Adverse event/specific toxicity|2|||
94675999|NCT02342886|324267101|FG004|Overall Study|Adverse event/specific toxicity|1|||
94676000|NCT02342886|324267097|FG000|Overall Study|Lost to Follow-up|1|||
94676001|NCT02342886|324267098|FG001|Overall Study|Lost to Follow-up|0|||
94676002|NCT02342886|324267099|FG002|Overall Study|Lost to Follow-up|0|||
94676003|NCT02342886|324267100|FG003|Overall Study|Lost to Follow-up|0|||
94676004|NCT02342886|324267101|FG004|Overall Study|Lost to Follow-up|0|||
94676005|NCT02342886|324267097|FG000|Overall Study|Death|1|||
94676006|NCT02342886|324267098|FG001|Overall Study|Death|2|||
94676007|NCT02342886|324267099|FG002|Overall Study|Death|1|||
94676008|NCT02342886|324267100|FG003|Overall Study|Death|0|||
94676009|NCT02342886|324267101|FG004|Overall Study|Death|1|||
94676010|NCT02342886|324267097|FG000|Overall Study|Withdrawal by Subject|0|||
94676011|NCT02342886|324267098|FG001|Overall Study|Withdrawal by Subject|1|||
94676012|NCT02342886|324267099|FG002|Overall Study|Withdrawal by Subject|0|||
94676013|NCT02342886|324267100|FG003|Overall Study|Withdrawal by Subject|1|||
94676014|NCT02342886|324267101|FG004|Overall Study|Withdrawal by Subject|0|||
94676015|NCT02342886|324267097|FG000|Overall Study|Investigator/sponsor decision|0|||
94676016|NCT02342886|324267098|FG001|Overall Study|Investigator/sponsor decision|2|||
94676017|NCT02342886|324267099|FG002|Overall Study|Investigator/sponsor decision|0|||
94676018|NCT02342886|324267100|FG003|Overall Study|Investigator/sponsor decision|3|||
94676019|NCT02342886|324267101|FG004|Overall Study|Investigator/sponsor decision|1|||
94676020|NCT02342886|324267097|FG000|Overall Study|Pregnancy|0|||
94676021|NCT02342886|324267098|FG001|Overall Study|Pregnancy|0|||
94676022|NCT02342886|324267099|FG002|Overall Study|Pregnancy|2|||
94676023|NCT02342886|324267100|FG003|Overall Study|Pregnancy|0|||
94676024|NCT02342886|324267101|FG004|Overall Study|Pregnancy|0|||
94676025|NCT02342886|324267097|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
94676026|NCT02342886|324267098|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
94676027|NCT02342886|324267099|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
94676028|NCT02342886|324267100|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
94676029|NCT02342886|324267101|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
94676030|NCT02342886|324267097|FG000|Overall Study|Protocol Violation|0|||
94676031|NCT02342886|324267098|FG001|Overall Study|Protocol Violation|0|||
94676032|NCT02342886|324267099|FG002|Overall Study|Protocol Violation|0|||
94676033|NCT02342886|324267100|FG003|Overall Study|Protocol Violation|2|||
94676034|NCT02342886|324267101|FG004|Overall Study|Protocol Violation|0|||
94676035|NCT03248375|324267107|FG000|Overall Study|Lost to Follow-up|5|||
94676036|NCT02703922|324267108|FG000|Overall Study|Death|5|||
94676037|NCT02703922|324267109|FG001|Overall Study|Death|8|||
94676038|NCT02703922|324267108|FG000|Overall Study|Lost to Follow-up|10|||
94676039|NCT02703922|324267109|FG001|Overall Study|Lost to Follow-up|10|||
94676040|NCT00633464|324267111|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
94676041|NCT00633464|324267112|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
94676042|NCT00633464|324267111|FG000|Overall Study|Never Treated (Randomized in error)|0|||
94676043|NCT00633464|324267112|FG001|Overall Study|Never Treated (Randomized in error)|1|||
94676044|NCT00394355|324267113|FG000|Overall Study|Adverse Event|10|||
94676045|NCT00394355|324267114|FG001|Overall Study|Adverse Event|6|||
94676046|NCT00394355|324267115|FG002|Overall Study|Adverse Event|7|||
94676047|NCT00394355|324267116|FG003|Overall Study|Adverse Event|8|||
94676048|NCT00394355|324267113|FG000|Overall Study|Did not meet protocol eligibility|1|||
94676049|NCT00394355|324267114|FG001|Overall Study|Did not meet protocol eligibility|5|||
94676050|NCT00394355|324267115|FG002|Overall Study|Did not meet protocol eligibility|4|||
94676051|NCT00394355|324267116|FG003|Overall Study|Did not meet protocol eligibility|2|||
94676052|NCT00394355|324267113|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
94676053|NCT00394355|324267114|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
94260076|NCT00261846|322745536|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
94260077|NCT00261846|322745537|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
94260078|NCT00325039|322745538|FG000|Overall Study|Lost to Follow-up|18|||
94260079|NCT00325039|322745539|FG001|Overall Study|Lost to Follow-up|14|||
94260080|NCT02147353|322745540|FG000|Overall Study|Lost to Follow-up|2|||
94260081|NCT02147353|322745541|FG001|Overall Study|Lost to Follow-up|0|||
94260082|NCT02147353|322745540|FG000|Overall Study|unable to make visits|4|||
94260083|NCT02147353|322745541|FG001|Overall Study|unable to make visits|0|||
94260084|NCT02147353|322745540|FG000|Overall Study|medication noncompliance|3|||
94260085|NCT02147353|322745541|FG001|Overall Study|medication noncompliance|0|||
94260086|NCT01009203|322745543|FG000|Overall Study|Withdrawal by Subject|1|||
94260087|NCT01009203|322745543|FG000|Overall Study|Adverse Event|5|||
94260088|NCT01009203|322745543|FG000|Overall Study|Treatment-unrelated death|1|||
94260089|NCT02974088|322745544|FG000|Overall Study|Lost to Follow-up|0|||
94260090|NCT02974088|322745545|FG001|Overall Study|Lost to Follow-up|2|||
94260091|NCT02974088|322745544|FG000|Overall Study|Adverse Event|0|||
94260092|NCT02974088|322745545|FG001|Overall Study|Adverse Event|1|||
94260093|NCT03093350|322745546|FG000|Overall Study|Death|1|||
94260094|NCT03093350|322745546|FG000|Overall Study|Signed consent, never began treartment|1|||
94260095|NCT01026454|322745553|FG000|Second Intervention|Pregnancy|1|||
94260096|NCT01026454|322745554|FG001|Second Intervention|Pregnancy|1|||
94260097|NCT02349360|322745555|FG000|Overall Study|Withdrawal by Subject|0|||
94260098|NCT02349360|322745556|FG001|Overall Study|Withdrawal by Subject|1|||
94260099|NCT01259284|322745557|FG000|Overall Study|Study Termination|2|||
94260100|NCT01259284|322745558|FG001|Overall Study|Study Termination|0|||
94260101|NCT01259284|322745559|FG002|Overall Study|Study Termination|0|||
94260102|NCT01326533|322745567|FG000|Overall Study|Lost to Follow-up|2|||
94260103|NCT01326533|322745568|FG001|Overall Study|Lost to Follow-up|0|||
94260104|NCT01326533|322745567|FG000|Overall Study|Withdrawal by Subject|1|||
94260105|NCT01326533|322745568|FG001|Overall Study|Withdrawal by Subject|0|||
94260106|NCT01326533|322745567|FG000|Overall Study|Adverse Event|1|||
94260107|NCT01326533|322745568|FG001|Overall Study|Adverse Event|0|||
94260108|NCT01106404|322745573|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
94260109|NCT01106404|322745574|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
94260110|NCT01106404|322745573|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
94260111|NCT01106404|322745574|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
94260112|NCT01106404|322745573|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
94260113|NCT01106404|322745574|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
94260114|NCT01106404|322745573|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
94260115|NCT01106404|322745574|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
94260116|NCT00775450|322745575|FG000|Overall Study|Serious Adverse Event|2|||
94260117|NCT00775450|322745576|FG001|Overall Study|Serious Adverse Event|0|||
94260118|NCT00775450|322745577|FG002|Overall Study|Serious Adverse Event|0|||
94260119|NCT00775450|322745578|FG003|Overall Study|Serious Adverse Event|0|||
94260120|NCT00775450|322745579|FG004|Overall Study|Serious Adverse Event|0|||
94260121|NCT00775450|322745575|FG000|Overall Study|Protocol Violation|0|||
94260122|NCT00775450|322745576|FG001|Overall Study|Protocol Violation|0|||
94260123|NCT00775450|322745577|FG002|Overall Study|Protocol Violation|0|||
94260124|NCT00775450|322745578|FG003|Overall Study|Protocol Violation|0|||
94260125|NCT00775450|322745579|FG004|Overall Study|Protocol Violation|1|||
94260126|NCT00775450|322745575|FG000|Overall Study|Withdrawal by Subject|1|||
94260127|NCT00775450|322745576|FG001|Overall Study|Withdrawal by Subject|0|||
94260128|NCT00775450|322745577|FG002|Overall Study|Withdrawal by Subject|0|||
94260129|NCT00775450|322745578|FG003|Overall Study|Withdrawal by Subject|0|||
94260130|NCT00775450|322745579|FG004|Overall Study|Withdrawal by Subject|1|||
94260131|NCT04640077|322745589|FG000|Period 1|Withdrawal by Subject|4|||
94632697|NCT01214629|324115086|FG007|Overall Study|Physician Decision|0|||
94632698|NCT01214629|324115087|FG008|Overall Study|Physician Decision|0|||
94632699|NCT01214629|324115088|FG009|Overall Study|Physician Decision|0|||
94632700|NCT01214629|324115089|FG010|Overall Study|Physician Decision|1|||
94632701|NCT01214629|324115079|FG000|Overall Study|Withdrawal by Subject|0|||
94632702|NCT01214629|324115080|FG001|Overall Study|Withdrawal by Subject|0|||
94632703|NCT01214629|324115081|FG002|Overall Study|Withdrawal by Subject|0|||
94632704|NCT01214629|324115082|FG003|Overall Study|Withdrawal by Subject|0|||
94260132|NCT04640077|322745590|FG001|Period 1|Withdrawal by Subject|5|||
94260133|NCT04640077|322745591|FG002|Period 1|Withdrawal by Subject|0|||
94260134|NCT04640077|322745589|FG000|Period 1|Adverse Event|1|||
94260135|NCT04640077|322745590|FG001|Period 1|Adverse Event|1|||
94260136|NCT04640077|322745591|FG002|Period 1|Adverse Event|0|||
94260137|NCT04640077|322745589|FG000|Period 1|Screen Failure|2|||
94632705|NCT01214629|324115083|FG004|Overall Study|Withdrawal by Subject|0|||
94632706|NCT01214629|324115084|FG005|Overall Study|Withdrawal by Subject|0|||
94260138|NCT04640077|322745590|FG001|Period 1|Screen Failure|0|||
94260139|NCT04640077|322745591|FG002|Period 1|Screen Failure|0|||
94260140|NCT04640077|322745589|FG000|Period 2|Withdrawal by Subject|0|||
94260141|NCT04640077|322745590|FG001|Period 2|Withdrawal by Subject|0|||
94260142|NCT04640077|322745591|FG002|Period 2|Withdrawal by Subject|18|||
94260143|NCT04640077|322745589|FG000|Period 2|Adverse Event|0|||
94362293|NCT03387423|323110651|FG000|Overall Study|Administrative Reason|166|||
94362294|NCT03387423|323110652|FG001|Overall Study|Administrative Reason|89|||
94362295|NCT03387423|323110653|FG002|Overall Study|Administrative Reason|17|||
94362296|NCT03387423|323110654|FG003|Overall Study|Administrative Reason|19|||
94362297|NCT03387423|323110651|FG000|Overall Study|Revocation Consent|76|||
94362298|NCT03387423|323110652|FG001|Overall Study|Revocation Consent|32|||
94362299|NCT03387423|323110653|FG002|Overall Study|Revocation Consent|3|||
94362300|NCT03387423|323110654|FG003|Overall Study|Revocation Consent|5|||
94362301|NCT01607398|323110655|FG000|Overall Study|Adverse Event|0|||
94362302|NCT01607398|323110656|FG001|Overall Study|Adverse Event|2|||
94362303|NCT01607398|323110655|FG000|Overall Study|Severe COPD|2|||
94362304|NCT01607398|323110656|FG001|Overall Study|Severe COPD|0|||
94362305|NCT05102162|323110664|FG000|Overall Study|Withdrawal by Subject|3|||
94362306|NCT05102162|323110665|FG001|Overall Study|Withdrawal by Subject|0|||
94362307|NCT05102162|323110664|FG000|Overall Study|Baseline cultures negative|4|||
94362308|NCT05102162|323110665|FG001|Overall Study|Baseline cultures negative|2|||
94362309|NCT05102162|323110664|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
94362310|NCT05102162|323110665|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
94362311|NCT05102162|323110664|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
94362312|NCT05102162|323110665|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
94362313|NCT01569594|323110666|FG000|Overall Study|Physician Decision|4|||
94362314|NCT01569594|323110666|FG000|Overall Study|Death|13|||
94362315|NCT01569594|323110666|FG000|Overall Study|Lost to Follow-up|22|||
94362316|NCT01569594|323110666|FG000|Overall Study|Adverse Event|2|||
94362317|NCT01569594|323110666|FG000|Overall Study|Withdrawal by Subject|13|||
94362318|NCT01569594|323110666|FG000|Overall Study|Other|4|||
94362319|NCT01569594|323110666|FG000|Overall Study|No ECM used|9|||
94362320|NCT00761969|323110669|FG000|Overall Study|Death|112|||
94362321|NCT00761969|323110670|FG001|Overall Study|Death|47|||
94362322|NCT00761969|323110669|FG000|Overall Study|Lost to Follow-up|88|||
94362323|NCT00761969|323110670|FG001|Overall Study|Lost to Follow-up|93|||
94362324|NCT00054275|323110674|FG000|Overall Study|Withdrawal by Subject|4|||
94362325|NCT00054275|323110674|FG000|Overall Study|Adverse Event|5|||
94362326|NCT00054275|323110674|FG000|Overall Study|Progressive disease in cycle 1|1|||
94362327|NCT00054275|323110674|FG000|Overall Study|Physician Decision|1|||
94362328|NCT00337727|323110677|FG000|Overall Study|Adverse Event|5|||
94362329|NCT00337727|323110678|FG001|Overall Study|Adverse Event|3|||
94362330|NCT00337727|323110677|FG000|Overall Study|Lost to Follow-up|5|||
94362331|NCT00337727|323110678|FG001|Overall Study|Lost to Follow-up|4|||
94362332|NCT00337727|323110677|FG000|Overall Study|Physician Decision|1|||
94362333|NCT00337727|323110678|FG001|Overall Study|Physician Decision|0|||
94362334|NCT00337727|323110677|FG000|Overall Study|Protocol Violation|4|||
94362335|NCT00337727|323110678|FG001|Overall Study|Protocol Violation|0|||
94362336|NCT00337727|323110677|FG000|Overall Study|Withdrawal by Subject|3|||
94362337|NCT00337727|323110678|FG001|Overall Study|Withdrawal by Subject|5|||
94362338|NCT04113746|323110679|FG000|Overall Study|Lost to Follow-up|4|||
94362339|NCT04113746|323110680|FG001|Overall Study|Lost to Follow-up|4|||
94362340|NCT02594384|323110681|FG000|Overall Study|Disease Progression|3|||
94362341|NCT02594384|323110682|FG001|Overall Study|Disease Progression|7|||
94362342|NCT02594384|323110683|FG002|Overall Study|Disease Progression|0|||
94362343|NCT02594384|323110684|FG003|Overall Study|Disease Progression|2|||
94362344|NCT02594384|323110685|FG004|Overall Study|Disease Progression|2|||
94362345|NCT02594384|323110686|FG005|Overall Study|Disease Progression|12|||
94362346|NCT02594384|323110687|FG006|Overall Study|Disease Progression|5|||
94362347|NCT02594384|323110688|FG007|Overall Study|Disease Progression|5|||
94362348|NCT02594384|323110681|FG000|Overall Study|Adverse Event|0|||
94362349|NCT02594384|323110682|FG001|Overall Study|Adverse Event|1|||
94362350|NCT02594384|323110683|FG002|Overall Study|Adverse Event|4|||
94362351|NCT02594384|323110684|FG003|Overall Study|Adverse Event|1|||
94362352|NCT02594384|323110685|FG004|Overall Study|Adverse Event|0|||
94362353|NCT02594384|323110686|FG005|Overall Study|Adverse Event|6|||
94632707|NCT01214629|324115085|FG006|Overall Study|Withdrawal by Subject|0|||
94632708|NCT01214629|324115086|FG007|Overall Study|Withdrawal by Subject|0|||
94632709|NCT01214629|324115087|FG008|Overall Study|Withdrawal by Subject|0|||
94632710|NCT01214629|324115088|FG009|Overall Study|Withdrawal by Subject|1|||
94632711|NCT01214629|324115089|FG010|Overall Study|Withdrawal by Subject|0|||
94632712|NCT02107482|324115090|FG000|Overall Study|inconveinence|2|||
94632713|NCT02107482|324115090|FG000|Overall Study|Lost to Follow-up|1|||
94632714|NCT02107482|324115090|FG000|Overall Study|Lack of Efficacy|1|||
94632715|NCT01085591|324115091|FG000|Overall Study|Adverse Event|0|||
94632716|NCT01085591|324115092|FG001|Overall Study|Adverse Event|1|||
94632717|NCT01085591|324115093|FG002|Overall Study|Adverse Event|3|||
94632718|NCT01085591|324115091|FG000|Overall Study|Physician Decision|1|||
94632719|NCT01085591|324115092|FG001|Overall Study|Physician Decision|0|||
94632720|NCT01085591|324115093|FG002|Overall Study|Physician Decision|1|||
94632721|NCT01085591|324115091|FG000|Overall Study|Withdrawal by Subject|0|||
94632722|NCT01085591|324115092|FG001|Overall Study|Withdrawal by Subject|2|||
94260144|NCT04640077|322745590|FG001|Period 2|Adverse Event|0|||
94260145|NCT04640077|322745591|FG002|Period 2|Adverse Event|6|||
94260146|NCT04640077|322745589|FG000|Period 2|Lost to Follow-up|0|||
94260147|NCT04640077|322745590|FG001|Period 2|Lost to Follow-up|0|||
94260148|NCT04640077|322745591|FG002|Period 2|Lost to Follow-up|2|||
94260149|NCT04640077|322745589|FG000|Period 2|Death|0|||
94260150|NCT04640077|322745590|FG001|Period 2|Death|0|||
94260151|NCT04640077|322745591|FG002|Period 2|Death|2|||
94260152|NCT04640077|322745589|FG000|Period 2|Progressive Disease|0|||
94260153|NCT04640077|322745590|FG001|Period 2|Progressive Disease|0|||
94260154|NCT04640077|322745591|FG002|Period 2|Progressive Disease|1|||
94260155|NCT04640077|322745589|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
94260156|NCT04640077|322745590|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
94260157|NCT04640077|322745591|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
94260158|NCT03291587|322745592|FG000|Overall Study|Lost to Follow-up|62|||
94260159|NCT03291587|322745593|FG001|Overall Study|Lost to Follow-up|43|||
94260160|NCT03291587|322745592|FG000|Overall Study|Refused to Answer|5|||
94260161|NCT03291587|322745593|FG001|Overall Study|Refused to Answer|2|||
94260162|NCT03291587|322745592|FG000|Overall Study|Death|2|||
94260163|NCT03291587|322745593|FG001|Overall Study|Death|4|||
94260164|NCT03291587|322745592|FG000|Overall Study|Not interested in participating|8|||
94260165|NCT03291587|322745593|FG001|Overall Study|Not interested in participating|6|||
94260166|NCT03291587|322745592|FG000|Overall Study|Too busy to participate|4|||
94260167|NCT03291587|322745593|FG001|Overall Study|Too busy to participate|2|||
94260168|NCT00547365|322745597|FG000|Overall Study|Physician Decision|1|||
94260169|NCT00547365|322745597|FG000|Overall Study|Lost to Follow-up|1|||
94260170|NCT00547365|322745597|FG000|Overall Study|Protocol Violation|2|||
94260171|NCT00547365|322745597|FG000|Overall Study|death (not related to study)|4|||
94260172|NCT01117857|322745598|FG000|Overall Study|Lost to Follow-up|4|||
94260173|NCT01117857|322745598|FG000|Overall Study|Withdrawal by Subject|4|||
94260174|NCT01117857|322745598|FG000|Overall Study|Physician Decision|1|||
94260175|NCT01163721|322745599|FG000|Overall Study|Adverse Event|5|||
94260176|NCT01163721|322745600|FG001|Overall Study|Adverse Event|6|||
94260177|NCT01163721|322745599|FG000|Overall Study|Withdrawal by Subject|3|||
94260178|NCT01163721|322745600|FG001|Overall Study|Withdrawal by Subject|4|||
94260179|NCT01163721|322745599|FG000|Overall Study|Lost to Follow-up|0|||
94260180|NCT01163721|322745600|FG001|Overall Study|Lost to Follow-up|1|||
94260181|NCT01163721|322745599|FG000|Overall Study|Physician Decision|0|||
94260182|NCT01163721|322745600|FG001|Overall Study|Physician Decision|1|||
94260183|NCT00364156|322745603|FG000|Overall Study|Withdrawal by Subject|73|||
94260184|NCT00364156|322745604|FG001|Overall Study|Withdrawal by Subject|80|||
94260185|NCT00364156|322745603|FG000|Overall Study|Protocol Violation|6|||
94260186|NCT00364156|322745604|FG001|Overall Study|Protocol Violation|1|||
94260187|NCT02477696|322745607|FG000|Overall Study|Death|89|||
94260188|NCT02477696|322745608|FG001|Overall Study|Death|106|||
94260189|NCT02477696|322745607|FG000|Overall Study|Lost to Follow-up|7|||
94260190|NCT02477696|322745608|FG001|Overall Study|Lost to Follow-up|5|||
94260191|NCT02477696|322745607|FG000|Overall Study|Withdrawal by Subject|37|||
94260192|NCT02477696|322745608|FG001|Overall Study|Withdrawal by Subject|34|||
94632723|NCT01085591|324115093|FG002|Overall Study|Withdrawal by Subject|1|||
94632724|NCT01085591|324115091|FG000|Overall Study|Lost to Follow-up|0|||
94632725|NCT01085591|324115092|FG001|Overall Study|Lost to Follow-up|1|||
94632726|NCT01085591|324115093|FG002|Overall Study|Lost to Follow-up|1|||
94260193|NCT02477696|322745607|FG000|Overall Study|Physician Decision|7|||
94260194|NCT02477696|322745608|FG001|Overall Study|Physician Decision|9|||
94260195|NCT02477696|322745607|FG000|Overall Study|Study terminated by sponsor|103|||
94260196|NCT02477696|322745608|FG001|Overall Study|Study terminated by sponsor|99|||
94260197|NCT02477696|322745607|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
94260198|NCT02477696|322745608|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
94260199|NCT02477696|322745607|FG000|Overall Study|Missing/Unknown|2|||
94260200|NCT02477696|322745608|FG001|Overall Study|Missing/Unknown|0|||
94260201|NCT01786174|322747193|FG000|Overall Study|Discontinued Study Drug|2|||
94260202|NCT01786174|322747194|FG001|Overall Study|Discontinued Study Drug|0|||
94260203|NCT00995020|322747195|FG000|Overall Study|margin analysis not performed|2|||
94260204|NCT00995020|322747196|FG001|Overall Study|margin analysis not performed|5|||
94260205|NCT00995020|322747195|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
94260206|NCT00995020|322747196|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
94260207|NCT02245672|322747197|FG000|Overall Study|Adverse Event|4|||
94260208|NCT02245672|322747198|FG001|Overall Study|Adverse Event|4|||
94260209|NCT02245672|322747199|FG002|Overall Study|Adverse Event|4|||
94260210|NCT02245672|322747197|FG000|Overall Study|Lost to Follow-up|3|||
94260211|NCT02245672|322747198|FG001|Overall Study|Lost to Follow-up|5|||
94260212|NCT02245672|322747199|FG002|Overall Study|Lost to Follow-up|1|||
94260213|NCT02245672|322747197|FG000|Overall Study|Withdrawal by Subject|6|||
94260214|NCT02245672|322747198|FG001|Overall Study|Withdrawal by Subject|3|||
94260215|NCT02245672|322747199|FG002|Overall Study|Withdrawal by Subject|0|||
94260216|NCT02245672|322747197|FG000|Overall Study|Randomized in error (not treated)|0|||
94260217|NCT02245672|322747198|FG001|Overall Study|Randomized in error (not treated)|1|||
94260218|NCT02245672|322747199|FG002|Overall Study|Randomized in error (not treated)|0|||
94260219|NCT01206777|322747200|FG000|Overall Study|Death|1|||
94260220|NCT01206777|322747200|FG000|Overall Study|Adverse Event|1|||
94260221|NCT00876694|322747203|FG000|Overall Study|Adverse Event|10|||
94260222|NCT00876694|322747204|FG001|Overall Study|Adverse Event|7|||
94260223|NCT00876694|322747203|FG000|Overall Study|Subject withdrew consent|6|||
94260224|NCT00876694|322747204|FG001|Overall Study|Subject withdrew consent|4|||
94260225|NCT00876694|322747203|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
94260226|NCT00876694|322747204|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94260227|NCT00876694|322747203|FG000|Overall Study|Abnormal test procedure result(s)|1|||
94260228|NCT00876694|322747204|FG001|Overall Study|Abnormal test procedure result(s)|0|||
94260229|NCT00876694|322747203|FG000|Overall Study|Administrative problems|1|||
94260230|NCT00876694|322747204|FG001|Overall Study|Administrative problems|1|||
94260231|NCT00876694|322747203|FG000|Overall Study|Death|1|||
94260232|NCT00876694|322747204|FG001|Overall Study|Death|0|||
94260233|NCT01215422|322747205|FG000|Overall Study|Relocation|1|||
94260234|NCT01215422|322747206|FG001|Overall Study|Relocation|0|||
94260235|NCT01215422|322747207|FG002|Overall Study|Relocation|0|||
94260236|NCT01215422|322747208|FG003|Overall Study|Relocation|0|||
94260237|NCT01215422|322747205|FG000|Overall Study|Failed intubations|0|||
94260238|NCT01215422|322747206|FG001|Overall Study|Failed intubations|0|||
94260239|NCT01215422|322747207|FG002|Overall Study|Failed intubations|3|||
94260240|NCT01215422|322747208|FG003|Overall Study|Failed intubations|8|||
94260241|NCT01215422|322747205|FG000|Overall Study|Did not complete all intubations|7|||
94260242|NCT01215422|322747206|FG001|Overall Study|Did not complete all intubations|0|||
94260243|NCT01215422|322747207|FG002|Overall Study|Did not complete all intubations|0|||
94632727|NCT01085591|324115091|FG000|Overall Study|Protocol Violation|1|||
94632728|NCT01085591|324115092|FG001|Overall Study|Protocol Violation|1|||
94632729|NCT01085591|324115093|FG002|Overall Study|Protocol Violation|1|||
94632730|NCT01085591|324115091|FG000|Overall Study|Other|0|||
94632731|NCT01085591|324115092|FG001|Overall Study|Other|1|||
94632732|NCT01085591|324115093|FG002|Overall Study|Other|0|||
94632733|NCT01085591|324115091|FG000|Overall Study|Not Properly Consented|1|||
94632734|NCT01085591|324115092|FG001|Overall Study|Not Properly Consented|0|||
94632735|NCT01085591|324115093|FG002|Overall Study|Not Properly Consented|0|||
94632736|NCT03715764|324115094|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
94632737|NCT03715764|324115095|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
94632738|NCT03715764|324115094|FG000|3 Month Follow-up|Lost to Follow-up|2|||
94632739|NCT03715764|324115095|FG001|3 Month Follow-up|Lost to Follow-up|2|||
94632740|NCT03715764|324115094|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
94632741|NCT03715764|324115095|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
94632742|NCT03715764|324115094|FG000|6 Month Follow-up|Lost to Follow-up|3|||
94632743|NCT03715764|324115095|FG001|6 Month Follow-up|Lost to Follow-up|0|||
94632744|NCT03715764|324115094|FG000|12 Month Follow-up|Lost to Follow-up|2|||
94632745|NCT03715764|324115095|FG001|12 Month Follow-up|Lost to Follow-up|3|||
94632746|NCT03715764|324115094|FG000|12 Month Follow-up|Pregnancy|0|||
94632747|NCT03715764|324115095|FG001|12 Month Follow-up|Pregnancy|1|||
94632748|NCT03715764|324115094|FG000|12 Month Follow-up|Surgery|2|||
94632749|NCT03715764|324115095|FG001|12 Month Follow-up|Surgery|0|||
94632750|NCT03715764|324115094|FG000|12 Month Follow-up|Wrong address|1|||
94632751|NCT03715764|324115095|FG001|12 Month Follow-up|Wrong address|0|||
94632752|NCT03715764|324115094|FG000|12 Month Follow-up|No symptoms|1|||
94632753|NCT03715764|324115095|FG001|12 Month Follow-up|No symptoms|0|||
94632754|NCT03715764|324115094|FG000|12 Month Follow-up|Changed primary care centre|0|||
94632755|NCT03715764|324115095|FG001|12 Month Follow-up|Changed primary care centre|1|||
94632756|NCT04128267|324115100|FG000|Overall Study|Withdrawal by Subject|6|||
94632757|NCT04128267|324115100|FG000|Overall Study|Death|2|||
94362354|NCT02594384|323110687|FG006|Overall Study|Adverse Event|1|||
94260244|NCT01215422|322747208|FG003|Overall Study|Did not complete all intubations|0|||
94260245|NCT00294554|322747211|FG000|Overall Study|Lack of Efficacy|0|||
94260246|NCT00294554|322747212|FG001|Overall Study|Lack of Efficacy|1|||
94260247|NCT00294554|322747211|FG000|Overall Study|Physician Decision|0|||
94260248|NCT00294554|322747212|FG001|Overall Study|Physician Decision|1|||
94260249|NCT01717989|322747213|FG000|Overall Study|Ineligibility determined|6|||
94260250|NCT01717989|322747213|FG000|Overall Study|Protocol deviation|6|||
94260251|NCT01717989|322747213|FG000|Overall Study|Withdrawal by Subject|11|||
94260252|NCT01717989|322747213|FG000|Overall Study|Physician Decision|2|||
94260253|NCT01717989|322747213|FG000|Overall Study|Lost to Follow-up|11|||
94260254|NCT01717989|322747213|FG000|Overall Study|Death|439|||
94260255|NCT01717989|322747213|FG000|Overall Study|Protocol-specified criteria|551|||
94260256|NCT01717989|322747213|FG000|Overall Study|Other|40|||
94260257|NCT01637623|322747217|FG000|Overall Study|Lost to Follow-up|0|||
94260258|NCT01637623|322747218|FG001|Overall Study|Lost to Follow-up|0|||
94260259|NCT01637623|322747219|FG002|Overall Study|Lost to Follow-up|2|||
94260260|NCT01637623|322747217|FG000|Overall Study|Physician Decision|1|||
94260261|NCT01637623|322747218|FG001|Overall Study|Physician Decision|0|||
94260262|NCT01637623|322747219|FG002|Overall Study|Physician Decision|1|||
94260263|NCT01207596|322747232|FG000|Overall Study|Physician Decision|4|||
94260264|NCT01207596|322747232|FG000|Overall Study|Lack of Efficacy|1|||
94260265|NCT01207596|322747232|FG000|Overall Study|Adverse Event|3|||
94260266|NCT01207596|322747232|FG000|Overall Study|Withdrawal by Subject|1|||
94260267|NCT04975438|322747233|FG000|Overall Study|Lost to Follow-up|1|||
94260268|NCT04975438|322747234|FG001|Overall Study|Lost to Follow-up|0|||
94260269|NCT04975438|322747235|FG002|Overall Study|Lost to Follow-up|1|||
94260270|NCT04975438|322747236|FG003|Overall Study|Lost to Follow-up|0|||
94260271|NCT04975438|322747233|FG000|Overall Study|Withdrawal by Subject|1|||
94260272|NCT04975438|322747234|FG001|Overall Study|Withdrawal by Subject|0|||
94260273|NCT04975438|322747235|FG002|Overall Study|Withdrawal by Subject|0|||
94260274|NCT04975438|322747236|FG003|Overall Study|Withdrawal by Subject|0|||
94260275|NCT00690820|322747237|FG000|Period 1|Withdrawal by Subject|0|||
94260276|NCT00690820|322747238|FG001|Period 1|Withdrawal by Subject|1|||
94260277|NCT00063154|322747239|FG000|Overall Study|Disease progression|27|||
94260278|NCT00063154|322747239|FG000|Overall Study|Adverse Event|2|||
94260279|NCT00063154|322747239|FG000|Overall Study|Physician Decision|10|||
94260280|NCT00063154|322747239|FG000|Overall Study|Death|3|||
94260281|NCT00063154|322747239|FG000|Overall Study|Reason unspecified|1|||
94260282|NCT00063154|322747239|FG000|Overall Study|Did not receive treatment|8|||
94260283|NCT00640016|322747242|FG000|Overall Study|Withdrawal by Subject|0|||
94260284|NCT00640016|322747243|FG001|Overall Study|Withdrawal by Subject|1|||
94260285|NCT00640016|322747244|FG002|Overall Study|Withdrawal by Subject|0|||
94260286|NCT00640016|322747245|FG003|Overall Study|Withdrawal by Subject|0|||
94260287|NCT00640016|322747242|FG000|Overall Study|Study termination|2|||
94260288|NCT00640016|322747243|FG001|Overall Study|Study termination|1|||
94260289|NCT00640016|322747244|FG002|Overall Study|Study termination|3|||
94260290|NCT00640016|322747245|FG003|Overall Study|Study termination|2|||
94260291|NCT00640016|322747242|FG000|Overall Study|Adverse Event|0|||
94260292|NCT00640016|322747243|FG001|Overall Study|Adverse Event|0|||
94260293|NCT00640016|322747244|FG002|Overall Study|Adverse Event|0|||
94260294|NCT00640016|322747245|FG003|Overall Study|Adverse Event|1|||
94260295|NCT03181451|322747260|FG000|Overall Study|Adverse Event|0|||
94260296|NCT03181451|322747261|FG001|Overall Study|Adverse Event|1|||
94260297|NCT03181451|322747262|FG002|Overall Study|Adverse Event|0|||
94260298|NCT03181451|322747260|FG000|Overall Study|Withdrawal by Subject|0|||
94260299|NCT03181451|322747261|FG001|Overall Study|Withdrawal by Subject|1|||
94260300|NCT03181451|322747262|FG002|Overall Study|Withdrawal by Subject|0|||
94260301|NCT01592864|322747270|FG000|Overall Study|Withdrawal by Subject|0|||
94260302|NCT01592864|322747271|FG001|Overall Study|Withdrawal by Subject|1|||
94260303|NCT01423253|322747272|FG000|Overall Study|Adverse Event|2|||
94260304|NCT01423253|322747272|FG000|Overall Study|Lack of Efficacy|2|||
94260305|NCT01423253|322747272|FG000|Overall Study|Lost to Follow-up|1|||
94260306|NCT01423253|322747272|FG000|Overall Study|Protocol Violation|2|||
94260307|NCT01423253|322747272|FG000|Overall Study|Withdrawal by Subject|2|||
94632758|NCT04128267|324115100|FG000|Overall Study|Disease progression|1|||
94260308|NCT04744285|322747276|FG000|Overall Study|Withdrawal by Subject|1|||
94260309|NCT04744285|322747277|FG001|Overall Study|Withdrawal by Subject|1|||
94260310|NCT04744285|322747278|FG002|Overall Study|Withdrawal by Subject|2|||
94260311|NCT04744285|322747279|FG003|Overall Study|Withdrawal by Subject|1|||
94260312|NCT00147823|322747282|FG000|Overall Study|Lost to Follow-up|6|||
94632759|NCT04128267|324115100|FG000|Overall Study|Participant had other medical issues|4|||
94260313|NCT00147823|322747283|FG001|Overall Study|Lost to Follow-up|12|||
94260314|NCT00147823|322747282|FG000|Overall Study|Physician Decision|1|||
94260315|NCT00147823|322747283|FG001|Overall Study|Physician Decision|0|||
94260316|NCT00147823|322747282|FG000|Overall Study|Withdrawal by Subject|0|||
94260317|NCT00147823|322747283|FG001|Overall Study|Withdrawal by Subject|1|||
94260318|NCT00147823|322747282|FG000|Overall Study|Did not receive vitoss due to infection|6|||
94260319|NCT00147823|322747283|FG001|Overall Study|Did not receive vitoss due to infection|2|||
94260320|NCT02804178|322747286|FG000|Overall Study|Adverse Event|1|||
94260321|NCT01032382|322747291|FG000|Overall Study|Disease dissemination|1|||
94260322|NCT01032382|322747292|FG001|Overall Study|Disease dissemination|1|||
94260323|NCT01032382|322747291|FG000|Overall Study|Treatment failure|3|||
94260324|NCT01032382|322747292|FG001|Overall Study|Treatment failure|1|||
94260325|NCT01032382|322747291|FG000|Overall Study|Index lesion relapse|1|||
94260326|NCT01032382|322747292|FG001|Overall Study|Index lesion relapse|3|||
94260327|NCT01774084|322747293|FG000|Overall Study|Personal reasons|1|||
94260328|NCT01774084|322747294|FG001|Overall Study|Personal reasons|0|||
94260329|NCT01290601|322747295|FG000|Overall Study|Adverse Event|0|||
94260330|NCT01290601|322747296|FG001|Overall Study|Adverse Event|2|||
94260331|NCT01290601|322747297|FG002|Overall Study|Adverse Event|0|||
94260332|NCT01290601|322747298|FG003|Overall Study|Adverse Event|0|||
94260333|NCT01290601|322747295|FG000|Overall Study|Lack of Efficacy|2|||
94260334|NCT01290601|322747296|FG001|Overall Study|Lack of Efficacy|1|||
94260335|NCT01290601|322747297|FG002|Overall Study|Lack of Efficacy|0|||
94260336|NCT01290601|322747298|FG003|Overall Study|Lack of Efficacy|0|||
94260337|NCT01290601|322747295|FG000|Overall Study|Lost to Follow-up|7|||
94260338|NCT01290601|322747296|FG001|Overall Study|Lost to Follow-up|2|||
94260339|NCT01290601|322747297|FG002|Overall Study|Lost to Follow-up|0|||
94260340|NCT01290601|322747298|FG003|Overall Study|Lost to Follow-up|0|||
94260341|NCT01290601|322747295|FG000|Overall Study|Other|1|||
94260342|NCT01290601|322747296|FG001|Overall Study|Other|0|||
94260343|NCT01290601|322747297|FG002|Overall Study|Other|0|||
94260344|NCT01290601|322747298|FG003|Overall Study|Other|0|||
94260345|NCT01290601|322747295|FG000|Overall Study|Protocol Violation|1|||
94260346|NCT01290601|322747296|FG001|Overall Study|Protocol Violation|0|||
94260347|NCT01290601|322747297|FG002|Overall Study|Protocol Violation|0|||
94260348|NCT01290601|322747298|FG003|Overall Study|Protocol Violation|0|||
94260349|NCT01749540|322747299|FG000|Overall Study|Protocol Violation|0|||
94260350|NCT01749540|322747300|FG001|Overall Study|Protocol Violation|0|||
94260351|NCT01749540|322747301|FG002|Overall Study|Protocol Violation|0|||
94260352|NCT01749540|322747302|FG003|Overall Study|Protocol Violation|0|||
94260353|NCT01749540|322747303|FG004|Overall Study|Protocol Violation|0|||
94260354|NCT01749540|322747304|FG005|Overall Study|Protocol Violation|1|||
94260355|NCT01749540|322747305|FG006|Overall Study|Protocol Violation|1|||
94260356|NCT01749540|322747299|FG000|Overall Study|Withdrawal by Subject|0|||
94260357|NCT01749540|322747300|FG001|Overall Study|Withdrawal by Subject|0|||
94260358|NCT01749540|322747301|FG002|Overall Study|Withdrawal by Subject|0|||
94260359|NCT01749540|322747302|FG003|Overall Study|Withdrawal by Subject|1|||
94260360|NCT01749540|322747303|FG004|Overall Study|Withdrawal by Subject|0|||
94260361|NCT01749540|322747304|FG005|Overall Study|Withdrawal by Subject|0|||
94260362|NCT01749540|322747305|FG006|Overall Study|Withdrawal by Subject|0|||
94260363|NCT01749540|322747299|FG000|Overall Study|Initiated into extension study A536-06|0|||
94260364|NCT01749540|322747300|FG001|Overall Study|Initiated into extension study A536-06|0|||
94260365|NCT01749540|322747301|FG002|Overall Study|Initiated into extension study A536-06|0|||
94260366|NCT01749540|322747302|FG003|Overall Study|Initiated into extension study A536-06|0|||
94260367|NCT01749540|322747303|FG004|Overall Study|Initiated into extension study A536-06|0|||
94260368|NCT01749540|322747304|FG005|Overall Study|Initiated into extension study A536-06|2|||
94260369|NCT01749540|322747305|FG006|Overall Study|Initiated into extension study A536-06|24|||
94260370|NCT01055262|322747306|FG000|Overall Study|Adverse Event|5|||
94260371|NCT01055262|322747306|FG000|Overall Study|Protocol Violation|3|||
94260372|NCT01055262|322747306|FG000|Overall Study|Uncooperativeness|1|||
94260373|NCT00894686|322747307|FG000|Overall Study|Withdrawal by Subject|50|||
94260374|NCT00894686|322747307|FG000|Overall Study|Physician Decision|1|||
94260375|NCT00894686|322747307|FG000|Overall Study|Other|5|||
94260376|NCT01323634|322747308|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
94260377|NCT01323634|322747309|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
94260378|NCT01323634|322747310|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
94260379|NCT01323634|322747308|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
94260380|NCT01323634|322747309|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
94260381|NCT01323634|322747310|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
94260382|NCT01323634|322747308|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
94260383|NCT01323634|322747309|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
94260384|NCT01323634|322747310|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
94260385|NCT01323634|322747308|FG000|2-week Run-in Period|Physician Decision|5|||
94260386|NCT01323634|322747309|FG001|2-week Run-in Period|Physician Decision|0|||
94260387|NCT01323634|322747310|FG002|2-week Run-in Period|Physician Decision|0|||
94260388|NCT01323634|322747308|FG000|2-week Run-in Period|Protocol Violation|1|||
94260389|NCT01323634|322747309|FG001|2-week Run-in Period|Protocol Violation|0|||
94260390|NCT01323634|322747310|FG002|2-week Run-in Period|Protocol Violation|0|||
94260391|NCT01323634|322747308|FG000|2-week Run-in Period|Adverse Event|1|||
94260392|NCT01323634|322747309|FG001|2-week Run-in Period|Adverse Event|0|||
94260393|NCT01323634|322747310|FG002|2-week Run-in Period|Adverse Event|0|||
94260394|NCT01323634|322747308|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
94260395|NCT01323634|322747309|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
94260396|NCT01323634|322747310|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
94260397|NCT01323634|322747308|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
94260398|NCT01323634|322747309|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
94260399|NCT01323634|322747310|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
94260400|NCT01323634|322747308|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
94260401|NCT01323634|322747309|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
94260402|NCT01323634|322747310|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
94260403|NCT01323634|322747308|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
94260404|NCT01323634|322747309|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
94260405|NCT01323634|322747310|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
94260406|NCT01323634|322747308|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
94260407|NCT01323634|322747309|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
94260408|NCT01323634|322747310|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
94260409|NCT01323634|322747308|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
94260410|NCT01323634|322747309|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
94260411|NCT01323634|322747310|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
94260412|NCT01323634|322747308|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
94260413|NCT01323634|322747309|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
94260414|NCT01323634|322747310|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
94260415|NCT00381303|322747311|FG000|Overall Study|Lost to Follow-up|25|||
94260416|NCT00381303|322747312|FG001|Overall Study|Lost to Follow-up|9|||
94260417|NCT00381303|322747311|FG000|Overall Study|AE/HIV-related event|22|||
94260418|NCT00381303|322747312|FG001|Overall Study|AE/HIV-related event|6|||
94260419|NCT00381303|322747311|FG000|Overall Study|Non-Adherence|13|||
94260420|NCT00381303|322747312|FG001|Overall Study|Non-Adherence|6|||
94260421|NCT00381303|322747311|FG000|Overall Study|Withdrawal by Subject|13|||
94260422|NCT00381303|322747312|FG001|Overall Study|Withdrawal by Subject|6|||
94260423|NCT00381303|322747311|FG000|Overall Study|Virologic failure|6|||
94260424|NCT00381303|322747312|FG001|Overall Study|Virologic failure|4|||
94260425|NCT00381303|322747311|FG000|Overall Study|Ineligible to continue the trial|2|||
94260426|NCT00381303|322747312|FG001|Overall Study|Ineligible to continue the trial|1|||
94260427|NCT00381303|322747311|FG000|Overall Study|Pregnancy|2|||
94260428|NCT00381303|322747312|FG001|Overall Study|Pregnancy|0|||
94260429|NCT00381303|322747311|FG000|Overall Study|Physician Decision|1|||
94632760|NCT04128267|324115100|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
94632761|NCT01472081|324115101|FG000|Overall Study|Continuing treatment at time of analysis|1|||
94632762|NCT01472081|324115102|FG001|Overall Study|Continuing treatment at time of analysis|4|||
94632763|NCT01472081|324115103|FG002|Overall Study|Continuing treatment at time of analysis|1|||
94632764|NCT01472081|324115104|FG003|Overall Study|Continuing treatment at time of analysis|8|||
94632765|NCT01472081|324115105|FG004|Overall Study|Continuing treatment at time of analysis|9|||
94632766|NCT01472081|324115106|FG005|Overall Study|Continuing treatment at time of analysis|0|||
94632767|NCT01472081|324115101|FG000|Overall Study|Disease Progression|4|||
94632768|NCT01472081|324115102|FG001|Overall Study|Disease Progression|10|||
94632769|NCT01472081|324115103|FG002|Overall Study|Disease Progression|12|||
94632770|NCT01472081|324115104|FG003|Overall Study|Disease Progression|31|||
94632771|NCT01472081|324115105|FG004|Overall Study|Disease Progression|22|||
94632772|NCT01472081|324115106|FG005|Overall Study|Disease Progression|3|||
94632773|NCT01472081|324115101|FG000|Overall Study|Study drug toxicity|2|||
94632774|NCT01472081|324115102|FG001|Overall Study|Study drug toxicity|9|||
94632775|NCT01472081|324115103|FG002|Overall Study|Study drug toxicity|4|||
94632776|NCT01472081|324115104|FG003|Overall Study|Study drug toxicity|6|||
94632777|NCT01472081|324115105|FG004|Overall Study|Study drug toxicity|13|||
94632778|NCT01472081|324115106|FG005|Overall Study|Study drug toxicity|2|||
94632779|NCT01472081|324115101|FG000|Overall Study|Death|0|||
94632780|NCT01472081|324115102|FG001|Overall Study|Death|0|||
94632781|NCT01472081|324115103|FG002|Overall Study|Death|0|||
94632782|NCT01472081|324115104|FG003|Overall Study|Death|0|||
94632783|NCT01472081|324115105|FG004|Overall Study|Death|1|||
94632784|NCT01472081|324115106|FG005|Overall Study|Death|0|||
94632785|NCT01472081|324115101|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
94632786|NCT01472081|324115102|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
94632787|NCT01472081|324115103|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
94260430|NCT00381303|322747312|FG001|Overall Study|Physician Decision|0|||
94260431|NCT00381303|322747311|FG000|Overall Study|Physician's decision to close the site|3|||
94632788|NCT01472081|324115104|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
94632789|NCT01472081|324115105|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
94632790|NCT01472081|324115106|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
94632791|NCT01472081|324115101|FG000|Overall Study|Withdrawal by Subject|0|||
94632792|NCT01472081|324115102|FG001|Overall Study|Withdrawal by Subject|0|||
94632793|NCT01472081|324115103|FG002|Overall Study|Withdrawal by Subject|0|||
94632794|NCT01472081|324115104|FG003|Overall Study|Withdrawal by Subject|0|||
94632795|NCT01472081|324115105|FG004|Overall Study|Withdrawal by Subject|0|||
94260432|NCT00381303|322747312|FG001|Overall Study|Physician's decision to close the site|1|||
94260433|NCT00381303|322747311|FG000|Overall Study|Subject moved out of state|2|||
94260434|NCT00381303|322747312|FG001|Overall Study|Subject moved out of state|0|||
94362355|NCT02594384|323110688|FG007|Overall Study|Adverse Event|1|||
94362356|NCT02594384|323110681|FG000|Overall Study|Withdrawal by Subject|0|||
94362357|NCT02594384|323110682|FG001|Overall Study|Withdrawal by Subject|0|||
94362358|NCT02594384|323110683|FG002|Overall Study|Withdrawal by Subject|0|||
94362359|NCT02594384|323110684|FG003|Overall Study|Withdrawal by Subject|1|||
94362360|NCT02594384|323110685|FG004|Overall Study|Withdrawal by Subject|0|||
94362361|NCT02594384|323110686|FG005|Overall Study|Withdrawal by Subject|0|||
94260435|NCT00381303|322747311|FG000|Overall Study|Subject taking too many different meds|1|||
94260436|NCT00381303|322747312|FG001|Overall Study|Subject taking too many different meds|0|||
94260437|NCT00381303|322747311|FG000|Overall Study|No virologic response by week 12|1|||
94362362|NCT02594384|323110687|FG006|Overall Study|Withdrawal by Subject|0|||
94362363|NCT02594384|323110688|FG007|Overall Study|Withdrawal by Subject|1|||
94362364|NCT02594384|323110681|FG000|Overall Study|Physician Decision|0|||
94362365|NCT02594384|323110682|FG001|Overall Study|Physician Decision|0|||
94362366|NCT02594384|323110683|FG002|Overall Study|Physician Decision|0|||
94362367|NCT02594384|323110684|FG003|Overall Study|Physician Decision|0|||
94362368|NCT02594384|323110685|FG004|Overall Study|Physician Decision|0|||
94362369|NCT02594384|323110686|FG005|Overall Study|Physician Decision|1|||
94362370|NCT02594384|323110687|FG006|Overall Study|Physician Decision|2|||
94362371|NCT02594384|323110688|FG007|Overall Study|Physician Decision|0|||
94362372|NCT02594384|323110681|FG000|Overall Study|Progressive Leukocytosis|0|||
94362373|NCT02594384|323110682|FG001|Overall Study|Progressive Leukocytosis|0|||
94362374|NCT02594384|323110683|FG002|Overall Study|Progressive Leukocytosis|1|||
94260438|NCT00381303|322747312|FG001|Overall Study|No virologic response by week 12|0|||
94260439|NCT00381303|322747311|FG000|Overall Study|Subject was too busy for appointments|1|||
94362375|NCT02594384|323110684|FG003|Overall Study|Progressive Leukocytosis|0|||
94362376|NCT02594384|323110685|FG004|Overall Study|Progressive Leukocytosis|0|||
94362377|NCT02594384|323110686|FG005|Overall Study|Progressive Leukocytosis|0|||
94362378|NCT02594384|323110687|FG006|Overall Study|Progressive Leukocytosis|0|||
94362379|NCT02594384|323110688|FG007|Overall Study|Progressive Leukocytosis|0|||
94362380|NCT02594384|323110681|FG000|Overall Study|Lack of Efficacy|0|||
94362381|NCT02594384|323110682|FG001|Overall Study|Lack of Efficacy|0|||
94362382|NCT02594384|323110683|FG002|Overall Study|Lack of Efficacy|0|||
94362383|NCT02594384|323110684|FG003|Overall Study|Lack of Efficacy|0|||
94362384|NCT02594384|323110685|FG004|Overall Study|Lack of Efficacy|1|||
94362385|NCT02594384|323110686|FG005|Overall Study|Lack of Efficacy|0|||
94362386|NCT02594384|323110687|FG006|Overall Study|Lack of Efficacy|0|||
94362387|NCT02594384|323110688|FG007|Overall Study|Lack of Efficacy|0|||
94362388|NCT02594384|323110681|FG000|Overall Study|Substantial noncompliance|0|||
94362389|NCT02594384|323110682|FG001|Overall Study|Substantial noncompliance|0|||
94362390|NCT02594384|323110683|FG002|Overall Study|Substantial noncompliance|0|||
94362391|NCT02594384|323110684|FG003|Overall Study|Substantial noncompliance|0|||
94362392|NCT02594384|323110685|FG004|Overall Study|Substantial noncompliance|0|||
94362393|NCT02594384|323110686|FG005|Overall Study|Substantial noncompliance|0|||
94362394|NCT02594384|323110687|FG006|Overall Study|Substantial noncompliance|1|||
94362395|NCT02594384|323110688|FG007|Overall Study|Substantial noncompliance|0|||
94362396|NCT02861534|323110689|FG000|Overall Study|Death|541|||
94362397|NCT02861534|323110690|FG001|Overall Study|Death|552|||
94362398|NCT02861534|323110689|FG000|Overall Study|Lost to Follow-up|14|||
94632796|NCT01472081|324115106|FG005|Overall Study|Withdrawal by Subject|1|||
94632797|NCT01472081|324115101|FG000|Overall Study|Poor/non-compliance|0|||
94260440|NCT00381303|322747312|FG001|Overall Study|Subject was too busy for appointments|0|||
94260441|NCT00381303|322747311|FG000|Overall Study|Subject did not continue visits|1|||
94260442|NCT00381303|322747312|FG001|Overall Study|Subject did not continue visits|0|||
94260443|NCT00381303|322747311|FG000|Overall Study|Subject primary physician's decision|1|||
94632798|NCT01472081|324115102|FG001|Overall Study|Poor/non-compliance|0|||
94632799|NCT01472081|324115103|FG002|Overall Study|Poor/non-compliance|1|||
94632800|NCT01472081|324115104|FG003|Overall Study|Poor/non-compliance|0|||
94632801|NCT01472081|324115105|FG004|Overall Study|Poor/non-compliance|1|||
94632802|NCT01472081|324115106|FG005|Overall Study|Poor/non-compliance|0|||
94632803|NCT01472081|324115101|FG000|Overall Study|No longer meets study criteria|0|||
94632804|NCT01472081|324115102|FG001|Overall Study|No longer meets study criteria|0|||
94632805|NCT01472081|324115103|FG002|Overall Study|No longer meets study criteria|1|||
94632806|NCT01472081|324115104|FG003|Overall Study|No longer meets study criteria|0|||
94260444|NCT00381303|322747312|FG001|Overall Study|Subject primary physician's decision|0|||
94260445|NCT01966471|322747315|FG000|Overall Study|Death|44|||
94362399|NCT02861534|323110690|FG001|Overall Study|Lost to Follow-up|14|||
94362400|NCT02861534|323110689|FG000|Overall Study|Site Terminated by Sponsor|4|||
94362401|NCT02861534|323110690|FG001|Overall Study|Site Terminated by Sponsor|3|||
94362402|NCT02861534|323110689|FG000|Overall Study|Withdrawal by Subject|15|||
94362403|NCT02861534|323110690|FG001|Overall Study|Withdrawal by Subject|18|||
94362404|NCT06067191|323110697|FG000|Overall Study|Withdrawal by Subject|0|||
94362405|NCT06067191|323110698|FG001|Overall Study|Withdrawal by Subject|1|||
94362406|NCT00769132|323110702|FG000|Period 1|Adverse Event|1|||
94362407|NCT00769132|323110703|FG001|Period 1|Adverse Event|0|||
94362408|NCT00769132|323110704|FG002|Period 1|Adverse Event|0|||
94260446|NCT01966471|322747316|FG001|Overall Study|Death|56|||
94260447|NCT01966471|322747315|FG000|Overall Study|Lost to Follow-up|46|||
94260448|NCT01966471|322747316|FG001|Overall Study|Lost to Follow-up|39|||
94260449|NCT01966471|322747315|FG000|Overall Study|Various reasons|4|||
94260450|NCT01966471|322747316|FG001|Overall Study|Various reasons|4|||
94260451|NCT01966471|322747315|FG000|Overall Study|Physician Decision|7|||
94260452|NCT01966471|322747316|FG001|Overall Study|Physician Decision|5|||
94260453|NCT01966471|322747315|FG000|Overall Study|Study Terminated By Sponsor|758|||
94260454|NCT01966471|322747316|FG001|Overall Study|Study Terminated By Sponsor|773|||
94260455|NCT01966471|322747315|FG000|Overall Study|Withdrawal by Subject|59|||
94260456|NCT01966471|322747316|FG001|Overall Study|Withdrawal by Subject|51|||
94260457|NCT06097273|322747318|FG000|Overall Study|Death|2|||
94260458|NCT06097273|322747319|FG001|Overall Study|Death|1|||
94260459|NCT06097273|322747320|FG002|Overall Study|Death|2|||
94260460|NCT06097273|322747321|FG003|Overall Study|Death|2|||
94260461|NCT06097273|322747318|FG000|Overall Study|Lost to Follow-up|27|||
94260462|NCT06097273|322747319|FG001|Overall Study|Lost to Follow-up|18|||
94260463|NCT06097273|322747320|FG002|Overall Study|Lost to Follow-up|36|||
94260464|NCT06097273|322747321|FG003|Overall Study|Lost to Follow-up|31|||
94260465|NCT06097273|322747318|FG000|Overall Study|Physician Decision|0|||
94260466|NCT06097273|322747319|FG001|Overall Study|Physician Decision|1|||
94260467|NCT06097273|322747320|FG002|Overall Study|Physician Decision|0|||
94260468|NCT06097273|322747321|FG003|Overall Study|Physician Decision|3|||
94260469|NCT06097273|322747318|FG000|Overall Study|Protocol Violation|1|||
94260470|NCT06097273|322747319|FG001|Overall Study|Protocol Violation|1|||
94260471|NCT06097273|322747320|FG002|Overall Study|Protocol Violation|2|||
94260472|NCT06097273|322747321|FG003|Overall Study|Protocol Violation|1|||
94260473|NCT06097273|322747318|FG000|Overall Study|Withdrawal by Subject|14|||
94260474|NCT06097273|322747319|FG001|Overall Study|Withdrawal by Subject|11|||
94260475|NCT06097273|322747320|FG002|Overall Study|Withdrawal by Subject|14|||
94260476|NCT06097273|322747321|FG003|Overall Study|Withdrawal by Subject|15|||
94260477|NCT06097273|322747318|FG000|Overall Study|Other Than Specified|7|||
94260478|NCT06097273|322747319|FG001|Overall Study|Other Than Specified|3|||
94260479|NCT06097273|322747320|FG002|Overall Study|Other Than Specified|11|||
94260480|NCT06097273|322747321|FG003|Overall Study|Other Than Specified|6|||
94260481|NCT05460273|322747322|FG000|Overall Study|Death|43|||
94260482|NCT05460273|322747323|FG001|Overall Study|Death|9|||
94260483|NCT05460273|322747322|FG000|Overall Study|Lost to Follow-up|7|||
94260484|NCT05460273|322747323|FG001|Overall Study|Lost to Follow-up|0|||
94260485|NCT05460273|322747322|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
94260486|NCT05460273|322747323|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
94260487|NCT04124614|322747325|FG000|Placebo Run-in Period|Not Randomized|34|||
94260488|NCT04124614|322747326|FG001|Placebo Run-in Period|Not Randomized|0|||
94260489|NCT04124614|322747327|FG002|Placebo Run-in Period|Not Randomized|0|||
94260490|NCT04124614|322747325|FG000|Double Blind Treatment Period|Adverse Event|0|||
94260491|NCT04124614|322747326|FG001|Double Blind Treatment Period|Adverse Event|7|||
94260492|NCT04124614|322747327|FG002|Double Blind Treatment Period|Adverse Event|22|||
94260493|NCT04124614|322747325|FG000|Double Blind Treatment Period|Death|0|||
94260494|NCT04124614|322747326|FG001|Double Blind Treatment Period|Death|0|||
94260495|NCT04124614|322747327|FG002|Double Blind Treatment Period|Death|1|||
94260496|NCT04124614|322747325|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
94260497|NCT04124614|322747326|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
94260498|NCT04124614|322747327|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
94260499|NCT04124614|322747325|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
94260500|NCT04124614|322747326|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
94260501|NCT04124614|322747327|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
94260502|NCT04124614|322747325|FG000|Double Blind Treatment Period|Physician Decision|0|||
94260503|NCT04124614|322747326|FG001|Double Blind Treatment Period|Physician Decision|0|||
94260504|NCT04124614|322747327|FG002|Double Blind Treatment Period|Physician Decision|3|||
94260505|NCT04124614|322747325|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
94260506|NCT04124614|322747326|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
94260507|NCT04124614|322747327|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
94260508|NCT04124614|322747325|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
94260509|NCT04124614|322747326|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
94260510|NCT04124614|322747327|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
94260511|NCT04124614|322747325|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
94260512|NCT04124614|322747326|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
94260513|NCT04124614|322747327|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
94260514|NCT01340196|322748480|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
94260515|NCT02101034|322748483|FG000|Overall Study|Enrolled but did not start treatment|0|||
94260516|NCT02101034|322748484|FG001|Overall Study|Enrolled but did not start treatment|0|||
94260517|NCT02101034|322748485|FG002|Overall Study|Enrolled but did not start treatment|1|||
94260518|NCT02101034|322748486|FG003|Overall Study|Enrolled but did not start treatment|0|||
94260519|NCT02101034|322748487|FG004|Overall Study|Enrolled but did not start treatment|0|||
94260520|NCT01101477|322748489|FG000|Overall Study|Protocol Violation|5|||
94260521|NCT01101477|322748490|FG001|Overall Study|Protocol Violation|3|||
94260522|NCT01101477|322748491|FG002|Overall Study|Protocol Violation|1|||
94260523|NCT02720536|322748492|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
94260524|NCT02720536|322748492|FG000|Overall Study|PR - pregnancy|2|||
94260525|NCT02720536|322748492|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
94260526|NCT02720536|322748492|FG000|Overall Study|PR - death|1|||
94260527|NCT02720536|322748492|FG000|Overall Study|PR - adverse event|1|||
94260528|NCT02720536|322748492|FG000|Overall Study|PR - abnormal lab value(s)|1|||
94260529|NCT02720536|322748492|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
94260530|NCT02382016|322748496|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
94260531|NCT02382016|322748497|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
94260532|NCT02382016|322748496|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
94260533|NCT02382016|322748497|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
94260534|NCT02382016|322748496|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
94260535|NCT02382016|322748497|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
94260536|NCT02382016|322748496|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
94260537|NCT02382016|322748497|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
94260538|NCT02382016|322748496|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
94260539|NCT02382016|322748497|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
94260540|NCT02382016|322748496|FG000|Open-label (OL) Treatment Period|Death|4|||
94260541|NCT02382016|322748497|FG001|Open-label (OL) Treatment Period|Death|0|||
94260542|NCT02382016|322748496|FG000|OL Extension Period|Physician Decision|3|||
94260543|NCT02382016|322748497|FG001|OL Extension Period|Physician Decision|0|||
94260544|NCT02382016|322748496|FG000|OL Extension Period|Death|2|||
94260545|NCT02382016|322748497|FG001|OL Extension Period|Death|0|||
94260546|NCT02382016|322748496|FG000|OL Extension Period|Withdrawal by Subject|1|||
94260547|NCT02382016|322748497|FG001|OL Extension Period|Withdrawal by Subject|0|||
94260548|NCT00730171|322748500|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
94260549|NCT00730171|322748500|FG000|Overall Study|Adverse Event|193|||
94260550|NCT00730171|322748500|FG000|Overall Study|Protocol Violation|48|||
94260551|NCT00730171|322748500|FG000|Overall Study|Withdrawal by Subject|202|||
94260552|NCT00730171|322748500|FG000|Overall Study|Lost to Follow-up|121|||
94260553|NCT00730171|322748500|FG000|Overall Study|Insufficient Therapeutic Response|141|||
94260554|NCT00730171|322748500|FG000|Overall Study|Other|61|||
94260555|NCT01177787|322748505|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
94260556|NCT01177787|322748505|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
94260557|NCT01177787|322748505|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
94260558|NCT02634346|322748515|FG000|Overall Study|Withdrawal by Subject|8|||
94260559|NCT02634346|322748516|FG001|Overall Study|Withdrawal by Subject|9|||
94260560|NCT02634346|322748517|FG002|Overall Study|Withdrawal by Subject|8|||
94260561|NCT02634346|322748515|FG000|Overall Study|Adverse Event|2|||
94260562|NCT02634346|322748516|FG001|Overall Study|Adverse Event|2|||
94260563|NCT02634346|322748517|FG002|Overall Study|Adverse Event|7|||
94260564|NCT02634346|322748515|FG000|Overall Study|Lack of Efficacy|1|||
94260565|NCT02634346|322748516|FG001|Overall Study|Lack of Efficacy|2|||
94260566|NCT02634346|322748517|FG002|Overall Study|Lack of Efficacy|8|||
94260567|NCT02634346|322748515|FG000|Overall Study|Lost to Follow-up|1|||
94260568|NCT02634346|322748516|FG001|Overall Study|Lost to Follow-up|0|||
94260569|NCT02634346|322748517|FG002|Overall Study|Lost to Follow-up|0|||
94260570|NCT02634346|322748515|FG000|Overall Study|Protocol Violation|0|||
94260571|NCT02634346|322748516|FG001|Overall Study|Protocol Violation|1|||
94260572|NCT02634346|322748517|FG002|Overall Study|Protocol Violation|0|||
94260573|NCT02170389|322748518|FG000|Overall Study|Study terminated prior to start of treat|1|||
94260574|NCT00718640|322748523|FG000|Overall Study|Adverse Event|4|||
94260575|NCT00718640|322748523|FG000|Overall Study|Death|1|||
94260576|NCT00718640|322748523|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
94260577|NCT03952806|322748524|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
94260578|NCT03952806|322748525|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
94260579|NCT03952806|322748524|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
94260580|NCT03952806|322748525|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
94260581|NCT03952806|322748524|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
94632807|NCT01472081|324115105|FG004|Overall Study|No longer meets study criteria|0|||
94260582|NCT03952806|322748525|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
94632808|NCT01472081|324115106|FG005|Overall Study|No longer meets study criteria|0|||
94632809|NCT01472081|324115101|FG000|Overall Study|Subject request to discontinue treatment|0|||
94632810|NCT01472081|324115102|FG001|Overall Study|Subject request to discontinue treatment|3|||
94632811|NCT01472081|324115103|FG002|Overall Study|Subject request to discontinue treatment|1|||
94260583|NCT03952806|322748524|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
94260584|NCT03952806|322748525|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
94260585|NCT03952806|322748524|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
94260586|NCT03952806|322748525|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
94260587|NCT03952806|322748524|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
94632812|NCT01472081|324115104|FG003|Overall Study|Subject request to discontinue treatment|1|||
94632813|NCT01472081|324115105|FG004|Overall Study|Subject request to discontinue treatment|0|||
94632814|NCT01472081|324115106|FG005|Overall Study|Subject request to discontinue treatment|0|||
94632815|NCT00656474|324115107|FG000|Overall Study|Other Reason|1|||
94632816|NCT05286307|324115108|FG000|Overall Study|Incomplete outcome assessments|2|||
94632817|NCT05286307|324115109|FG001|Overall Study|Incomplete outcome assessments|1|||
94632818|NCT05286307|324115108|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
94632819|NCT05286307|324115109|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
94632820|NCT05286307|324115108|FG000|Overall Study|Lost to follow up at 6 months|25|||
94632821|NCT05286307|324115109|FG001|Overall Study|Lost to follow up at 6 months|35|||
94632822|NCT05286307|324115108|FG000|Overall Study|Study medication not available|1|||
94632823|NCT05286307|324115109|FG001|Overall Study|Study medication not available|1|||
94632824|NCT01572909|324116273|FG000|Overall Study|Adverse Event|7|||
94632825|NCT01572909|324116274|FG001|Overall Study|Adverse Event|2|||
94632826|NCT01572909|324116273|FG000|Overall Study|Death|3|||
94632827|NCT01572909|324116274|FG001|Overall Study|Death|1|||
94632828|NCT01572909|324116273|FG000|Overall Study|Lost to Follow-up|8|||
94632829|NCT01572909|324116274|FG001|Overall Study|Lost to Follow-up|7|||
94676054|NCT00394355|324267115|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
94461720|NCT02612610|323479589|FG001|Overall Study|Withdrawal by Subject|1|||
94632830|NCT01572909|324116273|FG000|Overall Study|Physician Decision|1|||
94632831|NCT01572909|324116274|FG001|Overall Study|Physician Decision|1|||
94632832|NCT01572909|324116273|FG000|Overall Study|Technical Issues|1|||
94632833|NCT01572909|324116274|FG001|Overall Study|Technical Issues|0|||
94676055|NCT00394355|324267116|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
94676056|NCT00394355|324267113|FG000|Overall Study|Subject withdrawal - related to drug|1|||
94362409|NCT00769132|323110705|FG003|Period 1|Adverse Event|1|||
94362410|NCT00769132|323110702|FG000|Period 2|Withdrawal by Subject|0|||
94362411|NCT00769132|323110703|FG001|Period 2|Withdrawal by Subject|0|||
94362412|NCT00769132|323110704|FG002|Period 2|Withdrawal by Subject|0|||
94362413|NCT00769132|323110705|FG003|Period 2|Withdrawal by Subject|1|||
94362414|NCT00769132|323110702|FG000|Period 3|Withdrawal by Subject|1|||
94362415|NCT00769132|323110703|FG001|Period 3|Withdrawal by Subject|0|||
94362416|NCT00769132|323110704|FG002|Period 3|Withdrawal by Subject|0|||
94362417|NCT00769132|323110705|FG003|Period 3|Withdrawal by Subject|0|||
94362418|NCT00769132|323110702|FG000|Period 4|Withdrawal by Subject|0|||
94362419|NCT00769132|323110703|FG001|Period 4|Withdrawal by Subject|1|||
94362420|NCT00769132|323110704|FG002|Period 4|Withdrawal by Subject|0|||
94362421|NCT00769132|323110705|FG003|Period 4|Withdrawal by Subject|0|||
94362422|NCT02230332|323110706|FG000|Overall Study|Adverse Event|2|||
94260588|NCT03952806|322748525|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
94362423|NCT02230332|323110707|FG001|Overall Study|Adverse Event|1|||
94362424|NCT02230332|323110706|FG000|Overall Study|Lost to Follow-up|1|||
94362425|NCT02230332|323110707|FG001|Overall Study|Lost to Follow-up|0|||
94362426|NCT02230332|323110706|FG000|Overall Study|Protocol Violation|1|||
94362427|NCT02230332|323110707|FG001|Overall Study|Protocol Violation|0|||
94362428|NCT01803464|323110709|FG000|Overall Study|Incomplete data|0|||
94362429|NCT01803464|323110710|FG001|Overall Study|Incomplete data|0|||
94362430|NCT01803464|323110711|FG002|Overall Study|Incomplete data|4|||
94362431|NCT01803464|323110712|FG003|Overall Study|Incomplete data|0|||
94362432|NCT01803464|323110709|FG000|Overall Study|Withdrawal by Subject|1|||
94362433|NCT01803464|323110710|FG001|Overall Study|Withdrawal by Subject|0|||
94362434|NCT01803464|323110711|FG002|Overall Study|Withdrawal by Subject|0|||
94362435|NCT01803464|323110712|FG003|Overall Study|Withdrawal by Subject|0|||
94362436|NCT03099161|323110713|FG000|Overall Study|Adverse Event|0|||
94362437|NCT03099161|323110714|FG001|Overall Study|Adverse Event|0|||
94461721|NCT02612610|323479590|FG002|Overall Study|Withdrawal by Subject|0|||
94461722|NCT02612610|323479591|FG003|Overall Study|Withdrawal by Subject|2|||
94461723|NCT02612610|323479588|FG000|Overall Study|Adverse Event|2|||
94260589|NCT03952806|322748524|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
94260590|NCT03952806|322748525|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
94260591|NCT03952806|322748524|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
94260592|NCT03952806|322748525|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
94260593|NCT03952806|322748524|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
94260594|NCT03952806|322748525|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
94260595|NCT03952806|322748524|FG000|OLE Phase (48 Weeks)|Other|16|||
94260596|NCT03952806|322748525|FG001|OLE Phase (48 Weeks)|Other|13|||
94260597|NCT01138007|322748526|FG000|Overall Study|Adverse Event|4|||
94260598|NCT01138007|322748527|FG001|Overall Study|Adverse Event|12|||
94260599|NCT01138007|322748528|FG002|Overall Study|Adverse Event|9|||
94260600|NCT01138007|322748526|FG000|Overall Study|Lack of Efficacy|2|||
94260601|NCT01138007|322748527|FG001|Overall Study|Lack of Efficacy|0|||
94260602|NCT01138007|322748528|FG002|Overall Study|Lack of Efficacy|6|||
94260603|NCT01138007|322748526|FG000|Overall Study|Protocol Violation|2|||
94260604|NCT01138007|322748527|FG001|Overall Study|Protocol Violation|3|||
94260605|NCT01138007|322748528|FG002|Overall Study|Protocol Violation|2|||
94260606|NCT01138007|322748526|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
94260607|NCT01138007|322748527|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
94260608|NCT01138007|322748528|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
94260609|NCT01138007|322748526|FG000|Overall Study|Lost to Follow-up|3|||
94260610|NCT01138007|322748527|FG001|Overall Study|Lost to Follow-up|3|||
94260611|NCT01138007|322748528|FG002|Overall Study|Lost to Follow-up|5|||
94260612|NCT01138007|322748526|FG000|Overall Study|Physician Decision|0|||
94260613|NCT01138007|322748527|FG001|Overall Study|Physician Decision|5|||
94260614|NCT01138007|322748528|FG002|Overall Study|Physician Decision|3|||
94260615|NCT01138007|322748526|FG000|Overall Study|Withdrawal by Subject|5|||
94260616|NCT01138007|322748527|FG001|Overall Study|Withdrawal by Subject|6|||
94260617|NCT01138007|322748528|FG002|Overall Study|Withdrawal by Subject|15|||
94260618|NCT00784693|322748531|FG000|Overall Study|Lost to Follow-up|0|||
94260619|NCT00784693|322748532|FG001|Overall Study|Lost to Follow-up|1|||
94260620|NCT00784693|322748531|FG000|Overall Study|Lack of Efficacy|1|||
94461724|NCT02612610|323479589|FG001|Overall Study|Adverse Event|2|||
94260621|NCT00784693|322748532|FG001|Overall Study|Lack of Efficacy|1|||
94260622|NCT00784693|322748531|FG000|Overall Study|Withdrawal by Subject|0|||
94260623|NCT00784693|322748532|FG001|Overall Study|Withdrawal by Subject|4|||
94260624|NCT00784693|322748531|FG000|Overall Study|Randomized but not Treated|1|||
94362438|NCT03099161|323110715|FG002|Overall Study|Adverse Event|2|||
94362439|NCT03099161|323110713|FG000|Overall Study|Physician Decision|2|||
94362440|NCT03099161|323110714|FG001|Overall Study|Physician Decision|0|||
94362441|NCT03099161|323110715|FG002|Overall Study|Physician Decision|0|||
94362442|NCT03099161|323110713|FG000|Overall Study|Progressive Disease|1|||
94362443|NCT03099161|323110714|FG001|Overall Study|Progressive Disease|4|||
94260625|NCT00784693|322748532|FG001|Overall Study|Randomized but not Treated|0|||
94362444|NCT03099161|323110715|FG002|Overall Study|Progressive Disease|1|||
94461725|NCT02612610|323479590|FG002|Overall Study|Adverse Event|3|||
94632834|NCT01572909|324116273|FG000|Overall Study|Withdrawal by Subject|12|||
94632835|NCT01572909|324116274|FG001|Overall Study|Withdrawal by Subject|11|||
94632836|NCT01572909|324116273|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
94632837|NCT01572909|324116274|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
94632838|NCT03641651|324116275|FG000|Overall Study|organizational issues at one study site|1|||
94632839|NCT03010254|324116276|FG000|Overall Study|Adverse Event|0|||
94632840|NCT03010254|324116277|FG001|Overall Study|Adverse Event|1|||
94632841|NCT03010254|324116276|FG000|Overall Study|Lost to Follow-up|4|||
94632842|NCT03010254|324116277|FG001|Overall Study|Lost to Follow-up|0|||
94632843|NCT03010254|324116276|FG000|Overall Study|Withdrawal by Subject|1|||
94632844|NCT03010254|324116277|FG001|Overall Study|Withdrawal by Subject|1|||
94632845|NCT03010254|324116276|FG000|Overall Study|Other|2|||
94632846|NCT03010254|324116277|FG001|Overall Study|Other|3|||
94632847|NCT02279173|324116282|FG000|Overall Study|Protocol-specified Criteria|67|||
94632848|NCT02279173|324116282|FG000|Overall Study|Withdrawal by Subject|20|||
94632849|NCT02279173|324116282|FG000|Overall Study|Decision by Sponsor|4|||
94632850|NCT02279173|324116282|FG000|Overall Study|Lost to Follow-up|3|||
94632851|NCT01164956|324116283|FG000|Overall Study|Side Effects|1|||
94260626|NCT00784693|322748531|FG000|Overall Study|Other|1|||
94260627|NCT00784693|322748532|FG001|Overall Study|Other|0|||
94632852|NCT01164956|324116284|FG001|Overall Study|Side Effects|0|||
94632853|NCT01164956|324116285|FG002|Overall Study|Side Effects|1|||
94632854|NCT04067544|324116286|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
94632855|NCT03316131|324116287|FG000|Treatment Period 2|Protocol deviation|1|||
94260628|NCT03588728|322748533|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
94260629|NCT03588728|322748534|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
94260630|NCT03588728|322748535|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
94260631|NCT03588728|322748536|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
94260632|NCT03588728|322748533|FG000|Overall Study|Lab shut down due to COVID-19|0|||
94260633|NCT03588728|322748534|FG001|Overall Study|Lab shut down due to COVID-19|0|||
94260634|NCT03588728|322748535|FG002|Overall Study|Lab shut down due to COVID-19|0|||
94260635|NCT03588728|322748536|FG003|Overall Study|Lab shut down due to COVID-19|1|||
94260636|NCT03588728|322748533|FG000|Overall Study|multiple technical issues|1|||
94260637|NCT03588728|322748534|FG001|Overall Study|multiple technical issues|0|||
94260638|NCT03588728|322748535|FG002|Overall Study|multiple technical issues|0|||
94260639|NCT03588728|322748536|FG003|Overall Study|multiple technical issues|0|||
94260640|NCT03588728|322748533|FG000|Overall Study|Hospitalized for COVID|1|||
94260641|NCT03588728|322748534|FG001|Overall Study|Hospitalized for COVID|0|||
94260642|NCT03588728|322748535|FG002|Overall Study|Hospitalized for COVID|0|||
94260643|NCT03588728|322748536|FG003|Overall Study|Hospitalized for COVID|0|||
94260644|NCT03588728|322748533|FG000|Overall Study|Schedule change unable to attend sessions|1|||
94260645|NCT03588728|322748534|FG001|Overall Study|Schedule change unable to attend sessions|0|||
94260646|NCT03588728|322748535|FG002|Overall Study|Schedule change unable to attend sessions|0|||
94260647|NCT03588728|322748536|FG003|Overall Study|Schedule change unable to attend sessions|0|||
94260648|NCT01122862|322748537|FG000|Period 1|Protocol Violation|0|||
94260649|NCT01122862|322748538|FG001|Period 1|Protocol Violation|1|||
94260650|NCT01122862|322748539|FG002|Period 1|Protocol Violation|0|||
94260651|NCT01122862|322748537|FG000|Period 2|Adverse Event|0|||
94260652|NCT01122862|322748538|FG001|Period 2|Adverse Event|0|||
94260653|NCT01122862|322748539|FG002|Period 2|Adverse Event|1|||
94260654|NCT00846391|322748540|FG000|Overall Study|Physician Decision|0|||
94260655|NCT00846391|322748541|FG001|Overall Study|Physician Decision|0|||
94260656|NCT00846391|322748542|FG002|Overall Study|Physician Decision|1|||
94260657|NCT00846391|322748540|FG000|Overall Study|Study Terminated by Sponsor|1|||
94260658|NCT00846391|322748541|FG001|Overall Study|Study Terminated by Sponsor|2|||
94260659|NCT00846391|322748542|FG002|Overall Study|Study Terminated by Sponsor|2|||
94260660|NCT01000636|322748543|FG000|Overall Study|Withdrawal by Subject|1|||
94260661|NCT01000636|322748543|FG000|Overall Study|Adverse Event|1|||
94632856|NCT03316131|324116288|FG001|Treatment Period 2|Protocol deviation|0|||
94632857|NCT01409564|324116289|FG000|Overall Study|low medication compliance|4|||
94632858|NCT01409564|324116290|FG001|Overall Study|low medication compliance|3|||
94632859|NCT01409564|324116289|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
94632860|NCT01409564|324116290|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
94260662|NCT00559585|322748546|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
94260663|NCT00559585|322748547|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
94260664|NCT00559585|322748546|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
94260665|NCT00559585|322748547|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
94632861|NCT00254540|324116291|FG000|Overall Study|Adverse Event|6|||
94632862|NCT00254540|324116292|FG001|Overall Study|Adverse Event|7|||
94632863|NCT00254540|324116291|FG000|Overall Study|Lack of Efficacy|13|||
94632864|NCT00254540|324116292|FG001|Overall Study|Lack of Efficacy|13|||
94632865|NCT00254540|324116291|FG000|Overall Study|Death|0|||
94632866|NCT00254540|324116292|FG001|Overall Study|Death|1|||
94632867|NCT00254540|324116291|FG000|Overall Study|Laboratory Test Abnormality|0|||
94632868|NCT00254540|324116292|FG001|Overall Study|Laboratory Test Abnormality|1|||
94260666|NCT00559585|322748546|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
94260667|NCT00559585|322748547|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
94260668|NCT00559585|322748546|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
94260669|NCT00559585|322748547|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
94260670|NCT00559585|322748546|FG000|Double Blind ST Period Main Study|Death|1|||
94260671|NCT00559585|322748547|FG001|Double Blind ST Period Main Study|Death|1|||
94260672|NCT00559585|322748546|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
94362445|NCT03170271|323110717|FG000|Overall Study|Adverse Event|7|||
94362446|NCT03170271|323110718|FG001|Overall Study|Adverse Event|2|||
94632869|NCT01529346|324116296|FG000|Overall Study|Lost to Follow-up|2|||
94632870|NCT01529346|324116297|FG001|Overall Study|Lost to Follow-up|0|||
94632871|NCT01529346|324116298|FG002|Overall Study|Lost to Follow-up|1|||
94632872|NCT01529346|324116299|FG003|Overall Study|Lost to Follow-up|0|||
94632873|NCT01529346|324116300|FG004|Overall Study|Lost to Follow-up|0|||
94632874|NCT01529346|324116296|FG000|Overall Study|Other|0|||
94632875|NCT01529346|324116297|FG001|Overall Study|Other|1|||
94632876|NCT01529346|324116298|FG002|Overall Study|Other|1|||
94632877|NCT01529346|324116299|FG003|Overall Study|Other|0|||
94632878|NCT01529346|324116300|FG004|Overall Study|Other|0|||
94632879|NCT02892760|324116301|FG000|Overall Study|Withdrawal by Subject|3|||
94632880|NCT02902965|324116307|FG000|Overall Study|Withdrawal by Subject|10|||
94632881|NCT02335489|324116308|FG000|Overall Study|Sponsor terminated study|4|||
94632882|NCT02335489|324116308|FG000|Overall Study|Lost to Follow-up|1|||
94632883|NCT02335489|324116308|FG000|Overall Study|Withdrawal by Subject|2|||
94632884|NCT02335489|324116308|FG000|Overall Study|Physician Decision|2|||
94632885|NCT02335489|324116308|FG000|Overall Study|Lack of Efficacy|1|||
94632886|NCT04483011|324116310|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
94632887|NCT04483011|324116311|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
94632888|NCT03804879|324116312|FG000|Overall Study|Adverse Event|3|||
94632889|NCT03804879|324116313|FG001|Overall Study|Adverse Event|0|||
94362447|NCT03170271|323110717|FG000|Overall Study|Lost to Follow-up|0|||
94632890|NCT03804879|324116312|FG000|Overall Study|Study Terminated By Sponsor|10|||
94632891|NCT03804879|324116313|FG001|Overall Study|Study Terminated By Sponsor|12|||
94632892|NCT03804879|324116312|FG000|Overall Study|Withdrawal by Subject|3|||
94632893|NCT03804879|324116313|FG001|Overall Study|Withdrawal by Subject|1|||
94632894|NCT01594125|324116314|FG000|Overall Study|Withdrawal by Subject|1|||
94632895|NCT01594125|324116315|FG001|Overall Study|Withdrawal by Subject|0|||
94632896|NCT01594125|324116316|FG002|Overall Study|Withdrawal by Subject|0|||
94632897|NCT01594125|324116317|FG003|Overall Study|Withdrawal by Subject|1|||
94632898|NCT01594125|324116318|FG004|Overall Study|Withdrawal by Subject|0|||
94632899|NCT01594125|324116314|FG000|Overall Study|Progressive Disease|3|||
94632900|NCT01594125|324116315|FG001|Overall Study|Progressive Disease|12|||
94632901|NCT01594125|324116316|FG002|Overall Study|Progressive Disease|3|||
94632902|NCT01594125|324116317|FG003|Overall Study|Progressive Disease|3|||
94632903|NCT01594125|324116318|FG004|Overall Study|Progressive Disease|7|||
94632904|NCT02345811|324116319|FG000|First Intervention|Withdrawal by Subject|1|||
94632905|NCT02345811|324116320|FG001|First Intervention|Withdrawal by Subject|1|||
94632906|NCT01870583|324116321|FG000|Overall Study|Protocol Violation|0|||
94676057|NCT00394355|324267114|FG001|Overall Study|Subject withdrawal - related to drug|0|||
94676058|NCT00394355|324267115|FG002|Overall Study|Subject withdrawal - related to drug|0|||
94260673|NCT00559585|322748547|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
94260674|NCT00559585|322748546|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
94260675|NCT00559585|322748547|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
94260676|NCT00559585|322748546|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
94260677|NCT00559585|322748547|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
94260678|NCT00559585|322748546|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
94260679|NCT00559585|322748547|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
94260680|NCT00559585|322748546|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
94260681|NCT00559585|322748547|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
94260682|NCT00559585|322748546|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
94260683|NCT00559585|322748547|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
94260684|NCT00559585|322748546|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
94260685|NCT00559585|322748547|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
94260686|NCT00559585|322748546|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
94260687|NCT00559585|322748547|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
94260688|NCT00559585|322748546|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
94260689|NCT00559585|322748547|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
94260690|NCT00559585|322748546|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
94260691|NCT00559585|322748547|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
94260692|NCT00559585|322748546|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
94260693|NCT00559585|322748547|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
94260694|NCT00559585|322748546|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
94260695|NCT00559585|322748547|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
94260696|NCT00559585|322748546|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
94260697|NCT00559585|322748547|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
94260698|NCT00559585|322748546|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
94260699|NCT00559585|322748547|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
94260700|NCT00559585|322748546|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
94260701|NCT00559585|322748547|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
94260702|NCT00559585|322748546|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
94260703|NCT00559585|322748547|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
94260704|NCT00559585|322748546|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
94260705|NCT00559585|322748547|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
94260706|NCT00559585|322748546|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
94260707|NCT00559585|322748547|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
94260708|NCT00559585|322748546|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
94260709|NCT00559585|322748547|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
94260710|NCT00559585|322748546|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
94260711|NCT00559585|322748547|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
94260712|NCT00559585|322748546|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
94260713|NCT00559585|322748547|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
94260714|NCT00559585|322748546|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
94260715|NCT00559585|322748547|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
94260716|NCT00559585|322748546|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
94260717|NCT00559585|322748547|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
94260718|NCT01630434|322748550|FG000|Overall Study|Donor lungs turned down|1|||
94260719|NCT01630434|322748551|FG001|Overall Study|Donor lungs turned down|0|||
94260720|NCT01630434|322748550|FG000|Overall Study|Protocol Violation|9|||
94260721|NCT01630434|322748551|FG001|Overall Study|Protocol Violation|4|||
94260722|NCT01630434|322748550|FG000|Overall Study|Death|20|||
94260723|NCT01630434|322748551|FG001|Overall Study|Death|26|||
94260724|NCT01230788|322748552|FG000|Overall Study|Prescribed exclusion drug|1|||
94260725|NCT01019317|322748558|FG000|Overall Study|Not Eligible|4|||
94260726|NCT03294109|322748559|FG000|Overall Study|Withdrawal by Subject|6|||
94260727|NCT03294109|322748560|FG001|Overall Study|Withdrawal by Subject|5|||
94260728|NCT01294683|322748561|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
94260729|NCT01294683|322748562|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
94260730|NCT01294683|322748561|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
94260731|NCT01294683|322748562|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
94260732|NCT01294683|322748561|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
94260733|NCT01294683|322748562|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
94260734|NCT01294683|322748561|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
94260735|NCT01294683|322748562|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
94260736|NCT01294683|322748561|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
94260737|NCT01294683|322748562|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
94260738|NCT01294683|322748561|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
94260739|NCT01294683|322748562|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
94260740|NCT01294683|322748561|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
94260741|NCT01294683|322748562|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
94260742|NCT01294683|322748561|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
94260743|NCT01294683|322748562|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
94260744|NCT01294683|322748561|FG000|Post Crossover (Period III)|Adverse Event|6|||
94260745|NCT01294683|322748562|FG001|Post Crossover (Period III)|Adverse Event|6|||
94260746|NCT01294683|322748561|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
94260747|NCT01294683|322748562|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
94260748|NCT01294683|322748561|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
94260749|NCT01294683|322748562|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
94260750|NCT01294683|322748561|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
94260751|NCT01294683|322748562|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
94260752|NCT02973048|322748564|FG000|Overall Study|Epidural catheter insertion failure|1|||
94260753|NCT02973048|322748565|FG001|Overall Study|Epidural catheter insertion failure|0|||
94260754|NCT02973048|322748564|FG000|Overall Study|Withdrawal by Subject|0|||
94260755|NCT02973048|322748565|FG001|Overall Study|Withdrawal by Subject|3|||
94260756|NCT01557348|322748570|FG000|Overall Study|Adverse Event|6|||
94260757|NCT01557348|322748571|FG001|Overall Study|Adverse Event|16|||
94260758|NCT01557348|322748570|FG000|Overall Study|Infusion reaction event|5|||
94260759|NCT01557348|322748571|FG001|Overall Study|Infusion reaction event|5|||
94260760|NCT01557348|322748570|FG000|Overall Study|Death|7|||
94260761|NCT01557348|322748571|FG001|Overall Study|Death|4|||
94260762|NCT01557348|322748570|FG000|Overall Study|Insufficient Therapeutic Response|13|||
94260763|NCT01557348|322748571|FG001|Overall Study|Insufficient Therapeutic Response|28|||
94260764|NCT01557348|322748570|FG000|Overall Study|Withdrawal by Subject|5|||
94260765|NCT01557348|322748571|FG001|Overall Study|Withdrawal by Subject|4|||
94260766|NCT01557348|322748570|FG000|Overall Study|Lost to Follow-up|26|||
94260767|NCT01557348|322748571|FG001|Overall Study|Lost to Follow-up|22|||
94260768|NCT01557348|322748570|FG000|Overall Study|Administrative|18|||
94260769|NCT01557348|322748571|FG001|Overall Study|Administrative|11|||
94260770|NCT02958267|322748572|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
94260771|NCT02958267|322748573|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
94260772|NCT02958267|322748572|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
94260773|NCT02958267|322748573|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
94260774|NCT02958267|322748572|FG000|Follow-up Visits|Additional treatment pursued|2|||
94260775|NCT02958267|322748573|FG001|Follow-up Visits|Additional treatment pursued|1|||
94260776|NCT01485354|322750216|FG000|Overall Study|Withdrawal by Subject|5|||
94260777|NCT03566810|322750217|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
94260778|NCT03566810|322750218|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
94260779|NCT03566810|322750219|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
94260780|NCT03566810|322750220|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
94260781|NCT00720941|322750221|FG000|Overall Study|Protocol Violation|1|||
94260782|NCT00720941|322750222|FG001|Overall Study|Protocol Violation|2|||
94260783|NCT00720941|322750221|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
94260784|NCT00720941|322750222|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
94260785|NCT00720941|322750221|FG000|Overall Study|Lost to Follow-up|20|||
94260786|NCT00720941|322750222|FG001|Overall Study|Lost to Follow-up|15|||
94260787|NCT00720941|322750221|FG000|Overall Study|Physician Decision|14|||
94260788|NCT00720941|322750222|FG001|Overall Study|Physician Decision|12|||
94260789|NCT00720941|322750221|FG000|Overall Study|Withdrawal by Subject|29|||
94260790|NCT00720941|322750222|FG001|Overall Study|Withdrawal by Subject|36|||
94260791|NCT00355056|322750223|FG000|Randomization Period|Early Termination|4|||
94260792|NCT00355056|322750224|FG001|Randomization Period|Early Termination|6|||
94260793|NCT01072877|322750225|FG000|Overall Study|Lost to Follow-up|1|||
94260794|NCT01072877|322750226|FG001|Overall Study|Lost to Follow-up|1|||
94260795|NCT01072877|322750227|FG002|Overall Study|Lost to Follow-up|0|||
94260796|NCT01072877|322750228|FG003|Overall Study|Lost to Follow-up|2|||
94260797|NCT01072877|322750229|FG004|Overall Study|Lost to Follow-up|0|||
94260798|NCT01929980|322750230|FG000|Overall Study|Physician Decision|1|||
94260799|NCT00985166|322750231|FG000|Overall Study|Lost to Follow-up|3|||
94260800|NCT00985166|322750232|FG001|Overall Study|Lost to Follow-up|2|||
94362448|NCT03170271|323110718|FG001|Overall Study|Lost to Follow-up|1|||
94362449|NCT03170271|323110717|FG000|Overall Study|Physician Decision|1|||
94362450|NCT03170271|323110718|FG001|Overall Study|Physician Decision|0|||
94260801|NCT00985166|322750233|FG002|Overall Study|Lost to Follow-up|2|||
94260802|NCT00985166|322750231|FG000|Overall Study|Withdrawal by Subject|3|||
94362451|NCT03170271|323110717|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
94362452|NCT03170271|323110718|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
94260803|NCT00985166|322750232|FG001|Overall Study|Withdrawal by Subject|2|||
94260804|NCT00985166|322750233|FG002|Overall Study|Withdrawal by Subject|0|||
94260805|NCT00985166|322750231|FG000|Overall Study|Test not done|2|||
94260806|NCT00985166|322750232|FG001|Overall Study|Test not done|0|||
94260807|NCT00985166|322750233|FG002|Overall Study|Test not done|4|||
94632907|NCT01870583|324116322|FG001|Overall Study|Protocol Violation|5|||
94632908|NCT01870583|324116323|FG002|Overall Study|Protocol Violation|3|||
94632909|NCT01870583|324116321|FG000|Overall Study|Lost to Follow-up|11|||
94632910|NCT01870583|324116322|FG001|Overall Study|Lost to Follow-up|13|||
94632911|NCT01870583|324116323|FG002|Overall Study|Lost to Follow-up|5|||
94632912|NCT00103142|324116326|FG000|Overall Study|Adverse Event|1|||
94260808|NCT00985166|322750231|FG000|Overall Study|Other|1|||
94260809|NCT00985166|322750232|FG001|Overall Study|Other|0|||
94260810|NCT00985166|322750233|FG002|Overall Study|Other|1|||
94260811|NCT01096342|322750234|FG000|Overall Study|Protocol Violation|1|||
94260812|NCT00300781|322750235|FG000|Overall Study|Disease Progression|55|||
94260813|NCT00300781|322750236|FG001|Overall Study|Disease Progression|52|||
94260814|NCT00300781|322750235|FG000|Overall Study|Adverse Event|5|||
94260815|NCT00300781|322750236|FG001|Overall Study|Adverse Event|6|||
94260816|NCT00300781|322750235|FG000|Overall Study|Withdrawal by Subject|1|||
94260817|NCT00300781|322750236|FG001|Overall Study|Withdrawal by Subject|2|||
94260818|NCT00300781|322750235|FG000|Overall Study|Physician Decision|1|||
94260819|NCT00300781|322750236|FG001|Overall Study|Physician Decision|0|||
94260820|NCT00300781|322750235|FG000|Overall Study|Not Recorded|0|||
94260821|NCT00300781|322750236|FG001|Overall Study|Not Recorded|1|||
94260822|NCT00300781|322750235|FG000|Overall Study|Symptomatic Deterioration|1|||
94260823|NCT00300781|322750236|FG001|Overall Study|Symptomatic Deterioration|0|||
94260824|NCT00300781|322750235|FG000|Overall Study|Lost to Follow-up|0|||
94260825|NCT00300781|322750236|FG001|Overall Study|Lost to Follow-up|1|||
94260826|NCT00462865|322750241|FG000|Overall Study|Adverse Event|1|||
94260827|NCT01369511|322750244|FG000|Overall Study|Adverse Event|1|||
94260828|NCT01369511|322750245|FG001|Overall Study|Adverse Event|1|||
94260829|NCT01369511|322750246|FG002|Overall Study|Adverse Event|5|||
94260830|NCT01369511|322750247|FG003|Overall Study|Adverse Event|0|||
94260831|NCT01369511|322750244|FG000|Overall Study|Entry criteria not met|2|||
94260832|NCT01369511|322750245|FG001|Overall Study|Entry criteria not met|0|||
94260833|NCT01369511|322750246|FG002|Overall Study|Entry criteria not met|0|||
94260834|NCT01369511|322750247|FG003|Overall Study|Entry criteria not met|1|||
94260835|NCT01369511|322750244|FG000|Overall Study|Lost to Follow-up|0|||
94260836|NCT01369511|322750245|FG001|Overall Study|Lost to Follow-up|1|||
94260837|NCT01369511|322750246|FG002|Overall Study|Lost to Follow-up|1|||
94260838|NCT01369511|322750247|FG003|Overall Study|Lost to Follow-up|2|||
94260839|NCT01369511|322750244|FG000|Overall Study|Protocol Violation|0|||
94632913|NCT00103142|324116327|FG001|Overall Study|Adverse Event|0|||
94632914|NCT00103142|324116326|FG000|Overall Study|Progression of disease|2|||
94632915|NCT00103142|324116327|FG001|Overall Study|Progression of disease|1|||
94632916|NCT03998189|324116328|FG000|Overall Study|Lack of Efficacy|0|||
94632917|NCT03998189|324116329|FG001|Overall Study|Lack of Efficacy|1|||
94632918|NCT02728895|324116330|FG000|Overall Study|Other|1|||
94632919|NCT02728895|324116331|FG001|Overall Study|Other|2|||
94632920|NCT02728895|324116330|FG000|Overall Study|Withdrawal by Subject|0|||
94632921|NCT02728895|324116331|FG001|Overall Study|Withdrawal by Subject|3|||
94632922|NCT01782859|324116334|FG000|Overall Study|Protocol Violation|6|||
94632923|NCT01782859|324116335|FG001|Overall Study|Protocol Violation|6|||
94632924|NCT01782859|324116334|FG000|Overall Study|Withdrawal by Subject|0|||
94632925|NCT01782859|324116335|FG001|Overall Study|Withdrawal by Subject|1|||
94632926|NCT02865187|324116336|FG000|Overall Study|Lost to Follow-up|12|||
94632927|NCT02865187|324116337|FG001|Overall Study|Lost to Follow-up|7|||
94632928|NCT02865187|324116336|FG000|Overall Study|Adverse Event|1|||
94632929|NCT02865187|324116337|FG001|Overall Study|Adverse Event|0|||
94632930|NCT00330616|324116342|FG000|Overall Study|Adverse Event|13|||
94632931|NCT00330616|324116342|FG000|Overall Study|Lack of Efficacy|1|||
94632932|NCT00330616|324116342|FG000|Overall Study|Lost to Follow-up|2|||
94632933|NCT00330616|324116342|FG000|Overall Study|Withdrawal by Subject|4|||
94632934|NCT00330616|324116342|FG000|Overall Study|Other|1|||
94632935|NCT01574612|324116343|FG000|Overall Study|Adverse Event|3|||
94632936|NCT01574612|324116343|FG000|Overall Study|non compliant with drug|2|||
94632937|NCT01574612|324116343|FG000|Overall Study|Withdrawal by Subject|1|||
94260840|NCT01369511|322750245|FG001|Overall Study|Protocol Violation|1|||
94260841|NCT01369511|322750246|FG002|Overall Study|Protocol Violation|0|||
94260842|NCT01369511|322750247|FG003|Overall Study|Protocol Violation|2|||
94260843|NCT01369511|322750244|FG000|Overall Study|Physician Decision|3|||
94632938|NCT01574612|324116343|FG000|Overall Study|Lost to Follow-up|2|||
94260844|NCT01369511|322750245|FG001|Overall Study|Physician Decision|4|||
94260845|NCT01369511|322750246|FG002|Overall Study|Physician Decision|0|||
94260846|NCT01369511|322750247|FG003|Overall Study|Physician Decision|0|||
94260847|NCT01369511|322750244|FG000|Overall Study|Sponsor decision|2|||
94260848|NCT01369511|322750245|FG001|Overall Study|Sponsor decision|0|||
94260849|NCT01369511|322750246|FG002|Overall Study|Sponsor decision|1|||
94632939|NCT01585194|324116344|FG000|Overall Study|Withdrawal by Subject|1|||
94632940|NCT01585194|324116344|FG000|Overall Study|Physician Decision|2|||
94632941|NCT01585194|324116344|FG000|Overall Study|Lack of insurance|1|||
94632942|NCT01957553|324116345|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
94632943|NCT01957553|324116346|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
94632944|NCT01957553|324116345|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
94632945|NCT01957553|324116346|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
94632946|NCT01957553|324116345|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
94632947|NCT01957553|324116346|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
94632948|NCT01957553|324116345|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
94632949|NCT01957553|324116346|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
94632950|NCT01957553|324116345|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
94632951|NCT01957553|324116346|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
94632952|NCT01957553|324116345|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
94632953|NCT01957553|324116346|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
94632954|NCT01957553|324116345|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
94632955|NCT01957553|324116346|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
94632956|NCT01957553|324116345|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
94260850|NCT01369511|322750247|FG003|Overall Study|Sponsor decision|0|||
94260851|NCT01369511|322750244|FG000|Overall Study|Withdrawal by Subject|5|||
94260852|NCT01369511|322750245|FG001|Overall Study|Withdrawal by Subject|6|||
94260853|NCT01369511|322750246|FG002|Overall Study|Withdrawal by Subject|4|||
94260854|NCT01369511|322750247|FG003|Overall Study|Withdrawal by Subject|6|||
94260855|NCT00820027|322750251|FG000|Overall Study|Adverse Event|15|||
94260856|NCT00820027|322750252|FG001|Overall Study|Adverse Event|8|||
94260857|NCT00820027|322750253|FG002|Overall Study|Adverse Event|10|||
94260858|NCT00820027|322750254|FG003|Overall Study|Adverse Event|5|||
94260859|NCT00820027|322750251|FG000|Overall Study|Lack of Efficacy|2|||
94260860|NCT00820027|322750252|FG001|Overall Study|Lack of Efficacy|1|||
94260861|NCT00820027|322750253|FG002|Overall Study|Lack of Efficacy|2|||
94260862|NCT00820027|322750254|FG003|Overall Study|Lack of Efficacy|2|||
94260863|NCT00820027|322750251|FG000|Overall Study|Physician Decision|0|||
94260864|NCT00820027|322750252|FG001|Overall Study|Physician Decision|1|||
94260865|NCT00820027|322750253|FG002|Overall Study|Physician Decision|1|||
94260866|NCT00820027|322750254|FG003|Overall Study|Physician Decision|0|||
94260867|NCT00820027|322750251|FG000|Overall Study|Protocol Violation|3|||
94260868|NCT00820027|322750252|FG001|Overall Study|Protocol Violation|0|||
94260869|NCT00820027|322750253|FG002|Overall Study|Protocol Violation|4|||
94260870|NCT00820027|322750254|FG003|Overall Study|Protocol Violation|0|||
94260871|NCT00820027|322750251|FG000|Overall Study|Withdrawal by Subject|6|||
94260872|NCT00820027|322750252|FG001|Overall Study|Withdrawal by Subject|4|||
94260873|NCT00820027|322750253|FG002|Overall Study|Withdrawal by Subject|4|||
94260874|NCT00820027|322750254|FG003|Overall Study|Withdrawal by Subject|6|||
94260875|NCT02982187|322750255|FG000|Overall Study|Withdrawal by Subject|0|||
94260876|NCT02982187|322750256|FG001|Overall Study|Withdrawal by Subject|0|||
94260877|NCT02982187|322750257|FG002|Overall Study|Withdrawal by Subject|0|||
94260878|NCT02982187|322750258|FG003|Overall Study|Withdrawal by Subject|0|||
94260879|NCT02982187|322750259|FG004|Overall Study|Withdrawal by Subject|0|||
94260880|NCT02982187|322750260|FG005|Overall Study|Withdrawal by Subject|0|||
94260881|NCT02982187|322750261|FG006|Overall Study|Withdrawal by Subject|1|||
94260882|NCT02982187|322750262|FG007|Overall Study|Withdrawal by Subject|0|||
94260883|NCT04209621|322750267|FG000|Overall Study|Death|1|||
94260884|NCT04209621|322750267|FG000|Overall Study|Study Terminated Early|2|||
94260885|NCT02249767|322750268|FG000|Overall Study|Did not use medication|8|||
94260886|NCT02249767|322750269|FG001|Overall Study|Did not use medication|9|||
94260887|NCT02249767|322750270|FG002|Overall Study|Did not use medication|8|||
94260888|NCT02644941|322750271|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
94260889|NCT02644941|322750272|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
94260890|NCT00867113|322750273|FG000|Treatment Period|Adverse Event|15|||
94260891|NCT00867113|322750273|FG000|Treatment Period|Death|2|||
94260892|NCT00867113|322750273|FG000|Treatment Period|Withdrawal by Subject|19|||
94260893|NCT00867113|322750273|FG000|Treatment Period|Lost to Follow-up|3|||
94260894|NCT00867113|322750273|FG000|Treatment Period|Administrative problems|1|||
94260895|NCT00867113|322750273|FG000|Treatment Period|Disease progression/relapse|1|||
94260896|NCT00867113|322750273|FG000|Treatment Period|Protocol Violation|4|||
94260897|NCT00867113|322750273|FG000|Post Treatment After Survival Follow-up|Death|1|||
94632957|NCT01957553|324116346|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
94632958|NCT01957553|324116345|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
94260898|NCT00867113|322750273|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
94260899|NCT00867113|322750273|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
94260900|NCT00867113|322750273|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
94632959|NCT01957553|324116346|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
94632960|NCT01333059|324116348|FG000|Overall Study|Physician Decision|3|||
94632961|NCT01333059|324116349|FG001|Overall Study|Physician Decision|3|||
94260901|NCT02465463|322750277|FG000|Overall Study|Lost to Follow-up|2|||
94260902|NCT02465463|322750278|FG001|Overall Study|Lost to Follow-up|1|||
94260903|NCT02465463|322750277|FG000|Overall Study|Death|1|||
94260904|NCT02465463|322750278|FG001|Overall Study|Death|0|||
94260905|NCT02465463|322750277|FG000|Overall Study|Protocol Violation|1|||
94632962|NCT01333059|324116348|FG000|Overall Study|Protocol Violation|3|||
94632963|NCT01333059|324116349|FG001|Overall Study|Protocol Violation|0|||
94676059|NCT00394355|324267116|FG003|Overall Study|Subject withdrawal - related to drug|0|||
94676060|NCT00394355|324267113|FG000|Overall Study|Lost to Follow-up|7|||
94632964|NCT02733367|324116350|FG000|Overall Study|Withdrawal by Subject|6|||
94632965|NCT04059094|324116360|FG000|Overall Study|Adverse Event|0|||
94632966|NCT04059094|324116361|FG001|Overall Study|Adverse Event|0|||
94632967|NCT04059094|324116362|FG002|Overall Study|Adverse Event|0|||
94632968|NCT04059094|324116363|FG003|Overall Study|Adverse Event|0|||
94632969|NCT04059094|324116364|FG004|Overall Study|Adverse Event|1|||
94632970|NCT04059094|324116360|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
94632971|NCT04059094|324116361|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
94632972|NCT04059094|324116362|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
94632973|NCT04059094|324116363|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
94632974|NCT04059094|324116364|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
94632975|NCT00511667|324116366|FG000|Overall Study|Adverse Event|1|||
94632976|NCT00511667|324116367|FG001|Overall Study|Adverse Event|0|||
94632977|NCT00511667|324116366|FG000|Overall Study|Protocol Violation|1|||
94632978|NCT00511667|324116367|FG001|Overall Study|Protocol Violation|1|||
94632979|NCT00511667|324116366|FG000|Overall Study|Withdrawal by Subject|2|||
94632980|NCT00511667|324116367|FG001|Overall Study|Withdrawal by Subject|0|||
94632981|NCT00511667|324116366|FG000|Overall Study|Site terminated|6|||
94632982|NCT00511667|324116367|FG001|Overall Study|Site terminated|1|||
94632983|NCT00511667|324116366|FG000|Overall Study|Other|2|||
94632984|NCT00511667|324116367|FG001|Overall Study|Other|1|||
94632985|NCT03251079|324116368|FG000|Overall Study|Withdrawal by Subject|1|||
94632986|NCT01026792|324116371|FG000|Overall Study|Protocol Violation|1|||
94632987|NCT00423150|324116372|FG000|Overall Study|Adverse Event|11|||
94632988|NCT00423150|324116372|FG000|Overall Study|Progression of disease being studied|69|||
94632989|NCT00423150|324116372|FG000|Overall Study|Withdrawal by Subject|1|||
94632990|NCT00423150|324116372|FG000|Overall Study|Non-compliance with protocol|1|||
94632991|NCT00423150|324116372|FG000|Overall Study|Administrative|4|||
94632992|NCT02951156|324116373|FG000|Overall Study|Death|3|||
94632993|NCT02951156|324116374|FG001|Overall Study|Death|8|||
94632994|NCT02951156|324116375|FG002|Overall Study|Death|5|||
94632995|NCT02951156|324116373|FG000|Overall Study|Progressive disease|1|||
94632996|NCT02951156|324116374|FG001|Overall Study|Progressive disease|0|||
94632997|NCT02951156|324116375|FG002|Overall Study|Progressive disease|1|||
94632998|NCT02951156|324116373|FG000|Overall Study|Withdrawal by Subject|0|||
94632999|NCT02951156|324116374|FG001|Overall Study|Withdrawal by Subject|0|||
94633000|NCT02951156|324116375|FG002|Overall Study|Withdrawal by Subject|1|||
94633001|NCT02951156|324116373|FG000|Overall Study|Study terminated by sponsor|0|||
94633002|NCT02951156|324116374|FG001|Overall Study|Study terminated by sponsor|0|||
94633003|NCT02951156|324116375|FG002|Overall Study|Study terminated by sponsor|1|||
94633004|NCT02951156|324116373|FG000|Overall Study|Other|5|||
94633005|NCT02951156|324116374|FG001|Overall Study|Other|1|||
94633006|NCT02951156|324116375|FG002|Overall Study|Other|2|||
94633007|NCT02626520|324116377|FG000|Overall Study|Physician Decision|1|||
94633008|NCT02626520|324116378|FG001|Overall Study|Physician Decision|1|||
94633009|NCT02626520|324116377|FG000|Overall Study|Adverse Event|0|||
94633010|NCT02626520|324116378|FG001|Overall Study|Adverse Event|4|||
94676061|NCT00394355|324267114|FG001|Overall Study|Lost to Follow-up|5|||
94260906|NCT02465463|322750278|FG001|Overall Study|Protocol Violation|0|||
94260907|NCT00578786|322750283|FG000|Overall Study|Adverse Event|27|||
94260908|NCT00578786|322750284|FG001|Overall Study|Adverse Event|37|||
94260909|NCT00578786|322750285|FG002|Overall Study|Adverse Event|17|||
94260910|NCT00578786|322750283|FG000|Overall Study|Lack of Efficacy|2|||
94260911|NCT00578786|322750284|FG001|Overall Study|Lack of Efficacy|5|||
94260912|NCT00578786|322750285|FG002|Overall Study|Lack of Efficacy|2|||
94260913|NCT00578786|322750283|FG000|Overall Study|Early Escape from Prior Study|2|||
94260914|NCT00578786|322750284|FG001|Overall Study|Early Escape from Prior Study|1|||
94260915|NCT00578786|322750285|FG002|Overall Study|Early Escape from Prior Study|2|||
94362453|NCT03170271|323110717|FG000|Overall Study|Withdrawal by Subject|17|||
94633011|NCT02626520|324116377|FG000|Overall Study|Lack of Efficacy|0|||
94633012|NCT02626520|324116378|FG001|Overall Study|Lack of Efficacy|2|||
94633013|NCT02626520|324116377|FG000|Overall Study|Did not start protocol therapy|0|||
94676062|NCT00394355|324267115|FG002|Overall Study|Lost to Follow-up|4|||
94633014|NCT02626520|324116378|FG001|Overall Study|Did not start protocol therapy|2|||
94676063|NCT00394355|324267116|FG003|Overall Study|Lost to Follow-up|3|||
94260916|NCT00578786|322750283|FG000|Overall Study|Withdrawal by Subject|7|||
94362454|NCT03170271|323110718|FG001|Overall Study|Withdrawal by Subject|5|||
94362455|NCT03170271|323110717|FG000|Overall Study|Other|2|||
94260917|NCT00578786|322750284|FG001|Overall Study|Withdrawal by Subject|8|||
94260918|NCT00578786|322750285|FG002|Overall Study|Withdrawal by Subject|5|||
94633015|NCT02626520|324116377|FG000|Overall Study|Study terminated|0|||
94633016|NCT02626520|324116378|FG001|Overall Study|Study terminated|1|||
94633017|NCT01996709|324116381|FG000|Overall Study|Withdrawal by Subject|1|||
94633018|NCT01996709|324116382|FG001|Overall Study|Withdrawal by Subject|0|||
94633019|NCT01996709|324116381|FG000|Overall Study|Lost to Follow-up|3|||
94260919|NCT00578786|322750283|FG000|Overall Study|Protocol Violation|0|||
94260920|NCT00578786|322750284|FG001|Overall Study|Protocol Violation|3|||
94260921|NCT00578786|322750285|FG002|Overall Study|Protocol Violation|1|||
94260922|NCT00578786|322750283|FG000|Overall Study|Physician Decision|1|||
94260923|NCT00578786|322750284|FG001|Overall Study|Physician Decision|0|||
94260924|NCT00578786|322750285|FG002|Overall Study|Physician Decision|1|||
94260925|NCT00578786|322750283|FG000|Overall Study|Sponsor Decision|0|||
94260926|NCT00578786|322750284|FG001|Overall Study|Sponsor Decision|0|||
94260927|NCT00578786|322750285|FG002|Overall Study|Sponsor Decision|1|||
94260928|NCT00578786|322750283|FG000|Overall Study|Lost to Follow-up|0|||
94260929|NCT00578786|322750284|FG001|Overall Study|Lost to Follow-up|4|||
94260930|NCT00578786|322750285|FG002|Overall Study|Lost to Follow-up|0|||
94260931|NCT00578786|322750283|FG000|Overall Study|Pregnancy|0|||
94260932|NCT00578786|322750284|FG001|Overall Study|Pregnancy|1|||
94260933|NCT00578786|322750285|FG002|Overall Study|Pregnancy|0|||
94260934|NCT00578786|322750283|FG000|Overall Study|Not Otherwise Specified|0|||
94260935|NCT00578786|322750284|FG001|Overall Study|Not Otherwise Specified|4|||
94260936|NCT00578786|322750285|FG002|Overall Study|Not Otherwise Specified|1|||
94260937|NCT00578786|322750283|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
94260938|NCT00578786|322750284|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
94260939|NCT00578786|322750285|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
94260940|NCT00866723|322750286|FG000|Overall Study|Withdrawal by Subject|1|||
94260941|NCT00866723|322750286|FG000|Overall Study|Disease Progression|4|||
94260942|NCT01067326|322750289|FG000|Overall Study|Adverse Event|0|||
94260943|NCT01067326|322750290|FG001|Overall Study|Adverse Event|2|||
94260944|NCT01067326|322750289|FG000|Overall Study|Withdrawal by Subject|1|||
94260945|NCT01067326|322750290|FG001|Overall Study|Withdrawal by Subject|0|||
94260946|NCT01067326|322750289|FG000|Overall Study|Early Study Termination|1|||
94260947|NCT01067326|322750290|FG001|Overall Study|Early Study Termination|1|||
94260948|NCT00769860|322750291|FG000|Overall Study|Withdrawal by Subject|2|||
94260949|NCT00769860|322750292|FG001|Overall Study|Withdrawal by Subject|0|||
94260950|NCT00323297|322750293|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
94260951|NCT00323297|322750294|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
94260952|NCT00323297|322750293|FG000|Part A (Double Blind Randomized)|Death|0|||
94260953|NCT00323297|322750294|FG001|Part A (Double Blind Randomized)|Death|1|||
94260954|NCT00323297|322750293|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
94260955|NCT00323297|322750294|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
94260956|NCT00323297|322750293|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
94260957|NCT00323297|322750294|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
94260958|NCT00323297|322750293|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
94260959|NCT00323297|322750294|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
94260960|NCT00323297|322750293|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
94260961|NCT00323297|322750294|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
94260962|NCT00323297|322750293|FG000|Part B (Open-label)|Death|0|||
94260963|NCT00323297|322750294|FG001|Part B (Open-label)|Death|1|||
94260964|NCT00323297|322750293|FG000|Part B (Open-label)|Reason unspecified|0|||
94260965|NCT00323297|322750294|FG001|Part B (Open-label)|Reason unspecified|1|||
94260966|NCT00323297|322750293|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
94260967|NCT00323297|322750294|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
94260968|NCT00323297|322750293|FG000|Part B (Open-label)|Lack of Efficacy|3|||
94260969|NCT00323297|322750294|FG001|Part B (Open-label)|Lack of Efficacy|1|||
94260970|NCT00323297|322750293|FG000|Part B (Open-label)|Adverse Event|5|||
94260971|NCT00323297|322750294|FG001|Part B (Open-label)|Adverse Event|5|||
94260972|NCT00323297|322750293|FG000|Part B (Open-label)|Protocol Violation|0|||
94260973|NCT00323297|322750294|FG001|Part B (Open-label)|Protocol Violation|1|||
94260974|NCT01003990|322750295|FG000|Overall Study|Adverse Event|8|||
94260975|NCT01003990|322750296|FG001|Overall Study|Adverse Event|5|||
94260976|NCT01003990|322750297|FG002|Overall Study|Adverse Event|11|||
94260977|NCT01003990|322750295|FG000|Overall Study|Death|0|||
94260978|NCT01003990|322750296|FG001|Overall Study|Death|8|||
94260979|NCT01003990|322750297|FG002|Overall Study|Death|1|||
94260980|NCT01003990|322750295|FG000|Overall Study|Lack of Efficacy|10|||
94260981|NCT01003990|322750296|FG001|Overall Study|Lack of Efficacy|2|||
94260982|NCT01003990|322750297|FG002|Overall Study|Lack of Efficacy|3|||
94260983|NCT01003990|322750295|FG000|Overall Study|Lost to Follow-up|30|||
94260984|NCT01003990|322750296|FG001|Overall Study|Lost to Follow-up|12|||
94260985|NCT01003990|322750297|FG002|Overall Study|Lost to Follow-up|7|||
94260986|NCT01003990|322750295|FG000|Overall Study|Reasons Not Identified|14|||
94260987|NCT01003990|322750296|FG001|Overall Study|Reasons Not Identified|13|||
94633020|NCT01996709|324116382|FG001|Overall Study|Lost to Follow-up|0|||
94260988|NCT01003990|322750297|FG002|Overall Study|Reasons Not Identified|8|||
94260989|NCT01003990|322750295|FG000|Overall Study|Poor/Non-compliance|4|||
94260990|NCT01003990|322750296|FG001|Overall Study|Poor/Non-compliance|3|||
94260991|NCT01003990|322750297|FG002|Overall Study|Poor/Non-compliance|2|||
94260992|NCT01003990|322750295|FG000|Overall Study|Pregnancy|10|||
94260993|NCT01003990|322750296|FG001|Overall Study|Pregnancy|2|||
94260994|NCT01003990|322750297|FG002|Overall Study|Pregnancy|4|||
94633021|NCT01996709|324116381|FG000|Overall Study|Subject Non-Compliant|1|||
94633022|NCT01996709|324116382|FG001|Overall Study|Subject Non-Compliant|0|||
94633023|NCT01996709|324116381|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
94633024|NCT01996709|324116382|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
94633025|NCT00492115|324116383|FG000|Overall Study|Withdrawal by Subject|3|||
94260995|NCT01003990|322750295|FG000|Overall Study|No Longer Met Study Criteria|4|||
94260996|NCT01003990|322750296|FG001|Overall Study|No Longer Met Study Criteria|1|||
94260997|NCT01003990|322750297|FG002|Overall Study|No Longer Met Study Criteria|0|||
94260998|NCT01003990|322750295|FG000|Overall Study|Subject Withdrew Consent|12|||
94260999|NCT01003990|322750296|FG001|Overall Study|Subject Withdrew Consent|5|||
94261000|NCT01003990|322750297|FG002|Overall Study|Subject Withdrew Consent|7|||
94261001|NCT01271803|322750298|FG000|Overall Study|Progressive disease|0|||
94261002|NCT01271803|322750299|FG001|Overall Study|Progressive disease|0|||
94261003|NCT01271803|322750300|FG002|Overall Study|Progressive disease|2|||
94261004|NCT01271803|322750298|FG000|Overall Study|Death|53|||
94261005|NCT01271803|322750299|FG001|Overall Study|Death|34|||
94261006|NCT01271803|322750300|FG002|Overall Study|Death|0|||
94261007|NCT01271803|322750298|FG000|Overall Study|Withdrawal by Subject|1|||
94261008|NCT01271803|322750299|FG001|Overall Study|Withdrawal by Subject|5|||
94261009|NCT01271803|322750300|FG002|Overall Study|Withdrawal by Subject|0|||
94261010|NCT01271803|322750298|FG000|Overall Study|Lost to Follow-up|1|||
94261011|NCT01271803|322750299|FG001|Overall Study|Lost to Follow-up|0|||
94261012|NCT01271803|322750300|FG002|Overall Study|Lost to Follow-up|0|||
94261013|NCT01603082|322750301|FG000|Overall Study|Adverse Event|0|||
94261014|NCT01603082|322750302|FG001|Overall Study|Adverse Event|1|||
94261015|NCT01603082|322750301|FG000|Overall Study|Withdrawal by Subject|1|||
94261016|NCT01603082|322750302|FG001|Overall Study|Withdrawal by Subject|0|||
94261017|NCT01603082|322750301|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
94261018|NCT01603082|322750302|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
94261019|NCT01176773|322750304|FG000|Overall Study|Screen Failure|2|||
94261020|NCT01176773|322750304|FG000|Overall Study|Withdrew consent|1|||
94261021|NCT00394953|322750305|FG000|First Treatment Period|Adverse Event|1|||
94261022|NCT00394953|322750306|FG001|First Treatment Period|Adverse Event|2|||
94261023|NCT00394953|322750305|FG000|First Treatment Period|Death|6|||
94261024|NCT00394953|322750306|FG001|First Treatment Period|Death|7|||
94261025|NCT00394953|322750305|FG000|First Treatment Period|Lack of Efficacy|1|||
94261026|NCT00394953|322750306|FG001|First Treatment Period|Lack of Efficacy|1|||
94261027|NCT00394953|322750305|FG000|First Treatment Period|Withdrawal by Subject|6|||
94261028|NCT00394953|322750306|FG001|First Treatment Period|Withdrawal by Subject|3|||
94261029|NCT00394953|322750305|FG000|First Treatment Period|Lost to Follow-up|0|||
94261030|NCT00394953|322750306|FG001|First Treatment Period|Lost to Follow-up|1|||
94261031|NCT00394953|322750305|FG000|First Treatment Period|Renal transplant|11|||
94261032|NCT00394953|322750306|FG001|First Treatment Period|Renal transplant|7|||
94261033|NCT00394953|322750305|FG000|First Treatment Period|Not defined|4|||
94261034|NCT00394953|322750306|FG001|First Treatment Period|Not defined|1|||
94261035|NCT00394953|322750305|FG000|Second Treatment Period|Adverse Event|2|||
94261036|NCT00394953|322750306|FG001|Second Treatment Period|Adverse Event|5|||
94261037|NCT00394953|322750305|FG000|Second Treatment Period|Death|8|||
94261038|NCT00394953|322750306|FG001|Second Treatment Period|Death|4|||
94261039|NCT00394953|322750305|FG000|Second Treatment Period|Lack of Efficacy|9|||
94261040|NCT00394953|322750306|FG001|Second Treatment Period|Lack of Efficacy|47|||
94261041|NCT00394953|322750305|FG000|Second Treatment Period|Withdrawal by Subject|3|||
94261042|NCT00394953|322750306|FG001|Second Treatment Period|Withdrawal by Subject|3|||
94261043|NCT00394953|322750305|FG000|Second Treatment Period|Lost to Follow-up|0|||
94261044|NCT00394953|322750306|FG001|Second Treatment Period|Lost to Follow-up|1|||
94261045|NCT00394953|322750305|FG000|Second Treatment Period|Renal transplant|4|||
94261046|NCT00394953|322750306|FG001|Second Treatment Period|Renal transplant|6|||
94261047|NCT00394953|322750305|FG000|Second Treatment Period|Not defined|3|||
94261048|NCT00394953|322750306|FG001|Second Treatment Period|Not defined|8|||
94261049|NCT01971203|322750317|FG000|Overall Study|Protocol Violation|3|||
94261050|NCT01971203|322750318|FG001|Overall Study|Protocol Violation|2|||
94261051|NCT01971203|322750317|FG000|Overall Study|Withdrawal by Subject|5|||
94261052|NCT01971203|322750318|FG001|Overall Study|Withdrawal by Subject|6|||
94261053|NCT01971203|322750317|FG000|Overall Study|Adverse Event|1|||
94261054|NCT01971203|322750318|FG001|Overall Study|Adverse Event|0|||
94261055|NCT03037619|322750320|FG000|Overall Study|Lost to Follow-up|0|||
94261056|NCT03037619|322750321|FG001|Overall Study|Lost to Follow-up|1|||
94261057|NCT01794923|322750328|FG000|Overall Study|Adverse Event|0|||
94633026|NCT00492115|324116384|FG001|Overall Study|Withdrawal by Subject|4|||
94261058|NCT01794923|322750329|FG001|Overall Study|Adverse Event|0|||
94261059|NCT01794923|322750330|FG002|Overall Study|Adverse Event|1|||
94261060|NCT01881750|322750331|FG000|Overall Study|Changes in concomitant therapies|2|||
94261061|NCT01881750|322750332|FG001|Overall Study|Changes in concomitant therapies|3|||
94261062|NCT01881750|322750331|FG000|Overall Study|Lost to Follow-up|0|||
94261063|NCT01881750|322750332|FG001|Overall Study|Lost to Follow-up|1|||
94261064|NCT00307125|322750333|FG000|Screening Phase|Adverse Event|1|||
94633027|NCT03564145|324116387|FG000|Overall Study|Adverse Event|4|||
94633028|NCT03564145|324116387|FG000|Overall Study|Lost to Follow-up|21|||
94633029|NCT03564145|324116387|FG000|Overall Study|Protocol Violation|2|||
94633030|NCT03564145|324116387|FG000|Overall Study|Withdrawal by Subject|48|||
94633031|NCT03564145|324116387|FG000|Overall Study|Study Terminated by Sponsor|146|||
94633032|NCT03564145|324116387|FG000|Overall Study|Physician Decision|1|||
94633033|NCT03564145|324116387|FG000|Overall Study|Other Than Specified|1|||
94633034|NCT03564145|324116387|FG000|Overall Study|Pregnancy|1|||
94633035|NCT02636868|324117923|FG000|Overall Study|Death|0|||
94633036|NCT02636868|324117924|FG001|Overall Study|Death|1|||
94633037|NCT02636868|324117925|FG002|Overall Study|Death|2|||
94633038|NCT00696696|324117927|FG000|Overall Study|Adverse Event|5|||
94362456|NCT03170271|323110718|FG001|Overall Study|Other|2|||
94362457|NCT03170271|323110717|FG000|Overall Study|Randomized in error|4|||
94362458|NCT03170271|323110718|FG001|Overall Study|Randomized in error|0|||
94362459|NCT00556166|323110719|FG000|Overall Study|Withdrawal by Subject|1|||
94362460|NCT03345485|323110726|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
94362461|NCT03345485|323110727|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
94362462|NCT03345485|323110728|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
94362463|NCT03345485|323110729|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
94362464|NCT03345485|323110730|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
94362465|NCT03345485|323110731|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
94362466|NCT03345485|323110732|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
94362467|NCT03345485|323110733|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
94362468|NCT03345485|323110734|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
94362469|NCT03345485|323110735|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
94362470|NCT03345485|323110736|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
94362471|NCT03345485|323110737|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
94362472|NCT03345485|323110738|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
94362473|NCT02985515|323110739|FG000|Olfaction Testing|Lost to Follow-up|0|||
94261065|NCT00307125|322750334|FG001|Screening Phase|Adverse Event|0|||
94261066|NCT00307125|322750335|FG002|Screening Phase|Adverse Event|0|||
94261067|NCT00307125|322750333|FG000|Screening Phase|Protocol Violation|27|||
94261068|NCT00307125|322750334|FG001|Screening Phase|Protocol Violation|0|||
94261069|NCT00307125|322750335|FG002|Screening Phase|Protocol Violation|0|||
94261070|NCT00307125|322750333|FG000|Screening Phase|Lost to Follow-up|87|||
94261071|NCT00307125|322750334|FG001|Screening Phase|Lost to Follow-up|0|||
94261072|NCT00307125|322750335|FG002|Screening Phase|Lost to Follow-up|0|||
94261073|NCT00307125|322750333|FG000|Screening Phase|Death|10|||
94261074|NCT00307125|322750334|FG001|Screening Phase|Death|0|||
94261075|NCT00307125|322750335|FG002|Screening Phase|Death|0|||
94261076|NCT00307125|322750333|FG000|Screening Phase|Withdrawal by Subject|77|||
94261077|NCT00307125|322750334|FG001|Screening Phase|Withdrawal by Subject|0|||
94261078|NCT00307125|322750335|FG002|Screening Phase|Withdrawal by Subject|0|||
94261079|NCT00307125|322750333|FG000|Screening Phase|Physician Decision|26|||
94261080|NCT00307125|322750334|FG001|Screening Phase|Physician Decision|0|||
94261081|NCT00307125|322750335|FG002|Screening Phase|Physician Decision|0|||
94261082|NCT00307125|322750333|FG000|Screening Phase|Sponsor Decision|4|||
94261083|NCT00307125|322750334|FG001|Screening Phase|Sponsor Decision|0|||
94261084|NCT00307125|322750335|FG002|Screening Phase|Sponsor Decision|0|||
94261085|NCT00307125|322750333|FG000|Screening Phase|Study Terminated|17|||
94261086|NCT00307125|322750334|FG001|Screening Phase|Study Terminated|0|||
94261087|NCT00307125|322750335|FG002|Screening Phase|Study Terminated|0|||
94261088|NCT00307125|322750333|FG000|Screening Phase|Graft Loss|3|||
94261089|NCT00307125|322750334|FG001|Screening Phase|Graft Loss|0|||
94261090|NCT00307125|322750335|FG002|Screening Phase|Graft Loss|0|||
94261091|NCT00307125|322750333|FG000|Screening Phase|Graft Failure|8|||
94261092|NCT00307125|322750334|FG001|Screening Phase|Graft Failure|0|||
94261093|NCT00307125|322750335|FG002|Screening Phase|Graft Failure|0|||
94261094|NCT00307125|322750333|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
94261095|NCT00307125|322750334|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
94261096|NCT00307125|322750335|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
94261097|NCT00307125|322750333|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
94261098|NCT00307125|322750334|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
94261099|NCT00307125|322750335|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
94261100|NCT00307125|322750333|FG000|Screening Phase|Moved or transferred facilities|34|||
94261101|NCT00307125|322750334|FG001|Screening Phase|Moved or transferred facilities|0|||
94261102|NCT00307125|322750335|FG002|Screening Phase|Moved or transferred facilities|0|||
94261103|NCT00307125|322750333|FG000|Screening Phase|Received Pancreas Transplant|8|||
94261104|NCT00307125|322750334|FG001|Screening Phase|Received Pancreas Transplant|0|||
94261105|NCT00307125|322750335|FG002|Screening Phase|Received Pancreas Transplant|0|||
94261106|NCT00307125|322750333|FG000|Screening Phase|Ineligible for pilot|4|||
94261107|NCT00307125|322750334|FG001|Screening Phase|Ineligible for pilot|0|||
94261108|NCT00307125|322750335|FG002|Screening Phase|Ineligible for pilot|0|||
94261109|NCT00307125|322750333|FG000|Screening Phase|Try to get pregnant|1|||
94261110|NCT00307125|322750334|FG001|Screening Phase|Try to get pregnant|0|||
94261111|NCT00307125|322750335|FG002|Screening Phase|Try to get pregnant|0|||
94261112|NCT00307125|322750333|FG000|Screening Phase|Developed acute leukemia|1|||
94261113|NCT00307125|322750334|FG001|Screening Phase|Developed acute leukemia|0|||
94261114|NCT00307125|322750335|FG002|Screening Phase|Developed acute leukemia|0|||
94261115|NCT00307125|322750333|FG000|Screening Phase|Metastatic colon cancer|1|||
94261116|NCT00307125|322750334|FG001|Screening Phase|Metastatic colon cancer|0|||
94261117|NCT00307125|322750335|FG002|Screening Phase|Metastatic colon cancer|0|||
94261118|NCT00307125|322750333|FG000|Screening Phase|Malignancy|1|||
94362474|NCT02985515|323110740|FG001|Olfaction Testing|Lost to Follow-up|5|||
94362475|NCT02985515|323110739|FG000|Olfaction Testing|Protocol Violation|0|||
94633039|NCT00696696|324117927|FG000|Overall Study|Withdrawal by Subject|8|||
94633040|NCT00696696|324117927|FG000|Overall Study|Physician Decision|2|||
94633041|NCT00696696|324117927|FG000|Overall Study|Death|3|||
94633042|NCT00503308|324117931|FG000|Overall Study|Protocol Violation|2|||
94633043|NCT00503308|324117932|FG001|Overall Study|Protocol Violation|1|||
94633044|NCT01034462|324117933|FG000|Overall Study|Adverse Event|7|||
94633045|NCT01034462|324117934|FG001|Overall Study|Adverse Event|17|||
94633046|NCT01034462|324117933|FG000|Overall Study|Lack of Efficacy|4|||
94633047|NCT01034462|324117934|FG001|Overall Study|Lack of Efficacy|4|||
94261119|NCT00307125|322750334|FG001|Screening Phase|Malignancy|0|||
94261120|NCT00307125|322750335|FG002|Screening Phase|Malignancy|0|||
94261121|NCT00307125|322750333|FG000|Screening Phase|PAK|1|||
94633048|NCT01034462|324117933|FG000|Overall Study|Protocol Violation|10|||
94633049|NCT01034462|324117934|FG001|Overall Study|Protocol Violation|7|||
94633050|NCT01034462|324117933|FG000|Overall Study|Withdrawal by Subject|9|||
94633051|NCT01034462|324117934|FG001|Overall Study|Withdrawal by Subject|8|||
94633052|NCT01034462|324117933|FG000|Overall Study|Lost to Follow-up|14|||
94633053|NCT01034462|324117934|FG001|Overall Study|Lost to Follow-up|16|||
94633054|NCT01034462|324117933|FG000|Overall Study|Other reasons|1|||
94676064|NCT00394355|324267113|FG000|Overall Study|Noncompliance with protocol|4|||
94676065|NCT00394355|324267114|FG001|Overall Study|Noncompliance with protocol|3|||
94676066|NCT00394355|324267115|FG002|Overall Study|Noncompliance with protocol|10|||
94261122|NCT00307125|322750334|FG001|Screening Phase|PAK|0|||
94633055|NCT01034462|324117934|FG001|Overall Study|Other reasons|2|||
94362476|NCT02985515|323110740|FG001|Olfaction Testing|Protocol Violation|3|||
94362477|NCT01856257|323110743|FG000|Overall Study|Death|2|||
94362478|NCT01856257|323110744|FG001|Overall Study|Death|0|||
94362479|NCT01856257|323110745|FG002|Overall Study|Death|0|||
94362480|NCT01856257|323110746|FG003|Overall Study|Death|0|||
94362481|NCT01856257|323110743|FG000|Overall Study|Physician Decision|0|||
94362482|NCT01856257|323110744|FG001|Overall Study|Physician Decision|0|||
94362483|NCT01856257|323110745|FG002|Overall Study|Physician Decision|0|||
94362484|NCT01856257|323110746|FG003|Overall Study|Physician Decision|1|||
94362485|NCT01856257|323110743|FG000|Overall Study|Withdrawal by Subject|1|||
94362486|NCT01856257|323110744|FG001|Overall Study|Withdrawal by Subject|1|||
94362487|NCT01856257|323110745|FG002|Overall Study|Withdrawal by Subject|0|||
94362488|NCT01856257|323110746|FG003|Overall Study|Withdrawal by Subject|0|||
94362489|NCT01856257|323110743|FG000|Overall Study|Donor complication|0|||
94362490|NCT01856257|323110744|FG001|Overall Study|Donor complication|0|||
94362491|NCT01856257|323110745|FG002|Overall Study|Donor complication|0|||
94362492|NCT01856257|323110746|FG003|Overall Study|Donor complication|1|||
94362493|NCT04797637|323110756|FG000|Overall Study|Lost to Follow-up|23|||
94362494|NCT04797637|323110757|FG001|Overall Study|Lost to Follow-up|32|||
94362495|NCT04797637|323110756|FG000|Overall Study|Withdrawal by Subject|0|||
94362496|NCT04797637|323110757|FG001|Overall Study|Withdrawal by Subject|1|||
94362497|NCT00061568|323110760|FG000|Overall Study|Lost to Follow-up|12|||
94362498|NCT00061568|323110761|FG001|Overall Study|Lost to Follow-up|0|||
94362499|NCT00061568|323110760|FG000|Overall Study|Death|6|||
94362500|NCT00061568|323110761|FG001|Overall Study|Death|0|||
94362501|NCT00061568|323110760|FG000|Overall Study|Withdrawal by Subject|1|||
94362502|NCT00061568|323110761|FG001|Overall Study|Withdrawal by Subject|0|||
94362503|NCT03239340|323110762|FG000|Overall Study|Other|26|||
94362504|NCT03239340|323110762|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
94362505|NCT03239340|323110762|FG000|Overall Study|Death|40|||
94362506|NCT03239340|323110762|FG000|Overall Study|Lost to Follow-up|2|||
94362507|NCT03239340|323110762|FG000|Overall Study|Physician Decision|16|||
94633056|NCT00788151|324117935|FG000|Overall Study|Other adverse event|0|||
94362508|NCT03239340|323110762|FG000|Overall Study|Withdrawal by Subject|27|||
94362509|NCT03868059|323110763|FG000|Overall Study|Adverse Event|3|||
94633057|NCT00788151|324117936|FG001|Overall Study|Other adverse event|2|||
94633058|NCT00788151|324117935|FG000|Overall Study|Protocol Violation|0|||
94633059|NCT00788151|324117936|FG001|Overall Study|Protocol Violation|1|||
94633060|NCT00788151|324117935|FG000|Overall Study|Withdrawal by Subject|13|||
94633061|NCT00788151|324117936|FG001|Overall Study|Withdrawal by Subject|6|||
94633062|NCT00788151|324117935|FG000|Overall Study|Enrolled but not treated|1|||
94633063|NCT00788151|324117936|FG001|Overall Study|Enrolled but not treated|1|||
94633064|NCT03635957|324117937|FG000|Run-In Period|Lost to Follow-up|1|||
94633065|NCT03635957|324117937|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
94633066|NCT00350636|324117938|FG000|Overall Study|Adverse Event|19|||
94633067|NCT00350636|324117939|FG001|Overall Study|Adverse Event|13|||
94676067|NCT00394355|324267116|FG003|Overall Study|Noncompliance with protocol|8|||
94362510|NCT03868059|323110763|FG000|Overall Study|Lost to Follow-up|3|||
94362511|NCT03868059|323110763|FG000|Overall Study|Withdrawal by Subject|6|||
94362512|NCT02061293|323110764|FG000|Overall Study|Elevated Blood Pressure|1|||
94676068|NCT00394355|324267113|FG000|Overall Study|Administrative|0|||
94676069|NCT00394355|324267114|FG001|Overall Study|Administrative|1|||
94676070|NCT00394355|324267115|FG002|Overall Study|Administrative|1|||
94676071|NCT00394355|324267116|FG003|Overall Study|Administrative|1|||
94676072|NCT00394355|324267113|FG000|Overall Study|Lack of Efficacy|0|||
94676073|NCT00394355|324267114|FG001|Overall Study|Lack of Efficacy|0|||
94676074|NCT00394355|324267115|FG002|Overall Study|Lack of Efficacy|2|||
94676075|NCT00394355|324267116|FG003|Overall Study|Lack of Efficacy|3|||
94676076|NCT01648348|324267120|FG000|Overall Study|Cancel|1|||
94676077|NCT01648348|324267121|FG001|Overall Study|Cancel|0|||
94261123|NCT00307125|322750335|FG002|Screening Phase|PAK|0|||
94261124|NCT00307125|322750333|FG000|Screening Phase|Ineligible|1|||
94261125|NCT00307125|322750334|FG001|Screening Phase|Ineligible|0|||
94261126|NCT00307125|322750335|FG002|Screening Phase|Ineligible|0|||
94261127|NCT00307125|322750333|FG000|Screening Phase|Screen Error|1|||
94261128|NCT00307125|322750334|FG001|Screening Phase|Screen Error|0|||
94261129|NCT00307125|322750335|FG002|Screening Phase|Screen Error|0|||
94261130|NCT00307125|322750333|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
94261131|NCT00307125|322750334|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
94676078|NCT01648348|324267122|FG002|Overall Study|Cancel|0|||
94261132|NCT00307125|322750335|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
94261133|NCT00307125|322750333|FG000|Screening Phase|AMR and treated with rituximab|1|||
94261134|NCT00307125|322750334|FG001|Screening Phase|AMR and treated with rituximab|0|||
94261135|NCT00307125|322750335|FG002|Screening Phase|AMR and treated with rituximab|0|||
94261136|NCT00307125|322750333|FG000|Screening Phase|Coronary artery bypass|1|||
94261137|NCT00307125|322750334|FG001|Screening Phase|Coronary artery bypass|0|||
94261138|NCT00307125|322750335|FG002|Screening Phase|Coronary artery bypass|0|||
94261139|NCT00307125|322750333|FG000|Pilot Phase|Lost to Follow-up|0|||
94261140|NCT00307125|322750334|FG001|Pilot Phase|Lost to Follow-up|1|||
94261141|NCT00307125|322750335|FG002|Pilot Phase|Lost to Follow-up|0|||
94261142|NCT00307125|322750333|FG000|Pilot Phase|Withdrawal by Subject|0|||
94261143|NCT00307125|322750334|FG001|Pilot Phase|Withdrawal by Subject|1|||
94261144|NCT00307125|322750335|FG002|Pilot Phase|Withdrawal by Subject|1|||
94261145|NCT01717768|322750336|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
94261146|NCT01717768|322750337|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
94261147|NCT01717768|322750338|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
94261148|NCT01717768|322750339|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
94261149|NCT01717768|322750340|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
94261150|NCT01717768|322750341|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
94261151|NCT01717768|322750342|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
94261152|NCT01717768|322750343|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
94261153|NCT01717768|322750344|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
94261154|NCT01717768|322750345|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
94261155|NCT01717768|322750346|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
94261156|NCT01717768|322750347|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
94261157|NCT01717768|322750336|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
94261158|NCT01717768|322750337|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
94261159|NCT01717768|322750338|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
94261160|NCT01717768|322750339|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
94261161|NCT01717768|322750340|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
94261162|NCT01717768|322750341|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
94261163|NCT01717768|322750342|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
94261164|NCT01717768|322750343|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
94261165|NCT01717768|322750344|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
94261166|NCT01717768|322750345|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
94261167|NCT01717768|322750346|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
94261168|NCT01717768|322750347|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
94261169|NCT01717768|322750336|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
94261170|NCT01717768|322750337|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
94362513|NCT02061293|323110765|FG001|Overall Study|Elevated Blood Pressure|1|||
94676079|NCT01648348|324267123|FG003|Overall Study|Cancel|0|||
94676080|NCT01648348|324267124|FG004|Overall Study|Cancel|3|||
94676081|NCT01648348|324267125|FG005|Overall Study|Cancel|6|||
94261171|NCT01717768|322750338|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
94261172|NCT01717768|322750339|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
94261173|NCT01717768|322750340|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
94261174|NCT01717768|322750341|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
94261175|NCT01717768|322750342|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
94362514|NCT03075215|323110766|FG000|12-Month Primary Endpoint|Death|152|||
94676082|NCT01648348|324267120|FG000|Overall Study|Replaced for MTD analysis|1|||
94676083|NCT01648348|324267121|FG001|Overall Study|Replaced for MTD analysis|0|||
94676084|NCT01648348|324267122|FG002|Overall Study|Replaced for MTD analysis|1|||
94633068|NCT00350636|324117938|FG000|Overall Study|Protocol Violation|1|||
94633069|NCT00350636|324117939|FG001|Overall Study|Protocol Violation|3|||
94633070|NCT00350636|324117938|FG000|Overall Study|Withdrawal by Subject|13|||
94261176|NCT01717768|322750343|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
94261177|NCT01717768|322750344|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
94261178|NCT01717768|322750345|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
94261179|NCT01717768|322750346|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
94261180|NCT01717768|322750347|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
94261181|NCT01717768|322750336|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
94261182|NCT01717768|322750337|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
94261183|NCT01717768|322750338|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
94261184|NCT01717768|322750339|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
94261185|NCT01717768|322750340|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
94261186|NCT01717768|322750341|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
94633071|NCT00350636|324117939|FG001|Overall Study|Withdrawal by Subject|17|||
94633072|NCT00350636|324117938|FG000|Overall Study|Lost to Follow-up|9|||
94633073|NCT00350636|324117939|FG001|Overall Study|Lost to Follow-up|8|||
94633074|NCT00350636|324117938|FG000|Overall Study|Physician Decision|0|||
94633075|NCT00350636|324117939|FG001|Overall Study|Physician Decision|2|||
94633076|NCT00350636|324117938|FG000|Overall Study|Other|1|||
94633077|NCT00350636|324117939|FG001|Overall Study|Other|2|||
94633078|NCT02877082|324117940|FG000|Overall Study|Trial was closed early|5|||
94633079|NCT00849381|324117942|FG000|Overall Study|Adverse Event|1|||
94633080|NCT00849381|324117942|FG000|Overall Study|Lost to Follow-up|129|||
94633081|NCT00849381|324117942|FG000|Overall Study|Protocol Violation|5|||
94633082|NCT00849381|324117942|FG000|Overall Study|Withdrawal by Subject|6|||
94633083|NCT00849381|324117942|FG000|Overall Study|Other|4|||
94633084|NCT04532099|324117943|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
94633085|NCT04532099|324117944|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
94633086|NCT04532099|324117945|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
94633087|NCT02618434|324117946|FG000|Overall Study|Withdrawal by Subject|0|||
94633088|NCT02618434|324117947|FG001|Overall Study|Withdrawal by Subject|2|||
94633089|NCT02618434|324117948|FG002|Overall Study|Withdrawal by Subject|3|||
94633090|NCT02618434|324117946|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
94633091|NCT02618434|324117947|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
94633092|NCT02618434|324117948|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
94633093|NCT02618434|324117946|FG000|Overall Study|Lost to Follow-up|3|||
94633094|NCT02618434|324117947|FG001|Overall Study|Lost to Follow-up|1|||
94633095|NCT02618434|324117948|FG002|Overall Study|Lost to Follow-up|3|||
94633096|NCT02618434|324117946|FG000|Overall Study|Adverse Event|1|||
94261187|NCT01717768|322750342|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
94261188|NCT01717768|322750343|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
94261189|NCT01717768|322750344|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
94261190|NCT01717768|322750345|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
94261191|NCT01717768|322750346|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
94261192|NCT01717768|322750347|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
94261193|NCT04427501|322750348|FG000|Overall Study|Death|0|||
94261194|NCT04427501|322750349|FG001|Overall Study|Death|0|||
94261195|NCT04427501|322750350|FG002|Overall Study|Death|0|||
94261196|NCT04427501|322750351|FG003|Overall Study|Death|0|||
94261197|NCT04427501|322750352|FG004|Overall Study|Death|0|||
94261198|NCT04427501|322750353|FG005|Overall Study|Death|15|||
94261199|NCT04427501|322750354|FG006|Overall Study|Death|0|||
94261200|NCT04427501|322750355|FG007|Overall Study|Death|0|||
94261201|NCT04427501|322750356|FG008|Overall Study|Death|0|||
94261202|NCT04427501|322750357|FG009|Overall Study|Death|0|||
94261203|NCT04427501|322750358|FG010|Overall Study|Death|0|||
94261204|NCT04427501|322750359|FG011|Overall Study|Death|0|||
94261205|NCT04427501|322750348|FG000|Overall Study|Lost to Follow-up|5|||
94261206|NCT04427501|322750349|FG001|Overall Study|Lost to Follow-up|1|||
94261207|NCT04427501|322750350|FG002|Overall Study|Lost to Follow-up|2|||
94261208|NCT04427501|322750351|FG003|Overall Study|Lost to Follow-up|0|||
94261209|NCT04427501|322750352|FG004|Overall Study|Lost to Follow-up|2|||
94261210|NCT04427501|322750353|FG005|Overall Study|Lost to Follow-up|11|||
94261211|NCT04427501|322750354|FG006|Overall Study|Lost to Follow-up|10|||
94633097|NCT02618434|324117947|FG001|Overall Study|Adverse Event|0|||
94633098|NCT02618434|324117948|FG002|Overall Study|Adverse Event|12|||
94633099|NCT02618434|324117946|FG000|Overall Study|Physician Decision|0|||
94633100|NCT02618434|324117947|FG001|Overall Study|Physician Decision|1|||
94633101|NCT02618434|324117948|FG002|Overall Study|Physician Decision|0|||
94633102|NCT02618434|324117946|FG000|Overall Study|Protocol Violation|0|||
94633103|NCT02618434|324117947|FG001|Overall Study|Protocol Violation|0|||
94633104|NCT02618434|324117948|FG002|Overall Study|Protocol Violation|1|||
94633105|NCT02618434|324117946|FG000|Overall Study|Other, Multiple categories|1|||
94261212|NCT04427501|322750355|FG007|Overall Study|Lost to Follow-up|10|||
94362515|NCT03075215|323110766|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
94633106|NCT02618434|324117947|FG001|Overall Study|Other, Multiple categories|1|||
94633107|NCT02618434|324117948|FG002|Overall Study|Other, Multiple categories|1|||
94633108|NCT03590041|324117951|FG000|Overall Study|Protocol Violation|4|||
94633109|NCT03590041|324117952|FG001|Overall Study|Protocol Violation|3|||
94633110|NCT03590041|324117951|FG000|Overall Study|No session data recorded|14|||
94633111|NCT03590041|324117952|FG001|Overall Study|No session data recorded|2|||
94633112|NCT02066233|324117955|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
94633113|NCT02066233|324117956|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
94633114|NCT02772081|324117957|FG000|Overall Study|Physician Decision|1|||
94633115|NCT02772081|324117958|FG001|Overall Study|Physician Decision|1|||
94633116|NCT02772081|324117957|FG000|Overall Study|Death|1|||
94633117|NCT02772081|324117958|FG001|Overall Study|Death|1|||
94633118|NCT00498602|324117963|FG000|Overall Study|Death|0|||
94633119|NCT00498602|324117964|FG001|Overall Study|Death|0|||
94633120|NCT00498602|324117965|FG002|Overall Study|Death|0|||
94633121|NCT00498602|324117966|FG003|Overall Study|Death|0|||
94633122|NCT00498602|324117967|FG004|Overall Study|Death|0|||
94633123|NCT00498602|324117968|FG005|Overall Study|Death|1|||
94633124|NCT00498602|324117969|FG006|Overall Study|Death|0|||
94633125|NCT00498602|324117963|FG000|Overall Study|Lack of Efficacy|1|||
94633126|NCT00498602|324117964|FG001|Overall Study|Lack of Efficacy|0|||
94633127|NCT00498602|324117965|FG002|Overall Study|Lack of Efficacy|0|||
94633128|NCT00498602|324117966|FG003|Overall Study|Lack of Efficacy|0|||
94633129|NCT00498602|324117967|FG004|Overall Study|Lack of Efficacy|0|||
94633130|NCT00498602|324117968|FG005|Overall Study|Lack of Efficacy|0|||
94633131|NCT00498602|324117969|FG006|Overall Study|Lack of Efficacy|0|||
94633132|NCT00498602|324117963|FG000|Overall Study|Lost to Follow-up|0|||
94633133|NCT00498602|324117964|FG001|Overall Study|Lost to Follow-up|2|||
94633134|NCT00498602|324117965|FG002|Overall Study|Lost to Follow-up|0|||
94633135|NCT00498602|324117966|FG003|Overall Study|Lost to Follow-up|2|||
94633136|NCT00498602|324117967|FG004|Overall Study|Lost to Follow-up|0|||
94633137|NCT00498602|324117968|FG005|Overall Study|Lost to Follow-up|0|||
94362516|NCT03075215|323110766|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
94633138|NCT00498602|324117969|FG006|Overall Study|Lost to Follow-up|0|||
94633139|NCT00498602|324117963|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
94633140|NCT00498602|324117964|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
94633141|NCT00498602|324117965|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
94633142|NCT00498602|324117966|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
94261213|NCT04427501|322750356|FG008|Overall Study|Lost to Follow-up|2|||
94261214|NCT04427501|322750357|FG009|Overall Study|Lost to Follow-up|5|||
94261215|NCT04427501|322750358|FG010|Overall Study|Lost to Follow-up|2|||
94261216|NCT04427501|322750359|FG011|Overall Study|Lost to Follow-up|0|||
94261217|NCT04427501|322750348|FG000|Overall Study|Physician Decision|0|||
94261218|NCT04427501|322750349|FG001|Overall Study|Physician Decision|3|||
94261219|NCT04427501|322750350|FG002|Overall Study|Physician Decision|0|||
94261220|NCT04427501|322750351|FG003|Overall Study|Physician Decision|0|||
94362517|NCT03075215|323110766|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
94362518|NCT01058707|323110767|FG000|Overall Study|Disease Progression|15|||
94261221|NCT04427501|322750352|FG004|Overall Study|Physician Decision|0|||
94261222|NCT04427501|322750353|FG005|Overall Study|Physician Decision|0|||
94362519|NCT01058707|323110768|FG001|Overall Study|Disease Progression|20|||
94261223|NCT04427501|322750354|FG006|Overall Study|Physician Decision|2|||
94362520|NCT01058707|323110769|FG002|Overall Study|Disease Progression|20|||
94362521|NCT01058707|323110770|FG003|Overall Study|Disease Progression|15|||
94362522|NCT01058707|323110771|FG004|Overall Study|Disease Progression|23|||
94362523|NCT01058707|323110772|FG005|Overall Study|Disease Progression|10|||
94362524|NCT01058707|323110773|FG006|Overall Study|Disease Progression|12|||
94362525|NCT01058707|323110767|FG000|Overall Study|Adverse Event|11|||
94362526|NCT01058707|323110768|FG001|Overall Study|Adverse Event|4|||
94362527|NCT01058707|323110769|FG002|Overall Study|Adverse Event|7|||
94362528|NCT01058707|323110770|FG003|Overall Study|Adverse Event|6|||
94261224|NCT04427501|322750355|FG007|Overall Study|Physician Decision|0|||
94261225|NCT04427501|322750356|FG008|Overall Study|Physician Decision|0|||
94362529|NCT01058707|323110771|FG004|Overall Study|Adverse Event|7|||
94362530|NCT01058707|323110772|FG005|Overall Study|Adverse Event|3|||
94633143|NCT00498602|324117967|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
94633144|NCT00498602|324117968|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
94633145|NCT00498602|324117969|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
94633146|NCT00498602|324117963|FG000|Overall Study|AE not related to Study Drug|1|||
94633147|NCT00498602|324117964|FG001|Overall Study|AE not related to Study Drug|3|||
94633148|NCT00498602|324117965|FG002|Overall Study|AE not related to Study Drug|0|||
94633149|NCT00498602|324117966|FG003|Overall Study|AE not related to Study Drug|0|||
94633150|NCT00498602|324117967|FG004|Overall Study|AE not related to Study Drug|2|||
94633151|NCT00498602|324117968|FG005|Overall Study|AE not related to Study Drug|2|||
94633152|NCT00498602|324117969|FG006|Overall Study|AE not related to Study Drug|1|||
94633153|NCT00498602|324117963|FG000|Overall Study|Caregiver Request|2|||
94633154|NCT00498602|324117964|FG001|Overall Study|Caregiver Request|2|||
94633155|NCT00498602|324117965|FG002|Overall Study|Caregiver Request|2|||
94633156|NCT00498602|324117966|FG003|Overall Study|Caregiver Request|0|||
94633157|NCT00498602|324117967|FG004|Overall Study|Caregiver Request|1|||
94633158|NCT00498602|324117968|FG005|Overall Study|Caregiver Request|2|||
94633159|NCT00498602|324117969|FG006|Overall Study|Caregiver Request|0|||
94633160|NCT00498602|324117963|FG000|Overall Study|Investigator Request|0|||
94633161|NCT00498602|324117964|FG001|Overall Study|Investigator Request|0|||
94633162|NCT00498602|324117965|FG002|Overall Study|Investigator Request|1|||
94633163|NCT00498602|324117966|FG003|Overall Study|Investigator Request|0|||
94633164|NCT00498602|324117967|FG004|Overall Study|Investigator Request|0|||
94633165|NCT00498602|324117968|FG005|Overall Study|Investigator Request|0|||
94633166|NCT00498602|324117969|FG006|Overall Study|Investigator Request|0|||
94633167|NCT00498602|324117963|FG000|Overall Study|Subject Request|3|||
94633168|NCT00498602|324117964|FG001|Overall Study|Subject Request|0|||
94633169|NCT00498602|324117965|FG002|Overall Study|Subject Request|1|||
94633170|NCT00498602|324117966|FG003|Overall Study|Subject Request|1|||
94633171|NCT00498602|324117967|FG004|Overall Study|Subject Request|1|||
94633172|NCT00498602|324117968|FG005|Overall Study|Subject Request|4|||
94633173|NCT00498602|324117969|FG006|Overall Study|Subject Request|1|||
94633174|NCT00498602|324117963|FG000|Overall Study|Other|2|||
94633175|NCT00498602|324117964|FG001|Overall Study|Other|3|||
94261226|NCT04427501|322750357|FG009|Overall Study|Physician Decision|0|||
94261227|NCT04427501|322750358|FG010|Overall Study|Physician Decision|0|||
94261228|NCT04427501|322750359|FG011|Overall Study|Physician Decision|0|||
94261229|NCT04427501|322750348|FG000|Overall Study|Withdrawal by Subject|9|||
94362531|NCT01058707|323110773|FG006|Overall Study|Adverse Event|1|||
94362532|NCT01058707|323110767|FG000|Overall Study|Subject Decision|5|||
94362533|NCT01058707|323110768|FG001|Overall Study|Subject Decision|3|||
94362534|NCT01058707|323110769|FG002|Overall Study|Subject Decision|3|||
94362535|NCT01058707|323110770|FG003|Overall Study|Subject Decision|1|||
94633176|NCT00498602|324117965|FG002|Overall Study|Other|1|||
94633177|NCT00498602|324117966|FG003|Overall Study|Other|0|||
94633178|NCT00498602|324117967|FG004|Overall Study|Other|0|||
94633179|NCT00498602|324117968|FG005|Overall Study|Other|3|||
94633180|NCT00498602|324117969|FG006|Overall Study|Other|0|||
94633181|NCT01382446|324117972|FG000|Overall Study|Withdrawal by Subject|0|||
94362536|NCT01058707|323110771|FG004|Overall Study|Subject Decision|2|||
94362537|NCT01058707|323110772|FG005|Overall Study|Subject Decision|3|||
94362538|NCT01058707|323110773|FG006|Overall Study|Subject Decision|6|||
94633182|NCT01382446|324117973|FG001|Overall Study|Withdrawal by Subject|1|||
94261230|NCT04427501|322750349|FG001|Overall Study|Withdrawal by Subject|2|||
94261231|NCT04427501|322750350|FG002|Overall Study|Withdrawal by Subject|2|||
94261232|NCT04427501|322750351|FG003|Overall Study|Withdrawal by Subject|3|||
94261233|NCT04427501|322750352|FG004|Overall Study|Withdrawal by Subject|7|||
94261234|NCT04427501|322750353|FG005|Overall Study|Withdrawal by Subject|25|||
94261235|NCT04427501|322750354|FG006|Overall Study|Withdrawal by Subject|15|||
94261236|NCT04427501|322750355|FG007|Overall Study|Withdrawal by Subject|7|||
94261237|NCT04427501|322750356|FG008|Overall Study|Withdrawal by Subject|4|||
94261238|NCT04427501|322750357|FG009|Overall Study|Withdrawal by Subject|1|||
94261239|NCT04427501|322750358|FG010|Overall Study|Withdrawal by Subject|4|||
94261240|NCT04427501|322750359|FG011|Overall Study|Withdrawal by Subject|0|||
94261241|NCT04427501|322750348|FG000|Overall Study|Other - as reported by the investigator|1|||
94261242|NCT04427501|322750349|FG001|Overall Study|Other - as reported by the investigator|0|||
94261243|NCT04427501|322750350|FG002|Overall Study|Other - as reported by the investigator|0|||
94261244|NCT04427501|322750351|FG003|Overall Study|Other - as reported by the investigator|0|||
94261245|NCT04427501|322750352|FG004|Overall Study|Other - as reported by the investigator|0|||
94261246|NCT04427501|322750353|FG005|Overall Study|Other - as reported by the investigator|6|||
94261247|NCT04427501|322750354|FG006|Overall Study|Other - as reported by the investigator|6|||
94261248|NCT04427501|322750355|FG007|Overall Study|Other - as reported by the investigator|0|||
94261249|NCT04427501|322750356|FG008|Overall Study|Other - as reported by the investigator|0|||
94261250|NCT04427501|322750357|FG009|Overall Study|Other - as reported by the investigator|0|||
94261251|NCT04427501|322750358|FG010|Overall Study|Other - as reported by the investigator|0|||
94261252|NCT04427501|322750359|FG011|Overall Study|Other - as reported by the investigator|0|||
94261253|NCT04427501|322750348|FG000|Overall Study|Other|0|||
94261254|NCT04427501|322750349|FG001|Overall Study|Other|0|||
94261255|NCT04427501|322750350|FG002|Overall Study|Other|0|||
94261256|NCT04427501|322750351|FG003|Overall Study|Other|0|||
94261257|NCT04427501|322750352|FG004|Overall Study|Other|0|||
94261258|NCT04427501|322750353|FG005|Overall Study|Other|0|||
94261259|NCT04427501|322750354|FG006|Overall Study|Other|0|||
94261260|NCT04427501|322750355|FG007|Overall Study|Other|0|||
94261261|NCT04427501|322750356|FG008|Overall Study|Other|0|||
94261262|NCT04427501|322750357|FG009|Overall Study|Other|0|||
94261263|NCT04427501|322750358|FG010|Overall Study|Other|0|||
94261264|NCT04427501|322750359|FG011|Overall Study|Other|1|||
94261265|NCT01891721|322750363|FG000|Overall Study|Lost to Follow-up|10|||
94261266|NCT01891721|322750364|FG001|Overall Study|Lost to Follow-up|5|||
94261267|NCT01891721|322750365|FG002|Overall Study|Lost to Follow-up|1|||
94261268|NCT02684279|322750366|FG000|Overall Study|Adverse Event|87|||
94362539|NCT01058707|323110767|FG000|Overall Study|Lost to Follow-up|0|||
94633183|NCT01382446|324117972|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
94633184|NCT01382446|324117973|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
94633185|NCT00770289|324117974|FG000|Overall Study|Other|6|||
94633186|NCT02956486|324117975|FG000|Core Phase|Adverse Event|51|||
94633187|NCT02956486|324117976|FG001|Core Phase|Adverse Event|88|||
94633188|NCT02956486|324117977|FG002|Core Phase|Adverse Event|0|||
94633189|NCT02956486|324117975|FG000|Core Phase|Lost to Follow-up|8|||
94633190|NCT02956486|324117976|FG001|Core Phase|Lost to Follow-up|6|||
94633191|NCT02956486|324117977|FG002|Core Phase|Lost to Follow-up|0|||
94633192|NCT02956486|324117975|FG000|Core Phase|Inadequate therapeutic effect|4|||
94633193|NCT02956486|324117976|FG001|Core Phase|Inadequate therapeutic effect|5|||
94633194|NCT02956486|324117977|FG002|Core Phase|Inadequate therapeutic effect|0|||
94633195|NCT02956486|324117975|FG000|Core Phase|Withdrawal by Subject|101|||
94633196|NCT02956486|324117976|FG001|Core Phase|Withdrawal by Subject|104|||
94633197|NCT02956486|324117977|FG002|Core Phase|Withdrawal by Subject|0|||
94633198|NCT02956486|324117975|FG000|Core Phase|Study terminated by sponsor|888|||
94633199|NCT02956486|324117976|FG001|Core Phase|Study terminated by sponsor|848|||
94633200|NCT02956486|324117977|FG002|Core Phase|Study terminated by sponsor|0|||
94633201|NCT02956486|324117975|FG000|Core Phase|Other|27|||
94633202|NCT02956486|324117976|FG001|Core Phase|Other|18|||
94633203|NCT02956486|324117977|FG002|Core Phase|Other|0|||
94633204|NCT02956486|324117975|FG000|Core Phase|Not treated|0|||
94633205|NCT02956486|324117976|FG001|Core Phase|Not treated|3|||
94261269|NCT02684279|322750366|FG000|Overall Study|Lack of Efficacy|4|||
94261270|NCT02684279|322750366|FG000|Overall Study|Lost to Follow-up|61|||
94261271|NCT02684279|322750366|FG000|Overall Study|Protocol Violation|6|||
94362540|NCT01058707|323110768|FG001|Overall Study|Lost to Follow-up|0|||
94633206|NCT02956486|324117977|FG002|Core Phase|Not treated|0|||
94261272|NCT02684279|322750366|FG000|Overall Study|Pregnancy|8|||
94261273|NCT02684279|322750366|FG000|Overall Study|Withdrawal by Subject|92|||
94261274|NCT02684279|322750366|FG000|Overall Study|non-compliance with study drug|9|||
94633207|NCT02956486|324117975|FG000|Extension Phase|Adverse Event|0|||
94261275|NCT02684279|322750366|FG000|Overall Study|non compliance with study visits|2|||
94362541|NCT01058707|323110769|FG002|Overall Study|Lost to Follow-up|1|||
94633208|NCT02956486|324117976|FG001|Extension Phase|Adverse Event|0|||
94633209|NCT02956486|324117977|FG002|Extension Phase|Adverse Event|2|||
94633210|NCT02956486|324117975|FG000|Extension Phase|Study terminated by sponsor|0|||
94633211|NCT02956486|324117976|FG001|Extension Phase|Study terminated by sponsor|0|||
94633212|NCT02956486|324117977|FG002|Extension Phase|Study terminated by sponsor|16|||
94633213|NCT02956486|324117975|FG000|Extension Phase|Not Treated|0|||
94633214|NCT02956486|324117976|FG001|Extension Phase|Not Treated|0|||
94633215|NCT02956486|324117977|FG002|Extension Phase|Not Treated|1|||
94633216|NCT03325075|324117978|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
94261276|NCT02684279|322750366|FG000|Overall Study|subject to have surgery|1|||
94261277|NCT02684279|322750366|FG000|Overall Study|family emergency|1|||
94261278|NCT02684279|322750366|FG000|Overall Study|Site closures|7|||
94261279|NCT02684279|322750366|FG000|Overall Study|Physician Decision|1|||
94261280|NCT02486718|322750367|FG000|Enrollment Phase|Death|19|||
94261281|NCT02486718|322750368|FG001|Enrollment Phase|Death|0|||
94261282|NCT02486718|322750369|FG002|Enrollment Phase|Death|0|||
94261283|NCT02486718|322750367|FG000|Enrollment Phase|Symptomatic deterioration|1|||
94261284|NCT02486718|322750368|FG001|Enrollment Phase|Symptomatic deterioration|0|||
94261285|NCT02486718|322750369|FG002|Enrollment Phase|Symptomatic deterioration|0|||
94633217|NCT03325075|324117979|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
94633218|NCT03325075|324117980|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
94261286|NCT02486718|322750367|FG000|Enrollment Phase|Withdrawal by Subject|86|||
94633219|NCT03325075|324117981|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
94633220|NCT03325075|324117978|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
94633221|NCT03325075|324117979|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
94633222|NCT03325075|324117980|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
94633223|NCT03325075|324117981|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
94633224|NCT03325075|324117978|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
94633225|NCT03325075|324117979|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
94633226|NCT03325075|324117980|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
94633227|NCT03325075|324117981|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
94633228|NCT00422591|324117982|FG000|Overall Study|Physician Decision|4|||
94633229|NCT00422591|324117982|FG000|Overall Study|Withdrawal by Subject|2|||
94633230|NCT01928329|324117987|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
94633231|NCT01928329|324117988|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
94633232|NCT01928329|324117987|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
94633233|NCT01928329|324117988|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
94633234|NCT01928329|324117987|FG000|Overall Study|Adverse Event|5|||
94633235|NCT01928329|324117988|FG001|Overall Study|Adverse Event|3|||
94633236|NCT01928329|324117987|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
94633237|NCT01928329|324117988|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
94633238|NCT01928329|324117987|FG000|Overall Study|Withdrawal by Subject|1|||
94261287|NCT02486718|322750368|FG001|Enrollment Phase|Withdrawal by Subject|0|||
94261288|NCT02486718|322750369|FG002|Enrollment Phase|Withdrawal by Subject|0|||
94261289|NCT02486718|322750367|FG000|Enrollment Phase|Protocol Violation|18|||
94261290|NCT02486718|322750368|FG001|Enrollment Phase|Protocol Violation|0|||
94261291|NCT02486718|322750369|FG002|Enrollment Phase|Protocol Violation|0|||
94261292|NCT02486718|322750367|FG000|Enrollment Phase|Physician Decision|18|||
94261293|NCT02486718|322750368|FG001|Enrollment Phase|Physician Decision|0|||
94261294|NCT02486718|322750369|FG002|Enrollment Phase|Physician Decision|0|||
94362542|NCT01058707|323110770|FG003|Overall Study|Lost to Follow-up|0|||
94362543|NCT01058707|323110771|FG004|Overall Study|Lost to Follow-up|0|||
94362544|NCT01058707|323110772|FG005|Overall Study|Lost to Follow-up|0|||
94633239|NCT01928329|324117988|FG001|Overall Study|Withdrawal by Subject|5|||
94633240|NCT01928329|324117987|FG000|Overall Study|Physician Decision|1|||
94633241|NCT01928329|324117988|FG001|Overall Study|Physician Decision|1|||
94633242|NCT00909389|324117991|FG000|Overall Study|Adverse Event|6|||
94633243|NCT00909389|324117991|FG000|Overall Study|Death|4|||
94633244|NCT00909389|324117991|FG000|Overall Study|Poor Compliance|16|||
94633245|NCT00909389|324117991|FG000|Overall Study|Lost to Follow-up|4|||
94633246|NCT00909389|324117991|FG000|Overall Study|No Information|103|||
94633247|NCT00993291|324117992|FG000|Overall Study|Withdrawal by Subject|1|||
94633248|NCT01166763|324117993|FG000|Overall Study|Withdrawal by Subject|3|||
94633249|NCT01528254|324117994|FG000|Overall Study|Administrative problems|96|||
94633250|NCT01528254|324117995|FG001|Overall Study|Administrative problems|94|||
94633251|NCT01528254|324117994|FG000|Overall Study|Adverse Event|28|||
94633252|NCT01528254|324117995|FG001|Overall Study|Adverse Event|44|||
94633253|NCT01528254|324117994|FG000|Overall Study|Lost to Follow-up|17|||
94633254|NCT01528254|324117995|FG001|Overall Study|Lost to Follow-up|24|||
94633255|NCT01528254|324117994|FG000|Overall Study|Death|13|||
94633256|NCT01528254|324117995|FG001|Overall Study|Death|9|||
94633257|NCT01528254|324117994|FG000|Overall Study|Protocol deviation|9|||
94633258|NCT01528254|324117995|FG001|Overall Study|Protocol deviation|19|||
94633259|NCT01528254|324117994|FG000|Overall Study|New therapy for study indication|8|||
94261295|NCT02486718|322750367|FG000|Enrollment Phase|Reason not provided|41|||
94633260|NCT01528254|324117995|FG001|Overall Study|New therapy for study indication|6|||
94633261|NCT01528254|324117994|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
94633262|NCT01528254|324117995|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
94362545|NCT01058707|323110773|FG006|Overall Study|Lost to Follow-up|0|||
94261296|NCT02486718|322750368|FG001|Enrollment Phase|Reason not provided|0|||
94261297|NCT02486718|322750369|FG002|Enrollment Phase|Reason not provided|0|||
94261298|NCT02486718|322750367|FG000|Enrollment Phase|Disease relapse|54|||
94261299|NCT02486718|322750368|FG001|Enrollment Phase|Disease relapse|0|||
94261300|NCT02486718|322750369|FG002|Enrollment Phase|Disease relapse|0|||
94261301|NCT02486718|322750367|FG000|Enrollment Phase|Lost to Follow-up|4|||
94261302|NCT02486718|322750368|FG001|Enrollment Phase|Lost to Follow-up|0|||
94261303|NCT02486718|322750369|FG002|Enrollment Phase|Lost to Follow-up|0|||
94261304|NCT02486718|322750367|FG000|Enrollment Phase|Adverse Event|34|||
94261305|NCT02486718|322750368|FG001|Enrollment Phase|Adverse Event|0|||
94261306|NCT02486718|322750369|FG002|Enrollment Phase|Adverse Event|0|||
94261307|NCT02486718|322750367|FG000|Randomized Phase|Withdrawal by Subject|0|||
94261308|NCT02486718|322750368|FG001|Randomized Phase|Withdrawal by Subject|44|||
94261309|NCT02486718|322750369|FG002|Randomized Phase|Withdrawal by Subject|47|||
94261310|NCT02486718|322750367|FG000|Randomized Phase|Protocol Violation|0|||
94261311|NCT02486718|322750368|FG001|Randomized Phase|Protocol Violation|2|||
94362546|NCT01058707|323110767|FG000|Overall Study|Reason Not Specified|0|||
94362547|NCT01058707|323110768|FG001|Overall Study|Reason Not Specified|3|||
94633263|NCT01528254|324117994|FG000|Overall Study|Withdrawal by Subject|5|||
94633264|NCT01528254|324117995|FG001|Overall Study|Withdrawal by Subject|4|||
94633265|NCT01528254|324117994|FG000|Overall Study|Abnormal laboratory value(s)|3|||
94633266|NCT01528254|324117995|FG001|Overall Study|Abnormal laboratory value(s)|7|||
94633267|NCT01528254|324117994|FG000|Overall Study|Abnormal test procedure result(s)|1|||
94633268|NCT01528254|324117995|FG001|Overall Study|Abnormal test procedure result(s)|0|||
94633269|NCT01528254|324117994|FG000|Overall Study|No longer requires study drug|1|||
94633270|NCT01528254|324117995|FG001|Overall Study|No longer requires study drug|1|||
94633271|NCT01348347|324117996|FG000|Overall Study|Withdrawal by Subject|1|||
94633272|NCT01348347|324117997|FG001|Overall Study|Withdrawal by Subject|1|||
94633273|NCT01348347|324117998|FG002|Overall Study|Withdrawal by Subject|1|||
94633274|NCT01348347|324117996|FG000|Overall Study|Progressive disease|2|||
94633275|NCT01348347|324117997|FG001|Overall Study|Progressive disease|5|||
94633276|NCT01348347|324117998|FG002|Overall Study|Progressive disease|5|||
94633277|NCT00748033|324118002|FG000|Overall Study|Adverse Event|0|||
94633278|NCT00748033|324118003|FG001|Overall Study|Adverse Event|1|||
94633279|NCT02763189|324118004|FG000|Overall Study|Device failure|0|||
94633280|NCT02763189|324118005|FG001|Overall Study|Device failure|2|||
94633281|NCT03557151|324118006|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
94633282|NCT03557151|324118007|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
94633283|NCT03557151|324118006|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
94633284|NCT03557151|324118007|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
94633285|NCT03557151|324118006|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
94633286|NCT03557151|324118007|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
94633287|NCT04285879|324118008|FG000|Overall Study|Lost to Follow-up|1|||
94633288|NCT04285879|324118009|FG001|Overall Study|Lost to Follow-up|8|||
94633289|NCT04285879|324118008|FG000|Overall Study|medical/surgical exclusion|16|||
94633290|NCT04285879|324118009|FG001|Overall Study|medical/surgical exclusion|0|||
94633291|NCT02056340|324118010|FG000|Overall Study|Lost to Follow-up|5|||
94633292|NCT02056340|324118011|FG001|Overall Study|Lost to Follow-up|5|||
94633293|NCT02056340|324118010|FG000|Overall Study|Withdrawal by Subject|2|||
94633294|NCT02056340|324118011|FG001|Overall Study|Withdrawal by Subject|6|||
94633295|NCT02669433|324118017|FG000|Overall Study|Protocol Violation|0|||
94633296|NCT02669433|324118018|FG001|Overall Study|Protocol Violation|4|||
94633297|NCT02669433|324118019|FG002|Overall Study|Protocol Violation|1|||
94633298|NCT02669433|324118017|FG000|Overall Study|Disease Progression|1|||
94633299|NCT02669433|324118018|FG001|Overall Study|Disease Progression|0|||
94633300|NCT02669433|324118019|FG002|Overall Study|Disease Progression|0|||
94633301|NCT02669433|324118017|FG000|Overall Study|Physician Decision|1|||
94633302|NCT02669433|324118018|FG001|Overall Study|Physician Decision|1|||
94633303|NCT02669433|324118019|FG002|Overall Study|Physician Decision|0|||
94633304|NCT02669433|324118017|FG000|Overall Study|Adverse Event|6|||
94633305|NCT02669433|324118018|FG001|Overall Study|Adverse Event|7|||
94633306|NCT02669433|324118019|FG002|Overall Study|Adverse Event|10|||
94633307|NCT02669433|324118017|FG000|Overall Study|Sponsor Termination|1|||
94633308|NCT02669433|324118018|FG001|Overall Study|Sponsor Termination|0|||
94633309|NCT02669433|324118019|FG002|Overall Study|Sponsor Termination|1|||
94633310|NCT02669433|324118017|FG000|Overall Study|Withdrawal by Subject|5|||
94633311|NCT02669433|324118018|FG001|Overall Study|Withdrawal by Subject|1|||
94633312|NCT02669433|324118019|FG002|Overall Study|Withdrawal by Subject|0|||
94633313|NCT02669433|324118017|FG000|Overall Study|Withdrawal by Caregiver|1|||
94633314|NCT02669433|324118018|FG001|Overall Study|Withdrawal by Caregiver|0|||
94633315|NCT02669433|324118019|FG002|Overall Study|Withdrawal by Caregiver|2|||
94633316|NCT02669433|324118017|FG000|Overall Study|Death|0|||
94633317|NCT02669433|324118018|FG001|Overall Study|Death|1|||
94633318|NCT02669433|324118019|FG002|Overall Study|Death|1|||
94633319|NCT00296374|324118021|FG000|Overall Study|Adverse Event|14|||
94633320|NCT00296374|324118022|FG001|Overall Study|Adverse Event|10|||
94633321|NCT00296374|324118023|FG002|Overall Study|Adverse Event|7|||
94633322|NCT00296374|324118021|FG000|Overall Study|Withdrawal by Subject|3|||
94633323|NCT00296374|324118022|FG001|Overall Study|Withdrawal by Subject|5|||
94633324|NCT00296374|324118023|FG002|Overall Study|Withdrawal by Subject|11|||
94633325|NCT00296374|324118021|FG000|Overall Study|Incorrect enrollment|3|||
94633326|NCT00296374|324118022|FG001|Overall Study|Incorrect enrollment|3|||
94633327|NCT00296374|324118023|FG002|Overall Study|Incorrect enrollment|4|||
94633328|NCT00296374|324118021|FG000|Overall Study|Protocol Violation|1|||
94633329|NCT00296374|324118022|FG001|Overall Study|Protocol Violation|2|||
94633330|NCT00296374|324118023|FG002|Overall Study|Protocol Violation|3|||
94633331|NCT00296374|324118021|FG000|Overall Study|Lost to Follow-up|3|||
94633332|NCT00296374|324118022|FG001|Overall Study|Lost to Follow-up|1|||
94633333|NCT00296374|324118023|FG002|Overall Study|Lost to Follow-up|1|||
94633334|NCT00296374|324118021|FG000|Overall Study|Relocated to another state|1|||
94633335|NCT00296374|324118022|FG001|Overall Study|Relocated to another state|0|||
94633336|NCT00296374|324118023|FG002|Overall Study|Relocated to another state|0|||
94633337|NCT00296374|324118021|FG000|Overall Study|Stopped drug before end of study visit|0|||
94633338|NCT00296374|324118022|FG001|Overall Study|Stopped drug before end of study visit|1|||
94633339|NCT00296374|324118023|FG002|Overall Study|Stopped drug before end of study visit|0|||
94633340|NCT00296374|324118021|FG000|Overall Study|Nephrologist introduced ACE|0|||
94633341|NCT00296374|324118022|FG001|Overall Study|Nephrologist introduced ACE|1|||
94633342|NCT00296374|324118023|FG002|Overall Study|Nephrologist introduced ACE|0|||
94633343|NCT00296374|324118021|FG000|Overall Study|Pregnancy|0|||
94633344|NCT00296374|324118022|FG001|Overall Study|Pregnancy|0|||
94633345|NCT00296374|324118023|FG002|Overall Study|Pregnancy|2|||
94633346|NCT00296374|324118021|FG000|Overall Study|Other|0|||
94633347|NCT00296374|324118022|FG001|Overall Study|Other|0|||
94633348|NCT00296374|324118023|FG002|Overall Study|Other|1|||
94633349|NCT00416078|324118024|FG000|Overall Study|Death|3|||
94633350|NCT00416078|324118025|FG001|Overall Study|Death|4|||
94633351|NCT00416078|324118024|FG000|Overall Study|Withdrawal by Subject|3|||
94633352|NCT00416078|324118025|FG001|Overall Study|Withdrawal by Subject|2|||
94633353|NCT00416078|324118024|FG000|Overall Study|Physician Decision|1|||
94633354|NCT00416078|324118025|FG001|Overall Study|Physician Decision|0|||
94633355|NCT00416078|324118024|FG000|Overall Study|Lost to Follow-up|4|||
94461726|NCT02612610|323479591|FG003|Overall Study|Adverse Event|10|||
94633356|NCT00416078|324118025|FG001|Overall Study|Lost to Follow-up|2|||
94633357|NCT03473808|324118026|FG000|Overall Study|Withdrawal by Subject|1|||
94633358|NCT02157298|324118033|FG000|Overall Study|Adverse Event|1|||
94633359|NCT02157298|324118034|FG001|Overall Study|Adverse Event|0|||
94633360|NCT02157298|324118033|FG000|Overall Study|Subject no longer meets study criteria|1|||
94633361|NCT02157298|324118034|FG001|Overall Study|Subject no longer meets study criteria|2|||
94633362|NCT02157298|324118033|FG000|Overall Study|Poor/Non-compliance|1|||
94633363|NCT02157298|324118034|FG001|Overall Study|Poor/Non-compliance|0|||
94633364|NCT02157298|324118033|FG000|Overall Study|Withdrawal by Subject|1|||
94633365|NCT02157298|324118034|FG001|Overall Study|Withdrawal by Subject|0|||
94261312|NCT02486718|322750369|FG002|Randomized Phase|Protocol Violation|0|||
94261313|NCT02486718|322750367|FG000|Randomized Phase|Physician Decision|0|||
94261314|NCT02486718|322750368|FG001|Randomized Phase|Physician Decision|0|||
94261315|NCT02486718|322750369|FG002|Randomized Phase|Physician Decision|3|||
94261316|NCT02486718|322750367|FG000|Randomized Phase|Lost to Follow-up|0|||
94261317|NCT02486718|322750368|FG001|Randomized Phase|Lost to Follow-up|5|||
94261318|NCT02486718|322750369|FG002|Randomized Phase|Lost to Follow-up|11|||
94261319|NCT02486718|322750367|FG000|Randomized Phase|Disease Relapse|0|||
94261320|NCT02486718|322750368|FG001|Randomized Phase|Disease Relapse|1|||
94261321|NCT02486718|322750369|FG002|Randomized Phase|Disease Relapse|0|||
94261322|NCT02486718|322750367|FG000|Randomized Phase|Death|0|||
94261323|NCT02486718|322750368|FG001|Randomized Phase|Death|154|||
94261324|NCT02486718|322750369|FG002|Randomized Phase|Death|155|||
94261325|NCT02486718|322750367|FG000|Randomized Phase|Ongoing|0|||
94633366|NCT00883116|324118039|FG000|Overall Study|Adverse event unrelated to study drug|5|||
94633367|NCT00883116|324118040|FG001|Overall Study|Adverse event unrelated to study drug|10|||
94633368|NCT00883116|324118039|FG000|Overall Study|Death|6|||
94633369|NCT00883116|324118040|FG001|Overall Study|Death|2|||
94633370|NCT00883116|324118039|FG000|Overall Study|Disease progression|130|||
94633371|NCT00883116|324118040|FG001|Overall Study|Disease progression|128|||
94633372|NCT00883116|324118039|FG000|Overall Study|Lost to Follow-up|0|||
94633373|NCT00883116|324118040|FG001|Overall Study|Lost to Follow-up|1|||
94633374|NCT00883116|324118039|FG000|Overall Study|Maximum clinical benefit|13|||
94633375|NCT00883116|324118040|FG001|Overall Study|Maximum clinical benefit|46|||
94633376|NCT00883116|324118039|FG000|Overall Study|Not identified|3|||
94633377|NCT00883116|324118040|FG001|Overall Study|Not identified|6|||
94633378|NCT00883116|324118039|FG000|Overall Study|Study drug toxicity|36|||
94633379|NCT00883116|324118040|FG001|Overall Study|Study drug toxicity|16|||
94633380|NCT00883116|324118039|FG000|Overall Study|Withdrawal by Subject|14|||
94633381|NCT00883116|324118040|FG001|Overall Study|Withdrawal by Subject|8|||
94633382|NCT00883116|324118039|FG000|Overall Study|No longer meets study criteria|2|||
94633383|NCT00883116|324118040|FG001|Overall Study|No longer meets study criteria|2|||
94633384|NCT00642941|324118042|FG000|Overall Study|Physician Decision|3|||
94633385|NCT00642941|324118043|FG001|Overall Study|Physician Decision|1|||
94633386|NCT00642941|324118044|FG002|Overall Study|Physician Decision|0|||
94633387|NCT00642941|324118045|FG003|Overall Study|Physician Decision|0|||
94633388|NCT00642941|324118046|FG004|Overall Study|Physician Decision|0|||
94633389|NCT00642941|324118047|FG005|Overall Study|Physician Decision|0|||
94633390|NCT00642941|324118048|FG006|Overall Study|Physician Decision|1|||
94633391|NCT00642941|324118049|FG007|Overall Study|Physician Decision|0|||
94633392|NCT00642941|324118050|FG008|Overall Study|Physician Decision|0|||
94633393|NCT00642941|324118051|FG009|Overall Study|Physician Decision|1|||
94633394|NCT00642941|324118052|FG010|Overall Study|Physician Decision|0|||
94633395|NCT00642941|324118053|FG011|Overall Study|Physician Decision|1|||
94633396|NCT00642941|324118042|FG000|Overall Study|Death|4|||
94633397|NCT00642941|324118043|FG001|Overall Study|Death|0|||
94633398|NCT00642941|324118044|FG002|Overall Study|Death|1|||
94633399|NCT00642941|324118045|FG003|Overall Study|Death|1|||
94633400|NCT00642941|324118046|FG004|Overall Study|Death|2|||
94633401|NCT00642941|324118047|FG005|Overall Study|Death|1|||
94633402|NCT00642941|324118048|FG006|Overall Study|Death|0|||
94633403|NCT00642941|324118049|FG007|Overall Study|Death|0|||
94633404|NCT00642941|324118050|FG008|Overall Study|Death|0|||
94633405|NCT00642941|324118051|FG009|Overall Study|Death|0|||
94633406|NCT00642941|324118052|FG010|Overall Study|Death|0|||
94633407|NCT00642941|324118053|FG011|Overall Study|Death|1|||
94633408|NCT00642941|324118042|FG000|Overall Study|Study closed by Sponsor|0|||
94633409|NCT00642941|324118043|FG001|Overall Study|Study closed by Sponsor|1|||
94633410|NCT00642941|324118044|FG002|Overall Study|Study closed by Sponsor|0|||
94633411|NCT00642941|324118045|FG003|Overall Study|Study closed by Sponsor|0|||
94633412|NCT00642941|324118046|FG004|Overall Study|Study closed by Sponsor|0|||
94633413|NCT00642941|324118047|FG005|Overall Study|Study closed by Sponsor|0|||
94261326|NCT02486718|322750368|FG001|Randomized Phase|Ongoing|301|||
94261327|NCT02486718|322750369|FG002|Randomized Phase|Ongoing|282|||
94261328|NCT05393037|322750370|FG000|Part A|Death|1|||
94261329|NCT05393037|322750371|FG001|Part A|Death|0|||
94261330|NCT05393037|322750370|FG000|Part A|Lost to Follow-up|1|||
94261331|NCT05393037|322750371|FG001|Part A|Lost to Follow-up|1|||
94633414|NCT00642941|324118048|FG006|Overall Study|Study closed by Sponsor|0|||
94633415|NCT00642941|324118049|FG007|Overall Study|Study closed by Sponsor|0|||
94633416|NCT00642941|324118050|FG008|Overall Study|Study closed by Sponsor|0|||
94633417|NCT00642941|324118051|FG009|Overall Study|Study closed by Sponsor|0|||
94633418|NCT00642941|324118052|FG010|Overall Study|Study closed by Sponsor|0|||
94633419|NCT00642941|324118053|FG011|Overall Study|Study closed by Sponsor|0|||
94633420|NCT00642941|324118042|FG000|Overall Study|Withdrawal by Subject|1|||
94633421|NCT00642941|324118043|FG001|Overall Study|Withdrawal by Subject|0|||
94633422|NCT00642941|324118044|FG002|Overall Study|Withdrawal by Subject|0|||
94633423|NCT00642941|324118045|FG003|Overall Study|Withdrawal by Subject|2|||
94633424|NCT00642941|324118046|FG004|Overall Study|Withdrawal by Subject|0|||
94633425|NCT00642941|324118047|FG005|Overall Study|Withdrawal by Subject|0|||
94676085|NCT01648348|324267123|FG003|Overall Study|Replaced for MTD analysis|0|||
94676086|NCT01648348|324267124|FG004|Overall Study|Replaced for MTD analysis|0|||
94676087|NCT01648348|324267125|FG005|Overall Study|Replaced for MTD analysis|0|||
94676088|NCT00717860|324267126|FG000|Overall Study|Clinical adverse experience|5|||
94676089|NCT00717860|324267127|FG001|Overall Study|Clinical adverse experience|9|||
94676090|NCT00717860|324267126|FG000|Overall Study|Laboratory adverse experience|2|||
94676091|NCT00717860|324267127|FG001|Overall Study|Laboratory adverse experience|2|||
94676092|NCT00717860|324267126|FG000|Overall Study|Lack of Efficacy|7|||
94676093|NCT00717860|324267127|FG001|Overall Study|Lack of Efficacy|13|||
94676094|NCT00717860|324267126|FG000|Overall Study|Discontinued for other reason|6|||
94676095|NCT00717860|324267127|FG001|Overall Study|Discontinued for other reason|1|||
94676096|NCT00717860|324267126|FG000|Overall Study|Withdrew consent|7|||
94676097|NCT00717860|324267127|FG001|Overall Study|Withdrew consent|3|||
94676098|NCT00453986|324267133|FG000|Overall Study|Lost to Follow-up|6|||
94676099|NCT00453986|324267134|FG001|Overall Study|Lost to Follow-up|5|||
94676100|NCT00453986|324267135|FG002|Overall Study|Lost to Follow-up|6|||
94676101|NCT00453986|324267136|FG003|Overall Study|Lost to Follow-up|2|||
94676102|NCT00453986|324267137|FG004|Overall Study|Lost to Follow-up|0|||
94676103|NCT00522626|324267138|FG000|Overall Study|Lost to Follow-up|7|||
94676104|NCT00696384|324267141|FG000|Open Label Phase|Adverse Event|27|||
94676105|NCT00696384|324267142|FG001|Open Label Phase|Adverse Event|0|||
94676106|NCT00696384|324267143|FG002|Open Label Phase|Adverse Event|0|||
94676107|NCT00696384|324267141|FG000|Open Label Phase|Protocol Violation|18|||
94676108|NCT00696384|324267142|FG001|Open Label Phase|Protocol Violation|0|||
94676109|NCT00696384|324267143|FG002|Open Label Phase|Protocol Violation|0|||
94676110|NCT00696384|324267141|FG000|Open Label Phase|Lost to Follow-up|24|||
94676111|NCT00696384|324267142|FG001|Open Label Phase|Lost to Follow-up|0|||
94676112|NCT00696384|324267143|FG002|Open Label Phase|Lost to Follow-up|0|||
94676113|NCT00696384|324267141|FG000|Open Label Phase|Withdrawal by Subject|37|||
94676114|NCT00696384|324267142|FG001|Open Label Phase|Withdrawal by Subject|0|||
94676115|NCT00696384|324267143|FG002|Open Label Phase|Withdrawal by Subject|0|||
94676116|NCT00696384|324267141|FG000|Open Label Phase|Other|6|||
94676117|NCT00696384|324267142|FG001|Open Label Phase|Other|0|||
94676118|NCT00696384|324267143|FG002|Open Label Phase|Other|0|||
94676119|NCT00696384|324267141|FG000|Open Label Phase|Lack of Efficacy|3|||
94676120|NCT00696384|324267142|FG001|Open Label Phase|Lack of Efficacy|0|||
94676121|NCT00696384|324267143|FG002|Open Label Phase|Lack of Efficacy|0|||
94676122|NCT00696384|324267141|FG000|Open Label Phase|Physician Decision|4|||
94676123|NCT00696384|324267142|FG001|Open Label Phase|Physician Decision|0|||
94676124|NCT00696384|324267143|FG002|Open Label Phase|Physician Decision|0|||
94676125|NCT00696384|324267141|FG000|Double Blind Phase|Adverse Event|0|||
94676126|NCT00696384|324267142|FG001|Double Blind Phase|Adverse Event|2|||
94633426|NCT00642941|324118048|FG006|Overall Study|Withdrawal by Subject|2|||
94633427|NCT00642941|324118049|FG007|Overall Study|Withdrawal by Subject|0|||
94633428|NCT00642941|324118050|FG008|Overall Study|Withdrawal by Subject|1|||
94633429|NCT00642941|324118051|FG009|Overall Study|Withdrawal by Subject|0|||
94633430|NCT00642941|324118052|FG010|Overall Study|Withdrawal by Subject|0|||
94633431|NCT00642941|324118053|FG011|Overall Study|Withdrawal by Subject|1|||
94633432|NCT00642941|324118042|FG000|Overall Study|Protocol Violation|0|||
94633433|NCT00642941|324118043|FG001|Overall Study|Protocol Violation|0|||
94633434|NCT00642941|324118044|FG002|Overall Study|Protocol Violation|0|||
94633435|NCT00642941|324118045|FG003|Overall Study|Protocol Violation|0|||
94633436|NCT00642941|324118046|FG004|Overall Study|Protocol Violation|0|||
94633437|NCT00642941|324118047|FG005|Overall Study|Protocol Violation|0|||
94633438|NCT00642941|324118048|FG006|Overall Study|Protocol Violation|1|||
94633439|NCT00642941|324118049|FG007|Overall Study|Protocol Violation|0|||
94633440|NCT00642941|324118050|FG008|Overall Study|Protocol Violation|0|||
94633441|NCT00642941|324118051|FG009|Overall Study|Protocol Violation|0|||
94633442|NCT00642941|324118052|FG010|Overall Study|Protocol Violation|0|||
94676127|NCT00696384|324267143|FG002|Double Blind Phase|Adverse Event|2|||
94676128|NCT00696384|324267141|FG000|Double Blind Phase|Lost to Follow-up|0|||
94676129|NCT00696384|324267142|FG001|Double Blind Phase|Lost to Follow-up|2|||
94676130|NCT00696384|324267143|FG002|Double Blind Phase|Lost to Follow-up|1|||
94633443|NCT00642941|324118053|FG011|Overall Study|Protocol Violation|0|||
94676131|NCT00696384|324267141|FG000|Double Blind Phase|Withdrawal by Subject|0|||
94676132|NCT00696384|324267142|FG001|Double Blind Phase|Withdrawal by Subject|4|||
94676133|NCT00696384|324267143|FG002|Double Blind Phase|Withdrawal by Subject|3|||
94633444|NCT00642941|324118042|FG000|Overall Study|Adverse Event|1|||
94633445|NCT00642941|324118043|FG001|Overall Study|Adverse Event|1|||
94633446|NCT00642941|324118044|FG002|Overall Study|Adverse Event|0|||
94633447|NCT00642941|324118045|FG003|Overall Study|Adverse Event|0|||
94633448|NCT00642941|324118046|FG004|Overall Study|Adverse Event|0|||
94633449|NCT00642941|324118047|FG005|Overall Study|Adverse Event|0|||
94261332|NCT05393037|322750370|FG000|Part A|Withdrawal by Subject|2|||
94261333|NCT05393037|322750371|FG001|Part A|Withdrawal by Subject|4|||
94261334|NCT05393037|322750370|FG000|Part B|Lost to Follow-up|1|||
94261335|NCT05393037|322750371|FG001|Part B|Lost to Follow-up|0|||
94261336|NCT03049735|322750372|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
94261337|NCT03049735|322750373|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
94261338|NCT03049735|322750374|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
94261339|NCT03049735|322750372|FG000|Overall Study|Other|5|||
94261340|NCT03049735|322750373|FG001|Overall Study|Other|3|||
94261341|NCT03049735|322750374|FG002|Overall Study|Other|1|||
94261342|NCT03049735|322750372|FG000|Overall Study|Lack of Efficacy|4|||
94261343|NCT03049735|322750373|FG001|Overall Study|Lack of Efficacy|0|||
94261344|NCT03049735|322750374|FG002|Overall Study|Lack of Efficacy|3|||
94261345|NCT03049735|322750372|FG000|Overall Study|Protocol deviation|1|||
94261346|NCT03049735|322750373|FG001|Overall Study|Protocol deviation|0|||
94261347|NCT03049735|322750374|FG002|Overall Study|Protocol deviation|0|||
94261348|NCT03049735|322750372|FG000|Overall Study|Pregnancy|0|||
94633450|NCT00642941|324118048|FG006|Overall Study|Adverse Event|1|||
94633451|NCT00642941|324118049|FG007|Overall Study|Adverse Event|1|||
94633452|NCT00642941|324118050|FG008|Overall Study|Adverse Event|0|||
94633453|NCT00642941|324118051|FG009|Overall Study|Adverse Event|1|||
94633454|NCT00642941|324118052|FG010|Overall Study|Adverse Event|0|||
94633455|NCT00642941|324118053|FG011|Overall Study|Adverse Event|0|||
94633456|NCT00642941|324118042|FG000|Overall Study|Other|1|||
94633457|NCT00642941|324118043|FG001|Overall Study|Other|1|||
94633458|NCT00642941|324118044|FG002|Overall Study|Other|1|||
94633459|NCT00642941|324118045|FG003|Overall Study|Other|1|||
94633460|NCT00642941|324118046|FG004|Overall Study|Other|0|||
94633461|NCT00642941|324118047|FG005|Overall Study|Other|1|||
94633462|NCT00642941|324118048|FG006|Overall Study|Other|0|||
94633463|NCT00642941|324118049|FG007|Overall Study|Other|1|||
94633464|NCT00642941|324118050|FG008|Overall Study|Other|0|||
94633465|NCT00642941|324118051|FG009|Overall Study|Other|0|||
94633466|NCT00642941|324118052|FG010|Overall Study|Other|0|||
94633467|NCT00642941|324118053|FG011|Overall Study|Other|1|||
94633468|NCT00642941|324118042|FG000|Overall Study|Disease progression|60|||
94633469|NCT00642941|324118043|FG001|Overall Study|Disease progression|50|||
94633470|NCT00642941|324118044|FG002|Overall Study|Disease progression|5|||
94633471|NCT00642941|324118045|FG003|Overall Study|Disease progression|36|||
94633472|NCT00642941|324118046|FG004|Overall Study|Disease progression|23|||
94633473|NCT00642941|324118047|FG005|Overall Study|Disease progression|39|||
94633474|NCT00642941|324118048|FG006|Overall Study|Disease progression|18|||
94633475|NCT00642941|324118049|FG007|Overall Study|Disease progression|12|||
94633476|NCT00642941|324118050|FG008|Overall Study|Disease progression|10|||
94633477|NCT00642941|324118051|FG009|Overall Study|Disease progression|7|||
94633478|NCT00642941|324118052|FG010|Overall Study|Disease progression|12|||
94633479|NCT00642941|324118053|FG011|Overall Study|Disease progression|7|||
94633480|NCT01698801|324118054|FG000|Treatment Phase|Adverse Event|4|||
94633481|NCT01698801|324118054|FG000|Treatment Phase|Protocol Violation|1|||
94633482|NCT01698801|324118054|FG000|Treatment Phase|Other|4|||
94633483|NCT01698801|324118054|FG000|Treatment Phase|Withdrawal by Subject|1|||
94633484|NCT01698801|324118054|FG000|Treatment Phase|Disease progression|1|||
94633485|NCT01698801|324118054|FG000|Follow Up Phase|Withdrawal by Subject|1|||
94633486|NCT01698801|324118054|FG000|Follow Up Phase|Death|4|||
94633487|NCT02484729|324118056|FG000|Overall Study|Failure of IntelliCap Error|0|||
94633488|NCT02484729|324118057|FG001|Overall Study|Failure of IntelliCap Error|0|||
94633489|NCT02484729|324118058|FG002|Overall Study|Failure of IntelliCap Error|0|||
94633490|NCT02484729|324118059|FG003|Overall Study|Failure of IntelliCap Error|0|||
94633491|NCT02484729|324118060|FG004|Overall Study|Failure of IntelliCap Error|0|||
94261349|NCT03049735|322750373|FG001|Overall Study|Pregnancy|0|||
94261350|NCT03049735|322750374|FG002|Overall Study|Pregnancy|1|||
94261351|NCT03049735|322750372|FG000|Overall Study|Adverse Event|7|||
94261352|NCT03049735|322750373|FG001|Overall Study|Adverse Event|18|||
94261353|NCT03049735|322750374|FG002|Overall Study|Adverse Event|5|||
94261354|NCT03049735|322750372|FG000|Overall Study|Withdrawal by Subject|10|||
94261355|NCT03049735|322750373|FG001|Overall Study|Withdrawal by Subject|3|||
94261356|NCT03049735|322750374|FG002|Overall Study|Withdrawal by Subject|7|||
94362548|NCT01058707|323110769|FG002|Overall Study|Reason Not Specified|2|||
94633492|NCT02484729|324118061|FG005|Overall Study|Failure of IntelliCap Error|0|||
94633493|NCT02484729|324118062|FG006|Overall Study|Failure of IntelliCap Error|0|||
94633494|NCT02484729|324118063|FG007|Overall Study|Failure of IntelliCap Error|0|||
94633495|NCT02484729|324118064|FG008|Overall Study|Failure of IntelliCap Error|0|||
94633496|NCT02484729|324118065|FG009|Overall Study|Failure of IntelliCap Error|1|||
94633497|NCT03061331|324118066|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
94633498|NCT03061331|324118067|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
94633499|NCT02625259|324118068|FG000|First Intervention (Day 1)|Other|0|||
94633500|NCT02625259|324118069|FG001|First Intervention (Day 1)|Other|0|||
94633501|NCT02625259|324118070|FG002|First Intervention (Day 1)|Other|1|||
94633502|NCT02625259|324118071|FG003|First Intervention (Day 1)|Other|0|||
94633503|NCT02625259|324118072|FG004|First Intervention (Day 1)|Other|0|||
94633504|NCT02625259|324118068|FG000|First Intervention (Day 1)|Adverse Event|2|||
94261357|NCT03049735|322750372|FG000|Overall Study|Lost to Follow-up|1|||
94261358|NCT03049735|322750373|FG001|Overall Study|Lost to Follow-up|5|||
94261359|NCT03049735|322750374|FG002|Overall Study|Lost to Follow-up|5|||
94633505|NCT02625259|324118069|FG001|First Intervention (Day 1)|Adverse Event|1|||
94633506|NCT02625259|324118070|FG002|First Intervention (Day 1)|Adverse Event|0|||
94633507|NCT02625259|324118071|FG003|First Intervention (Day 1)|Adverse Event|0|||
94633508|NCT02625259|324118072|FG004|First Intervention (Day 1)|Adverse Event|0|||
94633509|NCT02625259|324118068|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
94633510|NCT02625259|324118069|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
94633511|NCT02625259|324118070|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
94633512|NCT02625259|324118071|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
94633513|NCT02625259|324118072|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
94633514|NCT00982488|324119553|FG000|Overall Study|Administrative reason by sponsor|81|||
94633515|NCT00982488|324119554|FG001|Overall Study|Administrative reason by sponsor|3|||
94633516|NCT00982488|324119555|FG002|Overall Study|Administrative reason by sponsor|11|||
94633517|NCT00982488|324119556|FG003|Overall Study|Administrative reason by sponsor|0|||
94633518|NCT00982488|324119557|FG004|Overall Study|Administrative reason by sponsor|0|||
94633519|NCT00982488|324119553|FG000|Overall Study|Adverse event unrelated to study drug|5|||
94633520|NCT00982488|324119554|FG001|Overall Study|Adverse event unrelated to study drug|1|||
94633521|NCT00982488|324119555|FG002|Overall Study|Adverse event unrelated to study drug|0|||
94633522|NCT00982488|324119556|FG003|Overall Study|Adverse event unrelated to study drug|0|||
94633523|NCT00982488|324119557|FG004|Overall Study|Adverse event unrelated to study drug|0|||
94633524|NCT00982488|324119553|FG000|Overall Study|Death|11|||
94633525|NCT00982488|324119554|FG001|Overall Study|Death|0|||
94633526|NCT00982488|324119555|FG002|Overall Study|Death|2|||
94633527|NCT00982488|324119556|FG003|Overall Study|Death|0|||
94633528|NCT00982488|324119557|FG004|Overall Study|Death|0|||
94633529|NCT00982488|324119553|FG000|Overall Study|Disease progression|30|||
94633530|NCT00982488|324119554|FG001|Overall Study|Disease progression|5|||
94633531|NCT00982488|324119555|FG002|Overall Study|Disease progression|10|||
94633532|NCT00982488|324119556|FG003|Overall Study|Disease progression|1|||
94633533|NCT00982488|324119557|FG004|Overall Study|Disease progression|1|||
94633534|NCT00982488|324119553|FG000|Overall Study|Lost to Follow-up|1|||
94633535|NCT00982488|324119554|FG001|Overall Study|Lost to Follow-up|0|||
94633536|NCT00982488|324119555|FG002|Overall Study|Lost to Follow-up|0|||
94633537|NCT00982488|324119556|FG003|Overall Study|Lost to Follow-up|0|||
94633538|NCT00982488|324119557|FG004|Overall Study|Lost to Follow-up|0|||
94633539|NCT00982488|324119553|FG000|Overall Study|Maximum clinical benefit|1|||
94633540|NCT00982488|324119554|FG001|Overall Study|Maximum clinical benefit|1|||
94633541|NCT00982488|324119555|FG002|Overall Study|Maximum clinical benefit|1|||
94633542|NCT00982488|324119556|FG003|Overall Study|Maximum clinical benefit|0|||
94633543|NCT00982488|324119557|FG004|Overall Study|Maximum clinical benefit|0|||
94633544|NCT00982488|324119553|FG000|Overall Study|Other|15|||
94633545|NCT00982488|324119554|FG001|Overall Study|Other|1|||
94633546|NCT00982488|324119555|FG002|Overall Study|Other|3|||
94633547|NCT00982488|324119556|FG003|Overall Study|Other|1|||
94633548|NCT00982488|324119557|FG004|Overall Study|Other|0|||
94633549|NCT00982488|324119553|FG000|Overall Study|Poor compliance/noncompliance|0|||
94633550|NCT00982488|324119554|FG001|Overall Study|Poor compliance/noncompliance|1|||
94633551|NCT00982488|324119555|FG002|Overall Study|Poor compliance/noncompliance|0|||
94633552|NCT00982488|324119556|FG003|Overall Study|Poor compliance/noncompliance|0|||
94633553|NCT00982488|324119557|FG004|Overall Study|Poor compliance/noncompliance|0|||
94676134|NCT00696384|324267141|FG000|Double Blind Phase|Lack of Efficacy|0|||
94676135|NCT00696384|324267142|FG001|Double Blind Phase|Lack of Efficacy|1|||
94676136|NCT00696384|324267143|FG002|Double Blind Phase|Lack of Efficacy|0|||
94261360|NCT00475033|322750378|FG000|Infant Series|Failed to return|3|||
94261361|NCT00475033|322750379|FG001|Infant Series|Failed to return|4|||
94261362|NCT00475033|322750378|FG000|Infant Series|Parent or legal guardian request|1|||
94261363|NCT00475033|322750379|FG001|Infant Series|Parent or legal guardian request|5|||
94633554|NCT00982488|324119553|FG000|Overall Study|Stem cell transplant|2|||
94633555|NCT00982488|324119554|FG001|Overall Study|Stem cell transplant|0|||
94633556|NCT00982488|324119555|FG002|Overall Study|Stem cell transplant|0|||
94633557|NCT00982488|324119556|FG003|Overall Study|Stem cell transplant|1|||
94633558|NCT00982488|324119557|FG004|Overall Study|Stem cell transplant|0|||
94633559|NCT00982488|324119553|FG000|Overall Study|Study drug toxicity|34|||
94633560|NCT00982488|324119554|FG001|Overall Study|Study drug toxicity|1|||
94633561|NCT00982488|324119555|FG002|Overall Study|Study drug toxicity|6|||
94633562|NCT00982488|324119556|FG003|Overall Study|Study drug toxicity|0|||
94633563|NCT00982488|324119557|FG004|Overall Study|Study drug toxicity|0|||
94676137|NCT00696384|324267141|FG000|Double Blind Phase|Physician Decision|0|||
94261364|NCT00475033|322750378|FG000|Infant Series|Protocol Violation|1|||
94633564|NCT00982488|324119553|FG000|Overall Study|Withdrawal by Subject|5|||
94633565|NCT00982488|324119554|FG001|Overall Study|Withdrawal by Subject|1|||
94633566|NCT00982488|324119555|FG002|Overall Study|Withdrawal by Subject|1|||
94633567|NCT00982488|324119556|FG003|Overall Study|Withdrawal by Subject|0|||
94633568|NCT00982488|324119557|FG004|Overall Study|Withdrawal by Subject|0|||
94261365|NCT00475033|322750379|FG001|Infant Series|Protocol Violation|2|||
94261366|NCT00475033|322750378|FG000|Infant Series|Lost to Follow-up|2|||
94261367|NCT00475033|322750379|FG001|Infant Series|Lost to Follow-up|0|||
94261368|NCT00475033|322750378|FG000|Infant Series|Adverse Event|0|||
94261369|NCT00475033|322750379|FG001|Infant Series|Adverse Event|2|||
94261370|NCT00475033|322750378|FG000|After the Infant Series|Adverse Event|0|||
94633569|NCT00531232|324119558|FG000|Overall Study|Investigator decision|0|||
94633570|NCT00531232|324119559|FG001|Overall Study|Investigator decision|0|||
94633571|NCT00531232|324119560|FG002|Overall Study|Investigator decision|4|||
94633572|NCT00531232|324119558|FG000|Overall Study|Participants refused further treatment|0|||
94633573|NCT00531232|324119559|FG001|Overall Study|Participants refused further treatment|1|||
94633574|NCT00531232|324119560|FG002|Overall Study|Participants refused further treatment|2|||
94633575|NCT00531232|324119558|FG000|Overall Study|Adverse events (AEs)|1|||
94633576|NCT00531232|324119559|FG001|Overall Study|Adverse events (AEs)|2|||
94633577|NCT00531232|324119560|FG002|Overall Study|Adverse events (AEs)|2|||
94633578|NCT00531232|324119558|FG000|Overall Study|Treatment failure|1|||
94633579|NCT00531232|324119559|FG001|Overall Study|Treatment failure|3|||
94633580|NCT00531232|324119560|FG002|Overall Study|Treatment failure|7|||
94633581|NCT00531232|324119558|FG000|Overall Study|Disease recurrence|0|||
94633582|NCT00531232|324119559|FG001|Overall Study|Disease recurrence|0|||
94633583|NCT00531232|324119560|FG002|Overall Study|Disease recurrence|1|||
94633584|NCT00531232|324119558|FG000|Overall Study|Deceased|2|||
94633585|NCT00531232|324119559|FG001|Overall Study|Deceased|2|||
94633586|NCT00531232|324119560|FG002|Overall Study|Deceased|2|||
94633587|NCT00531232|324119558|FG000|Overall Study|Withdrawal by Subject|0|||
94633588|NCT00531232|324119559|FG001|Overall Study|Withdrawal by Subject|1|||
94633589|NCT00531232|324119560|FG002|Overall Study|Withdrawal by Subject|2|||
94633590|NCT00531232|324119558|FG000|Overall Study|Other|0|||
94633591|NCT00531232|324119559|FG001|Overall Study|Other|0|||
94633592|NCT00531232|324119560|FG002|Overall Study|Other|5|||
94633593|NCT02762266|324119561|FG000|Overall Study|Physician Decision|2|||
94633594|NCT02762266|324119562|FG001|Overall Study|Physician Decision|0|||
94633595|NCT00180414|324119563|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
94633596|NCT00180414|324119564|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
94633597|NCT00463346|324119565|FG000|Overall Study|Withdrawal by Subject|3|||
94633598|NCT00463346|324119566|FG001|Overall Study|Withdrawal by Subject|3|||
94633599|NCT01404325|324119573|FG000|Overall Study|Lost to Follow-up|1|||
94633600|NCT01404325|324119574|FG001|Overall Study|Lost to Follow-up|0|||
94633601|NCT01404325|324119573|FG000|Overall Study|Death|2|||
94633602|NCT01404325|324119574|FG001|Overall Study|Death|0|||
94633603|NCT01404325|324119573|FG000|Overall Study|Graft loss/Retransplantation|1|||
94633604|NCT01404325|324119574|FG001|Overall Study|Graft loss/Retransplantation|0|||
94633605|NCT01404325|324119573|FG000|Overall Study|non-specified reason|0|||
94633606|NCT01404325|324119574|FG001|Overall Study|non-specified reason|2|||
94633607|NCT00613938|324119575|FG000|Overall Study|Withdrawal by Subject|2|||
94633608|NCT00613938|324119576|FG001|Overall Study|Withdrawal by Subject|4|||
94633609|NCT00613938|324119577|FG002|Overall Study|Withdrawal by Subject|9|||
94633610|NCT00613938|324119578|FG003|Overall Study|Withdrawal by Subject|9|||
94633611|NCT00613938|324119575|FG000|Overall Study|Adverse Event|1|||
94633612|NCT00613938|324119576|FG001|Overall Study|Adverse Event|4|||
94633613|NCT00613938|324119577|FG002|Overall Study|Adverse Event|8|||
94633614|NCT00613938|324119578|FG003|Overall Study|Adverse Event|5|||
94633615|NCT00613938|324119575|FG000|Overall Study|Lack of Efficacy|16|||
94633616|NCT00613938|324119576|FG001|Overall Study|Lack of Efficacy|18|||
94633617|NCT00613938|324119577|FG002|Overall Study|Lack of Efficacy|5|||
94633618|NCT00613938|324119578|FG003|Overall Study|Lack of Efficacy|9|||
94633619|NCT00613938|324119575|FG000|Overall Study|Other|1|||
94633620|NCT00613938|324119576|FG001|Overall Study|Other|2|||
94633621|NCT00613938|324119577|FG002|Overall Study|Other|1|||
94633622|NCT00613938|324119578|FG003|Overall Study|Other|3|||
94633623|NCT04779489|324119580|FG000|Overall Study|Physician Decision|1|||
94633624|NCT02723084|324119581|FG000|Overall Study|Withdrawal by Subject|1|||
94633625|NCT02723084|324119582|FG001|Overall Study|Withdrawal by Subject|1|||
94633626|NCT02723084|324119581|FG000|Overall Study|Lost to Follow-up|3|||
94633627|NCT02723084|324119582|FG001|Overall Study|Lost to Follow-up|0|||
94261371|NCT00475033|322750379|FG001|After the Infant Series|Adverse Event|4|||
94261372|NCT00475033|322750378|FG000|After the Infant Series|Parent or legal guardian request|2|||
94261373|NCT00475033|322750379|FG001|After the Infant Series|Parent or legal guardian request|2|||
94261374|NCT00475033|322750378|FG000|After the Infant Series|Failed to return|2|||
94362549|NCT01058707|323110770|FG003|Overall Study|Reason Not Specified|0|||
94633628|NCT04317066|324119583|FG000|Overall Study|Sponsor decision|5|||
94633629|NCT04317066|324119583|FG000|Overall Study|Death|2|||
94633630|NCT03745937|324119584|FG000|Overall Study|Withdrawal by Subject|0|||
94633631|NCT03745937|324119585|FG001|Overall Study|Withdrawal by Subject|0|||
94633632|NCT03745937|324119586|FG002|Overall Study|Withdrawal by Subject|0|||
94633633|NCT03745937|324119587|FG003|Overall Study|Withdrawal by Subject|1|||
94633634|NCT03745937|324119584|FG000|Overall Study|Not-specifed|0|||
94633635|NCT03745937|324119585|FG001|Overall Study|Not-specifed|1|||
94261375|NCT00475033|322750379|FG001|After the Infant Series|Failed to return|1|||
94261376|NCT00475033|322750378|FG000|After the Infant Series|Protocol Violation|1|||
94261377|NCT00475033|322750379|FG001|After the Infant Series|Protocol Violation|0|||
94261378|NCT00475033|322750378|FG000|After the Infant Series|Lost to Follow-up|1|||
94261379|NCT00475033|322750379|FG001|After the Infant Series|Lost to Follow-up|0|||
94261380|NCT00475033|322750378|FG000|After the Infant Series|Other|0|||
94633636|NCT03745937|324119586|FG002|Overall Study|Not-specifed|0|||
94633637|NCT03745937|324119587|FG003|Overall Study|Not-specifed|1|||
94633638|NCT00501293|324119593|FG000|Optimization Period|Enrolled in error|1|||
94633639|NCT00501293|324119594|FG001|Optimization Period|Enrolled in error|0|||
94633640|NCT00501293|324119593|FG000|Maintenance Period|Withdrawal by Subject|14|||
94633641|NCT00501293|324119594|FG001|Maintenance Period|Withdrawal by Subject|13|||
94633642|NCT00501293|324119593|FG000|Maintenance Period|Lost to Follow-up|12|||
94633643|NCT00501293|324119594|FG001|Maintenance Period|Lost to Follow-up|7|||
94633644|NCT00501293|324119593|FG000|Maintenance Period|Adverse Event|6|||
94633645|NCT00501293|324119594|FG001|Maintenance Period|Adverse Event|6|||
94633646|NCT00501293|324119593|FG000|Maintenance Period|Protocol Violation|2|||
94633647|NCT00501293|324119594|FG001|Maintenance Period|Protocol Violation|1|||
94633648|NCT00501293|324119593|FG000|Maintenance Period|Lack of Efficacy|4|||
94633649|NCT00501293|324119594|FG001|Maintenance Period|Lack of Efficacy|1|||
94633650|NCT00501293|324119593|FG000|Maintenance Period|Noncompliant with study medication|5|||
94633651|NCT00501293|324119594|FG001|Maintenance Period|Noncompliant with study medication|0|||
94633652|NCT00501293|324119593|FG000|Maintenance Period|Went into rehabilitation|1|||
94633653|NCT00501293|324119594|FG001|Maintenance Period|Went into rehabilitation|0|||
94633654|NCT00501293|324119593|FG000|Maintenance Period|Would not wear patch|1|||
94633655|NCT00501293|324119594|FG001|Maintenance Period|Would not wear patch|0|||
94633656|NCT00501293|324119593|FG000|Maintenance Period|Application site reaction|1|||
94633657|NCT00501293|324119594|FG001|Maintenance Period|Application site reaction|0|||
94633658|NCT00127712|324119597|FG000|Overall Study|Adverse Event|3|||
94633659|NCT00127712|324119598|FG001|Overall Study|Adverse Event|0|||
94633660|NCT00127712|324119597|FG000|Overall Study|Lack of GI access to continue|2|||
94633661|NCT00127712|324119598|FG001|Overall Study|Lack of GI access to continue|0|||
94633662|NCT03055260|324119599|FG000|Overall Study|Withdrawal by Subject|1|||
94633663|NCT03055260|324119600|FG001|Overall Study|Withdrawal by Subject|0|||
94633664|NCT02642614|324119601|FG000|Overall Study|Adverse Event|1|||
94633665|NCT02642614|324119602|FG001|Overall Study|Adverse Event|1|||
94633666|NCT02642614|324119603|FG002|Overall Study|Adverse Event|2|||
94633667|NCT02642614|324119604|FG003|Overall Study|Adverse Event|2|||
94633668|NCT02642614|324119601|FG000|Overall Study|Lost to Follow-up|1|||
94633669|NCT02642614|324119602|FG001|Overall Study|Lost to Follow-up|0|||
94633670|NCT02642614|324119603|FG002|Overall Study|Lost to Follow-up|0|||
94633671|NCT02642614|324119604|FG003|Overall Study|Lost to Follow-up|0|||
94633672|NCT02642614|324119601|FG000|Overall Study|Withdrawal by Subject|1|||
94633673|NCT02642614|324119602|FG001|Overall Study|Withdrawal by Subject|1|||
94633674|NCT02642614|324119603|FG002|Overall Study|Withdrawal by Subject|0|||
94633675|NCT02642614|324119604|FG003|Overall Study|Withdrawal by Subject|0|||
94633676|NCT02507505|324119605|FG000|Overall Study|Withdrawal by Subject|13|||
94633677|NCT02507505|324119606|FG001|Overall Study|Withdrawal by Subject|11|||
94633678|NCT02507505|324119605|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
94633679|NCT02507505|324119606|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
94633680|NCT02507505|324119605|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
94633681|NCT02507505|324119606|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
94633682|NCT02507505|324119605|FG000|Overall Study|Death before receipt of anesthesia|0|||
94633683|NCT02507505|324119606|FG001|Overall Study|Death before receipt of anesthesia|1|||
94633684|NCT02450903|324119607|FG000|Overall Study|Adverse Event|3|||
94633685|NCT02450903|324119607|FG000|Overall Study|Progressive disease|15|||
94633686|NCT02450903|324119607|FG000|Overall Study|Switched to commercial drug|1|||
94633687|NCT02450903|324119607|FG000|Overall Study|Subject/guardian decision|1|||
94633688|NCT00967798|324119608|FG000|Overall Study|Withdrawal by Subject|5|||
94633689|NCT00967798|324119609|FG001|Overall Study|Withdrawal by Subject|2|||
94633690|NCT00967798|324119608|FG000|Overall Study|Lost to Follow-up|4|||
94633691|NCT00967798|324119609|FG001|Overall Study|Lost to Follow-up|1|||
94633692|NCT00592839|324119615|FG000|Overall Study|Withdrawal by Subject|1|||
94633693|NCT00592839|324119616|FG001|Overall Study|Withdrawal by Subject|1|||
94633694|NCT00592839|324119617|FG002|Overall Study|Withdrawal by Subject|3|||
94633695|NCT00592839|324119615|FG000|Overall Study|Protocol Violation|1|||
94633696|NCT00592839|324119616|FG001|Overall Study|Protocol Violation|1|||
94633697|NCT00592839|324119617|FG002|Overall Study|Protocol Violation|2|||
94633698|NCT00592839|324119615|FG000|Overall Study|Adverse Event|0|||
94261381|NCT00475033|322750379|FG001|After the Infant Series|Other|1|||
94261382|NCT00475033|322750378|FG000|Toddler Dose|Parent or legal guardian request|2|||
94261383|NCT00475033|322750379|FG001|Toddler Dose|Parent or legal guardian request|0|||
94633699|NCT00592839|324119616|FG001|Overall Study|Adverse Event|1|||
94261384|NCT00475033|322750378|FG000|Toddler Dose|Failed to return|1|||
94676138|NCT00696384|324267142|FG001|Double Blind Phase|Physician Decision|2|||
94676139|NCT00696384|324267143|FG002|Double Blind Phase|Physician Decision|0|||
94676140|NCT01678131|324267144|FG000|Overall Study|Adverse Event|0|||
94676141|NCT01678131|324267145|FG001|Overall Study|Adverse Event|1|||
94676142|NCT01678131|324267146|FG002|Overall Study|Adverse Event|0|||
94676143|NCT01678131|324267144|FG000|Overall Study|Withdrawal by Subject|0|||
94676144|NCT01678131|324267145|FG001|Overall Study|Withdrawal by Subject|0|||
94676145|NCT01678131|324267146|FG002|Overall Study|Withdrawal by Subject|2|||
94676146|NCT04179721|324267147|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
94676147|NCT04179721|324267148|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
94676148|NCT04179721|324267147|FG000|Overall Study|Lost to Follow-up|0|||
94676149|NCT04179721|324267148|FG001|Overall Study|Lost to Follow-up|1|||
94676150|NCT00552084|324267149|FG000|Overall Study|Adverse Event|2|||
94676151|NCT00552084|324267150|FG001|Overall Study|Adverse Event|3|||
94676152|NCT00552084|324267149|FG000|Overall Study|Withdrawal by Subject|4|||
94676153|NCT00552084|324267150|FG001|Overall Study|Withdrawal by Subject|5|||
94676154|NCT00552084|324267149|FG000|Overall Study|Protocol Violation|1|||
94676155|NCT00552084|324267150|FG001|Overall Study|Protocol Violation|0|||
94676156|NCT00552084|324267149|FG000|Overall Study|change in anti-arrythmic drug|1|||
94676157|NCT00552084|324267150|FG001|Overall Study|change in anti-arrythmic drug|1|||
94676158|NCT01525602|324267151|FG000|Overall Study|Adverse Event|1|||
94676159|NCT01525602|324267152|FG001|Overall Study|Adverse Event|0|||
94676160|NCT01525602|324267153|FG002|Overall Study|Adverse Event|1|||
94676161|NCT01525602|324267154|FG003|Overall Study|Adverse Event|1|||
94676162|NCT01525602|324267155|FG004|Overall Study|Adverse Event|3|||
94676163|NCT01525602|324267156|FG005|Overall Study|Adverse Event|3|||
94676164|NCT01525602|324267157|FG006|Overall Study|Adverse Event|0|||
94676165|NCT01525602|324267158|FG007|Overall Study|Adverse Event|1|||
94676166|NCT01525602|324267151|FG000|Overall Study|Disease progression|6|||
94676167|NCT01525602|324267152|FG001|Overall Study|Disease progression|3|||
94676168|NCT01525602|324267153|FG002|Overall Study|Disease progression|2|||
94676169|NCT01525602|324267154|FG003|Overall Study|Disease progression|5|||
94676170|NCT01525602|324267155|FG004|Overall Study|Disease progression|22|||
94676171|NCT01525602|324267156|FG005|Overall Study|Disease progression|2|||
94676172|NCT01525602|324267157|FG006|Overall Study|Disease progression|3|||
94676173|NCT01525602|324267158|FG007|Overall Study|Disease progression|3|||
94676174|NCT01525602|324267151|FG000|Overall Study|Clinical progression|2|||
94676175|NCT01525602|324267152|FG001|Overall Study|Clinical progression|0|||
94676176|NCT01525602|324267153|FG002|Overall Study|Clinical progression|0|||
94676177|NCT01525602|324267154|FG003|Overall Study|Clinical progression|0|||
94676178|NCT01525602|324267155|FG004|Overall Study|Clinical progression|0|||
94676179|NCT01525602|324267156|FG005|Overall Study|Clinical progression|0|||
94676180|NCT01525602|324267157|FG006|Overall Study|Clinical progression|1|||
94676181|NCT01525602|324267158|FG007|Overall Study|Clinical progression|1|||
94261385|NCT00475033|322750379|FG001|Toddler Dose|Failed to return|0|||
94261386|NCT00475033|322750378|FG000|Toddler Dose|Lost to Follow-up|1|||
94261387|NCT00475033|322750379|FG001|Toddler Dose|Lost to Follow-up|0|||
94676182|NCT01525602|324267151|FG000|Overall Study|Non-compliance|0|||
94676183|NCT01525602|324267152|FG001|Overall Study|Non-compliance|0|||
94261388|NCT00174265|322750382|FG000|Overall Study|Adverse Event|7|||
94261389|NCT00174265|322750383|FG001|Overall Study|Adverse Event|4|||
94261390|NCT00174265|322750382|FG000|Overall Study|Lack of Efficacy|2|||
94261391|NCT00174265|322750383|FG001|Overall Study|Lack of Efficacy|2|||
94261392|NCT00174265|322750382|FG000|Overall Study|Withdrawal by Subject|3|||
94261393|NCT00174265|322750383|FG001|Overall Study|Withdrawal by Subject|5|||
94261394|NCT00174265|322750382|FG000|Overall Study|Lost to Follow-up|1|||
94261395|NCT00174265|322750383|FG001|Overall Study|Lost to Follow-up|0|||
94261396|NCT00174265|322750382|FG000|Overall Study|Other (Not specified)|16|||
94261397|NCT00174265|322750383|FG001|Overall Study|Other (Not specified)|10|||
94261398|NCT03602261|322750384|FG000|Overall Study|Adverse Event|5|||
94261399|NCT03602261|322750385|FG001|Overall Study|Adverse Event|1|||
94261400|NCT03602261|322750384|FG000|Overall Study|Physician Decision|1|||
94261401|NCT03602261|322750385|FG001|Overall Study|Physician Decision|0|||
94261402|NCT03602261|322750384|FG000|Overall Study|Withdrawal by Subject|1|||
94261403|NCT03602261|322750385|FG001|Overall Study|Withdrawal by Subject|1|||
94261404|NCT03602261|322750384|FG000|Overall Study|Lack of Efficacy|0|||
94261405|NCT03602261|322750385|FG001|Overall Study|Lack of Efficacy|1|||
94261406|NCT03602261|322750384|FG000|Overall Study|Subject moving out of state|1|||
94261407|NCT03602261|322750385|FG001|Overall Study|Subject moving out of state|0|||
94261408|NCT04091451|322750386|FG000|Overall Study|Adverse Event|15|||
94261409|NCT04091451|322750387|FG001|Overall Study|Adverse Event|10|||
94261410|NCT04091451|322750386|FG000|Overall Study|Lost to Follow-up|8|||
94261411|NCT04091451|322750387|FG001|Overall Study|Lost to Follow-up|8|||
94261412|NCT04091451|322750386|FG000|Overall Study|Protocol Violation|5|||
94261413|NCT04091451|322750387|FG001|Overall Study|Protocol Violation|4|||
94261414|NCT04091451|322750386|FG000|Overall Study|Withdrawal by Subject|21|||
94261415|NCT04091451|322750387|FG001|Overall Study|Withdrawal by Subject|27|||
94261416|NCT04091451|322750386|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
94261417|NCT04091451|322750387|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
94633700|NCT00592839|324119617|FG002|Overall Study|Adverse Event|0|||
94633701|NCT00592839|324119615|FG000|Overall Study|Lost to Follow-up|0|||
94633702|NCT00592839|324119616|FG001|Overall Study|Lost to Follow-up|1|||
94633703|NCT00592839|324119617|FG002|Overall Study|Lost to Follow-up|1|||
94633704|NCT01313767|324119618|FG000|Overall Study|Adverse Event|1|||
94633705|NCT01313767|324119619|FG001|Overall Study|Adverse Event|0|||
94633706|NCT01313767|324119618|FG000|Overall Study|Lost to Follow-up|1|||
94633707|NCT01313767|324119619|FG001|Overall Study|Lost to Follow-up|0|||
94633708|NCT01313767|324119618|FG000|Overall Study|Withdrawal by Subject|2|||
94633709|NCT01313767|324119619|FG001|Overall Study|Withdrawal by Subject|1|||
94633710|NCT01313767|324119618|FG000|Overall Study|Protocol Violation|3|||
94633711|NCT01313767|324119619|FG001|Overall Study|Protocol Violation|1|||
94633712|NCT01287897|324119620|FG000|Overall Study|Adverse Event|5|||
94633713|NCT01287897|324119621|FG001|Overall Study|Adverse Event|3|||
94633714|NCT01287897|324119622|FG002|Overall Study|Adverse Event|6|||
94633715|NCT01287897|324119623|FG003|Overall Study|Adverse Event|4|||
94633716|NCT01287897|324119620|FG000|Overall Study|Lack of Efficacy|2|||
94633717|NCT01287897|324119621|FG001|Overall Study|Lack of Efficacy|0|||
94633718|NCT01287897|324119622|FG002|Overall Study|Lack of Efficacy|0|||
94633719|NCT01287897|324119623|FG003|Overall Study|Lack of Efficacy|0|||
94633720|NCT01287897|324119620|FG000|Overall Study|Protocol Violation|1|||
94633721|NCT01287897|324119621|FG001|Overall Study|Protocol Violation|1|||
94633722|NCT01287897|324119622|FG002|Overall Study|Protocol Violation|0|||
94633723|NCT01287897|324119623|FG003|Overall Study|Protocol Violation|1|||
94633724|NCT01287897|324119620|FG000|Overall Study|Lost to Follow-up|0|||
94633725|NCT01287897|324119621|FG001|Overall Study|Lost to Follow-up|0|||
94633726|NCT01287897|324119622|FG002|Overall Study|Lost to Follow-up|2|||
94633727|NCT01287897|324119623|FG003|Overall Study|Lost to Follow-up|0|||
94633728|NCT01287897|324119620|FG000|Overall Study|Withdrawal by Subject|1|||
94633729|NCT01287897|324119621|FG001|Overall Study|Withdrawal by Subject|5|||
94633730|NCT01287897|324119622|FG002|Overall Study|Withdrawal by Subject|3|||
94633731|NCT01287897|324119623|FG003|Overall Study|Withdrawal by Subject|2|||
94633732|NCT01287897|324119620|FG000|Overall Study|Not consented properly|0|||
94261418|NCT04091451|322750386|FG000|Overall Study|Migrated/moved from the study area|3|||
94261419|NCT04091451|322750387|FG001|Overall Study|Migrated/moved from the study area|5|||
94633733|NCT01287897|324119621|FG001|Overall Study|Not consented properly|1|||
94633734|NCT01287897|324119622|FG002|Overall Study|Not consented properly|0|||
94633735|NCT01287897|324119623|FG003|Overall Study|Not consented properly|0|||
94633736|NCT01287897|324119620|FG000|Overall Study|Not meeting entrance criteria|1|||
94633737|NCT01287897|324119621|FG001|Overall Study|Not meeting entrance criteria|1|||
94633738|NCT01287897|324119622|FG002|Overall Study|Not meeting entrance criteria|0|||
94633739|NCT01287897|324119623|FG003|Overall Study|Not meeting entrance criteria|0|||
94633740|NCT01287897|324119620|FG000|Overall Study|Other|1|||
94633741|NCT01287897|324119621|FG001|Overall Study|Other|0|||
94261420|NCT04091451|322750386|FG000|Overall Study|Suspected HZ episode|1|||
94261421|NCT04091451|322750387|FG001|Overall Study|Suspected HZ episode|0|||
94633742|NCT01287897|324119622|FG002|Overall Study|Other|1|||
94261422|NCT01390181|322752316|FG000|Overall Study|Lost to Follow-up|1|||
94261423|NCT01390181|322752316|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
94261424|NCT02425644|322752318|FG000|Overall Study|Lost to Follow-up|2|||
94676184|NCT01525602|324267153|FG002|Overall Study|Non-compliance|0|||
94676185|NCT01525602|324267154|FG003|Overall Study|Non-compliance|0|||
94676186|NCT01525602|324267155|FG004|Overall Study|Non-compliance|1|||
94676187|NCT01525602|324267156|FG005|Overall Study|Non-compliance|0|||
94676188|NCT01525602|324267157|FG006|Overall Study|Non-compliance|0|||
94676189|NCT01525602|324267158|FG007|Overall Study|Non-compliance|0|||
94676190|NCT01525602|324267151|FG000|Overall Study|Withdrawal by Subject|0|||
94676191|NCT01525602|324267152|FG001|Overall Study|Withdrawal by Subject|0|||
94676192|NCT01525602|324267153|FG002|Overall Study|Withdrawal by Subject|0|||
94676193|NCT01525602|324267154|FG003|Overall Study|Withdrawal by Subject|0|||
94676194|NCT01525602|324267155|FG004|Overall Study|Withdrawal by Subject|3|||
94676195|NCT01525602|324267156|FG005|Overall Study|Withdrawal by Subject|1|||
94676196|NCT01525602|324267157|FG006|Overall Study|Withdrawal by Subject|0|||
94676197|NCT01525602|324267158|FG007|Overall Study|Withdrawal by Subject|1|||
94676198|NCT01525602|324267151|FG000|Overall Study|Physician Decision|0|||
94676199|NCT01525602|324267152|FG001|Overall Study|Physician Decision|0|||
94676200|NCT01525602|324267153|FG002|Overall Study|Physician Decision|0|||
94676201|NCT01525602|324267154|FG003|Overall Study|Physician Decision|0|||
94676202|NCT01525602|324267155|FG004|Overall Study|Physician Decision|3|||
94676203|NCT01525602|324267156|FG005|Overall Study|Physician Decision|0|||
94676204|NCT01525602|324267157|FG006|Overall Study|Physician Decision|1|||
94676205|NCT01525602|324267158|FG007|Overall Study|Physician Decision|0|||
94676206|NCT01525602|324267151|FG000|Overall Study|Death|0|||
94676207|NCT01525602|324267152|FG001|Overall Study|Death|0|||
94676208|NCT01525602|324267153|FG002|Overall Study|Death|0|||
94676209|NCT01525602|324267154|FG003|Overall Study|Death|0|||
94676210|NCT01525602|324267155|FG004|Overall Study|Death|1|||
94676211|NCT01525602|324267156|FG005|Overall Study|Death|1|||
94676212|NCT01525602|324267157|FG006|Overall Study|Death|0|||
94676213|NCT01525602|324267158|FG007|Overall Study|Death|0|||
94676214|NCT01525602|324267151|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
94676215|NCT01525602|324267152|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
94676216|NCT01525602|324267153|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
94676217|NCT01525602|324267154|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
94676218|NCT01525602|324267155|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
94676219|NCT01525602|324267156|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
94676220|NCT01525602|324267157|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
94676221|NCT01525602|324267158|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
94676222|NCT03017079|324267164|FG000|Overall Study|Physician Decision|1|||
94676223|NCT03017079|324267165|FG001|Overall Study|Physician Decision|1|||
94676224|NCT03017079|324267164|FG000|Overall Study|Death|3|||
94676225|NCT03017079|324267165|FG001|Overall Study|Death|2|||
94261425|NCT02425644|322752319|FG001|Overall Study|Lost to Follow-up|3|||
94261426|NCT02425644|322752318|FG000|Overall Study|Withdrawal by Subject|41|||
94261427|NCT02425644|322752319|FG001|Overall Study|Withdrawal by Subject|36|||
94676226|NCT03017079|324267164|FG000|Overall Study|Lack of Efficacy|2|||
94676227|NCT03017079|324267165|FG001|Overall Study|Lack of Efficacy|2|||
94676228|NCT03017079|324267164|FG000|Overall Study|Protocol Violation|0|||
94362550|NCT01058707|323110771|FG004|Overall Study|Reason Not Specified|7|||
94362551|NCT01058707|323110772|FG005|Overall Study|Reason Not Specified|1|||
94362552|NCT01058707|323110773|FG006|Overall Study|Reason Not Specified|7|||
94362553|NCT00314262|323110774|FG000|Overall Study|Adverse Event|2|||
94362554|NCT00314262|323110774|FG000|Overall Study|Withdrawal by Subject|2|||
94362555|NCT00314262|323110774|FG000|Overall Study|Physician Decision|1|||
94362556|NCT00083226|323110775|FG000|Overall Study|Lack of Efficacy|19|||
94362557|NCT00083226|323110775|FG000|Overall Study|Adverse Event|9|||
94362558|NCT00083226|323110775|FG000|Overall Study|Death|4|||
94362559|NCT00083226|323110775|FG000|Overall Study|Withdrawal by Subject|4|||
94362560|NCT00083226|323110775|FG000|Overall Study|Other|2|||
94362561|NCT00083226|323110775|FG000|Overall Study|ineligible or not receiving treatment|4|||
94362562|NCT01682681|323110776|FG000|Overall Study|Lack of Efficacy|62|||
94362563|NCT01682681|323110776|FG000|Overall Study|Withdrawal by Subject|1|||
94362564|NCT01682681|323110776|FG000|Overall Study|Moved to other hospital|10|||
94362565|NCT01682681|323110776|FG000|Overall Study|Lost to Follow-up|174|||
94362566|NCT01682681|323110776|FG000|Overall Study|Adverse Event|46|||
94362567|NCT01682681|323110776|FG000|Overall Study|tapering of topiramate|5|||
94362568|NCT01682681|323110776|FG000|Overall Study|Other|21|||
94362569|NCT01682681|323110776|FG000|Overall Study|Low compliance|13|||
94362570|NCT02044094|323110777|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
94362571|NCT02044094|323110777|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
94362572|NCT02044094|323110777|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
94461727|NCT02612610|323479588|FG000|Overall Study|Lost to Follow-up|0|||
94633743|NCT01287897|324119623|FG003|Overall Study|Other|0|||
94633744|NCT00249444|324119624|FG000|Overall Study|Lost to Follow-up|2|||
94633745|NCT00249444|324119625|FG001|Overall Study|Lost to Follow-up|2|||
94633746|NCT00249444|324119624|FG000|Overall Study|non-compliant|9|||
94633747|NCT00249444|324119625|FG001|Overall Study|non-compliant|11|||
94633748|NCT00249444|324119624|FG000|Overall Study|Adverse Event|1|||
94633749|NCT00249444|324119625|FG001|Overall Study|Adverse Event|1|||
94633750|NCT00249444|324119624|FG000|Overall Study|life event|0|||
94633751|NCT00249444|324119625|FG001|Overall Study|life event|1|||
94633752|NCT01499667|324119626|FG000|Overall Study|administrative problems|4|||
94633753|NCT01499667|324119627|FG001|Overall Study|administrative problems|5|||
94362573|NCT02044094|323110777|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
94362574|NCT02044094|323110777|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
94362575|NCT02044094|323110777|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
94362576|NCT02044094|323110777|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
94362577|NCT02044094|323110777|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
94461728|NCT02612610|323479589|FG001|Overall Study|Lost to Follow-up|1|||
94461729|NCT02612610|323479590|FG002|Overall Study|Lost to Follow-up|0|||
94461730|NCT02612610|323479591|FG003|Overall Study|Lost to Follow-up|0|||
94461731|NCT02612610|323479588|FG000|Overall Study|Protocol Violation|0|||
94461732|NCT02612610|323479589|FG001|Overall Study|Protocol Violation|1|||
94461733|NCT02612610|323479590|FG002|Overall Study|Protocol Violation|1|||
94461734|NCT02612610|323479591|FG003|Overall Study|Protocol Violation|0|||
94461735|NCT02612610|323479588|FG000|Overall Study|Lack of Efficacy|1|||
94461736|NCT02612610|323479589|FG001|Overall Study|Lack of Efficacy|2|||
94461737|NCT02612610|323479590|FG002|Overall Study|Lack of Efficacy|0|||
94461738|NCT02612610|323479591|FG003|Overall Study|Lack of Efficacy|1|||
94461739|NCT02612610|323479588|FG000|Overall Study|Physician Decision|0|||
94461740|NCT02612610|323479589|FG001|Overall Study|Physician Decision|1|||
94461741|NCT02612610|323479590|FG002|Overall Study|Physician Decision|0|||
94461742|NCT02612610|323479591|FG003|Overall Study|Physician Decision|0|||
94461743|NCT02612610|323479588|FG000|Overall Study|Noncompliance|1|||
94461744|NCT02612610|323479589|FG001|Overall Study|Noncompliance|0|||
94633754|NCT01499667|324119628|FG002|Overall Study|administrative problems|5|||
94633755|NCT01499667|324119626|FG000|Overall Study|Protocol Violation|1|||
94633756|NCT01499667|324119627|FG001|Overall Study|Protocol Violation|3|||
94633757|NCT01499667|324119628|FG002|Overall Study|Protocol Violation|2|||
94633758|NCT01499667|324119626|FG000|Overall Study|Adverse Event|0|||
94633759|NCT01499667|324119627|FG001|Overall Study|Adverse Event|2|||
94633760|NCT01499667|324119628|FG002|Overall Study|Adverse Event|2|||
94633761|NCT01499667|324119626|FG000|Overall Study|Withdrawal by Subject|2|||
94633762|NCT01499667|324119627|FG001|Overall Study|Withdrawal by Subject|1|||
94633763|NCT01499667|324119628|FG002|Overall Study|Withdrawal by Subject|1|||
94633764|NCT01499667|324119626|FG000|Overall Study|Lack of Efficacy|2|||
94362578|NCT03353415|323110780|FG000|Masked CGM Wear|Lost to Follow-up|2|||
94461745|NCT02612610|323479590|FG002|Overall Study|Noncompliance|0|||
94461746|NCT02612610|323479591|FG003|Overall Study|Noncompliance|0|||
94461747|NCT02612610|323479588|FG000|Overall Study|Cough Improvement|0|||
94633765|NCT01499667|324119627|FG001|Overall Study|Lack of Efficacy|0|||
94461748|NCT02612610|323479589|FG001|Overall Study|Cough Improvement|0|||
94461749|NCT02612610|323479590|FG002|Overall Study|Cough Improvement|1|||
94461750|NCT02612610|323479591|FG003|Overall Study|Cough Improvement|0|||
94633766|NCT01499667|324119628|FG002|Overall Study|Lack of Efficacy|0|||
94261428|NCT02425644|322752318|FG000|Overall Study|Lack of Efficacy|3|||
94261429|NCT02425644|322752319|FG001|Overall Study|Lack of Efficacy|10|||
94261430|NCT02425644|322752318|FG000|Overall Study|Adverse Event|13|||
94261431|NCT02425644|322752319|FG001|Overall Study|Adverse Event|3|||
94261432|NCT02425644|322752318|FG000|Overall Study|Death|0|||
94261433|NCT02425644|322752319|FG001|Overall Study|Death|2|||
94261434|NCT02425644|322752318|FG000|Overall Study|Other|18|||
94261435|NCT02425644|322752319|FG001|Overall Study|Other|17|||
94261436|NCT01940354|322752320|FG000|Overall Study|Withdrawal by Subject|4|||
94261437|NCT01940354|322752321|FG001|Overall Study|Withdrawal by Subject|2|||
94261438|NCT01028222|322752322|FG000|Overall Study|Protocol deviation|1|||
94261439|NCT01028222|322752323|FG001|Overall Study|Protocol deviation|0|||
94261440|NCT01028222|322752322|FG000|Overall Study|Disease progression|33|||
94261441|NCT01028222|322752323|FG001|Overall Study|Disease progression|9|||
94261442|NCT01028222|322752322|FG000|Overall Study|Administrative problems|1|||
94261443|NCT01028222|322752323|FG001|Overall Study|Administrative problems|1|||
94261444|NCT01028222|322752322|FG000|Overall Study|Lost to Follow-up|0|||
94261445|NCT01028222|322752323|FG001|Overall Study|Lost to Follow-up|1|||
94261446|NCT01028222|322752322|FG000|Overall Study|Withdrawal by Subject|1|||
94261447|NCT01028222|322752323|FG001|Overall Study|Withdrawal by Subject|0|||
94261448|NCT01028222|322752322|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
94261449|NCT01028222|322752323|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
94261450|NCT01028222|322752322|FG000|Overall Study|Adverse Event|2|||
94261451|NCT01028222|322752323|FG001|Overall Study|Adverse Event|0|||
94261452|NCT00909792|322752324|FG000|Period 1|Did not meet inclusion criteria|0|||
94261453|NCT00909792|322752325|FG001|Period 1|Did not meet inclusion criteria|1|||
94261454|NCT00909792|322752324|FG000|Period 2|Biomicroscopy|1|||
94261455|NCT00909792|322752325|FG001|Period 2|Biomicroscopy|0|||
94261456|NCT00909792|322752324|FG000|Period 2|Lost to Follow-up|0|||
94261457|NCT00909792|322752325|FG001|Period 2|Lost to Follow-up|1|||
94261458|NCT04906616|322752326|FG000|Overall Study|Divorce|3|||
94633767|NCT02259582|324119629|FG000|Overall Study|Physician Decision|0|||
94633768|NCT02259582|324119630|FG001|Overall Study|Physician Decision|1|||
94633769|NCT02259582|324119631|FG002|Overall Study|Physician Decision|0|||
94633770|NCT02259582|324119629|FG000|Overall Study|Death|0|||
94633771|NCT02259582|324119630|FG001|Overall Study|Death|0|||
94633772|NCT02259582|324119631|FG002|Overall Study|Death|1|||
94633773|NCT02259582|324119629|FG000|Overall Study|Adverse Event|1|||
94633774|NCT02259582|324119630|FG001|Overall Study|Adverse Event|0|||
94633775|NCT02259582|324119631|FG002|Overall Study|Adverse Event|1|||
94633776|NCT02259582|324119629|FG000|Overall Study|Withdrawal by Subject|0|||
94633777|NCT02259582|324119630|FG001|Overall Study|Withdrawal by Subject|0|||
94633778|NCT02259582|324119631|FG002|Overall Study|Withdrawal by Subject|1|||
94633779|NCT02259582|324119629|FG000|Overall Study|Disease progression|14|||
94633780|NCT02259582|324119630|FG001|Overall Study|Disease progression|15|||
94633781|NCT02259582|324119631|FG002|Overall Study|Disease progression|17|||
94633782|NCT02259582|324119629|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
94633783|NCT02259582|324119630|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
94633784|NCT02259582|324119631|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
94633785|NCT00936910|324119637|FG000|Overall Study|Lack of Efficacy|3|||
94633786|NCT01647282|324119647|FG000|Overall Study|Physician Decision|7|||
94633787|NCT01647282|324119648|FG001|Overall Study|Physician Decision|5|||
94633788|NCT03060447|324119651|FG000|Overall Study|Withdrawal by Subject|2|||
94633789|NCT03060447|324119652|FG001|Overall Study|Withdrawal by Subject|0|||
94633790|NCT04577118|324119655|FG000|Overall Study|Withdrawal by Subject|4|||
94633791|NCT02611778|324119656|FG000|Overall Study|Withdrawal by Subject|2|||
94633792|NCT02611778|324119657|FG001|Overall Study|Withdrawal by Subject|8|||
94633793|NCT02611778|324119656|FG000|Overall Study|Adverse Event|1|||
94633794|NCT02611778|324119657|FG001|Overall Study|Adverse Event|2|||
94633795|NCT02611778|324119656|FG000|Overall Study|Death|2|||
94633796|NCT02611778|324119657|FG001|Overall Study|Death|1|||
94633797|NCT02611778|324119656|FG000|Overall Study|Protocol Violation|1|||
94633798|NCT02611778|324119657|FG001|Overall Study|Protocol Violation|0|||
94676229|NCT03017079|324267165|FG001|Overall Study|Protocol Violation|1|||
94261459|NCT04906616|322752327|FG001|Overall Study|Divorce|2|||
94261460|NCT02598557|322752328|FG000|Overall Study|Withdrawal by Subject|1|||
94676230|NCT01194570|324269047|FG000|Overall Study|Adverse Event|22|||
94261461|NCT02598557|322752329|FG001|Overall Study|Withdrawal by Subject|0|||
94261462|NCT02598557|322752330|FG002|Overall Study|Withdrawal by Subject|1|||
94261463|NCT02598557|322752328|FG000|Overall Study|Participant did not start treatment|2|||
94261464|NCT02598557|322752329|FG001|Overall Study|Participant did not start treatment|1|||
94461751|NCT00176644|323479593|FG000|Overall Study|Withdrawal by Subject|1|||
94633799|NCT02611778|324119656|FG000|Overall Study|Lost to Follow-up|3|||
94633800|NCT02611778|324119657|FG001|Overall Study|Lost to Follow-up|1|||
94633801|NCT02611778|324119656|FG000|Overall Study|Need for alternative treatment|1|||
94633802|NCT02611778|324119657|FG001|Overall Study|Need for alternative treatment|0|||
94676231|NCT01194570|324269048|FG001|Overall Study|Adverse Event|40|||
94261465|NCT02598557|322752330|FG002|Overall Study|Participant did not start treatment|1|||
94461752|NCT05087966|323479597|FG000|Overall Study|Lost to Follow-up|1|||
94261466|NCT02598557|322752328|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
94261467|NCT02598557|322752329|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
94261468|NCT02598557|322752330|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
94261469|NCT02598557|322752328|FG000|Overall Study|Adverse Event|1|||
94261470|NCT02598557|322752329|FG001|Overall Study|Adverse Event|1|||
94261471|NCT02598557|322752330|FG002|Overall Study|Adverse Event|0|||
94261472|NCT03224325|322752331|FG000|Overall Study|Adverse Event|1|||
94261473|NCT03224325|322752332|FG001|Overall Study|Adverse Event|0|||
94261474|NCT03224325|322752333|FG002|Overall Study|Adverse Event|0|||
94261475|NCT03224325|322752334|FG003|Overall Study|Adverse Event|0|||
94261476|NCT03224325|322752335|FG004|Overall Study|Adverse Event|0|||
94261477|NCT03224325|322752336|FG005|Overall Study|Adverse Event|0|||
94261478|NCT03224325|322752337|FG006|Overall Study|Adverse Event|1|||
94261479|NCT03224325|322752331|FG000|Overall Study|Withdrawal by Subject|0|||
94261480|NCT03224325|322752332|FG001|Overall Study|Withdrawal by Subject|0|||
94261481|NCT03224325|322752333|FG002|Overall Study|Withdrawal by Subject|0|||
94261482|NCT03224325|322752334|FG003|Overall Study|Withdrawal by Subject|1|||
94261483|NCT03224325|322752335|FG004|Overall Study|Withdrawal by Subject|0|||
94261484|NCT03224325|322752336|FG005|Overall Study|Withdrawal by Subject|0|||
94261485|NCT03224325|322752337|FG006|Overall Study|Withdrawal by Subject|0|||
94261486|NCT02864381|322752338|FG000|Overall Study|Death|58|||
94261487|NCT02864381|322752339|FG001|Overall Study|Death|61|||
94261488|NCT02864381|322752338|FG000|Overall Study|Withdrew Consent|5|||
94261489|NCT02864381|322752339|FG001|Overall Study|Withdrew Consent|6|||
94633803|NCT02611778|324119656|FG000|Overall Study|Other Reason|2|||
94633804|NCT02611778|324119657|FG001|Overall Study|Other Reason|1|||
94633805|NCT00810407|324119658|FG000|Overall Study|Protocol Violation|3|||
94261490|NCT02864381|322752338|FG000|Overall Study|Reason Unknown|7|||
94261491|NCT02864381|322752339|FG001|Overall Study|Reason Unknown|3|||
94261492|NCT02864381|322752338|FG000|Overall Study|Lost to Follow-up|1|||
94261493|NCT02864381|322752339|FG001|Overall Study|Lost to Follow-up|1|||
94633806|NCT00810407|324119658|FG000|Overall Study|No Visit After First Day of Treatment|3|||
94633807|NCT02369341|324119659|FG000|Overall Study|Migrated/moved from study area|1|||
94633808|NCT02369341|324119660|FG001|Overall Study|Migrated/moved from study area|0|||
94633809|NCT03108027|324119667|FG000|Period 1|Subject/Guardian Decision|0|||
94633810|NCT03108027|324119668|FG001|Period 1|Subject/Guardian Decision|0|||
94633811|NCT03108027|324119669|FG002|Period 1|Subject/Guardian Decision|0|||
94633812|NCT03108027|324119670|FG003|Period 1|Subject/Guardian Decision|2|||
94633813|NCT03108027|324119671|FG004|Period 1|Subject/Guardian Decision|0|||
94633814|NCT03108027|324119672|FG005|Period 1|Subject/Guardian Decision|0|||
94633815|NCT03108027|324119667|FG000|Period 3|Adverse Event|0|||
94633816|NCT03108027|324119668|FG001|Period 3|Adverse Event|1|||
94633817|NCT03108027|324119669|FG002|Period 3|Adverse Event|0|||
94633818|NCT03108027|324119670|FG003|Period 3|Adverse Event|0|||
94633819|NCT03108027|324119671|FG004|Period 3|Adverse Event|0|||
94633820|NCT03108027|324119672|FG005|Period 3|Adverse Event|0|||
94633821|NCT04035499|324119675|FG000|Overall Study|Death|2|||
94633822|NCT04035499|324119675|FG000|Overall Study|Withdrawal by Subject|1|||
94633823|NCT02064166|324119679|FG000|Overall Study|Adverse Event|1|||
94633824|NCT02064166|324119680|FG001|Overall Study|Adverse Event|0|||
94633825|NCT02810392|324119689|FG000|Overall Study|Subject too ill to continue|1|||
94633826|NCT02810392|324119690|FG001|Overall Study|Subject too ill to continue|0|||
94633827|NCT02810392|324119689|FG000|Overall Study|COVID 19 research restrictions|0|||
94633828|NCT02810392|324119690|FG001|Overall Study|COVID 19 research restrictions|1|||
94633829|NCT02457910|324119691|FG000|Overall Study|Withdrawal by Subject|0|||
94633830|NCT02457910|324119692|FG001|Overall Study|Withdrawal by Subject|0|||
94633831|NCT02457910|324119693|FG002|Overall Study|Withdrawal by Subject|0|||
94633832|NCT02457910|324119694|FG003|Overall Study|Withdrawal by Subject|0|||
94633833|NCT02457910|324119695|FG004|Overall Study|Withdrawal by Subject|0|||
94633834|NCT02457910|324119696|FG005|Overall Study|Withdrawal by Subject|1|||
94261494|NCT02864381|322752338|FG000|Overall Study|Investigator's Discretion|1|||
94261495|NCT02864381|322752339|FG001|Overall Study|Investigator's Discretion|0|||
94261496|NCT02864381|322752338|FG000|Overall Study|Protocol Violation|0|||
94261497|NCT02864381|322752339|FG001|Overall Study|Protocol Violation|1|||
94633835|NCT02457910|324119691|FG000|Overall Study|Adverse Event|0|||
94633836|NCT02457910|324119692|FG001|Overall Study|Adverse Event|2|||
94633837|NCT02457910|324119693|FG002|Overall Study|Adverse Event|1|||
94633838|NCT02457910|324119694|FG003|Overall Study|Adverse Event|1|||
94261498|NCT04175808|322752341|FG000|Part A|Miscellaneous|2|||
94261499|NCT04175808|322752342|FG001|Part A|Miscellaneous|0|||
94261500|NCT04175808|322752343|FG002|Part A|Miscellaneous|0|||
94261501|NCT04175808|322752344|FG003|Part A|Miscellaneous|0|||
94261502|NCT04175808|322752345|FG004|Part A|Miscellaneous|0|||
94633839|NCT02457910|324119695|FG004|Overall Study|Adverse Event|1|||
94633840|NCT02457910|324119696|FG005|Overall Study|Adverse Event|3|||
94633841|NCT02457910|324119691|FG000|Overall Study|Disease progression|3|||
94261503|NCT04175808|322752346|FG005|Part A|Miscellaneous|0|||
94633842|NCT02457910|324119692|FG001|Overall Study|Disease progression|3|||
94633843|NCT02457910|324119693|FG002|Overall Study|Disease progression|1|||
94676232|NCT01194570|324269047|FG000|Overall Study|Death|6|||
94676233|NCT01194570|324269048|FG001|Overall Study|Death|20|||
94676234|NCT01194570|324269047|FG000|Overall Study|Lack of Efficacy|32|||
94676235|NCT01194570|324269048|FG001|Overall Study|Lack of Efficacy|33|||
94676236|NCT01194570|324269047|FG000|Overall Study|Lost to Follow-up|4|||
94676237|NCT01194570|324269048|FG001|Overall Study|Lost to Follow-up|15|||
94676238|NCT01194570|324269047|FG000|Overall Study|Non-Compliance|2|||
94676239|NCT01194570|324269048|FG001|Overall Study|Non-Compliance|2|||
94676240|NCT01194570|324269047|FG000|Overall Study|Non-Compliance With Study Drug|2|||
94676241|NCT01194570|324269048|FG001|Overall Study|Non-Compliance With Study Drug|2|||
94676242|NCT01194570|324269047|FG000|Overall Study|Other|18|||
94676243|NCT01194570|324269048|FG001|Overall Study|Other|47|||
94676244|NCT01194570|324269047|FG000|Overall Study|Physician Decision|10|||
94676245|NCT01194570|324269048|FG001|Overall Study|Physician Decision|25|||
94676246|NCT01194570|324269047|FG000|Overall Study|Protocol Violation|1|||
94676247|NCT01194570|324269048|FG001|Overall Study|Protocol Violation|2|||
94676248|NCT01194570|324269047|FG000|Overall Study|Study Terminated By Sponsor|0|||
94676249|NCT01194570|324269048|FG001|Overall Study|Study Terminated By Sponsor|1|||
94676250|NCT01194570|324269047|FG000|Overall Study|Withdrawal by Subject|57|||
94676251|NCT01194570|324269048|FG001|Overall Study|Withdrawal by Subject|82|||
94676252|NCT01194570|324269047|FG000|Overall Study|Pregnancy|1|||
94676253|NCT01194570|324269048|FG001|Overall Study|Pregnancy|1|||
94676254|NCT02240108|324269052|FG000|Overall Study|Other than specified|8|||
94676255|NCT02240108|324269053|FG001|Overall Study|Other than specified|6|||
94676256|NCT02240108|324269052|FG000|Overall Study|Adverse Event|1|||
94676257|NCT02240108|324269053|FG001|Overall Study|Adverse Event|9|||
94676258|NCT02240108|324269052|FG000|Overall Study|Pregnancy|1|||
94676259|NCT02240108|324269053|FG001|Overall Study|Pregnancy|0|||
94676260|NCT02240108|324269052|FG000|Overall Study|Withdrawal by Subject|4|||
94676261|NCT02240108|324269053|FG001|Overall Study|Withdrawal by Subject|9|||
94676262|NCT02240108|324269052|FG000|Overall Study|StudyTerminated by Sponsor|0|||
94676263|NCT02240108|324269053|FG001|Overall Study|StudyTerminated by Sponsor|1|||
94676264|NCT03308825|324269054|FG000|Overall Study|Lost to Follow-up|2|||
94676265|NCT03308825|324269055|FG001|Overall Study|Lost to Follow-up|2|||
94676266|NCT03308825|324269056|FG002|Overall Study|Lost to Follow-up|1|||
94676267|NCT03308825|324269057|FG003|Overall Study|Lost to Follow-up|0|||
94676268|NCT03308825|324269054|FG000|Overall Study|Protocol Violation|0|||
94676269|NCT03308825|324269055|FG001|Overall Study|Protocol Violation|2|||
94676270|NCT03308825|324269056|FG002|Overall Study|Protocol Violation|0|||
94676271|NCT03308825|324269057|FG003|Overall Study|Protocol Violation|0|||
94676272|NCT01224925|324269061|FG000|Overall Study|Lost to Follow-up|3|||
94676273|NCT01224925|324269062|FG001|Overall Study|Lost to Follow-up|2|||
94676274|NCT00553501|324269068|FG000|Overall Study|Adverse Event|2|||
94261504|NCT04175808|322752347|FG006|Part A|Miscellaneous|0|||
94261505|NCT02021292|322752348|FG000|Overall Study|Physician Decision|0|||
94676275|NCT00553501|324269068|FG000|Overall Study|Death|1|||
94676276|NCT00553501|324269068|FG000|Overall Study|Progression|1|||
94676277|NCT01464021|324269072|FG000|Overall Study|Withdrawal by Subject|13|||
94676278|NCT01464021|324269072|FG000|Overall Study|Lost to Follow-up|1|||
94676279|NCT01464021|324269072|FG000|Overall Study|Lack of Efficacy|1|||
94676280|NCT01464021|324269072|FG000|Overall Study|various|11|||
94676281|NCT03966053|324269078|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
94261506|NCT02021292|322752349|FG001|Overall Study|Physician Decision|1|||
94261507|NCT02021292|322752348|FG000|Overall Study|Lost to Follow-up|0|||
94261508|NCT02021292|322752349|FG001|Overall Study|Lost to Follow-up|1|||
94261509|NCT02021292|322752348|FG000|Overall Study|Death|0|||
94261510|NCT02021292|322752349|FG001|Overall Study|Death|1|||
94261511|NCT01008696|322752354|FG000|Overall Study|Participant's evasion of hospital visit|5|||
94261512|NCT01008696|322752355|FG001|Overall Study|Participant's evasion of hospital visit|4|||
94261513|NCT01008696|322752354|FG000|Overall Study|Withdrawal by Subject|2|||
94261514|NCT01008696|322752355|FG001|Overall Study|Withdrawal by Subject|4|||
94676282|NCT00989092|324269083|FG000|Overall Study|Physician Decision|9|||
94676283|NCT00989092|324269084|FG001|Overall Study|Physician Decision|6|||
94261515|NCT01008696|322752354|FG000|Overall Study|Physician Decision|5|||
94261516|NCT01008696|322752355|FG001|Overall Study|Physician Decision|1|||
94676284|NCT00989092|324269083|FG000|Overall Study|Adverse Event|20|||
94676285|NCT00989092|324269084|FG001|Overall Study|Adverse Event|1|||
94676286|NCT00989092|324269083|FG000|Overall Study|Chemotherapy initiated|12|||
94676287|NCT00989092|324269084|FG001|Overall Study|Chemotherapy initiated|4|||
94261517|NCT01008696|322752354|FG000|Overall Study|Adverse Event|1|||
94676288|NCT00989092|324269083|FG000|Overall Study|Withdrawal by Subject|17|||
94676289|NCT00989092|324269084|FG001|Overall Study|Withdrawal by Subject|9|||
94676290|NCT00989092|324269083|FG000|Overall Study|Death|14|||
94676291|NCT00989092|324269084|FG001|Overall Study|Death|2|||
94676292|NCT00989092|324269083|FG000|Overall Study|Ineligibility determined|3|||
94676293|NCT00989092|324269084|FG001|Overall Study|Ineligibility determined|3|||
94676294|NCT00989092|324269083|FG000|Overall Study|Lost to Follow-up|6|||
94676295|NCT00989092|324269084|FG001|Overall Study|Lost to Follow-up|2|||
94676296|NCT00989092|324269083|FG000|Overall Study|Other|3|||
94676297|NCT00989092|324269084|FG001|Overall Study|Other|1|||
94676298|NCT00989092|324269083|FG000|Overall Study|Protocol deviation|2|||
94676299|NCT00989092|324269084|FG001|Overall Study|Protocol deviation|0|||
94676300|NCT00989092|324269083|FG000|Overall Study|Erythropoietin therapy initiated|2|||
94676301|NCT00989092|324269084|FG001|Overall Study|Erythropoietin therapy initiated|0|||
94676302|NCT00989092|324269083|FG000|Overall Study|Did not receive study drug|2|||
94676303|NCT00989092|324269084|FG001|Overall Study|Did not receive study drug|0|||
94676304|NCT02243280|324269086|FG000|Treated|Adverse Event|1|||
94676305|NCT02243280|324269087|FG001|Treated|Adverse Event|0|||
94676306|NCT02243280|324269088|FG002|Treated|Adverse Event|0|||
94676307|NCT02243280|324269089|FG003|Treated|Adverse Event|0|||
94676308|NCT02243280|324269090|FG004|Treated|Adverse Event|0|||
94676309|NCT02243280|324269091|FG005|Treated|Adverse Event|0|||
94676310|NCT02243280|324269092|FG006|Treated|Adverse Event|0|||
94676311|NCT02243280|324269093|FG007|Treated|Adverse Event|0|||
94676312|NCT02243280|324269094|FG008|Treated|Adverse Event|0|||
94676313|NCT02243280|324269095|FG009|Treated|Adverse Event|0|||
94676314|NCT02243280|324269096|FG010|Treated|Adverse Event|1|||
94676315|NCT02243280|324269086|FG000|Treated|Lost to Follow-up|0|||
94676316|NCT02243280|324269087|FG001|Treated|Lost to Follow-up|0|||
94676317|NCT02243280|324269088|FG002|Treated|Lost to Follow-up|0|||
94676318|NCT02243280|324269089|FG003|Treated|Lost to Follow-up|0|||
94676319|NCT02243280|324269090|FG004|Treated|Lost to Follow-up|0|||
94676320|NCT02243280|324269091|FG005|Treated|Lost to Follow-up|0|||
94676321|NCT02243280|324269092|FG006|Treated|Lost to Follow-up|0|||
94676322|NCT02243280|324269093|FG007|Treated|Lost to Follow-up|0|||
94676323|NCT02243280|324269094|FG008|Treated|Lost to Follow-up|1|||
94676324|NCT02243280|324269095|FG009|Treated|Lost to Follow-up|0|||
94676325|NCT02243280|324269096|FG010|Treated|Lost to Follow-up|2|||
94676326|NCT01392300|324269105|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
94676327|NCT01392300|324269106|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
94676328|NCT01392300|324269107|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
94676329|NCT01392300|324269105|FG000|Main Period (MP)|Withdrawal by Subject|5|||
94676330|NCT01392300|324269106|FG001|Main Period (MP)|Withdrawal by Subject|1|||
94676331|NCT01392300|324269107|FG002|Main Period (MP)|Withdrawal by Subject|0|||
94676332|NCT01392300|324269105|FG000|Main Period (MP)|Lost to Follow-up|3|||
94676333|NCT01392300|324269106|FG001|Main Period (MP)|Lost to Follow-up|3|||
94676334|NCT01392300|324269107|FG002|Main Period (MP)|Lost to Follow-up|0|||
94676335|NCT01392300|324269105|FG000|Main Period (MP)|Non-compliance|1|||
94676336|NCT01392300|324269106|FG001|Main Period (MP)|Non-compliance|0|||
94676337|NCT01392300|324269107|FG002|Main Period (MP)|Non-compliance|0|||
94676338|NCT01392300|324269105|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
94676339|NCT01392300|324269106|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
94676340|NCT01392300|324269107|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
94676341|NCT01392300|324269105|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
94676342|NCT01392300|324269106|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
94676343|NCT01392300|324269107|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
94676344|NCT01392300|324269105|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
94676345|NCT01392300|324269106|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
94676346|NCT01392300|324269107|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
94676347|NCT01392300|324269105|FG000|Open Label Extension (OLEX) Period|Death|0|||
94676348|NCT01392300|324269106|FG001|Open Label Extension (OLEX) Period|Death|0|||
94676349|NCT01392300|324269107|FG002|Open Label Extension (OLEX) Period|Death|4|||
94676350|NCT01392300|324269105|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
94461753|NCT05087966|323479597|FG000|Overall Study|Withdrawal by Subject|5|||
94676351|NCT01392300|324269106|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
94676352|NCT01392300|324269107|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
94676353|NCT01392300|324269105|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
94676354|NCT01392300|324269106|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
94676355|NCT01392300|324269107|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
94676356|NCT01392300|324269105|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
94676357|NCT01392300|324269106|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
94676358|NCT01392300|324269107|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
94676359|NCT02323646|324269108|FG000|Treatment Course 1|Adverse Event|1|||
94676360|NCT02323646|324269109|FG001|Treatment Course 1|Adverse Event|0|||
94676361|NCT02323646|324269110|FG002|Treatment Course 1|Adverse Event|1|||
94676362|NCT02323646|324269108|FG000|Treatment Course 1|Heavy Bleeding|1|||
94676363|NCT02323646|324269109|FG001|Treatment Course 1|Heavy Bleeding|1|||
94261518|NCT01008696|322752355|FG001|Overall Study|Adverse Event|0|||
94261519|NCT01008696|322752354|FG000|Overall Study|Participants' non-cooperation|2|||
94261520|NCT01008696|322752355|FG001|Overall Study|Participants' non-cooperation|3|||
94261521|NCT01008696|322752354|FG000|Overall Study|Other|2|||
94261522|NCT01008696|322752355|FG001|Overall Study|Other|3|||
94261523|NCT01008696|322752354|FG000|Overall Study|Other|0|||
94261524|NCT01008696|322752355|FG001|Overall Study|Other|2|||
94261525|NCT00568321|322752356|FG000|Overall Study|Adverse Event|1|||
94261526|NCT00568321|322752357|FG001|Overall Study|Adverse Event|0|||
94261527|NCT00568321|322752358|FG002|Overall Study|Adverse Event|0|||
94261528|NCT00568321|322752356|FG000|Overall Study|Lack of Efficacy|8|||
94261529|NCT00568321|322752357|FG001|Overall Study|Lack of Efficacy|5|||
94261530|NCT00568321|322752358|FG002|Overall Study|Lack of Efficacy|6|||
94261531|NCT00568321|322752356|FG000|Overall Study|Lost to Follow-up|0|||
94261532|NCT00568321|322752357|FG001|Overall Study|Lost to Follow-up|0|||
94261533|NCT00568321|322752358|FG002|Overall Study|Lost to Follow-up|1|||
94261534|NCT00568321|322752356|FG000|Overall Study|Withdrawal by Subject|2|||
94261535|NCT00568321|322752357|FG001|Overall Study|Withdrawal by Subject|0|||
94261536|NCT00568321|322752358|FG002|Overall Study|Withdrawal by Subject|0|||
94261537|NCT00568321|322752356|FG000|Overall Study|Protocol Violation|0|||
94261538|NCT00568321|322752357|FG001|Overall Study|Protocol Violation|0|||
94261539|NCT00568321|322752358|FG002|Overall Study|Protocol Violation|1|||
94261540|NCT00568321|322752356|FG000|Overall Study|Randomized, not treated|2|||
94261541|NCT00568321|322752357|FG001|Overall Study|Randomized, not treated|0|||
94261542|NCT00568321|322752358|FG002|Overall Study|Randomized, not treated|1|||
94261543|NCT00667355|322752359|FG000|Overall Study|Adverse Event|5|||
94261544|NCT00667355|322752359|FG000|Overall Study|Lost to Follow-up|1|||
94633844|NCT02457910|324119694|FG003|Overall Study|Disease progression|1|||
94633845|NCT02457910|324119695|FG004|Overall Study|Disease progression|4|||
94633846|NCT02457910|324119696|FG005|Overall Study|Disease progression|6|||
94633847|NCT02457910|324119691|FG000|Overall Study|Other complicating illness|0|||
94633848|NCT02457910|324119692|FG001|Overall Study|Other complicating illness|0|||
94633849|NCT02457910|324119693|FG002|Overall Study|Other complicating illness|0|||
94633850|NCT02457910|324119694|FG003|Overall Study|Other complicating illness|0|||
94633851|NCT02457910|324119695|FG004|Overall Study|Other complicating illness|0|||
94633852|NCT02457910|324119696|FG005|Overall Study|Other complicating illness|1|||
94633853|NCT02457910|324119691|FG000|Overall Study|Death|0|||
94633854|NCT02457910|324119692|FG001|Overall Study|Death|0|||
94633855|NCT02457910|324119693|FG002|Overall Study|Death|1|||
94633856|NCT02457910|324119694|FG003|Overall Study|Death|0|||
94633857|NCT02457910|324119695|FG004|Overall Study|Death|0|||
94633858|NCT02457910|324119696|FG005|Overall Study|Death|0|||
94633859|NCT02375113|324119698|FG000|Overall Study|Undisclosed Reason(s).|1|||
94633860|NCT02375113|324119699|FG001|Overall Study|Undisclosed Reason(s).|1|||
94633861|NCT02375113|324119698|FG000|Overall Study|Poor adherence (<70%).|1|||
94633862|NCT02375113|324119699|FG001|Overall Study|Poor adherence (<70%).|0|||
94633863|NCT02375113|324119698|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
94633864|NCT02375113|324119699|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
94633865|NCT00001596|324121327|FG000|Overall Study|Death|1|||
94633866|NCT00001596|324121328|FG001|Overall Study|Death|0|||
94633867|NCT00001596|324121327|FG000|Overall Study|Withdrawal by Subject|3|||
94633868|NCT00001596|324121328|FG001|Overall Study|Withdrawal by Subject|1|||
94633869|NCT00001596|324121327|FG000|Overall Study|Study Termination|12|||
94633870|NCT00001596|324121328|FG001|Overall Study|Study Termination|9|||
94633871|NCT00001596|324121327|FG000|Overall Study|Adverse Event|1|||
94633872|NCT00001596|324121328|FG001|Overall Study|Adverse Event|0|||
94633873|NCT00951665|324121333|FG000|Phase 1b|Adverse Event|2|||
94633874|NCT00951665|324121334|FG001|Phase 1b|Adverse Event|1|||
94633875|NCT00951665|324121335|FG002|Phase 1b|Adverse Event|0|||
94633876|NCT00951665|324121336|FG003|Phase 1b|Adverse Event|1|||
94633877|NCT00951665|324121337|FG004|Phase 1b|Adverse Event|0|||
94633878|NCT00951665|324121338|FG005|Phase 1b|Adverse Event|0|||
94633879|NCT00951665|324121333|FG000|Phase 1b|Death|1|||
94633880|NCT00951665|324121334|FG001|Phase 1b|Death|0|||
94633881|NCT00951665|324121335|FG002|Phase 1b|Death|2|||
94633882|NCT00951665|324121336|FG003|Phase 1b|Death|0|||
94676364|NCT02323646|324269110|FG002|Treatment Course 1|Heavy Bleeding|0|||
94261545|NCT00667355|322752359|FG000|Overall Study|Other reason was not specified|5|||
94261546|NCT00992511|322752360|FG000|Overall Study|Migrated/moved from study area|1|||
94261547|NCT00992511|322752361|FG001|Overall Study|Migrated/moved from study area|0|||
94461754|NCT00430352|323479609|FG000|Overall Study|Disease progression|58|||
94461755|NCT00430352|323479609|FG000|Overall Study|Withdrawal by Subject|11|||
94633883|NCT00951665|324121337|FG004|Phase 1b|Death|0|||
94633884|NCT00951665|324121338|FG005|Phase 1b|Death|0|||
94633885|NCT00951665|324121333|FG000|Phase 1b|Physician Decision|4|||
94633886|NCT00951665|324121334|FG001|Phase 1b|Physician Decision|0|||
94261548|NCT00992511|322752362|FG002|Overall Study|Migrated/moved from study area|1|||
94461756|NCT00430352|323479609|FG000|Overall Study|Adverse Event|16|||
94633887|NCT00951665|324121335|FG002|Phase 1b|Physician Decision|1|||
94633888|NCT00951665|324121336|FG003|Phase 1b|Physician Decision|0|||
94676365|NCT02323646|324269108|FG000|Treatment Course 1|Lost to Follow-up|1|||
94261549|NCT00992511|322752363|FG003|Overall Study|Migrated/moved from study area|2|||
94261550|NCT00992511|322752360|FG000|Overall Study|Lost to Follow-up|1|||
94261551|NCT00992511|322752361|FG001|Overall Study|Lost to Follow-up|0|||
94261552|NCT00992511|322752362|FG002|Overall Study|Lost to Follow-up|0|||
94261553|NCT00992511|322752363|FG003|Overall Study|Lost to Follow-up|2|||
94261554|NCT00992511|322752360|FG000|Overall Study|Withdrawal by Subject|0|||
94261555|NCT00992511|322752361|FG001|Overall Study|Withdrawal by Subject|0|||
94261556|NCT00992511|322752362|FG002|Overall Study|Withdrawal by Subject|1|||
94261557|NCT00992511|322752363|FG003|Overall Study|Withdrawal by Subject|1|||
94261558|NCT04615247|322752365|FG000|Overall Study|Adverse Event|0|||
94261559|NCT04615247|322752366|FG001|Overall Study|Adverse Event|2|||
94261560|NCT04615247|322752365|FG000|Overall Study|Withdrawal by Subject|1|||
94261561|NCT04615247|322752366|FG001|Overall Study|Withdrawal by Subject|1|||
94261562|NCT01112306|322752369|FG000|Overall Study|Death|175|||
94261563|NCT01112306|322752369|FG000|Overall Study|Lost to Follow-up|9|||
94261564|NCT01112306|322752369|FG000|Overall Study|Withdrawal by Subject|31|||
94261565|NCT01112306|322752369|FG000|Overall Study|Other|70|||
94261566|NCT03278106|322752370|FG000|Overall Study|No protocol treatment|1|||
94461757|NCT00430352|323479609|FG000|Overall Study|Death|5|||
94461758|NCT00430352|323479609|FG000|Overall Study|Other|48|||
94633889|NCT00951665|324121337|FG004|Phase 1b|Physician Decision|0|||
94633890|NCT00951665|324121338|FG005|Phase 1b|Physician Decision|0|||
94633891|NCT00951665|324121333|FG000|Phase 1b|Withdrawal by Subject|0|||
94633892|NCT00951665|324121334|FG001|Phase 1b|Withdrawal by Subject|1|||
94633893|NCT00951665|324121335|FG002|Phase 1b|Withdrawal by Subject|0|||
94633894|NCT00951665|324121336|FG003|Phase 1b|Withdrawal by Subject|0|||
94633895|NCT00951665|324121337|FG004|Phase 1b|Withdrawal by Subject|0|||
94633896|NCT00951665|324121338|FG005|Phase 1b|Withdrawal by Subject|0|||
94633897|NCT00951665|324121333|FG000|Phase 1b|Disease Progression|13|||
94633898|NCT00951665|324121334|FG001|Phase 1b|Disease Progression|2|||
94633899|NCT00951665|324121335|FG002|Phase 1b|Disease Progression|14|||
94633900|NCT00951665|324121336|FG003|Phase 1b|Disease Progression|0|||
94633901|NCT00951665|324121337|FG004|Phase 1b|Disease Progression|0|||
94633902|NCT00951665|324121338|FG005|Phase 1b|Disease Progression|0|||
94633903|NCT00951665|324121333|FG000|Phase 1b|Protocol Violation|2|||
94633904|NCT00951665|324121334|FG001|Phase 1b|Protocol Violation|0|||
94633905|NCT00951665|324121335|FG002|Phase 1b|Protocol Violation|0|||
94633906|NCT00951665|324121336|FG003|Phase 1b|Protocol Violation|0|||
94633907|NCT00951665|324121337|FG004|Phase 1b|Protocol Violation|0|||
94633908|NCT00951665|324121338|FG005|Phase 1b|Protocol Violation|0|||
94633909|NCT00951665|324121333|FG000|Phase 2a|Adverse Event|0|||
94633910|NCT00951665|324121334|FG001|Phase 2a|Adverse Event|0|||
94633911|NCT00951665|324121335|FG002|Phase 2a|Adverse Event|0|||
94633912|NCT00951665|324121336|FG003|Phase 2a|Adverse Event|0|||
94633913|NCT00951665|324121337|FG004|Phase 2a|Adverse Event|2|||
94633914|NCT00951665|324121338|FG005|Phase 2a|Adverse Event|0|||
94633915|NCT00951665|324121333|FG000|Phase 2a|Death|0|||
94633916|NCT00951665|324121334|FG001|Phase 2a|Death|0|||
94633917|NCT00951665|324121335|FG002|Phase 2a|Death|0|||
94633918|NCT00951665|324121336|FG003|Phase 2a|Death|0|||
94633919|NCT00951665|324121337|FG004|Phase 2a|Death|1|||
94633920|NCT00951665|324121338|FG005|Phase 2a|Death|1|||
94633921|NCT00951665|324121333|FG000|Phase 2a|Lost to Follow-up|0|||
94633922|NCT00951665|324121334|FG001|Phase 2a|Lost to Follow-up|0|||
94633923|NCT00951665|324121335|FG002|Phase 2a|Lost to Follow-up|0|||
94633924|NCT00951665|324121336|FG003|Phase 2a|Lost to Follow-up|0|||
94633925|NCT00951665|324121337|FG004|Phase 2a|Lost to Follow-up|1|||
94633926|NCT00951665|324121338|FG005|Phase 2a|Lost to Follow-up|0|||
94633927|NCT00951665|324121333|FG000|Phase 2a|Physician Decision|0|||
94633928|NCT00951665|324121334|FG001|Phase 2a|Physician Decision|0|||
94633929|NCT00951665|324121335|FG002|Phase 2a|Physician Decision|0|||
94633930|NCT00951665|324121336|FG003|Phase 2a|Physician Decision|0|||
94633931|NCT00951665|324121337|FG004|Phase 2a|Physician Decision|0|||
94633932|NCT00951665|324121338|FG005|Phase 2a|Physician Decision|1|||
94633933|NCT00951665|324121333|FG000|Phase 2a|Withdrawal by Subject|0|||
94633934|NCT00951665|324121334|FG001|Phase 2a|Withdrawal by Subject|0|||
94633935|NCT00951665|324121335|FG002|Phase 2a|Withdrawal by Subject|0|||
94633936|NCT00951665|324121336|FG003|Phase 2a|Withdrawal by Subject|0|||
94633937|NCT00951665|324121337|FG004|Phase 2a|Withdrawal by Subject|2|||
94633938|NCT00951665|324121338|FG005|Phase 2a|Withdrawal by Subject|0|||
94633939|NCT00951665|324121333|FG000|Phase 2a|Disease Progression|0|||
94633940|NCT00951665|324121334|FG001|Phase 2a|Disease Progression|0|||
94261567|NCT00833911|322752371|FG000|Titration|Adverse Event|18|||
94461759|NCT03099694|323479610|FG000|Overall Study|Withdrawal by Subject|11|||
94633941|NCT00951665|324121335|FG002|Phase 2a|Disease Progression|0|||
94633942|NCT00951665|324121336|FG003|Phase 2a|Disease Progression|0|||
94633943|NCT00951665|324121337|FG004|Phase 2a|Disease Progression|6|||
94633944|NCT00951665|324121338|FG005|Phase 2a|Disease Progression|5|||
94633945|NCT00488345|324121339|FG000|Overall Study|Adverse Event|0|||
94633946|NCT00488345|324121340|FG001|Overall Study|Adverse Event|1|||
94633947|NCT00488345|324121341|FG002|Overall Study|Adverse Event|1|||
94633948|NCT00488345|324121339|FG000|Overall Study|Unable to administer antibiotics at home|0|||
94261568|NCT00833911|322752371|FG000|Titration|Withdrawal by Subject|3|||
94261569|NCT00833911|322752371|FG000|Maintenance Phase I|Adverse Event|73|||
94261570|NCT00833911|322752371|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
94261571|NCT00833911|322752371|FG000|Maintenance Phase I|Physician Decision|10|||
94261572|NCT00833911|322752371|FG000|Maintenance Phase I|Lack of Efficacy|4|||
94261573|NCT00833911|322752371|FG000|Maintenance Phase II|Adverse Event|6|||
94261574|NCT00833911|322752371|FG000|Maintenance Phase II|Physician Decision|2|||
94261575|NCT00833911|322752371|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
94261576|NCT00833911|322752371|FG000|Maintenance Phase II|Lack of Efficacy|1|||
94261577|NCT03942406|322752378|FG000|Overall Study|Lost to Follow-up|4|||
94261578|NCT03942406|322752379|FG001|Overall Study|Lost to Follow-up|5|||
94261579|NCT03942406|322752380|FG002|Overall Study|Lost to Follow-up|3|||
94261580|NCT03942406|322752381|FG003|Overall Study|Lost to Follow-up|7|||
94261581|NCT03942406|322752382|FG004|Overall Study|Lost to Follow-up|1|||
94261582|NCT03942406|322752383|FG005|Overall Study|Lost to Follow-up|0|||
94261583|NCT03942406|322752384|FG006|Overall Study|Lost to Follow-up|0|||
94633949|NCT00488345|324121340|FG001|Overall Study|Unable to administer antibiotics at home|1|||
94633950|NCT00488345|324121341|FG002|Overall Study|Unable to administer antibiotics at home|0|||
94633951|NCT00488345|324121339|FG000|Overall Study|Institutional Review Board review|0|||
94633952|NCT00488345|324121340|FG001|Overall Study|Institutional Review Board review|0|||
94633953|NCT00488345|324121341|FG002|Overall Study|Institutional Review Board review|1|||
94633954|NCT00488345|324121339|FG000|Overall Study|Surgical team recommendation|0|||
94633955|NCT00488345|324121340|FG001|Overall Study|Surgical team recommendation|1|||
94633956|NCT00488345|324121341|FG002|Overall Study|Surgical team recommendation|0|||
94633957|NCT00488345|324121339|FG000|Overall Study|Parent/legal guardian request|0|||
94633958|NCT00488345|324121340|FG001|Overall Study|Parent/legal guardian request|1|||
94633959|NCT00488345|324121341|FG002|Overall Study|Parent/legal guardian request|1|||
94633960|NCT02673489|324121346|FG000|Treatment Period|Lost to Follow-up|3|||
94633961|NCT02673489|324121347|FG001|Treatment Period|Lost to Follow-up|0|||
94633962|NCT02673489|324121346|FG000|Treatment Period|Participant request to discontinue|1|||
94633963|NCT02673489|324121347|FG001|Treatment Period|Participant request to discontinue|1|||
94633964|NCT02673489|324121346|FG000|Treatment Period|Participant moved to another province|1|||
94633965|NCT02673489|324121347|FG001|Treatment Period|Participant moved to another province|0|||
94633966|NCT02673489|324121346|FG000|Treatment Period|Participant was incarcerated|0|||
94633967|NCT02673489|324121347|FG001|Treatment Period|Participant was incarcerated|1|||
94633968|NCT02673489|324121346|FG000|Treatment Period|Adverse Event|0|||
94633969|NCT02673489|324121347|FG001|Treatment Period|Adverse Event|1|||
94633970|NCT02673489|324121346|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
94633971|NCT02673489|324121347|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
94633972|NCT02673489|324121346|FG000|Follow Up Period|Unable to return for follow-up|0|||
94633973|NCT02673489|324121347|FG001|Follow Up Period|Unable to return for follow-up|1|||
94633974|NCT01485640|324121348|FG000|Overall Study|Adverse Event|10|||
94633975|NCT01485640|324121348|FG000|Overall Study|Lack of Efficacy|2|||
94633976|NCT01485640|324121348|FG000|Overall Study|Protocol Violation|1|||
94633977|NCT01485640|324121348|FG000|Overall Study|Withdrawal by Subject|14|||
94633978|NCT01485640|324121348|FG000|Overall Study|Terminated by Sponsor|95|||
94633979|NCT01853046|324121349|FG000|Overall Study|Withdrawal by Subject|1|||
94633980|NCT01853046|324121350|FG001|Overall Study|Withdrawal by Subject|1|||
94633981|NCT01853046|324121349|FG000|Overall Study|Adverse Event|4|||
94633982|NCT01853046|324121350|FG001|Overall Study|Adverse Event|2|||
94633983|NCT01853046|324121349|FG000|Overall Study|Disease progression|13|||
94633984|NCT01853046|324121350|FG001|Overall Study|Disease progression|3|||
94633985|NCT00708643|324121353|FG000|Overall Study|Adverse Event|0|||
94633986|NCT00708643|324121354|FG001|Overall Study|Adverse Event|1|||
94633987|NCT02699554|324121355|FG000|Overall Study|Lost to Follow-up|9|||
94633988|NCT01710033|324121357|FG000|Stage 2|Adverse Event|0|||
94261584|NCT03942406|322752378|FG000|Overall Study|Withdrawal by Subject|3|||
94261585|NCT03942406|322752379|FG001|Overall Study|Withdrawal by Subject|1|||
94261586|NCT03942406|322752380|FG002|Overall Study|Withdrawal by Subject|1|||
94633989|NCT01710033|324121358|FG001|Stage 2|Adverse Event|0|||
94633990|NCT01710033|324121359|FG002|Stage 2|Adverse Event|0|||
94633991|NCT01710033|324121360|FG003|Stage 2|Adverse Event|0|||
94633992|NCT01710033|324121361|FG004|Stage 2|Adverse Event|1|||
94633993|NCT01132482|324121364|FG000|Overall Study|Adverse Event|1|||
94633994|NCT01132482|324121365|FG001|Overall Study|Adverse Event|0|||
94633995|NCT01172847|324121370|FG000|Overall Study|Withdrawal by Subject|3|||
94633996|NCT00303498|324121374|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
94633997|NCT00303498|324121375|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
94633998|NCT00303498|324121374|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
94261587|NCT03942406|322752381|FG003|Overall Study|Withdrawal by Subject|3|||
94261588|NCT03942406|322752382|FG004|Overall Study|Withdrawal by Subject|0|||
94261589|NCT03942406|322752383|FG005|Overall Study|Withdrawal by Subject|0|||
94633999|NCT00303498|324121375|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
94634000|NCT00303498|324121374|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
94634001|NCT00303498|324121375|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
94676366|NCT02323646|324269109|FG001|Treatment Course 1|Lost to Follow-up|0|||
94676367|NCT02323646|324269110|FG002|Treatment Course 1|Lost to Follow-up|2|||
94676368|NCT02323646|324269108|FG000|Treatment Course 1|Withdrawal by Subject|0|||
94676369|NCT02323646|324269109|FG001|Treatment Course 1|Withdrawal by Subject|2|||
94676370|NCT02323646|324269110|FG002|Treatment Course 1|Withdrawal by Subject|0|||
94676371|NCT02323646|324269108|FG000|Treatment Course 2|Adverse Event|1|||
94676372|NCT02323646|324269109|FG001|Treatment Course 2|Adverse Event|0|||
94676373|NCT02323646|324269110|FG002|Treatment Course 2|Adverse Event|1|||
94676374|NCT02323646|324269108|FG000|Treatment Course 2|Lost to Follow-up|0|||
94676375|NCT02323646|324269109|FG001|Treatment Course 2|Lost to Follow-up|0|||
94676376|NCT02323646|324269110|FG002|Treatment Course 2|Lost to Follow-up|1|||
94676377|NCT02323646|324269108|FG000|Treatment Course 2|Non-compliance|0|||
94676378|NCT02323646|324269109|FG001|Treatment Course 2|Non-compliance|1|||
94676379|NCT02323646|324269110|FG002|Treatment Course 2|Non-compliance|1|||
94676380|NCT02313909|324269116|FG000|Overall Study|Consent withdrawn by participant|33|||
94676381|NCT02313909|324269117|FG001|Overall Study|Consent withdrawn by participant|33|||
94676382|NCT02313909|324269116|FG000|Overall Study|Lost to Follow-up|24|||
94676383|NCT02313909|324269117|FG001|Overall Study|Lost to Follow-up|17|||
94676384|NCT00409682|324269125|FG000|Open-label Induction Period|Adverse Event|1|||
94676385|NCT00409682|324269126|FG001|Open-label Induction Period|Adverse Event|0|||
94362579|NCT03353415|323110780|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
94362580|NCT01126359|323110781|FG000|First Intervention (20-minutes)|Physician Decision|0|||
94362581|NCT01126359|323110782|FG001|First Intervention (20-minutes)|Physician Decision|1|||
94362582|NCT03205163|323110783|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
94362583|NCT03205163|323110784|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
94676386|NCT00409682|324269127|FG002|Open-label Induction Period|Adverse Event|0|||
94676387|NCT00409682|324269125|FG000|Open-label Induction Period|Lack of Efficacy|1|||
94676388|NCT00409682|324269126|FG001|Open-label Induction Period|Lack of Efficacy|0|||
94362584|NCT01843660|323110785|FG000|Overall Study|Other|30|||
94362585|NCT00209560|323110786|FG000|Overall Study|Lack of Efficacy|1|||
94362586|NCT00209560|323110787|FG001|Overall Study|Lack of Efficacy|0|||
94362587|NCT05022121|323110788|FG000|Overall Study|Lack of Efficacy|1|||
94362588|NCT05022121|323110789|FG001|Overall Study|Lack of Efficacy|0|||
94362589|NCT05022121|323110788|FG000|Overall Study|Lost to Follow-up|0|||
94362590|NCT05022121|323110789|FG001|Overall Study|Lost to Follow-up|2|||
94362591|NCT01876082|323112738|FG000|Overall Study|Withdrawal by Subject|0|||
94362592|NCT01876082|323112739|FG001|Overall Study|Withdrawal by Subject|2|||
94362593|NCT01876082|323112738|FG000|Overall Study|Protocol Violation|1|||
94362594|NCT01876082|323112739|FG001|Overall Study|Protocol Violation|0|||
94362595|NCT01876082|323112738|FG000|Overall Study|Adverse Event|1|||
94362596|NCT01876082|323112739|FG001|Overall Study|Adverse Event|1|||
94362597|NCT01876082|323112738|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
94362598|NCT01876082|323112739|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
94362599|NCT00359073|323112767|FG000|Overall Study|Withdrawal by Subject|1|||
94362600|NCT00359073|323112768|FG001|Overall Study|Withdrawal by Subject|1|||
94362601|NCT00359073|323112767|FG000|Overall Study|Eligibility criteria no longer met|3|||
94362602|NCT00359073|323112768|FG001|Overall Study|Eligibility criteria no longer met|0|||
94362603|NCT00359073|323112767|FG000|Overall Study|developed RV16 antibody|0|||
94362604|NCT00359073|323112768|FG001|Overall Study|developed RV16 antibody|1|||
94362605|NCT03457727|323112771|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
94362606|NCT03457727|323112772|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
94362607|NCT03457727|323112773|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
94362608|NCT03457727|323112774|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
94362609|NCT01491737|323112775|FG000|Overall Study|Withdrawal by Subject|20|||
94362610|NCT01491737|323112776|FG001|Overall Study|Withdrawal by Subject|17|||
94362611|NCT01491737|323112775|FG000|Overall Study|Lost to Follow-up|2|||
94362612|NCT01491737|323112776|FG001|Overall Study|Lost to Follow-up|10|||
94362613|NCT01491737|323112775|FG000|Overall Study|Death|63|||
94362614|NCT01491737|323112776|FG001|Overall Study|Death|57|||
94362615|NCT01491737|323112775|FG000|Overall Study|Study Termination by Sponsor|36|||
94362616|NCT01491737|323112776|FG001|Overall Study|Study Termination by Sponsor|36|||
94362617|NCT01491737|323112775|FG000|Overall Study|Reason Not Specified|8|||
94362618|NCT01491737|323112776|FG001|Overall Study|Reason Not Specified|9|||
94362619|NCT00630994|323112777|FG000|Overall Study|Adverse Event|1|||
94362620|NCT00630994|323112777|FG000|Overall Study|Disease Progression|1|||
94362621|NCT00630994|323112777|FG000|Overall Study|Lack of Efficacy|1|||
94676389|NCT00409682|324269127|FG002|Open-label Induction Period|Lack of Efficacy|0|||
94676390|NCT00409682|324269125|FG000|Open-label Induction Period|Protocol Violation|1|||
94676391|NCT00409682|324269126|FG001|Open-label Induction Period|Protocol Violation|0|||
94362622|NCT00630994|323112777|FG000|Overall Study|Other|1|||
94362623|NCT03669640|323112778|FG000|Overall Study|Study Terminated by Sponsor|0|||
94362624|NCT03669640|323112779|FG001|Overall Study|Study Terminated by Sponsor|0|||
94362625|NCT03669640|323112780|FG002|Overall Study|Study Terminated by Sponsor|0|||
94676392|NCT00409682|324269127|FG002|Open-label Induction Period|Protocol Violation|0|||
94676393|NCT00409682|324269125|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
94634002|NCT00303498|324121374|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
94634003|NCT00303498|324121375|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
94634004|NCT00303498|324121374|FG000|Run-In-Phase (10 Weeks)|Other|4|||
94634005|NCT00303498|324121375|FG001|Run-In-Phase (10 Weeks)|Other|1|||
94634006|NCT00303498|324121374|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
94634007|NCT00303498|324121375|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
94634008|NCT00303498|324121374|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
94634009|NCT00303498|324121375|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
94634010|NCT00303498|324121374|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
94634011|NCT00303498|324121375|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
94634012|NCT00303498|324121374|FG000|Maintenance Phase (24 Weeks)|Death|1|||
94634013|NCT00303498|324121375|FG001|Maintenance Phase (24 Weeks)|Death|0|||
94634014|NCT00303498|324121374|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
94634015|NCT00303498|324121375|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
94634016|NCT00303498|324121374|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
94634017|NCT00303498|324121375|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
94634018|NCT00303498|324121374|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
94634019|NCT00303498|324121375|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
94634020|NCT00303498|324121374|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
94634021|NCT00303498|324121375|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
94634022|NCT00303498|324121374|FG000|Maintenance Phase (24 Weeks)|Other|1|||
94634023|NCT00303498|324121375|FG001|Maintenance Phase (24 Weeks)|Other|0|||
94634024|NCT00303498|324121374|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
94634025|NCT00303498|324121375|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
94634026|NCT00303498|324121374|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
94634027|NCT00303498|324121375|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
94634028|NCT02432846|324121378|FG000|Overall Study (4 Arms/Strata)|Death|3|||
94634029|NCT02432846|324121379|FG001|Overall Study (4 Arms/Strata)|Death|2|||
94634030|NCT02432846|324121380|FG002|Overall Study (4 Arms/Strata)|Death|4|||
94634031|NCT02432846|324121381|FG003|Overall Study (4 Arms/Strata)|Death|3|||
94634032|NCT02432846|324121382|FG004|Overall Study (4 Arms/Strata)|Death|0|||
94634033|NCT02432846|324121383|FG005|Overall Study (4 Arms/Strata)|Death|0|||
94634034|NCT02432846|324121378|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
94634035|NCT02432846|324121379|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
94634036|NCT02432846|324121380|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
94634037|NCT02432846|324121381|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
94634038|NCT02432846|324121382|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
94634039|NCT02432846|324121383|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
94634040|NCT02432846|324121378|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
94634041|NCT02432846|324121379|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
94634042|NCT02432846|324121380|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
94634043|NCT02432846|324121381|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
94634044|NCT02432846|324121382|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
94634045|NCT02432846|324121383|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
94634046|NCT02432846|324121378|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
94634047|NCT02432846|324121379|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
94634048|NCT02432846|324121380|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
94634049|NCT02432846|324121381|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
94634050|NCT02432846|324121382|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
94634051|NCT02432846|324121383|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
94634052|NCT02432846|324121378|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
94634053|NCT02432846|324121379|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
94634054|NCT02432846|324121380|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
94634055|NCT02432846|324121381|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
94634056|NCT02432846|324121382|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
94634057|NCT02432846|324121383|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
94634058|NCT02432846|324121378|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
94634059|NCT02432846|324121379|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
94634060|NCT02432846|324121380|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
94634061|NCT02432846|324121381|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
94634062|NCT02432846|324121382|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
94461760|NCT03099694|323479611|FG001|Overall Study|Withdrawal by Subject|13|||
94461761|NCT03099694|323479610|FG000|Overall Study|Lost to Follow-up|9|||
94634063|NCT02432846|324121383|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
94634064|NCT02432846|324121378|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
94634065|NCT02432846|324121379|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
94634066|NCT02432846|324121380|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
94634067|NCT02432846|324121381|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
94634068|NCT02432846|324121382|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
94634069|NCT02432846|324121383|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
94634070|NCT02432846|324121378|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
94634071|NCT02432846|324121379|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
94634072|NCT02432846|324121380|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
94634073|NCT02432846|324121381|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
94634074|NCT02432846|324121382|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
94634075|NCT02432846|324121383|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
94634076|NCT02432846|324121378|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
94634077|NCT02432846|324121379|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
94634078|NCT02432846|324121380|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
94634079|NCT02432846|324121381|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
94634080|NCT02432846|324121382|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
94634081|NCT02432846|324121383|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
94634082|NCT02432846|324121378|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
94634083|NCT02432846|324121379|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
94634084|NCT02432846|324121380|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
94634085|NCT02432846|324121381|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
94634086|NCT02432846|324121382|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
94634087|NCT02432846|324121383|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
94634088|NCT02432846|324121378|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
94634089|NCT02432846|324121379|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
94634090|NCT02432846|324121380|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
94634091|NCT02432846|324121381|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
94634092|NCT02432846|324121382|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
94634093|NCT02432846|324121383|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
94634094|NCT02432846|324121378|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
94634095|NCT02432846|324121379|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
94634096|NCT02432846|324121380|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
94634097|NCT02432846|324121381|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
94634098|NCT02432846|324121382|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
94634099|NCT02432846|324121383|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
94634100|NCT02432846|324121378|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
94634101|NCT02432846|324121379|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
94634102|NCT02432846|324121380|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
94634103|NCT02432846|324121381|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
94634104|NCT02432846|324121382|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
94634105|NCT02432846|324121383|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
94634106|NCT02432846|324121378|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
94634107|NCT02432846|324121379|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
94634108|NCT02432846|324121380|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
94634109|NCT02432846|324121381|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
94634110|NCT02432846|324121382|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
94634111|NCT02432846|324121383|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
94634112|NCT01770379|324121384|FG000|Overall Study|Technical issues|1|||
94634113|NCT01770379|324121385|FG001|Overall Study|Technical issues|0|||
94634114|NCT01770379|324121386|FG002|Overall Study|Technical issues|0|||
94634115|NCT01770379|324121384|FG000|Overall Study|Withdrawal by Subject|7|||
94634116|NCT01770379|324121385|FG001|Overall Study|Withdrawal by Subject|10|||
94634117|NCT01770379|324121386|FG002|Overall Study|Withdrawal by Subject|7|||
94634118|NCT01770379|324121384|FG000|Overall Study|study terminated by sponsor|22|||
94634119|NCT01770379|324121385|FG001|Overall Study|study terminated by sponsor|23|||
94634120|NCT01770379|324121386|FG002|Overall Study|study terminated by sponsor|22|||
94634121|NCT01770379|324121384|FG000|Overall Study|Protocol Violation|0|||
94634122|NCT01770379|324121385|FG001|Overall Study|Protocol Violation|1|||
94634123|NCT01770379|324121386|FG002|Overall Study|Protocol Violation|1|||
94634124|NCT01770379|324121384|FG000|Overall Study|Physician Decision|0|||
94634125|NCT01770379|324121385|FG001|Overall Study|Physician Decision|1|||
94261590|NCT03942406|322752384|FG006|Overall Study|Withdrawal by Subject|0|||
94634126|NCT01770379|324121386|FG002|Overall Study|Physician Decision|2|||
94634127|NCT01770379|324121384|FG000|Overall Study|Lost to Follow-up|0|||
94634128|NCT01770379|324121385|FG001|Overall Study|Lost to Follow-up|0|||
94634129|NCT01770379|324121386|FG002|Overall Study|Lost to Follow-up|2|||
94634130|NCT01770379|324121384|FG000|Overall Study|Lack of Efficacy|8|||
94634131|NCT01770379|324121385|FG001|Overall Study|Lack of Efficacy|6|||
94634132|NCT01770379|324121386|FG002|Overall Study|Lack of Efficacy|6|||
94261591|NCT03942406|322752378|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
94461762|NCT03099694|323479611|FG001|Overall Study|Lost to Follow-up|5|||
94261592|NCT03942406|322752379|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
94261593|NCT03942406|322752380|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
94261594|NCT03942406|322752381|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
94261595|NCT03942406|322752382|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
94261596|NCT03942406|322752383|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
94261597|NCT03942406|322752384|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
94261598|NCT04263909|322752385|FG000|Overall Study|Physician Decision|1|||
94634133|NCT01770379|324121384|FG000|Overall Study|Adverse Event|1|||
94634134|NCT01770379|324121385|FG001|Overall Study|Adverse Event|3|||
94634135|NCT01770379|324121386|FG002|Overall Study|Adverse Event|2|||
94634136|NCT00311623|324121389|FG000|Overall Study|Physician Decision|0|||
94634137|NCT00311623|324121390|FG001|Overall Study|Physician Decision|0|||
94634138|NCT00311623|324121391|FG002|Overall Study|Physician Decision|2|||
94634139|NCT01912287|324121392|FG000|Overall Study|Ineligible|1|||
94634140|NCT01912287|324121393|FG001|Overall Study|Ineligible|0|||
94634141|NCT01912287|324121394|FG002|Overall Study|Ineligible|1|||
94634142|NCT01912287|324121392|FG000|Overall Study|No-show|0|||
94634143|NCT01912287|324121393|FG001|Overall Study|No-show|0|||
94634144|NCT01912287|324121394|FG002|Overall Study|No-show|1|||
94634145|NCT01912287|324121392|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
94634146|NCT01912287|324121393|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
94634147|NCT01912287|324121394|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
94634148|NCT01912287|324121392|FG000|Overall Study|Felt treatment no longer needed|0|||
94634149|NCT01912287|324121393|FG001|Overall Study|Felt treatment no longer needed|1|||
94634150|NCT01912287|324121394|FG002|Overall Study|Felt treatment no longer needed|0|||
94634151|NCT01912287|324121392|FG000|Overall Study|Life circumstances|4|||
94634152|NCT01912287|324121393|FG001|Overall Study|Life circumstances|2|||
94634153|NCT01912287|324121394|FG002|Overall Study|Life circumstances|0|||
94634154|NCT01912287|324121392|FG000|Overall Study|Lost Interest|1|||
94634155|NCT01912287|324121393|FG001|Overall Study|Lost Interest|0|||
94634156|NCT01912287|324121394|FG002|Overall Study|Lost Interest|0|||
94634157|NCT01912287|324121392|FG000|Overall Study|Uknown reason - subject drop out|5|||
94634158|NCT01912287|324121393|FG001|Overall Study|Uknown reason - subject drop out|7|||
94634159|NCT01912287|324121394|FG002|Overall Study|Uknown reason - subject drop out|3|||
94634160|NCT01912287|324121392|FG000|Overall Study|Missed Assesment|1|||
94634161|NCT01912287|324121393|FG001|Overall Study|Missed Assesment|1|||
94634162|NCT01912287|324121394|FG002|Overall Study|Missed Assesment|1|||
94634163|NCT01912287|324121392|FG000|Overall Study|Scheduling/change in availability|17|||
94634164|NCT01912287|324121393|FG001|Overall Study|Scheduling/change in availability|10|||
94634165|NCT01912287|324121394|FG002|Overall Study|Scheduling/change in availability|8|||
94634166|NCT03103919|324121395|FG000|Overall Study|Adverse Event|2|||
94634167|NCT03103919|324121396|FG001|Overall Study|Adverse Event|2|||
94634168|NCT00937157|324121401|FG000|Overall Study|Pregnancy|1|||
94634169|NCT00937157|324121401|FG000|Overall Study|Lost to Follow-up|3|||
94634170|NCT01846507|324121402|FG000|Overall Study|Lost to Follow-up|4|||
94634171|NCT01846507|324121402|FG000|Overall Study|Protocol Violation|1|||
94634172|NCT01846507|324121402|FG000|Overall Study|Missing data|2|||
94634173|NCT00450450|324121403|FG000|Overall Study|Death|1|||
94634174|NCT00450450|324121404|FG001|Overall Study|Death|3|||
94634175|NCT00450450|324121403|FG000|Overall Study|Relapse|2|||
94634176|NCT00450450|324121404|FG001|Overall Study|Relapse|0|||
94634177|NCT00450450|324121403|FG000|Overall Study|Missing Data|2|||
94634178|NCT00450450|324121404|FG001|Overall Study|Missing Data|0|||
94634179|NCT04984993|324121405|FG000|Overall Study|Withdrawal by Subject|8|||
94634180|NCT04984993|324121406|FG001|Overall Study|Withdrawal by Subject|2|||
94634181|NCT04984993|324121405|FG000|Overall Study|Lost to Follow-up|2|||
94634182|NCT04984993|324121406|FG001|Overall Study|Lost to Follow-up|2|||
94634183|NCT04984993|324121405|FG000|Overall Study|Both patients moved to another country|4|||
94634184|NCT04984993|324121406|FG001|Overall Study|Both patients moved to another country|0|||
94261599|NCT04263909|322752386|FG001|Overall Study|Physician Decision|0|||
94634185|NCT01110707|324121409|FG000|Overall Study|Protocol Violation|0|||
94634186|NCT01110707|324121410|FG001|Overall Study|Protocol Violation|3|||
94634187|NCT01998633|324121411|FG000|Overall Study|Death|1|||
94634188|NCT01086540|324121412|FG000|Overall Study|Death|3|||
94634189|NCT01086540|324121413|FG001|Overall Study|Death|1|||
94261600|NCT04263909|322752387|FG002|Overall Study|Physician Decision|0|||
94261601|NCT04263909|322752385|FG000|Overall Study|Adverse Event|3|||
94261602|NCT04263909|322752386|FG001|Overall Study|Adverse Event|0|||
94634190|NCT01086540|324121412|FG000|Overall Study|Physician Decision|2|||
94634191|NCT01086540|324121413|FG001|Overall Study|Physician Decision|1|||
94634192|NCT01086540|324121412|FG000|Overall Study|Addition of new therapy for PAH|1|||
94634193|NCT01086540|324121413|FG001|Overall Study|Addition of new therapy for PAH|0|||
94634194|NCT02278263|324121414|FG000|Overall Study|Protocol Violation|7|||
94634195|NCT02278263|324121415|FG001|Overall Study|Protocol Violation|0|||
94634196|NCT02278263|324121416|FG002|Overall Study|Protocol Violation|9|||
94634197|NCT00143403|324121420|FG000|Overall Study|Adverse Event|3|||
94634198|NCT00143403|324121421|FG001|Overall Study|Adverse Event|8|||
94261603|NCT04263909|322752387|FG002|Overall Study|Adverse Event|0|||
94261604|NCT04263909|322752385|FG000|Overall Study|Protocol Violation|5|||
94261605|NCT04263909|322752386|FG001|Overall Study|Protocol Violation|0|||
94261606|NCT04263909|322752387|FG002|Overall Study|Protocol Violation|0|||
94261607|NCT05458479|322752388|FG000|Overall Study|Lost to Follow-up|1|||
94261608|NCT02027701|322752389|FG000|Overall Study|Adverse Event|3|||
94261609|NCT02027701|322752389|FG000|Overall Study|Lack of Efficacy|8|||
94261610|NCT02027701|322752389|FG000|Overall Study|Physician Decision|2|||
94261611|NCT02027701|322752389|FG000|Overall Study|Withdrawal by Subject|3|||
94634199|NCT00143403|324121420|FG000|Overall Study|Death|1|||
94634200|NCT00143403|324121421|FG001|Overall Study|Death|0|||
94634201|NCT00143403|324121420|FG000|Overall Study|Withdrawal by Subject|3|||
94634202|NCT00143403|324121421|FG001|Overall Study|Withdrawal by Subject|12|||
94634203|NCT00143403|324121420|FG000|Overall Study|Relapse|15|||
94634204|NCT00143403|324121421|FG001|Overall Study|Relapse|7|||
94634205|NCT00143403|324121420|FG000|Overall Study|Protocol Violation|2|||
94634206|NCT00143403|324121421|FG001|Overall Study|Protocol Violation|2|||
94634207|NCT00143403|324121420|FG000|Overall Study|specified by site|4|||
94634208|NCT00143403|324121421|FG001|Overall Study|specified by site|9|||
94634209|NCT00143403|324121420|FG000|Overall Study|Randomized Not Treated|7|||
94634210|NCT00143403|324121421|FG001|Overall Study|Randomized Not Treated|8|||
94634211|NCT02733991|324121422|FG000|Overall Study|Adverse Event|1|||
94634212|NCT02733991|324121423|FG001|Overall Study|Adverse Event|0|||
94634213|NCT02733991|324121422|FG000|Overall Study|Withdrawal by Subject|0|||
94634214|NCT02733991|324121423|FG001|Overall Study|Withdrawal by Subject|5|||
94634215|NCT00268996|324121424|FG000|Overall Study|Adverse Event|11|||
94634216|NCT00268996|324121425|FG001|Overall Study|Adverse Event|7|||
94634217|NCT00268996|324121424|FG000|Overall Study|Lost to Follow-up|3|||
94634218|NCT00268996|324121425|FG001|Overall Study|Lost to Follow-up|1|||
94634219|NCT00268996|324121424|FG000|Overall Study|Withdrawal by Subject|5|||
94634220|NCT00268996|324121425|FG001|Overall Study|Withdrawal by Subject|11|||
94634221|NCT00268996|324121424|FG000|Overall Study|Non-compliance|1|||
94634222|NCT00268996|324121425|FG001|Overall Study|Non-compliance|0|||
94634223|NCT00268996|324121424|FG000|Overall Study|Other|1|||
94634224|NCT00268996|324121425|FG001|Overall Study|Other|1|||
94634225|NCT02268864|324121426|FG000|Overall Study|Withdrawal by Subject|2|||
94634226|NCT02268864|324121427|FG001|Overall Study|Withdrawal by Subject|0|||
94634227|NCT02268864|324121428|FG002|Overall Study|Withdrawal by Subject|0|||
94634228|NCT02268864|324121426|FG000|Overall Study|Death|0|||
94634229|NCT02268864|324121427|FG001|Overall Study|Death|1|||
94634230|NCT02268864|324121428|FG002|Overall Study|Death|0|||
94634231|NCT00495170|324121431|FG000|Overall Study|Lost to Follow-up|9|||
94634232|NCT00495170|324121431|FG000|Overall Study|Withdrawal by Subject|3|||
94634233|NCT00495170|324121431|FG000|Overall Study|Inappropriate staging|8|||
94634234|NCT02914769|324121433|FG000|Overall Study|Protocol Violation|3|||
94634235|NCT02914769|324121434|FG001|Overall Study|Protocol Violation|2|||
94634236|NCT02914769|324121433|FG000|Overall Study|Withdrawal by Subject|0|||
94634237|NCT02914769|324121434|FG001|Overall Study|Withdrawal by Subject|1|||
94634238|NCT00742001|324121435|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
94634239|NCT00742001|324121436|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
94634240|NCT00742001|324121437|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
94634241|NCT01408914|324121438|FG000|Overall Study|Could not complete tx in protocol period|5|||
94634242|NCT01408914|324121439|FG001|Overall Study|Could not complete tx in protocol period|5|||
94634243|NCT01408914|324121440|FG002|Overall Study|Could not complete tx in protocol period|6|||
94634244|NCT01408914|324121438|FG000|Overall Study|Lost to Follow-up|4|||
94634245|NCT01408914|324121439|FG001|Overall Study|Lost to Follow-up|1|||
94634246|NCT01408914|324121440|FG002|Overall Study|Lost to Follow-up|2|||
94634247|NCT01408914|324121438|FG000|Overall Study|Physician Decision|1|||
94634248|NCT01408914|324121439|FG001|Overall Study|Physician Decision|1|||
94634249|NCT01408914|324121440|FG002|Overall Study|Physician Decision|0|||
94676394|NCT00409682|324269126|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
94676395|NCT00409682|324269127|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
94261612|NCT02202551|322752390|FG000|Overall Study|Adverse Event|8|||
94261613|NCT02202551|322752391|FG001|Overall Study|Adverse Event|19|||
94634250|NCT01408914|324121438|FG000|Overall Study|Withdrawal by Subject|1|||
94634251|NCT01408914|324121439|FG001|Overall Study|Withdrawal by Subject|0|||
94634252|NCT01408914|324121440|FG002|Overall Study|Withdrawal by Subject|1|||
94261614|NCT02202551|322752392|FG002|Overall Study|Adverse Event|5|||
94261615|NCT02202551|322752393|FG003|Overall Study|Adverse Event|9|||
94634253|NCT01408914|324121438|FG000|Overall Study|Moved out of study jurisdiction|1|||
94634254|NCT01408914|324121439|FG001|Overall Study|Moved out of study jurisdiction|1|||
94634255|NCT01408914|324121440|FG002|Overall Study|Moved out of study jurisdiction|0|||
94634256|NCT01408914|324121438|FG000|Overall Study|Late exclusion|0|||
94634257|NCT01408914|324121439|FG001|Overall Study|Late exclusion|3|||
94634258|NCT01408914|324121440|FG002|Overall Study|Late exclusion|3|||
94634259|NCT01408914|324121438|FG000|Overall Study|Change in local TB/HIV norms|0|||
94634260|NCT01408914|324121439|FG001|Overall Study|Change in local TB/HIV norms|1|||
94676396|NCT00409682|324269125|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
94676397|NCT00409682|324269126|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
94676398|NCT00409682|324269127|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
94676399|NCT00409682|324269125|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
94676400|NCT00409682|324269126|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
94676401|NCT00409682|324269127|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
94676402|NCT00409682|324269125|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
94676403|NCT00409682|324269126|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
94676404|NCT00409682|324269127|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
94676405|NCT00409682|324269125|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
94676406|NCT00409682|324269126|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
94676407|NCT00409682|324269127|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
94676408|NCT00409682|324269125|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
94676409|NCT00409682|324269126|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
94676410|NCT00409682|324269127|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
94676411|NCT00409682|324269125|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
94261616|NCT02202551|322752390|FG000|Overall Study|Death|3|||
94261617|NCT02202551|322752391|FG001|Overall Study|Death|2|||
94261618|NCT02202551|322752392|FG002|Overall Study|Death|1|||
94261619|NCT02202551|322752393|FG003|Overall Study|Death|1|||
94261620|NCT02202551|322752390|FG000|Overall Study|Lost to Follow-up|0|||
94261621|NCT02202551|322752391|FG001|Overall Study|Lost to Follow-up|1|||
94261622|NCT02202551|322752392|FG002|Overall Study|Lost to Follow-up|0|||
94261623|NCT02202551|322752393|FG003|Overall Study|Lost to Follow-up|1|||
94261624|NCT02202551|322752390|FG000|Overall Study|Needed to take excluded medication|0|||
94261625|NCT02202551|322752391|FG001|Overall Study|Needed to take excluded medication|2|||
94261626|NCT02202551|322752392|FG002|Overall Study|Needed to take excluded medication|0|||
94261627|NCT02202551|322752393|FG003|Overall Study|Needed to take excluded medication|1|||
94261628|NCT02202551|322752390|FG000|Overall Study|Subject moved away|0|||
94261629|NCT02202551|322752391|FG001|Overall Study|Subject moved away|1|||
94261630|NCT02202551|322752392|FG002|Overall Study|Subject moved away|0|||
94261631|NCT02202551|322752393|FG003|Overall Study|Subject moved away|0|||
94261632|NCT02202551|322752390|FG000|Overall Study|DBS surgery|3|||
94261633|NCT02202551|322752391|FG001|Overall Study|DBS surgery|0|||
94261634|NCT02202551|322752392|FG002|Overall Study|DBS surgery|0|||
94261635|NCT02202551|322752393|FG003|Overall Study|DBS surgery|0|||
94261636|NCT02202551|322752390|FG000|Overall Study|Dyskinesia upon taper|1|||
94261637|NCT02202551|322752391|FG001|Overall Study|Dyskinesia upon taper|0|||
94261638|NCT02202551|322752392|FG002|Overall Study|Dyskinesia upon taper|0|||
94261639|NCT02202551|322752393|FG003|Overall Study|Dyskinesia upon taper|0|||
94261640|NCT02202551|322752390|FG000|Overall Study|Lack of Efficacy|0|||
94261641|NCT02202551|322752391|FG001|Overall Study|Lack of Efficacy|1|||
94261642|NCT02202551|322752392|FG002|Overall Study|Lack of Efficacy|0|||
94261643|NCT02202551|322752393|FG003|Overall Study|Lack of Efficacy|0|||
94261644|NCT02202551|322752390|FG000|Overall Study|Physician Decision|1|||
94261645|NCT02202551|322752391|FG001|Overall Study|Physician Decision|0|||
94261646|NCT02202551|322752392|FG002|Overall Study|Physician Decision|0|||
94261647|NCT02202551|322752393|FG003|Overall Study|Physician Decision|0|||
94261648|NCT02202551|322752390|FG000|Overall Study|Site closure|3|||
94261649|NCT02202551|322752391|FG001|Overall Study|Site closure|0|||
94261650|NCT02202551|322752392|FG002|Overall Study|Site closure|0|||
94261651|NCT02202551|322752393|FG003|Overall Study|Site closure|1|||
94261652|NCT02202551|322752390|FG000|Overall Study|Unable to complete visits per protocol|1|||
94261653|NCT02202551|322752391|FG001|Overall Study|Unable to complete visits per protocol|0|||
94261654|NCT02202551|322752392|FG002|Overall Study|Unable to complete visits per protocol|0|||
94261655|NCT02202551|322752393|FG003|Overall Study|Unable to complete visits per protocol|0|||
94261656|NCT02202551|322752390|FG000|Overall Study|Worsening Dyskinesia|0|||
94261657|NCT02202551|322752391|FG001|Overall Study|Worsening Dyskinesia|0|||
94261658|NCT02202551|322752392|FG002|Overall Study|Worsening Dyskinesia|0|||
94261659|NCT02202551|322752393|FG003|Overall Study|Worsening Dyskinesia|1|||
94261660|NCT02202551|322752390|FG000|Overall Study|Protocol Violation|0|||
94261661|NCT02202551|322752391|FG001|Overall Study|Protocol Violation|1|||
94676412|NCT00409682|324269126|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
94261662|NCT02202551|322752392|FG002|Overall Study|Protocol Violation|0|||
94261663|NCT02202551|322752393|FG003|Overall Study|Protocol Violation|0|||
94676413|NCT00409682|324269127|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
94676414|NCT01059630|324269128|FG000|Overall Study|Death|100|||
94261664|NCT02202551|322752390|FG000|Overall Study|Sponsor's decision|2|||
94261665|NCT02202551|322752391|FG001|Overall Study|Sponsor's decision|0|||
94261666|NCT02202551|322752392|FG002|Overall Study|Sponsor's decision|0|||
94261667|NCT02202551|322752393|FG003|Overall Study|Sponsor's decision|0|||
94261668|NCT02202551|322752390|FG000|Overall Study|Subject unwilling to proceed|1|||
94261669|NCT02202551|322752391|FG001|Overall Study|Subject unwilling to proceed|5|||
94261670|NCT02202551|322752392|FG002|Overall Study|Subject unwilling to proceed|3|||
94261671|NCT02202551|322752393|FG003|Overall Study|Subject unwilling to proceed|5|||
94261672|NCT02202551|322752390|FG000|Overall Study|Subject consent withdrawn|0|||
94261673|NCT02202551|322752391|FG001|Overall Study|Subject consent withdrawn|3|||
94261674|NCT02202551|322752392|FG002|Overall Study|Subject consent withdrawn|1|||
94261675|NCT02202551|322752393|FG003|Overall Study|Subject consent withdrawn|2|||
94634261|NCT01408914|324121440|FG002|Overall Study|Change in local TB/HIV norms|1|||
94634262|NCT00137423|324121441|FG000|Overall Study|Adverse Event|7|||
94634263|NCT00137423|324121442|FG001|Overall Study|Adverse Event|9|||
94634264|NCT00137423|324121441|FG000|Overall Study|consent withdrawn|1|||
94634265|NCT00137423|324121442|FG001|Overall Study|consent withdrawn|1|||
94634266|NCT00137423|324121441|FG000|Overall Study|Lack of Efficacy|31|||
94634267|NCT00137423|324121442|FG001|Overall Study|Lack of Efficacy|33|||
94634268|NCT00137423|324121441|FG000|Overall Study|Death|0|||
94634269|NCT00137423|324121442|FG001|Overall Study|Death|1|||
94634270|NCT03187262|324121443|FG000|Induction|Lack of Efficacy|2|||
94634271|NCT03187262|324121443|FG000|Induction|Progressive Disease|4|||
94634272|NCT03187262|324121443|FG000|Consolidation|Progressive Disease|5|||
94634273|NCT00278109|324121448|FG000|Overall Study|Adverse Event|3|||
94634274|NCT00278109|324121448|FG000|Overall Study|social circumstances|1|||
94634275|NCT04903626|324121455|FG000|Overall Study|Lost to Follow-up|6|||
94634276|NCT04903626|324121455|FG000|Overall Study|Withdrawal by Subject|1|||
94634277|NCT04903626|324121455|FG000|Overall Study|Other, Not Specified|1|||
94634278|NCT02196558|324121464|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
94634279|NCT02196558|324121465|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
94634280|NCT02196558|324121466|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
94634281|NCT02196558|324121464|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
94634282|NCT02196558|324121465|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
94634283|NCT02196558|324121466|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
94634284|NCT02196558|324121464|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
94634285|NCT02196558|324121465|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
94634286|NCT02196558|324121466|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
94634287|NCT02196558|324121464|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
94634288|NCT02196558|324121465|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
94634289|NCT02196558|324121466|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
94634290|NCT02196558|324121464|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
94634291|NCT02196558|324121465|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
94634292|NCT02196558|324121466|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
94634293|NCT01505868|324121475|FG000|Overall Study|Withdrawal by Subject|1|||
94634294|NCT01505868|324121476|FG001|Overall Study|Withdrawal by Subject|0|||
94634295|NCT01505868|324121477|FG002|Overall Study|Withdrawal by Subject|0|||
94634296|NCT01505868|324121478|FG003|Overall Study|Withdrawal by Subject|0|||
94634297|NCT01505868|324121479|FG004|Overall Study|Withdrawal by Subject|0|||
94634298|NCT00407563|324123040|FG000|Overall Study|Patient continues on treatment|1|||
94634299|NCT00225251|324123041|FG000|Overall Study|Withdrawal by Subject|1|||
94634300|NCT00225251|324123042|FG001|Overall Study|Withdrawal by Subject|1|||
94634301|NCT00082355|324123045|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
94634302|NCT00082355|324123045|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
94634303|NCT00082355|324123045|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
94634304|NCT00759863|324123046|FG000|Overall Study|Death, moved, or lost contact|20|||
94634305|NCT00759863|324123047|FG001|Overall Study|Death, moved, or lost contact|18|||
94634306|NCT00412854|324123048|FG000|Overall Study|Withdrawn due to adverse events|1|||
94634307|NCT00412854|324123049|FG001|Overall Study|Withdrawn due to adverse events|5|||
94634308|NCT00412854|324123048|FG000|Overall Study|Withdrawn for other reasons|13|||
94634309|NCT00412854|324123049|FG001|Overall Study|Withdrawn for other reasons|11|||
94634310|NCT03683758|324123053|FG000|Overall Study|Non-study commitment conflict|1|||
94634311|NCT03683758|324123054|FG001|Overall Study|Non-study commitment conflict|3|||
94634312|NCT03683758|324123053|FG000|Overall Study|Illness preventing participation|1|||
94634313|NCT03683758|324123054|FG001|Overall Study|Illness preventing participation|0|||
94634314|NCT03683758|324123053|FG000|Overall Study|Adverse Event|1|||
94634315|NCT03683758|324123054|FG001|Overall Study|Adverse Event|0|||
94634316|NCT01163279|324123055|FG000|Overall Study|Withdrawal by Subject|2|||
94634317|NCT01163279|324123056|FG001|Overall Study|Withdrawal by Subject|0|||
94261676|NCT02202551|322752390|FG000|Overall Study|eGFR<50mL/min/m2|2|||
94261677|NCT02202551|322752391|FG001|Overall Study|eGFR<50mL/min/m2|2|||
94261678|NCT02202551|322752392|FG002|Overall Study|eGFR<50mL/min/m2|0|||
94634318|NCT02411292|324123057|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
94634319|NCT02411292|324123057|FG000|Overall Study|Death|2|||
94634320|NCT02411292|324123057|FG000|Overall Study|Lost to Follow-up|3|||
94634321|NCT00453921|324123058|FG000|Overall Study|Withdrawal by Subject|1|||
94634322|NCT00453921|324123059|FG001|Overall Study|Withdrawal by Subject|1|||
94634323|NCT00453921|324123060|FG002|Overall Study|Withdrawal by Subject|1|||
94634324|NCT00453921|324123061|FG003|Overall Study|Withdrawal by Subject|1|||
94634325|NCT00453921|324123058|FG000|Overall Study|Lost to Follow-up|0|||
94634326|NCT00453921|324123059|FG001|Overall Study|Lost to Follow-up|0|||
94634327|NCT00453921|324123060|FG002|Overall Study|Lost to Follow-up|1|||
94634328|NCT00453921|324123061|FG003|Overall Study|Lost to Follow-up|0|||
94634329|NCT00460031|324123062|FG000|Overall Study|Adverse Event|5|||
94261679|NCT02202551|322752393|FG003|Overall Study|eGFR<50mL/min/m2|1|||
94261680|NCT00954174|322752394|FG000|Overall Study|Adverse Event|28|||
94261681|NCT00954174|322752395|FG001|Overall Study|Adverse Event|23|||
94261682|NCT00954174|322752396|FG002|Overall Study|Adverse Event|4|||
94261683|NCT00954174|322752397|FG003|Overall Study|Adverse Event|9|||
94261684|NCT00954174|322752394|FG000|Overall Study|Death|4|||
94261685|NCT00954174|322752395|FG001|Overall Study|Death|2|||
94261686|NCT00954174|322752396|FG002|Overall Study|Death|0|||
94261687|NCT00954174|322752397|FG003|Overall Study|Death|0|||
94261688|NCT00954174|322752394|FG000|Overall Study|Lack of Efficacy|32|||
94261689|NCT00954174|322752395|FG001|Overall Study|Lack of Efficacy|22|||
94261690|NCT00954174|322752396|FG002|Overall Study|Lack of Efficacy|8|||
94261691|NCT00954174|322752397|FG003|Overall Study|Lack of Efficacy|6|||
94261692|NCT00954174|322752394|FG000|Overall Study|Withdrawal by Subject|14|||
94261693|NCT00954174|322752395|FG001|Overall Study|Withdrawal by Subject|10|||
94261694|NCT00954174|322752396|FG002|Overall Study|Withdrawal by Subject|4|||
94261695|NCT00954174|322752397|FG003|Overall Study|Withdrawal by Subject|3|||
94634330|NCT00460031|324123062|FG000|Overall Study|Withdrawal by Subject|5|||
94634331|NCT00460031|324123062|FG000|Overall Study|Death|1|||
94634332|NCT01998737|324123068|FG000|Overall Study|Corrupted database|23|||
94634333|NCT01998737|324123069|FG001|Overall Study|Corrupted database|0|||
94634334|NCT00453544|324123074|FG000|Overall Study|Withdrawal by Subject|1|||
94634335|NCT00453544|324123075|FG001|Overall Study|Withdrawal by Subject|0|||
94634336|NCT00453544|324123076|FG002|Overall Study|Withdrawal by Subject|0|||
94634337|NCT00453544|324123077|FG003|Overall Study|Withdrawal by Subject|0|||
94634338|NCT00453544|324123074|FG000|Overall Study|Primary outcome measure not completed|1|||
94634339|NCT00453544|324123075|FG001|Overall Study|Primary outcome measure not completed|1|||
94634340|NCT00453544|324123076|FG002|Overall Study|Primary outcome measure not completed|0|||
94634341|NCT00453544|324123077|FG003|Overall Study|Primary outcome measure not completed|1|||
94634342|NCT01558752|324123078|FG000|Overall Study|Physician Decision|2|||
94634343|NCT01558752|324123079|FG001|Overall Study|Physician Decision|0|||
94634344|NCT03721276|324123082|FG000|Overall Study|Lost to Follow-up|5|||
94634345|NCT03721276|324123083|FG001|Overall Study|Lost to Follow-up|3|||
94634346|NCT03721276|324123082|FG000|Overall Study|Adverse Event|0|||
94634347|NCT03721276|324123083|FG001|Overall Study|Adverse Event|1|||
94634348|NCT00450333|324123086|FG000|Overall Study|Study terminated|47|||
94634349|NCT00450333|324123087|FG001|Overall Study|Study terminated|54|||
94634350|NCT00450333|324123088|FG002|Overall Study|Study terminated|16|||
94634351|NCT00450333|324123089|FG003|Overall Study|Study terminated|21|||
94634352|NCT00450333|324123086|FG000|Overall Study|Adverse Event|1|||
94634353|NCT00450333|324123087|FG001|Overall Study|Adverse Event|7|||
94634354|NCT00450333|324123088|FG002|Overall Study|Adverse Event|2|||
94634355|NCT00450333|324123089|FG003|Overall Study|Adverse Event|2|||
94634356|NCT00450333|324123086|FG000|Overall Study|Protocol Violation|1|||
94634357|NCT00450333|324123087|FG001|Overall Study|Protocol Violation|0|||
94634358|NCT00450333|324123088|FG002|Overall Study|Protocol Violation|1|||
94634359|NCT00450333|324123089|FG003|Overall Study|Protocol Violation|0|||
94634360|NCT00450333|324123086|FG000|Overall Study|Withdrawal by Subject|1|||
94634361|NCT00450333|324123087|FG001|Overall Study|Withdrawal by Subject|0|||
94634362|NCT00450333|324123088|FG002|Overall Study|Withdrawal by Subject|3|||
94634363|NCT00450333|324123089|FG003|Overall Study|Withdrawal by Subject|0|||
94634364|NCT00450333|324123086|FG000|Overall Study|Kidney transplant|1|||
94634365|NCT00450333|324123087|FG001|Overall Study|Kidney transplant|0|||
94634366|NCT00450333|324123088|FG002|Overall Study|Kidney transplant|1|||
94634367|NCT00450333|324123089|FG003|Overall Study|Kidney transplant|3|||
94634368|NCT00450333|324123086|FG000|Overall Study|Death|3|||
94634369|NCT00450333|324123087|FG001|Overall Study|Death|2|||
94634370|NCT00450333|324123088|FG002|Overall Study|Death|2|||
94634371|NCT00450333|324123089|FG003|Overall Study|Death|2|||
94634372|NCT01721330|324123095|FG000|Overall Study|Withdrawal by Subject|0|||
94634373|NCT01721330|324123096|FG001|Overall Study|Withdrawal by Subject|1|||
94634374|NCT03358290|324123097|FG000|Overall Study|Study discontinued by Sponsor|0|||
94634375|NCT03358290|324123098|FG001|Overall Study|Study discontinued by Sponsor|1|||
94634376|NCT03358290|324123099|FG002|Overall Study|Study discontinued by Sponsor|1|||
94634377|NCT03358290|324123100|FG003|Overall Study|Study discontinued by Sponsor|0|||
94634378|NCT03358290|324123101|FG004|Overall Study|Study discontinued by Sponsor|0|||
94261696|NCT00954174|322752394|FG000|Overall Study|Medical Reason|4|||
94634379|NCT03358290|324123097|FG000|Overall Study|Adverse Event|0|||
94676415|NCT01059630|324269129|FG001|Overall Study|Death|84|||
94261697|NCT00954174|322752395|FG001|Overall Study|Medical Reason|2|||
94634380|NCT03358290|324123098|FG001|Overall Study|Adverse Event|0|||
94634381|NCT03358290|324123099|FG002|Overall Study|Adverse Event|1|||
94634382|NCT03358290|324123100|FG003|Overall Study|Adverse Event|2|||
94634383|NCT03358290|324123101|FG004|Overall Study|Adverse Event|0|||
94634384|NCT03358290|324123097|FG000|Overall Study|Withdrawal by Subject|0|||
94634385|NCT03358290|324123098|FG001|Overall Study|Withdrawal by Subject|0|||
94634386|NCT03358290|324123099|FG002|Overall Study|Withdrawal by Subject|0|||
94634387|NCT03358290|324123100|FG003|Overall Study|Withdrawal by Subject|0|||
94261698|NCT00954174|322752396|FG002|Overall Study|Medical Reason|1|||
94261699|NCT00954174|322752397|FG003|Overall Study|Medical Reason|0|||
94261700|NCT00954174|322752394|FG000|Overall Study|Ineligible|40|||
94261701|NCT00954174|322752395|FG001|Overall Study|Ineligible|47|||
94261702|NCT00954174|322752396|FG002|Overall Study|Ineligible|7|||
94261703|NCT00954174|322752397|FG003|Overall Study|Ineligible|4|||
94261704|NCT00954174|322752394|FG000|Overall Study|Never Treated|4|||
94261705|NCT00954174|322752395|FG001|Overall Study|Never Treated|17|||
94261706|NCT00954174|322752396|FG002|Overall Study|Never Treated|0|||
94261707|NCT00954174|322752397|FG003|Overall Study|Never Treated|3|||
94261708|NCT01776424|322752398|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
94261709|NCT01776424|322752399|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
94261710|NCT01776424|322752400|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
94261711|NCT01776424|322752398|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
94261712|NCT01776424|322752399|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
94261713|NCT01776424|322752400|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
94261714|NCT01776424|322752398|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
94261715|NCT01776424|322752399|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
94261716|NCT01776424|322752400|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
94261717|NCT01776424|322752398|FG000|LTOLE Part (Open Label)|Refused|5|||
94261718|NCT01776424|322752399|FG001|LTOLE Part (Open Label)|Refused|2|||
94261719|NCT01776424|322752400|FG002|LTOLE Part (Open Label)|Refused|11|||
94261720|NCT01776424|322752398|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
94261721|NCT01776424|322752399|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
94634388|NCT03358290|324123101|FG004|Overall Study|Withdrawal by Subject|1|||
94634389|NCT01829230|324123102|FG000|Overall Study|Protocol Violation|0|||
94634390|NCT01829230|324123103|FG001|Overall Study|Protocol Violation|2|||
94634391|NCT01829230|324123102|FG000|Overall Study|Withdrawal by Subject|0|||
94634392|NCT01829230|324123103|FG001|Overall Study|Withdrawal by Subject|1|||
94634393|NCT01829230|324123102|FG000|Overall Study|Lost to Follow-up|1|||
94634394|NCT01829230|324123103|FG001|Overall Study|Lost to Follow-up|1|||
94634395|NCT03855280|324123104|FG000|Treatment Phase|Adverse Event|1|||
94634396|NCT03855280|324123104|FG000|Treatment Phase|Withdrawal by Subject|1|||
94634397|NCT03855280|324123104|FG000|Continuation Phase|Protocol Violation|1|||
94634398|NCT03855280|324123104|FG000|Continuation Phase|Adverse Event|1|||
94634399|NCT03855280|324123104|FG000|Continuation Phase|Sponsor Concluded Study|1|||
94634400|NCT00461682|324123105|FG000|Overall Study|Protocol Violation|1|||
94634401|NCT01361464|324123106|FG000|Overall Study|Death|1|||
94634402|NCT01361464|324123106|FG000|Overall Study|Withdrawal by Subject|2|||
94634403|NCT04501666|324123115|FG000|Overall Study|Physician Decision|0|||
94634404|NCT04501666|324123116|FG001|Overall Study|Physician Decision|1|||
94634405|NCT04501666|324123115|FG000|Overall Study|Adverse Event|12|||
94634406|NCT04501666|324123116|FG001|Overall Study|Adverse Event|4|||
94634407|NCT04501666|324123115|FG000|Overall Study|Subject's request|10|||
94634408|NCT04501666|324123116|FG001|Overall Study|Subject's request|6|||
94634409|NCT04501666|324123115|FG000|Overall Study|Protocol Deviation|2|||
94634410|NCT04501666|324123116|FG001|Overall Study|Protocol Deviation|1|||
94634411|NCT04501666|324123115|FG000|Overall Study|Other-- site permanently closing|0|||
94634412|NCT04501666|324123116|FG001|Overall Study|Other-- site permanently closing|1|||
94634413|NCT01722071|324123117|FG000|Overall Study|Protocol Violation|1|||
94634414|NCT01722071|324123118|FG001|Overall Study|Protocol Violation|0|||
94634415|NCT01106898|324123119|FG000|Overall Study|Adverse Event|6|||
94634416|NCT00818662|324123120|FG000|Overall Study|Adverse Event|5|||
94634417|NCT00818662|324123121|FG001|Overall Study|Adverse Event|14|||
94634418|NCT00818662|324123122|FG002|Overall Study|Adverse Event|4|||
94634419|NCT00818662|324123123|FG003|Overall Study|Adverse Event|3|||
94634420|NCT00818662|324123120|FG000|Overall Study|Withdrawal by Subject|5|||
94634421|NCT00818662|324123121|FG001|Overall Study|Withdrawal by Subject|4|||
94634422|NCT00818662|324123122|FG002|Overall Study|Withdrawal by Subject|2|||
94634423|NCT00818662|324123123|FG003|Overall Study|Withdrawal by Subject|2|||
94634424|NCT00818662|324123120|FG000|Overall Study|Death|1|||
94634425|NCT00818662|324123121|FG001|Overall Study|Death|3|||
94634426|NCT00818662|324123122|FG002|Overall Study|Death|0|||
94634427|NCT00818662|324123123|FG003|Overall Study|Death|0|||
94261722|NCT01776424|322752400|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
94461763|NCT00381043|323479612|FG000|Overall Study|Lost to Follow-up|8|||
94634428|NCT00818662|324123120|FG000|Overall Study|Physician Decision|1|||
94634429|NCT00818662|324123121|FG001|Overall Study|Physician Decision|0|||
94261723|NCT01372410|322752401|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
94261724|NCT01372410|322752402|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
94634430|NCT00818662|324123122|FG002|Overall Study|Physician Decision|0|||
94634431|NCT00818662|324123123|FG003|Overall Study|Physician Decision|0|||
94634432|NCT00818662|324123120|FG000|Overall Study|Lost to Follow-up|0|||
94634433|NCT00818662|324123121|FG001|Overall Study|Lost to Follow-up|0|||
94634434|NCT00818662|324123122|FG002|Overall Study|Lost to Follow-up|0|||
94634435|NCT00818662|324123123|FG003|Overall Study|Lost to Follow-up|1|||
94634436|NCT00818662|324123120|FG000|Overall Study|Unwilling or Unable to Participate|4|||
94634437|NCT00818662|324123121|FG001|Overall Study|Unwilling or Unable to Participate|6|||
94362626|NCT03669640|323112781|FG003|Overall Study|Study Terminated by Sponsor|0|||
94634438|NCT00818662|324123122|FG002|Overall Study|Unwilling or Unable to Participate|2|||
94634439|NCT00818662|324123123|FG003|Overall Study|Unwilling or Unable to Participate|4|||
94634440|NCT00818662|324123120|FG000|Overall Study|Protocol Violation|1|||
94634441|NCT00818662|324123121|FG001|Overall Study|Protocol Violation|1|||
94634442|NCT00818662|324123122|FG002|Overall Study|Protocol Violation|0|||
94634443|NCT00818662|324123123|FG003|Overall Study|Protocol Violation|0|||
94634444|NCT00818662|324123120|FG000|Overall Study|Requires a Prohibited Medication|1|||
94634445|NCT00818662|324123121|FG001|Overall Study|Requires a Prohibited Medication|0|||
94634446|NCT00818662|324123122|FG002|Overall Study|Requires a Prohibited Medication|0|||
94634447|NCT00818662|324123123|FG003|Overall Study|Requires a Prohibited Medication|0|||
94634448|NCT00818662|324123120|FG000|Overall Study|Safety Risk|1|||
94634449|NCT00818662|324123121|FG001|Overall Study|Safety Risk|1|||
94634450|NCT00818662|324123122|FG002|Overall Study|Safety Risk|0|||
94634451|NCT00818662|324123123|FG003|Overall Study|Safety Risk|1|||
94634452|NCT00818662|324123120|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
94634453|NCT00818662|324123121|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
94634454|NCT00818662|324123122|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
94634455|NCT00818662|324123123|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
94634456|NCT00818662|324123120|FG000|Overall Study|Participant's health declined|0|||
94634457|NCT00818662|324123121|FG001|Overall Study|Participant's health declined|0|||
94634458|NCT00818662|324123122|FG002|Overall Study|Participant's health declined|0|||
94634459|NCT00818662|324123123|FG003|Overall Study|Participant's health declined|1|||
94634460|NCT00818662|324123120|FG000|Overall Study|Caregiver to pursue other treatment|0|||
94634461|NCT00818662|324123121|FG001|Overall Study|Caregiver to pursue other treatment|1|||
94634462|NCT00818662|324123122|FG002|Overall Study|Caregiver to pursue other treatment|0|||
94634463|NCT00818662|324123123|FG003|Overall Study|Caregiver to pursue other treatment|0|||
94634464|NCT00818662|324123120|FG000|Overall Study|Moving out of state|0|||
94634465|NCT00818662|324123121|FG001|Overall Study|Moving out of state|0|||
94634466|NCT00818662|324123122|FG002|Overall Study|Moving out of state|0|||
94634467|NCT00818662|324123123|FG003|Overall Study|Moving out of state|1|||
94634468|NCT00818662|324123120|FG000|Overall Study|Declined move to another study site|1|||
94634469|NCT00818662|324123121|FG001|Overall Study|Declined move to another study site|0|||
94634470|NCT00818662|324123122|FG002|Overall Study|Declined move to another study site|0|||
94634471|NCT00818662|324123123|FG003|Overall Study|Declined move to another study site|0|||
94634472|NCT00818662|324123120|FG000|Overall Study|Change in living situation|0|||
94634473|NCT00818662|324123121|FG001|Overall Study|Change in living situation|0|||
94634474|NCT00818662|324123122|FG002|Overall Study|Change in living situation|0|||
94634475|NCT00818662|324123123|FG003|Overall Study|Change in living situation|1|||
94634476|NCT00818662|324123120|FG000|Overall Study|Study partner decision|0|||
94634477|NCT00818662|324123121|FG001|Overall Study|Study partner decision|0|||
94634478|NCT00818662|324123122|FG002|Overall Study|Study partner decision|0|||
94634479|NCT00818662|324123123|FG003|Overall Study|Study partner decision|1|||
94634480|NCT00818662|324123120|FG000|Overall Study|Admitted to long term nursing care|0|||
94634481|NCT00818662|324123121|FG001|Overall Study|Admitted to long term nursing care|1|||
94634482|NCT00818662|324123122|FG002|Overall Study|Admitted to long term nursing care|0|||
94634483|NCT00818662|324123123|FG003|Overall Study|Admitted to long term nursing care|0|||
94634484|NCT00271609|324123124|FG000|Overall Study|Adverse Event|11|||
94634485|NCT00271609|324123125|FG001|Overall Study|Adverse Event|3|||
94634486|NCT00271609|324123124|FG000|Overall Study|Withdrawal by Subject|2|||
94634487|NCT00271609|324123125|FG001|Overall Study|Withdrawal by Subject|0|||
94634488|NCT01846611|324123126|FG000|Overall Study|Lost to Follow-up|4|||
94634489|NCT01846611|324123127|FG001|Overall Study|Lost to Follow-up|6|||
94634490|NCT01846611|324123126|FG000|Overall Study|Withdrawal by Subject|15|||
94634491|NCT01846611|324123127|FG001|Overall Study|Withdrawal by Subject|19|||
94362627|NCT03669640|323112782|FG004|Overall Study|Study Terminated by Sponsor|1|||
94362628|NCT03669640|323112783|FG005|Overall Study|Study Terminated by Sponsor|0|||
94634492|NCT01846611|324123126|FG000|Overall Study|Other|19|||
94634493|NCT01846611|324123127|FG001|Overall Study|Other|18|||
94634494|NCT00541034|324123128|FG000|Overall Study|Non-Compliance|3|||
94634495|NCT02062879|324123129|FG000|Overall Study|Withdrawal by Subject|4|||
94634496|NCT02062879|324123130|FG001|Overall Study|Withdrawal by Subject|1|||
94634497|NCT00553150|324123133|FG000|Overall Study|Withdrawal by Subject|0|||
94634498|NCT00553150|324123134|FG001|Overall Study|Withdrawal by Subject|0|||
94676416|NCT01059630|324269128|FG000|Overall Study|Lost to Follow-up|4|||
94362629|NCT03669640|323112778|FG000|Overall Study|Lost to Follow-up|0|||
94362630|NCT03669640|323112779|FG001|Overall Study|Lost to Follow-up|0|||
94634499|NCT00553150|324123135|FG002|Overall Study|Withdrawal by Subject|0|||
94634500|NCT00553150|324123136|FG003|Overall Study|Withdrawal by Subject|2|||
94634501|NCT00553150|324123133|FG000|Overall Study|Protocol Violation|0|||
94634502|NCT00553150|324123134|FG001|Overall Study|Protocol Violation|0|||
94634503|NCT00553150|324123135|FG002|Overall Study|Protocol Violation|0|||
94634504|NCT00553150|324123136|FG003|Overall Study|Protocol Violation|1|||
94634505|NCT00553150|324123133|FG000|Overall Study|Ineligible|0|||
94634506|NCT00553150|324123134|FG001|Overall Study|Ineligible|0|||
94676417|NCT01059630|324269129|FG001|Overall Study|Lost to Follow-up|1|||
94634507|NCT00553150|324123135|FG002|Overall Study|Ineligible|0|||
94634508|NCT00553150|324123136|FG003|Overall Study|Ineligible|1|||
94634509|NCT03338855|324123140|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
94634510|NCT03338855|324123141|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
94634511|NCT01686633|324123142|FG000|Overall Study|Lack of Efficacy|33|||
94634512|NCT01686633|324123143|FG001|Overall Study|Lack of Efficacy|13|||
94634513|NCT01686633|324123144|FG002|Overall Study|Lack of Efficacy|11|||
94634514|NCT01686633|324123142|FG000|Overall Study|Withdrawal by Subject|8|||
94634515|NCT01686633|324123143|FG001|Overall Study|Withdrawal by Subject|8|||
94634516|NCT01686633|324123144|FG002|Overall Study|Withdrawal by Subject|5|||
94634517|NCT01686633|324123142|FG000|Overall Study|Physician Decision|3|||
94634518|NCT01686633|324123143|FG001|Overall Study|Physician Decision|4|||
94634519|NCT01686633|324123144|FG002|Overall Study|Physician Decision|4|||
94634520|NCT01686633|324123142|FG000|Overall Study|Adverse Event|4|||
94634521|NCT01686633|324123143|FG001|Overall Study|Adverse Event|3|||
94634522|NCT01686633|324123144|FG002|Overall Study|Adverse Event|3|||
94634523|NCT01686633|324123142|FG000|Overall Study|Protocol Violation|2|||
94634524|NCT01686633|324123143|FG001|Overall Study|Protocol Violation|3|||
94634525|NCT01686633|324123144|FG002|Overall Study|Protocol Violation|0|||
94634526|NCT01686633|324123142|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
94634527|NCT01686633|324123143|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
94634528|NCT01686633|324123144|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
94634529|NCT01686633|324123142|FG000|Overall Study|Lost to Follow-up|0|||
94634530|NCT01686633|324123143|FG001|Overall Study|Lost to Follow-up|1|||
94634531|NCT01686633|324123144|FG002|Overall Study|Lost to Follow-up|1|||
94676418|NCT01059630|324269128|FG000|Overall Study|Physician Decision|2|||
94676419|NCT01059630|324269129|FG001|Overall Study|Physician Decision|4|||
94676420|NCT01059630|324269128|FG000|Overall Study|Withdrawal by Subject|21|||
94261725|NCT01372410|322752403|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
94261726|NCT01372410|322752404|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
94261727|NCT01372410|322752405|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
94261728|NCT01372410|322752406|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
94261729|NCT01372410|322752407|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
94261730|NCT01372410|322752408|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
94261731|NCT01372410|322752401|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
94261732|NCT01372410|322752402|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
94261733|NCT01372410|322752403|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
94261734|NCT01372410|322752404|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
94261735|NCT01372410|322752405|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
94261736|NCT01372410|322752406|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
94261737|NCT01372410|322752407|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
94261738|NCT01372410|322752408|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
94261739|NCT01372410|322752401|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
94261740|NCT01372410|322752402|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
94261741|NCT01372410|322752403|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
94261742|NCT01372410|322752404|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
94261743|NCT01372410|322752405|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
94261744|NCT01372410|322752406|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
94261745|NCT01372410|322752407|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
94261746|NCT01372410|322752408|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
94261747|NCT01372410|322752401|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
94261748|NCT01372410|322752402|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
94261749|NCT01372410|322752403|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
94261750|NCT01372410|322752404|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
94261751|NCT01372410|322752405|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
94261752|NCT01372410|322752406|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
94261753|NCT01372410|322752407|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
94261754|NCT01372410|322752408|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
94261755|NCT01372410|322752401|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
94261756|NCT01372410|322752402|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
94261757|NCT01372410|322752403|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
94261758|NCT01372410|322752404|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
94261759|NCT01372410|322752405|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
94261760|NCT01372410|322752406|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
94634532|NCT01189812|324123145|FG000|Overall Study|Withdrawal by Subject|2|||
94634533|NCT01189812|324123146|FG001|Overall Study|Withdrawal by Subject|3|||
94634534|NCT01189812|324123145|FG000|Overall Study|Adverse Event|1|||
94634535|NCT01189812|324123146|FG001|Overall Study|Adverse Event|0|||
94634536|NCT01189812|324123145|FG000|Overall Study|Out of Window|4|||
94634537|NCT01189812|324123146|FG001|Overall Study|Out of Window|3|||
94634538|NCT01189812|324123145|FG000|Overall Study|Moved out of State|1|||
94634539|NCT01189812|324123146|FG001|Overall Study|Moved out of State|2|||
94634540|NCT02738450|324123147|FG000|Overall Study|Withdrawal by Subject|0|||
94261761|NCT01372410|322752407|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
94261762|NCT01372410|322752408|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
94261763|NCT01372410|322752401|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
94261764|NCT01372410|322752402|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
94261765|NCT01372410|322752403|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
94261766|NCT01372410|322752404|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
94261767|NCT01372410|322752405|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
94261768|NCT01372410|322752406|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
94261769|NCT01372410|322752407|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
94261770|NCT01372410|322752408|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
94261771|NCT01372410|322752401|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
94261772|NCT01372410|322752402|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
94261773|NCT01372410|322752403|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
94261774|NCT01372410|322752404|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
94261775|NCT01372410|322752405|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
94261776|NCT01372410|322752406|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
94261777|NCT01372410|322752407|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
94261778|NCT01372410|322752408|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
94261779|NCT01372410|322752401|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
94261780|NCT01372410|322752402|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
94261781|NCT01372410|322752403|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
94261782|NCT01372410|322752404|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
94634541|NCT02738450|324123148|FG001|Overall Study|Withdrawal by Subject|2|||
94634542|NCT02738450|324123149|FG002|Overall Study|Withdrawal by Subject|0|||
94634543|NCT03559257|324123150|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
94634544|NCT03559257|324123151|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
94634545|NCT03559257|324123150|FG000|Double Blind Treatment Period|Protocol Violation|1|||
94634546|NCT03559257|324123151|FG001|Double Blind Treatment Period|Protocol Violation|4|||
94634547|NCT03559257|324123150|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
94634548|NCT03559257|324123151|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
94261783|NCT01372410|322752405|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
94261784|NCT01372410|322752406|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
94261785|NCT01372410|322752407|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
94261786|NCT01372410|322752408|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
94261787|NCT01372410|322752401|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
94261788|NCT01372410|322752402|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
94261789|NCT01372410|322752403|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
94261790|NCT01372410|322752404|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
94261791|NCT01372410|322752405|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
94261792|NCT01372410|322752406|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
94634549|NCT03559257|324123150|FG000|Double Blind Treatment Period|Adverse Event|0|||
94634550|NCT03559257|324123151|FG001|Double Blind Treatment Period|Adverse Event|1|||
94634551|NCT03559257|324123150|FG000|Double Blind Treatment Period|Screen Failure|0|||
94634552|NCT03559257|324123151|FG001|Double Blind Treatment Period|Screen Failure|1|||
94634553|NCT03559257|324123150|FG000|Open-label Treatment Period|Adverse Event|1|||
94634554|NCT03559257|324123151|FG001|Open-label Treatment Period|Adverse Event|4|||
94634555|NCT03559257|324123150|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
94634556|NCT03559257|324123151|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
94634557|NCT03559257|324123150|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
94634558|NCT03559257|324123151|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
94634559|NCT03559257|324123150|FG000|Open-label Treatment Period|Protocol Violation|2|||
94634560|NCT03559257|324123151|FG001|Open-label Treatment Period|Protocol Violation|0|||
94634561|NCT03559257|324123150|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
94634562|NCT03559257|324123151|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
94634563|NCT03559257|324123150|FG000|Open-label Treatment Period|Physician Decision|0|||
94634564|NCT03559257|324123151|FG001|Open-label Treatment Period|Physician Decision|1|||
94634565|NCT03761147|324123152|FG000|Overall Study|Withdrawal by Subject|6|||
94634566|NCT03761147|324123153|FG001|Overall Study|Withdrawal by Subject|1|||
94634567|NCT03761147|324123152|FG000|Overall Study|Adverse Event|1|||
94634568|NCT03761147|324123153|FG001|Overall Study|Adverse Event|3|||
94634569|NCT01519960|324123155|FG000|Overall Study|Withdrawal from the study|26|||
94634570|NCT01519960|324123156|FG001|Overall Study|Withdrawal from the study|22|||
94634571|NCT01519960|324123157|FG002|Overall Study|Withdrawal from the study|5|||
94634572|NCT03605303|324123158|FG000|Period 1|Study Terminated|2|||
94676421|NCT01059630|324269129|FG001|Overall Study|Withdrawal by Subject|14|||
94261793|NCT01372410|322752407|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
94634573|NCT03605303|324123159|FG001|Period 1|Study Terminated|1|||
94634574|NCT01165554|324123160|FG000|Overall Study|Withdrawal by Subject|23|||
94634575|NCT05517382|324123161|FG000|Overall Study|Lost to Follow-up|0|||
94634576|NCT05517382|324123162|FG001|Overall Study|Lost to Follow-up|1|||
94634577|NCT01641692|324123163|FG000|Treatment Period 1|Adverse Event|1|||
94634578|NCT01641692|324123164|FG001|Treatment Period 1|Adverse Event|0|||
94634579|NCT01641692|324123165|FG002|Treatment Period 1|Adverse Event|0|||
94634580|NCT01641692|324123166|FG003|Treatment Period 1|Adverse Event|0|||
94634581|NCT01641692|324123167|FG004|Treatment Period 1|Adverse Event|0|||
94634582|NCT01641692|324123168|FG005|Treatment Period 1|Adverse Event|0|||
94634583|NCT01641692|324123169|FG006|Treatment Period 1|Adverse Event|0|||
94634584|NCT01641692|324123170|FG007|Treatment Period 1|Adverse Event|0|||
94634585|NCT01641692|324123163|FG000|Treatment Period 1|Lack of Efficacy|0|||
94634586|NCT01641692|324123164|FG001|Treatment Period 1|Lack of Efficacy|0|||
94634587|NCT01641692|324123165|FG002|Treatment Period 1|Lack of Efficacy|0|||
94634588|NCT01641692|324123166|FG003|Treatment Period 1|Lack of Efficacy|0|||
94634589|NCT01641692|324123167|FG004|Treatment Period 1|Lack of Efficacy|0|||
94634590|NCT01641692|324123168|FG005|Treatment Period 1|Lack of Efficacy|0|||
94634591|NCT01641692|324123169|FG006|Treatment Period 1|Lack of Efficacy|0|||
94634592|NCT01641692|324123170|FG007|Treatment Period 1|Lack of Efficacy|1|||
94634593|NCT01641692|324123163|FG000|Treatment Period 1|Protocol Violation|1|||
94634594|NCT01641692|324123164|FG001|Treatment Period 1|Protocol Violation|0|||
94634595|NCT01641692|324123165|FG002|Treatment Period 1|Protocol Violation|0|||
94634596|NCT01641692|324123166|FG003|Treatment Period 1|Protocol Violation|0|||
94634597|NCT01641692|324123167|FG004|Treatment Period 1|Protocol Violation|2|||
94634598|NCT01641692|324123168|FG005|Treatment Period 1|Protocol Violation|0|||
94634599|NCT01641692|324123169|FG006|Treatment Period 1|Protocol Violation|0|||
94634600|NCT01641692|324123170|FG007|Treatment Period 1|Protocol Violation|0|||
94634601|NCT01641692|324123163|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
94634602|NCT01641692|324123164|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
94634603|NCT01641692|324123165|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
94634604|NCT01641692|324123166|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
94676422|NCT02227875|324269131|FG000|Overall Study|Protocol Violation|10|||
94634605|NCT01641692|324123167|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
94634606|NCT01641692|324123168|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
94634607|NCT01641692|324123169|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
94634608|NCT01641692|324123170|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
94634609|NCT01641692|324123163|FG000|Treatment Period 1|Lost to Follow-up|0|||
94634610|NCT01641692|324123164|FG001|Treatment Period 1|Lost to Follow-up|0|||
94634611|NCT01641692|324123165|FG002|Treatment Period 1|Lost to Follow-up|1|||
94261794|NCT01372410|322752408|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
94261795|NCT01372410|322752401|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
94261796|NCT01372410|322752402|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
94261797|NCT01372410|322752403|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
94261798|NCT01372410|322752404|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
94261799|NCT01372410|322752405|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
94261800|NCT01372410|322752406|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
94261801|NCT01372410|322752407|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
94261802|NCT01372410|322752408|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
94261803|NCT01498289|322752409|FG000|Overall Study|Adverse Event|16|||
94261804|NCT01498289|322752410|FG001|Overall Study|Adverse Event|18|||
94261805|NCT01498289|322752409|FG000|Overall Study|Death|6|||
94261806|NCT01498289|322752410|FG001|Overall Study|Death|8|||
94261807|NCT01498289|322752409|FG000|Overall Study|Withdrawal unrelated to AE|16|||
94261808|NCT01498289|322752410|FG001|Overall Study|Withdrawal unrelated to AE|16|||
94261809|NCT01498289|322752409|FG000|Overall Study|Progression/relapse|53|||
94261810|NCT01498289|322752410|FG001|Overall Study|Progression/relapse|59|||
94261811|NCT01498289|322752409|FG000|Overall Study|Not protocol specified|7|||
94261812|NCT01498289|322752410|FG001|Overall Study|Not protocol specified|2|||
94261813|NCT01498289|322752409|FG000|Overall Study|Reason under review|0|||
94261814|NCT01498289|322752410|FG001|Overall Study|Reason under review|1|||
94261815|NCT05125679|322752414|FG000|Overall Study|Study Terminated by Sponsor|2|||
94261816|NCT05125679|322752415|FG001|Overall Study|Study Terminated by Sponsor|5|||
94261817|NCT04540133|322752416|FG000|Overall Study|Lost to Follow-up|1|||
94261818|NCT04540133|322752417|FG001|Overall Study|Lost to Follow-up|0|||
94261819|NCT03153111|322752418|FG000|Overall Study|Death|2|||
94261820|NCT03153111|322752419|FG001|Overall Study|Death|5|||
94261821|NCT03153111|322752418|FG000|Overall Study|Lost to Follow-up|1|||
94261822|NCT03153111|322752419|FG001|Overall Study|Lost to Follow-up|0|||
94261823|NCT03153111|322752418|FG000|Overall Study|Physician Decision|5|||
94261824|NCT03153111|322752419|FG001|Overall Study|Physician Decision|1|||
94261825|NCT03153111|322752418|FG000|Overall Study|Withdrawal by Subject|3|||
94362631|NCT03669640|323112780|FG002|Overall Study|Lost to Follow-up|2|||
94634612|NCT01641692|324123166|FG003|Treatment Period 1|Lost to Follow-up|0|||
94261826|NCT03153111|322752419|FG001|Overall Study|Withdrawal by Subject|3|||
94261827|NCT01210118|322752420|FG000|Overall Study|Lost to Follow-up|1|||
94261828|NCT01210118|322752421|FG001|Overall Study|Lost to Follow-up|1|||
94261829|NCT01210118|322752420|FG000|Overall Study|Protocol Violation|1|||
94261830|NCT01210118|322752421|FG001|Overall Study|Protocol Violation|1|||
94261831|NCT01210118|322752420|FG000|Overall Study|Spontaneous abortion|1|||
94261832|NCT01210118|322752421|FG001|Overall Study|Spontaneous abortion|3|||
94362632|NCT03669640|323112781|FG003|Overall Study|Lost to Follow-up|0|||
94634613|NCT01641692|324123167|FG004|Treatment Period 1|Lost to Follow-up|0|||
94676423|NCT02227875|324269132|FG001|Overall Study|Protocol Violation|7|||
94676424|NCT02227875|324269131|FG000|Overall Study|Other|1|||
94676425|NCT02227875|324269132|FG001|Overall Study|Other|3|||
94676426|NCT02227875|324269131|FG000|Overall Study|Physician Decision|1|||
94676427|NCT02227875|324269132|FG001|Overall Study|Physician Decision|0|||
94676428|NCT02227875|324269131|FG000|Overall Study|Adverse Event|3|||
94676429|NCT02227875|324269132|FG001|Overall Study|Adverse Event|0|||
94676430|NCT02227875|324269131|FG000|Overall Study|Withdrawal by Subject|12|||
94676431|NCT02227875|324269132|FG001|Overall Study|Withdrawal by Subject|13|||
94676432|NCT02227875|324269131|FG000|Overall Study|Lost to Follow-up|10|||
94676433|NCT02227875|324269132|FG001|Overall Study|Lost to Follow-up|10|||
94261833|NCT01839487|322752422|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
94261834|NCT01839487|322752423|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
94261835|NCT01839487|322752424|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
94261836|NCT01839487|322752425|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
94261837|NCT01839487|322752426|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
94261838|NCT01839487|322752427|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
94261839|NCT01839487|322752422|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
94261840|NCT01839487|322752423|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
94261841|NCT01839487|322752424|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
94261842|NCT01839487|322752425|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
94676434|NCT01201811|324269135|FG000|Overall Study|Adverse Event|6|||
94676435|NCT01201811|324269135|FG000|Overall Study|Disease progression|3|||
94676436|NCT01201811|324269135|FG000|Overall Study|Withdrawal by Subject|3|||
94676437|NCT01201811|324269135|FG000|Overall Study|Death|4|||
94362633|NCT03669640|323112782|FG004|Overall Study|Lost to Follow-up|0|||
94362634|NCT03669640|323112783|FG005|Overall Study|Lost to Follow-up|0|||
94362635|NCT03669640|323112778|FG000|Overall Study|Death|0|||
94362636|NCT03669640|323112779|FG001|Overall Study|Death|0|||
94362637|NCT03669640|323112780|FG002|Overall Study|Death|1|||
94362638|NCT03669640|323112781|FG003|Overall Study|Death|0|||
94362639|NCT03669640|323112782|FG004|Overall Study|Death|0|||
94362640|NCT03669640|323112783|FG005|Overall Study|Death|0|||
94634614|NCT01641692|324123168|FG005|Treatment Period 1|Lost to Follow-up|0|||
94634615|NCT01641692|324123169|FG006|Treatment Period 1|Lost to Follow-up|0|||
94634616|NCT01641692|324123170|FG007|Treatment Period 1|Lost to Follow-up|0|||
94634617|NCT01641692|324123163|FG000|Treatment Period 1|Physician Decision|0|||
94634618|NCT01641692|324123164|FG001|Treatment Period 1|Physician Decision|0|||
94634619|NCT01641692|324123165|FG002|Treatment Period 1|Physician Decision|0|||
94634620|NCT01641692|324123166|FG003|Treatment Period 1|Physician Decision|0|||
94634621|NCT01641692|324123167|FG004|Treatment Period 1|Physician Decision|1|||
94634622|NCT01641692|324123168|FG005|Treatment Period 1|Physician Decision|0|||
94634623|NCT01641692|324123169|FG006|Treatment Period 1|Physician Decision|0|||
94634624|NCT01641692|324123170|FG007|Treatment Period 1|Physician Decision|0|||
94634625|NCT01641692|324123163|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94634626|NCT01641692|324123164|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94634627|NCT01641692|324123165|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94634628|NCT01641692|324123166|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94634629|NCT01641692|324123167|FG004|Treatment Period 1|Withdrawal by Subject|0|||
94634630|NCT01641692|324123168|FG005|Treatment Period 1|Withdrawal by Subject|2|||
94634631|NCT01641692|324123169|FG006|Treatment Period 1|Withdrawal by Subject|0|||
94634632|NCT01641692|324123170|FG007|Treatment Period 1|Withdrawal by Subject|1|||
94634633|NCT01641692|324123163|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
94634634|NCT01641692|324123164|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
94634635|NCT01641692|324123165|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
94634636|NCT01641692|324123166|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
94634637|NCT01641692|324123167|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
94634638|NCT01641692|324123168|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
94634639|NCT01641692|324123169|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
94634640|NCT01641692|324123170|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
94634641|NCT01641692|324123163|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
94634642|NCT01641692|324123164|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
94634643|NCT01641692|324123165|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
94634644|NCT01641692|324123166|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
94634645|NCT01641692|324123167|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
94634646|NCT01641692|324123168|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
94634647|NCT01641692|324123169|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
94634648|NCT01641692|324123170|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
94634649|NCT01641692|324123163|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
94634650|NCT01641692|324123164|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
94634651|NCT01641692|324123165|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
94634652|NCT01641692|324123166|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
94634653|NCT01641692|324123167|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
94634654|NCT01641692|324123168|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
94634655|NCT01641692|324123169|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
94634656|NCT01641692|324123170|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
94634657|NCT01641692|324123163|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
94634658|NCT01641692|324123164|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
94634659|NCT01641692|324123165|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
94634660|NCT01641692|324123166|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
94634661|NCT01641692|324123167|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
94634662|NCT01641692|324123168|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
94634663|NCT01641692|324123169|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
94634664|NCT01641692|324123170|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
94634665|NCT01641692|324123163|FG000|Treatment Period 2|Lack of Efficacy|1|||
94634666|NCT01641692|324123164|FG001|Treatment Period 2|Lack of Efficacy|0|||
94634667|NCT01641692|324123165|FG002|Treatment Period 2|Lack of Efficacy|0|||
94634668|NCT01641692|324123166|FG003|Treatment Period 2|Lack of Efficacy|0|||
94634669|NCT01641692|324123167|FG004|Treatment Period 2|Lack of Efficacy|0|||
94634670|NCT01641692|324123168|FG005|Treatment Period 2|Lack of Efficacy|0|||
94634671|NCT01641692|324123169|FG006|Treatment Period 2|Lack of Efficacy|0|||
94676438|NCT01201811|324269135|FG000|Overall Study|Treatment Failure|2|||
94634672|NCT01641692|324123170|FG007|Treatment Period 2|Lack of Efficacy|0|||
94634673|NCT01641692|324123163|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
94676439|NCT01201811|324269135|FG000|Overall Study|Physician Decision|1|||
94362641|NCT03669640|323112778|FG000|Overall Study|Withdrawal by Subject|1|||
94362642|NCT03669640|323112779|FG001|Overall Study|Withdrawal by Subject|2|||
94634674|NCT01641692|324123164|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
94634675|NCT01641692|324123165|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
94634676|NCT01641692|324123166|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
94634677|NCT01641692|324123167|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
94634678|NCT01641692|324123168|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
94634679|NCT01641692|324123169|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
94634680|NCT01641692|324123170|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
94634681|NCT01641692|324123163|FG000|Treatment Period 2|Lost to Follow-up|0|||
94634682|NCT01641692|324123164|FG001|Treatment Period 2|Lost to Follow-up|0|||
94634683|NCT01641692|324123165|FG002|Treatment Period 2|Lost to Follow-up|0|||
94634684|NCT01641692|324123166|FG003|Treatment Period 2|Lost to Follow-up|0|||
94634685|NCT01641692|324123167|FG004|Treatment Period 2|Lost to Follow-up|0|||
94634686|NCT01641692|324123168|FG005|Treatment Period 2|Lost to Follow-up|1|||
94634687|NCT01641692|324123169|FG006|Treatment Period 2|Lost to Follow-up|0|||
94634688|NCT01641692|324123170|FG007|Treatment Period 2|Lost to Follow-up|0|||
94634689|NCT01641692|324123163|FG000|Treatment Period 2|Withdrawal by Subject|1|||
94634690|NCT01641692|324123164|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94634691|NCT01641692|324123165|FG002|Treatment Period 2|Withdrawal by Subject|0|||
94634692|NCT01641692|324123166|FG003|Treatment Period 2|Withdrawal by Subject|0|||
94634693|NCT01641692|324123167|FG004|Treatment Period 2|Withdrawal by Subject|0|||
94634694|NCT01641692|324123168|FG005|Treatment Period 2|Withdrawal by Subject|1|||
94634695|NCT01641692|324123169|FG006|Treatment Period 2|Withdrawal by Subject|0|||
94634696|NCT01641692|324123170|FG007|Treatment Period 2|Withdrawal by Subject|1|||
94634697|NCT01641692|324123163|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
94634698|NCT01641692|324123164|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
94634699|NCT01641692|324123165|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
94634700|NCT01641692|324123166|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
94634701|NCT01641692|324123167|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
94634702|NCT01641692|324123168|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
94634703|NCT01641692|324123169|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
94634704|NCT01641692|324123170|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
94634705|NCT01641692|324123163|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
94634706|NCT01641692|324123164|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
94634707|NCT01641692|324123165|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
94634708|NCT01641692|324123166|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
94634709|NCT01641692|324123167|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
94634710|NCT01641692|324123168|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
94634711|NCT01641692|324123169|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
94634712|NCT01641692|324123170|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
94634713|NCT01641692|324123163|FG000|Treatment Period 3|Adverse Event|0|||
94634714|NCT01641692|324123164|FG001|Treatment Period 3|Adverse Event|0|||
94634715|NCT01641692|324123165|FG002|Treatment Period 3|Adverse Event|0|||
94634716|NCT01641692|324123166|FG003|Treatment Period 3|Adverse Event|0|||
94634717|NCT01641692|324123167|FG004|Treatment Period 3|Adverse Event|0|||
94634718|NCT01641692|324123168|FG005|Treatment Period 3|Adverse Event|0|||
94634719|NCT01641692|324123169|FG006|Treatment Period 3|Adverse Event|1|||
94634720|NCT01641692|324123170|FG007|Treatment Period 3|Adverse Event|0|||
94634721|NCT01641692|324123163|FG000|Treatment Period 3|Protocol Violation|0|||
94634722|NCT01641692|324123164|FG001|Treatment Period 3|Protocol Violation|0|||
94634723|NCT01641692|324123165|FG002|Treatment Period 3|Protocol Violation|1|||
94634724|NCT01641692|324123166|FG003|Treatment Period 3|Protocol Violation|0|||
94634725|NCT01641692|324123167|FG004|Treatment Period 3|Protocol Violation|0|||
94634726|NCT01641692|324123168|FG005|Treatment Period 3|Protocol Violation|0|||
94634727|NCT01641692|324123169|FG006|Treatment Period 3|Protocol Violation|0|||
94634728|NCT01641692|324123170|FG007|Treatment Period 3|Protocol Violation|0|||
94634729|NCT01641692|324123163|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
94634730|NCT01641692|324123164|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
94634731|NCT01641692|324123165|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
94634732|NCT01641692|324123166|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
94634733|NCT01641692|324123167|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
94634734|NCT01641692|324123168|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
94634735|NCT01641692|324123169|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
94634736|NCT01641692|324123170|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
94634737|NCT01641692|324123163|FG000|Treatment Period 3|Lost to Follow-up|0|||
94676440|NCT01089374|324269136|FG000|Overall Study|Lost to Follow-up|3|||
94634738|NCT01641692|324123164|FG001|Treatment Period 3|Lost to Follow-up|1|||
94634739|NCT01641692|324123165|FG002|Treatment Period 3|Lost to Follow-up|0|||
94634740|NCT01641692|324123166|FG003|Treatment Period 3|Lost to Follow-up|0|||
94634741|NCT01641692|324123167|FG004|Treatment Period 3|Lost to Follow-up|0|||
94634742|NCT01641692|324123168|FG005|Treatment Period 3|Lost to Follow-up|0|||
94634743|NCT01641692|324123169|FG006|Treatment Period 3|Lost to Follow-up|0|||
94634744|NCT01641692|324123170|FG007|Treatment Period 3|Lost to Follow-up|0|||
94634745|NCT01641692|324123163|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
94634746|NCT01641692|324123164|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
94634747|NCT01641692|324123165|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
94634748|NCT01641692|324123166|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
94634749|NCT01641692|324123167|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
94634750|NCT01641692|324123168|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
94634751|NCT01641692|324123169|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
94634752|NCT01641692|324123170|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
94634753|NCT01641692|324123163|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
94634754|NCT01641692|324123164|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
94634755|NCT01641692|324123165|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
94634756|NCT01641692|324123166|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
94634757|NCT01641692|324123167|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
94634758|NCT01641692|324123168|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
94634759|NCT01641692|324123169|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
94634760|NCT01641692|324123170|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
94634761|NCT05778786|324123182|FG000|Period 1|COVID-19 Related|3|||
94634762|NCT05778786|324123183|FG001|Period 1|COVID-19 Related|3|||
94634763|NCT05778786|324123182|FG000|Period 1|Withdrew Consent during Study|1|||
94634764|NCT05778786|324123183|FG001|Period 1|Withdrew Consent during Study|0|||
94634765|NCT05778786|324123182|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
94634766|NCT05778786|324123183|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
94634767|NCT05778786|324123182|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
94634768|NCT05778786|324123183|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
94634769|NCT01173718|324123184|FG000|Overall Study|Death|17|||
94634770|NCT01173718|324123184|FG000|Overall Study|Abandonment of study graft|27|||
94634771|NCT01765153|324123185|FG000|Training Phase 1|Format of intervention differed|1|||
94634772|NCT01765153|324123186|FG001|Training Phase 1|Format of intervention differed|0|||
94634773|NCT01765153|324123185|FG000|Training Phase 1|Poor participation in intervention|0|||
94634774|NCT01765153|324123186|FG001|Training Phase 1|Poor participation in intervention|1|||
94634775|NCT01765153|324123185|FG000|Rest Phase 1|Withdrawal by Subject|0|||
94634776|NCT01765153|324123186|FG001|Rest Phase 1|Withdrawal by Subject|1|||
94634777|NCT01765153|324123185|FG000|Training Phase 2|Withdrawal by Subject|0|||
94634778|NCT01765153|324123186|FG001|Training Phase 2|Withdrawal by Subject|1|||
94634779|NCT01765153|324123185|FG000|Rest Phase 2|Lost to Follow-up|2|||
94634780|NCT01765153|324123186|FG001|Rest Phase 2|Lost to Follow-up|1|||
94634781|NCT02057198|324124661|FG000|Overall Study|Death|0|||
94634782|NCT02057198|324124662|FG001|Overall Study|Death|0|||
94634783|NCT02057198|324124663|FG002|Overall Study|Death|1|||
94634784|NCT02057198|324124661|FG000|Overall Study|Discharged early; lost to followup|0|||
94634785|NCT02057198|324124662|FG001|Overall Study|Discharged early; lost to followup|1|||
94634786|NCT02057198|324124663|FG002|Overall Study|Discharged early; lost to followup|0|||
94634787|NCT03720470|324124676|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
94634788|NCT03720470|324124677|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
94634789|NCT03720470|324124678|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
94634790|NCT03720470|324124679|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
94634791|NCT03720470|324124680|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
94634792|NCT03720470|324124681|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
94634793|NCT03720470|324124676|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
94634794|NCT03720470|324124677|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
94634795|NCT03720470|324124678|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
94634796|NCT03720470|324124679|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
94634797|NCT03720470|324124680|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
94634798|NCT03720470|324124681|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
94634799|NCT03720470|324124676|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
94634800|NCT03720470|324124677|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
94634801|NCT03720470|324124678|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
94461764|NCT00381043|323479613|FG001|Overall Study|Lost to Follow-up|6|||
94676441|NCT01089374|324269137|FG001|Overall Study|Lost to Follow-up|0|||
94362643|NCT03669640|323112780|FG002|Overall Study|Withdrawal by Subject|1|||
94362644|NCT03669640|323112781|FG003|Overall Study|Withdrawal by Subject|0|||
94362645|NCT03669640|323112782|FG004|Overall Study|Withdrawal by Subject|1|||
94634802|NCT03720470|324124679|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
94634803|NCT03720470|324124680|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
94634804|NCT03720470|324124681|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
94634805|NCT03720470|324124676|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
94634806|NCT03720470|324124677|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
94634807|NCT03720470|324124678|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
94634808|NCT03720470|324124679|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
94634809|NCT03720470|324124680|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
94634810|NCT03720470|324124681|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
94634811|NCT03720470|324124676|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
94634812|NCT03720470|324124677|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
94634813|NCT03720470|324124678|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
94634814|NCT03720470|324124679|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
94634815|NCT03720470|324124680|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
94634816|NCT03720470|324124681|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
94634817|NCT03720470|324124676|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
94634818|NCT03720470|324124677|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
94634819|NCT03720470|324124678|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
94634820|NCT03720470|324124679|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
94634821|NCT03720470|324124680|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
94634822|NCT03720470|324124681|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
94634823|NCT03720470|324124676|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
94634824|NCT03720470|324124677|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
94634825|NCT03720470|324124678|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
94634826|NCT03720470|324124679|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
94634827|NCT03720470|324124680|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
94634828|NCT03720470|324124681|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
94634829|NCT03720470|324124676|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
94634830|NCT03720470|324124677|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
94634831|NCT03720470|324124678|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
94634832|NCT03720470|324124679|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
94634833|NCT03720470|324124680|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
94634834|NCT03720470|324124681|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
94634835|NCT03720470|324124676|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
94634836|NCT03720470|324124677|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
94634837|NCT03720470|324124678|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
94634838|NCT03720470|324124679|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
94634839|NCT03720470|324124680|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
94634840|NCT03720470|324124681|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
94634841|NCT03720470|324124676|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
94634842|NCT03720470|324124677|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
94634843|NCT03720470|324124678|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
94634844|NCT03720470|324124679|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
94634845|NCT03720470|324124680|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
94634846|NCT03720470|324124681|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
94634847|NCT03720470|324124676|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
94634848|NCT03720470|324124677|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
94634849|NCT03720470|324124678|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
94634850|NCT03720470|324124679|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
94634851|NCT03720470|324124680|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
94634852|NCT03720470|324124681|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
94362646|NCT03669640|323112783|FG005|Overall Study|Withdrawal by Subject|3|||
94362647|NCT03669640|323112778|FG000|Overall Study|Protocol Violation|1|||
94676442|NCT01089374|324269136|FG000|Overall Study|Withdrawal by Subject|1|||
94676443|NCT01089374|324269137|FG001|Overall Study|Withdrawal by Subject|0|||
94676444|NCT01089374|324269136|FG000|Overall Study|Study closed early - low accrual|6|||
94676445|NCT01089374|324269137|FG001|Overall Study|Study closed early - low accrual|0|||
94676446|NCT02856113|324269138|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
94676447|NCT02856113|324269139|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
94676448|NCT02856113|324269138|FG000|Overall Study|Significant Protocol Deviation|1|||
94676449|NCT02856113|324269139|FG001|Overall Study|Significant Protocol Deviation|0|||
94676450|NCT02856113|324269138|FG000|Overall Study|Lost to Follow-up|3|||
94676451|NCT02856113|324269139|FG001|Overall Study|Lost to Follow-up|5|||
94676452|NCT02856113|324269138|FG000|Overall Study|Voluntary Withdrawal|3|||
94676453|NCT02856113|324269139|FG001|Overall Study|Voluntary Withdrawal|5|||
94676454|NCT02856113|324269138|FG000|Overall Study|Pregnancy|0|||
94676455|NCT02856113|324269139|FG001|Overall Study|Pregnancy|1|||
94676456|NCT02856113|324269138|FG000|Overall Study|Principal Investigator Discretion|2|||
94676457|NCT02856113|324269139|FG001|Overall Study|Principal Investigator Discretion|1|||
94676458|NCT02856113|324269138|FG000|Overall Study|Randomized but not Treated|1|||
94676459|NCT02856113|324269139|FG001|Overall Study|Randomized but not Treated|0|||
94676460|NCT02856113|324269138|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
94676461|NCT02856113|324269139|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
94676462|NCT03494166|324269140|FG000|Overall Study|Death|0|||
94676463|NCT03494166|324269141|FG001|Overall Study|Death|0|||
94676464|NCT03494166|324269142|FG002|Overall Study|Death|0|||
94676465|NCT03494166|324269143|FG003|Overall Study|Death|1|||
94676466|NCT03494166|324269144|FG004|Overall Study|Death|3|||
94676467|NCT03494166|324269145|FG005|Overall Study|Death|0|||
94676468|NCT03494166|324269140|FG000|Overall Study|Lost to Follow-up|2|||
94676469|NCT03494166|324269141|FG001|Overall Study|Lost to Follow-up|2|||
94676470|NCT03494166|324269142|FG002|Overall Study|Lost to Follow-up|2|||
94676471|NCT03494166|324269143|FG003|Overall Study|Lost to Follow-up|2|||
94676472|NCT03494166|324269144|FG004|Overall Study|Lost to Follow-up|14|||
94676473|NCT03494166|324269145|FG005|Overall Study|Lost to Follow-up|0|||
94676474|NCT03494166|324269140|FG000|Overall Study|Withdrawal by Subject|10|||
94676475|NCT03494166|324269141|FG001|Overall Study|Withdrawal by Subject|7|||
94676476|NCT03494166|324269142|FG002|Overall Study|Withdrawal by Subject|0|||
94676477|NCT03494166|324269143|FG003|Overall Study|Withdrawal by Subject|5|||
94362648|NCT03669640|323112779|FG001|Overall Study|Protocol Violation|0|||
94362649|NCT03669640|323112780|FG002|Overall Study|Protocol Violation|0|||
94676478|NCT03494166|324269144|FG004|Overall Study|Withdrawal by Subject|3|||
94676479|NCT03494166|324269145|FG005|Overall Study|Withdrawal by Subject|17|||
94676480|NCT03494166|324269140|FG000|Overall Study|Screen failure|1|||
94676481|NCT03494166|324269141|FG001|Overall Study|Screen failure|0|||
94676482|NCT03494166|324269142|FG002|Overall Study|Screen failure|0|||
94676483|NCT03494166|324269143|FG003|Overall Study|Screen failure|0|||
94676484|NCT03494166|324269144|FG004|Overall Study|Screen failure|1|||
94676485|NCT03494166|324269145|FG005|Overall Study|Screen failure|0|||
94676486|NCT00117676|324269146|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
94676487|NCT00117676|324269147|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
94676488|NCT00117676|324269146|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
94676489|NCT00117676|324269147|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
94676490|NCT00117676|324269146|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
94676491|NCT00117676|324269147|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
94676492|NCT00117676|324269146|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
94676493|NCT00117676|324269147|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
94676494|NCT00117676|324269146|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
94362650|NCT03669640|323112781|FG003|Overall Study|Protocol Violation|0|||
94362651|NCT03669640|323112782|FG004|Overall Study|Protocol Violation|0|||
94362652|NCT03669640|323112783|FG005|Overall Study|Protocol Violation|0|||
94362653|NCT03669640|323112778|FG000|Overall Study|Physician Decision|0|||
94676495|NCT00117676|324269147|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
94362654|NCT03669640|323112779|FG001|Overall Study|Physician Decision|2|||
94362655|NCT03669640|323112780|FG002|Overall Study|Physician Decision|0|||
94362656|NCT03669640|323112781|FG003|Overall Study|Physician Decision|0|||
94362657|NCT03669640|323112782|FG004|Overall Study|Physician Decision|0|||
94362658|NCT03669640|323112783|FG005|Overall Study|Physician Decision|0|||
94676496|NCT00117676|324269146|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
94676497|NCT00117676|324269147|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
94362659|NCT03669640|323112778|FG000|Overall Study|Disease Relapse|1|||
94676498|NCT00117676|324269146|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
94676499|NCT00117676|324269147|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
94676500|NCT00117676|324269146|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
94362660|NCT03669640|323112779|FG001|Overall Study|Disease Relapse|0|||
94362661|NCT03669640|323112780|FG002|Overall Study|Disease Relapse|0|||
94362662|NCT03669640|323112781|FG003|Overall Study|Disease Relapse|0|||
94362663|NCT03669640|323112782|FG004|Overall Study|Disease Relapse|0|||
94362664|NCT03669640|323112783|FG005|Overall Study|Disease Relapse|0|||
94634853|NCT03720470|324124676|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
94634854|NCT03720470|324124677|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
94634855|NCT03720470|324124678|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
94634856|NCT03720470|324124679|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
94634857|NCT03720470|324124680|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
94634858|NCT03720470|324124681|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
94634859|NCT03720470|324124676|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
94634860|NCT03720470|324124677|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
94634861|NCT03720470|324124678|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
94634862|NCT03720470|324124679|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
94634863|NCT03720470|324124680|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
94634864|NCT03720470|324124681|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
94634865|NCT03720470|324124676|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
94634866|NCT03720470|324124677|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
94634867|NCT03720470|324124678|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
94634868|NCT03720470|324124679|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
94634869|NCT03720470|324124680|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
94634870|NCT03720470|324124681|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
94634871|NCT03720470|324124676|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
94634872|NCT03720470|324124677|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
94634873|NCT03720470|324124678|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
94634874|NCT03720470|324124679|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
94634875|NCT03720470|324124680|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
94634876|NCT03720470|324124681|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
94634877|NCT03720470|324124676|FG000|Treatment Period: Final 4 Weeks|Other|0|||
94634878|NCT03720470|324124677|FG001|Treatment Period: Final 4 Weeks|Other|1|||
94634879|NCT03720470|324124678|FG002|Treatment Period: Final 4 Weeks|Other|0|||
94634880|NCT03720470|324124679|FG003|Treatment Period: Final 4 Weeks|Other|2|||
94634881|NCT03720470|324124680|FG004|Treatment Period: Final 4 Weeks|Other|1|||
94634882|NCT03720470|324124681|FG005|Treatment Period: Final 4 Weeks|Other|0|||
94634883|NCT04782856|324124682|FG000|Overall Study|Withdrawal by Subject|0|||
94634884|NCT04782856|324124683|FG001|Overall Study|Withdrawal by Subject|1|||
94634885|NCT03226392|324124689|FG000|Overall Study|Protocol Deviation|1|||
94634886|NCT03226392|324124690|FG001|Overall Study|Protocol Deviation|0|||
94634887|NCT03226392|324124689|FG000|Overall Study|Physician Decision|1|||
94634888|NCT03226392|324124690|FG001|Overall Study|Physician Decision|0|||
94634889|NCT03226392|324124689|FG000|Overall Study|Lost to Follow-up|1|||
94634890|NCT03226392|324124690|FG001|Overall Study|Lost to Follow-up|0|||
94634891|NCT03226392|324124689|FG000|Overall Study|Adverse Event|1|||
94634892|NCT03226392|324124690|FG001|Overall Study|Adverse Event|0|||
94634893|NCT03226392|324124689|FG000|Overall Study|Technical Problems|0|||
94634894|NCT03226392|324124690|FG001|Overall Study|Technical Problems|2|||
94634895|NCT03226392|324124689|FG000|Overall Study|Subject/Guardian Decision|7|||
94634896|NCT03226392|324124690|FG001|Overall Study|Subject/Guardian Decision|6|||
94634897|NCT02357901|324124691|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
94634898|NCT02357901|324124692|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
94634899|NCT02357901|324124693|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
94634900|NCT02357901|324124694|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
94634901|NCT02357901|324124691|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
94634902|NCT02357901|324124692|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
94634903|NCT02357901|324124693|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
94634904|NCT02357901|324124694|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
94634905|NCT02357901|324124691|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
94634906|NCT02357901|324124692|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
94634907|NCT02357901|324124693|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
94634908|NCT02357901|324124694|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
94362665|NCT03669640|323112778|FG000|Overall Study|Adverse Event|2|||
94362666|NCT03669640|323112779|FG001|Overall Study|Adverse Event|1|||
94362667|NCT03669640|323112780|FG002|Overall Study|Adverse Event|0|||
94362668|NCT03669640|323112781|FG003|Overall Study|Adverse Event|0|||
94634909|NCT02357901|324124691|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
94634910|NCT02357901|324124692|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
94634911|NCT02357901|324124693|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
94634912|NCT02357901|324124694|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
94634913|NCT02357901|324124691|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
94634914|NCT02357901|324124692|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
94634915|NCT02357901|324124693|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
94634916|NCT02357901|324124694|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
94634917|NCT02357901|324124691|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
94634918|NCT02357901|324124692|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
94634919|NCT02357901|324124693|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
94634920|NCT02357901|324124694|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
94634921|NCT02357901|324124691|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
94634922|NCT02357901|324124692|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
94634923|NCT02357901|324124693|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
94634924|NCT02357901|324124694|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
94634925|NCT02357901|324124691|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
94634926|NCT02357901|324124692|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
94634927|NCT02357901|324124693|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
94634928|NCT02357901|324124694|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
94634929|NCT02357901|324124691|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
94634930|NCT02357901|324124692|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
94634931|NCT02357901|324124693|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
94634932|NCT02357901|324124694|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
94634933|NCT02357901|324124691|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
94634934|NCT02357901|324124692|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
94634935|NCT02357901|324124693|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
94634936|NCT02357901|324124694|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
94634937|NCT02357901|324124691|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
94634938|NCT02357901|324124692|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
94634939|NCT02357901|324124693|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
94634940|NCT02357901|324124694|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
94634941|NCT02436356|324124695|FG000|Overall Study|Excluded by MRI Screening|0|||
94634942|NCT02436356|324124696|FG001|Overall Study|Excluded by MRI Screening|0|||
94634943|NCT02436356|324124697|FG002|Overall Study|Excluded by MRI Screening|2|||
94634944|NCT02436356|324124695|FG000|Overall Study|Lost to Follow-up|0|||
94634945|NCT02436356|324124696|FG001|Overall Study|Lost to Follow-up|1|||
94634946|NCT02436356|324124697|FG002|Overall Study|Lost to Follow-up|0|||
94634947|NCT02436356|324124695|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
94634948|NCT02436356|324124696|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
94634949|NCT02436356|324124697|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
94634950|NCT02436356|324124695|FG000|Overall Study|Excluded due to other medical conditions|3|||
94634951|NCT02436356|324124696|FG001|Overall Study|Excluded due to other medical conditions|0|||
94634952|NCT02436356|324124697|FG002|Overall Study|Excluded due to other medical conditions|0|||
94634953|NCT02436356|324124695|FG000|Overall Study|Withdrawal by Subject|1|||
94634954|NCT02436356|324124696|FG001|Overall Study|Withdrawal by Subject|0|||
94634955|NCT02436356|324124697|FG002|Overall Study|Withdrawal by Subject|0|||
94634956|NCT02574247|324124704|FG000|Overall Study|Withdrawal by Subject|1|||
94634957|NCT02574247|324124705|FG001|Overall Study|Withdrawal by Subject|0|||
94634958|NCT02574247|324124706|FG002|Overall Study|Withdrawal by Subject|0|||
94362669|NCT03669640|323112782|FG004|Overall Study|Adverse Event|1|||
94634959|NCT02574247|324124704|FG000|Overall Study|Did not meet inclusion criteria|4|||
94634960|NCT02574247|324124705|FG001|Overall Study|Did not meet inclusion criteria|3|||
94634961|NCT02574247|324124706|FG002|Overall Study|Did not meet inclusion criteria|5|||
94634962|NCT00227305|324124709|FG000|Overall Study|Adverse Event|40|||
94634963|NCT00227305|324124709|FG000|Overall Study|Withdrawal by Subject|42|||
94634964|NCT00227305|324124709|FG000|Overall Study|Lost to Follow-up|33|||
94634965|NCT00227305|324124709|FG000|Overall Study|Study specific discontinuation|13|||
94634966|NCT00227305|324124709|FG000|Overall Study|MOVED OUT OF AREA|3|||
94634967|NCT00227305|324124709|FG000|Overall Study|Lack of Efficacy|7|||
94634968|NCT00227305|324124709|FG000|Overall Study|Physician Decision|3|||
94634969|NCT00227305|324124709|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
94634970|NCT00227305|324124709|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
94634971|NCT00227305|324124709|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
94634972|NCT03178773|324124710|FG000|Overall Study|Death|0|||
94634973|NCT03178773|324124711|FG001|Overall Study|Death|1|||
94634974|NCT03178773|324124710|FG000|Overall Study|Lost to Follow-up|29|||
94634975|NCT03178773|324124711|FG001|Overall Study|Lost to Follow-up|25|||
94634976|NCT03178773|324124710|FG000|Overall Study|Withdrawal by Subject|10|||
94634977|NCT03178773|324124711|FG001|Overall Study|Withdrawal by Subject|14|||
94261843|NCT01839487|322752426|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
94261844|NCT01839487|322752427|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
94261845|NCT01839487|322752422|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
94261846|NCT01839487|322752423|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
94261847|NCT01839487|322752424|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
94261848|NCT01839487|322752425|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
94634978|NCT02118012|324124713|FG000|Overall Study|Adverse Event|0|||
94261849|NCT01839487|322752426|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
94261850|NCT01839487|322752427|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
94261851|NCT01839487|322752422|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
94634979|NCT02118012|324124714|FG001|Overall Study|Adverse Event|1|||
94634980|NCT02118012|324124713|FG000|Overall Study|Physician Decision|0|||
94261852|NCT01839487|322752423|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
94634981|NCT02118012|324124714|FG001|Overall Study|Physician Decision|1|||
94634982|NCT00483379|324124715|FG000|Treatment Period|Adverse Event|1|||
94261853|NCT01839487|322752424|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
94261854|NCT01839487|322752425|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
94261855|NCT01839487|322752426|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
94261856|NCT01839487|322752427|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
94261857|NCT01839487|322752422|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
94261858|NCT01839487|322752423|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
94261859|NCT01839487|322752424|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
94261860|NCT01839487|322752425|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
94261861|NCT01839487|322752426|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
94261862|NCT01839487|322752427|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
94261863|NCT01839487|322752422|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
94261864|NCT01839487|322752423|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
94261865|NCT01839487|322752424|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
94261866|NCT01839487|322752425|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
94261867|NCT01839487|322752426|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
94634983|NCT00483379|324124716|FG001|Treatment Period|Adverse Event|0|||
94634984|NCT00483379|324124715|FG000|Treatment Period|Withdrawal by Subject|1|||
94634985|NCT00483379|324124716|FG001|Treatment Period|Withdrawal by Subject|0|||
94634986|NCT04210310|324124719|FG000|Overall Study|Lost to Follow-up|32|||
94634987|NCT04210310|324124720|FG001|Overall Study|Lost to Follow-up|1|||
94634988|NCT00680745|324124721|FG000|Overall Study|Withdrawal by Subject|8|||
94634989|NCT00680745|324124722|FG001|Overall Study|Withdrawal by Subject|3|||
94634990|NCT00680745|324124723|FG002|Overall Study|Withdrawal by Subject|2|||
94634991|NCT00680745|324124724|FG003|Overall Study|Withdrawal by Subject|8|||
94634992|NCT00680745|324124721|FG000|Overall Study|Lost to Follow-up|0|||
94634993|NCT00680745|324124722|FG001|Overall Study|Lost to Follow-up|1|||
94634994|NCT00680745|324124723|FG002|Overall Study|Lost to Follow-up|1|||
94634995|NCT00680745|324124724|FG003|Overall Study|Lost to Follow-up|0|||
94634996|NCT00680745|324124721|FG000|Overall Study|Death|1|||
94634997|NCT00680745|324124722|FG001|Overall Study|Death|0|||
94634998|NCT00680745|324124723|FG002|Overall Study|Death|1|||
94634999|NCT00680745|324124724|FG003|Overall Study|Death|0|||
94635000|NCT00680745|324124721|FG000|Overall Study|Adverse Event|5|||
94635001|NCT00680745|324124722|FG001|Overall Study|Adverse Event|3|||
94635002|NCT00680745|324124723|FG002|Overall Study|Adverse Event|3|||
94635003|NCT00680745|324124724|FG003|Overall Study|Adverse Event|3|||
94635004|NCT00680745|324124721|FG000|Overall Study|Poor/Non-compliance|0|||
94635005|NCT00680745|324124722|FG001|Overall Study|Poor/Non-compliance|3|||
94635006|NCT00680745|324124723|FG002|Overall Study|Poor/Non-compliance|0|||
94676501|NCT00117676|324269147|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
94676502|NCT00117676|324269146|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
94676503|NCT00117676|324269147|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
94676504|NCT00117676|324269146|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
94676505|NCT00117676|324269147|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
94676506|NCT00117676|324269146|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
94676507|NCT00117676|324269147|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
94676508|NCT00117676|324269146|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
94676509|NCT00117676|324269147|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
94676510|NCT00117676|324269146|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
94261868|NCT01839487|322752427|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
94261869|NCT01839487|322752422|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
94261870|NCT01839487|322752423|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
94261871|NCT01839487|322752424|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
94261872|NCT01839487|322752425|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
94261873|NCT01839487|322752426|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
94261874|NCT01839487|322752427|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
94261875|NCT01839487|322752422|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
94261876|NCT01839487|322752423|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
94261877|NCT01839487|322752424|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
94261878|NCT01839487|322752425|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
94261879|NCT01839487|322752426|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
94261880|NCT01839487|322752427|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
94261881|NCT01839487|322752422|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
94261882|NCT01839487|322752423|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
94261883|NCT01839487|322752424|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
94261884|NCT01839487|322752425|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
94261885|NCT01839487|322752426|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
94261886|NCT01839487|322752427|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
94261887|NCT01422850|322752435|FG000|Overall Study|Physician Decision|3|||
94261888|NCT04484831|322752442|FG000|Overall Study|Withdrawal by Subject|1|||
94261889|NCT04484831|322752443|FG001|Overall Study|Withdrawal by Subject|0|||
94261890|NCT02244996|322752444|FG000|Overall Study|Lack of Efficacy|2|||
94261891|NCT02244996|322752445|FG001|Overall Study|Lack of Efficacy|6|||
94261892|NCT04051827|322752446|FG000|Overall Study|Death|1|||
94261893|NCT04051827|322752446|FG000|Overall Study|Withdrawal by Subject|4|||
94261894|NCT04051827|322752446|FG000|Overall Study|Progressive disease|16|||
94261895|NCT04051827|322752446|FG000|Overall Study|Physician Decision|1|||
94261896|NCT04051827|322752446|FG000|Overall Study|Other|4|||
94261897|NCT01810016|322752451|FG000|Overall Study|Progressive disease|1|||
94261898|NCT01810016|322752452|FG001|Overall Study|Progressive disease|1|||
94261899|NCT01810016|322752453|FG002|Overall Study|Progressive disease|0|||
94261900|NCT01810016|322752451|FG000|Overall Study|Death|0|||
94261901|NCT01810016|322752452|FG001|Overall Study|Death|0|||
94261902|NCT01810016|322752453|FG002|Overall Study|Death|1|||
94261903|NCT03231943|322752454|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
94261904|NCT03231943|322752455|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
94261905|NCT03231943|322752456|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
94261906|NCT03231943|322752457|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
94261907|NCT03231943|322752458|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
94261908|NCT03231943|322752459|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
94261909|NCT03231943|322752460|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
94261910|NCT03231943|322752461|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
94261911|NCT03231943|322752462|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
94261912|NCT03231943|322752463|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
94261913|NCT03231943|322752464|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
94261914|NCT03231943|322752465|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
94261915|NCT03231943|322752466|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
94261916|NCT03231943|322752454|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
94261917|NCT03231943|322752455|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
94261918|NCT03231943|322752456|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
94676511|NCT00117676|324269147|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
94261919|NCT03231943|322752457|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
94261920|NCT03231943|322752458|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
94261921|NCT03231943|322752459|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
94261922|NCT03231943|322752460|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
94261923|NCT03231943|322752461|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
94261924|NCT03231943|322752462|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
94362670|NCT03669640|323112783|FG005|Overall Study|Adverse Event|0|||
94362671|NCT01826201|323112789|FG000|Overall Study|Non compliance with protocol|4|||
94362672|NCT01615822|323112790|FG000|Period 1|Withdrawal by Subject|0|||
94362673|NCT01615822|323112791|FG001|Period 1|Withdrawal by Subject|1|||
94362674|NCT01615822|323112792|FG002|Period 1|Withdrawal by Subject|0|||
94362675|NCT01615822|323112790|FG000|Period 1|Adverse Event|1|||
94362676|NCT01615822|323112791|FG001|Period 1|Adverse Event|1|||
94362677|NCT01615822|323112792|FG002|Period 1|Adverse Event|0|||
94362678|NCT01615822|323112790|FG000|Period 2|Lost to Follow-up|0|||
94362679|NCT01615822|323112791|FG001|Period 2|Lost to Follow-up|1|||
94362680|NCT01615822|323112792|FG002|Period 2|Lost to Follow-up|2|||
94362681|NCT02769832|323112793|FG000|Overall Study|Death|30|||
94362682|NCT01965431|323112794|FG000|Overall Study|Adverse Event|0|||
94362683|NCT01965431|323112795|FG001|Overall Study|Adverse Event|1|||
94362684|NCT01965431|323112796|FG002|Overall Study|Adverse Event|0|||
94362685|NCT01965431|323112797|FG003|Overall Study|Adverse Event|0|||
94362686|NCT01965431|323112798|FG004|Overall Study|Adverse Event|0|||
94362687|NCT01965431|323112799|FG005|Overall Study|Adverse Event|0|||
94362688|NCT01965431|323112794|FG000|Overall Study|Other than stated above|6|||
94362689|NCT01965431|323112795|FG001|Overall Study|Other than stated above|5|||
94362690|NCT01965431|323112796|FG002|Overall Study|Other than stated above|6|||
94362691|NCT01965431|323112797|FG003|Overall Study|Other than stated above|6|||
94362692|NCT01965431|323112798|FG004|Overall Study|Other than stated above|6|||
94362693|NCT01965431|323112799|FG005|Overall Study|Other than stated above|6|||
94362694|NCT02787785|323112802|FG000|Overall Study|Death|3|||
94362695|NCT02787785|323112803|FG001|Overall Study|Death|4|||
94362696|NCT02787785|323112802|FG000|Overall Study|Lost to Follow-up|1|||
94362697|NCT02787785|323112803|FG001|Overall Study|Lost to Follow-up|1|||
94362698|NCT02787785|323112802|FG000|Overall Study|Withdrawal by Subject|0|||
94362699|NCT02787785|323112803|FG001|Overall Study|Withdrawal by Subject|5|||
94362700|NCT00902265|323112804|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
94362701|NCT00902265|323112804|FG000|Overall Study|Adverse Event|2|||
94362702|NCT00902265|323112804|FG000|Overall Study|Lack of Efficacy|2|||
94362703|NCT00902265|323112804|FG000|Overall Study|Protocol Violation|1|||
94362704|NCT02050373|323112805|FG000|Overall Study|Adverse Event|4|||
94362705|NCT02050373|323112806|FG001|Overall Study|Adverse Event|7|||
94362706|NCT02050373|323112805|FG000|Overall Study|Death|3|||
94362707|NCT02050373|323112806|FG001|Overall Study|Death|3|||
94362708|NCT01977625|323112807|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
94362709|NCT01977625|323112808|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
94362710|NCT01977625|323112807|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
94362711|NCT01977625|323112808|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
94362712|NCT00572910|323112810|FG000|Overall Study|Adverse Event|1|||
94362713|NCT00572910|323112811|FG001|Overall Study|Adverse Event|2|||
94362714|NCT00572910|323112812|FG002|Overall Study|Adverse Event|0|||
94635007|NCT00680745|324124724|FG003|Overall Study|Poor/Non-compliance|0|||
94635008|NCT00680745|324124721|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
94635009|NCT00680745|324124722|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
94635010|NCT00680745|324124723|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
94635011|NCT00680745|324124724|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
94635012|NCT00680745|324124721|FG000|Overall Study|False Treatment|0|||
94635013|NCT00680745|324124722|FG001|Overall Study|False Treatment|1|||
94635014|NCT00680745|324124723|FG002|Overall Study|False Treatment|3|||
94635015|NCT00680745|324124724|FG003|Overall Study|False Treatment|0|||
94635016|NCT00730912|324124727|FG000|Overall Study|Discontinued|0|||
94635017|NCT00730912|324124728|FG001|Overall Study|Discontinued|0|||
94635018|NCT00730912|324124729|FG002|Overall Study|Discontinued|1|||
94635019|NCT01119131|324124730|FG000|Overall Study|Adverse Event|1|||
94635020|NCT01119131|324124731|FG001|Overall Study|Adverse Event|1|||
94635021|NCT01119131|324124732|FG002|Overall Study|Adverse Event|1|||
94635022|NCT01119131|324124730|FG000|Overall Study|Non-Compliance|1|||
94635023|NCT01119131|324124731|FG001|Overall Study|Non-Compliance|0|||
94635024|NCT01119131|324124732|FG002|Overall Study|Non-Compliance|4|||
94635025|NCT01119131|324124730|FG000|Overall Study|Physician Decision|0|||
94635026|NCT01119131|324124731|FG001|Overall Study|Physician Decision|0|||
94362715|NCT00572910|323112813|FG003|Overall Study|Adverse Event|2|||
94362716|NCT00572910|323112814|FG004|Overall Study|Adverse Event|0|||
94635027|NCT01119131|324124732|FG002|Overall Study|Physician Decision|1|||
94362717|NCT00572910|323112815|FG005|Overall Study|Adverse Event|0|||
94362718|NCT00572910|323112816|FG006|Overall Study|Adverse Event|4|||
94362719|NCT00572910|323112817|FG007|Overall Study|Adverse Event|2|||
94362720|NCT00572910|323112818|FG008|Overall Study|Adverse Event|1|||
94362721|NCT00572910|323112819|FG009|Overall Study|Adverse Event|3|||
94362722|NCT00572910|323112820|FG010|Overall Study|Adverse Event|2|||
94362723|NCT00572910|323112810|FG000|Overall Study|Lost to Follow-up|0|||
94362724|NCT00572910|323112811|FG001|Overall Study|Lost to Follow-up|1|||
94362725|NCT00572910|323112812|FG002|Overall Study|Lost to Follow-up|1|||
94635028|NCT04339296|324124733|FG000|Overall Study|Refuse to participate after allocation|1|||
94362726|NCT00572910|323112813|FG003|Overall Study|Lost to Follow-up|2|||
94635029|NCT04339296|324124734|FG001|Overall Study|Refuse to participate after allocation|1|||
94635030|NCT04339296|324124733|FG000|Overall Study|Withdrew after completion of baseline|2|||
94635031|NCT04339296|324124734|FG001|Overall Study|Withdrew after completion of baseline|1|||
94635032|NCT04339296|324124733|FG000|Overall Study|Lost to Follow-up|0|||
94635033|NCT04339296|324124734|FG001|Overall Study|Lost to Follow-up|4|||
94635034|NCT04339296|324124733|FG000|Overall Study|Discontinued intervention|5|||
94635035|NCT04339296|324124734|FG001|Overall Study|Discontinued intervention|3|||
94635036|NCT00840294|324124735|FG000|Overall Study|Withdrawal by Subject|2|||
94635037|NCT00840294|324124736|FG001|Overall Study|Withdrawal by Subject|1|||
94635038|NCT00840294|324124735|FG000|Overall Study|Protocol Violation|1|||
94635039|NCT00840294|324124736|FG001|Overall Study|Protocol Violation|3|||
94635040|NCT00840294|324124735|FG000|Overall Study|Illness|0|||
94635041|NCT00840294|324124736|FG001|Overall Study|Illness|1|||
94635042|NCT01994629|324124737|FG000|Overall Study|Withdrawal by Subject|1|||
94635043|NCT01994629|324124738|FG001|Overall Study|Withdrawal by Subject|0|||
94635044|NCT01994629|324124737|FG000|Overall Study|Lost to Follow-up|0|||
94635045|NCT01994629|324124738|FG001|Overall Study|Lost to Follow-up|3|||
94635046|NCT01187043|324124739|FG000|Overall Study|Adverse Event|0|||
94635047|NCT01187043|324124740|FG001|Overall Study|Adverse Event|0|||
94635048|NCT01187043|324124741|FG002|Overall Study|Adverse Event|0|||
94635049|NCT01187043|324124742|FG003|Overall Study|Adverse Event|0|||
94635050|NCT01187043|324124743|FG004|Overall Study|Adverse Event|1|||
94635051|NCT01187043|324124739|FG000|Overall Study|Unable to make scheduled visits|1|||
94635052|NCT01187043|324124740|FG001|Overall Study|Unable to make scheduled visits|0|||
94461765|NCT00381043|323479612|FG000|Overall Study|Withdrawal by Subject|3|||
94461766|NCT00381043|323479613|FG001|Overall Study|Withdrawal by Subject|1|||
94461767|NCT00381043|323479612|FG000|Overall Study|wanted more care|0|||
94461768|NCT00381043|323479613|FG001|Overall Study|wanted more care|1|||
94461769|NCT00381043|323479612|FG000|Overall Study|incarcerated|1|||
94461770|NCT00381043|323479613|FG001|Overall Study|incarcerated|0|||
94461771|NCT05619536|323479617|FG000|Overall Study|Withdrawal by Subject|0|||
94461772|NCT05619536|323479618|FG001|Overall Study|Withdrawal by Subject|1|||
94461773|NCT05619536|323479619|FG002|Overall Study|Withdrawal by Subject|0|||
94461774|NCT05619536|323479620|FG003|Overall Study|Withdrawal by Subject|1|||
94635053|NCT01187043|324124741|FG002|Overall Study|Unable to make scheduled visits|4|||
94635054|NCT01187043|324124742|FG003|Overall Study|Unable to make scheduled visits|0|||
94635055|NCT01187043|324124743|FG004|Overall Study|Unable to make scheduled visits|1|||
94635056|NCT04256785|324124744|FG000|Overall Study|Adverse Event|8|||
94635057|NCT04256785|324124745|FG001|Overall Study|Adverse Event|6|||
94635058|NCT04256785|324124744|FG000|Overall Study|Lack of Efficacy|3|||
94635059|NCT04256785|324124745|FG001|Overall Study|Lack of Efficacy|4|||
94635060|NCT04256785|324124744|FG000|Overall Study|Lost to Follow-up|7|||
94635061|NCT04256785|324124745|FG001|Overall Study|Lost to Follow-up|7|||
94635062|NCT04256785|324124744|FG000|Overall Study|Protocol Violation|1|||
94635063|NCT04256785|324124745|FG001|Overall Study|Protocol Violation|0|||
94676512|NCT00117676|324269146|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
94676513|NCT00117676|324269147|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
94635064|NCT04256785|324124744|FG000|Overall Study|Withdrawal by Subject|4|||
94635065|NCT04256785|324124745|FG001|Overall Study|Withdrawal by Subject|1|||
94635066|NCT04256785|324124744|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
94635067|NCT04256785|324124745|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
94635068|NCT00383149|324124746|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
94461775|NCT05619536|323479617|FG000|Overall Study|Lost to Follow-up|0|||
94461776|NCT05619536|323479618|FG001|Overall Study|Lost to Follow-up|1|||
94461777|NCT05619536|323479619|FG002|Overall Study|Lost to Follow-up|1|||
94635069|NCT00383149|324124746|FG000|Overall Study|Death|2|||
94635070|NCT00383149|324124746|FG000|Overall Study|Disease Progression|38|||
94635071|NCT00383149|324124746|FG000|Overall Study|Lost to Follow-up|1|||
94635072|NCT00383149|324124746|FG000|Overall Study|Other|1|||
94635073|NCT00383149|324124746|FG000|Overall Study|Study Drug Toxicity|4|||
94635074|NCT00383149|324124746|FG000|Overall Study|Request to Discontinue Treatment|4|||
94635075|NCT00383149|324124746|FG000|Overall Study|Participant Withdrew Consent|1|||
94635076|NCT01170091|324124749|FG000|Overall Study|Missing efficacy evaluation|3|||
94635077|NCT01170091|324124749|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
94635078|NCT04387435|324124754|FG000|Overall Study|Physician Decision|1|||
94635079|NCT00969150|324124755|FG000|Overall Study|Adverse Event|4|||
94635080|NCT00969150|324124756|FG001|Overall Study|Adverse Event|14|||
94635081|NCT00969150|324124755|FG000|Overall Study|Lack of Efficacy|1|||
94635082|NCT00969150|324124756|FG001|Overall Study|Lack of Efficacy|1|||
94635083|NCT00969150|324124755|FG000|Overall Study|Protocol Violation|9|||
94635084|NCT00969150|324124756|FG001|Overall Study|Protocol Violation|12|||
94635085|NCT00969150|324124755|FG000|Overall Study|Withdrawal by Subject|13|||
94635086|NCT00969150|324124756|FG001|Overall Study|Withdrawal by Subject|9|||
94635087|NCT00969150|324124755|FG000|Overall Study|Lost to Follow-up|5|||
94635088|NCT00969150|324124756|FG001|Overall Study|Lost to Follow-up|4|||
94635089|NCT00969150|324124755|FG000|Overall Study|Other reasons|1|||
94635090|NCT00969150|324124756|FG001|Overall Study|Other reasons|0|||
94635091|NCT03194321|324124757|FG000|Overall Study|Withdrawal by Subject|1|||
94635092|NCT03194321|324124757|FG000|Overall Study|Lost to Follow-up|1|||
94635093|NCT03194321|324124757|FG000|Overall Study|Travel for Follow-up|1|||
94635094|NCT00391274|324124764|FG000|Overall Study|Death Due to Study Disease|55|||
94635095|NCT00391274|324124765|FG001|Overall Study|Death Due to Study Disease|45|||
94635096|NCT00391274|324124764|FG000|Overall Study|Lost to Follow-up|0|||
94635097|NCT00391274|324124765|FG001|Overall Study|Lost to Follow-up|3|||
94635098|NCT00391274|324124764|FG000|Overall Study|Physician Decision|4|||
94635099|NCT00391274|324124765|FG001|Overall Study|Physician Decision|2|||
94635100|NCT00391274|324124764|FG000|Overall Study|Withdrawal by Subject|0|||
94635101|NCT00391274|324124765|FG001|Overall Study|Withdrawal by Subject|3|||
94635102|NCT00391274|324124764|FG000|Overall Study|Death Due to Adverse Event|1|||
94635103|NCT00391274|324124765|FG001|Overall Study|Death Due to Adverse Event|3|||
94635104|NCT00391274|324124764|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
94635105|NCT00391274|324124765|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
94635106|NCT00391274|324124764|FG000|Overall Study|Death Not Study Related|0|||
94635107|NCT00391274|324124765|FG001|Overall Study|Death Not Study Related|1|||
94635108|NCT03021265|324124766|FG000|Overall Study|Adverse Event|29|||
94635109|NCT03021265|324124766|FG000|Overall Study|Lack of Efficacy|3|||
94635110|NCT03021265|324124766|FG000|Overall Study|Improved|17|||
94635111|NCT03021265|324124766|FG000|Overall Study|Lost to Follow-up|67|||
94635112|NCT03021265|324124766|FG000|Overall Study|No reason given|2|||
94635113|NCT03021265|324124766|FG000|Overall Study|No visit since the first visit|4|||
94635114|NCT00894322|324124767|FG000|Overall Study|Withdrawal by Subject|1|||
94635115|NCT00894322|324124768|FG001|Overall Study|Withdrawal by Subject|0|||
94635116|NCT00894322|324124769|FG002|Overall Study|Withdrawal by Subject|0|||
94635117|NCT01980875|324124770|FG000|Overall Study|Withdrew Consent|1|||
94635118|NCT01980875|324124771|FG001|Overall Study|Withdrew Consent|1|||
94635119|NCT01980875|324124772|FG002|Overall Study|Withdrew Consent|1|||
94635120|NCT01980875|324124770|FG000|Overall Study|Study Terminated by Sponsor|7|||
94635121|NCT01980875|324124771|FG001|Overall Study|Study Terminated by Sponsor|24|||
94635122|NCT01980875|324124772|FG002|Overall Study|Study Terminated by Sponsor|22|||
94635123|NCT01980875|324124770|FG000|Overall Study|Lost to Follow-up|0|||
94635124|NCT01980875|324124771|FG001|Overall Study|Lost to Follow-up|0|||
94635125|NCT01980875|324124772|FG002|Overall Study|Lost to Follow-up|1|||
94635126|NCT00665847|324124773|FG000|Overall Study|Adverse Event|8|||
94635127|NCT00665847|324124773|FG000|Overall Study|Withdrawal by Subject|2|||
94635128|NCT00665847|324124773|FG000|Overall Study|Subject non-compliant|8|||
94635129|NCT00665847|324124773|FG000|Overall Study|Subject reached a virologic endpoint|4|||
94635130|NCT00665847|324124773|FG000|Overall Study|Resistance to TMC125|1|||
94635131|NCT00665847|324124773|FG000|Overall Study|Subject ineligible to continue the trial|1|||
94635132|NCT00665847|324124773|FG000|Overall Study|Switch to Commercial Medication|1|||
94635133|NCT00056407|324124775|FG000|Overall Study|Adverse Event|282|||
94635134|NCT00056407|324124776|FG001|Overall Study|Adverse Event|364|||
94635135|NCT00056407|324124775|FG000|Overall Study|Withdrawal by Subject|377|||
94635136|NCT00056407|324124776|FG001|Overall Study|Withdrawal by Subject|361|||
94635137|NCT00056407|324124775|FG000|Overall Study|Lost to Follow-up|123|||
94635138|NCT00056407|324124776|FG001|Overall Study|Lost to Follow-up|113|||
94635139|NCT00056407|324124775|FG000|Overall Study|Protocol Violation|104|||
94635140|NCT00056407|324124776|FG001|Overall Study|Protocol Violation|95|||
94635141|NCT00056407|324124775|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
94635142|NCT00056407|324124776|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
94635143|NCT00056407|324124775|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
94635144|NCT00056407|324124776|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
94635145|NCT00056407|324124775|FG000|Overall Study|Missing|25|||
94635146|NCT00056407|324124776|FG001|Overall Study|Missing|34|||
94635147|NCT00616655|324124777|FG000|Overall Study|Adverse Event|10|||
94635148|NCT00616655|324124778|FG001|Overall Study|Adverse Event|7|||
94635149|NCT00616655|324124779|FG002|Overall Study|Adverse Event|12|||
94635150|NCT00616655|324124777|FG000|Overall Study|Lack of Efficacy|5|||
94635151|NCT00616655|324124778|FG001|Overall Study|Lack of Efficacy|5|||
94635152|NCT00616655|324124779|FG002|Overall Study|Lack of Efficacy|5|||
94635153|NCT00616655|324124777|FG000|Overall Study|Lost to Follow-up|3|||
94635154|NCT00616655|324124778|FG001|Overall Study|Lost to Follow-up|12|||
94635155|NCT00616655|324124779|FG002|Overall Study|Lost to Follow-up|10|||
94635156|NCT00616655|324124777|FG000|Overall Study|Protocol Violation|2|||
94635157|NCT00616655|324124778|FG001|Overall Study|Protocol Violation|4|||
94635158|NCT00616655|324124779|FG002|Overall Study|Protocol Violation|3|||
94635159|NCT00616655|324124777|FG000|Overall Study|Withdrawal by Subject|9|||
94635160|NCT00616655|324124778|FG001|Overall Study|Withdrawal by Subject|7|||
94635161|NCT00616655|324124779|FG002|Overall Study|Withdrawal by Subject|11|||
94635162|NCT00616655|324124777|FG000|Overall Study|Does not meet in/ex criteria|0|||
94635163|NCT00616655|324124778|FG001|Overall Study|Does not meet in/ex criteria|0|||
94635164|NCT00616655|324124779|FG002|Overall Study|Does not meet in/ex criteria|2|||
94635165|NCT00616655|324124777|FG000|Overall Study|Other|6|||
94635166|NCT00616655|324124778|FG001|Overall Study|Other|6|||
94635167|NCT00616655|324124779|FG002|Overall Study|Other|5|||
94635168|NCT03630120|324124780|FG000|Overall Study|Disease progression|0|||
94635169|NCT03630120|324124781|FG001|Overall Study|Disease progression|1|||
94635170|NCT03630120|324124782|FG002|Overall Study|Disease progression|1|||
94635171|NCT03630120|324124783|FG003|Overall Study|Disease progression|1|||
94635172|NCT03204305|324124784|FG000|Overall Study|Lost to Follow-up|6|||
94635173|NCT03204305|324124785|FG001|Overall Study|Lost to Follow-up|4|||
94635174|NCT03204305|324124786|FG002|Overall Study|Lost to Follow-up|0|||
94635175|NCT03204305|324124787|FG003|Overall Study|Lost to Follow-up|0|||
94635176|NCT03204305|324124784|FG000|Overall Study|Physician Decision|1|||
94635177|NCT03204305|324124785|FG001|Overall Study|Physician Decision|0|||
94635178|NCT03204305|324124786|FG002|Overall Study|Physician Decision|0|||
94635179|NCT03204305|324124787|FG003|Overall Study|Physician Decision|0|||
94635180|NCT03204305|324124784|FG000|Overall Study|failure to place arterial line|2|||
94635181|NCT03204305|324124785|FG001|Overall Study|failure to place arterial line|1|||
94635182|NCT03204305|324124786|FG002|Overall Study|failure to place arterial line|0|||
94635183|NCT03204305|324124787|FG003|Overall Study|failure to place arterial line|0|||
94635184|NCT03204305|324124784|FG000|Overall Study|Withdrawal by Subject|2|||
94635185|NCT03204305|324124785|FG001|Overall Study|Withdrawal by Subject|0|||
94635186|NCT03204305|324124786|FG002|Overall Study|Withdrawal by Subject|0|||
94635187|NCT03204305|324124787|FG003|Overall Study|Withdrawal by Subject|0|||
94635188|NCT04351087|324124788|FG000|Overall Study|Lost to Follow-up|7|||
94635189|NCT04351087|324124789|FG001|Overall Study|Lost to Follow-up|3|||
94635190|NCT04351087|324124788|FG000|Overall Study|Withdrawal by Subject|3|||
94635191|NCT04351087|324124789|FG001|Overall Study|Withdrawal by Subject|4|||
94635192|NCT04351087|324124788|FG000|Overall Study|Lack of Efficacy|3|||
94635193|NCT04351087|324124789|FG001|Overall Study|Lack of Efficacy|2|||
94635194|NCT00399360|324124790|FG000|Overall Study|Lost to Follow-up|2|||
94635195|NCT00399360|324124791|FG001|Overall Study|Lost to Follow-up|1|||
94635196|NCT00399360|324124792|FG002|Overall Study|Lost to Follow-up|2|||
94362727|NCT00572910|323112814|FG004|Overall Study|Lost to Follow-up|1|||
94635197|NCT00399360|324124793|FG003|Overall Study|Lost to Follow-up|4|||
94635198|NCT00399360|324124790|FG000|Overall Study|Adverse Event|0|||
94635199|NCT00399360|324124791|FG001|Overall Study|Adverse Event|0|||
94635200|NCT00399360|324124792|FG002|Overall Study|Adverse Event|1|||
94635201|NCT00399360|324124793|FG003|Overall Study|Adverse Event|0|||
94635202|NCT00399360|324124790|FG000|Overall Study|Withdrawal by Subject|0|||
94635203|NCT00399360|324124791|FG001|Overall Study|Withdrawal by Subject|2|||
94635204|NCT00399360|324124792|FG002|Overall Study|Withdrawal by Subject|0|||
94635205|NCT00399360|324124793|FG003|Overall Study|Withdrawal by Subject|2|||
94635206|NCT02588833|324124798|FG000|Part 1|Withdrawal by Subject|1|||
94635207|NCT02588833|324124799|FG001|Part 1|Withdrawal by Subject|0|||
94635208|NCT02588833|324124798|FG000|Part 2A|Physician Decision|0|||
94676514|NCT00117676|324269146|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
94676515|NCT00117676|324269147|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
94676516|NCT00117676|324269146|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
94676517|NCT00117676|324269147|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
94676518|NCT00117676|324269146|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
94676519|NCT00117676|324269147|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
94676520|NCT00117676|324269146|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
94676521|NCT00117676|324269147|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
94676522|NCT00117676|324269146|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
94676523|NCT00117676|324269147|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
94676524|NCT00117676|324269146|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
94676525|NCT00117676|324269147|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
94676526|NCT00117676|324269146|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
94676527|NCT00117676|324269147|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
94676528|NCT00117676|324269146|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
94676529|NCT00117676|324269147|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
94261925|NCT03231943|322752463|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
94261926|NCT03231943|322752464|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
94261927|NCT03231943|322752465|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
94261928|NCT03231943|322752466|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
94261929|NCT03231943|322752454|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
94261930|NCT03231943|322752455|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
94261931|NCT03231943|322752456|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
94261932|NCT03231943|322752457|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
94261933|NCT03231943|322752458|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
94261934|NCT03231943|322752459|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
94261935|NCT03231943|322752460|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
94261936|NCT03231943|322752461|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
94261937|NCT03231943|322752462|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
94261938|NCT03231943|322752463|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
94261939|NCT03231943|322752464|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
94261940|NCT03231943|322752465|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
94261941|NCT03231943|322752466|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
94261942|NCT03231943|322752454|FG000|Part 2|Adverse Event|0|||
94261943|NCT03231943|322752455|FG001|Part 2|Adverse Event|0|||
94261944|NCT03231943|322752456|FG002|Part 2|Adverse Event|0|||
94261945|NCT03231943|322752457|FG003|Part 2|Adverse Event|0|||
94261946|NCT03231943|322752458|FG004|Part 2|Adverse Event|0|||
94261947|NCT03231943|322752459|FG005|Part 2|Adverse Event|0|||
94261948|NCT03231943|322752460|FG006|Part 2|Adverse Event|0|||
94261949|NCT03231943|322752461|FG007|Part 2|Adverse Event|0|||
94261950|NCT03231943|322752462|FG008|Part 2|Adverse Event|0|||
94261951|NCT03231943|322752463|FG009|Part 2|Adverse Event|0|||
94261952|NCT03231943|322752464|FG010|Part 2|Adverse Event|1|||
94261953|NCT03231943|322752465|FG011|Part 2|Adverse Event|0|||
94261954|NCT03231943|322752466|FG012|Part 2|Adverse Event|0|||
94261955|NCT03231943|322752454|FG000|Part 2|Withdrawal by Subject|0|||
94261956|NCT03231943|322752455|FG001|Part 2|Withdrawal by Subject|0|||
94261957|NCT03231943|322752456|FG002|Part 2|Withdrawal by Subject|0|||
94261958|NCT03231943|322752457|FG003|Part 2|Withdrawal by Subject|0|||
94261959|NCT03231943|322752458|FG004|Part 2|Withdrawal by Subject|0|||
94261960|NCT03231943|322752459|FG005|Part 2|Withdrawal by Subject|0|||
94261961|NCT03231943|322752460|FG006|Part 2|Withdrawal by Subject|0|||
94261962|NCT03231943|322752461|FG007|Part 2|Withdrawal by Subject|0|||
94261963|NCT03231943|322752462|FG008|Part 2|Withdrawal by Subject|0|||
94261964|NCT03231943|322752463|FG009|Part 2|Withdrawal by Subject|0|||
94261965|NCT03231943|322752464|FG010|Part 2|Withdrawal by Subject|0|||
94261966|NCT03231943|322752465|FG011|Part 2|Withdrawal by Subject|1|||
94261967|NCT03231943|322752466|FG012|Part 2|Withdrawal by Subject|0|||
94261968|NCT00708175|322752474|FG000|Overall Study|Adverse Event|4|||
94261969|NCT00708175|322752475|FG001|Overall Study|Adverse Event|5|||
94261970|NCT00708175|322752474|FG000|Overall Study|Protocol Violation|2|||
94362728|NCT00572910|323112815|FG005|Overall Study|Lost to Follow-up|0|||
94261971|NCT00708175|322752475|FG001|Overall Study|Protocol Violation|3|||
94261972|NCT00708175|322752474|FG000|Overall Study|Lost to Follow-up|5|||
94261973|NCT00708175|322752475|FG001|Overall Study|Lost to Follow-up|3|||
94261974|NCT00708175|322752474|FG000|Overall Study|Withdrawal by Subject|5|||
94261975|NCT00708175|322752475|FG001|Overall Study|Withdrawal by Subject|7|||
94261976|NCT00708175|322752474|FG000|Overall Study|BMD loss >7%|2|||
94261977|NCT00708175|322752475|FG001|Overall Study|BMD loss >7%|3|||
94261978|NCT02038920|322752476|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
94261979|NCT02038920|322752477|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
94362729|NCT00572910|323112816|FG006|Overall Study|Lost to Follow-up|0|||
94261980|NCT02038920|322752478|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
94261981|NCT02038920|322752479|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
94261982|NCT02038920|322752480|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
94261983|NCT02038920|322752481|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
94261984|NCT02038920|322752476|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
94261985|NCT02038920|322752477|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
94261986|NCT02038920|322752478|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
94261987|NCT02038920|322752479|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
94261988|NCT02038920|322752480|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
94261989|NCT02038920|322752481|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
94261990|NCT02038920|322752476|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
94635209|NCT02588833|324124799|FG001|Part 2A|Physician Decision|1|||
94635210|NCT02588833|324124798|FG000|Part 2A|Withdrawal by Subject|0|||
94635211|NCT02588833|324124799|FG001|Part 2A|Withdrawal by Subject|1|||
94635212|NCT02588833|324124798|FG000|Part 2B|Adverse Event|0|||
94635213|NCT02588833|324124799|FG001|Part 2B|Adverse Event|1|||
94635214|NCT02588833|324124798|FG000|Part 2C|Adverse Event|0|||
94635215|NCT02588833|324124799|FG001|Part 2C|Adverse Event|1|||
94635216|NCT02588833|324124798|FG000|Part 2C|Withdrawal by Subject|0|||
94635217|NCT02588833|324124799|FG001|Part 2C|Withdrawal by Subject|1|||
94635218|NCT02588833|324124798|FG000|Part 3 (Safety Follow-up)|Other|0|||
94635219|NCT02588833|324124799|FG001|Part 3 (Safety Follow-up)|Other|2|||
94635220|NCT02738151|324124800|FG000|Overall Study|Randomized but not treated|4|||
94635221|NCT02738151|324124801|FG001|Overall Study|Randomized but not treated|1|||
94635222|NCT02738151|324124800|FG000|Overall Study|Adverse Event|4|||
94635223|NCT02738151|324124801|FG001|Overall Study|Adverse Event|5|||
94635224|NCT02738151|324124800|FG000|Overall Study|Hypoglycemia|0|||
94635225|NCT02738151|324124801|FG001|Overall Study|Hypoglycemia|1|||
94635226|NCT02738151|324124800|FG000|Overall Study|Poor Compliance to Protocol|4|||
94635227|NCT02738151|324124801|FG001|Overall Study|Poor Compliance to Protocol|3|||
94635228|NCT02738151|324124800|FG000|Overall Study|Other than specified above|11|||
94635229|NCT02738151|324124801|FG001|Overall Study|Other than specified above|21|||
94635230|NCT04007094|324124804|FG000|Overall Study|Lost to Follow-up|1|||
94635231|NCT04007094|324124805|FG001|Overall Study|Lost to Follow-up|1|||
94635232|NCT04350788|324124813|FG000|Overall Study|Lost to Follow-up|6|||
94635233|NCT04350788|324124814|FG001|Overall Study|Lost to Follow-up|2|||
94635234|NCT04350788|324124813|FG000|Overall Study|Withdrawal by Subject|2|||
94635235|NCT04350788|324124814|FG001|Overall Study|Withdrawal by Subject|4|||
94635236|NCT04350788|324124813|FG000|Overall Study|Protocol Violation|4|||
94635237|NCT04350788|324124814|FG001|Overall Study|Protocol Violation|0|||
94635238|NCT03615105|324124815|FG000|Overall Study|Protocol Violation|1|||
94635239|NCT03615105|324124816|FG001|Overall Study|Protocol Violation|0|||
94635240|NCT03615105|324124817|FG002|Overall Study|Protocol Violation|0|||
94635241|NCT03615105|324124815|FG000|Overall Study|Death|0|||
94635242|NCT03615105|324124816|FG001|Overall Study|Death|2|||
94635243|NCT03615105|324124817|FG002|Overall Study|Death|0|||
94635244|NCT01581307|324124818|FG000|Overall Study|Withdrawal by Subject|1|||
94635245|NCT02496533|324124819|FG000|Overall Study|Lack of data on outcome|3|||
94635246|NCT02496533|324124820|FG001|Overall Study|Lack of data on outcome|0|||
94635247|NCT02496533|324124819|FG000|Overall Study|Patient did not complete all measures|0|||
94635248|NCT02496533|324124820|FG001|Overall Study|Patient did not complete all measures|4|||
94635249|NCT02496533|324124819|FG000|Overall Study|Late for radiologic testing|0|||
94635250|NCT02496533|324124820|FG001|Overall Study|Late for radiologic testing|2|||
94635251|NCT01344161|324124821|FG000|Overall Study|Lost to Follow-up|4|||
94635252|NCT01344161|324124822|FG001|Overall Study|Lost to Follow-up|1|||
94635253|NCT01344161|324124821|FG000|Overall Study|Pregnancy|0|||
94676530|NCT00117676|324269146|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
94676531|NCT00117676|324269147|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
94261991|NCT02038920|322752477|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
94261992|NCT02038920|322752478|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
94261993|NCT02038920|322752479|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
94261994|NCT02038920|322752480|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
94261995|NCT02038920|322752481|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
94261996|NCT02038920|322752476|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
94264161|NCT02876835|322761860|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
94635254|NCT01344161|324124822|FG001|Overall Study|Pregnancy|1|||
94635255|NCT01344161|324124821|FG000|Overall Study|Protocol Violation|1|||
94635256|NCT01344161|324124822|FG001|Overall Study|Protocol Violation|1|||
94676532|NCT00117676|324269146|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
94635257|NCT04690751|324124823|FG000|Overall Study|Protocol Violation|0|||
94635258|NCT04690751|324124824|FG001|Overall Study|Protocol Violation|1|||
94635259|NCT04690751|324124825|FG002|Overall Study|Protocol Violation|0|||
94635260|NCT04690751|324124826|FG003|Overall Study|Protocol Violation|1|||
94635261|NCT04690751|324124827|FG004|Overall Study|Protocol Violation|2|||
94635262|NCT04690751|324124828|FG005|Overall Study|Protocol Violation|0|||
94676533|NCT00117676|324269147|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
94676534|NCT00117676|324269146|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
94676535|NCT00117676|324269147|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
94676536|NCT00117676|324269146|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
94676537|NCT00117676|324269147|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
94676538|NCT00117676|324269146|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
94676539|NCT00117676|324269147|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
94676540|NCT00117676|324269146|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
94676541|NCT00117676|324269147|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
94676542|NCT00117676|324269146|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
94676543|NCT00117676|324269147|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
94676544|NCT00117676|324269146|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
94676545|NCT00117676|324269147|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
94676546|NCT00117676|324269146|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
94676547|NCT00117676|324269147|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
94676548|NCT00117676|324269146|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
94676549|NCT00117676|324269147|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
94676550|NCT00117676|324269146|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
94676551|NCT00117676|324269147|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
94676552|NCT00117676|324269146|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
94676553|NCT00117676|324269147|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
94676554|NCT00117676|324269146|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
94676555|NCT00117676|324269147|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
94676556|NCT01755702|324269152|FG000|Wash Out Period I|Other Reason|3|||
94676557|NCT01755702|324269152|FG000|Washout Period II|Other Reason|5|||
94676558|NCT00691938|324269153|FG000|Overall Study|QTc prolongation|1|||
94676559|NCT00691938|324269154|FG001|Overall Study|QTc prolongation|0|||
94676560|NCT00691938|324269155|FG002|Overall Study|QTc prolongation|0|||
94676561|NCT00691938|324269156|FG003|Overall Study|QTc prolongation|0|||
94676562|NCT00691938|324269157|FG004|Overall Study|QTc prolongation|0|||
94676563|NCT00691938|324269158|FG005|Overall Study|QTc prolongation|0|||
94676564|NCT00691938|324269159|FG006|Overall Study|QTc prolongation|0|||
94676565|NCT00758459|324269160|FG000|Overall Study|Adverse Event|3|||
94676566|NCT00758459|324269161|FG001|Overall Study|Adverse Event|2|||
94676567|NCT00758459|324269160|FG000|Overall Study|Protocol Violation|0|||
94676568|NCT00758459|324269161|FG001|Overall Study|Protocol Violation|1|||
94676569|NCT00758459|324269160|FG000|Overall Study|Withdrawal by Subject|0|||
94676570|NCT00758459|324269161|FG001|Overall Study|Withdrawal by Subject|1|||
94676571|NCT01780935|324269168|FG000|Overall Study|Admin problems due to early termination|321|||
94676572|NCT01780935|324269169|FG001|Overall Study|Admin problems due to early termination|309|||
94676573|NCT01780935|324269168|FG000|Overall Study|Adverse Event|2|||
94676574|NCT01780935|324269169|FG001|Overall Study|Adverse Event|4|||
94676575|NCT01780935|324269168|FG000|Overall Study|Death|1|||
94676576|NCT01780935|324269169|FG001|Overall Study|Death|6|||
94676577|NCT01780935|324269168|FG000|Overall Study|Lost to Follow-up|2|||
94676578|NCT01780935|324269169|FG001|Overall Study|Lost to Follow-up|6|||
94676579|NCT01780935|324269168|FG000|Overall Study|Physician Decision|1|||
94676580|NCT01780935|324269169|FG001|Overall Study|Physician Decision|1|||
94676581|NCT01780935|324269168|FG000|Overall Study|Protocol deviation|0|||
94676582|NCT01780935|324269169|FG001|Overall Study|Protocol deviation|1|||
94676583|NCT01780935|324269168|FG000|Overall Study|Patient withdrew consent|8|||
94676584|NCT01780935|324269169|FG001|Overall Study|Patient withdrew consent|9|||
94676585|NCT01058304|324269172|FG000|Overall Study|Withdrawal by Subject|8|||
94676586|NCT01058304|324269173|FG001|Overall Study|Withdrawal by Subject|5|||
94676587|NCT01058304|324269172|FG000|Overall Study|Lost to Follow-up|13|||
94676588|NCT01058304|324269173|FG001|Overall Study|Lost to Follow-up|16|||
94676589|NCT01058304|324269172|FG000|Overall Study|Developed exclusion criterion|6|||
94676590|NCT01058304|324269173|FG001|Overall Study|Developed exclusion criterion|12|||
94676591|NCT01533493|324269174|FG000|Overall Study|Adverse Event|2|||
94676592|NCT01533493|324269175|FG001|Overall Study|Adverse Event|1|||
94676593|NCT01533493|324269174|FG000|Overall Study|Withdrawal by Subject|1|||
94676594|NCT01533493|324269175|FG001|Overall Study|Withdrawal by Subject|2|||
94676595|NCT01533493|324269174|FG000|Overall Study|Lost to Follow-up|2|||
94676596|NCT01533493|324269175|FG001|Overall Study|Lost to Follow-up|0|||
94676597|NCT04899245|324269179|FG000|Overall Study|Withdrawal by Subject|3|||
94676598|NCT04899245|324269180|FG001|Overall Study|Withdrawal by Subject|5|||
94676599|NCT04899245|324269181|FG002|Overall Study|Withdrawal by Subject|2|||
94676600|NCT04899245|324269179|FG000|Overall Study|No longer eligible - Left staff position|0|||
94676601|NCT04899245|324269180|FG001|Overall Study|No longer eligible - Left staff position|0|||
94676602|NCT04899245|324269181|FG002|Overall Study|No longer eligible - Left staff position|1|||
94676603|NCT04899245|324269179|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
94635263|NCT04690751|324124823|FG000|Overall Study|Adverse Event|0|||
94635264|NCT04690751|324124824|FG001|Overall Study|Adverse Event|0|||
94635265|NCT04690751|324124825|FG002|Overall Study|Adverse Event|1|||
94635266|NCT04690751|324124826|FG003|Overall Study|Adverse Event|0|||
94635267|NCT04690751|324124827|FG004|Overall Study|Adverse Event|0|||
94635268|NCT04690751|324124828|FG005|Overall Study|Adverse Event|0|||
94635269|NCT04690751|324124823|FG000|Overall Study|Positive urine drug screen test|0|||
94635270|NCT04690751|324124824|FG001|Overall Study|Positive urine drug screen test|0|||
94635271|NCT04690751|324124825|FG002|Overall Study|Positive urine drug screen test|0|||
94635272|NCT04690751|324124826|FG003|Overall Study|Positive urine drug screen test|0|||
94635273|NCT04690751|324124827|FG004|Overall Study|Positive urine drug screen test|1|||
94635274|NCT04690751|324124828|FG005|Overall Study|Positive urine drug screen test|0|||
94635275|NCT04364620|324124829|FG000|Overall Study|Disease Progression|20|||
94635276|NCT04364620|324124829|FG000|Overall Study|Adverse Event|5|||
94635277|NCT04364620|324124829|FG000|Overall Study|Physician Decision|4|||
94635278|NCT04364620|324124829|FG000|Overall Study|Death|3|||
94635279|NCT04364620|324124829|FG000|Overall Study|Other|2|||
94635280|NCT04364620|324124829|FG000|Overall Study|Withdrawal by Subject|1|||
94635281|NCT03045081|324126442|FG000|Overall Study|Withdrawal by Subject|6|||
94635282|NCT03045081|324126443|FG001|Overall Study|Withdrawal by Subject|11|||
94635283|NCT00174915|324126444|FG000|Overall Study|Lost to Follow-up|19|||
94635284|NCT00174915|324126445|FG001|Overall Study|Lost to Follow-up|17|||
94635285|NCT00174915|324126446|FG002|Overall Study|Lost to Follow-up|9|||
94635286|NCT00174915|324126447|FG003|Overall Study|Lost to Follow-up|17|||
94635287|NCT00174915|324126448|FG004|Overall Study|Lost to Follow-up|10|||
94635288|NCT00174915|324126444|FG000|Overall Study|Adverse Event|18|||
94635289|NCT00174915|324126445|FG001|Overall Study|Adverse Event|16|||
94635290|NCT00174915|324126446|FG002|Overall Study|Adverse Event|11|||
94635291|NCT00174915|324126447|FG003|Overall Study|Adverse Event|18|||
94635292|NCT00174915|324126448|FG004|Overall Study|Adverse Event|5|||
94635293|NCT00174915|324126444|FG000|Overall Study|Personal Reason(s)|16|||
94635294|NCT00174915|324126445|FG001|Overall Study|Personal Reason(s)|16|||
94635295|NCT00174915|324126446|FG002|Overall Study|Personal Reason(s)|9|||
94635296|NCT00174915|324126447|FG003|Overall Study|Personal Reason(s)|9|||
94635297|NCT00174915|324126448|FG004|Overall Study|Personal Reason(s)|9|||
94635298|NCT00174915|324126444|FG000|Overall Study|Other|15|||
94635299|NCT00174915|324126445|FG001|Overall Study|Other|8|||
94635300|NCT00174915|324126446|FG002|Overall Study|Other|6|||
94635301|NCT00174915|324126447|FG003|Overall Study|Other|5|||
94635302|NCT00174915|324126448|FG004|Overall Study|Other|3|||
94635303|NCT00174915|324126444|FG000|Overall Study|Gout Flare|13|||
94635304|NCT00174915|324126445|FG001|Overall Study|Gout Flare|6|||
94635305|NCT00174915|324126446|FG002|Overall Study|Gout Flare|8|||
94635306|NCT00174915|324126447|FG003|Overall Study|Gout Flare|1|||
94635307|NCT00174915|324126448|FG004|Overall Study|Gout Flare|0|||
94635308|NCT00174915|324126444|FG000|Overall Study|Protocol Violation|6|||
94635309|NCT00174915|324126445|FG001|Overall Study|Protocol Violation|3|||
94635310|NCT00174915|324126446|FG002|Overall Study|Protocol Violation|3|||
94635311|NCT00174915|324126447|FG003|Overall Study|Protocol Violation|6|||
94635312|NCT00174915|324126448|FG004|Overall Study|Protocol Violation|3|||
94635313|NCT00174915|324126444|FG000|Overall Study|Therapeutic Failure|6|||
94635314|NCT00174915|324126445|FG001|Overall Study|Therapeutic Failure|3|||
94635315|NCT00174915|324126446|FG002|Overall Study|Therapeutic Failure|2|||
94635316|NCT00174915|324126447|FG003|Overall Study|Therapeutic Failure|1|||
94635317|NCT00174915|324126448|FG004|Overall Study|Therapeutic Failure|3|||
94635318|NCT04127786|324126453|FG000|Primary Series|Adverse Event|1|||
94635319|NCT04127786|324126454|FG001|Primary Series|Adverse Event|0|||
94635320|NCT04127786|324126455|FG002|Primary Series|Adverse Event|0|||
94635321|NCT04127786|324126456|FG003|Primary Series|Adverse Event|1|||
94635322|NCT04127786|324126457|FG004|Primary Series|Adverse Event|0|||
94635323|NCT04127786|324126458|FG005|Primary Series|Adverse Event|1|||
94635324|NCT04127786|324126453|FG000|Primary Series|Protocol Violation|5|||
94635325|NCT04127786|324126454|FG001|Primary Series|Protocol Violation|3|||
94635326|NCT04127786|324126455|FG002|Primary Series|Protocol Violation|4|||
94261997|NCT02038920|322752477|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
94261998|NCT02038920|322752478|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
94261999|NCT02038920|322752479|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
94262000|NCT02038920|322752480|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
94262001|NCT02038920|322752481|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
94262002|NCT02038920|322752476|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
94262003|NCT02038920|322752477|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
94262004|NCT02038920|322752478|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
94262005|NCT02038920|322752479|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
94262006|NCT02038920|322752480|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
94262007|NCT02038920|322752481|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
94262008|NCT02038920|322752476|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
94262009|NCT02038920|322752477|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
94262010|NCT02038920|322752478|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
94262011|NCT02038920|322752479|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
94262012|NCT02038920|322752480|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
94262013|NCT02038920|322752481|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
94262014|NCT02038920|322752476|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
94262015|NCT02038920|322752477|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
94262016|NCT02038920|322752478|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
94262017|NCT02038920|322752479|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
94262018|NCT02038920|322752480|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
94262019|NCT02038920|322752481|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
94262020|NCT02038920|322752476|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
94262021|NCT02038920|322752477|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
94262022|NCT02038920|322752478|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
94362730|NCT00572910|323112817|FG007|Overall Study|Lost to Follow-up|0|||
94635327|NCT04127786|324126456|FG003|Primary Series|Protocol Violation|3|||
94635328|NCT04127786|324126457|FG004|Primary Series|Protocol Violation|2|||
94635329|NCT04127786|324126458|FG005|Primary Series|Protocol Violation|0|||
94635330|NCT04127786|324126453|FG000|Primary Series|Withdrawal by Subject|0|||
94635331|NCT04127786|324126454|FG001|Primary Series|Withdrawal by Subject|0|||
94635332|NCT04127786|324126455|FG002|Primary Series|Withdrawal by Subject|0|||
94635333|NCT04127786|324126456|FG003|Primary Series|Withdrawal by Subject|1|||
94635334|NCT04127786|324126457|FG004|Primary Series|Withdrawal by Subject|0|||
94635335|NCT04127786|324126458|FG005|Primary Series|Withdrawal by Subject|0|||
94635336|NCT04127786|324126453|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
94635337|NCT04127786|324126454|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
94635338|NCT04127786|324126455|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
94635339|NCT04127786|324126456|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
94635340|NCT04127786|324126457|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
94635341|NCT04127786|324126458|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
94635342|NCT04127786|324126453|FG000|Booster Phase|Withdrawal by Subject|2|||
94635343|NCT04127786|324126454|FG001|Booster Phase|Withdrawal by Subject|0|||
94635344|NCT04127786|324126455|FG002|Booster Phase|Withdrawal by Subject|0|||
94635345|NCT04127786|324126456|FG003|Booster Phase|Withdrawal by Subject|0|||
94635346|NCT04127786|324126457|FG004|Booster Phase|Withdrawal by Subject|0|||
94635347|NCT04127786|324126458|FG005|Booster Phase|Withdrawal by Subject|0|||
94635348|NCT02232425|324126459|FG000|Overall Study|Lost to Follow-up|6|||
94635349|NCT02232425|324126460|FG001|Overall Study|Lost to Follow-up|2|||
94635350|NCT02232425|324126459|FG000|Overall Study|Adverse Event|2|||
94635351|NCT02232425|324126460|FG001|Overall Study|Adverse Event|0|||
94635352|NCT02232425|324126459|FG000|Overall Study|Withdrawal by Subject|5|||
94635353|NCT02232425|324126460|FG001|Overall Study|Withdrawal by Subject|6|||
94635354|NCT02232425|324126459|FG000|Overall Study|Lack of Efficacy|1|||
94635355|NCT02232425|324126460|FG001|Overall Study|Lack of Efficacy|0|||
94635356|NCT00665353|324126461|FG000|Study Step 1|Adverse Event|1|||
94635357|NCT00665353|324126461|FG000|Study Step 1|Withdrawal by Subject|2|||
94635358|NCT00665353|324126461|FG000|Study Step 2|Lost to Follow-up|2|||
94635359|NCT00665353|324126461|FG000|Study Step 2|Lack of Efficacy|12|||
94635360|NCT01030523|324126463|FG000|Initial Study (5 Years)|Death|1|||
94635361|NCT01030523|324126464|FG001|Initial Study (5 Years)|Death|0|||
94635362|NCT01030523|324126463|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
94635363|NCT01030523|324126464|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
94635364|NCT01030523|324126463|FG000|Initial Study (5 Years)|Implant failure|1|||
94635365|NCT01030523|324126464|FG001|Initial Study (5 Years)|Implant failure|0|||
94635366|NCT01030523|324126463|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
94635367|NCT01030523|324126464|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
94635368|NCT01030523|324126463|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
94676604|NCT04899245|324269180|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
94262023|NCT02038920|322752479|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
94262024|NCT02038920|322752480|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
94262025|NCT02038920|322752481|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
94262026|NCT02038920|322752476|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
94262027|NCT02038920|322752477|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
94262028|NCT02038920|322752478|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
94262029|NCT02038920|322752479|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
94262030|NCT02038920|322752480|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
94262031|NCT02038920|322752481|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
94262032|NCT02038920|322752476|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
94262033|NCT02038920|322752477|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
94262034|NCT02038920|322752478|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
94262035|NCT02038920|322752479|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
94262036|NCT02038920|322752480|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
94262037|NCT02038920|322752481|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
94262038|NCT02038920|322752476|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
94262039|NCT02038920|322752477|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
94262040|NCT02038920|322752478|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
94262041|NCT02038920|322752479|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
94262042|NCT02038920|322752480|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
94262043|NCT02038920|322752481|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
94262044|NCT02038920|322752476|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
94262045|NCT02038920|322752477|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
94262046|NCT02038920|322752478|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
94262047|NCT02038920|322752479|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
94262048|NCT02038920|322752480|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
94262049|NCT02038920|322752481|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
94262050|NCT03471871|322752483|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
94262051|NCT03471871|322752484|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
94262052|NCT03471871|322752485|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
94262053|NCT03471871|322752486|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
94262054|NCT03471871|322752487|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
94262055|NCT03471871|322752483|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
94262056|NCT03471871|322752484|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
94262057|NCT03471871|322752485|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
94262058|NCT03471871|322752486|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
94262059|NCT03471871|322752487|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
94635369|NCT01030523|324126464|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
94635370|NCT01030523|324126463|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
94635371|NCT01030523|324126464|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
94635372|NCT03724812|324126465|FG000|Overall Study|Missed Visit|1|||
94635373|NCT03724812|324126465|FG000|Overall Study|Death|2|||
94635374|NCT03724812|324126465|FG000|Overall Study|Withdrawal by Subject|1|||
94635375|NCT01528072|324126466|FG000|Overall Study|Withdrawal by Subject|5|||
94635376|NCT01528072|324126466|FG000|Overall Study|Physician Decision|1|||
94635377|NCT01528072|324126466|FG000|Overall Study|Determined not eligible by AEAC|1|||
94635378|NCT01528072|324126466|FG000|Overall Study|Missed Visit|2|||
94635379|NCT01528072|324126466|FG000|Overall Study|Lost to Follow-up|5|||
94635380|NCT01528072|324126466|FG000|Overall Study|Explanted|2|||
94635381|NCT01528072|324126466|FG000|Overall Study|Site Closure|4|||
94635382|NCT01528072|324126466|FG000|Overall Study|Death|2|||
94635383|NCT01528072|324126466|FG000|Overall Study|Early Termination of Study|52|||
94635384|NCT01394523|324126467|FG000|Overall Study|Unable to place block|1|||
94635385|NCT01394523|324126468|FG001|Overall Study|Unable to place block|0|||
94635386|NCT01394523|324126469|FG002|Overall Study|Unable to place block|0|||
94635387|NCT04741074|324126470|FG000|Overall Study|Withdrawal by Subject|1|||
94635388|NCT04741074|324126471|FG001|Overall Study|Withdrawal by Subject|1|||
94635389|NCT04741074|324126470|FG000|Overall Study|Study terminated prematurely|1|||
94635390|NCT04741074|324126471|FG001|Overall Study|Study terminated prematurely|0|||
94635391|NCT02769247|324126475|FG000|Overall Study|Withdrawal by Subject|1|||
94262060|NCT03471871|322752483|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
94262061|NCT03471871|322752484|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
94262062|NCT03471871|322752485|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
94362731|NCT00572910|323112818|FG008|Overall Study|Lost to Follow-up|0|||
94362732|NCT00572910|323112819|FG009|Overall Study|Lost to Follow-up|1|||
94635392|NCT02769247|324126476|FG001|Overall Study|Withdrawal by Subject|0|||
94635393|NCT02769247|324126477|FG002|Overall Study|Withdrawal by Subject|0|||
94635394|NCT02769247|324126478|FG003|Overall Study|Withdrawal by Subject|1|||
94635395|NCT02769247|324126475|FG000|Overall Study|Protocol Violation|0|||
94635396|NCT02769247|324126476|FG001|Overall Study|Protocol Violation|0|||
94635397|NCT02769247|324126477|FG002|Overall Study|Protocol Violation|1|||
94635398|NCT02769247|324126478|FG003|Overall Study|Protocol Violation|0|||
94635399|NCT02769247|324126475|FG000|Overall Study|Physician Decision|1|||
94635400|NCT02769247|324126476|FG001|Overall Study|Physician Decision|0|||
94635401|NCT02769247|324126477|FG002|Overall Study|Physician Decision|0|||
94635402|NCT02769247|324126478|FG003|Overall Study|Physician Decision|0|||
94635403|NCT00469092|324126479|FG000|Overall Study|Adverse Event|5|||
94635404|NCT00469092|324126480|FG001|Overall Study|Adverse Event|4|||
94635405|NCT00469092|324126479|FG000|Overall Study|Lack of Efficacy|1|||
94635406|NCT00469092|324126480|FG001|Overall Study|Lack of Efficacy|0|||
94635407|NCT00469092|324126479|FG000|Overall Study|Lost to Follow-up|1|||
94635408|NCT00469092|324126480|FG001|Overall Study|Lost to Follow-up|2|||
94635409|NCT00469092|324126479|FG000|Overall Study|Protocol Violation|3|||
94635410|NCT00469092|324126480|FG001|Overall Study|Protocol Violation|3|||
94635411|NCT00469092|324126479|FG000|Overall Study|Withdrawal by Subject|4|||
94635412|NCT00469092|324126480|FG001|Overall Study|Withdrawal by Subject|4|||
94635413|NCT00469092|324126479|FG000|Overall Study|Withdrawal Criteria|3|||
94635414|NCT00469092|324126480|FG001|Overall Study|Withdrawal Criteria|4|||
94635415|NCT00469092|324126479|FG000|Overall Study|Incorrectly Randomised|4|||
94635416|NCT00469092|324126480|FG001|Overall Study|Incorrectly Randomised|3|||
94635417|NCT00469092|324126479|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
94635418|NCT00469092|324126480|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
94635419|NCT00469092|324126479|FG000|Overall Study|Use of lipid lowering drug|1|||
94635420|NCT00469092|324126480|FG001|Overall Study|Use of lipid lowering drug|0|||
94635421|NCT00469092|324126479|FG000|Overall Study|Hypoglycaemic Episodes|1|||
94635422|NCT00469092|324126480|FG001|Overall Study|Hypoglycaemic Episodes|1|||
94635423|NCT00469092|324126479|FG000|Overall Study|Abnormal lab value|1|||
94635424|NCT00469092|324126480|FG001|Overall Study|Abnormal lab value|0|||
94635425|NCT00469092|324126479|FG000|Overall Study|Use of Corticosteroid|1|||
94635426|NCT00469092|324126480|FG001|Overall Study|Use of Corticosteroid|0|||
94635427|NCT02024867|324126481|FG000|Overall Study|Protocol Violation|3|||
94635428|NCT02024867|324126482|FG001|Overall Study|Protocol Violation|3|||
94635429|NCT02024867|324126481|FG000|Overall Study|Lost to Follow-up|6|||
94635430|NCT02024867|324126482|FG001|Overall Study|Lost to Follow-up|4|||
94635431|NCT00413192|324126483|FG000|Overall Study|Disease progression|26|||
94635432|NCT00413192|324126484|FG001|Overall Study|Disease progression|31|||
94635433|NCT00413192|324126485|FG002|Overall Study|Disease progression|16|||
94635434|NCT00413192|324126486|FG003|Overall Study|Disease progression|25|||
94635435|NCT00413192|324126483|FG000|Overall Study|Toxicity|3|||
94635436|NCT00413192|324126484|FG001|Overall Study|Toxicity|2|||
94635437|NCT00413192|324126485|FG002|Overall Study|Toxicity|2|||
94635438|NCT00413192|324126486|FG003|Overall Study|Toxicity|2|||
94635439|NCT00413192|324126483|FG000|Overall Study|Withdrawal by Subject|3|||
94635440|NCT00413192|324126484|FG001|Overall Study|Withdrawal by Subject|5|||
94635441|NCT00413192|324126485|FG002|Overall Study|Withdrawal by Subject|0|||
94635442|NCT00413192|324126486|FG003|Overall Study|Withdrawal by Subject|1|||
94635443|NCT00413192|324126483|FG000|Overall Study|Intercurrent illness|0|||
94635444|NCT00413192|324126484|FG001|Overall Study|Intercurrent illness|0|||
94635445|NCT00413192|324126485|FG002|Overall Study|Intercurrent illness|0|||
94635446|NCT00413192|324126486|FG003|Overall Study|Intercurrent illness|1|||
94635447|NCT00413192|324126483|FG000|Overall Study|Intercurrent death|0|||
94635448|NCT00413192|324126484|FG001|Overall Study|Intercurrent death|1|||
94635449|NCT00413192|324126485|FG002|Overall Study|Intercurrent death|0|||
94635450|NCT00413192|324126486|FG003|Overall Study|Intercurrent death|0|||
94635451|NCT00413192|324126483|FG000|Overall Study|Other|5|||
94635452|NCT00413192|324126484|FG001|Overall Study|Other|1|||
94635453|NCT00413192|324126485|FG002|Overall Study|Other|1|||
94635454|NCT00413192|324126486|FG003|Overall Study|Other|2|||
94635455|NCT00413192|324126483|FG000|Overall Study|Not treated|0|||
94635456|NCT00413192|324126484|FG001|Overall Study|Not treated|0|||
94635457|NCT00413192|324126485|FG002|Overall Study|Not treated|0|||
94635458|NCT00413192|324126486|FG003|Overall Study|Not treated|1|||
94635459|NCT03538158|324126488|FG000|Overall Study|Lost to Follow-up|13|||
94635460|NCT03538158|324126489|FG001|Overall Study|Lost to Follow-up|7|||
94635461|NCT03538158|324126488|FG000|Overall Study|Withdrawal by Subject|2|||
94635462|NCT03538158|324126489|FG001|Overall Study|Withdrawal by Subject|1|||
94635463|NCT02968563|324126490|FG000|Overall Study|Adverse Event|0|||
94635464|NCT02968563|324126491|FG001|Overall Study|Adverse Event|6|||
94635465|NCT02968563|324126490|FG000|Overall Study|Death|1|||
94635466|NCT02968563|324126491|FG001|Overall Study|Death|1|||
94635467|NCT02968563|324126490|FG000|Overall Study|Lost to Follow-up|0|||
94635468|NCT02968563|324126491|FG001|Overall Study|Lost to Follow-up|1|||
94635469|NCT03992781|324126492|FG000|Overall Study|Lost to Follow-up|5|||
94635470|NCT03992781|324126492|FG000|Overall Study|Adverse Event|1|||
94635471|NCT03992781|324126492|FG000|Overall Study|Lack of Efficacy|5|||
94635472|NCT00695396|324126493|FG000|Overall Study|Study Closed Prematurely|5|||
94635473|NCT00695396|324126494|FG001|Overall Study|Study Closed Prematurely|6|||
94635474|NCT00695396|324126495|FG002|Overall Study|Study Closed Prematurely|8|||
94635475|NCT00695396|324126493|FG000|Overall Study|Withdrawal by Subject|2|||
94262063|NCT03471871|322752486|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
94262064|NCT03471871|322752487|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
94262065|NCT03471871|322752483|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
94262066|NCT03471871|322752484|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
94262067|NCT03471871|322752485|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
94262068|NCT03471871|322752486|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
94262069|NCT03471871|322752487|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
94262070|NCT03471871|322752483|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
94262071|NCT03471871|322752484|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
94262072|NCT03471871|322752485|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
94262073|NCT03471871|322752486|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
94262074|NCT03471871|322752487|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
94262075|NCT00447382|322752488|FG000|Overall Study|Adverse Event|1|||
94262076|NCT00447382|322752489|FG001|Overall Study|Adverse Event|1|||
94262077|NCT00447382|322752488|FG000|Overall Study|Lack of Efficacy|1|||
94262078|NCT00447382|322752489|FG001|Overall Study|Lack of Efficacy|0|||
94262079|NCT00447382|322752488|FG000|Overall Study|Protocol Violation|2|||
94635476|NCT00695396|324126494|FG001|Overall Study|Withdrawal by Subject|2|||
94635477|NCT00695396|324126495|FG002|Overall Study|Withdrawal by Subject|0|||
94635478|NCT04446377|324126498|FG000|Overall Study|Withdrawal by Subject|6|||
94635479|NCT04446377|324126499|FG001|Overall Study|Withdrawal by Subject|1|||
94635480|NCT04446377|324126498|FG000|Overall Study|Physician Decision|1|||
94635481|NCT04446377|324126499|FG001|Overall Study|Physician Decision|1|||
94635482|NCT04446377|324126498|FG000|Overall Study|Lost to Follow-up|0|||
94262080|NCT00447382|322752489|FG001|Overall Study|Protocol Violation|0|||
94262081|NCT00447382|322752488|FG000|Overall Study|Unclassified|2|||
94262082|NCT00447382|322752489|FG001|Overall Study|Unclassified|5|||
94262083|NCT04435782|322752490|FG000|Overall Study|Study terminated by sponsor|4|||
94262084|NCT05677893|322754711|FG000|Overall Study|Withdrawal by Subject|0|||
94262085|NCT05677893|322754712|FG001|Overall Study|Withdrawal by Subject|0|||
94262086|NCT05677893|322754713|FG002|Overall Study|Withdrawal by Subject|0|||
94262087|NCT05677893|322754714|FG003|Overall Study|Withdrawal by Subject|0|||
94262088|NCT05677893|322754715|FG004|Overall Study|Withdrawal by Subject|1|||
94262089|NCT05677893|322754716|FG005|Overall Study|Withdrawal by Subject|1|||
94262090|NCT05677893|322754717|FG006|Overall Study|Withdrawal by Subject|0|||
94262091|NCT05677893|322754711|FG000|Overall Study|Others|1|||
94262092|NCT05677893|322754712|FG001|Overall Study|Others|0|||
94262093|NCT05677893|322754713|FG002|Overall Study|Others|0|||
94262094|NCT05677893|322754714|FG003|Overall Study|Others|0|||
94262095|NCT05677893|322754715|FG004|Overall Study|Others|0|||
94262096|NCT05677893|322754716|FG005|Overall Study|Others|0|||
94262097|NCT05677893|322754717|FG006|Overall Study|Others|0|||
94262098|NCT04751656|322754718|FG000|Overall Study|Lost to Follow-up|1|||
94262099|NCT02805725|322754719|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
94262100|NCT02805725|322754720|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
94262101|NCT02805725|322754721|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
94635483|NCT04446377|324126499|FG001|Overall Study|Lost to Follow-up|2|||
94635484|NCT04446377|324126498|FG000|Overall Study|Not eligible|0|||
94635485|NCT04446377|324126499|FG001|Overall Study|Not eligible|1|||
94635486|NCT00619801|324126500|FG000|Overall Study|Lack of Efficacy|0|||
94635487|NCT00619801|324126501|FG001|Overall Study|Lack of Efficacy|1|||
94635488|NCT00619801|324126500|FG000|Overall Study|Withdrawal by Subject|1|||
94635489|NCT00619801|324126501|FG001|Overall Study|Withdrawal by Subject|1|||
94635490|NCT00619801|324126500|FG000|Overall Study|Loss of efficacy|0|||
94635491|NCT00619801|324126501|FG001|Overall Study|Loss of efficacy|1|||
94635492|NCT03447990|324126502|FG000|Overall Study|Withdrawal by Subject|0|||
94635493|NCT03447990|324126503|FG001|Overall Study|Withdrawal by Subject|0|||
94635494|NCT03447990|324126504|FG002|Overall Study|Withdrawal by Subject|0|||
94635495|NCT03447990|324126505|FG003|Overall Study|Withdrawal by Subject|0|||
94635496|NCT03447990|324126506|FG004|Overall Study|Withdrawal by Subject|0|||
94262102|NCT02805725|322754722|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
94262103|NCT02805725|322754723|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
94262104|NCT02805725|322754719|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
94262105|NCT02805725|322754720|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
94262106|NCT02805725|322754721|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
94262107|NCT02805725|322754722|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
94262108|NCT02805725|322754723|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
94635497|NCT03447990|324126507|FG005|Overall Study|Withdrawal by Subject|0|||
94635498|NCT03447990|324126508|FG006|Overall Study|Withdrawal by Subject|1|||
94635499|NCT00455429|324126509|FG000|Overall Study|Study Terminated by Sponsor|0|||
94635500|NCT00455429|324126510|FG001|Overall Study|Study Terminated by Sponsor|0|||
94635501|NCT00455429|324126511|FG002|Overall Study|Study Terminated by Sponsor|0|||
94635502|NCT00455429|324126512|FG003|Overall Study|Study Terminated by Sponsor|3|||
94635503|NCT00455429|324126509|FG000|Overall Study|Lost to Follow-up|1|||
94262109|NCT02805725|322754719|FG000|Phase II|Protocol Violation|0|||
94262110|NCT02805725|322754720|FG001|Phase II|Protocol Violation|0|||
94262111|NCT02805725|322754721|FG002|Phase II|Protocol Violation|0|||
94262112|NCT02805725|322754722|FG003|Phase II|Protocol Violation|0|||
94262113|NCT02805725|322754723|FG004|Phase II|Protocol Violation|6|||
94262114|NCT01195545|322754724|FG000|Overall Study|Protocol Violation|4|||
94262115|NCT03236246|322754728|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
94262116|NCT03236246|322754729|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
94262117|NCT03236246|322754728|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
94262118|NCT03236246|322754729|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
94262119|NCT03236246|322754728|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
94262120|NCT03236246|322754729|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
94262121|NCT03236246|322754728|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
94262122|NCT03236246|322754729|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
94262123|NCT03236246|322754728|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
94262124|NCT03236246|322754729|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
94262125|NCT03236246|322754728|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
94262126|NCT03236246|322754729|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
94262127|NCT03236246|322754728|FG000|24-Week Dose Titration Period|Death|3|||
94262128|NCT03236246|322754729|FG001|24-Week Dose Titration Period|Death|1|||
94262129|NCT03236246|322754728|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
94262130|NCT03236246|322754729|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
94262131|NCT03236246|322754728|FG000|24-Week Dose Titration Period|Adverse Event|7|||
94262132|NCT03236246|322754729|FG001|24-Week Dose Titration Period|Adverse Event|8|||
94262133|NCT03236246|322754728|FG000|24-Week Dose Titration Period|Captured as Other|1|||
94262134|NCT03236246|322754729|FG001|24-Week Dose Titration Period|Captured as Other|2|||
94362733|NCT00572910|323112820|FG010|Overall Study|Lost to Follow-up|0|||
94635504|NCT00455429|324126510|FG001|Overall Study|Lost to Follow-up|0|||
94635505|NCT00455429|324126511|FG002|Overall Study|Lost to Follow-up|0|||
94635506|NCT00455429|324126512|FG003|Overall Study|Lost to Follow-up|3|||
94635507|NCT00455429|324126509|FG000|Overall Study|Withdrawal by Subject|0|||
94635508|NCT00455429|324126510|FG001|Overall Study|Withdrawal by Subject|1|||
94635509|NCT00455429|324126511|FG002|Overall Study|Withdrawal by Subject|1|||
94635510|NCT00455429|324126512|FG003|Overall Study|Withdrawal by Subject|0|||
94635511|NCT00455429|324126509|FG000|Overall Study|Lack of Efficacy|0|||
94635512|NCT00455429|324126510|FG001|Overall Study|Lack of Efficacy|1|||
94635513|NCT00455429|324126511|FG002|Overall Study|Lack of Efficacy|0|||
94635514|NCT00455429|324126512|FG003|Overall Study|Lack of Efficacy|1|||
94635515|NCT00455429|324126509|FG000|Overall Study|Adverse Event|0|||
94635516|NCT00455429|324126510|FG001|Overall Study|Adverse Event|1|||
94635517|NCT00455429|324126511|FG002|Overall Study|Adverse Event|0|||
94635518|NCT00455429|324126512|FG003|Overall Study|Adverse Event|3|||
94635519|NCT00455429|324126509|FG000|Overall Study|Randomly assigned but not treated|0|||
94635520|NCT00455429|324126510|FG001|Overall Study|Randomly assigned but not treated|0|||
94635521|NCT00455429|324126511|FG002|Overall Study|Randomly assigned but not treated|0|||
94635522|NCT00455429|324126512|FG003|Overall Study|Randomly assigned but not treated|2|||
94635523|NCT00455429|324126509|FG000|Overall Study|Personal Reason|1|||
94635524|NCT00455429|324126510|FG001|Overall Study|Personal Reason|0|||
94635525|NCT00455429|324126511|FG002|Overall Study|Personal Reason|0|||
94635526|NCT00455429|324126512|FG003|Overall Study|Personal Reason|0|||
94635527|NCT00455429|324126509|FG000|Overall Study|Non-compliance|0|||
94635528|NCT00455429|324126510|FG001|Overall Study|Non-compliance|0|||
94635529|NCT00455429|324126511|FG002|Overall Study|Non-compliance|0|||
94635530|NCT00455429|324126512|FG003|Overall Study|Non-compliance|1|||
94635531|NCT00455429|324126509|FG000|Overall Study|Other|0|||
94635532|NCT00455429|324126510|FG001|Overall Study|Other|2|||
94635533|NCT00455429|324126511|FG002|Overall Study|Other|0|||
94635534|NCT00455429|324126512|FG003|Overall Study|Other|1|||
94635535|NCT01603459|324126519|FG000|Overall Study|Adverse Event|5|||
94635536|NCT01603459|324126519|FG000|Overall Study|Withdrawal by Subject|5|||
94635537|NCT01603459|324126519|FG000|Overall Study|Lost to Follow-up|3|||
94635538|NCT01603459|324126519|FG000|Overall Study|Predefined discontinuation criteria|3|||
94635539|NCT01603459|324126519|FG000|Overall Study|Non-compliance|1|||
94635540|NCT01603459|324126519|FG000|Overall Study|Administrative reason|1|||
94635541|NCT00535223|324126521|FG000|Overall Study|Withdrawal by Subject|4|||
94635542|NCT00535223|324126522|FG001|Overall Study|Withdrawal by Subject|1|||
94635543|NCT01412021|324126523|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
94635544|NCT01412021|324126523|FG000|Overall Study|Treatment Prior to Approval|3|||
94635545|NCT01412021|324126523|FG000|Overall Study|Transferred to Other Hospital|9|||
94262135|NCT03236246|322754728|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
94262136|NCT03236246|322754729|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
94262137|NCT03236246|322754728|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
94635546|NCT01166178|324126526|FG000|Overall Study|Withdrawal by Subject|1|||
94635547|NCT01166178|324126527|FG001|Overall Study|Withdrawal by Subject|0|||
94635548|NCT01166178|324126526|FG000|Overall Study|Study was terminated|20|||
94635549|NCT01166178|324126527|FG001|Overall Study|Study was terminated|8|||
94635550|NCT04948450|324126530|FG000|Overall Study|Return home|1|||
94635551|NCT04948450|324126531|FG001|Overall Study|Return home|3|||
94635552|NCT00101907|324126535|FG000|Overall Study|Adverse Event|1|||
94635553|NCT00101907|324126536|FG001|Overall Study|Adverse Event|0|||
94635554|NCT00101907|324126537|FG002|Overall Study|Adverse Event|0|||
94635555|NCT00101907|324126538|FG003|Overall Study|Adverse Event|0|||
94635556|NCT00101907|324126539|FG004|Overall Study|Adverse Event|0|||
94635557|NCT00101907|324126540|FG005|Overall Study|Adverse Event|0|||
94635558|NCT00101907|324126535|FG000|Overall Study|Death|0|||
94635559|NCT00101907|324126536|FG001|Overall Study|Death|1|||
94635560|NCT00101907|324126537|FG002|Overall Study|Death|0|||
94635561|NCT00101907|324126538|FG003|Overall Study|Death|0|||
94635562|NCT00101907|324126539|FG004|Overall Study|Death|3|||
94635563|NCT00101907|324126540|FG005|Overall Study|Death|0|||
94635564|NCT00101907|324126535|FG000|Overall Study|Physician Decision|0|||
94635565|NCT00101907|324126536|FG001|Overall Study|Physician Decision|0|||
94635566|NCT00101907|324126537|FG002|Overall Study|Physician Decision|0|||
94635567|NCT00101907|324126538|FG003|Overall Study|Physician Decision|1|||
94635568|NCT00101907|324126539|FG004|Overall Study|Physician Decision|1|||
94635569|NCT00101907|324126540|FG005|Overall Study|Physician Decision|0|||
94635570|NCT00101907|324126535|FG000|Overall Study|Withdrawal by Subject|1|||
94635571|NCT00101907|324126536|FG001|Overall Study|Withdrawal by Subject|0|||
94635572|NCT00101907|324126537|FG002|Overall Study|Withdrawal by Subject|1|||
94635573|NCT00101907|324126538|FG003|Overall Study|Withdrawal by Subject|0|||
94635574|NCT00101907|324126539|FG004|Overall Study|Withdrawal by Subject|1|||
94635575|NCT00101907|324126540|FG005|Overall Study|Withdrawal by Subject|0|||
94635576|NCT00673179|324126543|FG000|Overall Study|Toxicity/Complications|3|||
94635577|NCT00673179|324126544|FG001|Overall Study|Toxicity/Complications|0|||
94635578|NCT00651755|324126545|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
94635579|NCT00651755|324126546|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
94635580|NCT00651755|324126545|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
94635581|NCT00651755|324126546|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
94635582|NCT00624052|324126547|FG000|Overall Study|Adverse Event|7|||
94635583|NCT00624052|324126548|FG001|Overall Study|Adverse Event|6|||
94635584|NCT00624052|324126549|FG002|Overall Study|Adverse Event|0|||
94635585|NCT00624052|324126550|FG003|Overall Study|Adverse Event|3|||
94635586|NCT00624052|324126547|FG000|Overall Study|Lack of Efficacy|1|||
94635587|NCT00624052|324126548|FG001|Overall Study|Lack of Efficacy|1|||
94635588|NCT00624052|324126549|FG002|Overall Study|Lack of Efficacy|0|||
94635589|NCT00624052|324126550|FG003|Overall Study|Lack of Efficacy|0|||
94635590|NCT00624052|324126547|FG000|Overall Study|Lost to Follow-up|2|||
94635591|NCT00624052|324126548|FG001|Overall Study|Lost to Follow-up|3|||
94635592|NCT00624052|324126549|FG002|Overall Study|Lost to Follow-up|1|||
94635593|NCT00624052|324126550|FG003|Overall Study|Lost to Follow-up|0|||
94635594|NCT00624052|324126547|FG000|Overall Study|Non compliant with the protocol|2|||
94635595|NCT00624052|324126548|FG001|Overall Study|Non compliant with the protocol|1|||
94635596|NCT00624052|324126549|FG002|Overall Study|Non compliant with the protocol|1|||
94635597|NCT00624052|324126550|FG003|Overall Study|Non compliant with the protocol|1|||
94635598|NCT00624052|324126547|FG000|Overall Study|Consent withdrawn|3|||
94635599|NCT00624052|324126548|FG001|Overall Study|Consent withdrawn|1|||
94635600|NCT00624052|324126549|FG002|Overall Study|Consent withdrawn|1|||
94635601|NCT00624052|324126550|FG003|Overall Study|Consent withdrawn|0|||
94635602|NCT00624052|324126547|FG000|Overall Study|Changed job/ran out if meds|0|||
94635603|NCT00624052|324126548|FG001|Overall Study|Changed job/ran out if meds|2|||
94635604|NCT00624052|324126549|FG002|Overall Study|Changed job/ran out if meds|0|||
94635605|NCT00624052|324126550|FG003|Overall Study|Changed job/ran out if meds|0|||
94635606|NCT00281684|324126551|FG000|Overall Study|Lost to Follow-up|0|||
94635607|NCT00281684|324126552|FG001|Overall Study|Lost to Follow-up|0|||
94635608|NCT00281684|324126553|FG002|Overall Study|Lost to Follow-up|1|||
94635609|NCT00281684|324126554|FG003|Overall Study|Lost to Follow-up|0|||
94635610|NCT00281684|324126551|FG000|Overall Study|Withdrawal by Subject|1|||
94635611|NCT00281684|324126552|FG001|Overall Study|Withdrawal by Subject|0|||
94635612|NCT00281684|324126553|FG002|Overall Study|Withdrawal by Subject|0|||
94635613|NCT00281684|324126554|FG003|Overall Study|Withdrawal by Subject|0|||
94635614|NCT03158051|324126556|FG000|Overall Study|Lost to Follow-up|41|||
94635615|NCT03158051|324126557|FG001|Overall Study|Lost to Follow-up|47|||
94635616|NCT03158051|324126556|FG000|Overall Study|Physician Decision|6|||
94635617|NCT03158051|324126557|FG001|Overall Study|Physician Decision|7|||
94635618|NCT03158051|324126556|FG000|Overall Study|Withdrawal by Subject|24|||
94635619|NCT03158051|324126557|FG001|Overall Study|Withdrawal by Subject|15|||
94635620|NCT03158051|324126556|FG000|Overall Study|Death|0|||
94635621|NCT03158051|324126557|FG001|Overall Study|Death|1|||
94635622|NCT00378209|324126568|FG000|Overall Study|Progressive disease|11|||
94635623|NCT00378209|324126568|FG000|Overall Study|Adverse Event|3|||
94635624|NCT00378209|324126568|FG000|Overall Study|Initiation of non-protocol therapy|3|||
94262138|NCT03236246|322754729|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
94262139|NCT03236246|322754728|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
94262140|NCT03236246|322754729|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
94262141|NCT03236246|322754728|FG000|24-Week Dose Maintenance Period|Death|0|||
94262142|NCT03236246|322754729|FG001|24-Week Dose Maintenance Period|Death|1|||
94262143|NCT03236246|322754728|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
94262144|NCT03236246|322754729|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
94262145|NCT02120625|322754733|FG000|Overall Study|Physician Decision|2|||
94262146|NCT04142450|322754736|FG000|Overall Study|Screen Failure|1|||
94262147|NCT04142450|322754736|FG000|Overall Study|Lost to Follow-up|1|||
94262148|NCT02952001|322754737|FG000|Overall Study|Adverse Event|3|||
94262149|NCT02952001|322754738|FG001|Overall Study|Adverse Event|0|||
94262150|NCT02952001|322754737|FG000|Overall Study|Prohibited therapy|10|||
94262151|NCT02952001|322754738|FG001|Overall Study|Prohibited therapy|3|||
94262152|NCT02952001|322754737|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
94262153|NCT02952001|322754738|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
94262154|NCT00234494|322754739|FG000|Overall Study|Protocol Violation|2|||
94262155|NCT02525861|322754740|FG000|Overall Study|Adverse Event|1|||
94262156|NCT02525861|322754741|FG001|Overall Study|Adverse Event|0|||
94262157|NCT02525861|322754740|FG000|Overall Study|Withdrawal by Subject|0|||
94635625|NCT00378209|324126568|FG000|Overall Study|Physician Decision|3|||
94635626|NCT00378209|324126568|FG000|Overall Study|Death|1|||
94635627|NCT00378209|324126568|FG000|Overall Study|Treatment delay|1|||
94635628|NCT03313804|324126572|FG000|Treatment|Death|5|||
94635629|NCT03313804|324126572|FG000|Treatment|still on treatment|2|||
94635630|NCT03313804|324126572|FG000|Follow Up|still on follow up|3|||
94635631|NCT01252940|324126573|FG000|Main Study Phase|Randomized but not treated|4|||
94635632|NCT01252940|324126574|FG001|Main Study Phase|Randomized but not treated|2|||
94635633|NCT01252940|324126573|FG000|Main Study Phase|Adverse Event|3|||
94635634|NCT01252940|324126574|FG001|Main Study Phase|Adverse Event|1|||
94635635|NCT01252940|324126573|FG000|Main Study Phase|Lack of Efficacy|1|||
94635636|NCT01252940|324126574|FG001|Main Study Phase|Lack of Efficacy|0|||
94635637|NCT01252940|324126573|FG000|Main Study Phase|Lost to Follow-up|6|||
94635638|NCT01252940|324126574|FG001|Main Study Phase|Lost to Follow-up|1|||
94635639|NCT01252940|324126573|FG000|Main Study Phase|Physician Decision|1|||
94635640|NCT01252940|324126574|FG001|Main Study Phase|Physician Decision|0|||
94635641|NCT01252940|324126573|FG000|Main Study Phase|Protocol Violation|4|||
94635642|NCT01252940|324126574|FG001|Main Study Phase|Protocol Violation|2|||
94635643|NCT01252940|324126573|FG000|Main Study Phase|Withdrawal by Subject|6|||
94635644|NCT01252940|324126574|FG001|Main Study Phase|Withdrawal by Subject|5|||
94635645|NCT01252940|324126573|FG000|Main Study Phase|Subject Non-compliance|1|||
94635646|NCT01252940|324126574|FG001|Main Study Phase|Subject Non-compliance|1|||
94635647|NCT01252940|324126573|FG000|Extension Phase|Adverse Event|2|||
94635648|NCT01252940|324126574|FG001|Extension Phase|Adverse Event|1|||
94635649|NCT01252940|324126573|FG000|Extension Phase|Lack of Efficacy|1|||
94635650|NCT01252940|324126574|FG001|Extension Phase|Lack of Efficacy|0|||
94635651|NCT01252940|324126573|FG000|Extension Phase|Lost to Follow-up|5|||
94635652|NCT01252940|324126574|FG001|Extension Phase|Lost to Follow-up|0|||
94635653|NCT01252940|324126573|FG000|Extension Phase|Physician Decision|0|||
94635654|NCT01252940|324126574|FG001|Extension Phase|Physician Decision|1|||
94635655|NCT01252940|324126573|FG000|Extension Phase|Subject Non-compliance|1|||
94635656|NCT01252940|324126574|FG001|Extension Phase|Subject Non-compliance|0|||
94635657|NCT01252940|324126573|FG000|Extension Phase|Withdrawal by Subject|1|||
94635658|NCT01252940|324126574|FG001|Extension Phase|Withdrawal by Subject|1|||
94635659|NCT04837131|324126575|FG000|Overall Study|Death|1|||
94262158|NCT02525861|322754741|FG001|Overall Study|Withdrawal by Subject|1|||
94262159|NCT02525861|322754740|FG000|Overall Study|Physician Decision|0|||
94262160|NCT02525861|322754741|FG001|Overall Study|Physician Decision|1|||
94262161|NCT01117454|322754744|FG000|Overall Study|Pregnancy|0|||
94262162|NCT01117454|322754745|FG001|Overall Study|Pregnancy|1|||
94635660|NCT04837131|324126575|FG000|Overall Study|Withdrawal by Subject|1|||
94635661|NCT04837131|324126575|FG000|Overall Study|Adverse Event|1|||
94635662|NCT04837131|324126575|FG000|Overall Study|Protocol Violation|1|||
94635663|NCT04219891|324126576|FG000|Overall Study|Lost to Follow-up|3|||
94635664|NCT04219891|324126576|FG000|Overall Study|Withdrawal by Subject|2|||
94635665|NCT02081690|324128578|FG000|Overall Study|Death|3|||
94635666|NCT02081690|324128578|FG000|Overall Study|Physician Decision|3|||
94635667|NCT02081690|324128578|FG000|Overall Study|Withdrawal by Subject|1|||
94635668|NCT03204981|324128580|FG000|Overall Study|Physician Decision|2|||
94635669|NCT03204981|324128580|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
94635670|NCT00397982|324128581|FG000|Overall Study|Withdrawal by Subject|1|||
94262163|NCT01521897|322754748|FG000|Overall Study|Protocol Violation|18|||
94262164|NCT01521897|322754748|FG000|Overall Study|Lost to Follow-up|5|||
94461778|NCT05619536|323479620|FG003|Overall Study|Lost to Follow-up|0|||
94635671|NCT00397982|324128581|FG000|Overall Study|Adverse Event|1|||
94635672|NCT00397982|324128581|FG000|Overall Study|noncompliance|1|||
94635673|NCT00397982|324128581|FG000|Overall Study|Unrelated health issues|1|||
94635674|NCT04244786|324128582|FG000|Overall Study|Adverse Event|0|||
94262165|NCT01794520|322754755|FG000|Overall Study|Adverse events- related to progression|0|||
94262166|NCT01794520|322754756|FG001|Overall Study|Adverse events- related to progression|0|||
94262167|NCT01794520|322754757|FG002|Overall Study|Adverse events- related to progression|1|||
94635675|NCT04244786|324128583|FG001|Overall Study|Adverse Event|0|||
94635676|NCT04244786|324128584|FG002|Overall Study|Adverse Event|2|||
94635677|NCT04244786|324128582|FG000|Overall Study|Withdrawal by Subject|0|||
94635678|NCT04244786|324128583|FG001|Overall Study|Withdrawal by Subject|0|||
94635679|NCT04244786|324128584|FG002|Overall Study|Withdrawal by Subject|5|||
94635680|NCT00623727|324128590|FG000|Double Blind (DB)|Adverse Event|1|||
94635681|NCT00623727|324128591|FG001|Double Blind (DB)|Adverse Event|3|||
94635682|NCT00623727|324128590|FG000|Double Blind (DB)|Physician Decision|0|||
94635683|NCT00623727|324128591|FG001|Double Blind (DB)|Physician Decision|1|||
94635684|NCT00623727|324128590|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
94635685|NCT00623727|324128591|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
94635686|NCT00623727|324128590|FG000|Double Blind (DB)|Lack of Efficacy|2|||
94635687|NCT00623727|324128591|FG001|Double Blind (DB)|Lack of Efficacy|2|||
94635688|NCT00623727|324128590|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
94635689|NCT00623727|324128591|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
94635690|NCT00623727|324128590|FG000|Double Blind (DB)|Lost to Follow-up|1|||
94635691|NCT00623727|324128591|FG001|Double Blind (DB)|Lost to Follow-up|1|||
94635692|NCT00623727|324128590|FG000|Double Blind (DB)|Protocol Violation|2|||
94635693|NCT00623727|324128591|FG001|Double Blind (DB)|Protocol Violation|2|||
94635694|NCT00623727|324128590|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
94635695|NCT00623727|324128591|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
94635696|NCT00623727|324128590|FG000|Open Label Follow-up|Study termination|0|||
94635697|NCT00623727|324128591|FG001|Open Label Follow-up|Study termination|6|||
94635698|NCT00623727|324128590|FG000|Open Label Follow-up|Participant convenience|0|||
94635699|NCT00623727|324128591|FG001|Open Label Follow-up|Participant convenience|1|||
94635700|NCT03220217|324128592|FG000|Overall Study|Withdrawal by Subject|0|||
94635701|NCT03220217|324128593|FG001|Overall Study|Withdrawal by Subject|1|||
94635702|NCT03220217|324128594|FG002|Overall Study|Withdrawal by Subject|0|||
94635703|NCT03220217|324128592|FG000|Overall Study|Subject Missed Procedure|0|||
94635704|NCT03220217|324128593|FG001|Overall Study|Subject Missed Procedure|0|||
94635705|NCT03220217|324128594|FG002|Overall Study|Subject Missed Procedure|1|||
94635706|NCT02734810|324128595|FG000|Overall Study|Adverse Event|1|||
94635707|NCT02734810|324128596|FG001|Overall Study|Adverse Event|0|||
94635708|NCT02734810|324128595|FG000|Overall Study|Lack of Efficacy|1|||
94635709|NCT02734810|324128596|FG001|Overall Study|Lack of Efficacy|0|||
94635710|NCT00903617|324128602|FG000|Overall Study|Adverse Event|0|||
94635711|NCT00903617|324128603|FG001|Overall Study|Adverse Event|1|||
94635712|NCT00903617|324128604|FG002|Overall Study|Adverse Event|1|||
94635713|NCT00903617|324128605|FG003|Overall Study|Adverse Event|0|||
94635714|NCT00903617|324128602|FG000|Overall Study|Protocol-defined stopping criteria|0|||
94635715|NCT00903617|324128603|FG001|Overall Study|Protocol-defined stopping criteria|2|||
94635716|NCT00903617|324128604|FG002|Overall Study|Protocol-defined stopping criteria|0|||
94635717|NCT00903617|324128605|FG003|Overall Study|Protocol-defined stopping criteria|0|||
94635718|NCT00903617|324128602|FG000|Overall Study|Lost to Follow-up|2|||
94635719|NCT00903617|324128603|FG001|Overall Study|Lost to Follow-up|0|||
94635720|NCT00903617|324128604|FG002|Overall Study|Lost to Follow-up|1|||
94635721|NCT00903617|324128605|FG003|Overall Study|Lost to Follow-up|1|||
94635722|NCT00903617|324128602|FG000|Overall Study|Withdrawal by Subject|1|||
94635723|NCT00903617|324128603|FG001|Overall Study|Withdrawal by Subject|2|||
94635724|NCT00903617|324128604|FG002|Overall Study|Withdrawal by Subject|3|||
94635725|NCT00903617|324128605|FG003|Overall Study|Withdrawal by Subject|0|||
94635726|NCT01104636|324128606|FG000|Overall Study|Lack of Efficacy|43|||
94635727|NCT01104636|324128606|FG000|Overall Study|Lost to Follow-up|24|||
94635728|NCT01104636|324128606|FG000|Overall Study|Withdrawal by Subject|4|||
94635729|NCT01104636|324128606|FG000|Overall Study|Other|43|||
94635730|NCT01104636|324128606|FG000|Overall Study|Study terminated by sponsor|1|||
94635731|NCT01104636|324128606|FG000|Overall Study|Pregnancy|2|||
94635732|NCT01104636|324128606|FG000|Overall Study|Adverse Event|40|||
94262168|NCT01794520|322754758|FG003|Overall Study|Adverse events- related to progression|2|||
94635733|NCT01104636|324128606|FG000|Overall Study|Ongoing|21|||
94635734|NCT01706003|324128607|FG000|Overall Study|Withdrawal by Subject|2|||
94635735|NCT01706003|324128608|FG001|Overall Study|Withdrawal by Subject|0|||
94635736|NCT01706003|324128607|FG000|Overall Study|Not scheduled|3|||
94635737|NCT01706003|324128608|FG001|Overall Study|Not scheduled|0|||
94635738|NCT01706003|324128607|FG000|Overall Study|Lost to Follow-up|6|||
94635739|NCT01706003|324128608|FG001|Overall Study|Lost to Follow-up|4|||
94635740|NCT03020407|324128609|FG000|Overall Study|Withdrawal by Subject|2|||
94635741|NCT03020407|324128610|FG001|Overall Study|Withdrawal by Subject|1|||
94635742|NCT03020407|324128609|FG000|Overall Study|Lost to Follow-up|2|||
94635743|NCT03020407|324128610|FG001|Overall Study|Lost to Follow-up|3|||
94635744|NCT03020407|324128609|FG000|Overall Study|Protocol Violation|0|||
94635745|NCT03020407|324128610|FG001|Overall Study|Protocol Violation|1|||
94635746|NCT02355691|324128611|FG000|Overall Study|Loss of Research Personnel|7|||
94262169|NCT01794520|322754759|FG004|Overall Study|Adverse events- related to progression|0|||
94262170|NCT01794520|322754760|FG005|Overall Study|Adverse events- related to progression|1|||
94262171|NCT01794520|322754761|FG006|Overall Study|Adverse events- related to progression|0|||
94262172|NCT01794520|322754755|FG000|Overall Study|Adverse event- not related to progression|1|||
94262173|NCT01794520|322754756|FG001|Overall Study|Adverse event- not related to progression|1|||
94262174|NCT01794520|322754757|FG002|Overall Study|Adverse event- not related to progression|0|||
94262175|NCT01794520|322754758|FG003|Overall Study|Adverse event- not related to progression|0|||
94262176|NCT01794520|322754759|FG004|Overall Study|Adverse event- not related to progression|2|||
94262177|NCT01794520|322754760|FG005|Overall Study|Adverse event- not related to progression|0|||
94262178|NCT01794520|322754761|FG006|Overall Study|Adverse event- not related to progression|0|||
94262179|NCT01794520|322754755|FG000|Overall Study|Progressive disease|5|||
94262180|NCT01794520|322754756|FG001|Overall Study|Progressive disease|6|||
94262181|NCT01794520|322754757|FG002|Overall Study|Progressive disease|2|||
94262182|NCT01794520|322754758|FG003|Overall Study|Progressive disease|5|||
94262183|NCT01794520|322754759|FG004|Overall Study|Progressive disease|27|||
94635747|NCT02355691|324128612|FG001|Overall Study|Loss of Research Personnel|9|||
94635748|NCT03232281|324128613|FG000|Overall Study|Adverse Event|1|||
94635749|NCT03232281|324128614|FG001|Overall Study|Adverse Event|1|||
94635750|NCT03232281|324128613|FG000|Overall Study|Withdrawal by Subject|5|||
94635751|NCT03232281|324128614|FG001|Overall Study|Withdrawal by Subject|4|||
94635752|NCT03232281|324128613|FG000|Overall Study|Protocol Deviation|1|||
94635753|NCT03232281|324128614|FG001|Overall Study|Protocol Deviation|1|||
94635754|NCT00462761|324128617|FG000|Overall Study|Adverse Event|6|||
94635755|NCT00462761|324128617|FG000|Overall Study|Withdrawal by Subject|9|||
94635756|NCT00462761|324128617|FG000|Overall Study|Physician Decision|5|||
94635757|NCT00462761|324128617|FG000|Overall Study|Disease progression|43|||
94635758|NCT00462761|324128617|FG000|Overall Study|Death|12|||
94635759|NCT00462761|324128617|FG000|Overall Study|Other|1|||
94635760|NCT01466348|324128618|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
94635761|NCT01466348|324128619|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
94635762|NCT02255981|324128622|FG000|Overall Study|Lost to Follow-up|3|||
94635763|NCT02255981|324128622|FG000|Overall Study|Withdrawal by Subject|1|||
94635764|NCT00518323|324128623|FG000|Overall Study|Lack of Efficacy|14|||
94635765|NCT00518323|324128624|FG001|Overall Study|Lack of Efficacy|2|||
94635766|NCT00518323|324128625|FG002|Overall Study|Lack of Efficacy|4|||
94635767|NCT00518323|324128626|FG003|Overall Study|Lack of Efficacy|20|||
94635768|NCT00518323|324128623|FG000|Overall Study|Withdrawal by Subject|1|||
94635769|NCT00518323|324128624|FG001|Overall Study|Withdrawal by Subject|2|||
94635770|NCT00518323|324128625|FG002|Overall Study|Withdrawal by Subject|4|||
94635771|NCT00518323|324128626|FG003|Overall Study|Withdrawal by Subject|2|||
94635772|NCT00518323|324128623|FG000|Overall Study|Lost to Follow-up|0|||
94635773|NCT00518323|324128624|FG001|Overall Study|Lost to Follow-up|2|||
94635774|NCT00518323|324128625|FG002|Overall Study|Lost to Follow-up|1|||
94635775|NCT00518323|324128626|FG003|Overall Study|Lost to Follow-up|3|||
94635776|NCT00518323|324128623|FG000|Overall Study|Adverse Event|1|||
94635777|NCT00518323|324128624|FG001|Overall Study|Adverse Event|1|||
94635778|NCT00518323|324128625|FG002|Overall Study|Adverse Event|1|||
94635779|NCT00518323|324128626|FG003|Overall Study|Adverse Event|0|||
94635780|NCT00518323|324128623|FG000|Overall Study|Prohibited medication and others|3|||
94635781|NCT00518323|324128624|FG001|Overall Study|Prohibited medication and others|1|||
94635782|NCT00518323|324128625|FG002|Overall Study|Prohibited medication and others|1|||
94635783|NCT00518323|324128626|FG003|Overall Study|Prohibited medication and others|0|||
94635784|NCT02672423|324128627|FG000|Period 1|Adverse Event|0|||
94635785|NCT02672423|324128628|FG001|Period 1|Adverse Event|0|||
94635786|NCT02672423|324128629|FG002|Period 1|Adverse Event|0|||
94635787|NCT02672423|324128630|FG003|Period 1|Adverse Event|0|||
94635788|NCT02672423|324128631|FG004|Period 1|Adverse Event|1|||
94635789|NCT02672423|324128632|FG005|Period 1|Adverse Event|0|||
94635790|NCT02672423|324128633|FG006|Period 1|Adverse Event|0|||
94635791|NCT02672423|324128634|FG007|Period 1|Adverse Event|0|||
94635792|NCT02672423|324128635|FG008|Period 1|Adverse Event|0|||
94635793|NCT02672423|324128636|FG009|Period 1|Adverse Event|0|||
94635794|NCT02672423|324128627|FG000|Period 2|Withdrawal by Subject|0|||
94635795|NCT02672423|324128628|FG001|Period 2|Withdrawal by Subject|0|||
94635796|NCT02672423|324128629|FG002|Period 2|Withdrawal by Subject|1|||
94635797|NCT02672423|324128630|FG003|Period 2|Withdrawal by Subject|0|||
94635798|NCT02672423|324128631|FG004|Period 2|Withdrawal by Subject|0|||
94635799|NCT02672423|324128632|FG005|Period 2|Withdrawal by Subject|0|||
94635800|NCT02672423|324128633|FG006|Period 2|Withdrawal by Subject|0|||
94635801|NCT02672423|324128634|FG007|Period 2|Withdrawal by Subject|0|||
94635802|NCT02672423|324128635|FG008|Period 2|Withdrawal by Subject|0|||
94635803|NCT02672423|324128636|FG009|Period 2|Withdrawal by Subject|0|||
94635804|NCT02672423|324128627|FG000|Period 3|Withdrawal by Subject|0|||
94635805|NCT02672423|324128628|FG001|Period 3|Withdrawal by Subject|0|||
94635806|NCT02672423|324128629|FG002|Period 3|Withdrawal by Subject|0|||
94635807|NCT02672423|324128630|FG003|Period 3|Withdrawal by Subject|0|||
94635808|NCT02672423|324128631|FG004|Period 3|Withdrawal by Subject|0|||
94635809|NCT02672423|324128632|FG005|Period 3|Withdrawal by Subject|0|||
94262184|NCT01794520|322754760|FG005|Overall Study|Progressive disease|18|||
94262185|NCT01794520|322754761|FG006|Overall Study|Progressive disease|0|||
94262186|NCT01794520|322754755|FG000|Overall Study|Withdrew consent|0|||
94262187|NCT01794520|322754756|FG001|Overall Study|Withdrew consent|0|||
94262188|NCT01794520|322754757|FG002|Overall Study|Withdrew consent|1|||
94262189|NCT01794520|322754758|FG003|Overall Study|Withdrew consent|1|||
94262190|NCT01794520|322754759|FG004|Overall Study|Withdrew consent|0|||
94262191|NCT01794520|322754760|FG005|Overall Study|Withdrew consent|0|||
94262192|NCT01794520|322754761|FG006|Overall Study|Withdrew consent|0|||
94262193|NCT01794520|322754755|FG000|Overall Study|Lost to Follow-up|0|||
94262194|NCT01794520|322754756|FG001|Overall Study|Lost to Follow-up|0|||
94262195|NCT01794520|322754757|FG002|Overall Study|Lost to Follow-up|0|||
94262196|NCT01794520|322754758|FG003|Overall Study|Lost to Follow-up|0|||
94262197|NCT01794520|322754759|FG004|Overall Study|Lost to Follow-up|1|||
94262198|NCT01794520|322754760|FG005|Overall Study|Lost to Follow-up|0|||
94262199|NCT01794520|322754761|FG006|Overall Study|Lost to Follow-up|0|||
94262200|NCT01794520|322754755|FG000|Overall Study|Toxicity|0|||
94262201|NCT01794520|322754756|FG001|Overall Study|Toxicity|2|||
94262202|NCT01794520|322754757|FG002|Overall Study|Toxicity|0|||
94262203|NCT01794520|322754758|FG003|Overall Study|Toxicity|0|||
94262204|NCT01794520|322754759|FG004|Overall Study|Toxicity|0|||
94262205|NCT01794520|322754760|FG005|Overall Study|Toxicity|0|||
94635810|NCT02672423|324128633|FG006|Period 3|Withdrawal by Subject|0|||
94635811|NCT02672423|324128634|FG007|Period 3|Withdrawal by Subject|1|||
94635812|NCT02672423|324128635|FG008|Period 3|Withdrawal by Subject|0|||
94635813|NCT02672423|324128636|FG009|Period 3|Withdrawal by Subject|0|||
94635814|NCT02672423|324128627|FG000|Period 3|Physician Decision|0|||
94635815|NCT02672423|324128628|FG001|Period 3|Physician Decision|0|||
94635816|NCT02672423|324128629|FG002|Period 3|Physician Decision|0|||
94635817|NCT02672423|324128630|FG003|Period 3|Physician Decision|0|||
94635818|NCT02672423|324128631|FG004|Period 3|Physician Decision|0|||
94635819|NCT02672423|324128632|FG005|Period 3|Physician Decision|1|||
94635820|NCT02672423|324128633|FG006|Period 3|Physician Decision|0|||
94635821|NCT02672423|324128634|FG007|Period 3|Physician Decision|0|||
94635822|NCT02672423|324128635|FG008|Period 3|Physician Decision|0|||
94635823|NCT02672423|324128636|FG009|Period 3|Physician Decision|0|||
94635824|NCT03880019|324128639|FG000|Overall Study|Competing disease|1|||
94635825|NCT02864251|324128640|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
94635826|NCT02864251|324128641|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
94635827|NCT02864251|324128642|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
94635828|NCT02864251|324128640|FG000|Pre-Treatment|Withdrawal by Participant|0|||
94635829|NCT02864251|324128641|FG001|Pre-Treatment|Withdrawal by Participant|0|||
94635830|NCT02864251|324128642|FG002|Pre-Treatment|Withdrawal by Participant|4|||
94635831|NCT02864251|324128640|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
94635832|NCT02864251|324128641|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
94635833|NCT02864251|324128642|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
94635834|NCT02864251|324128640|FG000|Pre-Treatment|Other Reasons|0|||
94635835|NCT02864251|324128641|FG001|Pre-Treatment|Other Reasons|1|||
94635836|NCT02864251|324128642|FG002|Pre-Treatment|Other Reasons|1|||
94635837|NCT02864251|324128640|FG000|Treatment|Disease Progression|109|||
94635838|NCT02864251|324128641|FG001|Treatment|Disease Progression|52|||
94635839|NCT02864251|324128642|FG002|Treatment|Disease Progression|101|||
94635840|NCT02864251|324128640|FG000|Treatment|Study Drug Toxicity|9|||
94635841|NCT02864251|324128641|FG001|Treatment|Study Drug Toxicity|4|||
94635842|NCT02864251|324128642|FG002|Treatment|Study Drug Toxicity|10|||
94635843|NCT02864251|324128640|FG000|Treatment|Death|0|||
94635844|NCT02864251|324128641|FG001|Treatment|Death|2|||
94635845|NCT02864251|324128642|FG002|Treatment|Death|3|||
94635846|NCT02864251|324128640|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
94635847|NCT02864251|324128641|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
94676605|NCT04899245|324269181|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
94676606|NCT04899245|324269179|FG000|Overall Study|No longer eligible - Moved away from area|2|||
94262206|NCT01794520|322754761|FG006|Overall Study|Toxicity|0|||
94262207|NCT01794520|322754755|FG000|Overall Study|Study terminated by sponsor|0|||
94262208|NCT01794520|322754756|FG001|Overall Study|Study terminated by sponsor|0|||
94262209|NCT01794520|322754757|FG002|Overall Study|Study terminated by sponsor|1|||
94262210|NCT01794520|322754758|FG003|Overall Study|Study terminated by sponsor|0|||
94635848|NCT02864251|324128642|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
94262211|NCT01794520|322754759|FG004|Overall Study|Study terminated by sponsor|1|||
94635849|NCT02864251|324128640|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
94635850|NCT02864251|324128641|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
94635851|NCT02864251|324128642|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
94635852|NCT02864251|324128640|FG000|Treatment|Withdrawal by Participant|8|||
94635853|NCT02864251|324128641|FG001|Treatment|Withdrawal by Participant|5|||
94635854|NCT02864251|324128642|FG002|Treatment|Withdrawal by Participant|13|||
94262212|NCT01794520|322754760|FG005|Overall Study|Study terminated by sponsor|0|||
94262213|NCT01794520|322754761|FG006|Overall Study|Study terminated by sponsor|7|||
94262214|NCT01794520|322754755|FG000|Overall Study|Death|0|||
94362734|NCT00572910|323112810|FG000|Overall Study|Withdrawal by Subject|3|||
94362735|NCT00572910|323112811|FG001|Overall Study|Withdrawal by Subject|0|||
94676607|NCT04899245|324269180|FG001|Overall Study|No longer eligible - Moved away from area|2|||
94676608|NCT04899245|324269181|FG002|Overall Study|No longer eligible - Moved away from area|0|||
94676609|NCT03804710|324269182|FG000|Overall Study|Adverse Event|0|||
94676610|NCT03804710|324269183|FG001|Overall Study|Adverse Event|3|||
94676611|NCT03804710|324269182|FG000|Overall Study|Withdrawal by Subject|2|||
94676612|NCT03804710|324269183|FG001|Overall Study|Withdrawal by Subject|1|||
94676613|NCT03804710|324269182|FG000|Overall Study|Other|0|||
94676614|NCT03804710|324269183|FG001|Overall Study|Other|1|||
94676615|NCT04987762|324269184|FG000|Overall Study|Study was Terminated by Sponsor|103|||
94676616|NCT01422408|324269185|FG000|Overall Study|Adverse Event|1|||
94676617|NCT01422408|324269185|FG000|Overall Study|Withdrawal by Subject|3|||
94676618|NCT01064297|324269201|FG000|Overall Study|Lost to Follow-up|791|||
94676619|NCT01064297|324269202|FG001|Overall Study|Lost to Follow-up|48|||
94676620|NCT01064297|324269203|FG002|Overall Study|Lost to Follow-up|133|||
94676621|NCT01685138|324269206|FG000|Overall Study|Lost to Follow-up|1|||
94676622|NCT01685138|324269206|FG000|Overall Study|Protocol Violation|1|||
94676623|NCT01685138|324269206|FG000|Overall Study|No longer requires treatment|1|||
94676624|NCT01685138|324269206|FG000|Overall Study|Subject/guardian decision|2|||
94676625|NCT01685138|324269206|FG000|Overall Study|Physician Decision|6|||
94676626|NCT01685138|324269206|FG000|Overall Study|Death|10|||
94676627|NCT01685138|324269206|FG000|Overall Study|Adverse Event|18|||
94676628|NCT01685138|324269206|FG000|Overall Study|Progressive disease|53|||
94676629|NCT02068495|324269215|FG000|Overall Study|Case Report Forms Uncollected|60|||
94676630|NCT02068495|324269215|FG000|Overall Study|Protocol Deviation|49|||
94676631|NCT00689026|324269218|FG000|Overall Study|Withdrawal by Subject|13|||
94676632|NCT00689026|324269219|FG001|Overall Study|Withdrawal by Subject|6|||
94676633|NCT01987817|324269220|FG000|Overall Study|Adverse Event|4|||
94676634|NCT01987817|324269221|FG001|Overall Study|Adverse Event|0|||
94676635|NCT01987817|324269220|FG000|Overall Study|Withdrawal by Subject|1|||
94676636|NCT01987817|324269221|FG001|Overall Study|Withdrawal by Subject|1|||
94676637|NCT01987817|324269220|FG000|Overall Study|Physician Decision|1|||
94362736|NCT00572910|323112812|FG002|Overall Study|Withdrawal by Subject|1|||
94362737|NCT00572910|323112813|FG003|Overall Study|Withdrawal by Subject|0|||
94362738|NCT00572910|323112814|FG004|Overall Study|Withdrawal by Subject|1|||
94362739|NCT00572910|323112815|FG005|Overall Study|Withdrawal by Subject|3|||
94676638|NCT01987817|324269221|FG001|Overall Study|Physician Decision|0|||
94676639|NCT04241094|324269233|FG000|Overall Study|Dropped out of treatment|4|||
94676640|NCT04241094|324269233|FG000|Overall Study|Ineligible after clinical assessment|2|||
94676641|NCT04241094|324269233|FG000|Overall Study|Lost to Follow-up|2|||
94676642|NCT02612064|324269234|FG000|Overall Study|Withdrawal by Subject|1|||
94676643|NCT02612064|324269235|FG001|Overall Study|Withdrawal by Subject|1|||
94676644|NCT02612064|324269234|FG000|Overall Study|Other|0|||
94676645|NCT02612064|324269235|FG001|Overall Study|Other|2|||
94676646|NCT01669798|324269238|FG000|Overall Study|Physician Decision|5|||
94676647|NCT02134587|324269239|FG000|Overall Study|Did not completed all meetings|30|||
94676648|NCT02453685|324269240|FG000|Overall Study|Adverse Event|0|||
94676649|NCT02453685|324269241|FG001|Overall Study|Adverse Event|1|||
94676650|NCT02453685|324269240|FG000|Overall Study|Protocol Violation|7|||
94676651|NCT02453685|324269241|FG001|Overall Study|Protocol Violation|4|||
94676652|NCT02453685|324269240|FG000|Overall Study|Lost to Follow-up|0|||
94676653|NCT02453685|324269241|FG001|Overall Study|Lost to Follow-up|1|||
94676654|NCT02453685|324269240|FG000|Overall Study|Withdrawal by Subject|8|||
94676655|NCT02453685|324269241|FG001|Overall Study|Withdrawal by Subject|4|||
94676656|NCT02453685|324269240|FG000|Overall Study|Unclassified|4|||
94676657|NCT02453685|324269241|FG001|Overall Study|Unclassified|2|||
94676658|NCT02390531|324269243|FG000|Overall Study|Death|0|||
94362740|NCT00572910|323112816|FG006|Overall Study|Withdrawal by Subject|0|||
94362741|NCT00572910|323112817|FG007|Overall Study|Withdrawal by Subject|2|||
94362742|NCT00572910|323112818|FG008|Overall Study|Withdrawal by Subject|2|||
94362743|NCT00572910|323112819|FG009|Overall Study|Withdrawal by Subject|2|||
94362744|NCT00572910|323112820|FG010|Overall Study|Withdrawal by Subject|1|||
94362745|NCT02723786|323112825|FG000|Overall Study|Lost to Follow-up|1|||
94676659|NCT02390531|324269244|FG001|Overall Study|Death|2|||
94676660|NCT02390531|324269245|FG002|Overall Study|Death|0|||
94676661|NCT02390531|324269246|FG003|Overall Study|Death|1|||
94461779|NCT00622336|323479623|FG000|Treatment Phase|Progression of Disease|181|||
94461780|NCT00622336|323479623|FG000|Treatment Phase|Adverse Event|46|||
94676662|NCT02390531|324269247|FG004|Overall Study|Death|0|||
94676663|NCT02390531|324269248|FG005|Overall Study|Death|0|||
94676664|NCT02390531|324269249|FG006|Overall Study|Death|0|||
94676665|NCT02390531|324269250|FG007|Overall Study|Death|1|||
94676666|NCT02390531|324269243|FG000|Overall Study|Protocol Violation|0|||
94676667|NCT02390531|324269244|FG001|Overall Study|Protocol Violation|0|||
94676668|NCT02390531|324269245|FG002|Overall Study|Protocol Violation|0|||
94676669|NCT02390531|324269246|FG003|Overall Study|Protocol Violation|0|||
94676670|NCT02390531|324269247|FG004|Overall Study|Protocol Violation|1|||
94676671|NCT02390531|324269248|FG005|Overall Study|Protocol Violation|0|||
94676672|NCT02390531|324269249|FG006|Overall Study|Protocol Violation|2|||
94676673|NCT02390531|324269250|FG007|Overall Study|Protocol Violation|0|||
94676674|NCT02618616|324269251|FG000|Overall Study|Lack of Efficacy|4|||
94676675|NCT02618616|324269252|FG001|Overall Study|Lack of Efficacy|0|||
94676676|NCT02618616|324269251|FG000|Overall Study|Pregnancy|0|||
94676677|NCT02618616|324269252|FG001|Overall Study|Pregnancy|1|||
94676678|NCT02618616|324269251|FG000|Overall Study|Adverse Event|8|||
94676679|NCT02618616|324269252|FG001|Overall Study|Adverse Event|0|||
94676680|NCT02618616|324269251|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
94676681|NCT02618616|324269252|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
94635855|NCT02864251|324128640|FG000|Treatment|Maximum Clinical Benefit|1|||
94635856|NCT02864251|324128641|FG001|Treatment|Maximum Clinical Benefit|0|||
94635857|NCT02864251|324128642|FG002|Treatment|Maximum Clinical Benefit|1|||
94635858|NCT02864251|324128640|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
94635859|NCT02864251|324128641|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
94635860|NCT02864251|324128642|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
94635861|NCT02864251|324128640|FG000|Treatment|Other Reasons|1|||
94635862|NCT02864251|324128641|FG001|Treatment|Other Reasons|1|||
94635863|NCT02864251|324128642|FG002|Treatment|Other Reasons|4|||
94635864|NCT02864251|324128640|FG000|Treatment|Administrative Reason by Sponsor|1|||
94635865|NCT02864251|324128641|FG001|Treatment|Administrative Reason by Sponsor|0|||
94635866|NCT02864251|324128642|FG002|Treatment|Administrative Reason by Sponsor|0|||
94635867|NCT01514760|324128643|FG000|Overall Study|Lost to Follow-up|2|||
94635868|NCT01454570|324128644|FG000|Overall Study|Withdrawal by Subject|2|||
94635869|NCT01454570|324128644|FG000|Overall Study|Screen Failure|7|||
94635870|NCT00885755|324128647|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
94635871|NCT00885755|324128648|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
94635872|NCT00885755|324128649|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
94635873|NCT00885755|324128647|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
94635874|NCT00885755|324128648|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
94635875|NCT00885755|324128649|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
94635876|NCT00885755|324128647|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
94635877|NCT00885755|324128648|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
94635878|NCT00885755|324128649|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
94635879|NCT00885755|324128647|FG000|Part I: Trastuzumab+Taxane|Death|0|||
94635880|NCT00885755|324128648|FG001|Part I: Trastuzumab+Taxane|Death|0|||
94635881|NCT00885755|324128649|FG002|Part I: Trastuzumab+Taxane|Death|1|||
94635882|NCT00885755|324128647|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
94635883|NCT00885755|324128648|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
94635884|NCT00885755|324128649|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
94635885|NCT02101775|324128650|FG000|Overall Study|Adverse Event|4|||
94635886|NCT02101775|324128651|FG001|Overall Study|Adverse Event|0|||
94635887|NCT02101775|324128652|FG002|Overall Study|Adverse Event|0|||
94635888|NCT02101775|324128650|FG000|Overall Study|Admission to Hospital|0|||
94635889|NCT02101775|324128651|FG001|Overall Study|Admission to Hospital|1|||
94635890|NCT02101775|324128652|FG002|Overall Study|Admission to Hospital|0|||
94635891|NCT02604212|324128656|FG000|Overall Study|Study Terminated by Sponsor|2|||
94635892|NCT02604212|324128657|FG001|Overall Study|Study Terminated by Sponsor|1|||
94635893|NCT02604212|324128658|FG002|Overall Study|Study Terminated by Sponsor|3|||
94635894|NCT02604212|324128659|FG003|Overall Study|Study Terminated by Sponsor|3|||
94635895|NCT02604212|324128656|FG000|Overall Study|Withdrawal by Subject|0|||
94635896|NCT02604212|324128657|FG001|Overall Study|Withdrawal by Subject|0|||
94635897|NCT02604212|324128658|FG002|Overall Study|Withdrawal by Subject|1|||
94635898|NCT02604212|324128659|FG003|Overall Study|Withdrawal by Subject|0|||
94635899|NCT00003492|324128660|FG000|Overall Study|Not evaluable|6|||
94635900|NCT00195676|324128666|FG000|Period O - Open-label Treatment|Adverse Event|82|||
94635901|NCT00195676|324128666|FG000|Period O - Open-label Treatment|Death|6|||
94635902|NCT00195676|324128666|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
94635903|NCT00195676|324128666|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
94635904|NCT00195676|324128666|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
94635905|NCT00195676|324128666|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
94635906|NCT00195676|324128666|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
94635907|NCT00195676|324128666|FG000|Period O - Open-label Treatment|Other reasons|68|||
94635908|NCT00195676|324128666|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
94635909|NCT00195676|324128666|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
94635910|NCT00195676|324128666|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
94676682|NCT02618616|324269251|FG000|Overall Study|Consent withdrawn by subject|8|||
94676683|NCT02618616|324269252|FG001|Overall Study|Consent withdrawn by subject|5|||
94676684|NCT02618616|324269251|FG000|Overall Study|Lost to Follow-up|0|||
94676685|NCT02618616|324269252|FG001|Overall Study|Lost to Follow-up|1|||
94635911|NCT00195676|324128666|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
94635912|NCT00195676|324128666|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
94635913|NCT00195676|324128666|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
94676686|NCT00459342|324269253|FG000|Overall Study|Not eligible|1|||
94635914|NCT00195676|324128666|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
94635915|NCT00195676|324128666|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
94635916|NCT00195676|324128666|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
94635917|NCT00195676|324128666|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
94635918|NCT00195676|324128666|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
94635919|NCT00195676|324128666|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
94635920|NCT00195676|324128666|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
94635921|NCT00309842|324128668|FG000|Overall Study|Lost to Follow-up|1|||
94676687|NCT04349280|324269257|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
94676688|NCT04349280|324269258|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
94635922|NCT02335099|324128669|FG000|Treatment|Withdrawal by Subject|1|||
94676689|NCT04349280|324269257|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
94676690|NCT04349280|324269258|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
94676691|NCT04349280|324269257|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
94676692|NCT04349280|324269258|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
94676693|NCT02532179|324271279|FG000|Overall Study|Lost to Follow-up|1|||
94676694|NCT02532179|324271279|FG000|Overall Study|Pregnancy|1|||
94676695|NCT02532179|324271279|FG000|Overall Study|Subject received depot steroid injection|1|||
94676696|NCT00847405|324271280|FG000|First Intervention|Adverse Event|0|||
94676697|NCT00847405|324271281|FG001|First Intervention|Adverse Event|1|||
94676698|NCT00847405|324271280|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
94676699|NCT00847405|324271281|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
94676700|NCT05178121|324271284|FG000|Overall Study|Other|4|||
94676701|NCT05178121|324271284|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
94676702|NCT00949884|324271285|FG000|Overall Study|Adverse Event|14|||
94676703|NCT00949884|324271286|FG001|Overall Study|Adverse Event|3|||
94676704|NCT00949884|324271287|FG002|Overall Study|Adverse Event|12|||
94676705|NCT00949884|324271285|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
94676706|NCT00949884|324271286|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
94676707|NCT00949884|324271287|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
94676708|NCT00949884|324271285|FG000|Overall Study|Lost to Follow-up|7|||
94676709|NCT00949884|324271286|FG001|Overall Study|Lost to Follow-up|5|||
94676710|NCT00949884|324271287|FG002|Overall Study|Lost to Follow-up|5|||
94676711|NCT00949884|324271285|FG000|Overall Study|Physician Decision|5|||
94676712|NCT00949884|324271286|FG001|Overall Study|Physician Decision|0|||
94676713|NCT00949884|324271287|FG002|Overall Study|Physician Decision|6|||
94676714|NCT00949884|324271285|FG000|Overall Study|Treatment non-compliance|5|||
94676715|NCT00949884|324271286|FG001|Overall Study|Treatment non-compliance|0|||
94676716|NCT00949884|324271287|FG002|Overall Study|Treatment non-compliance|8|||
94676717|NCT00949884|324271285|FG000|Overall Study|Withdrawal by Subject|13|||
94676718|NCT00949884|324271286|FG001|Overall Study|Withdrawal by Subject|4|||
94676719|NCT00949884|324271287|FG002|Overall Study|Withdrawal by Subject|16|||
94676720|NCT00949884|324271285|FG000|Overall Study|Lack of Efficacy|4|||
94676721|NCT00949884|324271286|FG001|Overall Study|Lack of Efficacy|2|||
94676722|NCT00949884|324271287|FG002|Overall Study|Lack of Efficacy|7|||
94676723|NCT00949884|324271285|FG000|Overall Study|Study terminated by sponsor|0|||
94676724|NCT00949884|324271286|FG001|Overall Study|Study terminated by sponsor|0|||
94676725|NCT00949884|324271287|FG002|Overall Study|Study terminated by sponsor|1|||
94676726|NCT00245102|324271288|FG000|Overall Study|Not Treated|1|||
94676727|NCT00245102|324271289|FG001|Overall Study|Not Treated|0|||
94676728|NCT00245102|324271290|FG002|Overall Study|Not Treated|1|||
94676729|NCT00245102|324271291|FG003|Overall Study|Not Treated|0|||
94676730|NCT00245102|324271292|FG004|Overall Study|Not Treated|0|||
94676731|NCT00245102|324271293|FG005|Overall Study|Not Treated|0|||
94676732|NCT00245102|324271288|FG000|Overall Study|Protocol Violation|1|||
94676733|NCT00245102|324271289|FG001|Overall Study|Protocol Violation|0|||
94676734|NCT00245102|324271290|FG002|Overall Study|Protocol Violation|0|||
94676735|NCT00245102|324271291|FG003|Overall Study|Protocol Violation|0|||
94676736|NCT00245102|324271292|FG004|Overall Study|Protocol Violation|0|||
94676737|NCT00245102|324271293|FG005|Overall Study|Protocol Violation|0|||
94676738|NCT00245102|324271288|FG000|Overall Study|Death|0|||
94676739|NCT00245102|324271289|FG001|Overall Study|Death|0|||
94676740|NCT00245102|324271290|FG002|Overall Study|Death|0|||
94676741|NCT00245102|324271291|FG003|Overall Study|Death|1|||
94676742|NCT00245102|324271292|FG004|Overall Study|Death|0|||
94262215|NCT01794520|322754756|FG001|Overall Study|Death|0|||
94262216|NCT01794520|322754757|FG002|Overall Study|Death|0|||
94262217|NCT01794520|322754758|FG003|Overall Study|Death|0|||
94676743|NCT00245102|324271293|FG005|Overall Study|Death|0|||
94262218|NCT01794520|322754759|FG004|Overall Study|Death|1|||
94262219|NCT01794520|322754760|FG005|Overall Study|Death|0|||
94262220|NCT01794520|322754761|FG006|Overall Study|Death|22|||
94676744|NCT00245102|324271288|FG000|Overall Study|Adverse Event|4|||
94676745|NCT00245102|324271289|FG001|Overall Study|Adverse Event|2|||
94676746|NCT00245102|324271290|FG002|Overall Study|Adverse Event|5|||
94262221|NCT01794520|322754755|FG000|Overall Study|Other, not specified|0|||
94676747|NCT00245102|324271291|FG003|Overall Study|Adverse Event|1|||
94676748|NCT00245102|324271292|FG004|Overall Study|Adverse Event|0|||
94635923|NCT02335099|324128670|FG001|Treatment|Withdrawal by Subject|3|||
94635924|NCT02335099|324128669|FG000|Treatment|Lost to Follow-up|2|||
94635925|NCT02335099|324128670|FG001|Treatment|Lost to Follow-up|0|||
94635926|NCT02335099|324128669|FG000|Treatment|Death|1|||
94635927|NCT02335099|324128670|FG001|Treatment|Death|0|||
94635928|NCT02335099|324128669|FG000|Treatment|Adverse Event|1|||
94635929|NCT02335099|324128670|FG001|Treatment|Adverse Event|2|||
94635930|NCT02335099|324128669|FG000|Follow-up|Death|0|||
94635931|NCT02335099|324128670|FG001|Follow-up|Death|1|||
94635932|NCT03519347|324128671|FG000|Interventional Crossover Period 1|Death|0|||
94635933|NCT03519347|324128672|FG001|Interventional Crossover Period 1|Death|0|||
94635934|NCT03519347|324128673|FG002|Interventional Crossover Period 1|Death|0|||
94635935|NCT03519347|324128674|FG003|Interventional Crossover Period 1|Death|1|||
94635936|NCT00484939|324128677|FG000|Overall Study|Death|9|||
94635937|NCT00484939|324128678|FG001|Overall Study|Death|13|||
94635938|NCT00484939|324128677|FG000|Overall Study|Adverse Event|22|||
94635939|NCT00484939|324128678|FG001|Overall Study|Adverse Event|12|||
94635940|NCT00484939|324128677|FG000|Overall Study|Patient Withdrew Consent|19|||
94635941|NCT00484939|324128678|FG001|Overall Study|Patient Withdrew Consent|10|||
94635942|NCT00484939|324128677|FG000|Overall Study|Protocol Violation|3|||
94635943|NCT00484939|324128678|FG001|Overall Study|Protocol Violation|3|||
94635944|NCT00484939|324128677|FG000|Overall Study|Lost to Follow-up|0|||
94635945|NCT00484939|324128678|FG001|Overall Study|Lost to Follow-up|3|||
94635946|NCT00484939|324128677|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
94635947|NCT00484939|324128678|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
94635948|NCT00484939|324128677|FG000|Overall Study|Disease progression|67|||
94262222|NCT01794520|322754756|FG001|Overall Study|Other, not specified|0|||
94262223|NCT01794520|322754757|FG002|Overall Study|Other, not specified|1|||
94262224|NCT01794520|322754758|FG003|Overall Study|Other, not specified|1|||
94262225|NCT01794520|322754759|FG004|Overall Study|Other, not specified|4|||
94262226|NCT01794520|322754760|FG005|Overall Study|Other, not specified|1|||
94262227|NCT01794520|322754761|FG006|Overall Study|Other, not specified|2|||
94262228|NCT02276872|322754762|FG000|Overall Study|Adverse Event|1|||
94262229|NCT02276872|322754763|FG001|Overall Study|Adverse Event|0|||
94262230|NCT02276872|322754764|FG002|Overall Study|Adverse Event|0|||
94262231|NCT04356183|322754768|FG000|Overall Study|Lost to Follow-up|1|||
94262232|NCT04356183|322754769|FG001|Overall Study|Lost to Follow-up|0|||
94262233|NCT04356183|322754768|FG000|Overall Study|Withdrawal by Subject|1|||
94262234|NCT04356183|322754769|FG001|Overall Study|Withdrawal by Subject|1|||
94262235|NCT01146054|322754772|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
94262236|NCT01146054|322754772|FG000|Overall Study|Rapid tumor progression|2|||
94262237|NCT01146054|322754772|FG000|Overall Study|Other illness precluded treatment|2|||
94262238|NCT01146054|322754772|FG000|Overall Study|Lost to Follow-up|1|||
94262239|NCT00402363|322754773|FG000|Overall Study|Adverse Event|9|||
94262240|NCT00402363|322754774|FG001|Overall Study|Adverse Event|14|||
94362746|NCT01244516|323112834|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
94362747|NCT01244516|323112835|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
94362748|NCT01244516|323112836|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
94362749|NCT01244516|323112834|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
94362750|NCT01244516|323112835|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
94362751|NCT01244516|323112836|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
94635949|NCT00484939|324128678|FG001|Overall Study|Disease progression|88|||
94635950|NCT00484939|324128677|FG000|Overall Study|Screen Failure|2|||
94362752|NCT01244516|323112834|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
94362753|NCT01244516|323112835|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
94362754|NCT01244516|323112836|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
94362755|NCT01244516|323112834|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
94362756|NCT01244516|323112835|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
94362757|NCT01244516|323112836|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
94362758|NCT01244516|323112834|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
94362759|NCT01244516|323112835|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
94461781|NCT00622336|323479623|FG000|Treatment Phase|Other|40|||
94635951|NCT00484939|324128678|FG001|Overall Study|Screen Failure|2|||
94635952|NCT00484939|324128677|FG000|Overall Study|Reason Not Specified|11|||
94635953|NCT00484939|324128678|FG001|Overall Study|Reason Not Specified|6|||
94635954|NCT02677987|324128679|FG000|Overall Study|Withdrawal by Subject|3|||
94635955|NCT02677987|324128680|FG001|Overall Study|Withdrawal by Subject|0|||
94635956|NCT02677987|324128679|FG000|Overall Study|Lost to Follow-up|1|||
94635957|NCT02677987|324128680|FG001|Overall Study|Lost to Follow-up|0|||
94635958|NCT01082965|324128681|FG000|Overall Study|Protocol Violation|0|||
94635959|NCT01082965|324128682|FG001|Overall Study|Protocol Violation|1|||
94262241|NCT00402363|322754775|FG002|Overall Study|Adverse Event|2|||
94262242|NCT00402363|322754776|FG003|Overall Study|Adverse Event|2|||
94262243|NCT00402363|322754773|FG000|Overall Study|Withdrew Consent|10|||
94262244|NCT00402363|322754774|FG001|Overall Study|Withdrew Consent|5|||
94635960|NCT01082965|324128681|FG000|Overall Study|Other|1|||
94635961|NCT01082965|324128682|FG001|Overall Study|Other|1|||
94676749|NCT00245102|324271293|FG005|Overall Study|Adverse Event|2|||
94676750|NCT00245102|324271288|FG000|Overall Study|Decline in performance|0|||
94676751|NCT00245102|324271289|FG001|Overall Study|Decline in performance|2|||
94676752|NCT00245102|324271290|FG002|Overall Study|Decline in performance|0|||
94676753|NCT00245102|324271291|FG003|Overall Study|Decline in performance|1|||
94676754|NCT00245102|324271292|FG004|Overall Study|Decline in performance|0|||
94635962|NCT02587065|324128683|FG000|Overall Study|Adverse Event|14|||
94635963|NCT02587065|324128683|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
94676755|NCT00245102|324271293|FG005|Overall Study|Decline in performance|2|||
94676756|NCT00245102|324271288|FG000|Overall Study|Participant needed surgery|0|||
94676757|NCT00245102|324271289|FG001|Overall Study|Participant needed surgery|0|||
94676758|NCT00245102|324271290|FG002|Overall Study|Participant needed surgery|1|||
94676759|NCT00245102|324271291|FG003|Overall Study|Participant needed surgery|0|||
94676760|NCT00245102|324271292|FG004|Overall Study|Participant needed surgery|0|||
94635964|NCT02587065|324128683|FG000|Overall Study|Non-adherence to the Protocol|3|||
94635965|NCT02587065|324128683|FG000|Overall Study|Discontinuation of Study Medication|2|||
94635966|NCT02587065|324128683|FG000|Overall Study|Reason not Specified|3|||
94635967|NCT01559012|324128686|FG000|Overall Study|Withdrawal by Subject|0|||
94635968|NCT01559012|324128687|FG001|Overall Study|Withdrawal by Subject|1|||
94635969|NCT00946712|324128688|FG000|Overall Study|Adverse Event|118|||
94635970|NCT00946712|324128689|FG001|Overall Study|Adverse Event|124|||
94635971|NCT00946712|324128688|FG000|Overall Study|Disease progression|308|||
94635972|NCT00946712|324128689|FG001|Overall Study|Disease progression|404|||
94635973|NCT00946712|324128688|FG000|Overall Study|Death|21|||
94676761|NCT00245102|324271293|FG005|Overall Study|Participant needed surgery|0|||
94676762|NCT00245102|324271288|FG000|Overall Study|Clinical progression|1|||
94676763|NCT00245102|324271289|FG001|Overall Study|Clinical progression|0|||
94676764|NCT00245102|324271290|FG002|Overall Study|Clinical progression|0|||
94676765|NCT00245102|324271291|FG003|Overall Study|Clinical progression|0|||
94676766|NCT00245102|324271292|FG004|Overall Study|Clinical progression|0|||
94262245|NCT00402363|322754775|FG002|Overall Study|Withdrew Consent|2|||
94262246|NCT00402363|322754776|FG003|Overall Study|Withdrew Consent|1|||
94262247|NCT00402363|322754773|FG000|Overall Study|Protocol Violation|3|||
94262248|NCT00402363|322754774|FG001|Overall Study|Protocol Violation|5|||
94262249|NCT00402363|322754775|FG002|Overall Study|Protocol Violation|0|||
94262250|NCT00402363|322754776|FG003|Overall Study|Protocol Violation|3|||
94262251|NCT00402363|322754773|FG000|Overall Study|Lost to Follow-up|5|||
94262252|NCT00402363|322754774|FG001|Overall Study|Lost to Follow-up|4|||
94262253|NCT00402363|322754775|FG002|Overall Study|Lost to Follow-up|0|||
94262254|NCT00402363|322754776|FG003|Overall Study|Lost to Follow-up|2|||
94262255|NCT00402363|322754773|FG000|Overall Study|"Captured as Other"|6|||
94262256|NCT00402363|322754774|FG001|Overall Study|"Captured as Other"|2|||
94262257|NCT00402363|322754775|FG002|Overall Study|"Captured as Other"|2|||
94262258|NCT00402363|322754776|FG003|Overall Study|"Captured as Other"|2|||
94262259|NCT00293722|322754785|FG000|Overall Study|Other|427|||
94262260|NCT00818389|322754792|FG000|Overall Study|Death|1|||
94262261|NCT00818389|322754793|FG001|Overall Study|Death|3|||
94262262|NCT00818389|322754792|FG000|Overall Study|ALS Disease Progression|1|||
94262263|NCT00818389|322754793|FG001|Overall Study|ALS Disease Progression|0|||
94262264|NCT00818389|322754792|FG000|Overall Study|Withdrawal by Subject|2|||
94262265|NCT00818389|322754793|FG001|Overall Study|Withdrawal by Subject|2|||
94262266|NCT00818389|322754792|FG000|Overall Study|Adverse Event|0|||
94262267|NCT00818389|322754793|FG001|Overall Study|Adverse Event|1|||
94262268|NCT01137955|322754794|FG000|Overall Study|Withdrawal by Subject|5|||
94262269|NCT01137955|322754795|FG001|Overall Study|Withdrawal by Subject|4|||
94262270|NCT05193500|322754798|FG000|Overall Study|Withdrawal by Subject|7|||
94262271|NCT05193500|322754799|FG001|Overall Study|Withdrawal by Subject|4|||
94635974|NCT00946712|324128689|FG001|Overall Study|Death|22|||
94635975|NCT00946712|324128688|FG000|Overall Study|No treatment given|25|||
94635976|NCT00946712|324128689|FG001|Overall Study|No treatment given|29|||
94635977|NCT00946712|324128688|FG000|Overall Study|Other reasons|61|||
94635978|NCT00946712|324128689|FG001|Overall Study|Other reasons|73|||
94635979|NCT00946712|324128688|FG000|Overall Study|On Treatment|0|||
94635980|NCT00946712|324128689|FG001|Overall Study|On Treatment|4|||
94676767|NCT00245102|324271293|FG005|Overall Study|Clinical progression|0|||
94676768|NCT04737109|324271294|FG000|Study Treatment|Disease Progression|5|||
94461782|NCT00622336|323479623|FG000|Treatment Phase|Death|14|||
94635981|NCT00946712|324128688|FG000|Overall Study|Ineligible|14|||
94676769|NCT04737109|324271295|FG001|Study Treatment|Disease Progression|0|||
94262272|NCT05193500|322754800|FG002|Overall Study|Withdrawal by Subject|3|||
94262273|NCT05193500|322754801|FG003|Overall Study|Withdrawal by Subject|5|||
94262274|NCT04098068|322754802|FG000|Overall Study|Disease Progression|7|||
94262275|NCT04098068|322754802|FG000|Overall Study|Withdrawal by Subject|2|||
94262276|NCT04098068|322754802|FG000|Overall Study|New Cancer Diagnosis|1|||
94635982|NCT00946712|324128689|FG001|Overall Study|Ineligible|6|||
94635983|NCT00853723|324128692|FG000|Overall Study|Adverse Event|3|||
94676770|NCT04737109|324271296|FG002|Study Treatment|Disease Progression|0|||
94676771|NCT04737109|324271297|FG003|Study Treatment|Disease Progression|0|||
94262277|NCT02310672|322754803|FG000|Overall Study|Death|1|||
94262278|NCT02310672|322754803|FG000|Overall Study|Lost to Follow-up|1|||
94262279|NCT02310672|322754803|FG000|Overall Study|Withdrawal by Subject|1|||
94262280|NCT02310672|322754803|FG000|Overall Study|Sponsor's decision|12|||
94262281|NCT01106014|322754804|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
94262282|NCT01106014|322754805|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
94262283|NCT01106014|322754804|FG000|Overall Study|Adverse Event|78|||
94262284|NCT01106014|322754805|FG001|Overall Study|Adverse Event|42|||
94262285|NCT01106014|322754804|FG000|Overall Study|Withdrawal by Subject|43|||
94262286|NCT01106014|322754805|FG001|Overall Study|Withdrawal by Subject|37|||
94262287|NCT01106014|322754804|FG000|Overall Study|Administrative reason|7|||
94262288|NCT01106014|322754805|FG001|Overall Study|Administrative reason|6|||
94262289|NCT01106014|322754804|FG000|Overall Study|Lost to Follow-up|2|||
94262290|NCT01106014|322754805|FG001|Overall Study|Lost to Follow-up|3|||
94262291|NCT01862640|322754807|FG000|Overall Study|Adverse Event|4|||
94262292|NCT01862640|322754808|FG001|Overall Study|Adverse Event|10|||
94262293|NCT01862640|322754809|FG002|Overall Study|Adverse Event|6|||
94262294|NCT01862640|322754810|FG003|Overall Study|Adverse Event|8|||
94262295|NCT01862640|322754807|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
94262296|NCT01862640|322754808|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
94262297|NCT01862640|322754809|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
94262298|NCT01862640|322754810|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
94262299|NCT01862640|322754807|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
94262300|NCT01862640|322754808|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
94262301|NCT01862640|322754809|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
94635984|NCT00853723|324128693|FG001|Overall Study|Adverse Event|4|||
94635985|NCT00853723|324128694|FG002|Overall Study|Adverse Event|1|||
94635986|NCT00853723|324128692|FG000|Overall Study|Withdrawal by Subject|2|||
94635987|NCT00853723|324128693|FG001|Overall Study|Withdrawal by Subject|1|||
94635988|NCT00853723|324128694|FG002|Overall Study|Withdrawal by Subject|0|||
94635989|NCT00853723|324128692|FG000|Overall Study|Protocol Violation|1|||
94635990|NCT00853723|324128693|FG001|Overall Study|Protocol Violation|2|||
94635991|NCT00853723|324128694|FG002|Overall Study|Protocol Violation|1|||
94635992|NCT00445965|324128697|FG000|Overall Study|Adverse Event|2|||
94635993|NCT00445965|324128697|FG000|Overall Study|Physician Decision|1|||
94635994|NCT00445965|324128697|FG000|Overall Study|Enrolled but not treated|1|||
94635995|NCT00445965|324128697|FG000|Overall Study|Removed due to progressive disease|29|||
94635996|NCT01848756|324128703|FG000|Overall Study|Adverse Event|1|||
94635997|NCT01848756|324128703|FG000|Overall Study|Withdrawal by Subject|1|||
94635998|NCT01848756|324128703|FG000|Overall Study|Enrolled in Error|1|||
94635999|NCT02075658|324128706|FG000|Overall Study|Physician Decision|2|||
94636000|NCT02075658|324128707|FG001|Overall Study|Physician Decision|2|||
94636001|NCT01286012|324128708|FG000|Overall Study|Adverse Event|3|||
94636002|NCT01286012|324128709|FG001|Overall Study|Adverse Event|3|||
94636003|NCT01286012|324128708|FG000|Overall Study|Death|2|||
94636004|NCT01286012|324128709|FG001|Overall Study|Death|3|||
94636005|NCT01286012|324128708|FG000|Overall Study|Protocol Violation|1|||
94636006|NCT01286012|324128709|FG001|Overall Study|Protocol Violation|1|||
94636007|NCT01286012|324128708|FG000|Overall Study|Withdrawal by Subject|4|||
94636008|NCT01286012|324128709|FG001|Overall Study|Withdrawal by Subject|4|||
94636009|NCT01286012|324128708|FG000|Overall Study|Physician Decision|2|||
94636010|NCT01286012|324128709|FG001|Overall Study|Physician Decision|0|||
94636011|NCT01286012|324128708|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
94636012|NCT01286012|324128709|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
94636013|NCT01367158|324128710|FG000|Overall Study|Withdrew consent|0|||
94636014|NCT01367158|324128711|FG001|Overall Study|Withdrew consent|2|||
94636015|NCT01367158|324128712|FG002|Overall Study|Withdrew consent|1|||
94636016|NCT01367158|324128713|FG003|Overall Study|Withdrew consent|0|||
94676772|NCT04737109|324271294|FG000|Study Treatment|Death on study|1|||
94676773|NCT04737109|324271295|FG001|Study Treatment|Death on study|0|||
94262302|NCT01862640|322754810|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
94262303|NCT01862640|322754807|FG000|Overall Study|Withdrawal by Subject|2|||
94262304|NCT01862640|322754808|FG001|Overall Study|Withdrawal by Subject|4|||
94262305|NCT01862640|322754809|FG002|Overall Study|Withdrawal by Subject|8|||
94461783|NCT00622336|323479623|FG000|Treatment Phase|Lack of therapeutic effect|13|||
94262306|NCT01862640|322754810|FG003|Overall Study|Withdrawal by Subject|5|||
94461784|NCT00622336|323479623|FG000|Treatment Phase|Withdrawal by Subject|13|||
94461785|NCT00622336|323479623|FG000|Treatment Phase|Lost to Follow-up|2|||
94461786|NCT00622336|323479623|FG000|Extension Phase|Adverse Event|2|||
94461787|NCT00622336|323479623|FG000|Extension Phase|Progressive Disease|6|||
94461788|NCT00622336|323479623|FG000|Extension Phase|Lack of therapeutic effect|2|||
94461789|NCT00622336|323479623|FG000|Extension Phase|Withdrawal by Subject|1|||
94461790|NCT00622336|323479623|FG000|Extension Phase|Lost to Follow-up|1|||
94461791|NCT00622336|323479623|FG000|Extension Phase|Other|9|||
94262307|NCT01862640|322754807|FG000|Overall Study|Protocol Deviation|0|||
94262308|NCT01862640|322754808|FG001|Overall Study|Protocol Deviation|0|||
94636017|NCT01367158|324128714|FG004|Overall Study|Withdrew consent|2|||
94676774|NCT04737109|324271296|FG002|Study Treatment|Death on study|0|||
94676775|NCT04737109|324271297|FG003|Study Treatment|Death on study|0|||
94676776|NCT02293395|324271300|FG000|Overall Study|Lost to Follow-up|1|||
94676777|NCT02293395|324271301|FG001|Overall Study|Lost to Follow-up|0|||
94676778|NCT02293395|324271300|FG000|Overall Study|Withdrawal by Subject|8|||
94676779|NCT02293395|324271301|FG001|Overall Study|Withdrawal by Subject|7|||
94676780|NCT00800202|324271311|FG000|Overall Study|Adverse Event|7|||
94676781|NCT00800202|324271312|FG001|Overall Study|Adverse Event|6|||
94676782|NCT00800202|324271311|FG000|Overall Study|Death|1|||
94676783|NCT00800202|324271312|FG001|Overall Study|Death|0|||
94676784|NCT00800202|324271311|FG000|Overall Study|Other|5|||
94676785|NCT00800202|324271312|FG001|Overall Study|Other|0|||
94676786|NCT00800202|324271311|FG000|Overall Study|Disease Progression|54|||
94676787|NCT00800202|324271312|FG001|Overall Study|Disease Progression|18|||
94676788|NCT00261495|324271316|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
94676789|NCT00261495|324271317|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
94676790|NCT00261495|324271316|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
94676791|NCT00261495|324271317|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
94676792|NCT00261495|324271316|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
94676793|NCT00261495|324271317|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
94676794|NCT00261495|324271316|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
94676795|NCT00261495|324271317|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
94676796|NCT00261495|324271316|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
94676797|NCT00261495|324271317|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
94676798|NCT00261495|324271316|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
94676799|NCT00261495|324271317|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
94676800|NCT00261495|324271316|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
94676801|NCT00261495|324271317|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
94676802|NCT00261495|324271316|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
94676803|NCT00261495|324271317|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
94676804|NCT00261495|324271316|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
94676805|NCT00261495|324271317|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
94676806|NCT00261495|324271316|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
94676807|NCT00261495|324271317|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
94676808|NCT00261495|324271316|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
94676809|NCT00261495|324271317|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
94676810|NCT00261495|324271316|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
94676811|NCT00261495|324271317|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
94676812|NCT00261495|324271316|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
94676813|NCT00261495|324271317|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
94676814|NCT00261495|324271316|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
94676815|NCT00261495|324271317|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
94676816|NCT00261495|324271316|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
94676817|NCT00261495|324271317|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
94676818|NCT00261495|324271316|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
94676819|NCT00261495|324271317|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
94676820|NCT00261495|324271316|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
94676821|NCT00261495|324271317|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
94676822|NCT00261495|324271316|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
94676823|NCT00261495|324271317|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
94676824|NCT00261495|324271316|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
94262309|NCT01862640|322754809|FG002|Overall Study|Protocol Deviation|1|||
94262310|NCT01862640|322754810|FG003|Overall Study|Protocol Deviation|0|||
94262311|NCT01641809|322754811|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
94262312|NCT01641809|322754812|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
94262313|NCT01641809|322754813|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
94262314|NCT01641809|322754814|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
94262315|NCT01641809|322754811|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
94262316|NCT01641809|322754812|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
94676825|NCT00261495|324271317|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
94676826|NCT00261495|324271316|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
94262317|NCT01641809|322754813|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
94262318|NCT01641809|322754814|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
94262319|NCT01641809|322754811|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
94676827|NCT00261495|324271317|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
94262320|NCT01641809|322754812|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
94262321|NCT01641809|322754813|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
94676828|NCT00261495|324271316|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
94676829|NCT00261495|324271317|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
94676830|NCT01424930|324271318|FG000|Overall Study|Adverse Event|0|||
94676831|NCT01424930|324271319|FG001|Overall Study|Adverse Event|1|||
94262322|NCT01641809|322754814|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
94262323|NCT01641809|322754811|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
94262324|NCT01641809|322754812|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
94262325|NCT01641809|322754813|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
94262326|NCT01641809|322754814|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
94262327|NCT01641809|322754811|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
94262328|NCT01641809|322754812|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
94262329|NCT01641809|322754813|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
94262330|NCT01641809|322754814|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
94262331|NCT01641809|322754811|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
94262332|NCT01641809|322754812|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
94262333|NCT01641809|322754813|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
94262334|NCT01641809|322754814|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
94262335|NCT01641809|322754811|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
94262336|NCT01641809|322754812|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
94461792|NCT04450407|323479624|FG000|Overall Study|Withdrawal by Subject|10|||
94461793|NCT04450407|323479625|FG001|Overall Study|Withdrawal by Subject|1|||
94461794|NCT04450407|323479626|FG002|Overall Study|Withdrawal by Subject|4|||
94461795|NCT04450407|323479624|FG000|Overall Study|Adverse Event|0|||
94461796|NCT04450407|323479625|FG001|Overall Study|Adverse Event|0|||
94461797|NCT04450407|323479626|FG002|Overall Study|Adverse Event|1|||
94461798|NCT04450407|323479624|FG000|Overall Study|Lost to Follow-up|1|||
94461799|NCT04450407|323479625|FG001|Overall Study|Lost to Follow-up|0|||
94461800|NCT04450407|323479626|FG002|Overall Study|Lost to Follow-up|0|||
94461801|NCT04450407|323479624|FG000|Overall Study|Physician Decision|0|||
94461802|NCT04450407|323479625|FG001|Overall Study|Physician Decision|0|||
94461803|NCT04450407|323479626|FG002|Overall Study|Physician Decision|1|||
94461804|NCT04450407|323479624|FG000|Overall Study|Pregnancy|1|||
94461805|NCT04450407|323479625|FG001|Overall Study|Pregnancy|0|||
94461806|NCT04450407|323479626|FG002|Overall Study|Pregnancy|0|||
94461807|NCT04450407|323479624|FG000|Overall Study|Protocol Violation|2|||
94461808|NCT04450407|323479625|FG001|Overall Study|Protocol Violation|0|||
94461809|NCT04450407|323479626|FG002|Overall Study|Protocol Violation|0|||
94461810|NCT04450407|323479624|FG000|Overall Study|Investigational site terminated by sponsor|3|||
94461811|NCT04450407|323479625|FG001|Overall Study|Investigational site terminated by sponsor|0|||
94461812|NCT04450407|323479626|FG002|Overall Study|Investigational site terminated by sponsor|2|||
94461813|NCT01959698|323479628|FG000|Overall Study|Adverse Event|0|||
94461814|NCT01959698|323479629|FG001|Overall Study|Adverse Event|0|||
94461815|NCT01959698|323479630|FG002|Overall Study|Adverse Event|0|||
94461816|NCT01959698|323479631|FG003|Overall Study|Adverse Event|0|||
94461817|NCT01959698|323479632|FG004|Overall Study|Adverse Event|0|||
94461818|NCT01959698|323479633|FG005|Overall Study|Adverse Event|0|||
94461819|NCT01959698|323479634|FG006|Overall Study|Adverse Event|1|||
94461820|NCT01959698|323479628|FG000|Overall Study|Physician Decision|1|||
94461821|NCT01959698|323479629|FG001|Overall Study|Physician Decision|0|||
94461822|NCT01959698|323479630|FG002|Overall Study|Physician Decision|1|||
94461823|NCT01959698|323479631|FG003|Overall Study|Physician Decision|2|||
94461824|NCT01959698|323479632|FG004|Overall Study|Physician Decision|0|||
94461825|NCT01959698|323479633|FG005|Overall Study|Physician Decision|3|||
94461826|NCT01959698|323479634|FG006|Overall Study|Physician Decision|3|||
94461827|NCT00778102|323479635|FG000|Overall Study|Adverse Event|8|||
94461828|NCT00778102|323479636|FG001|Overall Study|Adverse Event|5|||
94461829|NCT00778102|323479635|FG000|Overall Study|Death|1|||
94461830|NCT00778102|323479636|FG001|Overall Study|Death|1|||
94636018|NCT01367158|324128715|FG005|Overall Study|Withdrew consent|0|||
94636019|NCT01367158|324128716|FG006|Overall Study|Withdrew consent|0|||
94262337|NCT01641809|322754813|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
94262338|NCT01641809|322754814|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
94262339|NCT01641809|322754811|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
94461831|NCT00778102|323479635|FG000|Overall Study|Lost to Follow-up|1|||
94461832|NCT00778102|323479636|FG001|Overall Study|Lost to Follow-up|0|||
94461833|NCT00778102|323479635|FG000|Overall Study|Violation of Selection Criteria|1|||
94461834|NCT00778102|323479636|FG001|Overall Study|Violation of Selection Criteria|1|||
94461835|NCT00778102|323479635|FG000|Overall Study|Protocol Violation|0|||
94461836|NCT00778102|323479636|FG001|Overall Study|Protocol Violation|1|||
94461837|NCT00778102|323479635|FG000|Overall Study|Refused Treatment|2|||
94461838|NCT00778102|323479636|FG001|Overall Study|Refused Treatment|3|||
94362760|NCT01244516|323112836|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
94362761|NCT01244516|323112834|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
94362762|NCT01244516|323112835|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
94362763|NCT01244516|323112836|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
94362764|NCT01244516|323112834|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
94362765|NCT01244516|323112835|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
94362766|NCT01244516|323112836|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
94362767|NCT01125358|323112839|FG000|Overall Study|Adverse Event|3|||
94362768|NCT01125358|323112840|FG001|Overall Study|Adverse Event|0|||
94362769|NCT01125358|323112841|FG002|Overall Study|Adverse Event|0|||
94362770|NCT01125358|323112842|FG003|Overall Study|Adverse Event|2|||
94362771|NCT01125358|323112839|FG000|Overall Study|Perceived Lack of Efficacy|6|||
94362772|NCT01125358|323112840|FG001|Overall Study|Perceived Lack of Efficacy|3|||
94362773|NCT01125358|323112841|FG002|Overall Study|Perceived Lack of Efficacy|7|||
94636020|NCT01367158|324128717|FG007|Overall Study|Withdrew consent|1|||
94636021|NCT01367158|324128718|FG008|Overall Study|Withdrew consent|0|||
94636022|NCT01367158|324128719|FG009|Overall Study|Withdrew consent|0|||
94636023|NCT01367158|324128720|FG010|Overall Study|Withdrew consent|0|||
94636024|NCT01367158|324128710|FG000|Overall Study|Lost to Follow-up|0|||
94636025|NCT01367158|324128711|FG001|Overall Study|Lost to Follow-up|0|||
94636026|NCT01367158|324128712|FG002|Overall Study|Lost to Follow-up|0|||
94636027|NCT01367158|324128713|FG003|Overall Study|Lost to Follow-up|1|||
94636028|NCT01367158|324128714|FG004|Overall Study|Lost to Follow-up|0|||
94636029|NCT01367158|324128715|FG005|Overall Study|Lost to Follow-up|2|||
94636030|NCT01367158|324128716|FG006|Overall Study|Lost to Follow-up|0|||
94636031|NCT01367158|324128717|FG007|Overall Study|Lost to Follow-up|1|||
94636032|NCT01367158|324128718|FG008|Overall Study|Lost to Follow-up|0|||
94636033|NCT01367158|324128719|FG009|Overall Study|Lost to Follow-up|0|||
94636034|NCT01367158|324128720|FG010|Overall Study|Lost to Follow-up|1|||
94636035|NCT01367158|324128710|FG000|Overall Study|Protocol Violation|0|||
94636036|NCT01367158|324128711|FG001|Overall Study|Protocol Violation|1|||
94636037|NCT01367158|324128712|FG002|Overall Study|Protocol Violation|0|||
94636038|NCT01367158|324128713|FG003|Overall Study|Protocol Violation|0|||
94636039|NCT01367158|324128714|FG004|Overall Study|Protocol Violation|0|||
94636040|NCT01367158|324128715|FG005|Overall Study|Protocol Violation|0|||
94636041|NCT01367158|324128716|FG006|Overall Study|Protocol Violation|0|||
94636042|NCT01367158|324128717|FG007|Overall Study|Protocol Violation|0|||
94636043|NCT01367158|324128718|FG008|Overall Study|Protocol Violation|0|||
94636044|NCT01367158|324128719|FG009|Overall Study|Protocol Violation|0|||
94636045|NCT01367158|324128720|FG010|Overall Study|Protocol Violation|0|||
94636046|NCT02446990|324128721|FG000|Overall Study|Death|485|||
94636047|NCT02446990|324128722|FG001|Overall Study|Death|458|||
94636048|NCT02446990|324128721|FG000|Overall Study|Lost to Follow-up|3|||
94636049|NCT02446990|324128722|FG001|Overall Study|Lost to Follow-up|1|||
94636050|NCT02446990|324128721|FG000|Overall Study|Physician Decision|1|||
94636051|NCT02446990|324128722|FG001|Overall Study|Physician Decision|0|||
94636052|NCT02446990|324128721|FG000|Overall Study|Withdrawal by Subject|231|||
94636053|NCT02446990|324128722|FG001|Overall Study|Withdrawal by Subject|199|||
94636054|NCT01064401|324128726|FG000|Overall Study|Adverse Event|47|||
94636055|NCT01064401|324128727|FG001|Overall Study|Adverse Event|56|||
94636056|NCT01064401|324128726|FG000|Overall Study|Lack of Efficacy|46|||
94636057|NCT01064401|324128727|FG001|Overall Study|Lack of Efficacy|23|||
94636058|NCT01064401|324128726|FG000|Overall Study|Lost to Follow-up|12|||
94636059|NCT01064401|324128727|FG001|Overall Study|Lost to Follow-up|9|||
94636060|NCT01064401|324128726|FG000|Overall Study|Consent Withdrawn|98|||
94636061|NCT01064401|324128727|FG001|Overall Study|Consent Withdrawn|80|||
94636062|NCT01064401|324128726|FG000|Overall Study|Investigator Decision|4|||
94636063|NCT01064401|324128727|FG001|Overall Study|Investigator Decision|6|||
94636064|NCT01064401|324128726|FG000|Overall Study|Death|4|||
94636065|NCT01064401|324128727|FG001|Overall Study|Death|0|||
94636066|NCT01064401|324128726|FG000|Overall Study|Pregnancy|4|||
94636067|NCT01064401|324128727|FG001|Overall Study|Pregnancy|7|||
94636068|NCT01064401|324128726|FG000|Overall Study|Noncompliance|7|||
94636069|NCT01064401|324128727|FG001|Overall Study|Noncompliance|8|||
94676832|NCT01424930|324271318|FG000|Overall Study|Death|1|||
94362774|NCT01125358|323112842|FG003|Overall Study|Perceived Lack of Efficacy|4|||
94362775|NCT01125358|323112839|FG000|Overall Study|Protocol Violation|1|||
94362776|NCT01125358|323112840|FG001|Overall Study|Protocol Violation|0|||
94636070|NCT01064401|324128726|FG000|Overall Study|Site Closure|4|||
94636071|NCT01064401|324128727|FG001|Overall Study|Site Closure|5|||
94636072|NCT01064401|324128726|FG000|Overall Study|Other|2|||
94362777|NCT01125358|323112841|FG002|Overall Study|Protocol Violation|0|||
94636073|NCT01064401|324128727|FG001|Overall Study|Other|1|||
94636074|NCT00323115|324128730|FG000|Vaccine Administration|Adverse Event|1|||
94636075|NCT00323115|324128730|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
94636076|NCT02005250|324128731|FG000|Overall Study|Lost to Follow-up|15|||
94636077|NCT02005250|324128732|FG001|Overall Study|Lost to Follow-up|5|||
94636078|NCT02921776|324128738|FG000|Overall Study|patient deterioration, fatigue|2|||
94636079|NCT02921776|324128739|FG001|Overall Study|patient deterioration, fatigue|6|||
94676833|NCT01424930|324271319|FG001|Overall Study|Death|0|||
94676834|NCT01424930|324271318|FG000|Overall Study|Progressive Disease|3|||
94676835|NCT01424930|324271319|FG001|Overall Study|Progressive Disease|6|||
94676836|NCT01424930|324271318|FG000|Overall Study|Screen Failure|0|||
94676837|NCT01424930|324271319|FG001|Overall Study|Screen Failure|1|||
94676838|NCT01424930|324271318|FG000|Overall Study|Reason not specified|0|||
94676839|NCT01424930|324271319|FG001|Overall Study|Reason not specified|6|||
94676840|NCT04493931|324271320|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
94676841|NCT04493931|324271321|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
94676842|NCT04493931|324271322|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
94676843|NCT04493931|324271323|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
94676844|NCT04493931|324271324|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
94676845|NCT04493931|324271325|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
94262340|NCT01641809|322754812|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
94262341|NCT01641809|322754813|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
94262342|NCT01641809|322754814|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
94262343|NCT01641809|322754811|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
94262344|NCT01641809|322754812|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
94262345|NCT01641809|322754813|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
94262346|NCT01641809|322754814|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
94262347|NCT01641809|322754811|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
94262348|NCT01641809|322754812|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
94262349|NCT01641809|322754813|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
94262350|NCT01641809|322754814|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
94262351|NCT01641809|322754811|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
94262352|NCT01641809|322754812|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
94262353|NCT01641809|322754813|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
94262354|NCT01641809|322754814|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
94262355|NCT01641809|322754811|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
94262356|NCT01641809|322754812|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
94262357|NCT01641809|322754813|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
94262358|NCT01641809|322754814|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
94262359|NCT01641809|322754811|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
94262360|NCT01641809|322754812|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
94262361|NCT01641809|322754813|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
94262362|NCT01641809|322754814|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
94262363|NCT01641809|322754811|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
94262364|NCT01641809|322754812|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
94262365|NCT01641809|322754813|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
94262366|NCT01641809|322754814|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
94262367|NCT01641809|322754811|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
94636080|NCT02921776|324128740|FG002|Overall Study|patient deterioration, fatigue|0|||
94636081|NCT02921776|324128741|FG003|Overall Study|patient deterioration, fatigue|0|||
94636082|NCT02921776|324128742|FG004|Overall Study|patient deterioration, fatigue|0|||
94636083|NCT02921776|324128743|FG005|Overall Study|patient deterioration, fatigue|0|||
94636084|NCT02921776|324128744|FG006|Overall Study|patient deterioration, fatigue|0|||
94636085|NCT02921776|324128745|FG007|Overall Study|patient deterioration, fatigue|0|||
94636086|NCT02921776|324128738|FG000|Overall Study|Withdrawal by Subject|0|||
94636087|NCT02921776|324128739|FG001|Overall Study|Withdrawal by Subject|2|||
94636088|NCT02921776|324128740|FG002|Overall Study|Withdrawal by Subject|0|||
94636089|NCT02921776|324128741|FG003|Overall Study|Withdrawal by Subject|1|||
94636090|NCT02921776|324128742|FG004|Overall Study|Withdrawal by Subject|1|||
94636091|NCT02921776|324128743|FG005|Overall Study|Withdrawal by Subject|0|||
94636092|NCT02921776|324128744|FG006|Overall Study|Withdrawal by Subject|8|||
94636093|NCT02921776|324128745|FG007|Overall Study|Withdrawal by Subject|1|||
94636094|NCT02921776|324128738|FG000|Overall Study|Death|0|||
94636095|NCT02921776|324128739|FG001|Overall Study|Death|0|||
94636096|NCT02921776|324128740|FG002|Overall Study|Death|0|||
94636097|NCT02921776|324128741|FG003|Overall Study|Death|2|||
94636098|NCT02921776|324128742|FG004|Overall Study|Death|0|||
94636099|NCT02921776|324128743|FG005|Overall Study|Death|0|||
94636100|NCT02921776|324128744|FG006|Overall Study|Death|0|||
94636101|NCT02921776|324128745|FG007|Overall Study|Death|0|||
94636102|NCT02921776|324128738|FG000|Overall Study|extubation or early discharge|0|||
94636103|NCT02921776|324128739|FG001|Overall Study|extubation or early discharge|0|||
94676846|NCT04493931|324271326|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
94676847|NCT04493931|324271320|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
94636104|NCT02921776|324128740|FG002|Overall Study|extubation or early discharge|0|||
94636105|NCT02921776|324128741|FG003|Overall Study|extubation or early discharge|5|||
94636106|NCT02921776|324128742|FG004|Overall Study|extubation or early discharge|5|||
94636107|NCT02921776|324128743|FG005|Overall Study|extubation or early discharge|0|||
94636108|NCT02921776|324128744|FG006|Overall Study|extubation or early discharge|0|||
94636109|NCT02921776|324128745|FG007|Overall Study|extubation or early discharge|0|||
94636110|NCT02921776|324128738|FG000|Overall Study|Lost to Follow-up|0|||
94636111|NCT02921776|324128739|FG001|Overall Study|Lost to Follow-up|0|||
94636112|NCT02921776|324128740|FG002|Overall Study|Lost to Follow-up|0|||
94636113|NCT02921776|324128741|FG003|Overall Study|Lost to Follow-up|0|||
94636114|NCT02921776|324128742|FG004|Overall Study|Lost to Follow-up|0|||
94636115|NCT02921776|324128743|FG005|Overall Study|Lost to Follow-up|2|||
94636116|NCT02921776|324128744|FG006|Overall Study|Lost to Follow-up|3|||
94636117|NCT02921776|324128745|FG007|Overall Study|Lost to Follow-up|6|||
94636118|NCT02946047|324128746|FG000|Overall Study|Adverse Event|1|||
94636119|NCT02946047|324128747|FG001|Overall Study|Adverse Event|0|||
94636120|NCT02946047|324128748|FG002|Overall Study|Adverse Event|0|||
94636121|NCT02946047|324128749|FG003|Overall Study|Adverse Event|0|||
94636122|NCT01894581|324128750|FG000|Overall Study|Withdrawal by Subject|2|||
94636123|NCT01894581|324128751|FG001|Overall Study|Withdrawal by Subject|3|||
94636124|NCT01894581|324128750|FG000|Overall Study|Screen Failure|3|||
94636125|NCT01894581|324128751|FG001|Overall Study|Screen Failure|4|||
94636126|NCT04814433|324128754|FG000|Overall Study|Survey not returned|4|||
94636127|NCT04814433|324128755|FG001|Overall Study|Survey not returned|8|||
94636128|NCT04814433|324128756|FG002|Overall Study|Survey not returned|4|||
94636129|NCT04814433|324128757|FG003|Overall Study|Survey not returned|5|||
94636130|NCT03482791|324128758|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
94636131|NCT03482791|324128759|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
94636132|NCT02750592|324130653|FG000|Overall Study|Adverse Event|3|||
94636133|NCT02750592|324130653|FG000|Overall Study|Lack of Efficacy|2|||
94636134|NCT01042236|324130654|FG000|Treatment Period 1|Adverse Event|0|||
94636135|NCT01042236|324130655|FG001|Treatment Period 1|Adverse Event|1|||
94636136|NCT01042236|324130656|FG002|Treatment Period 1|Adverse Event|0|||
94636137|NCT01042236|324130657|FG003|Treatment Period 1|Adverse Event|0|||
94636138|NCT01042236|324130658|FG004|Treatment Period 1|Adverse Event|1|||
94636139|NCT01042236|324130659|FG005|Treatment Period 1|Adverse Event|0|||
94636140|NCT01042236|324130654|FG000|Treatment Period 3|Adverse Event|0|||
94636141|NCT01042236|324130655|FG001|Treatment Period 3|Adverse Event|0|||
94636142|NCT01042236|324130656|FG002|Treatment Period 3|Adverse Event|0|||
94636143|NCT01042236|324130657|FG003|Treatment Period 3|Adverse Event|1|||
94636144|NCT01042236|324130658|FG004|Treatment Period 3|Adverse Event|0|||
94636145|NCT01042236|324130659|FG005|Treatment Period 3|Adverse Event|0|||
94636146|NCT01042236|324130654|FG000|Treatment Period 3|Protocol Violation|0|||
94636147|NCT01042236|324130655|FG001|Treatment Period 3|Protocol Violation|0|||
94636148|NCT01042236|324130656|FG002|Treatment Period 3|Protocol Violation|0|||
94636149|NCT01042236|324130657|FG003|Treatment Period 3|Protocol Violation|1|||
94636150|NCT01042236|324130658|FG004|Treatment Period 3|Protocol Violation|0|||
94636151|NCT01042236|324130659|FG005|Treatment Period 3|Protocol Violation|0|||
94636152|NCT01372501|324130665|FG000|Overall Study|Adverse Event|4|||
94636153|NCT01372501|324130665|FG000|Overall Study|Device migration|1|||
94636154|NCT01541969|324130666|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
94636155|NCT01541969|324130667|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
94636156|NCT01541969|324130666|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
94636157|NCT01541969|324130667|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
94636158|NCT01541969|324130666|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
94636159|NCT01541969|324130667|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
94636160|NCT01541969|324130666|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
94636161|NCT01541969|324130667|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
94636162|NCT01541969|324130666|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
94636163|NCT01541969|324130667|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
94636164|NCT01541969|324130666|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
94636165|NCT01541969|324130667|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
94636166|NCT01541969|324130666|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
94636167|NCT01541969|324130667|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
94636168|NCT01541969|324130666|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
94262368|NCT01641809|322754812|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
94262369|NCT01641809|322754813|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
94262370|NCT01641809|322754814|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
94262371|NCT01641809|322754811|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
94262372|NCT01641809|322754812|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
94636169|NCT01541969|324130667|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
94636170|NCT01541969|324130666|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
94636171|NCT01541969|324130667|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
94636172|NCT01541969|324130666|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
94636173|NCT01541969|324130667|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
94636174|NCT02522286|324130668|FG000|Overall Study|Withdrawal by Subject|3|||
94262373|NCT01641809|322754813|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
94262374|NCT01641809|322754814|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
94262375|NCT01641809|322754811|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
94262376|NCT01641809|322754812|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
94262377|NCT01641809|322754813|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
94262378|NCT01641809|322754814|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
94636175|NCT02522286|324130669|FG001|Overall Study|Withdrawal by Subject|0|||
94636176|NCT02522286|324130670|FG002|Overall Study|Withdrawal by Subject|0|||
94636177|NCT02522286|324130671|FG003|Overall Study|Withdrawal by Subject|3|||
94636178|NCT03970733|324130672|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
94636179|NCT03970733|324130673|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
94636180|NCT03970733|324130674|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
94636181|NCT03970733|324130675|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
94636182|NCT03970733|324130676|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
94636183|NCT03970733|324130672|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
94636184|NCT03970733|324130673|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
94636185|NCT03970733|324130674|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
94636186|NCT03970733|324130675|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
94636187|NCT03970733|324130676|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
94636188|NCT03970733|324130672|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
94636189|NCT03970733|324130673|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
94636190|NCT03970733|324130674|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
94636191|NCT03970733|324130675|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
94636192|NCT03970733|324130676|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
94636193|NCT03970733|324130672|FG000|Main Study Phase (18 Months)|Other|1|||
94636194|NCT03970733|324130673|FG001|Main Study Phase (18 Months)|Other|1|||
94636195|NCT03970733|324130674|FG002|Main Study Phase (18 Months)|Other|0|||
94636196|NCT03970733|324130675|FG003|Main Study Phase (18 Months)|Other|0|||
94636197|NCT03970733|324130676|FG004|Main Study Phase (18 Months)|Other|0|||
94636198|NCT03970733|324130672|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
94636199|NCT03970733|324130673|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
94636200|NCT03970733|324130674|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
94636201|NCT03970733|324130675|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
94636202|NCT03970733|324130676|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
94636203|NCT02189473|324130680|FG000|Overall Study|Death|22|||
94636204|NCT02189473|324130681|FG001|Overall Study|Death|23|||
94636205|NCT02189473|324130680|FG000|Overall Study|Lost to Follow-up|1|||
94636206|NCT02189473|324130681|FG001|Overall Study|Lost to Follow-up|2|||
94636207|NCT01955161|324130682|FG000|Overall Study|Withdrawal before treatment|2|||
94636208|NCT01955161|324130683|FG001|Overall Study|Withdrawal before treatment|0|||
94636209|NCT01955161|324130684|FG002|Overall Study|Withdrawal before treatment|1|||
94636210|NCT01955161|324130682|FG000|Overall Study|Adverse Event|10|||
94636211|NCT01955161|324130683|FG001|Overall Study|Adverse Event|14|||
94636212|NCT01955161|324130684|FG002|Overall Study|Adverse Event|15|||
94636213|NCT01955161|324130682|FG000|Overall Study|Death|1|||
94636214|NCT01955161|324130683|FG001|Overall Study|Death|1|||
94636215|NCT01955161|324130684|FG002|Overall Study|Death|3|||
94636216|NCT01955161|324130682|FG000|Overall Study|Withdrawal by Subject|9|||
94636217|NCT01955161|324130683|FG001|Overall Study|Withdrawal by Subject|8|||
94636218|NCT01955161|324130684|FG002|Overall Study|Withdrawal by Subject|12|||
94636219|NCT01955161|324130682|FG000|Overall Study|Protocol Violation|2|||
94636220|NCT01955161|324130683|FG001|Overall Study|Protocol Violation|0|||
94636221|NCT01955161|324130684|FG002|Overall Study|Protocol Violation|0|||
94636222|NCT01955161|324130682|FG000|Overall Study|Other reason: physician decision|0|||
94636223|NCT01955161|324130683|FG001|Overall Study|Other reason: physician decision|1|||
94636224|NCT01955161|324130684|FG002|Overall Study|Other reason: physician decision|1|||
94636225|NCT01955161|324130682|FG000|Overall Study|Other reason: disallowed medication|1|||
94636226|NCT01955161|324130683|FG001|Overall Study|Other reason: disallowed medication|0|||
94636227|NCT01955161|324130684|FG002|Overall Study|Other reason: disallowed medication|1|||
94636228|NCT01955161|324130682|FG000|Overall Study|Other reason: caregiver unavailable|1|||
94262379|NCT01641809|322754811|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
94262380|NCT01641809|322754812|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
94636229|NCT01955161|324130683|FG001|Overall Study|Other reason: caregiver unavailable|0|||
94636230|NCT01955161|324130684|FG002|Overall Study|Other reason: caregiver unavailable|0|||
94636231|NCT01955161|324130682|FG000|Overall Study|Other reason: moved to nursing home|0|||
94636232|NCT01955161|324130683|FG001|Overall Study|Other reason: moved to nursing home|1|||
94262381|NCT01641809|322754813|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
94461839|NCT00778102|323479635|FG000|Overall Study|Withdrawal by Subject|1|||
94636233|NCT01955161|324130684|FG002|Overall Study|Other reason: moved to nursing home|0|||
94636234|NCT01955161|324130682|FG000|Overall Study|Other reason: insufficient compliance|0|||
94676848|NCT04493931|324271321|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
94636235|NCT01955161|324130683|FG001|Overall Study|Other reason: insufficient compliance|0|||
94636236|NCT01955161|324130684|FG002|Overall Study|Other reason: insufficient compliance|1|||
94636237|NCT01955161|324130682|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
94636238|NCT01955161|324130683|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
94636239|NCT01955161|324130684|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
94636240|NCT01955161|324130682|FG000|Overall Study|Other reason: patient's will|0|||
94636241|NCT01955161|324130683|FG001|Overall Study|Other reason: patient's will|0|||
94636242|NCT01955161|324130684|FG002|Overall Study|Other reason: patient's will|1|||
94636243|NCT04608500|324130687|FG000|Overall Study|Adverse Event|2|||
94636244|NCT04608500|324130688|FG001|Overall Study|Adverse Event|0|||
94636245|NCT04608500|324130687|FG000|Overall Study|Lost to Follow-up|15|||
94636246|NCT04608500|324130688|FG001|Overall Study|Lost to Follow-up|9|||
94636247|NCT04608500|324130687|FG000|Overall Study|Participant request|11|||
94636248|NCT04608500|324130688|FG001|Overall Study|Participant request|7|||
94636249|NCT04608500|324130687|FG000|Overall Study|Protocol Violation|1|||
94636250|NCT04608500|324130688|FG001|Overall Study|Protocol Violation|0|||
94636251|NCT04608500|324130687|FG000|Overall Study|Other|6|||
94636252|NCT04608500|324130688|FG001|Overall Study|Other|2|||
94636253|NCT04865354|324130695|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
94636254|NCT04865354|324130696|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
94636255|NCT04865354|324130695|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
94636256|NCT04865354|324130696|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
94636257|NCT04865354|324130695|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
94636258|NCT04865354|324130696|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
94636259|NCT00573755|324130697|FG000|Overall Study|Still receiving treatment|1|||
94636260|NCT00573755|324130698|FG001|Overall Study|Still receiving treatment|0|||
94636261|NCT01465022|324130699|FG000|Overall Study|Lost to Follow-up|15|||
94636262|NCT01465022|324130700|FG001|Overall Study|Lost to Follow-up|14|||
94636263|NCT01465022|324130701|FG002|Overall Study|Lost to Follow-up|0|||
94636264|NCT01465022|324130699|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
94636265|NCT01465022|324130700|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
94636266|NCT01465022|324130701|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
94636267|NCT01465022|324130699|FG000|Overall Study|Not Randomized|0|||
94636268|NCT01465022|324130700|FG001|Overall Study|Not Randomized|0|||
94636269|NCT01465022|324130701|FG002|Overall Study|Not Randomized|70|||
94636270|NCT04475588|324130702|FG000|Overall Study|Adverse Event|2|||
94636271|NCT04475588|324130703|FG001|Overall Study|Adverse Event|0|||
94636272|NCT03287804|324130718|FG000|Overall Study|Death|1|||
94636273|NCT03287804|324130718|FG000|Overall Study|Physician Decision|2|||
94636274|NCT03287804|324130718|FG000|Overall Study|Progressive disease|8|||
94636275|NCT01996826|324130720|FG000|Overall Study|Lost to Follow-up|6|||
94636276|NCT01996826|324130721|FG001|Overall Study|Lost to Follow-up|2|||
94636277|NCT01996826|324130720|FG000|Overall Study|Physician Decision|1|||
94636278|NCT01996826|324130721|FG001|Overall Study|Physician Decision|1|||
94636279|NCT00326950|324130723|FG000|Overall Study|Progressive Disease|1|||
94636280|NCT02092662|324130724|FG000|Overall Study|Lost to Follow-up|13|||
94636281|NCT02092662|324130725|FG001|Overall Study|Lost to Follow-up|0|||
94636282|NCT01266460|324130726|FG000|Overall Study|Adverse Event|3|||
94636283|NCT01266460|324130726|FG000|Overall Study|Withdrawal by Subject|5|||
94636284|NCT01266460|324130726|FG000|Overall Study|Disease Progression|18|||
94636285|NCT01266460|324130726|FG000|Overall Study|Not otherwise specified|8|||
94636286|NCT01050257|324130732|FG000|Overall Study|Adverse Event|4|||
94636287|NCT01050257|324130733|FG001|Overall Study|Adverse Event|4|||
94636288|NCT01050257|324130734|FG002|Overall Study|Adverse Event|2|||
94636289|NCT01050257|324130732|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
94636290|NCT01050257|324130733|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
94636291|NCT01050257|324130734|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
94636292|NCT01050257|324130732|FG000|Overall Study|Withdrawal by Subject|0|||
94636293|NCT01050257|324130733|FG001|Overall Study|Withdrawal by Subject|3|||
94636294|NCT01050257|324130734|FG002|Overall Study|Withdrawal by Subject|0|||
94636295|NCT01050257|324130732|FG000|Overall Study|No reason specified|0|||
94636296|NCT01050257|324130733|FG001|Overall Study|No reason specified|0|||
94636297|NCT01050257|324130734|FG002|Overall Study|No reason specified|2|||
94636298|NCT01050257|324130732|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
94636299|NCT01050257|324130733|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
94636300|NCT01050257|324130734|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
94636301|NCT01050257|324130732|FG000|Overall Study|Violation criteria|0|||
94636302|NCT01050257|324130733|FG001|Overall Study|Violation criteria|1|||
94636303|NCT01050257|324130734|FG002|Overall Study|Violation criteria|0|||
94636304|NCT01050257|324130732|FG000|Overall Study|Failure to return|0|||
94636305|NCT01050257|324130733|FG001|Overall Study|Failure to return|2|||
94636306|NCT01050257|324130734|FG002|Overall Study|Failure to return|0|||
94636307|NCT01050257|324130732|FG000|Overall Study|Death|0|||
94636308|NCT01050257|324130733|FG001|Overall Study|Death|0|||
94636309|NCT01050257|324130734|FG002|Overall Study|Death|1|||
94636310|NCT00720057|324130735|FG000|Overall Study|Lost to Follow-up|0|||
94636311|NCT00720057|324130736|FG001|Overall Study|Lost to Follow-up|2|||
94636312|NCT00720057|324130735|FG000|Overall Study|Protocol Violation|1|||
94636313|NCT00720057|324130736|FG001|Overall Study|Protocol Violation|0|||
94636314|NCT00720057|324130735|FG000|Overall Study|Withdrawal by Subject|0|||
94636315|NCT00720057|324130736|FG001|Overall Study|Withdrawal by Subject|1|||
94636316|NCT01679002|324130739|FG000|Overall Study|Adverse Event|1|||
94636317|NCT01679002|324130740|FG001|Overall Study|Adverse Event|1|||
94636318|NCT01679002|324130741|FG002|Overall Study|Adverse Event|0|||
94636319|NCT00597766|324130748|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
94636320|NCT00597766|324130749|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
94636321|NCT00597766|324130750|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
94636322|NCT00597766|324130748|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
94636323|NCT00597766|324130749|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
94636324|NCT00597766|324130750|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
94636325|NCT00071760|324130751|FG000|Overall Study|Adverse Event|2|||
94636326|NCT00071760|324130752|FG001|Overall Study|Adverse Event|1|||
94636327|NCT00071760|324130751|FG000|Overall Study|Lost to Follow-up|0|||
94636328|NCT00071760|324130752|FG001|Overall Study|Lost to Follow-up|3|||
94636329|NCT00071760|324130751|FG000|Overall Study|Protocol Violation|1|||
94636330|NCT00071760|324130752|FG001|Overall Study|Protocol Violation|0|||
94636331|NCT00071760|324130751|FG000|Overall Study|Withdrawal by Subject|0|||
94636332|NCT00071760|324130752|FG001|Overall Study|Withdrawal by Subject|1|||
94636333|NCT00071760|324130751|FG000|Overall Study|Insufficient Viral Load Response|1|||
94636334|NCT00071760|324130752|FG001|Overall Study|Insufficient Viral Load Response|1|||
94636335|NCT00071760|324130751|FG000|Overall Study|Lack of availability of RTV|1|||
94636336|NCT00071760|324130752|FG001|Overall Study|Lack of availability of RTV|0|||
94636337|NCT00071760|324130751|FG000|Overall Study|Physician Decision|2|||
94636338|NCT00071760|324130752|FG001|Overall Study|Physician Decision|1|||
94636339|NCT00071760|324130751|FG000|Overall Study|Relocation|0|||
94636340|NCT00071760|324130752|FG001|Overall Study|Relocation|1|||
94636341|NCT00975481|324130760|FG000|Second Intervention Period|Adverse Event|2|||
94636342|NCT00975481|324130761|FG001|Second Intervention Period|Adverse Event|1|||
94636343|NCT00975481|324130762|FG002|Second Intervention Period|Adverse Event|0|||
94636344|NCT00975481|324130763|FG003|Second Intervention Period|Adverse Event|0|||
94636345|NCT00975481|324130764|FG004|Second Intervention Period|Adverse Event|0|||
94636346|NCT00975481|324130765|FG005|Second Intervention Period|Adverse Event|0|||
94636347|NCT00975481|324130760|FG000|Second Intervention Period|Withdrawal by Subject|0|||
94636348|NCT00975481|324130761|FG001|Second Intervention Period|Withdrawal by Subject|0|||
94636349|NCT00975481|324130762|FG002|Second Intervention Period|Withdrawal by Subject|1|||
94636350|NCT00975481|324130763|FG003|Second Intervention Period|Withdrawal by Subject|0|||
94636351|NCT00975481|324130764|FG004|Second Intervention Period|Withdrawal by Subject|0|||
94636352|NCT00975481|324130765|FG005|Second Intervention Period|Withdrawal by Subject|0|||
94636353|NCT00975481|324130760|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
94636354|NCT00975481|324130761|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
94636355|NCT00975481|324130762|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
94636356|NCT00975481|324130763|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
94636357|NCT00975481|324130764|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
94636358|NCT00975481|324130765|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
94636359|NCT00975481|324130760|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
94636360|NCT00975481|324130761|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
94636361|NCT00975481|324130762|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
94636362|NCT00975481|324130763|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
94636363|NCT00975481|324130764|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
94636364|NCT00975481|324130765|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
94636365|NCT01826487|324130767|FG000|Overall Study|Adverse Event|1|||
94636366|NCT01826487|324130768|FG001|Overall Study|Adverse Event|1|||
94636367|NCT01826487|324130767|FG000|Overall Study|Lost to Follow-up|1|||
94636368|NCT01826487|324130768|FG001|Overall Study|Lost to Follow-up|0|||
94636369|NCT01826487|324130767|FG000|Overall Study|Withdrawal by Subject|1|||
94636370|NCT01826487|324130768|FG001|Overall Study|Withdrawal by Subject|3|||
94636371|NCT01826487|324130767|FG000|Overall Study|Protocol Violation|1|||
94636372|NCT01826487|324130768|FG001|Overall Study|Protocol Violation|1|||
94636373|NCT01408030|324130769|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
94636374|NCT01408030|324130770|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
94636375|NCT01408030|324130771|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
94636376|NCT01408030|324130772|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
94636377|NCT01408030|324130769|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
94636378|NCT01408030|324130770|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
94636379|NCT01408030|324130771|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
94636380|NCT01408030|324130772|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
94636381|NCT01408030|324130769|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
94636382|NCT01408030|324130770|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
94636383|NCT01408030|324130771|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
94636384|NCT01408030|324130772|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
94636385|NCT01408030|324130769|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
94262382|NCT01641809|322754814|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
94262383|NCT00778622|322754815|FG000|Overall Study|Adverse Event|5|||
94262384|NCT00778622|322754816|FG001|Overall Study|Adverse Event|4|||
94262385|NCT00778622|322754817|FG002|Overall Study|Adverse Event|7|||
94262386|NCT00778622|322754815|FG000|Overall Study|Withdrawal by Subject|4|||
94262387|NCT00778622|322754816|FG001|Overall Study|Withdrawal by Subject|5|||
94262388|NCT00778622|322754817|FG002|Overall Study|Withdrawal by Subject|5|||
94262389|NCT00778622|322754815|FG000|Overall Study|Lost to Follow-up|3|||
94262390|NCT00778622|322754816|FG001|Overall Study|Lost to Follow-up|3|||
94262391|NCT00778622|322754817|FG002|Overall Study|Lost to Follow-up|2|||
94262392|NCT00778622|322754815|FG000|Overall Study|Protocol Violation|0|||
94262393|NCT00778622|322754816|FG001|Overall Study|Protocol Violation|3|||
94262394|NCT00778622|322754817|FG002|Overall Study|Protocol Violation|0|||
94262395|NCT00778622|322754815|FG000|Overall Study|Lack of Efficacy|2|||
94262396|NCT00778622|322754816|FG001|Overall Study|Lack of Efficacy|0|||
94636386|NCT01408030|324130770|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
94636387|NCT01408030|324130771|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
94636388|NCT01408030|324130772|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
94636389|NCT01408030|324130769|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
94636390|NCT01408030|324130770|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
94636391|NCT01408030|324130771|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
94636392|NCT01408030|324130772|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
94636393|NCT01408030|324130769|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
94636394|NCT01408030|324130770|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
94636395|NCT01408030|324130771|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
94636396|NCT01408030|324130772|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
94636397|NCT01408030|324130769|FG000|Observation Phase (Off Drug)|Other|1|||
94636398|NCT01408030|324130770|FG001|Observation Phase (Off Drug)|Other|1|||
94636399|NCT01408030|324130771|FG002|Observation Phase (Off Drug)|Other|1|||
94636400|NCT01408030|324130772|FG003|Observation Phase (Off Drug)|Other|1|||
94636401|NCT03755414|324130773|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
94636402|NCT03755414|324130774|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
94636403|NCT03755414|324130775|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
94636404|NCT03755414|324130773|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
94636405|NCT03755414|324130774|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
94636406|NCT03755414|324130775|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
94636407|NCT03755414|324130773|FG000|Overall Study|Non-compliance|0|||
94636408|NCT03755414|324130774|FG001|Overall Study|Non-compliance|1|||
94636409|NCT03755414|324130775|FG002|Overall Study|Non-compliance|0|||
94636410|NCT00561080|324130776|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
94636411|NCT00561080|324130777|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
94636412|NCT00561080|324130778|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
94636413|NCT00561080|324130776|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
94636414|NCT00561080|324130777|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
94636415|NCT00561080|324130778|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
94636416|NCT00561080|324130776|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
94636417|NCT00561080|324130777|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
94636418|NCT00561080|324130778|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
94636419|NCT00561080|324130776|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
94636420|NCT00561080|324130777|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
94636421|NCT00561080|324130778|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
94636422|NCT00561080|324130776|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
94636423|NCT00561080|324130777|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
94636424|NCT00561080|324130778|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
94636425|NCT00561080|324130776|FG000|Vaccination Period (up to Month 4)|Other|0|||
94636426|NCT00561080|324130777|FG001|Vaccination Period (up to Month 4)|Other|2|||
94636427|NCT00561080|324130778|FG002|Vaccination Period (up to Month 4)|Other|1|||
94636428|NCT00561080|324130776|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
94636429|NCT00561080|324130777|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
94636430|NCT00561080|324130778|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
94636431|NCT00561080|324130776|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
94262397|NCT00778622|322754817|FG002|Overall Study|Lack of Efficacy|0|||
94636432|NCT00561080|324130777|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
94636433|NCT00561080|324130778|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
94676849|NCT04493931|324271322|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
94262398|NCT00778622|322754815|FG000|Overall Study|immigration|1|||
94262399|NCT00778622|322754816|FG001|Overall Study|immigration|0|||
94262400|NCT00778622|322754817|FG002|Overall Study|immigration|0|||
94262401|NCT00778622|322754815|FG000|Overall Study|Other|1|||
94262402|NCT00778622|322754816|FG001|Overall Study|Other|0|||
94262403|NCT00778622|322754817|FG002|Overall Study|Other|1|||
94262404|NCT01505010|322754818|FG000|Overall Study|Protocol Violation|0|||
94262405|NCT01505010|322754819|FG001|Overall Study|Protocol Violation|1|||
94262406|NCT01505010|322754818|FG000|Overall Study|Lost to Follow-up|0|||
94262407|NCT01505010|322754819|FG001|Overall Study|Lost to Follow-up|1|||
94262408|NCT01968070|322754820|FG000|Period 1|Withdrawal by Subject|0|||
94262409|NCT01968070|322754821|FG001|Period 1|Withdrawal by Subject|1|||
94262410|NCT01968070|322754822|FG002|Period 1|Withdrawal by Subject|0|||
94636434|NCT00561080|324130776|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
94636435|NCT00561080|324130777|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
94636436|NCT00561080|324130778|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
94636437|NCT00561080|324130776|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
94636438|NCT00561080|324130777|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
94636439|NCT00561080|324130778|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
94636440|NCT00075582|324130779|FG000|Overall Study|Adverse Event|3|||
94636441|NCT00075582|324130780|FG001|Overall Study|Adverse Event|1|||
94636442|NCT00075582|324130779|FG000|Overall Study|Lack of Efficacy|4|||
94636443|NCT00075582|324130780|FG001|Overall Study|Lack of Efficacy|8|||
94636444|NCT00075582|324130779|FG000|Overall Study|Physician Decision|5|||
94636445|NCT00075582|324130780|FG001|Overall Study|Physician Decision|8|||
94636446|NCT00075582|324130779|FG000|Overall Study|Withdrawal by Subject|2|||
94636447|NCT00075582|324130780|FG001|Overall Study|Withdrawal by Subject|2|||
94636448|NCT00075582|324130779|FG000|Overall Study|Ineligible for study|36|||
94636449|NCT00075582|324130780|FG001|Overall Study|Ineligible for study|16|||
94636450|NCT01288287|324130781|FG000|Overall Study|Lost to Follow-up|8|||
94636451|NCT01288287|324130781|FG000|Overall Study|Withdrawal by Subject|4|||
94636452|NCT01288287|324130781|FG000|Overall Study|Lack of Efficacy|13|||
94636453|NCT01288287|324130781|FG000|Overall Study|Other Reason|13|||
94636454|NCT01288287|324130781|FG000|Overall Study|Unknown Reason|1|||
94636455|NCT01288287|324130781|FG000|Overall Study|Unknown Status|7|||
94636456|NCT00768300|324130785|FG000|Overall Study|Randomized but not treated|1|||
94636457|NCT00768300|324130786|FG001|Overall Study|Randomized but not treated|1|||
94636458|NCT00768300|324130785|FG000|Overall Study|Adverse Event|10|||
94636459|NCT00768300|324130786|FG001|Overall Study|Adverse Event|2|||
94636460|NCT00768300|324130785|FG000|Overall Study|Protocol Violation|6|||
94636461|NCT00768300|324130786|FG001|Overall Study|Protocol Violation|1|||
94636462|NCT00768300|324130785|FG000|Overall Study|Withdrawal by Subject|13|||
94636463|NCT00768300|324130786|FG001|Overall Study|Withdrawal by Subject|7|||
94636464|NCT00768300|324130785|FG000|Overall Study|Physician Decision|2|||
94636465|NCT00768300|324130786|FG001|Overall Study|Physician Decision|3|||
94636466|NCT00768300|324130785|FG000|Overall Study|Study discontinued by Sponsor|271|||
94636467|NCT00768300|324130786|FG001|Overall Study|Study discontinued by Sponsor|140|||
94636468|NCT00768300|324130785|FG000|Overall Study|Death|21|||
94636469|NCT00768300|324130786|FG001|Overall Study|Death|5|||
94636470|NCT00768300|324130785|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
94636471|NCT00768300|324130786|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
94636472|NCT00768300|324130785|FG000|Overall Study|Screen failure following randomization|1|||
94636473|NCT00768300|324130786|FG001|Overall Study|Screen failure following randomization|0|||
94636474|NCT00768300|324130785|FG000|Overall Study|Received lung transplant|1|||
94636475|NCT00768300|324130786|FG001|Overall Study|Received lung transplant|1|||
94636476|NCT00768300|324130785|FG000|Overall Study|Lost to Follow-up|0|||
94636477|NCT00768300|324130786|FG001|Overall Study|Lost to Follow-up|1|||
94676850|NCT04493931|324271323|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
94262411|NCT01968070|322754823|FG003|Period 1|Withdrawal by Subject|0|||
94262412|NCT01968070|322754824|FG004|Period 1|Withdrawal by Subject|0|||
94262413|NCT01968070|322754825|FG005|Period 1|Withdrawal by Subject|0|||
94262414|NCT01968070|322754826|FG006|Period 1|Withdrawal by Subject|1|||
94262415|NCT01968070|322754827|FG007|Period 1|Withdrawal by Subject|0|||
94262416|NCT01968070|322754828|FG008|Period 1|Withdrawal by Subject|0|||
94262417|NCT01968070|322754829|FG009|Period 1|Withdrawal by Subject|0|||
94262418|NCT01968070|322754830|FG010|Period 1|Withdrawal by Subject|0|||
94636478|NCT00768300|324130785|FG000|Overall Study|Began prohibited concomitant medication|0|||
94636479|NCT00768300|324130786|FG001|Overall Study|Began prohibited concomitant medication|1|||
94636480|NCT00768300|324130785|FG000|Overall Study|Treated but never dosed with Study drug|1|||
94636481|NCT00768300|324130786|FG001|Overall Study|Treated but never dosed with Study drug|0|||
94636482|NCT00768300|324130785|FG000|Overall Study|Missing data|1|||
94636483|NCT00768300|324130786|FG001|Overall Study|Missing data|0|||
94636484|NCT00322842|324130791|FG000|Overall Study|Withdrawal by Subject|0|||
94636485|NCT00322842|324130792|FG001|Overall Study|Withdrawal by Subject|1|||
94636486|NCT00322842|324130791|FG000|Overall Study|Lost to Follow-up|0|||
94636487|NCT00322842|324130792|FG001|Overall Study|Lost to Follow-up|1|||
94636488|NCT00322842|324130791|FG000|Overall Study|Refused transplant|1|||
94636489|NCT00322842|324130792|FG001|Overall Study|Refused transplant|0|||
94636490|NCT00322842|324130791|FG000|Overall Study|Death|1|||
94262419|NCT01968070|322754831|FG011|Period 1|Withdrawal by Subject|0|||
94262420|NCT01968070|322754832|FG012|Period 1|Withdrawal by Subject|0|||
94262421|NCT01968070|322754833|FG013|Period 1|Withdrawal by Subject|0|||
94636491|NCT00322842|324130792|FG001|Overall Study|Death|0|||
94636492|NCT00238121|324130793|FG000|Overall Study|Withdrawal by Subject|1|||
94636493|NCT00238121|324130794|FG001|Overall Study|Withdrawal by Subject|1|||
94636494|NCT00238121|324130793|FG000|Overall Study|Adverse Event|2|||
94636495|NCT00238121|324130794|FG001|Overall Study|Adverse Event|1|||
94636496|NCT01374087|324130796|FG000|Overall Study|Adverse Event|1|||
94636497|NCT01374087|324130797|FG001|Overall Study|Adverse Event|0|||
94636498|NCT01374087|324130796|FG000|Overall Study|Disease progression|2|||
94636499|NCT01374087|324130797|FG001|Overall Study|Disease progression|2|||
94636500|NCT01374087|324130796|FG000|Overall Study|Study discontinued|13|||
94636501|NCT01374087|324130797|FG001|Overall Study|Study discontinued|13|||
94636502|NCT00529542|324130803|FG000|Overall Study|Withdrawal by Subject|1|||
94636503|NCT00529542|324130804|FG001|Overall Study|Withdrawal by Subject|0|||
94636504|NCT00529542|324130803|FG000|Overall Study|Lost to Follow-up|0|||
94636505|NCT00529542|324130804|FG001|Overall Study|Lost to Follow-up|1|||
94636506|NCT00679263|324130807|FG000|Visit 2/Dose 1|Adverse Event|1|||
94636507|NCT00679263|324130808|FG001|Visit 2/Dose 1|Adverse Event|0|||
94636508|NCT00679263|324130809|FG002|Visit 2/Dose 1|Adverse Event|0|||
94636509|NCT00679263|324130807|FG000|Visit 2/Dose 1|subject not compliance|1|||
94636510|NCT00679263|324130808|FG001|Visit 2/Dose 1|subject not compliance|1|||
94636511|NCT00679263|324130809|FG002|Visit 2/Dose 1|subject not compliance|0|||
94636512|NCT00733746|324130810|FG000|Overall Study|Ineligible|5|||
94636513|NCT02113956|324130813|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
94636514|NCT02113956|324130814|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
94636515|NCT02113956|324130813|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
94636516|NCT02113956|324130814|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
94636517|NCT02113956|324130813|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
94636518|NCT02113956|324130814|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
94636519|NCT02406651|324130815|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
94636520|NCT03649711|324130821|FG000|Overall Study|Adverse Event|0|||
94636521|NCT03649711|324130822|FG001|Overall Study|Adverse Event|1|||
94636522|NCT03649711|324130823|FG002|Overall Study|Adverse Event|0|||
94636523|NCT03649711|324130821|FG000|Overall Study|Kidney Transplant|1|||
94636524|NCT03649711|324130822|FG001|Overall Study|Kidney Transplant|0|||
94636525|NCT03649711|324130823|FG002|Overall Study|Kidney Transplant|0|||
94636526|NCT01502423|324130824|FG000|Overall Study|Withdrawal by Subject|0|||
94636527|NCT01502423|324130825|FG001|Overall Study|Withdrawal by Subject|1|||
94636528|NCT05024058|324132670|FG000|Treatment|Study terminated by sponsor|5|||
94636529|NCT05024058|324132671|FG001|Treatment|Study terminated by sponsor|6|||
94636530|NCT05024058|324132672|FG002|Treatment|Study terminated by sponsor|4|||
94636531|NCT05024058|324132673|FG003|Treatment|Study terminated by sponsor|2|||
94636532|NCT05024058|324132674|FG004|Treatment|Study terminated by sponsor|3|||
94636533|NCT05024058|324132675|FG005|Treatment|Study terminated by sponsor|3|||
94636534|NCT05024058|324132676|FG006|Treatment|Study terminated by sponsor|1|||
94636535|NCT05024058|324132677|FG007|Treatment|Study terminated by sponsor|3|||
94636536|NCT05024058|324132678|FG008|Treatment|Study terminated by sponsor|6|||
94636537|NCT05024058|324132679|FG009|Treatment|Study terminated by sponsor|6|||
94636538|NCT05024058|324132670|FG000|Follow-up|Withdrawal by Subject|1|||
94636539|NCT05024058|324132671|FG001|Follow-up|Withdrawal by Subject|0|||
94636540|NCT05024058|324132672|FG002|Follow-up|Withdrawal by Subject|1|||
94636541|NCT05024058|324132673|FG003|Follow-up|Withdrawal by Subject|0|||
94636542|NCT05024058|324132674|FG004|Follow-up|Withdrawal by Subject|0|||
94636543|NCT05024058|324132675|FG005|Follow-up|Withdrawal by Subject|0|||
94636544|NCT05024058|324132676|FG006|Follow-up|Withdrawal by Subject|0|||
94636545|NCT05024058|324132677|FG007|Follow-up|Withdrawal by Subject|1|||
94636546|NCT05024058|324132678|FG008|Follow-up|Withdrawal by Subject|0|||
94636547|NCT05024058|324132679|FG009|Follow-up|Withdrawal by Subject|1|||
94636548|NCT00380978|324132681|FG000|Overall Study|Refused allocated intervention|0|||
94636549|NCT00380978|324132682|FG001|Overall Study|Refused allocated intervention|6|||
94636550|NCT00380978|324132681|FG000|Overall Study|Wrong study envelope|0|||
94636551|NCT00380978|324132682|FG001|Overall Study|Wrong study envelope|2|||
94636552|NCT00380978|324132681|FG000|Overall Study|Allocation prior to analgesia request|1|||
94636553|NCT00380978|324132682|FG001|Overall Study|Allocation prior to analgesia request|2|||
94636554|NCT00380978|324132681|FG000|Overall Study|Parous patient|1|||
94636555|NCT00380978|324132682|FG001|Overall Study|Parous patient|0|||
94636556|NCT00773292|324132683|FG000|Treatment 48 Weeks|Adverse Event|1|||
94636557|NCT00773292|324132683|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
94636558|NCT00202644|324132684|FG000|Overall Study|Adverse Event|12|||
94636559|NCT00202644|324132685|FG001|Overall Study|Adverse Event|13|||
94262422|NCT01968070|322754834|FG014|Period 1|Withdrawal by Subject|0|||
94636560|NCT00202644|324132684|FG000|Overall Study|Withdrawal by Subject|8|||
94636561|NCT00202644|324132685|FG001|Overall Study|Withdrawal by Subject|6|||
94636562|NCT00202644|324132684|FG000|Overall Study|Lack of Efficacy|6|||
94636563|NCT00202644|324132685|FG001|Overall Study|Lack of Efficacy|6|||
94636564|NCT00202644|324132684|FG000|Overall Study|Lost to Follow-up|0|||
94262423|NCT01968070|322754835|FG015|Period 1|Withdrawal by Subject|1|||
94262424|NCT01968070|322754836|FG016|Period 1|Withdrawal by Subject|0|||
94262425|NCT01968070|322754837|FG017|Period 1|Withdrawal by Subject|0|||
94636565|NCT00202644|324132685|FG001|Overall Study|Lost to Follow-up|1|||
94636566|NCT00202644|324132684|FG000|Overall Study|Other|9|||
94636567|NCT00202644|324132685|FG001|Overall Study|Other|1|||
94636568|NCT01881230|324132691|FG000|Overall Study|Death|2|||
94636569|NCT01881230|324132692|FG001|Overall Study|Death|0|||
94636570|NCT01881230|324132693|FG002|Overall Study|Death|1|||
94636571|NCT01881230|324132691|FG000|Overall Study|Adverse Event|9|||
94636572|NCT01881230|324132692|FG001|Overall Study|Adverse Event|13|||
94636573|NCT01881230|324132693|FG002|Overall Study|Adverse Event|12|||
94636574|NCT01881230|324132691|FG000|Overall Study|Progressive Disease|31|||
94636575|NCT01881230|324132692|FG001|Overall Study|Progressive Disease|35|||
94636576|NCT01881230|324132693|FG002|Overall Study|Progressive Disease|36|||
94636577|NCT01881230|324132691|FG000|Overall Study|Symptomatic Deterioration|3|||
94636578|NCT01881230|324132692|FG001|Overall Study|Symptomatic Deterioration|3|||
94636579|NCT01881230|324132693|FG002|Overall Study|Symptomatic Deterioration|1|||
94636580|NCT01881230|324132691|FG000|Overall Study|Withdrawal by Subject|6|||
94636581|NCT01881230|324132692|FG001|Overall Study|Withdrawal by Subject|4|||
94636582|NCT01881230|324132693|FG002|Overall Study|Withdrawal by Subject|6|||
94636583|NCT01881230|324132691|FG000|Overall Study|Physician Decision|4|||
94636584|NCT01881230|324132692|FG001|Overall Study|Physician Decision|3|||
94636585|NCT01881230|324132693|FG002|Overall Study|Physician Decision|6|||
94636586|NCT01881230|324132691|FG000|Overall Study|Non-Compliance with Study Drug|1|||
94636587|NCT01881230|324132692|FG001|Overall Study|Non-Compliance with Study Drug|2|||
94636588|NCT01881230|324132693|FG002|Overall Study|Non-Compliance with Study Drug|0|||
94636589|NCT01881230|324132691|FG000|Overall Study|Given Commercially Available Drug|0|||
94636590|NCT01881230|324132692|FG001|Overall Study|Given Commercially Available Drug|0|||
94636591|NCT01881230|324132693|FG002|Overall Study|Given Commercially Available Drug|2|||
94636592|NCT01881230|324132691|FG000|Overall Study|Protocol Violation|1|||
94636593|NCT01881230|324132692|FG001|Overall Study|Protocol Violation|1|||
94636594|NCT01881230|324132693|FG002|Overall Study|Protocol Violation|0|||
94636595|NCT01881230|324132691|FG000|Overall Study|Miscellaneous|3|||
94636596|NCT01881230|324132692|FG001|Overall Study|Miscellaneous|3|||
94636597|NCT01881230|324132693|FG002|Overall Study|Miscellaneous|0|||
94636598|NCT01881230|324132691|FG000|Overall Study|Untreated: Other|0|||
94636599|NCT01881230|324132692|FG001|Overall Study|Untreated: Other|0|||
94636600|NCT01881230|324132693|FG002|Overall Study|Untreated: Other|1|||
94636601|NCT01881230|324132691|FG000|Overall Study|Untreated: Death|0|||
94636602|NCT01881230|324132692|FG001|Overall Study|Untreated: Death|0|||
94636603|NCT01881230|324132693|FG002|Overall Study|Untreated: Death|1|||
94636604|NCT01881230|324132691|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
94636605|NCT01881230|324132692|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
94636606|NCT01881230|324132693|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
94636607|NCT00112502|324132694|FG000|Overall Study|Withdrawal by Subject|0|||
94636608|NCT00112502|324132695|FG001|Overall Study|Withdrawal by Subject|1|||
94636609|NCT00112502|324132696|FG002|Overall Study|Withdrawal by Subject|1|||
94636610|NCT00112502|324132697|FG003|Overall Study|Withdrawal by Subject|4|||
94636611|NCT00112502|324132698|FG004|Overall Study|Withdrawal by Subject|2|||
94636612|NCT00112502|324132699|FG005|Overall Study|Withdrawal by Subject|5|||
94636613|NCT00112502|324132700|FG006|Overall Study|Withdrawal by Subject|3|||
94636614|NCT00112502|324132701|FG007|Overall Study|Withdrawal by Subject|7|||
94636615|NCT02385266|324132702|FG000|Overall Study|Withdrawal by Subject|1|||
94636616|NCT02385266|324132703|FG001|Overall Study|Withdrawal by Subject|3|||
94636617|NCT00778700|324132706|FG000|Overall Study|Adverse Event|6|||
94636618|NCT00778700|324132707|FG001|Overall Study|Adverse Event|1|||
94636619|NCT00778700|324132708|FG002|Overall Study|Adverse Event|3|||
94636620|NCT00778700|324132709|FG003|Overall Study|Adverse Event|5|||
94636621|NCT00778700|324132706|FG000|Overall Study|Protocol Violation|1|||
94636622|NCT00778700|324132707|FG001|Overall Study|Protocol Violation|1|||
94636623|NCT00778700|324132708|FG002|Overall Study|Protocol Violation|0|||
94636624|NCT00778700|324132709|FG003|Overall Study|Protocol Violation|0|||
94636625|NCT00778700|324132706|FG000|Overall Study|Subject Withdrew Consent|6|||
94636626|NCT00778700|324132707|FG001|Overall Study|Subject Withdrew Consent|4|||
94636627|NCT00778700|324132708|FG002|Overall Study|Subject Withdrew Consent|1|||
94636628|NCT00778700|324132709|FG003|Overall Study|Subject Withdrew Consent|4|||
94636629|NCT00778700|324132706|FG000|Overall Study|Lost to Follow-up|3|||
94636630|NCT00778700|324132707|FG001|Overall Study|Lost to Follow-up|1|||
94636631|NCT00778700|324132708|FG002|Overall Study|Lost to Follow-up|0|||
94636632|NCT00778700|324132709|FG003|Overall Study|Lost to Follow-up|1|||
94636633|NCT00778700|324132706|FG000|Overall Study|Reason not Specified|2|||
94636634|NCT00778700|324132707|FG001|Overall Study|Reason not Specified|0|||
94262426|NCT01968070|322754820|FG000|Period 1|Protocol Violation|0|||
94636635|NCT00778700|324132708|FG002|Overall Study|Reason not Specified|1|||
94636636|NCT00778700|324132709|FG003|Overall Study|Reason not Specified|3|||
94636637|NCT00778700|324132706|FG000|Overall Study|Other|0|||
94636638|NCT00778700|324132707|FG001|Overall Study|Other|0|||
94262427|NCT01968070|322754821|FG001|Period 1|Protocol Violation|0|||
94262428|NCT01968070|322754822|FG002|Period 1|Protocol Violation|0|||
94636639|NCT00778700|324132708|FG002|Overall Study|Other|1|||
94636640|NCT00778700|324132709|FG003|Overall Study|Other|0|||
94636641|NCT04267133|324132715|FG000|Overall Study|Withdrawal by Subject|1|||
94636642|NCT04267133|324132715|FG000|Overall Study|Adverse Event|4|||
94636643|NCT03318315|324132719|FG000|Overall Study|Lost to Follow-up|3|||
94636644|NCT03318315|324132720|FG001|Overall Study|Lost to Follow-up|2|||
94636645|NCT03318315|324132721|FG002|Overall Study|Lost to Follow-up|1|||
94636646|NCT03318315|324132719|FG000|Overall Study|Protocol Violation|1|||
94636647|NCT03318315|324132720|FG001|Overall Study|Protocol Violation|1|||
94636648|NCT03318315|324132721|FG002|Overall Study|Protocol Violation|1|||
94636649|NCT03318315|324132719|FG000|Overall Study|Withdrawal by Subject|0|||
94636650|NCT03318315|324132720|FG001|Overall Study|Withdrawal by Subject|0|||
94636651|NCT03318315|324132721|FG002|Overall Study|Withdrawal by Subject|2|||
94636652|NCT02631850|324132722|FG000|Treatment Period|Lost to Follow-up|0|||
94636653|NCT02631850|324132723|FG001|Treatment Period|Lost to Follow-up|1|||
94636654|NCT02631850|324132724|FG002|Treatment Period|Lost to Follow-up|0|||
94636655|NCT02631850|324132725|FG003|Treatment Period|Lost to Follow-up|0|||
94636656|NCT02631850|324132722|FG000|Treatment Period|Protocol Violation|1|||
94636657|NCT02631850|324132723|FG001|Treatment Period|Protocol Violation|0|||
94636658|NCT02631850|324132724|FG002|Treatment Period|Protocol Violation|0|||
94636659|NCT02631850|324132725|FG003|Treatment Period|Protocol Violation|0|||
94636660|NCT02631850|324132722|FG000|Treatment Period|Withdrawal by Subject|0|||
94636661|NCT02631850|324132723|FG001|Treatment Period|Withdrawal by Subject|5|||
94636662|NCT02631850|324132724|FG002|Treatment Period|Withdrawal by Subject|2|||
94636663|NCT02631850|324132725|FG003|Treatment Period|Withdrawal by Subject|2|||
94636664|NCT02631850|324132722|FG000|Treatment Period|Adverse Event|1|||
94636665|NCT02631850|324132723|FG001|Treatment Period|Adverse Event|0|||
94636666|NCT02631850|324132724|FG002|Treatment Period|Adverse Event|2|||
94636667|NCT02631850|324132725|FG003|Treatment Period|Adverse Event|3|||
94636668|NCT02631850|324132722|FG000|Treatment Period|Family medical issue|1|||
94636669|NCT02631850|324132723|FG001|Treatment Period|Family medical issue|0|||
94636670|NCT02631850|324132724|FG002|Treatment Period|Family medical issue|0|||
94636671|NCT02631850|324132725|FG003|Treatment Period|Family medical issue|0|||
94636672|NCT02631850|324132722|FG000|6 Month Follow up|Lost to Follow-up|5|||
94636673|NCT02631850|324132723|FG001|6 Month Follow up|Lost to Follow-up|8|||
94636674|NCT02631850|324132724|FG002|6 Month Follow up|Lost to Follow-up|3|||
94636675|NCT02631850|324132725|FG003|6 Month Follow up|Lost to Follow-up|5|||
94636676|NCT02631850|324132722|FG000|6 Month Follow up|Withdrawal by Subject|1|||
94636677|NCT02631850|324132723|FG001|6 Month Follow up|Withdrawal by Subject|0|||
94636678|NCT02631850|324132724|FG002|6 Month Follow up|Withdrawal by Subject|0|||
94636679|NCT02631850|324132725|FG003|6 Month Follow up|Withdrawal by Subject|2|||
94636680|NCT02631850|324132722|FG000|6 Month Follow up|Adverse Event|1|||
94636681|NCT02631850|324132723|FG001|6 Month Follow up|Adverse Event|4|||
94636682|NCT02631850|324132724|FG002|6 Month Follow up|Adverse Event|1|||
94636683|NCT02631850|324132725|FG003|6 Month Follow up|Adverse Event|3|||
94636684|NCT02631850|324132722|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
94636685|NCT02631850|324132723|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
94636686|NCT02631850|324132724|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
94636687|NCT02631850|324132725|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
94636688|NCT02063854|324132726|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
94636689|NCT02063854|324132727|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
94636690|NCT02063854|324132728|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
94636691|NCT02063854|324132729|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
94636692|NCT02063854|324132730|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
94636693|NCT02063854|324132731|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
94636694|NCT02063854|324132732|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
94676851|NCT04493931|324271324|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
94676852|NCT04493931|324271325|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
94676853|NCT04493931|324271326|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
94636695|NCT02063854|324132726|FG000|Overall Study|Major Protocol Deviation|0|||
94636696|NCT02063854|324132727|FG001|Overall Study|Major Protocol Deviation|0|||
94636697|NCT02063854|324132728|FG002|Overall Study|Major Protocol Deviation|3|||
94636698|NCT02063854|324132729|FG003|Overall Study|Major Protocol Deviation|0|||
94676854|NCT04493931|324271320|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
94676855|NCT04493931|324271321|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
94636699|NCT02063854|324132730|FG004|Overall Study|Major Protocol Deviation|0|||
94636700|NCT02063854|324132731|FG005|Overall Study|Major Protocol Deviation|0|||
94636701|NCT02063854|324132732|FG006|Overall Study|Major Protocol Deviation|0|||
94636702|NCT02063854|324132726|FG000|Overall Study|Voluntary Withdrawal|2|||
94636703|NCT02063854|324132727|FG001|Overall Study|Voluntary Withdrawal|0|||
94636704|NCT02063854|324132728|FG002|Overall Study|Voluntary Withdrawal|8|||
94636705|NCT02063854|324132729|FG003|Overall Study|Voluntary Withdrawal|1|||
94636706|NCT02063854|324132730|FG004|Overall Study|Voluntary Withdrawal|3|||
94636707|NCT02063854|324132731|FG005|Overall Study|Voluntary Withdrawal|6|||
94636708|NCT02063854|324132732|FG006|Overall Study|Voluntary Withdrawal|1|||
94636709|NCT02063854|324132726|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
94676856|NCT04493931|324271322|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
94676857|NCT04493931|324271323|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
94262429|NCT01968070|322754823|FG003|Period 1|Protocol Violation|1|||
94636710|NCT02063854|324132727|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
94636711|NCT02063854|324132728|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
94636712|NCT02063854|324132729|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
94636713|NCT02063854|324132730|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
94636714|NCT02063854|324132731|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
94636715|NCT02063854|324132732|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
94636716|NCT02063854|324132726|FG000|Overall Study|Reason Not Specified|1|||
94636717|NCT02063854|324132727|FG001|Overall Study|Reason Not Specified|0|||
94636718|NCT02063854|324132728|FG002|Overall Study|Reason Not Specified|0|||
94636719|NCT02063854|324132729|FG003|Overall Study|Reason Not Specified|0|||
94636720|NCT02063854|324132730|FG004|Overall Study|Reason Not Specified|0|||
94636721|NCT02063854|324132731|FG005|Overall Study|Reason Not Specified|0|||
94636722|NCT02063854|324132732|FG006|Overall Study|Reason Not Specified|0|||
94461840|NCT00778102|323479636|FG001|Overall Study|Withdrawal by Subject|1|||
94461841|NCT00778102|323479635|FG000|Overall Study|Administrative Reason|7|||
94461842|NCT00778102|323479636|FG001|Overall Study|Administrative Reason|10|||
94461843|NCT00743288|323481238|FG000|Overall Study|Adverse Event|1|||
94461844|NCT00743288|323481239|FG001|Overall Study|Adverse Event|1|||
94461845|NCT00743288|323481240|FG002|Overall Study|Adverse Event|2|||
94461846|NCT00743288|323481241|FG003|Overall Study|Adverse Event|2|||
94461847|NCT00743288|323481242|FG004|Overall Study|Adverse Event|1|||
94461848|NCT00743288|323481243|FG005|Overall Study|Adverse Event|1|||
94461849|NCT00743288|323481244|FG006|Overall Study|Adverse Event|2|||
94461850|NCT00743288|323481238|FG000|Overall Study|Withdrawal by Subject|0|||
94461851|NCT00743288|323481239|FG001|Overall Study|Withdrawal by Subject|0|||
94636723|NCT02063854|324132726|FG000|Overall Study|Did Not Receive Study Drug|0|||
94636724|NCT02063854|324132727|FG001|Overall Study|Did Not Receive Study Drug|0|||
94636725|NCT02063854|324132728|FG002|Overall Study|Did Not Receive Study Drug|0|||
94636726|NCT02063854|324132729|FG003|Overall Study|Did Not Receive Study Drug|0|||
94636727|NCT02063854|324132730|FG004|Overall Study|Did Not Receive Study Drug|0|||
94636728|NCT02063854|324132731|FG005|Overall Study|Did Not Receive Study Drug|1|||
94636729|NCT02063854|324132732|FG006|Overall Study|Did Not Receive Study Drug|0|||
94636730|NCT01462084|324132740|FG000|Overall Study|Withdrawal by Subject|1|||
94636731|NCT01462084|324132741|FG001|Overall Study|Withdrawal by Subject|0|||
94636732|NCT01462084|324132740|FG000|Overall Study|Protocol Violation|1|||
94636733|NCT01462084|324132741|FG001|Overall Study|Protocol Violation|1|||
94636734|NCT00772707|324132742|FG000|Overall Study|Withdrawn|3|||
94636735|NCT01275833|324132743|FG000|Overall Study|Study terminated|1|||
94636736|NCT01275833|324132744|FG001|Overall Study|Study terminated|1|||
94636737|NCT02420691|324132747|FG000|Overall Study|Adverse Event|3|||
94636738|NCT02420691|324132747|FG000|Overall Study|Withdrawal by Subject|3|||
94636739|NCT02617511|324132751|FG000|Overall Study|Withdrawal by Subject|1|||
94636740|NCT02617511|324132752|FG001|Overall Study|Withdrawal by Subject|0|||
94636741|NCT02141997|324132753|FG000|Overall Study|Adverse Event|0|||
94636742|NCT02141997|324132754|FG001|Overall Study|Adverse Event|2|||
94636743|NCT02141997|324132755|FG002|Overall Study|Adverse Event|0|||
94636744|NCT02141997|324132756|FG003|Overall Study|Adverse Event|1|||
94636745|NCT02141997|324132753|FG000|Overall Study|Participant noncompliance|1|||
94636746|NCT02141997|324132754|FG001|Overall Study|Participant noncompliance|0|||
94636747|NCT02141997|324132755|FG002|Overall Study|Participant noncompliance|0|||
94636748|NCT02141997|324132756|FG003|Overall Study|Participant noncompliance|0|||
94636749|NCT02141997|324132753|FG000|Overall Study|Withdrew consent|1|||
94636750|NCT02141997|324132754|FG001|Overall Study|Withdrew consent|0|||
94636751|NCT02141997|324132755|FG002|Overall Study|Withdrew consent|3|||
94636752|NCT02141997|324132756|FG003|Overall Study|Withdrew consent|0|||
94636753|NCT02141997|324132753|FG000|Overall Study|Other|1|||
94636754|NCT02141997|324132754|FG001|Overall Study|Other|4|||
94636755|NCT02141997|324132755|FG002|Overall Study|Other|0|||
94636756|NCT02141997|324132756|FG003|Overall Study|Other|0|||
94636757|NCT04105998|324132757|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
94636758|NCT04105998|324132758|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
94676858|NCT04493931|324271324|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
94676859|NCT04493931|324271325|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
94262430|NCT01968070|322754824|FG004|Period 1|Protocol Violation|1|||
94461852|NCT00743288|323481240|FG002|Overall Study|Withdrawal by Subject|1|||
94461853|NCT00743288|323481241|FG003|Overall Study|Withdrawal by Subject|0|||
94636759|NCT03311659|324132766|FG000|Overall Study|Protocol Violation|1|||
94636760|NCT01909479|324132767|FG000|From Baseline to Week 26|Adverse Event|3|||
94362778|NCT01125358|323112842|FG003|Overall Study|Protocol Violation|0|||
94362779|NCT01125358|323112839|FG000|Overall Study|Sponsor Decision|0|||
94362780|NCT01125358|323112840|FG001|Overall Study|Sponsor Decision|0|||
94362781|NCT01125358|323112841|FG002|Overall Study|Sponsor Decision|1|||
94362782|NCT01125358|323112842|FG003|Overall Study|Sponsor Decision|1|||
94362783|NCT01125358|323112839|FG000|Overall Study|Withdrawal by Subject|2|||
94362784|NCT01125358|323112840|FG001|Overall Study|Withdrawal by Subject|1|||
94362785|NCT01125358|323112841|FG002|Overall Study|Withdrawal by Subject|1|||
94362786|NCT01125358|323112842|FG003|Overall Study|Withdrawal by Subject|1|||
94362787|NCT03000075|323112847|FG000|Part A|Adverse Event|4|||
94362788|NCT03000075|323112848|FG001|Part A|Adverse Event|0|||
94362789|NCT03000075|323112849|FG002|Part A|Adverse Event|0|||
94362790|NCT03000075|323112850|FG003|Part A|Adverse Event|0|||
94362791|NCT03000075|323112851|FG004|Part A|Adverse Event|0|||
94362792|NCT03000075|323112852|FG005|Part A|Adverse Event|0|||
94362793|NCT03000075|323112853|FG006|Part A|Adverse Event|0|||
94362794|NCT03000075|323112847|FG000|Part B|Not dosed due to AE|0|||
94362795|NCT03000075|323112848|FG001|Part B|Not dosed due to AE|0|||
94362796|NCT03000075|323112849|FG002|Part B|Not dosed due to AE|0|||
94676860|NCT04493931|324271326|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
94676861|NCT04493931|324271320|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
94676862|NCT04493931|324271321|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
94676863|NCT04493931|324271322|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
94676864|NCT04493931|324271323|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
94676865|NCT04493931|324271324|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
94676866|NCT04493931|324271325|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
94676867|NCT04493931|324271326|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
94676868|NCT01127646|324271327|FG000|Overall Study|Entry Criteria Not Met|1|||
94676869|NCT01127646|324271328|FG001|Overall Study|Entry Criteria Not Met|0|||
94676870|NCT01127646|324271327|FG000|Overall Study|Protocol Violation|0|||
94676871|NCT01127646|324271328|FG001|Overall Study|Protocol Violation|1|||
94676872|NCT04067401|324271331|FG000|Overall Study|Withdrawal by Subject|7|||
94676873|NCT04067401|324271332|FG001|Overall Study|Withdrawal by Subject|0|||
94676874|NCT04067401|324271331|FG000|Overall Study|no data provided|1|||
94676875|NCT04067401|324271332|FG001|Overall Study|no data provided|0|||
94676876|NCT00595504|324271333|FG000|Overall Study|Withdrawal by Subject|1|||
94676877|NCT00595504|324271334|FG001|Overall Study|Withdrawal by Subject|3|||
94676878|NCT00595504|324271333|FG000|Overall Study|Physician Decision|1|||
94676879|NCT00595504|324271334|FG001|Overall Study|Physician Decision|0|||
94676880|NCT00638235|324271335|FG000|Overall Study|Lost to Follow-up|31|||
94676881|NCT00638235|324271336|FG001|Overall Study|Lost to Follow-up|3|||
94676882|NCT00638235|324271337|FG002|Overall Study|Lost to Follow-up|18|||
94676883|NCT00638235|324271338|FG003|Overall Study|Lost to Follow-up|10|||
94676884|NCT00638235|324271339|FG004|Overall Study|Lost to Follow-up|13|||
94676885|NCT00638235|324271340|FG005|Overall Study|Lost to Follow-up|26|||
94676886|NCT00638235|324271341|FG006|Overall Study|Lost to Follow-up|0|||
94676887|NCT00638235|324271342|FG007|Overall Study|Lost to Follow-up|1|||
94676888|NCT00638235|324271343|FG008|Overall Study|Lost to Follow-up|18|||
94676889|NCT01814748|324271345|FG000|Overall Study|Lost to Follow-up|1|||
94676890|NCT01814748|324271346|FG001|Overall Study|Lost to Follow-up|2|||
94676891|NCT01814748|324271345|FG000|Overall Study|Study site terminated by sponsor|1|||
94676892|NCT01814748|324271346|FG001|Overall Study|Study site terminated by sponsor|1|||
94676893|NCT01814748|324271345|FG000|Overall Study|Withdrawal by Subject|6|||
94676894|NCT01814748|324271346|FG001|Overall Study|Withdrawal by Subject|4|||
94676895|NCT01445652|324271351|FG000|Overall Study|Not comfortable in lenses|5|||
94676896|NCT01445652|324271352|FG001|Overall Study|Not comfortable in lenses|0|||
94676897|NCT01445652|324271351|FG000|Overall Study|Failed to attend scheduled visit|2|||
94676898|NCT01445652|324271352|FG001|Overall Study|Failed to attend scheduled visit|3|||
94676899|NCT01445652|324271351|FG000|Overall Study|Failed teach session|2|||
94262431|NCT01968070|322754825|FG005|Period 1|Protocol Violation|0|||
94262432|NCT01968070|322754826|FG006|Period 1|Protocol Violation|0|||
94262433|NCT01968070|322754827|FG007|Period 1|Protocol Violation|0|||
94262434|NCT01968070|322754828|FG008|Period 1|Protocol Violation|0|||
94262435|NCT01968070|322754829|FG009|Period 1|Protocol Violation|0|||
94262436|NCT01968070|322754830|FG010|Period 1|Protocol Violation|0|||
94262437|NCT01968070|322754831|FG011|Period 1|Protocol Violation|0|||
94262438|NCT01968070|322754832|FG012|Period 1|Protocol Violation|0|||
94262439|NCT01968070|322754833|FG013|Period 1|Protocol Violation|0|||
94262440|NCT01968070|322754834|FG014|Period 1|Protocol Violation|0|||
94262441|NCT01968070|322754835|FG015|Period 1|Protocol Violation|0|||
94262442|NCT01968070|322754836|FG016|Period 1|Protocol Violation|0|||
94362797|NCT03000075|323112850|FG003|Part B|Not dosed due to AE|0|||
94362798|NCT03000075|323112851|FG004|Part B|Not dosed due to AE|0|||
94262443|NCT01968070|322754837|FG017|Period 1|Protocol Violation|0|||
94262444|NCT01968070|322754820|FG000|Period 1|Lost to Follow-up|0|||
94362799|NCT03000075|323112852|FG005|Part B|Not dosed due to AE|2|||
94362800|NCT03000075|323112853|FG006|Part B|Not dosed due to AE|1|||
94636761|NCT01909479|324132768|FG001|From Baseline to Week 26|Adverse Event|2|||
94636762|NCT01909479|324132767|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
94636763|NCT01909479|324132768|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
94636764|NCT01909479|324132767|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
94636765|NCT01909479|324132768|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
94636766|NCT01909479|324132767|FG000|26 - 52 Weeks|Adverse Event|0|||
94636767|NCT01909479|324132768|FG001|26 - 52 Weeks|Adverse Event|1|||
94636768|NCT01909479|324132767|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
94636769|NCT01909479|324132768|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
94636770|NCT01909479|324132767|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
94636771|NCT01909479|324132768|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
94636772|NCT01909479|324132767|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
94636773|NCT01909479|324132768|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
94636774|NCT01909479|324132767|FG000|52 Weeks to End of Study|Adverse Event|2|||
94636775|NCT01909479|324132768|FG001|52 Weeks to End of Study|Adverse Event|1|||
94636776|NCT01909479|324132767|FG000|52 Weeks to End of Study|Death|0|||
94636777|NCT01909479|324132768|FG001|52 Weeks to End of Study|Death|1|||
94636778|NCT01909479|324132767|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
94636779|NCT01909479|324132768|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
94636780|NCT01909479|324132767|FG000|52 Weeks to End of Study|Protocol Violation|1|||
94636781|NCT01909479|324132768|FG001|52 Weeks to End of Study|Protocol Violation|0|||
94636782|NCT01909479|324132767|FG000|52 Weeks to End of Study|Progressive disease|1|||
94636783|NCT01909479|324132768|FG001|52 Weeks to End of Study|Progressive disease|1|||
94636784|NCT01909479|324132767|FG000|52 Weeks to End of Study|Personal reasons|2|||
94636785|NCT01909479|324132768|FG001|52 Weeks to End of Study|Personal reasons|1|||
94636786|NCT01909479|324132767|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
94636787|NCT01909479|324132768|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
94636788|NCT01909479|324132767|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
94636789|NCT01909479|324132768|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
94636790|NCT01909479|324132767|FG000|52 Weeks to End of Study|Lack of contact|1|||
94636791|NCT01909479|324132768|FG001|52 Weeks to End of Study|Lack of contact|0|||
94636792|NCT01909479|324132767|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
94636793|NCT01909479|324132768|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
94636794|NCT01909479|324132767|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
94636795|NCT01909479|324132768|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
94636796|NCT00613015|324132769|FG000|Overall Study|Lost to Follow-up|0|||
94636797|NCT00613015|324132770|FG001|Overall Study|Lost to Follow-up|1|||
94636798|NCT00613015|324132771|FG002|Overall Study|Lost to Follow-up|3|||
94636799|NCT00613015|324132772|FG003|Overall Study|Lost to Follow-up|3|||
94636800|NCT00613015|324132773|FG004|Overall Study|Lost to Follow-up|2|||
94636801|NCT00613015|324132774|FG005|Overall Study|Lost to Follow-up|3|||
94636802|NCT01179477|324132777|FG000|Overall Study|Death|542|||
94636803|NCT01179477|324132777|FG000|Overall Study|Unsuccessful implant|80|||
94636804|NCT01179477|324132777|FG000|Overall Study|Non-death withdrawal|438|||
94636805|NCT01179477|324132777|FG000|Overall Study|Did not complete final visit|27|||
94636806|NCT04053023|324132778|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
94636807|NCT04053023|324132779|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
94636808|NCT04120974|324132780|FG000|Overall Study|Death|1|||
94636809|NCT04120974|324132780|FG000|Overall Study|Physician Decision|1|||
94636810|NCT04120974|324132780|FG000|Overall Study|Lost to Follow-up|6|||
94636811|NCT05075850|324132781|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
94636812|NCT03424265|324132782|FG000|Overall Study|screening failure|1|||
94636813|NCT03424265|324132783|FG001|Overall Study|screening failure|0|||
94636814|NCT03424265|324132782|FG000|Overall Study|Withdrawal by Subject|0|||
94636815|NCT03424265|324132783|FG001|Overall Study|Withdrawal by Subject|2|||
94636816|NCT03089606|324132784|FG000|Overall Study|Progression after Cycle 1|1|||
94636817|NCT03051607|324132786|FG000|Overall Study|Adverse Event|66|||
94636818|NCT02188589|324132787|FG000|Overall Study|Withdrawal by Subject|5|||
94636819|NCT03341533|324132792|FG000|Overall Study|Withdrawal by Subject|1|||
94636820|NCT03341533|324132793|FG001|Overall Study|Withdrawal by Subject|1|||
94636821|NCT03341533|324132792|FG000|Overall Study|Not eligible after randomization|2|||
94636822|NCT03341533|324132793|FG001|Overall Study|Not eligible after randomization|1|||
94636823|NCT02153112|324132796|FG000|Overall Study|Adverse Event|0|||
94636824|NCT02153112|324132797|FG001|Overall Study|Adverse Event|0|||
94636825|NCT02153112|324132798|FG002|Overall Study|Adverse Event|1|||
94636826|NCT02153112|324132799|FG003|Overall Study|Adverse Event|0|||
94636827|NCT02153112|324132800|FG004|Overall Study|Adverse Event|0|||
94636828|NCT02153112|324132801|FG005|Overall Study|Adverse Event|0|||
94636829|NCT02153112|324132802|FG006|Overall Study|Adverse Event|0|||
94636830|NCT02153112|324132803|FG007|Overall Study|Adverse Event|0|||
94636831|NCT02153112|324132804|FG008|Overall Study|Adverse Event|0|||
94636832|NCT02153112|324132805|FG009|Overall Study|Adverse Event|0|||
94362801|NCT03000075|323112847|FG000|Part B|Adverse Event|0|||
94362802|NCT03000075|323112848|FG001|Part B|Adverse Event|0|||
94636833|NCT02153112|324132796|FG000|Overall Study|Lost to Follow-up|1|||
94636834|NCT02153112|324132797|FG001|Overall Study|Lost to Follow-up|1|||
94636835|NCT02153112|324132798|FG002|Overall Study|Lost to Follow-up|0|||
94636836|NCT02153112|324132799|FG003|Overall Study|Lost to Follow-up|0|||
94636837|NCT02153112|324132800|FG004|Overall Study|Lost to Follow-up|2|||
94636838|NCT02153112|324132801|FG005|Overall Study|Lost to Follow-up|1|||
94636839|NCT02153112|324132802|FG006|Overall Study|Lost to Follow-up|1|||
94636840|NCT02153112|324132803|FG007|Overall Study|Lost to Follow-up|0|||
94636841|NCT02153112|324132804|FG008|Overall Study|Lost to Follow-up|1|||
94636842|NCT02153112|324132805|FG009|Overall Study|Lost to Follow-up|1|||
94636843|NCT02153112|324132796|FG000|Overall Study|Withdrawal by Subject|3|||
94636844|NCT02153112|324132797|FG001|Overall Study|Withdrawal by Subject|1|||
94636845|NCT02153112|324132798|FG002|Overall Study|Withdrawal by Subject|2|||
94636846|NCT02153112|324132799|FG003|Overall Study|Withdrawal by Subject|2|||
94636847|NCT02153112|324132800|FG004|Overall Study|Withdrawal by Subject|1|||
94636848|NCT02153112|324132801|FG005|Overall Study|Withdrawal by Subject|1|||
94636849|NCT02153112|324132802|FG006|Overall Study|Withdrawal by Subject|7|||
94636850|NCT02153112|324132803|FG007|Overall Study|Withdrawal by Subject|2|||
94636851|NCT02153112|324132804|FG008|Overall Study|Withdrawal by Subject|13|||
94636852|NCT02153112|324132805|FG009|Overall Study|Withdrawal by Subject|12|||
94636853|NCT02153112|324132796|FG000|Overall Study|Reason not Specified|0|||
94636854|NCT02153112|324132797|FG001|Overall Study|Reason not Specified|0|||
94636855|NCT02153112|324132798|FG002|Overall Study|Reason not Specified|0|||
94636856|NCT02153112|324132799|FG003|Overall Study|Reason not Specified|0|||
94636857|NCT02153112|324132800|FG004|Overall Study|Reason not Specified|0|||
94636858|NCT02153112|324132801|FG005|Overall Study|Reason not Specified|0|||
94636859|NCT02153112|324132802|FG006|Overall Study|Reason not Specified|0|||
94636860|NCT02153112|324132803|FG007|Overall Study|Reason not Specified|0|||
94636861|NCT02153112|324132804|FG008|Overall Study|Reason not Specified|1|||
94636862|NCT02153112|324132805|FG009|Overall Study|Reason not Specified|1|||
94636863|NCT02154581|324132813|FG000|Overall Study|Lost to Follow-up|7|||
94636864|NCT02154581|324132814|FG001|Overall Study|Lost to Follow-up|8|||
94636865|NCT00741039|324132815|FG000|Overall Study|Patient non-compliance|2|||
94636866|NCT00741039|324132816|FG001|Overall Study|Patient non-compliance|0|||
94636867|NCT01712854|324132817|FG000|Overall Study|Physician Decision|1|||
94636868|NCT02225743|324132818|FG000|Overall Study|Withdrawal by Subject|18|||
94636869|NCT02515045|324132821|FG000|Overall Study|Adverse Event|0|||
94636870|NCT02515045|324132822|FG001|Overall Study|Adverse Event|3|||
94636871|NCT02515045|324132823|FG002|Overall Study|Adverse Event|3|||
94636872|NCT02515045|324132821|FG000|Overall Study|Lost to Follow-up|0|||
94636873|NCT02515045|324132822|FG001|Overall Study|Lost to Follow-up|1|||
94636874|NCT02515045|324132823|FG002|Overall Study|Lost to Follow-up|1|||
94636875|NCT02068222|324132824|FG000|Overall Study|Lost to Follow-up|1|||
94636876|NCT03082599|324132825|FG000|Overall Study|Lost to Follow-up|1|||
94636877|NCT03082599|324132826|FG001|Overall Study|Lost to Follow-up|0|||
94636878|NCT02221284|324132829|FG000|Overall Study|Case Report Forms Uncollected|56|||
94636879|NCT02221284|324132829|FG000|Overall Study|Protocol Deviation|5|||
94636880|NCT01675128|324132830|FG000|Overall Study|Disease progression on study|1|||
94636881|NCT01675128|324132831|FG001|Overall Study|Disease progression on study|1|||
94636882|NCT01675128|324132832|FG002|Overall Study|Disease progression on study|1|||
94636883|NCT01675128|324132830|FG000|Overall Study|Refused further treatment|1|||
94636884|NCT01675128|324132831|FG001|Overall Study|Refused further treatment|0|||
94636885|NCT01675128|324132832|FG002|Overall Study|Refused further treatment|0|||
94636886|NCT01675128|324132830|FG000|Overall Study|Pulmonary complication; off study|0|||
94636887|NCT01675128|324132831|FG001|Overall Study|Pulmonary complication; off study|1|||
94636888|NCT01675128|324132832|FG002|Overall Study|Pulmonary complication; off study|0|||
94636889|NCT03011307|324132833|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
94636890|NCT03011307|324132834|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
94636891|NCT03011307|324132833|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
94636892|NCT03011307|324132834|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
94636893|NCT03011307|324132833|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
94636894|NCT03011307|324132834|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
94636895|NCT01782664|324132835|FG000|Overall Study|Adverse Event|2|||
94636896|NCT01782664|324132836|FG001|Overall Study|Adverse Event|2|||
94636897|NCT01782664|324132837|FG002|Overall Study|Adverse Event|2|||
94636898|NCT01782664|324132838|FG003|Overall Study|Adverse Event|2|||
94636899|NCT01782664|324132839|FG004|Overall Study|Adverse Event|0|||
94636900|NCT01782664|324132840|FG005|Overall Study|Adverse Event|0|||
94636901|NCT01782664|324132835|FG000|Overall Study|Lack of Efficacy|2|||
94636902|NCT01782664|324132836|FG001|Overall Study|Lack of Efficacy|0|||
94636903|NCT01782664|324132837|FG002|Overall Study|Lack of Efficacy|2|||
94636904|NCT01782664|324132838|FG003|Overall Study|Lack of Efficacy|2|||
94636905|NCT01782664|324132839|FG004|Overall Study|Lack of Efficacy|0|||
94636906|NCT01782664|324132840|FG005|Overall Study|Lack of Efficacy|0|||
94636907|NCT01782664|324132835|FG000|Overall Study|Protocol Violation|0|||
94636908|NCT01782664|324132836|FG001|Overall Study|Protocol Violation|1|||
94636909|NCT01782664|324132837|FG002|Overall Study|Protocol Violation|0|||
94636910|NCT01782664|324132838|FG003|Overall Study|Protocol Violation|1|||
94636911|NCT01782664|324132839|FG004|Overall Study|Protocol Violation|0|||
94636912|NCT01782664|324132840|FG005|Overall Study|Protocol Violation|0|||
94636913|NCT01782664|324132835|FG000|Overall Study|Withdrawal by Subject|2|||
94636914|NCT01782664|324132836|FG001|Overall Study|Withdrawal by Subject|2|||
94636915|NCT01782664|324132837|FG002|Overall Study|Withdrawal by Subject|0|||
94636916|NCT01782664|324132838|FG003|Overall Study|Withdrawal by Subject|0|||
94636917|NCT01782664|324132839|FG004|Overall Study|Withdrawal by Subject|0|||
94636918|NCT01782664|324132840|FG005|Overall Study|Withdrawal by Subject|0|||
94636919|NCT01474876|324132841|FG000|Overall Study|Adverse Event|11|||
94636920|NCT01474876|324132842|FG001|Overall Study|Adverse Event|5|||
94636921|NCT01474876|324132843|FG002|Overall Study|Adverse Event|0|||
94636922|NCT01474876|324132841|FG000|Overall Study|Serious Adverse Event|2|||
94636923|NCT01474876|324132842|FG001|Overall Study|Serious Adverse Event|3|||
94636924|NCT01474876|324132843|FG002|Overall Study|Serious Adverse Event|0|||
94636925|NCT01474876|324132841|FG000|Overall Study|Lost to Follow-up|5|||
94636926|NCT01474876|324132842|FG001|Overall Study|Lost to Follow-up|4|||
94636927|NCT01474876|324132843|FG002|Overall Study|Lost to Follow-up|0|||
94636928|NCT01474876|324132841|FG000|Overall Study|Investigator's decision|28|||
94636929|NCT01474876|324132842|FG001|Overall Study|Investigator's decision|6|||
94636930|NCT01474876|324132843|FG002|Overall Study|Investigator's decision|0|||
94636931|NCT01474876|324132841|FG000|Overall Study|Patient's request|19|||
94636932|NCT01474876|324132842|FG001|Overall Study|Patient's request|5|||
94636933|NCT01474876|324132843|FG002|Overall Study|Patient's request|0|||
94636934|NCT01474876|324132841|FG000|Overall Study|Investigator's decision and pt request|1|||
94636935|NCT01474876|324132842|FG001|Overall Study|Investigator's decision and pt request|0|||
94636936|NCT01474876|324132843|FG002|Overall Study|Investigator's decision and pt request|0|||
94636937|NCT03839212|324132844|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
94636938|NCT03025542|324134583|FG000|Overall Study|Adverse Event|0|||
94636939|NCT03025542|324134584|FG001|Overall Study|Adverse Event|2|||
94636940|NCT03025542|324134583|FG000|Overall Study|Lost to Follow-up|1|||
94636941|NCT03025542|324134584|FG001|Overall Study|Lost to Follow-up|0|||
94636942|NCT03025542|324134583|FG000|Overall Study|Withdrawal by Subject|1|||
94636943|NCT03025542|324134584|FG001|Overall Study|Withdrawal by Subject|0|||
94636944|NCT01729754|324134586|FG000|Part 1|Adverse Event|2|||
94636945|NCT01729754|324134587|FG001|Part 1|Adverse Event|0|||
94636946|NCT01729754|324134588|FG002|Part 1|Adverse Event|0|||
94636947|NCT01729754|324134589|FG003|Part 1|Adverse Event|1|||
94636948|NCT01729754|324134590|FG004|Part 1|Adverse Event|0|||
94636949|NCT01729754|324134591|FG005|Part 1|Adverse Event|0|||
94636950|NCT01729754|324134592|FG006|Part 1|Adverse Event|2|||
94636951|NCT01729754|324134593|FG007|Part 1|Adverse Event|0|||
94636952|NCT01729754|324134594|FG008|Part 1|Adverse Event|0|||
94636953|NCT01729754|324134595|FG009|Part 1|Adverse Event|5|||
94636954|NCT01729754|324134586|FG000|Part 1|Lack of Efficacy|1|||
94636955|NCT01729754|324134587|FG001|Part 1|Lack of Efficacy|0|||
94636956|NCT01729754|324134588|FG002|Part 1|Lack of Efficacy|0|||
94636957|NCT01729754|324134589|FG003|Part 1|Lack of Efficacy|0|||
94636958|NCT01729754|324134590|FG004|Part 1|Lack of Efficacy|0|||
94636959|NCT01729754|324134591|FG005|Part 1|Lack of Efficacy|0|||
94636960|NCT01729754|324134592|FG006|Part 1|Lack of Efficacy|2|||
94636961|NCT01729754|324134593|FG007|Part 1|Lack of Efficacy|0|||
94636962|NCT01729754|324134594|FG008|Part 1|Lack of Efficacy|0|||
94636963|NCT01729754|324134595|FG009|Part 1|Lack of Efficacy|0|||
94636964|NCT01729754|324134586|FG000|Part 1|Lost to Follow-up|1|||
94636965|NCT01729754|324134587|FG001|Part 1|Lost to Follow-up|0|||
94636966|NCT01729754|324134588|FG002|Part 1|Lost to Follow-up|0|||
94636967|NCT01729754|324134589|FG003|Part 1|Lost to Follow-up|2|||
94636968|NCT01729754|324134590|FG004|Part 1|Lost to Follow-up|0|||
94636969|NCT01729754|324134591|FG005|Part 1|Lost to Follow-up|0|||
94636970|NCT01729754|324134592|FG006|Part 1|Lost to Follow-up|3|||
94636971|NCT01729754|324134593|FG007|Part 1|Lost to Follow-up|0|||
94636972|NCT01729754|324134594|FG008|Part 1|Lost to Follow-up|0|||
94636973|NCT01729754|324134595|FG009|Part 1|Lost to Follow-up|3|||
94636974|NCT01729754|324134586|FG000|Part 1|Non-compliance with Study Drug|1|||
94636975|NCT01729754|324134587|FG001|Part 1|Non-compliance with Study Drug|0|||
94636976|NCT01729754|324134588|FG002|Part 1|Non-compliance with Study Drug|0|||
94636977|NCT01729754|324134589|FG003|Part 1|Non-compliance with Study Drug|0|||
94636978|NCT01729754|324134590|FG004|Part 1|Non-compliance with Study Drug|0|||
94636979|NCT01729754|324134591|FG005|Part 1|Non-compliance with Study Drug|0|||
94636980|NCT01729754|324134592|FG006|Part 1|Non-compliance with Study Drug|0|||
94636981|NCT01729754|324134593|FG007|Part 1|Non-compliance with Study Drug|0|||
94636982|NCT01729754|324134594|FG008|Part 1|Non-compliance with Study Drug|0|||
94636983|NCT01729754|324134595|FG009|Part 1|Non-compliance with Study Drug|0|||
94636984|NCT01729754|324134586|FG000|Part 1|Physician Decision|0|||
94636985|NCT01729754|324134587|FG001|Part 1|Physician Decision|0|||
94636986|NCT01729754|324134588|FG002|Part 1|Physician Decision|0|||
94636987|NCT01729754|324134589|FG003|Part 1|Physician Decision|0|||
94636988|NCT01729754|324134590|FG004|Part 1|Physician Decision|0|||
94636989|NCT01729754|324134591|FG005|Part 1|Physician Decision|0|||
94262445|NCT01968070|322754821|FG001|Period 1|Lost to Follow-up|0|||
94262446|NCT01968070|322754822|FG002|Period 1|Lost to Follow-up|0|||
94262447|NCT01968070|322754823|FG003|Period 1|Lost to Follow-up|1|||
94262448|NCT01968070|322754824|FG004|Period 1|Lost to Follow-up|0|||
94262449|NCT01968070|322754825|FG005|Period 1|Lost to Follow-up|0|||
94262450|NCT01968070|322754826|FG006|Period 1|Lost to Follow-up|0|||
94262451|NCT01968070|322754827|FG007|Period 1|Lost to Follow-up|0|||
94262452|NCT01968070|322754828|FG008|Period 1|Lost to Follow-up|0|||
94262453|NCT01968070|322754829|FG009|Period 1|Lost to Follow-up|0|||
94262454|NCT01968070|322754830|FG010|Period 1|Lost to Follow-up|0|||
94262455|NCT01968070|322754831|FG011|Period 1|Lost to Follow-up|0|||
94262456|NCT01968070|322754832|FG012|Period 1|Lost to Follow-up|0|||
94262457|NCT01968070|322754833|FG013|Period 1|Lost to Follow-up|0|||
94262458|NCT01968070|322754834|FG014|Period 1|Lost to Follow-up|0|||
94262459|NCT01968070|322754835|FG015|Period 1|Lost to Follow-up|0|||
94262460|NCT01968070|322754836|FG016|Period 1|Lost to Follow-up|0|||
94262461|NCT01968070|322754837|FG017|Period 1|Lost to Follow-up|0|||
94636990|NCT01729754|324134592|FG006|Part 1|Physician Decision|0|||
94636991|NCT01729754|324134593|FG007|Part 1|Physician Decision|0|||
94636992|NCT01729754|324134594|FG008|Part 1|Physician Decision|0|||
94636993|NCT01729754|324134595|FG009|Part 1|Physician Decision|4|||
94636994|NCT01729754|324134586|FG000|Part 1|Pregnancy|0|||
94636995|NCT01729754|324134587|FG001|Part 1|Pregnancy|0|||
94636996|NCT01729754|324134588|FG002|Part 1|Pregnancy|0|||
94636997|NCT01729754|324134589|FG003|Part 1|Pregnancy|1|||
94636998|NCT01729754|324134590|FG004|Part 1|Pregnancy|0|||
94636999|NCT01729754|324134591|FG005|Part 1|Pregnancy|0|||
94637000|NCT01729754|324134592|FG006|Part 1|Pregnancy|0|||
94637001|NCT01729754|324134593|FG007|Part 1|Pregnancy|0|||
94637002|NCT01729754|324134594|FG008|Part 1|Pregnancy|0|||
94637003|NCT01729754|324134595|FG009|Part 1|Pregnancy|1|||
94637004|NCT01729754|324134586|FG000|Part 1|Progressive Disease|0|||
94637005|NCT01729754|324134587|FG001|Part 1|Progressive Disease|0|||
94637006|NCT01729754|324134588|FG002|Part 1|Progressive Disease|0|||
94637007|NCT01729754|324134589|FG003|Part 1|Progressive Disease|0|||
94637008|NCT01729754|324134590|FG004|Part 1|Progressive Disease|0|||
94637009|NCT01729754|324134591|FG005|Part 1|Progressive Disease|0|||
94637010|NCT01729754|324134592|FG006|Part 1|Progressive Disease|0|||
94637011|NCT01729754|324134593|FG007|Part 1|Progressive Disease|0|||
94637012|NCT01729754|324134594|FG008|Part 1|Progressive Disease|0|||
94637013|NCT01729754|324134595|FG009|Part 1|Progressive Disease|1|||
94637014|NCT01729754|324134586|FG000|Part 1|Protocol Violation|2|||
94637015|NCT01729754|324134587|FG001|Part 1|Protocol Violation|0|||
94637016|NCT01729754|324134588|FG002|Part 1|Protocol Violation|0|||
94637017|NCT01729754|324134589|FG003|Part 1|Protocol Violation|1|||
94637018|NCT01729754|324134590|FG004|Part 1|Protocol Violation|0|||
94637019|NCT01729754|324134591|FG005|Part 1|Protocol Violation|0|||
94637020|NCT01729754|324134592|FG006|Part 1|Protocol Violation|1|||
94637021|NCT01729754|324134593|FG007|Part 1|Protocol Violation|0|||
94637022|NCT01729754|324134594|FG008|Part 1|Protocol Violation|0|||
94637023|NCT01729754|324134595|FG009|Part 1|Protocol Violation|0|||
94637024|NCT01729754|324134586|FG000|Part 1|Withdrawal by Subject|5|||
94637025|NCT01729754|324134587|FG001|Part 1|Withdrawal by Subject|0|||
94637026|NCT01729754|324134588|FG002|Part 1|Withdrawal by Subject|0|||
94637027|NCT01729754|324134589|FG003|Part 1|Withdrawal by Subject|7|||
94637028|NCT01729754|324134590|FG004|Part 1|Withdrawal by Subject|0|||
94637029|NCT01729754|324134591|FG005|Part 1|Withdrawal by Subject|0|||
94637030|NCT01729754|324134592|FG006|Part 1|Withdrawal by Subject|5|||
94637031|NCT01729754|324134593|FG007|Part 1|Withdrawal by Subject|0|||
94262462|NCT01968070|322754820|FG000|Period 1|Adverse Event|0|||
94262463|NCT01968070|322754821|FG001|Period 1|Adverse Event|0|||
94262464|NCT01968070|322754822|FG002|Period 1|Adverse Event|0|||
94262465|NCT01968070|322754823|FG003|Period 1|Adverse Event|0|||
94262466|NCT01968070|322754824|FG004|Period 1|Adverse Event|0|||
94262467|NCT01968070|322754825|FG005|Period 1|Adverse Event|0|||
94637032|NCT01729754|324134594|FG008|Part 1|Withdrawal by Subject|0|||
94637033|NCT01729754|324134595|FG009|Part 1|Withdrawal by Subject|6|||
94637034|NCT01729754|324134586|FG000|Part 1|Other Protocol Specified Criteria|2|||
94637035|NCT01729754|324134587|FG001|Part 1|Other Protocol Specified Criteria|0|||
94637036|NCT01729754|324134588|FG002|Part 1|Other Protocol Specified Criteria|0|||
94637037|NCT01729754|324134589|FG003|Part 1|Other Protocol Specified Criteria|0|||
94637038|NCT01729754|324134590|FG004|Part 1|Other Protocol Specified Criteria|0|||
94637039|NCT01729754|324134591|FG005|Part 1|Other Protocol Specified Criteria|0|||
94637040|NCT01729754|324134592|FG006|Part 1|Other Protocol Specified Criteria|1|||
94262468|NCT01968070|322754826|FG006|Period 1|Adverse Event|1|||
94262469|NCT01968070|322754827|FG007|Period 1|Adverse Event|0|||
94262470|NCT01968070|322754828|FG008|Period 1|Adverse Event|0|||
94262471|NCT01968070|322754829|FG009|Period 1|Adverse Event|0|||
94262472|NCT01968070|322754830|FG010|Period 1|Adverse Event|0|||
94262473|NCT01968070|322754831|FG011|Period 1|Adverse Event|0|||
94637041|NCT01729754|324134593|FG007|Part 1|Other Protocol Specified Criteria|0|||
94637042|NCT01729754|324134594|FG008|Part 1|Other Protocol Specified Criteria|0|||
94637043|NCT01729754|324134595|FG009|Part 1|Other Protocol Specified Criteria|4|||
94637044|NCT01729754|324134586|FG000|Part 2|Adverse Event|2|||
94676900|NCT01445652|324271352|FG001|Overall Study|Failed teach session|0|||
94676901|NCT01445652|324271351|FG000|Overall Study|Adverse Event|1|||
94676902|NCT01445652|324271352|FG001|Overall Study|Adverse Event|0|||
94676903|NCT00855062|324271361|FG000|Step1|Early Study Closure|5|||
94676904|NCT00855062|324271362|FG001|Step1|Early Study Closure|7|||
94676905|NCT00855062|324271361|FG000|Step1|Adverse Event|1|||
94676906|NCT00855062|324271362|FG001|Step1|Adverse Event|1|||
94676907|NCT00855062|324271361|FG000|Step1|Protocol Violation|1|||
94676908|NCT00855062|324271362|FG001|Step1|Protocol Violation|0|||
94676909|NCT00855062|324271361|FG000|Step1|Pregnancy|1|||
94676910|NCT00855062|324271362|FG001|Step1|Pregnancy|0|||
94676911|NCT00855062|324271361|FG000|Step1|Withdrawal by Subject|2|||
94676912|NCT00855062|324271362|FG001|Step1|Withdrawal by Subject|3|||
94676913|NCT00855062|324271361|FG000|Step2|Early Study Closure|6|||
94676914|NCT00855062|324271362|FG001|Step2|Early Study Closure|2|||
94676915|NCT00855062|324271361|FG000|Step2|Adverse Event|0|||
94676916|NCT00855062|324271362|FG001|Step2|Adverse Event|3|||
94676917|NCT00855062|324271361|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
94676918|NCT00855062|324271362|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
94676919|NCT03002610|324271363|FG000|Overall Study|Withdrawal by Subject|6|||
94676920|NCT03002610|324271364|FG001|Overall Study|Withdrawal by Subject|25|||
94676921|NCT03002610|324271365|FG002|Overall Study|Withdrawal by Subject|13|||
94676922|NCT00509236|324271366|FG000|Overall Study|Adverse Event|7|||
94676923|NCT00509236|324271367|FG001|Overall Study|Adverse Event|9|||
94676924|NCT00509236|324271366|FG000|Overall Study|Withdrawal by Subject|5|||
94676925|NCT00509236|324271367|FG001|Overall Study|Withdrawal by Subject|10|||
94676926|NCT00509236|324271366|FG000|Overall Study|Protocol Violation|3|||
94676927|NCT00509236|324271367|FG001|Overall Study|Protocol Violation|0|||
94676928|NCT00509236|324271366|FG000|Overall Study|Excluded Medication|1|||
94676929|NCT00509236|324271367|FG001|Overall Study|Excluded Medication|1|||
94676930|NCT00509236|324271366|FG000|Overall Study|Scheduled Kidney Transplant|1|||
94676931|NCT00509236|324271367|FG001|Overall Study|Scheduled Kidney Transplant|0|||
94676932|NCT01376323|324271368|FG000|Overall Study|Adverse Event|1|||
94676933|NCT01376323|324271369|FG001|Overall Study|Adverse Event|0|||
94676934|NCT01376323|324271370|FG002|Overall Study|Adverse Event|0|||
94676935|NCT01376323|324271371|FG003|Overall Study|Adverse Event|2|||
94676936|NCT01376323|324271372|FG004|Overall Study|Adverse Event|0|||
94676937|NCT01376323|324271368|FG000|Overall Study|Lost to Follow-up|0|||
94676938|NCT01376323|324271369|FG001|Overall Study|Lost to Follow-up|0|||
94676939|NCT01376323|324271370|FG002|Overall Study|Lost to Follow-up|0|||
94676940|NCT01376323|324271371|FG003|Overall Study|Lost to Follow-up|2|||
94676941|NCT01376323|324271372|FG004|Overall Study|Lost to Follow-up|0|||
94676942|NCT01376323|324271368|FG000|Overall Study|Physician Decision|1|||
94676943|NCT01376323|324271369|FG001|Overall Study|Physician Decision|0|||
94637045|NCT01729754|324134587|FG001|Part 2|Adverse Event|0|||
94637046|NCT01729754|324134588|FG002|Part 2|Adverse Event|0|||
94637047|NCT01729754|324134589|FG003|Part 2|Adverse Event|0|||
94637048|NCT01729754|324134590|FG004|Part 2|Adverse Event|0|||
94637049|NCT01729754|324134591|FG005|Part 2|Adverse Event|0|||
94637050|NCT01729754|324134592|FG006|Part 2|Adverse Event|0|||
94637051|NCT01729754|324134593|FG007|Part 2|Adverse Event|0|||
94637052|NCT01729754|324134594|FG008|Part 2|Adverse Event|1|||
94637053|NCT01729754|324134595|FG009|Part 2|Adverse Event|2|||
94637054|NCT01729754|324134586|FG000|Part 2|Lack of Efficacy|0|||
94637055|NCT01729754|324134587|FG001|Part 2|Lack of Efficacy|0|||
94637056|NCT01729754|324134588|FG002|Part 2|Lack of Efficacy|0|||
94676944|NCT01376323|324271370|FG002|Overall Study|Physician Decision|2|||
94676945|NCT01376323|324271371|FG003|Overall Study|Physician Decision|1|||
94676946|NCT01376323|324271372|FG004|Overall Study|Physician Decision|1|||
94676947|NCT01376323|324271368|FG000|Overall Study|Withdrawal by Subject|0|||
94262474|NCT01968070|322754832|FG012|Period 1|Adverse Event|0|||
94262475|NCT01968070|322754833|FG013|Period 1|Adverse Event|0|||
94637057|NCT01729754|324134589|FG003|Part 2|Lack of Efficacy|0|||
94676948|NCT01376323|324271369|FG001|Overall Study|Withdrawal by Subject|1|||
94676949|NCT01376323|324271370|FG002|Overall Study|Withdrawal by Subject|1|||
94637058|NCT01729754|324134590|FG004|Part 2|Lack of Efficacy|0|||
94676950|NCT01376323|324271371|FG003|Overall Study|Withdrawal by Subject|0|||
94262476|NCT01968070|322754834|FG014|Period 1|Adverse Event|0|||
94637059|NCT01729754|324134591|FG005|Part 2|Lack of Efficacy|0|||
94676951|NCT01376323|324271372|FG004|Overall Study|Withdrawal by Subject|0|||
94676952|NCT00454571|324271373|FG000|Overall Study|Adverse Event|2|||
94676953|NCT00454571|324271374|FG001|Overall Study|Adverse Event|0|||
94676954|NCT00454571|324271373|FG000|Overall Study|Physician Decision|0|||
94676955|NCT00454571|324271374|FG001|Overall Study|Physician Decision|1|||
94676956|NCT00454571|324271373|FG000|Overall Study|Protocol Violation|1|||
94262477|NCT01968070|322754835|FG015|Period 1|Adverse Event|0|||
94637060|NCT01729754|324134592|FG006|Part 2|Lack of Efficacy|0|||
94637061|NCT01729754|324134593|FG007|Part 2|Lack of Efficacy|0|||
94637062|NCT01729754|324134594|FG008|Part 2|Lack of Efficacy|2|||
94637063|NCT01729754|324134595|FG009|Part 2|Lack of Efficacy|2|||
94676957|NCT00454571|324271374|FG001|Overall Study|Protocol Violation|0|||
94676958|NCT00454571|324271373|FG000|Overall Study|Withdrawal by Subject|10|||
94676959|NCT00454571|324271374|FG001|Overall Study|Withdrawal by Subject|5|||
94262478|NCT01968070|322754836|FG016|Period 1|Adverse Event|0|||
94262479|NCT01968070|322754837|FG017|Period 1|Adverse Event|0|||
94262480|NCT01968070|322754820|FG000|Period 1|Physician Decision|0|||
94262481|NCT01968070|322754821|FG001|Period 1|Physician Decision|0|||
94262482|NCT01968070|322754822|FG002|Period 1|Physician Decision|0|||
94262483|NCT01968070|322754823|FG003|Period 1|Physician Decision|0|||
94262484|NCT01968070|322754824|FG004|Period 1|Physician Decision|0|||
94262485|NCT01968070|322754825|FG005|Period 1|Physician Decision|0|||
94262486|NCT01968070|322754826|FG006|Period 1|Physician Decision|0|||
94262487|NCT01968070|322754827|FG007|Period 1|Physician Decision|0|||
94262488|NCT01968070|322754828|FG008|Period 1|Physician Decision|0|||
94262489|NCT01968070|322754829|FG009|Period 1|Physician Decision|0|||
94262490|NCT01968070|322754830|FG010|Period 1|Physician Decision|0|||
94262491|NCT01968070|322754831|FG011|Period 1|Physician Decision|1|||
94262492|NCT01968070|322754832|FG012|Period 1|Physician Decision|0|||
94262493|NCT01968070|322754833|FG013|Period 1|Physician Decision|0|||
94262494|NCT01968070|322754834|FG014|Period 1|Physician Decision|0|||
94262495|NCT01968070|322754835|FG015|Period 1|Physician Decision|0|||
94262496|NCT01968070|322754836|FG016|Period 1|Physician Decision|0|||
94262497|NCT01968070|322754837|FG017|Period 1|Physician Decision|0|||
94262498|NCT01968070|322754820|FG000|Period 2|Withdrawal by Subject|0|||
94262499|NCT01968070|322754821|FG001|Period 2|Withdrawal by Subject|0|||
94262500|NCT01968070|322754822|FG002|Period 2|Withdrawal by Subject|0|||
94262501|NCT01968070|322754823|FG003|Period 2|Withdrawal by Subject|0|||
94262502|NCT01968070|322754824|FG004|Period 2|Withdrawal by Subject|1|||
94262503|NCT01968070|322754825|FG005|Period 2|Withdrawal by Subject|0|||
94262504|NCT01968070|322754826|FG006|Period 2|Withdrawal by Subject|0|||
94262505|NCT01968070|322754827|FG007|Period 2|Withdrawal by Subject|0|||
94262506|NCT01968070|322754828|FG008|Period 2|Withdrawal by Subject|0|||
94262507|NCT01968070|322754829|FG009|Period 2|Withdrawal by Subject|0|||
94262508|NCT01968070|322754830|FG010|Period 2|Withdrawal by Subject|0|||
94262509|NCT01968070|322754831|FG011|Period 2|Withdrawal by Subject|0|||
94262510|NCT01968070|322754832|FG012|Period 2|Withdrawal by Subject|0|||
94262511|NCT01968070|322754833|FG013|Period 2|Withdrawal by Subject|0|||
94262512|NCT01968070|322754834|FG014|Period 2|Withdrawal by Subject|0|||
94262513|NCT01968070|322754835|FG015|Period 2|Withdrawal by Subject|0|||
94262514|NCT01968070|322754836|FG016|Period 2|Withdrawal by Subject|0|||
94262515|NCT01968070|322754837|FG017|Period 2|Withdrawal by Subject|0|||
94262516|NCT01610687|322754848|FG000|Overall Study|Lack of Efficacy|26|||
94262517|NCT01610687|322754848|FG000|Overall Study|Adverse Event|18|||
94262518|NCT01610687|322754848|FG000|Overall Study|Moved out of area|6|||
94262519|NCT01610687|322754848|FG000|Overall Study|Withdrawal by Subject|7|||
94362803|NCT03000075|323112849|FG002|Part B|Adverse Event|0|||
94637064|NCT01729754|324134586|FG000|Part 2|Lost to Follow-up|0|||
94637065|NCT01729754|324134587|FG001|Part 2|Lost to Follow-up|0|||
94637066|NCT01729754|324134588|FG002|Part 2|Lost to Follow-up|0|||
94637067|NCT01729754|324134589|FG003|Part 2|Lost to Follow-up|2|||
94637068|NCT01729754|324134590|FG004|Part 2|Lost to Follow-up|0|||
94637069|NCT01729754|324134591|FG005|Part 2|Lost to Follow-up|0|||
94637070|NCT01729754|324134592|FG006|Part 2|Lost to Follow-up|0|||
94637071|NCT01729754|324134593|FG007|Part 2|Lost to Follow-up|1|||
94637072|NCT01729754|324134594|FG008|Part 2|Lost to Follow-up|0|||
94637073|NCT01729754|324134595|FG009|Part 2|Lost to Follow-up|2|||
94637074|NCT01729754|324134586|FG000|Part 2|Non-Compliance with Study Drug|0|||
94637075|NCT01729754|324134587|FG001|Part 2|Non-Compliance with Study Drug|0|||
94637076|NCT01729754|324134588|FG002|Part 2|Non-Compliance with Study Drug|0|||
94637077|NCT01729754|324134589|FG003|Part 2|Non-Compliance with Study Drug|0|||
94637078|NCT01729754|324134590|FG004|Part 2|Non-Compliance with Study Drug|0|||
94637079|NCT01729754|324134591|FG005|Part 2|Non-Compliance with Study Drug|0|||
94637080|NCT01729754|324134592|FG006|Part 2|Non-Compliance with Study Drug|0|||
94637081|NCT01729754|324134593|FG007|Part 2|Non-Compliance with Study Drug|0|||
94637082|NCT01729754|324134594|FG008|Part 2|Non-Compliance with Study Drug|0|||
94637083|NCT01729754|324134595|FG009|Part 2|Non-Compliance with Study Drug|1|||
94637084|NCT01729754|324134586|FG000|Part 2|Pregnancy|0|||
94637085|NCT01729754|324134587|FG001|Part 2|Pregnancy|0|||
94637086|NCT01729754|324134588|FG002|Part 2|Pregnancy|0|||
94262520|NCT01610687|322754848|FG000|Overall Study|Lost to Follow-up|4|||
94362804|NCT03000075|323112850|FG003|Part B|Adverse Event|0|||
94362805|NCT03000075|323112851|FG004|Part B|Adverse Event|1|||
94362806|NCT03000075|323112852|FG005|Part B|Adverse Event|0|||
94637087|NCT01729754|324134589|FG003|Part 2|Pregnancy|1|||
94637088|NCT01729754|324134590|FG004|Part 2|Pregnancy|0|||
94637089|NCT01729754|324134591|FG005|Part 2|Pregnancy|0|||
94262521|NCT01610687|322754848|FG000|Overall Study|Symptom control without study medication|2|||
94262522|NCT01610687|322754848|FG000|Overall Study|Unable to make journey|1|||
94262523|NCT01610687|322754848|FG000|Overall Study|Death|1|||
94262524|NCT01610687|322754848|FG000|Overall Study|Cannabis affecting job|1|||
94262525|NCT01610687|322754848|FG000|Overall Study|Felt more alter without study medication|1|||
94362807|NCT03000075|323112853|FG006|Part B|Adverse Event|0|||
94637090|NCT01729754|324134592|FG006|Part 2|Pregnancy|0|||
94637091|NCT01729754|324134593|FG007|Part 2|Pregnancy|0|||
94637092|NCT01729754|324134594|FG008|Part 2|Pregnancy|0|||
94637093|NCT01729754|324134595|FG009|Part 2|Pregnancy|1|||
94262526|NCT02520284|322754861|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
94262527|NCT02520284|322754862|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
94262528|NCT02520284|322754863|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
94262529|NCT02520284|322754861|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
94262530|NCT02520284|322754862|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
94262531|NCT02520284|322754863|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
94262532|NCT02520284|322754861|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
94262533|NCT02520284|322754862|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
94262534|NCT02520284|322754863|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
94262535|NCT02520284|322754861|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
94262536|NCT02520284|322754862|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
94262537|NCT02520284|322754863|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
94262538|NCT02520284|322754861|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
94262539|NCT02520284|322754862|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
94262540|NCT02520284|322754863|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
94262541|NCT02520284|322754861|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
94262542|NCT02520284|322754862|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
94262543|NCT02520284|322754863|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
94262544|NCT02520284|322754861|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
94262545|NCT02520284|322754862|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
94262546|NCT02520284|322754863|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
94637094|NCT01729754|324134586|FG000|Part 2|Withdrawal by Subject|3|||
94637095|NCT01729754|324134587|FG001|Part 2|Withdrawal by Subject|0|||
94637096|NCT01729754|324134588|FG002|Part 2|Withdrawal by Subject|0|||
94637097|NCT01729754|324134589|FG003|Part 2|Withdrawal by Subject|2|||
94637098|NCT01729754|324134590|FG004|Part 2|Withdrawal by Subject|0|||
94637099|NCT01729754|324134591|FG005|Part 2|Withdrawal by Subject|0|||
94637100|NCT01729754|324134592|FG006|Part 2|Withdrawal by Subject|0|||
94637101|NCT01729754|324134593|FG007|Part 2|Withdrawal by Subject|1|||
94637102|NCT01729754|324134594|FG008|Part 2|Withdrawal by Subject|1|||
94637103|NCT01729754|324134595|FG009|Part 2|Withdrawal by Subject|4|||
94637104|NCT01729754|324134586|FG000|Part 2|Other Protocol Specified Criteria|1|||
94637105|NCT01729754|324134587|FG001|Part 2|Other Protocol Specified Criteria|0|||
94637106|NCT01729754|324134588|FG002|Part 2|Other Protocol Specified Criteria|0|||
94637107|NCT01729754|324134589|FG003|Part 2|Other Protocol Specified Criteria|0|||
94637108|NCT01729754|324134590|FG004|Part 2|Other Protocol Specified Criteria|0|||
94637109|NCT01729754|324134591|FG005|Part 2|Other Protocol Specified Criteria|0|||
94637110|NCT01729754|324134592|FG006|Part 2|Other Protocol Specified Criteria|0|||
94637111|NCT01729754|324134593|FG007|Part 2|Other Protocol Specified Criteria|1|||
94637112|NCT01729754|324134594|FG008|Part 2|Other Protocol Specified Criteria|0|||
94637113|NCT01729754|324134595|FG009|Part 2|Other Protocol Specified Criteria|0|||
94637114|NCT01729754|324134586|FG000|Part 3|Adverse Event|0|||
94637115|NCT01729754|324134587|FG001|Part 3|Adverse Event|0|||
94637116|NCT01729754|324134588|FG002|Part 3|Adverse Event|1|||
94637117|NCT01729754|324134589|FG003|Part 3|Adverse Event|0|||
94637118|NCT01729754|324134590|FG004|Part 3|Adverse Event|0|||
94637119|NCT01729754|324134591|FG005|Part 3|Adverse Event|5|||
94637120|NCT01729754|324134592|FG006|Part 3|Adverse Event|0|||
94637121|NCT01729754|324134593|FG007|Part 3|Adverse Event|0|||
94637122|NCT01729754|324134594|FG008|Part 3|Adverse Event|0|||
94637123|NCT01729754|324134595|FG009|Part 3|Adverse Event|3|||
94637124|NCT01729754|324134586|FG000|Part 3|Death|0|||
94637125|NCT01729754|324134587|FG001|Part 3|Death|0|||
94637126|NCT01729754|324134588|FG002|Part 3|Death|0|||
94637127|NCT01729754|324134589|FG003|Part 3|Death|0|||
94637128|NCT01729754|324134590|FG004|Part 3|Death|0|||
94637129|NCT01729754|324134591|FG005|Part 3|Death|2|||
94637130|NCT01729754|324134592|FG006|Part 3|Death|0|||
94637131|NCT01729754|324134593|FG007|Part 3|Death|0|||
94637132|NCT01729754|324134594|FG008|Part 3|Death|0|||
94637133|NCT01729754|324134595|FG009|Part 3|Death|0|||
94637134|NCT01729754|324134586|FG000|Part 3|Lack of Efficacy|0|||
94637135|NCT01729754|324134587|FG001|Part 3|Lack of Efficacy|0|||
94637136|NCT01729754|324134588|FG002|Part 3|Lack of Efficacy|0|||
94637137|NCT01729754|324134589|FG003|Part 3|Lack of Efficacy|0|||
94637138|NCT01729754|324134590|FG004|Part 3|Lack of Efficacy|2|||
94637139|NCT01729754|324134591|FG005|Part 3|Lack of Efficacy|0|||
94637140|NCT01729754|324134592|FG006|Part 3|Lack of Efficacy|0|||
94637141|NCT01729754|324134593|FG007|Part 3|Lack of Efficacy|0|||
94637142|NCT01729754|324134594|FG008|Part 3|Lack of Efficacy|0|||
94637143|NCT01729754|324134595|FG009|Part 3|Lack of Efficacy|4|||
94637144|NCT01729754|324134586|FG000|Part 3|Lost to Follow-up|0|||
94637145|NCT01729754|324134587|FG001|Part 3|Lost to Follow-up|1|||
94637146|NCT01729754|324134588|FG002|Part 3|Lost to Follow-up|2|||
94637147|NCT01729754|324134589|FG003|Part 3|Lost to Follow-up|0|||
94637148|NCT01729754|324134590|FG004|Part 3|Lost to Follow-up|0|||
94637149|NCT01729754|324134591|FG005|Part 3|Lost to Follow-up|3|||
94637150|NCT01729754|324134592|FG006|Part 3|Lost to Follow-up|0|||
94676960|NCT02436811|324271375|FG000|Overall Study|Lost to Follow-up|2|||
94676961|NCT02436811|324271376|FG001|Overall Study|Lost to Follow-up|9|||
94676962|NCT02436811|324271377|FG002|Overall Study|Lost to Follow-up|7|||
94676963|NCT03595332|324271380|FG000|Overall Study|Lost to Follow-up|16|||
94676964|NCT03595332|324271381|FG001|Overall Study|Lost to Follow-up|22|||
94637151|NCT01729754|324134593|FG007|Part 3|Lost to Follow-up|0|||
94676965|NCT03595332|324271380|FG000|Overall Study|Unable to retrieve ID from school|0|||
94676966|NCT03595332|324271381|FG001|Overall Study|Unable to retrieve ID from school|2|||
94676967|NCT03185481|324271387|FG000|Overall Study|Adverse Event|1|||
94676968|NCT03185481|324271387|FG000|Overall Study|Study Terminated by Sponsor|4|||
94676969|NCT03371940|324271391|FG000|Overall Study|Withdrawal by Subject|8|||
94676970|NCT03371940|324271392|FG001|Overall Study|Withdrawal by Subject|1|||
94676971|NCT03371940|324271393|FG002|Overall Study|Withdrawal by Subject|3|||
94676972|NCT03371940|324271394|FG003|Overall Study|Withdrawal by Subject|4|||
94676973|NCT00724152|324271396|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
94676974|NCT00724152|324271397|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
94676975|NCT00724152|324271398|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
94676976|NCT00724152|324271396|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
94676977|NCT00724152|324271397|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
94676978|NCT00724152|324271398|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
94676979|NCT03848403|324271409|FG000|Period 2 (Day 8)|Adverse Event|1|||
94676980|NCT03848403|324271410|FG001|Period 2 (Day 8)|Adverse Event|2|||
94676981|NCT03848403|324271411|FG002|Period 2 (Day 8)|Adverse Event|2|||
94676982|NCT03848403|324271409|FG000|Period 2 (Day 8)|Physician Decision|0|||
94676983|NCT03848403|324271410|FG001|Period 2 (Day 8)|Physician Decision|1|||
94676984|NCT03848403|324271411|FG002|Period 2 (Day 8)|Physician Decision|0|||
94676985|NCT03848403|324271409|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
94676986|NCT03848403|324271410|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
94676987|NCT03848403|324271411|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
94676988|NCT00031486|324271414|FG000|Overall Study|Adverse Event|1|||
94676989|NCT00031486|324271415|FG001|Overall Study|Adverse Event|0|||
94676990|NCT00031486|324271414|FG000|Overall Study|Lost to Follow-up|0|||
94676991|NCT00031486|324271415|FG001|Overall Study|Lost to Follow-up|1|||
94676992|NCT00031486|324271414|FG000|Overall Study|Withdrawal by Subject|3|||
94676993|NCT00031486|324271415|FG001|Overall Study|Withdrawal by Subject|2|||
94676994|NCT00031486|324271414|FG000|Overall Study|Death|0|||
94676995|NCT00031486|324271415|FG001|Overall Study|Death|3|||
94676996|NCT00031486|324271414|FG000|Overall Study|Non-compliant|0|||
94676997|NCT00031486|324271415|FG001|Overall Study|Non-compliant|4|||
94676998|NCT00031486|324271414|FG000|Overall Study|Did not meet eligibility requirement|2|||
94676999|NCT00031486|324271415|FG001|Overall Study|Did not meet eligibility requirement|1|||
94677000|NCT00031486|324271414|FG000|Overall Study|Other|1|||
94677001|NCT00031486|324271415|FG001|Overall Study|Other|1|||
94677002|NCT02124265|324271416|FG000|Overall Study|Adverse Event|1|||
94677003|NCT00168038|324271417|FG000|Overall Study|Adverse Event|1|||
94637152|NCT01729754|324134594|FG008|Part 3|Lost to Follow-up|1|||
94637153|NCT01729754|324134595|FG009|Part 3|Lost to Follow-up|0|||
94677004|NCT00168038|324271417|FG000|Overall Study|Therapy failure|1|||
94677005|NCT01313286|324271420|FG000|Period 1|Withdrawal by Subject|2|||
94677006|NCT01313286|324271421|FG001|Period 1|Withdrawal by Subject|0|||
94677007|NCT02220894|324271422|FG000|Overall Study|Adverse Event|127|||
94637154|NCT01729754|324134586|FG000|Part 3|Physician Decision|0|||
94637155|NCT01729754|324134587|FG001|Part 3|Physician Decision|0|||
94637156|NCT01729754|324134588|FG002|Part 3|Physician Decision|1|||
94637157|NCT01729754|324134589|FG003|Part 3|Physician Decision|0|||
94637158|NCT01729754|324134590|FG004|Part 3|Physician Decision|0|||
94637159|NCT01729754|324134591|FG005|Part 3|Physician Decision|0|||
94637160|NCT01729754|324134592|FG006|Part 3|Physician Decision|0|||
94637161|NCT01729754|324134593|FG007|Part 3|Physician Decision|0|||
94637162|NCT01729754|324134594|FG008|Part 3|Physician Decision|0|||
94637163|NCT01729754|324134595|FG009|Part 3|Physician Decision|0|||
94637164|NCT01729754|324134586|FG000|Part 3|Withdrawal by Subject|0|||
94677008|NCT02220894|324271423|FG001|Overall Study|Adverse Event|74|||
94677009|NCT02220894|324271422|FG000|Overall Study|Death|418|||
94677010|NCT02220894|324271423|FG001|Overall Study|Death|508|||
94677011|NCT02220894|324271422|FG000|Overall Study|Lost to Follow-up|0|||
94677012|NCT02220894|324271423|FG001|Overall Study|Lost to Follow-up|4|||
94677013|NCT02220894|324271422|FG000|Overall Study|Site Terminated by Sponsor|2|||
94677014|NCT02220894|324271423|FG001|Overall Study|Site Terminated by Sponsor|0|||
94677015|NCT02220894|324271422|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
94677016|NCT02220894|324271423|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
94637165|NCT01729754|324134587|FG001|Part 3|Withdrawal by Subject|4|||
94677017|NCT02220894|324271422|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94677018|NCT02220894|324271423|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
94362808|NCT02380248|323112858|FG000|Overall Study|Lost to Follow-up|11|||
94362809|NCT02380248|323112858|FG000|Overall Study|Withdrawal by Subject|3|||
94637166|NCT01729754|324134588|FG002|Part 3|Withdrawal by Subject|1|||
94637167|NCT01729754|324134589|FG003|Part 3|Withdrawal by Subject|0|||
94262547|NCT02520284|322754861|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
94262548|NCT02520284|322754862|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
94262549|NCT02520284|322754863|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
94262550|NCT02520284|322754861|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
94262551|NCT02520284|322754862|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
94262552|NCT02520284|322754863|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
94262553|NCT02520284|322754861|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
94262554|NCT02520284|322754862|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
94262555|NCT02520284|322754863|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
94262556|NCT02520284|322754861|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
94262557|NCT02520284|322754862|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
94262558|NCT02520284|322754863|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
94262559|NCT01136811|322754864|FG000|Overall Study|Physician Decision|11|||
94262560|NCT01699789|322754865|FG000|Overall Study|Withdrawal by Subject|18|||
94262561|NCT01699789|322754866|FG001|Overall Study|Withdrawal by Subject|23|||
94262562|NCT01699789|322754865|FG000|Overall Study|Death|1|||
94262563|NCT01699789|322754866|FG001|Overall Study|Death|2|||
94262564|NCT01699789|322754865|FG000|Overall Study|Lost to Follow-up|83|||
94262565|NCT01699789|322754866|FG001|Overall Study|Lost to Follow-up|101|||
94262566|NCT03240874|322754868|FG000|Overall Study|Lost to Follow-up|0|||
94262567|NCT03240874|322754869|FG001|Overall Study|Lost to Follow-up|2|||
94262568|NCT03240874|322754870|FG002|Overall Study|Lost to Follow-up|4|||
94262569|NCT03240874|322754871|FG003|Overall Study|Lost to Follow-up|1|||
94262570|NCT00593957|322754872|FG000|Overall Study|Physician Decision|0|||
94262571|NCT00593957|322754873|FG001|Overall Study|Physician Decision|1|||
94262572|NCT00593957|322754874|FG002|Overall Study|Physician Decision|2|||
94262573|NCT02411578|322754875|FG000|Crossover Trial Phase|Pregnancy|0|||
94262574|NCT02411578|322754876|FG001|Crossover Trial Phase|Pregnancy|1|||
94262575|NCT02554903|322754877|FG000|Overall Study|Death|1|||
94637168|NCT01729754|324134590|FG004|Part 3|Withdrawal by Subject|2|||
94637169|NCT01729754|324134591|FG005|Part 3|Withdrawal by Subject|1|||
94637170|NCT01729754|324134592|FG006|Part 3|Withdrawal by Subject|0|||
94637171|NCT01729754|324134593|FG007|Part 3|Withdrawal by Subject|2|||
94637172|NCT01729754|324134594|FG008|Part 3|Withdrawal by Subject|0|||
94637173|NCT01729754|324134595|FG009|Part 3|Withdrawal by Subject|0|||
94637174|NCT01729754|324134586|FG000|Part 3|Other Protocol Specified Criteria|0|||
94637175|NCT01729754|324134587|FG001|Part 3|Other Protocol Specified Criteria|0|||
94637176|NCT01729754|324134588|FG002|Part 3|Other Protocol Specified Criteria|0|||
94637177|NCT01729754|324134589|FG003|Part 3|Other Protocol Specified Criteria|0|||
94637178|NCT01729754|324134590|FG004|Part 3|Other Protocol Specified Criteria|0|||
94637179|NCT01729754|324134591|FG005|Part 3|Other Protocol Specified Criteria|2|||
94637180|NCT01729754|324134592|FG006|Part 3|Other Protocol Specified Criteria|0|||
94637181|NCT01729754|324134593|FG007|Part 3|Other Protocol Specified Criteria|1|||
94637182|NCT01729754|324134594|FG008|Part 3|Other Protocol Specified Criteria|0|||
94637183|NCT01729754|324134595|FG009|Part 3|Other Protocol Specified Criteria|0|||
94637184|NCT03873987|324134596|FG000|Overall Study|Adverse Event|1|||
94637185|NCT03873987|324134597|FG001|Overall Study|Adverse Event|0|||
94637186|NCT03873987|324134596|FG000|Overall Study|staff was unable to start a new IV line|1|||
94637187|NCT03873987|324134597|FG001|Overall Study|staff was unable to start a new IV line|0|||
94637188|NCT03873987|324134596|FG000|Overall Study|Lost to Follow-up|0|||
94637189|NCT03873987|324134597|FG001|Overall Study|Lost to Follow-up|1|||
94637190|NCT01327300|324134598|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
94637191|NCT01327300|324134599|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
94637192|NCT03739112|324134600|FG000|Overall Study|Adverse Event|2|||
94637193|NCT03739112|324134601|FG001|Overall Study|Adverse Event|2|||
94637194|NCT03739112|324134600|FG000|Overall Study|Withdrawal by Subject|38|||
94637195|NCT03739112|324134601|FG001|Overall Study|Withdrawal by Subject|19|||
94637196|NCT03739112|324134600|FG000|Overall Study|Lost to Follow-up|31|||
94637197|NCT03739112|324134601|FG001|Overall Study|Lost to Follow-up|33|||
94262576|NCT02554903|322754878|FG001|Overall Study|Death|1|||
94262577|NCT02554903|322754877|FG000|Overall Study|Physician Decision|2|||
94262578|NCT02554903|322754878|FG001|Overall Study|Physician Decision|2|||
94262579|NCT02554903|322754877|FG000|Overall Study|Heart Transplant|1|||
94262580|NCT02554903|322754878|FG001|Overall Study|Heart Transplant|2|||
94262581|NCT01050205|322754883|FG000|Overall Study|Lost to Follow-up|7|||
94637198|NCT03739112|324134600|FG000|Overall Study|Protocol Deviation|12|||
94637199|NCT03739112|324134601|FG001|Overall Study|Protocol Deviation|9|||
94637200|NCT03739112|324134600|FG000|Overall Study|Physician Decision|1|||
94262582|NCT01050205|322754884|FG001|Overall Study|Lost to Follow-up|1|||
94262583|NCT01050205|322754883|FG000|Overall Study|Withdrawal by Subject|1|||
94637201|NCT03739112|324134601|FG001|Overall Study|Physician Decision|0|||
94637202|NCT03739112|324134600|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
94637203|NCT03739112|324134601|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
94637204|NCT03739112|324134600|FG000|Overall Study|Site went on hold|65|||
94262584|NCT01050205|322754884|FG001|Overall Study|Withdrawal by Subject|1|||
94262585|NCT01050205|322754883|FG000|Overall Study|Relocated from area|1|||
94262586|NCT01050205|322754884|FG001|Overall Study|Relocated from area|2|||
94262587|NCT01050205|322754883|FG000|Overall Study|Discontinued Intervention|2|||
94262588|NCT01050205|322754884|FG001|Overall Study|Discontinued Intervention|0|||
94262589|NCT00954421|322754885|FG000|Screening|screen failures|3|||
94262590|NCT00954421|322754885|FG000|6 Months of DBS|Withdrawal by Subject|1|||
94262591|NCT00954421|322754885|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
94637205|NCT03739112|324134601|FG001|Overall Study|Site went on hold|67|||
94637206|NCT03739112|324134600|FG000|Overall Study|Other than specified|8|||
94637207|NCT03739112|324134601|FG001|Overall Study|Other than specified|5|||
94637208|NCT03739112|324134600|FG000|Overall Study|Randomized but not vaccinated|31|||
94637209|NCT03739112|324134601|FG001|Overall Study|Randomized but not vaccinated|25|||
94637210|NCT02520011|324134606|FG000|Overall Study|Adverse Event|0|||
94637211|NCT02520011|324134607|FG001|Overall Study|Adverse Event|1|||
94637212|NCT02520011|324134608|FG002|Overall Study|Adverse Event|2|||
94637213|NCT02520011|324134606|FG000|Overall Study|Death|0|||
94637214|NCT02520011|324134607|FG001|Overall Study|Death|8|||
94637215|NCT02520011|324134608|FG002|Overall Study|Death|1|||
94637216|NCT02520011|324134606|FG000|Overall Study|Lack of Efficacy|4|||
94637217|NCT02520011|324134607|FG001|Overall Study|Lack of Efficacy|26|||
94637218|NCT02520011|324134608|FG002|Overall Study|Lack of Efficacy|4|||
94637219|NCT02520011|324134606|FG000|Overall Study|Physician Decision|0|||
94637220|NCT02520011|324134607|FG001|Overall Study|Physician Decision|2|||
94637221|NCT02520011|324134608|FG002|Overall Study|Physician Decision|0|||
94637222|NCT02520011|324134606|FG000|Overall Study|Withdrawal by Subject|1|||
94637223|NCT02520011|324134607|FG001|Overall Study|Withdrawal by Subject|3|||
94637224|NCT02520011|324134608|FG002|Overall Study|Withdrawal by Subject|0|||
94637225|NCT02520011|324134606|FG000|Overall Study|Protocol Deviation|0|||
94637226|NCT02520011|324134607|FG001|Overall Study|Protocol Deviation|1|||
94637227|NCT02520011|324134608|FG002|Overall Study|Protocol Deviation|0|||
94637228|NCT02520011|324134606|FG000|Overall Study|Patient went to hospice|0|||
94637229|NCT02520011|324134607|FG001|Overall Study|Patient went to hospice|1|||
94637230|NCT02520011|324134608|FG002|Overall Study|Patient went to hospice|0|||
94637231|NCT02520011|324134606|FG000|Overall Study|Progressive disease following response|0|||
94637232|NCT02520011|324134607|FG001|Overall Study|Progressive disease following response|4|||
94637233|NCT02520011|324134608|FG002|Overall Study|Progressive disease following response|2|||
94637234|NCT00697515|324134612|FG000|Dose Optimization Period|Adverse Event|4|||
94637235|NCT00697515|324134613|FG001|Dose Optimization Period|Adverse Event|0|||
94637236|NCT00697515|324134612|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
94637237|NCT00697515|324134613|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
94637238|NCT00697515|324134612|FG000|Dose Optimization Period|Lost to Follow-up|2|||
94637239|NCT00697515|324134613|FG001|Dose Optimization Period|Lost to Follow-up|0|||
94637240|NCT00697515|324134612|FG000|Dose Optimization Period|sponsor request|2|||
94637241|NCT00697515|324134613|FG001|Dose Optimization Period|sponsor request|0|||
94677019|NCT02220894|324271422|FG000|Overall Study|Withdrawal by Subject|10|||
94677020|NCT02220894|324271423|FG001|Overall Study|Withdrawal by Subject|9|||
94262592|NCT00390910|322754892|FG000|Overall Study|Adverse Event|1|||
94262593|NCT00390910|322754893|FG001|Overall Study|Adverse Event|0|||
94262594|NCT00390910|322754894|FG002|Overall Study|Adverse Event|0|||
94362810|NCT01275170|323112859|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
94362811|NCT01275170|323112860|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
94362812|NCT01275170|323112861|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
94362813|NCT01275170|323112862|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
94362814|NCT01275170|323112863|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
94362815|NCT01275170|323112864|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
94362816|NCT01275170|323112865|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
94362817|NCT01275170|323112866|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
94362818|NCT02864953|323112867|FG000|Overall Study|Adverse Event|22|||
94362819|NCT02864953|323112868|FG001|Overall Study|Adverse Event|19|||
94362820|NCT02864953|323112867|FG000|Overall Study|Withdrawal by Subject|1|||
94362821|NCT02864953|323112868|FG001|Overall Study|Withdrawal by Subject|0|||
94362822|NCT02864953|323112867|FG000|Overall Study|Physician Decision|4|||
94362823|NCT02864953|323112868|FG001|Overall Study|Physician Decision|2|||
94362824|NCT02864953|323112867|FG000|Overall Study|Death|3|||
94362825|NCT02864953|323112868|FG001|Overall Study|Death|13|||
94362826|NCT02864953|323112867|FG000|Overall Study|Reason not specified|14|||
94362827|NCT02864953|323112868|FG001|Overall Study|Reason not specified|12|||
94362828|NCT02864953|323112867|FG000|Overall Study|Withdrew Prior to Dosing|9|||
94362829|NCT02864953|323112868|FG001|Overall Study|Withdrew Prior to Dosing|8|||
94362830|NCT00358670|323112869|FG000|Overall Study|Adverse Event|26|||
94637242|NCT00697515|324134612|FG000|Dose Optimization Period|called to active duty|1|||
94637243|NCT00697515|324134613|FG001|Dose Optimization Period|called to active duty|0|||
94637244|NCT00697515|324134612|FG000|Dose Optimization Period|elevated QTc|1|||
94637245|NCT00697515|324134613|FG001|Dose Optimization Period|elevated QTc|0|||
94637246|NCT00697515|324134612|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
94637247|NCT00697515|324134613|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
94637248|NCT00697515|324134612|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
94637249|NCT00697515|324134613|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
94637250|NCT00697515|324134612|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
94637251|NCT00697515|324134613|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
94637252|NCT00697515|324134612|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
94637253|NCT00697515|324134613|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
94637254|NCT02529137|324134614|FG000|Overall Study|Discontinuation for different reasons|8|||
94637255|NCT02389998|324134615|FG000|Overall Study|car accident|1|||
94637256|NCT02389998|324134616|FG001|Overall Study|car accident|0|||
94637257|NCT02132767|324134618|FG000|Overall Study|Death|3|||
94637258|NCT02132767|324134619|FG001|Overall Study|Death|2|||
94637259|NCT02132767|324134618|FG000|Overall Study|Withdrawal by Subject|10|||
94637260|NCT02132767|324134619|FG001|Overall Study|Withdrawal by Subject|9|||
94637261|NCT02132767|324134618|FG000|Overall Study|Lost to Follow-up|4|||
94637262|NCT02132767|324134619|FG001|Overall Study|Lost to Follow-up|4|||
94637263|NCT05089682|324134620|FG000|Overall Study|Withdrawal by Subject|2|||
94637264|NCT03164928|324134622|FG000|Overall Study|Lost to Follow-up|1|||
94637265|NCT03164928|324134623|FG001|Overall Study|Lost to Follow-up|0|||
94637266|NCT01480076|324134625|FG000|Overall Study|Run-in Failure|52|||
94637267|NCT01480076|324134625|FG000|Overall Study|Adverse Event|39|||
94637268|NCT01480076|324134625|FG000|Overall Study|Death|2|||
94637269|NCT01480076|324134625|FG000|Overall Study|Disease Progression|5|||
94637270|NCT01480076|324134625|FG000|Overall Study|Non-compliance With Study Protocol|15|||
94637271|NCT01480076|324134625|FG000|Overall Study|Withdrawal by Subject|105|||
94637272|NCT01480076|324134625|FG000|Overall Study|Lost to Follow-up|7|||
94637273|NCT01480076|324134625|FG000|Overall Study|Investigator Decision|13|||
94637274|NCT01480076|324134625|FG000|Overall Study|Other|52|||
94637275|NCT02503332|324134627|FG000|Overall Study|Adverse Event|17|||
94677021|NCT02178566|324271426|FG000|Overall Study|patient did not complete due to noncompliance|0|||
94677022|NCT02178566|324271427|FG001|Overall Study|patient did not complete due to noncompliance|1|||
94677023|NCT02332590|324271434|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
94677024|NCT02332590|324271435|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
94677025|NCT02332590|324271434|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
94637276|NCT02503332|324134628|FG001|Overall Study|Adverse Event|5|||
94637277|NCT02503332|324134629|FG002|Overall Study|Adverse Event|3|||
94637278|NCT02503332|324134630|FG003|Overall Study|Adverse Event|1|||
94262595|NCT00390910|322754892|FG000|Overall Study|Lost to Follow-up|0|||
94262596|NCT00390910|322754893|FG001|Overall Study|Lost to Follow-up|1|||
94262597|NCT00390910|322754894|FG002|Overall Study|Lost to Follow-up|5|||
94262598|NCT00390910|322754892|FG000|Overall Study|Withdrawal by Subject|1|||
94262599|NCT00390910|322754893|FG001|Overall Study|Withdrawal by Subject|3|||
94637279|NCT02503332|324134627|FG000|Overall Study|Investigator's Decision|5|||
94637280|NCT02503332|324134628|FG001|Overall Study|Investigator's Decision|1|||
94637281|NCT02503332|324134629|FG002|Overall Study|Investigator's Decision|0|||
94637282|NCT02503332|324134630|FG003|Overall Study|Investigator's Decision|0|||
94637283|NCT02503332|324134627|FG000|Overall Study|Sponsor's Decision|1|||
94637284|NCT02503332|324134628|FG001|Overall Study|Sponsor's Decision|0|||
94637285|NCT02503332|324134629|FG002|Overall Study|Sponsor's Decision|0|||
94637286|NCT02503332|324134630|FG003|Overall Study|Sponsor's Decision|1|||
94637287|NCT02503332|324134627|FG000|Overall Study|Subject Request|6|||
94637288|NCT02503332|324134628|FG001|Overall Study|Subject Request|5|||
94637289|NCT02503332|324134629|FG002|Overall Study|Subject Request|2|||
94637290|NCT02503332|324134630|FG003|Overall Study|Subject Request|1|||
94637291|NCT02503332|324134627|FG000|Overall Study|Death|0|||
94637292|NCT02503332|324134628|FG001|Overall Study|Death|2|||
94637293|NCT02503332|324134629|FG002|Overall Study|Death|2|||
94637294|NCT02503332|324134630|FG003|Overall Study|Death|0|||
94637295|NCT02503332|324134627|FG000|Overall Study|Other|5|||
94637296|NCT02503332|324134628|FG001|Overall Study|Other|6|||
94637297|NCT02503332|324134629|FG002|Overall Study|Other|1|||
94637298|NCT02503332|324134630|FG003|Overall Study|Other|1|||
94637299|NCT02337907|324134631|FG000|Overall Study|Other than listed|1|||
94637300|NCT02337907|324134632|FG001|Overall Study|Other than listed|0|||
94637301|NCT02337907|324134633|FG002|Overall Study|Other than listed|0|||
94637302|NCT02337907|324134634|FG003|Overall Study|Other than listed|1|||
94637303|NCT02337907|324134635|FG004|Overall Study|Other than listed|1|||
94637304|NCT02337907|324134636|FG005|Overall Study|Other than listed|0|||
94637305|NCT02337907|324134631|FG000|Overall Study|Withdrawal by Subject|2|||
94637306|NCT02337907|324134632|FG001|Overall Study|Withdrawal by Subject|3|||
94637307|NCT02337907|324134633|FG002|Overall Study|Withdrawal by Subject|0|||
94637308|NCT02337907|324134634|FG003|Overall Study|Withdrawal by Subject|2|||
94637309|NCT02337907|324134635|FG004|Overall Study|Withdrawal by Subject|5|||
94637310|NCT02337907|324134636|FG005|Overall Study|Withdrawal by Subject|0|||
94637311|NCT02337907|324134631|FG000|Overall Study|Lost to Follow-up|0|||
94637312|NCT02337907|324134632|FG001|Overall Study|Lost to Follow-up|0|||
94637313|NCT02337907|324134633|FG002|Overall Study|Lost to Follow-up|0|||
94637314|NCT02337907|324134634|FG003|Overall Study|Lost to Follow-up|0|||
94637315|NCT02337907|324134635|FG004|Overall Study|Lost to Follow-up|0|||
94637316|NCT02337907|324134636|FG005|Overall Study|Lost to Follow-up|1|||
94637317|NCT02337907|324134631|FG000|Overall Study|Adverse Event|1|||
94637318|NCT02337907|324134632|FG001|Overall Study|Adverse Event|1|||
94637319|NCT02337907|324134633|FG002|Overall Study|Adverse Event|1|||
94637320|NCT02337907|324134634|FG003|Overall Study|Adverse Event|1|||
94637321|NCT02337907|324134635|FG004|Overall Study|Adverse Event|4|||
94637322|NCT02337907|324134636|FG005|Overall Study|Adverse Event|0|||
94637323|NCT04356963|324134637|FG000|First Session|Withdrawal by Subject|1|||
94637324|NCT04356963|324134637|FG000|Second Session|Withdrawal by Subject|3|||
94637325|NCT04356963|324134637|FG000|Second Session|Lost to Follow-up|1|||
94637326|NCT04356963|324134637|FG000|Third Session|Lost to Follow-up|6|||
94637327|NCT04356963|324134637|FG000|Third Session|Withdrawal by Subject|1|||
94637328|NCT00791518|324134638|FG000|Overall Study|Protocol Violation|93|||
94637329|NCT00171223|324134639|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
94637330|NCT00171223|324134640|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
94637331|NCT00171223|324134641|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
94637332|NCT00171223|324134639|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
94637333|NCT00171223|324134640|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
94637334|NCT00171223|324134641|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
94637335|NCT00171223|324134639|FG000|Overall Study|Abnormal Procedure|1|||
94262600|NCT00390910|322754894|FG002|Overall Study|Withdrawal by Subject|2|||
94262601|NCT00390910|322754892|FG000|Overall Study|Migrated/moved from study area|0|||
94262602|NCT00390910|322754893|FG001|Overall Study|Migrated/moved from study area|0|||
94262603|NCT00390910|322754894|FG002|Overall Study|Migrated/moved from study area|3|||
94637336|NCT00171223|324134640|FG001|Overall Study|Abnormal Procedure|0|||
94637337|NCT00171223|324134641|FG002|Overall Study|Abnormal Procedure|0|||
94637338|NCT00171223|324134639|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
94637339|NCT00171223|324134640|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
94637340|NCT00171223|324134641|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
94637341|NCT00171223|324134639|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
94637342|NCT00171223|324134640|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
94637343|NCT00171223|324134641|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
94637344|NCT00171223|324134639|FG000|Overall Study|Protocol Violation|2|||
94637345|NCT00171223|324134640|FG001|Overall Study|Protocol Violation|2|||
94637346|NCT00171223|324134641|FG002|Overall Study|Protocol Violation|3|||
94637347|NCT00171223|324134639|FG000|Overall Study|Participant Withdrew Consent|12|||
94637348|NCT00171223|324134640|FG001|Overall Study|Participant Withdrew Consent|21|||
94637349|NCT00171223|324134641|FG002|Overall Study|Participant Withdrew Consent|15|||
94637350|NCT00171223|324134639|FG000|Overall Study|Lost to Follow-up|5|||
94637351|NCT00171223|324134640|FG001|Overall Study|Lost to Follow-up|2|||
94637352|NCT00171223|324134641|FG002|Overall Study|Lost to Follow-up|3|||
94637353|NCT00171223|324134639|FG000|Overall Study|Administrative Problems|4|||
94637354|NCT00171223|324134640|FG001|Overall Study|Administrative Problems|7|||
94637355|NCT00171223|324134641|FG002|Overall Study|Administrative Problems|6|||
94637356|NCT00171223|324134639|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
94637357|NCT00171223|324134640|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
94637358|NCT00171223|324134641|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
94461854|NCT00743288|323481242|FG004|Overall Study|Withdrawal by Subject|0|||
94461855|NCT00743288|323481243|FG005|Overall Study|Withdrawal by Subject|1|||
94637359|NCT00171223|324134639|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
94637360|NCT00171223|324134640|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
94637361|NCT00171223|324134641|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
94637362|NCT02488681|324134642|FG000|Overall Study|Implant unsuccessful|7|||
94637363|NCT00451321|324134643|FG000|Overall Study|Lost to Follow-up|3|||
94637364|NCT00451321|324134644|FG001|Overall Study|Lost to Follow-up|3|||
94637365|NCT00451321|324134645|FG002|Overall Study|Lost to Follow-up|1|||
94637366|NCT00451321|324134646|FG003|Overall Study|Lost to Follow-up|3|||
94637367|NCT00451321|324134647|FG004|Overall Study|Lost to Follow-up|0|||
94637368|NCT00451321|324134648|FG005|Overall Study|Lost to Follow-up|1|||
94637369|NCT00451321|324134649|FG006|Overall Study|Lost to Follow-up|0|||
94637370|NCT00451321|324134650|FG007|Overall Study|Lost to Follow-up|0|||
94637371|NCT00451321|324134643|FG000|Overall Study|Withdrawal by Subject|3|||
94637372|NCT00451321|324134644|FG001|Overall Study|Withdrawal by Subject|1|||
94637373|NCT00451321|324134645|FG002|Overall Study|Withdrawal by Subject|0|||
94637374|NCT00451321|324134646|FG003|Overall Study|Withdrawal by Subject|4|||
94637375|NCT00451321|324134647|FG004|Overall Study|Withdrawal by Subject|0|||
94637376|NCT00451321|324134648|FG005|Overall Study|Withdrawal by Subject|0|||
94637377|NCT00451321|324134649|FG006|Overall Study|Withdrawal by Subject|0|||
94637378|NCT00451321|324134650|FG007|Overall Study|Withdrawal by Subject|0|||
94637379|NCT00451321|324134643|FG000|Overall Study|Study closed/terminated|1|||
94637380|NCT00451321|324134644|FG001|Overall Study|Study closed/terminated|1|||
94637381|NCT00451321|324134645|FG002|Overall Study|Study closed/terminated|17|||
94637382|NCT00451321|324134646|FG003|Overall Study|Study closed/terminated|5|||
94637383|NCT00451321|324134647|FG004|Overall Study|Study closed/terminated|7|||
94637384|NCT00451321|324134648|FG005|Overall Study|Study closed/terminated|7|||
94637385|NCT00451321|324134649|FG006|Overall Study|Study closed/terminated|5|||
94637386|NCT00451321|324134650|FG007|Overall Study|Study closed/terminated|3|||
94637387|NCT00451321|324134643|FG000|Overall Study|Sponsor decision to amend protocol|0|||
94637388|NCT00451321|324134644|FG001|Overall Study|Sponsor decision to amend protocol|0|||
94637389|NCT00451321|324134645|FG002|Overall Study|Sponsor decision to amend protocol|0|||
94637390|NCT00451321|324134646|FG003|Overall Study|Sponsor decision to amend protocol|0|||
94637391|NCT00451321|324134647|FG004|Overall Study|Sponsor decision to amend protocol|0|||
94637392|NCT00451321|324134648|FG005|Overall Study|Sponsor decision to amend protocol|1|||
94637393|NCT00451321|324134649|FG006|Overall Study|Sponsor decision to amend protocol|1|||
94637394|NCT00451321|324134650|FG007|Overall Study|Sponsor decision to amend protocol|3|||
94637395|NCT03165110|324134653|FG000|Overall Study|Anroid phone software incompatibility|1|||
94637396|NCT02726074|324134654|FG000|Overall Study|Withdrawal by Subject|4|||
94637397|NCT02726074|324134654|FG000|Overall Study|Adverse Event|14|||
94637398|NCT02726074|324134654|FG000|Overall Study|Protocol Violation|3|||
94637399|NCT02726074|324134654|FG000|Overall Study|Lost to Follow-up|2|||
94637400|NCT02726074|324134654|FG000|Overall Study|Others|3|||
94637401|NCT01892501|324134655|FG000|Overall Study|Protocol Violation|2|||
94637402|NCT01892501|324134655|FG000|Overall Study|Puncture not carried out|9|||
94637403|NCT01892501|324134655|FG000|Overall Study|Radiological monitoring not carried out|5|||
94637404|NCT01892501|324134655|FG000|Overall Study|Non-contributory histological result|12|||
94461856|NCT00743288|323481244|FG006|Overall Study|Withdrawal by Subject|1|||
94461857|NCT00743288|323481238|FG000|Overall Study|Progressive disease (PD)|2|||
94637405|NCT02319031|324134659|FG000|Treatment Period|Death|1|||
94637406|NCT02319031|324134660|FG001|Treatment Period|Death|0|||
94677026|NCT02332590|324271435|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
94677027|NCT02332590|324271434|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
94677028|NCT02332590|324271435|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
94677029|NCT02332590|324271434|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
94677030|NCT02332590|324271435|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
94677031|NCT02332590|324271434|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
94677032|NCT02332590|324271435|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
94677033|NCT02332590|324271434|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
94262604|NCT00835120|322754897|FG000|Overall Study|Lack of Efficacy|1|||
94637407|NCT00454987|324134661|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
94637408|NCT00454987|324134662|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
94637409|NCT00454987|324134663|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
94637410|NCT00454987|324134661|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
94637411|NCT00454987|324134662|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
94637412|NCT00454987|324134663|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
94637413|NCT00454987|324134661|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
94637414|NCT00454987|324134662|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
94637415|NCT00454987|324134663|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
94637416|NCT01476696|324134666|FG000|Overall Study|Sponsor decision|2|||
94637417|NCT01476696|324134667|FG001|Overall Study|Sponsor decision|1|||
94637418|NCT01476696|324134668|FG002|Overall Study|Sponsor decision|0|||
94637419|NCT01476696|324134666|FG000|Overall Study|Withdrawal by Subject|1|||
94637420|NCT01476696|324134667|FG001|Overall Study|Withdrawal by Subject|0|||
94637421|NCT01476696|324134668|FG002|Overall Study|Withdrawal by Subject|0|||
94637422|NCT03054870|324134671|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
94637423|NCT03054870|324134671|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
94637424|NCT00728130|324134672|FG000|Overall Study|Withdrawal by Subject|1|||
94637425|NCT00728130|324134672|FG000|Overall Study|Paperwork not completed in time|1|||
94637426|NCT00728130|324134672|FG000|Overall Study|Physician Decision|1|||
94637427|NCT01265849|324134676|FG000|Overall Study|Randomized//Treatment not initiated|1|||
94637428|NCT01265849|324134677|FG001|Overall Study|Randomized//Treatment not initiated|4|||
94637429|NCT01265849|324134678|FG002|Overall Study|Randomized//Treatment not initiated|0|||
94637430|NCT01265849|324134676|FG000|Overall Study|Physician Decision|1|||
94637431|NCT01265849|324134677|FG001|Overall Study|Physician Decision|2|||
94637432|NCT01265849|324134678|FG002|Overall Study|Physician Decision|0|||
94637433|NCT01265849|324134676|FG000|Overall Study|Lost to Follow-up|18|||
94637434|NCT01265849|324134677|FG001|Overall Study|Lost to Follow-up|15|||
94637435|NCT01265849|324134678|FG002|Overall Study|Lost to Follow-up|5|||
94637436|NCT01265849|324134676|FG000|Overall Study|Not otherwise specified|1|||
94637437|NCT01265849|324134677|FG001|Overall Study|Not otherwise specified|6|||
94637438|NCT01265849|324134678|FG002|Overall Study|Not otherwise specified|1|||
94637439|NCT01265849|324134676|FG000|Overall Study|Withdrawal by Subject|25|||
94637440|NCT01265849|324134677|FG001|Overall Study|Withdrawal by Subject|34|||
94637441|NCT01265849|324134678|FG002|Overall Study|Withdrawal by Subject|13|||
94637442|NCT00362115|324134679|FG000|Overall Study|Adverse Event|0|||
94637443|NCT00362115|324134680|FG001|Overall Study|Adverse Event|1|||
94637444|NCT00362115|324134681|FG002|Overall Study|Adverse Event|1|||
94637445|NCT00362115|324134682|FG003|Overall Study|Adverse Event|1|||
94637446|NCT00362115|324134683|FG004|Overall Study|Adverse Event|2|||
94637447|NCT00362115|324134684|FG005|Overall Study|Adverse Event|2|||
94637448|NCT00362115|324134685|FG006|Overall Study|Adverse Event|1|||
94637449|NCT00362115|324134679|FG000|Overall Study|Protocol Violation|0|||
94637450|NCT00362115|324134680|FG001|Overall Study|Protocol Violation|0|||
94637451|NCT00362115|324134681|FG002|Overall Study|Protocol Violation|0|||
94637452|NCT00362115|324134682|FG003|Overall Study|Protocol Violation|0|||
94637453|NCT00362115|324134683|FG004|Overall Study|Protocol Violation|0|||
94262605|NCT00835120|322754897|FG000|Overall Study|Lost to Follow-up|3|||
94262606|NCT00835120|322754897|FG000|Overall Study|Adverse Event|2|||
94262607|NCT00835120|322754897|FG000|Overall Study|Withdrawal by Subject|2|||
94262608|NCT02499770|322754900|FG000|Overall Study|Death|17|||
94262609|NCT02499770|322754901|FG001|Overall Study|Death|56|||
94262610|NCT02499770|322754900|FG000|Overall Study|Study completion|1|||
94262611|NCT02499770|322754901|FG001|Overall Study|Study completion|10|||
94262612|NCT02499770|322754900|FG000|Overall Study|Withdrawal by Subject|0|||
94262613|NCT02499770|322754901|FG001|Overall Study|Withdrawal by Subject|7|||
94262614|NCT02499770|322754900|FG000|Overall Study|Lost to Follow-up|0|||
94637454|NCT00362115|324134684|FG005|Overall Study|Protocol Violation|1|||
94637455|NCT00362115|324134685|FG006|Overall Study|Protocol Violation|0|||
94637456|NCT00362115|324134679|FG000|Overall Study|Lost to Follow-up|0|||
94637457|NCT00362115|324134680|FG001|Overall Study|Lost to Follow-up|1|||
94637458|NCT00362115|324134681|FG002|Overall Study|Lost to Follow-up|0|||
94262615|NCT02499770|322754901|FG001|Overall Study|Lost to Follow-up|2|||
94637459|NCT00362115|324134682|FG003|Overall Study|Lost to Follow-up|0|||
94637460|NCT00362115|324134683|FG004|Overall Study|Lost to Follow-up|2|||
94637461|NCT00362115|324134684|FG005|Overall Study|Lost to Follow-up|0|||
94262616|NCT02499770|322754900|FG000|Overall Study|Subject declined further treatment|1|||
94262617|NCT02499770|322754901|FG001|Overall Study|Subject declined further treatment|0|||
94262618|NCT02499770|322754900|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
94262619|NCT02499770|322754901|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
94262620|NCT02499770|322754900|FG000|Overall Study|Randomized but not enrolled|0|||
94262621|NCT02499770|322754901|FG001|Overall Study|Randomized but not enrolled|1|||
94262622|NCT00232141|322754903|FG000|Overall Study|Adverse Event|9|||
94262623|NCT00232141|322754904|FG001|Overall Study|Adverse Event|4|||
94262624|NCT00232141|322754903|FG000|Overall Study|Lack of Efficacy|0|||
94362831|NCT00358670|323112870|FG001|Overall Study|Adverse Event|29|||
94637462|NCT00362115|324134685|FG006|Overall Study|Lost to Follow-up|1|||
94262625|NCT00232141|322754904|FG001|Overall Study|Lack of Efficacy|3|||
94262626|NCT00232141|322754903|FG000|Overall Study|Lost to Follow-up|9|||
94262627|NCT00232141|322754904|FG001|Overall Study|Lost to Follow-up|6|||
94262628|NCT00232141|322754903|FG000|Overall Study|Other|8|||
94262629|NCT00232141|322754904|FG001|Overall Study|Other|10|||
94262630|NCT00232141|322754903|FG000|Overall Study|Withdrawal by Subject|5|||
94262631|NCT00232141|322754904|FG001|Overall Study|Withdrawal by Subject|3|||
94262632|NCT03610165|322754906|FG000|Overall Study|Device didn't work|0|||
94262633|NCT03610165|322754907|FG001|Overall Study|Device didn't work|1|||
94262634|NCT01103245|322756501|FG000|Overall Study|Withdrawal by Subject|1|||
94262635|NCT01103245|322756502|FG001|Overall Study|Withdrawal by Subject|0|||
94262636|NCT01103245|322756503|FG002|Overall Study|Withdrawal by Subject|3|||
94262637|NCT01103245|322756504|FG003|Overall Study|Withdrawal by Subject|0|||
94262638|NCT01103245|322756501|FG000|Overall Study|Inadequate IV access|1|||
94262639|NCT01103245|322756502|FG001|Overall Study|Inadequate IV access|0|||
94262640|NCT01103245|322756503|FG002|Overall Study|Inadequate IV access|0|||
94262641|NCT01103245|322756504|FG003|Overall Study|Inadequate IV access|0|||
94262642|NCT01103245|322756501|FG000|Overall Study|Adverse Event|0|||
94262643|NCT01103245|322756502|FG001|Overall Study|Adverse Event|2|||
94262644|NCT01103245|322756503|FG002|Overall Study|Adverse Event|1|||
94262645|NCT01103245|322756504|FG003|Overall Study|Adverse Event|0|||
94262646|NCT01103245|322756501|FG000|Overall Study|Physician Decision|1|||
94262647|NCT01103245|322756502|FG001|Overall Study|Physician Decision|0|||
94262648|NCT01103245|322756503|FG002|Overall Study|Physician Decision|0|||
94262649|NCT01103245|322756504|FG003|Overall Study|Physician Decision|0|||
94262650|NCT01310803|322756511|FG000|Overall Study|Subject terminated by Sponsor|1|||
94262651|NCT01310803|322756512|FG001|Overall Study|Subject terminated by Sponsor|0|||
94262652|NCT03078907|322756514|FG000|Overall Study|Adverse Event|2|||
94262653|NCT03078907|322756515|FG001|Overall Study|Adverse Event|0|||
94262654|NCT03078907|322756514|FG000|Overall Study|Other|1|||
94262655|NCT03078907|322756515|FG001|Overall Study|Other|0|||
94262656|NCT03078907|322756514|FG000|Overall Study|Protocol Violation|0|||
94262657|NCT03078907|322756515|FG001|Overall Study|Protocol Violation|1|||
94262658|NCT01444651|322756516|FG000|Overall Study|Adverse Event|3|||
94262659|NCT01444651|322756517|FG001|Overall Study|Adverse Event|2|||
94262660|NCT01444651|322756516|FG000|Overall Study|Lost to Follow-up|5|||
94262661|NCT01444651|322756517|FG001|Overall Study|Lost to Follow-up|5|||
94262662|NCT01444651|322756516|FG000|Overall Study|Non-fasting|2|||
94262663|NCT01444651|322756517|FG001|Overall Study|Non-fasting|1|||
94362832|NCT00358670|323112869|FG000|Overall Study|Lack of Efficacy|20|||
94637463|NCT00362115|324134679|FG000|Overall Study|Withdrawal by Subject|1|||
94637464|NCT00362115|324134680|FG001|Overall Study|Withdrawal by Subject|3|||
94637465|NCT00362115|324134681|FG002|Overall Study|Withdrawal by Subject|1|||
94637466|NCT00362115|324134682|FG003|Overall Study|Withdrawal by Subject|0|||
94637467|NCT00362115|324134683|FG004|Overall Study|Withdrawal by Subject|1|||
94637468|NCT00362115|324134684|FG005|Overall Study|Withdrawal by Subject|3|||
94637469|NCT00362115|324134685|FG006|Overall Study|Withdrawal by Subject|4|||
94637470|NCT00362115|324134679|FG000|Overall Study|Lack of Efficacy|1|||
94637471|NCT00362115|324134680|FG001|Overall Study|Lack of Efficacy|0|||
94637472|NCT00362115|324134681|FG002|Overall Study|Lack of Efficacy|5|||
94637473|NCT00362115|324134682|FG003|Overall Study|Lack of Efficacy|2|||
94637474|NCT00362115|324134683|FG004|Overall Study|Lack of Efficacy|2|||
94637475|NCT00362115|324134684|FG005|Overall Study|Lack of Efficacy|0|||
94637476|NCT00362115|324134685|FG006|Overall Study|Lack of Efficacy|3|||
94677034|NCT02332590|324271435|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
94362833|NCT00358670|323112870|FG001|Overall Study|Lack of Efficacy|23|||
94637477|NCT00362115|324134679|FG000|Overall Study|Physician Decision|0|||
94637478|NCT00362115|324134680|FG001|Overall Study|Physician Decision|0|||
94677035|NCT02332590|324271434|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
94262664|NCT01444651|322756516|FG000|Overall Study|Missing data|1|||
94262665|NCT01444651|322756517|FG001|Overall Study|Missing data|1|||
94262666|NCT01955122|322756518|FG000|Overall Study|Physician Decision|5|||
94262667|NCT01955122|322756519|FG001|Overall Study|Physician Decision|5|||
94262668|NCT00604279|322756523|FG000|Overall Study|Lack of Efficacy|22|||
94262669|NCT00604279|322756524|FG001|Overall Study|Lack of Efficacy|9|||
94262670|NCT00604279|322756523|FG000|Overall Study|Lost to Follow-up|9|||
94262671|NCT00604279|322756524|FG001|Overall Study|Lost to Follow-up|14|||
94362834|NCT00358670|323112869|FG000|Overall Study|Protocol Violation|6|||
94637479|NCT00362115|324134681|FG002|Overall Study|Physician Decision|0|||
94637480|NCT00362115|324134682|FG003|Overall Study|Physician Decision|0|||
94637481|NCT00362115|324134683|FG004|Overall Study|Physician Decision|0|||
94637482|NCT00362115|324134684|FG005|Overall Study|Physician Decision|0|||
94637483|NCT00362115|324134685|FG006|Overall Study|Physician Decision|3|||
94637484|NCT00362115|324134679|FG000|Overall Study|Other|0|||
94637485|NCT00362115|324134680|FG001|Overall Study|Other|1|||
94637486|NCT00362115|324134681|FG002|Overall Study|Other|0|||
94637487|NCT00362115|324134682|FG003|Overall Study|Other|1|||
94637488|NCT00362115|324134683|FG004|Overall Study|Other|0|||
94637489|NCT00362115|324134684|FG005|Overall Study|Other|1|||
94637490|NCT00362115|324134685|FG006|Overall Study|Other|0|||
94637491|NCT00335972|324134686|FG000|Overall Study|not given treatments|0|||
94637492|NCT00335972|324134687|FG001|Overall Study|not given treatments|3|||
94637493|NCT02081079|324134695|FG000|Overall Study|Lack of Efficacy|3|||
94637494|NCT02081079|324134696|FG001|Overall Study|Lack of Efficacy|2|||
94637495|NCT02081079|324134695|FG000|Overall Study|Lost to Follow-up|1|||
94637496|NCT02081079|324134696|FG001|Overall Study|Lost to Follow-up|0|||
94637497|NCT02447081|324134702|FG000|Overall Study|Death|161|||
94637498|NCT02447081|324134702|FG000|Overall Study|Lost to Follow-up|36|||
94637499|NCT02447081|324134702|FG000|Overall Study|Visit not completed|17|||
94637500|NCT02447081|324134702|FG000|Overall Study|unsuccessful implant procedure|10|||
94637501|NCT01498458|324134703|FG000|Overall Study|Adverse Event|4|||
94637502|NCT01498458|324134703|FG000|Overall Study|Physician Decision|3|||
94637503|NCT02226003|324134704|FG000|Overall Study|Lost to Follow-up|2|||
94637504|NCT02226003|324134705|FG001|Overall Study|Lost to Follow-up|1|||
94637505|NCT02226003|324134706|FG002|Overall Study|Lost to Follow-up|3|||
94637506|NCT02226003|324134704|FG000|Overall Study|Withdrawal by Subject|0|||
94637507|NCT02226003|324134705|FG001|Overall Study|Withdrawal by Subject|0|||
94637508|NCT02226003|324134706|FG002|Overall Study|Withdrawal by Subject|3|||
94637509|NCT00670800|324136095|FG000|Overall Study|2 controls were insulin resistant|0|||
94637510|NCT00670800|324136096|FG001|Overall Study|2 controls were insulin resistant|2|||
94637511|NCT01786629|324136097|FG000|Overall Study|Lack of Efficacy|0|||
94637512|NCT01786629|324136098|FG001|Overall Study|Lack of Efficacy|4|||
94637513|NCT01786629|324136097|FG000|Overall Study|Adverse Event|0|||
94637514|NCT01786629|324136098|FG001|Overall Study|Adverse Event|1|||
94637515|NCT02926924|324136099|FG000|Overall Study|withdrawal - reason unknown|0|||
94637516|NCT02926924|324136100|FG001|Overall Study|withdrawal - reason unknown|1|||
94637517|NCT01536379|324136101|FG000|Overall Study|Adverse Event|1|||
94637518|NCT01536379|324136102|FG001|Overall Study|Adverse Event|2|||
94637519|NCT01536379|324136101|FG000|Overall Study|Withdrawal by Subject|1|||
94637520|NCT01536379|324136102|FG001|Overall Study|Withdrawal by Subject|1|||
94637521|NCT00702403|324136108|FG000|From Consent to Engraftment|Progressive leukemia|6|||
94637522|NCT00702403|324136108|FG000|From Consent to Engraftment|Critically ill|2|||
94637523|NCT00702403|324136108|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
94637524|NCT00702403|324136108|FG000|From Consent to Engraftment|Myocardial infarction|1|||
94637525|NCT00702403|324136108|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
94637526|NCT00702403|324136108|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
94637527|NCT00702403|324136108|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
94637528|NCT00702403|324136108|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
94637529|NCT00702403|324136108|FG000|From Engraftment to Study Completion|Non-compliance|2|||
94637530|NCT00702403|324136108|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
94637531|NCT00702403|324136108|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
94637532|NCT00702403|324136108|FG000|From Engraftment to Study Completion|Suicide|1|||
94637533|NCT00702403|324136108|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
94637534|NCT00702403|324136108|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
94637535|NCT00702403|324136108|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
94637536|NCT00858442|324136109|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
94637537|NCT00858442|324136110|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
94637538|NCT02066467|324136115|FG000|Overall Study|Did not undergo implant procedure|24|||
94637539|NCT02066467|324136115|FG000|Overall Study|Attempted to implant withoput success|43|||
94637540|NCT02066467|324136115|FG000|Overall Study|Consent ineligible|1|||
94637541|NCT02066467|324136115|FG000|Overall Study|Death|54|||
94637542|NCT02066467|324136115|FG000|Overall Study|Lost to Follow-up|51|||
94637543|NCT02066467|324136115|FG000|Overall Study|Adverse Event|20|||
94637544|NCT02066467|324136115|FG000|Overall Study|Withdrawal by Subject|16|||
94637545|NCT02066467|324136115|FG000|Overall Study|Physician Decision|2|||
94637546|NCT02066467|324136115|FG000|Overall Study|Not defined|4|||
94637547|NCT03045887|324136116|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
94637548|NCT03045887|324136117|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
94637549|NCT03045887|324136118|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
94637550|NCT03045887|324136119|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
94637551|NCT03045887|324136120|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
94637552|NCT03045887|324136121|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
94637553|NCT03045887|324136122|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
94637554|NCT03045887|324136123|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
94637555|NCT03045887|324136124|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
94637556|NCT03045887|324136125|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
94637557|NCT03045887|324136116|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
94637558|NCT03045887|324136117|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
94637559|NCT03045887|324136118|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
94637560|NCT03045887|324136119|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
94637561|NCT03045887|324136120|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
94637562|NCT03045887|324136121|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
94637563|NCT03045887|324136122|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
94637564|NCT03045887|324136123|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
94637565|NCT03045887|324136124|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
94637566|NCT03045887|324136125|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
94637567|NCT03045887|324136116|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
94637568|NCT03045887|324136117|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
94637569|NCT03045887|324136118|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
94637570|NCT03045887|324136119|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
94637571|NCT03045887|324136120|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
94637572|NCT03045887|324136121|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
94637573|NCT03045887|324136122|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
94637574|NCT03045887|324136123|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
94637575|NCT03045887|324136124|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
94637576|NCT03045887|324136125|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
94637577|NCT03045887|324136116|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
94262672|NCT00604279|322756523|FG000|Overall Study|Pregnancy|2|||
94637578|NCT03045887|324136117|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
94637579|NCT03045887|324136118|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
94637580|NCT03045887|324136119|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
94637581|NCT03045887|324136120|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
94637582|NCT03045887|324136121|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
94637583|NCT03045887|324136122|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
94262673|NCT00604279|322756524|FG001|Overall Study|Pregnancy|0|||
94637584|NCT03045887|324136123|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
94637585|NCT03045887|324136124|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
94637586|NCT03045887|324136125|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
94637587|NCT03045887|324136116|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
94637588|NCT03045887|324136117|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
94637589|NCT03045887|324136118|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
94637590|NCT03045887|324136119|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
94637591|NCT03045887|324136120|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
94637592|NCT03045887|324136121|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
94637593|NCT03045887|324136122|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
94637594|NCT03045887|324136123|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
94637595|NCT03045887|324136124|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
94637596|NCT03045887|324136125|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
94637597|NCT02632552|324136126|FG000|Overall Study|Lost to Follow-up|14|||
94637598|NCT02632552|324136127|FG001|Overall Study|Lost to Follow-up|8|||
94637599|NCT02632552|324136126|FG000|Overall Study|Withdrawal by Subject|2|||
94637600|NCT02632552|324136127|FG001|Overall Study|Withdrawal by Subject|0|||
94637601|NCT02632552|324136126|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
94637602|NCT02632552|324136127|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
94637603|NCT00491387|324136128|FG000|Overall Study|study terminated|20|||
94637604|NCT02150954|324136129|FG000|Overall Study|Protocol Violation|1|||
94637605|NCT02150954|324136130|FG001|Overall Study|Protocol Violation|0|||
94637606|NCT02419742|324136134|FG000|Overall Study|Adverse Event|2|||
94637607|NCT02419742|324136135|FG001|Overall Study|Adverse Event|0|||
94637608|NCT02419742|324136134|FG000|Overall Study|Disease Progression|0|||
94637609|NCT02419742|324136135|FG001|Overall Study|Disease Progression|1|||
94637610|NCT02419742|324136134|FG000|Overall Study|Withdrew Consent|2|||
94637611|NCT02419742|324136135|FG001|Overall Study|Withdrew Consent|1|||
94637612|NCT02419742|324136134|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
94637613|NCT02419742|324136135|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
94637614|NCT00930579|324136136|FG000|Overall Study|Withdrawal by Subject|1|||
94637615|NCT00930579|324136136|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
94637616|NCT00536107|324136139|FG000|Overall Study|Death|5|||
94637617|NCT00536107|324136140|FG001|Overall Study|Death|1|||
94637618|NCT00536107|324136139|FG000|Overall Study|Incorrect enrolment|1|||
94637619|NCT00536107|324136140|FG001|Overall Study|Incorrect enrolment|0|||
94637620|NCT00536107|324136139|FG000|Overall Study|Withdrawal by Subject|0|||
94637621|NCT00536107|324136140|FG001|Overall Study|Withdrawal by Subject|1|||
94637622|NCT00536107|324136139|FG000|Overall Study|Study Termination|2|||
94637623|NCT00536107|324136140|FG001|Overall Study|Study Termination|4|||
94637624|NCT00003901|324136142|FG000|Overall Study|Adverse Event|1|||
94637625|NCT00003901|324136142|FG000|Overall Study|Withdrawal by Subject|1|||
94637626|NCT00003901|324136142|FG000|Overall Study|Ineligible|6|||
94637627|NCT00003901|324136142|FG000|Overall Study|CT Scan not within protocol requirement|2|||
94637628|NCT00003901|324136142|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
94637629|NCT00003901|324136142|FG000|Overall Study|Medical problems|6|||
94637630|NCT00949325|324136152|FG000|Overall Study|Adverse Event|0|||
94637631|NCT00949325|324136153|FG001|Overall Study|Adverse Event|2|||
94637632|NCT00949325|324136154|FG002|Overall Study|Adverse Event|0|||
94637633|NCT02009046|324136155|FG000|Overall Study|Lost to Follow-up|256|||
94637634|NCT02009046|324136156|FG001|Overall Study|Lost to Follow-up|206|||
94637635|NCT03338062|324136161|FG000|Overall Study|Alternative Therapy|1|||
94637636|NCT03338062|324136162|FG001|Overall Study|Alternative Therapy|0|||
94637637|NCT01524692|324136166|FG000|Overall Study|Withdrawal by Subject|3|||
94637638|NCT00643682|324136167|FG000|Overall Study|did not keep appointment|522|||
94637639|NCT00643682|324136168|FG001|Overall Study|did not keep appointment|509|||
94637640|NCT01092182|324136172|FG000|Overall Study|Death|0|||
94637641|NCT01092182|324136173|FG001|Overall Study|Death|5|||
94637642|NCT01092182|324136174|FG002|Overall Study|Death|3|||
94637643|NCT01092182|324136172|FG000|Overall Study|participant safety|1|||
94637644|NCT01092182|324136173|FG001|Overall Study|participant safety|2|||
94637645|NCT01092182|324136174|FG002|Overall Study|participant safety|0|||
94637646|NCT01092182|324136172|FG000|Overall Study|Physician Decision|0|||
94637647|NCT01092182|324136173|FG001|Overall Study|Physician Decision|6|||
94637648|NCT01092182|324136174|FG002|Overall Study|Physician Decision|0|||
94637649|NCT01092182|324136172|FG000|Overall Study|Did not meet criteria|0|||
94637650|NCT01092182|324136173|FG001|Overall Study|Did not meet criteria|0|||
94637651|NCT01092182|324136174|FG002|Overall Study|Did not meet criteria|25|||
94637652|NCT01092182|324136172|FG000|Overall Study|Non-compliance|0|||
94461858|NCT00743288|323481239|FG001|Overall Study|Progressive disease (PD)|0|||
94637653|NCT01092182|324136173|FG001|Overall Study|Non-compliance|3|||
94637654|NCT01092182|324136174|FG002|Overall Study|Non-compliance|0|||
94637655|NCT01092182|324136172|FG000|Overall Study|Participant refused follow-up|0|||
94637656|NCT01092182|324136173|FG001|Overall Study|Participant refused follow-up|2|||
94637657|NCT01092182|324136174|FG002|Overall Study|Participant refused follow-up|0|||
94637658|NCT00878709|324136175|FG000|Overall Study|Withdrawal by Subject|197|||
94637659|NCT00878709|324136176|FG001|Overall Study|Withdrawal by Subject|120|||
94637660|NCT00878709|324136175|FG000|Overall Study|Lost to Follow-up|35|||
94637661|NCT00878709|324136176|FG001|Overall Study|Lost to Follow-up|33|||
94637662|NCT00878709|324136175|FG000|Overall Study|Other Reasons|93|||
94637663|NCT00878709|324136176|FG001|Overall Study|Other Reasons|84|||
94637664|NCT00323492|324136181|FG000|Study Phase 1|Adverse Event|2|||
94637665|NCT00323492|324136182|FG001|Study Phase 1|Adverse Event|0|||
94637666|NCT00323492|324136183|FG002|Study Phase 1|Adverse Event|0|||
94637667|NCT00323492|324136181|FG000|Study Phase 2|Adverse Event|1|||
94637668|NCT00323492|324136182|FG001|Study Phase 2|Adverse Event|0|||
94637669|NCT00323492|324136183|FG002|Study Phase 2|Adverse Event|0|||
94637670|NCT00323492|324136181|FG000|Study Phase 2|Physician Decision|1|||
94637671|NCT00323492|324136182|FG001|Study Phase 2|Physician Decision|0|||
94637672|NCT00323492|324136183|FG002|Study Phase 2|Physician Decision|0|||
94637673|NCT00323492|324136181|FG000|Study Phase 2|Lost to Follow-up|1|||
94637674|NCT00323492|324136182|FG001|Study Phase 2|Lost to Follow-up|0|||
94637675|NCT00323492|324136183|FG002|Study Phase 2|Lost to Follow-up|0|||
94637676|NCT00323492|324136181|FG000|Study Phase 2|Withdrawal by Subject|0|||
94637677|NCT00323492|324136182|FG001|Study Phase 2|Withdrawal by Subject|1|||
94637678|NCT00323492|324136183|FG002|Study Phase 2|Withdrawal by Subject|0|||
94637679|NCT00323492|324136181|FG000|Study Phase 2|Noncompliance with study schedule|0|||
94637680|NCT00323492|324136182|FG001|Study Phase 2|Noncompliance with study schedule|0|||
94637681|NCT00323492|324136183|FG002|Study Phase 2|Noncompliance with study schedule|1|||
94637682|NCT00323492|324136181|FG000|Study Phase 2|Protocol Violation|1|||
94637683|NCT00323492|324136182|FG001|Study Phase 2|Protocol Violation|0|||
94637684|NCT00323492|324136183|FG002|Study Phase 2|Protocol Violation|0|||
94637685|NCT03255382|324136184|FG000|Overall Study|Adverse Event|3|||
94637686|NCT03255382|324136185|FG001|Overall Study|Adverse Event|0|||
94637687|NCT03255382|324136184|FG000|Overall Study|Lost to Follow-up|2|||
94637688|NCT03255382|324136185|FG001|Overall Study|Lost to Follow-up|0|||
94637689|NCT03255382|324136184|FG000|Overall Study|Withdrawal by Subject|2|||
94637690|NCT03255382|324136185|FG001|Overall Study|Withdrawal by Subject|0|||
94637691|NCT03255382|324136184|FG000|Overall Study|Other|6|||
94637692|NCT03255382|324136185|FG001|Overall Study|Other|0|||
94637693|NCT00832585|324136190|FG000|Overall Study|Withdrawal by Subject|1|||
94637694|NCT00832585|324136190|FG000|Overall Study|Lost to Follow-up|1|||
94637695|NCT00698581|324136191|FG000|Overall Study|Lack of Efficacy|23|||
94637696|NCT00698581|324136192|FG001|Overall Study|Lack of Efficacy|11|||
94637697|NCT00698581|324136191|FG000|Overall Study|Withdrawal by Subject|6|||
94637698|NCT00698581|324136192|FG001|Overall Study|Withdrawal by Subject|0|||
94637699|NCT00698581|324136191|FG000|Overall Study|Other reason|9|||
94637700|NCT00698581|324136192|FG001|Overall Study|Other reason|1|||
94637701|NCT00698581|324136191|FG000|Overall Study|SAE, non-fatal|1|||
94637702|NCT00698581|324136192|FG001|Overall Study|SAE, non-fatal|0|||
94637703|NCT00698581|324136191|FG000|Overall Study|AE, non-serious non-fatal|4|||
94637704|NCT00698581|324136192|FG001|Overall Study|AE, non-serious non-fatal|0|||
94637705|NCT00698581|324136191|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
94637706|NCT00698581|324136192|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
94637707|NCT00698581|324136191|FG000|Overall Study|AE of unknown type|1|||
94637708|NCT00698581|324136192|FG001|Overall Study|AE of unknown type|0|||
94637709|NCT01523886|324136197|FG000|Overall Study|surgery cancelled|0|||
94637710|NCT01523886|324136198|FG001|Overall Study|surgery cancelled|1|||
94637711|NCT01531387|324136199|FG000|Overall Study|Early termination of study|11|||
94637712|NCT01531387|324136200|FG001|Overall Study|Early termination of study|11|||
94637713|NCT01464346|324136207|FG000|Overall Study|Withdrawal by Subject|0|||
94637714|NCT01464346|324136208|FG001|Overall Study|Withdrawal by Subject|0|||
94637715|NCT01464346|324136209|FG002|Overall Study|Withdrawal by Subject|1|||
94637716|NCT02642432|324136210|FG000|Overall Study|Adverse Event|2|||
94637717|NCT02642432|324136210|FG000|Overall Study|Withdrew Consent|1|||
94637718|NCT02642432|324136210|FG000|Overall Study|Lost to Follow-up|2|||
94637719|NCT02642432|324136210|FG000|Overall Study|Other|3|||
94637720|NCT03999892|324136211|FG000|Overall Study|Lost to Follow-up|1|||
94677036|NCT02332590|324271435|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
94637721|NCT02295995|324136212|FG000|Overall Study|Lost to Follow-up|5|||
94637722|NCT02295995|324136213|FG001|Overall Study|Lost to Follow-up|1|||
94637723|NCT02680639|324136214|FG000|Screening Period|Screen Failure|7|||
94677037|NCT02332590|324271434|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
94637724|NCT02680639|324136215|FG001|Screening Period|Screen Failure|0|||
94677038|NCT02332590|324271435|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
94637725|NCT02680639|324136216|FG002|Screening Period|Screen Failure|0|||
94637726|NCT02867709|324136217|FG000|Treatment Period|Adverse Event|1|||
94637727|NCT02867709|324136218|FG001|Treatment Period|Adverse Event|1|||
94637728|NCT02867709|324136219|FG002|Treatment Period|Adverse Event|2|||
94637729|NCT02867709|324136217|FG000|Treatment Period|Withdrawal of Consent|7|||
94637730|NCT02867709|324136218|FG001|Treatment Period|Withdrawal of Consent|9|||
94637731|NCT02867709|324136219|FG002|Treatment Period|Withdrawal of Consent|8|||
94637732|NCT02867709|324136217|FG000|Treatment Period|Lost to Follow-up|17|||
94637733|NCT02867709|324136218|FG001|Treatment Period|Lost to Follow-up|20|||
94637734|NCT02867709|324136219|FG002|Treatment Period|Lost to Follow-up|20|||
94637735|NCT02867709|324136217|FG000|Treatment Period|Lack of Qualifying Event|42|||
94637736|NCT02867709|324136218|FG001|Treatment Period|Lack of Qualifying Event|55|||
94637737|NCT02867709|324136219|FG002|Treatment Period|Lack of Qualifying Event|42|||
94637738|NCT02867709|324136217|FG000|Treatment Period|Protocol Violation|3|||
94637739|NCT02867709|324136218|FG001|Treatment Period|Protocol Violation|2|||
94637740|NCT02867709|324136219|FG002|Treatment Period|Protocol Violation|3|||
94637741|NCT02867709|324136217|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
94637742|NCT02867709|324136218|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
94637743|NCT02867709|324136219|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
94637744|NCT02867709|324136217|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
94637745|NCT02867709|324136218|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
94637746|NCT02867709|324136219|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
94637747|NCT02867709|324136217|FG000|Safety Follow-up Period|Pregnancy|0|||
94637748|NCT02867709|324136218|FG001|Safety Follow-up Period|Pregnancy|1|||
94637749|NCT02867709|324136219|FG002|Safety Follow-up Period|Pregnancy|0|||
94637750|NCT02867709|324136217|FG000|Safety Follow-up Period|Protocol Violation|0|||
94637751|NCT02867709|324136218|FG001|Safety Follow-up Period|Protocol Violation|1|||
94637752|NCT02867709|324136219|FG002|Safety Follow-up Period|Protocol Violation|1|||
94637753|NCT03245008|324136220|FG000|Overall Study|Adverse Event|15|||
94637754|NCT03245008|324136221|FG001|Overall Study|Adverse Event|18|||
94637755|NCT03245008|324136222|FG002|Overall Study|Adverse Event|15|||
94637756|NCT03245008|324136223|FG003|Overall Study|Adverse Event|0|||
94637757|NCT03245008|324136224|FG004|Overall Study|Adverse Event|1|||
94637758|NCT03245008|324136220|FG000|Overall Study|Lack of Efficacy|0|||
94637759|NCT03245008|324136221|FG001|Overall Study|Lack of Efficacy|1|||
94637760|NCT03245008|324136222|FG002|Overall Study|Lack of Efficacy|0|||
94637761|NCT03245008|324136223|FG003|Overall Study|Lack of Efficacy|0|||
94637762|NCT03245008|324136224|FG004|Overall Study|Lack of Efficacy|0|||
94637763|NCT03245008|324136220|FG000|Overall Study|Lost to Follow-up|4|||
94637764|NCT03245008|324136221|FG001|Overall Study|Lost to Follow-up|1|||
94637765|NCT03245008|324136222|FG002|Overall Study|Lost to Follow-up|0|||
94637766|NCT03245008|324136223|FG003|Overall Study|Lost to Follow-up|0|||
94637767|NCT03245008|324136224|FG004|Overall Study|Lost to Follow-up|1|||
94637768|NCT03245008|324136220|FG000|Overall Study|Physician Decision|1|||
94637769|NCT03245008|324136221|FG001|Overall Study|Physician Decision|3|||
94637770|NCT03245008|324136222|FG002|Overall Study|Physician Decision|4|||
94637771|NCT03245008|324136223|FG003|Overall Study|Physician Decision|0|||
94637772|NCT03245008|324136224|FG004|Overall Study|Physician Decision|0|||
94637773|NCT03245008|324136220|FG000|Overall Study|Protocol Violation|0|||
94637774|NCT03245008|324136221|FG001|Overall Study|Protocol Violation|1|||
94637775|NCT03245008|324136222|FG002|Overall Study|Protocol Violation|0|||
94637776|NCT03245008|324136223|FG003|Overall Study|Protocol Violation|0|||
94637777|NCT03245008|324136224|FG004|Overall Study|Protocol Violation|0|||
94637778|NCT03245008|324136220|FG000|Overall Study|Withdrawal by Subject|20|||
94637779|NCT03245008|324136221|FG001|Overall Study|Withdrawal by Subject|19|||
94637780|NCT03245008|324136222|FG002|Overall Study|Withdrawal by Subject|11|||
94637781|NCT03245008|324136223|FG003|Overall Study|Withdrawal by Subject|0|||
94637782|NCT03245008|324136224|FG004|Overall Study|Withdrawal by Subject|0|||
94637783|NCT03245008|324136220|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
94637784|NCT03245008|324136221|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
94637785|NCT03245008|324136222|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
94637786|NCT03245008|324136223|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
94637787|NCT03245008|324136224|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
94637788|NCT03245008|324136220|FG000|Overall Study|Failure to meet randomization criteria|0|||
94637789|NCT03245008|324136221|FG001|Overall Study|Failure to meet randomization criteria|1|||
94637790|NCT03245008|324136222|FG002|Overall Study|Failure to meet randomization criteria|0|||
94637791|NCT03245008|324136223|FG003|Overall Study|Failure to meet randomization criteria|1|||
94637792|NCT03245008|324136224|FG004|Overall Study|Failure to meet randomization criteria|0|||
94637793|NCT01853826|324138898|FG000|Overall Study|Patients who switched to commercial drug|11|||
94637794|NCT01853826|324138898|FG000|Overall Study|Patient refused to continue medication|21|||
94637795|NCT01853826|324138898|FG000|Overall Study|Lost to Follow-up|2|||
94637796|NCT01853826|324138898|FG000|Overall Study|Non-compliant with protocol|4|||
94637797|NCT01853826|324138898|FG000|Overall Study|Other adverse events (AE)|62|||
94637798|NCT01853826|324138898|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
94637799|NCT01853826|324138898|FG000|Overall Study|Progressive disease|342|||
94637800|NCT01853826|324138898|FG000|Overall Study|Other than listed|13|||
94637801|NCT01853826|324138898|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
94637802|NCT02016625|324138905|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
94637803|NCT02016625|324138906|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
94637804|NCT02016625|324138905|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
94637805|NCT02016625|324138906|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
94637806|NCT02016625|324138905|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
94637807|NCT02016625|324138906|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
94637808|NCT00156533|324138909|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
94637809|NCT00156533|324138910|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
94637810|NCT00156533|324138911|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
94637811|NCT00156533|324138912|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
94637812|NCT00156533|324138909|FG000|Overall Study|Withdrawal by Subject|1|||
94677039|NCT02332590|324271434|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
94677040|NCT02332590|324271435|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
94677041|NCT03183388|324272994|FG000|Overall Study|Lost to Follow-up|3|||
94677042|NCT03183388|324272995|FG001|Overall Study|Lost to Follow-up|5|||
94677043|NCT03183388|324272994|FG000|Overall Study|Physician Decision|1|||
94677044|NCT03183388|324272995|FG001|Overall Study|Physician Decision|4|||
94677045|NCT03183388|324272994|FG000|Overall Study|Withdrawal by Subject|4|||
94677046|NCT03183388|324272995|FG001|Overall Study|Withdrawal by Subject|1|||
94677047|NCT03183388|324272994|FG000|Overall Study|Moved|1|||
94677048|NCT03183388|324272995|FG001|Overall Study|Moved|0|||
94677049|NCT03183388|324272994|FG000|Overall Study|Met Exclusion Criteria|2|||
94677050|NCT03183388|324272995|FG001|Overall Study|Met Exclusion Criteria|2|||
94677051|NCT03183388|324272994|FG000|Overall Study|COVID Pandemic Related|2|||
94677052|NCT03183388|324272995|FG001|Overall Study|COVID Pandemic Related|4|||
94677053|NCT01090310|324272996|FG000|Core Study|Adverse Event|2|||
94677054|NCT01090310|324272997|FG001|Core Study|Adverse Event|2|||
94677055|NCT01090310|324272998|FG002|Core Study|Adverse Event|1|||
94677056|NCT01090310|324272999|FG003|Core Study|Adverse Event|1|||
94677057|NCT01090310|324272996|FG000|Core Study|Subject withdrew consent|0|||
94677058|NCT01090310|324272997|FG001|Core Study|Subject withdrew consent|3|||
94677059|NCT01090310|324272998|FG002|Core Study|Subject withdrew consent|1|||
94677060|NCT01090310|324272999|FG003|Core Study|Subject withdrew consent|1|||
94677061|NCT01090310|324272996|FG000|Core Study|Abnormal test procedure result|0|||
94677062|NCT01090310|324272997|FG001|Core Study|Abnormal test procedure result|0|||
94677063|NCT01090310|324272998|FG002|Core Study|Abnormal test procedure result|1|||
94677064|NCT01090310|324272999|FG003|Core Study|Abnormal test procedure result|0|||
94677065|NCT01090310|324272996|FG000|Core Study|Administrative reasons|5|||
94677066|NCT01090310|324272997|FG001|Core Study|Administrative reasons|6|||
94677067|NCT01090310|324272998|FG002|Core Study|Administrative reasons|4|||
94677068|NCT01090310|324272999|FG003|Core Study|Administrative reasons|4|||
94677069|NCT01090310|324272996|FG000|Core Study|Protocol deviation|1|||
94677070|NCT01090310|324272997|FG001|Core Study|Protocol deviation|0|||
94677071|NCT01090310|324272998|FG002|Core Study|Protocol deviation|0|||
94677072|NCT01090310|324272999|FG003|Core Study|Protocol deviation|1|||
94677073|NCT01090310|324272996|FG000|Extension Study|Aministrative problems|13|||
94677074|NCT01090310|324272997|FG001|Extension Study|Aministrative problems|15|||
94677075|NCT01090310|324272998|FG002|Extension Study|Aministrative problems|14|||
94677076|NCT01090310|324272999|FG003|Extension Study|Aministrative problems|18|||
94677077|NCT01090310|324272996|FG000|Extension Study|Adverse Event|0|||
94677078|NCT01090310|324272997|FG001|Extension Study|Adverse Event|0|||
94677079|NCT01090310|324272998|FG002|Extension Study|Adverse Event|0|||
94677080|NCT01090310|324272999|FG003|Extension Study|Adverse Event|1|||
94677081|NCT01090310|324272996|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
94262674|NCT00604279|322756523|FG000|Overall Study|Protocol Violation|3|||
94262675|NCT00604279|322756524|FG001|Overall Study|Protocol Violation|1|||
94262676|NCT00604279|322756523|FG000|Overall Study|Withdrawal by Subject|16|||
94262677|NCT00604279|322756524|FG001|Overall Study|Withdrawal by Subject|5|||
94262678|NCT00604279|322756523|FG000|Overall Study|Adverse Event|4|||
94262679|NCT00604279|322756524|FG001|Overall Study|Adverse Event|5|||
94262680|NCT00604279|322756523|FG000|Overall Study|Other|8|||
94262681|NCT00604279|322756524|FG001|Overall Study|Other|4|||
94262682|NCT00440700|322756525|FG000|Overall Study|Withdrawal by Subject|8|||
94262683|NCT00440700|322756526|FG001|Overall Study|Withdrawal by Subject|8|||
94262684|NCT00440700|322756527|FG002|Overall Study|Withdrawal by Subject|4|||
94637813|NCT00156533|324138910|FG001|Overall Study|Withdrawal by Subject|0|||
94637814|NCT00156533|324138911|FG002|Overall Study|Withdrawal by Subject|0|||
94677082|NCT01090310|324272997|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
94677083|NCT01090310|324272998|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
94677084|NCT01090310|324272999|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
94677085|NCT01090310|324272996|FG000|Extension Study|Subject withdrew consent|0|||
94677086|NCT01090310|324272997|FG001|Extension Study|Subject withdrew consent|1|||
94677087|NCT01090310|324272998|FG002|Extension Study|Subject withdrew consent|0|||
94677088|NCT01090310|324272999|FG003|Extension Study|Subject withdrew consent|0|||
94262685|NCT01256658|322756528|FG000|Period 1|Lost to Follow-up|837|||
94677089|NCT01364922|324273000|FG000|Open-label (OL) Period|Adverse Event|7|||
94677090|NCT01364922|324273001|FG001|Open-label (OL) Period|Adverse Event|0|||
94262686|NCT01256658|322756529|FG001|Period 1|Lost to Follow-up|661|||
94677091|NCT01364922|324273002|FG002|Open-label (OL) Period|Adverse Event|0|||
94262687|NCT01256658|322756528|FG000|Period 1|Withdrawal by Subject|35|||
94637815|NCT00156533|324138912|FG003|Overall Study|Withdrawal by Subject|1|||
94637816|NCT00156533|324138909|FG000|Overall Study|Failed Screening|1|||
94637817|NCT00156533|324138910|FG001|Overall Study|Failed Screening|0|||
94637818|NCT00156533|324138911|FG002|Overall Study|Failed Screening|1|||
94637819|NCT00156533|324138912|FG003|Overall Study|Failed Screening|1|||
94637820|NCT01365507|324138914|FG000|Overall Study|Withdrawal Criteria|8|||
94637821|NCT01365507|324138915|FG001|Overall Study|Withdrawal Criteria|5|||
94637822|NCT01365507|324138914|FG000|Overall Study|Unclassified|1|||
94637823|NCT01365507|324138915|FG001|Overall Study|Unclassified|4|||
94637824|NCT00192504|324138918|FG000|Overall Study|Lost to Follow-up|1|||
94637825|NCT00192504|324138919|FG001|Overall Study|Lost to Follow-up|0|||
94637826|NCT00192504|324138920|FG002|Overall Study|Lost to Follow-up|0|||
94637827|NCT00192504|324138921|FG003|Overall Study|Lost to Follow-up|0|||
94637828|NCT00192504|324138918|FG000|Overall Study|Dosing window missed|0|||
94637829|NCT00192504|324138919|FG001|Overall Study|Dosing window missed|0|||
94637830|NCT00192504|324138920|FG002|Overall Study|Dosing window missed|1|||
94637831|NCT00192504|324138921|FG003|Overall Study|Dosing window missed|0|||
94637832|NCT03989440|324138922|FG000|Overall Study|COVID-19 travel restrictions|0|||
94637833|NCT03989440|324138923|FG001|Overall Study|COVID-19 travel restrictions|0|||
94637834|NCT03989440|324138924|FG002|Overall Study|COVID-19 travel restrictions|1|||
94637835|NCT03989440|324138925|FG003|Overall Study|COVID-19 travel restrictions|0|||
94637836|NCT03989440|324138926|FG004|Overall Study|COVID-19 travel restrictions|0|||
94637837|NCT03989440|324138927|FG005|Overall Study|COVID-19 travel restrictions|0|||
94637838|NCT03989440|324138922|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
94637839|NCT03989440|324138923|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
94637840|NCT03989440|324138924|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
94637841|NCT03989440|324138925|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
94637842|NCT03989440|324138926|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
94637843|NCT03989440|324138927|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
94637844|NCT03265249|324138928|FG000|Overall Study|Withdrawal by Subject|0|||
94637845|NCT03265249|324138929|FG001|Overall Study|Withdrawal by Subject|1|||
94637846|NCT02784821|324138930|FG000|Overall Study|Death|0|||
94637847|NCT02784821|324138931|FG001|Overall Study|Death|5|||
94637848|NCT02784821|324138932|FG002|Overall Study|Death|4|||
94637849|NCT02784821|324138933|FG003|Overall Study|Death|5|||
94637850|NCT02794103|324138934|FG000|Overall Study|Loss to follow up due to high sedation|3|||
94637851|NCT01277523|324138935|FG000|Overall Study|Adverse Event|1|||
94637852|NCT01277523|324138936|FG001|Overall Study|Adverse Event|0|||
94637853|NCT01277523|324138937|FG002|Overall Study|Adverse Event|0|||
94637854|NCT01277523|324138935|FG000|Overall Study|Protocol Violation|2|||
94637855|NCT01277523|324138936|FG001|Overall Study|Protocol Violation|0|||
94637856|NCT01277523|324138937|FG002|Overall Study|Protocol Violation|0|||
94637857|NCT01277523|324138935|FG000|Overall Study|Other Reason not Defined|0|||
94637858|NCT01277523|324138936|FG001|Overall Study|Other Reason not Defined|1|||
94637859|NCT01277523|324138937|FG002|Overall Study|Other Reason not Defined|0|||
94637860|NCT02255500|324138938|FG000|Overall Study|Withdrawal by Subject|1|||
94637861|NCT02255500|324138939|FG001|Overall Study|Withdrawal by Subject|0|||
94637862|NCT00914810|324138940|FG000|Overall Study|Withdrawal by Subject|1|||
94637863|NCT00914810|324138941|FG001|Overall Study|Withdrawal by Subject|0|||
94637864|NCT00914810|324138940|FG000|Overall Study|Relocated out of state|1|||
94637865|NCT00914810|324138941|FG001|Overall Study|Relocated out of state|0|||
94637866|NCT00914810|324138940|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
94637867|NCT00914810|324138941|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
94637868|NCT02747420|324138942|FG000|Overall Study|Lost to Follow-up|4|||
94637869|NCT02747420|324138943|FG001|Overall Study|Lost to Follow-up|2|||
94637870|NCT02747420|324138942|FG000|Overall Study|Withdrawal by Subject|3|||
94637871|NCT02747420|324138943|FG001|Overall Study|Withdrawal by Subject|2|||
94637872|NCT05129488|324138944|FG000|Overall Study|Protocol Violation|3|||
94637873|NCT02608268|324138945|FG000|Overall Study|Adverse Event|0|||
94637874|NCT02608268|324138946|FG001|Overall Study|Adverse Event|0|||
94262688|NCT01256658|322756529|FG001|Period 1|Withdrawal by Subject|43|||
94637875|NCT02608268|324138947|FG002|Overall Study|Adverse Event|1|||
94637876|NCT02608268|324138948|FG003|Overall Study|Adverse Event|0|||
94637877|NCT02608268|324138949|FG004|Overall Study|Adverse Event|0|||
94637878|NCT02608268|324138950|FG005|Overall Study|Adverse Event|0|||
94637879|NCT02608268|324138951|FG006|Overall Study|Adverse Event|0|||
94637880|NCT02608268|324138952|FG007|Overall Study|Adverse Event|0|||
94637881|NCT02608268|324138953|FG008|Overall Study|Adverse Event|0|||
94637882|NCT02608268|324138954|FG009|Overall Study|Adverse Event|0|||
94637883|NCT02608268|324138955|FG010|Overall Study|Adverse Event|0|||
94637884|NCT02608268|324138956|FG011|Overall Study|Adverse Event|0|||
94637885|NCT02608268|324138957|FG012|Overall Study|Adverse Event|2|||
94637886|NCT02608268|324138958|FG013|Overall Study|Adverse Event|0|||
94637887|NCT02608268|324138959|FG014|Overall Study|Adverse Event|0|||
94637888|NCT02608268|324138960|FG015|Overall Study|Adverse Event|0|||
94637889|NCT02608268|324138961|FG016|Overall Study|Adverse Event|0|||
94262689|NCT01256658|322756528|FG000|Period 1|Death|48|||
94677092|NCT01364922|324273000|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
94677093|NCT01364922|324273001|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
94677094|NCT01364922|324273002|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
94677095|NCT01364922|324273000|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
94677096|NCT01364922|324273001|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
94677097|NCT01364922|324273002|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
94677098|NCT01364922|324273000|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
94677099|NCT01364922|324273001|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
94677100|NCT01364922|324273002|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
94677101|NCT01364922|324273000|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
94677102|NCT01364922|324273001|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
94677103|NCT01364922|324273002|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
94677104|NCT01364922|324273000|FG000|Open-label (OL) Period|Other, Unspecified|1|||
94677105|NCT01364922|324273001|FG001|Open-label (OL) Period|Other, Unspecified|0|||
94677106|NCT01364922|324273002|FG002|Open-label (OL) Period|Other, Unspecified|0|||
94677107|NCT01364922|324273000|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
94677108|NCT01364922|324273001|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
94677109|NCT01364922|324273002|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
94677110|NCT01364922|324273000|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
94677111|NCT01364922|324273001|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
94677112|NCT01364922|324273002|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
94677113|NCT01364922|324273000|FG000|Double-Blind (DB) Period|Adverse Event|0|||
94677114|NCT01364922|324273001|FG001|Double-Blind (DB) Period|Adverse Event|0|||
94677115|NCT01364922|324273002|FG002|Double-Blind (DB) Period|Adverse Event|1|||
94677116|NCT01364922|324273000|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
94677117|NCT01364922|324273001|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
94677118|NCT01364922|324273002|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
94677119|NCT01782742|324273005|FG000|Double-blind Treatment Phase|Adverse Event|1|||
94677120|NCT01782742|324273006|FG001|Double-blind Treatment Phase|Adverse Event|0|||
94677121|NCT01953003|324273007|FG000|Overall Study|Not treated|0|||
94677122|NCT01953003|324273008|FG001|Overall Study|Not treated|1|||
94677123|NCT01953003|324273007|FG000|Overall Study|Progressive disease|35|||
94677124|NCT01953003|324273008|FG001|Overall Study|Progressive disease|45|||
94677125|NCT01953003|324273007|FG000|Overall Study|Related Adverse events|7|||
94677126|NCT01953003|324273008|FG001|Overall Study|Related Adverse events|2|||
94677127|NCT01953003|324273007|FG000|Overall Study|Non-related adverse events|0|||
94677128|NCT01953003|324273008|FG001|Overall Study|Non-related adverse events|2|||
94677129|NCT01953003|324273007|FG000|Overall Study|Protocol Violation|0|||
94677130|NCT01953003|324273008|FG001|Overall Study|Protocol Violation|1|||
94677131|NCT01953003|324273007|FG000|Overall Study|Withdrawal by Subject|14|||
94677132|NCT01953003|324273008|FG001|Overall Study|Withdrawal by Subject|4|||
94677133|NCT00949715|324273009|FG000|Overall Study|Physician Decision|1|||
94677134|NCT00949715|324273010|FG001|Overall Study|Physician Decision|0|||
94677135|NCT00949715|324273009|FG000|Overall Study|Lost to Follow-up|1|||
94677136|NCT00949715|324273010|FG001|Overall Study|Lost to Follow-up|0|||
94677137|NCT00949715|324273009|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
94677138|NCT00949715|324273010|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
94677139|NCT04858802|324273011|FG000|Overall Study|Lost to Follow-up|1|||
94637890|NCT02608268|324138962|FG017|Overall Study|Adverse Event|0|||
94637891|NCT02608268|324138963|FG018|Overall Study|Adverse Event|0|||
94637892|NCT02608268|324138964|FG019|Overall Study|Adverse Event|0|||
94637893|NCT02608268|324138965|FG020|Overall Study|Adverse Event|1|||
94637894|NCT02608268|324138966|FG021|Overall Study|Adverse Event|1|||
94637895|NCT02608268|324138967|FG022|Overall Study|Adverse Event|0|||
94637896|NCT02608268|324138968|FG023|Overall Study|Adverse Event|0|||
94637897|NCT02608268|324138969|FG024|Overall Study|Adverse Event|1|||
94637898|NCT02608268|324138970|FG025|Overall Study|Adverse Event|0|||
94637899|NCT02608268|324138971|FG026|Overall Study|Adverse Event|0|||
94637900|NCT02608268|324138972|FG027|Overall Study|Adverse Event|0|||
94637901|NCT02608268|324138973|FG028|Overall Study|Adverse Event|1|||
94637902|NCT02608268|324138974|FG029|Overall Study|Adverse Event|0|||
94637903|NCT02608268|324138945|FG000|Overall Study|Death|1|||
94637904|NCT02608268|324138946|FG001|Overall Study|Death|0|||
94677140|NCT04858802|324273012|FG001|Overall Study|Lost to Follow-up|1|||
94677141|NCT04858802|324273011|FG000|Overall Study|Withdrawal by Subject|1|||
94677142|NCT04858802|324273012|FG001|Overall Study|Withdrawal by Subject|1|||
94677143|NCT01106430|324273015|FG000|Overall Study|Adverse Event|8|||
94677144|NCT01106430|324273016|FG001|Overall Study|Adverse Event|10|||
94637905|NCT02608268|324138947|FG002|Overall Study|Death|0|||
94677145|NCT01106430|324273015|FG000|Overall Study|Lack of Efficacy|2|||
94677146|NCT01106430|324273016|FG001|Overall Study|Lack of Efficacy|13|||
94637906|NCT02608268|324138948|FG003|Overall Study|Death|0|||
94637907|NCT02608268|324138949|FG004|Overall Study|Death|0|||
94637908|NCT02608268|324138950|FG005|Overall Study|Death|0|||
94677147|NCT01106430|324273015|FG000|Overall Study|Lost to Follow-up|5|||
94677148|NCT01106430|324273016|FG001|Overall Study|Lost to Follow-up|1|||
94637909|NCT02608268|324138951|FG006|Overall Study|Death|0|||
94637910|NCT02608268|324138952|FG007|Overall Study|Death|0|||
94637911|NCT02608268|324138953|FG008|Overall Study|Death|1|||
94637912|NCT02608268|324138954|FG009|Overall Study|Death|1|||
94637913|NCT02608268|324138955|FG010|Overall Study|Death|0|||
94637914|NCT02608268|324138956|FG011|Overall Study|Death|0|||
94637915|NCT02608268|324138957|FG012|Overall Study|Death|0|||
94637916|NCT02608268|324138958|FG013|Overall Study|Death|0|||
94637917|NCT02608268|324138959|FG014|Overall Study|Death|0|||
94637918|NCT02608268|324138960|FG015|Overall Study|Death|1|||
94637919|NCT02608268|324138961|FG016|Overall Study|Death|0|||
94637920|NCT02608268|324138962|FG017|Overall Study|Death|1|||
94637921|NCT02608268|324138963|FG018|Overall Study|Death|0|||
94637922|NCT02608268|324138964|FG019|Overall Study|Death|1|||
94637923|NCT02608268|324138965|FG020|Overall Study|Death|1|||
94637924|NCT02608268|324138966|FG021|Overall Study|Death|0|||
94637925|NCT02608268|324138967|FG022|Overall Study|Death|0|||
94637926|NCT02608268|324138968|FG023|Overall Study|Death|0|||
94637927|NCT02608268|324138969|FG024|Overall Study|Death|1|||
94637928|NCT02608268|324138970|FG025|Overall Study|Death|2|||
94637929|NCT02608268|324138971|FG026|Overall Study|Death|0|||
94637930|NCT02608268|324138972|FG027|Overall Study|Death|1|||
94637931|NCT02608268|324138973|FG028|Overall Study|Death|4|||
94637932|NCT02608268|324138974|FG029|Overall Study|Death|0|||
94637933|NCT02608268|324138945|FG000|Overall Study|Physician Decision|0|||
94637934|NCT02608268|324138946|FG001|Overall Study|Physician Decision|0|||
94637935|NCT02608268|324138947|FG002|Overall Study|Physician Decision|0|||
94637936|NCT02608268|324138948|FG003|Overall Study|Physician Decision|0|||
94637937|NCT02608268|324138949|FG004|Overall Study|Physician Decision|0|||
94637938|NCT02608268|324138950|FG005|Overall Study|Physician Decision|0|||
94637939|NCT02608268|324138951|FG006|Overall Study|Physician Decision|0|||
94637940|NCT02608268|324138952|FG007|Overall Study|Physician Decision|0|||
94637941|NCT02608268|324138953|FG008|Overall Study|Physician Decision|0|||
94637942|NCT02608268|324138954|FG009|Overall Study|Physician Decision|0|||
94637943|NCT02608268|324138955|FG010|Overall Study|Physician Decision|1|||
94637944|NCT02608268|324138956|FG011|Overall Study|Physician Decision|0|||
94637945|NCT02608268|324138957|FG012|Overall Study|Physician Decision|0|||
94637946|NCT02608268|324138958|FG013|Overall Study|Physician Decision|1|||
94637947|NCT02608268|324138959|FG014|Overall Study|Physician Decision|0|||
94637948|NCT02608268|324138960|FG015|Overall Study|Physician Decision|0|||
94637949|NCT02608268|324138961|FG016|Overall Study|Physician Decision|0|||
94637950|NCT02608268|324138962|FG017|Overall Study|Physician Decision|0|||
94637951|NCT02608268|324138963|FG018|Overall Study|Physician Decision|0|||
94637952|NCT02608268|324138964|FG019|Overall Study|Physician Decision|0|||
94637953|NCT02608268|324138965|FG020|Overall Study|Physician Decision|0|||
94637954|NCT02608268|324138966|FG021|Overall Study|Physician Decision|0|||
94637955|NCT02608268|324138967|FG022|Overall Study|Physician Decision|1|||
94637956|NCT02608268|324138968|FG023|Overall Study|Physician Decision|1|||
94637957|NCT02608268|324138969|FG024|Overall Study|Physician Decision|1|||
94637958|NCT02608268|324138970|FG025|Overall Study|Physician Decision|0|||
94637959|NCT02608268|324138971|FG026|Overall Study|Physician Decision|0|||
94637960|NCT02608268|324138972|FG027|Overall Study|Physician Decision|2|||
94637961|NCT02608268|324138973|FG028|Overall Study|Physician Decision|1|||
94637962|NCT02608268|324138974|FG029|Overall Study|Physician Decision|1|||
94637963|NCT02608268|324138945|FG000|Overall Study|Progressive disease|12|||
94637964|NCT02608268|324138946|FG001|Overall Study|Progressive disease|8|||
94637965|NCT02608268|324138947|FG002|Overall Study|Progressive disease|13|||
94637966|NCT02608268|324138948|FG003|Overall Study|Progressive disease|5|||
94637967|NCT02608268|324138949|FG004|Overall Study|Progressive disease|2|||
94637968|NCT02608268|324138950|FG005|Overall Study|Progressive disease|4|||
94637969|NCT02608268|324138951|FG006|Overall Study|Progressive disease|6|||
94637970|NCT02608268|324138952|FG007|Overall Study|Progressive disease|2|||
94637971|NCT02608268|324138953|FG008|Overall Study|Progressive disease|5|||
94637972|NCT02608268|324138954|FG009|Overall Study|Progressive disease|6|||
94637973|NCT02608268|324138955|FG010|Overall Study|Progressive disease|5|||
94637974|NCT02608268|324138956|FG011|Overall Study|Progressive disease|5|||
94637975|NCT02608268|324138957|FG012|Overall Study|Progressive disease|4|||
94637976|NCT02608268|324138958|FG013|Overall Study|Progressive disease|11|||
94637977|NCT02608268|324138959|FG014|Overall Study|Progressive disease|6|||
94637978|NCT02608268|324138960|FG015|Overall Study|Progressive disease|3|||
94637979|NCT02608268|324138961|FG016|Overall Study|Progressive disease|5|||
94637980|NCT02608268|324138962|FG017|Overall Study|Progressive disease|5|||
94637981|NCT02608268|324138963|FG018|Overall Study|Progressive disease|5|||
94637982|NCT02608268|324138964|FG019|Overall Study|Progressive disease|2|||
94637983|NCT02608268|324138965|FG020|Overall Study|Progressive disease|10|||
94637984|NCT02608268|324138966|FG021|Overall Study|Progressive disease|4|||
94637985|NCT02608268|324138967|FG022|Overall Study|Progressive disease|5|||
94637986|NCT02608268|324138968|FG023|Overall Study|Progressive disease|5|||
94637987|NCT02608268|324138969|FG024|Overall Study|Progressive disease|3|||
94637988|NCT02608268|324138970|FG025|Overall Study|Progressive disease|11|||
94637989|NCT02608268|324138971|FG026|Overall Study|Progressive disease|16|||
94637990|NCT02608268|324138972|FG027|Overall Study|Progressive disease|11|||
94637991|NCT02608268|324138973|FG028|Overall Study|Progressive disease|10|||
94637992|NCT02608268|324138974|FG029|Overall Study|Progressive disease|15|||
94637993|NCT02608268|324138945|FG000|Overall Study|Subject/guardian decision|1|||
94637994|NCT02608268|324138946|FG001|Overall Study|Subject/guardian decision|1|||
94637995|NCT02608268|324138947|FG002|Overall Study|Subject/guardian decision|2|||
94262690|NCT01256658|322756529|FG001|Period 1|Death|44|||
94262691|NCT00888433|322756532|FG000|Overall Study|Withdrawal by Subject|1|||
94262692|NCT00888433|322756533|FG001|Overall Study|Withdrawal by Subject|2|||
94637996|NCT02608268|324138948|FG003|Overall Study|Subject/guardian decision|0|||
94637997|NCT02608268|324138949|FG004|Overall Study|Subject/guardian decision|0|||
94637998|NCT02608268|324138950|FG005|Overall Study|Subject/guardian decision|0|||
94637999|NCT02608268|324138951|FG006|Overall Study|Subject/guardian decision|0|||
94638000|NCT02608268|324138952|FG007|Overall Study|Subject/guardian decision|0|||
94638001|NCT02608268|324138953|FG008|Overall Study|Subject/guardian decision|2|||
94638002|NCT02608268|324138954|FG009|Overall Study|Subject/guardian decision|2|||
94638003|NCT02608268|324138955|FG010|Overall Study|Subject/guardian decision|0|||
94638004|NCT02608268|324138956|FG011|Overall Study|Subject/guardian decision|1|||
94638005|NCT02608268|324138957|FG012|Overall Study|Subject/guardian decision|0|||
94638006|NCT02608268|324138958|FG013|Overall Study|Subject/guardian decision|1|||
94638007|NCT02608268|324138959|FG014|Overall Study|Subject/guardian decision|0|||
94638008|NCT02608268|324138960|FG015|Overall Study|Subject/guardian decision|1|||
94638009|NCT02608268|324138961|FG016|Overall Study|Subject/guardian decision|0|||
94638010|NCT02608268|324138962|FG017|Overall Study|Subject/guardian decision|0|||
94638011|NCT02608268|324138963|FG018|Overall Study|Subject/guardian decision|1|||
94638012|NCT02608268|324138964|FG019|Overall Study|Subject/guardian decision|0|||
94638013|NCT02608268|324138965|FG020|Overall Study|Subject/guardian decision|0|||
94638014|NCT02608268|324138966|FG021|Overall Study|Subject/guardian decision|0|||
94638015|NCT02608268|324138967|FG022|Overall Study|Subject/guardian decision|1|||
94638016|NCT02608268|324138968|FG023|Overall Study|Subject/guardian decision|0|||
94638017|NCT02608268|324138969|FG024|Overall Study|Subject/guardian decision|0|||
94638018|NCT02608268|324138970|FG025|Overall Study|Subject/guardian decision|1|||
94638019|NCT02608268|324138971|FG026|Overall Study|Subject/guardian decision|1|||
94638020|NCT02608268|324138972|FG027|Overall Study|Subject/guardian decision|1|||
94638021|NCT02608268|324138973|FG028|Overall Study|Subject/guardian decision|1|||
94638022|NCT02608268|324138974|FG029|Overall Study|Subject/guardian decision|0|||
94638023|NCT01012622|324138981|FG000|Overall Study|Withdrawal by Subject|6|||
94638024|NCT01012622|324138981|FG000|Overall Study|Lost to Follow-up|5|||
94638025|NCT01012622|324138981|FG000|Overall Study|Adverse Event|7|||
94638026|NCT01012622|324138981|FG000|Overall Study|non-compliance with the drug|9|||
94638027|NCT01012622|324138981|FG000|Overall Study|Other|1|||
94638028|NCT01012622|324138981|FG000|Overall Study|screening failure|1|||
94638029|NCT01012622|324138981|FG000|Overall Study|withdrawal of consent by a parent|2|||
94638030|NCT00706641|324138982|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
94638031|NCT00706641|324138982|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
94638032|NCT00706641|324138982|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
94638033|NCT02082210|324138985|FG000|Overall Study|Death|0|||
94638034|NCT02082210|324138986|FG001|Overall Study|Death|0|||
94638035|NCT02082210|324138987|FG002|Overall Study|Death|1|||
94638036|NCT02082210|324138988|FG003|Overall Study|Death|1|||
94638037|NCT02082210|324138989|FG004|Overall Study|Death|1|||
94638038|NCT02082210|324138990|FG005|Overall Study|Death|0|||
94638039|NCT02082210|324138985|FG000|Overall Study|Withdrawal by Subject|0|||
94638040|NCT02082210|324138986|FG001|Overall Study|Withdrawal by Subject|0|||
94638041|NCT02082210|324138987|FG002|Overall Study|Withdrawal by Subject|0|||
94638042|NCT02082210|324138988|FG003|Overall Study|Withdrawal by Subject|1|||
94638043|NCT02082210|324138989|FG004|Overall Study|Withdrawal by Subject|2|||
94638044|NCT02082210|324138990|FG005|Overall Study|Withdrawal by Subject|2|||
94638045|NCT02082210|324138985|FG000|Overall Study|Clinical Progression|0|||
94638046|NCT02082210|324138986|FG001|Overall Study|Clinical Progression|0|||
94638047|NCT02082210|324138987|FG002|Overall Study|Clinical Progression|0|||
94638048|NCT02082210|324138988|FG003|Overall Study|Clinical Progression|1|||
94638049|NCT02082210|324138989|FG004|Overall Study|Clinical Progression|0|||
94638050|NCT02082210|324138990|FG005|Overall Study|Clinical Progression|0|||
94638051|NCT02082210|324138985|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
94638052|NCT02082210|324138986|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
94638053|NCT02082210|324138987|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
94638054|NCT02082210|324138988|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
94638055|NCT02082210|324138989|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
94638056|NCT02082210|324138990|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
94638057|NCT02082210|324138985|FG000|Overall Study|Physician Decision|0|||
94638058|NCT02082210|324138986|FG001|Overall Study|Physician Decision|0|||
94638059|NCT02082210|324138987|FG002|Overall Study|Physician Decision|1|||
94638060|NCT02082210|324138988|FG003|Overall Study|Physician Decision|1|||
94638061|NCT02082210|324138989|FG004|Overall Study|Physician Decision|0|||
94638062|NCT02082210|324138990|FG005|Overall Study|Physician Decision|0|||
94638063|NCT01859494|324138991|FG000|Overall Study|Adverse Event|1|||
94638064|NCT01063764|324138992|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
94638065|NCT01063764|324138992|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
94677149|NCT01106430|324273015|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
94677150|NCT01106430|324273016|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
94677151|NCT01106430|324273015|FG000|Overall Study|Moved Out Of State|0|||
94677152|NCT01106430|324273016|FG001|Overall Study|Moved Out Of State|1|||
94677153|NCT01106430|324273015|FG000|Overall Study|Refused To Take Medication|0|||
94677154|NCT01106430|324273016|FG001|Overall Study|Refused To Take Medication|1|||
94677155|NCT01106430|324273015|FG000|Overall Study|Noncompliance|0|||
94677156|NCT01106430|324273016|FG001|Overall Study|Noncompliance|1|||
94677157|NCT01106430|324273015|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
94677158|NCT01106430|324273016|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
94677159|NCT01106430|324273015|FG000|Overall Study|Previous Use Of Marijuana|1|||
94677160|NCT01106430|324273016|FG001|Overall Study|Previous Use Of Marijuana|0|||
94677161|NCT01106430|324273015|FG000|Overall Study|Protocol Violation|7|||
94677162|NCT01106430|324273016|FG001|Overall Study|Protocol Violation|2|||
94677163|NCT01106430|324273015|FG000|Overall Study|Withdrawal by Subject|8|||
94677164|NCT01106430|324273016|FG001|Overall Study|Withdrawal by Subject|4|||
94677165|NCT03439189|324273018|FG000|Overall Study|Protocol Violation|19|||
94677166|NCT03439189|324273018|FG000|Overall Study|Lack of Efficacy|63|||
94677167|NCT04098406|324273019|FG000|Overall Study|Adverse Event|2|||
94677168|NCT04098406|324273020|FG001|Overall Study|Adverse Event|1|||
94677169|NCT04098406|324273019|FG000|Overall Study|Withdrawal by Subject|1|||
94677170|NCT04098406|324273020|FG001|Overall Study|Withdrawal by Subject|0|||
94677171|NCT03928028|324273027|FG000|Overall Study|Physician Decision|9|||
94677172|NCT03928028|324273028|FG001|Overall Study|Physician Decision|6|||
94677173|NCT03928028|324273029|FG002|Overall Study|Physician Decision|3|||
94677174|NCT03928028|324273027|FG000|Overall Study|Withdrawal by Subject|12|||
94677175|NCT03928028|324273028|FG001|Overall Study|Withdrawal by Subject|3|||
94677176|NCT03928028|324273029|FG002|Overall Study|Withdrawal by Subject|3|||
94677177|NCT02710292|324273030|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
94677178|NCT02710292|324273031|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
94677179|NCT02710292|324273030|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
94677180|NCT02710292|324273031|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
94677181|NCT01191840|324273035|FG000|Overall Study|withdrew consent|2|||
94677182|NCT01191840|324273036|FG001|Overall Study|withdrew consent|1|||
94677183|NCT01191840|324273035|FG000|Overall Study|Subject discontinued treatment|1|||
94677184|NCT01191840|324273036|FG001|Overall Study|Subject discontinued treatment|2|||
94677185|NCT01191840|324273035|FG000|Overall Study|Lost to Follow-up|4|||
94262693|NCT00888433|322756532|FG000|Overall Study|Missed Visit|2|||
94262694|NCT00888433|322756533|FG001|Overall Study|Missed Visit|1|||
94262695|NCT03871829|322756538|FG000|Overall Study|Lost to Follow-up|0|||
94262696|NCT03871829|322756539|FG001|Overall Study|Lost to Follow-up|1|||
94262697|NCT03871829|322756538|FG000|Overall Study|Withdrawal by Subject|1|||
94262698|NCT03871829|322756539|FG001|Overall Study|Withdrawal by Subject|1|||
94262699|NCT03871829|322756538|FG000|Overall Study|Death|12|||
94262700|NCT03871829|322756539|FG001|Overall Study|Death|8|||
94262701|NCT03871829|322756538|FG000|Overall Study|Study terminated by sponsor|31|||
94262702|NCT03871829|322756539|FG001|Overall Study|Study terminated by sponsor|34|||
94262703|NCT04288778|322756540|FG000|Overall Study|Withdrawal by Subject|2|||
94638066|NCT01063764|324138992|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
94638067|NCT01063764|324138992|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
94638068|NCT01063764|324138992|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
94638069|NCT01063764|324138992|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
94638070|NCT01063764|324138992|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
94638071|NCT02436759|324138993|FG000|Overall Study|Adverse Event|3|||
94638072|NCT02436759|324138994|FG001|Overall Study|Adverse Event|0|||
94638073|NCT02436759|324138993|FG000|Overall Study|Protocol Violation|1|||
94638074|NCT02436759|324138994|FG001|Overall Study|Protocol Violation|0|||
94638075|NCT02436759|324138993|FG000|Overall Study|Withdrawal by Subject|0|||
94638076|NCT02436759|324138994|FG001|Overall Study|Withdrawal by Subject|1|||
94638077|NCT01023581|324138997|FG000|Overall Study|Adverse Event|4|||
94638078|NCT01023581|324138998|FG001|Overall Study|Adverse Event|4|||
94638079|NCT01023581|324138999|FG002|Overall Study|Adverse Event|7|||
94638080|NCT01023581|324139000|FG003|Overall Study|Adverse Event|3|||
94638081|NCT01023581|324139001|FG004|Overall Study|Adverse Event|2|||
94262704|NCT04288778|322756540|FG000|Overall Study|Adverse Event|5|||
94262705|NCT04288778|322756540|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94677186|NCT01191840|324273036|FG001|Overall Study|Lost to Follow-up|6|||
94262706|NCT04288778|322756540|FG000|Overall Study|Other|1|||
94262707|NCT04288778|322756540|FG000|Overall Study|Started but not treated|2|||
94638082|NCT01023581|324139002|FG005|Overall Study|Adverse Event|5|||
94638083|NCT01023581|324139003|FG006|Overall Study|Adverse Event|11|||
94638084|NCT01023581|324138997|FG000|Overall Study|Major protocol deviation|2|||
94677187|NCT01191840|324273035|FG000|Overall Study|Non Staph Infection|4|||
94677188|NCT01191840|324273036|FG001|Overall Study|Non Staph Infection|3|||
94262708|NCT00528866|322756544|FG000|Overall Study|Protocol Violation|6|||
94677189|NCT01191840|324273035|FG000|Overall Study|ineligible at enrollment|1|||
94638085|NCT01023581|324138998|FG001|Overall Study|Major protocol deviation|0|||
94638086|NCT01023581|324138999|FG002|Overall Study|Major protocol deviation|3|||
94638087|NCT01023581|324139000|FG003|Overall Study|Major protocol deviation|0|||
94638088|NCT01023581|324139001|FG004|Overall Study|Major protocol deviation|0|||
94638089|NCT01023581|324139002|FG005|Overall Study|Major protocol deviation|0|||
94262709|NCT00993915|322756545|FG000|Overall Study|Insufficient clinical response|3|||
94262710|NCT00993915|322756545|FG000|Overall Study|Withdrawal by Subject|2|||
94262711|NCT00993915|322756545|FG000|Overall Study|Other|1|||
94262712|NCT00993915|322756545|FG000|Overall Study|Ongoing|3|||
94262713|NCT02119325|322756546|FG000|Washout Period 1|Adverse Event|0|||
94262714|NCT02119325|322756547|FG001|Washout Period 1|Adverse Event|1|||
94262715|NCT01386658|322756548|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
94262716|NCT01386658|322756549|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
94262717|NCT01386658|322756548|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
94262718|NCT01386658|322756549|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
94262719|NCT01284062|322756550|FG000|Overall Study|Adverse Event|4|||
94638090|NCT01023581|324139003|FG006|Overall Study|Major protocol deviation|0|||
94638091|NCT01023581|324138997|FG000|Overall Study|Lost to Follow-up|4|||
94638092|NCT01023581|324138998|FG001|Overall Study|Lost to Follow-up|8|||
94638093|NCT01023581|324138999|FG002|Overall Study|Lost to Follow-up|7|||
94638094|NCT01023581|324139000|FG003|Overall Study|Lost to Follow-up|2|||
94638095|NCT01023581|324139001|FG004|Overall Study|Lost to Follow-up|5|||
94638096|NCT01023581|324139002|FG005|Overall Study|Lost to Follow-up|2|||
94638097|NCT01023581|324139003|FG006|Overall Study|Lost to Follow-up|2|||
94638098|NCT01023581|324138997|FG000|Overall Study|Withdrawal by Subject|13|||
94638099|NCT01023581|324138998|FG001|Overall Study|Withdrawal by Subject|8|||
94638100|NCT01023581|324138999|FG002|Overall Study|Withdrawal by Subject|16|||
94638101|NCT01023581|324139000|FG003|Overall Study|Withdrawal by Subject|10|||
94638102|NCT01023581|324139001|FG004|Overall Study|Withdrawal by Subject|6|||
94638103|NCT01023581|324139002|FG005|Overall Study|Withdrawal by Subject|8|||
94638104|NCT01023581|324139003|FG006|Overall Study|Withdrawal by Subject|5|||
94638105|NCT01023581|324138997|FG000|Overall Study|Pregnancy|0|||
94638106|NCT01023581|324138998|FG001|Overall Study|Pregnancy|0|||
94638107|NCT01023581|324138999|FG002|Overall Study|Pregnancy|0|||
94638108|NCT01023581|324139000|FG003|Overall Study|Pregnancy|2|||
94638109|NCT01023581|324139001|FG004|Overall Study|Pregnancy|0|||
94638110|NCT01023581|324139002|FG005|Overall Study|Pregnancy|1|||
94638111|NCT01023581|324139003|FG006|Overall Study|Pregnancy|0|||
94638112|NCT01023581|324138997|FG000|Overall Study|Lack of Efficacy|9|||
94638113|NCT01023581|324138998|FG001|Overall Study|Lack of Efficacy|3|||
94638114|NCT01023581|324138999|FG002|Overall Study|Lack of Efficacy|6|||
94638115|NCT01023581|324139000|FG003|Overall Study|Lack of Efficacy|2|||
94638116|NCT01023581|324139001|FG004|Overall Study|Lack of Efficacy|1|||
94638117|NCT01023581|324139002|FG005|Overall Study|Lack of Efficacy|2|||
94638118|NCT01023581|324139003|FG006|Overall Study|Lack of Efficacy|1|||
94638119|NCT01023581|324138997|FG000|Overall Study|Physician Decision|2|||
94638120|NCT01023581|324138998|FG001|Overall Study|Physician Decision|0|||
94638121|NCT01023581|324138999|FG002|Overall Study|Physician Decision|2|||
94638122|NCT01023581|324139000|FG003|Overall Study|Physician Decision|1|||
94638123|NCT01023581|324139001|FG004|Overall Study|Physician Decision|1|||
94638124|NCT01023581|324139002|FG005|Overall Study|Physician Decision|1|||
94638125|NCT01023581|324139003|FG006|Overall Study|Physician Decision|1|||
94638126|NCT01023581|324138997|FG000|Overall Study|Other|1|||
94638127|NCT01023581|324138998|FG001|Overall Study|Other|0|||
94638128|NCT01023581|324138999|FG002|Overall Study|Other|1|||
94638129|NCT01023581|324139000|FG003|Overall Study|Other|0|||
94638130|NCT01023581|324139001|FG004|Overall Study|Other|1|||
94638131|NCT01023581|324139002|FG005|Overall Study|Other|0|||
94262720|NCT01284062|322756551|FG001|Overall Study|Adverse Event|5|||
94262721|NCT01284062|322756552|FG002|Overall Study|Adverse Event|0|||
94262722|NCT01284062|322756553|FG003|Overall Study|Adverse Event|5|||
94262723|NCT01284062|322756550|FG000|Overall Study|Lack of Efficacy|3|||
94262724|NCT01284062|322756551|FG001|Overall Study|Lack of Efficacy|2|||
94262725|NCT01284062|322756552|FG002|Overall Study|Lack of Efficacy|2|||
94262726|NCT01284062|322756553|FG003|Overall Study|Lack of Efficacy|1|||
94262727|NCT01284062|322756550|FG000|Overall Study|Medication error without adverse event|0|||
94638132|NCT01023581|324139003|FG006|Overall Study|Other|0|||
94638133|NCT01231581|324139009|FG000|Overall Study|Lost to Follow-up|2|||
94638134|NCT01231581|324139010|FG001|Overall Study|Lost to Follow-up|2|||
94638135|NCT01231581|324139009|FG000|Overall Study|Withdrawal by Subject|6|||
94638136|NCT01231581|324139010|FG001|Overall Study|Withdrawal by Subject|9|||
94638137|NCT01231581|324139009|FG000|Overall Study|Study Closed/Terminated|6|||
94638138|NCT01231581|324139010|FG001|Overall Study|Study Closed/Terminated|5|||
94262728|NCT01284062|322756551|FG001|Overall Study|Medication error without adverse event|0|||
94638139|NCT01231581|324139009|FG000|Overall Study|Death|65|||
94638140|NCT01231581|324139010|FG001|Overall Study|Death|64|||
94638141|NCT01231581|324139009|FG000|Overall Study|Ongoing|1|||
94638142|NCT01231581|324139010|FG001|Overall Study|Ongoing|0|||
94638143|NCT01124604|324139013|FG000|Overall Study|Adverse Event|10|||
94638144|NCT01124604|324139014|FG001|Overall Study|Adverse Event|1|||
94638145|NCT01124604|324139013|FG000|Overall Study|Lack of Efficacy|1|||
94638146|NCT01124604|324139014|FG001|Overall Study|Lack of Efficacy|0|||
94638147|NCT01124604|324139013|FG000|Overall Study|Withdrawal by Subject|4|||
94638148|NCT01124604|324139014|FG001|Overall Study|Withdrawal by Subject|0|||
94638149|NCT01124604|324139013|FG000|Overall Study|Disease Progression|0|||
94638150|NCT01124604|324139014|FG001|Overall Study|Disease Progression|1|||
94638151|NCT00507442|324139017|FG000|Overall Study|Adverse Event|8|||
94638152|NCT00507442|324139018|FG001|Overall Study|Adverse Event|11|||
94638153|NCT00507442|324139019|FG002|Overall Study|Adverse Event|4|||
94638154|NCT00507442|324139020|FG003|Overall Study|Adverse Event|1|||
94638155|NCT00507442|324139017|FG000|Overall Study|Protocol Violation|0|||
94638156|NCT00507442|324139018|FG001|Overall Study|Protocol Violation|1|||
94638157|NCT00507442|324139019|FG002|Overall Study|Protocol Violation|0|||
94638158|NCT00507442|324139020|FG003|Overall Study|Protocol Violation|0|||
94638159|NCT00507442|324139017|FG000|Overall Study|Lost to Follow-up|0|||
94638160|NCT00507442|324139018|FG001|Overall Study|Lost to Follow-up|0|||
94638161|NCT00507442|324139019|FG002|Overall Study|Lost to Follow-up|1|||
94638162|NCT00507442|324139020|FG003|Overall Study|Lost to Follow-up|0|||
94638163|NCT00507442|324139017|FG000|Overall Study|Physician Decision|0|||
94638164|NCT00507442|324139018|FG001|Overall Study|Physician Decision|2|||
94262729|NCT01284062|322756552|FG002|Overall Study|Medication error without adverse event|1|||
94262730|NCT01284062|322756553|FG003|Overall Study|Medication error without adverse event|0|||
94638165|NCT00507442|324139019|FG002|Overall Study|Physician Decision|4|||
94638166|NCT00507442|324139020|FG003|Overall Study|Physician Decision|1|||
94638167|NCT00507442|324139017|FG000|Overall Study|Progressive Disease|2|||
94638168|NCT00507442|324139018|FG001|Overall Study|Progressive Disease|4|||
94638169|NCT00507442|324139019|FG002|Overall Study|Progressive Disease|2|||
94638170|NCT00507442|324139020|FG003|Overall Study|Progressive Disease|0|||
94638171|NCT00507442|324139017|FG000|Overall Study|Withdrawal by Subject|4|||
94638172|NCT00507442|324139018|FG001|Overall Study|Withdrawal by Subject|4|||
94638173|NCT00507442|324139019|FG002|Overall Study|Withdrawal by Subject|2|||
94638174|NCT00507442|324139020|FG003|Overall Study|Withdrawal by Subject|1|||
94638175|NCT00507442|324139017|FG000|Overall Study|Other|2|||
94638176|NCT00507442|324139018|FG001|Overall Study|Other|5|||
94638177|NCT00507442|324139019|FG002|Overall Study|Other|2|||
94638178|NCT00507442|324139020|FG003|Overall Study|Other|2|||
94638179|NCT01046682|324139023|FG000|Overall Study|Adverse Event|2|||
94677190|NCT01191840|324273036|FG001|Overall Study|ineligible at enrollment|0|||
94677191|NCT01191840|324273035|FG000|Overall Study|IRB approval lapse|0|||
94638180|NCT01046682|324139024|FG001|Overall Study|Adverse Event|0|||
94638181|NCT01132547|324139025|FG000|Overall Study|Withdrawal by Subject|3|||
94638182|NCT01132547|324139026|FG001|Overall Study|Withdrawal by Subject|1|||
94638183|NCT01132547|324139025|FG000|Overall Study|Death|1|||
94677192|NCT01191840|324273036|FG001|Overall Study|IRB approval lapse|2|||
94677193|NCT01191840|324273035|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
94677194|NCT01191840|324273036|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
94677195|NCT01191840|324273035|FG000|Overall Study|Withdrawal by Subject|2|||
94677196|NCT01191840|324273036|FG001|Overall Study|Withdrawal by Subject|0|||
94677197|NCT00180479|324273037|FG000|Overall Study|Death|4|||
94677198|NCT00180479|324273038|FG001|Overall Study|Death|2|||
94677199|NCT00180479|324273037|FG000|Overall Study|Lost to Follow-up|9|||
94677200|NCT00180479|324273038|FG001|Overall Study|Lost to Follow-up|7|||
94677201|NCT00180479|324273037|FG000|Overall Study|Withdrawal by Subject|3|||
94677202|NCT00180479|324273038|FG001|Overall Study|Withdrawal by Subject|3|||
94677203|NCT00180479|324273037|FG000|Overall Study|Informed consent not signed|0|||
94677204|NCT00180479|324273038|FG001|Overall Study|Informed consent not signed|1|||
94677205|NCT00840801|324273043|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
94677206|NCT00840801|324273044|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
94677207|NCT00840801|324273045|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
94677208|NCT00840801|324273043|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
94677209|NCT00840801|324273044|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
94677210|NCT00840801|324273045|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
94677211|NCT00840801|324273043|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
94677212|NCT00840801|324273044|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
94677213|NCT00840801|324273045|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
94677214|NCT00840801|324273043|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
94677215|NCT00840801|324273044|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
94677216|NCT00840801|324273045|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
94677217|NCT03243422|324273048|FG000|Overall Study|Death|20|||
94677218|NCT03243422|324273049|FG001|Overall Study|Death|21|||
94677219|NCT03243422|324273048|FG000|Overall Study|Lost to Follow-up|9|||
94677220|NCT03243422|324273049|FG001|Overall Study|Lost to Follow-up|21|||
94677221|NCT03243422|324273048|FG000|Overall Study|Withdrawal by Subject|22|||
94677222|NCT03243422|324273049|FG001|Overall Study|Withdrawal by Subject|8|||
94677223|NCT01505387|324273050|FG000|Overall Study|Protocol Violation|1|||
94677224|NCT01505387|324273051|FG001|Overall Study|Protocol Violation|0|||
94677225|NCT01505387|324273050|FG000|Overall Study|Withdrawal by Subject|1|||
94677226|NCT01505387|324273051|FG001|Overall Study|Withdrawal by Subject|1|||
94677227|NCT03420781|324273053|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
94677228|NCT03420781|324273054|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
94677229|NCT03420781|324273055|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
94677230|NCT03420781|324273056|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
94677231|NCT03420781|324273057|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
94677232|NCT03420781|324273053|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
94677233|NCT03420781|324273054|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
94677234|NCT03420781|324273055|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
94677235|NCT03420781|324273056|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
94677236|NCT03420781|324273057|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
94677237|NCT03420781|324273053|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
94677238|NCT03420781|324273054|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
94677239|NCT03420781|324273055|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
94677240|NCT03420781|324273056|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
94677241|NCT03420781|324273057|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
94677242|NCT03420781|324273053|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
94677243|NCT03420781|324273054|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
94677244|NCT03420781|324273055|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
94677245|NCT03420781|324273056|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
94677246|NCT03420781|324273057|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
94677247|NCT03420781|324273053|FG000|Treatment Period (40 Weeks)|Death|2|||
94677248|NCT03420781|324273054|FG001|Treatment Period (40 Weeks)|Death|2|||
94677249|NCT03420781|324273055|FG002|Treatment Period (40 Weeks)|Death|0|||
94677250|NCT03420781|324273056|FG003|Treatment Period (40 Weeks)|Death|0|||
94677251|NCT03420781|324273057|FG004|Treatment Period (40 Weeks)|Death|0|||
94677252|NCT03420781|324273053|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
94677253|NCT03420781|324273054|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
94262731|NCT01284062|322756550|FG000|Overall Study|Protocol Violation|1|||
94262732|NCT01284062|322756551|FG001|Overall Study|Protocol Violation|0|||
94262733|NCT01284062|322756552|FG002|Overall Study|Protocol Violation|0|||
94262734|NCT01284062|322756553|FG003|Overall Study|Protocol Violation|2|||
94262735|NCT01284062|322756550|FG000|Overall Study|Withdrawal by Subject|3|||
94262736|NCT01284062|322756551|FG001|Overall Study|Withdrawal by Subject|1|||
94262737|NCT01284062|322756552|FG002|Overall Study|Withdrawal by Subject|2|||
94262738|NCT01284062|322756553|FG003|Overall Study|Withdrawal by Subject|5|||
94262739|NCT01284062|322756550|FG000|Overall Study|Other|0|||
94262740|NCT01284062|322756551|FG001|Overall Study|Other|0|||
94262741|NCT01284062|322756552|FG002|Overall Study|Other|0|||
94262742|NCT01284062|322756553|FG003|Overall Study|Other|1|||
94262743|NCT01284062|322756550|FG000|Overall Study|Site Closed|0|||
94262744|NCT01284062|322756551|FG001|Overall Study|Site Closed|0|||
94262745|NCT01284062|322756552|FG002|Overall Study|Site Closed|1|||
94262746|NCT01284062|322756553|FG003|Overall Study|Site Closed|0|||
94262747|NCT02234323|322756556|FG000|All Enrolled|Not Treated: Completed study in database|2|||
94262748|NCT02234323|322756556|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
94262749|NCT02234323|322756556|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
94262750|NCT02234323|322756556|FG000|All Treated|Death|1|||
94262751|NCT02234323|322756556|FG000|All Treated|Physician Decision|5|||
94262752|NCT02234323|322756556|FG000|All Treated|Lack of Efficacy|3|||
94262753|NCT02234323|322756556|FG000|All Treated|Exceeded lab value limit|2|||
94262754|NCT02234323|322756556|FG000|All Treated|Other|7|||
94262755|NCT04585646|322756557|FG000|First Intervention|Physician Decision|1|||
94262756|NCT04585646|322756558|FG001|First Intervention|Physician Decision|0|||
94262757|NCT04585646|322756557|FG000|First Intervention|Lost to Follow-up|0|||
94262758|NCT04585646|322756558|FG001|First Intervention|Lost to Follow-up|3|||
94262759|NCT04585646|322756557|FG000|First Intervention|Withdrawal by Subject|0|||
94262760|NCT04585646|322756558|FG001|First Intervention|Withdrawal by Subject|1|||
94262761|NCT05372653|322756559|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
94262762|NCT05372653|322756560|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
94262763|NCT05372653|322756559|FG000|Overall Study|Adverse Event|0|||
94262764|NCT05372653|322756560|FG001|Overall Study|Adverse Event|1|||
94262765|NCT02060721|322756561|FG000|Overall Study|Lost to Follow-up|1|||
94262766|NCT02060721|322756561|FG000|Overall Study|Physician Decision|2|||
94638184|NCT01132547|324139026|FG001|Overall Study|Death|0|||
94638185|NCT00371254|324139027|FG000|Overall Study|Disease progression|13|||
94638186|NCT00371254|324139028|FG001|Overall Study|Disease progression|13|||
94638187|NCT00371254|324139027|FG000|Overall Study|Study drug toxicity|3|||
94638188|NCT00371254|324139028|FG001|Overall Study|Study drug toxicity|5|||
94638189|NCT00371254|324139027|FG000|Overall Study|Subject request|5|||
94638190|NCT00371254|324139028|FG001|Overall Study|Subject request|0|||
94638191|NCT00371254|324139027|FG000|Overall Study|Investigator Decision|2|||
94638192|NCT00371254|324139028|FG001|Overall Study|Investigator Decision|0|||
94638193|NCT00371254|324139027|FG000|Overall Study|Adverse event unrelated to study drug|0|||
94638194|NCT00371254|324139028|FG001|Overall Study|Adverse event unrelated to study drug|1|||
94638195|NCT00371254|324139027|FG000|Overall Study|Lost to Follow-up|0|||
94638196|NCT00371254|324139028|FG001|Overall Study|Lost to Follow-up|1|||
94638197|NCT00371254|324139027|FG000|Overall Study|Withdrawal by Subject|0|||
94638198|NCT00371254|324139028|FG001|Overall Study|Withdrawal by Subject|1|||
94638199|NCT03329690|324139029|FG000|Overall Study|Progressive disease per RECIST|85|||
94638200|NCT03329690|324139030|FG001|Overall Study|Progressive disease per RECIST|44|||
94638201|NCT03329690|324139031|FG002|Overall Study|Progressive disease per RECIST|6|||
94638202|NCT03329690|324139032|FG003|Overall Study|Progressive disease per RECIST|16|||
94638203|NCT03329690|324139033|FG004|Overall Study|Progressive disease per RECIST|20|||
94638204|NCT03329690|324139029|FG000|Overall Study|Clinical progression|7|||
94638205|NCT03329690|324139030|FG001|Overall Study|Clinical progression|4|||
94638206|NCT03329690|324139031|FG002|Overall Study|Clinical progression|1|||
94638207|NCT03329690|324139032|FG003|Overall Study|Clinical progression|1|||
94638208|NCT03329690|324139033|FG004|Overall Study|Clinical progression|1|||
94638209|NCT03329690|324139029|FG000|Overall Study|Adverse Event|22|||
94638210|NCT03329690|324139030|FG001|Overall Study|Adverse Event|4|||
94638211|NCT03329690|324139031|FG002|Overall Study|Adverse Event|0|||
94638212|NCT03329690|324139032|FG003|Overall Study|Adverse Event|1|||
94638213|NCT03329690|324139033|FG004|Overall Study|Adverse Event|2|||
94638214|NCT03329690|324139029|FG000|Overall Study|Death|2|||
94638215|NCT03329690|324139030|FG001|Overall Study|Death|0|||
94638216|NCT03329690|324139031|FG002|Overall Study|Death|0|||
94638217|NCT03329690|324139032|FG003|Overall Study|Death|1|||
94262767|NCT02060721|322756561|FG000|Overall Study|Death|14|||
94638218|NCT03329690|324139033|FG004|Overall Study|Death|0|||
94638219|NCT03329690|324139029|FG000|Overall Study|Withdrawal by Subject|2|||
94638220|NCT03329690|324139030|FG001|Overall Study|Withdrawal by Subject|3|||
94638221|NCT03329690|324139031|FG002|Overall Study|Withdrawal by Subject|0|||
94262768|NCT02060721|322756561|FG000|Overall Study|Withdrawal by Subject|2|||
94262769|NCT02060721|322756561|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
94262770|NCT00711529|322756568|FG000|Overall Study|Protocol Violation|2|||
94638222|NCT03329690|324139032|FG003|Overall Study|Withdrawal by Subject|1|||
94638223|NCT03329690|324139033|FG004|Overall Study|Withdrawal by Subject|0|||
94638224|NCT03329690|324139029|FG000|Overall Study|Physician Decision|1|||
94638225|NCT03329690|324139030|FG001|Overall Study|Physician Decision|0|||
94638226|NCT03329690|324139031|FG002|Overall Study|Physician Decision|0|||
94638227|NCT03329690|324139032|FG003|Overall Study|Physician Decision|0|||
94638228|NCT03329690|324139033|FG004|Overall Study|Physician Decision|1|||
94638229|NCT03329690|324139029|FG000|Overall Study|Miscellaneous|6|||
94638230|NCT03329690|324139030|FG001|Overall Study|Miscellaneous|0|||
94638231|NCT03329690|324139031|FG002|Overall Study|Miscellaneous|0|||
94638232|NCT03329690|324139032|FG003|Overall Study|Miscellaneous|0|||
94638233|NCT03329690|324139033|FG004|Overall Study|Miscellaneous|0|||
94638234|NCT03329690|324139029|FG000|Overall Study|Did not receive treatment|1|||
94638235|NCT03329690|324139030|FG001|Overall Study|Did not receive treatment|0|||
94638236|NCT03329690|324139031|FG002|Overall Study|Did not receive treatment|0|||
94638237|NCT03329690|324139032|FG003|Overall Study|Did not receive treatment|1|||
94638238|NCT03329690|324139033|FG004|Overall Study|Did not receive treatment|0|||
94638239|NCT01852812|324139035|FG000|Overall Study|Adverse Event|0|||
94638240|NCT01852812|324139036|FG001|Overall Study|Adverse Event|0|||
94638241|NCT01852812|324139037|FG002|Overall Study|Adverse Event|1|||
94638242|NCT01852812|324139035|FG000|Overall Study|Non-compliance With Study Drug|0|||
94638243|NCT01852812|324139036|FG001|Overall Study|Non-compliance With Study Drug|1|||
94638244|NCT01852812|324139037|FG002|Overall Study|Non-compliance With Study Drug|0|||
94638245|NCT02625090|324139040|FG000|Overall Study|Participant wants to be pregnant|2|||
94638246|NCT02625090|324139040|FG000|Overall Study|For the Promoter|1|||
94638247|NCT02625090|324139040|FG000|Overall Study|Sponsor's Decision|9|||
94638248|NCT02625090|324139040|FG000|Overall Study|Somnolence|1|||
94638249|NCT02625090|324139040|FG000|Overall Study|Study terminated by Sponsor|7|||
94638250|NCT02625090|324139040|FG000|Overall Study|Negative Benefit/Risk|1|||
94638251|NCT02625090|324139040|FG000|Overall Study|Protocol Deviation|2|||
94638252|NCT02625090|324139040|FG000|Overall Study|Lack of Efficacy|16|||
94638253|NCT02625090|324139040|FG000|Overall Study|Adverse Event|3|||
94638254|NCT01592344|324139041|FG000|Overall Study|Adverse Event|1|||
94638255|NCT01592344|324139042|FG001|Overall Study|Adverse Event|1|||
94638256|NCT01592344|324139041|FG000|Overall Study|Lack of Efficacy|1|||
94638257|NCT01592344|324139042|FG001|Overall Study|Lack of Efficacy|0|||
94638258|NCT01592344|324139041|FG000|Overall Study|not available at primary outcome visit|2|||
94638259|NCT01592344|324139042|FG001|Overall Study|not available at primary outcome visit|4|||
94638260|NCT02016482|324139043|FG000|Period A|Adverse Event|3|||
94638261|NCT02016482|324139044|FG001|Period A|Adverse Event|5|||
94638262|NCT02016482|324139043|FG000|Period A|Withdrawal by Subject|3|||
94638263|NCT02016482|324139044|FG001|Period A|Withdrawal by Subject|4|||
94638264|NCT02016482|324139043|FG000|Period A|Lost to Follow-up|3|||
94638265|NCT02016482|324139044|FG001|Period A|Lost to Follow-up|3|||
94638266|NCT02016482|324139043|FG000|Period A|Lack of Efficacy|2|||
94638267|NCT02016482|324139044|FG001|Period A|Lack of Efficacy|1|||
94638268|NCT02016482|324139043|FG000|Period A|Other|3|||
94638269|NCT02016482|324139044|FG001|Period A|Other|0|||
94638270|NCT02016482|324139043|FG000|Period A|Protocol Violation|0|||
94638271|NCT02016482|324139044|FG001|Period A|Protocol Violation|1|||
94638272|NCT02016482|324139043|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
94638273|NCT02016482|324139044|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
94638274|NCT02016482|324139043|FG000|Period B|Withdrawal by Subject|1|||
94638275|NCT02016482|324139044|FG001|Period B|Withdrawal by Subject|1|||
94638276|NCT02016482|324139043|FG000|Period B|Lost to Follow-up|2|||
94638277|NCT02016482|324139044|FG001|Period B|Lost to Follow-up|0|||
94638278|NCT02016482|324139043|FG000|Period B|Lack of Efficacy|6|||
94638279|NCT02016482|324139044|FG001|Period B|Lack of Efficacy|4|||
94638280|NCT02016482|324139043|FG000|Period B|Other|4|||
94638281|NCT02016482|324139044|FG001|Period B|Other|0|||
94638282|NCT02016482|324139043|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
94638283|NCT02016482|324139044|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
94638284|NCT02410954|324139048|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
94638285|NCT02410954|324139049|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
94638286|NCT02410954|324139048|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
94638287|NCT02410954|324139049|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
94638288|NCT02580357|324139061|FG000|Overall Study|Lost to Follow-up|2|||
94638289|NCT02580357|324139062|FG001|Overall Study|Lost to Follow-up|0|||
94638290|NCT02580357|324139063|FG002|Overall Study|Lost to Follow-up|0|||
94638291|NCT02580357|324139061|FG000|Overall Study|Protocol Violation|1|||
94638292|NCT02580357|324139062|FG001|Overall Study|Protocol Violation|0|||
94638293|NCT02580357|324139063|FG002|Overall Study|Protocol Violation|0|||
94638294|NCT00751348|324139064|FG000|Overall Study|Withdrawal by Subject|5|||
94638295|NCT00751348|324139065|FG001|Overall Study|Withdrawal by Subject|2|||
94638296|NCT00751348|324139064|FG000|Overall Study|Migration from study area|1|||
94638297|NCT00751348|324139065|FG001|Overall Study|Migration from study area|0|||
94638298|NCT02205333|324139068|FG000|Overall Study|Death|5|||
94638299|NCT02205333|324139069|FG001|Overall Study|Death|6|||
94461859|NCT00743288|323481240|FG002|Overall Study|Progressive disease (PD)|1|||
94461860|NCT00743288|323481241|FG003|Overall Study|Progressive disease (PD)|4|||
94638300|NCT02205333|324139070|FG002|Overall Study|Death|2|||
94638301|NCT02205333|324139071|FG003|Overall Study|Death|6|||
94638302|NCT02205333|324139072|FG004|Overall Study|Death|5|||
94638303|NCT02205333|324139073|FG005|Overall Study|Death|3|||
94638304|NCT02205333|324139074|FG006|Overall Study|Death|3|||
94638305|NCT02205333|324139075|FG007|Overall Study|Death|2|||
94638306|NCT02205333|324139076|FG008|Overall Study|Death|0|||
94638307|NCT02205333|324139068|FG000|Overall Study|Withdrawal by Subject|1|||
94638308|NCT02205333|324139069|FG001|Overall Study|Withdrawal by Subject|0|||
94638309|NCT02205333|324139070|FG002|Overall Study|Withdrawal by Subject|0|||
94638310|NCT02205333|324139071|FG003|Overall Study|Withdrawal by Subject|1|||
94638311|NCT02205333|324139072|FG004|Overall Study|Withdrawal by Subject|0|||
94638312|NCT02205333|324139073|FG005|Overall Study|Withdrawal by Subject|0|||
94638313|NCT02205333|324139074|FG006|Overall Study|Withdrawal by Subject|2|||
94638314|NCT02205333|324139075|FG007|Overall Study|Withdrawal by Subject|0|||
94638315|NCT02205333|324139076|FG008|Overall Study|Withdrawal by Subject|0|||
94638316|NCT01154218|324139079|FG000|Third Intervention Period|Adverse Event|0|||
94638317|NCT01154218|324139080|FG001|Third Intervention Period|Adverse Event|1|||
94638318|NCT01154218|324139081|FG002|Third Intervention Period|Adverse Event|0|||
94638319|NCT01154218|324139082|FG003|Third Intervention Period|Adverse Event|0|||
94638320|NCT01154218|324139079|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
94638321|NCT01154218|324139080|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
94638322|NCT01154218|324139081|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
94638323|NCT01154218|324139082|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
94638324|NCT01154218|324139079|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
94638325|NCT01154218|324139080|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
94638326|NCT01154218|324139081|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
94638327|NCT01154218|324139082|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
94638328|NCT02802592|324139085|FG000|Overall Study|Study terminated due to loss of funding|4|||
94638329|NCT02268812|324139086|FG000|Overall Study|Adverse Event|8|||
94638330|NCT02268812|324139087|FG001|Overall Study|Adverse Event|26|||
94638331|NCT02268812|324139088|FG002|Overall Study|Adverse Event|7|||
94638332|NCT02268812|324139089|FG003|Overall Study|Adverse Event|10|||
94638333|NCT02268812|324139086|FG000|Overall Study|Protocol deviation|0|||
94638334|NCT02268812|324139087|FG001|Overall Study|Protocol deviation|0|||
94638335|NCT02268812|324139088|FG002|Overall Study|Protocol deviation|1|||
94638336|NCT02268812|324139089|FG003|Overall Study|Protocol deviation|0|||
94638337|NCT02268812|324139086|FG000|Overall Study|Withdrawal by Subject|0|||
94638338|NCT02268812|324139087|FG001|Overall Study|Withdrawal by Subject|1|||
94638339|NCT02268812|324139088|FG002|Overall Study|Withdrawal by Subject|0|||
94638340|NCT02268812|324139089|FG003|Overall Study|Withdrawal by Subject|0|||
94638341|NCT02268812|324139086|FG000|Overall Study|Physician Decision|3|||
94362835|NCT00358670|323112870|FG001|Overall Study|Protocol Violation|9|||
94362836|NCT00358670|323112869|FG000|Overall Study|Lost to Follow-up|4|||
94362837|NCT00358670|323112870|FG001|Overall Study|Lost to Follow-up|5|||
94362838|NCT00358670|323112869|FG000|Overall Study|Withdrawal by Subject|13|||
94362839|NCT00358670|323112870|FG001|Overall Study|Withdrawal by Subject|24|||
94638342|NCT02268812|324139087|FG001|Overall Study|Physician Decision|1|||
94638343|NCT02268812|324139088|FG002|Overall Study|Physician Decision|0|||
94638344|NCT02268812|324139089|FG003|Overall Study|Physician Decision|1|||
94638345|NCT02268812|324139086|FG000|Overall Study|Other|5|||
94638346|NCT02268812|324139087|FG001|Overall Study|Other|4|||
94638347|NCT02268812|324139088|FG002|Overall Study|Other|1|||
94638348|NCT02268812|324139089|FG003|Overall Study|Other|3|||
94638349|NCT03526458|324139093|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
94638350|NCT03526458|324139094|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
94638351|NCT03526458|324139093|FG000|Overall Study|Stone passed, surgery cancelled|2|||
94638352|NCT03526458|324139094|FG001|Overall Study|Stone passed, surgery cancelled|1|||
94638353|NCT03526458|324139093|FG000|Overall Study|Withdrawal by Subject|1|||
94638354|NCT03526458|324139094|FG001|Overall Study|Withdrawal by Subject|0|||
94638355|NCT03526458|324139093|FG000|Overall Study|Physician Decision|2|||
94638356|NCT03526458|324139094|FG001|Overall Study|Physician Decision|1|||
94638357|NCT03526458|324139093|FG000|Overall Study|Lack of equipment|1|||
94638358|NCT03526458|324139094|FG001|Overall Study|Lack of equipment|1|||
94638359|NCT04404855|324139095|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
94638360|NCT04404855|324139096|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
94638361|NCT00994240|324139097|FG000|Overall Study|Lost to Follow-up|3|||
94638362|NCT00994240|324139098|FG001|Overall Study|Lost to Follow-up|2|||
94638363|NCT00994240|324139097|FG000|Overall Study|Withdrawal by Subject|1|||
94638364|NCT00994240|324139098|FG001|Overall Study|Withdrawal by Subject|0|||
94638365|NCT00994240|324139097|FG000|Overall Study|study termination|2|||
94638366|NCT00994240|324139098|FG001|Overall Study|study termination|3|||
94638367|NCT03760146|324139099|FG000|Overall Study|Adverse Event|11|||
94638368|NCT03760146|324139100|FG001|Overall Study|Adverse Event|8|||
94638369|NCT03760146|324139101|FG002|Overall Study|Adverse Event|0|||
94638370|NCT03760146|324139102|FG003|Overall Study|Adverse Event|0|||
94638371|NCT03760146|324139103|FG004|Overall Study|Adverse Event|0|||
94638372|NCT03760146|324139104|FG005|Overall Study|Adverse Event|0|||
94638373|NCT03760146|324139099|FG000|Overall Study|Death|1|||
94638374|NCT03760146|324139100|FG001|Overall Study|Death|0|||
94638375|NCT03760146|324139101|FG002|Overall Study|Death|0|||
94362840|NCT00358670|323112869|FG000|Overall Study|Protocol Defined Clinical Event|0|||
94638376|NCT03760146|324139102|FG003|Overall Study|Death|0|||
94638377|NCT03760146|324139103|FG004|Overall Study|Death|0|||
94638378|NCT03760146|324139104|FG005|Overall Study|Death|0|||
94362841|NCT00358670|323112870|FG001|Overall Study|Protocol Defined Clinical Event|1|||
94638379|NCT03760146|324139099|FG000|Overall Study|Lost to Follow-up|41|||
94677254|NCT03420781|324273055|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
94677255|NCT03420781|324273056|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
94677256|NCT03420781|324273057|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
94677257|NCT03420781|324273053|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
94677258|NCT03420781|324273054|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
94677259|NCT03420781|324273055|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
94677260|NCT03420781|324273056|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
94677261|NCT03420781|324273057|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
94677262|NCT03420781|324273053|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
94677263|NCT03420781|324273054|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
94677264|NCT03420781|324273055|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
94677265|NCT03420781|324273056|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
94677266|NCT03420781|324273057|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
94677267|NCT03420781|324273053|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
94677268|NCT03420781|324273054|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
94677269|NCT03420781|324273055|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
94677270|NCT03420781|324273056|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
94677271|NCT03420781|324273057|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
94677272|NCT03420781|324273053|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
94677273|NCT03420781|324273054|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
94677274|NCT03420781|324273055|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
94677275|NCT03420781|324273056|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
94677276|NCT03420781|324273057|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
94677277|NCT03420781|324273053|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
94677278|NCT03420781|324273054|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
94677279|NCT03420781|324273055|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
94677280|NCT03420781|324273056|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
94677281|NCT03420781|324273057|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
94677282|NCT03420781|324273053|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
94677283|NCT03420781|324273054|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
94677284|NCT03420781|324273055|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
94677285|NCT03420781|324273056|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
94677286|NCT03420781|324273057|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
94677287|NCT03420781|324273053|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
94677288|NCT03420781|324273054|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
94677289|NCT03420781|324273055|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
94677290|NCT03420781|324273056|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
94677291|NCT03420781|324273057|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
94677292|NCT01078155|324273058|FG000|Overall Study|Adverse Event|7|||
94677293|NCT01078155|324273058|FG000|Overall Study|Lack of Efficacy|16|||
94677294|NCT01078155|324273058|FG000|Overall Study|Participant's Decision|6|||
94677295|NCT01078155|324273058|FG000|Overall Study|Lost to Follow-up|15|||
94677296|NCT00266825|324273059|FG000|Completed Follow-Up|Lost to Follow-up|14|||
94677297|NCT00266825|324273060|FG001|Completed Follow-Up|Lost to Follow-up|19|||
94677298|NCT00266825|324273059|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
94677299|NCT00266825|324273060|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
94677300|NCT01621880|324273063|FG000|Overall Study|Adverse Event|5|||
94677301|NCT01621880|324273064|FG001|Overall Study|Adverse Event|1|||
94677302|NCT01621880|324273063|FG000|Overall Study|Withdrawal by Subject|5|||
94677303|NCT01621880|324273064|FG001|Overall Study|Withdrawal by Subject|4|||
94677304|NCT00674570|324273066|FG000|Overall Study|Withdrawal by Subject|0|||
94677305|NCT00674570|324273067|FG001|Overall Study|Withdrawal by Subject|2|||
94677306|NCT00674570|324273068|FG002|Overall Study|Withdrawal by Subject|0|||
94677307|NCT02923739|324273078|FG000|Overall Study|Withdrawal by Subject|2|||
94677308|NCT02923739|324273079|FG001|Overall Study|Withdrawal by Subject|0|||
94677309|NCT02923739|324273080|FG002|Overall Study|Withdrawal by Subject|0|||
94677310|NCT02923739|324273081|FG003|Overall Study|Withdrawal by Subject|0|||
94677311|NCT02923739|324273078|FG000|Overall Study|Failed Screening|3|||
94677312|NCT02923739|324273079|FG001|Overall Study|Failed Screening|0|||
94677313|NCT02923739|324273080|FG002|Overall Study|Failed Screening|0|||
94262771|NCT00711529|322756569|FG001|Overall Study|Protocol Violation|0|||
94262772|NCT00711529|322756568|FG000|Overall Study|Withdrawal by Subject|2|||
94262773|NCT00711529|322756569|FG001|Overall Study|Withdrawal by Subject|6|||
94262774|NCT00634010|322756572|FG000|Overall Study|Adverse Event|2|||
94262775|NCT00634010|322756573|FG001|Overall Study|Adverse Event|5|||
94262776|NCT00634010|322756572|FG000|Overall Study|Withdrawal by Subject|5|||
94677314|NCT02923739|324273081|FG003|Overall Study|Failed Screening|0|||
94262777|NCT00634010|322756573|FG001|Overall Study|Withdrawal by Subject|6|||
94262778|NCT00634010|322756572|FG000|Overall Study|Physician Decision|1|||
94638380|NCT03760146|324139100|FG001|Overall Study|Lost to Follow-up|28|||
94638381|NCT03760146|324139101|FG002|Overall Study|Lost to Follow-up|9|||
94638382|NCT03760146|324139102|FG003|Overall Study|Lost to Follow-up|2|||
94638383|NCT03760146|324139103|FG004|Overall Study|Lost to Follow-up|14|||
94638384|NCT03760146|324139104|FG005|Overall Study|Lost to Follow-up|8|||
94262779|NCT00634010|322756573|FG001|Overall Study|Physician Decision|1|||
94262780|NCT00634010|322756572|FG000|Overall Study|Disease Progression|1|||
94262781|NCT00634010|322756573|FG001|Overall Study|Disease Progression|1|||
94262782|NCT00634010|322756572|FG000|Overall Study|Non-Compliant|1|||
94262783|NCT00634010|322756573|FG001|Overall Study|Non-Compliant|1|||
94262784|NCT05211739|322756574|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
94262785|NCT05211739|322756575|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
94262786|NCT05211739|322756574|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
94262787|NCT05211739|322756575|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
94262788|NCT05211739|322756574|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
94262789|NCT05211739|322756575|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
94262790|NCT05211739|322756574|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
94262791|NCT05211739|322756575|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
94262792|NCT01975428|322756576|FG000|Overall Study|Lost to Follow-up|17|||
94262793|NCT01975428|322756577|FG001|Overall Study|Lost to Follow-up|4|||
94262794|NCT01975428|322756576|FG000|Overall Study|Withdrawal by Subject|3|||
94262795|NCT01975428|322756577|FG001|Overall Study|Withdrawal by Subject|10|||
94262796|NCT03027557|322756578|FG000|Overall Study|Adverse Event|1|||
94262797|NCT03027557|322756579|FG001|Overall Study|Adverse Event|0|||
94362842|NCT00358670|323112869|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
94638385|NCT03760146|324139099|FG000|Overall Study|No longer met eligibility criteria|3|||
94638386|NCT03760146|324139100|FG001|Overall Study|No longer met eligibility criteria|9|||
94638387|NCT03760146|324139101|FG002|Overall Study|No longer met eligibility criteria|0|||
94638388|NCT03760146|324139102|FG003|Overall Study|No longer met eligibility criteria|0|||
94638389|NCT03760146|324139103|FG004|Overall Study|No longer met eligibility criteria|1|||
94638390|NCT03760146|324139104|FG005|Overall Study|No longer met eligibility criteria|0|||
94638391|NCT03760146|324139099|FG000|Overall Study|Protocol Violation|21|||
94638392|NCT03760146|324139100|FG001|Overall Study|Protocol Violation|13|||
94638393|NCT03760146|324139101|FG002|Overall Study|Protocol Violation|1|||
94638394|NCT03760146|324139102|FG003|Overall Study|Protocol Violation|0|||
94638395|NCT03760146|324139103|FG004|Overall Study|Protocol Violation|1|||
94638396|NCT03760146|324139104|FG005|Overall Study|Protocol Violation|0|||
94638397|NCT03760146|324139099|FG000|Overall Study|Withdrawal by Subject|19|||
94638398|NCT03760146|324139100|FG001|Overall Study|Withdrawal by Subject|20|||
94638399|NCT03760146|324139101|FG002|Overall Study|Withdrawal by Subject|1|||
94638400|NCT03760146|324139102|FG003|Overall Study|Withdrawal by Subject|0|||
94638401|NCT03760146|324139103|FG004|Overall Study|Withdrawal by Subject|1|||
94638402|NCT03760146|324139104|FG005|Overall Study|Withdrawal by Subject|0|||
94638403|NCT02291055|324139105|FG000|Overall Study|Death|2|||
94638404|NCT02291055|324139106|FG001|Overall Study|Death|2|||
94638405|NCT02291055|324139107|FG002|Overall Study|Death|5|||
94638406|NCT02291055|324139108|FG003|Overall Study|Death|8|||
94638407|NCT02291055|324139109|FG004|Overall Study|Death|12|||
94638408|NCT02291055|324139105|FG000|Overall Study|Lost to Follow-up|0|||
94638409|NCT02291055|324139106|FG001|Overall Study|Lost to Follow-up|0|||
94638410|NCT02291055|324139107|FG002|Overall Study|Lost to Follow-up|0|||
94638411|NCT02291055|324139108|FG003|Overall Study|Lost to Follow-up|1|||
94638412|NCT02291055|324139109|FG004|Overall Study|Lost to Follow-up|2|||
94638413|NCT02291055|324139105|FG000|Overall Study|Withdrawal by Subject|3|||
94638414|NCT02291055|324139106|FG001|Overall Study|Withdrawal by Subject|1|||
94638415|NCT02291055|324139107|FG002|Overall Study|Withdrawal by Subject|1|||
94638416|NCT02291055|324139108|FG003|Overall Study|Withdrawal by Subject|5|||
94638417|NCT02291055|324139109|FG004|Overall Study|Withdrawal by Subject|10|||
94638418|NCT02291055|324139105|FG000|Overall Study|Progressive Disease|0|||
94638419|NCT02291055|324139106|FG001|Overall Study|Progressive Disease|0|||
94638420|NCT02291055|324139107|FG002|Overall Study|Progressive Disease|1|||
94638421|NCT02291055|324139108|FG003|Overall Study|Progressive Disease|4|||
94638422|NCT02291055|324139109|FG004|Overall Study|Progressive Disease|2|||
94638423|NCT02291055|324139105|FG000|Overall Study|Study Terminated by Sponsor|0|||
94262798|NCT03027557|322756580|FG002|Overall Study|Adverse Event|0|||
94262799|NCT01006265|322756581|FG000|Overall Study|Lost to Follow-up|1|||
94638424|NCT02291055|324139106|FG001|Overall Study|Study Terminated by Sponsor|0|||
94638425|NCT02291055|324139107|FG002|Overall Study|Study Terminated by Sponsor|0|||
94638426|NCT02291055|324139108|FG003|Overall Study|Study Terminated by Sponsor|5|||
94638427|NCT02291055|324139109|FG004|Overall Study|Study Terminated by Sponsor|1|||
94638428|NCT02291055|324139105|FG000|Overall Study|Other|0|||
94262800|NCT01006265|322756582|FG001|Overall Study|Lost to Follow-up|0|||
94638429|NCT02291055|324139106|FG001|Overall Study|Other|2|||
94638430|NCT02291055|324139107|FG002|Overall Study|Other|1|||
94638431|NCT02291055|324139108|FG003|Overall Study|Other|4|||
94677315|NCT01477853|324273082|FG000|Phase A|Adverse Event|1|||
94638432|NCT02291055|324139109|FG004|Overall Study|Other|0|||
94638433|NCT02910167|324139110|FG000|Overall Study|Adverse Event|1|||
94638434|NCT02910167|324139110|FG000|Overall Study|Lost to Follow-up|18|||
94638435|NCT00663052|324139112|FG000|Overall Study|Adverse Event|6|||
94638436|NCT00663052|324139113|FG001|Overall Study|Adverse Event|3|||
94638437|NCT00663052|324139112|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
94638438|NCT00663052|324139113|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
94638439|NCT00663052|324139112|FG000|Overall Study|Protocol Violation|1|||
94638440|NCT00663052|324139113|FG001|Overall Study|Protocol Violation|0|||
94638441|NCT00663052|324139112|FG000|Overall Study|Withdrawal by Subject|2|||
94638442|NCT00663052|324139113|FG001|Overall Study|Withdrawal by Subject|5|||
94638443|NCT00663052|324139112|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
94638444|NCT00663052|324139113|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
94262801|NCT01006265|322756583|FG002|Overall Study|Lost to Follow-up|1|||
94262802|NCT01006265|322756584|FG003|Overall Study|Lost to Follow-up|0|||
94262803|NCT01006265|322756581|FG000|Overall Study|Withdrawal by Subject|4|||
94262804|NCT01006265|322756582|FG001|Overall Study|Withdrawal by Subject|7|||
94262805|NCT01006265|322756583|FG002|Overall Study|Withdrawal by Subject|5|||
94262806|NCT01006265|322756584|FG003|Overall Study|Withdrawal by Subject|5|||
94262807|NCT01006265|322756581|FG000|Overall Study|Administrative reason|1|||
94262808|NCT01006265|322756582|FG001|Overall Study|Administrative reason|2|||
94262809|NCT01006265|322756583|FG002|Overall Study|Administrative reason|3|||
94262810|NCT01006265|322756584|FG003|Overall Study|Administrative reason|0|||
94262811|NCT00796120|322756585|FG000|Overall Study|Death|3|||
94638445|NCT00663052|324139112|FG000|Overall Study|Other|0|||
94638446|NCT00663052|324139113|FG001|Overall Study|Other|1|||
94638447|NCT01921179|324140637|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
94638448|NCT01921179|324140638|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
94638449|NCT01921179|324140637|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
94638450|NCT01921179|324140638|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
94638451|NCT04568590|324140639|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
94638452|NCT00415909|324140641|FG000|Overall Study|Withdrawal by Subject|2|||
94638453|NCT00415909|324140641|FG000|Overall Study|Death|1|||
94638454|NCT00312494|324140642|FG000|Overall Study|Randomized; not treated with study drug|9|||
94638455|NCT00312494|324140643|FG001|Overall Study|Randomized; not treated with study drug|10|||
94638456|NCT00312494|324140644|FG002|Overall Study|Randomized; not treated with study drug|5|||
94638457|NCT00312494|324140642|FG000|Overall Study|Adverse Event|33|||
94638458|NCT00312494|324140643|FG001|Overall Study|Adverse Event|15|||
94638459|NCT00312494|324140644|FG002|Overall Study|Adverse Event|11|||
94638460|NCT00312494|324140642|FG000|Overall Study|Lack of Efficacy|4|||
94638461|NCT00312494|324140643|FG001|Overall Study|Lack of Efficacy|6|||
94638462|NCT00312494|324140644|FG002|Overall Study|Lack of Efficacy|8|||
94638463|NCT00312494|324140642|FG000|Overall Study|Laboratory abnormality|1|||
94638464|NCT00312494|324140643|FG001|Overall Study|Laboratory abnormality|0|||
94638465|NCT00312494|324140644|FG002|Overall Study|Laboratory abnormality|0|||
94638466|NCT00312494|324140642|FG000|Overall Study|Lost to Follow-up|8|||
94638467|NCT00312494|324140643|FG001|Overall Study|Lost to Follow-up|8|||
94638468|NCT00312494|324140644|FG002|Overall Study|Lost to Follow-up|8|||
94638469|NCT00312494|324140642|FG000|Overall Study|Withdrawal by Subject|6|||
94262812|NCT00796120|322756586|FG001|Overall Study|Death|0|||
94262813|NCT00796120|322756585|FG000|Overall Study|Adverse Event|11|||
94262814|NCT00796120|322756586|FG001|Overall Study|Adverse Event|6|||
94262815|NCT00796120|322756585|FG000|Overall Study|Progressive disease|22|||
94262816|NCT00796120|322756586|FG001|Overall Study|Progressive disease|13|||
94262817|NCT00796120|322756585|FG000|Overall Study|Participant refusal|3|||
94262818|NCT00796120|322756586|FG001|Overall Study|Participant refusal|4|||
94262819|NCT00796120|322756585|FG000|Overall Study|Other|6|||
94262820|NCT00796120|322756586|FG001|Overall Study|Other|17|||
94262821|NCT00796120|322756585|FG000|Overall Study|Physician Decision|16|||
94262822|NCT00796120|322756586|FG001|Overall Study|Physician Decision|17|||
94262823|NCT00796120|322756585|FG000|Overall Study|Randomized but not treated|0|||
94262824|NCT00796120|322756586|FG001|Overall Study|Randomized but not treated|3|||
94262825|NCT02742766|322756589|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
94262826|NCT02742766|322756590|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
94262827|NCT02742766|322756591|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
94262828|NCT02742766|322756592|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
94262829|NCT02742766|322756593|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
94262830|NCT02742766|322756594|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
94262831|NCT02742766|322756595|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
94262832|NCT02742766|322756596|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
94638470|NCT00312494|324140643|FG001|Overall Study|Withdrawal by Subject|9|||
94638471|NCT00312494|324140644|FG002|Overall Study|Withdrawal by Subject|10|||
94638472|NCT00312494|324140642|FG000|Overall Study|Other|10|||
94677316|NCT01477853|324273083|FG001|Phase A|Adverse Event|2|||
94677317|NCT01477853|324273084|FG002|Phase A|Adverse Event|2|||
94262833|NCT02742766|322756597|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
94262834|NCT02742766|322756598|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
94262835|NCT02742766|322756599|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
94262836|NCT02742766|322756600|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
94262837|NCT02742766|322756601|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
94262838|NCT02742766|322756602|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
94262839|NCT02742766|322756603|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
94262840|NCT02742766|322756604|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
94262841|NCT02742766|322756605|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
94262842|NCT02742766|322756606|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
94262843|NCT02742766|322756607|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
94262844|NCT02742766|322756589|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
94262845|NCT02742766|322756590|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
94262846|NCT02742766|322756591|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
94262847|NCT02742766|322756592|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
94362843|NCT00358670|323112870|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
94362844|NCT00358670|323112869|FG000|Overall Study|Administrative|153|||
94362845|NCT00358670|323112870|FG001|Overall Study|Administrative|125|||
94362846|NCT03707145|323112871|FG000|Overall Study|Lost to Follow-up|0|||
94638473|NCT00312494|324140643|FG001|Overall Study|Other|10|||
94638474|NCT00312494|324140644|FG002|Overall Study|Other|1|||
94638475|NCT01190254|324140650|FG000|Overall Study|Adverse Event|3|||
94638476|NCT01190254|324140651|FG001|Overall Study|Adverse Event|6|||
94638477|NCT01190254|324140652|FG002|Overall Study|Adverse Event|8|||
94638478|NCT01190254|324140650|FG000|Overall Study|Lack of Efficacy|7|||
94638479|NCT01190254|324140651|FG001|Overall Study|Lack of Efficacy|4|||
94638480|NCT01190254|324140652|FG002|Overall Study|Lack of Efficacy|5|||
94638481|NCT01190254|324140650|FG000|Overall Study|Lost to Follow-up|4|||
94638482|NCT01190254|324140651|FG001|Overall Study|Lost to Follow-up|2|||
94638483|NCT01190254|324140652|FG002|Overall Study|Lost to Follow-up|0|||
94638484|NCT01190254|324140650|FG000|Overall Study|Withdrawal by Subject|4|||
94638485|NCT01190254|324140651|FG001|Overall Study|Withdrawal by Subject|5|||
94638486|NCT01190254|324140652|FG002|Overall Study|Withdrawal by Subject|7|||
94638487|NCT01190254|324140650|FG000|Overall Study|Protocol Violation|2|||
94638488|NCT01190254|324140651|FG001|Overall Study|Protocol Violation|0|||
94638489|NCT01190254|324140652|FG002|Overall Study|Protocol Violation|2|||
94638490|NCT01190254|324140650|FG000|Overall Study|Did not meet protocol eligibility|1|||
94638491|NCT01190254|324140651|FG001|Overall Study|Did not meet protocol eligibility|0|||
94638492|NCT01190254|324140652|FG002|Overall Study|Did not meet protocol eligibility|0|||
94638493|NCT01254227|324140655|FG000|Overall Study|Withdrawal by Subject|6|||
94638494|NCT01254227|324140655|FG000|Overall Study|Lost to Follow-up|6|||
94638495|NCT01254227|324140655|FG000|Overall Study|Adverse Event|5|||
94638496|NCT01254227|324140655|FG000|Overall Study|Abnormal test procedure result|5|||
94638497|NCT01254227|324140655|FG000|Overall Study|Administrative problems|2|||
94638498|NCT01254227|324140655|FG000|Overall Study|Death|1|||
94638499|NCT01254227|324140655|FG000|Overall Study|Protocol deviation|1|||
94638500|NCT02981342|324140656|FG000|Overall Study|Adverse Event|0|||
94638501|NCT02981342|324140657|FG001|Overall Study|Adverse Event|0|||
94638502|NCT02981342|324140658|FG002|Overall Study|Adverse Event|0|||
94638503|NCT02981342|324140659|FG003|Overall Study|Adverse Event|1|||
94638504|NCT02981342|324140656|FG000|Overall Study|Death|0|||
94638505|NCT02981342|324140657|FG001|Overall Study|Death|9|||
94638506|NCT02981342|324140658|FG002|Overall Study|Death|9|||
94638507|NCT02981342|324140659|FG003|Overall Study|Death|4|||
94638508|NCT02981342|324140656|FG000|Overall Study|Withdrawal by Subject|0|||
94638509|NCT02981342|324140657|FG001|Overall Study|Withdrawal by Subject|0|||
94638510|NCT02981342|324140658|FG002|Overall Study|Withdrawal by Subject|3|||
94638511|NCT02981342|324140659|FG003|Overall Study|Withdrawal by Subject|1|||
94638512|NCT02981342|324140656|FG000|Overall Study|Study closed by sponsor|0|||
94638513|NCT02981342|324140657|FG001|Overall Study|Study closed by sponsor|0|||
94638514|NCT02981342|324140658|FG002|Overall Study|Study closed by sponsor|1|||
94638515|NCT02981342|324140659|FG003|Overall Study|Study closed by sponsor|1|||
94638516|NCT02981342|324140656|FG000|Overall Study|Randomized, Never Treated|0|||
94638517|NCT02981342|324140657|FG001|Overall Study|Randomized, Never Treated|1|||
94638518|NCT02981342|324140658|FG002|Overall Study|Randomized, Never Treated|0|||
94638519|NCT02981342|324140659|FG003|Overall Study|Randomized, Never Treated|7|||
94638520|NCT02981342|324140656|FG000|Overall Study|Lost to Follow-up|0|||
94638521|NCT02981342|324140657|FG001|Overall Study|Lost to Follow-up|1|||
94638522|NCT02981342|324140658|FG002|Overall Study|Lost to Follow-up|0|||
94638523|NCT02981342|324140659|FG003|Overall Study|Lost to Follow-up|0|||
94638524|NCT05333900|324140660|FG000|Overall Study|Protocol Violation|0|||
94638525|NCT05333900|324140661|FG001|Overall Study|Protocol Violation|1|||
94638526|NCT05333900|324140660|FG000|Overall Study|Withdrawal by Subject|0|||
94638527|NCT05333900|324140661|FG001|Overall Study|Withdrawal by Subject|1|||
94638528|NCT05333900|324140660|FG000|Overall Study|COVID-19 Pandemic|1|||
94638529|NCT05333900|324140661|FG001|Overall Study|COVID-19 Pandemic|1|||
94638530|NCT00265343|324140662|FG000|Overall Study|Adverse Event|10|||
94638531|NCT00265343|324140663|FG001|Overall Study|Adverse Event|7|||
94262848|NCT02742766|322756593|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
94362847|NCT03707145|323112872|FG001|Overall Study|Lost to Follow-up|1|||
94677318|NCT01477853|324273082|FG000|Phase A|Lost to Follow-up|4|||
94677319|NCT01477853|324273083|FG001|Phase A|Lost to Follow-up|3|||
94677320|NCT01477853|324273084|FG002|Phase A|Lost to Follow-up|2|||
94677321|NCT01477853|324273082|FG000|Phase A|Physician Decision|1|||
94677322|NCT01477853|324273083|FG001|Phase A|Physician Decision|0|||
94677323|NCT01477853|324273084|FG002|Phase A|Physician Decision|1|||
94677324|NCT01477853|324273082|FG000|Phase A|Study terminated by sponsor|37|||
94677325|NCT01477853|324273083|FG001|Phase A|Study terminated by sponsor|40|||
94677326|NCT01477853|324273084|FG002|Phase A|Study terminated by sponsor|39|||
94677327|NCT01477853|324273082|FG000|Phase B|Lost to Follow-up|0|||
94677328|NCT01477853|324273083|FG001|Phase B|Lost to Follow-up|1|||
94677329|NCT01477853|324273084|FG002|Phase B|Lost to Follow-up|0|||
94677330|NCT01477853|324273082|FG000|Phase B|Study terminated by sponsor|12|||
94677331|NCT01477853|324273083|FG001|Phase B|Study terminated by sponsor|10|||
94677332|NCT01477853|324273084|FG002|Phase B|Study terminated by sponsor|11|||
94677333|NCT03086330|324273085|FG000|Overall Study|Withdrawal by Subject|3|||
94677334|NCT03086330|324273086|FG001|Overall Study|Withdrawal by Subject|2|||
94677335|NCT03086330|324273085|FG000|Overall Study|Lost to Follow-up|1|||
94677336|NCT03086330|324273086|FG001|Overall Study|Lost to Follow-up|2|||
94677337|NCT00948974|324273093|FG000|Overall Study|Lost to Follow-up|23|||
94677338|NCT00948974|324273094|FG001|Overall Study|Lost to Follow-up|20|||
94677339|NCT01889186|324273097|FG000|Overall Study|Adverse event- not related to progression|18|||
94677340|NCT01889186|324273098|FG001|Overall Study|Adverse event- not related to progression|5|||
94677341|NCT01889186|324273097|FG000|Overall Study|Adverse event- related to progression|7|||
94677342|NCT01889186|324273098|FG001|Overall Study|Adverse event- related to progression|2|||
94677343|NCT01889186|324273097|FG000|Overall Study|COVID-19 logistical restrictions|1|||
94677344|NCT01889186|324273098|FG001|Overall Study|COVID-19 logistical restrictions|0|||
94677345|NCT01889186|324273097|FG000|Overall Study|Investigator request|1|||
94677346|NCT01889186|324273098|FG001|Overall Study|Investigator request|1|||
94677347|NCT01889186|324273097|FG000|Overall Study|Progressive disease- Richter's|12|||
94677348|NCT01889186|324273098|FG001|Overall Study|Progressive disease- Richter's|7|||
94677349|NCT01889186|324273097|FG000|Overall Study|Progressive disease per protocol|46|||
94677350|NCT01889186|324273098|FG001|Overall Study|Progressive disease per protocol|17|||
94677351|NCT01889186|324273097|FG000|Overall Study|Stem cell transplant|2|||
94677352|NCT01889186|324273098|FG001|Overall Study|Stem cell transplant|1|||
94677353|NCT01889186|324273097|FG000|Overall Study|Withdrew consent|2|||
94677354|NCT01889186|324273098|FG001|Overall Study|Withdrew consent|3|||
94677355|NCT01889186|324273097|FG000|Overall Study|Other, not specified|18|||
94677356|NCT01889186|324273098|FG001|Overall Study|Other, not specified|15|||
94677357|NCT00077064|324273100|FG000|Overall Study|Adverse Event|0|||
94677358|NCT00077064|324273101|FG001|Overall Study|Adverse Event|4|||
94677359|NCT00077064|324273100|FG000|Overall Study|Patient refusal|0|||
94677360|NCT00077064|324273101|FG001|Overall Study|Patient refusal|2|||
94677361|NCT00621543|324273106|FG000|Overall Study|Lost to Follow-up|23|||
94677362|NCT02007434|324273107|FG000|Overall Study|Lost to Follow-up|0|||
94677363|NCT02007434|324273108|FG001|Overall Study|Lost to Follow-up|1|||
94677364|NCT02007434|324273109|FG002|Overall Study|Lost to Follow-up|0|||
94677365|NCT02007434|324273110|FG003|Overall Study|Lost to Follow-up|0|||
94677366|NCT02007434|324273111|FG004|Overall Study|Lost to Follow-up|0|||
94677367|NCT02007434|324273112|FG005|Overall Study|Lost to Follow-up|0|||
94677368|NCT02007434|324273113|FG006|Overall Study|Lost to Follow-up|0|||
94677369|NCT02007434|324273114|FG007|Overall Study|Lost to Follow-up|0|||
94677370|NCT02007434|324273107|FG000|Overall Study|Non-compliance|1|||
94677371|NCT02007434|324273108|FG001|Overall Study|Non-compliance|0|||
94677372|NCT02007434|324273109|FG002|Overall Study|Non-compliance|1|||
94677373|NCT02007434|324273110|FG003|Overall Study|Non-compliance|0|||
94677374|NCT02007434|324273111|FG004|Overall Study|Non-compliance|0|||
94677375|NCT02007434|324273112|FG005|Overall Study|Non-compliance|0|||
94677376|NCT02007434|324273113|FG006|Overall Study|Non-compliance|0|||
94262849|NCT02742766|322756594|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
94262850|NCT02742766|322756595|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
94262851|NCT02742766|322756596|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
94262852|NCT02742766|322756597|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
94677377|NCT02007434|324273114|FG007|Overall Study|Non-compliance|0|||
94677378|NCT04766086|324273118|FG000|Overall Study|Lost to Follow-up|3|||
94677379|NCT04766086|324273119|FG001|Overall Study|Lost to Follow-up|5|||
94677380|NCT04766086|324273120|FG002|Overall Study|Lost to Follow-up|3|||
94677381|NCT04766086|324273118|FG000|Overall Study|Withdrawal by Subject|1|||
94677382|NCT04766086|324273119|FG001|Overall Study|Withdrawal by Subject|1|||
94677383|NCT04766086|324273120|FG002|Overall Study|Withdrawal by Subject|2|||
94461861|NCT00743288|323481242|FG004|Overall Study|Progressive disease (PD)|5|||
94461862|NCT00743288|323481243|FG005|Overall Study|Progressive disease (PD)|3|||
94677384|NCT04766086|324273118|FG000|Overall Study|Other|0|||
94461863|NCT00743288|323481244|FG006|Overall Study|Progressive disease (PD)|6|||
94677385|NCT04766086|324273119|FG001|Overall Study|Other|0|||
94677386|NCT04766086|324273120|FG002|Overall Study|Other|1|||
94677387|NCT00386022|324273125|FG000|Plus Estrogen|Lost to Follow-up|2|||
94677388|NCT00386022|324273126|FG001|Plus Estrogen|Lost to Follow-up|0|||
94677389|NCT00386022|324273125|FG000|Plus Estrogen|Adverse Event|0|||
94677390|NCT00386022|324273126|FG001|Plus Estrogen|Adverse Event|1|||
94677391|NCT00779779|324273127|FG000|Overall Study|Adverse Event|1|||
94677392|NCT00779779|324273127|FG000|Overall Study|Protocol Violation|14|||
94677393|NCT00779779|324273127|FG000|Overall Study|Withdrawal by Subject|4|||
94677394|NCT00779779|324273127|FG000|Overall Study|Lost to Follow-up|5|||
94677395|NCT05158296|324273128|FG000|Overall Study|Sponsor Decision|2|||
94677396|NCT05158296|324273129|FG001|Overall Study|Sponsor Decision|3|||
94262853|NCT02742766|322756598|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
94262854|NCT02742766|322756599|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
94262855|NCT02742766|322756600|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
94262856|NCT02742766|322756601|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
94262857|NCT02742766|322756602|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
94262858|NCT02742766|322756603|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
94262859|NCT02742766|322756604|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
94262860|NCT02742766|322756605|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
94262861|NCT02742766|322756606|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
94262862|NCT02742766|322756607|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
94262863|NCT01395316|322756610|FG000|Overall Study|Lost to Follow-up|2|||
94262864|NCT01395316|322756610|FG000|Overall Study|poor MRI quality|1|||
94262865|NCT02000427|322756614|FG000|Overall Study|Death|22|||
94638532|NCT00265343|324140662|FG000|Overall Study|Withdrawal by Subject|3|||
94262866|NCT04598477|322756627|FG000|Overall Study|Adverse Event|2|||
94262867|NCT04598477|322756628|FG001|Overall Study|Adverse Event|0|||
94262868|NCT04598477|322756627|FG000|Overall Study|Death|0|||
94262869|NCT04598477|322756628|FG001|Overall Study|Death|1|||
94262870|NCT04598477|322756627|FG000|Overall Study|Lost to Follow-up|1|||
94262871|NCT04598477|322756628|FG001|Overall Study|Lost to Follow-up|0|||
94262872|NCT04598477|322756627|FG000|Overall Study|Physician Decision|7|||
94262873|NCT04598477|322756628|FG001|Overall Study|Physician Decision|2|||
94262874|NCT04598477|322756627|FG000|Overall Study|Pregnancy|0|||
94262875|NCT04598477|322756628|FG001|Overall Study|Pregnancy|1|||
94262876|NCT04598477|322756627|FG000|Overall Study|Requires Prohibited Medication|0|||
94262877|NCT04598477|322756628|FG001|Overall Study|Requires Prohibited Medication|1|||
94262878|NCT04598477|322756627|FG000|Overall Study|Study Terminated by Sponsor|18|||
94262879|NCT04598477|322756628|FG001|Overall Study|Study Terminated by Sponsor|12|||
94262880|NCT04598477|322756627|FG000|Overall Study|Withdrawal by Subject|16|||
94262881|NCT04598477|322756628|FG001|Overall Study|Withdrawal by Subject|12|||
94262882|NCT04598477|322756627|FG000|Overall Study|Other|15|||
94638533|NCT00265343|324140663|FG001|Overall Study|Withdrawal by Subject|9|||
94638534|NCT00265343|324140662|FG000|Overall Study|Other|8|||
94638535|NCT00265343|324140663|FG001|Overall Study|Other|3|||
94638536|NCT02535741|324140664|FG000|Overall Study|Adverse Event|3|||
94638537|NCT02535741|324140664|FG000|Overall Study|Withdrawal by Subject|9|||
94638538|NCT02535741|324140664|FG000|Overall Study|Lost to Follow-up|10|||
94638539|NCT02535741|324140664|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
94638540|NCT02535741|324140664|FG000|Overall Study|Missing data|6|||
94638541|NCT01851720|324140665|FG000|Overall Study|Lost to Follow-up|0|||
94638542|NCT01851720|324140666|FG001|Overall Study|Lost to Follow-up|1|||
94638543|NCT00798369|324140667|FG000|Overall Study|Subject withdrew consent|0|||
94638544|NCT00798369|324140668|FG001|Overall Study|Subject withdrew consent|0|||
94638545|NCT00798369|324140669|FG002|Overall Study|Subject withdrew consent|1|||
94638546|NCT00798369|324140670|FG003|Overall Study|Subject withdrew consent|1|||
94638547|NCT00798369|324140671|FG004|Overall Study|Subject withdrew consent|0|||
94638548|NCT00798369|324140672|FG005|Overall Study|Subject withdrew consent|2|||
94638549|NCT00798369|324140667|FG000|Overall Study|Lost to Follow-up|1|||
94638550|NCT00798369|324140668|FG001|Overall Study|Lost to Follow-up|1|||
94638551|NCT00798369|324140669|FG002|Overall Study|Lost to Follow-up|1|||
94638552|NCT00798369|324140670|FG003|Overall Study|Lost to Follow-up|0|||
94677397|NCT05158296|324273130|FG002|Overall Study|Sponsor Decision|2|||
94677398|NCT01778556|324273131|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
94677399|NCT01778556|324273132|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
94262883|NCT04598477|322756628|FG001|Overall Study|Other|8|||
94638553|NCT00798369|324140671|FG004|Overall Study|Lost to Follow-up|1|||
94677400|NCT01778556|324273131|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
94262884|NCT01313650|322756629|FG000|Overall Study|Adverse Event|9|||
94262885|NCT01313650|322756630|FG001|Overall Study|Adverse Event|34|||
94262886|NCT01313650|322756631|FG002|Overall Study|Adverse Event|24|||
94262887|NCT01313650|322756632|FG003|Overall Study|Adverse Event|23|||
94262888|NCT01313650|322756629|FG000|Overall Study|Lack of Efficacy|37|||
94262889|NCT01313650|322756630|FG001|Overall Study|Lack of Efficacy|20|||
94262890|NCT01313650|322756631|FG002|Overall Study|Lack of Efficacy|32|||
94638554|NCT00798369|324140672|FG005|Overall Study|Lost to Follow-up|0|||
94638555|NCT00798369|324140667|FG000|Overall Study|Adminstrative problems|0|||
94638556|NCT00798369|324140668|FG001|Overall Study|Adminstrative problems|0|||
94638557|NCT00798369|324140669|FG002|Overall Study|Adminstrative problems|0|||
94638558|NCT00798369|324140670|FG003|Overall Study|Adminstrative problems|0|||
94638559|NCT00798369|324140671|FG004|Overall Study|Adminstrative problems|0|||
94677401|NCT01778556|324273132|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
94677402|NCT01778556|324273131|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
94677403|NCT01778556|324273132|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
94677404|NCT01778556|324273131|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
94677405|NCT01778556|324273132|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
94677406|NCT01235403|324273134|FG000|Overall Study|Adverse Event|14|||
94677407|NCT01235403|324273134|FG000|Overall Study|Lost to Follow-up|2|||
94677408|NCT01235403|324273134|FG000|Overall Study|Withdrawal by Subject|4|||
94677409|NCT01235403|324273134|FG000|Overall Study|Lack of Efficacy|2|||
94677410|NCT01235403|324273134|FG000|Overall Study|Other reasons for premature termination|4|||
94677411|NCT00117156|324273135|FG000|Overall Study|Adverse Event|9|||
94677412|NCT00117156|324273135|FG000|Overall Study|Physician Decision|1|||
94677413|NCT00117156|324273135|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
94677414|NCT04058353|324273137|FG000|Overall Study|Adverse Event|2|||
94677415|NCT04058353|324273138|FG001|Overall Study|Adverse Event|1|||
94677416|NCT04058353|324273137|FG000|Overall Study|Physician Decision|1|||
94677417|NCT04058353|324273138|FG001|Overall Study|Physician Decision|0|||
94677418|NCT04058353|324273137|FG000|Overall Study|Other|1|||
94677419|NCT04058353|324273138|FG001|Overall Study|Other|0|||
94677420|NCT03445065|324273139|FG000|Overall Study|Withdrawal by Subject|3|||
94677421|NCT03445065|324273140|FG001|Overall Study|Withdrawal by Subject|6|||
94677422|NCT03445065|324273141|FG002|Overall Study|Withdrawal by Subject|2|||
94677423|NCT03445065|324273142|FG003|Overall Study|Withdrawal by Subject|2|||
94677424|NCT03445065|324273139|FG000|Overall Study|Other|4|||
94677425|NCT03445065|324273140|FG001|Overall Study|Other|3|||
94677426|NCT03445065|324273141|FG002|Overall Study|Other|3|||
94677427|NCT03445065|324273142|FG003|Overall Study|Other|1|||
94677428|NCT03750006|324273149|FG000|Overall Study|Withdrawal by Subject|8|||
94677429|NCT03750006|324273149|FG000|Overall Study|COVID PANDEMIC|11|||
94677430|NCT01787097|324274761|FG000|Overall Study|Withdrawal by Subject|1|||
94677431|NCT01787097|324274762|FG001|Overall Study|Withdrawal by Subject|0|||
94677432|NCT01787097|324274763|FG002|Overall Study|Withdrawal by Subject|0|||
94677433|NCT01787097|324274764|FG003|Overall Study|Withdrawal by Subject|0|||
94677434|NCT01352585|324274767|FG000|Overall Study|Adverse Event|2|||
94677435|NCT01352585|324274768|FG001|Overall Study|Adverse Event|1|||
94677436|NCT01352585|324274767|FG000|Overall Study|Lost to Follow-up|1|||
94677437|NCT01352585|324274768|FG001|Overall Study|Lost to Follow-up|0|||
94677438|NCT01352585|324274767|FG000|Overall Study|Other|5|||
94677439|NCT01352585|324274768|FG001|Overall Study|Other|2|||
94677440|NCT00838682|324274769|FG000|Overall Study|Lost to Follow-up|21|||
94677441|NCT00838682|324274770|FG001|Overall Study|Lost to Follow-up|14|||
94677442|NCT00838682|324274769|FG000|Overall Study|detection of exclusion criteria|4|||
94677443|NCT00838682|324274770|FG001|Overall Study|detection of exclusion criteria|3|||
94677444|NCT00838682|324274769|FG000|Overall Study|Protocol Violation|0|||
94677445|NCT00838682|324274770|FG001|Overall Study|Protocol Violation|1|||
94677446|NCT00838682|324274769|FG000|Overall Study|Withdrawal by Subject|0|||
94677447|NCT00838682|324274770|FG001|Overall Study|Withdrawal by Subject|1|||
94677448|NCT02832622|324274771|FG000|Overall Study|MPP not programmed|1259|||
94677449|NCT02832622|324274771|FG000|Overall Study|Withdrawal by Subject|123|||
94677450|NCT02832622|324274771|FG000|Overall Study|Death|119|||
94677451|NCT02832622|324274771|FG000|Overall Study|Unsuccessful CRT implant|93|||
94677452|NCT02832622|324274771|FG000|Overall Study|Lost to Follow-up|45|||
94677453|NCT02832622|324274771|FG000|Overall Study|Patient non-compliance|42|||
94677454|NCT02832622|324274771|FG000|Overall Study|Withdrawal by other reasons|25|||
94677455|NCT02832622|324274771|FG000|Overall Study|System explant|24|||
94677456|NCT02832622|324274771|FG000|Overall Study|Physician Decision|6|||
94677457|NCT00998400|324274772|FG000|Overall Study|Lack of interest/motivation|1|||
94677458|NCT00998400|324274773|FG001|Overall Study|Lack of interest/motivation|2|||
94677459|NCT00998400|324274772|FG000|Overall Study|Logistical problems|1|||
94677460|NCT00998400|324274773|FG001|Overall Study|Logistical problems|0|||
94677461|NCT01083641|324274774|FG000|Overall Study|Withdrawal by Subject|2|||
94677462|NCT03386032|324274775|FG000|Overall Study|Lack of Efficacy|6|||
94677463|NCT03386032|324274776|FG001|Overall Study|Lack of Efficacy|2|||
94677464|NCT03386032|324274777|FG002|Overall Study|Lack of Efficacy|0|||
94677465|NCT03386032|324274775|FG000|Overall Study|Adverse Event|2|||
94677466|NCT03386032|324274776|FG001|Overall Study|Adverse Event|2|||
94677467|NCT03386032|324274777|FG002|Overall Study|Adverse Event|0|||
94677468|NCT03386032|324274775|FG000|Overall Study|Withdrawal by Subject|1|||
94677469|NCT03386032|324274776|FG001|Overall Study|Withdrawal by Subject|0|||
94677470|NCT03386032|324274777|FG002|Overall Study|Withdrawal by Subject|0|||
94677471|NCT03386032|324274775|FG000|Overall Study|Lost to Follow-up|9|||
94677472|NCT03386032|324274776|FG001|Overall Study|Lost to Follow-up|3|||
94677473|NCT03386032|324274777|FG002|Overall Study|Lost to Follow-up|0|||
94677474|NCT01807156|324274778|FG000|Overall Study|Physician Decision|1|||
94677475|NCT03122119|324274780|FG000|Overall Study|Did not meet eligibility critria|1|||
94677476|NCT01649232|324274785|FG000|Overall Study|Physician Decision|2|||
94262891|NCT01313650|322756632|FG003|Overall Study|Lack of Efficacy|20|||
94262892|NCT01313650|322756629|FG000|Overall Study|Lost to Follow-up|1|||
94262893|NCT01313650|322756630|FG001|Overall Study|Lost to Follow-up|0|||
94262894|NCT01313650|322756631|FG002|Overall Study|Lost to Follow-up|3|||
94262895|NCT01313650|322756632|FG003|Overall Study|Lost to Follow-up|2|||
94262896|NCT01313650|322756629|FG000|Overall Study|Withdrawal by Subject|16|||
94262897|NCT01313650|322756630|FG001|Overall Study|Withdrawal by Subject|20|||
94262898|NCT01313650|322756631|FG002|Overall Study|Withdrawal by Subject|15|||
94262899|NCT01313650|322756632|FG003|Overall Study|Withdrawal by Subject|15|||
94262900|NCT01313650|322756629|FG000|Overall Study|Protocol Violation|4|||
94262901|NCT01313650|322756630|FG001|Overall Study|Protocol Violation|7|||
94262902|NCT01313650|322756631|FG002|Overall Study|Protocol Violation|5|||
94262903|NCT01313650|322756632|FG003|Overall Study|Protocol Violation|6|||
94262904|NCT01313650|322756629|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
94262905|NCT01313650|322756630|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
94262906|NCT01313650|322756631|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
94262907|NCT01313650|322756632|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
94262908|NCT00601250|322756633|FG000|Overall Study|Adverse Event|3|||
94262909|NCT00601250|322756634|FG001|Overall Study|Adverse Event|9|||
94262910|NCT00601250|322756633|FG000|Overall Study|Protocol Violation|3|||
94262911|NCT00601250|322756634|FG001|Overall Study|Protocol Violation|2|||
94262912|NCT00601250|322756633|FG000|Overall Study|Lost to Follow-up|2|||
94262913|NCT00601250|322756634|FG001|Overall Study|Lost to Follow-up|6|||
94262914|NCT00601250|322756633|FG000|Overall Study|Withdrawal by Subject|4|||
94262915|NCT00601250|322756634|FG001|Overall Study|Withdrawal by Subject|13|||
94262916|NCT00601250|322756633|FG000|Overall Study|Other incl. lack of efficacy|2|||
94461864|NCT00743288|323481238|FG000|Overall Study|Worsening of condition (Not PD)|0|||
94638560|NCT00798369|324140672|FG005|Overall Study|Adminstrative problems|1|||
94638561|NCT03020823|324140677|FG000|Overall Study|Physician Decision|4|||
94638562|NCT03020823|324140677|FG000|Overall Study|Lack of Efficacy|4|||
94638563|NCT03020823|324140677|FG000|Overall Study|Adverse Event|2|||
94638564|NCT03662542|324140678|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
94638565|NCT03662542|324140679|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
94638566|NCT03662542|324140680|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
94638567|NCT03662542|324140681|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
94638568|NCT03662542|324140682|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
94638569|NCT03662542|324140683|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
94638570|NCT03662542|324140684|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
94638571|NCT03662542|324140685|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
94638572|NCT03662542|324140686|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
94638573|NCT03662542|324140678|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
94638574|NCT03662542|324140679|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
94638575|NCT03662542|324140680|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
94638576|NCT03662542|324140681|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
94638577|NCT03662542|324140682|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
94638578|NCT03662542|324140683|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
94638579|NCT03662542|324140684|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
94638580|NCT03662542|324140685|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
94638581|NCT03662542|324140686|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
94638582|NCT03662542|324140678|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
94638583|NCT03662542|324140679|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
94638584|NCT03662542|324140680|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
94638585|NCT03662542|324140681|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
94638586|NCT03662542|324140682|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
94638587|NCT03662542|324140683|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
94638588|NCT03662542|324140684|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
94638589|NCT03662542|324140685|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
94638590|NCT03662542|324140686|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
94638591|NCT03662542|324140678|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
94638592|NCT03662542|324140679|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
94638593|NCT03662542|324140680|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
94638594|NCT03662542|324140681|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
94262917|NCT00601250|322756634|FG001|Overall Study|Other incl. lack of efficacy|9|||
94262918|NCT00047320|322756635|FG000|Overall Study|Lack of Efficacy|8|||
94262919|NCT00047320|322756635|FG000|Overall Study|Lost to Follow-up|1|||
94262920|NCT00047320|322756635|FG000|Overall Study|Physician Decision|8|||
94262921|NCT00047320|322756635|FG000|Overall Study|Withdrawal by Subject|9|||
94262922|NCT00047320|322756635|FG000|Overall Study|Ineligible|2|||
94262923|NCT04824521|322756639|FG000|Overall Study|Lost to Follow-up|1|||
94638595|NCT03662542|324140682|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
94638596|NCT03662542|324140683|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
94638597|NCT03662542|324140684|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
94262924|NCT02673619|322756640|FG000|Overall Study|Lost to Follow-up|1|||
94262925|NCT02673619|322756641|FG001|Overall Study|Lost to Follow-up|0|||
94262926|NCT02673619|322756642|FG002|Overall Study|Lost to Follow-up|0|||
94262927|NCT02673619|322756643|FG003|Overall Study|Lost to Follow-up|0|||
94262928|NCT02673619|322756640|FG000|Overall Study|Withdrawal by Subject|1|||
94262929|NCT02673619|322756641|FG001|Overall Study|Withdrawal by Subject|1|||
94262930|NCT02673619|322756642|FG002|Overall Study|Withdrawal by Subject|1|||
94262931|NCT02673619|322756643|FG003|Overall Study|Withdrawal by Subject|0|||
94262932|NCT02673619|322756640|FG000|Overall Study|Adverse Event|0|||
94262933|NCT02673619|322756641|FG001|Overall Study|Adverse Event|0|||
94262934|NCT02673619|322756642|FG002|Overall Study|Adverse Event|1|||
94262935|NCT02673619|322756643|FG003|Overall Study|Adverse Event|0|||
94262936|NCT02673619|322756640|FG000|Overall Study|Lack of Efficacy|0|||
94262937|NCT02673619|322756641|FG001|Overall Study|Lack of Efficacy|0|||
94262938|NCT02673619|322756642|FG002|Overall Study|Lack of Efficacy|1|||
94262939|NCT02673619|322756643|FG003|Overall Study|Lack of Efficacy|0|||
94262940|NCT01791803|322756646|FG000|Overall Study|Withdrawal by Subject|0|||
94262941|NCT01791803|322756647|FG001|Overall Study|Withdrawal by Subject|0|||
94262942|NCT01791803|322756648|FG002|Overall Study|Withdrawal by Subject|0|||
94262943|NCT01791803|322756649|FG003|Overall Study|Withdrawal by Subject|2|||
94262944|NCT01791803|322756646|FG000|Overall Study|Physician Decision|0|||
94262945|NCT01791803|322756647|FG001|Overall Study|Physician Decision|2|||
94262946|NCT01791803|322756648|FG002|Overall Study|Physician Decision|0|||
94262947|NCT01791803|322756649|FG003|Overall Study|Physician Decision|1|||
94262948|NCT01791803|322756646|FG000|Overall Study|Death|0|||
94262949|NCT01791803|322756647|FG001|Overall Study|Death|0|||
94262950|NCT01791803|322756648|FG002|Overall Study|Death|2|||
94262951|NCT01791803|322756649|FG003|Overall Study|Death|2|||
94638598|NCT03662542|324140685|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
94638599|NCT03662542|324140686|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
94638600|NCT03662542|324140678|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
94638601|NCT03662542|324140679|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
94638602|NCT03662542|324140680|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
94638603|NCT03662542|324140681|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
94638604|NCT03662542|324140682|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
94638605|NCT03662542|324140683|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
94638606|NCT03662542|324140684|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
94638607|NCT03662542|324140685|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
94638608|NCT03662542|324140686|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
94638609|NCT03662542|324140678|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
94638610|NCT03662542|324140679|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
94638611|NCT03662542|324140680|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
94638612|NCT03662542|324140681|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
94638613|NCT03662542|324140682|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
94638614|NCT03662542|324140683|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
94638615|NCT03662542|324140684|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
94638616|NCT03662542|324140685|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
94638617|NCT03662542|324140686|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
94638618|NCT03662542|324140678|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
94638619|NCT03662542|324140679|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
94638620|NCT03662542|324140680|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
94638621|NCT03662542|324140681|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
94638622|NCT03662542|324140682|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
94638623|NCT03662542|324140683|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
94638624|NCT03662542|324140684|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
94638625|NCT03662542|324140685|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
94638626|NCT03662542|324140686|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
94638627|NCT03662542|324140678|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
94638628|NCT03662542|324140679|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
94638629|NCT03662542|324140680|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
94638630|NCT03662542|324140681|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
94638631|NCT03662542|324140682|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
94638632|NCT03662542|324140683|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
94262952|NCT04600336|322756652|FG000|Initial Treatment|Withdrawal by Subject|1|||
94262953|NCT04600336|322756653|FG001|Initial Treatment|Withdrawal by Subject|2|||
94262954|NCT04600336|322756654|FG002|Initial Treatment|Withdrawal by Subject|0|||
94262955|NCT04600336|322756655|FG003|Initial Treatment|Withdrawal by Subject|0|||
94262956|NCT04600336|322756652|FG000|Initial Treatment|Adverse Event|0|||
94262957|NCT04600336|322756653|FG001|Initial Treatment|Adverse Event|2|||
94262958|NCT04600336|322756654|FG002|Initial Treatment|Adverse Event|0|||
94262959|NCT04600336|322756655|FG003|Initial Treatment|Adverse Event|0|||
94262960|NCT04600336|322756652|FG000|Initial Treatment|Other complicating disease|0|||
94262961|NCT04600336|322756653|FG001|Initial Treatment|Other complicating disease|0|||
94262962|NCT04600336|322756654|FG002|Initial Treatment|Other complicating disease|1|||
94262963|NCT04600336|322756655|FG003|Initial Treatment|Other complicating disease|0|||
94262964|NCT04600336|322756652|FG000|Crossover Treatment|Withdrawal by Subject|0|||
94262965|NCT04600336|322756653|FG001|Crossover Treatment|Withdrawal by Subject|0|||
94262966|NCT04600336|322756654|FG002|Crossover Treatment|Withdrawal by Subject|2|||
94262967|NCT04600336|322756655|FG003|Crossover Treatment|Withdrawal by Subject|1|||
94262968|NCT04600336|322756652|FG000|Crossover Treatment|Adverse Event|0|||
94262969|NCT04600336|322756653|FG001|Crossover Treatment|Adverse Event|0|||
94262970|NCT04600336|322756654|FG002|Crossover Treatment|Adverse Event|1|||
94262971|NCT04600336|322756655|FG003|Crossover Treatment|Adverse Event|1|||
94262972|NCT01093326|322756657|FG000|Overall Study|Death|0|||
94262973|NCT01093326|322756658|FG001|Overall Study|Death|1|||
94262974|NCT01093326|322756659|FG002|Overall Study|Death|0|||
94262975|NCT01093326|322756657|FG000|Overall Study|Lack of Efficacy|7|||
94262976|NCT01093326|322756658|FG001|Overall Study|Lack of Efficacy|6|||
94262977|NCT01093326|322756659|FG002|Overall Study|Lack of Efficacy|3|||
94262978|NCT01093326|322756657|FG000|Overall Study|Lost to Follow-up|2|||
94262979|NCT01093326|322756658|FG001|Overall Study|Lost to Follow-up|5|||
94262980|NCT01093326|322756659|FG002|Overall Study|Lost to Follow-up|4|||
94262981|NCT01093326|322756657|FG000|Overall Study|Physician Decision|3|||
94262982|NCT01093326|322756658|FG001|Overall Study|Physician Decision|1|||
94262983|NCT01093326|322756659|FG002|Overall Study|Physician Decision|3|||
94262984|NCT01093326|322756657|FG000|Overall Study|Withdrawal by Subject|30|||
94262985|NCT01093326|322756658|FG001|Overall Study|Withdrawal by Subject|27|||
94262986|NCT01093326|322756659|FG002|Overall Study|Withdrawal by Subject|26|||
94638633|NCT03662542|324140684|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
94362848|NCT03707145|323112873|FG002|Overall Study|Lost to Follow-up|1|||
94362849|NCT03707145|323112874|FG003|Overall Study|Lost to Follow-up|0|||
94362850|NCT03940742|323112876|FG000|Overall Study|Lost to Follow-up|0|||
94362851|NCT03940742|323112877|FG001|Overall Study|Lost to Follow-up|0|||
94638634|NCT03662542|324140685|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
94638635|NCT03662542|324140686|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
94638636|NCT03662542|324140678|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
94638637|NCT03662542|324140679|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
94638638|NCT03662542|324140680|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
94638639|NCT03662542|324140681|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
94638640|NCT03662542|324140682|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
94638641|NCT03662542|324140683|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
94638642|NCT03662542|324140684|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
94638643|NCT03662542|324140685|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
94638644|NCT03662542|324140686|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
94638645|NCT03662542|324140678|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
94638646|NCT03662542|324140679|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
94638647|NCT03662542|324140680|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
94638648|NCT03662542|324140681|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
94638649|NCT03662542|324140682|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
94638650|NCT03662542|324140683|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
94638651|NCT03662542|324140684|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
94638652|NCT03662542|324140685|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
94638653|NCT03662542|324140686|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
94638654|NCT03662542|324140678|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
94638655|NCT03662542|324140679|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
94638656|NCT03662542|324140680|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
94638657|NCT03662542|324140681|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
94638658|NCT03662542|324140682|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
94638659|NCT03662542|324140683|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
94638660|NCT03662542|324140684|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
94638661|NCT03662542|324140685|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
94638662|NCT03662542|324140686|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
94638663|NCT03662542|324140678|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
94638664|NCT03662542|324140679|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
94638665|NCT03662542|324140680|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
94638666|NCT03662542|324140681|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
94638667|NCT03662542|324140682|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
94638668|NCT03662542|324140683|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
94638669|NCT03662542|324140684|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
94638670|NCT03662542|324140685|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
94638671|NCT03662542|324140686|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
94638672|NCT03662542|324140678|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
94262987|NCT01093326|322756657|FG000|Overall Study|Adverse Event|2|||
94262988|NCT01093326|322756658|FG001|Overall Study|Adverse Event|1|||
94262989|NCT01093326|322756659|FG002|Overall Study|Adverse Event|4|||
94262990|NCT01093326|322756657|FG000|Overall Study|Other|0|||
94262991|NCT01093326|322756658|FG001|Overall Study|Other|0|||
94262992|NCT01093326|322756659|FG002|Overall Study|Other|1|||
94262993|NCT01444456|322756660|FG000|Overall Study|Withdrawal by Subject|21|||
94262994|NCT01444456|322756660|FG000|Overall Study|Physician Decision|9|||
94262995|NCT01444456|322756660|FG000|Overall Study|Lost to Follow-up|37|||
94262996|NCT01444456|322756660|FG000|Overall Study|Death|73|||
94262997|NCT01444456|322756660|FG000|Overall Study|Ineligibility determined|23|||
94262998|NCT01444456|322756660|FG000|Overall Study|Other|18|||
94262999|NCT01444456|322756660|FG000|Overall Study|Not treated|104|||
94638673|NCT03662542|324140679|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
94638674|NCT03662542|324140680|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
94638675|NCT03662542|324140681|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
94638676|NCT03662542|324140682|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
94638677|NCT03662542|324140683|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
94638678|NCT03662542|324140684|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
94638679|NCT03662542|324140685|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
94638680|NCT03662542|324140686|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
94638681|NCT01217060|324140687|FG000|Overall Study|Withdrawal by Subject|1|||
94638682|NCT01816893|324140688|FG000|Washout Period|Withdrawal by Subject|2|||
94638683|NCT01816893|324140689|FG001|Washout Period|Withdrawal by Subject|0|||
94638684|NCT00004888|324140690|FG000|Overall Study|Adverse Event|5|||
94638685|NCT00004888|324140691|FG001|Overall Study|Adverse Event|10|||
94638686|NCT00004888|324140690|FG000|Overall Study|Withdrawal by Subject|0|||
94638687|NCT00004888|324140691|FG001|Overall Study|Withdrawal by Subject|3|||
94638688|NCT00004888|324140690|FG000|Overall Study|Physician Decision|1|||
94638689|NCT00004888|324140691|FG001|Overall Study|Physician Decision|1|||
94638690|NCT00004888|324140690|FG000|Overall Study|Progressive Disease|4|||
94638691|NCT00004888|324140691|FG001|Overall Study|Progressive Disease|9|||
94638692|NCT00004888|324140690|FG000|Overall Study|Death without progressive disease|0|||
94638693|NCT00004888|324140691|FG001|Overall Study|Death without progressive disease|1|||
94638694|NCT00004888|324140690|FG000|Overall Study|Toxic death|1|||
94638695|NCT00004888|324140691|FG001|Overall Study|Toxic death|0|||
94638696|NCT00588822|324140692|FG000|Overall Study|progression of disease|8|||
94638697|NCT03388138|324140695|FG000|Overall Study|Protocol Violation|1|||
94638698|NCT03388138|324140696|FG001|Overall Study|Protocol Violation|0|||
94638699|NCT03616912|324140699|FG000|Overall Study|Adverse Event|17|||
94638700|NCT03616912|324140700|FG001|Overall Study|Adverse Event|21|||
94638701|NCT03616912|324140701|FG002|Overall Study|Adverse Event|9|||
94638702|NCT03616912|324140702|FG003|Overall Study|Adverse Event|0|||
94638703|NCT03616912|324140703|FG004|Overall Study|Adverse Event|0|||
94638704|NCT03616912|324140704|FG005|Overall Study|Adverse Event|0|||
94638705|NCT03616912|324140699|FG000|Overall Study|Death|1|||
94638706|NCT03616912|324140700|FG001|Overall Study|Death|1|||
94638707|NCT03616912|324140701|FG002|Overall Study|Death|0|||
94638708|NCT03616912|324140702|FG003|Overall Study|Death|0|||
94638709|NCT03616912|324140703|FG004|Overall Study|Death|0|||
94638710|NCT03616912|324140704|FG005|Overall Study|Death|0|||
94638711|NCT03616912|324140699|FG000|Overall Study|Lack of Efficacy|13|||
94638712|NCT03616912|324140700|FG001|Overall Study|Lack of Efficacy|6|||
94638713|NCT03616912|324140701|FG002|Overall Study|Lack of Efficacy|8|||
94638714|NCT03616912|324140702|FG003|Overall Study|Lack of Efficacy|4|||
94638715|NCT03616912|324140703|FG004|Overall Study|Lack of Efficacy|5|||
94638716|NCT03616912|324140704|FG005|Overall Study|Lack of Efficacy|1|||
94638717|NCT03616912|324140699|FG000|Overall Study|Lost to Follow-up|1|||
94638718|NCT03616912|324140700|FG001|Overall Study|Lost to Follow-up|2|||
94638719|NCT03616912|324140701|FG002|Overall Study|Lost to Follow-up|3|||
94638720|NCT03616912|324140702|FG003|Overall Study|Lost to Follow-up|0|||
94638721|NCT03616912|324140703|FG004|Overall Study|Lost to Follow-up|0|||
94638722|NCT03616912|324140704|FG005|Overall Study|Lost to Follow-up|0|||
94638723|NCT03616912|324140699|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
94638724|NCT03616912|324140700|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
94638725|NCT03616912|324140701|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
94638726|NCT03616912|324140702|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
94638727|NCT03616912|324140703|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
94638728|NCT03616912|324140704|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
94638729|NCT03616912|324140699|FG000|Overall Study|Withdrawal by Subject|12|||
94638730|NCT03616912|324140700|FG001|Overall Study|Withdrawal by Subject|12|||
94638731|NCT03616912|324140701|FG002|Overall Study|Withdrawal by Subject|15|||
94638732|NCT03616912|324140702|FG003|Overall Study|Withdrawal by Subject|2|||
94638733|NCT03616912|324140703|FG004|Overall Study|Withdrawal by Subject|0|||
94638734|NCT03616912|324140704|FG005|Overall Study|Withdrawal by Subject|2|||
94638735|NCT03616912|324140699|FG000|Overall Study|Study Terminated by Sponsor|0|||
94638736|NCT03616912|324140700|FG001|Overall Study|Study Terminated by Sponsor|0|||
94638737|NCT03616912|324140701|FG002|Overall Study|Study Terminated by Sponsor|0|||
94638738|NCT03616912|324140702|FG003|Overall Study|Study Terminated by Sponsor|10|||
94638739|NCT03616912|324140703|FG004|Overall Study|Study Terminated by Sponsor|9|||
94362852|NCT03940742|323112878|FG002|Overall Study|Lost to Follow-up|0|||
94638740|NCT03616912|324140704|FG005|Overall Study|Study Terminated by Sponsor|11|||
94638741|NCT03616912|324140699|FG000|Overall Study|Protocol Deviation|1|||
94638742|NCT03616912|324140700|FG001|Overall Study|Protocol Deviation|1|||
94638743|NCT03616912|324140701|FG002|Overall Study|Protocol Deviation|0|||
94638744|NCT03616912|324140702|FG003|Overall Study|Protocol Deviation|0|||
94638745|NCT03616912|324140703|FG004|Overall Study|Protocol Deviation|0|||
94638746|NCT03616912|324140704|FG005|Overall Study|Protocol Deviation|0|||
94638747|NCT03616912|324140699|FG000|Overall Study|Pregnancy|1|||
94638748|NCT03616912|324140700|FG001|Overall Study|Pregnancy|0|||
94638749|NCT03616912|324140701|FG002|Overall Study|Pregnancy|4|||
94638750|NCT03616912|324140702|FG003|Overall Study|Pregnancy|0|||
94638751|NCT03616912|324140703|FG004|Overall Study|Pregnancy|0|||
94638752|NCT03616912|324140704|FG005|Overall Study|Pregnancy|0|||
94638753|NCT03616912|324140699|FG000|Overall Study|Protocol Violation|1|||
94638754|NCT03616912|324140700|FG001|Overall Study|Protocol Violation|0|||
94638755|NCT03616912|324140701|FG002|Overall Study|Protocol Violation|2|||
94638756|NCT03616912|324140702|FG003|Overall Study|Protocol Violation|0|||
94638757|NCT03616912|324140703|FG004|Overall Study|Protocol Violation|0|||
94638758|NCT03616912|324140704|FG005|Overall Study|Protocol Violation|0|||
94638759|NCT03616912|324140699|FG000|Overall Study|Physician Decision|2|||
94638760|NCT03616912|324140700|FG001|Overall Study|Physician Decision|0|||
94638761|NCT03616912|324140701|FG002|Overall Study|Physician Decision|0|||
94638762|NCT03616912|324140702|FG003|Overall Study|Physician Decision|0|||
94638763|NCT03616912|324140703|FG004|Overall Study|Physician Decision|1|||
94638764|NCT03616912|324140704|FG005|Overall Study|Physician Decision|0|||
94638765|NCT03616912|324140699|FG000|Overall Study|Randomized But Never Treated|0|||
94638766|NCT03616912|324140700|FG001|Overall Study|Randomized But Never Treated|2|||
94638767|NCT03616912|324140701|FG002|Overall Study|Randomized But Never Treated|0|||
94638768|NCT03616912|324140702|FG003|Overall Study|Randomized But Never Treated|0|||
94638769|NCT03616912|324140703|FG004|Overall Study|Randomized But Never Treated|0|||
94638770|NCT03616912|324140704|FG005|Overall Study|Randomized But Never Treated|0|||
94638771|NCT01649375|324140705|FG000|Up to Week 16|Adverse Event|2|||
94638772|NCT01649375|324140706|FG001|Up to Week 16|Adverse Event|5|||
94638773|NCT01649375|324140707|FG002|Up to Week 16|Adverse Event|4|||
94638774|NCT01649375|324140708|FG003|Up to Week 16|Adverse Event|0|||
94638775|NCT01649375|324140709|FG004|Up to Week 16|Adverse Event|0|||
94638776|NCT01649375|324140705|FG000|Up to Week 16|Lack of Efficacy|0|||
94638777|NCT01649375|324140706|FG001|Up to Week 16|Lack of Efficacy|0|||
94638778|NCT01649375|324140707|FG002|Up to Week 16|Lack of Efficacy|1|||
94638779|NCT01649375|324140708|FG003|Up to Week 16|Lack of Efficacy|0|||
94638780|NCT01649375|324140709|FG004|Up to Week 16|Lack of Efficacy|0|||
94638781|NCT01649375|324140705|FG000|Up to Week 16|Physician Decision|0|||
94638782|NCT01649375|324140706|FG001|Up to Week 16|Physician Decision|0|||
94638783|NCT01649375|324140707|FG002|Up to Week 16|Physician Decision|1|||
94638784|NCT01649375|324140708|FG003|Up to Week 16|Physician Decision|0|||
94638785|NCT01649375|324140709|FG004|Up to Week 16|Physician Decision|0|||
94638786|NCT01649375|324140705|FG000|Up to Week 16|Withdrawal by Subject|2|||
94638787|NCT01649375|324140706|FG001|Up to Week 16|Withdrawal by Subject|1|||
94638788|NCT01649375|324140707|FG002|Up to Week 16|Withdrawal by Subject|2|||
94638789|NCT01649375|324140708|FG003|Up to Week 16|Withdrawal by Subject|0|||
94638790|NCT01649375|324140709|FG004|Up to Week 16|Withdrawal by Subject|0|||
94638791|NCT01649375|324140705|FG000|Up to Week 16|Death|1|||
94638792|NCT01649375|324140706|FG001|Up to Week 16|Death|0|||
94638793|NCT01649375|324140707|FG002|Up to Week 16|Death|0|||
94638794|NCT01649375|324140708|FG003|Up to Week 16|Death|0|||
94638795|NCT01649375|324140709|FG004|Up to Week 16|Death|0|||
94638796|NCT01649375|324140705|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
94638797|NCT01649375|324140706|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
94638798|NCT01649375|324140707|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
94638799|NCT01649375|324140708|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
94638800|NCT01649375|324140709|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
94638801|NCT01649375|324140705|FG000|Week 16 up to Week 260|Non-compliance|0|||
94638802|NCT01649375|324140706|FG001|Week 16 up to Week 260|Non-compliance|1|||
94638803|NCT01649375|324140707|FG002|Week 16 up to Week 260|Non-compliance|0|||
94638804|NCT01649375|324140708|FG003|Week 16 up to Week 260|Non-compliance|1|||
94638805|NCT01649375|324140709|FG004|Week 16 up to Week 260|Non-compliance|0|||
94638806|NCT01649375|324140705|FG000|Week 16 up to Week 260|Physician Decision|0|||
94638807|NCT01649375|324140706|FG001|Week 16 up to Week 260|Physician Decision|2|||
94638808|NCT01649375|324140707|FG002|Week 16 up to Week 260|Physician Decision|0|||
94638809|NCT01649375|324140708|FG003|Week 16 up to Week 260|Physician Decision|0|||
94638810|NCT01649375|324140709|FG004|Week 16 up to Week 260|Physician Decision|0|||
94638811|NCT01649375|324140705|FG000|Week 16 up to Week 260|Technical issues|0|||
94638812|NCT01649375|324140706|FG001|Week 16 up to Week 260|Technical issues|1|||
94638813|NCT01649375|324140707|FG002|Week 16 up to Week 260|Technical issues|0|||
94638814|NCT01649375|324140708|FG003|Week 16 up to Week 260|Technical issues|1|||
94638815|NCT01649375|324140709|FG004|Week 16 up to Week 260|Technical issues|0|||
94638816|NCT01649375|324140705|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
94638817|NCT01649375|324140706|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
94362853|NCT03940742|323112879|FG003|Overall Study|Lost to Follow-up|1|||
94638818|NCT01649375|324140707|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
94638819|NCT01649375|324140708|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
94638820|NCT01649375|324140709|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
94638821|NCT01649375|324140705|FG000|Week 16 up to Week 260|Death|1|||
94638822|NCT01649375|324140706|FG001|Week 16 up to Week 260|Death|1|||
94638823|NCT01649375|324140707|FG002|Week 16 up to Week 260|Death|0|||
94638824|NCT01649375|324140708|FG003|Week 16 up to Week 260|Death|0|||
94638825|NCT01649375|324140709|FG004|Week 16 up to Week 260|Death|0|||
94638826|NCT01649375|324140705|FG000|Week 16 up to Week 260|Adverse Event|5|||
94638827|NCT01649375|324140706|FG001|Week 16 up to Week 260|Adverse Event|2|||
94638828|NCT01649375|324140707|FG002|Week 16 up to Week 260|Adverse Event|0|||
94638829|NCT01649375|324140708|FG003|Week 16 up to Week 260|Adverse Event|3|||
94638830|NCT01649375|324140709|FG004|Week 16 up to Week 260|Adverse Event|2|||
94638831|NCT00456521|324140713|FG000|Overall Study|Adverse Event|150|||
94638832|NCT00456521|324140714|FG001|Overall Study|Adverse Event|25|||
94638833|NCT00456521|324140713|FG000|Overall Study|Withdrawal by Subject|43|||
94638834|NCT00456521|324140714|FG001|Overall Study|Withdrawal by Subject|24|||
94638835|NCT00456521|324140713|FG000|Overall Study|Lost to Follow-up|22|||
94638836|NCT00456521|324140714|FG001|Overall Study|Lost to Follow-up|17|||
94638837|NCT00456521|324140713|FG000|Overall Study|Lack of Efficacy|3|||
94638838|NCT00456521|324140714|FG001|Overall Study|Lack of Efficacy|6|||
94638839|NCT00456521|324140713|FG000|Overall Study|Protocol Violation|4|||
94638840|NCT00456521|324140714|FG001|Overall Study|Protocol Violation|0|||
94638841|NCT00456521|324140713|FG000|Overall Study|Pregnancy|1|||
94638842|NCT00456521|324140714|FG001|Overall Study|Pregnancy|1|||
94638843|NCT00456521|324140713|FG000|Overall Study|Drug non-compliance, moved, other|26|||
94638844|NCT00456521|324140714|FG001|Overall Study|Drug non-compliance, moved, other|11|||
94638845|NCT00605475|324140719|FG000|Overall Study|Abnormal Laboratory Values|0|||
94638846|NCT00605475|324140720|FG001|Overall Study|Abnormal Laboratory Values|0|||
94638847|NCT00605475|324140721|FG002|Overall Study|Abnormal Laboratory Values|0|||
94638848|NCT00605475|324140722|FG003|Overall Study|Abnormal Laboratory Values|0|||
94638849|NCT00605475|324140723|FG004|Overall Study|Abnormal Laboratory Values|0|||
94638850|NCT00605475|324140724|FG005|Overall Study|Abnormal Laboratory Values|0|||
94638851|NCT00605475|324140725|FG006|Overall Study|Abnormal Laboratory Values|0|||
94638852|NCT00605475|324140726|FG007|Overall Study|Abnormal Laboratory Values|0|||
94638853|NCT00605475|324140727|FG008|Overall Study|Abnormal Laboratory Values|1|||
94638854|NCT00605475|324140728|FG009|Overall Study|Abnormal Laboratory Values|0|||
94638855|NCT00605475|324140719|FG000|Overall Study|Administrative problems|0|||
94638856|NCT00605475|324140720|FG001|Overall Study|Administrative problems|0|||
94638857|NCT00605475|324140721|FG002|Overall Study|Administrative problems|0|||
94638858|NCT00605475|324140722|FG003|Overall Study|Administrative problems|0|||
94638859|NCT00605475|324140723|FG004|Overall Study|Administrative problems|0|||
94638860|NCT00605475|324140724|FG005|Overall Study|Administrative problems|0|||
94638861|NCT00605475|324140725|FG006|Overall Study|Administrative problems|1|||
94638862|NCT00605475|324140726|FG007|Overall Study|Administrative problems|0|||
94638863|NCT00605475|324140727|FG008|Overall Study|Administrative problems|0|||
94638864|NCT00605475|324140728|FG009|Overall Study|Administrative problems|0|||
94638865|NCT00605475|324140719|FG000|Overall Study|Lost to Follow-up|0|||
94638866|NCT00605475|324140720|FG001|Overall Study|Lost to Follow-up|0|||
94638867|NCT00605475|324140721|FG002|Overall Study|Lost to Follow-up|0|||
94638868|NCT00605475|324140722|FG003|Overall Study|Lost to Follow-up|0|||
94638869|NCT00605475|324140723|FG004|Overall Study|Lost to Follow-up|0|||
94638870|NCT00605475|324140724|FG005|Overall Study|Lost to Follow-up|0|||
94638871|NCT00605475|324140725|FG006|Overall Study|Lost to Follow-up|0|||
94638872|NCT00605475|324140726|FG007|Overall Study|Lost to Follow-up|0|||
94638873|NCT00605475|324140727|FG008|Overall Study|Lost to Follow-up|1|||
94638874|NCT00605475|324140728|FG009|Overall Study|Lost to Follow-up|1|||
94638875|NCT00605475|324140719|FG000|Overall Study|Protocol Violation|0|||
94638876|NCT00605475|324140720|FG001|Overall Study|Protocol Violation|0|||
94638877|NCT00605475|324140721|FG002|Overall Study|Protocol Violation|0|||
94638878|NCT00605475|324140722|FG003|Overall Study|Protocol Violation|0|||
94638879|NCT00605475|324140723|FG004|Overall Study|Protocol Violation|1|||
94638880|NCT00605475|324140724|FG005|Overall Study|Protocol Violation|0|||
94638881|NCT00605475|324140725|FG006|Overall Study|Protocol Violation|0|||
94638882|NCT00605475|324140726|FG007|Overall Study|Protocol Violation|0|||
94638883|NCT00605475|324140727|FG008|Overall Study|Protocol Violation|0|||
94638884|NCT00605475|324140728|FG009|Overall Study|Protocol Violation|0|||
94638885|NCT00605475|324140719|FG000|Overall Study|Withdrawal by Subject|0|||
94638886|NCT00605475|324140720|FG001|Overall Study|Withdrawal by Subject|0|||
94638887|NCT00605475|324140721|FG002|Overall Study|Withdrawal by Subject|0|||
94638888|NCT00605475|324140722|FG003|Overall Study|Withdrawal by Subject|0|||
94638889|NCT00605475|324140723|FG004|Overall Study|Withdrawal by Subject|0|||
94638890|NCT00605475|324140724|FG005|Overall Study|Withdrawal by Subject|2|||
94638891|NCT00605475|324140725|FG006|Overall Study|Withdrawal by Subject|0|||
94638892|NCT00605475|324140726|FG007|Overall Study|Withdrawal by Subject|0|||
94263000|NCT03338192|322758101|FG000|Year One to Year Two|High Blood Pressure|7|||
94263001|NCT03338192|322758102|FG001|Year One to Year Two|High Blood Pressure|1|||
94263002|NCT03338192|322758101|FG000|Year One to Year Two|HIV +|1|||
94263003|NCT03338192|322758102|FG001|Year One to Year Two|HIV +|0|||
94263004|NCT03338192|322758101|FG000|Year Two to Year Four|High Blood Pressure|1|||
94263005|NCT03338192|322758102|FG001|Year Two to Year Four|High Blood Pressure|0|||
94263006|NCT03338192|322758101|FG000|Year Two to Year Four|HIV +|2|||
94263007|NCT03338192|322758102|FG001|Year Two to Year Four|HIV +|0|||
94263008|NCT03338192|322758101|FG000|Year Four to Year Six|High Blood Pressure|2|||
94263009|NCT03338192|322758102|FG001|Year Four to Year Six|High Blood Pressure|1|||
94263010|NCT00352885|322758103|FG000|Overall Study|Withdrawal by Subject|0|||
94362854|NCT00621309|323112880|FG000|Overall Study|Withdrawal by Subject|2|||
94362855|NCT00621309|323112881|FG001|Overall Study|Withdrawal by Subject|0|||
94362856|NCT00621309|323112882|FG002|Overall Study|Withdrawal by Subject|1|||
94362857|NCT00621309|323112883|FG003|Overall Study|Withdrawal by Subject|1|||
94362858|NCT00621309|323112884|FG004|Overall Study|Withdrawal by Subject|1|||
94362859|NCT00621309|323112885|FG005|Overall Study|Withdrawal by Subject|1|||
94362860|NCT00285012|323112886|FG000|Assigned to Study Treatment (Tx)|Other|2|||
94362861|NCT00285012|323112887|FG001|Assigned to Study Treatment (Tx)|Other|3|||
94362862|NCT00285012|323112886|FG000|Received Study Tx|Death|2|||
94362863|NCT00285012|323112887|FG001|Received Study Tx|Death|1|||
94362864|NCT00285012|323112886|FG000|Received Study Tx|Adverse Event|5|||
94362865|NCT00285012|323112887|FG001|Received Study Tx|Adverse Event|11|||
94362866|NCT00285012|323112886|FG000|Received Study Tx|Lack of Efficacy|0|||
94362867|NCT00285012|323112887|FG001|Received Study Tx|Lack of Efficacy|3|||
94362868|NCT00285012|323112886|FG000|Received Study Tx|Lost to Follow-up|29|||
94362869|NCT00285012|323112887|FG001|Received Study Tx|Lost to Follow-up|31|||
94362870|NCT00285012|323112886|FG000|Received Study Tx|Withdrawal by Subject|31|||
94362871|NCT00285012|323112887|FG001|Received Study Tx|Withdrawal by Subject|43|||
94362872|NCT00285012|323112886|FG000|Received Study Tx|Other|5|||
94362873|NCT00285012|323112887|FG001|Received Study Tx|Other|5|||
94362874|NCT04798027|323112888|FG000|Overall Study|Protocol Violation|0|||
94362875|NCT04798027|323112889|FG001|Overall Study|Protocol Violation|0|||
94362876|NCT04798027|323112890|FG002|Overall Study|Protocol Violation|0|||
94362877|NCT04798027|323112891|FG003|Overall Study|Protocol Violation|0|||
94362878|NCT04798027|323112892|FG004|Overall Study|Protocol Violation|1|||
94362879|NCT04798027|323112893|FG005|Overall Study|Protocol Violation|0|||
94362880|NCT04798027|323112894|FG006|Overall Study|Protocol Violation|0|||
94638893|NCT00605475|324140727|FG008|Overall Study|Withdrawal by Subject|0|||
94638894|NCT00605475|324140728|FG009|Overall Study|Withdrawal by Subject|1|||
94638895|NCT01290666|324140729|FG000|Overall Study|Lost to Follow-up|11|||
94638896|NCT01290666|324140729|FG000|Overall Study|Withdrawal by Subject|23|||
94638897|NCT01290666|324140729|FG000|Overall Study|Early Termination of Study|4|||
94638898|NCT00076011|324140732|FG000|Overall Study|Death|1|||
94638899|NCT00076011|324140732|FG000|Overall Study|Adverse Event|10|||
94638900|NCT00076011|324140732|FG000|Overall Study|Lack of Efficacy|25|||
94638901|NCT00076011|324140732|FG000|Overall Study|Withdrawal by Subject|1|||
94638902|NCT00076011|324140732|FG000|Overall Study|Study terminated by sponsor|3|||
94638903|NCT00076011|324140732|FG000|Overall Study|Other|11|||
94638904|NCT00076011|324140732|FG000|Overall Study|Ongoing|1|||
94638905|NCT04461015|324140737|FG000|Overall Study|IV access lost during the study|0|||
94638906|NCT04461015|324140738|FG001|Overall Study|IV access lost during the study|1|||
94638907|NCT04461015|324140737|FG000|Overall Study|Withdrawal by Subject|0|||
94638908|NCT04461015|324140738|FG001|Overall Study|Withdrawal by Subject|1|||
94638909|NCT00464568|324140742|FG000|Overall Study|Adverse Event|2|||
94638910|NCT00857220|324140752|FG000|Overall Study|Adverse Event|35|||
94263011|NCT00352885|322758104|FG001|Overall Study|Withdrawal by Subject|3|||
94263012|NCT00352885|322758103|FG000|Overall Study|Development of major depression|0|||
94362881|NCT04798027|323112895|FG007|Overall Study|Protocol Violation|1|||
94362882|NCT04798027|323112896|FG008|Overall Study|Protocol Violation|0|||
94362883|NCT04798027|323112888|FG000|Overall Study|Withdrawal by Subject|1|||
94638911|NCT00857220|324140752|FG000|Overall Study|Death|1|||
94638912|NCT00857220|324140752|FG000|Overall Study|Lack of Efficacy|11|||
94638913|NCT00857220|324140752|FG000|Overall Study|Lost to Follow-up|30|||
94638914|NCT00857220|324140752|FG000|Overall Study|Physician Decision|4|||
94638915|NCT00857220|324140752|FG000|Overall Study|Protocol Violation|16|||
94638916|NCT00857220|324140752|FG000|Overall Study|Withdrawal by Subject|67|||
94638917|NCT00857220|324140752|FG000|Overall Study|Clinical Hold|6|||
94638918|NCT00857220|324140752|FG000|Overall Study|Site Closed|5|||
94638919|NCT00857220|324140752|FG000|Overall Study|Miscellaneous|8|||
94362884|NCT04798027|323112889|FG001|Overall Study|Withdrawal by Subject|0|||
94362885|NCT04798027|323112890|FG002|Overall Study|Withdrawal by Subject|1|||
94638920|NCT02612428|324140753|FG000|VTL-308|Death|14|||
94263013|NCT00352885|322758104|FG001|Overall Study|Development of major depression|1|||
94263014|NCT00352885|322758103|FG000|Overall Study|Progression of metastatic melanoma|5|||
94362886|NCT04798027|323112891|FG003|Overall Study|Withdrawal by Subject|1|||
94362887|NCT04798027|323112892|FG004|Overall Study|Withdrawal by Subject|1|||
94362888|NCT04798027|323112893|FG005|Overall Study|Withdrawal by Subject|1|||
94362889|NCT04798027|323112894|FG006|Overall Study|Withdrawal by Subject|3|||
94638921|NCT02612428|324140754|FG001|VTL-308|Death|16|||
94638922|NCT02612428|324140753|FG000|VTL-308|Withdrawal by Subject|0|||
94638923|NCT02612428|324140754|FG001|VTL-308|Withdrawal by Subject|1|||
94638924|NCT02612428|324140753|FG000|VTL-308E|Death|9|||
94638925|NCT02612428|324140754|FG001|VTL-308E|Death|7|||
94638926|NCT02612428|324140753|FG000|VTL-308E|Lost to Follow-up|2|||
94638927|NCT02612428|324140754|FG001|VTL-308E|Lost to Follow-up|0|||
94638928|NCT01176266|324140759|FG000|Overall Study|Death|6|||
94638929|NCT01176266|324140759|FG000|Overall Study|Withdrawal by Subject|3|||
94638930|NCT02073279|324140760|FG000|Double-blind Period|Adverse Event|1|||
94638931|NCT02073279|324140761|FG001|Double-blind Period|Adverse Event|1|||
94638932|NCT02073279|324140760|FG000|Double-blind Period|Switched to another treatment|1|||
94638933|NCT02073279|324140761|FG001|Double-blind Period|Switched to another treatment|2|||
94638934|NCT02073279|324140760|FG000|Double-blind Period|Protocol Violation|0|||
94638935|NCT02073279|324140761|FG001|Double-blind Period|Protocol Violation|1|||
94638936|NCT02073279|324140760|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
94638937|NCT02073279|324140761|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
94638938|NCT02073279|324140760|FG000|Double-blind Period|Withdrawal by Subject|2|||
94638939|NCT02073279|324140761|FG001|Double-blind Period|Withdrawal by Subject|2|||
94638940|NCT02073279|324140760|FG000|Open-label Extension Period|Adverse Event|1|||
94638941|NCT02073279|324140761|FG001|Open-label Extension Period|Adverse Event|0|||
94638942|NCT02073279|324140760|FG000|Open-label Extension Period|Lack of Efficacy|1|||
94638943|NCT02073279|324140761|FG001|Open-label Extension Period|Lack of Efficacy|0|||
94638944|NCT02073279|324140760|FG000|Open-label Extension Period|Lost to Follow-up|0|||
94638945|NCT02073279|324140761|FG001|Open-label Extension Period|Lost to Follow-up|4|||
94638946|NCT02073279|324140760|FG000|Open-label Extension Period|Switched to another treatment|1|||
94638947|NCT02073279|324140761|FG001|Open-label Extension Period|Switched to another treatment|4|||
94638948|NCT02073279|324140760|FG000|Open-label Extension Period|Protocol Violation|0|||
94638949|NCT02073279|324140761|FG001|Open-label Extension Period|Protocol Violation|1|||
94638950|NCT02073279|324140760|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
94638951|NCT02073279|324140761|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
94638952|NCT02073279|324140760|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
94638953|NCT02073279|324140761|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
94638954|NCT00973479|324140762|FG000|Overall Study|Lost to Follow-up|0|||
94638955|NCT00973479|324140763|FG001|Overall Study|Lost to Follow-up|3|||
94638956|NCT00973479|324140762|FG000|Overall Study|Death|2|||
94638957|NCT00973479|324140763|FG001|Overall Study|Death|2|||
94638958|NCT00973479|324140762|FG000|Overall Study|Withdrawal by Subject|15|||
94638959|NCT00973479|324140763|FG001|Overall Study|Withdrawal by Subject|16|||
94638960|NCT00973479|324140762|FG000|Overall Study|Lack of Efficacy|5|||
94638961|NCT00973479|324140763|FG001|Overall Study|Lack of Efficacy|7|||
94638962|NCT00973479|324140762|FG000|Overall Study|Adverse Event|12|||
94638963|NCT00973479|324140763|FG001|Overall Study|Adverse Event|32|||
94638964|NCT00973479|324140762|FG000|Overall Study|Protocol Violation|2|||
94638965|NCT00973479|324140763|FG001|Overall Study|Protocol Violation|2|||
94638966|NCT00973479|324140762|FG000|Overall Study|Other|1|||
94638967|NCT00973479|324140763|FG001|Overall Study|Other|7|||
94638968|NCT02882854|324140764|FG000|Overall Study|Lost to Follow-up|1|||
94638969|NCT02882854|324140765|FG001|Overall Study|Lost to Follow-up|2|||
94638970|NCT02882854|324140764|FG000|Overall Study|Physician Decision|0|||
94638971|NCT02882854|324140765|FG001|Overall Study|Physician Decision|1|||
94638972|NCT02039674|324140766|FG000|Overall Study|Adverse Event|0|||
94638973|NCT02039674|324140767|FG001|Overall Study|Adverse Event|0|||
94638974|NCT02039674|324140768|FG002|Overall Study|Adverse Event|0|||
94638975|NCT02039674|324140769|FG003|Overall Study|Adverse Event|1|||
94638976|NCT02039674|324140770|FG004|Overall Study|Adverse Event|0|||
94638977|NCT02039674|324140771|FG005|Overall Study|Adverse Event|0|||
94638978|NCT02039674|324140772|FG006|Overall Study|Adverse Event|0|||
94638979|NCT02039674|324140773|FG007|Overall Study|Adverse Event|0|||
94638980|NCT02039674|324140774|FG008|Overall Study|Adverse Event|2|||
94638981|NCT02039674|324140775|FG009|Overall Study|Adverse Event|1|||
94638982|NCT02039674|324140776|FG010|Overall Study|Adverse Event|0|||
94638983|NCT02039674|324140777|FG011|Overall Study|Adverse Event|2|||
94638984|NCT02039674|324140778|FG012|Overall Study|Adverse Event|3|||
94638985|NCT02039674|324140779|FG013|Overall Study|Adverse Event|1|||
94638986|NCT02039674|324140766|FG000|Overall Study|Death|2|||
94638987|NCT02039674|324140767|FG001|Overall Study|Death|0|||
94638988|NCT02039674|324140768|FG002|Overall Study|Death|2|||
94638989|NCT02039674|324140769|FG003|Overall Study|Death|3|||
94638990|NCT02039674|324140770|FG004|Overall Study|Death|0|||
94638991|NCT02039674|324140771|FG005|Overall Study|Death|0|||
94362890|NCT04798027|323112895|FG007|Overall Study|Withdrawal by Subject|2|||
94362891|NCT04798027|323112896|FG008|Overall Study|Withdrawal by Subject|2|||
94638992|NCT02039674|324140772|FG006|Overall Study|Death|1|||
94362892|NCT04798027|323112888|FG000|Overall Study|Lost to Follow-up|1|||
94638993|NCT02039674|324140773|FG007|Overall Study|Death|0|||
94638994|NCT02039674|324140774|FG008|Overall Study|Death|2|||
94638995|NCT02039674|324140775|FG009|Overall Study|Death|0|||
94263015|NCT00352885|322758104|FG001|Overall Study|Progression of metastatic melanoma|3|||
94263016|NCT00352885|322758103|FG000|Overall Study|Side effects of IL-2 administration|1|||
94263017|NCT00352885|322758104|FG001|Overall Study|Side effects of IL-2 administration|0|||
94263018|NCT01729156|322758105|FG000|Overall Study|Withdrawal by Subject|1|||
94263019|NCT01729156|322758106|FG001|Overall Study|Withdrawal by Subject|0|||
94263020|NCT01729156|322758107|FG002|Overall Study|Withdrawal by Subject|0|||
94263021|NCT00146328|322758108|FG000|Overall Study|Adverse Event|39|||
94263022|NCT00146328|322758109|FG001|Overall Study|Adverse Event|48|||
94263023|NCT00146328|322758110|FG002|Overall Study|Adverse Event|79|||
94263024|NCT00146328|322758108|FG000|Overall Study|Protocol Violation|11|||
94263025|NCT00146328|322758109|FG001|Overall Study|Protocol Violation|6|||
94263026|NCT00146328|322758110|FG002|Overall Study|Protocol Violation|12|||
94263027|NCT00146328|322758108|FG000|Overall Study|Lost to Follow-up|7|||
94263028|NCT00146328|322758109|FG001|Overall Study|Lost to Follow-up|4|||
94263029|NCT00146328|322758110|FG002|Overall Study|Lost to Follow-up|7|||
94263030|NCT00146328|322758108|FG000|Overall Study|Withdrawal by Subject|16|||
94263031|NCT00146328|322758109|FG001|Overall Study|Withdrawal by Subject|16|||
94263032|NCT00146328|322758110|FG002|Overall Study|Withdrawal by Subject|22|||
94263033|NCT00146328|322758108|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
94263034|NCT00146328|322758109|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
94263035|NCT00146328|322758110|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
94263036|NCT00146328|322758108|FG000|Overall Study|Trial ended/site closed|8|||
94638996|NCT02039674|324140776|FG010|Overall Study|Death|1|||
94638997|NCT02039674|324140777|FG011|Overall Study|Death|3|||
94638998|NCT02039674|324140778|FG012|Overall Study|Death|2|||
94638999|NCT02039674|324140779|FG013|Overall Study|Death|8|||
94639000|NCT02039674|324140766|FG000|Overall Study|Excluded Medication|1|||
94639001|NCT02039674|324140767|FG001|Overall Study|Excluded Medication|1|||
94639002|NCT02039674|324140768|FG002|Overall Study|Excluded Medication|0|||
94639003|NCT02039674|324140769|FG003|Overall Study|Excluded Medication|1|||
94639004|NCT02039674|324140770|FG004|Overall Study|Excluded Medication|0|||
94639005|NCT02039674|324140771|FG005|Overall Study|Excluded Medication|1|||
94639006|NCT02039674|324140772|FG006|Overall Study|Excluded Medication|0|||
94639007|NCT02039674|324140773|FG007|Overall Study|Excluded Medication|0|||
94639008|NCT02039674|324140774|FG008|Overall Study|Excluded Medication|2|||
94639009|NCT02039674|324140775|FG009|Overall Study|Excluded Medication|3|||
94639010|NCT02039674|324140776|FG010|Overall Study|Excluded Medication|5|||
94639011|NCT02039674|324140777|FG011|Overall Study|Excluded Medication|6|||
94639012|NCT02039674|324140778|FG012|Overall Study|Excluded Medication|8|||
94639013|NCT02039674|324140779|FG013|Overall Study|Excluded Medication|3|||
94639014|NCT02039674|324140766|FG000|Overall Study|Lost to Follow-up|0|||
94639015|NCT02039674|324140767|FG001|Overall Study|Lost to Follow-up|0|||
94639016|NCT02039674|324140768|FG002|Overall Study|Lost to Follow-up|0|||
94639017|NCT02039674|324140769|FG003|Overall Study|Lost to Follow-up|0|||
94639018|NCT02039674|324140770|FG004|Overall Study|Lost to Follow-up|1|||
94639019|NCT02039674|324140771|FG005|Overall Study|Lost to Follow-up|1|||
94639020|NCT02039674|324140772|FG006|Overall Study|Lost to Follow-up|0|||
94639021|NCT02039674|324140773|FG007|Overall Study|Lost to Follow-up|0|||
94639022|NCT02039674|324140774|FG008|Overall Study|Lost to Follow-up|0|||
94639023|NCT02039674|324140775|FG009|Overall Study|Lost to Follow-up|0|||
94639024|NCT02039674|324140776|FG010|Overall Study|Lost to Follow-up|0|||
94639025|NCT02039674|324140777|FG011|Overall Study|Lost to Follow-up|2|||
94639026|NCT02039674|324140778|FG012|Overall Study|Lost to Follow-up|2|||
94639027|NCT02039674|324140779|FG013|Overall Study|Lost to Follow-up|1|||
94639028|NCT02039674|324140766|FG000|Overall Study|Physician Decision|0|||
94639029|NCT02039674|324140767|FG001|Overall Study|Physician Decision|0|||
94639030|NCT02039674|324140768|FG002|Overall Study|Physician Decision|0|||
94639031|NCT02039674|324140769|FG003|Overall Study|Physician Decision|0|||
94639032|NCT02039674|324140770|FG004|Overall Study|Physician Decision|0|||
94639033|NCT02039674|324140771|FG005|Overall Study|Physician Decision|0|||
94639034|NCT02039674|324140772|FG006|Overall Study|Physician Decision|0|||
94263037|NCT00146328|322758109|FG001|Overall Study|Trial ended/site closed|2|||
94362893|NCT04798027|323112889|FG001|Overall Study|Lost to Follow-up|3|||
94639035|NCT02039674|324140773|FG007|Overall Study|Physician Decision|0|||
94639036|NCT02039674|324140774|FG008|Overall Study|Physician Decision|0|||
94639037|NCT02039674|324140775|FG009|Overall Study|Physician Decision|0|||
94639038|NCT02039674|324140776|FG010|Overall Study|Physician Decision|0|||
94263038|NCT00146328|322758110|FG002|Overall Study|Trial ended/site closed|19|||
94263039|NCT00146328|322758108|FG000|Overall Study|Patient decision to end|0|||
94263040|NCT00146328|322758109|FG001|Overall Study|Patient decision to end|1|||
94263041|NCT00146328|322758110|FG002|Overall Study|Patient decision to end|6|||
94263042|NCT00146328|322758108|FG000|Overall Study|Enroll into other trial|2|||
94263043|NCT00146328|322758109|FG001|Overall Study|Enroll into other trial|4|||
94639039|NCT02039674|324140777|FG011|Overall Study|Physician Decision|1|||
94639040|NCT02039674|324140778|FG012|Overall Study|Physician Decision|1|||
94639041|NCT02039674|324140779|FG013|Overall Study|Physician Decision|0|||
94639042|NCT02039674|324140766|FG000|Overall Study|Progressive Disease|8|||
94639043|NCT02039674|324140767|FG001|Overall Study|Progressive Disease|8|||
94639044|NCT02039674|324140768|FG002|Overall Study|Progressive Disease|6|||
94677477|NCT01649232|324274786|FG001|Overall Study|Physician Decision|0|||
94677478|NCT04539821|324274787|FG000|Overall Study|Withdrawal by Subject|2|||
94677479|NCT04539821|324274787|FG000|Overall Study|continued care with their physician|20|||
94677480|NCT04539821|324274787|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
94677481|NCT04810221|324274788|FG000|Overall Study|Physician Decision|3|||
94677482|NCT02691182|324274789|FG000|Overall Study|Withdrawal by Subject|4|||
94677483|NCT02691182|324274790|FG001|Overall Study|Withdrawal by Subject|7|||
94677484|NCT02691182|324274791|FG002|Overall Study|Withdrawal by Subject|6|||
94677485|NCT02691182|324274792|FG003|Overall Study|Withdrawal by Subject|8|||
94677486|NCT02691182|324274789|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
94677487|NCT02691182|324274790|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
94677488|NCT02691182|324274791|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
94677489|NCT02691182|324274792|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
94677490|NCT02691182|324274789|FG000|Overall Study|Lost to Follow-up|8|||
94677491|NCT02691182|324274790|FG001|Overall Study|Lost to Follow-up|33|||
94677492|NCT02691182|324274791|FG002|Overall Study|Lost to Follow-up|19|||
94677493|NCT02691182|324274792|FG003|Overall Study|Lost to Follow-up|22|||
94677494|NCT02691182|324274789|FG000|Overall Study|Adverse Event|3|||
94677495|NCT02691182|324274790|FG001|Overall Study|Adverse Event|10|||
94263044|NCT00146328|322758110|FG002|Overall Study|Enroll into other trial|2|||
94263045|NCT00146328|322758108|FG000|Overall Study|Death|0|||
94263046|NCT00146328|322758109|FG001|Overall Study|Death|1|||
94677496|NCT02691182|324274791|FG002|Overall Study|Adverse Event|10|||
94677497|NCT02691182|324274792|FG003|Overall Study|Adverse Event|11|||
94677498|NCT02691182|324274789|FG000|Overall Study|Physician Decision|3|||
94677499|NCT02691182|324274790|FG001|Overall Study|Physician Decision|7|||
94677500|NCT02691182|324274791|FG002|Overall Study|Physician Decision|14|||
94677501|NCT02691182|324274792|FG003|Overall Study|Physician Decision|8|||
94677502|NCT02691182|324274789|FG000|Overall Study|Lack of Efficacy|0|||
94677503|NCT02691182|324274790|FG001|Overall Study|Lack of Efficacy|0|||
94677504|NCT02691182|324274791|FG002|Overall Study|Lack of Efficacy|0|||
94677505|NCT02691182|324274792|FG003|Overall Study|Lack of Efficacy|4|||
94263047|NCT00146328|322758110|FG002|Overall Study|Death|1|||
94263048|NCT00146328|322758108|FG000|Overall Study|Moved|2|||
94263049|NCT00146328|322758109|FG001|Overall Study|Moved|0|||
94263050|NCT00146328|322758110|FG002|Overall Study|Moved|0|||
94263051|NCT00146328|322758108|FG000|Overall Study|Interaction with other medication|2|||
94263052|NCT00146328|322758109|FG001|Overall Study|Interaction with other medication|0|||
94263053|NCT00146328|322758110|FG002|Overall Study|Interaction with other medication|1|||
94263054|NCT00719563|322758111|FG000|Overall Study|Adverse Event|16|||
94263055|NCT00719563|322758112|FG001|Overall Study|Adverse Event|13|||
94263056|NCT00719563|322758111|FG000|Overall Study|Medical condition changed|3|||
94263057|NCT00719563|322758112|FG001|Overall Study|Medical condition changed|5|||
94263058|NCT00719563|322758111|FG000|Overall Study|Lack of Efficacy|3|||
94263059|NCT00719563|322758112|FG001|Overall Study|Lack of Efficacy|7|||
94263060|NCT00719563|322758111|FG000|Overall Study|Personal reasons|6|||
94263061|NCT00719563|322758112|FG001|Overall Study|Personal reasons|7|||
94263062|NCT00719563|322758111|FG000|Overall Study|Unknown reasons|4|||
94263063|NCT00719563|322758112|FG001|Overall Study|Unknown reasons|6|||
94263064|NCT00719563|322758111|FG000|Overall Study|Noncompliant|1|||
94263065|NCT00719563|322758112|FG001|Overall Study|Noncompliant|1|||
94263066|NCT00719563|322758111|FG000|Overall Study|Lost to Follow-up|5|||
94263067|NCT00719563|322758112|FG001|Overall Study|Lost to Follow-up|3|||
94263068|NCT02072434|322758113|FG000|Overall Study|Protocol Violation|10|||
94263069|NCT02072434|322758114|FG001|Overall Study|Protocol Violation|9|||
94263070|NCT02072434|322758113|FG000|Overall Study|Physician Decision|5|||
94263071|NCT02072434|322758114|FG001|Overall Study|Physician Decision|10|||
94263072|NCT02072434|322758113|FG000|Overall Study|Adverse event, serious fatal|1|||
94263073|NCT02072434|322758114|FG001|Overall Study|Adverse event, serious fatal|6|||
94263074|NCT02072434|322758113|FG000|Overall Study|Adverse Event|7|||
94263075|NCT02072434|322758114|FG001|Overall Study|Adverse Event|6|||
94263076|NCT02072434|322758113|FG000|Overall Study|Withdrawal by Subject|17|||
94263077|NCT02072434|322758114|FG001|Overall Study|Withdrawal by Subject|29|||
94263078|NCT02072434|322758113|FG000|Overall Study|Other|14|||
94263079|NCT02072434|322758114|FG001|Overall Study|Other|29|||
94677506|NCT02691182|324274789|FG000|Overall Study|Protocol Violation|2|||
94677507|NCT02691182|324274790|FG001|Overall Study|Protocol Violation|6|||
94677508|NCT02691182|324274791|FG002|Overall Study|Protocol Violation|6|||
94263080|NCT02072434|322758113|FG000|Overall Study|Lost to Follow-up|0|||
94263081|NCT02072434|322758114|FG001|Overall Study|Lost to Follow-up|1|||
94263082|NCT00993954|322758115|FG000|Overall Study|Protocol Violation|21|||
94263083|NCT00993954|322758116|FG001|Overall Study|Protocol Violation|2|||
94263084|NCT01681628|322758119|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
94263085|NCT01681628|322758120|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
94263086|NCT01681628|322758119|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
94677509|NCT02691182|324274792|FG003|Overall Study|Protocol Violation|8|||
94677510|NCT02691182|324274789|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
94639045|NCT02039674|324140769|FG003|Overall Study|Progressive Disease|7|||
94639046|NCT02039674|324140770|FG004|Overall Study|Progressive Disease|9|||
94639047|NCT02039674|324140771|FG005|Overall Study|Progressive Disease|10|||
94639048|NCT02039674|324140772|FG006|Overall Study|Progressive Disease|1|||
94639049|NCT02039674|324140773|FG007|Overall Study|Progressive Disease|3|||
94639050|NCT02039674|324140774|FG008|Overall Study|Progressive Disease|6|||
94639051|NCT02039674|324140775|FG009|Overall Study|Progressive Disease|4|||
94639052|NCT02039674|324140776|FG010|Overall Study|Progressive Disease|0|||
94639053|NCT02039674|324140777|FG011|Overall Study|Progressive Disease|34|||
94639054|NCT02039674|324140778|FG012|Overall Study|Progressive Disease|34|||
94639055|NCT02039674|324140779|FG013|Overall Study|Progressive Disease|18|||
94639056|NCT02039674|324140766|FG000|Overall Study|Withdrawal by Subject|1|||
94639057|NCT02039674|324140767|FG001|Overall Study|Withdrawal by Subject|2|||
94639058|NCT02039674|324140768|FG002|Overall Study|Withdrawal by Subject|3|||
94639059|NCT02039674|324140769|FG003|Overall Study|Withdrawal by Subject|0|||
94639060|NCT02039674|324140770|FG004|Overall Study|Withdrawal by Subject|1|||
94639061|NCT02039674|324140771|FG005|Overall Study|Withdrawal by Subject|0|||
94639062|NCT02039674|324140772|FG006|Overall Study|Withdrawal by Subject|0|||
94639063|NCT02039674|324140773|FG007|Overall Study|Withdrawal by Subject|0|||
94639064|NCT02039674|324140774|FG008|Overall Study|Withdrawal by Subject|0|||
94639065|NCT02039674|324140775|FG009|Overall Study|Withdrawal by Subject|1|||
94639066|NCT02039674|324140776|FG010|Overall Study|Withdrawal by Subject|1|||
94639067|NCT02039674|324140777|FG011|Overall Study|Withdrawal by Subject|4|||
94639068|NCT02039674|324140778|FG012|Overall Study|Withdrawal by Subject|6|||
94639069|NCT02039674|324140779|FG013|Overall Study|Withdrawal by Subject|2|||
94639070|NCT02039674|324140766|FG000|Overall Study|Clinical Progression|0|||
94639071|NCT02039674|324140767|FG001|Overall Study|Clinical Progression|0|||
94639072|NCT02039674|324140768|FG002|Overall Study|Clinical Progression|0|||
94639073|NCT02039674|324140769|FG003|Overall Study|Clinical Progression|0|||
94639074|NCT02039674|324140770|FG004|Overall Study|Clinical Progression|0|||
94639075|NCT02039674|324140771|FG005|Overall Study|Clinical Progression|0|||
94639076|NCT02039674|324140772|FG006|Overall Study|Clinical Progression|1|||
94639077|NCT02039674|324140773|FG007|Overall Study|Clinical Progression|0|||
94639078|NCT02039674|324140774|FG008|Overall Study|Clinical Progression|0|||
94639079|NCT02039674|324140775|FG009|Overall Study|Clinical Progression|0|||
94639080|NCT02039674|324140776|FG010|Overall Study|Clinical Progression|0|||
94639081|NCT02039674|324140777|FG011|Overall Study|Clinical Progression|0|||
94639082|NCT02039674|324140778|FG012|Overall Study|Clinical Progression|1|||
94639083|NCT02039674|324140779|FG013|Overall Study|Clinical Progression|0|||
94639084|NCT02039674|324140766|FG000|Overall Study|Sponsor Decision|1|||
94639085|NCT02039674|324140767|FG001|Overall Study|Sponsor Decision|1|||
94639086|NCT02039674|324140768|FG002|Overall Study|Sponsor Decision|1|||
94639087|NCT02039674|324140769|FG003|Overall Study|Sponsor Decision|1|||
94639088|NCT02039674|324140770|FG004|Overall Study|Sponsor Decision|1|||
94639089|NCT02039674|324140771|FG005|Overall Study|Sponsor Decision|0|||
94639090|NCT02039674|324140772|FG006|Overall Study|Sponsor Decision|0|||
94639091|NCT02039674|324140773|FG007|Overall Study|Sponsor Decision|0|||
94639092|NCT02039674|324140774|FG008|Overall Study|Sponsor Decision|0|||
94639093|NCT02039674|324140775|FG009|Overall Study|Sponsor Decision|3|||
94639094|NCT02039674|324140776|FG010|Overall Study|Sponsor Decision|0|||
94362894|NCT04798027|323112890|FG002|Overall Study|Lost to Follow-up|0|||
94639095|NCT02039674|324140777|FG011|Overall Study|Sponsor Decision|8|||
94639096|NCT02039674|324140778|FG012|Overall Study|Sponsor Decision|5|||
94639097|NCT02039674|324140779|FG013|Overall Study|Sponsor Decision|0|||
94362895|NCT04798027|323112891|FG003|Overall Study|Lost to Follow-up|0|||
94362896|NCT04798027|323112892|FG004|Overall Study|Lost to Follow-up|0|||
94263087|NCT01681628|322758120|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
94263088|NCT01681628|322758119|FG000|19 Months Follow-up|Death|1|||
94263089|NCT01681628|322758120|FG001|19 Months Follow-up|Death|0|||
94263090|NCT01681628|322758119|FG000|19 Months Follow-up|Lost to Follow-up|61|||
94263091|NCT01681628|322758120|FG001|19 Months Follow-up|Lost to Follow-up|43|||
94263092|NCT03308942|322758124|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
94263093|NCT03308942|322758125|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
94263094|NCT03308942|322758126|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
94263095|NCT03308942|322758127|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
94263096|NCT03308942|322758128|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
94263097|NCT03308942|322758124|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
94263098|NCT03308942|322758125|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
94263099|NCT03308942|322758126|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
94263100|NCT03308942|322758127|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
94263101|NCT03308942|322758128|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
94263102|NCT03308942|322758124|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
94263103|NCT03308942|322758125|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
94263104|NCT03308942|322758126|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
94263105|NCT03308942|322758127|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
94263106|NCT03308942|322758128|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
94263107|NCT03308942|322758124|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
94263108|NCT03308942|322758125|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
94263109|NCT03308942|322758126|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
94263110|NCT03308942|322758127|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
94263111|NCT03308942|322758128|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
94677511|NCT02691182|324274790|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
94677512|NCT02691182|324274791|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
94677513|NCT02691182|324274792|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
94677514|NCT02691182|324274789|FG000|Overall Study|Missing|0|||
94677515|NCT02691182|324274790|FG001|Overall Study|Missing|5|||
94677516|NCT02691182|324274791|FG002|Overall Study|Missing|1|||
94677517|NCT02691182|324274792|FG003|Overall Study|Missing|5|||
94677518|NCT01264380|324274793|FG000|Period C|Disease Progression|0|||
94677519|NCT01264380|324274794|FG001|Period C|Disease Progression|0|||
94677520|NCT01264380|324274795|FG002|Period C|Disease Progression|4|||
94677521|NCT01264380|324274793|FG000|Period C|Death|0|||
94677522|NCT01264380|324274794|FG001|Period C|Death|0|||
94677523|NCT01264380|324274795|FG002|Period C|Death|2|||
94677524|NCT01264380|324274793|FG000|Period C|Follow-up for survival status|0|||
94677525|NCT01264380|324274794|FG001|Period C|Follow-up for survival status|0|||
94677526|NCT01264380|324274795|FG002|Period C|Follow-up for survival status|6|||
94677527|NCT01264380|324274793|FG000|Period C|Withdrawal by Subject|0|||
94677528|NCT01264380|324274794|FG001|Period C|Withdrawal by Subject|0|||
94677529|NCT01264380|324274795|FG002|Period C|Withdrawal by Subject|1|||
94677530|NCT01264380|324274793|FG000|Period C|Adverse Event|0|||
94677531|NCT01264380|324274794|FG001|Period C|Adverse Event|0|||
94677532|NCT01264380|324274795|FG002|Period C|Adverse Event|1|||
94677533|NCT02563002|324274796|FG000|Overall Study|Death|72|||
94677534|NCT02563002|324274797|FG001|Overall Study|Death|87|||
94677535|NCT02563002|324274796|FG000|Overall Study|Lost to Follow-up|5|||
94677536|NCT02563002|324274797|FG001|Overall Study|Lost to Follow-up|0|||
94677537|NCT02563002|324274796|FG000|Overall Study|Physician Decision|0|||
94677538|NCT02563002|324274797|FG001|Overall Study|Physician Decision|2|||
94677539|NCT02563002|324274796|FG000|Overall Study|Withdrawal by Subject|2|||
94677540|NCT02563002|324274797|FG001|Overall Study|Withdrawal by Subject|10|||
94677541|NCT02563002|324274796|FG000|Overall Study|Sponsor decision|74|||
94677542|NCT02563002|324274797|FG001|Overall Study|Sponsor decision|55|||
94677543|NCT03518125|324274798|FG000|Overall Study|Lost to Follow-up|0|||
94677544|NCT03518125|324274799|FG001|Overall Study|Lost to Follow-up|2|||
94677545|NCT03518125|324274800|FG002|Overall Study|Lost to Follow-up|0|||
94677546|NCT03518125|324274801|FG003|Overall Study|Lost to Follow-up|0|||
94263112|NCT03308942|322758124|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
94677547|NCT03518125|324274802|FG004|Overall Study|Lost to Follow-up|3|||
94677548|NCT03518125|324274803|FG005|Overall Study|Lost to Follow-up|5|||
94677549|NCT03518125|324274798|FG000|Overall Study|Physician Decision|0|||
94677550|NCT03518125|324274799|FG001|Overall Study|Physician Decision|1|||
94677551|NCT03518125|324274800|FG002|Overall Study|Physician Decision|0|||
94677552|NCT03518125|324274801|FG003|Overall Study|Physician Decision|0|||
94263113|NCT03308942|322758125|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
94263114|NCT03308942|322758126|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
94263115|NCT03308942|322758127|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
94677553|NCT03518125|324274802|FG004|Overall Study|Physician Decision|0|||
94677554|NCT03518125|324274803|FG005|Overall Study|Physician Decision|0|||
94263116|NCT03308942|322758128|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
94263117|NCT03308942|322758124|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
94263118|NCT03308942|322758125|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
94263119|NCT03308942|322758126|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
94263120|NCT03308942|322758127|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
94263121|NCT03308942|322758128|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
94263122|NCT03308942|322758124|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
94263123|NCT03308942|322758125|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
94263124|NCT03308942|322758126|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
94263125|NCT03308942|322758127|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
94263126|NCT03308942|322758128|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
94263127|NCT02194062|322758129|FG000|Overall Study|Lost to Follow-up|2|||
94263128|NCT02194062|322758130|FG001|Overall Study|Lost to Follow-up|2|||
94263129|NCT02194062|322758131|FG002|Overall Study|Lost to Follow-up|5|||
94362897|NCT04798027|323112893|FG005|Overall Study|Lost to Follow-up|1|||
94362898|NCT04798027|323112894|FG006|Overall Study|Lost to Follow-up|0|||
94362899|NCT04798027|323112895|FG007|Overall Study|Lost to Follow-up|0|||
94362900|NCT04798027|323112896|FG008|Overall Study|Lost to Follow-up|1|||
94362901|NCT04798027|323112888|FG000|Overall Study|Withdrawal by Sponsor|8|||
94362902|NCT04798027|323112889|FG001|Overall Study|Withdrawal by Sponsor|22|||
94362903|NCT04798027|323112890|FG002|Overall Study|Withdrawal by Sponsor|9|||
94362904|NCT04798027|323112891|FG003|Overall Study|Withdrawal by Sponsor|26|||
94362905|NCT04798027|323112892|FG004|Overall Study|Withdrawal by Sponsor|24|||
94362906|NCT04798027|323112893|FG005|Overall Study|Withdrawal by Sponsor|11|||
94677555|NCT03518125|324274798|FG000|Overall Study|Withdrawal by Subject|1|||
94677556|NCT03518125|324274799|FG001|Overall Study|Withdrawal by Subject|1|||
94677557|NCT03518125|324274800|FG002|Overall Study|Withdrawal by Subject|0|||
94677558|NCT03518125|324274801|FG003|Overall Study|Withdrawal by Subject|1|||
94677559|NCT03518125|324274802|FG004|Overall Study|Withdrawal by Subject|1|||
94677560|NCT03518125|324274803|FG005|Overall Study|Withdrawal by Subject|3|||
94362907|NCT04798027|323112894|FG006|Overall Study|Withdrawal by Sponsor|25|||
94677561|NCT03518125|324274798|FG000|Overall Study|Missed Day 394 Visit|1|||
94677562|NCT03518125|324274799|FG001|Overall Study|Missed Day 394 Visit|0|||
94677563|NCT03518125|324274800|FG002|Overall Study|Missed Day 394 Visit|0|||
94677564|NCT03518125|324274801|FG003|Overall Study|Missed Day 394 Visit|0|||
94677565|NCT03518125|324274802|FG004|Overall Study|Missed Day 394 Visit|0|||
94677566|NCT03518125|324274803|FG005|Overall Study|Missed Day 394 Visit|0|||
94677567|NCT00429663|324274804|FG000|Overall Study|Lost to Follow-up|24|||
94677568|NCT00429663|324274805|FG001|Overall Study|Lost to Follow-up|31|||
94677569|NCT00429663|324274804|FG000|Overall Study|Physician Decision|6|||
94677570|NCT00429663|324274805|FG001|Overall Study|Physician Decision|3|||
94677571|NCT00429663|324274804|FG000|Overall Study|Withdrawal by Subject|2|||
94677572|NCT00429663|324274805|FG001|Overall Study|Withdrawal by Subject|5|||
94677573|NCT00429663|324274804|FG000|Overall Study|Death|4|||
94677574|NCT00429663|324274805|FG001|Overall Study|Death|0|||
94677575|NCT02066402|324274806|FG000|Overall Study|Adverse Event|1|||
94677576|NCT02066402|324274807|FG001|Overall Study|Adverse Event|2|||
94677577|NCT02066402|324274806|FG000|Overall Study|Lost to Follow-up|11|||
94362908|NCT04798027|323112895|FG007|Overall Study|Withdrawal by Sponsor|26|||
94362909|NCT04798027|323112896|FG008|Overall Study|Withdrawal by Sponsor|11|||
94362910|NCT00797316|323112897|FG000|Overall Study|Administrative problems|1|||
94362911|NCT00797316|323112898|FG001|Overall Study|Administrative problems|0|||
94677578|NCT02066402|324274807|FG001|Overall Study|Lost to Follow-up|8|||
94677579|NCT02066402|324274806|FG000|Overall Study|Withdrawal by Subject|14|||
94263130|NCT02294682|322758132|FG000|Overall Study|Could not swallow pills|1|||
94263131|NCT02294682|322758133|FG001|Overall Study|Could not swallow pills|0|||
94362912|NCT00797316|323112897|FG000|Overall Study|Adverse Event|5|||
94362913|NCT00797316|323112898|FG001|Overall Study|Adverse Event|3|||
94362914|NCT00797316|323112897|FG000|Overall Study|Lost to Follow-up|4|||
94362915|NCT00797316|323112898|FG001|Overall Study|Lost to Follow-up|8|||
94677580|NCT02066402|324274807|FG001|Overall Study|Withdrawal by Subject|11|||
94677581|NCT02066402|324274806|FG000|Overall Study|Progressive disease-clinical progression|0|||
94677582|NCT02066402|324274807|FG001|Overall Study|Progressive disease-clinical progression|1|||
94677583|NCT02066402|324274806|FG000|Overall Study|Protocol driven decision point|0|||
94677584|NCT02066402|324274807|FG001|Overall Study|Protocol driven decision point|1|||
94677585|NCT01559454|324274811|FG000|Overall Study|Lost to Follow-up|3|||
94677586|NCT01559454|324274812|FG001|Overall Study|Lost to Follow-up|2|||
94677587|NCT01559454|324274811|FG000|Overall Study|Withdrawal by Subject|0|||
94263132|NCT00763971|322758134|FG000|Overall Study|Adverse Event|5|||
94263133|NCT00763971|322758135|FG001|Overall Study|Adverse Event|2|||
94263134|NCT00763971|322758136|FG002|Overall Study|Adverse Event|4|||
94263135|NCT00763971|322758134|FG000|Overall Study|Protocol Violation|3|||
94362916|NCT00797316|323112897|FG000|Overall Study|Protocol Deviation|1|||
94362917|NCT00797316|323112898|FG001|Overall Study|Protocol Deviation|2|||
94362918|NCT00797316|323112897|FG000|Overall Study|Patient withdrew consent|12|||
94362919|NCT00797316|323112898|FG001|Overall Study|Patient withdrew consent|6|||
94263136|NCT00763971|322758135|FG001|Overall Study|Protocol Violation|3|||
94677588|NCT01559454|324274812|FG001|Overall Study|Withdrawal by Subject|1|||
94677589|NCT01559454|324274811|FG000|Overall Study|Physician Decision|0|||
94677590|NCT01559454|324274812|FG001|Overall Study|Physician Decision|1|||
94677591|NCT01559454|324274811|FG000|Overall Study|Protocol Violation|0|||
94677592|NCT01559454|324274812|FG001|Overall Study|Protocol Violation|1|||
94677593|NCT01559454|324274811|FG000|Overall Study|Lack of Efficacy|0|||
94677594|NCT01559454|324274812|FG001|Overall Study|Lack of Efficacy|1|||
94677595|NCT01114204|324274815|FG000|Overall Study|Adverse Event|3|||
94677596|NCT01114204|324274816|FG001|Overall Study|Adverse Event|2|||
94677597|NCT01114204|324274815|FG000|Overall Study|Lost to Follow-up|1|||
94677598|NCT01114204|324274816|FG001|Overall Study|Lost to Follow-up|0|||
94677599|NCT01114204|324274815|FG000|Overall Study|Withdrawal by Subject|10|||
94677600|NCT01114204|324274816|FG001|Overall Study|Withdrawal by Subject|6|||
94677601|NCT01114204|324274815|FG000|Overall Study|Death|1|||
94677602|NCT01114204|324274816|FG001|Overall Study|Death|0|||
94677603|NCT01114204|324274815|FG000|Overall Study|Other-Personal reasons|2|||
94677604|NCT01114204|324274816|FG001|Overall Study|Other-Personal reasons|0|||
94677605|NCT01114204|324274815|FG000|Overall Study|Other-Medical monitor request|1|||
94677606|NCT01114204|324274816|FG001|Overall Study|Other-Medical monitor request|0|||
94677607|NCT01114204|324274815|FG000|Overall Study|Other-Participant request|2|||
94677608|NCT01114204|324274816|FG001|Overall Study|Other-Participant request|0|||
94677609|NCT01114204|324274815|FG000|Overall Study|Other-Protocol Violation|1|||
94677610|NCT01114204|324274816|FG001|Overall Study|Other-Protocol Violation|0|||
94677611|NCT02799784|324274817|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
94677612|NCT02799784|324274818|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
94677613|NCT02799784|324274817|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
94677614|NCT02799784|324274818|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
94677615|NCT02799784|324274817|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
94677616|NCT02799784|324274818|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
94677617|NCT02799784|324274817|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
94677618|NCT02799784|324274818|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
94677619|NCT02799784|324274817|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
94677620|NCT02799784|324274818|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
94677621|NCT02799784|324274817|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
94677622|NCT02799784|324274818|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
94677623|NCT02296190|324274823|FG000|Overall Study|Lost to Follow-up|0|||
94677624|NCT02296190|324274824|FG001|Overall Study|Lost to Follow-up|0|||
94677625|NCT02296190|324274825|FG002|Overall Study|Lost to Follow-up|0|||
94677626|NCT02296190|324274826|FG003|Overall Study|Lost to Follow-up|0|||
94677627|NCT02296190|324274827|FG004|Overall Study|Lost to Follow-up|1|||
94677628|NCT02296190|324274828|FG005|Overall Study|Lost to Follow-up|0|||
94677629|NCT02296190|324274823|FG000|Overall Study|Failure to induce PSVT|6|||
94677630|NCT02296190|324274824|FG001|Overall Study|Failure to induce PSVT|10|||
94677631|NCT02296190|324274825|FG002|Overall Study|Failure to induce PSVT|5|||
94677632|NCT02296190|324274826|FG003|Overall Study|Failure to induce PSVT|13|||
94677633|NCT02296190|324274827|FG004|Overall Study|Failure to induce PSVT|8|||
94677634|NCT02296190|324274828|FG005|Overall Study|Failure to induce PSVT|0|||
94677635|NCT02296190|324274823|FG000|Overall Study|Physician Decision|1|||
94677636|NCT02296190|324274824|FG001|Overall Study|Physician Decision|1|||
94677637|NCT02296190|324274825|FG002|Overall Study|Physician Decision|0|||
94263137|NCT00763971|322758136|FG002|Overall Study|Protocol Violation|2|||
94263138|NCT00763971|322758134|FG000|Overall Study|Withdrawal by Subject|4|||
94677638|NCT02296190|324274826|FG003|Overall Study|Physician Decision|1|||
94677639|NCT02296190|324274827|FG004|Overall Study|Physician Decision|2|||
94677640|NCT02296190|324274828|FG005|Overall Study|Physician Decision|0|||
94677641|NCT02296190|324274823|FG000|Overall Study|Withdrawal by Subject|0|||
94677642|NCT02296190|324274824|FG001|Overall Study|Withdrawal by Subject|1|||
94677643|NCT02296190|324274825|FG002|Overall Study|Withdrawal by Subject|0|||
94677644|NCT02296190|324274826|FG003|Overall Study|Withdrawal by Subject|0|||
94677645|NCT02296190|324274827|FG004|Overall Study|Withdrawal by Subject|0|||
94677646|NCT02296190|324274828|FG005|Overall Study|Withdrawal by Subject|0|||
94677647|NCT02296190|324274823|FG000|Overall Study|PSVT < 5 minutes|5|||
94263139|NCT00763971|322758135|FG001|Overall Study|Withdrawal by Subject|5|||
94263140|NCT00763971|322758136|FG002|Overall Study|Withdrawal by Subject|5|||
94263141|NCT00763971|322758134|FG000|Overall Study|Lost to Follow-up|0|||
94263142|NCT00763971|322758135|FG001|Overall Study|Lost to Follow-up|1|||
94263143|NCT00763971|322758136|FG002|Overall Study|Lost to Follow-up|0|||
94263144|NCT00763971|322758134|FG000|Overall Study|Lack of Efficacy|11|||
94263145|NCT00763971|322758135|FG001|Overall Study|Lack of Efficacy|22|||
94263146|NCT00763971|322758136|FG002|Overall Study|Lack of Efficacy|54|||
94677648|NCT02296190|324274824|FG001|Overall Study|PSVT < 5 minutes|6|||
94677649|NCT02296190|324274825|FG002|Overall Study|PSVT < 5 minutes|6|||
94677650|NCT02296190|324274826|FG003|Overall Study|PSVT < 5 minutes|6|||
94677651|NCT02296190|324274827|FG004|Overall Study|PSVT < 5 minutes|5|||
94677652|NCT02296190|324274828|FG005|Overall Study|PSVT < 5 minutes|0|||
94677653|NCT02296190|324274823|FG000|Overall Study|Patient was given Propofol|0|||
94677654|NCT02296190|324274824|FG001|Overall Study|Patient was given Propofol|1|||
94677655|NCT02296190|324274825|FG002|Overall Study|Patient was given Propofol|0|||
94677656|NCT02296190|324274826|FG003|Overall Study|Patient was given Propofol|1|||
94677657|NCT02296190|324274827|FG004|Overall Study|Patient was given Propofol|0|||
94677658|NCT02296190|324274828|FG005|Overall Study|Patient was given Propofol|0|||
94677659|NCT02296190|324274823|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
94677660|NCT02296190|324274824|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
94677661|NCT02296190|324274825|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
94677662|NCT02296190|324274826|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
94677663|NCT02296190|324274827|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
94677664|NCT02296190|324274828|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
94677665|NCT02296190|324274823|FG000|Overall Study|Blood pressure <100 after sedation|0|||
94677666|NCT02296190|324274824|FG001|Overall Study|Blood pressure <100 after sedation|0|||
94677667|NCT02296190|324274825|FG002|Overall Study|Blood pressure <100 after sedation|0|||
94677668|NCT02296190|324274826|FG003|Overall Study|Blood pressure <100 after sedation|1|||
94677669|NCT02296190|324274827|FG004|Overall Study|Blood pressure <100 after sedation|0|||
94677670|NCT02296190|324274828|FG005|Overall Study|Blood pressure <100 after sedation|0|||
94677671|NCT02296190|324274823|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
94677672|NCT02296190|324274824|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
94677673|NCT02296190|324274825|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
94677674|NCT02296190|324274826|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
94677675|NCT02296190|324274827|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
94677676|NCT02296190|324274828|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
94677677|NCT02296190|324274823|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
94677678|NCT02296190|324274824|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
94677679|NCT02296190|324274825|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
94677680|NCT02296190|324274826|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
94677681|NCT02296190|324274827|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
94677682|NCT02296190|324274828|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
94677683|NCT02296190|324274823|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
94677684|NCT02296190|324274824|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
94677685|NCT02296190|324274825|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
94677686|NCT02296190|324274826|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
94677687|NCT02296190|324274827|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
94677688|NCT02296190|324274828|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
94677689|NCT02296190|324274823|FG000|Overall Study|Lab result not available in time|1|||
94677690|NCT02296190|324274824|FG001|Overall Study|Lab result not available in time|0|||
94677691|NCT02296190|324274825|FG002|Overall Study|Lab result not available in time|0|||
94677692|NCT02296190|324274826|FG003|Overall Study|Lab result not available in time|0|||
94677693|NCT02296190|324274827|FG004|Overall Study|Lab result not available in time|0|||
94677694|NCT02296190|324274828|FG005|Overall Study|Lab result not available in time|0|||
94677695|NCT02658630|324274829|FG000|Overall Study|Withdrawal by Subject|4|||
94677696|NCT00263328|324274831|FG000|Overall Study|Death|0|||
94677697|NCT00263328|324274832|FG001|Overall Study|Death|0|||
94677698|NCT00263328|324274833|FG002|Overall Study|Death|1|||
94677699|NCT00263328|324274831|FG000|Overall Study|Lost to Follow-up|1|||
94677700|NCT00263328|324274832|FG001|Overall Study|Lost to Follow-up|1|||
94677701|NCT00263328|324274833|FG002|Overall Study|Lost to Follow-up|0|||
94677702|NCT00263328|324274831|FG000|Overall Study|Withdrawal by Subject|3|||
94677703|NCT00263328|324274832|FG001|Overall Study|Withdrawal by Subject|0|||
94677704|NCT00263328|324274833|FG002|Overall Study|Withdrawal by Subject|1|||
94677705|NCT00263328|324274831|FG000|Overall Study|Other|3|||
94677706|NCT00263328|324274832|FG001|Overall Study|Other|0|||
94677707|NCT00263328|324274833|FG002|Overall Study|Other|1|||
94677708|NCT00263328|324274831|FG000|Overall Study|Adverse Event|1|||
94677709|NCT00263328|324274832|FG001|Overall Study|Adverse Event|1|||
94639098|NCT02039674|324140766|FG000|Overall Study|Other|0|||
94639099|NCT02039674|324140767|FG001|Overall Study|Other|0|||
94639100|NCT02039674|324140768|FG002|Overall Study|Other|0|||
94639101|NCT02039674|324140769|FG003|Overall Study|Other|0|||
94639102|NCT02039674|324140770|FG004|Overall Study|Other|0|||
94639103|NCT02039674|324140771|FG005|Overall Study|Other|0|||
94639104|NCT02039674|324140772|FG006|Overall Study|Other|0|||
94639105|NCT02039674|324140773|FG007|Overall Study|Other|0|||
94639106|NCT02039674|324140774|FG008|Overall Study|Other|0|||
94639107|NCT02039674|324140775|FG009|Overall Study|Other|0|||
94639108|NCT02039674|324140776|FG010|Overall Study|Other|0|||
94639109|NCT02039674|324140777|FG011|Overall Study|Other|0|||
94639110|NCT02039674|324140778|FG012|Overall Study|Other|1|||
94639111|NCT02039674|324140779|FG013|Overall Study|Other|0|||
94639112|NCT00744627|324140785|FG000|Overall Study|Adverse Event|6|||
94639113|NCT00744627|324140786|FG001|Overall Study|Adverse Event|9|||
94639114|NCT00744627|324140785|FG000|Overall Study|Lack of Efficacy|7|||
94639115|NCT00744627|324140786|FG001|Overall Study|Lack of Efficacy|3|||
94639116|NCT00744627|324140785|FG000|Overall Study|Noncompliance|0|||
94639117|NCT00744627|324140786|FG001|Overall Study|Noncompliance|1|||
94639118|NCT00744627|324140785|FG000|Overall Study|Protocol Deviations|0|||
94639119|NCT00744627|324140786|FG001|Overall Study|Protocol Deviations|2|||
94639120|NCT00744627|324140785|FG000|Overall Study|Voluntary Withdrawal|9|||
94639121|NCT00744627|324140786|FG001|Overall Study|Voluntary Withdrawal|6|||
94639122|NCT00744627|324140785|FG000|Overall Study|Lost to Follow-up|2|||
94639123|NCT00744627|324140786|FG001|Overall Study|Lost to Follow-up|1|||
94639124|NCT00744627|324140785|FG000|Overall Study|Other|1|||
94639125|NCT00744627|324140786|FG001|Overall Study|Other|0|||
94639126|NCT00768144|324140787|FG000|Overall Study|Adverse Event|13|||
94639127|NCT00768144|324140787|FG000|Overall Study|Progressive Disease|21|||
94639128|NCT00768144|324140787|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
94639129|NCT00768144|324140787|FG000|Overall Study|Pt Withdrew Consent|1|||
94639130|NCT01466387|324140789|FG000|Overall Study|Adverse Event|0|||
94639131|NCT01466387|324140790|FG001|Overall Study|Adverse Event|0|||
94639132|NCT01466387|324140791|FG002|Overall Study|Adverse Event|1|||
94639133|NCT01466387|324140792|FG003|Overall Study|Adverse Event|1|||
94639134|NCT01466387|324140793|FG004|Overall Study|Adverse Event|0|||
94639135|NCT01466387|324140794|FG005|Overall Study|Adverse Event|0|||
94639136|NCT01466387|324140789|FG000|Overall Study|Lost to Follow-up|0|||
94639137|NCT01466387|324140790|FG001|Overall Study|Lost to Follow-up|0|||
94639138|NCT01466387|324140791|FG002|Overall Study|Lost to Follow-up|0|||
94639139|NCT01466387|324140792|FG003|Overall Study|Lost to Follow-up|0|||
94639140|NCT01466387|324140793|FG004|Overall Study|Lost to Follow-up|0|||
94639141|NCT01466387|324140794|FG005|Overall Study|Lost to Follow-up|1|||
94639142|NCT01466387|324140789|FG000|Overall Study|Protocol Violation|1|||
94639143|NCT01466387|324140790|FG001|Overall Study|Protocol Violation|0|||
94639144|NCT01466387|324140791|FG002|Overall Study|Protocol Violation|0|||
94639145|NCT01466387|324140792|FG003|Overall Study|Protocol Violation|1|||
94639146|NCT01466387|324140793|FG004|Overall Study|Protocol Violation|0|||
94639147|NCT01466387|324140794|FG005|Overall Study|Protocol Violation|0|||
94639148|NCT00271947|324140798|FG000|Overall Study|Lost to Follow-up|1|||
94639149|NCT04248933|324140799|FG000|Overall Study|Lost to Follow-up|9|||
94639150|NCT04248933|324140799|FG000|Overall Study|Withdrawal by Subject|2|||
94639151|NCT00718328|324140800|FG000|Overall Study|Lost to Follow-up|1|||
94639152|NCT00718328|324140801|FG001|Overall Study|Lost to Follow-up|0|||
94639153|NCT00567892|324140802|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
94639154|NCT00567892|324140803|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
94639155|NCT00567892|324140804|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
94639156|NCT00567892|324140805|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
94639157|NCT00567892|324140802|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
94639158|NCT00567892|324140803|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
94639159|NCT00567892|324140804|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
94263147|NCT00763971|322758134|FG000|Overall Study|Unable to swallow capsule|2|||
94639160|NCT00567892|324140805|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
94639161|NCT00939809|324142709|FG000|Overall Study|Adverse Event|2|||
94639162|NCT00939809|324142709|FG000|Overall Study|Death|1|||
94639163|NCT01286272|324142710|FG000|Overall Study|Ineligible after beginning treatment|1|||
94639164|NCT01286272|324142711|FG001|Overall Study|Ineligible after beginning treatment|3|||
94639165|NCT01852942|324142712|FG000|Overall Study|Physician Decision|1|||
94639166|NCT01852942|324142713|FG001|Overall Study|Physician Decision|0|||
94639167|NCT01852942|324142712|FG000|Overall Study|Death|1|||
94639168|NCT01852942|324142713|FG001|Overall Study|Death|1|||
94639169|NCT01852942|324142712|FG000|Overall Study|Withdrawal by Subject|2|||
94639170|NCT01852942|324142713|FG001|Overall Study|Withdrawal by Subject|3|||
94639171|NCT01852942|324142712|FG000|Overall Study|Lost to Follow-up|1|||
94639172|NCT01852942|324142713|FG001|Overall Study|Lost to Follow-up|2|||
94639173|NCT02356783|324142714|FG000|Overall Study|Lost to Follow-up|1|||
94639174|NCT02356783|324142715|FG001|Overall Study|Lost to Follow-up|3|||
94639175|NCT02603809|324142716|FG000|Overall Study|Withdrawal by Subject|4|||
94639176|NCT02603809|324142717|FG001|Overall Study|Withdrawal by Subject|1|||
94639177|NCT02603809|324142718|FG002|Overall Study|Withdrawal by Subject|2|||
94639178|NCT02603809|324142719|FG003|Overall Study|Withdrawal by Subject|3|||
94639179|NCT02603809|324142720|FG004|Overall Study|Withdrawal by Subject|3|||
94639180|NCT02603809|324142721|FG005|Overall Study|Withdrawal by Subject|4|||
94639181|NCT02603809|324142716|FG000|Overall Study|Lost to Follow-up|2|||
94639182|NCT02603809|324142717|FG001|Overall Study|Lost to Follow-up|3|||
94639183|NCT02603809|324142718|FG002|Overall Study|Lost to Follow-up|1|||
94639184|NCT02603809|324142719|FG003|Overall Study|Lost to Follow-up|4|||
94639185|NCT02603809|324142720|FG004|Overall Study|Lost to Follow-up|2|||
94639186|NCT02603809|324142721|FG005|Overall Study|Lost to Follow-up|2|||
94639187|NCT02603809|324142716|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
94639188|NCT02603809|324142717|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
94639189|NCT02603809|324142718|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
94639190|NCT02603809|324142719|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
94639191|NCT02603809|324142720|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
94639192|NCT02603809|324142721|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
94639193|NCT02603809|324142716|FG000|Overall Study|Physician Decision|0|||
94639194|NCT02603809|324142717|FG001|Overall Study|Physician Decision|0|||
94639195|NCT02603809|324142718|FG002|Overall Study|Physician Decision|0|||
94639196|NCT02603809|324142719|FG003|Overall Study|Physician Decision|1|||
94639197|NCT02603809|324142720|FG004|Overall Study|Physician Decision|2|||
94639198|NCT02603809|324142721|FG005|Overall Study|Physician Decision|1|||
94639199|NCT02603809|324142716|FG000|Overall Study|Adverse Event|3|||
94639200|NCT02603809|324142717|FG001|Overall Study|Adverse Event|0|||
94639201|NCT02603809|324142718|FG002|Overall Study|Adverse Event|2|||
94639202|NCT02603809|324142719|FG003|Overall Study|Adverse Event|2|||
94639203|NCT02603809|324142720|FG004|Overall Study|Adverse Event|1|||
94639204|NCT02603809|324142721|FG005|Overall Study|Adverse Event|1|||
94639205|NCT02603809|324142716|FG000|Overall Study|Lack of Efficacy|0|||
94639206|NCT02603809|324142717|FG001|Overall Study|Lack of Efficacy|1|||
94639207|NCT02603809|324142718|FG002|Overall Study|Lack of Efficacy|0|||
94639208|NCT02603809|324142719|FG003|Overall Study|Lack of Efficacy|0|||
94639209|NCT02603809|324142720|FG004|Overall Study|Lack of Efficacy|0|||
94639210|NCT02603809|324142721|FG005|Overall Study|Lack of Efficacy|1|||
94639211|NCT04729127|324142722|FG000|Overall Study|Suspended/Terminated EI Services|4|||
94639212|NCT04729127|324142723|FG001|Overall Study|Suspended/Terminated EI Services|0|||
94639213|NCT04729127|324142724|FG002|Overall Study|Suspended/Terminated EI Services|4|||
94639214|NCT04729127|324142725|FG003|Overall Study|Suspended/Terminated EI Services|6|||
94639215|NCT04729127|324142726|FG004|Overall Study|Suspended/Terminated EI Services|0|||
94639216|NCT04729127|324142727|FG005|Overall Study|Suspended/Terminated EI Services|6|||
94639217|NCT04729127|324142728|FG006|Overall Study|Suspended/Terminated EI Services|2|||
94639218|NCT04729127|324142729|FG007|Overall Study|Suspended/Terminated EI Services|0|||
94639219|NCT04729127|324142730|FG008|Overall Study|Suspended/Terminated EI Services|2|||
94639220|NCT04729127|324142722|FG000|Overall Study|Withdrawal by Subject|1|||
94639221|NCT04729127|324142723|FG001|Overall Study|Withdrawal by Subject|0|||
94639222|NCT04729127|324142724|FG002|Overall Study|Withdrawal by Subject|1|||
94639223|NCT04729127|324142725|FG003|Overall Study|Withdrawal by Subject|0|||
94639224|NCT04729127|324142726|FG004|Overall Study|Withdrawal by Subject|0|||
94639225|NCT04729127|324142727|FG005|Overall Study|Withdrawal by Subject|0|||
94639226|NCT04729127|324142728|FG006|Overall Study|Withdrawal by Subject|0|||
94677710|NCT00263328|324274833|FG002|Overall Study|Adverse Event|4|||
94677711|NCT00622180|324274834|FG000|Overall Study|Lost to Follow-up|1|||
94677712|NCT00622180|324274835|FG001|Overall Study|Lost to Follow-up|2|||
94639227|NCT04729127|324142729|FG007|Overall Study|Withdrawal by Subject|0|||
94639228|NCT04729127|324142730|FG008|Overall Study|Withdrawal by Subject|0|||
94639229|NCT04729127|324142722|FG000|Overall Study|Switched Agency/Setting|1|||
94677713|NCT01120249|324274838|FG000|Overall Study|No protocol treatment received|21|||
94677714|NCT01120249|324274839|FG001|Overall Study|No protocol treatment received|15|||
94677715|NCT01120249|324274838|FG000|Overall Study|Disease recurrence|107|||
94677716|NCT01120249|324274839|FG001|Overall Study|Disease recurrence|57|||
94677717|NCT01120249|324274838|FG000|Overall Study|Death|1|||
94677718|NCT01120249|324274839|FG001|Overall Study|Death|0|||
94677719|NCT01120249|324274838|FG000|Overall Study|Adverse Event|40|||
94677720|NCT01120249|324274839|FG001|Overall Study|Adverse Event|276|||
94677721|NCT01120249|324274838|FG000|Overall Study|Participant refusal|34|||
94677722|NCT01120249|324274839|FG001|Overall Study|Participant refusal|42|||
94677723|NCT01120249|324274838|FG000|Overall Study|Other reasons, not protocol specified|29|||
94677724|NCT01120249|324274839|FG001|Overall Study|Other reasons, not protocol specified|22|||
94677725|NCT04512066|324274841|FG000|Double-blind Treatment Period|Adverse Event|6|||
94677726|NCT04512066|324274842|FG001|Double-blind Treatment Period|Adverse Event|4|||
94677727|NCT04512066|324274843|FG002|Double-blind Treatment Period|Adverse Event|5|||
94677728|NCT04512066|324274844|FG003|Double-blind Treatment Period|Adverse Event|1|||
94677729|NCT04512066|324274845|FG004|Double-blind Treatment Period|Adverse Event|0|||
94677730|NCT04512066|324274846|FG005|Double-blind Treatment Period|Adverse Event|0|||
94677731|NCT04512066|324274841|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
94677732|NCT04512066|324274842|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
94677733|NCT04512066|324274843|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
94677734|NCT04512066|324274844|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
94677735|NCT04512066|324274845|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
94677736|NCT04512066|324274846|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
94677737|NCT04512066|324274841|FG000|Double-blind Treatment Period|Physician Decision|1|||
94677738|NCT04512066|324274842|FG001|Double-blind Treatment Period|Physician Decision|0|||
94677739|NCT04512066|324274843|FG002|Double-blind Treatment Period|Physician Decision|1|||
94677740|NCT04512066|324274844|FG003|Double-blind Treatment Period|Physician Decision|0|||
94677741|NCT04512066|324274845|FG004|Double-blind Treatment Period|Physician Decision|0|||
94677742|NCT04512066|324274846|FG005|Double-blind Treatment Period|Physician Decision|0|||
94677743|NCT04512066|324274841|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
94677744|NCT04512066|324274842|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
94677745|NCT04512066|324274843|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
94677746|NCT04512066|324274844|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
94677747|NCT04512066|324274845|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
94677748|NCT04512066|324274846|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
94677749|NCT04512066|324274841|FG000|Extension Period|Adverse Event|0|||
94677750|NCT04512066|324274842|FG001|Extension Period|Adverse Event|1|||
94677751|NCT04512066|324274843|FG002|Extension Period|Adverse Event|4|||
94677752|NCT04512066|324274844|FG003|Extension Period|Adverse Event|3|||
94677753|NCT04512066|324274845|FG004|Extension Period|Adverse Event|1|||
94677754|NCT04512066|324274846|FG005|Extension Period|Adverse Event|3|||
94677755|NCT04512066|324274841|FG000|Extension Period|Death|0|||
94677756|NCT04512066|324274842|FG001|Extension Period|Death|0|||
94677757|NCT04512066|324274843|FG002|Extension Period|Death|0|||
94677758|NCT04512066|324274844|FG003|Extension Period|Death|0|||
94677759|NCT04512066|324274845|FG004|Extension Period|Death|0|||
94677760|NCT04512066|324274846|FG005|Extension Period|Death|1|||
94677761|NCT04512066|324274841|FG000|Extension Period|Lack of Efficacy|0|||
94677762|NCT04512066|324274842|FG001|Extension Period|Lack of Efficacy|4|||
94677763|NCT04512066|324274843|FG002|Extension Period|Lack of Efficacy|4|||
94639230|NCT04729127|324142723|FG001|Overall Study|Switched Agency/Setting|0|||
94639231|NCT04729127|324142724|FG002|Overall Study|Switched Agency/Setting|1|||
94639232|NCT04729127|324142725|FG003|Overall Study|Switched Agency/Setting|1|||
94639233|NCT04729127|324142726|FG004|Overall Study|Switched Agency/Setting|0|||
94639234|NCT04729127|324142727|FG005|Overall Study|Switched Agency/Setting|1|||
94639235|NCT04729127|324142728|FG006|Overall Study|Switched Agency/Setting|1|||
94639236|NCT04729127|324142729|FG007|Overall Study|Switched Agency/Setting|0|||
94639237|NCT04729127|324142730|FG008|Overall Study|Switched Agency/Setting|1|||
94639238|NCT00887354|324142731|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
94639239|NCT00887354|324142732|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
94639240|NCT00887354|324142731|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
94639241|NCT00887354|324142732|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
94639242|NCT00887354|324142731|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
94639243|NCT00887354|324142732|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
94677764|NCT04512066|324274844|FG003|Extension Period|Lack of Efficacy|1|||
94677765|NCT04512066|324274845|FG004|Extension Period|Lack of Efficacy|3|||
94677766|NCT04512066|324274846|FG005|Extension Period|Lack of Efficacy|3|||
94677767|NCT04512066|324274841|FG000|Extension Period|Lost to Follow-up|0|||
94677768|NCT04512066|324274842|FG001|Extension Period|Lost to Follow-up|1|||
94677769|NCT04512066|324274843|FG002|Extension Period|Lost to Follow-up|5|||
94677770|NCT04512066|324274844|FG003|Extension Period|Lost to Follow-up|2|||
94677771|NCT04512066|324274845|FG004|Extension Period|Lost to Follow-up|3|||
94677772|NCT04512066|324274846|FG005|Extension Period|Lost to Follow-up|2|||
94677773|NCT04512066|324274841|FG000|Extension Period|Non-compliance with study drug|0|||
94677774|NCT04512066|324274842|FG001|Extension Period|Non-compliance with study drug|1|||
94677775|NCT04512066|324274843|FG002|Extension Period|Non-compliance with study drug|0|||
94677776|NCT04512066|324274844|FG003|Extension Period|Non-compliance with study drug|0|||
94677777|NCT04512066|324274845|FG004|Extension Period|Non-compliance with study drug|0|||
94677778|NCT04512066|324274846|FG005|Extension Period|Non-compliance with study drug|1|||
94677779|NCT04512066|324274841|FG000|Extension Period|Other|0|||
94677780|NCT04512066|324274842|FG001|Extension Period|Other|2|||
94677781|NCT04512066|324274843|FG002|Extension Period|Other|0|||
94677782|NCT04512066|324274844|FG003|Extension Period|Other|0|||
94677783|NCT04512066|324274845|FG004|Extension Period|Other|0|||
94677784|NCT04512066|324274846|FG005|Extension Period|Other|0|||
94677785|NCT04512066|324274841|FG000|Extension Period|Physician Decision|0|||
94677786|NCT04512066|324274842|FG001|Extension Period|Physician Decision|2|||
94677787|NCT04512066|324274843|FG002|Extension Period|Physician Decision|0|||
94677788|NCT04512066|324274844|FG003|Extension Period|Physician Decision|1|||
94677789|NCT04512066|324274845|FG004|Extension Period|Physician Decision|1|||
94677790|NCT04512066|324274846|FG005|Extension Period|Physician Decision|0|||
94677791|NCT04512066|324274841|FG000|Extension Period|Withdrawal by Subject|0|||
94677792|NCT04512066|324274842|FG001|Extension Period|Withdrawal by Subject|3|||
94677793|NCT04512066|324274843|FG002|Extension Period|Withdrawal by Subject|7|||
94677794|NCT04512066|324274844|FG003|Extension Period|Withdrawal by Subject|11|||
94677795|NCT04512066|324274845|FG004|Extension Period|Withdrawal by Subject|8|||
94677796|NCT04512066|324274846|FG005|Extension Period|Withdrawal by Subject|4|||
94677797|NCT00316173|324274849|FG000|Run-in Phase|Adverse Event|1|||
94677798|NCT00316173|324274850|FG001|Run-in Phase|Adverse Event|0|||
94677799|NCT00316173|324274849|FG000|Run-in Phase|Protocol Violation|1|||
94677800|NCT00316173|324274850|FG001|Run-in Phase|Protocol Violation|0|||
94677801|NCT00316173|324274849|FG000|Run-in Phase|Study Follow-up Stopped|5|||
94677802|NCT00316173|324274850|FG001|Run-in Phase|Study Follow-up Stopped|0|||
94263148|NCT00763971|322758135|FG001|Overall Study|Unable to swallow capsule|1|||
94677803|NCT00316173|324274849|FG000|Treatment Phase|Adverse Event|0|||
94677804|NCT00316173|324274850|FG001|Treatment Phase|Adverse Event|1|||
94677805|NCT00316173|324274849|FG000|Treatment Phase|Lack of Efficacy|0|||
94677806|NCT00316173|324274850|FG001|Treatment Phase|Lack of Efficacy|3|||
94677807|NCT00316173|324274849|FG000|Treatment Phase|Lost to Follow-up|0|||
94677808|NCT00316173|324274850|FG001|Treatment Phase|Lost to Follow-up|3|||
94677809|NCT00316173|324274849|FG000|Treatment Phase|Withdrawal by Subject|0|||
94677810|NCT00316173|324274850|FG001|Treatment Phase|Withdrawal by Subject|1|||
94639244|NCT00887354|324142731|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
94639245|NCT00887354|324142732|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
94639246|NCT00887354|324142731|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
94639247|NCT00887354|324142732|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
94639248|NCT00887354|324142731|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
94639249|NCT00887354|324142732|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
94639250|NCT00887354|324142731|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
94639251|NCT00887354|324142732|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
94461865|NCT00743288|323481239|FG001|Overall Study|Worsening of condition (Not PD)|2|||
94461866|NCT00743288|323481240|FG002|Overall Study|Worsening of condition (Not PD)|1|||
94461867|NCT00743288|323481241|FG003|Overall Study|Worsening of condition (Not PD)|1|||
94461868|NCT00743288|323481242|FG004|Overall Study|Worsening of condition (Not PD)|0|||
94639252|NCT00887354|324142731|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
94639253|NCT00887354|324142732|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
94639254|NCT00887354|324142731|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
94639255|NCT00887354|324142732|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
94639256|NCT00887354|324142731|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
94639257|NCT00887354|324142732|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
94639258|NCT00887354|324142731|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
94639259|NCT00887354|324142732|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
94639260|NCT00887354|324142731|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
94461869|NCT00743288|323481243|FG005|Overall Study|Worsening of condition (Not PD)|0|||
94461870|NCT00743288|323481244|FG006|Overall Study|Worsening of condition (Not PD)|0|||
94461871|NCT04338269|323481245|FG000|Overall Study|Death|86|||
94461872|NCT04338269|323481246|FG001|Overall Study|Death|89|||
94461873|NCT04338269|323481245|FG000|Overall Study|Lost to Follow-up|1|||
94461874|NCT04338269|323481246|FG001|Overall Study|Lost to Follow-up|2|||
94461875|NCT04338269|323481245|FG000|Overall Study|Physician Decision|1|||
94461876|NCT04338269|323481246|FG001|Overall Study|Physician Decision|0|||
94639261|NCT00887354|324142732|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
94639262|NCT00887354|324142731|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
94639263|NCT00887354|324142732|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
94639264|NCT00887354|324142731|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
94639265|NCT00887354|324142732|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
94639266|NCT00887354|324142731|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
94639267|NCT00887354|324142732|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
94639268|NCT00605813|324142735|FG000|Overall Study|Protocol Violation|25|||
94639269|NCT01614990|324142736|FG000|Overall Study|Protocol Violation|1|||
94639270|NCT01614990|324142737|FG001|Overall Study|Protocol Violation|1|||
94639271|NCT01139450|324142738|FG000|Overall Study|Withdrawal by Subject|7|||
94639272|NCT01139450|324142739|FG001|Overall Study|Withdrawal by Subject|10|||
94639273|NCT01139450|324142740|FG002|Overall Study|Withdrawal by Subject|13|||
94639274|NCT01139450|324142738|FG000|Overall Study|Lack of Efficacy|3|||
94639275|NCT01139450|324142739|FG001|Overall Study|Lack of Efficacy|1|||
94639276|NCT01139450|324142740|FG002|Overall Study|Lack of Efficacy|8|||
94639277|NCT01139450|324142738|FG000|Overall Study|Protocol Violation|6|||
94639278|NCT01139450|324142739|FG001|Overall Study|Protocol Violation|5|||
94639279|NCT01139450|324142740|FG002|Overall Study|Protocol Violation|2|||
94639280|NCT01139450|324142738|FG000|Overall Study|Lost to Follow-up|9|||
94639281|NCT01139450|324142739|FG001|Overall Study|Lost to Follow-up|7|||
94639282|NCT01139450|324142740|FG002|Overall Study|Lost to Follow-up|11|||
94639283|NCT01139450|324142738|FG000|Overall Study|Administrative|0|||
94639284|NCT01139450|324142739|FG001|Overall Study|Administrative|0|||
94639285|NCT01139450|324142740|FG002|Overall Study|Administrative|1|||
94639286|NCT01139450|324142738|FG000|Overall Study|Adverse Event|2|||
94639287|NCT01139450|324142739|FG001|Overall Study|Adverse Event|2|||
94639288|NCT01139450|324142740|FG002|Overall Study|Adverse Event|3|||
94639289|NCT00542919|324142741|FG000|Overall Study|Adverse Event|1|||
94639290|NCT00542919|324142742|FG001|Overall Study|Adverse Event|5|||
94639291|NCT00542919|324142743|FG002|Overall Study|Adverse Event|1|||
94639292|NCT00542919|324142741|FG000|Overall Study|Withdrawal by Subject|1|||
94639293|NCT00542919|324142742|FG001|Overall Study|Withdrawal by Subject|0|||
94639294|NCT00542919|324142743|FG002|Overall Study|Withdrawal by Subject|3|||
94639295|NCT00542919|324142741|FG000|Overall Study|Physician Decision|2|||
94639296|NCT00542919|324142742|FG001|Overall Study|Physician Decision|2|||
94639297|NCT00542919|324142743|FG002|Overall Study|Physician Decision|1|||
94639298|NCT00542919|324142741|FG000|Overall Study|Sponsor Decision|1|||
94639299|NCT00542919|324142742|FG001|Overall Study|Sponsor Decision|0|||
94639300|NCT00542919|324142743|FG002|Overall Study|Sponsor Decision|0|||
94639301|NCT00542919|324142741|FG000|Overall Study|Lost to Follow-up|2|||
94639302|NCT00542919|324142742|FG001|Overall Study|Lost to Follow-up|0|||
94639303|NCT00542919|324142743|FG002|Overall Study|Lost to Follow-up|1|||
94461877|NCT04338269|323481245|FG000|Overall Study|Withdrawal by Subject|14|||
94461878|NCT04338269|323481246|FG001|Overall Study|Withdrawal by Subject|11|||
94461879|NCT03339726|323481247|FG000|Overall Study|Withdrawal by Subject|1|||
94461880|NCT03339726|323481248|FG001|Overall Study|Withdrawal by Subject|0|||
94461881|NCT03339726|323481249|FG002|Overall Study|Withdrawal by Subject|0|||
94461882|NCT03339726|323481247|FG000|Overall Study|Lost to Follow-up|0|||
94461883|NCT03339726|323481248|FG001|Overall Study|Lost to Follow-up|1|||
94461884|NCT03339726|323481249|FG002|Overall Study|Lost to Follow-up|0|||
94461885|NCT04542499|323481250|FG000|Overall Study|Adverse Event|23|||
94461886|NCT04542499|323481251|FG001|Overall Study|Adverse Event|43|||
94461887|NCT04542499|323481250|FG000|Overall Study|Lack of Efficacy|5|||
94461888|NCT04542499|323481251|FG001|Overall Study|Lack of Efficacy|2|||
94461889|NCT04542499|323481250|FG000|Overall Study|Lost to Follow-up|3|||
94461890|NCT04542499|323481251|FG001|Overall Study|Lost to Follow-up|4|||
94461891|NCT04542499|323481250|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
94461892|NCT04542499|323481251|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
94461893|NCT04542499|323481250|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
94461894|NCT04542499|323481251|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
94461895|NCT04542499|323481250|FG000|Overall Study|Non-Compliance with Study Drug|0|||
94461896|NCT04542499|323481251|FG001|Overall Study|Non-Compliance with Study Drug|2|||
94461897|NCT04542499|323481250|FG000|Overall Study|Physician Decision|0|||
94461898|NCT04542499|323481251|FG001|Overall Study|Physician Decision|1|||
94461899|NCT04542499|323481250|FG000|Overall Study|Site Terminated by Sponsor|3|||
94639304|NCT02579265|324142744|FG000|Overall Study|Weaned off earlier than 28 days|44|||
94639305|NCT02579265|324142745|FG001|Overall Study|Weaned off earlier than 28 days|43|||
94639306|NCT02579265|324142744|FG000|Overall Study|Adverse Event|2|||
94639307|NCT02579265|324142745|FG001|Overall Study|Adverse Event|0|||
94639308|NCT02579265|324142744|FG000|Overall Study|Any other reason not specified|0|||
94639309|NCT02579265|324142745|FG001|Overall Study|Any other reason not specified|2|||
94639310|NCT02579265|324142744|FG000|Overall Study|Withdrawal by Subject|2|||
94639311|NCT02579265|324142745|FG001|Overall Study|Withdrawal by Subject|0|||
94639312|NCT02579265|324142744|FG000|Overall Study|Physician Decision|1|||
94639313|NCT02579265|324142745|FG001|Overall Study|Physician Decision|0|||
94639314|NCT02579265|324142744|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
94639315|NCT02579265|324142745|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
94639316|NCT02174848|324142749|FG000|Overall Study|Adverse Event|2|||
94639317|NCT02174848|324142750|FG001|Overall Study|Adverse Event|1|||
94639318|NCT02174848|324142749|FG000|Overall Study|Withdrawal by Subject|3|||
94639319|NCT02174848|324142750|FG001|Overall Study|Withdrawal by Subject|3|||
94639320|NCT02174848|324142749|FG000|Overall Study|Lost to Follow-up|0|||
94639321|NCT02174848|324142750|FG001|Overall Study|Lost to Follow-up|1|||
94639322|NCT02174848|324142749|FG000|Overall Study|Worsening of disease|1|||
94639323|NCT02174848|324142750|FG001|Overall Study|Worsening of disease|1|||
94639324|NCT02174848|324142749|FG000|Overall Study|Unable to comply with study requirements|1|||
94639325|NCT02174848|324142750|FG001|Overall Study|Unable to comply with study requirements|0|||
94639326|NCT04307446|324142754|FG000|Overall Study|Lost to Follow-up|2|||
94639327|NCT04307446|324142755|FG001|Overall Study|Lost to Follow-up|0|||
94639328|NCT01727141|324142766|FG000|Overall Study|Physician Decision|0|||
94639329|NCT01727141|324142767|FG001|Overall Study|Physician Decision|1|||
94639330|NCT01727141|324142768|FG002|Overall Study|Physician Decision|0|||
94639331|NCT01727141|324142769|FG003|Overall Study|Physician Decision|2|||
94639332|NCT01727141|324142766|FG000|Overall Study|Lost to Follow-up|0|||
94639333|NCT01727141|324142767|FG001|Overall Study|Lost to Follow-up|2|||
94639334|NCT01727141|324142768|FG002|Overall Study|Lost to Follow-up|0|||
94639335|NCT01727141|324142769|FG003|Overall Study|Lost to Follow-up|0|||
94639336|NCT01727141|324142766|FG000|Overall Study|Death|0|||
94639337|NCT01727141|324142767|FG001|Overall Study|Death|1|||
94639338|NCT01727141|324142768|FG002|Overall Study|Death|1|||
94639339|NCT01727141|324142769|FG003|Overall Study|Death|1|||
94639340|NCT01727141|324142766|FG000|Overall Study|Protocol deviation|1|||
94639341|NCT01727141|324142767|FG001|Overall Study|Protocol deviation|1|||
94639342|NCT01727141|324142768|FG002|Overall Study|Protocol deviation|0|||
94639343|NCT01727141|324142769|FG003|Overall Study|Protocol deviation|1|||
94639344|NCT01727141|324142766|FG000|Overall Study|Withdrawal by Subject|4|||
94639345|NCT01727141|324142767|FG001|Overall Study|Withdrawal by Subject|4|||
94639346|NCT01727141|324142768|FG002|Overall Study|Withdrawal by Subject|2|||
94639347|NCT01727141|324142769|FG003|Overall Study|Withdrawal by Subject|11|||
94639348|NCT02603432|324142770|FG000|Overall Study|Adverse Event|1|||
94639349|NCT02603432|324142771|FG001|Overall Study|Adverse Event|0|||
94639350|NCT02603432|324142770|FG000|Overall Study|Death|221|||
94639351|NCT02603432|324142771|FG001|Overall Study|Death|242|||
94639352|NCT02603432|324142770|FG000|Overall Study|Lost to Follow-up|3|||
94639353|NCT02603432|324142771|FG001|Overall Study|Lost to Follow-up|9|||
94639354|NCT02603432|324142770|FG000|Overall Study|Progressive Disease|7|||
94639355|NCT02603432|324142771|FG001|Overall Study|Progressive Disease|5|||
94639356|NCT02603432|324142770|FG000|Overall Study|Withdrawal by Subject|12|||
94639357|NCT02603432|324142771|FG001|Overall Study|Withdrawal by Subject|18|||
94639358|NCT02603432|324142770|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
94639359|NCT02603432|324142771|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
94639360|NCT02603432|324142770|FG000|Overall Study|Study terminated by sponsor|74|||
94639361|NCT02603432|324142771|FG001|Overall Study|Study terminated by sponsor|75|||
94639362|NCT02603432|324142770|FG000|Overall Study|Other|13|||
94639363|NCT02603432|324142771|FG001|Overall Study|Other|0|||
94639364|NCT00666757|324142772|FG000|Overall Study|Lost to Follow-up|39|||
94639365|NCT00666757|324142773|FG001|Overall Study|Lost to Follow-up|35|||
94639366|NCT00666757|324142772|FG000|Overall Study|Protocol Violation|23|||
94639367|NCT00666757|324142773|FG001|Overall Study|Protocol Violation|24|||
94639368|NCT00666757|324142772|FG000|Overall Study|Adverse Event|22|||
94639369|NCT00666757|324142773|FG001|Overall Study|Adverse Event|12|||
94639370|NCT00666757|324142772|FG000|Overall Study|Withdrawal by Subject|13|||
94639371|NCT00666757|324142773|FG001|Overall Study|Withdrawal by Subject|17|||
94639372|NCT00666757|324142772|FG000|Overall Study|Lack of Efficacy|3|||
94639373|NCT00666757|324142773|FG001|Overall Study|Lack of Efficacy|6|||
94362920|NCT00797316|323112897|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94362921|NCT00797316|323112898|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
94639374|NCT00666757|324142772|FG000|Overall Study|Physician Decision|0|||
94639375|NCT00666757|324142773|FG001|Overall Study|Physician Decision|2|||
94639376|NCT00666757|324142772|FG000|Overall Study|Sponsor decision|0|||
94639377|NCT00666757|324142773|FG001|Overall Study|Sponsor decision|1|||
94639378|NCT01957462|324142774|FG000|Test Period 1|Withdrawal by Subject|1|||
94639379|NCT01957462|324142775|FG001|Test Period 1|Withdrawal by Subject|0|||
94639380|NCT01957462|324142774|FG000|Test Period 1|Adverse Event|1|||
94639381|NCT01957462|324142775|FG001|Test Period 1|Adverse Event|0|||
94639382|NCT01856790|324142776|FG000|Closed Loop Control|Withdrawal by Subject|2|||
94639383|NCT01856790|324142776|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
94639384|NCT03090100|324142780|FG000|Overall Study|Adverse Event|9|||
94639385|NCT03090100|324142781|FG001|Overall Study|Adverse Event|11|||
94639386|NCT03090100|324142780|FG000|Overall Study|Pregnancy|1|||
94639387|NCT03090100|324142781|FG001|Overall Study|Pregnancy|1|||
94639388|NCT03090100|324142780|FG000|Overall Study|Lack of Efficacy|2|||
94639389|NCT03090100|324142781|FG001|Overall Study|Lack of Efficacy|7|||
94639390|NCT03090100|324142780|FG000|Overall Study|Lost to Follow-up|2|||
94639391|NCT03090100|324142781|FG001|Overall Study|Lost to Follow-up|2|||
94639392|NCT03090100|324142780|FG000|Overall Study|Withdrawal by Subject|7|||
94639393|NCT03090100|324142781|FG001|Overall Study|Withdrawal by Subject|19|||
94639394|NCT03090100|324142780|FG000|Overall Study|Protocol Violation|2|||
94639395|NCT03090100|324142781|FG001|Overall Study|Protocol Violation|6|||
94639396|NCT03090100|324142780|FG000|Overall Study|Non-compliance|2|||
94639397|NCT03090100|324142781|FG001|Overall Study|Non-compliance|0|||
94639398|NCT03090100|324142780|FG000|Overall Study|Other|2|||
94639399|NCT03090100|324142781|FG001|Overall Study|Other|2|||
94362922|NCT03252756|323112903|FG000|Overall Study|Protocol Violation|2|||
94362923|NCT03252756|323112904|FG001|Overall Study|Protocol Violation|4|||
94362924|NCT03252756|323112903|FG000|Overall Study|COVID-19 Pandemic|1|||
94362925|NCT03252756|323112904|FG001|Overall Study|COVID-19 Pandemic|1|||
94362926|NCT03252756|323112903|FG000|Overall Study|Study Drug Expiration|0|||
94362927|NCT03252756|323112904|FG001|Overall Study|Study Drug Expiration|1|||
94362928|NCT03494816|323112905|FG000|Overall Study|Protocol Violation|2|||
94362929|NCT03494816|323112905|FG000|Overall Study|Physician Decision|2|||
94362930|NCT03494816|323112905|FG000|Overall Study|Did not start trial treatment|1|||
94362931|NCT03494816|323112905|FG000|Overall Study|Adverse Event|1|||
94362932|NCT00902486|323112910|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
94362933|NCT00902486|323112911|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
94362934|NCT00902486|323112912|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
94362935|NCT00902486|323112913|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
94362936|NCT00902486|323112914|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
94362937|NCT00902486|323112915|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
94362938|NCT00902486|323112910|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
94362939|NCT00902486|323112911|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
94362940|NCT00902486|323112912|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
94639400|NCT00581776|324142782|FG000|Overall Study|Disease progression or no response|3|||
94639401|NCT00405587|324142783|FG000|Overall Study|Death|0|||
94639402|NCT00405587|324142784|FG001|Overall Study|Death|0|||
94639403|NCT00405587|324142785|FG002|Overall Study|Death|0|||
94639404|NCT00405587|324142786|FG003|Overall Study|Death|1|||
94639405|NCT00405587|324142783|FG000|Overall Study|Disease Progression|22|||
94639406|NCT00405587|324142784|FG001|Overall Study|Disease Progression|23|||
94639407|NCT00405587|324142785|FG002|Overall Study|Disease Progression|21|||
94639408|NCT00405587|324142786|FG003|Overall Study|Disease Progression|17|||
94639409|NCT00405587|324142783|FG000|Overall Study|Physician Decision|3|||
94639410|NCT00405587|324142784|FG001|Overall Study|Physician Decision|2|||
94639411|NCT00405587|324142785|FG002|Overall Study|Physician Decision|0|||
94639412|NCT00405587|324142786|FG003|Overall Study|Physician Decision|0|||
94362941|NCT00902486|323112913|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
94639413|NCT00405587|324142783|FG000|Overall Study|Adverse Event|1|||
94639414|NCT00405587|324142784|FG001|Overall Study|Adverse Event|0|||
94639415|NCT00405587|324142785|FG002|Overall Study|Adverse Event|0|||
94263149|NCT00763971|322758136|FG002|Overall Study|Unable to swallow capsule|1|||
94263150|NCT00763971|322758134|FG000|Overall Study|Personal reason|3|||
94263151|NCT00763971|322758135|FG001|Overall Study|Personal reason|0|||
94263152|NCT00763971|322758136|FG002|Overall Study|Personal reason|0|||
94263153|NCT00763971|322758134|FG000|Overall Study|Exclusion criteria met|1|||
94263154|NCT00763971|322758135|FG001|Overall Study|Exclusion criteria met|0|||
94263155|NCT00763971|322758136|FG002|Overall Study|Exclusion criteria met|0|||
94263156|NCT00763971|322758134|FG000|Overall Study|Sponsor decision|1|||
94639416|NCT00405587|324142786|FG003|Overall Study|Adverse Event|0|||
94639417|NCT00405587|324142783|FG000|Overall Study|Lost to Follow-up|0|||
94639418|NCT00405587|324142784|FG001|Overall Study|Lost to Follow-up|1|||
94639419|NCT00405587|324142785|FG002|Overall Study|Lost to Follow-up|1|||
94639420|NCT00405587|324142786|FG003|Overall Study|Lost to Follow-up|0|||
94639421|NCT00405587|324142783|FG000|Overall Study|Radiation induced necrosis|0|||
94639422|NCT00405587|324142784|FG001|Overall Study|Radiation induced necrosis|1|||
94639423|NCT00405587|324142785|FG002|Overall Study|Radiation induced necrosis|0|||
94639424|NCT00405587|324142786|FG003|Overall Study|Radiation induced necrosis|0|||
94639425|NCT00405587|324142783|FG000|Overall Study|Withdrawal by Subject|0|||
94639426|NCT00405587|324142784|FG001|Overall Study|Withdrawal by Subject|0|||
94639427|NCT00405587|324142785|FG002|Overall Study|Withdrawal by Subject|0|||
94639428|NCT00405587|324142786|FG003|Overall Study|Withdrawal by Subject|2|||
94639429|NCT00405587|324142783|FG000|Overall Study|Participant not dosed|0|||
94639430|NCT00405587|324142784|FG001|Overall Study|Participant not dosed|1|||
94639431|NCT00405587|324142785|FG002|Overall Study|Participant not dosed|0|||
94639432|NCT00405587|324142786|FG003|Overall Study|Participant not dosed|0|||
94639433|NCT02424383|324142793|FG000|Overall Study|Withdrawal by Subject|32|||
94639434|NCT02424383|324142793|FG000|Overall Study|Death|170|||
94639435|NCT02424383|324142793|FG000|Overall Study|Sponsor's decision|3|||
94639436|NCT02424383|324142793|FG000|Overall Study|Investigator's decision|44|||
94639437|NCT02424383|324142793|FG000|Overall Study|Lost to Follow-up|81|||
94639438|NCT02424383|324142793|FG000|Overall Study|Other|7|||
94639439|NCT02424383|324142793|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
94639440|NCT02250443|324142800|FG000|Overall Study|Administrative problems|7|||
94639441|NCT02250443|324142800|FG000|Overall Study|Adverse Event|3|||
94639442|NCT01085097|324142803|FG000|Overall Study|Adverse Event|0|||
94639443|NCT01085097|324142804|FG001|Overall Study|Adverse Event|0|||
94639444|NCT01085097|324142805|FG002|Overall Study|Adverse Event|2|||
94639445|NCT01085097|324142803|FG000|Overall Study|Treatment failure|2|||
94639446|NCT01085097|324142804|FG001|Overall Study|Treatment failure|0|||
94639447|NCT01085097|324142805|FG002|Overall Study|Treatment failure|0|||
94639448|NCT02036502|324142808|FG000|Part 1:Dose Determination/Escalation|Death|3|||
94639449|NCT02036502|324142809|FG001|Part 1:Dose Determination/Escalation|Death|2|||
94263157|NCT00763971|322758135|FG001|Overall Study|Sponsor decision|0|||
94263158|NCT00763971|322758136|FG002|Overall Study|Sponsor decision|0|||
94263159|NCT00763971|322758134|FG000|Overall Study|Due to holiday season|2|||
94639450|NCT02036502|324142810|FG002|Part 1:Dose Determination/Escalation|Death|0|||
94639451|NCT02036502|324142811|FG003|Part 1:Dose Determination/Escalation|Death|0|||
94639452|NCT02036502|324142812|FG004|Part 1:Dose Determination/Escalation|Death|0|||
94639453|NCT02036502|324142813|FG005|Part 1:Dose Determination/Escalation|Death|0|||
94639454|NCT02036502|324142814|FG006|Part 1:Dose Determination/Escalation|Death|0|||
94639455|NCT02036502|324142815|FG007|Part 1:Dose Determination/Escalation|Death|0|||
94639456|NCT02036502|324142808|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
94639457|NCT02036502|324142809|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
94639458|NCT02036502|324142810|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
94639459|NCT02036502|324142811|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
94639460|NCT02036502|324142812|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
94639461|NCT02036502|324142813|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
94639462|NCT02036502|324142814|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
94639463|NCT02036502|324142815|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
94639464|NCT02036502|324142808|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
94639465|NCT02036502|324142809|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
94639466|NCT02036502|324142810|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
94639467|NCT02036502|324142811|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
94639468|NCT02036502|324142812|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
94639469|NCT02036502|324142813|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
94639470|NCT02036502|324142814|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
94639471|NCT02036502|324142815|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
94639472|NCT02036502|324142808|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
94639473|NCT02036502|324142809|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
94639474|NCT02036502|324142810|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
94639475|NCT02036502|324142811|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
94639476|NCT02036502|324142812|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
94639477|NCT02036502|324142813|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
94639478|NCT02036502|324142814|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
94639479|NCT02036502|324142815|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
94639480|NCT02036502|324142808|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
94639481|NCT02036502|324142809|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
94639482|NCT02036502|324142810|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
94639483|NCT02036502|324142811|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
94639484|NCT02036502|324142812|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
94639485|NCT02036502|324142813|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
94639486|NCT02036502|324142814|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
94639487|NCT02036502|324142815|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
94639488|NCT02036502|324142808|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
94639489|NCT02036502|324142809|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
94639490|NCT02036502|324142810|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
94639491|NCT02036502|324142811|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
94639492|NCT02036502|324142812|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
94639493|NCT02036502|324142813|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
94639494|NCT02036502|324142814|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
94263160|NCT00763971|322758135|FG001|Overall Study|Due to holiday season|0|||
94677811|NCT00316173|324274849|FG000|Treatment Phase|Study Follow-up Stopped|0|||
94677812|NCT00316173|324274850|FG001|Treatment Phase|Study Follow-up Stopped|34|||
94677813|NCT00511875|324274851|FG000|Overall Study|Lost to Follow-up|4|||
94677814|NCT00511875|324274852|FG001|Overall Study|Lost to Follow-up|0|||
94677815|NCT00511875|324274851|FG000|Overall Study|Missing variables|1|||
94677816|NCT00511875|324274852|FG001|Overall Study|Missing variables|0|||
94677817|NCT00445679|324274854|FG000|Overall Study|Adverse Event|22|||
94677818|NCT00445679|324274855|FG001|Overall Study|Adverse Event|12|||
94677819|NCT00445679|324274856|FG002|Overall Study|Adverse Event|30|||
94677820|NCT00445679|324274857|FG003|Overall Study|Adverse Event|19|||
94677821|NCT00445679|324274854|FG000|Overall Study|Failed to return|1|||
94677822|NCT00445679|324274855|FG001|Overall Study|Failed to return|3|||
94677823|NCT00445679|324274856|FG002|Overall Study|Failed to return|2|||
94677824|NCT00445679|324274857|FG003|Overall Study|Failed to return|2|||
94677825|NCT00445679|324274854|FG000|Overall Study|Physician Decision|0|||
94677826|NCT00445679|324274855|FG001|Overall Study|Physician Decision|0|||
94677827|NCT00445679|324274856|FG002|Overall Study|Physician Decision|1|||
94677828|NCT00445679|324274857|FG003|Overall Study|Physician Decision|0|||
94677829|NCT00445679|324274854|FG000|Overall Study|Lost to Follow-up|10|||
94677830|NCT00445679|324274855|FG001|Overall Study|Lost to Follow-up|6|||
94677831|NCT00445679|324274856|FG002|Overall Study|Lost to Follow-up|6|||
94677832|NCT00445679|324274857|FG003|Overall Study|Lost to Follow-up|5|||
94677833|NCT00445679|324274854|FG000|Overall Study|Compliance|3|||
94677834|NCT00445679|324274855|FG001|Overall Study|Compliance|2|||
94677835|NCT00445679|324274856|FG002|Overall Study|Compliance|1|||
94677836|NCT00445679|324274857|FG003|Overall Study|Compliance|2|||
94677837|NCT00445679|324274854|FG000|Overall Study|Withdrawal of Informed Consent|0|||
94677838|NCT00445679|324274855|FG001|Overall Study|Withdrawal of Informed Consent|0|||
94677839|NCT00445679|324274856|FG002|Overall Study|Withdrawal of Informed Consent|1|||
94677840|NCT00445679|324274857|FG003|Overall Study|Withdrawal of Informed Consent|0|||
94677841|NCT00445679|324274854|FG000|Overall Study|Protocol Violation|2|||
94677842|NCT00445679|324274855|FG001|Overall Study|Protocol Violation|3|||
94677843|NCT00445679|324274856|FG002|Overall Study|Protocol Violation|3|||
94677844|NCT00445679|324274857|FG003|Overall Study|Protocol Violation|1|||
94677845|NCT00445679|324274854|FG000|Overall Study|Withdrawal by Subject|8|||
94677846|NCT00445679|324274855|FG001|Overall Study|Withdrawal by Subject|14|||
94677847|NCT00445679|324274856|FG002|Overall Study|Withdrawal by Subject|20|||
94677848|NCT00445679|324274857|FG003|Overall Study|Withdrawal by Subject|18|||
94677849|NCT00445679|324274854|FG000|Overall Study|Lack of Efficacy|2|||
94677850|NCT00445679|324274855|FG001|Overall Study|Lack of Efficacy|6|||
94677851|NCT00445679|324274856|FG002|Overall Study|Lack of Efficacy|2|||
94677852|NCT00445679|324274857|FG003|Overall Study|Lack of Efficacy|0|||
94677853|NCT03764072|324274858|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
94677854|NCT03764072|324274859|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
94677855|NCT03764072|324274860|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
94677856|NCT03764072|324274861|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
94677857|NCT03764072|324274862|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
94677858|NCT03764072|324274863|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
94677859|NCT03764072|324274858|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
94639495|NCT02036502|324142815|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
94639496|NCT02036502|324142808|FG000|Part 2:Dose Confirmation|Death|0|||
94639497|NCT02036502|324142809|FG001|Part 2:Dose Confirmation|Death|0|||
94639498|NCT02036502|324142810|FG002|Part 2:Dose Confirmation|Death|1|||
94639499|NCT02036502|324142811|FG003|Part 2:Dose Confirmation|Death|0|||
94639500|NCT02036502|324142812|FG004|Part 2:Dose Confirmation|Death|0|||
94639501|NCT02036502|324142813|FG005|Part 2:Dose Confirmation|Death|0|||
94639502|NCT02036502|324142814|FG006|Part 2:Dose Confirmation|Death|0|||
94639503|NCT02036502|324142815|FG007|Part 2:Dose Confirmation|Death|0|||
94639504|NCT02036502|324142808|FG000|Part 2:Dose Confirmation|Not treated|0|||
94639505|NCT02036502|324142809|FG001|Part 2:Dose Confirmation|Not treated|0|||
94639506|NCT02036502|324142810|FG002|Part 2:Dose Confirmation|Not treated|0|||
94639507|NCT02036502|324142811|FG003|Part 2:Dose Confirmation|Not treated|1|||
94639508|NCT02036502|324142812|FG004|Part 2:Dose Confirmation|Not treated|0|||
94677860|NCT03764072|324274859|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
94677861|NCT03764072|324274860|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
94677862|NCT03764072|324274861|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
94677863|NCT03764072|324274862|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
94677864|NCT03764072|324274863|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
94677865|NCT03764072|324274858|FG000|Overall Study|Lost to Follow-up|0|||
94677866|NCT03764072|324274859|FG001|Overall Study|Lost to Follow-up|0|||
94677867|NCT03764072|324274860|FG002|Overall Study|Lost to Follow-up|0|||
94677868|NCT03764072|324274861|FG003|Overall Study|Lost to Follow-up|0|||
94677869|NCT03764072|324274862|FG004|Overall Study|Lost to Follow-up|1|||
94677870|NCT03764072|324274863|FG005|Overall Study|Lost to Follow-up|0|||
94639509|NCT02036502|324142813|FG005|Part 2:Dose Confirmation|Not treated|0|||
94639510|NCT02036502|324142814|FG006|Part 2:Dose Confirmation|Not treated|0|||
94639511|NCT02036502|324142815|FG007|Part 2:Dose Confirmation|Not treated|0|||
94639512|NCT02036502|324142808|FG000|Part 3:Dose Expansion|Adverse Event|0|||
94639513|NCT02036502|324142809|FG001|Part 3:Dose Expansion|Adverse Event|0|||
94639514|NCT02036502|324142810|FG002|Part 3:Dose Expansion|Adverse Event|0|||
94639515|NCT02036502|324142811|FG003|Part 3:Dose Expansion|Adverse Event|0|||
94639516|NCT02036502|324142812|FG004|Part 3:Dose Expansion|Adverse Event|0|||
94639517|NCT02036502|324142813|FG005|Part 3:Dose Expansion|Adverse Event|4|||
94639518|NCT02036502|324142814|FG006|Part 3:Dose Expansion|Adverse Event|0|||
94639519|NCT02036502|324142815|FG007|Part 3:Dose Expansion|Adverse Event|2|||
94639520|NCT02036502|324142808|FG000|Part 3:Dose Expansion|Death|0|||
94639521|NCT02036502|324142809|FG001|Part 3:Dose Expansion|Death|0|||
94639522|NCT02036502|324142810|FG002|Part 3:Dose Expansion|Death|0|||
94639523|NCT02036502|324142811|FG003|Part 3:Dose Expansion|Death|0|||
94639524|NCT02036502|324142812|FG004|Part 3:Dose Expansion|Death|0|||
94639525|NCT02036502|324142813|FG005|Part 3:Dose Expansion|Death|24|||
94639526|NCT02036502|324142814|FG006|Part 3:Dose Expansion|Death|0|||
94639527|NCT02036502|324142815|FG007|Part 3:Dose Expansion|Death|3|||
94639528|NCT02036502|324142808|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
94639529|NCT02036502|324142809|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
94639530|NCT02036502|324142810|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
94639531|NCT02036502|324142811|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
94639532|NCT02036502|324142812|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
94639533|NCT02036502|324142813|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
94639534|NCT02036502|324142814|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
94639535|NCT02036502|324142815|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
94639536|NCT02036502|324142808|FG000|Part 3:Dose Expansion|Physician Decision|0|||
94639537|NCT02036502|324142809|FG001|Part 3:Dose Expansion|Physician Decision|0|||
94639538|NCT02036502|324142810|FG002|Part 3:Dose Expansion|Physician Decision|0|||
94639539|NCT02036502|324142811|FG003|Part 3:Dose Expansion|Physician Decision|0|||
94639540|NCT02036502|324142812|FG004|Part 3:Dose Expansion|Physician Decision|0|||
94639541|NCT02036502|324142813|FG005|Part 3:Dose Expansion|Physician Decision|1|||
94639542|NCT02036502|324142814|FG006|Part 3:Dose Expansion|Physician Decision|0|||
94639543|NCT02036502|324142815|FG007|Part 3:Dose Expansion|Physician Decision|0|||
94639544|NCT02036502|324142808|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
94639545|NCT02036502|324142809|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
94639546|NCT02036502|324142810|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
94639547|NCT02036502|324142811|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
94639548|NCT02036502|324142812|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
94639549|NCT02036502|324142813|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
94639550|NCT02036502|324142814|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
94639551|NCT02036502|324142815|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
94639552|NCT02036502|324142808|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
94639553|NCT02036502|324142809|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
94639554|NCT02036502|324142810|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
94639555|NCT02036502|324142811|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
94639556|NCT02036502|324142812|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
94639557|NCT02036502|324142813|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
94639558|NCT02036502|324142814|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
94639559|NCT02036502|324142815|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
94639560|NCT02036502|324142808|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
94639561|NCT02036502|324142809|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
94639562|NCT02036502|324142810|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
94639563|NCT02036502|324142811|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
94639564|NCT02036502|324142812|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
94639565|NCT02036502|324142813|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
94639566|NCT02036502|324142814|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
94639567|NCT02036502|324142815|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
94639568|NCT02036502|324142808|FG000|Part 3:Dose Expansion|Not Treated|0|||
94639569|NCT02036502|324142809|FG001|Part 3:Dose Expansion|Not Treated|0|||
94639570|NCT02036502|324142810|FG002|Part 3:Dose Expansion|Not Treated|0|||
94639571|NCT02036502|324142811|FG003|Part 3:Dose Expansion|Not Treated|0|||
94639572|NCT02036502|324142812|FG004|Part 3:Dose Expansion|Not Treated|0|||
94639573|NCT02036502|324142813|FG005|Part 3:Dose Expansion|Not Treated|2|||
94639574|NCT02036502|324142814|FG006|Part 3:Dose Expansion|Not Treated|0|||
94639575|NCT02036502|324142815|FG007|Part 3:Dose Expansion|Not Treated|0|||
94639576|NCT01387347|324142816|FG000|Overall Study|Lost to Follow-up|2|||
94639577|NCT01387347|324142817|FG001|Overall Study|Lost to Follow-up|1|||
94639578|NCT02136576|324142818|FG000|Overall Study|Lost to Follow-up|2|||
94639579|NCT02136576|324142819|FG001|Overall Study|Lost to Follow-up|0|||
94639580|NCT02136576|324142820|FG002|Overall Study|Lost to Follow-up|0|||
94639581|NCT00537381|324142825|FG000|Overall Study|Adverse Event|13|||
94639582|NCT00537381|324142826|FG001|Overall Study|Adverse Event|9|||
94639583|NCT00537381|324142825|FG000|Overall Study|Death|3|||
94639584|NCT00537381|324142826|FG001|Overall Study|Death|3|||
94639585|NCT00537381|324142825|FG000|Overall Study|Withdrawal by Subject|5|||
94639586|NCT00537381|324142826|FG001|Overall Study|Withdrawal by Subject|14|||
94639587|NCT00537381|324142825|FG000|Overall Study|Physician Decision|7|||
94639588|NCT00537381|324142826|FG001|Overall Study|Physician Decision|6|||
94639589|NCT00537381|324142825|FG000|Overall Study|Disease Progression|9|||
94639590|NCT00537381|324142826|FG001|Overall Study|Disease Progression|18|||
94639591|NCT00537381|324142825|FG000|Overall Study|Sponsor decision|14|||
94639592|NCT00537381|324142826|FG001|Overall Study|Sponsor decision|9|||
94639593|NCT00537381|324142825|FG000|Overall Study|Other|5|||
94639594|NCT00537381|324142826|FG001|Overall Study|Other|3|||
94639595|NCT02268786|324142827|FG000|Overall Study|No Euploid Embryos available|42|||
94639596|NCT02268786|324142828|FG001|Overall Study|No Euploid Embryos available|0|||
94639597|NCT02268786|324142827|FG000|Overall Study|Withdrawal by Subject|7|||
94639598|NCT02268786|324142828|FG001|Overall Study|Withdrawal by Subject|14|||
94639599|NCT02268786|324142827|FG000|Overall Study|Thaw Failure|6|||
94639600|NCT02268786|324142828|FG001|Overall Study|Thaw Failure|4|||
94639601|NCT02268786|324142827|FG000|Overall Study|Protocol Violation|1|||
94639602|NCT02268786|324142828|FG001|Overall Study|Protocol Violation|0|||
94639603|NCT04251221|324142829|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
94639604|NCT04251221|324142830|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
94639605|NCT01150123|324142831|FG000|Overall Study|Withdrawal by Subject|1|||
94639606|NCT01150123|324142832|FG001|Overall Study|Withdrawal by Subject|1|||
94639607|NCT01150123|324142833|FG002|Overall Study|Withdrawal by Subject|2|||
94639608|NCT01150123|324142834|FG003|Overall Study|Withdrawal by Subject|1|||
94639609|NCT01150123|324142835|FG004|Overall Study|Withdrawal by Subject|1|||
94639610|NCT01150123|324142836|FG005|Overall Study|Withdrawal by Subject|1|||
94639611|NCT01150123|324142837|FG006|Overall Study|Withdrawal by Subject|0|||
94639612|NCT01150123|324142838|FG007|Overall Study|Withdrawal by Subject|3|||
94639613|NCT01150123|324142839|FG008|Overall Study|Withdrawal by Subject|2|||
94639614|NCT01150123|324142840|FG009|Overall Study|Withdrawal by Subject|0|||
94639615|NCT01150123|324142841|FG010|Overall Study|Withdrawal by Subject|1|||
94639616|NCT01150123|324142842|FG011|Overall Study|Withdrawal by Subject|0|||
94639617|NCT01150123|324142843|FG012|Overall Study|Withdrawal by Subject|1|||
94639618|NCT01150123|324142844|FG013|Overall Study|Withdrawal by Subject|0|||
94639619|NCT01150123|324142845|FG014|Overall Study|Withdrawal by Subject|0|||
94639620|NCT01150123|324142846|FG015|Overall Study|Withdrawal by Subject|1|||
94639621|NCT01150123|324142847|FG016|Overall Study|Withdrawal by Subject|0|||
94639622|NCT01150123|324142848|FG017|Overall Study|Withdrawal by Subject|1|||
94639623|NCT01150123|324142831|FG000|Overall Study|Lost to Follow-up|2|||
94639624|NCT01150123|324142832|FG001|Overall Study|Lost to Follow-up|1|||
94639625|NCT01150123|324142833|FG002|Overall Study|Lost to Follow-up|2|||
94639626|NCT01150123|324142834|FG003|Overall Study|Lost to Follow-up|2|||
94639627|NCT01150123|324142835|FG004|Overall Study|Lost to Follow-up|2|||
94639628|NCT01150123|324142836|FG005|Overall Study|Lost to Follow-up|5|||
94639629|NCT01150123|324142837|FG006|Overall Study|Lost to Follow-up|0|||
94639630|NCT01150123|324142838|FG007|Overall Study|Lost to Follow-up|0|||
94639631|NCT01150123|324142839|FG008|Overall Study|Lost to Follow-up|3|||
94639632|NCT01150123|324142840|FG009|Overall Study|Lost to Follow-up|1|||
94639633|NCT01150123|324142841|FG010|Overall Study|Lost to Follow-up|1|||
94639634|NCT01150123|324142842|FG011|Overall Study|Lost to Follow-up|1|||
94639635|NCT01150123|324142843|FG012|Overall Study|Lost to Follow-up|2|||
94639636|NCT01150123|324142844|FG013|Overall Study|Lost to Follow-up|0|||
94639637|NCT01150123|324142845|FG014|Overall Study|Lost to Follow-up|0|||
94639638|NCT01150123|324142846|FG015|Overall Study|Lost to Follow-up|0|||
94639639|NCT01150123|324142847|FG016|Overall Study|Lost to Follow-up|0|||
94639640|NCT01150123|324142848|FG017|Overall Study|Lost to Follow-up|0|||
94639641|NCT02171260|324142849|FG000|Overall Study|Death|0|||
94639642|NCT02171260|324142850|FG001|Overall Study|Death|0|||
94639643|NCT02171260|324142851|FG002|Overall Study|Death|0|||
94263161|NCT00763971|322758136|FG002|Overall Study|Due to holiday season|1|||
94639644|NCT02171260|324142852|FG003|Overall Study|Death|1|||
94639645|NCT02171260|324142849|FG000|Overall Study|Physician Decision|1|||
94639646|NCT02171260|324142850|FG001|Overall Study|Physician Decision|0|||
94639647|NCT02171260|324142851|FG002|Overall Study|Physician Decision|1|||
94639648|NCT02171260|324142852|FG003|Overall Study|Physician Decision|0|||
94639649|NCT02171260|324142849|FG000|Overall Study|Withdrawal by Subject|1|||
94639650|NCT02171260|324142850|FG001|Overall Study|Withdrawal by Subject|0|||
94639651|NCT02171260|324142851|FG002|Overall Study|Withdrawal by Subject|0|||
94639652|NCT02171260|324142852|FG003|Overall Study|Withdrawal by Subject|0|||
94639653|NCT02171260|324142849|FG000|Overall Study|Evidence of progressive disease|4|||
94639654|NCT02171260|324142850|FG001|Overall Study|Evidence of progressive disease|6|||
94639655|NCT02171260|324142851|FG002|Overall Study|Evidence of progressive disease|4|||
94639656|NCT02171260|324142852|FG003|Overall Study|Evidence of progressive disease|4|||
94639657|NCT01319877|324142853|FG000|Overall Study|Lost to Follow-up|100|||
94639658|NCT01319877|324142854|FG001|Overall Study|Lost to Follow-up|37|||
94639659|NCT01319877|324142853|FG000|Overall Study|Physician Decision|2|||
94677871|NCT01122381|324274868|FG000|Overall Study|study terminated early|0|||
94677872|NCT01122381|324274869|FG001|Overall Study|study terminated early|1|||
94677873|NCT00941798|324274872|FG000|Overall Study|Withdrawal by Subject|72|||
94677874|NCT00941798|324274873|FG001|Overall Study|Withdrawal by Subject|74|||
94677875|NCT00941798|324274872|FG000|Overall Study|Adverse Event|43|||
94677876|NCT00941798|324274873|FG001|Overall Study|Adverse Event|23|||
94677877|NCT00941798|324274872|FG000|Overall Study|Lost to Follow-up|29|||
94677878|NCT00941798|324274873|FG001|Overall Study|Lost to Follow-up|23|||
94677879|NCT00941798|324274872|FG000|Overall Study|Protocol Violation|17|||
94677880|NCT00941798|324274873|FG001|Overall Study|Protocol Violation|20|||
94677881|NCT00941798|324274872|FG000|Overall Study|Administrative problems|13|||
94677882|NCT00941798|324274873|FG001|Overall Study|Administrative problems|23|||
94677883|NCT00941798|324274872|FG000|Overall Study|Lack of Efficacy|10|||
94677884|NCT00941798|324274873|FG001|Overall Study|Lack of Efficacy|17|||
94677885|NCT00941798|324274872|FG000|Overall Study|Patient's inability to use device|6|||
94677886|NCT00941798|324274873|FG001|Overall Study|Patient's inability to use device|1|||
94677887|NCT00941798|324274872|FG000|Overall Study|Abnormal test procedure results|3|||
94677888|NCT00941798|324274873|FG001|Overall Study|Abnormal test procedure results|1|||
94677889|NCT00941798|324274872|FG000|Overall Study|Abnormal laboratory values|1|||
94677890|NCT00941798|324274873|FG001|Overall Study|Abnormal laboratory values|2|||
94677891|NCT00941798|324274872|FG000|Overall Study|Death|0|||
94677892|NCT00941798|324274873|FG001|Overall Study|Death|1|||
94677893|NCT00112580|324274878|FG000|Overall Study|Adverse Event|1|||
94677894|NCT00112580|324274879|FG001|Overall Study|Adverse Event|2|||
94677895|NCT00112580|324274878|FG000|Overall Study|Disease progression|5|||
94677896|NCT00112580|324274879|FG001|Overall Study|Disease progression|16|||
94677897|NCT00112580|324274878|FG000|Overall Study|Participant withdrew consent|2|||
94677898|NCT00112580|324274879|FG001|Overall Study|Participant withdrew consent|1|||
94677899|NCT05597722|324274882|FG000|Overall Study|Study was terminated|6|||
94677900|NCT05597722|324274883|FG001|Overall Study|Study was terminated|1|||
94677901|NCT04108000|324274885|FG000|Overall Study|Death of patient|1|||
94677902|NCT04108000|324274886|FG001|Overall Study|Death of patient|0|||
94677903|NCT04108000|324274887|FG002|Overall Study|Death of patient|1|||
94677904|NCT04108000|324274888|FG003|Overall Study|Death of patient|0|||
94677905|NCT04108000|324274885|FG000|Overall Study|Withdrawal by Subject|2|||
94677906|NCT04108000|324274886|FG001|Overall Study|Withdrawal by Subject|2|||
94677907|NCT04108000|324274887|FG002|Overall Study|Withdrawal by Subject|0|||
94677908|NCT04108000|324274888|FG003|Overall Study|Withdrawal by Subject|0|||
94677909|NCT04108000|324274885|FG000|Overall Study|Death of surrogate partner|0|||
94677910|NCT04108000|324274886|FG001|Overall Study|Death of surrogate partner|1|||
94677911|NCT04108000|324274887|FG002|Overall Study|Death of surrogate partner|0|||
94677912|NCT04108000|324274888|FG003|Overall Study|Death of surrogate partner|1|||
94677913|NCT02969525|324274890|FG000|Double-Blind Period|Adverse Event|0|||
94677914|NCT02969525|324274891|FG001|Double-Blind Period|Adverse Event|0|||
94677915|NCT02969525|324274892|FG002|Double-Blind Period|Adverse Event|1|||
94677916|NCT02969525|324274893|FG003|Double-Blind Period|Adverse Event|1|||
94677917|NCT02969525|324274894|FG004|Double-Blind Period|Adverse Event|0|||
94677918|NCT02969525|324274895|FG005|Double-Blind Period|Adverse Event|0|||
94677919|NCT02969525|324274896|FG006|Double-Blind Period|Adverse Event|0|||
94362942|NCT00902486|323112914|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
94362943|NCT00902486|323112915|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
94362944|NCT00902486|323112910|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
94362945|NCT00902486|323112911|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
94677920|NCT02969525|324274897|FG007|Double-Blind Period|Adverse Event|0|||
94677921|NCT02969525|324274898|FG008|Double-Blind Period|Adverse Event|0|||
94677922|NCT02969525|324274899|FG009|Double-Blind Period|Adverse Event|0|||
94677923|NCT02969525|324274900|FG010|Double-Blind Period|Adverse Event|0|||
94677924|NCT02969525|324274901|FG011|Double-Blind Period|Adverse Event|0|||
94677925|NCT02969525|324274890|FG000|Double-Blind Period|LOW EGFR|0|||
94677926|NCT02969525|324274891|FG001|Double-Blind Period|LOW EGFR|0|||
94677927|NCT02969525|324274892|FG002|Double-Blind Period|LOW EGFR|0|||
94677928|NCT02969525|324274893|FG003|Double-Blind Period|LOW EGFR|1|||
94677929|NCT02969525|324274894|FG004|Double-Blind Period|LOW EGFR|0|||
94677930|NCT02969525|324274895|FG005|Double-Blind Period|LOW EGFR|0|||
94639660|NCT01319877|324142854|FG001|Overall Study|Physician Decision|0|||
94677931|NCT02969525|324274896|FG006|Double-Blind Period|LOW EGFR|0|||
94677932|NCT02969525|324274897|FG007|Double-Blind Period|LOW EGFR|0|||
94677933|NCT02969525|324274898|FG008|Double-Blind Period|LOW EGFR|0|||
94639661|NCT01319877|324142853|FG000|Overall Study|Disease Progression|2|||
94639662|NCT01319877|324142854|FG001|Overall Study|Disease Progression|2|||
94639663|NCT01319877|324142853|FG000|Overall Study|Withdrawal by Subject|0|||
94639664|NCT01319877|324142854|FG001|Overall Study|Withdrawal by Subject|1|||
94639665|NCT01319877|324142853|FG000|Overall Study|Reason Not Specified|4|||
94639666|NCT01319877|324142854|FG001|Overall Study|Reason Not Specified|5|||
94639667|NCT02968979|324142855|FG000|Overall Study|Protocol Violation|7|||
94639668|NCT02968979|324142855|FG000|Overall Study|Withdrawal by Subject|1|||
94639669|NCT01471379|324142856|FG000|Overall Study|Adverse Event|1|||
94639670|NCT01471379|324142857|FG001|Overall Study|Adverse Event|0|||
94639671|NCT01471379|324142858|FG002|Overall Study|Adverse Event|0|||
94639672|NCT01471379|324142856|FG000|Overall Study|Study terminated|0|||
94639673|NCT01471379|324142857|FG001|Overall Study|Study terminated|1|||
94639674|NCT01471379|324142858|FG002|Overall Study|Study terminated|0|||
94639675|NCT01522365|324142859|FG000|Overall Study|Withdrawal by Subject|1|||
94639676|NCT01522365|324142860|FG001|Overall Study|Withdrawal by Subject|1|||
94639677|NCT01522365|324142859|FG000|Overall Study|Lost to Follow-up|1|||
94639678|NCT01522365|324142860|FG001|Overall Study|Lost to Follow-up|1|||
94639679|NCT00449644|324142865|FG000|Overall Study|Adverse Event|0|||
94639680|NCT00449644|324142866|FG001|Overall Study|Adverse Event|0|||
94639681|NCT00449644|324142867|FG002|Overall Study|Adverse Event|3|||
94639682|NCT00449644|324142868|FG003|Overall Study|Adverse Event|5|||
94639683|NCT00449644|324142865|FG000|Overall Study|Death|1|||
94639684|NCT00449644|324142866|FG001|Overall Study|Death|0|||
94639685|NCT00449644|324142867|FG002|Overall Study|Death|6|||
94639686|NCT00449644|324142868|FG003|Overall Study|Death|1|||
94639687|NCT00449644|324142865|FG000|Overall Study|Lost to Follow-up|1|||
94639688|NCT00449644|324142866|FG001|Overall Study|Lost to Follow-up|1|||
94639689|NCT00449644|324142867|FG002|Overall Study|Lost to Follow-up|5|||
94639690|NCT00449644|324142868|FG003|Overall Study|Lost to Follow-up|3|||
94639691|NCT00449644|324142865|FG000|Overall Study|Pregnancy|0|||
94639692|NCT00449644|324142866|FG001|Overall Study|Pregnancy|0|||
94639693|NCT00449644|324142867|FG002|Overall Study|Pregnancy|3|||
94639694|NCT00449644|324142868|FG003|Overall Study|Pregnancy|2|||
94639695|NCT00449644|324142865|FG000|Overall Study|Protocol Violation|4|||
94639696|NCT00449644|324142866|FG001|Overall Study|Protocol Violation|4|||
94639697|NCT00449644|324142867|FG002|Overall Study|Protocol Violation|3|||
94639698|NCT00449644|324142868|FG003|Overall Study|Protocol Violation|7|||
94639699|NCT00449644|324142865|FG000|Overall Study|Withdrawal by Subject|3|||
94639700|NCT00449644|324142866|FG001|Overall Study|Withdrawal by Subject|4|||
94639701|NCT00449644|324142867|FG002|Overall Study|Withdrawal by Subject|6|||
94639702|NCT00449644|324142868|FG003|Overall Study|Withdrawal by Subject|7|||
94639703|NCT00449644|324142865|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
94639704|NCT00449644|324142866|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
94639705|NCT00449644|324142867|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
94639706|NCT00449644|324142868|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
94639707|NCT00449644|324142865|FG000|Overall Study|Other|1|||
94639708|NCT00449644|324142866|FG001|Overall Study|Other|4|||
94639709|NCT00449644|324142867|FG002|Overall Study|Other|1|||
94639710|NCT00449644|324142868|FG003|Overall Study|Other|0|||
94639711|NCT00449644|324142865|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
94639712|NCT00449644|324142866|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
94639713|NCT00449644|324142867|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
94639714|NCT00449644|324142868|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
94639715|NCT02268409|324144366|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
94639716|NCT02268409|324144366|FG000|Overall Study|Death|1|||
94639717|NCT02268409|324144366|FG000|Overall Study|Lost to Follow-up|1|||
94639718|NCT02268409|324144366|FG000|Overall Study|Protocol Violation|3|||
94639719|NCT02268409|324144366|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
94639720|NCT02268409|324144366|FG000|Overall Study|Withdrawal by Subject|5|||
94639721|NCT02155738|324144367|FG000|Overall Study|Missing critical information|1|||
94639722|NCT02155738|324144368|FG001|Overall Study|Missing critical information|0|||
94639723|NCT02155738|324144369|FG002|Overall Study|Missing critical information|0|||
94639724|NCT02155738|324144370|FG003|Overall Study|Missing critical information|1|||
94639725|NCT04254978|324144371|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
94639726|NCT04254978|324144371|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
94639727|NCT04254978|324144371|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
94639728|NCT04254978|324144371|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
94639729|NCT04254978|324144371|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
94639730|NCT04254978|324144371|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
94639731|NCT02515942|324144372|FG000|Overall Study|Adverse Event|5|||
94639732|NCT02515942|324144373|FG001|Overall Study|Adverse Event|0|||
94639733|NCT02515942|324144374|FG002|Overall Study|Adverse Event|0|||
94263162|NCT00763971|322758134|FG000|Overall Study|Randomization error|0|||
94263163|NCT00763971|322758135|FG001|Overall Study|Randomization error|0|||
94263164|NCT00763971|322758136|FG002|Overall Study|Randomization error|1|||
94639734|NCT02515942|324144372|FG000|Overall Study|Death|0|||
94639735|NCT02515942|324144373|FG001|Overall Study|Death|0|||
94639736|NCT02515942|324144374|FG002|Overall Study|Death|1|||
94639737|NCT02515942|324144372|FG000|Overall Study|Lack of Efficacy|0|||
94639738|NCT02515942|324144373|FG001|Overall Study|Lack of Efficacy|0|||
94639739|NCT02515942|324144374|FG002|Overall Study|Lack of Efficacy|1|||
94639740|NCT02515942|324144372|FG000|Overall Study|Lost to Follow-up|2|||
94639741|NCT02515942|324144373|FG001|Overall Study|Lost to Follow-up|0|||
94639742|NCT02515942|324144374|FG002|Overall Study|Lost to Follow-up|0|||
94639743|NCT02515942|324144372|FG000|Overall Study|Withdrawal by Subject|0|||
94639744|NCT02515942|324144373|FG001|Overall Study|Withdrawal by Subject|3|||
94639745|NCT02515942|324144374|FG002|Overall Study|Withdrawal by Subject|2|||
94639746|NCT03257631|324144375|FG000|Overall Study|Death|1|||
94639747|NCT03257631|324144376|FG001|Overall Study|Death|0|||
94639748|NCT03257631|324144377|FG002|Overall Study|Death|1|||
94639749|NCT03257631|324144378|FG003|Overall Study|Death|1|||
94639750|NCT03257631|324144375|FG000|Overall Study|Progressive Disease|10|||
94639751|NCT03257631|324144376|FG001|Overall Study|Progressive Disease|9|||
94639752|NCT03257631|324144377|FG002|Overall Study|Progressive Disease|17|||
94639753|NCT03257631|324144378|FG003|Overall Study|Progressive Disease|8|||
94639754|NCT03257631|324144375|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94639755|NCT03257631|324144376|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94639756|NCT03257631|324144377|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
94639757|NCT03257631|324144378|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
94639758|NCT03257631|324144375|FG000|Overall Study|Adverse Event|0|||
94639759|NCT03257631|324144376|FG001|Overall Study|Adverse Event|0|||
94263165|NCT00763971|322758134|FG000|Overall Study|Medical monitor decision|0|||
94639760|NCT03257631|324144377|FG002|Overall Study|Adverse Event|2|||
94639761|NCT03257631|324144378|FG003|Overall Study|Adverse Event|0|||
94639762|NCT03336216|324144380|FG000|Randomization|Not reported|2|||
94639763|NCT03336216|324144381|FG001|Randomization|Not reported|0|||
94639764|NCT03336216|324144382|FG002|Randomization|Not reported|1|||
94639765|NCT03336216|324144383|FG003|Randomization|Not reported|0|||
94677934|NCT02969525|324274899|FG009|Double-Blind Period|LOW EGFR|0|||
94639766|NCT03336216|324144380|FG000|Randomization|Other reasons|1|||
94639767|NCT03336216|324144381|FG001|Randomization|Other reasons|1|||
94639768|NCT03336216|324144382|FG002|Randomization|Other reasons|1|||
94639769|NCT03336216|324144383|FG003|Randomization|Other reasons|0|||
94639770|NCT03336216|324144380|FG000|Randomization|Participant no longer meets study criteria|0|||
94639771|NCT03336216|324144381|FG001|Randomization|Participant no longer meets study criteria|2|||
94639772|NCT03336216|324144382|FG002|Randomization|Participant no longer meets study criteria|4|||
94639773|NCT03336216|324144383|FG003|Randomization|Participant no longer meets study criteria|1|||
94639774|NCT03336216|324144380|FG000|Randomization|Lost to Follow-up|1|||
94639775|NCT03336216|324144381|FG001|Randomization|Lost to Follow-up|0|||
94639776|NCT03336216|324144382|FG002|Randomization|Lost to Follow-up|0|||
94639777|NCT03336216|324144383|FG003|Randomization|Lost to Follow-up|0|||
94639778|NCT03336216|324144380|FG000|Randomization|Participant withdrew consent|9|||
94639779|NCT03336216|324144381|FG001|Randomization|Participant withdrew consent|1|||
94639780|NCT03336216|324144382|FG002|Randomization|Participant withdrew consent|0|||
94639781|NCT03336216|324144383|FG003|Randomization|Participant withdrew consent|0|||
94639782|NCT03336216|324144380|FG000|Randomization|Adverse Event|1|||
94639783|NCT03336216|324144381|FG001|Randomization|Adverse Event|1|||
94639784|NCT03336216|324144382|FG002|Randomization|Adverse Event|0|||
94639785|NCT03336216|324144383|FG003|Randomization|Adverse Event|0|||
94639786|NCT03336216|324144380|FG000|Treatment|Adverse Event|2|||
94639787|NCT03336216|324144381|FG001|Treatment|Adverse Event|3|||
94639788|NCT03336216|324144382|FG002|Treatment|Adverse Event|4|||
94639789|NCT03336216|324144383|FG003|Treatment|Adverse Event|4|||
94639790|NCT03336216|324144380|FG000|Treatment|Participant request to discontinue treatment|2|||
94639791|NCT03336216|324144381|FG001|Treatment|Participant request to discontinue treatment|1|||
94639792|NCT03336216|324144382|FG002|Treatment|Participant request to discontinue treatment|2|||
94639793|NCT03336216|324144383|FG003|Treatment|Participant request to discontinue treatment|2|||
94639794|NCT03336216|324144380|FG000|Treatment|Participant withdrew consent|7|||
94639795|NCT03336216|324144381|FG001|Treatment|Participant withdrew consent|2|||
94639796|NCT03336216|324144382|FG002|Treatment|Participant withdrew consent|3|||
94639797|NCT03336216|324144383|FG003|Treatment|Participant withdrew consent|2|||
94639798|NCT03336216|324144380|FG000|Treatment|Death|2|||
94639799|NCT03336216|324144381|FG001|Treatment|Death|3|||
94639800|NCT03336216|324144382|FG002|Treatment|Death|3|||
94639801|NCT03336216|324144383|FG003|Treatment|Death|4|||
94639802|NCT03336216|324144380|FG000|Treatment|Participant no longer meets study criteria|0|||
94263166|NCT00763971|322758135|FG001|Overall Study|Medical monitor decision|0|||
94461900|NCT04542499|323481251|FG001|Overall Study|Site Terminated by Sponsor|5|||
94461901|NCT04542499|323481250|FG000|Overall Study|Withdrawal by Subject|12|||
94639803|NCT03336216|324144381|FG001|Treatment|Participant no longer meets study criteria|1|||
94639804|NCT03336216|324144382|FG002|Treatment|Participant no longer meets study criteria|0|||
94639805|NCT03336216|324144383|FG003|Treatment|Participant no longer meets study criteria|0|||
94639806|NCT03336216|324144380|FG000|Treatment|Other reasons|2|||
94639807|NCT03336216|324144381|FG001|Treatment|Other reasons|0|||
94639808|NCT03336216|324144382|FG002|Treatment|Other reasons|0|||
94263167|NCT00763971|322758136|FG002|Overall Study|Medical monitor decision|1|||
94362946|NCT00902486|323112912|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
94362947|NCT00902486|323112913|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
94362948|NCT00902486|323112914|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
94362949|NCT00902486|323112915|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
94362950|NCT00902486|323112910|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
94362951|NCT00902486|323112911|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
94362952|NCT00902486|323112912|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
94362953|NCT00902486|323112913|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
94362954|NCT00902486|323112914|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
94362955|NCT00902486|323112915|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
94362956|NCT00902486|323112910|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
94362957|NCT00902486|323112911|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
94639809|NCT03336216|324144383|FG003|Treatment|Other reasons|3|||
94639810|NCT03336216|324144380|FG000|Treatment|Disease progression|23|||
94639811|NCT03336216|324144381|FG001|Treatment|Disease progression|34|||
94639812|NCT03336216|324144382|FG002|Treatment|Disease progression|33|||
94639813|NCT03336216|324144383|FG003|Treatment|Disease progression|26|||
94639814|NCT03336216|324144380|FG000|Treatment|Study drug toxicity|0|||
94639815|NCT03336216|324144381|FG001|Treatment|Study drug toxicity|3|||
94639816|NCT03336216|324144382|FG002|Treatment|Study drug toxicity|2|||
94639817|NCT03336216|324144383|FG003|Treatment|Study drug toxicity|0|||
94639818|NCT03336216|324144380|FG000|Treatment|Adverse Event unrelated to study drug|1|||
94639819|NCT03336216|324144381|FG001|Treatment|Adverse Event unrelated to study drug|1|||
94639820|NCT03336216|324144382|FG002|Treatment|Adverse Event unrelated to study drug|1|||
94639821|NCT03336216|324144383|FG003|Treatment|Adverse Event unrelated to study drug|0|||
94639822|NCT03336216|324144380|FG000|Treatment|Disease Recurrence|1|||
94639823|NCT03336216|324144381|FG001|Treatment|Disease Recurrence|0|||
94639824|NCT03336216|324144382|FG002|Treatment|Disease Recurrence|0|||
94639825|NCT03336216|324144383|FG003|Treatment|Disease Recurrence|0|||
94639826|NCT00922766|324144386|FG000|Overall Study|Death|3|||
94639827|NCT00922766|324144386|FG000|Overall Study|Withdrawal by Subject|2|||
94639828|NCT00922766|324144386|FG000|Overall Study|Other|1|||
94639829|NCT00922766|324144386|FG000|Overall Study|Adverse Event|1|||
94639830|NCT02622828|324144387|FG000|Overall Study|participant withdrew|3|||
94639831|NCT02510794|324144388|FG000|Overall Study|Adverse Event|0|||
94639832|NCT02510794|324144389|FG001|Overall Study|Adverse Event|1|||
94639833|NCT02510794|324144390|FG002|Overall Study|Adverse Event|0|||
94639834|NCT02510794|324144391|FG003|Overall Study|Adverse Event|0|||
94639835|NCT02510794|324144388|FG000|Overall Study|Death|1|||
94639836|NCT02510794|324144389|FG001|Overall Study|Death|2|||
94639837|NCT02510794|324144390|FG002|Overall Study|Death|1|||
94639838|NCT02510794|324144391|FG003|Overall Study|Death|1|||
94639839|NCT02510794|324144388|FG000|Overall Study|Lack of Efficacy|3|||
94639840|NCT02510794|324144389|FG001|Overall Study|Lack of Efficacy|1|||
94639841|NCT02510794|324144390|FG002|Overall Study|Lack of Efficacy|1|||
94639842|NCT02510794|324144391|FG003|Overall Study|Lack of Efficacy|0|||
94639843|NCT02510794|324144388|FG000|Overall Study|Participant moved out of the area|0|||
94639844|NCT02510794|324144389|FG001|Overall Study|Participant moved out of the area|0|||
94639845|NCT02510794|324144390|FG002|Overall Study|Participant moved out of the area|0|||
94639846|NCT02510794|324144391|FG003|Overall Study|Participant moved out of the area|1|||
94639847|NCT02510794|324144388|FG000|Overall Study|Physician Decision|3|||
94639848|NCT02510794|324144389|FG001|Overall Study|Physician Decision|0|||
94639849|NCT02510794|324144390|FG002|Overall Study|Physician Decision|0|||
94639850|NCT02510794|324144391|FG003|Overall Study|Physician Decision|0|||
94639851|NCT02510794|324144388|FG000|Overall Study|Protocol Violation|0|||
94639852|NCT02510794|324144389|FG001|Overall Study|Protocol Violation|0|||
94639853|NCT02510794|324144390|FG002|Overall Study|Protocol Violation|1|||
94639854|NCT02510794|324144391|FG003|Overall Study|Protocol Violation|0|||
94639855|NCT02510794|324144388|FG000|Overall Study|Withdrawal by Subject|1|||
94639856|NCT02510794|324144389|FG001|Overall Study|Withdrawal by Subject|2|||
94639857|NCT02510794|324144390|FG002|Overall Study|Withdrawal by Subject|4|||
94639858|NCT02510794|324144391|FG003|Overall Study|Withdrawal by Subject|3|||
94639859|NCT04765358|324144392|FG000|Overall Study|Withdrawal by Subject|1|||
94639860|NCT00159588|324144393|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
94639861|NCT00159588|324144394|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
94639862|NCT00159588|324144395|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
94639863|NCT00952341|324144400|FG000|Cycle 1|Adverse Event|4|||
94639864|NCT00952341|324144401|FG001|Cycle 1|Adverse Event|1|||
94639865|NCT00952341|324144400|FG000|Cycle 1|Withdrawal by Subject|3|||
94639866|NCT00952341|324144401|FG001|Cycle 1|Withdrawal by Subject|8|||
94639867|NCT00952341|324144400|FG000|Cycle 1|Protocol Violation|2|||
94639868|NCT00952341|324144401|FG001|Cycle 1|Protocol Violation|1|||
94639869|NCT00952341|324144400|FG000|Cycle 1|Lost to Follow-up|11|||
94639870|NCT00952341|324144401|FG001|Cycle 1|Lost to Follow-up|2|||
94639871|NCT00952341|324144400|FG000|Cycle 1|Physician Decision|0|||
94639872|NCT00952341|324144401|FG001|Cycle 1|Physician Decision|1|||
94639873|NCT00952341|324144400|FG000|Cycle 2|Withdrawal by Subject|1|||
94639874|NCT00952341|324144401|FG001|Cycle 2|Withdrawal by Subject|1|||
94639875|NCT00952341|324144400|FG000|Cycle 2|Protocol Violation|1|||
94639876|NCT00952341|324144401|FG001|Cycle 2|Protocol Violation|0|||
94639877|NCT00952341|324144400|FG000|Cycle 2|Lost to Follow-up|6|||
94639878|NCT00952341|324144401|FG001|Cycle 2|Lost to Follow-up|9|||
94639879|NCT00952341|324144400|FG000|Cycle 2|Physician Decision|1|||
94639880|NCT00952341|324144401|FG001|Cycle 2|Physician Decision|1|||
94639881|NCT00952341|324144400|FG000|Cycle 2|Progressive Disease|0|||
94639882|NCT00952341|324144401|FG001|Cycle 2|Progressive Disease|1|||
94639883|NCT01316276|324144402|FG000|Overall Study|Death|1|||
94639884|NCT01316276|324144402|FG000|Overall Study|Adverse Event|19|||
94639885|NCT01316276|324144402|FG000|Overall Study|Withdrawal of consent|24|||
94639886|NCT01316276|324144402|FG000|Overall Study|Lost to Follow-up|1|||
94639887|NCT01316276|324144402|FG000|Overall Study|Other|22|||
94639888|NCT02596854|324144403|FG000|Overall Study|Withdrawn|8|||
94639889|NCT01652664|324144404|FG000|Overall Study|Treatment Failure|5|||
94639890|NCT01652664|324144405|FG001|Overall Study|Treatment Failure|1|||
94639891|NCT01652664|324144404|FG000|Overall Study|Inadequate IOP control|1|||
94639892|NCT01652664|324144405|FG001|Overall Study|Inadequate IOP control|0|||
94639893|NCT00297037|324144408|FG000|Overall Study|Withdrawal by Subject|2|||
94639894|NCT00297037|324144409|FG001|Overall Study|Withdrawal by Subject|0|||
94639895|NCT05352815|324144410|FG000|Overall Study|Withdrawal by Subject|28|||
94639896|NCT05352815|324144411|FG001|Overall Study|Withdrawal by Subject|24|||
94639897|NCT05352815|324144410|FG000|Overall Study|Lost to Follow-up|4|||
94639898|NCT05352815|324144411|FG001|Overall Study|Lost to Follow-up|7|||
94639899|NCT05352815|324144410|FG000|Overall Study|Death|2|||
94639900|NCT05352815|324144411|FG001|Overall Study|Death|3|||
94639901|NCT05352815|324144410|FG000|Overall Study|Site closure|1|||
94639902|NCT05352815|324144411|FG001|Overall Study|Site closure|0|||
94639905|NCT02939560|324144428|FG000|Overall Study|Withdrawal by Subject|2|||
94639906|NCT02939560|324144428|FG000|Overall Study|Protocol Violation|1|||
94639907|NCT03340025|324144429|FG000|Overall Study|Lost to Follow-up|2|||
94639908|NCT03340025|324144430|FG001|Overall Study|Lost to Follow-up|2|||
94639909|NCT03616535|324144431|FG000|Overall Study|Death|2|||
94639910|NCT03616535|324144432|FG001|Overall Study|Death|0|||
94639911|NCT03616535|324144433|FG002|Overall Study|Death|0|||
94639912|NCT03616535|324144434|FG003|Overall Study|Death|1|||
94639913|NCT03616535|324144431|FG000|Overall Study|Lost to Follow-up|2|||
94639914|NCT03616535|324144432|FG001|Overall Study|Lost to Follow-up|1|||
94639915|NCT03616535|324144433|FG002|Overall Study|Lost to Follow-up|0|||
94639916|NCT03616535|324144434|FG003|Overall Study|Lost to Follow-up|2|||
94639917|NCT03616535|324144431|FG000|Overall Study|Withdrawal by Subject|1|||
94639918|NCT03616535|324144432|FG001|Overall Study|Withdrawal by Subject|2|||
94639919|NCT03616535|324144433|FG002|Overall Study|Withdrawal by Subject|5|||
94639920|NCT03616535|324144434|FG003|Overall Study|Withdrawal by Subject|1|||
94639921|NCT03616535|324144431|FG000|Overall Study|Not specified or change in eligibility|2|||
94639922|NCT03616535|324144432|FG001|Overall Study|Not specified or change in eligibility|3|||
94639923|NCT03616535|324144433|FG002|Overall Study|Not specified or change in eligibility|3|||
94639924|NCT03616535|324144434|FG003|Overall Study|Not specified or change in eligibility|1|||
94639925|NCT03897179|324144438|FG000|Overall Study|Withdrawal by Subject|1|||
94639926|NCT00704535|324144439|FG000|Overall Study|Adverse Event|2|||
94639927|NCT00704535|324144439|FG000|Overall Study|Death|2|||
94639928|NCT00704535|324144439|FG000|Overall Study|Lost to Follow-up|8|||
94639929|NCT00704535|324144439|FG000|Overall Study|Protocol Violation|10|||
94677935|NCT02969525|324274900|FG010|Double-Blind Period|LOW EGFR|0|||
94639930|NCT00704535|324144439|FG000|Overall Study|Completed status not on Case Report Form|124|||
94639931|NCT01413360|324144440|FG000|Overall Study|Lost to Follow-up|2|||
94639932|NCT01413360|324144440|FG000|Overall Study|Adverse Event|1|||
94639933|NCT01589445|324144444|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
94639934|NCT01589445|324144444|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
94639935|NCT01589445|324144444|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
94639936|NCT01589445|324144444|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
94639937|NCT01589445|324144444|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
94639938|NCT01589445|324144444|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
94639939|NCT01589445|324144444|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
94639940|NCT01589445|324144444|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
94639941|NCT01589445|324144444|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
94639942|NCT01589445|324144444|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
94639943|NCT02246673|324144448|FG000|Overall Study|Sponsor Decision|1|||
94639944|NCT02246673|324144449|FG001|Overall Study|Sponsor Decision|0|||
94639945|NCT02246673|324144450|FG002|Overall Study|Sponsor Decision|0|||
94639946|NCT02246673|324144451|FG003|Overall Study|Sponsor Decision|0|||
94639947|NCT02246673|324144452|FG004|Overall Study|Sponsor Decision|0|||
94639948|NCT02246673|324144448|FG000|Overall Study|Withdrawal by Subject|0|||
94639949|NCT02246673|324144449|FG001|Overall Study|Withdrawal by Subject|0|||
94639950|NCT02246673|324144450|FG002|Overall Study|Withdrawal by Subject|0|||
94639951|NCT02246673|324144451|FG003|Overall Study|Withdrawal by Subject|0|||
94639952|NCT02246673|324144452|FG004|Overall Study|Withdrawal by Subject|1|||
94639953|NCT02246673|324144448|FG000|Overall Study|Lost to Follow-up|0|||
94639954|NCT02246673|324144449|FG001|Overall Study|Lost to Follow-up|0|||
94639955|NCT02246673|324144450|FG002|Overall Study|Lost to Follow-up|0|||
94639956|NCT02246673|324144451|FG003|Overall Study|Lost to Follow-up|1|||
94639957|NCT02246673|324144452|FG004|Overall Study|Lost to Follow-up|0|||
94639958|NCT02246673|324144448|FG000|Overall Study|Protocol Violation|0|||
94639959|NCT02246673|324144449|FG001|Overall Study|Protocol Violation|0|||
94639960|NCT02246673|324144450|FG002|Overall Study|Protocol Violation|0|||
94639961|NCT02246673|324144451|FG003|Overall Study|Protocol Violation|1|||
94639962|NCT02246673|324144452|FG004|Overall Study|Protocol Violation|0|||
94639963|NCT01928862|324144458|FG000|Overall Study|Lost to Follow-up|1|||
94639964|NCT01928862|324144459|FG001|Overall Study|Lost to Follow-up|0|||
94639965|NCT01928862|324144460|FG002|Overall Study|Lost to Follow-up|0|||
94639966|NCT01928862|324144461|FG003|Overall Study|Lost to Follow-up|0|||
94639967|NCT01928862|324144462|FG004|Overall Study|Lost to Follow-up|1|||
94639968|NCT01478321|324144463|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
94639969|NCT01478321|324144463|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
94639970|NCT01478321|324144463|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
94639971|NCT01478321|324144463|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
94639972|NCT01478321|324144463|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
94639973|NCT01478321|324144463|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
94639974|NCT01478321|324144463|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
94639975|NCT01478321|324144463|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
94639976|NCT01251380|324144469|FG000|Overall Study|Other (Not otherwise specified)|12|||
94639977|NCT01251380|324144469|FG000|Overall Study|Withdrawal by Subject|6|||
94639978|NCT01251380|324144469|FG000|Overall Study|Lack of Efficacy|1|||
94639979|NCT01251380|324144469|FG000|Overall Study|Adverse Event|1|||
94639980|NCT01251380|324144469|FG000|Overall Study|Lost to Follow-up|2|||
94639981|NCT04007523|324144472|FG000|Overall Study|Withdrawal by Subject|0|||
94639982|NCT04007523|324144473|FG001|Overall Study|Withdrawal by Subject|1|||
94639983|NCT04007523|324144474|FG002|Overall Study|Withdrawal by Subject|1|||
94639984|NCT04007523|324144475|FG003|Overall Study|Withdrawal by Subject|0|||
94639985|NCT04007523|324144472|FG000|Overall Study|ICU Transfer|0|||
94639986|NCT04007523|324144473|FG001|Overall Study|ICU Transfer|1|||
94639987|NCT04007523|324144474|FG002|Overall Study|ICU Transfer|0|||
94639988|NCT04007523|324144475|FG003|Overall Study|ICU Transfer|0|||
94639989|NCT04007523|324144472|FG000|Overall Study|COVID hospital closure|0|||
94639990|NCT04007523|324144473|FG001|Overall Study|COVID hospital closure|0|||
94639991|NCT04007523|324144474|FG002|Overall Study|COVID hospital closure|1|||
94639992|NCT04007523|324144475|FG003|Overall Study|COVID hospital closure|2|||
94639993|NCT04007523|324144472|FG000|Overall Study|Surgery cancelled|0|||
94639994|NCT04007523|324144473|FG001|Overall Study|Surgery cancelled|0|||
94362958|NCT00902486|323112912|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
94639995|NCT04007523|324144474|FG002|Overall Study|Surgery cancelled|1|||
94639996|NCT04007523|324144475|FG003|Overall Study|Surgery cancelled|1|||
94639997|NCT02197806|324144476|FG000|Overall Study|Adverse Event|0|||
94639998|NCT02197806|324144477|FG001|Overall Study|Adverse Event|1|||
94639999|NCT02197806|324144478|FG002|Overall Study|Adverse Event|0|||
94640000|NCT02197806|324144479|FG003|Overall Study|Adverse Event|1|||
94640001|NCT00923559|324144480|FG000|Overall Study|Lost to Follow-up|2|||
94640002|NCT00923559|324144481|FG001|Overall Study|Lost to Follow-up|3|||
94640003|NCT01774786|324144484|FG000|Overall Study|Death|300|||
94640004|NCT01774786|324144485|FG001|Overall Study|Death|319|||
94640005|NCT01774786|324144484|FG000|Overall Study|Lost to Follow-up|6|||
94362959|NCT00902486|323112913|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
94362960|NCT00902486|323112914|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
94362961|NCT00902486|323112915|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
94362962|NCT00902486|323112910|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
94362963|NCT00902486|323112911|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
94362964|NCT00902486|323112912|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
94362965|NCT00902486|323112913|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
94362966|NCT00902486|323112914|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
94362967|NCT00902486|323112915|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
94362968|NCT00902486|323112910|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
94362969|NCT00902486|323112911|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
94362970|NCT00902486|323112912|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
94362971|NCT00902486|323112913|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
94461902|NCT04542499|323481251|FG001|Overall Study|Withdrawal by Subject|33|||
94461903|NCT04542499|323481250|FG000|Overall Study|Other|2|||
94640006|NCT01774786|324144485|FG001|Overall Study|Lost to Follow-up|7|||
94640007|NCT01774786|324144484|FG000|Overall Study|Withdrawal by Subject|18|||
94640008|NCT01774786|324144485|FG001|Overall Study|Withdrawal by Subject|14|||
94640009|NCT01774786|324144484|FG000|Overall Study|Physician Decision|2|||
94640010|NCT01774786|324144485|FG001|Overall Study|Physician Decision|0|||
94640011|NCT01774786|324144484|FG000|Overall Study|Non-compliance|0|||
94640012|NCT01774786|324144485|FG001|Overall Study|Non-compliance|1|||
94640013|NCT01774786|324144484|FG000|Overall Study|Reason Not Specified|2|||
94640014|NCT01774786|324144485|FG001|Overall Study|Reason Not Specified|5|||
94640015|NCT01951157|324144486|FG000|Overall Study|Progressive Disease|12|||
94640016|NCT01951157|324144487|FG001|Overall Study|Progressive Disease|13|||
94640017|NCT01951157|324144488|FG002|Overall Study|Progressive Disease|10|||
94640018|NCT01951157|324144486|FG000|Overall Study|Treatment-unrelated AE|1|||
94640019|NCT01951157|324144487|FG001|Overall Study|Treatment-unrelated AE|0|||
94640020|NCT01951157|324144488|FG002|Overall Study|Treatment-unrelated AE|3|||
94640021|NCT01951157|324144486|FG000|Overall Study|Study Termination|0|||
94640022|NCT01951157|324144487|FG001|Overall Study|Study Termination|0|||
94640023|NCT01951157|324144488|FG002|Overall Study|Study Termination|1|||
94640024|NCT01951157|324144486|FG000|Overall Study|Physician Decision|5|||
94640025|NCT01951157|324144487|FG001|Overall Study|Physician Decision|3|||
94640026|NCT01951157|324144488|FG002|Overall Study|Physician Decision|2|||
94640027|NCT01951157|324144486|FG000|Overall Study|Non-treatmentrelated death|2|||
94640028|NCT01951157|324144487|FG001|Overall Study|Non-treatmentrelated death|2|||
94640029|NCT01951157|324144488|FG002|Overall Study|Non-treatmentrelated death|2|||
94640030|NCT01951157|324144486|FG000|Overall Study|No treated|0|||
94640031|NCT01951157|324144487|FG001|Overall Study|No treated|1|||
94640032|NCT01951157|324144488|FG002|Overall Study|No treated|0|||
94640033|NCT01951157|324144486|FG000|Overall Study|Treatment-related AE|2|||
94640034|NCT01951157|324144487|FG001|Overall Study|Treatment-related AE|0|||
94640035|NCT01951157|324144488|FG002|Overall Study|Treatment-related AE|4|||
94640036|NCT01951157|324144486|FG000|Overall Study|Consent withdrawn by subject|0|||
94640037|NCT01951157|324144487|FG001|Overall Study|Consent withdrawn by subject|1|||
94640038|NCT01951157|324144488|FG002|Overall Study|Consent withdrawn by subject|3|||
94640039|NCT01951157|324144486|FG000|Overall Study|Treatment-related death|0|||
94640040|NCT01951157|324144487|FG001|Overall Study|Treatment-related death|2|||
94640041|NCT01951157|324144488|FG002|Overall Study|Treatment-related death|0|||
94640042|NCT03560531|324144490|FG000|Overall Study|Death|4|||
94640043|NCT03560531|324144491|FG001|Overall Study|Death|1|||
94640044|NCT03560531|324144492|FG002|Overall Study|Death|1|||
94640045|NCT03560531|324144493|FG003|Overall Study|Death|2|||
94640046|NCT03560531|324144494|FG004|Overall Study|Death|6|||
94640047|NCT03560531|324144495|FG005|Overall Study|Death|1|||
94640048|NCT03560531|324144496|FG006|Overall Study|Death|4|||
94640049|NCT03560531|324144497|FG007|Overall Study|Death|8|||
94640050|NCT03560531|324144498|FG008|Overall Study|Death|1|||
94640051|NCT03560531|324144499|FG009|Overall Study|Death|3|||
94640052|NCT03560531|324144500|FG010|Overall Study|Death|2|||
94640053|NCT03560531|324144501|FG011|Overall Study|Death|0|||
94640054|NCT03560531|324144502|FG012|Overall Study|Death|4|||
94640055|NCT03560531|324144503|FG013|Overall Study|Death|1|||
94640056|NCT03560531|324144490|FG000|Overall Study|Lost to Follow-up|1|||
94640057|NCT03560531|324144491|FG001|Overall Study|Lost to Follow-up|1|||
94640058|NCT03560531|324144492|FG002|Overall Study|Lost to Follow-up|0|||
94640059|NCT03560531|324144493|FG003|Overall Study|Lost to Follow-up|0|||
94640060|NCT03560531|324144494|FG004|Overall Study|Lost to Follow-up|0|||
94640061|NCT03560531|324144495|FG005|Overall Study|Lost to Follow-up|0|||
94640062|NCT03560531|324144496|FG006|Overall Study|Lost to Follow-up|1|||
94640063|NCT03560531|324144497|FG007|Overall Study|Lost to Follow-up|0|||
94640064|NCT03560531|324144498|FG008|Overall Study|Lost to Follow-up|0|||
94640065|NCT03560531|324144499|FG009|Overall Study|Lost to Follow-up|0|||
94640066|NCT03560531|324144500|FG010|Overall Study|Lost to Follow-up|0|||
94640067|NCT03560531|324144501|FG011|Overall Study|Lost to Follow-up|0|||
94362972|NCT00902486|323112914|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
94362973|NCT00902486|323112915|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
94362974|NCT00902486|323112910|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
94461904|NCT04542499|323481251|FG001|Overall Study|Other|2|||
94640068|NCT03560531|324144502|FG012|Overall Study|Lost to Follow-up|0|||
94640069|NCT03560531|324144503|FG013|Overall Study|Lost to Follow-up|0|||
94640070|NCT03560531|324144490|FG000|Overall Study|Withdrawal by Subject|1|||
94640071|NCT03560531|324144491|FG001|Overall Study|Withdrawal by Subject|0|||
94640072|NCT03560531|324144492|FG002|Overall Study|Withdrawal by Subject|0|||
94640073|NCT03560531|324144493|FG003|Overall Study|Withdrawal by Subject|0|||
94640074|NCT03560531|324144494|FG004|Overall Study|Withdrawal by Subject|0|||
94640075|NCT03560531|324144495|FG005|Overall Study|Withdrawal by Subject|0|||
94640076|NCT03560531|324144496|FG006|Overall Study|Withdrawal by Subject|0|||
94640077|NCT03560531|324144497|FG007|Overall Study|Withdrawal by Subject|3|||
94640078|NCT03560531|324144498|FG008|Overall Study|Withdrawal by Subject|2|||
94640079|NCT03560531|324144499|FG009|Overall Study|Withdrawal by Subject|0|||
94640080|NCT03560531|324144500|FG010|Overall Study|Withdrawal by Subject|0|||
94640081|NCT03560531|324144501|FG011|Overall Study|Withdrawal by Subject|0|||
94640082|NCT03560531|324144502|FG012|Overall Study|Withdrawal by Subject|2|||
94640083|NCT03560531|324144503|FG013|Overall Study|Withdrawal by Subject|0|||
94640084|NCT03560531|324144490|FG000|Overall Study|Study end per-protocol|1|||
94640085|NCT03560531|324144491|FG001|Overall Study|Study end per-protocol|1|||
94640086|NCT03560531|324144492|FG002|Overall Study|Study end per-protocol|2|||
94640087|NCT03560531|324144493|FG003|Overall Study|Study end per-protocol|0|||
94640088|NCT03560531|324144494|FG004|Overall Study|Study end per-protocol|1|||
94640089|NCT03560531|324144495|FG005|Overall Study|Study end per-protocol|0|||
94640090|NCT03560531|324144496|FG006|Overall Study|Study end per-protocol|0|||
94640091|NCT03560531|324144497|FG007|Overall Study|Study end per-protocol|0|||
94640092|NCT03560531|324144498|FG008|Overall Study|Study end per-protocol|0|||
94640093|NCT03560531|324144499|FG009|Overall Study|Study end per-protocol|0|||
94640094|NCT03560531|324144500|FG010|Overall Study|Study end per-protocol|0|||
94640095|NCT03560531|324144501|FG011|Overall Study|Study end per-protocol|0|||
94640096|NCT03560531|324144502|FG012|Overall Study|Study end per-protocol|0|||
94640097|NCT03560531|324144503|FG013|Overall Study|Study end per-protocol|0|||
94640098|NCT03560531|324144490|FG000|Overall Study|Early study termination by sponsor|9|||
94640099|NCT03560531|324144491|FG001|Overall Study|Early study termination by sponsor|0|||
94640100|NCT03560531|324144492|FG002|Overall Study|Early study termination by sponsor|0|||
94640101|NCT03560531|324144493|FG003|Overall Study|Early study termination by sponsor|4|||
94640102|NCT03560531|324144494|FG004|Overall Study|Early study termination by sponsor|8|||
94640103|NCT03560531|324144495|FG005|Overall Study|Early study termination by sponsor|2|||
94640104|NCT03560531|324144496|FG006|Overall Study|Early study termination by sponsor|5|||
94640105|NCT03560531|324144497|FG007|Overall Study|Early study termination by sponsor|64|||
94640106|NCT03560531|324144498|FG008|Overall Study|Early study termination by sponsor|7|||
94640107|NCT03560531|324144499|FG009|Overall Study|Early study termination by sponsor|2|||
94640108|NCT03560531|324144500|FG010|Overall Study|Early study termination by sponsor|16|||
94640109|NCT03560531|324144501|FG011|Overall Study|Early study termination by sponsor|2|||
94640110|NCT03560531|324144502|FG012|Overall Study|Early study termination by sponsor|6|||
94640111|NCT03560531|324144503|FG013|Overall Study|Early study termination by sponsor|2|||
94640112|NCT00735878|324144505|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
94640113|NCT00735878|324144506|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
94640114|NCT00735878|324144507|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
94640115|NCT01239368|324146683|FG000|Overall Study|Principal investigator discretion|1|||
94640116|NCT01239368|324146684|FG001|Overall Study|Principal investigator discretion|0|||
94640117|NCT01239368|324146685|FG002|Overall Study|Principal investigator discretion|0|||
94640118|NCT01239368|324146686|FG003|Overall Study|Principal investigator discretion|0|||
94640119|NCT01239368|324146687|FG004|Overall Study|Principal investigator discretion|1|||
94640120|NCT01239368|324146688|FG005|Overall Study|Principal investigator discretion|2|||
94640121|NCT01239368|324146689|FG006|Overall Study|Principal investigator discretion|0|||
94640122|NCT01239368|324146690|FG007|Overall Study|Principal investigator discretion|0|||
94640123|NCT01239368|324146691|FG008|Overall Study|Principal investigator discretion|0|||
94640124|NCT01239368|324146692|FG009|Overall Study|Principal investigator discretion|1|||
94640125|NCT01239368|324146683|FG000|Overall Study|Disease progression on study|1|||
94640126|NCT01239368|324146684|FG001|Overall Study|Disease progression on study|1|||
94640127|NCT01239368|324146685|FG002|Overall Study|Disease progression on study|1|||
94640128|NCT01239368|324146686|FG003|Overall Study|Disease progression on study|1|||
94640129|NCT01239368|324146687|FG004|Overall Study|Disease progression on study|4|||
94640130|NCT01239368|324146688|FG005|Overall Study|Disease progression on study|2|||
94640131|NCT01239368|324146689|FG006|Overall Study|Disease progression on study|5|||
94640132|NCT01239368|324146690|FG007|Overall Study|Disease progression on study|0|||
94640133|NCT01239368|324146691|FG008|Overall Study|Disease progression on study|0|||
94640134|NCT01239368|324146692|FG009|Overall Study|Disease progression on study|2|||
94640135|NCT01239368|324146683|FG000|Overall Study|Refused further treatment|0|||
94640136|NCT01239368|324146684|FG001|Overall Study|Refused further treatment|0|||
94640137|NCT01239368|324146685|FG002|Overall Study|Refused further treatment|0|||
94640138|NCT01239368|324146686|FG003|Overall Study|Refused further treatment|0|||
94640139|NCT01239368|324146687|FG004|Overall Study|Refused further treatment|0|||
94640140|NCT01239368|324146688|FG005|Overall Study|Refused further treatment|0|||
94640141|NCT01239368|324146689|FG006|Overall Study|Refused further treatment|0|||
94640142|NCT01239368|324146690|FG007|Overall Study|Refused further treatment|0|||
94640143|NCT01239368|324146691|FG008|Overall Study|Refused further treatment|0|||
94640144|NCT01239368|324146692|FG009|Overall Study|Refused further treatment|1|||
94640145|NCT01239368|324146683|FG000|Overall Study|Death|0|||
94640146|NCT01239368|324146684|FG001|Overall Study|Death|0|||
94640147|NCT01239368|324146685|FG002|Overall Study|Death|0|||
94640148|NCT01239368|324146686|FG003|Overall Study|Death|0|||
94640149|NCT01239368|324146687|FG004|Overall Study|Death|0|||
94640150|NCT01239368|324146688|FG005|Overall Study|Death|0|||
94640151|NCT01239368|324146689|FG006|Overall Study|Death|1|||
94640152|NCT01239368|324146690|FG007|Overall Study|Death|0|||
94640153|NCT01239368|324146691|FG008|Overall Study|Death|0|||
94640154|NCT01239368|324146692|FG009|Overall Study|Death|0|||
94640155|NCT00489853|324146696|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
94640156|NCT00489853|324146697|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
94640157|NCT00489853|324146698|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
94640158|NCT00489853|324146696|FG000|Wash-out Period 1|Adverse Event|0|||
94640159|NCT00489853|324146697|FG001|Wash-out Period 1|Adverse Event|1|||
94640160|NCT00489853|324146698|FG002|Wash-out Period 1|Adverse Event|1|||
94640161|NCT00489853|324146696|FG000|Wash-out Period 1|Protocol Violation|0|||
94640162|NCT00489853|324146697|FG001|Wash-out Period 1|Protocol Violation|1|||
94640163|NCT00489853|324146698|FG002|Wash-out Period 1|Protocol Violation|1|||
94640164|NCT00489853|324146696|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
94640165|NCT00489853|324146697|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
94640166|NCT00489853|324146698|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
94640167|NCT00489853|324146696|FG000|Wash-out Period 2|Adverse Event|1|||
94640168|NCT00489853|324146697|FG001|Wash-out Period 2|Adverse Event|1|||
94640169|NCT00489853|324146698|FG002|Wash-out Period 2|Adverse Event|0|||
94640170|NCT00489853|324146696|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
94640171|NCT00489853|324146697|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
94640172|NCT00489853|324146698|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
94640173|NCT00489853|324146696|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
94640174|NCT00489853|324146697|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
94640175|NCT00489853|324146698|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
94640176|NCT00644969|324146700|FG000|Treatment Phase|Randomized, not treated|1|||
94640177|NCT00644969|324146701|FG001|Treatment Phase|Randomized, not treated|0|||
94640178|NCT00644969|324146700|FG000|Treatment Phase|Adverse Event|3|||
94640179|NCT00644969|324146701|FG001|Treatment Phase|Adverse Event|0|||
94640180|NCT00644969|324146700|FG000|Treatment Phase|Withdrawal by Subject|4|||
94640181|NCT00644969|324146701|FG001|Treatment Phase|Withdrawal by Subject|0|||
94640182|NCT00644969|324146700|FG000|Treatment Phase|Lost to Follow-up|2|||
94640183|NCT00644969|324146701|FG001|Treatment Phase|Lost to Follow-up|2|||
94640184|NCT00644969|324146700|FG000|Treatment Phase|Other|4|||
94640185|NCT00644969|324146701|FG001|Treatment Phase|Other|1|||
94640186|NCT00644969|324146700|FG000|Post Treatment Phase|Death|1|||
94640187|NCT00644969|324146701|FG001|Post Treatment Phase|Death|0|||
94640188|NCT00644969|324146700|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
94640189|NCT00644969|324146701|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
94640190|NCT00644969|324146700|FG000|Post Treatment Phase|Lost to Follow-up|4|||
94640191|NCT00644969|324146701|FG001|Post Treatment Phase|Lost to Follow-up|1|||
94640192|NCT00644969|324146700|FG000|Post Treatment Phase|Other|1|||
94640193|NCT00644969|324146701|FG001|Post Treatment Phase|Other|0|||
94640194|NCT00902564|324146702|FG000|Overall Study|Withdrawal by Subject|2|||
94640195|NCT00277212|324146703|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
94640196|NCT00277212|324146704|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
94640197|NCT00277212|324146705|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
94640198|NCT00277212|324146703|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
94640199|NCT00277212|324146704|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
94640200|NCT00277212|324146705|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
94640201|NCT00277212|324146703|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
94640202|NCT00277212|324146704|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
94640203|NCT00277212|324146705|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
94640204|NCT00277212|324146703|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
94640205|NCT00277212|324146704|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
94640206|NCT00277212|324146705|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
94640207|NCT00277212|324146703|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
94640208|NCT00277212|324146704|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
94640209|NCT00277212|324146705|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
94640210|NCT00277212|324146703|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
94640211|NCT00277212|324146704|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
94640212|NCT00277212|324146705|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
94640213|NCT00277212|324146703|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
94640214|NCT00277212|324146704|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
94640215|NCT00277212|324146705|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
94640216|NCT00277212|324146703|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
94640217|NCT00277212|324146704|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
94640218|NCT00277212|324146705|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
94640219|NCT00277212|324146703|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
94640220|NCT00277212|324146704|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
94640221|NCT00277212|324146705|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
94640222|NCT00277212|324146703|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
94640223|NCT00277212|324146704|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
94640224|NCT00277212|324146705|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
94640225|NCT00277212|324146703|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
94640226|NCT00277212|324146704|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
94640227|NCT00277212|324146705|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
94640228|NCT00277212|324146703|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
94640229|NCT00277212|324146704|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
94640230|NCT00277212|324146705|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
94640231|NCT00277212|324146703|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
94640232|NCT00277212|324146704|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
94640233|NCT00277212|324146705|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
94640234|NCT00277212|324146703|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
94640235|NCT00277212|324146704|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
94640236|NCT00277212|324146705|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
94640237|NCT00277212|324146703|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
94640238|NCT00277212|324146704|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
94640239|NCT00277212|324146705|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
94640240|NCT00277212|324146703|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
94640241|NCT00277212|324146704|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
94640242|NCT00277212|324146705|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
94640243|NCT00277212|324146703|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
94640244|NCT00277212|324146704|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
94640245|NCT00277212|324146705|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
94640246|NCT00277212|324146703|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
94640247|NCT00277212|324146704|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
94640248|NCT00277212|324146705|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
94640249|NCT05620576|324146711|FG000|Overall Study|Adverse Event|1|||
94640250|NCT05620576|324146712|FG001|Overall Study|Adverse Event|1|||
94640251|NCT05620576|324146711|FG000|Overall Study|Lost to Follow-up|3|||
94640252|NCT05620576|324146712|FG001|Overall Study|Lost to Follow-up|1|||
94640253|NCT05620576|324146711|FG000|Overall Study|Physician Decision|0|||
94640254|NCT05620576|324146712|FG001|Overall Study|Physician Decision|1|||
94640255|NCT05620576|324146711|FG000|Overall Study|Protocol Deviation|1|||
94640256|NCT05620576|324146712|FG001|Overall Study|Protocol Deviation|1|||
94640257|NCT05620576|324146711|FG000|Overall Study|Withdrawal by Subject|2|||
94640258|NCT05620576|324146712|FG001|Overall Study|Withdrawal by Subject|3|||
94640259|NCT03055013|324146713|FG000|Overall Study|Adverse Event|78|||
94677936|NCT02969525|324274901|FG011|Double-Blind Period|LOW EGFR|0|||
94640260|NCT03055013|324146714|FG001|Overall Study|Adverse Event|0|||
94640261|NCT03055013|324146713|FG000|Overall Study|Death|6|||
94362975|NCT00902486|323112911|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
94677937|NCT02969525|324274890|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
94677938|NCT02969525|324274891|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
94677939|NCT02969525|324274892|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
94677940|NCT02969525|324274893|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
94677941|NCT02969525|324274894|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
94677942|NCT02969525|324274895|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
94677943|NCT02969525|324274896|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
94677944|NCT02969525|324274897|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
94677945|NCT02969525|324274898|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
94677946|NCT02969525|324274899|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
94677947|NCT02969525|324274900|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
94677948|NCT02969525|324274901|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
94677949|NCT02969525|324274890|FG000|Dose-Blind Period|Adverse Event|0|||
94677950|NCT02969525|324274891|FG001|Dose-Blind Period|Adverse Event|0|||
94677951|NCT02969525|324274892|FG002|Dose-Blind Period|Adverse Event|0|||
94677952|NCT02969525|324274893|FG003|Dose-Blind Period|Adverse Event|0|||
94677953|NCT02969525|324274894|FG004|Dose-Blind Period|Adverse Event|0|||
94677954|NCT02969525|324274895|FG005|Dose-Blind Period|Adverse Event|0|||
94677955|NCT02969525|324274896|FG006|Dose-Blind Period|Adverse Event|0|||
94677956|NCT02969525|324274897|FG007|Dose-Blind Period|Adverse Event|0|||
94677957|NCT02969525|324274898|FG008|Dose-Blind Period|Adverse Event|0|||
94677958|NCT02969525|324274899|FG009|Dose-Blind Period|Adverse Event|1|||
94677959|NCT02969525|324274900|FG010|Dose-Blind Period|Adverse Event|1|||
94677960|NCT02969525|324274901|FG011|Dose-Blind Period|Adverse Event|1|||
94677961|NCT02969525|324274890|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
94677962|NCT02969525|324274891|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
94677963|NCT02969525|324274892|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
94677964|NCT02969525|324274893|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
94677965|NCT02969525|324274894|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
94677966|NCT02969525|324274895|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
94677967|NCT02969525|324274896|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
94677968|NCT02969525|324274897|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
94677969|NCT02969525|324274898|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
94677970|NCT02969525|324274899|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
94677971|NCT02969525|324274900|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
94677972|NCT02969525|324274901|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
94677973|NCT02969525|324274890|FG000|Dose-Blind Period|Non-cooperating patient|0|||
94677974|NCT02969525|324274891|FG001|Dose-Blind Period|Non-cooperating patient|0|||
94677975|NCT02969525|324274892|FG002|Dose-Blind Period|Non-cooperating patient|0|||
94677976|NCT02969525|324274893|FG003|Dose-Blind Period|Non-cooperating patient|0|||
94677977|NCT02969525|324274894|FG004|Dose-Blind Period|Non-cooperating patient|0|||
94677978|NCT02969525|324274895|FG005|Dose-Blind Period|Non-cooperating patient|0|||
94677979|NCT02969525|324274896|FG006|Dose-Blind Period|Non-cooperating patient|0|||
94677980|NCT02969525|324274897|FG007|Dose-Blind Period|Non-cooperating patient|0|||
94677981|NCT02969525|324274898|FG008|Dose-Blind Period|Non-cooperating patient|0|||
94677982|NCT02969525|324274899|FG009|Dose-Blind Period|Non-cooperating patient|0|||
94677983|NCT02969525|324274900|FG010|Dose-Blind Period|Non-cooperating patient|0|||
94677984|NCT02969525|324274901|FG011|Dose-Blind Period|Non-cooperating patient|1|||
94677985|NCT02969525|324274890|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
94677986|NCT02969525|324274891|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
94677987|NCT02969525|324274892|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
94677988|NCT02969525|324274893|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
94677989|NCT02969525|324274894|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
94362976|NCT00902486|323112912|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
94677990|NCT02969525|324274895|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
94677991|NCT02969525|324274896|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
94677992|NCT02969525|324274897|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
94677993|NCT02969525|324274898|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
94677994|NCT02969525|324274899|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
94362977|NCT00902486|323112913|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
94677995|NCT02969525|324274900|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
94677996|NCT02969525|324274901|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
94677997|NCT04398537|324274902|FG000|Overall Study|Physician Decision|10|||
94677998|NCT04398537|324274903|FG001|Overall Study|Physician Decision|15|||
94461905|NCT02203851|323481252|FG000|Overall Study|Lost to Follow-up|4|||
94640262|NCT03055013|324146714|FG001|Overall Study|Death|0|||
94640263|NCT03055013|324146713|FG000|Overall Study|Disease relapse|33|||
94640264|NCT03055013|324146714|FG001|Overall Study|Disease relapse|0|||
94640265|NCT03055013|324146713|FG000|Overall Study|Withdrawal by Subject|28|||
94640266|NCT03055013|324146714|FG001|Overall Study|Withdrawal by Subject|0|||
94640267|NCT03055013|324146713|FG000|Overall Study|Other complicating disease|5|||
94640268|NCT03055013|324146714|FG001|Overall Study|Other complicating disease|0|||
94640269|NCT03055013|324146713|FG000|Overall Study|Physician Decision|1|||
94640270|NCT03055013|324146714|FG001|Overall Study|Physician Decision|0|||
94640271|NCT03055013|324146713|FG000|Overall Study|Benign mass/non-RCC|4|||
94640272|NCT03055013|324146714|FG001|Overall Study|Benign mass/non-RCC|0|||
94640273|NCT03055013|324146713|FG000|Overall Study|Enrolled in another trial|1|||
94640274|NCT03055013|324146714|FG001|Overall Study|Enrolled in another trial|0|||
94640275|NCT03055013|324146713|FG000|Overall Study|Non-protocol therapy|1|||
94640276|NCT03055013|324146714|FG001|Overall Study|Non-protocol therapy|0|||
94640277|NCT03055013|324146713|FG000|Overall Study|Incompliance|1|||
94640278|NCT03055013|324146714|FG001|Overall Study|Incompliance|0|||
94640279|NCT03055013|324146713|FG000|Overall Study|Insurance issues|1|||
94640280|NCT03055013|324146714|FG001|Overall Study|Insurance issues|0|||
94640281|NCT03055013|324146713|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
94640282|NCT03055013|324146714|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
94640283|NCT03055013|324146713|FG000|Overall Study|Did not receive nivolumab|10|||
94640284|NCT03055013|324146714|FG001|Overall Study|Did not receive nivolumab|0|||
94640285|NCT03055013|324146713|FG000|Overall Study|Did not receive surgery|0|||
94640286|NCT03055013|324146714|FG001|Overall Study|Did not receive surgery|28|||
94640287|NCT03240133|324146715|FG000|Overall Study|Withdrawal by Subject|0|||
94640288|NCT03240133|324146716|FG001|Overall Study|Withdrawal by Subject|1|||
94640289|NCT03240133|324146717|FG002|Overall Study|Withdrawal by Subject|0|||
94640290|NCT03240133|324146715|FG000|Overall Study|Adverse Event|1|||
94640291|NCT03240133|324146716|FG001|Overall Study|Adverse Event|1|||
94640292|NCT03240133|324146717|FG002|Overall Study|Adverse Event|0|||
94640293|NCT03240133|324146715|FG000|Overall Study|Rash|1|||
94640294|NCT03240133|324146716|FG001|Overall Study|Rash|0|||
94640295|NCT03240133|324146717|FG002|Overall Study|Rash|0|||
94640296|NCT03240133|324146715|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
94640297|NCT03240133|324146716|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
94640298|NCT03240133|324146717|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
94640299|NCT03240133|324146715|FG000|Overall Study|Intercurrent illness.|0|||
94640300|NCT03240133|324146716|FG001|Overall Study|Intercurrent illness.|1|||
94640301|NCT03240133|324146717|FG002|Overall Study|Intercurrent illness.|0|||
94640302|NCT03240133|324146715|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
94640303|NCT03240133|324146716|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
94640304|NCT03240133|324146717|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
94640305|NCT03239470|324146718|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
94640306|NCT03239470|324146719|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
94640307|NCT04014075|324146720|FG000|Overall Study|Progressive Disease|53|||
94640308|NCT04014075|324146720|FG000|Overall Study|Adverse Event|15|||
94640309|NCT04014075|324146720|FG000|Overall Study|Clinical Progression|4|||
94640310|NCT04014075|324146720|FG000|Overall Study|Death|2|||
94640311|NCT04014075|324146720|FG000|Overall Study|Withdrawal by Subject|2|||
94640312|NCT04014075|324146720|FG000|Overall Study|Miscellaneous|2|||
94640313|NCT04014075|324146720|FG000|Overall Study|Physician Decision|1|||
94640314|NCT00116831|324146721|FG000|Overall Study|Adverse Event|14|||
94640315|NCT00116831|324146722|FG001|Overall Study|Adverse Event|16|||
94640316|NCT00116831|324146721|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
94640317|NCT00116831|324146722|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
94640318|NCT00116831|324146721|FG000|Overall Study|Lost to Follow-up|8|||
94640319|NCT00116831|324146722|FG001|Overall Study|Lost to Follow-up|6|||
94640320|NCT00116831|324146721|FG000|Overall Study|Protocol Violation|3|||
94640321|NCT00116831|324146722|FG001|Overall Study|Protocol Violation|6|||
94640322|NCT00116831|324146721|FG000|Overall Study|Hypoglycaemic events|1|||
94640323|NCT00116831|324146722|FG001|Overall Study|Hypoglycaemic events|0|||
94640324|NCT00116831|324146721|FG000|Overall Study|Low haemoglobin on screening|1|||
94640325|NCT00116831|324146722|FG001|Overall Study|Low haemoglobin on screening|0|||
94640326|NCT00116831|324146721|FG000|Overall Study|Withdrawn investigational product|1|||
94640327|NCT00116831|324146722|FG001|Overall Study|Withdrawn investigational product|0|||
94461906|NCT02203851|323481252|FG000|Overall Study|Withdrawal by Subject|6|||
94640328|NCT00116831|324146721|FG000|Overall Study|Withdrawal by Subject|32|||
94640329|NCT00116831|324146722|FG001|Overall Study|Withdrawal by Subject|32|||
94461907|NCT02203851|323481252|FG000|Overall Study|Other|1|||
94677999|NCT03535337|324274904|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
94678000|NCT03535337|324274905|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
94678001|NCT03535337|324274906|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
94678002|NCT03535337|324274907|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
94678003|NCT03535337|324274908|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
94678004|NCT03535337|324274909|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
94678005|NCT03535337|324274910|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
94678006|NCT03535337|324274911|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
94678007|NCT03535337|324274912|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
94678008|NCT03535337|324274913|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
94678009|NCT01529008|324276683|FG000|Bone Marrow Harvesting|Physician Decision|1|||
94678010|NCT01529008|324276684|FG001|Bone Marrow Harvesting|Physician Decision|1|||
94678011|NCT01529008|324276683|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
94678012|NCT01529008|324276684|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
94678013|NCT01529008|324276683|FG000|Treatment|Adverse Event|6|||
94678014|NCT01529008|324276684|FG001|Treatment|Adverse Event|0|||
94678015|NCT01529008|324276683|FG000|Treatment|Other|3|||
94678016|NCT01529008|324276684|FG001|Treatment|Other|1|||
94678017|NCT01529008|324276683|FG000|Efficacy Analysis|Protocol Violation|2|||
94678018|NCT01529008|324276684|FG001|Efficacy Analysis|Protocol Violation|0|||
94678019|NCT01529008|324276683|FG000|Efficacy Analysis|Physician Decision|0|||
94678020|NCT01529008|324276684|FG001|Efficacy Analysis|Physician Decision|1|||
94678021|NCT01529008|324276683|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
94678022|NCT01529008|324276684|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
94678023|NCT00861614|324276685|FG000|Overall Study|Disease Progression|182|||
94678024|NCT00861614|324276686|FG001|Overall Study|Disease Progression|263|||
94678025|NCT00861614|324276685|FG000|Overall Study|Study Drug Toxicity|79|||
94678026|NCT00861614|324276686|FG001|Overall Study|Study Drug Toxicity|6|||
94678027|NCT00861614|324276685|FG000|Overall Study|Death|32|||
94678028|NCT00861614|324276686|FG001|Overall Study|Death|19|||
94678029|NCT00861614|324276685|FG000|Overall Study|Adverse Event|27|||
94678030|NCT00861614|324276686|FG001|Overall Study|Adverse Event|23|||
94678031|NCT00861614|324276685|FG000|Overall Study|Withdrawal by Subject|34|||
94678032|NCT00861614|324276686|FG001|Overall Study|Withdrawal by Subject|35|||
94678033|NCT00861614|324276685|FG000|Overall Study|Other|17|||
94678034|NCT00861614|324276686|FG001|Overall Study|Other|22|||
94678035|NCT03391765|324276687|FG000|Overall Study|Adverse Event|2|||
94678036|NCT03391765|324276688|FG001|Overall Study|Adverse Event|0|||
94678037|NCT03391765|324276689|FG002|Overall Study|Adverse Event|0|||
94678038|NCT03391765|324276690|FG003|Overall Study|Adverse Event|2|||
94678039|NCT03391765|324276687|FG000|Overall Study|Withdrew consent|5|||
94678040|NCT03391765|324276688|FG001|Overall Study|Withdrew consent|7|||
94678041|NCT03391765|324276689|FG002|Overall Study|Withdrew consent|2|||
94678042|NCT03391765|324276690|FG003|Overall Study|Withdrew consent|5|||
94678043|NCT03391765|324276687|FG000|Overall Study|Other, not specified|44|||
94678044|NCT03391765|324276688|FG001|Overall Study|Other, not specified|38|||
94640330|NCT00116831|324146721|FG000|Overall Study|Insufficient therapeutic effect|0|||
94640331|NCT00116831|324146722|FG001|Overall Study|Insufficient therapeutic effect|1|||
94640332|NCT00116831|324146721|FG000|Overall Study|Missing data for participant|1|||
94640333|NCT00116831|324146722|FG001|Overall Study|Missing data for participant|0|||
94640334|NCT02780804|324146723|FG000|Overall Study|Death|1|||
94640335|NCT02780804|324146724|FG001|Overall Study|Death|0|||
94640336|NCT02780804|324146725|FG002|Overall Study|Death|0|||
94640337|NCT02780804|324146723|FG000|Overall Study|Lack of Efficacy|5|||
94640338|NCT02780804|324146724|FG001|Overall Study|Lack of Efficacy|8|||
94640339|NCT02780804|324146725|FG002|Overall Study|Lack of Efficacy|4|||
94678045|NCT03391765|324276689|FG002|Overall Study|Other, not specified|21|||
94678046|NCT03391765|324276690|FG003|Overall Study|Other, not specified|16|||
94678047|NCT01777321|324276691|FG000|Overall Study|Withdrawal by Subject|0|||
94678048|NCT01777321|324276692|FG001|Overall Study|Withdrawal by Subject|1|||
94678049|NCT04425902|324276693|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
94678050|NCT01493687|324276694|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
94678051|NCT01493687|324276695|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
94678052|NCT01493687|324276694|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
94678053|NCT01493687|324276695|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
94678054|NCT01493687|324276694|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
94678055|NCT01493687|324276695|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
94678056|NCT01493687|324276694|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
94678057|NCT01493687|324276695|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
94640340|NCT02780804|324146723|FG000|Overall Study|Physician Decision|0|||
94640341|NCT02780804|324146724|FG001|Overall Study|Physician Decision|0|||
94678058|NCT01493687|324276694|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
94678059|NCT01493687|324276695|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
94678060|NCT01493687|324276694|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
94678061|NCT01493687|324276695|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
94640342|NCT02780804|324146725|FG002|Overall Study|Physician Decision|2|||
94678062|NCT01493687|324276694|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
94678063|NCT01493687|324276695|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
94678064|NCT01493687|324276694|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
94678065|NCT01493687|324276695|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
94678066|NCT01493687|324276694|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
94678067|NCT01493687|324276695|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
94678068|NCT01493687|324276694|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
94678069|NCT01493687|324276695|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
94678070|NCT01493687|324276694|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
94678071|NCT01493687|324276695|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
94678072|NCT01493687|324276694|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
94678073|NCT01493687|324276695|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
94678074|NCT01493687|324276694|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
94678075|NCT01493687|324276695|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
94678076|NCT01493687|324276694|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
94678077|NCT01493687|324276695|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
94678078|NCT01493687|324276694|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
94678079|NCT01493687|324276695|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
94678080|NCT00521144|324276697|FG000|Overall Study|Not Treated|0|||
94678081|NCT00521144|324276698|FG001|Overall Study|Not Treated|0|||
94678082|NCT00521144|324276699|FG002|Overall Study|Not Treated|0|||
94678083|NCT00521144|324276700|FG003|Overall Study|Not Treated|1|||
94678084|NCT00521144|324276701|FG004|Overall Study|Not Treated|0|||
94678085|NCT00521144|324276697|FG000|Overall Study|Adverse Event|0|||
94678086|NCT00521144|324276698|FG001|Overall Study|Adverse Event|1|||
94678087|NCT00521144|324276699|FG002|Overall Study|Adverse Event|0|||
94678088|NCT00521144|324276700|FG003|Overall Study|Adverse Event|0|||
94678089|NCT00521144|324276701|FG004|Overall Study|Adverse Event|1|||
94678090|NCT00521144|324276697|FG000|Overall Study|Progressive Disease|4|||
94678091|NCT00521144|324276698|FG001|Overall Study|Progressive Disease|2|||
94678092|NCT00521144|324276699|FG002|Overall Study|Progressive Disease|2|||
94678093|NCT00521144|324276700|FG003|Overall Study|Progressive Disease|0|||
94678094|NCT00521144|324276701|FG004|Overall Study|Progressive Disease|6|||
94678095|NCT01370525|324276702|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
94678096|NCT01370525|324276703|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
94678097|NCT01370525|324276702|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
94678098|NCT01370525|324276703|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
94678099|NCT01370525|324276702|FG000|Overall Study|Adverse Event|0|||
94678100|NCT01370525|324276703|FG001|Overall Study|Adverse Event|1|||
94678101|NCT01370525|324276702|FG000|Overall Study|Protocol Violation|2|||
94678102|NCT01370525|324276703|FG001|Overall Study|Protocol Violation|1|||
94678103|NCT01370525|324276702|FG000|Overall Study|Lost to follow up|2|||
94678104|NCT01370525|324276703|FG001|Overall Study|Lost to follow up|6|||
94678105|NCT00089141|324276707|FG000|Overall Study|Termination of trial|18|||
94678106|NCT00089141|324276708|FG001|Overall Study|Termination of trial|24|||
94678107|NCT00514683|324276709|FG000|Overall Study|Not treated|2|||
94678108|NCT00514683|324276710|FG001|Overall Study|Not treated|1|||
94678109|NCT00514683|324276711|FG002|Overall Study|Not treated|0|||
94678110|NCT00514683|324276712|FG003|Overall Study|Not treated|0|||
94678111|NCT00514683|324276713|FG004|Overall Study|Not treated|1|||
94678112|NCT00514683|324276709|FG000|Overall Study|Adverse Event|21|||
94678113|NCT00514683|324276710|FG001|Overall Study|Adverse Event|20|||
94678114|NCT00514683|324276711|FG002|Overall Study|Adverse Event|15|||
94678115|NCT00514683|324276712|FG003|Overall Study|Adverse Event|13|||
94678116|NCT00514683|324276713|FG004|Overall Study|Adverse Event|27|||
94678117|NCT00514683|324276709|FG000|Overall Study|Protocol Violation|1|||
94678118|NCT00514683|324276710|FG001|Overall Study|Protocol Violation|1|||
94678119|NCT00514683|324276711|FG002|Overall Study|Protocol Violation|0|||
94678120|NCT00514683|324276712|FG003|Overall Study|Protocol Violation|1|||
94678121|NCT00514683|324276713|FG004|Overall Study|Protocol Violation|0|||
94678122|NCT00514683|324276709|FG000|Overall Study|Withdrawal by Subject|2|||
94678123|NCT00514683|324276710|FG001|Overall Study|Withdrawal by Subject|2|||
94678124|NCT00514683|324276711|FG002|Overall Study|Withdrawal by Subject|1|||
94678125|NCT00514683|324276712|FG003|Overall Study|Withdrawal by Subject|0|||
94678126|NCT00514683|324276713|FG004|Overall Study|Withdrawal by Subject|4|||
94678127|NCT00514683|324276709|FG000|Overall Study|Reason other than listed above|0|||
94678128|NCT00514683|324276710|FG001|Overall Study|Reason other than listed above|1|||
94678129|NCT00514683|324276711|FG002|Overall Study|Reason other than listed above|2|||
94678130|NCT00514683|324276712|FG003|Overall Study|Reason other than listed above|0|||
94678131|NCT00514683|324276713|FG004|Overall Study|Reason other than listed above|1|||
94678132|NCT00335452|324276714|FG000|Overall Study|Death|156|||
94678133|NCT00335452|324276715|FG001|Overall Study|Death|144|||
94678134|NCT00335452|324276716|FG002|Overall Study|Death|158|||
94678135|NCT00335452|324276717|FG003|Overall Study|Death|129|||
94678136|NCT00335452|324276714|FG000|Overall Study|Lost to Follow-up|2|||
94640343|NCT02780804|324146723|FG000|Overall Study|Withdrawal by Subject|0|||
94640344|NCT02780804|324146724|FG001|Overall Study|Withdrawal by Subject|1|||
94640345|NCT02780804|324146725|FG002|Overall Study|Withdrawal by Subject|0|||
94640346|NCT02584504|324146728|FG000|Double-blind Treatment|Participant withdrew consent|0|||
94640347|NCT02584504|324146729|FG001|Double-blind Treatment|Participant withdrew consent|0|||
94640348|NCT02584504|324146730|FG002|Double-blind Treatment|Participant withdrew consent|1|||
94640349|NCT02584504|324146728|FG000|Double-blind Treatment|Adverse Event|0|||
94640350|NCT02584504|324146729|FG001|Double-blind Treatment|Adverse Event|1|||
94640351|NCT02584504|324146730|FG002|Double-blind Treatment|Adverse Event|0|||
94640352|NCT02584504|324146728|FG000|Double-blind Treatment|Family Matter|0|||
94640353|NCT02584504|324146729|FG001|Double-blind Treatment|Family Matter|1|||
94640354|NCT02584504|324146730|FG002|Double-blind Treatment|Family Matter|0|||
94640355|NCT02584504|324146728|FG000|Open-label Treatment|Participant withdrew consent|0|||
94640356|NCT02584504|324146729|FG001|Open-label Treatment|Participant withdrew consent|0|||
94640357|NCT02584504|324146730|FG002|Open-label Treatment|Participant withdrew consent|4|||
94640358|NCT02584504|324146728|FG000|Open-label Treatment|Adverse Event|2|||
94640359|NCT02584504|324146729|FG001|Open-label Treatment|Adverse Event|2|||
94640360|NCT02584504|324146730|FG002|Open-label Treatment|Adverse Event|3|||
94640361|NCT02584504|324146728|FG000|Open-label Treatment|Physician Decision|0|||
94640362|NCT02584504|324146729|FG001|Open-label Treatment|Physician Decision|1|||
94640363|NCT02584504|324146730|FG002|Open-label Treatment|Physician Decision|0|||
94640364|NCT02584504|324146728|FG000|Open-label Treatment|Entered but not treated|0|||
94640365|NCT02584504|324146729|FG001|Open-label Treatment|Entered but not treated|1|||
94640366|NCT02584504|324146730|FG002|Open-label Treatment|Entered but not treated|1|||
94640367|NCT00539838|324146731|FG000|Overall Study|Fail to return|2|||
94640368|NCT00539838|324146732|FG001|Overall Study|Fail to return|0|||
94640369|NCT00539838|324146733|FG002|Overall Study|Fail to return|0|||
94640370|NCT00539838|324146731|FG000|Overall Study|Withdrawal by Subject|0|||
94640371|NCT00539838|324146732|FG001|Overall Study|Withdrawal by Subject|4|||
94640372|NCT00539838|324146733|FG002|Overall Study|Withdrawal by Subject|0|||
94640373|NCT00539838|324146731|FG000|Overall Study|Death|0|||
94640374|NCT00539838|324146732|FG001|Overall Study|Death|2|||
94640375|NCT00539838|324146733|FG002|Overall Study|Death|0|||
94640376|NCT00539838|324146731|FG000|Overall Study|Did not cooperate|1|||
94640377|NCT00539838|324146732|FG001|Overall Study|Did not cooperate|0|||
94640378|NCT00539838|324146733|FG002|Overall Study|Did not cooperate|1|||
94640379|NCT00539838|324146731|FG000|Overall Study|Administrative|4|||
94640380|NCT00539838|324146732|FG001|Overall Study|Administrative|0|||
94640381|NCT00539838|324146733|FG002|Overall Study|Administrative|8|||
94640382|NCT02731729|324146734|FG000|Overall Study|Death|2|||
94640383|NCT02731729|324146735|FG001|Overall Study|Death|2|||
94640384|NCT02731729|324146734|FG000|Overall Study|Study terminated by Sponsor|6|||
94640385|NCT02731729|324146735|FG001|Overall Study|Study terminated by Sponsor|6|||
94640386|NCT02731729|324146734|FG000|Overall Study|Withdrawal by Subject|1|||
94640387|NCT02731729|324146735|FG001|Overall Study|Withdrawal by Subject|0|||
94640388|NCT05071183|324146747|FG000|Overall Study|Death|1|||
94640389|NCT05071183|324146748|FG001|Overall Study|Death|2|||
94640390|NCT05071183|324146749|FG002|Overall Study|Death|0|||
94640391|NCT05071183|324146747|FG000|Overall Study|Other Reasons|1|||
94640392|NCT05071183|324146748|FG001|Overall Study|Other Reasons|3|||
94640393|NCT05071183|324146749|FG002|Overall Study|Other Reasons|2|||
94640394|NCT02046148|324146750|FG000|Overall Study|Lost to Follow-up|1|||
94640395|NCT02046148|324146751|FG001|Overall Study|Lost to Follow-up|1|||
94640396|NCT02046148|324146750|FG000|Overall Study|Withdrawal by Subject|0|||
94640397|NCT02046148|324146751|FG001|Overall Study|Withdrawal by Subject|2|||
94640398|NCT02532647|324146758|FG000|Overall Study|Did not receive trial medication|1|||
94640399|NCT02532647|324146759|FG001|Overall Study|Did not receive trial medication|0|||
94640400|NCT02532647|324146760|FG002|Overall Study|Did not receive trial medication|1|||
94640401|NCT02211131|324146761|FG000|Overall Study|Death|26|||
94640402|NCT02211131|324146762|FG001|Overall Study|Death|16|||
94640403|NCT02211131|324146761|FG000|Overall Study|Lost to Follow-up|4|||
94640404|NCT02211131|324146762|FG001|Overall Study|Lost to Follow-up|3|||
94640405|NCT02211131|324146761|FG000|Overall Study|Decision by Sponsor|1|||
94640406|NCT02211131|324146762|FG001|Overall Study|Decision by Sponsor|1|||
94640407|NCT02211131|324146761|FG000|Overall Study|Withdrawal by Subject|3|||
94640408|NCT02211131|324146762|FG001|Overall Study|Withdrawal by Subject|8|||
94640409|NCT01549964|324146764|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
94640410|NCT01549964|324146765|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
94640411|NCT01549964|324146766|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
94640412|NCT01549964|324146767|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
94640413|NCT01549964|324146764|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
94640414|NCT01549964|324146765|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
94640415|NCT01549964|324146766|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
94640416|NCT01549964|324146767|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
94640417|NCT01549964|324146764|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
94640418|NCT01549964|324146765|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
94263168|NCT00763971|322758134|FG000|Overall Study|Moved to another country|0|||
94263169|NCT00763971|322758135|FG001|Overall Study|Moved to another country|1|||
94263170|NCT00763971|322758136|FG002|Overall Study|Moved to another country|0|||
94640419|NCT01549964|324146766|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
94640420|NCT01549964|324146767|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
94640421|NCT01549964|324146764|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
94640422|NCT01549964|324146765|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
94640423|NCT01549964|324146766|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
94640424|NCT01549964|324146767|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
94640425|NCT01549964|324146764|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
94640426|NCT01549964|324146765|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
94640427|NCT01549964|324146766|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
94640428|NCT01549964|324146767|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
94640429|NCT01549964|324146764|FG000|24-Week Treatment Period|Other|1|||
94640430|NCT01549964|324146765|FG001|24-Week Treatment Period|Other|0|||
94640431|NCT01549964|324146766|FG002|24-Week Treatment Period|Other|1|||
94640432|NCT01549964|324146767|FG003|24-Week Treatment Period|Other|0|||
94640433|NCT01549964|324146764|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
94640434|NCT01549964|324146765|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
94640435|NCT01549964|324146766|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
94640436|NCT01549964|324146767|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
94640437|NCT01549964|324146764|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
94640438|NCT01549964|324146765|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
94640439|NCT01549964|324146766|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
94640440|NCT01549964|324146767|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
94640441|NCT01549964|324146764|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
94640442|NCT01549964|324146765|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
94640443|NCT01549964|324146766|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
94640444|NCT01549964|324146767|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
94640445|NCT01549964|324146764|FG000|80-Week Extension Period|Pregnancy|0|||
94640446|NCT01549964|324146765|FG001|80-Week Extension Period|Pregnancy|0|||
94640447|NCT01549964|324146766|FG002|80-Week Extension Period|Pregnancy|1|||
94640448|NCT01549964|324146767|FG003|80-Week Extension Period|Pregnancy|0|||
94640449|NCT01549964|324146764|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
94640450|NCT01549964|324146765|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
94640451|NCT01549964|324146766|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
94640452|NCT01549964|324146767|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
94640453|NCT01549964|324146764|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
94640454|NCT01549964|324146765|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
94640455|NCT01549964|324146766|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
94640456|NCT01549964|324146767|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
94640457|NCT01549964|324146764|FG000|80-Week Extension Period|Lost to Follow-up|1|||
94640458|NCT01549964|324146765|FG001|80-Week Extension Period|Lost to Follow-up|0|||
94640459|NCT01549964|324146766|FG002|80-Week Extension Period|Lost to Follow-up|2|||
94640460|NCT01549964|324146767|FG003|80-Week Extension Period|Lost to Follow-up|1|||
94640461|NCT01549964|324146764|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
94640462|NCT01549964|324146765|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
94640463|NCT01549964|324146766|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
94640464|NCT01549964|324146767|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
94640465|NCT00634088|324146768|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
94640466|NCT00634088|324146769|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
94640467|NCT00634088|324146770|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
94640468|NCT00634088|324146771|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
94640469|NCT00634088|324146768|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
94640470|NCT00634088|324146769|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
94640471|NCT00634088|324146770|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
94640472|NCT00634088|324146771|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
94640473|NCT00634088|324146768|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
94640474|NCT00634088|324146769|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
94640475|NCT00634088|324146770|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
94640476|NCT00634088|324146771|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
94640477|NCT00634088|324146768|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
94640478|NCT00634088|324146769|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
94640479|NCT00634088|324146770|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
94640480|NCT00634088|324146771|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
94640481|NCT00634088|324146768|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
94640482|NCT00634088|324146769|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
94640483|NCT00634088|324146770|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
94640484|NCT00634088|324146771|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
94640485|NCT00634088|324146768|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
94640486|NCT00634088|324146769|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
94640487|NCT00634088|324146770|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
94640488|NCT00634088|324146771|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
94640489|NCT02290821|324146772|FG000|Overall Study|Withdrawal by Subject|1|||
94640490|NCT02290821|324146773|FG001|Overall Study|Withdrawal by Subject|1|||
94640491|NCT02290821|324146772|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
94640492|NCT02290821|324146773|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
94640493|NCT02290821|324146772|FG000|Overall Study|Lost to Follow-up|3|||
94640494|NCT02290821|324146773|FG001|Overall Study|Lost to Follow-up|2|||
94640495|NCT00235872|324146778|FG000|Overall Study|Adverse Event|34|||
94640496|NCT00235872|324146778|FG000|Overall Study|Death|1|||
94640497|NCT00235872|324146778|FG000|Overall Study|Lost to Follow-up|1|||
94640498|NCT00235872|324146778|FG000|Overall Study|Withdrawal by Subject|50|||
94640499|NCT00235872|324146778|FG000|Overall Study|Administrative reason|61|||
94640500|NCT02972632|324146779|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
94640501|NCT02972632|324146779|FG000|Overall Study|Lost to Follow-up|4|||
94640502|NCT02972632|324146779|FG000|Overall Study|Voluntary Withdrawal|10|||
94640503|NCT02418468|324146780|FG000|Overall Study|Adverse Event|1|||
94640504|NCT02418468|324146781|FG001|Overall Study|Adverse Event|0|||
94640505|NCT02418468|324146780|FG000|Overall Study|Withdrawal of informed consent|1|||
94640506|NCT02418468|324146781|FG001|Overall Study|Withdrawal of informed consent|1|||
94640507|NCT02932904|324146783|FG000|Overall Study|Reason not Specified|1|||
94640508|NCT02932904|324146784|FG001|Overall Study|Reason not Specified|0|||
94640509|NCT02932904|324146785|FG002|Overall Study|Reason not Specified|2|||
94640510|NCT02932904|324146786|FG003|Overall Study|Reason not Specified|2|||
94640511|NCT02932904|324146783|FG000|Overall Study|Noncompliance with Study Drug|2|||
94640512|NCT02932904|324146784|FG001|Overall Study|Noncompliance with Study Drug|3|||
94640513|NCT02932904|324146785|FG002|Overall Study|Noncompliance with Study Drug|3|||
94640514|NCT02932904|324146786|FG003|Overall Study|Noncompliance with Study Drug|4|||
94640515|NCT02932904|324146783|FG000|Overall Study|Pregnancy|0|||
94640516|NCT02932904|324146784|FG001|Overall Study|Pregnancy|1|||
94640517|NCT02932904|324146785|FG002|Overall Study|Pregnancy|1|||
94640518|NCT02932904|324146786|FG003|Overall Study|Pregnancy|0|||
94640519|NCT02932904|324146783|FG000|Overall Study|Study Termination|0|||
94640520|NCT02932904|324146784|FG001|Overall Study|Study Termination|1|||
94640521|NCT02932904|324146785|FG002|Overall Study|Study Termination|0|||
94640522|NCT02932904|324146786|FG003|Overall Study|Study Termination|0|||
94640523|NCT02932904|324146783|FG000|Overall Study|Voluntary Withdrawal|2|||
94640524|NCT02932904|324146784|FG001|Overall Study|Voluntary Withdrawal|1|||
94640525|NCT02932904|324146785|FG002|Overall Study|Voluntary Withdrawal|4|||
94640526|NCT02932904|324146786|FG003|Overall Study|Voluntary Withdrawal|2|||
94640527|NCT02932904|324146783|FG000|Overall Study|Lost to Follow-up|5|||
94640528|NCT02932904|324146784|FG001|Overall Study|Lost to Follow-up|3|||
94640529|NCT02932904|324146785|FG002|Overall Study|Lost to Follow-up|6|||
94640530|NCT02932904|324146786|FG003|Overall Study|Lost to Follow-up|0|||
94640531|NCT02932904|324146783|FG000|Overall Study|Significant Protocol Deviation|2|||
94640532|NCT02932904|324146784|FG001|Overall Study|Significant Protocol Deviation|3|||
94640533|NCT02932904|324146785|FG002|Overall Study|Significant Protocol Deviation|6|||
94640534|NCT02932904|324146786|FG003|Overall Study|Significant Protocol Deviation|1|||
94640535|NCT02932904|324146783|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
94640536|NCT02932904|324146784|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
94678137|NCT00335452|324276715|FG001|Overall Study|Lost to Follow-up|3|||
94640537|NCT02932904|324146785|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
94640538|NCT02932904|324146786|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
94640539|NCT02932904|324146783|FG000|Overall Study|Randomized But Not Treated|1|||
94678138|NCT00335452|324276716|FG002|Overall Study|Lost to Follow-up|1|||
94461908|NCT04161079|323481253|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
94640540|NCT02932904|324146784|FG001|Overall Study|Randomized But Not Treated|1|||
94678139|NCT00335452|324276717|FG003|Overall Study|Lost to Follow-up|2|||
94678140|NCT02736825|324276718|FG000|Overall Study|Lost to Follow-up|10|||
94461909|NCT03617861|323481254|FG000|Second Intervention (1 Day)|Adverse Event|0|||
94461910|NCT03617861|323481255|FG001|Second Intervention (1 Day)|Adverse Event|0|||
94678141|NCT02736825|324276719|FG001|Overall Study|Lost to Follow-up|11|||
94678142|NCT02736825|324276718|FG000|Overall Study|Early Termination|0|||
94678143|NCT02736825|324276719|FG001|Overall Study|Early Termination|1|||
94640541|NCT02932904|324146785|FG002|Overall Study|Randomized But Not Treated|0|||
94640542|NCT02932904|324146786|FG003|Overall Study|Randomized But Not Treated|2|||
94640543|NCT01577758|324146787|FG000|Dose Escalation Phase|Adverse Event|0|||
94640544|NCT01577758|324146788|FG001|Dose Escalation Phase|Adverse Event|0|||
94640545|NCT01577758|324146789|FG002|Dose Escalation Phase|Adverse Event|0|||
94640546|NCT01577758|324146790|FG003|Dose Escalation Phase|Adverse Event|0|||
94640547|NCT01577758|324146791|FG004|Dose Escalation Phase|Adverse Event|0|||
94640548|NCT01577758|324146792|FG005|Dose Escalation Phase|Adverse Event|2|||
94640549|NCT01577758|324146793|FG006|Dose Escalation Phase|Adverse Event|1|||
94640550|NCT01577758|324146794|FG007|Dose Escalation Phase|Adverse Event|0|||
94640551|NCT01577758|324146787|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
94640552|NCT01577758|324146788|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
94640553|NCT01577758|324146789|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
94640554|NCT01577758|324146790|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
94640555|NCT01577758|324146791|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
94640556|NCT01577758|324146792|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
94640557|NCT01577758|324146793|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
94640558|NCT01577758|324146794|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
94640559|NCT01577758|324146787|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
94640560|NCT01577758|324146788|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
94640561|NCT01577758|324146789|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
94640562|NCT01577758|324146790|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
94640563|NCT01577758|324146791|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
94640564|NCT01577758|324146792|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
94640565|NCT01577758|324146793|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
94640566|NCT01577758|324146794|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
94640567|NCT01577758|324146787|FG000|Dose Escalation Phase|Progression Disease|2|||
94640568|NCT01577758|324146788|FG001|Dose Escalation Phase|Progression Disease|2|||
94640569|NCT01577758|324146789|FG002|Dose Escalation Phase|Progression Disease|1|||
94640570|NCT01577758|324146790|FG003|Dose Escalation Phase|Progression Disease|2|||
94640571|NCT01577758|324146791|FG004|Dose Escalation Phase|Progression Disease|5|||
94640572|NCT01577758|324146792|FG005|Dose Escalation Phase|Progression Disease|0|||
94640573|NCT01577758|324146793|FG006|Dose Escalation Phase|Progression Disease|0|||
94640574|NCT01577758|324146794|FG007|Dose Escalation Phase|Progression Disease|0|||
94640575|NCT01577758|324146787|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
94640576|NCT01577758|324146788|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
94640577|NCT01577758|324146789|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
94640578|NCT01577758|324146790|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
94640579|NCT01577758|324146791|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
94640580|NCT01577758|324146792|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
94640581|NCT01577758|324146793|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
94640582|NCT01577758|324146794|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
94640583|NCT01577758|324146787|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
94640584|NCT01577758|324146788|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
94640585|NCT01577758|324146789|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
94640586|NCT01577758|324146790|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
94640587|NCT01577758|324146791|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
94640588|NCT01577758|324146792|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
94640589|NCT01577758|324146793|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
94640590|NCT01577758|324146794|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
94640591|NCT01577758|324146787|FG000|mCRC Expansion Phase|Progression Disease|0|||
94640592|NCT01577758|324146788|FG001|mCRC Expansion Phase|Progression Disease|0|||
94640593|NCT01577758|324146789|FG002|mCRC Expansion Phase|Progression Disease|0|||
94640594|NCT01577758|324146790|FG003|mCRC Expansion Phase|Progression Disease|0|||
94640595|NCT01577758|324146791|FG004|mCRC Expansion Phase|Progression Disease|0|||
94640596|NCT01577758|324146792|FG005|mCRC Expansion Phase|Progression Disease|0|||
94640597|NCT01577758|324146793|FG006|mCRC Expansion Phase|Progression Disease|0|||
94640598|NCT01577758|324146794|FG007|mCRC Expansion Phase|Progression Disease|19|||
94640599|NCT03792672|324146799|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
94640600|NCT03792672|324146800|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
94640601|NCT03792672|324146801|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
94640602|NCT03792672|324146802|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
94640603|NCT03792672|324146803|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
94640604|NCT03792672|324146804|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
94640605|NCT03792672|324146799|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
94640606|NCT03792672|324146800|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
94640607|NCT03792672|324146801|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
94640608|NCT03792672|324146802|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
94640609|NCT03792672|324146803|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
94640610|NCT03792672|324146804|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
94640611|NCT03792672|324146799|FG000|Treatment Period 4 (2 Days)|Other|1|||
94640612|NCT03792672|324146800|FG001|Treatment Period 4 (2 Days)|Other|0|||
94678144|NCT00790452|324276720|FG000|Overall Study|Drug supply issue|1|||
94678145|NCT00790452|324276721|FG001|Overall Study|Drug supply issue|0|||
94678146|NCT04082884|324276730|FG000|Overall Study|Withdrawal by Subject|1|||
94678147|NCT00387894|324276731|FG000|Overall Study|Withdrawal by Subject|1|||
94678148|NCT00827541|324276732|FG000|Overall Study|Exitus|1|||
94678149|NCT00827541|324276733|FG001|Overall Study|Exitus|8|||
94678150|NCT00827541|324276732|FG000|Overall Study|Other|1|||
94678151|NCT00827541|324276733|FG001|Overall Study|Other|3|||
94678152|NCT00827541|324276732|FG000|Overall Study|Pathogen not susceptible|1|||
94678153|NCT00827541|324276733|FG001|Overall Study|Pathogen not susceptible|0|||
94678154|NCT00827541|324276732|FG000|Overall Study|Lack of effectiveness|1|||
94678155|NCT00827541|324276733|FG001|Overall Study|Lack of effectiveness|0|||
94678156|NCT03642938|324276734|FG000|Overall Study|Withdrawal by Subject|0|||
94678157|NCT03642938|324276735|FG001|Overall Study|Withdrawal by Subject|0|||
94678158|NCT03642938|324276736|FG002|Overall Study|Withdrawal by Subject|0|||
94678159|NCT03642938|324276737|FG003|Overall Study|Withdrawal by Subject|1|||
94678160|NCT04439136|324276738|FG000|Overall Study|Ineligible|1|||
94678161|NCT04439136|324276738|FG000|Overall Study|Never Started Treatment|2|||
94678162|NCT04439136|324276738|FG000|Overall Study|Adverse Event|4|||
94678163|NCT04439136|324276738|FG000|Overall Study|Death|3|||
94678164|NCT04439136|324276738|FG000|Overall Study|Disease Progression|27|||
94678165|NCT04439136|324276738|FG000|Overall Study|Alternative Therapy|1|||
94678166|NCT04439136|324276738|FG000|Overall Study|Increased Tumor Burden|1|||
94678167|NCT04439136|324276738|FG000|Overall Study|Symptomatic Detrioration|1|||
94678168|NCT00742079|324276739|FG000|Overall Study|Lost to Follow-up|0|||
94678169|NCT00742079|324276740|FG001|Overall Study|Lost to Follow-up|1|||
94678170|NCT01964326|324276741|FG000|Overall Study|Adverse Event|48|||
94678171|NCT01964326|324276741|FG000|Overall Study|Death|2|||
94678172|NCT01964326|324276741|FG000|Overall Study|Protocol Violation|4|||
94678173|NCT01964326|324276741|FG000|Overall Study|Lost to Follow-up|88|||
94678174|NCT01964326|324276741|FG000|Overall Study|Withdrawal by Subject|87|||
94678175|NCT01964326|324276741|FG000|Overall Study|Pregnancy|1|||
94678176|NCT01964326|324276741|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
94678177|NCT01964326|324276741|FG000|Overall Study|Physician Decision|55|||
94678178|NCT01964326|324276741|FG000|Overall Study|Investigator Discretion|1|||
94678179|NCT01964326|324276741|FG000|Overall Study|Other|9|||
94678180|NCT01964326|324276741|FG000|Overall Study|Did not meet eligibility criteria|1|||
94678181|NCT02347657|324276742|FG000|Overall Study|Physician Decision|0|||
94678182|NCT02347657|324276743|FG001|Overall Study|Physician Decision|1|||
94678183|NCT02347657|324276742|FG000|Overall Study|Adverse Event|8|||
94678184|NCT02347657|324276743|FG001|Overall Study|Adverse Event|4|||
94678185|NCT02347657|324276742|FG000|Overall Study|Withdrawal by Subject|6|||
94678186|NCT02347657|324276743|FG001|Overall Study|Withdrawal by Subject|7|||
94678187|NCT02347657|324276742|FG000|Overall Study|Randomized but not treated|1|||
94678188|NCT02347657|324276743|FG001|Overall Study|Randomized but not treated|0|||
94678189|NCT02347657|324276742|FG000|Overall Study|Other|3|||
94678190|NCT02347657|324276743|FG001|Overall Study|Other|3|||
94678191|NCT01995539|324276744|FG000|Overall Study|Screening Failure|1|||
94678192|NCT01995539|324276744|FG000|Overall Study|Withdrawal by Investigator|15|||
94678193|NCT01995539|324276744|FG000|Overall Study|Withdrawal by Subject|11|||
94678194|NCT01995539|324276744|FG000|Overall Study|Lost to Follow-up|5|||
94678195|NCT01995539|324276744|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
94678196|NCT02013388|324276753|FG000|Overall Study|work emergency|1|||
94678197|NCT02013388|324276754|FG001|Overall Study|work emergency|0|||
94678198|NCT02013388|324276755|FG002|Overall Study|work emergency|0|||
94678199|NCT02013388|324276756|FG003|Overall Study|work emergency|0|||
94678200|NCT02013388|324276757|FG004|Overall Study|work emergency|1|||
94678201|NCT02013388|324276758|FG005|Overall Study|work emergency|0|||
94678202|NCT02013388|324276759|FG006|Overall Study|work emergency|0|||
94678203|NCT02013388|324276760|FG007|Overall Study|work emergency|0|||
94678204|NCT02093663|324276761|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
94678205|NCT02093663|324276762|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
94678206|NCT02093663|324276763|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
94678207|NCT02093663|324276764|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
94678208|NCT02093663|324276765|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
94678209|NCT02093663|324276761|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
94678210|NCT02093663|324276762|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
94678211|NCT02093663|324276763|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
94678212|NCT02093663|324276764|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
94678213|NCT02093663|324276765|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
94678214|NCT02093663|324276761|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
94678215|NCT02093663|324276762|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
94678216|NCT02093663|324276763|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
94678217|NCT02093663|324276764|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
94678218|NCT02093663|324276765|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
94678219|NCT02093663|324276761|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
94678220|NCT02093663|324276762|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
94678221|NCT02093663|324276763|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
94678222|NCT02093663|324276764|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
94678223|NCT02093663|324276765|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
94678224|NCT02093663|324276761|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
94678225|NCT02093663|324276762|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
94678226|NCT02093663|324276763|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
94678227|NCT02093663|324276764|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
94678228|NCT02093663|324276765|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
94678229|NCT02093663|324276761|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
94678230|NCT02093663|324276762|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
94678231|NCT02093663|324276763|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
94678232|NCT02093663|324276764|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
94678233|NCT02093663|324276765|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
94678234|NCT02093663|324276761|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
94678235|NCT02093663|324276762|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
94678236|NCT02093663|324276763|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
94678237|NCT02093663|324276764|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
94678238|NCT02093663|324276765|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
94678239|NCT02093663|324276761|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
94678240|NCT02093663|324276762|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
94678241|NCT02093663|324276763|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
94678242|NCT02093663|324276764|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
94678243|NCT02093663|324276765|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
94678244|NCT02093663|324276761|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
94678245|NCT02093663|324276762|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
94678246|NCT02093663|324276763|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
94678247|NCT02093663|324276764|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
94678248|NCT02093663|324276765|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
94678249|NCT04207840|324276766|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
94678250|NCT04207840|324276767|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
94678251|NCT04207840|324276768|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
94678252|NCT04207840|324276766|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
94678253|NCT04207840|324276767|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
94678254|NCT04207840|324276768|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
94678255|NCT00508404|324276771|FG000|Overall Study|Ongoing at Data Cut-off|12|||
94678256|NCT00508404|324276771|FG000|Overall Study|Adverse Event|2|||
94678257|NCT00508404|324276771|FG000|Overall Study|Death|16|||
94678258|NCT00508404|324276771|FG000|Overall Study|Physician Decision|2|||
94678259|NCT00508404|324276771|FG000|Overall Study|Withdrawal by Subject|3|||
94678260|NCT00508404|324276771|FG000|Overall Study|Protocol-specified Criteria|2|||
94678261|NCT00508404|324276771|FG000|Overall Study|Lost to Follow-up|2|||
94678262|NCT00508404|324276771|FG000|Overall Study|Other - Not Specified|3|||
94678263|NCT01538472|324276786|FG000|Overall Study|Disease Progression|3|||
94640613|NCT03792672|324146801|FG002|Treatment Period 4 (2 Days)|Other|0|||
94640614|NCT03792672|324146802|FG003|Treatment Period 4 (2 Days)|Other|0|||
94640615|NCT03792672|324146803|FG004|Treatment Period 4 (2 Days)|Other|0|||
94640616|NCT03792672|324146804|FG005|Treatment Period 4 (2 Days)|Other|0|||
94640617|NCT03373383|324146813|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
94640618|NCT03373383|324146814|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
94640619|NCT03373383|324146815|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
94640620|NCT03373383|324146816|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
94640621|NCT03373383|324146817|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
94678264|NCT01538472|324276786|FG000|Overall Study|Death|1|||
94678265|NCT04209725|324276787|FG000|Overall Study|Adverse Event|1|||
94678266|NCT01960725|324276788|FG000|Overall Study|Lost to Follow-up|4|||
94678267|NCT01960725|324276789|FG001|Overall Study|Lost to Follow-up|3|||
94678268|NCT01960725|324276788|FG000|Overall Study|Withdrawal by Subject|1|||
94678269|NCT01960725|324276789|FG001|Overall Study|Withdrawal by Subject|0|||
94678270|NCT01960725|324276788|FG000|Overall Study|unable to obtain blood sample|1|||
94678271|NCT01960725|324276789|FG001|Overall Study|unable to obtain blood sample|2|||
94678272|NCT02535364|324276792|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
94678273|NCT02535364|324276792|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
94678274|NCT02535364|324276792|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
94678275|NCT02535364|324276792|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
94678276|NCT02535364|324276792|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
94678277|NCT02535364|324276792|FG000|Part B Screening|Death|2|||
94678278|NCT02535364|324276792|FG000|Part B Screening|Physician Decision|1|||
94678279|NCT02535364|324276792|FG000|Part B Screening|Withdrawal by Subject|1|||
94640622|NCT03373383|324146813|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
94640623|NCT03373383|324146814|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
94640624|NCT03373383|324146815|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
94640625|NCT03373383|324146816|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
94640626|NCT03373383|324146817|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
94678280|NCT02535364|324276792|FG000|Part B Screening|Adverse Event|1|||
94678281|NCT02535364|324276792|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
94678282|NCT02535364|324276792|FG000|Study Treatment|Death|1|||
94678283|NCT02535364|324276792|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
94678284|NCT02535364|324276792|FG000|12-Month Follow-up Period|Disease progression|22|||
94678285|NCT02535364|324276792|FG000|12-Month Follow-up Period|Death|5|||
94640627|NCT03373383|324146813|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
94640628|NCT03373383|324146814|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
94640629|NCT03373383|324146815|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
94640630|NCT03373383|324146816|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
94640631|NCT03373383|324146817|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
94678286|NCT02535364|324276792|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
94640632|NCT03373383|324146813|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
94640633|NCT03373383|324146814|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
94640634|NCT03373383|324146815|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
94640635|NCT03373383|324146816|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
94640636|NCT03373383|324146817|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
94640637|NCT03373383|324146813|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
94640638|NCT03373383|324146814|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
94640639|NCT03373383|324146815|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
94640640|NCT03373383|324146816|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
94640641|NCT03373383|324146817|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
94640642|NCT03373383|324146813|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
94640643|NCT03373383|324146814|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
94640644|NCT03373383|324146815|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
94640645|NCT03373383|324146816|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
94640646|NCT03373383|324146817|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
94640647|NCT03373383|324146813|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
94640648|NCT03373383|324146814|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
94640649|NCT03373383|324146815|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
94640650|NCT03373383|324146816|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
94640651|NCT03373383|324146817|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
94640652|NCT03373383|324146813|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
94640653|NCT03373383|324146814|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
94640654|NCT03373383|324146815|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
94640655|NCT03373383|324146816|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
94640656|NCT03373383|324146817|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
94640657|NCT03373383|324146813|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
94640658|NCT03373383|324146814|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
94640659|NCT03373383|324146815|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
94640660|NCT03373383|324146816|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
94640661|NCT03373383|324146817|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
94640662|NCT02159521|324146818|FG000|Overall Study|Enrolled but not treated|3|||
94640663|NCT02159521|324146818|FG000|Overall Study|Withdrawal by Subject|7|||
94640664|NCT02159521|324146818|FG000|Overall Study|Lost to Follow-up|6|||
94640665|NCT02159521|324146818|FG000|Overall Study|Death|1|||
94640666|NCT02159521|324146818|FG000|Overall Study|Other than specified|1|||
94640667|NCT01324388|324146819|FG000|Part 1 of Study|Adverse Event|2|||
94640668|NCT01324388|324146820|FG001|Part 1 of Study|Adverse Event|0|||
94678287|NCT02535364|324276792|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
94640669|NCT01324388|324146821|FG002|Part 1 of Study|Adverse Event|0|||
94640670|NCT01324388|324146822|FG003|Part 1 of Study|Adverse Event|0|||
94678288|NCT02535364|324276792|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
94678289|NCT00571701|324276793|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
94678290|NCT00571701|324276794|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
94678291|NCT00571701|324276793|FG000|First Intervention 12 Months|Death|1|||
94640671|NCT01324388|324146819|FG000|Part 1 of Study|Protocol Violation|1|||
94640672|NCT01324388|324146820|FG001|Part 1 of Study|Protocol Violation|2|||
94640673|NCT01324388|324146821|FG002|Part 1 of Study|Protocol Violation|0|||
94640674|NCT01324388|324146822|FG003|Part 1 of Study|Protocol Violation|0|||
94640675|NCT01324388|324146819|FG000|Part 1 of Study|Physician Decision|1|||
94640676|NCT01324388|324146820|FG001|Part 1 of Study|Physician Decision|0|||
94640677|NCT01324388|324146821|FG002|Part 1 of Study|Physician Decision|0|||
94640678|NCT01324388|324146822|FG003|Part 1 of Study|Physician Decision|0|||
94640679|NCT01324388|324146819|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
94640680|NCT01324388|324146820|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
94640681|NCT01324388|324146821|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
94640682|NCT01324388|324146822|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
94640683|NCT01324388|324146819|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
94640684|NCT01324388|324146820|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
94640685|NCT01324388|324146821|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
94640686|NCT01324388|324146822|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
94640687|NCT00304356|324146826|FG000|Nitazoxanide|Physician Decision|5|||
94640688|NCT00304356|324146826|FG000|Nitazoxanide|Physician Decision|1|||
94640689|NCT00304356|324146826|FG000|Nitazoxanide|number is 0|1|||
94640690|NCT00304356|324146826|FG000|Nitazoxanide|Physician Decision|1|||
94640691|NCT00304356|324146826|FG000|Nitazoxanide|Physician Decision|1|||
94640692|NCT00304356|324146826|FG000|Nitazoxanide|Physician Decision|1|||
94640693|NCT00129129|324146827|FG000|Primary Phase|Adverse Event|2|||
94640694|NCT00129129|324146828|FG001|Primary Phase|Adverse Event|1|||
94640695|NCT00129129|324146829|FG002|Primary Phase|Adverse Event|0|||
94640696|NCT00129129|324146830|FG003|Primary Phase|Adverse Event|0|||
94640697|NCT00129129|324146831|FG004|Primary Phase|Adverse Event|0|||
94640698|NCT00129129|324146827|FG000|Primary Phase|Withdrawal by Subject|12|||
94640699|NCT00129129|324146828|FG001|Primary Phase|Withdrawal by Subject|10|||
94640700|NCT00129129|324146829|FG002|Primary Phase|Withdrawal by Subject|0|||
94640701|NCT00129129|324146830|FG003|Primary Phase|Withdrawal by Subject|0|||
94640702|NCT00129129|324146831|FG004|Primary Phase|Withdrawal by Subject|0|||
94640703|NCT00129129|324146827|FG000|Primary Phase|Migration from study area|1|||
94640704|NCT00129129|324146828|FG001|Primary Phase|Migration from study area|3|||
94640705|NCT00129129|324146829|FG002|Primary Phase|Migration from study area|0|||
94640706|NCT00129129|324146830|FG003|Primary Phase|Migration from study area|0|||
94640707|NCT00129129|324146831|FG004|Primary Phase|Migration from study area|0|||
94640708|NCT00129129|324146827|FG000|Primary Phase|Lost to Follow-up|8|||
94640709|NCT00129129|324146828|FG001|Primary Phase|Lost to Follow-up|6|||
94640710|NCT00129129|324146829|FG002|Primary Phase|Lost to Follow-up|0|||
94640711|NCT00129129|324146830|FG003|Primary Phase|Lost to Follow-up|0|||
94640712|NCT00129129|324146831|FG004|Primary Phase|Lost to Follow-up|0|||
94640713|NCT00129129|324146827|FG000|Primary Phase|Other|2|||
94640714|NCT00129129|324146828|FG001|Primary Phase|Other|5|||
94640715|NCT00129129|324146829|FG002|Primary Phase|Other|0|||
94640716|NCT00129129|324146830|FG003|Primary Phase|Other|0|||
94640717|NCT00129129|324146831|FG004|Primary Phase|Other|0|||
94640718|NCT00129129|324146827|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
94640719|NCT00129129|324146828|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
94640720|NCT00129129|324146829|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
94640721|NCT00129129|324146830|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
94640722|NCT00129129|324146831|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
94640723|NCT00129129|324146827|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
94640724|NCT00129129|324146828|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
94640725|NCT00129129|324146829|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
94640726|NCT00129129|324146830|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
94640727|NCT00129129|324146831|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
94640728|NCT00129129|324146827|FG000|Fourth Dose Phase|Migration from study area|0|||
94640729|NCT00129129|324146828|FG001|Fourth Dose Phase|Migration from study area|0|||
94678292|NCT00571701|324276794|FG001|First Intervention 12 Months|Death|0|||
94640730|NCT00129129|324146829|FG002|Fourth Dose Phase|Migration from study area|0|||
94640731|NCT00129129|324146830|FG003|Fourth Dose Phase|Migration from study area|0|||
94640732|NCT00129129|324146831|FG004|Fourth Dose Phase|Migration from study area|2|||
94640733|NCT00129129|324146827|FG000|Fourth Dose Phase|Other|0|||
94640734|NCT00129129|324146828|FG001|Fourth Dose Phase|Other|0|||
94640735|NCT00129129|324146829|FG002|Fourth Dose Phase|Other|0|||
94640736|NCT00129129|324146830|FG003|Fourth Dose Phase|Other|1|||
94640737|NCT00129129|324146831|FG004|Fourth Dose Phase|Other|1|||
94640738|NCT00129129|324146827|FG000|Fourth Dose Phase|Protocol Violation|0|||
94640739|NCT00129129|324146828|FG001|Fourth Dose Phase|Protocol Violation|0|||
94640740|NCT00129129|324146829|FG002|Fourth Dose Phase|Protocol Violation|0|||
94640741|NCT00129129|324146830|FG003|Fourth Dose Phase|Protocol Violation|1|||
94640742|NCT00129129|324146831|FG004|Fourth Dose Phase|Protocol Violation|0|||
94640743|NCT02140567|324146832|FG000|Overall Study|Problems with recording equipment|6|||
94640744|NCT01358357|324146835|FG000|Open Label Phase|Adverse Event|0|||
94640745|NCT01358357|324146836|FG001|Open Label Phase|Adverse Event|0|||
94640746|NCT01358357|324146837|FG002|Open Label Phase|Adverse Event|59|||
94640747|NCT01358357|324146835|FG000|Open Label Phase|Lack of Efficacy|0|||
94640748|NCT01358357|324146836|FG001|Open Label Phase|Lack of Efficacy|0|||
94640749|NCT01358357|324146837|FG002|Open Label Phase|Lack of Efficacy|107|||
94640750|NCT01358357|324146835|FG000|Open Label Phase|Lost to Follow-up|0|||
94640751|NCT01358357|324146836|FG001|Open Label Phase|Lost to Follow-up|0|||
94640752|NCT01358357|324146837|FG002|Open Label Phase|Lost to Follow-up|76|||
94640753|NCT01358357|324146835|FG000|Open Label Phase|Protocol Violation|0|||
94640754|NCT01358357|324146836|FG001|Open Label Phase|Protocol Violation|0|||
94640755|NCT01358357|324146837|FG002|Open Label Phase|Protocol Violation|45|||
94640756|NCT01358357|324146835|FG000|Open Label Phase|Withdrawal by Subject|0|||
94640757|NCT01358357|324146836|FG001|Open Label Phase|Withdrawal by Subject|0|||
94640758|NCT01358357|324146837|FG002|Open Label Phase|Withdrawal by Subject|112|||
94640759|NCT01358357|324146835|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
94640760|NCT01358357|324146836|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
94640761|NCT01358357|324146837|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
94640762|NCT01358357|324146835|FG000|Open Label Phase|Terminated at study completion|0|||
94640763|NCT01358357|324146836|FG001|Open Label Phase|Terminated at study completion|0|||
94640764|NCT01358357|324146837|FG002|Open Label Phase|Terminated at study completion|5|||
94640765|NCT01358357|324146835|FG000|Open Label Phase|Mood episode|0|||
94640766|NCT01358357|324146836|FG001|Open Label Phase|Mood episode|0|||
94640767|NCT01358357|324146837|FG002|Open Label Phase|Mood episode|42|||
94640768|NCT01358357|324146835|FG000|Double-Blind Phase|Adverse Event|8|||
94640769|NCT01358357|324146836|FG001|Double-Blind Phase|Adverse Event|5|||
94640770|NCT01358357|324146837|FG002|Double-Blind Phase|Adverse Event|0|||
94640771|NCT01358357|324146835|FG000|Double-Blind Phase|Lost to Follow-up|5|||
94640772|NCT01358357|324146836|FG001|Double-Blind Phase|Lost to Follow-up|7|||
94640773|NCT01358357|324146837|FG002|Double-Blind Phase|Lost to Follow-up|0|||
94640774|NCT01358357|324146835|FG000|Double-Blind Phase|Protocol Violation|1|||
94640775|NCT01358357|324146836|FG001|Double-Blind Phase|Protocol Violation|11|||
94640776|NCT01358357|324146837|FG002|Double-Blind Phase|Protocol Violation|0|||
94640777|NCT01358357|324146835|FG000|Double-Blind Phase|Protocol Violation|16|||
94640778|NCT01358357|324146836|FG001|Double-Blind Phase|Protocol Violation|12|||
94640779|NCT01358357|324146837|FG002|Double-Blind Phase|Protocol Violation|0|||
94640780|NCT01358357|324146835|FG000|Double-Blind Phase|Terminated at study completion|2|||
94640781|NCT01358357|324146836|FG001|Double-Blind Phase|Terminated at study completion|0|||
94640782|NCT01358357|324146837|FG002|Double-Blind Phase|Terminated at study completion|0|||
94640783|NCT01358357|324146835|FG000|Double-Blind Phase|Recurrence of mood event|48|||
94640784|NCT01358357|324146836|FG001|Double-Blind Phase|Recurrence of mood event|64|||
94640785|NCT01358357|324146837|FG002|Double-Blind Phase|Recurrence of mood event|0|||
94640786|NCT01358357|324146835|FG000|Double-Blind Phase|Administrative|0|||
94640787|NCT01358357|324146836|FG001|Double-Blind Phase|Administrative|1|||
94640788|NCT01358357|324146837|FG002|Double-Blind Phase|Administrative|0|||
94640789|NCT02590939|324146839|FG000|Overall Study|Withdrawal by Subject|3|||
94640790|NCT02590939|324146840|FG001|Overall Study|Withdrawal by Subject|1|||
94263171|NCT00763971|322758134|FG000|Overall Study|Subject wanted dose reduction|0|||
94640791|NCT02590939|324146839|FG000|Overall Study|Failed the nociceptive test|2|||
94640792|NCT02590939|324146840|FG001|Overall Study|Failed the nociceptive test|1|||
94640793|NCT05045144|324146846|FG000|Overall Study|Lost to Follow-up|3|||
94640794|NCT05045144|324146847|FG001|Overall Study|Lost to Follow-up|2|||
94640795|NCT05045144|324146848|FG002|Overall Study|Lost to Follow-up|3|||
94640796|NCT05045144|324146849|FG003|Overall Study|Lost to Follow-up|5|||
94640797|NCT05045144|324146850|FG004|Overall Study|Lost to Follow-up|13|||
94640798|NCT05045144|324146846|FG000|Overall Study|Withdrawal by Subject|0|||
94640799|NCT05045144|324146847|FG001|Overall Study|Withdrawal by Subject|1|||
94640800|NCT05045144|324146848|FG002|Overall Study|Withdrawal by Subject|0|||
94640801|NCT05045144|324146849|FG003|Overall Study|Withdrawal by Subject|0|||
94640802|NCT05045144|324146850|FG004|Overall Study|Withdrawal by Subject|0|||
94640803|NCT05045144|324146846|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94678293|NCT00571701|324276793|FG000|Second Intervention 12 Months|Adverse Event|0|||
94678294|NCT00571701|324276794|FG001|Second Intervention 12 Months|Adverse Event|1|||
94678295|NCT00571701|324276793|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
94678296|NCT00571701|324276794|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
94678297|NCT02634788|324276795|FG000|Overall Study|Adverse Event|0|||
94678298|NCT02634788|324276796|FG001|Overall Study|Adverse Event|8|||
94678299|NCT02634788|324276797|FG002|Overall Study|Adverse Event|3|||
94678300|NCT02634788|324276798|FG003|Overall Study|Adverse Event|1|||
94678301|NCT02634788|324276795|FG000|Overall Study|Lack of Efficacy|4|||
94678302|NCT02634788|324276796|FG001|Overall Study|Lack of Efficacy|0|||
94678303|NCT02634788|324276797|FG002|Overall Study|Lack of Efficacy|1|||
94678304|NCT02634788|324276798|FG003|Overall Study|Lack of Efficacy|4|||
94678305|NCT02634788|324276795|FG000|Overall Study|Lost to Follow-up|0|||
94678306|NCT02634788|324276796|FG001|Overall Study|Lost to Follow-up|1|||
94678307|NCT02634788|324276797|FG002|Overall Study|Lost to Follow-up|0|||
94678308|NCT02634788|324276798|FG003|Overall Study|Lost to Follow-up|0|||
94678309|NCT02634788|324276795|FG000|Overall Study|Withdrawal by Subject|0|||
94678310|NCT02634788|324276796|FG001|Overall Study|Withdrawal by Subject|1|||
94678311|NCT02634788|324276797|FG002|Overall Study|Withdrawal by Subject|1|||
94678312|NCT02634788|324276798|FG003|Overall Study|Withdrawal by Subject|0|||
94678313|NCT00855595|324276804|FG000|Overall Study|Withdrawal by Subject|1|||
94678314|NCT00855595|324276805|FG001|Overall Study|Withdrawal by Subject|2|||
94678315|NCT00855595|324276804|FG000|Overall Study|Lost to Follow-up|3|||
94678316|NCT00855595|324276805|FG001|Overall Study|Lost to Follow-up|3|||
94678317|NCT00855595|324276804|FG000|Overall Study|Adverse Event|1|||
94678318|NCT00855595|324276805|FG001|Overall Study|Adverse Event|1|||
94678319|NCT00855595|324276804|FG000|Overall Study|patient moved out of state|1|||
94678320|NCT00855595|324276805|FG001|Overall Study|patient moved out of state|0|||
94678321|NCT00855595|324276804|FG000|Overall Study|patient left country|0|||
94678322|NCT00855595|324276805|FG001|Overall Study|patient left country|1|||
94678323|NCT04555096|324276806|FG000|Overall Study|Death|4|||
94678324|NCT04555096|324276807|FG001|Overall Study|Death|4|||
94678325|NCT04555096|324276806|FG000|Overall Study|Withdrawal by Subject|1|||
94678326|NCT04555096|324276807|FG001|Overall Study|Withdrawal by Subject|0|||
94678327|NCT04555096|324276806|FG000|Overall Study|Other|0|||
94678328|NCT04555096|324276807|FG001|Overall Study|Other|1|||
94678329|NCT02496767|324276808|FG000|Open-label Lead-in Phase|Adverse Event|176|||
94678330|NCT02496767|324276809|FG001|Open-label Lead-in Phase|Adverse Event|0|||
94678331|NCT02496767|324276810|FG002|Open-label Lead-in Phase|Adverse Event|0|||
94678332|NCT02496767|324276811|FG003|Open-label Lead-in Phase|Adverse Event|0|||
94678333|NCT02496767|324276812|FG004|Open-label Lead-in Phase|Adverse Event|0|||
94678334|NCT02496767|324276813|FG005|Open-label Lead-in Phase|Adverse Event|0|||
94678335|NCT02496767|324276814|FG006|Open-label Lead-in Phase|Adverse Event|0|||
94678336|NCT02496767|324276815|FG007|Open-label Lead-in Phase|Adverse Event|0|||
94678337|NCT02496767|324276808|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
94678338|NCT02496767|324276809|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
94678339|NCT02496767|324276810|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
94678340|NCT02496767|324276811|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
94678341|NCT02496767|324276812|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
94678342|NCT02496767|324276813|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
94678343|NCT02496767|324276814|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
94678344|NCT02496767|324276815|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
94678345|NCT02496767|324276808|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
94678346|NCT02496767|324276809|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
94678347|NCT02496767|324276810|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
94678348|NCT02496767|324276811|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
94678349|NCT02496767|324276812|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
94678350|NCT02496767|324276813|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
94678351|NCT02496767|324276814|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
94678352|NCT02496767|324276815|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
94678353|NCT02496767|324276808|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
94678354|NCT02496767|324276809|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
94678355|NCT02496767|324276810|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
94678356|NCT02496767|324276811|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
94678357|NCT02496767|324276812|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
94461911|NCT03617861|323481256|FG002|Second Intervention (1 Day)|Adverse Event|1|||
94678358|NCT02496767|324276813|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
94678359|NCT02496767|324276814|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
94678360|NCT02496767|324276815|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
94678361|NCT02496767|324276808|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
94678362|NCT02496767|324276809|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
94678363|NCT02496767|324276810|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
94678364|NCT02496767|324276811|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
94678365|NCT02496767|324276812|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
94678366|NCT02496767|324276813|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
94678367|NCT02496767|324276814|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
94678368|NCT02496767|324276815|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
94678369|NCT02496767|324276808|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
94678370|NCT02496767|324276809|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
94678371|NCT02496767|324276810|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
94678372|NCT02496767|324276811|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
94678373|NCT02496767|324276812|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
94678374|NCT02496767|324276813|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
94678375|NCT02496767|324276814|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
94678376|NCT02496767|324276815|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
94678377|NCT02496767|324276808|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
94678378|NCT02496767|324276809|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
94678379|NCT02496767|324276810|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
94678380|NCT02496767|324276811|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
94678381|NCT02496767|324276812|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
94678382|NCT02496767|324276813|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
94678383|NCT02496767|324276814|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
94678384|NCT02496767|324276815|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
94678385|NCT02496767|324276808|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
94678386|NCT02496767|324276809|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
94678387|NCT02496767|324276810|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
94678388|NCT02496767|324276811|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
94678389|NCT02496767|324276812|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
94678390|NCT02496767|324276813|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
94678391|NCT02496767|324276814|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
94678392|NCT02496767|324276815|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
94678393|NCT02496767|324276808|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
94678394|NCT02496767|324276809|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
94678395|NCT02496767|324276810|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
94678396|NCT02496767|324276811|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
94678397|NCT02496767|324276812|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
94678398|NCT02496767|324276813|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
94678399|NCT02496767|324276814|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
94678400|NCT02496767|324276815|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
94678401|NCT02496767|324276808|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
94678402|NCT02496767|324276809|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
94678403|NCT02496767|324276810|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
94678404|NCT02496767|324276811|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
94678405|NCT02496767|324276812|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
94678406|NCT02496767|324276813|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
94678407|NCT02496767|324276814|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
94678408|NCT02496767|324276815|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
94678409|NCT02496767|324276808|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
94678410|NCT02496767|324276809|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
94678411|NCT02496767|324276810|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
94678412|NCT02496767|324276811|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
94678413|NCT02496767|324276812|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
94678414|NCT02496767|324276813|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
94678415|NCT02496767|324276814|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
94678416|NCT02496767|324276815|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
94678417|NCT02496767|324276808|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
94362978|NCT00902486|323112914|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
94362979|NCT00902486|323112915|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
94362980|NCT00902486|323112910|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
94362981|NCT00902486|323112911|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
94362982|NCT00902486|323112912|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
94640804|NCT05045144|324146847|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94640805|NCT05045144|324146848|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
94640806|NCT05045144|324146849|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94640807|NCT05045144|324146850|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94640808|NCT02385084|324146851|FG000|Period 2|Protocol Violation|0|||
94640809|NCT02385084|324146852|FG001|Period 2|Protocol Violation|0|||
94640810|NCT02385084|324146853|FG002|Period 2|Protocol Violation|1|||
94640811|NCT02385084|324146854|FG003|Period 2|Protocol Violation|0|||
94640812|NCT02385084|324146855|FG004|Period 2|Protocol Violation|0|||
94640813|NCT02385084|324146856|FG005|Period 2|Protocol Violation|0|||
94640814|NCT03886220|324146863|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
94640815|NCT03886220|324146864|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
94640816|NCT03886220|324146863|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
94640817|NCT03886220|324146864|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94640818|NCT03886220|324146863|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
94640819|NCT03886220|324146864|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
94640820|NCT00978068|324146869|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
94640821|NCT00978068|324146870|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
94640822|NCT00978068|324146869|FG000|Overall Study|Death|1|||
94640823|NCT00978068|324146870|FG001|Overall Study|Death|2|||
94640824|NCT00978068|324146869|FG000|Overall Study|Lost to Follow-up|1|||
94640825|NCT00978068|324146870|FG001|Overall Study|Lost to Follow-up|2|||
94640826|NCT00978068|324146869|FG000|Overall Study|Physician Decision|0|||
94640827|NCT00978068|324146870|FG001|Overall Study|Physician Decision|1|||
94640828|NCT00978068|324146869|FG000|Overall Study|Unable to Comply with Study|0|||
94640829|NCT00978068|324146870|FG001|Overall Study|Unable to Comply with Study|2|||
94640830|NCT02347189|324146871|FG000|Overall Study|No implant attempted of study device|9|||
94640831|NCT02347189|324146871|FG000|Overall Study|No primary outcome data available|2|||
94640832|NCT01165138|324146872|FG000|Overall Study|Adverse Event|0|||
94640833|NCT01165138|324146873|FG001|Overall Study|Adverse Event|1|||
94640834|NCT01165138|324146874|FG002|Overall Study|Adverse Event|0|||
94640835|NCT01165138|324146875|FG003|Overall Study|Adverse Event|2|||
94640836|NCT01165138|324146872|FG000|Overall Study|Lack of Efficacy|0|||
94640837|NCT01165138|324146873|FG001|Overall Study|Lack of Efficacy|32|||
94640838|NCT01165138|324146874|FG002|Overall Study|Lack of Efficacy|6|||
94640839|NCT01165138|324146875|FG003|Overall Study|Lack of Efficacy|7|||
94640840|NCT01165138|324146872|FG000|Overall Study|Protocol Violation|0|||
94640841|NCT01165138|324146873|FG001|Overall Study|Protocol Violation|7|||
94640842|NCT01165138|324146874|FG002|Overall Study|Protocol Violation|0|||
94640843|NCT01165138|324146875|FG003|Overall Study|Protocol Violation|2|||
94640844|NCT01165138|324146872|FG000|Overall Study|Lost to Follow-up|0|||
94640845|NCT01165138|324146873|FG001|Overall Study|Lost to Follow-up|0|||
94640846|NCT01165138|324146874|FG002|Overall Study|Lost to Follow-up|1|||
94640847|NCT01165138|324146875|FG003|Overall Study|Lost to Follow-up|2|||
94640848|NCT01165138|324146872|FG000|Overall Study|Physician Decision|0|||
94640849|NCT01165138|324146873|FG001|Overall Study|Physician Decision|6|||
94640850|NCT01165138|324146874|FG002|Overall Study|Physician Decision|7|||
94640851|NCT01165138|324146875|FG003|Overall Study|Physician Decision|6|||
94640852|NCT01165138|324146872|FG000|Overall Study|Withdrawal by Subject|0|||
94640853|NCT01165138|324146873|FG001|Overall Study|Withdrawal by Subject|6|||
94640854|NCT01165138|324146874|FG002|Overall Study|Withdrawal by Subject|6|||
94640855|NCT01165138|324146875|FG003|Overall Study|Withdrawal by Subject|3|||
94640856|NCT04964128|324146876|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
94640857|NCT04964128|324146876|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
94640858|NCT03320564|324146879|FG000|Overall Study|Protocol Violation|1|||
94640859|NCT01148511|324146880|FG000|Exposed to Study Drug|Protocol Violation|2|||
94640860|NCT01148511|324146881|FG001|Exposed to Study Drug|Protocol Violation|0|||
94640861|NCT01148511|324146882|FG002|Exposed to Study Drug|Protocol Violation|0|||
94640862|NCT01148511|324146880|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
94640863|NCT01148511|324146881|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
94640864|NCT01148511|324146882|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
94640865|NCT01148511|324146880|FG000|Randomized|Adverse Event|0|||
94640866|NCT01148511|324146881|FG001|Randomized|Adverse Event|1|||
94640867|NCT01148511|324146882|FG002|Randomized|Adverse Event|0|||
94640868|NCT01148511|324146880|FG000|Randomized|Protocol Violation|0|||
94640869|NCT01148511|324146881|FG001|Randomized|Protocol Violation|2|||
94640870|NCT01148511|324146882|FG002|Randomized|Protocol Violation|1|||
94640871|NCT01148511|324146880|FG000|Randomized|Lost to Follow-up|0|||
94640872|NCT01148511|324146881|FG001|Randomized|Lost to Follow-up|1|||
94640873|NCT01148511|324146882|FG002|Randomized|Lost to Follow-up|1|||
94640874|NCT01148511|324146880|FG000|Randomized|Consent withdrawal|0|||
94640875|NCT01148511|324146881|FG001|Randomized|Consent withdrawal|5|||
94640876|NCT01148511|324146882|FG002|Randomized|Consent withdrawal|3|||
94640877|NCT01148511|324146880|FG000|Randomized|Other|0|||
94640878|NCT01148511|324146881|FG001|Randomized|Other|1|||
94640879|NCT01148511|324146882|FG002|Randomized|Other|1|||
94640880|NCT00788827|324146883|FG000|Overall Study|Lack of Efficacy|2|||
94640881|NCT01527682|324146884|FG000|Overall Study|Protocol Violation|8|||
94640882|NCT03745144|324146886|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
94640883|NCT03745144|324146887|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
94640884|NCT03745144|324146888|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
94640885|NCT03745144|324146886|FG000|Period 1|Other|0|||
94640886|NCT03745144|324146887|FG001|Period 1|Other|0|||
94640887|NCT03745144|324146888|FG002|Period 1|Other|1|||
94640888|NCT03642717|324146889|FG000|Overall Study|Lost to Follow-up|2|||
94640889|NCT03642717|324146889|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
94640890|NCT03642717|324146889|FG000|Overall Study|Taken study drug prior to contract date|3|||
94640891|NCT03608774|324146890|FG000|Overall Study|Lost to Follow-up|5|||
94640892|NCT03608774|324146891|FG001|Overall Study|Lost to Follow-up|5|||
94640893|NCT03608774|324146890|FG000|Overall Study|Withdrawal by Subject|1|||
94640894|NCT03608774|324146891|FG001|Overall Study|Withdrawal by Subject|0|||
94640895|NCT03608774|324146890|FG000|Overall Study|Protocol Violation|1|||
94640896|NCT03608774|324146891|FG001|Overall Study|Protocol Violation|0|||
94640897|NCT03608774|324146890|FG000|Overall Study|Not eligible at enrollment|0|||
94640898|NCT03608774|324146891|FG001|Overall Study|Not eligible at enrollment|1|||
94640899|NCT03608774|324146890|FG000|Overall Study|Health related event|0|||
94640900|NCT03608774|324146891|FG001|Overall Study|Health related event|1|||
94640901|NCT00642668|324146892|FG000|Overall Study|Lost to Follow-up|1|||
94640902|NCT00642668|324146892|FG000|Overall Study|Adverse Event|2|||
94640903|NCT00642668|324146892|FG000|Overall Study|Death|2|||
94640904|NCT00642668|324146892|FG000|Overall Study|Insufficient Therapeutic Response|1|||
94640905|NCT00642668|324146892|FG000|Overall Study|Failure to Return|1|||
94640906|NCT00642668|324146892|FG000|Overall Study|Dialysis Initiation|5|||
94640907|NCT00642668|324146892|FG000|Overall Study|Blood Transfusion|2|||
94640908|NCT01177540|324146893|FG000|Overall Study|Adverse Event|1|||
94640909|NCT01177540|324146894|FG001|Overall Study|Adverse Event|0|||
94640910|NCT00896337|324146895|FG000|Overall Study|Death|7|||
94640911|NCT00896337|324146895|FG000|Overall Study|Withdrawal by Subject|7|||
94640912|NCT00896337|324146895|FG000|Overall Study|Lost to Follow-up|11|||
94640913|NCT01586819|324146896|FG000|Overall Study|Withdrawal by Subject|1|||
94640914|NCT01586819|324146897|FG001|Overall Study|Withdrawal by Subject|0|||
94640915|NCT00302458|324146898|FG000|Overall Study|Lost to Follow-up|1|||
94640916|NCT00302458|324146898|FG000|Overall Study|Ineligible after screening|1|||
94640917|NCT00302458|324146898|FG000|Overall Study|Withdrawal by Subject|1|||
94640918|NCT00026793|324146899|FG000|Overall Study|Death on study due to underlying disease|4|||
94640919|NCT00026793|324146899|FG000|Overall Study|Physician Decision|2|||
94640920|NCT00026793|324146899|FG000|Overall Study|Off study|2|||
94640921|NCT00066066|324148371|FG000|Overall Study|Lost to Follow-up|6|||
94640922|NCT00066066|324148372|FG001|Overall Study|Lost to Follow-up|4|||
94640923|NCT00066066|324148373|FG002|Overall Study|Lost to Follow-up|7|||
94640924|NCT00066066|324148374|FG003|Overall Study|Lost to Follow-up|4|||
94640925|NCT00066066|324148375|FG004|Overall Study|Lost to Follow-up|3|||
94640926|NCT00066066|324148376|FG005|Overall Study|Lost to Follow-up|5|||
94640927|NCT05123222|324148381|FG000|Overall Study|Lost to Follow-up|2|||
94640928|NCT05123222|324148382|FG001|Overall Study|Lost to Follow-up|0|||
94640929|NCT05123222|324148383|FG002|Overall Study|Lost to Follow-up|0|||
94640930|NCT05123222|324148384|FG003|Overall Study|Lost to Follow-up|0|||
94640931|NCT05123222|324148381|FG000|Overall Study|Protocol Violation|0|||
94640932|NCT05123222|324148382|FG001|Overall Study|Protocol Violation|0|||
94640933|NCT05123222|324148383|FG002|Overall Study|Protocol Violation|1|||
94640934|NCT05123222|324148384|FG003|Overall Study|Protocol Violation|0|||
94640935|NCT02476968|324148388|FG000|Overall Study|Other|0|||
94640936|NCT02476968|324148389|FG001|Overall Study|Other|2|||
94640937|NCT02476968|324148390|FG002|Overall Study|Other|0|||
94640938|NCT02476968|324148388|FG000|Overall Study|Lost to Follow-up|10|||
94640939|NCT02476968|324148389|FG001|Overall Study|Lost to Follow-up|0|||
94640940|NCT02476968|324148390|FG002|Overall Study|Lost to Follow-up|1|||
94640941|NCT02476968|324148388|FG000|Overall Study|Death|48|||
94640942|NCT02476968|324148389|FG001|Overall Study|Death|8|||
94640943|NCT02476968|324148390|FG002|Overall Study|Death|1|||
94640944|NCT02476968|324148388|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
94640945|NCT02476968|324148389|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
94640946|NCT02476968|324148390|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
94640947|NCT02476968|324148388|FG000|Overall Study|Patient decision|37|||
94640948|NCT02476968|324148389|FG001|Overall Study|Patient decision|8|||
94640949|NCT02476968|324148390|FG002|Overall Study|Patient decision|0|||
94640950|NCT02120950|324148397|FG000|Overall Study|Adverse Event|5|||
94640951|NCT02120950|324148398|FG001|Overall Study|Adverse Event|4|||
94640952|NCT02120950|324148399|FG002|Overall Study|Adverse Event|3|||
94640953|NCT02120950|324148397|FG000|Overall Study|Death|3|||
94640954|NCT02120950|324148398|FG001|Overall Study|Death|0|||
94640955|NCT02120950|324148399|FG002|Overall Study|Death|1|||
94640956|NCT02120950|324148397|FG000|Overall Study|Withdrawal by Subject|6|||
94640957|NCT02120950|324148398|FG001|Overall Study|Withdrawal by Subject|3|||
94640958|NCT02120950|324148399|FG002|Overall Study|Withdrawal by Subject|2|||
94640959|NCT02120950|324148397|FG000|Overall Study|Protocol Violation|1|||
94640960|NCT02120950|324148398|FG001|Overall Study|Protocol Violation|1|||
94678418|NCT02496767|324276809|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
94678419|NCT02496767|324276810|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
94678420|NCT02496767|324276811|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
94678421|NCT02496767|324276812|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
94678422|NCT02496767|324276813|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
94678423|NCT02496767|324276814|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
94678424|NCT02496767|324276815|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
94678425|NCT02496767|324276808|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
94678426|NCT02496767|324276809|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
94678427|NCT02496767|324276810|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
94678428|NCT02496767|324276811|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
94640961|NCT02120950|324148399|FG002|Overall Study|Protocol Violation|7|||
94640962|NCT02120950|324148397|FG000|Overall Study|Other reasons|5|||
94640963|NCT02120950|324148398|FG001|Overall Study|Other reasons|4|||
94640964|NCT02120950|324148399|FG002|Overall Study|Other reasons|1|||
94640965|NCT02120950|324148397|FG000|Overall Study|Lost to Follow-up|0|||
94640966|NCT02120950|324148398|FG001|Overall Study|Lost to Follow-up|2|||
94640967|NCT02120950|324148399|FG002|Overall Study|Lost to Follow-up|1|||
94640968|NCT00325754|324148400|FG000|Overall Study|Adverse Event|4|||
94640969|NCT00325754|324148401|FG001|Overall Study|Adverse Event|1|||
94640970|NCT03450707|324148405|FG000|Overall Study|Outside enrollment window|4|||
94640971|NCT03450707|324148406|FG001|Overall Study|Outside enrollment window|1|||
94640972|NCT03450707|324148405|FG000|Overall Study|Death|1|||
94640973|NCT03450707|324148406|FG001|Overall Study|Death|0|||
94640974|NCT03450707|324148405|FG000|Overall Study|Indication for thiamine|1|||
94640975|NCT03450707|324148406|FG001|Overall Study|Indication for thiamine|1|||
94640976|NCT03450707|324148405|FG000|Overall Study|Evidence of traumatic brain injury|1|||
94640977|NCT03450707|324148406|FG001|Overall Study|Evidence of traumatic brain injury|0|||
94640978|NCT03450707|324148405|FG000|Overall Study|Following commands|0|||
94640979|NCT03450707|324148406|FG001|Overall Study|Following commands|3|||
94640980|NCT03450707|324148405|FG000|Overall Study|Lactate < 3.5|0|||
94640981|NCT03450707|324148406|FG001|Overall Study|Lactate < 3.5|2|||
94640982|NCT03450707|324148405|FG000|Overall Study|Rearrest with ECMO|0|||
94640983|NCT03450707|324148406|FG001|Overall Study|Rearrest with ECMO|1|||
94640984|NCT03450707|324148405|FG000|Overall Study|Indication for thiamine + head CT results|0|||
94640985|NCT03450707|324148406|FG001|Overall Study|Indication for thiamine + head CT results|1|||
94640986|NCT03450707|324148405|FG000|Overall Study|Family/patient goals of care|0|||
94640987|NCT03450707|324148406|FG001|Overall Study|Family/patient goals of care|1|||
94640988|NCT01232296|324148407|FG000|Overall Study|Adverse Event|24|||
94640989|NCT01232296|324148408|FG001|Overall Study|Adverse Event|12|||
94640990|NCT01232296|324148407|FG000|Overall Study|Physician Decision|1|||
94640991|NCT01232296|324148408|FG001|Overall Study|Physician Decision|1|||
94640992|NCT01232296|324148407|FG000|Overall Study|Progressive disease|43|||
94640993|NCT01232296|324148408|FG001|Overall Study|Progressive disease|61|||
94640994|NCT01232296|324148407|FG000|Overall Study|Study terminated by sponsor|0|||
94640995|NCT01232296|324148408|FG001|Overall Study|Study terminated by sponsor|1|||
94640996|NCT01232296|324148407|FG000|Overall Study|Technical problems|3|||
94640997|NCT01232296|324148408|FG001|Overall Study|Technical problems|0|||
94640998|NCT01232296|324148407|FG000|Overall Study|Subject/guardian decision|10|||
94640999|NCT01232296|324148408|FG001|Overall Study|Subject/guardian decision|2|||
94641000|NCT01232296|324148407|FG000|Overall Study|Death|1|||
94641001|NCT01232296|324148408|FG001|Overall Study|Death|6|||
94641002|NCT00481195|324148409|FG000|Overall Study|Adverse Event|16|||
94641003|NCT00481195|324148410|FG001|Overall Study|Adverse Event|11|||
94641004|NCT00481195|324148409|FG000|Overall Study|Lack of Efficacy|1|||
94641005|NCT00481195|324148410|FG001|Overall Study|Lack of Efficacy|3|||
94641006|NCT00481195|324148409|FG000|Overall Study|Lost to Follow-up|4|||
94641007|NCT00481195|324148410|FG001|Overall Study|Lost to Follow-up|6|||
94641008|NCT00481195|324148409|FG000|Overall Study|Physician Decision|3|||
94641009|NCT00481195|324148410|FG001|Overall Study|Physician Decision|1|||
94641010|NCT00481195|324148409|FG000|Overall Study|Protocol Violation|10|||
94641011|NCT00481195|324148410|FG001|Overall Study|Protocol Violation|7|||
94678429|NCT02496767|324276812|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
94678430|NCT02496767|324276813|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
94678431|NCT02496767|324276814|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
94678432|NCT02496767|324276815|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
94678433|NCT02496767|324276808|FG000|Double-blind, Withdrawal Phase|Death|0|||
94678434|NCT02496767|324276809|FG001|Double-blind, Withdrawal Phase|Death|0|||
94678435|NCT02496767|324276810|FG002|Double-blind, Withdrawal Phase|Death|0|||
94678436|NCT02496767|324276811|FG003|Double-blind, Withdrawal Phase|Death|0|||
94641012|NCT00481195|324148409|FG000|Overall Study|Withdrawal by Subject|3|||
94641013|NCT00481195|324148410|FG001|Overall Study|Withdrawal by Subject|9|||
94678437|NCT02496767|324276812|FG004|Double-blind, Withdrawal Phase|Death|0|||
94678438|NCT02496767|324276813|FG005|Double-blind, Withdrawal Phase|Death|0|||
94678439|NCT02496767|324276814|FG006|Double-blind, Withdrawal Phase|Death|1|||
94678440|NCT02496767|324276815|FG007|Double-blind, Withdrawal Phase|Death|2|||
94678441|NCT02496767|324276808|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
94678442|NCT02496767|324276809|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
94678443|NCT02496767|324276810|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
94678444|NCT02496767|324276811|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
94678445|NCT02496767|324276812|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
94678446|NCT02496767|324276813|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
94678447|NCT02496767|324276814|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
94678448|NCT02496767|324276815|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
94678449|NCT01281202|324276816|FG000|Overall Study|Adverse Event|2|||
94678450|NCT01281202|324276817|FG001|Overall Study|Adverse Event|0|||
94678451|NCT01281202|324276816|FG000|Overall Study|Withdrawal by Subject|2|||
94678452|NCT01281202|324276817|FG001|Overall Study|Withdrawal by Subject|2|||
94678453|NCT01281202|324276816|FG000|Overall Study|Protocol Violation|11|||
94678454|NCT01281202|324276817|FG001|Overall Study|Protocol Violation|10|||
94678455|NCT01281202|324276816|FG000|Overall Study|Administrative|2|||
94678456|NCT01281202|324276817|FG001|Overall Study|Administrative|8|||
94678457|NCT01281202|324276816|FG000|Overall Study|Lost to Follow-up|11|||
94678458|NCT01281202|324276817|FG001|Overall Study|Lost to Follow-up|13|||
94678459|NCT01281202|324276816|FG000|Overall Study|Incarceration|0|||
94678460|NCT01281202|324276817|FG001|Overall Study|Incarceration|3|||
94678461|NCT01060553|324276821|FG000|Overall Study|Lost to Follow-up|3|||
94678462|NCT01060553|324276822|FG001|Overall Study|Lost to Follow-up|5|||
94678463|NCT01060553|324276821|FG000|Overall Study|Withdrawal by Subject|5|||
94678464|NCT01060553|324276822|FG001|Overall Study|Withdrawal by Subject|5|||
94678465|NCT01060553|324276821|FG000|Overall Study|Lack of Efficacy|1|||
94678466|NCT01060553|324276822|FG001|Overall Study|Lack of Efficacy|0|||
94678467|NCT00733980|324276826|FG000|Overall Study|Adverse Event|5|||
94678468|NCT00733980|324276827|FG001|Overall Study|Adverse Event|2|||
94678469|NCT00733980|324276826|FG000|Overall Study|Lack of Efficacy|0|||
94678470|NCT00733980|324276827|FG001|Overall Study|Lack of Efficacy|1|||
94678471|NCT00733980|324276826|FG000|Overall Study|Protocol Violation|2|||
94678472|NCT00733980|324276827|FG001|Overall Study|Protocol Violation|1|||
94641014|NCT00481195|324148409|FG000|Overall Study|Miscellaneous|2|||
94641015|NCT00481195|324148410|FG001|Overall Study|Miscellaneous|2|||
94641016|NCT01505608|324148413|FG000|Phase I|Lack of Efficacy|0|||
94641017|NCT01505608|324148414|FG001|Phase I|Lack of Efficacy|4|||
94641018|NCT01505608|324148413|FG000|Phase I|Adverse Event|0|||
94641019|NCT01505608|324148414|FG001|Phase I|Adverse Event|1|||
94641020|NCT01505608|324148413|FG000|Phase I|Withdrawal by Subject|0|||
94641021|NCT01505608|324148414|FG001|Phase I|Withdrawal by Subject|1|||
94641022|NCT01505608|324148413|FG000|Phase II|Lack of Efficacy|2|||
94641023|NCT01505608|324148414|FG001|Phase II|Lack of Efficacy|1|||
94641024|NCT01505608|324148413|FG000|Phase II|Protocol Violation|0|||
94678473|NCT00733980|324276826|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
94678474|NCT00733980|324276827|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
94678475|NCT00733980|324276826|FG000|Overall Study|Lost to Follow-up|6|||
94678476|NCT00733980|324276827|FG001|Overall Study|Lost to Follow-up|11|||
94678477|NCT00733980|324276826|FG000|Overall Study|Physician Decision|2|||
94678478|NCT00733980|324276827|FG001|Overall Study|Physician Decision|3|||
94678479|NCT00733980|324276826|FG000|Overall Study|Withdrawal by Subject|6|||
94263172|NCT00763971|322758135|FG001|Overall Study|Subject wanted dose reduction|1|||
94263173|NCT00763971|322758136|FG002|Overall Study|Subject wanted dose reduction|0|||
94678480|NCT00733980|324276827|FG001|Overall Study|Withdrawal by Subject|2|||
94263174|NCT00763971|322758134|FG000|Overall Study|Lack of availability|0|||
94641025|NCT01505608|324148414|FG001|Phase II|Protocol Violation|1|||
94641026|NCT02738333|324148417|FG000|Overall Study|Death|1|||
94641027|NCT02738333|324148418|FG001|Overall Study|Death|0|||
94641028|NCT02738333|324148419|FG002|Overall Study|Death|0|||
94641029|NCT02738333|324148417|FG000|Overall Study|Lost to Follow-up|1|||
94678481|NCT02552238|324276828|FG000|Overall Study|Withdrawal by Subject|2|||
94678482|NCT02552238|324276828|FG000|Overall Study|Adverse Event|2|||
94678483|NCT02070484|324276829|FG000|Overall Study|Withdrawal by Subject|1|||
94678484|NCT02070484|324276830|FG001|Overall Study|Withdrawal by Subject|0|||
94678485|NCT00085202|324276831|FG000|Overall Study|Still on therapy|2|||
94678486|NCT00085202|324276832|FG001|Overall Study|Still on therapy|0|||
94678487|NCT00085202|324276831|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
94678488|NCT00085202|324276832|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
94678489|NCT00085202|324276831|FG000|Overall Study|Excessive toxicity|6|||
94678490|NCT00085202|324276832|FG001|Overall Study|Excessive toxicity|5|||
94678491|NCT00085202|324276831|FG000|Overall Study|Non-specified|3|||
94678492|NCT00085202|324276832|FG001|Overall Study|Non-specified|5|||
94678493|NCT00085202|324276831|FG000|Overall Study|Withdrawal by Subject|2|||
94678494|NCT00085202|324276832|FG001|Overall Study|Withdrawal by Subject|1|||
94678495|NCT00085202|324276831|FG000|Overall Study|Physician Decision|4|||
94678496|NCT00085202|324276832|FG001|Overall Study|Physician Decision|1|||
94678497|NCT00085202|324276831|FG000|Overall Study|Progressive disease|1|||
94678498|NCT00085202|324276832|FG001|Overall Study|Progressive disease|11|||
94678499|NCT03238300|324276833|FG000|Baseline (Before Intervention)|Physician Decision|0|||
94678500|NCT03238300|324276834|FG001|Baseline (Before Intervention)|Physician Decision|1|||
94678501|NCT03238300|324276833|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
94678502|NCT03238300|324276834|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
94678503|NCT03238300|324276833|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
94678504|NCT03238300|324276834|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
94678505|NCT03238300|324276833|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
94678506|NCT03238300|324276834|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
94678507|NCT00404495|324276840|FG000|Overall Study|Death|37|||
94678508|NCT00404495|324276841|FG001|Overall Study|Death|11|||
94678509|NCT00404495|324276840|FG000|Overall Study|Lost to Follow-up|5|||
94678510|NCT00404495|324276841|FG001|Overall Study|Lost to Follow-up|0|||
94678511|NCT00404495|324276840|FG000|Overall Study|Other|1|||
94678512|NCT00404495|324276841|FG001|Overall Study|Other|0|||
94678513|NCT00404495|324276840|FG000|Overall Study|Withdrawal by Subject|1|||
94678514|NCT00404495|324276841|FG001|Overall Study|Withdrawal by Subject|0|||
94678515|NCT03315130|324276842|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
94678516|NCT03315130|324276843|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
94678517|NCT03315130|324276844|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
94678518|NCT03315130|324276845|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
94678519|NCT03315130|324276842|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
94678520|NCT03315130|324276843|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
94678521|NCT03315130|324276844|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
94678522|NCT03315130|324276845|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
94678523|NCT03315130|324276842|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
94678524|NCT03315130|324276843|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
94678525|NCT03315130|324276844|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
94678526|NCT03315130|324276845|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
94678527|NCT03315130|324276842|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
94678528|NCT03315130|324276843|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
94678529|NCT03315130|324276844|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
94678530|NCT03315130|324276845|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
94678531|NCT03315130|324276842|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
94678532|NCT03315130|324276843|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
94678533|NCT03315130|324276844|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
94678534|NCT03315130|324276845|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
94678535|NCT03315130|324276842|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
94678536|NCT03315130|324276843|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
94678537|NCT03315130|324276844|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
94678538|NCT03315130|324276845|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
94678539|NCT00766675|324278771|FG000|Overall Study|Adverse Event|16|||
94678540|NCT00766675|324278771|FG000|Overall Study|Lost to Follow-up|2|||
94678541|NCT00766675|324278771|FG000|Overall Study|Withdrawal by Subject|11|||
94678542|NCT00766675|324278771|FG000|Overall Study|Protocol Violation|8|||
94678543|NCT00766675|324278771|FG000|Overall Study|Participant took prohibited medication|1|||
94678544|NCT00766675|324278771|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
94678545|NCT00766675|324278771|FG000|Overall Study|Insufficient therapy|1|||
94678546|NCT01984697|324278772|FG000|Overall Study|Adverse Event|0|||
94678547|NCT01984697|324278773|FG001|Overall Study|Adverse Event|0|||
94678548|NCT01984697|324278774|FG002|Overall Study|Adverse Event|2|||
94678549|NCT01984697|324278775|FG003|Overall Study|Adverse Event|0|||
94678550|NCT01984697|324278776|FG004|Overall Study|Adverse Event|0|||
94678551|NCT01984697|324278772|FG000|Overall Study|Lost to Follow-up|14|||
94678552|NCT01984697|324278773|FG001|Overall Study|Lost to Follow-up|5|||
94678553|NCT01984697|324278774|FG002|Overall Study|Lost to Follow-up|10|||
94678554|NCT01984697|324278775|FG003|Overall Study|Lost to Follow-up|6|||
94678555|NCT01984697|324278776|FG004|Overall Study|Lost to Follow-up|21|||
94641030|NCT02738333|324148418|FG001|Overall Study|Lost to Follow-up|0|||
94641031|NCT02738333|324148419|FG002|Overall Study|Lost to Follow-up|0|||
94641032|NCT04327999|324148422|FG000|Overall Study|Protocol Violation|1|||
94641033|NCT01293240|324148423|FG000|Overall Study|Noncompliance|2|||
94641034|NCT01520363|324148424|FG000|Overall Study|Withdrawal by Subject|2|||
94641035|NCT01520363|324148425|FG001|Overall Study|Withdrawal by Subject|0|||
94641036|NCT01256593|324148431|FG000|Overall Study|Protocol Violation|26|||
94641037|NCT01256593|324148431|FG000|Overall Study|No Drug Administration Information|2|||
94641038|NCT01256593|324148431|FG000|Overall Study|No Visit After Treatment|186|||
94641039|NCT03261947|324148432|FG000|Overall Study|Death|10|||
94641040|NCT03261947|324148433|FG001|Overall Study|Death|13|||
94641041|NCT03261947|324148434|FG002|Overall Study|Death|17|||
94641042|NCT03261947|324148435|FG003|Overall Study|Death|12|||
94641043|NCT03261947|324148436|FG004|Overall Study|Death|8|||
94641044|NCT03261947|324148432|FG000|Overall Study|Lost to Follow-up|0|||
94641045|NCT03261947|324148433|FG001|Overall Study|Lost to Follow-up|0|||
94641046|NCT03261947|324148434|FG002|Overall Study|Lost to Follow-up|2|||
94641047|NCT03261947|324148435|FG003|Overall Study|Lost to Follow-up|1|||
94641048|NCT03261947|324148436|FG004|Overall Study|Lost to Follow-up|0|||
94641049|NCT03261947|324148432|FG000|Overall Study|Withdrawal by Subject|0|||
94641050|NCT03261947|324148433|FG001|Overall Study|Withdrawal by Subject|0|||
94641051|NCT03261947|324148434|FG002|Overall Study|Withdrawal by Subject|3|||
94641052|NCT03261947|324148435|FG003|Overall Study|Withdrawal by Subject|0|||
94641053|NCT03261947|324148436|FG004|Overall Study|Withdrawal by Subject|1|||
94641054|NCT03261947|324148432|FG000|Overall Study|Site Terminated by Sponsor|0|||
94641055|NCT03261947|324148433|FG001|Overall Study|Site Terminated by Sponsor|0|||
94641056|NCT03261947|324148434|FG002|Overall Study|Site Terminated by Sponsor|4|||
94641057|NCT03261947|324148435|FG003|Overall Study|Site Terminated by Sponsor|7|||
94641058|NCT03261947|324148436|FG004|Overall Study|Site Terminated by Sponsor|5|||
94641059|NCT03261947|324148432|FG000|Overall Study|Reason not Specified|2|||
94641060|NCT03261947|324148433|FG001|Overall Study|Reason not Specified|0|||
94641061|NCT03261947|324148434|FG002|Overall Study|Reason not Specified|4|||
94641062|NCT03261947|324148435|FG003|Overall Study|Reason not Specified|1|||
94641063|NCT03261947|324148436|FG004|Overall Study|Reason not Specified|3|||
94641064|NCT00409617|324148437|FG000|Overall Study|Adverse Event|57|||
94641065|NCT00409617|324148437|FG000|Overall Study|Lack of Efficacy|54|||
94641066|NCT00409617|324148437|FG000|Overall Study|Lost to Follow-up|2|||
94641067|NCT00409617|324148437|FG000|Overall Study|Protocol Violation|24|||
94641068|NCT00409617|324148437|FG000|Overall Study|Withdrawal by Subject|8|||
94678556|NCT01984697|324278772|FG000|Overall Study|Physician Decision|3|||
94678557|NCT01984697|324278773|FG001|Overall Study|Physician Decision|0|||
94678558|NCT01984697|324278774|FG002|Overall Study|Physician Decision|0|||
94678559|NCT01984697|324278775|FG003|Overall Study|Physician Decision|1|||
94678560|NCT01984697|324278776|FG004|Overall Study|Physician Decision|0|||
94678561|NCT01984697|324278772|FG000|Overall Study|Protocol Violation|8|||
94678562|NCT01984697|324278773|FG001|Overall Study|Protocol Violation|5|||
94678563|NCT01984697|324278774|FG002|Overall Study|Protocol Violation|3|||
94678564|NCT01984697|324278775|FG003|Overall Study|Protocol Violation|2|||
94678565|NCT01984697|324278776|FG004|Overall Study|Protocol Violation|0|||
94678566|NCT01984697|324278772|FG000|Overall Study|Withdrawal by Subject|15|||
94678567|NCT01984697|324278773|FG001|Overall Study|Withdrawal by Subject|21|||
94678568|NCT01984697|324278774|FG002|Overall Study|Withdrawal by Subject|13|||
94678569|NCT01984697|324278775|FG003|Overall Study|Withdrawal by Subject|11|||
94678570|NCT01984697|324278776|FG004|Overall Study|Withdrawal by Subject|13|||
94678571|NCT01984697|324278772|FG000|Overall Study|Missed last follow-up visit|1|||
94678572|NCT01984697|324278773|FG001|Overall Study|Missed last follow-up visit|0|||
94678573|NCT01984697|324278774|FG002|Overall Study|Missed last follow-up visit|0|||
94678574|NCT01984697|324278775|FG003|Overall Study|Missed last follow-up visit|0|||
94678575|NCT01984697|324278776|FG004|Overall Study|Missed last follow-up visit|0|||
94263175|NCT00763971|322758135|FG001|Overall Study|Lack of availability|1|||
94263176|NCT00763971|322758136|FG002|Overall Study|Lack of availability|0|||
94263177|NCT00763971|322758134|FG000|Overall Study|Performed final visit on phone|0|||
94641069|NCT00409617|324148437|FG000|Overall Study|Administrative reasons|1|||
94641070|NCT00409617|324148437|FG000|Overall Study|Not described|14|||
94641071|NCT00149747|324148440|FG000|Overall Study|Death|1|||
94641072|NCT00149747|324148441|FG001|Overall Study|Death|0|||
94641073|NCT00149747|324148440|FG000|Overall Study|Withdrawal by Subject|3|||
94641074|NCT00149747|324148441|FG001|Overall Study|Withdrawal by Subject|3|||
94641075|NCT02689258|324148442|FG000|Overall Study|Subject Non-Compliance|0|||
94641076|NCT02689258|324148443|FG001|Overall Study|Subject Non-Compliance|1|||
94678576|NCT01984697|324278772|FG000|Overall Study|Death|0|||
94263178|NCT00763971|322758135|FG001|Overall Study|Performed final visit on phone|1|||
94641077|NCT02689258|324148444|FG002|Overall Study|Subject Non-Compliance|0|||
94641078|NCT02689258|324148445|FG003|Overall Study|Subject Non-Compliance|0|||
94641079|NCT02689258|324148446|FG004|Overall Study|Subject Non-Compliance|0|||
94678577|NCT01984697|324278773|FG001|Overall Study|Death|0|||
94678578|NCT01984697|324278774|FG002|Overall Study|Death|0|||
94641080|NCT02689258|324148447|FG005|Overall Study|Subject Non-Compliance|0|||
94641081|NCT02689258|324148448|FG006|Overall Study|Subject Non-Compliance|0|||
94641082|NCT02689258|324148449|FG007|Overall Study|Subject Non-Compliance|0|||
94641083|NCT02689258|324148450|FG008|Overall Study|Subject Non-Compliance|0|||
94641084|NCT02689258|324148451|FG009|Overall Study|Subject Non-Compliance|0|||
94641085|NCT02689258|324148452|FG010|Overall Study|Subject Non-Compliance|0|||
94641086|NCT02689258|324148453|FG011|Overall Study|Subject Non-Compliance|0|||
94641087|NCT02689258|324148442|FG000|Overall Study|Subject Refusal to Continue|0|||
94641088|NCT02689258|324148443|FG001|Overall Study|Subject Refusal to Continue|1|||
94641089|NCT02689258|324148444|FG002|Overall Study|Subject Refusal to Continue|0|||
94641090|NCT02689258|324148445|FG003|Overall Study|Subject Refusal to Continue|0|||
94641091|NCT02689258|324148446|FG004|Overall Study|Subject Refusal to Continue|0|||
94641092|NCT02689258|324148447|FG005|Overall Study|Subject Refusal to Continue|0|||
94641093|NCT02689258|324148448|FG006|Overall Study|Subject Refusal to Continue|0|||
94641094|NCT02689258|324148449|FG007|Overall Study|Subject Refusal to Continue|0|||
94641095|NCT02689258|324148450|FG008|Overall Study|Subject Refusal to Continue|1|||
94641096|NCT02689258|324148451|FG009|Overall Study|Subject Refusal to Continue|0|||
94641097|NCT02689258|324148452|FG010|Overall Study|Subject Refusal to Continue|0|||
94641098|NCT02689258|324148453|FG011|Overall Study|Subject Refusal to Continue|1|||
94641099|NCT02689258|324148442|FG000|Overall Study|Other|0|||
94641100|NCT02689258|324148443|FG001|Overall Study|Other|2|||
94641101|NCT02689258|324148444|FG002|Overall Study|Other|0|||
94641102|NCT02689258|324148445|FG003|Overall Study|Other|0|||
94641103|NCT02689258|324148446|FG004|Overall Study|Other|1|||
94641104|NCT02689258|324148447|FG005|Overall Study|Other|0|||
94641105|NCT02689258|324148448|FG006|Overall Study|Other|0|||
94641106|NCT02689258|324148449|FG007|Overall Study|Other|0|||
94641107|NCT02689258|324148450|FG008|Overall Study|Other|1|||
94641108|NCT02689258|324148451|FG009|Overall Study|Other|0|||
94641109|NCT02689258|324148452|FG010|Overall Study|Other|0|||
94641110|NCT02689258|324148453|FG011|Overall Study|Other|0|||
94641111|NCT01405963|324148458|FG000|Overall Study|Moved Away|2|||
94641112|NCT01405963|324148459|FG001|Overall Study|Moved Away|0|||
94641113|NCT01405963|324148458|FG000|Overall Study|Adverse Event|0|||
94641114|NCT01405963|324148459|FG001|Overall Study|Adverse Event|1|||
94641115|NCT01405963|324148458|FG000|Overall Study|Lost to Follow-up|0|||
94641116|NCT01405963|324148459|FG001|Overall Study|Lost to Follow-up|1|||
94641117|NCT00746941|324148460|FG000|Overall Study|Death|2|||
94641118|NCT00746941|324148461|FG001|Overall Study|Death|0|||
94641119|NCT00746941|324148462|FG002|Overall Study|Death|0|||
94641120|NCT00746941|324148463|FG003|Overall Study|Death|6|||
94641121|NCT00746941|324148460|FG000|Overall Study|Physician Decision|0|||
94641122|NCT00746941|324148461|FG001|Overall Study|Physician Decision|0|||
94641123|NCT00746941|324148462|FG002|Overall Study|Physician Decision|2|||
94641124|NCT00746941|324148463|FG003|Overall Study|Physician Decision|0|||
94641125|NCT00746941|324148460|FG000|Overall Study|Withdrawal by Subject|3|||
94641126|NCT00746941|324148461|FG001|Overall Study|Withdrawal by Subject|0|||
94641127|NCT00746941|324148462|FG002|Overall Study|Withdrawal by Subject|0|||
94641128|NCT00746941|324148463|FG003|Overall Study|Withdrawal by Subject|2|||
94641129|NCT00746941|324148460|FG000|Overall Study|Other, reason not provided|2|||
94641130|NCT00746941|324148461|FG001|Overall Study|Other, reason not provided|4|||
94641131|NCT00746941|324148462|FG002|Overall Study|Other, reason not provided|0|||
94641132|NCT00746941|324148463|FG003|Overall Study|Other, reason not provided|4|||
94641133|NCT00746941|324148460|FG000|Overall Study|Adverse Event|0|||
94641134|NCT00746941|324148461|FG001|Overall Study|Adverse Event|0|||
94641135|NCT00746941|324148462|FG002|Overall Study|Adverse Event|0|||
94641136|NCT00746941|324148463|FG003|Overall Study|Adverse Event|1|||
94641137|NCT03316885|324148468|FG000|Overall Study|Adverse Event|1|||
94641138|NCT03316885|324148468|FG000|Overall Study|Death|10|||
94641139|NCT03316885|324148468|FG000|Overall Study|Lost to Follow-up|4|||
94641140|NCT03316885|324148468|FG000|Overall Study|Withdrawal by Subject|9|||
94641141|NCT03316885|324148468|FG000|Overall Study|COVID related|8|||
94641142|NCT04180020|324148469|FG000|Overall Study|missed visit|18|||
94641143|NCT04180020|324148470|FG001|Overall Study|missed visit|16|||
94641144|NCT04180020|324148469|FG000|Overall Study|Death|2|||
94641145|NCT04180020|324148470|FG001|Overall Study|Death|3|||
94641146|NCT04180020|324148469|FG000|Overall Study|Withdrawal by Subject|1|||
94641147|NCT04180020|324148470|FG001|Overall Study|Withdrawal by Subject|5|||
94641148|NCT04180020|324148469|FG000|Overall Study|incarcerated|1|||
94641149|NCT04180020|324148470|FG001|Overall Study|incarcerated|1|||
94263179|NCT00763971|322758136|FG002|Overall Study|Performed final visit on phone|0|||
94263180|NCT00763971|322758134|FG000|Overall Study|Participation in 489-326 required|1|||
94263181|NCT00763971|322758135|FG001|Overall Study|Participation in 489-326 required|0|||
94263182|NCT00763971|322758136|FG002|Overall Study|Participation in 489-326 required|0|||
94263183|NCT04498169|322758140|FG000|Study Completion|Adverse Event|1|||
94641150|NCT04180020|324148469|FG000|Overall Study|Physician Decision|0|||
94641151|NCT04180020|324148470|FG001|Overall Study|Physician Decision|2|||
94641152|NCT03065244|324148476|FG000|Overall Study|Lost to Follow-up|1|||
94641153|NCT03065244|324148477|FG001|Overall Study|Lost to Follow-up|1|||
94641154|NCT03065244|324148476|FG000|Overall Study|Diagnosed with a different disease|1|||
94641155|NCT03065244|324148477|FG001|Overall Study|Diagnosed with a different disease|1|||
94678579|NCT01984697|324278775|FG003|Overall Study|Death|1|||
94678580|NCT01984697|324278776|FG004|Overall Study|Death|0|||
94678581|NCT01984697|324278772|FG000|Overall Study|Pregnancy|2|||
94678582|NCT01984697|324278773|FG001|Overall Study|Pregnancy|0|||
94678583|NCT01984697|324278774|FG002|Overall Study|Pregnancy|1|||
94678584|NCT01984697|324278775|FG003|Overall Study|Pregnancy|0|||
94678585|NCT01984697|324278776|FG004|Overall Study|Pregnancy|1|||
94678586|NCT02044848|324278777|FG000|Overall Study|Administrative Problems|2|||
94678587|NCT02044848|324278778|FG001|Overall Study|Administrative Problems|3|||
94641156|NCT03065244|324148476|FG000|Overall Study|Protocol Violation|0|||
94641157|NCT03065244|324148477|FG001|Overall Study|Protocol Violation|1|||
94641158|NCT03065244|324148476|FG000|Overall Study|Withdrawal by Subject|1|||
94641159|NCT03065244|324148477|FG001|Overall Study|Withdrawal by Subject|1|||
94641160|NCT00108160|324148478|FG000|Overall Study|Lost to Follow-up|25|||
94641161|NCT00108160|324148479|FG001|Overall Study|Lost to Follow-up|12|||
94641162|NCT00108160|324148478|FG000|Overall Study|Death|1|||
94641163|NCT00108160|324148479|FG001|Overall Study|Death|2|||
94641164|NCT00108160|324148478|FG000|Overall Study|Withdrawal by Subject|4|||
94641165|NCT00108160|324148479|FG001|Overall Study|Withdrawal by Subject|2|||
94678588|NCT00045708|324278779|FG000|Phase 1|early progressive disease|0|||
94678589|NCT00045708|324278780|FG001|Phase 1|early progressive disease|1|||
94678590|NCT00045708|324278781|FG002|Phase 1|early progressive disease|0|||
94678591|NCT03938454|324278782|FG000|Overall Study|Protocol Violation|1|||
94678592|NCT03938454|324278782|FG000|Overall Study|Withdrawal by Subject|2|||
94678593|NCT03938454|324278782|FG000|Overall Study|Lost to Follow-up|3|||
94678594|NCT03181399|324278783|FG000|6 Months on Treatment|Protocol non-compliance|7|||
94678595|NCT03181399|324278783|FG000|6 Months on Treatment|Adverse Event|4|||
94678596|NCT03181399|324278783|FG000|6 Months on Treatment|Tried alternative treatment|2|||
94678597|NCT03181399|324278783|FG000|6 Months on Treatment|Lost to Follow-up|2|||
94678598|NCT03181399|324278783|FG000|6 Months on Treatment|Personal reasons|1|||
94678599|NCT03181399|324278783|FG000|3 Months Off-treatment|Parent unable to travel|1|||
94678600|NCT00695786|324278784|FG000|Overall Study|Adverse Event|0|||
94678601|NCT00695786|324278785|FG001|Overall Study|Adverse Event|3|||
94678602|NCT00695786|324278786|FG002|Overall Study|Adverse Event|4|||
94678603|NCT00695786|324278787|FG003|Overall Study|Adverse Event|2|||
94678604|NCT00695786|324278784|FG000|Overall Study|Lost to Follow-up|0|||
94678605|NCT00695786|324278785|FG001|Overall Study|Lost to Follow-up|5|||
94678606|NCT00695786|324278786|FG002|Overall Study|Lost to Follow-up|1|||
94678607|NCT00695786|324278787|FG003|Overall Study|Lost to Follow-up|1|||
94678608|NCT00695786|324278784|FG000|Overall Study|Withdrawal by Subject|0|||
94678609|NCT00695786|324278785|FG001|Overall Study|Withdrawal by Subject|4|||
94678610|NCT00695786|324278786|FG002|Overall Study|Withdrawal by Subject|3|||
94678611|NCT00695786|324278787|FG003|Overall Study|Withdrawal by Subject|1|||
94678612|NCT00695786|324278784|FG000|Overall Study|Deemed Ineligible|1|||
94678613|NCT00695786|324278785|FG001|Overall Study|Deemed Ineligible|0|||
94678614|NCT00695786|324278786|FG002|Overall Study|Deemed Ineligible|0|||
94461912|NCT03617861|323481257|FG003|Second Intervention (1 Day)|Adverse Event|0|||
94641166|NCT00108160|324148478|FG000|Overall Study|Protocol Violation|9|||
94678615|NCT00695786|324278787|FG003|Overall Study|Deemed Ineligible|0|||
94678616|NCT00695786|324278784|FG000|Overall Study|Lack of Efficacy|0|||
94678617|NCT00695786|324278785|FG001|Overall Study|Lack of Efficacy|0|||
94678618|NCT00695786|324278786|FG002|Overall Study|Lack of Efficacy|0|||
94678619|NCT00695786|324278787|FG003|Overall Study|Lack of Efficacy|4|||
94678620|NCT01728792|324278788|FG000|Overall Study|Withdrawal of Consent|1|||
94461913|NCT01846221|323481260|FG000|Overall Study|Catheter Failure|2|||
94641167|NCT00108160|324148479|FG001|Overall Study|Protocol Violation|5|||
94641168|NCT02486042|324148480|FG000|Overall Study|Physician Decision|1|||
94678621|NCT01728792|324278789|FG001|Overall Study|Withdrawal of Consent|1|||
94461914|NCT01846221|323481261|FG001|Overall Study|Catheter Failure|0|||
94641169|NCT02486042|324148481|FG001|Overall Study|Physician Decision|7|||
94641170|NCT02486042|324148480|FG000|Overall Study|Hospital transfer|2|||
94678622|NCT01728792|324278790|FG002|Overall Study|Withdrawal of Consent|0|||
94641171|NCT02486042|324148481|FG001|Overall Study|Hospital transfer|2|||
94678623|NCT01728792|324278791|FG003|Overall Study|Withdrawal of Consent|1|||
94678624|NCT01728792|324278792|FG004|Overall Study|Withdrawal of Consent|0|||
94678625|NCT01728792|324278788|FG000|Overall Study|Lost to Follow-up|2|||
94678626|NCT01728792|324278789|FG001|Overall Study|Lost to Follow-up|1|||
94678627|NCT01728792|324278790|FG002|Overall Study|Lost to Follow-up|4|||
94461915|NCT01846221|323481260|FG000|Overall Study|Age Exclusion|1|||
94641172|NCT02486042|324148480|FG000|Overall Study|Withdrawal by Subject|0|||
94678628|NCT01728792|324278791|FG003|Overall Study|Lost to Follow-up|2|||
94641173|NCT02486042|324148481|FG001|Overall Study|Withdrawal by Subject|2|||
94641174|NCT00329407|324148482|FG000|Overall Study|Withdrawal by Subject|1|||
94641175|NCT02120794|324148483|FG000|Overall Study|Withdrawal by Subject|43|||
94641176|NCT02120794|324148483|FG000|Overall Study|Adverse Event|10|||
94641177|NCT02120794|324148483|FG000|Overall Study|Physician Decision|4|||
94641178|NCT02120794|324148483|FG000|Overall Study|Due to insurance coverage|1|||
94641179|NCT03571581|324148485|FG000|Overall Study|Death|2|||
94641180|NCT03571581|324148485|FG000|Overall Study|Withdrawal by Subject|2|||
94641181|NCT00729183|324148486|FG000|Overall Study|Adverse Event|11|||
94641182|NCT00729183|324148487|FG001|Overall Study|Adverse Event|5|||
94641183|NCT00729183|324148486|FG000|Overall Study|Lack of Efficacy|0|||
94641184|NCT00729183|324148487|FG001|Overall Study|Lack of Efficacy|1|||
94641185|NCT00729183|324148486|FG000|Overall Study|Lost to Follow-up|3|||
94641186|NCT00729183|324148487|FG001|Overall Study|Lost to Follow-up|1|||
94641187|NCT00729183|324148486|FG000|Overall Study|Physician Decision|1|||
94641188|NCT00729183|324148487|FG001|Overall Study|Physician Decision|1|||
94641189|NCT00729183|324148486|FG000|Overall Study|Protocol Violation|1|||
94641190|NCT00729183|324148487|FG001|Overall Study|Protocol Violation|0|||
94641191|NCT00729183|324148486|FG000|Overall Study|Withdrawal by Subject|9|||
94641192|NCT00729183|324148487|FG001|Overall Study|Withdrawal by Subject|7|||
94641193|NCT01120756|324148488|FG000|Overall Study|Withdrawal by Subject|1|||
94641194|NCT01120756|324148489|FG001|Overall Study|Withdrawal by Subject|1|||
94641195|NCT01200797|324148490|FG000|Overall Study|symptomatic deterioration|2|||
94641196|NCT01200797|324148490|FG000|Overall Study|Adverse Event|4|||
94641197|NCT01200797|324148490|FG000|Overall Study|Disease Progression|13|||
94641198|NCT01359254|324148495|FG000|Overall Study|Death|1|||
94641199|NCT01359254|324148496|FG001|Overall Study|Death|0|||
94641200|NCT04668950|324148504|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
94641201|NCT04668950|324148505|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
94641202|NCT04668950|324148504|FG000|Overall Study|Could not confirm started study medication|15|||
94641203|NCT04668950|324148505|FG001|Overall Study|Could not confirm started study medication|15|||
94641204|NCT04668950|324148504|FG000|Overall Study|Could not confirm baseline status|6|||
94641205|NCT04668950|324148505|FG001|Overall Study|Could not confirm baseline status|2|||
94641206|NCT04668950|324148504|FG000|Overall Study|Drop out and did not start medication|15|||
94641207|NCT04668950|324148505|FG001|Overall Study|Drop out and did not start medication|17|||
94641208|NCT04668950|324148504|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
94641209|NCT04668950|324148505|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
94641210|NCT04668950|324148504|FG000|Overall Study|Other|2|||
94641211|NCT04668950|324148505|FG001|Overall Study|Other|4|||
94641212|NCT00747435|324148508|FG000|Overall Study|Lost to Follow-up|2|||
94641213|NCT00747435|324148508|FG000|Overall Study|Withdrawal by Subject|3|||
94641214|NCT00747435|324148508|FG000|Overall Study|Still undergoing follow up|1|||
94641215|NCT04056195|324148509|FG000|Overall Study|Adverse Event|1|||
94641216|NCT04056195|324148510|FG001|Overall Study|Adverse Event|0|||
94641217|NCT04056195|324148511|FG002|Overall Study|Adverse Event|0|||
94641218|NCT04056195|324148509|FG000|Overall Study|Withdrawal by Subject|0|||
94641219|NCT04056195|324148510|FG001|Overall Study|Withdrawal by Subject|1|||
94641220|NCT04056195|324148511|FG002|Overall Study|Withdrawal by Subject|1|||
94641221|NCT04056195|324148509|FG000|Overall Study|Physician Decision|1|||
94641222|NCT04056195|324148510|FG001|Overall Study|Physician Decision|1|||
94641223|NCT04056195|324148511|FG002|Overall Study|Physician Decision|1|||
94641224|NCT01449526|324148520|FG000|Overall Study|Lost to Follow-up|1|||
94641225|NCT01449526|324148521|FG001|Overall Study|Lost to Follow-up|2|||
94641226|NCT01449526|324148520|FG000|Overall Study|Withdrawal by Subject|1|||
94641227|NCT01449526|324148521|FG001|Overall Study|Withdrawal by Subject|1|||
94641228|NCT01449526|324148520|FG000|Overall Study|Symptoms/complaints|0|||
94641229|NCT01449526|324148521|FG001|Overall Study|Symptoms/complaints|1|||
94641230|NCT01449526|324148520|FG000|Overall Study|Lack of Motivation|0|||
94641231|NCT01449526|324148521|FG001|Overall Study|Lack of Motivation|1|||
94641232|NCT01449526|324148520|FG000|Overall Study|Cannot maintain visits|0|||
94641233|NCT01449526|324148521|FG001|Overall Study|Cannot maintain visits|1|||
94641234|NCT01400516|324148522|FG000|Primary Trial|Withdrawal by Subject|0|||
94641235|NCT01400516|324148523|FG001|Primary Trial|Withdrawal by Subject|2|||
94641236|NCT02865915|324148526|FG000|Overall Study|Pregnancy|1|||
94641237|NCT02865915|324148527|FG001|Overall Study|Pregnancy|0|||
94641238|NCT02865915|324148526|FG000|Overall Study|Withdrawal by Subject|1|||
94641239|NCT02865915|324148527|FG001|Overall Study|Withdrawal by Subject|1|||
94641240|NCT02865915|324148526|FG000|Overall Study|Adverse Event|0|||
94641241|NCT02865915|324148527|FG001|Overall Study|Adverse Event|4|||
94641242|NCT02865915|324148526|FG000|Overall Study|Lost to Follow-up|0|||
94641243|NCT02865915|324148527|FG001|Overall Study|Lost to Follow-up|1|||
94641244|NCT02865915|324148526|FG000|Overall Study|Protocol Violation|0|||
94641245|NCT02865915|324148527|FG001|Overall Study|Protocol Violation|1|||
94641246|NCT02865915|324148526|FG000|Overall Study|Study terminated by sponsor|23|||
94641247|NCT02865915|324148527|FG001|Overall Study|Study terminated by sponsor|18|||
94641248|NCT02865915|324148526|FG000|Overall Study|Dosing group discontinued|0|||
94641249|NCT02865915|324148527|FG001|Overall Study|Dosing group discontinued|5|||
94263184|NCT04498169|322758141|FG001|Study Completion|Adverse Event|1|||
94263185|NCT00823901|322758142|FG000|Overall Study|Adverse Event|1|||
94641250|NCT00082433|324148528|FG000|Overall Study|Adverse Event|12|||
94641251|NCT00082433|324148529|FG001|Overall Study|Adverse Event|17|||
94641252|NCT00082433|324148528|FG000|Overall Study|Death|8|||
94641253|NCT00082433|324148529|FG001|Overall Study|Death|18|||
94641254|NCT00082433|324148528|FG000|Overall Study|Disease Progression/Relapse|270|||
94641255|NCT00082433|324148529|FG001|Overall Study|Disease Progression/Relapse|388|||
94641256|NCT00082433|324148528|FG000|Overall Study|Physician Decision|50|||
94641257|NCT00082433|324148529|FG001|Overall Study|Physician Decision|61|||
94641258|NCT00082433|324148528|FG000|Overall Study|Lost to Follow-up|1|||
94641259|NCT00082433|324148529|FG001|Overall Study|Lost to Follow-up|2|||
94641260|NCT00082433|324148528|FG000|Overall Study|Study Drug Toxicity|179|||
94641261|NCT00082433|324148529|FG001|Overall Study|Study Drug Toxicity|66|||
94641262|NCT00082433|324148528|FG000|Overall Study|Withdrawal by Subject|55|||
94641263|NCT00082433|324148529|FG001|Overall Study|Withdrawal by Subject|30|||
94641264|NCT00082433|324148528|FG000|Overall Study|Still On Treatment|2|||
94641265|NCT00082433|324148529|FG001|Overall Study|Still On Treatment|1|||
94641266|NCT00082433|324148528|FG000|Overall Study|Not Treated|12|||
94641267|NCT00082433|324148529|FG001|Overall Study|Not Treated|11|||
94641268|NCT00082433|324148528|FG000|Overall Study|Ineligible|2|||
94641269|NCT00082433|324148529|FG001|Overall Study|Ineligible|1|||
94641270|NCT00082433|324148528|FG000|Overall Study|Noncompliance|2|||
94641271|NCT00082433|324148529|FG001|Overall Study|Noncompliance|1|||
94641272|NCT00082433|324148528|FG000|Overall Study|New primary cancer|1|||
94641273|NCT00082433|324148529|FG001|Overall Study|New primary cancer|0|||
94641274|NCT00082433|324148528|FG000|Overall Study|Impending surgery|0|||
94641275|NCT00082433|324148529|FG001|Overall Study|Impending surgery|1|||
94641276|NCT04146545|324150178|FG000|Overall Study|deemed ineligible after randomization|1|||
94641277|NCT04146545|324150179|FG001|Overall Study|deemed ineligible after randomization|0|||
94641278|NCT01723163|324150180|FG000|Treatment Phase|Withdrawal by Subject|14|||
94641279|NCT01723163|324150181|FG001|Treatment Phase|Withdrawal by Subject|6|||
94641280|NCT01723163|324150180|FG000|Treatment Phase|Withdrawal by PI|5|||
94641281|NCT01723163|324150181|FG001|Treatment Phase|Withdrawal by PI|1|||
94641282|NCT01723163|324150180|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
94461916|NCT01846221|323481261|FG001|Overall Study|Age Exclusion|0|||
94641283|NCT01723163|324150181|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
94641284|NCT01723163|324150180|FG000|3-Month Follow-up|Unable to Contact|12|||
94641285|NCT01723163|324150181|FG001|3-Month Follow-up|Unable to Contact|19|||
94641286|NCT01723163|324150180|FG000|6-Month Follow-up|Death|1|||
94641287|NCT01723163|324150181|FG001|6-Month Follow-up|Death|0|||
94641288|NCT01723163|324150180|FG000|6-Month Follow-up|Unable to Contact|17|||
94641289|NCT01723163|324150181|FG001|6-Month Follow-up|Unable to Contact|15|||
94641290|NCT01723163|324150180|FG000|12-Month Follow-up|Death|1|||
94641291|NCT01723163|324150181|FG001|12-Month Follow-up|Death|0|||
94641292|NCT01723163|324150180|FG000|12-Month Follow-up|Unable to Contact|23|||
94641293|NCT01723163|324150181|FG001|12-Month Follow-up|Unable to Contact|28|||
94641294|NCT04091646|324150182|FG000|Overall Study|Adverse Event|2|||
94641295|NCT04091646|324150183|FG001|Overall Study|Adverse Event|1|||
94641296|NCT04091646|324150182|FG000|Overall Study|Lost to Follow-up|6|||
94641297|NCT04091646|324150183|FG001|Overall Study|Lost to Follow-up|2|||
94641298|NCT04091646|324150182|FG000|Overall Study|Protocol Violation|0|||
94641299|NCT04091646|324150183|FG001|Overall Study|Protocol Violation|1|||
94641300|NCT04091646|324150182|FG000|Overall Study|Withdrawal by Subject|4|||
94641301|NCT04091646|324150183|FG001|Overall Study|Withdrawal by Subject|1|||
94641302|NCT04091646|324150182|FG000|Overall Study|Participant Incarcerated|1|||
94641303|NCT04091646|324150183|FG001|Overall Study|Participant Incarcerated|0|||
94641304|NCT03102918|324150184|FG000|Overall Study|Protocol Violation|1|||
94263186|NCT00823901|322758143|FG001|Overall Study|Adverse Event|1|||
94641305|NCT03102918|324150185|FG001|Overall Study|Protocol Violation|0|||
94641306|NCT01762943|324150188|FG000|Overall Study|Physician Decision|1|||
94678629|NCT01728792|324278792|FG004|Overall Study|Lost to Follow-up|0|||
94641307|NCT01762943|324150189|FG001|Overall Study|Physician Decision|1|||
94461917|NCT04392167|323481263|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
94641308|NCT01762943|324150188|FG000|Overall Study|Protocol Violation|1|||
94641309|NCT01762943|324150189|FG001|Overall Study|Protocol Violation|0|||
94641310|NCT01762943|324150188|FG000|Overall Study|Withdrawal by Subject|2|||
94641311|NCT01762943|324150189|FG001|Overall Study|Withdrawal by Subject|1|||
94641312|NCT02658890|324150190|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641313|NCT02658890|324150191|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641314|NCT02658890|324150192|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641315|NCT02658890|324150193|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641316|NCT02658890|324150194|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641317|NCT02658890|324150195|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641318|NCT02658890|324150196|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641319|NCT02658890|324150197|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641320|NCT02658890|324150198|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
94641321|NCT02658890|324150199|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641322|NCT02658890|324150200|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641323|NCT02658890|324150201|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641324|NCT02658890|324150202|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641325|NCT02658890|324150203|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641326|NCT02658890|324150204|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641327|NCT02658890|324150205|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641328|NCT02658890|324150206|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641329|NCT02658890|324150207|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641330|NCT02658890|324150208|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641331|NCT02658890|324150209|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641332|NCT02658890|324150210|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641333|NCT02658890|324150211|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641334|NCT02658890|324150212|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641335|NCT02658890|324150213|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641336|NCT02658890|324150214|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641337|NCT02658890|324150215|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641338|NCT02658890|324150216|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641339|NCT02658890|324150190|FG000|Treatment Phase|Adverse Event|0|||
94641340|NCT02658890|324150191|FG001|Treatment Phase|Adverse Event|1|||
94641341|NCT02658890|324150192|FG002|Treatment Phase|Adverse Event|2|||
94641342|NCT02658890|324150193|FG003|Treatment Phase|Adverse Event|2|||
94641343|NCT02658890|324150194|FG004|Treatment Phase|Adverse Event|1|||
94641344|NCT02658890|324150195|FG005|Treatment Phase|Adverse Event|0|||
94641345|NCT02658890|324150196|FG006|Treatment Phase|Adverse Event|0|||
94641346|NCT02658890|324150197|FG007|Treatment Phase|Adverse Event|2|||
94641347|NCT02658890|324150198|FG008|Treatment Phase|Adverse Event|1|||
94641348|NCT02658890|324150199|FG009|Treatment Phase|Adverse Event|2|||
94641349|NCT02658890|324150200|FG010|Treatment Phase|Adverse Event|3|||
94641350|NCT02658890|324150201|FG011|Treatment Phase|Adverse Event|0|||
94641351|NCT02658890|324150202|FG012|Treatment Phase|Adverse Event|1|||
94641352|NCT02658890|324150203|FG013|Treatment Phase|Adverse Event|4|||
94641353|NCT02658890|324150204|FG014|Treatment Phase|Adverse Event|0|||
94641354|NCT02658890|324150205|FG015|Treatment Phase|Adverse Event|0|||
94641355|NCT02658890|324150206|FG016|Treatment Phase|Adverse Event|0|||
94641356|NCT02658890|324150207|FG017|Treatment Phase|Adverse Event|0|||
94641357|NCT02658890|324150208|FG018|Treatment Phase|Adverse Event|5|||
94641358|NCT02658890|324150209|FG019|Treatment Phase|Adverse Event|1|||
94641359|NCT02658890|324150210|FG020|Treatment Phase|Adverse Event|3|||
94641360|NCT02658890|324150211|FG021|Treatment Phase|Adverse Event|0|||
94641361|NCT02658890|324150212|FG022|Treatment Phase|Adverse Event|5|||
94641362|NCT02658890|324150213|FG023|Treatment Phase|Adverse Event|0|||
94641363|NCT02658890|324150214|FG024|Treatment Phase|Adverse Event|0|||
94641364|NCT02658890|324150215|FG025|Treatment Phase|Adverse Event|2|||
94641365|NCT02658890|324150216|FG026|Treatment Phase|Adverse Event|1|||
94641366|NCT02658890|324150190|FG000|Treatment Phase|Death|0|||
94641367|NCT02658890|324150191|FG001|Treatment Phase|Death|0|||
94641368|NCT02658890|324150192|FG002|Treatment Phase|Death|0|||
94641369|NCT02658890|324150193|FG003|Treatment Phase|Death|0|||
94641370|NCT02658890|324150194|FG004|Treatment Phase|Death|0|||
94461918|NCT02091960|323481267|FG000|Overall Study|Death|7|||
94641371|NCT02658890|324150195|FG005|Treatment Phase|Death|0|||
94641372|NCT02658890|324150196|FG006|Treatment Phase|Death|0|||
94641373|NCT02658890|324150197|FG007|Treatment Phase|Death|0|||
94641374|NCT02658890|324150198|FG008|Treatment Phase|Death|0|||
94641375|NCT02658890|324150199|FG009|Treatment Phase|Death|0|||
94641376|NCT02658890|324150200|FG010|Treatment Phase|Death|0|||
94641377|NCT02658890|324150201|FG011|Treatment Phase|Death|0|||
94641378|NCT02658890|324150202|FG012|Treatment Phase|Death|0|||
94641379|NCT02658890|324150203|FG013|Treatment Phase|Death|0|||
94641380|NCT02658890|324150204|FG014|Treatment Phase|Death|0|||
94641381|NCT02658890|324150205|FG015|Treatment Phase|Death|0|||
94641382|NCT02658890|324150206|FG016|Treatment Phase|Death|0|||
94641383|NCT02658890|324150207|FG017|Treatment Phase|Death|0|||
94641384|NCT02658890|324150208|FG018|Treatment Phase|Death|1|||
94641385|NCT02658890|324150209|FG019|Treatment Phase|Death|0|||
94641386|NCT02658890|324150210|FG020|Treatment Phase|Death|0|||
94641387|NCT02658890|324150211|FG021|Treatment Phase|Death|0|||
94641388|NCT02658890|324150212|FG022|Treatment Phase|Death|0|||
94641389|NCT02658890|324150213|FG023|Treatment Phase|Death|0|||
94641390|NCT02658890|324150214|FG024|Treatment Phase|Death|0|||
94641391|NCT02658890|324150215|FG025|Treatment Phase|Death|0|||
94641392|NCT02658890|324150216|FG026|Treatment Phase|Death|0|||
94641393|NCT02658890|324150190|FG000|Treatment Phase|Lost to Follow-up|0|||
94641394|NCT02658890|324150191|FG001|Treatment Phase|Lost to Follow-up|0|||
94641395|NCT02658890|324150192|FG002|Treatment Phase|Lost to Follow-up|0|||
94641396|NCT02658890|324150193|FG003|Treatment Phase|Lost to Follow-up|0|||
94641397|NCT02658890|324150194|FG004|Treatment Phase|Lost to Follow-up|0|||
94641398|NCT02658890|324150195|FG005|Treatment Phase|Lost to Follow-up|0|||
94641399|NCT02658890|324150196|FG006|Treatment Phase|Lost to Follow-up|1|||
94641400|NCT02658890|324150197|FG007|Treatment Phase|Lost to Follow-up|0|||
94641401|NCT02658890|324150198|FG008|Treatment Phase|Lost to Follow-up|0|||
94641402|NCT02658890|324150199|FG009|Treatment Phase|Lost to Follow-up|0|||
94641403|NCT02658890|324150200|FG010|Treatment Phase|Lost to Follow-up|0|||
94641404|NCT02658890|324150201|FG011|Treatment Phase|Lost to Follow-up|0|||
94641405|NCT02658890|324150202|FG012|Treatment Phase|Lost to Follow-up|0|||
94641406|NCT02658890|324150203|FG013|Treatment Phase|Lost to Follow-up|0|||
94641407|NCT02658890|324150204|FG014|Treatment Phase|Lost to Follow-up|0|||
94641408|NCT02658890|324150205|FG015|Treatment Phase|Lost to Follow-up|0|||
94641409|NCT02658890|324150206|FG016|Treatment Phase|Lost to Follow-up|0|||
94641410|NCT02658890|324150207|FG017|Treatment Phase|Lost to Follow-up|0|||
94641411|NCT02658890|324150208|FG018|Treatment Phase|Lost to Follow-up|0|||
94641412|NCT02658890|324150209|FG019|Treatment Phase|Lost to Follow-up|0|||
94641413|NCT02658890|324150210|FG020|Treatment Phase|Lost to Follow-up|0|||
94641414|NCT02658890|324150211|FG021|Treatment Phase|Lost to Follow-up|0|||
94641415|NCT02658890|324150212|FG022|Treatment Phase|Lost to Follow-up|0|||
94641416|NCT02658890|324150213|FG023|Treatment Phase|Lost to Follow-up|0|||
94641417|NCT02658890|324150214|FG024|Treatment Phase|Lost to Follow-up|0|||
94641418|NCT02658890|324150215|FG025|Treatment Phase|Lost to Follow-up|0|||
94641419|NCT02658890|324150216|FG026|Treatment Phase|Lost to Follow-up|0|||
94641420|NCT02658890|324150190|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
94641421|NCT02658890|324150191|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
94641422|NCT02658890|324150192|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
94641423|NCT02658890|324150193|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
94641424|NCT02658890|324150194|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
94641425|NCT02658890|324150195|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
94641426|NCT02658890|324150196|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
94641427|NCT02658890|324150197|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
94641428|NCT02658890|324150198|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
94641429|NCT02658890|324150199|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
94641430|NCT02658890|324150200|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
94641431|NCT02658890|324150201|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
94641432|NCT02658890|324150202|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
94641433|NCT02658890|324150203|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
94641434|NCT02658890|324150204|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
94641435|NCT02658890|324150205|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
94641436|NCT02658890|324150206|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
94641437|NCT02658890|324150207|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
94641438|NCT02658890|324150208|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
94641439|NCT02658890|324150209|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
94263187|NCT00823901|322758142|FG000|Overall Study|Lack of Efficacy|1|||
94641440|NCT02658890|324150210|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
94641441|NCT02658890|324150211|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
94641442|NCT02658890|324150212|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
94263188|NCT00823901|322758143|FG001|Overall Study|Lack of Efficacy|0|||
94263189|NCT00823901|322758142|FG000|Overall Study|Lost to Follow-up|2|||
94641443|NCT02658890|324150213|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
94641444|NCT02658890|324150214|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
94641445|NCT02658890|324150215|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
94641446|NCT02658890|324150216|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
94641447|NCT02658890|324150190|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
94641448|NCT02658890|324150191|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
94641449|NCT02658890|324150192|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
94641450|NCT02658890|324150193|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
94641451|NCT02658890|324150194|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
94641452|NCT02658890|324150195|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
94641453|NCT02658890|324150196|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
94641454|NCT02658890|324150197|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
94641455|NCT02658890|324150198|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
94641456|NCT02658890|324150199|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
94641457|NCT02658890|324150200|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
94641458|NCT02658890|324150201|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
94641459|NCT02658890|324150202|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
94641460|NCT02658890|324150203|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
94641461|NCT02658890|324150204|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
94641462|NCT02658890|324150205|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
94641463|NCT02658890|324150206|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
94641464|NCT02658890|324150207|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
94641465|NCT02658890|324150208|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
94641466|NCT02658890|324150209|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
94641467|NCT02658890|324150210|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
94641468|NCT02658890|324150211|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
94641469|NCT02658890|324150212|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
94641470|NCT02658890|324150213|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
94641471|NCT02658890|324150214|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
94641472|NCT02658890|324150215|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
94641473|NCT02658890|324150216|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
94641474|NCT02658890|324150190|FG000|Treatment Phase|Other Reasons|0|||
94641475|NCT02658890|324150191|FG001|Treatment Phase|Other Reasons|0|||
94641476|NCT02658890|324150192|FG002|Treatment Phase|Other Reasons|0|||
94641477|NCT02658890|324150193|FG003|Treatment Phase|Other Reasons|0|||
94641478|NCT02658890|324150194|FG004|Treatment Phase|Other Reasons|0|||
94641479|NCT02658890|324150195|FG005|Treatment Phase|Other Reasons|0|||
94641480|NCT02658890|324150196|FG006|Treatment Phase|Other Reasons|1|||
94641481|NCT02658890|324150197|FG007|Treatment Phase|Other Reasons|0|||
94641482|NCT02658890|324150198|FG008|Treatment Phase|Other Reasons|1|||
94641483|NCT02658890|324150199|FG009|Treatment Phase|Other Reasons|0|||
94263190|NCT00823901|322758143|FG001|Overall Study|Lost to Follow-up|1|||
94641484|NCT02658890|324150200|FG010|Treatment Phase|Other Reasons|0|||
94641485|NCT02658890|324150201|FG011|Treatment Phase|Other Reasons|0|||
94641486|NCT02658890|324150202|FG012|Treatment Phase|Other Reasons|0|||
94641487|NCT02658890|324150203|FG013|Treatment Phase|Other Reasons|2|||
94641488|NCT02658890|324150204|FG014|Treatment Phase|Other Reasons|0|||
94641489|NCT02658890|324150205|FG015|Treatment Phase|Other Reasons|0|||
94641490|NCT02658890|324150206|FG016|Treatment Phase|Other Reasons|0|||
94641491|NCT02658890|324150207|FG017|Treatment Phase|Other Reasons|0|||
94641492|NCT02658890|324150208|FG018|Treatment Phase|Other Reasons|1|||
94641493|NCT02658890|324150209|FG019|Treatment Phase|Other Reasons|0|||
94641494|NCT02658890|324150210|FG020|Treatment Phase|Other Reasons|0|||
94641495|NCT02658890|324150211|FG021|Treatment Phase|Other Reasons|0|||
94641496|NCT02658890|324150212|FG022|Treatment Phase|Other Reasons|0|||
94641497|NCT02658890|324150213|FG023|Treatment Phase|Other Reasons|0|||
94641498|NCT02658890|324150214|FG024|Treatment Phase|Other Reasons|1|||
94641499|NCT02658890|324150215|FG025|Treatment Phase|Other Reasons|0|||
94641500|NCT02658890|324150216|FG026|Treatment Phase|Other Reasons|1|||
94641501|NCT02658890|324150190|FG000|Treatment Phase|Progressive Disease|6|||
94641502|NCT02658890|324150191|FG001|Treatment Phase|Progressive Disease|7|||
94641503|NCT02658890|324150192|FG002|Treatment Phase|Progressive Disease|6|||
94641504|NCT02658890|324150193|FG003|Treatment Phase|Progressive Disease|12|||
94641505|NCT02658890|324150194|FG004|Treatment Phase|Progressive Disease|6|||
94641506|NCT02658890|324150195|FG005|Treatment Phase|Progressive Disease|18|||
94641507|NCT02658890|324150196|FG006|Treatment Phase|Progressive Disease|12|||
94641508|NCT02658890|324150197|FG007|Treatment Phase|Progressive Disease|19|||
94641509|NCT02658890|324150198|FG008|Treatment Phase|Progressive Disease|26|||
94641510|NCT02658890|324150199|FG009|Treatment Phase|Progressive Disease|8|||
94641511|NCT02658890|324150200|FG010|Treatment Phase|Progressive Disease|7|||
94641512|NCT02658890|324150201|FG011|Treatment Phase|Progressive Disease|9|||
94641513|NCT02658890|324150202|FG012|Treatment Phase|Progressive Disease|8|||
94641514|NCT02658890|324150203|FG013|Treatment Phase|Progressive Disease|29|||
94641515|NCT02658890|324150204|FG014|Treatment Phase|Progressive Disease|6|||
94641516|NCT02658890|324150205|FG015|Treatment Phase|Progressive Disease|2|||
94641517|NCT02658890|324150206|FG016|Treatment Phase|Progressive Disease|32|||
94641518|NCT02658890|324150207|FG017|Treatment Phase|Progressive Disease|14|||
94641519|NCT02658890|324150208|FG018|Treatment Phase|Progressive Disease|40|||
94641520|NCT02658890|324150209|FG019|Treatment Phase|Progressive Disease|32|||
94641521|NCT02658890|324150210|FG020|Treatment Phase|Progressive Disease|19|||
94641522|NCT02658890|324150211|FG021|Treatment Phase|Progressive Disease|30|||
94641523|NCT02658890|324150212|FG022|Treatment Phase|Progressive Disease|15|||
94641524|NCT02658890|324150213|FG023|Treatment Phase|Progressive Disease|0|||
94641525|NCT02658890|324150214|FG024|Treatment Phase|Progressive Disease|0|||
94641526|NCT02658890|324150215|FG025|Treatment Phase|Progressive Disease|14|||
94641527|NCT02658890|324150216|FG026|Treatment Phase|Progressive Disease|11|||
94641528|NCT02658890|324150190|FG000|Treatment Phase|Study Drug Toxicity|0|||
94641529|NCT02658890|324150191|FG001|Treatment Phase|Study Drug Toxicity|0|||
94641530|NCT02658890|324150192|FG002|Treatment Phase|Study Drug Toxicity|2|||
94641531|NCT02658890|324150193|FG003|Treatment Phase|Study Drug Toxicity|0|||
94641532|NCT02658890|324150194|FG004|Treatment Phase|Study Drug Toxicity|0|||
94641533|NCT02658890|324150195|FG005|Treatment Phase|Study Drug Toxicity|0|||
94641534|NCT02658890|324150196|FG006|Treatment Phase|Study Drug Toxicity|0|||
94641535|NCT02658890|324150197|FG007|Treatment Phase|Study Drug Toxicity|0|||
94641536|NCT02658890|324150198|FG008|Treatment Phase|Study Drug Toxicity|3|||
94641537|NCT02658890|324150199|FG009|Treatment Phase|Study Drug Toxicity|0|||
94641538|NCT02658890|324150200|FG010|Treatment Phase|Study Drug Toxicity|1|||
94641539|NCT02658890|324150201|FG011|Treatment Phase|Study Drug Toxicity|1|||
94641540|NCT02658890|324150202|FG012|Treatment Phase|Study Drug Toxicity|2|||
94641541|NCT02658890|324150203|FG013|Treatment Phase|Study Drug Toxicity|9|||
94641542|NCT02658890|324150204|FG014|Treatment Phase|Study Drug Toxicity|0|||
94641543|NCT02658890|324150205|FG015|Treatment Phase|Study Drug Toxicity|1|||
94641544|NCT02658890|324150206|FG016|Treatment Phase|Study Drug Toxicity|1|||
94641545|NCT02658890|324150207|FG017|Treatment Phase|Study Drug Toxicity|0|||
94641546|NCT02658890|324150208|FG018|Treatment Phase|Study Drug Toxicity|8|||
94641547|NCT02658890|324150209|FG019|Treatment Phase|Study Drug Toxicity|3|||
94641548|NCT02658890|324150210|FG020|Treatment Phase|Study Drug Toxicity|2|||
94641549|NCT02658890|324150211|FG021|Treatment Phase|Study Drug Toxicity|0|||
94641550|NCT02658890|324150212|FG022|Treatment Phase|Study Drug Toxicity|8|||
94641551|NCT02658890|324150213|FG023|Treatment Phase|Study Drug Toxicity|0|||
94641552|NCT02658890|324150214|FG024|Treatment Phase|Study Drug Toxicity|0|||
94641553|NCT02658890|324150215|FG025|Treatment Phase|Study Drug Toxicity|2|||
94641554|NCT02658890|324150216|FG026|Treatment Phase|Study Drug Toxicity|0|||
94641555|NCT02658890|324150190|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641556|NCT02658890|324150191|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641557|NCT02658890|324150192|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641558|NCT02658890|324150193|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
94641559|NCT02658890|324150194|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641560|NCT02658890|324150195|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641561|NCT02658890|324150196|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641562|NCT02658890|324150197|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641563|NCT02658890|324150198|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641564|NCT02658890|324150199|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
94641565|NCT02658890|324150200|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641566|NCT02658890|324150201|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641567|NCT02658890|324150202|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641568|NCT02658890|324150203|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641569|NCT02658890|324150204|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641570|NCT02658890|324150205|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641571|NCT02658890|324150206|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641572|NCT02658890|324150207|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641573|NCT02658890|324150208|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
94641574|NCT02658890|324150209|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641575|NCT02658890|324150210|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641576|NCT02658890|324150211|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641577|NCT02658890|324150212|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
94641578|NCT02658890|324150213|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641579|NCT02658890|324150214|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641580|NCT02658890|324150215|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641581|NCT02658890|324150216|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
94641582|NCT02658890|324150190|FG000|Treatment Phase|Withdrawal by Subject|0|||
94641583|NCT02658890|324150191|FG001|Treatment Phase|Withdrawal by Subject|1|||
94641584|NCT02658890|324150192|FG002|Treatment Phase|Withdrawal by Subject|0|||
94641585|NCT02658890|324150193|FG003|Treatment Phase|Withdrawal by Subject|0|||
94641586|NCT02658890|324150194|FG004|Treatment Phase|Withdrawal by Subject|0|||
94641587|NCT02658890|324150195|FG005|Treatment Phase|Withdrawal by Subject|0|||
94641588|NCT02658890|324150196|FG006|Treatment Phase|Withdrawal by Subject|1|||
94641589|NCT02658890|324150197|FG007|Treatment Phase|Withdrawal by Subject|0|||
94641590|NCT02658890|324150198|FG008|Treatment Phase|Withdrawal by Subject|0|||
94641591|NCT02658890|324150199|FG009|Treatment Phase|Withdrawal by Subject|1|||
94641592|NCT02658890|324150200|FG010|Treatment Phase|Withdrawal by Subject|0|||
94641593|NCT02658890|324150201|FG011|Treatment Phase|Withdrawal by Subject|0|||
94641594|NCT02658890|324150202|FG012|Treatment Phase|Withdrawal by Subject|1|||
94641595|NCT02658890|324150203|FG013|Treatment Phase|Withdrawal by Subject|3|||
94641596|NCT02658890|324150204|FG014|Treatment Phase|Withdrawal by Subject|0|||
94641597|NCT02658890|324150205|FG015|Treatment Phase|Withdrawal by Subject|0|||
94641598|NCT02658890|324150206|FG016|Treatment Phase|Withdrawal by Subject|1|||
94641599|NCT02658890|324150207|FG017|Treatment Phase|Withdrawal by Subject|0|||
94641600|NCT02658890|324150208|FG018|Treatment Phase|Withdrawal by Subject|4|||
94641601|NCT02658890|324150209|FG019|Treatment Phase|Withdrawal by Subject|3|||
94641602|NCT02658890|324150210|FG020|Treatment Phase|Withdrawal by Subject|0|||
94641603|NCT02658890|324150211|FG021|Treatment Phase|Withdrawal by Subject|4|||
94641604|NCT02658890|324150212|FG022|Treatment Phase|Withdrawal by Subject|1|||
94641605|NCT02658890|324150213|FG023|Treatment Phase|Withdrawal by Subject|1|||
94641606|NCT02658890|324150214|FG024|Treatment Phase|Withdrawal by Subject|0|||
94641607|NCT02658890|324150215|FG025|Treatment Phase|Withdrawal by Subject|0|||
94641608|NCT02658890|324150216|FG026|Treatment Phase|Withdrawal by Subject|0|||
94641609|NCT02474199|324150217|FG000|Overall Study|Lost to Follow-up|1|||
94641610|NCT02474199|324150218|FG001|Overall Study|Lost to Follow-up|0|||
94641611|NCT02474199|324150219|FG002|Overall Study|Lost to Follow-up|0|||
94641612|NCT02474199|324150220|FG003|Overall Study|Lost to Follow-up|0|||
94641613|NCT02474199|324150217|FG000|Overall Study|Withdrawal by Subject|1|||
94641614|NCT02474199|324150218|FG001|Overall Study|Withdrawal by Subject|2|||
94641615|NCT02474199|324150219|FG002|Overall Study|Withdrawal by Subject|0|||
94641616|NCT02474199|324150220|FG003|Overall Study|Withdrawal by Subject|1|||
94641617|NCT02474199|324150217|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
94641618|NCT02474199|324150218|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
94641619|NCT02474199|324150219|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
94641620|NCT02474199|324150220|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
94641621|NCT02474199|324150217|FG000|Overall Study|Did not meet eligibility criteria|0|||
94641622|NCT02474199|324150218|FG001|Overall Study|Did not meet eligibility criteria|0|||
94641623|NCT02474199|324150219|FG002|Overall Study|Did not meet eligibility criteria|2|||
94641624|NCT02474199|324150220|FG003|Overall Study|Did not meet eligibility criteria|2|||
94641625|NCT02342704|324150221|FG000|Overall Study|Physician Decision|0|||
94641626|NCT02342704|324150222|FG001|Overall Study|Physician Decision|3|||
94641627|NCT02342704|324150221|FG000|Overall Study|Sponsor Termination|49|||
94641628|NCT02342704|324150222|FG001|Overall Study|Sponsor Termination|43|||
94641629|NCT02342704|324150221|FG000|Overall Study|Other|0|||
94641630|NCT02342704|324150222|FG001|Overall Study|Other|1|||
94641631|NCT02342704|324150221|FG000|Overall Study|Withdrawal by Subject|1|||
94641632|NCT02342704|324150222|FG001|Overall Study|Withdrawal by Subject|0|||
94641633|NCT02342704|324150221|FG000|Overall Study|Lost to Follow-up|2|||
94641634|NCT02342704|324150222|FG001|Overall Study|Lost to Follow-up|1|||
94641635|NCT02342704|324150221|FG000|Overall Study|Adverse Event|1|||
94641636|NCT02342704|324150222|FG001|Overall Study|Adverse Event|3|||
94641637|NCT01660711|324150223|FG000|Overall Study|Adverse Event|7|||
94641638|NCT01660711|324150223|FG000|Overall Study|Withdrawal by Subject|1|||
94641639|NCT03253848|324150227|FG000|Overall Study|Adverse Event|7|||
94641640|NCT03253848|324150227|FG000|Overall Study|Death|5|||
94641641|NCT03253848|324150227|FG000|Overall Study|initiation of other treatments|3|||
94641642|NCT03253848|324150227|FG000|Overall Study|Other complicating disease|1|||
94641643|NCT03253848|324150227|FG000|Overall Study|Withdrawal by Subject|1|||
94641644|NCT03253848|324150227|FG000|Overall Study|Declining health|1|||
94641645|NCT00278954|324150228|FG000|Overall Study|Adverse Event|3|||
94641646|NCT00278954|324150228|FG000|Overall Study|Lost to Follow-up|1|||
94641647|NCT00278954|324150228|FG000|Overall Study|Withdrawal by Subject|1|||
94641648|NCT03412084|324150229|FG000|Overall Study|Withdrawal by Subject|2|||
94641649|NCT03412084|324150230|FG001|Overall Study|Withdrawal by Subject|0|||
94641650|NCT03412084|324150229|FG000|Overall Study|Participant moved|1|||
94641651|NCT03412084|324150230|FG001|Overall Study|Participant moved|0|||
94641652|NCT03412084|324150229|FG000|Overall Study|Lost to Follow-up|1|||
94641653|NCT03412084|324150230|FG001|Overall Study|Lost to Follow-up|1|||
94641654|NCT01752855|324150231|FG000|Overall Study|Adverse Event|1|||
94641655|NCT01752855|324150232|FG001|Overall Study|Adverse Event|0|||
94641656|NCT01752855|324150231|FG000|Overall Study|Withdrew Consent|0|||
94641657|NCT01752855|324150232|FG001|Overall Study|Withdrew Consent|2|||
94641658|NCT01752855|324150231|FG000|Overall Study|Lack of Efficacy|0|||
94641659|NCT01752855|324150232|FG001|Overall Study|Lack of Efficacy|2|||
94641660|NCT04649164|324150235|FG000|Overall Study|Withdrawal by Subject|1|||
94641661|NCT04649164|324150236|FG001|Overall Study|Withdrawal by Subject|1|||
94641662|NCT04649164|324150237|FG002|Overall Study|Withdrawal by Subject|2|||
94641663|NCT04649164|324150235|FG000|Overall Study|Participant's care recipient expired|0|||
94641664|NCT04649164|324150236|FG001|Overall Study|Participant's care recipient expired|0|||
94641665|NCT04649164|324150237|FG002|Overall Study|Participant's care recipient expired|2|||
94641666|NCT02439320|324150238|FG000|Overall Study|Adverse Event|0|||
94641667|NCT02439320|324150239|FG001|Overall Study|Adverse Event|2|||
94641668|NCT02439320|324150240|FG002|Overall Study|Adverse Event|0|||
94641669|NCT02439320|324150238|FG000|Overall Study|Lost to Follow-up|37|||
94641670|NCT02439320|324150239|FG001|Overall Study|Lost to Follow-up|34|||
94641671|NCT02439320|324150240|FG002|Overall Study|Lost to Follow-up|42|||
94641672|NCT02439320|324150238|FG000|Overall Study|Death|0|||
94641673|NCT02439320|324150239|FG001|Overall Study|Death|1|||
94641674|NCT02439320|324150240|FG002|Overall Study|Death|0|||
94641675|NCT02439320|324150238|FG000|Overall Study|Noncompliance with Protocol|10|||
94641676|NCT02439320|324150239|FG001|Overall Study|Noncompliance with Protocol|11|||
94641677|NCT02439320|324150240|FG002|Overall Study|Noncompliance with Protocol|7|||
94641678|NCT02439320|324150238|FG000|Overall Study|Pregnancy|0|||
94641679|NCT02439320|324150239|FG001|Overall Study|Pregnancy|1|||
94641680|NCT02439320|324150240|FG002|Overall Study|Pregnancy|1|||
94641681|NCT02439320|324150238|FG000|Overall Study|Withdrawal by Subject|12|||
94641682|NCT02439320|324150239|FG001|Overall Study|Withdrawal by Subject|16|||
94641683|NCT02439320|324150240|FG002|Overall Study|Withdrawal by Subject|14|||
94641684|NCT02439320|324150238|FG000|Overall Study|Physician Decision|2|||
94641685|NCT02439320|324150239|FG001|Overall Study|Physician Decision|1|||
94641686|NCT02439320|324150240|FG002|Overall Study|Physician Decision|0|||
94641687|NCT02439320|324150238|FG000|Overall Study|Sponsor Request|0|||
94641688|NCT02439320|324150239|FG001|Overall Study|Sponsor Request|2|||
94641689|NCT02439320|324150240|FG002|Overall Study|Sponsor Request|1|||
94641690|NCT02439320|324150238|FG000|Overall Study|Randomization Failure|35|||
94641691|NCT02439320|324150239|FG001|Overall Study|Randomization Failure|46|||
94641692|NCT02439320|324150240|FG002|Overall Study|Randomization Failure|34|||
94678630|NCT04244396|324278795|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
94641693|NCT04064294|324150241|FG000|Overall Study|Adverse Event|1|||
94641694|NCT04064294|324150242|FG001|Overall Study|Adverse Event|0|||
94641695|NCT04064294|324150243|FG002|Overall Study|Adverse Event|0|||
94641696|NCT03343483|324150247|FG000|Overall Study|Death|0|||
94641697|NCT03343483|324150248|FG001|Overall Study|Death|3|||
94641698|NCT03343483|324150247|FG000|Overall Study|Lost to Follow-up|9|||
94641699|NCT03343483|324150248|FG001|Overall Study|Lost to Follow-up|13|||
94641700|NCT03343483|324150247|FG000|Overall Study|Withdrawal by Subject|8|||
94641701|NCT03343483|324150248|FG001|Overall Study|Withdrawal by Subject|17|||
94641702|NCT01488097|324150255|FG000|Overall Study|Lost to Follow-up|1|||
94641703|NCT00909779|324150256|FG000|Overall Study|Adverse Event|53|||
94641704|NCT00909779|324150257|FG001|Overall Study|Adverse Event|55|||
94641705|NCT00909779|324150256|FG000|Overall Study|Lack of Efficacy|7|||
94641706|NCT00909779|324150257|FG001|Overall Study|Lack of Efficacy|4|||
94641707|NCT00909779|324150256|FG000|Overall Study|Lost to Follow-up|19|||
94641708|NCT00909779|324150257|FG001|Overall Study|Lost to Follow-up|15|||
94461919|NCT02091960|323481267|FG000|Overall Study|Withdrawal by Subject|1|||
94641709|NCT00909779|324150256|FG000|Overall Study|Physician Decision|8|||
94641710|NCT00909779|324150257|FG001|Overall Study|Physician Decision|2|||
94641711|NCT00909779|324150256|FG000|Overall Study|Protocol Violation|2|||
94641712|NCT00909779|324150257|FG001|Overall Study|Protocol Violation|5|||
94641713|NCT00909779|324150256|FG000|Overall Study|Withdrawal by Subject|116|||
94641714|NCT00909779|324150257|FG001|Overall Study|Withdrawal by Subject|80|||
94641715|NCT00909779|324150256|FG000|Overall Study|Site Ceasing Operation|2|||
94641716|NCT00909779|324150257|FG001|Overall Study|Site Ceasing Operation|2|||
94641717|NCT00909779|324150256|FG000|Overall Study|Medical Monitor Decision|1|||
94641718|NCT00909779|324150257|FG001|Overall Study|Medical Monitor Decision|0|||
94641719|NCT00909779|324150256|FG000|Overall Study|Noncompliance|1|||
94641720|NCT00909779|324150257|FG001|Overall Study|Noncompliance|1|||
94641721|NCT00909779|324150256|FG000|Overall Study|Randomized in error|1|||
94641722|NCT00909779|324150257|FG001|Overall Study|Randomized in error|1|||
94641723|NCT01498952|324150258|FG000|Overall Study|Death|2|||
94641724|NCT01498952|324150259|FG001|Overall Study|Death|2|||
94641725|NCT01498952|324150260|FG002|Overall Study|Death|0|||
94641726|NCT01498952|324150261|FG003|Overall Study|Death|0|||
94641727|NCT01498952|324150262|FG004|Overall Study|Death|0|||
94641728|NCT00579826|324150265|FG000|Overall Study|Withdrawal by Subject|5|||
94641729|NCT00579826|324150266|FG001|Overall Study|Withdrawal by Subject|3|||
94641730|NCT03161483|324150267|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
94641731|NCT03161483|324150268|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
94641732|NCT03161483|324150269|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
94641733|NCT03161483|324150270|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
94641734|NCT03161483|324150267|FG000|Treatment Period|Death|1|||
94641735|NCT03161483|324150268|FG001|Treatment Period|Death|0|||
94641736|NCT03161483|324150269|FG002|Treatment Period|Death|0|||
94641737|NCT03161483|324150270|FG003|Treatment Period|Death|0|||
94641738|NCT03161483|324150267|FG000|Treatment Period|Adverse Event|5|||
94641739|NCT03161483|324150268|FG001|Treatment Period|Adverse Event|2|||
94641740|NCT03161483|324150269|FG002|Treatment Period|Adverse Event|1|||
94641741|NCT03161483|324150270|FG003|Treatment Period|Adverse Event|11|||
94641742|NCT03161483|324150267|FG000|Treatment Period|Pregnancy|1|||
94641743|NCT03161483|324150268|FG001|Treatment Period|Pregnancy|0|||
94641744|NCT03161483|324150269|FG002|Treatment Period|Pregnancy|0|||
94641745|NCT03161483|324150270|FG003|Treatment Period|Pregnancy|0|||
94641746|NCT03161483|324150267|FG000|Treatment Period|Lack of Efficacy|0|||
94641747|NCT03161483|324150268|FG001|Treatment Period|Lack of Efficacy|0|||
94641748|NCT03161483|324150269|FG002|Treatment Period|Lack of Efficacy|0|||
94641749|NCT03161483|324150270|FG003|Treatment Period|Lack of Efficacy|1|||
94641750|NCT03161483|324150267|FG000|Treatment Period|Withdrawal by Subject|2|||
94641751|NCT03161483|324150268|FG001|Treatment Period|Withdrawal by Subject|5|||
94641752|NCT03161483|324150269|FG002|Treatment Period|Withdrawal by Subject|2|||
94641753|NCT03161483|324150270|FG003|Treatment Period|Withdrawal by Subject|6|||
94641754|NCT03161483|324150267|FG000|Treatment Period|Lost to Follow-up|0|||
94641755|NCT03161483|324150268|FG001|Treatment Period|Lost to Follow-up|0|||
94461920|NCT02091960|323481267|FG000|Overall Study|Miscellaneous Reasons|37|||
94641756|NCT03161483|324150269|FG002|Treatment Period|Lost to Follow-up|0|||
94641757|NCT03161483|324150270|FG003|Treatment Period|Lost to Follow-up|1|||
94641758|NCT03161483|324150267|FG000|Treatment Period|Protocol Violation|0|||
94641759|NCT03161483|324150268|FG001|Treatment Period|Protocol Violation|0|||
94461921|NCT01995175|323481274|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
94641760|NCT03161483|324150269|FG002|Treatment Period|Protocol Violation|0|||
94641761|NCT03161483|324150270|FG003|Treatment Period|Protocol Violation|1|||
94641762|NCT03161483|324150267|FG000|Treatment Period|Other reasons|1|||
94641763|NCT03161483|324150268|FG001|Treatment Period|Other reasons|1|||
94641764|NCT03161483|324150269|FG002|Treatment Period|Other reasons|0|||
94641765|NCT03161483|324150270|FG003|Treatment Period|Other reasons|0|||
94641766|NCT04372602|324150276|FG000|Overall Study|Withdrawal by Subject|1|||
94641767|NCT04372602|324150277|FG001|Overall Study|Withdrawal by Subject|1|||
94641768|NCT04372602|324150276|FG000|Overall Study|Adverse Event|0|||
94641769|NCT04372602|324150277|FG001|Overall Study|Adverse Event|1|||
94678631|NCT04244396|324278795|FG000|Overall Study|Withdrawal by Subject|2|||
94678632|NCT04244396|324278795|FG000|Overall Study|Study termination|37|||
94678633|NCT03237858|324278796|FG000|Overall Study|Death|19|||
94678634|NCT03237858|324278796|FG000|Overall Study|Withdrawal by Subject|37|||
94678635|NCT01255592|324278800|FG000|Overall Study|Adverse Event|5|||
94678636|NCT01255592|324278801|FG001|Overall Study|Adverse Event|0|||
94678637|NCT01255592|324278800|FG000|Overall Study|Withdrawal by Subject|1|||
94678638|NCT01255592|324278801|FG001|Overall Study|Withdrawal by Subject|0|||
94678639|NCT01255592|324278800|FG000|Overall Study|Other|0|||
94678640|NCT01255592|324278801|FG001|Overall Study|Other|1|||
94678641|NCT02259517|324278802|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
94678642|NCT02259517|324278803|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
94678643|NCT02259517|324278804|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
94678644|NCT02259517|324278802|FG000|Overall Study|Withdrawal by Subject|0|||
94678645|NCT02259517|324278803|FG001|Overall Study|Withdrawal by Subject|0|||
94678646|NCT02259517|324278804|FG002|Overall Study|Withdrawal by Subject|3|||
94678647|NCT01061333|324278807|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
94641770|NCT04372602|324150276|FG000|Overall Study|Transitioned to comfort care|0|||
94641771|NCT04372602|324150277|FG001|Overall Study|Transitioned to comfort care|1|||
94678648|NCT01061333|324278808|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
94678649|NCT05050578|324278809|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
94678650|NCT05050578|324278810|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
94678651|NCT05050578|324278809|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
94678652|NCT05050578|324278810|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
94678653|NCT05050578|324278809|FG000|Period 2, 30 Days|Protocol Violation|0|||
94678654|NCT05050578|324278810|FG001|Period 2, 30 Days|Protocol Violation|1|||
94678655|NCT02472652|324278811|FG000|Overall Study|Lost to Follow-up|1|||
94678656|NCT03704584|324278812|FG000|Overall Study|Withdrawal by Subject|1|||
94678657|NCT03704584|324278813|FG001|Overall Study|Withdrawal by Subject|0|||
94678658|NCT03185832|324278814|FG000|Overall Study|Death|9|||
94678659|NCT03185832|324278815|FG001|Overall Study|Death|14|||
94678660|NCT03185832|324278816|FG002|Overall Study|Death|9|||
94678661|NCT03185832|324278817|FG003|Overall Study|Death|7|||
94678662|NCT03185832|324278814|FG000|Overall Study|Withdrawn - vital status available|0|||
94678663|NCT03185832|324278815|FG001|Overall Study|Withdrawn - vital status available|1|||
94678664|NCT03185832|324278816|FG002|Overall Study|Withdrawn - vital status available|1|||
94678665|NCT03185832|324278817|FG003|Overall Study|Withdrawn - vital status available|4|||
94678666|NCT02364180|324278819|FG000|Overall Study|Screen Fail|1|||
94678667|NCT00508261|324278824|FG000|Overall Study|Other|0|||
94263191|NCT01376349|322758144|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
94263192|NCT01376349|322758145|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
94641772|NCT03717480|324150286|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
94641773|NCT03774433|324150289|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
94641774|NCT01708174|324150290|FG000|Treatment Period|Withdrawal by Subject|1|||
94641775|NCT01708174|324150291|FG001|Treatment Period|Withdrawal by Subject|0|||
94641776|NCT01708174|324150292|FG002|Treatment Period|Withdrawal by Subject|0|||
94641777|NCT01708174|324150290|FG000|Treatment Period|Progressive disease|0|||
94641778|NCT01708174|324150291|FG001|Treatment Period|Progressive disease|1|||
94641779|NCT01708174|324150292|FG002|Treatment Period|Progressive disease|0|||
94641780|NCT01708174|324150290|FG000|Treatment Period|Death|0|||
94641781|NCT01708174|324150291|FG001|Treatment Period|Death|0|||
94641782|NCT01708174|324150292|FG002|Treatment Period|Death|1|||
94641783|NCT01708174|324150290|FG000|Treatment Period|Adverse Event|0|||
94641784|NCT01708174|324150291|FG001|Treatment Period|Adverse Event|1|||
94641785|NCT01708174|324150292|FG002|Treatment Period|Adverse Event|0|||
94641786|NCT01062555|324150297|FG000|Phase 1|Death|10|||
94641787|NCT01062555|324150298|FG001|Phase 1|Death|17|||
94641788|NCT01062555|324150299|FG002|Phase 1|Death|0|||
94641789|NCT01062555|324150300|FG003|Phase 1|Death|0|||
94641790|NCT01062555|324150297|FG000|Phase 1|Graft Failure|12|||
94641791|NCT01062555|324150298|FG001|Phase 1|Graft Failure|8|||
94641792|NCT01062555|324150299|FG002|Phase 1|Graft Failure|0|||
94641793|NCT01062555|324150300|FG003|Phase 1|Graft Failure|0|||
94641794|NCT01062555|324150297|FG000|Phase 1|Withdrawal by Subject|1|||
94641795|NCT01062555|324150298|FG001|Phase 1|Withdrawal by Subject|1|||
94641796|NCT01062555|324150299|FG002|Phase 1|Withdrawal by Subject|0|||
94641797|NCT01062555|324150300|FG003|Phase 1|Withdrawal by Subject|0|||
94678668|NCT00508261|324278825|FG001|Overall Study|Other|1|||
94678669|NCT00508261|324278826|FG002|Overall Study|Other|1|||
94678670|NCT00508261|324278827|FG003|Overall Study|Other|0|||
94678671|NCT00508261|324278824|FG000|Overall Study|Serious Adverse Event|0|||
94678672|NCT00508261|324278825|FG001|Overall Study|Serious Adverse Event|1|||
94678673|NCT00508261|324278826|FG002|Overall Study|Serious Adverse Event|0|||
94678674|NCT00508261|324278827|FG003|Overall Study|Serious Adverse Event|0|||
94641798|NCT01062555|324150297|FG000|Phase 2|Death|0|||
94678675|NCT00508261|324278824|FG000|Overall Study|Withdrawal by Subject|3|||
94678676|NCT00508261|324278825|FG001|Overall Study|Withdrawal by Subject|4|||
94678677|NCT00508261|324278826|FG002|Overall Study|Withdrawal by Subject|4|||
94641799|NCT01062555|324150298|FG001|Phase 2|Death|0|||
94641800|NCT01062555|324150299|FG002|Phase 2|Death|8|||
94641801|NCT01062555|324150300|FG003|Phase 2|Death|3|||
94641802|NCT01062555|324150297|FG000|Phase 2|Graft failure|0|||
94641803|NCT01062555|324150298|FG001|Phase 2|Graft failure|0|||
94641804|NCT01062555|324150299|FG002|Phase 2|Graft failure|7|||
94641805|NCT01062555|324150300|FG003|Phase 2|Graft failure|4|||
94641806|NCT01062555|324150297|FG000|Phase 2|Withdrawal by Subject|0|||
94641807|NCT01062555|324150298|FG001|Phase 2|Withdrawal by Subject|0|||
94641808|NCT01062555|324150299|FG002|Phase 2|Withdrawal by Subject|0|||
94641809|NCT01062555|324150300|FG003|Phase 2|Withdrawal by Subject|7|||
94641810|NCT01062555|324150297|FG000|Phase 2|Protocol Violation|0|||
94641811|NCT01062555|324150298|FG001|Phase 2|Protocol Violation|0|||
94641812|NCT01062555|324150299|FG002|Phase 2|Protocol Violation|0|||
94641813|NCT01062555|324150300|FG003|Phase 2|Protocol Violation|3|||
94641814|NCT01062555|324150297|FG000|Phase 2|Physician Decision|0|||
94641815|NCT01062555|324150298|FG001|Phase 2|Physician Decision|0|||
94641816|NCT01062555|324150299|FG002|Phase 2|Physician Decision|0|||
94641817|NCT01062555|324150300|FG003|Phase 2|Physician Decision|17|||
94641818|NCT01124643|324150321|FG000|Overall Study|Death|1|||
94641819|NCT04220411|324150322|FG000|Overall Study|Adverse Event|0|||
94641820|NCT04220411|324150323|FG001|Overall Study|Adverse Event|0|||
94641821|NCT04220411|324150324|FG002|Overall Study|Adverse Event|0|||
94641822|NCT04220411|324150325|FG003|Overall Study|Adverse Event|1|||
94641823|NCT02028988|324150328|FG000|Overall Study|Withdrawal by Subject|2|||
94641824|NCT04059146|324150330|FG000|Overall Study|Withdrawal by Subject|0|||
94641825|NCT04059146|324150331|FG001|Overall Study|Withdrawal by Subject|1|||
94641826|NCT01623596|324150332|FG000|Overall Study|Abnormal laboratory values|2|||
94641827|NCT01623596|324150333|FG001|Overall Study|Abnormal laboratory values|0|||
94641828|NCT01623596|324150332|FG000|Overall Study|Administrative problems|9|||
94641829|NCT01623596|324150333|FG001|Overall Study|Administrative problems|13|||
94641830|NCT01623596|324150332|FG000|Overall Study|Adverse Event|20|||
94641831|NCT01623596|324150333|FG001|Overall Study|Adverse Event|29|||
94641832|NCT01623596|324150332|FG000|Overall Study|Death|0|||
94641833|NCT01623596|324150333|FG001|Overall Study|Death|2|||
94641834|NCT01623596|324150332|FG000|Overall Study|Lost to Follow-up|12|||
94641835|NCT01623596|324150333|FG001|Overall Study|Lost to Follow-up|16|||
94641836|NCT01623596|324150332|FG000|Overall Study|Withdrawal by Subject|13|||
94641837|NCT01623596|324150333|FG001|Overall Study|Withdrawal by Subject|31|||
94641838|NCT01623596|324150332|FG000|Overall Study|Patient no longer requires study drug|1|||
94641839|NCT01623596|324150333|FG001|Overall Study|Patient no longer requires study drug|0|||
94641840|NCT01623596|324150332|FG000|Overall Study|Protocol Violation|0|||
94641841|NCT01623596|324150333|FG001|Overall Study|Protocol Violation|6|||
94641842|NCT01623596|324150332|FG000|Overall Study|Lack of Efficacy|5|||
94641843|NCT01623596|324150333|FG001|Overall Study|Lack of Efficacy|3|||
94641844|NCT01324349|324150334|FG000|Overall Study|Death|1|||
94641845|NCT01324349|324150335|FG001|Overall Study|Death|1|||
94641846|NCT01324349|324150334|FG000|Overall Study|Withdrawal by Subject|0|||
94641847|NCT01324349|324150335|FG001|Overall Study|Withdrawal by Subject|1|||
94641848|NCT01070316|324150336|FG000|Extension Phase|Lack of Efficacy|3|||
94641849|NCT01070316|324150336|FG000|Extension Phase|Withdrawal by Subject|1|||
94641850|NCT03274986|324150337|FG000|Overall Study|Withdrawal by Subject|0|||
94641851|NCT03274986|324150338|FG001|Overall Study|Withdrawal by Subject|1|||
94641852|NCT03274986|324150337|FG000|Overall Study|Lost to Follow-up|0|||
94641853|NCT03274986|324150338|FG001|Overall Study|Lost to Follow-up|1|||
94641854|NCT01342510|324150341|FG000|Overall Study|Protocol Violation|12|||
94641855|NCT01342510|324150342|FG001|Overall Study|Protocol Violation|6|||
94641856|NCT01342510|324150343|FG002|Overall Study|Protocol Violation|13|||
94641857|NCT01342510|324150344|FG003|Overall Study|Protocol Violation|11|||
94641858|NCT03323658|324150345|FG000|Overall Study|Adverse Event|0|||
94641859|NCT03323658|324150346|FG001|Overall Study|Adverse Event|1|||
94641860|NCT03323658|324150347|FG002|Overall Study|Adverse Event|0|||
94641861|NCT00549562|324150348|FG000|Overall Study|Adverse Event|1|||
94641862|NCT00549562|324150348|FG000|Overall Study|Lack of Efficacy|1|||
94641863|NCT01132495|324150349|FG000|Overall Study|Various reasons|40|||
94641864|NCT01132495|324150350|FG001|Overall Study|Various reasons|38|||
94641865|NCT01132495|324150351|FG002|Overall Study|Various reasons|20|||
94641866|NCT01132495|324150352|FG003|Overall Study|Various reasons|12|||
94641867|NCT03913091|324150353|FG000|Overall Study|Lost to Follow-up|18|||
94641868|NCT03913091|324150354|FG001|Overall Study|Lost to Follow-up|11|||
94641869|NCT03913091|324150353|FG000|Overall Study|Required additional meds/surgery|1|||
94641870|NCT03913091|324150354|FG001|Overall Study|Required additional meds/surgery|2|||
94641871|NCT03913091|324150353|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
94641872|NCT03913091|324150354|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
94362983|NCT00902486|323112913|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
94362984|NCT00902486|323112914|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
94362985|NCT00902486|323112915|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
94641873|NCT02276612|324150357|FG000|Overall Study|Death|1|||
94641874|NCT02276612|324150358|FG001|Overall Study|Death|0|||
94641875|NCT02276612|324150357|FG000|Overall Study|Pregnancy|1|||
94641876|NCT02276612|324150358|FG001|Overall Study|Pregnancy|0|||
94641877|NCT02276612|324150357|FG000|Overall Study|Withdrew Consent|1|||
94641878|NCT02276612|324150358|FG001|Overall Study|Withdrew Consent|0|||
94641879|NCT02276612|324150357|FG000|Overall Study|Lost to Follow-up|1|||
94641880|NCT02276612|324150358|FG001|Overall Study|Lost to Follow-up|0|||
94641881|NCT01380184|324150359|FG000|Part 1 (19 Days)|Adverse Event|1|||
94641882|NCT01380184|324150359|FG000|Part 2|Adverse Event|5|||
94641883|NCT01380184|324150359|FG000|Part 2|Disease Progression|8|||
94641884|NCT01380184|324150359|FG000|Part 2|Lost to Follow-up|1|||
94641885|NCT04327986|324150360|FG000|Overall Study|Physician Decision|2|||
94641886|NCT04327986|324150361|FG001|Overall Study|Physician Decision|0|||
94641887|NCT04327986|324150362|FG002|Overall Study|Physician Decision|0|||
94641888|NCT04327986|324150360|FG000|Overall Study|Death|1|||
94641889|NCT04327986|324150361|FG001|Overall Study|Death|0|||
94641890|NCT04327986|324150362|FG002|Overall Study|Death|0|||
94641891|NCT03848845|324151638|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
94641892|NCT03848845|324151639|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
94641893|NCT03848845|324151640|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
94641894|NCT03848845|324151641|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
94641895|NCT03848845|324151638|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
94641896|NCT03848845|324151639|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
94641897|NCT03848845|324151640|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
94641898|NCT03848845|324151641|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
94641899|NCT03848845|324151638|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
94641900|NCT03848845|324151639|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
94641901|NCT03848845|324151640|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
94641902|NCT03848845|324151641|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
94641903|NCT03848845|324151638|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
94641904|NCT03848845|324151639|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
94641905|NCT03848845|324151640|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
94641906|NCT03848845|324151641|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
94641907|NCT01859507|324151642|FG000|Overall Study|left the country|4|||
94641908|NCT02506816|324151653|FG000|Overall Study|Adverse Event|3|||
94641909|NCT04214288|324151656|FG000|Overall Study|Ongoing in the study|41|||
94641910|NCT04214288|324151657|FG001|Overall Study|Ongoing in the study|51|||
94641911|NCT04214288|324151658|FG002|Overall Study|Ongoing in the study|12|||
94641912|NCT04214288|324151659|FG003|Overall Study|Ongoing in the study|39|||
94641913|NCT04214288|324151656|FG000|Overall Study|Adverse Event|1|||
94641914|NCT04214288|324151657|FG001|Overall Study|Adverse Event|0|||
94641915|NCT04214288|324151658|FG002|Overall Study|Adverse Event|0|||
94641916|NCT04214288|324151659|FG003|Overall Study|Adverse Event|0|||
94641917|NCT04214288|324151656|FG000|Overall Study|Death|22|||
94641918|NCT04214288|324151657|FG001|Overall Study|Death|13|||
94641919|NCT04214288|324151658|FG002|Overall Study|Death|7|||
94641920|NCT04214288|324151659|FG003|Overall Study|Death|19|||
94641921|NCT04214288|324151656|FG000|Overall Study|Lost to Follow-up|1|||
94641922|NCT04214288|324151657|FG001|Overall Study|Lost to Follow-up|2|||
94641923|NCT04214288|324151658|FG002|Overall Study|Lost to Follow-up|1|||
94641924|NCT04214288|324151659|FG003|Overall Study|Lost to Follow-up|0|||
94641925|NCT04214288|324151656|FG000|Overall Study|Other|1|||
94641926|NCT04214288|324151657|FG001|Overall Study|Other|2|||
94641927|NCT04214288|324151658|FG002|Overall Study|Other|0|||
94641928|NCT04214288|324151659|FG003|Overall Study|Other|6|||
94641929|NCT04214288|324151656|FG000|Overall Study|Protocol Violation|0|||
94641930|NCT04214288|324151657|FG001|Overall Study|Protocol Violation|1|||
94641931|NCT04214288|324151658|FG002|Overall Study|Protocol Violation|0|||
94641932|NCT04214288|324151659|FG003|Overall Study|Protocol Violation|0|||
94641933|NCT04214288|324151656|FG000|Overall Study|Withdrawal by Subject|8|||
94641934|NCT04214288|324151657|FG001|Overall Study|Withdrawal by Subject|4|||
94641935|NCT04214288|324151658|FG002|Overall Study|Withdrawal by Subject|0|||
94641936|NCT04214288|324151659|FG003|Overall Study|Withdrawal by Subject|9|||
94641937|NCT01990495|324151662|FG000|Overall Study|Physician Decision|5|||
94641938|NCT01990495|324151663|FG001|Overall Study|Physician Decision|4|||
94641939|NCT03925324|324151666|FG000|Overall Study|Death|1|||
94641940|NCT03925324|324151667|FG001|Overall Study|Death|1|||
94641941|NCT00228917|324151668|FG000|Overall Study|Migrated/moved from study area|0|||
94641942|NCT00228917|324151669|FG001|Overall Study|Migrated/moved from study area|0|||
94641943|NCT00228917|324151670|FG002|Overall Study|Migrated/moved from study area|0|||
94641944|NCT00228917|324151671|FG003|Overall Study|Migrated/moved from study area|0|||
94641945|NCT00228917|324151672|FG004|Overall Study|Migrated/moved from study area|0|||
94641946|NCT00228917|324151673|FG005|Overall Study|Migrated/moved from study area|2|||
94641947|NCT00228917|324151674|FG006|Overall Study|Migrated/moved from study area|0|||
94678678|NCT00508261|324278827|FG003|Overall Study|Withdrawal by Subject|0|||
94678679|NCT00508261|324278824|FG000|Overall Study|Migrated/ moved from study area|0|||
94678680|NCT00508261|324278825|FG001|Overall Study|Migrated/ moved from study area|1|||
94678681|NCT00508261|324278826|FG002|Overall Study|Migrated/ moved from study area|0|||
94678682|NCT00508261|324278827|FG003|Overall Study|Migrated/ moved from study area|0|||
94678683|NCT00508261|324278824|FG000|Overall Study|Lost to Follow-up|0|||
94678684|NCT00508261|324278825|FG001|Overall Study|Lost to Follow-up|1|||
94678685|NCT00508261|324278826|FG002|Overall Study|Lost to Follow-up|1|||
94678686|NCT00508261|324278827|FG003|Overall Study|Lost to Follow-up|1|||
94678687|NCT00710606|324278830|FG000|Overall Study|Adverse Event|0|||
94678688|NCT00710606|324278831|FG001|Overall Study|Adverse Event|2|||
94678689|NCT05168579|324278841|FG000|Overall Study|Lack of Consent|1|||
94678690|NCT05168579|324278842|FG001|Overall Study|Lack of Consent|0|||
94678691|NCT05168579|324278841|FG000|Overall Study|Conflicts with time|2|||
94678692|NCT05168579|324278842|FG001|Overall Study|Conflicts with time|0|||
94678693|NCT05168579|324278841|FG000|Overall Study|Time slots were full|3|||
94678694|NCT05168579|324278842|FG001|Overall Study|Time slots were full|0|||
94641948|NCT00228917|324151675|FG007|Overall Study|Migrated/moved from study area|0|||
94641949|NCT02871739|324151678|FG000|Overall Study|Lost to Follow-up|3|||
94641950|NCT02871739|324151679|FG001|Overall Study|Lost to Follow-up|2|||
94641951|NCT02871739|324151680|FG002|Overall Study|Lost to Follow-up|0|||
94678695|NCT05168579|324278841|FG000|Overall Study|Lost to Follow-up|0|||
94678696|NCT05168579|324278842|FG001|Overall Study|Lost to Follow-up|15|||
94678697|NCT05056870|324278843|FG000|Period 1|Site COVID-19 Related|3|||
94678698|NCT05056870|324278844|FG001|Period 1|Site COVID-19 Related|3|||
94678699|NCT05056870|324278843|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
94678700|NCT05056870|324278844|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
94678701|NCT05056870|324278843|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
94678702|NCT05056870|324278844|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
94678703|NCT05056870|324278843|FG000|Period 2|COVID-19 Related|1|||
94678704|NCT05056870|324278844|FG001|Period 2|COVID-19 Related|0|||
94678705|NCT05056870|324278843|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
94678706|NCT05056870|324278844|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
94678707|NCT02901626|324278845|FG000|Overall Study|Lost to Follow-up|1|||
94678708|NCT02901626|324278846|FG001|Overall Study|Lost to Follow-up|1|||
94678709|NCT00331344|324278847|FG000|Phase I|Adverse Event|0|||
94678710|NCT00331344|324278848|FG001|Phase I|Adverse Event|0|||
94678711|NCT00331344|324278849|FG002|Phase I|Adverse Event|0|||
94678712|NCT00331344|324278850|FG003|Phase I|Adverse Event|1|||
94678713|NCT00331344|324278851|FG004|Phase I|Adverse Event|2|||
94678714|NCT00331344|324278852|FG005|Phase I|Adverse Event|2|||
94678715|NCT00331344|324278853|FG006|Phase I|Adverse Event|0|||
94678716|NCT00331344|324278854|FG007|Phase I|Adverse Event|1|||
94678717|NCT00331344|324278855|FG008|Phase I|Adverse Event|0|||
94678718|NCT00331344|324278847|FG000|Phase II|Death|0|||
94678719|NCT00331344|324278848|FG001|Phase II|Death|0|||
94678720|NCT00331344|324278849|FG002|Phase II|Death|0|||
94678721|NCT00331344|324278850|FG003|Phase II|Death|0|||
94678722|NCT00331344|324278851|FG004|Phase II|Death|0|||
94678723|NCT00331344|324278852|FG005|Phase II|Death|0|||
94678724|NCT00331344|324278853|FG006|Phase II|Death|0|||
94641952|NCT02871739|324151681|FG003|Overall Study|Lost to Follow-up|2|||
94678725|NCT00331344|324278854|FG007|Phase II|Death|0|||
94678726|NCT00331344|324278855|FG008|Phase II|Death|4|||
94678727|NCT01750879|324278856|FG000|Overall Study|Adverse Event|8|||
94678728|NCT01750879|324278857|FG001|Overall Study|Adverse Event|0|||
94678729|NCT01750879|324278856|FG000|Overall Study|Lack of Efficacy|1|||
94641953|NCT00775437|324151682|FG000|Overall Study|Loss of efficacy|2|||
94641954|NCT00775437|324151682|FG000|Overall Study|Withdrawal by Subject|3|||
94641955|NCT00775437|324151682|FG000|Overall Study|Lost to Follow-up|1|||
94641956|NCT03131440|324151683|FG000|Overall Study|Withdrawal by Subject|1|||
94641957|NCT03131440|324151684|FG001|Overall Study|Withdrawal by Subject|3|||
94641958|NCT03131440|324151685|FG002|Overall Study|Withdrawal by Subject|0|||
94641959|NCT03131440|324151686|FG003|Overall Study|Withdrawal by Subject|0|||
94641960|NCT03131440|324151687|FG004|Overall Study|Withdrawal by Subject|1|||
94641961|NCT03131440|324151688|FG005|Overall Study|Withdrawal by Subject|0|||
94641962|NCT03131440|324151689|FG006|Overall Study|Withdrawal by Subject|0|||
94641963|NCT03131440|324151690|FG007|Overall Study|Withdrawal by Subject|1|||
94641964|NCT03131440|324151691|FG008|Overall Study|Withdrawal by Subject|1|||
94641965|NCT03131440|324151692|FG009|Overall Study|Withdrawal by Subject|1|||
94641966|NCT03131440|324151693|FG010|Overall Study|Withdrawal by Subject|0|||
94641967|NCT03131440|324151694|FG011|Overall Study|Withdrawal by Subject|1|||
94641968|NCT03131440|324151695|FG012|Overall Study|Withdrawal by Subject|1|||
94641969|NCT03131440|324151696|FG013|Overall Study|Withdrawal by Subject|0|||
94641970|NCT03131440|324151697|FG014|Overall Study|Withdrawal by Subject|1|||
94641971|NCT03131440|324151698|FG015|Overall Study|Withdrawal by Subject|0|||
94641972|NCT03131440|324151699|FG016|Overall Study|Withdrawal by Subject|0|||
94641973|NCT03131440|324151700|FG017|Overall Study|Withdrawal by Subject|0|||
94641974|NCT03131440|324151701|FG018|Overall Study|Withdrawal by Subject|1|||
94641975|NCT03131440|324151702|FG019|Overall Study|Withdrawal by Subject|0|||
94641976|NCT03131440|324151703|FG020|Overall Study|Withdrawal by Subject|1|||
94641977|NCT03131440|324151704|FG021|Overall Study|Withdrawal by Subject|1|||
94641978|NCT03131440|324151705|FG022|Overall Study|Withdrawal by Subject|1|||
94641979|NCT03131440|324151706|FG023|Overall Study|Withdrawal by Subject|0|||
94641980|NCT03131440|324151707|FG024|Overall Study|Withdrawal by Subject|0|||
94641981|NCT03131440|324151708|FG025|Overall Study|Withdrawal by Subject|0|||
94641982|NCT03131440|324151709|FG026|Overall Study|Withdrawal by Subject|0|||
94641983|NCT03131440|324151710|FG027|Overall Study|Withdrawal by Subject|0|||
94641984|NCT03131440|324151711|FG028|Overall Study|Withdrawal by Subject|0|||
94641985|NCT03131440|324151712|FG029|Overall Study|Withdrawal by Subject|0|||
94641986|NCT03131440|324151713|FG030|Overall Study|Withdrawal by Subject|1|||
94641987|NCT03131440|324151714|FG031|Overall Study|Withdrawal by Subject|0|||
94641988|NCT03131440|324151683|FG000|Overall Study|Lost to Follow-up|0|||
94641989|NCT03131440|324151684|FG001|Overall Study|Lost to Follow-up|0|||
94641990|NCT03131440|324151685|FG002|Overall Study|Lost to Follow-up|0|||
94641991|NCT03131440|324151686|FG003|Overall Study|Lost to Follow-up|0|||
94641992|NCT03131440|324151687|FG004|Overall Study|Lost to Follow-up|0|||
94641993|NCT03131440|324151688|FG005|Overall Study|Lost to Follow-up|1|||
94641994|NCT03131440|324151689|FG006|Overall Study|Lost to Follow-up|0|||
94641995|NCT03131440|324151690|FG007|Overall Study|Lost to Follow-up|0|||
94641996|NCT03131440|324151691|FG008|Overall Study|Lost to Follow-up|0|||
94641997|NCT03131440|324151692|FG009|Overall Study|Lost to Follow-up|0|||
94641998|NCT03131440|324151693|FG010|Overall Study|Lost to Follow-up|0|||
94641999|NCT03131440|324151694|FG011|Overall Study|Lost to Follow-up|0|||
94642000|NCT03131440|324151695|FG012|Overall Study|Lost to Follow-up|0|||
94642001|NCT03131440|324151696|FG013|Overall Study|Lost to Follow-up|0|||
94642002|NCT03131440|324151697|FG014|Overall Study|Lost to Follow-up|0|||
94642003|NCT03131440|324151698|FG015|Overall Study|Lost to Follow-up|0|||
94642004|NCT03131440|324151699|FG016|Overall Study|Lost to Follow-up|0|||
94642005|NCT03131440|324151700|FG017|Overall Study|Lost to Follow-up|0|||
94642006|NCT03131440|324151701|FG018|Overall Study|Lost to Follow-up|0|||
94642007|NCT03131440|324151702|FG019|Overall Study|Lost to Follow-up|2|||
94642008|NCT03131440|324151703|FG020|Overall Study|Lost to Follow-up|1|||
94642009|NCT03131440|324151704|FG021|Overall Study|Lost to Follow-up|0|||
94642010|NCT03131440|324151705|FG022|Overall Study|Lost to Follow-up|1|||
94642011|NCT03131440|324151706|FG023|Overall Study|Lost to Follow-up|0|||
94642012|NCT03131440|324151707|FG024|Overall Study|Lost to Follow-up|1|||
94642013|NCT03131440|324151708|FG025|Overall Study|Lost to Follow-up|0|||
94642014|NCT03131440|324151709|FG026|Overall Study|Lost to Follow-up|0|||
94642015|NCT03131440|324151710|FG027|Overall Study|Lost to Follow-up|2|||
94642016|NCT03131440|324151711|FG028|Overall Study|Lost to Follow-up|0|||
94642017|NCT03131440|324151712|FG029|Overall Study|Lost to Follow-up|2|||
94642018|NCT03131440|324151713|FG030|Overall Study|Lost to Follow-up|0|||
94642019|NCT03131440|324151714|FG031|Overall Study|Lost to Follow-up|0|||
94642020|NCT03131440|324151683|FG000|Overall Study|Death|0|||
94642021|NCT03131440|324151684|FG001|Overall Study|Death|0|||
94642022|NCT03131440|324151685|FG002|Overall Study|Death|0|||
94642023|NCT03131440|324151686|FG003|Overall Study|Death|0|||
94642024|NCT03131440|324151687|FG004|Overall Study|Death|0|||
94642025|NCT03131440|324151688|FG005|Overall Study|Death|0|||
94642026|NCT03131440|324151689|FG006|Overall Study|Death|0|||
94642027|NCT03131440|324151690|FG007|Overall Study|Death|0|||
94642028|NCT03131440|324151691|FG008|Overall Study|Death|0|||
94642029|NCT03131440|324151692|FG009|Overall Study|Death|0|||
94642030|NCT03131440|324151693|FG010|Overall Study|Death|0|||
94642031|NCT03131440|324151694|FG011|Overall Study|Death|0|||
94642032|NCT03131440|324151695|FG012|Overall Study|Death|0|||
94642033|NCT03131440|324151696|FG013|Overall Study|Death|0|||
94642034|NCT03131440|324151697|FG014|Overall Study|Death|0|||
94642035|NCT03131440|324151698|FG015|Overall Study|Death|0|||
94642036|NCT03131440|324151699|FG016|Overall Study|Death|0|||
94642037|NCT03131440|324151700|FG017|Overall Study|Death|0|||
94642038|NCT03131440|324151701|FG018|Overall Study|Death|0|||
94642039|NCT03131440|324151702|FG019|Overall Study|Death|0|||
94642040|NCT03131440|324151703|FG020|Overall Study|Death|0|||
94642041|NCT03131440|324151704|FG021|Overall Study|Death|0|||
94642042|NCT03131440|324151705|FG022|Overall Study|Death|0|||
94642043|NCT03131440|324151706|FG023|Overall Study|Death|0|||
94642044|NCT03131440|324151707|FG024|Overall Study|Death|0|||
94642045|NCT03131440|324151708|FG025|Overall Study|Death|1|||
94642046|NCT03131440|324151709|FG026|Overall Study|Death|0|||
94642047|NCT03131440|324151710|FG027|Overall Study|Death|0|||
94642048|NCT03131440|324151711|FG028|Overall Study|Death|0|||
94642049|NCT03131440|324151712|FG029|Overall Study|Death|0|||
94642050|NCT03131440|324151713|FG030|Overall Study|Death|0|||
94642051|NCT03131440|324151714|FG031|Overall Study|Death|0|||
94642052|NCT01498640|324151717|FG000|Overall Study|Lost to Follow-up|1|||
94642053|NCT01498640|324151717|FG000|Overall Study|Death|1|||
94642054|NCT01498640|324151717|FG000|Overall Study|Other|3|||
94642055|NCT04371380|324151718|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
94642056|NCT04371380|324151719|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
94642057|NCT04371380|324151720|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
94642058|NCT03190889|324151725|FG000|Overall Study|Lost to Follow-up|7|||
94642059|NCT03190889|324151726|FG001|Overall Study|Lost to Follow-up|7|||
94642060|NCT03190889|324151727|FG002|Overall Study|Lost to Follow-up|3|||
94642061|NCT03190889|324151725|FG000|Overall Study|Withdrawal by Subject|1|||
94642062|NCT03190889|324151726|FG001|Overall Study|Withdrawal by Subject|1|||
94642063|NCT03190889|324151727|FG002|Overall Study|Withdrawal by Subject|2|||
94642064|NCT03190889|324151725|FG000|Overall Study|Did not complete protocol|4|||
94642065|NCT03190889|324151726|FG001|Overall Study|Did not complete protocol|9|||
94642066|NCT03190889|324151727|FG002|Overall Study|Did not complete protocol|0|||
94642067|NCT03190889|324151725|FG000|Overall Study|COVID-19|1|||
94642068|NCT03190889|324151726|FG001|Overall Study|COVID-19|0|||
94642069|NCT03190889|324151727|FG002|Overall Study|COVID-19|2|||
94642070|NCT02466555|324151729|FG000|Overall Study|Lost to Follow-up|2|||
94642071|NCT00578942|324151735|FG000|Overall Study|Lost to Follow-up|1|||
94642072|NCT01063595|324151738|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
94642073|NCT01063595|324151739|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
94642074|NCT01063595|324151738|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
94642075|NCT01063595|324151739|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
94642076|NCT01063595|324151738|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
94642077|NCT01063595|324151739|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
94642078|NCT01063595|324151738|FG000|First Intervention|Adverse Event|1|||
94642079|NCT01063595|324151739|FG001|First Intervention|Adverse Event|4|||
94642080|NCT01063595|324151738|FG000|First Intervention|Withdrawal by Subject|1|||
94642081|NCT01063595|324151739|FG001|First Intervention|Withdrawal by Subject|0|||
94642082|NCT01063595|324151738|FG000|First Intervention|Reason not Specified|0|||
94642083|NCT01063595|324151739|FG001|First Intervention|Reason not Specified|1|||
94642084|NCT00451035|324151741|FG000|Overall Study|Disease progression|11|||
94642085|NCT00451035|324151741|FG000|Overall Study|Death|3|||
94642086|NCT00451035|324151741|FG000|Overall Study|New anti-neoplastic therapy|3|||
94642087|NCT01712256|324151745|FG000|Overall Study|Lost to Follow-up|1|||
94642088|NCT00748215|324151746|FG000|Overall Study|Withdrawal by Subject|7|||
94642089|NCT00748215|324151747|FG001|Overall Study|Withdrawal by Subject|7|||
94642090|NCT00748215|324151746|FG000|Overall Study|Treatment change|2|||
94642091|NCT00748215|324151747|FG001|Overall Study|Treatment change|1|||
94642092|NCT00748215|324151746|FG000|Overall Study|Change in patient condition|0|||
94642093|NCT00748215|324151747|FG001|Overall Study|Change in patient condition|3|||
94642094|NCT00748215|324151746|FG000|Overall Study|Non-compliant|0|||
94642095|NCT00748215|324151747|FG001|Overall Study|Non-compliant|2|||
94642096|NCT00748215|324151746|FG000|Overall Study|Adverse Event|0|||
94642097|NCT00748215|324151747|FG001|Overall Study|Adverse Event|5|||
94642098|NCT00851799|324151748|FG000|Overall Study|Death|1|||
94642099|NCT00851799|324151749|FG001|Overall Study|Death|0|||
94642100|NCT00851799|324151750|FG002|Overall Study|Death|1|||
94642101|NCT00851799|324151748|FG000|Overall Study|Lost to Follow-up|5|||
94642102|NCT00851799|324151749|FG001|Overall Study|Lost to Follow-up|3|||
94642103|NCT00851799|324151750|FG002|Overall Study|Lost to Follow-up|10|||
94642104|NCT00851799|324151748|FG000|Overall Study|Not able to get to clinic|8|||
94642105|NCT00851799|324151749|FG001|Overall Study|Not able to get to clinic|5|||
94642106|NCT00851799|324151750|FG002|Overall Study|Not able to get to clinic|9|||
94642107|NCT00851799|324151748|FG000|Overall Study|Not willing to adhere to requirements|1|||
94642108|NCT00851799|324151749|FG001|Overall Study|Not willing to adhere to requirements|2|||
94642109|NCT00851799|324151750|FG002|Overall Study|Not willing to adhere to requirements|2|||
94642110|NCT00851799|324151748|FG000|Overall Study|Withdrew consent prior study completion|1|||
94642111|NCT00851799|324151749|FG001|Overall Study|Withdrew consent prior study completion|2|||
94642112|NCT00851799|324151750|FG002|Overall Study|Withdrew consent prior study completion|1|||
94642113|NCT00851799|324151748|FG000|Overall Study|Severe Debilitation|0|||
94642114|NCT00851799|324151749|FG001|Overall Study|Severe Debilitation|1|||
94642115|NCT00851799|324151750|FG002|Overall Study|Severe Debilitation|0|||
94642116|NCT00851799|324151748|FG000|Overall Study|Completed protocol due to pregnancy|0|||
94642117|NCT00851799|324151749|FG001|Overall Study|Completed protocol due to pregnancy|0|||
94642118|NCT00851799|324151750|FG002|Overall Study|Completed protocol due to pregnancy|1|||
94642119|NCT00962104|324151751|FG000|Overall Study|Adverse Event|10|||
94642120|NCT00962104|324151752|FG001|Overall Study|Adverse Event|3|||
94642121|NCT00962104|324151751|FG000|Overall Study|Entry Criteria Not Met|1|||
94461922|NCT01995175|323481274|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
94461923|NCT01995175|323481274|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
94461924|NCT01995175|323481274|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
94461925|NCT01995175|323481274|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
94461926|NCT01995175|323481274|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
94461927|NCT01995175|323481274|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
94461928|NCT01995175|323481274|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
94461929|NCT01995175|323481274|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
94461930|NCT03781583|323481275|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
94461931|NCT03781583|323481276|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
94461932|NCT03781583|323481277|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
94461933|NCT03781583|323481278|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
94461934|NCT03781583|323481275|FG000|Overall Study|Technology did not work for that person in that environment|1|||
94642122|NCT00962104|324151752|FG001|Overall Study|Entry Criteria Not Met|2|||
94642123|NCT00962104|324151751|FG000|Overall Study|Lack of Efficacy|0|||
94642124|NCT00962104|324151752|FG001|Overall Study|Lack of Efficacy|1|||
94642125|NCT00962104|324151751|FG000|Overall Study|Lost to Follow-up|10|||
94642126|NCT00962104|324151752|FG001|Overall Study|Lost to Follow-up|4|||
94642127|NCT00962104|324151751|FG000|Overall Study|Physician Decision|1|||
94642128|NCT00962104|324151752|FG001|Overall Study|Physician Decision|0|||
94642129|NCT00962104|324151751|FG000|Overall Study|Protocol Violation|6|||
94642130|NCT00962104|324151752|FG001|Overall Study|Protocol Violation|8|||
94642131|NCT00962104|324151751|FG000|Overall Study|Sponsor Decision|0|||
94642132|NCT00962104|324151752|FG001|Overall Study|Sponsor Decision|1|||
94642133|NCT00962104|324151751|FG000|Overall Study|Withdrawal by Subject|10|||
94642134|NCT00962104|324151752|FG001|Overall Study|Withdrawal by Subject|6|||
94642135|NCT00962104|324151751|FG000|Overall Study|Other|2|||
94642136|NCT00962104|324151752|FG001|Overall Study|Other|0|||
94642137|NCT02013167|324151753|FG000|Overall Study|Withdrawal by Subject|15|||
94642138|NCT02013167|324151754|FG001|Overall Study|Withdrawal by Subject|14|||
94642139|NCT02013167|324151753|FG000|Overall Study|Sponsor Decision|1|||
94642140|NCT02013167|324151754|FG001|Overall Study|Sponsor Decision|3|||
94642141|NCT02013167|324151753|FG000|Overall Study|Lost to Follow-up|0|||
94263193|NCT01376349|322758146|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
94263194|NCT01376349|322758144|FG000|Raondomized Treatment|Adverse Event|13|||
94642142|NCT02013167|324151754|FG001|Overall Study|Lost to Follow-up|1|||
94642143|NCT02013167|324151753|FG000|Overall Study|Death|85|||
94642144|NCT02013167|324151754|FG001|Overall Study|Death|160|||
94642145|NCT03200899|324151755|FG000|Overall Study|Lost to Follow-up|10|||
94642146|NCT03200899|324151756|FG001|Overall Study|Lost to Follow-up|23|||
94642147|NCT02620046|324151764|FG000|Overall Study|Adverse Event|22|||
94362986|NCT00902486|323112910|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
94362987|NCT00902486|323112911|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
94362988|NCT00902486|323112912|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
94362989|NCT00902486|323112913|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
94362990|NCT00902486|323112914|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
94362991|NCT00902486|323112915|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
94362992|NCT00902486|323112910|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
94362993|NCT00902486|323112911|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
94362994|NCT00902486|323112912|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
94362995|NCT00902486|323112913|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
94362996|NCT00902486|323112914|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
94362997|NCT00902486|323112915|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
94362998|NCT02332655|323112916|FG000|Overall Study|Lack of Efficacy|1|||
94362999|NCT00005879|323112921|FG000|Overall Study|Withdrawal by Subject|8|||
94363000|NCT00005879|323112922|FG001|Overall Study|Withdrawal by Subject|10|||
94363001|NCT02395536|323112924|FG000|Overall Study|Lost to Follow-up|4|||
94363002|NCT02395536|323112925|FG001|Overall Study|Lost to Follow-up|4|||
94363003|NCT02395536|323112924|FG000|Overall Study|Death|2|||
94363004|NCT02395536|323112925|FG001|Overall Study|Death|0|||
94363005|NCT02395536|323112924|FG000|Overall Study|Physician Decision|4|||
94363006|NCT02395536|323112925|FG001|Overall Study|Physician Decision|6|||
94363007|NCT02395536|323112924|FG000|Overall Study|Withdrawal by Subject|9|||
94363008|NCT02395536|323112925|FG001|Overall Study|Withdrawal by Subject|17|||
94363009|NCT02395536|323112924|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
94363010|NCT02395536|323112925|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
94363011|NCT02395536|323112924|FG000|Overall Study|Insurance issue|0|||
94363012|NCT02395536|323112925|FG001|Overall Study|Insurance issue|1|||
94363013|NCT00131937|323112926|FG000|Overall Study|Adverse Event|3|||
94363014|NCT00131937|323112926|FG000|Overall Study|Withdrawal by Subject|2|||
94363015|NCT00131937|323112926|FG000|Overall Study|Physician Decision|1|||
94363016|NCT00131937|323112926|FG000|Overall Study|Disease Progression|7|||
94363017|NCT00131937|323112926|FG000|Overall Study|Alternative therapy|1|||
94363018|NCT05257109|323112935|FG000|Overall Study|Withdrawal by Subject|1|||
94363019|NCT05257109|323112936|FG001|Overall Study|Withdrawal by Subject|0|||
94363020|NCT05257109|323112937|FG002|Overall Study|Withdrawal by Subject|0|||
94363021|NCT05257109|323112938|FG003|Overall Study|Withdrawal by Subject|0|||
94642148|NCT02620046|324151765|FG001|Overall Study|Adverse Event|42|||
94642149|NCT02620046|324151764|FG000|Overall Study|Lost to Follow-up|4|||
94642150|NCT02620046|324151765|FG001|Overall Study|Lost to Follow-up|10|||
94642151|NCT02620046|324151764|FG000|Overall Study|Withdrawal by Subject|36|||
94642152|NCT02620046|324151765|FG001|Overall Study|Withdrawal by Subject|66|||
94642153|NCT02620046|324151764|FG000|Overall Study|Site Termination|3|||
94642154|NCT02620046|324151765|FG001|Overall Study|Site Termination|3|||
94642155|NCT02620046|324151764|FG000|Overall Study|Pregnancy|3|||
94642156|NCT02620046|324151765|FG001|Overall Study|Pregnancy|7|||
94642157|NCT02620046|324151764|FG000|Overall Study|Lack of Efficacy|81|||
94642158|NCT02620046|324151765|FG001|Overall Study|Lack of Efficacy|146|||
94642159|NCT02620046|324151764|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
94642160|NCT02620046|324151765|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
94642161|NCT02620046|324151764|FG000|Overall Study|Reason Not Specified|13|||
94642162|NCT02620046|324151765|FG001|Overall Study|Reason Not Specified|21|||
94642163|NCT02620046|324151764|FG000|Overall Study|Significant Protocol Deviation|0|||
94363022|NCT03280628|323114446|FG000|Overall Study|Lost to Follow-up|8|||
94363023|NCT03280628|323114447|FG001|Overall Study|Lost to Follow-up|6|||
94363024|NCT03280628|323114448|FG002|Overall Study|Lost to Follow-up|11|||
94642164|NCT02620046|324151765|FG001|Overall Study|Significant Protocol Deviation|1|||
94363025|NCT00299546|323114449|FG000|Overall Study|Death|3|||
94363026|NCT00299546|323114450|FG001|Overall Study|Death|2|||
94363027|NCT00299546|323114451|FG002|Overall Study|Death|0|||
94642165|NCT03100149|324151767|FG000|Overall Study|Adverse Event|0|||
94642166|NCT03100149|324151768|FG001|Overall Study|Adverse Event|1|||
94642167|NCT03100149|324151769|FG002|Overall Study|Adverse Event|0|||
94363028|NCT00299546|323114449|FG000|Overall Study|Lost to Follow-up|2|||
94363029|NCT00299546|323114450|FG001|Overall Study|Lost to Follow-up|2|||
94363030|NCT00299546|323114451|FG002|Overall Study|Lost to Follow-up|5|||
94678730|NCT01750879|324278857|FG001|Overall Study|Lack of Efficacy|0|||
94678731|NCT01750879|324278856|FG000|Overall Study|Withdrawal by Subject|1|||
94678732|NCT01750879|324278857|FG001|Overall Study|Withdrawal by Subject|0|||
94678733|NCT01750879|324278856|FG000|Overall Study|Did not complete per protocol|0|||
94678734|NCT01750879|324278857|FG001|Overall Study|Did not complete per protocol|3|||
94678735|NCT02421666|324278860|FG000|6-month Follow-up|Lost to Follow-up|8|||
94678736|NCT02421666|324278861|FG001|6-month Follow-up|Lost to Follow-up|7|||
94363031|NCT00299546|323114449|FG000|Overall Study|Adverse Event|37|||
94363032|NCT00299546|323114450|FG001|Overall Study|Adverse Event|22|||
94363033|NCT00299546|323114451|FG002|Overall Study|Adverse Event|27|||
94678737|NCT02421666|324278860|FG000|6-month Follow-up|Withdrawal by Subject|5|||
94678738|NCT02421666|324278861|FG001|6-month Follow-up|Withdrawal by Subject|6|||
94678739|NCT02421666|324278860|FG000|12-month Follow-up|Lost to Follow-up|5|||
94678740|NCT02421666|324278861|FG001|12-month Follow-up|Lost to Follow-up|5|||
94678741|NCT02421666|324278860|FG000|12-month Follow-up|Withdrawal by Subject|6|||
94678742|NCT02421666|324278861|FG001|12-month Follow-up|Withdrawal by Subject|11|||
94678743|NCT04382924|324278863|FG000|Overall Study|Death|2|||
94678744|NCT04382924|324278864|FG001|Overall Study|Death|5|||
94678745|NCT04382924|324278865|FG002|Overall Study|Death|4|||
94678746|NCT04382924|324278863|FG000|Overall Study|Protocol Violation|0|||
94678747|NCT04382924|324278864|FG001|Overall Study|Protocol Violation|1|||
94363034|NCT00299546|323114449|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
94363035|NCT00299546|323114450|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
94363036|NCT00299546|323114451|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
94363037|NCT00299546|323114449|FG000|Overall Study|Other|24|||
94363038|NCT00299546|323114450|FG001|Overall Study|Other|26|||
94363039|NCT00299546|323114451|FG002|Overall Study|Other|19|||
94363040|NCT00299546|323114449|FG000|Overall Study|Not treated|0|||
94363041|NCT00299546|323114450|FG001|Overall Study|Not treated|1|||
94363042|NCT00299546|323114451|FG002|Overall Study|Not treated|1|||
94363043|NCT01392469|323114452|FG000|Overall Study|Adverse Event|2|||
94363044|NCT01392469|323114452|FG000|Overall Study|Withdrawal by Subject|1|||
94363045|NCT01392469|323114452|FG000|Overall Study|Protocol Violation|1|||
94678748|NCT04382924|324278865|FG002|Overall Study|Protocol Violation|1|||
94678749|NCT04382924|324278863|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
94363046|NCT02674568|323114453|FG000|Overall Study|Withdrawal by Subject|5|||
94363047|NCT02674568|323114453|FG000|Overall Study|Death|303|||
94363048|NCT02674568|323114453|FG000|Overall Study|Physician Decision|2|||
94363049|NCT02674568|323114453|FG000|Overall Study|Lost to Follow-up|9|||
94363050|NCT02674568|323114453|FG000|Overall Study|Other, Not Specified|20|||
94363051|NCT01371006|323114454|FG000|Overall Study|Adverse Event|1|||
94363052|NCT01371006|323114455|FG001|Overall Study|Adverse Event|0|||
94363053|NCT04362761|323114456|FG000|Part A (48 Weeks)|Adverse Event|2|||
94363054|NCT04362761|323114456|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
94363055|NCT04362761|323114456|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
94363056|NCT04362761|323114456|FG000|Part A (48 Weeks)|Other|5|||
94363057|NCT04362761|323114456|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
94363058|NCT04362761|323114456|FG000|Part B (86 Weeks)|Other|4|||
94363059|NCT02856282|323114460|FG000|Overall Study|Withdrawal by Subject|1|||
94363060|NCT02074982|323114461|FG000|Overall Study|Adverse Event|15|||
94363061|NCT02074982|323114462|FG001|Overall Study|Adverse Event|7|||
94363062|NCT02074982|323114461|FG000|Overall Study|Lack of Efficacy|6|||
94363063|NCT02074982|323114462|FG001|Overall Study|Lack of Efficacy|1|||
94363064|NCT02074982|323114461|FG000|Overall Study|Lost to Follow-up|9|||
94363065|NCT02074982|323114462|FG001|Overall Study|Lost to Follow-up|10|||
94363066|NCT02074982|323114461|FG000|Overall Study|Non-compliance with study treatment|0|||
94363067|NCT02074982|323114462|FG001|Overall Study|Non-compliance with study treatment|2|||
94678750|NCT04382924|324278864|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
94678751|NCT04382924|324278865|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
94461935|NCT03781583|323481276|FG001|Overall Study|Technology did not work for that person in that environment|0|||
94642168|NCT03100149|324151767|FG000|Overall Study|Participant Moved out of Country|0|||
94642169|NCT03100149|324151768|FG001|Overall Study|Participant Moved out of Country|0|||
94642170|NCT03100149|324151769|FG002|Overall Study|Participant Moved out of Country|1|||
94642171|NCT03100149|324151767|FG000|Overall Study|Withdrawal by Subject|0|||
94642172|NCT03100149|324151768|FG001|Overall Study|Withdrawal by Subject|3|||
94642173|NCT03100149|324151769|FG002|Overall Study|Withdrawal by Subject|1|||
94642174|NCT00560950|324151770|FG000|Overall Study|Lost to Follow-up|1|||
94642175|NCT00560950|324151771|FG001|Overall Study|Lost to Follow-up|0|||
94642176|NCT01064648|324151772|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
94642177|NCT01064648|324151773|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
94642178|NCT01064648|324151774|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
94642179|NCT01064648|324151775|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
94642180|NCT01064648|324151772|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
94642181|NCT01064648|324151773|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
94642182|NCT01064648|324151774|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
94642183|NCT01064648|324151775|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
94642184|NCT01064648|324151772|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
94642185|NCT01064648|324151773|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
94642186|NCT01064648|324151774|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
94642187|NCT01064648|324151775|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
94642188|NCT01064648|324151772|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
94642189|NCT01064648|324151773|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
94642190|NCT01064648|324151774|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
94642191|NCT01064648|324151775|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
94642192|NCT01064648|324151772|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
94642193|NCT01064648|324151773|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
94642194|NCT01064648|324151774|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
94642195|NCT01064648|324151775|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
94642196|NCT01064648|324151772|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
94642197|NCT01064648|324151773|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
94642198|NCT01064648|324151774|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
94642199|NCT01064648|324151775|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
94642200|NCT01064648|324151772|FG000|Phase II|Adverse Event|0|||
94642201|NCT01064648|324151773|FG001|Phase II|Adverse Event|0|||
94642202|NCT01064648|324151774|FG002|Phase II|Adverse Event|15|||
94642203|NCT01064648|324151775|FG003|Phase II|Adverse Event|8|||
94642204|NCT01064648|324151772|FG000|Phase II|Death|0|||
94642205|NCT01064648|324151773|FG001|Phase II|Death|0|||
94642206|NCT01064648|324151774|FG002|Phase II|Death|4|||
94642207|NCT01064648|324151775|FG003|Phase II|Death|5|||
94642208|NCT01064648|324151772|FG000|Phase II|Withdrawal by Subject|0|||
94642209|NCT01064648|324151773|FG001|Phase II|Withdrawal by Subject|0|||
94642210|NCT01064648|324151774|FG002|Phase II|Withdrawal by Subject|2|||
94642211|NCT01064648|324151775|FG003|Phase II|Withdrawal by Subject|5|||
94642212|NCT01064648|324151772|FG000|Phase II|Progression|0|||
94642213|NCT01064648|324151773|FG001|Phase II|Progression|0|||
94642214|NCT01064648|324151774|FG002|Phase II|Progression|21|||
94642215|NCT01064648|324151775|FG003|Phase II|Progression|27|||
94642216|NCT01064648|324151772|FG000|Phase II|Non-protocol specified|0|||
94642217|NCT01064648|324151773|FG001|Phase II|Non-protocol specified|0|||
94642218|NCT01064648|324151774|FG002|Phase II|Non-protocol specified|5|||
94642219|NCT01064648|324151775|FG003|Phase II|Non-protocol specified|3|||
94642220|NCT01064648|324151772|FG000|Phase II|Under Review|0|||
94642221|NCT01064648|324151773|FG001|Phase II|Under Review|0|||
94642222|NCT01064648|324151774|FG002|Phase II|Under Review|2|||
94642223|NCT01064648|324151775|FG003|Phase II|Under Review|0|||
94642224|NCT02283788|324151781|FG000|Overall Study|Adverse Event|1|||
94642225|NCT02283788|324151782|FG001|Overall Study|Adverse Event|3|||
94642226|NCT02283788|324151783|FG002|Overall Study|Adverse Event|5|||
94642227|NCT02283788|324151784|FG003|Overall Study|Adverse Event|1|||
94642228|NCT02283788|324151781|FG000|Overall Study|Withdrawal by Subject|0|||
94642229|NCT02283788|324151782|FG001|Overall Study|Withdrawal by Subject|1|||
94642230|NCT02283788|324151783|FG002|Overall Study|Withdrawal by Subject|0|||
94461936|NCT03781583|323481277|FG002|Overall Study|Technology did not work for that person in that environment|0|||
94461937|NCT03781583|323481278|FG003|Overall Study|Technology did not work for that person in that environment|0|||
94642231|NCT02283788|324151784|FG003|Overall Study|Withdrawal by Subject|1|||
94642232|NCT04709575|324153428|FG000|Overall Study|Withdrawal by Subject|6|||
94642233|NCT04709575|324153429|FG001|Overall Study|Withdrawal by Subject|2|||
94642234|NCT04709575|324153428|FG000|Overall Study|Lost to Follow-up|2|||
94642235|NCT04709575|324153429|FG001|Overall Study|Lost to Follow-up|2|||
94642236|NCT04709575|324153428|FG000|Overall Study|Adverse Event|1|||
94642237|NCT04709575|324153429|FG001|Overall Study|Adverse Event|0|||
94642238|NCT04709575|324153428|FG000|Overall Study|Protocol Violation|1|||
94642239|NCT04709575|324153429|FG001|Overall Study|Protocol Violation|1|||
94642240|NCT00699972|324153430|FG000|Overall Study|Adverse Event|7|||
94642241|NCT00699972|324153431|FG001|Overall Study|Adverse Event|9|||
94642242|NCT00699972|324153432|FG002|Overall Study|Adverse Event|24|||
94642243|NCT00699972|324153430|FG000|Overall Study|Lost to Follow-up|0|||
94642244|NCT00699972|324153431|FG001|Overall Study|Lost to Follow-up|2|||
94642245|NCT00699972|324153432|FG002|Overall Study|Lost to Follow-up|0|||
94642246|NCT00699972|324153430|FG000|Overall Study|Withdrawal by Subject|3|||
94642247|NCT00699972|324153431|FG001|Overall Study|Withdrawal by Subject|7|||
94642248|NCT00699972|324153432|FG002|Overall Study|Withdrawal by Subject|4|||
94642249|NCT00699972|324153430|FG000|Overall Study|Lack of Efficacy|2|||
94642250|NCT00699972|324153431|FG001|Overall Study|Lack of Efficacy|0|||
94642251|NCT00699972|324153432|FG002|Overall Study|Lack of Efficacy|2|||
94642252|NCT00699972|324153430|FG000|Overall Study|Administrative/Other|3|||
94642253|NCT00699972|324153431|FG001|Overall Study|Administrative/Other|1|||
94642254|NCT00699972|324153432|FG002|Overall Study|Administrative/Other|4|||
94642255|NCT00699972|324153430|FG000|Overall Study|Randomized, Not Treated|1|||
94642256|NCT00699972|324153431|FG001|Overall Study|Randomized, Not Treated|0|||
94642257|NCT00699972|324153432|FG002|Overall Study|Randomized, Not Treated|1|||
94642258|NCT01852292|324153435|FG000|Overall Study|Untreated - did not receive study drug|3|||
94642259|NCT01852292|324153436|FG001|Overall Study|Untreated - did not receive study drug|1|||
94642260|NCT01852292|324153435|FG000|Overall Study|Death|9|||
94642261|NCT01852292|324153436|FG001|Overall Study|Death|8|||
94642262|NCT01852292|324153435|FG000|Overall Study|Patient/guardian decision|8|||
94642263|NCT01852292|324153436|FG001|Overall Study|Patient/guardian decision|4|||
94642264|NCT01852292|324153435|FG000|Overall Study|Adverse Event|8|||
94642265|NCT01852292|324153436|FG001|Overall Study|Adverse Event|11|||
94642266|NCT01852292|324153435|FG000|Overall Study|Physician Decision|6|||
94642267|NCT01852292|324153436|FG001|Overall Study|Physician Decision|2|||
94642268|NCT01852292|324153435|FG000|Overall Study|Protocol Violation|2|||
94642269|NCT01852292|324153436|FG001|Overall Study|Protocol Violation|0|||
94642270|NCT01852292|324153435|FG000|Overall Study|Non-compliance with study treatment|1|||
94642271|NCT01852292|324153436|FG001|Overall Study|Non-compliance with study treatment|0|||
94642272|NCT01852292|324153435|FG000|Overall Study|Study terminated by Sponsor|0|||
94642273|NCT01852292|324153436|FG001|Overall Study|Study terminated by Sponsor|1|||
94642274|NCT01852292|324153435|FG000|Overall Study|Progressive disease|42|||
94642275|NCT01852292|324153436|FG001|Overall Study|Progressive disease|52|||
94642276|NCT03299842|324153438|FG000|Overall Study|Caregiver withdrew consent|2|||
94642277|NCT03299842|324153438|FG000|Overall Study|Child would not keep the watch on|3|||
94642278|NCT02558790|324153441|FG000|Overall Study|Lost to Follow-up|2|||
94642279|NCT02558790|324153441|FG000|Overall Study|Physician Decision|1|||
94642280|NCT02558790|324153441|FG000|Overall Study|Withdrawal by Subject|1|||
94642281|NCT02558790|324153441|FG000|Overall Study|Screen Fail|3|||
94642282|NCT00838201|324153442|FG000|Overall Study|Investigator decision, or other reasons|2|||
94642283|NCT00838201|324153443|FG001|Overall Study|Investigator decision, or other reasons|3|||
94642284|NCT00838201|324153442|FG000|Overall Study|Noncompliance|0|||
94642285|NCT00838201|324153443|FG001|Overall Study|Noncompliance|1|||
94642286|NCT00838201|324153442|FG000|Overall Study|Administrative decision|1|||
94642287|NCT00838201|324153443|FG001|Overall Study|Administrative decision|2|||
94642288|NCT00838201|324153442|FG000|Overall Study|Disease progression|3|||
94642289|NCT00838201|324153443|FG001|Overall Study|Disease progression|3|||
94642290|NCT00838201|324153442|FG000|Overall Study|Consent withdrawn|16|||
94642291|NCT00838201|324153443|FG001|Overall Study|Consent withdrawn|19|||
94642292|NCT00838201|324153442|FG000|Overall Study|Lost to Follow-up|4|||
94642293|NCT00838201|324153443|FG001|Overall Study|Lost to Follow-up|3|||
94642294|NCT00838201|324153442|FG000|Overall Study|Adverse Event|5|||
94642295|NCT00838201|324153443|FG001|Overall Study|Adverse Event|9|||
94642296|NCT00838201|324153442|FG000|Overall Study|Death|11|||
94642297|NCT00838201|324153443|FG001|Overall Study|Death|13|||
94642298|NCT05083442|324153444|FG000|Overall Study|Lost to Follow-up|1|||
94642299|NCT05083442|324153445|FG001|Overall Study|Lost to Follow-up|0|||
94642300|NCT05083442|324153444|FG000|Overall Study|Lack of Efficacy|0|||
94642301|NCT05083442|324153445|FG001|Overall Study|Lack of Efficacy|1|||
94642302|NCT05083442|324153444|FG000|Overall Study|Withdrawal by Subject|1|||
94642303|NCT05083442|324153445|FG001|Overall Study|Withdrawal by Subject|3|||
94678752|NCT04382924|324278863|FG000|Overall Study|Withdrawal by Subject|6|||
94642304|NCT05083442|324153444|FG000|Overall Study|scheduling difficulties|1|||
94642305|NCT05083442|324153445|FG001|Overall Study|scheduling difficulties|2|||
94642306|NCT03711162|324153446|FG000|Overall Study|Adverse Event|5|||
94642307|NCT03711162|324153447|FG001|Overall Study|Adverse Event|2|||
94642308|NCT03711162|324153448|FG002|Overall Study|Adverse Event|4|||
94642309|NCT03711162|324153446|FG000|Overall Study|Death|11|||
94642310|NCT03711162|324153447|FG001|Overall Study|Death|7|||
94642311|NCT03711162|324153448|FG002|Overall Study|Death|8|||
94642312|NCT03711162|324153446|FG000|Overall Study|Lost to Follow-up|1|||
94642313|NCT03711162|324153447|FG001|Overall Study|Lost to Follow-up|0|||
94642314|NCT03711162|324153448|FG002|Overall Study|Lost to Follow-up|1|||
94642315|NCT03711162|324153446|FG000|Overall Study|Study Terminated by Sponsor|139|||
94642316|NCT03711162|324153447|FG001|Overall Study|Study Terminated by Sponsor|152|||
94642317|NCT03711162|324153448|FG002|Overall Study|Study Terminated by Sponsor|146|||
94642318|NCT03711162|324153446|FG000|Overall Study|Withdrawal by Subject|17|||
94642319|NCT03711162|324153447|FG001|Overall Study|Withdrawal by Subject|10|||
94642320|NCT03711162|324153448|FG002|Overall Study|Withdrawal by Subject|10|||
94642321|NCT03711162|324153446|FG000|Overall Study|Miscellaneous|1|||
94642322|NCT03711162|324153447|FG001|Overall Study|Miscellaneous|2|||
94642323|NCT03711162|324153448|FG002|Overall Study|Miscellaneous|2|||
94642324|NCT03711162|324153446|FG000|Overall Study|Not Treated|1|||
94642325|NCT03711162|324153447|FG001|Overall Study|Not Treated|0|||
94642326|NCT03711162|324153448|FG002|Overall Study|Not Treated|1|||
94642327|NCT03711162|324153446|FG000|Overall Study|Physician Decision|0|||
94642328|NCT03711162|324153447|FG001|Overall Study|Physician Decision|2|||
94642329|NCT03711162|324153448|FG002|Overall Study|Physician Decision|0|||
94642330|NCT03711162|324153446|FG000|Overall Study|Lack of Efficacy|0|||
94642331|NCT03711162|324153447|FG001|Overall Study|Lack of Efficacy|0|||
94642332|NCT03711162|324153448|FG002|Overall Study|Lack of Efficacy|2|||
94642333|NCT03711162|324153446|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
94642334|NCT03711162|324153447|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
94642335|NCT03711162|324153448|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
94642336|NCT03034954|324153452|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
94642337|NCT03034954|324153453|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
94642338|NCT05228470|324153461|FG000|Overall Study|Death|6|||
94642339|NCT05228470|324153462|FG001|Overall Study|Death|11|||
94642340|NCT05228470|324153461|FG000|Overall Study|Withdrawal by Subject|1|||
94642341|NCT05228470|324153462|FG001|Overall Study|Withdrawal by Subject|8|||
94642342|NCT05228470|324153461|FG000|Overall Study|Ongoing|1|||
94642343|NCT05228470|324153462|FG001|Overall Study|Ongoing|11|||
94642344|NCT00136084|324153463|FG000|Overall Study|Death|12|||
94642345|NCT00136084|324153464|FG001|Overall Study|Death|5|||
94642346|NCT00136084|324153463|FG000|Overall Study|Unacceptable toxicity|8|||
94642347|NCT00136084|324153464|FG001|Overall Study|Unacceptable toxicity|11|||
94642348|NCT00136084|324153463|FG000|Overall Study|Relapse|20|||
94642349|NCT00136084|324153464|FG001|Overall Study|Relapse|23|||
94642350|NCT00136084|324153463|FG000|Overall Study|Lost to Follow-up|2|||
94642351|NCT00136084|324153464|FG001|Overall Study|Lost to Follow-up|0|||
94642352|NCT00136084|324153463|FG000|Overall Study|No Response|1|||
94642353|NCT00136084|324153464|FG001|Overall Study|No Response|2|||
94642354|NCT00136084|324153463|FG000|Overall Study|Withdrawal by Subject|5|||
94642355|NCT00136084|324153464|FG001|Overall Study|Withdrawal by Subject|1|||
94642356|NCT01275066|324153465|FG000|Overall Study|Withdrawal by Subject|0|||
94642357|NCT01275066|324153466|FG001|Overall Study|Withdrawal by Subject|0|||
94642358|NCT01275066|324153467|FG002|Overall Study|Withdrawal by Subject|1|||
94642359|NCT01275066|324153465|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
94642360|NCT01275066|324153466|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
94642361|NCT01275066|324153467|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
94363068|NCT02074982|323114461|FG000|Overall Study|Physician Decision|1|||
94642362|NCT03509675|324153468|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
94642363|NCT03509675|324153469|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
94642364|NCT03509675|324153468|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
94642365|NCT03509675|324153469|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
94642366|NCT03509675|324153468|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
94642367|NCT03509675|324153469|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
94642368|NCT03509675|324153468|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
94363069|NCT02074982|323114462|FG001|Overall Study|Physician Decision|1|||
94363070|NCT02074982|323114461|FG000|Overall Study|Pregnancy|1|||
94363071|NCT02074982|323114462|FG001|Overall Study|Pregnancy|2|||
94363072|NCT02074982|323114461|FG000|Overall Study|Protocol deviation|4|||
94363073|NCT02074982|323114462|FG001|Overall Study|Protocol deviation|3|||
94363074|NCT02074982|323114461|FG000|Overall Study|Technical problems|0|||
94363075|NCT02074982|323114462|FG001|Overall Study|Technical problems|2|||
94363076|NCT02074982|323114461|FG000|Overall Study|Subject/guardian decision|15|||
94363077|NCT02074982|323114462|FG001|Overall Study|Subject/guardian decision|24|||
94363078|NCT02074982|323114461|FG000|Overall Study|Death|0|||
94363079|NCT02074982|323114462|FG001|Overall Study|Death|2|||
94363080|NCT00798707|323114470|FG000|Overall Study|Adverse Event|6|||
94363081|NCT00798707|323114471|FG001|Overall Study|Adverse Event|8|||
94363082|NCT00798707|323114472|FG002|Overall Study|Adverse Event|8|||
94363083|NCT00798707|323114470|FG000|Overall Study|Failed to return|2|||
94363084|NCT00798707|323114471|FG001|Overall Study|Failed to return|2|||
94363085|NCT00798707|323114472|FG002|Overall Study|Failed to return|0|||
94363086|NCT00798707|323114470|FG000|Overall Study|Investigator|0|||
94363087|NCT00798707|323114471|FG001|Overall Study|Investigator|1|||
94363088|NCT00798707|323114472|FG002|Overall Study|Investigator|2|||
94363089|NCT00798707|323114470|FG000|Overall Study|Lack of Efficacy|2|||
94363090|NCT00798707|323114471|FG001|Overall Study|Lack of Efficacy|2|||
94363091|NCT00798707|323114472|FG002|Overall Study|Lack of Efficacy|1|||
94363092|NCT00798707|323114470|FG000|Overall Study|Lost to Follow-up|5|||
94363093|NCT00798707|323114471|FG001|Overall Study|Lost to Follow-up|6|||
94363094|NCT00798707|323114472|FG002|Overall Study|Lost to Follow-up|6|||
94363095|NCT00798707|323114470|FG000|Overall Study|Other|0|||
94363096|NCT00798707|323114471|FG001|Overall Study|Other|1|||
94363097|NCT00798707|323114472|FG002|Overall Study|Other|0|||
94363098|NCT00798707|323114470|FG000|Overall Study|Protocol Violation|4|||
94363099|NCT00798707|323114471|FG001|Overall Study|Protocol Violation|0|||
94363100|NCT00798707|323114472|FG002|Overall Study|Protocol Violation|2|||
94363101|NCT00798707|323114470|FG000|Overall Study|Withdrawal by Subject|3|||
94363102|NCT00798707|323114471|FG001|Overall Study|Withdrawal by Subject|8|||
94363103|NCT00798707|323114472|FG002|Overall Study|Withdrawal by Subject|2|||
94363104|NCT00798707|323114470|FG000|Overall Study|Randomized not treated|4|||
94363105|NCT00798707|323114471|FG001|Overall Study|Randomized not treated|5|||
94363106|NCT00798707|323114472|FG002|Overall Study|Randomized not treated|1|||
94363107|NCT02094573|323114475|FG000|Overall Study|Adverse Event|4|||
94363108|NCT02094573|323114476|FG001|Overall Study|Adverse Event|14|||
94363109|NCT02094573|323114475|FG000|Overall Study|Clinical Progressive Disease|9|||
94363110|NCT02094573|323114476|FG001|Overall Study|Clinical Progressive Disease|13|||
94363111|NCT02094573|323114475|FG000|Overall Study|Death|11|||
94363112|NCT02094573|323114476|FG001|Overall Study|Death|3|||
94363113|NCT02094573|323114475|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
94363114|NCT02094573|323114476|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
94363115|NCT02094573|323114475|FG000|Overall Study|Non-compliance with Study Drug|1|||
94363116|NCT02094573|323114476|FG001|Overall Study|Non-compliance with Study Drug|1|||
94363117|NCT02094573|323114475|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
94363118|NCT02094573|323114476|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
94363119|NCT02094573|323114475|FG000|Overall Study|Physician Decision|4|||
94363120|NCT02094573|323114476|FG001|Overall Study|Physician Decision|4|||
94363121|NCT02094573|323114475|FG000|Overall Study|Site Terminated by Sponsor|10|||
94363122|NCT02094573|323114476|FG001|Overall Study|Site Terminated by Sponsor|17|||
94363123|NCT02094573|323114475|FG000|Overall Study|Withdrawal by Subject|6|||
94678753|NCT04382924|324278864|FG001|Overall Study|Withdrawal by Subject|3|||
94678754|NCT04382924|324278865|FG002|Overall Study|Withdrawal by Subject|6|||
94678755|NCT00642902|324278868|FG000|Overall Study|Adverse Event|0|||
94363124|NCT02094573|323114476|FG001|Overall Study|Withdrawal by Subject|8|||
94363125|NCT02094573|323114475|FG000|Overall Study|Randomized but not Treated|3|||
94363126|NCT02094573|323114476|FG001|Overall Study|Randomized but not Treated|0|||
94363127|NCT01819467|323114477|FG000|Overall Study|Physician Decision|20|||
94363128|NCT01819467|323114478|FG001|Overall Study|Physician Decision|9|||
94363129|NCT03256526|323114479|FG000|Overall Study|Adverse Event|1|||
94363130|NCT03256526|323114480|FG001|Overall Study|Adverse Event|0|||
94363131|NCT03256526|323114481|FG002|Overall Study|Adverse Event|1|||
94678756|NCT00642902|324278869|FG001|Overall Study|Adverse Event|1|||
94678757|NCT00642902|324278870|FG002|Overall Study|Adverse Event|3|||
94363132|NCT03256526|323114479|FG000|Overall Study|Lost to Follow-up|1|||
94363133|NCT03256526|323114480|FG001|Overall Study|Lost to Follow-up|0|||
94363134|NCT03256526|323114481|FG002|Overall Study|Lost to Follow-up|2|||
94363135|NCT03606109|323114484|FG000|Overall Study|Lost to Follow-up|2|||
94363136|NCT03606109|323114485|FG001|Overall Study|Lost to Follow-up|1|||
94363137|NCT03514121|323114486|FG000|Overall Study|Withdrawal by Subject|0|||
94363138|NCT03514121|323114487|FG001|Overall Study|Withdrawal by Subject|0|||
94363139|NCT03514121|323114488|FG002|Overall Study|Withdrawal by Subject|0|||
94363140|NCT03514121|323114489|FG003|Overall Study|Withdrawal by Subject|0|||
94363141|NCT03514121|323114490|FG004|Overall Study|Withdrawal by Subject|1|||
94363142|NCT03514121|323114491|FG005|Overall Study|Withdrawal by Subject|2|||
94363143|NCT03514121|323114492|FG006|Overall Study|Withdrawal by Subject|1|||
94678758|NCT00642902|324278871|FG003|Overall Study|Adverse Event|1|||
94678759|NCT00642902|324278868|FG000|Overall Study|Lost to Follow-up|1|||
94678760|NCT00642902|324278869|FG001|Overall Study|Lost to Follow-up|1|||
94678761|NCT00642902|324278870|FG002|Overall Study|Lost to Follow-up|0|||
94678762|NCT00642902|324278871|FG003|Overall Study|Lost to Follow-up|0|||
94678763|NCT00642902|324278868|FG000|Overall Study|Lack of Efficacy|0|||
94678764|NCT00642902|324278869|FG001|Overall Study|Lack of Efficacy|3|||
94678765|NCT00642902|324278870|FG002|Overall Study|Lack of Efficacy|3|||
94678766|NCT00642902|324278871|FG003|Overall Study|Lack of Efficacy|0|||
94678767|NCT00642902|324278868|FG000|Overall Study|Death|1|||
94678768|NCT00642902|324278869|FG001|Overall Study|Death|0|||
94678769|NCT00642902|324278870|FG002|Overall Study|Death|0|||
94678770|NCT00642902|324278871|FG003|Overall Study|Death|0|||
94678771|NCT00642902|324278868|FG000|Overall Study|Premature termination of clinical trial|37|||
94678772|NCT00642902|324278869|FG001|Overall Study|Premature termination of clinical trial|32|||
94678773|NCT00642902|324278870|FG002|Overall Study|Premature termination of clinical trial|35|||
94678774|NCT00642902|324278871|FG003|Overall Study|Premature termination of clinical trial|35|||
94678775|NCT00642902|324278868|FG000|Overall Study|Randomized, but not treated|0|||
94678776|NCT00642902|324278869|FG001|Overall Study|Randomized, but not treated|0|||
94678777|NCT00642902|324278870|FG002|Overall Study|Randomized, but not treated|1|||
94678778|NCT00642902|324278871|FG003|Overall Study|Randomized, but not treated|0|||
94678779|NCT00642902|324278868|FG000|Overall Study|Other|1|||
94678780|NCT00642902|324278869|FG001|Overall Study|Other|5|||
94678781|NCT00642902|324278870|FG002|Overall Study|Other|1|||
94678782|NCT00642902|324278871|FG003|Overall Study|Other|4|||
94678783|NCT02173054|324278872|FG000|Overall Study|lack of compliance|1|||
94678784|NCT02173054|324278873|FG001|Overall Study|lack of compliance|0|||
94678785|NCT02173054|324278874|FG002|Overall Study|lack of compliance|0|||
94678786|NCT02173054|324278872|FG000|Overall Study|Withdrawal by Subject|0|||
94678787|NCT02173054|324278873|FG001|Overall Study|Withdrawal by Subject|0|||
94678788|NCT02173054|324278874|FG002|Overall Study|Withdrawal by Subject|1|||
94678789|NCT01119768|324278875|FG000|Treatment Period|Lack of Efficacy|18|||
94678790|NCT01119768|324278876|FG001|Treatment Period|Lack of Efficacy|25|||
94678791|NCT03145766|324278877|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
94678792|NCT03145766|324278878|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
94678793|NCT03145766|324278879|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
94678794|NCT03145766|324278880|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
94678795|NCT03145766|324278881|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
94678796|NCT03145766|324278877|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
94678797|NCT03145766|324278878|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
94678798|NCT03145766|324278879|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
94678799|NCT03145766|324278880|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
94678800|NCT03145766|324278881|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
94678801|NCT03145766|324278877|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
94678802|NCT03145766|324278878|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
94678803|NCT03145766|324278879|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
94678804|NCT03145766|324278880|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
94678805|NCT03145766|324278881|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
94678806|NCT03145766|324278877|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
94678807|NCT03145766|324278878|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
94678808|NCT03145766|324278879|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
94678809|NCT03145766|324278880|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
94678810|NCT03145766|324278881|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
94678811|NCT03145766|324278877|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
94678812|NCT03145766|324278878|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
94263195|NCT01376349|322758145|FG001|Raondomized Treatment|Adverse Event|17|||
94678813|NCT03145766|324278879|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
94678814|NCT03145766|324278880|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
94263196|NCT01376349|322758146|FG002|Raondomized Treatment|Adverse Event|14|||
94263197|NCT01376349|322758144|FG000|Raondomized Treatment|Unkown|1|||
94263198|NCT01376349|322758145|FG001|Raondomized Treatment|Unkown|2|||
94642369|NCT03509675|324153469|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
94642370|NCT00588445|324153472|FG000|Overall Study|Protocol Violation|1|||
94642371|NCT00588445|324153472|FG000|Overall Study|Withdrawal by Subject|3|||
94642372|NCT00588445|324153472|FG000|Overall Study|Disease Progression|1|||
94642373|NCT00588445|324153472|FG000|Overall Study|Not Treated|10|||
94642374|NCT01176292|324153474|FG000|Overall Study|Lost to Follow-up|2|||
94642375|NCT01176292|324153475|FG001|Overall Study|Lost to Follow-up|4|||
94642376|NCT01176292|324153474|FG000|Overall Study|Adverse Event|1|||
94642377|NCT01176292|324153475|FG001|Overall Study|Adverse Event|1|||
94642378|NCT01176292|324153474|FG000|Overall Study|Physician Decision|0|||
94642379|NCT01176292|324153475|FG001|Overall Study|Physician Decision|2|||
94642380|NCT01176292|324153474|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
94642381|NCT01176292|324153475|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
94642382|NCT00997503|324153476|FG000|Overall Study|Death|53|||
94642383|NCT00997503|324153476|FG000|Overall Study|Withdrawal by Subject|76|||
94642384|NCT00997503|324153476|FG000|Overall Study|Lost to Follow-up|33|||
94642385|NCT00997503|324153476|FG000|Overall Study|Adverse Event|3|||
94642386|NCT00997503|324153476|FG000|Overall Study|Physician Decision|10|||
94642387|NCT00997503|324153476|FG000|Overall Study|Missed 12-month follow-up|85|||
94642388|NCT00997503|324153476|FG000|Overall Study|Other reason|13|||
94642389|NCT02945410|324153477|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
94642390|NCT02945410|324153478|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
94642391|NCT02945410|324153479|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
94642392|NCT02945410|324153480|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
94642393|NCT02945410|324153481|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
94363144|NCT03514121|323114493|FG007|Overall Study|Withdrawal by Subject|1|||
94363145|NCT03514121|323114494|FG008|Overall Study|Withdrawal by Subject|7|||
94642394|NCT02945410|324153482|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
94642395|NCT02945410|324153477|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
94642396|NCT02945410|324153478|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
94642397|NCT02945410|324153479|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
94642398|NCT02945410|324153480|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
94678815|NCT03145766|324278881|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
94363146|NCT03514121|323114495|FG009|Overall Study|Withdrawal by Subject|2|||
94363147|NCT03514121|323114486|FG000|Overall Study|Death|0|||
94363148|NCT03514121|323114487|FG001|Overall Study|Death|0|||
94363149|NCT03514121|323114488|FG002|Overall Study|Death|0|||
94363150|NCT03514121|323114489|FG003|Overall Study|Death|0|||
94363151|NCT03514121|323114490|FG004|Overall Study|Death|0|||
94363152|NCT03514121|323114491|FG005|Overall Study|Death|3|||
94363153|NCT03514121|323114492|FG006|Overall Study|Death|2|||
94363154|NCT03514121|323114493|FG007|Overall Study|Death|1|||
94363155|NCT03514121|323114494|FG008|Overall Study|Death|26|||
94363156|NCT03514121|323114495|FG009|Overall Study|Death|3|||
94642399|NCT02945410|324153481|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
94642400|NCT02945410|324153482|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
94642401|NCT02945410|324153477|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
94642402|NCT02945410|324153478|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
94642403|NCT02945410|324153479|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
94642404|NCT02945410|324153480|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
94642405|NCT02945410|324153481|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
94642406|NCT02945410|324153482|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
94642407|NCT01344369|324153483|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
94642408|NCT01344369|324153484|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
94642409|NCT01344369|324153483|FG000|Washout of 28 Days|Physician Decision|0|||
94642410|NCT01344369|324153484|FG001|Washout of 28 Days|Physician Decision|1|||
94642411|NCT01344369|324153483|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
94642412|NCT01344369|324153484|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
94642413|NCT00380393|324153485|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
94642414|NCT00380393|324153486|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
94642415|NCT00380393|324153485|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
94642416|NCT00380393|324153486|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
94642417|NCT00380393|324153485|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
94642418|NCT00380393|324153486|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
94642419|NCT00380393|324153485|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
94642420|NCT00380393|324153486|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
94642421|NCT00380393|324153485|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
94642422|NCT00380393|324153486|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
94642423|NCT00380393|324153485|FG000|Month 14|Withdrawal by Subject|9|||
94642424|NCT00380393|324153486|FG001|Month 14|Withdrawal by Subject|7|||
94642425|NCT00380393|324153485|FG000|Month 14|Death|1|||
94642426|NCT00380393|324153486|FG001|Month 14|Death|0|||
94642427|NCT00380393|324153485|FG000|Month 14|Lost to Follow-up|0|||
94642428|NCT00380393|324153486|FG001|Month 14|Lost to Follow-up|1|||
94642429|NCT00380393|324153485|FG000|Month 14|Migrated/moved from study area|39|||
94363157|NCT03514121|323114486|FG000|Overall Study|Lost to Follow-up|0|||
94363158|NCT03514121|323114487|FG001|Overall Study|Lost to Follow-up|0|||
94363159|NCT03514121|323114488|FG002|Overall Study|Lost to Follow-up|1|||
94363160|NCT03514121|323114489|FG003|Overall Study|Lost to Follow-up|0|||
94363161|NCT03514121|323114490|FG004|Overall Study|Lost to Follow-up|0|||
94363162|NCT03514121|323114491|FG005|Overall Study|Lost to Follow-up|0|||
94363163|NCT03514121|323114492|FG006|Overall Study|Lost to Follow-up|0|||
94363164|NCT03514121|323114493|FG007|Overall Study|Lost to Follow-up|0|||
94363165|NCT03514121|323114494|FG008|Overall Study|Lost to Follow-up|1|||
94363166|NCT03514121|323114495|FG009|Overall Study|Lost to Follow-up|0|||
94363167|NCT03514121|323114486|FG000|Overall Study|Adverse Event|0|||
94363168|NCT03514121|323114487|FG001|Overall Study|Adverse Event|0|||
94363169|NCT03514121|323114488|FG002|Overall Study|Adverse Event|0|||
94642430|NCT00380393|324153486|FG001|Month 14|Migrated/moved from study area|42|||
94642431|NCT00380393|324153485|FG000|Month 14|Protocol Violation|2|||
94642432|NCT00380393|324153486|FG001|Month 14|Protocol Violation|0|||
94642433|NCT00380393|324153485|FG000|Month 14|Others|6|||
94363170|NCT03514121|323114489|FG003|Overall Study|Adverse Event|0|||
94363171|NCT03514121|323114490|FG004|Overall Study|Adverse Event|0|||
94363172|NCT03514121|323114491|FG005|Overall Study|Adverse Event|0|||
94363173|NCT03514121|323114492|FG006|Overall Study|Adverse Event|1|||
94363174|NCT03514121|323114493|FG007|Overall Study|Adverse Event|0|||
94642434|NCT00380393|324153486|FG001|Month 14|Others|6|||
94642435|NCT00218296|324153491|FG000|Overall Study|Lost to Follow-up|9|||
94642436|NCT00218296|324153492|FG001|Overall Study|Lost to Follow-up|7|||
94642437|NCT00218296|324153491|FG000|Overall Study|Withdrawal by Subject|36|||
94642438|NCT00218296|324153492|FG001|Overall Study|Withdrawal by Subject|47|||
94642439|NCT00218296|324153491|FG000|Overall Study|Randomized but did not enter treatment|66|||
94642440|NCT00218296|324153492|FG001|Overall Study|Randomized but did not enter treatment|67|||
94642441|NCT02759120|324153498|FG000|Overall Study|Death|34|||
94642442|NCT02759120|324153499|FG001|Overall Study|Death|36|||
94642443|NCT02759120|324153498|FG000|Overall Study|Lost to Follow-up|4|||
94642444|NCT02759120|324153499|FG001|Overall Study|Lost to Follow-up|7|||
94642445|NCT02759120|324153498|FG000|Overall Study|Physician Decision|3|||
94642446|NCT02759120|324153499|FG001|Overall Study|Physician Decision|0|||
94642447|NCT02759120|324153498|FG000|Overall Study|Withdrawal by Subject|28|||
94642448|NCT02759120|324153499|FG001|Overall Study|Withdrawal by Subject|15|||
94642449|NCT02759120|324153498|FG000|Overall Study|Moved out of area|3|||
94642450|NCT02759120|324153499|FG001|Overall Study|Moved out of area|4|||
94642451|NCT02759120|324153498|FG000|Overall Study|Lung transplant|3|||
94642452|NCT02759120|324153499|FG001|Overall Study|Lung transplant|5|||
94642453|NCT02759120|324153498|FG000|Overall Study|Other reason not completed|10|||
94642454|NCT02759120|324153499|FG001|Overall Study|Other reason not completed|12|||
94642455|NCT05664490|324153504|FG000|Overall Study|Withdrawal by Subject|0|||
94642456|NCT05664490|324153505|FG001|Overall Study|Withdrawal by Subject|1|||
94642457|NCT05664490|324153504|FG000|Overall Study|Lost to Follow-up|14|||
94642458|NCT05664490|324153505|FG001|Overall Study|Lost to Follow-up|22|||
94642459|NCT01817725|324153506|FG000|Overall Study|Withdrawal by Subject|1|||
94642460|NCT01709695|324153516|FG000|Overall Study|Withdrawal by Subject|1|||
94642461|NCT01709695|324153517|FG001|Overall Study|Withdrawal by Subject|1|||
94642462|NCT01228747|324153518|FG000|Overall Study|Adverse Event|8|||
94642463|NCT01228747|324153519|FG001|Overall Study|Adverse Event|4|||
94642464|NCT01228747|324153518|FG000|Overall Study|Lack of Efficacy|40|||
94642465|NCT01228747|324153519|FG001|Overall Study|Lack of Efficacy|27|||
94642466|NCT01228747|324153518|FG000|Overall Study|Protocol Violation|6|||
94642467|NCT01228747|324153519|FG001|Overall Study|Protocol Violation|5|||
94642468|NCT01228747|324153518|FG000|Overall Study|Lost to Follow-up|4|||
94642469|NCT01228747|324153519|FG001|Overall Study|Lost to Follow-up|3|||
94263199|NCT01376349|322758146|FG002|Raondomized Treatment|Unkown|1|||
94263200|NCT01376349|322758144|FG000|Raondomized Treatment|Alternative Treatment|0|||
94642470|NCT01228747|324153518|FG000|Overall Study|Withdrawal by Subject|5|||
94642471|NCT01228747|324153519|FG001|Overall Study|Withdrawal by Subject|1|||
94642472|NCT01228747|324153518|FG000|Overall Study|Other Reason|2|||
94642473|NCT01228747|324153519|FG001|Overall Study|Other Reason|5|||
94642474|NCT04809220|324153520|FG000|Overall Study|Adverse Event|4|||
94642475|NCT04809220|324153521|FG001|Overall Study|Adverse Event|0|||
94642476|NCT04809220|324153520|FG000|Overall Study|Death|1|||
94642477|NCT04809220|324153521|FG001|Overall Study|Death|0|||
94642478|NCT04809220|324153520|FG000|Overall Study|Lost to Follow-up|3|||
94642479|NCT04809220|324153521|FG001|Overall Study|Lost to Follow-up|0|||
94642480|NCT04809220|324153520|FG000|Overall Study|Physician Decision|0|||
94263201|NCT01376349|322758145|FG001|Raondomized Treatment|Alternative Treatment|0|||
94263202|NCT01376349|322758146|FG002|Raondomized Treatment|Alternative Treatment|1|||
94263203|NCT01176968|322758147|FG000|Overall Study|Adverse Event|10|||
94263204|NCT01176968|322758148|FG001|Overall Study|Adverse Event|11|||
94263205|NCT01176968|322758147|FG000|Overall Study|Death|2|||
94263206|NCT01176968|322758148|FG001|Overall Study|Death|3|||
94263207|NCT01176968|322758147|FG000|Overall Study|Lack of Efficacy|0|||
94263208|NCT01176968|322758148|FG001|Overall Study|Lack of Efficacy|1|||
94263209|NCT01176968|322758147|FG000|Overall Study|Lost to Follow-up|16|||
94263210|NCT01176968|322758148|FG001|Overall Study|Lost to Follow-up|14|||
94263211|NCT01176968|322758147|FG000|Overall Study|Withdrawal by Subject|48|||
94263212|NCT01176968|322758148|FG001|Overall Study|Withdrawal by Subject|48|||
94263213|NCT01176968|322758147|FG000|Overall Study|Protocol Violation|2|||
94263214|NCT01176968|322758148|FG001|Overall Study|Protocol Violation|1|||
94263215|NCT01176968|322758147|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
94263216|NCT01176968|322758148|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
94263217|NCT01176968|322758147|FG000|Overall Study|Study terminated by sponsor|0|||
94263218|NCT01176968|322758148|FG001|Overall Study|Study terminated by sponsor|1|||
94263219|NCT01176968|322758147|FG000|Overall Study|Reason not defined|5|||
94263220|NCT01176968|322758148|FG001|Overall Study|Reason not defined|3|||
94263221|NCT01383161|322758149|FG000|Overall Study|Adverse Event|5|||
94642481|NCT04809220|324153521|FG001|Overall Study|Physician Decision|1|||
94642482|NCT04809220|324153520|FG000|Overall Study|Withdrawal by Subject|9|||
94642483|NCT04809220|324153521|FG001|Overall Study|Withdrawal by Subject|5|||
94642484|NCT04809220|324153520|FG000|Overall Study|Due to long-term overseas business trips|1|||
94642485|NCT04809220|324153521|FG001|Overall Study|Due to long-term overseas business trips|0|||
94642486|NCT00352846|324153522|FG000|Overall Study|Disease progression|0|||
94263222|NCT01383161|322758150|FG001|Overall Study|Adverse Event|1|||
94263223|NCT01383161|322758149|FG000|Overall Study|Withdrawal by Subject|0|||
94363175|NCT03514121|323114494|FG008|Overall Study|Adverse Event|0|||
94363176|NCT03514121|323114495|FG009|Overall Study|Adverse Event|0|||
94363177|NCT03514121|323114486|FG000|Overall Study|Other|0|||
94363178|NCT03514121|323114487|FG001|Overall Study|Other|1|||
94363179|NCT03514121|323114488|FG002|Overall Study|Other|1|||
94363180|NCT03514121|323114489|FG003|Overall Study|Other|0|||
94363181|NCT03514121|323114490|FG004|Overall Study|Other|1|||
94363182|NCT03514121|323114491|FG005|Overall Study|Other|2|||
94363183|NCT03514121|323114492|FG006|Overall Study|Other|3|||
94363184|NCT03514121|323114493|FG007|Overall Study|Other|2|||
94363185|NCT03514121|323114494|FG008|Overall Study|Other|7|||
94363186|NCT03514121|323114495|FG009|Overall Study|Other|3|||
94363187|NCT03514121|323114486|FG000|Overall Study|Study termination by Sponsor|0|||
94363188|NCT03514121|323114487|FG001|Overall Study|Study termination by Sponsor|0|||
94363189|NCT03514121|323114488|FG002|Overall Study|Study termination by Sponsor|0|||
94363190|NCT03514121|323114489|FG003|Overall Study|Study termination by Sponsor|0|||
94363191|NCT03514121|323114490|FG004|Overall Study|Study termination by Sponsor|0|||
94461938|NCT03781583|323481275|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
94461939|NCT03781583|323481276|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
94461940|NCT03781583|323481277|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
94461941|NCT03781583|323481278|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
94461942|NCT03781583|323481275|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
94461943|NCT03781583|323481276|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
94461944|NCT03781583|323481277|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
94461945|NCT03781583|323481278|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
94461946|NCT00916344|323481279|FG000|Overall Study|Death|2|||
94461947|NCT00916344|323481279|FG000|Overall Study|ICD upgrade|1|||
94461948|NCT00916344|323481279|FG000|Overall Study|Drop-out|5|||
94461949|NCT03385304|323481280|FG000|Overall Study|Death|19|||
94461950|NCT03385304|323481281|FG001|Overall Study|Death|7|||
94461951|NCT03385304|323481280|FG000|Overall Study|Lost to Follow-up|17|||
94461952|NCT03385304|323481281|FG001|Overall Study|Lost to Follow-up|14|||
94461953|NCT03385304|323481280|FG000|Overall Study|Withdrawal by Subject|3|||
94642487|NCT00352846|324153523|FG001|Overall Study|Disease progression|2|||
94363192|NCT03514121|323114491|FG005|Overall Study|Study termination by Sponsor|0|||
94363193|NCT03514121|323114492|FG006|Overall Study|Study termination by Sponsor|0|||
94263224|NCT01383161|322758150|FG001|Overall Study|Withdrawal by Subject|2|||
94263225|NCT01383161|322758149|FG000|Overall Study|Lack of Efficacy|0|||
94263226|NCT01383161|322758150|FG001|Overall Study|Lack of Efficacy|1|||
94263227|NCT03548987|322758151|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
94263228|NCT03548987|322758152|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
94263229|NCT03548987|322758151|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
94263230|NCT03548987|322758152|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
94363194|NCT03514121|323114493|FG007|Overall Study|Study termination by Sponsor|0|||
94363195|NCT03514121|323114494|FG008|Overall Study|Study termination by Sponsor|11|||
94363196|NCT03514121|323114495|FG009|Overall Study|Study termination by Sponsor|3|||
94363197|NCT03514121|323114486|FG000|Overall Study|Investigator decision|0|||
94363198|NCT03514121|323114487|FG001|Overall Study|Investigator decision|0|||
94363199|NCT03514121|323114488|FG002|Overall Study|Investigator decision|0|||
94363200|NCT03514121|323114489|FG003|Overall Study|Investigator decision|0|||
94363201|NCT03514121|323114490|FG004|Overall Study|Investigator decision|0|||
94363202|NCT03514121|323114491|FG005|Overall Study|Investigator decision|0|||
94363203|NCT03514121|323114492|FG006|Overall Study|Investigator decision|0|||
94363204|NCT03514121|323114493|FG007|Overall Study|Investigator decision|0|||
94363205|NCT03514121|323114494|FG008|Overall Study|Investigator decision|1|||
94363206|NCT03514121|323114495|FG009|Overall Study|Investigator decision|0|||
94363207|NCT04930536|323114496|FG000|Overall Study|Adverse Event|1|||
94363208|NCT04930536|323114497|FG001|Overall Study|Adverse Event|0|||
94363209|NCT04930536|323114496|FG000|Overall Study|Disease Progression|2|||
94363210|NCT04930536|323114497|FG001|Overall Study|Disease Progression|0|||
94363211|NCT04930536|323114496|FG000|Overall Study|Patient Decision|4|||
94642488|NCT00352846|324153522|FG000|Overall Study|Withdrawal by Subject|3|||
94642489|NCT00352846|324153523|FG001|Overall Study|Withdrawal by Subject|8|||
94642490|NCT00352846|324153522|FG000|Overall Study|Ineligible|3|||
94642491|NCT00352846|324153523|FG001|Overall Study|Ineligible|2|||
94642492|NCT00352846|324153522|FG000|Overall Study|Non-compliance|2|||
94642493|NCT00352846|324153523|FG001|Overall Study|Non-compliance|0|||
94642494|NCT00352846|324153522|FG000|Overall Study|Death|0|||
94642495|NCT00352846|324153523|FG001|Overall Study|Death|1|||
94642496|NCT03979638|324153528|FG000|Period 1|Physician Decision|1|||
94642497|NCT03979638|324153529|FG001|Period 1|Physician Decision|1|||
94642498|NCT03979638|324153528|FG000|Period 1|Withdrawal by Subject|4|||
94642499|NCT03979638|324153529|FG001|Period 1|Withdrawal by Subject|3|||
94642500|NCT03979638|324153528|FG000|Period 1|Study terminated by Sponsor|1|||
94642501|NCT03979638|324153529|FG001|Period 1|Study terminated by Sponsor|3|||
94642502|NCT03979638|324153528|FG000|Period 1|Protocol Violation|1|||
94642503|NCT03979638|324153529|FG001|Period 1|Protocol Violation|0|||
94642504|NCT03979638|324153528|FG000|Period 2|Study terminated by Sponsor|1|||
94642505|NCT03979638|324153529|FG001|Period 2|Study terminated by Sponsor|1|||
94263231|NCT03548987|322758151|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
94363212|NCT04930536|323114497|FG001|Overall Study|Patient Decision|2|||
94363213|NCT04930536|323114496|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
94642506|NCT00600938|324153542|FG000|Core Study|Abnormal test procedure result(s)|3|||
94642507|NCT00600938|324153543|FG001|Core Study|Abnormal test procedure result(s)|2|||
94642508|NCT00600938|324153544|FG002|Core Study|Abnormal test procedure result(s)|0|||
94642509|NCT00600938|324153545|FG003|Core Study|Abnormal test procedure result(s)|0|||
94642510|NCT00600938|324153542|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
94642511|NCT00600938|324153543|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
94642512|NCT00600938|324153544|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
94642513|NCT00600938|324153545|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
94642514|NCT00600938|324153542|FG000|Core Study|Patient withdrew consent|7|||
94642515|NCT00600938|324153543|FG001|Core Study|Patient withdrew consent|12|||
94642516|NCT00600938|324153544|FG002|Core Study|Patient withdrew consent|0|||
94642517|NCT00600938|324153545|FG003|Core Study|Patient withdrew consent|0|||
94642518|NCT00600938|324153542|FG000|Core Study|Lost to Follow-up|3|||
94642519|NCT00600938|324153543|FG001|Core Study|Lost to Follow-up|2|||
94642520|NCT00600938|324153544|FG002|Core Study|Lost to Follow-up|0|||
94363214|NCT04930536|323114497|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
94363215|NCT00398632|323114498|FG000|Overall Study|Withdrawal by Subject|1|||
94363216|NCT00398632|323114498|FG000|Overall Study|Lack of Efficacy|1|||
94363217|NCT02545868|323114505|FG000|Overall Study|Lack of Efficacy|1|||
94363218|NCT02545868|323114506|FG001|Overall Study|Lack of Efficacy|1|||
94363219|NCT02545868|323114507|FG002|Overall Study|Lack of Efficacy|0|||
94363220|NCT02545868|323114505|FG000|Overall Study|Lost to Follow-up|1|||
94363221|NCT02545868|323114506|FG001|Overall Study|Lost to Follow-up|5|||
94363222|NCT02545868|323114507|FG002|Overall Study|Lost to Follow-up|1|||
94363223|NCT02545868|323114505|FG000|Overall Study|Non-compliance|1|||
94363224|NCT02545868|323114506|FG001|Overall Study|Non-compliance|1|||
94363225|NCT02545868|323114507|FG002|Overall Study|Non-compliance|1|||
94363226|NCT02545868|323114505|FG000|Overall Study|Treatment change|21|||
94363227|NCT02545868|323114506|FG001|Overall Study|Treatment change|19|||
94363228|NCT02545868|323114507|FG002|Overall Study|Treatment change|22|||
94363229|NCT02545868|323114505|FG000|Overall Study|Physician Decision|1|||
94363230|NCT02545868|323114506|FG001|Overall Study|Physician Decision|1|||
94363231|NCT02545868|323114507|FG002|Overall Study|Physician Decision|1|||
94363232|NCT02545868|323114505|FG000|Overall Study|Withdrawal by Subject|6|||
94363233|NCT02545868|323114506|FG001|Overall Study|Withdrawal by Subject|7|||
94363234|NCT02545868|323114507|FG002|Overall Study|Withdrawal by Subject|9|||
94363235|NCT04057573|323114508|FG000|24-Week Double-Blind Period|Adverse Event|2|||
94363236|NCT04057573|323114509|FG001|24-Week Double-Blind Period|Adverse Event|0|||
94363237|NCT04057573|323114510|FG002|24-Week Double-Blind Period|Adverse Event|0|||
94363238|NCT04057573|323114511|FG003|24-Week Double-Blind Period|Adverse Event|0|||
94363239|NCT04057573|323114508|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
94363240|NCT04057573|323114509|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
94363241|NCT04057573|323114510|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
94363242|NCT04057573|323114511|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
94363243|NCT04057573|323114508|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
94461954|NCT03385304|323481281|FG001|Overall Study|Withdrawal by Subject|2|||
94363244|NCT04057573|323114509|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
94363245|NCT04057573|323114510|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
94363246|NCT04057573|323114511|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
94363247|NCT04057573|323114508|FG000|24-Week Double-Blind Period|Physician Decision|1|||
94363248|NCT04057573|323114509|FG001|24-Week Double-Blind Period|Physician Decision|0|||
94461955|NCT03385304|323481280|FG000|Overall Study|Incarceration|2|||
94461956|NCT03385304|323481281|FG001|Overall Study|Incarceration|3|||
94461957|NCT03602391|323481284|FG000|Overall Study|COVID-19|7|||
94461958|NCT03602391|323481285|FG001|Overall Study|COVID-19|6|||
94461959|NCT02083185|323481286|FG000|Overall Study|Lost to Follow-up|0|||
94461960|NCT02083185|323481287|FG001|Overall Study|Lost to Follow-up|3|||
94461961|NCT02083185|323481288|FG002|Overall Study|Lost to Follow-up|0|||
94363249|NCT04057573|323114510|FG002|24-Week Double-Blind Period|Physician Decision|0|||
94363250|NCT04057573|323114511|FG003|24-Week Double-Blind Period|Physician Decision|0|||
94461962|NCT02083185|323481286|FG000|Overall Study|Withdrawal by Subject|9|||
94363251|NCT04057573|323114508|FG000|24-Week Double-Blind Period|Pregnancy|1|||
94363252|NCT04057573|323114509|FG001|24-Week Double-Blind Period|Pregnancy|0|||
94363253|NCT04057573|323114510|FG002|24-Week Double-Blind Period|Pregnancy|0|||
94363254|NCT04057573|323114511|FG003|24-Week Double-Blind Period|Pregnancy|0|||
94363255|NCT04057573|323114508|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
94363256|NCT04057573|323114509|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
94363257|NCT04057573|323114510|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
94363258|NCT04057573|323114511|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
94363259|NCT04057573|323114508|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
94363260|NCT04057573|323114509|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
94363261|NCT04057573|323114510|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
94363262|NCT04057573|323114511|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
94363263|NCT04057573|323114508|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
94363264|NCT04057573|323114509|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
94363265|NCT04057573|323114510|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
94363266|NCT04057573|323114511|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
94363267|NCT04057573|323114508|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
94363268|NCT04057573|323114509|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
94363269|NCT04057573|323114510|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
94363270|NCT04057573|323114511|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
94363271|NCT04057573|323114508|FG000|24-Week Double-Blind Period|Not Treated|1|||
94363272|NCT04057573|323114509|FG001|24-Week Double-Blind Period|Not Treated|0|||
94363273|NCT04057573|323114510|FG002|24-Week Double-Blind Period|Not Treated|0|||
94363274|NCT04057573|323114511|FG003|24-Week Double-Blind Period|Not Treated|0|||
94363275|NCT04057573|323114508|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
94363276|NCT04057573|323114509|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
94642521|NCT00600938|324153545|FG003|Core Study|Lost to Follow-up|0|||
94642522|NCT00600938|324153542|FG000|Core Study|Death|1|||
94642523|NCT00600938|324153543|FG001|Core Study|Death|1|||
94642524|NCT00600938|324153544|FG002|Core Study|Death|0|||
94642525|NCT00600938|324153545|FG003|Core Study|Death|0|||
94642526|NCT00600938|324153542|FG000|Core Study|Protocol Violation|1|||
94642527|NCT00600938|324153543|FG001|Core Study|Protocol Violation|2|||
94642528|NCT00600938|324153544|FG002|Core Study|Protocol Violation|0|||
94642529|NCT00600938|324153545|FG003|Core Study|Protocol Violation|0|||
94678816|NCT03145766|324278877|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
94642530|NCT00600938|324153542|FG000|Extension Study|Adverse Event|1|||
94678817|NCT03145766|324278878|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
94642531|NCT00600938|324153543|FG001|Extension Study|Adverse Event|0|||
94363277|NCT04057573|323114510|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
94363278|NCT04057573|323114511|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
94363279|NCT04057573|323114508|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
94363280|NCT04057573|323114509|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
94363281|NCT04057573|323114510|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
94363282|NCT04057573|323114511|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
94642532|NCT00600938|324153544|FG002|Extension Study|Adverse Event|2|||
94642533|NCT00600938|324153545|FG003|Extension Study|Adverse Event|0|||
94642534|NCT00600938|324153542|FG000|Extension Study|Abnormal test procedure results|0|||
94642535|NCT00600938|324153543|FG001|Extension Study|Abnormal test procedure results|1|||
94642536|NCT00600938|324153544|FG002|Extension Study|Abnormal test procedure results|1|||
94642537|NCT00600938|324153545|FG003|Extension Study|Abnormal test procedure results|1|||
94642538|NCT00600938|324153542|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
94642539|NCT00600938|324153543|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
94642540|NCT00600938|324153544|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
94642541|NCT00600938|324153545|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
94642542|NCT00600938|324153542|FG000|Extension Study|Withdrawal by Subject|2|||
94642543|NCT00600938|324153543|FG001|Extension Study|Withdrawal by Subject|2|||
94642544|NCT00600938|324153544|FG002|Extension Study|Withdrawal by Subject|3|||
94642545|NCT00600938|324153545|FG003|Extension Study|Withdrawal by Subject|0|||
94642546|NCT00600938|324153542|FG000|Extension Study|Lost to Follow-up|1|||
94642547|NCT00600938|324153543|FG001|Extension Study|Lost to Follow-up|1|||
94642548|NCT00600938|324153544|FG002|Extension Study|Lost to Follow-up|2|||
94642549|NCT00600938|324153545|FG003|Extension Study|Lost to Follow-up|0|||
94642550|NCT00600938|324153542|FG000|Extension Study|Death|1|||
94642551|NCT00600938|324153543|FG001|Extension Study|Death|0|||
94642552|NCT00600938|324153544|FG002|Extension Study|Death|0|||
94642553|NCT00600938|324153545|FG003|Extension Study|Death|0|||
94642554|NCT00856908|324153555|FG000|Overall Study|Lost to Follow-up|1|||
94642555|NCT00856908|324153556|FG001|Overall Study|Lost to Follow-up|0|||
94642556|NCT02678676|324153559|FG000|Overall Study|Death|619|||
94642557|NCT02678676|324153560|FG001|Overall Study|Death|649|||
94642558|NCT02678676|324153559|FG000|Overall Study|Withdrawal by Subject|13|||
94642559|NCT02678676|324153560|FG001|Overall Study|Withdrawal by Subject|5|||
94642560|NCT02678676|324153559|FG000|Overall Study|Lost to Follow-up|171|||
94642561|NCT02678676|324153560|FG001|Overall Study|Lost to Follow-up|151|||
94642562|NCT02678676|324153559|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
94642563|NCT02678676|324153560|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
94642564|NCT04536727|324153570|FG000|Overall Study|Lost to Follow-up|1|||
94642565|NCT04536727|324153571|FG001|Overall Study|Lost to Follow-up|1|||
94642566|NCT04536727|324153570|FG000|Overall Study|Death|0|||
94642567|NCT04536727|324153571|FG001|Overall Study|Death|1|||
94642568|NCT02141074|324153574|FG000|Pre-prophylaxis|Adverse Event|3|||
94642569|NCT02141074|324153575|FG001|Pre-prophylaxis|Adverse Event|0|||
94642570|NCT02141074|324153574|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
94642571|NCT02141074|324153575|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
94642572|NCT02141074|324153574|FG000|Prophylaxis|Adverse Event|0|||
94642573|NCT02141074|324153575|FG001|Prophylaxis|Adverse Event|4|||
94642574|NCT02141074|324153574|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
94642575|NCT02141074|324153575|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
94642576|NCT02141074|324153574|FG000|Prophylaxis|Withdrawal by Subject|0|||
94642577|NCT02141074|324153575|FG001|Prophylaxis|Withdrawal by Subject|1|||
94642578|NCT03210714|324153576|FG000|Overall Study|Adverse Event|6|||
94642579|NCT03210714|324153576|FG000|Overall Study|Physician Decision|1|||
94642580|NCT03210714|324153576|FG000|Overall Study|Progressive disease|11|||
94642581|NCT03210714|324153576|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
94642582|NCT01077804|324153577|FG000|Overall Study|Unreachable|102|||
94642583|NCT01077804|324153577|FG000|Overall Study|Refused to continue|79|||
94642584|NCT01077804|324153577|FG000|Overall Study|Other|18|||
94642585|NCT02357147|324153578|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
94363283|NCT04057573|323114508|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
94363284|NCT04057573|323114509|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
94363285|NCT04057573|323114510|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
94363286|NCT04057573|323114511|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
94363287|NCT04057573|323114508|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
94363288|NCT04057573|323114509|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
94363289|NCT04057573|323114510|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
94363290|NCT04057573|323114511|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
94363291|NCT04057573|323114508|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
94363292|NCT04057573|323114509|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
94363293|NCT04057573|323114510|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
94363294|NCT04057573|323114511|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
94363295|NCT03286400|323114512|FG000|Overall Study|Death|10|||
94363296|NCT03286400|323114512|FG000|Overall Study|Lost to Follow-up|10|||
94363297|NCT03286400|323114512|FG000|Overall Study|Physician Decision|1|||
94642586|NCT02357147|324153579|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
94642587|NCT02357147|324153578|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
94642588|NCT02357147|324153579|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
94642589|NCT02357147|324153578|FG000|Combination Treatment Phase|Investigator Discretion|1|||
94642590|NCT02357147|324153579|FG001|Combination Treatment Phase|Investigator Discretion|1|||
94642591|NCT02357147|324153578|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
94642592|NCT02357147|324153579|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
94363298|NCT03286400|323114512|FG000|Overall Study|Scheduling difficulty|4|||
94363299|NCT02118896|323114515|FG000|Overall Study|Death|4|||
94363300|NCT02118896|323114516|FG001|Overall Study|Death|0|||
94363301|NCT02118896|323114517|FG002|Overall Study|Death|4|||
94363302|NCT02118896|323114518|FG003|Overall Study|Death|6|||
94363303|NCT02118896|323114519|FG004|Overall Study|Death|3|||
94363304|NCT02118896|323114520|FG005|Overall Study|Death|1|||
94363305|NCT02118896|323114521|FG006|Overall Study|Death|0|||
94363306|NCT02118896|323114522|FG007|Overall Study|Death|0|||
94363307|NCT02118896|323114523|FG008|Overall Study|Death|0|||
94363308|NCT02118896|323114524|FG009|Overall Study|Death|0|||
94363309|NCT02118896|323114515|FG000|Overall Study|Adverse Event|5|||
94363310|NCT02118896|323114516|FG001|Overall Study|Adverse Event|4|||
94363311|NCT02118896|323114517|FG002|Overall Study|Adverse Event|4|||
94363312|NCT02118896|323114518|FG003|Overall Study|Adverse Event|5|||
94363313|NCT02118896|323114519|FG004|Overall Study|Adverse Event|5|||
94363314|NCT02118896|323114520|FG005|Overall Study|Adverse Event|9|||
94363315|NCT02118896|323114521|FG006|Overall Study|Adverse Event|1|||
94363316|NCT02118896|323114522|FG007|Overall Study|Adverse Event|1|||
94363317|NCT02118896|323114523|FG008|Overall Study|Adverse Event|4|||
94363318|NCT02118896|323114524|FG009|Overall Study|Adverse Event|0|||
94363319|NCT02118896|323114515|FG000|Overall Study|Consent withdrawn|2|||
94363320|NCT02118896|323114516|FG001|Overall Study|Consent withdrawn|0|||
94363321|NCT02118896|323114517|FG002|Overall Study|Consent withdrawn|3|||
94363322|NCT02118896|323114518|FG003|Overall Study|Consent withdrawn|4|||
94363323|NCT02118896|323114519|FG004|Overall Study|Consent withdrawn|1|||
94363324|NCT02118896|323114520|FG005|Overall Study|Consent withdrawn|4|||
94363325|NCT02118896|323114521|FG006|Overall Study|Consent withdrawn|0|||
94363326|NCT02118896|323114522|FG007|Overall Study|Consent withdrawn|0|||
94363327|NCT02118896|323114523|FG008|Overall Study|Consent withdrawn|0|||
94363328|NCT02118896|323114524|FG009|Overall Study|Consent withdrawn|0|||
94363329|NCT02118896|323114515|FG000|Overall Study|Non-compliance|2|||
94363330|NCT02118896|323114516|FG001|Overall Study|Non-compliance|1|||
94363331|NCT02118896|323114517|FG002|Overall Study|Non-compliance|1|||
94363332|NCT02118896|323114518|FG003|Overall Study|Non-compliance|5|||
94363333|NCT02118896|323114519|FG004|Overall Study|Non-compliance|0|||
94363334|NCT02118896|323114520|FG005|Overall Study|Non-compliance|1|||
94642593|NCT02357147|324153578|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
94642594|NCT02357147|324153579|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
94642595|NCT02357147|324153578|FG000|Combination Treatment Phase|Adverse Event|12|||
94642596|NCT02357147|324153579|FG001|Combination Treatment Phase|Adverse Event|4|||
94461963|NCT02083185|323481287|FG001|Overall Study|Withdrawal by Subject|15|||
94461964|NCT02083185|323481288|FG002|Overall Study|Withdrawal by Subject|1|||
94461965|NCT02083185|323481286|FG000|Overall Study|Death|2|||
94461966|NCT02083185|323481287|FG001|Overall Study|Death|2|||
94461967|NCT02083185|323481288|FG002|Overall Study|Death|1|||
94461968|NCT02083185|323481286|FG000|Overall Study|Reason not Specified|9|||
94461969|NCT02083185|323481287|FG001|Overall Study|Reason not Specified|6|||
94461970|NCT02083185|323481288|FG002|Overall Study|Reason not Specified|5|||
94461971|NCT02083185|323481286|FG000|Overall Study|Study Terminated by Sponsor|0|||
94461972|NCT02083185|323481287|FG001|Overall Study|Study Terminated by Sponsor|1|||
94461973|NCT02083185|323481288|FG002|Overall Study|Study Terminated by Sponsor|0|||
94461974|NCT02083185|323481286|FG000|Overall Study|Did not Receive Study Drug|0|||
94461975|NCT02083185|323481287|FG001|Overall Study|Did not Receive Study Drug|2|||
94461976|NCT02083185|323481288|FG002|Overall Study|Did not Receive Study Drug|0|||
94461977|NCT02370667|323481291|FG000|Overall Study|Lost to Follow-up|0|||
94461978|NCT02370667|323481292|FG001|Overall Study|Lost to Follow-up|1|||
94461979|NCT02370667|323481293|FG002|Overall Study|Lost to Follow-up|0|||
94461980|NCT00423189|323481296|FG000|Overall Study|Death|0|||
94461981|NCT00423189|323481297|FG001|Overall Study|Death|1|||
94461982|NCT00423189|323481298|FG002|Overall Study|Death|0|||
94461983|NCT01801358|323481299|FG000|Overall Study|Adverse Event|0|||
94461984|NCT01801358|323481300|FG001|Overall Study|Adverse Event|2|||
94461985|NCT01801358|323481301|FG002|Overall Study|Adverse Event|1|||
94461986|NCT01801358|323481302|FG003|Overall Study|Adverse Event|0|||
94461987|NCT01801358|323481303|FG004|Overall Study|Adverse Event|0|||
94363335|NCT02118896|323114521|FG006|Overall Study|Non-compliance|0|||
94363336|NCT02118896|323114522|FG007|Overall Study|Non-compliance|1|||
94363337|NCT02118896|323114523|FG008|Overall Study|Non-compliance|0|||
94363338|NCT02118896|323114524|FG009|Overall Study|Non-compliance|0|||
94363339|NCT02118896|323114515|FG000|Overall Study|Pregnancy|1|||
94461988|NCT01801358|323481304|FG005|Overall Study|Adverse Event|1|||
94461989|NCT01801358|323481299|FG000|Overall Study|Physician Decision|0|||
94461990|NCT01801358|323481300|FG001|Overall Study|Physician Decision|0|||
94642597|NCT02357147|324153578|FG000|Combination Treatment Phase|Death|1|||
94642598|NCT02357147|324153579|FG001|Combination Treatment Phase|Death|1|||
94363340|NCT02118896|323114516|FG001|Overall Study|Pregnancy|1|||
94363341|NCT02118896|323114517|FG002|Overall Study|Pregnancy|0|||
94461991|NCT01801358|323481301|FG002|Overall Study|Physician Decision|1|||
94461992|NCT01801358|323481302|FG003|Overall Study|Physician Decision|0|||
94461993|NCT01801358|323481303|FG004|Overall Study|Physician Decision|0|||
94363342|NCT02118896|323114518|FG003|Overall Study|Pregnancy|0|||
94363343|NCT02118896|323114519|FG004|Overall Study|Pregnancy|1|||
94363344|NCT02118896|323114520|FG005|Overall Study|Pregnancy|3|||
94363345|NCT02118896|323114521|FG006|Overall Study|Pregnancy|1|||
94363346|NCT02118896|323114522|FG007|Overall Study|Pregnancy|0|||
94363347|NCT02118896|323114523|FG008|Overall Study|Pregnancy|0|||
94363348|NCT02118896|323114524|FG009|Overall Study|Pregnancy|0|||
94363349|NCT02118896|323114515|FG000|Overall Study|Lost to Follow-up|1|||
94363350|NCT02118896|323114516|FG001|Overall Study|Lost to Follow-up|2|||
94363351|NCT02118896|323114517|FG002|Overall Study|Lost to Follow-up|1|||
94363352|NCT02118896|323114518|FG003|Overall Study|Lost to Follow-up|0|||
94363353|NCT02118896|323114519|FG004|Overall Study|Lost to Follow-up|2|||
94363354|NCT02118896|323114520|FG005|Overall Study|Lost to Follow-up|1|||
94363355|NCT02118896|323114521|FG006|Overall Study|Lost to Follow-up|0|||
94363356|NCT02118896|323114522|FG007|Overall Study|Lost to Follow-up|0|||
94363357|NCT02118896|323114523|FG008|Overall Study|Lost to Follow-up|0|||
94363358|NCT02118896|323114524|FG009|Overall Study|Lost to Follow-up|0|||
94363359|NCT02118896|323114515|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
94461994|NCT01801358|323481304|FG005|Overall Study|Physician Decision|0|||
94461995|NCT01801358|323481299|FG000|Overall Study|Progressive Disease|6|||
94461996|NCT01801358|323481300|FG001|Overall Study|Progressive Disease|4|||
94461997|NCT01801358|323481301|FG002|Overall Study|Progressive Disease|4|||
94461998|NCT01801358|323481302|FG003|Overall Study|Progressive Disease|5|||
94461999|NCT01801358|323481303|FG004|Overall Study|Progressive Disease|6|||
94462000|NCT01801358|323481304|FG005|Overall Study|Progressive Disease|5|||
94462001|NCT01801358|323481299|FG000|Overall Study|Withdrawal by Subject|0|||
94462002|NCT01801358|323481300|FG001|Overall Study|Withdrawal by Subject|0|||
94462003|NCT01801358|323481301|FG002|Overall Study|Withdrawal by Subject|0|||
94462004|NCT01801358|323481302|FG003|Overall Study|Withdrawal by Subject|1|||
94462005|NCT01801358|323481303|FG004|Overall Study|Withdrawal by Subject|0|||
94462006|NCT01801358|323481304|FG005|Overall Study|Withdrawal by Subject|2|||
94462007|NCT02998476|323481319|FG000|Overall Study|Lost to Follow-up|1|||
94462008|NCT02998476|323481320|FG001|Overall Study|Lost to Follow-up|0|||
94462009|NCT02998476|323481319|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
94462010|NCT02998476|323481320|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
94462011|NCT02998476|323481319|FG000|Overall Study|Withdrawal by Subject|1|||
94462012|NCT02998476|323481320|FG001|Overall Study|Withdrawal by Subject|2|||
94462013|NCT02998476|323481319|FG000|Overall Study|Death|45|||
94462014|NCT02998476|323481320|FG001|Overall Study|Death|2|||
94462015|NCT02998476|323481319|FG000|Overall Study|Other|6|||
94462016|NCT02998476|323481320|FG001|Overall Study|Other|1|||
94642599|NCT02357147|324153578|FG000|Combination Treatment Phase|Sponsor Decision|0|||
94642600|NCT02357147|324153579|FG001|Combination Treatment Phase|Sponsor Decision|12|||
94642601|NCT02357147|324153578|FG000|Combination Treatment Phase|Other|1|||
94642602|NCT02357147|324153579|FG001|Combination Treatment Phase|Other|0|||
94642603|NCT02357147|324153578|FG000|Combination Treatment Phase|Not treated|0|||
94642604|NCT02357147|324153579|FG001|Combination Treatment Phase|Not treated|2|||
94642605|NCT02357147|324153578|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
94642606|NCT02357147|324153579|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
94642607|NCT02357147|324153578|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
94642608|NCT02357147|324153579|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
94642609|NCT02357147|324153578|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
94642610|NCT02357147|324153579|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
94642611|NCT02357147|324153578|FG000|Maintenance Treatment Phase|Adverse Event|0|||
94642612|NCT02357147|324153579|FG001|Maintenance Treatment Phase|Adverse Event|3|||
94363360|NCT02118896|323114516|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
94363361|NCT02118896|323114517|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
94462017|NCT06011161|323481323|FG000|Overall Study|Withdrawal by Subject|2|||
94642613|NCT02357147|324153578|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
94642614|NCT02357147|324153579|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
94462018|NCT06011161|323481323|FG000|Overall Study|Lost to Follow-up|5|||
94462019|NCT04326439|323481324|FG000|Overall Study|Withdrawal by Subject|1|||
94462020|NCT04326439|323481325|FG001|Overall Study|Withdrawal by Subject|0|||
94462021|NCT04326439|323481324|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
94462022|NCT04326439|323481325|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
94462023|NCT04326439|323481324|FG000|Overall Study|Relapse after Induction 2|0|||
94462024|NCT04326439|323481325|FG001|Overall Study|Relapse after Induction 2|1|||
94462025|NCT04326439|323481324|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
94462026|NCT04326439|323481325|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
94462027|NCT00725101|323481326|FG000|Overall Study|Death|3|||
94462028|NCT00725101|323481326|FG000|Overall Study|Lost to Follow-up|353|||
94462029|NCT00725101|323481326|FG000|Overall Study|Protocol Violation|1|||
94462030|NCT00725101|323481326|FG000|Overall Study|Withdrawal by Subject|127|||
94462031|NCT00725101|323481326|FG000|Overall Study|not specified/no reason given|11|||
94462032|NCT00819780|323481327|FG000|Overall Study|Did not receive study drug|3|||
94462033|NCT00819780|323481328|FG001|Overall Study|Did not receive study drug|4|||
94462034|NCT00819780|323481327|FG000|Overall Study|Still in treatment|25|||
94462035|NCT00819780|323481328|FG001|Overall Study|Still in treatment|17|||
94462036|NCT01793688|323481329|FG000|Overall Study|Protocol Violation|2|||
94462037|NCT01984892|323481330|FG000|Overall Study|Progressive disease|7|||
94462038|NCT00824382|323481331|FG000|Overall Study|Adverse Event|4|||
94462039|NCT00824382|323481332|FG001|Overall Study|Adverse Event|1|||
94462040|NCT00824382|323481333|FG002|Overall Study|Adverse Event|1|||
94462041|NCT00824382|323481334|FG003|Overall Study|Adverse Event|4|||
94462042|NCT00824382|323481331|FG000|Overall Study|Protocol Violation|1|||
94462043|NCT00824382|323481332|FG001|Overall Study|Protocol Violation|0|||
94462044|NCT00824382|323481333|FG002|Overall Study|Protocol Violation|0|||
94462045|NCT00824382|323481334|FG003|Overall Study|Protocol Violation|1|||
94462046|NCT00824382|323481331|FG000|Overall Study|Investigator's decision|0|||
94462047|NCT00824382|323481332|FG001|Overall Study|Investigator's decision|1|||
94462048|NCT00824382|323481333|FG002|Overall Study|Investigator's decision|2|||
94462049|NCT00824382|323481334|FG003|Overall Study|Investigator's decision|0|||
94462050|NCT02089334|323481337|FG000|Overall Study|Withdrawal by Subject|0|||
94462051|NCT02089334|323481338|FG001|Overall Study|Withdrawal by Subject|0|||
94462052|NCT02089334|323481339|FG002|Overall Study|Withdrawal by Subject|0|||
94462053|NCT02089334|323481340|FG003|Overall Study|Withdrawal by Subject|2|||
94462054|NCT02089334|323481337|FG000|Overall Study|Adverse Event|0|||
94462055|NCT02089334|323481338|FG001|Overall Study|Adverse Event|0|||
94462056|NCT02089334|323481339|FG002|Overall Study|Adverse Event|0|||
94462057|NCT02089334|323481340|FG003|Overall Study|Adverse Event|2|||
94462058|NCT02089334|323481337|FG000|Overall Study|Progressive disease|0|||
94462059|NCT02089334|323481338|FG001|Overall Study|Progressive disease|0|||
94462060|NCT02089334|323481339|FG002|Overall Study|Progressive disease|0|||
94462061|NCT02089334|323481340|FG003|Overall Study|Progressive disease|2|||
94462062|NCT02089334|323481337|FG000|Overall Study|Physician Decision|0|||
94462063|NCT02089334|323481338|FG001|Overall Study|Physician Decision|0|||
94462064|NCT02089334|323481339|FG002|Overall Study|Physician Decision|1|||
94462065|NCT02089334|323481340|FG003|Overall Study|Physician Decision|1|||
94462066|NCT02680834|323481341|FG000|Overall Study|Physician Decision|5|||
94462067|NCT02680834|323481342|FG001|Overall Study|Physician Decision|2|||
94462068|NCT02680834|323481341|FG000|Overall Study|Withdrawal by Subject|6|||
94462069|NCT02680834|323481342|FG001|Overall Study|Withdrawal by Subject|0|||
94462070|NCT02680834|323481341|FG000|Overall Study|Lost to Follow-up|0|||
94462071|NCT02680834|323481342|FG001|Overall Study|Lost to Follow-up|1|||
94462072|NCT00793624|323481345|FG000|Overall Study|Adverse Event|18|||
94462073|NCT00793624|323481346|FG001|Overall Study|Adverse Event|16|||
94462074|NCT00793624|323481347|FG002|Overall Study|Adverse Event|15|||
94462075|NCT00793624|323481348|FG003|Overall Study|Adverse Event|20|||
94462076|NCT00793624|323481345|FG000|Overall Study|Lost to Follow-up|2|||
94462077|NCT00793624|323481346|FG001|Overall Study|Lost to Follow-up|2|||
94462078|NCT00793624|323481347|FG002|Overall Study|Lost to Follow-up|4|||
94462079|NCT00793624|323481348|FG003|Overall Study|Lost to Follow-up|0|||
94462080|NCT00793624|323481345|FG000|Overall Study|Withdrawal by Subject|20|||
94462081|NCT00793624|323481346|FG001|Overall Study|Withdrawal by Subject|9|||
94462082|NCT00793624|323481347|FG002|Overall Study|Withdrawal by Subject|11|||
94462083|NCT00793624|323481348|FG003|Overall Study|Withdrawal by Subject|14|||
94462084|NCT00793624|323481345|FG000|Overall Study|Lack of Efficacy|9|||
94462085|NCT00793624|323481346|FG001|Overall Study|Lack of Efficacy|2|||
94462086|NCT00793624|323481347|FG002|Overall Study|Lack of Efficacy|1|||
94462087|NCT00793624|323481348|FG003|Overall Study|Lack of Efficacy|3|||
94462088|NCT00793624|323481345|FG000|Overall Study|Non compliance with protocol|2|||
94462089|NCT00793624|323481346|FG001|Overall Study|Non compliance with protocol|3|||
94462090|NCT00793624|323481347|FG002|Overall Study|Non compliance with protocol|2|||
94462091|NCT00793624|323481348|FG003|Overall Study|Non compliance with protocol|3|||
94462092|NCT00793624|323481345|FG000|Overall Study|Other reason not described above|6|||
94462093|NCT00793624|323481346|FG001|Overall Study|Other reason not described above|4|||
94462094|NCT00793624|323481347|FG002|Overall Study|Other reason not described above|6|||
94462095|NCT00793624|323481348|FG003|Overall Study|Other reason not described above|3|||
94462096|NCT00710684|323481349|FG000|Overall Study|Adverse Event|11|||
94462097|NCT00710684|323481350|FG001|Overall Study|Adverse Event|19|||
94462098|NCT00710684|323481351|FG002|Overall Study|Adverse Event|16|||
94462099|NCT00710684|323481349|FG000|Overall Study|Lack of Efficacy|4|||
94462100|NCT00710684|323481350|FG001|Overall Study|Lack of Efficacy|3|||
94462101|NCT00710684|323481351|FG002|Overall Study|Lack of Efficacy|5|||
94462102|NCT00710684|323481349|FG000|Overall Study|Protocol Violation|5|||
94462103|NCT00710684|323481350|FG001|Overall Study|Protocol Violation|5|||
94462104|NCT00710684|323481351|FG002|Overall Study|Protocol Violation|5|||
94462105|NCT00710684|323481349|FG000|Overall Study|Lost to Follow-up|4|||
94462106|NCT00710684|323481350|FG001|Overall Study|Lost to Follow-up|6|||
94462107|NCT00710684|323481351|FG002|Overall Study|Lost to Follow-up|7|||
94642615|NCT02357147|324153578|FG000|Maintenance Treatment Phase|Not Treated|1|||
94642616|NCT02357147|324153579|FG001|Maintenance Treatment Phase|Not Treated|0|||
94642617|NCT00283439|324154906|FG000|Overall Study|Adverse Event|0|||
94642618|NCT00283439|324154907|FG001|Overall Study|Adverse Event|0|||
94642619|NCT00283439|324154908|FG002|Overall Study|Adverse Event|0|||
94642620|NCT00283439|324154909|FG003|Overall Study|Adverse Event|1|||
94642621|NCT00283439|324154906|FG000|Overall Study|Death|0|||
94642622|NCT00283439|324154907|FG001|Overall Study|Death|0|||
94642623|NCT00283439|324154908|FG002|Overall Study|Death|1|||
94642624|NCT00283439|324154909|FG003|Overall Study|Death|0|||
94642625|NCT00283439|324154906|FG000|Overall Study|Disease progression|0|||
94462108|NCT00710684|323481349|FG000|Overall Study|Physician Decision|0|||
94363362|NCT02118896|323114518|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
94363363|NCT02118896|323114519|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
94363364|NCT02118896|323114520|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
94363365|NCT02118896|323114521|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
94363366|NCT02118896|323114522|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
94363367|NCT02118896|323114523|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
94363368|NCT02118896|323114524|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
94363369|NCT02118896|323114515|FG000|Overall Study|Prohibited medication|0|||
94363370|NCT02118896|323114516|FG001|Overall Study|Prohibited medication|0|||
94363371|NCT02118896|323114517|FG002|Overall Study|Prohibited medication|0|||
94363372|NCT02118896|323114518|FG003|Overall Study|Prohibited medication|0|||
94363373|NCT02118896|323114519|FG004|Overall Study|Prohibited medication|1|||
94363374|NCT02118896|323114520|FG005|Overall Study|Prohibited medication|3|||
94363375|NCT02118896|323114521|FG006|Overall Study|Prohibited medication|0|||
94363376|NCT02118896|323114522|FG007|Overall Study|Prohibited medication|0|||
94363377|NCT02118896|323114523|FG008|Overall Study|Prohibited medication|0|||
94363378|NCT02118896|323114524|FG009|Overall Study|Prohibited medication|0|||
94363379|NCT02118896|323114515|FG000|Overall Study|Miscellaneous|1|||
94363380|NCT02118896|323114516|FG001|Overall Study|Miscellaneous|2|||
94363381|NCT02118896|323114517|FG002|Overall Study|Miscellaneous|0|||
94363382|NCT02118896|323114518|FG003|Overall Study|Miscellaneous|2|||
94363383|NCT02118896|323114519|FG004|Overall Study|Miscellaneous|0|||
94363384|NCT02118896|323114520|FG005|Overall Study|Miscellaneous|4|||
94363385|NCT02118896|323114521|FG006|Overall Study|Miscellaneous|0|||
94363386|NCT02118896|323114522|FG007|Overall Study|Miscellaneous|0|||
94363387|NCT02118896|323114523|FG008|Overall Study|Miscellaneous|0|||
94363388|NCT02118896|323114524|FG009|Overall Study|Miscellaneous|0|||
94363389|NCT00592007|323114532|FG000|Overall Study|Withdrawal by Subject|1|||
94363390|NCT00592007|323114532|FG000|Overall Study|patient ineligible (out of lab range)|1|||
94363391|NCT00557830|323114534|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
94363392|NCT00557830|323114535|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
94363393|NCT00557830|323114536|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
94363394|NCT00557830|323114534|FG000|Screening Treatment Phase|Adverse Event|2|||
94363395|NCT00557830|323114535|FG001|Screening Treatment Phase|Adverse Event|0|||
94363396|NCT00557830|323114536|FG002|Screening Treatment Phase|Adverse Event|0|||
94363397|NCT00557830|323114534|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
94363398|NCT00557830|323114535|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
94363399|NCT00557830|323114536|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
94363400|NCT02086968|323114537|FG000|Overall Study|Adverse Event|1|||
94363401|NCT02086968|323114538|FG001|Overall Study|Adverse Event|5|||
94363402|NCT02086968|323114537|FG000|Overall Study|Lost to Follow-up|2|||
94363403|NCT02086968|323114538|FG001|Overall Study|Lost to Follow-up|3|||
94363404|NCT02086968|323114537|FG000|Overall Study|Study drug received outside protocol|0|||
94363405|NCT02086968|323114538|FG001|Overall Study|Study drug received outside protocol|1|||
94363406|NCT02086968|323114537|FG000|Overall Study|Physician Decision|4|||
94363407|NCT02086968|323114538|FG001|Overall Study|Physician Decision|0|||
94462109|NCT00710684|323481350|FG001|Overall Study|Physician Decision|2|||
94462110|NCT00710684|323481351|FG002|Overall Study|Physician Decision|4|||
94462111|NCT00710684|323481349|FG000|Overall Study|Withdrawal by Subject|24|||
94642626|NCT00283439|324154907|FG001|Overall Study|Disease progression|1|||
94642627|NCT00283439|324154908|FG002|Overall Study|Disease progression|0|||
94462112|NCT00710684|323481350|FG001|Overall Study|Withdrawal by Subject|18|||
94462113|NCT00710684|323481351|FG002|Overall Study|Withdrawal by Subject|11|||
94462114|NCT00710684|323481349|FG000|Overall Study|Missing|1|||
94462115|NCT00710684|323481350|FG001|Overall Study|Missing|0|||
94462116|NCT00710684|323481351|FG002|Overall Study|Missing|0|||
94462117|NCT00710684|323481349|FG000|Overall Study|Did not continue after week 24|25|||
94462118|NCT00710684|323481350|FG001|Overall Study|Did not continue after week 24|21|||
94462119|NCT00710684|323481351|FG002|Overall Study|Did not continue after week 24|16|||
94462120|NCT02832375|323481352|FG000|Overall Study|Lost to Follow-up|1|||
94462121|NCT02832375|323481353|FG001|Overall Study|Lost to Follow-up|0|||
94462122|NCT02832375|323481352|FG000|Overall Study|Withdrawal of Consent|1|||
94462123|NCT02832375|323481353|FG001|Overall Study|Withdrawal of Consent|0|||
94462124|NCT01317797|323481354|FG000|Overall Study|Other|0|||
94462125|NCT01317797|323481355|FG001|Overall Study|Other|1|||
94462126|NCT01317797|323481356|FG002|Overall Study|Other|0|||
94462127|NCT01317797|323481354|FG000|Overall Study|Withdrawal of Patient|0|||
94462128|NCT01317797|323481355|FG001|Overall Study|Withdrawal of Patient|0|||
94462129|NCT01317797|323481356|FG002|Overall Study|Withdrawal of Patient|1|||
94462130|NCT00157820|323481358|FG000|Randomized|Physician Decision|4|||
94462131|NCT00157820|323481359|FG001|Randomized|Physician Decision|2|||
94462132|NCT00157820|323481360|FG002|Randomized|Physician Decision|3|||
94462133|NCT00157820|323481358|FG000|Randomized|Withdrawal by Subject|1|||
94462134|NCT00157820|323481359|FG001|Randomized|Withdrawal by Subject|2|||
94462135|NCT00157820|323481360|FG002|Randomized|Withdrawal by Subject|3|||
94462136|NCT00157820|323481358|FG000|Randomized|Protocol Violation|2|||
94462137|NCT00157820|323481359|FG001|Randomized|Protocol Violation|1|||
94462138|NCT00157820|323481360|FG002|Randomized|Protocol Violation|2|||
94462139|NCT00157820|323481358|FG000|1st 8 Month|Death|7|||
94462140|NCT00157820|323481359|FG001|1st 8 Month|Death|8|||
94462141|NCT00157820|323481360|FG002|1st 8 Month|Death|3|||
94462142|NCT00157820|323481358|FG000|1st 8 Month|Lost to Follow-up|1|||
94462143|NCT00157820|323481359|FG001|1st 8 Month|Lost to Follow-up|2|||
94462144|NCT00157820|323481360|FG002|1st 8 Month|Lost to Follow-up|1|||
94462145|NCT00157820|323481358|FG000|1st 8 Month|Premature cross-over|0|||
94462146|NCT00157820|323481359|FG001|1st 8 Month|Premature cross-over|2|||
94462147|NCT00157820|323481360|FG002|1st 8 Month|Premature cross-over|2|||
94462148|NCT00157820|323481358|FG000|2nd 8 Months|Death|3|||
94462149|NCT00157820|323481359|FG001|2nd 8 Months|Death|1|||
94462150|NCT00157820|323481360|FG002|2nd 8 Months|Death|3|||
94462151|NCT00157820|323481358|FG000|2nd 8 Months|Lost to Follow-up|1|||
94462152|NCT00157820|323481359|FG001|2nd 8 Months|Lost to Follow-up|5|||
94462153|NCT00157820|323481360|FG002|2nd 8 Months|Lost to Follow-up|2|||
94462154|NCT00157820|323481358|FG000|2nd 8 Months|Premature cross-over|1|||
94462155|NCT00157820|323481359|FG001|2nd 8 Months|Premature cross-over|7|||
94462156|NCT00157820|323481360|FG002|2nd 8 Months|Premature cross-over|9|||
94462157|NCT03026530|323481361|FG000|Overall Study|Lost to Follow-up|19|||
94462158|NCT03026530|323481362|FG001|Overall Study|Lost to Follow-up|24|||
94462159|NCT03026530|323481361|FG000|Overall Study|Protocol Violation|2|||
94462160|NCT03026530|323481362|FG001|Overall Study|Protocol Violation|5|||
94462161|NCT03301740|323481363|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
94462162|NCT03301740|323481364|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
94462163|NCT03301740|323481363|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
94462164|NCT03301740|323481364|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
94462165|NCT02892513|323481366|FG000|Overall Study|Withdrawal by Subject|0|||
94462166|NCT02892513|323481367|FG001|Overall Study|Withdrawal by Subject|1|||
94462167|NCT03521817|323481372|FG000|Overall Study|Protocol Violation|0|||
94462168|NCT03521817|323481373|FG001|Overall Study|Protocol Violation|1|||
94462169|NCT03634033|323483049|FG000|Overall Study|Did not have a post-assessment|384|||
94462170|NCT03634033|323483050|FG001|Overall Study|Did not have a post-assessment|291|||
94462171|NCT03634033|323483051|FG002|Overall Study|Did not have a post-assessment|114|||
94462172|NCT03634033|323483052|FG003|Overall Study|Did not have a post-assessment|161|||
94462173|NCT03634033|323483053|FG004|Overall Study|Did not have a post-assessment|5|||
94263232|NCT03548987|322758152|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
94263233|NCT03548987|322758151|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
94263234|NCT03548987|322758152|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
94263235|NCT03548987|322758151|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
94263236|NCT03548987|322758152|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
94263237|NCT03548987|322758151|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
94263238|NCT03548987|322758152|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
94263239|NCT03548987|322758151|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
94263240|NCT03548987|322758152|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
94263241|NCT03548987|322758151|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
94263242|NCT03548987|322758152|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
94263243|NCT03548987|322758151|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
94263244|NCT03548987|322758152|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
94263245|NCT03548987|322758151|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
94263246|NCT03548987|322758152|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
94263247|NCT03548987|322758151|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
94263248|NCT03548987|322758152|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
94263249|NCT03548987|322758151|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
94263250|NCT03548987|322758152|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
94263251|NCT03548987|322758151|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
94263252|NCT03548987|322758152|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
94263253|NCT03548987|322758151|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
94263254|NCT03548987|322758152|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
94263255|NCT00216203|322758153|FG000|Overall Study|Withdrawal by Subject|2|||
94263256|NCT01338415|322758154|FG000|Core + Extension|Adverse Event|8|||
94263257|NCT01338415|322758155|FG001|Core + Extension|Adverse Event|6|||
94263258|NCT01338415|322758156|FG002|Core + Extension|Adverse Event|0|||
94263259|NCT01338415|322758154|FG000|Core + Extension|Withdrawal by Subject|1|||
94263260|NCT01338415|322758155|FG001|Core + Extension|Withdrawal by Subject|1|||
94263261|NCT01338415|322758156|FG002|Core + Extension|Withdrawal by Subject|0|||
94462174|NCT03634033|323483054|FG005|Overall Study|Did not have a post-assessment|0|||
94642628|NCT00283439|324154909|FG003|Overall Study|Disease progression|0|||
94642629|NCT00283439|324154906|FG000|Overall Study|Requirement for alternative therapy|1|||
94642630|NCT00283439|324154907|FG001|Overall Study|Requirement for alternative therapy|2|||
94642631|NCT00283439|324154908|FG002|Overall Study|Requirement for alternative therapy|5|||
94642632|NCT00283439|324154909|FG003|Overall Study|Requirement for alternative therapy|2|||
94642633|NCT00283439|324154906|FG000|Overall Study|Stem cell transplant|6|||
94642634|NCT00283439|324154907|FG001|Overall Study|Stem cell transplant|6|||
94642635|NCT00283439|324154908|FG002|Overall Study|Stem cell transplant|4|||
94642636|NCT00283439|324154909|FG003|Overall Study|Stem cell transplant|3|||
94462175|NCT03634033|323483055|FG006|Overall Study|Did not have a post-assessment|0|||
94462176|NCT03634033|323483049|FG000|Overall Study|Death|0|||
94462177|NCT03634033|323483050|FG001|Overall Study|Death|0|||
94462178|NCT03634033|323483051|FG002|Overall Study|Death|0|||
94462179|NCT03634033|323483052|FG003|Overall Study|Death|0|||
94462180|NCT03634033|323483053|FG004|Overall Study|Death|0|||
94462181|NCT03634033|323483054|FG005|Overall Study|Death|7|||
94462182|NCT03634033|323483055|FG006|Overall Study|Death|7|||
94462183|NCT03634033|323483049|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
94462184|NCT03634033|323483050|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
94462185|NCT03634033|323483051|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
94462186|NCT03634033|323483052|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
94642637|NCT00283439|324154906|FG000|Overall Study|Treatment discontinued|0|||
94642638|NCT00283439|324154907|FG001|Overall Study|Treatment discontinued|2|||
94642639|NCT00283439|324154908|FG002|Overall Study|Treatment discontinued|1|||
94678818|NCT03145766|324278879|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
94678819|NCT03145766|324278880|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
94263262|NCT01338415|322758154|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
94263263|NCT01338415|322758155|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
94263264|NCT01338415|322758156|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
94642640|NCT00283439|324154909|FG003|Overall Study|Treatment discontinued|3|||
94642641|NCT00283439|324154906|FG000|Overall Study|Other|1|||
94642642|NCT00283439|324154907|FG001|Overall Study|Other|0|||
94642643|NCT00283439|324154908|FG002|Overall Study|Other|0|||
94642644|NCT00283439|324154909|FG003|Overall Study|Other|0|||
94678820|NCT03145766|324278881|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
94363408|NCT02086968|323114537|FG000|Overall Study|Withdrawal by Subject|1|||
94363409|NCT02086968|323114538|FG001|Overall Study|Withdrawal by Subject|4|||
94363410|NCT00537056|323114542|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
94363411|NCT01870921|323114543|FG000|Overall Study|Subject decision|80|||
94363412|NCT01870921|323114543|FG000|Overall Study|Severe non-compliance to protocol|7|||
94363413|NCT01870921|323114543|FG000|Overall Study|Subject Lost to Follow up|2|||
94363414|NCT01870921|323114543|FG000|Overall Study|Other|1|||
94363415|NCT00203892|323114548|FG000|Overall Study|Physician Decision|1|||
94363416|NCT00203892|323114549|FG001|Overall Study|Physician Decision|2|||
94363417|NCT00203892|323114550|FG002|Overall Study|Physician Decision|0|||
94363418|NCT00203892|323114548|FG000|Overall Study|Death|1|||
94363419|NCT00203892|323114549|FG001|Overall Study|Death|0|||
94678821|NCT03145766|324278877|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
94678822|NCT03145766|324278878|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
94678823|NCT03145766|324278879|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
94678824|NCT03145766|324278880|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
94678825|NCT03145766|324278881|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
94678826|NCT01226511|324278882|FG000|Acute Treatment Period|Adverse Event|7|||
94678827|NCT01226511|324278883|FG001|Acute Treatment Period|Adverse Event|6|||
94678828|NCT01226511|324278882|FG000|Acute Treatment Period|Lack of Efficacy|2|||
94678829|NCT01226511|324278883|FG001|Acute Treatment Period|Lack of Efficacy|1|||
94678830|NCT01226511|324278882|FG000|Acute Treatment Period|Lost to Follow-up|3|||
94678831|NCT01226511|324278883|FG001|Acute Treatment Period|Lost to Follow-up|6|||
94678832|NCT01226511|324278882|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
94678833|NCT01226511|324278883|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
94678834|NCT01226511|324278882|FG000|Acute Treatment Period|Protocol Violation|5|||
94678835|NCT01226511|324278883|FG001|Acute Treatment Period|Protocol Violation|5|||
94678836|NCT01226511|324278882|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
94678837|NCT01226511|324278883|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
94678838|NCT01226511|324278882|FG000|Extension Treatment Period|Adverse Event|8|||
94678839|NCT01226511|324278883|FG001|Extension Treatment Period|Adverse Event|8|||
94678840|NCT01226511|324278882|FG000|Extension Treatment Period|Lack of Efficacy|3|||
94678841|NCT01226511|324278883|FG001|Extension Treatment Period|Lack of Efficacy|2|||
94678842|NCT01226511|324278882|FG000|Extension Treatment Period|Lost to Follow-up|4|||
94363420|NCT00203892|323114550|FG002|Overall Study|Death|0|||
94363421|NCT00742859|323114558|FG000|Overall Study|Adverse Event|5|||
94363422|NCT00742859|323114559|FG001|Overall Study|Adverse Event|6|||
94363423|NCT00742859|323114560|FG002|Overall Study|Adverse Event|3|||
94363424|NCT00742859|323114561|FG003|Overall Study|Adverse Event|1|||
94363425|NCT00742859|323114558|FG000|Overall Study|Death|1|||
94363426|NCT00742859|323114559|FG001|Overall Study|Death|0|||
94363427|NCT00742859|323114560|FG002|Overall Study|Death|0|||
94363428|NCT00742859|323114561|FG003|Overall Study|Death|1|||
94363429|NCT00742859|323114558|FG000|Overall Study|Physician Decision|1|||
94363430|NCT00742859|323114559|FG001|Overall Study|Physician Decision|2|||
94363431|NCT00742859|323114560|FG002|Overall Study|Physician Decision|0|||
94363432|NCT00742859|323114561|FG003|Overall Study|Physician Decision|0|||
94363433|NCT00742859|323114558|FG000|Overall Study|Withdrawal by Subject|4|||
94363434|NCT00742859|323114559|FG001|Overall Study|Withdrawal by Subject|2|||
94363435|NCT00742859|323114560|FG002|Overall Study|Withdrawal by Subject|4|||
94363436|NCT00742859|323114561|FG003|Overall Study|Withdrawal by Subject|1|||
94363437|NCT00742859|323114558|FG000|Overall Study|Endpoint|0|||
94363438|NCT00742859|323114559|FG001|Overall Study|Endpoint|1|||
94363439|NCT00742859|323114560|FG002|Overall Study|Endpoint|1|||
94363440|NCT00742859|323114561|FG003|Overall Study|Endpoint|2|||
94363441|NCT00742859|323114558|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
94363442|NCT00742859|323114559|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
94363443|NCT00742859|323114560|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
94363444|NCT00742859|323114561|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
94678843|NCT01226511|324278883|FG001|Extension Treatment Period|Lost to Follow-up|3|||
94363445|NCT00742859|323114558|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
94363446|NCT00742859|323114559|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
94363447|NCT00742859|323114560|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
94363448|NCT00742859|323114561|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
94462187|NCT03634033|323483053|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
94462188|NCT03634033|323483054|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
94462189|NCT03634033|323483055|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
94462190|NCT03634033|323483049|FG000|Overall Study|Lost to Follow-up|0|||
94462191|NCT03634033|323483050|FG001|Overall Study|Lost to Follow-up|0|||
94462192|NCT03634033|323483051|FG002|Overall Study|Lost to Follow-up|0|||
94462193|NCT03634033|323483052|FG003|Overall Study|Lost to Follow-up|0|||
94462194|NCT03634033|323483053|FG004|Overall Study|Lost to Follow-up|0|||
94462195|NCT03634033|323483054|FG005|Overall Study|Lost to Follow-up|1|||
94462196|NCT03634033|323483055|FG006|Overall Study|Lost to Follow-up|2|||
94462197|NCT03634033|323483049|FG000|Overall Study|Withdrawal by Subject|0|||
94642645|NCT02884089|324154912|FG000|Period 1|Dosing error|2|||
94642646|NCT02884089|324154913|FG001|Period 1|Dosing error|2|||
94642647|NCT02884089|324154914|FG002|Period 1|Dosing error|0|||
94642648|NCT02884089|324154915|FG003|Period 1|Dosing error|0|||
94642649|NCT02884089|324154912|FG000|Washout Period 1|Lost to Follow-up|0|||
94642650|NCT02884089|324154913|FG001|Washout Period 1|Lost to Follow-up|1|||
94642651|NCT02884089|324154914|FG002|Washout Period 1|Lost to Follow-up|0|||
94642652|NCT02884089|324154915|FG003|Washout Period 1|Lost to Follow-up|1|||
94642653|NCT02884089|324154912|FG000|Washout Period 1|Withdrawal by Subject|0|||
94642654|NCT02884089|324154913|FG001|Washout Period 1|Withdrawal by Subject|1|||
94642655|NCT02884089|324154914|FG002|Washout Period 1|Withdrawal by Subject|0|||
94642656|NCT02884089|324154915|FG003|Washout Period 1|Withdrawal by Subject|0|||
94642657|NCT02884089|324154912|FG000|Period 2|Adverse Event|1|||
94642658|NCT02884089|324154913|FG001|Period 2|Adverse Event|0|||
94642659|NCT02884089|324154914|FG002|Period 2|Adverse Event|0|||
94642660|NCT02884089|324154915|FG003|Period 2|Adverse Event|0|||
94642661|NCT02884089|324154912|FG000|Period 3|Withdrawal by Subject|0|||
94642662|NCT02884089|324154913|FG001|Period 3|Withdrawal by Subject|0|||
94642663|NCT02884089|324154914|FG002|Period 3|Withdrawal by Subject|1|||
94642664|NCT02884089|324154915|FG003|Period 3|Withdrawal by Subject|0|||
94642665|NCT02884089|324154912|FG000|Washout Period 3|Withdrawal by Subject|0|||
94642666|NCT02884089|324154913|FG001|Washout Period 3|Withdrawal by Subject|0|||
94642667|NCT02884089|324154914|FG002|Washout Period 3|Withdrawal by Subject|1|||
94642668|NCT02884089|324154915|FG003|Washout Period 3|Withdrawal by Subject|0|||
94642669|NCT02884089|324154912|FG000|Washout Period 3|Lost to Follow-up|0|||
94642670|NCT02884089|324154913|FG001|Washout Period 3|Lost to Follow-up|0|||
94642671|NCT02884089|324154914|FG002|Washout Period 3|Lost to Follow-up|0|||
94642672|NCT02884089|324154915|FG003|Washout Period 3|Lost to Follow-up|1|||
94642673|NCT02884089|324154912|FG000|Period 4|Withdrawal by Subject|0|||
94642674|NCT02884089|324154913|FG001|Period 4|Withdrawal by Subject|1|||
94642675|NCT02884089|324154914|FG002|Period 4|Withdrawal by Subject|0|||
94642676|NCT02884089|324154915|FG003|Period 4|Withdrawal by Subject|0|||
94642677|NCT02884089|324154912|FG000|Period 4|Lost to Follow-up|1|||
94642678|NCT02884089|324154913|FG001|Period 4|Lost to Follow-up|0|||
94642679|NCT02884089|324154914|FG002|Period 4|Lost to Follow-up|0|||
94642680|NCT02884089|324154915|FG003|Period 4|Lost to Follow-up|0|||
94642681|NCT02884089|324154912|FG000|Follow-up Visit|Withdrawal by Subject|1|||
94462198|NCT03634033|323483050|FG001|Overall Study|Withdrawal by Subject|0|||
94462199|NCT03634033|323483051|FG002|Overall Study|Withdrawal by Subject|0|||
94462200|NCT03634033|323483052|FG003|Overall Study|Withdrawal by Subject|0|||
94462201|NCT03634033|323483053|FG004|Overall Study|Withdrawal by Subject|0|||
94462202|NCT03634033|323483054|FG005|Overall Study|Withdrawal by Subject|0|||
94462203|NCT03634033|323483055|FG006|Overall Study|Withdrawal by Subject|1|||
94462204|NCT03197467|323483056|FG000|Overall Study|Withdrawal by Subject|1|||
94462205|NCT02276053|323483057|FG000|Overall Study|Death|2|||
94462206|NCT02276053|323483057|FG000|Overall Study|Adverse Event|5|||
94462207|NCT02276053|323483057|FG000|Overall Study|Lack of Efficacy|2|||
94462208|NCT02276053|323483057|FG000|Overall Study|Withdrawal by Subject|1|||
94462209|NCT02276053|323483057|FG000|Overall Study|Patient does not meet selection criteria|3|||
94462210|NCT02276053|323483057|FG000|Overall Study|Patient needs to increase baseline AED|1|||
94462211|NCT01632904|323483058|FG000|Overall Study|Adverse Event|4|||
94462212|NCT01632904|323483059|FG001|Overall Study|Adverse Event|1|||
94462213|NCT01632904|323483058|FG000|Overall Study|Physician Decision|0|||
94462214|NCT01632904|323483059|FG001|Overall Study|Physician Decision|1|||
94462215|NCT01632904|323483058|FG000|Overall Study|Subject decision|3|||
94462216|NCT01632904|323483059|FG001|Overall Study|Subject decision|2|||
94462217|NCT01632904|323483058|FG000|Overall Study|Disease Progression|0|||
94462218|NCT01632904|323483059|FG001|Overall Study|Disease Progression|1|||
94678844|NCT01226511|324278882|FG000|Extension Treatment Period|Protocol Violation|2|||
94678845|NCT01226511|324278883|FG001|Extension Treatment Period|Protocol Violation|2|||
94678846|NCT01226511|324278882|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
94678847|NCT01226511|324278883|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
94678848|NCT01226511|324278882|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
94678849|NCT01226511|324278883|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
94678850|NCT01226511|324278882|FG000|Extension Treatment Period|Sponsor Decision|1|||
94678851|NCT01226511|324278883|FG001|Extension Treatment Period|Sponsor Decision|1|||
94678852|NCT01226511|324278882|FG000|Taper Period|Adverse Event|1|||
94678853|NCT01226511|324278883|FG001|Taper Period|Adverse Event|0|||
94678854|NCT01226511|324278882|FG000|Taper Period|Lost to Follow-up|2|||
94678855|NCT01226511|324278883|FG001|Taper Period|Lost to Follow-up|2|||
94678856|NCT01226511|324278882|FG000|Taper Period|Protocol Violation|1|||
94678857|NCT01226511|324278883|FG001|Taper Period|Protocol Violation|0|||
94678858|NCT01226511|324278882|FG000|Taper Period|Parent/Caregiver Decision|1|||
94678859|NCT01226511|324278883|FG001|Taper Period|Parent/Caregiver Decision|1|||
94678860|NCT01966003|324278884|FG000|Overall Study|Death|43|||
94678861|NCT01966003|324278885|FG001|Overall Study|Death|36|||
94678862|NCT01966003|324278884|FG000|Overall Study|Protocol Violation|6|||
94678863|NCT01966003|324278885|FG001|Overall Study|Protocol Violation|4|||
94678864|NCT01966003|324278884|FG000|Overall Study|Lost to Follow-up|4|||
94678865|NCT01966003|324278885|FG001|Overall Study|Lost to Follow-up|3|||
94678866|NCT01966003|324278884|FG000|Overall Study|Physician Decision|12|||
94678867|NCT01966003|324278885|FG001|Overall Study|Physician Decision|13|||
94678868|NCT01966003|324278884|FG000|Overall Study|Withdrawal by Subject|29|||
94678869|NCT01966003|324278885|FG001|Overall Study|Withdrawal by Subject|19|||
94678870|NCT01966003|324278884|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
94678871|NCT01966003|324278885|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
94678872|NCT01966003|324278884|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
94363449|NCT00742859|323114558|FG000|Overall Study|Sponsor request patient out of town|0|||
94363450|NCT00742859|323114559|FG001|Overall Study|Sponsor request patient out of town|0|||
94363451|NCT00742859|323114560|FG002|Overall Study|Sponsor request patient out of town|1|||
94363452|NCT00742859|323114561|FG003|Overall Study|Sponsor request patient out of town|1|||
94363453|NCT00742859|323114558|FG000|Overall Study|Site error|0|||
94363454|NCT00742859|323114559|FG001|Overall Study|Site error|0|||
94363455|NCT00742859|323114560|FG002|Overall Study|Site error|1|||
94363456|NCT00742859|323114561|FG003|Overall Study|Site error|1|||
94363457|NCT03128931|323114563|FG000|Overall Study|Physician Decision|1|||
94363458|NCT03128931|323114563|FG000|Overall Study|Equipment Issues|3|||
94363459|NCT04993339|323114564|FG000|Overall Study|Lost to Follow-up|0|||
94363460|NCT04993339|323114565|FG001|Overall Study|Lost to Follow-up|1|||
94363461|NCT04993339|323114564|FG000|Overall Study|no MRI scan|3|||
94363462|NCT04993339|323114565|FG001|Overall Study|no MRI scan|1|||
94363463|NCT02149199|323114568|FG000|Overall Study|Study specific withdrawal criteria|4|||
94363464|NCT02149199|323114569|FG001|Overall Study|Study specific withdrawal criteria|21|||
94363465|NCT02149199|323114570|FG002|Overall Study|Study specific withdrawal criteria|6|||
94363466|NCT02149199|323114568|FG000|Overall Study|Other|20|||
94363467|NCT02149199|323114569|FG001|Overall Study|Other|25|||
94363468|NCT02149199|323114570|FG002|Overall Study|Other|20|||
94363469|NCT02149199|323114568|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
94363470|NCT02149199|323114569|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
94363471|NCT02149199|323114570|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
94363472|NCT02149199|323114568|FG000|Overall Study|Withdrawal by Subject|75|||
94363473|NCT02149199|323114569|FG001|Overall Study|Withdrawal by Subject|93|||
94363474|NCT02149199|323114570|FG002|Overall Study|Withdrawal by Subject|77|||
94363475|NCT02149199|323114568|FG000|Overall Study|Protocol Violation|16|||
94363476|NCT02149199|323114569|FG001|Overall Study|Protocol Violation|13|||
94363477|NCT02149199|323114570|FG002|Overall Study|Protocol Violation|15|||
94363478|NCT02149199|323114568|FG000|Overall Study|Lost to Follow-up|3|||
94462219|NCT01632904|323483058|FG000|Overall Study|Reason for discontinuation not available|0|||
94462220|NCT01632904|323483059|FG001|Overall Study|Reason for discontinuation not available|1|||
94462221|NCT01004406|323483062|FG000|Overall Study|Withdrawal by Subject|2|||
94462222|NCT01004406|323483063|FG001|Overall Study|Withdrawal by Subject|0|||
94462223|NCT01004406|323483062|FG000|Overall Study|Lost to Follow-up|1|||
94462224|NCT01004406|323483063|FG001|Overall Study|Lost to Follow-up|0|||
94462225|NCT02907593|323483064|FG000|Overall Study|Withdrawal by Subject|0|||
94462226|NCT02907593|323483065|FG001|Overall Study|Withdrawal by Subject|0|||
94462227|NCT02907593|323483066|FG002|Overall Study|Withdrawal by Subject|1|||
94462228|NCT02907593|323483067|FG003|Overall Study|Withdrawal by Subject|0|||
94462229|NCT04322539|323483071|FG000|Overall Study|Adverse Event|2|||
94462230|NCT04322539|323483072|FG001|Overall Study|Adverse Event|0|||
94462231|NCT04322539|323483071|FG000|Overall Study|Death|411|||
94462232|NCT04322539|323483072|FG001|Overall Study|Death|203|||
94462233|NCT04322539|323483071|FG000|Overall Study|Lost to Follow-up|3|||
94462234|NCT04322539|323483072|FG001|Overall Study|Lost to Follow-up|1|||
94462235|NCT04322539|323483071|FG000|Overall Study|Withdrawal of consent|14|||
94462236|NCT04322539|323483072|FG001|Overall Study|Withdrawal of consent|8|||
94462237|NCT04322539|323483071|FG000|Overall Study|Radiological Disease Progression|6|||
94462238|NCT04322539|323483072|FG001|Overall Study|Radiological Disease Progression|0|||
94462239|NCT04322539|323483071|FG000|Overall Study|Sponsor Decision|19|||
94462240|NCT04322539|323483072|FG001|Overall Study|Sponsor Decision|14|||
94462241|NCT04322539|323483071|FG000|Overall Study|Other|6|||
94462242|NCT04322539|323483072|FG001|Overall Study|Other|4|||
94462243|NCT02963558|323483077|FG000|Overall Study|Withdrawn by investigator|1|||
94462244|NCT02963558|323483078|FG001|Overall Study|Withdrawn by investigator|0|||
94462245|NCT02963558|323483077|FG000|Overall Study|Withdrawal by Subject|0|||
94462246|NCT02963558|323483078|FG001|Overall Study|Withdrawal by Subject|1|||
94462247|NCT03309696|323483079|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
94462248|NCT03309696|323483080|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
94462249|NCT03309696|323483081|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
94263265|NCT01338415|322758154|FG000|Core + Extension|Other (administrative reason)|1|||
94263266|NCT01338415|322758155|FG001|Core + Extension|Other (administrative reason)|0|||
94462250|NCT03309696|323483082|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
94462251|NCT03408444|323483083|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
94462252|NCT03408444|323483084|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
94263267|NCT01338415|322758156|FG002|Core + Extension|Other (administrative reason)|0|||
94462253|NCT03408444|323483085|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
94462254|NCT03408444|323483086|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
94462255|NCT03408444|323483083|FG000|Overall Study|Lens Discomfort|0|||
94462256|NCT03408444|323483084|FG001|Overall Study|Lens Discomfort|1|||
94462257|NCT03408444|323483085|FG002|Overall Study|Lens Discomfort|0|||
94263268|NCT01338415|322758154|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
94263269|NCT01338415|322758155|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
94263270|NCT01338415|322758156|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
94263271|NCT01338415|322758154|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
94263272|NCT01338415|322758155|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
94263273|NCT01338415|322758156|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
94263274|NCT01338415|322758154|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
94363479|NCT02149199|323114569|FG001|Overall Study|Lost to Follow-up|12|||
94462258|NCT03408444|323483086|FG003|Overall Study|Lens Discomfort|0|||
94462259|NCT03408444|323483083|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
94462260|NCT03408444|323483084|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
94462261|NCT03408444|323483085|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
94462262|NCT03408444|323483086|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
94462263|NCT03408444|323483083|FG000|Overall Study|Withdrawal by Subject|0|||
94462264|NCT03408444|323483084|FG001|Overall Study|Withdrawal by Subject|2|||
94363480|NCT02149199|323114570|FG002|Overall Study|Lost to Follow-up|11|||
94363481|NCT02149199|323114568|FG000|Overall Study|Death|0|||
94363482|NCT02149199|323114569|FG001|Overall Study|Death|0|||
94363483|NCT02149199|323114570|FG002|Overall Study|Death|1|||
94363484|NCT02149199|323114568|FG000|Overall Study|Adverse Event|6|||
94363485|NCT02149199|323114569|FG001|Overall Study|Adverse Event|15|||
94363486|NCT02149199|323114570|FG002|Overall Study|Adverse Event|9|||
94363487|NCT02949219|323114571|FG000|Overall Study|Withdrawal by Subject|1|||
94363488|NCT00909857|323114574|FG000|Overall Study|Withdrawal by Subject|6|||
94363489|NCT00909857|323114575|FG001|Overall Study|Withdrawal by Subject|10|||
94363490|NCT00909857|323114574|FG000|Overall Study|Adverse Event|5|||
94363491|NCT00909857|323114575|FG001|Overall Study|Adverse Event|5|||
94363492|NCT00909857|323114574|FG000|Overall Study|Lost to Follow-up|2|||
94363493|NCT00909857|323114575|FG001|Overall Study|Lost to Follow-up|5|||
94363494|NCT00909857|323114574|FG000|Overall Study|Protocol Violation|2|||
94363495|NCT00909857|323114575|FG001|Overall Study|Protocol Violation|1|||
94363496|NCT00909857|323114574|FG000|Overall Study|Pregnancy|1|||
94363497|NCT00909857|323114575|FG001|Overall Study|Pregnancy|0|||
94363498|NCT00909857|323114574|FG000|Overall Study|Other|1|||
94363499|NCT00909857|323114575|FG001|Overall Study|Other|0|||
94363500|NCT00909857|323114574|FG000|Overall Study|Did not receive study medication|19|||
94363501|NCT00909857|323114575|FG001|Overall Study|Did not receive study medication|24|||
94363502|NCT00604175|323114576|FG000|Entry Through Week 28|Death|2|||
94462265|NCT03408444|323483085|FG002|Overall Study|Withdrawal by Subject|3|||
94462266|NCT03408444|323483086|FG003|Overall Study|Withdrawal by Subject|0|||
94462267|NCT03408444|323483083|FG000|Overall Study|Lost to Follow-up|0|||
94462268|NCT03408444|323483084|FG001|Overall Study|Lost to Follow-up|0|||
94462269|NCT03408444|323483085|FG002|Overall Study|Lost to Follow-up|1|||
94462270|NCT03408444|323483086|FG003|Overall Study|Lost to Follow-up|0|||
94462271|NCT03408444|323483083|FG000|Overall Study|Adverse Event|0|||
94462272|NCT03408444|323483084|FG001|Overall Study|Adverse Event|0|||
94462273|NCT03408444|323483085|FG002|Overall Study|Adverse Event|0|||
94462274|NCT03408444|323483086|FG003|Overall Study|Adverse Event|1|||
94462275|NCT03408444|323483083|FG000|Overall Study|Lens Handling Difficulties|0|||
94462276|NCT03408444|323483084|FG001|Overall Study|Lens Handling Difficulties|0|||
94462277|NCT03408444|323483085|FG002|Overall Study|Lens Handling Difficulties|1|||
94462278|NCT03408444|323483086|FG003|Overall Study|Lens Handling Difficulties|0|||
94462279|NCT03408444|323483083|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
94462280|NCT03408444|323483084|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
94462281|NCT03408444|323483085|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
94462282|NCT03408444|323483086|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
94363503|NCT00604175|323114577|FG001|Entry Through Week 28|Death|0|||
94363504|NCT00604175|323114578|FG002|Entry Through Week 28|Death|0|||
94363505|NCT00604175|323114576|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
94363506|NCT00604175|323114577|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
94363507|NCT00604175|323114578|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
94462283|NCT04984681|323483087|FG000|Overall Study|Lost to Follow-up|3|||
94462284|NCT04984681|323483088|FG001|Overall Study|Lost to Follow-up|1|||
94462285|NCT01214252|323483089|FG000|Overall Study|Not eligible per protocol|82|||
94462286|NCT04327661|323483090|FG000|Overall Study|Withdrawal by Subject|1|||
94462287|NCT04327661|323483091|FG001|Overall Study|Withdrawal by Subject|0|||
94462288|NCT04327661|323483092|FG002|Overall Study|Withdrawal by Subject|0|||
94462289|NCT03332628|323483093|FG000|Overall Study|Physician Decision|2|||
94462290|NCT02956057|323483094|FG000|Overall Study|Discontinued intervention|14|||
94462291|NCT02956057|323483095|FG001|Overall Study|Discontinued intervention|10|||
94363508|NCT00604175|323114576|FG000|Entry Through Week 28|Lost to Follow-up|4|||
94363509|NCT00604175|323114577|FG001|Entry Through Week 28|Lost to Follow-up|3|||
94363510|NCT00604175|323114578|FG002|Entry Through Week 28|Lost to Follow-up|0|||
94263275|NCT01338415|322758155|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
94263276|NCT01338415|322758156|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
94263277|NCT01338415|322758154|FG000|Exceptional Use Treatment Period|Death|0|||
94263278|NCT01338415|322758155|FG001|Exceptional Use Treatment Period|Death|0|||
94263279|NCT01338415|322758156|FG002|Exceptional Use Treatment Period|Death|1|||
94263280|NCT00756470|322758161|FG000|Overall Study|Withdrawal by Subject|1|||
94263281|NCT00756470|322758161|FG000|Overall Study|Adverse Event|4|||
94263282|NCT01214187|322758162|FG000|Overall Study|Adverse Event|6|||
94263283|NCT01214187|322758163|FG001|Overall Study|Adverse Event|2|||
94263284|NCT01214187|322758162|FG000|Overall Study|Death|1|||
94263285|NCT01214187|322758163|FG001|Overall Study|Death|1|||
94263286|NCT01214187|322758162|FG000|Overall Study|Withdrawal by Subject|0|||
94263287|NCT01214187|322758163|FG001|Overall Study|Withdrawal by Subject|3|||
94263288|NCT03118674|322758164|FG000|Overall Study|Lost to Follow-up|2|||
94263289|NCT03118674|322758164|FG000|Overall Study|Screen Faliure|8|||
94263290|NCT03118674|322758164|FG000|Overall Study|Withdrawal by Subject|5|||
94263291|NCT03153137|322758165|FG000|Overall Study|Lost to Follow-up|1|||
94263292|NCT03153137|322758166|FG001|Overall Study|Lost to Follow-up|0|||
94263293|NCT03153137|322758165|FG000|Overall Study|Withdrawal by Subject|2|||
94263294|NCT03153137|322758166|FG001|Overall Study|Withdrawal by Subject|1|||
94263295|NCT03153137|322758165|FG000|Overall Study|Physician Decision|0|||
94263296|NCT03153137|322758166|FG001|Overall Study|Physician Decision|3|||
94263297|NCT00631189|322758168|FG000|Initial Phase|Protocol Violation|347|||
94263298|NCT00631189|322758169|FG001|Initial Phase|Protocol Violation|0|||
94263299|NCT00631189|322758170|FG002|Initial Phase|Protocol Violation|0|||
94263300|NCT00631189|322758171|FG003|Initial Phase|Protocol Violation|0|||
94263301|NCT00631189|322758168|FG000|Initial Phase|Withdrawal by Subject|4|||
94263302|NCT00631189|322758169|FG001|Initial Phase|Withdrawal by Subject|0|||
94263303|NCT00631189|322758170|FG002|Initial Phase|Withdrawal by Subject|0|||
94263304|NCT00631189|322758171|FG003|Initial Phase|Withdrawal by Subject|0|||
94263305|NCT00631189|322758168|FG000|Treatment Phase|Withdrawal by Subject|0|||
94263306|NCT00631189|322758169|FG001|Treatment Phase|Withdrawal by Subject|2|||
94263307|NCT00631189|322758170|FG002|Treatment Phase|Withdrawal by Subject|1|||
94263308|NCT00631189|322758171|FG003|Treatment Phase|Withdrawal by Subject|1|||
94263309|NCT00631189|322758168|FG000|Treatment Phase|Protocol Violation|0|||
94263310|NCT00631189|322758169|FG001|Treatment Phase|Protocol Violation|1|||
94263311|NCT00631189|322758170|FG002|Treatment Phase|Protocol Violation|6|||
94263312|NCT00631189|322758171|FG003|Treatment Phase|Protocol Violation|2|||
94263313|NCT00631189|322758168|FG000|Treatment Phase|Adverse Event|0|||
94263314|NCT00631189|322758169|FG001|Treatment Phase|Adverse Event|3|||
94263315|NCT00631189|322758170|FG002|Treatment Phase|Adverse Event|2|||
94263316|NCT00631189|322758171|FG003|Treatment Phase|Adverse Event|4|||
94263317|NCT00631189|322758168|FG000|Treatment Phase|Lost to Follow-up|0|||
94263318|NCT00631189|322758169|FG001|Treatment Phase|Lost to Follow-up|1|||
94263319|NCT00631189|322758170|FG002|Treatment Phase|Lost to Follow-up|0|||
94263320|NCT00631189|322758171|FG003|Treatment Phase|Lost to Follow-up|0|||
94263321|NCT00631189|322758168|FG000|Treatment Phase|Pregnancy|0|||
94263322|NCT00631189|322758169|FG001|Treatment Phase|Pregnancy|0|||
94263323|NCT00631189|322758170|FG002|Treatment Phase|Pregnancy|1|||
94263324|NCT00631189|322758171|FG003|Treatment Phase|Pregnancy|0|||
94263325|NCT00631189|322758168|FG000|Treatment Phase|patient did not take pravastatin|0|||
94263326|NCT00631189|322758169|FG001|Treatment Phase|patient did not take pravastatin|0|||
94363511|NCT00604175|323114576|FG000|Entry Through Week 28|Ineligible|1|||
94363512|NCT00604175|323114577|FG001|Entry Through Week 28|Ineligible|0|||
94363513|NCT00604175|323114578|FG002|Entry Through Week 28|Ineligible|0|||
94363514|NCT00604175|323114576|FG000|Entry Through Week 28|Did not start intervention|2|||
94363515|NCT00604175|323114577|FG001|Entry Through Week 28|Did not start intervention|0|||
94363516|NCT00604175|323114578|FG002|Entry Through Week 28|Did not start intervention|1|||
94363517|NCT00604175|323114576|FG000|Week 29 Through Week 72|Death|0|||
94363518|NCT00604175|323114577|FG001|Week 29 Through Week 72|Death|0|||
94363519|NCT00604175|323114578|FG002|Week 29 Through Week 72|Death|1|||
94363520|NCT00604175|323114576|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
94363521|NCT00604175|323114577|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
94363522|NCT00604175|323114578|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
94363523|NCT00604175|323114576|FG000|Week 29 Through Week 72|Site closure|0|||
94263327|NCT00631189|322758170|FG002|Treatment Phase|patient did not take pravastatin|1|||
94263328|NCT00631189|322758171|FG003|Treatment Phase|patient did not take pravastatin|0|||
94363524|NCT00604175|323114577|FG001|Week 29 Through Week 72|Site closure|1|||
94363525|NCT00604175|323114578|FG002|Week 29 Through Week 72|Site closure|0|||
94363526|NCT00604175|323114576|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
94363527|NCT00604175|323114577|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
94263329|NCT00146757|322758184|FG000|Overall Study|Death|1|||
94363528|NCT00604175|323114578|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
94263330|NCT00146757|322758185|FG001|Overall Study|Death|0|||
94263331|NCT00146757|322758184|FG000|Overall Study|Adverse Event|1|||
94263332|NCT00146757|322758185|FG001|Overall Study|Adverse Event|0|||
94263333|NCT05395104|322758186|FG000|Overall Study|Met Liver Stopping Criteria|1|||
94363529|NCT01640964|323114582|FG000|Overall Study|Lost to Follow-up|0|||
94363530|NCT01640964|323114583|FG001|Overall Study|Lost to Follow-up|0|||
94363531|NCT01640964|323114584|FG002|Overall Study|Lost to Follow-up|1|||
94363532|NCT01640964|323114582|FG000|Overall Study|Protocol Deviation|1|||
94363533|NCT01640964|323114583|FG001|Overall Study|Protocol Deviation|1|||
94363534|NCT01640964|323114584|FG002|Overall Study|Protocol Deviation|2|||
94363535|NCT02787746|323114585|FG000|Overall Study|Adverse Event|42|||
94363536|NCT02787746|323114585|FG000|Overall Study|Withdrawal by Subject|65|||
94363537|NCT02787746|323114585|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
94363538|NCT03533608|323116639|FG000|Overall Study|Withdrawal by Subject|3|||
94363539|NCT03533608|323116639|FG000|Overall Study|Physician Decision|2|||
94363540|NCT01856686|323116640|FG000|Overall Study|Lost to Follow-up|5|||
94363541|NCT01856686|323116641|FG001|Overall Study|Lost to Follow-up|11|||
94363542|NCT00602979|323116643|FG000|Overall Study|Lost to Follow-up|3|||
94363543|NCT00602979|323116644|FG001|Overall Study|Lost to Follow-up|2|||
94363544|NCT00602979|323116645|FG002|Overall Study|Lost to Follow-up|3|||
94363545|NCT00602979|323116646|FG003|Overall Study|Lost to Follow-up|2|||
94363546|NCT00602979|323116647|FG004|Overall Study|Lost to Follow-up|3|||
94363547|NCT00602979|323116643|FG000|Overall Study|Failed Intubation|0|||
94462292|NCT02956057|323483096|FG002|Overall Study|Discontinued intervention|7|||
94462293|NCT02956057|323483097|FG003|Overall Study|Discontinued intervention|14|||
94462294|NCT02956057|323483098|FG004|Overall Study|Discontinued intervention|4|||
94462295|NCT02956057|323483099|FG005|Overall Study|Discontinued intervention|17|||
94462296|NCT02956057|323483094|FG000|Overall Study|Lost to Follow-up|0|||
94462297|NCT02956057|323483095|FG001|Overall Study|Lost to Follow-up|2|||
94462298|NCT02956057|323483096|FG002|Overall Study|Lost to Follow-up|1|||
94462299|NCT02956057|323483097|FG003|Overall Study|Lost to Follow-up|1|||
94462300|NCT02956057|323483098|FG004|Overall Study|Lost to Follow-up|1|||
94462301|NCT02956057|323483099|FG005|Overall Study|Lost to Follow-up|0|||
94462302|NCT02505334|323483100|FG000|Main Treatment Period|Adverse Event|3|||
94462303|NCT02505334|323483101|FG001|Main Treatment Period|Adverse Event|3|||
94462304|NCT02505334|323483100|FG000|Main Treatment Period|Lack of Efficacy|7|||
94462305|NCT02505334|323483101|FG001|Main Treatment Period|Lack of Efficacy|17|||
94462306|NCT02505334|323483100|FG000|Main Treatment Period|Protocol Violation|0|||
94462307|NCT02505334|323483101|FG001|Main Treatment Period|Protocol Violation|1|||
94462308|NCT02505334|323483100|FG000|Main Treatment Period|Withdrawal by Subject|1|||
94462309|NCT02505334|323483101|FG001|Main Treatment Period|Withdrawal by Subject|8|||
94462310|NCT02505334|323483100|FG000|Main Treatment Period|Unclassified|4|||
94462311|NCT02505334|323483101|FG001|Main Treatment Period|Unclassified|10|||
94462312|NCT02505334|323483100|FG000|Extension Treatment Period|Adverse Event|5|||
94462313|NCT02505334|323483101|FG001|Extension Treatment Period|Adverse Event|0|||
94462314|NCT02505334|323483100|FG000|Extension Treatment Period|Lack of Efficacy|4|||
94462315|NCT02505334|323483101|FG001|Extension Treatment Period|Lack of Efficacy|0|||
94462316|NCT02505334|323483100|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
94678873|NCT01966003|324278885|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
94363548|NCT00602979|323116644|FG001|Overall Study|Failed Intubation|1|||
94363549|NCT00602979|323116645|FG002|Overall Study|Failed Intubation|0|||
94678874|NCT01966003|324278884|FG000|Overall Study|Other|1|||
94363550|NCT00602979|323116646|FG003|Overall Study|Failed Intubation|1|||
94462317|NCT02505334|323483101|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
94462318|NCT02505334|323483100|FG000|Extension Treatment Period|Unclassified|3|||
94462319|NCT02505334|323483101|FG001|Extension Treatment Period|Unclassified|0|||
94462320|NCT01549041|323483102|FG000|Overall Study|Lack of Efficacy|2|||
94462321|NCT01549041|323483103|FG001|Overall Study|Lack of Efficacy|4|||
94462322|NCT01549041|323483102|FG000|Overall Study|Adverse Event|0|||
94462323|NCT01549041|323483103|FG001|Overall Study|Adverse Event|4|||
94462324|NCT02939716|323483107|FG000|Overall Study|scanner failure|0|||
94462325|NCT02939716|323483108|FG001|Overall Study|scanner failure|0|||
94462326|NCT02939716|323483109|FG002|Overall Study|scanner failure|0|||
94462327|NCT02939716|323483110|FG003|Overall Study|scanner failure|1|||
94462328|NCT02939716|323483111|FG004|Overall Study|scanner failure|1|||
94462329|NCT02939716|323483112|FG005|Overall Study|scanner failure|1|||
94462330|NCT02543892|323483115|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
94462331|NCT02543892|323483116|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
94462332|NCT02543892|323483117|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
94462333|NCT02543892|323483118|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
94462334|NCT02543892|323483119|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
94462335|NCT02543892|323483120|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
94462336|NCT02543892|323483121|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
94462337|NCT02543892|323483122|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
94462338|NCT02543892|323483115|FG000|Received Vaccination 2|Physician Decision|0|||
94462339|NCT02543892|323483116|FG001|Received Vaccination 2|Physician Decision|0|||
94462340|NCT02543892|323483117|FG002|Received Vaccination 2|Physician Decision|0|||
94462341|NCT02543892|323483118|FG003|Received Vaccination 2|Physician Decision|0|||
94462342|NCT02543892|323483119|FG004|Received Vaccination 2|Physician Decision|0|||
94462343|NCT02543892|323483120|FG005|Received Vaccination 2|Physician Decision|1|||
94462344|NCT02543892|323483121|FG006|Received Vaccination 2|Physician Decision|0|||
94462345|NCT02543892|323483122|FG007|Received Vaccination 2|Physician Decision|0|||
94462346|NCT02543892|323483115|FG000|Received Vaccination 2|Adverse Event|0|||
94462347|NCT02543892|323483116|FG001|Received Vaccination 2|Adverse Event|1|||
94462348|NCT02543892|323483117|FG002|Received Vaccination 2|Adverse Event|0|||
94462349|NCT02543892|323483118|FG003|Received Vaccination 2|Adverse Event|0|||
94642682|NCT02884089|324154913|FG001|Follow-up Visit|Withdrawal by Subject|0|||
94462350|NCT02543892|323483119|FG004|Received Vaccination 2|Adverse Event|0|||
94462351|NCT02543892|323483120|FG005|Received Vaccination 2|Adverse Event|0|||
94462352|NCT02543892|323483121|FG006|Received Vaccination 2|Adverse Event|0|||
94462353|NCT02543892|323483122|FG007|Received Vaccination 2|Adverse Event|0|||
94462354|NCT02543892|323483115|FG000|Had Immunology Data|Withdrawal by Subject|0|||
94462355|NCT02543892|323483116|FG001|Had Immunology Data|Withdrawal by Subject|0|||
94462356|NCT02543892|323483117|FG002|Had Immunology Data|Withdrawal by Subject|0|||
94462357|NCT02543892|323483118|FG003|Had Immunology Data|Withdrawal by Subject|0|||
94462358|NCT02543892|323483119|FG004|Had Immunology Data|Withdrawal by Subject|0|||
94462359|NCT02543892|323483120|FG005|Had Immunology Data|Withdrawal by Subject|0|||
94462360|NCT02543892|323483121|FG006|Had Immunology Data|Withdrawal by Subject|1|||
94462361|NCT02543892|323483122|FG007|Had Immunology Data|Withdrawal by Subject|0|||
94462362|NCT04240457|323483123|FG000|Overall Study|Lost to Follow-up|5|||
94462363|NCT04240457|323483124|FG001|Overall Study|Lost to Follow-up|1|||
94462364|NCT01500213|323483125|FG000|Overall Study|Adverse Event|35|||
94462365|NCT01500213|323483126|FG001|Overall Study|Adverse Event|35|||
94462366|NCT01500213|323483125|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
94462367|NCT01500213|323483126|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
94462368|NCT01500213|323483125|FG000|Overall Study|Withdrawal by Subject|28|||
94263334|NCT05395104|322758186|FG000|Overall Study|Withdrawal by Subject|1|||
94263335|NCT00024167|322758188|FG000|Overall Study|Death|53|||
94263336|NCT00024167|322758189|FG001|Overall Study|Death|47|||
94462369|NCT01500213|323483126|FG001|Overall Study|Withdrawal by Subject|37|||
94462370|NCT01500213|323483125|FG000|Overall Study|Death|7|||
94462371|NCT01500213|323483126|FG001|Overall Study|Death|3|||
94462372|NCT01500213|323483125|FG000|Overall Study|Disease Progression|13|||
94462373|NCT01500213|323483126|FG001|Overall Study|Disease Progression|21|||
94462374|NCT01500213|323483125|FG000|Overall Study|Protocol Violation|19|||
94462375|NCT01500213|323483126|FG001|Overall Study|Protocol Violation|19|||
94462376|NCT01500213|323483125|FG000|Overall Study|Physician Decision|12|||
94462377|NCT01500213|323483126|FG001|Overall Study|Physician Decision|10|||
94462378|NCT01500213|323483125|FG000|Overall Study|Lack of Efficacy|9|||
94462379|NCT01500213|323483126|FG001|Overall Study|Lack of Efficacy|7|||
94462380|NCT01500213|323483125|FG000|Overall Study|Lost to Follow-up|3|||
94462381|NCT01500213|323483126|FG001|Overall Study|Lost to Follow-up|6|||
94462382|NCT01500213|323483125|FG000|Overall Study|Other Reasons|7|||
94462383|NCT01500213|323483126|FG001|Overall Study|Other Reasons|5|||
94462384|NCT02258542|323483127|FG000|Overall Study|eg. not made to the visit|7|||
94462385|NCT02258542|323483128|FG001|Overall Study|eg. not made to the visit|4|||
94462386|NCT02258542|323483129|FG002|Overall Study|eg. not made to the visit|0|||
94462387|NCT02258542|323483130|FG003|Overall Study|eg. not made to the visit|1|||
94462388|NCT02258542|323483127|FG000|Overall Study|study specific discount. criteria|1|||
94462389|NCT02258542|323483128|FG001|Overall Study|study specific discount. criteria|1|||
94462390|NCT02258542|323483129|FG002|Overall Study|study specific discount. criteria|0|||
94462391|NCT02258542|323483130|FG003|Overall Study|study specific discount. criteria|0|||
94462392|NCT02258542|323483127|FG000|Overall Study|Withdrawal by Subject|20|||
94462393|NCT02258542|323483128|FG001|Overall Study|Withdrawal by Subject|20|||
94462394|NCT02258542|323483129|FG002|Overall Study|Withdrawal by Subject|7|||
94462395|NCT02258542|323483130|FG003|Overall Study|Withdrawal by Subject|1|||
94462396|NCT02258542|323483127|FG000|Overall Study|Lost to Follow-up|5|||
94462397|NCT02258542|323483128|FG001|Overall Study|Lost to Follow-up|12|||
94462398|NCT02258542|323483129|FG002|Overall Study|Lost to Follow-up|1|||
94462399|NCT02258542|323483130|FG003|Overall Study|Lost to Follow-up|2|||
94462400|NCT02258542|323483127|FG000|Overall Study|Death|5|||
94462401|NCT02258542|323483128|FG001|Overall Study|Death|4|||
94462402|NCT02258542|323483129|FG002|Overall Study|Death|0|||
94263337|NCT02092350|322758190|FG000|Overall Study|Adverse Event|0|||
94263338|NCT02092350|322758191|FG001|Overall Study|Adverse Event|3|||
94263339|NCT02092350|322758190|FG000|Overall Study|Death|2|||
94462403|NCT02258542|323483130|FG003|Overall Study|Death|1|||
94462404|NCT02258542|323483127|FG000|Overall Study|Adverse Event|3|||
94462405|NCT02258542|323483128|FG001|Overall Study|Adverse Event|4|||
94263340|NCT02092350|322758191|FG001|Overall Study|Death|5|||
94462406|NCT02258542|323483129|FG002|Overall Study|Adverse Event|0|||
94462407|NCT02258542|323483130|FG003|Overall Study|Adverse Event|0|||
94462408|NCT02258542|323483127|FG000|Overall Study|Protocol Violation|1|||
94462409|NCT02258542|323483128|FG001|Overall Study|Protocol Violation|2|||
94462410|NCT02258542|323483129|FG002|Overall Study|Protocol Violation|0|||
94462411|NCT02258542|323483130|FG003|Overall Study|Protocol Violation|0|||
94462412|NCT02258542|323483127|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
94462413|NCT02258542|323483128|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
94462414|NCT02258542|323483129|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
94462415|NCT02258542|323483130|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
94462416|NCT00976209|323483131|FG000|Treatment Period 1|Protocol Violation|1|||
94462417|NCT00976209|323483132|FG001|Treatment Period 1|Protocol Violation|0|||
94462418|NCT00976209|323483131|FG000|Treatment Period 1|Lost to Follow-up|2|||
94462419|NCT00976209|323483132|FG001|Treatment Period 1|Lost to Follow-up|0|||
94462420|NCT00976209|323483131|FG000|Treatment Period 1|Other|0|||
94462421|NCT00976209|323483132|FG001|Treatment Period 1|Other|1|||
94462422|NCT00976209|323483131|FG000|Wash-out Period|Adverse Event|1|||
94462423|NCT00976209|323483132|FG001|Wash-out Period|Adverse Event|2|||
94462424|NCT00976209|323483131|FG000|Wash-out Period|Lost to Follow-up|1|||
94462425|NCT00976209|323483132|FG001|Wash-out Period|Lost to Follow-up|0|||
94462426|NCT00976209|323483131|FG000|Wash-out Period|Protocol Violation|1|||
94462427|NCT00976209|323483132|FG001|Wash-out Period|Protocol Violation|0|||
94462428|NCT00976209|323483131|FG000|Wash-out Period|Other|1|||
94462429|NCT00976209|323483132|FG001|Wash-out Period|Other|0|||
94462430|NCT00976209|323483131|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94462431|NCT00976209|323483132|FG001|Treatment Period 2|Withdrawal by Subject|1|||
94462432|NCT00976209|323483131|FG000|Treatment Period 2|Lost to Follow-up|0|||
94462433|NCT00976209|323483132|FG001|Treatment Period 2|Lost to Follow-up|1|||
94462434|NCT01259375|323483133|FG000|Overall Study|Adverse Event|1|||
94462435|NCT00986986|323483134|FG000|Overall Study|Lost to Follow-up|0|||
94462436|NCT00986986|323483135|FG001|Overall Study|Lost to Follow-up|1|||
94462437|NCT01618019|323483137|FG000|Overall Study|Withdrawal by Subject|14|||
94462438|NCT01618019|323483138|FG001|Overall Study|Withdrawal by Subject|14|||
94462439|NCT01542034|323483141|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
94462440|NCT01542034|323483142|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
94462441|NCT01542034|323483141|FG000|Overall Study|Administrative decision|0|||
94462442|NCT01542034|323483142|FG001|Overall Study|Administrative decision|3|||
94462443|NCT01542034|323483141|FG000|Overall Study|Subject Noncompliance|1|||
94462444|NCT01542034|323483142|FG001|Overall Study|Subject Noncompliance|0|||
94462445|NCT01542034|323483141|FG000|Overall Study|Adverse Event|2|||
94462446|NCT01542034|323483142|FG001|Overall Study|Adverse Event|2|||
94462447|NCT01542034|323483141|FG000|Overall Study|Lost to Follow-up|7|||
94462448|NCT01542034|323483142|FG001|Overall Study|Lost to Follow-up|6|||
94462449|NCT00478699|323483143|FG000|Overall Study|Inclusion Error|1|||
94462450|NCT00478699|323483144|FG001|Overall Study|Inclusion Error|7|||
94363551|NCT00602979|323116647|FG004|Overall Study|Failed Intubation|0|||
94363552|NCT01052038|323116648|FG000|Overall Study|Lost to Follow-up|2|||
94363553|NCT01052038|323116649|FG001|Overall Study|Lost to Follow-up|3|||
94462451|NCT00478699|323483143|FG000|Overall Study|Not receive study treatment|6|||
94462452|NCT00478699|323483144|FG001|Overall Study|Not receive study treatment|30|||
94462453|NCT01195844|323483147|FG000|Overall Study|Fecal sample not collected|40|||
94462454|NCT00581542|323483148|FG000|Overall Study|they met an exclusion criteria|2|||
94462455|NCT00581542|323483149|FG001|Overall Study|they met an exclusion criteria|2|||
94462456|NCT00581542|323483148|FG000|Overall Study|Lost to Follow-up|9|||
94462457|NCT00581542|323483149|FG001|Overall Study|Lost to Follow-up|21|||
94462458|NCT01123941|323483150|FG000|Overall Study|Lost to Follow-up|2|||
94462459|NCT01123941|323483151|FG001|Overall Study|Lost to Follow-up|1|||
94462460|NCT01537068|323483159|FG000|Overall Study|Lost to Follow-up|2|||
94462461|NCT01537068|323483160|FG001|Overall Study|Lost to Follow-up|1|||
94462462|NCT01537068|323483159|FG000|Overall Study|Adverse Event|0|||
94462463|NCT01537068|323483160|FG001|Overall Study|Adverse Event|1|||
94462464|NCT01537068|323483159|FG000|Overall Study|Withdrawal by Subject|1|||
94462465|NCT01537068|323483160|FG001|Overall Study|Withdrawal by Subject|1|||
94462466|NCT01537068|323483159|FG000|Overall Study|Lack of Efficacy|1|||
94462467|NCT01537068|323483160|FG001|Overall Study|Lack of Efficacy|0|||
94462468|NCT01068626|323483161|FG000|Overall Study|Adverse Event|3|||
94462469|NCT01068626|323483162|FG001|Overall Study|Adverse Event|0|||
94462470|NCT01068626|323483161|FG000|Overall Study|Withdrawal by Subject|0|||
94462471|NCT01068626|323483162|FG001|Overall Study|Withdrawal by Subject|2|||
94462472|NCT01797081|323483163|FG000|Overall Study|Adverse Event|1|||
94462473|NCT01797081|323483164|FG001|Overall Study|Adverse Event|0|||
94462474|NCT01797081|323483165|FG002|Overall Study|Adverse Event|1|||
94462475|NCT01797081|323483166|FG003|Overall Study|Adverse Event|0|||
94462476|NCT01797081|323483163|FG000|Overall Study|Pregnancy|1|||
94462477|NCT01797081|323483164|FG001|Overall Study|Pregnancy|0|||
94462478|NCT01797081|323483165|FG002|Overall Study|Pregnancy|0|||
94462479|NCT01797081|323483166|FG003|Overall Study|Pregnancy|0|||
94462480|NCT01797081|323483163|FG000|Overall Study|Personal Reasons|12|||
94462481|NCT01797081|323483164|FG001|Overall Study|Personal Reasons|4|||
94462482|NCT01797081|323483165|FG002|Overall Study|Personal Reasons|4|||
94462483|NCT01797081|323483166|FG003|Overall Study|Personal Reasons|8|||
94462484|NCT01797081|323483163|FG000|Overall Study|Protocol Violation|0|||
94462485|NCT01797081|323483164|FG001|Overall Study|Protocol Violation|0|||
94462486|NCT01797081|323483165|FG002|Overall Study|Protocol Violation|0|||
94462487|NCT01797081|323483166|FG003|Overall Study|Protocol Violation|1|||
94462488|NCT03434249|323483167|FG000|Overall Study|Adverse Event|1|||
94462489|NCT03434249|323483168|FG001|Overall Study|Adverse Event|0|||
94462490|NCT03434249|323483167|FG000|Overall Study|Lost to Follow-up|0|||
94462491|NCT03434249|323483168|FG001|Overall Study|Lost to Follow-up|1|||
94462492|NCT03434249|323483167|FG000|Overall Study|Non-compliance of family|2|||
94462493|NCT03434249|323483168|FG001|Overall Study|Non-compliance of family|1|||
94462494|NCT03434249|323483167|FG000|Overall Study|Difficulties in completing daily diary|2|||
94462495|NCT03434249|323483168|FG001|Overall Study|Difficulties in completing daily diary|1|||
94462496|NCT04272606|323483169|FG000|Overall Study|Protocol Violation|1|||
94462497|NCT04272606|323483170|FG001|Overall Study|Protocol Violation|1|||
94462498|NCT04272606|323483169|FG000|Overall Study|Physician Decision|0|||
94462499|NCT04272606|323483170|FG001|Overall Study|Physician Decision|1|||
94462500|NCT02450552|323483171|FG000|Overall Study|Withdrawal by Subject|4|||
94462501|NCT02450552|323483172|FG001|Overall Study|Withdrawal by Subject|0|||
94462502|NCT02450552|323483173|FG002|Overall Study|Withdrawal by Subject|4|||
94462503|NCT02450552|323483171|FG000|Overall Study|Physician Decision|1|||
94462504|NCT02450552|323483172|FG001|Overall Study|Physician Decision|0|||
94462505|NCT02450552|323483173|FG002|Overall Study|Physician Decision|1|||
94462506|NCT03430895|323483174|FG000|Overall Study|Not Treated|2|||
94462507|NCT02847182|323483179|FG000|Overall Study|Withdrawal by Subject|0|||
94462508|NCT02847182|323483180|FG001|Overall Study|Withdrawal by Subject|1|||
94462509|NCT02345889|323483183|FG000|Overall Study|Inadequate Bowel Prep|17|||
94462510|NCT02345889|323483184|FG001|Overall Study|Inadequate Bowel Prep|16|||
94462511|NCT02345889|323483185|FG002|Overall Study|Inadequate Bowel Prep|18|||
94462512|NCT02345889|323483186|FG003|Overall Study|Inadequate Bowel Prep|14|||
94462513|NCT02345889|323483183|FG000|Overall Study|Polyposis identified during procedure|1|||
94462514|NCT02345889|323483184|FG001|Overall Study|Polyposis identified during procedure|1|||
94462515|NCT02345889|323483185|FG002|Overall Study|Polyposis identified during procedure|0|||
94462516|NCT02345889|323483186|FG003|Overall Study|Polyposis identified during procedure|1|||
94462517|NCT02345889|323483183|FG000|Overall Study|Recognized ineligible post-randomization|1|||
94678875|NCT01966003|324278885|FG001|Overall Study|Other|1|||
94678876|NCT01337986|324278886|FG000|Overall Study|Adverse Event|2|||
94462518|NCT02345889|323483184|FG001|Overall Study|Recognized ineligible post-randomization|0|||
94462519|NCT02345889|323483185|FG002|Overall Study|Recognized ineligible post-randomization|2|||
94462520|NCT02345889|323483186|FG003|Overall Study|Recognized ineligible post-randomization|1|||
94462521|NCT02345889|323483183|FG000|Overall Study|Ulcerative Colitis identified|1|||
94462522|NCT02345889|323483184|FG001|Overall Study|Ulcerative Colitis identified|0|||
94462523|NCT02345889|323483185|FG002|Overall Study|Ulcerative Colitis identified|0|||
94462524|NCT02345889|323483186|FG003|Overall Study|Ulcerative Colitis identified|0|||
94462525|NCT02345889|323483183|FG000|Overall Study|Cecum not intubated|1|||
94462526|NCT02345889|323483184|FG001|Overall Study|Cecum not intubated|0|||
94462527|NCT02345889|323483185|FG002|Overall Study|Cecum not intubated|0|||
94462528|NCT02345889|323483186|FG003|Overall Study|Cecum not intubated|0|||
94462529|NCT01173055|323483187|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
94678877|NCT01337986|324278887|FG001|Overall Study|Adverse Event|2|||
94678878|NCT01337986|324278886|FG000|Overall Study|Lost to Follow-up|1|||
94678879|NCT01337986|324278887|FG001|Overall Study|Lost to Follow-up|0|||
94678880|NCT01337986|324278886|FG000|Overall Study|Protocol Violation|0|||
94678881|NCT01337986|324278887|FG001|Overall Study|Protocol Violation|3|||
94678882|NCT02309112|324278888|FG000|Overall Study|Withdrawal by Subject|1|||
94678883|NCT02309112|324278889|FG001|Overall Study|Withdrawal by Subject|0|||
94678884|NCT02309112|324278890|FG002|Overall Study|Withdrawal by Subject|1|||
94678885|NCT02309112|324278888|FG000|Overall Study|Lost to Follow-up|0|||
94678886|NCT02309112|324278889|FG001|Overall Study|Lost to Follow-up|1|||
94678887|NCT02309112|324278890|FG002|Overall Study|Lost to Follow-up|0|||
94678888|NCT02889133|324278895|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
94678889|NCT02889133|324278896|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
94678890|NCT02889133|324278895|FG000|Completed Primary Outcome|Manufacturing error|3|||
94678891|NCT02889133|324278896|FG001|Completed Primary Outcome|Manufacturing error|8|||
94678892|NCT02889133|324278895|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
94678893|NCT02889133|324278896|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
94678894|NCT02889133|324278895|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
94678895|NCT02889133|324278896|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
94678896|NCT02889133|324278895|FG000|Completed Primary Outcome|Protocol Violation|1|||
94678897|NCT02889133|324278896|FG001|Completed Primary Outcome|Protocol Violation|0|||
94678898|NCT02889133|324278895|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
94678899|NCT02889133|324278896|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
94678900|NCT02889133|324278895|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
94678901|NCT02889133|324278896|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
94678902|NCT02889133|324278895|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
94678903|NCT02889133|324278896|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
94678904|NCT02889133|324278895|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
94363554|NCT01052038|323116650|FG002|Overall Study|Lost to Follow-up|1|||
94363555|NCT01052038|323116648|FG000|Overall Study|Protocol Violation|2|||
94363556|NCT01052038|323116649|FG001|Overall Study|Protocol Violation|3|||
94363557|NCT01052038|323116650|FG002|Overall Study|Protocol Violation|3|||
94678905|NCT02889133|324278896|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
94678906|NCT02889133|324278895|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
94678907|NCT02889133|324278896|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
94678908|NCT04035200|324278897|FG000|Overall Study|Lost to Follow-up|0|||
94263341|NCT02092350|322758190|FG000|Overall Study|Lost to Follow-up|3|||
94263342|NCT02092350|322758191|FG001|Overall Study|Lost to Follow-up|1|||
94363558|NCT01268683|323116653|FG000|Overall Study|Lost to Follow-up|1|||
94363559|NCT01268683|323116653|FG000|Overall Study|Death|1|||
94363560|NCT05354206|323116654|FG000|Overall Study|Withdrawal by Subject|1|||
94363561|NCT05354206|323116655|FG001|Overall Study|Withdrawal by Subject|0|||
94363562|NCT04484805|323116657|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
94363563|NCT04484805|323116658|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
94678909|NCT04035200|324278898|FG001|Overall Study|Lost to Follow-up|1|||
94678910|NCT04035200|324278899|FG002|Overall Study|Lost to Follow-up|0|||
94678911|NCT04035200|324278897|FG000|Overall Study|Withdrawal by Subject|1|||
94263343|NCT02092350|322758190|FG000|Overall Study|Protocol Violation|1|||
94263344|NCT02092350|322758191|FG001|Overall Study|Protocol Violation|0|||
94263345|NCT02092350|322758190|FG000|Overall Study|Physician Decision|1|||
94263346|NCT02092350|322758191|FG001|Overall Study|Physician Decision|1|||
94263347|NCT02092350|322758190|FG000|Overall Study|Screen Failure|1|||
94263348|NCT02092350|322758191|FG001|Overall Study|Screen Failure|0|||
94263349|NCT02092350|322758190|FG000|Overall Study|Withdrawal by Subject|2|||
94263350|NCT02092350|322758191|FG001|Overall Study|Withdrawal by Subject|2|||
94263351|NCT00931944|322758192|FG000|Overall Study|Adverse Event|4|||
94263352|NCT00931944|322758192|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
94263353|NCT00931944|322758192|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
94263354|NCT00931944|322758192|FG000|Overall Study|Death|28|||
94263355|NCT00931944|322758192|FG000|Overall Study|Other|2|||
94263356|NCT00995007|322758193|FG000|Overall Study|Withdrew consent|1|||
94263357|NCT00995007|322758194|FG001|Overall Study|Withdrew consent|0|||
94263358|NCT00995007|322758193|FG000|Overall Study|Refused further treatment|8|||
94263359|NCT00995007|322758194|FG001|Overall Study|Refused further treatment|2|||
94263360|NCT00995007|322758193|FG000|Overall Study|Toxicity|8|||
94263361|NCT00995007|322758194|FG001|Overall Study|Toxicity|0|||
94263362|NCT02066051|322758196|FG000|Overall Study|Subject developed active GVHD|1|||
94263363|NCT00752622|322758197|FG000|Induction Phase|Adverse Event|3|||
94263364|NCT00752622|322758197|FG000|Induction Phase|Other|3|||
94263365|NCT00752622|322758197|FG000|Induction Phase|Non-responder|14|||
94678912|NCT04035200|324278898|FG001|Overall Study|Withdrawal by Subject|4|||
94263366|NCT00752622|322758197|FG000|Induction Phase|Withdrawal by Subject|1|||
94263367|NCT00752622|322758197|FG000|Induction Phase|Premature study termination|14|||
94263368|NCT00752622|322758197|FG000|Observational Phase|Premature Study Termination|36|||
94462530|NCT01173055|323483188|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
94462531|NCT01173055|323483187|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
94462532|NCT01173055|323483188|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
94462533|NCT03426436|323483190|FG000|Overall Study|Incorrect lead placement|12|||
94462534|NCT03426436|323483190|FG000|Overall Study|Withdrawal by Subject|2|||
94462535|NCT03426436|323483190|FG000|Overall Study|Consent issue|1|||
94462536|NCT03426436|323483190|FG000|Overall Study|ECGs not saved|4|||
94462537|NCT04325698|323483191|FG000|Overall Study|Study Terminated By Sponsor|1|||
94462538|NCT04325698|323483192|FG001|Overall Study|Study Terminated By Sponsor|1|||
94462539|NCT04325698|323483191|FG000|Overall Study|Withdrawal by Subject|0|||
94462540|NCT04325698|323483192|FG001|Overall Study|Withdrawal by Subject|2|||
94462541|NCT04253782|323483193|FG000|Overall Study|Death|2|||
94462542|NCT04253782|323483194|FG001|Overall Study|Death|0|||
94462543|NCT00962091|323483195|FG000|Overall Study|Withdrawal by Subject|1|||
94462544|NCT00962091|323483196|FG001|Overall Study|Withdrawal by Subject|2|||
94462545|NCT00962091|323483197|FG002|Overall Study|Withdrawal by Subject|1|||
94462546|NCT00962091|323483198|FG003|Overall Study|Withdrawal by Subject|1|||
94462547|NCT00962091|323483199|FG004|Overall Study|Withdrawal by Subject|0|||
94462548|NCT00962091|323483200|FG005|Overall Study|Withdrawal by Subject|1|||
94462549|NCT00962091|323483201|FG006|Overall Study|Withdrawal by Subject|0|||
94462550|NCT00962091|323483195|FG000|Overall Study|Adverse Event|0|||
94462551|NCT00962091|323483196|FG001|Overall Study|Adverse Event|0|||
94462552|NCT00962091|323483197|FG002|Overall Study|Adverse Event|0|||
94462553|NCT00962091|323483198|FG003|Overall Study|Adverse Event|0|||
94462554|NCT00962091|323483199|FG004|Overall Study|Adverse Event|0|||
94462555|NCT00962091|323483200|FG005|Overall Study|Adverse Event|0|||
94462556|NCT00962091|323483201|FG006|Overall Study|Adverse Event|1|||
94462557|NCT04216589|323483203|FG000|Overall Study|Withdrawal by Subject|2|||
94462558|NCT04216589|323483203|FG000|Overall Study|Protocol Violation|1|||
94462559|NCT04216589|323483203|FG000|Overall Study|Incarceration|1|||
94462560|NCT02326298|323483208|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94462561|NCT02326298|323483209|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94462562|NCT02326298|323483210|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
94462563|NCT02326298|323483211|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94462564|NCT02326298|323483212|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94462565|NCT02326298|323483213|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94462566|NCT02326298|323483214|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94462567|NCT02326298|323483215|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94462568|NCT02326298|323483216|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94462569|NCT02326298|323483217|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94462570|NCT02326298|323483218|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94462571|NCT02326298|323483219|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94462572|NCT02326298|323483220|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94462573|NCT02326298|323483221|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94462574|NCT02326298|323483208|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
94462575|NCT02326298|323483209|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
94462576|NCT02326298|323483210|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
94462577|NCT02326298|323483211|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
94462578|NCT02326298|323483212|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
94462579|NCT02326298|323483213|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
94462580|NCT02326298|323483214|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
94642683|NCT02884089|324154914|FG002|Follow-up Visit|Withdrawal by Subject|0|||
94642684|NCT02884089|324154915|FG003|Follow-up Visit|Withdrawal by Subject|1|||
94642685|NCT03406858|324154916|FG000|Overall Study|Failure to receive treatment drug.|1|||
94642686|NCT03406858|324154916|FG000|Overall Study|ineligible|1|||
94642687|NCT02053753|324154923|FG000|Overall Study|Withdrawal by Subject|2|||
94642688|NCT02053753|324154924|FG001|Overall Study|Withdrawal by Subject|4|||
94642689|NCT02053753|324154923|FG000|Overall Study|Decision by Sponsor|1|||
94642690|NCT02053753|324154924|FG001|Overall Study|Decision by Sponsor|1|||
94642691|NCT02053753|324154923|FG000|Overall Study|Lost to Follow-up|4|||
94642692|NCT02053753|324154924|FG001|Overall Study|Lost to Follow-up|3|||
94642693|NCT01203072|324154929|FG000|Overall Study|Adverse Event|5|||
94642694|NCT01203072|324154930|FG001|Overall Study|Adverse Event|3|||
94642695|NCT01203072|324154931|FG002|Overall Study|Adverse Event|2|||
94642696|NCT01203072|324154932|FG003|Overall Study|Adverse Event|4|||
94642697|NCT01203072|324154933|FG004|Overall Study|Adverse Event|2|||
94642698|NCT01203072|324154929|FG000|Overall Study|Lack of Efficacy|1|||
94642699|NCT01203072|324154930|FG001|Overall Study|Lack of Efficacy|0|||
94642700|NCT01203072|324154931|FG002|Overall Study|Lack of Efficacy|0|||
94642701|NCT01203072|324154932|FG003|Overall Study|Lack of Efficacy|0|||
94642702|NCT01203072|324154933|FG004|Overall Study|Lack of Efficacy|0|||
94642703|NCT01203072|324154929|FG000|Overall Study|Lost to Follow-up|0|||
94642704|NCT01203072|324154930|FG001|Overall Study|Lost to Follow-up|1|||
94642705|NCT01203072|324154931|FG002|Overall Study|Lost to Follow-up|0|||
94642706|NCT01203072|324154932|FG003|Overall Study|Lost to Follow-up|0|||
94642707|NCT01203072|324154933|FG004|Overall Study|Lost to Follow-up|0|||
94642708|NCT01203072|324154929|FG000|Overall Study|Protocol Violation|2|||
94263369|NCT00752622|322758197|FG000|Observational Phase|Non-responder|2|||
94263370|NCT00752622|322758197|FG000|Observational Phase|Withdrawal by Subject|2|||
94263371|NCT00752622|322758197|FG000|Observational Phase|Adverse Event|1|||
94263372|NCT00752622|322758197|FG000|Observational Phase|Other|2|||
94263373|NCT00752622|322758197|FG000|Interventional Phase|Non-responder|2|||
94263374|NCT00752622|322758197|FG000|Interventional Phase|Physician Decision|1|||
94263375|NCT00752622|322758197|FG000|Interventional Phase|Premature Study Termination|5|||
94263376|NCT01272947|322758199|FG000|Overall Study|Abnormal Laboratory Value|2|||
94263377|NCT01272947|322758200|FG001|Overall Study|Abnormal Laboratory Value|2|||
94263378|NCT02030405|322758203|FG000|Overall Study|Withdrawal by Subject|1|||
94263379|NCT02030405|322758203|FG000|Overall Study|Lost to Follow-up|1|||
94263380|NCT00803270|322758204|FG000|Overall Study|Lost to Follow-up|1|||
94263381|NCT00803270|322758205|FG001|Overall Study|Lost to Follow-up|2|||
94263382|NCT01130974|322758206|FG000|Overall Study|Protocol Violation|10|||
94263383|NCT01130974|322758207|FG001|Overall Study|Protocol Violation|10|||
94263384|NCT01130974|322758206|FG000|Overall Study|Withdrawal by Subject|0|||
94263385|NCT01130974|322758207|FG001|Overall Study|Withdrawal by Subject|1|||
94263386|NCT01130974|322758206|FG000|Overall Study|Ineligibility criteria|5|||
94263387|NCT01130974|322758207|FG001|Overall Study|Ineligibility criteria|2|||
94263388|NCT03431857|322758208|FG000|Overall Study|Death|6|||
94263389|NCT03431857|322758208|FG000|Overall Study|Lost to Follow-up|41|||
94263390|NCT03431857|322758208|FG000|Overall Study|Adverse Event|6|||
94263391|NCT03431857|322758208|FG000|Overall Study|Withdrawal by Subject|1|||
94263392|NCT03359590|322758210|FG000|First Intervention|Withdrawal by Subject|1|||
94263393|NCT03359590|322758211|FG001|First Intervention|Withdrawal by Subject|1|||
94263394|NCT03359590|322758210|FG000|First Intervention|Protocol Violation|0|||
94263395|NCT03359590|322758211|FG001|First Intervention|Protocol Violation|1|||
94263396|NCT04399122|322758212|FG000|Overall Study|Lost to Follow-up|2|||
94263397|NCT04399122|322758213|FG001|Overall Study|Lost to Follow-up|0|||
94263398|NCT04399122|322758212|FG000|Overall Study|Withdrawal by Subject|1|||
94263399|NCT04399122|322758213|FG001|Overall Study|Withdrawal by Subject|0|||
94263400|NCT02536755|322758214|FG000|Overall Study|Adverse Event|4|||
94263401|NCT02374021|322758218|FG000|Overall Study|Adverse Event|1|||
94263402|NCT02374021|322758219|FG001|Overall Study|Adverse Event|0|||
94263403|NCT02374021|322758218|FG000|Overall Study|Lost to Follow-up|3|||
94263404|NCT02374021|322758219|FG001|Overall Study|Lost to Follow-up|2|||
94263405|NCT02374021|322758218|FG000|Overall Study|Physician Decision|0|||
94365714|NCT05553600|323124751|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
94642709|NCT01203072|324154930|FG001|Overall Study|Protocol Violation|0|||
94642710|NCT01203072|324154931|FG002|Overall Study|Protocol Violation|0|||
94642711|NCT01203072|324154932|FG003|Overall Study|Protocol Violation|0|||
94263406|NCT02374021|322758219|FG001|Overall Study|Physician Decision|3|||
94263407|NCT02374021|322758218|FG000|Overall Study|Withdrawal by Subject|6|||
94642712|NCT01203072|324154933|FG004|Overall Study|Protocol Violation|1|||
94642713|NCT01203072|324154929|FG000|Overall Study|Withdrawal by Subject|2|||
94642714|NCT01203072|324154930|FG001|Overall Study|Withdrawal by Subject|2|||
94642715|NCT01203072|324154931|FG002|Overall Study|Withdrawal by Subject|1|||
94642716|NCT01203072|324154932|FG003|Overall Study|Withdrawal by Subject|2|||
94642717|NCT01203072|324154933|FG004|Overall Study|Withdrawal by Subject|3|||
94642718|NCT02023151|324154934|FG000|Overall Study|Lost to Follow-up|4|||
94642719|NCT00337103|324154935|FG000|Overall Study|Progressive Disease|414|||
94263408|NCT02374021|322758219|FG001|Overall Study|Withdrawal by Subject|5|||
94263409|NCT02374021|322758218|FG000|Overall Study|Poor Adherence|0|||
94263410|NCT02374021|322758219|FG001|Overall Study|Poor Adherence|1|||
94642720|NCT00337103|324154936|FG001|Overall Study|Progressive Disease|410|||
94642721|NCT00337103|324154935|FG000|Overall Study|Adverse Event|45|||
94642722|NCT00337103|324154936|FG001|Overall Study|Adverse Event|59|||
94642723|NCT00337103|324154935|FG000|Overall Study|Subject Choice|34|||
94642724|NCT00337103|324154936|FG001|Overall Study|Subject Choice|27|||
94642725|NCT00337103|324154935|FG000|Overall Study|Clinical Progression|27|||
94642726|NCT00337103|324154936|FG001|Overall Study|Clinical Progression|24|||
94642727|NCT00337103|324154935|FG000|Overall Study|Physician Decision|15|||
94642728|NCT00337103|324154936|FG001|Overall Study|Physician Decision|14|||
94642729|NCT00337103|324154935|FG000|Overall Study|Withdrawal by Subject|8|||
94642730|NCT00337103|324154936|FG001|Overall Study|Withdrawal by Subject|5|||
94642731|NCT00337103|324154935|FG000|Overall Study|Other|5|||
94642732|NCT00337103|324154936|FG001|Overall Study|Other|6|||
94642733|NCT00337103|324154935|FG000|Overall Study|Entry Criteria Not Met|4|||
94642734|NCT00337103|324154936|FG001|Overall Study|Entry Criteria Not Met|1|||
94642735|NCT00337103|324154935|FG000|Overall Study|Lost to Follow-up|1|||
94642736|NCT00337103|324154936|FG001|Overall Study|Lost to Follow-up|2|||
94642737|NCT00337103|324154935|FG000|Overall Study|Death|1|||
94642738|NCT00337103|324154936|FG001|Overall Study|Death|0|||
94642739|NCT01289847|324154937|FG000|Overall Study|Patient could not comply with visits|1|||
94642740|NCT00006478|324154942|FG000|Overall Study|Vaccine could not be produced|1|||
94642741|NCT00006478|324154942|FG000|Overall Study|Physician Decision|6|||
94642742|NCT02404350|324154948|FG000|Overall Study|Adverse Event|2|||
94642743|NCT02404350|324154949|FG001|Overall Study|Adverse Event|2|||
94642744|NCT02404350|324154950|FG002|Overall Study|Adverse Event|3|||
94642745|NCT02404350|324154951|FG003|Overall Study|Adverse Event|9|||
94642746|NCT02404350|324154948|FG000|Overall Study|Lack of Efficacy|3|||
94642747|NCT02404350|324154949|FG001|Overall Study|Lack of Efficacy|1|||
94642748|NCT02404350|324154950|FG002|Overall Study|Lack of Efficacy|0|||
94462581|NCT02326298|323483215|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
94462582|NCT02326298|323483216|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
94462583|NCT02326298|323483217|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
94462584|NCT02326298|323483218|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
94462585|NCT02326298|323483219|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
94642749|NCT02404350|324154951|FG003|Overall Study|Lack of Efficacy|3|||
94462586|NCT02326298|323483220|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
94462587|NCT02326298|323483221|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
94462588|NCT02326298|323483208|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
94462589|NCT02326298|323483209|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
94462590|NCT02326298|323483210|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94462591|NCT02326298|323483211|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94462592|NCT02326298|323483212|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94462593|NCT02326298|323483213|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94642750|NCT02404350|324154948|FG000|Overall Study|Lost to Follow-up|2|||
94642751|NCT02404350|324154949|FG001|Overall Study|Lost to Follow-up|0|||
94263411|NCT02374021|322758218|FG000|Overall Study|Scan protocol not followed|0|||
94642752|NCT02404350|324154950|FG002|Overall Study|Lost to Follow-up|0|||
94462594|NCT02326298|323483214|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94462595|NCT02326298|323483215|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94462596|NCT02326298|323483216|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94462597|NCT02326298|323483217|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94462598|NCT02326298|323483218|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94462599|NCT02326298|323483219|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94462600|NCT02326298|323483220|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94462601|NCT02326298|323483221|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94462602|NCT02326298|323483208|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
94462603|NCT02326298|323483209|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
94462604|NCT02326298|323483210|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94462605|NCT02326298|323483211|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94462606|NCT02326298|323483212|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94462607|NCT02326298|323483213|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94462608|NCT02326298|323483214|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94462609|NCT02326298|323483215|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94462610|NCT02326298|323483216|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94462611|NCT02326298|323483217|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94462612|NCT02326298|323483218|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94462613|NCT02326298|323483219|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94462614|NCT02326298|323483220|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94462615|NCT02326298|323483221|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94462616|NCT02326298|323483208|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
94462617|NCT02326298|323483209|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
94462618|NCT02326298|323483210|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
94462619|NCT02326298|323483211|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
94462620|NCT02326298|323483212|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
94462621|NCT02326298|323483213|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
94462622|NCT02326298|323483214|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
94462623|NCT02326298|323483215|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
94642753|NCT02404350|324154951|FG003|Overall Study|Lost to Follow-up|1|||
94642754|NCT02404350|324154948|FG000|Overall Study|Physician Decision|1|||
94642755|NCT02404350|324154949|FG001|Overall Study|Physician Decision|0|||
94642756|NCT02404350|324154950|FG002|Overall Study|Physician Decision|0|||
94642757|NCT02404350|324154951|FG003|Overall Study|Physician Decision|2|||
94263412|NCT02374021|322758219|FG001|Overall Study|Scan protocol not followed|1|||
94263413|NCT02374021|322758218|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
94263414|NCT02374021|322758219|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
94263415|NCT01472380|322758220|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
94263416|NCT01472380|322758220|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
94263417|NCT00292461|322758223|FG000|Overall Study|Adverse Event|4|||
94263418|NCT00292461|322758224|FG001|Overall Study|Adverse Event|2|||
94263419|NCT00292461|322758223|FG000|Overall Study|Lack of Efficacy|1|||
94642758|NCT02404350|324154948|FG000|Overall Study|Pregnancy|0|||
94642759|NCT02404350|324154949|FG001|Overall Study|Pregnancy|0|||
94642760|NCT02404350|324154950|FG002|Overall Study|Pregnancy|0|||
94363564|NCT04484805|323116657|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
94363565|NCT04484805|323116658|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
94363566|NCT03927989|323116659|FG000|Overall Study|Withdrawal by Subject|0|||
94363567|NCT03927989|323116660|FG001|Overall Study|Withdrawal by Subject|1|||
94363568|NCT04285983|323116661|FG000|Overall Study|Protocol Violation|6|||
94363569|NCT00713830|323116665|FG000|Overall Study|Adverse Event|23|||
94363570|NCT00713830|323116666|FG001|Overall Study|Adverse Event|71|||
94462624|NCT02326298|323483216|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
94462625|NCT02326298|323483217|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
94642761|NCT02404350|324154951|FG003|Overall Study|Pregnancy|1|||
94642762|NCT02404350|324154948|FG000|Overall Study|Withdrawal by Subject|7|||
94642763|NCT02404350|324154949|FG001|Overall Study|Withdrawal by Subject|3|||
94642764|NCT02404350|324154950|FG002|Overall Study|Withdrawal by Subject|3|||
94642765|NCT02404350|324154951|FG003|Overall Study|Withdrawal by Subject|19|||
94642766|NCT02404350|324154948|FG000|Overall Study|Due to Non-compliance with treatment|0|||
94642767|NCT02404350|324154949|FG001|Overall Study|Due to Non-compliance with treatment|0|||
94642768|NCT02404350|324154950|FG002|Overall Study|Due to Non-compliance with treatment|0|||
94642769|NCT02404350|324154951|FG003|Overall Study|Due to Non-compliance with treatment|1|||
94642770|NCT02404350|324154948|FG000|Overall Study|Due to Technical problems|0|||
94642771|NCT02404350|324154949|FG001|Overall Study|Due to Technical problems|0|||
94642772|NCT02404350|324154950|FG002|Overall Study|Due to Technical problems|0|||
94642773|NCT02404350|324154951|FG003|Overall Study|Due to Technical problems|1|||
94642774|NCT04238728|324154952|FG000|Overall Study|Withdrawal by Subject|1|||
94363571|NCT00713830|323116665|FG000|Overall Study|Lack of Efficacy|24|||
94363572|NCT00713830|323116666|FG001|Overall Study|Lack of Efficacy|16|||
94363573|NCT00713830|323116665|FG000|Overall Study|Lost to Follow-up|2|||
94363574|NCT00713830|323116666|FG001|Overall Study|Lost to Follow-up|9|||
94363575|NCT00713830|323116665|FG000|Overall Study|Withdrawal by Subject|13|||
94363576|NCT00713830|323116666|FG001|Overall Study|Withdrawal by Subject|23|||
94363577|NCT00713830|323116665|FG000|Overall Study|Poor Compliance to Protocol|7|||
94363578|NCT00713830|323116666|FG001|Overall Study|Poor Compliance to Protocol|14|||
94363579|NCT00713830|323116665|FG000|Overall Study|Familial and Personal Reasons|9|||
94363580|NCT00713830|323116666|FG001|Overall Study|Familial and Personal Reasons|34|||
94363581|NCT00713830|323116665|FG000|Overall Study|Sponsor Decision|4|||
94363582|NCT00713830|323116666|FG001|Overall Study|Sponsor Decision|10|||
94363583|NCT03069365|323116669|FG000|Overall Study|Adverse Event|1|||
94363584|NCT04635631|323116670|FG000|Overall Study|Adverse Event|1|||
94363585|NCT04635631|323116670|FG000|Overall Study|Progressive disease|13|||
94363586|NCT04635631|323116670|FG000|Overall Study|Withdrawal by Subject|1|||
94363587|NCT00326625|323116671|FG000|Overall Study|Adverse Event|20|||
94363588|NCT00326625|323116672|FG001|Overall Study|Adverse Event|9|||
94363589|NCT00326625|323116671|FG000|Overall Study|Withdrawal by Subject|15|||
94363590|NCT00326625|323116672|FG001|Overall Study|Withdrawal by Subject|12|||
94363591|NCT00326625|323116671|FG000|Overall Study|Death|18|||
94363592|NCT00326625|323116672|FG001|Overall Study|Death|16|||
94363593|NCT00326625|323116671|FG000|Overall Study|Lost to Follow-up|1|||
94363594|NCT00326625|323116672|FG001|Overall Study|Lost to Follow-up|0|||
94363595|NCT00326625|323116671|FG000|Overall Study|prescheduled medical intervention|0|||
94363596|NCT00326625|323116672|FG001|Overall Study|prescheduled medical intervention|1|||
94363597|NCT03981614|323116673|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
94363598|NCT03981614|323116674|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
94363599|NCT03981614|323116675|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
94363600|NCT03901339|323116676|FG000|Overall Study|Death|220|||
94363601|NCT03901339|323116677|FG001|Overall Study|Death|192|||
94363602|NCT03901339|323116676|FG000|Overall Study|Informed consent withdrawn|13|||
94363603|NCT03901339|323116677|FG001|Overall Study|Informed consent withdrawn|40|||
94363604|NCT03901339|323116676|FG000|Overall Study|Sponsor request|30|||
94363605|NCT03901339|323116677|FG001|Overall Study|Sponsor request|23|||
94363606|NCT03901339|323116676|FG000|Overall Study|Reason not specified|5|||
94363607|NCT03901339|323116677|FG001|Overall Study|Reason not specified|7|||
94363608|NCT03901339|323116676|FG000|Overall Study|Lost to Follow-up|4|||
94642775|NCT04238728|324154952|FG000|Overall Study|Lost to Follow-up|2|||
94363609|NCT03901339|323116677|FG001|Overall Study|Lost to Follow-up|7|||
94363610|NCT03901339|323116676|FG000|Overall Study|Covid19|0|||
94363611|NCT03901339|323116677|FG001|Overall Study|Covid19|2|||
94363612|NCT00916617|323116683|FG000|Overall Study|Adverse Event|3|||
94363613|NCT00916617|323116684|FG001|Overall Study|Adverse Event|2|||
94642776|NCT00743652|324154958|FG000|Overall Study|Parent/Legal Guardian Request|3|||
94642777|NCT00743652|324154959|FG001|Overall Study|Parent/Legal Guardian Request|2|||
94642778|NCT00743652|324154960|FG002|Overall Study|Parent/Legal Guardian Request|2|||
94642779|NCT00743652|324154961|FG003|Overall Study|Parent/Legal Guardian Request|2|||
94642780|NCT00743652|324154962|FG004|Overall Study|Parent/Legal Guardian Request|0|||
94642781|NCT00743652|324154958|FG000|Overall Study|Adverse Event|3|||
94642782|NCT00743652|324154959|FG001|Overall Study|Adverse Event|0|||
94363614|NCT00916617|323116685|FG002|Overall Study|Adverse Event|6|||
94363615|NCT00916617|323116686|FG003|Overall Study|Adverse Event|3|||
94642783|NCT00743652|324154960|FG002|Overall Study|Adverse Event|0|||
94642784|NCT00743652|324154961|FG003|Overall Study|Adverse Event|0|||
94642785|NCT00743652|324154962|FG004|Overall Study|Adverse Event|0|||
94642786|NCT00743652|324154958|FG000|Overall Study|Death|2|||
94642787|NCT00743652|324154959|FG001|Overall Study|Death|0|||
94642788|NCT00743652|324154960|FG002|Overall Study|Death|0|||
94642789|NCT00743652|324154961|FG003|Overall Study|Death|0|||
94642790|NCT00743652|324154962|FG004|Overall Study|Death|0|||
94263420|NCT00292461|322758224|FG001|Overall Study|Lack of Efficacy|0|||
94263421|NCT00292461|322758223|FG000|Overall Study|Withdrawal by Subject|0|||
94263422|NCT00292461|322758224|FG001|Overall Study|Withdrawal by Subject|1|||
94263423|NCT00292461|322758223|FG000|Overall Study|Protocol Violation|4|||
94263424|NCT00292461|322758224|FG001|Overall Study|Protocol Violation|3|||
94642791|NCT00743652|324154958|FG000|Overall Study|Investigator Request|0|||
94642792|NCT00743652|324154959|FG001|Overall Study|Investigator Request|0|||
94642793|NCT00743652|324154960|FG002|Overall Study|Investigator Request|0|||
94642794|NCT00743652|324154961|FG003|Overall Study|Investigator Request|2|||
94642795|NCT00743652|324154962|FG004|Overall Study|Investigator Request|0|||
94642796|NCT00743652|324154958|FG000|Overall Study|Other|1|||
94642797|NCT00743652|324154959|FG001|Overall Study|Other|1|||
94642798|NCT00743652|324154960|FG002|Overall Study|Other|0|||
94642799|NCT00743652|324154961|FG003|Overall Study|Other|0|||
94642800|NCT00743652|324154962|FG004|Overall Study|Other|0|||
94642801|NCT00743652|324154958|FG000|Overall Study|Lost to Follow-up|1|||
94642802|NCT00743652|324154959|FG001|Overall Study|Lost to Follow-up|0|||
94642803|NCT00743652|324154960|FG002|Overall Study|Lost to Follow-up|0|||
94263425|NCT00292461|322758223|FG000|Overall Study|Lost to Follow-up|1|||
94642804|NCT00743652|324154961|FG003|Overall Study|Lost to Follow-up|0|||
94263426|NCT00292461|322758224|FG001|Overall Study|Lost to Follow-up|0|||
94642805|NCT00743652|324154962|FG004|Overall Study|Lost to Follow-up|0|||
94678913|NCT04035200|324278899|FG002|Overall Study|Withdrawal by Subject|4|||
94678914|NCT04035200|324278897|FG000|Overall Study|COVID-19|1|||
94678915|NCT04035200|324278898|FG001|Overall Study|COVID-19|0|||
94678916|NCT04035200|324278899|FG002|Overall Study|COVID-19|0|||
94678917|NCT04035200|324278897|FG000|Overall Study|Early Termination|0|||
94678918|NCT04035200|324278898|FG001|Overall Study|Early Termination|1|||
94678919|NCT04035200|324278899|FG002|Overall Study|Early Termination|0|||
94678920|NCT04035200|324278897|FG000|Overall Study|Non-compliance|0|||
94678921|NCT04035200|324278898|FG001|Overall Study|Non-compliance|1|||
94678922|NCT04035200|324278899|FG002|Overall Study|Non-compliance|0|||
94678923|NCT02277990|324278900|FG000|Overall Study|Death|170|||
94678924|NCT02277990|324278901|FG001|Overall Study|Death|188|||
94678925|NCT02277990|324278900|FG000|Overall Study|Withdrawal by Subject|64|||
94678926|NCT02277990|324278901|FG001|Overall Study|Withdrawal by Subject|53|||
94678927|NCT02277990|324278900|FG000|Overall Study|Physician Decision|40|||
94678928|NCT02277990|324278901|FG001|Overall Study|Physician Decision|34|||
94678929|NCT02277990|324278900|FG000|Overall Study|Lost to Follow-up|66|||
94678930|NCT02277990|324278901|FG001|Overall Study|Lost to Follow-up|69|||
94678931|NCT02277990|324278900|FG000|Overall Study|Had other reason|26|||
94678932|NCT02277990|324278901|FG001|Overall Study|Had other reason|32|||
94678933|NCT01498822|324278902|FG000|Overall Study|Protocol Violation|8|||
94678934|NCT01498822|324278903|FG001|Overall Study|Protocol Violation|4|||
94678935|NCT01498822|324278902|FG000|Overall Study|Other Reason|5|||
94678936|NCT01498822|324278903|FG001|Overall Study|Other Reason|2|||
94678937|NCT01498822|324278902|FG000|Overall Study|Lack of Efficacy|7|||
94678938|NCT01498822|324278903|FG001|Overall Study|Lack of Efficacy|2|||
94678939|NCT01498822|324278902|FG000|Overall Study|AE, non-serious non-fatal|8|||
94678940|NCT01498822|324278903|FG001|Overall Study|AE, non-serious non-fatal|17|||
94678941|NCT01498822|324278902|FG000|Overall Study|SAE, non-fatal|2|||
94678942|NCT01498822|324278903|FG001|Overall Study|SAE, non-fatal|2|||
94678943|NCT01498822|324278902|FG000|Overall Study|Adverse Event, serious fatal|1|||
94678944|NCT01498822|324278903|FG001|Overall Study|Adverse Event, serious fatal|1|||
94678945|NCT01498822|324278902|FG000|Overall Study|Withdrawal by Subject|15|||
94678946|NCT01498822|324278903|FG001|Overall Study|Withdrawal by Subject|25|||
94678947|NCT01498822|324278902|FG000|Overall Study|Lost to Follow-up|8|||
94678948|NCT01498822|324278903|FG001|Overall Study|Lost to Follow-up|3|||
94678949|NCT02063828|324278912|FG000|Overall Study|Withdrawal by Subject|4|||
94678950|NCT02063828|324278913|FG001|Overall Study|Withdrawal by Subject|6|||
94678951|NCT02063828|324278914|FG002|Overall Study|Withdrawal by Subject|3|||
94678952|NCT02063828|324278912|FG000|Overall Study|Death|0|||
94678953|NCT02063828|324278913|FG001|Overall Study|Death|0|||
94678954|NCT02063828|324278914|FG002|Overall Study|Death|1|||
94263427|NCT00375219|322758228|FG000|Overall Study|Failure to achieve a response|16|||
94263428|NCT00375219|322758229|FG001|Overall Study|Failure to achieve a response|2|||
94678955|NCT04027348|324278919|FG000|Overall Study|Adverse Event|2|||
94678956|NCT02487472|324278920|FG000|Overall Study|Did not complete telephonic interviews|9|||
94678957|NCT02487472|324278920|FG000|Overall Study|Other|2|||
94678958|NCT02034708|324278925|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
94678959|NCT02034708|324278926|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
94678960|NCT02034708|324278925|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
94678961|NCT02034708|324278926|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
94462626|NCT02326298|323483218|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
94462627|NCT02326298|323483219|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
94462628|NCT02326298|323483220|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
94462629|NCT02326298|323483221|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
94462630|NCT02326298|323483208|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94462631|NCT02326298|323483209|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94462632|NCT02326298|323483210|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94462633|NCT02326298|323483211|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94462634|NCT02326298|323483212|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94462635|NCT02326298|323483213|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
94462636|NCT02326298|323483214|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
94462637|NCT02326298|323483215|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
94462638|NCT02326298|323483216|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
94462639|NCT02326298|323483217|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
94462640|NCT02326298|323483218|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94462641|NCT02326298|323483219|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94462642|NCT02326298|323483220|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94462643|NCT02326298|323483221|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94462644|NCT02326298|323483208|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
94462645|NCT02326298|323483209|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
94642806|NCT00805766|324154963|FG000|Screening Period|Adverse Event|1|||
94642807|NCT00805766|324154963|FG000|Screening Period|Lack of Efficacy|2|||
94462646|NCT02326298|323483210|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
94462647|NCT02326298|323483211|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
94462648|NCT02326298|323483212|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
94462649|NCT02326298|323483213|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
94462650|NCT02326298|323483214|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
94462651|NCT02326298|323483215|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
94462652|NCT02326298|323483216|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
94642808|NCT00805766|324154963|FG000|Screening Period|Pregnancy|1|||
94642809|NCT00805766|324154963|FG000|Screening Period|Responder|2|||
94642810|NCT00805766|324154963|FG000|Increased Dose Period|Adverse Event|4|||
94642811|NCT00805766|324154963|FG000|Increased Dose Period|Lack of Efficacy|7|||
94642812|NCT00805766|324154963|FG000|Increased Dose Period|Pregnancy|1|||
94642813|NCT00805766|324154963|FG000|Increased Dose Period|Withdrawal by Subject|1|||
94642814|NCT00600756|324154964|FG000|Analysis After 6 Months|Adverse Event|43|||
94642815|NCT00600756|324154965|FG001|Analysis After 6 Months|Adverse Event|33|||
94642816|NCT00600756|324154964|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
94642817|NCT00600756|324154965|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
94642818|NCT00600756|324154964|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
94642819|NCT00600756|324154965|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
94462653|NCT02326298|323483217|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
94462654|NCT02326298|323483218|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
94462655|NCT02326298|323483219|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
94462656|NCT02326298|323483220|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
94462657|NCT02326298|323483221|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
94462658|NCT02326298|323483208|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
94462659|NCT02326298|323483209|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
94465952|NCT04769739|323494961|FG002|Overall Study|Poor bowel preparation|0|||
94263429|NCT00375219|322758230|FG002|Overall Study|Failure to achieve a response|0|||
94263430|NCT00375219|322758228|FG000|Overall Study|Adverse Event|8|||
94263431|NCT00375219|322758229|FG001|Overall Study|Adverse Event|2|||
94263432|NCT00375219|322758230|FG002|Overall Study|Adverse Event|1|||
94263433|NCT00375219|322758228|FG000|Overall Study|Protocol Violation|1|||
94263434|NCT00375219|322758229|FG001|Overall Study|Protocol Violation|0|||
94363616|NCT00916617|323116683|FG000|Overall Study|Withdrawal by Subject|3|||
94363617|NCT00916617|323116684|FG001|Overall Study|Withdrawal by Subject|2|||
94363618|NCT00916617|323116685|FG002|Overall Study|Withdrawal by Subject|0|||
94363619|NCT00916617|323116686|FG003|Overall Study|Withdrawal by Subject|1|||
94363620|NCT00916617|323116683|FG000|Overall Study|Caregiver Request|3|||
94363621|NCT00916617|323116684|FG001|Overall Study|Caregiver Request|2|||
94363622|NCT00916617|323116685|FG002|Overall Study|Caregiver Request|1|||
94363623|NCT00916617|323116686|FG003|Overall Study|Caregiver Request|0|||
94363624|NCT00916617|323116683|FG000|Overall Study|Physician Decision|1|||
94363625|NCT00916617|323116684|FG001|Overall Study|Physician Decision|1|||
94363626|NCT00916617|323116685|FG002|Overall Study|Physician Decision|0|||
94363627|NCT00916617|323116686|FG003|Overall Study|Physician Decision|0|||
94363628|NCT00916617|323116683|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
94363629|NCT00916617|323116684|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
94363630|NCT00916617|323116685|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
94363631|NCT00916617|323116686|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
94363632|NCT00916617|323116683|FG000|Overall Study|Lost to Follow-up|2|||
94363633|NCT00916617|323116684|FG001|Overall Study|Lost to Follow-up|1|||
94363634|NCT00916617|323116685|FG002|Overall Study|Lost to Follow-up|0|||
94363635|NCT00916617|323116686|FG003|Overall Study|Lost to Follow-up|0|||
94363636|NCT00916617|323116683|FG000|Overall Study|Lack of Efficacy|1|||
94363637|NCT00916617|323116684|FG001|Overall Study|Lack of Efficacy|0|||
94363638|NCT00916617|323116685|FG002|Overall Study|Lack of Efficacy|0|||
94363639|NCT00916617|323116686|FG003|Overall Study|Lack of Efficacy|0|||
94363640|NCT00916617|323116683|FG000|Overall Study|Other|2|||
94363641|NCT00916617|323116684|FG001|Overall Study|Other|0|||
94363642|NCT00916617|323116685|FG002|Overall Study|Other|0|||
94678962|NCT02034708|324278925|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
94678963|NCT02034708|324278926|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
94678964|NCT02034708|324278925|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
94678965|NCT02034708|324278926|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
94678966|NCT03988166|324278929|FG000|Overall Study|Lost to Follow-up|2|||
94678967|NCT03988166|324278929|FG000|Overall Study|Death|1|||
94678968|NCT02010632|324278930|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
94678969|NCT02010632|324278931|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
94678970|NCT01412801|324278936|FG000|Overall Study|Death|0|||
94678971|NCT01412801|324278937|FG001|Overall Study|Death|1|||
94678972|NCT01412801|324278938|FG002|Overall Study|Death|0|||
94678973|NCT01412801|324278939|FG003|Overall Study|Death|4|||
94678974|NCT01412801|324278940|FG004|Overall Study|Death|2|||
94678975|NCT01412801|324278941|FG005|Overall Study|Death|2|||
94678976|NCT01412801|324278936|FG000|Overall Study|Lost to Follow-up|1|||
94462660|NCT02326298|323483210|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
94462661|NCT02326298|323483211|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
94462662|NCT02326298|323483212|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
94462663|NCT02326298|323483213|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
94462664|NCT02326298|323483214|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
94462665|NCT02326298|323483215|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
94462666|NCT02326298|323483216|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
94462667|NCT02326298|323483217|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
94462668|NCT02326298|323483218|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
94462669|NCT02326298|323483219|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
94462670|NCT02326298|323483220|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
94462671|NCT02326298|323483221|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
94462672|NCT02326298|323483208|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94462673|NCT02326298|323483209|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94462674|NCT02326298|323483210|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94462675|NCT02326298|323483211|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94462676|NCT02326298|323483212|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94462677|NCT02326298|323483213|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94462678|NCT02326298|323483214|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
94462679|NCT02326298|323483215|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94462680|NCT02326298|323483216|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94462681|NCT02326298|323483217|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94462682|NCT02326298|323483218|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94462683|NCT02326298|323483219|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94462684|NCT02326298|323483220|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94462685|NCT02326298|323483221|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94462686|NCT02326298|323483208|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
94462687|NCT02326298|323483209|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
94462688|NCT02326298|323483210|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
94263435|NCT00375219|322758230|FG002|Overall Study|Protocol Violation|1|||
94263436|NCT00375219|322758228|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
94263437|NCT00375219|322758229|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
94263438|NCT00375219|322758230|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
94263439|NCT00375219|322758228|FG000|Overall Study|Lost to Follow-up|1|||
94263440|NCT00375219|322758229|FG001|Overall Study|Lost to Follow-up|1|||
94263441|NCT00375219|322758230|FG002|Overall Study|Lost to Follow-up|0|||
94263442|NCT00375219|322758228|FG000|Overall Study|Disease progression|18|||
94263443|NCT00375219|322758229|FG001|Overall Study|Disease progression|9|||
94263444|NCT00375219|322758230|FG002|Overall Study|Disease progression|12|||
94263445|NCT00375219|322758228|FG000|Overall Study|Death|4|||
94263446|NCT00375219|322758229|FG001|Overall Study|Death|3|||
94263447|NCT00375219|322758230|FG002|Overall Study|Death|7|||
94263448|NCT00375219|322758228|FG000|Overall Study|Hematologic resistance|1|||
94263449|NCT00375219|322758229|FG001|Overall Study|Hematologic resistance|0|||
94363643|NCT00916617|323116686|FG003|Overall Study|Other|2|||
94363644|NCT01988337|323116687|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
94363645|NCT04054011|323116689|FG000|Overall Study|COVID|3|||
94363646|NCT02297438|323116692|FG000|Overall Study|Death|79|||
94363647|NCT02297438|323116693|FG001|Overall Study|Death|86|||
94363648|NCT02297438|323116692|FG000|Overall Study|Lost to Follow-up|9|||
94363649|NCT02297438|323116693|FG001|Overall Study|Lost to Follow-up|7|||
94263450|NCT00375219|322758230|FG002|Overall Study|Hematologic resistance|0|||
94263451|NCT00375219|322758228|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
94263452|NCT00375219|322758229|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
94462689|NCT02326298|323483211|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
94462690|NCT02326298|323483212|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
94363650|NCT02297438|323116692|FG000|Overall Study|Withdrawal by Subject|7|||
94363651|NCT02297438|323116693|FG001|Overall Study|Withdrawal by Subject|0|||
94363652|NCT02297438|323116692|FG000|Overall Study|Other|9|||
94363653|NCT02297438|323116693|FG001|Overall Study|Other|5|||
94363654|NCT02297438|323116692|FG000|Overall Study|Ongoing|65|||
94363655|NCT02297438|323116693|FG001|Overall Study|Ongoing|73|||
94363656|NCT01833897|323116694|FG000|Overall Study|Lack of Efficacy|1|||
94363657|NCT02860039|323116699|FG000|Overall Study|Death|4|||
94363658|NCT02860039|323116700|FG001|Overall Study|Death|0|||
94363659|NCT02860039|323116699|FG000|Overall Study|Lost to Follow-up|2|||
94363660|NCT02860039|323116700|FG001|Overall Study|Lost to Follow-up|2|||
94363661|NCT02860039|323116699|FG000|Overall Study|Protocol Violation|3|||
94363662|NCT02860039|323116700|FG001|Overall Study|Protocol Violation|1|||
94363663|NCT02860039|323116699|FG000|Overall Study|Withdrawal by Subject|1|||
94363664|NCT02860039|323116700|FG001|Overall Study|Withdrawal by Subject|0|||
94363665|NCT02860039|323116699|FG000|Overall Study|Not otherwise eligible|1|||
94363666|NCT02860039|323116700|FG001|Overall Study|Not otherwise eligible|1|||
94363667|NCT01257737|323116702|FG000|Overall Study|Lost to Follow-up|1|||
94363668|NCT01257737|323116703|FG001|Overall Study|Lost to Follow-up|2|||
94363669|NCT01257737|323116702|FG000|Overall Study|Liver transplant|1|||
94363670|NCT01257737|323116703|FG001|Overall Study|Liver transplant|0|||
94363671|NCT01257737|323116702|FG000|Overall Study|Relocation out of the country|0|||
94363672|NCT01257737|323116703|FG001|Overall Study|Relocation out of the country|1|||
94363673|NCT01257737|323116702|FG000|Overall Study|Withdrew from study|0|||
94363674|NCT01257737|323116703|FG001|Overall Study|Withdrew from study|1|||
94363675|NCT03466060|323116710|FG000|Period 1|Test Lens Damage|0|||
94363676|NCT03466060|323116711|FG001|Period 1|Test Lens Damage|2|||
94363677|NCT03466060|323116712|FG002|Period 1|Test Lens Damage|0|||
94363678|NCT03466060|323116713|FG003|Period 1|Test Lens Damage|0|||
94363679|NCT03466060|323116714|FG004|Period 1|Test Lens Damage|0|||
94363680|NCT03466060|323116715|FG005|Period 1|Test Lens Damage|0|||
94363681|NCT03466060|323116710|FG000|Period 1|Withdrawal by Subject|0|||
94363682|NCT03466060|323116711|FG001|Period 1|Withdrawal by Subject|0|||
94363683|NCT03466060|323116712|FG002|Period 1|Withdrawal by Subject|2|||
94363684|NCT03466060|323116713|FG003|Period 1|Withdrawal by Subject|0|||
94363685|NCT03466060|323116714|FG004|Period 1|Withdrawal by Subject|0|||
94363686|NCT03466060|323116715|FG005|Period 1|Withdrawal by Subject|0|||
94363687|NCT03466060|323116710|FG000|Period 1|Lost to Follow-up|0|||
94363688|NCT03466060|323116711|FG001|Period 1|Lost to Follow-up|0|||
94363689|NCT03466060|323116712|FG002|Period 1|Lost to Follow-up|0|||
94363690|NCT03466060|323116713|FG003|Period 1|Lost to Follow-up|1|||
94363691|NCT03466060|323116714|FG004|Period 1|Lost to Follow-up|0|||
94363692|NCT03466060|323116715|FG005|Period 1|Lost to Follow-up|0|||
94363693|NCT03466060|323116710|FG000|Period 1|Grade 2 Conjunctivitis|0|||
94363694|NCT03466060|323116711|FG001|Period 1|Grade 2 Conjunctivitis|0|||
94363695|NCT03466060|323116712|FG002|Period 1|Grade 2 Conjunctivitis|1|||
94363696|NCT03466060|323116713|FG003|Period 1|Grade 2 Conjunctivitis|0|||
94363697|NCT03466060|323116714|FG004|Period 1|Grade 2 Conjunctivitis|0|||
94363698|NCT03466060|323116715|FG005|Period 1|Grade 2 Conjunctivitis|0|||
94363699|NCT03466060|323116710|FG000|Period 2|Lens Handling Difficulties|0|||
94363700|NCT03466060|323116711|FG001|Period 2|Lens Handling Difficulties|0|||
94363701|NCT03466060|323116712|FG002|Period 2|Lens Handling Difficulties|1|||
94363702|NCT03466060|323116713|FG003|Period 2|Lens Handling Difficulties|0|||
94363703|NCT03466060|323116714|FG004|Period 2|Lens Handling Difficulties|0|||
94363704|NCT03466060|323116715|FG005|Period 2|Lens Handling Difficulties|0|||
94363705|NCT04527549|323116716|FG000|Overall Study|Withdrawal by Subject|1|||
94363706|NCT04527549|323116717|FG001|Overall Study|Withdrawal by Subject|1|||
94363707|NCT00424632|323116720|FG000|Overall Study|Death|0|||
94363708|NCT00424632|323116721|FG001|Overall Study|Death|0|||
94363709|NCT00424632|323116722|FG002|Overall Study|Death|0|||
94363710|NCT00424632|323116723|FG003|Overall Study|Death|0|||
94363711|NCT00424632|323116724|FG004|Overall Study|Death|0|||
94363712|NCT00424632|323116725|FG005|Overall Study|Death|2|||
94363713|NCT00424632|323116726|FG006|Overall Study|Death|0|||
94363714|NCT00424632|323116727|FG007|Overall Study|Death|0|||
94363715|NCT00424632|323116728|FG008|Overall Study|Death|0|||
94363716|NCT00424632|323116729|FG009|Overall Study|Death|0|||
94363717|NCT00424632|323116720|FG000|Overall Study|Adverse Event|0|||
94363718|NCT00424632|323116721|FG001|Overall Study|Adverse Event|0|||
94363719|NCT00424632|323116722|FG002|Overall Study|Adverse Event|0|||
94363720|NCT00424632|323116723|FG003|Overall Study|Adverse Event|0|||
94363721|NCT00424632|323116724|FG004|Overall Study|Adverse Event|0|||
94363722|NCT00424632|323116725|FG005|Overall Study|Adverse Event|0|||
94363723|NCT00424632|323116726|FG006|Overall Study|Adverse Event|0|||
94363724|NCT00424632|323116727|FG007|Overall Study|Adverse Event|0|||
94363725|NCT00424632|323116728|FG008|Overall Study|Adverse Event|3|||
94363726|NCT00424632|323116729|FG009|Overall Study|Adverse Event|2|||
94363727|NCT00424632|323116720|FG000|Overall Study|Global deterioration of health status|0|||
94363728|NCT00424632|323116721|FG001|Overall Study|Global deterioration of health status|0|||
94363729|NCT00424632|323116722|FG002|Overall Study|Global deterioration of health status|0|||
94363730|NCT00424632|323116723|FG003|Overall Study|Global deterioration of health status|1|||
94462691|NCT02326298|323483213|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
94462692|NCT02326298|323483214|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
94462693|NCT02326298|323483215|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
94462694|NCT02326298|323483216|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
94462695|NCT02326298|323483217|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
94462696|NCT02326298|323483218|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
94462697|NCT02326298|323483219|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
94462698|NCT02326298|323483220|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
94462699|NCT02326298|323483221|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
94462700|NCT02326298|323483208|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94462701|NCT02326298|323483209|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94462702|NCT02326298|323483210|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94462703|NCT02326298|323483211|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94462704|NCT02326298|323483212|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94462705|NCT02326298|323483213|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94462706|NCT02326298|323483214|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
94462707|NCT02326298|323483215|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
94462708|NCT02326298|323483216|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94462709|NCT02326298|323483217|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94462710|NCT02326298|323483218|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94462711|NCT02326298|323483219|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94462712|NCT02326298|323483220|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94462713|NCT02326298|323483221|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94462714|NCT02326298|323483208|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94462715|NCT02326298|323483209|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94462716|NCT02326298|323483210|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94462717|NCT02326298|323483211|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94462718|NCT02326298|323483212|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94462719|NCT02326298|323483213|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94462720|NCT02326298|323483214|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94642820|NCT00600756|324154964|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
94642821|NCT00600756|324154965|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
94642822|NCT00600756|324154964|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
94642823|NCT00600756|324154965|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
94642824|NCT00600756|324154964|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
94642825|NCT00600756|324154965|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
94642826|NCT00600756|324154964|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
94642827|NCT00600756|324154965|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
94642828|NCT00600756|324154964|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
94642829|NCT00600756|324154965|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
94642830|NCT00600756|324154964|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
94642831|NCT00600756|324154965|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
94642832|NCT00600756|324154964|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
94642833|NCT00600756|324154965|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
94642834|NCT00600756|324154964|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
94642835|NCT00600756|324154965|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
94642836|NCT00600756|324154964|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
94642837|NCT00600756|324154965|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
94462721|NCT02326298|323483215|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
94462722|NCT02326298|323483216|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94462723|NCT02326298|323483217|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94363731|NCT00424632|323116724|FG004|Overall Study|Global deterioration of health status|1|||
94363732|NCT00424632|323116725|FG005|Overall Study|Global deterioration of health status|0|||
94363733|NCT00424632|323116726|FG006|Overall Study|Global deterioration of health status|0|||
94363734|NCT00424632|323116727|FG007|Overall Study|Global deterioration of health status|0|||
94363735|NCT00424632|323116728|FG008|Overall Study|Global deterioration of health status|0|||
94363736|NCT00424632|323116729|FG009|Overall Study|Global deterioration of health status|0|||
94363737|NCT00424632|323116720|FG000|Overall Study|Objective progression or relapse|1|||
94462724|NCT02326298|323483218|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94462725|NCT02326298|323483219|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94462726|NCT02326298|323483220|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94462727|NCT02326298|323483221|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94462728|NCT02326298|323483208|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
94462729|NCT02326298|323483209|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
94462730|NCT02326298|323483210|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
94462731|NCT02326298|323483211|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
94462732|NCT02326298|323483212|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
94462733|NCT02326298|323483213|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
94462734|NCT02326298|323483214|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
94462735|NCT02326298|323483215|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
94462736|NCT02326298|323483216|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
94462737|NCT02326298|323483217|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
94462738|NCT02326298|323483218|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
94462739|NCT02326298|323483219|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
94462740|NCT02326298|323483220|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
94462741|NCT02326298|323483221|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
94462742|NCT02326298|323483208|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
94462743|NCT02326298|323483209|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
94462744|NCT02326298|323483210|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
94462745|NCT02326298|323483211|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
94642838|NCT00600756|324154964|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
94363738|NCT00424632|323116721|FG001|Overall Study|Objective progression or relapse|1|||
94363739|NCT00424632|323116722|FG002|Overall Study|Objective progression or relapse|1|||
94363740|NCT00424632|323116723|FG003|Overall Study|Objective progression or relapse|2|||
94363741|NCT00424632|323116724|FG004|Overall Study|Objective progression or relapse|2|||
94363742|NCT00424632|323116725|FG005|Overall Study|Objective progression or relapse|13|||
94363743|NCT00424632|323116726|FG006|Overall Study|Objective progression or relapse|7|||
94363744|NCT00424632|323116727|FG007|Overall Study|Objective progression or relapse|3|||
94363745|NCT00424632|323116728|FG008|Overall Study|Objective progression or relapse|12|||
94363746|NCT00424632|323116729|FG009|Overall Study|Objective progression or relapse|4|||
94363747|NCT00424632|323116720|FG000|Overall Study|Other|0|||
94363748|NCT00424632|323116721|FG001|Overall Study|Other|0|||
94363749|NCT00424632|323116722|FG002|Overall Study|Other|0|||
94363750|NCT00424632|323116723|FG003|Overall Study|Other|1|||
94363751|NCT00424632|323116724|FG004|Overall Study|Other|0|||
94363752|NCT00424632|323116725|FG005|Overall Study|Other|0|||
94363753|NCT00424632|323116726|FG006|Overall Study|Other|0|||
94363754|NCT00424632|323116727|FG007|Overall Study|Other|0|||
94363755|NCT00424632|323116728|FG008|Overall Study|Other|1|||
94363756|NCT00424632|323116729|FG009|Overall Study|Other|0|||
94363757|NCT00445458|323116730|FG000|Overall Study|Disease Progression|3|||
94363758|NCT00445458|323116731|FG001|Overall Study|Disease Progression|4|||
94363759|NCT00445458|323116732|FG002|Overall Study|Disease Progression|54|||
94363760|NCT00445458|323116733|FG003|Overall Study|Disease Progression|27|||
94363761|NCT00445458|323116730|FG000|Overall Study|Withdrawal by Subject|0|||
94363762|NCT00445458|323116731|FG001|Overall Study|Withdrawal by Subject|0|||
94363763|NCT00445458|323116732|FG002|Overall Study|Withdrawal by Subject|7|||
94363764|NCT00445458|323116733|FG003|Overall Study|Withdrawal by Subject|0|||
94363765|NCT00445458|323116730|FG000|Overall Study|Adverse Event|0|||
94363766|NCT00445458|323116731|FG001|Overall Study|Adverse Event|0|||
94363767|NCT00445458|323116732|FG002|Overall Study|Adverse Event|3|||
94363768|NCT00445458|323116733|FG003|Overall Study|Adverse Event|0|||
94363769|NCT00445458|323116730|FG000|Overall Study|Death|0|||
94363770|NCT00445458|323116731|FG001|Overall Study|Death|1|||
94363771|NCT00445458|323116732|FG002|Overall Study|Death|2|||
94363772|NCT00445458|323116733|FG003|Overall Study|Death|0|||
94363773|NCT00445458|323116730|FG000|Overall Study|Physician Decision|0|||
94363774|NCT00445458|323116731|FG001|Overall Study|Physician Decision|0|||
94363775|NCT00445458|323116732|FG002|Overall Study|Physician Decision|1|||
94363776|NCT00445458|323116733|FG003|Overall Study|Physician Decision|1|||
94363777|NCT00445458|323116730|FG000|Overall Study|Surgery|0|||
94363778|NCT00445458|323116731|FG001|Overall Study|Surgery|0|||
94363779|NCT00445458|323116732|FG002|Overall Study|Surgery|1|||
94363780|NCT00445458|323116733|FG003|Overall Study|Surgery|0|||
94363781|NCT01071083|323116734|FG000|Overall Study|Adverse Event|1|||
94363782|NCT01071083|323116735|FG001|Overall Study|Adverse Event|0|||
94363783|NCT01071083|323116736|FG002|Overall Study|Adverse Event|1|||
94363784|NCT01071083|323116737|FG003|Overall Study|Adverse Event|0|||
94363785|NCT01071083|323116738|FG004|Overall Study|Adverse Event|1|||
94363786|NCT01071083|323116734|FG000|Overall Study|Withdrawal by Subject|3|||
94363787|NCT01071083|323116735|FG001|Overall Study|Withdrawal by Subject|0|||
94363788|NCT01071083|323116736|FG002|Overall Study|Withdrawal by Subject|2|||
94363789|NCT01071083|323116737|FG003|Overall Study|Withdrawal by Subject|0|||
94363790|NCT01071083|323116738|FG004|Overall Study|Withdrawal by Subject|3|||
94363791|NCT01071083|323116734|FG000|Overall Study|Physician Decision|1|||
94363792|NCT01071083|323116735|FG001|Overall Study|Physician Decision|0|||
94363793|NCT01071083|323116736|FG002|Overall Study|Physician Decision|0|||
94642839|NCT00600756|324154965|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
94642840|NCT00600756|324154964|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
94642841|NCT00600756|324154965|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
94642842|NCT04414553|324154966|FG000|Overall Study|Lost to Follow-up|20|||
94363794|NCT01071083|323116737|FG003|Overall Study|Physician Decision|1|||
94363795|NCT01071083|323116738|FG004|Overall Study|Physician Decision|1|||
94363796|NCT01071083|323116734|FG000|Overall Study|Early Rescue|1|||
94363797|NCT01071083|323116735|FG001|Overall Study|Early Rescue|0|||
94363798|NCT01071083|323116736|FG002|Overall Study|Early Rescue|0|||
94363799|NCT01071083|323116737|FG003|Overall Study|Early Rescue|0|||
94363800|NCT01071083|323116738|FG004|Overall Study|Early Rescue|1|||
94363801|NCT01071083|323116734|FG000|Overall Study|Subject Moved|0|||
94363802|NCT01071083|323116735|FG001|Overall Study|Subject Moved|1|||
94363803|NCT01071083|323116736|FG002|Overall Study|Subject Moved|0|||
94462746|NCT02326298|323483212|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
94462747|NCT02326298|323483213|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
94462748|NCT02326298|323483214|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
94462749|NCT02326298|323483215|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
94462750|NCT02326298|323483216|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
94462751|NCT02326298|323483217|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
94462752|NCT02326298|323483218|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
94462753|NCT02326298|323483219|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
94462754|NCT02326298|323483220|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
94462755|NCT02326298|323483221|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
94462756|NCT02326298|323483208|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94462757|NCT02326298|323483209|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94462758|NCT02326298|323483210|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94462759|NCT02326298|323483211|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94462760|NCT02326298|323483212|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94462761|NCT02326298|323483213|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94462762|NCT02326298|323483214|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94462763|NCT02326298|323483215|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94462764|NCT02326298|323483216|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94462765|NCT02326298|323483217|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94462766|NCT02326298|323483218|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94462767|NCT02326298|323483219|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
94462768|NCT02326298|323483220|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
94462769|NCT02326298|323483221|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94462770|NCT02326298|323483208|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94462771|NCT02326298|323483209|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94462772|NCT02326298|323483210|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94462773|NCT02326298|323483211|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94462774|NCT02326298|323483212|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94462775|NCT02326298|323483213|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94462776|NCT02326298|323483214|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94462777|NCT02326298|323483215|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94462778|NCT02326298|323483216|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94462779|NCT02326298|323483217|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94462780|NCT02326298|323483218|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94462781|NCT02326298|323483219|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
94462782|NCT02326298|323483220|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
94462783|NCT02326298|323483221|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94462784|NCT02326298|323483208|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94462785|NCT02326298|323483209|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94462786|NCT02326298|323483210|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94462787|NCT02326298|323483211|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94462788|NCT02326298|323483212|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94642843|NCT04753164|324154970|FG000|Overall Study|Adverse Event|0|||
94642844|NCT04753164|324154971|FG001|Overall Study|Adverse Event|2|||
94263453|NCT00375219|322758230|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
94263454|NCT00375219|322758228|FG000|Overall Study|Allograft|2|||
94642845|NCT04753164|324154970|FG000|Overall Study|Withdrawal by Subject|9|||
94642846|NCT04753164|324154971|FG001|Overall Study|Withdrawal by Subject|7|||
94642847|NCT04753164|324154970|FG000|Overall Study|Lost to Follow-up|6|||
94642848|NCT04753164|324154971|FG001|Overall Study|Lost to Follow-up|6|||
94642849|NCT04753164|324154970|FG000|Overall Study|Other|12|||
94642850|NCT04753164|324154971|FG001|Overall Study|Other|5|||
94462789|NCT02326298|323483213|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94462790|NCT02326298|323483214|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94462791|NCT02326298|323483215|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94462792|NCT02326298|323483216|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94462793|NCT02326298|323483217|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94678977|NCT01412801|324278937|FG001|Overall Study|Lost to Follow-up|2|||
94678978|NCT01412801|324278938|FG002|Overall Study|Lost to Follow-up|4|||
94462794|NCT02326298|323483218|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94642851|NCT00694369|324154972|FG000|Overall Study|Adverse Event|0|||
94642852|NCT00694369|324154973|FG001|Overall Study|Adverse Event|1|||
94642853|NCT00694369|324154974|FG002|Overall Study|Adverse Event|0|||
94462795|NCT02326298|323483219|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94462796|NCT02326298|323483220|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94462797|NCT02326298|323483221|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
94462798|NCT02326298|323483208|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94462799|NCT02326298|323483209|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94462800|NCT02326298|323483210|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94462801|NCT02326298|323483211|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94462802|NCT02326298|323483212|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94462803|NCT02326298|323483213|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94462804|NCT02326298|323483214|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94462805|NCT02326298|323483215|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94462806|NCT02326298|323483216|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94462807|NCT02326298|323483217|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94462808|NCT02326298|323483218|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94462809|NCT02326298|323483219|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
94462810|NCT02326298|323483220|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
94642854|NCT00694369|324154975|FG003|Overall Study|Adverse Event|1|||
94462811|NCT02326298|323483221|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
94462812|NCT02326298|323483208|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94462813|NCT02326298|323483209|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94642855|NCT00694369|324154976|FG004|Overall Study|Adverse Event|3|||
94642856|NCT00694369|324154972|FG000|Overall Study|Lost to Follow-up|0|||
94363804|NCT01071083|323116737|FG003|Overall Study|Subject Moved|0|||
94363805|NCT01071083|323116738|FG004|Overall Study|Subject Moved|0|||
94363806|NCT01071083|323116734|FG000|Overall Study|Images Not Usable (Motion)|0|||
94363807|NCT01071083|323116735|FG001|Overall Study|Images Not Usable (Motion)|1|||
94363808|NCT01071083|323116736|FG002|Overall Study|Images Not Usable (Motion)|0|||
94363809|NCT01071083|323116737|FG003|Overall Study|Images Not Usable (Motion)|0|||
94363810|NCT01071083|323116738|FG004|Overall Study|Images Not Usable (Motion)|0|||
94363811|NCT01071083|323116734|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
94363812|NCT01071083|323116735|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
94363813|NCT01071083|323116736|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
94462814|NCT02326298|323483210|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94363814|NCT01071083|323116737|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
94363815|NCT01071083|323116738|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
94462815|NCT02326298|323483211|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94462816|NCT02326298|323483212|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94462817|NCT02326298|323483213|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94462818|NCT02326298|323483214|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94462819|NCT02326298|323483215|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94462820|NCT02326298|323483216|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94462821|NCT02326298|323483217|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94462822|NCT02326298|323483218|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94462823|NCT02326298|323483219|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
94462824|NCT02326298|323483220|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
94462825|NCT02326298|323483221|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
94462826|NCT02326298|323483208|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94462827|NCT02326298|323483209|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94462828|NCT02326298|323483210|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94462829|NCT02326298|323483211|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94462830|NCT02326298|323483212|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94462831|NCT02326298|323483213|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94462832|NCT02326298|323483214|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94462833|NCT02326298|323483215|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94462834|NCT02326298|323483216|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94462835|NCT02326298|323483217|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94462836|NCT02326298|323483218|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94462837|NCT02326298|323483219|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
94462838|NCT02326298|323483220|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
94462839|NCT02326298|323483221|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
94462840|NCT03191864|323483222|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
94462841|NCT03191864|323483223|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
94462842|NCT03191864|323483224|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
94462843|NCT03191864|323483225|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
94462844|NCT03191864|323483226|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
94462845|NCT03191864|323483227|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
94363816|NCT01071083|323116734|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
94363817|NCT01071083|323116735|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
94462846|NCT03191864|323483222|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
94462847|NCT03191864|323483223|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
94678979|NCT01412801|324278939|FG003|Overall Study|Lost to Follow-up|0|||
94363818|NCT01071083|323116736|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
94363819|NCT01071083|323116737|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
94363820|NCT01071083|323116738|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
94462848|NCT03191864|323483224|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
94462849|NCT03191864|323483225|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
94462850|NCT03191864|323483226|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
94462851|NCT03191864|323483227|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
94462852|NCT03191864|323483222|FG000|Baseline Symptom Assessment|Adverse Event|0|||
94462853|NCT03191864|323483223|FG001|Baseline Symptom Assessment|Adverse Event|0|||
94462854|NCT03191864|323483224|FG002|Baseline Symptom Assessment|Adverse Event|0|||
94462855|NCT03191864|323483225|FG003|Baseline Symptom Assessment|Adverse Event|0|||
94462856|NCT03191864|323483226|FG004|Baseline Symptom Assessment|Adverse Event|0|||
94462857|NCT03191864|323483227|FG005|Baseline Symptom Assessment|Adverse Event|2|||
94462858|NCT03191864|323483222|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
94462859|NCT03191864|323483223|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
94462860|NCT03191864|323483224|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
94462861|NCT03191864|323483225|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
94462862|NCT03191864|323483226|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
94462863|NCT03191864|323483227|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
94642857|NCT00694369|324154973|FG001|Overall Study|Lost to Follow-up|0|||
94642858|NCT00694369|324154974|FG002|Overall Study|Lost to Follow-up|1|||
94642859|NCT00694369|324154975|FG003|Overall Study|Lost to Follow-up|1|||
94642860|NCT00694369|324154976|FG004|Overall Study|Lost to Follow-up|0|||
94642861|NCT00694369|324154972|FG000|Overall Study|Physician Decision|0|||
94642862|NCT00694369|324154973|FG001|Overall Study|Physician Decision|0|||
94642863|NCT00694369|324154974|FG002|Overall Study|Physician Decision|0|||
94642864|NCT00694369|324154975|FG003|Overall Study|Physician Decision|0|||
94642865|NCT00694369|324154976|FG004|Overall Study|Physician Decision|1|||
94642866|NCT00694369|324154972|FG000|Overall Study|Protocol Violation|0|||
94642867|NCT00694369|324154973|FG001|Overall Study|Protocol Violation|1|||
94642868|NCT00694369|324154974|FG002|Overall Study|Protocol Violation|0|||
94642869|NCT00694369|324154975|FG003|Overall Study|Protocol Violation|0|||
94642870|NCT00694369|324154976|FG004|Overall Study|Protocol Violation|0|||
94642871|NCT00694369|324154972|FG000|Overall Study|Withdrawal by Subject|1|||
94642872|NCT00694369|324154973|FG001|Overall Study|Withdrawal by Subject|1|||
94642873|NCT00694369|324154974|FG002|Overall Study|Withdrawal by Subject|1|||
94642874|NCT00694369|324154975|FG003|Overall Study|Withdrawal by Subject|1|||
94642875|NCT00694369|324154976|FG004|Overall Study|Withdrawal by Subject|2|||
94642876|NCT06049043|324154979|FG000|Overall Study|Lost to Follow-up|11|||
94642877|NCT06049043|324154980|FG001|Overall Study|Lost to Follow-up|9|||
94642878|NCT02722928|324154981|FG000|Overall Study|Standard CT was not as required per prot|5|||
94642879|NCT02722928|324154982|FG001|Overall Study|Standard CT was not as required per prot|13|||
94642880|NCT02722928|324154981|FG000|Overall Study|Required Intraoperative MRI|5|||
94642881|NCT02722928|324154982|FG001|Overall Study|Required Intraoperative MRI|7|||
94642882|NCT02818777|324154983|FG000|Overall Study|Adverse Event|3|||
94642883|NCT00291668|324154984|FG000|Overall Study|Lack of Efficacy|1|||
94642884|NCT00291668|324154985|FG001|Overall Study|Lack of Efficacy|0|||
94642885|NCT00291668|324154986|FG002|Overall Study|Lack of Efficacy|0|||
94642886|NCT00291668|324154984|FG000|Overall Study|SAE, non-fatal|1|||
94642887|NCT00291668|324154985|FG001|Overall Study|SAE, non-fatal|1|||
94642888|NCT00291668|324154986|FG002|Overall Study|SAE, non-fatal|1|||
94642889|NCT00291668|324154984|FG000|Overall Study|AE, non-serious non-fatal|1|||
94642890|NCT00291668|324154985|FG001|Overall Study|AE, non-serious non-fatal|0|||
94363821|NCT01071083|323116734|FG000|Overall Study|Subject Refused to Continue|1|||
94363822|NCT01071083|323116735|FG001|Overall Study|Subject Refused to Continue|0|||
94363823|NCT01071083|323116736|FG002|Overall Study|Subject Refused to Continue|0|||
94363824|NCT01071083|323116737|FG003|Overall Study|Subject Refused to Continue|0|||
94363825|NCT01071083|323116738|FG004|Overall Study|Subject Refused to Continue|0|||
94363826|NCT03972709|323116739|FG000|Overall Study|Withdrawal by Subject|18|||
94642891|NCT00291668|324154986|FG002|Overall Study|AE, non-serious non-fatal|0|||
94642892|NCT00291668|324154984|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
94642893|NCT00291668|324154985|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
94642894|NCT00291668|324154986|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
94642895|NCT00842348|324154989|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
94642896|NCT00842348|324154990|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
94642897|NCT00842348|324154989|FG000|Study 729|Disease progression/death|19|||
94642898|NCT00842348|324154990|FG001|Study 729|Disease progression/death|30|||
94642899|NCT00842348|324154989|FG000|Study 729|Adverse Event|1|||
94642900|NCT00842348|324154990|FG001|Study 729|Adverse Event|1|||
94642901|NCT00842348|324154989|FG000|Study 729|Protocol Violation|1|||
94678980|NCT01412801|324278940|FG004|Overall Study|Lost to Follow-up|1|||
94678981|NCT01412801|324278941|FG005|Overall Study|Lost to Follow-up|1|||
94678982|NCT01412801|324278936|FG000|Overall Study|Withdrawal by Subject|3|||
94678983|NCT01412801|324278937|FG001|Overall Study|Withdrawal by Subject|2|||
94678984|NCT01412801|324278938|FG002|Overall Study|Withdrawal by Subject|1|||
94678985|NCT01412801|324278939|FG003|Overall Study|Withdrawal by Subject|0|||
94678986|NCT01412801|324278940|FG004|Overall Study|Withdrawal by Subject|0|||
94678987|NCT01412801|324278941|FG005|Overall Study|Withdrawal by Subject|0|||
94678988|NCT01412801|324278936|FG000|Overall Study|Relocated to another area|0|||
94678989|NCT01412801|324278937|FG001|Overall Study|Relocated to another area|0|||
94678990|NCT01412801|324278938|FG002|Overall Study|Relocated to another area|2|||
94678991|NCT01412801|324278939|FG003|Overall Study|Relocated to another area|0|||
94678992|NCT01412801|324278940|FG004|Overall Study|Relocated to another area|0|||
94678993|NCT01412801|324278941|FG005|Overall Study|Relocated to another area|0|||
94678994|NCT00116272|324278942|FG000|Overall Study|Lost to Follow-up|11|||
94642902|NCT00842348|324154990|FG001|Study 729|Protocol Violation|1|||
94678995|NCT00116272|324278943|FG001|Overall Study|Lost to Follow-up|6|||
94678996|NCT03188120|324278944|FG000|Overall Study|Adverse Event|4|||
94678997|NCT03188120|324278944|FG000|Overall Study|Insufficient Effectiveness|8|||
94678998|NCT03188120|324278944|FG000|Overall Study|Improved|12|||
94642903|NCT00842348|324154989|FG000|Study 729|Withdrawal by Subject|2|||
94678999|NCT03188120|324278944|FG000|Overall Study|Lost to Follow-up|7|||
94679000|NCT03188120|324278944|FG000|Overall Study|Other than specified|3|||
94679001|NCT03188120|324278944|FG000|Overall Study|No visit after the first visit|13|||
94679002|NCT00717314|324278945|FG000|Overall Study|Adverse Event|3|||
94679003|NCT00717314|324278946|FG001|Overall Study|Adverse Event|2|||
94679004|NCT00717314|324278945|FG000|Overall Study|Protocol Violation|1|||
94679005|NCT00717314|324278946|FG001|Overall Study|Protocol Violation|0|||
94679006|NCT00717314|324278945|FG000|Overall Study|Lost to Follow-up|1|||
94679007|NCT00717314|324278946|FG001|Overall Study|Lost to Follow-up|5|||
94679008|NCT00717314|324278945|FG000|Overall Study|Withdrawal by Subject|1|||
94679009|NCT00717314|324278946|FG001|Overall Study|Withdrawal by Subject|3|||
94679010|NCT05076149|324278947|FG000|Overall Study|Adverse Event|3|||
94642904|NCT00842348|324154990|FG001|Study 729|Withdrawal by Subject|4|||
94642905|NCT00842348|324154989|FG000|Study 729|Due to Sponsor stopping the study|1|||
94642906|NCT00842348|324154990|FG001|Study 729|Due to Sponsor stopping the study|1|||
94642907|NCT00842348|324154989|FG000|Study 729|Due to non-availability of IP|0|||
94642908|NCT00842348|324154990|FG001|Study 729|Due to non-availability of IP|1|||
94642909|NCT00842348|324154989|FG000|Study 729|Sponsor's decision|1|||
94642910|NCT00842348|324154990|FG001|Study 729|Sponsor's decision|0|||
94642911|NCT00842348|324154989|FG000|Study 729|Surgical resection|1|||
94642912|NCT00842348|324154990|FG001|Study 729|Surgical resection|0|||
94642913|NCT00603746|324154991|FG000|Overall Study|Adverse Event|2|||
94642914|NCT00603746|324154992|FG001|Overall Study|Adverse Event|3|||
94642915|NCT00603746|324154993|FG002|Overall Study|Adverse Event|0|||
94642916|NCT00603746|324154994|FG003|Overall Study|Adverse Event|1|||
94642917|NCT00603746|324154995|FG004|Overall Study|Adverse Event|0|||
94642918|NCT00603746|324154996|FG005|Overall Study|Adverse Event|4|||
94642919|NCT00603746|324154991|FG000|Overall Study|Lack of Efficacy|34|||
94642920|NCT00603746|324154992|FG001|Overall Study|Lack of Efficacy|11|||
94642921|NCT00603746|324154993|FG002|Overall Study|Lack of Efficacy|6|||
94642922|NCT00603746|324154994|FG003|Overall Study|Lack of Efficacy|11|||
94642923|NCT00603746|324154995|FG004|Overall Study|Lack of Efficacy|12|||
94642924|NCT00603746|324154996|FG005|Overall Study|Lack of Efficacy|8|||
94642925|NCT00603746|324154991|FG000|Overall Study|Protocol Violation|0|||
94642926|NCT00603746|324154992|FG001|Overall Study|Protocol Violation|3|||
94642927|NCT00603746|324154993|FG002|Overall Study|Protocol Violation|1|||
94642928|NCT00603746|324154994|FG003|Overall Study|Protocol Violation|0|||
94642929|NCT00603746|324154995|FG004|Overall Study|Protocol Violation|1|||
94642930|NCT00603746|324154996|FG005|Overall Study|Protocol Violation|0|||
94642931|NCT00603746|324154991|FG000|Overall Study|Lost to Follow-up|0|||
94679011|NCT05076149|324278948|FG001|Overall Study|Adverse Event|9|||
94263455|NCT00375219|322758229|FG001|Overall Study|Allograft|0|||
94642932|NCT00603746|324154992|FG001|Overall Study|Lost to Follow-up|1|||
94642933|NCT00603746|324154993|FG002|Overall Study|Lost to Follow-up|1|||
94642934|NCT00603746|324154994|FG003|Overall Study|Lost to Follow-up|0|||
94642935|NCT00603746|324154995|FG004|Overall Study|Lost to Follow-up|0|||
94642936|NCT00603746|324154996|FG005|Overall Study|Lost to Follow-up|0|||
94642937|NCT00603746|324154991|FG000|Overall Study|Physician Decision|1|||
94679012|NCT05076149|324278947|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
94679013|NCT05076149|324278948|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
94679014|NCT05076149|324278947|FG000|Overall Study|Lost to Follow-up|0|||
94679015|NCT05076149|324278948|FG001|Overall Study|Lost to Follow-up|1|||
94679016|NCT05076149|324278947|FG000|Overall Study|Commercial drug is available for participant|0|||
94679017|NCT05076149|324278948|FG001|Overall Study|Commercial drug is available for participant|1|||
94679018|NCT05076149|324278947|FG000|Overall Study|Other non compliance|1|||
94679019|NCT05076149|324278948|FG001|Overall Study|Other non compliance|1|||
94642938|NCT00603746|324154992|FG001|Overall Study|Physician Decision|0|||
94642939|NCT00603746|324154993|FG002|Overall Study|Physician Decision|0|||
94642940|NCT00603746|324154994|FG003|Overall Study|Physician Decision|0|||
94642941|NCT00603746|324154995|FG004|Overall Study|Physician Decision|1|||
94642942|NCT00603746|324154996|FG005|Overall Study|Physician Decision|0|||
94642943|NCT00603746|324154991|FG000|Overall Study|Withdrawal by Subject|1|||
94642944|NCT00603746|324154992|FG001|Overall Study|Withdrawal by Subject|0|||
94642945|NCT00603746|324154993|FG002|Overall Study|Withdrawal by Subject|0|||
94642946|NCT00603746|324154994|FG003|Overall Study|Withdrawal by Subject|1|||
94642947|NCT00603746|324154995|FG004|Overall Study|Withdrawal by Subject|3|||
94642948|NCT00603746|324154996|FG005|Overall Study|Withdrawal by Subject|1|||
94642949|NCT01113879|324154999|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
94642950|NCT01113879|324155000|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
94642951|NCT01524627|324155009|FG000|Overall Study|Physician Decision|0|||
94642952|NCT01524627|324155010|FG001|Overall Study|Physician Decision|1|||
94642953|NCT01524627|324155009|FG000|Overall Study|Lost to Follow-up|1|||
94642954|NCT01524627|324155010|FG001|Overall Study|Lost to Follow-up|1|||
94642955|NCT00969553|324155011|FG000|Overall Study|Progressive disease (PD)|2|||
94642956|NCT00969553|324155012|FG001|Overall Study|Progressive disease (PD)|2|||
94642957|NCT00969553|324155013|FG002|Overall Study|Progressive disease (PD)|6|||
94642958|NCT00969553|324155014|FG003|Overall Study|Progressive disease (PD)|9|||
94642959|NCT00969553|324155015|FG004|Overall Study|Progressive disease (PD)|2|||
94642960|NCT00969553|324155016|FG005|Overall Study|Progressive disease (PD)|4|||
94642961|NCT00969553|324155017|FG006|Overall Study|Progressive disease (PD)|2|||
94642962|NCT00969553|324155018|FG007|Overall Study|Progressive disease (PD)|12|||
94642963|NCT00969553|324155019|FG008|Overall Study|Progressive disease (PD)|3|||
94642964|NCT00969553|324155011|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
94263456|NCT00375219|322758230|FG002|Overall Study|Allograft|0|||
94462864|NCT03191864|323483222|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
94462865|NCT03191864|323483223|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
94462866|NCT03191864|323483224|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
94462867|NCT03191864|323483225|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
94462868|NCT03191864|323483226|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
94462869|NCT03191864|323483227|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
94462870|NCT03191864|323483222|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
94462871|NCT03191864|323483223|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
94462872|NCT03191864|323483224|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
94462873|NCT03191864|323483225|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
94462874|NCT03191864|323483226|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
94462875|NCT03191864|323483227|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
94462876|NCT03191864|323483222|FG000|Part 1 - Induction|Adverse Event|0|||
94462877|NCT03191864|323483223|FG001|Part 1 - Induction|Adverse Event|2|||
94462878|NCT03191864|323483224|FG002|Part 1 - Induction|Adverse Event|0|||
94462879|NCT03191864|323483225|FG003|Part 1 - Induction|Adverse Event|1|||
94462880|NCT03191864|323483226|FG004|Part 1 - Induction|Adverse Event|0|||
94462881|NCT03191864|323483227|FG005|Part 1 - Induction|Adverse Event|2|||
94462882|NCT03191864|323483222|FG000|Part 1 - Induction|Randomized but never dosed|0|||
94462883|NCT03191864|323483223|FG001|Part 1 - Induction|Randomized but never dosed|0|||
94462884|NCT03191864|323483224|FG002|Part 1 - Induction|Randomized but never dosed|1|||
94462885|NCT03191864|323483225|FG003|Part 1 - Induction|Randomized but never dosed|0|||
94462886|NCT03191864|323483226|FG004|Part 1 - Induction|Randomized but never dosed|0|||
94462887|NCT03191864|323483227|FG005|Part 1 - Induction|Randomized but never dosed|0|||
94462888|NCT03191864|323483222|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
94462889|NCT03191864|323483223|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
94462890|NCT03191864|323483224|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
94462891|NCT03191864|323483225|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
94462892|NCT03191864|323483226|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
94462893|NCT03191864|323483227|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
94462894|NCT03191864|323483222|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
94363827|NCT03972709|323116740|FG001|Overall Study|Withdrawal by Subject|7|||
94363828|NCT03972709|323116741|FG002|Overall Study|Withdrawal by Subject|14|||
94679020|NCT05076149|324278947|FG000|Overall Study|Physician Decision|0|||
94679021|NCT05076149|324278948|FG001|Overall Study|Physician Decision|1|||
94679022|NCT05076149|324278947|FG000|Overall Study|Other|5|||
94679023|NCT05076149|324278948|FG001|Overall Study|Other|4|||
94679024|NCT00782496|324278949|FG000|Overall Study|Lost to Follow-up|14|||
94679025|NCT00782496|324278950|FG001|Overall Study|Lost to Follow-up|15|||
94679026|NCT01521884|324278951|FG000|Overall Study|Non Responders|10|||
94679027|NCT01521884|324278951|FG000|Overall Study|Adverse Event|5|||
94462895|NCT03191864|323483223|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
94462896|NCT03191864|323483224|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
94462897|NCT03191864|323483225|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
94462898|NCT03191864|323483226|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
94462899|NCT03191864|323483227|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
94462900|NCT03191864|323483222|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
94462901|NCT03191864|323483223|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
94462902|NCT03191864|323483224|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
94462903|NCT03191864|323483225|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
94462904|NCT03191864|323483226|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
94462905|NCT03191864|323483227|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
94462906|NCT03191864|323483222|FG000|Part 2 - Maintenance|Physician Decision|1|||
94462907|NCT03191864|323483223|FG001|Part 2 - Maintenance|Physician Decision|0|||
94462908|NCT03191864|323483224|FG002|Part 2 - Maintenance|Physician Decision|0|||
94462909|NCT03191864|323483225|FG003|Part 2 - Maintenance|Physician Decision|0|||
94462910|NCT03191864|323483226|FG004|Part 2 - Maintenance|Physician Decision|0|||
94462911|NCT03191864|323483227|FG005|Part 2 - Maintenance|Physician Decision|0|||
94462912|NCT03191864|323483222|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
94363829|NCT03972709|323116739|FG000|Overall Study|Study Terminated by Sponsor|48|||
94363830|NCT03972709|323116740|FG001|Overall Study|Study Terminated by Sponsor|25|||
94363831|NCT03972709|323116741|FG002|Overall Study|Study Terminated by Sponsor|50|||
94363832|NCT03972709|323116739|FG000|Overall Study|Physician Decision|1|||
94363833|NCT03972709|323116740|FG001|Overall Study|Physician Decision|0|||
94363834|NCT03972709|323116741|FG002|Overall Study|Physician Decision|0|||
94363835|NCT03972709|323116739|FG000|Overall Study|COVID-19|0|||
94363836|NCT03972709|323116740|FG001|Overall Study|COVID-19|1|||
94363837|NCT03972709|323116741|FG002|Overall Study|COVID-19|1|||
94363838|NCT03972709|323116739|FG000|Overall Study|Lost to Follow-up|6|||
94363839|NCT03972709|323116740|FG001|Overall Study|Lost to Follow-up|1|||
94363840|NCT03972709|323116741|FG002|Overall Study|Lost to Follow-up|2|||
94363841|NCT03972709|323116739|FG000|Overall Study|Death|5|||
94363842|NCT03972709|323116740|FG001|Overall Study|Death|1|||
94363843|NCT03972709|323116741|FG002|Overall Study|Death|4|||
94363844|NCT03972709|323116739|FG000|Overall Study|Adverse Event|3|||
94363845|NCT03972709|323116740|FG001|Overall Study|Adverse Event|1|||
94363846|NCT03972709|323116741|FG002|Overall Study|Adverse Event|4|||
94363847|NCT03972709|323116739|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
94363848|NCT03972709|323116740|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
94363849|NCT03972709|323116741|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
94363850|NCT03972709|323116739|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
94363851|NCT03972709|323116740|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
94363852|NCT03972709|323116741|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
94363853|NCT03972709|323116739|FG000|Overall Study|Subject Unable to be Contacted|0|||
94363854|NCT03972709|323116740|FG001|Overall Study|Subject Unable to be Contacted|1|||
94363855|NCT03972709|323116741|FG002|Overall Study|Subject Unable to be Contacted|0|||
94363856|NCT03972709|323116739|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
94363857|NCT03972709|323116740|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
94363858|NCT03972709|323116741|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
94363859|NCT03972709|323116739|FG000|Overall Study|Subject Moved|0|||
94462913|NCT03191864|323483223|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
94679028|NCT01521884|324278951|FG000|Overall Study|Pregnancy|1|||
94679029|NCT01521884|324278951|FG000|Overall Study|Withdrawal by Subject|1|||
94462914|NCT03191864|323483224|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
94462915|NCT03191864|323483225|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
94462916|NCT03191864|323483226|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
94462917|NCT03191864|323483227|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
94462918|NCT03191864|323483222|FG000|Part 2 - Maintenance|Adverse Event|0|||
94462919|NCT03191864|323483223|FG001|Part 2 - Maintenance|Adverse Event|0|||
94462920|NCT03191864|323483224|FG002|Part 2 - Maintenance|Adverse Event|0|||
94462921|NCT03191864|323483225|FG003|Part 2 - Maintenance|Adverse Event|0|||
94462922|NCT03191864|323483226|FG004|Part 2 - Maintenance|Adverse Event|1|||
94462923|NCT03191864|323483227|FG005|Part 2 - Maintenance|Adverse Event|0|||
94462924|NCT03191864|323483222|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
94462925|NCT03191864|323483223|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
94462926|NCT03191864|323483224|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
94462927|NCT03191864|323483225|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
94462928|NCT03191864|323483226|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
94462929|NCT03191864|323483227|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
94462930|NCT03191864|323483222|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
94462931|NCT03191864|323483223|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
94462932|NCT03191864|323483224|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
94462933|NCT03191864|323483225|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
94462934|NCT03191864|323483226|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
94462935|NCT03191864|323483227|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
94462936|NCT02044874|323483228|FG000|Overall Study|Adverse Event|5|||
94462937|NCT02044874|323483229|FG001|Overall Study|Adverse Event|6|||
94462938|NCT02044874|323483230|FG002|Overall Study|Adverse Event|6|||
94462939|NCT02044874|323483228|FG000|Overall Study|Withdrawal by Subject|8|||
94462940|NCT02044874|323483229|FG001|Overall Study|Withdrawal by Subject|16|||
94462941|NCT02044874|323483230|FG002|Overall Study|Withdrawal by Subject|23|||
94462942|NCT02044874|323483228|FG000|Overall Study|Physician Decision|0|||
94462943|NCT02044874|323483229|FG001|Overall Study|Physician Decision|2|||
94462944|NCT02044874|323483230|FG002|Overall Study|Physician Decision|1|||
94462945|NCT02044874|323483228|FG000|Overall Study|Lost to Follow-up|10|||
94462946|NCT02044874|323483229|FG001|Overall Study|Lost to Follow-up|27|||
94462947|NCT02044874|323483230|FG002|Overall Study|Lost to Follow-up|21|||
94462948|NCT02044874|323483228|FG000|Overall Study|Sponsor Decision|0|||
94462949|NCT02044874|323483229|FG001|Overall Study|Sponsor Decision|1|||
94462950|NCT02044874|323483230|FG002|Overall Study|Sponsor Decision|1|||
94462951|NCT02044874|323483228|FG000|Overall Study|Other|7|||
94462952|NCT02044874|323483229|FG001|Overall Study|Other|3|||
94462953|NCT02044874|323483230|FG002|Overall Study|Other|8|||
94462954|NCT05072964|323483233|FG000|Overall Study|Withdrawal by Subject|4|||
94462955|NCT05072964|323483233|FG000|Overall Study|Death|1|||
94462956|NCT02017717|323484972|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
94462957|NCT02017717|323484973|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
94462958|NCT02017717|323484974|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
94462959|NCT02017717|323484975|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
94462960|NCT02017717|323484976|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
94462961|NCT02017717|323484977|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
94462962|NCT02017717|323484978|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
94462963|NCT02017717|323484979|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
94462964|NCT02017717|323484980|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
94462965|NCT02017717|323484972|FG000|Before Treatment Period|Participant request to stop therapy|0|||
94462966|NCT02017717|323484973|FG001|Before Treatment Period|Participant request to stop therapy|0|||
94462967|NCT02017717|323484974|FG002|Before Treatment Period|Participant request to stop therapy|0|||
94462968|NCT02017717|323484975|FG003|Before Treatment Period|Participant request to stop therapy|0|||
94462969|NCT02017717|323484976|FG004|Before Treatment Period|Participant request to stop therapy|0|||
94462970|NCT02017717|323484977|FG005|Before Treatment Period|Participant request to stop therapy|0|||
94462971|NCT02017717|323484978|FG006|Before Treatment Period|Participant request to stop therapy|0|||
94462972|NCT02017717|323484979|FG007|Before Treatment Period|Participant request to stop therapy|0|||
94462973|NCT02017717|323484980|FG008|Before Treatment Period|Participant request to stop therapy|5|||
94462974|NCT02017717|323484972|FG000|Before Treatment Period|Participant withdrew consent|0|||
94462975|NCT02017717|323484973|FG001|Before Treatment Period|Participant withdrew consent|0|||
94642965|NCT00969553|324155012|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
94642966|NCT00969553|324155013|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
94642967|NCT00969553|324155014|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
94642968|NCT00969553|324155015|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
94642969|NCT00969553|324155016|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
94642970|NCT00969553|324155017|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
94642971|NCT00969553|324155018|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
94642972|NCT00969553|324155019|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
94642973|NCT00969553|324155011|FG000|Overall Study|Other Adverse Event|0|||
94642974|NCT00969553|324155012|FG001|Overall Study|Other Adverse Event|0|||
94642975|NCT00969553|324155013|FG002|Overall Study|Other Adverse Event|0|||
94642976|NCT00969553|324155014|FG003|Overall Study|Other Adverse Event|1|||
94642977|NCT00969553|324155015|FG004|Overall Study|Other Adverse Event|0|||
94642978|NCT00969553|324155016|FG005|Overall Study|Other Adverse Event|0|||
94642979|NCT00969553|324155017|FG006|Overall Study|Other Adverse Event|1|||
94642980|NCT00969553|324155018|FG007|Overall Study|Other Adverse Event|0|||
94642981|NCT00969553|324155019|FG008|Overall Study|Other Adverse Event|0|||
94642982|NCT00969553|324155011|FG000|Overall Study|Refused cont. medication|1|||
94642983|NCT00969553|324155012|FG001|Overall Study|Refused cont. medication|1|||
94642984|NCT00969553|324155013|FG002|Overall Study|Refused cont. medication|0|||
94642985|NCT00969553|324155014|FG003|Overall Study|Refused cont. medication|2|||
94642986|NCT00969553|324155015|FG004|Overall Study|Refused cont. medication|0|||
94642987|NCT00969553|324155016|FG005|Overall Study|Refused cont. medication|0|||
94642988|NCT00969553|324155017|FG006|Overall Study|Refused cont. medication|0|||
94642989|NCT00969553|324155018|FG007|Overall Study|Refused cont. medication|1|||
94642990|NCT00969553|324155019|FG008|Overall Study|Refused cont. medication|0|||
94642991|NCT00969553|324155011|FG000|Overall Study|Not specified above|0|||
94642992|NCT00969553|324155012|FG001|Overall Study|Not specified above|0|||
94642993|NCT00969553|324155013|FG002|Overall Study|Not specified above|0|||
94642994|NCT00969553|324155014|FG003|Overall Study|Not specified above|4|||
94642995|NCT00969553|324155015|FG004|Overall Study|Not specified above|0|||
94642996|NCT00969553|324155016|FG005|Overall Study|Not specified above|0|||
94642997|NCT00969553|324155017|FG006|Overall Study|Not specified above|1|||
94363860|NCT03972709|323116740|FG001|Overall Study|Subject Moved|1|||
94642998|NCT00969553|324155018|FG007|Overall Study|Not specified above|1|||
94462976|NCT02017717|323484974|FG002|Before Treatment Period|Participant withdrew consent|0|||
94462977|NCT02017717|323484975|FG003|Before Treatment Period|Participant withdrew consent|0|||
94462978|NCT02017717|323484976|FG004|Before Treatment Period|Participant withdrew consent|0|||
94462979|NCT02017717|323484977|FG005|Before Treatment Period|Participant withdrew consent|0|||
94462980|NCT02017717|323484978|FG006|Before Treatment Period|Participant withdrew consent|2|||
94462981|NCT02017717|323484979|FG007|Before Treatment Period|Participant withdrew consent|0|||
94462982|NCT02017717|323484980|FG008|Before Treatment Period|Participant withdrew consent|11|||
94462983|NCT02017717|323484972|FG000|Before Treatment Period|Lost to Follow-up|0|||
94462984|NCT02017717|323484973|FG001|Before Treatment Period|Lost to Follow-up|0|||
94462985|NCT02017717|323484974|FG002|Before Treatment Period|Lost to Follow-up|0|||
94462986|NCT02017717|323484975|FG003|Before Treatment Period|Lost to Follow-up|0|||
94462987|NCT02017717|323484976|FG004|Before Treatment Period|Lost to Follow-up|0|||
94462988|NCT02017717|323484977|FG005|Before Treatment Period|Lost to Follow-up|0|||
94462989|NCT02017717|323484978|FG006|Before Treatment Period|Lost to Follow-up|0|||
94462990|NCT02017717|323484979|FG007|Before Treatment Period|Lost to Follow-up|0|||
94462991|NCT02017717|323484980|FG008|Before Treatment Period|Lost to Follow-up|1|||
94462992|NCT02017717|323484972|FG000|Before Treatment Period|Participant no longer met criteria|0|||
94462993|NCT02017717|323484973|FG001|Before Treatment Period|Participant no longer met criteria|0|||
94462994|NCT02017717|323484974|FG002|Before Treatment Period|Participant no longer met criteria|0|||
94462995|NCT02017717|323484975|FG003|Before Treatment Period|Participant no longer met criteria|0|||
94462996|NCT02017717|323484976|FG004|Before Treatment Period|Participant no longer met criteria|0|||
94462997|NCT02017717|323484977|FG005|Before Treatment Period|Participant no longer met criteria|1|||
94462998|NCT02017717|323484978|FG006|Before Treatment Period|Participant no longer met criteria|0|||
94462999|NCT02017717|323484979|FG007|Before Treatment Period|Participant no longer met criteria|1|||
94463000|NCT02017717|323484980|FG008|Before Treatment Period|Participant no longer met criteria|2|||
94463001|NCT02017717|323484972|FG000|Before Treatment Period|other reason|0|||
94463002|NCT02017717|323484973|FG001|Before Treatment Period|other reason|0|||
94463003|NCT02017717|323484974|FG002|Before Treatment Period|other reason|0|||
94463004|NCT02017717|323484975|FG003|Before Treatment Period|other reason|0|||
94463005|NCT02017717|323484976|FG004|Before Treatment Period|other reason|0|||
94463006|NCT02017717|323484977|FG005|Before Treatment Period|other reason|0|||
94363861|NCT03972709|323116741|FG002|Overall Study|Subject Moved|0|||
94363862|NCT03972709|323116739|FG000|Overall Study|Missed Study Visits|1|||
94463007|NCT02017717|323484978|FG006|Before Treatment Period|other reason|0|||
94463008|NCT02017717|323484979|FG007|Before Treatment Period|other reason|0|||
94463009|NCT02017717|323484980|FG008|Before Treatment Period|other reason|1|||
94463010|NCT02017717|323484972|FG000|Treatment Period|Disease progression|7|||
94463011|NCT02017717|323484973|FG001|Treatment Period|Disease progression|9|||
94463012|NCT02017717|323484974|FG002|Treatment Period|Disease progression|12|||
94463013|NCT02017717|323484975|FG003|Treatment Period|Disease progression|20|||
94463014|NCT02017717|323484976|FG004|Treatment Period|Disease progression|26|||
94463015|NCT02017717|323484977|FG005|Treatment Period|Disease progression|16|||
94463016|NCT02017717|323484978|FG006|Treatment Period|Disease progression|22|||
94463017|NCT02017717|323484979|FG007|Treatment Period|Disease progression|165|||
94463018|NCT02017717|323484980|FG008|Treatment Period|Disease progression|135|||
94463019|NCT02017717|323484972|FG000|Treatment Period|Study drug toxicity|3|||
94463020|NCT02017717|323484973|FG001|Treatment Period|Study drug toxicity|0|||
94679030|NCT01521884|324278951|FG000|Overall Study|Physician Decision|2|||
94679031|NCT01521884|324278951|FG000|Overall Study|Protocol Violation|3|||
94463021|NCT02017717|323484974|FG002|Treatment Period|Study drug toxicity|1|||
94463022|NCT02017717|323484975|FG003|Treatment Period|Study drug toxicity|4|||
94463023|NCT02017717|323484976|FG004|Treatment Period|Study drug toxicity|4|||
94463024|NCT02017717|323484977|FG005|Treatment Period|Study drug toxicity|5|||
94463025|NCT02017717|323484978|FG006|Treatment Period|Study drug toxicity|3|||
94463026|NCT02017717|323484979|FG007|Treatment Period|Study drug toxicity|7|||
94463027|NCT02017717|323484980|FG008|Treatment Period|Study drug toxicity|11|||
94463028|NCT02017717|323484972|FG000|Treatment Period|Death|0|||
94463029|NCT02017717|323484973|FG001|Treatment Period|Death|0|||
94463030|NCT02017717|323484974|FG002|Treatment Period|Death|1|||
94463031|NCT02017717|323484975|FG003|Treatment Period|Death|0|||
94463032|NCT02017717|323484976|FG004|Treatment Period|Death|0|||
94463033|NCT02017717|323484977|FG005|Treatment Period|Death|2|||
94463034|NCT02017717|323484978|FG006|Treatment Period|Death|0|||
94463035|NCT02017717|323484979|FG007|Treatment Period|Death|0|||
94463036|NCT02017717|323484980|FG008|Treatment Period|Death|0|||
94463037|NCT02017717|323484972|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
94463038|NCT02017717|323484973|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
94463039|NCT02017717|323484974|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
94463040|NCT02017717|323484975|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
94463041|NCT02017717|323484976|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
94463042|NCT02017717|323484977|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
94463043|NCT02017717|323484978|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
94463044|NCT02017717|323484979|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
94463045|NCT02017717|323484980|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
94463046|NCT02017717|323484972|FG000|Treatment Period|Participant request to stop therapy|0|||
94463047|NCT02017717|323484973|FG001|Treatment Period|Participant request to stop therapy|0|||
94463048|NCT02017717|323484974|FG002|Treatment Period|Participant request to stop therapy|3|||
94463049|NCT02017717|323484975|FG003|Treatment Period|Participant request to stop therapy|6|||
94463050|NCT02017717|323484976|FG004|Treatment Period|Participant request to stop therapy|0|||
94463051|NCT02017717|323484977|FG005|Treatment Period|Participant request to stop therapy|2|||
94463052|NCT02017717|323484978|FG006|Treatment Period|Participant request to stop therapy|1|||
94463053|NCT02017717|323484979|FG007|Treatment Period|Participant request to stop therapy|4|||
94463054|NCT02017717|323484980|FG008|Treatment Period|Participant request to stop therapy|7|||
94463055|NCT02017717|323484972|FG000|Treatment Period|Participant withdrew consent|0|||
94463056|NCT02017717|323484973|FG001|Treatment Period|Participant withdrew consent|0|||
94463057|NCT02017717|323484974|FG002|Treatment Period|Participant withdrew consent|1|||
94463058|NCT02017717|323484975|FG003|Treatment Period|Participant withdrew consent|0|||
94463059|NCT02017717|323484976|FG004|Treatment Period|Participant withdrew consent|0|||
94463060|NCT02017717|323484977|FG005|Treatment Period|Participant withdrew consent|2|||
94463061|NCT02017717|323484978|FG006|Treatment Period|Participant withdrew consent|0|||
94463062|NCT02017717|323484979|FG007|Treatment Period|Participant withdrew consent|1|||
94463063|NCT02017717|323484980|FG008|Treatment Period|Participant withdrew consent|4|||
94463064|NCT02017717|323484972|FG000|Treatment Period|Participant no longer met criteria|0|||
94463065|NCT02017717|323484973|FG001|Treatment Period|Participant no longer met criteria|0|||
94463066|NCT02017717|323484974|FG002|Treatment Period|Participant no longer met criteria|0|||
94463067|NCT02017717|323484975|FG003|Treatment Period|Participant no longer met criteria|0|||
94463068|NCT02017717|323484976|FG004|Treatment Period|Participant no longer met criteria|0|||
94463069|NCT02017717|323484977|FG005|Treatment Period|Participant no longer met criteria|0|||
94463070|NCT02017717|323484978|FG006|Treatment Period|Participant no longer met criteria|0|||
94463071|NCT02017717|323484979|FG007|Treatment Period|Participant no longer met criteria|0|||
94463072|NCT02017717|323484980|FG008|Treatment Period|Participant no longer met criteria|1|||
94463073|NCT02017717|323484972|FG000|Treatment Period|Other reasons|0|||
94463074|NCT02017717|323484973|FG001|Treatment Period|Other reasons|0|||
94463075|NCT02017717|323484974|FG002|Treatment Period|Other reasons|0|||
94463076|NCT02017717|323484975|FG003|Treatment Period|Other reasons|1|||
94463077|NCT02017717|323484976|FG004|Treatment Period|Other reasons|0|||
94463078|NCT02017717|323484977|FG005|Treatment Period|Other reasons|1|||
94463079|NCT02017717|323484978|FG006|Treatment Period|Other reasons|1|||
94463080|NCT02017717|323484979|FG007|Treatment Period|Other reasons|1|||
94463081|NCT02017717|323484980|FG008|Treatment Period|Other reasons|1|||
94463082|NCT02017717|323484972|FG000|Treatment Period|Maximum clinical benefit|0|||
94463083|NCT02017717|323484973|FG001|Treatment Period|Maximum clinical benefit|0|||
94463084|NCT02017717|323484974|FG002|Treatment Period|Maximum clinical benefit|0|||
94463085|NCT02017717|323484975|FG003|Treatment Period|Maximum clinical benefit|0|||
94463086|NCT02017717|323484976|FG004|Treatment Period|Maximum clinical benefit|0|||
94463087|NCT02017717|323484977|FG005|Treatment Period|Maximum clinical benefit|0|||
94463088|NCT02017717|323484978|FG006|Treatment Period|Maximum clinical benefit|0|||
94463089|NCT02017717|323484979|FG007|Treatment Period|Maximum clinical benefit|0|||
94463090|NCT02017717|323484980|FG008|Treatment Period|Maximum clinical benefit|1|||
94463091|NCT02017717|323484972|FG000|Treatment Period|Not reported|0|||
94463092|NCT02017717|323484973|FG001|Treatment Period|Not reported|1|||
94463093|NCT02017717|323484974|FG002|Treatment Period|Not reported|0|||
94463094|NCT02017717|323484975|FG003|Treatment Period|Not reported|0|||
94463095|NCT02017717|323484976|FG004|Treatment Period|Not reported|0|||
94463096|NCT02017717|323484977|FG005|Treatment Period|Not reported|0|||
94463097|NCT02017717|323484978|FG006|Treatment Period|Not reported|0|||
94463098|NCT02017717|323484979|FG007|Treatment Period|Not reported|0|||
94463099|NCT02017717|323484980|FG008|Treatment Period|Not reported|0|||
94463100|NCT00860249|323484981|FG000|Overall Study|trial was terminated prior to completion|21|||
94463101|NCT00860249|323484982|FG001|Overall Study|trial was terminated prior to completion|18|||
94463102|NCT00860249|323484983|FG002|Overall Study|trial was terminated prior to completion|21|||
94463103|NCT02928770|323484984|FG000|Overall Study|Withdrawal by Subject|2|||
94463104|NCT01092637|323484987|FG000|Overall Study|Death|47|||
94463105|NCT01092637|323484988|FG001|Overall Study|Death|49|||
94463106|NCT05903924|323484989|FG000|Overall Study|Lost to Follow-up|1|||
94463107|NCT05903924|323484990|FG001|Overall Study|Lost to Follow-up|0|||
94463108|NCT05903924|323484991|FG002|Overall Study|Lost to Follow-up|0|||
94463109|NCT04676412|323484992|FG000|Overall Study|Death|28|||
94463110|NCT04676412|323484993|FG001|Overall Study|Death|31|||
94463111|NCT04676412|323484992|FG000|Overall Study|Lost to Follow-up|1|||
94463112|NCT04676412|323484993|FG001|Overall Study|Lost to Follow-up|2|||
94463113|NCT04676412|323484992|FG000|Overall Study|Sponsor Decision|20|||
94463114|NCT04676412|323484993|FG001|Overall Study|Sponsor Decision|23|||
94463115|NCT04676412|323484992|FG000|Overall Study|Withdrawal by Subject|0|||
94463116|NCT04676412|323484993|FG001|Overall Study|Withdrawal by Subject|2|||
94463117|NCT04063657|323485000|FG000|Overall Study|Lost to Follow-up|1|||
94463118|NCT04063657|323485001|FG001|Overall Study|Lost to Follow-up|0|||
94463119|NCT03226678|323485004|FG000|Part A (Core Study Phase)|Adverse Event|0|||
94463120|NCT03226678|323485005|FG001|Part A (Core Study Phase)|Adverse Event|1|||
94463121|NCT03226678|323485006|FG002|Part A (Core Study Phase)|Adverse Event|0|||
94463122|NCT03226678|323485007|FG003|Part A (Core Study Phase)|Adverse Event|0|||
94463123|NCT03226678|323485008|FG004|Part A (Core Study Phase)|Adverse Event|0|||
94463124|NCT03226678|323485009|FG005|Part A (Core Study Phase)|Adverse Event|0|||
94463125|NCT03226678|323485004|FG000|Part A (Core Study Phase)|Death|0|||
94463126|NCT03226678|323485005|FG001|Part A (Core Study Phase)|Death|0|||
94463127|NCT03226678|323485006|FG002|Part A (Core Study Phase)|Death|1|||
94463128|NCT03226678|323485007|FG003|Part A (Core Study Phase)|Death|0|||
94463129|NCT03226678|323485008|FG004|Part A (Core Study Phase)|Death|0|||
94463130|NCT03226678|323485009|FG005|Part A (Core Study Phase)|Death|0|||
94463131|NCT03226678|323485004|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
94463132|NCT03226678|323485005|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
94463133|NCT03226678|323485006|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
94463134|NCT03226678|323485007|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
94463135|NCT03226678|323485008|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
94463136|NCT03226678|323485009|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
94463137|NCT03226678|323485004|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
94463138|NCT03226678|323485005|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
94463139|NCT03226678|323485006|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
94463140|NCT03226678|323485007|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
94463141|NCT03226678|323485008|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
94463142|NCT03226678|323485009|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
94463143|NCT03226678|323485004|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
94463144|NCT03226678|323485005|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
94463145|NCT03226678|323485006|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
94463146|NCT03226678|323485007|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
94463147|NCT03226678|323485008|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
94463148|NCT03226678|323485009|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
94463149|NCT03226678|323485004|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
94463150|NCT03226678|323485005|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
94463151|NCT03226678|323485006|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
94463152|NCT03226678|323485007|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
94463153|NCT03226678|323485008|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
94463154|NCT03226678|323485009|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
94463155|NCT03226678|323485004|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
94463156|NCT03226678|323485005|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
94463157|NCT03226678|323485006|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
94463158|NCT03226678|323485007|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
94463159|NCT03226678|323485008|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
94463160|NCT03226678|323485009|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
94463161|NCT03226678|323485004|FG000|Part B (Long-Term Extension Phase)|Death|0|||
94463162|NCT03226678|323485005|FG001|Part B (Long-Term Extension Phase)|Death|0|||
94463163|NCT03226678|323485006|FG002|Part B (Long-Term Extension Phase)|Death|0|||
94463164|NCT03226678|323485007|FG003|Part B (Long-Term Extension Phase)|Death|0|||
94463165|NCT03226678|323485008|FG004|Part B (Long-Term Extension Phase)|Death|0|||
94463166|NCT03226678|323485009|FG005|Part B (Long-Term Extension Phase)|Death|1|||
94463167|NCT03226678|323485004|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
94463168|NCT03226678|323485005|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
94463169|NCT03226678|323485006|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
94463170|NCT03226678|323485007|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
94463171|NCT03226678|323485008|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
94463172|NCT03226678|323485009|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
94463173|NCT03226678|323485004|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
94642999|NCT00969553|324155019|FG008|Overall Study|Not specified above|0|||
94643000|NCT00316199|324155020|FG000|Overall Study|Adverse Event|2|||
94643001|NCT00316199|324155020|FG000|Overall Study|Death|8|||
94643002|NCT00316199|324155020|FG000|Overall Study|Lost to Follow-up|2|||
94463174|NCT03226678|323485005|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
94463175|NCT03226678|323485006|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
94463176|NCT03226678|323485007|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
94463177|NCT03226678|323485008|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
94463178|NCT03226678|323485009|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
94463179|NCT03226678|323485004|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
94463180|NCT03226678|323485005|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
94463181|NCT03226678|323485006|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
94463182|NCT03226678|323485007|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
94463183|NCT03226678|323485008|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
94463184|NCT03226678|323485009|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
94463185|NCT03427268|323485010|FG000|Overall Study|Progressive disease|25|||
94463186|NCT03427268|323485010|FG000|Overall Study|Never treated|2|||
94463187|NCT03427268|323485010|FG000|Overall Study|Compassionate use|1|||
94463188|NCT03427268|323485010|FG000|Overall Study|Withdrawal by Subject|1|||
94463189|NCT03427268|323485010|FG000|Overall Study|Adverse Event|3|||
94463190|NCT03535194|323485011|FG000|Induction Period|Adverse Event|2|||
94463191|NCT03535194|323485012|FG001|Induction Period|Adverse Event|2|||
94463192|NCT03535194|323485013|FG002|Induction Period|Adverse Event|1|||
94463193|NCT03535194|323485014|FG003|Induction Period|Adverse Event|3|||
94463194|NCT03535194|323485015|FG004|Induction Period|Adverse Event|0|||
94463195|NCT03535194|323485011|FG000|Induction Period|Death|0|||
94463196|NCT03535194|323485012|FG001|Induction Period|Death|1|||
94463197|NCT03535194|323485013|FG002|Induction Period|Death|0|||
94463198|NCT03535194|323485014|FG003|Induction Period|Death|0|||
94363863|NCT03972709|323116740|FG001|Overall Study|Missed Study Visits|0|||
94363864|NCT03972709|323116741|FG002|Overall Study|Missed Study Visits|0|||
94463199|NCT03535194|323485015|FG004|Induction Period|Death|0|||
94463200|NCT03535194|323485011|FG000|Induction Period|Lack of Efficacy|1|||
94463201|NCT03535194|323485012|FG001|Induction Period|Lack of Efficacy|3|||
94463202|NCT03535194|323485013|FG002|Induction Period|Lack of Efficacy|2|||
94463203|NCT03535194|323485014|FG003|Induction Period|Lack of Efficacy|2|||
94643003|NCT06023394|324155021|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
94643004|NCT06023394|324155022|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
94643005|NCT06023394|324155021|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
94463204|NCT03535194|323485015|FG004|Induction Period|Lack of Efficacy|0|||
94463205|NCT03535194|323485011|FG000|Induction Period|Lost to Follow-up|3|||
94463206|NCT03535194|323485012|FG001|Induction Period|Lost to Follow-up|5|||
94463207|NCT03535194|323485013|FG002|Induction Period|Lost to Follow-up|2|||
94463208|NCT03535194|323485014|FG003|Induction Period|Lost to Follow-up|3|||
94463209|NCT03535194|323485015|FG004|Induction Period|Lost to Follow-up|0|||
94463210|NCT03535194|323485011|FG000|Induction Period|Physician Decision|1|||
94463211|NCT03535194|323485012|FG001|Induction Period|Physician Decision|1|||
94463212|NCT03535194|323485013|FG002|Induction Period|Physician Decision|0|||
94463213|NCT03535194|323485014|FG003|Induction Period|Physician Decision|0|||
94463214|NCT03535194|323485015|FG004|Induction Period|Physician Decision|0|||
94463215|NCT03535194|323485011|FG000|Induction Period|Protocol Violation|1|||
94463216|NCT03535194|323485012|FG001|Induction Period|Protocol Violation|0|||
94463217|NCT03535194|323485013|FG002|Induction Period|Protocol Violation|0|||
94463218|NCT03535194|323485014|FG003|Induction Period|Protocol Violation|1|||
94463219|NCT03535194|323485015|FG004|Induction Period|Protocol Violation|0|||
94463220|NCT03535194|323485011|FG000|Induction Period|Screen Failure|0|||
94463221|NCT03535194|323485012|FG001|Induction Period|Screen Failure|1|||
94463222|NCT03535194|323485013|FG002|Induction Period|Screen Failure|0|||
94463223|NCT03535194|323485014|FG003|Induction Period|Screen Failure|0|||
94463224|NCT03535194|323485015|FG004|Induction Period|Screen Failure|0|||
94463225|NCT03535194|323485011|FG000|Induction Period|Withdrawal by Subject|3|||
94463226|NCT03535194|323485012|FG001|Induction Period|Withdrawal by Subject|4|||
94463227|NCT03535194|323485013|FG002|Induction Period|Withdrawal by Subject|3|||
94463228|NCT03535194|323485014|FG003|Induction Period|Withdrawal by Subject|2|||
94463229|NCT03535194|323485015|FG004|Induction Period|Withdrawal by Subject|0|||
94463230|NCT03535194|323485011|FG000|Maintenance Period|Adverse Event|6|||
94463231|NCT03535194|323485012|FG001|Maintenance Period|Adverse Event|5|||
94643006|NCT06023394|324155022|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
94643007|NCT06023394|324155021|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
94643008|NCT06023394|324155022|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
94643009|NCT06023394|324155021|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
94643010|NCT06023394|324155022|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
94643011|NCT02917031|324155023|FG000|Overall Study|Reason not specified|7|||
94643012|NCT02917031|324155024|FG001|Overall Study|Reason not specified|5|||
94643013|NCT02917031|324155025|FG002|Overall Study|Reason not specified|6|||
94643014|NCT02917031|324155023|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
94643015|NCT02917031|324155024|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
94643016|NCT02917031|324155025|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
94643017|NCT02917031|324155023|FG000|Overall Study|Withdrawal by Subject|3|||
94643018|NCT02917031|324155024|FG001|Overall Study|Withdrawal by Subject|3|||
94643019|NCT02917031|324155025|FG002|Overall Study|Withdrawal by Subject|0|||
94643020|NCT02917031|324155023|FG000|Overall Study|Physician Decision|1|||
94643021|NCT02917031|324155024|FG001|Overall Study|Physician Decision|0|||
94643022|NCT02917031|324155025|FG002|Overall Study|Physician Decision|0|||
94643023|NCT02917031|324155023|FG000|Overall Study|Adverse Event|4|||
94643024|NCT02917031|324155024|FG001|Overall Study|Adverse Event|1|||
94643025|NCT02917031|324155025|FG002|Overall Study|Adverse Event|5|||
94643026|NCT02917031|324155023|FG000|Overall Study|Death|2|||
94643027|NCT02917031|324155024|FG001|Overall Study|Death|3|||
94643028|NCT02917031|324155025|FG002|Overall Study|Death|4|||
94643029|NCT01251861|324155026|FG000|Overall Study|Disease progression|6|||
94643030|NCT01251861|324155027|FG001|Overall Study|Disease progression|6|||
94643031|NCT01251861|324155026|FG000|Overall Study|Adverse Event|2|||
94679032|NCT01521884|324278951|FG000|Overall Study|Participant non-eligible|1|||
94679033|NCT01521884|324278951|FG000|Overall Study|Lost to Follow-up|4|||
94263457|NCT00375219|322758228|FG000|Overall Study|Cord blood transplantation|1|||
94263458|NCT00375219|322758229|FG001|Overall Study|Cord blood transplantation|0|||
94263459|NCT00375219|322758230|FG002|Overall Study|Cord blood transplantation|0|||
94263460|NCT00375219|322758228|FG000|Overall Study|Withdrawal by Subject|1|||
94263461|NCT00375219|322758229|FG001|Overall Study|Withdrawal by Subject|0|||
94263462|NCT00375219|322758230|FG002|Overall Study|Withdrawal by Subject|0|||
94263463|NCT00403754|322758231|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
94263464|NCT00403754|322758232|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
94643032|NCT01251861|324155027|FG001|Overall Study|Adverse Event|17|||
94643033|NCT01251861|324155026|FG000|Overall Study|Withdrawal by Subject|2|||
94643034|NCT01251861|324155027|FG001|Overall Study|Withdrawal by Subject|2|||
94643035|NCT01251861|324155026|FG000|Overall Study|Alternative therapy|1|||
94643036|NCT01251861|324155027|FG001|Overall Study|Alternative therapy|0|||
94263465|NCT00403754|322758233|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
94463232|NCT03535194|323485013|FG002|Maintenance Period|Adverse Event|1|||
94643037|NCT01251861|324155026|FG000|Overall Study|Other complicating disease|0|||
94643038|NCT01251861|324155027|FG001|Overall Study|Other complicating disease|1|||
94643039|NCT01251861|324155026|FG000|Overall Study|Physician Decision|1|||
94363865|NCT03159611|323116742|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
94643040|NCT01251861|324155027|FG001|Overall Study|Physician Decision|0|||
94643041|NCT01251861|324155026|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
94643042|NCT01251861|324155027|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
94643043|NCT01251861|324155026|FG000|Overall Study|Other|1|||
94643044|NCT01251861|324155027|FG001|Overall Study|Other|0|||
94643045|NCT01251861|324155026|FG000|Overall Study|Never started therapy|4|||
94643046|NCT01251861|324155027|FG001|Overall Study|Never started therapy|1|||
94643047|NCT01251861|324155026|FG000|Overall Study|Potential interaction of drugs|0|||
94643048|NCT01251861|324155027|FG001|Overall Study|Potential interaction of drugs|1|||
94643049|NCT00403273|324156507|FG000|Overall Study|Lost to Follow-up|3|||
94643050|NCT00403273|324156508|FG001|Overall Study|Lost to Follow-up|2|||
94643051|NCT00403273|324156507|FG000|Overall Study|Physician Decision|0|||
94643052|NCT00403273|324156508|FG001|Overall Study|Physician Decision|1|||
94643053|NCT00403273|324156507|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
94643054|NCT00403273|324156508|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
94643055|NCT04013191|324156515|FG000|Overall Study|Adverse Event|1|||
94463233|NCT03535194|323485014|FG003|Maintenance Period|Adverse Event|11|||
94463234|NCT03535194|323485015|FG004|Maintenance Period|Adverse Event|4|||
94463235|NCT03535194|323485011|FG000|Maintenance Period|Lack of Efficacy|3|||
94463236|NCT03535194|323485012|FG001|Maintenance Period|Lack of Efficacy|2|||
94463237|NCT03535194|323485013|FG002|Maintenance Period|Lack of Efficacy|5|||
94463238|NCT03535194|323485014|FG003|Maintenance Period|Lack of Efficacy|9|||
94463239|NCT03535194|323485015|FG004|Maintenance Period|Lack of Efficacy|0|||
94463240|NCT03535194|323485011|FG000|Maintenance Period|Lost to Follow-up|4|||
94643056|NCT04013191|324156516|FG001|Overall Study|Adverse Event|0|||
94643057|NCT02547129|324156528|FG000|Overall Study|Difficulty with ongoing infection|1|||
94643058|NCT02547129|324156529|FG001|Overall Study|Difficulty with ongoing infection|0|||
94643059|NCT00794196|324156530|FG000|Overall Study|Lost to Follow-up|5|||
94643060|NCT00794196|324156531|FG001|Overall Study|Lost to Follow-up|23|||
94643061|NCT02063737|324156535|FG000|Overall Study|Lost to Follow-up|11|||
94643062|NCT02063737|324156536|FG001|Overall Study|Lost to Follow-up|4|||
94643063|NCT00696137|324156544|FG000|Overall Study|Withdrawal by Subject|2|||
94643064|NCT01183975|324156554|FG000|Overall Study|Lost to Follow-up|73|||
94643065|NCT00850395|324156559|FG000|Overall Study|Death|1|||
94643066|NCT00850395|324156559|FG000|Overall Study|Adverse Event|1|||
94643067|NCT00850395|324156559|FG000|Overall Study|Insufficient clinical response|3|||
94643068|NCT00850395|324156559|FG000|Overall Study|Other|5|||
94643069|NCT01640366|324156564|FG000|Overall Study|Withdrawal by Subject|1|||
94643070|NCT01640366|324156564|FG000|Overall Study|Protocol Violation|16|||
94643071|NCT01640366|324156564|FG000|Overall Study|Lost to Follow-up|5|||
94643072|NCT03216850|324156569|FG000|Overall Study|Pre-analytical error|6|||
94643073|NCT00405548|324156570|FG000|Overall Study|Cognitive Memory problems on study day|1|||
94643074|NCT00405548|324156571|FG001|Overall Study|Cognitive Memory problems on study day|0|||
94643075|NCT00405548|324156570|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
94643076|NCT00405548|324156571|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
94643077|NCT00405548|324156570|FG000|Overall Study|Unable to self-administer shots|1|||
94643078|NCT00405548|324156571|FG001|Overall Study|Unable to self-administer shots|0|||
94643079|NCT00405548|324156570|FG000|Overall Study|Venous access failed during study day|1|||
94643080|NCT00405548|324156571|FG001|Overall Study|Venous access failed during study day|0|||
94643081|NCT00405548|324156570|FG000|Overall Study|Withdrawal by Subject|1|||
94643082|NCT00405548|324156571|FG001|Overall Study|Withdrawal by Subject|0|||
94643083|NCT03554291|324156572|FG000|Overall Study|Death|2|||
94643084|NCT03554291|324156573|FG001|Overall Study|Death|1|||
94643085|NCT03554291|324156572|FG000|Overall Study|Lost to Follow-up|1|||
94643086|NCT03554291|324156573|FG001|Overall Study|Lost to Follow-up|0|||
94643087|NCT03554291|324156572|FG000|Overall Study|Withdrawal by Subject|1|||
94643088|NCT03554291|324156573|FG001|Overall Study|Withdrawal by Subject|0|||
94643089|NCT03554291|324156572|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
94643090|NCT03554291|324156573|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
94643091|NCT00500292|324156577|FG000|Overall Study|Adverse Event|3|||
94679034|NCT01353222|324278952|FG000|Overall Study|Death|30|||
94679035|NCT01353222|324278953|FG001|Overall Study|Death|30|||
94363866|NCT03159611|323116743|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
94643092|NCT00500292|324156578|FG001|Overall Study|Adverse Event|6|||
94643093|NCT00500292|324156579|FG002|Overall Study|Adverse Event|4|||
94643094|NCT00500292|324156577|FG000|Overall Study|Condition under investigation worsened|21|||
94643095|NCT00500292|324156578|FG001|Overall Study|Condition under investigation worsened|23|||
94643096|NCT00500292|324156579|FG002|Overall Study|Condition under investigation worsened|19|||
94643097|NCT00500292|324156577|FG000|Overall Study|Withdrawal by Subject|0|||
94643098|NCT00500292|324156578|FG001|Overall Study|Withdrawal by Subject|1|||
94643099|NCT00500292|324156579|FG002|Overall Study|Withdrawal by Subject|0|||
94643100|NCT00500292|324156577|FG000|Overall Study|Other|1|||
94643101|NCT00500292|324156578|FG001|Overall Study|Other|1|||
94643102|NCT00500292|324156579|FG002|Overall Study|Other|4|||
94643103|NCT01894152|324156580|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
94643104|NCT02741700|324156581|FG000|Overall Study|Lost to Follow-up|17|||
94643105|NCT02741700|324156582|FG001|Overall Study|Lost to Follow-up|8|||
94643106|NCT02741700|324156581|FG000|Overall Study|Withdrawal by Subject|2|||
94643107|NCT02741700|324156582|FG001|Overall Study|Withdrawal by Subject|5|||
94643108|NCT02741700|324156581|FG000|Overall Study|Physician Decision|3|||
94643109|NCT02741700|324156582|FG001|Overall Study|Physician Decision|0|||
94643110|NCT02741700|324156581|FG000|Overall Study|Moved out of State|0|||
94643111|NCT02741700|324156582|FG001|Overall Study|Moved out of State|1|||
94363867|NCT03159611|323116742|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
94363868|NCT03159611|323116743|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
94643112|NCT02741700|324156581|FG000|Overall Study|Death|4|||
94643113|NCT02741700|324156582|FG001|Overall Study|Death|5|||
94643114|NCT00811577|324156583|FG000|Overall Study|Lost to Follow-up|7|||
94643115|NCT00811577|324156584|FG001|Overall Study|Lost to Follow-up|1|||
94643116|NCT00811577|324156583|FG000|Overall Study|Withdrawal by Subject|3|||
94643117|NCT00811577|324156584|FG001|Overall Study|Withdrawal by Subject|0|||
94643118|NCT04011410|324156587|FG000|Overall Study|Withdrawal by Subject|1|||
94643119|NCT01068509|324156588|FG000|Overall Study|Death|0|||
94643120|NCT01068509|324156589|FG001|Overall Study|Death|0|||
94643121|NCT01068509|324156590|FG002|Overall Study|Death|1|||
94643122|NCT01068509|324156588|FG000|Overall Study|Disease Progression|5|||
94643123|NCT01068509|324156589|FG001|Overall Study|Disease Progression|20|||
94643124|NCT01068509|324156590|FG002|Overall Study|Disease Progression|18|||
94643125|NCT01068509|324156588|FG000|Overall Study|Lost to Follow-up|1|||
94643126|NCT01068509|324156589|FG001|Overall Study|Lost to Follow-up|0|||
94643127|NCT01068509|324156590|FG002|Overall Study|Lost to Follow-up|0|||
94643128|NCT01068509|324156588|FG000|Overall Study|Withdrew Consent|0|||
94643129|NCT01068509|324156589|FG001|Overall Study|Withdrew Consent|1|||
94643130|NCT01068509|324156590|FG002|Overall Study|Withdrew Consent|2|||
94643131|NCT01068509|324156588|FG000|Overall Study|Reason Not Specified|0|||
94643132|NCT01068509|324156589|FG001|Overall Study|Reason Not Specified|1|||
94643133|NCT01068509|324156590|FG002|Overall Study|Reason Not Specified|0|||
94643134|NCT02357940|324156592|FG000|Overall Study|Adverse Event|0|||
94643135|NCT02357940|324156593|FG001|Overall Study|Adverse Event|1|||
94643136|NCT02357940|324156592|FG000|Overall Study|Investigator's judgement|0|||
94643137|NCT02357940|324156593|FG001|Overall Study|Investigator's judgement|1|||
94643138|NCT02641379|324156596|FG000|Overall Study|Exclusion criterion during screening|1|||
94643139|NCT02641379|324156597|FG001|Overall Study|Exclusion criterion during screening|0|||
94679036|NCT01353222|324278952|FG000|Overall Study|Withdrawal by Subject|8|||
94643140|NCT02641379|324156598|FG002|Overall Study|Exclusion criterion during screening|0|||
94643141|NCT02641379|324156599|FG003|Overall Study|Exclusion criterion during screening|1|||
94643142|NCT02641379|324156600|FG004|Overall Study|Exclusion criterion during screening|2|||
94643143|NCT02641379|324156601|FG005|Overall Study|Exclusion criterion during screening|0|||
94643144|NCT02641379|324156602|FG006|Overall Study|Exclusion criterion during screening|0|||
94643145|NCT02641379|324156603|FG007|Overall Study|Exclusion criterion during screening|0|||
94643146|NCT02641379|324156604|FG008|Overall Study|Exclusion criterion during screening|0|||
94643147|NCT02641379|324156605|FG009|Overall Study|Exclusion criterion during screening|0|||
94643148|NCT02641379|324156606|FG010|Overall Study|Exclusion criterion during screening|0|||
94643149|NCT02641379|324156596|FG000|Overall Study|Withdrawal of informed consent|0|||
94643150|NCT02641379|324156597|FG001|Overall Study|Withdrawal of informed consent|1|||
94643151|NCT02641379|324156598|FG002|Overall Study|Withdrawal of informed consent|0|||
94643152|NCT02641379|324156599|FG003|Overall Study|Withdrawal of informed consent|0|||
94643153|NCT02641379|324156600|FG004|Overall Study|Withdrawal of informed consent|0|||
94463241|NCT03535194|323485012|FG001|Maintenance Period|Lost to Follow-up|2|||
94463242|NCT03535194|323485013|FG002|Maintenance Period|Lost to Follow-up|1|||
94463243|NCT03535194|323485014|FG003|Maintenance Period|Lost to Follow-up|5|||
94463244|NCT03535194|323485015|FG004|Maintenance Period|Lost to Follow-up|2|||
94463245|NCT03535194|323485011|FG000|Maintenance Period|Other|1|||
94463246|NCT03535194|323485012|FG001|Maintenance Period|Other|2|||
94463247|NCT03535194|323485013|FG002|Maintenance Period|Other|0|||
94463248|NCT03535194|323485014|FG003|Maintenance Period|Other|0|||
94463249|NCT03535194|323485015|FG004|Maintenance Period|Other|0|||
94463250|NCT03535194|323485011|FG000|Maintenance Period|Physician Decision|1|||
94463251|NCT03535194|323485012|FG001|Maintenance Period|Physician Decision|2|||
94643154|NCT02641379|324156601|FG005|Overall Study|Withdrawal of informed consent|0|||
94643155|NCT02641379|324156602|FG006|Overall Study|Withdrawal of informed consent|0|||
94643156|NCT02641379|324156603|FG007|Overall Study|Withdrawal of informed consent|1|||
94643157|NCT02641379|324156604|FG008|Overall Study|Withdrawal of informed consent|0|||
94643158|NCT02641379|324156605|FG009|Overall Study|Withdrawal of informed consent|0|||
94643159|NCT02641379|324156606|FG010|Overall Study|Withdrawal of informed consent|0|||
94463252|NCT03535194|323485013|FG002|Maintenance Period|Physician Decision|0|||
94463253|NCT03535194|323485014|FG003|Maintenance Period|Physician Decision|2|||
94463254|NCT03535194|323485015|FG004|Maintenance Period|Physician Decision|0|||
94463255|NCT03535194|323485011|FG000|Maintenance Period|Pregnancy|0|||
94463256|NCT03535194|323485012|FG001|Maintenance Period|Pregnancy|0|||
94463257|NCT03535194|323485013|FG002|Maintenance Period|Pregnancy|0|||
94463258|NCT03535194|323485014|FG003|Maintenance Period|Pregnancy|2|||
94463259|NCT03535194|323485015|FG004|Maintenance Period|Pregnancy|0|||
94463260|NCT03535194|323485011|FG000|Maintenance Period|Protocol Violation|0|||
94463261|NCT03535194|323485012|FG001|Maintenance Period|Protocol Violation|1|||
94643160|NCT02641379|324156596|FG000|Overall Study|Adverse Event|7|||
94643161|NCT02641379|324156597|FG001|Overall Study|Adverse Event|8|||
94643162|NCT02641379|324156598|FG002|Overall Study|Adverse Event|2|||
94643163|NCT02641379|324156599|FG003|Overall Study|Adverse Event|2|||
94643164|NCT02641379|324156600|FG004|Overall Study|Adverse Event|5|||
94643165|NCT02641379|324156601|FG005|Overall Study|Adverse Event|1|||
94643166|NCT02641379|324156602|FG006|Overall Study|Adverse Event|5|||
94643167|NCT02641379|324156603|FG007|Overall Study|Adverse Event|0|||
94643168|NCT02641379|324156604|FG008|Overall Study|Adverse Event|1|||
94643169|NCT02641379|324156605|FG009|Overall Study|Adverse Event|1|||
94463262|NCT03535194|323485013|FG002|Maintenance Period|Protocol Violation|0|||
94463263|NCT03535194|323485014|FG003|Maintenance Period|Protocol Violation|0|||
94463264|NCT03535194|323485015|FG004|Maintenance Period|Protocol Violation|0|||
94643170|NCT02641379|324156606|FG010|Overall Study|Adverse Event|5|||
94643171|NCT02641379|324156596|FG000|Overall Study|Lack of Efficacy|0|||
94643172|NCT02641379|324156597|FG001|Overall Study|Lack of Efficacy|0|||
94643173|NCT02641379|324156598|FG002|Overall Study|Lack of Efficacy|2|||
94643174|NCT02641379|324156599|FG003|Overall Study|Lack of Efficacy|0|||
94643175|NCT02641379|324156600|FG004|Overall Study|Lack of Efficacy|0|||
94463265|NCT03535194|323485011|FG000|Maintenance Period|Withdrawal by Subject|7|||
94463266|NCT03535194|323485012|FG001|Maintenance Period|Withdrawal by Subject|2|||
94463267|NCT03535194|323485013|FG002|Maintenance Period|Withdrawal by Subject|1|||
94463268|NCT03535194|323485014|FG003|Maintenance Period|Withdrawal by Subject|8|||
94463269|NCT03535194|323485015|FG004|Maintenance Period|Withdrawal by Subject|0|||
94463270|NCT03535194|323485011|FG000|Post-Treatment Followup Period|Adverse Event|4|||
94463271|NCT03535194|323485012|FG001|Post-Treatment Followup Period|Adverse Event|5|||
94679037|NCT01353222|324278953|FG001|Overall Study|Withdrawal by Subject|5|||
94463272|NCT03535194|323485013|FG002|Post-Treatment Followup Period|Adverse Event|1|||
94463273|NCT03535194|323485014|FG003|Post-Treatment Followup Period|Adverse Event|8|||
94463274|NCT03535194|323485015|FG004|Post-Treatment Followup Period|Adverse Event|0|||
94463275|NCT03535194|323485011|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
94463276|NCT03535194|323485012|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
94463277|NCT03535194|323485013|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
94463278|NCT03535194|323485014|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
94463279|NCT03535194|323485015|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
94643176|NCT02641379|324156601|FG005|Overall Study|Lack of Efficacy|2|||
94643177|NCT02641379|324156602|FG006|Overall Study|Lack of Efficacy|0|||
94643178|NCT02641379|324156603|FG007|Overall Study|Lack of Efficacy|5|||
94643179|NCT02641379|324156604|FG008|Overall Study|Lack of Efficacy|0|||
94643180|NCT02641379|324156605|FG009|Overall Study|Lack of Efficacy|0|||
94643181|NCT02641379|324156606|FG010|Overall Study|Lack of Efficacy|0|||
94643182|NCT02641379|324156596|FG000|Overall Study|Participant unable to attend study visit|4|||
94643183|NCT02641379|324156597|FG001|Overall Study|Participant unable to attend study visit|10|||
94643184|NCT02641379|324156598|FG002|Overall Study|Participant unable to attend study visit|1|||
94463280|NCT03535194|323485011|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
94463281|NCT03535194|323485012|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
94463282|NCT03535194|323485013|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
94463283|NCT03535194|323485014|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
94463284|NCT03535194|323485015|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
94463285|NCT03535194|323485011|FG000|Post-Treatment Followup Period|Other|1|||
94463286|NCT03535194|323485012|FG001|Post-Treatment Followup Period|Other|0|||
94463287|NCT03535194|323485013|FG002|Post-Treatment Followup Period|Other|0|||
94463288|NCT03535194|323485014|FG003|Post-Treatment Followup Period|Other|5|||
94463289|NCT03535194|323485015|FG004|Post-Treatment Followup Period|Other|0|||
94463290|NCT03535194|323485011|FG000|Post-Treatment Followup Period|Physician Decision|0|||
94463291|NCT03535194|323485012|FG001|Post-Treatment Followup Period|Physician Decision|2|||
94463292|NCT03535194|323485013|FG002|Post-Treatment Followup Period|Physician Decision|1|||
94643185|NCT02641379|324156599|FG003|Overall Study|Participant unable to attend study visit|2|||
94643186|NCT02641379|324156600|FG004|Overall Study|Participant unable to attend study visit|5|||
94643187|NCT02641379|324156601|FG005|Overall Study|Participant unable to attend study visit|1|||
94643188|NCT02641379|324156602|FG006|Overall Study|Participant unable to attend study visit|1|||
94643189|NCT02641379|324156603|FG007|Overall Study|Participant unable to attend study visit|1|||
94643190|NCT02641379|324156604|FG008|Overall Study|Participant unable to attend study visit|0|||
94463293|NCT03535194|323485014|FG003|Post-Treatment Followup Period|Physician Decision|1|||
94463294|NCT03535194|323485015|FG004|Post-Treatment Followup Period|Physician Decision|0|||
94463295|NCT03535194|323485011|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
94463296|NCT03535194|323485012|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
94463297|NCT03535194|323485013|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
94463298|NCT03535194|323485014|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
94463299|NCT03535194|323485015|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
94463300|NCT01482962|323485016|FG000|Overall Study|Progressive Disease|65|||
94463301|NCT01482962|323485017|FG001|Overall Study|Progressive Disease|53|||
94463302|NCT01482962|323485016|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
94463303|NCT01482962|323485017|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
94463304|NCT01482962|323485016|FG000|Overall Study|Adverse Event|18|||
94643191|NCT02641379|324156605|FG009|Overall Study|Participant unable to attend study visit|2|||
94643192|NCT02641379|324156606|FG010|Overall Study|Participant unable to attend study visit|0|||
94643193|NCT02641379|324156596|FG000|Overall Study|Participant's compliance|0|||
94643194|NCT02641379|324156597|FG001|Overall Study|Participant's compliance|1|||
94643195|NCT02641379|324156598|FG002|Overall Study|Participant's compliance|0|||
94643196|NCT02641379|324156599|FG003|Overall Study|Participant's compliance|1|||
94643197|NCT02641379|324156600|FG004|Overall Study|Participant's compliance|0|||
94643198|NCT02641379|324156601|FG005|Overall Study|Participant's compliance|2|||
94643199|NCT02641379|324156602|FG006|Overall Study|Participant's compliance|0|||
94643200|NCT02641379|324156603|FG007|Overall Study|Participant's compliance|0|||
94643201|NCT02641379|324156604|FG008|Overall Study|Participant's compliance|1|||
94643202|NCT02641379|324156605|FG009|Overall Study|Participant's compliance|1|||
94643203|NCT02641379|324156606|FG010|Overall Study|Participant's compliance|1|||
94643204|NCT02641379|324156596|FG000|Overall Study|Participant cannot be reached|4|||
94643205|NCT02641379|324156597|FG001|Overall Study|Participant cannot be reached|4|||
94643206|NCT02641379|324156598|FG002|Overall Study|Participant cannot be reached|0|||
94643207|NCT02641379|324156599|FG003|Overall Study|Participant cannot be reached|8|||
94643208|NCT02641379|324156600|FG004|Overall Study|Participant cannot be reached|2|||
94643209|NCT02641379|324156601|FG005|Overall Study|Participant cannot be reached|1|||
94643210|NCT02641379|324156602|FG006|Overall Study|Participant cannot be reached|0|||
94643211|NCT02641379|324156603|FG007|Overall Study|Participant cannot be reached|1|||
94643212|NCT02641379|324156604|FG008|Overall Study|Participant cannot be reached|0|||
94643213|NCT02641379|324156605|FG009|Overall Study|Participant cannot be reached|2|||
94463305|NCT01482962|323485017|FG001|Overall Study|Adverse Event|22|||
94463306|NCT01482962|323485016|FG000|Overall Study|Withdrawal by Participant|8|||
94463307|NCT01482962|323485017|FG001|Overall Study|Withdrawal by Participant|13|||
94463308|NCT01482962|323485016|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
94463309|NCT01482962|323485017|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
94463310|NCT01482962|323485016|FG000|Overall Study|Other Reason|1|||
94463311|NCT01482962|323485017|FG001|Overall Study|Other Reason|5|||
94463312|NCT01482962|323485016|FG000|Overall Study|Study Terminated by Sponsor|5|||
94463313|NCT01482962|323485017|FG001|Overall Study|Study Terminated by Sponsor|2|||
94463314|NCT01482962|323485016|FG000|Overall Study|Did not Receive Study Drug|1|||
94463315|NCT01482962|323485017|FG001|Overall Study|Did not Receive Study Drug|6|||
94463316|NCT01447446|323485018|FG000|Overall Study|Death|6|||
94463317|NCT01447446|323485019|FG001|Overall Study|Death|3|||
94463318|NCT01447446|323485020|FG002|Overall Study|Death|2|||
94463319|NCT01447446|323485021|FG003|Overall Study|Death|1|||
94679038|NCT01353222|324278952|FG000|Overall Study|Study Terminated|31|||
94679039|NCT01353222|324278953|FG001|Overall Study|Study Terminated|37|||
94679040|NCT01353222|324278952|FG000|Overall Study|Site closed research department|1|||
94679041|NCT01353222|324278953|FG001|Overall Study|Site closed research department|0|||
94679042|NCT01654601|324278954|FG000|1st Administration|Withdrawal by Subject|2|||
94679043|NCT01654601|324278955|FG001|1st Administration|Withdrawal by Subject|0|||
94679044|NCT01654601|324278954|FG000|1st Administration|Protocol Violation|0|||
94679045|NCT01654601|324278955|FG001|1st Administration|Protocol Violation|2|||
94679046|NCT01654601|324278954|FG000|2nd Administration|Adverse Event|1|||
94679047|NCT01654601|324278955|FG001|2nd Administration|Adverse Event|0|||
94679048|NCT01654601|324278954|FG000|2nd Administration|Protocol Violation|0|||
94679049|NCT01654601|324278955|FG001|2nd Administration|Protocol Violation|1|||
94679050|NCT01119898|324278956|FG000|Overall Study|Adverse Event|4|||
94263466|NCT00403754|322758234|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
94263467|NCT00403754|322758231|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
94263468|NCT00403754|322758232|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
94263469|NCT00403754|322758233|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
94263470|NCT00403754|322758234|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
94263471|NCT04484259|322758235|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
94263472|NCT04484259|322758236|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
94263473|NCT04484259|322758237|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
94263474|NCT04484259|322758238|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
94263475|NCT04484259|322758239|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
94263476|NCT04484259|322758235|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
94263477|NCT04484259|322758236|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
94263478|NCT04484259|322758237|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
94263479|NCT04484259|322758238|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
94263480|NCT04484259|322758239|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
94263481|NCT04484259|322758235|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
94263482|NCT04484259|322758236|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
94263483|NCT04484259|322758237|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
94263484|NCT04484259|322758238|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
94263485|NCT04484259|322758239|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
94263486|NCT04484259|322758235|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
94263487|NCT04484259|322758236|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
94263488|NCT04484259|322758237|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
94263489|NCT04484259|322758238|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
94263490|NCT04484259|322758239|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
94263491|NCT04484259|322758235|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
94263492|NCT04484259|322758236|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
94263493|NCT04484259|322758237|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
94463320|NCT01447446|323485022|FG004|Overall Study|Death|7|||
94463321|NCT01447446|323485023|FG005|Overall Study|Death|0|||
94463322|NCT01447446|323485018|FG000|Overall Study|Adverse Event|3|||
94463323|NCT01447446|323485019|FG001|Overall Study|Adverse Event|0|||
94463324|NCT01447446|323485020|FG002|Overall Study|Adverse Event|1|||
94463325|NCT01447446|323485021|FG003|Overall Study|Adverse Event|0|||
94463326|NCT01447446|323485022|FG004|Overall Study|Adverse Event|2|||
94463327|NCT01447446|323485023|FG005|Overall Study|Adverse Event|0|||
94463328|NCT01447446|323485018|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
94463329|NCT01447446|323485019|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
94463330|NCT01447446|323485020|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
94463331|NCT01447446|323485021|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
94463332|NCT01447446|323485022|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
94463333|NCT01447446|323485023|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
94463334|NCT01447446|323485018|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
94463335|NCT01447446|323485019|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
94463336|NCT01447446|323485020|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
94463337|NCT01447446|323485021|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
94463338|NCT01447446|323485022|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
94463339|NCT01447446|323485023|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
94463340|NCT01447446|323485018|FG000|Overall Study|Administrative/Other|34|||
94463341|NCT01447446|323485019|FG001|Overall Study|Administrative/Other|9|||
94463342|NCT01447446|323485020|FG002|Overall Study|Administrative/Other|10|||
94463343|NCT01447446|323485021|FG003|Overall Study|Administrative/Other|2|||
94463344|NCT01447446|323485022|FG004|Overall Study|Administrative/Other|33|||
94463345|NCT01447446|323485023|FG005|Overall Study|Administrative/Other|4|||
94463346|NCT01447446|323485018|FG000|Overall Study|SVR12 Assessment|13|||
94463347|NCT01447446|323485019|FG001|Overall Study|SVR12 Assessment|1|||
94463348|NCT01447446|323485020|FG002|Overall Study|SVR12 Assessment|2|||
94679051|NCT01119898|324278957|FG001|Overall Study|Adverse Event|5|||
94679052|NCT01119898|324278956|FG000|Overall Study|Withdrawal by Subject|1|||
94679053|NCT01119898|324278957|FG001|Overall Study|Withdrawal by Subject|4|||
94679054|NCT01119898|324278956|FG000|Overall Study|Lack of Efficacy|0|||
94679055|NCT01119898|324278957|FG001|Overall Study|Lack of Efficacy|2|||
94679056|NCT01119898|324278956|FG000|Overall Study|Protocol Violation|1|||
94679057|NCT01119898|324278957|FG001|Overall Study|Protocol Violation|1|||
94679058|NCT01119898|324278956|FG000|Overall Study|Medical procedure|1|||
94679059|NCT01119898|324278957|FG001|Overall Study|Medical procedure|0|||
94679060|NCT01119898|324278956|FG000|Overall Study|Randomized in error did not participate|1|||
94679061|NCT01119898|324278957|FG001|Overall Study|Randomized in error did not participate|0|||
94679062|NCT01833143|324278958|FG000|Overall Study|Not Treated|1|||
94679063|NCT00116844|324278959|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
94679064|NCT00116844|324278960|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
94679065|NCT00116844|324278959|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
94679066|NCT00116844|324278960|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
94679067|NCT00116844|324278959|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
94679068|NCT00116844|324278960|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
94679069|NCT00116844|324278959|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
94679070|NCT00116844|324278960|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
94679071|NCT00116844|324278959|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
94679072|NCT00116844|324278960|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
94679073|NCT00116844|324278959|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
94679074|NCT00116844|324278960|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
94679075|NCT00116844|324278959|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
94679076|NCT00116844|324278960|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
94679077|NCT00116844|324278959|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
94679078|NCT00116844|324278960|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
94679079|NCT00116844|324278959|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
94679080|NCT00116844|324278960|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
94679081|NCT03474549|324278961|FG000|Overall Study|Death|31|||
94679082|NCT03474549|324278961|FG000|Overall Study|Lost to Follow-up|4|||
94679083|NCT03474549|324278961|FG000|Overall Study|Withdrawal by Subject|2|||
94679084|NCT02272725|324278964|FG000|Overall Study|equipment malfunction|2|||
94463349|NCT01447446|323485021|FG003|Overall Study|SVR12 Assessment|1|||
94463350|NCT01447446|323485022|FG004|Overall Study|SVR12 Assessment|5|||
94463351|NCT01447446|323485023|FG005|Overall Study|SVR12 Assessment|5|||
94463352|NCT01447446|323485018|FG000|Overall Study|New Treatment Started|8|||
94463353|NCT01447446|323485019|FG001|Overall Study|New Treatment Started|2|||
94463354|NCT01447446|323485020|FG002|Overall Study|New Treatment Started|1|||
94463355|NCT01447446|323485021|FG003|Overall Study|New Treatment Started|0|||
94463356|NCT01447446|323485022|FG004|Overall Study|New Treatment Started|2|||
94463357|NCT01447446|323485023|FG005|Overall Study|New Treatment Started|0|||
94463358|NCT01447446|323485018|FG000|Overall Study|Reason not Specified|1|||
94463359|NCT01447446|323485019|FG001|Overall Study|Reason not Specified|1|||
94463360|NCT01447446|323485020|FG002|Overall Study|Reason not Specified|1|||
94463361|NCT01447446|323485021|FG003|Overall Study|Reason not Specified|1|||
94463362|NCT01447446|323485022|FG004|Overall Study|Reason not Specified|1|||
94463363|NCT01447446|323485023|FG005|Overall Study|Reason not Specified|0|||
94463364|NCT04495816|323485026|FG000|Overall Study|Lost to Follow-up|10|||
94463365|NCT04495816|323485027|FG001|Overall Study|Lost to Follow-up|4|||
94463366|NCT04495816|323485026|FG000|Overall Study|Withdrawal by Subject|3|||
94463367|NCT04495816|323485027|FG001|Overall Study|Withdrawal by Subject|5|||
94463368|NCT02457832|323485028|FG000|Training|Lost to Follow-up|10|||
94463369|NCT02457832|323485029|FG001|Training|Lost to Follow-up|6|||
94463370|NCT02457832|323485030|FG002|Training|Lost to Follow-up|3|||
94463371|NCT02457832|323485028|FG000|One Month Washout|Lost to Follow-up|0|||
94463372|NCT02457832|323485029|FG001|One Month Washout|Lost to Follow-up|1|||
94679085|NCT02272725|324278965|FG001|Overall Study|equipment malfunction|0|||
94679086|NCT04170686|324280451|FG000|Screening|Physician Decision|12|||
94679087|NCT04170686|324280452|FG001|Screening|Physician Decision|13|||
94679088|NCT04170686|324280451|FG000|Randomization and Treatment|Lost to Follow-up|26|||
94679089|NCT04170686|324280452|FG001|Randomization and Treatment|Lost to Follow-up|15|||
94679090|NCT00944658|324280453|FG000|Treatment 12 Weeks|Adverse Event|0|||
94679091|NCT00944658|324280454|FG001|Treatment 12 Weeks|Adverse Event|2|||
94679092|NCT02035332|324280455|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
94679093|NCT01289418|324280458|FG000|Day 8 Survey|email address invalid|283|||
94679094|NCT01289418|324280458|FG000|Day 8 Survey|participants did not complete the survey|1935|||
94679095|NCT01289418|324280458|FG000|Day 29 Survey|email address invalid|283|||
94679096|NCT01289418|324280458|FG000|Day 29 Survey|participants did not complete the survey|2185|||
94679097|NCT05131165|324280461|FG000|Overall Study|Death|1|||
94679098|NCT05131165|324280462|FG001|Overall Study|Death|1|||
94679099|NCT05131165|324280463|FG002|Overall Study|Death|0|||
94679100|NCT05131165|324280461|FG000|Overall Study|Lost to Follow-up|2|||
94679101|NCT05131165|324280462|FG001|Overall Study|Lost to Follow-up|2|||
94679102|NCT05131165|324280463|FG002|Overall Study|Lost to Follow-up|5|||
94679103|NCT05131165|324280461|FG000|Overall Study|Transferred out of clinic|1|||
94679104|NCT05131165|324280462|FG001|Overall Study|Transferred out of clinic|0|||
94679105|NCT05131165|324280463|FG002|Overall Study|Transferred out of clinic|3|||
94679106|NCT05131165|324280461|FG000|Overall Study|Dropped out|1|||
94679107|NCT05131165|324280462|FG001|Overall Study|Dropped out|2|||
94679108|NCT05131165|324280463|FG002|Overall Study|Dropped out|0|||
94679109|NCT02487498|324280465|FG000|Period: Period 1|Adverse Event|2|||
94679110|NCT02487498|324280466|FG001|Period: Period 1|Adverse Event|4|||
94679111|NCT02487498|324280465|FG000|Period: Period 1|Subject/guardian decision|2|||
94679112|NCT02487498|324280466|FG001|Period: Period 1|Subject/guardian decision|4|||
94679113|NCT02487498|324280465|FG000|Period: Period 1|Lost to Follow-up|0|||
94679114|NCT02487498|324280466|FG001|Period: Period 1|Lost to Follow-up|2|||
94679115|NCT02487498|324280465|FG000|Period: Period 1|Lack of Efficacy|1|||
94679116|NCT02487498|324280466|FG001|Period: Period 1|Lack of Efficacy|0|||
94679117|NCT02487498|324280465|FG000|Period: Period 1|Physician Decision|0|||
94679118|NCT02487498|324280466|FG001|Period: Period 1|Physician Decision|1|||
94679119|NCT02487498|324280465|FG000|Period: Period 1|Protocol deviation|1|||
94679120|NCT02487498|324280466|FG001|Period: Period 1|Protocol deviation|0|||
94679121|NCT02487498|324280465|FG000|Period: Washout|Subject/guardian decision|0|||
94679122|NCT02487498|324280466|FG001|Period: Washout|Subject/guardian decision|5|||
94679123|NCT02487498|324280465|FG000|Period: Washout|Lack of Efficacy|1|||
94679124|NCT02487498|324280466|FG001|Period: Washout|Lack of Efficacy|1|||
94679125|NCT02487498|324280465|FG000|Period: Washout|Physician Decision|1|||
94679126|NCT02487498|324280466|FG001|Period: Washout|Physician Decision|0|||
94679127|NCT02487498|324280465|FG000|Period: Washout|Non-compliance with study treatment|0|||
94679128|NCT02487498|324280466|FG001|Period: Washout|Non-compliance with study treatment|1|||
94679129|NCT02487498|324280465|FG000|Period: Period 2|Adverse Event|2|||
94679130|NCT02487498|324280466|FG001|Period: Period 2|Adverse Event|2|||
94463373|NCT02457832|323485030|FG002|One Month Washout|Lost to Follow-up|1|||
94463374|NCT01149421|323485035|FG000|Overall Study|Adverse Event|22|||
94463375|NCT01149421|323485036|FG001|Overall Study|Adverse Event|6|||
94463376|NCT01149421|323485037|FG002|Overall Study|Adverse Event|11|||
94463377|NCT01149421|323485035|FG000|Overall Study|Withdrawal by Subject|20|||
94463378|NCT01149421|323485036|FG001|Overall Study|Withdrawal by Subject|12|||
94463379|NCT01149421|323485037|FG002|Overall Study|Withdrawal by Subject|13|||
94263494|NCT04484259|322758238|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
94463380|NCT01149421|323485035|FG000|Overall Study|Sponsor Decision|0|||
94463381|NCT01149421|323485036|FG001|Overall Study|Sponsor Decision|1|||
94679131|NCT02487498|324280465|FG000|Period: Period 2|Subject/guardian decision|2|||
94679132|NCT02487498|324280466|FG001|Period: Period 2|Subject/guardian decision|1|||
94679133|NCT02487498|324280465|FG000|Period: Period 2|Lost to Follow-up|1|||
94679134|NCT02487498|324280466|FG001|Period: Period 2|Lost to Follow-up|1|||
94679135|NCT02487498|324280465|FG000|Period: Period 2|Death|0|||
94679136|NCT02487498|324280466|FG001|Period: Period 2|Death|1|||
94679137|NCT02487498|324280465|FG000|Period: Period 2|Physician Decision|1|||
94679138|NCT02487498|324280466|FG001|Period: Period 2|Physician Decision|0|||
94679139|NCT00676130|324280467|FG000|Overall Study|Lost to Follow-up|0|||
94463382|NCT01149421|323485037|FG002|Overall Study|Sponsor Decision|1|||
94463383|NCT01149421|323485035|FG000|Overall Study|Lost to Follow-up|2|||
94463384|NCT01149421|323485036|FG001|Overall Study|Lost to Follow-up|4|||
94463385|NCT01149421|323485037|FG002|Overall Study|Lost to Follow-up|5|||
94463386|NCT01149421|323485035|FG000|Overall Study|Physician Decision|5|||
94463387|NCT01149421|323485036|FG001|Overall Study|Physician Decision|3|||
94463388|NCT01149421|323485037|FG002|Overall Study|Physician Decision|6|||
94463389|NCT01149421|323485035|FG000|Overall Study|Entry Criteria Not Met|1|||
94463390|NCT01149421|323485036|FG001|Overall Study|Entry Criteria Not Met|1|||
94463391|NCT01149421|323485037|FG002|Overall Study|Entry Criteria Not Met|2|||
94463392|NCT01149421|323485035|FG000|Overall Study|Protocol Violation|2|||
94463393|NCT01149421|323485036|FG001|Overall Study|Protocol Violation|2|||
94463394|NCT01149421|323485037|FG002|Overall Study|Protocol Violation|6|||
94463395|NCT03181503|323485038|FG000|Overall Study|Adverse Event|2|||
94463396|NCT03181503|323485039|FG001|Overall Study|Adverse Event|2|||
94643214|NCT02641379|324156606|FG010|Overall Study|Participant cannot be reached|1|||
94643215|NCT02641379|324156596|FG000|Overall Study|PCR positive at Week 24|15|||
94643216|NCT02641379|324156597|FG001|Overall Study|PCR positive at Week 24|21|||
94643217|NCT02641379|324156598|FG002|Overall Study|PCR positive at Week 24|62|||
94679140|NCT00676130|324280468|FG001|Overall Study|Lost to Follow-up|1|||
94679141|NCT00676130|324280467|FG000|Overall Study|Found ineligible|3|||
94679142|NCT00676130|324280468|FG001|Overall Study|Found ineligible|2|||
94679143|NCT00676130|324280467|FG000|Overall Study|Withdrawal by Subject|0|||
94679144|NCT00676130|324280468|FG001|Overall Study|Withdrawal by Subject|1|||
94679145|NCT01564368|324280471|FG000|Overall Study|Ineligible|18|||
94679146|NCT01564368|324280471|FG000|Overall Study|Not Randomized in Parent study|116|||
94679147|NCT01564368|324280471|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
94679148|NCT01564368|324280471|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
94679149|NCT01802437|324280472|FG000|Overall Study|Lost to Follow-up|1|||
94679150|NCT01802437|324280473|FG001|Overall Study|Lost to Follow-up|0|||
94679151|NCT01802437|324280472|FG000|Overall Study|Withdrawal by Subject|3|||
94679152|NCT01802437|324280473|FG001|Overall Study|Withdrawal by Subject|4|||
94679153|NCT01373931|324280476|FG000|Lead-in Period|Adverse Event|2|||
94679154|NCT01373931|324280477|FG001|Lead-in Period|Adverse Event|0|||
94679155|NCT01373931|324280476|FG000|Period 1|Adverse Event|2|||
94679156|NCT01373931|324280477|FG001|Period 1|Adverse Event|0|||
94363869|NCT03159611|323116742|FG000|Overall Study|Protocol Violation|7|||
94463397|NCT03181503|323485038|FG000|Overall Study|Protocol Violation|1|||
94463398|NCT03181503|323485039|FG001|Overall Study|Protocol Violation|0|||
94463399|NCT03181503|323485038|FG000|Overall Study|Withdrawal by Subject|3|||
94643218|NCT02641379|324156599|FG003|Overall Study|PCR positive at Week 24|0|||
94643219|NCT02641379|324156600|FG004|Overall Study|PCR positive at Week 24|0|||
94643220|NCT02641379|324156601|FG005|Overall Study|PCR positive at Week 24|6|||
94643221|NCT02641379|324156602|FG006|Overall Study|PCR positive at Week 24|3|||
94643222|NCT02641379|324156603|FG007|Overall Study|PCR positive at Week 24|8|||
94643223|NCT02641379|324156604|FG008|Overall Study|PCR positive at Week 24|0|||
94643224|NCT02641379|324156605|FG009|Overall Study|PCR positive at Week 24|1|||
94643225|NCT02641379|324156606|FG010|Overall Study|PCR positive at Week 24|0|||
94643226|NCT02641379|324156596|FG000|Overall Study|PCR positive at follow up 2|1|||
94643227|NCT02641379|324156597|FG001|Overall Study|PCR positive at follow up 2|0|||
94643228|NCT02641379|324156598|FG002|Overall Study|PCR positive at follow up 2|0|||
94643229|NCT02641379|324156599|FG003|Overall Study|PCR positive at follow up 2|0|||
94643230|NCT02641379|324156600|FG004|Overall Study|PCR positive at follow up 2|0|||
94643231|NCT02641379|324156601|FG005|Overall Study|PCR positive at follow up 2|0|||
94643232|NCT02641379|324156602|FG006|Overall Study|PCR positive at follow up 2|0|||
94643233|NCT02641379|324156603|FG007|Overall Study|PCR positive at follow up 2|0|||
94643234|NCT02641379|324156604|FG008|Overall Study|PCR positive at follow up 2|0|||
94643235|NCT02641379|324156605|FG009|Overall Study|PCR positive at follow up 2|0|||
94643236|NCT02641379|324156606|FG010|Overall Study|PCR positive at follow up 2|0|||
94643237|NCT02641379|324156596|FG000|Overall Study|Participant showed relapse|1|||
94643238|NCT02641379|324156597|FG001|Overall Study|Participant showed relapse|0|||
94643239|NCT02641379|324156598|FG002|Overall Study|Participant showed relapse|0|||
94643240|NCT02641379|324156599|FG003|Overall Study|Participant showed relapse|0|||
94643241|NCT02641379|324156600|FG004|Overall Study|Participant showed relapse|0|||
94643242|NCT02641379|324156601|FG005|Overall Study|Participant showed relapse|0|||
94643243|NCT02641379|324156602|FG006|Overall Study|Participant showed relapse|1|||
94643244|NCT02641379|324156603|FG007|Overall Study|Participant showed relapse|0|||
94643245|NCT02641379|324156604|FG008|Overall Study|Participant showed relapse|0|||
94643246|NCT02641379|324156605|FG009|Overall Study|Participant showed relapse|0|||
94643247|NCT02641379|324156606|FG010|Overall Study|Participant showed relapse|0|||
94643248|NCT02641379|324156596|FG000|Overall Study|Participant stopped study/treatment|1|||
94643249|NCT02641379|324156597|FG001|Overall Study|Participant stopped study/treatment|3|||
94643250|NCT02641379|324156598|FG002|Overall Study|Participant stopped study/treatment|1|||
94643251|NCT02641379|324156599|FG003|Overall Study|Participant stopped study/treatment|0|||
94643252|NCT02641379|324156600|FG004|Overall Study|Participant stopped study/treatment|0|||
94643253|NCT02641379|324156601|FG005|Overall Study|Participant stopped study/treatment|1|||
94643254|NCT02641379|324156602|FG006|Overall Study|Participant stopped study/treatment|2|||
94643255|NCT02641379|324156603|FG007|Overall Study|Participant stopped study/treatment|0|||
94643256|NCT02641379|324156604|FG008|Overall Study|Participant stopped study/treatment|1|||
94643257|NCT02641379|324156605|FG009|Overall Study|Participant stopped study/treatment|0|||
94643258|NCT02641379|324156606|FG010|Overall Study|Participant stopped study/treatment|0|||
94643259|NCT02641379|324156596|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
94463400|NCT03181503|323485039|FG001|Overall Study|Withdrawal by Subject|0|||
94463401|NCT03181503|323485038|FG000|Overall Study|Lost to Follow-up|1|||
94643260|NCT02641379|324156597|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
94643261|NCT02641379|324156598|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
94463402|NCT03181503|323485039|FG001|Overall Study|Lost to Follow-up|1|||
94463403|NCT01892085|323485040|FG000|Overall Study|Death|4|||
94463404|NCT01892085|323485041|FG001|Overall Study|Death|1|||
94463405|NCT01892085|323485042|FG002|Overall Study|Death|3|||
94463406|NCT01892085|323485040|FG000|Overall Study|Withdrawal by Subject|2|||
94463407|NCT01892085|323485041|FG001|Overall Study|Withdrawal by Subject|0|||
94643262|NCT02641379|324156599|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
94643263|NCT02641379|324156600|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
94643264|NCT02641379|324156601|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
94643265|NCT02641379|324156602|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
94643266|NCT02641379|324156603|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
94643267|NCT02641379|324156604|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
94643268|NCT02641379|324156605|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
94643269|NCT02641379|324156606|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
94643270|NCT02641379|324156596|FG000|Overall Study|Financial problems|0|||
94643271|NCT02641379|324156597|FG001|Overall Study|Financial problems|1|||
94643272|NCT02641379|324156598|FG002|Overall Study|Financial problems|0|||
94643273|NCT02641379|324156599|FG003|Overall Study|Financial problems|0|||
94643274|NCT02641379|324156600|FG004|Overall Study|Financial problems|0|||
94643275|NCT02641379|324156601|FG005|Overall Study|Financial problems|0|||
94643276|NCT02641379|324156602|FG006|Overall Study|Financial problems|0|||
94643277|NCT02641379|324156603|FG007|Overall Study|Financial problems|0|||
94643278|NCT02641379|324156604|FG008|Overall Study|Financial problems|0|||
94643279|NCT02641379|324156605|FG009|Overall Study|Financial problems|0|||
94643280|NCT02641379|324156606|FG010|Overall Study|Financial problems|0|||
94643281|NCT02641379|324156596|FG000|Overall Study|PCR positive at Week 68|0|||
94643282|NCT02641379|324156597|FG001|Overall Study|PCR positive at Week 68|1|||
94643283|NCT02641379|324156598|FG002|Overall Study|PCR positive at Week 68|0|||
94643284|NCT02641379|324156599|FG003|Overall Study|PCR positive at Week 68|0|||
94643285|NCT02641379|324156600|FG004|Overall Study|PCR positive at Week 68|0|||
94643286|NCT02641379|324156601|FG005|Overall Study|PCR positive at Week 68|0|||
94643287|NCT02641379|324156602|FG006|Overall Study|PCR positive at Week 68|0|||
94643288|NCT02641379|324156603|FG007|Overall Study|PCR positive at Week 68|0|||
94643289|NCT02641379|324156604|FG008|Overall Study|PCR positive at Week 68|0|||
94643290|NCT02641379|324156605|FG009|Overall Study|PCR positive at Week 68|0|||
94643291|NCT02641379|324156606|FG010|Overall Study|PCR positive at Week 68|0|||
94643292|NCT02641379|324156596|FG000|Overall Study|PCR positive at Week 48|0|||
94643293|NCT02641379|324156597|FG001|Overall Study|PCR positive at Week 48|1|||
94643294|NCT02641379|324156598|FG002|Overall Study|PCR positive at Week 48|0|||
94643295|NCT02641379|324156599|FG003|Overall Study|PCR positive at Week 48|0|||
94643296|NCT02641379|324156600|FG004|Overall Study|PCR positive at Week 48|0|||
94643297|NCT02641379|324156601|FG005|Overall Study|PCR positive at Week 48|0|||
94643298|NCT02641379|324156602|FG006|Overall Study|PCR positive at Week 48|0|||
94643299|NCT02641379|324156603|FG007|Overall Study|PCR positive at Week 48|0|||
94643300|NCT02641379|324156604|FG008|Overall Study|PCR positive at Week 48|0|||
94643301|NCT02641379|324156605|FG009|Overall Study|PCR positive at Week 48|0|||
94643302|NCT02641379|324156606|FG010|Overall Study|PCR positive at Week 48|0|||
94679157|NCT01373931|324280476|FG000|Period 1|Withdrawal by Subject|0|||
94643303|NCT02641379|324156596|FG000|Overall Study|PCR not performed at Week 12|0|||
94463408|NCT01892085|323485042|FG002|Overall Study|Withdrawal by Subject|2|||
94643304|NCT02641379|324156597|FG001|Overall Study|PCR not performed at Week 12|0|||
94643305|NCT02641379|324156598|FG002|Overall Study|PCR not performed at Week 12|1|||
94643306|NCT02641379|324156599|FG003|Overall Study|PCR not performed at Week 12|0|||
94643307|NCT02641379|324156600|FG004|Overall Study|PCR not performed at Week 12|0|||
94643308|NCT02641379|324156601|FG005|Overall Study|PCR not performed at Week 12|0|||
94643309|NCT02641379|324156602|FG006|Overall Study|PCR not performed at Week 12|0|||
94643310|NCT02641379|324156603|FG007|Overall Study|PCR not performed at Week 12|0|||
94643311|NCT02641379|324156604|FG008|Overall Study|PCR not performed at Week 12|0|||
94643312|NCT02641379|324156605|FG009|Overall Study|PCR not performed at Week 12|0|||
94643313|NCT02641379|324156606|FG010|Overall Study|PCR not performed at Week 12|0|||
94643314|NCT02641379|324156596|FG000|Overall Study|No PCR at baseline|0|||
94643315|NCT02641379|324156597|FG001|Overall Study|No PCR at baseline|0|||
94643316|NCT02641379|324156598|FG002|Overall Study|No PCR at baseline|1|||
94643317|NCT02641379|324156599|FG003|Overall Study|No PCR at baseline|0|||
94643318|NCT02641379|324156600|FG004|Overall Study|No PCR at baseline|0|||
94643319|NCT02641379|324156601|FG005|Overall Study|No PCR at baseline|0|||
94643320|NCT02641379|324156602|FG006|Overall Study|No PCR at baseline|0|||
94643321|NCT02641379|324156603|FG007|Overall Study|No PCR at baseline|0|||
94643322|NCT02641379|324156604|FG008|Overall Study|No PCR at baseline|0|||
94643323|NCT02641379|324156605|FG009|Overall Study|No PCR at baseline|0|||
94643324|NCT02641379|324156606|FG010|Overall Study|No PCR at baseline|0|||
94643325|NCT02641379|324156596|FG000|Overall Study|PCR positive at Week 28|0|||
94643326|NCT02641379|324156597|FG001|Overall Study|PCR positive at Week 28|0|||
94643327|NCT02641379|324156598|FG002|Overall Study|PCR positive at Week 28|1|||
94643328|NCT02641379|324156599|FG003|Overall Study|PCR positive at Week 28|0|||
94643329|NCT02641379|324156600|FG004|Overall Study|PCR positive at Week 28|0|||
94643330|NCT02641379|324156601|FG005|Overall Study|PCR positive at Week 28|0|||
94643331|NCT02641379|324156602|FG006|Overall Study|PCR positive at Week 28|0|||
94643332|NCT02641379|324156603|FG007|Overall Study|PCR positive at Week 28|0|||
94643333|NCT02641379|324156604|FG008|Overall Study|PCR positive at Week 28|0|||
94643334|NCT02641379|324156605|FG009|Overall Study|PCR positive at Week 28|0|||
94643335|NCT02641379|324156606|FG010|Overall Study|PCR positive at Week 28|0|||
94643336|NCT02641379|324156596|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
94643337|NCT02641379|324156597|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
94643338|NCT02641379|324156598|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
94643339|NCT02641379|324156599|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
94643340|NCT02641379|324156600|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
94643341|NCT02641379|324156601|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
94643342|NCT02641379|324156602|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
94643343|NCT02641379|324156603|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
94643344|NCT02641379|324156604|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
94643345|NCT02641379|324156605|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
94643346|NCT02641379|324156606|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
94643347|NCT02641379|324156596|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
94643348|NCT02641379|324156597|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
94643349|NCT02641379|324156598|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
94643350|NCT02641379|324156599|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
94643351|NCT02641379|324156600|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
94643352|NCT02641379|324156601|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
94643353|NCT02641379|324156602|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
94643354|NCT02641379|324156603|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
94643355|NCT02641379|324156604|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
94643356|NCT02641379|324156605|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
94643357|NCT02641379|324156606|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
94643358|NCT02641379|324156596|FG000|Overall Study|Baseline viral load unavailable|0|||
94643359|NCT02641379|324156597|FG001|Overall Study|Baseline viral load unavailable|0|||
94643360|NCT02641379|324156598|FG002|Overall Study|Baseline viral load unavailable|0|||
94643361|NCT02641379|324156599|FG003|Overall Study|Baseline viral load unavailable|1|||
94643362|NCT02641379|324156600|FG004|Overall Study|Baseline viral load unavailable|0|||
94643363|NCT02641379|324156601|FG005|Overall Study|Baseline viral load unavailable|0|||
94643364|NCT02641379|324156602|FG006|Overall Study|Baseline viral load unavailable|0|||
94643365|NCT02641379|324156603|FG007|Overall Study|Baseline viral load unavailable|0|||
94643366|NCT02641379|324156604|FG008|Overall Study|Baseline viral load unavailable|0|||
94643367|NCT02641379|324156605|FG009|Overall Study|Baseline viral load unavailable|0|||
94643368|NCT02641379|324156606|FG010|Overall Study|Baseline viral load unavailable|0|||
94643369|NCT02641379|324156596|FG000|Overall Study|Blood could not be drawn|0|||
94643370|NCT02641379|324156597|FG001|Overall Study|Blood could not be drawn|0|||
94643371|NCT02641379|324156598|FG002|Overall Study|Blood could not be drawn|0|||
94643372|NCT02641379|324156599|FG003|Overall Study|Blood could not be drawn|0|||
94643373|NCT02641379|324156600|FG004|Overall Study|Blood could not be drawn|1|||
94643374|NCT02641379|324156601|FG005|Overall Study|Blood could not be drawn|0|||
94643375|NCT02641379|324156602|FG006|Overall Study|Blood could not be drawn|0|||
94643376|NCT02641379|324156603|FG007|Overall Study|Blood could not be drawn|0|||
94643377|NCT02641379|324156604|FG008|Overall Study|Blood could not be drawn|0|||
94643378|NCT02641379|324156605|FG009|Overall Study|Blood could not be drawn|0|||
94643379|NCT02641379|324156606|FG010|Overall Study|Blood could not be drawn|0|||
94643380|NCT02641379|324156596|FG000|Overall Study|Protocol Violation|0|||
94643381|NCT02641379|324156597|FG001|Overall Study|Protocol Violation|0|||
94643382|NCT02641379|324156598|FG002|Overall Study|Protocol Violation|0|||
94643383|NCT02641379|324156599|FG003|Overall Study|Protocol Violation|0|||
94643384|NCT02641379|324156600|FG004|Overall Study|Protocol Violation|2|||
94643385|NCT02641379|324156601|FG005|Overall Study|Protocol Violation|0|||
94643386|NCT02641379|324156602|FG006|Overall Study|Protocol Violation|0|||
94643387|NCT02641379|324156603|FG007|Overall Study|Protocol Violation|0|||
94643388|NCT02641379|324156604|FG008|Overall Study|Protocol Violation|1|||
94643389|NCT02641379|324156605|FG009|Overall Study|Protocol Violation|0|||
94643390|NCT02641379|324156606|FG010|Overall Study|Protocol Violation|0|||
94643391|NCT02641379|324156596|FG000|Overall Study|Participation in sili rescue study|0|||
94643392|NCT02641379|324156597|FG001|Overall Study|Participation in sili rescue study|0|||
94643393|NCT02641379|324156598|FG002|Overall Study|Participation in sili rescue study|0|||
94643394|NCT02641379|324156599|FG003|Overall Study|Participation in sili rescue study|0|||
94643395|NCT02641379|324156600|FG004|Overall Study|Participation in sili rescue study|0|||
94643396|NCT02641379|324156601|FG005|Overall Study|Participation in sili rescue study|1|||
94643397|NCT02641379|324156602|FG006|Overall Study|Participation in sili rescue study|0|||
94643398|NCT02641379|324156603|FG007|Overall Study|Participation in sili rescue study|0|||
94643399|NCT02641379|324156604|FG008|Overall Study|Participation in sili rescue study|0|||
94643400|NCT02641379|324156605|FG009|Overall Study|Participation in sili rescue study|0|||
94643401|NCT02641379|324156606|FG010|Overall Study|Participation in sili rescue study|0|||
94643402|NCT02641379|324156596|FG000|Overall Study|Lost to Follow-up|0|||
94643403|NCT02641379|324156597|FG001|Overall Study|Lost to Follow-up|0|||
94679158|NCT01373931|324280477|FG001|Period 1|Withdrawal by Subject|2|||
94643404|NCT02641379|324156598|FG002|Overall Study|Lost to Follow-up|0|||
94643405|NCT02641379|324156599|FG003|Overall Study|Lost to Follow-up|0|||
94643406|NCT02641379|324156600|FG004|Overall Study|Lost to Follow-up|0|||
94643407|NCT02641379|324156601|FG005|Overall Study|Lost to Follow-up|0|||
94643408|NCT02641379|324156602|FG006|Overall Study|Lost to Follow-up|0|||
94643409|NCT02641379|324156603|FG007|Overall Study|Lost to Follow-up|0|||
94643410|NCT02641379|324156604|FG008|Overall Study|Lost to Follow-up|1|||
94643411|NCT02641379|324156605|FG009|Overall Study|Lost to Follow-up|0|||
94643412|NCT02641379|324156606|FG010|Overall Study|Lost to Follow-up|0|||
94643413|NCT02641379|324156596|FG000|Overall Study|Source data not found|0|||
94643414|NCT02641379|324156597|FG001|Overall Study|Source data not found|0|||
94643415|NCT02641379|324156598|FG002|Overall Study|Source data not found|0|||
94643416|NCT02641379|324156599|FG003|Overall Study|Source data not found|0|||
94643417|NCT02641379|324156600|FG004|Overall Study|Source data not found|0|||
94643418|NCT02641379|324156601|FG005|Overall Study|Source data not found|1|||
94643419|NCT02641379|324156602|FG006|Overall Study|Source data not found|0|||
94643420|NCT02641379|324156603|FG007|Overall Study|Source data not found|0|||
94643421|NCT02641379|324156604|FG008|Overall Study|Source data not found|0|||
94643422|NCT02641379|324156605|FG009|Overall Study|Source data not found|0|||
94643423|NCT02641379|324156606|FG010|Overall Study|Source data not found|0|||
94263495|NCT04484259|322758239|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
94263496|NCT04484259|322758235|FG000|Randomized Treatment|Withdrawal by Subject|1|||
94643424|NCT02641379|324156596|FG000|Overall Study|Participant showed weight reduction|0|||
94643425|NCT02641379|324156597|FG001|Overall Study|Participant showed weight reduction|0|||
94643426|NCT02641379|324156598|FG002|Overall Study|Participant showed weight reduction|0|||
94643427|NCT02641379|324156599|FG003|Overall Study|Participant showed weight reduction|0|||
94643428|NCT02641379|324156600|FG004|Overall Study|Participant showed weight reduction|0|||
94643429|NCT02641379|324156601|FG005|Overall Study|Participant showed weight reduction|0|||
94643430|NCT02641379|324156602|FG006|Overall Study|Participant showed weight reduction|0|||
94643431|NCT02641379|324156603|FG007|Overall Study|Participant showed weight reduction|1|||
94643432|NCT02641379|324156604|FG008|Overall Study|Participant showed weight reduction|0|||
94643433|NCT02641379|324156605|FG009|Overall Study|Participant showed weight reduction|0|||
94643434|NCT02641379|324156606|FG010|Overall Study|Participant showed weight reduction|0|||
94643435|NCT02641379|324156596|FG000|Overall Study|Non-response Week 12|0|||
94643436|NCT02641379|324156597|FG001|Overall Study|Non-response Week 12|0|||
94643437|NCT02641379|324156598|FG002|Overall Study|Non-response Week 12|0|||
94643438|NCT02641379|324156599|FG003|Overall Study|Non-response Week 12|0|||
94643439|NCT02641379|324156600|FG004|Overall Study|Non-response Week 12|0|||
94643440|NCT02641379|324156601|FG005|Overall Study|Non-response Week 12|0|||
94643441|NCT02641379|324156602|FG006|Overall Study|Non-response Week 12|0|||
94643442|NCT02641379|324156603|FG007|Overall Study|Non-response Week 12|1|||
94643443|NCT02641379|324156604|FG008|Overall Study|Non-response Week 12|0|||
94643444|NCT02641379|324156605|FG009|Overall Study|Non-response Week 12|0|||
94643445|NCT02641379|324156606|FG010|Overall Study|Non-response Week 12|0|||
94643446|NCT02641379|324156596|FG000|Overall Study|No 2 Log drop at Week 12|0|||
94643447|NCT02641379|324156597|FG001|Overall Study|No 2 Log drop at Week 12|0|||
94643448|NCT02641379|324156598|FG002|Overall Study|No 2 Log drop at Week 12|0|||
94643449|NCT02641379|324156599|FG003|Overall Study|No 2 Log drop at Week 12|0|||
94643450|NCT02641379|324156600|FG004|Overall Study|No 2 Log drop at Week 12|0|||
94263497|NCT04484259|322758236|FG001|Randomized Treatment|Withdrawal by Subject|0|||
94643451|NCT02641379|324156601|FG005|Overall Study|No 2 Log drop at Week 12|0|||
94643452|NCT02641379|324156602|FG006|Overall Study|No 2 Log drop at Week 12|0|||
94643453|NCT02641379|324156603|FG007|Overall Study|No 2 Log drop at Week 12|0|||
94643454|NCT02641379|324156604|FG008|Overall Study|No 2 Log drop at Week 12|0|||
94643455|NCT02641379|324156605|FG009|Overall Study|No 2 Log drop at Week 12|0|||
94643456|NCT02641379|324156606|FG010|Overall Study|No 2 Log drop at Week 12|1|||
94643457|NCT02641379|324156596|FG000|Overall Study|Negative PCR result|0|||
94643458|NCT02641379|324156597|FG001|Overall Study|Negative PCR result|0|||
94643459|NCT02641379|324156598|FG002|Overall Study|Negative PCR result|0|||
94643460|NCT02641379|324156599|FG003|Overall Study|Negative PCR result|0|||
94643461|NCT02641379|324156600|FG004|Overall Study|Negative PCR result|0|||
94643462|NCT02641379|324156601|FG005|Overall Study|Negative PCR result|0|||
94643463|NCT02641379|324156602|FG006|Overall Study|Negative PCR result|0|||
94643464|NCT02641379|324156603|FG007|Overall Study|Negative PCR result|0|||
94643465|NCT02641379|324156604|FG008|Overall Study|Negative PCR result|0|||
94643466|NCT02641379|324156605|FG009|Overall Study|Negative PCR result|1|||
94643467|NCT02641379|324156606|FG010|Overall Study|Negative PCR result|0|||
94643468|NCT02641379|324156596|FG000|Overall Study|Participant's PCR high|0|||
94643469|NCT02641379|324156597|FG001|Overall Study|Participant's PCR high|0|||
94643470|NCT02641379|324156598|FG002|Overall Study|Participant's PCR high|0|||
94643471|NCT02641379|324156599|FG003|Overall Study|Participant's PCR high|0|||
94643472|NCT02641379|324156600|FG004|Overall Study|Participant's PCR high|0|||
94643473|NCT02641379|324156601|FG005|Overall Study|Participant's PCR high|0|||
94643474|NCT02641379|324156602|FG006|Overall Study|Participant's PCR high|0|||
94643475|NCT02641379|324156603|FG007|Overall Study|Participant's PCR high|1|||
94643476|NCT02641379|324156604|FG008|Overall Study|Participant's PCR high|0|||
94643477|NCT02641379|324156605|FG009|Overall Study|Participant's PCR high|0|||
94643478|NCT02641379|324156606|FG010|Overall Study|Participant's PCR high|0|||
94643479|NCT02641379|324156596|FG000|Overall Study|Participant treated after Week 24|0|||
94643480|NCT02641379|324156597|FG001|Overall Study|Participant treated after Week 24|0|||
94643481|NCT02641379|324156598|FG002|Overall Study|Participant treated after Week 24|0|||
94643482|NCT02641379|324156599|FG003|Overall Study|Participant treated after Week 24|0|||
94643483|NCT02641379|324156600|FG004|Overall Study|Participant treated after Week 24|0|||
94643484|NCT02641379|324156601|FG005|Overall Study|Participant treated after Week 24|0|||
94643485|NCT02641379|324156602|FG006|Overall Study|Participant treated after Week 24|0|||
94643486|NCT02641379|324156603|FG007|Overall Study|Participant treated after Week 24|0|||
94643487|NCT02641379|324156604|FG008|Overall Study|Participant treated after Week 24|1|||
94643488|NCT02641379|324156605|FG009|Overall Study|Participant treated after Week 24|0|||
94643489|NCT02641379|324156606|FG010|Overall Study|Participant treated after Week 24|0|||
94643490|NCT02641379|324156596|FG000|Overall Study|Missing PCR result at Week 8|0|||
94643491|NCT02641379|324156597|FG001|Overall Study|Missing PCR result at Week 8|0|||
94643492|NCT02641379|324156598|FG002|Overall Study|Missing PCR result at Week 8|0|||
94643493|NCT02641379|324156599|FG003|Overall Study|Missing PCR result at Week 8|0|||
94643494|NCT02641379|324156600|FG004|Overall Study|Missing PCR result at Week 8|0|||
94643495|NCT02641379|324156601|FG005|Overall Study|Missing PCR result at Week 8|0|||
94643496|NCT02641379|324156602|FG006|Overall Study|Missing PCR result at Week 8|0|||
94643497|NCT02641379|324156603|FG007|Overall Study|Missing PCR result at Week 8|0|||
94643498|NCT02641379|324156604|FG008|Overall Study|Missing PCR result at Week 8|0|||
94643499|NCT02641379|324156605|FG009|Overall Study|Missing PCR result at Week 8|1|||
94643500|NCT02641379|324156606|FG010|Overall Study|Missing PCR result at Week 8|0|||
94643501|NCT02641379|324156596|FG000|Overall Study|PCR positive|0|||
94643502|NCT02641379|324156597|FG001|Overall Study|PCR positive|0|||
94643503|NCT02641379|324156598|FG002|Overall Study|PCR positive|0|||
94263498|NCT04484259|322758237|FG002|Randomized Treatment|Withdrawal by Subject|0|||
94263499|NCT04484259|322758238|FG003|Randomized Treatment|Withdrawal by Subject|0|||
94263500|NCT04484259|322758239|FG004|Randomized Treatment|Withdrawal by Subject|0|||
94263501|NCT00458341|322758242|FG000|Cycle 1|Adverse Event|1|||
94679159|NCT00659490|324280478|FG000|Overall Study|Lost to Follow-up|2|||
94679160|NCT00659490|324280479|FG001|Overall Study|Lost to Follow-up|0|||
94679161|NCT00659490|324280480|FG002|Overall Study|Lost to Follow-up|1|||
94679162|NCT05674890|324280485|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
94679163|NCT05674890|324280486|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
94679164|NCT05674890|324280485|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
94679165|NCT05674890|324280486|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
94679166|NCT05674890|324280485|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
94679167|NCT05674890|324280486|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
94679168|NCT00520975|324280487|FG000|Overall Study|Disease progression|31|||
94679169|NCT00520975|324280488|FG001|Overall Study|Disease progression|23|||
94679170|NCT00520975|324280487|FG000|Overall Study|Adverse Event|7|||
94679171|NCT00520975|324280488|FG001|Overall Study|Adverse Event|10|||
94679172|NCT00520975|324280487|FG000|Overall Study|Death|0|||
94679173|NCT00520975|324280488|FG001|Overall Study|Death|2|||
94679174|NCT00520975|324280487|FG000|Overall Study|Withdrawal by Subject|3|||
94679175|NCT00520975|324280488|FG001|Overall Study|Withdrawal by Subject|5|||
94679176|NCT00520975|324280487|FG000|Overall Study|Other therapy|2|||
94679177|NCT00520975|324280488|FG001|Overall Study|Other therapy|4|||
94679178|NCT00520975|324280487|FG000|Overall Study|Other reasons|4|||
94679179|NCT00520975|324280488|FG001|Overall Study|Other reasons|2|||
94679180|NCT00520975|324280487|FG000|Overall Study|Not start protocol therapy|1|||
94679181|NCT00520975|324280488|FG001|Overall Study|Not start protocol therapy|2|||
94679182|NCT00105235|324280491|FG000|Overall Study|Death|4|||
94679183|NCT00105235|324280491|FG000|Overall Study|Physician Decision|1|||
94679184|NCT00105235|324280491|FG000|Overall Study|Withdrawal by Subject|2|||
94679185|NCT01682213|324280492|FG000|Overall Study|Withdrawal by Subject|2|||
94679186|NCT01181726|324280493|FG000|First Intervention|Adverse Event|1|||
94679187|NCT01181726|324280494|FG001|First Intervention|Adverse Event|0|||
94679188|NCT01147822|324280495|FG000|Overall Study|Lost to Follow-up|14|||
94679189|NCT01147822|324280496|FG001|Overall Study|Lost to Follow-up|6|||
94679190|NCT01147822|324280495|FG000|Overall Study|Withdrawal by Subject|10|||
94679191|NCT01147822|324280496|FG001|Overall Study|Withdrawal by Subject|16|||
94679192|NCT01147822|324280495|FG000|Overall Study|Physician Decision|9|||
94679193|NCT01147822|324280496|FG001|Overall Study|Physician Decision|8|||
94679194|NCT01147822|324280495|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
94679195|NCT01147822|324280496|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
94679196|NCT01147822|324280495|FG000|Overall Study|Protocol Violation|1|||
94679197|NCT01147822|324280496|FG001|Overall Study|Protocol Violation|1|||
94679198|NCT00991341|324280504|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
94679199|NCT00991341|324280505|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
94679200|NCT00991341|324280504|FG000|Overall Study|Death|3|||
94679201|NCT00991341|324280505|FG001|Overall Study|Death|0|||
94679202|NCT00991341|324280504|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
94679203|NCT00991341|324280505|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
94679204|NCT00991341|324280504|FG000|Overall Study|Physician Decision|1|||
94679205|NCT00991341|324280505|FG001|Overall Study|Physician Decision|2|||
94679206|NCT00991341|324280504|FG000|Overall Study|Withdrawal by Subject|3|||
94679207|NCT00991341|324280505|FG001|Overall Study|Withdrawal by Subject|4|||
94679208|NCT00615264|324280522|FG000|Overall Study|Withdrawal by Subject|17|||
94679209|NCT00615264|324280523|FG001|Overall Study|Withdrawal by Subject|19|||
94679210|NCT00615264|324280522|FG000|Overall Study|Lost to Follow-up|6|||
94679211|NCT00615264|324280523|FG001|Overall Study|Lost to Follow-up|13|||
94679212|NCT00615264|324280522|FG000|Overall Study|Adverse Event|8|||
94679213|NCT00615264|324280523|FG001|Overall Study|Adverse Event|5|||
94679214|NCT00615264|324280522|FG000|Overall Study|Death|1|||
94679215|NCT00615264|324280523|FG001|Overall Study|Death|1|||
94679216|NCT00615264|324280522|FG000|Overall Study|Protocol Violation|11|||
94679217|NCT00615264|324280523|FG001|Overall Study|Protocol Violation|7|||
94679218|NCT00615264|324280522|FG000|Overall Study|Not defined|7|||
94679219|NCT00615264|324280523|FG001|Overall Study|Not defined|4|||
94679220|NCT00615264|324280522|FG000|Overall Study|Dermal Hypersensitivity|0|||
94679221|NCT00615264|324280523|FG001|Overall Study|Dermal Hypersensitivity|3|||
94679222|NCT01520402|324280526|FG000|Overall Study|Withdrawal by Subject|2|||
94679223|NCT01520402|324280526|FG000|Overall Study|Physician Decision|3|||
94679224|NCT00643123|324280530|FG000|Overall Study|Lost to Follow-up|4|||
94679225|NCT00643123|324280531|FG001|Overall Study|Lost to Follow-up|0|||
94679226|NCT00643123|324280530|FG000|Overall Study|Withdrawal by Subject|1|||
94679227|NCT00643123|324280531|FG001|Overall Study|Withdrawal by Subject|1|||
94679228|NCT01982435|324280532|FG000|Overall Study|Adverse Event|1|||
94679229|NCT01982435|324280533|FG001|Overall Study|Adverse Event|0|||
94679230|NCT01892345|324280534|FG000|Overall Study|Adverse Event|0|||
94679231|NCT01892345|324280535|FG001|Overall Study|Adverse Event|2|||
94679232|NCT01892345|324280534|FG000|Overall Study|Death|1|||
94679233|NCT01892345|324280535|FG001|Overall Study|Death|0|||
94679234|NCT01892345|324280534|FG000|Overall Study|Lost to Follow-up|3|||
94679235|NCT01892345|324280535|FG001|Overall Study|Lost to Follow-up|0|||
94679236|NCT01892345|324280534|FG000|Overall Study|Withdrawal by Subject|12|||
94679237|NCT01892345|324280535|FG001|Overall Study|Withdrawal by Subject|1|||
94679238|NCT02255357|324280546|FG000|Overall Study|Physician Decision|10|||
94679239|NCT02255357|324280547|FG001|Overall Study|Physician Decision|24|||
94679240|NCT04074590|324280548|FG000|Overall Study|Adverse Event|1|||
94679241|NCT04074590|324280549|FG001|Overall Study|Adverse Event|0|||
94679242|NCT04074590|324280548|FG000|Overall Study|Physician Decision|1|||
94679243|NCT04074590|324280549|FG001|Overall Study|Physician Decision|0|||
94679244|NCT04074590|324280548|FG000|Overall Study|Withdrawal by Subject|2|||
94679245|NCT04074590|324280549|FG001|Overall Study|Withdrawal by Subject|0|||
94679246|NCT03299686|324280552|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
94679247|NCT03299686|324280553|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
94679248|NCT03299686|324280552|FG000|Treatment Epoch|Physician Decision|1|||
94679249|NCT03299686|324280553|FG001|Treatment Epoch|Physician Decision|0|||
94679250|NCT03299686|324280552|FG000|Treatment Epoch|Adverse Event|8|||
94679251|NCT03299686|324280553|FG001|Treatment Epoch|Adverse Event|4|||
94679252|NCT03299686|324280552|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
94679253|NCT03299686|324280553|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
94679254|NCT02709005|324280554|FG000|Overall Study|Lost to Follow-up|1|||
94679255|NCT02709005|324280555|FG001|Overall Study|Lost to Follow-up|1|||
94679256|NCT02709005|324280554|FG000|Overall Study|Withdrawal by Subject|3|||
94679257|NCT02709005|324280555|FG001|Overall Study|Withdrawal by Subject|0|||
94679258|NCT02857426|324280559|FG000|Overall Study|Disease progression|34|||
94679259|NCT02857426|324280560|FG001|Overall Study|Disease progression|13|||
94679260|NCT02857426|324280559|FG000|Overall Study|Study drug toxicity|4|||
94679261|NCT02857426|324280560|FG001|Overall Study|Study drug toxicity|1|||
94679262|NCT02857426|324280559|FG000|Overall Study|Death|1|||
94679263|NCT02857426|324280560|FG001|Overall Study|Death|0|||
94679264|NCT02857426|324280559|FG000|Overall Study|Adverse event unrelated to study drug|6|||
94679265|NCT02857426|324280560|FG001|Overall Study|Adverse event unrelated to study drug|2|||
94679266|NCT02857426|324280559|FG000|Overall Study|Participant withdrew consent|1|||
94679267|NCT02857426|324280560|FG001|Overall Study|Participant withdrew consent|1|||
94679268|NCT02857426|324280559|FG000|Overall Study|Maximum clinical benefit|1|||
94679269|NCT02857426|324280560|FG001|Overall Study|Maximum clinical benefit|0|||
94679270|NCT02857426|324280559|FG000|Overall Study|Completed treatment|0|||
94679271|NCT02857426|324280560|FG001|Overall Study|Completed treatment|2|||
94679272|NCT01282801|324280561|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
94679273|NCT01282801|324280562|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
94679274|NCT01862796|324280567|FG000|Overall Study|Prohibited medications|0|||
94679275|NCT01862796|324280568|FG001|Overall Study|Prohibited medications|0|||
94679276|NCT01862796|324280569|FG002|Overall Study|Prohibited medications|1|||
94679277|NCT04404478|324280570|FG000|Overall Study|Withdrawal by Subject|1|||
94679278|NCT04404478|324280571|FG001|Overall Study|Withdrawal by Subject|3|||
94679279|NCT04995419|324280577|FG000|Overall Study|Withdrawal by Subject|3|||
94679280|NCT04995419|324280577|FG000|Overall Study|Progressive Disease|19|||
94679281|NCT04995419|324280577|FG000|Overall Study|Adverse Event|2|||
94679282|NCT04995419|324280577|FG000|Overall Study|Ongoing|16|||
94679283|NCT05375955|324280578|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
94679284|NCT05375955|324280579|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
94679285|NCT05375955|324280580|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
94679286|NCT05375955|324280581|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
94679287|NCT05375955|324280582|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
94679288|NCT05375955|324280583|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
94679289|NCT05375955|324280584|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
94679290|NCT05375955|324280578|FG000|Treatment (12 Weeks)|Physician Decision|4|||
94679291|NCT05375955|324280579|FG001|Treatment (12 Weeks)|Physician Decision|1|||
94679292|NCT05375955|324280580|FG002|Treatment (12 Weeks)|Physician Decision|3|||
94679293|NCT05375955|324280581|FG003|Treatment (12 Weeks)|Physician Decision|0|||
94679294|NCT05375955|324280582|FG004|Treatment (12 Weeks)|Physician Decision|0|||
94679295|NCT05375955|324280583|FG005|Treatment (12 Weeks)|Physician Decision|1|||
94679296|NCT05375955|324280584|FG006|Treatment (12 Weeks)|Physician Decision|0|||
94679297|NCT05375955|324280578|FG000|Treatment (12 Weeks)|Other|0|||
94679298|NCT05375955|324280579|FG001|Treatment (12 Weeks)|Other|1|||
94679299|NCT05375955|324280580|FG002|Treatment (12 Weeks)|Other|0|||
94679300|NCT05375955|324280581|FG003|Treatment (12 Weeks)|Other|0|||
94679301|NCT05375955|324280582|FG004|Treatment (12 Weeks)|Other|0|||
94679302|NCT05375955|324280583|FG005|Treatment (12 Weeks)|Other|0|||
94679303|NCT05375955|324280584|FG006|Treatment (12 Weeks)|Other|0|||
94679304|NCT05375955|324280578|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
94679305|NCT05375955|324280579|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
94679306|NCT05375955|324280580|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
94679307|NCT05375955|324280581|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
94679308|NCT05375955|324280582|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
94679309|NCT05375955|324280583|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
94679310|NCT05375955|324280584|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
94679311|NCT05375955|324280578|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
94679312|NCT05375955|324280579|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
94679313|NCT05375955|324280580|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
94679314|NCT05375955|324280581|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
94679315|NCT05375955|324280582|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
94679316|NCT05375955|324280583|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
94679317|NCT05375955|324280584|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
94679318|NCT05375955|324280578|FG000|Treatment (12 Weeks)|Pregnancy|0|||
94679319|NCT05375955|324280579|FG001|Treatment (12 Weeks)|Pregnancy|0|||
94679320|NCT05375955|324280580|FG002|Treatment (12 Weeks)|Pregnancy|1|||
94679321|NCT05375955|324280581|FG003|Treatment (12 Weeks)|Pregnancy|0|||
94679322|NCT05375955|324280582|FG004|Treatment (12 Weeks)|Pregnancy|0|||
94679323|NCT05375955|324280583|FG005|Treatment (12 Weeks)|Pregnancy|0|||
94679324|NCT05375955|324280584|FG006|Treatment (12 Weeks)|Pregnancy|0|||
94679325|NCT05375955|324280578|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
94679326|NCT05375955|324280579|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
94679327|NCT05375955|324280580|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
94679328|NCT05375955|324280581|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
94679329|NCT05375955|324280582|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
94679330|NCT05375955|324280583|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
94679331|NCT05375955|324280584|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
94679332|NCT05375955|324280578|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
94679333|NCT05375955|324280579|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
94679334|NCT05375955|324280580|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
94679335|NCT05375955|324280581|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
94679336|NCT05375955|324280582|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
94679337|NCT05375955|324280583|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
94679338|NCT05375955|324280584|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
94679339|NCT05375955|324280578|FG000|Follow-up (up to 5 Weeks)|Other|0|||
94679340|NCT05375955|324280579|FG001|Follow-up (up to 5 Weeks)|Other|1|||
94679341|NCT05375955|324280580|FG002|Follow-up (up to 5 Weeks)|Other|0|||
94679342|NCT05375955|324280581|FG003|Follow-up (up to 5 Weeks)|Other|0|||
94679343|NCT05375955|324280582|FG004|Follow-up (up to 5 Weeks)|Other|0|||
94679344|NCT05375955|324280583|FG005|Follow-up (up to 5 Weeks)|Other|0|||
94679345|NCT05375955|324280584|FG006|Follow-up (up to 5 Weeks)|Other|0|||
94679346|NCT05375955|324280578|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
94679347|NCT05375955|324280579|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
94679348|NCT05375955|324280580|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
94679349|NCT05375955|324280581|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
94679350|NCT05375955|324280582|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
94679351|NCT05375955|324280583|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
94679352|NCT05375955|324280584|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
94679353|NCT05375955|324280578|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
94679354|NCT05375955|324280579|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
94679355|NCT05375955|324280580|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
94679356|NCT05375955|324280581|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
94679357|NCT05375955|324280582|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
94679358|NCT05375955|324280583|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
94679359|NCT05375955|324280584|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
94679360|NCT00946296|324280585|FG000|Overall Study|Physician Decision|3|||
94679361|NCT00946296|324280586|FG001|Overall Study|Physician Decision|0|||
94679362|NCT03879408|324280587|FG000|Overall Study|Lost to Follow-up|0|||
94679363|NCT03879408|324280588|FG001|Overall Study|Lost to Follow-up|3|||
94679364|NCT03879408|324280589|FG002|Overall Study|Lost to Follow-up|2|||
94679365|NCT03879408|324280590|FG003|Overall Study|Lost to Follow-up|1|||
94679366|NCT03879408|324280591|FG004|Overall Study|Lost to Follow-up|0|||
94679367|NCT03879408|324280587|FG000|Overall Study|Withdrawal by Subject|2|||
94679368|NCT03879408|324280588|FG001|Overall Study|Withdrawal by Subject|1|||
94679369|NCT03879408|324280589|FG002|Overall Study|Withdrawal by Subject|1|||
94679370|NCT03879408|324280590|FG003|Overall Study|Withdrawal by Subject|0|||
94679371|NCT03879408|324280591|FG004|Overall Study|Withdrawal by Subject|1|||
94679372|NCT02237508|324280592|FG000|Overall Study|Withdrawal by Subject|0|||
94679373|NCT02237508|324280593|FG001|Overall Study|Withdrawal by Subject|2|||
94679374|NCT02237508|324280594|FG002|Overall Study|Withdrawal by Subject|0|||
94679375|NCT02237508|324280595|FG003|Overall Study|Withdrawal by Subject|1|||
94679376|NCT02237508|324280596|FG004|Overall Study|Withdrawal by Subject|0|||
94679377|NCT02237508|324280597|FG005|Overall Study|Withdrawal by Subject|1|||
94679378|NCT02237508|324280598|FG006|Overall Study|Withdrawal by Subject|1|||
94679379|NCT02237508|324280599|FG007|Overall Study|Withdrawal by Subject|0|||
94679380|NCT02237508|324280600|FG008|Overall Study|Withdrawal by Subject|1|||
94679381|NCT02237508|324280601|FG009|Overall Study|Withdrawal by Subject|0|||
94679382|NCT02237508|324280592|FG000|Overall Study|Physician Decision|0|||
94679383|NCT02237508|324280593|FG001|Overall Study|Physician Decision|1|||
94679384|NCT02237508|324280594|FG002|Overall Study|Physician Decision|0|||
94679385|NCT02237508|324280595|FG003|Overall Study|Physician Decision|0|||
94679386|NCT02237508|324280596|FG004|Overall Study|Physician Decision|0|||
94679387|NCT02237508|324280597|FG005|Overall Study|Physician Decision|0|||
94679388|NCT02237508|324280598|FG006|Overall Study|Physician Decision|0|||
94679389|NCT02237508|324280599|FG007|Overall Study|Physician Decision|0|||
94679390|NCT02237508|324280600|FG008|Overall Study|Physician Decision|0|||
94679391|NCT02237508|324280601|FG009|Overall Study|Physician Decision|0|||
94679392|NCT02237508|324280592|FG000|Overall Study|Protocol Violation|0|||
94679393|NCT02237508|324280593|FG001|Overall Study|Protocol Violation|0|||
94679394|NCT02237508|324280594|FG002|Overall Study|Protocol Violation|1|||
94679395|NCT02237508|324280595|FG003|Overall Study|Protocol Violation|0|||
94679396|NCT02237508|324280596|FG004|Overall Study|Protocol Violation|0|||
94679397|NCT02237508|324280597|FG005|Overall Study|Protocol Violation|0|||
94679398|NCT02237508|324280598|FG006|Overall Study|Protocol Violation|0|||
94679399|NCT02237508|324280599|FG007|Overall Study|Protocol Violation|0|||
94679400|NCT02237508|324280600|FG008|Overall Study|Protocol Violation|0|||
94679401|NCT02237508|324280601|FG009|Overall Study|Protocol Violation|0|||
94679402|NCT00654901|324280602|FG000|Overall Study|Lost to Follow-up|1|||
94679403|NCT00654901|324280603|FG001|Overall Study|Lost to Follow-up|0|||
94679404|NCT00654901|324280604|FG002|Overall Study|Lost to Follow-up|1|||
94679405|NCT00654901|324280605|FG003|Overall Study|Lost to Follow-up|0|||
94679406|NCT00654901|324280602|FG000|Overall Study|Withdrawal by Subject|3|||
94679407|NCT00654901|324280603|FG001|Overall Study|Withdrawal by Subject|0|||
94679408|NCT00654901|324280604|FG002|Overall Study|Withdrawal by Subject|1|||
94679409|NCT00654901|324280605|FG003|Overall Study|Withdrawal by Subject|0|||
94679410|NCT01301274|324280607|FG000|Overall Study|Physician Decision|2|||
94679411|NCT01301274|324280608|FG001|Overall Study|Physician Decision|1|||
94679412|NCT00661661|324280609|FG000|Overall Study|Adverse Event|99|||
94679413|NCT00661661|324280610|FG001|Overall Study|Adverse Event|24|||
94679414|NCT00661661|324280609|FG000|Overall Study|Lack of Efficacy|3|||
94679415|NCT00661661|324280610|FG001|Overall Study|Lack of Efficacy|2|||
94463409|NCT00767039|323485043|FG000|Overall Study|Death|5|||
94679416|NCT00661661|324280609|FG000|Overall Study|Lost to Follow-up|0|||
94679417|NCT00661661|324280610|FG001|Overall Study|Lost to Follow-up|1|||
94679418|NCT00661661|324280609|FG000|Overall Study|Withdrawal by Subject|15|||
94679419|NCT00661661|324280610|FG001|Overall Study|Withdrawal by Subject|5|||
94679420|NCT00661661|324280609|FG000|Overall Study|Other|22|||
94679421|NCT00661661|324280610|FG001|Overall Study|Other|7|||
94679422|NCT00661661|324280609|FG000|Overall Study|Not assigned treatment|1|||
94679423|NCT00661661|324280610|FG001|Overall Study|Not assigned treatment|0|||
94679424|NCT02946918|324280613|FG000|Overall Study|Patient unblinded himself|1|||
94679425|NCT02946918|324280614|FG001|Overall Study|Patient unblinded himself|0|||
94679426|NCT02946918|324280613|FG000|Overall Study|Physician Decision|0|||
94679427|NCT02946918|324280614|FG001|Overall Study|Physician Decision|2|||
94679428|NCT02946918|324280613|FG000|Overall Study|Ran out of study medication|0|||
94679429|NCT02946918|324280614|FG001|Overall Study|Ran out of study medication|1|||
94679430|NCT00069784|324280615|FG000|Overall Study|Adverse Event|105|||
94679431|NCT00069784|324280616|FG001|Overall Study|Adverse Event|0|||
94679432|NCT00069784|324280615|FG000|Overall Study|Withdrawal by Subject|1090|||
94679433|NCT00069784|324280616|FG001|Overall Study|Withdrawal by Subject|0|||
94679434|NCT00069784|324280615|FG000|Overall Study|Other|17|||
94679435|NCT00069784|324280616|FG001|Overall Study|Other|0|||
94679436|NCT00738101|324280617|FG000|Overall Study|Physician Decision|5|||
94679437|NCT00738101|324280617|FG000|Overall Study|Death|1|||
94679438|NCT00738101|324280617|FG000|Overall Study|Repeat enrollment|1|||
94679439|NCT01679301|324282248|FG000|Screening Period|screen failure|3|||
94679440|NCT01679301|324282249|FG001|Screening Period|screen failure|0|||
94679441|NCT01679301|324282250|FG002|Screening Period|screen failure|0|||
94679442|NCT02026232|324282251|FG000|Overall Study|incomplete visit/missing data|3|||
94263502|NCT00458341|322758243|FG001|Cycle 1|Adverse Event|0|||
94263503|NCT04014361|322758246|FG000|Period 2|Physician Decision|0|||
94263504|NCT04014361|322758247|FG001|Period 2|Physician Decision|0|||
94263505|NCT04014361|322758248|FG002|Period 2|Physician Decision|0|||
94263506|NCT04014361|322758249|FG003|Period 2|Physician Decision|1|||
94263507|NCT04014361|322758250|FG004|Period 2|Physician Decision|0|||
94263508|NCT04014361|322758251|FG005|Period 2|Physician Decision|0|||
94263509|NCT04014361|322758252|FG006|Period 2|Physician Decision|0|||
94263510|NCT04014361|322758253|FG007|Period 2|Physician Decision|0|||
94263511|NCT00866697|322758254|FG000|Overall Study|Study closed/terminated|156|||
94263512|NCT00866697|322758255|FG001|Overall Study|Study closed/terminated|138|||
94263513|NCT00866697|322758254|FG000|Overall Study|Lost to Follow-up|22|||
94263514|NCT00866697|322758255|FG001|Overall Study|Lost to Follow-up|28|||
94263515|NCT00866697|322758254|FG000|Overall Study|Physician Decision|3|||
94263516|NCT00866697|322758255|FG001|Overall Study|Physician Decision|5|||
94263517|NCT00866697|322758254|FG000|Overall Study|Withdrawal by Subject|33|||
94263518|NCT00866697|322758255|FG001|Overall Study|Withdrawal by Subject|57|||
94263519|NCT00594516|322759845|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
94263520|NCT00594516|322759846|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
94463410|NCT00767039|323485044|FG001|Overall Study|Death|2|||
94679443|NCT02026232|324282252|FG001|Overall Study|incomplete visit/missing data|2|||
94679444|NCT02276066|324282255|FG000|Overall Study|Lost to Follow-up|21|||
94679445|NCT02276066|324282256|FG001|Overall Study|Lost to Follow-up|11|||
94679446|NCT01242748|324282257|FG000|Overall Study|Adverse Event|10|||
94679447|NCT01242748|324282258|FG001|Overall Study|Adverse Event|5|||
94679448|NCT01242748|324282257|FG000|Overall Study|Lost to Follow-up|6|||
94679449|NCT01242748|324282258|FG001|Overall Study|Lost to Follow-up|2|||
94463411|NCT03435224|323485049|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
94463412|NCT01382225|323485050|FG000|Overall Study|Adverse Event|3|||
94463413|NCT01382225|323485051|FG001|Overall Study|Adverse Event|2|||
94643504|NCT02641379|324156599|FG003|Overall Study|PCR positive|0|||
94643505|NCT02641379|324156600|FG004|Overall Study|PCR positive|0|||
94643506|NCT02641379|324156601|FG005|Overall Study|PCR positive|0|||
94643507|NCT02641379|324156602|FG006|Overall Study|PCR positive|1|||
94643508|NCT02641379|324156603|FG007|Overall Study|PCR positive|0|||
94643509|NCT02641379|324156604|FG008|Overall Study|PCR positive|0|||
94643510|NCT02641379|324156605|FG009|Overall Study|PCR positive|0|||
94643511|NCT02641379|324156606|FG010|Overall Study|PCR positive|0|||
94643512|NCT02275481|324156607|FG000|Overall Study|Death|2|||
94643513|NCT02275481|324156608|FG001|Overall Study|Death|1|||
94643514|NCT02275481|324156607|FG000|Overall Study|Lost to Follow-up|2|||
94643515|NCT02275481|324156608|FG001|Overall Study|Lost to Follow-up|0|||
94643516|NCT02275481|324156607|FG000|Overall Study|Withdrawal by Subject|3|||
94643517|NCT02275481|324156608|FG001|Overall Study|Withdrawal by Subject|0|||
94643518|NCT02275481|324156607|FG000|Overall Study|all other reasons combined|2|||
94643519|NCT02275481|324156608|FG001|Overall Study|all other reasons combined|1|||
94643520|NCT02275481|324156607|FG000|Overall Study|Physician Decision|0|||
94643521|NCT02275481|324156608|FG001|Overall Study|Physician Decision|1|||
94643522|NCT01644175|324156609|FG000|Overall Study|Randomized But Not Treated|0|||
94643523|NCT01644175|324156610|FG001|Overall Study|Randomized But Not Treated|2|||
94643524|NCT01644175|324156609|FG000|Overall Study|Adverse Event|8|||
94643525|NCT01644175|324156610|FG001|Overall Study|Adverse Event|13|||
94643526|NCT01644175|324156609|FG000|Overall Study|Death|1|||
94643527|NCT01644175|324156610|FG001|Overall Study|Death|2|||
94643528|NCT01644175|324156609|FG000|Overall Study|Poor compliance to protocol|9|||
94643529|NCT01644175|324156610|FG001|Overall Study|Poor compliance to protocol|10|||
94643530|NCT01644175|324156609|FG000|Overall Study|Physician Decision|1|||
94643531|NCT01644175|324156610|FG001|Overall Study|Physician Decision|2|||
94643532|NCT01644175|324156609|FG000|Overall Study|Participant Moved|1|||
94643533|NCT01644175|324156610|FG001|Overall Study|Participant Moved|2|||
94643534|NCT01644175|324156609|FG000|Overall Study|Consent withdrawn by participant|3|||
94643535|NCT01644175|324156610|FG001|Overall Study|Consent withdrawn by participant|4|||
94643536|NCT01644175|324156609|FG000|Overall Study|Related to Autoinjector Administration|2|||
94643537|NCT01644175|324156610|FG001|Overall Study|Related to Autoinjector Administration|1|||
94643538|NCT01644175|324156609|FG000|Overall Study|Last visit outside protocol visit window|4|||
94643539|NCT01644175|324156610|FG001|Overall Study|Last visit outside protocol visit window|11|||
94643540|NCT01644175|324156609|FG000|Overall Study|Selection criteria finally not met|0|||
94643541|NCT01644175|324156610|FG001|Overall Study|Selection criteria finally not met|1|||
94643542|NCT01644175|324156609|FG000|Overall Study|Site closure|2|||
94643543|NCT01644175|324156610|FG001|Overall Study|Site closure|2|||
94643544|NCT01644175|324156609|FG000|Overall Study|Lost to Follow-up|1|||
94643545|NCT01644175|324156610|FG001|Overall Study|Lost to Follow-up|0|||
94643546|NCT01644175|324156609|FG000|Overall Study|Other than specified above|0|||
94643547|NCT01644175|324156610|FG001|Overall Study|Other than specified above|3|||
94643548|NCT04258605|324156611|FG000|Overall Study|Death|1|||
94643549|NCT04258605|324156612|FG001|Overall Study|Death|0|||
94643550|NCT04258605|324156611|FG000|Overall Study|Early study termination|21|||
94643551|NCT04258605|324156612|FG001|Overall Study|Early study termination|2|||
94643552|NCT01418937|324156615|FG000|Overall Study|Lost to Follow-up|5|||
94643553|NCT01418937|324156615|FG000|Overall Study|Protocol Violation|1|||
94643554|NCT01418937|324156615|FG000|Overall Study|Pregnancy|1|||
94463414|NCT01382225|323485050|FG000|Overall Study|Protocol Violation|2|||
94643555|NCT01418937|324156615|FG000|Overall Study|Withdrawal by Subject|1|||
94643556|NCT00313612|324156616|FG000|Overall Study|Patient never received treatment|0|||
94643557|NCT00313612|324156617|FG001|Overall Study|Patient never received treatment|1|||
94643558|NCT01393405|324156620|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
94643559|NCT01393405|324156621|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
94643560|NCT01393405|324156622|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
94643561|NCT01393405|324156620|FG000|Induction Period (week1-16)|Adverse Event|16|||
94643562|NCT01393405|324156621|FG001|Induction Period (week1-16)|Adverse Event|0|||
94643563|NCT01393405|324156622|FG002|Induction Period (week1-16)|Adverse Event|0|||
94263521|NCT00594516|322759847|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
94363870|NCT03159611|323116743|FG001|Overall Study|Protocol Violation|4|||
94363871|NCT03159611|323116742|FG000|Overall Study|Adverse Event|1|||
94363872|NCT03159611|323116743|FG001|Overall Study|Adverse Event|0|||
94363873|NCT03159611|323116742|FG000|Overall Study|Withdrawal by Subject|1|||
94363874|NCT03159611|323116743|FG001|Overall Study|Withdrawal by Subject|1|||
94643564|NCT01393405|324156620|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
94643565|NCT01393405|324156621|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
94643566|NCT01393405|324156622|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
94643567|NCT01393405|324156620|FG000|Maintenance Period Week|Lack of Efficacy|0|||
94643568|NCT01393405|324156621|FG001|Maintenance Period Week|Lack of Efficacy|22|||
94643569|NCT01393405|324156622|FG002|Maintenance Period Week|Lack of Efficacy|22|||
94643570|NCT01393405|324156620|FG000|Maintenance Period Week|Adverse Event|0|||
94643571|NCT01393405|324156621|FG001|Maintenance Period Week|Adverse Event|5|||
94643572|NCT01393405|324156622|FG002|Maintenance Period Week|Adverse Event|2|||
94643573|NCT01393405|324156620|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
94643574|NCT01393405|324156621|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
94643575|NCT01393405|324156622|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
94643576|NCT01393405|324156620|FG000|Maintenance Period Week|Lost to Follow-up|0|||
94643577|NCT01393405|324156621|FG001|Maintenance Period Week|Lost to Follow-up|1|||
94643578|NCT01393405|324156622|FG002|Maintenance Period Week|Lost to Follow-up|0|||
94643579|NCT04151290|324156623|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
94643580|NCT03465878|324156624|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
94643581|NCT03465878|324156625|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
94643582|NCT03465878|324156626|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
94643583|NCT03465878|324156627|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
94643584|NCT03465878|324156624|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
94643585|NCT03465878|324156625|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
94643586|NCT03465878|324156626|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
94643587|NCT03465878|324156627|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
94643588|NCT03465878|324156624|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
94643589|NCT03465878|324156625|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
94643590|NCT03465878|324156626|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
94643591|NCT03465878|324156627|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
94643592|NCT00615056|324156628|FG000|Overall Study|Death|31|||
94643593|NCT00615056|324156629|FG001|Overall Study|Death|31|||
94643594|NCT00615056|324156630|FG002|Overall Study|Death|21|||
94643595|NCT00615056|324156631|FG003|Overall Study|Death|23|||
94643596|NCT00615056|324156628|FG000|Overall Study|Lost to Follow-up|1|||
94643597|NCT00615056|324156629|FG001|Overall Study|Lost to Follow-up|2|||
94643598|NCT00615056|324156630|FG002|Overall Study|Lost to Follow-up|4|||
94643599|NCT00615056|324156631|FG003|Overall Study|Lost to Follow-up|5|||
94643600|NCT00615056|324156628|FG000|Overall Study|Other|13|||
94643601|NCT00615056|324156629|FG001|Overall Study|Other|15|||
94643602|NCT00615056|324156630|FG002|Overall Study|Other|10|||
94643603|NCT00615056|324156631|FG003|Overall Study|Other|7|||
94643604|NCT00615056|324156628|FG000|Overall Study|Objective progression or relapse|0|||
94643605|NCT00615056|324156629|FG001|Overall Study|Objective progression or relapse|2|||
94643606|NCT00615056|324156630|FG002|Overall Study|Objective progression or relapse|0|||
94643607|NCT00615056|324156631|FG003|Overall Study|Objective progression or relapse|0|||
94643608|NCT00615056|324156628|FG000|Overall Study|Withdrawal by Subject|0|||
94643609|NCT00615056|324156629|FG001|Overall Study|Withdrawal by Subject|1|||
94643610|NCT00615056|324156630|FG002|Overall Study|Withdrawal by Subject|1|||
94643611|NCT00615056|324156631|FG003|Overall Study|Withdrawal by Subject|0|||
94643612|NCT00615056|324156628|FG000|Overall Study|Discontinued by Sponsor|1|||
94643613|NCT00615056|324156629|FG001|Overall Study|Discontinued by Sponsor|0|||
94643614|NCT00615056|324156630|FG002|Overall Study|Discontinued by Sponsor|0|||
94643615|NCT00615056|324156631|FG003|Overall Study|Discontinued by Sponsor|0|||
94643616|NCT00615056|324156628|FG000|Overall Study|Randomized but not treated|3|||
94643617|NCT00615056|324156629|FG001|Overall Study|Randomized but not treated|0|||
94643618|NCT00615056|324156630|FG002|Overall Study|Randomized but not treated|0|||
94643619|NCT00615056|324156631|FG003|Overall Study|Randomized but not treated|0|||
94643620|NCT00692770|324156634|FG000|Overall Study|Protocol Violation|2|||
94643621|NCT00692770|324156635|FG001|Overall Study|Protocol Violation|7|||
94643622|NCT00692770|324156634|FG000|Overall Study|Withdrawal by Subject|97|||
94643623|NCT00692770|324156635|FG001|Overall Study|Withdrawal by Subject|36|||
94643624|NCT00692770|324156634|FG000|Overall Study|Adverse Event|136|||
94643625|NCT00692770|324156635|FG001|Overall Study|Adverse Event|41|||
94643626|NCT00692770|324156634|FG000|Overall Study|Death|10|||
94643627|NCT00692770|324156635|FG001|Overall Study|Death|5|||
94643628|NCT00692770|324156634|FG000|Overall Study|Lost to Follow-up|7|||
94643629|NCT00692770|324156635|FG001|Overall Study|Lost to Follow-up|3|||
94643630|NCT00692770|324156634|FG000|Overall Study|Non-compliant with study medication|11|||
94643631|NCT00692770|324156635|FG001|Overall Study|Non-compliant with study medication|5|||
94643632|NCT00692770|324156634|FG000|Overall Study|Progression by clinical judgment|2|||
94643633|NCT00692770|324156635|FG001|Overall Study|Progression by clinical judgment|3|||
94643634|NCT00692770|324156634|FG000|Overall Study|Physician decision not protocol driven|10|||
94643635|NCT00692770|324156635|FG001|Overall Study|Physician decision not protocol driven|14|||
94643636|NCT00692770|324156634|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
94643637|NCT00692770|324156635|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
94643638|NCT00692770|324156634|FG000|Overall Study|Protocol driven decision point|3|||
94643639|NCT00692770|324156635|FG001|Overall Study|Protocol driven decision point|7|||
94643640|NCT00692770|324156634|FG000|Overall Study|Completed all planned assessments|79|||
94643641|NCT00692770|324156635|FG001|Overall Study|Completed all planned assessments|101|||
94643642|NCT00692770|324156634|FG000|Overall Study|Radiological and clinical progression|8|||
94643643|NCT00692770|324156635|FG001|Overall Study|Radiological and clinical progression|8|||
94643644|NCT00692770|324156634|FG000|Overall Study|Clinical endpoint reached|16|||
94643645|NCT00692770|324156635|FG001|Overall Study|Clinical endpoint reached|43|||
94643646|NCT00692770|324156634|FG000|Overall Study|Study terminated by sponsor|2|||
94643647|NCT00692770|324156635|FG001|Overall Study|Study terminated by sponsor|2|||
94643648|NCT00692770|324156634|FG000|Overall Study|Randomized but not treated|3|||
94643649|NCT00692770|324156635|FG001|Overall Study|Randomized but not treated|4|||
94643650|NCT03350503|324156637|FG000|Overall Study|Adverse Event|5|||
94643651|NCT03350503|324156637|FG000|Overall Study|Withdrawal by Subject|5|||
94643652|NCT03350503|324156637|FG000|Overall Study|Continuation impossible due to move|4|||
94643653|NCT03350503|324156637|FG000|Overall Study|Physician Decision|3|||
94643654|NCT00834912|324156638|FG000|Treatment Period 1|Adverse Event|0|||
94643655|NCT00834912|324156639|FG001|Treatment Period 1|Adverse Event|1|||
94263522|NCT00594516|322759845|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
94263523|NCT00594516|322759846|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
94643656|NCT00834912|324156640|FG002|Treatment Period 1|Adverse Event|0|||
94643657|NCT00834912|324156641|FG003|Treatment Period 1|Adverse Event|1|||
94679450|NCT01242748|324282257|FG000|Overall Study|Physician Decision|3|||
94679451|NCT01242748|324282258|FG001|Overall Study|Physician Decision|2|||
94679452|NCT01242748|324282257|FG000|Overall Study|Protocol Violation|1|||
94263524|NCT00594516|322759847|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
94263525|NCT00594516|322759845|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
94263526|NCT00594516|322759846|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
94643658|NCT00834912|324156642|FG004|Treatment Period 1|Adverse Event|0|||
94643659|NCT00834912|324156643|FG005|Treatment Period 1|Adverse Event|0|||
94643660|NCT00834912|324156638|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94643661|NCT00834912|324156639|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94679453|NCT01242748|324282258|FG001|Overall Study|Protocol Violation|0|||
94679454|NCT01242748|324282257|FG000|Overall Study|Withdrawal by Subject|10|||
94679455|NCT01242748|324282258|FG001|Overall Study|Withdrawal by Subject|2|||
94679456|NCT01242748|324282257|FG000|Overall Study|Miscellaneous reasons|8|||
94679457|NCT01242748|324282258|FG001|Overall Study|Miscellaneous reasons|3|||
94679458|NCT05044325|324282259|FG000|Part A:Treatment Period 1|Adverse Event|0|||
94679459|NCT05044325|324282260|FG001|Part A:Treatment Period 1|Adverse Event|0|||
94679460|NCT05044325|324282261|FG002|Part A:Treatment Period 1|Adverse Event|0|||
94679461|NCT05044325|324282262|FG003|Part A:Treatment Period 1|Adverse Event|0|||
94679462|NCT05044325|324282263|FG004|Part A:Treatment Period 1|Adverse Event|0|||
94679463|NCT05044325|324282264|FG005|Part A:Treatment Period 1|Adverse Event|1|||
94679464|NCT05044325|324282265|FG006|Part A:Treatment Period 1|Adverse Event|0|||
94679465|NCT05044325|324282266|FG007|Part A:Treatment Period 1|Adverse Event|1|||
94679466|NCT05044325|324282267|FG008|Part A:Treatment Period 1|Adverse Event|0|||
94679467|NCT05044325|324282268|FG009|Part A:Treatment Period 1|Adverse Event|0|||
94679468|NCT05044325|324282259|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
94679469|NCT05044325|324282260|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
94679470|NCT05044325|324282261|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
94679471|NCT05044325|324282262|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
94679472|NCT05044325|324282263|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
94679473|NCT05044325|324282264|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
94679474|NCT05044325|324282265|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
94679475|NCT05044325|324282266|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
94679476|NCT05044325|324282267|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
94679477|NCT05044325|324282268|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
94679478|NCT05044325|324282259|FG000|Part A:Treatment Period 1|Physician Decision|0|||
94679479|NCT05044325|324282260|FG001|Part A:Treatment Period 1|Physician Decision|0|||
94679480|NCT05044325|324282261|FG002|Part A:Treatment Period 1|Physician Decision|0|||
94679481|NCT05044325|324282262|FG003|Part A:Treatment Period 1|Physician Decision|0|||
94679482|NCT05044325|324282263|FG004|Part A:Treatment Period 1|Physician Decision|0|||
94679483|NCT05044325|324282264|FG005|Part A:Treatment Period 1|Physician Decision|0|||
94679484|NCT05044325|324282265|FG006|Part A:Treatment Period 1|Physician Decision|1|||
94679485|NCT05044325|324282266|FG007|Part A:Treatment Period 1|Physician Decision|0|||
94679486|NCT05044325|324282267|FG008|Part A:Treatment Period 1|Physician Decision|0|||
94679487|NCT05044325|324282268|FG009|Part A:Treatment Period 1|Physician Decision|0|||
94679488|NCT05044325|324282259|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
94679489|NCT05044325|324282260|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
94679490|NCT05044325|324282261|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
94679491|NCT05044325|324282262|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
94679492|NCT05044325|324282263|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
94679493|NCT05044325|324282264|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
94679494|NCT05044325|324282265|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
94679495|NCT05044325|324282266|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
94679496|NCT05044325|324282267|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
94679497|NCT05044325|324282268|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
94679498|NCT05044325|324282259|FG000|Part A:Treatment Period 2|Adverse Event|0|||
94679499|NCT05044325|324282260|FG001|Part A:Treatment Period 2|Adverse Event|1|||
94679500|NCT05044325|324282261|FG002|Part A:Treatment Period 2|Adverse Event|0|||
94463415|NCT01382225|323485051|FG001|Overall Study|Protocol Violation|1|||
94463416|NCT01382225|323485050|FG000|Overall Study|Subject Withdrew Consent|5|||
94643662|NCT00834912|324156640|FG002|Treatment Period 2|Withdrawal by Subject|1|||
94643663|NCT00834912|324156641|FG003|Treatment Period 2|Withdrawal by Subject|0|||
94643664|NCT00834912|324156642|FG004|Treatment Period 2|Withdrawal by Subject|1|||
94643665|NCT00834912|324156643|FG005|Treatment Period 2|Withdrawal by Subject|0|||
94643666|NCT00344773|324156647|FG000|Overall Study|Adverse Event|2|||
94643667|NCT00344773|324156647|FG000|Overall Study|Objective Disease Progression|16|||
94643668|NCT00344773|324156647|FG000|Overall Study|Withdrawal by Subject|1|||
94643669|NCT00344773|324156647|FG000|Overall Study|Not Eligible for the study|2|||
94643670|NCT00244712|324156648|FG000|Overall Study|Adverse Event|20|||
94643671|NCT00244712|324156649|FG001|Overall Study|Adverse Event|21|||
94643672|NCT00244712|324156648|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
94643673|NCT00244712|324156649|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
94643674|NCT00244712|324156648|FG000|Overall Study|Lack of Compliance|10|||
94643675|NCT00244712|324156649|FG001|Overall Study|Lack of Compliance|11|||
94643676|NCT00244712|324156648|FG000|Overall Study|Lost to Follow-up|45|||
94463417|NCT01382225|323485051|FG001|Overall Study|Subject Withdrew Consent|2|||
94463418|NCT01382225|323485050|FG000|Overall Study|Other|4|||
94463419|NCT01382225|323485051|FG001|Overall Study|Other|2|||
94463420|NCT02520427|323485057|FG000|Overall Study|Decision by sponsor|0|||
94463421|NCT02520427|323485058|FG001|Overall Study|Decision by sponsor|0|||
94463422|NCT02520427|323485059|FG002|Overall Study|Decision by sponsor|0|||
94463423|NCT02520427|323485060|FG003|Overall Study|Decision by sponsor|0|||
94463424|NCT02520427|323485061|FG004|Overall Study|Decision by sponsor|0|||
94463425|NCT02520427|323485062|FG005|Overall Study|Decision by sponsor|0|||
94463426|NCT02520427|323485063|FG006|Overall Study|Decision by sponsor|0|||
94463427|NCT02520427|323485064|FG007|Overall Study|Decision by sponsor|0|||
94463428|NCT02520427|323485065|FG008|Overall Study|Decision by sponsor|1|||
94643677|NCT00244712|324156649|FG001|Overall Study|Lost to Follow-up|52|||
94643678|NCT00244712|324156648|FG000|Overall Study|Withdrawal by Subject|13|||
94643679|NCT00244712|324156649|FG001|Overall Study|Withdrawal by Subject|23|||
94679501|NCT05044325|324282262|FG003|Part A:Treatment Period 2|Adverse Event|0|||
94679502|NCT05044325|324282263|FG004|Part A:Treatment Period 2|Adverse Event|1|||
94643680|NCT00244712|324156648|FG000|Overall Study|Protocol Violation, disease progression|13|||
94643681|NCT00244712|324156649|FG001|Overall Study|Protocol Violation, disease progression|11|||
94679503|NCT05044325|324282264|FG005|Part A:Treatment Period 2|Adverse Event|1|||
94463429|NCT02520427|323485066|FG009|Overall Study|Decision by sponsor|1|||
94463430|NCT02520427|323485067|FG010|Overall Study|Decision by sponsor|0|||
94463431|NCT02520427|323485068|FG011|Overall Study|Decision by sponsor|0|||
94643682|NCT01806896|324156652|FG000|Overall Study|Adverse Event|2|||
94643683|NCT01806896|324156653|FG001|Overall Study|Adverse Event|0|||
94643684|NCT01806896|324156652|FG000|Overall Study|Other|1|||
94643685|NCT01806896|324156653|FG001|Overall Study|Other|0|||
94643686|NCT00660348|324156654|FG000|Overall Study|Withdrawal by Subject|1|||
94643687|NCT00660348|324156655|FG001|Overall Study|Withdrawal by Subject|0|||
94643688|NCT02849548|324156656|FG000|Overall Study|Lost to Follow-up|1|||
94643689|NCT02849548|324156657|FG001|Overall Study|Lost to Follow-up|2|||
94643690|NCT02849548|324156656|FG000|Overall Study|Protocol Violation|1|||
94643691|NCT02849548|324156657|FG001|Overall Study|Protocol Violation|0|||
94643692|NCT00714259|324156658|FG000|Overall Study|Death|2|||
94643693|NCT00256698|324156661|FG000|Overall Study|Withdrawal by Subject|7|||
94643694|NCT00256698|324156662|FG001|Overall Study|Withdrawal by Subject|7|||
94643695|NCT00256698|324156661|FG000|Overall Study|Adverse Event|13|||
94643696|NCT00256698|324156662|FG001|Overall Study|Adverse Event|6|||
94643697|NCT00256698|324156661|FG000|Overall Study|Protocol Violation|6|||
94643698|NCT00256698|324156662|FG001|Overall Study|Protocol Violation|5|||
94643699|NCT00256698|324156661|FG000|Overall Study|Lost to Follow-up|1|||
94643700|NCT00256698|324156662|FG001|Overall Study|Lost to Follow-up|3|||
94643701|NCT00256698|324156661|FG000|Overall Study|disease progression|97|||
94643702|NCT00256698|324156662|FG001|Overall Study|disease progression|105|||
94643703|NCT00256698|324156661|FG000|Overall Study|still ongoing at data cut-off|41|||
94643704|NCT00256698|324156662|FG001|Overall Study|still ongoing at data cut-off|46|||
94643705|NCT00256698|324156661|FG000|Overall Study|withdrawn due to osteoporosis|1|||
94643706|NCT00256698|324156662|FG001|Overall Study|withdrawn due to osteoporosis|0|||
94643707|NCT00256698|324156661|FG000|Overall Study|Prematurely Discontinued|1|||
94643708|NCT00256698|324156662|FG001|Overall Study|Prematurely Discontinued|0|||
94643709|NCT05292391|324156663|FG000|Overall Study|Lost to Follow-up|0|||
94643710|NCT05292391|324156664|FG001|Overall Study|Lost to Follow-up|0|||
94643711|NCT05292391|324156665|FG002|Overall Study|Lost to Follow-up|0|||
94643712|NCT05292391|324156666|FG003|Overall Study|Lost to Follow-up|1|||
94643713|NCT05292391|324156667|FG004|Overall Study|Lost to Follow-up|0|||
94643714|NCT02404311|324158298|FG000|Part A: Month 0-18|Death|2|||
94643715|NCT02404311|324158299|FG001|Part A: Month 0-18|Death|0|||
94643716|NCT02404311|324158300|FG002|Part A: Month 0-18|Death|0|||
94643717|NCT02404311|324158301|FG003|Part A: Month 0-18|Death|0|||
94643718|NCT02404311|324158302|FG004|Part A: Month 0-18|Death|0|||
94643719|NCT02404311|324158298|FG000|Part A: Month 0-18|Physician Decision|1|||
94643720|NCT02404311|324158299|FG001|Part A: Month 0-18|Physician Decision|0|||
94643721|NCT02404311|324158300|FG002|Part A: Month 0-18|Physician Decision|0|||
94643722|NCT02404311|324158301|FG003|Part A: Month 0-18|Physician Decision|0|||
94643723|NCT02404311|324158302|FG004|Part A: Month 0-18|Physician Decision|0|||
94643724|NCT02404311|324158298|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
94643725|NCT02404311|324158299|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
94643726|NCT02404311|324158300|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
94643727|NCT02404311|324158301|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
94643728|NCT02404311|324158302|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
94643729|NCT02404311|324158298|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
94643730|NCT02404311|324158299|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
94643731|NCT02404311|324158300|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
94643732|NCT02404311|324158301|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
94643733|NCT02404311|324158302|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
94643734|NCT02404311|324158298|FG000|Part A: Month 0-18|HIV Infection|6|||
94643735|NCT02404311|324158299|FG001|Part A: Month 0-18|HIV Infection|2|||
94643736|NCT02404311|324158300|FG002|Part A: Month 0-18|HIV Infection|0|||
94643737|NCT02404311|324158301|FG003|Part A: Month 0-18|HIV Infection|0|||
94643738|NCT02404311|324158302|FG004|Part A: Month 0-18|HIV Infection|0|||
94643739|NCT02404311|324158298|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
94643740|NCT02404311|324158299|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
94643741|NCT02404311|324158300|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
94643742|NCT02404311|324158301|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
94643743|NCT02404311|324158302|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
94643744|NCT02347527|324158306|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
94643745|NCT02347527|324158307|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
94643746|NCT02347527|324158308|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
94643747|NCT02347527|324158309|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
94643748|NCT02347527|324158306|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
94643749|NCT02347527|324158307|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
94643750|NCT02347527|324158308|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
94643751|NCT02347527|324158309|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
94643752|NCT02347527|324158306|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
94643753|NCT02347527|324158307|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
94643754|NCT02347527|324158308|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
94643755|NCT02347527|324158309|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
94643756|NCT02347527|324158306|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
94643757|NCT02347527|324158307|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
94643758|NCT02347527|324158308|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
94643759|NCT02347527|324158309|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
94643760|NCT02347527|324158306|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
94643761|NCT02347527|324158307|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
94643762|NCT02347527|324158308|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
94643763|NCT02347527|324158309|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
94643764|NCT00934544|324158310|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
94643765|NCT00934544|324158311|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
94643766|NCT00934544|324158312|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
94643767|NCT00934544|324158310|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
94643768|NCT00934544|324158311|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
94643769|NCT00934544|324158312|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
94643770|NCT00934544|324158310|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
94643771|NCT00934544|324158311|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
94643772|NCT00934544|324158312|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
94643773|NCT00934544|324158310|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
94643774|NCT00934544|324158311|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
94643775|NCT00934544|324158312|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
94643776|NCT00934544|324158310|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
94643777|NCT00934544|324158311|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
94643778|NCT00934544|324158312|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
94643779|NCT00934544|324158310|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
94643780|NCT00934544|324158311|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
94643781|NCT00934544|324158312|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
94643782|NCT00934544|324158310|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
94643783|NCT00934544|324158311|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
94643784|NCT00934544|324158312|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
94643785|NCT00934544|324158310|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
94643786|NCT00934544|324158311|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
94463432|NCT02520427|323485069|FG012|Overall Study|Decision by sponsor|0|||
94463433|NCT02520427|323485070|FG013|Overall Study|Decision by sponsor|0|||
94463434|NCT02520427|323485071|FG014|Overall Study|Decision by sponsor|0|||
94463435|NCT02520427|323485072|FG015|Overall Study|Decision by sponsor|0|||
94463436|NCT02520427|323485073|FG016|Overall Study|Decision by sponsor|0|||
94463437|NCT02520427|323485074|FG017|Overall Study|Decision by sponsor|0|||
94463438|NCT02520427|323485075|FG018|Overall Study|Decision by sponsor|0|||
94643787|NCT00934544|324158312|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
94643788|NCT00934544|324158310|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
94643789|NCT00934544|324158311|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
94643790|NCT00934544|324158312|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
94643791|NCT00934544|324158310|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
94643792|NCT00934544|324158311|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
94643793|NCT00934544|324158312|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
94643794|NCT00934544|324158310|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
94643795|NCT00934544|324158311|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
94643796|NCT00934544|324158312|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
94643797|NCT00934544|324158310|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
94643798|NCT00934544|324158311|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
94643799|NCT00934544|324158312|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
94643800|NCT00934544|324158310|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
94643801|NCT00934544|324158311|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
94643802|NCT00934544|324158312|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
94643803|NCT00934544|324158310|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
94643804|NCT00934544|324158311|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
94643805|NCT00934544|324158312|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
94643806|NCT00934544|324158310|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
94643807|NCT00934544|324158311|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
94643808|NCT00934544|324158312|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
94643809|NCT00934544|324158310|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
94643810|NCT00934544|324158311|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
94643811|NCT00934544|324158312|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
94643812|NCT00302003|324158313|FG000|Overall Study|Lack of Efficacy|62|||
94643813|NCT00302003|324158313|FG000|Overall Study|Lost to Follow-up|1|||
94643814|NCT00302003|324158313|FG000|Overall Study|Physician Decision|2|||
94643815|NCT00302003|324158313|FG000|Overall Study|Withdrawal by Subject|5|||
94643816|NCT00302003|324158313|FG000|Overall Study|Ineligible|9|||
94643817|NCT00302003|324158313|FG000|Overall Study|Protocol Violation|1|||
94643818|NCT01218516|324158314|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
94643819|NCT01218516|324158315|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
94643820|NCT01218516|324158316|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
94643821|NCT01218516|324158317|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
94643822|NCT01218516|324158314|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
94643823|NCT01218516|324158315|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
94643824|NCT01218516|324158316|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
94643825|NCT01218516|324158317|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
94643826|NCT01218516|324158314|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
94643827|NCT01218516|324158315|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
94643828|NCT01218516|324158316|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
94643829|NCT01218516|324158317|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
94643830|NCT01218516|324158314|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
94463439|NCT02520427|323485076|FG019|Overall Study|Decision by sponsor|0|||
94463440|NCT02520427|323485077|FG020|Overall Study|Decision by sponsor|0|||
94679504|NCT05044325|324282265|FG006|Part A:Treatment Period 2|Adverse Event|0|||
94679505|NCT05044325|324282266|FG007|Part A:Treatment Period 2|Adverse Event|0|||
94679506|NCT05044325|324282267|FG008|Part A:Treatment Period 2|Adverse Event|0|||
94679507|NCT05044325|324282268|FG009|Part A:Treatment Period 2|Adverse Event|0|||
94679508|NCT05044325|324282259|FG000|Part A:Treatment Period 2|Physician Decision|0|||
94679509|NCT05044325|324282260|FG001|Part A:Treatment Period 2|Physician Decision|0|||
94643831|NCT01218516|324158315|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
94643832|NCT01218516|324158316|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
94643833|NCT01218516|324158317|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
94643834|NCT01218516|324158314|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
94643835|NCT01218516|324158315|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
94643836|NCT01218516|324158316|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
94643837|NCT01218516|324158317|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
94643838|NCT01218516|324158314|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
94643839|NCT01218516|324158315|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
94643840|NCT01218516|324158316|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
94643841|NCT01218516|324158317|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
94643842|NCT01218516|324158314|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
94643843|NCT01218516|324158315|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
94643844|NCT01218516|324158316|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
94643845|NCT01218516|324158317|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
94643846|NCT01218516|324158314|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
94643847|NCT01218516|324158315|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
94643848|NCT01218516|324158316|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
94643849|NCT01218516|324158317|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
94643850|NCT01218516|324158314|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
94643851|NCT01218516|324158315|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
94643852|NCT01218516|324158316|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
94643853|NCT01218516|324158317|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
94643854|NCT01218516|324158314|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
94643855|NCT01218516|324158315|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
94643856|NCT01218516|324158316|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
94643857|NCT01218516|324158317|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
94643858|NCT01218516|324158314|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
94643859|NCT01218516|324158315|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
94643860|NCT01218516|324158316|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
94643861|NCT01218516|324158317|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
94643862|NCT01218516|324158314|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
94643863|NCT01218516|324158315|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
94643864|NCT01218516|324158316|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
94643865|NCT01218516|324158317|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
94643866|NCT01539226|324158318|FG000|Overall Study|Withdrawal by Subject|24|||
94643867|NCT01539226|324158319|FG001|Overall Study|Withdrawal by Subject|54|||
94643868|NCT01539226|324158318|FG000|Overall Study|Lost to Follow-up|20|||
94643869|NCT01539226|324158319|FG001|Overall Study|Lost to Follow-up|54|||
94643870|NCT01539226|324158318|FG000|Overall Study|Death|1|||
94643871|NCT01539226|324158319|FG001|Overall Study|Death|2|||
94643872|NCT01539226|324158318|FG000|Overall Study|Adverse Event|2|||
94643873|NCT01539226|324158319|FG001|Overall Study|Adverse Event|0|||
94643874|NCT01539226|324158318|FG000|Overall Study|Pregnancy|13|||
94643875|NCT01539226|324158319|FG001|Overall Study|Pregnancy|29|||
94643876|NCT01539226|324158318|FG000|Overall Study|inappropriate enrollment|0|||
94643877|NCT01539226|324158319|FG001|Overall Study|inappropriate enrollment|1|||
94643878|NCT01539226|324158318|FG000|Overall Study|Multiple Reasons|3|||
94643879|NCT01539226|324158319|FG001|Overall Study|Multiple Reasons|1|||
94643880|NCT01539226|324158318|FG000|Overall Study|not HIV seroconversion-related|93|||
94643881|NCT01539226|324158319|FG001|Overall Study|not HIV seroconversion-related|176|||
94643882|NCT01539226|324158318|FG000|Overall Study|HIV seroconversion-related|55|||
94643883|NCT01539226|324158319|FG001|Overall Study|HIV seroconversion-related|80|||
94643884|NCT01539226|324158318|FG000|Overall Study|Non-compliance|6|||
94643885|NCT01539226|324158319|FG001|Overall Study|Non-compliance|8|||
94643886|NCT04033003|324158320|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
94643887|NCT04033003|324158321|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
94643888|NCT04033003|324158320|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
94643889|NCT04033003|324158321|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
94643890|NCT04033003|324158320|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
94679510|NCT05044325|324282261|FG002|Part A:Treatment Period 2|Physician Decision|0|||
94679511|NCT05044325|324282262|FG003|Part A:Treatment Period 2|Physician Decision|0|||
94679512|NCT05044325|324282263|FG004|Part A:Treatment Period 2|Physician Decision|0|||
94679513|NCT05044325|324282264|FG005|Part A:Treatment Period 2|Physician Decision|1|||
94679514|NCT05044325|324282265|FG006|Part A:Treatment Period 2|Physician Decision|0|||
94679515|NCT05044325|324282266|FG007|Part A:Treatment Period 2|Physician Decision|0|||
94643891|NCT04033003|324158321|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
94643892|NCT04033003|324158320|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
94643893|NCT04033003|324158321|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
94363875|NCT03159611|323116742|FG000|Overall Study|Non-compliance with protocol requirement|3|||
94363876|NCT03159611|323116743|FG001|Overall Study|Non-compliance with protocol requirement|2|||
94363877|NCT03159611|323116742|FG000|Overall Study|Inability to perform procedures|1|||
94363878|NCT03159611|323116743|FG001|Overall Study|Inability to perform procedures|0|||
94363879|NCT03087773|323116746|FG000|Overall Study|Withdrawal by Subject|8|||
94363880|NCT03087773|323116747|FG001|Overall Study|Withdrawal by Subject|4|||
94363881|NCT03087773|323116746|FG000|Overall Study|Lost to Follow-up|12|||
94363882|NCT03087773|323116747|FG001|Overall Study|Lost to Follow-up|8|||
94363883|NCT00185731|323116748|FG000|Overall Study|Withdrawal by Subject|1|||
94363884|NCT00185731|323116748|FG000|Overall Study|Not Eligible|1|||
94363885|NCT02180659|323116758|FG000|Overall Study|Adverse Event|1|||
94643894|NCT04033003|324158320|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
94643895|NCT04033003|324158321|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
94643896|NCT04033003|324158320|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
94643897|NCT04033003|324158321|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
94643898|NCT04033003|324158320|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
94643899|NCT04033003|324158321|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
94643900|NCT04033003|324158320|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
94643901|NCT04033003|324158321|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
94643902|NCT04033003|324158320|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
94643903|NCT04033003|324158321|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
94643904|NCT04033003|324158320|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
94643905|NCT04033003|324158321|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
94643906|NCT04033003|324158320|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
94643907|NCT04033003|324158321|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
94643908|NCT04033003|324158320|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
94643909|NCT04033003|324158321|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
94643910|NCT04033003|324158320|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
94643911|NCT04033003|324158321|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
94643912|NCT00240071|324158324|FG000|Overall Study|Withdrawal by Subject|3|||
94643913|NCT02256891|324158325|FG000|Overall Study|Death|0|||
94643914|NCT02256891|324158326|FG001|Overall Study|Death|2|||
94643915|NCT02256891|324158325|FG000|Overall Study|Lost to Follow-up|0|||
94643916|NCT02256891|324158326|FG001|Overall Study|Lost to Follow-up|3|||
94643917|NCT02256891|324158325|FG000|Overall Study|Physician Decision|7|||
94643918|NCT02256891|324158326|FG001|Overall Study|Physician Decision|3|||
94643919|NCT02256891|324158325|FG000|Overall Study|Screen Fail|5|||
94643920|NCT02256891|324158326|FG001|Overall Study|Screen Fail|4|||
94643921|NCT02256891|324158325|FG000|Overall Study|Equipment Malfunction|0|||
94643922|NCT02256891|324158326|FG001|Overall Study|Equipment Malfunction|1|||
94643923|NCT01344447|324158327|FG000|Overall Study|Adverse Event|1|||
94643924|NCT01344447|324158327|FG000|Overall Study|Protocol Violation|1|||
94643925|NCT01344447|324158327|FG000|Overall Study|Withdrawal by Subject|1|||
94643926|NCT01344447|324158327|FG000|Overall Study|The contrast was not seen|1|||
94643927|NCT01344447|324158327|FG000|Overall Study|Physician Decision|1|||
94643928|NCT01344447|324158327|FG000|Overall Study|MRA unsuccessful|1|||
94263527|NCT00594516|322759847|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
94263528|NCT00594516|322759845|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
94263529|NCT00594516|322759846|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
94263530|NCT00594516|322759847|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
94263531|NCT00594516|322759845|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
94263532|NCT00594516|322759846|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
94263533|NCT00594516|322759847|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
94263534|NCT00594516|322759845|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
94263535|NCT00594516|322759846|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
94263536|NCT00594516|322759847|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
94643929|NCT01344447|324158327|FG000|Overall Study|Bolus tracking failed|1|||
94643930|NCT01344447|324158327|FG000|Overall Study|Error of power injector|1|||
94643931|NCT00430092|324158328|FG000|Overall Study|Adverse Event|0|||
94643932|NCT00430092|324158329|FG001|Overall Study|Adverse Event|0|||
94643933|NCT00430092|324158330|FG002|Overall Study|Adverse Event|1|||
94643934|NCT00430092|324158328|FG000|Overall Study|Lack of Efficacy|5|||
94643935|NCT00430092|324158329|FG001|Overall Study|Lack of Efficacy|2|||
94643936|NCT00430092|324158330|FG002|Overall Study|Lack of Efficacy|54|||
94263537|NCT00594516|322759845|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
94643937|NCT00430092|324158328|FG000|Overall Study|Lost to Follow-up|1|||
94643938|NCT00430092|324158329|FG001|Overall Study|Lost to Follow-up|0|||
94643939|NCT00430092|324158330|FG002|Overall Study|Lost to Follow-up|0|||
94643940|NCT00430092|324158328|FG000|Overall Study|Protocol Violation|0|||
94643941|NCT00430092|324158329|FG001|Overall Study|Protocol Violation|1|||
94643942|NCT00430092|324158330|FG002|Overall Study|Protocol Violation|1|||
94643943|NCT00430092|324158328|FG000|Overall Study|Withdrawal by Subject|0|||
94643944|NCT00430092|324158329|FG001|Overall Study|Withdrawal by Subject|1|||
94643945|NCT00430092|324158330|FG002|Overall Study|Withdrawal by Subject|1|||
94643946|NCT01714310|324158331|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
94643947|NCT01714310|324158332|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
94643948|NCT01714310|324158333|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
94643949|NCT01714310|324158331|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
94643950|NCT01714310|324158332|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
94643951|NCT01714310|324158333|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
94643952|NCT01714310|324158331|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
94643953|NCT01714310|324158332|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
94643954|NCT01714310|324158333|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
94643955|NCT01714310|324158331|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
94643956|NCT01714310|324158332|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
94643957|NCT01714310|324158333|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
94643958|NCT01641367|324158336|FG000|Cohorts|Death|18|||
94643959|NCT01641367|324158337|FG001|Cohorts|Death|1|||
94643960|NCT01641367|324158338|FG002|Cohorts|Death|2|||
94643961|NCT01641367|324158339|FG003|Cohorts|Death|0|||
94643962|NCT01641367|324158340|FG004|Cohorts|Death|1|||
94643963|NCT01641367|324158341|FG005|Cohorts|Death|1|||
94643964|NCT01641367|324158342|FG006|Cohorts|Death|0|||
94643965|NCT01641367|324158343|FG007|Cohorts|Death|0|||
94643966|NCT01641367|324158336|FG000|Cohorts|Lost to Follow-up|16|||
94643967|NCT01641367|324158337|FG001|Cohorts|Lost to Follow-up|0|||
94643968|NCT01641367|324158338|FG002|Cohorts|Lost to Follow-up|2|||
94643969|NCT01641367|324158339|FG003|Cohorts|Lost to Follow-up|0|||
94643970|NCT01641367|324158340|FG004|Cohorts|Lost to Follow-up|2|||
94643971|NCT01641367|324158341|FG005|Cohorts|Lost to Follow-up|0|||
94643972|NCT01641367|324158342|FG006|Cohorts|Lost to Follow-up|0|||
94643973|NCT01641367|324158343|FG007|Cohorts|Lost to Follow-up|0|||
94643974|NCT01641367|324158336|FG000|Randomized Adherence Intervention|Death|0|||
94643975|NCT01641367|324158337|FG001|Randomized Adherence Intervention|Death|0|||
94643976|NCT01641367|324158338|FG002|Randomized Adherence Intervention|Death|0|||
94643977|NCT01641367|324158339|FG003|Randomized Adherence Intervention|Death|0|||
94643978|NCT01641367|324158340|FG004|Randomized Adherence Intervention|Death|0|||
94643979|NCT01641367|324158341|FG005|Randomized Adherence Intervention|Death|0|||
94643980|NCT01641367|324158342|FG006|Randomized Adherence Intervention|Death|11|||
94643981|NCT01641367|324158343|FG007|Randomized Adherence Intervention|Death|12|||
94643982|NCT01641367|324158336|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
94643983|NCT01641367|324158337|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
94643984|NCT01641367|324158338|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
94643985|NCT01641367|324158339|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
94643986|NCT01641367|324158340|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
94643987|NCT01641367|324158341|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
94679516|NCT05044325|324282267|FG008|Part A:Treatment Period 2|Physician Decision|0|||
94679517|NCT05044325|324282268|FG009|Part A:Treatment Period 2|Physician Decision|0|||
94679518|NCT05044325|324282259|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
94679519|NCT05044325|324282260|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
94679520|NCT05044325|324282261|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
94679521|NCT05044325|324282262|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
94679522|NCT05044325|324282263|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
94679523|NCT05044325|324282264|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
94679524|NCT05044325|324282265|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
94679525|NCT05044325|324282266|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
94679526|NCT05044325|324282267|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
94679527|NCT05044325|324282268|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
94679528|NCT00755222|324282269|FG000|Overall Study|Withdrawal by Subject|4|||
94679529|NCT00755222|324282270|FG001|Overall Study|Withdrawal by Subject|2|||
94679530|NCT00755222|324282269|FG000|Overall Study|Adverse Event|2|||
94463441|NCT02520427|323485078|FG021|Overall Study|Decision by sponsor|0|||
94463442|NCT02520427|323485079|FG022|Overall Study|Decision by sponsor|0|||
94463443|NCT02520427|323485080|FG023|Overall Study|Decision by sponsor|0|||
94463444|NCT02520427|323485081|FG024|Overall Study|Decision by sponsor|0|||
94679531|NCT00755222|324282270|FG001|Overall Study|Adverse Event|0|||
94263538|NCT00594516|322759846|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
94463445|NCT02520427|323485082|FG025|Overall Study|Decision by sponsor|0|||
94643988|NCT01641367|324158342|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
94643989|NCT01641367|324158343|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
94643990|NCT02586493|324158344|FG000|Overall Study|Adverse Event|4|||
94643991|NCT02586493|324158344|FG000|Overall Study|Protocol Violation|6|||
94643992|NCT02586493|324158344|FG000|Overall Study|Lost to Follow-up|1|||
94643993|NCT02586493|324158344|FG000|Overall Study|Withdrawal by Subject|1|||
94643994|NCT00994448|324158345|FG000|Overall Study|Adverse Event|1|||
94643995|NCT00994448|324158346|FG001|Overall Study|Adverse Event|0|||
94643996|NCT00994448|324158345|FG000|Overall Study|Lost to Follow-up|5|||
94643997|NCT00994448|324158346|FG001|Overall Study|Lost to Follow-up|1|||
94643998|NCT00994448|324158345|FG000|Overall Study|Withdrawal by Subject|1|||
94643999|NCT00994448|324158346|FG001|Overall Study|Withdrawal by Subject|1|||
94644000|NCT00994448|324158345|FG000|Overall Study|Physician Decision|1|||
94644001|NCT00994448|324158346|FG001|Overall Study|Physician Decision|0|||
94644002|NCT04164901|324158347|FG000|Overall Study|Withdrawal by Subject|4|||
94644003|NCT04164901|324158348|FG001|Overall Study|Withdrawal by Subject|4|||
94644004|NCT04033159|324158351|FG000|Washout Period|Physician Decision|0|||
94644005|NCT04033159|324158352|FG001|Washout Period|Physician Decision|1|||
94644006|NCT04033159|324158353|FG002|Washout Period|Physician Decision|0|||
94644007|NCT04033159|324158351|FG000|Washout Period|Study terminated by Sponsor|0|||
94644008|NCT04033159|324158352|FG001|Washout Period|Study terminated by Sponsor|7|||
94644009|NCT04033159|324158353|FG002|Washout Period|Study terminated by Sponsor|0|||
94644010|NCT04033159|324158351|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
94644011|NCT04033159|324158352|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
94644012|NCT04033159|324158353|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
94644013|NCT03168464|324158354|FG000|Overall Study|Death|9|||
94644014|NCT03168464|324158354|FG000|Overall Study|Progression of disease|6|||
94644015|NCT02286193|324158370|FG000|Overall Study|Referred: CRS unable to make contact|62|||
94644016|NCT02286193|324158370|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
94644017|NCT02286193|324158370|FG000|Overall Study|Referred: Declined service|38|||
94644018|NCT01446965|324158371|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
94644019|NCT01446965|324158372|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
94644020|NCT01446965|324158371|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
94644021|NCT01446965|324158372|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
94644022|NCT04889625|324158375|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
94644023|NCT04889625|324158376|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
94644024|NCT04889625|324158375|FG000|Period 1|Subject out of window|0|||
94644025|NCT04889625|324158376|FG001|Period 1|Subject out of window|1|||
94644026|NCT04889625|324158375|FG000|Period 1|Wrong add power dispensed|0|||
94644027|NCT04889625|324158376|FG001|Period 1|Wrong add power dispensed|1|||
94644028|NCT04889625|324158375|FG000|Period 1|Discontinued due to fitting guide error|1|||
94644029|NCT04889625|324158376|FG001|Period 1|Discontinued due to fitting guide error|1|||
94644030|NCT04889625|324158375|FG000|Period 2|Test article no longer available|1|||
94644031|NCT04889625|324158376|FG001|Period 2|Test article no longer available|0|||
94644032|NCT04889625|324158375|FG000|Period 2|Incorrect lens dispensed|1|||
94644033|NCT04889625|324158376|FG001|Period 2|Incorrect lens dispensed|0|||
94644034|NCT04889625|324158375|FG000|Period 2|Wrong add power dispensed|0|||
94644035|NCT04889625|324158376|FG001|Period 2|Wrong add power dispensed|1|||
94644036|NCT00404352|324158377|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
94644037|NCT00404352|324158378|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
94644038|NCT00404352|324158379|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
94644039|NCT00404352|324158380|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
94644040|NCT00404352|324158381|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
94644041|NCT00404352|324158382|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
94644042|NCT00404352|324158383|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
94644043|NCT00404352|324158384|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
94644044|NCT00404352|324158385|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
94644045|NCT00404352|324158377|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
94644046|NCT00404352|324158378|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
94644047|NCT00404352|324158379|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
94644048|NCT00404352|324158380|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
94644049|NCT00404352|324158381|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
94644050|NCT00404352|324158382|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
94644051|NCT00404352|324158383|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
94644052|NCT00404352|324158384|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
94644053|NCT00404352|324158385|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
94644054|NCT00404352|324158377|FG000|Double Blind (up to 24 Month)|Death|0|||
94644055|NCT00404352|324158378|FG001|Double Blind (up to 24 Month)|Death|0|||
94644056|NCT00404352|324158379|FG002|Double Blind (up to 24 Month)|Death|1|||
94644057|NCT00404352|324158380|FG003|Double Blind (up to 24 Month)|Death|0|||
94644058|NCT00404352|324158381|FG004|Double Blind (up to 24 Month)|Death|0|||
94644059|NCT00404352|324158382|FG005|Double Blind (up to 24 Month)|Death|0|||
94644060|NCT00404352|324158383|FG006|Double Blind (up to 24 Month)|Death|0|||
94644061|NCT00404352|324158384|FG007|Double Blind (up to 24 Month)|Death|0|||
94644062|NCT00404352|324158385|FG008|Double Blind (up to 24 Month)|Death|0|||
94644063|NCT00404352|324158377|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
94644064|NCT00404352|324158378|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
94644065|NCT00404352|324158379|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
94644066|NCT00404352|324158380|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
94644067|NCT00404352|324158381|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
94644068|NCT00404352|324158382|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
94644069|NCT00404352|324158383|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
94644070|NCT00404352|324158384|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
94644071|NCT00404352|324158385|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
94644072|NCT00404352|324158377|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
94644073|NCT00404352|324158378|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
94644074|NCT00404352|324158379|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
94644075|NCT00404352|324158380|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
94644076|NCT00404352|324158381|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
94644077|NCT00404352|324158382|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
94644078|NCT00404352|324158383|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
94644079|NCT00404352|324158384|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
94644080|NCT00404352|324158385|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
94644081|NCT00404352|324158377|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
94644082|NCT00404352|324158378|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
94644083|NCT00404352|324158379|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
94644084|NCT00404352|324158380|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
94644085|NCT00404352|324158381|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
94644086|NCT00404352|324158382|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
94644087|NCT00404352|324158383|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
94644088|NCT00404352|324158384|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
94644089|NCT00404352|324158385|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
94644090|NCT00404352|324158377|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
94644091|NCT00404352|324158378|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
94644092|NCT00404352|324158379|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
94644093|NCT00404352|324158380|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
94644094|NCT00404352|324158381|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
94644095|NCT00404352|324158382|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
94263539|NCT00594516|322759847|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
94263540|NCT00594516|322759845|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
94263541|NCT00594516|322759846|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
94263542|NCT00594516|322759847|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
94644096|NCT00404352|324158383|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
94644097|NCT00404352|324158384|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
94644098|NCT00404352|324158385|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
94644099|NCT00404352|324158377|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
94644100|NCT00404352|324158378|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
94679532|NCT00755222|324282269|FG000|Overall Study|Protocol Violation|2|||
94679533|NCT00755222|324282270|FG001|Overall Study|Protocol Violation|0|||
94679534|NCT02940574|324282276|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
94679535|NCT02940574|324282277|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
94679536|NCT02940574|324282276|FG000|1-year Follow-up|Lost to Follow-up|3|||
94679537|NCT02940574|324282277|FG001|1-year Follow-up|Lost to Follow-up|4|||
94679538|NCT02228967|324282278|FG000|Overall Study|Lost to Follow-up|146|||
94679539|NCT02228967|324282279|FG001|Overall Study|Lost to Follow-up|142|||
94679540|NCT02228967|324282278|FG000|Overall Study|Withdrawal by Subject|13|||
94679541|NCT02228967|324282279|FG001|Overall Study|Withdrawal by Subject|18|||
94679542|NCT03261271|324282280|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
94679543|NCT03261271|324282281|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
94679544|NCT01330316|324282287|FG000|Overall Study|Adverse Event|2|||
94679545|NCT01330316|324282288|FG001|Overall Study|Adverse Event|2|||
94679546|NCT01330316|324282287|FG000|Overall Study|Lack of Efficacy|0|||
94679547|NCT01330316|324282288|FG001|Overall Study|Lack of Efficacy|10|||
94679548|NCT01330316|324282287|FG000|Overall Study|Lost to Follow-up|0|||
94679549|NCT01330316|324282288|FG001|Overall Study|Lost to Follow-up|1|||
94679550|NCT01330316|324282287|FG000|Overall Study|Withdrawal by Subject|0|||
94679551|NCT01330316|324282288|FG001|Overall Study|Withdrawal by Subject|1|||
94679552|NCT01330316|324282287|FG000|Overall Study|other than above|0|||
94679553|NCT01330316|324282288|FG001|Overall Study|other than above|1|||
94679554|NCT00215540|324282289|FG000|Overall Study|Withdrew from study medication|1|||
94679555|NCT00215540|324282290|FG001|Overall Study|Withdrew from study medication|0|||
94679556|NCT00215540|324282291|FG002|Overall Study|Withdrew from study medication|0|||
94679557|NCT01059643|324282292|FG000|Overall Study|Adverse Event|3|||
94679558|NCT01059643|324282292|FG000|Overall Study|Withdrawal by Subject|2|||
94679559|NCT01059643|324282292|FG000|Overall Study|Physician Decision|1|||
94644101|NCT00404352|324158379|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
94644102|NCT00404352|324158380|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
94644103|NCT00404352|324158381|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
94644104|NCT00404352|324158382|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
94644105|NCT00404352|324158383|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
94644106|NCT00404352|324158384|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
94644107|NCT00404352|324158385|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
94644108|NCT00404352|324158377|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
94644109|NCT00404352|324158378|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
94644110|NCT00404352|324158379|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
94644111|NCT00404352|324158380|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
94644112|NCT00404352|324158381|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
94644113|NCT00404352|324158382|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
94644114|NCT00404352|324158383|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
94644115|NCT00404352|324158384|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
94679560|NCT03010462|324282293|FG000|Overall Study|Withdrawal by Subject|3|||
94679561|NCT03010462|324282294|FG001|Overall Study|Withdrawal by Subject|1|||
94679562|NCT02207725|324282295|FG000|Overall Study|Did Not Receive Treatment|0|||
94679563|NCT02207725|324282296|FG001|Overall Study|Did Not Receive Treatment|1|||
94644116|NCT00404352|324158385|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
94644117|NCT00404352|324158377|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
94644118|NCT00404352|324158378|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
94679564|NCT02207725|324282297|FG002|Overall Study|Did Not Receive Treatment|1|||
94679565|NCT02207725|324282298|FG003|Overall Study|Did Not Receive Treatment|1|||
94679566|NCT00246337|324282303|FG000|Overall Study|Lost to Follow-up|3|||
94363886|NCT02180659|323116759|FG001|Overall Study|Adverse Event|0|||
94363887|NCT02180659|323116758|FG000|Overall Study|Lost to Follow-up|4|||
94363888|NCT02180659|323116759|FG001|Overall Study|Lost to Follow-up|2|||
94363889|NCT02180659|323116758|FG000|Overall Study|Subject incarcerated during conduct|1|||
94363890|NCT02180659|323116759|FG001|Overall Study|Subject incarcerated during conduct|0|||
94363891|NCT02180659|323116758|FG000|Overall Study|Withdrawal by Subject|0|||
94363892|NCT02180659|323116759|FG001|Overall Study|Withdrawal by Subject|2|||
94363893|NCT02180659|323116758|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
94363894|NCT02180659|323116759|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
94363895|NCT01495793|323116760|FG000|Overall Study|Lost to Follow-up|1|||
94363896|NCT01495793|323116760|FG000|Overall Study|Violation of inclusion criteria|1|||
94363897|NCT00824993|323116761|FG000|Overall Study|Withdrawal by Subject|1|||
94363898|NCT00824993|323116762|FG001|Overall Study|Withdrawal by Subject|1|||
94363899|NCT00824993|323116761|FG000|Overall Study|Malignancy Relapse|9|||
94363900|NCT00824993|323116762|FG001|Overall Study|Malignancy Relapse|10|||
94363901|NCT00824993|323116761|FG000|Overall Study|Rapid Bone Loss|0|||
94363902|NCT00824993|323116762|FG001|Overall Study|Rapid Bone Loss|1|||
94363903|NCT00824993|323116761|FG000|Overall Study|Non-Compliant|2|||
94644119|NCT00404352|324158379|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
94644120|NCT00404352|324158380|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
94644121|NCT00404352|324158381|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
94644122|NCT00404352|324158382|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
94644123|NCT00404352|324158383|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
94644124|NCT00404352|324158384|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
94644125|NCT00404352|324158385|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
94644126|NCT00404352|324158377|FG000|Double Blind (up to 24 Month)|Other|0|||
94644127|NCT00404352|324158378|FG001|Double Blind (up to 24 Month)|Other|1|||
94644128|NCT00404352|324158379|FG002|Double Blind (up to 24 Month)|Other|0|||
94644129|NCT00404352|324158380|FG003|Double Blind (up to 24 Month)|Other|0|||
94644130|NCT00404352|324158381|FG004|Double Blind (up to 24 Month)|Other|0|||
94644131|NCT00404352|324158382|FG005|Double Blind (up to 24 Month)|Other|0|||
94363904|NCT00824993|323116762|FG001|Overall Study|Non-Compliant|1|||
94363905|NCT00824993|323116761|FG000|Overall Study|Insurance Issue|2|||
94363906|NCT00824993|323116762|FG001|Overall Study|Insurance Issue|1|||
94363907|NCT00824993|323116761|FG000|Overall Study|Death|0|||
94363908|NCT00824993|323116762|FG001|Overall Study|Death|3|||
94363909|NCT00834366|323116763|FG000|Treatment Period 1|Adverse Event|1|||
94363910|NCT00834366|323116764|FG001|Treatment Period 1|Adverse Event|1|||
94363911|NCT03428217|323116768|FG000|Overall Study|Death|89|||
94363912|NCT03428217|323116769|FG001|Overall Study|Death|93|||
94363913|NCT03428217|323116768|FG000|Overall Study|Withdrawal by Subject|8|||
94363914|NCT03428217|323116769|FG001|Overall Study|Withdrawal by Subject|7|||
94644132|NCT00404352|324158383|FG006|Double Blind (up to 24 Month)|Other|0|||
94644133|NCT00404352|324158384|FG007|Double Blind (up to 24 Month)|Other|0|||
94363915|NCT03428217|323116768|FG000|Overall Study|Lost to Follow-up|1|||
94644134|NCT00404352|324158385|FG008|Double Blind (up to 24 Month)|Other|0|||
94644135|NCT00404352|324158377|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
94679567|NCT00246337|324282304|FG001|Overall Study|Lost to Follow-up|0|||
94679568|NCT00246337|324282305|FG002|Overall Study|Lost to Follow-up|0|||
94679569|NCT00246337|324282306|FG003|Overall Study|Lost to Follow-up|0|||
94679570|NCT00246337|324282307|FG004|Overall Study|Lost to Follow-up|2|||
94679571|NCT00246337|324282308|FG005|Overall Study|Lost to Follow-up|2|||
94679572|NCT00246337|324282309|FG006|Overall Study|Lost to Follow-up|1|||
94679573|NCT00246337|324282310|FG007|Overall Study|Lost to Follow-up|2|||
94679574|NCT00246337|324282311|FG008|Overall Study|Lost to Follow-up|0|||
94679575|NCT00246337|324282303|FG000|Overall Study|Protocol Violation|1|||
94679576|NCT00246337|324282304|FG001|Overall Study|Protocol Violation|0|||
94679577|NCT00246337|324282305|FG002|Overall Study|Protocol Violation|0|||
94363916|NCT03428217|323116769|FG001|Overall Study|Lost to Follow-up|3|||
94679578|NCT00246337|324282306|FG003|Overall Study|Protocol Violation|0|||
94679579|NCT00246337|324282307|FG004|Overall Study|Protocol Violation|1|||
94679580|NCT00246337|324282308|FG005|Overall Study|Protocol Violation|0|||
94644136|NCT00404352|324158378|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
94644137|NCT00404352|324158379|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
94644138|NCT00404352|324158380|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
94644139|NCT00404352|324158381|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
94644140|NCT00404352|324158382|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
94644141|NCT00404352|324158383|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
94644142|NCT00404352|324158384|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
94644143|NCT00404352|324158385|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
94644144|NCT00404352|324158377|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
94644145|NCT00404352|324158378|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
94644146|NCT00404352|324158379|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
94644147|NCT00404352|324158380|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
94644148|NCT00404352|324158381|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
94644149|NCT00404352|324158382|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
94644150|NCT00404352|324158383|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
94644151|NCT00404352|324158384|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
94644152|NCT00404352|324158385|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
94644153|NCT00404352|324158377|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
94644154|NCT00404352|324158378|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
94644155|NCT00404352|324158379|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
94644156|NCT00404352|324158380|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
94644157|NCT00404352|324158381|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
94644158|NCT00404352|324158382|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
94644159|NCT00404352|324158383|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
94644160|NCT00404352|324158384|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
94644161|NCT00404352|324158385|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
94644162|NCT00404352|324158377|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
94644163|NCT00404352|324158378|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
94644164|NCT00404352|324158379|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
94644165|NCT00404352|324158380|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
94644166|NCT00404352|324158381|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
94644167|NCT00404352|324158382|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
94644168|NCT00404352|324158383|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
94644169|NCT00404352|324158384|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
94644170|NCT00404352|324158385|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
94644171|NCT00404352|324158377|FG000|Open Label (up to 24 Month)|Disease progression|0|||
94644172|NCT00404352|324158378|FG001|Open Label (up to 24 Month)|Disease progression|0|||
94644173|NCT00404352|324158379|FG002|Open Label (up to 24 Month)|Disease progression|0|||
94644174|NCT00404352|324158380|FG003|Open Label (up to 24 Month)|Disease progression|1|||
94463446|NCT02520427|323485057|FG000|Overall Study|Withdrawal by Subject|0|||
94463447|NCT02520427|323485058|FG001|Overall Study|Withdrawal by Subject|0|||
94463448|NCT02520427|323485059|FG002|Overall Study|Withdrawal by Subject|1|||
94679581|NCT00246337|324282309|FG006|Overall Study|Protocol Violation|1|||
94679582|NCT00246337|324282310|FG007|Overall Study|Protocol Violation|1|||
94679583|NCT00246337|324282311|FG008|Overall Study|Protocol Violation|0|||
94679584|NCT00246337|324282303|FG000|Overall Study|Withdrawal by Subject|2|||
94463449|NCT02520427|323485060|FG003|Overall Study|Withdrawal by Subject|0|||
94644175|NCT00404352|324158381|FG004|Open Label (up to 24 Month)|Disease progression|0|||
94644176|NCT00404352|324158382|FG005|Open Label (up to 24 Month)|Disease progression|0|||
94644177|NCT00404352|324158383|FG006|Open Label (up to 24 Month)|Disease progression|0|||
94644178|NCT00404352|324158384|FG007|Open Label (up to 24 Month)|Disease progression|0|||
94644179|NCT00404352|324158385|FG008|Open Label (up to 24 Month)|Disease progression|0|||
94679585|NCT00246337|324282304|FG001|Overall Study|Withdrawal by Subject|0|||
94679586|NCT00246337|324282305|FG002|Overall Study|Withdrawal by Subject|0|||
94679587|NCT00246337|324282306|FG003|Overall Study|Withdrawal by Subject|0|||
94679588|NCT00246337|324282307|FG004|Overall Study|Withdrawal by Subject|0|||
94679589|NCT00246337|324282308|FG005|Overall Study|Withdrawal by Subject|0|||
94679590|NCT00246337|324282309|FG006|Overall Study|Withdrawal by Subject|1|||
94679591|NCT00246337|324282310|FG007|Overall Study|Withdrawal by Subject|1|||
94644180|NCT00404352|324158377|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
94644181|NCT00404352|324158378|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
94644182|NCT00404352|324158379|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
94679592|NCT00246337|324282311|FG008|Overall Study|Withdrawal by Subject|0|||
94679593|NCT00246337|324282303|FG000|Overall Study|Lack of Qualifying Event|8|||
94644183|NCT00404352|324158380|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
94644184|NCT00404352|324158381|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
94644185|NCT00404352|324158382|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
94644186|NCT00404352|324158383|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
94644187|NCT00404352|324158384|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
94644188|NCT00404352|324158385|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
94644189|NCT00404352|324158377|FG000|Open Label Extension (up to 36 Months)|Other|0|||
94644190|NCT00404352|324158378|FG001|Open Label Extension (up to 36 Months)|Other|0|||
94644191|NCT00404352|324158379|FG002|Open Label Extension (up to 36 Months)|Other|0|||
94644192|NCT00404352|324158380|FG003|Open Label Extension (up to 36 Months)|Other|0|||
94644193|NCT00404352|324158381|FG004|Open Label Extension (up to 36 Months)|Other|0|||
94644194|NCT00404352|324158382|FG005|Open Label Extension (up to 36 Months)|Other|0|||
94644195|NCT00404352|324158383|FG006|Open Label Extension (up to 36 Months)|Other|0|||
94644196|NCT00404352|324158384|FG007|Open Label Extension (up to 36 Months)|Other|0|||
94644197|NCT00404352|324158385|FG008|Open Label Extension (up to 36 Months)|Other|2|||
94644198|NCT03746522|324158386|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
94644199|NCT03746522|324158387|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
94644200|NCT03746522|324158388|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
94644201|NCT03746522|324158386|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
94644202|NCT03746522|324158387|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
94644203|NCT03746522|324158388|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
94644204|NCT03746522|324158386|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
94644205|NCT03746522|324158387|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
94644206|NCT03746522|324158388|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
94644207|NCT03746522|324158386|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
94644208|NCT03746522|324158387|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
94644209|NCT03746522|324158388|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
94644210|NCT03746522|324158386|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
94644211|NCT03746522|324158387|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
94644212|NCT03746522|324158388|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
94644213|NCT02659020|324158394|FG000|Overall Study|Adverse Event|0|||
94644214|NCT02659020|324158395|FG001|Overall Study|Adverse Event|0|||
94644215|NCT02659020|324158396|FG002|Overall Study|Adverse Event|0|||
94644216|NCT02659020|324158397|FG003|Overall Study|Adverse Event|2|||
94263543|NCT00594516|322759845|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
94263544|NCT00594516|322759846|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
94263545|NCT00594516|322759847|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
94263546|NCT00084266|322759850|FG000|Overall Study|Death|42|||
94263547|NCT00084266|322759851|FG001|Overall Study|Death|39|||
94263548|NCT00084266|322759850|FG000|Overall Study|Adverse Event|8|||
94263549|NCT00084266|322759851|FG001|Overall Study|Adverse Event|5|||
94263550|NCT00084266|322759850|FG000|Overall Study|Lack of Efficacy|2|||
94263551|NCT00084266|322759851|FG001|Overall Study|Lack of Efficacy|4|||
94263552|NCT00084266|322759850|FG000|Overall Study|Lost to Follow-up|5|||
94263553|NCT00084266|322759851|FG001|Overall Study|Lost to Follow-up|3|||
94263554|NCT00084266|322759850|FG000|Overall Study|Participant not willing to participate|3|||
94263555|NCT00084266|322759851|FG001|Overall Study|Participant not willing to participate|8|||
94263556|NCT00084266|322759850|FG000|Overall Study|Other|360|||
94263557|NCT00084266|322759851|FG001|Overall Study|Other|344|||
94263558|NCT00084266|322759850|FG000|Overall Study|Randomized not treated|21|||
94263559|NCT00084266|322759851|FG001|Overall Study|Randomized not treated|20|||
94263560|NCT00567268|322759852|FG000|Overall Study|Protocol Violation|7|||
94263561|NCT00567268|322759852|FG000|Overall Study|Lost to Follow-up|36|||
94263562|NCT00567268|322759852|FG000|Overall Study|No Visit After First Day of Treatment|2|||
94263563|NCT00567268|322759852|FG000|Overall Study|No Drug Administration|4|||
94263564|NCT00567268|322759852|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
94263565|NCT03434353|322759853|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
94263566|NCT03434353|322759854|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
94263567|NCT03434353|322759855|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
94263568|NCT03434353|322759856|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
94263569|NCT03434353|322759857|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
94263570|NCT03434353|322759853|FG000|Overall Study|Withdrew consent|1|||
94263571|NCT03434353|322759854|FG001|Overall Study|Withdrew consent|0|||
94263572|NCT03434353|322759855|FG002|Overall Study|Withdrew consent|3|||
94263573|NCT03434353|322759856|FG003|Overall Study|Withdrew consent|0|||
94263574|NCT03434353|322759857|FG004|Overall Study|Withdrew consent|0|||
94263575|NCT03434353|322759853|FG000|Overall Study|Adverse Event|1|||
94263576|NCT03434353|322759854|FG001|Overall Study|Adverse Event|0|||
94263577|NCT03434353|322759855|FG002|Overall Study|Adverse Event|0|||
94263578|NCT03434353|322759856|FG003|Overall Study|Adverse Event|0|||
94463450|NCT02520427|323485061|FG004|Overall Study|Withdrawal by Subject|0|||
94644217|NCT02659020|324158398|FG004|Overall Study|Adverse Event|0|||
94363917|NCT03428217|323116768|FG000|Overall Study|Study terminated by sponsor|124|||
94363918|NCT03428217|323116769|FG001|Overall Study|Study terminated by sponsor|118|||
94363919|NCT03428217|323116768|FG000|Overall Study|Other, Not Specified|1|||
94363920|NCT03428217|323116769|FG001|Overall Study|Other, Not Specified|0|||
94363921|NCT01306968|323116770|FG000|Overall Study|Lost to Follow-up|1|||
94363922|NCT01306968|323116771|FG001|Overall Study|Lost to Follow-up|1|||
94363923|NCT01306968|323116772|FG002|Overall Study|Lost to Follow-up|0|||
94363924|NCT01306968|323116773|FG003|Overall Study|Lost to Follow-up|0|||
94363925|NCT01306968|323116770|FG000|Overall Study|Physician Decision|0|||
94363926|NCT01306968|323116771|FG001|Overall Study|Physician Decision|1|||
94644218|NCT02659020|324158399|FG005|Overall Study|Adverse Event|0|||
94644219|NCT02659020|324158400|FG006|Overall Study|Adverse Event|2|||
94644220|NCT02659020|324158394|FG000|Overall Study|Lost to Follow-up|1|||
94644221|NCT02659020|324158395|FG001|Overall Study|Lost to Follow-up|2|||
94644222|NCT02659020|324158396|FG002|Overall Study|Lost to Follow-up|1|||
94644223|NCT02659020|324158397|FG003|Overall Study|Lost to Follow-up|6|||
94644224|NCT02659020|324158398|FG004|Overall Study|Lost to Follow-up|1|||
94644225|NCT02659020|324158399|FG005|Overall Study|Lost to Follow-up|5|||
94644226|NCT02659020|324158400|FG006|Overall Study|Lost to Follow-up|0|||
94644227|NCT02659020|324158394|FG000|Overall Study|Physician Decision|0|||
94644228|NCT02659020|324158395|FG001|Overall Study|Physician Decision|0|||
94644229|NCT02659020|324158396|FG002|Overall Study|Physician Decision|0|||
94644230|NCT02659020|324158397|FG003|Overall Study|Physician Decision|1|||
94644231|NCT02659020|324158398|FG004|Overall Study|Physician Decision|1|||
94644232|NCT02659020|324158399|FG005|Overall Study|Physician Decision|0|||
94644233|NCT02659020|324158400|FG006|Overall Study|Physician Decision|1|||
94644234|NCT02659020|324158394|FG000|Overall Study|Withdrawal by Subject|2|||
94644235|NCT02659020|324158395|FG001|Overall Study|Withdrawal by Subject|1|||
94644236|NCT02659020|324158396|FG002|Overall Study|Withdrawal by Subject|0|||
94644237|NCT02659020|324158397|FG003|Overall Study|Withdrawal by Subject|3|||
94644238|NCT02659020|324158398|FG004|Overall Study|Withdrawal by Subject|3|||
94644239|NCT02659020|324158399|FG005|Overall Study|Withdrawal by Subject|6|||
94644240|NCT02659020|324158400|FG006|Overall Study|Withdrawal by Subject|3|||
94644241|NCT02659020|324158394|FG000|Overall Study|Progressive Disease|0|||
94644242|NCT02659020|324158395|FG001|Overall Study|Progressive Disease|0|||
94644243|NCT02659020|324158396|FG002|Overall Study|Progressive Disease|0|||
94644244|NCT02659020|324158397|FG003|Overall Study|Progressive Disease|4|||
94644245|NCT02659020|324158398|FG004|Overall Study|Progressive Disease|1|||
94644246|NCT02659020|324158399|FG005|Overall Study|Progressive Disease|0|||
94644247|NCT02659020|324158400|FG006|Overall Study|Progressive Disease|2|||
94644248|NCT00829296|324158401|FG000|Overall Study|Adverse Event|5|||
94644249|NCT00829296|324158402|FG001|Overall Study|Adverse Event|4|||
94644250|NCT01073865|324158403|FG000|Overall Study|Reasons other than below|19|||
94644251|NCT01073865|324158404|FG001|Overall Study|Reasons other than below|31|||
94644252|NCT01073865|324158403|FG000|Overall Study|Lost to Follow-up|1|||
94644253|NCT01073865|324158404|FG001|Overall Study|Lost to Follow-up|1|||
94644254|NCT01073865|324158403|FG000|Overall Study|Death|3|||
94644255|NCT01073865|324158404|FG001|Overall Study|Death|2|||
94644256|NCT01073865|324158403|FG000|Overall Study|Withdrawal by Subject|5|||
94644257|NCT01073865|324158404|FG001|Overall Study|Withdrawal by Subject|5|||
94644258|NCT02129803|324158405|FG000|Overall Study|Protocol Violation|4|||
94644259|NCT02129803|324158406|FG001|Overall Study|Protocol Violation|0|||
94644260|NCT02129803|324158405|FG000|Overall Study|Physician Decision|0|||
94644261|NCT02129803|324158406|FG001|Overall Study|Physician Decision|1|||
94644262|NCT02129803|324158405|FG000|Overall Study|Difficulty sleeping|1|||
94644263|NCT02129803|324158406|FG001|Overall Study|Difficulty sleeping|0|||
94644264|NCT02129803|324158405|FG000|Overall Study|Morning headache|0|||
94644265|NCT02129803|324158406|FG001|Overall Study|Morning headache|1|||
94644266|NCT02129803|324158405|FG000|Overall Study|Withdrawal by Subject|1|||
94644267|NCT02129803|324158406|FG001|Overall Study|Withdrawal by Subject|1|||
94363927|NCT01306968|323116772|FG002|Overall Study|Physician Decision|0|||
94363928|NCT01306968|323116773|FG003|Overall Study|Physician Decision|0|||
94363929|NCT01306968|323116770|FG000|Overall Study|Relocated and left active duty|0|||
94644268|NCT00907374|324158407|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
94644269|NCT00907374|324158408|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
94644270|NCT00439556|324158409|FG000|Overall Study|Patient was taken off study for non-comp|0|||
94363930|NCT01306968|323116771|FG001|Overall Study|Relocated and left active duty|1|||
94463451|NCT02520427|323485062|FG005|Overall Study|Withdrawal by Subject|0|||
94463452|NCT02520427|323485063|FG006|Overall Study|Withdrawal by Subject|0|||
94644271|NCT00439556|324158410|FG001|Overall Study|Patient was taken off study for non-comp|1|||
94644272|NCT00439556|324158411|FG002|Overall Study|Patient was taken off study for non-comp|0|||
94644273|NCT03818516|324158412|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
94644274|NCT00594464|324158418|FG000|Overall Study|Withdrawal by Subject|1|||
94644275|NCT00594464|324158418|FG000|Overall Study|Delay in operation|2|||
94644276|NCT02907359|324158419|FG000|Overall Study|Death|234|||
94644277|NCT02907359|324158420|FG001|Overall Study|Death|117|||
94644278|NCT02907359|324158419|FG000|Overall Study|Withdrawal by Subject|6|||
94644279|NCT02907359|324158420|FG001|Overall Study|Withdrawal by Subject|11|||
94644280|NCT02907359|324158419|FG000|Overall Study|Lost to Follow-up|1|||
94644281|NCT02907359|324158420|FG001|Overall Study|Lost to Follow-up|0|||
94644282|NCT00058825|324158425|FG000|Overall Study|Relapse|9|||
94644283|NCT00058825|324158425|FG000|Overall Study|Progressive Disease|5|||
94644284|NCT00058825|324158425|FG000|Overall Study|Graft Failure|5|||
94644285|NCT00058825|324158425|FG000|Overall Study|Death|3|||
94644286|NCT04399161|324158426|FG000|Overall Study|Withdrawal by Subject|1|||
94644287|NCT04399161|324158427|FG001|Overall Study|Withdrawal by Subject|0|||
94644288|NCT04399161|324158428|FG002|Overall Study|Withdrawal by Subject|2|||
94644289|NCT04399161|324158426|FG000|Overall Study|Protocol Violation|1|||
94644290|NCT04399161|324158427|FG001|Overall Study|Protocol Violation|2|||
94644291|NCT04399161|324158428|FG002|Overall Study|Protocol Violation|0|||
94644292|NCT02739269|324158429|FG000|Overall Study|Protocol Violation|5|||
94644293|NCT02739269|324158430|FG001|Overall Study|Protocol Violation|0|||
94644294|NCT02739269|324158429|FG000|Overall Study|Cycle cancellation|2|||
94644295|NCT02739269|324158430|FG001|Overall Study|Cycle cancellation|2|||
94644296|NCT02739269|324158429|FG000|Overall Study|Withdrawal by Subject|0|||
94644297|NCT02739269|324158430|FG001|Overall Study|Withdrawal by Subject|2|||
94644298|NCT01354496|324158431|FG000|Period 1|Adverse Event|0|||
94644299|NCT01354496|324158432|FG001|Period 1|Adverse Event|0|||
94644300|NCT01354496|324158433|FG002|Period 1|Adverse Event|1|||
94644301|NCT01354496|324158434|FG003|Period 1|Adverse Event|0|||
94644302|NCT01354496|324158435|FG004|Period 1|Adverse Event|0|||
94644303|NCT01354496|324158436|FG005|Period 1|Adverse Event|0|||
94644304|NCT01354496|324158431|FG000|Period 1|Physician Decision|0|||
94644305|NCT01354496|324158432|FG001|Period 1|Physician Decision|0|||
94644306|NCT01354496|324158433|FG002|Period 1|Physician Decision|1|||
94644307|NCT01354496|324158434|FG003|Period 1|Physician Decision|0|||
94644308|NCT01354496|324158435|FG004|Period 1|Physician Decision|0|||
94644309|NCT01354496|324158436|FG005|Period 1|Physician Decision|0|||
94644310|NCT01354496|324158431|FG000|Period 2|Adverse Event|0|||
94644311|NCT01354496|324158432|FG001|Period 2|Adverse Event|0|||
94644312|NCT01354496|324158433|FG002|Period 2|Adverse Event|0|||
94644313|NCT01354496|324158434|FG003|Period 2|Adverse Event|1|||
94644314|NCT01354496|324158435|FG004|Period 2|Adverse Event|0|||
94644315|NCT01354496|324158436|FG005|Period 2|Adverse Event|0|||
94644316|NCT01354496|324158431|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
94644317|NCT01354496|324158432|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
94644318|NCT01354496|324158433|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
94644319|NCT01354496|324158434|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
94644320|NCT01354496|324158435|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
94644321|NCT01354496|324158436|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
94644322|NCT01116232|324158437|FG000|Overall Study|Progressive diease|4|||
94644323|NCT02449239|324159525|FG000|Induction Phase|Lack of Efficacy|64|||
94644324|NCT02449239|324159525|FG000|Induction Phase|Adverse Event|1|||
94644325|NCT02449239|324159525|FG000|Induction Phase|Lost to Follow-up|1|||
94644326|NCT02449239|324159525|FG000|Induction Phase|Protocol Violation|1|||
94644327|NCT02449239|324159525|FG000|Induction Phase|Physician Decision|1|||
94644328|NCT02449239|324159525|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
94644329|NCT02449239|324159525|FG000|Induction Phase|Withdrawal by Subject|1|||
94644330|NCT02449239|324159525|FG000|Maintenance Month 3|Lack of Efficacy|14|||
94644331|NCT02449239|324159525|FG000|Maintenance Month 6|Lack of Efficacy|10|||
94644332|NCT02449239|324159525|FG000|Maintenance Month 6|Adverse Event|2|||
94644333|NCT02449239|324159525|FG000|Maintenance Month 6|Physician Decision|1|||
94644334|NCT02449239|324159525|FG000|Maintenance Month 9|Lack of Efficacy|2|||
94644335|NCT02449239|324159525|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
94644336|NCT02449239|324159525|FG000|Maintenance Month 12|Lack of Efficacy|5|||
94644337|NCT02449239|324159525|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
94644338|NCT02449239|324159525|FG000|Maintenance Month 12|Subject moved from area|1|||
94644339|NCT02449239|324159525|FG000|Maintenance Month 15|Lack of Efficacy|1|||
94644340|NCT02449239|324159525|FG000|Maintenance Month 21|Lack of Efficacy|1|||
94644341|NCT02449239|324159525|FG000|Maintenance Month 21|Sponsor decision|1|||
94644342|NCT03569371|324159526|FG000|Overall Study|Lack of Efficacy|1|||
94644343|NCT03569371|324159526|FG000|Overall Study|Lost to Follow-up|1|||
94644344|NCT03569371|324159526|FG000|Overall Study|Adverse Event|1|||
94644345|NCT01236755|324159527|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
94644346|NCT01236755|324159527|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
94644347|NCT01236755|324159527|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
94644348|NCT01236755|324159527|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
94644349|NCT00110812|324159528|FG000|Main Study|Death|0|||
94644350|NCT00110812|324159529|FG001|Main Study|Death|0|||
94644351|NCT00110812|324159530|FG002|Main Study|Death|2|||
94644352|NCT00110812|324159528|FG000|Main Study|Withdrawal by Subject|0|||
94679594|NCT00246337|324282304|FG001|Overall Study|Lack of Qualifying Event|2|||
94644353|NCT00110812|324159529|FG001|Main Study|Withdrawal by Subject|0|||
94644354|NCT00110812|324159530|FG002|Main Study|Withdrawal by Subject|1|||
94644355|NCT00110812|324159528|FG000|Main Study|Lost to Follow-up|8|||
94644356|NCT00110812|324159529|FG001|Main Study|Lost to Follow-up|11|||
94644357|NCT00110812|324159530|FG002|Main Study|Lost to Follow-up|10|||
94644358|NCT00110812|324159528|FG000|Extended Follow-up|Death|1|||
94644359|NCT00110812|324159529|FG001|Extended Follow-up|Death|0|||
94644360|NCT00110812|324159530|FG002|Extended Follow-up|Death|3|||
94644361|NCT00110812|324159528|FG000|Extended Follow-up|Withdrawal by Subject|0|||
94644362|NCT00110812|324159529|FG001|Extended Follow-up|Withdrawal by Subject|1|||
94644363|NCT00110812|324159530|FG002|Extended Follow-up|Withdrawal by Subject|0|||
94644364|NCT00110812|324159528|FG000|Extended Follow-up|Lost to Follow-up|1|||
94644365|NCT00110812|324159529|FG001|Extended Follow-up|Lost to Follow-up|3|||
94644366|NCT00110812|324159530|FG002|Extended Follow-up|Lost to Follow-up|1|||
94644367|NCT01454726|324159531|FG000|Overall Study|Withdrawal by Subject|0|||
94644368|NCT01454726|324159532|FG001|Overall Study|Withdrawal by Subject|1|||
94644369|NCT04476030|324159533|FG000|Overall Study|Withdrawal by Subject|20|||
94644370|NCT04476030|324159534|FG001|Overall Study|Withdrawal by Subject|16|||
94644371|NCT04476030|324159533|FG000|Overall Study|Adverse Event|10|||
94644372|NCT04476030|324159534|FG001|Overall Study|Adverse Event|11|||
94644373|NCT04476030|324159533|FG000|Overall Study|Lost to Follow-up|7|||
94644374|NCT04476030|324159534|FG001|Overall Study|Lost to Follow-up|4|||
94644375|NCT04476030|324159533|FG000|Overall Study|Physician Decision|1|||
94644376|NCT04476030|324159534|FG001|Overall Study|Physician Decision|1|||
94644377|NCT04476030|324159533|FG000|Overall Study|Protocol Deviation|2|||
94644378|NCT04476030|324159534|FG001|Overall Study|Protocol Deviation|0|||
94644379|NCT04476030|324159533|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
94644380|NCT04476030|324159534|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
94644381|NCT04476030|324159533|FG000|Overall Study|Randomized but not Dosed|2|||
94644382|NCT04476030|324159534|FG001|Overall Study|Randomized but not Dosed|8|||
94644383|NCT00006489|324159537|FG000|Overall Study|Adverse Event|3|||
94263579|NCT03434353|322759857|FG004|Overall Study|Adverse Event|1|||
94263580|NCT03434353|322759853|FG000|Overall Study|Lost to Follow-up|2|||
94644384|NCT00006489|324159538|FG001|Overall Study|Adverse Event|2|||
94644385|NCT00006489|324159539|FG002|Overall Study|Adverse Event|4|||
94644386|NCT00006489|324159540|FG003|Overall Study|Adverse Event|3|||
94644387|NCT00006489|324159537|FG000|Overall Study|Withdrawal by Subject|10|||
94644388|NCT00006489|324159538|FG001|Overall Study|Withdrawal by Subject|9|||
94644389|NCT00006489|324159539|FG002|Overall Study|Withdrawal by Subject|9|||
94644390|NCT00006489|324159540|FG003|Overall Study|Withdrawal by Subject|6|||
94644391|NCT00006489|324159537|FG000|Overall Study|Scheduling Conflict|0|||
94644392|NCT00006489|324159538|FG001|Overall Study|Scheduling Conflict|3|||
94644393|NCT00006489|324159539|FG002|Overall Study|Scheduling Conflict|2|||
94644394|NCT00006489|324159540|FG003|Overall Study|Scheduling Conflict|1|||
94644395|NCT00006489|324159537|FG000|Overall Study|Death|0|||
94644396|NCT00006489|324159538|FG001|Overall Study|Death|0|||
94644397|NCT00006489|324159539|FG002|Overall Study|Death|0|||
94644398|NCT00006489|324159540|FG003|Overall Study|Death|1|||
94644399|NCT02086110|324159541|FG000|Overall Study|Withdrawal by Subject|1|||
94644400|NCT02086110|324159542|FG001|Overall Study|Withdrawal by Subject|1|||
94644401|NCT00116558|324159543|FG000|Overall Study|Death|11|||
94644402|NCT00116558|324159544|FG001|Overall Study|Death|5|||
94644403|NCT00116558|324159545|FG002|Overall Study|Death|3|||
94644404|NCT00116558|324159543|FG000|Overall Study|Withdrawal by Subject|17|||
94644405|NCT00116558|324159544|FG001|Overall Study|Withdrawal by Subject|3|||
94644406|NCT00116558|324159545|FG002|Overall Study|Withdrawal by Subject|12|||
94644407|NCT00116558|324159543|FG000|Overall Study|disease progression|3|||
94644408|NCT00116558|324159544|FG001|Overall Study|disease progression|7|||
94644409|NCT00116558|324159545|FG002|Overall Study|disease progression|18|||
94644410|NCT02852265|324159547|FG000|3-month Follow-up|Lost to Follow-up|1|||
94644411|NCT02852265|324159548|FG001|3-month Follow-up|Lost to Follow-up|1|||
94644412|NCT00937547|324159551|FG000|Overall Study|misdiagnosis|1|||
94644413|NCT00937547|324159552|FG001|Overall Study|misdiagnosis|6|||
94644414|NCT00937547|324159553|FG002|Overall Study|misdiagnosis|7|||
94644415|NCT01234467|324159554|FG000|Overall Study|Adverse Event|3|||
94644416|NCT01234467|324159554|FG000|Overall Study|Death|2|||
94644417|NCT01234467|324159554|FG000|Overall Study|Withdrawal by Subject|2|||
94644418|NCT01234467|324159554|FG000|Overall Study|Disease Progression|2|||
94644419|NCT01234467|324159554|FG000|Overall Study|Clinical deterioration|1|||
94644420|NCT01234467|324159554|FG000|Overall Study|Physician Decision|1|||
94644421|NCT01234467|324159554|FG000|Overall Study|Other complicating disease (stroke)|1|||
94644422|NCT02308735|324159559|FG000|Overall Study|Physician Decision|2|||
94644423|NCT02308735|324159560|FG001|Overall Study|Physician Decision|0|||
94644424|NCT02308735|324159561|FG002|Overall Study|Physician Decision|0|||
94644425|NCT02308735|324159562|FG003|Overall Study|Physician Decision|2|||
94644426|NCT01417481|324159570|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
94644427|NCT01417481|324159571|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
94644428|NCT01364428|324159577|FG000|Overall Study|Adverse Event|1|||
94644429|NCT01364428|324159578|FG001|Overall Study|Adverse Event|2|||
94644430|NCT01364428|324159577|FG000|Overall Study|Protocol Violation|2|||
94644431|NCT01364428|324159578|FG001|Overall Study|Protocol Violation|0|||
94644432|NCT01364428|324159577|FG000|Overall Study|Withdrawal Criteria|14|||
94644433|NCT01364428|324159578|FG001|Overall Study|Withdrawal Criteria|10|||
94644434|NCT01364428|324159577|FG000|Overall Study|Other|3|||
94644435|NCT01364428|324159578|FG001|Overall Study|Other|3|||
94644436|NCT01987427|324159579|FG000|Overall Study|Adverse Event|4|||
94644437|NCT01987427|324159580|FG001|Overall Study|Adverse Event|2|||
94644438|NCT01987427|324159581|FG002|Overall Study|Adverse Event|8|||
94644439|NCT01987427|324159579|FG000|Overall Study|Lost to Follow-up|6|||
94644440|NCT01987427|324159580|FG001|Overall Study|Lost to Follow-up|6|||
94644441|NCT01987427|324159581|FG002|Overall Study|Lost to Follow-up|9|||
94644442|NCT01987427|324159579|FG000|Overall Study|Withdrawal by Subject|2|||
94644443|NCT01987427|324159580|FG001|Overall Study|Withdrawal by Subject|1|||
94644444|NCT01987427|324159581|FG002|Overall Study|Withdrawal by Subject|3|||
94644445|NCT01987427|324159579|FG000|Overall Study|Lack of Efficacy|1|||
94644446|NCT01987427|324159580|FG001|Overall Study|Lack of Efficacy|0|||
94644447|NCT01987427|324159581|FG002|Overall Study|Lack of Efficacy|0|||
94644448|NCT01987427|324159579|FG000|Overall Study|Other|1|||
94644449|NCT01987427|324159580|FG001|Overall Study|Other|1|||
94644450|NCT01987427|324159581|FG002|Overall Study|Other|0|||
94644451|NCT02350309|324159583|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
94644452|NCT02350309|324159584|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
94644453|NCT02350309|324159585|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
94644454|NCT02350309|324159586|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
94644455|NCT02350309|324159587|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
94644456|NCT02350309|324159588|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
94644457|NCT02350309|324159583|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
94644458|NCT02350309|324159584|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
94644459|NCT02350309|324159585|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
94644460|NCT02350309|324159586|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
94644461|NCT02350309|324159587|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
94644462|NCT02350309|324159588|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
94644463|NCT01434290|324159593|FG000|Overall Study|Protocol Violation|6|||
94644464|NCT01434290|324159594|FG001|Overall Study|Protocol Violation|3|||
94644465|NCT01434290|324159593|FG000|Overall Study|No protocol treatment|2|||
94644466|NCT01434290|324159594|FG001|Overall Study|No protocol treatment|4|||
94644467|NCT02281552|324159595|FG000|Overall Study|Medication error|1|||
94644468|NCT02281552|324159596|FG001|Overall Study|Medication error|0|||
94644469|NCT02281552|324159595|FG000|Overall Study|Insufficient clinical response|0|||
94679595|NCT00246337|324282305|FG002|Overall Study|Lack of Qualifying Event|1|||
94644470|NCT02281552|324159596|FG001|Overall Study|Insufficient clinical response|1|||
94644471|NCT02281552|324159595|FG000|Overall Study|Adverse Event|3|||
94644472|NCT02281552|324159596|FG001|Overall Study|Adverse Event|9|||
94644473|NCT00717769|324159597|FG000|Overall Study|Adverse Event|9|||
94644474|NCT00717769|324159598|FG001|Overall Study|Adverse Event|6|||
94644475|NCT00717769|324159599|FG002|Overall Study|Adverse Event|1|||
94644476|NCT00717769|324159597|FG000|Overall Study|Lack of compliance|0|||
94644477|NCT00717769|324159598|FG001|Overall Study|Lack of compliance|2|||
94644478|NCT00717769|324159599|FG002|Overall Study|Lack of compliance|0|||
94644479|NCT00717769|324159597|FG000|Overall Study|Lost to Follow-up|3|||
94644480|NCT00717769|324159598|FG001|Overall Study|Lost to Follow-up|4|||
94644481|NCT00717769|324159599|FG002|Overall Study|Lost to Follow-up|0|||
94644482|NCT00717769|324159597|FG000|Overall Study|Lack of Efficacy|1|||
94644483|NCT00717769|324159598|FG001|Overall Study|Lack of Efficacy|2|||
94644484|NCT00717769|324159599|FG002|Overall Study|Lack of Efficacy|0|||
94644485|NCT00717769|324159597|FG000|Overall Study|Protocol Violation|0|||
94644486|NCT00717769|324159598|FG001|Overall Study|Protocol Violation|2|||
94644487|NCT00717769|324159599|FG002|Overall Study|Protocol Violation|0|||
94644488|NCT00717769|324159597|FG000|Overall Study|Sponsor decision|1|||
94644489|NCT00717769|324159598|FG001|Overall Study|Sponsor decision|0|||
94644490|NCT00717769|324159599|FG002|Overall Study|Sponsor decision|10|||
94644491|NCT00717769|324159597|FG000|Overall Study|Withdrew consent|2|||
94644492|NCT00717769|324159598|FG001|Overall Study|Withdrew consent|2|||
94644493|NCT00717769|324159599|FG002|Overall Study|Withdrew consent|0|||
94644494|NCT02196324|324159601|FG000|Overall Study|Withdrawal by Subject|8|||
94644495|NCT02196324|324159602|FG001|Overall Study|Withdrawal by Subject|4|||
94644496|NCT02196324|324159601|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
94644497|NCT02196324|324159602|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
94644498|NCT02196324|324159601|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
94644499|NCT02196324|324159602|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
94644500|NCT02196324|324159601|FG000|Overall Study|Other|1|||
94644501|NCT02196324|324159602|FG001|Overall Study|Other|0|||
94644502|NCT00558103|324159603|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
94644503|NCT00558103|324159604|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
94644504|NCT00558103|324159605|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
94644505|NCT00558103|324159606|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
94644506|NCT00558103|324159607|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
94644507|NCT00558103|324159608|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
94644508|NCT00558103|324159603|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
94644509|NCT00558103|324159604|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
94644510|NCT00558103|324159605|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
94644511|NCT00558103|324159606|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
94644512|NCT00558103|324159607|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
94644513|NCT00558103|324159608|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
94644514|NCT00558103|324159603|FG000|Randomized Treatment Phase|Disease Progression|1|||
94644515|NCT00558103|324159604|FG001|Randomized Treatment Phase|Disease Progression|0|||
94644516|NCT00558103|324159605|FG002|Randomized Treatment Phase|Disease Progression|1|||
94644517|NCT00558103|324159606|FG003|Randomized Treatment Phase|Disease Progression|0|||
94644518|NCT00558103|324159607|FG004|Randomized Treatment Phase|Disease Progression|0|||
94644519|NCT00558103|324159608|FG005|Randomized Treatment Phase|Disease Progression|0|||
94644520|NCT00558103|324159603|FG000|Randomized Treatment Phase|Adverse Event|0|||
94644521|NCT00558103|324159604|FG001|Randomized Treatment Phase|Adverse Event|0|||
94644522|NCT00558103|324159605|FG002|Randomized Treatment Phase|Adverse Event|0|||
94644523|NCT00558103|324159606|FG003|Randomized Treatment Phase|Adverse Event|1|||
94644524|NCT00558103|324159607|FG004|Randomized Treatment Phase|Adverse Event|1|||
94644525|NCT00558103|324159608|FG005|Randomized Treatment Phase|Adverse Event|0|||
94644526|NCT00558103|324159603|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
94644527|NCT00558103|324159604|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
94644528|NCT00558103|324159605|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
94644529|NCT00558103|324159606|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
94644530|NCT00558103|324159607|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
94263581|NCT03434353|322759854|FG001|Overall Study|Lost to Follow-up|0|||
94263582|NCT03434353|322759855|FG002|Overall Study|Lost to Follow-up|0|||
94263583|NCT03434353|322759856|FG003|Overall Study|Lost to Follow-up|0|||
94263584|NCT03434353|322759857|FG004|Overall Study|Lost to Follow-up|0|||
94263585|NCT02464228|322759858|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
94263586|NCT02464228|322759859|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
94263587|NCT02464228|322759860|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
94263588|NCT02464228|322759861|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
94263589|NCT02464228|322759858|FG000|Overall Study|Physician Decision|2|||
94263590|NCT02464228|322759859|FG001|Overall Study|Physician Decision|0|||
94263591|NCT02464228|322759860|FG002|Overall Study|Physician Decision|1|||
94263592|NCT02464228|322759861|FG003|Overall Study|Physician Decision|0|||
94263593|NCT02464228|322759858|FG000|Overall Study|Miscellaneous|1|||
94263594|NCT02464228|322759859|FG001|Overall Study|Miscellaneous|0|||
94263595|NCT02464228|322759860|FG002|Overall Study|Miscellaneous|1|||
94463453|NCT02520427|323485064|FG007|Overall Study|Withdrawal by Subject|0|||
94644531|NCT00558103|324159608|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
94644532|NCT00558103|324159603|FG000|Monotherapy Extension Phase|Disease Progression|0|||
94644533|NCT00558103|324159604|FG001|Monotherapy Extension Phase|Disease Progression|0|||
94644534|NCT00558103|324159605|FG002|Monotherapy Extension Phase|Disease Progression|0|||
94644535|NCT00558103|324159606|FG003|Monotherapy Extension Phase|Disease Progression|0|||
94644536|NCT00558103|324159607|FG004|Monotherapy Extension Phase|Disease Progression|0|||
94644537|NCT00558103|324159608|FG005|Monotherapy Extension Phase|Disease Progression|8|||
94644538|NCT04248816|324159618|FG000|Overall Study|Ineligible post-randomization|7|||
94644539|NCT04248816|324159619|FG001|Overall Study|Ineligible post-randomization|21|||
94644540|NCT04248816|324159620|FG002|Overall Study|Ineligible post-randomization|25|||
94644541|NCT00655564|324159625|FG000|Overall Study|Adverse Event|1|||
94263596|NCT02464228|322759861|FG003|Overall Study|Miscellaneous|0|||
94263597|NCT02464228|322759858|FG000|Overall Study|Adverse Event|9|||
94263598|NCT02464228|322759859|FG001|Overall Study|Adverse Event|0|||
94263599|NCT02464228|322759860|FG002|Overall Study|Adverse Event|3|||
94263600|NCT02464228|322759861|FG003|Overall Study|Adverse Event|0|||
94263601|NCT02464228|322759858|FG000|Overall Study|Withdrawal by Subject|1|||
94263602|NCT02464228|322759859|FG001|Overall Study|Withdrawal by Subject|1|||
94263603|NCT02464228|322759860|FG002|Overall Study|Withdrawal by Subject|1|||
94263604|NCT02464228|322759861|FG003|Overall Study|Withdrawal by Subject|0|||
94263605|NCT02464228|322759858|FG000|Overall Study|Disease Progression|22|||
94263606|NCT02464228|322759859|FG001|Overall Study|Disease Progression|12|||
94263607|NCT02464228|322759860|FG002|Overall Study|Disease Progression|5|||
94263608|NCT02464228|322759861|FG003|Overall Study|Disease Progression|2|||
94263609|NCT01990534|322759862|FG000|Overall Study|Death|22|||
94463454|NCT02520427|323485065|FG008|Overall Study|Withdrawal by Subject|0|||
94644542|NCT00655564|324159625|FG000|Overall Study|Lost to Follow-up|1|||
94644543|NCT00655564|324159625|FG000|Overall Study|Desired Alternate Therapy|1|||
94644544|NCT00989833|324159626|FG000|Overall Study|Lost to Follow-up|0|||
94644545|NCT00989833|324159627|FG001|Overall Study|Lost to Follow-up|1|||
94644546|NCT00989833|324159628|FG002|Overall Study|Lost to Follow-up|0|||
94644547|NCT00989833|324159626|FG000|Overall Study|Protocol Violation|1|||
94644548|NCT00989833|324159627|FG001|Overall Study|Protocol Violation|2|||
94644549|NCT00989833|324159628|FG002|Overall Study|Protocol Violation|1|||
94644550|NCT00989833|324159626|FG000|Overall Study|Withdrawal by Subject|0|||
94644551|NCT00989833|324159627|FG001|Overall Study|Withdrawal by Subject|0|||
94644552|NCT00989833|324159628|FG002|Overall Study|Withdrawal by Subject|1|||
94644553|NCT00989833|324159626|FG000|Overall Study|Incorrectly randomized|1|||
94644554|NCT00989833|324159627|FG001|Overall Study|Incorrectly randomized|0|||
94644555|NCT00989833|324159628|FG002|Overall Study|Incorrectly randomized|0|||
94644556|NCT00500370|324159637|FG000|Overall Study|Adverse Event|9|||
94644557|NCT00500370|324159638|FG001|Overall Study|Adverse Event|3|||
94644558|NCT00500370|324159637|FG000|Overall Study|Lost to Follow-up|10|||
94263610|NCT01990534|322759862|FG000|Overall Study|Progressive disease|3|||
94263611|NCT01990534|322759862|FG000|Overall Study|Protocol Violation|1|||
94263612|NCT01990534|322759862|FG000|Overall Study|Withdrawal of Informed Consent|2|||
94263613|NCT01990534|322759862|FG000|Overall Study|Symptomatic Deterioration|1|||
94263614|NCT01990534|322759862|FG000|Overall Study|Withdrawal by Subject|3|||
94263615|NCT01990534|322759862|FG000|Overall Study|Reason not Specified|2|||
94644559|NCT00500370|324159638|FG001|Overall Study|Lost to Follow-up|10|||
94644560|NCT00500370|324159637|FG000|Overall Study|Protocol Violation|2|||
94644561|NCT00500370|324159638|FG001|Overall Study|Protocol Violation|4|||
94644562|NCT00500370|324159637|FG000|Overall Study|Sponsor Decision|2|||
94644563|NCT00500370|324159638|FG001|Overall Study|Sponsor Decision|0|||
94644564|NCT00500370|324159637|FG000|Overall Study|Subject Decision|10|||
94644565|NCT00500370|324159638|FG001|Overall Study|Subject Decision|17|||
94644566|NCT04804813|324159639|FG000|Overall Study|Protocol Violation|2|||
94644567|NCT04804813|324159640|FG001|Overall Study|Protocol Violation|0|||
94644568|NCT04804813|324159639|FG000|Overall Study|Withdrawal by Subject|1|||
94644569|NCT04804813|324159640|FG001|Overall Study|Withdrawal by Subject|0|||
94644570|NCT05627518|324159641|FG000|Treatment Period 1|Adverse Event|0|||
94644571|NCT05627518|324159642|FG001|Treatment Period 1|Adverse Event|0|||
94644572|NCT05627518|324159643|FG002|Treatment Period 1|Adverse Event|1|||
94644573|NCT05627518|324159644|FG003|Treatment Period 1|Adverse Event|0|||
94644574|NCT05627518|324159645|FG004|Treatment Period 1|Adverse Event|0|||
94644575|NCT05627518|324159646|FG005|Treatment Period 1|Adverse Event|0|||
94644576|NCT05627518|324159647|FG006|Treatment Period 1|Adverse Event|0|||
94644577|NCT05627518|324159648|FG007|Treatment Period 1|Adverse Event|1|||
94644578|NCT05627518|324159641|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94644579|NCT05627518|324159642|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94644580|NCT05627518|324159643|FG002|Treatment Period 1|Withdrawal by Subject|1|||
94644581|NCT05627518|324159644|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94644582|NCT05627518|324159645|FG004|Treatment Period 1|Withdrawal by Subject|0|||
94644583|NCT05627518|324159646|FG005|Treatment Period 1|Withdrawal by Subject|1|||
94644584|NCT05627518|324159647|FG006|Treatment Period 1|Withdrawal by Subject|0|||
94644585|NCT05627518|324159648|FG007|Treatment Period 1|Withdrawal by Subject|0|||
94644586|NCT05627518|324159641|FG000|Treatment Period 1|Protocol Violation|0|||
94644587|NCT05627518|324159642|FG001|Treatment Period 1|Protocol Violation|0|||
94644588|NCT05627518|324159643|FG002|Treatment Period 1|Protocol Violation|0|||
94644589|NCT05627518|324159644|FG003|Treatment Period 1|Protocol Violation|0|||
94644590|NCT05627518|324159645|FG004|Treatment Period 1|Protocol Violation|0|||
94644591|NCT05627518|324159646|FG005|Treatment Period 1|Protocol Violation|0|||
94644592|NCT05627518|324159647|FG006|Treatment Period 1|Protocol Violation|6|||
94644593|NCT05627518|324159648|FG007|Treatment Period 1|Protocol Violation|6|||
94644594|NCT05627518|324159641|FG000|Treatment Period 2|Adverse Event|1|||
94644595|NCT05627518|324159642|FG001|Treatment Period 2|Adverse Event|0|||
94644596|NCT05627518|324159643|FG002|Treatment Period 2|Adverse Event|0|||
94644597|NCT05627518|324159644|FG003|Treatment Period 2|Adverse Event|0|||
94644598|NCT05627518|324159645|FG004|Treatment Period 2|Adverse Event|0|||
94644599|NCT05627518|324159646|FG005|Treatment Period 2|Adverse Event|0|||
94644600|NCT05627518|324159647|FG006|Treatment Period 2|Adverse Event|0|||
94644601|NCT05627518|324159648|FG007|Treatment Period 2|Adverse Event|0|||
94644602|NCT05627518|324159641|FG000|Treatment Period 2|Withdrawal by Subject|1|||
94644603|NCT05627518|324159642|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94644604|NCT05627518|324159643|FG002|Treatment Period 2|Withdrawal by Subject|0|||
94644605|NCT05627518|324159644|FG003|Treatment Period 2|Withdrawal by Subject|0|||
94644606|NCT05627518|324159645|FG004|Treatment Period 2|Withdrawal by Subject|0|||
94644607|NCT05627518|324159646|FG005|Treatment Period 2|Withdrawal by Subject|0|||
94644608|NCT05627518|324159647|FG006|Treatment Period 2|Withdrawal by Subject|0|||
94644609|NCT05627518|324159648|FG007|Treatment Period 2|Withdrawal by Subject|0|||
94644610|NCT02777125|324159652|FG000|Overall Study|Consent form violation|14|||
94644611|NCT02777125|324159653|FG001|Overall Study|Consent form violation|12|||
94644612|NCT02777125|324159652|FG000|Overall Study|Assent form violation|21|||
94644613|NCT02777125|324159653|FG001|Overall Study|Assent form violation|23|||
94644614|NCT02777125|324159652|FG000|Overall Study|Protocol Violation|8|||
94644615|NCT02777125|324159653|FG001|Overall Study|Protocol Violation|12|||
94644616|NCT03256552|324161823|FG000|Overall Study|Protocol Violation|1|||
94644617|NCT03256552|324161823|FG000|Overall Study|Physician Decision|1|||
94644618|NCT03256552|324161823|FG000|Overall Study|Adverse Event|1|||
94644619|NCT03256552|324161823|FG000|Overall Study|Withdrawal by Subject|2|||
94644620|NCT01914666|324161824|FG000|Treatment Period|Lack of Efficacy|0|||
94644621|NCT01914666|324161825|FG001|Treatment Period|Lack of Efficacy|0|||
94644622|NCT01914666|324161826|FG002|Treatment Period|Lack of Efficacy|2|||
94644623|NCT01914666|324161824|FG000|Treatment Period|Adverse Event|10|||
94644624|NCT01914666|324161825|FG001|Treatment Period|Adverse Event|4|||
94644625|NCT01914666|324161826|FG002|Treatment Period|Adverse Event|2|||
94644626|NCT01914666|324161824|FG000|Treatment Period|Withdrawal by Subject|3|||
94644627|NCT01914666|324161825|FG001|Treatment Period|Withdrawal by Subject|2|||
94644628|NCT01914666|324161826|FG002|Treatment Period|Withdrawal by Subject|2|||
94644629|NCT01914666|324161824|FG000|Treatment Period|Physician Decision|0|||
94644630|NCT01914666|324161825|FG001|Treatment Period|Physician Decision|0|||
94644631|NCT01914666|324161826|FG002|Treatment Period|Physician Decision|2|||
94644632|NCT03252522|324161827|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
94644633|NCT03252522|324161828|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
94644634|NCT03252522|324161829|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
94644635|NCT03252522|324161827|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
94644636|NCT03252522|324161828|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
94644637|NCT03252522|324161829|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
94644638|NCT03252522|324161827|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
94679596|NCT00246337|324282306|FG003|Overall Study|Lack of Qualifying Event|1|||
94679597|NCT00246337|324282307|FG004|Overall Study|Lack of Qualifying Event|1|||
94644639|NCT03252522|324161828|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
94644640|NCT03252522|324161829|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
94644641|NCT03252522|324161827|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
94644642|NCT03252522|324161828|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
94644643|NCT03252522|324161829|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
94644644|NCT03252522|324161827|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
94644645|NCT03252522|324161828|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
94644646|NCT03252522|324161829|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
94644647|NCT03252522|324161827|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
94679598|NCT00246337|324282308|FG005|Overall Study|Lack of Qualifying Event|3|||
94679599|NCT00246337|324282309|FG006|Overall Study|Lack of Qualifying Event|3|||
94679600|NCT00246337|324282310|FG007|Overall Study|Lack of Qualifying Event|2|||
94644648|NCT03252522|324161828|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
94644649|NCT03252522|324161829|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
94644650|NCT03252522|324161827|FG000|Phase 2: Open Label|Adverse Event|0|||
94679601|NCT00246337|324282311|FG008|Overall Study|Lack of Qualifying Event|5|||
94679602|NCT00246337|324282303|FG000|Overall Study|Site Terminated|10|||
94679603|NCT00246337|324282304|FG001|Overall Study|Site Terminated|0|||
94679604|NCT00246337|324282305|FG002|Overall Study|Site Terminated|0|||
94679605|NCT00246337|324282306|FG003|Overall Study|Site Terminated|0|||
94679606|NCT00246337|324282307|FG004|Overall Study|Site Terminated|0|||
94644651|NCT03252522|324161828|FG001|Phase 2: Open Label|Adverse Event|0|||
94644652|NCT03252522|324161829|FG002|Phase 2: Open Label|Adverse Event|2|||
94679607|NCT00246337|324282308|FG005|Overall Study|Site Terminated|7|||
94679608|NCT00246337|324282309|FG006|Overall Study|Site Terminated|1|||
94679609|NCT00246337|324282310|FG007|Overall Study|Site Terminated|6|||
94679610|NCT00246337|324282311|FG008|Overall Study|Site Terminated|2|||
94644653|NCT03252522|324161827|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
94644654|NCT03252522|324161828|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
94644655|NCT03252522|324161829|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
94644656|NCT03026257|324161836|FG000|Overall Study|Adverse Event|3|||
94644657|NCT03026257|324161837|FG001|Overall Study|Adverse Event|0|||
94644658|NCT03026257|324161838|FG002|Overall Study|Adverse Event|0|||
94644659|NCT03026257|324161839|FG003|Overall Study|Adverse Event|0|||
94644660|NCT03026257|324161840|FG004|Overall Study|Adverse Event|0|||
94644661|NCT03026257|324161841|FG005|Overall Study|Adverse Event|0|||
94644662|NCT03026257|324161836|FG000|Overall Study|Lost to Follow-up|1|||
94644663|NCT03026257|324161837|FG001|Overall Study|Lost to Follow-up|0|||
94644664|NCT03026257|324161838|FG002|Overall Study|Lost to Follow-up|0|||
94644665|NCT03026257|324161839|FG003|Overall Study|Lost to Follow-up|0|||
94644666|NCT03026257|324161840|FG004|Overall Study|Lost to Follow-up|0|||
94644667|NCT03026257|324161841|FG005|Overall Study|Lost to Follow-up|0|||
94644668|NCT03026257|324161836|FG000|Overall Study|Protocol Violation|1|||
94644669|NCT03026257|324161837|FG001|Overall Study|Protocol Violation|0|||
94644670|NCT03026257|324161838|FG002|Overall Study|Protocol Violation|0|||
94644671|NCT03026257|324161839|FG003|Overall Study|Protocol Violation|1|||
94644672|NCT03026257|324161840|FG004|Overall Study|Protocol Violation|1|||
94644673|NCT03026257|324161841|FG005|Overall Study|Protocol Violation|0|||
94644674|NCT03026257|324161836|FG000|Overall Study|Withdrawal by Subject|1|||
94644675|NCT03026257|324161837|FG001|Overall Study|Withdrawal by Subject|1|||
94644676|NCT03026257|324161838|FG002|Overall Study|Withdrawal by Subject|0|||
94644677|NCT03026257|324161839|FG003|Overall Study|Withdrawal by Subject|0|||
94644678|NCT03026257|324161840|FG004|Overall Study|Withdrawal by Subject|0|||
94644679|NCT03026257|324161841|FG005|Overall Study|Withdrawal by Subject|0|||
94644680|NCT02181556|324161842|FG000|Overall Study|Withdrawal by Subject|1|||
94644681|NCT04380857|324161843|FG000|Overall Study|Lost to Follow-up|3|||
94644682|NCT04380857|324161844|FG001|Overall Study|Lost to Follow-up|3|||
94644683|NCT01940120|324161847|FG000|Overall Study|Death|40|||
94644684|NCT01940120|324161847|FG000|Overall Study|Withdrawal by Subject|8|||
94644685|NCT01888497|324161848|FG000|Washout Period 1|Withdrawal by Subject|0|||
94644686|NCT01888497|324161849|FG001|Washout Period 1|Withdrawal by Subject|0|||
94644687|NCT01888497|324161850|FG002|Washout Period 1|Withdrawal by Subject|1|||
94644688|NCT01888497|324161851|FG003|Washout Period 1|Withdrawal by Subject|1|||
94644689|NCT01888497|324161848|FG000|Washout Period 2|Adverse Event|0|||
94644690|NCT01888497|324161849|FG001|Washout Period 2|Adverse Event|0|||
94644691|NCT01888497|324161850|FG002|Washout Period 2|Adverse Event|0|||
94644692|NCT01888497|324161851|FG003|Washout Period 2|Adverse Event|1|||
94644693|NCT01888497|324161848|FG000|Washout Period 2|Withdrawal by Subject|0|||
94644694|NCT01888497|324161849|FG001|Washout Period 2|Withdrawal by Subject|0|||
94644695|NCT01888497|324161850|FG002|Washout Period 2|Withdrawal by Subject|0|||
94644696|NCT01888497|324161851|FG003|Washout Period 2|Withdrawal by Subject|1|||
94644697|NCT04152447|324161852|FG000|Overall Study|Lost to Follow-up|1|||
94644698|NCT04152447|324161853|FG001|Overall Study|Lost to Follow-up|0|||
94644699|NCT04152447|324161852|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
94644700|NCT04152447|324161853|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
94644701|NCT04152447|324161852|FG000|Overall Study|Withdrawal by Subject|0|||
94644702|NCT04152447|324161853|FG001|Overall Study|Withdrawal by Subject|1|||
94644703|NCT04152447|324161852|FG000|Overall Study|Found ineligible after enrolling|1|||
94644704|NCT04152447|324161853|FG001|Overall Study|Found ineligible after enrolling|1|||
94644705|NCT04152447|324161852|FG000|Overall Study|Did not receive VR headset in time.|0|||
94644706|NCT04152447|324161853|FG001|Overall Study|Did not receive VR headset in time.|2|||
94644707|NCT03240575|324161854|FG000|Overall Study|Adverse Event|0|||
94644708|NCT03240575|324161855|FG001|Overall Study|Adverse Event|2|||
94644709|NCT03240575|324161856|FG002|Overall Study|Adverse Event|0|||
94644710|NCT03240575|324161857|FG003|Overall Study|Adverse Event|1|||
94644711|NCT03240575|324161854|FG000|Overall Study|Withdrawal by Subject|2|||
94644712|NCT03240575|324161855|FG001|Overall Study|Withdrawal by Subject|11|||
94644713|NCT03240575|324161856|FG002|Overall Study|Withdrawal by Subject|0|||
94644714|NCT03240575|324161857|FG003|Overall Study|Withdrawal by Subject|1|||
94644715|NCT03240575|324161854|FG000|Overall Study|Other|0|||
94644716|NCT03240575|324161855|FG001|Overall Study|Other|1|||
94644717|NCT03240575|324161856|FG002|Overall Study|Other|0|||
94644718|NCT03240575|324161857|FG003|Overall Study|Other|0|||
94644719|NCT00394212|324161860|FG000|Overall Study|Lost to Follow-up|3|||
94644720|NCT00394212|324161861|FG001|Overall Study|Lost to Follow-up|0|||
94644721|NCT00394212|324161860|FG000|Overall Study|Withdrawal by Subject|4|||
94644722|NCT00394212|324161861|FG001|Overall Study|Withdrawal by Subject|1|||
94644723|NCT01982253|324161866|FG000|Overall Study|Withdrawal by Subject|1|||
94644724|NCT01982253|324161867|FG001|Overall Study|Withdrawal by Subject|0|||
94644725|NCT01982253|324161868|FG002|Overall Study|Withdrawal by Subject|0|||
94644726|NCT01982253|324161866|FG000|Overall Study|Study terminated by sponsor|1|||
94644727|NCT01982253|324161867|FG001|Overall Study|Study terminated by sponsor|4|||
94644728|NCT01982253|324161868|FG002|Overall Study|Study terminated by sponsor|4|||
94644729|NCT04145895|324161869|FG000|Overall Study|Physician Decision|2|||
94644730|NCT04145895|324161870|FG001|Overall Study|Physician Decision|0|||
94644731|NCT04145895|324161869|FG000|Overall Study|Withdrawal by Subject|0|||
94644732|NCT04145895|324161870|FG001|Overall Study|Withdrawal by Subject|2|||
94644733|NCT00913744|324161871|FG000|Overall Study|Adverse Event|2|||
94644734|NCT00913744|324161872|FG001|Overall Study|Adverse Event|0|||
94644735|NCT00913744|324161871|FG000|Overall Study|Withdrawal by Subject|2|||
94644736|NCT00913744|324161872|FG001|Overall Study|Withdrawal by Subject|1|||
94644737|NCT00913744|324161871|FG000|Overall Study|Death|1|||
94644738|NCT00913744|324161872|FG001|Overall Study|Death|0|||
94644739|NCT00805935|324161873|FG000|Overall Study|Stimulation Failure|1|||
94644740|NCT00805935|324161874|FG001|Overall Study|Stimulation Failure|5|||
94644741|NCT00805935|324161875|FG002|Overall Study|Stimulation Failure|2|||
94644742|NCT00805935|324161876|FG003|Overall Study|Stimulation Failure|2|||
94644743|NCT00805935|324161873|FG000|Overall Study|Cycle cancelled|0|||
94644744|NCT00805935|324161874|FG001|Overall Study|Cycle cancelled|0|||
94644745|NCT00805935|324161875|FG002|Overall Study|Cycle cancelled|2|||
94644746|NCT00805935|324161876|FG003|Overall Study|Cycle cancelled|0|||
94644747|NCT00805935|324161873|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
94644748|NCT00805935|324161874|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
94644749|NCT00805935|324161875|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
94644750|NCT00805935|324161876|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
94644751|NCT00805935|324161873|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
94644752|NCT00805935|324161874|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
94644753|NCT00805935|324161875|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
94644754|NCT00805935|324161876|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
94644755|NCT00805935|324161873|FG000|Overall Study|Lost to Follow-up|1|||
94644756|NCT00805935|324161874|FG001|Overall Study|Lost to Follow-up|0|||
94644757|NCT00805935|324161875|FG002|Overall Study|Lost to Follow-up|0|||
94644758|NCT00805935|324161876|FG003|Overall Study|Lost to Follow-up|0|||
94644759|NCT00805935|324161873|FG000|Overall Study|No positive serum pregnancy|8|||
94644760|NCT00805935|324161874|FG001|Overall Study|No positive serum pregnancy|7|||
94644761|NCT00805935|324161875|FG002|Overall Study|No positive serum pregnancy|6|||
94644762|NCT00805935|324161876|FG003|Overall Study|No positive serum pregnancy|5|||
94644763|NCT00805935|324161873|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
94644764|NCT00805935|324161874|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
94644765|NCT00805935|324161875|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
94644766|NCT00805935|324161876|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
94644767|NCT00805935|324161873|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
94644768|NCT00805935|324161874|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
94644769|NCT00805935|324161875|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
94644770|NCT00805935|324161876|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
94644771|NCT00805935|324161873|FG000|Overall Study|Biochemical pregnancy|0|||
94644772|NCT00805935|324161874|FG001|Overall Study|Biochemical pregnancy|1|||
94644773|NCT00805935|324161875|FG002|Overall Study|Biochemical pregnancy|0|||
94644774|NCT00805935|324161876|FG003|Overall Study|Biochemical pregnancy|0|||
94644775|NCT00805935|324161873|FG000|Overall Study|Chemical pregnancy|0|||
94644776|NCT00805935|324161874|FG001|Overall Study|Chemical pregnancy|5|||
94644777|NCT00805935|324161875|FG002|Overall Study|Chemical pregnancy|3|||
94644778|NCT00805935|324161876|FG003|Overall Study|Chemical pregnancy|2|||
94644779|NCT00805935|324161873|FG000|Overall Study|Ectopic pregnancy|0|||
94644780|NCT00805935|324161874|FG001|Overall Study|Ectopic pregnancy|0|||
94644781|NCT00805935|324161875|FG002|Overall Study|Ectopic pregnancy|1|||
94644782|NCT00805935|324161876|FG003|Overall Study|Ectopic pregnancy|0|||
94644783|NCT00805935|324161873|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
94644784|NCT00805935|324161874|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
94644785|NCT00805935|324161875|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
94644786|NCT00805935|324161876|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
94644787|NCT04200248|324161886|FG000|Overall Study|Personal reasons|0|||
94644788|NCT04200248|324161887|FG001|Overall Study|Personal reasons|0|||
94679611|NCT00246337|324282303|FG000|Overall Study|Abnormal baseline lab values|7|||
94679612|NCT00246337|324282304|FG001|Overall Study|Abnormal baseline lab values|0|||
94679613|NCT00246337|324282305|FG002|Overall Study|Abnormal baseline lab values|2|||
94679614|NCT00246337|324282306|FG003|Overall Study|Abnormal baseline lab values|0|||
94679615|NCT00246337|324282307|FG004|Overall Study|Abnormal baseline lab values|0|||
94679616|NCT00246337|324282308|FG005|Overall Study|Abnormal baseline lab values|2|||
94679617|NCT00246337|324282309|FG006|Overall Study|Abnormal baseline lab values|2|||
94679618|NCT00246337|324282310|FG007|Overall Study|Abnormal baseline lab values|0|||
94679619|NCT00246337|324282311|FG008|Overall Study|Abnormal baseline lab values|4|||
94679620|NCT00246337|324282303|FG000|Overall Study|Overwhelmed|0|||
94679621|NCT00246337|324282304|FG001|Overall Study|Overwhelmed|0|||
94679622|NCT00246337|324282305|FG002|Overall Study|Overwhelmed|0|||
94644789|NCT04200248|324161888|FG002|Overall Study|Personal reasons|1|||
94644790|NCT04200248|324161886|FG000|Overall Study|Discontinued prior to treatment|3|||
94644791|NCT04200248|324161887|FG001|Overall Study|Discontinued prior to treatment|3|||
94644792|NCT04200248|324161888|FG002|Overall Study|Discontinued prior to treatment|2|||
94644793|NCT00418691|324161892|FG000|Overall Study|Lost to Follow-up|1|||
94644794|NCT00418691|324161893|FG001|Overall Study|Lost to Follow-up|2|||
94644795|NCT00418691|324161894|FG002|Overall Study|Lost to Follow-up|3|||
94644796|NCT00418691|324161892|FG000|Overall Study|Started new medication voiding entry|0|||
94644797|NCT00418691|324161893|FG001|Overall Study|Started new medication voiding entry|0|||
94644798|NCT00418691|324161894|FG002|Overall Study|Started new medication voiding entry|1|||
94644799|NCT00418691|324161892|FG000|Overall Study|Progressive Disease|1|||
94644800|NCT00418691|324161893|FG001|Overall Study|Progressive Disease|0|||
94644801|NCT00418691|324161894|FG002|Overall Study|Progressive Disease|1|||
94644802|NCT01802775|324161899|FG000|Overall Study|Death|0|||
94644803|NCT01802775|324161900|FG001|Overall Study|Death|3|||
94644804|NCT01802775|324161899|FG000|Overall Study|Reason not provided|0|||
94644805|NCT01802775|324161900|FG001|Overall Study|Reason not provided|1|||
94644806|NCT01802775|324161899|FG000|Overall Study|Physician Decision|1|||
94644807|NCT01802775|324161900|FG001|Overall Study|Physician Decision|0|||
94644808|NCT01802775|324161899|FG000|Overall Study|Adverse Event|1|||
94644809|NCT01802775|324161900|FG001|Overall Study|Adverse Event|1|||
94644810|NCT01802775|324161899|FG000|Overall Study|Withdrawal by Subject|3|||
94644811|NCT01802775|324161900|FG001|Overall Study|Withdrawal by Subject|5|||
94644812|NCT01802775|324161899|FG000|Overall Study|Lost to Follow-up|1|||
94644813|NCT01802775|324161900|FG001|Overall Study|Lost to Follow-up|2|||
94644814|NCT00782210|324161910|FG000|Overall Study|Adverse Event|21|||
94679623|NCT00246337|324282306|FG003|Overall Study|Overwhelmed|0|||
94679624|NCT00246337|324282307|FG004|Overall Study|Overwhelmed|0|||
94679625|NCT00246337|324282308|FG005|Overall Study|Overwhelmed|1|||
94679626|NCT00246337|324282309|FG006|Overall Study|Overwhelmed|0|||
94679627|NCT00246337|324282310|FG007|Overall Study|Overwhelmed|0|||
94679628|NCT00246337|324282311|FG008|Overall Study|Overwhelmed|0|||
94679629|NCT00246337|324282303|FG000|Overall Study|Protocol Violator|1|||
94679630|NCT00246337|324282304|FG001|Overall Study|Protocol Violator|0|||
94679631|NCT00246337|324282305|FG002|Overall Study|Protocol Violator|0|||
94679632|NCT00246337|324282306|FG003|Overall Study|Protocol Violator|0|||
94679633|NCT00246337|324282307|FG004|Overall Study|Protocol Violator|0|||
94679634|NCT00246337|324282308|FG005|Overall Study|Protocol Violator|0|||
94679635|NCT00246337|324282309|FG006|Overall Study|Protocol Violator|0|||
94679636|NCT00246337|324282310|FG007|Overall Study|Protocol Violator|0|||
94679637|NCT00246337|324282311|FG008|Overall Study|Protocol Violator|0|||
94679638|NCT00246337|324282303|FG000|Overall Study|Reported as completing trial in error|0|||
94679639|NCT00246337|324282304|FG001|Overall Study|Reported as completing trial in error|0|||
94679640|NCT00246337|324282305|FG002|Overall Study|Reported as completing trial in error|0|||
94679641|NCT00246337|324282306|FG003|Overall Study|Reported as completing trial in error|0|||
94679642|NCT00246337|324282307|FG004|Overall Study|Reported as completing trial in error|0|||
94679643|NCT00246337|324282308|FG005|Overall Study|Reported as completing trial in error|0|||
94679644|NCT00246337|324282309|FG006|Overall Study|Reported as completing trial in error|0|||
94679645|NCT00246337|324282310|FG007|Overall Study|Reported as completing trial in error|1|||
94679646|NCT00246337|324282311|FG008|Overall Study|Reported as completing trial in error|0|||
94679647|NCT04176939|324282312|FG000|Overall Study|Adverse Event|7|||
94679648|NCT04176939|324282312|FG000|Overall Study|Unspecified reason|2|||
94679649|NCT04176939|324282312|FG000|Overall Study|Migrated/Moved from the study area|1|||
94679650|NCT04176939|324282312|FG000|Overall Study|Withdrawal by Subject|4|||
94679651|NCT04176939|324282312|FG000|Overall Study|In follow-up|54|||
94679652|NCT03633929|324282315|FG000|Overall Study|Lost to Follow-up|1|||
94679653|NCT03633929|324282315|FG000|Overall Study|Did not login to software. Did not participate|3|||
94679654|NCT04461795|324282316|FG000|Overall Study|Lost to Follow-up|2|||
94679655|NCT04461795|324282316|FG000|Overall Study|Withdrawal by Subject|2|||
94679656|NCT04461795|324282316|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
94679657|NCT00058422|324282317|FG000|Overall Study|Not treated|2|||
94679658|NCT00106184|324282318|FG000|Overall Study|Withdrawal by Subject|3|||
94679659|NCT00106184|324282319|FG001|Overall Study|Withdrawal by Subject|2|||
94679660|NCT01492686|324282323|FG000|Double-blind Phase|Adverse Event|0|||
94679661|NCT01492686|324282324|FG001|Double-blind Phase|Adverse Event|2|||
94679662|NCT01492686|324282323|FG000|Double-blind Phase|Physician Decision|0|||
94679663|NCT01492686|324282324|FG001|Double-blind Phase|Physician Decision|1|||
94679664|NCT01492686|324282323|FG000|Double-blind Phase|Withdrawal by Subject|0|||
94679665|NCT01492686|324282324|FG001|Double-blind Phase|Withdrawal by Subject|2|||
94679666|NCT01492686|324282323|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
94679667|NCT01492686|324282324|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
94679668|NCT01492686|324282323|FG000|Open-label Phase|Adverse Event|1|||
94679669|NCT01492686|324282324|FG001|Open-label Phase|Adverse Event|2|||
94679670|NCT01492686|324282323|FG000|Open-label Phase|Physician Decision|1|||
94644815|NCT00782210|324161911|FG001|Overall Study|Adverse Event|17|||
94644816|NCT00782210|324161912|FG002|Overall Study|Adverse Event|16|||
94644817|NCT00782210|324161910|FG000|Overall Study|Lost to Follow-up|2|||
94644818|NCT00782210|324161911|FG001|Overall Study|Lost to Follow-up|1|||
94644819|NCT00782210|324161912|FG002|Overall Study|Lost to Follow-up|2|||
94644820|NCT00782210|324161910|FG000|Overall Study|Withdrawal by Subject|11|||
94644821|NCT00782210|324161911|FG001|Overall Study|Withdrawal by Subject|8|||
94644822|NCT00782210|324161912|FG002|Overall Study|Withdrawal by Subject|11|||
94463455|NCT02520427|323485066|FG009|Overall Study|Withdrawal by Subject|0|||
94644823|NCT00782210|324161910|FG000|Overall Study|Non compliance with protocol|0|||
94644824|NCT00782210|324161911|FG001|Overall Study|Non compliance with protocol|3|||
94644825|NCT00782210|324161912|FG002|Overall Study|Non compliance with protocol|2|||
94679671|NCT01492686|324282324|FG001|Open-label Phase|Physician Decision|0|||
94644826|NCT00782210|324161910|FG000|Overall Study|Lack of Efficacy|13|||
94644827|NCT00782210|324161911|FG001|Overall Study|Lack of Efficacy|4|||
94679672|NCT01492686|324282323|FG000|Open-label Phase|Withdrawal by Subject|6|||
94679673|NCT01492686|324282324|FG001|Open-label Phase|Withdrawal by Subject|7|||
94679674|NCT01492686|324282323|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
94679675|NCT01492686|324282324|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
94679676|NCT05292534|324282325|FG000|Overall Study|Protocol Violation|3|||
94679677|NCT05292534|324282326|FG001|Overall Study|Protocol Violation|4|||
94644828|NCT00782210|324161912|FG002|Overall Study|Lack of Efficacy|1|||
94644829|NCT00782210|324161910|FG000|Overall Study|Other reason not described above|3|||
94644830|NCT00782210|324161911|FG001|Overall Study|Other reason not described above|2|||
94644831|NCT00782210|324161912|FG002|Overall Study|Other reason not described above|3|||
94644832|NCT00654381|324161917|FG000|1st Stage|Adverse Event|3|||
94644833|NCT00654381|324161918|FG001|1st Stage|Adverse Event|3|||
94644834|NCT00654381|324161919|FG002|1st Stage|Adverse Event|3|||
94644835|NCT00654381|324161920|FG003|1st Stage|Adverse Event|3|||
94644836|NCT00654381|324161921|FG004|1st Stage|Adverse Event|2|||
94644837|NCT00654381|324161922|FG005|1st Stage|Adverse Event|1|||
94644838|NCT00654381|324161917|FG000|1st Stage|Withdrawal by Subject|0|||
94644839|NCT00654381|324161918|FG001|1st Stage|Withdrawal by Subject|0|||
94644840|NCT00654381|324161919|FG002|1st Stage|Withdrawal by Subject|0|||
94644841|NCT00654381|324161920|FG003|1st Stage|Withdrawal by Subject|1|||
94644842|NCT00654381|324161921|FG004|1st Stage|Withdrawal by Subject|0|||
94644843|NCT00654381|324161922|FG005|1st Stage|Withdrawal by Subject|1|||
94644844|NCT00654381|324161917|FG000|1st Stage|Investigator's decision|0|||
94644845|NCT00654381|324161918|FG001|1st Stage|Investigator's decision|0|||
94644846|NCT00654381|324161919|FG002|1st Stage|Investigator's decision|0|||
94644847|NCT00654381|324161920|FG003|1st Stage|Investigator's decision|1|||
94644848|NCT00654381|324161921|FG004|1st Stage|Investigator's decision|0|||
94644849|NCT00654381|324161922|FG005|1st Stage|Investigator's decision|0|||
94644850|NCT00654381|324161917|FG000|2nd Stage|Adverse Event|2|||
94644851|NCT00654381|324161918|FG001|2nd Stage|Adverse Event|0|||
94644852|NCT00654381|324161919|FG002|2nd Stage|Adverse Event|2|||
94644853|NCT00654381|324161920|FG003|2nd Stage|Adverse Event|3|||
94644854|NCT00654381|324161921|FG004|2nd Stage|Adverse Event|7|||
94644855|NCT00654381|324161922|FG005|2nd Stage|Adverse Event|2|||
94644856|NCT00654381|324161917|FG000|2nd Stage|Withdrawal by Subject|0|||
94644857|NCT00654381|324161918|FG001|2nd Stage|Withdrawal by Subject|0|||
94644858|NCT00654381|324161919|FG002|2nd Stage|Withdrawal by Subject|0|||
94644859|NCT00654381|324161920|FG003|2nd Stage|Withdrawal by Subject|0|||
94644860|NCT00654381|324161921|FG004|2nd Stage|Withdrawal by Subject|1|||
94644861|NCT00654381|324161922|FG005|2nd Stage|Withdrawal by Subject|1|||
94644862|NCT00654381|324161917|FG000|2nd Stage|Investigator's decision|0|||
94644863|NCT00654381|324161918|FG001|2nd Stage|Investigator's decision|0|||
94644864|NCT00654381|324161919|FG002|2nd Stage|Investigator's decision|1|||
94644865|NCT00654381|324161920|FG003|2nd Stage|Investigator's decision|1|||
94644866|NCT00654381|324161921|FG004|2nd Stage|Investigator's decision|0|||
94644867|NCT00654381|324161922|FG005|2nd Stage|Investigator's decision|0|||
94644868|NCT00654381|324161917|FG000|Extension Stage|Adverse Event|1|||
94644869|NCT00654381|324161918|FG001|Extension Stage|Adverse Event|2|||
94644870|NCT00654381|324161919|FG002|Extension Stage|Adverse Event|9|||
94644871|NCT00654381|324161920|FG003|Extension Stage|Adverse Event|7|||
94644872|NCT00654381|324161921|FG004|Extension Stage|Adverse Event|1|||
94644873|NCT00654381|324161922|FG005|Extension Stage|Adverse Event|1|||
94644874|NCT00654381|324161917|FG000|Extension Stage|Protocol Violation|0|||
94644875|NCT00654381|324161918|FG001|Extension Stage|Protocol Violation|0|||
94644876|NCT00654381|324161919|FG002|Extension Stage|Protocol Violation|0|||
94644877|NCT00654381|324161920|FG003|Extension Stage|Protocol Violation|1|||
94644878|NCT00654381|324161921|FG004|Extension Stage|Protocol Violation|0|||
94644879|NCT00654381|324161922|FG005|Extension Stage|Protocol Violation|0|||
94644880|NCT00654381|324161917|FG000|Extension Stage|Lack of Efficacy|0|||
94644881|NCT00654381|324161918|FG001|Extension Stage|Lack of Efficacy|0|||
94644882|NCT00654381|324161919|FG002|Extension Stage|Lack of Efficacy|1|||
94644883|NCT00654381|324161920|FG003|Extension Stage|Lack of Efficacy|0|||
94644884|NCT00654381|324161921|FG004|Extension Stage|Lack of Efficacy|0|||
94644885|NCT00654381|324161922|FG005|Extension Stage|Lack of Efficacy|0|||
94644886|NCT00654381|324161917|FG000|Extension Stage|Withdrawal by Subject|0|||
94644887|NCT00654381|324161918|FG001|Extension Stage|Withdrawal by Subject|0|||
94644888|NCT00654381|324161919|FG002|Extension Stage|Withdrawal by Subject|1|||
94644889|NCT00654381|324161920|FG003|Extension Stage|Withdrawal by Subject|1|||
94644890|NCT00654381|324161921|FG004|Extension Stage|Withdrawal by Subject|1|||
94644891|NCT00654381|324161922|FG005|Extension Stage|Withdrawal by Subject|1|||
94644892|NCT00654381|324161917|FG000|Extension Stage|Closure of the trial site|0|||
94263616|NCT01990534|322759862|FG000|Overall Study|Lost to Follow-up|1|||
94644893|NCT00654381|324161918|FG001|Extension Stage|Closure of the trial site|0|||
94644894|NCT00654381|324161919|FG002|Extension Stage|Closure of the trial site|0|||
94644895|NCT00654381|324161920|FG003|Extension Stage|Closure of the trial site|0|||
94644896|NCT00654381|324161921|FG004|Extension Stage|Closure of the trial site|1|||
94644897|NCT00654381|324161922|FG005|Extension Stage|Closure of the trial site|1|||
94644898|NCT03100825|324161923|FG000|Overall Study|Participant/Guardian Decision|7|||
94644899|NCT03100825|324161923|FG000|Overall Study|Physician Decision|1|||
94644900|NCT01675882|324161931|FG000|Overall Study|Adverse Event|0|||
94644901|NCT01675882|324161932|FG001|Overall Study|Adverse Event|2|||
94644902|NCT01675882|324161933|FG002|Overall Study|Adverse Event|1|||
94644903|NCT01675882|324161934|FG003|Overall Study|Adverse Event|0|||
94644904|NCT01675882|324161931|FG000|Overall Study|Participant unwilling to continue|2|||
94644905|NCT01675882|324161932|FG001|Overall Study|Participant unwilling to continue|4|||
94679678|NCT05292534|324282325|FG000|Overall Study|Withdrawal by Subject|0|||
94679679|NCT05292534|324282326|FG001|Overall Study|Withdrawal by Subject|1|||
94679680|NCT04887948|324282327|FG000|Overall Study|Death|1|||
94679681|NCT04887948|324282328|FG001|Overall Study|Death|0|||
94679682|NCT04887948|324282329|FG002|Overall Study|Death|0|||
94679683|NCT04887948|324282327|FG000|Overall Study|Lost to Follow-up|1|||
94679684|NCT04887948|324282328|FG001|Overall Study|Lost to Follow-up|0|||
94679685|NCT04887948|324282329|FG002|Overall Study|Lost to Follow-up|3|||
94679686|NCT04887948|324282327|FG000|Overall Study|Physician Decision|0|||
94679687|NCT04887948|324282328|FG001|Overall Study|Physician Decision|4|||
94679688|NCT04887948|324282329|FG002|Overall Study|Physician Decision|1|||
94679689|NCT04887948|324282327|FG000|Overall Study|Protocol Violation|1|||
94679690|NCT04887948|324282328|FG001|Overall Study|Protocol Violation|1|||
94679691|NCT04887948|324282329|FG002|Overall Study|Protocol Violation|0|||
94679692|NCT04887948|324282327|FG000|Overall Study|Withdrawal by Subject|0|||
94679693|NCT04887948|324282328|FG001|Overall Study|Withdrawal by Subject|6|||
94679694|NCT04887948|324282329|FG002|Overall Study|Withdrawal by Subject|1|||
94679695|NCT04887948|324282327|FG000|Overall Study|No longer met eligibility criteria|1|||
94679696|NCT04887948|324282328|FG001|Overall Study|No longer met eligibility criteria|2|||
94679697|NCT04887948|324282329|FG002|Overall Study|No longer met eligibility criteria|1|||
94679698|NCT04887948|324282327|FG000|Overall Study|Other|2|||
94679699|NCT04887948|324282328|FG001|Overall Study|Other|1|||
94679700|NCT04887948|324282329|FG002|Overall Study|Other|1|||
94679701|NCT01782872|324282330|FG000|Overall Study|Protocol Violation|0|||
94679702|NCT01782872|324282331|FG001|Overall Study|Protocol Violation|0|||
94679703|NCT01782872|324282332|FG002|Overall Study|Protocol Violation|0|||
94679704|NCT01782872|324282333|FG003|Overall Study|Protocol Violation|1|||
94679705|NCT01782872|324282330|FG000|Overall Study|Withdrawal by Subject|0|||
94679706|NCT01782872|324282331|FG001|Overall Study|Withdrawal by Subject|1|||
94679707|NCT01782872|324282332|FG002|Overall Study|Withdrawal by Subject|0|||
94679708|NCT01782872|324282333|FG003|Overall Study|Withdrawal by Subject|0|||
94679709|NCT00659984|324282334|FG000|Overall Study|Adverse Event|1|||
94679710|NCT02228395|324282335|FG000|First Intervention Period|No longer willing to participate|1|||
94679711|NCT02228395|324282336|FG001|First Intervention Period|No longer willing to participate|0|||
94679712|NCT02228395|324282337|FG002|First Intervention Period|No longer willing to participate|0|||
94679713|NCT02228395|324282335|FG000|First Intervention Period|Unable to comply with study dates|0|||
94679714|NCT02228395|324282336|FG001|First Intervention Period|Unable to comply with study dates|1|||
94679715|NCT02228395|324282337|FG002|First Intervention Period|Unable to comply with study dates|1|||
94679716|NCT02487810|324282343|FG000|Overall Study|Withdrawal by Subject|1|||
94679717|NCT02487810|324282344|FG001|Overall Study|Withdrawal by Subject|0|||
94679718|NCT02569437|324282350|FG000|Overall Study|Lost to Follow-up|12|||
94679719|NCT02569437|324282351|FG001|Overall Study|Lost to Follow-up|14|||
94679720|NCT00441701|324282352|FG000|Overall Study|Adverse Event|3|||
94679721|NCT00441701|324282353|FG001|Overall Study|Adverse Event|2|||
94679722|NCT00441701|324282354|FG002|Overall Study|Adverse Event|1|||
94679723|NCT00441701|324282355|FG003|Overall Study|Adverse Event|0|||
94679724|NCT00441701|324282356|FG004|Overall Study|Adverse Event|2|||
94679725|NCT00441701|324282357|FG005|Overall Study|Adverse Event|2|||
94679726|NCT00441701|324282358|FG006|Overall Study|Adverse Event|0|||
94679727|NCT00441701|324282359|FG007|Overall Study|Adverse Event|0|||
94679728|NCT00441701|324282360|FG008|Overall Study|Adverse Event|0|||
94679729|NCT00441701|324282361|FG009|Overall Study|Adverse Event|0|||
94679730|NCT00441701|324282352|FG000|Overall Study|Lack of Efficacy|2|||
94679731|NCT00441701|324282353|FG001|Overall Study|Lack of Efficacy|0|||
94679732|NCT00441701|324282354|FG002|Overall Study|Lack of Efficacy|2|||
94679733|NCT00441701|324282355|FG003|Overall Study|Lack of Efficacy|2|||
94679734|NCT00441701|324282356|FG004|Overall Study|Lack of Efficacy|0|||
94679735|NCT00441701|324282357|FG005|Overall Study|Lack of Efficacy|1|||
94679736|NCT00441701|324282358|FG006|Overall Study|Lack of Efficacy|0|||
94679737|NCT00441701|324282359|FG007|Overall Study|Lack of Efficacy|0|||
94679738|NCT00441701|324282360|FG008|Overall Study|Lack of Efficacy|0|||
94679739|NCT00441701|324282361|FG009|Overall Study|Lack of Efficacy|0|||
94679740|NCT00441701|324282352|FG000|Overall Study|Withdrawal by Subject|0|||
94263617|NCT00907257|322759863|FG000|Overall Study|Adverse Event|0|||
94679741|NCT00441701|324282353|FG001|Overall Study|Withdrawal by Subject|2|||
94679742|NCT00441701|324282354|FG002|Overall Study|Withdrawal by Subject|1|||
94679743|NCT00441701|324282355|FG003|Overall Study|Withdrawal by Subject|1|||
94679744|NCT00441701|324282356|FG004|Overall Study|Withdrawal by Subject|0|||
94679745|NCT00441701|324282357|FG005|Overall Study|Withdrawal by Subject|0|||
94679746|NCT00441701|324282358|FG006|Overall Study|Withdrawal by Subject|0|||
94679747|NCT00441701|324282359|FG007|Overall Study|Withdrawal by Subject|0|||
94679748|NCT00441701|324282360|FG008|Overall Study|Withdrawal by Subject|0|||
94679749|NCT00441701|324282361|FG009|Overall Study|Withdrawal by Subject|0|||
94679750|NCT04710927|324282362|FG000|Overall Study|Lost to Follow-up|7|||
94679751|NCT04710927|324282363|FG001|Overall Study|Lost to Follow-up|6|||
94679752|NCT04710927|324282364|FG002|Overall Study|Lost to Follow-up|5|||
94679753|NCT00985985|324282365|FG000|Overall Study|Adverse Event|4|||
94679754|NCT00985985|324282366|FG001|Overall Study|Adverse Event|2|||
94679755|NCT00985985|324282367|FG002|Overall Study|Adverse Event|2|||
94679756|NCT00985985|324282368|FG003|Overall Study|Adverse Event|2|||
94679757|NCT00985985|324282365|FG000|Overall Study|Lost to Follow-up|4|||
94679758|NCT00985985|324282366|FG001|Overall Study|Lost to Follow-up|11|||
94679759|NCT00985985|324282367|FG002|Overall Study|Lost to Follow-up|2|||
94679760|NCT00985985|324282368|FG003|Overall Study|Lost to Follow-up|3|||
94679761|NCT00985985|324282365|FG000|Overall Study|Protocol Violation|1|||
94679762|NCT00985985|324282366|FG001|Overall Study|Protocol Violation|2|||
94679763|NCT00985985|324282367|FG002|Overall Study|Protocol Violation|0|||
94679764|NCT00985985|324282368|FG003|Overall Study|Protocol Violation|1|||
94679765|NCT00985985|324282365|FG000|Overall Study|Lack of Efficacy|5|||
94679766|NCT00985985|324282366|FG001|Overall Study|Lack of Efficacy|6|||
94679767|NCT00985985|324282367|FG002|Overall Study|Lack of Efficacy|1|||
94679768|NCT00985985|324282368|FG003|Overall Study|Lack of Efficacy|3|||
94679769|NCT00985985|324282365|FG000|Overall Study|Withdrawal by Subject|4|||
94679770|NCT00985985|324282366|FG001|Overall Study|Withdrawal by Subject|2|||
94679771|NCT00985985|324282367|FG002|Overall Study|Withdrawal by Subject|2|||
94679772|NCT00985985|324282368|FG003|Overall Study|Withdrawal by Subject|2|||
94679773|NCT00985985|324282365|FG000|Overall Study|Other Reason|6|||
94679774|NCT00985985|324282366|FG001|Overall Study|Other Reason|1|||
94679775|NCT00985985|324282367|FG002|Overall Study|Other Reason|4|||
94679776|NCT00985985|324282368|FG003|Overall Study|Other Reason|2|||
94679777|NCT02192970|324282371|FG000|Overall Study|Lost to Follow-up|6|||
94679778|NCT02192970|324282372|FG001|Overall Study|Lost to Follow-up|0|||
94679779|NCT01364597|324282373|FG000|Overall Study|Adverse Event|4|||
94679780|NCT01364597|324282374|FG001|Overall Study|Adverse Event|5|||
94679781|NCT01364597|324282375|FG002|Overall Study|Adverse Event|16|||
94679782|NCT01364597|324282376|FG003|Overall Study|Adverse Event|7|||
94679783|NCT01364597|324282373|FG000|Overall Study|Lack of Efficacy|4|||
94679784|NCT01364597|324282374|FG001|Overall Study|Lack of Efficacy|4|||
94679785|NCT01364597|324282375|FG002|Overall Study|Lack of Efficacy|23|||
94679786|NCT01364597|324282376|FG003|Overall Study|Lack of Efficacy|8|||
94679787|NCT01364597|324282373|FG000|Overall Study|Protocol Violation|0|||
94679788|NCT01364597|324282374|FG001|Overall Study|Protocol Violation|0|||
94679789|NCT01364597|324282375|FG002|Overall Study|Protocol Violation|2|||
94679790|NCT01364597|324282376|FG003|Overall Study|Protocol Violation|0|||
94679791|NCT01364597|324282373|FG000|Overall Study|Lost to Follow-up|0|||
94679792|NCT01364597|324282374|FG001|Overall Study|Lost to Follow-up|0|||
94679793|NCT01364597|324282375|FG002|Overall Study|Lost to Follow-up|5|||
94679794|NCT01364597|324282376|FG003|Overall Study|Lost to Follow-up|3|||
94679795|NCT01364597|324282373|FG000|Overall Study|Withdrawal by Subject|4|||
94679796|NCT01364597|324282374|FG001|Overall Study|Withdrawal by Subject|1|||
94679797|NCT01364597|324282375|FG002|Overall Study|Withdrawal by Subject|18|||
94263618|NCT00907257|322759864|FG001|Overall Study|Adverse Event|4|||
94263619|NCT00907257|322759863|FG000|Overall Study|Protocol Violation|1|||
94644906|NCT01675882|324161933|FG002|Overall Study|Participant unwilling to continue|2|||
94644907|NCT01675882|324161934|FG003|Overall Study|Participant unwilling to continue|1|||
94644908|NCT01675882|324161931|FG000|Overall Study|Lost to Follow-up|0|||
94644909|NCT01675882|324161932|FG001|Overall Study|Lost to Follow-up|1|||
94644910|NCT01675882|324161933|FG002|Overall Study|Lost to Follow-up|0|||
94644911|NCT01675882|324161934|FG003|Overall Study|Lost to Follow-up|0|||
94644912|NCT01675882|324161931|FG000|Overall Study|Non-compliance|0|||
94644913|NCT01675882|324161932|FG001|Overall Study|Non-compliance|0|||
94644914|NCT01675882|324161933|FG002|Overall Study|Non-compliance|0|||
94679798|NCT01364597|324282376|FG003|Overall Study|Withdrawal by Subject|6|||
94679799|NCT01364597|324282373|FG000|Overall Study|Non compliance|1|||
94679800|NCT01364597|324282374|FG001|Overall Study|Non compliance|0|||
94263620|NCT00907257|322759864|FG001|Overall Study|Protocol Violation|2|||
94679801|NCT01364597|324282375|FG002|Overall Study|Non compliance|1|||
94679802|NCT01364597|324282376|FG003|Overall Study|Non compliance|0|||
94263621|NCT00907257|322759863|FG000|Overall Study|Lost to Follow-up|3|||
94263622|NCT00907257|322759864|FG001|Overall Study|Lost to Follow-up|3|||
94679803|NCT01364597|324282373|FG000|Overall Study|Lack of compliance|1|||
94679804|NCT01364597|324282374|FG001|Overall Study|Lack of compliance|0|||
94679805|NCT01364597|324282375|FG002|Overall Study|Lack of compliance|0|||
94679806|NCT01364597|324282376|FG003|Overall Study|Lack of compliance|0|||
94679807|NCT01364597|324282373|FG000|Overall Study|End of treatment epilepsy|1|||
94679808|NCT01364597|324282374|FG001|Overall Study|End of treatment epilepsy|0|||
94644915|NCT01675882|324161934|FG003|Overall Study|Non-compliance|1|||
94644916|NCT00735371|324161938|FG000|Overall Study|Adverse Event|3|||
94679809|NCT01364597|324282375|FG002|Overall Study|End of treatment epilepsy|0|||
94679810|NCT01364597|324282376|FG003|Overall Study|End of treatment epilepsy|0|||
94679811|NCT01364597|324282373|FG000|Overall Study|No Seizures|1|||
94679812|NCT01364597|324282374|FG001|Overall Study|No Seizures|0|||
94679813|NCT01364597|324282375|FG002|Overall Study|No Seizures|0|||
94679814|NCT01364597|324282376|FG003|Overall Study|No Seizures|0|||
94679815|NCT01364597|324282373|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
94679816|NCT01364597|324282374|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
94679817|NCT01364597|324282375|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
94679818|NCT01364597|324282376|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
94679819|NCT01364597|324282373|FG000|Overall Study|Cure|1|||
94679820|NCT01364597|324282374|FG001|Overall Study|Cure|0|||
94679821|NCT01364597|324282375|FG002|Overall Study|Cure|0|||
94679822|NCT01364597|324282376|FG003|Overall Study|Cure|0|||
94679823|NCT01364597|324282373|FG000|Overall Study|Patient was moving|0|||
94679824|NCT01364597|324282374|FG001|Overall Study|Patient was moving|1|||
94679825|NCT01364597|324282375|FG002|Overall Study|Patient was moving|0|||
94679826|NCT01364597|324282376|FG003|Overall Study|Patient was moving|0|||
94679827|NCT01364597|324282373|FG000|Overall Study|Seizures resolved|0|||
94679828|NCT01364597|324282374|FG001|Overall Study|Seizures resolved|0|||
94679829|NCT01364597|324282375|FG002|Overall Study|Seizures resolved|1|||
94679830|NCT01364597|324282376|FG003|Overall Study|Seizures resolved|0|||
94679831|NCT01364597|324282373|FG000|Overall Study|Patient became seizure-free after surgery|0|||
94679832|NCT01364597|324282374|FG001|Overall Study|Patient became seizure-free after surgery|0|||
94679833|NCT01364597|324282375|FG002|Overall Study|Patient became seizure-free after surgery|1|||
94679834|NCT01364597|324282376|FG003|Overall Study|Patient became seizure-free after surgery|0|||
94679835|NCT01364597|324282373|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
94679836|NCT01364597|324282374|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
94679837|NCT01364597|324282375|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
94679838|NCT01364597|324282376|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
94679839|NCT01364597|324282373|FG000|Overall Study|Patient cured from Epilepsy|0|||
94679840|NCT01364597|324282374|FG001|Overall Study|Patient cured from Epilepsy|0|||
94679841|NCT01364597|324282375|FG002|Overall Study|Patient cured from Epilepsy|1|||
94679842|NCT01364597|324282376|FG003|Overall Study|Patient cured from Epilepsy|0|||
94679843|NCT01364597|324282373|FG000|Overall Study|Investigator decision|0|||
94679844|NCT01364597|324282374|FG001|Overall Study|Investigator decision|0|||
94679845|NCT01364597|324282375|FG002|Overall Study|Investigator decision|1|||
94679846|NCT01364597|324282376|FG003|Overall Study|Investigator decision|0|||
94679847|NCT01364597|324282373|FG000|Overall Study|Sponsor recommended discontinuation|0|||
94644917|NCT00735371|324161939|FG001|Overall Study|Adverse Event|3|||
94644918|NCT00735371|324161940|FG002|Overall Study|Adverse Event|4|||
94644919|NCT00735371|324161941|FG003|Overall Study|Adverse Event|1|||
94644920|NCT00735371|324161938|FG000|Overall Study|Protocol Violation|2|||
94644921|NCT00735371|324161939|FG001|Overall Study|Protocol Violation|2|||
94644922|NCT00735371|324161940|FG002|Overall Study|Protocol Violation|0|||
94644923|NCT00735371|324161941|FG003|Overall Study|Protocol Violation|3|||
94644924|NCT00735371|324161938|FG000|Overall Study|Withdrawal by Subject|0|||
94644925|NCT00735371|324161939|FG001|Overall Study|Withdrawal by Subject|2|||
94644926|NCT00735371|324161940|FG002|Overall Study|Withdrawal by Subject|2|||
94644927|NCT00735371|324161941|FG003|Overall Study|Withdrawal by Subject|0|||
94644928|NCT00735371|324161938|FG000|Overall Study|Lost to Follow-up|1|||
94679848|NCT01364597|324282374|FG001|Overall Study|Sponsor recommended discontinuation|0|||
94679849|NCT01364597|324282375|FG002|Overall Study|Sponsor recommended discontinuation|0|||
94679850|NCT01364597|324282376|FG003|Overall Study|Sponsor recommended discontinuation|1|||
94679851|NCT01364597|324282373|FG000|Overall Study|Parents went abroad with the patient|0|||
94679852|NCT01364597|324282374|FG001|Overall Study|Parents went abroad with the patient|0|||
94644929|NCT00735371|324161939|FG001|Overall Study|Lost to Follow-up|1|||
94679853|NCT01364597|324282375|FG002|Overall Study|Parents went abroad with the patient|1|||
94679854|NCT01364597|324282376|FG003|Overall Study|Parents went abroad with the patient|0|||
94679855|NCT01364597|324282373|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
94644930|NCT00735371|324161940|FG002|Overall Study|Lost to Follow-up|3|||
94644931|NCT00735371|324161941|FG003|Overall Study|Lost to Follow-up|1|||
94679856|NCT01364597|324282374|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
94679857|NCT01364597|324282375|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
94679858|NCT01364597|324282376|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
94679859|NCT01364597|324282373|FG000|Overall Study|BRV administration dropout|0|||
94679860|NCT01364597|324282374|FG001|Overall Study|BRV administration dropout|0|||
94644932|NCT00735371|324161938|FG000|Overall Study|Lack of Efficacy|4|||
94644933|NCT00735371|324161939|FG001|Overall Study|Lack of Efficacy|2|||
94644934|NCT00735371|324161940|FG002|Overall Study|Lack of Efficacy|0|||
94644935|NCT00735371|324161941|FG003|Overall Study|Lack of Efficacy|4|||
94644936|NCT00735371|324161938|FG000|Overall Study|Sponsor Decision|3|||
94644937|NCT00735371|324161939|FG001|Overall Study|Sponsor Decision|1|||
94644938|NCT00735371|324161940|FG002|Overall Study|Sponsor Decision|0|||
94644939|NCT00735371|324161941|FG003|Overall Study|Sponsor Decision|1|||
94644940|NCT00735371|324161938|FG000|Overall Study|Protocol Violation|0|||
94644941|NCT00735371|324161939|FG001|Overall Study|Protocol Violation|1|||
94644942|NCT00735371|324161940|FG002|Overall Study|Protocol Violation|2|||
94644943|NCT00735371|324161941|FG003|Overall Study|Protocol Violation|0|||
94644944|NCT00735371|324161938|FG000|Overall Study|Prior Vyvanse Exposure|1|||
94644945|NCT00735371|324161939|FG001|Overall Study|Prior Vyvanse Exposure|1|||
94644946|NCT00735371|324161940|FG002|Overall Study|Prior Vyvanse Exposure|0|||
94644947|NCT00735371|324161941|FG003|Overall Study|Prior Vyvanse Exposure|0|||
94644948|NCT00735371|324161938|FG000|Overall Study|Exclusion criteria|1|||
94644949|NCT00735371|324161939|FG001|Overall Study|Exclusion criteria|0|||
94644950|NCT00735371|324161940|FG002|Overall Study|Exclusion criteria|0|||
94644951|NCT00735371|324161941|FG003|Overall Study|Exclusion criteria|0|||
94644952|NCT01604343|324161942|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
94644953|NCT01604343|324161943|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
94644954|NCT01604343|324161944|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
94644955|NCT01604343|324161945|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
94644956|NCT01604343|324161946|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
94644957|NCT01604343|324161942|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
94644958|NCT01604343|324161943|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
94644959|NCT01604343|324161944|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
94644960|NCT01604343|324161945|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
94644961|NCT01604343|324161946|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
94644962|NCT01604343|324161942|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
94644963|NCT01604343|324161943|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
94644964|NCT01604343|324161944|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
94644965|NCT01604343|324161945|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
94644966|NCT01604343|324161946|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
94644967|NCT01604343|324161942|FG000|Prior to W52 Administration(Through W52)|Death|5|||
94644968|NCT01604343|324161943|FG001|Prior to W52 Administration(Through W52)|Death|0|||
94644969|NCT01604343|324161944|FG002|Prior to W52 Administration(Through W52)|Death|2|||
94644970|NCT01604343|324161945|FG003|Prior to W52 Administration(Through W52)|Death|0|||
94644971|NCT01604343|324161946|FG004|Prior to W52 Administration(Through W52)|Death|4|||
94644972|NCT01604343|324161942|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
94644973|NCT01604343|324161943|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
94644974|NCT01604343|324161944|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
94644975|NCT01604343|324161945|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
94644976|NCT01604343|324161946|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
94644977|NCT01604343|324161942|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
94644978|NCT01604343|324161943|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
94644979|NCT01604343|324161944|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
94644980|NCT01604343|324161945|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
94644981|NCT01604343|324161946|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
94644982|NCT01604343|324161942|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
94644983|NCT01604343|324161943|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
94644984|NCT01604343|324161944|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
94679861|NCT01364597|324282375|FG002|Overall Study|BRV administration dropout|1|||
94679862|NCT01364597|324282376|FG003|Overall Study|BRV administration dropout|0|||
94644985|NCT01604343|324161945|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
94644986|NCT01604343|324161946|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
94679863|NCT01364597|324282373|FG000|Overall Study|Dropout|0|||
94363931|NCT01306968|323116772|FG002|Overall Study|Relocated and left active duty|1|||
94644987|NCT01604343|324161942|FG000|Prior to W52 Administration(Through W52)|Other|15|||
94644988|NCT01604343|324161943|FG001|Prior to W52 Administration(Through W52)|Other|0|||
94644989|NCT01604343|324161944|FG002|Prior to W52 Administration(Through W52)|Other|10|||
94644990|NCT01604343|324161945|FG003|Prior to W52 Administration(Through W52)|Other|0|||
94644991|NCT01604343|324161946|FG004|Prior to W52 Administration(Through W52)|Other|6|||
94644992|NCT01604343|324161942|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
94644993|NCT01604343|324161943|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
94644994|NCT01604343|324161944|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
94644995|NCT01604343|324161945|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
94644996|NCT01604343|324161946|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
94644997|NCT01604343|324161942|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
94644998|NCT01604343|324161943|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
94644999|NCT01604343|324161944|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
94645000|NCT01604343|324161945|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
94645001|NCT01604343|324161946|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
94645002|NCT01604343|324161942|FG000|Week 52 to Week 104|Adverse Event|0|||
94645003|NCT01604343|324161943|FG001|Week 52 to Week 104|Adverse Event|12|||
94645004|NCT01604343|324161944|FG002|Week 52 to Week 104|Adverse Event|26|||
94645005|NCT01604343|324161945|FG003|Week 52 to Week 104|Adverse Event|21|||
94645006|NCT01604343|324161946|FG004|Week 52 to Week 104|Adverse Event|27|||
94645007|NCT01604343|324161942|FG000|Week 52 to Week 104|Death|0|||
94645008|NCT01604343|324161943|FG001|Week 52 to Week 104|Death|4|||
94645009|NCT01604343|324161944|FG002|Week 52 to Week 104|Death|2|||
94645010|NCT01604343|324161945|FG003|Week 52 to Week 104|Death|5|||
94645011|NCT01604343|324161946|FG004|Week 52 to Week 104|Death|0|||
94645012|NCT01604343|324161942|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
94645013|NCT01604343|324161943|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
94645014|NCT01604343|324161944|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
94645015|NCT01604343|324161945|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
94645016|NCT01604343|324161946|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
94645017|NCT01604343|324161942|FG000|Week 52 to Week 104|Physician Decision|0|||
94645018|NCT01604343|324161943|FG001|Week 52 to Week 104|Physician Decision|1|||
94645019|NCT01604343|324161944|FG002|Week 52 to Week 104|Physician Decision|0|||
94645020|NCT01604343|324161945|FG003|Week 52 to Week 104|Physician Decision|0|||
94645021|NCT01604343|324161946|FG004|Week 52 to Week 104|Physician Decision|2|||
94645022|NCT01604343|324161942|FG000|Week 52 to Week 104|Pregnancy|0|||
94645023|NCT01604343|324161943|FG001|Week 52 to Week 104|Pregnancy|0|||
94645024|NCT01604343|324161944|FG002|Week 52 to Week 104|Pregnancy|1|||
94645025|NCT01604343|324161945|FG003|Week 52 to Week 104|Pregnancy|2|||
94645026|NCT01604343|324161946|FG004|Week 52 to Week 104|Pregnancy|1|||
94645027|NCT01604343|324161942|FG000|Week 52 to Week 104|Other|0|||
94645028|NCT01604343|324161943|FG001|Week 52 to Week 104|Other|11|||
94645029|NCT01604343|324161944|FG002|Week 52 to Week 104|Other|11|||
94645030|NCT01604343|324161945|FG003|Week 52 to Week 104|Other|6|||
94645031|NCT01604343|324161946|FG004|Week 52 to Week 104|Other|3|||
94645032|NCT01604343|324161942|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
94645033|NCT01604343|324161943|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
94645034|NCT01604343|324161944|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
94679864|NCT01364597|324282374|FG001|Overall Study|Dropout|0|||
94679865|NCT01364597|324282375|FG002|Overall Study|Dropout|3|||
94679866|NCT01364597|324282376|FG003|Overall Study|Dropout|1|||
94679867|NCT01364597|324282373|FG000|Overall Study|Unreliable subject|0|||
94679868|NCT01364597|324282374|FG001|Overall Study|Unreliable subject|0|||
94679869|NCT01364597|324282375|FG002|Overall Study|Unreliable subject|0|||
94679870|NCT01364597|324282376|FG003|Overall Study|Unreliable subject|1|||
94679871|NCT01364597|324282373|FG000|Overall Study|Other|0|||
94679872|NCT01364597|324282374|FG001|Overall Study|Other|0|||
94679873|NCT01364597|324282375|FG002|Overall Study|Other|0|||
94679874|NCT01364597|324282376|FG003|Overall Study|Other|1|||
94679875|NCT03131960|324282378|FG000|Overall Study|Adverse Event|0|||
94679876|NCT03131960|324282379|FG001|Overall Study|Adverse Event|1|||
94645035|NCT01604343|324161945|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
94645036|NCT01604343|324161946|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
94645037|NCT01604343|324161942|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
94645038|NCT01604343|324161943|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
94679877|NCT04707196|324282380|FG000|Overall Study|Withdrawal by Subject|9|||
94645039|NCT01604343|324161944|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
94645040|NCT01604343|324161945|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
94645041|NCT01604343|324161946|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
94645042|NCT01604343|324161942|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
94645043|NCT01604343|324161943|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
94645044|NCT01604343|324161944|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
94679878|NCT04707196|324282381|FG001|Overall Study|Withdrawal by Subject|6|||
94679879|NCT04707196|324282380|FG000|Overall Study|Lost to Follow-up|1|||
94679880|NCT04707196|324282381|FG001|Overall Study|Lost to Follow-up|0|||
94645045|NCT01604343|324161945|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
94645046|NCT01604343|324161946|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
94645047|NCT00850200|324161953|FG000|Overall Study|Physician Decision|2|||
94645048|NCT00850200|324161953|FG000|Overall Study|Did not recieve treatment|2|||
94645049|NCT00850200|324161953|FG000|Overall Study|Withdrawal by Subject|1|||
94645050|NCT00048542|324161954|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
94645051|NCT00048542|324161955|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
94645052|NCT00048542|324161956|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
94645053|NCT00048542|324161957|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
94645054|NCT00048542|324161958|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
94645055|NCT00048542|324161959|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
94645056|NCT00048542|324161960|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
94645057|NCT00048542|324161961|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
94645058|NCT00048542|324161954|FG000|Double-Blind Phase|Protocol Violation|0|||
94645059|NCT00048542|324161955|FG001|Double-Blind Phase|Protocol Violation|0|||
94645060|NCT00048542|324161956|FG002|Double-Blind Phase|Protocol Violation|1|||
94645061|NCT00048542|324161957|FG003|Double-Blind Phase|Protocol Violation|0|||
94679881|NCT04707196|324282380|FG000|Overall Study|Protocol Violation|4|||
94679882|NCT04707196|324282381|FG001|Overall Study|Protocol Violation|1|||
94679883|NCT04707196|324282380|FG000|Overall Study|Adverse Event|2|||
94679884|NCT04707196|324282381|FG001|Overall Study|Adverse Event|2|||
94679885|NCT04707196|324282380|FG000|Overall Study|Death|3|||
94679886|NCT04707196|324282381|FG001|Overall Study|Death|1|||
94679887|NCT04707196|324282380|FG000|Overall Study|Non-compliance with study drug|1|||
94679888|NCT04707196|324282381|FG001|Overall Study|Non-compliance with study drug|0|||
94679889|NCT04707196|324282380|FG000|Overall Study|Progressive disease|9|||
94679890|NCT04707196|324282381|FG001|Overall Study|Progressive disease|10|||
94679891|NCT03351738|324282382|FG000|Overall Study|Withdrawal by Subject|0|||
94679892|NCT03351738|324282383|FG001|Overall Study|Withdrawal by Subject|1|||
94679893|NCT03351738|324282384|FG002|Overall Study|Withdrawal by Subject|0|||
94263623|NCT00907257|322759863|FG000|Overall Study|Withdrawal by Subject|1|||
94263624|NCT00907257|322759864|FG001|Overall Study|Withdrawal by Subject|2|||
94263625|NCT00907257|322759863|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
94263626|NCT00907257|322759864|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
94263627|NCT00907257|322759863|FG000|Overall Study|Moved|1|||
94263628|NCT00907257|322759864|FG001|Overall Study|Moved|0|||
94263629|NCT00907257|322759863|FG000|Overall Study|Personal Reasons|6|||
94263630|NCT00907257|322759864|FG001|Overall Study|Personal Reasons|1|||
94263631|NCT01131351|322759865|FG000|Overall Study|Adverse Event|0|||
94263632|NCT01131351|322759866|FG001|Overall Study|Adverse Event|2|||
94263633|NCT01131351|322759865|FG000|Overall Study|Protocol Deviation|0|||
94263634|NCT01131351|322759866|FG001|Overall Study|Protocol Deviation|1|||
94263635|NCT03383289|322759870|FG000|Overall Study|Death|83|||
94263636|NCT03383289|322759871|FG001|Overall Study|Death|78|||
94263637|NCT03383289|322759870|FG000|Overall Study|discharge from facility|84|||
94263638|NCT03383289|322759871|FG001|Overall Study|discharge from facility|84|||
94263639|NCT03383289|322759870|FG000|Overall Study|Withdrawal by Subject|4|||
94263640|NCT03383289|322759871|FG001|Overall Study|Withdrawal by Subject|1|||
94263641|NCT00892177|322759872|FG000|Phase II|Ineligible|0|||
94263642|NCT00892177|322759873|FG001|Phase II|Ineligible|0|||
94263643|NCT00892177|322759874|FG002|Phase II|Ineligible|0|||
94263644|NCT00892177|322759875|FG003|Phase II|Ineligible|0|||
94263645|NCT00892177|322759876|FG004|Phase II|Ineligible|1|||
94263646|NCT00892177|322759877|FG005|Phase II|Ineligible|1|||
94263647|NCT00892177|322759872|FG000|Phase II|Withdrawal by Subject|0|||
94263648|NCT00892177|322759873|FG001|Phase II|Withdrawal by Subject|0|||
94263649|NCT00892177|322759874|FG002|Phase II|Withdrawal by Subject|0|||
94263650|NCT00892177|322759875|FG003|Phase II|Withdrawal by Subject|0|||
94263651|NCT00892177|322759876|FG004|Phase II|Withdrawal by Subject|4|||
94263652|NCT00892177|322759877|FG005|Phase II|Withdrawal by Subject|1|||
94463456|NCT02520427|323485067|FG010|Overall Study|Withdrawal by Subject|0|||
94463457|NCT02520427|323485068|FG011|Overall Study|Withdrawal by Subject|0|||
94645062|NCT00048542|324161958|FG004|Double-Blind Phase|Protocol Violation|0|||
94263653|NCT04982588|322759882|FG000|Overall Study|Withdrawal by Subject|2|||
94263654|NCT00937833|322759884|FG000|Overall Study|Protocol Violation|1|||
94263655|NCT00937833|322759885|FG001|Overall Study|Protocol Violation|2|||
94263656|NCT00937833|322759884|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
94263657|NCT00937833|322759885|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
94263658|NCT00937833|322759884|FG000|Overall Study|Lost to Follow-up|10|||
94263659|NCT00937833|322759885|FG001|Overall Study|Lost to Follow-up|8|||
94263660|NCT00937833|322759884|FG000|Overall Study|Withdrawal by Subject|4|||
94263661|NCT00937833|322759885|FG001|Overall Study|Withdrawal by Subject|6|||
94263662|NCT02366728|322759886|FG000|Overall Study|Death|0|||
94645063|NCT00048542|324161959|FG005|Double-Blind Phase|Protocol Violation|0|||
94645064|NCT00048542|324161960|FG006|Double-Blind Phase|Protocol Violation|0|||
94263663|NCT02366728|322759887|FG001|Overall Study|Death|0|||
94679894|NCT03351738|324282385|FG003|Overall Study|Withdrawal by Subject|1|||
94679895|NCT03351738|324282386|FG004|Overall Study|Withdrawal by Subject|0|||
94645065|NCT00048542|324161961|FG007|Double-Blind Phase|Protocol Violation|0|||
94645066|NCT00048542|324161954|FG000|Double-Blind Phase|Sponsor request or decision|2|||
94645067|NCT00048542|324161955|FG001|Double-Blind Phase|Sponsor request or decision|0|||
94645068|NCT00048542|324161956|FG002|Double-Blind Phase|Sponsor request or decision|0|||
94645069|NCT00048542|324161957|FG003|Double-Blind Phase|Sponsor request or decision|0|||
94645070|NCT00048542|324161958|FG004|Double-Blind Phase|Sponsor request or decision|0|||
94645071|NCT00048542|324161959|FG005|Double-Blind Phase|Sponsor request or decision|0|||
94645072|NCT00048542|324161960|FG006|Double-Blind Phase|Sponsor request or decision|0|||
94645073|NCT00048542|324161961|FG007|Double-Blind Phase|Sponsor request or decision|0|||
94645074|NCT00048542|324161954|FG000|Double-Blind Phase|Randomized in error|1|||
94645075|NCT00048542|324161955|FG001|Double-Blind Phase|Randomized in error|0|||
94645076|NCT00048542|324161956|FG002|Double-Blind Phase|Randomized in error|0|||
94645077|NCT00048542|324161957|FG003|Double-Blind Phase|Randomized in error|0|||
94645078|NCT00048542|324161958|FG004|Double-Blind Phase|Randomized in error|0|||
94645079|NCT00048542|324161959|FG005|Double-Blind Phase|Randomized in error|0|||
94645080|NCT00048542|324161960|FG006|Double-Blind Phase|Randomized in error|0|||
94645081|NCT00048542|324161961|FG007|Double-Blind Phase|Randomized in error|0|||
94645082|NCT00048542|324161954|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
94645083|NCT00048542|324161955|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
94645084|NCT00048542|324161956|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
94645085|NCT00048542|324161957|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
94645086|NCT00048542|324161958|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
94645087|NCT00048542|324161959|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
94645088|NCT00048542|324161960|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
94645089|NCT00048542|324161961|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
94645090|NCT00048542|324161954|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
94645091|NCT00048542|324161955|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
94645092|NCT00048542|324161956|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
94645093|NCT00048542|324161957|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
94645094|NCT00048542|324161958|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
94645095|NCT00048542|324161959|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
94645096|NCT00048542|324161960|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
94645097|NCT00048542|324161961|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
94645098|NCT00048542|324161954|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
94645099|NCT00048542|324161955|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
94645100|NCT00048542|324161956|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
94645101|NCT00048542|324161957|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
94645102|NCT00048542|324161958|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
94645103|NCT00048542|324161959|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
94645104|NCT00048542|324161960|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
94645105|NCT00048542|324161961|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
94645106|NCT00048542|324161954|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
94645107|NCT00048542|324161955|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
94645108|NCT00048542|324161956|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
94645109|NCT00048542|324161957|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
94645110|NCT00048542|324161958|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
94645111|NCT00048542|324161959|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
94645112|NCT00048542|324161960|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
94645113|NCT00048542|324161961|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
94645114|NCT00048542|324161954|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
94645115|NCT00048542|324161955|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
94645116|NCT00048542|324161956|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
94645117|NCT00048542|324161957|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
94645118|NCT00048542|324161958|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
94645119|NCT00048542|324161959|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
94645120|NCT00048542|324161960|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
94645121|NCT00048542|324161961|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
94645122|NCT00048542|324161954|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
94645123|NCT00048542|324161955|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
94645124|NCT00048542|324161956|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
94645125|NCT00048542|324161957|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
94645126|NCT00048542|324161958|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
94645127|NCT00048542|324161959|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
94645128|NCT00048542|324161960|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
94645129|NCT00048542|324161961|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
94645130|NCT00048542|324161954|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
94645131|NCT00048542|324161955|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
94679896|NCT03351738|324282387|FG005|Overall Study|Withdrawal by Subject|0|||
94679897|NCT01148862|324282392|FG000|Second Intervention|Withdrawal by Subject|0|||
94679898|NCT01148862|324282393|FG001|Second Intervention|Withdrawal by Subject|2|||
94679899|NCT03056534|324282397|FG000|Overall Study|Participant withdrew consent|8|||
94679900|NCT03056534|324282397|FG000|Overall Study|Participant not able to return|6|||
94679901|NCT03056534|324282397|FG000|Overall Study|Lost to Follow-up|37|||
94679902|NCT03056534|324282397|FG000|Overall Study|Investigator judgment|1|||
94679903|NCT03056534|324282397|FG000|Overall Study|Death|4|||
94679904|NCT03056534|324282397|FG000|Overall Study|Adverse Event|1|||
94679905|NCT03056534|324282397|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
94679906|NCT00744263|324282398|FG000|Overall Study|Death|3006|||
94679907|NCT00744263|324282399|FG001|Overall Study|Death|3005|||
94679908|NCT00744263|324282398|FG000|Overall Study|Lost to Follow-up|2038|||
94679909|NCT00744263|324282399|FG001|Overall Study|Lost to Follow-up|2135|||
94679910|NCT00744263|324282398|FG000|Overall Study|Withdrawal by Subject|166|||
94679911|NCT00744263|324282399|FG001|Overall Study|Withdrawal by Subject|150|||
94679912|NCT00744263|324282398|FG000|Overall Study|Physician Decision|20|||
94679913|NCT00744263|324282399|FG001|Overall Study|Physician Decision|23|||
94679914|NCT00744263|324282398|FG000|Overall Study|Protocol Violation|3|||
94679915|NCT00744263|324282399|FG001|Overall Study|Protocol Violation|5|||
94679916|NCT00744263|324282398|FG000|Overall Study|Adverse Event|1|||
94679917|NCT00744263|324282399|FG001|Overall Study|Adverse Event|0|||
94679918|NCT00744263|324282398|FG000|Overall Study|Other|2|||
94679919|NCT00744263|324282399|FG001|Overall Study|Other|2|||
94679920|NCT03138733|324282400|FG000|Overall Study|Death|17|||
94679921|NCT03138733|324282401|FG001|Overall Study|Death|18|||
94679922|NCT03138733|324282400|FG000|Overall Study|Withdrawal by Subject|11|||
94679923|NCT03138733|324282401|FG001|Overall Study|Withdrawal by Subject|6|||
94679924|NCT03138733|324282400|FG000|Overall Study|Lost to Follow-up|3|||
94679925|NCT03138733|324282401|FG001|Overall Study|Lost to Follow-up|2|||
94645132|NCT00048542|324161956|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
94645133|NCT00048542|324161957|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
94645134|NCT00048542|324161958|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
94645135|NCT00048542|324161959|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
94645136|NCT00048542|324161960|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
94645137|NCT00048542|324161961|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
94645138|NCT00048542|324161954|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
94645139|NCT00048542|324161955|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
94645140|NCT00048542|324161956|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
94645141|NCT00048542|324161957|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
94645142|NCT00048542|324161958|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
94645143|NCT00048542|324161959|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
94645144|NCT00048542|324161960|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
94645145|NCT00048542|324161961|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
94645146|NCT00048542|324161954|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
94645147|NCT00048542|324161955|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
94645148|NCT00048542|324161956|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
94645149|NCT00048542|324161957|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
94645150|NCT00048542|324161958|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
94645151|NCT00048542|324161959|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
94645152|NCT00048542|324161960|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
94645153|NCT00048542|324161961|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
94645154|NCT00048542|324161954|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
94645155|NCT00048542|324161955|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
94645156|NCT00048542|324161956|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
94645157|NCT00048542|324161957|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
94645158|NCT00048542|324161958|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
94645159|NCT00048542|324161959|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
94645160|NCT00048542|324161960|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
94645161|NCT00048542|324161961|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
94645162|NCT00048542|324161954|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
94645163|NCT00048542|324161955|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
94645164|NCT00048542|324161956|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
94645165|NCT00048542|324161957|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
94645166|NCT00048542|324161958|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
94645167|NCT00048542|324161959|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
94645168|NCT00048542|324161960|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
94645169|NCT00048542|324161961|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
94645170|NCT02018458|324161962|FG000|Overall Study|Death|4|||
94645171|NCT04098458|324161986|FG000|Overall Study|Death|1|||
94645172|NCT04098458|324161986|FG000|Overall Study|did not meet study inclusion criteria|3|||
94645173|NCT00097721|324161987|FG000|Overall Study|Adverse Event|8|||
94645174|NCT00097721|324161988|FG001|Overall Study|Adverse Event|1|||
94645175|NCT00097721|324161987|FG000|Overall Study|Withdrawal by Subject|6|||
94645176|NCT00097721|324161988|FG001|Overall Study|Withdrawal by Subject|1|||
94645177|NCT00097721|324161987|FG000|Overall Study|Progressive Disease|55|||
94645178|NCT00097721|324161988|FG001|Overall Study|Progressive Disease|27|||
94645179|NCT00097721|324161987|FG000|Overall Study|Physician Decision|1|||
94645180|NCT00097721|324161988|FG001|Overall Study|Physician Decision|3|||
94645181|NCT00097721|324161987|FG000|Overall Study|Reason not given|1|||
94645182|NCT00097721|324161988|FG001|Overall Study|Reason not given|1|||
94645183|NCT00449956|324161989|FG000|Overall Study|Adverse Event|7|||
94645184|NCT00449956|324161990|FG001|Overall Study|Adverse Event|1|||
94645185|NCT00449956|324161991|FG002|Overall Study|Adverse Event|6|||
94645186|NCT00449956|324161989|FG000|Overall Study|Lack of Efficacy|0|||
94645187|NCT00449956|324161990|FG001|Overall Study|Lack of Efficacy|0|||
94645188|NCT00449956|324161991|FG002|Overall Study|Lack of Efficacy|1|||
94645189|NCT00449956|324161989|FG000|Overall Study|Protocol Violation|1|||
94645190|NCT00449956|324161990|FG001|Overall Study|Protocol Violation|1|||
94645191|NCT00449956|324161991|FG002|Overall Study|Protocol Violation|1|||
94645192|NCT00449956|324161989|FG000|Overall Study|Withdrawal by Subject|0|||
94645193|NCT00449956|324161990|FG001|Overall Study|Withdrawal by Subject|1|||
94645194|NCT00449956|324161991|FG002|Overall Study|Withdrawal by Subject|0|||
94645195|NCT00449956|324161989|FG000|Overall Study|Physician Decision|2|||
94645196|NCT00449956|324161990|FG001|Overall Study|Physician Decision|1|||
94645197|NCT00449956|324161991|FG002|Overall Study|Physician Decision|1|||
94645198|NCT01533246|324161995|FG000|Overall Study|Adverse Event|1|||
94645199|NCT01533246|324161995|FG000|Overall Study|Withdrawal by Subject|1|||
94645200|NCT01639040|324162005|FG000|Overall Study|Adverse Event|1|||
94645201|NCT01639040|324162006|FG001|Overall Study|Adverse Event|0|||
94645202|NCT01479621|324162007|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
94645203|NCT01479621|324162008|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
94645204|NCT01479621|324162009|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
94645205|NCT01479621|324162010|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
94645206|NCT01479621|324162011|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
94645207|NCT01479621|324162012|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
94645208|NCT01479621|324162013|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
94645209|NCT01479621|324162007|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
94645210|NCT01479621|324162008|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
94645211|NCT01479621|324162009|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
94645212|NCT01479621|324162010|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
94645213|NCT01479621|324162011|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
94263664|NCT02366728|322759888|FG002|Overall Study|Death|1|||
94263665|NCT02366728|322759886|FG000|Overall Study|Adverse Event|1|||
94263666|NCT02366728|322759887|FG001|Overall Study|Adverse Event|0|||
94263667|NCT02366728|322759888|FG002|Overall Study|Adverse Event|0|||
94263668|NCT02366728|322759886|FG000|Overall Study|Screen Failure|2|||
94263669|NCT02366728|322759887|FG001|Overall Study|Screen Failure|1|||
94263670|NCT02366728|322759888|FG002|Overall Study|Screen Failure|0|||
94263671|NCT02366728|322759886|FG000|Overall Study|Only yielded 2 vaccines|1|||
94263672|NCT02366728|322759887|FG001|Overall Study|Only yielded 2 vaccines|0|||
94263673|NCT02366728|322759888|FG002|Overall Study|Only yielded 2 vaccines|0|||
94645214|NCT01479621|324162012|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
94645215|NCT01479621|324162013|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
94645216|NCT01479621|324162007|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
94645217|NCT01479621|324162008|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
94645218|NCT01479621|324162009|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
94645219|NCT01479621|324162010|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
94645220|NCT01479621|324162011|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
94645221|NCT01479621|324162012|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
94645222|NCT01479621|324162013|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
94645223|NCT01479621|324162007|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
94645224|NCT01479621|324162008|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
94645225|NCT01479621|324162009|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
94645226|NCT01479621|324162010|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
94645227|NCT01479621|324162011|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
94645228|NCT01479621|324162012|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
94645229|NCT01479621|324162013|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
94645230|NCT01479621|324162007|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
94645231|NCT01479621|324162008|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
94645232|NCT01479621|324162009|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
94645233|NCT01479621|324162010|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
94645234|NCT01479621|324162011|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
94645235|NCT01479621|324162012|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
94645236|NCT01479621|324162013|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
94645237|NCT01479621|324162007|FG000|Treatment Period|Adverse Event|0|||
94645238|NCT01479621|324162008|FG001|Treatment Period|Adverse Event|0|||
94645239|NCT01479621|324162009|FG002|Treatment Period|Adverse Event|0|||
94645240|NCT01479621|324162010|FG003|Treatment Period|Adverse Event|0|||
94645241|NCT01479621|324162011|FG004|Treatment Period|Adverse Event|1|||
94645242|NCT01479621|324162012|FG005|Treatment Period|Adverse Event|2|||
94645243|NCT01479621|324162013|FG006|Treatment Period|Adverse Event|2|||
94645244|NCT01479621|324162007|FG000|Treatment Period|Withdrawal by Subject|0|||
94645245|NCT01479621|324162008|FG001|Treatment Period|Withdrawal by Subject|4|||
94645246|NCT01479621|324162009|FG002|Treatment Period|Withdrawal by Subject|2|||
94645247|NCT01479621|324162010|FG003|Treatment Period|Withdrawal by Subject|2|||
94645248|NCT01479621|324162011|FG004|Treatment Period|Withdrawal by Subject|5|||
94645249|NCT01479621|324162012|FG005|Treatment Period|Withdrawal by Subject|5|||
94645250|NCT01479621|324162013|FG006|Treatment Period|Withdrawal by Subject|1|||
94645251|NCT01479621|324162007|FG000|Treatment Period|Physician Decision|0|||
94645252|NCT01479621|324162008|FG001|Treatment Period|Physician Decision|0|||
94645253|NCT01479621|324162009|FG002|Treatment Period|Physician Decision|0|||
94645254|NCT01479621|324162010|FG003|Treatment Period|Physician Decision|0|||
94645255|NCT01479621|324162011|FG004|Treatment Period|Physician Decision|1|||
94645256|NCT01479621|324162012|FG005|Treatment Period|Physician Decision|1|||
94645257|NCT01479621|324162013|FG006|Treatment Period|Physician Decision|0|||
94645258|NCT01479621|324162007|FG000|Treatment Period|Non-compliance to study drug|0|||
94645259|NCT01479621|324162008|FG001|Treatment Period|Non-compliance to study drug|1|||
94645260|NCT01479621|324162009|FG002|Treatment Period|Non-compliance to study drug|0|||
94645261|NCT01479621|324162010|FG003|Treatment Period|Non-compliance to study drug|0|||
94645262|NCT01479621|324162011|FG004|Treatment Period|Non-compliance to study drug|0|||
94645263|NCT01479621|324162012|FG005|Treatment Period|Non-compliance to study drug|0|||
94645264|NCT01479621|324162013|FG006|Treatment Period|Non-compliance to study drug|1|||
94645265|NCT01479621|324162007|FG000|Treatment Period|Protocol Violation|0|||
94645266|NCT01479621|324162008|FG001|Treatment Period|Protocol Violation|9|||
94645267|NCT01479621|324162009|FG002|Treatment Period|Protocol Violation|6|||
94645268|NCT01479621|324162010|FG003|Treatment Period|Protocol Violation|5|||
94645269|NCT01479621|324162011|FG004|Treatment Period|Protocol Violation|2|||
94645270|NCT01479621|324162012|FG005|Treatment Period|Protocol Violation|10|||
94645271|NCT01479621|324162013|FG006|Treatment Period|Protocol Violation|6|||
94645272|NCT01479621|324162007|FG000|Treatment Period|Pregnancy|0|||
94645273|NCT01479621|324162008|FG001|Treatment Period|Pregnancy|0|||
94645274|NCT01479621|324162009|FG002|Treatment Period|Pregnancy|2|||
94645275|NCT01479621|324162010|FG003|Treatment Period|Pregnancy|0|||
94645276|NCT01479621|324162011|FG004|Treatment Period|Pregnancy|0|||
94645277|NCT01479621|324162012|FG005|Treatment Period|Pregnancy|0|||
94645278|NCT01479621|324162013|FG006|Treatment Period|Pregnancy|0|||
94645279|NCT01479621|324162007|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
94645280|NCT01479621|324162008|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
94645281|NCT01479621|324162009|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
94645282|NCT01479621|324162010|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
94263674|NCT00537485|322759895|FG000|Overall Study|Adverse Event|10|||
94645283|NCT01479621|324162011|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
94645284|NCT01479621|324162012|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
94645285|NCT01479621|324162013|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
94645286|NCT01479621|324162007|FG000|Treatment Period|Lost to Follow-up|0|||
94645287|NCT01479621|324162008|FG001|Treatment Period|Lost to Follow-up|0|||
94645288|NCT01479621|324162009|FG002|Treatment Period|Lost to Follow-up|1|||
94645289|NCT01479621|324162010|FG003|Treatment Period|Lost to Follow-up|0|||
94645290|NCT01479621|324162011|FG004|Treatment Period|Lost to Follow-up|2|||
94645291|NCT01479621|324162012|FG005|Treatment Period|Lost to Follow-up|2|||
94645292|NCT01479621|324162013|FG006|Treatment Period|Lost to Follow-up|1|||
94363932|NCT01306968|323116773|FG003|Overall Study|Relocated and left active duty|1|||
94363933|NCT01306968|323116770|FG000|Overall Study|Withdrew - time commitment|0|||
94363934|NCT01306968|323116771|FG001|Overall Study|Withdrew - time commitment|0|||
94363935|NCT01306968|323116772|FG002|Overall Study|Withdrew - time commitment|0|||
94645293|NCT01479621|324162007|FG000|Treatment Period|Met stopping criteria|0|||
94645294|NCT01479621|324162008|FG001|Treatment Period|Met stopping criteria|8|||
94645295|NCT01479621|324162009|FG002|Treatment Period|Met stopping criteria|7|||
94645296|NCT01479621|324162010|FG003|Treatment Period|Met stopping criteria|4|||
94645297|NCT01479621|324162011|FG004|Treatment Period|Met stopping criteria|9|||
94645298|NCT01479621|324162012|FG005|Treatment Period|Met stopping criteria|20|||
94645299|NCT01479621|324162013|FG006|Treatment Period|Met stopping criteria|6|||
94645300|NCT00453999|324162020|FG000|Overall Study|Adverse Event|1|||
94645301|NCT00453999|324162021|FG001|Overall Study|Adverse Event|2|||
94645302|NCT00453999|324162022|FG002|Overall Study|Adverse Event|1|||
94645303|NCT00453999|324162020|FG000|Overall Study|Lost to Follow-up|0|||
94645304|NCT00453999|324162021|FG001|Overall Study|Lost to Follow-up|1|||
94645305|NCT00453999|324162022|FG002|Overall Study|Lost to Follow-up|1|||
94645306|NCT00453999|324162020|FG000|Overall Study|Withdrawal by Subject|2|||
94645307|NCT00453999|324162021|FG001|Overall Study|Withdrawal by Subject|1|||
94645308|NCT00453999|324162022|FG002|Overall Study|Withdrawal by Subject|1|||
94645309|NCT00453999|324162020|FG000|Overall Study|Subject Request|2|||
94645310|NCT00453999|324162021|FG001|Overall Study|Subject Request|1|||
94645311|NCT00453999|324162022|FG002|Overall Study|Subject Request|0|||
94645312|NCT03013543|324162028|FG000|Overall Study|Withdrawal by Subject|0|||
94645313|NCT03013543|324162029|FG001|Overall Study|Withdrawal by Subject|2|||
94645314|NCT03013543|324162030|FG002|Overall Study|Withdrawal by Subject|0|||
94645315|NCT03013543|324162031|FG003|Overall Study|Withdrawal by Subject|5|||
94679926|NCT03138733|324282400|FG000|Overall Study|Adverse Event|1|||
94679927|NCT03138733|324282401|FG001|Overall Study|Adverse Event|0|||
94679928|NCT03138733|324282400|FG000|Overall Study|Protocol Violation|1|||
94679929|NCT03138733|324282401|FG001|Overall Study|Protocol Violation|3|||
94679930|NCT03138733|324282400|FG000|Overall Study|Administrative or logistical reason|1|||
94679931|NCT03138733|324282401|FG001|Overall Study|Administrative or logistical reason|0|||
94679932|NCT03138733|324282400|FG000|Overall Study|The patient was transferred to another hospital|1|||
94679933|NCT03138733|324282401|FG001|Overall Study|The patient was transferred to another hospital|0|||
94679934|NCT01320943|324282402|FG000|Overall Study|Lost to Follow-up|1|||
94679935|NCT01320943|324282403|FG001|Overall Study|Lost to Follow-up|0|||
94679936|NCT01320943|324282402|FG000|Overall Study|Physician Decision|0|||
94679937|NCT01320943|324282403|FG001|Overall Study|Physician Decision|1|||
94645316|NCT03013543|324162032|FG004|Overall Study|Withdrawal by Subject|6|||
94645317|NCT03013543|324162033|FG005|Overall Study|Withdrawal by Subject|2|||
94645318|NCT03013543|324162034|FG006|Overall Study|Withdrawal by Subject|3|||
94645319|NCT03013543|324162035|FG007|Overall Study|Withdrawal by Subject|1|||
94363936|NCT01306968|323116773|FG003|Overall Study|Withdrew - time commitment|2|||
94679938|NCT01320943|324282402|FG000|Overall Study|Randomized but not Treated|0|||
94363937|NCT01306968|323116770|FG000|Overall Study|Withdrew over privacy concerns|0|||
94645320|NCT03013543|324162036|FG008|Overall Study|Withdrawal by Subject|0|||
94679939|NCT01320943|324282403|FG001|Overall Study|Randomized but not Treated|1|||
94679940|NCT04954586|324282408|FG000|Overall Study|Withdrawal by Subject|5|||
94679941|NCT04522180|324282409|FG000|Overall Study|Investigator judgement|3|||
94679942|NCT04522180|324282410|FG001|Overall Study|Investigator judgement|4|||
94679943|NCT04522180|324282409|FG000|Overall Study|Voluntary withdrawal|1|||
94679944|NCT04522180|324282410|FG001|Overall Study|Voluntary withdrawal|0|||
94679945|NCT04522180|324282409|FG000|Overall Study|Pregnancy|0|||
94679946|NCT04522180|324282410|FG001|Overall Study|Pregnancy|1|||
94679947|NCT04522180|324282409|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
94679948|NCT04522180|324282410|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
94679949|NCT04522180|324282409|FG000|Overall Study|Reason not specified|8|||
94679950|NCT04522180|324282410|FG001|Overall Study|Reason not specified|5|||
94679951|NCT02277743|324282412|FG000|Overall Study|Protocol Violation|1|||
94679952|NCT02277743|324282413|FG001|Overall Study|Protocol Violation|1|||
94679953|NCT02277743|324282414|FG002|Overall Study|Protocol Violation|1|||
94679954|NCT02277743|324282412|FG000|Overall Study|Adverse Event|10|||
94679955|NCT02277743|324282413|FG001|Overall Study|Adverse Event|6|||
94679956|NCT02277743|324282414|FG002|Overall Study|Adverse Event|6|||
94679957|NCT02277743|324282412|FG000|Overall Study|Lack of Efficacy|11|||
94679958|NCT02277743|324282413|FG001|Overall Study|Lack of Efficacy|4|||
94679959|NCT02277743|324282414|FG002|Overall Study|Lack of Efficacy|3|||
94679960|NCT02277743|324282412|FG000|Overall Study|Other than specified above|18|||
94679961|NCT02277743|324282413|FG001|Overall Study|Other than specified above|5|||
94679962|NCT02277743|324282414|FG002|Overall Study|Other than specified above|16|||
94679963|NCT01552954|324282416|FG000|Overall Study|Adverse Event|1|||
94679964|NCT01552954|324282417|FG001|Overall Study|Adverse Event|2|||
94679965|NCT01552954|324282416|FG000|Overall Study|Lost to Follow-up|1|||
94679966|NCT01552954|324282417|FG001|Overall Study|Lost to Follow-up|1|||
94679967|NCT01552954|324282416|FG000|Overall Study|Withdrawal by Subject|1|||
94679968|NCT01552954|324282417|FG001|Overall Study|Withdrawal by Subject|1|||
94679969|NCT01552954|324282416|FG000|Overall Study|Protocol Violation|1|||
94679970|NCT01552954|324282417|FG001|Overall Study|Protocol Violation|2|||
94679971|NCT01552954|324282416|FG000|Overall Study|diagnosed DM|1|||
94679972|NCT01552954|324282417|FG001|Overall Study|diagnosed DM|0|||
94679973|NCT00110890|324282418|FG000|Overall Study|Adverse Event|30|||
94679974|NCT00110890|324282419|FG001|Overall Study|Adverse Event|7|||
94679975|NCT00110890|324282418|FG000|Overall Study|Death|16|||
94679976|NCT00110890|324282419|FG001|Overall Study|Death|9|||
94679977|NCT00110890|324282418|FG000|Overall Study|Lost to Follow-up|3|||
94679978|NCT00110890|324282419|FG001|Overall Study|Lost to Follow-up|1|||
94679979|NCT00110890|324282418|FG000|Overall Study|Physician Decision|4|||
94679980|NCT00110890|324282419|FG001|Overall Study|Physician Decision|5|||
94679981|NCT00110890|324282418|FG000|Overall Study|Withdrawal by Subject|17|||
94679982|NCT00110890|324282419|FG001|Overall Study|Withdrawal by Subject|5|||
94679983|NCT00110890|324282418|FG000|Overall Study|Protocol Deviation|1|||
94679984|NCT00110890|324282419|FG001|Overall Study|Protocol Deviation|0|||
94679985|NCT00110890|324282418|FG000|Overall Study|Noncompliance|10|||
94679986|NCT00110890|324282419|FG001|Overall Study|Noncompliance|0|||
94679987|NCT00110890|324282418|FG000|Overall Study|Kidney Transplant|16|||
94679988|NCT00110890|324282419|FG001|Overall Study|Kidney Transplant|12|||
94679989|NCT00110890|324282418|FG000|Overall Study|Invest. Product Commercially Available|217|||
94679990|NCT00110890|324282419|FG001|Overall Study|Invest. Product Commercially Available|110|||
94679991|NCT00110890|324282418|FG000|Overall Study|Other|34|||
94679992|NCT00110890|324282419|FG001|Overall Study|Other|23|||
94679993|NCT00110890|324282418|FG000|Overall Study|Ineligibility determined|3|||
94679994|NCT00110890|324282419|FG001|Overall Study|Ineligibility determined|0|||
94679995|NCT00110890|324282418|FG000|Overall Study|Requirement for alternative therapy|0|||
94679996|NCT00110890|324282419|FG001|Overall Study|Requirement for alternative therapy|1|||
94679997|NCT00110890|324282418|FG000|Overall Study|Disease progression|0|||
94679998|NCT00110890|324282419|FG001|Overall Study|Disease progression|1|||
94679999|NCT00110890|324282418|FG000|Overall Study|Parathyroidectomy|0|||
94680000|NCT00110890|324282419|FG001|Overall Study|Parathyroidectomy|1|||
94680001|NCT00110890|324282418|FG000|Overall Study|Did not enter follow-up phase|10|||
94680002|NCT00110890|324282419|FG001|Overall Study|Did not enter follow-up phase|4|||
94680003|NCT01786330|324282420|FG000|Overall Study|Withdrawal by Subject|0|||
94680004|NCT01786330|324282421|FG001|Overall Study|Withdrawal by Subject|1|||
94680005|NCT01786330|324282420|FG000|Overall Study|Lost to Follow-up|0|||
94680006|NCT01786330|324282421|FG001|Overall Study|Lost to Follow-up|1|||
94680007|NCT01786330|324282420|FG000|Overall Study|Excluded intraoperatively|0|||
94680008|NCT01786330|324282421|FG001|Overall Study|Excluded intraoperatively|1|||
94680009|NCT01786330|324282420|FG000|Overall Study|Protocol Violation|1|||
94680010|NCT01786330|324282421|FG001|Overall Study|Protocol Violation|0|||
94680011|NCT04836858|324284200|FG000|Overall Study|Adverse Event|0|||
94463458|NCT02520427|323485069|FG012|Overall Study|Withdrawal by Subject|1|||
94680012|NCT04836858|324284201|FG001|Overall Study|Adverse Event|0|||
94680013|NCT04836858|324284202|FG002|Overall Study|Adverse Event|0|||
94680014|NCT04836858|324284203|FG003|Overall Study|Adverse Event|1|||
94680015|NCT04836858|324284200|FG000|Overall Study|Lost to Follow-up|1|||
94680016|NCT04836858|324284201|FG001|Overall Study|Lost to Follow-up|0|||
94645321|NCT03013543|324162037|FG009|Overall Study|Withdrawal by Subject|4|||
94645322|NCT03013543|324162028|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
94645323|NCT03013543|324162029|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
94645324|NCT03013543|324162030|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
94645325|NCT03013543|324162031|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
94645326|NCT03013543|324162032|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
94645327|NCT03013543|324162033|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
94645328|NCT03013543|324162034|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
94645329|NCT03013543|324162035|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
94645330|NCT03013543|324162036|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
94645331|NCT03013543|324162037|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
94645332|NCT03013543|324162028|FG000|Overall Study|Other|0|||
94645333|NCT03013543|324162029|FG001|Overall Study|Other|0|||
94645334|NCT03013543|324162030|FG002|Overall Study|Other|2|||
94645335|NCT03013543|324162031|FG003|Overall Study|Other|0|||
94645336|NCT03013543|324162032|FG004|Overall Study|Other|2|||
94645337|NCT03013543|324162033|FG005|Overall Study|Other|0|||
94645338|NCT03013543|324162034|FG006|Overall Study|Other|0|||
94645339|NCT03013543|324162035|FG007|Overall Study|Other|0|||
94645340|NCT03013543|324162036|FG008|Overall Study|Other|1|||
94645341|NCT03013543|324162037|FG009|Overall Study|Other|0|||
94645342|NCT03013543|324162028|FG000|Overall Study|Adverse Event|0|||
94645343|NCT03013543|324162029|FG001|Overall Study|Adverse Event|0|||
94645344|NCT03013543|324162030|FG002|Overall Study|Adverse Event|0|||
94645345|NCT03013543|324162031|FG003|Overall Study|Adverse Event|3|||
94645346|NCT03013543|324162032|FG004|Overall Study|Adverse Event|2|||
94645347|NCT03013543|324162033|FG005|Overall Study|Adverse Event|1|||
94645348|NCT03013543|324162034|FG006|Overall Study|Adverse Event|3|||
94645349|NCT03013543|324162035|FG007|Overall Study|Adverse Event|8|||
94645350|NCT03013543|324162036|FG008|Overall Study|Adverse Event|0|||
94645351|NCT03013543|324162037|FG009|Overall Study|Adverse Event|2|||
94645352|NCT03013543|324162028|FG000|Overall Study|Death|0|||
94645353|NCT03013543|324162029|FG001|Overall Study|Death|0|||
94645354|NCT03013543|324162030|FG002|Overall Study|Death|0|||
94645355|NCT03013543|324162031|FG003|Overall Study|Death|1|||
94645356|NCT03013543|324162032|FG004|Overall Study|Death|0|||
94645357|NCT03013543|324162033|FG005|Overall Study|Death|0|||
94645358|NCT03013543|324162034|FG006|Overall Study|Death|0|||
94645359|NCT03013543|324162035|FG007|Overall Study|Death|0|||
94645360|NCT03013543|324162036|FG008|Overall Study|Death|0|||
94645361|NCT03013543|324162037|FG009|Overall Study|Death|0|||
94645362|NCT03013543|324162028|FG000|Overall Study|Lack of Efficacy|0|||
94645363|NCT03013543|324162029|FG001|Overall Study|Lack of Efficacy|0|||
94645364|NCT03013543|324162030|FG002|Overall Study|Lack of Efficacy|0|||
94645365|NCT03013543|324162031|FG003|Overall Study|Lack of Efficacy|1|||
94645366|NCT03013543|324162032|FG004|Overall Study|Lack of Efficacy|0|||
94645367|NCT03013543|324162033|FG005|Overall Study|Lack of Efficacy|0|||
94645368|NCT03013543|324162034|FG006|Overall Study|Lack of Efficacy|0|||
94645369|NCT03013543|324162035|FG007|Overall Study|Lack of Efficacy|0|||
94645370|NCT03013543|324162036|FG008|Overall Study|Lack of Efficacy|0|||
94645371|NCT03013543|324162037|FG009|Overall Study|Lack of Efficacy|0|||
94645372|NCT03013543|324162028|FG000|Overall Study|Lost to Follow-up|0|||
94645373|NCT03013543|324162029|FG001|Overall Study|Lost to Follow-up|0|||
94645374|NCT03013543|324162030|FG002|Overall Study|Lost to Follow-up|0|||
94645375|NCT03013543|324162031|FG003|Overall Study|Lost to Follow-up|1|||
94645376|NCT03013543|324162032|FG004|Overall Study|Lost to Follow-up|0|||
94645377|NCT03013543|324162033|FG005|Overall Study|Lost to Follow-up|0|||
94645378|NCT03013543|324162034|FG006|Overall Study|Lost to Follow-up|1|||
94645379|NCT03013543|324162035|FG007|Overall Study|Lost to Follow-up|0|||
94645380|NCT03013543|324162036|FG008|Overall Study|Lost to Follow-up|0|||
94645381|NCT03013543|324162037|FG009|Overall Study|Lost to Follow-up|2|||
94645382|NCT03013543|324162028|FG000|Overall Study|Non-Compliance With Study Drug|0|||
94645383|NCT03013543|324162029|FG001|Overall Study|Non-Compliance With Study Drug|0|||
94645384|NCT03013543|324162030|FG002|Overall Study|Non-Compliance With Study Drug|0|||
94645385|NCT03013543|324162031|FG003|Overall Study|Non-Compliance With Study Drug|0|||
94645386|NCT03013543|324162032|FG004|Overall Study|Non-Compliance With Study Drug|0|||
94645387|NCT03013543|324162033|FG005|Overall Study|Non-Compliance With Study Drug|0|||
94645388|NCT03013543|324162034|FG006|Overall Study|Non-Compliance With Study Drug|0|||
94645389|NCT03013543|324162035|FG007|Overall Study|Non-Compliance With Study Drug|0|||
94645390|NCT03013543|324162036|FG008|Overall Study|Non-Compliance With Study Drug|1|||
94645391|NCT03013543|324162037|FG009|Overall Study|Non-Compliance With Study Drug|0|||
94645392|NCT03013543|324162028|FG000|Overall Study|Physician Decision|0|||
94645393|NCT03013543|324162029|FG001|Overall Study|Physician Decision|0|||
94645394|NCT03013543|324162030|FG002|Overall Study|Physician Decision|0|||
94645395|NCT03013543|324162031|FG003|Overall Study|Physician Decision|0|||
94645396|NCT03013543|324162032|FG004|Overall Study|Physician Decision|1|||
94645397|NCT03013543|324162033|FG005|Overall Study|Physician Decision|0|||
94645398|NCT03013543|324162034|FG006|Overall Study|Physician Decision|0|||
94645399|NCT03013543|324162035|FG007|Overall Study|Physician Decision|0|||
94645400|NCT03013543|324162036|FG008|Overall Study|Physician Decision|0|||
94645401|NCT03013543|324162037|FG009|Overall Study|Physician Decision|0|||
94645402|NCT03013543|324162028|FG000|Overall Study|Protocol Violation|0|||
94645403|NCT03013543|324162029|FG001|Overall Study|Protocol Violation|0|||
94645404|NCT03013543|324162030|FG002|Overall Study|Protocol Violation|0|||
94645405|NCT03013543|324162031|FG003|Overall Study|Protocol Violation|0|||
94645406|NCT03013543|324162032|FG004|Overall Study|Protocol Violation|0|||
94645407|NCT03013543|324162033|FG005|Overall Study|Protocol Violation|0|||
94645408|NCT03013543|324162034|FG006|Overall Study|Protocol Violation|0|||
94645409|NCT03013543|324162035|FG007|Overall Study|Protocol Violation|0|||
94645410|NCT03013543|324162036|FG008|Overall Study|Protocol Violation|0|||
94645411|NCT03013543|324162037|FG009|Overall Study|Protocol Violation|1|||
94645412|NCT00323414|324162038|FG000|Overall Study|Withdrawal by Subject|0|||
94645413|NCT00323414|324162039|FG001|Overall Study|Withdrawal by Subject|1|||
94645414|NCT00606892|324162040|FG000|First Intervention|Protocol Violation|1|||
94645415|NCT00606892|324162041|FG001|First Intervention|Protocol Violation|4|||
94645416|NCT04382911|324162043|FG000|Overall Study|unable to be imaged prior to surgery|2|||
94645417|NCT00855309|324162044|FG000|Overall Study|patient never recieved drug|1|||
94645418|NCT00855309|324162045|FG001|Overall Study|patient never recieved drug|0|||
94645419|NCT01907828|324162046|FG000|Overall Study|Exclusion criteria not met|0|||
94645420|NCT01907828|324162047|FG001|Overall Study|Exclusion criteria not met|1|||
94645421|NCT01907828|324162046|FG000|Overall Study|Withdrawal by Subject|3|||
94645422|NCT01907828|324162047|FG001|Overall Study|Withdrawal by Subject|4|||
94645423|NCT01907828|324162046|FG000|Overall Study|Lost to Follow-up|3|||
94645424|NCT01907828|324162047|FG001|Overall Study|Lost to Follow-up|0|||
94645425|NCT01907828|324162046|FG000|Overall Study|Participant refused 24-month follow-up|1|||
94645426|NCT01907828|324162047|FG001|Overall Study|Participant refused 24-month follow-up|0|||
94645427|NCT01907828|324162046|FG000|Overall Study|Participant met exclusion criteria|0|||
94645428|NCT01907828|324162047|FG001|Overall Study|Participant met exclusion criteria|1|||
94645429|NCT01494610|324162052|FG000|Period 1|Withdrawal by Subject|1|||
94645430|NCT01494610|324162053|FG001|Period 1|Withdrawal by Subject|1|||
94645431|NCT01494610|324162052|FG000|Period 3|Adverse Event|1|||
94645432|NCT01494610|324162053|FG001|Period 3|Adverse Event|0|||
94645433|NCT01494610|324162052|FG000|Period 3|Withdrawal by Subject|1|||
94645434|NCT01494610|324162053|FG001|Period 3|Withdrawal by Subject|0|||
94645435|NCT01494610|324162052|FG000|Period 4|Protocol Violation|1|||
94645436|NCT01494610|324162053|FG001|Period 4|Protocol Violation|0|||
94645438|NCT00589108|324163460|FG000|Overall Study|Lost to Follow-up|1|||
94645439|NCT00589108|324163461|FG001|Overall Study|Lost to Follow-up|1|||
94645440|NCT00589108|324163462|FG002|Overall Study|Lost to Follow-up|1|||
94645441|NCT00589108|324163460|FG000|Overall Study|Death|3|||
94645442|NCT00589108|324163461|FG001|Overall Study|Death|3|||
94645443|NCT00589108|324163462|FG002|Overall Study|Death|4|||
94645444|NCT02586012|324163463|FG000|Overall Study|Withdrawal by Subject|1|||
94645445|NCT02586012|324163464|FG001|Overall Study|Withdrawal by Subject|1|||
94645446|NCT02586012|324163465|FG002|Overall Study|Withdrawal by Subject|0|||
94645447|NCT02586012|324163466|FG003|Overall Study|Withdrawal by Subject|1|||
94645448|NCT02586012|324163467|FG004|Overall Study|Withdrawal by Subject|0|||
94645449|NCT02586012|324163468|FG005|Overall Study|Withdrawal by Subject|2|||
94645450|NCT02586012|324163463|FG000|Overall Study|Protocol Violation|0|||
94645451|NCT02586012|324163464|FG001|Overall Study|Protocol Violation|0|||
94645452|NCT02586012|324163465|FG002|Overall Study|Protocol Violation|0|||
94645453|NCT02586012|324163466|FG003|Overall Study|Protocol Violation|0|||
94645454|NCT02586012|324163467|FG004|Overall Study|Protocol Violation|0|||
94645455|NCT02586012|324163468|FG005|Overall Study|Protocol Violation|1|||
94645456|NCT02586012|324163463|FG000|Overall Study|study terminated|0|||
94645457|NCT02586012|324163464|FG001|Overall Study|study terminated|2|||
94645458|NCT02586012|324163465|FG002|Overall Study|study terminated|1|||
94645459|NCT02586012|324163466|FG003|Overall Study|study terminated|1|||
94645460|NCT02586012|324163467|FG004|Overall Study|study terminated|1|||
94645461|NCT02586012|324163468|FG005|Overall Study|study terminated|0|||
94645462|NCT02388737|324163469|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
94645463|NCT02388737|324163470|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
94645464|NCT02388737|324163471|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
94645465|NCT02388737|324163469|FG000|Overall Study|Major Protocol Deviation|18|||
94645466|NCT02388737|324163470|FG001|Overall Study|Major Protocol Deviation|25|||
94645467|NCT02388737|324163471|FG002|Overall Study|Major Protocol Deviation|22|||
94645468|NCT02388737|324163469|FG000|Overall Study|Lost to Follow-up|5|||
94645469|NCT02388737|324163470|FG001|Overall Study|Lost to Follow-up|1|||
94645470|NCT02388737|324163471|FG002|Overall Study|Lost to Follow-up|4|||
94645471|NCT02388737|324163469|FG000|Overall Study|Voluntary Withdrawal|10|||
94645472|NCT02388737|324163470|FG001|Overall Study|Voluntary Withdrawal|18|||
94645473|NCT02388737|324163471|FG002|Overall Study|Voluntary Withdrawal|17|||
94645474|NCT02388737|324163469|FG000|Overall Study|Lack of Efficacy|3|||
94645475|NCT02388737|324163470|FG001|Overall Study|Lack of Efficacy|0|||
94645476|NCT02388737|324163471|FG002|Overall Study|Lack of Efficacy|3|||
94645477|NCT02388737|324163469|FG000|Overall Study|Reason Not Specified|5|||
94645478|NCT02388737|324163470|FG001|Overall Study|Reason Not Specified|5|||
94645479|NCT02388737|324163471|FG002|Overall Study|Reason Not Specified|4|||
94645480|NCT00427635|324163472|FG000|Treatment Phase|Withdrawal by Subject|1|||
94645481|NCT00427635|324163473|FG001|Treatment Phase|Withdrawal by Subject|0|||
94645482|NCT00427635|324163472|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
94645483|NCT00427635|324163473|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
94645484|NCT03277846|324163474|FG000|Overall Study|Inpatient stay too brief|12|||
94645485|NCT03277846|324163475|FG001|Overall Study|Inpatient stay too brief|11|||
94645486|NCT00326612|324163476|FG000|Overall Study|They did not have a seizure requiring tx|129|||
94645487|NCT00326612|324163477|FG001|Overall Study|They did not have a seizure requiring tx|137|||
94645488|NCT02223767|324163481|FG000|Overall Study|Withdrawal by Subject|4|||
94645489|NCT02223767|324163482|FG001|Overall Study|Withdrawal by Subject|4|||
94645490|NCT02042924|324163483|FG000|Overall Study|Early Death|1|||
94645491|NCT01944059|324163484|FG000|Overall Study|Lost to Follow-up|1|||
94645492|NCT01944059|324163484|FG000|Overall Study|Physician Decision|3|||
94645493|NCT01944059|324163484|FG000|Overall Study|Withdrawal by Subject|1|||
94645494|NCT01944059|324163484|FG000|Overall Study|Adverse Event|2|||
94645495|NCT04206293|324163493|FG000|Overall Study|Consent withdrawal|1|||
94645496|NCT02118428|324163499|FG000|Overall Study|Physician Decision|0|||
94645497|NCT02118428|324163500|FG001|Overall Study|Physician Decision|1|||
94645498|NCT02118428|324163501|FG002|Overall Study|Physician Decision|0|||
94645499|NCT02118428|324163499|FG000|Overall Study|Withdrawal by Subject|2|||
94645500|NCT02118428|324163500|FG001|Overall Study|Withdrawal by Subject|2|||
94645501|NCT02118428|324163501|FG002|Overall Study|Withdrawal by Subject|0|||
94645502|NCT02118428|324163499|FG000|Overall Study|Death|7|||
94645503|NCT02118428|324163500|FG001|Overall Study|Death|5|||
94645504|NCT02118428|324163501|FG002|Overall Study|Death|0|||
94645505|NCT02118428|324163499|FG000|Overall Study|Lost to Follow-up|3|||
94645506|NCT02118428|324163500|FG001|Overall Study|Lost to Follow-up|1|||
94645507|NCT02118428|324163501|FG002|Overall Study|Lost to Follow-up|0|||
94645508|NCT02118428|324163499|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
94645509|NCT02118428|324163500|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
94645510|NCT02118428|324163501|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
94645511|NCT03325166|324163505|FG000|Overall Study|Adverse Event|1|||
94645512|NCT04171414|324163506|FG000|Overall Study|Death|1|||
94645513|NCT04171414|324163506|FG000|Overall Study|Withdrawal by Subject|1|||
94645514|NCT00463060|324163507|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
94645515|NCT00463060|324163507|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
94645516|NCT01631474|324163508|FG000|Overall Study|Lost to Follow-up|8|||
94645517|NCT01631474|324163509|FG001|Overall Study|Lost to Follow-up|5|||
94645518|NCT01631474|324163510|FG002|Overall Study|Lost to Follow-up|7|||
94645519|NCT01631474|324163511|FG003|Overall Study|Lost to Follow-up|5|||
94645520|NCT01631474|324163512|FG004|Overall Study|Lost to Follow-up|5|||
94645521|NCT01631474|324163508|FG000|Overall Study|Withdrawal by Subject|4|||
94645522|NCT01631474|324163509|FG001|Overall Study|Withdrawal by Subject|4|||
94645523|NCT01631474|324163510|FG002|Overall Study|Withdrawal by Subject|2|||
94645524|NCT01631474|324163511|FG003|Overall Study|Withdrawal by Subject|6|||
94645525|NCT01631474|324163512|FG004|Overall Study|Withdrawal by Subject|5|||
94645526|NCT01631474|324163508|FG000|Overall Study|Lack of Efficacy|2|||
94645527|NCT01631474|324163509|FG001|Overall Study|Lack of Efficacy|2|||
94645528|NCT01631474|324163510|FG002|Overall Study|Lack of Efficacy|0|||
94645529|NCT01631474|324163511|FG003|Overall Study|Lack of Efficacy|0|||
94645530|NCT01631474|324163512|FG004|Overall Study|Lack of Efficacy|2|||
94645531|NCT01631474|324163508|FG000|Overall Study|Noncompliance with Study Drug|0|||
94645532|NCT01631474|324163509|FG001|Overall Study|Noncompliance with Study Drug|0|||
94645533|NCT01631474|324163510|FG002|Overall Study|Noncompliance with Study Drug|0|||
94645534|NCT01631474|324163511|FG003|Overall Study|Noncompliance with Study Drug|0|||
94645535|NCT01631474|324163512|FG004|Overall Study|Noncompliance with Study Drug|1|||
94645536|NCT01631474|324163508|FG000|Overall Study|Adverse Event|0|||
94645537|NCT01631474|324163509|FG001|Overall Study|Adverse Event|1|||
94645538|NCT01631474|324163510|FG002|Overall Study|Adverse Event|0|||
94645539|NCT01631474|324163511|FG003|Overall Study|Adverse Event|0|||
94645540|NCT01631474|324163512|FG004|Overall Study|Adverse Event|0|||
94645541|NCT01782313|324163513|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
94645542|NCT01782313|324163513|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
94645543|NCT01782313|324163513|FG000|Treated Cycle 3|Progressive Disease|21|||
94645544|NCT01782313|324163513|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
94645545|NCT01782313|324163513|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
94645546|NCT01782313|324163513|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
94645547|NCT01782313|324163513|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
94645548|NCT01782313|324163513|FG000|Survival Follow up|Lost to Follow-up|1|||
94645549|NCT02487394|324163516|FG000|Phase 1|Withdrawal by Subject|0|||
94645550|NCT02487394|324163517|FG001|Phase 1|Withdrawal by Subject|1|||
94645551|NCT01067352|324163520|FG000|Overall Study|Withdrawal by Subject|1|||
94645552|NCT01067352|324163521|FG001|Overall Study|Withdrawal by Subject|2|||
94645553|NCT01067352|324163522|FG002|Overall Study|Withdrawal by Subject|1|||
94645554|NCT01067352|324163520|FG000|Overall Study|Physician Decision|0|||
94645555|NCT01067352|324163521|FG001|Overall Study|Physician Decision|1|||
94645556|NCT01067352|324163522|FG002|Overall Study|Physician Decision|0|||
94645557|NCT00436748|324163525|FG000|Overall Study|Ineligibility Determined|1|||
94645558|NCT00436748|324163526|FG001|Overall Study|Ineligibility Determined|1|||
94645559|NCT00436748|324163525|FG000|Overall Study|Adverse Event|0|||
94645560|NCT00436748|324163526|FG001|Overall Study|Adverse Event|2|||
94645561|NCT00436748|324163525|FG000|Overall Study|Consent Withdrawn|1|||
94645562|NCT00436748|324163526|FG001|Overall Study|Consent Withdrawn|4|||
94645563|NCT00436748|324163525|FG000|Overall Study|Administrative Decision|1|||
94645564|NCT00436748|324163526|FG001|Overall Study|Administrative Decision|0|||
94645565|NCT00436748|324163525|FG000|Overall Study|Lost to Follow-up|0|||
94645566|NCT00436748|324163526|FG001|Overall Study|Lost to Follow-up|1|||
94645567|NCT00436748|324163525|FG000|Overall Study|Protocol-specified Criteria|5|||
94645568|NCT00436748|324163526|FG001|Overall Study|Protocol-specified Criteria|4|||
94645569|NCT00436748|324163525|FG000|Overall Study|Other|3|||
94645570|NCT00436748|324163526|FG001|Overall Study|Other|0|||
94645571|NCT02775344|324163528|FG000|Overall Study|No ovarian cyst identified|3|||
94645572|NCT02775344|324163529|FG001|Overall Study|No ovarian cyst identified|2|||
94645573|NCT00314574|324163532|FG000|Overall Study|Death|3|||
94645574|NCT00314574|324163533|FG001|Overall Study|Death|0|||
94645575|NCT00314574|324163532|FG000|Overall Study|Adverse Event|11|||
94645576|NCT00314574|324163533|FG001|Overall Study|Adverse Event|16|||
94645577|NCT00314574|324163532|FG000|Overall Study|Lost to Follow-up|19|||
94645578|NCT00314574|324163533|FG001|Overall Study|Lost to Follow-up|25|||
94645579|NCT00314574|324163532|FG000|Overall Study|Withdrawal by Subject|33|||
94645580|NCT00314574|324163533|FG001|Overall Study|Withdrawal by Subject|22|||
94645581|NCT00314574|324163532|FG000|Overall Study|Physician Decision|22|||
94645582|NCT00314574|324163533|FG001|Overall Study|Physician Decision|15|||
94645583|NCT00314574|324163532|FG000|Overall Study|Pregnancy|6|||
94645584|NCT00314574|324163533|FG001|Overall Study|Pregnancy|4|||
94645585|NCT00314574|324163532|FG000|Overall Study|Data unknown at database lock|0|||
94645586|NCT00314574|324163533|FG001|Overall Study|Data unknown at database lock|1|||
94645587|NCT02272413|324163536|FG000|Randomized Through Treatment Start|Not treated|3|||
94645588|NCT02272413|324163537|FG001|Randomized Through Treatment Start|Not treated|5|||
94645589|NCT02272413|324163536|FG000|Pre-switch Period|Adverse Event|38|||
94645590|NCT02272413|324163537|FG001|Pre-switch Period|Adverse Event|37|||
94645591|NCT02272413|324163536|FG000|Pre-switch Period|Death|26|||
94645592|NCT02272413|324163537|FG001|Pre-switch Period|Death|26|||
94645593|NCT02272413|324163536|FG000|Pre-switch Period|Withdrawal by Subject|27|||
94645594|NCT02272413|324163537|FG001|Pre-switch Period|Withdrawal by Subject|15|||
94645595|NCT02272413|324163536|FG000|Pre-switch Period|Physician Decision|6|||
94645596|NCT02272413|324163537|FG001|Pre-switch Period|Physician Decision|18|||
94645597|NCT02272413|324163536|FG000|Pre-switch Period|Progressive disease|185|||
94645598|NCT02272413|324163537|FG001|Pre-switch Period|Progressive disease|173|||
94645599|NCT02272413|324163536|FG000|Pre-switch Period|Lost to Follow-up|0|||
94645600|NCT02272413|324163537|FG001|Pre-switch Period|Lost to Follow-up|2|||
94645601|NCT02272413|324163536|FG000|Pre-switch Period|Protocol Violation|1|||
94645602|NCT02272413|324163537|FG001|Pre-switch Period|Protocol Violation|0|||
94645603|NCT02272413|324163536|FG000|Pre-switch Period|Other than listed|10|||
94645604|NCT02272413|324163537|FG001|Pre-switch Period|Other than listed|11|||
94645605|NCT02272413|324163536|FG000|Post-switch Period|Adverse Event|4|||
94645606|NCT02272413|324163537|FG001|Post-switch Period|Adverse Event|4|||
94645607|NCT02272413|324163536|FG000|Post-switch Period|Death|3|||
94645608|NCT02272413|324163537|FG001|Post-switch Period|Death|2|||
94645609|NCT02272413|324163536|FG000|Post-switch Period|Withdrawal by Subject|1|||
94645610|NCT02272413|324163537|FG001|Post-switch Period|Withdrawal by Subject|2|||
94645611|NCT02272413|324163536|FG000|Post-switch Period|Physician Decision|1|||
94645612|NCT02272413|324163537|FG001|Post-switch Period|Physician Decision|1|||
94645613|NCT02272413|324163536|FG000|Post-switch Period|Progressive disease|21|||
94645614|NCT02272413|324163537|FG001|Post-switch Period|Progressive disease|21|||
94645615|NCT02272413|324163536|FG000|Post-switch Period|Study terminated by sponsor|8|||
94645616|NCT02272413|324163537|FG001|Post-switch Period|Study terminated by sponsor|11|||
94645617|NCT02272413|324163536|FG000|Post-switch Period|Other than listed|4|||
94645618|NCT02272413|324163537|FG001|Post-switch Period|Other than listed|5|||
94645619|NCT02126969|324163538|FG000|Overall Study|Withdrawal by Subject|1|||
94645620|NCT02126969|324163539|FG001|Overall Study|Withdrawal by Subject|2|||
94645621|NCT00423891|324163540|FG000|Enrolled|Withdrawal by Subject|0|||
94645622|NCT00423891|324163541|FG001|Enrolled|Withdrawal by Subject|0|||
94645623|NCT00423891|324163542|FG002|Enrolled|Withdrawal by Subject|1|||
94645624|NCT00423891|324163540|FG000|Enrolled|Lost to Follow-up|0|||
94645625|NCT00423891|324163541|FG001|Enrolled|Lost to Follow-up|0|||
94645626|NCT00423891|324163542|FG002|Enrolled|Lost to Follow-up|1|||
94645627|NCT00423891|324163540|FG000|Enrolled|No longer met criteria|11|||
94645628|NCT00423891|324163541|FG001|Enrolled|No longer met criteria|2|||
94645629|NCT00423891|324163542|FG002|Enrolled|No longer met criteria|1|||
94645630|NCT00423891|324163540|FG000|Treatment|Withdrawal by Subject|1|||
94645631|NCT00423891|324163541|FG001|Treatment|Withdrawal by Subject|0|||
94363938|NCT01306968|323116771|FG001|Overall Study|Withdrew over privacy concerns|0|||
94645632|NCT00423891|324163542|FG002|Treatment|Withdrawal by Subject|0|||
94645633|NCT00423891|324163540|FG000|Treatment|Lost to Follow-up|1|||
94645634|NCT00423891|324163541|FG001|Treatment|Lost to Follow-up|0|||
94645635|NCT00423891|324163542|FG002|Treatment|Lost to Follow-up|0|||
94645636|NCT00423891|324163540|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
94645637|NCT00423891|324163541|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
94645638|NCT00423891|324163542|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
94645639|NCT00423891|324163540|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
94645640|NCT00423891|324163541|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
94645641|NCT00423891|324163542|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
94645642|NCT00414661|324163543|FG000|Overall Study|Death|2|||
94645643|NCT00414661|324163544|FG001|Overall Study|Death|5|||
94645644|NCT00414661|324163545|FG002|Overall Study|Death|0|||
94645645|NCT00414661|324163546|FG003|Overall Study|Death|0|||
94645646|NCT00414661|324163543|FG000|Overall Study|Lost to Follow-up|1|||
94645647|NCT00414661|324163544|FG001|Overall Study|Lost to Follow-up|4|||
94645648|NCT00414661|324163545|FG002|Overall Study|Lost to Follow-up|0|||
94645649|NCT00414661|324163546|FG003|Overall Study|Lost to Follow-up|1|||
94645650|NCT00414661|324163543|FG000|Overall Study|Withdrawal by Subject|5|||
94645651|NCT00414661|324163544|FG001|Overall Study|Withdrawal by Subject|2|||
94645652|NCT00414661|324163545|FG002|Overall Study|Withdrawal by Subject|2|||
94645653|NCT00414661|324163546|FG003|Overall Study|Withdrawal by Subject|2|||
94645654|NCT00414661|324163543|FG000|Overall Study|Other|6|||
94645655|NCT00414661|324163544|FG001|Overall Study|Other|3|||
94645656|NCT00414661|324163545|FG002|Overall Study|Other|0|||
94645657|NCT00414661|324163546|FG003|Overall Study|Other|0|||
94645658|NCT01143090|324163547|FG000|Overall Study|Lack of Efficacy|2|||
94645659|NCT01143090|324163547|FG000|Overall Study|Adverse Event|17|||
94645660|NCT01143090|324163547|FG000|Overall Study|Lost to Follow-up|9|||
94645661|NCT01143090|324163547|FG000|Overall Study|Protocol Violation|2|||
94645662|NCT01143090|324163547|FG000|Overall Study|Withdrawal by Subject|18|||
94645663|NCT01143090|324163547|FG000|Overall Study|Non-compliance with study drug|1|||
94645664|NCT01143090|324163547|FG000|Overall Study|Failure to meet eligibility criteria|1|||
94645665|NCT01143090|324163547|FG000|Overall Study|Administrative|1|||
94645666|NCT03491150|324163548|FG000|Overall Study|Adverse Event|1|||
94645667|NCT03491150|324163549|FG001|Overall Study|Adverse Event|0|||
94645668|NCT03491150|324163548|FG000|Overall Study|Study Terminated by Sponsor|74|||
94645669|NCT03491150|324163549|FG001|Overall Study|Study Terminated by Sponsor|70|||
94645670|NCT03491150|324163548|FG000|Overall Study|Other|0|||
94645671|NCT03491150|324163549|FG001|Overall Study|Other|1|||
94645672|NCT03491150|324163548|FG000|Overall Study|Withdrawal by Subject|1|||
94645673|NCT03491150|324163549|FG001|Overall Study|Withdrawal by Subject|2|||
94645674|NCT01828034|324163550|FG000|Overall Study|Withdrawal by Subject|0|||
94645675|NCT01828034|324163551|FG001|Overall Study|Withdrawal by Subject|0|||
94645676|NCT01828034|324163552|FG002|Overall Study|Withdrawal by Subject|0|||
94645677|NCT01828034|324163553|FG003|Overall Study|Withdrawal by Subject|1|||
94645678|NCT01988571|324163554|FG000|Overall Study|Death|3|||
94645679|NCT01988571|324163555|FG001|Overall Study|Death|1|||
94645680|NCT01988571|324163554|FG000|Overall Study|Physician Decision|2|||
94645681|NCT01988571|324163555|FG001|Overall Study|Physician Decision|1|||
94645682|NCT01988571|324163554|FG000|Overall Study|Lost to Follow-up|3|||
94645683|NCT01988571|324163555|FG001|Overall Study|Lost to Follow-up|0|||
94645684|NCT01988571|324163554|FG000|Overall Study|Withdrawal by Subject|31|||
94645685|NCT01988571|324163555|FG001|Overall Study|Withdrawal by Subject|33|||
94645686|NCT00486265|324163558|FG000|Overall Study|Adverse Event|1|||
94645687|NCT00486265|324163558|FG000|Overall Study|Lack of Efficacy|8|||
94645688|NCT02346136|324163559|FG000|Overall Study|Withdrawal by Subject|7|||
94645689|NCT02346136|324163560|FG001|Overall Study|Withdrawal by Subject|5|||
94680017|NCT04836858|324284202|FG002|Overall Study|Lost to Follow-up|0|||
94680018|NCT04836858|324284203|FG003|Overall Study|Lost to Follow-up|0|||
94680019|NCT04836858|324284200|FG000|Overall Study|Subject/Guardian decision|3|||
94680020|NCT04836858|324284201|FG001|Overall Study|Subject/Guardian decision|0|||
94680021|NCT04836858|324284202|FG002|Overall Study|Subject/Guardian decision|0|||
94680022|NCT04836858|324284203|FG003|Overall Study|Subject/Guardian decision|1|||
94680023|NCT04836858|324284200|FG000|Overall Study|Randomized but not treated|4|||
94680024|NCT04836858|324284201|FG001|Overall Study|Randomized but not treated|0|||
94680025|NCT04836858|324284202|FG002|Overall Study|Randomized but not treated|0|||
94680026|NCT04836858|324284203|FG003|Overall Study|Randomized but not treated|0|||
94680027|NCT03124199|324284205|FG000|Overall Study|Lost to Follow-up|4|||
94680028|NCT02798211|324284206|FG000|Period 1|Adverse Event|1|||
94680029|NCT02798211|324284207|FG001|Period 1|Adverse Event|1|||
94680030|NCT02798211|324284208|FG002|Period 1|Adverse Event|0|||
94680031|NCT02798211|324284209|FG003|Period 1|Adverse Event|0|||
94680032|NCT02798211|324284210|FG004|Period 1|Adverse Event|0|||
94680033|NCT02798211|324284211|FG005|Period 1|Adverse Event|0|||
94680034|NCT02798211|324284206|FG000|Period 1|Lost to Follow-up|2|||
94680035|NCT02798211|324284207|FG001|Period 1|Lost to Follow-up|1|||
94680036|NCT02798211|324284208|FG002|Period 1|Lost to Follow-up|0|||
94680037|NCT02798211|324284209|FG003|Period 1|Lost to Follow-up|0|||
94680038|NCT02798211|324284210|FG004|Period 1|Lost to Follow-up|0|||
94680039|NCT02798211|324284211|FG005|Period 1|Lost to Follow-up|0|||
94680040|NCT02798211|324284206|FG000|Period 1|Protocol Violation|0|||
94680041|NCT02798211|324284207|FG001|Period 1|Protocol Violation|0|||
94680042|NCT02798211|324284208|FG002|Period 1|Protocol Violation|2|||
94680043|NCT02798211|324284209|FG003|Period 1|Protocol Violation|0|||
94680044|NCT02798211|324284210|FG004|Period 1|Protocol Violation|0|||
94680045|NCT02798211|324284211|FG005|Period 1|Protocol Violation|0|||
94680046|NCT02798211|324284206|FG000|Period 1|Withdrawal by Subject|1|||
94680047|NCT02798211|324284207|FG001|Period 1|Withdrawal by Subject|1|||
94680048|NCT02798211|324284208|FG002|Period 1|Withdrawal by Subject|0|||
94680049|NCT02798211|324284209|FG003|Period 1|Withdrawal by Subject|0|||
94680050|NCT02798211|324284210|FG004|Period 1|Withdrawal by Subject|0|||
94680051|NCT02798211|324284211|FG005|Period 1|Withdrawal by Subject|0|||
94680052|NCT02798211|324284206|FG000|Period 1|Death|0|||
94680053|NCT02798211|324284207|FG001|Period 1|Death|0|||
94680054|NCT02798211|324284208|FG002|Period 1|Death|1|||
94680055|NCT02798211|324284209|FG003|Period 1|Death|0|||
94680056|NCT02798211|324284210|FG004|Period 1|Death|0|||
94680057|NCT02798211|324284211|FG005|Period 1|Death|0|||
94680058|NCT02798211|324284206|FG000|Period 1|Withdrawal of Informed Consent|2|||
94680059|NCT02798211|324284207|FG001|Period 1|Withdrawal of Informed Consent|7|||
94680060|NCT02798211|324284208|FG002|Period 1|Withdrawal of Informed Consent|3|||
94680061|NCT02798211|324284209|FG003|Period 1|Withdrawal of Informed Consent|0|||
94680062|NCT02798211|324284210|FG004|Period 1|Withdrawal of Informed Consent|0|||
94680063|NCT02798211|324284211|FG005|Period 1|Withdrawal of Informed Consent|0|||
94680064|NCT02798211|324284206|FG000|Period 2|Withdrawal by Subject|2|||
94680065|NCT02798211|324284207|FG001|Period 2|Withdrawal by Subject|0|||
94680066|NCT02798211|324284208|FG002|Period 2|Withdrawal by Subject|0|||
94680067|NCT02798211|324284209|FG003|Period 2|Withdrawal by Subject|0|||
94680068|NCT02798211|324284210|FG004|Period 2|Withdrawal by Subject|2|||
94680069|NCT02798211|324284211|FG005|Period 2|Withdrawal by Subject|2|||
94680070|NCT02798211|324284206|FG000|Period 2|Adverse Event|5|||
94680071|NCT02798211|324284207|FG001|Period 2|Adverse Event|0|||
94680072|NCT02798211|324284208|FG002|Period 2|Adverse Event|0|||
94680073|NCT02798211|324284209|FG003|Period 2|Adverse Event|0|||
94680074|NCT02798211|324284210|FG004|Period 2|Adverse Event|1|||
94680075|NCT02798211|324284211|FG005|Period 2|Adverse Event|0|||
94680076|NCT02798211|324284206|FG000|Period 2|Lack of Efficacy|1|||
94680077|NCT02798211|324284207|FG001|Period 2|Lack of Efficacy|0|||
94680078|NCT02798211|324284208|FG002|Period 2|Lack of Efficacy|0|||
94680079|NCT02798211|324284209|FG003|Period 2|Lack of Efficacy|1|||
94645690|NCT02346136|324163559|FG000|Overall Study|Death|1|||
94645691|NCT02346136|324163560|FG001|Overall Study|Death|0|||
94645692|NCT02346136|324163559|FG000|Overall Study|Study termination|14|||
94645693|NCT02346136|324163560|FG001|Overall Study|Study termination|18|||
94645694|NCT03029624|324163564|FG000|Overall Study|Adverse Event|1|||
94645695|NCT03029624|324163564|FG000|Overall Study|Withdrawal by Subject|1|||
94645696|NCT03029624|324163564|FG000|Overall Study|Lack of Efficacy|1|||
94645697|NCT03029624|324163564|FG000|Overall Study|MRI need|2|||
94645698|NCT04116710|324163568|FG000|Overall Study|Death|4|||
94645699|NCT04116710|324163569|FG001|Overall Study|Death|6|||
94645700|NCT04116710|324163570|FG002|Overall Study|Death|3|||
94645701|NCT04116710|324163571|FG003|Overall Study|Death|1|||
94645702|NCT04116710|324163568|FG000|Overall Study|Withdrawal by Subject|0|||
94645703|NCT04116710|324163569|FG001|Overall Study|Withdrawal by Subject|0|||
94645704|NCT04116710|324163570|FG002|Overall Study|Withdrawal by Subject|0|||
94645705|NCT04116710|324163571|FG003|Overall Study|Withdrawal by Subject|1|||
94645706|NCT00582933|324163574|FG000|Overall Study|Physician Decision|3|||
94645707|NCT00547703|324163575|FG000|Overall Study|Lost to Follow-up|1|||
94645708|NCT00547703|324163576|FG001|Overall Study|Lost to Follow-up|0|||
94645709|NCT03742141|324163581|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
94645710|NCT00838565|324163583|FG000|Overall Study|Withdrawal by Subject|0|||
94645711|NCT00838565|324163584|FG001|Overall Study|Withdrawal by Subject|0|||
94645712|NCT00838565|324163585|FG002|Overall Study|Withdrawal by Subject|1|||
94645713|NCT00838565|324163586|FG003|Overall Study|Withdrawal by Subject|0|||
94645714|NCT00838565|324163587|FG004|Overall Study|Withdrawal by Subject|0|||
94645715|NCT00838565|324163588|FG005|Overall Study|Withdrawal by Subject|2|||
94645716|NCT00838565|324163583|FG000|Overall Study|Other|0|||
94645717|NCT00838565|324163584|FG001|Overall Study|Other|2|||
94645718|NCT00838565|324163585|FG002|Overall Study|Other|0|||
94645719|NCT00838565|324163586|FG003|Overall Study|Other|0|||
94645720|NCT00838565|324163587|FG004|Overall Study|Other|0|||
94645721|NCT00838565|324163588|FG005|Overall Study|Other|0|||
94645722|NCT00838565|324163583|FG000|Overall Study|Randomized but not Treated|0|||
94645723|NCT00838565|324163584|FG001|Overall Study|Randomized but not Treated|1|||
94645724|NCT00838565|324163585|FG002|Overall Study|Randomized but not Treated|0|||
94645725|NCT00838565|324163586|FG003|Overall Study|Randomized but not Treated|0|||
94645726|NCT00838565|324163587|FG004|Overall Study|Randomized but not Treated|0|||
94645727|NCT00838565|324163588|FG005|Overall Study|Randomized but not Treated|0|||
94645728|NCT04552587|324163590|FG000|Overall Study|Lost to Follow-up|4|||
94645729|NCT04019041|324163593|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
94645730|NCT04019041|324163594|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
94645731|NCT04019041|324163595|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
94645732|NCT04019041|324163596|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
94645733|NCT04019041|324163597|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
94645734|NCT04019041|324163598|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
94645735|NCT04019041|324163593|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
94645736|NCT04019041|324163594|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
94645737|NCT04019041|324163595|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
94645738|NCT04019041|324163596|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
94645739|NCT04019041|324163597|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
94645740|NCT04019041|324163598|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
94645741|NCT04019041|324163593|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
94645742|NCT04019041|324163594|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
94645743|NCT04019041|324163595|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
94645744|NCT04019041|324163596|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
94645745|NCT04019041|324163597|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
94645746|NCT04019041|324163598|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
94645747|NCT04019041|324163593|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
94645748|NCT04019041|324163594|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
94645749|NCT04019041|324163595|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
94645750|NCT04019041|324163596|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
94645751|NCT04019041|324163597|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
94645752|NCT04019041|324163598|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
94645753|NCT04019041|324163593|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
94645754|NCT04019041|324163594|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
94645755|NCT04019041|324163595|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
94645756|NCT04019041|324163596|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
94645757|NCT04019041|324163597|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
94680080|NCT02798211|324284210|FG004|Period 2|Lack of Efficacy|0|||
94680081|NCT02798211|324284211|FG005|Period 2|Lack of Efficacy|1|||
94680082|NCT02798211|324284206|FG000|Period 2|Lost to Follow-up|3|||
94680083|NCT02798211|324284207|FG001|Period 2|Lost to Follow-up|0|||
94680084|NCT02798211|324284208|FG002|Period 2|Lost to Follow-up|0|||
94680085|NCT02798211|324284209|FG003|Period 2|Lost to Follow-up|0|||
94680086|NCT02798211|324284210|FG004|Period 2|Lost to Follow-up|2|||
94680087|NCT02798211|324284211|FG005|Period 2|Lost to Follow-up|0|||
94680088|NCT02798211|324284206|FG000|Period 2|Physician Decision|1|||
94680089|NCT02798211|324284207|FG001|Period 2|Physician Decision|0|||
94680090|NCT02798211|324284208|FG002|Period 2|Physician Decision|0|||
94680091|NCT02798211|324284209|FG003|Period 2|Physician Decision|1|||
94680092|NCT02798211|324284210|FG004|Period 2|Physician Decision|1|||
94680093|NCT02798211|324284211|FG005|Period 2|Physician Decision|0|||
94680094|NCT02798211|324284206|FG000|Period 2|Pregnancy|0|||
94680095|NCT02798211|324284207|FG001|Period 2|Pregnancy|0|||
94680096|NCT02798211|324284208|FG002|Period 2|Pregnancy|0|||
94680097|NCT02798211|324284209|FG003|Period 2|Pregnancy|2|||
94680098|NCT02798211|324284210|FG004|Period 2|Pregnancy|0|||
94680099|NCT02798211|324284211|FG005|Period 2|Pregnancy|0|||
94680100|NCT02798211|324284206|FG000|Period 2|Technical problems|1|||
94680101|NCT02798211|324284207|FG001|Period 2|Technical problems|0|||
94680102|NCT02798211|324284208|FG002|Period 2|Technical problems|0|||
94680103|NCT02798211|324284209|FG003|Period 2|Technical problems|1|||
94680104|NCT02798211|324284210|FG004|Period 2|Technical problems|0|||
94680105|NCT02798211|324284211|FG005|Period 2|Technical problems|0|||
94680106|NCT02798211|324284206|FG000|Period 2|Withdrawal of Informed Consent|1|||
94680107|NCT02798211|324284207|FG001|Period 2|Withdrawal of Informed Consent|0|||
94680108|NCT02798211|324284208|FG002|Period 2|Withdrawal of Informed Consent|0|||
94680109|NCT02798211|324284209|FG003|Period 2|Withdrawal of Informed Consent|2|||
94680110|NCT02798211|324284210|FG004|Period 2|Withdrawal of Informed Consent|2|||
94680111|NCT02798211|324284211|FG005|Period 2|Withdrawal of Informed Consent|3|||
94680112|NCT02312856|324284215|FG000|Overall Study|Death|1|||
94680113|NCT02312856|324284215|FG000|Overall Study|Lost to Follow-up|3|||
94680114|NCT03086018|324284217|FG000|Final Testing for End of Trial|Adverse Event|1|||
94680115|NCT03086018|324284217|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
94680116|NCT03505476|324284220|FG000|Overall Study|Physician Decision|18|||
94680117|NCT03505476|324284220|FG000|Overall Study|Device Malfunctioned|101|||
94680118|NCT03505476|324284220|FG000|Overall Study|Data Corrupt|6|||
94680119|NCT03505476|324284220|FG000|Overall Study|Device application insufficiant|3|||
94680120|NCT04026165|324284225|FG000|Run-in Placebo Period|Enrollment Error|13|||
94680121|NCT04026165|324284226|FG001|Run-in Placebo Period|Enrollment Error|0|||
94680122|NCT04026165|324284227|FG002|Run-in Placebo Period|Enrollment Error|0|||
94680123|NCT04026165|324284228|FG003|Run-in Placebo Period|Enrollment Error|0|||
94680124|NCT04026165|324284225|FG000|Run-in Placebo Period|Run-in Failure|4|||
94680125|NCT04026165|324284226|FG001|Run-in Placebo Period|Run-in Failure|0|||
94680126|NCT04026165|324284227|FG002|Run-in Placebo Period|Run-in Failure|0|||
94680127|NCT04026165|324284228|FG003|Run-in Placebo Period|Run-in Failure|0|||
94680128|NCT04026165|324284225|FG000|Run-in Placebo Period|Protocol Violation|2|||
94680129|NCT04026165|324284226|FG001|Run-in Placebo Period|Protocol Violation|0|||
94680130|NCT04026165|324284227|FG002|Run-in Placebo Period|Protocol Violation|0|||
94680131|NCT04026165|324284228|FG003|Run-in Placebo Period|Protocol Violation|0|||
94680132|NCT04026165|324284225|FG000|Run-in Placebo Period|Withdrew Consent|2|||
94680133|NCT04026165|324284226|FG001|Run-in Placebo Period|Withdrew Consent|0|||
94680134|NCT04026165|324284227|FG002|Run-in Placebo Period|Withdrew Consent|0|||
94680135|NCT04026165|324284228|FG003|Run-in Placebo Period|Withdrew Consent|0|||
94680136|NCT04026165|324284225|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
94680137|NCT04026165|324284226|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
94680138|NCT04026165|324284227|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
94680139|NCT04026165|324284228|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
94680140|NCT04026165|324284225|FG000|Run-in SEL Period|Run-in Failure|0|||
94680141|NCT04026165|324284226|FG001|Run-in SEL Period|Run-in Failure|26|||
94680142|NCT04026165|324284227|FG002|Run-in SEL Period|Run-in Failure|0|||
94680143|NCT04026165|324284228|FG003|Run-in SEL Period|Run-in Failure|0|||
94680144|NCT04026165|324284225|FG000|Run-in SEL Period|Withdrew Consent|0|||
94680145|NCT04026165|324284226|FG001|Run-in SEL Period|Withdrew Consent|10|||
94680146|NCT04026165|324284227|FG002|Run-in SEL Period|Withdrew Consent|0|||
94680147|NCT04026165|324284228|FG003|Run-in SEL Period|Withdrew Consent|0|||
94680148|NCT04026165|324284225|FG000|Run-in SEL Period|Enrollment Error|0|||
94680149|NCT04026165|324284226|FG001|Run-in SEL Period|Enrollment Error|4|||
94680150|NCT04026165|324284227|FG002|Run-in SEL Period|Enrollment Error|0|||
94680151|NCT04026165|324284228|FG003|Run-in SEL Period|Enrollment Error|0|||
94680152|NCT04026165|324284225|FG000|Run-in SEL Period|Protocol Violation|0|||
94680153|NCT04026165|324284226|FG001|Run-in SEL Period|Protocol Violation|3|||
94645758|NCT04019041|324163598|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
94645759|NCT04019041|324163593|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
94645760|NCT04019041|324163594|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
94645761|NCT04019041|324163595|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
94645762|NCT04019041|324163596|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
94645763|NCT04019041|324163597|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
94645764|NCT04019041|324163598|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
94645765|NCT04019041|324163593|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
94645766|NCT04019041|324163594|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
94645767|NCT04019041|324163595|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
94645768|NCT04019041|324163596|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
94645769|NCT04019041|324163597|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
94645770|NCT04019041|324163598|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
94645771|NCT04019041|324163593|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
94645772|NCT04019041|324163594|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
94645773|NCT04019041|324163595|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
94645774|NCT04019041|324163596|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
94645775|NCT04019041|324163597|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
94645776|NCT04019041|324163598|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
94645777|NCT04019041|324163593|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
94645778|NCT04019041|324163594|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
94645779|NCT04019041|324163595|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
94645780|NCT04019041|324163596|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
94645781|NCT04019041|324163597|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
94645782|NCT04019041|324163598|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
94645783|NCT00590954|324163603|FG000|Overall Study|Inevaluable|2|||
94645784|NCT00502697|324165226|FG000|Overall Study|Withdrawal by Subject|3|||
94645785|NCT00502697|324165227|FG001|Overall Study|Withdrawal by Subject|1|||
94645786|NCT00502697|324165226|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
94645787|NCT00502697|324165227|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
94645788|NCT00502697|324165226|FG000|Overall Study|found not to meet eligibility criteria|3|||
94645789|NCT00502697|324165227|FG001|Overall Study|found not to meet eligibility criteria|4|||
94645790|NCT00502697|324165226|FG000|Overall Study|did not meet assignment criteria|4|||
94645791|NCT00502697|324165227|FG001|Overall Study|did not meet assignment criteria|2|||
94645792|NCT01545817|324165228|FG000|Pazopanib|Disease progression|51|||
94645793|NCT01545817|324165229|FG001|Pazopanib|Disease progression|0|||
94645794|NCT01545817|324165228|FG000|Pazopanib|Adverse Event|19|||
94645795|NCT01545817|324165229|FG001|Pazopanib|Adverse Event|0|||
94645796|NCT01545817|324165228|FG000|Pazopanib|Other reason|4|||
94645797|NCT01545817|324165229|FG001|Pazopanib|Other reason|0|||
94645798|NCT01545817|324165228|FG000|Everolimus|Other reason|0|||
94645799|NCT01545817|324165229|FG001|Everolimus|Other reason|7|||
94645800|NCT01545817|324165228|FG000|Everolimus|Disease progression|0|||
94645801|NCT01545817|324165229|FG001|Everolimus|Disease progression|25|||
94645802|NCT01545817|324165228|FG000|Everolimus|Adverse Event|0|||
94645803|NCT01545817|324165229|FG001|Everolimus|Adverse Event|6|||
94645804|NCT01572038|324165237|FG000|Overall Study|Death|648|||
94645805|NCT01572038|324165237|FG000|Overall Study|Withdrawal by Subject|204|||
94645806|NCT01572038|324165237|FG000|Overall Study|Lost to Follow-up|81|||
94645807|NCT01572038|324165237|FG000|Overall Study|Physician Decision|20|||
94645808|NCT01572038|324165237|FG000|Overall Study|Patient Decision|14|||
94645809|NCT01572038|324165237|FG000|Overall Study|Progressive Disease|8|||
94645810|NCT01572038|324165237|FG000|Overall Study|Site Closed Before Completing Form|6|||
94645811|NCT01572038|324165237|FG000|Overall Study|Enrolled into Another Trial|3|||
94645812|NCT01572038|324165237|FG000|Overall Study|Participated in Another Trial|3|||
94645813|NCT01572038|324165237|FG000|Overall Study|Termination by Sponsor|2|||
94645814|NCT01572038|324165237|FG000|Overall Study|Patient Deterioration|1|||
94645815|NCT01572038|324165237|FG000|Overall Study|Sponsor Decision|1|||
94645816|NCT03643562|324165238|FG000|Overall Study|Adverse Event|1|||
94645817|NCT03643562|324165239|FG001|Overall Study|Adverse Event|0|||
94645818|NCT03643562|324165238|FG000|Overall Study|Lack of Efficacy|0|||
94645819|NCT03643562|324165239|FG001|Overall Study|Lack of Efficacy|1|||
94645820|NCT03643562|324165238|FG000|Overall Study|Physician Decision|0|||
94645821|NCT03643562|324165239|FG001|Overall Study|Physician Decision|1|||
94645822|NCT03643562|324165238|FG000|Overall Study|Study Terminated by Sponsor|2|||
94645823|NCT03643562|324165239|FG001|Overall Study|Study Terminated by Sponsor|10|||
94645824|NCT03643562|324165238|FG000|Overall Study|Withdrawal by Subject|2|||
94645825|NCT03643562|324165239|FG001|Overall Study|Withdrawal by Subject|2|||
94645826|NCT03643562|324165238|FG000|Overall Study|Other than specified|3|||
94645827|NCT03643562|324165239|FG001|Overall Study|Other than specified|2|||
94645828|NCT01933048|324165240|FG000|Overall Study|Lost to Follow-up|15|||
94645829|NCT01933048|324165241|FG001|Overall Study|Lost to Follow-up|18|||
94645830|NCT01933048|324165240|FG000|Overall Study|personal reasons|1|||
94680154|NCT04026165|324284227|FG002|Run-in SEL Period|Protocol Violation|0|||
94680155|NCT04026165|324284228|FG003|Run-in SEL Period|Protocol Violation|0|||
94680156|NCT04026165|324284225|FG000|Run-in SEL Period|Investigator's Discretion|0|||
94680157|NCT04026165|324284226|FG001|Run-in SEL Period|Investigator's Discretion|2|||
94680158|NCT04026165|324284227|FG002|Run-in SEL Period|Investigator's Discretion|0|||
94680159|NCT04026165|324284228|FG003|Run-in SEL Period|Investigator's Discretion|0|||
94680160|NCT04026165|324284225|FG000|Run-in SEL Period|Death|0|||
94680161|NCT04026165|324284226|FG001|Run-in SEL Period|Death|1|||
94680162|NCT04026165|324284227|FG002|Run-in SEL Period|Death|0|||
94680163|NCT04026165|324284228|FG003|Run-in SEL Period|Death|0|||
94680164|NCT04026165|324284225|FG000|Randomized Period|Withdrew Consent|0|||
94680165|NCT04026165|324284226|FG001|Randomized Period|Withdrew Consent|0|||
94680166|NCT04026165|324284227|FG002|Randomized Period|Withdrew Consent|5|||
94680167|NCT04026165|324284228|FG003|Randomized Period|Withdrew Consent|8|||
94680168|NCT04026165|324284225|FG000|Randomized Period|Death|0|||
94680169|NCT04026165|324284226|FG001|Randomized Period|Death|0|||
94680170|NCT04026165|324284227|FG002|Randomized Period|Death|5|||
94680171|NCT04026165|324284228|FG003|Randomized Period|Death|7|||
94680172|NCT04026165|324284225|FG000|Randomized Period|Investigator's Discretion|0|||
94680173|NCT04026165|324284226|FG001|Randomized Period|Investigator's Discretion|0|||
94680174|NCT04026165|324284227|FG002|Randomized Period|Investigator's Discretion|2|||
94263675|NCT00537485|322759896|FG001|Overall Study|Adverse Event|5|||
94645831|NCT01933048|324165241|FG001|Overall Study|personal reasons|1|||
94645832|NCT01933048|324165240|FG000|Overall Study|Protocol Violation|7|||
94645833|NCT01933048|324165241|FG001|Overall Study|Protocol Violation|8|||
94645834|NCT01933048|324165240|FG000|Overall Study|Physician Decision|1|||
94645835|NCT01933048|324165241|FG001|Overall Study|Physician Decision|0|||
94645836|NCT01933048|324165240|FG000|Overall Study|unknown reasons|1|||
94645837|NCT01933048|324165241|FG001|Overall Study|unknown reasons|1|||
94645838|NCT01921829|324165242|FG000|Overall Study|Withdrawal by Subject|0|||
94645839|NCT01921829|324165243|FG001|Overall Study|Withdrawal by Subject|1|||
94645840|NCT02643251|324165244|FG000|Overall Study|Adverse Event|3|||
94645841|NCT02643251|324165245|FG001|Overall Study|Adverse Event|1|||
94645842|NCT02643251|324165244|FG000|Overall Study|Withdrawal by Subject|2|||
94645843|NCT02643251|324165245|FG001|Overall Study|Withdrawal by Subject|0|||
94645844|NCT02643251|324165244|FG000|Overall Study|Lost to Follow-up|4|||
94645845|NCT02643251|324165245|FG001|Overall Study|Lost to Follow-up|1|||
94645846|NCT02643251|324165244|FG000|Overall Study|Protocol Violation|1|||
94645847|NCT02643251|324165245|FG001|Overall Study|Protocol Violation|0|||
94645848|NCT02643251|324165244|FG000|Overall Study|PI Decision to terminate patient|1|||
94645849|NCT02643251|324165245|FG001|Overall Study|PI Decision to terminate patient|0|||
94645850|NCT01632891|324165246|FG000|Overall Study|Lost to Follow-up|0|||
94645851|NCT01632891|324165247|FG001|Overall Study|Lost to Follow-up|1|||
94645852|NCT01632891|324165246|FG000|Overall Study|Withdrawal by Subject|1|||
94645853|NCT01632891|324165247|FG001|Overall Study|Withdrawal by Subject|0|||
94645854|NCT02365636|324165253|FG000|Overall Study|Adverse Event|3|||
94645855|NCT02365636|324165254|FG001|Overall Study|Adverse Event|3|||
94645856|NCT02365636|324165255|FG002|Overall Study|Adverse Event|2|||
94645857|NCT02365636|324165253|FG000|Overall Study|Protocol Violation|1|||
94645858|NCT02365636|324165254|FG001|Overall Study|Protocol Violation|4|||
94645859|NCT02365636|324165255|FG002|Overall Study|Protocol Violation|0|||
94645860|NCT02365636|324165253|FG000|Overall Study|Lost to Follow-up|0|||
94645861|NCT02365636|324165254|FG001|Overall Study|Lost to Follow-up|0|||
94645862|NCT02365636|324165255|FG002|Overall Study|Lost to Follow-up|1|||
94645863|NCT02365636|324165253|FG000|Overall Study|Other|2|||
94645864|NCT02365636|324165254|FG001|Overall Study|Other|0|||
94645865|NCT02365636|324165255|FG002|Overall Study|Other|0|||
94645866|NCT01454934|324165256|FG000|Overall Study|Clinical progression|28|||
94645867|NCT01454934|324165257|FG001|Overall Study|Clinical progression|25|||
94645868|NCT01454934|324165256|FG000|Overall Study|Other|6|||
94645869|NCT01454934|324165257|FG001|Overall Study|Other|17|||
94645870|NCT01454934|324165256|FG000|Overall Study|Adverse Event|28|||
94645871|NCT01454934|324165257|FG001|Overall Study|Adverse Event|24|||
94645872|NCT01454934|324165256|FG000|Overall Study|Withdrawn consent|2|||
94645873|NCT01454934|324165257|FG001|Overall Study|Withdrawn consent|5|||
94645874|NCT01454934|324165256|FG000|Overall Study|Withdrawal by Subject|11|||
94645875|NCT01454934|324165257|FG001|Overall Study|Withdrawal by Subject|15|||
94645876|NCT01454934|324165256|FG000|Overall Study|Disease progression|194|||
94645877|NCT01454934|324165257|FG001|Overall Study|Disease progression|181|||
94645878|NCT01454934|324165256|FG000|Overall Study|Lost to Follow-up|0|||
94645879|NCT01454934|324165257|FG001|Overall Study|Lost to Follow-up|1|||
94645880|NCT01454934|324165256|FG000|Overall Study|Not treated|1|||
94645881|NCT01454934|324165257|FG001|Overall Study|Not treated|2|||
94645882|NCT01461096|324165262|FG000|Overall Study|Death|3|||
94645883|NCT01461096|324165263|FG001|Overall Study|Death|6|||
94645884|NCT01461096|324165262|FG000|Overall Study|Severe debilitation, unable to continue|1|||
94645885|NCT01461096|324165263|FG001|Overall Study|Severe debilitation, unable to continue|1|||
94645886|NCT01461096|324165262|FG000|Overall Study|Subj not able to get to clinic|15|||
94645887|NCT01461096|324165263|FG001|Overall Study|Subj not able to get to clinic|13|||
94645888|NCT01461096|324165262|FG000|Overall Study|Site is closing|27|||
94645889|NCT01461096|324165263|FG001|Overall Study|Site is closing|30|||
94645890|NCT01461096|324165262|FG000|Overall Study|Withdrawal by Subject|5|||
94645891|NCT01461096|324165263|FG001|Overall Study|Withdrawal by Subject|3|||
94645892|NCT01461096|324165262|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
94645893|NCT01461096|324165263|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
94645894|NCT01461096|324165262|FG000|Overall Study|Lost to Follow-up|8|||
94645895|NCT01461096|324165263|FG001|Overall Study|Lost to Follow-up|4|||
94645896|NCT01452412|324165266|FG000|Overall Study|Withdrawal by Subject|15|||
94645897|NCT01452412|324165267|FG001|Overall Study|Withdrawal by Subject|11|||
94645898|NCT01452412|324165266|FG000|Overall Study|Adverse Event|4|||
94645899|NCT01452412|324165267|FG001|Overall Study|Adverse Event|3|||
94645900|NCT01452412|324165266|FG000|Overall Study|Lost to Follow-up|5|||
94645901|NCT01452412|324165267|FG001|Overall Study|Lost to Follow-up|3|||
94645902|NCT01452412|324165266|FG000|Overall Study|Death|1|||
94645903|NCT01452412|324165267|FG001|Overall Study|Death|0|||
94645904|NCT01452412|324165266|FG000|Overall Study|Initiated dialysis|1|||
94645905|NCT01452412|324165267|FG001|Overall Study|Initiated dialysis|0|||
94645906|NCT01452412|324165266|FG000|Overall Study|Other|2|||
94645907|NCT01452412|324165267|FG001|Overall Study|Other|0|||
94645908|NCT03690388|324165268|FG000|Overall Study|Adverse Event|8|||
94645909|NCT03690388|324165269|FG001|Overall Study|Adverse Event|1|||
94645910|NCT03690388|324165268|FG000|Overall Study|Radiographic Progression|14|||
94645911|NCT03690388|324165269|FG001|Overall Study|Radiographic Progression|29|||
94645912|NCT03690388|324165268|FG000|Overall Study|Clinical deterioration|10|||
94645913|NCT03690388|324165269|FG001|Overall Study|Clinical deterioration|6|||
94645914|NCT03690388|324165268|FG000|Overall Study|Withdrawal by Subject|2|||
94645915|NCT03690388|324165269|FG001|Overall Study|Withdrawal by Subject|0|||
94645916|NCT03690388|324165268|FG000|Overall Study|Lack of Efficacy|1|||
94645917|NCT03690388|324165269|FG001|Overall Study|Lack of Efficacy|0|||
94645918|NCT03690388|324165268|FG000|Overall Study|Lost to Follow-up|1|||
94645919|NCT03690388|324165269|FG001|Overall Study|Lost to Follow-up|0|||
94645920|NCT04960228|324165270|FG000|Overall Study|Withdrawal by Subject|216|||
94645921|NCT04960228|324165271|FG001|Overall Study|Withdrawal by Subject|35|||
94645922|NCT04960228|324165270|FG000|Overall Study|Failed attention check|69|||
94645923|NCT04960228|324165271|FG001|Overall Study|Failed attention check|148|||
94645924|NCT04960228|324165270|FG000|Overall Study|Flagged for response quality by Dynata|3|||
94645925|NCT04960228|324165271|FG001|Overall Study|Flagged for response quality by Dynata|3|||
94645926|NCT01077960|324165272|FG000|Overall Study|Adverse Event|6|||
94645927|NCT01077960|324165272|FG000|Overall Study|Protocol Violation|3|||
94645928|NCT01077960|324165272|FG000|Overall Study|Lost to Follow-up|5|||
94645929|NCT01077960|324165272|FG000|Overall Study|Subject decision|1|||
94645930|NCT01077960|324165272|FG000|Overall Study|Reason unspecified|1|||
94645931|NCT03837899|324165273|FG000|Overall Study|Death|6|||
94645932|NCT03837899|324165274|FG001|Overall Study|Death|8|||
94263676|NCT00537485|322759895|FG000|Overall Study|Withdrawal by Subject|3|||
94263677|NCT00537485|322759896|FG001|Overall Study|Withdrawal by Subject|2|||
94263678|NCT00537485|322759895|FG000|Overall Study|Withdrawal by Subject|1|||
94645933|NCT03837899|324165275|FG002|Overall Study|Death|3|||
94645934|NCT03837899|324165276|FG003|Overall Study|Death|7|||
94645935|NCT03837899|324165277|FG004|Overall Study|Death|8|||
94645936|NCT03837899|324165278|FG005|Overall Study|Death|7|||
94645937|NCT03837899|324165273|FG000|Overall Study|Moved to post-trial access program|0|||
94645938|NCT03837899|324165274|FG001|Overall Study|Moved to post-trial access program|1|||
94645939|NCT03837899|324165275|FG002|Overall Study|Moved to post-trial access program|0|||
94645940|NCT03837899|324165276|FG003|Overall Study|Moved to post-trial access program|0|||
94645941|NCT03837899|324165277|FG004|Overall Study|Moved to post-trial access program|0|||
94680175|NCT04026165|324284228|FG003|Randomized Period|Investigator's Discretion|2|||
94680176|NCT04026165|324284225|FG000|Randomized Period|Lost to Follow-up|0|||
94680177|NCT04026165|324284226|FG001|Randomized Period|Lost to Follow-up|0|||
94680178|NCT04026165|324284227|FG002|Randomized Period|Lost to Follow-up|2|||
94680179|NCT04026165|324284228|FG003|Randomized Period|Lost to Follow-up|2|||
94680180|NCT01287611|324284233|FG000|Overall Study|Lost to Follow-up|29|||
94680181|NCT01287611|324284234|FG001|Overall Study|Lost to Follow-up|16|||
94680182|NCT01287611|324284233|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
94680183|NCT01287611|324284234|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
94680184|NCT00792103|324284235|FG000|Overall Study|Enrolled, not treated|15|||
94680185|NCT00792103|324284235|FG000|Overall Study|Lost to Follow-up|17|||
94680186|NCT00792103|324284235|FG000|Overall Study|Adverse Event|25|||
94680187|NCT00792103|324284235|FG000|Overall Study|Withdrawal by Subject|52|||
94680188|NCT00792103|324284235|FG000|Overall Study|Protocol Violation|10|||
94680189|NCT00792103|324284235|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
94680190|NCT03745222|324284236|FG000|Overall Study|Withdrawal by Subject|0|||
94680191|NCT03745222|324284237|FG001|Overall Study|Withdrawal by Subject|1|||
94680192|NCT03745222|324284238|FG002|Overall Study|Withdrawal by Subject|0|||
94680193|NCT01111838|324284239|FG000|Overall Study|Patient Ineligible|2|||
94680194|NCT01111838|324284239|FG000|Overall Study|Not Treated|3|||
94680195|NCT01111838|324284239|FG000|Overall Study|Clinical deterioration|1|||
94680196|NCT01111838|324284239|FG000|Overall Study|Other Complicating Disease|1|||
94680197|NCT02768662|324284240|FG000|Overall Study|Adverse Event|1|||
94680198|NCT02768662|324284240|FG000|Overall Study|Lost to Follow-up|4|||
94680199|NCT02768662|324284240|FG000|Overall Study|Withdrawal by Subject|3|||
94680200|NCT02768662|324284240|FG000|Overall Study|Study terminated by Sponsor|78|||
94680201|NCT01800201|324284241|FG000|Overall Study|Withdrawal by Subject|2|||
94680202|NCT01800201|324284242|FG001|Overall Study|Withdrawal by Subject|0|||
94680203|NCT01800201|324284241|FG000|Overall Study|patient privacy concerns|1|||
94680204|NCT01800201|324284242|FG001|Overall Study|patient privacy concerns|1|||
94680205|NCT01800201|324284241|FG000|Overall Study|did not want to use device|0|||
94680206|NCT01800201|324284242|FG001|Overall Study|did not want to use device|1|||
94680207|NCT01800201|324284241|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
94680208|NCT01800201|324284242|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
94680209|NCT00708435|324284243|FG000|Overall Study|Death / Serious Adverse Event|10|||
94680210|NCT00708435|324284244|FG001|Overall Study|Death / Serious Adverse Event|5|||
94680211|NCT00708435|324284243|FG000|Overall Study|Lost to Follow-up|9|||
94680212|NCT00708435|324284244|FG001|Overall Study|Lost to Follow-up|4|||
94680213|NCT00708435|324284243|FG000|Overall Study|Withdrawal by Subject|3|||
94680214|NCT00708435|324284244|FG001|Overall Study|Withdrawal by Subject|7|||
94680215|NCT00708435|324284243|FG000|Overall Study|Adverse Event|1|||
94680216|NCT00708435|324284244|FG001|Overall Study|Adverse Event|0|||
94680217|NCT00708435|324284243|FG000|Overall Study|Protocol Violation|0|||
94680218|NCT00708435|324284244|FG001|Overall Study|Protocol Violation|1|||
94680219|NCT00708435|324284243|FG000|Overall Study|Intervention by primary care physician|1|||
94680220|NCT00708435|324284244|FG001|Overall Study|Intervention by primary care physician|0|||
94680221|NCT00708435|324284243|FG000|Overall Study|Refused hospitalization|1|||
94680222|NCT00708435|324284244|FG001|Overall Study|Refused hospitalization|0|||
94680223|NCT00691132|324284245|FG000|Overall Study|Adverse Event|2|||
94680224|NCT00691132|324284246|FG001|Overall Study|Adverse Event|3|||
94680225|NCT00691132|324284245|FG000|Overall Study|Withdrawal by Subject|10|||
94680226|NCT00691132|324284246|FG001|Overall Study|Withdrawal by Subject|10|||
94680227|NCT00312702|324284249|FG000|Immunization Phase|Lost to Follow-up|0|||
94680228|NCT00312702|324284250|FG001|Immunization Phase|Lost to Follow-up|1|||
94680229|NCT00312702|324284251|FG002|Immunization Phase|Lost to Follow-up|0|||
94680230|NCT03485911|324284254|FG000|Part 1|Perceived lack of efficacy|1|||
94680231|NCT03485911|324284255|FG001|Part 1|Perceived lack of efficacy|1|||
94680232|NCT03485911|324284256|FG002|Part 1|Perceived lack of efficacy|2|||
94680233|NCT03485911|324284257|FG003|Part 1|Perceived lack of efficacy|0|||
94680234|NCT03485911|324284254|FG000|Part 1|Subject withdrew consent|0|||
94680235|NCT03485911|324284255|FG001|Part 1|Subject withdrew consent|1|||
94680236|NCT03485911|324284256|FG002|Part 1|Subject withdrew consent|0|||
94680237|NCT03485911|324284257|FG003|Part 1|Subject withdrew consent|1|||
94680238|NCT03485911|324284254|FG000|Part 1|Lab abnormalities/AEs|3|||
94680239|NCT03485911|324284255|FG001|Part 1|Lab abnormalities/AEs|1|||
94680240|NCT03485911|324284256|FG002|Part 1|Lab abnormalities/AEs|1|||
94680241|NCT03485911|324284257|FG003|Part 1|Lab abnormalities/AEs|0|||
94680242|NCT03485911|324284254|FG000|Part 1|Withdrew Consent prior to dosing|0|||
94680243|NCT03485911|324284255|FG001|Part 1|Withdrew Consent prior to dosing|0|||
94680244|NCT03485911|324284256|FG002|Part 1|Withdrew Consent prior to dosing|0|||
94680245|NCT03485911|324284257|FG003|Part 1|Withdrew Consent prior to dosing|1|||
94680246|NCT03485911|324284254|FG000|Part 1|Other NOS|0|||
94680247|NCT03485911|324284255|FG001|Part 1|Other NOS|0|||
94680248|NCT03485911|324284256|FG002|Part 1|Other NOS|0|||
94680249|NCT03485911|324284257|FG003|Part 1|Other NOS|1|||
94680250|NCT03485911|324284254|FG000|Part 2|Perceived lack of efficacy|5|||
94680251|NCT03485911|324284255|FG001|Part 2|Perceived lack of efficacy|3|||
94645942|NCT03837899|324165278|FG005|Overall Study|Moved to post-trial access program|0|||
94645943|NCT03837899|324165273|FG000|Overall Study|Other|0|||
94645944|NCT03837899|324165274|FG001|Overall Study|Other|0|||
94645945|NCT03837899|324165275|FG002|Overall Study|Other|0|||
94645946|NCT03837899|324165276|FG003|Overall Study|Other|0|||
94645947|NCT03837899|324165277|FG004|Overall Study|Other|0|||
94645948|NCT03837899|324165278|FG005|Overall Study|Other|2|||
94645949|NCT03837899|324165273|FG000|Overall Study|Lost to Follow-up|0|||
94645950|NCT03837899|324165274|FG001|Overall Study|Lost to Follow-up|1|||
94645951|NCT03837899|324165275|FG002|Overall Study|Lost to Follow-up|0|||
94645952|NCT03837899|324165276|FG003|Overall Study|Lost to Follow-up|0|||
94645953|NCT03837899|324165277|FG004|Overall Study|Lost to Follow-up|0|||
94645954|NCT03837899|324165278|FG005|Overall Study|Lost to Follow-up|0|||
94645955|NCT03837899|324165273|FG000|Overall Study|Withdrawal by Subject|0|||
94645956|NCT03837899|324165274|FG001|Overall Study|Withdrawal by Subject|0|||
94645957|NCT03837899|324165275|FG002|Overall Study|Withdrawal by Subject|0|||
94645958|NCT03837899|324165276|FG003|Overall Study|Withdrawal by Subject|1|||
94645959|NCT03837899|324165277|FG004|Overall Study|Withdrawal by Subject|0|||
94645960|NCT03837899|324165278|FG005|Overall Study|Withdrawal by Subject|0|||
94645961|NCT03837899|324165273|FG000|Overall Study|Study specific discontinuation criteria|0|||
94645962|NCT03837899|324165274|FG001|Overall Study|Study specific discontinuation criteria|1|||
94645963|NCT03837899|324165275|FG002|Overall Study|Study specific discontinuation criteria|0|||
94645964|NCT03837899|324165276|FG003|Overall Study|Study specific discontinuation criteria|0|||
94645965|NCT03837899|324165277|FG004|Overall Study|Study specific discontinuation criteria|3|||
94645966|NCT03837899|324165278|FG005|Overall Study|Study specific discontinuation criteria|1|||
94645967|NCT01526889|324165279|FG000|Treatment Period|Adverse Event|2|||
94645968|NCT01526889|324165280|FG001|Treatment Period|Adverse Event|0|||
94645969|NCT01526889|324165279|FG000|Treatment Extension Period|Administrative problems|1|||
94645970|NCT01526889|324165280|FG001|Treatment Extension Period|Administrative problems|0|||
94645971|NCT01371656|324165281|FG000|Overall Study|Death|7|||
94645972|NCT01371656|324165282|FG001|Overall Study|Death|4|||
94645973|NCT01371656|324165281|FG000|Overall Study|Physician Decision|46|||
94645974|NCT01371656|324165282|FG001|Overall Study|Physician Decision|7|||
94645975|NCT01371656|324165281|FG000|Overall Study|Withdrawal by Subject|7|||
94645976|NCT01371656|324165282|FG001|Overall Study|Withdrawal by Subject|0|||
94645977|NCT01371656|324165281|FG000|Overall Study|Ineligible|4|||
94645978|NCT01371656|324165282|FG001|Overall Study|Ineligible|3|||
94645979|NCT00974571|324165283|FG000|Overall Study|Adverse Event|31|||
94645980|NCT00974571|324165284|FG001|Overall Study|Adverse Event|4|||
94645981|NCT00974571|324165285|FG002|Overall Study|Adverse Event|27|||
94645982|NCT00974571|324165283|FG000|Overall Study|Lack of Efficacy|3|||
94645983|NCT00974571|324165284|FG001|Overall Study|Lack of Efficacy|2|||
94645984|NCT00974571|324165285|FG002|Overall Study|Lack of Efficacy|9|||
94645985|NCT00974571|324165283|FG000|Overall Study|Lost to Follow-up|2|||
94645986|NCT00974571|324165284|FG001|Overall Study|Lost to Follow-up|1|||
94645987|NCT00974571|324165285|FG002|Overall Study|Lost to Follow-up|2|||
94645988|NCT00974571|324165283|FG000|Overall Study|Protocol Violation|13|||
94645989|NCT00974571|324165284|FG001|Overall Study|Protocol Violation|4|||
94645990|NCT00974571|324165285|FG002|Overall Study|Protocol Violation|18|||
94645991|NCT00974571|324165283|FG000|Overall Study|Withdrawal by Subject|14|||
94645992|NCT00974571|324165284|FG001|Overall Study|Withdrawal by Subject|5|||
94645993|NCT00974571|324165285|FG002|Overall Study|Withdrawal by Subject|16|||
94645994|NCT00974571|324165283|FG000|Overall Study|Patient Moved|1|||
94645995|NCT00974571|324165284|FG001|Overall Study|Patient Moved|0|||
94645996|NCT00974571|324165285|FG002|Overall Study|Patient Moved|1|||
94645997|NCT00974571|324165283|FG000|Overall Study|Other|4|||
94645998|NCT00974571|324165284|FG001|Overall Study|Other|0|||
94645999|NCT00974571|324165285|FG002|Overall Study|Other|10|||
94646000|NCT02703636|324165294|FG000|Overall Study|Adverse Event|14|||
94646001|NCT02703636|324165294|FG000|Overall Study|Study stopped by sponsor|1|||
94646002|NCT02703636|324165294|FG000|Overall Study|Withdrawal by Subject|1|||
94646003|NCT04334460|324165298|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
94646004|NCT04334460|324165299|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
94680252|NCT03485911|324284256|FG002|Part 2|Perceived lack of efficacy|0|||
94646005|NCT04334460|324165298|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
94646006|NCT04334460|324165299|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
94646007|NCT02385799|324165302|FG000|Overall Study|Lost to Follow-up|1|||
94646008|NCT02385799|324165303|FG001|Overall Study|Lost to Follow-up|2|||
94646009|NCT02385799|324165302|FG000|Overall Study|Adverse Event|4|||
94680253|NCT03485911|324284257|FG003|Part 2|Perceived lack of efficacy|2|||
94680254|NCT03485911|324284254|FG000|Part 2|Subject withdrew consent|1|||
94680255|NCT03485911|324284255|FG001|Part 2|Subject withdrew consent|0|||
94680256|NCT03485911|324284256|FG002|Part 2|Subject withdrew consent|2|||
94680257|NCT03485911|324284257|FG003|Part 2|Subject withdrew consent|1|||
94680258|NCT03485911|324284254|FG000|Part 2|Lab abnormalities/AEs|1|||
94680259|NCT03485911|324284255|FG001|Part 2|Lab abnormalities/AEs|2|||
94680260|NCT03485911|324284256|FG002|Part 2|Lab abnormalities/AEs|0|||
94680261|NCT03485911|324284257|FG003|Part 2|Lab abnormalities/AEs|0|||
94680262|NCT03485911|324284254|FG000|Part 2|Other NOS|0|||
94680263|NCT03485911|324284255|FG001|Part 2|Other NOS|1|||
94680264|NCT03485911|324284256|FG002|Part 2|Other NOS|0|||
94680265|NCT03485911|324284257|FG003|Part 2|Other NOS|0|||
94680266|NCT03485911|324284254|FG000|Part 2|Intercurrent illness/new medical condition|1|||
94680267|NCT03485911|324284255|FG001|Part 2|Intercurrent illness/new medical condition|0|||
94680268|NCT03485911|324284256|FG002|Part 2|Intercurrent illness/new medical condition|0|||
94680269|NCT03485911|324284257|FG003|Part 2|Intercurrent illness/new medical condition|0|||
94680270|NCT03485911|324284254|FG000|Part 2|Investigator judgement|1|||
94680271|NCT03485911|324284255|FG001|Part 2|Investigator judgement|0|||
94680272|NCT03485911|324284256|FG002|Part 2|Investigator judgement|0|||
94680273|NCT03485911|324284257|FG003|Part 2|Investigator judgement|0|||
94680274|NCT03485911|324284254|FG000|Part 3|Perceived lack of efficacy|2|||
94680275|NCT03485911|324284255|FG001|Part 3|Perceived lack of efficacy|2|||
94680276|NCT03485911|324284256|FG002|Part 3|Perceived lack of efficacy|2|||
94680277|NCT03485911|324284257|FG003|Part 3|Perceived lack of efficacy|0|||
94680278|NCT03485911|324284254|FG000|Part 3|Subject withdrew consent|1|||
94680279|NCT03485911|324284255|FG001|Part 3|Subject withdrew consent|4|||
94680280|NCT03485911|324284256|FG002|Part 3|Subject withdrew consent|0|||
94680281|NCT03485911|324284257|FG003|Part 3|Subject withdrew consent|1|||
94680282|NCT03485911|324284254|FG000|Part 3|Lab abnormalities/AEs|1|||
94680283|NCT03485911|324284255|FG001|Part 3|Lab abnormalities/AEs|1|||
94680284|NCT03485911|324284256|FG002|Part 3|Lab abnormalities/AEs|0|||
94680285|NCT03485911|324284257|FG003|Part 3|Lab abnormalities/AEs|2|||
94646010|NCT02385799|324165303|FG001|Overall Study|Adverse Event|2|||
94646011|NCT02385799|324165302|FG000|Overall Study|Withdrawal by Subject|0|||
94646012|NCT02385799|324165303|FG001|Overall Study|Withdrawal by Subject|4|||
94680286|NCT03485911|324284254|FG000|Part 3|Other NOS|1|||
94680287|NCT03485911|324284255|FG001|Part 3|Other NOS|1|||
94680288|NCT03485911|324284256|FG002|Part 3|Other NOS|0|||
94680289|NCT03485911|324284257|FG003|Part 3|Other NOS|0|||
94680290|NCT03485911|324284254|FG000|Part 3|Intercurrent illness/new medical condition|0|||
94680291|NCT03485911|324284255|FG001|Part 3|Intercurrent illness/new medical condition|1|||
94680292|NCT03485911|324284256|FG002|Part 3|Intercurrent illness/new medical condition|1|||
94680293|NCT03485911|324284257|FG003|Part 3|Intercurrent illness/new medical condition|0|||
94680294|NCT03485911|324284254|FG000|Part 3|Sponsor discontinuation|1|||
94680295|NCT03485911|324284255|FG001|Part 3|Sponsor discontinuation|0|||
94680296|NCT03485911|324284256|FG002|Part 3|Sponsor discontinuation|0|||
94680297|NCT03485911|324284257|FG003|Part 3|Sponsor discontinuation|0|||
94646013|NCT00785486|324165304|FG000|Midazolam Alone|Withdrawal by Subject|1|||
94646014|NCT02130765|324165305|FG000|Overall Study|Did not receive treatment|4|||
94646015|NCT02130765|324165306|FG001|Overall Study|Did not receive treatment|0|||
94646016|NCT02130765|324165307|FG002|Overall Study|Did not receive treatment|0|||
94646017|NCT02130765|324165308|FG003|Overall Study|Did not receive treatment|0|||
94646018|NCT01537783|324165324|FG000|Overall Study|Lost to Follow-up|11|||
94646019|NCT01537783|324165325|FG001|Overall Study|Lost to Follow-up|2|||
94646020|NCT00376168|324165327|FG000|Overall Study|Adverse Event|1|||
94646021|NCT00376168|324165328|FG001|Overall Study|Adverse Event|1|||
94646022|NCT00376168|324165327|FG000|Overall Study|Pregnancy|1|||
94646023|NCT00376168|324165328|FG001|Overall Study|Pregnancy|0|||
94680298|NCT03485911|324284254|FG000|Part 3|Berotralstat provided by alternative means|13|||
94680299|NCT03485911|324284255|FG001|Part 3|Berotralstat provided by alternative means|13|||
94646024|NCT01554618|324165329|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
94646025|NCT01554618|324165330|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
94646026|NCT01554618|324165329|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
94646027|NCT01554618|324165330|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
94680300|NCT03485911|324284256|FG002|Part 3|Berotralstat provided by alternative means|7|||
94680301|NCT03485911|324284257|FG003|Part 3|Berotralstat provided by alternative means|7|||
94680302|NCT00909480|324284258|FG000|Overall Study|Adverse Event|5|||
94680303|NCT00909480|324284259|FG001|Overall Study|Adverse Event|3|||
94680304|NCT00909480|324284258|FG000|Overall Study|Protocol Violation|6|||
94680305|NCT00909480|324284259|FG001|Overall Study|Protocol Violation|8|||
94680306|NCT00909480|324284258|FG000|Overall Study|Withdrawal criteria|9|||
94680307|NCT00909480|324284259|FG001|Overall Study|Withdrawal criteria|11|||
94680308|NCT00909480|324284258|FG000|Overall Study|Unclassified|18|||
94646028|NCT01554618|324165329|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
94646029|NCT01554618|324165330|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
94646030|NCT01554618|324165329|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
94646031|NCT01554618|324165330|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
94646032|NCT01554618|324165329|FG000|Open-Label Extension Period|Physician Decision|0|||
94646033|NCT01554618|324165330|FG001|Open-Label Extension Period|Physician Decision|1|||
94646034|NCT01554618|324165329|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
94646035|NCT01554618|324165330|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
94646036|NCT01256710|324165331|FG000|Overall Study|Death|449|||
94646037|NCT01256710|324165331|FG000|Overall Study|System Explant|67|||
94646038|NCT01256710|324165331|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
94646039|NCT01256710|324165331|FG000|Overall Study|Lost to Follow-up|67|||
94646040|NCT01256710|324165331|FG000|Overall Study|Withdrawal by Subject|29|||
94646041|NCT01256710|324165331|FG000|Overall Study|Physician Decision|9|||
94646042|NCT01256710|324165331|FG000|Overall Study|Subject Noncompliance|2|||
94646043|NCT01256710|324165331|FG000|Overall Study|Study Terminated by Sponsor|273|||
94646044|NCT02376166|324165332|FG000|Overall Study|Adverse Event|1|||
94646045|NCT02376166|324165332|FG000|Overall Study|Discontinued metformin early|2|||
94646046|NCT02519712|324165339|FG000|Overall Study|Disease Relapse|1|||
94646047|NCT02519712|324165339|FG000|Overall Study|Disease Progression|1|||
94646048|NCT02519712|324165339|FG000|Overall Study|Accruals are donors|2|||
94646049|NCT02540954|324165349|FG000|Overall Study|Physician Decision|3|||
94646050|NCT02540954|324165350|FG001|Overall Study|Physician Decision|1|||
94646051|NCT02540954|324165349|FG000|Overall Study|Withdrawal by Subject|6|||
94646052|NCT02540954|324165350|FG001|Overall Study|Withdrawal by Subject|5|||
94646053|NCT02540954|324165349|FG000|Overall Study|Lost to Follow-up|1|||
94646054|NCT02540954|324165350|FG001|Overall Study|Lost to Follow-up|1|||
94646055|NCT02540954|324165349|FG000|Overall Study|Adverse Event|4|||
94646056|NCT02540954|324165350|FG001|Overall Study|Adverse Event|2|||
94646057|NCT02540954|324165349|FG000|Overall Study|Death|0|||
94646058|NCT02540954|324165350|FG001|Overall Study|Death|3|||
94646059|NCT02540954|324165349|FG000|Overall Study|Treatment failure|1|||
94646060|NCT02540954|324165350|FG001|Overall Study|Treatment failure|0|||
94646061|NCT02540954|324165349|FG000|Overall Study|Other reason|4|||
94646062|NCT02540954|324165350|FG001|Overall Study|Other reason|2|||
94646063|NCT03925727|324165351|FG000|Overall Study|Adverse Event|4|||
94646064|NCT03925727|324165352|FG001|Overall Study|Adverse Event|0|||
94646065|NCT03925727|324165353|FG002|Overall Study|Adverse Event|3|||
94646066|NCT03925727|324165351|FG000|Overall Study|Protocol Violation|1|||
94646067|NCT03925727|324165352|FG001|Overall Study|Protocol Violation|2|||
94646068|NCT03925727|324165353|FG002|Overall Study|Protocol Violation|2|||
94646069|NCT03925727|324165351|FG000|Overall Study|Withdrawal by Subject|3|||
94646070|NCT03925727|324165352|FG001|Overall Study|Withdrawal by Subject|2|||
94646071|NCT03925727|324165353|FG002|Overall Study|Withdrawal by Subject|4|||
94646072|NCT03925727|324165351|FG000|Overall Study|Administrative Reasons|3|||
94646073|NCT03925727|324165352|FG001|Overall Study|Administrative Reasons|1|||
94646074|NCT03925727|324165353|FG002|Overall Study|Administrative Reasons|2|||
94646075|NCT03925727|324165351|FG000|Overall Study|Randomized in error or Disqualified|8|||
94646076|NCT03925727|324165352|FG001|Overall Study|Randomized in error or Disqualified|1|||
94646077|NCT03925727|324165353|FG002|Overall Study|Randomized in error or Disqualified|7|||
94646078|NCT00213148|324165356|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
94646079|NCT00213148|324165357|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
94646080|NCT00213148|324165358|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
94646081|NCT00213148|324165359|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
94646082|NCT00213148|324165360|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
94646083|NCT00213148|324165356|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
94646084|NCT00213148|324165357|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
94646085|NCT00213148|324165358|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
94646086|NCT00213148|324165359|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
94646087|NCT00213148|324165360|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
94646088|NCT00213148|324165356|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
94646089|NCT00213148|324165357|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
94646090|NCT00213148|324165358|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
94646091|NCT00213148|324165359|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
94646092|NCT00213148|324165360|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
94646093|NCT00213148|324165356|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
94646094|NCT00213148|324165357|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
94646095|NCT00213148|324165358|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
94646096|NCT00213148|324165359|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
94646097|NCT00213148|324165360|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
94646098|NCT00213148|324165356|FG000|Cycle 1 (1 Month)|Other|3|||
94646099|NCT00213148|324165357|FG001|Cycle 1 (1 Month)|Other|0|||
94646100|NCT00213148|324165358|FG002|Cycle 1 (1 Month)|Other|2|||
94646101|NCT00213148|324165359|FG003|Cycle 1 (1 Month)|Other|2|||
94646102|NCT00213148|324165360|FG004|Cycle 1 (1 Month)|Other|7|||
94646103|NCT00213148|324165356|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
94646104|NCT00213148|324165357|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
94646105|NCT00213148|324165358|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
94646106|NCT00213148|324165359|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
94646107|NCT00213148|324165360|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
94646108|NCT00213148|324165356|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
94646109|NCT00213148|324165357|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
94646110|NCT00213148|324165358|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
94646111|NCT00213148|324165359|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
94646112|NCT00213148|324165360|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
94646113|NCT00213148|324165356|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
94646114|NCT00213148|324165357|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
94646115|NCT00213148|324165358|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
94646116|NCT00213148|324165359|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
94646117|NCT00213148|324165360|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
94646118|NCT00213148|324165356|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
94646119|NCT00213148|324165357|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
94646120|NCT00213148|324165358|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
94646121|NCT00213148|324165359|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
94646122|NCT00213148|324165360|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
94646123|NCT00213148|324165356|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
94646124|NCT00213148|324165357|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
94646125|NCT00213148|324165358|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
94646126|NCT00213148|324165359|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
94646127|NCT00213148|324165360|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
94646128|NCT00213148|324165356|FG000|Cycle 2 (1 Month)|Other|2|||
94646129|NCT00213148|324165357|FG001|Cycle 2 (1 Month)|Other|1|||
94646130|NCT00213148|324165358|FG002|Cycle 2 (1 Month)|Other|2|||
94646131|NCT00213148|324165359|FG003|Cycle 2 (1 Month)|Other|8|||
94646132|NCT00213148|324165360|FG004|Cycle 2 (1 Month)|Other|7|||
94646133|NCT00213148|324165356|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
94646134|NCT00213148|324165357|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
94646135|NCT00213148|324165358|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
94646136|NCT00213148|324165359|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
94646137|NCT00213148|324165360|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
94646138|NCT00213148|324165356|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
94646139|NCT00213148|324165357|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
94646140|NCT00213148|324165358|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
94646141|NCT00213148|324165359|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
94646142|NCT00213148|324165360|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
94646143|NCT00213148|324165356|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
94646144|NCT00213148|324165357|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
94646145|NCT00213148|324165358|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
94646146|NCT00213148|324165359|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
94646147|NCT00213148|324165360|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
94646148|NCT00213148|324165356|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
94646149|NCT00213148|324165357|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
94646150|NCT00213148|324165358|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
94646151|NCT00213148|324165359|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
94646152|NCT00213148|324165360|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
94646153|NCT00213148|324165356|FG000|Cycle 3 (1 Month)|Other|0|||
94646154|NCT00213148|324165357|FG001|Cycle 3 (1 Month)|Other|0|||
94646155|NCT00213148|324165358|FG002|Cycle 3 (1 Month)|Other|1|||
94646156|NCT00213148|324165359|FG003|Cycle 3 (1 Month)|Other|1|||
94646157|NCT00213148|324165360|FG004|Cycle 3 (1 Month)|Other|0|||
94646158|NCT02321462|324165361|FG000|Overall Study|Withdrawal by Subject|5|||
94646159|NCT02321462|324165362|FG001|Overall Study|Withdrawal by Subject|2|||
94646160|NCT02321462|324165361|FG000|Overall Study|Subject withdrawn before any treatment|1|||
94646161|NCT02321462|324165362|FG001|Overall Study|Subject withdrawn before any treatment|1|||
94646162|NCT03044197|324165363|FG000|Overall Study|Withdrawal by Subject|3|||
94646163|NCT03044197|324165364|FG001|Overall Study|Withdrawal by Subject|1|||
94646164|NCT00262067|324165365|FG000|Overall Study|Death|190|||
94646165|NCT00262067|324165366|FG001|Overall Study|Death|89|||
94646166|NCT00262067|324165367|FG002|Overall Study|Death|186|||
94646167|NCT00262067|324165368|FG003|Overall Study|Death|99|||
94680309|NCT00909480|324284259|FG001|Overall Study|Unclassified|19|||
94680310|NCT03002038|324284271|FG000|Overall Study|Adverse Event|3|||
94680311|NCT03002038|324284272|FG001|Overall Study|Adverse Event|1|||
94680312|NCT03002038|324284271|FG000|Overall Study|Withdrawal by Subject|8|||
94680313|NCT03002038|324284272|FG001|Overall Study|Withdrawal by Subject|4|||
94680314|NCT03002038|324284271|FG000|Overall Study|Immigration to another region|0|||
94680315|NCT03002038|324284272|FG001|Overall Study|Immigration to another region|2|||
94680316|NCT02904902|324284281|FG000|Overall Study|Withdrawal by Subject|1|||
94680317|NCT01725386|324284283|FG000|Overall Study|Death|84|||
94680318|NCT01725386|324284284|FG001|Overall Study|Death|40|||
94680319|NCT01725386|324284283|FG000|Overall Study|Lost to Follow-up|81|||
94680320|NCT01725386|324284284|FG001|Overall Study|Lost to Follow-up|6|||
94680321|NCT01725386|324284283|FG000|Overall Study|Withdrawal by Subject|10|||
94680322|NCT01725386|324284284|FG001|Overall Study|Withdrawal by Subject|0|||
94680323|NCT01859793|324284285|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
94680324|NCT01859793|324284286|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
94680325|NCT01859793|324284285|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
94680326|NCT01859793|324284286|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
94680327|NCT01859793|324284285|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
94680328|NCT01859793|324284286|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
94680329|NCT01859793|324284285|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
94680330|NCT01859793|324284286|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
94680331|NCT04000594|324284290|FG000|Overall Study|Withdrawal by Subject|1|||
94680332|NCT04000594|324284291|FG001|Overall Study|Withdrawal by Subject|0|||
94680333|NCT04000594|324284292|FG002|Overall Study|Withdrawal by Subject|0|||
94680334|NCT01368900|324284294|FG000|Overall Study|Lost to Follow-up|7|||
94680335|NCT01224158|324284295|FG000|Overall Study|Withdrawal by Subject|1|||
94680336|NCT01224158|324284296|FG001|Overall Study|Withdrawal by Subject|0|||
94680337|NCT02055157|324284299|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
94680338|NCT02055157|324284300|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
94680339|NCT02055157|324284301|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
94680340|NCT02055157|324284302|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
94680341|NCT02055157|324284299|FG000|Initial 6 Months|Adverse Event|0|||
94680342|NCT02055157|324284300|FG001|Initial 6 Months|Adverse Event|0|||
94680343|NCT02055157|324284301|FG002|Initial 6 Months|Adverse Event|0|||
94680344|NCT02055157|324284302|FG003|Initial 6 Months|Adverse Event|1|||
94680345|NCT02055157|324284299|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
94680346|NCT02055157|324284300|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
94680347|NCT02055157|324284301|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
94680348|NCT02055157|324284302|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
94680349|NCT02055157|324284299|FG000|18-month Extension|Investigator decision|0|||
94680350|NCT02055157|324284300|FG001|18-month Extension|Investigator decision|1|||
94680351|NCT02055157|324284301|FG002|18-month Extension|Investigator decision|0|||
94680352|NCT02055157|324284302|FG003|18-month Extension|Investigator decision|0|||
94680353|NCT02055157|324284299|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
94646168|NCT00262067|324165365|FG000|Overall Study|Lost to Follow-up|5|||
94646169|NCT00262067|324165366|FG001|Overall Study|Lost to Follow-up|4|||
94646170|NCT00262067|324165367|FG002|Overall Study|Lost to Follow-up|7|||
94646171|NCT00262067|324165368|FG003|Overall Study|Lost to Follow-up|5|||
94646172|NCT00262067|324165365|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
94646173|NCT00262067|324165366|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
94646174|NCT00262067|324165367|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
94646175|NCT00262067|324165368|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
94646176|NCT00262067|324165365|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
94646177|NCT00262067|324165366|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
94646178|NCT00262067|324165367|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
94646179|NCT00262067|324165368|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
94646180|NCT03829046|324165369|FG000|Overall Study|Withdrawal by Subject|1|||
94646181|NCT03829046|324165370|FG001|Overall Study|Withdrawal by Subject|0|||
94646182|NCT01399593|324165375|FG000|Overall Study|Physician Decision|1|||
94646183|NCT01399593|324165376|FG001|Overall Study|Physician Decision|0|||
94646184|NCT01399593|324165375|FG000|Overall Study|Adverse Event|1|||
94646185|NCT01399593|324165376|FG001|Overall Study|Adverse Event|0|||
94646186|NCT01399593|324165375|FG000|Overall Study|Death|1|||
94646187|NCT01399593|324165376|FG001|Overall Study|Death|1|||
94646188|NCT01399593|324165375|FG000|Overall Study|Transplantectomy|0|||
94646189|NCT01399593|324165376|FG001|Overall Study|Transplantectomy|1|||
94646190|NCT02448875|324165378|FG000|Overall Study|Adverse Event|2|||
94646191|NCT02448875|324165379|FG001|Overall Study|Adverse Event|1|||
94646192|NCT02448875|324165380|FG002|Overall Study|Adverse Event|0|||
94646193|NCT02448875|324165378|FG000|Overall Study|Lost to Follow-up|1|||
94646194|NCT02448875|324165379|FG001|Overall Study|Lost to Follow-up|0|||
94363939|NCT01306968|323116772|FG002|Overall Study|Withdrew over privacy concerns|0|||
94363940|NCT01306968|323116773|FG003|Overall Study|Withdrew over privacy concerns|1|||
94363941|NCT02304302|323116774|FG000|Overall Study|Adverse Event|2|||
94363942|NCT02304302|323116775|FG001|Overall Study|Adverse Event|3|||
94646195|NCT02448875|324165380|FG002|Overall Study|Lost to Follow-up|0|||
94363943|NCT02304302|323116774|FG000|Overall Study|Lost to Follow-up|1|||
94363944|NCT02304302|323116775|FG001|Overall Study|Lost to Follow-up|4|||
94363945|NCT02304302|323116774|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
94363946|NCT02304302|323116775|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
94363947|NCT02392559|323116778|FG000|Overall Study|Withdrawal by Subject|0|||
94363948|NCT02392559|323116779|FG001|Overall Study|Withdrawal by Subject|1|||
94363949|NCT02508649|323116782|FG000|Overall Study|Withdrawal by Subject|4|||
94363950|NCT02508649|323116783|FG001|Overall Study|Withdrawal by Subject|6|||
94363951|NCT02508649|323116784|FG002|Overall Study|Withdrawal by Subject|5|||
94363952|NCT02508649|323116785|FG003|Overall Study|Withdrawal by Subject|6|||
94363953|NCT02508649|323116782|FG000|Overall Study|Investigator withdrew the subject|1|||
94363954|NCT02508649|323116783|FG001|Overall Study|Investigator withdrew the subject|2|||
94363955|NCT02508649|323116784|FG002|Overall Study|Investigator withdrew the subject|1|||
94363956|NCT02508649|323116785|FG003|Overall Study|Investigator withdrew the subject|0|||
94363957|NCT02508649|323116782|FG000|Overall Study|Post randomization screening failure|12|||
94363958|NCT02508649|323116783|FG001|Overall Study|Post randomization screening failure|4|||
94363959|NCT02508649|323116784|FG002|Overall Study|Post randomization screening failure|9|||
94363960|NCT02508649|323116785|FG003|Overall Study|Post randomization screening failure|3|||
94363961|NCT02508649|323116782|FG000|Overall Study|Lost to Follow-up|1|||
94363962|NCT02508649|323116783|FG001|Overall Study|Lost to Follow-up|1|||
94363963|NCT02508649|323116784|FG002|Overall Study|Lost to Follow-up|0|||
94363964|NCT02508649|323116785|FG003|Overall Study|Lost to Follow-up|1|||
94363965|NCT03107715|323116787|FG000|Overall Study|did not deliver at the home hospital|4|||
94363966|NCT03107715|323116788|FG001|Overall Study|did not deliver at the home hospital|6|||
94363967|NCT03107715|323116787|FG000|Overall Study|infant stillborn|0|||
94363968|NCT03107715|323116788|FG001|Overall Study|infant stillborn|1|||
94363969|NCT00567996|323116795|FG000|Overall Study|Adverse Event|18|||
94363970|NCT00567996|323116796|FG001|Overall Study|Adverse Event|16|||
94363971|NCT00567996|323116797|FG002|Overall Study|Adverse Event|13|||
94363972|NCT00567996|323116795|FG000|Overall Study|Protocol Deviation|9|||
94680354|NCT02055157|324284300|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
94680355|NCT02055157|324284301|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
94680356|NCT02055157|324284302|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
94680357|NCT03976466|324284303|FG000|Overall Study|Lost to Follow-up|1|||
94680358|NCT03976466|324284304|FG001|Overall Study|Lost to Follow-up|3|||
94680359|NCT01931735|324284305|FG000|Randomized Phase|Lost to Follow-up|2|||
94680360|NCT01931735|324284306|FG001|Randomized Phase|Lost to Follow-up|2|||
94680361|NCT01931735|324284307|FG002|Randomized Phase|Lost to Follow-up|5|||
94680362|NCT01931735|324284308|FG003|Randomized Phase|Lost to Follow-up|0|||
94680363|NCT01931735|324284305|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
94680364|NCT01931735|324284306|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
94363973|NCT00567996|323116796|FG001|Overall Study|Protocol Deviation|11|||
94363974|NCT00567996|323116797|FG002|Overall Study|Protocol Deviation|13|||
94363975|NCT00567996|323116795|FG000|Overall Study|Withdrawal by Subject|8|||
94363976|NCT00567996|323116796|FG001|Overall Study|Withdrawal by Subject|12|||
94363977|NCT00567996|323116797|FG002|Overall Study|Withdrawal by Subject|22|||
94463459|NCT02520427|323485070|FG013|Overall Study|Withdrawal by Subject|1|||
94463460|NCT02520427|323485071|FG014|Overall Study|Withdrawal by Subject|1|||
94463461|NCT02520427|323485072|FG015|Overall Study|Withdrawal by Subject|0|||
94680365|NCT01931735|324284307|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
94680366|NCT01931735|324284308|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
94680367|NCT01931735|324284305|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
94680368|NCT01931735|324284306|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
94680369|NCT01931735|324284307|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
94680370|NCT01931735|324284308|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
94680371|NCT01395823|324284311|FG000|Overall Study|Death|4|||
94680372|NCT01395823|324284312|FG001|Overall Study|Death|4|||
94680373|NCT01395823|324284311|FG000|Overall Study|Physician Decision|3|||
94680374|NCT01395823|324284312|FG001|Overall Study|Physician Decision|1|||
94680375|NCT01395823|324284311|FG000|Overall Study|Lost to Follow-up|1|||
94680376|NCT01395823|324284312|FG001|Overall Study|Lost to Follow-up|0|||
94680377|NCT01395823|324284311|FG000|Overall Study|Transplant|1|||
94680378|NCT01395823|324284312|FG001|Overall Study|Transplant|0|||
94463462|NCT02520427|323485073|FG016|Overall Study|Withdrawal by Subject|1|||
94463463|NCT02520427|323485074|FG017|Overall Study|Withdrawal by Subject|0|||
94463464|NCT02520427|323485075|FG018|Overall Study|Withdrawal by Subject|0|||
94680379|NCT01395823|324284311|FG000|Overall Study|GI symptoms|1|||
94680380|NCT01395823|324284312|FG001|Overall Study|GI symptoms|0|||
94680381|NCT01395823|324284311|FG000|Overall Study|Withdrawal by Subject|5|||
94680382|NCT01395823|324284312|FG001|Overall Study|Withdrawal by Subject|4|||
94680383|NCT02036645|324284320|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
94680384|NCT02036645|324284321|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
94680385|NCT02036645|324284322|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
94680386|NCT02036645|324284323|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
94680387|NCT02036645|324284324|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
94680388|NCT02036645|324284325|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
94680389|NCT02036645|324284326|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
94680390|NCT02036645|324284327|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
94680391|NCT02036645|324284328|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
94680392|NCT02036645|324284329|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
94680393|NCT02036645|324284330|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
94680394|NCT02036645|324284331|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
94680395|NCT02036645|324284320|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
94680396|NCT02036645|324284321|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
94680397|NCT02036645|324284322|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
94680398|NCT02036645|324284323|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
94680399|NCT02036645|324284324|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
94680400|NCT02036645|324284325|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
94680401|NCT02036645|324284326|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
94680402|NCT02036645|324284327|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
94680403|NCT02036645|324284328|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
94680404|NCT02036645|324284329|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
94680405|NCT02036645|324284330|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
94680406|NCT02036645|324284331|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
94680407|NCT01693692|324284332|FG000|Overall Study|Withdrawal by Subject|12|||
94680408|NCT01693692|324284333|FG001|Overall Study|Withdrawal by Subject|10|||
94680409|NCT01693692|324284334|FG002|Overall Study|Withdrawal by Subject|11|||
94680410|NCT01693692|324284332|FG000|Overall Study|Adverse Event|7|||
94680411|NCT01693692|324284333|FG001|Overall Study|Adverse Event|14|||
94680412|NCT01693692|324284334|FG002|Overall Study|Adverse Event|9|||
94680413|NCT01693692|324284332|FG000|Overall Study|Physician Decision|0|||
94463465|NCT02520427|323485076|FG019|Overall Study|Withdrawal by Subject|3|||
94463466|NCT02520427|323485077|FG020|Overall Study|Withdrawal by Subject|2|||
94680414|NCT01693692|324284333|FG001|Overall Study|Physician Decision|0|||
94680415|NCT01693692|324284334|FG002|Overall Study|Physician Decision|1|||
94680416|NCT01693692|324284332|FG000|Overall Study|Protocol Violation|5|||
94680417|NCT01693692|324284333|FG001|Overall Study|Protocol Violation|4|||
94680418|NCT01693692|324284334|FG002|Overall Study|Protocol Violation|6|||
94680419|NCT01693692|324284332|FG000|Overall Study|Lost to Follow-up|2|||
94680420|NCT01693692|324284333|FG001|Overall Study|Lost to Follow-up|2|||
94680421|NCT01693692|324284334|FG002|Overall Study|Lost to Follow-up|3|||
94680422|NCT01693692|324284332|FG000|Overall Study|Other|4|||
94680423|NCT01693692|324284333|FG001|Overall Study|Other|4|||
94463467|NCT02520427|323485078|FG021|Overall Study|Withdrawal by Subject|0|||
94463468|NCT02520427|323485079|FG022|Overall Study|Withdrawal by Subject|0|||
94646196|NCT02448875|324165378|FG000|Overall Study|Investigator Decision|3|||
94646197|NCT02448875|324165379|FG001|Overall Study|Investigator Decision|0|||
94646198|NCT02448875|324165380|FG002|Overall Study|Investigator Decision|1|||
94646199|NCT02448875|324165378|FG000|Overall Study|Withdrawal by Subject|1|||
94646200|NCT02448875|324165379|FG001|Overall Study|Withdrawal by Subject|0|||
94646201|NCT02448875|324165380|FG002|Overall Study|Withdrawal by Subject|0|||
94646202|NCT02434770|324165386|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
94646203|NCT02434770|324165387|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
94646204|NCT02434770|324165388|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
94646205|NCT02434770|324165386|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
94646206|NCT02434770|324165387|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
94646207|NCT02434770|324165388|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
94646208|NCT02434770|324165386|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
94646209|NCT02434770|324165387|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
94646210|NCT02434770|324165388|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
94646211|NCT02434770|324165386|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
94646212|NCT02434770|324165387|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
94680424|NCT01693692|324284334|FG002|Overall Study|Other|6|||
94680425|NCT02719990|324284335|FG000|Overall Study|Physician Decision|2|||
94680426|NCT02719990|324284335|FG000|Overall Study|Withdrawal by Subject|2|||
94680427|NCT02719990|324284335|FG000|Overall Study|Study Terminated By Sponsor|32|||
94680428|NCT02978443|324284336|FG000|Overall Study|Withdrawal by Subject|1|||
94680429|NCT02978443|324284336|FG000|Overall Study|Adverse Event|3|||
94680430|NCT02978443|324284336|FG000|Overall Study|Disease Progression on study|6|||
94680431|NCT02978443|324284336|FG000|Overall Study|Death|1|||
94680432|NCT02978443|324284336|FG000|Overall Study|Physician Decision|1|||
94680433|NCT02978443|324284336|FG000|Overall Study|Switch to alternative therapy|1|||
94680434|NCT02978443|324284336|FG000|Overall Study|Refused further treatment|1|||
94680435|NCT01919970|324284339|FG000|Overall Study|Withdrawal by Subject|3|||
94680436|NCT01919970|324284340|FG001|Overall Study|Withdrawal by Subject|0|||
94680437|NCT00682643|324284341|FG000|Overall Study|Adverse Event|12|||
94680438|NCT00682643|324284342|FG001|Overall Study|Adverse Event|23|||
94680439|NCT00682643|324284341|FG000|Overall Study|Lack of Efficacy|2|||
94680440|NCT00682643|324284342|FG001|Overall Study|Lack of Efficacy|0|||
94680441|NCT00682643|324284341|FG000|Overall Study|Protocol Violation|38|||
94680442|NCT00682643|324284342|FG001|Overall Study|Protocol Violation|76|||
94680443|NCT00682643|324284341|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
94680444|NCT00682643|324284342|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
94680445|NCT00682643|324284341|FG000|Overall Study|Lost to Follow-up|1|||
94680446|NCT00682643|324284342|FG001|Overall Study|Lost to Follow-up|6|||
94680447|NCT00682643|324284341|FG000|Overall Study|Physician Decision|2|||
94680448|NCT00682643|324284342|FG001|Overall Study|Physician Decision|6|||
94680449|NCT00682643|324284341|FG000|Overall Study|Withdrawal by Subject|19|||
94680450|NCT00682643|324284342|FG001|Overall Study|Withdrawal by Subject|53|||
94680451|NCT00682643|324284341|FG000|Overall Study|Did Not Receive Study Drug|1|||
94680452|NCT00682643|324284342|FG001|Overall Study|Did Not Receive Study Drug|1|||
94680453|NCT03565068|324284344|FG000|Overall Study|Protocol Violation|0|||
94680454|NCT03565068|324284345|FG001|Overall Study|Protocol Violation|0|||
94680455|NCT03565068|324284346|FG002|Overall Study|Protocol Violation|0|||
94680456|NCT03565068|324284347|FG003|Overall Study|Protocol Violation|0|||
94680457|NCT03565068|324284348|FG004|Overall Study|Protocol Violation|1|||
94680458|NCT03565068|324284349|FG005|Overall Study|Protocol Violation|0|||
94680459|NCT03565068|324284350|FG006|Overall Study|Protocol Violation|0|||
94680460|NCT03565068|324284351|FG007|Overall Study|Protocol Violation|1|||
94680461|NCT03565068|324284352|FG008|Overall Study|Protocol Violation|0|||
94680462|NCT03565068|324284344|FG000|Overall Study|Sponsor decision|0|||
94680463|NCT03565068|324284345|FG001|Overall Study|Sponsor decision|0|||
94680464|NCT03565068|324284346|FG002|Overall Study|Sponsor decision|0|||
94680465|NCT03565068|324284347|FG003|Overall Study|Sponsor decision|0|||
94680466|NCT03565068|324284348|FG004|Overall Study|Sponsor decision|1|||
94680467|NCT03565068|324284349|FG005|Overall Study|Sponsor decision|1|||
94680468|NCT03565068|324284350|FG006|Overall Study|Sponsor decision|0|||
94680469|NCT03565068|324284351|FG007|Overall Study|Sponsor decision|0|||
94680470|NCT03565068|324284352|FG008|Overall Study|Sponsor decision|0|||
94680471|NCT03565068|324284344|FG000|Overall Study|Withdrawal by Subject|0|||
94680472|NCT03565068|324284345|FG001|Overall Study|Withdrawal by Subject|0|||
94680473|NCT03565068|324284346|FG002|Overall Study|Withdrawal by Subject|1|||
94680474|NCT03565068|324284347|FG003|Overall Study|Withdrawal by Subject|0|||
94680475|NCT03565068|324284348|FG004|Overall Study|Withdrawal by Subject|2|||
94680476|NCT03565068|324284349|FG005|Overall Study|Withdrawal by Subject|0|||
94680477|NCT03565068|324284350|FG006|Overall Study|Withdrawal by Subject|1|||
94680478|NCT03565068|324284351|FG007|Overall Study|Withdrawal by Subject|5|||
94680479|NCT03565068|324284352|FG008|Overall Study|Withdrawal by Subject|1|||
94363978|NCT00567996|323116795|FG000|Overall Study|Abnormal Lab value(s)|2|||
94363979|NCT00567996|323116796|FG001|Overall Study|Abnormal Lab value(s)|1|||
94363980|NCT00567996|323116797|FG002|Overall Study|Abnormal Lab value(s)|2|||
94680480|NCT03565068|324284344|FG000|Overall Study|Physician Decision|0|||
94680481|NCT03565068|324284345|FG001|Overall Study|Physician Decision|0|||
94680482|NCT03565068|324284346|FG002|Overall Study|Physician Decision|0|||
94680483|NCT03565068|324284347|FG003|Overall Study|Physician Decision|0|||
94680484|NCT03565068|324284348|FG004|Overall Study|Physician Decision|0|||
94680485|NCT03565068|324284349|FG005|Overall Study|Physician Decision|0|||
94680486|NCT03565068|324284350|FG006|Overall Study|Physician Decision|0|||
94680487|NCT03565068|324284351|FG007|Overall Study|Physician Decision|1|||
94680488|NCT03565068|324284352|FG008|Overall Study|Physician Decision|0|||
94680489|NCT03565068|324284344|FG000|Overall Study|Lost to Follow-up|0|||
94680490|NCT03565068|324284345|FG001|Overall Study|Lost to Follow-up|0|||
94680491|NCT03565068|324284346|FG002|Overall Study|Lost to Follow-up|0|||
94363981|NCT00567996|323116795|FG000|Overall Study|Abnormal test procedure result(s)|2|||
94680492|NCT03565068|324284347|FG003|Overall Study|Lost to Follow-up|0|||
94680493|NCT03565068|324284348|FG004|Overall Study|Lost to Follow-up|0|||
94680494|NCT03565068|324284349|FG005|Overall Study|Lost to Follow-up|0|||
94680495|NCT03565068|324284350|FG006|Overall Study|Lost to Follow-up|0|||
94680496|NCT03565068|324284351|FG007|Overall Study|Lost to Follow-up|1|||
94680497|NCT03565068|324284352|FG008|Overall Study|Lost to Follow-up|0|||
94680498|NCT01435655|324284359|FG000|Overall Study|Death|2|||
94680499|NCT01435655|324284359|FG000|Overall Study|Other|1|||
94680500|NCT01436201|324284360|FG000|Overall Study|Adverse Event|2|||
94680501|NCT01436201|324284360|FG000|Overall Study|Withdrawal by Subject|1|||
94680502|NCT01436201|324284360|FG000|Overall Study|Protocol Violation|1|||
94680503|NCT02839343|324284361|FG000|Overall Study|Withdrawal by Subject|3|||
94680504|NCT02839343|324284362|FG001|Overall Study|Withdrawal by Subject|1|||
94680505|NCT02839343|324284361|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
94680506|NCT02839343|324284362|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
94680507|NCT02839343|324284361|FG000|Overall Study|Adverse Event|1|||
94680508|NCT02839343|324284362|FG001|Overall Study|Adverse Event|0|||
94680509|NCT01852058|324284365|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
94680510|NCT01852058|324284366|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
94680511|NCT01852058|324284367|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
94680512|NCT01852058|324284368|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
94680513|NCT01852058|324284369|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
94680514|NCT01852058|324284370|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
94680515|NCT01852058|324284371|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
94680516|NCT01852058|324284372|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
94680517|NCT01852058|324284373|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
94680518|NCT01852058|324284374|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
94680519|NCT01852058|324284375|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
94680520|NCT01852058|324284376|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
94680521|NCT01852058|324284365|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
94680522|NCT01852058|324284366|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
94680523|NCT01852058|324284367|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
94680524|NCT01852058|324284368|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
94680525|NCT01852058|324284369|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
94680526|NCT01852058|324284370|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
94363982|NCT00567996|323116796|FG001|Overall Study|Abnormal test procedure result(s)|1|||
94363983|NCT00567996|323116797|FG002|Overall Study|Abnormal test procedure result(s)|1|||
94363984|NCT00567996|323116795|FG000|Overall Study|Lost to Follow-up|2|||
94680527|NCT01852058|324284371|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
94363985|NCT00567996|323116796|FG001|Overall Study|Lost to Follow-up|5|||
94680528|NCT01852058|324284372|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
94680529|NCT01852058|324284373|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
94680530|NCT01852058|324284374|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
94680531|NCT01852058|324284375|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
94680532|NCT01852058|324284376|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
94680533|NCT01852058|324284365|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
94680534|NCT01852058|324284366|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
94680535|NCT01852058|324284367|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
94680536|NCT01852058|324284368|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
94680537|NCT01852058|324284369|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
94680538|NCT01852058|324284370|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
94680539|NCT01852058|324284371|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
94680540|NCT01852058|324284372|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
94680541|NCT01852058|324284373|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
94680542|NCT01852058|324284374|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
94680543|NCT01852058|324284375|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
94680544|NCT01852058|324284376|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
94680545|NCT01852058|324284365|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
94680546|NCT01852058|324284366|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
94680547|NCT01852058|324284367|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
94680548|NCT01852058|324284368|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
94680549|NCT01852058|324284369|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
94680550|NCT01852058|324284370|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
94680551|NCT01852058|324284371|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
94680552|NCT01852058|324284372|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
94680553|NCT01852058|324284373|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
94680554|NCT01852058|324284374|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
94680555|NCT01852058|324284375|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
94680556|NCT01852058|324284376|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
94680557|NCT01852058|324284365|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
94680558|NCT01852058|324284366|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
94680559|NCT01852058|324284367|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
94680560|NCT01852058|324284368|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
94680561|NCT01852058|324284369|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
94680562|NCT01852058|324284370|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
94680563|NCT01852058|324284371|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
94680564|NCT01852058|324284372|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
94680565|NCT01852058|324284373|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
94680566|NCT01852058|324284374|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
94680567|NCT01852058|324284375|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
94680568|NCT01852058|324284376|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
94680569|NCT01852058|324284365|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
94680570|NCT01852058|324284366|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
94680571|NCT01852058|324284367|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
94680572|NCT01852058|324284368|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
94680573|NCT01852058|324284369|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
94680574|NCT01852058|324284370|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
94680575|NCT01852058|324284371|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
94680576|NCT01852058|324284372|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
94680577|NCT01852058|324284373|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
94680578|NCT01852058|324284374|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
94680579|NCT01852058|324284375|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
94680580|NCT01852058|324284376|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
94680581|NCT01852058|324284365|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
94680582|NCT01852058|324284366|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
94680583|NCT01852058|324284367|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
94680584|NCT01852058|324284368|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
94680585|NCT01852058|324284369|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
94680586|NCT01852058|324284370|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
94680587|NCT01852058|324284371|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
94680588|NCT01852058|324284372|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
94680589|NCT01852058|324284373|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
94680590|NCT01852058|324284374|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
94680591|NCT01852058|324284375|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
94680592|NCT01852058|324284376|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
94680593|NCT01852058|324284365|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
94680594|NCT01852058|324284366|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
94680595|NCT01852058|324284367|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
94680596|NCT01852058|324284368|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
94680597|NCT01852058|324284369|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
94680598|NCT01852058|324284370|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
94680599|NCT01852058|324284371|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
94680600|NCT01852058|324284372|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
94680601|NCT01852058|324284373|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
94680602|NCT01852058|324284374|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
94680603|NCT01852058|324284375|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
94680604|NCT01852058|324284376|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
94680605|NCT01852058|324284365|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
94680606|NCT01852058|324284366|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
94680607|NCT01852058|324284367|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
94680608|NCT01852058|324284368|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
94680609|NCT01852058|324284369|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
94680610|NCT01852058|324284370|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
94680611|NCT01852058|324284371|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
94680612|NCT01852058|324284372|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
94680613|NCT01852058|324284373|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
94680614|NCT01852058|324284374|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
94680615|NCT01852058|324284375|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
94680616|NCT01852058|324284376|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
94680617|NCT02636270|324284377|FG000|Overall Study|Adverse Event|1|||
94680618|NCT02636270|324284378|FG001|Overall Study|Adverse Event|0|||
94680619|NCT02636270|324284379|FG002|Overall Study|Adverse Event|0|||
94680620|NCT02636270|324284377|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
94680621|NCT02636270|324284378|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
94680622|NCT02636270|324284379|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
94680623|NCT03995784|324284380|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
94680624|NCT02172625|324284384|FG000|Overall Study|Adverse Event|0|||
94680625|NCT02172625|324284385|FG001|Overall Study|Adverse Event|1|||
94680626|NCT02172625|324284384|FG000|Overall Study|Pregnancy|0|||
94680627|NCT02172625|324284385|FG001|Overall Study|Pregnancy|1|||
94680628|NCT02172625|324284384|FG000|Overall Study|car accident|0|||
94680629|NCT02172625|324284385|FG001|Overall Study|car accident|1|||
94680630|NCT04277455|324286714|FG000|Overall Study|Lost to Follow-up|1|||
94680631|NCT01108458|324286720|FG000|Overall Study|Withdrawal by Subject|1|||
94680632|NCT01382602|324286721|FG000|Overall Study|Protocol Violation|0|||
94680633|NCT01382602|324286722|FG001|Overall Study|Protocol Violation|3|||
94680634|NCT01382602|324286721|FG000|Overall Study|Withdrawal by Subject|0|||
94680635|NCT01382602|324286722|FG001|Overall Study|Withdrawal by Subject|1|||
94680636|NCT01582789|324286724|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
94680637|NCT01582789|324286725|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
94680638|NCT04525547|324286726|FG000|Overall Study|Not treated with Ofev|2|||
94680639|NCT04525547|324286726|FG000|Overall Study|Off-label use|2|||
94680640|NCT04525547|324286726|FG000|Overall Study|Lost to Follow-up|1|||
94680641|NCT04439253|324286727|FG000|Overall Study|Adverse Event|1|||
94680642|NCT04439253|324286727|FG000|Overall Study|Disease progression|2|||
94680643|NCT04439253|324286727|FG000|Overall Study|Complicating disease|1|||
94680644|NCT02991482|324286728|FG000|Overall Study|Disease progression|56|||
94680645|NCT02991482|324286729|FG001|Overall Study|Disease progression|47|||
94680646|NCT02991482|324286728|FG000|Overall Study|Death|4|||
94680647|NCT02991482|324286729|FG001|Overall Study|Death|4|||
94680648|NCT02991482|324286728|FG000|Overall Study|Adverse Event|1|||
94680649|NCT02991482|324286729|FG001|Overall Study|Adverse Event|6|||
94680650|NCT02991482|324286728|FG000|Overall Study|Patient decision|1|||
94680651|NCT02991482|324286729|FG001|Overall Study|Patient decision|1|||
94680652|NCT02991482|324286728|FG000|Overall Study|Physician Decision|0|||
94680653|NCT02991482|324286729|FG001|Overall Study|Physician Decision|6|||
94680654|NCT02991482|324286728|FG000|Overall Study|Clinical deterioration|1|||
94680655|NCT02991482|324286729|FG001|Overall Study|Clinical deterioration|0|||
94680656|NCT02991482|324286728|FG000|Overall Study|Patient feeling too unwell|1|||
94680657|NCT02991482|324286729|FG001|Overall Study|Patient feeling too unwell|0|||
94680658|NCT02991482|324286728|FG000|Overall Study|Worsening of performance status|0|||
94680659|NCT02991482|324286729|FG001|Overall Study|Worsening of performance status|1|||
94680660|NCT02991482|324286728|FG000|Overall Study|Death prior to study drug initiation|1|||
94680661|NCT02991482|324286729|FG001|Overall Study|Death prior to study drug initiation|0|||
94680662|NCT02991482|324286728|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
94680663|NCT02991482|324286729|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
94680664|NCT00185640|324286737|FG000|Overall Study|Not Eligible|4|||
94680665|NCT00185640|324286737|FG000|Overall Study|Withdrawal by Subject|3|||
94680666|NCT00185640|324286737|FG000|Overall Study|Death|138|||
94680667|NCT01722162|324286741|FG000|Overall Study|Withdrawal by Subject|1|||
94680668|NCT01722162|324286742|FG001|Overall Study|Withdrawal by Subject|1|||
94680669|NCT01722162|324286741|FG000|Overall Study|Found ineligible|1|||
94680670|NCT01722162|324286742|FG001|Overall Study|Found ineligible|0|||
94680671|NCT01722162|324286741|FG000|Overall Study|Unrelated to study adverse event|2|||
94680672|NCT01722162|324286742|FG001|Overall Study|Unrelated to study adverse event|2|||
94680673|NCT01722162|324286741|FG000|Overall Study|Adverse Event|1|||
94680674|NCT01722162|324286742|FG001|Overall Study|Adverse Event|1|||
94680675|NCT01722162|324286741|FG000|Overall Study|Insurance denial post enrollment|0|||
94680676|NCT01722162|324286742|FG001|Overall Study|Insurance denial post enrollment|1|||
94680677|NCT01722162|324286741|FG000|Overall Study|Noncompliance|0|||
94680678|NCT01722162|324286742|FG001|Overall Study|Noncompliance|1|||
94680679|NCT02748694|324286743|FG000|Overall Study|Voluntary Withdrawal|0|||
94680680|NCT02748694|324286744|FG001|Overall Study|Voluntary Withdrawal|0|||
94680681|NCT02748694|324286745|FG002|Overall Study|Voluntary Withdrawal|0|||
94680682|NCT02748694|324286746|FG003|Overall Study|Voluntary Withdrawal|0|||
94680683|NCT02748694|324286747|FG004|Overall Study|Voluntary Withdrawal|0|||
94680684|NCT02748694|324286748|FG005|Overall Study|Voluntary Withdrawal|0|||
94680685|NCT02748694|324286749|FG006|Overall Study|Voluntary Withdrawal|0|||
94680686|NCT02748694|324286750|FG007|Overall Study|Voluntary Withdrawal|0|||
94680687|NCT02748694|324286751|FG008|Overall Study|Voluntary Withdrawal|0|||
94680688|NCT02748694|324286752|FG009|Overall Study|Voluntary Withdrawal|0|||
94680689|NCT02748694|324286753|FG010|Overall Study|Voluntary Withdrawal|0|||
94680690|NCT02748694|324286754|FG011|Overall Study|Voluntary Withdrawal|0|||
94363986|NCT00567996|323116797|FG002|Overall Study|Lost to Follow-up|2|||
94680691|NCT02748694|324286755|FG012|Overall Study|Voluntary Withdrawal|0|||
94680692|NCT02748694|324286756|FG013|Overall Study|Voluntary Withdrawal|0|||
94680693|NCT02748694|324286757|FG014|Overall Study|Voluntary Withdrawal|2|||
94680694|NCT01287520|324286762|FG000|Overall Study|Adverse Event|2|||
94680695|NCT01287520|324286763|FG001|Overall Study|Adverse Event|2|||
94680696|NCT01287520|324286764|FG002|Overall Study|Adverse Event|2|||
94680697|NCT01287520|324286765|FG003|Overall Study|Adverse Event|1|||
94680698|NCT01287520|324286766|FG004|Overall Study|Adverse Event|1|||
94680699|NCT01287520|324286767|FG005|Overall Study|Adverse Event|2|||
94680700|NCT01287520|324286768|FG006|Overall Study|Adverse Event|0|||
94680701|NCT01287520|324286769|FG007|Overall Study|Adverse Event|2|||
94680702|NCT01287520|324286770|FG008|Overall Study|Adverse Event|0|||
94680703|NCT01287520|324286762|FG000|Overall Study|Physician Decision|1|||
94680704|NCT01287520|324286763|FG001|Overall Study|Physician Decision|1|||
94680705|NCT01287520|324286764|FG002|Overall Study|Physician Decision|2|||
94680706|NCT01287520|324286765|FG003|Overall Study|Physician Decision|0|||
94680707|NCT01287520|324286766|FG004|Overall Study|Physician Decision|1|||
94680708|NCT01287520|324286767|FG005|Overall Study|Physician Decision|1|||
94680709|NCT01287520|324286768|FG006|Overall Study|Physician Decision|0|||
94680710|NCT01287520|324286769|FG007|Overall Study|Physician Decision|1|||
94680711|NCT01287520|324286770|FG008|Overall Study|Physician Decision|0|||
94680712|NCT01287520|324286762|FG000|Overall Study|Progressive disease|0|||
94680713|NCT01287520|324286763|FG001|Overall Study|Progressive disease|4|||
94680714|NCT01287520|324286764|FG002|Overall Study|Progressive disease|1|||
94680715|NCT01287520|324286765|FG003|Overall Study|Progressive disease|6|||
94680716|NCT01287520|324286766|FG004|Overall Study|Progressive disease|1|||
94680717|NCT01287520|324286767|FG005|Overall Study|Progressive disease|0|||
94680718|NCT01287520|324286768|FG006|Overall Study|Progressive disease|2|||
94680719|NCT01287520|324286769|FG007|Overall Study|Progressive disease|2|||
94680720|NCT01287520|324286770|FG008|Overall Study|Progressive disease|4|||
94680721|NCT01287520|324286762|FG000|Overall Study|Withdrawal by Subject|0|||
94680722|NCT01287520|324286763|FG001|Overall Study|Withdrawal by Subject|0|||
94680723|NCT01287520|324286764|FG002|Overall Study|Withdrawal by Subject|0|||
94680724|NCT01287520|324286765|FG003|Overall Study|Withdrawal by Subject|0|||
94680725|NCT01287520|324286766|FG004|Overall Study|Withdrawal by Subject|0|||
94680726|NCT01287520|324286767|FG005|Overall Study|Withdrawal by Subject|1|||
94680727|NCT01287520|324286768|FG006|Overall Study|Withdrawal by Subject|0|||
94680728|NCT01287520|324286769|FG007|Overall Study|Withdrawal by Subject|0|||
94680729|NCT01287520|324286770|FG008|Overall Study|Withdrawal by Subject|1|||
94680730|NCT03587142|324286771|FG000|Overall Study|Lost to Follow-up|5|||
94680731|NCT03587142|324286772|FG001|Overall Study|Lost to Follow-up|3|||
94680732|NCT03587142|324286771|FG000|Overall Study|Did not complete the f4 visit|3|||
94680733|NCT03587142|324286772|FG001|Overall Study|Did not complete the f4 visit|7|||
94680734|NCT00499863|324286773|FG000|Overall Study|Lack of Efficacy|21|||
94680735|NCT00499863|324286774|FG001|Overall Study|Lack of Efficacy|27|||
94680736|NCT00499863|324286773|FG000|Overall Study|Protocol Violation|12|||
94680737|NCT00499863|324286774|FG001|Overall Study|Protocol Violation|7|||
94680738|NCT00499863|324286773|FG000|Overall Study|Withdrawal by Subject|6|||
94680739|NCT00499863|324286774|FG001|Overall Study|Withdrawal by Subject|4|||
94680740|NCT00499863|324286773|FG000|Overall Study|Adverse Event|8|||
94680741|NCT00499863|324286774|FG001|Overall Study|Adverse Event|2|||
94680742|NCT00499863|324286773|FG000|Overall Study|Sponsor decision|2|||
94680743|NCT00499863|324286774|FG001|Overall Study|Sponsor decision|2|||
94680744|NCT00499863|324286773|FG000|Overall Study|Lost to Follow-up|1|||
94680745|NCT00499863|324286774|FG001|Overall Study|Lost to Follow-up|1|||
94680746|NCT03303469|324286775|FG000|Overall Study|Lost to Follow-up|2|||
94680747|NCT03097861|324286780|FG000|Overall Study|Adverse Event|3|||
94680748|NCT03097861|324286781|FG001|Overall Study|Adverse Event|8|||
94680749|NCT03097861|324286782|FG002|Overall Study|Adverse Event|4|||
94680750|NCT03097861|324286780|FG000|Overall Study|Investigator Decision|0|||
94680751|NCT03097861|324286781|FG001|Overall Study|Investigator Decision|1|||
94680752|NCT03097861|324286782|FG002|Overall Study|Investigator Decision|0|||
94680753|NCT03097861|324286780|FG000|Overall Study|Lost to Follow-up|0|||
94680754|NCT03097861|324286781|FG001|Overall Study|Lost to Follow-up|7|||
94680755|NCT03097861|324286782|FG002|Overall Study|Lost to Follow-up|1|||
94680756|NCT03097861|324286780|FG000|Overall Study|Withdrawal by Subject|1|||
94680757|NCT03097861|324286781|FG001|Overall Study|Withdrawal by Subject|5|||
94680758|NCT03097861|324286782|FG002|Overall Study|Withdrawal by Subject|3|||
94680759|NCT03097861|324286780|FG000|Overall Study|Reason not provided|3|||
94680760|NCT03097861|324286781|FG001|Overall Study|Reason not provided|1|||
94680761|NCT03097861|324286782|FG002|Overall Study|Reason not provided|1|||
94680762|NCT01959347|324286783|FG000|Overall Study|Protocol Violation|9|||
94680763|NCT01959347|324286784|FG001|Overall Study|Protocol Violation|7|||
94680764|NCT05061537|324286787|FG000|Treatment Phase|Progressive disease|0|||
94680765|NCT05061537|324286788|FG001|Treatment Phase|Progressive disease|1|||
94680766|NCT05061537|324286789|FG002|Treatment Phase|Progressive disease|2|||
94680767|NCT05061537|324286790|FG003|Treatment Phase|Progressive disease|0|||
94680768|NCT05061537|324286791|FG004|Treatment Phase|Progressive disease|0|||
94680769|NCT05061537|324286787|FG000|Treatment Phase|Adverse Event|0|||
94680770|NCT05061537|324286788|FG001|Treatment Phase|Adverse Event|0|||
94680771|NCT05061537|324286789|FG002|Treatment Phase|Adverse Event|2|||
94680772|NCT05061537|324286790|FG003|Treatment Phase|Adverse Event|0|||
94680773|NCT05061537|324286791|FG004|Treatment Phase|Adverse Event|0|||
94680774|NCT05061537|324286787|FG000|Treatment Phase|Global deterioration of health status|0|||
94680775|NCT05061537|324286788|FG001|Treatment Phase|Global deterioration of health status|1|||
94680776|NCT05061537|324286789|FG002|Treatment Phase|Global deterioration of health status|0|||
94680777|NCT05061537|324286790|FG003|Treatment Phase|Global deterioration of health status|0|||
94680778|NCT05061537|324286791|FG004|Treatment Phase|Global deterioration of health status|0|||
94680779|NCT05061537|324286787|FG000|Follow up|Other|2|||
94680780|NCT05061537|324286788|FG001|Follow up|Other|0|||
94680781|NCT05061537|324286789|FG002|Follow up|Other|2|||
94680782|NCT05061537|324286790|FG003|Follow up|Other|0|||
94680783|NCT05061537|324286791|FG004|Follow up|Other|0|||
94680784|NCT05061537|324286787|FG000|Follow up|Study terminated by sponsor|0|||
94680785|NCT05061537|324286788|FG001|Follow up|Study terminated by sponsor|0|||
94680786|NCT05061537|324286789|FG002|Follow up|Study terminated by sponsor|2|||
94680787|NCT05061537|324286790|FG003|Follow up|Study terminated by sponsor|0|||
94680788|NCT05061537|324286791|FG004|Follow up|Study terminated by sponsor|0|||
94680789|NCT05061537|324286787|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
94680790|NCT05061537|324286788|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
94680791|NCT05061537|324286789|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
94680792|NCT05061537|324286790|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
94680793|NCT05061537|324286791|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
94680794|NCT05061537|324286787|FG000|Long-term Follow-up|Death|0|||
94680795|NCT05061537|324286788|FG001|Long-term Follow-up|Death|1|||
94680796|NCT05061537|324286789|FG002|Long-term Follow-up|Death|0|||
94680797|NCT05061537|324286790|FG003|Long-term Follow-up|Death|0|||
94680798|NCT05061537|324286791|FG004|Long-term Follow-up|Death|0|||
94680799|NCT03502616|324286792|FG000|Up to Week 16|Withdrawal by Subject|1|||
94680800|NCT03502616|324286793|FG001|Up to Week 16|Withdrawal by Subject|2|||
94680801|NCT03502616|324286792|FG000|Up to Week 16|Lost to Follow-up|0|||
94680802|NCT03502616|324286793|FG001|Up to Week 16|Lost to Follow-up|1|||
94680803|NCT03502616|324286792|FG000|Up to Week 16|Randomized, but not treated|1|||
94680804|NCT03502616|324286793|FG001|Up to Week 16|Randomized, but not treated|0|||
94680805|NCT03502616|324286792|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
94680806|NCT03502616|324286793|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
94680807|NCT03502616|324286792|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
94680808|NCT03502616|324286793|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
94680809|NCT01691521|324286794|FG000|Overall Study|Adverse Event|4|||
94680810|NCT01691521|324286795|FG001|Overall Study|Adverse Event|0|||
94680811|NCT01691521|324286796|FG002|Overall Study|Adverse Event|1|||
94680812|NCT01691521|324286794|FG000|Overall Study|Lack of Efficacy|1|||
94680813|NCT01691521|324286795|FG001|Overall Study|Lack of Efficacy|1|||
94680814|NCT01691521|324286796|FG002|Overall Study|Lack of Efficacy|2|||
94680815|NCT01691521|324286794|FG000|Overall Study|Protocol Violation|0|||
94680816|NCT01691521|324286795|FG001|Overall Study|Protocol Violation|3|||
94680817|NCT01691521|324286796|FG002|Overall Study|Protocol Violation|0|||
94680818|NCT01691521|324286794|FG000|Overall Study|Lost to Follow-up|0|||
94680819|NCT01691521|324286795|FG001|Overall Study|Lost to Follow-up|2|||
94680820|NCT01691521|324286796|FG002|Overall Study|Lost to Follow-up|2|||
94680821|NCT01691521|324286794|FG000|Overall Study|Physician Decision|2|||
94680822|NCT01691521|324286795|FG001|Overall Study|Physician Decision|1|||
94680823|NCT01691521|324286796|FG002|Overall Study|Physician Decision|0|||
94680824|NCT01691521|324286794|FG000|Overall Study|Withdrawal by Subject|5|||
94680825|NCT01691521|324286795|FG001|Overall Study|Withdrawal by Subject|9|||
94680826|NCT01691521|324286796|FG002|Overall Study|Withdrawal by Subject|4|||
94680827|NCT04503096|324286797|FG000|Overall Study|Withdrawal by Subject|3|||
94680828|NCT01480596|324286798|FG000|Overall Study|Adverse Event|3|||
94680829|NCT01480596|324286799|FG001|Overall Study|Adverse Event|0|||
94680830|NCT01480596|324286798|FG000|Overall Study|MG exacerbation or change in medication|2|||
94680831|NCT01480596|324286799|FG001|Overall Study|MG exacerbation or change in medication|2|||
94680832|NCT02343003|324286800|FG000|Overall Study|Withdrawal by Subject|9|||
94680833|NCT02343003|324286801|FG001|Overall Study|Withdrawal by Subject|4|||
94680834|NCT02343003|324286800|FG000|Overall Study|Lost to Follow-up|5|||
94680835|NCT02343003|324286801|FG001|Overall Study|Lost to Follow-up|1|||
94680836|NCT02343003|324286800|FG000|Overall Study|Protocol Violation|1|||
94680837|NCT02343003|324286801|FG001|Overall Study|Protocol Violation|0|||
94680838|NCT02343003|324286800|FG000|Overall Study|Death|0|||
94680839|NCT02343003|324286801|FG001|Overall Study|Death|1|||
94680840|NCT02343003|324286800|FG000|Overall Study|exclusion criteria met|1|||
94680841|NCT02343003|324286801|FG001|Overall Study|exclusion criteria met|1|||
94680842|NCT02343003|324286800|FG000|Overall Study|terminated by sponsor|2|||
94680843|NCT02343003|324286801|FG001|Overall Study|terminated by sponsor|0|||
94680844|NCT01453348|324286806|FG000|Overall Study|Death|0|||
94680845|NCT01453348|324286807|FG001|Overall Study|Death|0|||
94680846|NCT01453348|324286808|FG002|Overall Study|Death|1|||
94680847|NCT01453348|324286806|FG000|Overall Study|Withdrawal by Subject|0|||
94680848|NCT01453348|324286807|FG001|Overall Study|Withdrawal by Subject|1|||
94680849|NCT01453348|324286808|FG002|Overall Study|Withdrawal by Subject|0|||
94680850|NCT01453348|324286806|FG000|Overall Study|Protocol Violation|1|||
94680851|NCT01453348|324286807|FG001|Overall Study|Protocol Violation|0|||
94680852|NCT01453348|324286808|FG002|Overall Study|Protocol Violation|0|||
94680853|NCT04359771|324286809|FG000|Overall Study|Lack of Efficacy|2|||
94680854|NCT04359771|324286810|FG001|Overall Study|Lack of Efficacy|2|||
94680855|NCT03579290|324286820|FG000|Overall Study|Lost to Follow-up|9|||
94680856|NCT00622713|324286823|FG000|Overall Study|Adverse Event|35|||
94680857|NCT00622713|324286823|FG000|Overall Study|Administrative problems|4|||
94680858|NCT00622713|324286823|FG000|Overall Study|Withdrawal by Subject|11|||
94680859|NCT00622713|324286823|FG000|Overall Study|Lost to Follow-up|5|||
94680860|NCT00622713|324286823|FG000|Overall Study|Death|2|||
94680861|NCT00622713|324286823|FG000|Overall Study|Subject no longer required study drug|1|||
94680862|NCT00622713|324286823|FG000|Overall Study|Did not meet eligibility criteria|1|||
94680863|NCT01375205|324286824|FG000|Overall Study|Lost to Follow-up|15|||
94680864|NCT01375205|324286825|FG001|Overall Study|Lost to Follow-up|12|||
94680865|NCT01375205|324286824|FG000|Overall Study|Withdrawal by Subject|6|||
94680866|NCT01375205|324286825|FG001|Overall Study|Withdrawal by Subject|1|||
94680867|NCT00152009|324286826|FG000|Overall Study|Adverse Event|9|||
94680868|NCT00152009|324286827|FG001|Overall Study|Adverse Event|13|||
94680869|NCT00152009|324286828|FG002|Overall Study|Adverse Event|20|||
94680870|NCT00152009|324286829|FG003|Overall Study|Adverse Event|1|||
94680871|NCT00152009|324286826|FG000|Overall Study|Protocol Violation|3|||
94680872|NCT00152009|324286827|FG001|Overall Study|Protocol Violation|0|||
94680873|NCT00152009|324286828|FG002|Overall Study|Protocol Violation|0|||
94680874|NCT00152009|324286829|FG003|Overall Study|Protocol Violation|1|||
94680875|NCT00152009|324286826|FG000|Overall Study|Withdrawal by Subject|2|||
94680876|NCT00152009|324286827|FG001|Overall Study|Withdrawal by Subject|3|||
94680877|NCT00152009|324286828|FG002|Overall Study|Withdrawal by Subject|4|||
94680878|NCT00152009|324286829|FG003|Overall Study|Withdrawal by Subject|9|||
94680879|NCT00152009|324286826|FG000|Overall Study|Lost to Follow-up|2|||
94680880|NCT00152009|324286827|FG001|Overall Study|Lost to Follow-up|4|||
94680881|NCT00152009|324286828|FG002|Overall Study|Lost to Follow-up|3|||
94680882|NCT00152009|324286829|FG003|Overall Study|Lost to Follow-up|3|||
94646213|NCT02434770|324165388|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
94646214|NCT02434770|324165386|FG000|Week 1 to Week 18|Death|1|||
94646215|NCT02434770|324165387|FG001|Week 1 to Week 18|Death|0|||
94646216|NCT02434770|324165388|FG002|Week 1 to Week 18|Death|0|||
94646217|NCT02434770|324165386|FG000|Week 18 to Week|Lost to Follow-up|2|||
94646218|NCT02434770|324165387|FG001|Week 18 to Week|Lost to Follow-up|2|||
94646219|NCT02434770|324165388|FG002|Week 18 to Week|Lost to Follow-up|1|||
94646220|NCT02434770|324165386|FG000|Week 18 to Week|Withdrawal by Subject|0|||
94646221|NCT02434770|324165387|FG001|Week 18 to Week|Withdrawal by Subject|0|||
94646222|NCT02434770|324165388|FG002|Week 18 to Week|Withdrawal by Subject|2|||
94646223|NCT02434770|324165386|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
94646224|NCT02434770|324165387|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
94646225|NCT02434770|324165388|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
94646226|NCT00245765|324165389|FG000|Overall Study|Adverse Event|1|||
94646227|NCT00245765|324165390|FG001|Overall Study|Adverse Event|1|||
94646228|NCT00245765|324165391|FG002|Overall Study|Adverse Event|0|||
94646229|NCT00245765|324165389|FG000|Overall Study|Lack of Efficacy|14|||
94646230|NCT00245765|324165390|FG001|Overall Study|Lack of Efficacy|7|||
94646231|NCT00245765|324165391|FG002|Overall Study|Lack of Efficacy|0|||
94646232|NCT00245765|324165389|FG000|Overall Study|Lost to Follow-up|1|||
94646233|NCT00245765|324165390|FG001|Overall Study|Lost to Follow-up|2|||
94646234|NCT00245765|324165391|FG002|Overall Study|Lost to Follow-up|0|||
94646235|NCT00245765|324165389|FG000|Overall Study|Withdrawal by Subject|1|||
94646236|NCT00245765|324165390|FG001|Overall Study|Withdrawal by Subject|0|||
94646237|NCT00245765|324165391|FG002|Overall Study|Withdrawal by Subject|3|||
94646238|NCT00245765|324165389|FG000|Overall Study|Other reason|2|||
94646239|NCT00245765|324165390|FG001|Overall Study|Other reason|0|||
94646240|NCT00245765|324165391|FG002|Overall Study|Other reason|1|||
94646241|NCT00245765|324165389|FG000|Overall Study|Other|13|||
94646242|NCT00245765|324165390|FG001|Overall Study|Other|4|||
94646243|NCT00245765|324165391|FG002|Overall Study|Other|4|||
94646244|NCT01574352|324165392|FG000|Overall Study|Withdrawal by Subject|6|||
94646245|NCT01574352|324165393|FG001|Overall Study|Withdrawal by Subject|13|||
94646246|NCT01574352|324165392|FG000|Overall Study|Injury in non-camp related sport|1|||
94646247|NCT01574352|324165393|FG001|Overall Study|Injury in non-camp related sport|0|||
94646248|NCT00528528|324165397|FG000|Overall Study|Lost to Follow-up|0|||
94646249|NCT00528528|324165398|FG001|Overall Study|Lost to Follow-up|0|||
94646250|NCT00528528|324165399|FG002|Overall Study|Lost to Follow-up|1|||
94646251|NCT00528528|324165400|FG003|Overall Study|Lost to Follow-up|1|||
94646252|NCT00528528|324165397|FG000|Overall Study|Ineligible to continue the trial|0|||
94646253|NCT00528528|324165398|FG001|Overall Study|Ineligible to continue the trial|0|||
94646254|NCT00528528|324165399|FG002|Overall Study|Ineligible to continue the trial|0|||
94646255|NCT00528528|324165400|FG003|Overall Study|Ineligible to continue the trial|1|||
94646256|NCT00528528|324165397|FG000|Overall Study|Other|0|||
94646257|NCT00528528|324165398|FG001|Overall Study|Other|1|||
94646258|NCT00528528|324165399|FG002|Overall Study|Other|0|||
94646259|NCT00528528|324165400|FG003|Overall Study|Other|0|||
94646260|NCT00528528|324165397|FG000|Overall Study|Withdrawal by Subject|3|||
94646261|NCT00528528|324165398|FG001|Overall Study|Withdrawal by Subject|2|||
94646262|NCT00528528|324165399|FG002|Overall Study|Withdrawal by Subject|1|||
94646263|NCT00528528|324165400|FG003|Overall Study|Withdrawal by Subject|1|||
94646264|NCT00528528|324165397|FG000|Overall Study|Ongoing participant|0|||
94646265|NCT00528528|324165398|FG001|Overall Study|Ongoing participant|0|||
94646266|NCT00528528|324165399|FG002|Overall Study|Ongoing participant|1|||
94646267|NCT00528528|324165400|FG003|Overall Study|Ongoing participant|0|||
94646268|NCT03945981|324165401|FG000|Overall Study|Lost to Follow-up|12|||
94646269|NCT03945981|324165401|FG000|Overall Study|Physician Decision|4|||
94646270|NCT03945981|324165401|FG000|Overall Study|Withdrawal by Subject|6|||
94646271|NCT03945981|324165401|FG000|Overall Study|Protocol Violation|1|||
94646272|NCT00445328|324165402|FG000|Overall Study|Death|0|||
94646273|NCT00445328|324165403|FG001|Overall Study|Death|1|||
94646274|NCT00445328|324165402|FG000|Overall Study|Adverse Event|0|||
94646275|NCT00445328|324165403|FG001|Overall Study|Adverse Event|3|||
94646276|NCT00445328|324165402|FG000|Overall Study|Other|0|||
94646277|NCT00445328|324165403|FG001|Overall Study|Other|2|||
94646278|NCT00445328|324165402|FG000|Overall Study|Withdrawal by Subject|2|||
94646279|NCT00445328|324165403|FG001|Overall Study|Withdrawal by Subject|0|||
94646280|NCT00445328|324165402|FG000|Overall Study|Protocol Violation|1|||
94646281|NCT00445328|324165403|FG001|Overall Study|Protocol Violation|0|||
94646282|NCT01332149|324167184|FG000|Overall Study|Adverse Event|11|||
94646283|NCT01332149|324167185|FG001|Overall Study|Adverse Event|9|||
94646284|NCT01332149|324167184|FG000|Overall Study|Other unspecified|5|||
94646285|NCT01332149|324167185|FG001|Overall Study|Other unspecified|7|||
94646286|NCT01332149|324167184|FG000|Overall Study|Protocol Violation|1|||
94646287|NCT01332149|324167185|FG001|Overall Study|Protocol Violation|3|||
94646288|NCT01332149|324167184|FG000|Overall Study|Withdrawal by Subject|4|||
94680883|NCT00152009|324286826|FG000|Overall Study|Lack of Efficacy|8|||
94680884|NCT00152009|324286827|FG001|Overall Study|Lack of Efficacy|6|||
94680885|NCT00152009|324286828|FG002|Overall Study|Lack of Efficacy|7|||
94680886|NCT00152009|324286829|FG003|Overall Study|Lack of Efficacy|15|||
94680887|NCT00152009|324286826|FG000|Overall Study|ECG abnormalities|2|||
94680888|NCT00152009|324286827|FG001|Overall Study|ECG abnormalities|2|||
94680889|NCT00152009|324286828|FG002|Overall Study|ECG abnormalities|2|||
94680890|NCT00152009|324286829|FG003|Overall Study|ECG abnormalities|1|||
94680891|NCT00152009|324286826|FG000|Overall Study|Sponsor's decision|3|||
94680892|NCT00152009|324286827|FG001|Overall Study|Sponsor's decision|3|||
94680893|NCT00152009|324286828|FG002|Overall Study|Sponsor's decision|1|||
94680894|NCT00152009|324286829|FG003|Overall Study|Sponsor's decision|3|||
94680895|NCT02914314|324286830|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
94680896|NCT02914314|324286831|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
94680897|NCT02914314|324286832|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
94263679|NCT00537485|322759896|FG001|Overall Study|Withdrawal by Subject|3|||
94680898|NCT02914314|324286833|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
94680899|NCT02914314|324286830|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
94680900|NCT02914314|324286831|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
94680901|NCT02914314|324286832|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
94680902|NCT02914314|324286833|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
94680903|NCT02914314|324286830|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
94680904|NCT02914314|324286831|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
94680905|NCT02914314|324286832|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
94680906|NCT02914314|324286833|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
94680907|NCT02914314|324286830|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
94680908|NCT02914314|324286831|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
94680909|NCT02914314|324286832|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
94680910|NCT02914314|324286833|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
94680911|NCT02914314|324286830|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
94680912|NCT02914314|324286831|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
94680913|NCT02914314|324286832|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
94680914|NCT02914314|324286833|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
94680915|NCT04702568|324286834|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
94680916|NCT04702568|324286835|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
94680917|NCT04702568|324286834|FG000|Overall Study|Pregnancy|1|||
94680918|NCT04702568|324286835|FG001|Overall Study|Pregnancy|0|||
94680919|NCT04702568|324286834|FG000|Overall Study|Bone marrow transplant|1|||
94680920|NCT04702568|324286835|FG001|Overall Study|Bone marrow transplant|0|||
94680921|NCT04702568|324286834|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
94680922|NCT04702568|324286835|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
94680923|NCT04702568|324286834|FG000|Overall Study|Withdrawal by Subject|0|||
94680924|NCT04702568|324286835|FG001|Overall Study|Withdrawal by Subject|2|||
94680925|NCT02158884|324286836|FG000|Baseline Assessment|Missed performance assessment|3|||
94680926|NCT02158884|324286836|FG000|Baseline Assessment|Missed SMFA|1|||
94680927|NCT02158884|324286836|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
94680928|NCT02158884|324286836|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
94680929|NCT02158884|324286836|FG000|6 Month Assessment|Missed SMFA|20|||
94680930|NCT02158884|324286836|FG000|12 Month Assessment|Missed SMFA|17|||
94680931|NCT00943306|324286840|FG000|Overall Study|Physician Decision|1|||
94680932|NCT00943306|324286840|FG000|Overall Study|Death|1|||
94680933|NCT00943306|324286840|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
94680934|NCT00733499|324286841|FG000|Pre-operative|Protocol Violation|0|||
94680935|NCT00733499|324286842|FG001|Pre-operative|Protocol Violation|1|||
94680936|NCT00733499|324286841|FG000|3 Months Follow-up|Death|1|||
94680937|NCT00733499|324286842|FG001|3 Months Follow-up|Death|2|||
94680938|NCT00733499|324286841|FG000|6 Months Follow-up|Death|0|||
94680939|NCT00733499|324286842|FG001|6 Months Follow-up|Death|2|||
94680940|NCT00733499|324286841|FG000|6 Months Follow-up|Adverse Event|0|||
94680941|NCT00733499|324286842|FG001|6 Months Follow-up|Adverse Event|1|||
94680942|NCT00733499|324286841|FG000|12 Months Follow-up|Death|2|||
94680943|NCT00733499|324286842|FG001|12 Months Follow-up|Death|1|||
94680944|NCT00733499|324286841|FG000|24 Months Follow-up|Death|0|||
94680945|NCT00733499|324286842|FG001|24 Months Follow-up|Death|1|||
94680946|NCT00733499|324286841|FG000|5 Year Followup|Adverse Event|2|||
94680947|NCT00733499|324286842|FG001|5 Year Followup|Adverse Event|2|||
94680948|NCT00733499|324286841|FG000|5 Year Followup|Non device related AE|0|||
94680949|NCT00733499|324286842|FG001|5 Year Followup|Non device related AE|1|||
94680950|NCT00733499|324286841|FG000|5 Year Followup|Revision of Study Implant|0|||
94680951|NCT00733499|324286842|FG001|5 Year Followup|Revision of Study Implant|1|||
94680952|NCT00733499|324286841|FG000|5 Year Followup|Lost to Follow-up|2|||
94680953|NCT00733499|324286842|FG001|5 Year Followup|Lost to Follow-up|0|||
94680954|NCT00733499|324286841|FG000|5 Year Followup|Death|13|||
94680955|NCT00733499|324286842|FG001|5 Year Followup|Death|19|||
94680956|NCT00733499|324286841|FG000|5 Year Followup|missing, unable to locate|0|||
94680957|NCT00733499|324286842|FG001|5 Year Followup|missing, unable to locate|1|||
94680958|NCT00733499|324286841|FG000|5 Year Followup|Withdrawal by Subject|4|||
94680959|NCT00733499|324286842|FG001|5 Year Followup|Withdrawal by Subject|1|||
94680960|NCT00733499|324286841|FG000|10 Year Followup|Death|9|||
94680961|NCT00733499|324286842|FG001|10 Year Followup|Death|7|||
94680962|NCT00733499|324286841|FG000|10 Year Followup|Adverse Event|3|||
94680963|NCT00733499|324286842|FG001|10 Year Followup|Adverse Event|3|||
94680964|NCT00733499|324286841|FG000|10 Year Followup|Lost to Follow-up|3|||
94680965|NCT00733499|324286842|FG001|10 Year Followup|Lost to Follow-up|2|||
94680966|NCT00733499|324286841|FG000|10 Year Followup|Withdrawal by Subject|5|||
94680967|NCT00733499|324286842|FG001|10 Year Followup|Withdrawal by Subject|5|||
94680968|NCT00733499|324286841|FG000|10 Year Followup|missing, unable to locate|0|||
94680969|NCT00733499|324286842|FG001|10 Year Followup|missing, unable to locate|2|||
94680970|NCT02739347|324286843|FG000|Overall Study|Adverse Event|3|||
94680971|NCT02739347|324286844|FG001|Overall Study|Adverse Event|0|||
94680972|NCT02739347|324286843|FG000|Overall Study|Protocol Violation|0|||
94680973|NCT02739347|324286844|FG001|Overall Study|Protocol Violation|1|||
94680974|NCT02739347|324286843|FG000|Overall Study|Lost to Follow-up|0|||
94680975|NCT02739347|324286844|FG001|Overall Study|Lost to Follow-up|2|||
94680976|NCT00990340|324286845|FG000|First 14-day Treatment|Not Compliant|2|||
94263680|NCT00537485|322759895|FG000|Overall Study|Physician Decision|1|||
94680977|NCT00990340|324286846|FG001|First 14-day Treatment|Not Compliant|1|||
94680978|NCT00990340|324286845|FG000|First 14-day Treatment|Lost to Follow-up|2|||
94680979|NCT00990340|324286846|FG001|First 14-day Treatment|Lost to Follow-up|1|||
94680980|NCT00990340|324286845|FG000|First 14-day Treatment|Protocol Violation|2|||
94680981|NCT00990340|324286846|FG001|First 14-day Treatment|Protocol Violation|2|||
94680982|NCT01874145|324286847|FG000|Core Period|Non-compliance|1|||
94680983|NCT01874145|324286848|FG001|Core Period|Non-compliance|0|||
94680984|NCT01874145|324286847|FG000|Core Period|Protocol Violation|1|||
94680985|NCT01874145|324286848|FG001|Core Period|Protocol Violation|1|||
94680986|NCT01874145|324286847|FG000|Core Period|Physician Decision|1|||
94680987|NCT01874145|324286848|FG001|Core Period|Physician Decision|1|||
94680988|NCT01874145|324286847|FG000|Core Period|Adverse Event|0|||
94680989|NCT01874145|324286848|FG001|Core Period|Adverse Event|1|||
94680990|NCT01874145|324286847|FG000|Core Period|Withdrawal by Subject|0|||
94680991|NCT01874145|324286848|FG001|Core Period|Withdrawal by Subject|4|||
94680992|NCT01874145|324286847|FG000|Extension Period|Adverse Event|3|||
94680993|NCT01874145|324286848|FG001|Extension Period|Adverse Event|2|||
94680994|NCT01874145|324286847|FG000|Extension Period|Withdrawal by Subject|2|||
94680995|NCT01874145|324286848|FG001|Extension Period|Withdrawal by Subject|1|||
94680996|NCT01874145|324286847|FG000|Extension Period|Lost to Follow-up|1|||
94680997|NCT01874145|324286848|FG001|Extension Period|Lost to Follow-up|1|||
94680998|NCT00402337|324286849|FG000|Overall Study|Adverse Event|0|||
94680999|NCT00402337|324286850|FG001|Overall Study|Adverse Event|2|||
94681000|NCT00402337|324286851|FG002|Overall Study|Adverse Event|2|||
94681001|NCT00402337|324286852|FG003|Overall Study|Adverse Event|3|||
94681002|NCT00402337|324286853|FG004|Overall Study|Adverse Event|2|||
94681003|NCT00402337|324286849|FG000|Overall Study|Noncompliance|0|||
94681004|NCT00402337|324286850|FG001|Overall Study|Noncompliance|0|||
94681005|NCT00402337|324286851|FG002|Overall Study|Noncompliance|0|||
94681006|NCT00402337|324286852|FG003|Overall Study|Noncompliance|0|||
94681007|NCT00402337|324286853|FG004|Overall Study|Noncompliance|2|||
94681008|NCT00402337|324286849|FG000|Overall Study|Withdrawal by Subject|5|||
94681009|NCT00402337|324286850|FG001|Overall Study|Withdrawal by Subject|3|||
94681010|NCT00402337|324286851|FG002|Overall Study|Withdrawal by Subject|1|||
94681011|NCT00402337|324286852|FG003|Overall Study|Withdrawal by Subject|6|||
94681012|NCT00402337|324286853|FG004|Overall Study|Withdrawal by Subject|4|||
94681013|NCT00402337|324286849|FG000|Overall Study|Lost to Follow-up|0|||
94681014|NCT00402337|324286850|FG001|Overall Study|Lost to Follow-up|0|||
94681015|NCT00402337|324286851|FG002|Overall Study|Lost to Follow-up|1|||
94681016|NCT00402337|324286852|FG003|Overall Study|Lost to Follow-up|2|||
94681017|NCT00402337|324286853|FG004|Overall Study|Lost to Follow-up|0|||
94681018|NCT00402337|324286849|FG000|Overall Study|Physician Decision|0|||
94681019|NCT00402337|324286850|FG001|Overall Study|Physician Decision|0|||
94681020|NCT00402337|324286851|FG002|Overall Study|Physician Decision|0|||
94681021|NCT00402337|324286852|FG003|Overall Study|Physician Decision|1|||
94681022|NCT00402337|324286853|FG004|Overall Study|Physician Decision|0|||
94681023|NCT00402337|324286849|FG000|Overall Study|Other Reason|0|||
94681024|NCT00402337|324286850|FG001|Overall Study|Other Reason|1|||
94681025|NCT00402337|324286851|FG002|Overall Study|Other Reason|0|||
94681026|NCT00402337|324286852|FG003|Overall Study|Other Reason|0|||
94681027|NCT00402337|324286853|FG004|Overall Study|Other Reason|0|||
94681028|NCT04631705|324286854|FG000|Overall Study|Withdrawal by Subject|0|||
94681029|NCT04631705|324286855|FG001|Overall Study|Withdrawal by Subject|0|||
94681030|NCT04631705|324286856|FG002|Overall Study|Withdrawal by Subject|0|||
94681031|NCT04631705|324286857|FG003|Overall Study|Withdrawal by Subject|0|||
94681032|NCT04631705|324286858|FG004|Overall Study|Withdrawal by Subject|0|||
94681033|NCT04631705|324286859|FG005|Overall Study|Withdrawal by Subject|0|||
94681034|NCT04631705|324286860|FG006|Overall Study|Withdrawal by Subject|1|||
94681035|NCT04631705|324286861|FG007|Overall Study|Withdrawal by Subject|0|||
94681036|NCT04631705|324286862|FG008|Overall Study|Withdrawal by Subject|0|||
94681037|NCT02130284|324286863|FG000|Overall Study|Withdrawal by Subject|3|||
94681038|NCT02130284|324286863|FG000|Overall Study|Subject Withdrew Consent|1|||
94681039|NCT02130284|324286863|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
94681040|NCT02130284|324286863|FG000|Overall Study|Subject was screened as backup for study|3|||
94681041|NCT02130284|324286863|FG000|Overall Study|Screen Failure|1|||
94681042|NCT03442569|324286864|FG000|Overall Study|Subject was ineligible after enrollment|1|||
94681043|NCT01807650|324286867|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
94681044|NCT01807650|324286867|FG000|Overall Study|Adverse Event|5|||
94681045|NCT01807650|324286867|FG000|Overall Study|Other|2|||
94681046|NCT00909428|324286868|FG000|Overall Study|Lost to Follow-up|13|||
94681047|NCT00909428|324286869|FG001|Overall Study|Lost to Follow-up|10|||
94681048|NCT00909428|324286870|FG002|Overall Study|Lost to Follow-up|9|||
94681049|NCT00736489|324286873|FG000|Period 1|Lost to Follow-up|1|||
94681050|NCT00736489|324286874|FG001|Period 1|Lost to Follow-up|0|||
94681051|NCT00736489|324286875|FG002|Period 1|Lost to Follow-up|0|||
94681052|NCT00736489|324286876|FG003|Period 1|Lost to Follow-up|0|||
94681053|NCT00736489|324286877|FG004|Period 1|Lost to Follow-up|0|||
94681054|NCT00736489|324286878|FG005|Period 1|Lost to Follow-up|0|||
94681055|NCT00736489|324286873|FG000|Period 1|Withdrawal by Subject|0|||
94681056|NCT00736489|324286874|FG001|Period 1|Withdrawal by Subject|0|||
94681057|NCT00736489|324286875|FG002|Period 1|Withdrawal by Subject|0|||
94681058|NCT00736489|324286876|FG003|Period 1|Withdrawal by Subject|0|||
94681059|NCT00736489|324286877|FG004|Period 1|Withdrawal by Subject|0|||
94681060|NCT00736489|324286878|FG005|Period 1|Withdrawal by Subject|1|||
94681061|NCT01933880|324286879|FG000|Overall Study|Withdrawal by Subject|5|||
94681062|NCT01933880|324286880|FG001|Overall Study|Withdrawal by Subject|0|||
94681063|NCT01933880|324286879|FG000|Overall Study|Lack of Efficacy|1|||
94681064|NCT01933880|324286880|FG001|Overall Study|Lack of Efficacy|0|||
94681065|NCT01933880|324286879|FG000|Overall Study|Concomitant medication Interference|0|||
94681066|NCT01933880|324286880|FG001|Overall Study|Concomitant medication Interference|1|||
94681067|NCT01933880|324286879|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
94681068|NCT01933880|324286880|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
94681069|NCT01933880|324286879|FG000|Overall Study|Other|4|||
94681070|NCT01933880|324286880|FG001|Overall Study|Other|0|||
94681071|NCT01933880|324286879|FG000|Overall Study|Protocol Violation|1|||
94681072|NCT01933880|324286880|FG001|Overall Study|Protocol Violation|0|||
94681073|NCT01125722|324286881|FG000|Overall Study|Withdrawal by Subject|2|||
94681074|NCT01125722|324286882|FG001|Overall Study|Withdrawal by Subject|1|||
94681075|NCT01125722|324286881|FG000|Overall Study|Lost to Follow-up|1|||
94681076|NCT01125722|324286882|FG001|Overall Study|Lost to Follow-up|0|||
94681077|NCT01396317|324286883|FG000|Overall Study|Adverse Event|1|||
94681078|NCT01396317|324286884|FG001|Overall Study|Adverse Event|0|||
94681079|NCT00384059|324286889|FG000|Infant Series|Not consented|2|||
94681080|NCT00384059|324286890|FG001|Infant Series|Not consented|6|||
94681081|NCT00384059|324286889|FG000|Infant Series|Withdrawal by Subject|2|||
94681082|NCT00384059|324286890|FG001|Infant Series|Withdrawal by Subject|2|||
94681083|NCT00384059|324286889|FG000|Infant Series|Adverse Event|1|||
94681084|NCT00384059|324286890|FG001|Infant Series|Adverse Event|2|||
94681085|NCT00384059|324286889|FG000|Infant Series|Protocol Violation|1|||
94681086|NCT00384059|324286890|FG001|Infant Series|Protocol Violation|2|||
94681087|NCT00384059|324286889|FG000|Infant Series|Lost to Follow-up|0|||
94681088|NCT00384059|324286890|FG001|Infant Series|Lost to Follow-up|1|||
94681089|NCT00384059|324286889|FG000|After Infant Series|Protocol Violation|2|||
94681090|NCT00384059|324286890|FG001|After Infant Series|Protocol Violation|3|||
94681091|NCT00384059|324286889|FG000|After Infant Series|Withdrawal by Subject|2|||
94681092|NCT00384059|324286890|FG001|After Infant Series|Withdrawal by Subject|2|||
94681093|NCT00384059|324286889|FG000|After Infant Series|Failed to Return|0|||
94681094|NCT00384059|324286890|FG001|After Infant Series|Failed to Return|2|||
94681095|NCT00384059|324286889|FG000|After Infant Series|Adverse Event|0|||
94681096|NCT00384059|324286890|FG001|After Infant Series|Adverse Event|1|||
94681097|NCT00384059|324286889|FG000|After Infant Series|Physician Decision|0|||
94681098|NCT00384059|324286890|FG001|After Infant Series|Physician Decision|1|||
94681099|NCT00384059|324286889|FG000|After Infant Series|Lost to Follow-up|0|||
94681100|NCT00384059|324286890|FG001|After Infant Series|Lost to Follow-up|1|||
94681101|NCT00384059|324286889|FG000|Toddler Dose|Lost to Follow-up|1|||
94681102|NCT00384059|324286890|FG001|Toddler Dose|Lost to Follow-up|1|||
94681103|NCT00384059|324286889|FG000|Toddler Dose|Failed to return|0|||
94681104|NCT00384059|324286890|FG001|Toddler Dose|Failed to return|1|||
94681105|NCT01338012|324286891|FG000|Overall Study|Death|4|||
94681106|NCT01338012|324286891|FG000|Overall Study|Study terminated|4|||
94681107|NCT02089230|324286892|FG000|Overall Study|Death|0|||
94681108|NCT02089230|324286893|FG001|Overall Study|Death|0|||
94681109|NCT02089230|324286894|FG002|Overall Study|Death|2|||
94681110|NCT02089230|324286892|FG000|Overall Study|Seeking Alternative Therapy|0|||
94681111|NCT02089230|324286893|FG001|Overall Study|Seeking Alternative Therapy|0|||
94681112|NCT02089230|324286894|FG002|Overall Study|Seeking Alternative Therapy|4|||
94681113|NCT04287868|324286895|FG000|Overall Study|Screening fail|1|||
94681114|NCT04287868|324286896|FG001|Overall Study|Screening fail|0|||
94681115|NCT02790073|324288968|FG000|Overall Study|Death|1|||
94681116|NCT02790073|324288968|FG000|Overall Study|Withdrawal from HD|1|||
94681117|NCT02790073|324288968|FG000|Overall Study|Withdrawal by Subject|1|||
94681118|NCT02801669|324288972|FG000|Overall Study|Death|66|||
94681119|NCT02801669|324288973|FG001|Overall Study|Death|69|||
94681120|NCT02801669|324288972|FG000|Overall Study|Withdrawal by Subject|81|||
94681121|NCT02801669|324288973|FG001|Overall Study|Withdrawal by Subject|77|||
94681122|NCT02801669|324288972|FG000|Overall Study|Other|4|||
94681123|NCT02801669|324288973|FG001|Overall Study|Other|6|||
94681124|NCT02287584|324288974|FG000|the Double-blind Phase|Adverse Event|17|||
94681125|NCT02287584|324288975|FG001|the Double-blind Phase|Adverse Event|17|||
94681126|NCT02287584|324288976|FG002|the Double-blind Phase|Adverse Event|12|||
94681127|NCT02287584|324288977|FG003|the Double-blind Phase|Adverse Event|0|||
94681128|NCT02287584|324288978|FG004|the Double-blind Phase|Adverse Event|0|||
94681129|NCT02287584|324288979|FG005|the Double-blind Phase|Adverse Event|0|||
94681130|NCT02287584|324288974|FG000|the Double-blind Phase|Lack of Efficacy|18|||
94681131|NCT02287584|324288975|FG001|the Double-blind Phase|Lack of Efficacy|8|||
94681132|NCT02287584|324288976|FG002|the Double-blind Phase|Lack of Efficacy|8|||
94681133|NCT02287584|324288977|FG003|the Double-blind Phase|Lack of Efficacy|0|||
94681134|NCT02287584|324288978|FG004|the Double-blind Phase|Lack of Efficacy|0|||
94681135|NCT02287584|324288979|FG005|the Double-blind Phase|Lack of Efficacy|0|||
94681136|NCT02287584|324288974|FG000|the Double-blind Phase|Lost to Follow-up|0|||
94681137|NCT02287584|324288975|FG001|the Double-blind Phase|Lost to Follow-up|1|||
94681138|NCT02287584|324288976|FG002|the Double-blind Phase|Lost to Follow-up|1|||
94681139|NCT02287584|324288977|FG003|the Double-blind Phase|Lost to Follow-up|0|||
94681140|NCT02287584|324288978|FG004|the Double-blind Phase|Lost to Follow-up|0|||
94681141|NCT02287584|324288979|FG005|the Double-blind Phase|Lost to Follow-up|0|||
94681142|NCT02287584|324288974|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
94681143|NCT02287584|324288975|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
94681144|NCT02287584|324288976|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
94681145|NCT02287584|324288977|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
94263681|NCT00537485|322759896|FG001|Overall Study|Physician Decision|0|||
94263682|NCT01601847|322759902|FG000|Overall Study|Death|1|||
94263683|NCT01601847|322759903|FG001|Overall Study|Death|0|||
94263684|NCT01601847|322759902|FG000|Overall Study|Withdrawal by Subject|11|||
94263685|NCT01601847|322759903|FG001|Overall Study|Withdrawal by Subject|7|||
94263686|NCT01601847|322759902|FG000|Overall Study|Lost to Follow-up|1|||
94263687|NCT01601847|322759903|FG001|Overall Study|Lost to Follow-up|3|||
94263688|NCT01145495|322759904|FG000|Overall Study|Adverse Event|6|||
94263689|NCT01145495|322759904|FG000|Overall Study|Withdrawal by Subject|6|||
94263690|NCT01145495|322759904|FG000|Overall Study|Disease progression after respone|2|||
94263691|NCT01020448|322759905|FG000|Pre-assignment|Adverse Event|6|||
94263692|NCT01020448|322759905|FG000|Pre-assignment|Withdrawal by Subject|5|||
94263693|NCT01020448|322759905|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
94263694|NCT01020448|322759905|FG000|Treatment|Adverse Event|11|||
94263695|NCT01020448|322759905|FG000|Treatment|Consent Withdrawn|3|||
94263696|NCT01020448|322759905|FG000|Treatment|Disease Progression|2|||
94263697|NCT01020448|322759905|FG000|Treatment|Lack of Efficacy|8|||
94263698|NCT01020448|322759905|FG000|Treatment|Lost to Follow-up|2|||
94263699|NCT00821431|322759909|FG000|Overall Study|Adverse Event|6|||
94263700|NCT00821431|322759910|FG001|Overall Study|Adverse Event|3|||
94263701|NCT00821431|322759909|FG000|Overall Study|Withdrawal by Subject|5|||
94263702|NCT00821431|322759910|FG001|Overall Study|Withdrawal by Subject|0|||
94263703|NCT00821431|322759909|FG000|Overall Study|Lost to Follow-up|1|||
94263704|NCT00821431|322759910|FG001|Overall Study|Lost to Follow-up|0|||
94263705|NCT00821431|322759909|FG000|Overall Study|Protocol Violation|3|||
94263706|NCT00821431|322759910|FG001|Overall Study|Protocol Violation|1|||
94263707|NCT00821431|322759909|FG000|Overall Study|Physician Decision|0|||
94263708|NCT00821431|322759910|FG001|Overall Study|Physician Decision|1|||
94263709|NCT00576836|322759912|FG000|Overall Study|Death|0|||
94263710|NCT00576836|322759913|FG001|Overall Study|Death|1|||
94263711|NCT00576836|322759912|FG000|Overall Study|Physician Decision|0|||
94263712|NCT00576836|322759913|FG001|Overall Study|Physician Decision|1|||
94263713|NCT02469896|322759914|FG000|Overall Study|Withdrawal by Subject|2|||
94263714|NCT02469896|322759915|FG001|Overall Study|Withdrawal by Subject|0|||
94263715|NCT01514136|322759916|FG000|Test Period 1; Test A|Protocol Violation|1|||
94263716|NCT01514136|322759917|FG001|Test Period 1; Test A|Protocol Violation|0|||
94263717|NCT01514136|322759918|FG002|Test Period 1; Test A|Protocol Violation|0|||
94263718|NCT01514136|322759919|FG003|Test Period 1; Test A|Protocol Violation|0|||
94263719|NCT01514136|322759920|FG004|Test Period 1; Test A|Protocol Violation|0|||
94263720|NCT01514136|322759921|FG005|Test Period 1; Test A|Protocol Violation|0|||
94263721|NCT01514136|322759922|FG006|Test Period 1; Test A|Protocol Violation|0|||
94263722|NCT01514136|322759923|FG007|Test Period 1; Test A|Protocol Violation|0|||
94263723|NCT01514136|322759916|FG000|Test Period 1; Test A|Break from study holiday|2|||
94263724|NCT01514136|322759917|FG001|Test Period 1; Test A|Break from study holiday|0|||
94263725|NCT01514136|322759918|FG002|Test Period 1; Test A|Break from study holiday|0|||
94263726|NCT01514136|322759919|FG003|Test Period 1; Test A|Break from study holiday|0|||
94681146|NCT02287584|324288978|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
94681147|NCT02287584|324288979|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
94681148|NCT02287584|324288974|FG000|the Double-blind Phase|Pregnancy|0|||
94681149|NCT02287584|324288975|FG001|the Double-blind Phase|Pregnancy|1|||
94681150|NCT02287584|324288976|FG002|the Double-blind Phase|Pregnancy|0|||
94681151|NCT02287584|324288977|FG003|the Double-blind Phase|Pregnancy|0|||
94681152|NCT02287584|324288978|FG004|the Double-blind Phase|Pregnancy|0|||
94681153|NCT02287584|324288979|FG005|the Double-blind Phase|Pregnancy|0|||
94681154|NCT02287584|324288974|FG000|the Double-blind Phase|Protocol Violation|0|||
94681155|NCT02287584|324288975|FG001|the Double-blind Phase|Protocol Violation|3|||
94681156|NCT02287584|324288976|FG002|the Double-blind Phase|Protocol Violation|0|||
94681157|NCT02287584|324288977|FG003|the Double-blind Phase|Protocol Violation|0|||
94681158|NCT02287584|324288978|FG004|the Double-blind Phase|Protocol Violation|0|||
94681159|NCT02287584|324288979|FG005|the Double-blind Phase|Protocol Violation|0|||
94681160|NCT02287584|324288974|FG000|the Double-blind Phase|other reasons|0|||
94681161|NCT02287584|324288975|FG001|the Double-blind Phase|other reasons|0|||
94681162|NCT02287584|324288976|FG002|the Double-blind Phase|other reasons|1|||
94681163|NCT02287584|324288977|FG003|the Double-blind Phase|other reasons|0|||
94681164|NCT02287584|324288978|FG004|the Double-blind Phase|other reasons|0|||
94681165|NCT02287584|324288979|FG005|the Double-blind Phase|other reasons|0|||
94681166|NCT02287584|324288974|FG000|the Open-label Phase|Did not receive drug|0|||
94681167|NCT02287584|324288975|FG001|the Open-label Phase|Did not receive drug|0|||
94681168|NCT02287584|324288976|FG002|the Open-label Phase|Did not receive drug|0|||
94681169|NCT02287584|324288977|FG003|the Open-label Phase|Did not receive drug|7|||
94681170|NCT02287584|324288978|FG004|the Open-label Phase|Did not receive drug|6|||
94681171|NCT02287584|324288979|FG005|the Open-label Phase|Did not receive drug|4|||
94681172|NCT02287584|324288974|FG000|the Open-label Phase|Adverse Event|0|||
94681173|NCT02287584|324288975|FG001|the Open-label Phase|Adverse Event|0|||
94681174|NCT02287584|324288976|FG002|the Open-label Phase|Adverse Event|0|||
94681175|NCT02287584|324288977|FG003|the Open-label Phase|Adverse Event|15|||
94681176|NCT02287584|324288978|FG004|the Open-label Phase|Adverse Event|12|||
94681177|NCT02287584|324288979|FG005|the Open-label Phase|Adverse Event|16|||
94681178|NCT02287584|324288974|FG000|the Open-label Phase|Lack of Efficacy|0|||
94681179|NCT02287584|324288975|FG001|the Open-label Phase|Lack of Efficacy|0|||
94681180|NCT02287584|324288976|FG002|the Open-label Phase|Lack of Efficacy|0|||
94681181|NCT02287584|324288977|FG003|the Open-label Phase|Lack of Efficacy|8|||
94681182|NCT02287584|324288978|FG004|the Open-label Phase|Lack of Efficacy|3|||
94681183|NCT02287584|324288979|FG005|the Open-label Phase|Lack of Efficacy|7|||
94681184|NCT02287584|324288974|FG000|the Open-label Phase|Lost to Follow-up|0|||
94681185|NCT02287584|324288975|FG001|the Open-label Phase|Lost to Follow-up|0|||
94681186|NCT02287584|324288976|FG002|the Open-label Phase|Lost to Follow-up|0|||
94681187|NCT02287584|324288977|FG003|the Open-label Phase|Lost to Follow-up|4|||
94681188|NCT02287584|324288978|FG004|the Open-label Phase|Lost to Follow-up|1|||
94681189|NCT02287584|324288979|FG005|the Open-label Phase|Lost to Follow-up|2|||
94681190|NCT02287584|324288974|FG000|the Open-label Phase|Withdrawal by Subject|0|||
94681191|NCT02287584|324288975|FG001|the Open-label Phase|Withdrawal by Subject|0|||
94681192|NCT02287584|324288976|FG002|the Open-label Phase|Withdrawal by Subject|0|||
94681193|NCT02287584|324288977|FG003|the Open-label Phase|Withdrawal by Subject|18|||
94681194|NCT02287584|324288978|FG004|the Open-label Phase|Withdrawal by Subject|29|||
94681195|NCT02287584|324288979|FG005|the Open-label Phase|Withdrawal by Subject|21|||
94681196|NCT02287584|324288974|FG000|the Open-label Phase|non-compliance|0|||
94681197|NCT02287584|324288975|FG001|the Open-label Phase|non-compliance|0|||
94681198|NCT02287584|324288976|FG002|the Open-label Phase|non-compliance|0|||
94681199|NCT02287584|324288977|FG003|the Open-label Phase|non-compliance|2|||
94681200|NCT02287584|324288978|FG004|the Open-label Phase|non-compliance|5|||
94681201|NCT02287584|324288979|FG005|the Open-label Phase|non-compliance|1|||
94681202|NCT02287584|324288974|FG000|the Open-label Phase|other reasons|0|||
94681203|NCT02287584|324288975|FG001|the Open-label Phase|other reasons|0|||
94681204|NCT02287584|324288976|FG002|the Open-label Phase|other reasons|0|||
94681205|NCT02287584|324288977|FG003|the Open-label Phase|other reasons|3|||
94681206|NCT02287584|324288978|FG004|the Open-label Phase|other reasons|6|||
94681207|NCT02287584|324288979|FG005|the Open-label Phase|other reasons|6|||
94681208|NCT03430063|324288985|FG000|Overall Study|Adverse Event|0|||
94681209|NCT03430063|324288986|FG001|Overall Study|Adverse Event|1|||
94681210|NCT03430063|324288987|FG002|Overall Study|Adverse Event|0|||
94681211|NCT03430063|324288985|FG000|Overall Study|Death|3|||
94681212|NCT03430063|324288986|FG001|Overall Study|Death|2|||
94681213|NCT03430063|324288987|FG002|Overall Study|Death|3|||
94681214|NCT03430063|324288985|FG000|Overall Study|Lost to Follow-up|0|||
94681215|NCT03430063|324288986|FG001|Overall Study|Lost to Follow-up|1|||
94681216|NCT03430063|324288987|FG002|Overall Study|Lost to Follow-up|0|||
94681217|NCT03430063|324288985|FG000|Overall Study|Withdrawal by Subject|0|||
94681218|NCT03430063|324288986|FG001|Overall Study|Withdrawal by Subject|0|||
94681219|NCT03430063|324288987|FG002|Overall Study|Withdrawal by Subject|1|||
94681220|NCT03430063|324288985|FG000|Overall Study|Withdrawal of consent|3|||
94681221|NCT03430063|324288986|FG001|Overall Study|Withdrawal of consent|1|||
94681222|NCT03430063|324288987|FG002|Overall Study|Withdrawal of consent|2|||
94681223|NCT03430063|324288985|FG000|Overall Study|Progressive disease|1|||
94681224|NCT03430063|324288986|FG001|Overall Study|Progressive disease|2|||
94681225|NCT03430063|324288987|FG002|Overall Study|Progressive disease|1|||
94681226|NCT03430063|324288985|FG000|Overall Study|Other un-specified|1|||
94681227|NCT03430063|324288986|FG001|Overall Study|Other un-specified|1|||
94681228|NCT03430063|324288987|FG002|Overall Study|Other un-specified|0|||
94681229|NCT03430063|324288985|FG000|Overall Study|Randomized, but never treated|0|||
94463469|NCT02520427|323485080|FG023|Overall Study|Withdrawal by Subject|0|||
94463470|NCT02520427|323485081|FG024|Overall Study|Withdrawal by Subject|0|||
94681230|NCT03430063|324288986|FG001|Overall Study|Randomized, but never treated|0|||
94681231|NCT03430063|324288987|FG002|Overall Study|Randomized, but never treated|1|||
94681232|NCT01350141|324288990|FG000|Overall Study|Lost to Follow-up|1|||
94681233|NCT01350141|324288991|FG001|Overall Study|Lost to Follow-up|0|||
94681234|NCT01350141|324288992|FG002|Overall Study|Lost to Follow-up|1|||
94681235|NCT01350141|324288990|FG000|Overall Study|Withdrawal by Subject|1|||
94681236|NCT01350141|324288991|FG001|Overall Study|Withdrawal by Subject|0|||
94681237|NCT01350141|324288992|FG002|Overall Study|Withdrawal by Subject|0|||
94681238|NCT01350141|324288990|FG000|Overall Study|Randomized but not treated|1|||
94681239|NCT01350141|324288991|FG001|Overall Study|Randomized but not treated|0|||
94681240|NCT01350141|324288992|FG002|Overall Study|Randomized but not treated|0|||
94681241|NCT01473381|324288993|FG000|Overall Study|Adverse Event|8|||
94681242|NCT01473381|324288994|FG001|Overall Study|Adverse Event|20|||
94681243|NCT01473381|324288995|FG002|Overall Study|Adverse Event|25|||
94681244|NCT01473381|324288996|FG003|Overall Study|Adverse Event|17|||
94681245|NCT01473381|324288993|FG000|Overall Study|Insufficient Therapeutic Response|10|||
94681246|NCT01473381|324288994|FG001|Overall Study|Insufficient Therapeutic Response|1|||
94681247|NCT01473381|324288995|FG002|Overall Study|Insufficient Therapeutic Response|2|||
94681248|NCT01473381|324288996|FG003|Overall Study|Insufficient Therapeutic Response|3|||
94681249|NCT01473381|324288993|FG000|Overall Study|Protocol Violation|17|||
94681250|NCT01473381|324288994|FG001|Overall Study|Protocol Violation|23|||
94681251|NCT01473381|324288995|FG002|Overall Study|Protocol Violation|19|||
94681252|NCT01473381|324288996|FG003|Overall Study|Protocol Violation|17|||
94681253|NCT01473381|324288993|FG000|Overall Study|Withdrawal of Consent|20|||
94681254|NCT01473381|324288994|FG001|Overall Study|Withdrawal of Consent|21|||
94681255|NCT01473381|324288995|FG002|Overall Study|Withdrawal of Consent|20|||
94681256|NCT01473381|324288996|FG003|Overall Study|Withdrawal of Consent|26|||
94681257|NCT01473381|324288993|FG000|Overall Study|Lost to Follow-up|25|||
94681258|NCT01473381|324288994|FG001|Overall Study|Lost to Follow-up|28|||
94681259|NCT01473381|324288995|FG002|Overall Study|Lost to Follow-up|35|||
94681260|NCT01473381|324288996|FG003|Overall Study|Lost to Follow-up|23|||
94681261|NCT01473381|324288993|FG000|Overall Study|Other Reasons|0|||
94681262|NCT01473381|324288994|FG001|Overall Study|Other Reasons|0|||
94681263|NCT01473381|324288995|FG002|Overall Study|Other Reasons|1|||
94681264|NCT01473381|324288996|FG003|Overall Study|Other Reasons|3|||
94681265|NCT03954743|324289008|FG000|Overall Study|Adverse Event|1|||
94681266|NCT03954743|324289009|FG001|Overall Study|Adverse Event|0|||
94681267|NCT03954743|324289008|FG000|Overall Study|Lost to Follow-up|6|||
94681268|NCT03954743|324289009|FG001|Overall Study|Lost to Follow-up|4|||
94681269|NCT03954743|324289008|FG000|Overall Study|Protocol Violation|1|||
94681270|NCT03954743|324289009|FG001|Overall Study|Protocol Violation|0|||
94681271|NCT03954743|324289008|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
94681272|NCT03954743|324289009|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
94681273|NCT03954743|324289008|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
94681274|NCT03954743|324289009|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
94681275|NCT00860067|324289010|FG000|Overall Study|Lost to Follow-up|46|||
94681276|NCT00860067|324289011|FG001|Overall Study|Lost to Follow-up|9|||
94681277|NCT00860067|324289012|FG002|Overall Study|Lost to Follow-up|9|||
94681278|NCT00860067|324289010|FG000|Overall Study|Withdrawal by Subject|4|||
94681279|NCT00860067|324289011|FG001|Overall Study|Withdrawal by Subject|0|||
94681280|NCT00860067|324289012|FG002|Overall Study|Withdrawal by Subject|0|||
94681281|NCT00860067|324289010|FG000|Overall Study|Pregnancy|1|||
94681282|NCT00860067|324289011|FG001|Overall Study|Pregnancy|0|||
94681283|NCT00860067|324289012|FG002|Overall Study|Pregnancy|0|||
94681284|NCT02387996|324289013|FG000|Overall Study|Disease Progression|167|||
94681285|NCT02387996|324289013|FG000|Overall Study|Study Drug Toxicity|31|||
94681286|NCT02387996|324289013|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
94681287|NCT02387996|324289013|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
94681288|NCT02387996|324289013|FG000|Overall Study|Subject Withdrew Consent|5|||
94681289|NCT02387996|324289013|FG000|Overall Study|Lost to Follow-up|1|||
94681290|NCT02387996|324289013|FG000|Overall Study|Poor/Non-Compliance|1|||
94681291|NCT02387996|324289013|FG000|Overall Study|Other Reasons|5|||
94681292|NCT02387996|324289013|FG000|Overall Study|Death|1|||
94681293|NCT01674621|324289018|FG000|Overall Study|Adverse Event|3|||
94681294|NCT01674621|324289019|FG001|Overall Study|Adverse Event|2|||
94681295|NCT01674621|324289020|FG002|Overall Study|Adverse Event|5|||
94681296|NCT01674621|324289021|FG003|Overall Study|Adverse Event|5|||
94681297|NCT01674621|324289022|FG004|Overall Study|Adverse Event|1|||
94681298|NCT01674621|324289018|FG000|Overall Study|Inability to Complete Study Procedures|0|||
94681299|NCT01674621|324289019|FG001|Overall Study|Inability to Complete Study Procedures|0|||
94681300|NCT01674621|324289020|FG002|Overall Study|Inability to Complete Study Procedures|0|||
94681301|NCT01674621|324289021|FG003|Overall Study|Inability to Complete Study Procedures|0|||
94681302|NCT01674621|324289022|FG004|Overall Study|Inability to Complete Study Procedures|2|||
94681303|NCT01674621|324289018|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
94681304|NCT01674621|324289019|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
94681305|NCT01674621|324289020|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
94681306|NCT01674621|324289021|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
94681307|NCT01674621|324289022|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
94681308|NCT01674621|324289018|FG000|Overall Study|Withdrawal by Subject|2|||
94681309|NCT01674621|324289019|FG001|Overall Study|Withdrawal by Subject|5|||
94681310|NCT01674621|324289020|FG002|Overall Study|Withdrawal by Subject|2|||
94681311|NCT01674621|324289021|FG003|Overall Study|Withdrawal by Subject|0|||
94681312|NCT01674621|324289022|FG004|Overall Study|Withdrawal by Subject|1|||
94681313|NCT01674621|324289018|FG000|Overall Study|Other than specified|0|||
94681314|NCT01674621|324289019|FG001|Overall Study|Other than specified|1|||
94681315|NCT01674621|324289020|FG002|Overall Study|Other than specified|0|||
94681316|NCT01674621|324289021|FG003|Overall Study|Other than specified|0|||
94681317|NCT01674621|324289022|FG004|Overall Study|Other than specified|2|||
94681318|NCT03812536|324289023|FG000|Overall Study|Protocol Violation|2|||
94681319|NCT03812536|324289024|FG001|Overall Study|Protocol Violation|0|||
94681320|NCT03812536|324289023|FG000|Overall Study|Withdrawal by Subject|1|||
94681321|NCT03812536|324289024|FG001|Overall Study|Withdrawal by Subject|1|||
94681322|NCT01216163|324289025|FG000|Overall Study|Withdrawal by Subject|1|||
94681323|NCT01216163|324289026|FG001|Overall Study|Withdrawal by Subject|1|||
94681324|NCT01216163|324289027|FG002|Overall Study|Withdrawal by Subject|0|||
94681325|NCT04145037|324289034|FG000|Overall Study|Study terminated|2|||
94681326|NCT04145037|324289035|FG001|Overall Study|Study terminated|0|||
94681327|NCT04145037|324289034|FG000|Overall Study|Withdrawal by Subject|1|||
94681328|NCT04145037|324289035|FG001|Overall Study|Withdrawal by Subject|0|||
94681329|NCT04145037|324289034|FG000|Overall Study|Lost to Follow-up|1|||
94681330|NCT04145037|324289035|FG001|Overall Study|Lost to Follow-up|0|||
94681331|NCT05004688|324289048|FG000|Overall Study|Protocol Violation|7|||
94681332|NCT05004688|324289048|FG000|Overall Study|Physician Decision|2|||
94681333|NCT05004688|324289048|FG000|Overall Study|Withdrawal by Subject|2|||
94681334|NCT00895622|324289049|FG000|Overall Study|Protocol Violation|5|||
94681335|NCT00895622|324289050|FG001|Overall Study|Protocol Violation|4|||
94681336|NCT00895622|324289051|FG002|Overall Study|Protocol Violation|4|||
94681337|NCT03724396|324289052|FG000|Overall Study|Lost to Follow-up|1|||
94681338|NCT03724396|324289053|FG001|Overall Study|Lost to Follow-up|1|||
94681339|NCT03724396|324289052|FG000|Overall Study|Withdrawal by Subject|1|||
94681340|NCT03724396|324289053|FG001|Overall Study|Withdrawal by Subject|0|||
94681341|NCT01490125|324289054|FG000|Period I|Adverse Event|4|||
94681342|NCT01490125|324289055|FG001|Period I|Adverse Event|1|||
94681343|NCT01490125|324289056|FG002|Period I|Adverse Event|1|||
94681344|NCT01490125|324289057|FG003|Period I|Adverse Event|3|||
94681345|NCT01490125|324289058|FG004|Period I|Adverse Event|2|||
94681346|NCT01490125|324289059|FG005|Period I|Adverse Event|4|||
94681347|NCT01490125|324289054|FG000|Period I|Protocol Violation|1|||
94681348|NCT01490125|324289055|FG001|Period I|Protocol Violation|1|||
94681349|NCT01490125|324289056|FG002|Period I|Protocol Violation|1|||
94681350|NCT01490125|324289057|FG003|Period I|Protocol Violation|1|||
94681351|NCT01490125|324289058|FG004|Period I|Protocol Violation|0|||
94681352|NCT01490125|324289059|FG005|Period I|Protocol Violation|0|||
94681353|NCT01490125|324289054|FG000|Period I|Withdrawal by Subject|1|||
94681354|NCT01490125|324289055|FG001|Period I|Withdrawal by Subject|3|||
94681355|NCT01490125|324289056|FG002|Period I|Withdrawal by Subject|2|||
94681356|NCT01490125|324289057|FG003|Period I|Withdrawal by Subject|1|||
94681357|NCT01490125|324289058|FG004|Period I|Withdrawal by Subject|2|||
94681358|NCT01490125|324289059|FG005|Period I|Withdrawal by Subject|1|||
94681359|NCT01490125|324289054|FG000|Period II|Adverse Event|2|||
94681360|NCT01490125|324289055|FG001|Period II|Adverse Event|3|||
94681361|NCT01490125|324289056|FG002|Period II|Adverse Event|2|||
94681362|NCT01490125|324289057|FG003|Period II|Adverse Event|2|||
94681363|NCT01490125|324289058|FG004|Period II|Adverse Event|4|||
94681364|NCT01490125|324289059|FG005|Period II|Adverse Event|2|||
94681365|NCT01490125|324289054|FG000|Period II|Protocol Violation|0|||
94681366|NCT01490125|324289055|FG001|Period II|Protocol Violation|0|||
94681367|NCT01490125|324289056|FG002|Period II|Protocol Violation|1|||
94681368|NCT01490125|324289057|FG003|Period II|Protocol Violation|1|||
94681369|NCT01490125|324289058|FG004|Period II|Protocol Violation|0|||
94681370|NCT01490125|324289059|FG005|Period II|Protocol Violation|0|||
94681371|NCT01490125|324289054|FG000|Period II|Lost to Follow-up|0|||
94681372|NCT01490125|324289055|FG001|Period II|Lost to Follow-up|1|||
94681373|NCT01490125|324289056|FG002|Period II|Lost to Follow-up|0|||
94263727|NCT01514136|322759920|FG004|Test Period 1; Test A|Break from study holiday|0|||
94263728|NCT01514136|322759921|FG005|Test Period 1; Test A|Break from study holiday|0|||
94263729|NCT01514136|322759922|FG006|Test Period 1; Test A|Break from study holiday|0|||
94263730|NCT01514136|322759923|FG007|Test Period 1; Test A|Break from study holiday|0|||
94263731|NCT01514136|322759916|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
94263732|NCT01514136|322759917|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
94263733|NCT01514136|322759918|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
94263734|NCT01514136|322759919|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
94263735|NCT01514136|322759920|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
94681374|NCT01490125|324289057|FG003|Period II|Lost to Follow-up|0|||
94681375|NCT01490125|324289058|FG004|Period II|Lost to Follow-up|0|||
94681376|NCT01490125|324289059|FG005|Period II|Lost to Follow-up|0|||
94681377|NCT01490125|324289054|FG000|Period II|Withdrawal by Subject|1|||
94681378|NCT01490125|324289055|FG001|Period II|Withdrawal by Subject|0|||
94681379|NCT01490125|324289056|FG002|Period II|Withdrawal by Subject|0|||
94681380|NCT01490125|324289057|FG003|Period II|Withdrawal by Subject|0|||
94681381|NCT01490125|324289058|FG004|Period II|Withdrawal by Subject|0|||
94681382|NCT01490125|324289059|FG005|Period II|Withdrawal by Subject|0|||
94681383|NCT01490125|324289054|FG000|Period III|Adverse Event|3|||
94263736|NCT01514136|322759921|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
94263737|NCT01514136|322759922|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
94646289|NCT01332149|324167185|FG001|Overall Study|Withdrawal by Subject|5|||
94646290|NCT01332149|324167184|FG000|Overall Study|Lost to Follow-up|1|||
94646291|NCT01332149|324167185|FG001|Overall Study|Lost to Follow-up|1|||
94646292|NCT01332149|324167184|FG000|Overall Study|Insufficient clinical response|4|||
94646293|NCT01332149|324167185|FG001|Overall Study|Insufficient clinical response|7|||
94646294|NCT01332149|324167184|FG000|Overall Study|Did not meet entrance criteria|3|||
94646295|NCT01332149|324167185|FG001|Overall Study|Did not meet entrance criteria|4|||
94646296|NCT01332149|324167184|FG000|Overall Study|Randomized but not treated|1|||
94646297|NCT01332149|324167185|FG001|Overall Study|Randomized but not treated|2|||
94646298|NCT01816139|324167186|FG000|Overall Study|Adverse Event|6|||
94646299|NCT01816139|324167187|FG001|Overall Study|Adverse Event|8|||
94646300|NCT01816139|324167186|FG000|Overall Study|Lack of Efficacy|1|||
94646301|NCT01816139|324167187|FG001|Overall Study|Lack of Efficacy|2|||
94646302|NCT01816139|324167186|FG000|Overall Study|Lost to Follow-up|5|||
94646303|NCT01816139|324167187|FG001|Overall Study|Lost to Follow-up|3|||
94646304|NCT01816139|324167186|FG000|Overall Study|Withdrew Consent|6|||
94646305|NCT01816139|324167187|FG001|Overall Study|Withdrew Consent|4|||
94646306|NCT01816139|324167186|FG000|Overall Study|Protocol Violation|6|||
94646307|NCT01816139|324167187|FG001|Overall Study|Protocol Violation|3|||
94646308|NCT01816139|324167186|FG000|Overall Study|Reason not Specified|4|||
94646309|NCT01816139|324167187|FG001|Overall Study|Reason not Specified|2|||
94646310|NCT02554656|324167188|FG000|Overall Study|Protocol Violation|3|||
94646311|NCT01904604|324167189|FG000|Overall Study|Withdrew before receiving dosing|0|||
94646312|NCT01904604|324167190|FG001|Overall Study|Withdrew before receiving dosing|1|||
94646313|NCT01904604|324167191|FG002|Overall Study|Withdrew before receiving dosing|0|||
94646314|NCT01904604|324167189|FG000|Overall Study|Non-compliance|1|||
94646315|NCT01904604|324167190|FG001|Overall Study|Non-compliance|0|||
94646316|NCT01904604|324167191|FG002|Overall Study|Non-compliance|0|||
94646317|NCT01904604|324167189|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
94646318|NCT01904604|324167190|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
94646319|NCT01904604|324167191|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
94646320|NCT01904604|324167189|FG000|Overall Study|Patch site reactions|1|||
94646321|NCT01904604|324167190|FG001|Overall Study|Patch site reactions|1|||
94646322|NCT01904604|324167191|FG002|Overall Study|Patch site reactions|0|||
94646323|NCT01904604|324167189|FG000|Overall Study|Increased syncope|0|||
94646324|NCT01904604|324167190|FG001|Overall Study|Increased syncope|1|||
94646325|NCT01904604|324167191|FG002|Overall Study|Increased syncope|0|||
94646326|NCT01904604|324167189|FG000|Overall Study|Unrelated illness|0|||
94646327|NCT01904604|324167190|FG001|Overall Study|Unrelated illness|1|||
94646328|NCT01904604|324167191|FG002|Overall Study|Unrelated illness|0|||
94646329|NCT01904604|324167189|FG000|Overall Study|Passed Week 52 OFC|1|||
94646330|NCT01904604|324167190|FG001|Overall Study|Passed Week 52 OFC|0|||
94646331|NCT01904604|324167191|FG002|Overall Study|Passed Week 52 OFC|0|||
94646332|NCT01904604|324167189|FG000|Overall Study|Withdrawal by Subject|1|||
94646333|NCT01904604|324167190|FG001|Overall Study|Withdrawal by Subject|2|||
94646334|NCT01904604|324167191|FG002|Overall Study|Withdrawal by Subject|0|||
94646335|NCT01904604|324167189|FG000|Overall Study|Participant Relocated|1|||
94646336|NCT01904604|324167190|FG001|Overall Study|Participant Relocated|1|||
94646337|NCT01904604|324167191|FG002|Overall Study|Participant Relocated|1|||
94646338|NCT01904604|324167189|FG000|Overall Study|Lost to Follow-up|0|||
94646339|NCT01904604|324167190|FG001|Overall Study|Lost to Follow-up|0|||
94646340|NCT01904604|324167191|FG002|Overall Study|Lost to Follow-up|1|||
94646341|NCT03568942|324167192|FG000|Overall Study|Family emergency|1|||
94646342|NCT03568942|324167192|FG000|Overall Study|Lost to Follow-up|1|||
94646343|NCT00358527|324167193|FG000|Overall Study|Adverse Event|4|||
94646344|NCT00358527|324167194|FG001|Overall Study|Adverse Event|0|||
94646345|NCT00358527|324167193|FG000|Overall Study|Withdrawal by Subject|1|||
94646346|NCT00358527|324167194|FG001|Overall Study|Withdrawal by Subject|1|||
94646347|NCT00358527|324167193|FG000|Overall Study|Non-compliance with protocol|6|||
94646348|NCT00358527|324167194|FG001|Overall Study|Non-compliance with protocol|1|||
94646349|NCT00358527|324167193|FG000|Overall Study|Administrative|2|||
94646350|NCT00358527|324167194|FG001|Overall Study|Administrative|1|||
94646351|NCT00640510|324167196|FG000|Overall Study|Lack of Efficacy|0|||
94646352|NCT00640510|324167197|FG001|Overall Study|Lack of Efficacy|1|||
94646353|NCT00640510|324167196|FG000|Overall Study|Protocol Violation|1|||
94646354|NCT00640510|324167197|FG001|Overall Study|Protocol Violation|0|||
94646355|NCT00640510|324167196|FG000|Overall Study|Physician Decision|0|||
94646356|NCT00640510|324167197|FG001|Overall Study|Physician Decision|1|||
94646357|NCT00348556|324167198|FG000|Overall Study|Adverse Event|1|||
94646358|NCT01466270|324167201|FG000|Overall Study|Withdrawal by Subject|4|||
94646359|NCT01466270|324167202|FG001|Overall Study|Withdrawal by Subject|1|||
94646360|NCT01466270|324167201|FG000|Overall Study|Physician Decision|1|||
94646361|NCT01466270|324167202|FG001|Overall Study|Physician Decision|0|||
94646362|NCT01466270|324167201|FG000|Overall Study|Lost to Follow-up|1|||
94646363|NCT01466270|324167202|FG001|Overall Study|Lost to Follow-up|3|||
94646364|NCT01466270|324167201|FG000|Overall Study|Progression|1|||
94646365|NCT01466270|324167202|FG001|Overall Study|Progression|0|||
94646366|NCT01466270|324167201|FG000|Overall Study|Toxicity|4|||
94646367|NCT01466270|324167202|FG001|Overall Study|Toxicity|1|||
94646368|NCT01466270|324167201|FG000|Overall Study|Multiple|1|||
94646369|NCT01466270|324167202|FG001|Overall Study|Multiple|1|||
94646370|NCT02624284|324167216|FG000|Overall Study|Withdrawal by Subject|3|||
94646371|NCT02624284|324167217|FG001|Overall Study|Withdrawal by Subject|6|||
94646372|NCT02624284|324167218|FG002|Overall Study|Withdrawal by Subject|3|||
94646373|NCT02624284|324167216|FG000|Overall Study|Protocol Violation|9|||
94646374|NCT02624284|324167217|FG001|Overall Study|Protocol Violation|10|||
94646375|NCT02624284|324167218|FG002|Overall Study|Protocol Violation|7|||
94646376|NCT02624284|324167216|FG000|Overall Study|Revealed exclusionary condition|2|||
94646377|NCT02624284|324167217|FG001|Overall Study|Revealed exclusionary condition|2|||
94646378|NCT02624284|324167218|FG002|Overall Study|Revealed exclusionary condition|0|||
94646379|NCT02624284|324167216|FG000|Overall Study|Adverse Event|0|||
94646380|NCT02624284|324167217|FG001|Overall Study|Adverse Event|0|||
94646381|NCT02624284|324167218|FG002|Overall Study|Adverse Event|1|||
94646382|NCT00654628|324167219|FG000|6-week Active Treatment Period|Adverse Event|9|||
94646383|NCT00654628|324167219|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
94646384|NCT00654628|324167219|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
94646385|NCT00654628|324167219|FG000|6-week Active Treatment Period|Out of window period|1|||
94646386|NCT00654628|324167219|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
94646387|NCT00654628|324167219|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
94646388|NCT01869192|324167221|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
94646389|NCT01869192|324167222|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
94646390|NCT01869192|324167221|FG000|Postoperative Chemotherapy|Physician Decision|0|||
94646391|NCT01869192|324167222|FG001|Postoperative Chemotherapy|Physician Decision|2|||
94681384|NCT01490125|324289055|FG001|Period III|Adverse Event|1|||
94681385|NCT01490125|324289056|FG002|Period III|Adverse Event|0|||
94681386|NCT01490125|324289057|FG003|Period III|Adverse Event|1|||
94681387|NCT01490125|324289058|FG004|Period III|Adverse Event|0|||
94681388|NCT01490125|324289059|FG005|Period III|Adverse Event|0|||
94681389|NCT01490125|324289054|FG000|Period III|Death|0|||
94681390|NCT01490125|324289055|FG001|Period III|Death|0|||
94681391|NCT01490125|324289056|FG002|Period III|Death|0|||
94681392|NCT01490125|324289057|FG003|Period III|Death|1|||
94681393|NCT01490125|324289058|FG004|Period III|Death|0|||
94681394|NCT01490125|324289059|FG005|Period III|Death|0|||
94681395|NCT01490125|324289054|FG000|Period III|Lack of Efficacy|0|||
94681396|NCT01490125|324289055|FG001|Period III|Lack of Efficacy|0|||
94681397|NCT01490125|324289056|FG002|Period III|Lack of Efficacy|0|||
94681398|NCT01490125|324289057|FG003|Period III|Lack of Efficacy|0|||
94681399|NCT01490125|324289058|FG004|Period III|Lack of Efficacy|1|||
94681400|NCT01490125|324289059|FG005|Period III|Lack of Efficacy|0|||
94681401|NCT03489057|324289063|FG000|Overall Study|Lost to Follow-up|16|||
94681402|NCT03489057|324289064|FG001|Overall Study|Lost to Follow-up|16|||
94681403|NCT03489057|324289065|FG002|Overall Study|Lost to Follow-up|14|||
94681404|NCT03489057|324289066|FG003|Overall Study|Lost to Follow-up|14|||
94681405|NCT03489057|324289063|FG000|Overall Study|Withdrawal by Subject|12|||
94681406|NCT03489057|324289064|FG001|Overall Study|Withdrawal by Subject|12|||
94681407|NCT03489057|324289065|FG002|Overall Study|Withdrawal by Subject|8|||
94681408|NCT03489057|324289066|FG003|Overall Study|Withdrawal by Subject|8|||
94681409|NCT03489057|324289063|FG000|Overall Study|Protocol Violation|7|||
94681410|NCT03489057|324289064|FG001|Overall Study|Protocol Violation|7|||
94681411|NCT03489057|324289065|FG002|Overall Study|Protocol Violation|2|||
94681412|NCT03489057|324289066|FG003|Overall Study|Protocol Violation|2|||
94681413|NCT03745313|324289069|FG000|At 30 Days Follow-up|Death|2|||
94681414|NCT03745313|324289069|FG000|At 6 Months Follow-up|Death|1|||
94681415|NCT03745313|324289069|FG000|At 6 Months Follow-up|Missed Visit|1|||
94463471|NCT02520427|323485082|FG025|Overall Study|Withdrawal by Subject|0|||
94681416|NCT03745313|324289069|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
94681417|NCT03745313|324289069|FG000|At 1 Year Follow-up|Death|2|||
94681418|NCT03745313|324289069|FG000|At 1 Year Follow-up|Missed Visit|2|||
94681419|NCT03745313|324289069|FG000|At 2 Year Follow-up|Missed Visit|1|||
94681420|NCT03635489|324289070|FG000|Overall Study|Death|19|||
94681421|NCT03635489|324289071|FG001|Overall Study|Death|13|||
94681422|NCT03635489|324289070|FG000|Overall Study|Lost to Follow-up|1|||
94681423|NCT03635489|324289071|FG001|Overall Study|Lost to Follow-up|2|||
94681424|NCT03635489|324289070|FG000|Overall Study|Withdrawal by Subject|1|||
94681425|NCT03635489|324289071|FG001|Overall Study|Withdrawal by Subject|2|||
94681426|NCT03635489|324289070|FG000|Overall Study|Study Ended by Sponsor|28|||
94681427|NCT03635489|324289071|FG001|Overall Study|Study Ended by Sponsor|34|||
94681428|NCT01696981|324289076|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
94681429|NCT01696981|324289077|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
94681430|NCT01696981|324289076|FG000|Overall Study|Died Before Randomization|3|||
94681431|NCT01696981|324289077|FG001|Overall Study|Died Before Randomization|8|||
94681432|NCT01696981|324289076|FG000|Overall Study|Died Before ASU (Control)|278|||
94681433|NCT01696981|324289077|FG001|Overall Study|Died Before ASU (Control)|0|||
94681434|NCT01696981|324289076|FG000|Overall Study|Refused ASU (Control)|920|||
94681435|NCT01696981|324289077|FG001|Overall Study|Refused ASU (Control)|0|||
94681436|NCT01696981|324289076|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
94681437|NCT01696981|324289077|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
94681438|NCT00652938|324289078|FG000|Overall Study|Adverse Event|1|||
94681439|NCT00652938|324289079|FG001|Overall Study|Adverse Event|0|||
94681440|NCT00652938|324289080|FG002|Overall Study|Adverse Event|2|||
94681441|NCT00652938|324289078|FG000|Overall Study|Withdrawal by Subject|0|||
94681442|NCT00652938|324289079|FG001|Overall Study|Withdrawal by Subject|6|||
94681443|NCT00652938|324289080|FG002|Overall Study|Withdrawal by Subject|1|||
94681444|NCT00652938|324289078|FG000|Overall Study|Lost to Follow-up|0|||
94681445|NCT00652938|324289079|FG001|Overall Study|Lost to Follow-up|0|||
94681446|NCT00652938|324289080|FG002|Overall Study|Lost to Follow-up|2|||
94681447|NCT00652938|324289078|FG000|Overall Study|fear of blood sampling|0|||
94681448|NCT00652938|324289079|FG001|Overall Study|fear of blood sampling|1|||
94681449|NCT00652938|324289080|FG002|Overall Study|fear of blood sampling|0|||
94681450|NCT03682705|324289081|FG000|Overall Study|Adverse Event|1|||
94681451|NCT03682705|324289082|FG001|Overall Study|Adverse Event|1|||
94681452|NCT03682705|324289083|FG002|Overall Study|Adverse Event|1|||
94681453|NCT03682705|324289084|FG003|Overall Study|Adverse Event|0|||
94681454|NCT03682705|324289085|FG004|Overall Study|Adverse Event|1|||
94681455|NCT03682705|324289086|FG005|Overall Study|Adverse Event|1|||
94681456|NCT03682705|324289081|FG000|Overall Study|Withdrawal by Subject|1|||
94681457|NCT03682705|324289082|FG001|Overall Study|Withdrawal by Subject|3|||
94681458|NCT03682705|324289083|FG002|Overall Study|Withdrawal by Subject|2|||
94681459|NCT03682705|324289084|FG003|Overall Study|Withdrawal by Subject|4|||
94681460|NCT03682705|324289085|FG004|Overall Study|Withdrawal by Subject|0|||
94681461|NCT03682705|324289086|FG005|Overall Study|Withdrawal by Subject|1|||
94681462|NCT03682705|324289081|FG000|Overall Study|Other, not specified|0|||
94681463|NCT03682705|324289082|FG001|Overall Study|Other, not specified|0|||
94681464|NCT03682705|324289083|FG002|Overall Study|Other, not specified|0|||
94681465|NCT03682705|324289084|FG003|Overall Study|Other, not specified|1|||
94681466|NCT03682705|324289085|FG004|Overall Study|Other, not specified|2|||
94681467|NCT03682705|324289086|FG005|Overall Study|Other, not specified|0|||
94681468|NCT03682705|324289081|FG000|Overall Study|Lost to Follow-up|0|||
94681469|NCT03682705|324289082|FG001|Overall Study|Lost to Follow-up|0|||
94681470|NCT03682705|324289083|FG002|Overall Study|Lost to Follow-up|0|||
94681471|NCT03682705|324289084|FG003|Overall Study|Lost to Follow-up|0|||
94681472|NCT03682705|324289085|FG004|Overall Study|Lost to Follow-up|3|||
94681473|NCT03682705|324289086|FG005|Overall Study|Lost to Follow-up|0|||
94681474|NCT01336621|324289087|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
94263738|NCT01514136|322759923|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
94681475|NCT01336621|324289087|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
94681476|NCT01336621|324289087|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
94681477|NCT01336621|324289087|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
94463472|NCT02520427|323485057|FG000|Overall Study|Death|1|||
94363987|NCT00567996|323116795|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94363988|NCT00567996|323116796|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
94363989|NCT00567996|323116797|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
94363990|NCT00567996|323116795|FG000|Overall Study|Administrative problems|1|||
94363991|NCT00567996|323116796|FG001|Overall Study|Administrative problems|1|||
94681478|NCT01336621|324289087|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
94681479|NCT01336621|324289087|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
94681480|NCT01336621|324289087|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
94681481|NCT01336621|324289087|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
94681482|NCT01336621|324289087|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
94681483|NCT01336621|324289087|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
94681484|NCT01336621|324289087|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
94681485|NCT01336621|324289087|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
94681486|NCT01336621|324289087|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
94681487|NCT01336621|324289087|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
94681488|NCT02487095|324289089|FG000|Dose Expansion|Unable to scan/restage participant|0|||
94681489|NCT02487095|324289090|FG001|Dose Expansion|Unable to scan/restage participant|0|||
94681490|NCT02487095|324289091|FG002|Dose Expansion|Unable to scan/restage participant|0|||
94681491|NCT02487095|324289092|FG003|Dose Expansion|Unable to scan/restage participant|0|||
94681492|NCT02487095|324289093|FG004|Dose Expansion|Unable to scan/restage participant|1|||
94681493|NCT01875185|324289094|FG000|Overall Study|study was terminated|52|||
94681494|NCT01875185|324289095|FG001|Overall Study|study was terminated|48|||
94681495|NCT04838613|324289096|FG000|Overall Study|Withdrawal by Subject|3|||
94681496|NCT04838613|324289097|FG001|Overall Study|Withdrawal by Subject|6|||
94681497|NCT04838613|324289096|FG000|Overall Study|Protocol Deviation|3|||
94681498|NCT04838613|324289097|FG001|Overall Study|Protocol Deviation|2|||
94681499|NCT04838613|324289096|FG000|Overall Study|Technical Problems|0|||
94681500|NCT04838613|324289097|FG001|Overall Study|Technical Problems|5|||
94681501|NCT04838613|324289096|FG000|Overall Study|Physician Decision|2|||
94681502|NCT04838613|324289097|FG001|Overall Study|Physician Decision|0|||
94681503|NCT03287414|324289099|FG000|Treatment Epoch|Adverse Event|0|||
94681504|NCT03287414|324289100|FG001|Treatment Epoch|Adverse Event|1|||
94681505|NCT03287414|324289099|FG000|Treatment Epoch|Study terminated by sponsor|2|||
94681506|NCT03287414|324289100|FG001|Treatment Epoch|Study terminated by sponsor|2|||
94681507|NCT03287414|324289099|FG000|Treatment Epoch|Subject/Guardian decision|4|||
94681508|NCT03287414|324289100|FG001|Treatment Epoch|Subject/Guardian decision|0|||
94681509|NCT03287414|324289099|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
94681510|NCT03287414|324289100|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
94681511|NCT03287414|324289099|FG000|Treatment Epoch|Withdrawal by Subject|1|||
94681512|NCT03287414|324289100|FG001|Treatment Epoch|Withdrawal by Subject|0|||
94681513|NCT03287414|324289099|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
94681514|NCT03287414|324289100|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
94681515|NCT03287414|324289099|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
94681516|NCT03287414|324289100|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
94681517|NCT03916744|324289101|FG000|Overall Study|Withdrawal by Subject|0|||
94681518|NCT03916744|324289102|FG001|Overall Study|Withdrawal by Subject|1|||
94681519|NCT03916744|324289103|FG002|Overall Study|Withdrawal by Subject|2|||
94681520|NCT01893827|324289107|FG000|Overall Study|Lost to Follow-up|19|||
94681521|NCT01893827|324289108|FG001|Overall Study|Lost to Follow-up|26|||
94681522|NCT03520400|324289112|FG000|Overall Study|Physician Decision|15|||
94681523|NCT03520400|324289113|FG001|Overall Study|Physician Decision|7|||
94681524|NCT03573908|324289118|FG000|Treatment Period|Adverse Event|4|||
94681525|NCT03573908|324289119|FG001|Treatment Period|Adverse Event|9|||
94681526|NCT03573908|324289120|FG002|Treatment Period|Adverse Event|0|||
94681527|NCT03573908|324289121|FG003|Treatment Period|Adverse Event|0|||
94681528|NCT03573908|324289122|FG004|Treatment Period|Adverse Event|0|||
94681529|NCT03573908|324289118|FG000|Treatment Period|Protocol Violation|1|||
94681530|NCT03573908|324289119|FG001|Treatment Period|Protocol Violation|0|||
94681531|NCT03573908|324289120|FG002|Treatment Period|Protocol Violation|0|||
94681532|NCT03573908|324289121|FG003|Treatment Period|Protocol Violation|0|||
94681533|NCT03573908|324289122|FG004|Treatment Period|Protocol Violation|0|||
94681534|NCT03573908|324289118|FG000|Treatment Period|Withdrawal by Subject|7|||
94681535|NCT03573908|324289119|FG001|Treatment Period|Withdrawal by Subject|5|||
94363992|NCT00567996|323116797|FG002|Overall Study|Administrative problems|0|||
94681536|NCT03573908|324289120|FG002|Treatment Period|Withdrawal by Subject|0|||
94681537|NCT03573908|324289121|FG003|Treatment Period|Withdrawal by Subject|0|||
94363993|NCT00567996|323116795|FG000|Overall Study|Death|1|||
94363994|NCT00567996|323116796|FG001|Overall Study|Death|0|||
94363995|NCT00567996|323116797|FG002|Overall Study|Death|2|||
94363996|NCT00567996|323116795|FG000|Overall Study|Patient's inability to use the device|0|||
94463473|NCT02520427|323485058|FG001|Overall Study|Death|0|||
94681538|NCT03573908|324289122|FG004|Treatment Period|Withdrawal by Subject|0|||
94681539|NCT03573908|324289118|FG000|Treatment Period|Lost to Follow-up|7|||
94681540|NCT03573908|324289119|FG001|Treatment Period|Lost to Follow-up|6|||
94263739|NCT01514136|322759916|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
94646392|NCT02027844|324167225|FG000|Overall Study|Withdrawal by Subject|3|||
94646393|NCT02027844|324167226|FG001|Overall Study|Withdrawal by Subject|2|||
94646394|NCT02027844|324167227|FG002|Overall Study|Withdrawal by Subject|1|||
94646395|NCT02027844|324167225|FG000|Overall Study|Lost to Follow-up|0|||
94646396|NCT02027844|324167226|FG001|Overall Study|Lost to Follow-up|2|||
94646397|NCT02027844|324167227|FG002|Overall Study|Lost to Follow-up|1|||
94646398|NCT02027844|324167225|FG000|Overall Study|Protocol Violation|0|||
94646399|NCT02027844|324167226|FG001|Overall Study|Protocol Violation|2|||
94646400|NCT02027844|324167227|FG002|Overall Study|Protocol Violation|0|||
94646401|NCT02027844|324167225|FG000|Overall Study|Incomlete data|2|||
94646402|NCT02027844|324167226|FG001|Overall Study|Incomlete data|0|||
94646403|NCT02027844|324167227|FG002|Overall Study|Incomlete data|0|||
94646404|NCT00354172|324167228|FG000|Overall Study|Did not receive transplant|1|||
94646405|NCT00357370|324167232|FG000|Cohort 2|Lack of Efficacy|0|||
94646406|NCT00357370|324167233|FG001|Cohort 2|Lack of Efficacy|2|||
94646407|NCT00357370|324167234|FG002|Cohort 2|Lack of Efficacy|1|||
94646408|NCT00357370|324167232|FG000|Cohort 2|Adverse Event|1|||
94646409|NCT00357370|324167233|FG001|Cohort 2|Adverse Event|1|||
94646410|NCT00357370|324167234|FG002|Cohort 2|Adverse Event|1|||
94646411|NCT00357370|324167232|FG000|Cohort 2|Lost to Follow-up|0|||
94646412|NCT00357370|324167233|FG001|Cohort 2|Lost to Follow-up|1|||
94646413|NCT00357370|324167234|FG002|Cohort 2|Lost to Follow-up|0|||
94646414|NCT00357370|324167232|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
94646415|NCT00357370|324167233|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
94646416|NCT00357370|324167234|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
94646417|NCT00357370|324167232|FG000|Cohort 2|Withdrawal by Subject|0|||
94646418|NCT00357370|324167233|FG001|Cohort 2|Withdrawal by Subject|2|||
94646419|NCT00357370|324167234|FG002|Cohort 2|Withdrawal by Subject|0|||
94646420|NCT02871375|324167238|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
94646421|NCT02871375|324167239|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
94646422|NCT00004412|324167240|FG000|Randomized Period|Moved to Crossover Period|3|||
94646423|NCT00004412|324167241|FG001|Randomized Period|Moved to Crossover Period|0|||
94646424|NCT00004412|324167242|FG002|Randomized Period|Moved to Crossover Period|0|||
94646425|NCT00499603|324167247|FG000|Overall Study|Adverse Event|0|||
94646426|NCT00499603|324167248|FG001|Overall Study|Adverse Event|1|||
94646427|NCT00727714|324167249|FG000|Overall Study|Lost to Follow-up|2|||
94646428|NCT00325234|324167255|FG000|Overall Study|Adverse Event|10|||
94646429|NCT00325234|324167256|FG001|Overall Study|Adverse Event|7|||
94646430|NCT00325234|324167255|FG000|Overall Study|Death due to Study Disease|1|||
94646431|NCT00325234|324167256|FG001|Overall Study|Death due to Study Disease|0|||
94646432|NCT00325234|324167255|FG000|Overall Study|Entry Criteria Not Met|1|||
94646433|NCT00325234|324167256|FG001|Overall Study|Entry Criteria Not Met|2|||
94646434|NCT00325234|324167255|FG000|Overall Study|Subject Decision|6|||
94646435|NCT00325234|324167256|FG001|Overall Study|Subject Decision|8|||
94646436|NCT00325234|324167255|FG000|Overall Study|Physician Decision|17|||
94646437|NCT00325234|324167256|FG001|Overall Study|Physician Decision|12|||
94646438|NCT00325234|324167255|FG000|Overall Study|Progressive Disease|34|||
94646439|NCT00325234|324167256|FG001|Overall Study|Progressive Disease|37|||
94646440|NCT01465464|324167257|FG000|Overall Study|Adverse Event|96|||
94646441|NCT01465464|324167258|FG001|Overall Study|Adverse Event|49|||
94646442|NCT01465464|324167257|FG000|Overall Study|Lack of Efficacy|139|||
94646443|NCT01465464|324167258|FG001|Overall Study|Lack of Efficacy|190|||
94646444|NCT01465464|324167257|FG000|Overall Study|Physician Decision|13|||
94646445|NCT01465464|324167258|FG001|Overall Study|Physician Decision|5|||
94646446|NCT01465464|324167257|FG000|Overall Study|Protocol Violation|1|||
94646447|NCT01465464|324167258|FG001|Overall Study|Protocol Violation|1|||
94646448|NCT01465464|324167257|FG000|Overall Study|Withdrawal by Subject|46|||
94646449|NCT01465464|324167258|FG001|Overall Study|Withdrawal by Subject|30|||
94646450|NCT01465464|324167257|FG000|Overall Study|Other|9|||
94646451|NCT01465464|324167258|FG001|Overall Study|Other|3|||
94646452|NCT01465464|324167257|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
94646453|NCT01465464|324167258|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
94646454|NCT02375672|324167259|FG000|Overall Study|remain on follow up|20|||
94646455|NCT00477672|324167260|FG000|Overall Study|Adverse Event|3|||
94646456|NCT00477672|324167261|FG001|Overall Study|Adverse Event|5|||
94363997|NCT00567996|323116796|FG001|Overall Study|Patient's inability to use the device|1|||
94363998|NCT00567996|323116797|FG002|Overall Study|Patient's inability to use the device|0|||
94363999|NCT03594175|323116799|FG000|Overall Study|Not treated|8|||
94364000|NCT03594175|323116800|FG001|Overall Study|Not treated|1|||
94364001|NCT03594175|323116801|FG002|Overall Study|Not treated|5|||
94364002|NCT03594175|323116799|FG000|Overall Study|Adverse Event|3|||
94364003|NCT03594175|323116800|FG001|Overall Study|Adverse Event|0|||
94364004|NCT03594175|323116801|FG002|Overall Study|Adverse Event|0|||
94364005|NCT03594175|323116799|FG000|Overall Study|Withdrawal by Subject|3|||
94364006|NCT03594175|323116800|FG001|Overall Study|Withdrawal by Subject|0|||
94364007|NCT03594175|323116801|FG002|Overall Study|Withdrawal by Subject|0|||
94364008|NCT03594175|323116799|FG000|Overall Study|Protocol Violation|2|||
94364009|NCT03594175|323116800|FG001|Overall Study|Protocol Violation|2|||
94364010|NCT03594175|323116801|FG002|Overall Study|Protocol Violation|2|||
94364011|NCT01915498|323116802|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
94364012|NCT01915498|323116803|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
94364013|NCT01915498|323116804|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
94364014|NCT01915498|323116805|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
94364015|NCT01915498|323116806|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
94364016|NCT01915498|323116807|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
94646457|NCT00477672|324167262|FG002|Overall Study|Adverse Event|6|||
94646458|NCT00477672|324167260|FG000|Overall Study|Death|0|||
94646459|NCT00477672|324167261|FG001|Overall Study|Death|1|||
94646460|NCT00477672|324167262|FG002|Overall Study|Death|0|||
94646461|NCT00477672|324167260|FG000|Overall Study|Disease progression|0|||
94646462|NCT00477672|324167261|FG001|Overall Study|Disease progression|1|||
94646463|NCT00477672|324167262|FG002|Overall Study|Disease progression|0|||
94646464|NCT00477672|324167260|FG000|Overall Study|Physician Decision|1|||
94646465|NCT00477672|324167261|FG001|Overall Study|Physician Decision|0|||
94646466|NCT00477672|324167262|FG002|Overall Study|Physician Decision|0|||
94646467|NCT00477672|324167260|FG000|Overall Study|Protocol noncompliance|0|||
94646468|NCT00477672|324167261|FG001|Overall Study|Protocol noncompliance|2|||
94646469|NCT00477672|324167262|FG002|Overall Study|Protocol noncompliance|0|||
94646470|NCT00477672|324167260|FG000|Overall Study|Consent withdrawn|2|||
94646471|NCT00477672|324167261|FG001|Overall Study|Consent withdrawn|5|||
94646472|NCT00477672|324167262|FG002|Overall Study|Consent withdrawn|10|||
94646473|NCT00477672|324167260|FG000|Overall Study|Discretion of Sponsor|1|||
94646474|NCT00477672|324167261|FG001|Overall Study|Discretion of Sponsor|2|||
94646475|NCT00477672|324167262|FG002|Overall Study|Discretion of Sponsor|0|||
94646476|NCT02244580|324167263|FG000|Overall Study|No cancer tissues available|241|||
94646477|NCT01736696|324167264|FG000|Overall Study|Withdrawal by Subject|0|||
94646478|NCT01736696|324167265|FG001|Overall Study|Withdrawal by Subject|0|||
94646479|NCT01736696|324167266|FG002|Overall Study|Withdrawal by Subject|1|||
94646480|NCT01736696|324167267|FG003|Overall Study|Withdrawal by Subject|0|||
94646481|NCT01736696|324167268|FG004|Overall Study|Withdrawal by Subject|0|||
94646482|NCT01736696|324167269|FG005|Overall Study|Withdrawal by Subject|0|||
94646483|NCT01736696|324167270|FG006|Overall Study|Withdrawal by Subject|0|||
94646484|NCT02114879|324167271|FG000|Overall Study|Withdrawal by Subject|9|||
94646485|NCT02114879|324167272|FG001|Overall Study|Withdrawal by Subject|5|||
94646486|NCT02114879|324167271|FG000|Overall Study|Death|6|||
94646487|NCT02114879|324167272|FG001|Overall Study|Death|11|||
94646488|NCT02114879|324167271|FG000|Overall Study|Lost to Follow-up|4|||
94646489|NCT02114879|324167272|FG001|Overall Study|Lost to Follow-up|6|||
94646490|NCT02114879|324167271|FG000|Overall Study|Physician Decision|0|||
94646491|NCT02114879|324167272|FG001|Overall Study|Physician Decision|2|||
94646492|NCT03571516|324167273|FG000|Overall Study|Severe diarrhea|1|||
94646493|NCT03571516|324167274|FG001|Overall Study|Severe diarrhea|0|||
94646494|NCT03571516|324167273|FG000|Overall Study|Withdrawal by Subject|0|||
94646495|NCT03571516|324167274|FG001|Overall Study|Withdrawal by Subject|1|||
94646496|NCT02442778|324167281|FG000|Overall Study|Adverse Event|2|||
94646497|NCT02442778|324167282|FG001|Overall Study|Adverse Event|6|||
94646498|NCT02442778|324167283|FG002|Overall Study|Adverse Event|6|||
94646499|NCT02442778|324167281|FG000|Overall Study|Death|0|||
94646500|NCT02442778|324167282|FG001|Overall Study|Death|2|||
94646501|NCT02442778|324167283|FG002|Overall Study|Death|0|||
94646502|NCT02442778|324167281|FG000|Overall Study|Lack of Efficacy|1|||
94646503|NCT02442778|324167282|FG001|Overall Study|Lack of Efficacy|0|||
94646504|NCT02442778|324167283|FG002|Overall Study|Lack of Efficacy|0|||
94646505|NCT02442778|324167281|FG000|Overall Study|Lost to Follow-up|1|||
94646506|NCT02442778|324167282|FG001|Overall Study|Lost to Follow-up|1|||
94646507|NCT02442778|324167283|FG002|Overall Study|Lost to Follow-up|1|||
94646508|NCT02442778|324167281|FG000|Overall Study|Non-compliance with study drug|2|||
94646509|NCT02442778|324167282|FG001|Overall Study|Non-compliance with study drug|0|||
94646510|NCT02442778|324167283|FG002|Overall Study|Non-compliance with study drug|1|||
94646511|NCT02442778|324167281|FG000|Overall Study|Physician Decision|1|||
94646512|NCT02442778|324167282|FG001|Overall Study|Physician Decision|1|||
94646513|NCT02442778|324167283|FG002|Overall Study|Physician Decision|1|||
94646514|NCT02442778|324167281|FG000|Overall Study|Protocol Deviation|3|||
94681541|NCT03573908|324289120|FG002|Treatment Period|Lost to Follow-up|0|||
94681542|NCT03573908|324289121|FG003|Treatment Period|Lost to Follow-up|0|||
94681543|NCT03573908|324289122|FG004|Treatment Period|Lost to Follow-up|0|||
94681544|NCT03573908|324289118|FG000|Treatment Period|Pregnancy|1|||
94681545|NCT03573908|324289119|FG001|Treatment Period|Pregnancy|0|||
94681546|NCT03573908|324289120|FG002|Treatment Period|Pregnancy|0|||
94681547|NCT03573908|324289121|FG003|Treatment Period|Pregnancy|0|||
94681548|NCT03573908|324289122|FG004|Treatment Period|Pregnancy|0|||
94681549|NCT03573908|324289118|FG000|Treatment Period|Other, Not Specified|4|||
94681550|NCT03573908|324289119|FG001|Treatment Period|Other, Not Specified|6|||
94681551|NCT03573908|324289120|FG002|Treatment Period|Other, Not Specified|0|||
94681552|NCT03573908|324289121|FG003|Treatment Period|Other, Not Specified|0|||
94681553|NCT03573908|324289122|FG004|Treatment Period|Other, Not Specified|0|||
94681554|NCT03573908|324289118|FG000|Randomized Withdrawal Period|Adverse Event|0|||
94681555|NCT03573908|324289119|FG001|Randomized Withdrawal Period|Adverse Event|0|||
94681556|NCT03573908|324289120|FG002|Randomized Withdrawal Period|Adverse Event|3|||
94681557|NCT03573908|324289121|FG003|Randomized Withdrawal Period|Adverse Event|0|||
94681558|NCT03573908|324289122|FG004|Randomized Withdrawal Period|Adverse Event|0|||
94681559|NCT03573908|324289118|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
94681560|NCT03573908|324289119|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
94681561|NCT03573908|324289120|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
94681562|NCT03573908|324289121|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
94681563|NCT03573908|324289122|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
94681564|NCT03573908|324289118|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
94681565|NCT03573908|324289119|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
94681566|NCT03573908|324289120|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
94681567|NCT03573908|324289121|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
94681568|NCT03573908|324289122|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
94681569|NCT03573908|324289118|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
94681570|NCT03573908|324289119|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
94681571|NCT03573908|324289120|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
94681572|NCT03573908|324289121|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
94681573|NCT03573908|324289122|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
94681574|NCT02090634|324289123|FG000|Overall Study|Lost to Follow-up|0|||
94681575|NCT02090634|324289124|FG001|Overall Study|Lost to Follow-up|1|||
94681576|NCT02090634|324289123|FG000|Overall Study|Death|0|||
94681577|NCT02090634|324289124|FG001|Overall Study|Death|1|||
94681578|NCT02090634|324289123|FG000|Overall Study|Protocol Violation|3|||
94681579|NCT02090634|324289124|FG001|Overall Study|Protocol Violation|1|||
94681580|NCT02090634|324289123|FG000|Overall Study|Adverse Event|2|||
94681581|NCT02090634|324289124|FG001|Overall Study|Adverse Event|0|||
94681582|NCT01518946|324289129|FG000|Open-label Phase|Other|4|||
94681583|NCT01518946|324289130|FG001|Open-label Phase|Other|0|||
94681584|NCT01518946|324289131|FG002|Open-label Phase|Other|0|||
94681585|NCT01518946|324289129|FG000|Randomized Phase (First Intervention)|Other|0|||
94681586|NCT01518946|324289130|FG001|Randomized Phase (First Intervention)|Other|1|||
94681587|NCT01518946|324289131|FG002|Randomized Phase (First Intervention)|Other|0|||
94681588|NCT00118898|324289132|FG000|Overall Study|Death|6|||
94681589|NCT00118898|324289133|FG001|Overall Study|Death|11|||
94681590|NCT00118898|324289134|FG002|Overall Study|Death|6|||
94681591|NCT00118898|324289135|FG003|Overall Study|Death|8|||
94681592|NCT00118898|324289132|FG000|Overall Study|Lost to Follow-up|26|||
94681593|NCT00118898|324289133|FG001|Overall Study|Lost to Follow-up|34|||
94681594|NCT00118898|324289134|FG002|Overall Study|Lost to Follow-up|33|||
94681595|NCT00118898|324289135|FG003|Overall Study|Lost to Follow-up|33|||
94646515|NCT02442778|324167282|FG001|Overall Study|Protocol Deviation|0|||
94646516|NCT02442778|324167283|FG002|Overall Study|Protocol Deviation|1|||
94646517|NCT02442778|324167281|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
94646518|NCT02442778|324167282|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
94646519|NCT02442778|324167283|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
94646520|NCT02442778|324167281|FG000|Overall Study|Withdrawal by Subject|4|||
94646521|NCT02442778|324167282|FG001|Overall Study|Withdrawal by Subject|4|||
94646522|NCT02442778|324167283|FG002|Overall Study|Withdrawal by Subject|3|||
94646523|NCT02442778|324167281|FG000|Overall Study|Reason not specified|1|||
94681596|NCT00118898|324289132|FG000|Overall Study|Withdrawal by Subject|10|||
94681597|NCT00118898|324289133|FG001|Overall Study|Withdrawal by Subject|5|||
94681598|NCT00118898|324289134|FG002|Overall Study|Withdrawal by Subject|8|||
94681599|NCT00118898|324289135|FG003|Overall Study|Withdrawal by Subject|8|||
94681600|NCT00118898|324289132|FG000|Overall Study|Site Closure|33|||
94681601|NCT00118898|324289133|FG001|Overall Study|Site Closure|31|||
94681602|NCT00118898|324289134|FG002|Overall Study|Site Closure|28|||
94463474|NCT02520427|323485059|FG002|Overall Study|Death|0|||
94681603|NCT00118898|324289135|FG003|Overall Study|Site Closure|37|||
94681604|NCT00118898|324289132|FG000|Overall Study|Severe debilitation|1|||
94681605|NCT00118898|324289133|FG001|Overall Study|Severe debilitation|4|||
94681606|NCT00118898|324289134|FG002|Overall Study|Severe debilitation|6|||
94681607|NCT00118898|324289135|FG003|Overall Study|Severe debilitation|4|||
94681608|NCT00118898|324289132|FG000|Overall Study|Not compliant with requirements|11|||
94681609|NCT00118898|324289133|FG001|Overall Study|Not compliant with requirements|13|||
94681610|NCT00118898|324289134|FG002|Overall Study|Not compliant with requirements|11|||
94681611|NCT00118898|324289135|FG003|Overall Study|Not compliant with requirements|11|||
94681612|NCT00118898|324289132|FG000|Overall Study|Not able to get to clinic|34|||
94681613|NCT00118898|324289133|FG001|Overall Study|Not able to get to clinic|43|||
94681614|NCT00118898|324289134|FG002|Overall Study|Not able to get to clinic|31|||
94681615|NCT00118898|324289135|FG003|Overall Study|Not able to get to clinic|40|||
94681616|NCT01679236|324290766|FG000|Overall Study|Lost to Follow-up|15|||
94681617|NCT01679236|324290767|FG001|Overall Study|Lost to Follow-up|15|||
94681618|NCT03559218|324290768|FG000|Overall Study|Withdrawal by Subject|1|||
94681619|NCT03559218|324290769|FG001|Overall Study|Withdrawal by Subject|0|||
94681620|NCT01659658|324290770|FG000|Overall Study|Withdrawal by Patient|18|||
94681621|NCT01659658|324290771|FG001|Overall Study|Withdrawal by Patient|4|||
94681622|NCT01659658|324290772|FG002|Overall Study|Withdrawal by Patient|2|||
94681623|NCT01659658|324290773|FG003|Overall Study|Withdrawal by Patient|0|||
94681624|NCT01659658|324290774|FG004|Overall Study|Withdrawal by Patient|11|||
94681625|NCT01659658|324290770|FG000|Overall Study|Study Terminated by Sponsor|9|||
94681626|NCT01659658|324290771|FG001|Overall Study|Study Terminated by Sponsor|7|||
94681627|NCT01659658|324290772|FG002|Overall Study|Study Terminated by Sponsor|0|||
94681628|NCT01659658|324290773|FG003|Overall Study|Study Terminated by Sponsor|1|||
94681629|NCT01659658|324290774|FG004|Overall Study|Study Terminated by Sponsor|4|||
94681630|NCT01659658|324290770|FG000|Overall Study|Reason not Specified|61|||
94681631|NCT01659658|324290771|FG001|Overall Study|Reason not Specified|15|||
94681632|NCT01659658|324290772|FG002|Overall Study|Reason not Specified|8|||
94681633|NCT01659658|324290773|FG003|Overall Study|Reason not Specified|1|||
94681634|NCT01659658|324290774|FG004|Overall Study|Reason not Specified|34|||
94681635|NCT01659658|324290770|FG000|Overall Study|Lost to Follow-up|2|||
94681636|NCT01659658|324290771|FG001|Overall Study|Lost to Follow-up|0|||
94681637|NCT01659658|324290772|FG002|Overall Study|Lost to Follow-up|0|||
94681638|NCT01659658|324290773|FG003|Overall Study|Lost to Follow-up|0|||
94681639|NCT01659658|324290774|FG004|Overall Study|Lost to Follow-up|0|||
94681640|NCT02202434|324290775|FG000|Overall Study|Death|70|||
94681641|NCT02202434|324290776|FG001|Overall Study|Death|39|||
94681642|NCT02202434|324290777|FG002|Overall Study|Death|13|||
94681643|NCT02202434|324290778|FG003|Overall Study|Death|27|||
94681644|NCT02202434|324290775|FG000|Overall Study|Lost to Follow-up|1|||
94681645|NCT02202434|324290776|FG001|Overall Study|Lost to Follow-up|1|||
94681646|NCT02202434|324290777|FG002|Overall Study|Lost to Follow-up|1|||
94681647|NCT02202434|324290778|FG003|Overall Study|Lost to Follow-up|0|||
94681648|NCT02202434|324290775|FG000|Overall Study|Physician Decision|2|||
94681649|NCT02202434|324290776|FG001|Overall Study|Physician Decision|3|||
94681650|NCT02202434|324290777|FG002|Overall Study|Physician Decision|0|||
94681651|NCT02202434|324290778|FG003|Overall Study|Physician Decision|0|||
94681652|NCT02202434|324290775|FG000|Overall Study|Withdrawal by Subject|13|||
94681653|NCT02202434|324290776|FG001|Overall Study|Withdrawal by Subject|14|||
94681654|NCT02202434|324290777|FG002|Overall Study|Withdrawal by Subject|1|||
94681655|NCT02202434|324290778|FG003|Overall Study|Withdrawal by Subject|4|||
94681656|NCT02202434|324290775|FG000|Overall Study|Completed Study|1|||
94681657|NCT02202434|324290776|FG001|Overall Study|Completed Study|0|||
94681658|NCT02202434|324290777|FG002|Overall Study|Completed Study|0|||
94681659|NCT02202434|324290778|FG003|Overall Study|Completed Study|0|||
94681660|NCT02202434|324290775|FG000|Overall Study|Visit Missed|21|||
94681661|NCT02202434|324290776|FG001|Overall Study|Visit Missed|12|||
94681662|NCT02202434|324290777|FG002|Overall Study|Visit Missed|0|||
94681663|NCT02202434|324290778|FG003|Overall Study|Visit Missed|5|||
94681664|NCT02202434|324290775|FG000|Overall Study|Other|1|||
94681665|NCT02202434|324290776|FG001|Overall Study|Other|0|||
94681666|NCT02202434|324290777|FG002|Overall Study|Other|0|||
94681667|NCT02202434|324290778|FG003|Overall Study|Other|1|||
94681668|NCT01160484|324290781|FG000|Overall Study|Lack of Efficacy|9|||
94681669|NCT01160484|324290781|FG000|Overall Study|Adverse Event|6|||
94681670|NCT01160484|324290781|FG000|Overall Study|Withdrawal by Subject|2|||
94681671|NCT01160484|324290781|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
94681672|NCT00803101|324290782|FG000|Overall Study|Death / Serious Adverse Event|4|||
94681673|NCT00803101|324290783|FG001|Overall Study|Death / Serious Adverse Event|6|||
94681674|NCT00803101|324290782|FG000|Overall Study|Withdrawal by Subject|6|||
94681675|NCT00803101|324290783|FG001|Overall Study|Withdrawal by Subject|4|||
94681676|NCT00803101|324290782|FG000|Overall Study|Lost to Follow-up|2|||
94681677|NCT00803101|324290783|FG001|Overall Study|Lost to Follow-up|2|||
94681678|NCT00803101|324290782|FG000|Overall Study|Protocol Violation|1|||
94681679|NCT00803101|324290783|FG001|Overall Study|Protocol Violation|7|||
94681680|NCT00803101|324290782|FG000|Overall Study|Surgery finished outside protocol window|1|||
94681681|NCT00803101|324290783|FG001|Overall Study|Surgery finished outside protocol window|1|||
94681682|NCT00803101|324290782|FG000|Overall Study|Patient died outside SAE report period|1|||
94681683|NCT00803101|324290783|FG001|Overall Study|Patient died outside SAE report period|0|||
94681684|NCT00803101|324290782|FG000|Overall Study|Patient did not attend scheduled visit|2|||
94681685|NCT00803101|324290783|FG001|Overall Study|Patient did not attend scheduled visit|1|||
94681686|NCT00803101|324290782|FG000|Overall Study|Patient did not have surgery|1|||
94681687|NCT00803101|324290783|FG001|Overall Study|Patient did not have surgery|1|||
94681688|NCT03328143|324290784|FG000|Overall Study|Declined|3|||
94681689|NCT03328143|324290784|FG000|Overall Study|Required increased sedation|4|||
94681690|NCT03328143|324290784|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
94681691|NCT03328143|324290784|FG000|Overall Study|Surgery cancelled|1|||
94681692|NCT02494921|324290785|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
94681693|NCT02494921|324290786|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
94681694|NCT02494921|324290787|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
94681695|NCT02494921|324290788|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
94681696|NCT02494921|324290789|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
94681697|NCT02494921|324290785|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
94681698|NCT02494921|324290786|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
94681699|NCT02494921|324290787|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
94681700|NCT02494921|324290788|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
94681701|NCT02494921|324290789|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
94681702|NCT02494921|324290785|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
94681703|NCT02494921|324290786|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
94681704|NCT02494921|324290787|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
94681705|NCT02494921|324290788|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
94681706|NCT02494921|324290789|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
94681707|NCT02799472|324290792|FG000|Overall Study|Withdrawal by Subject|2|||
94681708|NCT02799472|324290793|FG001|Overall Study|Withdrawal by Subject|4|||
94681709|NCT02799472|324290792|FG000|Overall Study|Lack of Efficacy|2|||
94681710|NCT02799472|324290793|FG001|Overall Study|Lack of Efficacy|0|||
94681711|NCT02799472|324290792|FG000|Overall Study|Lost to Follow-up|0|||
94681712|NCT02799472|324290793|FG001|Overall Study|Lost to Follow-up|1|||
94681713|NCT01696968|324290794|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
94681714|NCT01696968|324290795|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
94681715|NCT01696968|324290794|FG000|Overall Study|Died Before Randomization|3|||
94681716|NCT01696968|324290795|FG001|Overall Study|Died Before Randomization|8|||
94681717|NCT01696968|324290794|FG000|Overall Study|Died Before ASU (Control)|278|||
94681718|NCT01696968|324290795|FG001|Overall Study|Died Before ASU (Control)|0|||
94681719|NCT01696968|324290794|FG000|Overall Study|Refused ASU (Control)|920|||
94681720|NCT01696968|324290795|FG001|Overall Study|Refused ASU (Control)|0|||
94681721|NCT01696968|324290794|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
94681722|NCT01696968|324290795|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
94681723|NCT02696564|324290796|FG000|Overall Study|Death|1|||
94646524|NCT02442778|324167282|FG001|Overall Study|Reason not specified|4|||
94646525|NCT02442778|324167283|FG002|Overall Study|Reason not specified|0|||
94646526|NCT04907032|324167284|FG000|Overall Study|Withdrawal by Subject|7|||
94646527|NCT04907032|324167285|FG001|Overall Study|Withdrawal by Subject|1|||
94646528|NCT01838642|324167286|FG000|Overall Study|Died on study|1|||
94646529|NCT00613509|324167290|FG000|Cycle 1|Adverse Event|2|||
94646530|NCT00613509|324167291|FG001|Cycle 1|Adverse Event|1|||
94646531|NCT00613509|324167290|FG000|Cycle 1|Disease Progression|2|||
94646532|NCT00613509|324167291|FG001|Cycle 1|Disease Progression|6|||
94646533|NCT00613509|324167290|FG000|Cycle 1|Unacceptable Toxicity|1|||
94646534|NCT00613509|324167291|FG001|Cycle 1|Unacceptable Toxicity|0|||
94646535|NCT00613509|324167290|FG000|Cycle 1|Other administrative reason|0|||
94646536|NCT00613509|324167291|FG001|Cycle 1|Other administrative reason|1|||
94646537|NCT01224639|324167300|FG000|Overall Study|Withdrawal by Subject|0|||
94646538|NCT01224639|324167301|FG001|Overall Study|Withdrawal by Subject|0|||
94646539|NCT01224639|324167302|FG002|Overall Study|Withdrawal by Subject|0|||
94646540|NCT01224639|324167303|FG003|Overall Study|Withdrawal by Subject|0|||
94646541|NCT01224639|324167304|FG004|Overall Study|Withdrawal by Subject|2|||
94646542|NCT01224639|324167305|FG005|Overall Study|Withdrawal by Subject|0|||
94646543|NCT01224639|324167306|FG006|Overall Study|Withdrawal by Subject|1|||
94646544|NCT01224639|324167307|FG007|Overall Study|Withdrawal by Subject|1|||
94646545|NCT01224639|324167300|FG000|Overall Study|Adverse Event|0|||
94646546|NCT01224639|324167301|FG001|Overall Study|Adverse Event|0|||
94681724|NCT02696564|324290797|FG001|Overall Study|Death|2|||
94681725|NCT02696564|324290796|FG000|Overall Study|Withdrawal by Subject|3|||
94681726|NCT02696564|324290797|FG001|Overall Study|Withdrawal by Subject|2|||
94681727|NCT02696564|324290796|FG000|Overall Study|Lost to Follow-up|3|||
94681728|NCT02696564|324290797|FG001|Overall Study|Lost to Follow-up|3|||
94646547|NCT01224639|324167302|FG002|Overall Study|Adverse Event|0|||
94646548|NCT01224639|324167303|FG003|Overall Study|Adverse Event|0|||
94646549|NCT01224639|324167304|FG004|Overall Study|Adverse Event|0|||
94646550|NCT01224639|324167305|FG005|Overall Study|Adverse Event|0|||
94646551|NCT01224639|324167306|FG006|Overall Study|Adverse Event|0|||
94646552|NCT01224639|324167307|FG007|Overall Study|Adverse Event|1|||
94646553|NCT03181542|324167308|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
94646554|NCT03181542|324167309|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
94646555|NCT01009099|324167310|FG000|Overall Study|Lost to Follow-up|1|||
94646556|NCT01009099|324167311|FG001|Overall Study|Lost to Follow-up|0|||
94646557|NCT01009099|324167310|FG000|Overall Study|Physician Decision|3|||
94646558|NCT01009099|324167311|FG001|Overall Study|Physician Decision|2|||
94646559|NCT01009099|324167310|FG000|Overall Study|Withdrawal by Subject|1|||
94646560|NCT01009099|324167311|FG001|Overall Study|Withdrawal by Subject|1|||
94646561|NCT01009099|324167310|FG000|Overall Study|Death|0|||
94646562|NCT01009099|324167311|FG001|Overall Study|Death|1|||
94646563|NCT04656132|324167312|FG000|Overall Study|Lost to Follow-up|4|||
94646564|NCT04656132|324167312|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
94646565|NCT02702401|324167313|FG000|Overall Study|Death|242|||
94646566|NCT02702401|324167314|FG001|Overall Study|Death|125|||
94646567|NCT02702401|324167313|FG000|Overall Study|Withdrawal by Subject|15|||
94646568|NCT02702401|324167314|FG001|Overall Study|Withdrawal by Subject|5|||
94646569|NCT02702401|324167313|FG000|Overall Study|Sponsor Decision|19|||
94646570|NCT02702401|324167314|FG001|Overall Study|Sponsor Decision|3|||
94646571|NCT02702401|324167313|FG000|Overall Study|Physician Decision|1|||
94646572|NCT02702401|324167314|FG001|Overall Study|Physician Decision|2|||
94646573|NCT02702401|324167313|FG000|Overall Study|Lost to Follow-up|1|||
94646574|NCT02702401|324167314|FG001|Overall Study|Lost to Follow-up|0|||
94646575|NCT00677807|324167316|FG000|Overall Study|Adverse Event|4|||
94646576|NCT00677807|324167317|FG001|Overall Study|Adverse Event|1|||
94646577|NCT00677807|324167318|FG002|Overall Study|Adverse Event|6|||
94646578|NCT00677807|324167316|FG000|Overall Study|Lack of Efficacy|0|||
94646579|NCT00677807|324167317|FG001|Overall Study|Lack of Efficacy|0|||
94646580|NCT00677807|324167318|FG002|Overall Study|Lack of Efficacy|2|||
94646581|NCT00677807|324167316|FG000|Overall Study|Participant no longer needs study drug|0|||
94646582|NCT00677807|324167317|FG001|Overall Study|Participant no longer needs study drug|0|||
94646583|NCT00677807|324167318|FG002|Overall Study|Participant no longer needs study drug|1|||
94646584|NCT00677807|324167316|FG000|Overall Study|Withdrawal by Subject|10|||
94646585|NCT00677807|324167317|FG001|Overall Study|Withdrawal by Subject|3|||
94646586|NCT00677807|324167318|FG002|Overall Study|Withdrawal by Subject|6|||
94646587|NCT00677807|324167316|FG000|Overall Study|Lost to Follow-up|2|||
94646588|NCT00677807|324167317|FG001|Overall Study|Lost to Follow-up|2|||
94646589|NCT00677807|324167318|FG002|Overall Study|Lost to Follow-up|2|||
94646590|NCT00677807|324167316|FG000|Overall Study|Administrative problems|1|||
94646591|NCT00677807|324167317|FG001|Overall Study|Administrative problems|1|||
94646592|NCT00677807|324167318|FG002|Overall Study|Administrative problems|2|||
94646593|NCT00677807|324167316|FG000|Overall Study|Death|0|||
94646594|NCT00677807|324167317|FG001|Overall Study|Death|1|||
94646595|NCT00677807|324167318|FG002|Overall Study|Death|1|||
94646596|NCT00677807|324167316|FG000|Overall Study|Protocol Deviation|1|||
94646597|NCT00677807|324167317|FG001|Overall Study|Protocol Deviation|3|||
94646598|NCT00677807|324167318|FG002|Overall Study|Protocol Deviation|0|||
94646599|NCT04365699|324167323|FG000|Overall Study|Death|2|||
94646600|NCT04365699|324167324|FG001|Overall Study|Death|5|||
94646601|NCT04365699|324167325|FG002|Overall Study|Death|15|||
94646602|NCT01527292|324167328|FG000|Overall Study|Physician Decision|0|||
94646603|NCT01527292|324167329|FG001|Overall Study|Physician Decision|3|||
94646604|NCT01482767|324167330|FG000|Overall Study|Death|1|||
94646605|NCT01482767|324167331|FG001|Overall Study|Death|1|||
94646606|NCT01482767|324167330|FG000|Overall Study|Withdrawal by Subject|7|||
94646607|NCT01482767|324167331|FG001|Overall Study|Withdrawal by Subject|5|||
94646608|NCT01482767|324167330|FG000|Overall Study|Lost to Follow-up|12|||
94646609|NCT01482767|324167331|FG001|Overall Study|Lost to Follow-up|6|||
94646610|NCT01482767|324167330|FG000|Overall Study|Adverse Event|0|||
94263740|NCT01514136|322759917|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
94646611|NCT01482767|324167331|FG001|Overall Study|Adverse Event|3|||
94646612|NCT01482767|324167330|FG000|Overall Study|Site closure|22|||
94646613|NCT01482767|324167331|FG001|Overall Study|Site closure|14|||
94646614|NCT01482767|324167330|FG000|Overall Study|Non-adherence to study requirements|4|||
94646615|NCT01482767|324167331|FG001|Overall Study|Non-adherence to study requirements|7|||
94646616|NCT01482767|324167330|FG000|Overall Study|Alternate HCV treatment|7|||
94646617|NCT01482767|324167331|FG001|Overall Study|Alternate HCV treatment|8|||
94646618|NCT01482767|324167330|FG000|Overall Study|Ineligible|0|||
94646619|NCT01482767|324167331|FG001|Overall Study|Ineligible|5|||
94646620|NCT01482767|324167330|FG000|Overall Study|Nurse error|1|||
94646621|NCT01482767|324167331|FG001|Overall Study|Nurse error|0|||
94646622|NCT01393743|324167332|FG000|Core Study|Adverse Event|5|||
94646623|NCT01393743|324167333|FG001|Core Study|Adverse Event|9|||
94646624|NCT01393743|324167334|FG002|Core Study|Adverse Event|0|||
94646625|NCT01393743|324167332|FG000|Core Study|Lost to Follow-up|1|||
94646626|NCT01393743|324167333|FG001|Core Study|Lost to Follow-up|1|||
94646627|NCT01393743|324167334|FG002|Core Study|Lost to Follow-up|0|||
94646628|NCT01393743|324167332|FG000|Core Study|Participant's Choice|2|||
94646629|NCT01393743|324167333|FG001|Core Study|Participant's Choice|3|||
94681729|NCT02696564|324290796|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
94681730|NCT02696564|324290797|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
94681731|NCT02696564|324290796|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
94681732|NCT02696564|324290797|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
94681733|NCT02696564|324290796|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
94681734|NCT02696564|324290797|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
94681735|NCT02696564|324290796|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
94681736|NCT02696564|324290797|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
94681737|NCT02696564|324290796|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
94681738|NCT02696564|324290797|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
94681739|NCT02508532|324290798|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
94681740|NCT02508532|324290799|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
94681741|NCT02508532|324290800|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
94681742|NCT02508532|324290801|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
94681743|NCT02508532|324290802|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
94681744|NCT02508532|324290803|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
94681745|NCT02508532|324290804|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
94681746|NCT02508532|324290805|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
94681747|NCT02508532|324290806|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
94681748|NCT02508532|324290798|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
94681749|NCT02508532|324290799|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
94681750|NCT02508532|324290800|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
94681751|NCT02508532|324290801|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
94681752|NCT02508532|324290802|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
94681753|NCT02508532|324290803|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
94681754|NCT02508532|324290804|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
94681755|NCT02508532|324290805|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
94681756|NCT02508532|324290806|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
94681757|NCT02508532|324290798|FG000|Part 2 - Treatment|Disease Progression|0|||
94681758|NCT02508532|324290799|FG001|Part 2 - Treatment|Disease Progression|0|||
94681759|NCT02508532|324290800|FG002|Part 2 - Treatment|Disease Progression|0|||
94681760|NCT02508532|324290801|FG003|Part 2 - Treatment|Disease Progression|0|||
94681761|NCT02508532|324290802|FG004|Part 2 - Treatment|Disease Progression|0|||
94681762|NCT02508532|324290803|FG005|Part 2 - Treatment|Disease Progression|0|||
94681763|NCT02508532|324290804|FG006|Part 2 - Treatment|Disease Progression|0|||
94681764|NCT02508532|324290805|FG007|Part 2 - Treatment|Disease Progression|0|||
94681765|NCT02508532|324290806|FG008|Part 2 - Treatment|Disease Progression|118|||
94681766|NCT02508532|324290798|FG000|Part 2 - Treatment|Adverse Event|0|||
94681767|NCT02508532|324290799|FG001|Part 2 - Treatment|Adverse Event|0|||
94681768|NCT02508532|324290800|FG002|Part 2 - Treatment|Adverse Event|0|||
94681769|NCT02508532|324290801|FG003|Part 2 - Treatment|Adverse Event|0|||
94681770|NCT02508532|324290802|FG004|Part 2 - Treatment|Adverse Event|0|||
94681771|NCT02508532|324290803|FG005|Part 2 - Treatment|Adverse Event|0|||
94681772|NCT02508532|324290804|FG006|Part 2 - Treatment|Adverse Event|0|||
94681773|NCT02508532|324290805|FG007|Part 2 - Treatment|Adverse Event|0|||
94681774|NCT02508532|324290806|FG008|Part 2 - Treatment|Adverse Event|49|||
94681775|NCT02508532|324290798|FG000|Part 2 - Treatment|Physician Decision|0|||
94681776|NCT02508532|324290799|FG001|Part 2 - Treatment|Physician Decision|0|||
94681777|NCT02508532|324290800|FG002|Part 2 - Treatment|Physician Decision|0|||
94681778|NCT02508532|324290801|FG003|Part 2 - Treatment|Physician Decision|0|||
94681779|NCT02508532|324290802|FG004|Part 2 - Treatment|Physician Decision|0|||
94681780|NCT02508532|324290803|FG005|Part 2 - Treatment|Physician Decision|0|||
94681781|NCT02508532|324290804|FG006|Part 2 - Treatment|Physician Decision|0|||
94681782|NCT02508532|324290805|FG007|Part 2 - Treatment|Physician Decision|0|||
94681783|NCT02508532|324290806|FG008|Part 2 - Treatment|Physician Decision|12|||
94681784|NCT02508532|324290798|FG000|Part 2 - Treatment|Administrative|0|||
94681785|NCT02508532|324290799|FG001|Part 2 - Treatment|Administrative|0|||
94681786|NCT02508532|324290800|FG002|Part 2 - Treatment|Administrative|0|||
94681787|NCT02508532|324290801|FG003|Part 2 - Treatment|Administrative|0|||
94681788|NCT02508532|324290802|FG004|Part 2 - Treatment|Administrative|0|||
94681789|NCT02508532|324290803|FG005|Part 2 - Treatment|Administrative|0|||
94681790|NCT02508532|324290804|FG006|Part 2 - Treatment|Administrative|0|||
94681791|NCT02508532|324290805|FG007|Part 2 - Treatment|Administrative|0|||
94681792|NCT02508532|324290806|FG008|Part 2 - Treatment|Administrative|3|||
94681793|NCT02508532|324290798|FG000|Part 2 - Treatment|Sponsor Decision|0|||
94681794|NCT02508532|324290799|FG001|Part 2 - Treatment|Sponsor Decision|0|||
94681795|NCT02508532|324290800|FG002|Part 2 - Treatment|Sponsor Decision|0|||
94681796|NCT02508532|324290801|FG003|Part 2 - Treatment|Sponsor Decision|0|||
94681797|NCT02508532|324290802|FG004|Part 2 - Treatment|Sponsor Decision|0|||
94364017|NCT01915498|323116808|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
94364018|NCT01915498|323116809|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
94463475|NCT02520427|323485060|FG003|Overall Study|Death|0|||
94646630|NCT01393743|324167334|FG002|Core Study|Participant's Choice|0|||
94646631|NCT01393743|324167332|FG000|Core Study|Inadequate therapeutic effect|2|||
94646632|NCT01393743|324167333|FG001|Core Study|Inadequate therapeutic effect|0|||
94646633|NCT01393743|324167334|FG002|Core Study|Inadequate therapeutic effect|0|||
94646634|NCT01393743|324167332|FG000|Extension Phase|Adverse Event|0|||
94646635|NCT01393743|324167333|FG001|Extension Phase|Adverse Event|0|||
94646636|NCT01393743|324167334|FG002|Extension Phase|Adverse Event|12|||
94646637|NCT01393743|324167332|FG000|Extension Phase|Lost to Follow-up|0|||
94646638|NCT01393743|324167333|FG001|Extension Phase|Lost to Follow-up|0|||
94646639|NCT01393743|324167334|FG002|Extension Phase|Lost to Follow-up|2|||
94646640|NCT01393743|324167332|FG000|Extension Phase|Participant choice|0|||
94646641|NCT01393743|324167333|FG001|Extension Phase|Participant choice|0|||
94646642|NCT01393743|324167334|FG002|Extension Phase|Participant choice|16|||
94646643|NCT01393743|324167332|FG000|Extension Phase|Inadequate therapeutic effect|0|||
94646644|NCT01393743|324167333|FG001|Extension Phase|Inadequate therapeutic effect|0|||
94646645|NCT01393743|324167334|FG002|Extension Phase|Inadequate therapeutic effect|7|||
94646646|NCT01393743|324167332|FG000|Extension Phase|Withdrawal by Subject|0|||
94646647|NCT01393743|324167333|FG001|Extension Phase|Withdrawal by Subject|0|||
94646648|NCT01393743|324167334|FG002|Extension Phase|Withdrawal by Subject|8|||
94646649|NCT01393743|324167332|FG000|Extension Phase|Pregnancy|0|||
94646650|NCT01393743|324167333|FG001|Extension Phase|Pregnancy|0|||
94646651|NCT01393743|324167334|FG002|Extension Phase|Pregnancy|1|||
94646652|NCT01393743|324167332|FG000|Extension Phase|Other|0|||
94646653|NCT01393743|324167333|FG001|Extension Phase|Other|0|||
94646654|NCT01393743|324167334|FG002|Extension Phase|Other|14|||
94646655|NCT00314366|324167335|FG000|Overall Study|not treated due to patient medical condi|1|||
94646656|NCT00314366|324167336|FG001|Overall Study|not treated due to patient medical condi|0|||
94646657|NCT03400033|324167339|FG000|Overall Study|Withdrawal by Subject|1|||
94646658|NCT03400033|324167340|FG001|Overall Study|Withdrawal by Subject|2|||
94646659|NCT01541930|324167343|FG000|Overall Study|Withdrawal by Subject|1|||
94646660|NCT02908529|324167352|FG000|Overall Study|Lost to Follow-up|0|||
94646661|NCT02908529|324167353|FG001|Overall Study|Lost to Follow-up|2|||
94646662|NCT04074317|324167354|FG000|Third Period|Withdrawal by Subject|0|||
94646663|NCT04074317|324167355|FG001|Third Period|Withdrawal by Subject|0|||
94646664|NCT04074317|324167356|FG002|Third Period|Withdrawal by Subject|0|||
94646665|NCT04074317|324167357|FG003|Third Period|Withdrawal by Subject|1|||
94646666|NCT04074317|324167358|FG004|Third Period|Withdrawal by Subject|0|||
94646667|NCT04074317|324167359|FG005|Third Period|Withdrawal by Subject|0|||
94646668|NCT02970968|324168830|FG000|Overall Study|Withdrawal by Subject|3|||
94646669|NCT02970968|324168831|FG001|Overall Study|Withdrawal by Subject|3|||
94646670|NCT02970968|324168830|FG000|Overall Study|Adverse Event|1|||
94646671|NCT02970968|324168831|FG001|Overall Study|Adverse Event|2|||
94646672|NCT02970968|324168830|FG000|Overall Study|Lost to Follow-up|1|||
94646673|NCT02970968|324168831|FG001|Overall Study|Lost to Follow-up|1|||
94646674|NCT02970968|324168830|FG000|Overall Study|Non-Compliance|0|||
94646675|NCT02970968|324168831|FG001|Overall Study|Non-Compliance|1|||
94646676|NCT03003520|324168832|FG000|Overall Study|Adverse Event|9|||
94646677|NCT03003520|324168833|FG001|Overall Study|Adverse Event|0|||
94646678|NCT03003520|324168832|FG000|Overall Study|Death|1|||
94646679|NCT03003520|324168833|FG001|Overall Study|Death|0|||
94646680|NCT03003520|324168832|FG000|Overall Study|Other reasons|4|||
94646681|NCT03003520|324168833|FG001|Overall Study|Other reasons|0|||
94646682|NCT03003520|324168832|FG000|Overall Study|Withdrawal by Subject|6|||
94646683|NCT03003520|324168833|FG001|Overall Study|Withdrawal by Subject|0|||
94646684|NCT03003520|324168832|FG000|Overall Study|Progressive disease|9|||
94646685|NCT03003520|324168833|FG001|Overall Study|Progressive disease|1|||
94646686|NCT03264404|324168834|FG000|Overall Study|Death|2|||
94646687|NCT03264404|324168834|FG000|Overall Study|Physician Decision|1|||
94646688|NCT03264404|324168834|FG000|Overall Study|Disease Progression|28|||
94646689|NCT03264404|324168834|FG000|Overall Study|Adverse Event|1|||
94646690|NCT03264404|324168834|FG000|Overall Study|Off study prior to treatment|2|||
94646691|NCT03036566|324168837|FG000|Overall Study|Lost to Follow-up|3|||
94646692|NCT01945489|324168845|FG000|Cycle 1|Adverse Event|2|||
94646693|NCT01945489|324168846|FG001|Cycle 1|Adverse Event|0|||
94646694|NCT01945489|324168845|FG000|Cycle 1|Lost to Follow-up|4|||
94646695|NCT01945489|324168846|FG001|Cycle 1|Lost to Follow-up|0|||
94646696|NCT01945489|324168845|FG000|Cycle 1|Personal Reasons|4|||
94646697|NCT01945489|324168846|FG001|Cycle 1|Personal Reasons|2|||
94646698|NCT01945489|324168845|FG000|Cycle 1|Protocol Violation|0|||
94646699|NCT01945489|324168846|FG001|Cycle 1|Protocol Violation|1|||
94646700|NCT01945489|324168845|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
94646701|NCT01945489|324168846|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
94646702|NCT01945489|324168845|FG000|Cycle 2|Adverse Event|1|||
94646703|NCT01945489|324168846|FG001|Cycle 2|Adverse Event|0|||
94646704|NCT01945489|324168845|FG000|Cycle 2|Lost to Follow-up|0|||
94646705|NCT01945489|324168846|FG001|Cycle 2|Lost to Follow-up|1|||
94646706|NCT04144166|324168851|FG000|Overall Study|Discharged before study start|1|||
94646707|NCT04144166|324168851|FG000|Overall Study|Pregnancy|1|||
94646708|NCT04144166|324168851|FG000|Overall Study|Nail polish could not be removed from finger|1|||
94646709|NCT01359592|324168855|FG000|Initial Registration|Adverse Event|1|||
94646710|NCT01359592|324168856|FG001|Initial Registration|Adverse Event|0|||
94646711|NCT01359592|324168857|FG002|Initial Registration|Adverse Event|0|||
94646712|NCT01359592|324168858|FG003|Initial Registration|Adverse Event|0|||
94646713|NCT01359592|324168855|FG000|Initial Registration|Death|1|||
94646714|NCT01359592|324168856|FG001|Initial Registration|Death|0|||
94646715|NCT01359592|324168857|FG002|Initial Registration|Death|0|||
94646716|NCT01359592|324168858|FG003|Initial Registration|Death|0|||
94646717|NCT01359592|324168855|FG000|Initial Registration|Other reason not protocol specified|1|||
94646718|NCT01359592|324168856|FG001|Initial Registration|Other reason not protocol specified|0|||
94646719|NCT01359592|324168857|FG002|Initial Registration|Other reason not protocol specified|0|||
94646720|NCT01359592|324168858|FG003|Initial Registration|Other reason not protocol specified|0|||
94646721|NCT01359592|324168855|FG000|Initial Registration|Ineligible|26|||
94646722|NCT01359592|324168856|FG001|Initial Registration|Ineligible|0|||
94646723|NCT01359592|324168857|FG002|Initial Registration|Ineligible|0|||
94646724|NCT01359592|324168858|FG003|Initial Registration|Ineligible|0|||
94646725|NCT01359592|324168855|FG000|PET-Directed Therapy|Adverse Event|0|||
94646726|NCT01359592|324168856|FG001|PET-Directed Therapy|Adverse Event|0|||
94646727|NCT01359592|324168857|FG002|PET-Directed Therapy|Adverse Event|1|||
94646728|NCT01359592|324168858|FG003|PET-Directed Therapy|Adverse Event|0|||
94646729|NCT01359592|324168855|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
94646730|NCT01359592|324168856|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
94646731|NCT01359592|324168857|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
94646732|NCT01359592|324168858|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
94646733|NCT01359592|324168855|FG000|PET-Directed Therapy|Ineligible|0|||
94646734|NCT01359592|324168856|FG001|PET-Directed Therapy|Ineligible|0|||
94646735|NCT01359592|324168857|FG002|PET-Directed Therapy|Ineligible|24|||
94646736|NCT01359592|324168858|FG003|PET-Directed Therapy|Ineligible|0|||
94646737|NCT00697346|324168865|FG000|Overall Study|Adverse Event|4|||
94646738|NCT00697346|324168866|FG001|Overall Study|Adverse Event|5|||
94646739|NCT00697346|324168867|FG002|Overall Study|Adverse Event|0|||
94646740|NCT00697346|324168865|FG000|Overall Study|Progressive Disease|19|||
94646741|NCT00697346|324168866|FG001|Overall Study|Progressive Disease|18|||
94646742|NCT00697346|324168867|FG002|Overall Study|Progressive Disease|0|||
94646743|NCT00697346|324168865|FG000|Overall Study|Symptomatic Deterioration|0|||
94646744|NCT00697346|324168866|FG001|Overall Study|Symptomatic Deterioration|1|||
94646745|NCT00697346|324168867|FG002|Overall Study|Symptomatic Deterioration|0|||
94646746|NCT00697346|324168865|FG000|Overall Study|Withdrawal by Subject|2|||
94646747|NCT00697346|324168866|FG001|Overall Study|Withdrawal by Subject|2|||
94646748|NCT00697346|324168867|FG002|Overall Study|Withdrawal by Subject|0|||
94646749|NCT00697346|324168865|FG000|Overall Study|Reason not Specified|3|||
94646750|NCT00697346|324168866|FG001|Overall Study|Reason not Specified|0|||
94646751|NCT00697346|324168867|FG002|Overall Study|Reason not Specified|1|||
94646752|NCT00419562|324168868|FG000|Overall Study|Lost to Follow-up|12|||
94646753|NCT00419562|324168869|FG001|Overall Study|Lost to Follow-up|13|||
94646754|NCT00419562|324168868|FG000|Overall Study|Withdrawal by Subject|20|||
94646755|NCT00419562|324168869|FG001|Overall Study|Withdrawal by Subject|18|||
94646756|NCT00419562|324168868|FG000|Overall Study|Participant Institutionalized|1|||
94646757|NCT00419562|324168869|FG001|Overall Study|Participant Institutionalized|0|||
94646758|NCT01886833|324168872|FG000|Overall Study|IgA not available from both periods|204|||
94263741|NCT01514136|322759918|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
94263742|NCT01514136|322759919|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
94263743|NCT01514136|322759920|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
94463476|NCT02520427|323485061|FG004|Overall Study|Death|0|||
94646759|NCT00333229|324168873|FG000|Overall Study|Lack of Efficacy|0|||
94646760|NCT00333229|324168874|FG001|Overall Study|Lack of Efficacy|1|||
94646761|NCT02821962|324168875|FG000|Overall Study|Lost to Follow-up|2|||
94646762|NCT02821962|324168876|FG001|Overall Study|Lost to Follow-up|0|||
94646763|NCT00910715|324168879|FG000|Overall Study|Lost to Follow-up|22|||
94646764|NCT00910715|324168880|FG001|Overall Study|Lost to Follow-up|26|||
94646765|NCT00910715|324168881|FG002|Overall Study|Lost to Follow-up|0|||
94646766|NCT02412631|324168882|FG000|Overall Study|Adverse Event|1|||
94646767|NCT02412631|324168883|FG001|Overall Study|Adverse Event|2|||
94646768|NCT02412631|324168882|FG000|Overall Study|Lost to Follow-up|5|||
94681798|NCT02508532|324290803|FG005|Part 2 - Treatment|Sponsor Decision|0|||
94681799|NCT02508532|324290804|FG006|Part 2 - Treatment|Sponsor Decision|0|||
94681800|NCT02508532|324290805|FG007|Part 2 - Treatment|Sponsor Decision|0|||
94681801|NCT02508532|324290806|FG008|Part 2 - Treatment|Sponsor Decision|28|||
94681802|NCT02508532|324290798|FG000|Part 2 - Treatment|Death|0|||
94681803|NCT02508532|324290799|FG001|Part 2 - Treatment|Death|0|||
94681804|NCT02508532|324290800|FG002|Part 2 - Treatment|Death|0|||
94681805|NCT02508532|324290801|FG003|Part 2 - Treatment|Death|0|||
94681806|NCT02508532|324290802|FG004|Part 2 - Treatment|Death|0|||
94681807|NCT02508532|324290803|FG005|Part 2 - Treatment|Death|0|||
94681808|NCT02508532|324290804|FG006|Part 2 - Treatment|Death|0|||
94681809|NCT02508532|324290805|FG007|Part 2 - Treatment|Death|0|||
94681810|NCT02508532|324290806|FG008|Part 2 - Treatment|Death|1|||
94681811|NCT02508532|324290798|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
94681812|NCT02508532|324290799|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
94681813|NCT02508532|324290800|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
94681814|NCT02508532|324290801|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
94681815|NCT02508532|324290802|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
94681816|NCT02508532|324290803|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
94681817|NCT02508532|324290804|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
94681818|NCT02508532|324290805|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
94681819|NCT02508532|324290806|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
94681820|NCT02508532|324290798|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
94681821|NCT02508532|324290799|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
94681822|NCT02508532|324290800|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
94681823|NCT02508532|324290801|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
94681824|NCT02508532|324290802|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
94681825|NCT02508532|324290803|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
94681826|NCT02508532|324290804|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
94681827|NCT02508532|324290805|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
94681828|NCT02508532|324290806|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
94681829|NCT02508532|324290798|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
94681830|NCT02508532|324290799|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
94681831|NCT02508532|324290800|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
94681832|NCT02508532|324290801|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
94681833|NCT02508532|324290802|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
94681834|NCT02508532|324290803|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
94681835|NCT02508532|324290804|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
94681836|NCT02508532|324290805|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
94681837|NCT02508532|324290806|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
94681838|NCT02508532|324290798|FG000|Part 1 and Part 2 End of Study|Death|0|||
94681839|NCT02508532|324290799|FG001|Part 1 and Part 2 End of Study|Death|4|||
94681840|NCT02508532|324290800|FG002|Part 1 and Part 2 End of Study|Death|2|||
94681841|NCT02508532|324290801|FG003|Part 1 and Part 2 End of Study|Death|4|||
94681842|NCT02508532|324290802|FG004|Part 1 and Part 2 End of Study|Death|3|||
94681843|NCT02508532|324290803|FG005|Part 1 and Part 2 End of Study|Death|0|||
94681844|NCT02508532|324290804|FG006|Part 1 and Part 2 End of Study|Death|0|||
94681845|NCT02508532|324290805|FG007|Part 1 and Part 2 End of Study|Death|1|||
94681846|NCT02508532|324290806|FG008|Part 1 and Part 2 End of Study|Death|111|||
94681847|NCT02508532|324290798|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
94681848|NCT02508532|324290799|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
94681849|NCT02508532|324290800|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
94681850|NCT02508532|324290801|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
94681851|NCT02508532|324290802|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
94681852|NCT02508532|324290803|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
94681853|NCT02508532|324290804|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
94681854|NCT02508532|324290805|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
94681855|NCT02508532|324290806|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
94681856|NCT02508532|324290798|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
94681857|NCT02508532|324290799|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
94681858|NCT02508532|324290800|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
94681859|NCT02508532|324290801|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
94681860|NCT02508532|324290802|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
94681861|NCT02508532|324290803|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
94681862|NCT02508532|324290804|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
94681863|NCT02508532|324290805|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
94681864|NCT02508532|324290806|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
94681865|NCT02508532|324290798|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
94681866|NCT02508532|324290799|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
94681867|NCT02508532|324290800|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
94681868|NCT02508532|324290801|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
94681869|NCT02508532|324290802|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
94681870|NCT02508532|324290803|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
94681871|NCT02508532|324290804|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
94681872|NCT02508532|324290805|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
94646769|NCT02412631|324168883|FG001|Overall Study|Lost to Follow-up|9|||
94646770|NCT02412631|324168882|FG000|Overall Study|Withdrawal by Subject|9|||
94681873|NCT02508532|324290806|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
94681874|NCT02508532|324290798|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
94681875|NCT02508532|324290799|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
94681876|NCT02508532|324290800|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
94681877|NCT02508532|324290801|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
94681878|NCT02508532|324290802|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
94681879|NCT02508532|324290803|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
94681880|NCT02508532|324290804|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
94681881|NCT02508532|324290805|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
94681882|NCT02508532|324290806|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
94681883|NCT02508532|324290798|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
94681884|NCT02508532|324290799|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
94681885|NCT02508532|324290800|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
94681886|NCT02508532|324290801|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
94681887|NCT02508532|324290802|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
94263744|NCT01514136|322759921|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
94263745|NCT01514136|322759922|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
94263746|NCT01514136|322759923|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
94263747|NCT01514136|322759916|FG000|Test Period 2; Test A*|Adverse Event|0|||
94263748|NCT01514136|322759917|FG001|Test Period 2; Test A*|Adverse Event|0|||
94263749|NCT01514136|322759918|FG002|Test Period 2; Test A*|Adverse Event|0|||
94263750|NCT01514136|322759919|FG003|Test Period 2; Test A*|Adverse Event|0|||
94263751|NCT01514136|322759920|FG004|Test Period 2; Test A*|Adverse Event|1|||
94263752|NCT01514136|322759921|FG005|Test Period 2; Test A*|Adverse Event|0|||
94646771|NCT02412631|324168883|FG001|Overall Study|Withdrawal by Subject|3|||
94646772|NCT02412631|324168882|FG000|Overall Study|Early stop by FDA|5|||
94646773|NCT02412631|324168883|FG001|Overall Study|Early stop by FDA|2|||
94646774|NCT02412631|324168882|FG000|Overall Study|Unspecified reason|6|||
94646775|NCT02412631|324168883|FG001|Overall Study|Unspecified reason|8|||
94646776|NCT00770120|324168885|FG000|Overall Study|Progression|31|||
94646777|NCT00770120|324168885|FG000|Overall Study|Adverse Event|11|||
94646778|NCT00770120|324168885|FG000|Overall Study|Not Protocol Specified|11|||
94646779|NCT00770120|324168885|FG000|Overall Study|Death|3|||
94646780|NCT00770120|324168885|FG000|Overall Study|Withdrawal by Subject|2|||
94646781|NCT00770120|324168885|FG000|Overall Study|Ineligible|1|||
94646782|NCT00770120|324168885|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
94646783|NCT00770120|324168885|FG000|Overall Study|Reason under Review|1|||
94646784|NCT00706966|324168886|FG000|Overall Study|Adverse Event|1|||
94646785|NCT01467076|324168892|FG000|Overall Study|Lost to Follow-up|1|||
94646786|NCT01467076|324168893|FG001|Overall Study|Lost to Follow-up|0|||
94646787|NCT01467076|324168894|FG002|Overall Study|Lost to Follow-up|0|||
94646788|NCT02488629|324168895|FG000|Overall Study|Lack of Efficacy|3|||
94646789|NCT02488629|324168896|FG001|Overall Study|Lack of Efficacy|1|||
94646790|NCT02488629|324168897|FG002|Overall Study|Lack of Efficacy|0|||
94646791|NCT02488629|324168898|FG003|Overall Study|Lack of Efficacy|0|||
94263753|NCT01514136|322759922|FG006|Test Period 2; Test A*|Adverse Event|0|||
94263754|NCT01514136|322759923|FG007|Test Period 2; Test A*|Adverse Event|0|||
94646792|NCT02488629|324168895|FG000|Overall Study|Withdrawal by Subject|0|||
94463477|NCT02520427|323485062|FG005|Overall Study|Death|0|||
94646793|NCT02488629|324168896|FG001|Overall Study|Withdrawal by Subject|1|||
94646794|NCT02488629|324168897|FG002|Overall Study|Withdrawal by Subject|0|||
94646795|NCT02488629|324168898|FG003|Overall Study|Withdrawal by Subject|0|||
94263755|NCT01514136|322759916|FG000|Test Period 2; Test A*|Holiday|0|||
94263756|NCT01514136|322759917|FG001|Test Period 2; Test A*|Holiday|0|||
94681888|NCT02508532|324290803|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
94681889|NCT02508532|324290804|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
94681890|NCT02508532|324290805|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
94681891|NCT02508532|324290806|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
94681892|NCT01785563|324290809|FG000|Overall Study|Physician Decision|10|||
94681893|NCT01785563|324290809|FG000|Overall Study|Withdrawal by Subject|1|||
94681894|NCT01785563|324290809|FG000|Overall Study|Protocol Violation|2|||
94681895|NCT02635724|324290820|FG000|Overall Study|Withdrawal by Subject|0|||
94681896|NCT02635724|324290821|FG001|Overall Study|Withdrawal by Subject|1|||
94681897|NCT02635724|324290822|FG002|Overall Study|Withdrawal by Subject|0|||
94681898|NCT02424591|324290829|FG000|Overall Study|Protocol Violation|2|||
94681899|NCT02424591|324290830|FG001|Overall Study|Protocol Violation|3|||
94681900|NCT01576367|324290831|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
94681901|NCT01576367|324290831|FG000|Overall Study|Moved to commercial use after 6 months|1|||
94681902|NCT01446796|324290832|FG000|Overall Study|Withdrawal by Subject|1|||
94681903|NCT01446796|324290833|FG001|Overall Study|Withdrawal by Subject|0|||
94681904|NCT00770432|324290836|FG000|Overall Study|Other|4|||
94681905|NCT00770432|324290837|FG001|Overall Study|Other|6|||
94681906|NCT00770432|324290836|FG000|Overall Study|Non-compliance|0|||
94681907|NCT00770432|324290837|FG001|Overall Study|Non-compliance|1|||
94681908|NCT02756832|324290840|FG000|Overall Study|Lost for Observation after Baseline|6|||
94681909|NCT02756832|324290840|FG000|Overall Study|Lost for Observation|13|||
94681910|NCT02756832|324290840|FG000|Overall Study|Patient's Unwillingness|12|||
94681911|NCT02756832|324290840|FG000|Overall Study|Insufficient Efficacy|2|||
94681912|NCT02756832|324290840|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
94681913|NCT02756832|324290840|FG000|Overall Study|Reason not Specified|9|||
94681914|NCT02756832|324290840|FG000|Overall Study|Protocol Deviation|10|||
94681915|NCT00954733|324290841|FG000|Overall Study|blood gas machine did not work|1|||
94681916|NCT01462162|324290844|FG000|Overall Study|Adverse Event|5|||
94263757|NCT01514136|322759918|FG002|Test Period 2; Test A*|Holiday|0|||
94263758|NCT01514136|322759919|FG003|Test Period 2; Test A*|Holiday|0|||
94681917|NCT01462162|324290844|FG000|Overall Study|Lack of Efficacy|4|||
94681918|NCT01462162|324290844|FG000|Overall Study|Abnormal laboratory parameters|1|||
94681919|NCT01462162|324290844|FG000|Overall Study|Other|2|||
94681920|NCT04251065|324290849|FG000|Overall Study|Death|2|||
94263759|NCT01514136|322759920|FG004|Test Period 2; Test A*|Holiday|1|||
94681921|NCT04251065|324290849|FG000|Overall Study|Lack of Efficacy|3|||
94681922|NCT04251065|324290849|FG000|Overall Study|Death|1|||
94681923|NCT01054573|324290850|FG000|Overall Study|Adverse Event|1|||
94681924|NCT01054573|324290851|FG001|Overall Study|Adverse Event|0|||
94681925|NCT01054573|324290852|FG002|Overall Study|Adverse Event|1|||
94681926|NCT01054573|324290853|FG003|Overall Study|Adverse Event|1|||
94681927|NCT01054573|324290850|FG000|Overall Study|Lost to Follow-up|0|||
94681928|NCT01054573|324290851|FG001|Overall Study|Lost to Follow-up|2|||
94681929|NCT01054573|324290852|FG002|Overall Study|Lost to Follow-up|0|||
94681930|NCT01054573|324290853|FG003|Overall Study|Lost to Follow-up|0|||
94681931|NCT01054573|324290850|FG000|Overall Study|Withdrawal by Subject|0|||
94681932|NCT01054573|324290851|FG001|Overall Study|Withdrawal by Subject|2|||
94681933|NCT01054573|324290852|FG002|Overall Study|Withdrawal by Subject|2|||
94681934|NCT01054573|324290853|FG003|Overall Study|Withdrawal by Subject|1|||
94681935|NCT01719237|324290857|FG000|Overall Study|Physician Decision|0|||
94681936|NCT01719237|324290858|FG001|Overall Study|Physician Decision|1|||
94681937|NCT01735396|324290869|FG000|Overall Study|not evaluable|1|||
94681938|NCT02002182|324290870|FG000|Overall Study|Withdraw from study|3|||
94681939|NCT02002182|324290871|FG001|Overall Study|Withdraw from study|1|||
94681940|NCT02002182|324290870|FG000|Overall Study|Health Reasons|1|||
94681941|NCT02002182|324290871|FG001|Overall Study|Health Reasons|0|||
94681942|NCT02002182|324290870|FG000|Overall Study|Death|1|||
94681943|NCT02002182|324290871|FG001|Overall Study|Death|0|||
94681944|NCT04599101|324290872|FG000|Overall Study|Lost to Follow-up|5|||
94681945|NCT04599101|324290873|FG001|Overall Study|Lost to Follow-up|5|||
94263760|NCT01514136|322759921|FG005|Test Period 2; Test A*|Holiday|0|||
94263761|NCT01514136|322759922|FG006|Test Period 2; Test A*|Holiday|0|||
94681946|NCT02404389|324290883|FG000|Overall Study|Adverse Event|1|||
94681947|NCT02404389|324290884|FG001|Overall Study|Adverse Event|0|||
94681948|NCT02404389|324290885|FG002|Overall Study|Adverse Event|1|||
94681949|NCT02404389|324290886|FG003|Overall Study|Adverse Event|0|||
94681950|NCT02404389|324290887|FG004|Overall Study|Adverse Event|2|||
94681951|NCT02404389|324290883|FG000|Overall Study|Subject/guardian decision|1|||
94681952|NCT02404389|324290884|FG001|Overall Study|Subject/guardian decision|0|||
94681953|NCT02404389|324290885|FG002|Overall Study|Subject/guardian decision|0|||
94681954|NCT02404389|324290886|FG003|Overall Study|Subject/guardian decision|1|||
94681955|NCT02404389|324290887|FG004|Overall Study|Subject/guardian decision|1|||
94681956|NCT01036022|324290891|FG000|Overall Study|Adverse Event|1|||
94681957|NCT01036022|324290892|FG001|Overall Study|Adverse Event|3|||
94681958|NCT01036022|324290893|FG002|Overall Study|Adverse Event|2|||
94681959|NCT01036022|324290894|FG003|Overall Study|Adverse Event|1|||
94681960|NCT01036022|324290895|FG004|Overall Study|Adverse Event|0|||
94681961|NCT01036022|324290896|FG005|Overall Study|Adverse Event|2|||
94681962|NCT01036022|324290891|FG000|Overall Study|Lack of Efficacy|1|||
94681963|NCT01036022|324290892|FG001|Overall Study|Lack of Efficacy|1|||
94681964|NCT01036022|324290893|FG002|Overall Study|Lack of Efficacy|1|||
94681965|NCT01036022|324290894|FG003|Overall Study|Lack of Efficacy|0|||
94681966|NCT01036022|324290895|FG004|Overall Study|Lack of Efficacy|1|||
94681967|NCT01036022|324290896|FG005|Overall Study|Lack of Efficacy|1|||
94681968|NCT01036022|324290891|FG000|Overall Study|Physician Decision|0|||
94681969|NCT01036022|324290892|FG001|Overall Study|Physician Decision|0|||
94681970|NCT01036022|324290893|FG002|Overall Study|Physician Decision|1|||
94681971|NCT01036022|324290894|FG003|Overall Study|Physician Decision|0|||
94681972|NCT01036022|324290895|FG004|Overall Study|Physician Decision|0|||
94681973|NCT01036022|324290896|FG005|Overall Study|Physician Decision|0|||
94681974|NCT01036022|324290891|FG000|Overall Study|Withdrawal by Subject|0|||
94681975|NCT01036022|324290892|FG001|Overall Study|Withdrawal by Subject|0|||
94681976|NCT01036022|324290893|FG002|Overall Study|Withdrawal by Subject|0|||
94681977|NCT01036022|324290894|FG003|Overall Study|Withdrawal by Subject|1|||
94681978|NCT01036022|324290895|FG004|Overall Study|Withdrawal by Subject|2|||
94681979|NCT01036022|324290896|FG005|Overall Study|Withdrawal by Subject|0|||
94681980|NCT03324880|324290897|FG000|Overall Study|Adverse Event|0|||
94681981|NCT03324880|324290898|FG001|Overall Study|Adverse Event|2|||
94681982|NCT03324880|324290897|FG000|Overall Study|Withdrawal by Subject|2|||
94681983|NCT03324880|324290898|FG001|Overall Study|Withdrawal by Subject|2|||
94681984|NCT03324880|324290897|FG000|Overall Study|Lost to Follow-up|0|||
94681985|NCT03324880|324290898|FG001|Overall Study|Lost to Follow-up|1|||
94681986|NCT03324880|324290897|FG000|Overall Study|Product Recall|0|||
94681987|NCT03324880|324290898|FG001|Overall Study|Product Recall|1|||
94681988|NCT03300570|324290899|FG000|Overall Study|Adverse Event|0|||
94681989|NCT03300570|324290900|FG001|Overall Study|Adverse Event|1|||
94681990|NCT03300570|324290899|FG000|Overall Study|Withdrawal by Subject|1|||
94681991|NCT03300570|324290900|FG001|Overall Study|Withdrawal by Subject|0|||
94681992|NCT03300570|324290899|FG000|Overall Study|Inadequate bowel prep|1|||
94681993|NCT03300570|324290900|FG001|Overall Study|Inadequate bowel prep|0|||
94681994|NCT00405639|324290902|FG000|Overall Study|Withdrawal by Subject|1|||
94681995|NCT00405639|324290903|FG001|Overall Study|Withdrawal by Subject|0|||
94681996|NCT00405639|324290902|FG000|Overall Study|Adverse Event|1|||
94681997|NCT00405639|324290903|FG001|Overall Study|Adverse Event|0|||
94681998|NCT00405639|324290902|FG000|Overall Study|Seizure prior to receiving BNP|1|||
94681999|NCT00405639|324290903|FG001|Overall Study|Seizure prior to receiving BNP|0|||
94682000|NCT05096208|324290904|FG000|Overall Study|Lost to Follow-up|3|||
94682001|NCT05096208|324290905|FG001|Overall Study|Lost to Follow-up|5|||
94682002|NCT05096208|324290906|FG002|Overall Study|Lost to Follow-up|5|||
94682003|NCT05096208|324290907|FG003|Overall Study|Lost to Follow-up|2|||
94682004|NCT05096208|324290904|FG000|Overall Study|Withdrawal by Subject|0|||
94682005|NCT05096208|324290905|FG001|Overall Study|Withdrawal by Subject|1|||
94682006|NCT05096208|324290906|FG002|Overall Study|Withdrawal by Subject|2|||
94682007|NCT05096208|324290907|FG003|Overall Study|Withdrawal by Subject|3|||
94682008|NCT05096208|324290904|FG000|Overall Study|No longer met eligibility criteria|1|||
94682009|NCT05096208|324290905|FG001|Overall Study|No longer met eligibility criteria|0|||
94682010|NCT05096208|324290906|FG002|Overall Study|No longer met eligibility criteria|0|||
94682011|NCT05096208|324290907|FG003|Overall Study|No longer met eligibility criteria|0|||
94682012|NCT05096208|324290904|FG000|Overall Study|Other|0|||
94682013|NCT05096208|324290905|FG001|Overall Study|Other|0|||
94682014|NCT05096208|324290906|FG002|Overall Study|Other|1|||
94682015|NCT05096208|324290907|FG003|Overall Study|Other|0|||
94682016|NCT02087501|324290908|FG000|Overall Study|Death|7|||
94364019|NCT01915498|323116810|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
94646796|NCT03019627|324168899|FG000|Overall Study|Adverse Event|8|||
94646797|NCT03019627|324168900|FG001|Overall Study|Adverse Event|0|||
94646798|NCT03019627|324168899|FG000|Overall Study|Unrelated to adverse event|1|||
94646799|NCT03019627|324168900|FG001|Overall Study|Unrelated to adverse event|3|||
94646800|NCT03019627|324168899|FG000|Overall Study|Lost to Follow-up|2|||
94646801|NCT03019627|324168900|FG001|Overall Study|Lost to Follow-up|1|||
94646802|NCT03019627|324168899|FG000|Overall Study|not compliance|2|||
94646803|NCT03019627|324168900|FG001|Overall Study|not compliance|2|||
94646804|NCT03019627|324168899|FG000|Overall Study|Other|2|||
94646805|NCT03019627|324168900|FG001|Overall Study|Other|2|||
94646806|NCT03364049|324168901|FG000|Overall Study|Death|6|||
94646807|NCT03364049|324168902|FG001|Overall Study|Death|4|||
94646808|NCT03364049|324168903|FG002|Overall Study|Death|5|||
94646809|NCT03364049|324168904|FG003|Overall Study|Death|14|||
94646810|NCT03364049|324168901|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
94646811|NCT03364049|324168902|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
94646812|NCT03364049|324168903|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
94646813|NCT03364049|324168904|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
94646814|NCT03364049|324168901|FG000|Overall Study|Withdrawal by Subject|0|||
94646815|NCT03364049|324168902|FG001|Overall Study|Withdrawal by Subject|1|||
94646816|NCT03364049|324168903|FG002|Overall Study|Withdrawal by Subject|1|||
94646817|NCT03364049|324168904|FG003|Overall Study|Withdrawal by Subject|1|||
94646818|NCT00546715|324168905|FG000|Overall Study|Withdrawal by Subject|0|||
94646819|NCT00546715|324168906|FG001|Overall Study|Withdrawal by Subject|1|||
94646820|NCT00546715|324168907|FG002|Overall Study|Withdrawal by Subject|0|||
94646821|NCT00546715|324168908|FG003|Overall Study|Withdrawal by Subject|0|||
94646822|NCT00953329|324168909|FG000|Overall Study|Lack of Efficacy|1|||
94646823|NCT00519649|324168910|FG000|Overall Study|Withdrawal by Subject|1|||
94646824|NCT01610791|324168913|FG000|Overall Study|Lost to Follow-up|7|||
94646825|NCT01610791|324168913|FG000|Overall Study|Adverse Event|6|||
94646826|NCT01610791|324168913|FG000|Overall Study|Physician Decision|1|||
94646827|NCT01610791|324168913|FG000|Overall Study|Adverse event and Investigator decision|1|||
94646828|NCT01610791|324168913|FG000|Overall Study|Death|1|||
94646829|NCT01610791|324168913|FG000|Overall Study|Not determined|5|||
94646830|NCT02711800|324168914|FG000|Overall Study|Lost to Follow-up|1|||
94646831|NCT02711800|324168914|FG000|Overall Study|Withdrawal by Subject|1|||
94646832|NCT03064126|324168917|FG000|Overall Study|Death|40|||
94646833|NCT03064126|324168918|FG001|Overall Study|Death|16|||
94646834|NCT03064126|324168919|FG002|Overall Study|Death|4|||
94646835|NCT03064126|324168920|FG003|Overall Study|Death|2|||
94646836|NCT03064126|324168917|FG000|Overall Study|Withdrawal by Subject|17|||
94646837|NCT03064126|324168918|FG001|Overall Study|Withdrawal by Subject|9|||
94646838|NCT03064126|324168919|FG002|Overall Study|Withdrawal by Subject|0|||
94646839|NCT03064126|324168920|FG003|Overall Study|Withdrawal by Subject|2|||
94646840|NCT03064126|324168917|FG000|Overall Study|Lost to Follow-up|7|||
94646841|NCT03064126|324168918|FG001|Overall Study|Lost to Follow-up|3|||
94646842|NCT03064126|324168919|FG002|Overall Study|Lost to Follow-up|0|||
94646843|NCT03064126|324168920|FG003|Overall Study|Lost to Follow-up|0|||
94646844|NCT03064126|324168917|FG000|Overall Study|Adverse Event|2|||
94646845|NCT03064126|324168918|FG001|Overall Study|Adverse Event|0|||
94646846|NCT03064126|324168919|FG002|Overall Study|Adverse Event|0|||
94646847|NCT03064126|324168920|FG003|Overall Study|Adverse Event|0|||
94646848|NCT03064126|324168917|FG000|Overall Study|Physician Decision|3|||
94646849|NCT03064126|324168918|FG001|Overall Study|Physician Decision|0|||
94646850|NCT03064126|324168919|FG002|Overall Study|Physician Decision|0|||
94682017|NCT02087501|324290908|FG000|Overall Study|Open repair of aneurysm|1|||
94682018|NCT02087501|324290908|FG000|Overall Study|Lost to Follow-up|2|||
94646851|NCT03064126|324168920|FG003|Overall Study|Physician Decision|0|||
94646852|NCT03064126|324168917|FG000|Overall Study|Other reason for early termination|3|||
94646853|NCT03064126|324168918|FG001|Overall Study|Other reason for early termination|2|||
94646854|NCT03064126|324168919|FG002|Overall Study|Other reason for early termination|0|||
94646855|NCT03064126|324168920|FG003|Overall Study|Other reason for early termination|0|||
94646856|NCT03064126|324168917|FG000|Overall Study|Missed Visit|3|||
94646857|NCT03064126|324168918|FG001|Overall Study|Missed Visit|1|||
94682019|NCT00094328|324290910|FG000|Overall Study|Lost to Follow-up|1|||
94463478|NCT02520427|323485063|FG006|Overall Study|Death|0|||
94646858|NCT03064126|324168919|FG002|Overall Study|Missed Visit|0|||
94646859|NCT03064126|324168920|FG003|Overall Study|Missed Visit|0|||
94646860|NCT00578175|324168921|FG000|Overall Study|Adverse Event|0|||
94646861|NCT00578175|324168922|FG001|Overall Study|Adverse Event|1|||
94646862|NCT00578175|324168923|FG002|Overall Study|Adverse Event|1|||
94646863|NCT00578175|324168921|FG000|Overall Study|Other reasons|70|||
94646864|NCT00578175|324168922|FG001|Overall Study|Other reasons|42|||
94646865|NCT00578175|324168923|FG002|Overall Study|Other reasons|23|||
94646866|NCT01252290|324168924|FG000|Overall Study|Withdrawal by Subject|1|||
94682020|NCT00612534|324290911|FG000|Overall Study|Adverse Event|0|||
94682021|NCT00612534|324290912|FG001|Overall Study|Adverse Event|4|||
94682022|NCT00612534|324290913|FG002|Overall Study|Adverse Event|2|||
94682023|NCT00612534|324290914|FG003|Overall Study|Adverse Event|1|||
94682024|NCT00612534|324290911|FG000|Overall Study|Lack of Efficacy|13|||
94682025|NCT00612534|324290912|FG001|Overall Study|Lack of Efficacy|12|||
94682026|NCT00612534|324290913|FG002|Overall Study|Lack of Efficacy|5|||
94682027|NCT00612534|324290914|FG003|Overall Study|Lack of Efficacy|16|||
94682028|NCT00612534|324290911|FG000|Overall Study|Other Reason|0|||
94682029|NCT00612534|324290912|FG001|Overall Study|Other Reason|1|||
94682030|NCT00612534|324290913|FG002|Overall Study|Other Reason|0|||
94682031|NCT00612534|324290914|FG003|Overall Study|Other Reason|0|||
94682032|NCT04043962|324290915|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
94682033|NCT04043962|324290915|FG000|Post-Treatment|Withdrawal by Subject|5|||
94682034|NCT04043962|324290915|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
94682035|NCT04615182|324290916|FG000|Overall Study|Re-transplanted|2|||
94682036|NCT04615182|324290916|FG000|Overall Study|Protocol Violation|6|||
94682037|NCT04615182|324290916|FG000|Overall Study|Death|6|||
94682038|NCT04615182|324290916|FG000|Overall Study|Death and protocol violation|1|||
94682039|NCT01576718|324290917|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
94682040|NCT01576718|324290918|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
94682041|NCT01576718|324290919|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
94682042|NCT01576718|324290920|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
94682043|NCT01576718|324290921|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
94682044|NCT01576718|324290922|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
94682045|NCT01576718|324290923|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
94682046|NCT01576718|324290917|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
94682047|NCT01576718|324290918|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
94682048|NCT01576718|324290919|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
94682049|NCT01576718|324290920|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
94682050|NCT01576718|324290921|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
94682051|NCT01576718|324290922|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
94682052|NCT01576718|324290923|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
94682053|NCT01576718|324290917|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
94682054|NCT01576718|324290918|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
94682055|NCT01576718|324290919|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
94682056|NCT01576718|324290920|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
94682057|NCT01576718|324290921|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
94682058|NCT01576718|324290922|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
94682059|NCT01576718|324290923|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
94682060|NCT01576718|324290917|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
94682061|NCT01576718|324290918|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
94682062|NCT01576718|324290919|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
94682063|NCT01576718|324290920|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
94682064|NCT01576718|324290921|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
94682065|NCT01576718|324290922|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
94682066|NCT01576718|324290923|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
94682067|NCT01576718|324290917|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
94682068|NCT01576718|324290918|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
94682069|NCT01576718|324290919|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
94682070|NCT01576718|324290920|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
94682071|NCT01576718|324290921|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
94682072|NCT01576718|324290922|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
94682073|NCT01576718|324290923|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
94682074|NCT01576718|324290917|FG000|Treatment Period|Adverse Event|0|||
94682075|NCT01576718|324290918|FG001|Treatment Period|Adverse Event|1|||
94682076|NCT01576718|324290919|FG002|Treatment Period|Adverse Event|1|||
94682077|NCT01576718|324290920|FG003|Treatment Period|Adverse Event|1|||
94682078|NCT01576718|324290921|FG004|Treatment Period|Adverse Event|1|||
94682079|NCT01576718|324290922|FG005|Treatment Period|Adverse Event|1|||
94682080|NCT01576718|324290923|FG006|Treatment Period|Adverse Event|0|||
94682081|NCT01576718|324290917|FG000|Treatment Period|Withdrawal by Subject|0|||
94682082|NCT01576718|324290918|FG001|Treatment Period|Withdrawal by Subject|1|||
94682083|NCT01576718|324290919|FG002|Treatment Period|Withdrawal by Subject|1|||
94682084|NCT01576718|324290920|FG003|Treatment Period|Withdrawal by Subject|0|||
94682085|NCT01576718|324290921|FG004|Treatment Period|Withdrawal by Subject|2|||
94682086|NCT01576718|324290922|FG005|Treatment Period|Withdrawal by Subject|4|||
94682087|NCT01576718|324290923|FG006|Treatment Period|Withdrawal by Subject|2|||
94682088|NCT01576718|324290917|FG000|Treatment Period|Physician Decision|0|||
94682089|NCT01576718|324290918|FG001|Treatment Period|Physician Decision|1|||
94682090|NCT01576718|324290919|FG002|Treatment Period|Physician Decision|1|||
94682091|NCT01576718|324290920|FG003|Treatment Period|Physician Decision|1|||
94682092|NCT01576718|324290921|FG004|Treatment Period|Physician Decision|1|||
94682093|NCT01576718|324290922|FG005|Treatment Period|Physician Decision|0|||
94682094|NCT01576718|324290923|FG006|Treatment Period|Physician Decision|0|||
94682095|NCT01576718|324290917|FG000|Treatment Period|Protocol Violation|0|||
94682096|NCT01576718|324290918|FG001|Treatment Period|Protocol Violation|5|||
94682097|NCT01576718|324290919|FG002|Treatment Period|Protocol Violation|4|||
94682098|NCT01576718|324290920|FG003|Treatment Period|Protocol Violation|10|||
94682099|NCT01576718|324290921|FG004|Treatment Period|Protocol Violation|6|||
94682100|NCT01576718|324290922|FG005|Treatment Period|Protocol Violation|8|||
94682101|NCT01576718|324290923|FG006|Treatment Period|Protocol Violation|12|||
94682102|NCT01576718|324290917|FG000|Treatment Period|Sponsor request|0|||
94682103|NCT01576718|324290918|FG001|Treatment Period|Sponsor request|1|||
94682104|NCT01576718|324290919|FG002|Treatment Period|Sponsor request|0|||
94682105|NCT01576718|324290920|FG003|Treatment Period|Sponsor request|0|||
94682106|NCT01576718|324290921|FG004|Treatment Period|Sponsor request|0|||
94682107|NCT01576718|324290922|FG005|Treatment Period|Sponsor request|1|||
94682108|NCT01576718|324290923|FG006|Treatment Period|Sponsor request|0|||
94682109|NCT01576718|324290917|FG000|Treatment Period|Met stopping criteria|0|||
94682110|NCT01576718|324290918|FG001|Treatment Period|Met stopping criteria|16|||
94682111|NCT01576718|324290919|FG002|Treatment Period|Met stopping criteria|13|||
94682112|NCT01576718|324290920|FG003|Treatment Period|Met stopping criteria|19|||
94682113|NCT01576718|324290921|FG004|Treatment Period|Met stopping criteria|16|||
94682114|NCT01576718|324290922|FG005|Treatment Period|Met stopping criteria|33|||
94682115|NCT01576718|324290923|FG006|Treatment Period|Met stopping criteria|15|||
94682116|NCT01576718|324290917|FG000|Treatment Period|Lost to Follow-up|0|||
94682117|NCT01576718|324290918|FG001|Treatment Period|Lost to Follow-up|0|||
94682118|NCT01576718|324290919|FG002|Treatment Period|Lost to Follow-up|0|||
94682119|NCT01576718|324290920|FG003|Treatment Period|Lost to Follow-up|0|||
94682120|NCT01576718|324290921|FG004|Treatment Period|Lost to Follow-up|1|||
94682121|NCT01576718|324290922|FG005|Treatment Period|Lost to Follow-up|0|||
94682122|NCT01576718|324290923|FG006|Treatment Period|Lost to Follow-up|0|||
94682123|NCT01576718|324290917|FG000|Treatment Period|Noncompliance to study medication|0|||
94682124|NCT01576718|324290918|FG001|Treatment Period|Noncompliance to study medication|0|||
94682125|NCT01576718|324290919|FG002|Treatment Period|Noncompliance to study medication|0|||
94682126|NCT01576718|324290920|FG003|Treatment Period|Noncompliance to study medication|0|||
94682127|NCT01576718|324290921|FG004|Treatment Period|Noncompliance to study medication|0|||
94682128|NCT01576718|324290922|FG005|Treatment Period|Noncompliance to study medication|1|||
94682129|NCT01576718|324290923|FG006|Treatment Period|Noncompliance to study medication|1|||
94682130|NCT00856661|324290924|FG000|Overall Study|Death|15|||
94682131|NCT00856661|324290925|FG001|Overall Study|Death|18|||
94682132|NCT00856661|324290924|FG000|Overall Study|Protocol Violation|2|||
94682133|NCT00856661|324290925|FG001|Overall Study|Protocol Violation|1|||
94682134|NCT00856661|324290924|FG000|Overall Study|Withdrawal by Subject|1|||
94682135|NCT00856661|324290925|FG001|Overall Study|Withdrawal by Subject|2|||
94682136|NCT00856661|324290924|FG000|Overall Study|Lost to Follow-up|1|||
94682137|NCT00856661|324290925|FG001|Overall Study|Lost to Follow-up|3|||
94682138|NCT00856661|324290924|FG000|Overall Study|Physician Judgement|8|||
94682139|NCT00856661|324290925|FG001|Overall Study|Physician Judgement|5|||
94682140|NCT01279343|324290926|FG000|Overall Study|Did not receive treatment|2|||
94682141|NCT01279343|324290927|FG001|Overall Study|Did not receive treatment|6|||
94682142|NCT05067933|324290928|FG000|Overall Study|Withdrawal by Subject|2|||
94682143|NCT05067933|324290929|FG001|Overall Study|Withdrawal by Subject|0|||
94682144|NCT05067933|324290930|FG002|Overall Study|Withdrawal by Subject|0|||
94682145|NCT05067933|324290931|FG003|Overall Study|Withdrawal by Subject|0|||
94682146|NCT05067933|324290932|FG004|Overall Study|Withdrawal by Subject|0|||
94682147|NCT05067933|324290933|FG005|Overall Study|Withdrawal by Subject|0|||
94682148|NCT05067933|324290928|FG000|Overall Study|Lost to Follow-up|1|||
94682149|NCT05067933|324290929|FG001|Overall Study|Lost to Follow-up|1|||
94682150|NCT05067933|324290930|FG002|Overall Study|Lost to Follow-up|1|||
94682151|NCT05067933|324290931|FG003|Overall Study|Lost to Follow-up|2|||
94646867|NCT01800916|324168927|FG000|Test Period 1 (1 Week)|Convex product user|0|||
94646868|NCT01800916|324168928|FG001|Test Period 1 (1 Week)|Convex product user|0|||
94646869|NCT01800916|324168929|FG002|Test Period 1 (1 Week)|Convex product user|0|||
94646870|NCT01800916|324168930|FG003|Test Period 1 (1 Week)|Convex product user|1|||
94646871|NCT01800916|324168931|FG004|Test Period 1 (1 Week)|Convex product user|0|||
94646872|NCT01800916|324168932|FG005|Test Period 1 (1 Week)|Convex product user|0|||
94646873|NCT01800916|324168933|FG006|Test Period 1 (1 Week)|Convex product user|0|||
94646874|NCT01800916|324168934|FG007|Test Period 1 (1 Week)|Convex product user|0|||
94646875|NCT01800916|324168935|FG008|Test Period 1 (1 Week)|Convex product user|0|||
94646876|NCT01800916|324168927|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
94646877|NCT01800916|324168928|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
94646878|NCT01800916|324168929|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
94646879|NCT01800916|324168930|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
94646880|NCT01800916|324168931|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
94646881|NCT01800916|324168932|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
94646882|NCT01800916|324168933|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
94646883|NCT01800916|324168934|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
94646884|NCT01800916|324168935|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
94646885|NCT04370691|324168937|FG000|Overall Study|Pending visit|48|||
94646886|NCT04370691|324168937|FG000|Overall Study|Have Not Reached Lower Window|15|||
94646887|NCT04370691|324168937|FG000|Overall Study|Termination|14|||
94646888|NCT04370691|324168937|FG000|Overall Study|Missed or Overdue|10|||
94646889|NCT00099437|324168938|FG000|Overall Study|Lost to Follow-up|30|||
94646890|NCT00099437|324168939|FG001|Overall Study|Lost to Follow-up|33|||
94646891|NCT00099437|324168938|FG000|Overall Study|Death|293|||
94646892|NCT00099437|324168939|FG001|Overall Study|Death|261|||
94646893|NCT00099437|324168938|FG000|Overall Study|Withdrawal by Subject|6|||
94646894|NCT00099437|324168939|FG001|Overall Study|Withdrawal by Subject|10|||
94646895|NCT00099437|324168938|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
94646896|NCT00099437|324168939|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
94646897|NCT03047135|324168942|FG000|Overall Study|Still being treated|3|||
94646898|NCT01120210|324168943|FG000|MAIN INFUSION|Adverse Event|1|||
94646899|NCT01120210|324168944|FG001|MAIN INFUSION|Adverse Event|0|||
94646900|NCT01120210|324168943|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
94646901|NCT01120210|324168944|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
94646902|NCT04049760|324168949|FG000|Overall Study|Withdrawal by Subject|1|||
94646903|NCT02098109|324168952|FG000|Overall Study|Protocol Violation|3|||
94646904|NCT02098109|324168953|FG001|Overall Study|Protocol Violation|0|||
94646905|NCT00480779|324168954|FG000|Overall Study|Other|2|||
94646906|NCT00480779|324168955|FG001|Overall Study|Other|0|||
94646907|NCT00480779|324168954|FG000|Overall Study|Job and Health-related|0|||
94646908|NCT00480779|324168955|FG001|Overall Study|Job and Health-related|3|||
94646909|NCT01822132|324168956|FG000|Overall Study|Lost to Follow-up|4|||
94646910|NCT01822132|324168957|FG001|Overall Study|Lost to Follow-up|2|||
94646911|NCT01215227|324168958|FG000|Overall Study|Adverse Event|11|||
94646912|NCT01215227|324168959|FG001|Overall Study|Adverse Event|11|||
94646913|NCT01215227|324168960|FG002|Overall Study|Adverse Event|4|||
94646914|NCT01215227|324168961|FG003|Overall Study|Adverse Event|8|||
94646915|NCT01215227|324168962|FG004|Overall Study|Adverse Event|7|||
94646916|NCT01215227|324168963|FG005|Overall Study|Adverse Event|6|||
94646917|NCT01215227|324168958|FG000|Overall Study|Treatment Failure|8|||
94646918|NCT01215227|324168959|FG001|Overall Study|Treatment Failure|4|||
94646919|NCT01215227|324168960|FG002|Overall Study|Treatment Failure|1|||
94646920|NCT01215227|324168961|FG003|Overall Study|Treatment Failure|5|||
94646921|NCT01215227|324168962|FG004|Overall Study|Treatment Failure|1|||
94646922|NCT01215227|324168963|FG005|Overall Study|Treatment Failure|1|||
94646923|NCT01215227|324168958|FG000|Overall Study|Lost to Follow-up|1|||
94646924|NCT01215227|324168959|FG001|Overall Study|Lost to Follow-up|4|||
94646925|NCT01215227|324168960|FG002|Overall Study|Lost to Follow-up|1|||
94646926|NCT01215227|324168961|FG003|Overall Study|Lost to Follow-up|1|||
94646927|NCT01215227|324168962|FG004|Overall Study|Lost to Follow-up|1|||
94646928|NCT01215227|324168963|FG005|Overall Study|Lost to Follow-up|2|||
94646929|NCT01215227|324168958|FG000|Overall Study|Subject Withdrew Consent|16|||
94646930|NCT01215227|324168959|FG001|Overall Study|Subject Withdrew Consent|20|||
94646931|NCT01215227|324168960|FG002|Overall Study|Subject Withdrew Consent|7|||
94646932|NCT01215227|324168961|FG003|Overall Study|Subject Withdrew Consent|10|||
94646933|NCT01215227|324168962|FG004|Overall Study|Subject Withdrew Consent|11|||
94646934|NCT01215227|324168963|FG005|Overall Study|Subject Withdrew Consent|8|||
94646935|NCT01215227|324168958|FG000|Overall Study|Non-Compliance With Protocol|2|||
94646936|NCT01215227|324168959|FG001|Overall Study|Non-Compliance With Protocol|6|||
94646937|NCT01215227|324168960|FG002|Overall Study|Non-Compliance With Protocol|1|||
94646938|NCT01215227|324168961|FG003|Overall Study|Non-Compliance With Protocol|0|||
94646939|NCT01215227|324168962|FG004|Overall Study|Non-Compliance With Protocol|0|||
94646940|NCT01215227|324168963|FG005|Overall Study|Non-Compliance With Protocol|0|||
94646941|NCT01215227|324168958|FG000|Overall Study|Administrative|83|||
94646942|NCT01215227|324168959|FG001|Overall Study|Administrative|73|||
94646943|NCT01215227|324168960|FG002|Overall Study|Administrative|42|||
94646944|NCT01215227|324168961|FG003|Overall Study|Administrative|24|||
94646945|NCT01215227|324168962|FG004|Overall Study|Administrative|28|||
94646946|NCT01215227|324168963|FG005|Overall Study|Administrative|40|||
94646947|NCT01215227|324168958|FG000|Overall Study|Missing Status|0|||
94646948|NCT01215227|324168959|FG001|Overall Study|Missing Status|1|||
94646949|NCT01215227|324168960|FG002|Overall Study|Missing Status|0|||
94646950|NCT01215227|324168961|FG003|Overall Study|Missing Status|0|||
94646951|NCT01215227|324168962|FG004|Overall Study|Missing Status|0|||
94646952|NCT01215227|324168963|FG005|Overall Study|Missing Status|0|||
94646953|NCT01215227|324168958|FG000|Overall Study|Randomized but not treated|0|||
94646954|NCT01215227|324168959|FG001|Overall Study|Randomized but not treated|0|||
94646955|NCT01215227|324168960|FG002|Overall Study|Randomized but not treated|1|||
94646956|NCT01215227|324168961|FG003|Overall Study|Randomized but not treated|1|||
94646957|NCT01215227|324168962|FG004|Overall Study|Randomized but not treated|0|||
94646958|NCT01215227|324168963|FG005|Overall Study|Randomized but not treated|1|||
94646959|NCT01398956|324168964|FG000|Overall Study|Withdrawal by Subject|4|||
94646960|NCT01398956|324168964|FG000|Overall Study|AE, non-serious non-fatal|4|||
94646961|NCT01398956|324168964|FG000|Overall Study|Withdrawal Criteria No.3|1|||
94646962|NCT01398956|324168964|FG000|Overall Study|Subject moved a long distance|1|||
94646963|NCT01339390|324168965|FG000|Overall Study|Death|32|||
94646964|NCT01339390|324168966|FG001|Overall Study|Death|29|||
94646965|NCT01339390|324168965|FG000|Overall Study|Lost to Follow-up|125|||
94646966|NCT01339390|324168966|FG001|Overall Study|Lost to Follow-up|127|||
94646967|NCT04847674|324168967|FG000|Overall Study|Withdrawal by Subject|0|||
94646968|NCT04847674|324168968|FG001|Overall Study|Withdrawal by Subject|1|||
94646969|NCT04847674|324168969|FG002|Overall Study|Withdrawal by Subject|0|||
94646970|NCT04847674|324168967|FG000|Overall Study|Lost to Follow-up|0|||
94646971|NCT04847674|324168968|FG001|Overall Study|Lost to Follow-up|0|||
94646972|NCT04847674|324168969|FG002|Overall Study|Lost to Follow-up|2|||
94646973|NCT04847674|324168967|FG000|Overall Study|Other than specified|21|||
94646974|NCT04847674|324168968|FG001|Overall Study|Other than specified|20|||
94646975|NCT04847674|324168969|FG002|Overall Study|Other than specified|20|||
94646976|NCT01557400|324168970|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
94646977|NCT01557400|324168970|FG000|Overall Study|Adverse Event|3|||
94646978|NCT01557400|324168970|FG000|Overall Study|Lost to Follow-up|5|||
94646979|NCT01557400|324168970|FG000|Overall Study|Withdrawal by Subject|9|||
94646980|NCT02563028|324168971|FG000|Overall Study|Lack of equipment|1|||
94646981|NCT02563028|324168971|FG000|Overall Study|Unable to elicit VEP post induction|1|||
94646982|NCT00378703|324168972|FG000|Overall Study|Disease progression|59|||
94646983|NCT00378703|324168973|FG001|Overall Study|Disease progression|43|||
94646984|NCT00378703|324168974|FG002|Overall Study|Disease progression|48|||
94646985|NCT00378703|324168975|FG003|Overall Study|Disease progression|49|||
94646986|NCT00378703|324168972|FG000|Overall Study|Adverse Event|11|||
94646987|NCT00378703|324168973|FG001|Overall Study|Adverse Event|17|||
94646988|NCT00378703|324168974|FG002|Overall Study|Adverse Event|20|||
94646989|NCT00378703|324168975|FG003|Overall Study|Adverse Event|18|||
94646990|NCT00378703|324168972|FG000|Overall Study|Death|2|||
94646991|NCT00378703|324168973|FG001|Overall Study|Death|2|||
94646992|NCT00378703|324168974|FG002|Overall Study|Death|4|||
94646993|NCT00378703|324168975|FG003|Overall Study|Death|3|||
94646994|NCT00378703|324168972|FG000|Overall Study|Withdrawal by Subject|4|||
94646995|NCT00378703|324168973|FG001|Overall Study|Withdrawal by Subject|8|||
94646996|NCT00378703|324168974|FG002|Overall Study|Withdrawal by Subject|5|||
94646997|NCT00378703|324168975|FG003|Overall Study|Withdrawal by Subject|7|||
94646998|NCT00378703|324168972|FG000|Overall Study|Physician Decision|1|||
94646999|NCT00378703|324168973|FG001|Overall Study|Physician Decision|4|||
94647000|NCT00378703|324168974|FG002|Overall Study|Physician Decision|1|||
94647001|NCT00378703|324168975|FG003|Overall Study|Physician Decision|0|||
94647002|NCT00378703|324168972|FG000|Overall Study|Alternative therapy|4|||
94647003|NCT00378703|324168973|FG001|Overall Study|Alternative therapy|2|||
94647004|NCT00378703|324168974|FG002|Overall Study|Alternative therapy|0|||
94647005|NCT00378703|324168975|FG003|Overall Study|Alternative therapy|0|||
94647006|NCT00378703|324168972|FG000|Overall Study|Other complicated disease|0|||
94647007|NCT00378703|324168973|FG001|Overall Study|Other complicated disease|2|||
94647008|NCT00378703|324168974|FG002|Overall Study|Other complicated disease|2|||
94647009|NCT00378703|324168975|FG003|Overall Study|Other complicated disease|0|||
94647010|NCT00378703|324168972|FG000|Overall Study|Symptomatic deterioration|0|||
94647011|NCT00378703|324168973|FG001|Overall Study|Symptomatic deterioration|1|||
94647012|NCT00378703|324168974|FG002|Overall Study|Symptomatic deterioration|0|||
94647013|NCT00378703|324168975|FG003|Overall Study|Symptomatic deterioration|2|||
94647014|NCT00378703|324168972|FG000|Overall Study|Surgery|1|||
94647015|NCT00378703|324168973|FG001|Overall Study|Surgery|0|||
94647016|NCT00378703|324168974|FG002|Overall Study|Surgery|0|||
94647017|NCT00378703|324168975|FG003|Overall Study|Surgery|1|||
94647018|NCT00378703|324168972|FG000|Overall Study|Joint decision of physician and patient|1|||
94647019|NCT00378703|324168973|FG001|Overall Study|Joint decision of physician and patient|0|||
94647020|NCT00378703|324168974|FG002|Overall Study|Joint decision of physician and patient|0|||
94647021|NCT00378703|324168975|FG003|Overall Study|Joint decision of physician and patient|0|||
94647022|NCT00378703|324168972|FG000|Overall Study|Adverse events and progressive disease|0|||
94647023|NCT00378703|324168973|FG001|Overall Study|Adverse events and progressive disease|0|||
94647024|NCT00378703|324168974|FG002|Overall Study|Adverse events and progressive disease|0|||
94647025|NCT00378703|324168975|FG003|Overall Study|Adverse events and progressive disease|1|||
94647026|NCT00378703|324168972|FG000|Overall Study|Relocation|0|||
94647027|NCT00378703|324168973|FG001|Overall Study|Relocation|0|||
94647028|NCT00378703|324168974|FG002|Overall Study|Relocation|1|||
94647029|NCT00378703|324168975|FG003|Overall Study|Relocation|0|||
94647030|NCT00378703|324168972|FG000|Overall Study|Ineligible|4|||
94647031|NCT00378703|324168973|FG001|Overall Study|Ineligible|7|||
94647032|NCT00378703|324168974|FG002|Overall Study|Ineligible|7|||
94647033|NCT00378703|324168975|FG003|Overall Study|Ineligible|7|||
94647034|NCT00378703|324168972|FG000|Overall Study|Never started treatment|1|||
94647035|NCT00378703|324168973|FG001|Overall Study|Never started treatment|4|||
94647036|NCT00378703|324168974|FG002|Overall Study|Never started treatment|0|||
94647037|NCT00378703|324168975|FG003|Overall Study|Never started treatment|0|||
94647038|NCT00378703|324168972|FG000|Overall Study|Other|1|||
94647039|NCT00378703|324168973|FG001|Overall Study|Other|1|||
94647040|NCT00378703|324168974|FG002|Overall Study|Other|2|||
94647041|NCT00378703|324168975|FG003|Overall Study|Other|3|||
94647042|NCT05402995|324168978|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
94647043|NCT05402995|324168979|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
94647044|NCT05402995|324168980|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
94647045|NCT05402995|324168981|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
94647046|NCT02239536|324168986|FG000|Overall Study|Non-neoplastic polyp|23|||
94647047|NCT02239536|324168987|FG001|Overall Study|Non-neoplastic polyp|17|||
94647048|NCT01336738|324170442|FG000|Overall Study|Adverse Event|0|||
94647049|NCT01336738|324170443|FG001|Overall Study|Adverse Event|3|||
94647050|NCT01336738|324170444|FG002|Overall Study|Adverse Event|2|||
94647051|NCT01336738|324170445|FG003|Overall Study|Adverse Event|1|||
94647052|NCT01336738|324170446|FG004|Overall Study|Adverse Event|3|||
94647053|NCT01336738|324170442|FG000|Overall Study|Lost to Follow-up|2|||
94647054|NCT01336738|324170443|FG001|Overall Study|Lost to Follow-up|1|||
94647055|NCT01336738|324170444|FG002|Overall Study|Lost to Follow-up|2|||
94647056|NCT01336738|324170445|FG003|Overall Study|Lost to Follow-up|2|||
94647057|NCT01336738|324170446|FG004|Overall Study|Lost to Follow-up|2|||
94647058|NCT01336738|324170442|FG000|Overall Study|Did not meet entrance criteria|0|||
94647059|NCT01336738|324170443|FG001|Overall Study|Did not meet entrance criteria|1|||
94647060|NCT01336738|324170444|FG002|Overall Study|Did not meet entrance criteria|0|||
94682152|NCT05067933|324290932|FG004|Overall Study|Lost to Follow-up|1|||
94647061|NCT01336738|324170445|FG003|Overall Study|Did not meet entrance criteria|0|||
94647062|NCT01336738|324170446|FG004|Overall Study|Did not meet entrance criteria|0|||
94647063|NCT01336738|324170442|FG000|Overall Study|Protocol Violation|0|||
94647064|NCT01336738|324170443|FG001|Overall Study|Protocol Violation|1|||
94647065|NCT01336738|324170444|FG002|Overall Study|Protocol Violation|0|||
94647066|NCT01336738|324170445|FG003|Overall Study|Protocol Violation|0|||
94647067|NCT01336738|324170446|FG004|Overall Study|Protocol Violation|0|||
94647068|NCT01336738|324170442|FG000|Overall Study|Withdrawal by Subject|2|||
94647069|NCT01336738|324170443|FG001|Overall Study|Withdrawal by Subject|0|||
94647070|NCT01336738|324170444|FG002|Overall Study|Withdrawal by Subject|2|||
94647071|NCT01336738|324170445|FG003|Overall Study|Withdrawal by Subject|1|||
94647072|NCT01336738|324170446|FG004|Overall Study|Withdrawal by Subject|1|||
94647073|NCT01336738|324170442|FG000|Overall Study|Other|3|||
94647074|NCT01336738|324170443|FG001|Overall Study|Other|3|||
94647075|NCT01336738|324170444|FG002|Overall Study|Other|2|||
94647076|NCT01336738|324170445|FG003|Overall Study|Other|3|||
94647077|NCT01336738|324170446|FG004|Overall Study|Other|4|||
94647078|NCT01101841|324170447|FG000|Overall Study|Adverse Event|15|||
94647079|NCT01101841|324170448|FG001|Overall Study|Adverse Event|15|||
94647080|NCT01101841|324170447|FG000|Overall Study|Lost to Follow-up|9|||
94647081|NCT01101841|324170448|FG001|Overall Study|Lost to Follow-up|3|||
94647082|NCT01101841|324170447|FG000|Overall Study|Withdrawal by Subject|21|||
94647083|NCT01101841|324170448|FG001|Overall Study|Withdrawal by Subject|40|||
94647084|NCT01101841|324170447|FG000|Overall Study|Protocol Violation|1|||
94647085|NCT01101841|324170448|FG001|Overall Study|Protocol Violation|1|||
94647086|NCT01101841|324170447|FG000|Overall Study|Physician Decision|0|||
94647087|NCT01101841|324170448|FG001|Overall Study|Physician Decision|2|||
94647088|NCT01101841|324170447|FG000|Overall Study|Lack of Efficacy|0|||
94647089|NCT01101841|324170448|FG001|Overall Study|Lack of Efficacy|2|||
94647090|NCT01101841|324170447|FG000|Overall Study|Other|0|||
94647091|NCT01101841|324170448|FG001|Overall Study|Other|1|||
94647092|NCT01101841|324170447|FG000|Overall Study|Suicidality Tracking Scale|3|||
94647093|NCT01101841|324170448|FG001|Overall Study|Suicidality Tracking Scale|1|||
94647094|NCT01101841|324170447|FG000|Overall Study|Eligibility Criteria|1|||
94647095|NCT01101841|324170448|FG001|Overall Study|Eligibility Criteria|2|||
94647096|NCT01707004|324170451|FG000|Overall Study|Physician Decision|3|||
94647097|NCT01920932|324170452|FG000|Overall Study|Death|1|||
94647098|NCT01920932|324170452|FG000|Overall Study|Withdrawal of consent|1|||
94647099|NCT01896895|324170453|FG000|Double-blind MP|Physician Decision|0|||
94647100|NCT01896895|324170454|FG001|Double-blind MP|Physician Decision|0|||
94647101|NCT01896895|324170455|FG002|Double-blind MP|Physician Decision|1|||
94647102|NCT01896895|324170456|FG003|Double-blind MP|Physician Decision|0|||
94647103|NCT01896895|324170453|FG000|Double-blind MP|Withdrawal by Subject|0|||
94647104|NCT01896895|324170454|FG001|Double-blind MP|Withdrawal by Subject|2|||
94647105|NCT01896895|324170455|FG002|Double-blind MP|Withdrawal by Subject|1|||
94647106|NCT01896895|324170456|FG003|Double-blind MP|Withdrawal by Subject|0|||
94647107|NCT01896895|324170453|FG000|Double-blind MP|Lost to Follow-up|1|||
94647108|NCT01896895|324170454|FG001|Double-blind MP|Lost to Follow-up|0|||
94647109|NCT01896895|324170455|FG002|Double-blind MP|Lost to Follow-up|1|||
94647110|NCT01896895|324170456|FG003|Double-blind MP|Lost to Follow-up|0|||
94647111|NCT05168475|324170457|FG000|Period 1|Protocol Violation|1|||
94647112|NCT05168475|324170457|FG000|Period 1|IMP shortage|2|||
94647113|NCT05168475|324170457|FG000|Period 1|Not randomised|2|||
94647114|NCT05168475|324170457|FG000|Period 2|IMP shortage|1|||
94647115|NCT01140477|324170460|FG000|Overall Study|Lost to Follow-up|4|||
94647116|NCT01140477|324170461|FG001|Overall Study|Lost to Follow-up|0|||
94647117|NCT01140477|324170460|FG000|Overall Study|Withdrawal by Subject|1|||
94647118|NCT01140477|324170461|FG001|Overall Study|Withdrawal by Subject|4|||
94647119|NCT01140477|324170460|FG000|Overall Study|Surgical complication preventing implant|2|||
94647120|NCT01140477|324170461|FG001|Overall Study|Surgical complication preventing implant|0|||
94647121|NCT01140477|324170460|FG000|Overall Study|Death|1|||
94647122|NCT01140477|324170461|FG001|Overall Study|Death|1|||
94647123|NCT01140477|324170460|FG000|Overall Study|Subject explanted|0|||
94647124|NCT01140477|324170461|FG001|Overall Study|Subject explanted|1|||
94647125|NCT00749463|324170467|FG000|Overall Study|Adverse Event|0|||
94647126|NCT00749463|324170468|FG001|Overall Study|Adverse Event|4|||
94647127|NCT00749463|324170469|FG002|Overall Study|Adverse Event|1|||
94647128|NCT00749463|324170467|FG000|Overall Study|Withdrawal by Subject|1|||
94647129|NCT00749463|324170468|FG001|Overall Study|Withdrawal by Subject|0|||
94647130|NCT00749463|324170469|FG002|Overall Study|Withdrawal by Subject|0|||
94647131|NCT00701129|324170472|FG000|Overall Study|Death|2|||
94647132|NCT02953821|324170473|FG000|Overall Study|Adverse Event|0|||
94647133|NCT02953821|324170474|FG001|Overall Study|Adverse Event|4|||
94647134|NCT02953821|324170473|FG000|Overall Study|Death|1|||
94647135|NCT02953821|324170474|FG001|Overall Study|Death|0|||
94647136|NCT02953821|324170473|FG000|Overall Study|Progressive Disease|5|||
94263762|NCT01514136|322759923|FG007|Test Period 2; Test A*|Holiday|0|||
94463479|NCT02520427|323485064|FG007|Overall Study|Death|0|||
94682153|NCT05067933|324290933|FG005|Overall Study|Lost to Follow-up|0|||
94682154|NCT05067933|324290928|FG000|Overall Study|Miscellaneous|1|||
94682155|NCT05067933|324290929|FG001|Overall Study|Miscellaneous|0|||
94682156|NCT05067933|324290930|FG002|Overall Study|Miscellaneous|0|||
94682157|NCT05067933|324290931|FG003|Overall Study|Miscellaneous|0|||
94682158|NCT05067933|324290932|FG004|Overall Study|Miscellaneous|0|||
94682159|NCT05067933|324290933|FG005|Overall Study|Miscellaneous|0|||
94682160|NCT05067933|324290928|FG000|Overall Study|Death|0|||
94682161|NCT05067933|324290929|FG001|Overall Study|Death|0|||
94682162|NCT05067933|324290930|FG002|Overall Study|Death|0|||
94682163|NCT05067933|324290931|FG003|Overall Study|Death|1|||
94682164|NCT05067933|324290932|FG004|Overall Study|Death|0|||
94682165|NCT05067933|324290933|FG005|Overall Study|Death|0|||
94682166|NCT02234063|324290936|FG000|Overall Study|Lost to Follow-up|235|||
94682167|NCT02234063|324290937|FG001|Overall Study|Lost to Follow-up|42|||
94682168|NCT02234063|324290936|FG000|Overall Study|Withdrawal by Subject|20|||
94682169|NCT02234063|324290937|FG001|Overall Study|Withdrawal by Subject|1|||
94682170|NCT02669095|324290940|FG000|Overall Study|Adverse Event|1|||
94682171|NCT02669095|324290941|FG001|Overall Study|Adverse Event|0|||
94682172|NCT02669095|324290940|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
94682173|NCT02669095|324290941|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
94682174|NCT02669095|324290940|FG000|Overall Study|Torn Lens|0|||
94682175|NCT02669095|324290941|FG001|Overall Study|Torn Lens|1|||
94682176|NCT02669095|324290940|FG000|Overall Study|Visit 5 assessments not completed|0|||
94682177|NCT02669095|324290941|FG001|Overall Study|Visit 5 assessments not completed|1|||
94682178|NCT03075501|324292646|FG000|Overall Study|Scheduling difficulties|15|||
94682179|NCT03075501|324292647|FG001|Overall Study|Scheduling difficulties|9|||
94682180|NCT02714868|324292649|FG000|Overall Study|Withdrawal by Subject|3|||
94682181|NCT02714868|324292650|FG001|Overall Study|Withdrawal by Subject|0|||
94682182|NCT02714868|324292649|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
94682183|NCT02714868|324292650|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
94682184|NCT02714868|324292649|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
94682185|NCT02714868|324292650|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
94682186|NCT05648357|324292653|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
94682187|NCT02243202|324292654|FG000|Overall Study|Adverse Event|5|||
94682188|NCT02243202|324292655|FG001|Overall Study|Adverse Event|6|||
94682189|NCT02243202|324292656|FG002|Overall Study|Adverse Event|10|||
94682190|NCT02243202|324292657|FG003|Overall Study|Adverse Event|4|||
94682191|NCT02243202|324292654|FG000|Overall Study|Lost to Follow-up|9|||
94682192|NCT02243202|324292655|FG001|Overall Study|Lost to Follow-up|9|||
94682193|NCT02243202|324292656|FG002|Overall Study|Lost to Follow-up|14|||
94682194|NCT02243202|324292657|FG003|Overall Study|Lost to Follow-up|11|||
94682195|NCT02243202|324292654|FG000|Overall Study|Protocol Violation|3|||
94682196|NCT02243202|324292655|FG001|Overall Study|Protocol Violation|1|||
94682197|NCT02243202|324292656|FG002|Overall Study|Protocol Violation|2|||
94682198|NCT02243202|324292657|FG003|Overall Study|Protocol Violation|1|||
94682199|NCT02243202|324292654|FG000|Overall Study|Withdrawal by Subject|7|||
94682200|NCT02243202|324292655|FG001|Overall Study|Withdrawal by Subject|6|||
94682201|NCT02243202|324292656|FG002|Overall Study|Withdrawal by Subject|4|||
94682202|NCT02243202|324292657|FG003|Overall Study|Withdrawal by Subject|4|||
94682203|NCT02243202|324292654|FG000|Overall Study|Other|1|||
94682204|NCT02243202|324292655|FG001|Overall Study|Other|3|||
94682205|NCT02243202|324292656|FG002|Overall Study|Other|1|||
94682206|NCT02243202|324292657|FG003|Overall Study|Other|2|||
94682207|NCT02243202|324292654|FG000|Overall Study|Randomized but not received treatment|0|||
94682208|NCT02243202|324292655|FG001|Overall Study|Randomized but not received treatment|0|||
94682209|NCT02243202|324292656|FG002|Overall Study|Randomized but not received treatment|0|||
94682210|NCT02243202|324292657|FG003|Overall Study|Randomized but not received treatment|1|||
94682211|NCT03585296|324292658|FG000|Overall Study|Adverse Event|1|||
94682212|NCT03585296|324292658|FG000|Overall Study|Lost to Follow-up|2|||
94682213|NCT03585296|324292658|FG000|Overall Study|Withdrawal by Subject|2|||
94682214|NCT00539643|324292661|FG000|Overall Study|Adverse Event|1|||
94682215|NCT00539643|324292662|FG001|Overall Study|Adverse Event|0|||
94682216|NCT00539643|324292661|FG000|Overall Study|Death|2|||
94682217|NCT00539643|324292662|FG001|Overall Study|Death|1|||
94682218|NCT00539643|324292661|FG000|Overall Study|Physician Decision|3|||
94682219|NCT00539643|324292662|FG001|Overall Study|Physician Decision|1|||
94682220|NCT00539643|324292661|FG000|Overall Study|Withdrawal by Subject|0|||
94682221|NCT00539643|324292662|FG001|Overall Study|Withdrawal by Subject|1|||
94682222|NCT01572389|324292663|FG000|Overall Study|Death|1|||
94682223|NCT01572389|324292664|FG001|Overall Study|Death|3|||
94682224|NCT01572389|324292663|FG000|Overall Study|Withdrawal by Subject|14|||
94263763|NCT01514136|322759916|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
94682225|NCT01572389|324292664|FG001|Overall Study|Withdrawal by Subject|2|||
94682226|NCT01572389|324292663|FG000|Overall Study|Lost to Follow-up|25|||
94682227|NCT01572389|324292664|FG001|Overall Study|Lost to Follow-up|14|||
94682228|NCT01572389|324292663|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
94682229|NCT01572389|324292664|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
94682230|NCT01641926|324292665|FG000|Overall Study|Adverse Event|5|||
94682231|NCT01641926|324292666|FG001|Overall Study|Adverse Event|2|||
94682232|NCT01641926|324292667|FG002|Overall Study|Adverse Event|3|||
94682233|NCT01641926|324292668|FG003|Overall Study|Adverse Event|1|||
94682234|NCT01641926|324292665|FG000|Overall Study|Lost to Follow-up|2|||
94682235|NCT01641926|324292666|FG001|Overall Study|Lost to Follow-up|2|||
94682236|NCT01641926|324292667|FG002|Overall Study|Lost to Follow-up|1|||
94682237|NCT01641926|324292668|FG003|Overall Study|Lost to Follow-up|0|||
94682238|NCT01641926|324292665|FG000|Overall Study|Physician Decision|6|||
94682239|NCT01641926|324292666|FG001|Overall Study|Physician Decision|5|||
94682240|NCT01641926|324292667|FG002|Overall Study|Physician Decision|0|||
94682241|NCT01641926|324292668|FG003|Overall Study|Physician Decision|1|||
94682242|NCT01641926|324292665|FG000|Overall Study|Protocol Violation|1|||
94682243|NCT01641926|324292666|FG001|Overall Study|Protocol Violation|0|||
94682244|NCT01641926|324292667|FG002|Overall Study|Protocol Violation|0|||
94682245|NCT01641926|324292668|FG003|Overall Study|Protocol Violation|1|||
94682246|NCT01641926|324292665|FG000|Overall Study|Withdrawal by Subject|13|||
94682247|NCT01641926|324292666|FG001|Overall Study|Withdrawal by Subject|5|||
94682248|NCT01641926|324292667|FG002|Overall Study|Withdrawal by Subject|6|||
94682249|NCT01641926|324292668|FG003|Overall Study|Withdrawal by Subject|1|||
94682250|NCT01641926|324292665|FG000|Overall Study|Not Treated|1|||
94682251|NCT01641926|324292666|FG001|Overall Study|Not Treated|1|||
94682252|NCT01641926|324292667|FG002|Overall Study|Not Treated|1|||
94682253|NCT01641926|324292668|FG003|Overall Study|Not Treated|0|||
94682254|NCT03673462|324292669|FG000|Overall Study|Adverse Event|11|||
94682255|NCT03673462|324292670|FG001|Overall Study|Adverse Event|1|||
94682256|NCT03673462|324292669|FG000|Overall Study|Protocol Violation|25|||
94682257|NCT03673462|324292670|FG001|Overall Study|Protocol Violation|11|||
94682258|NCT03673462|324292669|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
94682259|NCT03673462|324292670|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
94682260|NCT03673462|324292669|FG000|Overall Study|Lost to Follow-up|102|||
94682261|NCT03673462|324292670|FG001|Overall Study|Lost to Follow-up|19|||
94682262|NCT02567825|324292673|FG000|Overall Study|No follow-up post-randomization|5|||
94682263|NCT02567825|324292674|FG001|Overall Study|No follow-up post-randomization|1|||
94682264|NCT02567825|324292673|FG000|Overall Study|Follow-up less than 23 months|16|||
94682265|NCT02567825|324292674|FG001|Overall Study|Follow-up less than 23 months|20|||
94682266|NCT03541044|324292680|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
94682267|NCT03541044|324292681|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
94682268|NCT03541044|324292680|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
94682269|NCT03541044|324292681|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
94682270|NCT01153269|324292682|FG000|Overall Study|Withdrawal by Subject|1|||
94682271|NCT01153269|324292682|FG000|Overall Study|Antiretroviral therapy break|1|||
94682272|NCT04146896|324292684|FG000|Overall Study|Adverse Event|5|||
94682273|NCT04146896|324292685|FG001|Overall Study|Adverse Event|8|||
94682274|NCT04146896|324292684|FG000|Overall Study|Lack of Efficacy|3|||
94682275|NCT04146896|324292685|FG001|Overall Study|Lack of Efficacy|2|||
94682276|NCT04146896|324292684|FG000|Overall Study|Lost to Follow-up|0|||
94682277|NCT04146896|324292685|FG001|Overall Study|Lost to Follow-up|1|||
94682278|NCT04146896|324292684|FG000|Overall Study|Non-compliance|5|||
94682279|NCT04146896|324292685|FG001|Overall Study|Non-compliance|4|||
94682280|NCT04146896|324292684|FG000|Overall Study|Withdrawal by Subject|3|||
94682281|NCT04146896|324292685|FG001|Overall Study|Withdrawal by Subject|5|||
94682282|NCT04146896|324292684|FG000|Overall Study|Randomized in error|1|||
94682283|NCT04146896|324292685|FG001|Overall Study|Randomized in error|2|||
94682284|NCT02118337|324292686|FG000|Overall Study|Other|1|||
94682285|NCT02118337|324292687|FG001|Overall Study|Other|0|||
94682286|NCT02118337|324292688|FG002|Overall Study|Other|0|||
94682287|NCT02118337|324292689|FG003|Overall Study|Other|0|||
94682288|NCT02118337|324292690|FG004|Overall Study|Other|2|||
94682289|NCT02118337|324292691|FG005|Overall Study|Other|3|||
94682290|NCT02118337|324292692|FG006|Overall Study|Other|1|||
94682291|NCT02118337|324292693|FG007|Overall Study|Other|28|||
94682292|NCT02118337|324292694|FG008|Overall Study|Other|15|||
94682293|NCT02118337|324292686|FG000|Overall Study|Lost to Follow-up|0|||
94682294|NCT02118337|324292687|FG001|Overall Study|Lost to Follow-up|0|||
94682295|NCT02118337|324292688|FG002|Overall Study|Lost to Follow-up|0|||
94682296|NCT02118337|324292689|FG003|Overall Study|Lost to Follow-up|0|||
94682297|NCT02118337|324292690|FG004|Overall Study|Lost to Follow-up|0|||
94682298|NCT02118337|324292691|FG005|Overall Study|Lost to Follow-up|0|||
94682299|NCT02118337|324292692|FG006|Overall Study|Lost to Follow-up|0|||
94682300|NCT02118337|324292693|FG007|Overall Study|Lost to Follow-up|1|||
94682301|NCT02118337|324292694|FG008|Overall Study|Lost to Follow-up|0|||
94364020|NCT01915498|323116811|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
94682302|NCT02118337|324292686|FG000|Overall Study|Withdrawal by Subject|1|||
94682303|NCT02118337|324292687|FG001|Overall Study|Withdrawal by Subject|3|||
94682304|NCT02118337|324292688|FG002|Overall Study|Withdrawal by Subject|2|||
94682305|NCT02118337|324292689|FG003|Overall Study|Withdrawal by Subject|1|||
94682306|NCT02118337|324292690|FG004|Overall Study|Withdrawal by Subject|2|||
94647137|NCT02953821|324170474|FG001|Overall Study|Progressive Disease|1|||
94647138|NCT02953821|324170473|FG000|Overall Study|Lost to Follow-up|2|||
94647139|NCT02953821|324170474|FG001|Overall Study|Lost to Follow-up|0|||
94647140|NCT02953821|324170473|FG000|Overall Study|Physician Decision|1|||
94647141|NCT02953821|324170474|FG001|Overall Study|Physician Decision|1|||
94647142|NCT02953821|324170473|FG000|Overall Study|Withdrawal by Subject|3|||
94647143|NCT02953821|324170474|FG001|Overall Study|Withdrawal by Subject|3|||
94647144|NCT02953821|324170473|FG000|Overall Study|Change of address|0|||
94647145|NCT02953821|324170474|FG001|Overall Study|Change of address|1|||
94647146|NCT02953821|324170473|FG000|Overall Study|Lack of Efficacy|1|||
94647147|NCT02953821|324170474|FG001|Overall Study|Lack of Efficacy|0|||
94647148|NCT02953821|324170473|FG000|Overall Study|Out of state for indeterminate time|0|||
94647149|NCT02953821|324170474|FG001|Overall Study|Out of state for indeterminate time|1|||
94647150|NCT02953821|324170473|FG000|Overall Study|No improvement|0|||
94647151|NCT02953821|324170474|FG001|Overall Study|No improvement|1|||
94647152|NCT02953821|324170473|FG000|Overall Study|Refused follow-up visit|2|||
94647153|NCT02953821|324170474|FG001|Overall Study|Refused follow-up visit|1|||
94647154|NCT01096784|324170476|FG000|Overall Study|Withdrawal by Subject|2|||
94647155|NCT01096784|324170477|FG001|Overall Study|Withdrawal by Subject|1|||
94647156|NCT01096784|324170476|FG000|Overall Study|Adverse Event|11|||
94647157|NCT01096784|324170477|FG001|Overall Study|Adverse Event|9|||
94647158|NCT01096784|324170476|FG000|Overall Study|Protocol Deviation|2|||
94647159|NCT01096784|324170477|FG001|Overall Study|Protocol Deviation|2|||
94647160|NCT01096784|324170476|FG000|Overall Study|Administrative Decision|0|||
94647161|NCT01096784|324170477|FG001|Overall Study|Administrative Decision|1|||
94647162|NCT01096784|324170476|FG000|Overall Study|Other Unspecified|0|||
94647163|NCT01096784|324170477|FG001|Overall Study|Other Unspecified|1|||
94647164|NCT00826267|324170478|FG000|Overall Study|Other Adverse Event|1|||
94647165|NCT00826267|324170479|FG001|Overall Study|Other Adverse Event|0|||
94647166|NCT00826267|324170480|FG002|Overall Study|Other Adverse Event|0|||
94647167|NCT05923229|324170484|FG000|Overall Study|Withdrawal by Subject|3|||
94647168|NCT05923229|324170485|FG001|Overall Study|Withdrawal by Subject|0|||
94647169|NCT05923229|324170484|FG000|Overall Study|Health related|2|||
94647170|NCT05923229|324170485|FG001|Overall Study|Health related|1|||
94647171|NCT04903288|324170486|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
94647172|NCT04903288|324170486|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
94647173|NCT04903288|324170486|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
94647174|NCT04903288|324170486|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
94647175|NCT02465528|324170489|FG000|Overall Study|Progressive disease|0|||
94647176|NCT02465528|324170490|FG001|Overall Study|Progressive disease|2|||
94647177|NCT02465528|324170491|FG002|Overall Study|Progressive disease|9|||
94682307|NCT02118337|324292691|FG005|Overall Study|Withdrawal by Subject|2|||
94682308|NCT02118337|324292692|FG006|Overall Study|Withdrawal by Subject|1|||
94682309|NCT02118337|324292693|FG007|Overall Study|Withdrawal by Subject|4|||
94682310|NCT02118337|324292694|FG008|Overall Study|Withdrawal by Subject|2|||
94682311|NCT02118337|324292686|FG000|Overall Study|Death|2|||
94682312|NCT02118337|324292687|FG001|Overall Study|Death|2|||
94682313|NCT02118337|324292688|FG002|Overall Study|Death|1|||
94682314|NCT02118337|324292689|FG003|Overall Study|Death|2|||
94682315|NCT02118337|324292690|FG004|Overall Study|Death|5|||
94682316|NCT02118337|324292691|FG005|Overall Study|Death|1|||
94682317|NCT02118337|324292692|FG006|Overall Study|Death|2|||
94682318|NCT02118337|324292693|FG007|Overall Study|Death|9|||
94682319|NCT02118337|324292694|FG008|Overall Study|Death|4|||
94682320|NCT03787680|324292695|FG000|Overall Study|Physician Decision|2|||
94682321|NCT03787680|324292696|FG001|Overall Study|Physician Decision|3|||
94682322|NCT03787680|324292695|FG000|Overall Study|Adverse Event|7|||
94682323|NCT03787680|324292696|FG001|Overall Study|Adverse Event|3|||
94682324|NCT03787680|324292695|FG000|Overall Study|Withdrawal by Subject|2|||
94682325|NCT03787680|324292696|FG001|Overall Study|Withdrawal by Subject|1|||
94682326|NCT05400746|324292697|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
94682327|NCT05400746|324292698|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
94682328|NCT05400746|324292699|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
94682329|NCT05454410|324292702|FG000|Overall Study|Withdrawal by Subject|0|||
94647178|NCT02465528|324170492|FG003|Overall Study|Progressive disease|4|||
94647179|NCT02465528|324170489|FG000|Overall Study|Study terminated by sponsor|1|||
94682330|NCT05454410|324292703|FG001|Overall Study|Withdrawal by Subject|0|||
94682331|NCT05454410|324292704|FG002|Overall Study|Withdrawal by Subject|1|||
94682332|NCT05454410|324292705|FG003|Overall Study|Withdrawal by Subject|1|||
94647180|NCT02465528|324170490|FG001|Overall Study|Study terminated by sponsor|2|||
94647181|NCT02465528|324170491|FG002|Overall Study|Study terminated by sponsor|0|||
94647182|NCT02465528|324170492|FG003|Overall Study|Study terminated by sponsor|0|||
94647183|NCT02465528|324170489|FG000|Overall Study|Withdrawal by Subject|0|||
94647184|NCT02465528|324170490|FG001|Overall Study|Withdrawal by Subject|0|||
94647185|NCT02465528|324170491|FG002|Overall Study|Withdrawal by Subject|2|||
94647186|NCT02465528|324170492|FG003|Overall Study|Withdrawal by Subject|0|||
94647187|NCT02465528|324170489|FG000|Overall Study|Adverse Event|0|||
94682333|NCT00576732|324292707|FG000|DOUBLE BLIND|Adverse Event|0|||
94682334|NCT00576732|324292708|FG001|DOUBLE BLIND|Adverse Event|0|||
94682335|NCT00576732|324292709|FG002|DOUBLE BLIND|Adverse Event|1|||
94682336|NCT00576732|324292710|FG003|DOUBLE BLIND|Adverse Event|0|||
94682337|NCT00576732|324292711|FG004|DOUBLE BLIND|Adverse Event|0|||
94682338|NCT00576732|324292712|FG005|DOUBLE BLIND|Adverse Event|0|||
94682339|NCT00576732|324292707|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
94682340|NCT00576732|324292708|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
94682341|NCT00576732|324292709|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
94682342|NCT00576732|324292710|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
94682343|NCT00576732|324292711|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
94682344|NCT00576732|324292712|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
94682345|NCT00576732|324292707|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
94682346|NCT00576732|324292708|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
94682347|NCT00576732|324292709|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
94682348|NCT00576732|324292710|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
94682349|NCT00576732|324292711|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
94682350|NCT00576732|324292712|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
94682351|NCT00576732|324292707|FG000|DOUBLE BLIND|OTHER|0|||
94682352|NCT00576732|324292708|FG001|DOUBLE BLIND|OTHER|2|||
94682353|NCT00576732|324292709|FG002|DOUBLE BLIND|OTHER|1|||
94682354|NCT00576732|324292710|FG003|DOUBLE BLIND|OTHER|0|||
94682355|NCT00576732|324292711|FG004|DOUBLE BLIND|OTHER|0|||
94682356|NCT00576732|324292712|FG005|DOUBLE BLIND|OTHER|0|||
94682357|NCT00576732|324292707|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
94682358|NCT00576732|324292708|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
94682359|NCT00576732|324292709|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
94682360|NCT00576732|324292710|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
94682361|NCT00576732|324292711|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
94682362|NCT00576732|324292712|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
94682363|NCT00576732|324292707|FG000|DOUBLE BLIND|Protocol Violation|1|||
94682364|NCT00576732|324292708|FG001|DOUBLE BLIND|Protocol Violation|0|||
94682365|NCT00576732|324292709|FG002|DOUBLE BLIND|Protocol Violation|0|||
94682366|NCT00576732|324292710|FG003|DOUBLE BLIND|Protocol Violation|0|||
94682367|NCT00576732|324292711|FG004|DOUBLE BLIND|Protocol Violation|0|||
94682368|NCT00576732|324292712|FG005|DOUBLE BLIND|Protocol Violation|0|||
94682369|NCT00576732|324292707|FG000|OPEN LABEL|Adverse Event|0|||
94682370|NCT00576732|324292708|FG001|OPEN LABEL|Adverse Event|0|||
94682371|NCT00576732|324292709|FG002|OPEN LABEL|Adverse Event|0|||
94682372|NCT00576732|324292710|FG003|OPEN LABEL|Adverse Event|4|||
94682373|NCT00576732|324292711|FG004|OPEN LABEL|Adverse Event|0|||
94682374|NCT00576732|324292712|FG005|OPEN LABEL|Adverse Event|1|||
94682375|NCT00576732|324292707|FG000|OPEN LABEL|Lost to Follow-up|0|||
94682376|NCT00576732|324292708|FG001|OPEN LABEL|Lost to Follow-up|0|||
94682377|NCT00576732|324292709|FG002|OPEN LABEL|Lost to Follow-up|0|||
94682378|NCT00576732|324292710|FG003|OPEN LABEL|Lost to Follow-up|2|||
94682379|NCT00576732|324292711|FG004|OPEN LABEL|Lost to Follow-up|1|||
94682380|NCT00576732|324292712|FG005|OPEN LABEL|Lost to Follow-up|1|||
94682381|NCT00576732|324292707|FG000|OPEN LABEL|Withdrawal by Subject|0|||
94682382|NCT00576732|324292708|FG001|OPEN LABEL|Withdrawal by Subject|0|||
94682383|NCT00576732|324292709|FG002|OPEN LABEL|Withdrawal by Subject|0|||
94682384|NCT00576732|324292710|FG003|OPEN LABEL|Withdrawal by Subject|1|||
94682385|NCT00576732|324292711|FG004|OPEN LABEL|Withdrawal by Subject|0|||
94682386|NCT00576732|324292712|FG005|OPEN LABEL|Withdrawal by Subject|1|||
94682387|NCT00576732|324292707|FG000|OPEN LABEL|OTHER|0|||
94682388|NCT00576732|324292708|FG001|OPEN LABEL|OTHER|0|||
94682389|NCT00576732|324292709|FG002|OPEN LABEL|OTHER|0|||
94682390|NCT00576732|324292710|FG003|OPEN LABEL|OTHER|0|||
94682391|NCT00576732|324292711|FG004|OPEN LABEL|OTHER|0|||
94682392|NCT00576732|324292712|FG005|OPEN LABEL|OTHER|2|||
94682393|NCT00576732|324292707|FG000|OPEN LABEL|Lack of Efficacy|0|||
94682394|NCT00576732|324292708|FG001|OPEN LABEL|Lack of Efficacy|0|||
94682395|NCT00576732|324292709|FG002|OPEN LABEL|Lack of Efficacy|0|||
94682396|NCT00576732|324292710|FG003|OPEN LABEL|Lack of Efficacy|2|||
94682397|NCT00576732|324292711|FG004|OPEN LABEL|Lack of Efficacy|2|||
94682398|NCT00576732|324292712|FG005|OPEN LABEL|Lack of Efficacy|3|||
94682399|NCT00576732|324292707|FG000|OPEN LABEL|Protocol Violation|0|||
94682400|NCT00576732|324292708|FG001|OPEN LABEL|Protocol Violation|0|||
94682401|NCT00576732|324292709|FG002|OPEN LABEL|Protocol Violation|0|||
94682402|NCT00576732|324292710|FG003|OPEN LABEL|Protocol Violation|2|||
94682403|NCT00576732|324292711|FG004|OPEN LABEL|Protocol Violation|1|||
94682404|NCT00576732|324292712|FG005|OPEN LABEL|Protocol Violation|0|||
94682405|NCT01547299|324292717|FG000|Overall Study|Withdrawal by Subject|2|||
94682406|NCT01547299|324292718|FG001|Overall Study|Withdrawal by Subject|2|||
94682407|NCT03108157|324292725|FG000|Overall Study|Protocol Violation|15|||
94682408|NCT03108157|324292726|FG001|Overall Study|Protocol Violation|4|||
94682409|NCT02613221|324292727|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
94682410|NCT02613221|324292727|FG000|Overall Study|Adverse Event|2|||
94682411|NCT02613221|324292727|FG000|Overall Study|Voluntary Discontinuation|1|||
94682412|NCT02613221|324292727|FG000|Overall Study|Delayed Treatment|1|||
94682413|NCT02613221|324292727|FG000|Overall Study|Enrolled but Not Treated|1|||
94682414|NCT01657266|324292738|FG000|Overall Study|Lost to Follow-up|2|||
94682415|NCT01657266|324292739|FG001|Overall Study|Lost to Follow-up|2|||
94682416|NCT01657266|324292738|FG000|Overall Study|Adverse Event|2|||
94682417|NCT01657266|324292739|FG001|Overall Study|Adverse Event|3|||
94682418|NCT01806584|324292745|FG000|Overall Study|Adverse Event|2|||
94682419|NCT01806584|324292746|FG001|Overall Study|Adverse Event|1|||
94682420|NCT01806584|324292745|FG000|Overall Study|Death|1|||
94682421|NCT01806584|324292746|FG001|Overall Study|Death|0|||
94682422|NCT01806584|324292745|FG000|Overall Study|Lost to Follow-up|0|||
94682423|NCT01806584|324292746|FG001|Overall Study|Lost to Follow-up|2|||
94682424|NCT01806584|324292745|FG000|Overall Study|Study terminated by sponsor|9|||
94682425|NCT01806584|324292746|FG001|Overall Study|Study terminated by sponsor|14|||
94682426|NCT01806584|324292745|FG000|Overall Study|Withdrawal by Subject|1|||
94682427|NCT01806584|324292746|FG001|Overall Study|Withdrawal by Subject|1|||
94682428|NCT01806584|324292745|FG000|Overall Study|Other unspecified|1|||
94682429|NCT01806584|324292746|FG001|Overall Study|Other unspecified|0|||
94682430|NCT03021668|324292747|FG000|Overall Study|Physician Decision|0|||
94682431|NCT03021668|324292748|FG001|Overall Study|Physician Decision|1|||
94682432|NCT00457639|324292749|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
94682433|NCT00457639|324292750|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
94682434|NCT00457639|324292749|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
94682435|NCT00457639|324292750|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
94682436|NCT00457639|324292749|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
94682437|NCT00457639|324292750|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
94682438|NCT02569710|324292757|FG000|Overall Study|Adverse Event|1|||
94682439|NCT02569710|324292758|FG001|Overall Study|Adverse Event|0|||
94682440|NCT02569710|324292759|FG002|Overall Study|Adverse Event|0|||
94682441|NCT02569710|324292760|FG003|Overall Study|Adverse Event|0|||
94682442|NCT02569710|324292761|FG004|Overall Study|Adverse Event|0|||
94682443|NCT02569710|324292762|FG005|Overall Study|Adverse Event|0|||
94682444|NCT02569710|324292763|FG006|Overall Study|Adverse Event|0|||
94682445|NCT02569710|324292764|FG007|Overall Study|Adverse Event|0|||
94682446|NCT02569710|324292765|FG008|Overall Study|Adverse Event|0|||
94682447|NCT02569710|324292766|FG009|Overall Study|Adverse Event|0|||
94682448|NCT02569710|324292757|FG000|Overall Study|Lost to Follow-up|0|||
94682449|NCT02569710|324292758|FG001|Overall Study|Lost to Follow-up|0|||
94682450|NCT02569710|324292759|FG002|Overall Study|Lost to Follow-up|0|||
94682451|NCT02569710|324292760|FG003|Overall Study|Lost to Follow-up|0|||
94682452|NCT02569710|324292761|FG004|Overall Study|Lost to Follow-up|0|||
94682453|NCT02569710|324292762|FG005|Overall Study|Lost to Follow-up|0|||
94682454|NCT02569710|324292763|FG006|Overall Study|Lost to Follow-up|1|||
94682455|NCT02569710|324292764|FG007|Overall Study|Lost to Follow-up|0|||
94682456|NCT02569710|324292765|FG008|Overall Study|Lost to Follow-up|1|||
94682457|NCT02569710|324292766|FG009|Overall Study|Lost to Follow-up|0|||
94682458|NCT02569710|324292757|FG000|Overall Study|Virologic failure|0|||
94682459|NCT02569710|324292758|FG001|Overall Study|Virologic failure|0|||
94682460|NCT02569710|324292759|FG002|Overall Study|Virologic failure|0|||
94682461|NCT02569710|324292760|FG003|Overall Study|Virologic failure|0|||
94682462|NCT02569710|324292761|FG004|Overall Study|Virologic failure|1|||
94263764|NCT01514136|322759917|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
94682463|NCT02569710|324292762|FG005|Overall Study|Virologic failure|0|||
94682464|NCT02569710|324292763|FG006|Overall Study|Virologic failure|1|||
94682465|NCT02569710|324292764|FG007|Overall Study|Virologic failure|0|||
94682466|NCT02569710|324292765|FG008|Overall Study|Virologic failure|0|||
94682467|NCT02569710|324292766|FG009|Overall Study|Virologic failure|0|||
94682468|NCT02569710|324292757|FG000|Overall Study|Withdrawal by Subject|0|||
94682469|NCT02569710|324292758|FG001|Overall Study|Withdrawal by Subject|0|||
94682470|NCT02569710|324292759|FG002|Overall Study|Withdrawal by Subject|0|||
94682471|NCT02569710|324292760|FG003|Overall Study|Withdrawal by Subject|0|||
94682472|NCT02569710|324292761|FG004|Overall Study|Withdrawal by Subject|0|||
94682473|NCT02569710|324292762|FG005|Overall Study|Withdrawal by Subject|1|||
94682474|NCT02569710|324292763|FG006|Overall Study|Withdrawal by Subject|0|||
94682475|NCT02569710|324292764|FG007|Overall Study|Withdrawal by Subject|0|||
94682476|NCT02569710|324292765|FG008|Overall Study|Withdrawal by Subject|0|||
94682477|NCT02569710|324292766|FG009|Overall Study|Withdrawal by Subject|0|||
94682478|NCT02716038|324292767|FG000|Overall Study|Not evaluable|1|||
94682479|NCT02716038|324292767|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
94682480|NCT02716038|324292767|FG000|Overall Study|Unresectable|3|||
94682481|NCT04152343|324292768|FG000|Overall Study|Transplanted|5|||
94682482|NCT04152343|324292768|FG000|Overall Study|Death|20|||
94682483|NCT04152343|324292768|FG000|Overall Study|Lost to Follow-up|3|||
94682484|NCT03757234|324292772|FG000|Overall Study|Adverse Event|0|||
94682485|NCT03757234|324292773|FG001|Overall Study|Adverse Event|0|||
94682486|NCT03757234|324292774|FG002|Overall Study|Adverse Event|0|||
94682487|NCT03757234|324292775|FG003|Overall Study|Adverse Event|0|||
94682488|NCT03757234|324292776|FG004|Overall Study|Adverse Event|1|||
94682489|NCT03757234|324292772|FG000|Overall Study|Lost to Follow-up|1|||
94682490|NCT03757234|324292773|FG001|Overall Study|Lost to Follow-up|0|||
94682491|NCT03757234|324292774|FG002|Overall Study|Lost to Follow-up|0|||
94682492|NCT03757234|324292775|FG003|Overall Study|Lost to Follow-up|0|||
94682493|NCT03757234|324292776|FG004|Overall Study|Lost to Follow-up|1|||
94682494|NCT03757234|324292772|FG000|Overall Study|Withdrawal by Subject|1|||
94682495|NCT03757234|324292773|FG001|Overall Study|Withdrawal by Subject|1|||
94682496|NCT03757234|324292774|FG002|Overall Study|Withdrawal by Subject|0|||
94682497|NCT03757234|324292775|FG003|Overall Study|Withdrawal by Subject|1|||
94682498|NCT03757234|324292776|FG004|Overall Study|Withdrawal by Subject|2|||
94682499|NCT03757234|324292772|FG000|Overall Study|Other|1|||
94682500|NCT03757234|324292773|FG001|Overall Study|Other|1|||
94682501|NCT03757234|324292774|FG002|Overall Study|Other|0|||
94682502|NCT03757234|324292775|FG003|Overall Study|Other|0|||
94682503|NCT03757234|324292776|FG004|Overall Study|Other|0|||
94682504|NCT00709059|324292777|FG000|Overall Study|Lost to Follow-up|34|||
94682505|NCT00709059|324292777|FG000|Overall Study|Withdrawal by Subject|19|||
94682506|NCT00709059|324292777|FG000|Overall Study|Physician Decision|7|||
94682507|NCT00709059|324292777|FG000|Overall Study|Disease complication|3|||
94682508|NCT00709059|324292777|FG000|Overall Study|Side effects|20|||
94682509|NCT00709059|324292777|FG000|Overall Study|Serious side effects|11|||
94682510|NCT00539279|324292779|FG000|Treatment|Withdrawal by Subject|10|||
94682511|NCT00539279|324292780|FG001|Treatment|Withdrawal by Subject|8|||
94682512|NCT00539279|324292779|FG000|Treatment|Death|1|||
94682513|NCT00539279|324292780|FG001|Treatment|Death|0|||
94682514|NCT00539279|324292779|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
94682515|NCT00539279|324292780|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
94682516|NCT00539279|324292779|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
94682517|NCT00539279|324292780|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
94682518|NCT00524030|324292781|FG000|Overall Study|Lack of Efficacy|10|||
94682519|NCT00524030|324292782|FG001|Overall Study|Lack of Efficacy|24|||
94682520|NCT00524030|324292781|FG000|Overall Study|Lost to Follow-up|0|||
94682521|NCT00524030|324292782|FG001|Overall Study|Lost to Follow-up|2|||
94682522|NCT00524030|324292781|FG000|Overall Study|Withdrawal by Subject|3|||
94682523|NCT00524030|324292782|FG001|Overall Study|Withdrawal by Subject|8|||
94682524|NCT00524030|324292781|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
94682525|NCT00524030|324292782|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
94682526|NCT00524030|324292781|FG000|Overall Study|Protocol Violation|0|||
94682527|NCT00524030|324292782|FG001|Overall Study|Protocol Violation|1|||
94682528|NCT00524030|324292781|FG000|Overall Study|Pregnancy|1|||
94682529|NCT00524030|324292782|FG001|Overall Study|Pregnancy|0|||
94364021|NCT01915498|323116812|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
94364022|NCT01915498|323116813|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
94647188|NCT02465528|324170490|FG001|Overall Study|Adverse Event|0|||
94647189|NCT02465528|324170491|FG002|Overall Study|Adverse Event|0|||
94647190|NCT02465528|324170492|FG003|Overall Study|Adverse Event|1|||
94647191|NCT02465528|324170489|FG000|Overall Study|Physician Decision|0|||
94647192|NCT02465528|324170490|FG001|Overall Study|Physician Decision|0|||
94647193|NCT02465528|324170491|FG002|Overall Study|Physician Decision|1|||
94647194|NCT02465528|324170492|FG003|Overall Study|Physician Decision|0|||
94647195|NCT03752619|324170493|FG000|Overall Study|Lost to Follow-up|2|||
94647196|NCT03752619|324170494|FG001|Overall Study|Lost to Follow-up|1|||
94647197|NCT03752619|324170493|FG000|Overall Study|Withdrawal by Subject|1|||
94647198|NCT03752619|324170494|FG001|Overall Study|Withdrawal by Subject|1|||
94647199|NCT03752619|324170493|FG000|Overall Study|Adverse Event|0|||
94647200|NCT03752619|324170494|FG001|Overall Study|Adverse Event|1|||
94647201|NCT05040152|324170495|FG000|Overall Study|Withdrawal by Subject|5|||
94647202|NCT05040152|324170496|FG001|Overall Study|Withdrawal by Subject|0|||
94647203|NCT05040152|324170495|FG000|Overall Study|Lost to Follow-up|0|||
94647204|NCT05040152|324170496|FG001|Overall Study|Lost to Follow-up|2|||
94647205|NCT00846742|324170499|FG000|Overall Study|Withdrawal by Subject|1|||
94647206|NCT01350128|324170506|FG000|Overall Study|Withdrawal by Subject|3|||
94647207|NCT01350128|324170506|FG000|Overall Study|Protocol discontinuation criteria|8|||
94647208|NCT01350128|324170506|FG000|Overall Study|Physician Decision|1|||
94647209|NCT01350128|324170506|FG000|Overall Study|Lost to Follow-up|2|||
94647210|NCT02684006|324170508|FG000|Overall Study|Ongoing|31|||
94647211|NCT02684006|324170509|FG001|Overall Study|Ongoing|10|||
94647212|NCT02684006|324170508|FG000|Overall Study|Other|7|||
94647213|NCT02684006|324170509|FG001|Overall Study|Other|6|||
94647214|NCT02684006|324170508|FG000|Overall Study|Protocol Violation|2|||
94647215|NCT02684006|324170509|FG001|Overall Study|Protocol Violation|1|||
94647216|NCT02684006|324170508|FG000|Overall Study|Non-compliance with study drug|1|||
94647217|NCT02684006|324170509|FG001|Overall Study|Non-compliance with study drug|1|||
94647218|NCT02684006|324170508|FG000|Overall Study|No longer meets eligibility criteria|6|||
94647219|NCT02684006|324170509|FG001|Overall Study|No longer meets eligibility criteria|2|||
94647220|NCT02684006|324170508|FG000|Overall Study|Lost to Follow-up|0|||
94647221|NCT02684006|324170509|FG001|Overall Study|Lost to Follow-up|1|||
94647222|NCT02684006|324170508|FG000|Overall Study|Death|24|||
94647223|NCT02684006|324170509|FG001|Overall Study|Death|22|||
94647224|NCT02684006|324170508|FG000|Overall Study|Global deterioration of health status|18|||
94647225|NCT02684006|324170509|FG001|Overall Study|Global deterioration of health status|20|||
94647226|NCT02684006|324170508|FG000|Overall Study|Physician Decision|14|||
94647227|NCT02684006|324170509|FG001|Overall Study|Physician Decision|9|||
94647228|NCT02684006|324170508|FG000|Overall Study|Adverse Event|74|||
94647229|NCT02684006|324170509|FG001|Overall Study|Adverse Event|65|||
94647230|NCT02684006|324170508|FG000|Overall Study|Withdrawal by Subject|29|||
94647231|NCT02684006|324170509|FG001|Overall Study|Withdrawal by Subject|41|||
94647232|NCT02684006|324170508|FG000|Overall Study|Progressive disease|236|||
94647233|NCT02684006|324170509|FG001|Overall Study|Progressive disease|266|||
94647234|NCT01428193|324170510|FG000|Overall Study|Physician Decision|1|||
94647235|NCT01428193|324170510|FG000|Overall Study|Elevated screening liver enzymes|1|||
94647236|NCT02457598|324170517|FG000|Overall Study|Progressive Disease|2|||
94647237|NCT02457598|324170518|FG001|Overall Study|Progressive Disease|2|||
94647238|NCT02457598|324170519|FG002|Overall Study|Progressive Disease|1|||
94647239|NCT02457598|324170520|FG003|Overall Study|Progressive Disease|11|||
94647240|NCT02457598|324170521|FG004|Overall Study|Progressive Disease|7|||
94647241|NCT02457598|324170522|FG005|Overall Study|Progressive Disease|3|||
94647242|NCT02457598|324170523|FG006|Overall Study|Progressive Disease|2|||
94647243|NCT02457598|324170524|FG007|Overall Study|Progressive Disease|1|||
94647244|NCT02457598|324170525|FG008|Overall Study|Progressive Disease|1|||
94647245|NCT02457598|324170526|FG009|Overall Study|Progressive Disease|2|||
94647246|NCT02457598|324170527|FG010|Overall Study|Progressive Disease|45|||
94647247|NCT02457598|324170528|FG011|Overall Study|Progressive Disease|6|||
94647248|NCT02457598|324170529|FG012|Overall Study|Progressive Disease|2|||
94647249|NCT02457598|324170530|FG013|Overall Study|Progressive Disease|2|||
94647250|NCT02457598|324170531|FG014|Overall Study|Progressive Disease|10|||
94647251|NCT02457598|324170532|FG015|Overall Study|Progressive Disease|1|||
94647252|NCT02457598|324170533|FG016|Overall Study|Progressive Disease|1|||
94647253|NCT02457598|324170517|FG000|Overall Study|Investigator's Discretion|0|||
94647254|NCT02457598|324170518|FG001|Overall Study|Investigator's Discretion|2|||
94647255|NCT02457598|324170519|FG002|Overall Study|Investigator's Discretion|2|||
94647256|NCT02457598|324170520|FG003|Overall Study|Investigator's Discretion|2|||
94647257|NCT02457598|324170521|FG004|Overall Study|Investigator's Discretion|0|||
94647258|NCT02457598|324170522|FG005|Overall Study|Investigator's Discretion|0|||
94647259|NCT02457598|324170523|FG006|Overall Study|Investigator's Discretion|0|||
94647260|NCT02457598|324170524|FG007|Overall Study|Investigator's Discretion|1|||
94647261|NCT02457598|324170525|FG008|Overall Study|Investigator's Discretion|2|||
94647262|NCT02457598|324170526|FG009|Overall Study|Investigator's Discretion|0|||
94647263|NCT02457598|324170527|FG010|Overall Study|Investigator's Discretion|10|||
94647264|NCT02457598|324170528|FG011|Overall Study|Investigator's Discretion|2|||
94647265|NCT02457598|324170529|FG012|Overall Study|Investigator's Discretion|2|||
94647266|NCT02457598|324170530|FG013|Overall Study|Investigator's Discretion|1|||
94647267|NCT02457598|324170531|FG014|Overall Study|Investigator's Discretion|5|||
94647268|NCT02457598|324170532|FG015|Overall Study|Investigator's Discretion|0|||
94647269|NCT02457598|324170533|FG016|Overall Study|Investigator's Discretion|0|||
94647270|NCT02457598|324170517|FG000|Overall Study|Study Terminated by Sponsor|0|||
94647271|NCT02457598|324170518|FG001|Overall Study|Study Terminated by Sponsor|1|||
94647272|NCT02457598|324170519|FG002|Overall Study|Study Terminated by Sponsor|0|||
94647273|NCT02457598|324170520|FG003|Overall Study|Study Terminated by Sponsor|4|||
94647274|NCT02457598|324170521|FG004|Overall Study|Study Terminated by Sponsor|1|||
94647275|NCT02457598|324170522|FG005|Overall Study|Study Terminated by Sponsor|0|||
94647276|NCT02457598|324170523|FG006|Overall Study|Study Terminated by Sponsor|1|||
94647277|NCT02457598|324170524|FG007|Overall Study|Study Terminated by Sponsor|0|||
94647278|NCT02457598|324170525|FG008|Overall Study|Study Terminated by Sponsor|0|||
94647279|NCT02457598|324170526|FG009|Overall Study|Study Terminated by Sponsor|0|||
94647280|NCT02457598|324170527|FG010|Overall Study|Study Terminated by Sponsor|4|||
94647281|NCT02457598|324170528|FG011|Overall Study|Study Terminated by Sponsor|0|||
94647282|NCT02457598|324170529|FG012|Overall Study|Study Terminated by Sponsor|1|||
94647283|NCT02457598|324170530|FG013|Overall Study|Study Terminated by Sponsor|0|||
94647284|NCT02457598|324170531|FG014|Overall Study|Study Terminated by Sponsor|8|||
94647285|NCT02457598|324170532|FG015|Overall Study|Study Terminated by Sponsor|1|||
94647286|NCT02457598|324170533|FG016|Overall Study|Study Terminated by Sponsor|0|||
94647287|NCT02457598|324170517|FG000|Overall Study|Adverse Event|0|||
94647288|NCT02457598|324170518|FG001|Overall Study|Adverse Event|1|||
94647289|NCT02457598|324170519|FG002|Overall Study|Adverse Event|1|||
94647290|NCT02457598|324170520|FG003|Overall Study|Adverse Event|4|||
94647291|NCT02457598|324170521|FG004|Overall Study|Adverse Event|1|||
94647292|NCT02457598|324170522|FG005|Overall Study|Adverse Event|0|||
94647293|NCT02457598|324170523|FG006|Overall Study|Adverse Event|0|||
94647294|NCT02457598|324170524|FG007|Overall Study|Adverse Event|1|||
94647295|NCT02457598|324170525|FG008|Overall Study|Adverse Event|0|||
94647296|NCT02457598|324170526|FG009|Overall Study|Adverse Event|1|||
94647297|NCT02457598|324170527|FG010|Overall Study|Adverse Event|6|||
94647298|NCT02457598|324170528|FG011|Overall Study|Adverse Event|0|||
94647299|NCT02457598|324170529|FG012|Overall Study|Adverse Event|0|||
94647300|NCT02457598|324170530|FG013|Overall Study|Adverse Event|1|||
94647301|NCT02457598|324170531|FG014|Overall Study|Adverse Event|2|||
94647302|NCT02457598|324170532|FG015|Overall Study|Adverse Event|0|||
94647303|NCT02457598|324170533|FG016|Overall Study|Adverse Event|0|||
94647304|NCT02457598|324170517|FG000|Overall Study|Death|0|||
94647305|NCT02457598|324170518|FG001|Overall Study|Death|0|||
94647306|NCT02457598|324170519|FG002|Overall Study|Death|0|||
94647307|NCT02457598|324170520|FG003|Overall Study|Death|3|||
94647308|NCT02457598|324170521|FG004|Overall Study|Death|0|||
94647309|NCT02457598|324170522|FG005|Overall Study|Death|1|||
94647310|NCT02457598|324170523|FG006|Overall Study|Death|0|||
94647311|NCT02457598|324170524|FG007|Overall Study|Death|0|||
94647312|NCT02457598|324170525|FG008|Overall Study|Death|0|||
94647313|NCT02457598|324170526|FG009|Overall Study|Death|0|||
94647314|NCT02457598|324170527|FG010|Overall Study|Death|3|||
94647315|NCT02457598|324170528|FG011|Overall Study|Death|0|||
94647316|NCT02457598|324170529|FG012|Overall Study|Death|0|||
94647317|NCT02457598|324170530|FG013|Overall Study|Death|1|||
94647318|NCT02457598|324170531|FG014|Overall Study|Death|2|||
94682530|NCT00524030|324292781|FG000|Overall Study|Adverse Event|3|||
94682531|NCT00524030|324292782|FG001|Overall Study|Adverse Event|21|||
94682532|NCT00524030|324292781|FG000|Overall Study|Death|0|||
94682533|NCT00524030|324292782|FG001|Overall Study|Death|1|||
94682534|NCT01493960|324294097|FG000|Overall Study|Adverse Event|0|||
94682535|NCT01493960|324294098|FG001|Overall Study|Adverse Event|1|||
94682536|NCT01493960|324294097|FG000|Overall Study|Lack of Efficacy|15|||
94682537|NCT01493960|324294098|FG001|Overall Study|Lack of Efficacy|9|||
94682538|NCT01493960|324294097|FG000|Overall Study|Protocol Violation|3|||
94682539|NCT01493960|324294098|FG001|Overall Study|Protocol Violation|0|||
94682540|NCT01493960|324294097|FG000|Overall Study|Withdrawal by Subject|10|||
94682541|NCT01493960|324294098|FG001|Overall Study|Withdrawal by Subject|4|||
94682542|NCT01493960|324294097|FG000|Overall Study|Non-specified|4|||
94682543|NCT01493960|324294098|FG001|Overall Study|Non-specified|4|||
94682544|NCT00284141|324294099|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
94682545|NCT00284141|324294099|FG000|Overall Study|Adverse Event|19|||
94682546|NCT00284141|324294099|FG000|Overall Study|Participant's request|9|||
94682547|NCT00284141|324294099|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
94682548|NCT00284141|324294099|FG000|Overall Study|Clinical deterioration / death|2|||
94682549|NCT00284141|324294099|FG000|Overall Study|General decline|1|||
94682550|NCT00284141|324294099|FG000|Overall Study|Pneumonia|1|||
94647319|NCT02457598|324170532|FG015|Overall Study|Death|0|||
94647320|NCT02457598|324170533|FG016|Overall Study|Death|1|||
94647321|NCT02457598|324170517|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
94647322|NCT02457598|324170518|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
94647323|NCT02457598|324170519|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
94647324|NCT02457598|324170520|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
94647325|NCT02457598|324170521|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
94647326|NCT02457598|324170522|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
94647327|NCT02457598|324170523|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
94647328|NCT02457598|324170524|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
94647329|NCT02457598|324170525|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
94647330|NCT02457598|324170526|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
94647331|NCT02457598|324170527|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
94647332|NCT02457598|324170528|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
94647333|NCT02457598|324170529|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
94647334|NCT02457598|324170530|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
94647335|NCT02457598|324170531|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
94647336|NCT02457598|324170532|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
94647337|NCT02457598|324170533|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
94647338|NCT02457598|324170517|FG000|Overall Study|Withdrew Consent|0|||
94647339|NCT02457598|324170518|FG001|Overall Study|Withdrew Consent|0|||
94647340|NCT02457598|324170519|FG002|Overall Study|Withdrew Consent|0|||
94647341|NCT02457598|324170520|FG003|Overall Study|Withdrew Consent|0|||
94647342|NCT02457598|324170521|FG004|Overall Study|Withdrew Consent|0|||
94647343|NCT02457598|324170522|FG005|Overall Study|Withdrew Consent|0|||
94647344|NCT02457598|324170523|FG006|Overall Study|Withdrew Consent|0|||
94647345|NCT02457598|324170524|FG007|Overall Study|Withdrew Consent|2|||
94647346|NCT02457598|324170525|FG008|Overall Study|Withdrew Consent|0|||
94682551|NCT00284141|324294099|FG000|Overall Study|Did not take study medication|2|||
94682552|NCT00284141|324294099|FG000|Overall Study|Ongoing treatment|2|||
94647347|NCT02457598|324170526|FG009|Overall Study|Withdrew Consent|0|||
94647348|NCT02457598|324170527|FG010|Overall Study|Withdrew Consent|3|||
94647349|NCT02457598|324170528|FG011|Overall Study|Withdrew Consent|0|||
94647350|NCT02457598|324170529|FG012|Overall Study|Withdrew Consent|0|||
94647351|NCT02457598|324170530|FG013|Overall Study|Withdrew Consent|1|||
94682553|NCT03610737|324294101|FG000|Overall Study|Withdrawal by Subject|1|||
94682554|NCT03610737|324294102|FG001|Overall Study|Withdrawal by Subject|5|||
94647352|NCT02457598|324170531|FG014|Overall Study|Withdrew Consent|0|||
94647353|NCT02457598|324170532|FG015|Overall Study|Withdrew Consent|0|||
94647354|NCT02457598|324170533|FG016|Overall Study|Withdrew Consent|0|||
94647355|NCT02457598|324170517|FG000|Overall Study|Unacceptable Toxicity|0|||
94647356|NCT02457598|324170518|FG001|Overall Study|Unacceptable Toxicity|0|||
94647357|NCT02457598|324170519|FG002|Overall Study|Unacceptable Toxicity|0|||
94647358|NCT02457598|324170520|FG003|Overall Study|Unacceptable Toxicity|0|||
94647359|NCT02457598|324170521|FG004|Overall Study|Unacceptable Toxicity|0|||
94647360|NCT02457598|324170522|FG005|Overall Study|Unacceptable Toxicity|0|||
94647361|NCT02457598|324170523|FG006|Overall Study|Unacceptable Toxicity|0|||
94647362|NCT02457598|324170524|FG007|Overall Study|Unacceptable Toxicity|0|||
94647363|NCT02457598|324170525|FG008|Overall Study|Unacceptable Toxicity|0|||
94647364|NCT02457598|324170526|FG009|Overall Study|Unacceptable Toxicity|0|||
94647365|NCT02457598|324170527|FG010|Overall Study|Unacceptable Toxicity|1|||
94647366|NCT02457598|324170528|FG011|Overall Study|Unacceptable Toxicity|0|||
94647367|NCT02457598|324170529|FG012|Overall Study|Unacceptable Toxicity|1|||
94647368|NCT02457598|324170530|FG013|Overall Study|Unacceptable Toxicity|1|||
94647369|NCT02457598|324170531|FG014|Overall Study|Unacceptable Toxicity|1|||
94647370|NCT02457598|324170532|FG015|Overall Study|Unacceptable Toxicity|0|||
94647371|NCT02457598|324170533|FG016|Overall Study|Unacceptable Toxicity|0|||
94647372|NCT02457598|324170517|FG000|Overall Study|Intercurrent Illness|0|||
94647373|NCT02457598|324170518|FG001|Overall Study|Intercurrent Illness|0|||
94647374|NCT02457598|324170519|FG002|Overall Study|Intercurrent Illness|0|||
94647375|NCT02457598|324170520|FG003|Overall Study|Intercurrent Illness|0|||
94647376|NCT02457598|324170521|FG004|Overall Study|Intercurrent Illness|0|||
94647377|NCT02457598|324170522|FG005|Overall Study|Intercurrent Illness|0|||
94647378|NCT02457598|324170523|FG006|Overall Study|Intercurrent Illness|0|||
94647379|NCT02457598|324170524|FG007|Overall Study|Intercurrent Illness|0|||
94647380|NCT02457598|324170525|FG008|Overall Study|Intercurrent Illness|0|||
94647381|NCT02457598|324170526|FG009|Overall Study|Intercurrent Illness|0|||
94647382|NCT02457598|324170527|FG010|Overall Study|Intercurrent Illness|1|||
94647383|NCT02457598|324170528|FG011|Overall Study|Intercurrent Illness|0|||
94647384|NCT02457598|324170529|FG012|Overall Study|Intercurrent Illness|0|||
94647385|NCT02457598|324170530|FG013|Overall Study|Intercurrent Illness|0|||
94647386|NCT02457598|324170531|FG014|Overall Study|Intercurrent Illness|0|||
94682555|NCT03610737|324294101|FG000|Overall Study|Death|1|||
94682556|NCT03610737|324294102|FG001|Overall Study|Death|0|||
94682557|NCT03610737|324294101|FG000|Overall Study|Not treated|5|||
94682558|NCT03610737|324294102|FG001|Overall Study|Not treated|2|||
94682559|NCT03610737|324294101|FG000|Overall Study|Missed Visit|1|||
94682560|NCT03610737|324294102|FG001|Overall Study|Missed Visit|2|||
94682561|NCT02392611|324294103|FG000|Overall Study|Adverse Event|0|||
94682562|NCT02392611|324294104|FG001|Overall Study|Adverse Event|0|||
94682563|NCT02392611|324294105|FG002|Overall Study|Adverse Event|0|||
94682564|NCT02392611|324294106|FG003|Overall Study|Adverse Event|1|||
94682565|NCT02392611|324294107|FG004|Overall Study|Adverse Event|0|||
94682566|NCT02392611|324294108|FG005|Overall Study|Adverse Event|0|||
94682567|NCT02392611|324294109|FG006|Overall Study|Adverse Event|0|||
94682568|NCT02392611|324294110|FG007|Overall Study|Adverse Event|0|||
94682569|NCT02392611|324294111|FG008|Overall Study|Adverse Event|0|||
94682570|NCT02392611|324294103|FG000|Overall Study|Progressive disease|0|||
94682571|NCT02392611|324294104|FG001|Overall Study|Progressive disease|0|||
94682572|NCT02392611|324294105|FG002|Overall Study|Progressive disease|0|||
94682573|NCT02392611|324294106|FG003|Overall Study|Progressive disease|2|||
94682574|NCT02392611|324294107|FG004|Overall Study|Progressive disease|1|||
94682575|NCT02392611|324294108|FG005|Overall Study|Progressive disease|0|||
94682576|NCT02392611|324294109|FG006|Overall Study|Progressive disease|0|||
94682577|NCT02392611|324294110|FG007|Overall Study|Progressive disease|0|||
94682578|NCT02392611|324294111|FG008|Overall Study|Progressive disease|0|||
94682579|NCT02392611|324294103|FG000|Overall Study|Death|1|||
94682580|NCT02392611|324294104|FG001|Overall Study|Death|0|||
94682581|NCT02392611|324294105|FG002|Overall Study|Death|0|||
94682582|NCT02392611|324294106|FG003|Overall Study|Death|0|||
94682583|NCT02392611|324294107|FG004|Overall Study|Death|0|||
94682584|NCT02392611|324294108|FG005|Overall Study|Death|1|||
94682585|NCT02392611|324294109|FG006|Overall Study|Death|0|||
94682586|NCT02392611|324294110|FG007|Overall Study|Death|0|||
94682587|NCT02392611|324294111|FG008|Overall Study|Death|0|||
94682588|NCT02392611|324294103|FG000|Overall Study|Withdrawal by Subject|0|||
94682589|NCT02392611|324294104|FG001|Overall Study|Withdrawal by Subject|0|||
94682590|NCT02392611|324294105|FG002|Overall Study|Withdrawal by Subject|0|||
94682591|NCT02392611|324294106|FG003|Overall Study|Withdrawal by Subject|1|||
94682592|NCT02392611|324294107|FG004|Overall Study|Withdrawal by Subject|0|||
94682593|NCT02392611|324294108|FG005|Overall Study|Withdrawal by Subject|0|||
94682594|NCT02392611|324294109|FG006|Overall Study|Withdrawal by Subject|0|||
94682595|NCT02392611|324294110|FG007|Overall Study|Withdrawal by Subject|0|||
94682596|NCT02392611|324294111|FG008|Overall Study|Withdrawal by Subject|0|||
94682597|NCT02392611|324294103|FG000|Overall Study|Lost to Follow-up|0|||
94682598|NCT02392611|324294104|FG001|Overall Study|Lost to Follow-up|0|||
94682599|NCT02392611|324294105|FG002|Overall Study|Lost to Follow-up|0|||
94682600|NCT02392611|324294106|FG003|Overall Study|Lost to Follow-up|0|||
94682601|NCT02392611|324294107|FG004|Overall Study|Lost to Follow-up|0|||
94682602|NCT02392611|324294108|FG005|Overall Study|Lost to Follow-up|0|||
94682603|NCT02392611|324294109|FG006|Overall Study|Lost to Follow-up|1|||
94682604|NCT02392611|324294110|FG007|Overall Study|Lost to Follow-up|0|||
94682605|NCT02392611|324294111|FG008|Overall Study|Lost to Follow-up|0|||
94682606|NCT02392611|324294103|FG000|Overall Study|Enrolled, not treated|0|||
94682607|NCT02392611|324294104|FG001|Overall Study|Enrolled, not treated|0|||
94682608|NCT02392611|324294105|FG002|Overall Study|Enrolled, not treated|0|||
94682609|NCT02392611|324294106|FG003|Overall Study|Enrolled, not treated|2|||
94682610|NCT02392611|324294107|FG004|Overall Study|Enrolled, not treated|0|||
94682611|NCT02392611|324294108|FG005|Overall Study|Enrolled, not treated|0|||
94682612|NCT02392611|324294109|FG006|Overall Study|Enrolled, not treated|0|||
94682613|NCT02392611|324294110|FG007|Overall Study|Enrolled, not treated|0|||
94682614|NCT02392611|324294111|FG008|Overall Study|Enrolled, not treated|0|||
94682615|NCT00369681|324294115|FG000|Overall Study|Death|1|||
94682616|NCT03101241|324294117|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
94682617|NCT03101241|324294118|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
94263765|NCT01514136|322759918|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
94263766|NCT01514136|322759919|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
94682618|NCT03101241|324294117|FG000|Overall Study|Participant withdrew consent|3|||
94682619|NCT03101241|324294118|FG001|Overall Study|Participant withdrew consent|1|||
94682620|NCT03101241|324294117|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
94682621|NCT03101241|324294118|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
94682622|NCT03101241|324294117|FG000|Overall Study|Lost to Follow-up|2|||
94263767|NCT01514136|322759920|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
94682623|NCT03101241|324294118|FG001|Overall Study|Lost to Follow-up|0|||
94682624|NCT03101241|324294117|FG000|Overall Study|Lack of Efficacy|0|||
94682625|NCT03101241|324294118|FG001|Overall Study|Lack of Efficacy|1|||
94682626|NCT03101241|324294117|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
94682627|NCT03101241|324294118|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
94682628|NCT03528174|324294121|FG000|Overall Study|Adverse Event|1|||
94682629|NCT03528174|324294121|FG000|Overall Study|sensors dislodged|1|||
94682630|NCT01834222|324294122|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
94682631|NCT05266963|324294123|FG000|Drug Period A|Withdrawal by Subject|0|||
94682632|NCT05266963|324294124|FG001|Drug Period A|Withdrawal by Subject|1|||
94682633|NCT02712398|324294125|FG000|Overall Study|Withdrawal by Subject|6|||
94682634|NCT02712398|324294125|FG000|Overall Study|Lost to Follow-up|6|||
94682635|NCT02712398|324294125|FG000|Overall Study|Sponsor Decision|1|||
94682636|NCT02712398|324294125|FG000|Overall Study|Physician Decision|1|||
94682637|NCT02712398|324294125|FG000|Overall Study|Death|2|||
94682638|NCT02712398|324294125|FG000|Overall Study|Re-operation|21|||
94682639|NCT05952297|324294128|FG000|Overall Study|Withdrawal by Subject|1|||
94682640|NCT05952297|324294129|FG001|Overall Study|Withdrawal by Subject|0|||
94682641|NCT00525265|324294130|FG000|Overall Study|Protocol Violation|1|||
94682642|NCT00525265|324294131|FG001|Overall Study|Protocol Violation|0|||
94682643|NCT03107377|324294132|FG000|Overall Study|Adverse Event|3|||
94682644|NCT03107377|324294133|FG001|Overall Study|Adverse Event|3|||
94682645|NCT03107377|324294132|FG000|Overall Study|Protocol Violation|9|||
94682646|NCT03107377|324294133|FG001|Overall Study|Protocol Violation|12|||
94682647|NCT03107377|324294132|FG000|Overall Study|Physician Decision|3|||
94682648|NCT03107377|324294133|FG001|Overall Study|Physician Decision|6|||
94682649|NCT03107377|324294132|FG000|Overall Study|Pregnancy|7|||
94682650|NCT03107377|324294133|FG001|Overall Study|Pregnancy|7|||
94682651|NCT03107377|324294132|FG000|Overall Study|Withdrawal by Subject|16|||
94682652|NCT03107377|324294133|FG001|Overall Study|Withdrawal by Subject|22|||
94682653|NCT03107377|324294132|FG000|Overall Study|Lost to Follow-up|37|||
94682654|NCT03107377|324294133|FG001|Overall Study|Lost to Follow-up|34|||
94682655|NCT03107377|324294132|FG000|Overall Study|Other reason not specified|16|||
94682656|NCT03107377|324294133|FG001|Overall Study|Other reason not specified|15|||
94682657|NCT01597505|324294144|FG000|Overall Study|Physician Decision|5|||
94682658|NCT01597505|324294145|FG001|Overall Study|Physician Decision|0|||
94682659|NCT01597505|324294144|FG000|Overall Study|Adverse Event|19|||
94682660|NCT01597505|324294145|FG001|Overall Study|Adverse Event|7|||
94682661|NCT01597505|324294144|FG000|Overall Study|Lost to Follow-up|4|||
94682662|NCT01597505|324294145|FG001|Overall Study|Lost to Follow-up|2|||
94682663|NCT01597505|324294144|FG000|Overall Study|Withdrawal by Subject|10|||
94682664|NCT01597505|324294145|FG001|Overall Study|Withdrawal by Subject|18|||
94682665|NCT01597505|324294144|FG000|Overall Study|Other|5|||
94682666|NCT01597505|324294145|FG001|Overall Study|Other|6|||
94682667|NCT01597505|324294144|FG000|Overall Study|Missing|1|||
94682668|NCT01597505|324294145|FG001|Overall Study|Missing|0|||
94682669|NCT01515189|324294147|FG000|Induction|Disease Progression|109|||
94682670|NCT01515189|324294148|FG001|Induction|Disease Progression|155|||
94682671|NCT01515189|324294147|FG000|Induction|Study drug toxicity|86|||
94682672|NCT01515189|324294148|FG001|Induction|Study drug toxicity|36|||
94682673|NCT01515189|324294147|FG000|Induction|Death|24|||
94682674|NCT01515189|324294148|FG001|Induction|Death|17|||
94682675|NCT01515189|324294147|FG000|Induction|Adverse Event|14|||
94682676|NCT01515189|324294148|FG001|Induction|Adverse Event|9|||
94682677|NCT01515189|324294147|FG000|Induction|Withdrawal by Subject|3|||
94682678|NCT01515189|324294148|FG001|Induction|Withdrawal by Subject|9|||
94682679|NCT01515189|324294147|FG000|Induction|No longer meets study criteria|0|||
94682680|NCT01515189|324294148|FG001|Induction|No longer meets study criteria|2|||
94682681|NCT01515189|324294147|FG000|Induction|Lost to Follow-up|1|||
94682682|NCT01515189|324294148|FG001|Induction|Lost to Follow-up|0|||
94682683|NCT01515189|324294147|FG000|Induction|Other|0|||
94682684|NCT01515189|324294148|FG001|Induction|Other|4|||
94682685|NCT01515189|324294147|FG000|First Re-Induction Phase|Disease progression|6|||
94682686|NCT01515189|324294148|FG001|First Re-Induction Phase|Disease progression|14|||
94682687|NCT01515189|324294147|FG000|First Re-Induction Phase|Study drug toxicity|5|||
94682688|NCT01515189|324294148|FG001|First Re-Induction Phase|Study drug toxicity|0|||
94682689|NCT01515189|324294147|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
94682690|NCT01515189|324294148|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
94682691|NCT01515189|324294147|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
94682692|NCT01515189|324294148|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
94682693|NCT01515189|324294147|FG000|First Re-Induction Phase|Other|1|||
94682694|NCT01515189|324294148|FG001|First Re-Induction Phase|Other|0|||
94682695|NCT01013792|324294149|FG000|Overall Study|Study suspended|2|||
94682696|NCT01013792|324294150|FG001|Overall Study|Study suspended|1|||
94682697|NCT01013792|324294149|FG000|Overall Study|Adverse Event|0|||
94682698|NCT01013792|324294150|FG001|Overall Study|Adverse Event|3|||
94682699|NCT01013792|324294149|FG000|Overall Study|Lost to Follow-up|0|||
94682700|NCT01013792|324294150|FG001|Overall Study|Lost to Follow-up|1|||
94682701|NCT04296890|324294151|FG000|Overall Study|Withdrawal by Subject|1|||
94682702|NCT04296890|324294151|FG000|Overall Study|Death|62|||
94682703|NCT04296890|324294151|FG000|Overall Study|Lost to Follow-up|3|||
94682704|NCT04296890|324294151|FG000|Overall Study|Other than specified|2|||
94682705|NCT02100722|324294155|FG000|Overall Study|Withdrawal pre-procedure|4|||
94364023|NCT01915498|323116814|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
94364024|NCT01915498|323116815|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
94647387|NCT02457598|324170532|FG015|Overall Study|Intercurrent Illness|0|||
94647388|NCT02457598|324170533|FG016|Overall Study|Intercurrent Illness|0|||
94647389|NCT02457598|324170517|FG000|Overall Study|Protocol Violation|0|||
94647390|NCT02457598|324170518|FG001|Overall Study|Protocol Violation|0|||
94647391|NCT02457598|324170519|FG002|Overall Study|Protocol Violation|0|||
94647392|NCT02457598|324170520|FG003|Overall Study|Protocol Violation|0|||
94647393|NCT02457598|324170521|FG004|Overall Study|Protocol Violation|0|||
94647394|NCT02457598|324170522|FG005|Overall Study|Protocol Violation|0|||
94647395|NCT02457598|324170523|FG006|Overall Study|Protocol Violation|0|||
94647396|NCT02457598|324170524|FG007|Overall Study|Protocol Violation|0|||
94647397|NCT02457598|324170525|FG008|Overall Study|Protocol Violation|0|||
94647398|NCT02457598|324170526|FG009|Overall Study|Protocol Violation|0|||
94647399|NCT02457598|324170527|FG010|Overall Study|Protocol Violation|1|||
94647400|NCT02457598|324170528|FG011|Overall Study|Protocol Violation|0|||
94647401|NCT02457598|324170529|FG012|Overall Study|Protocol Violation|0|||
94647402|NCT02457598|324170530|FG013|Overall Study|Protocol Violation|0|||
94647403|NCT02457598|324170531|FG014|Overall Study|Protocol Violation|0|||
94647404|NCT02457598|324170532|FG015|Overall Study|Protocol Violation|0|||
94647405|NCT02457598|324170533|FG016|Overall Study|Protocol Violation|0|||
94647406|NCT02214121|324170534|FG000|Part A|Patient decision|2|||
94647407|NCT02214121|324170535|FG001|Part A|Patient decision|0|||
94647408|NCT02214121|324170536|FG002|Part A|Patient decision|0|||
94647409|NCT02214121|324170534|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
94647410|NCT02214121|324170535|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
94647411|NCT02214121|324170536|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
94647412|NCT02214121|324170534|FG000|Part A|Other|1|||
94647413|NCT02214121|324170535|FG001|Part A|Other|0|||
94647414|NCT02214121|324170536|FG002|Part A|Other|0|||
94647415|NCT02214121|324170534|FG000|Part B|Patient decision|0|||
94647416|NCT02214121|324170535|FG001|Part B|Patient decision|1|||
94647417|NCT02214121|324170536|FG002|Part B|Patient decision|0|||
94647418|NCT02214121|324170534|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
94647419|NCT02214121|324170535|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
94647420|NCT02214121|324170536|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
94647421|NCT02214121|324170534|FG000|Part B|Lost to Follow-up|0|||
94647422|NCT02214121|324170535|FG001|Part B|Lost to Follow-up|0|||
94647423|NCT02214121|324170536|FG002|Part B|Lost to Follow-up|1|||
94647424|NCT02346240|324170537|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94364025|NCT01915498|323116816|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
94364026|NCT01915498|323116817|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
94364027|NCT01915498|323116818|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
94647425|NCT02346240|324170538|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
94647426|NCT02346240|324170539|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
94647427|NCT02346240|324170540|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
94647428|NCT02346240|324170541|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647429|NCT02346240|324170542|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647430|NCT02346240|324170543|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647431|NCT02346240|324170544|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647432|NCT02346240|324170545|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647433|NCT02346240|324170546|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647434|NCT02346240|324170547|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647435|NCT02346240|324170548|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647436|NCT02346240|324170549|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647437|NCT02346240|324170550|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647438|NCT02346240|324170551|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647439|NCT02346240|324170552|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647440|NCT02346240|324170553|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647441|NCT02346240|324170554|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647442|NCT02346240|324170555|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647443|NCT02346240|324170556|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647444|NCT02346240|324170557|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647445|NCT02346240|324170558|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647446|NCT02346240|324170559|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647447|NCT02346240|324170560|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
94647448|NCT02346240|324170537|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647449|NCT02346240|324170538|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
94647450|NCT02346240|324170539|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647451|NCT02346240|324170540|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647452|NCT02346240|324170541|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647453|NCT02346240|324170542|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647454|NCT02346240|324170543|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647455|NCT02346240|324170544|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647456|NCT02346240|324170545|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647457|NCT02346240|324170546|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647458|NCT02346240|324170547|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647459|NCT02346240|324170548|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647460|NCT02346240|324170549|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647461|NCT02346240|324170550|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647462|NCT02346240|324170551|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647463|NCT02346240|324170552|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647464|NCT02346240|324170553|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647465|NCT02346240|324170554|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647466|NCT02346240|324170555|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647467|NCT02346240|324170556|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647468|NCT02346240|324170557|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647469|NCT02346240|324170558|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647470|NCT02346240|324170559|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647471|NCT02346240|324170560|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
94647472|NCT02346240|324170537|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647473|NCT02346240|324170538|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
94647474|NCT02346240|324170539|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647475|NCT02346240|324170540|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94364028|NCT01915498|323116819|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
94682706|NCT02100722|324294156|FG001|Overall Study|Withdrawal pre-procedure|9|||
94682707|NCT02100722|324294155|FG000|Overall Study|Withdrawal post-procedure|0|||
94682708|NCT02100722|324294156|FG001|Overall Study|Withdrawal post-procedure|3|||
94682709|NCT02100722|324294155|FG000|Overall Study|Lost to Follow-up|2|||
94682710|NCT02100722|324294156|FG001|Overall Study|Lost to Follow-up|2|||
94682711|NCT02100722|324294155|FG000|Overall Study|Continuing on study|751|||
94682712|NCT02100722|324294156|FG001|Overall Study|Continuing on study|729|||
94682713|NCT02541383|324294158|FG000|Overall Study|Death|50|||
94682714|NCT02541383|324294159|FG001|Overall Study|Death|37|||
94682715|NCT02541383|324294160|FG002|Overall Study|Death|48|||
94682716|NCT02541383|324294161|FG003|Overall Study|Death|41|||
94682717|NCT02541383|324294162|FG004|Overall Study|Death|21|||
94682718|NCT02541383|324294163|FG005|Overall Study|Death|25|||
94682719|NCT02541383|324294158|FG000|Overall Study|Lost to Follow-up|5|||
94682720|NCT02541383|324294159|FG001|Overall Study|Lost to Follow-up|3|||
94682721|NCT02541383|324294160|FG002|Overall Study|Lost to Follow-up|1|||
94682722|NCT02541383|324294161|FG003|Overall Study|Lost to Follow-up|1|||
94682723|NCT02541383|324294162|FG004|Overall Study|Lost to Follow-up|3|||
94682724|NCT02541383|324294163|FG005|Overall Study|Lost to Follow-up|0|||
94682725|NCT02541383|324294158|FG000|Overall Study|Consent withdrawn|5|||
94682726|NCT02541383|324294159|FG001|Overall Study|Consent withdrawn|6|||
94682727|NCT02541383|324294160|FG002|Overall Study|Consent withdrawn|1|||
94682728|NCT02541383|324294161|FG003|Overall Study|Consent withdrawn|1|||
94682729|NCT02541383|324294162|FG004|Overall Study|Consent withdrawn|0|||
94682730|NCT02541383|324294163|FG005|Overall Study|Consent withdrawn|0|||
94682731|NCT02541383|324294158|FG000|Overall Study|Sponsor's decision|1|||
94682732|NCT02541383|324294159|FG001|Overall Study|Sponsor's decision|1|||
94682733|NCT02541383|324294160|FG002|Overall Study|Sponsor's decision|0|||
94682734|NCT02541383|324294161|FG003|Overall Study|Sponsor's decision|0|||
94682735|NCT02541383|324294162|FG004|Overall Study|Sponsor's decision|0|||
94682736|NCT02541383|324294163|FG005|Overall Study|Sponsor's decision|0|||
94682737|NCT05014412|324294166|FG000|Overall Study|Death|11|||
94682738|NCT05014412|324294167|FG001|Overall Study|Death|7|||
94682739|NCT05014412|324294168|FG002|Overall Study|Death|4|||
94682740|NCT05014412|324294169|FG003|Overall Study|Death|7|||
94682741|NCT05014412|324294166|FG000|Overall Study|Withdrawal by Subject|1|||
94682742|NCT05014412|324294167|FG001|Overall Study|Withdrawal by Subject|1|||
94682743|NCT05014412|324294168|FG002|Overall Study|Withdrawal by Subject|1|||
94682744|NCT05014412|324294169|FG003|Overall Study|Withdrawal by Subject|2|||
94682745|NCT05014412|324294166|FG000|Overall Study|Ongoing|21|||
94682746|NCT05014412|324294167|FG001|Overall Study|Ongoing|4|||
94682747|NCT05014412|324294168|FG002|Overall Study|Ongoing|6|||
94682748|NCT05014412|324294169|FG003|Overall Study|Ongoing|20|||
94682749|NCT02513563|324294170|FG000|Overall Study|Death|4|||
94682750|NCT02513563|324294170|FG000|Overall Study|Withdrawal by Subject|4|||
94682751|NCT02513563|324294170|FG000|Overall Study|Physician Decision|1|||
94682752|NCT02521285|324294171|FG000|Overall Study|Lost to Follow-up|1|||
94682753|NCT02521285|324294172|FG001|Overall Study|Lost to Follow-up|1|||
94682754|NCT02521285|324294171|FG000|Overall Study|Withdrawal by Subject|1|||
94682755|NCT02521285|324294172|FG001|Overall Study|Withdrawal by Subject|1|||
94682756|NCT02521285|324294171|FG000|Overall Study|Adverse Event|0|||
94682757|NCT02521285|324294172|FG001|Overall Study|Adverse Event|1|||
94682758|NCT05229653|324294175|FG000|Overall Study|Lost to Follow-up|1|||
94682759|NCT05229653|324294176|FG001|Overall Study|Lost to Follow-up|0|||
94682760|NCT00594217|324294177|FG000|Overall Study|Withdrawal by Subject|1|||
94682761|NCT00594217|324294178|FG001|Overall Study|Withdrawal by Subject|3|||
94682762|NCT05807919|324294179|FG000|Overall Study|Received antibiotics - excluded|0|||
94682763|NCT05807919|324294180|FG001|Overall Study|Received antibiotics - excluded|1|||
94682764|NCT05807919|324294179|FG000|Overall Study|Withdrawal by Subject|0|||
94682765|NCT05807919|324294180|FG001|Overall Study|Withdrawal by Subject|3|||
94682766|NCT05807919|324294179|FG000|Overall Study|Adverse Event|1|||
94263768|NCT01514136|322759921|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
94263769|NCT01514136|322759922|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
94682767|NCT05807919|324294180|FG001|Overall Study|Adverse Event|1|||
94682768|NCT01905046|324294181|FG000|Months 13-24|Withdrawal by Subject|10|||
94682769|NCT01905046|324294182|FG001|Months 13-24|Withdrawal by Subject|10|||
94682770|NCT01905046|324294181|FG000|Months 13-24|Adverse Event|3|||
94682771|NCT01905046|324294182|FG001|Months 13-24|Adverse Event|2|||
94682772|NCT01905046|324294181|FG000|Months 13-24|Protocol Violation|3|||
94682773|NCT01905046|324294182|FG001|Months 13-24|Protocol Violation|3|||
94682774|NCT01905046|324294181|FG000|Months 13-24|Physician Decision|1|||
94682775|NCT01905046|324294182|FG001|Months 13-24|Physician Decision|0|||
94682776|NCT02421939|324294183|FG000|Overall Study|Progressive disease|70|||
94682777|NCT02421939|324294184|FG001|Overall Study|Progressive disease|16|||
94682778|NCT02421939|324294183|FG000|Overall Study|Lack of Efficacy|21|||
94682779|NCT02421939|324294184|FG001|Overall Study|Lack of Efficacy|31|||
94682780|NCT02421939|324294183|FG000|Overall Study|Death|36|||
94682781|NCT02421939|324294184|FG001|Overall Study|Death|10|||
94682782|NCT02421939|324294183|FG000|Overall Study|Disease relapse|33|||
94682783|NCT02421939|324294184|FG001|Overall Study|Disease relapse|2|||
94682784|NCT02421939|324294183|FG000|Overall Study|Adverse Event|28|||
94682785|NCT02421939|324294184|FG001|Overall Study|Adverse Event|5|||
94682786|NCT02421939|324294183|FG000|Overall Study|Withdrawal by Subject|5|||
94682787|NCT02421939|324294184|FG001|Overall Study|Withdrawal by Subject|24|||
94682788|NCT02421939|324294183|FG000|Overall Study|Physician Decision|11|||
94682789|NCT02421939|324294184|FG001|Overall Study|Physician Decision|11|||
94682790|NCT02421939|324294183|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
94682791|NCT02421939|324294184|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
94682792|NCT02421939|324294183|FG000|Overall Study|Miscellaneous|4|||
94682793|NCT02421939|324294184|FG001|Overall Study|Miscellaneous|5|||
94682794|NCT02421939|324294183|FG000|Overall Study|Protocol deviation|1|||
94682795|NCT02421939|324294184|FG001|Overall Study|Protocol deviation|1|||
94682796|NCT03929562|324294185|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
94682797|NCT03929562|324294186|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
94682798|NCT03929562|324294185|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
94682799|NCT03929562|324294186|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
94682800|NCT03929562|324294185|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
94682801|NCT03929562|324294186|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
94682802|NCT01483937|324294188|FG000|Overall Study|Withdrawal by Subject|4|||
94682803|NCT01483937|324294189|FG001|Overall Study|Withdrawal by Subject|3|||
94682804|NCT02759185|324294192|FG000|Stage 1|Adverse Event|0|||
94682805|NCT02759185|324294193|FG001|Stage 1|Adverse Event|1|||
94682806|NCT02759185|324294194|FG002|Stage 1|Adverse Event|3|||
94682807|NCT02759185|324294195|FG003|Stage 1|Adverse Event|0|||
94682808|NCT02759185|324294196|FG004|Stage 1|Adverse Event|0|||
94682809|NCT02759185|324294197|FG005|Stage 1|Adverse Event|0|||
94682810|NCT02759185|324294198|FG006|Stage 1|Adverse Event|0|||
94682811|NCT02759185|324294192|FG000|Stage 1|Withdrawal by Subject|1|||
94682812|NCT02759185|324294193|FG001|Stage 1|Withdrawal by Subject|0|||
94682813|NCT02759185|324294194|FG002|Stage 1|Withdrawal by Subject|0|||
94682814|NCT02759185|324294195|FG003|Stage 1|Withdrawal by Subject|0|||
94682815|NCT02759185|324294196|FG004|Stage 1|Withdrawal by Subject|0|||
94682816|NCT02759185|324294197|FG005|Stage 1|Withdrawal by Subject|0|||
94682817|NCT02759185|324294198|FG006|Stage 1|Withdrawal by Subject|0|||
94682818|NCT02759185|324294192|FG000|Stage 2|Adverse Event|0|||
94682819|NCT02759185|324294193|FG001|Stage 2|Adverse Event|0|||
94682820|NCT02759185|324294194|FG002|Stage 2|Adverse Event|0|||
94682821|NCT02759185|324294195|FG003|Stage 2|Adverse Event|0|||
94682822|NCT02759185|324294196|FG004|Stage 2|Adverse Event|1|||
94682823|NCT02759185|324294197|FG005|Stage 2|Adverse Event|2|||
94682824|NCT02759185|324294198|FG006|Stage 2|Adverse Event|0|||
94682825|NCT02759185|324294192|FG000|Stage 2|Withdrawal by Subject|0|||
94682826|NCT02759185|324294193|FG001|Stage 2|Withdrawal by Subject|0|||
94682827|NCT02759185|324294194|FG002|Stage 2|Withdrawal by Subject|0|||
94682828|NCT02759185|324294195|FG003|Stage 2|Withdrawal by Subject|0|||
94682829|NCT02759185|324294196|FG004|Stage 2|Withdrawal by Subject|1|||
94682830|NCT02759185|324294197|FG005|Stage 2|Withdrawal by Subject|1|||
94682831|NCT02759185|324294198|FG006|Stage 2|Withdrawal by Subject|1|||
94682832|NCT04524598|324294201|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
94682833|NCT04524598|324294202|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
94682834|NCT04524598|324294203|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
94682835|NCT04524598|324294204|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
94682836|NCT04524598|324294205|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
94682837|NCT04524598|324294201|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
94682838|NCT04524598|324294202|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
94682839|NCT04524598|324294203|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
94682840|NCT04524598|324294204|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
94682841|NCT04524598|324294205|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
94682842|NCT04524598|324294201|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
94682843|NCT04524598|324294202|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
94682844|NCT04524598|324294203|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
94682845|NCT04524598|324294204|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
94364029|NCT01915498|323116820|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
94364030|NCT01915498|323116802|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
94682846|NCT04524598|324294205|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
94682847|NCT04524598|324294201|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
94682848|NCT04524598|324294202|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
94682849|NCT04524598|324294203|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
94682850|NCT04524598|324294204|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
94682851|NCT04524598|324294205|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
94682852|NCT04524598|324294201|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
94682853|NCT04524598|324294202|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
94682854|NCT04524598|324294203|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
94682855|NCT04524598|324294204|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
94682856|NCT04524598|324294205|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
94682857|NCT04524598|324294201|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
94682858|NCT04524598|324294202|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
94682859|NCT04524598|324294203|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
94682860|NCT04524598|324294204|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
94682861|NCT04524598|324294205|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
94682862|NCT04524598|324294201|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
94682863|NCT04524598|324294202|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
94682864|NCT04524598|324294203|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
94682865|NCT04524598|324294204|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
94682866|NCT04524598|324294205|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
94682867|NCT04395183|324294206|FG000|Overall Study|Withdrawal by Subject|1|||
94682868|NCT04395183|324294207|FG001|Overall Study|Withdrawal by Subject|0|||
94682869|NCT04395183|324294208|FG002|Overall Study|Withdrawal by Subject|2|||
94682870|NCT04395183|324294209|FG003|Overall Study|Withdrawal by Subject|2|||
94682871|NCT02668016|324294210|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
94682872|NCT02668016|324294210|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
94682873|NCT02668016|324294210|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
94682874|NCT02668016|324294210|FG000|Month 4|Withdrawal due to severe symptoms|1|||
94682875|NCT02668016|324294210|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
94682876|NCT02668016|324294210|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
94682877|NCT02668016|324294210|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
94682878|NCT02668016|324294210|FG000|Month 6|Withdrawal due to severe symptoms|2|||
94682879|NCT02668016|324294210|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
94682880|NCT02668016|324294210|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
94682881|NCT02668016|324294210|FG000|Month 8|Withdrawal due to severe symptoms|1|||
94682882|NCT02668016|324294210|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
94682883|NCT02668016|324294210|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
94682884|NCT02668016|324294210|FG000|Month 10|Withdrawal due to severe symptoms|1|||
94682885|NCT02668016|324294210|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
94682886|NCT03389477|324294211|FG000|Step 1|Withdrawal by Subject|1|||
94682887|NCT03389477|324294212|FG001|Step 1|Withdrawal by Subject|0|||
94682888|NCT03389477|324294211|FG000|Step 2|Withdrawal by Subject|1|||
94682889|NCT03389477|324294212|FG001|Step 2|Withdrawal by Subject|2|||
94682890|NCT03389477|324294211|FG000|Step 2|Disease progression|1|||
94682891|NCT03389477|324294212|FG001|Step 2|Disease progression|0|||
94682892|NCT03389477|324294211|FG000|Step 2|Death|0|||
94682893|NCT03389477|324294212|FG001|Step 2|Death|1|||
94682894|NCT03389477|324294211|FG000|Step 2|Poor performance status and nutrition|0|||
94682895|NCT03389477|324294212|FG001|Step 2|Poor performance status and nutrition|1|||
94682896|NCT03389477|324294211|FG000|Step 3|Withdrawal after 3 cycles|0|||
94682897|NCT03389477|324294212|FG001|Step 3|Withdrawal after 3 cycles|1|||
94682898|NCT03389477|324294211|FG000|Step 3|Still receiving active treatment|4|||
94682899|NCT03389477|324294212|FG001|Step 3|Still receiving active treatment|0|||
94682900|NCT03389477|324294211|FG000|Step 3|Progressive disease after 2 cycles|1|||
94682901|NCT03389477|324294212|FG001|Step 3|Progressive disease after 2 cycles|0|||
94682902|NCT03403426|324294213|FG000|Overall Study|Death|1|||
94682903|NCT03403426|324294213|FG000|Overall Study|Lost to Follow-up|2|||
94682904|NCT01065350|324294214|FG000|Overall Study|Received incorrect drug allocation|0|||
94682905|NCT01065350|324294215|FG001|Overall Study|Received incorrect drug allocation|1|||
94682906|NCT02217280|324294219|FG000|Overall Study|Withdrawal by Subject|2|||
94682907|NCT02217280|324294219|FG000|Overall Study|Post-consent sceen fail|2|||
94682908|NCT02395133|324294220|FG000|Overall Study|Adverse Event|4|||
94682909|NCT02395133|324294221|FG001|Overall Study|Adverse Event|1|||
94682910|NCT02395133|324294222|FG002|Overall Study|Adverse Event|3|||
94682911|NCT02395133|324294223|FG003|Overall Study|Adverse Event|0|||
94463480|NCT02520427|323485065|FG008|Overall Study|Death|0|||
94463481|NCT02520427|323485066|FG009|Overall Study|Death|0|||
94463482|NCT02520427|323485067|FG010|Overall Study|Death|0|||
94463483|NCT02520427|323485068|FG011|Overall Study|Death|0|||
94463484|NCT02520427|323485069|FG012|Overall Study|Death|0|||
94463485|NCT02520427|323485070|FG013|Overall Study|Death|0|||
94463486|NCT02520427|323485071|FG014|Overall Study|Death|0|||
94463487|NCT02520427|323485072|FG015|Overall Study|Death|0|||
94682912|NCT02395133|324294220|FG000|Overall Study|Lack of Efficacy|1|||
94682913|NCT02395133|324294221|FG001|Overall Study|Lack of Efficacy|0|||
94682914|NCT02395133|324294222|FG002|Overall Study|Lack of Efficacy|1|||
94682915|NCT02395133|324294223|FG003|Overall Study|Lack of Efficacy|1|||
94463488|NCT02520427|323485073|FG016|Overall Study|Death|2|||
94364031|NCT01915498|323116803|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
94364032|NCT01915498|323116804|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
94364033|NCT01915498|323116805|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
94364034|NCT01915498|323116806|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
94364035|NCT01915498|323116807|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
94364036|NCT01915498|323116808|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
94364037|NCT01915498|323116809|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
94647476|NCT02346240|324170541|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647477|NCT02346240|324170542|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647478|NCT02346240|324170543|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647479|NCT02346240|324170544|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647480|NCT02346240|324170545|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647481|NCT02346240|324170546|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647482|NCT02346240|324170547|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647483|NCT02346240|324170548|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647484|NCT02346240|324170549|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647485|NCT02346240|324170550|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647486|NCT02346240|324170551|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647487|NCT02346240|324170552|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647488|NCT02346240|324170553|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647489|NCT02346240|324170554|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94263770|NCT01514136|322759923|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
94263771|NCT01514136|322759916|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
94263772|NCT01514136|322759917|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
94647490|NCT02346240|324170555|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647491|NCT02346240|324170556|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647492|NCT02346240|324170557|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647493|NCT02346240|324170558|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647494|NCT02346240|324170559|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647495|NCT02346240|324170560|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
94647496|NCT02346240|324170537|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
94647497|NCT02346240|324170538|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
94647498|NCT02346240|324170539|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
94647499|NCT02346240|324170540|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
94647500|NCT02346240|324170541|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647501|NCT02346240|324170542|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647502|NCT02346240|324170543|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647503|NCT02346240|324170544|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647504|NCT02346240|324170545|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647505|NCT02346240|324170546|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94682916|NCT02395133|324294220|FG000|Overall Study|Protocol Violation|1|||
94263773|NCT01514136|322759918|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
94263774|NCT01514136|322759919|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
94263775|NCT01514136|322759920|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
94263776|NCT01514136|322759921|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
94263777|NCT01514136|322759922|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
94263778|NCT01514136|322759923|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
94263779|NCT01514136|322759916|FG000|Test Period 2; Test C*|holiday|0|||
94263780|NCT01514136|322759917|FG001|Test Period 2; Test C*|holiday|0|||
94463489|NCT02520427|323485074|FG017|Overall Study|Death|1|||
94263781|NCT01514136|322759918|FG002|Test Period 2; Test C*|holiday|0|||
94263782|NCT01514136|322759919|FG003|Test Period 2; Test C*|holiday|0|||
94463490|NCT02520427|323485075|FG018|Overall Study|Death|3|||
94463491|NCT02520427|323485076|FG019|Overall Study|Death|2|||
94682917|NCT02395133|324294221|FG001|Overall Study|Protocol Violation|1|||
94682918|NCT02395133|324294222|FG002|Overall Study|Protocol Violation|0|||
94682919|NCT02395133|324294223|FG003|Overall Study|Protocol Violation|3|||
94682920|NCT02395133|324294220|FG000|Overall Study|Lost to Follow-up|0|||
94682921|NCT02395133|324294221|FG001|Overall Study|Lost to Follow-up|1|||
94682922|NCT02395133|324294222|FG002|Overall Study|Lost to Follow-up|1|||
94682923|NCT02395133|324294223|FG003|Overall Study|Lost to Follow-up|0|||
94682924|NCT02395133|324294220|FG000|Overall Study|Pregnancy|0|||
94682925|NCT02395133|324294221|FG001|Overall Study|Pregnancy|0|||
94682926|NCT02395133|324294222|FG002|Overall Study|Pregnancy|3|||
94682927|NCT02395133|324294223|FG003|Overall Study|Pregnancy|0|||
94682928|NCT02395133|324294220|FG000|Overall Study|Consent withdrawn with no reason given|1|||
94682929|NCT02395133|324294221|FG001|Overall Study|Consent withdrawn with no reason given|3|||
94682930|NCT02395133|324294222|FG002|Overall Study|Consent withdrawn with no reason given|0|||
94682931|NCT02395133|324294223|FG003|Overall Study|Consent withdrawn with no reason given|2|||
94682932|NCT02395133|324294220|FG000|Overall Study|Consent withdrawn with personal reason|0|||
94682933|NCT02395133|324294221|FG001|Overall Study|Consent withdrawn with personal reason|1|||
94682934|NCT02395133|324294222|FG002|Overall Study|Consent withdrawn with personal reason|0|||
94682935|NCT02395133|324294223|FG003|Overall Study|Consent withdrawn with personal reason|3|||
94682936|NCT02395133|324294220|FG000|Overall Study|Sponsor decision|2|||
94682937|NCT02395133|324294221|FG001|Overall Study|Sponsor decision|0|||
94682938|NCT02395133|324294222|FG002|Overall Study|Sponsor decision|0|||
94682939|NCT02395133|324294223|FG003|Overall Study|Sponsor decision|1|||
94682940|NCT02395133|324294220|FG000|Overall Study|Other than specified above|5|||
94682941|NCT02395133|324294221|FG001|Overall Study|Other than specified above|2|||
94263783|NCT01514136|322759920|FG004|Test Period 2; Test C*|holiday|0|||
94463492|NCT02520427|323485077|FG020|Overall Study|Death|0|||
94463493|NCT02520427|323485078|FG021|Overall Study|Death|0|||
94647506|NCT02346240|324170547|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647507|NCT02346240|324170548|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647508|NCT02346240|324170549|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647509|NCT02346240|324170550|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647510|NCT02346240|324170551|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647511|NCT02346240|324170552|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647512|NCT02346240|324170553|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647513|NCT02346240|324170554|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647514|NCT02346240|324170555|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647515|NCT02346240|324170556|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647516|NCT02346240|324170557|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647517|NCT02346240|324170558|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647518|NCT02346240|324170559|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647519|NCT02346240|324170560|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
94647520|NCT02346240|324170537|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
94647521|NCT02346240|324170538|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
94647522|NCT02346240|324170539|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
94647523|NCT02346240|324170540|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
94647524|NCT02346240|324170541|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94647525|NCT02346240|324170542|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94647526|NCT02346240|324170543|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94682942|NCT02395133|324294222|FG002|Overall Study|Other than specified above|2|||
94682943|NCT02395133|324294223|FG003|Overall Study|Other than specified above|4|||
94682944|NCT00962247|324294224|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
94682945|NCT00962247|324294224|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
94682946|NCT00510458|324294225|FG000|Overall Study|5 year not evaluable/missed|21|||
94263784|NCT01514136|322759921|FG005|Test Period 2; Test C*|holiday|0|||
94263785|NCT01514136|322759922|FG006|Test Period 2; Test C*|holiday|1|||
94263786|NCT01514136|322759923|FG007|Test Period 2; Test C*|holiday|0|||
94263787|NCT01514136|322759916|FG000|Test Period 2; Test C*|Protocol Violation|0|||
94263788|NCT01514136|322759917|FG001|Test Period 2; Test C*|Protocol Violation|0|||
94263789|NCT01514136|322759918|FG002|Test Period 2; Test C*|Protocol Violation|0|||
94263790|NCT01514136|322759919|FG003|Test Period 2; Test C*|Protocol Violation|0|||
94263791|NCT01514136|322759920|FG004|Test Period 2; Test C*|Protocol Violation|0|||
94263792|NCT01514136|322759921|FG005|Test Period 2; Test C*|Protocol Violation|0|||
94263793|NCT01514136|322759922|FG006|Test Period 2; Test C*|Protocol Violation|1|||
94263794|NCT01514136|322759923|FG007|Test Period 2; Test C*|Protocol Violation|0|||
94263795|NCT00999713|322759924|FG000|Overall Study|Physician Decision|2|||
94263796|NCT00999713|322759925|FG001|Overall Study|Physician Decision|0|||
94263797|NCT01906346|322759926|FG000|Overall Study|AEs|1|||
94263798|NCT00639223|322759927|FG000|Overall Study|Lost to Follow-up|0|||
94463494|NCT02520427|323485079|FG022|Overall Study|Death|1|||
94463495|NCT02520427|323485080|FG023|Overall Study|Death|0|||
94647527|NCT02346240|324170544|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94647528|NCT02346240|324170545|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94364038|NCT01915498|323116810|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
94364039|NCT01915498|323116811|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
94364040|NCT01915498|323116812|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
94364041|NCT01915498|323116813|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
94364042|NCT01915498|323116814|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
94364043|NCT01915498|323116815|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
94364044|NCT01915498|323116816|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
94364045|NCT01915498|323116817|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
94364046|NCT01915498|323116818|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
94364047|NCT01915498|323116819|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
94364048|NCT01915498|323116820|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
94364049|NCT01915498|323116802|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
94364050|NCT01915498|323116803|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
94647529|NCT02346240|324170546|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94647530|NCT02346240|324170547|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94647531|NCT02346240|324170548|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94647532|NCT02346240|324170549|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94647533|NCT02346240|324170550|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94647534|NCT02346240|324170551|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94647535|NCT02346240|324170552|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94647536|NCT02346240|324170553|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94647537|NCT02346240|324170554|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94647538|NCT02346240|324170555|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94647539|NCT02346240|324170556|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94647540|NCT02346240|324170557|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94647541|NCT02346240|324170558|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94647542|NCT02346240|324170559|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94647543|NCT02346240|324170560|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
94647544|NCT02346240|324170537|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94682947|NCT00510458|324294225|FG000|Overall Study|Death|1|||
94364051|NCT01915498|323116804|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
94364052|NCT01915498|323116805|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
94364053|NCT01915498|323116806|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
94364054|NCT01915498|323116807|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
94364055|NCT01915498|323116808|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
94364056|NCT01915498|323116809|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
94364057|NCT01915498|323116810|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
94364058|NCT01915498|323116811|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
94364059|NCT01915498|323116812|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
94364060|NCT01915498|323116813|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
94364061|NCT01915498|323116814|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
94364062|NCT01915498|323116815|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
94364063|NCT01915498|323116816|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
94364064|NCT01915498|323116817|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
94364065|NCT01915498|323116818|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
94463496|NCT02520427|323485081|FG024|Overall Study|Death|1|||
94463497|NCT02520427|323485082|FG025|Overall Study|Death|0|||
94647545|NCT02346240|324170538|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
94647546|NCT02346240|324170539|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647547|NCT02346240|324170540|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
94647548|NCT02346240|324170541|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647549|NCT02346240|324170542|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647550|NCT02346240|324170543|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647551|NCT02346240|324170544|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647552|NCT02346240|324170545|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647553|NCT02346240|324170546|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647554|NCT02346240|324170547|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647555|NCT02346240|324170548|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647556|NCT02346240|324170549|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647557|NCT02346240|324170550|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647558|NCT02346240|324170551|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647559|NCT02346240|324170552|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647560|NCT02346240|324170553|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647561|NCT02346240|324170554|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647562|NCT02346240|324170555|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647563|NCT02346240|324170556|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647564|NCT02346240|324170557|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647565|NCT02346240|324170558|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647566|NCT02346240|324170559|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94682948|NCT00510458|324294225|FG000|Overall Study|Terminated|14|||
94647567|NCT02346240|324170560|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
94647568|NCT02346240|324170537|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647569|NCT02346240|324170538|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647570|NCT02346240|324170539|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
94647571|NCT02346240|324170540|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647572|NCT02346240|324170541|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647573|NCT02346240|324170542|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647574|NCT02346240|324170543|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647575|NCT02346240|324170544|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647576|NCT02346240|324170545|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647577|NCT02346240|324170546|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647578|NCT02346240|324170547|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647579|NCT02346240|324170548|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647580|NCT02346240|324170549|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647581|NCT02346240|324170550|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647582|NCT02346240|324170551|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647583|NCT02346240|324170552|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647584|NCT02346240|324170553|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647585|NCT02346240|324170554|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647586|NCT02346240|324170555|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647587|NCT02346240|324170556|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647588|NCT02346240|324170557|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647589|NCT02346240|324170558|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647590|NCT02346240|324170559|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647591|NCT02346240|324170560|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
94647592|NCT02346240|324170537|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94647593|NCT02346240|324170538|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94647594|NCT02346240|324170539|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94647595|NCT02346240|324170540|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94647596|NCT02346240|324170541|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94647597|NCT02346240|324170542|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94647598|NCT02346240|324170543|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94647599|NCT02346240|324170544|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
94647600|NCT02346240|324170545|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
94647601|NCT02346240|324170546|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94647602|NCT02346240|324170547|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94647603|NCT02346240|324170548|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94647604|NCT02346240|324170549|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94647605|NCT02346240|324170550|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
94647606|NCT02346240|324170551|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
94647607|NCT02346240|324170552|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
94647608|NCT02346240|324170553|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
94647609|NCT02346240|324170554|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94647610|NCT02346240|324170555|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94647611|NCT02346240|324170556|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94647612|NCT02346240|324170557|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94647613|NCT02346240|324170558|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94647614|NCT02346240|324170559|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94647615|NCT02346240|324170560|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94647616|NCT02346240|324170537|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647617|NCT02346240|324170538|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647618|NCT02346240|324170539|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647619|NCT02346240|324170540|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647620|NCT02346240|324170541|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647621|NCT02346240|324170542|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647622|NCT02346240|324170543|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647623|NCT02346240|324170544|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647624|NCT02346240|324170545|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647625|NCT02346240|324170546|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647626|NCT02346240|324170547|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647627|NCT02346240|324170548|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647628|NCT02346240|324170549|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94682949|NCT00510458|324294225|FG000|Overall Study|Lost to Follow-up|6|||
94682950|NCT00510458|324294225|FG000|Overall Study|Withdrawal by Subject|3|||
94682951|NCT00510458|324294225|FG000|Overall Study|Revision|2|||
94682952|NCT01164228|324294230|FG000|Overall Study|Progression|24|||
94682953|NCT01164228|324294231|FG001|Overall Study|Progression|25|||
94682954|NCT01164228|324294230|FG000|Overall Study|Adverse Event|13|||
94682955|NCT01164228|324294231|FG001|Overall Study|Adverse Event|7|||
94682956|NCT01164228|324294230|FG000|Overall Study|Death|1|||
94682957|NCT01164228|324294231|FG001|Overall Study|Death|1|||
94682958|NCT01164228|324294230|FG000|Overall Study|Withdrawal by Subject|2|||
94682959|NCT01164228|324294231|FG001|Overall Study|Withdrawal by Subject|0|||
94682960|NCT01164228|324294230|FG000|Overall Study|Physician Decision|1|||
94682961|NCT01164228|324294231|FG001|Overall Study|Physician Decision|2|||
94682962|NCT01164228|324294230|FG000|Overall Study|Symptomatic deterioration|1|||
94682963|NCT01164228|324294231|FG001|Overall Study|Symptomatic deterioration|0|||
94682964|NCT01164228|324294230|FG000|Overall Study|Never started treatment|1|||
94682965|NCT01164228|324294231|FG001|Overall Study|Never started treatment|3|||
94682966|NCT01164228|324294230|FG000|Overall Study|Ineligible|1|||
94682967|NCT01164228|324294231|FG001|Overall Study|Ineligible|0|||
94682968|NCT05200936|324294240|FG000|Overall Study|Withdrawal by Subject|2|||
94682969|NCT05200936|324294241|FG001|Overall Study|Withdrawal by Subject|2|||
94682970|NCT05200936|324294240|FG000|Overall Study|Lost to Follow-up|2|||
94682971|NCT05200936|324294241|FG001|Overall Study|Lost to Follow-up|0|||
94682972|NCT05200936|324294240|FG000|Overall Study|Pregnancy|0|||
94682973|NCT05200936|324294241|FG001|Overall Study|Pregnancy|1|||
94682974|NCT03443713|324294242|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
94682975|NCT03443713|324294243|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
94682976|NCT03443713|324294244|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
94682977|NCT03713021|324294245|FG000|Overall Study|Did not have CT sim scan available|6|||
94682978|NCT03713021|324294245|FG000|Overall Study|Not eligible|4|||
94682979|NCT03713021|324294245|FG000|Overall Study|Issues with TraceIT markers|5|||
94682980|NCT02714205|324294246|FG000|Overall Study|Cannot tolerate medication|1|||
94682981|NCT02714205|324294247|FG001|Overall Study|Cannot tolerate medication|0|||
94682982|NCT02714205|324294246|FG000|Overall Study|Adverse Event|2|||
94682983|NCT02714205|324294247|FG001|Overall Study|Adverse Event|0|||
94682984|NCT02714205|324294246|FG000|Overall Study|Too busy|1|||
94682985|NCT02714205|324294247|FG001|Overall Study|Too busy|0|||
94682986|NCT02714205|324294246|FG000|Overall Study|Incomplete outcome data|0|||
94682987|NCT02714205|324294247|FG001|Overall Study|Incomplete outcome data|1|||
94682988|NCT01598298|324294250|FG000|Overall Study|Not eligible|5|||
94682989|NCT01598298|324294251|FG001|Overall Study|Not eligible|5|||
94682990|NCT01598298|324294250|FG000|Overall Study|Adverse Event|21|||
94682991|NCT01598298|324294251|FG001|Overall Study|Adverse Event|19|||
94682992|NCT01598298|324294250|FG000|Overall Study|Progression/relapse|0|||
94682993|NCT01598298|324294251|FG001|Overall Study|Progression/relapse|2|||
94682994|NCT01598298|324294250|FG000|Overall Study|Withdrawal by Subject|10|||
94682995|NCT01598298|324294251|FG001|Overall Study|Withdrawal by Subject|15|||
94682996|NCT01598298|324294250|FG000|Overall Study|Other reason (not protocol specified)|4|||
94682997|NCT01598298|324294251|FG001|Overall Study|Other reason (not protocol specified)|0|||
94682998|NCT03935217|324295527|FG000|Overall Study|Adverse Event|1|||
94682999|NCT03935217|324295528|FG001|Overall Study|Adverse Event|0|||
94683000|NCT03935217|324295527|FG000|Overall Study|Lost to Follow-up|0|||
94683001|NCT03935217|324295528|FG001|Overall Study|Lost to Follow-up|1|||
94683002|NCT03935217|324295527|FG000|Overall Study|Withdrawal by Subject|0|||
94683003|NCT03935217|324295528|FG001|Overall Study|Withdrawal by Subject|2|||
94683004|NCT01862991|324295529|FG000|Overall Study|Lost to Follow-up|2|||
94683005|NCT01862991|324295530|FG001|Overall Study|Lost to Follow-up|1|||
94683006|NCT01862991|324295531|FG002|Overall Study|Lost to Follow-up|1|||
94683007|NCT01862991|324295529|FG000|Overall Study|Protocol Violation|1|||
94683008|NCT01862991|324295530|FG001|Overall Study|Protocol Violation|0|||
94683009|NCT01862991|324295531|FG002|Overall Study|Protocol Violation|0|||
94683010|NCT01062763|324295533|FG000|Overall Study|Adverse Event|3|||
94683011|NCT01062763|324295534|FG001|Overall Study|Adverse Event|4|||
94683012|NCT02305381|324295535|FG000|Overall Study|Unclassified|5|||
94683013|NCT02305381|324295536|FG001|Overall Study|Unclassified|5|||
94683014|NCT02305381|324295537|FG002|Overall Study|Unclassified|7|||
94683015|NCT00787319|324295542|FG000|Overall Study|Lost to Follow-up|2|||
94683016|NCT00787319|324295542|FG000|Overall Study|Withdrawal by Subject|15|||
94683017|NCT00787319|324295542|FG000|Overall Study|Adverse Event|3|||
94683018|NCT00787319|324295542|FG000|Overall Study|Objective progression or relapse|30|||
94683019|NCT00787319|324295542|FG000|Overall Study|Lack of Efficacy|1|||
94683020|NCT00787319|324295542|FG000|Overall Study|Budget exhausted/exceeded|1|||
94683021|NCT00787319|324295542|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
94683022|NCT00787319|324295542|FG000|Overall Study|No health insurance reimbursement|2|||
94683023|NCT00787319|324295542|FG000|Overall Study|Stabilized disease findings|3|||
94683024|NCT00787319|324295542|FG000|Overall Study|Inactive disease|5|||
94683025|NCT04415151|324295543|FG000|Overall Study|Death|1|||
94683026|NCT04415151|324295544|FG001|Overall Study|Death|1|||
94683027|NCT04415151|324295543|FG000|Overall Study|Withdrawal by Subject|1|||
94683028|NCT04415151|324295544|FG001|Overall Study|Withdrawal by Subject|0|||
94683029|NCT04399356|324295551|FG000|Overall Study|Lost to Follow-up|1|||
94683030|NCT04399356|324295552|FG001|Overall Study|Lost to Follow-up|1|||
94683031|NCT04399356|324295551|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
94683032|NCT04399356|324295552|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
94683033|NCT04399356|324295551|FG000|Overall Study|Withdrawal by Subject|1|||
94683034|NCT04399356|324295552|FG001|Overall Study|Withdrawal by Subject|0|||
94683035|NCT00154310|324295553|FG000|Overall Study|Adverse Event|19|||
94683036|NCT00154310|324295554|FG001|Overall Study|Adverse Event|9|||
94683037|NCT00154310|324295553|FG000|Overall Study|Lack of Efficacy|5|||
94683038|NCT00154310|324295554|FG001|Overall Study|Lack of Efficacy|4|||
94683039|NCT00154310|324295553|FG000|Overall Study|Protocol Violation|4|||
94683040|NCT00154310|324295554|FG001|Overall Study|Protocol Violation|2|||
94683041|NCT00154310|324295553|FG000|Overall Study|Withdrawal by Subject|9|||
94683042|NCT00154310|324295554|FG001|Overall Study|Withdrawal by Subject|3|||
94683043|NCT00154310|324295553|FG000|Overall Study|Lost to Follow-up|0|||
94683044|NCT00154310|324295554|FG001|Overall Study|Lost to Follow-up|8|||
94683045|NCT00154310|324295553|FG000|Overall Study|Administrative problems|0|||
94683046|NCT00154310|324295554|FG001|Overall Study|Administrative problems|1|||
94683047|NCT00154310|324295553|FG000|Overall Study|Death|0|||
94683048|NCT00154310|324295554|FG001|Overall Study|Death|1|||
94683049|NCT03592277|324295555|FG000|Overall Study|Withdrawal by Subject|6|||
94683050|NCT03592277|324295556|FG001|Overall Study|Withdrawal by Subject|8|||
94683051|NCT01781390|324295557|FG000|Overall Study|Withdrawal of Consent|0|||
94683052|NCT01781390|324295558|FG001|Overall Study|Withdrawal of Consent|3|||
94683053|NCT01781390|324295559|FG002|Overall Study|Withdrawal of Consent|1|||
94683054|NCT01781390|324295557|FG000|Overall Study|Lost to Follow-up|1|||
94683055|NCT01781390|324295558|FG001|Overall Study|Lost to Follow-up|1|||
94683056|NCT01781390|324295559|FG002|Overall Study|Lost to Follow-up|1|||
94683057|NCT01781390|324295557|FG000|Overall Study|Adverse Event|1|||
94683058|NCT01781390|324295558|FG001|Overall Study|Adverse Event|2|||
94683059|NCT01781390|324295559|FG002|Overall Study|Adverse Event|1|||
94683060|NCT01781390|324295557|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
94683061|NCT01781390|324295558|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
94683062|NCT01781390|324295559|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
94683063|NCT04041440|324295561|FG000|Overall Study|Withdrawal by Subject|0|||
94683064|NCT04041440|324295562|FG001|Overall Study|Withdrawal by Subject|1|||
94683065|NCT04041440|324295561|FG000|Overall Study|Lost to Follow-up|0|||
94683066|NCT04041440|324295562|FG001|Overall Study|Lost to Follow-up|1|||
94683067|NCT01381874|324295563|FG000|Overall Study|Lost to Follow-up|1|||
94683068|NCT01381874|324295564|FG001|Overall Study|Lost to Follow-up|1|||
94683069|NCT01381874|324295565|FG002|Overall Study|Lost to Follow-up|0|||
94683070|NCT01381874|324295563|FG000|Overall Study|Withdrawal by Subject|9|||
94683071|NCT01381874|324295564|FG001|Overall Study|Withdrawal by Subject|10|||
94683072|NCT01381874|324295565|FG002|Overall Study|Withdrawal by Subject|9|||
94683073|NCT01381874|324295563|FG000|Overall Study|Other|67|||
94683074|NCT01381874|324295564|FG001|Overall Study|Other|52|||
94683075|NCT01381874|324295565|FG002|Overall Study|Other|67|||
94683076|NCT04488003|324295566|FG000|Assessed for Eligibility|Screen Failure|24|||
94683077|NCT04488003|324295567|FG001|Assessed for Eligibility|Screen Failure|0|||
94683078|NCT04488003|324295568|FG002|Assessed for Eligibility|Screen Failure|0|||
94683079|NCT04488003|324295566|FG000|Assessed for Eligibility|Adverse Event|1|||
94683080|NCT04488003|324295567|FG001|Assessed for Eligibility|Adverse Event|0|||
94683081|NCT04488003|324295568|FG002|Assessed for Eligibility|Adverse Event|0|||
94683082|NCT04488003|324295566|FG000|Assessed for Eligibility|Death|1|||
94683083|NCT04488003|324295567|FG001|Assessed for Eligibility|Death|0|||
94683084|NCT04488003|324295568|FG002|Assessed for Eligibility|Death|0|||
94683085|NCT04488003|324295566|FG000|Assessed for Eligibility|Physician Decision|1|||
94683086|NCT04488003|324295567|FG001|Assessed for Eligibility|Physician Decision|0|||
94683087|NCT04488003|324295568|FG002|Assessed for Eligibility|Physician Decision|0|||
94683088|NCT04488003|324295566|FG000|Allocated to Treatment|Progressive Disease|51|||
94683089|NCT04488003|324295567|FG001|Allocated to Treatment|Progressive Disease|0|||
94263799|NCT00639223|322759928|FG001|Overall Study|Lost to Follow-up|2|||
94683090|NCT04488003|324295568|FG002|Allocated to Treatment|Progressive Disease|0|||
94683091|NCT04488003|324295566|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
94683092|NCT04488003|324295567|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
94683093|NCT04488003|324295568|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
94683094|NCT04488003|324295566|FG000|Allocated to Treatment|Adverse Event|6|||
94683095|NCT04488003|324295567|FG001|Allocated to Treatment|Adverse Event|0|||
94683096|NCT04488003|324295568|FG002|Allocated to Treatment|Adverse Event|0|||
94683097|NCT04488003|324295566|FG000|Allocated to Treatment|Other|5|||
94683098|NCT04488003|324295567|FG001|Allocated to Treatment|Other|0|||
94683099|NCT04488003|324295568|FG002|Allocated to Treatment|Other|0|||
94683100|NCT04488003|324295566|FG000|Allocated to Treatment|Physician Decision|4|||
94683101|NCT04488003|324295567|FG001|Allocated to Treatment|Physician Decision|0|||
94683102|NCT04488003|324295568|FG002|Allocated to Treatment|Physician Decision|0|||
94683103|NCT04488003|324295566|FG000|Allocated to Treatment|Death|4|||
94683104|NCT04488003|324295567|FG001|Allocated to Treatment|Death|0|||
94683105|NCT04488003|324295568|FG002|Allocated to Treatment|Death|0|||
94683106|NCT02086162|324295572|FG000|Overall Study|Withdrawal by Subject|4|||
94683107|NCT02086162|324295573|FG001|Overall Study|Withdrawal by Subject|4|||
94683108|NCT02086162|324295572|FG000|Overall Study|moved|1|||
94683109|NCT02086162|324295573|FG001|Overall Study|moved|1|||
94683110|NCT02086162|324295572|FG000|Overall Study|Lost to Follow-up|4|||
94683111|NCT02086162|324295573|FG001|Overall Study|Lost to Follow-up|2|||
94683112|NCT02086162|324295572|FG000|Overall Study|Death|1|||
94683113|NCT02086162|324295573|FG001|Overall Study|Death|0|||
94683114|NCT01737996|324295574|FG000|Overall Study|Adverse Event|0|||
94683115|NCT01737996|324295575|FG001|Overall Study|Adverse Event|1|||
94683116|NCT01737996|324295576|FG002|Overall Study|Adverse Event|1|||
94683117|NCT01737996|324295574|FG000|Overall Study|Withdrawal by Subject|0|||
94683118|NCT01737996|324295575|FG001|Overall Study|Withdrawal by Subject|0|||
94683119|NCT01737996|324295576|FG002|Overall Study|Withdrawal by Subject|1|||
94683120|NCT01350505|324295580|FG000|Overall Study|Lost to Follow-up|4|||
94683121|NCT03820323|324295581|FG000|Overall Study|Lost to Follow-up|2|||
94683122|NCT03820323|324295582|FG001|Overall Study|Lost to Follow-up|1|||
94683123|NCT03820323|324295581|FG000|Overall Study|Missed 12-month visit|22|||
94683124|NCT03820323|324295582|FG001|Overall Study|Missed 12-month visit|14|||
94683125|NCT03820323|324295581|FG000|Overall Study|Death|2|||
94683126|NCT03820323|324295582|FG001|Overall Study|Death|1|||
94683127|NCT03820323|324295581|FG000|Overall Study|Transferred out|13|||
94683128|NCT03820323|324295582|FG001|Overall Study|Transferred out|11|||
94683129|NCT03820323|324295581|FG000|Overall Study|Terminated|0|||
94683130|NCT03820323|324295582|FG001|Overall Study|Terminated|3|||
94683131|NCT03820323|324295581|FG000|Overall Study|Withdrawal by Subject|1|||
94683132|NCT03820323|324295582|FG001|Overall Study|Withdrawal by Subject|6|||
94683133|NCT01306201|324295586|FG000|Overall Study|Arrhythmia|4|||
94683134|NCT01306201|324295586|FG000|Overall Study|Files could not be processed|3|||
94683135|NCT01306201|324295586|FG000|Overall Study|Files unreadable|3|||
94683136|NCT00393523|324295587|FG000|Overall Study|Lost to Follow-up|0|||
94683137|NCT00393523|324295588|FG001|Overall Study|Lost to Follow-up|0|||
94683138|NCT00393523|324295589|FG002|Overall Study|Lost to Follow-up|0|||
94683139|NCT00393523|324295590|FG003|Overall Study|Lost to Follow-up|2|||
94683140|NCT00393523|324295591|FG004|Overall Study|Lost to Follow-up|1|||
94683141|NCT00393523|324295587|FG000|Overall Study|Protocol Violation|6|||
94683142|NCT00393523|324295588|FG001|Overall Study|Protocol Violation|2|||
94683143|NCT00393523|324295589|FG002|Overall Study|Protocol Violation|0|||
94683144|NCT00393523|324295590|FG003|Overall Study|Protocol Violation|1|||
94683145|NCT00393523|324295591|FG004|Overall Study|Protocol Violation|0|||
94683146|NCT00393523|324295587|FG000|Overall Study|Withdrawal by Subject|6|||
94683147|NCT00393523|324295588|FG001|Overall Study|Withdrawal by Subject|7|||
94683148|NCT00393523|324295589|FG002|Overall Study|Withdrawal by Subject|2|||
94683149|NCT00393523|324295590|FG003|Overall Study|Withdrawal by Subject|3|||
94683150|NCT00393523|324295591|FG004|Overall Study|Withdrawal by Subject|0|||
94683151|NCT00393523|324295587|FG000|Overall Study|Difficulties in specimen collection|0|||
94683152|NCT00393523|324295588|FG001|Overall Study|Difficulties in specimen collection|0|||
94683153|NCT00393523|324295589|FG002|Overall Study|Difficulties in specimen collection|1|||
94683154|NCT00393523|324295590|FG003|Overall Study|Difficulties in specimen collection|0|||
94683155|NCT00393523|324295591|FG004|Overall Study|Difficulties in specimen collection|0|||
94683156|NCT00393523|324295587|FG000|Overall Study|Vaccine supply issue|0|||
94683157|NCT00393523|324295588|FG001|Overall Study|Vaccine supply issue|0|||
94683158|NCT00393523|324295589|FG002|Overall Study|Vaccine supply issue|1|||
94683159|NCT00393523|324295590|FG003|Overall Study|Vaccine supply issue|0|||
94683160|NCT00393523|324295591|FG004|Overall Study|Vaccine supply issue|0|||
94683161|NCT02912468|324295592|FG000|Overall Study|Adverse Event|3|||
94683162|NCT02912468|324295593|FG001|Overall Study|Adverse Event|2|||
94683163|NCT02912468|324295592|FG000|Overall Study|Withdrawal by Subject|6|||
94683164|NCT02912468|324295593|FG001|Overall Study|Withdrawal by Subject|2|||
94683165|NCT02912468|324295592|FG000|Overall Study|Randomized and not treated|0|||
94683166|NCT02912468|324295593|FG001|Overall Study|Randomized and not treated|1|||
94683167|NCT00423852|324295594|FG000|Overall Study|Removed pior to the high-dose portion|3|||
94683168|NCT00980005|324295595|FG000|Overall Study|Withdrawal by Subject|6|||
94683169|NCT00980005|324295596|FG001|Overall Study|Withdrawal by Subject|17|||
94683170|NCT00980005|324295595|FG000|Overall Study|Lost to Follow-up|37|||
94683171|NCT00980005|324295596|FG001|Overall Study|Lost to Follow-up|43|||
94683172|NCT00980005|324295595|FG000|Overall Study|Other|4|||
94683173|NCT00980005|324295596|FG001|Overall Study|Other|3|||
94683174|NCT00692406|324295599|FG000|Overall Study|PI dropped, bad data|57|||
94683175|NCT01696994|324295600|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
94683176|NCT01696994|324295601|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
94683177|NCT01696994|324295600|FG000|Overall Study|Died Before Randomization|1|||
94683178|NCT01696994|324295601|FG001|Overall Study|Died Before Randomization|2|||
94683179|NCT01696994|324295600|FG000|Overall Study|Died Before ASU (Control)|73|||
94683180|NCT01696994|324295601|FG001|Overall Study|Died Before ASU (Control)|0|||
94683181|NCT01696994|324295600|FG000|Overall Study|No Ovaries at Baseline|4807|||
94683182|NCT01696994|324295601|FG001|Overall Study|No Ovaries at Baseline|4851|||
94683183|NCT01696994|324295600|FG000|Overall Study|Refused ASU (Control)|311|||
94683184|NCT01696994|324295601|FG001|Overall Study|Refused ASU (Control)|0|||
94683185|NCT01696994|324295600|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
94683186|NCT01696994|324295601|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
94683187|NCT01617005|324295602|FG000|Overall Study|Pregnancy|1|||
94683188|NCT01617005|324295602|FG000|Overall Study|Lack of motivation for treatment|1|||
94683189|NCT04772053|324295603|FG000|Overall Study|Physician Decision|2|||
94683190|NCT04772053|324295603|FG000|Overall Study|Withdrawal by Subject|3|||
94683191|NCT04772053|324295603|FG000|Overall Study|Study Terminated by Sponsor|1|||
94683192|NCT01708954|324295608|FG000|Step 1|Disease progression|26|||
94683193|NCT01708954|324295609|FG001|Step 1|Disease progression|17|||
94683194|NCT01708954|324295610|FG002|Step 1|Disease progression|14|||
94683195|NCT01708954|324295608|FG000|Step 1|Adverse Event|3|||
94683196|NCT01708954|324295609|FG001|Step 1|Adverse Event|11|||
94683197|NCT01708954|324295610|FG002|Step 1|Adverse Event|13|||
94683198|NCT01708954|324295608|FG000|Step 1|Death|3|||
94683199|NCT01708954|324295609|FG001|Step 1|Death|2|||
94683200|NCT01708954|324295610|FG002|Step 1|Death|3|||
94683201|NCT01708954|324295608|FG000|Step 1|Withdrawal by Subject|2|||
94683202|NCT01708954|324295609|FG001|Step 1|Withdrawal by Subject|5|||
94683203|NCT01708954|324295610|FG002|Step 1|Withdrawal by Subject|3|||
94683204|NCT01708954|324295608|FG000|Step 1|Other complicating disease|0|||
94683205|NCT01708954|324295609|FG001|Step 1|Other complicating disease|2|||
94683206|NCT01708954|324295610|FG002|Step 1|Other complicating disease|0|||
94683207|NCT01708954|324295608|FG000|Step 1|Crossed over to Step 2|2|||
94683208|NCT01708954|324295609|FG001|Step 1|Crossed over to Step 2|0|||
94683209|NCT01708954|324295610|FG002|Step 1|Crossed over to Step 2|0|||
94683210|NCT01708954|324295608|FG000|Step 1|Symptomatic deterioration|1|||
94683211|NCT01708954|324295609|FG001|Step 1|Symptomatic deterioration|0|||
94683212|NCT01708954|324295610|FG002|Step 1|Symptomatic deterioration|1|||
94683213|NCT01708954|324295608|FG000|Step 1|Off-treatment reason not submitted|1|||
94683214|NCT01708954|324295609|FG001|Step 1|Off-treatment reason not submitted|1|||
94683215|NCT01708954|324295610|FG002|Step 1|Off-treatment reason not submitted|1|||
94683216|NCT01708954|324295608|FG000|Step 1|Ineligible or never received treatment|4|||
94683217|NCT01708954|324295609|FG001|Step 1|Ineligible or never received treatment|2|||
94647629|NCT02346240|324170550|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
94647630|NCT02346240|324170551|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647631|NCT02346240|324170552|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
94647632|NCT02346240|324170553|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647633|NCT02346240|324170554|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647634|NCT02346240|324170555|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647635|NCT02346240|324170556|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647636|NCT02346240|324170557|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647637|NCT02346240|324170558|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647638|NCT02346240|324170559|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647639|NCT02346240|324170560|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94647640|NCT02346240|324170537|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647641|NCT02346240|324170538|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647642|NCT02346240|324170539|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647643|NCT02346240|324170540|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647644|NCT02346240|324170541|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647645|NCT02346240|324170542|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647646|NCT02346240|324170543|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647647|NCT02346240|324170544|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647648|NCT02346240|324170545|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647649|NCT02346240|324170546|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647650|NCT02346240|324170547|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647651|NCT02346240|324170548|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647652|NCT02346240|324170549|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647653|NCT02346240|324170550|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647654|NCT02346240|324170551|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
94647655|NCT02346240|324170552|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94683218|NCT01708954|324295610|FG002|Step 1|Ineligible or never received treatment|8|||
94683219|NCT01708954|324295608|FG000|Step 2|Disease progression|9|||
94263800|NCT01840605|322759929|FG000|Overall Study|Adverse Event|0|||
94683220|NCT01708954|324295609|FG001|Step 2|Disease progression|4|||
94683221|NCT01708954|324295610|FG002|Step 2|Disease progression|0|||
94683222|NCT01708954|324295608|FG000|Step 2|Adverse Event|3|||
94683223|NCT01708954|324295609|FG001|Step 2|Adverse Event|2|||
94647656|NCT02346240|324170553|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647657|NCT02346240|324170554|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647658|NCT02346240|324170555|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647659|NCT02346240|324170556|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647660|NCT02346240|324170557|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647661|NCT02346240|324170558|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647662|NCT02346240|324170559|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647663|NCT02346240|324170560|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94647664|NCT02346240|324170537|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94647665|NCT02346240|324170538|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94647666|NCT02346240|324170539|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94647667|NCT02346240|324170540|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94647668|NCT02346240|324170541|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94647669|NCT02346240|324170542|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
94647670|NCT02346240|324170543|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
94647671|NCT02346240|324170544|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
94647672|NCT02346240|324170545|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
94647673|NCT02346240|324170546|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94647674|NCT02346240|324170547|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
94647675|NCT02346240|324170548|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
94647676|NCT02346240|324170549|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94647677|NCT02346240|324170550|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
94647678|NCT02346240|324170551|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
94647679|NCT02346240|324170552|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
94647680|NCT02346240|324170553|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
94647681|NCT02346240|324170554|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94647682|NCT02346240|324170555|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94647683|NCT02346240|324170556|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94647684|NCT02346240|324170557|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94647685|NCT02346240|324170558|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94647686|NCT02346240|324170559|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94647687|NCT02346240|324170560|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94647688|NCT02346240|324170537|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647689|NCT02346240|324170538|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647690|NCT02346240|324170539|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647691|NCT02346240|324170540|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647692|NCT02346240|324170541|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647693|NCT02346240|324170542|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647694|NCT02346240|324170543|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647695|NCT02346240|324170544|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647696|NCT02346240|324170545|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647697|NCT02346240|324170546|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647698|NCT02346240|324170547|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647699|NCT02346240|324170548|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647700|NCT02346240|324170549|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647701|NCT02346240|324170550|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
94647702|NCT02346240|324170551|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
94647703|NCT02346240|324170552|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
94647704|NCT02346240|324170553|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
94647705|NCT02346240|324170554|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647706|NCT02346240|324170555|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647707|NCT02346240|324170556|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647708|NCT02346240|324170557|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647709|NCT02346240|324170558|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647710|NCT02346240|324170559|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647711|NCT02346240|324170560|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94647712|NCT02346240|324170537|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94683224|NCT01708954|324295610|FG002|Step 2|Adverse Event|0|||
94683225|NCT01708954|324295608|FG000|Step 2|Withdrawal by Subject|1|||
94683226|NCT01708954|324295609|FG001|Step 2|Withdrawal by Subject|1|||
94683227|NCT01708954|324295610|FG002|Step 2|Withdrawal by Subject|0|||
94683228|NCT03500640|324295611|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
94683229|NCT03500640|324295612|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
94683230|NCT03500640|324295613|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
94683231|NCT03500640|324295611|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
94683232|NCT03500640|324295612|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
94683233|NCT03500640|324295613|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
94683234|NCT03500640|324295611|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
94683235|NCT03500640|324295612|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
94683236|NCT03500640|324295613|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
94683237|NCT03500640|324295611|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
94683238|NCT03500640|324295612|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
94683239|NCT03500640|324295613|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
94683240|NCT03500640|324295611|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
94683241|NCT03500640|324295612|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
94683242|NCT03500640|324295613|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
94683243|NCT03500640|324295611|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
94683244|NCT03500640|324295612|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
94683245|NCT03500640|324295613|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
94683246|NCT03500640|324295611|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
94683247|NCT03500640|324295612|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
94683248|NCT03500640|324295613|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
94683249|NCT03500640|324295611|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
94683250|NCT03500640|324295612|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
94683251|NCT03500640|324295613|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
94683252|NCT03500640|324295611|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
94683253|NCT03500640|324295612|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
94683254|NCT03500640|324295613|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
94683255|NCT03500640|324295611|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
94683256|NCT03500640|324295612|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
94683257|NCT03500640|324295613|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
94683258|NCT00728962|324295614|FG000|Implant Placement Surgery|Adverse Event|8|||
94683259|NCT00728962|324295614|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
94683260|NCT00728962|324295614|FG000|Implant Placement Surgery|Protocol Violation|1|||
94683261|NCT00728962|324295614|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
94683262|NCT00728962|324295614|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
94683263|NCT05458024|324295617|FG000|Overall Study|Withdrawal by Subject|1|||
94683264|NCT05458024|324295618|FG001|Overall Study|Withdrawal by Subject|1|||
94683265|NCT01845974|324295620|FG000|Overall Study|screen failure|1|||
94683266|NCT01845974|324295621|FG001|Overall Study|screen failure|0|||
94683267|NCT05408468|324295622|FG000|Overall Study|Lost to Follow-up|3|||
94683268|NCT05408468|324295623|FG001|Overall Study|Lost to Follow-up|1|||
94683269|NCT05408468|324295622|FG000|Overall Study|Physician Decision|1|||
94683270|NCT05408468|324295623|FG001|Overall Study|Physician Decision|0|||
94683271|NCT05408468|324295622|FG000|Overall Study|Overwhelmed by clinical situation|3|||
94683272|NCT05408468|324295623|FG001|Overall Study|Overwhelmed by clinical situation|0|||
94683273|NCT05408468|324295622|FG000|Overall Study|Personal illness precluding participation|1|||
94683274|NCT05408468|324295623|FG001|Overall Study|Personal illness precluding participation|0|||
94683275|NCT05408468|324295622|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
94683276|NCT05408468|324295623|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
94683277|NCT02204579|324295624|FG000|Overall Study|Screen failures|2|||
94683278|NCT01126060|324295628|FG000|Overall Study|Protocol Violation|0|||
94683279|NCT01126060|324295629|FG001|Overall Study|Protocol Violation|2|||
94683280|NCT01686581|324295630|FG000|Overall Study|Side-effects or Health Problems|15|||
94683281|NCT01686581|324295630|FG000|Overall Study|Lack of Efficacy|90|||
94683282|NCT01686581|324295630|FG000|Overall Study|Participant Concerned about Risks|6|||
94683283|NCT01686581|324295630|FG000|Overall Study|Thinks Injections Too Painful|8|||
94683284|NCT01686581|324295630|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
94683285|NCT01686581|324295630|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
94683286|NCT01686581|324295630|FG000|Overall Study|Thinks it is Inconvenient|17|||
94683287|NCT01686581|324295630|FG000|Overall Study|Other Miscellaneous Reasons|36|||
94683288|NCT01686581|324295630|FG000|Overall Study|Reason Missing|1|||
94683289|NCT01975220|324295631|FG000|Test Period 1|Not treated|0|||
94683290|NCT01975220|324295632|FG001|Test Period 1|Not treated|1|||
94683291|NCT01975220|324295633|FG002|Test Period 1|Not treated|0|||
94683292|NCT01975220|324295634|FG003|Test Period 1|Not treated|0|||
94683293|NCT01975220|324295635|FG004|Test Period 1|Not treated|0|||
94683294|NCT01975220|324295636|FG005|Test Period 1|Not treated|0|||
94683295|NCT02965703|324295637|FG000|Overall Study|Withdrawal by Subject|6|||
94683296|NCT02965703|324295638|FG001|Overall Study|Withdrawal by Subject|3|||
94683297|NCT02965703|324295639|FG002|Overall Study|Withdrawal by Subject|1|||
94683298|NCT02965703|324295637|FG000|Overall Study|Protocol Violation|1|||
94683299|NCT02965703|324295638|FG001|Overall Study|Protocol Violation|0|||
94683300|NCT02965703|324295639|FG002|Overall Study|Protocol Violation|0|||
94683301|NCT02965703|324295637|FG000|Overall Study|Adverse Event|1|||
94683302|NCT02965703|324295638|FG001|Overall Study|Adverse Event|1|||
94683303|NCT02965703|324295639|FG002|Overall Study|Adverse Event|0|||
94683304|NCT02965703|324295637|FG000|Overall Study|Lost to Follow-up|2|||
94683305|NCT02965703|324295638|FG001|Overall Study|Lost to Follow-up|1|||
94683306|NCT02965703|324295639|FG002|Overall Study|Lost to Follow-up|1|||
94683307|NCT04534114|324295640|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
94683308|NCT04534114|324295641|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
94683309|NCT04534114|324295642|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
94683310|NCT04534114|324295643|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
94683311|NCT04534114|324295640|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
94683312|NCT04534114|324295641|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
94683313|NCT04534114|324295642|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
94683314|NCT04534114|324295643|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
94683315|NCT04534114|324295640|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
94683316|NCT04534114|324295641|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
94683317|NCT04534114|324295642|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
94683318|NCT04534114|324295643|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
94683319|NCT04534114|324295640|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
94683320|NCT04534114|324295641|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
94683321|NCT04534114|324295642|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
94683322|NCT04534114|324295643|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
94683323|NCT04534114|324295640|FG000|Main Treatment Period|Physician Decision|0|||
94683324|NCT04534114|324295641|FG001|Main Treatment Period|Physician Decision|0|||
94683325|NCT04534114|324295642|FG002|Main Treatment Period|Physician Decision|0|||
94683326|NCT04534114|324295643|FG003|Main Treatment Period|Physician Decision|1|||
94683327|NCT04534114|324295640|FG000|Main Treatment Period|Death|1|||
94683328|NCT04534114|324295641|FG001|Main Treatment Period|Death|0|||
94683329|NCT04534114|324295642|FG002|Main Treatment Period|Death|0|||
94683330|NCT04534114|324295643|FG003|Main Treatment Period|Death|1|||
94683331|NCT04534114|324295640|FG000|Main Treatment Period|Other reason|1|||
94683332|NCT04534114|324295641|FG001|Main Treatment Period|Other reason|1|||
94683333|NCT04534114|324295642|FG002|Main Treatment Period|Other reason|0|||
94683334|NCT04534114|324295643|FG003|Main Treatment Period|Other reason|0|||
94683335|NCT04534114|324295640|FG000|Main Treatment Period|Participant decision|1|||
94683336|NCT04534114|324295641|FG001|Main Treatment Period|Participant decision|3|||
94683337|NCT04534114|324295642|FG002|Main Treatment Period|Participant decision|3|||
94683338|NCT04534114|324295643|FG003|Main Treatment Period|Participant decision|1|||
94683339|NCT04534114|324295640|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
94683340|NCT04534114|324295641|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
94683341|NCT04534114|324295642|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
94683342|NCT04534114|324295643|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
94683343|NCT04534114|324295640|FG000|Main Treatment Period|Adverse Event|4|||
94683344|NCT04534114|324295641|FG001|Main Treatment Period|Adverse Event|2|||
94683345|NCT04534114|324295642|FG002|Main Treatment Period|Adverse Event|1|||
94683346|NCT04534114|324295643|FG003|Main Treatment Period|Adverse Event|2|||
94683347|NCT04534114|324295640|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
94683348|NCT04534114|324295641|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
94683349|NCT04534114|324295642|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
94683350|NCT04534114|324295643|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
94683351|NCT04534114|324295640|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
94683352|NCT04534114|324295641|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
94683353|NCT04534114|324295642|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
94683354|NCT04534114|324295643|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
94683355|NCT04534114|324295640|FG000|Extension Treatment Period|Other reason|0|||
94683356|NCT04534114|324295641|FG001|Extension Treatment Period|Other reason|1|||
94683357|NCT04534114|324295642|FG002|Extension Treatment Period|Other reason|0|||
94683358|NCT04534114|324295643|FG003|Extension Treatment Period|Other reason|0|||
94683359|NCT04534114|324295640|FG000|Extension Treatment Period|Death|0|||
94683360|NCT04534114|324295641|FG001|Extension Treatment Period|Death|0|||
94683361|NCT04534114|324295642|FG002|Extension Treatment Period|Death|1|||
94683362|NCT04534114|324295643|FG003|Extension Treatment Period|Death|2|||
94683363|NCT04534114|324295640|FG000|Extension Treatment Period|Adverse Event|0|||
94683364|NCT04534114|324295641|FG001|Extension Treatment Period|Adverse Event|1|||
94263801|NCT01840605|322759930|FG001|Overall Study|Adverse Event|1|||
94683365|NCT04534114|324295642|FG002|Extension Treatment Period|Adverse Event|0|||
94683366|NCT04534114|324295643|FG003|Extension Treatment Period|Adverse Event|1|||
94683367|NCT04534114|324295640|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
94683368|NCT04534114|324295641|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
94683369|NCT04534114|324295642|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
94683370|NCT04534114|324295643|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
94683371|NCT04006925|324295644|FG000|Overall Study|Side effects|2|||
94683372|NCT04006925|324295645|FG001|Overall Study|Side effects|0|||
94683373|NCT00876460|324295646|FG000|Combination Therapy Phase|Progressive disease|2|||
94683374|NCT00876460|324295647|FG001|Combination Therapy Phase|Progressive disease|3|||
94683375|NCT00876460|324295648|FG002|Combination Therapy Phase|Progressive disease|3|||
94683376|NCT00876460|324295649|FG003|Combination Therapy Phase|Progressive disease|3|||
94683377|NCT00876460|324295650|FG004|Combination Therapy Phase|Progressive disease|3|||
94683378|NCT00876460|324295651|FG005|Combination Therapy Phase|Progressive disease|1|||
94683379|NCT00876460|324295652|FG006|Combination Therapy Phase|Progressive disease|1|||
94683380|NCT00876460|324295653|FG007|Combination Therapy Phase|Progressive disease|1|||
94683381|NCT00876460|324295646|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
94683382|NCT00876460|324295647|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
94683383|NCT00876460|324295648|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
94683384|NCT00876460|324295649|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
94683385|NCT00876460|324295650|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
94683386|NCT00876460|324295651|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
94683387|NCT00876460|324295652|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
94683388|NCT00876460|324295653|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
94683389|NCT00876460|324295646|FG000|Combination Therapy Phase|Adverse Event|0|||
94683390|NCT00876460|324295647|FG001|Combination Therapy Phase|Adverse Event|2|||
94683391|NCT00876460|324295648|FG002|Combination Therapy Phase|Adverse Event|0|||
94683392|NCT00876460|324295649|FG003|Combination Therapy Phase|Adverse Event|2|||
94683393|NCT00876460|324295650|FG004|Combination Therapy Phase|Adverse Event|2|||
94683394|NCT00876460|324295651|FG005|Combination Therapy Phase|Adverse Event|0|||
94683395|NCT00876460|324295652|FG006|Combination Therapy Phase|Adverse Event|3|||
94683396|NCT00876460|324295653|FG007|Combination Therapy Phase|Adverse Event|2|||
94683397|NCT00876460|324295646|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
94683398|NCT00876460|324295647|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
94683399|NCT00876460|324295648|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
94683400|NCT00876460|324295649|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
94683401|NCT00876460|324295650|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
94683402|NCT00876460|324295651|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
94683403|NCT00876460|324295652|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
94683404|NCT00876460|324295653|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
94683405|NCT00876460|324295646|FG000|Combination Therapy Phase|Other reason not defined above|0|||
94683406|NCT00876460|324295647|FG001|Combination Therapy Phase|Other reason not defined above|0|||
94683407|NCT00876460|324295648|FG002|Combination Therapy Phase|Other reason not defined above|0|||
94683408|NCT00876460|324295649|FG003|Combination Therapy Phase|Other reason not defined above|0|||
94683409|NCT00876460|324295650|FG004|Combination Therapy Phase|Other reason not defined above|0|||
94683410|NCT00876460|324295651|FG005|Combination Therapy Phase|Other reason not defined above|0|||
94683411|NCT00876460|324295652|FG006|Combination Therapy Phase|Other reason not defined above|1|||
94683412|NCT00876460|324295653|FG007|Combination Therapy Phase|Other reason not defined above|2|||
94683413|NCT00876460|324295646|FG000|Combination Therapy Phase|Not treated|0|||
94683414|NCT00876460|324295647|FG001|Combination Therapy Phase|Not treated|0|||
94683415|NCT00876460|324295648|FG002|Combination Therapy Phase|Not treated|0|||
94683416|NCT00876460|324295649|FG003|Combination Therapy Phase|Not treated|0|||
94683417|NCT00876460|324295650|FG004|Combination Therapy Phase|Not treated|0|||
94683418|NCT00876460|324295651|FG005|Combination Therapy Phase|Not treated|0|||
94263802|NCT01840605|322759929|FG000|Overall Study|Physician Decision|2|||
94263803|NCT01840605|322759930|FG001|Overall Study|Physician Decision|1|||
94263804|NCT01351623|322759931|FG000|Overall Study|Protocol Violation|2|||
94263805|NCT01351623|322759931|FG000|Overall Study|Adverse Event|4|||
94263806|NCT01351623|322759931|FG000|Overall Study|Withdrawal by Subject|1|||
94263807|NCT01351623|322759931|FG000|Overall Study|Death|2|||
94263808|NCT04201821|322759932|FG000|Overall Study|Withdrawal by Subject|2|||
94263809|NCT00387764|322759933|FG000|Overall Study|Adverse Event|12|||
94263810|NCT00387764|322759933|FG000|Overall Study|Withdrawal by Subject|8|||
94263811|NCT00387764|322759933|FG000|Overall Study|Sponsor Terminated Study|1|||
94263812|NCT00387764|322759933|FG000|Overall Study|Physician Decision|1|||
94463498|NCT00336024|323485083|FG000|Overall Study|Death|2|||
94683419|NCT00876460|324295652|FG006|Combination Therapy Phase|Not treated|1|||
94683420|NCT00876460|324295653|FG007|Combination Therapy Phase|Not treated|0|||
94683421|NCT00876460|324295646|FG000|Mono Therapy Phase|Progressive disease|0|||
94683422|NCT00876460|324295647|FG001|Mono Therapy Phase|Progressive disease|0|||
94683423|NCT00876460|324295648|FG002|Mono Therapy Phase|Progressive disease|0|||
94463499|NCT00336024|323485084|FG001|Overall Study|Death|1|||
94647713|NCT02346240|324170538|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647714|NCT02346240|324170539|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647715|NCT02346240|324170540|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647716|NCT02346240|324170541|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647717|NCT02346240|324170542|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647718|NCT02346240|324170543|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
94647719|NCT02346240|324170544|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647720|NCT02346240|324170545|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647721|NCT02346240|324170546|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647722|NCT02346240|324170547|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647723|NCT02346240|324170548|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647724|NCT02346240|324170549|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647725|NCT02346240|324170550|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647726|NCT02346240|324170551|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647727|NCT02346240|324170552|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647728|NCT02346240|324170553|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647729|NCT02346240|324170554|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647730|NCT02346240|324170555|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647731|NCT02346240|324170556|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647732|NCT02346240|324170557|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647733|NCT02346240|324170558|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647734|NCT02346240|324170559|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647735|NCT02346240|324170560|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
94647736|NCT02346240|324170537|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647737|NCT02346240|324170538|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647738|NCT02346240|324170539|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647739|NCT02346240|324170540|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647740|NCT02346240|324170541|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647741|NCT02346240|324170542|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647742|NCT02346240|324170543|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647743|NCT02346240|324170544|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647744|NCT02346240|324170545|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
94647745|NCT02346240|324170546|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647746|NCT02346240|324170547|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647747|NCT02346240|324170548|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
94647748|NCT02346240|324170549|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647749|NCT02346240|324170550|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
94647750|NCT02346240|324170551|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
94647751|NCT02346240|324170552|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647752|NCT02346240|324170553|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647753|NCT02346240|324170554|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647754|NCT02346240|324170555|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647755|NCT02346240|324170556|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647756|NCT02346240|324170557|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647757|NCT02346240|324170558|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647758|NCT02346240|324170559|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647759|NCT02346240|324170560|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
94647760|NCT02346240|324170537|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647761|NCT02346240|324170538|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647762|NCT02346240|324170539|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647763|NCT02346240|324170540|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647764|NCT02346240|324170541|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647765|NCT02346240|324170542|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647766|NCT02346240|324170543|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647767|NCT02346240|324170544|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647768|NCT02346240|324170545|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94683424|NCT00876460|324295649|FG003|Mono Therapy Phase|Progressive disease|0|||
94683425|NCT00876460|324295650|FG004|Mono Therapy Phase|Progressive disease|2|||
94683426|NCT00876460|324295651|FG005|Mono Therapy Phase|Progressive disease|0|||
94683427|NCT00876460|324295652|FG006|Mono Therapy Phase|Progressive disease|1|||
94683428|NCT00876460|324295653|FG007|Mono Therapy Phase|Progressive disease|3|||
94683429|NCT00876460|324295646|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
94683430|NCT00876460|324295647|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
94683431|NCT00876460|324295648|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
94683432|NCT00876460|324295649|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
94683433|NCT00876460|324295650|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
94683434|NCT00876460|324295651|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
94683435|NCT00876460|324295652|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
94683436|NCT00876460|324295653|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
94683437|NCT00876460|324295646|FG000|Mono Therapy Phase|Adverse Event|0|||
94683438|NCT00876460|324295647|FG001|Mono Therapy Phase|Adverse Event|0|||
94683439|NCT00876460|324295648|FG002|Mono Therapy Phase|Adverse Event|0|||
94683440|NCT00876460|324295649|FG003|Mono Therapy Phase|Adverse Event|1|||
94683441|NCT00876460|324295650|FG004|Mono Therapy Phase|Adverse Event|0|||
94683442|NCT00876460|324295651|FG005|Mono Therapy Phase|Adverse Event|0|||
94683443|NCT00876460|324295652|FG006|Mono Therapy Phase|Adverse Event|0|||
94683444|NCT00876460|324295653|FG007|Mono Therapy Phase|Adverse Event|0|||
94683445|NCT00621296|324295656|FG000|Overall Study|Adverse Event|2|||
94683446|NCT00621296|324295656|FG000|Overall Study|Lack of Efficacy|1|||
94683447|NCT00621296|324295656|FG000|Overall Study|Physician Decision|7|||
94683448|NCT00621296|324295656|FG000|Overall Study|Unmatch Criteria|1|||
94683449|NCT00621296|324295656|FG000|Overall Study|Stopping Criteria|3|||
94683450|NCT02073097|324295657|FG000|Overall Study|Adverse Event|0|||
94683451|NCT02073097|324295658|FG001|Overall Study|Adverse Event|0|||
94683452|NCT02073097|324295659|FG002|Overall Study|Adverse Event|0|||
94683453|NCT02073097|324295660|FG003|Overall Study|Adverse Event|0|||
94683454|NCT02073097|324295661|FG004|Overall Study|Adverse Event|0|||
94683455|NCT02073097|324295662|FG005|Overall Study|Adverse Event|0|||
94683456|NCT02073097|324295663|FG006|Overall Study|Adverse Event|0|||
94683457|NCT02073097|324295664|FG007|Overall Study|Adverse Event|2|||
94683458|NCT02073097|324295657|FG000|Overall Study|Withdrawal by Subject|0|||
94683459|NCT02073097|324295658|FG001|Overall Study|Withdrawal by Subject|0|||
94683460|NCT02073097|324295659|FG002|Overall Study|Withdrawal by Subject|0|||
94683461|NCT02073097|324295660|FG003|Overall Study|Withdrawal by Subject|0|||
94683462|NCT02073097|324295661|FG004|Overall Study|Withdrawal by Subject|0|||
94683463|NCT02073097|324295662|FG005|Overall Study|Withdrawal by Subject|0|||
94683464|NCT02073097|324295663|FG006|Overall Study|Withdrawal by Subject|0|||
94683465|NCT02073097|324295664|FG007|Overall Study|Withdrawal by Subject|2|||
94683466|NCT02073097|324295657|FG000|Overall Study|Death|0|||
94683467|NCT02073097|324295658|FG001|Overall Study|Death|0|||
94683468|NCT02073097|324295659|FG002|Overall Study|Death|0|||
94683469|NCT02073097|324295660|FG003|Overall Study|Death|0|||
94683470|NCT02073097|324295661|FG004|Overall Study|Death|0|||
94683471|NCT02073097|324295662|FG005|Overall Study|Death|0|||
94683472|NCT02073097|324295663|FG006|Overall Study|Death|0|||
94683473|NCT02073097|324295664|FG007|Overall Study|Death|1|||
94683474|NCT02073097|324295657|FG000|Overall Study|Physician Decision|0|||
94683475|NCT02073097|324295658|FG001|Overall Study|Physician Decision|0|||
94683476|NCT02073097|324295659|FG002|Overall Study|Physician Decision|0|||
94683477|NCT02073097|324295660|FG003|Overall Study|Physician Decision|0|||
94683478|NCT02073097|324295661|FG004|Overall Study|Physician Decision|0|||
94683479|NCT02073097|324295662|FG005|Overall Study|Physician Decision|0|||
94683480|NCT02073097|324295663|FG006|Overall Study|Physician Decision|0|||
94683481|NCT02073097|324295664|FG007|Overall Study|Physician Decision|1|||
94683482|NCT01785628|324296715|FG000|Overall Study|Lost to Follow-up|2|||
94683483|NCT01785628|324296716|FG001|Overall Study|Lost to Follow-up|3|||
94683484|NCT03285295|324296721|FG000|Alinity s HBsAg|Protocol Violation|11|||
94683485|NCT03285295|324296722|FG001|Alinity s HBsAg|Protocol Violation|0|||
94683486|NCT03285295|324296723|FG002|Alinity s HBsAg|Protocol Violation|0|||
94683487|NCT03285295|324296724|FG003|Alinity s HBsAg|Protocol Violation|0|||
94683488|NCT03285295|324296725|FG004|Alinity s HBsAg|Protocol Violation|0|||
94683489|NCT03285295|324296721|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
94683490|NCT03285295|324296722|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
94463500|NCT00336024|323485083|FG000|Overall Study|Physician Decision|4|||
94463501|NCT00336024|323485084|FG001|Overall Study|Physician Decision|1|||
94683491|NCT03285295|324296723|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
94683492|NCT03285295|324296724|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
94683493|NCT03285295|324296725|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
94683494|NCT03285295|324296721|FG000|Alinity s HBsAg|No Results Generated|74|||
94683495|NCT03285295|324296722|FG001|Alinity s HBsAg|No Results Generated|6|||
94683496|NCT03285295|324296723|FG002|Alinity s HBsAg|No Results Generated|0|||
94683497|NCT03285295|324296724|FG003|Alinity s HBsAg|No Results Generated|0|||
94683498|NCT03285295|324296725|FG004|Alinity s HBsAg|No Results Generated|0|||
94683499|NCT03285295|324296721|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
94683500|NCT03285295|324296722|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
94683501|NCT03285295|324296723|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
94683502|NCT03285295|324296724|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
94683503|NCT03285295|324296725|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
94683504|NCT03285295|324296721|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
94683505|NCT03285295|324296722|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
94683506|NCT03285295|324296723|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
94683507|NCT03285295|324296724|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
94683508|NCT03285295|324296725|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
94683509|NCT03285295|324296721|FG000|Alinity s HTLV I/II|No Results Generated|70|||
94683510|NCT03285295|324296722|FG001|Alinity s HTLV I/II|No Results Generated|0|||
94683511|NCT03285295|324296723|FG002|Alinity s HTLV I/II|No Results Generated|0|||
94683512|NCT03285295|324296724|FG003|Alinity s HTLV I/II|No Results Generated|0|||
94683513|NCT03285295|324296725|FG004|Alinity s HTLV I/II|No Results Generated|0|||
94683514|NCT03285295|324296721|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
94683515|NCT03285295|324296722|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
94683516|NCT03285295|324296723|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
94683517|NCT03285295|324296724|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
94683518|NCT03285295|324296725|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
94683519|NCT03285295|324296721|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
94683520|NCT03285295|324296722|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
94683521|NCT03285295|324296723|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
94683522|NCT03285295|324296724|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
94683523|NCT03285295|324296725|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
94683524|NCT03285295|324296721|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
94683525|NCT03285295|324296722|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
94683526|NCT03285295|324296723|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
94683527|NCT03285295|324296724|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
94683528|NCT03285295|324296725|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
94683529|NCT03285295|324296721|FG000|Alinity s Anti-HCV|No Results Generated|71|||
94683530|NCT03285295|324296722|FG001|Alinity s Anti-HCV|No Results Generated|0|||
94683531|NCT03285295|324296723|FG002|Alinity s Anti-HCV|No Results Generated|0|||
94683532|NCT03285295|324296724|FG003|Alinity s Anti-HCV|No Results Generated|0|||
94683533|NCT03285295|324296725|FG004|Alinity s Anti-HCV|No Results Generated|0|||
94683534|NCT03285295|324296721|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
94683535|NCT03285295|324296722|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
94683536|NCT03285295|324296723|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
94683537|NCT03285295|324296724|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
94683538|NCT03285295|324296725|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
94683539|NCT03285295|324296721|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
94683540|NCT03285295|324296722|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
94683541|NCT03285295|324296723|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
94683542|NCT03285295|324296724|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
94683543|NCT03285295|324296725|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
94683544|NCT03285295|324296721|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
94683545|NCT03285295|324296722|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
94683546|NCT03285295|324296723|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
94683547|NCT03285295|324296724|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
94683548|NCT03285295|324296725|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
94683549|NCT03285295|324296721|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
94683550|NCT03285295|324296722|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
94683551|NCT03285295|324296723|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
94683552|NCT03285295|324296724|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
94683553|NCT03285295|324296725|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
94683554|NCT03285295|324296721|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
94683555|NCT03285295|324296722|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
94683556|NCT03285295|324296723|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
94683557|NCT03285295|324296724|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
94683558|NCT03285295|324296725|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
94683559|NCT03285295|324296721|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
94683560|NCT03285295|324296722|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
94683561|NCT03285295|324296723|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
94683562|NCT03285295|324296724|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
94683563|NCT03285295|324296725|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
94683564|NCT03285295|324296721|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
94683565|NCT03285295|324296722|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
94683566|NCT03285295|324296723|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
94683567|NCT03285295|324296724|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
94263813|NCT00387764|322759933|FG000|Overall Study|Other|2|||
94683568|NCT03285295|324296725|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
94683569|NCT03285295|324296721|FG000|Alinity s Anti-HBc|No Results Generated|70|||
94683570|NCT03285295|324296722|FG001|Alinity s Anti-HBc|No Results Generated|0|||
94683571|NCT03285295|324296723|FG002|Alinity s Anti-HBc|No Results Generated|0|||
94683572|NCT03285295|324296724|FG003|Alinity s Anti-HBc|No Results Generated|0|||
94683573|NCT03285295|324296725|FG004|Alinity s Anti-HBc|No Results Generated|0|||
94683574|NCT03285295|324296721|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
94683575|NCT03285295|324296722|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
94683576|NCT03285295|324296723|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
94683577|NCT03285295|324296724|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
94683578|NCT03285295|324296725|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
94683579|NCT03285295|324296721|FG000|Alinity s Chagas|Protocol Violation|76|||
94683580|NCT03285295|324296722|FG001|Alinity s Chagas|Protocol Violation|0|||
94683581|NCT03285295|324296723|FG002|Alinity s Chagas|Protocol Violation|0|||
94683582|NCT03285295|324296724|FG003|Alinity s Chagas|Protocol Violation|0|||
94683583|NCT03285295|324296725|FG004|Alinity s Chagas|Protocol Violation|0|||
94683584|NCT03285295|324296721|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
94683585|NCT03285295|324296722|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
94683586|NCT03285295|324296723|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
94683587|NCT03285295|324296724|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
94683588|NCT03285295|324296725|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
94683589|NCT03285295|324296721|FG000|Alinity s Chagas|No Results Generated|105|||
94683590|NCT03285295|324296722|FG001|Alinity s Chagas|No Results Generated|0|||
94683591|NCT03285295|324296723|FG002|Alinity s Chagas|No Results Generated|0|||
94683592|NCT03285295|324296724|FG003|Alinity s Chagas|No Results Generated|0|||
94683593|NCT03285295|324296725|FG004|Alinity s Chagas|No Results Generated|0|||
94683594|NCT03285295|324296721|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
94683595|NCT03285295|324296722|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
94683596|NCT03285295|324296723|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
94683597|NCT03285295|324296724|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
94683598|NCT03285295|324296725|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
94683599|NCT00332332|324296728|FG000|Overall Study|Adverse Event|13|||
94683600|NCT00332332|324296728|FG000|Overall Study|Death|1|||
94683601|NCT00332332|324296728|FG000|Overall Study|Withdrawal by Subject|8|||
94683602|NCT00332332|324296728|FG000|Overall Study|Physician Decision|1|||
94683603|NCT00332332|324296728|FG000|Overall Study|Lost to Follow-up|3|||
94683604|NCT00332332|324296728|FG000|Overall Study|Protocol deviation|4|||
94683605|NCT00332332|324296728|FG000|Overall Study|Noncompliance|2|||
94683606|NCT00332332|324296728|FG000|Overall Study|Disease progression|2|||
94683607|NCT00332332|324296728|FG000|Overall Study|Other|18|||
94683608|NCT00332332|324296728|FG000|Overall Study|Did not receive study treatment|16|||
94683609|NCT02200939|324296729|FG000|Overall Study|Participant withdrew consent|0|||
94683610|NCT02200939|324296730|FG001|Overall Study|Participant withdrew consent|1|||
94683611|NCT02200939|324296729|FG000|Overall Study|Lost to Follow-up|2|||
94683612|NCT02200939|324296730|FG001|Overall Study|Lost to Follow-up|9|||
94683613|NCT02200939|324296729|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
94683614|NCT02200939|324296730|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
94683615|NCT02746575|324296731|FG000|Overall Study|Surgery cancelled or time chaned|13|||
94683616|NCT02746575|324296731|FG000|Overall Study|Received epidural|10|||
94683617|NCT02746575|324296731|FG000|Overall Study|Withdrawal by Subject|3|||
94683618|NCT02746575|324296731|FG000|Overall Study|Bradycardia/hypotension|9|||
94683619|NCT02746575|324296731|FG000|Overall Study|Study paused|8|||
94683620|NCT02746575|324296731|FG000|Overall Study|put on beta-blocker|3|||
94683621|NCT02746575|324296731|FG000|Overall Study|type of surgery|1|||
94683622|NCT02746575|324296731|FG000|Overall Study|typ of surgery|1|||
94683623|NCT02746575|324296731|FG000|Overall Study|PI unavailable|1|||
94683624|NCT02746575|324296731|FG000|Overall Study|Unknown history of CVA|1|||
94683625|NCT00453310|324296732|FG000|Overall Study|Progression of Disease|10|||
94683626|NCT04567693|324296733|FG000|Overall Study|Death|0|||
94683627|NCT04567693|324296734|FG001|Overall Study|Death|0|||
94683628|NCT04567693|324296735|FG002|Overall Study|Death|2|||
94683629|NCT04567693|324296733|FG000|Overall Study|Lost to Follow-up|1|||
94683630|NCT04567693|324296734|FG001|Overall Study|Lost to Follow-up|0|||
94683631|NCT04567693|324296735|FG002|Overall Study|Lost to Follow-up|2|||
94683632|NCT04567693|324296733|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
94683633|NCT04567693|324296734|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
94683634|NCT04567693|324296735|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
94683635|NCT01250119|324296745|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
94683636|NCT01250119|324296746|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
94683637|NCT01250119|324296745|FG000|Diagnostic Phase|Participants Not Tested|44|||
94683638|NCT01250119|324296746|FG001|Diagnostic Phase|Participants Not Tested|0|||
94683639|NCT01250119|324296745|FG000|Treatment Phase|Progressive Disease|0|||
94683640|NCT01250119|324296746|FG001|Treatment Phase|Progressive Disease|32|||
94683641|NCT01250119|324296745|FG000|Treatment Phase|Death|0|||
94683642|NCT01250119|324296746|FG001|Treatment Phase|Death|2|||
94683643|NCT01250119|324296745|FG000|Treatment Phase|Withdrawal by Subject|0|||
94683644|NCT01250119|324296746|FG001|Treatment Phase|Withdrawal by Subject|1|||
94683645|NCT01250119|324296745|FG000|Treatment Phase|Adverse Event|0|||
94683646|NCT01250119|324296746|FG001|Treatment Phase|Adverse Event|2|||
94683647|NCT01250119|324296745|FG000|Treatment Phase|Unknown reason|0|||
94683648|NCT01250119|324296746|FG001|Treatment Phase|Unknown reason|4|||
94683649|NCT00255346|324296750|FG000|Overall Study|Adverse Event|1|||
94683650|NCT00255346|324296751|FG001|Overall Study|Adverse Event|0|||
94683651|NCT00255346|324296752|FG002|Overall Study|Adverse Event|0|||
94683652|NCT00255346|324296753|FG003|Overall Study|Adverse Event|0|||
94683653|NCT00255346|324296754|FG004|Overall Study|Adverse Event|0|||
94683654|NCT03093428|324296759|FG000|Overall Study|Not eligible for treatment|2|||
94683655|NCT03093428|324296760|FG001|Overall Study|Not eligible for treatment|1|||
94683656|NCT03093428|324296759|FG000|Overall Study|Progression|14|||
94683657|NCT03093428|324296760|FG001|Overall Study|Progression|4|||
94683658|NCT03093428|324296759|FG000|Overall Study|Death|1|||
94683659|NCT03093428|324296760|FG001|Overall Study|Death|0|||
94683660|NCT03093428|324296759|FG000|Overall Study|Adverse Event|1|||
94683661|NCT03093428|324296760|FG001|Overall Study|Adverse Event|0|||
94683662|NCT03093428|324296759|FG000|Overall Study|Withdrawal by Subject|1|||
94683663|NCT03093428|324296760|FG001|Overall Study|Withdrawal by Subject|1|||
94683664|NCT01616771|324296761|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
94683665|NCT00988221|324296762|FG000|Part I|Adverse Event|0|||
94683666|NCT00988221|324296763|FG001|Part I|Adverse Event|1|||
94683667|NCT00988221|324296764|FG002|Part I|Adverse Event|2|||
94683668|NCT00988221|324296765|FG003|Part I|Adverse Event|0|||
94683669|NCT00988221|324296762|FG000|Part I|Insufficient Therapeutic Response|4|||
94683670|NCT00988221|324296763|FG001|Part I|Insufficient Therapeutic Response|6|||
94683671|NCT00988221|324296764|FG002|Part I|Insufficient Therapeutic Response|5|||
94683672|NCT00988221|324296765|FG003|Part I|Insufficient Therapeutic Response|0|||
94683673|NCT00988221|324296762|FG000|Part I|Refused Treatment|0|||
94683674|NCT00988221|324296763|FG001|Part I|Refused Treatment|2|||
94683675|NCT00988221|324296764|FG002|Part I|Refused Treatment|1|||
94683676|NCT00988221|324296765|FG003|Part I|Refused Treatment|0|||
94683677|NCT00988221|324296762|FG000|Part I|Lost to Follow-up|0|||
94683678|NCT00988221|324296763|FG001|Part I|Lost to Follow-up|1|||
94683679|NCT00988221|324296764|FG002|Part I|Lost to Follow-up|0|||
94683680|NCT00988221|324296765|FG003|Part I|Lost to Follow-up|0|||
94683681|NCT00988221|324296762|FG000|Part II|Adverse Event|1|||
94683682|NCT00988221|324296763|FG001|Part II|Adverse Event|0|||
94683683|NCT00988221|324296764|FG002|Part II|Adverse Event|0|||
94683684|NCT00988221|324296765|FG003|Part II|Adverse Event|1|||
94683685|NCT00988221|324296762|FG000|Part II|Withdrawal by Subject|0|||
94683686|NCT00988221|324296763|FG001|Part II|Withdrawal by Subject|0|||
94683687|NCT00988221|324296764|FG002|Part II|Withdrawal by Subject|2|||
94683688|NCT00988221|324296765|FG003|Part II|Withdrawal by Subject|2|||
94683689|NCT00988221|324296762|FG000|Part II|Reason not Specified|0|||
94683690|NCT00988221|324296763|FG001|Part II|Reason not Specified|0|||
94683691|NCT00988221|324296764|FG002|Part II|Reason not Specified|1|||
94683692|NCT00988221|324296765|FG003|Part II|Reason not Specified|0|||
94683693|NCT00988221|324296762|FG000|Part III|Adverse Event|1|||
94683694|NCT00988221|324296763|FG001|Part III|Adverse Event|0|||
94683695|NCT00988221|324296764|FG002|Part III|Adverse Event|1|||
94683696|NCT00988221|324296765|FG003|Part III|Adverse Event|0|||
94683697|NCT00988221|324296762|FG000|Part III|Insufficient Therapeutic Response|0|||
94683698|NCT00988221|324296763|FG001|Part III|Insufficient Therapeutic Response|1|||
94683699|NCT00988221|324296764|FG002|Part III|Insufficient Therapeutic Response|1|||
94683700|NCT00988221|324296765|FG003|Part III|Insufficient Therapeutic Response|0|||
94683701|NCT00988221|324296762|FG000|Part III|Refused Treatment|0|||
94683702|NCT00988221|324296763|FG001|Part III|Refused Treatment|0|||
94683703|NCT00988221|324296764|FG002|Part III|Refused Treatment|1|||
94463502|NCT00336024|323485083|FG000|Overall Study|Protocol Violation|1|||
94683704|NCT00988221|324296765|FG003|Part III|Refused Treatment|0|||
94683705|NCT01215357|324296766|FG000|Overall Study|Withdrawal by Subject|3|||
94683706|NCT01215357|324296766|FG000|Overall Study|Protocol Violation|9|||
94683707|NCT02693834|324296767|FG000|Baseline Measurement|Withdrawal by Subject|1|||
94683708|NCT02693834|324296768|FG001|Baseline Measurement|Withdrawal by Subject|0|||
94683709|NCT02693834|324296767|FG000|Baseline Measurement|Adverse Event|1|||
94683710|NCT02693834|324296768|FG001|Baseline Measurement|Adverse Event|0|||
94683711|NCT02693834|324296767|FG000|Week 2 Practice|Adverse Event|0|||
94683712|NCT02693834|324296768|FG001|Week 2 Practice|Adverse Event|1|||
94683713|NCT00007475|324296769|FG000|Overall Study|Withdrawal by Subject|1|||
94463503|NCT00336024|323485084|FG001|Overall Study|Protocol Violation|0|||
94683714|NCT00007475|324296770|FG001|Overall Study|Withdrawal by Subject|0|||
94683715|NCT00007475|324296771|FG002|Overall Study|Withdrawal by Subject|0|||
94683716|NCT00007475|324296772|FG003|Overall Study|Withdrawal by Subject|0|||
94683717|NCT00007475|324296769|FG000|Overall Study|Adverse Event|3|||
94683718|NCT00007475|324296770|FG001|Overall Study|Adverse Event|0|||
94683719|NCT00007475|324296771|FG002|Overall Study|Adverse Event|0|||
94683720|NCT00007475|324296772|FG003|Overall Study|Adverse Event|0|||
94683721|NCT05796518|324296774|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
94683722|NCT02460263|324296778|FG000|Transition Period|Withdrawal by Subject|1|||
94683723|NCT02460263|324296778|FG000|Transition Period|Death|1|||
94683724|NCT00118092|324296779|FG000|Overall Study|Withdrawal by Subject|1|||
94683725|NCT00118092|324296779|FG000|Overall Study|Protocol Violation|1|||
94683726|NCT02459093|324296780|FG000|Overall Study|Protocol Violation|6|||
94683727|NCT02459093|324296781|FG001|Overall Study|Protocol Violation|11|||
94683728|NCT02459093|324296780|FG000|Overall Study|Lost to Follow-up|6|||
94683729|NCT02459093|324296781|FG001|Overall Study|Lost to Follow-up|7|||
94683730|NCT01965938|324296782|FG000|Overall Study|Withdrawal by Subject|1|||
94683731|NCT01965938|324296783|FG001|Overall Study|Withdrawal by Subject|0|||
94683732|NCT01555164|324296784|FG000|Overall Study|Adverse Event|5|||
94683733|NCT01555164|324296785|FG001|Overall Study|Adverse Event|7|||
94683734|NCT01555164|324296784|FG000|Overall Study|Hyperglycemia|0|||
94683735|NCT01555164|324296785|FG001|Overall Study|Hyperglycemia|1|||
94683736|NCT01555164|324296784|FG000|Overall Study|Investigator's Discretion|2|||
94683737|NCT01555164|324296785|FG001|Overall Study|Investigator's Discretion|2|||
94683738|NCT01555164|324296784|FG000|Overall Study|Lost to Follow-up|4|||
94683739|NCT01555164|324296785|FG001|Overall Study|Lost to Follow-up|3|||
94683740|NCT01555164|324296784|FG000|Overall Study|Protocol Violation|9|||
94683741|NCT01555164|324296785|FG001|Overall Study|Protocol Violation|5|||
94683742|NCT01555164|324296784|FG000|Overall Study|Subject Non-compliance|14|||
94683743|NCT01555164|324296785|FG001|Overall Study|Subject Non-compliance|6|||
94683744|NCT01555164|324296784|FG000|Overall Study|Subject Withdrew Consent|6|||
94683745|NCT01555164|324296785|FG001|Overall Study|Subject Withdrew Consent|11|||
94683746|NCT00886639|324296790|FG000|Overall Study|acute exacerbation|14|||
94683747|NCT00886639|324296790|FG000|Overall Study|non-compliance|2|||
94683748|NCT03203694|324296794|FG000|Overall Study|Withdrawal by Subject|2|||
94683749|NCT03203694|324296795|FG001|Overall Study|Withdrawal by Subject|0|||
94683750|NCT03203694|324296796|FG002|Overall Study|Withdrawal by Subject|0|||
94683751|NCT03203694|324296797|FG003|Overall Study|Withdrawal by Subject|0|||
94683752|NCT03203694|324296798|FG004|Overall Study|Withdrawal by Subject|0|||
94683753|NCT03203694|324296799|FG005|Overall Study|Withdrawal by Subject|0|||
94683754|NCT03311230|324296804|FG000|Overall Study|Withdrawal by Subject|1|||
94683755|NCT03311230|324296805|FG001|Overall Study|Withdrawal by Subject|4|||
94683756|NCT03311230|324296806|FG002|Overall Study|Withdrawal by Subject|2|||
94683757|NCT03311230|324296807|FG003|Overall Study|Withdrawal by Subject|7|||
94683758|NCT03311230|324296804|FG000|Overall Study|Unrelated injury|0|||
94683759|NCT03311230|324296805|FG001|Overall Study|Unrelated injury|1|||
94683760|NCT03311230|324296806|FG002|Overall Study|Unrelated injury|0|||
94683761|NCT03311230|324296807|FG003|Overall Study|Unrelated injury|0|||
94683762|NCT00171873|324296808|FG000|Overall Study|Withdrawal by Subject|4|||
94683763|NCT00171873|324296809|FG001|Overall Study|Withdrawal by Subject|2|||
94683764|NCT00171873|324296808|FG000|Overall Study|Adverse Event|5|||
94683765|NCT00171873|324296809|FG001|Overall Study|Adverse Event|0|||
94683766|NCT00171873|324296808|FG000|Overall Study|Switched to Octreotide|0|||
94683767|NCT00171873|324296809|FG001|Overall Study|Switched to Octreotide|1|||
94683768|NCT02041923|324296810|FG000|Overall Study|Lost to Follow-up|26|||
94683769|NCT02041923|324296811|FG001|Overall Study|Lost to Follow-up|30|||
94683770|NCT00381641|324296814|FG000|Overall Study|Withdrawal by Subject|0|||
94683771|NCT00381641|324296815|FG001|Overall Study|Withdrawal by Subject|2|||
94683772|NCT03813147|324296816|FG000|Overall Study|Lack of Efficacy|4|||
94683773|NCT03813147|324296817|FG001|Overall Study|Lack of Efficacy|4|||
94683774|NCT03813147|324296816|FG000|Overall Study|Physician Decision|2|||
94683775|NCT03813147|324296817|FG001|Overall Study|Physician Decision|1|||
94683776|NCT02581930|324296818|FG000|Overall Study|Withdrawal by Subject|1|||
94683777|NCT02581930|324296818|FG000|Overall Study|patient declined further treatment|1|||
94683778|NCT02936037|324298099|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
94683779|NCT02936037|324298100|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
94683780|NCT02936037|324298099|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
94683781|NCT02936037|324298100|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
94683782|NCT02936037|324298099|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
94683783|NCT02936037|324298100|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
94683784|NCT02936037|324298099|FG000|Double-Blind Treatment Period|Death|0|||
94683785|NCT02936037|324298100|FG001|Double-Blind Treatment Period|Death|1|||
94683786|NCT02936037|324298099|FG000|Double-Blind Treatment Period|Adverse Event|11|||
94683787|NCT02936037|324298100|FG001|Double-Blind Treatment Period|Adverse Event|11|||
94683788|NCT02936037|324298099|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
94683789|NCT02936037|324298100|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
94683790|NCT02936037|324298099|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
94683791|NCT02936037|324298100|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
94683792|NCT02936037|324298099|FG000|Open Label Extension|Adverse Event|0|||
94683793|NCT02936037|324298100|FG001|Open Label Extension|Adverse Event|3|||
94683794|NCT02936037|324298099|FG000|Open Label Extension|Other|0|||
94683795|NCT02936037|324298100|FG001|Open Label Extension|Other|3|||
94683796|NCT02936037|324298099|FG000|Open Label Extension|Withdrawal by Subject|0|||
94683797|NCT02936037|324298100|FG001|Open Label Extension|Withdrawal by Subject|4|||
94683798|NCT00244374|324298108|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
94683799|NCT00244374|324298109|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
94683800|NCT00244374|324298110|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
94683801|NCT00244374|324298111|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
94683802|NCT00244374|324298112|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
94683803|NCT00244374|324298108|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
94683804|NCT00244374|324298109|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
94683805|NCT00244374|324298110|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
94683806|NCT00244374|324298111|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
94683807|NCT00244374|324298112|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
94683808|NCT00244374|324298108|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
94683809|NCT00244374|324298109|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
94683810|NCT00244374|324298110|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
94683811|NCT00244374|324298111|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
94683812|NCT00244374|324298112|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
94683813|NCT00244374|324298108|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
94683814|NCT00244374|324298109|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
94683815|NCT00244374|324298110|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
94683816|NCT00244374|324298111|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
94683817|NCT00244374|324298112|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
94683818|NCT00244374|324298108|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
94683819|NCT00244374|324298109|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
94683820|NCT00244374|324298110|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
94683821|NCT00244374|324298111|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
94683822|NCT00244374|324298112|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
94683823|NCT00244374|324298108|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
94683824|NCT00244374|324298109|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
94683825|NCT00244374|324298110|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
94683826|NCT00244374|324298111|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
94683827|NCT00244374|324298112|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
94683828|NCT00244374|324298108|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
94683829|NCT00244374|324298109|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
94683830|NCT00244374|324298110|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
94683831|NCT00244374|324298111|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
94683832|NCT00244374|324298112|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
94683833|NCT00244374|324298108|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
94683834|NCT00244374|324298109|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
94683835|NCT00244374|324298110|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
94683836|NCT00244374|324298111|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
94683837|NCT00244374|324298112|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
94683838|NCT00244374|324298108|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
94683839|NCT00244374|324298109|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
94683840|NCT00244374|324298110|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
94683841|NCT00244374|324298111|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
94683842|NCT00244374|324298112|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
94683843|NCT00976482|324298113|FG000|Overall Study|Death|208|||
94683844|NCT00976482|324298113|FG000|Overall Study|Withdrawal by Subject|45|||
94683845|NCT00976482|324298113|FG000|Overall Study|Center terminated|1|||
94683846|NCT00976482|324298113|FG000|Overall Study|Protocol Violation|5|||
94683847|NCT00603265|324298117|FG000|Overall Study|Adverse Event|2|||
94683848|NCT00603265|324298118|FG001|Overall Study|Adverse Event|11|||
94683849|NCT00603265|324298119|FG002|Overall Study|Adverse Event|1|||
94683850|NCT00603265|324298117|FG000|Overall Study|Withdrawal by Subject|1|||
94683851|NCT00603265|324298118|FG001|Overall Study|Withdrawal by Subject|2|||
94683852|NCT00603265|324298119|FG002|Overall Study|Withdrawal by Subject|1|||
94683853|NCT00603265|324298117|FG000|Overall Study|Lack of Efficacy|3|||
94683854|NCT00603265|324298118|FG001|Overall Study|Lack of Efficacy|0|||
94683855|NCT00603265|324298119|FG002|Overall Study|Lack of Efficacy|3|||
94263814|NCT00387764|322759933|FG000|Overall Study|Death|7|||
94683856|NCT00603265|324298117|FG000|Overall Study|Lost to Follow-up|0|||
94683857|NCT00603265|324298118|FG001|Overall Study|Lost to Follow-up|1|||
94683858|NCT00603265|324298119|FG002|Overall Study|Lost to Follow-up|0|||
94683859|NCT00603265|324298117|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
94683860|NCT00603265|324298118|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
94683861|NCT00603265|324298119|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
94683862|NCT00603265|324298117|FG000|Overall Study|Participant Left Country, No Responses|0|||
94683863|NCT00603265|324298118|FG001|Overall Study|Participant Left Country, No Responses|1|||
94683864|NCT00603265|324298119|FG002|Overall Study|Participant Left Country, No Responses|0|||
94683865|NCT00603265|324298117|FG000|Overall Study|Protocol Violation|1|||
94683866|NCT00603265|324298118|FG001|Overall Study|Protocol Violation|0|||
94683867|NCT00603265|324298119|FG002|Overall Study|Protocol Violation|0|||
94683868|NCT00462670|324298120|FG000|Overall Study|Adverse Event|3|||
94683869|NCT00462670|324298121|FG001|Overall Study|Adverse Event|5|||
94683870|NCT00462670|324298120|FG000|Overall Study|Lack of Efficacy|1|||
94683871|NCT00462670|324298121|FG001|Overall Study|Lack of Efficacy|0|||
94683872|NCT00462670|324298120|FG000|Overall Study|Protocol Violation|1|||
94683873|NCT00462670|324298121|FG001|Overall Study|Protocol Violation|0|||
94683874|NCT00462670|324298120|FG000|Overall Study|Resolution of signs and symptoms|0|||
94683875|NCT00462670|324298121|FG001|Overall Study|Resolution of signs and symptoms|2|||
94683876|NCT02110732|324298122|FG000|Overall Study|Physician Decision|5|||
94683877|NCT02110732|324298123|FG001|Overall Study|Physician Decision|2|||
94683878|NCT02110732|324298122|FG000|Overall Study|Lost to Follow-up|1|||
94683879|NCT02110732|324298123|FG001|Overall Study|Lost to Follow-up|1|||
94683880|NCT01336634|324298125|FG000|Overall Study|Study closed/terminated|5|||
94683881|NCT01336634|324298126|FG001|Overall Study|Study closed/terminated|6|||
94683882|NCT01336634|324298127|FG002|Overall Study|Study closed/terminated|6|||
94683883|NCT01336634|324298125|FG000|Overall Study|Lost to Follow-up|2|||
94683884|NCT01336634|324298126|FG001|Overall Study|Lost to Follow-up|1|||
94683885|NCT01336634|324298127|FG002|Overall Study|Lost to Follow-up|1|||
94683886|NCT01336634|324298125|FG000|Overall Study|Physician Decision|1|||
94683887|NCT01336634|324298126|FG001|Overall Study|Physician Decision|1|||
94683888|NCT01336634|324298127|FG002|Overall Study|Physician Decision|0|||
94683889|NCT01336634|324298125|FG000|Overall Study|Withdrawal by Subject|6|||
94683890|NCT01336634|324298126|FG001|Overall Study|Withdrawal by Subject|0|||
94683891|NCT01336634|324298127|FG002|Overall Study|Withdrawal by Subject|2|||
94683892|NCT01118455|324298128|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
94683893|NCT01118455|324298129|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
94683894|NCT02948959|324298134|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
94683895|NCT02948959|324298135|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
94683896|NCT02948959|324298134|FG000|52 Weeks Treatment Period|Adverse Event|2|||
94683897|NCT02948959|324298135|FG001|52 Weeks Treatment Period|Adverse Event|5|||
94683898|NCT02948959|324298134|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
94683899|NCT02948959|324298135|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
94683900|NCT02948959|324298134|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
94683901|NCT02948959|324298135|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
94683902|NCT02948959|324298134|FG000|52 Weeks Treatment Period|Randomized by error|0|||
94683903|NCT02948959|324298135|FG001|52 Weeks Treatment Period|Randomized by error|5|||
94683904|NCT02948959|324298134|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
94683905|NCT02948959|324298135|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
94683906|NCT02948959|324298134|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
94683907|NCT02948959|324298135|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
94683908|NCT02948959|324298134|FG000|52 Weeks Treatment Period|Change of residence location|0|||
94683909|NCT02948959|324298135|FG001|52 Weeks Treatment Period|Change of residence location|1|||
94683910|NCT02948959|324298134|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
94683911|NCT02948959|324298135|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
94683912|NCT02948959|324298134|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
94683913|NCT02948959|324298135|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
94683914|NCT02948959|324298134|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
94683915|NCT02948959|324298135|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
94683916|NCT02948959|324298134|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
94683917|NCT02948959|324298135|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
94683918|NCT02948959|324298134|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
94683919|NCT02948959|324298135|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
94683920|NCT02948959|324298134|FG000|12 Weeks Follow-up Period|Study site closure|1|||
94683921|NCT02948959|324298135|FG001|12 Weeks Follow-up Period|Study site closure|0|||
94683922|NCT01932294|324298136|FG000|Overall Study|Death|43|||
94683923|NCT01932294|324298136|FG000|Overall Study|Lost to Follow-up|8|||
94683924|NCT01932294|324298136|FG000|Overall Study|VAD Implantation|20|||
94683925|NCT01932294|324298136|FG000|Overall Study|Heart Transplantation|16|||
94683926|NCT01932294|324298136|FG000|Overall Study|Transferred to other hospitals|12|||
94683927|NCT00409786|324298137|FG000|Overall Study|Withdrawal by Subject|3|||
94683928|NCT03075904|324298138|FG000|Overall Study|Physician Decision|3|||
94683929|NCT03075904|324298138|FG000|Overall Study|Need for Medication not Permitted|1|||
94683930|NCT00519896|324298139|FG000|Overall Study|Protocol Violation|1|||
94683931|NCT00519896|324298139|FG000|Overall Study|Adverse Event|1|||
94683932|NCT02367716|324298140|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
94683933|NCT00301080|324298142|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
94683934|NCT00301080|324298143|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
94683935|NCT00301080|324298144|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
94683936|NCT00301080|324298145|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
94683937|NCT00301080|324298146|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
94683938|NCT00927355|324298147|FG000|Overall Study|Adverse Event|1|||
94683939|NCT00927355|324298148|FG001|Overall Study|Adverse Event|1|||
94683940|NCT03066622|324298149|FG000|Overall Study|Lost to Follow-up|24|||
94683941|NCT03066622|324298150|FG001|Overall Study|Lost to Follow-up|25|||
94683942|NCT03066622|324298149|FG000|Overall Study|Withdrawal by Subject|2|||
94683943|NCT03066622|324298150|FG001|Overall Study|Withdrawal by Subject|1|||
94683944|NCT04741802|324298155|FG000|Overall Study|Death|1|||
94683945|NCT04741802|324298155|FG000|Overall Study|Lost to Follow-up|11|||
94683946|NCT03560258|324298157|FG000|Overall Study|Lost to Follow-up|3|||
94683947|NCT03560258|324298158|FG001|Overall Study|Lost to Follow-up|0|||
94683948|NCT03560258|324298159|FG002|Overall Study|Lost to Follow-up|0|||
94683949|NCT03560258|324298157|FG000|Overall Study|Protocol Violation|0|||
94683950|NCT03560258|324298158|FG001|Overall Study|Protocol Violation|1|||
94683951|NCT03560258|324298159|FG002|Overall Study|Protocol Violation|0|||
94683952|NCT03560258|324298157|FG000|Overall Study|Withdrawal by Subject|0|||
94683953|NCT03560258|324298158|FG001|Overall Study|Withdrawal by Subject|0|||
94683954|NCT03560258|324298159|FG002|Overall Study|Withdrawal by Subject|1|||
94683955|NCT02281760|324298160|FG000|Overall Study|Withdrawal by Subject|1|||
94683956|NCT00744328|324298161|FG000|Overall Study|Lost to Follow-up|2|||
94683957|NCT00744328|324298162|FG001|Overall Study|Lost to Follow-up|5|||
94683958|NCT00744328|324298163|FG002|Overall Study|Lost to Follow-up|3|||
94683959|NCT00744328|324298161|FG000|Overall Study|Withdrawal by Subject|5|||
94683960|NCT00744328|324298162|FG001|Overall Study|Withdrawal by Subject|3|||
94683961|NCT00744328|324298163|FG002|Overall Study|Withdrawal by Subject|4|||
94683962|NCT00744328|324298161|FG000|Overall Study|Found ineligible after randomization|0|||
94683963|NCT00744328|324298162|FG001|Overall Study|Found ineligible after randomization|0|||
94683964|NCT00744328|324298163|FG002|Overall Study|Found ineligible after randomization|1|||
94647769|NCT02346240|324170546|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
94647770|NCT02346240|324170547|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647771|NCT02346240|324170548|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647772|NCT02346240|324170549|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647773|NCT02346240|324170550|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647774|NCT02346240|324170551|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647775|NCT02346240|324170552|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647776|NCT02346240|324170553|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647777|NCT02346240|324170554|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647778|NCT02346240|324170555|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647779|NCT02346240|324170556|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647780|NCT02346240|324170557|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647781|NCT02346240|324170558|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647782|NCT02346240|324170559|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647783|NCT02346240|324170560|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
94647784|NCT02346240|324170537|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647785|NCT02346240|324170538|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647786|NCT02346240|324170539|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647787|NCT02346240|324170540|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647788|NCT02346240|324170541|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647789|NCT02346240|324170542|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647790|NCT02346240|324170543|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647791|NCT02346240|324170544|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647792|NCT02346240|324170545|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94683965|NCT01540565|324298164|FG000|Overall Study|Ineligible|2|||
94683966|NCT01678820|324298167|FG000|Overall Study|Study Terminated by Sponsor|45|||
94683967|NCT01678820|324298168|FG001|Overall Study|Study Terminated by Sponsor|43|||
94683968|NCT01678820|324298169|FG002|Overall Study|Study Terminated by Sponsor|43|||
94683969|NCT01678820|324298167|FG000|Overall Study|Withdrawal by Subject|2|||
94683970|NCT01678820|324298168|FG001|Overall Study|Withdrawal by Subject|5|||
94683971|NCT01678820|324298169|FG002|Overall Study|Withdrawal by Subject|2|||
94683972|NCT01678820|324298167|FG000|Overall Study|Protocol Specified Criteria|2|||
94683973|NCT01678820|324298168|FG001|Overall Study|Protocol Specified Criteria|3|||
94683974|NCT01678820|324298169|FG002|Overall Study|Protocol Specified Criteria|1|||
94683975|NCT01678820|324298167|FG000|Overall Study|Adverse Event|2|||
94683976|NCT01678820|324298168|FG001|Overall Study|Adverse Event|2|||
94683977|NCT01678820|324298169|FG002|Overall Study|Adverse Event|2|||
94683978|NCT01678820|324298167|FG000|Overall Study|Lost to Follow-up|7|||
94683979|NCT01678820|324298168|FG001|Overall Study|Lost to Follow-up|2|||
94683980|NCT01678820|324298169|FG002|Overall Study|Lost to Follow-up|2|||
94683981|NCT01678820|324298167|FG000|Overall Study|Non-compliance with study drug|0|||
94683982|NCT01678820|324298168|FG001|Overall Study|Non-compliance with study drug|1|||
94683983|NCT01678820|324298169|FG002|Overall Study|Non-compliance with study drug|0|||
94683984|NCT01678820|324298167|FG000|Overall Study|Physician Decision|0|||
94683985|NCT01678820|324298168|FG001|Overall Study|Physician Decision|0|||
94683986|NCT01678820|324298169|FG002|Overall Study|Physician Decision|1|||
94683987|NCT01678820|324298167|FG000|Overall Study|Protocol Violation|4|||
94683988|NCT01678820|324298168|FG001|Overall Study|Protocol Violation|5|||
94683989|NCT01678820|324298169|FG002|Overall Study|Protocol Violation|4|||
94683990|NCT01678820|324298167|FG000|Overall Study|Not treated with double-blind study drug|0|||
94683991|NCT01678820|324298168|FG001|Overall Study|Not treated with double-blind study drug|2|||
94683992|NCT01678820|324298169|FG002|Overall Study|Not treated with double-blind study drug|2|||
94683993|NCT01346514|324298172|FG000|Overall Study|Lost to Follow-up|19|||
94683994|NCT01346514|324298173|FG001|Overall Study|Lost to Follow-up|30|||
94683995|NCT01346514|324298172|FG000|Overall Study|Withdrawal by Subject|7|||
94683996|NCT01346514|324298173|FG001|Overall Study|Withdrawal by Subject|3|||
94683997|NCT01346514|324298172|FG000|Overall Study|Death|3|||
94683998|NCT01346514|324298173|FG001|Overall Study|Death|4|||
94683999|NCT03906071|324298174|FG000|Overall Study|Death|180|||
94684000|NCT03906071|324298175|FG001|Overall Study|Death|185|||
94684001|NCT03906071|324298174|FG000|Overall Study|Lost to Follow-up|3|||
94684002|NCT03906071|324298175|FG001|Overall Study|Lost to Follow-up|3|||
94684003|NCT03906071|324298174|FG000|Overall Study|Withdrawal by Subject|15|||
94684004|NCT03906071|324298175|FG001|Overall Study|Withdrawal by Subject|27|||
94684005|NCT03906071|324298174|FG000|Overall Study|Other|2|||
94684006|NCT03906071|324298175|FG001|Overall Study|Other|1|||
94684007|NCT00245856|324298179|FG000|Period Two|Withdrawal by Subject|0|||
94684008|NCT00245856|324298180|FG001|Period Two|Withdrawal by Subject|1|||
94684009|NCT00557622|324298181|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
94684010|NCT00557622|324298182|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
94684011|NCT00557622|324298181|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
94684012|NCT00557622|324298182|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
94684013|NCT00557622|324298181|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
94684014|NCT00557622|324298182|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
94684015|NCT00879996|324298189|FG000|Overall Study|Lost to Follow-up|7|||
94684016|NCT00879996|324298190|FG001|Overall Study|Lost to Follow-up|6|||
94684017|NCT00879996|324298189|FG000|Overall Study|non-compliance|6|||
94684018|NCT00879996|324298190|FG001|Overall Study|non-compliance|4|||
94684019|NCT00879996|324298189|FG000|Overall Study|Physician Decision|1|||
94684020|NCT00879996|324298190|FG001|Overall Study|Physician Decision|2|||
94684021|NCT00879996|324298189|FG000|Overall Study|psychiatric problem|0|||
94684022|NCT00879996|324298190|FG001|Overall Study|psychiatric problem|1|||
94684023|NCT00879996|324298189|FG000|Overall Study|put on parole|1|||
94684024|NCT00879996|324298190|FG001|Overall Study|put on parole|0|||
94684025|NCT00098254|324298191|FG000|Overall Study|Adverse Event|2|||
94684026|NCT00098254|324298191|FG000|Overall Study|Death|1|||
94684027|NCT00130793|324298192|FG000|Overall Study|Lost to Follow-up|1|||
94684028|NCT00130793|324298193|FG001|Overall Study|Lost to Follow-up|4|||
94684029|NCT00130793|324298192|FG000|Overall Study|Withdrew consent|2|||
94684030|NCT00130793|324298193|FG001|Overall Study|Withdrew consent|0|||
94684031|NCT01650519|324298194|FG000|Overall Study|Withdrawal by Subject|1|||
94684032|NCT01650519|324298195|FG001|Overall Study|Withdrawal by Subject|0|||
94684033|NCT02667886|324298196|FG000|Dose Escalation (Part A)|Adverse Event|1|||
94684034|NCT02667886|324298197|FG001|Dose Escalation (Part A)|Adverse Event|3|||
94684035|NCT02667886|324298198|FG002|Dose Escalation (Part A)|Adverse Event|1|||
94684036|NCT02667886|324298199|FG003|Dose Escalation (Part A)|Adverse Event|0|||
94684037|NCT02667886|324298200|FG004|Dose Escalation (Part A)|Adverse Event|0|||
94684038|NCT02667886|324298196|FG000|Dose Escalation (Part A)|Disease Progression|1|||
94684039|NCT02667886|324298197|FG001|Dose Escalation (Part A)|Disease Progression|4|||
94684040|NCT02667886|324298198|FG002|Dose Escalation (Part A)|Disease Progression|3|||
94684041|NCT02667886|324298199|FG003|Dose Escalation (Part A)|Disease Progression|0|||
94684042|NCT02667886|324298200|FG004|Dose Escalation (Part A)|Disease Progression|0|||
94684043|NCT02667886|324298196|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
94684044|NCT02667886|324298197|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
94684045|NCT02667886|324298198|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
94684046|NCT02667886|324298199|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
94684047|NCT02667886|324298200|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
94684048|NCT02667886|324298196|FG000|Dose Expansion (Part B)|Adverse Event|0|||
94647793|NCT02346240|324170546|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647794|NCT02346240|324170547|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
94647795|NCT02346240|324170548|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647796|NCT02346240|324170549|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647797|NCT02346240|324170550|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647798|NCT02346240|324170551|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647799|NCT02346240|324170552|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647800|NCT02346240|324170553|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647801|NCT02346240|324170554|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647802|NCT02346240|324170555|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647803|NCT02346240|324170556|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647804|NCT02346240|324170557|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647805|NCT02346240|324170558|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647806|NCT02346240|324170559|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647807|NCT02346240|324170560|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
94647808|NCT02346240|324170537|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647809|NCT02346240|324170538|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647810|NCT02346240|324170539|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647811|NCT02346240|324170540|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647812|NCT02346240|324170541|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647813|NCT02346240|324170542|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647814|NCT02346240|324170543|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647815|NCT02346240|324170544|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647816|NCT02346240|324170545|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647817|NCT02346240|324170546|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647818|NCT02346240|324170547|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647819|NCT02346240|324170548|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647820|NCT02346240|324170549|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647821|NCT02346240|324170550|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647822|NCT02346240|324170551|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
94647823|NCT02346240|324170552|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647824|NCT02346240|324170553|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647825|NCT02346240|324170554|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647826|NCT02346240|324170555|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647827|NCT02346240|324170556|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647828|NCT02346240|324170557|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647829|NCT02346240|324170558|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647830|NCT02346240|324170559|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647831|NCT02346240|324170560|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
94647832|NCT02346240|324170537|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647833|NCT02346240|324170538|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647834|NCT02346240|324170539|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647835|NCT02346240|324170540|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647836|NCT02346240|324170541|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647837|NCT02346240|324170542|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647838|NCT02346240|324170543|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647839|NCT02346240|324170544|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647840|NCT02346240|324170545|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647841|NCT02346240|324170546|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647842|NCT02346240|324170547|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647843|NCT02346240|324170548|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647844|NCT02346240|324170549|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647845|NCT02346240|324170550|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647846|NCT02346240|324170551|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
94647847|NCT02346240|324170552|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647848|NCT02346240|324170553|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647849|NCT02346240|324170554|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94684049|NCT02667886|324298197|FG001|Dose Expansion (Part B)|Adverse Event|0|||
94684050|NCT02667886|324298198|FG002|Dose Expansion (Part B)|Adverse Event|0|||
94647850|NCT02346240|324170555|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647851|NCT02346240|324170556|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647852|NCT02346240|324170557|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647853|NCT02346240|324170558|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647854|NCT02346240|324170559|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647855|NCT02346240|324170560|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
94647856|NCT02346240|324170537|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647857|NCT02346240|324170538|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647858|NCT02346240|324170539|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647859|NCT02346240|324170540|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647860|NCT02346240|324170541|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647861|NCT02346240|324170542|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647862|NCT02346240|324170543|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647863|NCT02346240|324170544|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647864|NCT02346240|324170545|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647865|NCT02346240|324170546|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647866|NCT02346240|324170547|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647867|NCT02346240|324170548|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647868|NCT02346240|324170549|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647869|NCT02346240|324170550|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647870|NCT02346240|324170551|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
94647871|NCT02346240|324170552|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647872|NCT02346240|324170553|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647873|NCT02346240|324170554|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647874|NCT02346240|324170555|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647875|NCT02346240|324170556|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647876|NCT02346240|324170557|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647877|NCT02346240|324170558|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647878|NCT02346240|324170559|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647879|NCT02346240|324170560|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
94647880|NCT02346240|324170537|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
94647881|NCT02346240|324170538|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
94647882|NCT02346240|324170539|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
94647883|NCT02346240|324170540|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
94647884|NCT02346240|324170541|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
94647885|NCT02346240|324170542|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
94647886|NCT02346240|324170543|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
94647887|NCT02346240|324170544|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
94647888|NCT02346240|324170545|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
94647889|NCT02346240|324170546|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
94647890|NCT02346240|324170547|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
94647891|NCT02346240|324170548|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
94647892|NCT02346240|324170549|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
94647893|NCT02346240|324170550|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
94647894|NCT02346240|324170551|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
94647895|NCT02346240|324170552|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
94647896|NCT02346240|324170553|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
94647897|NCT02346240|324170554|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
94647898|NCT02346240|324170555|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
94647899|NCT02346240|324170556|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
94647900|NCT02346240|324170557|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
94647901|NCT02346240|324170558|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
94647902|NCT02346240|324170559|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
94647903|NCT02346240|324170560|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
94647904|NCT02346240|324170537|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
94684051|NCT02667886|324298199|FG003|Dose Expansion (Part B)|Adverse Event|9|||
94684052|NCT02667886|324298200|FG004|Dose Expansion (Part B)|Adverse Event|0|||
94684053|NCT02667886|324298196|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
94263815|NCT04226833|322759934|FG000|Overall Study|Death|0|||
94684054|NCT02667886|324298197|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
94684055|NCT02667886|324298198|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
94684056|NCT02667886|324298199|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
94684057|NCT02667886|324298200|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
94684058|NCT02667886|324298196|FG000|Dose Expansion (Part B)|Disease Progression|0|||
94684059|NCT02667886|324298197|FG001|Dose Expansion (Part B)|Disease Progression|0|||
94684060|NCT02667886|324298198|FG002|Dose Expansion (Part B)|Disease Progression|0|||
94684061|NCT02667886|324298199|FG003|Dose Expansion (Part B)|Disease Progression|38|||
94684062|NCT02667886|324298200|FG004|Dose Expansion (Part B)|Disease Progression|0|||
94684063|NCT02667886|324298196|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
94684064|NCT02667886|324298197|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
94684065|NCT02667886|324298198|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
94684066|NCT02667886|324298199|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
94684067|NCT02667886|324298200|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
94684068|NCT02667886|324298196|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
94684069|NCT02667886|324298197|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
94684070|NCT02667886|324298198|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
94684071|NCT02667886|324298199|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
94684072|NCT02667886|324298200|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
94263816|NCT04226833|322759935|FG001|Overall Study|Death|0|||
94647905|NCT02346240|324170538|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647906|NCT02346240|324170539|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647907|NCT02346240|324170540|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647908|NCT02346240|324170541|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647909|NCT02346240|324170542|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647910|NCT02346240|324170543|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647911|NCT02346240|324170544|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647912|NCT02346240|324170545|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647913|NCT02346240|324170546|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647914|NCT02346240|324170547|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647915|NCT02346240|324170548|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647916|NCT02346240|324170549|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647917|NCT02346240|324170550|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647918|NCT02346240|324170551|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647919|NCT02346240|324170552|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647920|NCT02346240|324170553|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647921|NCT02346240|324170554|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647922|NCT02346240|324170555|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
94647923|NCT02346240|324170556|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
94647924|NCT02346240|324170557|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647925|NCT02346240|324170558|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
94647926|NCT02346240|324170559|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647927|NCT02346240|324170560|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
94647928|NCT02346240|324170537|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647929|NCT02346240|324170538|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647930|NCT02346240|324170539|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647931|NCT02346240|324170540|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647932|NCT02346240|324170541|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647933|NCT02346240|324170542|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647934|NCT02346240|324170543|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647935|NCT02346240|324170544|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647936|NCT02346240|324170545|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647937|NCT02346240|324170546|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647938|NCT02346240|324170547|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647939|NCT02346240|324170548|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647940|NCT02346240|324170549|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647941|NCT02346240|324170550|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647942|NCT02346240|324170551|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647943|NCT02346240|324170552|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94684073|NCT02667886|324298196|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
94684074|NCT02667886|324298197|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
94684075|NCT02667886|324298198|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
94684076|NCT02667886|324298199|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
94684077|NCT02667886|324298200|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
94684078|NCT05672680|324298201|FG000|Overall Study|Patient Did Not Complete the Form|5|||
94684079|NCT05672680|324298202|FG001|Overall Study|Patient Did Not Complete the Form|4|||
94684080|NCT05672680|324298201|FG000|Overall Study|Procedure Aborted|1|||
94684081|NCT05672680|324298202|FG001|Overall Study|Procedure Aborted|0|||
94684082|NCT03006848|324298203|FG000|Overall Study|Adverse Event|1|||
94684083|NCT03006848|324298203|FG000|Overall Study|Physician Decision|1|||
94684084|NCT03006848|324298203|FG000|Overall Study|Lack of Efficacy|16|||
94684085|NCT00265330|324298207|FG000|Overall Study|Adverse Event|41|||
94684086|NCT00265330|324298207|FG000|Overall Study|Lost to Follow-up|8|||
94684087|NCT00265330|324298207|FG000|Overall Study|Withdrawal by Subject|34|||
94684088|NCT00265330|324298207|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
94684089|NCT00265330|324298207|FG000|Overall Study|Lack of Efficacy|4|||
94684090|NCT00265330|324298207|FG000|Overall Study|Family Scheduling Conflicts|1|||
94684091|NCT00265330|324298207|FG000|Overall Study|Began Taking Formulary Geodon|1|||
94684092|NCT00265330|324298207|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
94684093|NCT00265330|324298207|FG000|Overall Study|Site Closed by Sponsor|1|||
94684094|NCT00265330|324298207|FG000|Overall Study|Principal Investigators Request|1|||
94684095|NCT00265330|324298207|FG000|Overall Study|Withdrew Consent|1|||
94684096|NCT00265330|324298207|FG000|Overall Study|Protocol Violation|1|||
94684097|NCT02213328|324298208|FG000|Overall Study|Withdrawal by Subject|10|||
94684098|NCT02213328|324298208|FG000|Overall Study|Physician Decision|2|||
94684099|NCT02213328|324298208|FG000|Overall Study|Lost to Follow-up|16|||
94684100|NCT02821819|324298209|FG000|Overall Study|Protocol Violation|1|||
94684101|NCT05778526|324298210|FG000|Overall Study|Lost to Follow-up|0|||
94684102|NCT05778526|324298211|FG001|Overall Study|Lost to Follow-up|1|||
94684103|NCT05778526|324298212|FG002|Overall Study|Lost to Follow-up|3|||
94684104|NCT05778526|324298210|FG000|Overall Study|Protocol Violation|0|||
94684105|NCT05778526|324298211|FG001|Overall Study|Protocol Violation|0|||
94684106|NCT05778526|324298212|FG002|Overall Study|Protocol Violation|8|||
94684107|NCT03556358|324298215|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
94684108|NCT03556358|324298216|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
94684109|NCT03556358|324298215|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
94684110|NCT03556358|324298216|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
94684111|NCT03556358|324298215|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
94684112|NCT03556358|324298216|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
94684113|NCT03556358|324298215|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
94684114|NCT03556358|324298216|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
94684115|NCT03556358|324298215|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
94684116|NCT03556358|324298216|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
94684117|NCT03556358|324298215|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
94684118|NCT03556358|324298216|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
94684119|NCT03556358|324298215|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
94684120|NCT03556358|324298216|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
94684121|NCT00399763|324298219|FG000|Overall Study|Lost to Follow-up|2|||
94684122|NCT00399763|324298220|FG001|Overall Study|Lost to Follow-up|3|||
94684123|NCT03734991|324298221|FG000|Overall Study|Adverse Event|4|||
94684124|NCT03734991|324298222|FG001|Overall Study|Adverse Event|0|||
94684125|NCT03734991|324298221|FG000|Overall Study|Lost to Follow-up|4|||
94684126|NCT03734991|324298222|FG001|Overall Study|Lost to Follow-up|0|||
94684127|NCT03734991|324298221|FG000|Overall Study|Physician Decision|0|||
94684128|NCT03734991|324298222|FG001|Overall Study|Physician Decision|1|||
94684129|NCT03734991|324298221|FG000|Overall Study|Pregnancy|1|||
94684130|NCT03734991|324298222|FG001|Overall Study|Pregnancy|0|||
94684131|NCT03734991|324298221|FG000|Overall Study|Withdrawal by Subject|6|||
94684132|NCT03734991|324298222|FG001|Overall Study|Withdrawal by Subject|3|||
94684133|NCT03734991|324298221|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
94684134|NCT03734991|324298222|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
94684135|NCT03734991|324298221|FG000|Overall Study|Other|2|||
94263817|NCT04226833|322759936|FG002|Overall Study|Death|1|||
94263818|NCT04226833|322759937|FG003|Overall Study|Death|0|||
94684136|NCT03734991|324298222|FG001|Overall Study|Other|2|||
94684137|NCT04182880|324298223|FG000|Overall Study|Pregnancy|1|||
94684138|NCT04182880|324298224|FG001|Overall Study|Pregnancy|0|||
94684139|NCT01861522|324298243|FG000|Overall Study|Adverse Event|1|||
94684140|NCT01861522|324298244|FG001|Overall Study|Adverse Event|0|||
94263819|NCT01102803|322759938|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
94684141|NCT01861522|324298243|FG000|Overall Study|Withdrawal by Subject|2|||
94684142|NCT01861522|324298244|FG001|Overall Study|Withdrawal by Subject|0|||
94684143|NCT00550550|324298245|FG000|Overall Study|Adverse Event|13|||
94684144|NCT00550550|324298246|FG001|Overall Study|Adverse Event|5|||
94263820|NCT01102803|322759939|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
94684145|NCT00550550|324298245|FG000|Overall Study|Treatment Failure|0|||
94684146|NCT00550550|324298246|FG001|Overall Study|Treatment Failure|1|||
94684147|NCT00550550|324298245|FG000|Overall Study|Lost to Follow-up|4|||
94684148|NCT00550550|324298246|FG001|Overall Study|Lost to Follow-up|0|||
94684149|NCT00550550|324298245|FG000|Overall Study|Withdrawal by Subject|10|||
94684150|NCT00550550|324298246|FG001|Overall Study|Withdrawal by Subject|8|||
94684151|NCT00550550|324298245|FG000|Overall Study|Protocol Violation|5|||
94684152|NCT00550550|324298246|FG001|Overall Study|Protocol Violation|14|||
94684153|NCT00550550|324298245|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
94684154|NCT00550550|324298246|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
94684155|NCT00550550|324298245|FG000|Overall Study|Randomized But Not Treated|1|||
94684156|NCT00550550|324298246|FG001|Overall Study|Randomized But Not Treated|0|||
94684157|NCT01103960|324298247|FG000|Overall Study|Adverse Event|2|||
94684158|NCT01103960|324298248|FG001|Overall Study|Adverse Event|1|||
94684159|NCT01103960|324298247|FG000|Overall Study|Withdrawal by Subject|2|||
94684160|NCT01103960|324298248|FG001|Overall Study|Withdrawal by Subject|1|||
94684161|NCT01103960|324298247|FG000|Overall Study|Other|1|||
94684162|NCT01103960|324298248|FG001|Overall Study|Other|0|||
94684163|NCT02049710|324298253|FG000|Overall Study|Lost to Follow-up|319|||
94684164|NCT02049710|324298254|FG001|Overall Study|Lost to Follow-up|324|||
94684165|NCT01672853|324298258|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
94684166|NCT01672853|324298259|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
94684167|NCT01672853|324298260|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
94684168|NCT01672853|324298258|FG000|Overall Study|Pregnancy|0|||
94684169|NCT01672853|324298259|FG001|Overall Study|Pregnancy|1|||
94684170|NCT01672853|324298260|FG002|Overall Study|Pregnancy|0|||
94684171|NCT01672853|324298258|FG000|Overall Study|Investigator's Discretion|1|||
94684172|NCT01672853|324298259|FG001|Overall Study|Investigator's Discretion|0|||
94684173|NCT01672853|324298260|FG002|Overall Study|Investigator's Discretion|0|||
94684174|NCT01672853|324298258|FG000|Overall Study|Withdrew Consent|5|||
94684175|NCT01672853|324298259|FG001|Overall Study|Withdrew Consent|5|||
94684176|NCT01672853|324298260|FG002|Overall Study|Withdrew Consent|5|||
94684177|NCT01672853|324298258|FG000|Overall Study|Adverse Event|4|||
94684178|NCT01672853|324298259|FG001|Overall Study|Adverse Event|6|||
94684179|NCT01672853|324298260|FG002|Overall Study|Adverse Event|8|||
94684180|NCT01672853|324298258|FG000|Overall Study|Lost to Follow-up|0|||
94684181|NCT01672853|324298259|FG001|Overall Study|Lost to Follow-up|1|||
94684182|NCT01672853|324298260|FG002|Overall Study|Lost to Follow-up|0|||
94684183|NCT01672853|324298258|FG000|Overall Study|Randomized but Never Treated|0|||
94684184|NCT01672853|324298259|FG001|Overall Study|Randomized but Never Treated|0|||
94684185|NCT01672853|324298260|FG002|Overall Study|Randomized but Never Treated|1|||
94684186|NCT05879198|324298262|FG000|Overall Study|Lost to Follow-up|1|||
94684187|NCT04921969|324298263|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
94684188|NCT04921969|324298264|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
94684189|NCT04921969|324298265|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
94684190|NCT04921969|324298266|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
94684191|NCT04921969|324298267|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
94684192|NCT04921969|324298268|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
94684193|NCT04921969|324298269|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
94684194|NCT04921969|324298263|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
94684195|NCT04921969|324298264|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94684196|NCT04921969|324298265|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94684197|NCT04921969|324298266|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94684198|NCT04921969|324298267|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94684199|NCT04921969|324298268|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94684200|NCT04921969|324298269|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94684201|NCT04921969|324298263|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
94684202|NCT04921969|324298264|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
94684203|NCT04921969|324298265|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
94684204|NCT04921969|324298266|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94684205|NCT04921969|324298267|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94684206|NCT04921969|324298268|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94684207|NCT04921969|324298269|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94684208|NCT04921969|324298263|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
94684209|NCT04921969|324298264|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
94684210|NCT04921969|324298265|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
94684211|NCT04921969|324298266|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
94684212|NCT04921969|324298267|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
94684213|NCT04921969|324298268|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
94684214|NCT04921969|324298269|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
94684215|NCT04921969|324298263|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
94684216|NCT04921969|324298264|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
94684217|NCT04921969|324298265|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
94684218|NCT04921969|324298266|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
94684219|NCT04921969|324298267|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
94684220|NCT04921969|324298268|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
94684221|NCT04921969|324298269|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
94684222|NCT04921969|324298263|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
94684223|NCT04921969|324298264|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
94684224|NCT04921969|324298265|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
94684225|NCT04921969|324298266|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94684226|NCT04921969|324298267|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94684227|NCT04921969|324298268|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94684228|NCT04921969|324298269|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94684229|NCT04921969|324298263|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
94684230|NCT04921969|324298264|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
94684231|NCT04921969|324298265|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
94684232|NCT04921969|324298266|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
94684233|NCT04921969|324298267|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
94684234|NCT04921969|324298268|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
94684235|NCT04921969|324298269|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
94684236|NCT04921969|324298263|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
94684237|NCT04921969|324298264|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
94684238|NCT04921969|324298265|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
94684239|NCT04921969|324298266|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
94684240|NCT04921969|324298267|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
94684241|NCT04921969|324298268|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
94684242|NCT04921969|324298269|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
94684243|NCT04921969|324298263|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
94684244|NCT04921969|324298264|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
94684245|NCT04921969|324298265|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
94684246|NCT04921969|324298266|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
94684247|NCT04921969|324298267|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
94684248|NCT04921969|324298268|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
94684249|NCT04921969|324298269|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
94684250|NCT04921969|324298263|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
94684251|NCT04921969|324298264|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
94684252|NCT04921969|324298265|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
94684253|NCT04921969|324298266|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
94684254|NCT04921969|324298267|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
94684255|NCT04921969|324298268|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
94684256|NCT04921969|324298269|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
94684257|NCT04921969|324298263|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
94684258|NCT04921969|324298264|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
94684259|NCT04921969|324298265|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
94684260|NCT04921969|324298266|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
94684261|NCT04921969|324298267|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
94684262|NCT04921969|324298268|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
94684263|NCT04921969|324298269|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
94684264|NCT04921969|324298263|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
94684265|NCT04921969|324298264|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
94684266|NCT04921969|324298265|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
94684267|NCT04921969|324298266|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
94684268|NCT04921969|324298267|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
94684269|NCT04921969|324298268|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
94684270|NCT04921969|324298269|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
94684271|NCT04921969|324298263|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
94684272|NCT04921969|324298264|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
94684273|NCT04921969|324298265|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
94684274|NCT04921969|324298266|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
94684275|NCT04921969|324298267|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
94684276|NCT04921969|324298268|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
94684277|NCT04921969|324298269|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
94684278|NCT04921969|324298263|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
94684279|NCT04921969|324298264|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
94684280|NCT04921969|324298265|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
94684281|NCT04921969|324298266|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
94684282|NCT04921969|324298267|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
94463504|NCT00336024|323485083|FG000|Overall Study|Withdrawal by Subject|1|||
94684283|NCT04921969|324298268|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
94684284|NCT04921969|324298269|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
94684285|NCT04921969|324298263|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
94684286|NCT04921969|324298264|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
94684287|NCT04921969|324298265|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
94684288|NCT04921969|324298266|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
94684289|NCT04921969|324298267|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
94684290|NCT04921969|324298268|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
94684291|NCT04921969|324298269|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
94684292|NCT00975221|324299776|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
94684293|NCT00975221|324299777|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
94684294|NCT00975221|324299776|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
94684295|NCT00975221|324299777|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
94684296|NCT00975221|324299776|FG000|Titration Phase (Weeks 1-12)|Other|0|||
94684297|NCT00975221|324299777|FG001|Titration Phase (Weeks 1-12)|Other|1|||
94684298|NCT00975221|324299776|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
94684299|NCT00975221|324299777|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
94684300|NCT00975221|324299776|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
94684301|NCT00975221|324299777|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
94684302|NCT00975221|324299776|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
94684303|NCT00975221|324299777|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
94684304|NCT00003511|324299787|FG000|Overall Study|Not evaluable|4|||
94684305|NCT02887989|324299791|FG000|Overall Study|Withdrawal by Subject|8|||
94684306|NCT02887989|324299792|FG001|Overall Study|Withdrawal by Subject|11|||
94684307|NCT02887989|324299791|FG000|Overall Study|Death|1|||
94684308|NCT02887989|324299792|FG001|Overall Study|Death|0|||
94684309|NCT00674323|324299793|FG000|Overall Study|Adverse Event|0|||
94684310|NCT00674323|324299794|FG001|Overall Study|Adverse Event|1|||
94684311|NCT00674323|324299795|FG002|Overall Study|Adverse Event|0|||
94684312|NCT00674323|324299793|FG000|Overall Study|Protocol Violation|1|||
94684313|NCT00674323|324299794|FG001|Overall Study|Protocol Violation|0|||
94684314|NCT00674323|324299795|FG002|Overall Study|Protocol Violation|0|||
94684315|NCT01478113|324299796|FG000|Overall Study|Withdrawal by Subject|0|||
94684316|NCT01478113|324299797|FG001|Overall Study|Withdrawal by Subject|1|||
94684317|NCT01478113|324299796|FG000|Overall Study|Physician Decision|1|||
94684318|NCT01478113|324299797|FG001|Overall Study|Physician Decision|0|||
94684319|NCT00041756|324299805|FG000|Overall Study|Adverse Event|4|||
94684320|NCT00041756|324299806|FG001|Overall Study|Adverse Event|10|||
94684321|NCT00041756|324299807|FG002|Overall Study|Adverse Event|6|||
94684322|NCT00041756|324299808|FG003|Overall Study|Adverse Event|11|||
94684323|NCT00041756|324299809|FG004|Overall Study|Adverse Event|34|||
94684324|NCT00041756|324299805|FG000|Overall Study|Protocol Violation|1|||
94684325|NCT00041756|324299806|FG001|Overall Study|Protocol Violation|1|||
94684326|NCT00041756|324299807|FG002|Overall Study|Protocol Violation|2|||
94684327|NCT00041756|324299808|FG003|Overall Study|Protocol Violation|2|||
94684328|NCT00041756|324299809|FG004|Overall Study|Protocol Violation|1|||
94684329|NCT00041756|324299805|FG000|Overall Study|Withdrawal by Subject|3|||
94684330|NCT00041756|324299806|FG001|Overall Study|Withdrawal by Subject|3|||
94684331|NCT00041756|324299807|FG002|Overall Study|Withdrawal by Subject|4|||
94684332|NCT00041756|324299808|FG003|Overall Study|Withdrawal by Subject|2|||
94684333|NCT00041756|324299809|FG004|Overall Study|Withdrawal by Subject|3|||
94684334|NCT00041756|324299805|FG000|Overall Study|Lost to Follow-up|0|||
94684335|NCT00041756|324299806|FG001|Overall Study|Lost to Follow-up|1|||
94684336|NCT00041756|324299807|FG002|Overall Study|Lost to Follow-up|0|||
94684337|NCT00041756|324299808|FG003|Overall Study|Lost to Follow-up|1|||
94684338|NCT00041756|324299809|FG004|Overall Study|Lost to Follow-up|0|||
94684339|NCT00041756|324299805|FG000|Overall Study|Unable to meet protocol criteria|0|||
94684340|NCT00041756|324299806|FG001|Overall Study|Unable to meet protocol criteria|0|||
94684341|NCT00041756|324299807|FG002|Overall Study|Unable to meet protocol criteria|1|||
94684342|NCT00041756|324299808|FG003|Overall Study|Unable to meet protocol criteria|0|||
94684343|NCT00041756|324299809|FG004|Overall Study|Unable to meet protocol criteria|1|||
94684344|NCT00041756|324299805|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
94684345|NCT00041756|324299806|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
94684346|NCT00041756|324299807|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
94684347|NCT00041756|324299808|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
94684348|NCT00041756|324299809|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
94684349|NCT03980184|324299810|FG000|Overall Study|Dropped out before treatment|2|||
94684350|NCT03980184|324299811|FG001|Overall Study|Dropped out before treatment|2|||
94647944|NCT02346240|324170553|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647945|NCT02346240|324170554|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647946|NCT02346240|324170555|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
94647947|NCT02346240|324170556|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647948|NCT02346240|324170557|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647949|NCT02346240|324170558|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
94647950|NCT02346240|324170559|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647951|NCT02346240|324170560|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94647952|NCT02346240|324170537|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647953|NCT02346240|324170538|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647954|NCT02346240|324170539|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647955|NCT02346240|324170540|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647956|NCT02346240|324170541|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647957|NCT02346240|324170542|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647958|NCT02346240|324170543|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647959|NCT02346240|324170544|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647960|NCT02346240|324170545|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647961|NCT02346240|324170546|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647962|NCT02346240|324170547|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647963|NCT02346240|324170548|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647964|NCT02346240|324170549|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647965|NCT02346240|324170550|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647966|NCT02346240|324170551|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647967|NCT02346240|324170552|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647968|NCT02346240|324170553|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647969|NCT02346240|324170554|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647970|NCT02346240|324170555|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647971|NCT02346240|324170556|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647972|NCT02346240|324170557|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647973|NCT02346240|324170558|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
94647974|NCT02346240|324170559|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647975|NCT02346240|324170560|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
94647976|NCT02346240|324170537|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94647977|NCT02346240|324170538|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94647978|NCT02346240|324170539|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94647979|NCT02346240|324170540|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94647980|NCT02346240|324170541|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94647981|NCT02346240|324170542|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94647982|NCT02346240|324170543|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94647983|NCT02346240|324170544|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94647984|NCT02346240|324170545|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94647985|NCT02346240|324170546|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94647986|NCT02346240|324170547|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94647987|NCT02346240|324170548|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94647988|NCT02346240|324170549|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94647989|NCT02346240|324170550|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94647990|NCT02346240|324170551|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94647991|NCT02346240|324170552|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94647992|NCT02346240|324170553|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94647993|NCT02346240|324170554|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
94647994|NCT02346240|324170555|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
94647995|NCT02346240|324170556|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
94647996|NCT02346240|324170557|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94647997|NCT02346240|324170558|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
94647998|NCT02346240|324170559|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
94647999|NCT02346240|324170560|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
94648000|NCT02346240|324170537|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94648001|NCT02346240|324170538|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94648002|NCT02346240|324170539|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94648003|NCT02346240|324170540|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94648004|NCT02346240|324170541|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94648005|NCT02346240|324170542|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94648006|NCT02346240|324170543|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94684351|NCT03980184|324299810|FG000|Overall Study|Lost to Follow-up|11|||
94648007|NCT02346240|324170544|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94648008|NCT02346240|324170545|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94648009|NCT02346240|324170546|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94648010|NCT02346240|324170547|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94648011|NCT02346240|324170548|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94648012|NCT02346240|324170549|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94648013|NCT02346240|324170550|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94648014|NCT02346240|324170551|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94648015|NCT02346240|324170552|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94648016|NCT02346240|324170553|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94648017|NCT02346240|324170554|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94648018|NCT02346240|324170555|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
94648019|NCT02346240|324170556|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
94648020|NCT02346240|324170557|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94648021|NCT02346240|324170558|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
94648022|NCT02346240|324170559|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
94648023|NCT02346240|324170560|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
94648024|NCT02346240|324170537|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648025|NCT02346240|324170538|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648026|NCT02346240|324170539|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648027|NCT02346240|324170540|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648028|NCT02346240|324170541|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648029|NCT02346240|324170542|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648030|NCT02346240|324170543|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648031|NCT02346240|324170544|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648032|NCT02346240|324170545|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648033|NCT02346240|324170546|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648034|NCT02346240|324170547|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648035|NCT02346240|324170548|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648036|NCT02346240|324170549|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648037|NCT02346240|324170550|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648038|NCT02346240|324170551|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648039|NCT02346240|324170552|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648040|NCT02346240|324170553|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648041|NCT02346240|324170554|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648042|NCT02346240|324170555|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
94648043|NCT02346240|324170556|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648044|NCT02346240|324170557|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
94648045|NCT02346240|324170558|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
94648046|NCT02346240|324170559|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
94648047|NCT02346240|324170560|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
94684352|NCT03980184|324299811|FG001|Overall Study|Lost to Follow-up|13|||
94684353|NCT00067990|324299815|FG000|Overall Study|Death|5|||
94684354|NCT00067990|324299816|FG001|Overall Study|Death|7|||
94684355|NCT00067990|324299815|FG000|Overall Study|ESRD, Non IF/TA|1|||
94684356|NCT00067990|324299816|FG001|Overall Study|ESRD, Non IF/TA|3|||
94684357|NCT00067990|324299815|FG000|Overall Study|Withdrawal by Subject|4|||
94684358|NCT00067990|324299816|FG001|Overall Study|Withdrawal by Subject|12|||
94684359|NCT03327402|324299819|FG000|Overall Study|Withdrawal by Subject|1|||
94684360|NCT03327402|324299819|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
94684361|NCT01588990|324299820|FG000|Phase A|Withdrawal by Subject|5|||
94684362|NCT01588990|324299820|FG000|Phase A|Physician Decision|11|||
94684363|NCT01588990|324299820|FG000|Phase A|Other|14|||
94684364|NCT01588990|324299820|FG000|Phase A|Lost to Follow-up|1|||
94684365|NCT01588990|324299820|FG000|Phase A|Death|5|||
94684366|NCT01588990|324299820|FG000|Phase A|Adverse Event|28|||
94684367|NCT01588990|324299820|FG000|Phase A|Still on therapy at end of study|6|||
94684368|NCT01588990|324299820|FG000|Phase B|Adverse Event|2|||
94684369|NCT01588990|324299820|FG000|Phase B|Still on therapy at end of study|5|||
94684370|NCT01588990|324299820|FG000|Phase B|Withdrawal by Subject|3|||
94684371|NCT01588990|324299820|FG000|Phase B|Physician Decision|4|||
94684372|NCT01588990|324299820|FG000|Phase B|Other|2|||
94684373|NCT03283696|324299827|FG000|Overall Study|Physician Decision|5|||
94684374|NCT03283696|324299828|FG001|Overall Study|Physician Decision|6|||
94684375|NCT03283696|324299827|FG000|Overall Study|Withdrawal by Subject|2|||
94684376|NCT03283696|324299828|FG001|Overall Study|Withdrawal by Subject|0|||
94684377|NCT02563522|324299829|FG000|Overall Study|Adverse Event|2|||
94684378|NCT02563522|324299830|FG001|Overall Study|Adverse Event|3|||
94684379|NCT02563522|324299829|FG000|Overall Study|Lost to Follow-up|1|||
94684380|NCT02563522|324299830|FG001|Overall Study|Lost to Follow-up|0|||
94684381|NCT02563522|324299829|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
94684382|NCT02563522|324299830|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
94684383|NCT00572624|324299831|FG000|Overall Study|Lost to Follow-up|10|||
94684384|NCT00572624|324299832|FG001|Overall Study|Lost to Follow-up|4|||
94684385|NCT00572624|324299831|FG000|Overall Study|Wanted to do a different diet program|1|||
94684386|NCT00572624|324299832|FG001|Overall Study|Wanted to do a different diet program|0|||
94684387|NCT00572624|324299831|FG000|Overall Study|Medication change|1|||
94684388|NCT00572624|324299832|FG001|Overall Study|Medication change|0|||
94684389|NCT00572624|324299831|FG000|Overall Study|Started a new job-- no time for study|1|||
94684390|NCT00572624|324299832|FG001|Overall Study|Started a new job-- no time for study|0|||
94684391|NCT00572624|324299831|FG000|Overall Study|Admitted to being a smoker|1|||
94684392|NCT00572624|324299832|FG001|Overall Study|Admitted to being a smoker|0|||
94684393|NCT00572624|324299831|FG000|Overall Study|Refused to do the stress test|1|||
94684394|NCT00572624|324299832|FG001|Overall Study|Refused to do the stress test|0|||
94684395|NCT00572624|324299831|FG000|Overall Study|Problem with vascular access|1|||
94684396|NCT00572624|324299832|FG001|Overall Study|Problem with vascular access|0|||
94684397|NCT00572624|324299831|FG000|Overall Study|Health issues unrelated to the study|1|||
94684398|NCT00572624|324299832|FG001|Overall Study|Health issues unrelated to the study|0|||
94684399|NCT02597933|324299833|FG000|Overall Study|Withdrawal by Subject|7|||
94684400|NCT02597933|324299834|FG001|Overall Study|Withdrawal by Subject|5|||
94684401|NCT02597933|324299833|FG000|Overall Study|Protocol Violation|2|||
94684402|NCT02597933|324299834|FG001|Overall Study|Protocol Violation|2|||
94684403|NCT02597933|324299833|FG000|Overall Study|Adverse Event|20|||
94684404|NCT02597933|324299834|FG001|Overall Study|Adverse Event|28|||
94684405|NCT02597933|324299833|FG000|Overall Study|Not treated|2|||
94684406|NCT02597933|324299834|FG001|Overall Study|Not treated|2|||
94684407|NCT02597933|324299833|FG000|Overall Study|Other than stated above|7|||
94684408|NCT02597933|324299834|FG001|Overall Study|Other than stated above|14|||
94684409|NCT02307513|324299841|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
94684410|NCT02307513|324299842|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
94684411|NCT02307513|324299841|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
94684412|NCT02307513|324299842|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
94684413|NCT02307513|324299841|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
94684414|NCT02307513|324299842|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
94684415|NCT02307513|324299841|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
94684416|NCT02307513|324299842|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
94684417|NCT02307513|324299841|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
94684418|NCT02307513|324299842|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
94684419|NCT02307513|324299841|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
94684420|NCT02307513|324299842|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
94684421|NCT02307513|324299841|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
94684422|NCT02307513|324299842|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
94684423|NCT02307513|324299841|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
94684424|NCT02307513|324299842|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
94684425|NCT02307513|324299841|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
94684426|NCT02307513|324299842|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
94684427|NCT02307513|324299841|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
94684428|NCT02307513|324299842|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
94684429|NCT02307513|324299841|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
94684430|NCT02307513|324299842|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
94684431|NCT02307513|324299841|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
94684432|NCT02307513|324299842|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
94684433|NCT02307513|324299841|FG000|Long-term Extension|Physician Decision|1|||
94684434|NCT02307513|324299842|FG001|Long-term Extension|Physician Decision|0|||
94684435|NCT01107743|324299845|FG000|Overall Study|Protocol Violation|46|||
94684436|NCT00211237|324299848|FG000|Baseline|Withdrew|1|||
94684437|NCT00211237|324299849|FG001|Baseline|Withdrew|3|||
94684438|NCT00211237|324299850|FG002|Baseline|Withdrew|0|||
94684439|NCT00211237|324299848|FG000|Baseline|Refused random assignment|1|||
94684440|NCT00211237|324299849|FG001|Baseline|Refused random assignment|0|||
94684441|NCT00211237|324299850|FG002|Baseline|Refused random assignment|0|||
94684442|NCT00211237|324299848|FG000|1 Month|Death|2|||
94684443|NCT00211237|324299849|FG001|1 Month|Death|1|||
94684444|NCT00211237|324299850|FG002|1 Month|Death|0|||
94684445|NCT00211237|324299848|FG000|1 Month|Lost to Follow-up|0|||
94684446|NCT00211237|324299849|FG001|1 Month|Lost to Follow-up|2|||
94684447|NCT00211237|324299850|FG002|1 Month|Lost to Follow-up|0|||
94684448|NCT00211237|324299848|FG000|1 Month|Withdrew|0|||
94684449|NCT00211237|324299849|FG001|1 Month|Withdrew|4|||
94684450|NCT00211237|324299850|FG002|1 Month|Withdrew|0|||
94684451|NCT00211237|324299848|FG000|1 Month|Additional surgery needed|1|||
94684452|NCT00211237|324299849|FG001|1 Month|Additional surgery needed|0|||
94684453|NCT00211237|324299850|FG002|1 Month|Additional surgery needed|0|||
94684454|NCT00211237|324299848|FG000|1 Month|Non-medical problem|0|||
94684455|NCT00211237|324299849|FG001|1 Month|Non-medical problem|2|||
94684456|NCT00211237|324299850|FG002|1 Month|Non-medical problem|0|||
94684457|NCT00211237|324299848|FG000|3 Months|Death|7|||
94684458|NCT00211237|324299849|FG001|3 Months|Death|3|||
94684459|NCT00211237|324299850|FG002|3 Months|Death|0|||
94684460|NCT00211237|324299848|FG000|3 Months|Could not comply with protocol|1|||
94684461|NCT00211237|324299849|FG001|3 Months|Could not comply with protocol|0|||
94684462|NCT00211237|324299850|FG002|3 Months|Could not comply with protocol|0|||
94684463|NCT00211237|324299848|FG000|3 Months|Withdrew|0|||
94684464|NCT00211237|324299849|FG001|3 Months|Withdrew|1|||
94684465|NCT00211237|324299850|FG002|3 Months|Withdrew|0|||
94684466|NCT00211237|324299848|FG000|3 Months|Non-medical problem|0|||
94684467|NCT00211237|324299849|FG001|3 Months|Non-medical problem|0|||
94684468|NCT00211237|324299850|FG002|3 Months|Non-medical problem|1|||
94684469|NCT00211237|324299848|FG000|6 Months|Death|6|||
94684470|NCT00211237|324299849|FG001|6 Months|Death|0|||
94684471|NCT00211237|324299850|FG002|6 Months|Death|3|||
94684472|NCT00211237|324299848|FG000|6 Months|Lost to Follow-up|2|||
94684473|NCT00211237|324299849|FG001|6 Months|Lost to Follow-up|0|||
94684474|NCT00211237|324299850|FG002|6 Months|Lost to Follow-up|0|||
94684475|NCT00211237|324299848|FG000|6 Months|Could not comply with protocol|0|||
94684476|NCT00211237|324299849|FG001|6 Months|Could not comply with protocol|2|||
94684477|NCT00211237|324299850|FG002|6 Months|Could not comply with protocol|0|||
94684478|NCT00211237|324299848|FG000|12 Months|Death|8|||
94684479|NCT00211237|324299849|FG001|12 Months|Death|2|||
94684480|NCT00211237|324299850|FG002|12 Months|Death|3|||
94684481|NCT00211237|324299848|FG000|12 Months|Lost to Follow-up|1|||
94648048|NCT02346240|324170537|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648049|NCT02346240|324170538|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648050|NCT02346240|324170539|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648051|NCT02346240|324170540|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648052|NCT02346240|324170541|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648053|NCT02346240|324170542|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648054|NCT02346240|324170543|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648055|NCT02346240|324170544|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648056|NCT02346240|324170545|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648057|NCT02346240|324170546|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648058|NCT02346240|324170547|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648059|NCT02346240|324170548|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648060|NCT02346240|324170549|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648061|NCT02346240|324170550|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648062|NCT02346240|324170551|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648063|NCT02346240|324170552|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648064|NCT02346240|324170553|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648065|NCT02346240|324170554|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648066|NCT02346240|324170555|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
94648067|NCT02346240|324170556|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648068|NCT02346240|324170557|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648069|NCT02346240|324170558|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648070|NCT02346240|324170559|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648071|NCT02346240|324170560|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
94648072|NCT02143843|324170563|FG000|Overall Study|Adverse Event|8|||
94648073|NCT02143843|324170563|FG000|Overall Study|Lack of Efficacy|2|||
94648074|NCT02143843|324170563|FG000|Overall Study|Withdrawal by Subject|2|||
94648075|NCT01455012|324170564|FG000|Overall Study|Adverse Event|0|||
94648076|NCT01455012|324170565|FG001|Overall Study|Adverse Event|2|||
94648077|NCT01455012|324170564|FG000|Overall Study|Lack of Efficacy|6|||
94648078|NCT01455012|324170565|FG001|Overall Study|Lack of Efficacy|1|||
94648079|NCT01455012|324170564|FG000|Overall Study|Withdrawal by Subject|3|||
94648080|NCT01455012|324170565|FG001|Overall Study|Withdrawal by Subject|1|||
94648081|NCT01455012|324170564|FG000|Overall Study|Unknown reason|2|||
94648082|NCT01455012|324170565|FG001|Overall Study|Unknown reason|0|||
94648083|NCT02705820|324170568|FG000|Overall Study|Death|2|||
94648084|NCT02705820|324170568|FG000|Overall Study|Disease Progression|34|||
94648085|NCT02705820|324170568|FG000|Overall Study|Clinical Deterioration|3|||
94648086|NCT00006916|324170569|FG000|Overall Study|Device not inserted|4|||
94648087|NCT00006916|324170569|FG000|Overall Study|Complication of device insertion|1|||
94648088|NCT01524770|324170571|FG000|First Intervention|Withdrawal by Subject|1|||
94648089|NCT01524770|324170572|FG001|First Intervention|Withdrawal by Subject|0|||
94648090|NCT01524770|324170571|FG000|First Intervention|Adverse Event|1|||
94648091|NCT01524770|324170572|FG001|First Intervention|Adverse Event|1|||
94648092|NCT01524770|324170571|FG000|First Intervention|Protocol Violation|1|||
94648093|NCT01524770|324170572|FG001|First Intervention|Protocol Violation|0|||
94648094|NCT01552772|324170576|FG000|Overall Study|Lost to Follow-up|2|||
94648095|NCT01552772|324170576|FG000|Overall Study|Adverse Event|1|||
94648096|NCT01552772|324170576|FG000|Overall Study|Protocol Deviation|1|||
94648097|NCT02469610|324170577|FG000|Overall Study|Death|1|||
94648098|NCT02469610|324170578|FG001|Overall Study|Death|0|||
94648099|NCT02469610|324170577|FG000|Overall Study|Lost to Follow-up|1|||
94648100|NCT02469610|324170578|FG001|Overall Study|Lost to Follow-up|0|||
94648101|NCT02469610|324170577|FG000|Overall Study|exclusion criteria|2|||
94648102|NCT02469610|324170578|FG001|Overall Study|exclusion criteria|1|||
94648103|NCT03080961|324170579|FG000|Overall Study|Withdrawal by Subject|3|||
94648104|NCT00586469|324170580|FG000|Overall Study|Adverse Event|0|||
94648105|NCT00586469|324170581|FG001|Overall Study|Adverse Event|1|||
94648106|NCT01282424|324170582|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
94648107|NCT01282424|324170582|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
94648108|NCT01282424|324170582|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
94648109|NCT01282424|324170582|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
94648110|NCT01282424|324170582|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
94648111|NCT01282424|324170582|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
94648112|NCT01282424|324170582|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
94648113|NCT01282424|324170582|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
94648114|NCT02741115|324170585|FG000|Overall Study|Adverse Event|1|||
94648115|NCT02741115|324170586|FG001|Overall Study|Adverse Event|0|||
94648116|NCT02741115|324170585|FG000|Overall Study|Lost to Follow-up|7|||
94648117|NCT02741115|324170586|FG001|Overall Study|Lost to Follow-up|4|||
94648118|NCT02741115|324170585|FG000|Overall Study|Withdrawal by Subject|4|||
94648119|NCT02741115|324170586|FG001|Overall Study|Withdrawal by Subject|2|||
94648120|NCT03551210|324170587|FG000|Overall Study|Adverse Event|5|||
94648121|NCT03551210|324170588|FG001|Overall Study|Adverse Event|6|||
94648122|NCT03551210|324170587|FG000|Overall Study|Withdrawal by Subject|1|||
94648123|NCT03551210|324170588|FG001|Overall Study|Withdrawal by Subject|7|||
94648124|NCT03551210|324170587|FG000|Overall Study|Needed in other antibiotic treatment|2|||
94648125|NCT03551210|324170588|FG001|Overall Study|Needed in other antibiotic treatment|5|||
94648126|NCT03551210|324170587|FG000|Overall Study|Lost to Follow-up|1|||
94648127|NCT03551210|324170588|FG001|Overall Study|Lost to Follow-up|1|||
94648128|NCT03551210|324170587|FG000|Overall Study|Absence of visit 4 and 5|1|||
94648129|NCT03551210|324170588|FG001|Overall Study|Absence of visit 4 and 5|0|||
94648130|NCT03551210|324170587|FG000|Overall Study|No drug for dispensing|0|||
94648131|NCT03551210|324170588|FG001|Overall Study|No drug for dispensing|1|||
94648132|NCT02565381|324171698|FG000|Overall Study|Lost to Follow-up|1|||
94648133|NCT02565381|324171699|FG001|Overall Study|Lost to Follow-up|0|||
94648134|NCT02565381|324171700|FG002|Overall Study|Lost to Follow-up|1|||
94648135|NCT05084053|324171703|FG000|Epoch 1: Up to 6 Months|Withdrawal by Subject|1|||
94648136|NCT05084053|324171704|FG001|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
94648137|NCT05084053|324171705|FG002|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
94648138|NCT05084053|324171706|FG003|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
94648139|NCT05084053|324171703|FG000|Epoch 1: Up to 6 Months|Physician Decision|1|||
94648140|NCT05084053|324171704|FG001|Epoch 1: Up to 6 Months|Physician Decision|0|||
94648141|NCT05084053|324171705|FG002|Epoch 1: Up to 6 Months|Physician Decision|0|||
94648142|NCT05084053|324171706|FG003|Epoch 1: Up to 6 Months|Physician Decision|0|||
94648143|NCT05084053|324171703|FG000|Epoch 2: Up to 6 Months|Physician Decision|0|||
94648144|NCT05084053|324171704|FG001|Epoch 2: Up to 6 Months|Physician Decision|0|||
94648145|NCT05084053|324171705|FG002|Epoch 2: Up to 6 Months|Physician Decision|1|||
94648146|NCT05084053|324171706|FG003|Epoch 2: Up to 6 Months|Physician Decision|0|||
94648147|NCT00978731|324171709|FG000|Overall Study|Death|4|||
94648148|NCT00978731|324171710|FG001|Overall Study|Death|1|||
94648149|NCT00978731|324171711|FG002|Overall Study|Death|1|||
94648150|NCT00978731|324171712|FG003|Overall Study|Death|0|||
94648151|NCT00978731|324171709|FG000|Overall Study|Lost to Follow-up|0|||
94648152|NCT00978731|324171710|FG001|Overall Study|Lost to Follow-up|0|||
94648153|NCT00978731|324171711|FG002|Overall Study|Lost to Follow-up|0|||
94648154|NCT00978731|324171712|FG003|Overall Study|Lost to Follow-up|1|||
94648155|NCT00978731|324171709|FG000|Overall Study|Adverse Event|5|||
94648156|NCT00978731|324171710|FG001|Overall Study|Adverse Event|2|||
94648157|NCT00978731|324171711|FG002|Overall Study|Adverse Event|0|||
94648158|NCT00978731|324171712|FG003|Overall Study|Adverse Event|0|||
94648159|NCT00978731|324171709|FG000|Overall Study|Participant's request|1|||
94648160|NCT00978731|324171710|FG001|Overall Study|Participant's request|0|||
94648161|NCT00978731|324171711|FG002|Overall Study|Participant's request|0|||
94648162|NCT00978731|324171712|FG003|Overall Study|Participant's request|0|||
94648163|NCT00978731|324171709|FG000|Overall Study|Administrative reason|3|||
94648164|NCT00978731|324171710|FG001|Overall Study|Administrative reason|3|||
94648165|NCT00978731|324171711|FG002|Overall Study|Administrative reason|1|||
94648166|NCT00978731|324171712|FG003|Overall Study|Administrative reason|0|||
94648167|NCT00978731|324171709|FG000|Overall Study|Deterioration without progression|0|||
94648168|NCT00978731|324171710|FG001|Overall Study|Deterioration without progression|1|||
94648169|NCT00978731|324171711|FG002|Overall Study|Deterioration without progression|0|||
94648170|NCT00978731|324171712|FG003|Overall Study|Deterioration without progression|0|||
94648171|NCT00978731|324171709|FG000|Overall Study|Disease progression/relapse|5|||
94648172|NCT00978731|324171710|FG001|Overall Study|Disease progression/relapse|4|||
94648173|NCT00978731|324171711|FG002|Overall Study|Disease progression/relapse|2|||
94648174|NCT00978731|324171712|FG003|Overall Study|Disease progression/relapse|2|||
94648175|NCT00978731|324171709|FG000|Overall Study|Study closure|3|||
94648176|NCT00978731|324171710|FG001|Overall Study|Study closure|4|||
94648177|NCT00978731|324171711|FG002|Overall Study|Study closure|1|||
94648178|NCT00978731|324171712|FG003|Overall Study|Study closure|1|||
94648179|NCT00978731|324171709|FG000|Overall Study|No response|1|||
94648180|NCT00978731|324171710|FG001|Overall Study|No response|0|||
94648181|NCT00978731|324171711|FG002|Overall Study|No response|0|||
94648182|NCT00978731|324171712|FG003|Overall Study|No response|0|||
94648183|NCT02097134|324171713|FG000|Overall Study|Physician Decision|4|||
94648184|NCT02097134|324171713|FG000|Overall Study|Non-Protocol Therapy|1|||
94648185|NCT02097134|324171713|FG000|Overall Study|Progressive Disease|3|||
94648186|NCT02097134|324171713|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
94263821|NCT01102803|322759938|FG000|Post to Follow-Up|Lost to Follow-up|1|||
94263822|NCT01102803|322759939|FG001|Post to Follow-Up|Lost to Follow-up|3|||
94263823|NCT01295281|322759940|FG000|First Intervention (7 Days)|Death|0|||
94263824|NCT01295281|322759941|FG001|First Intervention (7 Days)|Death|1|||
94263825|NCT04029961|322759942|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
94263826|NCT04029961|322759943|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
94263827|NCT04029961|322759942|FG000|Overall Study|Change in Treatment Course|0|||
94263828|NCT04029961|322759943|FG001|Overall Study|Change in Treatment Course|1|||
94263829|NCT01252810|322759944|FG000|Overall Study|Withdrawal by Subject|4|||
94263830|NCT01252810|322759945|FG001|Overall Study|Withdrawal by Subject|1|||
94263831|NCT01252810|322759944|FG000|Overall Study|Lost to Follow-up|0|||
94684482|NCT00211237|324299849|FG001|12 Months|Lost to Follow-up|0|||
94684483|NCT00211237|324299850|FG002|12 Months|Lost to Follow-up|1|||
94684484|NCT00211237|324299848|FG000|12 Months|Withdrew|0|||
94684485|NCT00211237|324299849|FG001|12 Months|Withdrew|0|||
94684486|NCT00211237|324299850|FG002|12 Months|Withdrew|1|||
94684487|NCT00211237|324299848|FG000|12 Months|unrelated medical problem|0|||
94684488|NCT00211237|324299849|FG001|12 Months|unrelated medical problem|0|||
94684489|NCT00211237|324299850|FG002|12 Months|unrelated medical problem|1|||
94684490|NCT05644353|324299859|FG000|Overall Study|Physician Decision|1|||
94684491|NCT05644353|324299860|FG001|Overall Study|Physician Decision|0|||
94684492|NCT05644353|324299861|FG002|Overall Study|Physician Decision|0|||
94684493|NCT05644353|324299862|FG003|Overall Study|Physician Decision|0|||
94684494|NCT05644353|324299863|FG004|Overall Study|Physician Decision|0|||
94684495|NCT05644353|324299864|FG005|Overall Study|Physician Decision|0|||
94684496|NCT05644353|324299859|FG000|Overall Study|Protocol Violation|1|||
94684497|NCT05644353|324299860|FG001|Overall Study|Protocol Violation|0|||
94684498|NCT05644353|324299861|FG002|Overall Study|Protocol Violation|0|||
94684499|NCT05644353|324299862|FG003|Overall Study|Protocol Violation|0|||
94684500|NCT05644353|324299863|FG004|Overall Study|Protocol Violation|0|||
94684501|NCT05644353|324299864|FG005|Overall Study|Protocol Violation|0|||
94684502|NCT05644353|324299859|FG000|Overall Study|Withdrawal by Subject|0|||
94684503|NCT05644353|324299860|FG001|Overall Study|Withdrawal by Subject|2|||
94684504|NCT05644353|324299861|FG002|Overall Study|Withdrawal by Subject|0|||
94684505|NCT05644353|324299862|FG003|Overall Study|Withdrawal by Subject|0|||
94684506|NCT05644353|324299863|FG004|Overall Study|Withdrawal by Subject|1|||
94684507|NCT05644353|324299864|FG005|Overall Study|Withdrawal by Subject|0|||
94684508|NCT05644353|324299859|FG000|Overall Study|Lost to Follow-up|0|||
94684509|NCT05644353|324299860|FG001|Overall Study|Lost to Follow-up|0|||
94684510|NCT05644353|324299861|FG002|Overall Study|Lost to Follow-up|1|||
94684511|NCT05644353|324299862|FG003|Overall Study|Lost to Follow-up|0|||
94684512|NCT05644353|324299863|FG004|Overall Study|Lost to Follow-up|0|||
94684513|NCT05644353|324299864|FG005|Overall Study|Lost to Follow-up|0|||
94684514|NCT01535274|324299865|FG000|Overall Study|Determined to be ineligible|0|||
94684515|NCT01535274|324299866|FG001|Overall Study|Determined to be ineligible|1|||
94684516|NCT01535274|324299865|FG000|Overall Study|Misallocated to propofol intervention|0|||
94684517|NCT01535274|324299866|FG001|Overall Study|Misallocated to propofol intervention|1|||
94684518|NCT03679767|324299867|FG000|Overall Study|Death|16|||
94684519|NCT03679767|324299868|FG001|Overall Study|Death|11|||
94684520|NCT03679767|324299869|FG002|Overall Study|Death|17|||
94684521|NCT03679767|324299870|FG003|Overall Study|Death|10|||
94684522|NCT03679767|324299867|FG000|Overall Study|Lost to Follow-up|1|||
94684523|NCT03679767|324299868|FG001|Overall Study|Lost to Follow-up|1|||
94684524|NCT03679767|324299869|FG002|Overall Study|Lost to Follow-up|1|||
94684525|NCT03679767|324299870|FG003|Overall Study|Lost to Follow-up|1|||
94684526|NCT03679767|324299867|FG000|Overall Study|Withdrawal by Subject|0|||
94684527|NCT03679767|324299868|FG001|Overall Study|Withdrawal by Subject|0|||
94684528|NCT03679767|324299869|FG002|Overall Study|Withdrawal by Subject|0|||
94684529|NCT03679767|324299870|FG003|Overall Study|Withdrawal by Subject|1|||
94684530|NCT03679767|324299867|FG000|Overall Study|Follow-up Completed|18|||
94684531|NCT03679767|324299868|FG001|Overall Study|Follow-up Completed|11|||
94684532|NCT03679767|324299869|FG002|Overall Study|Follow-up Completed|11|||
94684533|NCT03679767|324299870|FG003|Overall Study|Follow-up Completed|20|||
94684534|NCT03679767|324299867|FG000|Overall Study|Entered Hospice Care|0|||
94684535|NCT03679767|324299868|FG001|Overall Study|Entered Hospice Care|0|||
94684536|NCT03679767|324299869|FG002|Overall Study|Entered Hospice Care|0|||
94684537|NCT03679767|324299870|FG003|Overall Study|Entered Hospice Care|1|||
94263832|NCT01252810|322759945|FG001|Overall Study|Lost to Follow-up|1|||
94263833|NCT01252810|322759944|FG000|Overall Study|Physician Decision|2|||
94263834|NCT01252810|322759945|FG001|Overall Study|Physician Decision|1|||
94263835|NCT01252810|322759944|FG000|Overall Study|Various reasons|8|||
94684538|NCT03679767|324299867|FG000|Overall Study|Progressive Disease|0|||
94684539|NCT03679767|324299868|FG001|Overall Study|Progressive Disease|0|||
94684540|NCT03679767|324299869|FG002|Overall Study|Progressive Disease|0|||
94684541|NCT03679767|324299870|FG003|Overall Study|Progressive Disease|1|||
94684542|NCT02954458|324299871|FG000|Overall Study|Adverse Event|0|||
94684543|NCT02954458|324299872|FG001|Overall Study|Adverse Event|0|||
94684544|NCT02954458|324299873|FG002|Overall Study|Adverse Event|0|||
94684545|NCT02954458|324299874|FG003|Overall Study|Adverse Event|1|||
94684546|NCT02954458|324299871|FG000|Overall Study|Withdrawal by Subject|0|||
94684547|NCT02954458|324299872|FG001|Overall Study|Withdrawal by Subject|0|||
94684548|NCT02954458|324299873|FG002|Overall Study|Withdrawal by Subject|0|||
94684549|NCT02954458|324299874|FG003|Overall Study|Withdrawal by Subject|1|||
94684550|NCT02954458|324299871|FG000|Overall Study|Physician Decision|0|||
94684551|NCT02954458|324299872|FG001|Overall Study|Physician Decision|0|||
94684552|NCT02954458|324299873|FG002|Overall Study|Physician Decision|1|||
94684553|NCT02954458|324299874|FG003|Overall Study|Physician Decision|1|||
94684554|NCT02954458|324299871|FG000|Overall Study|Lost to Follow-up|1|||
94684555|NCT02954458|324299872|FG001|Overall Study|Lost to Follow-up|0|||
94684556|NCT02954458|324299873|FG002|Overall Study|Lost to Follow-up|0|||
94684557|NCT02954458|324299874|FG003|Overall Study|Lost to Follow-up|1|||
94684558|NCT02954458|324299871|FG000|Overall Study|Death|0|||
94684559|NCT02954458|324299872|FG001|Overall Study|Death|0|||
94684560|NCT02954458|324299873|FG002|Overall Study|Death|0|||
94684561|NCT02954458|324299874|FG003|Overall Study|Death|1|||
94684562|NCT02954458|324299871|FG000|Overall Study|Other|0|||
94684563|NCT02954458|324299872|FG001|Overall Study|Other|0|||
94364066|NCT01915498|323116819|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
94364067|NCT01915498|323116820|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
94648187|NCT00679341|324171714|FG000|Overall Study|Disease progression|42|||
94648188|NCT00679341|324171715|FG001|Overall Study|Disease progression|36|||
94648189|NCT00679341|324171714|FG000|Overall Study|Adverse Event|5|||
94648190|NCT00679341|324171715|FG001|Overall Study|Adverse Event|6|||
94648191|NCT00679341|324171714|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
94648192|NCT00679341|324171715|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
94648193|NCT00679341|324171714|FG000|Overall Study|Death|1|||
94648194|NCT00679341|324171715|FG001|Overall Study|Death|1|||
94648195|NCT00679341|324171714|FG000|Overall Study|Other|1|||
94648196|NCT00679341|324171715|FG001|Overall Study|Other|0|||
94648197|NCT00679341|324171714|FG000|Overall Study|Physician Decision|1|||
94648198|NCT00679341|324171715|FG001|Overall Study|Physician Decision|0|||
94648199|NCT00679341|324171714|FG000|Overall Study|Not treated|0|||
94648200|NCT00679341|324171715|FG001|Overall Study|Not treated|2|||
94648201|NCT00679341|324171714|FG000|Overall Study|Physician/patient decision to withdraw|0|||
94648202|NCT00679341|324171715|FG001|Overall Study|Physician/patient decision to withdraw|6|||
94648203|NCT00646204|324171716|FG000|Overall Study|Adverse Event|3|||
94648204|NCT00646204|324171717|FG001|Overall Study|Adverse Event|0|||
94648205|NCT00646204|324171716|FG000|Overall Study|Withdrawal by Subject|1|||
94648206|NCT00646204|324171717|FG001|Overall Study|Withdrawal by Subject|0|||
94648207|NCT01302964|324171718|FG000|Overall Study|Adverse Event|1|||
94648208|NCT01302964|324171719|FG001|Overall Study|Adverse Event|0|||
94648209|NCT03907683|324171742|FG000|Overall Study|Pregnancy|1|||
94648210|NCT03907683|324171742|FG000|Overall Study|Withdrawal by Subject|1|||
94648211|NCT02704364|324171745|FG000|Overall Study|Adverse Event|1|||
94648212|NCT02704364|324171746|FG001|Overall Study|Adverse Event|1|||
94648213|NCT02704364|324171747|FG002|Overall Study|Adverse Event|0|||
94648214|NCT02704364|324171745|FG000|Overall Study|Noncompliance with study drug|1|||
94648215|NCT02704364|324171746|FG001|Overall Study|Noncompliance with study drug|1|||
94648216|NCT02704364|324171747|FG002|Overall Study|Noncompliance with study drug|0|||
94648217|NCT02704364|324171745|FG000|Overall Study|Other|0|||
94648218|NCT02704364|324171746|FG001|Overall Study|Other|1|||
94648219|NCT02704364|324171747|FG002|Overall Study|Other|1|||
94648220|NCT06034496|324171753|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
94648221|NCT06034496|324171754|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
94648222|NCT06034496|324171753|FG000|Overall Study|Withdrawal by Subject|5|||
94648223|NCT06034496|324171754|FG001|Overall Study|Withdrawal by Subject|4|||
94648224|NCT00378014|324171758|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
94648225|NCT00378014|324171759|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
94648226|NCT00378014|324171758|FG000|Core (Randomization to Month 11)|Graft loss|1|||
94648227|NCT00378014|324171759|FG001|Core (Randomization to Month 11)|Graft loss|2|||
94648228|NCT00378014|324171758|FG000|Core (Randomization to Month 11)|Death|5|||
94648229|NCT00378014|324171759|FG001|Core (Randomization to Month 11)|Death|3|||
94648230|NCT00378014|324171758|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
94648231|NCT00378014|324171759|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
94648232|NCT00378014|324171758|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
94648233|NCT00378014|324171759|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
94648234|NCT00378014|324171758|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
94648235|NCT00378014|324171759|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
94648236|NCT00378014|324171758|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
94684564|NCT02954458|324299873|FG002|Overall Study|Other|0|||
94684565|NCT02954458|324299874|FG003|Overall Study|Other|7|||
94684566|NCT00747123|324299875|FG000|Overall Study|Investigator's request|0|||
94684567|NCT00747123|324299876|FG001|Overall Study|Investigator's request|0|||
94684568|NCT00747123|324299877|FG002|Overall Study|Investigator's request|1|||
94684569|NCT00747123|324299878|FG003|Overall Study|Investigator's request|0|||
94684570|NCT00747123|324299875|FG000|Overall Study|Withdrew consent|0|||
94684571|NCT00747123|324299876|FG001|Overall Study|Withdrew consent|1|||
94684572|NCT00747123|324299877|FG002|Overall Study|Withdrew consent|0|||
94684573|NCT00747123|324299878|FG003|Overall Study|Withdrew consent|0|||
94684574|NCT00747123|324299875|FG000|Overall Study|Adverse Event|0|||
94684575|NCT00747123|324299876|FG001|Overall Study|Adverse Event|1|||
94684576|NCT00747123|324299877|FG002|Overall Study|Adverse Event|0|||
94684577|NCT00747123|324299878|FG003|Overall Study|Adverse Event|1|||
94684578|NCT02120664|324299879|FG000|Overall Study|Withdrawal by Subject|0|||
94684579|NCT02120664|324299880|FG001|Overall Study|Withdrawal by Subject|0|||
94684580|NCT02120664|324299881|FG002|Overall Study|Withdrawal by Subject|0|||
94684581|NCT02120664|324299882|FG003|Overall Study|Withdrawal by Subject|1|||
94684582|NCT02120664|324299883|FG004|Overall Study|Withdrawal by Subject|0|||
94684583|NCT02223754|324299886|FG000|Period 1|Adverse Event|1|||
94684584|NCT02223754|324299887|FG001|Period 1|Adverse Event|0|||
94684585|NCT02223754|324299886|FG000|Period 1|Lost to Follow-up|0|||
94684586|NCT02223754|324299887|FG001|Period 1|Lost to Follow-up|1|||
94684587|NCT02223754|324299886|FG000|Period 1|Protocol Violation|2|||
94684588|NCT02223754|324299887|FG001|Period 1|Protocol Violation|4|||
94684589|NCT02223754|324299886|FG000|Period 1|Withdrawal by Subject|0|||
94684590|NCT02223754|324299887|FG001|Period 1|Withdrawal by Subject|4|||
94684591|NCT02223754|324299886|FG000|Period 1|Test Article No Longer Available|1|||
94684592|NCT02223754|324299887|FG001|Period 1|Test Article No Longer Available|5|||
94684593|NCT02223754|324299886|FG000|Period 1|Unsatisfactory Visual Response|0|||
94684594|NCT02223754|324299887|FG001|Period 1|Unsatisfactory Visual Response|1|||
94684595|NCT02223754|324299886|FG000|Period 2|Adverse Event|0|||
94684596|NCT02223754|324299887|FG001|Period 2|Adverse Event|1|||
94684597|NCT02223754|324299886|FG000|Period 2|Protocol Violation|1|||
94684598|NCT02223754|324299887|FG001|Period 2|Protocol Violation|0|||
94684599|NCT02223754|324299886|FG000|Period 2|Lens Discomfort|1|||
94684600|NCT02223754|324299887|FG001|Period 2|Lens Discomfort|1|||
94684601|NCT02223754|324299886|FG000|Period 2|Lost to Follow-up|1|||
94684602|NCT02223754|324299887|FG001|Period 2|Lost to Follow-up|0|||
94684603|NCT02223754|324299886|FG000|Period 2|Test Article No Longer Available|0|||
94684604|NCT02223754|324299887|FG001|Period 2|Test Article No Longer Available|1|||
94684605|NCT03176238|324299891|FG000|Overall Study|Unacceptable AEs|15|||
94684606|NCT03176238|324299892|FG001|Overall Study|Unacceptable AEs|8|||
94684607|NCT03176238|324299891|FG000|Overall Study|Abnormal lab value(s)|2|||
94684608|NCT03176238|324299892|FG001|Overall Study|Abnormal lab value(s)|0|||
94648237|NCT00378014|324171759|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
94648238|NCT00378014|324171758|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
94648239|NCT00378014|324171759|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
94648240|NCT00378014|324171758|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
94648241|NCT00378014|324171759|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
94648242|NCT00378014|324171758|FG000|Extension (Month 12 to Month 59)|Death|1|||
94648243|NCT00378014|324171759|FG001|Extension (Month 12 to Month 59)|Death|2|||
94648244|NCT00378014|324171758|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
94648245|NCT00378014|324171759|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
94648246|NCT00378014|324171758|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
94648247|NCT00378014|324171759|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
94648248|NCT00378014|324171758|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
94648249|NCT00378014|324171759|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
94648250|NCT00378014|324171758|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
94648251|NCT00378014|324171759|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
94648252|NCT02287896|324171763|FG000|Second Injection Visit|Withdrawal by Subject|0|||
94648253|NCT02287896|324171764|FG001|Second Injection Visit|Withdrawal by Subject|1|||
94648254|NCT00559962|324171765|FG000|Overall Study|Adverse Event|1|||
94648255|NCT00559962|324171766|FG001|Overall Study|Adverse Event|7|||
94648256|NCT00559962|324171767|FG002|Overall Study|Adverse Event|8|||
94648257|NCT00559962|324171768|FG003|Overall Study|Adverse Event|5|||
94648258|NCT00559962|324171769|FG004|Overall Study|Adverse Event|11|||
94648259|NCT00559962|324171770|FG005|Overall Study|Adverse Event|4|||
94648260|NCT00559962|324171771|FG006|Overall Study|Adverse Event|4|||
94648261|NCT00559962|324171772|FG007|Overall Study|Adverse Event|2|||
94648262|NCT00559962|324171765|FG000|Overall Study|Lost to Follow-up|0|||
94648263|NCT00559962|324171766|FG001|Overall Study|Lost to Follow-up|1|||
94648264|NCT00559962|324171767|FG002|Overall Study|Lost to Follow-up|0|||
94648265|NCT00559962|324171768|FG003|Overall Study|Lost to Follow-up|0|||
94648266|NCT00559962|324171769|FG004|Overall Study|Lost to Follow-up|0|||
94648267|NCT00559962|324171770|FG005|Overall Study|Lost to Follow-up|0|||
94648268|NCT00559962|324171771|FG006|Overall Study|Lost to Follow-up|0|||
94648269|NCT00559962|324171772|FG007|Overall Study|Lost to Follow-up|0|||
94648270|NCT00559962|324171765|FG000|Overall Study|Withdrawal by Subject|1|||
94648271|NCT00559962|324171766|FG001|Overall Study|Withdrawal by Subject|1|||
94648272|NCT00559962|324171767|FG002|Overall Study|Withdrawal by Subject|2|||
94648273|NCT00559962|324171768|FG003|Overall Study|Withdrawal by Subject|0|||
94648274|NCT00559962|324171769|FG004|Overall Study|Withdrawal by Subject|3|||
94648275|NCT00559962|324171770|FG005|Overall Study|Withdrawal by Subject|1|||
94648276|NCT00559962|324171771|FG006|Overall Study|Withdrawal by Subject|0|||
94648277|NCT00559962|324171772|FG007|Overall Study|Withdrawal by Subject|2|||
94648278|NCT00559962|324171765|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
94648279|NCT00559962|324171766|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
94648280|NCT00559962|324171767|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
94648281|NCT00559962|324171768|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
94648282|NCT00559962|324171769|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
94648283|NCT00559962|324171770|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
94648284|NCT00559962|324171771|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
94648285|NCT00559962|324171772|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
94648286|NCT03144180|324171773|FG000|Overall Study|STAT Delivery|1|||
94648287|NCT03144180|324171774|FG001|Overall Study|STAT Delivery|1|||
94648288|NCT03144180|324171773|FG000|Overall Study|Provider forgot to fill out forms|1|||
94648289|NCT03144180|324171774|FG001|Overall Study|Provider forgot to fill out forms|3|||
94648290|NCT03144180|324171773|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
94648291|NCT03144180|324171774|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
94648292|NCT03144180|324171773|FG000|Overall Study|Scrub tech removed tube cap|0|||
94648293|NCT03144180|324171774|FG001|Overall Study|Scrub tech removed tube cap|1|||
94648294|NCT02552316|324171775|FG000|Overall Study|Withdrawal by Subject|1|||
94648295|NCT02552316|324171775|FG000|Overall Study|Withdrawal due to non-compliance|1|||
94648296|NCT04225923|324171776|FG000|Overall Study|Protocol Violation|1|||
94648297|NCT04225923|324171777|FG001|Overall Study|Protocol Violation|0|||
94648298|NCT04225923|324171778|FG002|Overall Study|Protocol Violation|1|||
94648299|NCT04225923|324171776|FG000|Overall Study|Withdrawal by Subject|4|||
94648300|NCT04225923|324171777|FG001|Overall Study|Withdrawal by Subject|1|||
94648301|NCT04225923|324171778|FG002|Overall Study|Withdrawal by Subject|3|||
94648302|NCT04225923|324171776|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
94648303|NCT04225923|324171777|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
94648304|NCT04225923|324171778|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
94648305|NCT03025828|324171781|FG000|Overall Study|Lost to Follow-up|1|||
94684609|NCT03176238|324299891|FG000|Overall Study|Inter-current illness|0|||
94684610|NCT03176238|324299892|FG001|Overall Study|Inter-current illness|1|||
94684611|NCT03176238|324299891|FG000|Overall Study|Consent withdrawal|14|||
94684612|NCT03176238|324299892|FG001|Overall Study|Consent withdrawal|2|||
94684613|NCT03176238|324299891|FG000|Overall Study|Lost to Follow-up|3|||
94684614|NCT03176238|324299892|FG001|Overall Study|Lost to Follow-up|0|||
94684615|NCT03176238|324299891|FG000|Overall Study|Administrative problems|1|||
94684616|NCT03176238|324299892|FG001|Overall Study|Administrative problems|0|||
94684617|NCT03176238|324299891|FG000|Overall Study|Death|3|||
94684618|NCT03176238|324299892|FG001|Overall Study|Death|0|||
94684619|NCT03176238|324299891|FG000|Overall Study|Disease Progression|133|||
94684620|NCT03176238|324299892|FG001|Overall Study|Disease Progression|22|||
94684621|NCT03176238|324299891|FG000|Overall Study|Tx duration completed per EAP|0|||
94684622|NCT03176238|324299892|FG001|Overall Study|Tx duration completed per EAP|1|||
94684623|NCT03176238|324299891|FG000|Overall Study|Patient is switched to commercial drug|16|||
94684624|NCT03176238|324299892|FG001|Overall Study|Patient is switched to commercial drug|1|||
94684625|NCT03176238|324299891|FG000|Overall Study|Protocol Violation|1|||
94684626|NCT03176238|324299892|FG001|Overall Study|Protocol Violation|0|||
94684627|NCT03176238|324299891|FG000|Overall Study|Changes in the patient's condition|2|||
94684628|NCT03176238|324299892|FG001|Overall Study|Changes in the patient's condition|1|||
94684629|NCT03176238|324299891|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
94684630|NCT03176238|324299892|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
94684631|NCT01008475|324299893|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
94684632|NCT01008475|324299894|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
94684633|NCT01008475|324299895|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
94684634|NCT01008475|324299896|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
94684635|NCT01008475|324299897|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
94684636|NCT01008475|324299898|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
94684637|NCT01008475|324299899|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
94684638|NCT02301156|324299900|FG000|Overall Study|Adverse Event|13|||
94684639|NCT02301156|324299901|FG001|Overall Study|Adverse Event|14|||
94684640|NCT02301156|324299900|FG000|Overall Study|Death|1|||
94684641|NCT02301156|324299901|FG001|Overall Study|Death|5|||
94684642|NCT02301156|324299900|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
94684643|NCT02301156|324299901|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
94684644|NCT02301156|324299900|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
94684645|NCT02301156|324299901|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
94684646|NCT02301156|324299900|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
94684647|NCT02301156|324299901|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
94684648|NCT02301156|324299900|FG000|Overall Study|Reason not Specified|6|||
94684649|NCT02301156|324299901|FG001|Overall Study|Reason not Specified|3|||
94684650|NCT00105586|324299906|FG000|Overall Study|Adverse Event|4|||
94684651|NCT00105586|324299907|FG001|Overall Study|Adverse Event|3|||
94684652|NCT00105586|324299906|FG000|Overall Study|Physician Decision|13|||
94684653|NCT00105586|324299907|FG001|Overall Study|Physician Decision|13|||
94684654|NCT02917941|324299908|FG000|Treatment Period|Adverse Event|11|||
94684655|NCT02917941|324299908|FG000|Treatment Period|Progressive Disease|11|||
94684656|NCT02917941|324299908|FG000|Treatment Period|Reason not Specified|2|||
94684657|NCT02917941|324299908|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
94684658|NCT02917941|324299908|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
94684659|NCT02306122|324299911|FG000|Initial Physician Randomization|Physician Decision|0|||
94684660|NCT02306122|324299912|FG001|Initial Physician Randomization|Physician Decision|0|||
94684661|NCT02306122|324299913|FG002|Initial Physician Randomization|Physician Decision|0|||
94684662|NCT02306122|324299914|FG003|Initial Physician Randomization|Physician Decision|0|||
94684663|NCT02306122|324299915|FG004|Initial Physician Randomization|Physician Decision|0|||
94684664|NCT02306122|324299916|FG005|Initial Physician Randomization|Physician Decision|0|||
94684665|NCT02306122|324299917|FG006|Initial Physician Randomization|Physician Decision|0|||
94684666|NCT02306122|324299918|FG007|Initial Physician Randomization|Physician Decision|0|||
94684667|NCT02306122|324299919|FG008|Initial Physician Randomization|Physician Decision|1|||
94684668|NCT02306122|324299920|FG009|Initial Physician Randomization|Physician Decision|0|||
94684669|NCT02306122|324299921|FG010|Initial Physician Randomization|Physician Decision|0|||
94684670|NCT01351025|324299924|FG000|Week 0 - 20|Lost to Follow-up|2|||
94684671|NCT01351025|324299925|FG001|Week 0 - 20|Lost to Follow-up|1|||
94684672|NCT01351025|324299924|FG000|Week 0 - 20|Withdrawal by Subject|1|||
94684673|NCT01351025|324299925|FG001|Week 0 - 20|Withdrawal by Subject|0|||
94684674|NCT01351025|324299924|FG000|Week 24 - 44|Lost to Follow-up|0|||
94684675|NCT01351025|324299925|FG001|Week 24 - 44|Lost to Follow-up|2|||
94684676|NCT01351025|324299924|FG000|Week 24 - 44|Site closed|0|||
94684677|NCT01351025|324299925|FG001|Week 24 - 44|Site closed|1|||
94684678|NCT01351025|324299924|FG000|Week 24 - 44|unable to get to clinic|1|||
94684679|NCT01351025|324299925|FG001|Week 24 - 44|unable to get to clinic|1|||
94684680|NCT01709305|324299931|FG000|Phase 1|Clinical Adverse Event|80|||
94684681|NCT01709305|324299932|FG001|Phase 1|Clinical Adverse Event|0|||
94684682|NCT01709305|324299933|FG002|Phase 1|Clinical Adverse Event|0|||
94684683|NCT01709305|324299934|FG003|Phase 1|Clinical Adverse Event|0|||
94684684|NCT01709305|324299935|FG004|Phase 1|Clinical Adverse Event|0|||
94684685|NCT01709305|324299931|FG000|Phase 1|Death|2|||
94684686|NCT01709305|324299932|FG001|Phase 1|Death|0|||
94684687|NCT01709305|324299933|FG002|Phase 1|Death|0|||
94684688|NCT01709305|324299934|FG003|Phase 1|Death|0|||
94684689|NCT01709305|324299935|FG004|Phase 1|Death|0|||
94684690|NCT01709305|324299931|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
94684691|NCT01709305|324299932|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
94684692|NCT01709305|324299933|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
94684693|NCT01709305|324299934|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
94684694|NCT01709305|324299935|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
94684695|NCT01709305|324299931|FG000|Phase 1|Laboratory Adverse Event|16|||
94684696|NCT01709305|324299932|FG001|Phase 1|Laboratory Adverse Event|0|||
94684697|NCT01709305|324299933|FG002|Phase 1|Laboratory Adverse Event|0|||
94684698|NCT01709305|324299934|FG003|Phase 1|Laboratory Adverse Event|0|||
94684699|NCT01709305|324299935|FG004|Phase 1|Laboratory Adverse Event|0|||
94684700|NCT01709305|324299931|FG000|Phase 1|Lost to Follow-up|147|||
94684701|NCT01709305|324299932|FG001|Phase 1|Lost to Follow-up|0|||
94684702|NCT01709305|324299933|FG002|Phase 1|Lost to Follow-up|0|||
94684703|NCT01709305|324299934|FG003|Phase 1|Lost to Follow-up|0|||
94684704|NCT01709305|324299935|FG004|Phase 1|Lost to Follow-up|0|||
94684705|NCT01709305|324299931|FG000|Phase 1|Travel, moving, etc.|30|||
94684706|NCT01709305|324299932|FG001|Phase 1|Travel, moving, etc.|0|||
94684707|NCT01709305|324299933|FG002|Phase 1|Travel, moving, etc.|0|||
94684708|NCT01709305|324299934|FG003|Phase 1|Travel, moving, etc.|0|||
94684709|NCT01709305|324299935|FG004|Phase 1|Travel, moving, etc.|0|||
94684710|NCT01709305|324299931|FG000|Phase 1|Physician Decision|13|||
94684711|NCT01709305|324299932|FG001|Phase 1|Physician Decision|0|||
94684712|NCT01709305|324299933|FG002|Phase 1|Physician Decision|0|||
94684713|NCT01709305|324299934|FG003|Phase 1|Physician Decision|0|||
94684714|NCT01709305|324299935|FG004|Phase 1|Physician Decision|0|||
94684715|NCT01709305|324299931|FG000|Phase 1|Protocol Violation|118|||
94684716|NCT01709305|324299932|FG001|Phase 1|Protocol Violation|0|||
94684717|NCT01709305|324299933|FG002|Phase 1|Protocol Violation|0|||
94684718|NCT01709305|324299934|FG003|Phase 1|Protocol Violation|0|||
94684719|NCT01709305|324299935|FG004|Phase 1|Protocol Violation|0|||
94684720|NCT01709305|324299931|FG000|Phase 1|Withdrawal by Subject|218|||
94684721|NCT01709305|324299932|FG001|Phase 1|Withdrawal by Subject|0|||
94684722|NCT01709305|324299933|FG002|Phase 1|Withdrawal by Subject|0|||
94684723|NCT01709305|324299934|FG003|Phase 1|Withdrawal by Subject|0|||
94684724|NCT01709305|324299935|FG004|Phase 1|Withdrawal by Subject|0|||
94684725|NCT01709305|324299931|FG000|Phase 2|Clinical Adverse Event|0|||
94684726|NCT01709305|324299932|FG001|Phase 2|Clinical Adverse Event|10|||
94684727|NCT01709305|324299933|FG002|Phase 2|Clinical Adverse Event|10|||
94684728|NCT01709305|324299934|FG003|Phase 2|Clinical Adverse Event|6|||
94684729|NCT01709305|324299935|FG004|Phase 2|Clinical Adverse Event|11|||
94684730|NCT01709305|324299931|FG000|Phase 2|Death|0|||
94684731|NCT01709305|324299932|FG001|Phase 2|Death|0|||
94684732|NCT01709305|324299933|FG002|Phase 2|Death|1|||
94684733|NCT01709305|324299934|FG003|Phase 2|Death|0|||
94684734|NCT01709305|324299935|FG004|Phase 2|Death|0|||
94684735|NCT01709305|324299931|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
94684736|NCT01709305|324299932|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
94684737|NCT01709305|324299933|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
94684738|NCT01709305|324299934|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
94684739|NCT01709305|324299935|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
94684740|NCT01709305|324299931|FG000|Phase 2|Laboratory Adverse Event|0|||
94684741|NCT01709305|324299932|FG001|Phase 2|Laboratory Adverse Event|1|||
94684742|NCT01709305|324299933|FG002|Phase 2|Laboratory Adverse Event|0|||
94684743|NCT01709305|324299934|FG003|Phase 2|Laboratory Adverse Event|1|||
94684744|NCT01709305|324299935|FG004|Phase 2|Laboratory Adverse Event|1|||
94684745|NCT01709305|324299931|FG000|Phase 2|Lost to Follow-up|0|||
94684746|NCT01709305|324299932|FG001|Phase 2|Lost to Follow-up|10|||
94684747|NCT01709305|324299933|FG002|Phase 2|Lost to Follow-up|6|||
94684748|NCT01709305|324299934|FG003|Phase 2|Lost to Follow-up|9|||
94684749|NCT01709305|324299935|FG004|Phase 2|Lost to Follow-up|5|||
94684750|NCT01709305|324299931|FG000|Phase 2|Travel, moving, etc.|0|||
94684751|NCT01709305|324299932|FG001|Phase 2|Travel, moving, etc.|2|||
94684752|NCT01709305|324299933|FG002|Phase 2|Travel, moving, etc.|3|||
94684753|NCT01709305|324299934|FG003|Phase 2|Travel, moving, etc.|3|||
94684754|NCT01709305|324299935|FG004|Phase 2|Travel, moving, etc.|5|||
94684755|NCT01709305|324299931|FG000|Phase 2|Physician Decision|0|||
94684756|NCT01709305|324299932|FG001|Phase 2|Physician Decision|2|||
94684757|NCT01709305|324299933|FG002|Phase 2|Physician Decision|0|||
94684758|NCT01709305|324299934|FG003|Phase 2|Physician Decision|1|||
94684759|NCT01709305|324299935|FG004|Phase 2|Physician Decision|2|||
94263836|NCT01252810|322759945|FG001|Overall Study|Various reasons|0|||
94684760|NCT01709305|324299931|FG000|Phase 2|Protocol Violation|0|||
94684761|NCT01709305|324299932|FG001|Phase 2|Protocol Violation|19|||
94684762|NCT01709305|324299933|FG002|Phase 2|Protocol Violation|19|||
94684763|NCT01709305|324299934|FG003|Phase 2|Protocol Violation|13|||
94684764|NCT01709305|324299935|FG004|Phase 2|Protocol Violation|9|||
94684765|NCT01709305|324299931|FG000|Phase 2|Withdrawal by Subject|0|||
94684766|NCT01709305|324299932|FG001|Phase 2|Withdrawal by Subject|8|||
94684767|NCT01709305|324299933|FG002|Phase 2|Withdrawal by Subject|6|||
94684768|NCT01709305|324299934|FG003|Phase 2|Withdrawal by Subject|15|||
94684769|NCT01709305|324299935|FG004|Phase 2|Withdrawal by Subject|12|||
94684770|NCT01302938|324299936|FG000|Overall Study|Withdrawal by Subject|1|||
94684771|NCT01302938|324299937|FG001|Overall Study|Withdrawal by Subject|0|||
94684772|NCT01302938|324299936|FG000|Overall Study|Adverse Event|1|||
94684773|NCT01302938|324299937|FG001|Overall Study|Adverse Event|0|||
94684774|NCT00874432|324299940|FG000|Overall Study|Withdrawal by Subject|1|||
94684775|NCT00874432|324299941|FG001|Overall Study|Withdrawal by Subject|0|||
94684776|NCT00874432|324299942|FG002|Overall Study|Withdrawal by Subject|0|||
94684777|NCT00874432|324299943|FG003|Overall Study|Withdrawal by Subject|0|||
94684778|NCT00874432|324299940|FG000|Overall Study|Physician Decision|1|||
94684779|NCT00874432|324299941|FG001|Overall Study|Physician Decision|0|||
94684780|NCT00874432|324299942|FG002|Overall Study|Physician Decision|0|||
94684781|NCT00874432|324299943|FG003|Overall Study|Physician Decision|0|||
94684782|NCT00874432|324299940|FG000|Overall Study|Other|1|||
94684783|NCT00874432|324299941|FG001|Overall Study|Other|2|||
94684784|NCT00874432|324299942|FG002|Overall Study|Other|8|||
94684785|NCT00874432|324299943|FG003|Overall Study|Other|3|||
94684786|NCT02944656|324299944|FG000|Overall Study|No longer eligible|3|||
94684787|NCT02944656|324299945|FG001|Overall Study|No longer eligible|0|||
94684788|NCT02944656|324299944|FG000|Overall Study|Lost to Follow-up|7|||
94684789|NCT02944656|324299945|FG001|Overall Study|Lost to Follow-up|10|||
94688615|NCT01394250|324315532|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
94688616|NCT01394250|324315533|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
94688617|NCT01394250|324315532|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
94688618|NCT01394250|324315533|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
94688619|NCT00951509|324315535|FG000|Overall Study|Withdrawal by Subject|2|||
94688620|NCT01258660|324315538|FG000|Overall Study|Adverse Event|2|||
94688621|NCT01258660|324315539|FG001|Overall Study|Adverse Event|4|||
94688622|NCT01258660|324315538|FG000|Overall Study|Withdrawal by Subject|3|||
94688623|NCT01258660|324315539|FG001|Overall Study|Withdrawal by Subject|0|||
94688624|NCT01258660|324315538|FG000|Overall Study|due to relocation|2|||
94688625|NCT01258660|324315539|FG001|Overall Study|due to relocation|0|||
94688626|NCT01258660|324315538|FG000|Overall Study|Protocol Violation|0|||
94688627|NCT01258660|324315539|FG001|Overall Study|Protocol Violation|1|||
94688628|NCT01258660|324315538|FG000|Overall Study|Invalid for primary analysis data set|4|||
94688629|NCT01258660|324315539|FG001|Overall Study|Invalid for primary analysis data set|6|||
94688630|NCT00734214|324315540|FG000|Overall Study|Withdrawal by Subject|3|||
94688631|NCT00734214|324315541|FG001|Overall Study|Withdrawal by Subject|4|||
94688632|NCT00734214|324315540|FG000|Overall Study|MD withdrawal|1|||
94688633|NCT00734214|324315541|FG001|Overall Study|MD withdrawal|0|||
94688634|NCT02443103|324315550|FG000|Overall Study|Adverse Event|2|||
94688635|NCT02443103|324315550|FG000|Overall Study|Noncompliance|1|||
94688636|NCT01630590|324315551|FG000|Overall Study|Adverse Event|9|||
94688637|NCT01630590|324315551|FG000|Overall Study|Lack of Efficacy|37|||
94688638|NCT01630590|324315551|FG000|Overall Study|Withdrawal by Subject|4|||
94688639|NCT01630590|324315551|FG000|Overall Study|2nd primary tumor|2|||
94688640|NCT01630590|324315551|FG000|Overall Study|Automobile accident|1|||
94688641|NCT01630590|324315551|FG000|Overall Study|Maximum benefit|4|||
94688642|NCT03632434|324315555|FG000|Overall Study|Withdrawal by Subject|2|||
94688643|NCT01751113|324315558|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
94688644|NCT01751113|324315559|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
94688645|NCT01751113|324315560|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
94688646|NCT01751113|324315561|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
94688647|NCT01751113|324315562|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
94688648|NCT01751113|324315563|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
94688649|NCT01751113|324315558|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
94688650|NCT01751113|324315559|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
94688651|NCT01751113|324315560|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
94688652|NCT01751113|324315561|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
94688653|NCT01751113|324315562|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
94688654|NCT01751113|324315563|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
94688655|NCT01775930|324315564|FG000|Overall Study|Futility stopping boundary met|1|||
94688656|NCT00363896|324315566|FG000|Overall Study|Withdrawal by Subject|29|||
94688657|NCT00363896|324315567|FG001|Overall Study|Withdrawal by Subject|16|||
94688658|NCT00363896|324315566|FG000|Overall Study|Adverse Event|24|||
94688659|NCT00363896|324315567|FG001|Overall Study|Adverse Event|13|||
94688660|NCT00363896|324315566|FG000|Overall Study|COPD exacerbation|13|||
94688661|NCT00363896|324315567|FG001|Overall Study|COPD exacerbation|7|||
94688662|NCT00363896|324315566|FG000|Overall Study|Lack of Efficacy|12|||
94648306|NCT00207142|324171782|FG000|Induction Phase|Adverse Event|9|||
94648307|NCT00207142|324171783|FG001|Induction Phase|Adverse Event|0|||
94648308|NCT00207142|324171784|FG002|Induction Phase|Adverse Event|0|||
94648309|NCT00207142|324171785|FG003|Induction Phase|Adverse Event|0|||
94648310|NCT00207142|324171782|FG000|Induction Phase|Death|1|||
94648311|NCT00207142|324171783|FG001|Induction Phase|Death|0|||
94648312|NCT00207142|324171784|FG002|Induction Phase|Death|0|||
94648313|NCT00207142|324171785|FG003|Induction Phase|Death|0|||
94648314|NCT00207142|324171782|FG000|Induction Phase|Lack of Efficacy|1|||
94648315|NCT00207142|324171783|FG001|Induction Phase|Lack of Efficacy|0|||
94648316|NCT00207142|324171784|FG002|Induction Phase|Lack of Efficacy|0|||
94648317|NCT00207142|324171785|FG003|Induction Phase|Lack of Efficacy|0|||
94648318|NCT00207142|324171782|FG000|Induction Phase|Lost to Follow-up|5|||
94648319|NCT00207142|324171783|FG001|Induction Phase|Lost to Follow-up|0|||
94648320|NCT00207142|324171784|FG002|Induction Phase|Lost to Follow-up|0|||
94648321|NCT00207142|324171785|FG003|Induction Phase|Lost to Follow-up|0|||
94648322|NCT00207142|324171782|FG000|Induction Phase|Physician Decision|2|||
94648323|NCT00207142|324171783|FG001|Induction Phase|Physician Decision|0|||
94648324|NCT00207142|324171784|FG002|Induction Phase|Physician Decision|0|||
94648325|NCT00207142|324171785|FG003|Induction Phase|Physician Decision|0|||
94648326|NCT00207142|324171782|FG000|Induction Phase|Poor/noncompliance|2|||
94648327|NCT00207142|324171783|FG001|Induction Phase|Poor/noncompliance|0|||
94648328|NCT00207142|324171784|FG002|Induction Phase|Poor/noncompliance|0|||
94648329|NCT00207142|324171785|FG003|Induction Phase|Poor/noncompliance|0|||
94648330|NCT00207142|324171782|FG000|Induction Phase|Pregnancy|1|||
94648331|NCT00207142|324171783|FG001|Induction Phase|Pregnancy|0|||
94648332|NCT00207142|324171784|FG002|Induction Phase|Pregnancy|0|||
94648333|NCT00207142|324171785|FG003|Induction Phase|Pregnancy|0|||
94648334|NCT00207142|324171782|FG000|Induction Phase|Subject no longer meets study criteria|3|||
94648335|NCT00207142|324171783|FG001|Induction Phase|Subject no longer meets study criteria|0|||
94648336|NCT00207142|324171784|FG002|Induction Phase|Subject no longer meets study criteria|0|||
94648337|NCT00207142|324171785|FG003|Induction Phase|Subject no longer meets study criteria|0|||
94648338|NCT00207142|324171782|FG000|Induction Phase|Withdrawal by Subject|4|||
94648339|NCT00207142|324171783|FG001|Induction Phase|Withdrawal by Subject|0|||
94648340|NCT00207142|324171784|FG002|Induction Phase|Withdrawal by Subject|0|||
94648341|NCT00207142|324171785|FG003|Induction Phase|Withdrawal by Subject|0|||
94648342|NCT00207142|324171782|FG000|Induction Phase|Incarceration|1|||
94648343|NCT00207142|324171783|FG001|Induction Phase|Incarceration|0|||
94648344|NCT00207142|324171784|FG002|Induction Phase|Incarceration|0|||
94648345|NCT00207142|324171785|FG003|Induction Phase|Incarceration|0|||
94648346|NCT00207142|324171782|FG000|Induction Phase|Missing lab data|1|||
94648347|NCT00207142|324171783|FG001|Induction Phase|Missing lab data|0|||
94648348|NCT00207142|324171784|FG002|Induction Phase|Missing lab data|0|||
94648349|NCT00207142|324171785|FG003|Induction Phase|Missing lab data|0|||
94648350|NCT00207142|324171782|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
94648351|NCT00207142|324171783|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
94648352|NCT00207142|324171784|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
94648353|NCT00207142|324171785|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
94648354|NCT00207142|324171782|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
94648355|NCT00207142|324171783|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
94648356|NCT00207142|324171784|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
94648357|NCT00207142|324171785|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
94648358|NCT00207142|324171782|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
94648359|NCT00207142|324171783|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
94648360|NCT00207142|324171784|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
94648361|NCT00207142|324171785|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
94648362|NCT00207142|324171782|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
94648363|NCT00207142|324171783|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
94648364|NCT00207142|324171784|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
94648365|NCT00207142|324171785|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
94648366|NCT00207142|324171782|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
94648367|NCT00207142|324171783|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
94648368|NCT00207142|324171784|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
94648369|NCT00207142|324171785|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
94648370|NCT00207142|324171782|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
94648371|NCT00207142|324171783|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
94648372|NCT00207142|324171784|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
94648373|NCT00207142|324171785|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
94648374|NCT00207142|324171782|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
94648375|NCT00207142|324171783|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
94648376|NCT00207142|324171784|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
94648377|NCT00207142|324171785|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
94648378|NCT00207142|324171782|FG000|Maintenance Phase/Rescue Phase|Death|0|||
94684790|NCT01816763|324301755|FG000|Overall Study|The main reason for an incomplete survey|4|||
94684791|NCT01816763|324301756|FG001|Overall Study|The main reason for an incomplete survey|15|||
94684792|NCT01816763|324301757|FG002|Overall Study|The main reason for an incomplete survey|11|||
94684793|NCT00976703|324301760|FG000|Overall Study|Physician Decision|1|||
94684794|NCT00976703|324301761|FG001|Overall Study|Physician Decision|1|||
94684795|NCT00976703|324301760|FG000|Overall Study|ineligible for study|2|||
94684796|NCT00976703|324301761|FG001|Overall Study|ineligible for study|2|||
94684797|NCT00840996|324301766|FG000|Overall Study|Withdrawal by Subject|1|||
94684798|NCT00840996|324301767|FG001|Overall Study|Withdrawal by Subject|0|||
94684799|NCT01806740|324301768|FG000|Overall Study|Withdrawal by Subject|4|||
94684800|NCT01806740|324301768|FG000|Overall Study|Physician Decision|1|||
94684801|NCT01806740|324301768|FG000|Overall Study|Patient's refusal of treatment|1|||
94684802|NCT01161472|324301771|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
94684803|NCT01161472|324301772|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
94684804|NCT01161472|324301773|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
94684805|NCT01161472|324301774|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
94684806|NCT02914184|324301775|FG000|Overall Study|Lost to Follow-up|7|||
94684807|NCT02914184|324301776|FG001|Overall Study|Lost to Follow-up|10|||
94684808|NCT02914184|324301777|FG002|Overall Study|Lost to Follow-up|8|||
94684809|NCT02914184|324301778|FG003|Overall Study|Lost to Follow-up|7|||
94684810|NCT02914184|324301775|FG000|Overall Study|Withdrawal by Subject|4|||
94684811|NCT02914184|324301776|FG001|Overall Study|Withdrawal by Subject|2|||
94684812|NCT02914184|324301777|FG002|Overall Study|Withdrawal by Subject|7|||
94684813|NCT02914184|324301778|FG003|Overall Study|Withdrawal by Subject|3|||
94684814|NCT02914184|324301775|FG000|Overall Study|Other|1|||
94684815|NCT02914184|324301776|FG001|Overall Study|Other|0|||
94684816|NCT02914184|324301777|FG002|Overall Study|Other|0|||
94684817|NCT02914184|324301778|FG003|Overall Study|Other|0|||
94684818|NCT02914184|324301775|FG000|Overall Study|Migrated/moved from the study area|2|||
94684819|NCT02914184|324301776|FG001|Overall Study|Migrated/moved from the study area|1|||
94684820|NCT02914184|324301777|FG002|Overall Study|Migrated/moved from the study area|2|||
94684821|NCT02914184|324301778|FG003|Overall Study|Migrated/moved from the study area|1|||
94684822|NCT00798174|324301780|FG000|Overall Study|inability to implant azygos coil|3|||
94684823|NCT00798174|324301781|FG001|Overall Study|inability to implant azygos coil|3|||
94684824|NCT00798174|324301780|FG000|Overall Study|Inability to sedate for DFT testing|1|||
94684825|NCT00798174|324301781|FG001|Overall Study|Inability to sedate for DFT testing|0|||
94684826|NCT02002884|324301782|FG000|Main Period (MP)|Other|0|||
94684827|NCT02002884|324301783|FG001|Main Period (MP)|Other|3|||
94684828|NCT02002884|324301784|FG002|Main Period (MP)|Other|3|||
94684829|NCT02002884|324301785|FG003|Main Period (MP)|Other|0|||
94684830|NCT02002884|324301782|FG000|Main Period (MP)|Adverse Event|0|||
94684831|NCT02002884|324301783|FG001|Main Period (MP)|Adverse Event|1|||
94684832|NCT02002884|324301784|FG002|Main Period (MP)|Adverse Event|1|||
94684833|NCT02002884|324301785|FG003|Main Period (MP)|Adverse Event|0|||
94684834|NCT02002884|324301782|FG000|Main Period (MP)|Withdrawal by Subject|6|||
94684835|NCT02002884|324301783|FG001|Main Period (MP)|Withdrawal by Subject|2|||
94684836|NCT02002884|324301784|FG002|Main Period (MP)|Withdrawal by Subject|2|||
94684837|NCT02002884|324301785|FG003|Main Period (MP)|Withdrawal by Subject|0|||
94684838|NCT02002884|324301782|FG000|Main Period (MP)|Lost to Follow-up|0|||
94684839|NCT02002884|324301783|FG001|Main Period (MP)|Lost to Follow-up|0|||
94684840|NCT02002884|324301784|FG002|Main Period (MP)|Lost to Follow-up|2|||
94684841|NCT02002884|324301785|FG003|Main Period (MP)|Lost to Follow-up|0|||
94684842|NCT02002884|324301782|FG000|Open-Label Extension Period (OLEX)|Other|0|||
94684843|NCT02002884|324301783|FG001|Open-Label Extension Period (OLEX)|Other|0|||
94684844|NCT02002884|324301784|FG002|Open-Label Extension Period (OLEX)|Other|0|||
94684845|NCT02002884|324301785|FG003|Open-Label Extension Period (OLEX)|Other|24|||
94684846|NCT02002884|324301782|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
94684847|NCT02002884|324301783|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
94684848|NCT02002884|324301784|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
94684849|NCT02002884|324301785|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
94684850|NCT02002884|324301782|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
94684851|NCT02002884|324301783|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
94684852|NCT02002884|324301784|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
94684853|NCT02002884|324301785|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
94684854|NCT02002884|324301782|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
94684855|NCT02002884|324301783|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
94684856|NCT02002884|324301784|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
94684857|NCT02002884|324301785|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
94684858|NCT02002884|324301782|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
94684859|NCT02002884|324301783|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
94684860|NCT02002884|324301784|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
94684861|NCT02002884|324301785|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
94684862|NCT02966002|324301786|FG000|Overall Study|Withdrawal by Subject|2|||
94684863|NCT02966002|324301786|FG000|Overall Study|Adverse Event|1|||
94684864|NCT02966002|324301786|FG000|Overall Study|Lost to Follow-up|1|||
94684865|NCT05340751|324301787|FG000|Overall Study|Physician Decision|3|||
94684866|NCT01014975|324301788|FG000|Overall Study|Withdrawal by Subject|1|||
94684867|NCT01014975|324301789|FG001|Overall Study|Withdrawal by Subject|0|||
94684868|NCT01014975|324301790|FG002|Overall Study|Withdrawal by Subject|1|||
94684869|NCT01014975|324301788|FG000|Overall Study|Death|3|||
94684870|NCT01014975|324301789|FG001|Overall Study|Death|3|||
94684871|NCT01014975|324301790|FG002|Overall Study|Death|4|||
94684872|NCT01014975|324301788|FG000|Overall Study|Lost to Follow-up|0|||
94684873|NCT01014975|324301789|FG001|Overall Study|Lost to Follow-up|0|||
94684874|NCT01014975|324301790|FG002|Overall Study|Lost to Follow-up|1|||
94684875|NCT01642602|324301791|FG000|Overall Study|Adverse Event|2|||
94684876|NCT00482274|324301792|FG000|Overall Study|Adverse Event|1|||
94684877|NCT01112514|324301793|FG000|Overall Study|Lost to Follow-up|1|||
94684878|NCT02961881|324301794|FG000|Overall Study|Adverse Event|1|||
94684879|NCT02961881|324301795|FG001|Overall Study|Adverse Event|2|||
94684880|NCT02961881|324301796|FG002|Overall Study|Adverse Event|2|||
94684881|NCT02961881|324301797|FG003|Overall Study|Adverse Event|0|||
94684882|NCT02961881|324301798|FG004|Overall Study|Adverse Event|1|||
94684883|NCT02961881|324301794|FG000|Overall Study|Participant request|0|||
94684884|NCT02961881|324301795|FG001|Overall Study|Participant request|2|||
94684885|NCT02961881|324301796|FG002|Overall Study|Participant request|0|||
94684886|NCT02961881|324301797|FG003|Overall Study|Participant request|0|||
94684887|NCT02961881|324301798|FG004|Overall Study|Participant request|0|||
94684888|NCT02961881|324301794|FG000|Overall Study|Disease progression|1|||
94684889|NCT02961881|324301795|FG001|Overall Study|Disease progression|0|||
94684890|NCT02961881|324301796|FG002|Overall Study|Disease progression|1|||
94684891|NCT02961881|324301797|FG003|Overall Study|Disease progression|0|||
94684892|NCT02961881|324301798|FG004|Overall Study|Disease progression|0|||
94684893|NCT02176421|324301799|FG000|Overall Study|Lost to Follow-up|4|||
94684894|NCT02176421|324301799|FG000|Overall Study|Adverse Event|1|||
94684895|NCT02396537|324301802|FG000|Overall Study|Protocol Violation|0|||
94684896|NCT02396537|324301803|FG001|Overall Study|Protocol Violation|1|||
94684897|NCT00871403|324301804|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
94684898|NCT00871403|324301805|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
94684899|NCT00871403|324301806|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
94684900|NCT00871403|324301804|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
94684901|NCT00871403|324301805|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
94684902|NCT00871403|324301806|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
94684903|NCT00871403|324301804|FG000|Combination Treatment Phase|Adverse Event|0|||
94684904|NCT00871403|324301805|FG001|Combination Treatment Phase|Adverse Event|17|||
94684905|NCT00871403|324301806|FG002|Combination Treatment Phase|Adverse Event|2|||
94684906|NCT00871403|324301804|FG000|Combination Treatment Phase|Disease Progression|0|||
94684907|NCT00871403|324301805|FG001|Combination Treatment Phase|Disease Progression|8|||
94684908|NCT00871403|324301806|FG002|Combination Treatment Phase|Disease Progression|5|||
94684909|NCT00871403|324301804|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
94684910|NCT00871403|324301805|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
94684911|NCT00871403|324301806|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
94684912|NCT00871403|324301804|FG000|Combination Treatment Phase|Physician Decision|0|||
94684913|NCT00871403|324301805|FG001|Combination Treatment Phase|Physician Decision|1|||
94684914|NCT00871403|324301806|FG002|Combination Treatment Phase|Physician Decision|3|||
94684915|NCT00871403|324301804|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
94684916|NCT00871403|324301805|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
94684917|NCT00871403|324301806|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
94684918|NCT00871403|324301804|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
94684919|NCT00871403|324301805|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
94684920|NCT00871403|324301806|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
94684921|NCT02145078|324301811|FG000|Overall Study|Death|1|||
94684922|NCT02145078|324301811|FG000|Overall Study|Reason not given|3|||
94684923|NCT02440594|324301818|FG000|Overall Study|Lost to Follow-up|34|||
94684924|NCT02440594|324301819|FG001|Overall Study|Lost to Follow-up|33|||
94684925|NCT02440594|324301820|FG002|Overall Study|Lost to Follow-up|54|||
94684926|NCT02440594|324301821|FG003|Overall Study|Lost to Follow-up|47|||
94684927|NCT02440594|324301822|FG004|Overall Study|Lost to Follow-up|5|||
94684928|NCT02440594|324301823|FG005|Overall Study|Lost to Follow-up|4|||
94684929|NCT02440594|324301824|FG006|Overall Study|Lost to Follow-up|28|||
94684930|NCT02440594|324301825|FG007|Overall Study|Lost to Follow-up|48|||
94684931|NCT02440594|324301818|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
94684932|NCT02440594|324301819|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
94364068|NCT01915498|323116802|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
94364069|NCT01915498|323116803|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
94364070|NCT01915498|323116804|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
94364071|NCT01915498|323116805|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
94648379|NCT00207142|324171783|FG001|Maintenance Phase/Rescue Phase|Death|0|||
94648380|NCT00207142|324171784|FG002|Maintenance Phase/Rescue Phase|Death|0|||
94648381|NCT00207142|324171785|FG003|Maintenance Phase/Rescue Phase|Death|1|||
94648382|NCT00207142|324171782|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
94648383|NCT00207142|324171783|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
94648384|NCT00207142|324171784|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
94648385|NCT00207142|324171785|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
94648386|NCT04641962|324171786|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
94648387|NCT04641962|324171787|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
94648388|NCT04641962|324171788|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
94648389|NCT04641962|324171789|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
94648390|NCT04641962|324171790|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
94648391|NCT04641962|324171786|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
94648392|NCT04641962|324171787|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
94648393|NCT04641962|324171788|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
94648394|NCT04641962|324171789|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
94648395|NCT04641962|324171790|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
94648396|NCT04641962|324171786|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
94648397|NCT04641962|324171787|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
94648398|NCT04641962|324171788|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
94648399|NCT04641962|324171789|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
94648400|NCT04641962|324171790|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
94648401|NCT04641962|324171786|FG000|DBT Period: Up to 52 Weeks|Death|1|||
94648402|NCT04641962|324171787|FG001|DBT Period: Up to 52 Weeks|Death|0|||
94648403|NCT04641962|324171788|FG002|DBT Period: Up to 52 Weeks|Death|0|||
94648404|NCT04641962|324171789|FG003|DBT Period: Up to 52 Weeks|Death|0|||
94648405|NCT04641962|324171790|FG004|DBT Period: Up to 52 Weeks|Death|0|||
94648406|NCT04641962|324171786|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
94648407|NCT04641962|324171787|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
94648408|NCT04641962|324171788|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
94648409|NCT04641962|324171789|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
94648410|NCT04641962|324171790|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
94648411|NCT04641962|324171786|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
94648412|NCT04641962|324171787|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
94648413|NCT04641962|324171788|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
94648414|NCT04641962|324171789|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
94648415|NCT04641962|324171790|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
94648416|NCT04641962|324171786|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
94648417|NCT04641962|324171787|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
94648418|NCT04641962|324171788|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
94648419|NCT04641962|324171789|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
94648420|NCT04641962|324171790|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
94684933|NCT02440594|324301820|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
94684934|NCT02440594|324301821|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
94684935|NCT02440594|324301822|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
94684936|NCT02440594|324301823|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
94684937|NCT02440594|324301824|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
94684938|NCT02440594|324301825|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
94684939|NCT02440594|324301818|FG000|Overall Study|Withdrawal by Subject|81|||
94684940|NCT02440594|324301819|FG001|Overall Study|Withdrawal by Subject|67|||
94684941|NCT02440594|324301820|FG002|Overall Study|Withdrawal by Subject|59|||
94684942|NCT02440594|324301821|FG003|Overall Study|Withdrawal by Subject|38|||
94684943|NCT02440594|324301822|FG004|Overall Study|Withdrawal by Subject|2|||
94684944|NCT02440594|324301823|FG005|Overall Study|Withdrawal by Subject|2|||
94684945|NCT02440594|324301824|FG006|Overall Study|Withdrawal by Subject|7|||
94684946|NCT02440594|324301825|FG007|Overall Study|Withdrawal by Subject|7|||
94684947|NCT02440594|324301818|FG000|Overall Study|Administratively w/drawn|3|||
94684948|NCT02440594|324301819|FG001|Overall Study|Administratively w/drawn|2|||
94684949|NCT02440594|324301820|FG002|Overall Study|Administratively w/drawn|0|||
94684950|NCT02440594|324301821|FG003|Overall Study|Administratively w/drawn|0|||
94684951|NCT02440594|324301822|FG004|Overall Study|Administratively w/drawn|0|||
94684952|NCT02440594|324301823|FG005|Overall Study|Administratively w/drawn|0|||
94684953|NCT02440594|324301824|FG006|Overall Study|Administratively w/drawn|2|||
94684954|NCT02440594|324301825|FG007|Overall Study|Administratively w/drawn|1|||
94684955|NCT04250337|324301826|FG000|Overall Study|Adverse Event|0|||
94684956|NCT04250337|324301827|FG001|Overall Study|Adverse Event|3|||
94684957|NCT04250337|324301826|FG000|Overall Study|Lack of Efficacy|1|||
94684958|NCT04250337|324301827|FG001|Overall Study|Lack of Efficacy|3|||
94684959|NCT04250337|324301826|FG000|Overall Study|Physician Decision|1|||
94684960|NCT04250337|324301827|FG001|Overall Study|Physician Decision|0|||
94684961|NCT04250337|324301826|FG000|Overall Study|Protocol Deviation|2|||
94684962|NCT04250337|324301827|FG001|Overall Study|Protocol Deviation|2|||
94684963|NCT04250337|324301826|FG000|Overall Study|Withdrawal by Subject|4|||
94684964|NCT04250337|324301827|FG001|Overall Study|Withdrawal by Subject|3|||
94684965|NCT00152763|324301828|FG000|Overall Study|Death|4|||
94684966|NCT00152763|324301829|FG001|Overall Study|Death|1|||
94684967|NCT00152763|324301830|FG002|Overall Study|Death|2|||
94684968|NCT00152763|324301831|FG003|Overall Study|Death|1|||
94684969|NCT00152763|324301828|FG000|Overall Study|Lost to Follow-up|6|||
94684970|NCT00152763|324301829|FG001|Overall Study|Lost to Follow-up|4|||
94684971|NCT00152763|324301830|FG002|Overall Study|Lost to Follow-up|2|||
94684972|NCT00152763|324301831|FG003|Overall Study|Lost to Follow-up|13|||
94684973|NCT00584805|324301832|FG000|Overall Study|No longer at risk of exposure|39|||
94684974|NCT00584805|324301832|FG000|Overall Study|Relocation|36|||
94684975|NCT00584805|324301832|FG000|Overall Study|Withdrawal by Subject|18|||
94684976|NCT00584805|324301832|FG000|Overall Study|Non-compliance|1|||
94684977|NCT00584805|324301832|FG000|Overall Study|Lost to follow up|3|||
94684978|NCT00584805|324301832|FG000|Overall Study|Screen failures|2|||
94684979|NCT00569803|324301836|FG000|Overall Study|Lost to Follow-up|1|||
94684980|NCT00569803|324301837|FG001|Overall Study|Lost to Follow-up|0|||
94684981|NCT00569803|324301838|FG002|Overall Study|Lost to Follow-up|0|||
94684982|NCT00569803|324301839|FG003|Overall Study|Lost to Follow-up|0|||
94684983|NCT00569803|324301840|FG004|Overall Study|Lost to Follow-up|0|||
94684984|NCT00569803|324301841|FG005|Overall Study|Lost to Follow-up|0|||
94684985|NCT00569803|324301842|FG006|Overall Study|Lost to Follow-up|0|||
94684986|NCT00569803|324301843|FG007|Overall Study|Lost to Follow-up|0|||
94684987|NCT00569803|324301836|FG000|Overall Study|injection syringe leaked during dosing|0|||
94684988|NCT00569803|324301837|FG001|Overall Study|injection syringe leaked during dosing|0|||
94684989|NCT00569803|324301838|FG002|Overall Study|injection syringe leaked during dosing|0|||
94684990|NCT00569803|324301839|FG003|Overall Study|injection syringe leaked during dosing|1|||
94684991|NCT00569803|324301840|FG004|Overall Study|injection syringe leaked during dosing|0|||
94684992|NCT00569803|324301841|FG005|Overall Study|injection syringe leaked during dosing|0|||
94684993|NCT00569803|324301842|FG006|Overall Study|injection syringe leaked during dosing|0|||
94684994|NCT00569803|324301843|FG007|Overall Study|injection syringe leaked during dosing|0|||
94684995|NCT00569803|324301836|FG000|Overall Study|Withdrawal by Subject|0|||
94684996|NCT00569803|324301837|FG001|Overall Study|Withdrawal by Subject|0|||
94684997|NCT00569803|324301838|FG002|Overall Study|Withdrawal by Subject|0|||
94684998|NCT00569803|324301839|FG003|Overall Study|Withdrawal by Subject|0|||
94684999|NCT00569803|324301840|FG004|Overall Study|Withdrawal by Subject|0|||
94648421|NCT03591575|324171791|FG000|Overall Study|Adverse Event|2|||
94648422|NCT03591575|324171792|FG001|Overall Study|Adverse Event|0|||
94648423|NCT03591575|324171791|FG000|Overall Study|Withdrawal by Subject|4|||
94648424|NCT03591575|324171792|FG001|Overall Study|Withdrawal by Subject|1|||
94648425|NCT00689481|324171795|FG000|Overall Study|Adverse Event|7|||
94648426|NCT00689481|324171796|FG001|Overall Study|Adverse Event|1|||
94648427|NCT00689481|324171795|FG000|Overall Study|Lost to Follow-up|4|||
94648428|NCT00689481|324171796|FG001|Overall Study|Lost to Follow-up|3|||
94648429|NCT00689481|324171795|FG000|Overall Study|Lack of Efficacy|4|||
94648430|NCT00689481|324171796|FG001|Overall Study|Lack of Efficacy|3|||
94648431|NCT00689481|324171795|FG000|Overall Study|Non-compliance with study treatment|1|||
94648432|NCT00689481|324171796|FG001|Overall Study|Non-compliance with study treatment|1|||
94648433|NCT00689481|324171795|FG000|Overall Study|Withdrawal by Subject|8|||
94648434|NCT00689481|324171796|FG001|Overall Study|Withdrawal by Subject|4|||
94648435|NCT00689481|324171795|FG000|Overall Study|Excluded medication started during study|0|||
94648436|NCT00689481|324171796|FG001|Overall Study|Excluded medication started during study|1|||
94648437|NCT00689481|324171795|FG000|Overall Study|Subject early term, left on vacation|0|||
94648438|NCT00689481|324171796|FG001|Overall Study|Subject early term, left on vacation|1|||
94648439|NCT03013491|324171797|FG000|Main Study|Death|2|||
94648440|NCT03013491|324171798|FG001|Main Study|Death|2|||
94648441|NCT03013491|324171799|FG002|Main Study|Death|5|||
94648442|NCT03013491|324171800|FG003|Main Study|Death|3|||
94648443|NCT03013491|324171801|FG004|Main Study|Death|9|||
94648444|NCT03013491|324171802|FG005|Main Study|Death|12|||
94648445|NCT03013491|324171803|FG006|Main Study|Death|3|||
94648446|NCT03013491|324171804|FG007|Main Study|Death|5|||
94648447|NCT03013491|324171805|FG008|Main Study|Death|1|||
94648448|NCT03013491|324171806|FG009|Main Study|Death|2|||
94648449|NCT03013491|324171807|FG010|Main Study|Death|4|||
94648450|NCT03013491|324171808|FG011|Main Study|Death|1|||
94648451|NCT03013491|324171809|FG012|Main Study|Death|1|||
94648452|NCT03013491|324171810|FG013|Main Study|Death|4|||
94648453|NCT03013491|324171811|FG014|Main Study|Death|0|||
94648454|NCT03013491|324171812|FG015|Main Study|Death|3|||
94648455|NCT03013491|324171813|FG016|Main Study|Death|5|||
94648456|NCT03013491|324171814|FG017|Main Study|Death|1|||
94648457|NCT03013491|324171815|FG018|Main Study|Death|47|||
94648458|NCT03013491|324171797|FG000|Main Study|Lost to Follow-up|0|||
94648459|NCT03013491|324171798|FG001|Main Study|Lost to Follow-up|0|||
94648460|NCT03013491|324171799|FG002|Main Study|Lost to Follow-up|1|||
94648461|NCT03013491|324171800|FG003|Main Study|Lost to Follow-up|0|||
94648462|NCT03013491|324171801|FG004|Main Study|Lost to Follow-up|1|||
94648463|NCT03013491|324171802|FG005|Main Study|Lost to Follow-up|0|||
94648464|NCT03013491|324171803|FG006|Main Study|Lost to Follow-up|0|||
94648465|NCT03013491|324171804|FG007|Main Study|Lost to Follow-up|0|||
94648466|NCT03013491|324171805|FG008|Main Study|Lost to Follow-up|0|||
94648467|NCT03013491|324171806|FG009|Main Study|Lost to Follow-up|0|||
94648468|NCT03013491|324171807|FG010|Main Study|Lost to Follow-up|0|||
94648469|NCT03013491|324171808|FG011|Main Study|Lost to Follow-up|0|||
94648470|NCT03013491|324171809|FG012|Main Study|Lost to Follow-up|0|||
94648471|NCT03013491|324171810|FG013|Main Study|Lost to Follow-up|0|||
94648472|NCT03013491|324171811|FG014|Main Study|Lost to Follow-up|0|||
94648473|NCT03013491|324171812|FG015|Main Study|Lost to Follow-up|0|||
94648474|NCT03013491|324171813|FG016|Main Study|Lost to Follow-up|0|||
94648475|NCT03013491|324171814|FG017|Main Study|Lost to Follow-up|0|||
94648476|NCT03013491|324171815|FG018|Main Study|Lost to Follow-up|3|||
94648477|NCT03013491|324171797|FG000|Main Study|Termination of the study by Sponsor|0|||
94648478|NCT03013491|324171798|FG001|Main Study|Termination of the study by Sponsor|0|||
94648479|NCT03013491|324171799|FG002|Main Study|Termination of the study by Sponsor|2|||
94648480|NCT03013491|324171800|FG003|Main Study|Termination of the study by Sponsor|0|||
94648481|NCT03013491|324171801|FG004|Main Study|Termination of the study by Sponsor|1|||
94648482|NCT03013491|324171802|FG005|Main Study|Termination of the study by Sponsor|2|||
94648483|NCT03013491|324171803|FG006|Main Study|Termination of the study by Sponsor|0|||
94648484|NCT03013491|324171804|FG007|Main Study|Termination of the study by Sponsor|0|||
94648485|NCT03013491|324171805|FG008|Main Study|Termination of the study by Sponsor|1|||
94648486|NCT03013491|324171806|FG009|Main Study|Termination of the study by Sponsor|1|||
94648487|NCT03013491|324171807|FG010|Main Study|Termination of the study by Sponsor|1|||
94648488|NCT03013491|324171808|FG011|Main Study|Termination of the study by Sponsor|2|||
94648489|NCT03013491|324171809|FG012|Main Study|Termination of the study by Sponsor|0|||
94648490|NCT03013491|324171810|FG013|Main Study|Termination of the study by Sponsor|0|||
94648491|NCT03013491|324171811|FG014|Main Study|Termination of the study by Sponsor|0|||
94648492|NCT03013491|324171812|FG015|Main Study|Termination of the study by Sponsor|0|||
94648493|NCT03013491|324171813|FG016|Main Study|Termination of the study by Sponsor|0|||
94648494|NCT03013491|324171814|FG017|Main Study|Termination of the study by Sponsor|1|||
94648495|NCT03013491|324171815|FG018|Main Study|Termination of the study by Sponsor|13|||
94648496|NCT03013491|324171797|FG000|Main Study|Withdrawal by Subject|0|||
94364072|NCT01915498|323116806|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
94364073|NCT01915498|323116807|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
94364074|NCT01915498|323116808|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
94364075|NCT01915498|323116809|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
94364076|NCT01915498|323116810|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
94364077|NCT01915498|323116811|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
94364078|NCT01915498|323116812|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
94685000|NCT00569803|324301841|FG005|Overall Study|Withdrawal by Subject|0|||
94685001|NCT00569803|324301842|FG006|Overall Study|Withdrawal by Subject|0|||
94685002|NCT00569803|324301843|FG007|Overall Study|Withdrawal by Subject|1|||
94685003|NCT01993823|324301844|FG000|Overall Study|Requested by the patient|6|||
94685004|NCT01993823|324301845|FG001|Overall Study|Requested by the patient|11|||
94685005|NCT01993823|324301844|FG000|Overall Study|Protocol Violation|0|||
94685006|NCT01993823|324301845|FG001|Overall Study|Protocol Violation|1|||
94685007|NCT01993823|324301844|FG000|Overall Study|Lost to Follow-up|1|||
94685008|NCT01993823|324301845|FG001|Overall Study|Lost to Follow-up|4|||
94685009|NCT00641719|324301849|FG000|Overall Study|Lack of Efficacy|1|||
94685010|NCT00641719|324301850|FG001|Overall Study|Lack of Efficacy|2|||
94685011|NCT00641719|324301849|FG000|Overall Study|Adverse Event|24|||
94685012|NCT00641719|324301850|FG001|Overall Study|Adverse Event|29|||
94685013|NCT00641719|324301849|FG000|Overall Study|Withdrawal by Subject|4|||
94685014|NCT00641719|324301850|FG001|Overall Study|Withdrawal by Subject|4|||
94685015|NCT00641719|324301849|FG000|Overall Study|Reason Not Specified|1|||
94685016|NCT00641719|324301850|FG001|Overall Study|Reason Not Specified|2|||
94685017|NCT00365378|324301851|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
94685018|NCT00365378|324301852|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
94685019|NCT00365378|324301853|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
94685020|NCT00365378|324301851|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
94685021|NCT00365378|324301852|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
94685022|NCT00365378|324301853|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
94685023|NCT00365378|324301851|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
94685024|NCT00365378|324301852|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
94685025|NCT00365378|324301853|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
94685026|NCT00365378|324301851|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
94685027|NCT00365378|324301852|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
94685028|NCT00365378|324301853|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
94685029|NCT00365378|324301851|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
94685030|NCT00365378|324301852|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
94685031|NCT00365378|324301853|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
94685032|NCT00365378|324301851|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
94685033|NCT00365378|324301852|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
94685034|NCT00365378|324301853|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
94685035|NCT00365378|324301851|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
94685036|NCT00365378|324301852|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
94685037|NCT00365378|324301853|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
94685038|NCT00365378|324301851|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
94685039|NCT00365378|324301852|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
94685040|NCT00365378|324301853|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
94685041|NCT00365378|324301851|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
94685042|NCT00365378|324301852|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
94685043|NCT00365378|324301853|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
94685044|NCT00365378|324301851|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
94685045|NCT00365378|324301852|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
94685046|NCT00365378|324301853|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
94685047|NCT00365378|324301851|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
94685048|NCT00365378|324301852|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
94685049|NCT00365378|324301853|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
94685050|NCT00365378|324301851|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
94685051|NCT00365378|324301852|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
94685052|NCT00365378|324301853|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
94364079|NCT01915498|323116813|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
94364080|NCT01915498|323116814|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
94685053|NCT00365378|324301851|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
94685054|NCT00365378|324301852|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
94685055|NCT00365378|324301853|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
94685056|NCT00365378|324301851|FG000|Extension|Adverse Event|0|||
94685057|NCT00365378|324301852|FG001|Extension|Adverse Event|0|||
94685058|NCT00365378|324301853|FG002|Extension|Adverse Event|1|||
94685059|NCT00365378|324301851|FG000|Extension|Moved|0|||
94685060|NCT00365378|324301852|FG001|Extension|Moved|0|||
94685061|NCT00365378|324301853|FG002|Extension|Moved|8|||
94685062|NCT00365378|324301851|FG000|Extension|Lost to Follow-up|0|||
94685063|NCT00365378|324301852|FG001|Extension|Lost to Follow-up|0|||
94685064|NCT00365378|324301853|FG002|Extension|Lost to Follow-up|57|||
94685065|NCT00365378|324301851|FG000|Extension|Protocol Violation|0|||
94685066|NCT00365378|324301852|FG001|Extension|Protocol Violation|0|||
94685067|NCT00365378|324301853|FG002|Extension|Protocol Violation|2|||
94685068|NCT00365378|324301851|FG000|Extension|Withdrawal by Subject|0|||
94685069|NCT00365378|324301852|FG001|Extension|Withdrawal by Subject|0|||
94685070|NCT00365378|324301853|FG002|Extension|Withdrawal by Subject|98|||
94685071|NCT00365378|324301851|FG000|Extension|Other|0|||
94685072|NCT00365378|324301852|FG001|Extension|Other|0|||
94685073|NCT00365378|324301853|FG002|Extension|Other|31|||
94685074|NCT01872910|324301854|FG000|Overall Study|Lost to Follow-up|2|||
94685075|NCT01872910|324301855|FG001|Overall Study|Lost to Follow-up|0|||
94685076|NCT01872910|324301856|FG002|Overall Study|Lost to Follow-up|2|||
94685077|NCT01872910|324301857|FG003|Overall Study|Lost to Follow-up|0|||
94685078|NCT01872910|324301858|FG004|Overall Study|Lost to Follow-up|0|||
94685079|NCT01872910|324301859|FG005|Overall Study|Lost to Follow-up|0|||
94685080|NCT04581200|324301863|FG000|Overall Study|Lost to Follow-up|6|||
94685081|NCT04581200|324301864|FG001|Overall Study|Lost to Follow-up|5|||
94685082|NCT00669903|324301865|FG000|Overall Study|Adverse Event|0|||
94685083|NCT00669903|324301866|FG001|Overall Study|Adverse Event|1|||
94685084|NCT00669903|324301867|FG002|Overall Study|Adverse Event|3|||
94685085|NCT00669903|324301868|FG003|Overall Study|Adverse Event|1|||
94685086|NCT00669903|324301865|FG000|Overall Study|Withdrawal by Subject|0|||
94685087|NCT00669903|324301866|FG001|Overall Study|Withdrawal by Subject|2|||
94685088|NCT00669903|324301867|FG002|Overall Study|Withdrawal by Subject|2|||
94685089|NCT00669903|324301868|FG003|Overall Study|Withdrawal by Subject|2|||
94685090|NCT00669903|324301865|FG000|Overall Study|Lost to Follow-up|1|||
94685091|NCT00669903|324301866|FG001|Overall Study|Lost to Follow-up|1|||
94685092|NCT00669903|324301867|FG002|Overall Study|Lost to Follow-up|0|||
94685093|NCT00669903|324301868|FG003|Overall Study|Lost to Follow-up|1|||
94685094|NCT00669903|324301865|FG000|Overall Study|Protocol Violation|0|||
94685095|NCT00669903|324301866|FG001|Overall Study|Protocol Violation|1|||
94685096|NCT00669903|324301867|FG002|Overall Study|Protocol Violation|0|||
94685097|NCT00669903|324301868|FG003|Overall Study|Protocol Violation|0|||
94685098|NCT03119610|324301869|FG000|Overall Study|Adverse Event|1|||
94685099|NCT03119610|324301870|FG001|Overall Study|Adverse Event|0|||
94685100|NCT03119610|324301869|FG000|Overall Study|Lost to Follow-up|0|||
94685101|NCT03119610|324301870|FG001|Overall Study|Lost to Follow-up|1|||
94685102|NCT04091360|324301899|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
94685103|NCT04091360|324301900|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
94685104|NCT04091360|324301901|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
94685105|NCT04091360|324301902|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
94685106|NCT04091360|324301903|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
94685107|NCT04091360|324301904|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
94685108|NCT04091360|324301905|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
94364081|NCT01915498|323116815|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
94364082|NCT01915498|323116816|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
94364083|NCT01915498|323116817|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
94364084|NCT01915498|323116818|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
94685109|NCT04091360|324301906|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
94364085|NCT01915498|323116819|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
94364086|NCT01915498|323116820|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
94364087|NCT01915498|323116802|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
94364088|NCT01915498|323116803|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
94364089|NCT01915498|323116804|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
94685110|NCT04091360|324301907|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
94685111|NCT04091360|324301908|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
94685112|NCT04091360|324301899|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
94685113|NCT04091360|324301900|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
94685114|NCT04091360|324301901|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
94685115|NCT04091360|324301902|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
94685116|NCT04091360|324301903|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
94685117|NCT04091360|324301904|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
94685118|NCT04091360|324301905|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
94685119|NCT04091360|324301906|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
94685120|NCT04091360|324301907|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
94688663|NCT00363896|324315567|FG001|Overall Study|Lack of Efficacy|8|||
94685121|NCT04091360|324301908|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
94685122|NCT04091360|324301899|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
94685123|NCT04091360|324301900|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
94685124|NCT04091360|324301901|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
94685125|NCT04091360|324301902|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
94685126|NCT04091360|324301903|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
94685127|NCT04091360|324301904|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
94685128|NCT04091360|324301905|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
94685129|NCT04091360|324301906|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
94685130|NCT04091360|324301907|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
94685131|NCT04091360|324301908|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
94685132|NCT00406419|324301909|FG000|Overall Study|Death|3|||
94685133|NCT00406419|324301910|FG001|Overall Study|Death|1|||
94685134|NCT00406419|324301911|FG002|Overall Study|Death|4|||
94685135|NCT00406419|324301909|FG000|Overall Study|Protocol Violation|6|||
94685136|NCT00406419|324301910|FG001|Overall Study|Protocol Violation|2|||
94685137|NCT00406419|324301911|FG002|Overall Study|Protocol Violation|5|||
94685138|NCT00406419|324301909|FG000|Overall Study|Study Terminated by Sponsor|260|||
94685139|NCT00406419|324301910|FG001|Overall Study|Study Terminated by Sponsor|288|||
94685140|NCT00406419|324301911|FG002|Overall Study|Study Terminated by Sponsor|282|||
94685141|NCT00406419|324301909|FG000|Overall Study|Withdrawal by Subject|17|||
94685142|NCT00406419|324301910|FG001|Overall Study|Withdrawal by Subject|24|||
94685143|NCT00406419|324301911|FG002|Overall Study|Withdrawal by Subject|26|||
94685144|NCT00406419|324301909|FG000|Overall Study|Lack of Efficacy|12|||
94685145|NCT00406419|324301910|FG001|Overall Study|Lack of Efficacy|1|||
94685146|NCT00406419|324301911|FG002|Overall Study|Lack of Efficacy|6|||
94685147|NCT00406419|324301909|FG000|Overall Study|Non-Compliance with Study Drug|5|||
94685148|NCT00406419|324301910|FG001|Overall Study|Non-Compliance with Study Drug|6|||
94685149|NCT00406419|324301911|FG002|Overall Study|Non-Compliance with Study Drug|3|||
94685150|NCT00406419|324301909|FG000|Overall Study|Adverse Event|10|||
94685151|NCT00406419|324301910|FG001|Overall Study|Adverse Event|12|||
94685152|NCT00406419|324301911|FG002|Overall Study|Adverse Event|16|||
94685153|NCT00406419|324301909|FG000|Overall Study|Lost to Follow-up|11|||
94685154|NCT00406419|324301910|FG001|Overall Study|Lost to Follow-up|10|||
94685155|NCT00406419|324301911|FG002|Overall Study|Lost to Follow-up|5|||
94685156|NCT00308737|324301912|FG000|Overall Study|Adverse Event|104|||
94685157|NCT00308737|324301913|FG001|Overall Study|Adverse Event|9|||
94685158|NCT00308737|324301914|FG002|Overall Study|Adverse Event|0|||
94685159|NCT00308737|324301912|FG000|Overall Study|Death|4|||
94685160|NCT00308737|324301913|FG001|Overall Study|Death|3|||
94685161|NCT00308737|324301914|FG002|Overall Study|Death|0|||
94685162|NCT00308737|324301912|FG000|Overall Study|Lost to Follow-up|56|||
94685163|NCT00308737|324301913|FG001|Overall Study|Lost to Follow-up|80|||
94685164|NCT00308737|324301914|FG002|Overall Study|Lost to Follow-up|5|||
94685165|NCT00308737|324301912|FG000|Overall Study|Physician Decision|15|||
94685166|NCT00308737|324301913|FG001|Overall Study|Physician Decision|2|||
94685167|NCT00308737|324301914|FG002|Overall Study|Physician Decision|1|||
94685168|NCT00308737|324301912|FG000|Overall Study|Protocol Violation|34|||
94685169|NCT00308737|324301913|FG001|Overall Study|Protocol Violation|9|||
94685170|NCT00308737|324301914|FG002|Overall Study|Protocol Violation|5|||
94685171|NCT00308737|324301912|FG000|Overall Study|Withdrawal by Subject|218|||
94685172|NCT00308737|324301913|FG001|Overall Study|Withdrawal by Subject|166|||
94685173|NCT00308737|324301914|FG002|Overall Study|Withdrawal by Subject|18|||
94685174|NCT00308737|324301912|FG000|Overall Study|Various|32|||
94685175|NCT00308737|324301913|FG001|Overall Study|Various|20|||
94685176|NCT00308737|324301914|FG002|Overall Study|Various|8|||
94685177|NCT01225822|324301915|FG000|Overall Study|Adverse Event|13|||
94685178|NCT01225822|324301916|FG001|Overall Study|Adverse Event|31|||
94685179|NCT01225822|324301917|FG002|Overall Study|Adverse Event|18|||
94685180|NCT01225822|324301918|FG003|Overall Study|Adverse Event|23|||
94685181|NCT01225822|324301919|FG004|Overall Study|Adverse Event|14|||
94685182|NCT01225822|324301915|FG000|Overall Study|Protocol Violation|6|||
94685183|NCT01225822|324301916|FG001|Overall Study|Protocol Violation|8|||
94685184|NCT01225822|324301917|FG002|Overall Study|Protocol Violation|6|||
94685185|NCT01225822|324301918|FG003|Overall Study|Protocol Violation|7|||
94685186|NCT01225822|324301919|FG004|Overall Study|Protocol Violation|4|||
94685187|NCT01225822|324301915|FG000|Overall Study|Lost to Follow-up|0|||
94685188|NCT01225822|324301916|FG001|Overall Study|Lost to Follow-up|0|||
94685189|NCT01225822|324301917|FG002|Overall Study|Lost to Follow-up|0|||
94685190|NCT01225822|324301918|FG003|Overall Study|Lost to Follow-up|1|||
94685191|NCT01225822|324301919|FG004|Overall Study|Lost to Follow-up|0|||
94685192|NCT01225822|324301915|FG000|Overall Study|Withdrawal by Subject|6|||
94685193|NCT01225822|324301916|FG001|Overall Study|Withdrawal by Subject|7|||
94685194|NCT01225822|324301917|FG002|Overall Study|Withdrawal by Subject|7|||
94685195|NCT01225822|324301918|FG003|Overall Study|Withdrawal by Subject|11|||
94685196|NCT01225822|324301919|FG004|Overall Study|Withdrawal by Subject|6|||
94685197|NCT01225822|324301915|FG000|Overall Study|Other|13|||
94685198|NCT01225822|324301916|FG001|Overall Study|Other|10|||
94685199|NCT01225822|324301917|FG002|Overall Study|Other|7|||
94685200|NCT01225822|324301918|FG003|Overall Study|Other|10|||
94685201|NCT01225822|324301919|FG004|Overall Study|Other|7|||
94685202|NCT00453102|324301922|FG000|Overall Study|Withdrawal by Subject|2|||
94685203|NCT04986982|324301923|FG000|Overall Study|Withdrawal by Subject|3|||
94685204|NCT04986982|324301924|FG001|Overall Study|Withdrawal by Subject|1|||
94685205|NCT04986982|324301923|FG000|Overall Study|Lack of Efficacy|0|||
94685206|NCT04986982|324301924|FG001|Overall Study|Lack of Efficacy|2|||
94685207|NCT04986982|324301923|FG000|Overall Study|Ineligibility|3|||
94685208|NCT04986982|324301924|FG001|Overall Study|Ineligibility|0|||
94685209|NCT04986982|324301923|FG000|Overall Study|Adverse Event|4|||
94685210|NCT04986982|324301924|FG001|Overall Study|Adverse Event|4|||
94685211|NCT04986982|324301923|FG000|Overall Study|Lost to Follow-up|0|||
94685212|NCT04986982|324301924|FG001|Overall Study|Lost to Follow-up|1|||
94685213|NCT04986982|324301923|FG000|Overall Study|Sponsor's discretion|1|||
94685214|NCT04986982|324301924|FG001|Overall Study|Sponsor's discretion|0|||
94685215|NCT01155661|324301925|FG000|Overall Study|Adverse Event|101|||
94685216|NCT01155661|324301925|FG000|Overall Study|Death|1|||
94685217|NCT01155661|324301925|FG000|Overall Study|Lack of Efficacy|32|||
94685218|NCT01155661|324301925|FG000|Overall Study|Lost to Follow-up|22|||
94685219|NCT01155661|324301925|FG000|Overall Study|Physician Decision|3|||
94685220|NCT01155661|324301925|FG000|Overall Study|Protocol Violation|35|||
94685221|NCT01155661|324301925|FG000|Overall Study|Withdrawal by Subject|73|||
94685222|NCT01155661|324301925|FG000|Overall Study|Sponsor Decision|13|||
94685223|NCT02690077|324301926|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
94685224|NCT02690077|324301927|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
94685225|NCT02690077|324301926|FG000|Overall Study|Withdrawal by Subject|0|||
94685226|NCT02690077|324301927|FG001|Overall Study|Withdrawal by Subject|5|||
94685227|NCT02690077|324301926|FG000|Overall Study|Excluded by IRB|0|||
94685228|NCT02690077|324301927|FG001|Overall Study|Excluded by IRB|2|||
94685229|NCT04186403|324301928|FG000|Overall Study|Adverse Event|1|||
94685230|NCT04186403|324301929|FG001|Overall Study|Adverse Event|8|||
94685231|NCT04186403|324301928|FG000|Overall Study|Lost to Follow-up|7|||
94685232|NCT04186403|324301929|FG001|Overall Study|Lost to Follow-up|3|||
94685233|NCT04186403|324301928|FG000|Overall Study|Physician Decision|1|||
94685234|NCT04186403|324301929|FG001|Overall Study|Physician Decision|0|||
94685235|NCT04186403|324301928|FG000|Overall Study|Withdrawal by Subject|7|||
94685236|NCT04186403|324301929|FG001|Overall Study|Withdrawal by Subject|8|||
94685237|NCT04186403|324301928|FG000|Overall Study|Other: Not Related to Covid-19|3|||
94685238|NCT04186403|324301929|FG001|Overall Study|Other: Not Related to Covid-19|0|||
94685239|NCT01407354|324301933|FG000|First Intervention|Withdrawal by Subject|0|||
94685240|NCT01407354|324301934|FG001|First Intervention|Withdrawal by Subject|2|||
94685241|NCT01407354|324301933|FG000|First Intervention|Adverse Event|1|||
94685242|NCT01407354|324301934|FG001|First Intervention|Adverse Event|0|||
94685243|NCT01407354|324301933|FG000|First Intervention|Physician Decision|1|||
94685244|NCT01407354|324301934|FG001|First Intervention|Physician Decision|0|||
94685245|NCT01396395|324301935|FG000|Overall Study|Withdrawal by Subject|10|||
94685246|NCT01396395|324301936|FG001|Overall Study|Withdrawal by Subject|12|||
94685247|NCT01396395|324301935|FG000|Overall Study|Protocol Violation|3|||
94685248|NCT01396395|324301936|FG001|Overall Study|Protocol Violation|1|||
94685249|NCT01396395|324301935|FG000|Overall Study|Adverse Event|10|||
94685250|NCT01396395|324301936|FG001|Overall Study|Adverse Event|2|||
94685251|NCT01396395|324301935|FG000|Overall Study|Lost to Follow-up|17|||
94685252|NCT01396395|324301936|FG001|Overall Study|Lost to Follow-up|11|||
94685253|NCT01396395|324301935|FG000|Overall Study|Other|0|||
94685254|NCT01396395|324301936|FG001|Overall Study|Other|1|||
94685255|NCT02009696|324301938|FG000|Overall Study|Withdrawal by Subject|2|||
94685256|NCT00960752|324301942|FG000|Overall Study|Adverse Event|0|||
94685257|NCT00960752|324301943|FG001|Overall Study|Adverse Event|0|||
94685258|NCT00960752|324301944|FG002|Overall Study|Adverse Event|1|||
94685259|NCT00960752|324301942|FG000|Overall Study|Progression|0|||
94463505|NCT00336024|323485084|FG001|Overall Study|Withdrawal by Subject|2|||
94685260|NCT00960752|324301943|FG001|Overall Study|Progression|0|||
94685261|NCT00960752|324301944|FG002|Overall Study|Progression|1|||
94685262|NCT00785707|324301945|FG000|Overall Study|Lost to Follow-up|7|||
94685263|NCT01992549|324303647|FG000|Overall Study|Lost to Follow-up|2|||
94685264|NCT01992549|324303647|FG000|Overall Study|Serious Adverse Event|1|||
94685265|NCT01992549|324303647|FG000|Overall Study|Product Switch to Extend Half Life|1|||
94685266|NCT01590771|324303648|FG000|Overall Study|Other Protocol Specified Criteria|5|||
94685267|NCT01590771|324303649|FG001|Overall Study|Other Protocol Specified Criteria|14|||
94648497|NCT03013491|324171798|FG001|Main Study|Withdrawal by Subject|0|||
94648498|NCT03013491|324171799|FG002|Main Study|Withdrawal by Subject|0|||
94648499|NCT03013491|324171800|FG003|Main Study|Withdrawal by Subject|4|||
94648500|NCT03013491|324171801|FG004|Main Study|Withdrawal by Subject|2|||
94648501|NCT03013491|324171802|FG005|Main Study|Withdrawal by Subject|1|||
94648502|NCT03013491|324171803|FG006|Main Study|Withdrawal by Subject|0|||
94648503|NCT03013491|324171804|FG007|Main Study|Withdrawal by Subject|0|||
94648504|NCT03013491|324171805|FG008|Main Study|Withdrawal by Subject|0|||
94648505|NCT03013491|324171806|FG009|Main Study|Withdrawal by Subject|0|||
94648506|NCT03013491|324171807|FG010|Main Study|Withdrawal by Subject|1|||
94648507|NCT03013491|324171808|FG011|Main Study|Withdrawal by Subject|2|||
94648508|NCT03013491|324171809|FG012|Main Study|Withdrawal by Subject|0|||
94648509|NCT03013491|324171810|FG013|Main Study|Withdrawal by Subject|2|||
94648510|NCT03013491|324171811|FG014|Main Study|Withdrawal by Subject|0|||
94648511|NCT03013491|324171812|FG015|Main Study|Withdrawal by Subject|0|||
94648512|NCT03013491|324171813|FG016|Main Study|Withdrawal by Subject|0|||
94648513|NCT03013491|324171814|FG017|Main Study|Withdrawal by Subject|0|||
94648514|NCT03013491|324171815|FG018|Main Study|Withdrawal by Subject|18|||
94648515|NCT03013491|324171797|FG000|Main Study|Disease progression|0|||
94648516|NCT03013491|324171798|FG001|Main Study|Disease progression|0|||
94648517|NCT03013491|324171799|FG002|Main Study|Disease progression|0|||
94648518|NCT03013491|324171800|FG003|Main Study|Disease progression|1|||
94648519|NCT03013491|324171801|FG004|Main Study|Disease progression|0|||
94648520|NCT03013491|324171802|FG005|Main Study|Disease progression|0|||
94648521|NCT03013491|324171803|FG006|Main Study|Disease progression|0|||
94648522|NCT03013491|324171804|FG007|Main Study|Disease progression|0|||
94648523|NCT03013491|324171805|FG008|Main Study|Disease progression|1|||
94648524|NCT03013491|324171806|FG009|Main Study|Disease progression|0|||
94648525|NCT03013491|324171807|FG010|Main Study|Disease progression|1|||
94648526|NCT03013491|324171808|FG011|Main Study|Disease progression|0|||
94648527|NCT03013491|324171809|FG012|Main Study|Disease progression|0|||
94648528|NCT03013491|324171810|FG013|Main Study|Disease progression|0|||
94648529|NCT03013491|324171811|FG014|Main Study|Disease progression|0|||
94648530|NCT03013491|324171812|FG015|Main Study|Disease progression|0|||
94648531|NCT03013491|324171813|FG016|Main Study|Disease progression|0|||
94648532|NCT03013491|324171814|FG017|Main Study|Disease progression|0|||
94648533|NCT03013491|324171815|FG018|Main Study|Disease progression|4|||
94648534|NCT03013491|324171797|FG000|Main Study|Symptomatic deterioration|0|||
94648535|NCT03013491|324171798|FG001|Main Study|Symptomatic deterioration|0|||
94648536|NCT03013491|324171799|FG002|Main Study|Symptomatic deterioration|0|||
94648537|NCT03013491|324171800|FG003|Main Study|Symptomatic deterioration|0|||
94648538|NCT03013491|324171801|FG004|Main Study|Symptomatic deterioration|0|||
94648539|NCT03013491|324171802|FG005|Main Study|Symptomatic deterioration|1|||
94648540|NCT03013491|324171803|FG006|Main Study|Symptomatic deterioration|0|||
94648541|NCT03013491|324171804|FG007|Main Study|Symptomatic deterioration|0|||
94648542|NCT03013491|324171805|FG008|Main Study|Symptomatic deterioration|0|||
94648543|NCT03013491|324171806|FG009|Main Study|Symptomatic deterioration|0|||
94648544|NCT03013491|324171807|FG010|Main Study|Symptomatic deterioration|0|||
94648545|NCT03013491|324171808|FG011|Main Study|Symptomatic deterioration|0|||
94648546|NCT03013491|324171809|FG012|Main Study|Symptomatic deterioration|0|||
94648547|NCT03013491|324171810|FG013|Main Study|Symptomatic deterioration|0|||
94648548|NCT03013491|324171811|FG014|Main Study|Symptomatic deterioration|0|||
94648549|NCT03013491|324171812|FG015|Main Study|Symptomatic deterioration|0|||
94648550|NCT03013491|324171813|FG016|Main Study|Symptomatic deterioration|0|||
94648551|NCT03013491|324171814|FG017|Main Study|Symptomatic deterioration|0|||
94648552|NCT03013491|324171815|FG018|Main Study|Symptomatic deterioration|0|||
94648553|NCT03013491|324171797|FG000|Main Study|Protocol version 8.0 approval|0|||
94648554|NCT03013491|324171798|FG001|Main Study|Protocol version 8.0 approval|0|||
94648555|NCT03013491|324171799|FG002|Main Study|Protocol version 8.0 approval|0|||
94648556|NCT03013491|324171800|FG003|Main Study|Protocol version 8.0 approval|0|||
94648557|NCT03013491|324171801|FG004|Main Study|Protocol version 8.0 approval|0|||
94648558|NCT03013491|324171802|FG005|Main Study|Protocol version 8.0 approval|0|||
94648559|NCT03013491|324171803|FG006|Main Study|Protocol version 8.0 approval|0|||
94648560|NCT03013491|324171804|FG007|Main Study|Protocol version 8.0 approval|0|||
94648561|NCT03013491|324171805|FG008|Main Study|Protocol version 8.0 approval|0|||
94685268|NCT01590771|324303648|FG000|Overall Study|Withdrawal by Subject|8|||
94685269|NCT01590771|324303649|FG001|Overall Study|Withdrawal by Subject|15|||
94685270|NCT01590771|324303648|FG000|Overall Study|Protocol Violation|1|||
94685271|NCT01590771|324303649|FG001|Overall Study|Protocol Violation|2|||
94648562|NCT03013491|324171806|FG009|Main Study|Protocol version 8.0 approval|0|||
94648563|NCT03013491|324171807|FG010|Main Study|Protocol version 8.0 approval|1|||
94648564|NCT03013491|324171808|FG011|Main Study|Protocol version 8.0 approval|0|||
94648565|NCT03013491|324171809|FG012|Main Study|Protocol version 8.0 approval|0|||
94648566|NCT03013491|324171810|FG013|Main Study|Protocol version 8.0 approval|0|||
94648567|NCT03013491|324171811|FG014|Main Study|Protocol version 8.0 approval|0|||
94648568|NCT03013491|324171812|FG015|Main Study|Protocol version 8.0 approval|0|||
94648569|NCT03013491|324171813|FG016|Main Study|Protocol version 8.0 approval|0|||
94685272|NCT01590771|324303648|FG000|Overall Study|Lost to Follow-up|1|||
94685273|NCT01590771|324303649|FG001|Overall Study|Lost to Follow-up|1|||
94685274|NCT01590771|324303648|FG000|Overall Study|Lack of Efficacy|1|||
94685275|NCT01590771|324303649|FG001|Overall Study|Lack of Efficacy|0|||
94685276|NCT01590771|324303648|FG000|Overall Study|Adverse Event|3|||
94685277|NCT01590771|324303649|FG001|Overall Study|Adverse Event|7|||
94685278|NCT00767104|324303650|FG000|Overall Study|Lost to Follow-up|1|||
94685279|NCT00767104|324303651|FG001|Overall Study|Lost to Follow-up|2|||
94685280|NCT04105972|324303657|FG000|Overall Study|Adverse Event|2|||
94685281|NCT04105972|324303658|FG001|Overall Study|Adverse Event|1|||
94685282|NCT02254408|324303659|FG000|Overall Study|Randomized But Not Treated|1|||
94685283|NCT02254408|324303660|FG001|Overall Study|Randomized But Not Treated|3|||
94685284|NCT02254408|324303659|FG000|Overall Study|Adverse Event|1|||
94685285|NCT02254408|324303660|FG001|Overall Study|Adverse Event|0|||
94685286|NCT02254408|324303659|FG000|Overall Study|Death|2|||
94685287|NCT02254408|324303660|FG001|Overall Study|Death|3|||
94685288|NCT02254408|324303659|FG000|Overall Study|Investigator's Discretion|0|||
94685289|NCT02254408|324303660|FG001|Overall Study|Investigator's Discretion|1|||
94685290|NCT02254408|324303659|FG000|Overall Study|Withdrawal by Subject|3|||
94685291|NCT02254408|324303660|FG001|Overall Study|Withdrawal by Subject|3|||
94685292|NCT02254408|324303659|FG000|Overall Study|Lost to Follow-up|1|||
94685293|NCT02254408|324303660|FG001|Overall Study|Lost to Follow-up|0|||
94685294|NCT00592319|324303661|FG000|Overall Study|Lost to Follow-up|0|||
94685295|NCT00592319|324303662|FG001|Overall Study|Lost to Follow-up|3|||
94685296|NCT03321513|324303663|FG000|Overall Study|Death|11|||
94685297|NCT03321513|324303664|FG001|Overall Study|Death|5|||
94685298|NCT03321513|324303663|FG000|Overall Study|Withdrawal by Subject|5|||
94685299|NCT03321513|324303664|FG001|Overall Study|Withdrawal by Subject|10|||
94685300|NCT03321513|324303663|FG000|Overall Study|Lost to Follow-up|10|||
94685301|NCT03321513|324303664|FG001|Overall Study|Lost to Follow-up|11|||
94685302|NCT01993017|324303665|FG000|Overall Study|Death|23|||
94685303|NCT01993017|324303666|FG001|Overall Study|Death|26|||
94685304|NCT01993017|324303667|FG002|Overall Study|Death|18|||
94685305|NCT01993017|324303665|FG000|Overall Study|Could not be contacted|43|||
94685306|NCT01993017|324303666|FG001|Overall Study|Could not be contacted|42|||
94685307|NCT01993017|324303667|FG002|Overall Study|Could not be contacted|38|||
94685308|NCT01993017|324303665|FG000|Overall Study|Dropped out|19|||
94685309|NCT01993017|324303666|FG001|Overall Study|Dropped out|6|||
94685310|NCT01993017|324303667|FG002|Overall Study|Dropped out|11|||
94685311|NCT01993017|324303665|FG000|Overall Study|Other reasons|17|||
94685312|NCT01993017|324303666|FG001|Overall Study|Other reasons|11|||
94685313|NCT01993017|324303667|FG002|Overall Study|Other reasons|7|||
94685314|NCT01993017|324303665|FG000|Overall Study|Ineligible after randomization|4|||
94685315|NCT01993017|324303666|FG001|Overall Study|Ineligible after randomization|5|||
94685316|NCT01993017|324303667|FG002|Overall Study|Ineligible after randomization|5|||
94685317|NCT01976364|324303668|FG000|Main Study (36 Months)|Adverse Event|63|||
94685318|NCT01976364|324303669|FG001|Main Study (36 Months)|Adverse Event|0|||
94685319|NCT01976364|324303670|FG002|Main Study (36 Months)|Adverse Event|0|||
94685320|NCT01976364|324303668|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
94685321|NCT01976364|324303669|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
94685322|NCT01976364|324303670|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
94685323|NCT01976364|324303668|FG000|Main Study (36 Months)|Other|13|||
94685324|NCT01976364|324303669|FG001|Main Study (36 Months)|Other|0|||
94685325|NCT01976364|324303670|FG002|Main Study (36 Months)|Other|0|||
94685326|NCT01976364|324303668|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
94685327|NCT01976364|324303669|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
94685328|NCT01976364|324303670|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
94685329|NCT01976364|324303668|FG000|Main Study (36 Months)|Medication error|1|||
94685330|NCT01976364|324303669|FG001|Main Study (36 Months)|Medication error|0|||
94685331|NCT01976364|324303670|FG002|Main Study (36 Months)|Medication error|0|||
94685332|NCT01976364|324303668|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
94685333|NCT01976364|324303669|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
94685334|NCT01976364|324303670|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
94685335|NCT01976364|324303668|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
94685336|NCT01976364|324303669|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
94685337|NCT01976364|324303670|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
94685338|NCT01976364|324303668|FG000|Main Study (36 Months)|Protocol Violation|13|||
94685339|NCT01976364|324303669|FG001|Main Study (36 Months)|Protocol Violation|0|||
94685340|NCT01976364|324303670|FG002|Main Study (36 Months)|Protocol Violation|0|||
94685341|NCT01976364|324303668|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
94685342|NCT01976364|324303669|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
94685343|NCT01976364|324303670|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
94685344|NCT01976364|324303668|FG000|Main Study (36 Months)|Death|5|||
94685345|NCT01976364|324303669|FG001|Main Study (36 Months)|Death|0|||
94685346|NCT01976364|324303670|FG002|Main Study (36 Months)|Death|0|||
94685347|NCT01976364|324303668|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
94688664|NCT00363896|324315566|FG000|Overall Study|Protocol Violation|6|||
94685348|NCT01976364|324303669|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
94685349|NCT01976364|324303670|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
94685350|NCT01976364|324303668|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
94685351|NCT01976364|324303669|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
94685352|NCT01976364|324303670|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
94685353|NCT01976364|324303668|FG000|Sub-study (12 Months)|Protocol Violation|0|||
94685354|NCT01976364|324303669|FG001|Sub-study (12 Months)|Protocol Violation|1|||
94685355|NCT01976364|324303670|FG002|Sub-study (12 Months)|Protocol Violation|1|||
94685356|NCT01976364|324303668|FG000|Sub-study (12 Months)|Adverse Event|0|||
94685357|NCT01976364|324303669|FG001|Sub-study (12 Months)|Adverse Event|4|||
94685358|NCT01976364|324303670|FG002|Sub-study (12 Months)|Adverse Event|3|||
94685359|NCT01190215|324303671|FG000|Up to Month 6|Lost to Follow-up|2|||
94685360|NCT01190215|324303672|FG001|Up to Month 6|Lost to Follow-up|0|||
94685361|NCT02670538|324303675|FG000|Overall Study|Withdrawal of Consent|8|||
94685362|NCT02670538|324303676|FG001|Overall Study|Withdrawal of Consent|6|||
94685363|NCT02670538|324303677|FG002|Overall Study|Withdrawal of Consent|5|||
94685364|NCT02670538|324303675|FG000|Overall Study|Lost to Follow-up|8|||
94685365|NCT02670538|324303676|FG001|Overall Study|Lost to Follow-up|12|||
94685366|NCT02670538|324303677|FG002|Overall Study|Lost to Follow-up|7|||
94685367|NCT02670538|324303675|FG000|Overall Study|Adverse Event|5|||
94648570|NCT03013491|324171814|FG017|Main Study|Protocol version 8.0 approval|0|||
94648571|NCT03013491|324171815|FG018|Main Study|Protocol version 8.0 approval|0|||
94648572|NCT03013491|324171797|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
94648573|NCT03013491|324171798|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
94648574|NCT03013491|324171799|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
94648575|NCT03013491|324171800|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
94648576|NCT03013491|324171801|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
94648577|NCT03013491|324171802|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
94648578|NCT03013491|324171803|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
94648579|NCT03013491|324171804|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
94648580|NCT03013491|324171805|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
94648581|NCT03013491|324171806|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
94648582|NCT03013491|324171807|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
94648583|NCT03013491|324171808|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
94648584|NCT03013491|324171809|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
94648585|NCT03013491|324171810|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
94648586|NCT03013491|324171811|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
94648587|NCT03013491|324171812|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
94648588|NCT03013491|324171813|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
94648589|NCT03013491|324171814|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
94648590|NCT03013491|324171815|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
94648591|NCT03013491|324171797|FG000|Main Study|Start of new anticancer therapy|0|||
94648592|NCT03013491|324171798|FG001|Main Study|Start of new anticancer therapy|0|||
94648593|NCT03013491|324171799|FG002|Main Study|Start of new anticancer therapy|0|||
94648594|NCT03013491|324171800|FG003|Main Study|Start of new anticancer therapy|0|||
94648595|NCT03013491|324171801|FG004|Main Study|Start of new anticancer therapy|0|||
94648596|NCT03013491|324171802|FG005|Main Study|Start of new anticancer therapy|0|||
94648597|NCT03013491|324171803|FG006|Main Study|Start of new anticancer therapy|0|||
94648598|NCT03013491|324171804|FG007|Main Study|Start of new anticancer therapy|0|||
94648599|NCT03013491|324171805|FG008|Main Study|Start of new anticancer therapy|0|||
94648600|NCT03013491|324171806|FG009|Main Study|Start of new anticancer therapy|0|||
94648601|NCT03013491|324171807|FG010|Main Study|Start of new anticancer therapy|0|||
94648602|NCT03013491|324171808|FG011|Main Study|Start of new anticancer therapy|0|||
94648603|NCT03013491|324171809|FG012|Main Study|Start of new anticancer therapy|0|||
94648604|NCT03013491|324171810|FG013|Main Study|Start of new anticancer therapy|0|||
94648605|NCT03013491|324171811|FG014|Main Study|Start of new anticancer therapy|0|||
94648606|NCT03013491|324171812|FG015|Main Study|Start of new anticancer therapy|0|||
94648607|NCT03013491|324171813|FG016|Main Study|Start of new anticancer therapy|0|||
94648608|NCT03013491|324171814|FG017|Main Study|Start of new anticancer therapy|0|||
94648609|NCT03013491|324171815|FG018|Main Study|Start of new anticancer therapy|2|||
94648610|NCT03013491|324171797|FG000|Long-term Extension|Disease progression|0|||
94648611|NCT03013491|324171798|FG001|Long-term Extension|Disease progression|0|||
94648612|NCT03013491|324171799|FG002|Long-term Extension|Disease progression|0|||
94685368|NCT02670538|324303676|FG001|Overall Study|Adverse Event|5|||
94648613|NCT03013491|324171800|FG003|Long-term Extension|Disease progression|1|||
94685369|NCT02670538|324303677|FG002|Overall Study|Adverse Event|11|||
94685370|NCT02670538|324303675|FG000|Overall Study|Lack of Efficacy|7|||
94685371|NCT02670538|324303676|FG001|Overall Study|Lack of Efficacy|1|||
94648614|NCT03013491|324171801|FG004|Long-term Extension|Disease progression|0|||
94648615|NCT03013491|324171802|FG005|Long-term Extension|Disease progression|0|||
94648616|NCT03013491|324171803|FG006|Long-term Extension|Disease progression|0|||
94648617|NCT03013491|324171804|FG007|Long-term Extension|Disease progression|0|||
94648618|NCT03013491|324171805|FG008|Long-term Extension|Disease progression|0|||
94648619|NCT03013491|324171806|FG009|Long-term Extension|Disease progression|0|||
94648620|NCT03013491|324171807|FG010|Long-term Extension|Disease progression|0|||
94648621|NCT03013491|324171808|FG011|Long-term Extension|Disease progression|0|||
94648622|NCT03013491|324171809|FG012|Long-term Extension|Disease progression|0|||
94648623|NCT03013491|324171810|FG013|Long-term Extension|Disease progression|0|||
94648624|NCT03013491|324171811|FG014|Long-term Extension|Disease progression|0|||
94648625|NCT03013491|324171812|FG015|Long-term Extension|Disease progression|0|||
94648626|NCT03013491|324171813|FG016|Long-term Extension|Disease progression|0|||
94648627|NCT03013491|324171814|FG017|Long-term Extension|Disease progression|0|||
94648628|NCT03013491|324171815|FG018|Long-term Extension|Disease progression|1|||
94648629|NCT03013491|324171797|FG000|Long-term Extension|Withdrawal by Subject|0|||
94648630|NCT03013491|324171798|FG001|Long-term Extension|Withdrawal by Subject|0|||
94648631|NCT03013491|324171799|FG002|Long-term Extension|Withdrawal by Subject|0|||
94648632|NCT03013491|324171800|FG003|Long-term Extension|Withdrawal by Subject|0|||
94648633|NCT03013491|324171801|FG004|Long-term Extension|Withdrawal by Subject|0|||
94648634|NCT03013491|324171802|FG005|Long-term Extension|Withdrawal by Subject|0|||
94648635|NCT03013491|324171803|FG006|Long-term Extension|Withdrawal by Subject|0|||
94648636|NCT03013491|324171804|FG007|Long-term Extension|Withdrawal by Subject|1|||
94648637|NCT03013491|324171805|FG008|Long-term Extension|Withdrawal by Subject|0|||
94648638|NCT03013491|324171806|FG009|Long-term Extension|Withdrawal by Subject|0|||
94648639|NCT03013491|324171807|FG010|Long-term Extension|Withdrawal by Subject|0|||
94648640|NCT03013491|324171808|FG011|Long-term Extension|Withdrawal by Subject|0|||
94648641|NCT03013491|324171809|FG012|Long-term Extension|Withdrawal by Subject|0|||
94648642|NCT03013491|324171810|FG013|Long-term Extension|Withdrawal by Subject|0|||
94648643|NCT03013491|324171811|FG014|Long-term Extension|Withdrawal by Subject|0|||
94648644|NCT03013491|324171812|FG015|Long-term Extension|Withdrawal by Subject|0|||
94648645|NCT03013491|324171813|FG016|Long-term Extension|Withdrawal by Subject|0|||
94648646|NCT03013491|324171814|FG017|Long-term Extension|Withdrawal by Subject|0|||
94648647|NCT03013491|324171815|FG018|Long-term Extension|Withdrawal by Subject|0|||
94648648|NCT03013491|324171797|FG000|Long-term Extension|Adverse Event|0|||
94648649|NCT03013491|324171798|FG001|Long-term Extension|Adverse Event|0|||
94648650|NCT03013491|324171799|FG002|Long-term Extension|Adverse Event|0|||
94648651|NCT03013491|324171800|FG003|Long-term Extension|Adverse Event|0|||
94648652|NCT03013491|324171801|FG004|Long-term Extension|Adverse Event|0|||
94648653|NCT03013491|324171802|FG005|Long-term Extension|Adverse Event|0|||
94648654|NCT03013491|324171803|FG006|Long-term Extension|Adverse Event|0|||
94648655|NCT03013491|324171804|FG007|Long-term Extension|Adverse Event|0|||
94648656|NCT03013491|324171805|FG008|Long-term Extension|Adverse Event|0|||
94648657|NCT03013491|324171806|FG009|Long-term Extension|Adverse Event|0|||
94648658|NCT03013491|324171807|FG010|Long-term Extension|Adverse Event|0|||
94648659|NCT03013491|324171808|FG011|Long-term Extension|Adverse Event|0|||
94648660|NCT03013491|324171809|FG012|Long-term Extension|Adverse Event|0|||
94648661|NCT03013491|324171810|FG013|Long-term Extension|Adverse Event|0|||
94648662|NCT03013491|324171811|FG014|Long-term Extension|Adverse Event|0|||
94648663|NCT03013491|324171812|FG015|Long-term Extension|Adverse Event|0|||
94648664|NCT03013491|324171813|FG016|Long-term Extension|Adverse Event|0|||
94648665|NCT03013491|324171814|FG017|Long-term Extension|Adverse Event|0|||
94648666|NCT03013491|324171815|FG018|Long-term Extension|Adverse Event|1|||
94648667|NCT03013491|324171797|FG000|Long-term Extension|Death|0|||
94648668|NCT03013491|324171798|FG001|Long-term Extension|Death|0|||
94648669|NCT03013491|324171799|FG002|Long-term Extension|Death|0|||
94648670|NCT03013491|324171800|FG003|Long-term Extension|Death|0|||
94648671|NCT03013491|324171801|FG004|Long-term Extension|Death|0|||
94648672|NCT03013491|324171802|FG005|Long-term Extension|Death|0|||
94648673|NCT03013491|324171803|FG006|Long-term Extension|Death|0|||
94648674|NCT03013491|324171804|FG007|Long-term Extension|Death|0|||
94648675|NCT03013491|324171805|FG008|Long-term Extension|Death|0|||
94648676|NCT03013491|324171806|FG009|Long-term Extension|Death|0|||
94263837|NCT03427125|322759946|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
94263838|NCT03427125|322759947|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
94648677|NCT03013491|324171807|FG010|Long-term Extension|Death|0|||
94648678|NCT03013491|324171808|FG011|Long-term Extension|Death|0|||
94648679|NCT03013491|324171809|FG012|Long-term Extension|Death|0|||
94648680|NCT03013491|324171810|FG013|Long-term Extension|Death|0|||
94648681|NCT03013491|324171811|FG014|Long-term Extension|Death|0|||
94648682|NCT03013491|324171812|FG015|Long-term Extension|Death|0|||
94648683|NCT03013491|324171813|FG016|Long-term Extension|Death|0|||
94648684|NCT03013491|324171814|FG017|Long-term Extension|Death|0|||
94648685|NCT03013491|324171815|FG018|Long-term Extension|Death|1|||
94648686|NCT04745689|324171816|FG000|Overall Study|Death|9|||
94648687|NCT04745689|324171817|FG001|Overall Study|Death|6|||
94648688|NCT04745689|324171816|FG000|Overall Study|Lost to Follow-up|1|||
94648689|NCT04745689|324171817|FG001|Overall Study|Lost to Follow-up|0|||
94648690|NCT04745689|324171816|FG000|Overall Study|Withdrawal by Subject|2|||
94685372|NCT02670538|324303677|FG002|Overall Study|Lack of Efficacy|2|||
94685373|NCT02670538|324303675|FG000|Overall Study|Protocol Violation|3|||
94685374|NCT02670538|324303676|FG001|Overall Study|Protocol Violation|4|||
94685375|NCT02670538|324303677|FG002|Overall Study|Protocol Violation|1|||
94685376|NCT02670538|324303675|FG000|Overall Study|Noncompliance with Study Drug|1|||
94685377|NCT02670538|324303676|FG001|Overall Study|Noncompliance with Study Drug|3|||
94685378|NCT02670538|324303677|FG002|Overall Study|Noncompliance with Study Drug|2|||
94685379|NCT02670538|324303675|FG000|Overall Study|Other Miscellaneous Reasons|0|||
94685380|NCT02670538|324303676|FG001|Overall Study|Other Miscellaneous Reasons|1|||
94685381|NCT02670538|324303677|FG002|Overall Study|Other Miscellaneous Reasons|2|||
94685382|NCT00768430|324303680|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
94685383|NCT00768430|324303681|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
94685384|NCT00633932|324303702|FG000|Overall Study|Adverse Event|1|||
94685385|NCT00633932|324303703|FG001|Overall Study|Adverse Event|3|||
94685386|NCT00633932|324303704|FG002|Overall Study|Adverse Event|4|||
94685387|NCT00633932|324303702|FG000|Overall Study|Withdrawal by Subject|3|||
94685388|NCT00633932|324303703|FG001|Overall Study|Withdrawal by Subject|9|||
94685389|NCT00633932|324303704|FG002|Overall Study|Withdrawal by Subject|1|||
94685390|NCT00633932|324303702|FG000|Overall Study|Lost to Follow-up|1|||
94685391|NCT00633932|324303703|FG001|Overall Study|Lost to Follow-up|0|||
94685392|NCT00633932|324303704|FG002|Overall Study|Lost to Follow-up|2|||
94685393|NCT00633932|324303702|FG000|Overall Study|Protocol Violation|5|||
94685394|NCT00633932|324303703|FG001|Overall Study|Protocol Violation|2|||
94685395|NCT00633932|324303704|FG002|Overall Study|Protocol Violation|3|||
94685396|NCT00633932|324303702|FG000|Overall Study|Physician Decision|0|||
94685397|NCT00633932|324303703|FG001|Overall Study|Physician Decision|0|||
94685398|NCT00633932|324303704|FG002|Overall Study|Physician Decision|1|||
94685399|NCT00633932|324303702|FG000|Overall Study|Doctor's judgement|1|||
94685400|NCT00633932|324303703|FG001|Overall Study|Doctor's judgement|0|||
94685401|NCT00633932|324303704|FG002|Overall Study|Doctor's judgement|0|||
94685402|NCT00633932|324303702|FG000|Overall Study|Moved Away|1|||
94685403|NCT00633932|324303703|FG001|Overall Study|Moved Away|0|||
94685404|NCT00633932|324303704|FG002|Overall Study|Moved Away|0|||
94685405|NCT02291432|324303705|FG000|Overall Study|Withdrawal by Subject|2|||
94685406|NCT00597714|324303709|FG000|Overall Study|Death|56|||
94685407|NCT00597714|324303710|FG001|Overall Study|Death|46|||
94685408|NCT00597714|324303711|FG002|Overall Study|Death|0|||
94685409|NCT00597714|324303709|FG000|Overall Study|Recipient death|0|||
94685410|NCT00597714|324303710|FG001|Overall Study|Recipient death|0|||
94685411|NCT00597714|324303711|FG002|Overall Study|Recipient death|10|||
94685412|NCT00810082|324303712|FG000|Overall Study|Lost to Follow-up|0|||
94685413|NCT00810082|324303713|FG001|Overall Study|Lost to Follow-up|4|||
94685414|NCT03810313|324303714|FG000|Overall Study|Study terminated by sponsor|164|||
94685415|NCT03810313|324303715|FG001|Overall Study|Study terminated by sponsor|159|||
94685416|NCT03810313|324303714|FG000|Overall Study|Subject decision|10|||
94685417|NCT03810313|324303715|FG001|Overall Study|Subject decision|11|||
94685418|NCT03810313|324303714|FG000|Overall Study|Lost to Follow-up|3|||
94685419|NCT03810313|324303715|FG001|Overall Study|Lost to Follow-up|3|||
94685420|NCT03810313|324303714|FG000|Overall Study|Adverse Event|2|||
94685421|NCT03810313|324303715|FG001|Overall Study|Adverse Event|1|||
94685422|NCT03810313|324303714|FG000|Overall Study|Death|2|||
94685423|NCT03810313|324303715|FG001|Overall Study|Death|1|||
94685424|NCT03810313|324303714|FG000|Overall Study|Physician Decision|0|||
94685425|NCT03810313|324303715|FG001|Overall Study|Physician Decision|1|||
94685426|NCT01460160|324303716|FG000|Treatment Phase|Lack of Efficacy|3|||
94685427|NCT01460160|324303716|FG000|Treatment Phase|Study Drug Toxicity|2|||
94685428|NCT01460160|324303716|FG000|Treatment Phase|Adverse Event|8|||
94685429|NCT01460160|324303716|FG000|Treatment Phase|Withdrawal by Subject|4|||
94685430|NCT01460160|324303716|FG000|Treatment Phase|Death|2|||
94685431|NCT01460160|324303716|FG000|Treatment Phase|Other reasons|9|||
94685432|NCT01460160|324303716|FG000|Follow-up Phase|Withdrawal by Subject|4|||
94685433|NCT01460160|324303716|FG000|Follow-up Phase|Death|14|||
94685434|NCT01460160|324303716|FG000|Follow-up Phase|Lost to Follow-up|7|||
94685435|NCT01460160|324303716|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
94685436|NCT01460160|324303716|FG000|Follow-up Phase|Other and not reported reasons|5|||
94685437|NCT00100932|324303717|FG000|Overall Study|Adverse Event|11|||
94685438|NCT00100932|324303718|FG001|Overall Study|Adverse Event|2|||
94685439|NCT00100932|324303717|FG000|Overall Study|Withdrawal by Subject|6|||
94685440|NCT00100932|324303718|FG001|Overall Study|Withdrawal by Subject|0|||
94685441|NCT00100932|324303717|FG000|Overall Study|Progressive Disease|44|||
94685442|NCT00100932|324303718|FG001|Overall Study|Progressive Disease|18|||
94685443|NCT00100932|324303717|FG000|Overall Study|Physician Decision|7|||
94685444|NCT00100932|324303718|FG001|Overall Study|Physician Decision|5|||
94685445|NCT00100932|324303717|FG000|Overall Study|Other|5|||
94685446|NCT00100932|324303718|FG001|Overall Study|Other|2|||
94685447|NCT02247804|324303721|FG000|Treatment Period 1|Adverse Event|9|||
94685448|NCT02247804|324303722|FG001|Treatment Period 1|Adverse Event|2|||
94685449|NCT02247804|324303723|FG002|Treatment Period 1|Adverse Event|0|||
94685450|NCT02247804|324303721|FG000|Treatment Period 1|Lack of Efficacy|0|||
94685451|NCT02247804|324303722|FG001|Treatment Period 1|Lack of Efficacy|0|||
94648691|NCT04745689|324171817|FG001|Overall Study|Withdrawal by Subject|0|||
94648692|NCT04745689|324171816|FG000|Overall Study|Study terminated by sponsor|10|||
94648693|NCT04745689|324171817|FG001|Overall Study|Study terminated by sponsor|3|||
94648694|NCT04740034|324171818|FG000|Overall Study|Death|0|||
94648695|NCT04740034|324171819|FG001|Overall Study|Death|1|||
94648696|NCT04740034|324171820|FG002|Overall Study|Death|2|||
94648697|NCT04740034|324171821|FG003|Overall Study|Death|3|||
94648698|NCT04740034|324171822|FG004|Overall Study|Death|4|||
94648699|NCT04740034|324171823|FG005|Overall Study|Death|4|||
94648700|NCT04740034|324171824|FG006|Overall Study|Death|2|||
94648701|NCT04740034|324171825|FG007|Overall Study|Death|2|||
94648702|NCT04740034|324171826|FG008|Overall Study|Death|2|||
94648703|NCT04740034|324171827|FG009|Overall Study|Death|4|||
94648704|NCT04740034|324171828|FG010|Overall Study|Death|0|||
94648705|NCT04740034|324171818|FG000|Overall Study|Lost to Follow-up|0|||
94648706|NCT04740034|324171819|FG001|Overall Study|Lost to Follow-up|0|||
94648707|NCT04740034|324171820|FG002|Overall Study|Lost to Follow-up|0|||
94648708|NCT04740034|324171821|FG003|Overall Study|Lost to Follow-up|1|||
94648709|NCT04740034|324171822|FG004|Overall Study|Lost to Follow-up|2|||
94648710|NCT04740034|324171823|FG005|Overall Study|Lost to Follow-up|2|||
94648711|NCT04740034|324171824|FG006|Overall Study|Lost to Follow-up|0|||
94648712|NCT04740034|324171825|FG007|Overall Study|Lost to Follow-up|0|||
94648713|NCT04740034|324171826|FG008|Overall Study|Lost to Follow-up|0|||
94648714|NCT04740034|324171827|FG009|Overall Study|Lost to Follow-up|1|||
94648715|NCT04740034|324171828|FG010|Overall Study|Lost to Follow-up|0|||
94648716|NCT04740034|324171818|FG000|Overall Study|Withdrawal by Subject|1|||
94648717|NCT04740034|324171819|FG001|Overall Study|Withdrawal by Subject|0|||
94648718|NCT04740034|324171820|FG002|Overall Study|Withdrawal by Subject|0|||
94648719|NCT04740034|324171821|FG003|Overall Study|Withdrawal by Subject|0|||
94648720|NCT04740034|324171822|FG004|Overall Study|Withdrawal by Subject|0|||
94648721|NCT04740034|324171823|FG005|Overall Study|Withdrawal by Subject|0|||
94648722|NCT04740034|324171824|FG006|Overall Study|Withdrawal by Subject|0|||
94648723|NCT04740034|324171825|FG007|Overall Study|Withdrawal by Subject|1|||
94648724|NCT04740034|324171826|FG008|Overall Study|Withdrawal by Subject|0|||
94648725|NCT04740034|324171827|FG009|Overall Study|Withdrawal by Subject|1|||
94648726|NCT04740034|324171828|FG010|Overall Study|Withdrawal by Subject|0|||
94648727|NCT04740034|324171818|FG000|Overall Study|Decision by sponsor|0|||
94648728|NCT04740034|324171819|FG001|Overall Study|Decision by sponsor|0|||
94648729|NCT04740034|324171820|FG002|Overall Study|Decision by sponsor|1|||
94648730|NCT04740034|324171821|FG003|Overall Study|Decision by sponsor|0|||
94648731|NCT04740034|324171822|FG004|Overall Study|Decision by sponsor|0|||
94648732|NCT04740034|324171823|FG005|Overall Study|Decision by sponsor|0|||
94648733|NCT04740034|324171824|FG006|Overall Study|Decision by sponsor|1|||
94648734|NCT04740034|324171825|FG007|Overall Study|Decision by sponsor|2|||
94648735|NCT04740034|324171826|FG008|Overall Study|Decision by sponsor|1|||
94648736|NCT04740034|324171827|FG009|Overall Study|Decision by sponsor|1|||
94648737|NCT04740034|324171828|FG010|Overall Study|Decision by sponsor|2|||
94648738|NCT03548584|324173489|FG000|Overall Study|Lost to Follow-up|0|||
94648739|NCT03548584|324173490|FG001|Overall Study|Lost to Follow-up|0|||
94648740|NCT03548584|324173491|FG002|Overall Study|Lost to Follow-up|1|||
94648741|NCT03548584|324173489|FG000|Overall Study|Adverse Event|1|||
94648742|NCT03548584|324173490|FG001|Overall Study|Adverse Event|11|||
94648743|NCT03548584|324173491|FG002|Overall Study|Adverse Event|5|||
94648744|NCT03548584|324173489|FG000|Overall Study|Site Terminated by Sponsor|1|||
94648745|NCT03548584|324173490|FG001|Overall Study|Site Terminated by Sponsor|3|||
94648746|NCT03548584|324173491|FG002|Overall Study|Site Terminated by Sponsor|2|||
94648747|NCT03548584|324173489|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
94648748|NCT03548584|324173490|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
94648749|NCT03548584|324173491|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
94648750|NCT03548584|324173489|FG000|Overall Study|Lack of Efficacy|0|||
94648751|NCT03548584|324173490|FG001|Overall Study|Lack of Efficacy|1|||
94648752|NCT03548584|324173491|FG002|Overall Study|Lack of Efficacy|0|||
94648753|NCT03548584|324173489|FG000|Overall Study|Non-compliance with Study Drug|0|||
94648754|NCT03548584|324173490|FG001|Overall Study|Non-compliance with Study Drug|1|||
94648755|NCT03548584|324173491|FG002|Overall Study|Non-compliance with Study Drug|0|||
94648756|NCT03548584|324173489|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
94648757|NCT03548584|324173490|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
94648758|NCT03548584|324173491|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
94648759|NCT04524403|324173492|FG000|Overall Study|Withdrawal by Subject|10|||
94648760|NCT04524403|324173493|FG001|Overall Study|Withdrawal by Subject|3|||
94648761|NCT04524403|324173494|FG002|Overall Study|Withdrawal by Subject|8|||
94648762|NCT04524403|324173492|FG000|Overall Study|Lost to Follow-up|3|||
94648763|NCT04524403|324173493|FG001|Overall Study|Lost to Follow-up|4|||
94648764|NCT04524403|324173494|FG002|Overall Study|Lost to Follow-up|3|||
94648765|NCT04524403|324173492|FG000|Overall Study|Adverse Event|3|||
94648766|NCT04524403|324173493|FG001|Overall Study|Adverse Event|1|||
94648767|NCT04524403|324173494|FG002|Overall Study|Adverse Event|4|||
94688665|NCT00363896|324315567|FG001|Overall Study|Protocol Violation|1|||
94685452|NCT02247804|324303723|FG002|Treatment Period 1|Lack of Efficacy|2|||
94685453|NCT02247804|324303721|FG000|Treatment Period 1|Lost to Follow-up|1|||
94685454|NCT02247804|324303722|FG001|Treatment Period 1|Lost to Follow-up|0|||
94685455|NCT02247804|324303723|FG002|Treatment Period 1|Lost to Follow-up|2|||
94685456|NCT02247804|324303721|FG000|Treatment Period 1|Personal Reasons|7|||
94685457|NCT02247804|324303722|FG001|Treatment Period 1|Personal Reasons|1|||
94685458|NCT02247804|324303723|FG002|Treatment Period 1|Personal Reasons|2|||
94685459|NCT02247804|324303721|FG000|Treatment Period 1|Protocol Deviation|0|||
94685460|NCT02247804|324303722|FG001|Treatment Period 1|Protocol Deviation|0|||
94685461|NCT02247804|324303723|FG002|Treatment Period 1|Protocol Deviation|1|||
94685462|NCT02247804|324303721|FG000|Treatment Period 1|Randomized but not Treated|5|||
94685463|NCT02247804|324303722|FG001|Treatment Period 1|Randomized but not Treated|1|||
94685464|NCT02247804|324303723|FG002|Treatment Period 1|Randomized but not Treated|1|||
94685465|NCT02247804|324303721|FG000|Treatment Period 2|Adverse Event|6|||
94685466|NCT02247804|324303722|FG001|Treatment Period 2|Adverse Event|3|||
94685467|NCT02247804|324303723|FG002|Treatment Period 2|Adverse Event|3|||
94685468|NCT02247804|324303721|FG000|Treatment Period 2|Lack of Efficacy|0|||
94685469|NCT02247804|324303722|FG001|Treatment Period 2|Lack of Efficacy|0|||
94685470|NCT02247804|324303723|FG002|Treatment Period 2|Lack of Efficacy|1|||
94685471|NCT02247804|324303721|FG000|Treatment Period 2|Lost to Follow-up|0|||
94685472|NCT02247804|324303722|FG001|Treatment Period 2|Lost to Follow-up|1|||
94685473|NCT02247804|324303723|FG002|Treatment Period 2|Lost to Follow-up|1|||
94685474|NCT02247804|324303721|FG000|Treatment Period 2|Personal Reasons|2|||
94685475|NCT02247804|324303722|FG001|Treatment Period 2|Personal Reasons|1|||
94685476|NCT02247804|324303723|FG002|Treatment Period 2|Personal Reasons|1|||
94685477|NCT02247804|324303721|FG000|Treatment Period 2|Reason not Specified|0|||
94685478|NCT02247804|324303722|FG001|Treatment Period 2|Reason not Specified|0|||
94685479|NCT02247804|324303723|FG002|Treatment Period 2|Reason not Specified|2|||
94685480|NCT02247804|324303721|FG000|Treatment Period 3|Adverse Event|4|||
94685481|NCT02247804|324303722|FG001|Treatment Period 3|Adverse Event|3|||
94685482|NCT02247804|324303723|FG002|Treatment Period 3|Adverse Event|3|||
94685483|NCT02247804|324303721|FG000|Treatment Period 3|Lack of Efficacy|0|||
94685484|NCT02247804|324303722|FG001|Treatment Period 3|Lack of Efficacy|1|||
94685485|NCT02247804|324303723|FG002|Treatment Period 3|Lack of Efficacy|0|||
94685486|NCT02247804|324303721|FG000|Treatment Period 3|Lost to Follow-up|1|||
94685487|NCT02247804|324303722|FG001|Treatment Period 3|Lost to Follow-up|2|||
94685488|NCT02247804|324303723|FG002|Treatment Period 3|Lost to Follow-up|2|||
94685489|NCT02247804|324303721|FG000|Treatment Period 3|Personal Reasons|4|||
94685490|NCT02247804|324303722|FG001|Treatment Period 3|Personal Reasons|3|||
94685491|NCT02247804|324303723|FG002|Treatment Period 3|Personal Reasons|2|||
94685492|NCT02247804|324303721|FG000|Treatment Period 3|Reason not Specified|2|||
94685493|NCT02247804|324303722|FG001|Treatment Period 3|Reason not Specified|1|||
94685494|NCT02247804|324303723|FG002|Treatment Period 3|Reason not Specified|3|||
94685495|NCT02917265|324303724|FG000|Overall Study|Physician Decision|1|||
94685496|NCT02917265|324303725|FG001|Overall Study|Physician Decision|0|||
94685497|NCT02917265|324303724|FG000|Overall Study|Withdrawal by Subject|1|||
94685498|NCT02917265|324303725|FG001|Overall Study|Withdrawal by Subject|0|||
94685499|NCT03447730|324303727|FG000|Overall Study|Adverse Event|0|||
94685500|NCT03447730|324303728|FG001|Overall Study|Adverse Event|2|||
94685501|NCT03447730|324303729|FG002|Overall Study|Adverse Event|0|||
94685502|NCT00452413|324303730|FG000|Overall Study|Progressive Disease|4|||
94685503|NCT00452413|324303731|FG001|Overall Study|Progressive Disease|11|||
94685504|NCT00452413|324303732|FG002|Overall Study|Progressive Disease|30|||
94685505|NCT00452413|324303730|FG000|Overall Study|Withdrawal by Subject|0|||
94685506|NCT00452413|324303731|FG001|Overall Study|Withdrawal by Subject|1|||
94685507|NCT00452413|324303732|FG002|Overall Study|Withdrawal by Subject|4|||
94685508|NCT00452413|324303730|FG000|Overall Study|Adverse Event|0|||
94685509|NCT00452413|324303731|FG001|Overall Study|Adverse Event|0|||
94685510|NCT00452413|324303732|FG002|Overall Study|Adverse Event|5|||
94685511|NCT00452413|324303730|FG000|Overall Study|Physician Decision|0|||
94685512|NCT00452413|324303731|FG001|Overall Study|Physician Decision|0|||
94685513|NCT00452413|324303732|FG002|Overall Study|Physician Decision|4|||
94685514|NCT00452413|324303730|FG000|Overall Study|Death due to study disease|0|||
94685515|NCT00452413|324303731|FG001|Overall Study|Death due to study disease|0|||
94365715|NCT05553600|323124752|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
94685516|NCT00452413|324303732|FG002|Overall Study|Death due to study disease|2|||
94685517|NCT00452413|324303730|FG000|Overall Study|Death due to adverse event (AE)|0|||
94685518|NCT00452413|324303731|FG001|Overall Study|Death due to adverse event (AE)|0|||
94685519|NCT00452413|324303732|FG002|Overall Study|Death due to adverse event (AE)|1|||
94685520|NCT00452413|324303730|FG000|Overall Study|On treatment|0|||
94685521|NCT00452413|324303731|FG001|Overall Study|On treatment|0|||
94685522|NCT00452413|324303732|FG002|Overall Study|On treatment|3|||
94685523|NCT01248962|324303733|FG000|Overall Study|Withdrawal by Subject|1|||
94685524|NCT01248962|324303734|FG001|Overall Study|Withdrawal by Subject|1|||
94685525|NCT01248962|324303733|FG000|Overall Study|Adverse Event|2|||
94648768|NCT04524403|324173492|FG000|Overall Study|Non-compliant with study drug|1|||
94648769|NCT04524403|324173493|FG001|Overall Study|Non-compliant with study drug|2|||
94648770|NCT04524403|324173494|FG002|Overall Study|Non-compliant with study drug|3|||
94648771|NCT04524403|324173492|FG000|Overall Study|Moved|0|||
94648772|NCT04524403|324173493|FG001|Overall Study|Moved|1|||
94648773|NCT04524403|324173494|FG002|Overall Study|Moved|0|||
94648774|NCT00574405|324173495|FG000|Overall Study|Withdrawal by Subject|3|||
94648775|NCT00574405|324173496|FG001|Overall Study|Withdrawal by Subject|2|||
94648776|NCT04982029|324173497|FG000|Overall Study|Lost to Follow-up|2|||
94648777|NCT04982029|324173498|FG001|Overall Study|Lost to Follow-up|3|||
94648778|NCT01700179|324173499|FG000|Overall Study|Physician Decision|2|||
94648779|NCT00071812|324173500|FG000|24-Week Double-Blind Period|Adverse Event|2|||
94648780|NCT00071812|324173501|FG001|24-Week Double-Blind Period|Adverse Event|3|||
94648781|NCT00071812|324173502|FG002|24-Week Double-Blind Period|Adverse Event|4|||
94648782|NCT00071812|324173503|FG003|24-Week Double-Blind Period|Adverse Event|4|||
94648783|NCT00071812|324173500|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
94648784|NCT00071812|324173501|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
94648785|NCT00071812|324173502|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
94648786|NCT00071812|324173503|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
94648787|NCT00071812|324173500|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
94648788|NCT00071812|324173501|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
94648789|NCT00071812|324173502|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
94648790|NCT00071812|324173503|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
94648791|NCT00071812|324173500|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
94648792|NCT00071812|324173501|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
94648793|NCT00071812|324173502|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
94648794|NCT00071812|324173503|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
94648795|NCT00071812|324173500|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
94648796|NCT00071812|324173501|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
94648797|NCT00071812|324173502|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
94648798|NCT00071812|324173503|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
94648799|NCT00071812|324173500|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
94648800|NCT00071812|324173501|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
94648801|NCT00071812|324173502|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
94648802|NCT00071812|324173503|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
94648803|NCT00071812|324173500|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
94648804|NCT00071812|324173501|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
94648805|NCT00071812|324173502|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
94648806|NCT00071812|324173503|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
94648807|NCT00071812|324173500|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
94648808|NCT00071812|324173501|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
94648809|NCT00071812|324173502|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
94648810|NCT00071812|324173503|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
94648811|NCT00071812|324173500|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
94648812|NCT00071812|324173501|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
94648813|NCT00071812|324173502|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
94648814|NCT00071812|324173503|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
94648815|NCT00071812|324173500|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
94648816|NCT00071812|324173501|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
94648817|NCT00071812|324173502|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
94648818|NCT00071812|324173503|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
94648819|NCT01433263|324173504|FG000|Overall Study|Adverse Event|3|||
94648820|NCT01433263|324173505|FG001|Overall Study|Adverse Event|1|||
94648821|NCT01433263|324173504|FG000|Overall Study|Death|5|||
94648822|NCT01433263|324173505|FG001|Overall Study|Death|3|||
94648823|NCT01433263|324173504|FG000|Overall Study|Lost to Follow-up|0|||
94648824|NCT01433263|324173505|FG001|Overall Study|Lost to Follow-up|1|||
94648825|NCT01433263|324173504|FG000|Overall Study|Protocol Deviation|1|||
94648826|NCT01433263|324173505|FG001|Overall Study|Protocol Deviation|0|||
94648827|NCT01433263|324173504|FG000|Overall Study|Withdrawal by Subject|10|||
94648828|NCT01433263|324173505|FG001|Overall Study|Withdrawal by Subject|7|||
94648829|NCT00293384|324173506|FG000|Overall Study|Non-compliance|2|||
94364090|NCT01915498|323116805|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
94648830|NCT00293384|324173506|FG000|Overall Study|Missed dosage/study drug|1|||
94648831|NCT00293384|324173506|FG000|Overall Study|Ineligible|2|||
94648832|NCT04709237|324173507|FG000|Overall Study|Lost to Follow-up|1|||
94648833|NCT04709237|324173508|FG001|Overall Study|Lost to Follow-up|0|||
94648834|NCT04709237|324173509|FG002|Overall Study|Lost to Follow-up|0|||
94648835|NCT00145509|324173511|FG000|Overall Study|Adverse Event|10|||
94648836|NCT00145509|324173512|FG001|Overall Study|Adverse Event|3|||
94648837|NCT00145509|324173511|FG000|Overall Study|Lack of Efficacy|3|||
94648838|NCT00145509|324173512|FG001|Overall Study|Lack of Efficacy|1|||
94648839|NCT00145509|324173511|FG000|Overall Study|Lost to Follow-up|5|||
94648840|NCT00145509|324173512|FG001|Overall Study|Lost to Follow-up|9|||
94648841|NCT00145509|324173511|FG000|Overall Study|Withdrew Consent|2|||
94648842|NCT00145509|324173512|FG001|Overall Study|Withdrew Consent|7|||
94648843|NCT00145509|324173511|FG000|Overall Study|Reason not provided|2|||
94648844|NCT00145509|324173512|FG001|Overall Study|Reason not provided|1|||
94648845|NCT02919670|324173514|FG000|Overall Study|Only 17 participants met compliance|43|||
94648846|NCT02919670|324173515|FG001|Overall Study|Only 17 participants met compliance|39|||
94648847|NCT01956110|324173523|FG000|Overall Study|Protocol Violation|25|||
94648848|NCT01956110|324173524|FG001|Overall Study|Protocol Violation|11|||
94648849|NCT01956110|324173523|FG000|Overall Study|Adverse Event|9|||
94648850|NCT01956110|324173524|FG001|Overall Study|Adverse Event|10|||
94648851|NCT01956110|324173523|FG000|Overall Study|Personal reasons|1|||
94648852|NCT01956110|324173524|FG001|Overall Study|Personal reasons|1|||
94648853|NCT00749775|324173525|FG000|Overall Study|Protocol Violation|24|||
94648854|NCT00749775|324173525|FG000|Overall Study|Lost to Follow-up|36|||
94648855|NCT00749775|324173525|FG000|Overall Study|No visit after first day of treatment|44|||
94648856|NCT00749775|324173525|FG000|Overall Study|No drug administration|3|||
94648857|NCT04300296|324173526|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
94648858|NCT04300296|324173527|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
94648859|NCT04300296|324173528|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
94648860|NCT04300296|324173529|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
94648861|NCT04300296|324173530|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
94648862|NCT04300296|324173531|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
94648863|NCT04300296|324173526|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
94648864|NCT04300296|324173527|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
94648865|NCT04300296|324173528|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
94648866|NCT04300296|324173529|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
94648867|NCT04300296|324173530|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
94648868|NCT04300296|324173531|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
94648869|NCT04300296|324173526|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
94648870|NCT04300296|324173527|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
94648871|NCT04300296|324173528|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
94648872|NCT04300296|324173529|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
94648873|NCT04300296|324173530|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
94648874|NCT04300296|324173531|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
94648875|NCT04300296|324173526|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
94648876|NCT04300296|324173527|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
94648877|NCT04300296|324173528|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
94648878|NCT04300296|324173529|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
94648879|NCT04300296|324173530|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
94648880|NCT04300296|324173531|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
94648881|NCT04300296|324173526|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
94648882|NCT04300296|324173527|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
94648883|NCT04300296|324173528|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
94648884|NCT04300296|324173529|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
94648885|NCT04300296|324173530|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
94648886|NCT04300296|324173531|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
94648887|NCT04300296|324173526|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
94648888|NCT04300296|324173527|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
94648889|NCT04300296|324173528|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
94648890|NCT04300296|324173529|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
94648891|NCT04300296|324173530|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
94648892|NCT04300296|324173531|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
94648893|NCT04300296|324173526|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
94685526|NCT01248962|324303734|FG001|Overall Study|Adverse Event|1|||
94685527|NCT01248962|324303733|FG000|Overall Study|Complete Response after 4 Cycles|1|||
94685528|NCT01248962|324303734|FG001|Overall Study|Complete Response after 4 Cycles|0|||
94685529|NCT01248962|324303733|FG000|Overall Study|Complete Response after 3 Cycles|0|||
94685530|NCT01248962|324303734|FG001|Overall Study|Complete Response after 3 Cycles|1|||
94685531|NCT01248962|324303733|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
94685532|NCT01248962|324303734|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
94685533|NCT01027364|324303735|FG000|Overall Study|Adverse Event|1|||
94685534|NCT01027364|324303736|FG001|Overall Study|Adverse Event|0|||
94685535|NCT01027364|324303737|FG002|Overall Study|Adverse Event|1|||
94685536|NCT01027364|324303738|FG003|Overall Study|Adverse Event|0|||
94685537|NCT01027364|324303735|FG000|Overall Study|Lost to Follow-up|1|||
94685538|NCT01027364|324303736|FG001|Overall Study|Lost to Follow-up|0|||
94685539|NCT01027364|324303737|FG002|Overall Study|Lost to Follow-up|0|||
94685540|NCT01027364|324303738|FG003|Overall Study|Lost to Follow-up|0|||
94685541|NCT01027364|324303735|FG000|Overall Study|Protocol Violation|1|||
94685542|NCT01027364|324303736|FG001|Overall Study|Protocol Violation|0|||
94685543|NCT01027364|324303737|FG002|Overall Study|Protocol Violation|0|||
94685544|NCT01027364|324303738|FG003|Overall Study|Protocol Violation|1|||
94685545|NCT01027364|324303735|FG000|Overall Study|Withdrawal by Subject|1|||
94685546|NCT01027364|324303736|FG001|Overall Study|Withdrawal by Subject|2|||
94685547|NCT01027364|324303737|FG002|Overall Study|Withdrawal by Subject|0|||
94685548|NCT01027364|324303738|FG003|Overall Study|Withdrawal by Subject|0|||
94685549|NCT00114634|324303740|FG000|Overall Study|failure to return forms|3|||
94685550|NCT00684762|324303742|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
94685551|NCT00684762|324303743|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
94685552|NCT01003184|324303752|FG000|Overall Study|Adverse Event|12|||
94685553|NCT01003184|324303753|FG001|Overall Study|Adverse Event|5|||
94685554|NCT01003184|324303752|FG000|Overall Study|Lost to Follow-up|1|||
94685555|NCT01003184|324303753|FG001|Overall Study|Lost to Follow-up|0|||
94685556|NCT01003184|324303752|FG000|Overall Study|Loss of glucose control|1|||
94685557|NCT01003184|324303753|FG001|Overall Study|Loss of glucose control|1|||
94685558|NCT01003184|324303752|FG000|Overall Study|Protocol Violation|3|||
94685559|NCT01003184|324303753|FG001|Overall Study|Protocol Violation|0|||
94685560|NCT01003184|324303752|FG000|Overall Study|Withdrawal by Subject|1|||
94685561|NCT01003184|324303753|FG001|Overall Study|Withdrawal by Subject|6|||
94685562|NCT01003184|324303752|FG000|Overall Study|Physician Decision|1|||
94685563|NCT01003184|324303753|FG001|Overall Study|Physician Decision|0|||
94685564|NCT01539863|324303754|FG000|Overall Study|Lost to Follow-up|5|||
94685565|NCT01539863|324303755|FG001|Overall Study|Lost to Follow-up|4|||
94685566|NCT01468922|324303758|FG000|Overall Study|Screening failure|0|||
94685567|NCT01468922|324303759|FG001|Overall Study|Screening failure|0|||
94685568|NCT01468922|324303760|FG002|Overall Study|Screening failure|0|||
94685569|NCT01468922|324303761|FG003|Overall Study|Screening failure|0|||
94685570|NCT01468922|324303762|FG004|Overall Study|Screening failure|0|||
94685571|NCT01468922|324303763|FG005|Overall Study|Screening failure|0|||
94685572|NCT01468922|324303764|FG006|Overall Study|Screening failure|0|||
94685573|NCT01468922|324303765|FG007|Overall Study|Screening failure|0|||
94685574|NCT01468922|324303766|FG008|Overall Study|Screening failure|1|||
94685575|NCT01468922|324303758|FG000|Overall Study|Per patient choice|1|||
94685576|NCT01468922|324303759|FG001|Overall Study|Per patient choice|0|||
94685577|NCT01468922|324303760|FG002|Overall Study|Per patient choice|0|||
94685578|NCT01468922|324303761|FG003|Overall Study|Per patient choice|0|||
94685579|NCT01468922|324303762|FG004|Overall Study|Per patient choice|0|||
94685580|NCT01468922|324303763|FG005|Overall Study|Per patient choice|0|||
94685581|NCT01468922|324303764|FG006|Overall Study|Per patient choice|0|||
94685582|NCT01468922|324303765|FG007|Overall Study|Per patient choice|0|||
94685583|NCT01468922|324303766|FG008|Overall Study|Per patient choice|0|||
94685584|NCT01468922|324303758|FG000|Overall Study|Switched to alternative treatment|1|||
94685585|NCT01468922|324303759|FG001|Overall Study|Switched to alternative treatment|0|||
94685586|NCT01468922|324303760|FG002|Overall Study|Switched to alternative treatment|0|||
94685587|NCT01468922|324303761|FG003|Overall Study|Switched to alternative treatment|0|||
94685588|NCT01468922|324303762|FG004|Overall Study|Switched to alternative treatment|1|||
94685589|NCT01468922|324303763|FG005|Overall Study|Switched to alternative treatment|0|||
94685590|NCT01468922|324303764|FG006|Overall Study|Switched to alternative treatment|0|||
94685591|NCT01468922|324303765|FG007|Overall Study|Switched to alternative treatment|0|||
94685592|NCT01468922|324303766|FG008|Overall Study|Switched to alternative treatment|0|||
94685593|NCT01468922|324303758|FG000|Overall Study|Enrolled on new protocol|0|||
94685594|NCT01468922|324303759|FG001|Overall Study|Enrolled on new protocol|0|||
94685595|NCT01468922|324303760|FG002|Overall Study|Enrolled on new protocol|0|||
94365716|NCT05553600|323124753|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
94685596|NCT01468922|324303761|FG003|Overall Study|Enrolled on new protocol|0|||
94685597|NCT01468922|324303762|FG004|Overall Study|Enrolled on new protocol|1|||
94685598|NCT01468922|324303763|FG005|Overall Study|Enrolled on new protocol|0|||
94685599|NCT01468922|324303764|FG006|Overall Study|Enrolled on new protocol|0|||
94688666|NCT00363896|324315566|FG000|Overall Study|Lost to Follow-up|3|||
94685600|NCT01468922|324303765|FG007|Overall Study|Enrolled on new protocol|0|||
94685601|NCT01468922|324303766|FG008|Overall Study|Enrolled on new protocol|0|||
94685602|NCT01468922|324303758|FG000|Overall Study|Adverse Event|0|||
94685603|NCT01468922|324303759|FG001|Overall Study|Adverse Event|0|||
94685604|NCT01468922|324303760|FG002|Overall Study|Adverse Event|0|||
94685605|NCT01468922|324303761|FG003|Overall Study|Adverse Event|0|||
94685606|NCT01468922|324303762|FG004|Overall Study|Adverse Event|0|||
94685607|NCT01468922|324303763|FG005|Overall Study|Adverse Event|0|||
94685608|NCT01468922|324303764|FG006|Overall Study|Adverse Event|0|||
94685609|NCT01468922|324303765|FG007|Overall Study|Adverse Event|1|||
94685610|NCT01468922|324303766|FG008|Overall Study|Adverse Event|0|||
94685611|NCT01468922|324303758|FG000|Overall Study|Infection of blood|0|||
94685612|NCT01468922|324303759|FG001|Overall Study|Infection of blood|0|||
94685613|NCT01468922|324303760|FG002|Overall Study|Infection of blood|0|||
94685614|NCT01468922|324303761|FG003|Overall Study|Infection of blood|0|||
94685615|NCT01468922|324303762|FG004|Overall Study|Infection of blood|0|||
94685616|NCT01468922|324303763|FG005|Overall Study|Infection of blood|0|||
94685617|NCT01468922|324303764|FG006|Overall Study|Infection of blood|0|||
94685618|NCT01468922|324303765|FG007|Overall Study|Infection of blood|1|||
94685619|NCT01468922|324303766|FG008|Overall Study|Infection of blood|0|||
94685620|NCT01468922|324303758|FG000|Overall Study|Patient choice - surgery|0|||
94685621|NCT01468922|324303759|FG001|Overall Study|Patient choice - surgery|0|||
94685622|NCT01468922|324303760|FG002|Overall Study|Patient choice - surgery|0|||
94685623|NCT01468922|324303761|FG003|Overall Study|Patient choice - surgery|0|||
94685624|NCT01468922|324303762|FG004|Overall Study|Patient choice - surgery|0|||
94685625|NCT01468922|324303763|FG005|Overall Study|Patient choice - surgery|0|||
94685626|NCT01468922|324303764|FG006|Overall Study|Patient choice - surgery|0|||
94685627|NCT01468922|324303765|FG007|Overall Study|Patient choice - surgery|1|||
94685628|NCT01468922|324303766|FG008|Overall Study|Patient choice - surgery|0|||
94685629|NCT01468922|324303758|FG000|Overall Study|Refused further treatment|0|||
94685630|NCT01468922|324303759|FG001|Overall Study|Refused further treatment|0|||
94685631|NCT01468922|324303760|FG002|Overall Study|Refused further treatment|0|||
94685632|NCT01468922|324303761|FG003|Overall Study|Refused further treatment|0|||
94364091|NCT01915498|323116806|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
94364092|NCT01915498|323116807|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
94648894|NCT04300296|324173527|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
94648895|NCT04300296|324173528|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
94648896|NCT04300296|324173529|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
94648897|NCT04300296|324173530|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
94648898|NCT04300296|324173531|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
94648899|NCT01633944|324173534|FG000|Open-label Titration Phase|Adverse Event|109|||
94648900|NCT01633944|324173535|FG001|Open-label Titration Phase|Adverse Event|0|||
94648901|NCT01633944|324173536|FG002|Open-label Titration Phase|Adverse Event|0|||
94648902|NCT01633944|324173534|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
94648903|NCT01633944|324173535|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
94648904|NCT01633944|324173536|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
94648905|NCT01633944|324173534|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
94648906|NCT01633944|324173535|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
94648907|NCT01633944|324173536|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
94648908|NCT01633944|324173534|FG000|Open-label Titration Phase|Protocol Violation|24|||
94648909|NCT01633944|324173535|FG001|Open-label Titration Phase|Protocol Violation|0|||
94648910|NCT01633944|324173536|FG002|Open-label Titration Phase|Protocol Violation|0|||
94648911|NCT01633944|324173534|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
94648912|NCT01633944|324173535|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
94648913|NCT01633944|324173536|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
94648914|NCT01633944|324173534|FG000|Open-label Titration Phase|Other|68|||
94648915|NCT01633944|324173535|FG001|Open-label Titration Phase|Other|0|||
94648916|NCT01633944|324173536|FG002|Open-label Titration Phase|Other|0|||
94648917|NCT01633944|324173534|FG000|Double-blind Treatment Phase|Adverse Event|0|||
94648918|NCT01633944|324173535|FG001|Double-blind Treatment Phase|Adverse Event|13|||
94648919|NCT01633944|324173536|FG002|Double-blind Treatment Phase|Adverse Event|7|||
94648920|NCT01633944|324173534|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
94685633|NCT01468922|324303762|FG004|Overall Study|Refused further treatment|0|||
94685634|NCT01468922|324303763|FG005|Overall Study|Refused further treatment|0|||
94648921|NCT01633944|324173535|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
94685635|NCT01468922|324303764|FG006|Overall Study|Refused further treatment|0|||
94648922|NCT01633944|324173536|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
94685636|NCT01468922|324303765|FG007|Overall Study|Refused further treatment|1|||
94685637|NCT01468922|324303766|FG008|Overall Study|Refused further treatment|0|||
94685638|NCT03662997|324303773|FG000|Overall Study|Adverse Event|0|||
94685639|NCT03662997|324303774|FG001|Overall Study|Adverse Event|2|||
94685640|NCT03662997|324303775|FG002|Overall Study|Adverse Event|0|||
94685641|NCT03662997|324303776|FG003|Overall Study|Adverse Event|0|||
94685642|NCT01719224|324303777|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
94648923|NCT01633944|324173534|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
94648924|NCT01633944|324173535|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
94648925|NCT01633944|324173536|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
94648926|NCT01633944|324173534|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
94648927|NCT01633944|324173535|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
94648928|NCT01633944|324173536|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
94648929|NCT01633944|324173534|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
94648930|NCT01633944|324173535|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
94648931|NCT01633944|324173536|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
94648932|NCT01633944|324173534|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
94648933|NCT01633944|324173535|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
94648934|NCT01633944|324173536|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
94648935|NCT01633944|324173534|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
94648936|NCT01633944|324173535|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
94648937|NCT01633944|324173536|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
94648938|NCT01633944|324173534|FG000|Double-blind Treatment Phase|Other|0|||
94648939|NCT01633944|324173535|FG001|Double-blind Treatment Phase|Other|7|||
94648940|NCT01633944|324173536|FG002|Double-blind Treatment Phase|Other|0|||
94648941|NCT01400841|324173538|FG000|Initial Study Phase (6 Months)|Death|1|||
94648942|NCT01400841|324173538|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
94648943|NCT00279708|324173543|FG000|Overall Study|Withdrawal by Subject|2|||
94648944|NCT00279708|324173544|FG001|Overall Study|Withdrawal by Subject|3|||
94648945|NCT00279708|324173543|FG000|Overall Study|Adverse Event|1|||
94648946|NCT00279708|324173544|FG001|Overall Study|Adverse Event|1|||
94648947|NCT03354429|324173545|FG000|Overall Study|Withdrawal by Subject|8|||
94648948|NCT03354429|324173546|FG001|Overall Study|Withdrawal by Subject|7|||
94648949|NCT03354429|324173545|FG000|Overall Study|Lost to Follow-up|1|||
94648950|NCT03354429|324173546|FG001|Overall Study|Lost to Follow-up|0|||
94648951|NCT00958776|324173547|FG000|Overall Study|Adverse Event|0|||
94648952|NCT00958776|324173548|FG001|Overall Study|Adverse Event|1|||
94648953|NCT00958776|324173547|FG000|Overall Study|Physician Decision|1|||
94648954|NCT00958776|324173548|FG001|Overall Study|Physician Decision|0|||
94648955|NCT00958776|324173547|FG000|Overall Study|Lost to Follow-up|2|||
94648956|NCT00958776|324173548|FG001|Overall Study|Lost to Follow-up|6|||
94648957|NCT00958776|324173547|FG000|Overall Study|Withdrawal by Subject|7|||
94648958|NCT00958776|324173548|FG001|Overall Study|Withdrawal by Subject|16|||
94648959|NCT00958776|324173547|FG000|Overall Study|Protocol Violation|1|||
94648960|NCT00958776|324173548|FG001|Overall Study|Protocol Violation|1|||
94648961|NCT00958776|324173547|FG000|Overall Study|Death|2|||
94648962|NCT00958776|324173548|FG001|Overall Study|Death|1|||
94648963|NCT00958776|324173547|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
94648964|NCT00958776|324173548|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
94648965|NCT00958776|324173547|FG000|Overall Study|Missing|1|||
94648966|NCT00958776|324173548|FG001|Overall Study|Missing|1|||
94648967|NCT00480636|324173549|FG000|Overall Study|Death|12|||
94648968|NCT00480636|324173549|FG000|Overall Study|Lost to Follow-up|4|||
94648969|NCT00480636|324173549|FG000|Overall Study|Other|2|||
94648970|NCT00480636|324173549|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
94648971|NCT02932891|324173550|FG000|Overall Study|Lost to Follow-up|2|||
94648972|NCT02932891|324173550|FG000|Overall Study|HPA Suppress|2|||
94648973|NCT03912233|324173551|FG000|Overall Study|Adverse Event|1|||
94648974|NCT03912233|324173552|FG001|Overall Study|Adverse Event|0|||
94648975|NCT03912233|324173553|FG002|Overall Study|Adverse Event|0|||
94648976|NCT03912233|324173554|FG003|Overall Study|Adverse Event|0|||
94648977|NCT03912233|324173555|FG004|Overall Study|Adverse Event|0|||
94648978|NCT03912233|324173556|FG005|Overall Study|Adverse Event|0|||
94648979|NCT03912233|324173551|FG000|Overall Study|Physician Decision|1|||
94648980|NCT03912233|324173552|FG001|Overall Study|Physician Decision|0|||
94648981|NCT03912233|324173553|FG002|Overall Study|Physician Decision|0|||
94648982|NCT03912233|324173554|FG003|Overall Study|Physician Decision|0|||
94648983|NCT03912233|324173555|FG004|Overall Study|Physician Decision|0|||
94648984|NCT03912233|324173556|FG005|Overall Study|Physician Decision|0|||
94648985|NCT03912233|324173551|FG000|Overall Study|Other|0|||
94648986|NCT03912233|324173552|FG001|Overall Study|Other|0|||
94648987|NCT03912233|324173553|FG002|Overall Study|Other|0|||
94648988|NCT03912233|324173554|FG003|Overall Study|Other|0|||
94648989|NCT03912233|324173555|FG004|Overall Study|Other|7|||
94364093|NCT01915498|323116808|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
94648990|NCT03912233|324173556|FG005|Overall Study|Other|12|||
94648991|NCT02583256|324173557|FG000|Overall Study|Withdrawal by Subject|0|||
94648992|NCT02583256|324173558|FG001|Overall Study|Withdrawal by Subject|1|||
94648993|NCT02583256|324173559|FG002|Overall Study|Withdrawal by Subject|1|||
94648994|NCT02583256|324173560|FG003|Overall Study|Withdrawal by Subject|0|||
94648995|NCT02583256|324173557|FG000|Overall Study|Lost to Follow-up|1|||
94648996|NCT02583256|324173558|FG001|Overall Study|Lost to Follow-up|1|||
94648997|NCT02583256|324173559|FG002|Overall Study|Lost to Follow-up|0|||
94685643|NCT01719224|324303778|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
94685644|NCT00439179|324303780|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
94685645|NCT00439179|324303781|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
94685646|NCT00439179|324303782|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
94685647|NCT00439179|324303783|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
94685648|NCT02357810|324303784|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
94685649|NCT02357810|324303784|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
94685650|NCT02357810|324303784|FG000|Reached 12 Weeks Response|Adverse Event|5|||
94685651|NCT02357810|324303784|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
94685652|NCT02357810|324303784|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
94685653|NCT02357810|324303784|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
94685654|NCT02357810|324303784|FG000|Reached 12 Weeks Response|Death|1|||
94685655|NCT02357810|324303784|FG000|Reached 12 Weeks Response|Physician Decision|1|||
94685656|NCT02357810|324303784|FG000|Reached 12 Weeks Response|Other|1|||
94685657|NCT02357810|324303784|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
94685658|NCT02357810|324303784|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
94685659|NCT02357810|324303784|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
94685660|NCT02357810|324303784|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
94685661|NCT02357810|324303784|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
94685662|NCT02357810|324303784|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
94685663|NCT00979602|324303785|FG000|Overall Study|Serious Adverse Event|5|||
94685664|NCT00979602|324303786|FG001|Overall Study|Serious Adverse Event|3|||
94685665|NCT00979602|324303785|FG000|Overall Study|Protocol Violation|3|||
94685666|NCT00979602|324303786|FG001|Overall Study|Protocol Violation|0|||
94685667|NCT00979602|324303785|FG000|Overall Study|Withdrawal by Subject|31|||
94685668|NCT00979602|324303786|FG001|Overall Study|Withdrawal by Subject|25|||
94685669|NCT00979602|324303785|FG000|Overall Study|Lost to Follow-up|100|||
94685670|NCT00979602|324303786|FG001|Overall Study|Lost to Follow-up|96|||
94685671|NCT00979602|324303785|FG000|Overall Study|Migrated/moved from study area|3|||
94685672|NCT00979602|324303786|FG001|Overall Study|Migrated/moved from study area|6|||
94685673|NCT00979602|324303785|FG000|Overall Study|Others|3|||
94685674|NCT00979602|324303786|FG001|Overall Study|Others|3|||
94685675|NCT00936221|324303791|FG000|Overall Study|Withdrawal by Subject|1|||
94685676|NCT00936221|324303792|FG001|Overall Study|Withdrawal by Subject|1|||
94685677|NCT02153359|324303793|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
94685678|NCT02153359|324303794|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
94648998|NCT02583256|324173560|FG003|Overall Study|Lost to Follow-up|1|||
94648999|NCT02583256|324173557|FG000|Overall Study|Administrative/Other|2|||
94649000|NCT02583256|324173558|FG001|Overall Study|Administrative/Other|0|||
94649001|NCT02583256|324173559|FG002|Overall Study|Administrative/Other|1|||
94649002|NCT02583256|324173560|FG003|Overall Study|Administrative/Other|2|||
94649003|NCT00326911|324173561|FG000|Overall Study|Hospitalization prior to treatment|0|||
94649004|NCT00326911|324173562|FG001|Overall Study|Hospitalization prior to treatment|1|||
94649005|NCT00326911|324173561|FG000|Overall Study|Physician decision prior to treatment|1|||
94649006|NCT00326911|324173562|FG001|Overall Study|Physician decision prior to treatment|0|||
94649007|NCT00326911|324173561|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
94649008|NCT00326911|324173562|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
94649009|NCT02177266|324173564|FG000|Overall Study|Adverse Event|0|||
94649010|NCT02177266|324173565|FG001|Overall Study|Adverse Event|1|||
94649011|NCT02177266|324173564|FG000|Overall Study|Withdrawal by Subject|1|||
94649012|NCT02177266|324173565|FG001|Overall Study|Withdrawal by Subject|0|||
94685679|NCT01964521|324303796|FG000|Overall Study|Lost to Follow-up|4|||
94685680|NCT01234649|324303798|FG000|Overall Study|Withdrawal by Subject|32|||
94685681|NCT01234649|324303799|FG001|Overall Study|Withdrawal by Subject|26|||
94685682|NCT01234649|324303798|FG000|Overall Study|Pregnancy|6|||
94649013|NCT03277261|324173571|FG000|Overall Study|Adverse Event|17|||
94649014|NCT03277261|324173572|FG001|Overall Study|Adverse Event|1|||
94649015|NCT03277261|324173571|FG000|Overall Study|Participant Withdrawal of Consent|6|||
94649016|NCT03277261|324173572|FG001|Overall Study|Participant Withdrawal of Consent|15|||
94649017|NCT03277261|324173571|FG000|Overall Study|Investigator / Sponsor Decision|4|||
94649018|NCT03277261|324173572|FG001|Overall Study|Investigator / Sponsor Decision|2|||
94649019|NCT03277261|324173571|FG000|Overall Study|Pregnancy|2|||
94649020|NCT03277261|324173572|FG001|Overall Study|Pregnancy|0|||
94649021|NCT03277261|324173571|FG000|Overall Study|Lost to Follow-up|2|||
94649022|NCT03277261|324173572|FG001|Overall Study|Lost to Follow-up|2|||
94649023|NCT03277261|324173571|FG000|Overall Study|Lack of Efficacy|2|||
94649024|NCT03277261|324173572|FG001|Overall Study|Lack of Efficacy|2|||
94649025|NCT03277261|324173571|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
94649026|NCT03277261|324173572|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
94649027|NCT00086580|324173573|FG000|Treatment Period|Disease progression|9|||
94649028|NCT00086580|324173574|FG001|Treatment Period|Disease progression|8|||
94649029|NCT00086580|324173573|FG000|Treatment Period|Unable to comply with protocol|3|||
94649030|NCT00086580|324173574|FG001|Treatment Period|Unable to comply with protocol|1|||
94649031|NCT00086580|324173573|FG000|Treatment Period|Withdrawal by Subject|7|||
94649032|NCT00086580|324173574|FG001|Treatment Period|Withdrawal by Subject|8|||
94649033|NCT00086580|324173573|FG000|Treatment Period|Physician Decision|13|||
94649034|NCT00086580|324173574|FG001|Treatment Period|Physician Decision|7|||
94649035|NCT00086580|324173573|FG000|Treatment Period|AE - not treatment related|7|||
94649036|NCT00086580|324173574|FG001|Treatment Period|AE - not treatment related|7|||
94649037|NCT00086580|324173573|FG000|Treatment Period|Toxicity - treatment related|15|||
94649038|NCT00086580|324173574|FG001|Treatment Period|Toxicity - treatment related|15|||
94649039|NCT00086580|324173573|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
94649040|NCT00086580|324173574|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
94649041|NCT00086580|324173573|FG000|Treatment Period|Death|5|||
94649042|NCT00086580|324173574|FG001|Treatment Period|Death|7|||
94649043|NCT00086580|324173573|FG000|Treatment Period|Other|5|||
94649044|NCT00086580|324173574|FG001|Treatment Period|Other|3|||
94649045|NCT00086580|324173573|FG000|Follow-up Period|Disease progression|72|||
94649046|NCT00086580|324173574|FG001|Follow-up Period|Disease progression|99|||
94649047|NCT00086580|324173573|FG000|Follow-up Period|Unable to comply with protocol|5|||
94649048|NCT00086580|324173574|FG001|Follow-up Period|Unable to comply with protocol|0|||
94649049|NCT00086580|324173573|FG000|Follow-up Period|Withdrawal by Subject|6|||
94649050|NCT00086580|324173574|FG001|Follow-up Period|Withdrawal by Subject|6|||
94649051|NCT00086580|324173573|FG000|Follow-up Period|Physician Decision|0|||
94649052|NCT00086580|324173574|FG001|Follow-up Period|Physician Decision|1|||
94649053|NCT00086580|324173573|FG000|Follow-up Period|AE - not related|1|||
94649054|NCT00086580|324173574|FG001|Follow-up Period|AE - not related|0|||
94649055|NCT00086580|324173573|FG000|Follow-up Period|Death|13|||
94649056|NCT00086580|324173574|FG001|Follow-up Period|Death|7|||
94649057|NCT00086580|324173573|FG000|Follow-up Period|Other|7|||
94649058|NCT00086580|324173574|FG001|Follow-up Period|Other|6|||
94649059|NCT00086580|324173573|FG000|Observation Period|Unable to comply with protocol|1|||
94649060|NCT00086580|324173574|FG001|Observation Period|Unable to comply with protocol|1|||
94649061|NCT00086580|324173573|FG000|Observation Period|Withdrawal by Subject|4|||
94649062|NCT00086580|324173574|FG001|Observation Period|Withdrawal by Subject|2|||
94649063|NCT00086580|324173573|FG000|Observation Period|Death|33|||
94649064|NCT00086580|324173574|FG001|Observation Period|Death|55|||
94649065|NCT00086580|324173573|FG000|Observation Period|Other|8|||
94649066|NCT00086580|324173574|FG001|Observation Period|Other|7|||
94649067|NCT05179421|324173576|FG000|First Infusion Day|Adverse Event|1|||
94649068|NCT05179421|324173577|FG001|First Infusion Day|Adverse Event|0|||
94649069|NCT01585766|324173578|FG000|Overall Study|Withdrawal by Subject|0|||
94649070|NCT01585766|324173579|FG001|Overall Study|Withdrawal by Subject|1|||
94649071|NCT01585766|324173580|FG002|Overall Study|Withdrawal by Subject|1|||
94649072|NCT01585766|324173581|FG003|Overall Study|Withdrawal by Subject|0|||
94649073|NCT01585766|324173582|FG004|Overall Study|Withdrawal by Subject|0|||
94649074|NCT01585766|324173583|FG005|Overall Study|Withdrawal by Subject|0|||
94649075|NCT01585766|324173578|FG000|Overall Study|Death|0|||
94649076|NCT01585766|324173579|FG001|Overall Study|Death|1|||
94649077|NCT01585766|324173580|FG002|Overall Study|Death|0|||
94649078|NCT01585766|324173581|FG003|Overall Study|Death|0|||
94649079|NCT01585766|324173582|FG004|Overall Study|Death|0|||
94649080|NCT01585766|324173583|FG005|Overall Study|Death|0|||
94649081|NCT01585766|324173578|FG000|Overall Study|Physician Decision|0|||
94649082|NCT01585766|324173579|FG001|Overall Study|Physician Decision|0|||
94649083|NCT01585766|324173580|FG002|Overall Study|Physician Decision|1|||
94649084|NCT01585766|324173581|FG003|Overall Study|Physician Decision|0|||
94649085|NCT01585766|324173582|FG004|Overall Study|Physician Decision|0|||
94685683|NCT01234649|324303799|FG001|Overall Study|Pregnancy|6|||
94649086|NCT01585766|324173583|FG005|Overall Study|Physician Decision|0|||
94649087|NCT02388997|324173587|FG000|Overall Study|Adverse Event|1|||
94649088|NCT02388997|324173588|FG001|Overall Study|Adverse Event|2|||
94649089|NCT02388997|324173587|FG000|Overall Study|Withdrawal by Subject|2|||
94649090|NCT02388997|324173588|FG001|Overall Study|Withdrawal by Subject|1|||
94649091|NCT02388997|324173587|FG000|Overall Study|Lung function exclusion criteria|0|||
94649092|NCT02388997|324173588|FG001|Overall Study|Lung function exclusion criteria|2|||
94649093|NCT02388997|324173587|FG000|Overall Study|Tested positive for virus during run-in|0|||
94649094|NCT02388997|324173588|FG001|Overall Study|Tested positive for virus during run-in|1|||
94649095|NCT05091528|324173599|FG000|Overall Study|Study Termination by Sponsor|0|||
94649096|NCT05091528|324173600|FG001|Overall Study|Study Termination by Sponsor|1|||
94649097|NCT05091528|324173601|FG002|Overall Study|Study Termination by Sponsor|0|||
94649098|NCT05091528|324173602|FG003|Overall Study|Study Termination by Sponsor|1|||
94649099|NCT01857063|324173603|FG000|Period 1 (7 Days)|Adverse Event|0|||
94649100|NCT01857063|324173604|FG001|Period 1 (7 Days)|Adverse Event|1|||
94649101|NCT01857063|324173603|FG000|Period 1 (7 Days)|Physician Decision|1|||
94649102|NCT01857063|324173604|FG001|Period 1 (7 Days)|Physician Decision|0|||
94649103|NCT01857063|324173603|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
94649104|NCT01857063|324173604|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
94649105|NCT01857063|324173603|FG000|Period 2 (7 Days)|Adverse Event|2|||
94649106|NCT01857063|324173604|FG001|Period 2 (7 Days)|Adverse Event|1|||
94649107|NCT01857063|324173603|FG000|Period 2 (7 Days)|Physician Decision|1|||
94649108|NCT01857063|324173604|FG001|Period 2 (7 Days)|Physician Decision|1|||
94649109|NCT01857063|324173603|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
94649110|NCT01857063|324173604|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
94649111|NCT04958109|324173605|FG000|Overall Study|Withdrawal by Subject|0|||
94649112|NCT04958109|324173606|FG001|Overall Study|Withdrawal by Subject|1|||
94649113|NCT04958109|324173605|FG000|Overall Study|Lost to Follow-up|0|||
94649114|NCT04958109|324173606|FG001|Overall Study|Lost to Follow-up|1|||
94649115|NCT01192152|324173609|FG000|Period 1|left prematurely (while on treatment B)|0|||
94649116|NCT01192152|324173610|FG001|Period 1|left prematurely (while on treatment B)|1|||
94649117|NCT01192152|324173609|FG000|Period 3|family emergency|1|||
94649118|NCT01192152|324173610|FG001|Period 3|family emergency|0|||
94649119|NCT00715793|324173611|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
94649120|NCT00715793|324173612|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
94649121|NCT00715793|324173611|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
94649122|NCT00715793|324173612|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
94649123|NCT01559311|324173613|FG000|Overall Study|Protocol Violation|0|||
94649124|NCT01559311|324173614|FG001|Overall Study|Protocol Violation|0|||
94649125|NCT01559311|324173615|FG002|Overall Study|Protocol Violation|2|||
94649126|NCT01559311|324173613|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
94649127|NCT01559311|324173614|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
94649128|NCT01559311|324173615|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
94649129|NCT01559311|324173613|FG000|Overall Study|Withdrawal by Subject|2|||
94649130|NCT01559311|324173614|FG001|Overall Study|Withdrawal by Subject|1|||
94649131|NCT01559311|324173615|FG002|Overall Study|Withdrawal by Subject|0|||
94649132|NCT01559311|324173613|FG000|Overall Study|Death|0|||
94649133|NCT01559311|324173614|FG001|Overall Study|Death|2|||
94649134|NCT01559311|324173615|FG002|Overall Study|Death|3|||
94649135|NCT01559311|324173613|FG000|Overall Study|Lost to Follow-up|0|||
94649136|NCT01559311|324173614|FG001|Overall Study|Lost to Follow-up|3|||
94649137|NCT01559311|324173615|FG002|Overall Study|Lost to Follow-up|2|||
94649138|NCT01559311|324173613|FG000|Overall Study|Adverse Event|0|||
94649139|NCT01559311|324173614|FG001|Overall Study|Adverse Event|0|||
94649140|NCT01559311|324173615|FG002|Overall Study|Adverse Event|1|||
94649141|NCT04115358|324173616|FG000|Overall Study|exfoliation|0|||
94649142|NCT04115358|324173617|FG001|Overall Study|exfoliation|0|||
94649143|NCT04115358|324173618|FG002|Overall Study|exfoliation|1|||
94649144|NCT01205165|324173619|FG000|Overall Study|Lost to Follow-up|2|||
94649145|NCT03306264|324173623|FG000|Overall Study|Death|33|||
94649146|NCT03306264|324173624|FG001|Overall Study|Death|25|||
94649147|NCT03306264|324173625|FG002|Overall Study|Death|34|||
94649148|NCT03306264|324173626|FG003|Overall Study|Death|34|||
94649149|NCT03306264|324173623|FG000|Overall Study|Complete Consent Withdrawal|4|||
94649150|NCT03306264|324173624|FG001|Overall Study|Complete Consent Withdrawal|4|||
94649151|NCT03306264|324173625|FG002|Overall Study|Complete Consent Withdrawal|1|||
94649152|NCT03306264|324173626|FG003|Overall Study|Complete Consent Withdrawal|8|||
94649153|NCT03306264|324173623|FG000|Overall Study|Lost to Follow-up|1|||
94649154|NCT03306264|324173624|FG001|Overall Study|Lost to Follow-up|0|||
94649155|NCT03306264|324173625|FG002|Overall Study|Lost to Follow-up|1|||
94649156|NCT03306264|324173626|FG003|Overall Study|Lost to Follow-up|0|||
94649157|NCT03306264|324173623|FG000|Overall Study|Rollover to ASTX727-06|10|||
94649158|NCT03306264|324173624|FG001|Overall Study|Rollover to ASTX727-06|18|||
94649159|NCT03306264|324173625|FG002|Overall Study|Rollover to ASTX727-06|4|||
94649160|NCT03306264|324173626|FG003|Overall Study|Rollover to ASTX727-06|2|||
94649161|NCT03306264|324173623|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
94649162|NCT03306264|324173624|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
94649163|NCT03306264|324173625|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
94649164|NCT03306264|324173626|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
94685684|NCT01234649|324303798|FG000|Overall Study|intolerant to side effects|4|||
94685685|NCT01234649|324303799|FG001|Overall Study|intolerant to side effects|3|||
94685686|NCT01234649|324303798|FG000|Overall Study|Allergic reaction|1|||
94685687|NCT01234649|324303799|FG001|Overall Study|Allergic reaction|0|||
94685688|NCT01234649|324303798|FG000|Overall Study|Lack of Efficacy|0|||
94685689|NCT01234649|324303799|FG001|Overall Study|Lack of Efficacy|3|||
94685690|NCT03691948|324303800|FG000|Overall Study|Lost to Follow-up|1|||
94685691|NCT03691948|324303801|FG001|Overall Study|Lost to Follow-up|3|||
94685692|NCT01370005|324303802|FG000|Overall Study|Not treated|1|||
94685693|NCT01370005|324303803|FG001|Overall Study|Not treated|0|||
94685694|NCT01370005|324303804|FG002|Overall Study|Not treated|0|||
94685695|NCT01370005|324303802|FG000|Overall Study|Adverse Event|5|||
94685696|NCT01370005|324303803|FG001|Overall Study|Adverse Event|5|||
94685697|NCT01370005|324303804|FG002|Overall Study|Adverse Event|6|||
94685698|NCT01370005|324303802|FG000|Overall Study|Lack of Efficacy|1|||
94685699|NCT01370005|324303803|FG001|Overall Study|Lack of Efficacy|0|||
94685700|NCT01370005|324303804|FG002|Overall Study|Lack of Efficacy|0|||
94685701|NCT01370005|324303802|FG000|Overall Study|Non compliant with protocol|0|||
94685702|NCT01370005|324303803|FG001|Overall Study|Non compliant with protocol|1|||
94685703|NCT01370005|324303804|FG002|Overall Study|Non compliant with protocol|2|||
94685704|NCT01370005|324303802|FG000|Overall Study|Lost to Follow-up|1|||
94685705|NCT01370005|324303803|FG001|Overall Study|Lost to Follow-up|1|||
94685706|NCT01370005|324303804|FG002|Overall Study|Lost to Follow-up|1|||
94685707|NCT01370005|324303802|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
94685708|NCT01370005|324303803|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
94685709|NCT01370005|324303804|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
94685710|NCT01370005|324303802|FG000|Overall Study|Other reason not defined above|3|||
94685711|NCT01370005|324303803|FG001|Overall Study|Other reason not defined above|0|||
94685712|NCT01370005|324303804|FG002|Overall Study|Other reason not defined above|2|||
94685713|NCT02344537|324303805|FG000|Overall Study|Protocol Violation|1|||
94685714|NCT02344537|324303806|FG001|Overall Study|Protocol Violation|1|||
94685715|NCT02344537|324303805|FG000|Overall Study|Subject started another treatment after wk 6|1|||
94685716|NCT02344537|324303806|FG001|Overall Study|Subject started another treatment after wk 6|0|||
94685717|NCT02344537|324303805|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
94685718|NCT02344537|324303806|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
94685719|NCT05490329|324303809|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
94685720|NCT05490329|324303810|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
94685721|NCT05490329|324303809|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
94685722|NCT05490329|324303810|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
94685723|NCT05490329|324303809|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
94685724|NCT05490329|324303810|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
94685725|NCT00903786|324303811|FG000|Overall Study|Physician Decision|6|||
94685726|NCT00903786|324303811|FG000|Overall Study|Lack of Efficacy|5|||
94685727|NCT00903786|324303811|FG000|Overall Study|Reason other than lack of efficacy|4|||
94685728|NCT00447954|324303812|FG000|Overall Study|Adverse Event|0|||
94685729|NCT00447954|324303813|FG001|Overall Study|Adverse Event|2|||
94685730|NCT00447954|324303814|FG002|Overall Study|Adverse Event|0|||
94685731|NCT00447954|324303812|FG000|Overall Study|Withdrawal by Subject|0|||
94685732|NCT00447954|324303813|FG001|Overall Study|Withdrawal by Subject|1|||
94685733|NCT00447954|324303814|FG002|Overall Study|Withdrawal by Subject|1|||
94685734|NCT00447954|324303812|FG000|Overall Study|Lost to Follow-up|0|||
94685735|NCT00447954|324303813|FG001|Overall Study|Lost to Follow-up|1|||
94685736|NCT00447954|324303814|FG002|Overall Study|Lost to Follow-up|0|||
94685737|NCT00447954|324303812|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
94685738|NCT00447954|324303813|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
94685739|NCT00447954|324303814|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
94685740|NCT02638623|324303817|FG000|Overall Study|Surgery timing|5|||
94685741|NCT02638623|324303818|FG001|Overall Study|Surgery timing|6|||
94685742|NCT02638623|324303817|FG000|Overall Study|Not given intervention|2|||
94685743|NCT02638623|324303818|FG001|Overall Study|Not given intervention|0|||
94685744|NCT02322814|324303821|FG000|Overall Study|Death|7|||
94463506|NCT00336024|323485083|FG000|Overall Study|Failure to fulfill consolidation|1|||
94685745|NCT02322814|324303822|FG001|Overall Study|Death|29|||
94685746|NCT02322814|324303823|FG002|Overall Study|Death|32|||
94685747|NCT02322814|324303824|FG003|Overall Study|Death|23|||
94685748|NCT02322814|324303825|FG004|Overall Study|Death|14|||
94685749|NCT02322814|324303821|FG000|Overall Study|Lost to Follow-up|1|||
94685750|NCT02322814|324303822|FG001|Overall Study|Lost to Follow-up|3|||
94685751|NCT02322814|324303823|FG002|Overall Study|Lost to Follow-up|3|||
94685752|NCT02322814|324303824|FG003|Overall Study|Lost to Follow-up|1|||
94685753|NCT02322814|324303825|FG004|Overall Study|Lost to Follow-up|0|||
94685754|NCT02322814|324303821|FG000|Overall Study|Various Reasons|2|||
94685755|NCT02322814|324303822|FG001|Overall Study|Various Reasons|0|||
94685756|NCT02322814|324303823|FG002|Overall Study|Various Reasons|1|||
94685757|NCT02322814|324303824|FG003|Overall Study|Various Reasons|1|||
94685758|NCT02322814|324303825|FG004|Overall Study|Various Reasons|0|||
94685759|NCT02322814|324303821|FG000|Overall Study|Progressive Disease|0|||
94685760|NCT02322814|324303822|FG001|Overall Study|Progressive Disease|0|||
94685761|NCT02322814|324303823|FG002|Overall Study|Progressive Disease|0|||
94685762|NCT02322814|324303824|FG003|Overall Study|Progressive Disease|1|||
94685763|NCT02322814|324303825|FG004|Overall Study|Progressive Disease|1|||
94685764|NCT02322814|324303821|FG000|Overall Study|Protocol Violation|1|||
94685765|NCT02322814|324303822|FG001|Overall Study|Protocol Violation|0|||
94685766|NCT02322814|324303823|FG002|Overall Study|Protocol Violation|0|||
94685767|NCT02322814|324303824|FG003|Overall Study|Protocol Violation|0|||
94685768|NCT02322814|324303825|FG004|Overall Study|Protocol Violation|0|||
94685769|NCT02322814|324303821|FG000|Overall Study|Study Terminated by Sponsor|0|||
94685770|NCT02322814|324303822|FG001|Overall Study|Study Terminated by Sponsor|7|||
94685771|NCT02322814|324303823|FG002|Overall Study|Study Terminated by Sponsor|9|||
94685772|NCT02322814|324303824|FG003|Overall Study|Study Terminated by Sponsor|5|||
94685773|NCT02322814|324303825|FG004|Overall Study|Study Terminated by Sponsor|13|||
94685774|NCT02322814|324303821|FG000|Overall Study|Withdrawal by Subject|5|||
94685775|NCT02322814|324303822|FG001|Overall Study|Withdrawal by Subject|4|||
94685776|NCT02322814|324303823|FG002|Overall Study|Withdrawal by Subject|2|||
94685777|NCT02322814|324303824|FG003|Overall Study|Withdrawal by Subject|1|||
94685778|NCT02322814|324303825|FG004|Overall Study|Withdrawal by Subject|3|||
94685779|NCT00591864|324303826|FG000|Overall Study|Incomplete Imaging|5|||
94685780|NCT00429494|324305466|FG000|Overall Study|Withdrawal by Subject|9|||
94685781|NCT00429494|324305466|FG000|Overall Study|Death|6|||
94685782|NCT02243631|324305467|FG000|Overall Study|no synovial fluid on second aspirate|0|||
94685783|NCT02243631|324305468|FG001|Overall Study|no synovial fluid on second aspirate|1|||
94685784|NCT01900054|324305469|FG000|Overall Study|Physician Decision|1|||
94685785|NCT01900054|324305469|FG000|Overall Study|Withdrawal by Subject|1|||
94685786|NCT00649389|324305470|FG000|Overall Study|Adverse Event|22|||
94685787|NCT00649389|324305471|FG001|Overall Study|Adverse Event|46|||
94685788|NCT00649389|324305472|FG002|Overall Study|Adverse Event|38|||
94685789|NCT00649389|324305473|FG003|Overall Study|Adverse Event|48|||
94685790|NCT00649389|324305470|FG000|Overall Study|Lost to Follow-up|15|||
94685791|NCT00649389|324305471|FG001|Overall Study|Lost to Follow-up|17|||
94685792|NCT00649389|324305472|FG002|Overall Study|Lost to Follow-up|21|||
94685793|NCT00649389|324305473|FG003|Overall Study|Lost to Follow-up|26|||
94685794|NCT00649389|324305470|FG000|Overall Study|Protocol Violation|11|||
94685795|NCT00649389|324305471|FG001|Overall Study|Protocol Violation|13|||
94685796|NCT00649389|324305472|FG002|Overall Study|Protocol Violation|9|||
94685797|NCT00649389|324305473|FG003|Overall Study|Protocol Violation|8|||
94685798|NCT00649389|324305470|FG000|Overall Study|Withdrawal by Subject|20|||
94685799|NCT00649389|324305471|FG001|Overall Study|Withdrawal by Subject|21|||
94685800|NCT00649389|324305472|FG002|Overall Study|Withdrawal by Subject|19|||
94685801|NCT00649389|324305473|FG003|Overall Study|Withdrawal by Subject|23|||
94685802|NCT00649389|324305470|FG000|Overall Study|Other|3|||
94685803|NCT00649389|324305471|FG001|Overall Study|Other|9|||
94685804|NCT00649389|324305472|FG002|Overall Study|Other|1|||
94685805|NCT00649389|324305473|FG003|Overall Study|Other|6|||
94685806|NCT03015116|324305474|FG000|Overall Study|Lost to Follow-up|3|||
94685807|NCT03015116|324305475|FG001|Overall Study|Lost to Follow-up|0|||
94685808|NCT03015116|324305476|FG002|Overall Study|Lost to Follow-up|2|||
94685809|NCT03015116|324305474|FG000|Overall Study|Withdrawal by Subject|3|||
94685810|NCT03015116|324305475|FG001|Overall Study|Withdrawal by Subject|1|||
94685811|NCT03015116|324305476|FG002|Overall Study|Withdrawal by Subject|0|||
94685812|NCT03015116|324305474|FG000|Overall Study|Subject has New Medical Status|1|||
94685813|NCT03015116|324305475|FG001|Overall Study|Subject has New Medical Status|0|||
94685814|NCT03015116|324305476|FG002|Overall Study|Subject has New Medical Status|0|||
94685815|NCT03015116|324305474|FG000|Overall Study|Physician Decision|0|||
94685816|NCT03015116|324305475|FG001|Overall Study|Physician Decision|1|||
94685817|NCT03015116|324305476|FG002|Overall Study|Physician Decision|0|||
94685818|NCT04666922|324305477|FG000|Overall Study|Withdrawal by Subject|1|||
94685819|NCT04666922|324305478|FG001|Overall Study|Withdrawal by Subject|0|||
94685820|NCT04666922|324305479|FG002|Overall Study|Withdrawal by Subject|0|||
94685821|NCT04666922|324305480|FG003|Overall Study|Withdrawal by Subject|0|||
94685822|NCT04666922|324305481|FG004|Overall Study|Withdrawal by Subject|0|||
94685823|NCT04666922|324305482|FG005|Overall Study|Withdrawal by Subject|0|||
94685824|NCT04666922|324305483|FG006|Overall Study|Withdrawal by Subject|0|||
94685825|NCT02762981|324305484|FG000|Overall Study|Adverse Event|2|||
94685826|NCT02762981|324305485|FG001|Overall Study|Adverse Event|3|||
94685827|NCT02762981|324305486|FG002|Overall Study|Adverse Event|1|||
94685828|NCT02762981|324305487|FG003|Overall Study|Adverse Event|1|||
94685829|NCT02762981|324305488|FG004|Overall Study|Adverse Event|3|||
94685830|NCT02762981|324305484|FG000|Overall Study|Physician Decision|0|||
94685831|NCT02762981|324305485|FG001|Overall Study|Physician Decision|1|||
94685832|NCT02762981|324305486|FG002|Overall Study|Physician Decision|0|||
94685833|NCT02762981|324305487|FG003|Overall Study|Physician Decision|0|||
94685834|NCT02762981|324305488|FG004|Overall Study|Physician Decision|1|||
94685835|NCT02762981|324305484|FG000|Overall Study|Disease progression|11|||
94685836|NCT02762981|324305485|FG001|Overall Study|Disease progression|23|||
94685837|NCT02762981|324305486|FG002|Overall Study|Disease progression|4|||
94685838|NCT02762981|324305487|FG003|Overall Study|Disease progression|10|||
94685839|NCT02762981|324305488|FG004|Overall Study|Disease progression|1|||
94685840|NCT02762981|324305484|FG000|Overall Study|Enrolled not treated|1|||
94685841|NCT02762981|324305485|FG001|Overall Study|Enrolled not treated|5|||
94685842|NCT02762981|324305486|FG002|Overall Study|Enrolled not treated|0|||
94685843|NCT02762981|324305487|FG003|Overall Study|Enrolled not treated|2|||
94685844|NCT02762981|324305488|FG004|Overall Study|Enrolled not treated|0|||
94685845|NCT02762981|324305484|FG000|Overall Study|Other|2|||
94685846|NCT02762981|324305485|FG001|Overall Study|Other|3|||
94685847|NCT02762981|324305486|FG002|Overall Study|Other|1|||
94685848|NCT02762981|324305487|FG003|Overall Study|Other|0|||
94685849|NCT02762981|324305488|FG004|Overall Study|Other|0|||
94685850|NCT02762981|324305484|FG000|Overall Study|Missing|1|||
94685851|NCT02762981|324305485|FG001|Overall Study|Missing|0|||
94685852|NCT02762981|324305486|FG002|Overall Study|Missing|0|||
94685853|NCT02762981|324305487|FG003|Overall Study|Missing|0|||
94685854|NCT02762981|324305488|FG004|Overall Study|Missing|0|||
94685855|NCT02762981|324305484|FG000|Overall Study|Withdrawal by Subject|0|||
94685856|NCT02762981|324305485|FG001|Overall Study|Withdrawal by Subject|5|||
94685857|NCT02762981|324305486|FG002|Overall Study|Withdrawal by Subject|1|||
94685858|NCT02762981|324305487|FG003|Overall Study|Withdrawal by Subject|3|||
94685859|NCT02762981|324305488|FG004|Overall Study|Withdrawal by Subject|0|||
94685860|NCT00957931|324305490|FG000|Overall Study|Death|4|||
94685861|NCT00857805|324305491|FG000|Overall Study|Withdrawal by Subject|1|||
94685862|NCT00857805|324305492|FG001|Overall Study|Withdrawal by Subject|1|||
94685863|NCT01289041|324305493|FG000|Overall Study|Adverse Event|24|||
94685864|NCT01289041|324305493|FG000|Overall Study|Physician Decision|1|||
94685865|NCT01289041|324305493|FG000|Overall Study|Progressive Disease|41|||
94685866|NCT01289041|324305493|FG000|Overall Study|Withdrawal by Subject|3|||
94685867|NCT01289041|324305493|FG000|Overall Study|Death|1|||
94685868|NCT01486758|324305494|FG000|Overall Study|Lost to Follow-up|0|||
94685869|NCT01486758|324305495|FG001|Overall Study|Lost to Follow-up|1|||
94685870|NCT02791490|324305496|FG000|Overall Study|Lost to Follow-up|1|||
94685871|NCT02791490|324305497|FG001|Overall Study|Lost to Follow-up|2|||
94685872|NCT02791490|324305496|FG000|Overall Study|Withdrawal by Subject|2|||
94685873|NCT02791490|324305497|FG001|Overall Study|Withdrawal by Subject|6|||
94685874|NCT01923896|324305504|FG000|Overall Study|Adverse Event|1|||
94685875|NCT01923896|324305505|FG001|Overall Study|Adverse Event|0|||
94685876|NCT00474929|324305506|FG000|Overall Study|Withdrawal by Subject|0|||
94685877|NCT00474929|324305507|FG001|Overall Study|Withdrawal by Subject|1|||
94685878|NCT00474929|324305508|FG002|Overall Study|Withdrawal by Subject|0|||
94685879|NCT00474929|324305509|FG003|Overall Study|Withdrawal by Subject|0|||
94685880|NCT00474929|324305510|FG004|Overall Study|Withdrawal by Subject|0|||
94685881|NCT00474929|324305506|FG000|Overall Study|Unrelated medical condition|0|||
94685882|NCT00474929|324305507|FG001|Overall Study|Unrelated medical condition|0|||
94685883|NCT00474929|324305508|FG002|Overall Study|Unrelated medical condition|1|||
94685884|NCT00474929|324305509|FG003|Overall Study|Unrelated medical condition|0|||
94685885|NCT00474929|324305510|FG004|Overall Study|Unrelated medical condition|0|||
94685886|NCT00474929|324305506|FG000|Overall Study|Physician Decision|0|||
94685887|NCT00474929|324305507|FG001|Overall Study|Physician Decision|0|||
94685888|NCT00474929|324305508|FG002|Overall Study|Physician Decision|1|||
94685889|NCT00474929|324305509|FG003|Overall Study|Physician Decision|2|||
94685890|NCT00474929|324305510|FG004|Overall Study|Physician Decision|0|||
94685891|NCT03661996|324305511|FG000|Overall Study|Adverse Event|0|||
94685892|NCT03661996|324305512|FG001|Overall Study|Adverse Event|0|||
94685893|NCT03661996|324305513|FG002|Overall Study|Adverse Event|1|||
94685894|NCT03661996|324305514|FG003|Overall Study|Adverse Event|1|||
94685895|NCT03661996|324305515|FG004|Overall Study|Adverse Event|0|||
94685896|NCT03661996|324305511|FG000|Overall Study|Lost to Follow-up|5|||
94685897|NCT03661996|324305512|FG001|Overall Study|Lost to Follow-up|1|||
94685898|NCT03661996|324305513|FG002|Overall Study|Lost to Follow-up|2|||
94685899|NCT03661996|324305514|FG003|Overall Study|Lost to Follow-up|2|||
94685900|NCT03661996|324305515|FG004|Overall Study|Lost to Follow-up|6|||
94685901|NCT03661996|324305511|FG000|Overall Study|Physician Decision|1|||
94685902|NCT03661996|324305512|FG001|Overall Study|Physician Decision|1|||
94685903|NCT03661996|324305513|FG002|Overall Study|Physician Decision|1|||
94685904|NCT03661996|324305514|FG003|Overall Study|Physician Decision|2|||
94685905|NCT03661996|324305515|FG004|Overall Study|Physician Decision|0|||
94685906|NCT03661996|324305511|FG000|Overall Study|Protocol Violation|0|||
94685907|NCT03661996|324305512|FG001|Overall Study|Protocol Violation|0|||
94685908|NCT03661996|324305513|FG002|Overall Study|Protocol Violation|0|||
94685909|NCT03661996|324305514|FG003|Overall Study|Protocol Violation|0|||
94685910|NCT03661996|324305515|FG004|Overall Study|Protocol Violation|1|||
94685911|NCT03661996|324305511|FG000|Overall Study|Withdrawal by Subject|3|||
94685912|NCT03661996|324305512|FG001|Overall Study|Withdrawal by Subject|5|||
94685913|NCT03661996|324305513|FG002|Overall Study|Withdrawal by Subject|1|||
94685914|NCT03661996|324305514|FG003|Overall Study|Withdrawal by Subject|7|||
94649165|NCT01849588|324173627|FG000|Overall Study|Lack of Efficacy|3|||
94649166|NCT00094653|324173631|FG000|Overall Study|Death|306|||
94649167|NCT00094653|324173632|FG001|Overall Study|Death|100|||
94649168|NCT00094653|324173633|FG002|Overall Study|Death|119|||
94649169|NCT00094653|324173631|FG000|Overall Study|Subject Withdrew Consent|10|||
94649170|NCT00094653|324173632|FG001|Overall Study|Subject Withdrew Consent|2|||
94649171|NCT00094653|324173633|FG002|Overall Study|Subject Withdrew Consent|3|||
94649172|NCT00094653|324173631|FG000|Overall Study|Other|2|||
94649173|NCT00094653|324173632|FG001|Overall Study|Other|2|||
94649174|NCT00094653|324173633|FG002|Overall Study|Other|2|||
94649175|NCT00094653|324173631|FG000|Overall Study|Lost to Follow-up|3|||
94649176|NCT00094653|324173632|FG001|Overall Study|Lost to Follow-up|2|||
94649177|NCT00094653|324173633|FG002|Overall Study|Lost to Follow-up|1|||
94649178|NCT00094653|324173631|FG000|Overall Study|Protocol Violation|0|||
94649179|NCT00094653|324173632|FG001|Overall Study|Protocol Violation|0|||
94649180|NCT00094653|324173633|FG002|Overall Study|Protocol Violation|1|||
94649181|NCT00813358|324173634|FG000|Overall Study|Death|32|||
94649182|NCT00813358|324173634|FG000|Overall Study|Lost to Follow-up|12|||
94649183|NCT00813358|324173634|FG000|Overall Study|other endpoints|5|||
94649184|NCT00813358|324173634|FG000|Overall Study|Withdrawal by Subject|20|||
94649185|NCT06748040|324173635|FG000|Overall Study|Death|3|||
94649186|NCT06748040|324173636|FG001|Overall Study|Death|4|||
94649187|NCT06748040|324173635|FG000|Overall Study|Lost to Follow-up|134|||
94649188|NCT06748040|324173636|FG001|Overall Study|Lost to Follow-up|132|||
94649189|NCT06748040|324173635|FG000|Overall Study|Withdrawal by Subject|3|||
94649190|NCT06748040|324173636|FG001|Overall Study|Withdrawal by Subject|5|||
94649191|NCT04346615|324175109|FG000|Overall Study|Lost to Follow-up|0|||
94649192|NCT04346615|324175110|FG001|Overall Study|Lost to Follow-up|2|||
94649193|NCT04346615|324175109|FG000|Overall Study|Withdrawal by Subject|1|||
94649194|NCT04346615|324175110|FG001|Overall Study|Withdrawal by Subject|0|||
94649195|NCT04346615|324175109|FG000|Overall Study|Death|5|||
94649196|NCT04346615|324175110|FG001|Overall Study|Death|1|||
94649197|NCT04346615|324175109|FG000|Overall Study|Other|0|||
94649198|NCT04346615|324175110|FG001|Overall Study|Other|2|||
94649199|NCT04346615|324175109|FG000|Overall Study|Randomized not treated|1|||
94649200|NCT04346615|324175110|FG001|Overall Study|Randomized not treated|0|||
94649201|NCT00727194|324175119|FG000|Screening Period|Low QMG scores|0|||
94649202|NCT00727194|324175120|FG001|Screening Period|Low QMG scores|0|||
94649203|NCT00727194|324175121|FG002|Screening Period|Low QMG scores|6|||
94649204|NCT00727194|324175119|FG000|Screening Period|Lacked AChR antibodies|0|||
94649205|NCT00727194|324175120|FG001|Screening Period|Lacked AChR antibodies|0|||
94649206|NCT00727194|324175121|FG002|Screening Period|Lacked AChR antibodies|5|||
94649207|NCT00727194|324175119|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
94649208|NCT00727194|324175120|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
94649209|NCT00727194|324175121|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
94649210|NCT00727194|324175119|FG000|Screening Period|Severe infections|0|||
94649211|NCT00727194|324175120|FG001|Screening Period|Severe infections|0|||
94649212|NCT00727194|324175121|FG002|Screening Period|Severe infections|2|||
94649213|NCT00727194|324175119|FG000|Screening Period|History of thymoma|0|||
94649214|NCT00727194|324175120|FG001|Screening Period|History of thymoma|0|||
94649215|NCT00727194|324175121|FG002|Screening Period|History of thymoma|1|||
94649216|NCT00727194|324175119|FG000|Treatment Period 2|Lack of Efficacy|0|||
94649217|NCT00727194|324175120|FG001|Treatment Period 2|Lack of Efficacy|1|||
94649218|NCT00727194|324175121|FG002|Treatment Period 2|Lack of Efficacy|0|||
94649219|NCT01513317|324175125|FG000|Overall Study|Withdrawal by Subject|15|||
94649220|NCT01513317|324175126|FG001|Overall Study|Withdrawal by Subject|4|||
94649221|NCT01513317|324175125|FG000|Overall Study|Death|1|||
94649222|NCT01513317|324175126|FG001|Overall Study|Death|1|||
94649223|NCT01513317|324175125|FG000|Overall Study|Study terminated by sponsor|18|||
94649224|NCT01513317|324175126|FG001|Overall Study|Study terminated by sponsor|18|||
94649225|NCT01513317|324175125|FG000|Overall Study|Other|0|||
94649226|NCT01513317|324175126|FG001|Overall Study|Other|1|||
94649227|NCT02472756|324175127|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
94649228|NCT02472756|324175127|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
94649229|NCT02472756|324175127|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
94649230|NCT02472756|324175127|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
94649231|NCT02472756|324175127|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
94649232|NCT02896400|324175128|FG000|1 Month Follow-up|Lost to Follow-up|7|||
94649233|NCT02896400|324175129|FG001|1 Month Follow-up|Lost to Follow-up|7|||
94649234|NCT02896400|324175130|FG002|1 Month Follow-up|Lost to Follow-up|5|||
94649235|NCT02896400|324175131|FG003|1 Month Follow-up|Lost to Follow-up|8|||
94649236|NCT02896400|324175132|FG004|1 Month Follow-up|Lost to Follow-up|9|||
94649237|NCT02896400|324175133|FG005|1 Month Follow-up|Lost to Follow-up|6|||
94649238|NCT02896400|324175134|FG006|1 Month Follow-up|Lost to Follow-up|5|||
94649239|NCT02896400|324175135|FG007|1 Month Follow-up|Lost to Follow-up|6|||
94649240|NCT02896400|324175136|FG008|1 Month Follow-up|Lost to Follow-up|4|||
94649241|NCT02896400|324175137|FG009|1 Month Follow-up|Lost to Follow-up|7|||
94649242|NCT02896400|324175138|FG010|1 Month Follow-up|Lost to Follow-up|5|||
94685915|NCT03661996|324305515|FG004|Overall Study|Withdrawal by Subject|7|||
94685916|NCT03661996|324305511|FG000|Overall Study|Sponsors Decision|2|||
94685917|NCT03661996|324305512|FG001|Overall Study|Sponsors Decision|0|||
94685918|NCT03661996|324305513|FG002|Overall Study|Sponsors Decision|0|||
94685919|NCT03661996|324305514|FG003|Overall Study|Sponsors Decision|0|||
94685920|NCT03661996|324305515|FG004|Overall Study|Sponsors Decision|0|||
94685921|NCT03661996|324305511|FG000|Overall Study|Other|1|||
94685922|NCT03661996|324305512|FG001|Overall Study|Other|1|||
94685923|NCT03661996|324305513|FG002|Overall Study|Other|1|||
94685924|NCT03661996|324305514|FG003|Overall Study|Other|1|||
94685925|NCT03661996|324305515|FG004|Overall Study|Other|0|||
94685926|NCT02632786|324305516|FG000|Overall Study|Adverse Event|2|||
94685927|NCT02632786|324305517|FG001|Overall Study|Adverse Event|1|||
94685928|NCT02632786|324305516|FG000|Overall Study|Death|3|||
94685929|NCT02632786|324305517|FG001|Overall Study|Death|2|||
94685930|NCT02632786|324305516|FG000|Overall Study|Physician Decision|5|||
94649243|NCT02896400|324175139|FG011|1 Month Follow-up|Lost to Follow-up|5|||
94649244|NCT02896400|324175140|FG012|1 Month Follow-up|Lost to Follow-up|3|||
94649245|NCT02896400|324175141|FG013|1 Month Follow-up|Lost to Follow-up|4|||
94649246|NCT02896400|324175142|FG014|1 Month Follow-up|Lost to Follow-up|1|||
94649247|NCT02896400|324175143|FG015|1 Month Follow-up|Lost to Follow-up|2|||
94649248|NCT02896400|324175128|FG000|1 Month Follow-up|Death|0|||
94649249|NCT02896400|324175129|FG001|1 Month Follow-up|Death|0|||
94649250|NCT02896400|324175130|FG002|1 Month Follow-up|Death|0|||
94649251|NCT02896400|324175131|FG003|1 Month Follow-up|Death|0|||
94649252|NCT02896400|324175132|FG004|1 Month Follow-up|Death|0|||
94649253|NCT02896400|324175133|FG005|1 Month Follow-up|Death|0|||
94649254|NCT02896400|324175134|FG006|1 Month Follow-up|Death|0|||
94649255|NCT02896400|324175135|FG007|1 Month Follow-up|Death|0|||
94649256|NCT02896400|324175136|FG008|1 Month Follow-up|Death|0|||
94649257|NCT02896400|324175137|FG009|1 Month Follow-up|Death|0|||
94649258|NCT02896400|324175138|FG010|1 Month Follow-up|Death|0|||
94649259|NCT02896400|324175139|FG011|1 Month Follow-up|Death|0|||
94649260|NCT02896400|324175140|FG012|1 Month Follow-up|Death|0|||
94649261|NCT02896400|324175141|FG013|1 Month Follow-up|Death|0|||
94649262|NCT02896400|324175142|FG014|1 Month Follow-up|Death|0|||
94649263|NCT02896400|324175143|FG015|1 Month Follow-up|Death|1|||
94649264|NCT02896400|324175128|FG000|3 Month Follow-up|Lost to Follow-up|6|||
94649265|NCT02896400|324175129|FG001|3 Month Follow-up|Lost to Follow-up|3|||
94649266|NCT02896400|324175130|FG002|3 Month Follow-up|Lost to Follow-up|6|||
94649267|NCT02896400|324175131|FG003|3 Month Follow-up|Lost to Follow-up|11|||
94649268|NCT02896400|324175132|FG004|3 Month Follow-up|Lost to Follow-up|12|||
94649269|NCT02896400|324175133|FG005|3 Month Follow-up|Lost to Follow-up|6|||
94649270|NCT02896400|324175134|FG006|3 Month Follow-up|Lost to Follow-up|4|||
94649271|NCT02896400|324175135|FG007|3 Month Follow-up|Lost to Follow-up|3|||
94649272|NCT02896400|324175136|FG008|3 Month Follow-up|Lost to Follow-up|6|||
94649273|NCT02896400|324175137|FG009|3 Month Follow-up|Lost to Follow-up|5|||
94649274|NCT02896400|324175138|FG010|3 Month Follow-up|Lost to Follow-up|6|||
94649275|NCT02896400|324175139|FG011|3 Month Follow-up|Lost to Follow-up|6|||
94649276|NCT02896400|324175140|FG012|3 Month Follow-up|Lost to Follow-up|3|||
94649277|NCT02896400|324175141|FG013|3 Month Follow-up|Lost to Follow-up|5|||
94649278|NCT02896400|324175142|FG014|3 Month Follow-up|Lost to Follow-up|3|||
94649279|NCT02896400|324175143|FG015|3 Month Follow-up|Lost to Follow-up|2|||
94649280|NCT02896400|324175128|FG000|3 Month Follow-up|Death|0|||
94649281|NCT02896400|324175129|FG001|3 Month Follow-up|Death|0|||
94649282|NCT02896400|324175130|FG002|3 Month Follow-up|Death|0|||
94649283|NCT02896400|324175131|FG003|3 Month Follow-up|Death|0|||
94649284|NCT02896400|324175132|FG004|3 Month Follow-up|Death|0|||
94649285|NCT02896400|324175133|FG005|3 Month Follow-up|Death|0|||
94649286|NCT02896400|324175134|FG006|3 Month Follow-up|Death|0|||
94649287|NCT02896400|324175135|FG007|3 Month Follow-up|Death|0|||
94649288|NCT02896400|324175136|FG008|3 Month Follow-up|Death|0|||
94649289|NCT02896400|324175137|FG009|3 Month Follow-up|Death|0|||
94685931|NCT02632786|324305517|FG001|Overall Study|Physician Decision|4|||
94685932|NCT02632786|324305516|FG000|Overall Study|Withdrawal by Subject|1|||
94685933|NCT02632786|324305517|FG001|Overall Study|Withdrawal by Subject|0|||
94649290|NCT02896400|324175138|FG010|3 Month Follow-up|Death|0|||
94649291|NCT02896400|324175139|FG011|3 Month Follow-up|Death|0|||
94649292|NCT02896400|324175140|FG012|3 Month Follow-up|Death|0|||
94649293|NCT02896400|324175141|FG013|3 Month Follow-up|Death|1|||
94649294|NCT02896400|324175142|FG014|3 Month Follow-up|Death|1|||
94685934|NCT01454830|324305518|FG000|Overall Study|Withdrawal by Subject|4|||
94685935|NCT01454830|324305519|FG001|Overall Study|Withdrawal by Subject|4|||
94685936|NCT01454830|324305518|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
94685937|NCT01454830|324305519|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
94685938|NCT01454830|324305518|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
94649295|NCT02896400|324175143|FG015|3 Month Follow-up|Death|0|||
94649296|NCT02896400|324175128|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
94649297|NCT02896400|324175129|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
94685939|NCT01454830|324305519|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
94649298|NCT02896400|324175130|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
94649299|NCT02896400|324175131|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
94649300|NCT02896400|324175132|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
94649301|NCT02896400|324175133|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
94649302|NCT02896400|324175134|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
94649303|NCT02896400|324175135|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
94649304|NCT02896400|324175136|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
94649305|NCT02896400|324175137|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
94649306|NCT02896400|324175138|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
94649307|NCT02896400|324175139|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
94649308|NCT02896400|324175140|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
94649309|NCT02896400|324175141|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
94649310|NCT02896400|324175142|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
94649311|NCT02896400|324175143|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
94649312|NCT02896400|324175128|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
94649313|NCT02896400|324175129|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
94649314|NCT02896400|324175130|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
94649315|NCT02896400|324175131|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
94649316|NCT02896400|324175132|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
94649317|NCT02896400|324175133|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
94649318|NCT02896400|324175134|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
94649319|NCT02896400|324175135|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
94649320|NCT02896400|324175136|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
94649321|NCT02896400|324175137|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
94649322|NCT02896400|324175138|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
94649323|NCT02896400|324175139|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
94649324|NCT02896400|324175140|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
94649325|NCT02896400|324175141|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
94649326|NCT02896400|324175142|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
94649327|NCT02896400|324175143|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
94649328|NCT00667342|324175144|FG000|Overall Study|Protocol Violation|1|||
94649329|NCT00667342|324175145|FG001|Overall Study|Protocol Violation|0|||
94649330|NCT00667342|324175146|FG002|Overall Study|Protocol Violation|0|||
94649331|NCT00667342|324175144|FG000|Overall Study|Withdrawal by Subject|1|||
94649332|NCT00667342|324175145|FG001|Overall Study|Withdrawal by Subject|0|||
94649333|NCT00667342|324175146|FG002|Overall Study|Withdrawal by Subject|0|||
94649334|NCT00667342|324175144|FG000|Overall Study|Physician Decision|3|||
94649335|NCT00667342|324175145|FG001|Overall Study|Physician Decision|0|||
94649336|NCT00667342|324175146|FG002|Overall Study|Physician Decision|0|||
94649337|NCT00667342|324175144|FG000|Overall Study|Relapse or tumor progression|9|||
94649338|NCT00667342|324175145|FG001|Overall Study|Relapse or tumor progression|0|||
94649339|NCT00667342|324175146|FG002|Overall Study|Relapse or tumor progression|7|||
94649340|NCT00667342|324175144|FG000|Overall Study|Adverse Event|0|||
94649341|NCT00667342|324175145|FG001|Overall Study|Adverse Event|0|||
94649342|NCT00667342|324175146|FG002|Overall Study|Adverse Event|1|||
94649343|NCT00667342|324175144|FG000|Overall Study|Ineligible|0|||
94649344|NCT00667342|324175145|FG001|Overall Study|Ineligible|0|||
94649345|NCT00667342|324175146|FG002|Overall Study|Ineligible|1|||
94649346|NCT01207778|324175147|FG000|Overall Study|Lost to Follow-up|0|||
94649347|NCT01207778|324175148|FG001|Overall Study|Lost to Follow-up|3|||
94649348|NCT01207778|324175149|FG002|Overall Study|Lost to Follow-up|3|||
94649349|NCT01589822|324175152|FG000|Overall Study|Withdrawal by Subject|1|||
94649350|NCT01589822|324175153|FG001|Overall Study|Withdrawal by Subject|2|||
94649351|NCT01589822|324175154|FG002|Overall Study|Withdrawal by Subject|0|||
94649352|NCT01589822|324175152|FG000|Overall Study|Death|1|||
94649353|NCT01589822|324175153|FG001|Overall Study|Death|0|||
94649354|NCT01589822|324175154|FG002|Overall Study|Death|0|||
94649355|NCT01589822|324175152|FG000|Overall Study|Missed 90 day visit|2|||
94649356|NCT01589822|324175153|FG001|Overall Study|Missed 90 day visit|1|||
94649357|NCT01589822|324175154|FG002|Overall Study|Missed 90 day visit|1|||
94649358|NCT00773175|324175171|FG000|Overall Study|Adverse Event|2|||
94649359|NCT00773175|324175172|FG001|Overall Study|Adverse Event|0|||
94649360|NCT00773175|324175171|FG000|Overall Study|Consent Withdrawn|0|||
94649361|NCT00773175|324175172|FG001|Overall Study|Consent Withdrawn|2|||
94649362|NCT03285646|324175173|FG000|Overall Study|Adverse Event|1|||
94649363|NCT03285646|324175174|FG001|Overall Study|Adverse Event|0|||
94685940|NCT01454830|324305518|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
94685941|NCT01454830|324305519|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
94685942|NCT01454830|324305518|FG000|Overall Study|Withdrawal - no polysomnography|3|||
94685943|NCT01454830|324305519|FG001|Overall Study|Withdrawal - no polysomnography|2|||
94685944|NCT01235975|324305522|FG000|Overall Study|Serious Adverse Event|0|||
94685945|NCT01235975|324305523|FG001|Overall Study|Serious Adverse Event|1|||
94685946|NCT01235975|324305522|FG000|Overall Study|Withdrawal by Subject|8|||
94685947|NCT01235975|324305523|FG001|Overall Study|Withdrawal by Subject|2|||
94685948|NCT01235975|324305522|FG000|Overall Study|Migrated/moved from study area|2|||
94685949|NCT01235975|324305523|FG001|Overall Study|Migrated/moved from study area|1|||
94685950|NCT01235975|324305522|FG000|Overall Study|Lost to Follow-up|7|||
94685951|NCT01235975|324305523|FG001|Overall Study|Lost to Follow-up|3|||
94685952|NCT02341456|324305524|FG000|Overall Study|Disease progression|2|||
94685953|NCT02341456|324305525|FG001|Overall Study|Disease progression|3|||
94685954|NCT02341456|324305526|FG002|Overall Study|Disease progression|1|||
94685955|NCT02341456|324305524|FG000|Overall Study|Death|1|||
94685956|NCT02341456|324305525|FG001|Overall Study|Death|1|||
94685957|NCT02341456|324305526|FG002|Overall Study|Death|1|||
94685958|NCT02341456|324305524|FG000|Overall Study|Withdrawal by Subject|0|||
94685959|NCT02341456|324305525|FG001|Overall Study|Withdrawal by Subject|1|||
94685960|NCT02341456|324305526|FG002|Overall Study|Withdrawal by Subject|1|||
94685961|NCT02341456|324305524|FG000|Overall Study|Moved to local access programme.|0|||
94685962|NCT02341456|324305525|FG001|Overall Study|Moved to local access programme.|1|||
94685963|NCT02341456|324305526|FG002|Overall Study|Moved to local access programme.|1|||
94685964|NCT02341456|324305524|FG000|Overall Study|Physician Decision|1|||
94685965|NCT02341456|324305525|FG001|Overall Study|Physician Decision|0|||
94685966|NCT02341456|324305526|FG002|Overall Study|Physician Decision|0|||
94685967|NCT01077362|324305527|FG000|Overall Study|Lack of Efficacy|13|||
94685968|NCT01077362|324305528|FG001|Overall Study|Lack of Efficacy|8|||
94685969|NCT01077362|324305529|FG002|Overall Study|Lack of Efficacy|10|||
94685970|NCT01077362|324305527|FG000|Overall Study|Lost to Follow-up|1|||
94685971|NCT01077362|324305528|FG001|Overall Study|Lost to Follow-up|0|||
94685972|NCT01077362|324305529|FG002|Overall Study|Lost to Follow-up|3|||
94685973|NCT01077362|324305527|FG000|Overall Study|Adverse Event|12|||
94685974|NCT01077362|324305528|FG001|Overall Study|Adverse Event|7|||
94685975|NCT01077362|324305529|FG002|Overall Study|Adverse Event|4|||
94685976|NCT01077362|324305527|FG000|Overall Study|Withdrawal by Subject|5|||
94685977|NCT01077362|324305528|FG001|Overall Study|Withdrawal by Subject|3|||
94685978|NCT01077362|324305529|FG002|Overall Study|Withdrawal by Subject|5|||
94685979|NCT01077362|324305527|FG000|Overall Study|Other|0|||
94685980|NCT01077362|324305528|FG001|Overall Study|Other|1|||
94685981|NCT01077362|324305529|FG002|Overall Study|Other|2|||
94685982|NCT00422799|324305530|FG000|Overall Study|Withdrawal by Subject|6|||
94685983|NCT00422799|324305530|FG000|Overall Study|Adverse Event|7|||
94685984|NCT02006121|324305535|FG000|Double Blind Phase|Adverse Event|6|||
94685985|NCT02006121|324305536|FG001|Double Blind Phase|Adverse Event|0|||
94685986|NCT02006121|324305535|FG000|Double Blind Phase|Lack of Efficacy|1|||
94685987|NCT02006121|324305536|FG001|Double Blind Phase|Lack of Efficacy|16|||
94685988|NCT02006121|324305535|FG000|Double Blind Phase|Withdrawal by Subject|3|||
94685989|NCT02006121|324305536|FG001|Double Blind Phase|Withdrawal by Subject|4|||
94685990|NCT02006121|324305535|FG000|Double Blind Phase|Non-compliance with study drug|1|||
94685991|NCT02006121|324305536|FG001|Double Blind Phase|Non-compliance with study drug|3|||
94685992|NCT02006121|324305535|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
94685993|NCT02006121|324305536|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
94685994|NCT02006121|324305535|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
94685995|NCT02006121|324305536|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
94685996|NCT02006121|324305535|FG000|Open Label Phase|Adverse Event|15|||
94685997|NCT02006121|324305536|FG001|Open Label Phase|Adverse Event|0|||
94685998|NCT02006121|324305535|FG000|Open Label Phase|Lack of Efficacy|2|||
94685999|NCT02006121|324305536|FG001|Open Label Phase|Lack of Efficacy|0|||
94686000|NCT02006121|324305535|FG000|Open Label Phase|Protocol Violation|2|||
94686001|NCT02006121|324305536|FG001|Open Label Phase|Protocol Violation|0|||
94686002|NCT02006121|324305535|FG000|Open Label Phase|Withdrawal by Subject|3|||
94686003|NCT02006121|324305536|FG001|Open Label Phase|Withdrawal by Subject|0|||
94686004|NCT02006121|324305535|FG000|Open Label Phase|Non-compliance with study drug|3|||
94686005|NCT02006121|324305536|FG001|Open Label Phase|Non-compliance with study drug|0|||
94686006|NCT02387216|324305540|FG000|Overall Study|Progressive disease|2|||
94686007|NCT02387216|324305541|FG001|Overall Study|Progressive disease|0|||
94686008|NCT02387216|324305540|FG000|Overall Study|Withdrawal by Subject|3|||
94686009|NCT02387216|324305541|FG001|Overall Study|Withdrawal by Subject|5|||
94686010|NCT02387216|324305540|FG000|Overall Study|Physician Decision|2|||
94686011|NCT02387216|324305541|FG001|Overall Study|Physician Decision|0|||
94686012|NCT02387216|324305540|FG000|Overall Study|Sponsor Decision|28|||
94686013|NCT02387216|324305541|FG001|Overall Study|Sponsor Decision|12|||
94686014|NCT02387216|324305540|FG000|Overall Study|Death|60|||
94686015|NCT02387216|324305541|FG001|Overall Study|Death|23|||
94686016|NCT02387216|324305540|FG000|Overall Study|Other|5|||
94686017|NCT02387216|324305541|FG001|Overall Study|Other|4|||
94686018|NCT02387216|324305540|FG000|Overall Study|Lost to Follow-up|0|||
94686019|NCT02387216|324305541|FG001|Overall Study|Lost to Follow-up|3|||
94686020|NCT04498247|324305542|FG000|Overall Study|Lost to Follow-up|0|||
94686021|NCT04498247|324305543|FG001|Overall Study|Lost to Follow-up|0|||
94686022|NCT04498247|324305544|FG002|Overall Study|Lost to Follow-up|0|||
94686023|NCT04498247|324305545|FG003|Overall Study|Lost to Follow-up|1|||
94686024|NCT04498247|324305546|FG004|Overall Study|Lost to Follow-up|0|||
94686025|NCT04498247|324305547|FG005|Overall Study|Lost to Follow-up|0|||
94686026|NCT04498247|324305548|FG006|Overall Study|Lost to Follow-up|0|||
94686027|NCT04498247|324305549|FG007|Overall Study|Lost to Follow-up|0|||
94686028|NCT04498247|324305542|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
94686029|NCT04498247|324305543|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
94686030|NCT04498247|324305544|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
94686031|NCT04498247|324305545|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
94686032|NCT04498247|324305546|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
94686033|NCT04498247|324305547|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
94686034|NCT04498247|324305548|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
94686035|NCT04498247|324305549|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
94686036|NCT04498247|324305542|FG000|Overall Study|Withdrawal by Subject|0|||
94686037|NCT04498247|324305543|FG001|Overall Study|Withdrawal by Subject|8|||
94686038|NCT04498247|324305544|FG002|Overall Study|Withdrawal by Subject|0|||
94686039|NCT04498247|324305545|FG003|Overall Study|Withdrawal by Subject|7|||
94686040|NCT04498247|324305546|FG004|Overall Study|Withdrawal by Subject|0|||
94686041|NCT04498247|324305547|FG005|Overall Study|Withdrawal by Subject|0|||
94686042|NCT04498247|324305548|FG006|Overall Study|Withdrawal by Subject|1|||
94686043|NCT04498247|324305549|FG007|Overall Study|Withdrawal by Subject|0|||
94686044|NCT04498247|324305542|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
94686045|NCT04498247|324305543|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
94686046|NCT04498247|324305544|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
94686047|NCT04498247|324305545|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
94686048|NCT04498247|324305546|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
94686049|NCT04498247|324305547|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
94686050|NCT04498247|324305548|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
94686051|NCT04498247|324305549|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
94686052|NCT00192023|324305550|FG000|Period III - Double-Blind|Adverse Event|3|||
94686053|NCT00192023|324305551|FG001|Period III - Double-Blind|Adverse Event|0|||
94686054|NCT00192023|324305550|FG000|Period III - Double-Blind|Physician Decision|2|||
94686055|NCT00192023|324305551|FG001|Period III - Double-Blind|Physician Decision|0|||
94263839|NCT03427125|322759948|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
94263840|NCT04343248|322759949|FG000|Overall Study|Withdrawal by Subject|5|||
94263841|NCT04343248|322759950|FG001|Overall Study|Withdrawal by Subject|6|||
94263842|NCT04343248|322759949|FG000|Overall Study|Death|1|||
94263843|NCT04343248|322759950|FG001|Overall Study|Death|2|||
94263844|NCT04343248|322759949|FG000|Overall Study|Lost to Follow-up|9|||
94263845|NCT04343248|322759950|FG001|Overall Study|Lost to Follow-up|6|||
94263846|NCT04343248|322759949|FG000|Overall Study|Physician Decision|0|||
94263847|NCT04343248|322759950|FG001|Overall Study|Physician Decision|1|||
94263848|NCT04343248|322759949|FG000|Overall Study|Adverse Event|1|||
94263849|NCT04343248|322759950|FG001|Overall Study|Adverse Event|0|||
94263850|NCT02846532|322759951|FG000|Overall Study|Lost to Follow-up|0|||
94263851|NCT02846532|322759952|FG001|Overall Study|Lost to Follow-up|1|||
94263852|NCT02846532|322759953|FG002|Overall Study|Lost to Follow-up|1|||
94263853|NCT02846532|322759951|FG000|Overall Study|Withdrawal by Subject|1|||
94263854|NCT02846532|322759952|FG001|Overall Study|Withdrawal by Subject|2|||
94263855|NCT02846532|322759953|FG002|Overall Study|Withdrawal by Subject|0|||
94263856|NCT04683731|322759954|FG000|Overall Study|Withdrawal by Subject|1|||
94263857|NCT04683731|322759955|FG001|Overall Study|Withdrawal by Subject|0|||
94263858|NCT04683731|322759956|FG002|Overall Study|Withdrawal by Subject|3|||
94263859|NCT04683731|322759957|FG003|Overall Study|Withdrawal by Subject|2|||
94263860|NCT04683731|322759954|FG000|Overall Study|Determined patient was not eligible|3|||
94263861|NCT04683731|322759955|FG001|Overall Study|Determined patient was not eligible|3|||
94263862|NCT04683731|322759956|FG002|Overall Study|Determined patient was not eligible|12|||
94463507|NCT00336024|323485084|FG001|Overall Study|Failure to fulfill consolidation|1|||
94463508|NCT00336024|323485083|FG000|Overall Study|Progressive Disease|4|||
94686056|NCT00192023|324305550|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
94686057|NCT00192023|324305551|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
94686058|NCT00192023|324305550|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
94686059|NCT00192023|324305551|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
94263863|NCT04683731|322759957|FG003|Overall Study|Determined patient was not eligible|3|||
94263864|NCT02733185|322759960|FG000|Overall Study|Withdrawal by Subject|12|||
94263865|NCT02733185|322759961|FG001|Overall Study|Withdrawal by Subject|10|||
94263866|NCT02733185|322759962|FG002|Overall Study|Withdrawal by Subject|17|||
94463509|NCT00336024|323485084|FG001|Overall Study|Progressive Disease|7|||
94686060|NCT00192023|324305550|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
94686061|NCT00192023|324305551|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
94686062|NCT00192023|324305550|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
94686063|NCT00192023|324305551|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
94686064|NCT00192023|324305550|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
94686065|NCT00192023|324305551|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
94686066|NCT00192023|324305550|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
94686067|NCT00192023|324305551|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
94686068|NCT00192023|324305550|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
94686069|NCT00192023|324305551|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
94364094|NCT01915498|323116809|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
94364095|NCT01915498|323116810|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
94686070|NCT00192023|324305550|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
94686071|NCT00192023|324305551|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
94686072|NCT03469349|324305552|FG000|Overall Study|Withdrawal by Subject|1|||
94686073|NCT03469349|324305553|FG001|Overall Study|Withdrawal by Subject|3|||
94686074|NCT03469349|324305552|FG000|Overall Study|Progressive Disease|0|||
94364096|NCT01915498|323116811|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
94364097|NCT01915498|323116812|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
94686075|NCT03469349|324305553|FG001|Overall Study|Progressive Disease|1|||
94686076|NCT03469349|324305552|FG000|Overall Study|Lost to Follow-up|2|||
94686077|NCT03469349|324305553|FG001|Overall Study|Lost to Follow-up|2|||
94686078|NCT03469349|324305552|FG000|Overall Study|Adverse Event|2|||
94686079|NCT03469349|324305553|FG001|Overall Study|Adverse Event|4|||
94686080|NCT00251927|324305555|FG000|Overall Study|Adverse Event|3|||
94686081|NCT00251927|324305556|FG001|Overall Study|Adverse Event|15|||
94686082|NCT00251927|324305555|FG000|Overall Study|Lack of Efficacy|22|||
94686083|NCT00251927|324305556|FG001|Overall Study|Lack of Efficacy|16|||
94686084|NCT00251927|324305555|FG000|Overall Study|Lost to Follow-up|22|||
94686085|NCT00251927|324305556|FG001|Overall Study|Lost to Follow-up|8|||
94686086|NCT00251927|324305555|FG000|Overall Study|Protocol Violation|1|||
94686087|NCT00251927|324305556|FG001|Overall Study|Protocol Violation|2|||
94686088|NCT00251927|324305555|FG000|Overall Study|Pregnancy|2|||
94686089|NCT00251927|324305556|FG001|Overall Study|Pregnancy|0|||
94686090|NCT00251927|324305555|FG000|Overall Study|Withdrawal by Subject|40|||
94686091|NCT00251927|324305556|FG001|Overall Study|Withdrawal by Subject|25|||
94686092|NCT00251927|324305555|FG000|Overall Study|Study-specific discont. achieved|13|||
94686093|NCT00251927|324305556|FG001|Overall Study|Study-specific discont. achieved|2|||
94686094|NCT00251927|324305555|FG000|Overall Study|Study procedure non-compliance|5|||
94686095|NCT00251927|324305556|FG001|Overall Study|Study procedure non-compliance|6|||
94686096|NCT02441946|324305557|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
94686097|NCT02441946|324305558|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
94686098|NCT02441946|324305559|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
94686099|NCT02441946|324305557|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
94686100|NCT02441946|324305558|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
94686101|NCT02441946|324305559|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
94686102|NCT02441946|324305557|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
94686103|NCT02441946|324305558|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
94686104|NCT02441946|324305559|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
94686105|NCT02441946|324305557|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
94686106|NCT02441946|324305558|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
94686107|NCT02441946|324305559|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
94686108|NCT02441946|324305557|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
94686109|NCT02441946|324305558|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
94686110|NCT02441946|324305559|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
94686111|NCT02441946|324305557|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
94686112|NCT02441946|324305558|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
94686113|NCT02441946|324305559|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
94686114|NCT02441946|324305557|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
94686115|NCT02441946|324305558|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
94364098|NCT01915498|323116813|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
94364099|NCT01915498|323116814|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
94364100|NCT01915498|323116815|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
94364101|NCT01915498|323116816|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
94686116|NCT02441946|324305559|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
94686117|NCT02441946|324305557|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
94686118|NCT02441946|324305558|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
94364102|NCT01915498|323116817|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
94364103|NCT01915498|323116818|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
94364104|NCT01915498|323116819|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
94364105|NCT01915498|323116820|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
94364106|NCT01915498|323116802|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
94364107|NCT01915498|323116803|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
94364108|NCT01915498|323116804|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
94364109|NCT01915498|323116805|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
94364110|NCT01915498|323116806|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
94364111|NCT01915498|323116807|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
94364112|NCT01915498|323116808|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
94364113|NCT01915498|323116809|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
94364114|NCT01915498|323116810|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
94364115|NCT01915498|323116811|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
94364116|NCT01915498|323116812|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
94364117|NCT01915498|323116813|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
94364118|NCT01915498|323116814|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
94364119|NCT01915498|323116815|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
94364120|NCT01915498|323116816|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
94364121|NCT01915498|323116817|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
94364122|NCT01915498|323116818|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
94364123|NCT01915498|323116819|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
94364124|NCT01915498|323116820|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
94364125|NCT01915498|323116802|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
94364126|NCT01915498|323116803|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
94364127|NCT01915498|323116804|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
94364128|NCT01915498|323116805|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
94364129|NCT01915498|323116806|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
94364130|NCT01915498|323116807|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
94364131|NCT01915498|323116808|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
94364132|NCT01915498|323116809|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
94364133|NCT01915498|323116810|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
94463510|NCT00336024|323485083|FG000|Overall Study|Ineligible|7|||
94649364|NCT03285646|324175173|FG000|Overall Study|Withdrawal by Subject|10|||
94649365|NCT03285646|324175174|FG001|Overall Study|Withdrawal by Subject|2|||
94649366|NCT03285646|324175173|FG000|Overall Study|Lost to Follow-up|2|||
94649367|NCT03285646|324175174|FG001|Overall Study|Lost to Follow-up|1|||
94649368|NCT03285646|324175173|FG000|Overall Study|Investigator/Sponsor Decision|0|||
94649369|NCT03285646|324175174|FG001|Overall Study|Investigator/Sponsor Decision|1|||
94649370|NCT02789176|324175175|FG000|Overall Study|Death|0|||
94649371|NCT02789176|324175176|FG001|Overall Study|Death|0|||
94649372|NCT02789176|324175177|FG002|Overall Study|Death|3|||
94649373|NCT02789176|324175178|FG003|Overall Study|Death|0|||
94649374|NCT02789176|324175175|FG000|Overall Study|Withdrawal by Subject|0|||
94649375|NCT02789176|324175176|FG001|Overall Study|Withdrawal by Subject|0|||
94649376|NCT02789176|324175177|FG002|Overall Study|Withdrawal by Subject|1|||
94649377|NCT02789176|324175178|FG003|Overall Study|Withdrawal by Subject|0|||
94649378|NCT02789176|324175175|FG000|Overall Study|Lost to Follow-up|8|||
94649379|NCT02789176|324175176|FG001|Overall Study|Lost to Follow-up|2|||
94649380|NCT02789176|324175177|FG002|Overall Study|Lost to Follow-up|6|||
94649381|NCT02789176|324175178|FG003|Overall Study|Lost to Follow-up|1|||
94649382|NCT00192075|324175179|FG000|Overall Study|Disease Progression|23|||
94649383|NCT00192075|324175180|FG001|Overall Study|Disease Progression|6|||
94649384|NCT00192075|324175179|FG000|Overall Study|Adverse Event|1|||
94649385|NCT00192075|324175180|FG001|Overall Study|Adverse Event|3|||
94649386|NCT00192075|324175179|FG000|Overall Study|Death|0|||
94649387|NCT00192075|324175180|FG001|Overall Study|Death|1|||
94649388|NCT00192075|324175179|FG000|Overall Study|Lack of Efficacy|0|||
94649389|NCT00192075|324175180|FG001|Overall Study|Lack of Efficacy|0|||
94649390|NCT00192075|324175179|FG000|Overall Study|Physician Decision|3|||
94649391|NCT00192075|324175180|FG001|Overall Study|Physician Decision|0|||
94649392|NCT00192075|324175179|FG000|Overall Study|Withdrawal by Subject|5|||
94649393|NCT00192075|324175180|FG001|Overall Study|Withdrawal by Subject|5|||
94649394|NCT00192075|324175179|FG000|Overall Study|Patient Non-Compliance|0|||
94649395|NCT00192075|324175180|FG001|Overall Study|Patient Non-Compliance|1|||
94649396|NCT00192075|324175179|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
94649397|NCT00192075|324175180|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
94649398|NCT00192075|324175179|FG000|Overall Study|Other|5|||
94649399|NCT00192075|324175180|FG001|Overall Study|Other|2|||
94649400|NCT00779675|324175181|FG000|Treatment Period|Adverse Event|87|||
94649401|NCT00779675|324175181|FG000|Treatment Period|Treatment Failure|80|||
94649402|NCT00779675|324175181|FG000|Treatment Period|Transferred to Another Study|38|||
94686119|NCT02441946|324305559|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
94686120|NCT02441946|324305557|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
94686121|NCT02441946|324305558|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
94686122|NCT02441946|324305559|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
94686123|NCT02441946|324305557|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
94686124|NCT02441946|324305558|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
94686125|NCT02441946|324305559|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
94686126|NCT02441946|324305557|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
94686127|NCT02441946|324305558|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
94686128|NCT02441946|324305559|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
94686129|NCT00675506|324305560|FG000|Overall Study|Lost to Follow-up|1|||
94686130|NCT00675506|324305561|FG001|Overall Study|Lost to Follow-up|5|||
94686131|NCT00675506|324305560|FG000|Overall Study|Lost interest|3|||
94686132|NCT00675506|324305561|FG001|Overall Study|Lost interest|5|||
94686133|NCT00675506|324305560|FG000|Overall Study|Elevated fasting glucose|2|||
94686134|NCT00675506|324305561|FG001|Overall Study|Elevated fasting glucose|1|||
94686135|NCT00675506|324305560|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
94686136|NCT00675506|324305561|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
94686137|NCT00675506|324305560|FG000|Overall Study|Elevated IGF-1|2|||
94686138|NCT00675506|324305561|FG001|Overall Study|Elevated IGF-1|0|||
94686139|NCT00675506|324305560|FG000|Overall Study|Hypersensitivity Reaction|1|||
94686140|NCT00675506|324305561|FG001|Overall Study|Hypersensitivity Reaction|0|||
94686141|NCT00675506|324305560|FG000|Overall Study|Disclosed history of cancer|1|||
94686142|NCT00675506|324305561|FG001|Overall Study|Disclosed history of cancer|0|||
94686143|NCT00675506|324305560|FG000|Overall Study|Declined participation|1|||
94686144|NCT00675506|324305561|FG001|Overall Study|Declined participation|0|||
94686145|NCT00675506|324305560|FG000|Overall Study|Schedule conflict|0|||
94686146|NCT00675506|324305561|FG001|Overall Study|Schedule conflict|1|||
94686147|NCT03292146|324305562|FG000|Baseline to 12 Months|Relocation|1|||
94686148|NCT03292146|324305563|FG001|Baseline to 12 Months|Relocation|0|||
94686149|NCT03292146|324305562|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
94364134|NCT01915498|323116811|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
94364135|NCT01915498|323116812|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
94364136|NCT01915498|323116813|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
94364137|NCT01915498|323116814|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
94364138|NCT01915498|323116815|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
94364139|NCT01915498|323116816|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
94364140|NCT01915498|323116817|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
94364141|NCT01915498|323116818|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
94364142|NCT01915498|323116819|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
94364143|NCT01915498|323116820|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
94364144|NCT01915498|323116802|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
94686150|NCT03292146|324305563|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
94686151|NCT03292146|324305562|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
94686152|NCT03292146|324305563|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
94686153|NCT03292146|324305562|FG000|12 Months to 24 Months|Planning pregnancy|2|||
94686154|NCT03292146|324305563|FG001|12 Months to 24 Months|Planning pregnancy|2|||
94686155|NCT03292146|324305562|FG000|12 Months to 24 Months|Personal reasons|1|||
94686156|NCT03292146|324305563|FG001|12 Months to 24 Months|Personal reasons|0|||
94686157|NCT03292146|324305562|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
94686158|NCT03292146|324305563|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
94686159|NCT03151395|324305564|FG000|Overall Study|Adverse Event|2|||
94686160|NCT03151395|324305564|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
94686161|NCT03151395|324305564|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
94686162|NCT03151395|324305564|FG000|Overall Study|Unspecified reason|4|||
94686163|NCT00545363|324305565|FG000|Overall Study|Adverse Event|6|||
94686164|NCT00545363|324305566|FG001|Overall Study|Adverse Event|7|||
94686165|NCT00545363|324305565|FG000|Overall Study|Withdrawal by Subject|6|||
94686166|NCT00545363|324305566|FG001|Overall Study|Withdrawal by Subject|5|||
94686167|NCT00545363|324305565|FG000|Overall Study|Non-compliance|3|||
94686168|NCT00545363|324305566|FG001|Overall Study|Non-compliance|1|||
94686169|NCT00545363|324305565|FG000|Overall Study|Did not meet entry criteria|1|||
94686170|NCT00545363|324305566|FG001|Overall Study|Did not meet entry criteria|1|||
94686171|NCT00545363|324305565|FG000|Overall Study|Lost to Follow-up|2|||
94686172|NCT00545363|324305566|FG001|Overall Study|Lost to Follow-up|0|||
94686173|NCT00545363|324305565|FG000|Overall Study|Other|1|||
94686174|NCT00545363|324305566|FG001|Overall Study|Other|1|||
94686175|NCT01108510|324305567|FG000|Overall Study|Randomized but Not Treated|5|||
94364145|NCT01915498|323116803|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
94364146|NCT01915498|323116804|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
94463511|NCT00336024|323485084|FG001|Overall Study|Ineligible|7|||
94686176|NCT01108510|324305568|FG001|Overall Study|Randomized but Not Treated|1|||
94649403|NCT00779675|324175181|FG000|Treatment Period|Lost to Follow-up|23|||
94649404|NCT00779675|324175181|FG000|Treatment Period|Withdrawal by Subject|46|||
94649405|NCT00779675|324175181|FG000|Treatment Period|Protocol Violation|54|||
94649406|NCT00779675|324175181|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
94649407|NCT00779675|324175181|FG000|Treatment Period|Administrative|3|||
94649408|NCT00779675|324175181|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
94649409|NCT00779675|324175181|FG000|Extended Treatment Period|Protocol Violation|13|||
94649410|NCT00779675|324175181|FG000|Extended Treatment Period|Adverse Event|6|||
94649411|NCT00779675|324175181|FG000|Extended Treatment Period|Treatment Failure|11|||
94649412|NCT00779675|324175181|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
94649413|NCT00779675|324175181|FG000|Extended Treatment Period|Lost to Follow-up|6|||
94649414|NCT04537806|324175195|FG000|Overall Study|Randomized but not treated|1|||
94649415|NCT04537806|324175196|FG001|Overall Study|Randomized but not treated|0|||
94649416|NCT04537806|324175195|FG000|Overall Study|Adverse Event|1|||
94649417|NCT04537806|324175196|FG001|Overall Study|Adverse Event|1|||
94649418|NCT00912405|324175197|FG000|Overall Study|Lost to Follow-up|5|||
94649419|NCT01434823|324175198|FG000|Overall Study|Incomplete data in medical record|4|||
94649420|NCT01434823|324175199|FG001|Overall Study|Incomplete data in medical record|7|||
94649421|NCT02477020|324175202|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
94649422|NCT02477020|324175203|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
94649423|NCT02477020|324175202|FG000|Overall Study|Voluntary Withdrawal|7|||
94649424|NCT02477020|324175203|FG001|Overall Study|Voluntary Withdrawal|16|||
94649425|NCT02477020|324175202|FG000|Overall Study|Reason not Specified|3|||
94649426|NCT02477020|324175203|FG001|Overall Study|Reason not Specified|1|||
94649427|NCT02477020|324175202|FG000|Overall Study|Lack of Efficacy|14|||
94649428|NCT02477020|324175203|FG001|Overall Study|Lack of Efficacy|5|||
94649429|NCT02148003|324175207|FG000|Overall Study|Failed inclusion criteria|1|||
94649430|NCT02148003|324175208|FG001|Overall Study|Failed inclusion criteria|0|||
94649431|NCT02148003|324175207|FG000|Overall Study|Met exclusion criteria|0|||
94649432|NCT02148003|324175208|FG001|Overall Study|Met exclusion criteria|1|||
94649433|NCT02148003|324175207|FG000|Overall Study|Withdrawal by Subject|0|||
94649434|NCT02148003|324175208|FG001|Overall Study|Withdrawal by Subject|1|||
94649435|NCT01018264|324175209|FG000|Overall Study|Withdrawal by Subject|1|||
94649436|NCT01018264|324175210|FG001|Overall Study|Withdrawal by Subject|0|||
94649437|NCT01018264|324175209|FG000|Overall Study|Lost to Follow-up|0|||
94649438|NCT01018264|324175210|FG001|Overall Study|Lost to Follow-up|1|||
94649439|NCT01470469|324175213|FG000|Overall Study|Withdrawal by Subject|4|||
94649440|NCT01470469|324175214|FG001|Overall Study|Withdrawal by Subject|6|||
94649441|NCT01470469|324175213|FG000|Overall Study|Lack of Efficacy|1|||
94649442|NCT01470469|324175214|FG001|Overall Study|Lack of Efficacy|7|||
94649443|NCT01470469|324175213|FG000|Overall Study|Adverse Event|0|||
94649444|NCT01470469|324175214|FG001|Overall Study|Adverse Event|7|||
94649445|NCT01470469|324175213|FG000|Overall Study|Lost to Follow-up|2|||
94649446|NCT01470469|324175214|FG001|Overall Study|Lost to Follow-up|2|||
94649447|NCT01470469|324175213|FG000|Overall Study|Protocol Violation|1|||
94649448|NCT01470469|324175214|FG001|Overall Study|Protocol Violation|1|||
94649449|NCT01470469|324175213|FG000|Overall Study|Other|2|||
94649450|NCT01470469|324175214|FG001|Overall Study|Other|1|||
94649451|NCT00482391|324175215|FG000|Overall Study|Withdrawal by Subject|1|||
94649452|NCT00482391|324175215|FG000|Overall Study|Adverse Event|1|||
94649453|NCT00482391|324175215|FG000|Overall Study|Death|1|||
94649454|NCT02075320|324175223|FG000|Overall Study|Withdrawal by Subject|2|||
94649455|NCT01502644|324175224|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
94649456|NCT01502644|324175225|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
94649457|NCT01502644|324175226|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
94649458|NCT01502644|324175227|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
94649459|NCT01502644|324175224|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
94649460|NCT01502644|324175225|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
94649461|NCT01502644|324175226|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
94649462|NCT01502644|324175227|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
94649463|NCT01502644|324175224|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
94649464|NCT01502644|324175225|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
94649465|NCT01502644|324175226|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
94649466|NCT01502644|324175227|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
94649467|NCT01502644|324175224|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
94649468|NCT01502644|324175225|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
94649469|NCT01502644|324175226|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
94649470|NCT01502644|324175227|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
94649471|NCT01502644|324175224|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
94649472|NCT01502644|324175225|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
94649473|NCT01502644|324175226|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
94364147|NCT01915498|323116805|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
94364148|NCT01915498|323116806|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
94364149|NCT01915498|323116807|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
94364150|NCT01915498|323116808|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
94649474|NCT01502644|324175227|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
94649475|NCT02043015|324175228|FG000|Overall Study|Lost to Follow-up|4|||
94649476|NCT02043015|324175228|FG000|Overall Study|Withdrawal by Subject|4|||
94649477|NCT02043015|324175228|FG000|Overall Study|Removed once target enrollment reached|15|||
94649478|NCT02043015|324175228|FG000|Overall Study|Participant moved away from study city|4|||
94649479|NCT02043015|324175228|FG000|Overall Study|Incarceration|1|||
94649480|NCT03194646|324175229|FG000|Overall Study|Adverse Event|24|||
94649481|NCT03194646|324175230|FG001|Overall Study|Adverse Event|25|||
94649482|NCT03194646|324175231|FG002|Overall Study|Adverse Event|14|||
94649483|NCT03194646|324175232|FG003|Overall Study|Adverse Event|17|||
94649484|NCT03194646|324175229|FG000|Overall Study|Lack of Efficacy|4|||
94649485|NCT03194646|324175230|FG001|Overall Study|Lack of Efficacy|2|||
94649486|NCT03194646|324175231|FG002|Overall Study|Lack of Efficacy|2|||
94649487|NCT03194646|324175232|FG003|Overall Study|Lack of Efficacy|12|||
94649488|NCT03194646|324175229|FG000|Overall Study|Lost to Follow-up|30|||
94649489|NCT03194646|324175230|FG001|Overall Study|Lost to Follow-up|22|||
94649490|NCT03194646|324175231|FG002|Overall Study|Lost to Follow-up|12|||
94649491|NCT03194646|324175232|FG003|Overall Study|Lost to Follow-up|35|||
94649492|NCT03194646|324175229|FG000|Overall Study|Non-compliance with study drug|4|||
94649493|NCT03194646|324175230|FG001|Overall Study|Non-compliance with study drug|0|||
94649494|NCT03194646|324175231|FG002|Overall Study|Non-compliance with study drug|1|||
94649495|NCT03194646|324175232|FG003|Overall Study|Non-compliance with study drug|1|||
94649496|NCT03194646|324175229|FG000|Overall Study|Other|89|||
94649497|NCT03194646|324175230|FG001|Overall Study|Other|68|||
94649498|NCT03194646|324175231|FG002|Overall Study|Other|34|||
94649499|NCT03194646|324175232|FG003|Overall Study|Other|31|||
94649500|NCT03194646|324175229|FG000|Overall Study|Physician Decision|7|||
94649501|NCT03194646|324175230|FG001|Overall Study|Physician Decision|9|||
94649502|NCT03194646|324175231|FG002|Overall Study|Physician Decision|5|||
94649503|NCT03194646|324175232|FG003|Overall Study|Physician Decision|4|||
94649504|NCT03194646|324175229|FG000|Overall Study|Pregnancy|4|||
94649505|NCT03194646|324175230|FG001|Overall Study|Pregnancy|5|||
94649506|NCT03194646|324175231|FG002|Overall Study|Pregnancy|1|||
94649507|NCT03194646|324175232|FG003|Overall Study|Pregnancy|2|||
94649508|NCT03194646|324175229|FG000|Overall Study|Protocol Violation|4|||
94649509|NCT03194646|324175230|FG001|Overall Study|Protocol Violation|2|||
94649510|NCT03194646|324175231|FG002|Overall Study|Protocol Violation|1|||
94649511|NCT03194646|324175232|FG003|Overall Study|Protocol Violation|1|||
94649512|NCT03194646|324175229|FG000|Overall Study|Site terminated by sponsor|0|||
94649513|NCT03194646|324175230|FG001|Overall Study|Site terminated by sponsor|0|||
94649514|NCT03194646|324175231|FG002|Overall Study|Site terminated by sponsor|2|||
94649515|NCT03194646|324175232|FG003|Overall Study|Site terminated by sponsor|0|||
94649516|NCT03194646|324175229|FG000|Overall Study|Study terminated by sponsor|62|||
94649517|NCT03194646|324175230|FG001|Overall Study|Study terminated by sponsor|61|||
94649518|NCT03194646|324175231|FG002|Overall Study|Study terminated by sponsor|30|||
94649519|NCT03194646|324175232|FG003|Overall Study|Study terminated by sponsor|34|||
94649520|NCT03194646|324175229|FG000|Overall Study|Withdrawal by Subject|75|||
94649521|NCT03194646|324175230|FG001|Overall Study|Withdrawal by Subject|74|||
94649522|NCT03194646|324175231|FG002|Overall Study|Withdrawal by Subject|36|||
94649523|NCT03194646|324175232|FG003|Overall Study|Withdrawal by Subject|131|||
94649524|NCT03194646|324175229|FG000|Overall Study|Missing|1|||
94649525|NCT03194646|324175230|FG001|Overall Study|Missing|0|||
94649526|NCT03194646|324175231|FG002|Overall Study|Missing|1|||
94649527|NCT03194646|324175232|FG003|Overall Study|Missing|12|||
94649528|NCT00458484|324175235|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
94649529|NCT00458484|324175236|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
94649530|NCT00458484|324175237|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
94649531|NCT00458484|324175238|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
94649532|NCT00458484|324175239|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
94649533|NCT00458484|324175240|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
94649534|NCT00458484|324175241|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
94649535|NCT01541826|324175243|FG000|Overall Study|Lost to Follow-up|2|||
94649536|NCT01541826|324175244|FG001|Overall Study|Lost to Follow-up|3|||
94649537|NCT01541826|324175245|FG002|Overall Study|Lost to Follow-up|0|||
94649538|NCT01541826|324175243|FG000|Overall Study|Withdrawal by Subject|2|||
94649539|NCT01541826|324175244|FG001|Overall Study|Withdrawal by Subject|0|||
94688667|NCT00363896|324315567|FG001|Overall Study|Lost to Follow-up|0|||
94649540|NCT01541826|324175245|FG002|Overall Study|Withdrawal by Subject|0|||
94649541|NCT00854581|324175246|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
94649542|NCT00854581|324175246|FG000|Induction (Up to Day 21)|Death|1|||
94649543|NCT00854581|324175246|FG000|Induction (Up to Day 21)|Physician Decision|1|||
94649544|NCT00854581|324175246|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
94649545|NCT00096044|324175249|FG000|Overall Study|Withdrawal by Subject|9|||
94649546|NCT00096044|324175249|FG000|Overall Study|Adverse Event|21|||
94649547|NCT00096044|324175249|FG000|Overall Study|Disease Progression|4|||
94649548|NCT02318693|324175252|FG000|Overall Study|Protocol Violation|0|||
94649549|NCT02318693|324175253|FG001|Overall Study|Protocol Violation|1|||
94649550|NCT00025883|324175254|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
94649551|NCT00025883|324175254|FG000|Overall Study|no baseline data|1|||
94649552|NCT00025883|324175254|FG000|Overall Study|Death|1|||
94649553|NCT00025883|324175254|FG000|Overall Study|Adverse Event|1|||
94649554|NCT00025883|324175254|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
94649555|NCT01723228|324175257|FG000|Overall Study|Adverse Event|2|||
94649556|NCT01723228|324175258|FG001|Overall Study|Adverse Event|6|||
94649557|NCT01723228|324175257|FG000|Overall Study|Withdrawal by Subject|2|||
94649558|NCT01723228|324175258|FG001|Overall Study|Withdrawal by Subject|1|||
94649559|NCT01723228|324175257|FG000|Overall Study|Protocol Violation|0|||
94649560|NCT01723228|324175258|FG001|Overall Study|Protocol Violation|2|||
94649561|NCT01723228|324175257|FG000|Overall Study|Lost to Follow-up|2|||
94649562|NCT01723228|324175258|FG001|Overall Study|Lost to Follow-up|1|||
94649563|NCT01723228|324175257|FG000|Overall Study|Other|2|||
94649564|NCT01723228|324175258|FG001|Overall Study|Other|1|||
94649565|NCT01864291|324175259|FG000|Overall Study|need for revision surgery|2|||
94649566|NCT02920983|324175260|FG000|Dispense 1|Unacceptable Lens Fit|0|||
94649567|NCT02920983|324175261|FG001|Dispense 1|Unacceptable Lens Fit|0|||
94649568|NCT02920983|324175262|FG002|Dispense 1|Unacceptable Lens Fit|0|||
94649569|NCT02920983|324175263|FG003|Dispense 1|Unacceptable Lens Fit|0|||
94649570|NCT02920983|324175264|FG004|Dispense 1|Unacceptable Lens Fit|1|||
94649571|NCT02920983|324175265|FG005|Dispense 1|Unacceptable Lens Fit|0|||
94649572|NCT02920983|324175260|FG000|Dispense 2|Unscceptable lens fit|1|||
94649573|NCT02920983|324175261|FG001|Dispense 2|Unscceptable lens fit|0|||
94649574|NCT02920983|324175262|FG002|Dispense 2|Unscceptable lens fit|0|||
94649575|NCT02920983|324175263|FG003|Dispense 2|Unscceptable lens fit|0|||
94649576|NCT02920983|324175264|FG004|Dispense 2|Unscceptable lens fit|1|||
94649577|NCT02920983|324175265|FG005|Dispense 2|Unscceptable lens fit|0|||
94649578|NCT02920983|324175260|FG000|Dispense 3|Unacceptable Lens Fit|1|||
94649579|NCT02920983|324175261|FG001|Dispense 3|Unacceptable Lens Fit|1|||
94649580|NCT02920983|324175262|FG002|Dispense 3|Unacceptable Lens Fit|0|||
94649581|NCT02920983|324175263|FG003|Dispense 3|Unacceptable Lens Fit|0|||
94649582|NCT02920983|324175264|FG004|Dispense 3|Unacceptable Lens Fit|1|||
94649583|NCT02920983|324175265|FG005|Dispense 3|Unacceptable Lens Fit|0|||
94649584|NCT02696096|324175268|FG000|Overall Study|ruled out at screening|1|||
94649585|NCT02696096|324175268|FG000|Overall Study|did not attend second fMRI|1|||
94649586|NCT02047604|324175271|FG000|Overall Study|Withdrawal by Subject|0|||
94649587|NCT02047604|324175272|FG001|Overall Study|Withdrawal by Subject|0|||
94649588|NCT02047604|324175273|FG002|Overall Study|Withdrawal by Subject|0|||
94649589|NCT02047604|324175274|FG003|Overall Study|Withdrawal by Subject|0|||
94649590|NCT02047604|324175275|FG004|Overall Study|Withdrawal by Subject|1|||
94649591|NCT02047604|324175276|FG005|Overall Study|Withdrawal by Subject|1|||
94649592|NCT03337724|324175279|FG000|Overall Study|Reason not Specified|12|||
94649593|NCT03337724|324175280|FG001|Overall Study|Reason not Specified|21|||
94649594|NCT03337724|324175281|FG002|Overall Study|Reason not Specified|9|||
94649595|NCT03337724|324175282|FG003|Overall Study|Reason not Specified|9|||
94649596|NCT03337724|324175283|FG004|Overall Study|Reason not Specified|29|||
94649597|NCT03337724|324175279|FG000|Overall Study|Withdrawal by Subject|13|||
94649598|NCT03337724|324175280|FG001|Overall Study|Withdrawal by Subject|15|||
94649599|NCT03337724|324175281|FG002|Overall Study|Withdrawal by Subject|4|||
94649600|NCT03337724|324175282|FG003|Overall Study|Withdrawal by Subject|15|||
94649601|NCT03337724|324175283|FG004|Overall Study|Withdrawal by Subject|6|||
94649602|NCT03337724|324175279|FG000|Overall Study|Protocol Deviation|0|||
94649603|NCT03337724|324175280|FG001|Overall Study|Protocol Deviation|1|||
94649604|NCT03337724|324175281|FG002|Overall Study|Protocol Deviation|1|||
94649605|NCT03337724|324175282|FG003|Overall Study|Protocol Deviation|1|||
94649606|NCT03337724|324175283|FG004|Overall Study|Protocol Deviation|0|||
94649607|NCT03337724|324175279|FG000|Overall Study|Adverse Event|1|||
94364151|NCT01915498|323116809|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
94649608|NCT03337724|324175280|FG001|Overall Study|Adverse Event|1|||
94649609|NCT03337724|324175281|FG002|Overall Study|Adverse Event|0|||
94649610|NCT03337724|324175282|FG003|Overall Study|Adverse Event|1|||
94649611|NCT03337724|324175283|FG004|Overall Study|Adverse Event|0|||
94649612|NCT03337724|324175279|FG000|Overall Study|Death|40|||
94649613|NCT03337724|324175280|FG001|Overall Study|Death|89|||
94649614|NCT03337724|324175281|FG002|Overall Study|Death|43|||
94364152|NCT01915498|323116810|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
94649615|NCT03337724|324175282|FG003|Overall Study|Death|76|||
94686177|NCT01108510|324305567|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
94649616|NCT03337724|324175283|FG004|Overall Study|Death|50|||
94649617|NCT03337724|324175279|FG000|Overall Study|Lost to Follow-up|5|||
94649618|NCT03337724|324175280|FG001|Overall Study|Lost to Follow-up|5|||
94649619|NCT03337724|324175281|FG002|Overall Study|Lost to Follow-up|4|||
94649620|NCT03337724|324175282|FG003|Overall Study|Lost to Follow-up|7|||
94649621|NCT03337724|324175283|FG004|Overall Study|Lost to Follow-up|4|||
94686178|NCT01108510|324305568|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
94686179|NCT01108510|324305567|FG000|Overall Study|Adverse Event|26|||
94686180|NCT01108510|324305568|FG001|Overall Study|Adverse Event|19|||
94686181|NCT01108510|324305567|FG000|Overall Study|Lost to Follow-up|20|||
94686182|NCT01108510|324305568|FG001|Overall Study|Lost to Follow-up|17|||
94686183|NCT01108510|324305567|FG000|Overall Study|Withdrew Consent|21|||
94686184|NCT01108510|324305568|FG001|Overall Study|Withdrew Consent|15|||
94686185|NCT01108510|324305567|FG000|Overall Study|Investigator's Discretion|12|||
94686186|NCT01108510|324305568|FG001|Overall Study|Investigator's Discretion|10|||
94686187|NCT01108510|324305567|FG000|Overall Study|Participant Noncompliance|5|||
94686188|NCT01108510|324305568|FG001|Overall Study|Participant Noncompliance|7|||
94686189|NCT01108510|324305567|FG000|Overall Study|Lack of Efficacy|3|||
94686190|NCT01108510|324305568|FG001|Overall Study|Lack of Efficacy|0|||
94686191|NCT01108510|324305567|FG000|Overall Study|Pregnancy|0|||
94686192|NCT01108510|324305568|FG001|Overall Study|Pregnancy|3|||
94686193|NCT01108510|324305567|FG000|Overall Study|Death|1|||
94686194|NCT01108510|324305568|FG001|Overall Study|Death|1|||
94686195|NCT03853317|324305569|FG000|Overall Study|Progressive Disease|5|||
94686196|NCT03853317|324305569|FG000|Overall Study|Adverse Event|1|||
94686197|NCT03853317|324305569|FG000|Overall Study|Death|1|||
94686198|NCT03853317|324305569|FG000|Overall Study|other event|2|||
94686199|NCT01290822|324305570|FG000|Overall Study|Withdrawal by Subject|1|||
94686200|NCT01290822|324305570|FG000|Overall Study|Physician Decision|10|||
94686201|NCT00785538|324305571|FG000|Treatment Period|Adverse Event|1|||
94686202|NCT00785538|324305572|FG001|Treatment Period|Adverse Event|2|||
94686203|NCT00785538|324305573|FG002|Treatment Period|Adverse Event|2|||
94686204|NCT00785538|324305574|FG003|Treatment Period|Adverse Event|0|||
94686205|NCT00785538|324305571|FG000|Treatment Period|Withdrawal by Subject|0|||
94686206|NCT00785538|324305572|FG001|Treatment Period|Withdrawal by Subject|0|||
94686207|NCT00785538|324305573|FG002|Treatment Period|Withdrawal by Subject|0|||
94686208|NCT00785538|324305574|FG003|Treatment Period|Withdrawal by Subject|1|||
94686209|NCT02302066|324305581|FG000|Overall Study|Adverse Event|1|||
94686210|NCT02302066|324305582|FG001|Overall Study|Adverse Event|1|||
94686211|NCT02302066|324305583|FG002|Overall Study|Adverse Event|3|||
94686212|NCT02302066|324305584|FG003|Overall Study|Adverse Event|0|||
94686213|NCT02302066|324305581|FG000|Overall Study|Lost to Follow-up|4|||
94686214|NCT02302066|324305582|FG001|Overall Study|Lost to Follow-up|5|||
94686215|NCT02302066|324305583|FG002|Overall Study|Lost to Follow-up|24|||
94686216|NCT02302066|324305584|FG003|Overall Study|Lost to Follow-up|7|||
94686217|NCT02302066|324305581|FG000|Overall Study|Withdrawal by Subject|25|||
94686218|NCT02302066|324305582|FG001|Overall Study|Withdrawal by Subject|58|||
94686219|NCT02302066|324305583|FG002|Overall Study|Withdrawal by Subject|124|||
94686220|NCT02302066|324305584|FG003|Overall Study|Withdrawal by Subject|33|||
94686221|NCT02302066|324305581|FG000|Overall Study|Pregnancy|2|||
94686222|NCT02302066|324305582|FG001|Overall Study|Pregnancy|10|||
94686223|NCT02302066|324305583|FG002|Overall Study|Pregnancy|12|||
94686224|NCT02302066|324305584|FG003|Overall Study|Pregnancy|0|||
94686225|NCT02302066|324305581|FG000|Overall Study|Reason Not Specified|1|||
94686226|NCT02302066|324305582|FG001|Overall Study|Reason Not Specified|1|||
94686227|NCT02302066|324305583|FG002|Overall Study|Reason Not Specified|9|||
94686228|NCT02302066|324305584|FG003|Overall Study|Reason Not Specified|1|||
94686229|NCT02180438|324305585|FG000|Overall Study|Lost to Follow-up|1|||
94686230|NCT00926003|324305586|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
94686231|NCT00926003|324305587|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
94686232|NCT00926003|324305588|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
94686233|NCT00926003|324305586|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
94686234|NCT00926003|324305587|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
94686235|NCT00926003|324305588|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
94686236|NCT01871558|324305590|FG000|Overall Study|Other reason|0|||
94686237|NCT01871558|324305591|FG001|Overall Study|Other reason|1|||
94686238|NCT01871558|324305590|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
94686239|NCT01871558|324305591|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
94686240|NCT01871558|324305590|FG000|Overall Study|Withdrawal by Subject|2|||
94463512|NCT00084318|323485085|FG000|Overall Study|Withdrawal by Subject|5|||
94686241|NCT01871558|324305591|FG001|Overall Study|Withdrawal by Subject|0|||
94686242|NCT02736968|324305597|FG000|Overall Study|Lost to Follow-up|0|||
94686243|NCT02736968|324305598|FG001|Overall Study|Lost to Follow-up|0|||
94686244|NCT02736968|324305599|FG002|Overall Study|Lost to Follow-up|0|||
94686245|NCT02736968|324305600|FG003|Overall Study|Lost to Follow-up|0|||
94686246|NCT02736968|324305601|FG004|Overall Study|Lost to Follow-up|0|||
94686247|NCT02736968|324305602|FG005|Overall Study|Lost to Follow-up|0|||
94686248|NCT02736968|324305603|FG006|Overall Study|Lost to Follow-up|5|||
94686249|NCT02736968|324305604|FG007|Overall Study|Lost to Follow-up|2|||
94686250|NCT02736968|324305597|FG000|Overall Study|COVID-19 Pandemic|0|||
94686251|NCT02736968|324305598|FG001|Overall Study|COVID-19 Pandemic|0|||
94686252|NCT02736968|324305599|FG002|Overall Study|COVID-19 Pandemic|0|||
94649622|NCT03337724|324175279|FG000|Overall Study|Physician Decision|16|||
94649623|NCT03337724|324175280|FG001|Overall Study|Physician Decision|34|||
94649624|NCT03337724|324175281|FG002|Overall Study|Physician Decision|14|||
94649625|NCT03337724|324175282|FG003|Overall Study|Physician Decision|34|||
94649626|NCT03337724|324175283|FG004|Overall Study|Physician Decision|13|||
94649627|NCT03337724|324175279|FG000|Overall Study|Progressive Disease|0|||
94649628|NCT03337724|324175280|FG001|Overall Study|Progressive Disease|2|||
94649629|NCT03337724|324175281|FG002|Overall Study|Progressive Disease|1|||
94649630|NCT03337724|324175282|FG003|Overall Study|Progressive Disease|2|||
94649631|NCT03337724|324175283|FG004|Overall Study|Progressive Disease|0|||
94649632|NCT03337724|324175279|FG000|Overall Study|Symptomatic Deterioration|0|||
94649633|NCT03337724|324175280|FG001|Overall Study|Symptomatic Deterioration|0|||
94649634|NCT03337724|324175281|FG002|Overall Study|Symptomatic Deterioration|0|||
94649635|NCT03337724|324175282|FG003|Overall Study|Symptomatic Deterioration|1|||
94649636|NCT03337724|324175283|FG004|Overall Study|Symptomatic Deterioration|0|||
94649637|NCT02707640|324175290|FG000|Overall Study|Adverse Event|4|||
94649638|NCT02707640|324175291|FG001|Overall Study|Adverse Event|2|||
94649639|NCT02707640|324175290|FG000|Overall Study|Death|1|||
94649640|NCT02707640|324175291|FG001|Overall Study|Death|2|||
94649641|NCT02707640|324175290|FG000|Overall Study|Physician Decision|2|||
94649642|NCT02707640|324175291|FG001|Overall Study|Physician Decision|0|||
94649643|NCT02707640|324175290|FG000|Overall Study|Withdrawal by Subject|0|||
94649644|NCT02707640|324175291|FG001|Overall Study|Withdrawal by Subject|1|||
94649645|NCT02707640|324175290|FG000|Overall Study|Participant's Personal Decision|1|||
94649646|NCT02707640|324175291|FG001|Overall Study|Participant's Personal Decision|2|||
94649647|NCT02707640|324175290|FG000|Overall Study|Sponsor Discretion|1|||
94649648|NCT02707640|324175291|FG001|Overall Study|Sponsor Discretion|0|||
94649649|NCT02517905|324175292|FG000|Overall Study|Lost to Follow-up|4|||
94649650|NCT02517905|324175293|FG001|Overall Study|Lost to Follow-up|0|||
94649651|NCT02517905|324175292|FG000|Overall Study|Withdrawal by Subject|4|||
94649652|NCT02517905|324175293|FG001|Overall Study|Withdrawal by Subject|0|||
94649653|NCT02517905|324175292|FG000|Overall Study|Screen failure|2|||
94649654|NCT02517905|324175293|FG001|Overall Study|Screen failure|2|||
94649655|NCT01755416|324175297|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
94649656|NCT01755416|324175298|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
94649657|NCT01660412|324175299|FG000|Overall Study|Protocol Violation|0|||
94649658|NCT01660412|324175300|FG001|Overall Study|Protocol Violation|3|||
94649659|NCT03265119|324175301|FG000|Overall Study|Adverse Event|2|||
94649660|NCT03265119|324175302|FG001|Overall Study|Adverse Event|1|||
94649661|NCT03265119|324175301|FG000|Overall Study|Lack of Efficacy|3|||
94649662|NCT03265119|324175302|FG001|Overall Study|Lack of Efficacy|0|||
94649663|NCT03265119|324175301|FG000|Overall Study|Protocol Violation|1|||
94649664|NCT03265119|324175302|FG001|Overall Study|Protocol Violation|2|||
94649665|NCT03265119|324175301|FG000|Overall Study|Withdrawal by Subject|2|||
94649666|NCT03265119|324175302|FG001|Overall Study|Withdrawal by Subject|4|||
94649667|NCT03265119|324175301|FG000|Overall Study|Lost to Follow-up|1|||
94649668|NCT03265119|324175302|FG001|Overall Study|Lost to Follow-up|0|||
94649669|NCT03265119|324175301|FG000|Overall Study|Lack of Compliance|1|||
94649670|NCT03265119|324175302|FG001|Overall Study|Lack of Compliance|0|||
94649671|NCT03370341|324176920|FG000|Overall Study|Lost to Follow-up|0|||
94649672|NCT03370341|324176921|FG001|Overall Study|Lost to Follow-up|1|||
94649673|NCT01581593|324176922|FG000|Overall Study|Withdrawal by Subject|1|||
94649674|NCT00298896|324176923|FG000|Overall Study|Death|3|||
94649675|NCT00298896|324176923|FG000|Overall Study|Physician Decision|2|||
94649676|NCT00298896|324176923|FG000|Overall Study|Intercurrent Illness|1|||
94649677|NCT00298896|324176923|FG000|Overall Study|Disease Progression|41|||
94649678|NCT00298896|324176923|FG000|Overall Study|Withdrawal by Subject|2|||
94649679|NCT00298896|324176923|FG000|Overall Study|Assigned to treatment in error|1|||
94649680|NCT01440322|324176924|FG000|Overall Study|Discomfort|2|||
94649681|NCT01440322|324176925|FG001|Overall Study|Discomfort|0|||
94649682|NCT01440322|324176924|FG000|Overall Study|Biomicroscopy|1|||
94649683|NCT01440322|324176925|FG001|Overall Study|Biomicroscopy|0|||
94649684|NCT01440322|324176924|FG000|Overall Study|Symptoms and Problems|1|||
94649685|NCT01440322|324176925|FG001|Overall Study|Symptoms and Problems|0|||
94649686|NCT01440322|324176924|FG000|Overall Study|Unacceptable Subjective Vision|1|||
94649687|NCT01440322|324176925|FG001|Overall Study|Unacceptable Subjective Vision|0|||
94649688|NCT01440322|324176924|FG000|Overall Study|Other Product Related|1|||
94649689|NCT01440322|324176925|FG001|Overall Study|Other Product Related|0|||
94649690|NCT01440322|324176924|FG000|Overall Study|Unrelated Medical Problem|0|||
94649691|NCT01440322|324176925|FG001|Overall Study|Unrelated Medical Problem|1|||
94649692|NCT01440322|324176924|FG000|Overall Study|Other Non-Product Related|1|||
94649693|NCT01440322|324176925|FG001|Overall Study|Other Non-Product Related|0|||
94649694|NCT01340976|324176929|FG000|Overall Study|Physician Decision|2|||
94649695|NCT01340976|324176930|FG001|Overall Study|Physician Decision|0|||
94649696|NCT01340976|324176931|FG002|Overall Study|Physician Decision|1|||
94649697|NCT01340976|324176932|FG003|Overall Study|Physician Decision|1|||
94649698|NCT01340976|324176933|FG004|Overall Study|Physician Decision|1|||
94649699|NCT01340976|324176934|FG005|Overall Study|Physician Decision|0|||
94649700|NCT01340976|324176929|FG000|Overall Study|Death|0|||
94649701|NCT01340976|324176930|FG001|Overall Study|Death|1|||
94649702|NCT01340976|324176931|FG002|Overall Study|Death|0|||
94649703|NCT01340976|324176932|FG003|Overall Study|Death|0|||
94649704|NCT01340976|324176933|FG004|Overall Study|Death|0|||
94649705|NCT01340976|324176934|FG005|Overall Study|Death|0|||
94649706|NCT01340976|324176929|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
94649707|NCT01340976|324176930|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
94649708|NCT01340976|324176931|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
94649709|NCT01340976|324176932|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
94649710|NCT01340976|324176933|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
94649711|NCT01340976|324176934|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
94649712|NCT01340976|324176929|FG000|Overall Study|Withdrawal by Subject|0|||
94649713|NCT01340976|324176930|FG001|Overall Study|Withdrawal by Subject|0|||
94649714|NCT01340976|324176931|FG002|Overall Study|Withdrawal by Subject|0|||
94649715|NCT01340976|324176932|FG003|Overall Study|Withdrawal by Subject|1|||
94649716|NCT01340976|324176933|FG004|Overall Study|Withdrawal by Subject|1|||
94649717|NCT01340976|324176934|FG005|Overall Study|Withdrawal by Subject|0|||
94649718|NCT01340976|324176929|FG000|Overall Study|Other anemia treatment|1|||
94649719|NCT01340976|324176930|FG001|Overall Study|Other anemia treatment|0|||
94649720|NCT01340976|324176931|FG002|Overall Study|Other anemia treatment|2|||
94649721|NCT01340976|324176932|FG003|Overall Study|Other anemia treatment|1|||
94649722|NCT01340976|324176933|FG004|Overall Study|Other anemia treatment|0|||
94649723|NCT01340976|324176934|FG005|Overall Study|Other anemia treatment|1|||
94649724|NCT01340976|324176929|FG000|Overall Study|Adverse Event|0|||
94649725|NCT01340976|324176930|FG001|Overall Study|Adverse Event|1|||
94649726|NCT01340976|324176931|FG002|Overall Study|Adverse Event|0|||
94649727|NCT01340976|324176932|FG003|Overall Study|Adverse Event|0|||
94649728|NCT01340976|324176933|FG004|Overall Study|Adverse Event|0|||
94649729|NCT01340976|324176934|FG005|Overall Study|Adverse Event|0|||
94649730|NCT03670810|324176937|FG000|Main Study|Adverse Event|37|||
94649731|NCT03670810|324176938|FG001|Main Study|Adverse Event|38|||
94649732|NCT03670810|324176939|FG002|Main Study|Adverse Event|3|||
94649733|NCT03670810|324176940|FG003|Main Study|Adverse Event|4|||
94649734|NCT03670810|324176941|FG004|Main Study|Adverse Event|4|||
94649735|NCT03670810|324176942|FG005|Main Study|Adverse Event|5|||
94649736|NCT03670810|324176943|FG006|Main Study|Adverse Event|0|||
94649737|NCT03670810|324176944|FG007|Main Study|Adverse Event|0|||
94649738|NCT03670810|324176945|FG008|Main Study|Adverse Event|0|||
94649739|NCT03670810|324176937|FG000|Main Study|Lack of Efficacy|8|||
94649740|NCT03670810|324176938|FG001|Main Study|Lack of Efficacy|9|||
94649741|NCT03670810|324176939|FG002|Main Study|Lack of Efficacy|3|||
94649742|NCT03670810|324176940|FG003|Main Study|Lack of Efficacy|4|||
94649743|NCT03670810|324176941|FG004|Main Study|Lack of Efficacy|0|||
94649744|NCT03670810|324176942|FG005|Main Study|Lack of Efficacy|0|||
94649745|NCT03670810|324176943|FG006|Main Study|Lack of Efficacy|0|||
94649746|NCT03670810|324176944|FG007|Main Study|Lack of Efficacy|0|||
94649747|NCT03670810|324176945|FG008|Main Study|Lack of Efficacy|0|||
94649748|NCT03670810|324176937|FG000|Main Study|Lost to Follow-up|9|||
94649749|NCT03670810|324176938|FG001|Main Study|Lost to Follow-up|7|||
94649750|NCT03670810|324176939|FG002|Main Study|Lost to Follow-up|4|||
94649751|NCT03670810|324176940|FG003|Main Study|Lost to Follow-up|6|||
94649752|NCT03670810|324176941|FG004|Main Study|Lost to Follow-up|1|||
94649753|NCT03670810|324176942|FG005|Main Study|Lost to Follow-up|0|||
94649754|NCT03670810|324176943|FG006|Main Study|Lost to Follow-up|0|||
94649755|NCT03670810|324176944|FG007|Main Study|Lost to Follow-up|0|||
94649756|NCT03670810|324176945|FG008|Main Study|Lost to Follow-up|0|||
94649757|NCT03670810|324176937|FG000|Main Study|Non-compliance with Study Drug|0|||
94649758|NCT03670810|324176938|FG001|Main Study|Non-compliance with Study Drug|2|||
94649759|NCT03670810|324176939|FG002|Main Study|Non-compliance with Study Drug|3|||
94649760|NCT03670810|324176940|FG003|Main Study|Non-compliance with Study Drug|0|||
94649761|NCT03670810|324176941|FG004|Main Study|Non-compliance with Study Drug|0|||
94649762|NCT03670810|324176942|FG005|Main Study|Non-compliance with Study Drug|0|||
94649763|NCT03670810|324176943|FG006|Main Study|Non-compliance with Study Drug|0|||
94649764|NCT03670810|324176944|FG007|Main Study|Non-compliance with Study Drug|1|||
94649765|NCT03670810|324176945|FG008|Main Study|Non-compliance with Study Drug|0|||
94649766|NCT03670810|324176937|FG000|Main Study|Physician Decision|3|||
94649767|NCT03670810|324176938|FG001|Main Study|Physician Decision|0|||
94649768|NCT03670810|324176939|FG002|Main Study|Physician Decision|1|||
94649769|NCT03670810|324176940|FG003|Main Study|Physician Decision|0|||
94649770|NCT03670810|324176941|FG004|Main Study|Physician Decision|0|||
94649771|NCT03670810|324176942|FG005|Main Study|Physician Decision|0|||
94649772|NCT03670810|324176943|FG006|Main Study|Physician Decision|1|||
94649773|NCT03670810|324176944|FG007|Main Study|Physician Decision|1|||
94649774|NCT03670810|324176945|FG008|Main Study|Physician Decision|0|||
94649775|NCT03670810|324176937|FG000|Main Study|Pregnancy|1|||
94686253|NCT02736968|324305600|FG003|Overall Study|COVID-19 Pandemic|0|||
94686254|NCT02736968|324305601|FG004|Overall Study|COVID-19 Pandemic|0|||
94686255|NCT02736968|324305602|FG005|Overall Study|COVID-19 Pandemic|0|||
94686256|NCT02736968|324305603|FG006|Overall Study|COVID-19 Pandemic|2|||
94686257|NCT02736968|324305604|FG007|Overall Study|COVID-19 Pandemic|0|||
94686258|NCT02736968|324305597|FG000|Overall Study|Withdrawal by Subject|0|||
94686259|NCT02736968|324305598|FG001|Overall Study|Withdrawal by Subject|0|||
94686260|NCT02736968|324305599|FG002|Overall Study|Withdrawal by Subject|0|||
94686261|NCT02736968|324305600|FG003|Overall Study|Withdrawal by Subject|0|||
94686262|NCT02736968|324305601|FG004|Overall Study|Withdrawal by Subject|0|||
94686263|NCT02736968|324305602|FG005|Overall Study|Withdrawal by Subject|0|||
94686264|NCT02736968|324305603|FG006|Overall Study|Withdrawal by Subject|1|||
94686265|NCT02736968|324305604|FG007|Overall Study|Withdrawal by Subject|0|||
94686266|NCT00147225|324305607|FG000|Overall Study|Withdrawal by Subject|1|||
94686267|NCT00147225|324305608|FG001|Overall Study|Withdrawal by Subject|0|||
94686268|NCT00147225|324305609|FG002|Overall Study|Withdrawal by Subject|1|||
94686269|NCT00147225|324305610|FG003|Overall Study|Withdrawal by Subject|0|||
94686270|NCT00147225|324305611|FG004|Overall Study|Withdrawal by Subject|0|||
94686271|NCT00147225|324305612|FG005|Overall Study|Withdrawal by Subject|1|||
94686272|NCT00147225|324305607|FG000|Overall Study|Adverse Event|0|||
94686273|NCT00147225|324305608|FG001|Overall Study|Adverse Event|0|||
94686274|NCT00147225|324305609|FG002|Overall Study|Adverse Event|1|||
94686275|NCT00147225|324305610|FG003|Overall Study|Adverse Event|1|||
94686276|NCT00147225|324305611|FG004|Overall Study|Adverse Event|0|||
94686277|NCT00147225|324305612|FG005|Overall Study|Adverse Event|0|||
94686278|NCT00147225|324305607|FG000|Overall Study|Screen Failure|0|||
94686279|NCT00147225|324305608|FG001|Overall Study|Screen Failure|0|||
94686280|NCT00147225|324305609|FG002|Overall Study|Screen Failure|0|||
94686281|NCT00147225|324305610|FG003|Overall Study|Screen Failure|0|||
94686282|NCT00147225|324305611|FG004|Overall Study|Screen Failure|1|||
94686283|NCT00147225|324305612|FG005|Overall Study|Screen Failure|0|||
94686284|NCT00147225|324305607|FG000|Overall Study|Chemotherapy Changed|0|||
94686285|NCT00147225|324305608|FG001|Overall Study|Chemotherapy Changed|0|||
94686286|NCT00147225|324305609|FG002|Overall Study|Chemotherapy Changed|0|||
94686287|NCT00147225|324305610|FG003|Overall Study|Chemotherapy Changed|0|||
94686288|NCT00147225|324305611|FG004|Overall Study|Chemotherapy Changed|0|||
94686289|NCT00147225|324305612|FG005|Overall Study|Chemotherapy Changed|1|||
94686290|NCT01032044|324305613|FG000|Overall Study|Protocol Violation|14|||
94686291|NCT01032044|324305614|FG001|Overall Study|Protocol Violation|8|||
94686292|NCT01032044|324305613|FG000|Overall Study|Adverse Event|0|||
94686293|NCT01032044|324305614|FG001|Overall Study|Adverse Event|1|||
94686294|NCT01032044|324305613|FG000|Overall Study|Lost to Follow-up|11|||
94686295|NCT01032044|324305614|FG001|Overall Study|Lost to Follow-up|11|||
94686296|NCT02875834|324305617|FG000|Open-label Phase|Withdrawal by Subject|3|||
94686297|NCT02875834|324305618|FG001|Open-label Phase|Withdrawal by Subject|0|||
94686298|NCT02875834|324305619|FG002|Open-label Phase|Withdrawal by Subject|0|||
94686299|NCT02875834|324305620|FG003|Open-label Phase|Withdrawal by Subject|0|||
94686300|NCT02875834|324305617|FG000|Open-label Phase|(Not collected)|4|||
94686301|NCT02875834|324305618|FG001|Open-label Phase|(Not collected)|0|||
94686302|NCT02875834|324305619|FG002|Open-label Phase|(Not collected)|0|||
94686303|NCT02875834|324305620|FG003|Open-label Phase|(Not collected)|0|||
94686304|NCT02875834|324305617|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
94686305|NCT02875834|324305618|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
94686306|NCT02875834|324305619|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
94686307|NCT02875834|324305620|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
94686308|NCT02875834|324305617|FG000|Randomized Treatment Phase|Protocol Violation|0|||
94686309|NCT02875834|324305618|FG001|Randomized Treatment Phase|Protocol Violation|2|||
94686310|NCT02875834|324305619|FG002|Randomized Treatment Phase|Protocol Violation|0|||
94686311|NCT02875834|324305620|FG003|Randomized Treatment Phase|Protocol Violation|0|||
94686312|NCT02875834|324305617|FG000|Randomized Treatment Phase|(Not collected)|0|||
94686313|NCT02875834|324305618|FG001|Randomized Treatment Phase|(Not collected)|9|||
94686314|NCT02875834|324305619|FG002|Randomized Treatment Phase|(Not collected)|10|||
94686315|NCT02875834|324305620|FG003|Randomized Treatment Phase|(Not collected)|9|||
94686316|NCT03342053|324305621|FG000|Overall Study|Adverse Event|2|||
94686317|NCT03342053|324305622|FG001|Overall Study|Adverse Event|0|||
94686318|NCT03342053|324305621|FG000|Overall Study|Withdrawal by Subject|0|||
94686319|NCT03342053|324305622|FG001|Overall Study|Withdrawal by Subject|1|||
94686320|NCT03872388|324305626|FG000|Overall Study|Disease Progression|0|||
94686321|NCT03872388|324305627|FG001|Overall Study|Disease Progression|0|||
94686322|NCT03872388|324305628|FG002|Overall Study|Disease Progression|0|||
94686323|NCT03872388|324305629|FG003|Overall Study|Disease Progression|0|||
94686324|NCT03872388|324305630|FG004|Overall Study|Disease Progression|0|||
94686325|NCT03872388|324305631|FG005|Overall Study|Disease Progression|0|||
94686326|NCT03872388|324305632|FG006|Overall Study|Disease Progression|1|||
94686327|NCT03872388|324305633|FG007|Overall Study|Disease Progression|1|||
94686328|NCT02601937|324305634|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
94686329|NCT02601937|324305635|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
94686330|NCT02601937|324305636|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
94686331|NCT02601937|324305637|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
94686332|NCT02601937|324305638|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
94686333|NCT02601937|324305639|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
94686334|NCT02601937|324305640|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
94686335|NCT02601937|324305641|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
94686336|NCT02601937|324305642|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
94686337|NCT02601937|324305643|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
94686338|NCT02601937|324305644|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
94686339|NCT02601937|324305634|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
94686340|NCT02601937|324305635|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
94686341|NCT02601937|324305636|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
94686342|NCT02601937|324305637|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
94686343|NCT02601937|324305638|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
94686344|NCT02601937|324305639|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
94686345|NCT02601937|324305640|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
94686346|NCT02601937|324305641|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
94686347|NCT02601937|324305642|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
94686348|NCT02601937|324305643|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
94686349|NCT02601937|324305644|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
94686350|NCT02601937|324305634|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
94686351|NCT02601937|324305635|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
94686352|NCT02601937|324305636|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
94686353|NCT02601937|324305637|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
94686354|NCT02601937|324305638|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
94686355|NCT02601937|324305639|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
94686356|NCT02601937|324305640|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
94686357|NCT02601937|324305641|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
94686358|NCT02601937|324305642|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
94686359|NCT02601937|324305643|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
94686360|NCT02601937|324305644|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
94686361|NCT02601937|324305634|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
94686362|NCT02601937|324305635|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
94686363|NCT02601937|324305636|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
94686364|NCT02601937|324305637|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
94686365|NCT02601937|324305638|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
94686366|NCT02601937|324305639|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
94686367|NCT02601937|324305640|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
94686368|NCT02601937|324305641|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
94686369|NCT02601937|324305642|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
94686370|NCT02601937|324305643|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
94686371|NCT02601937|324305644|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
94686372|NCT02601937|324305634|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
94686373|NCT02601937|324305635|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
94686374|NCT02601937|324305636|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
94686375|NCT02601937|324305637|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
94686376|NCT02601937|324305638|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
94686377|NCT02601937|324305639|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
94686378|NCT02601937|324305640|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
94686379|NCT02601937|324305641|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
94686380|NCT02601937|324305642|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
94686381|NCT02601937|324305643|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
94686382|NCT02601937|324305644|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
94686383|NCT02601937|324305634|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
94686384|NCT02601937|324305635|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
94686385|NCT02601937|324305636|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
94686386|NCT02601937|324305637|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
94686387|NCT02601937|324305638|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
94686388|NCT02601937|324305639|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
94686389|NCT02601937|324305640|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
94686390|NCT02601937|324305641|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
94686391|NCT02601937|324305642|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
94263867|NCT02733185|322759963|FG003|Overall Study|Withdrawal by Subject|21|||
94686392|NCT02601937|324305643|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
94686393|NCT02601937|324305644|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
94686394|NCT02601937|324305634|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
94686395|NCT02601937|324305635|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
94686396|NCT02601937|324305636|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
94686397|NCT02601937|324305637|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
94686398|NCT02601937|324305638|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
94686399|NCT02601937|324305639|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
94686400|NCT02601937|324305640|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
94686401|NCT02601937|324305641|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
94686402|NCT02601937|324305642|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
94686403|NCT02601937|324305643|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
94686404|NCT02601937|324305644|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
94686405|NCT02601937|324305634|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
94686406|NCT02601937|324305635|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
94686407|NCT02601937|324305636|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
94686408|NCT02601937|324305637|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
94686409|NCT02601937|324305638|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
94686410|NCT02601937|324305639|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
94686411|NCT02601937|324305640|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
94686412|NCT02601937|324305641|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
94686413|NCT02601937|324305642|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
94686414|NCT02601937|324305643|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
94686415|NCT02601937|324305644|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
94686416|NCT02601937|324305634|FG000|Period 2: Dose Expansion Cohort|Other|0|||
94686417|NCT02601937|324305635|FG001|Period 2: Dose Expansion Cohort|Other|0|||
94686418|NCT02601937|324305636|FG002|Period 2: Dose Expansion Cohort|Other|0|||
94686419|NCT02601937|324305637|FG003|Period 2: Dose Expansion Cohort|Other|0|||
94686420|NCT02601937|324305638|FG004|Period 2: Dose Expansion Cohort|Other|0|||
94686421|NCT02601937|324305639|FG005|Period 2: Dose Expansion Cohort|Other|0|||
94686422|NCT02601937|324305640|FG006|Period 2: Dose Expansion Cohort|Other|0|||
94686423|NCT02601937|324305641|FG007|Period 2: Dose Expansion Cohort|Other|0|||
94686424|NCT02601937|324305642|FG008|Period 2: Dose Expansion Cohort|Other|2|||
94686425|NCT02601937|324305643|FG009|Period 2: Dose Expansion Cohort|Other|2|||
94686426|NCT02601937|324305644|FG010|Period 2: Dose Expansion Cohort|Other|0|||
94686427|NCT02601937|324305634|FG000|Period 2: Dose Expansion Cohort|Death|0|||
94686428|NCT02601937|324305635|FG001|Period 2: Dose Expansion Cohort|Death|0|||
94686429|NCT02601937|324305636|FG002|Period 2: Dose Expansion Cohort|Death|0|||
94686430|NCT02601937|324305637|FG003|Period 2: Dose Expansion Cohort|Death|0|||
94686431|NCT02601937|324305638|FG004|Period 2: Dose Expansion Cohort|Death|0|||
94686432|NCT02601937|324305639|FG005|Period 2: Dose Expansion Cohort|Death|0|||
94686433|NCT02601937|324305640|FG006|Period 2: Dose Expansion Cohort|Death|0|||
94686434|NCT02601937|324305641|FG007|Period 2: Dose Expansion Cohort|Death|0|||
94686435|NCT02601937|324305642|FG008|Period 2: Dose Expansion Cohort|Death|1|||
94686436|NCT02601937|324305643|FG009|Period 2: Dose Expansion Cohort|Death|0|||
94686437|NCT02601937|324305644|FG010|Period 2: Dose Expansion Cohort|Death|0|||
94686438|NCT03391960|324305645|FG000|Overall Study|Protocol Violation|0|||
94686439|NCT03391960|324305646|FG001|Overall Study|Protocol Violation|0|||
94686440|NCT02924389|324305647|FG000|Overall Study|Lost to Follow-up|1|||
94686441|NCT02924389|324305648|FG001|Overall Study|Lost to Follow-up|0|||
94686442|NCT02924389|324305647|FG000|Overall Study|Physician Decision|2|||
94686443|NCT02924389|324305648|FG001|Overall Study|Physician Decision|0|||
94686444|NCT02924389|324305647|FG000|Overall Study|Withdrawal by Subject|3|||
94686445|NCT02924389|324305648|FG001|Overall Study|Withdrawal by Subject|0|||
94686446|NCT02924389|324305647|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
94686447|NCT02924389|324305648|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
94686448|NCT01186328|324307647|FG000|Overall Study|Death|1|||
94686449|NCT01186328|324307648|FG001|Overall Study|Death|0|||
94686450|NCT01186328|324307649|FG002|Overall Study|Death|0|||
94686451|NCT01382940|324307652|FG000|Overall Study|Adverse Event|19|||
94686452|NCT01382940|324307652|FG000|Overall Study|Lost to Follow-up|4|||
94686453|NCT01382940|324307652|FG000|Overall Study|Physician Decision|7|||
94686454|NCT01382940|324307652|FG000|Overall Study|Withdrawal by Subject|23|||
94686455|NCT01382940|324307652|FG000|Overall Study|Protocol Violation|20|||
94686456|NCT04867785|324307659|FG000|Overall Study|Adverse Event|1|||
94686457|NCT04867785|324307660|FG001|Overall Study|Adverse Event|0|||
94686458|NCT04867785|324307661|FG002|Overall Study|Adverse Event|1|||
94686459|NCT04867785|324307662|FG003|Overall Study|Adverse Event|0|||
94686460|NCT04867785|324307663|FG004|Overall Study|Adverse Event|0|||
94686461|NCT04867785|324307664|FG005|Overall Study|Adverse Event|0|||
94686462|NCT04867785|324307665|FG006|Overall Study|Adverse Event|0|||
94364153|NCT01915498|323116811|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
94364154|NCT01915498|323116812|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
94364155|NCT01915498|323116813|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
94686463|NCT04867785|324307666|FG007|Overall Study|Adverse Event|2|||
94686464|NCT04867785|324307659|FG000|Overall Study|Lost to Follow-up|4|||
94686465|NCT04867785|324307660|FG001|Overall Study|Lost to Follow-up|4|||
94686466|NCT04867785|324307661|FG002|Overall Study|Lost to Follow-up|3|||
94364156|NCT01915498|323116814|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
94364157|NCT01915498|323116815|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
94364158|NCT01915498|323116816|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
94364159|NCT01915498|323116817|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
94364160|NCT01915498|323116818|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
94364161|NCT01915498|323116819|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
94686467|NCT04867785|324307662|FG003|Overall Study|Lost to Follow-up|2|||
94686468|NCT04867785|324307663|FG004|Overall Study|Lost to Follow-up|0|||
94686469|NCT04867785|324307664|FG005|Overall Study|Lost to Follow-up|1|||
94686470|NCT04867785|324307665|FG006|Overall Study|Lost to Follow-up|0|||
94686471|NCT04867785|324307666|FG007|Overall Study|Lost to Follow-up|1|||
94686472|NCT04867785|324307659|FG000|Overall Study|Withdrawal by Subject|6|||
94686473|NCT04867785|324307660|FG001|Overall Study|Withdrawal by Subject|2|||
94686474|NCT04867785|324307661|FG002|Overall Study|Withdrawal by Subject|2|||
94686475|NCT04867785|324307662|FG003|Overall Study|Withdrawal by Subject|1|||
94686476|NCT04867785|324307663|FG004|Overall Study|Withdrawal by Subject|2|||
94686477|NCT04867785|324307664|FG005|Overall Study|Withdrawal by Subject|0|||
94686478|NCT04867785|324307665|FG006|Overall Study|Withdrawal by Subject|2|||
94686479|NCT04867785|324307666|FG007|Overall Study|Withdrawal by Subject|5|||
94686480|NCT04867785|324307659|FG000|Overall Study|Physician Decision|0|||
94686481|NCT04867785|324307660|FG001|Overall Study|Physician Decision|0|||
94686482|NCT04867785|324307661|FG002|Overall Study|Physician Decision|0|||
94686483|NCT04867785|324307662|FG003|Overall Study|Physician Decision|0|||
94686484|NCT04867785|324307663|FG004|Overall Study|Physician Decision|0|||
94686485|NCT04867785|324307664|FG005|Overall Study|Physician Decision|0|||
94686486|NCT04867785|324307665|FG006|Overall Study|Physician Decision|0|||
94686487|NCT04867785|324307666|FG007|Overall Study|Physician Decision|1|||
94686488|NCT04867785|324307659|FG000|Overall Study|Inadvertent Enrollment|0|||
94686489|NCT04867785|324307660|FG001|Overall Study|Inadvertent Enrollment|0|||
94686490|NCT04867785|324307661|FG002|Overall Study|Inadvertent Enrollment|0|||
94686491|NCT04867785|324307662|FG003|Overall Study|Inadvertent Enrollment|1|||
94686492|NCT04867785|324307663|FG004|Overall Study|Inadvertent Enrollment|1|||
94686493|NCT04867785|324307664|FG005|Overall Study|Inadvertent Enrollment|0|||
94686494|NCT04867785|324307665|FG006|Overall Study|Inadvertent Enrollment|0|||
94686495|NCT04867785|324307666|FG007|Overall Study|Inadvertent Enrollment|1|||
94364162|NCT01915498|323116820|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
94364163|NCT01915498|323116802|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
94649776|NCT03670810|324176938|FG001|Main Study|Pregnancy|2|||
94649777|NCT03670810|324176939|FG002|Main Study|Pregnancy|0|||
94649778|NCT03670810|324176940|FG003|Main Study|Pregnancy|0|||
94649779|NCT03670810|324176941|FG004|Main Study|Pregnancy|0|||
94649780|NCT03670810|324176942|FG005|Main Study|Pregnancy|0|||
94649781|NCT03670810|324176943|FG006|Main Study|Pregnancy|0|||
94649782|NCT03670810|324176944|FG007|Main Study|Pregnancy|0|||
94649783|NCT03670810|324176945|FG008|Main Study|Pregnancy|0|||
94649784|NCT03670810|324176937|FG000|Main Study|Protocol Deviation|2|||
94649785|NCT03670810|324176938|FG001|Main Study|Protocol Deviation|12|||
94649786|NCT03670810|324176939|FG002|Main Study|Protocol Deviation|8|||
94686496|NCT04867785|324307659|FG000|Overall Study|Eligibility Criteria Not Met|0|||
94686497|NCT04867785|324307660|FG001|Overall Study|Eligibility Criteria Not Met|0|||
94686498|NCT04867785|324307661|FG002|Overall Study|Eligibility Criteria Not Met|0|||
94686499|NCT04867785|324307662|FG003|Overall Study|Eligibility Criteria Not Met|0|||
94364164|NCT01915498|323116803|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
94686500|NCT04867785|324307663|FG004|Overall Study|Eligibility Criteria Not Met|0|||
94686501|NCT04867785|324307664|FG005|Overall Study|Eligibility Criteria Not Met|0|||
94686502|NCT04867785|324307665|FG006|Overall Study|Eligibility Criteria Not Met|0|||
94686503|NCT04867785|324307666|FG007|Overall Study|Eligibility Criteria Not Met|1|||
94686504|NCT03462706|324307667|FG000|Overall Study|Polyp was pedunculated|1|||
94686505|NCT03462706|324307668|FG001|Overall Study|Polyp was pedunculated|0|||
94364165|NCT01915498|323116804|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
94649787|NCT03670810|324176940|FG003|Main Study|Protocol Deviation|4|||
94649788|NCT03670810|324176941|FG004|Main Study|Protocol Deviation|0|||
94649789|NCT03670810|324176942|FG005|Main Study|Protocol Deviation|0|||
94649790|NCT03670810|324176943|FG006|Main Study|Protocol Deviation|0|||
94649791|NCT03670810|324176944|FG007|Main Study|Protocol Deviation|0|||
94649792|NCT03670810|324176945|FG008|Main Study|Protocol Deviation|0|||
94649793|NCT03670810|324176937|FG000|Main Study|Withdrawal by Subject|21|||
94649794|NCT03670810|324176938|FG001|Main Study|Withdrawal by Subject|21|||
94649795|NCT03670810|324176939|FG002|Main Study|Withdrawal by Subject|8|||
94649796|NCT03670810|324176940|FG003|Main Study|Withdrawal by Subject|9|||
94649797|NCT03670810|324176941|FG004|Main Study|Withdrawal by Subject|5|||
94649798|NCT03670810|324176942|FG005|Main Study|Withdrawal by Subject|2|||
94649799|NCT03670810|324176943|FG006|Main Study|Withdrawal by Subject|1|||
94649800|NCT03670810|324176944|FG007|Main Study|Withdrawal by Subject|1|||
94649801|NCT03670810|324176945|FG008|Main Study|Withdrawal by Subject|0|||
94649802|NCT03670810|324176937|FG000|Main Study|Participant did not want to take the three other treatments|1|||
94649803|NCT03670810|324176938|FG001|Main Study|Participant did not want to take the three other treatments|0|||
94649804|NCT03670810|324176939|FG002|Main Study|Participant did not want to take the three other treatments|0|||
94649805|NCT03670810|324176940|FG003|Main Study|Participant did not want to take the three other treatments|0|||
94649806|NCT03670810|324176941|FG004|Main Study|Participant did not want to take the three other treatments|0|||
94649807|NCT03670810|324176942|FG005|Main Study|Participant did not want to take the three other treatments|0|||
94649808|NCT03670810|324176943|FG006|Main Study|Participant did not want to take the three other treatments|0|||
94649809|NCT03670810|324176944|FG007|Main Study|Participant did not want to take the three other treatments|0|||
94649810|NCT03670810|324176945|FG008|Main Study|Participant did not want to take the three other treatments|0|||
94649811|NCT03670810|324176937|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
94649812|NCT03670810|324176938|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
94649813|NCT03670810|324176939|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
94649814|NCT03670810|324176940|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
94649815|NCT03670810|324176941|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
94649816|NCT03670810|324176942|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
94649817|NCT03670810|324176943|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
94649818|NCT03670810|324176944|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
94649819|NCT03670810|324176945|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
94649820|NCT03670810|324176937|FG000|Main Study|Travel and Coronavirus issues|0|||
94649821|NCT03670810|324176938|FG001|Main Study|Travel and Coronavirus issues|0|||
94649822|NCT03670810|324176939|FG002|Main Study|Travel and Coronavirus issues|0|||
94649823|NCT03670810|324176940|FG003|Main Study|Travel and Coronavirus issues|1|||
94649824|NCT03670810|324176941|FG004|Main Study|Travel and Coronavirus issues|0|||
94649825|NCT03670810|324176942|FG005|Main Study|Travel and Coronavirus issues|0|||
94649826|NCT03670810|324176943|FG006|Main Study|Travel and Coronavirus issues|0|||
94649827|NCT03670810|324176944|FG007|Main Study|Travel and Coronavirus issues|0|||
94649828|NCT03670810|324176945|FG008|Main Study|Travel and Coronavirus issues|0|||
94649829|NCT03670810|324176937|FG000|Open Label Extension|Protocol Deviation|0|||
94649830|NCT03670810|324176938|FG001|Open Label Extension|Protocol Deviation|0|||
94649831|NCT03670810|324176939|FG002|Open Label Extension|Protocol Deviation|0|||
94649832|NCT03670810|324176940|FG003|Open Label Extension|Protocol Deviation|0|||
94649833|NCT03670810|324176941|FG004|Open Label Extension|Protocol Deviation|0|||
94649834|NCT03670810|324176942|FG005|Open Label Extension|Protocol Deviation|0|||
94649835|NCT03670810|324176943|FG006|Open Label Extension|Protocol Deviation|0|||
94649836|NCT03670810|324176944|FG007|Open Label Extension|Protocol Deviation|0|||
94649837|NCT03670810|324176945|FG008|Open Label Extension|Protocol Deviation|5|||
94649838|NCT03670810|324176937|FG000|Open Label Extension|Death|0|||
94649839|NCT03670810|324176938|FG001|Open Label Extension|Death|0|||
94649840|NCT03670810|324176939|FG002|Open Label Extension|Death|0|||
94649841|NCT03670810|324176940|FG003|Open Label Extension|Death|0|||
94649842|NCT03670810|324176941|FG004|Open Label Extension|Death|0|||
94649843|NCT03670810|324176942|FG005|Open Label Extension|Death|0|||
94649844|NCT03670810|324176943|FG006|Open Label Extension|Death|0|||
94649845|NCT03670810|324176944|FG007|Open Label Extension|Death|0|||
94649846|NCT03670810|324176945|FG008|Open Label Extension|Death|1|||
94649847|NCT03670810|324176937|FG000|Open Label Extension|COVID-19|0|||
94649848|NCT03670810|324176938|FG001|Open Label Extension|COVID-19|0|||
94649849|NCT03670810|324176939|FG002|Open Label Extension|COVID-19|0|||
94649850|NCT03670810|324176940|FG003|Open Label Extension|COVID-19|0|||
94649851|NCT03670810|324176941|FG004|Open Label Extension|COVID-19|0|||
94649852|NCT03670810|324176942|FG005|Open Label Extension|COVID-19|0|||
94649853|NCT03670810|324176943|FG006|Open Label Extension|COVID-19|0|||
94649854|NCT03670810|324176944|FG007|Open Label Extension|COVID-19|0|||
94649855|NCT03670810|324176945|FG008|Open Label Extension|COVID-19|1|||
94649856|NCT03670810|324176937|FG000|Open Label Extension|Lack of Efficacy|0|||
94649857|NCT03670810|324176938|FG001|Open Label Extension|Lack of Efficacy|0|||
94649858|NCT03670810|324176939|FG002|Open Label Extension|Lack of Efficacy|0|||
94649859|NCT03670810|324176940|FG003|Open Label Extension|Lack of Efficacy|0|||
94649860|NCT03670810|324176941|FG004|Open Label Extension|Lack of Efficacy|0|||
94649861|NCT03670810|324176942|FG005|Open Label Extension|Lack of Efficacy|0|||
94649862|NCT03670810|324176943|FG006|Open Label Extension|Lack of Efficacy|0|||
94649863|NCT03670810|324176944|FG007|Open Label Extension|Lack of Efficacy|0|||
94649864|NCT03670810|324176945|FG008|Open Label Extension|Lack of Efficacy|39|||
94649865|NCT03670810|324176937|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
94649866|NCT03670810|324176938|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
94649867|NCT03670810|324176939|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
94649868|NCT03670810|324176940|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
94649869|NCT03670810|324176941|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
94649870|NCT03670810|324176942|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
94649871|NCT03670810|324176943|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
94649872|NCT03670810|324176944|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
94649873|NCT03670810|324176945|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
94649874|NCT03670810|324176937|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
94649875|NCT03670810|324176938|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
94649876|NCT03670810|324176939|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
94649877|NCT03670810|324176940|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
94649878|NCT03670810|324176941|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
94649879|NCT03670810|324176942|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
94649880|NCT03670810|324176943|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
94649881|NCT03670810|324176944|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
94649882|NCT03670810|324176945|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
94649883|NCT03670810|324176937|FG000|Open Label Extension|Withdrawal by Subject|0|||
94649884|NCT03670810|324176938|FG001|Open Label Extension|Withdrawal by Subject|0|||
94649885|NCT03670810|324176939|FG002|Open Label Extension|Withdrawal by Subject|0|||
94649886|NCT03670810|324176940|FG003|Open Label Extension|Withdrawal by Subject|0|||
94649887|NCT03670810|324176941|FG004|Open Label Extension|Withdrawal by Subject|0|||
94649888|NCT03670810|324176942|FG005|Open Label Extension|Withdrawal by Subject|0|||
94649889|NCT03670810|324176943|FG006|Open Label Extension|Withdrawal by Subject|0|||
94649890|NCT03670810|324176944|FG007|Open Label Extension|Withdrawal by Subject|0|||
94649891|NCT03670810|324176945|FG008|Open Label Extension|Withdrawal by Subject|46|||
94649892|NCT03670810|324176937|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
94649893|NCT03670810|324176938|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
94649894|NCT03670810|324176939|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
94649895|NCT03670810|324176940|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
94649896|NCT03670810|324176941|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
94649897|NCT03670810|324176942|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
94649898|NCT03670810|324176943|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
94649899|NCT03670810|324176944|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
94649900|NCT03670810|324176945|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
94649901|NCT03670810|324176937|FG000|Open Label Extension|Physician Decision|0|||
94649902|NCT03670810|324176938|FG001|Open Label Extension|Physician Decision|0|||
94649903|NCT03670810|324176939|FG002|Open Label Extension|Physician Decision|0|||
94649904|NCT03670810|324176940|FG003|Open Label Extension|Physician Decision|0|||
94649905|NCT03670810|324176941|FG004|Open Label Extension|Physician Decision|0|||
94649906|NCT03670810|324176942|FG005|Open Label Extension|Physician Decision|0|||
94649907|NCT03670810|324176943|FG006|Open Label Extension|Physician Decision|0|||
94649908|NCT03670810|324176944|FG007|Open Label Extension|Physician Decision|0|||
94649909|NCT03670810|324176945|FG008|Open Label Extension|Physician Decision|2|||
94649910|NCT03670810|324176937|FG000|Open Label Extension|Non-compliance with study drug|0|||
94649911|NCT03670810|324176938|FG001|Open Label Extension|Non-compliance with study drug|0|||
94649912|NCT03670810|324176939|FG002|Open Label Extension|Non-compliance with study drug|0|||
94649913|NCT03670810|324176940|FG003|Open Label Extension|Non-compliance with study drug|0|||
94649914|NCT03670810|324176941|FG004|Open Label Extension|Non-compliance with study drug|0|||
94649915|NCT03670810|324176942|FG005|Open Label Extension|Non-compliance with study drug|0|||
94649916|NCT03670810|324176943|FG006|Open Label Extension|Non-compliance with study drug|0|||
94649917|NCT03670810|324176944|FG007|Open Label Extension|Non-compliance with study drug|0|||
94649918|NCT03670810|324176945|FG008|Open Label Extension|Non-compliance with study drug|5|||
94649919|NCT03670810|324176937|FG000|Open Label Extension|Pregnancy|0|||
94649920|NCT03670810|324176938|FG001|Open Label Extension|Pregnancy|0|||
94649921|NCT03670810|324176939|FG002|Open Label Extension|Pregnancy|0|||
94649922|NCT03670810|324176940|FG003|Open Label Extension|Pregnancy|0|||
94649923|NCT03670810|324176941|FG004|Open Label Extension|Pregnancy|0|||
94649924|NCT03670810|324176942|FG005|Open Label Extension|Pregnancy|0|||
94649925|NCT03670810|324176943|FG006|Open Label Extension|Pregnancy|0|||
94649926|NCT03670810|324176944|FG007|Open Label Extension|Pregnancy|0|||
94686506|NCT03462706|324307669|FG002|Overall Study|Polyp was pedunculated|1|||
94686507|NCT03462706|324307670|FG003|Overall Study|Polyp was pedunculated|0|||
94686508|NCT03462706|324307667|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
94686509|NCT03462706|324307668|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
94686510|NCT03462706|324307669|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
94686511|NCT03462706|324307670|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
94686512|NCT01984424|324307687|FG000|Overall Study|Withdrawal by Subject|3|||
94686513|NCT01984424|324307688|FG001|Overall Study|Withdrawal by Subject|5|||
94686514|NCT01984424|324307687|FG000|Overall Study|Sponsor Decision|0|||
94686515|NCT01984424|324307688|FG001|Overall Study|Sponsor Decision|1|||
94686516|NCT01984424|324307687|FG000|Overall Study|Lost to Follow-up|0|||
94686517|NCT01984424|324307688|FG001|Overall Study|Lost to Follow-up|1|||
94686518|NCT00553202|324307689|FG000|Overall Study|Death|16|||
94364166|NCT01915498|323116805|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
94364167|NCT01915498|323116806|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
94364168|NCT01915498|323116807|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
94364169|NCT01915498|323116808|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
94364170|NCT01915498|323116809|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
94364171|NCT01915498|323116810|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
94649927|NCT03670810|324176945|FG008|Open Label Extension|Pregnancy|3|||
94649928|NCT03670810|324176937|FG000|Open Label Extension|Adverse Event|0|||
94649929|NCT03670810|324176938|FG001|Open Label Extension|Adverse Event|0|||
94649930|NCT03670810|324176939|FG002|Open Label Extension|Adverse Event|0|||
94649931|NCT03670810|324176940|FG003|Open Label Extension|Adverse Event|0|||
94649932|NCT03670810|324176941|FG004|Open Label Extension|Adverse Event|0|||
94649933|NCT03670810|324176942|FG005|Open Label Extension|Adverse Event|0|||
94649934|NCT03670810|324176943|FG006|Open Label Extension|Adverse Event|0|||
94649935|NCT03670810|324176944|FG007|Open Label Extension|Adverse Event|0|||
94649936|NCT03670810|324176945|FG008|Open Label Extension|Adverse Event|24|||
94649937|NCT03670810|324176937|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
94649938|NCT03670810|324176938|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
94649939|NCT03670810|324176939|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
94649940|NCT03670810|324176940|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
94649941|NCT03670810|324176941|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
94649942|NCT03670810|324176942|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
94649943|NCT03670810|324176943|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
94649944|NCT03670810|324176944|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
94649945|NCT03670810|324176945|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
94649946|NCT03670810|324176937|FG000|Open Label Extension|Lost to Follow-up|0|||
94649947|NCT03670810|324176938|FG001|Open Label Extension|Lost to Follow-up|0|||
94649948|NCT03670810|324176939|FG002|Open Label Extension|Lost to Follow-up|0|||
94649949|NCT03670810|324176940|FG003|Open Label Extension|Lost to Follow-up|0|||
94649950|NCT03670810|324176941|FG004|Open Label Extension|Lost to Follow-up|0|||
94649951|NCT03670810|324176942|FG005|Open Label Extension|Lost to Follow-up|0|||
94649952|NCT03670810|324176943|FG006|Open Label Extension|Lost to Follow-up|0|||
94649953|NCT03670810|324176944|FG007|Open Label Extension|Lost to Follow-up|0|||
94649954|NCT03670810|324176945|FG008|Open Label Extension|Lost to Follow-up|23|||
94649955|NCT02579616|324176946|FG000|Overall Study|Participants did not receive treatment|3|||
94649956|NCT02247349|324176947|FG000|Overall Study|Disease Progression|7|||
94649957|NCT02247349|324176948|FG001|Overall Study|Disease Progression|4|||
94649958|NCT02247349|324176949|FG002|Overall Study|Disease Progression|26|||
94649959|NCT02247349|324176950|FG003|Overall Study|Disease Progression|31|||
94649960|NCT02247349|324176951|FG004|Overall Study|Disease Progression|16|||
94649961|NCT02247349|324176952|FG005|Overall Study|Disease Progression|6|||
94649962|NCT02247349|324176947|FG000|Overall Study|Study drug toxicity|0|||
94649963|NCT02247349|324176948|FG001|Overall Study|Study drug toxicity|1|||
94649964|NCT02247349|324176949|FG002|Overall Study|Study drug toxicity|1|||
94649965|NCT02247349|324176950|FG003|Overall Study|Study drug toxicity|1|||
94649966|NCT02247349|324176951|FG004|Overall Study|Study drug toxicity|2|||
94649967|NCT02247349|324176952|FG005|Overall Study|Study drug toxicity|2|||
94649968|NCT02247349|324176947|FG000|Overall Study|Death|0|||
94649969|NCT02247349|324176948|FG001|Overall Study|Death|0|||
94649970|NCT02247349|324176949|FG002|Overall Study|Death|0|||
94649971|NCT02247349|324176950|FG003|Overall Study|Death|1|||
94686519|NCT00553202|324307689|FG000|Overall Study|Lost to Follow-up|1|||
94649972|NCT02247349|324176951|FG004|Overall Study|Death|0|||
94649973|NCT02247349|324176952|FG005|Overall Study|Death|0|||
94649974|NCT02247349|324176947|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
94649975|NCT02247349|324176948|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
94649976|NCT02247349|324176949|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
94649977|NCT02247349|324176950|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
94649978|NCT02247349|324176951|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
94649979|NCT02247349|324176952|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
94649980|NCT02247349|324176947|FG000|Overall Study|Participant request to discontinue study treatment|0|||
94649981|NCT02247349|324176948|FG001|Overall Study|Participant request to discontinue study treatment|0|||
94649982|NCT02247349|324176949|FG002|Overall Study|Participant request to discontinue study treatment|1|||
94649983|NCT02247349|324176950|FG003|Overall Study|Participant request to discontinue study treatment|2|||
94649984|NCT02247349|324176951|FG004|Overall Study|Participant request to discontinue study treatment|1|||
94649985|NCT02247349|324176952|FG005|Overall Study|Participant request to discontinue study treatment|0|||
94649986|NCT02247349|324176947|FG000|Overall Study|Withdrawal by Subject|0|||
94649987|NCT02247349|324176948|FG001|Overall Study|Withdrawal by Subject|1|||
94649988|NCT02247349|324176949|FG002|Overall Study|Withdrawal by Subject|0|||
94649989|NCT02247349|324176950|FG003|Overall Study|Withdrawal by Subject|0|||
94649990|NCT02247349|324176951|FG004|Overall Study|Withdrawal by Subject|0|||
94649991|NCT02247349|324176952|FG005|Overall Study|Withdrawal by Subject|0|||
94649992|NCT02247349|324176947|FG000|Overall Study|Administrative reason by sponsor|0|||
94649993|NCT02247349|324176948|FG001|Overall Study|Administrative reason by sponsor|0|||
94649994|NCT02247349|324176949|FG002|Overall Study|Administrative reason by sponsor|0|||
94649995|NCT02247349|324176950|FG003|Overall Study|Administrative reason by sponsor|0|||
94649996|NCT02247349|324176951|FG004|Overall Study|Administrative reason by sponsor|1|||
94649997|NCT02247349|324176952|FG005|Overall Study|Administrative reason by sponsor|0|||
94649998|NCT02247349|324176947|FG000|Overall Study|Other reasons|0|||
94649999|NCT02247349|324176948|FG001|Overall Study|Other reasons|0|||
94650000|NCT02247349|324176949|FG002|Overall Study|Other reasons|1|||
94650001|NCT02247349|324176950|FG003|Overall Study|Other reasons|0|||
94650002|NCT02247349|324176951|FG004|Overall Study|Other reasons|0|||
94650003|NCT02247349|324176952|FG005|Overall Study|Other reasons|0|||
94650004|NCT02644967|324176953|FG000|Overall Study|Death|26|||
94650005|NCT02644967|324176953|FG000|Overall Study|Physician Decision|1|||
94650006|NCT02644967|324176953|FG000|Overall Study|Withdrawal by Subject|2|||
94650007|NCT02644967|324176953|FG000|Overall Study|Protocol Violation|1|||
94650008|NCT02644967|324176953|FG000|Overall Study|Progressive Disease|1|||
94650009|NCT02644967|324176953|FG000|Overall Study|Study Terminated by Sponsor|4|||
94650010|NCT00280566|324176958|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
94650011|NCT00280566|324176959|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
94650012|NCT00280566|324176960|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
94650013|NCT00280566|324176958|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
94650014|NCT00280566|324176959|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
94650015|NCT00280566|324176960|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
94650016|NCT00280566|324176958|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
94650017|NCT00280566|324176959|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
94650018|NCT00280566|324176960|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
94650019|NCT00280566|324176958|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
94650020|NCT00280566|324176959|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
94650021|NCT00280566|324176960|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
94650022|NCT00280566|324176958|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
94650023|NCT00280566|324176959|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
94650024|NCT00280566|324176960|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
94650025|NCT00280566|324176958|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
94650026|NCT00280566|324176959|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
94650027|NCT00280566|324176960|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
94650028|NCT00280566|324176958|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
94650029|NCT00280566|324176959|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
94650030|NCT00280566|324176960|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
94650031|NCT00280566|324176958|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
94650032|NCT00280566|324176959|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
94650033|NCT00280566|324176960|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
94650034|NCT00280566|324176958|FG000|Period 2 Double Blind|Adverse Event|0|||
94650035|NCT00280566|324176959|FG001|Period 2 Double Blind|Adverse Event|11|||
94650036|NCT00280566|324176960|FG002|Period 2 Double Blind|Adverse Event|15|||
94650037|NCT00280566|324176958|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
94650038|NCT00280566|324176959|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
94650039|NCT00280566|324176960|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
94650040|NCT00280566|324176958|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
94650041|NCT00280566|324176959|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
94650042|NCT00280566|324176960|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
94650043|NCT00280566|324176958|FG000|Period 2 Double Blind|miscellaneous|0|||
94650044|NCT00280566|324176959|FG001|Period 2 Double Blind|miscellaneous|10|||
94650045|NCT00280566|324176960|FG002|Period 2 Double Blind|miscellaneous|5|||
94650046|NCT00353366|324176961|FG000|Overall Study|Adverse Event|8|||
94650047|NCT00353366|324176961|FG000|Overall Study|Protocol Violation|12|||
94686520|NCT00553202|324307689|FG000|Overall Study|Physician Decision|28|||
94364172|NCT01915498|323116811|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
94364173|NCT01915498|323116812|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
94364174|NCT01915498|323116813|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
94364175|NCT01915498|323116814|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
94364176|NCT01915498|323116815|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
94364177|NCT01915498|323116816|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
94686521|NCT00553202|324307689|FG000|Overall Study|Withdrawal by Subject|1|||
94686522|NCT00553202|324307689|FG000|Overall Study|No donor identified|16|||
94686523|NCT00553202|324307689|FG000|Overall Study|Fails to meet organ function|6|||
94686524|NCT04651114|324307690|FG000|Overall Study|Withdrawal by Subject|8|||
94686525|NCT00235443|324307693|FG000|Overall Study|Adverse Event|4|||
94686526|NCT00235443|324307694|FG001|Overall Study|Adverse Event|12|||
94686527|NCT00235443|324307695|FG002|Overall Study|Adverse Event|17|||
94686528|NCT00235443|324307696|FG003|Overall Study|Adverse Event|44|||
94686529|NCT00235443|324307697|FG004|Overall Study|Adverse Event|10|||
94686530|NCT00235443|324307698|FG005|Overall Study|Adverse Event|15|||
94686531|NCT00235443|324307693|FG000|Overall Study|Lack of Efficacy|0|||
94686532|NCT00235443|324307694|FG001|Overall Study|Lack of Efficacy|1|||
94686533|NCT00235443|324307695|FG002|Overall Study|Lack of Efficacy|5|||
94686534|NCT00235443|324307696|FG003|Overall Study|Lack of Efficacy|12|||
94686535|NCT00235443|324307697|FG004|Overall Study|Lack of Efficacy|2|||
94686536|NCT00235443|324307698|FG005|Overall Study|Lack of Efficacy|9|||
94686537|NCT00235443|324307693|FG000|Overall Study|Withdrawal by Subject|3|||
94686538|NCT00235443|324307694|FG001|Overall Study|Withdrawal by Subject|9|||
94686539|NCT00235443|324307695|FG002|Overall Study|Withdrawal by Subject|25|||
94686540|NCT00235443|324307696|FG003|Overall Study|Withdrawal by Subject|24|||
94686541|NCT00235443|324307697|FG004|Overall Study|Withdrawal by Subject|10|||
94686542|NCT00235443|324307698|FG005|Overall Study|Withdrawal by Subject|12|||
94686543|NCT00235443|324307693|FG000|Overall Study|Lost to Follow-up|0|||
94686544|NCT00235443|324307694|FG001|Overall Study|Lost to Follow-up|8|||
94686545|NCT00235443|324307695|FG002|Overall Study|Lost to Follow-up|6|||
94686546|NCT00235443|324307696|FG003|Overall Study|Lost to Follow-up|6|||
94686547|NCT00235443|324307697|FG004|Overall Study|Lost to Follow-up|4|||
94686548|NCT00235443|324307698|FG005|Overall Study|Lost to Follow-up|3|||
94686549|NCT00235443|324307693|FG000|Overall Study|Unsatisfactory compliance|0|||
94686550|NCT00235443|324307694|FG001|Overall Study|Unsatisfactory compliance|2|||
94686551|NCT00235443|324307695|FG002|Overall Study|Unsatisfactory compliance|3|||
94686552|NCT00235443|324307696|FG003|Overall Study|Unsatisfactory compliance|4|||
94686553|NCT00235443|324307697|FG004|Overall Study|Unsatisfactory compliance|1|||
94686554|NCT00235443|324307698|FG005|Overall Study|Unsatisfactory compliance|0|||
94686555|NCT00235443|324307693|FG000|Overall Study|Other reasons for premature termination|1|||
94686556|NCT00235443|324307694|FG001|Overall Study|Other reasons for premature termination|6|||
94686557|NCT00235443|324307695|FG002|Overall Study|Other reasons for premature termination|6|||
94686558|NCT00235443|324307696|FG003|Overall Study|Other reasons for premature termination|7|||
94686559|NCT00235443|324307697|FG004|Overall Study|Other reasons for premature termination|3|||
94686560|NCT00235443|324307698|FG005|Overall Study|Other reasons for premature termination|6|||
94686561|NCT00917267|324307699|FG000|Overall Study|Adverse Event|15|||
94686562|NCT00917267|324307700|FG001|Overall Study|Adverse Event|36|||
94686563|NCT00917267|324307699|FG000|Overall Study|Physician Decision|2|||
94686564|NCT00917267|324307700|FG001|Overall Study|Physician Decision|4|||
94686565|NCT00917267|324307699|FG000|Overall Study|Protocol Violation|9|||
94686566|NCT00917267|324307700|FG001|Overall Study|Protocol Violation|18|||
94686567|NCT00917267|324307699|FG000|Overall Study|Withdrawal by Subject|5|||
94686568|NCT00917267|324307700|FG001|Overall Study|Withdrawal by Subject|12|||
94686569|NCT00917267|324307699|FG000|Overall Study|Lost to follow up|0|||
94686570|NCT00917267|324307700|FG001|Overall Study|Lost to follow up|2|||
94686571|NCT00917267|324307699|FG000|Overall Study|Entry Criteria Not Met|1|||
94686572|NCT00917267|324307700|FG001|Overall Study|Entry Criteria Not Met|0|||
94686573|NCT00917267|324307699|FG000|Overall Study|Sponsor Decision|5|||
94686574|NCT00917267|324307700|FG001|Overall Study|Sponsor Decision|5|||
94686575|NCT00917267|324307699|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
94686576|NCT00917267|324307700|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
94686577|NCT02765490|324307701|FG000|Overall Study|Lost to Follow-up|1|||
94364178|NCT01915498|323116817|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
94686578|NCT02765490|324307702|FG001|Overall Study|Lost to Follow-up|1|||
94686579|NCT02765490|324307701|FG000|Overall Study|Other|0|||
94686580|NCT02765490|324307702|FG001|Overall Study|Other|1|||
94686581|NCT02765490|324307701|FG000|Overall Study|Death|0|||
94686582|NCT02765490|324307702|FG001|Overall Study|Death|1|||
94686583|NCT00152971|324307705|FG000|Overall Study|Adverse Event|12|||
94686584|NCT00152971|324307706|FG001|Overall Study|Adverse Event|10|||
94686585|NCT00152971|324307707|FG002|Overall Study|Adverse Event|9|||
94463513|NCT00084318|323485086|FG001|Overall Study|Withdrawal by Subject|2|||
94650048|NCT00353366|324176961|FG000|Overall Study|Withdrawal by Subject|12|||
94650049|NCT00353366|324176961|FG000|Overall Study|Lost to Follow-up|92|||
94650050|NCT00353366|324176961|FG000|Overall Study|Other|19|||
94650051|NCT01109316|324176962|FG000|Study Period 1|Adverse Event|0|||
94650052|NCT01109316|324176963|FG001|Study Period 1|Adverse Event|0|||
94650053|NCT01109316|324176964|FG002|Study Period 1|Adverse Event|1|||
94650054|NCT01109316|324176965|FG003|Study Period 1|Adverse Event|0|||
94650055|NCT01109316|324176966|FG004|Study Period 1|Adverse Event|0|||
94650056|NCT01109316|324176967|FG005|Study Period 1|Adverse Event|0|||
94650057|NCT01109316|324176962|FG000|Study Period 1|Lost to Follow-up|0|||
94650058|NCT01109316|324176963|FG001|Study Period 1|Lost to Follow-up|0|||
94650059|NCT01109316|324176964|FG002|Study Period 1|Lost to Follow-up|1|||
94650060|NCT01109316|324176965|FG003|Study Period 1|Lost to Follow-up|1|||
94650061|NCT01109316|324176966|FG004|Study Period 1|Lost to Follow-up|0|||
94650062|NCT01109316|324176967|FG005|Study Period 1|Lost to Follow-up|0|||
94650063|NCT01109316|324176962|FG000|Study Period 1|Withdrawal by Subject|0|||
94650064|NCT01109316|324176963|FG001|Study Period 1|Withdrawal by Subject|0|||
94650065|NCT01109316|324176964|FG002|Study Period 1|Withdrawal by Subject|1|||
94650066|NCT01109316|324176965|FG003|Study Period 1|Withdrawal by Subject|0|||
94650067|NCT01109316|324176966|FG004|Study Period 1|Withdrawal by Subject|2|||
94650068|NCT01109316|324176967|FG005|Study Period 1|Withdrawal by Subject|0|||
94650069|NCT01109316|324176962|FG000|Study Period 1|Sponsor Decision|0|||
94650070|NCT01109316|324176963|FG001|Study Period 1|Sponsor Decision|0|||
94650071|NCT01109316|324176964|FG002|Study Period 1|Sponsor Decision|0|||
94650072|NCT01109316|324176965|FG003|Study Period 1|Sponsor Decision|0|||
94650073|NCT01109316|324176966|FG004|Study Period 1|Sponsor Decision|0|||
94650074|NCT01109316|324176967|FG005|Study Period 1|Sponsor Decision|2|||
94650075|NCT01109316|324176962|FG000|Study Period 2|Entry Criteria Not Met|0|||
94650076|NCT01109316|324176963|FG001|Study Period 2|Entry Criteria Not Met|1|||
94650077|NCT01109316|324176964|FG002|Study Period 2|Entry Criteria Not Met|0|||
94650078|NCT01109316|324176965|FG003|Study Period 2|Entry Criteria Not Met|0|||
94650079|NCT01109316|324176966|FG004|Study Period 2|Entry Criteria Not Met|0|||
94650080|NCT01109316|324176967|FG005|Study Period 2|Entry Criteria Not Met|0|||
94650081|NCT01109316|324176962|FG000|Study Period 2|Physician Decision|0|||
94650082|NCT01109316|324176963|FG001|Study Period 2|Physician Decision|0|||
94650083|NCT01109316|324176964|FG002|Study Period 2|Physician Decision|0|||
94650084|NCT01109316|324176965|FG003|Study Period 2|Physician Decision|1|||
94650085|NCT01109316|324176966|FG004|Study Period 2|Physician Decision|0|||
94650086|NCT01109316|324176967|FG005|Study Period 2|Physician Decision|0|||
94650087|NCT01109316|324176962|FG000|Study Period 2|Protocol Violation|1|||
94650088|NCT01109316|324176963|FG001|Study Period 2|Protocol Violation|0|||
94650089|NCT01109316|324176964|FG002|Study Period 2|Protocol Violation|0|||
94650090|NCT01109316|324176965|FG003|Study Period 2|Protocol Violation|0|||
94650091|NCT01109316|324176966|FG004|Study Period 2|Protocol Violation|0|||
94650092|NCT01109316|324176967|FG005|Study Period 2|Protocol Violation|0|||
94463514|NCT00084318|323485085|FG000|Overall Study|Protocol Violation|15|||
94650093|NCT01109316|324176962|FG000|Study Period 2|Withdrawal by Subject|0|||
94650094|NCT01109316|324176963|FG001|Study Period 2|Withdrawal by Subject|0|||
94650095|NCT01109316|324176964|FG002|Study Period 2|Withdrawal by Subject|1|||
94650096|NCT01109316|324176965|FG003|Study Period 2|Withdrawal by Subject|0|||
94650097|NCT01109316|324176966|FG004|Study Period 2|Withdrawal by Subject|0|||
94650098|NCT01109316|324176967|FG005|Study Period 2|Withdrawal by Subject|1|||
94650099|NCT01109316|324176962|FG000|Study Period 3|Lost to Follow-up|0|||
94650100|NCT01109316|324176963|FG001|Study Period 3|Lost to Follow-up|0|||
94650101|NCT01109316|324176964|FG002|Study Period 3|Lost to Follow-up|0|||
94650102|NCT01109316|324176965|FG003|Study Period 3|Lost to Follow-up|0|||
94650103|NCT01109316|324176966|FG004|Study Period 3|Lost to Follow-up|1|||
94650104|NCT01109316|324176967|FG005|Study Period 3|Lost to Follow-up|0|||
94650105|NCT01109316|324176962|FG000|Study Period 3|Withdrawal by Subject|1|||
94650106|NCT01109316|324176963|FG001|Study Period 3|Withdrawal by Subject|0|||
94686586|NCT00152971|324307705|FG000|Overall Study|Protocol Violation|10|||
94650107|NCT01109316|324176964|FG002|Study Period 3|Withdrawal by Subject|0|||
94650108|NCT01109316|324176965|FG003|Study Period 3|Withdrawal by Subject|0|||
94650109|NCT01109316|324176966|FG004|Study Period 3|Withdrawal by Subject|1|||
94650110|NCT01109316|324176967|FG005|Study Period 3|Withdrawal by Subject|0|||
94650111|NCT00393939|324176968|FG000|Overall Study|Protocol Violation|1|||
94650112|NCT00393939|324176969|FG001|Overall Study|Protocol Violation|1|||
94650113|NCT00393939|324176968|FG000|Overall Study|Lost to Follow-up|2|||
94650114|NCT00393939|324176969|FG001|Overall Study|Lost to Follow-up|4|||
94650115|NCT00393939|324176968|FG000|Overall Study|Death|10|||
94650116|NCT00393939|324176969|FG001|Overall Study|Death|4|||
94650117|NCT00393939|324176968|FG000|Overall Study|Sponsor|5|||
94650118|NCT00393939|324176969|FG001|Overall Study|Sponsor|13|||
94650119|NCT00393939|324176968|FG000|Overall Study|Objective progression or relapse|239|||
94650120|NCT00393939|324176969|FG001|Overall Study|Objective progression or relapse|223|||
94650121|NCT00393939|324176968|FG000|Overall Study|Withdrawal by Subject|2|||
94650122|NCT00393939|324176969|FG001|Overall Study|Withdrawal by Subject|7|||
94650123|NCT00393939|324176968|FG000|Overall Study|Other|37|||
94650124|NCT00393939|324176969|FG001|Overall Study|Other|45|||
94650125|NCT00637195|324176970|FG000|Overall Study|Lost to Follow-up|1|||
94650126|NCT00637195|324176971|FG001|Overall Study|Lost to Follow-up|0|||
94650127|NCT00637195|324176970|FG000|Overall Study|Other|2|||
94650128|NCT00637195|324176971|FG001|Overall Study|Other|0|||
94650129|NCT00637195|324176970|FG000|Overall Study|Withdrawal by Subject|0|||
94650130|NCT00637195|324176971|FG001|Overall Study|Withdrawal by Subject|1|||
94650131|NCT00006184|324176975|FG000|Overall Study|Death|1|||
94650132|NCT00006184|324176976|FG001|Overall Study|Death|0|||
94650133|NCT03075644|324176977|FG000|Overall Study|Withdrawal by Subject|1|||
94650134|NCT03075644|324176978|FG001|Overall Study|Withdrawal by Subject|1|||
94650135|NCT01110915|324176979|FG000|Overall Study|Death|2|||
94650136|NCT01110915|324176980|FG001|Overall Study|Death|1|||
94650137|NCT01110915|324176979|FG000|Overall Study|Lost to Follow-up|1|||
94650138|NCT01110915|324176980|FG001|Overall Study|Lost to Follow-up|0|||
94650139|NCT01110915|324176979|FG000|Overall Study|Withdrawal by Subject|7|||
94650140|NCT01110915|324176980|FG001|Overall Study|Withdrawal by Subject|1|||
94650141|NCT02161718|324176981|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
94650142|NCT02161718|324176982|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
94650143|NCT02161718|324176983|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
94650144|NCT02161718|324176981|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
94650145|NCT02161718|324176982|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
94650146|NCT02161718|324176983|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
94650147|NCT02161718|324176981|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
94364179|NCT01915498|323116818|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
94364180|NCT01915498|323116819|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
94364181|NCT01915498|323116820|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
94364182|NCT01915498|323116802|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
94364183|NCT01915498|323116803|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
94364184|NCT01915498|323116804|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
94364185|NCT01915498|323116805|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
94364186|NCT01915498|323116806|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
94364187|NCT01915498|323116807|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
94364188|NCT01915498|323116808|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
94364189|NCT01915498|323116809|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
94364190|NCT01915498|323116810|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
94364191|NCT01915498|323116811|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
94364192|NCT01915498|323116812|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
94364193|NCT01915498|323116813|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
94364194|NCT01915498|323116814|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
94364195|NCT01915498|323116815|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
94364196|NCT01915498|323116816|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
94364197|NCT01915498|323116817|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
94364198|NCT01915498|323116818|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
94364199|NCT01915498|323116819|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
94364200|NCT01915498|323116820|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
94364201|NCT01915498|323116802|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
94364202|NCT01915498|323116803|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
94364203|NCT01915498|323116804|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
94364204|NCT01915498|323116805|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
94650148|NCT02161718|324176982|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
94650149|NCT02161718|324176983|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
94650150|NCT02161718|324176981|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
94650151|NCT02161718|324176982|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
94650152|NCT02161718|324176983|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
94364205|NCT01915498|323116806|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
94364206|NCT01915498|323116807|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
94364207|NCT01915498|323116808|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
94364208|NCT01915498|323116809|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
94364209|NCT01915498|323116810|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
94364210|NCT01915498|323116811|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
94364211|NCT01915498|323116812|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
94364212|NCT01915498|323116813|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
94364213|NCT01915498|323116814|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
94364214|NCT01915498|323116815|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
94364215|NCT01915498|323116816|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
94364216|NCT01915498|323116817|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
94364217|NCT01915498|323116818|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
94364218|NCT01915498|323116819|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
94364219|NCT01915498|323116820|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
94364220|NCT01915498|323116802|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
94364221|NCT01915498|323116803|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
94364222|NCT01915498|323116804|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
94364223|NCT01915498|323116805|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
94364224|NCT01915498|323116806|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
94364225|NCT01915498|323116807|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
94364226|NCT01915498|323116808|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
94364227|NCT01915498|323116809|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
94364228|NCT01915498|323116810|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
94364229|NCT01915498|323116811|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
94364230|NCT01915498|323116812|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
94364231|NCT01915498|323116813|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
94364232|NCT01915498|323116814|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
94364233|NCT01915498|323116815|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
94364234|NCT01915498|323116816|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
94364235|NCT01915498|323116817|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
94364236|NCT01915498|323116818|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
94364237|NCT01915498|323116819|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
94364238|NCT01915498|323116820|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
94364239|NCT01915498|323116802|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
94364240|NCT01915498|323116803|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
94364241|NCT01915498|323116804|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
94364242|NCT01915498|323116805|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
94364243|NCT01915498|323116806|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
94364244|NCT01915498|323116807|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
94364245|NCT01915498|323116808|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
94364246|NCT01915498|323116809|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
94364247|NCT01915498|323116810|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
94364248|NCT01915498|323116811|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
94364249|NCT01915498|323116812|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
94364250|NCT01915498|323116813|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
94364251|NCT01915498|323116814|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
94364252|NCT01915498|323116815|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
94364253|NCT01915498|323116816|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
94364254|NCT01915498|323116817|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
94364255|NCT01915498|323116818|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
94364256|NCT01915498|323116819|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
94364257|NCT01915498|323116820|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
94364258|NCT01915498|323116802|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
94364259|NCT01915498|323116803|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
94364260|NCT01915498|323116804|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
94364261|NCT01915498|323116805|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
94364262|NCT01915498|323116806|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
94364263|NCT01915498|323116807|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
94364264|NCT01915498|323116808|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
94364265|NCT01915498|323116809|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
94364266|NCT01915498|323116810|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
94463515|NCT00084318|323485086|FG001|Overall Study|Protocol Violation|11|||
94463516|NCT00084318|323485085|FG000|Overall Study|No protocol treatment|2|||
94463517|NCT00084318|323485086|FG001|Overall Study|No protocol treatment|0|||
94463518|NCT01645891|323485090|FG000|Overall Study|Adverse Event|6|||
94463519|NCT01645891|323485091|FG001|Overall Study|Adverse Event|10|||
94463520|NCT01645891|323485090|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
94463521|NCT01645891|323485091|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
94463522|NCT01645891|323485090|FG000|Overall Study|Withdrawal by Subject|3|||
94463523|NCT01645891|323485091|FG001|Overall Study|Withdrawal by Subject|3|||
94463524|NCT01645891|323485090|FG000|Overall Study|Protocol Violation|4|||
94463525|NCT01645891|323485091|FG001|Overall Study|Protocol Violation|0|||
94463526|NCT01645891|323485090|FG000|Overall Study|Lost to Follow-up|4|||
94463527|NCT01645891|323485091|FG001|Overall Study|Lost to Follow-up|1|||
94463528|NCT01645891|323485090|FG000|Overall Study|Death|0|||
94463529|NCT01645891|323485091|FG001|Overall Study|Death|2|||
94463530|NCT01037127|323485092|FG000|Overall Study|Lost to Follow-up|2|||
94463531|NCT01037127|323485093|FG001|Overall Study|Lost to Follow-up|4|||
94463532|NCT01037127|323485092|FG000|Overall Study|Physician Decision|1|||
94463533|NCT01037127|323485093|FG001|Overall Study|Physician Decision|0|||
94463534|NCT01037127|323485092|FG000|Overall Study|Study Closed Terminated|2|||
94463535|NCT01037127|323485093|FG001|Overall Study|Study Closed Terminated|17|||
94463536|NCT05153148|323485094|FG000|Overall Study|Adverse Event|1|||
94463537|NCT05153148|323485095|FG001|Overall Study|Adverse Event|0|||
94463538|NCT05153148|323485096|FG002|Overall Study|Adverse Event|3|||
94463539|NCT05153148|323485097|FG003|Overall Study|Adverse Event|5|||
94463540|NCT05153148|323485094|FG000|Overall Study|Lost to Follow-up|1|||
94463541|NCT05153148|323485095|FG001|Overall Study|Lost to Follow-up|1|||
94463542|NCT05153148|323485096|FG002|Overall Study|Lost to Follow-up|2|||
94463543|NCT05153148|323485097|FG003|Overall Study|Lost to Follow-up|0|||
94463544|NCT05153148|323485094|FG000|Overall Study|Withdrawal by Subject|6|||
94463545|NCT05153148|323485095|FG001|Overall Study|Withdrawal by Subject|8|||
94463546|NCT05153148|323485096|FG002|Overall Study|Withdrawal by Subject|6|||
94463547|NCT05153148|323485097|FG003|Overall Study|Withdrawal by Subject|8|||
94463548|NCT05153148|323485094|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
94463549|NCT05153148|323485095|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
94463550|NCT05153148|323485096|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
94463551|NCT05153148|323485097|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
94463552|NCT05153148|323485094|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
94463553|NCT05153148|323485095|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
94463554|NCT05153148|323485096|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
94463555|NCT05153148|323485097|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
94463556|NCT05153148|323485094|FG000|Overall Study|Reason not Specified|1|||
94463557|NCT05153148|323485095|FG001|Overall Study|Reason not Specified|1|||
94463558|NCT05153148|323485096|FG002|Overall Study|Reason not Specified|1|||
94463559|NCT05153148|323485097|FG003|Overall Study|Reason not Specified|1|||
94463560|NCT02637713|323485101|FG000|Overall Study|Screen Failure|2|||
94463561|NCT00232596|323485102|FG000|6-Week Titration Phase|Adverse Event|6|||
94463562|NCT00232596|323485103|FG001|6-Week Titration Phase|Adverse Event|19|||
94463563|NCT00232596|323485102|FG000|6-Week Titration Phase|Failed to Return|2|||
94463564|NCT00232596|323485103|FG001|6-Week Titration Phase|Failed to Return|1|||
94463565|NCT00232596|323485102|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
94463566|NCT00232596|323485103|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
94463567|NCT00232596|323485102|FG000|6-Week Titration Phase|Protocol Violation|1|||
94463568|NCT00232596|323485103|FG001|6-Week Titration Phase|Protocol Violation|3|||
94463569|NCT00232596|323485102|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
94463570|NCT00232596|323485103|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
94463571|NCT00232596|323485102|FG000|6-Week Titration Phase|Other|3|||
94463572|NCT00232596|323485103|FG001|6-Week Titration Phase|Other|3|||
94463573|NCT00232596|323485102|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
94463574|NCT00232596|323485103|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
94463575|NCT00232596|323485102|FG000|12-Week Maintenance Phase|Adverse Event|7|||
94463576|NCT00232596|323485103|FG001|12-Week Maintenance Phase|Adverse Event|22|||
94463577|NCT00232596|323485102|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
94463578|NCT00232596|323485103|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
94463579|NCT00232596|323485102|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
94686587|NCT00152971|324307706|FG001|Overall Study|Protocol Violation|11|||
94263868|NCT02733185|322759960|FG000|Overall Study|Death|46|||
94463580|NCT00232596|323485103|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
94463581|NCT00232596|323485102|FG000|12-Week Maintenance Phase|Other|1|||
94463582|NCT00232596|323485103|FG001|12-Week Maintenance Phase|Other|3|||
94463583|NCT01732471|323485104|FG000|Overall Study|Withdrawal by Subject|1|||
94463584|NCT02987972|323485105|FG000|Overall Study|Adverse Event|1|||
94463585|NCT02987972|323485106|FG001|Overall Study|Adverse Event|1|||
94463586|NCT02987972|323485107|FG002|Overall Study|Adverse Event|0|||
94463587|NCT02987972|323485105|FG000|Overall Study|Death|1|||
94463588|NCT02987972|323485106|FG001|Overall Study|Death|0|||
94463589|NCT02987972|323485107|FG002|Overall Study|Death|0|||
94364267|NCT01915498|323116811|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
94364268|NCT01915498|323116812|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
94364269|NCT01915498|323116813|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
94364270|NCT01915498|323116814|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
94364271|NCT01915498|323116815|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
94364272|NCT01915498|323116816|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
94364273|NCT01915498|323116817|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
94364274|NCT01915498|323116818|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
94364275|NCT01915498|323116819|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
94364276|NCT01915498|323116820|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
94364277|NCT01907516|323116821|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
94364278|NCT01907516|323116822|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
94364279|NCT01907516|323116821|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
94364280|NCT01907516|323116822|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
94364281|NCT01907516|323116821|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
94364282|NCT01907516|323116822|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
94364283|NCT01907516|323116821|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
94364284|NCT01907516|323116822|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
94364285|NCT05004181|323116824|FG000|Overall Study|Withdrawal of consent|0|||
94364286|NCT05004181|323116825|FG001|Overall Study|Withdrawal of consent|0|||
94364287|NCT05004181|323116826|FG002|Overall Study|Withdrawal of consent|1|||
94364288|NCT05004181|323116827|FG003|Overall Study|Withdrawal of consent|3|||
94364289|NCT05004181|323116828|FG004|Overall Study|Withdrawal of consent|3|||
94364290|NCT05004181|323116829|FG005|Overall Study|Withdrawal of consent|0|||
94364291|NCT05004181|323116830|FG006|Overall Study|Withdrawal of consent|30|||
94364292|NCT05004181|323116831|FG007|Overall Study|Withdrawal of consent|9|||
94364293|NCT05004181|323116832|FG008|Overall Study|Withdrawal of consent|3|||
94364294|NCT05004181|323116833|FG009|Overall Study|Withdrawal of consent|2|||
94364295|NCT05004181|323116834|FG010|Overall Study|Withdrawal of consent|5|||
94364296|NCT05004181|323116835|FG011|Overall Study|Withdrawal of consent|1|||
94364297|NCT05004181|323116824|FG000|Overall Study|Lost to Follow-up|2|||
94364298|NCT05004181|323116825|FG001|Overall Study|Lost to Follow-up|4|||
94364299|NCT05004181|323116826|FG002|Overall Study|Lost to Follow-up|2|||
94364300|NCT05004181|323116827|FG003|Overall Study|Lost to Follow-up|3|||
94364301|NCT05004181|323116828|FG004|Overall Study|Lost to Follow-up|5|||
94364302|NCT05004181|323116829|FG005|Overall Study|Lost to Follow-up|2|||
94364303|NCT05004181|323116830|FG006|Overall Study|Lost to Follow-up|15|||
94364304|NCT05004181|323116831|FG007|Overall Study|Lost to Follow-up|12|||
94364305|NCT05004181|323116832|FG008|Overall Study|Lost to Follow-up|38|||
94364306|NCT05004181|323116833|FG009|Overall Study|Lost to Follow-up|6|||
94364307|NCT05004181|323116834|FG010|Overall Study|Lost to Follow-up|6|||
94364308|NCT05004181|323116835|FG011|Overall Study|Lost to Follow-up|0|||
94364309|NCT05004181|323116824|FG000|Overall Study|Death|0|||
94364310|NCT05004181|323116825|FG001|Overall Study|Death|0|||
94364311|NCT05004181|323116826|FG002|Overall Study|Death|0|||
94364312|NCT05004181|323116827|FG003|Overall Study|Death|0|||
94364313|NCT05004181|323116828|FG004|Overall Study|Death|0|||
94364314|NCT05004181|323116829|FG005|Overall Study|Death|0|||
94364315|NCT05004181|323116830|FG006|Overall Study|Death|1|||
94364316|NCT05004181|323116831|FG007|Overall Study|Death|0|||
94364317|NCT05004181|323116832|FG008|Overall Study|Death|2|||
94364318|NCT05004181|323116833|FG009|Overall Study|Death|0|||
94364319|NCT05004181|323116834|FG010|Overall Study|Death|0|||
94364320|NCT05004181|323116835|FG011|Overall Study|Death|0|||
94364321|NCT05004181|323116824|FG000|Overall Study|Physician Decision|0|||
94364322|NCT05004181|323116825|FG001|Overall Study|Physician Decision|0|||
94364323|NCT05004181|323116826|FG002|Overall Study|Physician Decision|0|||
94364324|NCT05004181|323116827|FG003|Overall Study|Physician Decision|0|||
94364325|NCT05004181|323116828|FG004|Overall Study|Physician Decision|0|||
94364326|NCT05004181|323116829|FG005|Overall Study|Physician Decision|0|||
94364327|NCT05004181|323116830|FG006|Overall Study|Physician Decision|2|||
94364328|NCT05004181|323116831|FG007|Overall Study|Physician Decision|0|||
94364329|NCT05004181|323116832|FG008|Overall Study|Physician Decision|7|||
94364330|NCT05004181|323116833|FG009|Overall Study|Physician Decision|0|||
94364331|NCT05004181|323116834|FG010|Overall Study|Physician Decision|0|||
94364332|NCT05004181|323116835|FG011|Overall Study|Physician Decision|0|||
94364333|NCT05004181|323116824|FG000|Overall Study|Withdrawal by Subject|2|||
94650153|NCT02161718|324176981|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
94686588|NCT00152971|324307707|FG002|Overall Study|Protocol Violation|8|||
94364334|NCT05004181|323116825|FG001|Overall Study|Withdrawal by Subject|3|||
94364335|NCT05004181|323116826|FG002|Overall Study|Withdrawal by Subject|2|||
94364336|NCT05004181|323116827|FG003|Overall Study|Withdrawal by Subject|2|||
94364337|NCT05004181|323116828|FG004|Overall Study|Withdrawal by Subject|4|||
94364338|NCT05004181|323116829|FG005|Overall Study|Withdrawal by Subject|2|||
94364339|NCT05004181|323116830|FG006|Overall Study|Withdrawal by Subject|4|||
94463590|NCT02987972|323485105|FG000|Overall Study|Lack of Efficacy|9|||
94364340|NCT05004181|323116831|FG007|Overall Study|Withdrawal by Subject|22|||
94364341|NCT05004181|323116832|FG008|Overall Study|Withdrawal by Subject|8|||
94364342|NCT05004181|323116833|FG009|Overall Study|Withdrawal by Subject|1|||
94364343|NCT05004181|323116834|FG010|Overall Study|Withdrawal by Subject|3|||
94364344|NCT05004181|323116835|FG011|Overall Study|Withdrawal by Subject|2|||
94364345|NCT05004181|323116824|FG000|Overall Study|Protocol Violation|2|||
94364346|NCT05004181|323116825|FG001|Overall Study|Protocol Violation|3|||
94364347|NCT05004181|323116826|FG002|Overall Study|Protocol Violation|0|||
94364348|NCT05004181|323116827|FG003|Overall Study|Protocol Violation|0|||
94364349|NCT05004181|323116828|FG004|Overall Study|Protocol Violation|1|||
94364350|NCT05004181|323116829|FG005|Overall Study|Protocol Violation|0|||
94364351|NCT05004181|323116830|FG006|Overall Study|Protocol Violation|16|||
94364352|NCT05004181|323116831|FG007|Overall Study|Protocol Violation|18|||
94364353|NCT05004181|323116832|FG008|Overall Study|Protocol Violation|2|||
94364354|NCT05004181|323116833|FG009|Overall Study|Protocol Violation|2|||
94364355|NCT05004181|323116834|FG010|Overall Study|Protocol Violation|2|||
94364356|NCT05004181|323116835|FG011|Overall Study|Protocol Violation|1|||
94364357|NCT05004181|323116824|FG000|Overall Study|Not further specified|1|||
94364358|NCT05004181|323116825|FG001|Overall Study|Not further specified|0|||
94364359|NCT05004181|323116826|FG002|Overall Study|Not further specified|0|||
94364360|NCT05004181|323116827|FG003|Overall Study|Not further specified|0|||
94364361|NCT05004181|323116828|FG004|Overall Study|Not further specified|0|||
94364362|NCT05004181|323116829|FG005|Overall Study|Not further specified|0|||
94364363|NCT05004181|323116830|FG006|Overall Study|Not further specified|1|||
94364364|NCT05004181|323116831|FG007|Overall Study|Not further specified|0|||
94364365|NCT05004181|323116832|FG008|Overall Study|Not further specified|2|||
94364366|NCT05004181|323116833|FG009|Overall Study|Not further specified|1|||
94364367|NCT05004181|323116834|FG010|Overall Study|Not further specified|0|||
94364368|NCT05004181|323116835|FG011|Overall Study|Not further specified|1|||
94364369|NCT03505606|323118454|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
94364370|NCT03505606|323118455|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
94364371|NCT03505606|323118456|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
94364372|NCT03505606|323118454|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
94364373|NCT03505606|323118455|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
94364374|NCT03505606|323118456|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
94364375|NCT03505606|323118454|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
94364376|NCT03505606|323118455|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
94364377|NCT03505606|323118456|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
94364378|NCT03505606|323118454|FG000|Overall Study|Poor compliance with refractive correction|0|||
94364379|NCT03505606|323118455|FG001|Overall Study|Poor compliance with refractive correction|0|||
94364380|NCT03505606|323118456|FG002|Overall Study|Poor compliance with refractive correction|1|||
94364381|NCT03505606|323118454|FG000|Overall Study|Insufficient anisometropia|0|||
94364382|NCT03505606|323118455|FG001|Overall Study|Insufficient anisometropia|0|||
94364383|NCT03505606|323118456|FG002|Overall Study|Insufficient anisometropia|2|||
94364384|NCT03505606|323118454|FG000|Overall Study|Ectopia Lentis|0|||
94364385|NCT03505606|323118455|FG001|Overall Study|Ectopia Lentis|0|||
94364386|NCT03505606|323118456|FG002|Overall Study|Ectopia Lentis|1|||
94364387|NCT03505606|323118454|FG000|Overall Study|alternation of amblyopic eye|0|||
94364388|NCT03505606|323118455|FG001|Overall Study|alternation of amblyopic eye|1|||
94364389|NCT03505606|323118456|FG002|Overall Study|alternation of amblyopic eye|0|||
94364390|NCT01017731|323118457|FG000|Overall Study|Lost to Follow-up|2|||
94364391|NCT01017731|323118457|FG000|Overall Study|Withdrawal by Subject|3|||
94364392|NCT01017731|323118457|FG000|Overall Study|Physician Decision|2|||
94364393|NCT01017731|323118457|FG000|Overall Study|Adverse Event|1|||
94364394|NCT02875340|323118458|FG000|Overall Study|Death|2|||
94364395|NCT02875340|323118458|FG000|Overall Study|Withdrawal by Subject|2|||
94364396|NCT02875340|323118458|FG000|Overall Study|Physician Decision|3|||
94364397|NCT02875340|323118458|FG000|Overall Study|Adverse Event|1|||
94364398|NCT03926728|323118459|FG000|Overall Study|Withdrawal by Subject|0|||
94364399|NCT03926728|323118460|FG001|Overall Study|Withdrawal by Subject|1|||
94364400|NCT03926728|323118461|FG002|Overall Study|Withdrawal by Subject|1|||
94364401|NCT03926728|323118462|FG003|Overall Study|Withdrawal by Subject|0|||
94364402|NCT03926728|323118463|FG004|Overall Study|Withdrawal by Subject|0|||
94364403|NCT03926728|323118464|FG005|Overall Study|Withdrawal by Subject|1|||
94364404|NCT03926728|323118465|FG006|Overall Study|Withdrawal by Subject|1|||
94364405|NCT03926728|323118466|FG007|Overall Study|Withdrawal by Subject|0|||
94364406|NCT03926728|323118467|FG008|Overall Study|Withdrawal by Subject|0|||
94364407|NCT03926728|323118468|FG009|Overall Study|Withdrawal by Subject|1|||
94364408|NCT03926728|323118469|FG010|Overall Study|Withdrawal by Subject|0|||
94364409|NCT03926728|323118470|FG011|Overall Study|Withdrawal by Subject|0|||
94364410|NCT04311411|323118471|FG000|Overall Study|Adverse Event|2|||
94364411|NCT04311411|323118472|FG001|Overall Study|Adverse Event|3|||
94364412|NCT04311411|323118473|FG002|Overall Study|Adverse Event|2|||
94364413|NCT04311411|323118471|FG000|Overall Study|Withdrawal by Subject|3|||
94463591|NCT02987972|323485106|FG001|Overall Study|Lack of Efficacy|12|||
94463592|NCT02987972|323485107|FG002|Overall Study|Lack of Efficacy|12|||
94463593|NCT02987972|323485105|FG000|Overall Study|Lost to Follow-up|7|||
94463594|NCT02987972|323485106|FG001|Overall Study|Lost to Follow-up|8|||
94463595|NCT02987972|323485107|FG002|Overall Study|Lost to Follow-up|4|||
94463596|NCT02987972|323485105|FG000|Overall Study|Physician Decision|1|||
94463597|NCT02987972|323485106|FG001|Overall Study|Physician Decision|6|||
94463598|NCT02987972|323485107|FG002|Overall Study|Physician Decision|0|||
94463599|NCT02987972|323485105|FG000|Overall Study|Protocol Violation|2|||
94463600|NCT02987972|323485106|FG001|Overall Study|Protocol Violation|1|||
94463601|NCT02987972|323485107|FG002|Overall Study|Protocol Violation|5|||
94463602|NCT02987972|323485105|FG000|Overall Study|Withdrawal by Subject|22|||
94463603|NCT02987972|323485106|FG001|Overall Study|Withdrawal by Subject|17|||
94463604|NCT02987972|323485107|FG002|Overall Study|Withdrawal by Subject|21|||
94463605|NCT01047332|323485110|FG000|Overall Study|SEMS Obstruction|11|||
94463606|NCT01047332|323485111|FG001|Overall Study|SEMS Obstruction|20|||
94463607|NCT01047332|323485110|FG000|Overall Study|Died Unobstructed|38|||
94463608|NCT01047332|323485111|FG001|Overall Study|Died Unobstructed|41|||
94463609|NCT01047332|323485110|FG000|Overall Study|Lost to Follow-up|8|||
94463610|NCT01047332|323485111|FG001|Overall Study|Lost to Follow-up|3|||
94463611|NCT03495154|323485112|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
94463612|NCT03495154|323485112|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
94463613|NCT03495154|323485112|FG000|Overall Study|Screen Failures During Surgery|6|||
94463614|NCT03495154|323485112|FG000|Overall Study|Death|2|||
94463615|NCT03495154|323485112|FG000|Overall Study|Lost to Follow-up|16|||
94463616|NCT03495154|323485112|FG000|Overall Study|Withdrawal by Subject|2|||
94463617|NCT03495154|323485112|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
94463618|NCT00787917|323485113|FG000|Blinded Treatment|Adverse Event|1|||
94463619|NCT00787917|323485114|FG001|Blinded Treatment|Adverse Event|0|||
94463620|NCT00787917|323485113|FG000|Blinded Treatment|Lack of Efficacy|1|||
94463621|NCT00787917|323485114|FG001|Blinded Treatment|Lack of Efficacy|0|||
94463622|NCT00787917|323485113|FG000|Blinded Treatment|Administrative problems|3|||
94463623|NCT00787917|323485114|FG001|Blinded Treatment|Administrative problems|2|||
94463624|NCT00787917|323485113|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
94463625|NCT00787917|323485114|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
94463626|NCT00787917|323485113|FG000|Open Label|Administrative problems|3|||
94463627|NCT00787917|323485114|FG001|Open Label|Administrative problems|0|||
94463628|NCT04506905|323485115|FG000|Overall Study|Lost to Follow-up|1|||
94463629|NCT04506905|323485116|FG001|Overall Study|Lost to Follow-up|0|||
94463630|NCT04506905|323485117|FG002|Overall Study|Lost to Follow-up|0|||
94463631|NCT04506905|323485118|FG003|Overall Study|Lost to Follow-up|1|||
94463632|NCT04506905|323485119|FG004|Overall Study|Lost to Follow-up|0|||
94463633|NCT04506905|323485120|FG005|Overall Study|Lost to Follow-up|0|||
94463634|NCT04506905|323485121|FG006|Overall Study|Lost to Follow-up|0|||
94463635|NCT04506905|323485122|FG007|Overall Study|Lost to Follow-up|0|||
94463636|NCT04506905|323485123|FG008|Overall Study|Lost to Follow-up|0|||
94463637|NCT04506905|323485115|FG000|Overall Study|Withdrawal by Subject|0|||
94463638|NCT04506905|323485116|FG001|Overall Study|Withdrawal by Subject|0|||
94463639|NCT04506905|323485117|FG002|Overall Study|Withdrawal by Subject|0|||
94463640|NCT04506905|323485118|FG003|Overall Study|Withdrawal by Subject|2|||
94650154|NCT02161718|324176982|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
94364414|NCT04311411|323118472|FG001|Overall Study|Withdrawal by Subject|3|||
94364415|NCT04311411|323118473|FG002|Overall Study|Withdrawal by Subject|0|||
94364416|NCT01817764|323118474|FG000|Overall Study|Adverse Event|7|||
94364417|NCT01817764|323118475|FG001|Overall Study|Adverse Event|10|||
94364418|NCT01817764|323118474|FG000|Overall Study|Lack of Efficacy|9|||
94364419|NCT01817764|323118475|FG001|Overall Study|Lack of Efficacy|7|||
94364420|NCT01817764|323118474|FG000|Overall Study|Protocol Violation|7|||
94364421|NCT01817764|323118475|FG001|Overall Study|Protocol Violation|5|||
94364422|NCT01817764|323118474|FG000|Overall Study|Lost to Follow-up|1|||
94364423|NCT01817764|323118475|FG001|Overall Study|Lost to Follow-up|4|||
94364424|NCT01817764|323118474|FG000|Overall Study|Withdrawal by Subject|10|||
94364425|NCT01817764|323118475|FG001|Overall Study|Withdrawal by Subject|12|||
94364426|NCT04465916|323118476|FG000|Overall Study|Withdrawal by Subject|0|||
94364427|NCT04465916|323118477|FG001|Overall Study|Withdrawal by Subject|1|||
94364428|NCT00826176|323118478|FG000|Overall Study|Lost to Follow-up|1|||
94364429|NCT00826176|323118479|FG001|Overall Study|Lost to Follow-up|0|||
94463641|NCT04506905|323485119|FG004|Overall Study|Withdrawal by Subject|0|||
94463642|NCT04506905|323485120|FG005|Overall Study|Withdrawal by Subject|0|||
94463643|NCT04506905|323485121|FG006|Overall Study|Withdrawal by Subject|0|||
94463644|NCT04506905|323485122|FG007|Overall Study|Withdrawal by Subject|0|||
94463645|NCT04506905|323485123|FG008|Overall Study|Withdrawal by Subject|0|||
94463646|NCT02417961|323486717|FG000|Overall Study|Adverse Event|1|||
94463647|NCT02417961|323486717|FG000|Overall Study|Lost to Follow-up|1|||
94463648|NCT02417961|323486717|FG000|Overall Study|Withdrawal by Subject|2|||
94650155|NCT02161718|324176983|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
94364430|NCT00826176|323118478|FG000|Overall Study|Subject Withdrew Consent|3|||
94686589|NCT00152971|324307705|FG000|Overall Study|Lost to Follow-up|17|||
94686590|NCT00152971|324307706|FG001|Overall Study|Lost to Follow-up|14|||
94686591|NCT00152971|324307707|FG002|Overall Study|Lost to Follow-up|13|||
94686592|NCT00152971|324307705|FG000|Overall Study|Withdrawal by Subject|9|||
94686593|NCT00152971|324307706|FG001|Overall Study|Withdrawal by Subject|8|||
94686594|NCT00152971|324307707|FG002|Overall Study|Withdrawal by Subject|14|||
94686595|NCT00152971|324307705|FG000|Overall Study|Other|3|||
94686596|NCT00152971|324307706|FG001|Overall Study|Other|5|||
94686597|NCT00152971|324307707|FG002|Overall Study|Other|5|||
94686598|NCT00152971|324307705|FG000|Treatment|Adverse Event|49|||
94686599|NCT00152971|324307706|FG001|Treatment|Adverse Event|40|||
94686600|NCT00152971|324307707|FG002|Treatment|Adverse Event|54|||
94686601|NCT00152971|324307705|FG000|Treatment|Protocol Violation|8|||
94686602|NCT00152971|324307706|FG001|Treatment|Protocol Violation|6|||
94686603|NCT00152971|324307707|FG002|Treatment|Protocol Violation|10|||
94686604|NCT00152971|324307705|FG000|Treatment|Lost to Follow-up|1|||
94686605|NCT00152971|324307706|FG001|Treatment|Lost to Follow-up|2|||
94686606|NCT00152971|324307707|FG002|Treatment|Lost to Follow-up|1|||
94686607|NCT00152971|324307705|FG000|Treatment|Withdrawal by Subject|4|||
94686608|NCT00152971|324307706|FG001|Treatment|Withdrawal by Subject|4|||
94686609|NCT00152971|324307707|FG002|Treatment|Withdrawal by Subject|5|||
94364431|NCT00826176|323118479|FG001|Overall Study|Subject Withdrew Consent|0|||
94364432|NCT00826176|323118478|FG000|Overall Study|Administrative|9|||
94364433|NCT00826176|323118479|FG001|Overall Study|Administrative|0|||
94364434|NCT04057118|323118482|FG000|Overall Study|Adverse Event|1|||
94463649|NCT04488419|323486718|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
94463650|NCT04488419|323486719|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
94463651|NCT04488419|323486720|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
94463652|NCT04488419|323486718|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
94463653|NCT04488419|323486719|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
94463654|NCT04488419|323486720|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
94463655|NCT04488419|323486718|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
94463656|NCT04488419|323486719|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
94463657|NCT04488419|323486720|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
94463658|NCT04488419|323486718|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
94463659|NCT04488419|323486719|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
94463660|NCT04488419|323486720|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
94463661|NCT04488419|323486718|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
94463662|NCT04488419|323486719|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
94463663|NCT04488419|323486720|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
94463664|NCT04488419|323486718|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
94463665|NCT04488419|323486719|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
94463666|NCT04488419|323486720|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
94463667|NCT04488419|323486718|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
94463668|NCT04488419|323486719|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
94463669|NCT04488419|323486720|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
94463670|NCT04488419|323486718|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
94463671|NCT04488419|323486719|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
94463672|NCT04488419|323486720|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
94463673|NCT04488419|323486718|FG000|Primary Analysis Population|Adverse Event|6|||
94463674|NCT04488419|323486719|FG001|Primary Analysis Population|Adverse Event|9|||
94364435|NCT04057118|323118483|FG001|Overall Study|Adverse Event|0|||
94364436|NCT04057118|323118484|FG002|Overall Study|Adverse Event|1|||
94364437|NCT04057118|323118485|FG003|Overall Study|Adverse Event|1|||
94364438|NCT04057118|323118482|FG000|Overall Study|Physician Decision|0|||
94364439|NCT04057118|323118483|FG001|Overall Study|Physician Decision|0|||
94364440|NCT04057118|323118484|FG002|Overall Study|Physician Decision|1|||
94364441|NCT04057118|323118485|FG003|Overall Study|Physician Decision|1|||
94364442|NCT04057118|323118482|FG000|Overall Study|Withdrawal by Subject|2|||
94364443|NCT04057118|323118483|FG001|Overall Study|Withdrawal by Subject|2|||
94364444|NCT04057118|323118484|FG002|Overall Study|Withdrawal by Subject|0|||
94364445|NCT04057118|323118485|FG003|Overall Study|Withdrawal by Subject|2|||
94463675|NCT04488419|323486720|FG002|Primary Analysis Population|Adverse Event|0|||
94463676|NCT04488419|323486718|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
94463677|NCT04488419|323486719|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
94686610|NCT00152971|324307705|FG000|Treatment|Other|9|||
94686611|NCT00152971|324307706|FG001|Treatment|Other|11|||
94686612|NCT00152971|324307707|FG002|Treatment|Other|10|||
94686613|NCT01613027|324307708|FG000|Overall Study|Lost to Follow-up|5|||
94364446|NCT04057118|323118482|FG000|Overall Study|Not Specific|0|||
94364447|NCT04057118|323118483|FG001|Overall Study|Not Specific|0|||
94364448|NCT04057118|323118484|FG002|Overall Study|Not Specific|1|||
94364449|NCT04057118|323118485|FG003|Overall Study|Not Specific|1|||
94463678|NCT04488419|323486720|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
94463679|NCT04488419|323486718|FG000|Primary Analysis Population|Protocol Violation|1|||
94463680|NCT04488419|323486719|FG001|Primary Analysis Population|Protocol Violation|1|||
94463681|NCT04488419|323486720|FG002|Primary Analysis Population|Protocol Violation|0|||
94364450|NCT01179191|323118486|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
94364451|NCT01179191|323118486|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
94364452|NCT01179191|323118486|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
94364453|NCT01179191|323118486|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
94364454|NCT01179191|323118486|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
94364455|NCT01179191|323118486|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
94364456|NCT01179191|323118486|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
94364457|NCT01179191|323118486|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
94364458|NCT01179191|323118486|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
94364459|NCT01179191|323118486|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
94364460|NCT01179191|323118486|FG000|Maintenance Phase (8 Weeks)|Other|66|||
94364461|NCT00595127|323118487|FG000|Overall Study|Death|6|||
94364462|NCT00595127|323118487|FG000|Overall Study|Relapsed|3|||
94364463|NCT00595127|323118487|FG000|Overall Study|joined another trial|1|||
94364464|NCT01785472|323118488|FG000|Overall Study|Adverse Event|5|||
94364465|NCT01785472|323118489|FG001|Overall Study|Adverse Event|4|||
94364466|NCT01785472|323118490|FG002|Overall Study|Adverse Event|6|||
94463682|NCT04488419|323486718|FG000|Primary Analysis Population|Undetermined|7|||
94463683|NCT04488419|323486719|FG001|Primary Analysis Population|Undetermined|3|||
94463684|NCT04488419|323486720|FG002|Primary Analysis Population|Undetermined|0|||
94463685|NCT04488419|323486718|FG000|Primary Analysis Population|>1 Reason|2|||
94463686|NCT04488419|323486719|FG001|Primary Analysis Population|>1 Reason|4|||
94463687|NCT04488419|323486720|FG002|Primary Analysis Population|>1 Reason|0|||
94463688|NCT04743804|323486723|FG000|Overall Study|Other|1|||
94463689|NCT04743804|323486724|FG001|Overall Study|Other|0|||
94463690|NCT04743804|323486723|FG000|Overall Study|Withdrawal by Subject|0|||
94463691|NCT04743804|323486724|FG001|Overall Study|Withdrawal by Subject|1|||
94463692|NCT04743804|323486723|FG000|Overall Study|Study Terminated by Sponsor|1|||
94463693|NCT04743804|323486724|FG001|Overall Study|Study Terminated by Sponsor|4|||
94463694|NCT04743804|323486723|FG000|Overall Study|Physician Decision|0|||
94463695|NCT04743804|323486724|FG001|Overall Study|Physician Decision|1|||
94463696|NCT04743804|323486723|FG000|Overall Study|Death|3|||
94463697|NCT04743804|323486724|FG001|Overall Study|Death|0|||
94463698|NCT02059434|323486728|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
94463699|NCT02059434|323486729|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
94463700|NCT02059434|323486730|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
94463701|NCT02059434|323486731|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
94463702|NCT02059434|323486732|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
94463703|NCT02059434|323486733|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
94463704|NCT02059434|323486734|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
94463705|NCT02059434|323486735|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
94463706|NCT02059434|323486736|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
94463707|NCT02059434|323486728|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
94463708|NCT02059434|323486729|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
94463709|NCT02059434|323486730|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
94463710|NCT02059434|323486731|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
94463711|NCT02059434|323486732|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
94463712|NCT02059434|323486733|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
94463713|NCT02059434|323486734|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
94463714|NCT02059434|323486735|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
94463715|NCT02059434|323486736|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
94463716|NCT02059434|323486728|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
94463717|NCT02059434|323486729|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
94463718|NCT02059434|323486730|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
94364467|NCT01785472|323118488|FG000|Overall Study|Lack of Efficacy|2|||
94364468|NCT01785472|323118489|FG001|Overall Study|Lack of Efficacy|0|||
94364469|NCT01785472|323118490|FG002|Overall Study|Lack of Efficacy|1|||
94364470|NCT01785472|323118488|FG000|Overall Study|Lost to Follow-up|1|||
94364471|NCT01785472|323118489|FG001|Overall Study|Lost to Follow-up|2|||
94463719|NCT02059434|323486731|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
94463720|NCT02059434|323486732|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
94463721|NCT02059434|323486733|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
94364472|NCT01785472|323118490|FG002|Overall Study|Lost to Follow-up|0|||
94364473|NCT01785472|323118488|FG000|Overall Study|Physician Decision|1|||
94364474|NCT01785472|323118489|FG001|Overall Study|Physician Decision|1|||
94463722|NCT02059434|323486734|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
94364475|NCT01785472|323118490|FG002|Overall Study|Physician Decision|1|||
94364476|NCT01785472|323118488|FG000|Overall Study|Protocol deviation|0|||
94364477|NCT01785472|323118489|FG001|Overall Study|Protocol deviation|2|||
94364478|NCT01785472|323118490|FG002|Overall Study|Protocol deviation|2|||
94364479|NCT01785472|323118488|FG000|Overall Study|Subject/guardian decision|15|||
94364480|NCT01785472|323118489|FG001|Overall Study|Subject/guardian decision|10|||
94364481|NCT01785472|323118490|FG002|Overall Study|Subject/guardian decision|11|||
94364482|NCT01785472|323118488|FG000|Overall Study|Technical problems|0|||
94364483|NCT01785472|323118489|FG001|Overall Study|Technical problems|0|||
94650156|NCT02161718|324176981|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
94650157|NCT02161718|324176982|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
94650158|NCT02161718|324176983|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
94650159|NCT02161718|324176981|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
94650160|NCT02161718|324176982|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
94650161|NCT02161718|324176983|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
94650162|NCT02161718|324176981|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
94650163|NCT02161718|324176982|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
94650164|NCT02161718|324176983|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
94650165|NCT02161718|324176981|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
94650166|NCT02161718|324176982|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
94650167|NCT02161718|324176983|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
94650168|NCT02161718|324176981|FG000|Post- Randomization Period|Lost to Follow-up|0|||
94650169|NCT02161718|324176982|FG001|Post- Randomization Period|Lost to Follow-up|9|||
94650170|NCT02161718|324176983|FG002|Post- Randomization Period|Lost to Follow-up|15|||
94650171|NCT02161718|324176981|FG000|Post- Randomization Period|Adverse Event|0|||
94650172|NCT02161718|324176982|FG001|Post- Randomization Period|Adverse Event|9|||
94650173|NCT02161718|324176983|FG002|Post- Randomization Period|Adverse Event|10|||
94650174|NCT02161718|324176981|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
94650175|NCT02161718|324176982|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
94364484|NCT01785472|323118490|FG002|Overall Study|Technical problems|1|||
94364485|NCT01569074|323118494|FG000|Overall Study|Study stopped|6|||
94364486|NCT01569074|323118495|FG001|Overall Study|Study stopped|6|||
94364487|NCT01569074|323118496|FG002|Overall Study|Study stopped|8|||
94364488|NCT01569074|323118497|FG003|Overall Study|Study stopped|7|||
94364489|NCT01569074|323118498|FG004|Overall Study|Study stopped|7|||
94364490|NCT01569074|323118494|FG000|Overall Study|Study-specific discontinuation criteria|0|||
94364491|NCT01569074|323118495|FG001|Overall Study|Study-specific discontinuation criteria|1|||
94364492|NCT01569074|323118496|FG002|Overall Study|Study-specific discontinuation criteria|0|||
94364493|NCT01569074|323118497|FG003|Overall Study|Study-specific discontinuation criteria|0|||
94364494|NCT01569074|323118498|FG004|Overall Study|Study-specific discontinuation criteria|0|||
94364495|NCT01569074|323118494|FG000|Overall Study|Severe non-compliance to protocol|0|||
94364496|NCT01569074|323118495|FG001|Overall Study|Severe non-compliance to protocol|0|||
94364497|NCT01569074|323118496|FG002|Overall Study|Severe non-compliance to protocol|1|||
94364498|NCT01569074|323118497|FG003|Overall Study|Severe non-compliance to protocol|0|||
94364499|NCT01569074|323118498|FG004|Overall Study|Severe non-compliance to protocol|0|||
94364500|NCT01569074|323118494|FG000|Overall Study|eg change in circumstances|0|||
94364501|NCT01569074|323118495|FG001|Overall Study|eg change in circumstances|2|||
94364502|NCT01569074|323118496|FG002|Overall Study|eg change in circumstances|0|||
94364503|NCT01569074|323118497|FG003|Overall Study|eg change in circumstances|1|||
94364504|NCT01569074|323118498|FG004|Overall Study|eg change in circumstances|1|||
94364505|NCT01569074|323118494|FG000|Overall Study|Adverse Event|1|||
94364506|NCT01569074|323118495|FG001|Overall Study|Adverse Event|0|||
94364507|NCT01569074|323118496|FG002|Overall Study|Adverse Event|3|||
94364508|NCT01569074|323118497|FG003|Overall Study|Adverse Event|0|||
94364509|NCT01569074|323118498|FG004|Overall Study|Adverse Event|0|||
94364510|NCT04856917|323118499|FG000|Overall Study|Withdrawal by Subject|4|||
94364511|NCT04856917|323118500|FG001|Overall Study|Withdrawal by Subject|3|||
94650176|NCT02161718|324176983|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
94650177|NCT02161718|324176981|FG000|Post- Randomization Period|Physician Decision|0|||
94650178|NCT02161718|324176982|FG001|Post- Randomization Period|Physician Decision|2|||
94364512|NCT04856917|323118501|FG002|Overall Study|Withdrawal by Subject|1|||
94364513|NCT04856917|323118499|FG000|Overall Study|Lost to Follow-up|3|||
94364514|NCT04856917|323118500|FG001|Overall Study|Lost to Follow-up|1|||
94364515|NCT04856917|323118501|FG002|Overall Study|Lost to Follow-up|1|||
94364516|NCT04856917|323118499|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
94364517|NCT04856917|323118500|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
94364518|NCT04856917|323118501|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
94364519|NCT04856917|323118499|FG000|Overall Study|Other|1|||
94364520|NCT04856917|323118500|FG001|Overall Study|Other|1|||
94364521|NCT04856917|323118501|FG002|Overall Study|Other|0|||
94364522|NCT01360021|323118502|FG000|Overall Study|Eligibility criteria + other|2|||
94364523|NCT01360021|323118503|FG001|Overall Study|Eligibility criteria + other|1|||
94364524|NCT01360021|323118504|FG002|Overall Study|Eligibility criteria + other|1|||
94364525|NCT01360021|323118502|FG000|Overall Study|Protocol Violation|0|||
94364526|NCT01360021|323118503|FG001|Overall Study|Protocol Violation|0|||
94364527|NCT01360021|323118504|FG002|Overall Study|Protocol Violation|1|||
94650179|NCT02161718|324176983|FG002|Post- Randomization Period|Physician Decision|4|||
94650180|NCT02161718|324176981|FG000|Post- Randomization Period|Protocol Violation|0|||
94650181|NCT02161718|324176982|FG001|Post- Randomization Period|Protocol Violation|2|||
94650182|NCT02161718|324176983|FG002|Post- Randomization Period|Protocol Violation|3|||
94650183|NCT02161718|324176981|FG000|Post- Randomization Period|Lack of Efficacy|0|||
94650184|NCT02161718|324176982|FG001|Post- Randomization Period|Lack of Efficacy|0|||
94650185|NCT02161718|324176983|FG002|Post- Randomization Period|Lack of Efficacy|1|||
94650186|NCT02161718|324176981|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
94650187|NCT02161718|324176982|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
94650188|NCT02161718|324176983|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
94650189|NCT02161718|324176981|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
94650190|NCT02161718|324176982|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
94650191|NCT02161718|324176983|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
94650192|NCT02161718|324176981|FG000|Post- Randomization Period|Relocation|0|||
94650193|NCT02161718|324176982|FG001|Post- Randomization Period|Relocation|3|||
94650194|NCT02161718|324176983|FG002|Post- Randomization Period|Relocation|0|||
94650195|NCT02948842|324176984|FG000|Overall Study|Withdrawal by Subject|4|||
94650196|NCT01020019|324176985|FG000|Overall Study|Lost to Follow-up|21|||
94650197|NCT01020019|324176986|FG001|Overall Study|Lost to Follow-up|18|||
94650198|NCT01020019|324176985|FG000|Overall Study|Adverse Event|1|||
94650199|NCT01020019|324176986|FG001|Overall Study|Adverse Event|5|||
94650200|NCT01020019|324176985|FG000|Overall Study|not interested in treatment|4|||
94650201|NCT01020019|324176986|FG001|Overall Study|not interested in treatment|4|||
94650202|NCT01020019|324176985|FG000|Overall Study|moving|0|||
94650203|NCT01020019|324176986|FG001|Overall Study|moving|2|||
94650204|NCT03120013|324176989|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
94650205|NCT03120013|324176990|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
94650206|NCT01565291|324176991|FG000|Overall Study|Withdrawal by Subject|1|||
94650207|NCT01565291|324176992|FG001|Overall Study|Withdrawal by Subject|0|||
94650208|NCT02673775|324176993|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
94650209|NCT02673775|324176994|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
94650210|NCT02673775|324176993|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
94650211|NCT02673775|324176994|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
94650212|NCT02673775|324176993|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
94650213|NCT02673775|324176994|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
94650214|NCT02673775|324176993|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
94650215|NCT02673775|324176994|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
94650216|NCT00515827|324176995|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
94686614|NCT01613027|324307708|FG000|Overall Study|Switched Physician|1|||
94686615|NCT01613027|324307708|FG000|Overall Study|Lack of Efficacy|1|||
94686616|NCT01613027|324307708|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
94650217|NCT00515827|324176996|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
94650218|NCT00515827|324176995|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
94650219|NCT00515827|324176996|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
94650220|NCT01365273|324176999|FG000|Overall Study|Lost to Follow-up|1|||
94650221|NCT01365273|324177000|FG001|Overall Study|Lost to Follow-up|0|||
94650222|NCT01365273|324176999|FG000|Overall Study|Protocol Violation|0|||
94650223|NCT01365273|324177000|FG001|Overall Study|Protocol Violation|1|||
94650224|NCT01365273|324176999|FG000|Overall Study|Physician Decision|1|||
94650225|NCT01365273|324177000|FG001|Overall Study|Physician Decision|0|||
94650226|NCT03254134|324177004|FG000|Overall Study|Not eligible patients|599|||
94650227|NCT03254134|324177005|FG001|Overall Study|Not eligible patients|3630|||
94650228|NCT00806546|324177023|FG000|Overall Study|Enrolled, not treated|35|||
94650229|NCT00806546|324177023|FG000|Overall Study|Lost to Follow-up|32|||
94650230|NCT00806546|324177023|FG000|Overall Study|Adverse Event|74|||
94650231|NCT00806546|324177023|FG000|Overall Study|Withdrawal by Subject|75|||
94650232|NCT00806546|324177023|FG000|Overall Study|Protocol Violation|49|||
94650233|NCT00806546|324177023|FG000|Overall Study|Various|42|||
94650234|NCT02188485|324177024|FG000|Overall Study|Withdrawal by Subject|2|||
94650235|NCT02188485|324177025|FG001|Overall Study|Withdrawal by Subject|1|||
94650236|NCT02188485|324177024|FG000|Overall Study|PI withdrew, lack of capacity|0|||
94650237|NCT02188485|324177025|FG001|Overall Study|PI withdrew, lack of capacity|2|||
94650238|NCT02457325|324177027|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
94650239|NCT02457325|324177028|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
94650240|NCT01574703|324177029|FG000|Overall Study|Adverse Event|0|||
94650241|NCT01574703|324177030|FG001|Overall Study|Adverse Event|2|||
94650242|NCT01574703|324177031|FG002|Overall Study|Adverse Event|1|||
94650243|NCT01574703|324177032|FG003|Overall Study|Adverse Event|1|||
94650244|NCT01574703|324177029|FG000|Overall Study|Protocol Violation|0|||
94650245|NCT01574703|324177030|FG001|Overall Study|Protocol Violation|0|||
94650246|NCT01574703|324177031|FG002|Overall Study|Protocol Violation|0|||
94650247|NCT01574703|324177032|FG003|Overall Study|Protocol Violation|1|||
94650248|NCT01574703|324177029|FG000|Overall Study|Unspecified Reason|27|||
94650249|NCT01574703|324177030|FG001|Overall Study|Unspecified Reason|15|||
94650250|NCT01574703|324177031|FG002|Overall Study|Unspecified Reason|20|||
94650251|NCT01574703|324177032|FG003|Overall Study|Unspecified Reason|16|||
94650252|NCT01574703|324177029|FG000|Overall Study|Withdrawal by Subject|53|||
94650253|NCT01574703|324177030|FG001|Overall Study|Withdrawal by Subject|52|||
94650254|NCT01574703|324177031|FG002|Overall Study|Withdrawal by Subject|36|||
94650255|NCT01574703|324177032|FG003|Overall Study|Withdrawal by Subject|61|||
94650256|NCT01574703|324177029|FG000|Overall Study|Met Withdrawal Criteria|0|||
94650257|NCT01574703|324177030|FG001|Overall Study|Met Withdrawal Criteria|1|||
94650258|NCT01574703|324177031|FG002|Overall Study|Met Withdrawal Criteria|1|||
94650259|NCT01574703|324177032|FG003|Overall Study|Met Withdrawal Criteria|0|||
94650260|NCT01574703|324177029|FG000|Overall Study|Lost to Follow-up|43|||
94650261|NCT01574703|324177030|FG001|Overall Study|Lost to Follow-up|41|||
94650262|NCT01574703|324177031|FG002|Overall Study|Lost to Follow-up|46|||
94650263|NCT01574703|324177032|FG003|Overall Study|Lost to Follow-up|35|||
94650264|NCT01574703|324177029|FG000|Overall Study|Death|2|||
94650265|NCT01574703|324177030|FG001|Overall Study|Death|1|||
94650266|NCT01574703|324177031|FG002|Overall Study|Death|1|||
94650267|NCT01574703|324177032|FG003|Overall Study|Death|0|||
94650268|NCT02751983|324177033|FG000|Treatment|Stopped ACT, but Remained in study|2|||
94650269|NCT02751983|324177034|FG001|Treatment|Stopped ACT, but Remained in study|0|||
94650270|NCT02751983|324177033|FG000|Treatment|Discharged prior to beginning ACT|2|||
94650271|NCT02751983|324177034|FG001|Treatment|Discharged prior to beginning ACT|0|||
94650272|NCT02751983|324177033|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
94650273|NCT02751983|324177034|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
94650274|NCT02751983|324177033|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
94650275|NCT02751983|324177034|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
94650276|NCT02751983|324177033|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
94650277|NCT02751983|324177034|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
94686617|NCT00779584|324307709|FG000|Overall Study|Protocol Violation|0|||
94686618|NCT00779584|324307710|FG001|Overall Study|Protocol Violation|0|||
94650278|NCT04187196|324177035|FG000|Overall Study|Screen Failure|2|||
94650279|NCT04187196|324177036|FG001|Overall Study|Screen Failure|0|||
94650280|NCT03149237|324177037|FG000|Overall Study|Withdrawal by Subject|4|||
94650281|NCT03149237|324177038|FG001|Overall Study|Withdrawal by Subject|5|||
94650282|NCT02167256|324177039|FG000|Overall Study|Adverse Event|13|||
94650283|NCT02167256|324177040|FG001|Overall Study|Adverse Event|6|||
94650284|NCT02167256|324177039|FG000|Overall Study|Withdrawal by Subject|4|||
94650285|NCT02167256|324177040|FG001|Overall Study|Withdrawal by Subject|4|||
94650286|NCT02167256|324177039|FG000|Overall Study|non-compliance|3|||
94686619|NCT00779584|324307711|FG002|Overall Study|Protocol Violation|0|||
94650287|NCT02167256|324177040|FG001|Overall Study|non-compliance|0|||
94650288|NCT02167256|324177039|FG000|Overall Study|Study partner unable to participate|1|||
94650289|NCT02167256|324177040|FG001|Overall Study|Study partner unable to participate|0|||
94650290|NCT01957475|324177041|FG000|Test Period 1|Withdrawal by Subject|1|||
94650291|NCT01957475|324177042|FG001|Test Period 1|Withdrawal by Subject|0|||
94650292|NCT01957475|324177041|FG000|Test Period 1|Other|1|||
94650293|NCT01957475|324177042|FG001|Test Period 1|Other|0|||
94650294|NCT01957475|324177041|FG000|Test Period 1|Lack of Efficacy|0|||
94650295|NCT01957475|324177042|FG001|Test Period 1|Lack of Efficacy|1|||
94650296|NCT01957475|324177041|FG000|Test Period 2|Adverse Event|1|||
94650297|NCT01957475|324177042|FG001|Test Period 2|Adverse Event|0|||
94650298|NCT01420081|324177043|FG000|Overall Study|Death|1|||
94650299|NCT01420081|324177044|FG001|Overall Study|Death|0|||
94650300|NCT01420081|324177045|FG002|Overall Study|Death|8|||
94650301|NCT01420081|324177046|FG003|Overall Study|Death|0|||
94650302|NCT01420081|324177047|FG004|Overall Study|Death|7|||
94650303|NCT01420081|324177048|FG005|Overall Study|Death|12|||
94650304|NCT01420081|324177049|FG006|Overall Study|Death|0|||
94650305|NCT01420081|324177050|FG007|Overall Study|Death|1|||
94650306|NCT01420081|324177051|FG008|Overall Study|Death|1|||
94650307|NCT01420081|324177043|FG000|Overall Study|Lost to Follow-up|0|||
94650308|NCT01420081|324177044|FG001|Overall Study|Lost to Follow-up|0|||
94650309|NCT01420081|324177045|FG002|Overall Study|Lost to Follow-up|0|||
94650310|NCT01420081|324177046|FG003|Overall Study|Lost to Follow-up|0|||
94650311|NCT01420081|324177047|FG004|Overall Study|Lost to Follow-up|1|||
94650312|NCT01420081|324177048|FG005|Overall Study|Lost to Follow-up|1|||
94650313|NCT01420081|324177049|FG006|Overall Study|Lost to Follow-up|0|||
94650314|NCT01420081|324177050|FG007|Overall Study|Lost to Follow-up|0|||
94650315|NCT01420081|324177051|FG008|Overall Study|Lost to Follow-up|0|||
94650316|NCT01420081|324177043|FG000|Overall Study|Study Terminated by Sponsor|2|||
94650317|NCT01420081|324177044|FG001|Overall Study|Study Terminated by Sponsor|1|||
94650318|NCT01420081|324177045|FG002|Overall Study|Study Terminated by Sponsor|1|||
94650319|NCT01420081|324177046|FG003|Overall Study|Study Terminated by Sponsor|3|||
94650320|NCT01420081|324177047|FG004|Overall Study|Study Terminated by Sponsor|11|||
94650321|NCT01420081|324177048|FG005|Overall Study|Study Terminated by Sponsor|7|||
94650322|NCT01420081|324177049|FG006|Overall Study|Study Terminated by Sponsor|3|||
94650323|NCT01420081|324177050|FG007|Overall Study|Study Terminated by Sponsor|2|||
94650324|NCT01420081|324177051|FG008|Overall Study|Study Terminated by Sponsor|2|||
94650325|NCT01420081|324177043|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
94650326|NCT01420081|324177044|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
94650327|NCT01420081|324177045|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
94650328|NCT01420081|324177046|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
94650329|NCT01420081|324177047|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
94650330|NCT01420081|324177048|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
94650331|NCT01420081|324177049|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
94263869|NCT02733185|322759961|FG001|Overall Study|Death|34|||
94650332|NCT01420081|324177050|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
94650333|NCT01420081|324177051|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
94650334|NCT01420081|324177043|FG000|Overall Study|Other Reasons|0|||
94650335|NCT01420081|324177044|FG001|Overall Study|Other Reasons|0|||
94650336|NCT01420081|324177045|FG002|Overall Study|Other Reasons|1|||
94650337|NCT01420081|324177046|FG003|Overall Study|Other Reasons|0|||
94650338|NCT01420081|324177047|FG004|Overall Study|Other Reasons|0|||
94650339|NCT01420081|324177048|FG005|Overall Study|Other Reasons|0|||
94650340|NCT01420081|324177049|FG006|Overall Study|Other Reasons|0|||
94650341|NCT01420081|324177050|FG007|Overall Study|Other Reasons|0|||
94650342|NCT01420081|324177051|FG008|Overall Study|Other Reasons|0|||
94650343|NCT00414388|324177052|FG000|Overall Study|Adverse Event|1|||
94650344|NCT03467425|324177053|FG000|Overall Study|Adverse Event|9|||
94650345|NCT03467425|324177054|FG001|Overall Study|Adverse Event|9|||
94364528|NCT01360021|323118502|FG000|Overall Study|Withdrawal by Subject|4|||
94364529|NCT01360021|323118503|FG001|Overall Study|Withdrawal by Subject|0|||
94364530|NCT01360021|323118504|FG002|Overall Study|Withdrawal by Subject|2|||
94364531|NCT01360021|323118502|FG000|Overall Study|Adverse Event|2|||
94364532|NCT01360021|323118503|FG001|Overall Study|Adverse Event|3|||
94364533|NCT01360021|323118504|FG002|Overall Study|Adverse Event|3|||
94650346|NCT03467425|324177053|FG000|Overall Study|Lack of Efficacy|3|||
94650347|NCT03467425|324177054|FG001|Overall Study|Lack of Efficacy|1|||
94364534|NCT00110084|323118505|FG000|Overall Study|Adverse Event|9|||
94364535|NCT00110084|323118505|FG000|Overall Study|Death|1|||
94364536|NCT00110084|323118505|FG000|Overall Study|Patient Refusal|10|||
94364537|NCT00110084|323118505|FG000|Overall Study|Alternate Therapy|5|||
94364538|NCT00110084|323118505|FG000|Overall Study|Intercurrent Illness|1|||
94650348|NCT03467425|324177053|FG000|Overall Study|Protocol Violation|0|||
94650349|NCT03467425|324177054|FG001|Overall Study|Protocol Violation|1|||
94650350|NCT03467425|324177053|FG000|Overall Study|Lost to Follow-up|18|||
94650351|NCT03467425|324177054|FG001|Overall Study|Lost to Follow-up|25|||
94650352|NCT03467425|324177053|FG000|Overall Study|Physician Decision|2|||
94650353|NCT03467425|324177054|FG001|Overall Study|Physician Decision|1|||
94650354|NCT03467425|324177053|FG000|Overall Study|Withdrawal by Subject|15|||
94650355|NCT03467425|324177054|FG001|Overall Study|Withdrawal by Subject|17|||
94650356|NCT04568122|324177055|FG000|Overall Study|Lost to Follow-up|48|||
94650357|NCT04568122|324177056|FG001|Overall Study|Lost to Follow-up|44|||
94650358|NCT04568122|324177057|FG002|Overall Study|Lost to Follow-up|4|||
94650359|NCT04568122|324177058|FG003|Overall Study|Lost to Follow-up|0|||
94650360|NCT04568122|324177059|FG004|Overall Study|Lost to Follow-up|0|||
94650361|NCT00218543|324177061|FG000|Overall Study|Lost to Follow-up|8|||
94650362|NCT00218543|324177061|FG000|Overall Study|relocated|1|||
94650363|NCT00218543|324177061|FG000|Overall Study|Withdrawal by Subject|1|||
94650364|NCT00218543|324177061|FG000|Overall Study|Physician Decision|3|||
94650365|NCT00218543|324177061|FG000|Overall Study|Adverse Event|2|||
94650366|NCT00004031|324177062|FG000|Overall Study|Adverse Event|5|||
94650367|NCT00004031|324177063|FG001|Overall Study|Adverse Event|0|||
94650368|NCT00004031|324177062|FG000|Overall Study|Refusal unrelated to adverse events|2|||
94650369|NCT00004031|324177063|FG001|Overall Study|Refusal unrelated to adverse events|11|||
94650370|NCT00004031|324177062|FG000|Overall Study|Progression/relapse|9|||
94650371|NCT00004031|324177063|FG001|Overall Study|Progression/relapse|4|||
94650372|NCT00004031|324177062|FG000|Overall Study|Death|3|||
94650373|NCT00004031|324177063|FG001|Overall Study|Death|1|||
94650374|NCT00004031|324177062|FG000|Overall Study|Other- not protocol specified|3|||
94650375|NCT00004031|324177063|FG001|Overall Study|Other- not protocol specified|3|||
94650376|NCT00004031|324177062|FG000|Overall Study|Reason under review|3|||
94364539|NCT00110084|323118505|FG000|Overall Study|Other|2|||
94463723|NCT02059434|323486735|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
94650377|NCT00004031|324177063|FG001|Overall Study|Reason under review|2|||
94650378|NCT01282216|324177064|FG000|Overall Study|Graft failure|0|||
94650379|NCT01282216|324177065|FG001|Overall Study|Graft failure|0|||
94650380|NCT01282216|324177066|FG002|Overall Study|Graft failure|3|||
94650381|NCT01282216|324177067|FG003|Overall Study|Graft failure|2|||
94650382|NCT01282216|324177064|FG000|Overall Study|Physician Decision|0|||
94650383|NCT01282216|324177065|FG001|Overall Study|Physician Decision|0|||
94650384|NCT01282216|324177066|FG002|Overall Study|Physician Decision|11|||
94463724|NCT02059434|323486736|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
94650385|NCT01282216|324177067|FG003|Overall Study|Physician Decision|0|||
94650386|NCT01282216|324177064|FG000|Overall Study|Relapse|0|||
94650387|NCT01282216|324177065|FG001|Overall Study|Relapse|0|||
94650388|NCT01282216|324177066|FG002|Overall Study|Relapse|17|||
94650389|NCT01282216|324177067|FG003|Overall Study|Relapse|6|||
94650390|NCT01282216|324177064|FG000|Overall Study|Death|0|||
94650391|NCT01282216|324177065|FG001|Overall Study|Death|0|||
94650392|NCT01282216|324177066|FG002|Overall Study|Death|2|||
94650393|NCT01282216|324177067|FG003|Overall Study|Death|0|||
94650394|NCT01387607|324177068|FG000|Overall Study|Adverse Event|23|||
94650395|NCT01387607|324177069|FG001|Overall Study|Adverse Event|11|||
94650396|NCT01387607|324177068|FG000|Overall Study|Lack of Efficacy|8|||
94650397|NCT01387607|324177069|FG001|Overall Study|Lack of Efficacy|6|||
94650398|NCT01387607|324177068|FG000|Overall Study|Lost to Follow-up|2|||
94650399|NCT01387607|324177069|FG001|Overall Study|Lost to Follow-up|1|||
94650400|NCT01387607|324177068|FG000|Overall Study|No longer meets eligibility criteria|0|||
94650401|NCT01387607|324177069|FG001|Overall Study|No longer meets eligibility criteria|1|||
94650402|NCT01387607|324177068|FG000|Overall Study|Protocol Violation|1|||
94650403|NCT01387607|324177069|FG001|Overall Study|Protocol Violation|5|||
94650404|NCT01387607|324177068|FG000|Overall Study|Withdrawal by Subject|13|||
94650405|NCT01387607|324177069|FG001|Overall Study|Withdrawal by Subject|14|||
94650406|NCT01387607|324177068|FG000|Overall Study|Other|1|||
94650407|NCT01387607|324177069|FG001|Overall Study|Other|1|||
94650408|NCT01387607|324177068|FG000|Overall Study|Randomized, not treated|3|||
94650409|NCT01387607|324177069|FG001|Overall Study|Randomized, not treated|6|||
94650410|NCT01227512|324177072|FG000|Overall Study|Physician Decision|6|||
94650411|NCT01227512|324177073|FG001|Overall Study|Physician Decision|6|||
94650412|NCT01227512|324177072|FG000|Overall Study|Adverse Event|4|||
94650413|NCT01227512|324177073|FG001|Overall Study|Adverse Event|3|||
94650414|NCT01227512|324177072|FG000|Overall Study|Withdrawal by Subject|3|||
94650415|NCT01227512|324177073|FG001|Overall Study|Withdrawal by Subject|0|||
94650416|NCT01227512|324177072|FG000|Overall Study|Participant met withdrawal criteria|0|||
94650417|NCT01227512|324177073|FG001|Overall Study|Participant met withdrawal criteria|1|||
94650418|NCT02774681|324177080|FG000|Treatment on Study|Progressive Disease|7|||
94650419|NCT02774681|324177080|FG000|Follow-Up for 3 Years|Death|11|||
94650420|NCT02774681|324177080|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
94650421|NCT04497987|324177081|FG000|Overall Study|Adverse Event|1|||
94650422|NCT04497987|324177082|FG001|Overall Study|Adverse Event|0|||
94650423|NCT04497987|324177081|FG000|Overall Study|Death|21|||
94650424|NCT04497987|324177082|FG001|Overall Study|Death|13|||
94650425|NCT04497987|324177081|FG000|Overall Study|Lost to Follow-up|19|||
94650426|NCT04497987|324177082|FG001|Overall Study|Lost to Follow-up|17|||
94650427|NCT04497987|324177081|FG000|Overall Study|Other - as reported by the investigator|22|||
94650428|NCT04497987|324177082|FG001|Overall Study|Other - as reported by the investigator|16|||
94650429|NCT04497987|324177081|FG000|Overall Study|Physician Decision|1|||
94650430|NCT04497987|324177082|FG001|Overall Study|Physician Decision|0|||
94650431|NCT04497987|324177081|FG000|Overall Study|Withdrawal by Subject|35|||
94650432|NCT04497987|324177082|FG001|Overall Study|Withdrawal by Subject|21|||
94650433|NCT00512096|324177083|FG000|Overall Study|Adverse Event|2|||
94650434|NCT00512096|324177083|FG000|Overall Study|Withdrawal by Subject|2|||
94650435|NCT00512096|324177083|FG000|Overall Study|Lack of Efficacy|3|||
94650436|NCT01209624|324177086|FG000|Overall Study|Death|2|||
94650437|NCT01209624|324177086|FG000|Overall Study|Adverse Event|13|||
94650438|NCT01209624|324177086|FG000|Overall Study|Lack of Efficacy|17|||
94650439|NCT01209624|324177086|FG000|Overall Study|Lost to Follow-up|290|||
94650440|NCT01209624|324177086|FG000|Overall Study|Other|4|||
94650441|NCT00991302|324179552|FG000|Overall Study|Death|0|||
94650442|NCT00991302|324179553|FG001|Overall Study|Death|1|||
94650443|NCT00991302|324179552|FG000|Overall Study|Lost to Follow-up|14|||
94650444|NCT00991302|324179553|FG001|Overall Study|Lost to Follow-up|12|||
94650445|NCT01083433|324179554|FG000|Overall Study|Lost to Follow-up|2|||
94650446|NCT01083433|324179555|FG001|Overall Study|Lost to Follow-up|1|||
94650447|NCT01083433|324179556|FG002|Overall Study|Lost to Follow-up|1|||
94650448|NCT01083433|324179554|FG000|Overall Study|Withdrawal by Subject|0|||
94650449|NCT01083433|324179555|FG001|Overall Study|Withdrawal by Subject|5|||
94650450|NCT01083433|324179556|FG002|Overall Study|Withdrawal by Subject|3|||
94650451|NCT01083433|324179554|FG000|Overall Study|Pregnancy|0|||
94650452|NCT01083433|324179555|FG001|Overall Study|Pregnancy|0|||
94650453|NCT01083433|324179556|FG002|Overall Study|Pregnancy|1|||
94650454|NCT00653224|324179559|FG000|Overall Study|Adverse Event|2|||
94650455|NCT00653224|324179560|FG001|Overall Study|Adverse Event|1|||
94650456|NCT00653224|324179559|FG000|Overall Study|Lack of Efficacy|1|||
94650457|NCT00653224|324179560|FG001|Overall Study|Lack of Efficacy|2|||
94650458|NCT00653224|324179559|FG000|Overall Study|Loss of efficacy|1|||
94650459|NCT00653224|324179560|FG001|Overall Study|Loss of efficacy|0|||
94650460|NCT00653224|324179559|FG000|Overall Study|Lost to Follow-up|1|||
94650461|NCT00653224|324179560|FG001|Overall Study|Lost to Follow-up|0|||
94650462|NCT00653224|324179559|FG000|Overall Study|Other|2|||
94650463|NCT00653224|324179560|FG001|Overall Study|Other|4|||
94650464|NCT00646958|324179561|FG000|Overall Study|Lack of Efficacy|1|||
94650465|NCT00646958|324179562|FG001|Overall Study|Lack of Efficacy|0|||
94650466|NCT00646958|324179563|FG002|Overall Study|Lack of Efficacy|0|||
94650467|NCT00646958|324179561|FG000|Overall Study|Adverse Event|4|||
94650468|NCT00646958|324179562|FG001|Overall Study|Adverse Event|0|||
94650469|NCT00646958|324179563|FG002|Overall Study|Adverse Event|0|||
94650470|NCT00646958|324179561|FG000|Overall Study|Lost to Follow-up|1|||
94650471|NCT00646958|324179562|FG001|Overall Study|Lost to Follow-up|5|||
94650472|NCT00646958|324179563|FG002|Overall Study|Lost to Follow-up|7|||
94650473|NCT00646958|324179561|FG000|Overall Study|Protocol Violation|1|||
94650474|NCT00646958|324179562|FG001|Overall Study|Protocol Violation|1|||
94650475|NCT00646958|324179563|FG002|Overall Study|Protocol Violation|0|||
94650476|NCT00646958|324179561|FG000|Overall Study|Abnormal screening lab tests|1|||
94650477|NCT00646958|324179562|FG001|Overall Study|Abnormal screening lab tests|1|||
94650478|NCT00646958|324179563|FG002|Overall Study|Abnormal screening lab tests|0|||
94650479|NCT00646958|324179561|FG000|Overall Study|Withdrawal by Subject|1|||
94650480|NCT00646958|324179562|FG001|Overall Study|Withdrawal by Subject|2|||
94650481|NCT00646958|324179563|FG002|Overall Study|Withdrawal by Subject|0|||
94650482|NCT00646958|324179561|FG000|Overall Study|Did not receive study drug|2|||
94650483|NCT00646958|324179562|FG001|Overall Study|Did not receive study drug|0|||
94650484|NCT00646958|324179563|FG002|Overall Study|Did not receive study drug|2|||
94650485|NCT00533949|324179564|FG000|Overall Study|Protocol Violation|12|||
94650486|NCT00533949|324179565|FG001|Overall Study|Protocol Violation|12|||
94650487|NCT00533949|324179566|FG002|Overall Study|Protocol Violation|9|||
94650488|NCT00533949|324179567|FG003|Overall Study|Protocol Violation|9|||
94650489|NCT00533949|324179564|FG000|Overall Study|Withdrawal by Subject|3|||
94650490|NCT00533949|324179565|FG001|Overall Study|Withdrawal by Subject|2|||
94650491|NCT00533949|324179566|FG002|Overall Study|Withdrawal by Subject|1|||
94650492|NCT00533949|324179567|FG003|Overall Study|Withdrawal by Subject|1|||
94650493|NCT00110266|324179572|FG000|Overall Study|Adverse Event|27|||
94650494|NCT00110266|324179572|FG000|Overall Study|Abnormal laboratory value|15|||
94650495|NCT00110266|324179572|FG000|Overall Study|Withdrawal by Subject|16|||
94650496|NCT00110266|324179572|FG000|Overall Study|Death|17|||
94650497|NCT00110266|324179572|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
94650498|NCT00110266|324179572|FG000|Overall Study|Participant condition no longer requires study drug|1|||
94650499|NCT02649972|324179573|FG000|Overall Study|Not treated|1|||
94650500|NCT00503841|324179576|FG000|Overall Study|All screen failures|44|||
94650501|NCT01344057|324179577|FG000|Overall Study|Premature Withdrawal|1|||
94650502|NCT01481116|324179578|FG000|Overall Study|Adverse Event|26|||
94650503|NCT01481116|324179579|FG001|Overall Study|Adverse Event|26|||
94650504|NCT01481116|324179580|FG002|Overall Study|Adverse Event|42|||
94650505|NCT01481116|324179578|FG000|Overall Study|Major Protocol Deviation|3|||
94650506|NCT01481116|324179579|FG001|Overall Study|Major Protocol Deviation|7|||
94650507|NCT01481116|324179580|FG002|Overall Study|Major Protocol Deviation|1|||
94650508|NCT01481116|324179578|FG000|Overall Study|Lost to Follow-up|8|||
94650509|NCT01481116|324179579|FG001|Overall Study|Lost to Follow-up|12|||
94650510|NCT01481116|324179580|FG002|Overall Study|Lost to Follow-up|11|||
94650511|NCT01481116|324179578|FG000|Overall Study|Withdrawal by Subject|37|||
94650512|NCT01481116|324179579|FG001|Overall Study|Withdrawal by Subject|33|||
94650513|NCT01481116|324179580|FG002|Overall Study|Withdrawal by Subject|37|||
94650514|NCT01481116|324179578|FG000|Overall Study|Study Termination|730|||
94650515|NCT01481116|324179579|FG001|Overall Study|Study Termination|729|||
94650516|NCT01481116|324179580|FG002|Overall Study|Study Termination|713|||
94650517|NCT01481116|324179578|FG000|Overall Study|Pregnancy|0|||
94650518|NCT01481116|324179579|FG001|Overall Study|Pregnancy|0|||
94650519|NCT01481116|324179580|FG002|Overall Study|Pregnancy|1|||
94650520|NCT01481116|324179578|FG000|Overall Study|Lack of Efficacy|3|||
94650521|NCT01481116|324179579|FG001|Overall Study|Lack of Efficacy|3|||
94650522|NCT01481116|324179580|FG002|Overall Study|Lack of Efficacy|1|||
94263870|NCT02733185|322759962|FG002|Overall Study|Death|35|||
94650523|NCT01481116|324179578|FG000|Overall Study|Contraindications|1|||
94650524|NCT01481116|324179579|FG001|Overall Study|Contraindications|1|||
94263871|NCT02733185|322759963|FG003|Overall Study|Death|43|||
94650525|NCT01481116|324179580|FG002|Overall Study|Contraindications|0|||
94263872|NCT02733185|322759960|FG000|Overall Study|Lost to Follow-up|17|||
94263873|NCT02733185|322759961|FG001|Overall Study|Lost to Follow-up|18|||
94263874|NCT02733185|322759962|FG002|Overall Study|Lost to Follow-up|16|||
94650526|NCT01481116|324179578|FG000|Overall Study|Other|1|||
94650527|NCT01481116|324179579|FG001|Overall Study|Other|1|||
94650528|NCT01481116|324179580|FG002|Overall Study|Other|0|||
94650529|NCT01481116|324179578|FG000|Overall Study|Participant Started Taking Glipizide|1|||
94650530|NCT01481116|324179579|FG001|Overall Study|Participant Started Taking Glipizide|0|||
94364540|NCT04854707|323118506|FG000|Overall Study|Lack of Efficacy|78|||
94364541|NCT04854707|323118507|FG001|Overall Study|Lack of Efficacy|59|||
94364542|NCT04854707|323118508|FG002|Overall Study|Lack of Efficacy|30|||
94650531|NCT01481116|324179580|FG002|Overall Study|Participant Started Taking Glipizide|0|||
94650532|NCT01481116|324179578|FG000|Overall Study|Participant Moved Out of Area|2|||
94650533|NCT01481116|324179579|FG001|Overall Study|Participant Moved Out of Area|0|||
94650534|NCT01481116|324179580|FG002|Overall Study|Participant Moved Out of Area|1|||
94650535|NCT01481116|324179578|FG000|Overall Study|Participant Moved Out of Country|1|||
94650536|NCT01481116|324179579|FG001|Overall Study|Participant Moved Out of Country|0|||
94650537|NCT01481116|324179580|FG002|Overall Study|Participant Moved Out of Country|1|||
94650538|NCT01481116|324179578|FG000|Overall Study|Investigator Decision|3|||
94650539|NCT01481116|324179579|FG001|Overall Study|Investigator Decision|2|||
94650540|NCT01481116|324179580|FG002|Overall Study|Investigator Decision|1|||
94650541|NCT01481116|324179578|FG000|Overall Study|Sponsor Decision|0|||
94650542|NCT01481116|324179579|FG001|Overall Study|Sponsor Decision|1|||
94650543|NCT01481116|324179580|FG002|Overall Study|Sponsor Decision|3|||
94650544|NCT01481116|324179578|FG000|Overall Study|Non-Compliant With Study Drug|0|||
94650545|NCT01481116|324179579|FG001|Overall Study|Non-Compliant With Study Drug|1|||
94650546|NCT01481116|324179580|FG002|Overall Study|Non-Compliant With Study Drug|1|||
94650547|NCT01481116|324179578|FG000|Overall Study|Investigator's Discretion|2|||
94650548|NCT01481116|324179579|FG001|Overall Study|Investigator's Discretion|0|||
94650549|NCT01481116|324179580|FG002|Overall Study|Investigator's Discretion|0|||
94650550|NCT01481116|324179578|FG000|Overall Study|Death|2|||
94650551|NCT01481116|324179579|FG001|Overall Study|Death|1|||
94650552|NCT01481116|324179580|FG002|Overall Study|Death|0|||
94650553|NCT01481116|324179578|FG000|Overall Study|Hypoglycemic Event|4|||
94650554|NCT01481116|324179579|FG001|Overall Study|Hypoglycemic Event|0|||
94650555|NCT01481116|324179580|FG002|Overall Study|Hypoglycemic Event|0|||
94650556|NCT02433834|324179581|FG000|Overall Study|Protocol-specified criteria|7|||
94650557|NCT02433834|324179581|FG000|Overall Study|Protocol Violation|3|||
94650558|NCT02433834|324179581|FG000|Overall Study|Lost to Follow-up|6|||
94650559|NCT02433834|324179581|FG000|Overall Study|Withdrawal by Subject|14|||
94650560|NCT02433834|324179581|FG000|Overall Study|Adverse Event|6|||
94650561|NCT02433834|324179581|FG000|Overall Study|Physician Decision|1|||
94650562|NCT00596011|324179582|FG000|Overall Study|Withdrawal by Subject|2|||
94650563|NCT00596011|324179583|FG001|Overall Study|Withdrawal by Subject|3|||
94650564|NCT00596011|324179582|FG000|Overall Study|Adverse Event|11|||
94650565|NCT00596011|324179583|FG001|Overall Study|Adverse Event|7|||
94650566|NCT00355238|324179589|FG000|Overall Study|Adverse event unrelated to study drug|2|||
94650567|NCT00355238|324179590|FG001|Overall Study|Adverse event unrelated to study drug|2|||
94650568|NCT00355238|324179591|FG002|Overall Study|Adverse event unrelated to study drug|0|||
94650569|NCT00355238|324179592|FG003|Overall Study|Adverse event unrelated to study drug|1|||
94650570|NCT00355238|324179589|FG000|Overall Study|Death|1|||
94650571|NCT00355238|324179590|FG001|Overall Study|Death|0|||
94650572|NCT00355238|324179591|FG002|Overall Study|Death|0|||
94650573|NCT00355238|324179592|FG003|Overall Study|Death|0|||
94650574|NCT00355238|324179589|FG000|Overall Study|Disease progression|37|||
94650575|NCT00355238|324179590|FG001|Overall Study|Disease progression|36|||
94650576|NCT00355238|324179591|FG002|Overall Study|Disease progression|16|||
94650577|NCT00355238|324179592|FG003|Overall Study|Disease progression|11|||
94650578|NCT00355238|324179589|FG000|Overall Study|Study drug toxicity|11|||
94650579|NCT00355238|324179590|FG001|Overall Study|Study drug toxicity|7|||
94650580|NCT00355238|324179591|FG002|Overall Study|Study drug toxicity|5|||
94650581|NCT00355238|324179592|FG003|Overall Study|Study drug toxicity|2|||
94650582|NCT00355238|324179589|FG000|Overall Study|Participant withdrew consent|3|||
94650583|NCT00355238|324179590|FG001|Overall Study|Participant withdrew consent|1|||
94650584|NCT00355238|324179591|FG002|Overall Study|Participant withdrew consent|0|||
94650585|NCT00355238|324179592|FG003|Overall Study|Participant withdrew consent|0|||
94650586|NCT00355238|324179589|FG000|Overall Study|Participant request to discontinue study treatment|1|||
94650587|NCT00355238|324179590|FG001|Overall Study|Participant request to discontinue study treatment|0|||
94650588|NCT00355238|324179591|FG002|Overall Study|Participant request to discontinue study treatment|1|||
94650589|NCT00355238|324179592|FG003|Overall Study|Participant request to discontinue study treatment|0|||
94650590|NCT00548808|324179593|FG000|Overall Study|Lost to Follow-up|9|||
94686620|NCT00779584|324307712|FG003|Overall Study|Protocol Violation|0|||
94364543|NCT00669110|323118509|FG000|Overall Study|Adverse Event|4|||
94650591|NCT00548808|324179594|FG001|Overall Study|Lost to Follow-up|3|||
94650592|NCT00548808|324179593|FG000|Overall Study|Protocol Violation|8|||
94650593|NCT00548808|324179594|FG001|Overall Study|Protocol Violation|8|||
94650594|NCT00548808|324179593|FG000|Overall Study|Withdrawal by Subject|8|||
94686621|NCT00779584|324307713|FG004|Overall Study|Protocol Violation|0|||
94650595|NCT00548808|324179594|FG001|Overall Study|Withdrawal by Subject|4|||
94650596|NCT00548808|324179593|FG000|Overall Study|Physician Decision|6|||
94650597|NCT00548808|324179594|FG001|Overall Study|Physician Decision|3|||
94364544|NCT00669110|323118510|FG001|Overall Study|Adverse Event|3|||
94650598|NCT00548808|324179593|FG000|Overall Study|Adverse Event|4|||
94650599|NCT00548808|324179594|FG001|Overall Study|Adverse Event|5|||
94650600|NCT00548808|324179593|FG000|Overall Study|Death|2|||
94650601|NCT00548808|324179594|FG001|Overall Study|Death|0|||
94650602|NCT00548808|324179593|FG000|Overall Study|Entry Criteria Not Met|2|||
94650603|NCT00548808|324179594|FG001|Overall Study|Entry Criteria Not Met|2|||
94650604|NCT00548808|324179593|FG000|Overall Study|Lack of Efficacy|2|||
94650605|NCT00548808|324179594|FG001|Overall Study|Lack of Efficacy|0|||
94650606|NCT00548808|324179593|FG000|Overall Study|Sponsor Decision|1|||
94650607|NCT00548808|324179594|FG001|Overall Study|Sponsor Decision|1|||
94650608|NCT00424372|324179597|FG000|Overall Study|Death|1|||
94650609|NCT00424372|324179597|FG000|Overall Study|Adverse Event|18|||
94650610|NCT00424372|324179597|FG000|Overall Study|Lack of Efficacy|6|||
94650611|NCT00424372|324179597|FG000|Overall Study|Withdrawal by Subject|4|||
94650612|NCT00424372|324179597|FG000|Overall Study|Protocol Violation|1|||
94650613|NCT00424372|324179597|FG000|Overall Study|Health deterioration|1|||
94650614|NCT05044234|324179598|FG000|Overall Study|Lost to Follow-up|2|||
94650615|NCT05044234|324179599|FG001|Overall Study|Lost to Follow-up|1|||
94650616|NCT05044234|324179600|FG002|Overall Study|Lost to Follow-up|1|||
94650617|NCT05044234|324179601|FG003|Overall Study|Lost to Follow-up|2|||
94650618|NCT05044234|324179598|FG000|Overall Study|Withdrawal by Subject|6|||
94650619|NCT05044234|324179599|FG001|Overall Study|Withdrawal by Subject|4|||
94650620|NCT05044234|324179600|FG002|Overall Study|Withdrawal by Subject|5|||
94650621|NCT05044234|324179601|FG003|Overall Study|Withdrawal by Subject|8|||
94650622|NCT05044234|324179598|FG000|Overall Study|Study terminated by Sponsor|21|||
94650623|NCT05044234|324179599|FG001|Overall Study|Study terminated by Sponsor|21|||
94650624|NCT05044234|324179600|FG002|Overall Study|Study terminated by Sponsor|20|||
94650625|NCT05044234|324179601|FG003|Overall Study|Study terminated by Sponsor|14|||
94650626|NCT05044234|324179598|FG000|Overall Study|Other, not specified|0|||
94650627|NCT05044234|324179599|FG001|Overall Study|Other, not specified|0|||
94650628|NCT05044234|324179600|FG002|Overall Study|Other, not specified|1|||
94650629|NCT05044234|324179601|FG003|Overall Study|Other, not specified|2|||
94650630|NCT05044234|324179598|FG000|Overall Study|Delayed data entry|0|||
94650631|NCT05044234|324179599|FG001|Overall Study|Delayed data entry|0|||
94650632|NCT05044234|324179600|FG002|Overall Study|Delayed data entry|0|||
94650633|NCT05044234|324179601|FG003|Overall Study|Delayed data entry|1|||
94650634|NCT02896127|324179602|FG000|COMPLETED WEEK 52|Adverse Event|9|||
94650635|NCT02896127|324179603|FG001|COMPLETED WEEK 52|Adverse Event|2|||
94650636|NCT02896127|324179602|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
94650637|NCT02896127|324179603|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
94650638|NCT02896127|324179602|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
94650639|NCT02896127|324179603|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
94650640|NCT02896127|324179602|FG000|COMPLETED WEEK 52|Physician Decision|1|||
94650641|NCT02896127|324179603|FG001|COMPLETED WEEK 52|Physician Decision|1|||
94650642|NCT02896127|324179602|FG000|COMPLETED WEEK 52|Pregnancy|2|||
94650643|NCT02896127|324179603|FG001|COMPLETED WEEK 52|Pregnancy|0|||
94650644|NCT02896127|324179602|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
94650645|NCT02896127|324179603|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
94650646|NCT02896127|324179602|FG000|COMPLETED WEEK 52|Technical problems|1|||
94650647|NCT02896127|324179603|FG001|COMPLETED WEEK 52|Technical problems|0|||
94650648|NCT02896127|324179602|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
94650649|NCT02896127|324179603|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
94650650|NCT02896127|324179602|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
94650651|NCT02896127|324179603|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
94650652|NCT02896127|324179602|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
94650653|NCT02896127|324179603|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
94650654|NCT02896127|324179602|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
94650655|NCT02896127|324179603|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
94650656|NCT02896127|324179602|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
94650657|NCT02896127|324179603|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
94650658|NCT02940691|324179604|FG000|Overall Study|Lost to Follow-up|5|||
94650659|NCT02940691|324179604|FG000|Overall Study|Incarceration|1|||
94650660|NCT04622254|324179607|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
94650661|NCT04622254|324179608|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
94650662|NCT04622254|324179609|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
94650663|NCT04622254|324179610|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
94650664|NCT04622254|324179611|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
94650665|NCT04622254|324179612|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
94650666|NCT04622254|324179607|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
94650667|NCT04622254|324179608|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
94650668|NCT04622254|324179609|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
94463725|NCT02059434|323486728|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
94650669|NCT04622254|324179610|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
94650670|NCT04622254|324179611|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
94650671|NCT04622254|324179612|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
94686622|NCT00779584|324307714|FG005|Overall Study|Protocol Violation|1|||
94463726|NCT02059434|323486729|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
94463727|NCT02059434|323486730|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
94463728|NCT02059434|323486731|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
94463729|NCT02059434|323486732|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
94463730|NCT02059434|323486733|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
94463731|NCT02059434|323486734|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
94463732|NCT02059434|323486735|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
94463733|NCT02059434|323486736|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
94463734|NCT02059434|323486728|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
94463735|NCT02059434|323486729|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
94463736|NCT02059434|323486730|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
94463737|NCT02059434|323486731|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
94463738|NCT02059434|323486732|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
94463739|NCT02059434|323486733|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
94463740|NCT02059434|323486734|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
94463741|NCT02059434|323486735|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
94463742|NCT02059434|323486736|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
94463743|NCT03201874|323486739|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
94463744|NCT03201874|323486740|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
94463745|NCT03201874|323486739|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
94463746|NCT03201874|323486740|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
94463747|NCT04250714|323486741|FG000|Overall Study|Treatment - withdrawal by subject|14|||
94463748|NCT04250714|323486741|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
94463749|NCT04250714|323486741|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
94463750|NCT04250714|323486741|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
94463751|NCT04250714|323486741|FG000|Overall Study|Treatment - Death|1|||
94463752|NCT04250714|323486741|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
94463753|NCT04250714|323486741|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
94463754|NCT04250714|323486741|FG000|Overall Study|Attempt|2|||
94463755|NCT04250714|323486741|FG000|Overall Study|Intent|7|||
94463756|NCT01702532|323486742|FG000|Overall Study|Adverse Event|0|||
94463757|NCT01702532|323486743|FG001|Overall Study|Adverse Event|1|||
94463758|NCT00623597|323486744|FG000|Overall Study|Failed to return|1|||
94463759|NCT00623597|323486745|FG001|Overall Study|Failed to return|0|||
94463760|NCT02879994|323486746|FG000|Overall Study|off treatment early|7|||
94463761|NCT02879994|323486746|FG000|Overall Study|Adverse Event|2|||
94463762|NCT02879994|323486746|FG000|Overall Study|Death|2|||
94463763|NCT01573767|323486748|FG000|Overall Study|Adverse Event|0|||
94463764|NCT01573767|323486749|FG001|Overall Study|Adverse Event|1|||
94463765|NCT01573767|323486750|FG002|Overall Study|Adverse Event|0|||
94463766|NCT01573767|323486751|FG003|Overall Study|Adverse Event|1|||
94463767|NCT01573767|323486748|FG000|Overall Study|Lack of Efficacy|18|||
94650672|NCT04622254|324179607|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
94650673|NCT04622254|324179608|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
94650674|NCT04622254|324179609|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
94650675|NCT04622254|324179610|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
94650676|NCT04622254|324179611|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
94650677|NCT04622254|324179612|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
94650678|NCT04622254|324179607|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
94650679|NCT04622254|324179608|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
94650680|NCT04622254|324179609|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
94650681|NCT04622254|324179610|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
94650682|NCT04622254|324179611|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
94650683|NCT04622254|324179612|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
94463768|NCT01573767|323486749|FG001|Overall Study|Lack of Efficacy|15|||
94463769|NCT01573767|323486750|FG002|Overall Study|Lack of Efficacy|12|||
94463770|NCT01573767|323486751|FG003|Overall Study|Lack of Efficacy|17|||
94463771|NCT01573767|323486748|FG000|Overall Study|Protocol Violation|3|||
94463772|NCT01573767|323486749|FG001|Overall Study|Protocol Violation|1|||
94463773|NCT01573767|323486750|FG002|Overall Study|Protocol Violation|1|||
94463774|NCT01573767|323486751|FG003|Overall Study|Protocol Violation|3|||
94463775|NCT01573767|323486748|FG000|Overall Study|Lost to Follow-up|0|||
94463776|NCT01573767|323486749|FG001|Overall Study|Lost to Follow-up|1|||
94463777|NCT01573767|323486750|FG002|Overall Study|Lost to Follow-up|1|||
94463778|NCT01573767|323486751|FG003|Overall Study|Lost to Follow-up|1|||
94463779|NCT01573767|323486748|FG000|Overall Study|Physician Decision|1|||
94463780|NCT01573767|323486749|FG001|Overall Study|Physician Decision|2|||
94463781|NCT01573767|323486750|FG002|Overall Study|Physician Decision|0|||
94686623|NCT00779584|324307715|FG006|Overall Study|Protocol Violation|0|||
94463782|NCT01573767|323486751|FG003|Overall Study|Physician Decision|2|||
94463783|NCT01573767|323486748|FG000|Overall Study|Withdrawal by Subject|0|||
94463784|NCT01573767|323486749|FG001|Overall Study|Withdrawal by Subject|1|||
94364545|NCT00669110|323118509|FG000|Overall Study|Caregiver request|3|||
94364546|NCT00669110|323118510|FG001|Overall Study|Caregiver request|2|||
94364547|NCT00669110|323118509|FG000|Overall Study|Physician Decision|0|||
94364548|NCT00669110|323118510|FG001|Overall Study|Physician Decision|1|||
94650684|NCT04622254|324179607|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
94650685|NCT04622254|324179608|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
94650686|NCT04622254|324179609|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
94650687|NCT04622254|324179610|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
94650688|NCT04622254|324179611|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
94650689|NCT04622254|324179612|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
94650690|NCT04622254|324179607|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
94650691|NCT04622254|324179608|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
94650692|NCT04622254|324179609|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
94650693|NCT04622254|324179610|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
94650694|NCT04622254|324179611|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
94650695|NCT04622254|324179612|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
94650696|NCT04622254|324179607|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
94650697|NCT04622254|324179608|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
94650698|NCT04622254|324179609|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
94650699|NCT04622254|324179610|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
94650700|NCT04622254|324179611|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
94650701|NCT04622254|324179612|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
94650702|NCT04622254|324179607|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
94650703|NCT04622254|324179608|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
94650704|NCT04622254|324179609|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
94650705|NCT04622254|324179610|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
94650706|NCT04622254|324179611|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
94650707|NCT04622254|324179612|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
94650708|NCT04622254|324179607|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
94650709|NCT04622254|324179608|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
94686624|NCT00779584|324307716|FG007|Overall Study|Protocol Violation|0|||
94686625|NCT00779584|324307717|FG008|Overall Study|Protocol Violation|0|||
94364549|NCT00669110|323118509|FG000|Overall Study|Lost to Follow-up|1|||
94364550|NCT00669110|323118510|FG001|Overall Study|Lost to Follow-up|0|||
94364551|NCT00669110|323118509|FG000|Overall Study|Protocol Violation|0|||
94364552|NCT00669110|323118510|FG001|Overall Study|Protocol Violation|5|||
94364553|NCT00669110|323118509|FG000|Overall Study|Withdrawal by Subject|0|||
94364554|NCT00669110|323118510|FG001|Overall Study|Withdrawal by Subject|2|||
94364555|NCT03123120|323118511|FG000|Overall Study|Lost to Follow-up|0|||
94364556|NCT03123120|323118512|FG001|Overall Study|Lost to Follow-up|1|||
94364557|NCT03123120|323118511|FG000|Overall Study|Withdrawal by Subject|0|||
94364558|NCT03123120|323118512|FG001|Overall Study|Withdrawal by Subject|1|||
94364559|NCT03224234|323118513|FG000|Main Study|Lost to Follow-up|5|||
94364560|NCT03224234|323118514|FG001|Main Study|Lost to Follow-up|5|||
94364561|NCT05302414|323118515|FG000|Pretest to Posttest|Lost to Follow-up|12|||
94364562|NCT05302414|323118516|FG001|Pretest to Posttest|Lost to Follow-up|8|||
94364563|NCT05302414|323118517|FG002|Pretest to Posttest|Lost to Follow-up|8|||
94364564|NCT05302414|323118515|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
94364565|NCT05302414|323118516|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
94364566|NCT05302414|323118517|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
94364567|NCT01102972|323118518|FG000|Overall Study|Adverse Event|8|||
94364568|NCT01102972|323118519|FG001|Overall Study|Adverse Event|2|||
94364569|NCT01102972|323118518|FG000|Overall Study|Lack of Efficacy|2|||
94364570|NCT01102972|323118519|FG001|Overall Study|Lack of Efficacy|1|||
94364571|NCT01102972|323118518|FG000|Overall Study|Protocol Violation|1|||
94364572|NCT01102972|323118519|FG001|Overall Study|Protocol Violation|0|||
94364573|NCT01102972|323118518|FG000|Overall Study|Lost to Follow-up|10|||
94364574|NCT01102972|323118519|FG001|Overall Study|Lost to Follow-up|5|||
94364575|NCT01102972|323118518|FG000|Overall Study|Investigator Discretion|2|||
94364576|NCT01102972|323118519|FG001|Overall Study|Investigator Discretion|0|||
94364577|NCT01102972|323118518|FG000|Overall Study|Withdrawal by Subject|6|||
94364578|NCT01102972|323118519|FG001|Overall Study|Withdrawal by Subject|6|||
94364579|NCT04003103|323118525|FG000|Overall Study|Death|1|||
94364580|NCT04003103|323118526|FG001|Overall Study|Death|0|||
94364581|NCT04003103|323118527|FG002|Overall Study|Death|0|||
94364582|NCT04003103|323118525|FG000|Overall Study|Lost to Follow-up|4|||
94364583|NCT04003103|323118526|FG001|Overall Study|Lost to Follow-up|3|||
94364584|NCT04003103|323118527|FG002|Overall Study|Lost to Follow-up|2|||
94364585|NCT04003103|323118525|FG000|Overall Study|Withdrawal by Subject|10|||
94364586|NCT04003103|323118526|FG001|Overall Study|Withdrawal by Subject|1|||
94364587|NCT04003103|323118527|FG002|Overall Study|Withdrawal by Subject|1|||
94364588|NCT04003103|323118525|FG000|Overall Study|Status not recorded|0|||
94364589|NCT04003103|323118526|FG001|Overall Study|Status not recorded|2|||
94364590|NCT04003103|323118527|FG002|Overall Study|Status not recorded|0|||
94650710|NCT04622254|324179609|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
94650711|NCT04622254|324179610|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
94650712|NCT04622254|324179611|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
94463785|NCT01573767|323486750|FG002|Overall Study|Withdrawal by Subject|0|||
94463786|NCT01573767|323486751|FG003|Overall Study|Withdrawal by Subject|0|||
94463787|NCT02339155|323486752|FG000|Overall Study|Adverse Event|0|||
94463788|NCT02339155|323486753|FG001|Overall Study|Adverse Event|6|||
94463789|NCT02339155|323486752|FG000|Overall Study|Death|1|||
94463790|NCT02339155|323486753|FG001|Overall Study|Death|1|||
94463791|NCT02339155|323486752|FG000|Overall Study|Lost to Follow-up|8|||
94463792|NCT02339155|323486753|FG001|Overall Study|Lost to Follow-up|9|||
94463793|NCT02339155|323486752|FG000|Overall Study|Physician Decision|2|||
94463794|NCT02339155|323486753|FG001|Overall Study|Physician Decision|1|||
94463795|NCT02339155|323486752|FG000|Overall Study|Withdrawal by Subject|4|||
94463796|NCT02339155|323486753|FG001|Overall Study|Withdrawal by Subject|4|||
94463797|NCT02045732|323486756|FG000|Overall Study|At the discretion of the investigator|1|||
94463798|NCT02045732|323486757|FG001|Overall Study|At the discretion of the investigator|1|||
94463799|NCT01210495|323486758|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
94463800|NCT01210495|323486759|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
94463801|NCT01210495|323486760|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
94463802|NCT01210495|323486761|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
94463803|NCT01210495|323486758|FG000|Overall Study|Death|14|||
94463804|NCT01210495|323486759|FG001|Overall Study|Death|7|||
94463805|NCT01210495|323486760|FG002|Overall Study|Death|112|||
94463806|NCT01210495|323486761|FG003|Overall Study|Death|54|||
94463807|NCT01210495|323486758|FG000|Overall Study|Study Terminated by Sponsor|0|||
94463808|NCT01210495|323486759|FG001|Overall Study|Study Terminated by Sponsor|0|||
94463809|NCT01210495|323486760|FG002|Overall Study|Study Terminated by Sponsor|4|||
94463810|NCT01210495|323486761|FG003|Overall Study|Study Terminated by Sponsor|11|||
94650713|NCT04622254|324179612|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
94650714|NCT04622254|324179607|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
94650715|NCT04622254|324179608|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
94650716|NCT04622254|324179609|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
94650717|NCT04622254|324179610|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
94650718|NCT04622254|324179611|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
94650719|NCT04622254|324179612|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
94650720|NCT04622254|324179607|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
94463811|NCT01210495|323486758|FG000|Overall Study|Lost to Follow-up|0|||
94463812|NCT01210495|323486759|FG001|Overall Study|Lost to Follow-up|0|||
94463813|NCT01210495|323486760|FG002|Overall Study|Lost to Follow-up|1|||
94463814|NCT01210495|323486761|FG003|Overall Study|Lost to Follow-up|1|||
94463815|NCT01210495|323486758|FG000|Overall Study|Other unspecified|0|||
94463816|NCT01210495|323486759|FG001|Overall Study|Other unspecified|0|||
94463817|NCT01210495|323486760|FG002|Overall Study|Other unspecified|6|||
94463818|NCT01210495|323486761|FG003|Overall Study|Other unspecified|0|||
94463819|NCT01384019|323486763|FG000|Overall Study|Withdrawal by Subject|3|||
94463820|NCT01384019|323486764|FG001|Overall Study|Withdrawal by Subject|0|||
94463821|NCT01384019|323486763|FG000|Overall Study|Death|1|||
94463822|NCT01384019|323486764|FG001|Overall Study|Death|0|||
94463823|NCT01384019|323486763|FG000|Overall Study|MRI refusal|6|||
94463824|NCT01384019|323486764|FG001|Overall Study|MRI refusal|6|||
94463825|NCT02719353|323486767|FG000|First Intervention|Physician Decision|0|||
94463826|NCT02719353|323486768|FG001|First Intervention|Physician Decision|1|||
94463827|NCT00367484|323486769|FG000|Overall Study|Adverse Event|7|||
94463828|NCT00367484|323486769|FG000|Overall Study|Withdrew informed consent|5|||
94463829|NCT00367484|323486769|FG000|Overall Study|Travel to USA|1|||
94463830|NCT00367484|323486769|FG000|Overall Study|Lost to Follow-up|1|||
94650721|NCT04622254|324179608|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
94650722|NCT04622254|324179609|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
94650723|NCT04622254|324179610|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
94650724|NCT04622254|324179611|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
94650725|NCT04622254|324179612|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
94650726|NCT02652624|324179613|FG000|Randomized Phase|Pregnancy|3|||
94463831|NCT00367484|323486769|FG000|Overall Study|Protocol Violation|1|||
94463832|NCT00367484|323486769|FG000|Overall Study|The choice of the patient|1|||
94463833|NCT00367484|323486769|FG000|Overall Study|Lack of Efficacy|1|||
94463834|NCT00081731|323486770|FG000|Overall Study|scientific integrity issue|8|||
94463835|NCT00081731|323486771|FG001|Overall Study|scientific integrity issue|8|||
94463836|NCT01629823|323486772|FG000|Trial Period|Missed visit|11|||
94463837|NCT01629823|323486773|FG001|Trial Period|Missed visit|9|||
94463838|NCT01629823|323486774|FG002|Trial Period|Missed visit|8|||
94463839|NCT01629823|323486772|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
94463840|NCT01629823|323486773|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
94463841|NCT01629823|323486774|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
94463842|NCT01629823|323486772|FG000|Trial Period|Pregnancy|1|||
94463843|NCT01629823|323486773|FG001|Trial Period|Pregnancy|0|||
94463844|NCT01629823|323486774|FG002|Trial Period|Pregnancy|0|||
94463845|NCT01629823|323486772|FG000|Trial Period|Adverse Event|0|||
94463846|NCT01629823|323486773|FG001|Trial Period|Adverse Event|1|||
94463847|NCT01629823|323486774|FG002|Trial Period|Adverse Event|0|||
94463848|NCT01629823|323486772|FG000|Trial Period|Out-of-window visit|0|||
94463849|NCT01629823|323486773|FG001|Trial Period|Out-of-window visit|2|||
94463850|NCT01629823|323486774|FG002|Trial Period|Out-of-window visit|0|||
94463851|NCT01629823|323486772|FG000|Trial Period|Failed to hold medication|0|||
94463852|NCT01629823|323486773|FG001|Trial Period|Failed to hold medication|0|||
94463853|NCT01629823|323486774|FG002|Trial Period|Failed to hold medication|1|||
94463854|NCT01629823|323486772|FG000|Washout Period|Safety|2|||
94463855|NCT01629823|323486773|FG001|Washout Period|Safety|5|||
94463856|NCT01629823|323486774|FG002|Washout Period|Safety|0|||
94650727|NCT02652624|324179614|FG001|Randomized Phase|Pregnancy|1|||
94650728|NCT02652624|324179613|FG000|Randomized Phase|Investigator's Discretion|0|||
94686626|NCT00779584|324307709|FG000|Overall Study|Withdrawal by Subject|1|||
94463857|NCT01629823|323486772|FG000|Washout Period|Pregnancy|1|||
94463858|NCT01629823|323486773|FG001|Washout Period|Pregnancy|0|||
94463859|NCT01629823|323486774|FG002|Washout Period|Pregnancy|0|||
94463860|NCT01629823|323486772|FG000|Washout Period|Protocol Violation|0|||
94463861|NCT01629823|323486773|FG001|Washout Period|Protocol Violation|1|||
94463862|NCT01629823|323486774|FG002|Washout Period|Protocol Violation|0|||
94463863|NCT00785213|323486775|FG000|Quinine Sulfate Alone|Adverse Event|4|||
94463864|NCT00785213|323486775|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
94463865|NCT02609724|323486776|FG000|Overall Study|Death|2|||
94463866|NCT02609724|323486777|FG001|Overall Study|Death|0|||
94463867|NCT02609724|323486778|FG002|Overall Study|Death|1|||
94463868|NCT02609724|323486776|FG000|Overall Study|Withdrawal by Subject|1|||
94463869|NCT02609724|323486777|FG001|Overall Study|Withdrawal by Subject|2|||
94463870|NCT02609724|323486778|FG002|Overall Study|Withdrawal by Subject|3|||
94463871|NCT02609724|323486776|FG000|Overall Study|Illness|2|||
94463872|NCT02609724|323486777|FG001|Overall Study|Illness|1|||
94463873|NCT02609724|323486778|FG002|Overall Study|Illness|0|||
94463874|NCT02844907|323486783|FG000|With Dexamethasone|No IV access|1|||
94463875|NCT00738062|323486784|FG000|Open Label Treatment|Lack of Efficacy|5|||
94463876|NCT00738062|323486785|FG001|Open Label Treatment|Lack of Efficacy|0|||
94463877|NCT00738062|323486786|FG002|Open Label Treatment|Lack of Efficacy|0|||
94463878|NCT00738062|323486784|FG000|Open Label Treatment|Adverse Event|11|||
94463879|NCT00738062|323486785|FG001|Open Label Treatment|Adverse Event|0|||
94463880|NCT00738062|323486786|FG002|Open Label Treatment|Adverse Event|0|||
94463881|NCT00738062|323486784|FG000|Open Label Treatment|Protocol Violation|2|||
94463882|NCT00738062|323486785|FG001|Open Label Treatment|Protocol Violation|0|||
94463883|NCT00738062|323486786|FG002|Open Label Treatment|Protocol Violation|0|||
94463884|NCT00738062|323486784|FG000|Open Label Treatment|Withdrawal by Subject|9|||
94463885|NCT00738062|323486785|FG001|Open Label Treatment|Withdrawal by Subject|0|||
94463886|NCT00738062|323486786|FG002|Open Label Treatment|Withdrawal by Subject|0|||
94463887|NCT00738062|323486784|FG000|Open Label Treatment|Investigator Decision|1|||
94463888|NCT00738062|323486785|FG001|Open Label Treatment|Investigator Decision|0|||
94463889|NCT00738062|323486786|FG002|Open Label Treatment|Investigator Decision|0|||
94463890|NCT00738062|323486784|FG000|Open-Label Extension|Adverse Event|5|||
94463891|NCT00738062|323486785|FG001|Open-Label Extension|Adverse Event|0|||
94463892|NCT00738062|323486786|FG002|Open-Label Extension|Adverse Event|0|||
94463893|NCT00738062|323486784|FG000|Open-Label Extension|Physician Decision|1|||
94463894|NCT00738062|323486785|FG001|Open-Label Extension|Physician Decision|0|||
94463895|NCT00738062|323486786|FG002|Open-Label Extension|Physician Decision|0|||
94463896|NCT00738062|323486784|FG000|Open-Label Extension|Lack of Efficacy|2|||
94463897|NCT00738062|323486785|FG001|Open-Label Extension|Lack of Efficacy|0|||
94463898|NCT00738062|323486786|FG002|Open-Label Extension|Lack of Efficacy|0|||
94463899|NCT00738062|323486784|FG000|Open-Label Extension|Withdrawal by Subject|6|||
94463900|NCT00738062|323486785|FG001|Open-Label Extension|Withdrawal by Subject|0|||
94463901|NCT00738062|323486786|FG002|Open-Label Extension|Withdrawal by Subject|0|||
94463902|NCT00738062|323486784|FG000|Open-Label Extension|Protocol Violation|1|||
94463903|NCT00738062|323486785|FG001|Open-Label Extension|Protocol Violation|0|||
94463904|NCT00738062|323486786|FG002|Open-Label Extension|Protocol Violation|0|||
94463905|NCT00738062|323486784|FG000|Open-Label Extension|Study Terminated|2|||
94463906|NCT00738062|323486785|FG001|Open-Label Extension|Study Terminated|0|||
94463907|NCT00738062|323486786|FG002|Open-Label Extension|Study Terminated|0|||
94463908|NCT00844480|323486787|FG000|Overall Study|Withdrawal by Subject|2|||
94463909|NCT00844480|323486788|FG001|Overall Study|Withdrawal by Subject|3|||
94463910|NCT00550862|323486789|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
94463911|NCT00550862|323486790|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
94463912|NCT00550862|323486791|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
94463913|NCT00550862|323486792|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
94463914|NCT00550862|323486793|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
94463915|NCT00550862|323486789|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
94463916|NCT00550862|323486790|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
94463917|NCT00550862|323486791|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
94463918|NCT00550862|323486792|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
94463919|NCT00550862|323486793|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
94463920|NCT00550862|323486789|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
94463921|NCT00550862|323486790|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
94463922|NCT00550862|323486791|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
94463923|NCT00550862|323486792|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
94463924|NCT00550862|323486793|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
94463925|NCT00550862|323486789|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
94463926|NCT00550862|323486790|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
94463927|NCT00550862|323486791|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
94463928|NCT00550862|323486792|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
94463929|NCT00550862|323486793|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
94463930|NCT00550862|323486789|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
94463931|NCT00550862|323486790|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
94463932|NCT00550862|323486791|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
94650729|NCT02652624|324179614|FG001|Randomized Phase|Investigator's Discretion|2|||
94650730|NCT02652624|324179613|FG000|Randomized Phase|Death|0|||
94463933|NCT00550862|323486792|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
94650731|NCT02652624|324179614|FG001|Randomized Phase|Death|1|||
94650732|NCT02652624|324179613|FG000|Randomized Phase|Lost to Follow-up|0|||
94650733|NCT02652624|324179614|FG001|Randomized Phase|Lost to Follow-up|1|||
94650734|NCT02652624|324179613|FG000|Extension Phase|Lost to Follow-up|3|||
94650735|NCT02652624|324179614|FG001|Extension Phase|Lost to Follow-up|1|||
94650736|NCT02652624|324179613|FG000|Extension Phase|Pregnancy|1|||
94650737|NCT02652624|324179614|FG001|Extension Phase|Pregnancy|1|||
94263875|NCT02733185|322759963|FG003|Overall Study|Lost to Follow-up|11|||
94463934|NCT00550862|323486793|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
94463935|NCT00550862|323486789|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
94463936|NCT00550862|323486790|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
94463937|NCT00550862|323486791|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
94463938|NCT00550862|323486792|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
94463939|NCT00550862|323486793|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
94463940|NCT00550862|323486789|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
94463941|NCT00550862|323486790|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
94463942|NCT00550862|323486791|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
94463943|NCT00550862|323486792|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
94463944|NCT00550862|323486793|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
94463945|NCT00550862|323486789|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
94463946|NCT00550862|323486790|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
94463947|NCT00550862|323486791|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
94463948|NCT00550862|323486792|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
94463949|NCT00550862|323486793|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
94463950|NCT00550862|323486789|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
94463951|NCT00550862|323486790|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
94463952|NCT00550862|323486791|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
94463953|NCT00550862|323486792|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
94463954|NCT00550862|323486793|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
94463955|NCT00550862|323486789|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
94463956|NCT00550862|323486790|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
94463957|NCT00550862|323486791|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
94463958|NCT00550862|323486792|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
94463959|NCT00550862|323486793|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
94463960|NCT02858180|323486794|FG000|Overall Study|Lost to Follow-up|0|||
94463961|NCT02858180|323486795|FG001|Overall Study|Lost to Follow-up|2|||
94463962|NCT00980174|323486796|FG000|Overall Study|Withdrawal by Subject|1|||
94463963|NCT00980174|323486797|FG001|Overall Study|Withdrawal by Subject|4|||
94463964|NCT00980174|323486796|FG000|Overall Study|Adverse Event|0|||
94463965|NCT00980174|323486797|FG001|Overall Study|Adverse Event|3|||
94463966|NCT00980174|323486796|FG000|Overall Study|Ineligibility determined|2|||
94463967|NCT00980174|323486797|FG001|Overall Study|Ineligibility determined|1|||
94463968|NCT00980174|323486796|FG000|Overall Study|Death|1|||
94463969|NCT00980174|323486797|FG001|Overall Study|Death|1|||
94463970|NCT00980174|323486796|FG000|Overall Study|Other|0|||
94463971|NCT00980174|323486797|FG001|Overall Study|Other|1|||
94463972|NCT00526331|323486799|FG000|Overall Study|Sponsor Termination|55|||
94463973|NCT00979420|323486800|FG000|Overall Study|Adverse Event|1|||
94463974|NCT00979420|323486801|FG001|Overall Study|Adverse Event|0|||
94463975|NCT00979420|323486802|FG002|Overall Study|Adverse Event|0|||
94463976|NCT00979420|323486803|FG003|Overall Study|Adverse Event|0|||
94463977|NCT00979420|323486800|FG000|Overall Study|Lack of Efficacy|3|||
94463978|NCT00979420|323486801|FG001|Overall Study|Lack of Efficacy|0|||
94463979|NCT00979420|323486802|FG002|Overall Study|Lack of Efficacy|1|||
94463980|NCT00979420|323486803|FG003|Overall Study|Lack of Efficacy|1|||
94463981|NCT00979420|323486800|FG000|Overall Study|Other reasons not related to Viramune|3|||
94463982|NCT00979420|323486801|FG001|Overall Study|Other reasons not related to Viramune|0|||
94463983|NCT00979420|323486802|FG002|Overall Study|Other reasons not related to Viramune|0|||
94463984|NCT00979420|323486803|FG003|Overall Study|Other reasons not related to Viramune|1|||
94463985|NCT00455520|323486804|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
94463986|NCT00455520|323486805|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
94463987|NCT00455520|323486804|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
94463988|NCT00455520|323486805|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
94463989|NCT00455520|323486804|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
94463990|NCT00455520|323486805|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
94463991|NCT00455520|323486804|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
94463992|NCT00455520|323486805|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
94650738|NCT02652624|324179613|FG000|Extension Phase|Adverse Event|0|||
94650739|NCT02652624|324179614|FG001|Extension Phase|Adverse Event|1|||
94650740|NCT02652624|324179613|FG000|Extension Phase|Withdrew Consent|0|||
94463993|NCT00455520|323486804|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
94463994|NCT00455520|323486805|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
94463995|NCT00455520|323486804|FG000|Open Label Tapentadol Extended Release|All other|33|||
94463996|NCT00455520|323486805|FG001|Open Label Tapentadol Extended Release|All other|0|||
94463997|NCT00455520|323486804|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
94463998|NCT00455520|323486805|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
94463999|NCT00455520|323486804|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
94464000|NCT00455520|323486805|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
94464001|NCT00455520|323486804|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
94464002|NCT00455520|323486805|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
94464003|NCT00455520|323486804|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
94464004|NCT00455520|323486805|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
94464005|NCT00455520|323486804|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
94464006|NCT00455520|323486805|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
94650741|NCT02652624|324179614|FG001|Extension Phase|Withdrew Consent|1|||
94650742|NCT01023659|324179615|FG000|Overall Study|Lost to Follow-up|73|||
94650743|NCT01023659|324179616|FG001|Overall Study|Lost to Follow-up|228|||
94650744|NCT01023659|324179617|FG002|Overall Study|Lost to Follow-up|99|||
94464007|NCT00455520|323486804|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
94464008|NCT00455520|323486805|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
94464009|NCT03488225|323486807|FG000|Overall Study|Off Protocol Therapy|2|||
94464010|NCT03488225|323486807|FG000|Overall Study|Stem Cell Transplant|2|||
94464011|NCT00894790|323486809|FG000|Overall Study|Protocol Violation|0|||
94464012|NCT00894790|323486810|FG001|Overall Study|Protocol Violation|1|||
94464013|NCT00894790|323486809|FG000|Overall Study|Lost to Follow-up|0|||
94464014|NCT00894790|323486810|FG001|Overall Study|Lost to Follow-up|1|||
94464015|NCT00894790|323486809|FG000|Overall Study|Did not meet entrance criteria|1|||
94464016|NCT00894790|323486810|FG001|Overall Study|Did not meet entrance criteria|0|||
94464017|NCT00662558|323486811|FG000|Overall Study|Adverse Event|21|||
94464018|NCT00662558|323486812|FG001|Overall Study|Adverse Event|59|||
94464019|NCT00662558|323486811|FG000|Overall Study|Lack of Efficacy|4|||
94464020|NCT00662558|323486812|FG001|Overall Study|Lack of Efficacy|7|||
94464021|NCT00662558|323486811|FG000|Overall Study|Lost to Follow-up|13|||
94464022|NCT00662558|323486812|FG001|Overall Study|Lost to Follow-up|10|||
94464023|NCT00662558|323486811|FG000|Overall Study|Other|9|||
94464024|NCT00662558|323486812|FG001|Overall Study|Other|14|||
94464025|NCT00662558|323486811|FG000|Overall Study|Withdrawal by Subject|7|||
94464026|NCT00662558|323486812|FG001|Overall Study|Withdrawal by Subject|12|||
94464027|NCT00662558|323486811|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
94464028|NCT00662558|323486812|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
94464029|NCT02945254|323486815|FG000|Overall Study|Lost to Follow-up|1|||
94464030|NCT02945254|323486816|FG001|Overall Study|Lost to Follow-up|0|||
94464031|NCT02945254|323486815|FG000|Overall Study|Withdrawal by Subject|1|||
94464032|NCT02945254|323486816|FG001|Overall Study|Withdrawal by Subject|0|||
94464033|NCT00783224|323486817|FG000|Overall Study|Adverse Event|0|||
94464034|NCT00783224|323486818|FG001|Overall Study|Adverse Event|0|||
94464035|NCT00783224|323486819|FG002|Overall Study|Adverse Event|1|||
94464036|NCT00783224|323486820|FG003|Overall Study|Adverse Event|0|||
94464037|NCT00783224|323486817|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
94464038|NCT00783224|323486818|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
94464039|NCT00783224|323486819|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
94464040|NCT00783224|323486820|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
94464041|NCT00783224|323486817|FG000|Overall Study|Inappropriate as a study subject|0|||
94464042|NCT00783224|323486818|FG001|Overall Study|Inappropriate as a study subject|0|||
94464043|NCT00783224|323486819|FG002|Overall Study|Inappropriate as a study subject|0|||
94464044|NCT00783224|323486820|FG003|Overall Study|Inappropriate as a study subject|1|||
94464045|NCT01432275|323486825|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
94464046|NCT01432275|323486826|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
94464047|NCT01432275|323486825|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
94464048|NCT01432275|323486826|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
94464049|NCT01432275|323486825|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
94464050|NCT01432275|323486826|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
94464051|NCT01432275|323486825|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
94650745|NCT02489981|324179618|FG000|Overall Study|Adverse Event|21|||
94464052|NCT01432275|323486826|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
94464053|NCT01432275|323486825|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
94464054|NCT01432275|323486826|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
94464055|NCT01432275|323486825|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
94464056|NCT01432275|323486826|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
94464057|NCT01432275|323486825|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
94464058|NCT01432275|323486826|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
94464059|NCT01432275|323486825|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
94464060|NCT01432275|323486826|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
94464061|NCT01432275|323486825|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
94464062|NCT01432275|323486826|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
94464063|NCT00551161|323486827|FG000|Overall Study|Withdrawal by Subject|1|||
94464064|NCT00204477|323486833|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
94464065|NCT00204477|323486834|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
94464066|NCT00204477|323486833|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
94464067|NCT00204477|323486834|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
94464068|NCT01294371|323486835|FG000|Overall Study|Adverse Event|1|||
94464069|NCT01294371|323486835|FG000|Overall Study|Withdrawal by Subject|12|||
94464070|NCT01294371|323486835|FG000|Overall Study|Lost to Follow-up|6|||
94464071|NCT01294371|323486835|FG000|Overall Study|Administrative Reason|1|||
94464072|NCT01294371|323486835|FG000|Overall Study|Other|14|||
94464073|NCT00157248|323486836|FG000|Overall Study|Adverse Event|36|||
94464074|NCT00157248|323486837|FG001|Overall Study|Adverse Event|25|||
94464075|NCT00157248|323486838|FG002|Overall Study|Adverse Event|13|||
94464076|NCT00157248|323486839|FG003|Overall Study|Adverse Event|33|||
94464077|NCT00157248|323486836|FG000|Overall Study|Protocol Violation|4|||
94464078|NCT00157248|323486837|FG001|Overall Study|Protocol Violation|0|||
94464079|NCT00157248|323486838|FG002|Overall Study|Protocol Violation|2|||
94464080|NCT00157248|323486839|FG003|Overall Study|Protocol Violation|2|||
94464081|NCT00157248|323486836|FG000|Overall Study|Lost to Follow-up|0|||
94464082|NCT00157248|323486837|FG001|Overall Study|Lost to Follow-up|1|||
94464083|NCT00157248|323486838|FG002|Overall Study|Lost to Follow-up|0|||
94464084|NCT00157248|323486839|FG003|Overall Study|Lost to Follow-up|0|||
94464085|NCT00157248|323486836|FG000|Overall Study|Withdrawal by Subject|1|||
94464086|NCT00157248|323486837|FG001|Overall Study|Withdrawal by Subject|4|||
94464087|NCT00157248|323486838|FG002|Overall Study|Withdrawal by Subject|3|||
94464088|NCT00157248|323486839|FG003|Overall Study|Withdrawal by Subject|3|||
94464089|NCT00157248|323486836|FG000|Overall Study|site closures, subject moving|7|||
94464090|NCT00157248|323486837|FG001|Overall Study|site closures, subject moving|7|||
94464091|NCT00157248|323486838|FG002|Overall Study|site closures, subject moving|3|||
94464092|NCT00157248|323486839|FG003|Overall Study|site closures, subject moving|9|||
94464093|NCT01253174|323486840|FG000|Period 1|Randomized but not treated|0|||
94464094|NCT01253174|323486841|FG001|Period 1|Randomized but not treated|1|||
94464095|NCT01253174|323486842|FG002|Period 1|Randomized but not treated|1|||
94464096|NCT01253174|323486843|FG003|Period 1|Randomized but not treated|0|||
94464097|NCT01253174|323486844|FG004|Period 1|Randomized but not treated|1|||
94464098|NCT01253174|323486845|FG005|Period 1|Randomized but not treated|0|||
94464099|NCT01253174|323486840|FG000|Period 2|Adverse Event|0|||
94464100|NCT01253174|323486841|FG001|Period 2|Adverse Event|0|||
94464101|NCT01253174|323486842|FG002|Period 2|Adverse Event|1|||
94464102|NCT01253174|323486843|FG003|Period 2|Adverse Event|0|||
94464103|NCT01253174|323486844|FG004|Period 2|Adverse Event|0|||
94464104|NCT01253174|323486845|FG005|Period 2|Adverse Event|0|||
94464105|NCT01253174|323486840|FG000|Period 3|Withdrawal by Subject|0|||
94464106|NCT01253174|323486841|FG001|Period 3|Withdrawal by Subject|1|||
94464107|NCT01253174|323486842|FG002|Period 3|Withdrawal by Subject|0|||
94464108|NCT01253174|323486843|FG003|Period 3|Withdrawal by Subject|0|||
94464109|NCT01253174|323486844|FG004|Period 3|Withdrawal by Subject|1|||
94464110|NCT01253174|323486845|FG005|Period 3|Withdrawal by Subject|0|||
94464111|NCT01253174|323486840|FG000|Period 3|Pregnancy|0|||
94464112|NCT01253174|323486841|FG001|Period 3|Pregnancy|0|||
94464113|NCT01253174|323486842|FG002|Period 3|Pregnancy|1|||
94686627|NCT00779584|324307710|FG001|Overall Study|Withdrawal by Subject|1|||
94464114|NCT01253174|323486843|FG003|Period 3|Pregnancy|0|||
94464115|NCT01253174|323486844|FG004|Period 3|Pregnancy|0|||
94464116|NCT01253174|323486845|FG005|Period 3|Pregnancy|0|||
94464117|NCT03467763|323486846|FG000|Overall Study|Lost to Follow-up|1|||
94464118|NCT03467763|323486846|FG000|Overall Study|Protocol Violation|2|||
94464119|NCT02889835|323486854|FG000|Overall Study|Lost to Follow-up|13|||
94464120|NCT02889835|323486855|FG001|Overall Study|Lost to Follow-up|13|||
94464121|NCT02889835|323486856|FG002|Overall Study|Lost to Follow-up|13|||
94686628|NCT00779584|324307711|FG002|Overall Study|Withdrawal by Subject|2|||
94464122|NCT02889835|323486854|FG000|Overall Study|Withdrawal by Subject|2|||
94364591|NCT04935931|323118532|FG000|Overall Study|Withdrawal by Subject|1|||
94364592|NCT05168657|323118533|FG000|Overall Study|Adverse Event|0|||
94364593|NCT05168657|323118534|FG001|Overall Study|Adverse Event|0|||
94364594|NCT05168657|323118535|FG002|Overall Study|Adverse Event|1|||
94364595|NCT05168657|323118536|FG003|Overall Study|Adverse Event|0|||
94364596|NCT05168657|323118537|FG004|Overall Study|Adverse Event|0|||
94364597|NCT05168657|323118538|FG005|Overall Study|Adverse Event|0|||
94364598|NCT05168657|323118539|FG006|Overall Study|Adverse Event|0|||
94364599|NCT05168657|323118540|FG007|Overall Study|Adverse Event|0|||
94364600|NCT00962013|323118543|FG000|Overall Study|Did not have surgery|1|||
94364601|NCT00962013|323118543|FG000|Overall Study|Death|8|||
94364602|NCT00962013|323118543|FG000|Overall Study|Lost to Follow-up|12|||
94364603|NCT00962013|323118543|FG000|Overall Study|Unable/Unwilling to return|6|||
94364604|NCT00962013|323118543|FG000|Overall Study|Withdrawal by Subject|8|||
94364605|NCT00962013|323118543|FG000|Overall Study|Removal of study device|3|||
94364606|NCT00962013|323118543|FG000|Overall Study|Site Termination|24|||
94364607|NCT00962013|323118543|FG000|Overall Study|No 5 year evaluation|6|||
94364608|NCT02007512|323118547|FG000|Double Blind Treatment Period|Adverse Event|4|||
94364609|NCT02007512|323118548|FG001|Double Blind Treatment Period|Adverse Event|2|||
94364610|NCT02007512|323118549|FG002|Double Blind Treatment Period|Adverse Event|6|||
94464123|NCT02889835|323486855|FG001|Overall Study|Withdrawal by Subject|2|||
94464124|NCT02889835|323486856|FG002|Overall Study|Withdrawal by Subject|2|||
94464125|NCT02889835|323486854|FG000|Overall Study|Protocol Violation|1|||
94650746|NCT02489981|324179618|FG000|Overall Study|Insufficient effectiveness|16|||
94650747|NCT02489981|324179618|FG000|Overall Study|Improved|31|||
94650748|NCT02489981|324179618|FG000|Overall Study|Lost to Follow-up|31|||
94364611|NCT02007512|323118550|FG003|Double Blind Treatment Period|Adverse Event|2|||
94364612|NCT02007512|323118547|FG000|Double Blind Treatment Period|Death|1|||
94364613|NCT02007512|323118548|FG001|Double Blind Treatment Period|Death|0|||
94650749|NCT02489981|324179618|FG000|Overall Study|Other than listed|28|||
94650750|NCT01049919|324179619|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
94650751|NCT01049919|324179620|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
94650752|NCT01049919|324179619|FG000|Overall Study|Withdrawal by Subject|5|||
94650753|NCT01049919|324179620|FG001|Overall Study|Withdrawal by Subject|0|||
94650754|NCT01049919|324179619|FG000|Overall Study|Lost to Follow-up|6|||
94650755|NCT01049919|324179620|FG001|Overall Study|Lost to Follow-up|1|||
94650756|NCT01049919|324179619|FG000|Overall Study|Physician Decision|2|||
94364614|NCT02007512|323118549|FG002|Double Blind Treatment Period|Death|0|||
94464126|NCT02889835|323486855|FG001|Overall Study|Protocol Violation|1|||
94464127|NCT02889835|323486856|FG002|Overall Study|Protocol Violation|1|||
94464128|NCT02889835|323486854|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
94464129|NCT02889835|323486855|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
94464130|NCT02889835|323486856|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
94464131|NCT02889835|323486854|FG000|Overall Study|Death|1|||
94464132|NCT02889835|323486855|FG001|Overall Study|Death|1|||
94464133|NCT02889835|323486856|FG002|Overall Study|Death|1|||
94464134|NCT02342548|323486857|FG000|Overall Study|Adverse Event|12|||
94464135|NCT02342548|323486858|FG001|Overall Study|Adverse Event|17|||
94464136|NCT02342548|323486859|FG002|Overall Study|Adverse Event|13|||
94464137|NCT02342548|323486857|FG000|Overall Study|Lost to Follow-up|0|||
94464138|NCT02342548|323486858|FG001|Overall Study|Lost to Follow-up|1|||
94364615|NCT02007512|323118550|FG003|Double Blind Treatment Period|Death|0|||
94464139|NCT02342548|323486859|FG002|Overall Study|Lost to Follow-up|0|||
94464140|NCT02342548|323486857|FG000|Overall Study|Study terminated by sponsor|20|||
94464141|NCT02342548|323486858|FG001|Overall Study|Study terminated by sponsor|39|||
94464142|NCT02342548|323486859|FG002|Overall Study|Study terminated by sponsor|25|||
94464143|NCT02342548|323486857|FG000|Overall Study|Protocol Violation|0|||
94464144|NCT02342548|323486858|FG001|Overall Study|Protocol Violation|1|||
94464145|NCT02342548|323486859|FG002|Overall Study|Protocol Violation|0|||
94464146|NCT02342548|323486857|FG000|Overall Study|Withdrawal by Subject|1|||
94464147|NCT02342548|323486858|FG001|Overall Study|Withdrawal by Subject|3|||
94464148|NCT02342548|323486859|FG002|Overall Study|Withdrawal by Subject|4|||
94464149|NCT02342548|323486857|FG000|Overall Study|Other|1|||
94464150|NCT02342548|323486858|FG001|Overall Study|Other|1|||
94464151|NCT02342548|323486859|FG002|Overall Study|Other|1|||
94364616|NCT02007512|323118547|FG000|Double Blind Treatment Period|Disease progression|44|||
94364617|NCT02007512|323118548|FG001|Double Blind Treatment Period|Disease progression|49|||
94364618|NCT02007512|323118549|FG002|Double Blind Treatment Period|Disease progression|45|||
94364619|NCT02007512|323118550|FG003|Double Blind Treatment Period|Disease progression|51|||
94464152|NCT03055494|323488345|FG000|Overall Study|Lost to Follow-up|6|||
94464153|NCT03055494|323488346|FG001|Overall Study|Lost to Follow-up|0|||
94464154|NCT03055494|323488345|FG000|Overall Study|Physician Decision|2|||
94464155|NCT03055494|323488346|FG001|Overall Study|Physician Decision|0|||
94464156|NCT03055494|323488345|FG000|Overall Study|Withdrawal by Subject|1|||
94650757|NCT01049919|324179620|FG001|Overall Study|Physician Decision|0|||
94464157|NCT03055494|323488346|FG001|Overall Study|Withdrawal by Subject|0|||
94464158|NCT03055494|323488345|FG000|Overall Study|Adverse Event|0|||
94464159|NCT03055494|323488346|FG001|Overall Study|Adverse Event|1|||
94464160|NCT03055494|323488345|FG000|Overall Study|Non-compliance with study treatment|1|||
94464161|NCT03055494|323488346|FG001|Overall Study|Non-compliance with study treatment|0|||
94464162|NCT04680052|323488347|FG000|Overall Study|Ongoing|244|||
94464163|NCT04680052|323488348|FG001|Overall Study|Ongoing|229|||
94464164|NCT04680052|323488349|FG002|Overall Study|Ongoing|39|||
94464165|NCT04680052|323488350|FG003|Overall Study|Ongoing|46|||
94464166|NCT04680052|323488347|FG000|Overall Study|Death|15|||
94464167|NCT04680052|323488348|FG001|Overall Study|Death|22|||
94464168|NCT04680052|323488349|FG002|Overall Study|Death|7|||
94464169|NCT04680052|323488350|FG003|Overall Study|Death|1|||
94464170|NCT04680052|323488347|FG000|Overall Study|Lost to Follow-up|3|||
94464171|NCT04680052|323488348|FG001|Overall Study|Lost to Follow-up|2|||
94464172|NCT04680052|323488349|FG002|Overall Study|Lost to Follow-up|0|||
94464173|NCT04680052|323488350|FG003|Overall Study|Lost to Follow-up|1|||
94464174|NCT04680052|323488347|FG000|Overall Study|Withdrawal by Subject|11|||
94464175|NCT04680052|323488348|FG001|Overall Study|Withdrawal by Subject|19|||
94464176|NCT04680052|323488349|FG002|Overall Study|Withdrawal by Subject|7|||
94464177|NCT04680052|323488350|FG003|Overall Study|Withdrawal by Subject|5|||
94464178|NCT04680052|323488347|FG000|Overall Study|Missing|0|||
94464179|NCT04680052|323488348|FG001|Overall Study|Missing|1|||
94464180|NCT04680052|323488349|FG002|Overall Study|Missing|0|||
94464181|NCT04680052|323488350|FG003|Overall Study|Missing|0|||
94464182|NCT04680052|323488347|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
94464183|NCT04680052|323488348|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
94464184|NCT04680052|323488349|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
94464185|NCT04680052|323488350|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
94464186|NCT04680052|323488347|FG000|Overall Study|Physician Decision|0|||
94464187|NCT04680052|323488348|FG001|Overall Study|Physician Decision|1|||
94464188|NCT04680052|323488349|FG002|Overall Study|Physician Decision|0|||
94464189|NCT04680052|323488350|FG003|Overall Study|Physician Decision|0|||
94464190|NCT01752634|323488354|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
94464191|NCT01752634|323488355|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
94464192|NCT01752634|323488356|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
94464193|NCT01752634|323488357|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
94464194|NCT01752634|323488358|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
94464195|NCT01752634|323488359|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
94464196|NCT01752634|323488354|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
94464197|NCT01752634|323488355|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
94464198|NCT01752634|323488356|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
94464199|NCT01752634|323488357|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
94464200|NCT01752634|323488358|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
94464201|NCT01752634|323488359|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
94464202|NCT01752634|323488354|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
94464203|NCT01752634|323488355|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
94464204|NCT01752634|323488356|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
94464205|NCT01752634|323488357|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
94464206|NCT01752634|323488358|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
94464207|NCT01752634|323488359|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
94464208|NCT01752634|323488354|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
94464209|NCT01752634|323488355|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
94464210|NCT01752634|323488356|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
94464211|NCT01752634|323488357|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
94464212|NCT01752634|323488358|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
94464213|NCT01752634|323488359|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
94464214|NCT01752634|323488354|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
94464215|NCT01752634|323488355|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
94650758|NCT01049919|324179619|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
94650759|NCT01049919|324179620|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
94650760|NCT01049919|324179619|FG000|Overall Study|Early study termination by sponsor.|2|||
94650761|NCT01049919|324179620|FG001|Overall Study|Early study termination by sponsor.|0|||
94650762|NCT00723606|324179622|FG000|Overall Study|Adverse Event|2|||
94650763|NCT00723606|324179623|FG001|Overall Study|Adverse Event|5|||
94650764|NCT00723606|324179622|FG000|Overall Study|Other|2|||
94650765|NCT00723606|324179623|FG001|Overall Study|Other|0|||
94650766|NCT00723606|324179622|FG000|Overall Study|Withdrawal by Subject|0|||
94650767|NCT00723606|324179623|FG001|Overall Study|Withdrawal by Subject|2|||
94650768|NCT01126541|324179624|FG000|Overall Study|Adverse Event|0|||
94686629|NCT00779584|324307712|FG003|Overall Study|Withdrawal by Subject|0|||
94464216|NCT01752634|323488356|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
94464217|NCT01752634|323488357|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
94464218|NCT01752634|323488358|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
94464219|NCT01752634|323488359|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
94650769|NCT01126541|324179625|FG001|Overall Study|Adverse Event|2|||
94464220|NCT01752634|323488354|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
94464221|NCT01752634|323488355|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
94464222|NCT01752634|323488356|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
94464223|NCT01752634|323488357|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
94464224|NCT01752634|323488358|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
94464225|NCT01752634|323488359|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
94464226|NCT01752634|323488354|FG000|Week 24 to Week 260|Physician Decision|1|||
94464227|NCT01752634|323488355|FG001|Week 24 to Week 260|Physician Decision|2|||
94464228|NCT01752634|323488356|FG002|Week 24 to Week 260|Physician Decision|4|||
94464229|NCT01752634|323488357|FG003|Week 24 to Week 260|Physician Decision|2|||
94464230|NCT01752634|323488358|FG004|Week 24 to Week 260|Physician Decision|1|||
94464231|NCT01752634|323488359|FG005|Week 24 to Week 260|Physician Decision|0|||
94464232|NCT01752634|323488354|FG000|Week 24 to Week 260|Death|0|||
94464233|NCT01752634|323488355|FG001|Week 24 to Week 260|Death|1|||
94464234|NCT01752634|323488356|FG002|Week 24 to Week 260|Death|0|||
94464235|NCT01752634|323488357|FG003|Week 24 to Week 260|Death|0|||
94464236|NCT01752634|323488358|FG004|Week 24 to Week 260|Death|0|||
94464237|NCT01752634|323488359|FG005|Week 24 to Week 260|Death|0|||
94464238|NCT01752634|323488354|FG000|Week 24 to Week 260|Pregnancy|0|||
94464239|NCT01752634|323488355|FG001|Week 24 to Week 260|Pregnancy|0|||
94464240|NCT01752634|323488356|FG002|Week 24 to Week 260|Pregnancy|1|||
94464241|NCT01752634|323488357|FG003|Week 24 to Week 260|Pregnancy|0|||
94464242|NCT01752634|323488358|FG004|Week 24 to Week 260|Pregnancy|0|||
94464243|NCT01752634|323488359|FG005|Week 24 to Week 260|Pregnancy|0|||
94464244|NCT01752634|323488354|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
94464245|NCT01752634|323488355|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
94464246|NCT01752634|323488356|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
94464247|NCT01752634|323488357|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
94464248|NCT01752634|323488358|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
94464249|NCT01752634|323488359|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
94464250|NCT01752634|323488354|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
94464251|NCT01752634|323488355|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
94464252|NCT01752634|323488356|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
94263876|NCT03891524|322759964|FG000|Overall Study|Death|0|||
94263877|NCT03891524|322759965|FG001|Overall Study|Death|0|||
94464253|NCT01752634|323488357|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
94464254|NCT01752634|323488358|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
94464255|NCT01752634|323488359|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
94464256|NCT01752634|323488354|FG000|Week 24 to Week 260|Adverse Event|4|||
94464257|NCT01752634|323488355|FG001|Week 24 to Week 260|Adverse Event|8|||
94464258|NCT01752634|323488356|FG002|Week 24 to Week 260|Adverse Event|8|||
94464259|NCT01752634|323488357|FG003|Week 24 to Week 260|Adverse Event|4|||
94464260|NCT01752634|323488358|FG004|Week 24 to Week 260|Adverse Event|2|||
94464261|NCT01752634|323488359|FG005|Week 24 to Week 260|Adverse Event|0|||
94464262|NCT01371877|323488363|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
94464263|NCT01371877|323488364|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
94464264|NCT05932225|323488365|FG000|Overall Study|Lost to Follow-up|0|||
94464265|NCT05932225|323488366|FG001|Overall Study|Lost to Follow-up|1|||
94464266|NCT05932225|323488367|FG002|Overall Study|Lost to Follow-up|0|||
94464267|NCT05932225|323488365|FG000|Overall Study|Withdrawal by Subject|1|||
94464268|NCT05932225|323488366|FG001|Overall Study|Withdrawal by Subject|0|||
94464269|NCT05932225|323488367|FG002|Overall Study|Withdrawal by Subject|0|||
94464270|NCT05932225|323488365|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
94464271|NCT05932225|323488366|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
94464272|NCT05932225|323488367|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
94464273|NCT03117881|323488372|FG000|Baseline|Withdrawal by Subject|21|||
94464274|NCT03117881|323488373|FG001|Baseline|Withdrawal by Subject|10|||
94464275|NCT03117881|323488374|FG002|Baseline|Withdrawal by Subject|0|||
94464276|NCT03117881|323488372|FG000|Baseline|Lost to Follow-up|22|||
94464277|NCT03117881|323488373|FG001|Baseline|Lost to Follow-up|25|||
94464278|NCT03117881|323488374|FG002|Baseline|Lost to Follow-up|0|||
94464279|NCT03117881|323488372|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
94464280|NCT03117881|323488373|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
94464281|NCT03117881|323488374|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
94464282|NCT03117881|323488372|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
94464283|NCT03117881|323488373|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
94464284|NCT03117881|323488374|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
94464285|NCT03117881|323488372|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
94464286|NCT03117881|323488373|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
94464287|NCT03117881|323488374|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
94650770|NCT01126541|324179626|FG002|Overall Study|Adverse Event|4|||
94650771|NCT01126541|324179624|FG000|Overall Study|Death|0|||
94464288|NCT03117881|323488372|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
94464289|NCT03117881|323488373|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
94464290|NCT03117881|323488374|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
94464291|NCT03117881|323488372|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
94464292|NCT03117881|323488373|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
94464293|NCT03117881|323488374|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
94464294|NCT03117881|323488372|FG000|6-Month Follow-Up|Did not complete test|53|||
94464295|NCT03117881|323488373|FG001|6-Month Follow-Up|Did not complete test|25|||
94464296|NCT03117881|323488374|FG002|6-Month Follow-Up|Did not complete test|7|||
94464297|NCT03117881|323488372|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
94464298|NCT03117881|323488373|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
94464299|NCT03117881|323488374|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
94464300|NCT03117881|323488372|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
94464301|NCT03117881|323488373|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
94464302|NCT03117881|323488374|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
94464303|NCT03117881|323488372|FG000|12-Month Follow-Up|Did not complete test|40|||
94464304|NCT03117881|323488373|FG001|12-Month Follow-Up|Did not complete test|0|||
94464305|NCT03117881|323488374|FG002|12-Month Follow-Up|Did not complete test|0|||
94464306|NCT00552032|323488375|FG000|Overall Study|Withdrawal by Subject|2|||
94464307|NCT00552032|323488376|FG001|Overall Study|Withdrawal by Subject|2|||
94464308|NCT00552032|323488375|FG000|Overall Study|Protocol Violation|7|||
94464309|NCT00552032|323488376|FG001|Overall Study|Protocol Violation|12|||
94464310|NCT00552032|323488375|FG000|Overall Study|Lost to Follow-up|8|||
94464311|NCT00552032|323488376|FG001|Overall Study|Lost to Follow-up|5|||
94464312|NCT00345878|323488377|FG000|Overall Study|Adverse Event|1|||
94464313|NCT00345878|323488378|FG001|Overall Study|Adverse Event|0|||
94464314|NCT00345878|323488377|FG000|Overall Study|Lost to Follow-up|2|||
94464315|NCT00345878|323488378|FG001|Overall Study|Lost to Follow-up|1|||
94464316|NCT00345878|323488377|FG000|Overall Study|Other|1|||
94464317|NCT00345878|323488378|FG001|Overall Study|Other|0|||
94464318|NCT01911780|323488379|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
94464319|NCT01911780|323488380|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
94464320|NCT01911780|323488379|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
94464321|NCT01911780|323488380|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
94464322|NCT01911780|323488379|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
94464323|NCT01911780|323488380|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
94464324|NCT01911780|323488379|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
94464325|NCT01911780|323488380|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
94464326|NCT01911780|323488379|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
94464327|NCT01911780|323488380|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
94464328|NCT01911780|323488379|FG000|Extension Period (52 Weeks)|Personal reason|1|||
94464329|NCT01911780|323488380|FG001|Extension Period (52 Weeks)|Personal reason|1|||
94464330|NCT00473824|323488383|FG000|Overall Study|Virologic Breakthrough|1|||
94464331|NCT00473824|323488384|FG001|Overall Study|Virologic Breakthrough|0|||
94464332|NCT00473824|323488383|FG000|Overall Study|Adverse Event|1|||
94464333|NCT00473824|323488384|FG001|Overall Study|Adverse Event|0|||
94464334|NCT00473824|323488383|FG000|Overall Study|Death|1|||
94464335|NCT00473824|323488384|FG001|Overall Study|Death|0|||
94464336|NCT00473824|323488383|FG000|Overall Study|Lost to Follow-up|1|||
94464337|NCT00473824|323488384|FG001|Overall Study|Lost to Follow-up|0|||
94464338|NCT00473824|323488383|FG000|Overall Study|Withdrawal by physician|1|||
94464339|NCT00473824|323488384|FG001|Overall Study|Withdrawal by physician|0|||
94464340|NCT04105010|323488385|FG000|Overall Study|Death|3|||
94464341|NCT04105010|323488386|FG001|Overall Study|Death|1|||
94464342|NCT04105010|323488387|FG002|Overall Study|Death|1|||
94464343|NCT04105010|323488388|FG003|Overall Study|Death|54|||
94464344|NCT04105010|323488385|FG000|Overall Study|Lost to Follow-up|0|||
94464345|NCT04105010|323488386|FG001|Overall Study|Lost to Follow-up|0|||
94464346|NCT04105010|323488387|FG002|Overall Study|Lost to Follow-up|0|||
94464347|NCT04105010|323488388|FG003|Overall Study|Lost to Follow-up|4|||
94464348|NCT04105010|323488385|FG000|Overall Study|Withdrawal by Subject|8|||
94464349|NCT04105010|323488386|FG001|Overall Study|Withdrawal by Subject|1|||
94464350|NCT04105010|323488387|FG002|Overall Study|Withdrawal by Subject|1|||
94464351|NCT04105010|323488388|FG003|Overall Study|Withdrawal by Subject|4|||
94464352|NCT04105010|323488385|FG000|Overall Study|Other reason|4|||
94464353|NCT04105010|323488386|FG001|Overall Study|Other reason|7|||
94464354|NCT04105010|323488387|FG002|Overall Study|Other reason|0|||
94464355|NCT04105010|323488388|FG003|Overall Study|Other reason|19|||
94464356|NCT02284568|323488392|FG000|Overall Study|Adverse Event|2|||
94464357|NCT02284568|323488393|FG001|Overall Study|Adverse Event|9|||
94464358|NCT02284568|323488394|FG002|Overall Study|Adverse Event|4|||
94464359|NCT02284568|323488392|FG000|Overall Study|Withdrawal by Subject|22|||
94464360|NCT02284568|323488393|FG001|Overall Study|Withdrawal by Subject|21|||
94464361|NCT02284568|323488394|FG002|Overall Study|Withdrawal by Subject|1|||
94464362|NCT02284568|323488392|FG000|Overall Study|Noncompliance with study drug admin|1|||
94464363|NCT02284568|323488393|FG001|Overall Study|Noncompliance with study drug admin|2|||
94464364|NCT02284568|323488394|FG002|Overall Study|Noncompliance with study drug admin|0|||
94464365|NCT02284568|323488392|FG000|Overall Study|Noncompliance|1|||
94464366|NCT02284568|323488393|FG001|Overall Study|Noncompliance|0|||
94464367|NCT02284568|323488394|FG002|Overall Study|Noncompliance|0|||
94464368|NCT02284568|323488392|FG000|Overall Study|Protocol Violation|0|||
94464369|NCT02284568|323488393|FG001|Overall Study|Protocol Violation|1|||
94464370|NCT02284568|323488394|FG002|Overall Study|Protocol Violation|0|||
94464371|NCT02284568|323488392|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
94464372|NCT02284568|323488393|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
94464373|NCT02284568|323488394|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
94464374|NCT02284568|323488392|FG000|Overall Study|Lost to Follow-up|0|||
94464375|NCT02284568|323488393|FG001|Overall Study|Lost to Follow-up|3|||
94464376|NCT02284568|323488394|FG002|Overall Study|Lost to Follow-up|0|||
94464377|NCT02284568|323488392|FG000|Overall Study|Lack of Efficacy|4|||
94464378|NCT02284568|323488393|FG001|Overall Study|Lack of Efficacy|7|||
94464379|NCT02284568|323488394|FG002|Overall Study|Lack of Efficacy|0|||
94464380|NCT02284568|323488392|FG000|Overall Study|Other|1|||
94464381|NCT02284568|323488393|FG001|Overall Study|Other|2|||
94464382|NCT02284568|323488394|FG002|Overall Study|Other|0|||
94464383|NCT02284568|323488392|FG000|Overall Study|Withdrew before taking study drug|0|||
94464384|NCT02284568|323488393|FG001|Overall Study|Withdrew before taking study drug|1|||
94464385|NCT02284568|323488394|FG002|Overall Study|Withdrew before taking study drug|0|||
94464386|NCT02499146|323488395|FG000|Overall Study|Lost to Follow-up|1|||
94464387|NCT02499146|323488395|FG000|Overall Study|Withdrawal by Subject|1|||
94464388|NCT02499146|323488395|FG000|Overall Study|Other|2|||
94464389|NCT02499146|323488395|FG000|Overall Study|Ongoing at date of cut-off|9|||
94464390|NCT02499146|323488395|FG000|Overall Study|Began other treatment/therapy|13|||
94464391|NCT00741091|323488401|FG000|Overall Study|Death|13|||
94464392|NCT00741091|323488401|FG000|Overall Study|Lost to Follow-up|16|||
94464393|NCT00741091|323488401|FG000|Overall Study|Withdrawal by Subject|6|||
94464394|NCT00741091|323488401|FG000|Overall Study|Missed Visit|22|||
94464395|NCT00454818|323488403|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
94464396|NCT00454818|323488404|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
94464397|NCT00454818|323488405|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
94464398|NCT00454818|323488406|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
94464399|NCT00454818|323488407|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
94464400|NCT00454818|323488403|FG000|Phase I: Open-label Dose-escalation|Death|0|||
94464401|NCT00454818|323488404|FG001|Phase I: Open-label Dose-escalation|Death|1|||
94464402|NCT00454818|323488405|FG002|Phase I: Open-label Dose-escalation|Death|0|||
94464403|NCT00454818|323488406|FG003|Phase I: Open-label Dose-escalation|Death|0|||
94464404|NCT00454818|323488407|FG004|Phase I: Open-label Dose-escalation|Death|0|||
94464405|NCT00454818|323488403|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
94464406|NCT00454818|323488404|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
94464407|NCT00454818|323488405|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
94464408|NCT00454818|323488406|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
94464409|NCT00454818|323488407|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
94464410|NCT00454818|323488403|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
94464411|NCT00454818|323488404|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
94464412|NCT00454818|323488405|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
94464413|NCT00454818|323488406|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
94464414|NCT00454818|323488407|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
94464415|NCT00454818|323488403|FG000|Phase 2: Randomized Double-blind|Death|0|||
94464416|NCT00454818|323488404|FG001|Phase 2: Randomized Double-blind|Death|1|||
94464417|NCT00454818|323488405|FG002|Phase 2: Randomized Double-blind|Death|0|||
94464418|NCT00454818|323488406|FG003|Phase 2: Randomized Double-blind|Death|0|||
94464419|NCT00454818|323488407|FG004|Phase 2: Randomized Double-blind|Death|1|||
94464420|NCT00454818|323488403|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
94464421|NCT00454818|323488404|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
94464422|NCT00454818|323488405|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
94464423|NCT00454818|323488406|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
94464424|NCT00454818|323488407|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
94464425|NCT00454818|323488403|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
94464426|NCT00454818|323488404|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
94464427|NCT00454818|323488405|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
94464428|NCT00454818|323488406|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
94464429|NCT00454818|323488407|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
94464430|NCT01917344|323488411|FG000|Overall Study|Withdrawal by Subject|1|||
94464431|NCT00597506|323488418|FG000|Overall Study|Subject is being followed for survival|1|||
94464432|NCT00070018|323488419|FG000|Overall Study|Adverse Event|2|||
94464433|NCT00070018|323488419|FG000|Overall Study|Lack of Efficacy|1|||
94464434|NCT00070018|323488419|FG000|Overall Study|Withdrawal by Subject|1|||
94650772|NCT01126541|324179625|FG001|Overall Study|Death|1|||
94650773|NCT01126541|324179626|FG002|Overall Study|Death|0|||
94650774|NCT01126541|324179624|FG000|Overall Study|Lack of Efficacy|6|||
94650775|NCT01126541|324179625|FG001|Overall Study|Lack of Efficacy|1|||
94650776|NCT01126541|324179626|FG002|Overall Study|Lack of Efficacy|11|||
94650777|NCT01126541|324179624|FG000|Overall Study|Lost to Follow-up|1|||
94650778|NCT01126541|324179625|FG001|Overall Study|Lost to Follow-up|2|||
94650779|NCT01126541|324179626|FG002|Overall Study|Lost to Follow-up|2|||
94650780|NCT01126541|324179624|FG000|Overall Study|Withdrawal by Subject|2|||
94650781|NCT01126541|324179625|FG001|Overall Study|Withdrawal by Subject|5|||
94650782|NCT01126541|324179626|FG002|Overall Study|Withdrawal by Subject|6|||
94650783|NCT01126541|324179624|FG000|Overall Study|Protocol Violation|0|||
94650784|NCT01126541|324179625|FG001|Overall Study|Protocol Violation|0|||
94650785|NCT01126541|324179626|FG002|Overall Study|Protocol Violation|1|||
94650786|NCT01126541|324179624|FG000|Overall Study|Administrative reason or other|1|||
94650787|NCT01126541|324179625|FG001|Overall Study|Administrative reason or other|1|||
94650788|NCT01126541|324179626|FG002|Overall Study|Administrative reason or other|2|||
94650789|NCT01513291|324179627|FG000|Treatment Period|Adverse Event|8|||
94650790|NCT01513291|324179628|FG001|Treatment Period|Adverse Event|4|||
94650791|NCT01513291|324179629|FG002|Treatment Period|Adverse Event|0|||
94650792|NCT01513291|324179630|FG003|Treatment Period|Adverse Event|0|||
94650793|NCT01513291|324179631|FG004|Treatment Period|Adverse Event|0|||
94650794|NCT01513291|324179627|FG000|Treatment Period|Lack of Efficacy|3|||
94650795|NCT01513291|324179628|FG001|Treatment Period|Lack of Efficacy|0|||
94650796|NCT01513291|324179629|FG002|Treatment Period|Lack of Efficacy|0|||
94650797|NCT01513291|324179630|FG003|Treatment Period|Lack of Efficacy|0|||
94650798|NCT01513291|324179631|FG004|Treatment Period|Lack of Efficacy|0|||
94650799|NCT01513291|324179627|FG000|Treatment Period|Lost to Follow-up|2|||
94650800|NCT01513291|324179628|FG001|Treatment Period|Lost to Follow-up|3|||
94650801|NCT01513291|324179629|FG002|Treatment Period|Lost to Follow-up|0|||
94650802|NCT01513291|324179630|FG003|Treatment Period|Lost to Follow-up|0|||
94650803|NCT01513291|324179631|FG004|Treatment Period|Lost to Follow-up|0|||
94650804|NCT01513291|324179627|FG000|Treatment Period|Physician Decision|1|||
94650805|NCT01513291|324179628|FG001|Treatment Period|Physician Decision|0|||
94650806|NCT01513291|324179629|FG002|Treatment Period|Physician Decision|0|||
94650807|NCT01513291|324179630|FG003|Treatment Period|Physician Decision|0|||
94650808|NCT01513291|324179631|FG004|Treatment Period|Physician Decision|0|||
94650809|NCT01513291|324179627|FG000|Treatment Period|Protocol Violation|1|||
94650810|NCT01513291|324179628|FG001|Treatment Period|Protocol Violation|2|||
94650811|NCT01513291|324179629|FG002|Treatment Period|Protocol Violation|0|||
94650812|NCT01513291|324179630|FG003|Treatment Period|Protocol Violation|0|||
94650813|NCT01513291|324179631|FG004|Treatment Period|Protocol Violation|0|||
94650814|NCT01513291|324179627|FG000|Treatment Period|Withdrawal by Subject|8|||
94650815|NCT01513291|324179628|FG001|Treatment Period|Withdrawal by Subject|5|||
94650816|NCT01513291|324179629|FG002|Treatment Period|Withdrawal by Subject|0|||
94650817|NCT01513291|324179630|FG003|Treatment Period|Withdrawal by Subject|0|||
94650818|NCT01513291|324179631|FG004|Treatment Period|Withdrawal by Subject|0|||
94650819|NCT01513291|324179627|FG000|Treatment Period|Randomized not treated|0|||
94650820|NCT01513291|324179628|FG001|Treatment Period|Randomized not treated|2|||
94650821|NCT01513291|324179629|FG002|Treatment Period|Randomized not treated|0|||
94650822|NCT01513291|324179630|FG003|Treatment Period|Randomized not treated|0|||
94650823|NCT01513291|324179631|FG004|Treatment Period|Randomized not treated|0|||
94650824|NCT01513291|324179627|FG000|Run-out Period|Lost to Follow-up|0|||
94650825|NCT01513291|324179628|FG001|Run-out Period|Lost to Follow-up|0|||
94650826|NCT01513291|324179629|FG002|Run-out Period|Lost to Follow-up|0|||
94650827|NCT01513291|324179630|FG003|Run-out Period|Lost to Follow-up|1|||
94650828|NCT01513291|324179631|FG004|Run-out Period|Lost to Follow-up|0|||
94650829|NCT01513291|324179627|FG000|Run-out Period|Withdrawal by Subject|0|||
94650830|NCT01513291|324179628|FG001|Run-out Period|Withdrawal by Subject|0|||
94650831|NCT01513291|324179629|FG002|Run-out Period|Withdrawal by Subject|0|||
94650832|NCT01513291|324179630|FG003|Run-out Period|Withdrawal by Subject|1|||
94364620|NCT02007512|323118547|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
94364621|NCT02007512|323118548|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
94364622|NCT02007512|323118549|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
94364623|NCT02007512|323118550|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
94364624|NCT02007512|323118547|FG000|Double Blind Treatment Period|Protocol Violation|0|||
94364625|NCT02007512|323118548|FG001|Double Blind Treatment Period|Protocol Violation|0|||
94650833|NCT01513291|324179631|FG004|Run-out Period|Withdrawal by Subject|0|||
94650834|NCT03732638|324179632|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
94650835|NCT03732638|324179633|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
94650836|NCT03732638|324179632|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
94650837|NCT03732638|324179633|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
94650838|NCT03732638|324179632|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
94650839|NCT03732638|324179633|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
94650840|NCT03732638|324179632|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
94364626|NCT02007512|323118549|FG002|Double Blind Treatment Period|Protocol Violation|0|||
94364627|NCT02007512|323118550|FG003|Double Blind Treatment Period|Protocol Violation|1|||
94364628|NCT02007512|323118547|FG000|Double Blind Treatment Period|Other|0|||
94364629|NCT02007512|323118548|FG001|Double Blind Treatment Period|Other|0|||
94364630|NCT02007512|323118549|FG002|Double Blind Treatment Period|Other|1|||
94364631|NCT02007512|323118550|FG003|Double Blind Treatment Period|Other|2|||
94364632|NCT02007512|323118547|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
94364633|NCT02007512|323118548|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
94364634|NCT02007512|323118549|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
94364635|NCT02007512|323118550|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
94364636|NCT02007512|323118547|FG000|Open Label Treatment Period|Adverse Event|0|||
94364637|NCT02007512|323118548|FG001|Open Label Treatment Period|Adverse Event|1|||
94364638|NCT02007512|323118549|FG002|Open Label Treatment Period|Adverse Event|0|||
94364639|NCT02007512|323118550|FG003|Open Label Treatment Period|Adverse Event|0|||
94364640|NCT02007512|323118547|FG000|Open Label Treatment Period|Other|0|||
94364641|NCT02007512|323118548|FG001|Open Label Treatment Period|Other|0|||
94364642|NCT02007512|323118549|FG002|Open Label Treatment Period|Other|0|||
94650841|NCT03732638|324179633|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
94650842|NCT03732638|324179632|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
94650843|NCT03732638|324179633|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
94650844|NCT03732638|324179632|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
94364643|NCT02007512|323118550|FG003|Open Label Treatment Period|Other|1|||
94364644|NCT02007512|323118547|FG000|Open Label Treatment Period|Disease progression|0|||
94364645|NCT02007512|323118548|FG001|Open Label Treatment Period|Disease progression|17|||
94364646|NCT02007512|323118549|FG002|Open Label Treatment Period|Disease progression|0|||
94464435|NCT03199612|323488422|FG000|Overall Study|Adverse Event|1|||
94650845|NCT03732638|324179633|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
94650846|NCT03732638|324179632|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
94650847|NCT03732638|324179633|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
94650848|NCT03732638|324179632|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
94650849|NCT03732638|324179633|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
94650850|NCT03732638|324179632|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
94650851|NCT03732638|324179633|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
94650852|NCT03732638|324179632|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
94650853|NCT03732638|324179633|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
94650854|NCT03732638|324179632|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
94464436|NCT03199612|323488423|FG001|Overall Study|Adverse Event|0|||
94464437|NCT04472026|323488426|FG000|Overall Study|Lost to Follow-up|5|||
94464438|NCT00525902|323488432|FG000|Overall Study|Lack of Efficacy|1|||
94464439|NCT02386345|323488433|FG000|Overall Study|Not treated|14|||
94464440|NCT02386345|323488433|FG000|Overall Study|Lost to Follow-up|1|||
94464441|NCT02386345|323488433|FG000|Overall Study|Adverse Event|5|||
94464442|NCT02386345|323488433|FG000|Overall Study|Repeat Procedure|10|||
94464443|NCT02386345|323488433|FG000|Overall Study|Did not complete 12-month follow-up|72|||
94464444|NCT03077659|323488434|FG000|Overall Study|Withdrawal by Subject|0|||
94464445|NCT03077659|323488435|FG001|Overall Study|Withdrawal by Subject|0|||
94464446|NCT03077659|323488436|FG002|Overall Study|Withdrawal by Subject|1|||
94464447|NCT04068688|323488446|FG000|Overall Study|Lost to Follow-up|1|||
94464448|NCT04068688|323488447|FG001|Overall Study|Lost to Follow-up|1|||
94464449|NCT04068688|323488448|FG002|Overall Study|Lost to Follow-up|0|||
94464450|NCT04068688|323488449|FG003|Overall Study|Lost to Follow-up|0|||
94464451|NCT04068688|323488450|FG004|Overall Study|Lost to Follow-up|5|||
94464452|NCT04068688|323488451|FG005|Overall Study|Lost to Follow-up|5|||
94464453|NCT04068688|323488452|FG006|Overall Study|Lost to Follow-up|0|||
94464454|NCT04068688|323488453|FG007|Overall Study|Lost to Follow-up|0|||
94464455|NCT04068688|323488454|FG008|Overall Study|Lost to Follow-up|1|||
94464456|NCT04068688|323488455|FG009|Overall Study|Lost to Follow-up|0|||
94464457|NCT04068688|323488446|FG000|Overall Study|Withdrawal by Subject|1|||
94464458|NCT04068688|323488447|FG001|Overall Study|Withdrawal by Subject|1|||
94364647|NCT02007512|323118550|FG003|Open Label Treatment Period|Disease progression|11|||
94364648|NCT02007512|323118547|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
94464459|NCT04068688|323488448|FG002|Overall Study|Withdrawal by Subject|0|||
94464460|NCT04068688|323488449|FG003|Overall Study|Withdrawal by Subject|0|||
94464461|NCT04068688|323488450|FG004|Overall Study|Withdrawal by Subject|0|||
94464462|NCT04068688|323488451|FG005|Overall Study|Withdrawal by Subject|0|||
94464463|NCT04068688|323488452|FG006|Overall Study|Withdrawal by Subject|0|||
94464464|NCT04068688|323488453|FG007|Overall Study|Withdrawal by Subject|0|||
94464465|NCT04068688|323488454|FG008|Overall Study|Withdrawal by Subject|0|||
94464466|NCT04068688|323488455|FG009|Overall Study|Withdrawal by Subject|0|||
94650855|NCT03732638|324179633|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
94650856|NCT03732638|324179632|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
94464467|NCT04068688|323488446|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
94464468|NCT04068688|323488447|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
94464469|NCT04068688|323488448|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
94464470|NCT04068688|323488449|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
94464471|NCT04068688|323488450|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
94464472|NCT04068688|323488451|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
94464473|NCT04068688|323488452|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
94464474|NCT04068688|323488453|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
94464475|NCT04068688|323488454|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
94464476|NCT04068688|323488455|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
94464477|NCT02248974|323488457|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
94464478|NCT02248974|323488458|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
94464479|NCT02248974|323488457|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
94464480|NCT02248974|323488458|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
94464481|NCT02248974|323488457|FG000|1-Day Follow-Up|Enrolled in another study|1|||
94464482|NCT02248974|323488458|FG001|1-Day Follow-Up|Enrolled in another study|0|||
94464483|NCT02248974|323488457|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
94464484|NCT02248974|323488458|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
94650857|NCT03732638|324179633|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
94464485|NCT02248974|323488457|FG000|1-Week Follow-Up|Enrolled in another study|1|||
94464486|NCT02248974|323488458|FG001|1-Week Follow-Up|Enrolled in another study|1|||
94464487|NCT02248974|323488457|FG000|1-Week Follow-Up|Transferred to another facility|1|||
94464488|NCT02248974|323488458|FG001|1-Week Follow-Up|Transferred to another facility|0|||
94464489|NCT02248974|323488457|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
94464490|NCT02248974|323488458|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
94464491|NCT02248974|323488457|FG000|1-Week Follow-Up|Death|1|||
94464492|NCT02248974|323488458|FG001|1-Week Follow-Up|Death|1|||
94464493|NCT02248974|323488457|FG000|1-Week Follow-Up|Excluded because of age|0|||
94464494|NCT02248974|323488458|FG001|1-Week Follow-Up|Excluded because of age|1|||
94464495|NCT02248974|323488457|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
94464496|NCT02248974|323488458|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
94464497|NCT02248974|323488457|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
94464498|NCT02248974|323488458|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
94464499|NCT02248974|323488457|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
94464500|NCT02248974|323488458|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
94464501|NCT02248974|323488457|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
94464502|NCT02248974|323488458|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
94464503|NCT02248974|323488457|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
94464504|NCT02248974|323488458|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
94464505|NCT03448939|323488461|FG000|Overall Study|Adverse Event|5|||
94464506|NCT03448939|323488462|FG001|Overall Study|Adverse Event|1|||
94464507|NCT03448939|323488461|FG000|Overall Study|Lost to Follow-up|6|||
94464508|NCT03448939|323488462|FG001|Overall Study|Lost to Follow-up|6|||
94464509|NCT03448939|323488461|FG000|Overall Study|Pregnancy|1|||
94464510|NCT03448939|323488462|FG001|Overall Study|Pregnancy|1|||
94464511|NCT03448939|323488461|FG000|Overall Study|Withdrawal by Subject|9|||
94464512|NCT03448939|323488462|FG001|Overall Study|Withdrawal by Subject|3|||
94464513|NCT04093492|323488463|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
94464514|NCT04093492|323488464|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
94464515|NCT04093492|323488465|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
94464516|NCT04093492|323488466|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
94464517|NCT04093492|323488463|FG000|25 Weeks Gestational Age (GA)|No response|5|||
94464518|NCT04093492|323488464|FG001|25 Weeks Gestational Age (GA)|No response|5|||
94464519|NCT04093492|323488465|FG002|25 Weeks Gestational Age (GA)|No response|5|||
94464520|NCT04093492|323488466|FG003|25 Weeks Gestational Age (GA)|No response|2|||
94464521|NCT04093492|323488463|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
94464522|NCT04093492|323488464|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
94464523|NCT04093492|323488465|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
94464524|NCT04093492|323488466|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
94650858|NCT03732638|324179632|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
94650859|NCT03732638|324179633|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
94650860|NCT03732638|324179632|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
94364649|NCT02007512|323118548|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
94364650|NCT02007512|323118549|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
94364651|NCT02007512|323118550|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
94364652|NCT02575807|323118553|FG000|Overall Study|Death|8|||
94364653|NCT02575807|323118554|FG001|Overall Study|Death|3|||
94364654|NCT02575807|323118555|FG002|Overall Study|Death|7|||
94364655|NCT02575807|323118556|FG003|Overall Study|Death|0|||
94364656|NCT02575807|323118557|FG004|Overall Study|Death|1|||
94364657|NCT02575807|323118553|FG000|Overall Study|Study terminated by Sponsor|0|||
94364658|NCT02575807|323118554|FG001|Overall Study|Study terminated by Sponsor|1|||
94364659|NCT02575807|323118555|FG002|Overall Study|Study terminated by Sponsor|7|||
94364660|NCT02575807|323118556|FG003|Overall Study|Study terminated by Sponsor|0|||
94364661|NCT02575807|323118557|FG004|Overall Study|Study terminated by Sponsor|1|||
94364662|NCT02575807|323118553|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
94364663|NCT02575807|323118554|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
94364664|NCT02575807|323118555|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
94364665|NCT02575807|323118556|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
94364666|NCT02575807|323118557|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
94364667|NCT02575807|323118553|FG000|Overall Study|Terminated due to physician decision|0|||
94364668|NCT02575807|323118554|FG001|Overall Study|Terminated due to physician decision|0|||
94464525|NCT04093492|323488463|FG000|30 Weeks GA|Delivered before assessment|1|||
94464526|NCT04093492|323488464|FG001|30 Weeks GA|Delivered before assessment|2|||
94464527|NCT04093492|323488465|FG002|30 Weeks GA|Delivered before assessment|0|||
94464528|NCT04093492|323488466|FG003|30 Weeks GA|Delivered before assessment|0|||
94464529|NCT04093492|323488463|FG000|30 Weeks GA|No response|7|||
94464530|NCT04093492|323488464|FG001|30 Weeks GA|No response|5|||
94364669|NCT02575807|323118555|FG002|Overall Study|Terminated due to physician decision|1|||
94364670|NCT02575807|323118556|FG003|Overall Study|Terminated due to physician decision|0|||
94364671|NCT02575807|323118557|FG004|Overall Study|Terminated due to physician decision|0|||
94364672|NCT02575807|323118553|FG000|Overall Study|Subject ineligible - medical implant|0|||
94464531|NCT04093492|323488465|FG002|30 Weeks GA|No response|5|||
94464532|NCT04093492|323488466|FG003|30 Weeks GA|No response|2|||
94464533|NCT04093492|323488463|FG000|30 Weeks GA|Lost to Follow-up|0|||
94464534|NCT04093492|323488464|FG001|30 Weeks GA|Lost to Follow-up|1|||
94464535|NCT04093492|323488465|FG002|30 Weeks GA|Lost to Follow-up|0|||
94464536|NCT04093492|323488466|FG003|30 Weeks GA|Lost to Follow-up|0|||
94464537|NCT04093492|323488463|FG000|34 Weeks GA|Delivered before assessment|6|||
94464538|NCT04093492|323488464|FG001|34 Weeks GA|Delivered before assessment|3|||
94464539|NCT04093492|323488465|FG002|34 Weeks GA|Delivered before assessment|0|||
94464540|NCT04093492|323488466|FG003|34 Weeks GA|Delivered before assessment|0|||
94464541|NCT04093492|323488463|FG000|34 Weeks GA|No response|0|||
94464542|NCT04093492|323488464|FG001|34 Weeks GA|No response|7|||
94464543|NCT04093492|323488465|FG002|34 Weeks GA|No response|5|||
94464544|NCT04093492|323488466|FG003|34 Weeks GA|No response|3|||
94464545|NCT04093492|323488463|FG000|34 Weeks GA|Lost to Follow-up|0|||
94364673|NCT02575807|323118554|FG001|Overall Study|Subject ineligible - medical implant|0|||
94464546|NCT04093492|323488464|FG001|34 Weeks GA|Lost to Follow-up|1|||
94464547|NCT04093492|323488465|FG002|34 Weeks GA|Lost to Follow-up|0|||
94464548|NCT04093492|323488466|FG003|34 Weeks GA|Lost to Follow-up|0|||
94650861|NCT03732638|324179633|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
94650862|NCT03732638|324179632|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
94364674|NCT02575807|323118555|FG002|Overall Study|Subject ineligible - medical implant|0|||
94364675|NCT02575807|323118556|FG003|Overall Study|Subject ineligible - medical implant|1|||
94650863|NCT03732638|324179633|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
94464549|NCT03235115|323488471|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
94464550|NCT03235115|323488472|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
94464551|NCT03235115|323488473|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
94464552|NCT03235115|323488474|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
94464553|NCT03235115|323488475|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
94464554|NCT03235115|323488476|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
94464555|NCT00006305|323488477|FG000|Overall Study|Withdrawal by Subject|17|||
94364676|NCT02575807|323118557|FG004|Overall Study|Subject ineligible - medical implant|0|||
94364677|NCT02575807|323118553|FG000|Overall Study|Withdrawal by Subject|0|||
94364678|NCT02575807|323118554|FG001|Overall Study|Withdrawal by Subject|0|||
94364679|NCT02575807|323118555|FG002|Overall Study|Withdrawal by Subject|1|||
94364680|NCT02575807|323118556|FG003|Overall Study|Withdrawal by Subject|1|||
94364681|NCT02575807|323118557|FG004|Overall Study|Withdrawal by Subject|2|||
94464556|NCT00006305|323488478|FG001|Overall Study|Withdrawal by Subject|10|||
94364682|NCT03319368|323118558|FG000|Overall Study|Discharge swabs not collected from resident|57|||
94364683|NCT03319368|323118559|FG001|Overall Study|Discharge swabs not collected from resident|46|||
94364684|NCT03014570|323118562|FG000|Overall Study|COVID-19 Restrictions|38|||
94364685|NCT03014570|323118563|FG001|Overall Study|COVID-19 Restrictions|24|||
94364686|NCT03014570|323118562|FG000|Overall Study|Death|70|||
94364687|NCT03014570|323118563|FG001|Overall Study|Death|79|||
94364688|NCT03014570|323118562|FG000|Overall Study|Transfer from facility|11|||
94364689|NCT03014570|323118563|FG001|Overall Study|Transfer from facility|14|||
94364690|NCT03014570|323118562|FG000|Overall Study|Hospitalized|5|||
94364691|NCT03014570|323118563|FG001|Overall Study|Hospitalized|3|||
94364692|NCT03014570|323118562|FG000|Overall Study|Transfer within facility|1|||
94364693|NCT03014570|323118563|FG001|Overall Study|Transfer within facility|0|||
94364694|NCT03014570|323118562|FG000|Overall Study|Site refusal|0|||
94364695|NCT03014570|323118563|FG001|Overall Study|Site refusal|11|||
94364696|NCT00090259|323118564|FG000|Overall Study|Lost to Follow-up|30|||
94364697|NCT00090259|323118565|FG001|Overall Study|Lost to Follow-up|26|||
94364698|NCT00090259|323118564|FG000|Overall Study|Withdrawal by Subject|21|||
94364699|NCT00090259|323118565|FG001|Overall Study|Withdrawal by Subject|15|||
94364700|NCT00090259|323118564|FG000|Overall Study|Investigator site closed|11|||
94364701|NCT00090259|323118565|FG001|Overall Study|Investigator site closed|7|||
94364702|NCT03701516|323118566|FG000|Period 1|Lost to Follow-up|0|||
94364703|NCT03701516|323118567|FG001|Period 1|Lost to Follow-up|1|||
94364704|NCT03701516|323118566|FG000|Period 1|Adverse Event|0|||
94364705|NCT03701516|323118567|FG001|Period 1|Adverse Event|2|||
94364706|NCT03701516|323118566|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
94464557|NCT00006305|323488479|FG002|Overall Study|Withdrawal by Subject|15|||
94464558|NCT00006305|323488480|FG003|Overall Study|Withdrawal by Subject|14|||
94464559|NCT00115037|323488483|FG000|Phase1|Lost to Follow-up|16|||
94464560|NCT00115037|323488484|FG001|Phase1|Lost to Follow-up|23|||
94464561|NCT00115037|323488485|FG002|Phase1|Lost to Follow-up|0|||
94464562|NCT00115037|323488486|FG003|Phase1|Lost to Follow-up|0|||
94464563|NCT00115037|323488487|FG004|Phase1|Lost to Follow-up|0|||
94650864|NCT03732638|324179632|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
94464564|NCT00115037|323488488|FG005|Phase1|Lost to Follow-up|0|||
94464565|NCT00115037|323488483|FG000|Phase1|Withdrawal by Subject|9|||
94464566|NCT00115037|323488484|FG001|Phase1|Withdrawal by Subject|4|||
94464567|NCT00115037|323488485|FG002|Phase1|Withdrawal by Subject|0|||
94464568|NCT00115037|323488486|FG003|Phase1|Withdrawal by Subject|0|||
94464569|NCT00115037|323488487|FG004|Phase1|Withdrawal by Subject|0|||
94464570|NCT00115037|323488488|FG005|Phase1|Withdrawal by Subject|0|||
94464571|NCT00115037|323488483|FG000|Phase2|Death|0|||
94464572|NCT00115037|323488484|FG001|Phase2|Death|0|||
94464573|NCT00115037|323488485|FG002|Phase2|Death|1|||
94464574|NCT00115037|323488486|FG003|Phase2|Death|0|||
94464575|NCT00115037|323488487|FG004|Phase2|Death|0|||
94464576|NCT00115037|323488488|FG005|Phase2|Death|1|||
94464577|NCT00115037|323488483|FG000|Phase2|Withdrawal by Subject|0|||
94464578|NCT00115037|323488484|FG001|Phase2|Withdrawal by Subject|0|||
94464579|NCT00115037|323488485|FG002|Phase2|Withdrawal by Subject|2|||
94464580|NCT00115037|323488486|FG003|Phase2|Withdrawal by Subject|1|||
94364707|NCT03701516|323118567|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
94364708|NCT03701516|323118566|FG000|Period 1|Non Compliance to Protocol|2|||
94464581|NCT00115037|323488487|FG004|Phase2|Withdrawal by Subject|2|||
94650865|NCT03732638|324179633|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
94364709|NCT03701516|323118567|FG001|Period 1|Non Compliance to Protocol|1|||
94364710|NCT03701516|323118566|FG000|Period 1|Withdrawal by Subject|0|||
94364711|NCT03701516|323118567|FG001|Period 1|Withdrawal by Subject|1|||
94364712|NCT03701516|323118566|FG000|Period 2|failed to meet all eligibility creiteria|1|||
94464582|NCT00115037|323488488|FG005|Phase2|Withdrawal by Subject|1|||
94464583|NCT00115037|323488483|FG000|Phase2|Lost to Follow-up|0|||
94464584|NCT00115037|323488484|FG001|Phase2|Lost to Follow-up|0|||
94464585|NCT00115037|323488485|FG002|Phase2|Lost to Follow-up|12|||
94650866|NCT03732638|324179632|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
94650867|NCT03732638|324179633|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
94650868|NCT03732638|324179632|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
94364713|NCT03701516|323118567|FG001|Period 2|failed to meet all eligibility creiteria|0|||
94364714|NCT03701516|323118566|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
94364715|NCT03701516|323118567|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
94364716|NCT02125734|323118569|FG000|Period 2|Adverse Event|0|||
94364717|NCT02125734|323118570|FG001|Period 2|Adverse Event|1|||
94364718|NCT01308762|323118571|FG000|Overall Study|Protocol Violation|0|||
94364719|NCT01308762|323118572|FG001|Overall Study|Protocol Violation|1|||
94364720|NCT01308762|323118573|FG002|Overall Study|Protocol Violation|0|||
94364721|NCT00865306|323118574|FG000|Controlled Trial|Lost to Follow-up|1|||
94364722|NCT00865306|323118575|FG001|Controlled Trial|Lost to Follow-up|1|||
94364723|NCT00865306|323118574|FG000|Controlled Trial|Difficulty commuting|2|||
94364724|NCT00865306|323118575|FG001|Controlled Trial|Difficulty commuting|0|||
94364725|NCT00865306|323118574|FG000|Controlled Trial|Improved btw baseline and first session|1|||
94364726|NCT00865306|323118575|FG001|Controlled Trial|Improved btw baseline and first session|0|||
94364727|NCT00865306|323118574|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
94364728|NCT00865306|323118575|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
94364729|NCT00865306|323118574|FG000|Controlled Trial|Withdrawal by Subject|0|||
94364730|NCT00865306|323118575|FG001|Controlled Trial|Withdrawal by Subject|1|||
94364731|NCT02666768|323118576|FG000|Overall Study|Withdrawal by Subject|4|||
94364732|NCT02032823|323118577|FG000|Overall Study|Death|75|||
94364733|NCT02032823|323118578|FG001|Overall Study|Death|109|||
94364734|NCT02032823|323118577|FG000|Overall Study|Lost to Follow-up|18|||
94364735|NCT02032823|323118578|FG001|Overall Study|Lost to Follow-up|17|||
94364736|NCT02032823|323118577|FG000|Overall Study|Withdrawal by Subject|70|||
94650869|NCT03732638|324179633|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
94650870|NCT03732638|324179632|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
94650871|NCT03732638|324179633|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
94650872|NCT03732638|324179632|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
94650873|NCT03732638|324179633|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
94464586|NCT00115037|323488486|FG003|Phase2|Lost to Follow-up|14|||
94464587|NCT00115037|323488487|FG004|Phase2|Lost to Follow-up|4|||
94464588|NCT00115037|323488488|FG005|Phase2|Lost to Follow-up|10|||
94464589|NCT02470403|323488489|FG000|Overall Study|Adverse Event|1|||
94464590|NCT02470403|323488490|FG001|Overall Study|Adverse Event|0|||
94464591|NCT02470403|323488491|FG002|Overall Study|Adverse Event|0|||
94464592|NCT02470403|323488492|FG003|Overall Study|Adverse Event|0|||
94464593|NCT02470403|323488493|FG004|Overall Study|Adverse Event|0|||
94464594|NCT02470403|323488489|FG000|Overall Study|Lost to Follow-up|0|||
94464595|NCT02470403|323488490|FG001|Overall Study|Lost to Follow-up|1|||
94464596|NCT02470403|323488491|FG002|Overall Study|Lost to Follow-up|0|||
94464597|NCT02470403|323488492|FG003|Overall Study|Lost to Follow-up|0|||
94464598|NCT02470403|323488493|FG004|Overall Study|Lost to Follow-up|0|||
94464599|NCT02470403|323488489|FG000|Overall Study|Subject/guardian decision|1|||
94464600|NCT02470403|323488490|FG001|Overall Study|Subject/guardian decision|0|||
94464601|NCT02470403|323488491|FG002|Overall Study|Subject/guardian decision|0|||
94464602|NCT02470403|323488492|FG003|Overall Study|Subject/guardian decision|4|||
94464603|NCT02470403|323488493|FG004|Overall Study|Subject/guardian decision|0|||
94464604|NCT04631107|323488494|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
94464605|NCT04631107|323488494|FG000|Second Intervention (1 Night)|Adverse Event|1|||
94464606|NCT04631107|323488494|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
94464607|NCT04631107|323488494|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
94464608|NCT02003963|323488495|FG000|Overall Study|Lost to Follow-up|2|||
94464609|NCT02003963|323488496|FG001|Overall Study|Lost to Follow-up|1|||
94464610|NCT01096589|323488506|FG000|Overall Study|Adverse Event|2|||
94464611|NCT01096589|323488507|FG001|Overall Study|Adverse Event|1|||
94464612|NCT01096589|323488508|FG002|Overall Study|Adverse Event|2|||
94464613|NCT01096589|323488509|FG003|Overall Study|Adverse Event|1|||
94464614|NCT01096589|323488506|FG000|Overall Study|Withdrawal by Subject|2|||
94464615|NCT01096589|323488507|FG001|Overall Study|Withdrawal by Subject|1|||
94650874|NCT03732638|324179632|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
94650875|NCT03732638|324179633|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
94650876|NCT03732638|324179632|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
94650877|NCT03732638|324179633|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
94464616|NCT01096589|323488508|FG002|Overall Study|Withdrawal by Subject|1|||
94464617|NCT01096589|323488509|FG003|Overall Study|Withdrawal by Subject|1|||
94464618|NCT01096589|323488506|FG000|Overall Study|Compliance with protocol|0|||
94464619|NCT01096589|323488507|FG001|Overall Study|Compliance with protocol|0|||
94464620|NCT01096589|323488508|FG002|Overall Study|Compliance with protocol|1|||
94464621|NCT01096589|323488509|FG003|Overall Study|Compliance with protocol|0|||
94464622|NCT01096589|323488506|FG000|Overall Study|found treatment exhausting|0|||
94464623|NCT01096589|323488507|FG001|Overall Study|found treatment exhausting|0|||
94464624|NCT01096589|323488508|FG002|Overall Study|found treatment exhausting|0|||
94464625|NCT01096589|323488509|FG003|Overall Study|found treatment exhausting|1|||
94464626|NCT02407054|323488510|FG000|Overall Study|Adverse Event|1|||
94464627|NCT02407054|323488511|FG001|Overall Study|Adverse Event|4|||
94464628|NCT02407054|323488512|FG002|Overall Study|Adverse Event|1|||
94464629|NCT02407054|323488510|FG000|Overall Study|Non-compliance with Study|0|||
94464630|NCT02407054|323488511|FG001|Overall Study|Non-compliance with Study|2|||
94464631|NCT02407054|323488512|FG002|Overall Study|Non-compliance with Study|1|||
94464632|NCT02407054|323488510|FG000|Overall Study|Physician Decision|1|||
94650878|NCT03732638|324179632|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
94650879|NCT03732638|324179633|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
94464633|NCT02407054|323488511|FG001|Overall Study|Physician Decision|3|||
94464634|NCT02407054|323488512|FG002|Overall Study|Physician Decision|3|||
94464635|NCT02407054|323488510|FG000|Overall Study|Withdrawal by Subject|5|||
94464636|NCT02407054|323488511|FG001|Overall Study|Withdrawal by Subject|9|||
94464637|NCT02407054|323488512|FG002|Overall Study|Withdrawal by Subject|2|||
94464638|NCT05079750|323490459|FG000|Overall Study|Lost to Follow-up|0|||
94464639|NCT05079750|323490460|FG001|Overall Study|Lost to Follow-up|0|||
94464640|NCT05079750|323490461|FG002|Overall Study|Lost to Follow-up|1|||
94650880|NCT03732638|324179632|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
94464641|NCT04618471|323490462|FG000|Overall Study|Screen Failure|62|||
94464642|NCT04618471|323490462|FG000|Overall Study|Withdrawal by Subject|6|||
94464643|NCT04618471|323490462|FG000|Overall Study|Physician Decision|2|||
94464644|NCT04618471|323490462|FG000|Overall Study|Lost to Follow-up|1|||
94464645|NCT04618471|323490462|FG000|Overall Study|Various other reasons|2|||
94464646|NCT04618471|323490462|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
94464647|NCT01250171|323490463|FG000|Overall Study|Administrative reasons|1|||
94464648|NCT01250171|323490464|FG001|Overall Study|Administrative reasons|0|||
94464649|NCT01250171|323490465|FG002|Overall Study|Administrative reasons|0|||
94464650|NCT03292458|323490466|FG000|Period 1|Adverse Event|2|||
94464651|NCT03292458|323490467|FG001|Period 1|Adverse Event|0|||
94464652|NCT02515994|323490470|FG000|Overall Study|Protocol Violation|3|||
94464653|NCT02515994|323490471|FG001|Overall Study|Protocol Violation|5|||
94464654|NCT02515994|323490470|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
94650881|NCT03732638|324179633|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
94650882|NCT03728582|324179634|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
94650883|NCT03728582|324179635|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
94650884|NCT03728582|324179634|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
94650885|NCT03728582|324179635|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
94650886|NCT02738775|324179636|FG000|Overall Study|Withdrawal by Subject|0|||
94650887|NCT02738775|324179637|FG001|Overall Study|Withdrawal by Subject|1|||
94650888|NCT02738775|324179638|FG002|Overall Study|Withdrawal by Subject|0|||
94650889|NCT02738775|324179639|FG003|Overall Study|Withdrawal by Subject|0|||
94650890|NCT02738775|324179640|FG004|Overall Study|Withdrawal by Subject|0|||
94650891|NCT02738775|324179641|FG005|Overall Study|Withdrawal by Subject|0|||
94650892|NCT02738775|324179636|FG000|Overall Study|Adverse Event|0|||
94650893|NCT02738775|324179637|FG001|Overall Study|Adverse Event|0|||
94650894|NCT02738775|324179638|FG002|Overall Study|Adverse Event|0|||
94650895|NCT02738775|324179639|FG003|Overall Study|Adverse Event|1|||
94650896|NCT02738775|324179640|FG004|Overall Study|Adverse Event|0|||
94650897|NCT02738775|324179641|FG005|Overall Study|Adverse Event|0|||
94650898|NCT02738775|324179636|FG000|Overall Study|Pregnancy|0|||
94650899|NCT02738775|324179637|FG001|Overall Study|Pregnancy|1|||
94650900|NCT02738775|324179638|FG002|Overall Study|Pregnancy|0|||
94650901|NCT02738775|324179639|FG003|Overall Study|Pregnancy|0|||
94650902|NCT02738775|324179640|FG004|Overall Study|Pregnancy|0|||
94650903|NCT02738775|324179641|FG005|Overall Study|Pregnancy|0|||
94650904|NCT02738775|324179636|FG000|Overall Study|Missing|0|||
94650905|NCT02738775|324179637|FG001|Overall Study|Missing|0|||
94650906|NCT02738775|324179638|FG002|Overall Study|Missing|0|||
94650907|NCT02738775|324179639|FG003|Overall Study|Missing|0|||
94686630|NCT00779584|324307713|FG004|Overall Study|Withdrawal by Subject|0|||
94686631|NCT00779584|324307714|FG005|Overall Study|Withdrawal by Subject|2|||
94686632|NCT00779584|324307715|FG006|Overall Study|Withdrawal by Subject|1|||
94686633|NCT00779584|324307716|FG007|Overall Study|Withdrawal by Subject|0|||
94686634|NCT00779584|324307717|FG008|Overall Study|Withdrawal by Subject|0|||
94686635|NCT00779584|324307709|FG000|Overall Study|Lost to Follow-up|0|||
94686636|NCT00779584|324307710|FG001|Overall Study|Lost to Follow-up|0|||
94686637|NCT00779584|324307711|FG002|Overall Study|Lost to Follow-up|0|||
94686638|NCT00779584|324307712|FG003|Overall Study|Lost to Follow-up|0|||
94686639|NCT00779584|324307713|FG004|Overall Study|Lost to Follow-up|1|||
94686640|NCT00779584|324307714|FG005|Overall Study|Lost to Follow-up|0|||
94686641|NCT00779584|324307715|FG006|Overall Study|Lost to Follow-up|0|||
94686642|NCT00779584|324307716|FG007|Overall Study|Lost to Follow-up|0|||
94686643|NCT00779584|324307717|FG008|Overall Study|Lost to Follow-up|0|||
94686644|NCT00779584|324307709|FG000|Overall Study|Progression of Disease|0|||
94686645|NCT00779584|324307710|FG001|Overall Study|Progression of Disease|1|||
94686646|NCT00779584|324307711|FG002|Overall Study|Progression of Disease|2|||
94686647|NCT00779584|324307712|FG003|Overall Study|Progression of Disease|6|||
94686648|NCT00779584|324307713|FG004|Overall Study|Progression of Disease|5|||
94686649|NCT00779584|324307714|FG005|Overall Study|Progression of Disease|1|||
94686650|NCT00779584|324307715|FG006|Overall Study|Progression of Disease|4|||
94686651|NCT00779584|324307716|FG007|Overall Study|Progression of Disease|2|||
94686652|NCT00779584|324307717|FG008|Overall Study|Progression of Disease|1|||
94686653|NCT00779584|324307709|FG000|Overall Study|Adverse Event|1|||
94686654|NCT00779584|324307710|FG001|Overall Study|Adverse Event|0|||
94686655|NCT00779584|324307711|FG002|Overall Study|Adverse Event|2|||
94686656|NCT00779584|324307712|FG003|Overall Study|Adverse Event|0|||
94686657|NCT00779584|324307713|FG004|Overall Study|Adverse Event|0|||
94686658|NCT00779584|324307714|FG005|Overall Study|Adverse Event|0|||
94686659|NCT00779584|324307715|FG006|Overall Study|Adverse Event|2|||
94650908|NCT02738775|324179640|FG004|Overall Study|Missing|0|||
94650909|NCT02738775|324179641|FG005|Overall Study|Missing|1|||
94686660|NCT00779584|324307716|FG007|Overall Study|Adverse Event|1|||
94686661|NCT00779584|324307717|FG008|Overall Study|Adverse Event|1|||
94686662|NCT00779584|324307709|FG000|Overall Study|Symptomatic Deterioration|1|||
94686663|NCT00779584|324307710|FG001|Overall Study|Symptomatic Deterioration|1|||
94650910|NCT03192150|324179643|FG000|Overall Study|Adverse Event|14|||
94650911|NCT03192150|324179644|FG001|Overall Study|Adverse Event|12|||
94364737|NCT02032823|323118578|FG001|Overall Study|Withdrawal by Subject|53|||
94364738|NCT02032823|323118577|FG000|Overall Study|Ongoing study at data cut-off|755|||
94364739|NCT02032823|323118578|FG001|Overall Study|Ongoing study at data cut-off|731|||
94364740|NCT02032823|323118577|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
94364741|NCT02032823|323118578|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
94364742|NCT01488071|323118579|FG000|Overall Study|Adverse Event|15|||
94364743|NCT01488071|323118580|FG001|Overall Study|Adverse Event|23|||
94364744|NCT01488071|323118579|FG000|Overall Study|Lack of Efficacy|11|||
94364745|NCT01488071|323118580|FG001|Overall Study|Lack of Efficacy|17|||
94364746|NCT01488071|323118579|FG000|Overall Study|Non-compliance with study drug|2|||
94364747|NCT01488071|323118580|FG001|Overall Study|Non-compliance with study drug|0|||
94364748|NCT01488071|323118579|FG000|Overall Study|Protocol Violation|5|||
94364749|NCT01488071|323118580|FG001|Overall Study|Protocol Violation|7|||
94364750|NCT01488071|323118579|FG000|Overall Study|Withdrawal of Consent|14|||
94364751|NCT01488071|323118580|FG001|Overall Study|Withdrawal of Consent|12|||
94364752|NCT01488071|323118579|FG000|Overall Study|Lost to Follow-up|1|||
94364753|NCT01488071|323118580|FG001|Overall Study|Lost to Follow-up|0|||
94364754|NCT01488071|323118579|FG000|Overall Study|Administrative or Other Reason(s)|5|||
94364755|NCT01488071|323118580|FG001|Overall Study|Administrative or Other Reason(s)|4|||
94364756|NCT03889197|323118581|FG000|Overall Study|Withdrawal by Subject|1|||
94364757|NCT03889197|323118582|FG001|Overall Study|Withdrawal by Subject|0|||
94364758|NCT03889197|323118581|FG000|Overall Study|Physician Decision|0|||
94364759|NCT03889197|323118582|FG001|Overall Study|Physician Decision|1|||
94364760|NCT03889197|323118581|FG000|Overall Study|met exclusion criteria|0|||
94650912|NCT03192150|324179643|FG000|Overall Study|Lack of Efficacy|23|||
94650913|NCT03192150|324179644|FG001|Overall Study|Lack of Efficacy|30|||
94650914|NCT03192150|324179643|FG000|Overall Study|Lost to Follow-up|1|||
94650915|NCT03192150|324179644|FG001|Overall Study|Lost to Follow-up|1|||
94650916|NCT03192150|324179643|FG000|Overall Study|Withdrawal by Subject|4|||
94650917|NCT03192150|324179644|FG001|Overall Study|Withdrawal by Subject|2|||
94464655|NCT02515994|323490471|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
94464656|NCT02515994|323490470|FG000|Overall Study|Adverse Event|3|||
94464657|NCT02515994|323490471|FG001|Overall Study|Adverse Event|1|||
94464658|NCT02515994|323490470|FG000|Overall Study|Withdrawal by Subject|2|||
94464659|NCT02515994|323490471|FG001|Overall Study|Withdrawal by Subject|0|||
94464660|NCT02278367|323490472|FG000|Overall Study|Physician Decision|5|||
94464661|NCT02278367|323490473|FG001|Overall Study|Physician Decision|0|||
94464662|NCT02278367|323490472|FG000|Overall Study|Withdrawal by Subject|5|||
94464663|NCT02278367|323490473|FG001|Overall Study|Withdrawal by Subject|0|||
94464664|NCT04643964|323490474|FG000|Overall Study|Lost to Follow-up|55|||
94464665|NCT04643964|323490475|FG001|Overall Study|Lost to Follow-up|59|||
94650918|NCT03192150|324179643|FG000|Overall Study|Protocol Violation|5|||
94650919|NCT03192150|324179644|FG001|Overall Study|Protocol Violation|2|||
94650920|NCT03192150|324179643|FG000|Overall Study|Surgery Canceled|6|||
94650921|NCT03192150|324179644|FG001|Overall Study|Surgery Canceled|2|||
94650922|NCT03192150|324179643|FG000|Overall Study|Other-Various Administrative Reasons|2|||
94650923|NCT03192150|324179644|FG001|Overall Study|Other-Various Administrative Reasons|5|||
94650924|NCT02178475|324179645|FG000|Overall Study|Withdrawal by Subject|7|||
94650925|NCT02178475|324179645|FG000|Overall Study|Lost to Follow-up|10|||
94650926|NCT02178475|324179645|FG000|Overall Study|Death|13|||
94650927|NCT02178475|324179645|FG000|Overall Study|Protocol-specified Criteria|99|||
94650928|NCT01430585|324179646|FG000|Overall Study|Death|1|||
94650929|NCT01430585|324179646|FG000|Overall Study|Objective Progression or Relapse|3|||
94650930|NCT01430585|324179646|FG000|Overall Study|Study Terminated by Sponsor|3|||
94650931|NCT01430585|324179646|FG000|Overall Study|Other|7|||
94650932|NCT01448850|324179647|FG000|Overall Study|Death|3|||
94650933|NCT01448850|324179648|FG001|Overall Study|Death|6|||
94650934|NCT01448850|324179647|FG000|Overall Study|Withdrawal by Subject|13|||
94650935|NCT01448850|324179648|FG001|Overall Study|Withdrawal by Subject|21|||
94650936|NCT01448850|324179647|FG000|Overall Study|Lost to Follow-up|3|||
94650937|NCT01448850|324179648|FG001|Overall Study|Lost to Follow-up|1|||
94650938|NCT01448850|324179647|FG000|Overall Study|Other|15|||
94650939|NCT01448850|324179648|FG001|Overall Study|Other|12|||
94650940|NCT01302392|324179660|FG000|Overall Study|Lost to Follow-up|1|||
94364761|NCT03889197|323118582|FG001|Overall Study|met exclusion criteria|1|||
94364762|NCT03889197|323118581|FG000|Overall Study|Protocol Violation|1|||
94364763|NCT03889197|323118582|FG001|Overall Study|Protocol Violation|0|||
94364764|NCT03252015|323118583|FG000|Overall Study|Withdrawal by Subject|0|||
94364765|NCT03252015|323118584|FG001|Overall Study|Withdrawal by Subject|1|||
94364766|NCT03252015|323118585|FG002|Overall Study|Withdrawal by Subject|1|||
94464666|NCT04643964|323490476|FG002|Overall Study|Lost to Follow-up|54|||
94464667|NCT04643964|323490477|FG003|Overall Study|Lost to Follow-up|129|||
94650941|NCT01302392|324179661|FG001|Overall Study|Lost to Follow-up|0|||
94650942|NCT01302392|324179660|FG000|Overall Study|Withdrawal by Subject|6|||
94650943|NCT01302392|324179661|FG001|Overall Study|Withdrawal by Subject|1|||
94650944|NCT00259857|324179662|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
94464668|NCT04643964|323490478|FG004|Overall Study|Lost to Follow-up|48|||
94464669|NCT04643964|323490474|FG000|Overall Study|Failed attention check|1|||
94464670|NCT04643964|323490475|FG001|Overall Study|Failed attention check|8|||
94464671|NCT04643964|323490476|FG002|Overall Study|Failed attention check|2|||
94464672|NCT04643964|323490477|FG003|Overall Study|Failed attention check|14|||
94464673|NCT04643964|323490478|FG004|Overall Study|Failed attention check|11|||
94464674|NCT03391232|323490480|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
94464675|NCT03391232|323490481|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
94464676|NCT03391232|323490480|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
94464677|NCT03391232|323490481|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
94464678|NCT05940077|323490486|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
94650945|NCT00259857|324179663|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
94650946|NCT00259857|324179662|FG000|24 Months Treatment|Lost to Follow-up|0|||
94650947|NCT00259857|324179663|FG001|24 Months Treatment|Lost to Follow-up|3|||
94650948|NCT01469065|324179664|FG000|Overall Study|Lack of Efficacy|0|||
94650949|NCT01469065|324179665|FG001|Overall Study|Lack of Efficacy|0|||
94650950|NCT01469065|324179666|FG002|Overall Study|Lack of Efficacy|0|||
94650951|NCT01469065|324179667|FG003|Overall Study|Lack of Efficacy|0|||
94650952|NCT01469065|324179668|FG004|Overall Study|Lack of Efficacy|1|||
94464679|NCT00388297|323490487|FG000|Overall Study|Lost to Follow-up|16|||
94464680|NCT00388297|323490488|FG001|Overall Study|Lost to Follow-up|12|||
94464681|NCT00388297|323490489|FG002|Overall Study|Lost to Follow-up|11|||
94464682|NCT00388297|323490490|FG003|Overall Study|Lost to Follow-up|8|||
94464683|NCT01643798|323490491|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
94464684|NCT01643798|323490492|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
94464685|NCT01027897|323490493|FG000|Overall Study|Protocol Violation|1|||
94464686|NCT01027897|323490493|FG000|Overall Study|Withdrawal by Subject|1|||
94464687|NCT02368210|323490494|FG000|Overall Study|Withdrawal by Subject|1|||
94464688|NCT02368210|323490495|FG001|Overall Study|Withdrawal by Subject|0|||
94464689|NCT02368210|323490494|FG000|Overall Study|Adverse Event|0|||
94464690|NCT02368210|323490495|FG001|Overall Study|Adverse Event|1|||
94464691|NCT00078949|323490496|FG000|Overall Study|No treated|4|||
94464692|NCT00078949|323490497|FG001|Overall Study|No treated|5|||
94464693|NCT00078949|323490498|FG002|Overall Study|No treated|3|||
94464694|NCT00078949|323490499|FG003|Overall Study|No treated|3|||
94464695|NCT01211483|323490500|FG000|Phase 1b|Death|6|||
94464696|NCT01211483|323490501|FG001|Phase 1b|Death|0|||
94464697|NCT01211483|323490502|FG002|Phase 1b|Death|0|||
94464698|NCT01211483|323490503|FG003|Phase 1b|Death|0|||
94464699|NCT01211483|323490500|FG000|Phase 1b|Withdrawal by Subject|1|||
94464700|NCT01211483|323490501|FG001|Phase 1b|Withdrawal by Subject|0|||
94650953|NCT01469065|324179664|FG000|Overall Study|Other|0|||
94650954|NCT01469065|324179665|FG001|Overall Study|Other|1|||
94650955|NCT01469065|324179666|FG002|Overall Study|Other|0|||
94650956|NCT01469065|324179667|FG003|Overall Study|Other|0|||
94650957|NCT01469065|324179668|FG004|Overall Study|Other|0|||
94650958|NCT01573624|324179680|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
94650959|NCT01573624|324179681|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
94650960|NCT01573624|324179682|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
94650961|NCT01573624|324179683|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
94650962|NCT01573624|324179684|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
94650963|NCT01573624|324179685|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
94650964|NCT01573624|324179686|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
94650965|NCT01573624|324179680|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
94650966|NCT01573624|324179681|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
94650967|NCT01573624|324179682|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
94650968|NCT01573624|324179683|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
94650969|NCT01573624|324179684|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
94650970|NCT01573624|324179685|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
94650971|NCT01573624|324179686|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
94650972|NCT01573624|324179680|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
94650973|NCT01573624|324179681|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
94650974|NCT01573624|324179682|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
94686664|NCT00779584|324307711|FG002|Overall Study|Symptomatic Deterioration|1|||
94464701|NCT01211483|323490502|FG002|Phase 1b|Withdrawal by Subject|0|||
94464702|NCT01211483|323490503|FG003|Phase 1b|Withdrawal by Subject|0|||
94464703|NCT01211483|323490500|FG000|Phase 2|Lost to Follow-up|0|||
94464704|NCT01211483|323490501|FG001|Phase 2|Lost to Follow-up|1|||
94464705|NCT01211483|323490502|FG002|Phase 2|Lost to Follow-up|1|||
94464706|NCT01211483|323490503|FG003|Phase 2|Lost to Follow-up|2|||
94464707|NCT01211483|323490500|FG000|Phase 2|Death|0|||
94650975|NCT01573624|324179683|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
94650976|NCT01573624|324179684|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
94650977|NCT01573624|324179685|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
94464708|NCT01211483|323490501|FG001|Phase 2|Death|64|||
94464709|NCT01211483|323490502|FG002|Phase 2|Death|53|||
94464710|NCT01211483|323490503|FG003|Phase 2|Death|53|||
94464711|NCT01211483|323490500|FG000|Phase 2|Withdrawal by Subject|0|||
94464712|NCT01211483|323490501|FG001|Phase 2|Withdrawal by Subject|1|||
94464713|NCT01211483|323490502|FG002|Phase 2|Withdrawal by Subject|10|||
94464714|NCT01211483|323490503|FG003|Phase 2|Withdrawal by Subject|5|||
94464715|NCT01211483|323490500|FG000|Phase 2|Study terminated by Sponsor|0|||
94464716|NCT01211483|323490501|FG001|Phase 2|Study terminated by Sponsor|6|||
94464717|NCT01211483|323490502|FG002|Phase 2|Study terminated by Sponsor|8|||
94464718|NCT01211483|323490503|FG003|Phase 2|Study terminated by Sponsor|11|||
94464719|NCT01675154|323490504|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
94464720|NCT01675154|323490505|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
94464721|NCT01675154|323490506|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
94464722|NCT01675154|323490507|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
94464723|NCT02327013|323490508|FG000|Overall Study|Adverse Event|4|||
94464724|NCT02327013|323490509|FG001|Overall Study|Adverse Event|4|||
94464725|NCT02327013|323490510|FG002|Overall Study|Adverse Event|3|||
94464726|NCT02327013|323490511|FG003|Overall Study|Adverse Event|0|||
94464727|NCT02327013|323490512|FG004|Overall Study|Adverse Event|1|||
94464728|NCT02327013|323490508|FG000|Overall Study|Lack of Efficacy|2|||
94464729|NCT02327013|323490509|FG001|Overall Study|Lack of Efficacy|0|||
94464730|NCT02327013|323490510|FG002|Overall Study|Lack of Efficacy|5|||
94464731|NCT02327013|323490511|FG003|Overall Study|Lack of Efficacy|0|||
94464732|NCT02327013|323490512|FG004|Overall Study|Lack of Efficacy|1|||
94686665|NCT00779584|324307712|FG003|Overall Study|Symptomatic Deterioration|0|||
94686666|NCT00779584|324307713|FG004|Overall Study|Symptomatic Deterioration|0|||
94686667|NCT00779584|324307714|FG005|Overall Study|Symptomatic Deterioration|1|||
94686668|NCT00779584|324307715|FG006|Overall Study|Symptomatic Deterioration|1|||
94686669|NCT00779584|324307716|FG007|Overall Study|Symptomatic Deterioration|0|||
94686670|NCT00779584|324307717|FG008|Overall Study|Symptomatic Deterioration|0|||
94686671|NCT00779584|324307709|FG000|Overall Study|Ongoing in Study|0|||
94686672|NCT00779584|324307710|FG001|Overall Study|Ongoing in Study|0|||
94686673|NCT00779584|324307711|FG002|Overall Study|Ongoing in Study|0|||
94686674|NCT00779584|324307712|FG003|Overall Study|Ongoing in Study|0|||
94686675|NCT00779584|324307713|FG004|Overall Study|Ongoing in Study|1|||
94686676|NCT00779584|324307714|FG005|Overall Study|Ongoing in Study|1|||
94686677|NCT00779584|324307715|FG006|Overall Study|Ongoing in Study|0|||
94686678|NCT00779584|324307716|FG007|Overall Study|Ongoing in Study|0|||
94686679|NCT00779584|324307717|FG008|Overall Study|Ongoing in Study|0|||
94464733|NCT02327013|323490508|FG000|Overall Study|Non-compliance with IMP|1|||
94464734|NCT02327013|323490509|FG001|Overall Study|Non-compliance with IMP|2|||
94464735|NCT02327013|323490510|FG002|Overall Study|Non-compliance with IMP|7|||
94464736|NCT02327013|323490511|FG003|Overall Study|Non-compliance with IMP|0|||
94464737|NCT02327013|323490512|FG004|Overall Study|Non-compliance with IMP|0|||
94464738|NCT02327013|323490508|FG000|Overall Study|Withdrawal of Consent|1|||
94464739|NCT02327013|323490509|FG001|Overall Study|Withdrawal of Consent|0|||
94464740|NCT02327013|323490510|FG002|Overall Study|Withdrawal of Consent|3|||
94464741|NCT02327013|323490511|FG003|Overall Study|Withdrawal of Consent|0|||
94464742|NCT02327013|323490512|FG004|Overall Study|Withdrawal of Consent|0|||
94464743|NCT02327013|323490508|FG000|Overall Study|Lost to Follow-up|2|||
94364767|NCT03252015|323118586|FG003|Overall Study|Withdrawal by Subject|0|||
94364768|NCT03252015|323118583|FG000|Overall Study|Adverse Event|1|||
94364769|NCT03252015|323118584|FG001|Overall Study|Adverse Event|0|||
94364770|NCT03252015|323118585|FG002|Overall Study|Adverse Event|0|||
94464744|NCT02327013|323490509|FG001|Overall Study|Lost to Follow-up|4|||
94464745|NCT02327013|323490510|FG002|Overall Study|Lost to Follow-up|5|||
94464746|NCT02327013|323490511|FG003|Overall Study|Lost to Follow-up|0|||
94464747|NCT02327013|323490512|FG004|Overall Study|Lost to Follow-up|0|||
94364771|NCT03252015|323118586|FG003|Overall Study|Adverse Event|1|||
94364772|NCT04278872|323118588|FG000|Overall Study|Adverse Event|1|||
94364773|NCT04278872|323118589|FG001|Overall Study|Adverse Event|0|||
94364774|NCT04278872|323118588|FG000|Overall Study|Protocol Violation|0|||
94364775|NCT04278872|323118589|FG001|Overall Study|Protocol Violation|1|||
94364776|NCT04278872|323118588|FG000|Overall Study|Study Termination|2|||
94364777|NCT04278872|323118589|FG001|Overall Study|Study Termination|0|||
94364778|NCT00883129|323118590|FG000|Overall Study|Adverse Event|7|||
94364779|NCT00883129|323118591|FG001|Overall Study|Adverse Event|15|||
94364780|NCT00883129|323118590|FG000|Overall Study|Withdrawal by Subject|8|||
94364781|NCT00883129|323118591|FG001|Overall Study|Withdrawal by Subject|9|||
94364782|NCT00883129|323118590|FG000|Overall Study|Non-compliance|3|||
94364783|NCT00883129|323118591|FG001|Overall Study|Non-compliance|6|||
94364784|NCT00883129|323118590|FG000|Overall Study|Lost to Follow-up|1|||
94364785|NCT00883129|323118591|FG001|Overall Study|Lost to Follow-up|2|||
94364786|NCT00883129|323118590|FG000|Overall Study|Death|1|||
94364787|NCT00883129|323118591|FG001|Overall Study|Death|2|||
94364788|NCT00883129|323118590|FG000|Overall Study|Defined Treatment Failure|0|||
94364789|NCT00883129|323118591|FG001|Overall Study|Defined Treatment Failure|2|||
94364790|NCT02392377|323118592|FG000|Overall Study|Withdrawal by Subject|0|||
94364791|NCT02392377|323118593|FG001|Overall Study|Withdrawal by Subject|1|||
94364792|NCT04355767|323118597|FG000|Overall Study|Withdrawal by Subject|2|||
94364793|NCT04355767|323118598|FG001|Overall Study|Withdrawal by Subject|2|||
94364794|NCT04355767|323118597|FG000|Overall Study|Death|5|||
94364795|NCT04355767|323118598|FG001|Overall Study|Death|1|||
94364796|NCT01966107|323118599|FG000|Overall Study|excluded from FAS|21|||
94364797|NCT01966107|323118600|FG001|Overall Study|excluded from FAS|20|||
94364798|NCT01966107|323118599|FG000|Overall Study|discontinued treatment|345|||
94364799|NCT01966107|323118600|FG001|Overall Study|discontinued treatment|372|||
94364800|NCT01966107|323118599|FG000|Overall Study|due to study closure|164|||
94364801|NCT01966107|323118600|FG001|Overall Study|due to study closure|186|||
94364802|NCT01966107|323118599|FG000|Overall Study|withdrew from the study|272|||
94364803|NCT01966107|323118600|FG001|Overall Study|withdrew from the study|303|||
94364804|NCT01808508|323120532|FG000|Overall Study|Lost to Follow-up|1|||
94364805|NCT01808508|323120533|FG001|Overall Study|Lost to Follow-up|0|||
94364806|NCT01808508|323120534|FG002|Overall Study|Lost to Follow-up|0|||
94364807|NCT02525627|323120535|FG000|Overall Study|Revision|1|||
94364808|NCT02525627|323120536|FG001|Overall Study|Revision|1|||
94464748|NCT02327013|323490508|FG000|Overall Study|Administrative or other reason(s)|1|||
94464749|NCT02327013|323490509|FG001|Overall Study|Administrative or other reason(s)|5|||
94464750|NCT02327013|323490510|FG002|Overall Study|Administrative or other reason(s)|11|||
94464751|NCT02327013|323490511|FG003|Overall Study|Administrative or other reason(s)|1|||
94464752|NCT02327013|323490512|FG004|Overall Study|Administrative or other reason(s)|1|||
94364809|NCT02525627|323120535|FG000|Overall Study|Withdrawal by Subject|1|||
94464753|NCT02327013|323490508|FG000|Overall Study|Protocol Violation|0|||
94464754|NCT02327013|323490509|FG001|Overall Study|Protocol Violation|0|||
94464755|NCT02327013|323490510|FG002|Overall Study|Protocol Violation|3|||
94464756|NCT02327013|323490511|FG003|Overall Study|Protocol Violation|0|||
94686680|NCT01320735|324307721|FG000|Overall Study|Adverse Event|3|||
94686681|NCT01320735|324307721|FG000|Overall Study|Withdrawal by Subject|3|||
94364810|NCT02525627|323120536|FG001|Overall Study|Withdrawal by Subject|2|||
94364811|NCT02525627|323120535|FG000|Overall Study|Death|1|||
94364812|NCT02525627|323120536|FG001|Overall Study|Death|0|||
94364813|NCT02525627|323120535|FG000|Overall Study|Site terminated|11|||
94364814|NCT02525627|323120536|FG001|Overall Study|Site terminated|10|||
94364815|NCT00929201|323120537|FG000|Period 1|Withdrawal by Subject|0|||
94364816|NCT00929201|323120538|FG001|Period 1|Withdrawal by Subject|1|||
94364817|NCT00242567|323120542|FG000|Overall Study|Adverse Event|70|||
94364818|NCT00242567|323120543|FG001|Overall Study|Adverse Event|43|||
94364819|NCT00242567|323120542|FG000|Overall Study|Disease Progression|17|||
94364820|NCT00242567|323120543|FG001|Overall Study|Disease Progression|22|||
94364821|NCT00242567|323120542|FG000|Overall Study|Symptomatic deterioration|9|||
94464757|NCT02327013|323490512|FG004|Overall Study|Protocol Violation|1|||
94464758|NCT02327013|323490508|FG000|Overall Study|Withdrawal before treatment|2|||
94464759|NCT02327013|323490509|FG001|Overall Study|Withdrawal before treatment|1|||
94464760|NCT02327013|323490510|FG002|Overall Study|Withdrawal before treatment|5|||
94464761|NCT02327013|323490511|FG003|Overall Study|Withdrawal before treatment|0|||
94464762|NCT02327013|323490512|FG004|Overall Study|Withdrawal before treatment|0|||
94464763|NCT02720744|323490515|FG000|Overall Study|Protocol Violation|0|||
94464764|NCT02720744|323490516|FG001|Overall Study|Protocol Violation|2|||
94464765|NCT02720744|323490515|FG000|Overall Study|Pregnancy|2|||
94464766|NCT02720744|323490516|FG001|Overall Study|Pregnancy|0|||
94464767|NCT02720744|323490515|FG000|Overall Study|Lack of Efficacy|2|||
94464768|NCT02720744|323490516|FG001|Overall Study|Lack of Efficacy|8|||
94464769|NCT02720744|323490515|FG000|Overall Study|Adverse Event|21|||
94464770|NCT02720744|323490516|FG001|Overall Study|Adverse Event|3|||
94464771|NCT02720744|323490515|FG000|Overall Study|Withdrawal by Subject|11|||
94464772|NCT02720744|323490516|FG001|Overall Study|Withdrawal by Subject|11|||
94464773|NCT02720744|323490515|FG000|Overall Study|Lost to follow up|2|||
94464774|NCT02720744|323490516|FG001|Overall Study|Lost to follow up|0|||
94464775|NCT02720744|323490515|FG000|Overall Study|Non Compliance with Investigational Product|0|||
94464776|NCT02720744|323490516|FG001|Overall Study|Non Compliance with Investigational Product|1|||
94464777|NCT02720744|323490515|FG000|Overall Study|Excluded Concomitant Medication|0|||
94464778|NCT02720744|323490516|FG001|Overall Study|Excluded Concomitant Medication|1|||
94464779|NCT02255552|323490517|FG000|Overall Study|Participants enrolled into another study|0|||
94464780|NCT02255552|323490518|FG001|Overall Study|Participants enrolled into another study|11|||
94464781|NCT02255552|323490517|FG000|Overall Study|Withdrawal by Subject|1|||
94464782|NCT02255552|323490518|FG001|Overall Study|Withdrawal by Subject|4|||
94464783|NCT00459706|323490519|FG000|Overall Study|Adverse Event|19|||
94464784|NCT00459706|323490520|FG001|Overall Study|Adverse Event|13|||
94464785|NCT00459706|323490519|FG000|Overall Study|Withdrawal by Subject|1|||
94464786|NCT00459706|323490520|FG001|Overall Study|Withdrawal by Subject|6|||
94464787|NCT00459706|323490519|FG000|Overall Study|Physician Decision|2|||
94464788|NCT00459706|323490520|FG001|Overall Study|Physician Decision|0|||
94464789|NCT00459706|323490519|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
94464790|NCT00459706|323490520|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
94464791|NCT00459706|323490519|FG000|Overall Study|Protocol Violation|2|||
94464792|NCT00459706|323490520|FG001|Overall Study|Protocol Violation|1|||
94464793|NCT00459706|323490519|FG000|Overall Study|Failed to Return|1|||
94464794|NCT00459706|323490520|FG001|Overall Study|Failed to Return|0|||
94464795|NCT00459706|323490519|FG000|Overall Study|Other|0|||
94464796|NCT00459706|323490520|FG001|Overall Study|Other|1|||
94364822|NCT00242567|323120543|FG001|Overall Study|Symptomatic deterioration|3|||
94364823|NCT00242567|323120542|FG000|Overall Study|Lack of Efficacy|2|||
94364824|NCT00242567|323120543|FG001|Overall Study|Lack of Efficacy|2|||
94364825|NCT00242567|323120542|FG000|Overall Study|Lost to Follow-up|9|||
94364826|NCT00242567|323120543|FG001|Overall Study|Lost to Follow-up|19|||
94364827|NCT00242567|323120542|FG000|Overall Study|Withdrawal by Subject|33|||
94364828|NCT00242567|323120543|FG001|Overall Study|Withdrawal by Subject|28|||
94364829|NCT00242567|323120542|FG000|Overall Study|Protocol Violation|12|||
94364830|NCT00242567|323120543|FG001|Overall Study|Protocol Violation|12|||
94364831|NCT00242567|323120542|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
94364832|NCT00242567|323120543|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
94364833|NCT00242567|323120542|FG000|Overall Study|Other|14|||
94364834|NCT00242567|323120543|FG001|Overall Study|Other|9|||
94364835|NCT01299272|323120544|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
94364836|NCT01299272|323120545|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
94364837|NCT01299272|323120546|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
94364838|NCT01299272|323120547|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
94364839|NCT01299272|323120544|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
94364840|NCT01299272|323120545|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
94364841|NCT01299272|323120546|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
94364842|NCT01299272|323120547|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
94364843|NCT01299272|323120544|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
94364844|NCT01299272|323120545|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
94364845|NCT01299272|323120546|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
94364846|NCT01299272|323120547|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
94364847|NCT01299272|323120544|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
94364848|NCT01299272|323120545|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
94364849|NCT01299272|323120546|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
94364850|NCT01299272|323120547|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
94364851|NCT01299272|323120544|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
94364852|NCT01299272|323120545|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
94364853|NCT01299272|323120546|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
94464797|NCT04829331|323490529|FG000|Overall Study|Lost to Follow-up|1|||
94364854|NCT01299272|323120547|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
94464798|NCT04829331|323490530|FG001|Overall Study|Lost to Follow-up|0|||
94464799|NCT00460265|323490531|FG000|Overall Study|Lost to Follow-up|14|||
94464800|NCT00460265|323490532|FG001|Overall Study|Lost to Follow-up|15|||
94464801|NCT00460265|323490531|FG000|Overall Study|Physician Decision|1|||
94464802|NCT00460265|323490532|FG001|Overall Study|Physician Decision|2|||
94464803|NCT00460265|323490531|FG000|Overall Study|Withdrawal by Subject|10|||
94464804|NCT00460265|323490532|FG001|Overall Study|Withdrawal by Subject|25|||
94464805|NCT00460265|323490531|FG000|Overall Study|Ongoing|60|||
94464806|NCT00460265|323490532|FG001|Overall Study|Ongoing|47|||
94464807|NCT01527487|323490533|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
94464808|NCT01527487|323490534|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
94464809|NCT01527487|323490533|FG000|Overall Study|Disease Progression|4|||
94464810|NCT01527487|323490534|FG001|Overall Study|Disease Progression|1|||
94464811|NCT01527487|323490533|FG000|Overall Study|Adverse Event|1|||
94464812|NCT01527487|323490534|FG001|Overall Study|Adverse Event|1|||
94464813|NCT01527487|323490533|FG000|Overall Study|Death|0|||
94464814|NCT01527487|323490534|FG001|Overall Study|Death|1|||
94464815|NCT01826370|323490535|FG000|Overall Study|Protocol Violation|6|||
94464816|NCT01826370|323490535|FG000|Overall Study|Lost to Follow-up|12|||
94464817|NCT01826370|323490535|FG000|Overall Study|Other reason not defined above|2|||
94464818|NCT03570554|323490538|FG000|Overall Study|Non-compliance with study drug|0|||
94464819|NCT03570554|323490539|FG001|Overall Study|Non-compliance with study drug|0|||
94464820|NCT03570554|323490540|FG002|Overall Study|Non-compliance with study drug|1|||
94464821|NCT03570554|323490541|FG003|Overall Study|Non-compliance with study drug|0|||
94464822|NCT03570554|323490538|FG000|Overall Study|Adverse Event|0|||
94464823|NCT03570554|323490539|FG001|Overall Study|Adverse Event|0|||
94464824|NCT03570554|323490540|FG002|Overall Study|Adverse Event|0|||
94464825|NCT03570554|323490541|FG003|Overall Study|Adverse Event|1|||
94464826|NCT03738800|323490545|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
94464827|NCT03738800|323490546|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
94464828|NCT03738800|323490547|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
94464829|NCT03738800|323490545|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
94464830|NCT03738800|323490546|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
94464831|NCT03738800|323490547|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
94464832|NCT03738800|323490545|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
94464833|NCT03738800|323490546|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
94464834|NCT03738800|323490547|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
94464835|NCT01404208|323490559|FG000|Overall Study|Discontinued|3|||
94464836|NCT01404208|323490560|FG001|Overall Study|Discontinued|0|||
94464837|NCT01472965|323490564|FG000|Overall Study|Withdrawal by Subject|1|||
94464838|NCT01472965|323490565|FG001|Overall Study|Withdrawal by Subject|0|||
94464839|NCT00503997|323490568|FG000|Overall Study|disease progression|1|||
94464840|NCT00503997|323490568|FG000|Overall Study|Adverse Event|5|||
94464841|NCT00503997|323490568|FG000|Overall Study|Death|1|||
94464842|NCT00503997|323490568|FG000|Overall Study|Withdrawal by Subject|1|||
94464843|NCT00835679|323490569|FG000|Overall Study|Withdrawal by Subject|1|||
94464844|NCT00835679|323490570|FG001|Overall Study|Withdrawal by Subject|0|||
94464845|NCT00835679|323490571|FG002|Overall Study|Withdrawal by Subject|0|||
94464846|NCT00835679|323490572|FG003|Overall Study|Withdrawal by Subject|0|||
94464847|NCT00090584|323490573|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
94464848|NCT00090584|323490574|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
94464849|NCT00090584|323490573|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
94464850|NCT00090584|323490574|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
94464851|NCT00955968|323490578|FG000|Overall Study|Death|2|||
94464852|NCT00955968|323490579|FG001|Overall Study|Death|4|||
94464853|NCT00955968|323490578|FG000|Overall Study|Withdrawal by Subject|35|||
94464854|NCT00955968|323490579|FG001|Overall Study|Withdrawal by Subject|31|||
94464855|NCT00955968|323490578|FG000|Overall Study|Lost to Follow-up|45|||
94464856|NCT00955968|323490579|FG001|Overall Study|Lost to Follow-up|39|||
94464857|NCT00955968|323490578|FG000|Overall Study|Site closed|55|||
94464858|NCT00955968|323490579|FG001|Overall Study|Site closed|52|||
94464859|NCT00672841|323490581|FG000|Overall Study|Comfort care|1|||
94464860|NCT00672841|323490582|FG001|Overall Study|Comfort care|4|||
94464861|NCT00672841|323490581|FG000|Overall Study|icteric specimens|0|||
94464862|NCT00672841|323490582|FG001|Overall Study|icteric specimens|3|||
94464863|NCT00672841|323490581|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
94464864|NCT00672841|323490582|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
94263878|NCT03891524|322759966|FG002|Overall Study|Death|0|||
94263879|NCT03891524|322759967|FG003|Overall Study|Death|0|||
94263880|NCT03891524|322759968|FG004|Overall Study|Death|0|||
94464865|NCT00672841|323490581|FG000|Overall Study|Adverse Event|0|||
94464866|NCT00672841|323490582|FG001|Overall Study|Adverse Event|3|||
94464867|NCT00672841|323490581|FG000|Overall Study|Pregnancy|0|||
94464868|NCT00672841|323490582|FG001|Overall Study|Pregnancy|1|||
94464869|NCT02968433|323490596|FG000|Overall Study|Withdrawal by Subject|1|||
94464870|NCT02079636|323490597|FG000|Overall Study|Death|2|||
94464871|NCT02079636|323490598|FG001|Overall Study|Death|1|||
94464872|NCT02079636|323490599|FG002|Overall Study|Death|0|||
94263881|NCT03891524|322759969|FG005|Overall Study|Death|0|||
94464873|NCT02079636|323490600|FG003|Overall Study|Death|5|||
94464874|NCT02079636|323490601|FG004|Overall Study|Death|1|||
94464875|NCT02079636|323490602|FG005|Overall Study|Death|2|||
94263882|NCT03891524|322759970|FG006|Overall Study|Death|0|||
94263883|NCT03891524|322759971|FG007|Overall Study|Death|1|||
94263884|NCT03891524|322759964|FG000|Overall Study|Withdrawal by Subject|0|||
94263885|NCT03891524|322759965|FG001|Overall Study|Withdrawal by Subject|1|||
94263886|NCT03891524|322759966|FG002|Overall Study|Withdrawal by Subject|2|||
94263887|NCT03891524|322759967|FG003|Overall Study|Withdrawal by Subject|1|||
94263888|NCT03891524|322759968|FG004|Overall Study|Withdrawal by Subject|2|||
94263889|NCT03891524|322759969|FG005|Overall Study|Withdrawal by Subject|2|||
94263890|NCT03891524|322759970|FG006|Overall Study|Withdrawal by Subject|2|||
94263891|NCT03891524|322759971|FG007|Overall Study|Withdrawal by Subject|1|||
94263892|NCT01298518|322759972|FG000|Overall Study|Withdrawal by Subject|0|||
94263893|NCT01298518|322759973|FG001|Overall Study|Withdrawal by Subject|0|||
94263894|NCT01298518|322759974|FG002|Overall Study|Withdrawal by Subject|1|||
94263895|NCT02273726|322759975|FG000|Overall Study|Death|70|||
94263896|NCT02273726|322759976|FG001|Overall Study|Death|62|||
94263897|NCT02273726|322759975|FG000|Overall Study|Withdrawal by Subject|41|||
94263898|NCT02273726|322759976|FG001|Overall Study|Withdrawal by Subject|29|||
94263899|NCT02273726|322759975|FG000|Overall Study|Kidney transplant|31|||
94263900|NCT02273726|322759976|FG001|Overall Study|Kidney transplant|39|||
94263901|NCT02273726|322759975|FG000|Overall Study|Physician Decision|30|||
94263902|NCT02273726|322759976|FG001|Overall Study|Physician Decision|15|||
94263903|NCT02273726|322759975|FG000|Overall Study|Adverse Event|27|||
94263904|NCT02273726|322759976|FG001|Overall Study|Adverse Event|9|||
94263905|NCT02273726|322759975|FG000|Overall Study|Lost to Follow-up|6|||
94263906|NCT02273726|322759976|FG001|Overall Study|Lost to Follow-up|3|||
94263907|NCT02273726|322759975|FG000|Overall Study|Lack of Efficacy|6|||
94263908|NCT02273726|322759976|FG001|Overall Study|Lack of Efficacy|1|||
94263909|NCT02273726|322759975|FG000|Overall Study|Protocol Violation|4|||
94263910|NCT02273726|322759976|FG001|Overall Study|Protocol Violation|0|||
94263911|NCT02273726|322759975|FG000|Overall Study|Other than specified|28|||
94263912|NCT02273726|322759976|FG001|Overall Study|Other than specified|30|||
94263913|NCT01019980|322759977|FG000|Overall Study|Drug not available.|2|||
94263914|NCT01019980|322759978|FG001|Overall Study|Drug not available.|0|||
94263915|NCT02129205|322759979|FG000|Overall Study|Withdrawal by Subject|0|||
94263916|NCT02129205|322759980|FG001|Overall Study|Withdrawal by Subject|0|||
94263917|NCT02129205|322759981|FG002|Overall Study|Withdrawal by Subject|0|||
94263918|NCT02129205|322759982|FG003|Overall Study|Withdrawal by Subject|0|||
94263919|NCT02129205|322759983|FG004|Overall Study|Withdrawal by Subject|1|||
94263920|NCT02129205|322759984|FG005|Overall Study|Withdrawal by Subject|1|||
94263921|NCT02129205|322759985|FG006|Overall Study|Withdrawal by Subject|1|||
94263922|NCT02129205|322759986|FG007|Overall Study|Withdrawal by Subject|0|||
94263923|NCT02129205|322759987|FG008|Overall Study|Withdrawal by Subject|1|||
94263924|NCT02129205|322759988|FG009|Overall Study|Withdrawal by Subject|0|||
94263925|NCT02129205|322759979|FG000|Overall Study|Other|1|||
94263926|NCT02129205|322759980|FG001|Overall Study|Other|0|||
94263927|NCT02129205|322759981|FG002|Overall Study|Other|0|||
94263928|NCT02129205|322759982|FG003|Overall Study|Other|0|||
94263929|NCT02129205|322759983|FG004|Overall Study|Other|2|||
94263930|NCT02129205|322759984|FG005|Overall Study|Other|3|||
94263931|NCT02129205|322759985|FG006|Overall Study|Other|3|||
94263932|NCT02129205|322759986|FG007|Overall Study|Other|2|||
94263933|NCT02129205|322759987|FG008|Overall Study|Other|1|||
94263934|NCT02129205|322759988|FG009|Overall Study|Other|0|||
94364855|NCT01299272|323120544|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
94263935|NCT02877927|322759989|FG000|Overall Study|Adverse Event|1|||
94263936|NCT02877927|322759990|FG001|Overall Study|Adverse Event|0|||
94263937|NCT02877927|322759989|FG000|Overall Study|Lost to Follow-up|37|||
94263938|NCT02877927|322759990|FG001|Overall Study|Lost to Follow-up|38|||
94263939|NCT02877927|322759989|FG000|Overall Study|Withdrawal by Subject|11|||
94364856|NCT01299272|323120545|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
94364857|NCT01299272|323120546|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
94364858|NCT01299272|323120547|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
94364859|NCT01299272|323120544|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
94364860|NCT01299272|323120545|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
94364861|NCT01299272|323120546|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
94364862|NCT01299272|323120547|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
94364863|NCT01299272|323120544|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
94364864|NCT01299272|323120545|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
94364865|NCT01299272|323120546|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
94464876|NCT02079636|323490603|FG006|Overall Study|Death|1|||
94464877|NCT02079636|323490604|FG007|Overall Study|Death|0|||
94464878|NCT02079636|323490605|FG008|Overall Study|Death|0|||
94464879|NCT02079636|323490606|FG009|Overall Study|Death|0|||
94464880|NCT02079636|323490607|FG010|Overall Study|Death|0|||
94464881|NCT02079636|323490608|FG011|Overall Study|Death|1|||
94464882|NCT02079636|323490609|FG012|Overall Study|Death|1|||
94464883|NCT02079636|323490610|FG013|Overall Study|Death|0|||
94464884|NCT02079636|323490611|FG014|Overall Study|Death|2|||
94464885|NCT02079636|323490597|FG000|Overall Study|Adverse Event|1|||
94464886|NCT02079636|323490598|FG001|Overall Study|Adverse Event|1|||
94464887|NCT02079636|323490599|FG002|Overall Study|Adverse Event|0|||
94464888|NCT02079636|323490600|FG003|Overall Study|Adverse Event|1|||
94464889|NCT02079636|323490601|FG004|Overall Study|Adverse Event|1|||
94464890|NCT02079636|323490602|FG005|Overall Study|Adverse Event|2|||
94464891|NCT02079636|323490603|FG006|Overall Study|Adverse Event|0|||
94464892|NCT02079636|323490604|FG007|Overall Study|Adverse Event|0|||
94464893|NCT02079636|323490605|FG008|Overall Study|Adverse Event|0|||
94464894|NCT02079636|323490606|FG009|Overall Study|Adverse Event|0|||
94464895|NCT02079636|323490607|FG010|Overall Study|Adverse Event|0|||
94464896|NCT02079636|323490608|FG011|Overall Study|Adverse Event|0|||
94464897|NCT02079636|323490609|FG012|Overall Study|Adverse Event|0|||
94464898|NCT02079636|323490610|FG013|Overall Study|Adverse Event|0|||
94464899|NCT02079636|323490611|FG014|Overall Study|Adverse Event|0|||
94464900|NCT02079636|323490597|FG000|Overall Study|Progressive disease|0|||
94464901|NCT02079636|323490598|FG001|Overall Study|Progressive disease|0|||
94464902|NCT02079636|323490599|FG002|Overall Study|Progressive disease|0|||
94464903|NCT02079636|323490600|FG003|Overall Study|Progressive disease|2|||
94464904|NCT02079636|323490601|FG004|Overall Study|Progressive disease|0|||
94464905|NCT02079636|323490602|FG005|Overall Study|Progressive disease|0|||
94464906|NCT02079636|323490603|FG006|Overall Study|Progressive disease|0|||
94464907|NCT02079636|323490604|FG007|Overall Study|Progressive disease|0|||
94464908|NCT02079636|323490605|FG008|Overall Study|Progressive disease|0|||
94464909|NCT02079636|323490606|FG009|Overall Study|Progressive disease|0|||
94464910|NCT02079636|323490607|FG010|Overall Study|Progressive disease|0|||
94464911|NCT02079636|323490608|FG011|Overall Study|Progressive disease|0|||
94464912|NCT02079636|323490609|FG012|Overall Study|Progressive disease|1|||
94464913|NCT02079636|323490610|FG013|Overall Study|Progressive disease|0|||
94464914|NCT02079636|323490611|FG014|Overall Study|Progressive disease|0|||
94464915|NCT02079636|323490597|FG000|Overall Study|Withdrawal by Subject|0|||
94464916|NCT02079636|323490598|FG001|Overall Study|Withdrawal by Subject|0|||
94464917|NCT02079636|323490599|FG002|Overall Study|Withdrawal by Subject|0|||
94464918|NCT02079636|323490600|FG003|Overall Study|Withdrawal by Subject|4|||
94464919|NCT02079636|323490601|FG004|Overall Study|Withdrawal by Subject|0|||
94464920|NCT02079636|323490602|FG005|Overall Study|Withdrawal by Subject|1|||
94464921|NCT02079636|323490603|FG006|Overall Study|Withdrawal by Subject|0|||
94464922|NCT02079636|323490604|FG007|Overall Study|Withdrawal by Subject|0|||
94464923|NCT02079636|323490605|FG008|Overall Study|Withdrawal by Subject|0|||
94464924|NCT02079636|323490606|FG009|Overall Study|Withdrawal by Subject|2|||
94464925|NCT02079636|323490607|FG010|Overall Study|Withdrawal by Subject|1|||
94464926|NCT02079636|323490608|FG011|Overall Study|Withdrawal by Subject|1|||
94464927|NCT02079636|323490609|FG012|Overall Study|Withdrawal by Subject|1|||
94464928|NCT02079636|323490610|FG013|Overall Study|Withdrawal by Subject|0|||
94464929|NCT02079636|323490611|FG014|Overall Study|Withdrawal by Subject|2|||
94464930|NCT02079636|323490597|FG000|Overall Study|Physician Decision|0|||
94464931|NCT02079636|323490598|FG001|Overall Study|Physician Decision|0|||
94464932|NCT02079636|323490599|FG002|Overall Study|Physician Decision|0|||
94464933|NCT02079636|323490600|FG003|Overall Study|Physician Decision|0|||
94464934|NCT02079636|323490601|FG004|Overall Study|Physician Decision|0|||
94464935|NCT02079636|323490602|FG005|Overall Study|Physician Decision|1|||
94464936|NCT02079636|323490603|FG006|Overall Study|Physician Decision|0|||
94464937|NCT02079636|323490604|FG007|Overall Study|Physician Decision|0|||
94464938|NCT02079636|323490605|FG008|Overall Study|Physician Decision|0|||
94464939|NCT02079636|323490606|FG009|Overall Study|Physician Decision|1|||
94464940|NCT02079636|323490607|FG010|Overall Study|Physician Decision|1|||
94464941|NCT02079636|323490608|FG011|Overall Study|Physician Decision|0|||
94464942|NCT02079636|323490609|FG012|Overall Study|Physician Decision|0|||
94464943|NCT02079636|323490610|FG013|Overall Study|Physician Decision|0|||
94464944|NCT02079636|323490611|FG014|Overall Study|Physician Decision|1|||
94464945|NCT02079636|323490597|FG000|Overall Study|Lost to Follow-up|0|||
94464946|NCT02079636|323490598|FG001|Overall Study|Lost to Follow-up|0|||
94464947|NCT02079636|323490599|FG002|Overall Study|Lost to Follow-up|0|||
94464948|NCT02079636|323490600|FG003|Overall Study|Lost to Follow-up|0|||
94464949|NCT02079636|323490601|FG004|Overall Study|Lost to Follow-up|0|||
94464950|NCT02079636|323490602|FG005|Overall Study|Lost to Follow-up|0|||
94464951|NCT02079636|323490603|FG006|Overall Study|Lost to Follow-up|0|||
94464952|NCT02079636|323490604|FG007|Overall Study|Lost to Follow-up|1|||
94464953|NCT02079636|323490605|FG008|Overall Study|Lost to Follow-up|0|||
94464954|NCT02079636|323490606|FG009|Overall Study|Lost to Follow-up|0|||
94464955|NCT02079636|323490607|FG010|Overall Study|Lost to Follow-up|0|||
94464956|NCT02079636|323490608|FG011|Overall Study|Lost to Follow-up|0|||
94464957|NCT02079636|323490609|FG012|Overall Study|Lost to Follow-up|0|||
94464958|NCT02079636|323490610|FG013|Overall Study|Lost to Follow-up|0|||
94464959|NCT02079636|323490611|FG014|Overall Study|Lost to Follow-up|0|||
94464960|NCT00637806|323490614|FG000|Double-blind Phase|Study Discontinued|2|||
94464961|NCT00637806|323490615|FG001|Double-blind Phase|Study Discontinued|0|||
94464962|NCT00637806|323490616|FG002|Double-blind Phase|Study Discontinued|1|||
94464963|NCT00637806|323490617|FG003|Double-blind Phase|Study Discontinued|0|||
94464964|NCT00637806|323490614|FG000|Extension Phase|Study Discontinued|0|||
94464965|NCT00637806|323490615|FG001|Extension Phase|Study Discontinued|0|||
94464966|NCT00637806|323490616|FG002|Extension Phase|Study Discontinued|0|||
94464967|NCT00637806|323490617|FG003|Extension Phase|Study Discontinued|1|||
94464968|NCT02923245|323490621|FG000|Overall Study|ultrasound order was cancelled|2|||
94464969|NCT02923245|323490622|FG001|Overall Study|ultrasound order was cancelled|1|||
94464970|NCT01306045|323490625|FG000|Met General Eligibility Criteria|Screen failures|193|||
94464971|NCT01306045|323490626|FG001|Met General Eligibility Criteria|Screen failures|11|||
94464972|NCT01306045|323490627|FG002|Met General Eligibility Criteria|Screen failures|8|||
94464973|NCT00655681|323490628|FG000|Overall Study|Lost to Follow-up|1|||
94464974|NCT00655681|323490629|FG001|Overall Study|Lost to Follow-up|1|||
94464975|NCT00467961|323490630|FG000|Overall Study|Technical Failures|5|||
94364866|NCT01299272|323120547|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
94364867|NCT01299272|323120544|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
94364868|NCT01299272|323120545|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
94364869|NCT01299272|323120546|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
94364870|NCT01299272|323120547|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
94364871|NCT01299272|323120544|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
94364872|NCT01299272|323120545|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
94364873|NCT01299272|323120546|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
94364874|NCT01299272|323120547|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
94364875|NCT01299272|323120544|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
94364876|NCT01299272|323120545|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
94364877|NCT01299272|323120546|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
94364878|NCT01299272|323120547|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
94364879|NCT01299272|323120544|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
94364880|NCT01299272|323120545|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
94364881|NCT01299272|323120546|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
94364882|NCT01299272|323120547|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
94364883|NCT01299272|323120544|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
94364884|NCT01299272|323120545|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
94364885|NCT01299272|323120546|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
94364886|NCT01299272|323120547|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
94364887|NCT01299272|323120544|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
94364888|NCT01299272|323120545|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
94364889|NCT01299272|323120546|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
94364890|NCT01299272|323120547|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
94364891|NCT01299272|323120544|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
94364892|NCT01299272|323120545|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
94364893|NCT01299272|323120546|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
94364894|NCT01299272|323120547|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
94364895|NCT01299272|323120544|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
94364896|NCT01299272|323120545|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
94364897|NCT01299272|323120546|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
94464976|NCT00467961|323490630|FG000|Overall Study|Disease Progression|2|||
94464977|NCT04776018|323490631|FG000|Overall Study|Death|0|||
94464978|NCT04776018|323490632|FG001|Overall Study|Death|1|||
94464979|NCT04776018|323490633|FG002|Overall Study|Death|4|||
94464980|NCT04776018|323490634|FG003|Overall Study|Death|1|||
94464981|NCT04776018|323490635|FG004|Overall Study|Death|4|||
94464982|NCT04776018|323490636|FG005|Overall Study|Death|0|||
94464983|NCT04776018|323490637|FG006|Overall Study|Death|0|||
94464984|NCT04776018|323490631|FG000|Overall Study|Study terminated by sponsor|2|||
94464985|NCT04776018|323490632|FG001|Overall Study|Study terminated by sponsor|1|||
94464986|NCT04776018|323490633|FG002|Overall Study|Study terminated by sponsor|4|||
94464987|NCT04776018|323490634|FG003|Overall Study|Study terminated by sponsor|0|||
94464988|NCT04776018|323490635|FG004|Overall Study|Study terminated by sponsor|3|||
94464989|NCT04776018|323490636|FG005|Overall Study|Study terminated by sponsor|0|||
94686682|NCT01320735|324307721|FG000|Overall Study|Lost to Follow-up|13|||
94464990|NCT04776018|323490637|FG006|Overall Study|Study terminated by sponsor|0|||
94464991|NCT04776018|323490631|FG000|Overall Study|Withdrawal by Subject|1|||
94464992|NCT04776018|323490632|FG001|Overall Study|Withdrawal by Subject|0|||
94464993|NCT04776018|323490633|FG002|Overall Study|Withdrawal by Subject|0|||
94464994|NCT04776018|323490634|FG003|Overall Study|Withdrawal by Subject|2|||
94464995|NCT04776018|323490635|FG004|Overall Study|Withdrawal by Subject|1|||
94464996|NCT04776018|323490636|FG005|Overall Study|Withdrawal by Subject|0|||
94464997|NCT04776018|323490637|FG006|Overall Study|Withdrawal by Subject|0|||
94464998|NCT04776018|323490631|FG000|Overall Study|Other|0|||
94464999|NCT04776018|323490632|FG001|Overall Study|Other|1|||
94465000|NCT04776018|323490633|FG002|Overall Study|Other|1|||
94465001|NCT04776018|323490634|FG003|Overall Study|Other|0|||
94465002|NCT04776018|323490635|FG004|Overall Study|Other|0|||
94465003|NCT04776018|323490636|FG005|Overall Study|Other|0|||
94465004|NCT04776018|323490637|FG006|Overall Study|Other|0|||
94465005|NCT04776018|323490631|FG000|Overall Study|Lost to Follow-up|0|||
94465006|NCT04776018|323490632|FG001|Overall Study|Lost to Follow-up|0|||
94465007|NCT04776018|323490633|FG002|Overall Study|Lost to Follow-up|1|||
94465008|NCT04776018|323490634|FG003|Overall Study|Lost to Follow-up|0|||
94465009|NCT04776018|323490635|FG004|Overall Study|Lost to Follow-up|0|||
94465010|NCT04776018|323490636|FG005|Overall Study|Lost to Follow-up|0|||
94465011|NCT04776018|323490637|FG006|Overall Study|Lost to Follow-up|0|||
94465012|NCT01298141|323490638|FG000|Overall Study|Adverse Event|3|||
94465013|NCT01298141|323490638|FG000|Overall Study|Refusal of Required Study Procedures|1|||
94465014|NCT01298141|323490638|FG000|Overall Study|Withdrawal by Subject|6|||
94465015|NCT01298141|323490638|FG000|Overall Study|Termination of Study by the Investigator|5|||
94465016|NCT01298141|323490638|FG000|Overall Study|Other|5|||
94465017|NCT01298141|323490638|FG000|Overall Study|Lost to Follow-up|1|||
94465018|NCT01298141|323490638|FG000|Overall Study|Death|6|||
94465019|NCT01298141|323490638|FG000|Overall Study|Not treated|4|||
94465020|NCT01854879|323490639|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
94465021|NCT01854879|323490639|FG000|Overall Study|screen fail|3|||
94465022|NCT01854879|323490639|FG000|Overall Study|incomplete data set|1|||
94465023|NCT04683939|323490640|FG000|Overall Study|Study termination by the sponsor|0|||
94465024|NCT04683939|323490641|FG001|Overall Study|Study termination by the sponsor|1|||
94465025|NCT04683939|323490642|FG002|Overall Study|Study termination by the sponsor|2|||
94465026|NCT04683939|323490643|FG003|Overall Study|Study termination by the sponsor|2|||
94465027|NCT04683939|323490640|FG000|Overall Study|Death|1|||
94465028|NCT04683939|323490641|FG001|Overall Study|Death|1|||
94465029|NCT04683939|323490642|FG002|Overall Study|Death|2|||
94465030|NCT04683939|323490643|FG003|Overall Study|Death|1|||
94465031|NCT04683939|323490640|FG000|Overall Study|Withdrawal by Subject|1|||
94465032|NCT04683939|323490641|FG001|Overall Study|Withdrawal by Subject|0|||
94465033|NCT04683939|323490642|FG002|Overall Study|Withdrawal by Subject|0|||
94465034|NCT04683939|323490643|FG003|Overall Study|Withdrawal by Subject|0|||
94465035|NCT04683939|323490640|FG000|Overall Study|Physician Decision|1|||
94465036|NCT04683939|323490641|FG001|Overall Study|Physician Decision|0|||
94465037|NCT04683939|323490642|FG002|Overall Study|Physician Decision|0|||
94465038|NCT04683939|323490643|FG003|Overall Study|Physician Decision|0|||
94465039|NCT04683939|323490640|FG000|Overall Study|Lost to Follow-up|0|||
94465040|NCT04683939|323490641|FG001|Overall Study|Lost to Follow-up|1|||
94465041|NCT04683939|323490642|FG002|Overall Study|Lost to Follow-up|0|||
94465042|NCT04683939|323490643|FG003|Overall Study|Lost to Follow-up|0|||
94465043|NCT01143064|323492489|FG000|Overall Study|Death|109|||
94465044|NCT01143064|323492490|FG001|Overall Study|Death|91|||
94465045|NCT01143064|323492489|FG000|Overall Study|Adverse Event|0|||
94465046|NCT01143064|323492490|FG001|Overall Study|Adverse Event|1|||
94465047|NCT01143064|323492489|FG000|Overall Study|Withdrawal by Subject|7|||
94465048|NCT01143064|323492490|FG001|Overall Study|Withdrawal by Subject|5|||
94465049|NCT01143064|323492489|FG000|Overall Study|Lost to Follow-up|17|||
94465050|NCT01143064|323492490|FG001|Overall Study|Lost to Follow-up|14|||
94465051|NCT01143064|323492489|FG000|Overall Study|Physician Decision|0|||
94465052|NCT01143064|323492490|FG001|Overall Study|Physician Decision|4|||
94465053|NCT00984061|323492491|FG000|Clarithromycin Alone|Protocol Violation|1|||
94465054|NCT00985426|323492492|FG000|Overall Study|Adverse Event|0|||
94465055|NCT00985426|323492493|FG001|Overall Study|Adverse Event|1|||
94465056|NCT00985426|323492492|FG000|Overall Study|Subject Non-Compliance|3|||
94465057|NCT00985426|323492493|FG001|Overall Study|Subject Non-Compliance|3|||
94465058|NCT00985426|323492492|FG000|Overall Study|Withdrawal by Subject|12|||
94465059|NCT00985426|323492493|FG001|Overall Study|Withdrawal by Subject|16|||
94465060|NCT00985426|323492492|FG000|Overall Study|Lost to Follow-up|8|||
94465061|NCT00985426|323492493|FG001|Overall Study|Lost to Follow-up|10|||
94465062|NCT00985426|323492492|FG000|Overall Study|Death|7|||
94465063|NCT00985426|323492493|FG001|Overall Study|Death|3|||
94465064|NCT00985426|323492492|FG000|Overall Study|Protocol Violation|2|||
94465065|NCT00985426|323492493|FG001|Overall Study|Protocol Violation|0|||
94465066|NCT00985426|323492492|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
94465067|NCT00985426|323492493|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
94465068|NCT00616603|323492496|FG000|Overall Study|Physician Decision|2|||
94465069|NCT00616603|323492497|FG001|Overall Study|Physician Decision|0|||
94465070|NCT00616603|323492498|FG002|Overall Study|Physician Decision|2|||
94465071|NCT00943670|323492514|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
94465072|NCT00943670|323492514|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
94465073|NCT00943670|323492514|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
94465074|NCT00943670|323492514|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
94465075|NCT00943670|323492514|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
94465076|NCT00943670|323492514|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
94465077|NCT00943670|323492514|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
94465078|NCT00943670|323492514|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
94465079|NCT00943670|323492514|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
94465080|NCT00943670|323492514|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
94465081|NCT00426660|323492520|FG000|Overall Study|Death|14|||
94465082|NCT00426660|323492520|FG000|Overall Study|Adverse Event|23|||
94465083|NCT00426660|323492520|FG000|Overall Study|Insufficient Clinical Response|22|||
94465084|NCT00426660|323492520|FG000|Overall Study|Lost to Follow-up|15|||
94465085|NCT00426660|323492520|FG000|Overall Study|Other|23|||
94465086|NCT00426660|323492520|FG000|Overall Study|Withdrawal by Subject|18|||
94465087|NCT00426660|323492520|FG000|Overall Study|Protocol Violation|1|||
94465088|NCT00426660|323492520|FG000|Overall Study|Enrolled Not Treated|15|||
94465089|NCT03114657|323492521|FG000|Overall Study|Adverse Event|9|||
94465090|NCT03114657|323492522|FG001|Overall Study|Adverse Event|6|||
94465091|NCT03114657|323492521|FG000|Overall Study|Death|4|||
94465092|NCT03114657|323492522|FG001|Overall Study|Death|0|||
94465093|NCT03114657|323492521|FG000|Overall Study|Multiple Reasons|1|||
94465094|NCT03114657|323492522|FG001|Overall Study|Multiple Reasons|2|||
94465095|NCT03114657|323492521|FG000|Overall Study|Physician Decision|2|||
94465096|NCT03114657|323492522|FG001|Overall Study|Physician Decision|2|||
94465097|NCT03114657|323492521|FG000|Overall Study|Study Terminated By Sponsor|355|||
94465098|NCT03114657|323492522|FG001|Overall Study|Study Terminated By Sponsor|374|||
94465099|NCT03114657|323492521|FG000|Overall Study|Symptomatic Deterioration|0|||
94465100|NCT03114657|323492522|FG001|Overall Study|Symptomatic Deterioration|1|||
94465101|NCT03114657|323492521|FG000|Overall Study|Withdrawal by Subject|28|||
94465102|NCT03114657|323492522|FG001|Overall Study|Withdrawal by Subject|22|||
94465103|NCT01711619|323492523|FG000|Overall Study|Early study termination|10|||
94465104|NCT01711619|323492524|FG001|Overall Study|Early study termination|14|||
94465105|NCT01711619|323492523|FG000|Overall Study|Withdrawal by Subject|3|||
94465106|NCT01711619|323492524|FG001|Overall Study|Withdrawal by Subject|7|||
94465107|NCT01711619|323492523|FG000|Overall Study|Protocol Violation|2|||
94465108|NCT01711619|323492524|FG001|Overall Study|Protocol Violation|3|||
94465109|NCT01711619|323492523|FG000|Overall Study|Adverse Event|2|||
94465110|NCT01711619|323492524|FG001|Overall Study|Adverse Event|0|||
94465111|NCT01711619|323492523|FG000|Overall Study|Lost to Follow-up|1|||
94465112|NCT01711619|323492524|FG001|Overall Study|Lost to Follow-up|0|||
94465113|NCT04245202|323492525|FG000|Overall Study|Lack of Efficacy|10|||
94465114|NCT04245202|323492526|FG001|Overall Study|Lack of Efficacy|1|||
94465115|NCT00334802|323492527|FG000|Overall Study|Progressive Disease|2|||
94465116|NCT00334802|323492528|FG001|Overall Study|Progressive Disease|24|||
94465117|NCT00334802|323492527|FG000|Overall Study|Toxicity|1|||
94465118|NCT00334802|323492528|FG001|Overall Study|Toxicity|5|||
94465119|NCT00334802|323492527|FG000|Overall Study|Lack of Efficacy|1|||
94465120|NCT00334802|323492528|FG001|Overall Study|Lack of Efficacy|3|||
94465121|NCT00334802|323492527|FG000|Overall Study|Patient Condition Aggrevated|1|||
94465122|NCT00334802|323492528|FG001|Overall Study|Patient Condition Aggrevated|0|||
94465123|NCT00334802|323492527|FG000|Overall Study|Physician Decision|1|||
94465124|NCT00334802|323492528|FG001|Overall Study|Physician Decision|0|||
94465125|NCT00334802|323492527|FG000|Overall Study|Withdrawal by Subject|0|||
94465126|NCT00334802|323492528|FG001|Overall Study|Withdrawal by Subject|4|||
94465127|NCT00334802|323492527|FG000|Overall Study|Adverse Event|0|||
94465128|NCT00334802|323492528|FG001|Overall Study|Adverse Event|3|||
94465129|NCT00334802|323492527|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
94465130|NCT00334802|323492528|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
94465131|NCT05020366|323492540|FG000|Overall Study|Lost to Follow-up|2|||
94465132|NCT05020366|323492541|FG001|Overall Study|Lost to Follow-up|0|||
94465133|NCT05020366|323492540|FG000|Overall Study|Withdrawal by Subject|2|||
94465134|NCT05020366|323492541|FG001|Overall Study|Withdrawal by Subject|0|||
94465135|NCT00990665|323492544|FG000|Overall Study|Unsuccessful Implant|8|||
94465136|NCT00990665|323492544|FG000|Overall Study|Death|29|||
94465137|NCT00990665|323492544|FG000|Overall Study|Heart Transplant|1|||
94465138|NCT00990665|323492544|FG000|Overall Study|Withdrawal by Subject|6|||
94465139|NCT00990665|323492544|FG000|Overall Study|Lost to Follow-up|1|||
94465140|NCT00990665|323492544|FG000|Overall Study|System Explant|3|||
94465141|NCT01267201|323492547|FG000|First Intervention Period|Withdrawal by Subject|1|||
94465142|NCT01267201|323492548|FG001|First Intervention Period|Withdrawal by Subject|0|||
94465143|NCT01267201|323492549|FG002|First Intervention Period|Withdrawal by Subject|0|||
94465144|NCT01267201|323492550|FG003|First Intervention Period|Withdrawal by Subject|0|||
94465145|NCT01267201|323492551|FG004|First Intervention Period|Withdrawal by Subject|0|||
94465146|NCT01267201|323492552|FG005|First Intervention Period|Withdrawal by Subject|0|||
94465147|NCT01267201|323492547|FG000|Second Intervention Period|Withdrawal by Subject|0|||
94465148|NCT01267201|323492548|FG001|Second Intervention Period|Withdrawal by Subject|1|||
94465149|NCT01267201|323492549|FG002|Second Intervention Period|Withdrawal by Subject|0|||
94465150|NCT01267201|323492550|FG003|Second Intervention Period|Withdrawal by Subject|0|||
94465151|NCT01267201|323492551|FG004|Second Intervention Period|Withdrawal by Subject|0|||
94465152|NCT01267201|323492552|FG005|Second Intervention Period|Withdrawal by Subject|0|||
94465153|NCT00501059|323492553|FG000|Overall Study|Protocol Violation|80|||
94465154|NCT00501059|323492554|FG001|Overall Study|Protocol Violation|69|||
94465155|NCT00501059|323492553|FG000|Overall Study|Death|140|||
94465156|NCT00501059|323492554|FG001|Overall Study|Death|137|||
94465157|NCT00501059|323492553|FG000|Overall Study|Other|236|||
94465158|NCT00501059|323492554|FG001|Overall Study|Other|239|||
94465159|NCT00501059|323492553|FG000|Overall Study|Missing end-of-study page|91|||
94465160|NCT00501059|323492554|FG001|Overall Study|Missing end-of-study page|92|||
94465161|NCT00501059|323492553|FG000|Overall Study|Clinical endpoint reached|110|||
94465162|NCT00501059|323492554|FG001|Overall Study|Clinical endpoint reached|123|||
94465163|NCT00501059|323492553|FG000|Overall Study|Insufficient therapeutic effect|4|||
94465164|NCT00501059|323492554|FG001|Overall Study|Insufficient therapeutic effect|5|||
94465165|NCT00501059|323492553|FG000|Overall Study|Consent withdrawn by subject|817|||
94465166|NCT00501059|323492554|FG001|Overall Study|Consent withdrawn by subject|873|||
94465167|NCT00501059|323492553|FG000|Overall Study|Non-compliant with study treatment|23|||
94465168|NCT00501059|323492554|FG001|Overall Study|Non-compliant with study treatment|16|||
94465169|NCT00501059|323492553|FG000|Overall Study|Reason not given|3|||
94465170|NCT00501059|323492554|FG001|Overall Study|Reason not given|1|||
94465171|NCT00501059|323492553|FG000|Overall Study|Adverse Event|129|||
94465172|NCT00501059|323492554|FG001|Overall Study|Adverse Event|122|||
94465173|NCT00501059|323492553|FG000|Overall Study|Lost to Follow-up|210|||
94465174|NCT00501059|323492554|FG001|Overall Study|Lost to Follow-up|198|||
94465175|NCT00501059|323492553|FG000|Overall Study|Not treated|25|||
94465176|NCT00501059|323492554|FG001|Overall Study|Not treated|17|||
94465177|NCT04442269|323492555|FG000|Overall Study|Adverse Event|1|||
94465178|NCT04442269|323492556|FG001|Overall Study|Adverse Event|0|||
94465179|NCT04442269|323492555|FG000|Overall Study|Death|0|||
94465180|NCT04442269|323492556|FG001|Overall Study|Death|1|||
94465181|NCT04442269|323492555|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
94465182|NCT04442269|323492556|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
94465183|NCT04442269|323492555|FG000|Overall Study|Lost to Follow-up|1|||
94465184|NCT04442269|323492556|FG001|Overall Study|Lost to Follow-up|0|||
94465185|NCT04442269|323492555|FG000|Overall Study|Withdrawal by Subject|3|||
94465186|NCT04442269|323492556|FG001|Overall Study|Withdrawal by Subject|2|||
94465187|NCT04442269|323492555|FG000|Overall Study|Protocol Deviation|0|||
94465188|NCT04442269|323492556|FG001|Overall Study|Protocol Deviation|1|||
94465189|NCT04442269|323492555|FG000|Overall Study|Travel Limitations|1|||
94465190|NCT04442269|323492556|FG001|Overall Study|Travel Limitations|1|||
94465191|NCT02124759|323492557|FG000|Overall Study|Withdrawal by Subject|3|||
94465192|NCT02124759|323492558|FG001|Overall Study|Withdrawal by Subject|1|||
94465193|NCT02124759|323492559|FG002|Overall Study|Withdrawal by Subject|1|||
94465194|NCT02124759|323492557|FG000|Overall Study|Screen Fail|2|||
94465195|NCT02124759|323492558|FG001|Overall Study|Screen Fail|2|||
94465196|NCT02124759|323492559|FG002|Overall Study|Screen Fail|3|||
94465197|NCT01785849|323492564|FG000|Overall Study|Death|7|||
94465198|NCT01785849|323492565|FG001|Overall Study|Death|9|||
94465199|NCT01785849|323492564|FG000|Overall Study|Protocol Specified Criteria|29|||
94465200|NCT01785849|323492565|FG001|Overall Study|Protocol Specified Criteria|1|||
94465201|NCT01785849|323492564|FG000|Overall Study|Withdrawal by Subject|15|||
94465202|NCT01785849|323492565|FG001|Overall Study|Withdrawal by Subject|12|||
94465203|NCT01785849|323492564|FG000|Overall Study|Sponsor Decision|0|||
94465204|NCT01785849|323492565|FG001|Overall Study|Sponsor Decision|1|||
94465205|NCT01785849|323492564|FG000|Overall Study|Lost to Follow-up|10|||
94364898|NCT01299272|323120547|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
94364899|NCT01299272|323120544|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
94364900|NCT01299272|323120545|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
94364901|NCT01299272|323120546|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
94364902|NCT01299272|323120547|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
94364903|NCT01299272|323120544|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
94364904|NCT01299272|323120545|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
94364905|NCT01299272|323120546|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
94364906|NCT01299272|323120547|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
94364907|NCT01299272|323120544|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
94364908|NCT01299272|323120545|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
94364909|NCT01299272|323120546|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
94364910|NCT01299272|323120547|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
94364911|NCT01299272|323120544|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
94364912|NCT01299272|323120545|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
94364913|NCT01299272|323120546|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
94364914|NCT01299272|323120547|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
94364915|NCT01299272|323120544|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
94364916|NCT01299272|323120545|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
94364917|NCT01299272|323120546|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
94364918|NCT01299272|323120547|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
94364919|NCT01299272|323120544|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
94364920|NCT01299272|323120545|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
94364921|NCT01299272|323120546|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
94364922|NCT01299272|323120547|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
94364923|NCT01299272|323120544|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
94364924|NCT01299272|323120545|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
94364925|NCT01299272|323120546|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
94364926|NCT01299272|323120547|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
94364927|NCT01299272|323120544|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
94364928|NCT01299272|323120545|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
94364929|NCT01299272|323120546|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
94364930|NCT01299272|323120547|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
94364931|NCT01299272|323120544|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
94364932|NCT01299272|323120545|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
94364933|NCT01299272|323120546|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
94364934|NCT01299272|323120547|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
94364935|NCT00464308|323120548|FG000|Overall Study|Adverse Event|22|||
94364936|NCT00464308|323120549|FG001|Overall Study|Adverse Event|27|||
94364937|NCT00464308|323120550|FG002|Overall Study|Adverse Event|16|||
94364938|NCT00464308|323120548|FG000|Overall Study|Lost to Follow-up|29|||
94364939|NCT00464308|323120549|FG001|Overall Study|Lost to Follow-up|19|||
94364940|NCT00464308|323120550|FG002|Overall Study|Lost to Follow-up|20|||
94364941|NCT00464308|323120548|FG000|Overall Study|Patient discontinued and other reasons|17|||
94364942|NCT00464308|323120549|FG001|Overall Study|Patient discontinued and other reasons|17|||
94364943|NCT00464308|323120550|FG002|Overall Study|Patient discontinued and other reasons|23|||
94364944|NCT00464308|323120548|FG000|Overall Study|Physician Decision|1|||
94364945|NCT00464308|323120549|FG001|Overall Study|Physician Decision|0|||
94364946|NCT00464308|323120550|FG002|Overall Study|Physician Decision|0|||
94364947|NCT01186744|323120551|FG000|Overall Study|Lack of Efficacy|156|||
94364948|NCT01186744|323120552|FG001|Overall Study|Lack of Efficacy|99|||
94364949|NCT01186744|323120553|FG002|Overall Study|Lack of Efficacy|0|||
94364950|NCT01186744|323120554|FG003|Overall Study|Lack of Efficacy|2|||
94364951|NCT01186744|323120555|FG004|Overall Study|Lack of Efficacy|2|||
94364952|NCT01186744|323120556|FG005|Overall Study|Lack of Efficacy|5|||
94364953|NCT01186744|323120551|FG000|Overall Study|Protocol Violation|1|||
94364954|NCT01186744|323120552|FG001|Overall Study|Protocol Violation|2|||
94364955|NCT01186744|323120553|FG002|Overall Study|Protocol Violation|0|||
94364956|NCT01186744|323120554|FG003|Overall Study|Protocol Violation|1|||
94364957|NCT01186744|323120555|FG004|Overall Study|Protocol Violation|1|||
94364958|NCT01186744|323120556|FG005|Overall Study|Protocol Violation|2|||
94364959|NCT01186744|323120551|FG000|Overall Study|Lost to Follow-up|15|||
94364960|NCT01186744|323120552|FG001|Overall Study|Lost to Follow-up|16|||
94364961|NCT01186744|323120553|FG002|Overall Study|Lost to Follow-up|2|||
94364962|NCT01186744|323120554|FG003|Overall Study|Lost to Follow-up|1|||
94364963|NCT01186744|323120555|FG004|Overall Study|Lost to Follow-up|1|||
94364964|NCT01186744|323120556|FG005|Overall Study|Lost to Follow-up|4|||
94364965|NCT01186744|323120551|FG000|Overall Study|Screen failure|1|||
94364966|NCT01186744|323120552|FG001|Overall Study|Screen failure|1|||
94364967|NCT01186744|323120553|FG002|Overall Study|Screen failure|0|||
94364968|NCT01186744|323120554|FG003|Overall Study|Screen failure|1|||
94364969|NCT01186744|323120555|FG004|Overall Study|Screen failure|0|||
94364970|NCT01186744|323120556|FG005|Overall Study|Screen failure|0|||
94364971|NCT01186744|323120551|FG000|Overall Study|Withdrawal by Subject|14|||
94364972|NCT01186744|323120552|FG001|Overall Study|Withdrawal by Subject|10|||
94364973|NCT01186744|323120553|FG002|Overall Study|Withdrawal by Subject|2|||
94364974|NCT01186744|323120554|FG003|Overall Study|Withdrawal by Subject|5|||
94364975|NCT01186744|323120555|FG004|Overall Study|Withdrawal by Subject|0|||
94364976|NCT01186744|323120556|FG005|Overall Study|Withdrawal by Subject|6|||
94465206|NCT01785849|323492565|FG001|Overall Study|Lost to Follow-up|11|||
94465207|NCT01987232|323492576|FG000|Overall Study|Ongoing in Study|0|||
94465208|NCT01987232|323492577|FG001|Overall Study|Ongoing in Study|0|||
94465209|NCT01987232|323492578|FG002|Overall Study|Ongoing in Study|0|||
94465210|NCT01987232|323492579|FG003|Overall Study|Ongoing in Study|1|||
94465211|NCT01987232|323492580|FG004|Overall Study|Ongoing in Study|0|||
94465212|NCT00875433|323492581|FG000|Overall Study|Progressive disease|41|||
94465213|NCT00875433|323492581|FG000|Overall Study|Other Adverse Event|14|||
94465214|NCT00875433|323492581|FG000|Overall Study|Withdrawal by Subject|2|||
94465215|NCT00875433|323492581|FG000|Overall Study|Other|3|||
94465216|NCT02918552|323492582|FG000|Overall Study|Failed Pharmacokinetics|1|||
94465217|NCT02918552|323492583|FG001|Overall Study|Failed Pharmacokinetics|0|||
94465218|NCT02918552|323492582|FG000|Overall Study|Withdrawal by Subject|0|||
94364977|NCT01186744|323120551|FG000|Overall Study|Study terminated by Sponsor|1|||
94465219|NCT02918552|323492583|FG001|Overall Study|Withdrawal by Subject|1|||
94465220|NCT02918552|323492582|FG000|Overall Study|Lost to Follow-up|0|||
94465221|NCT02918552|323492583|FG001|Overall Study|Lost to Follow-up|1|||
94465222|NCT01731470|323492584|FG000|Overall Study|Withdrawal by Subject|1|||
94465223|NCT01731470|323492584|FG000|Overall Study|Did not meet study criteria|1|||
94465224|NCT04395274|323492585|FG000|Overall Study|Lost to Follow-up|20|||
94465225|NCT04395274|323492586|FG001|Overall Study|Lost to Follow-up|11|||
94465226|NCT04395274|323492585|FG000|Overall Study|Withdrawal by Subject|13|||
94465227|NCT04395274|323492586|FG001|Overall Study|Withdrawal by Subject|10|||
94465228|NCT04395274|323492585|FG000|Overall Study|Moved Abroad|0|||
94465229|NCT04395274|323492586|FG001|Overall Study|Moved Abroad|1|||
94465230|NCT03325894|323492587|FG000|Overall Study|Adverse Event|2|||
94465231|NCT03325894|323492588|FG001|Overall Study|Adverse Event|3|||
94465232|NCT03325894|323492587|FG000|Overall Study|Protocol Violation|1|||
94465233|NCT03325894|323492588|FG001|Overall Study|Protocol Violation|2|||
94364978|NCT01186744|323120552|FG001|Overall Study|Study terminated by Sponsor|0|||
94364979|NCT01186744|323120553|FG002|Overall Study|Study terminated by Sponsor|0|||
94465234|NCT03325894|323492587|FG000|Overall Study|Withdrawal by Subject|10|||
94465235|NCT03325894|323492588|FG001|Overall Study|Withdrawal by Subject|6|||
94465236|NCT03325894|323492587|FG000|Overall Study|Lost to Follow-up|4|||
94465237|NCT03325894|323492588|FG001|Overall Study|Lost to Follow-up|9|||
94465238|NCT03325894|323492587|FG000|Overall Study|Lack of Efficacy|8|||
94465239|NCT03325894|323492588|FG001|Overall Study|Lack of Efficacy|14|||
94465240|NCT03325894|323492587|FG000|Overall Study|Study Terminated by Sponsor|38|||
94465241|NCT03325894|323492588|FG001|Overall Study|Study Terminated by Sponsor|43|||
94465242|NCT03325894|323492587|FG000|Overall Study|Other (Not received Treatment)|1|||
94465243|NCT03325894|323492588|FG001|Overall Study|Other (Not received Treatment)|0|||
94465244|NCT01592292|323492589|FG000|Overall Study|Follow-up loss|3|||
94465245|NCT01592292|323492590|FG001|Overall Study|Follow-up loss|3|||
94465246|NCT01592292|323492591|FG002|Overall Study|Follow-up loss|1|||
94465247|NCT01592292|323492592|FG003|Overall Study|Follow-up loss|0|||
94465248|NCT01592292|323492589|FG000|Overall Study|Withdrew consent|2|||
94465249|NCT01592292|323492590|FG001|Overall Study|Withdrew consent|1|||
94465250|NCT01592292|323492591|FG002|Overall Study|Withdrew consent|0|||
94465251|NCT01592292|323492592|FG003|Overall Study|Withdrew consent|0|||
94465252|NCT01592292|323492589|FG000|Overall Study|Other|1|||
94465253|NCT01592292|323492590|FG001|Overall Study|Other|1|||
94465254|NCT01592292|323492591|FG002|Overall Study|Other|2|||
94465255|NCT01592292|323492592|FG003|Overall Study|Other|1|||
94364980|NCT01186744|323120554|FG003|Overall Study|Study terminated by Sponsor|0|||
94364981|NCT01186744|323120555|FG004|Overall Study|Study terminated by Sponsor|0|||
94364982|NCT01186744|323120556|FG005|Overall Study|Study terminated by Sponsor|0|||
94364983|NCT01186744|323120551|FG000|Overall Study|Other|9|||
94364984|NCT01186744|323120552|FG001|Overall Study|Other|10|||
94465256|NCT00335959|323492593|FG000|Overall Study|Adverse Event|2|||
94465257|NCT00335959|323492593|FG000|Overall Study|Ineligible|1|||
94465258|NCT03482167|323492594|FG000|Allocated to Intervention|Physician Decision|1|||
94465259|NCT03482167|323492595|FG001|Allocated to Intervention|Physician Decision|2|||
94465260|NCT03482167|323492594|FG000|Received Intervention|Adverse Event|3|||
94465261|NCT03482167|323492595|FG001|Received Intervention|Adverse Event|1|||
94465262|NCT03482167|323492594|FG000|Received Intervention|Physician Decision|1|||
94465263|NCT03482167|323492595|FG001|Received Intervention|Physician Decision|1|||
94364985|NCT01186744|323120553|FG002|Overall Study|Other|1|||
94465264|NCT03482167|323492594|FG000|Received Intervention|Withdrawal by Subject|1|||
94465265|NCT03482167|323492595|FG001|Received Intervention|Withdrawal by Subject|0|||
94465266|NCT01001598|323492598|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
94465267|NCT01001598|323492598|FG000|Overall Study|Adverse Event|1|||
94465268|NCT01524783|323492605|FG000|Blinded Period|Adverse Event|64|||
94465269|NCT01524783|323492606|FG001|Blinded Period|Adverse Event|7|||
94465270|NCT01524783|323492607|FG002|Blinded Period|Adverse Event|0|||
94465271|NCT01524783|323492605|FG000|Blinded Period|Disease Progression|89|||
94650978|NCT01573624|324179686|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
94364986|NCT01186744|323120554|FG003|Overall Study|Other|2|||
94650979|NCT01573624|324179680|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
94650980|NCT01573624|324179681|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
94364987|NCT01186744|323120555|FG004|Overall Study|Other|1|||
94364988|NCT01186744|323120556|FG005|Overall Study|Other|5|||
94364989|NCT01186744|323120551|FG000|Overall Study|Adverse Event|10|||
94364990|NCT01186744|323120552|FG001|Overall Study|Adverse Event|14|||
94364991|NCT01186744|323120553|FG002|Overall Study|Adverse Event|1|||
94364992|NCT01186744|323120554|FG003|Overall Study|Adverse Event|0|||
94364993|NCT01186744|323120555|FG004|Overall Study|Adverse Event|1|||
94364994|NCT01186744|323120556|FG005|Overall Study|Adverse Event|4|||
94364995|NCT01186744|323120551|FG000|Overall Study|Death|1|||
94364996|NCT01186744|323120552|FG001|Overall Study|Death|0|||
94364997|NCT01186744|323120553|FG002|Overall Study|Death|0|||
94364998|NCT01186744|323120554|FG003|Overall Study|Death|0|||
94364999|NCT01186744|323120555|FG004|Overall Study|Death|0|||
94365000|NCT01186744|323120556|FG005|Overall Study|Death|0|||
94365001|NCT00819091|323120557|FG000|Overall Study|Adverse Event|3|||
94365002|NCT00819091|323120558|FG001|Overall Study|Adverse Event|5|||
94365003|NCT00819091|323120557|FG000|Overall Study|Protocol Violation|0|||
94365004|NCT00819091|323120558|FG001|Overall Study|Protocol Violation|1|||
94365005|NCT00819091|323120557|FG000|Overall Study|Lost to Follow-up|2|||
94365006|NCT00819091|323120558|FG001|Overall Study|Lost to Follow-up|0|||
94365007|NCT00819091|323120557|FG000|Overall Study|Withdrawal by Subject|1|||
94365008|NCT00819091|323120558|FG001|Overall Study|Withdrawal by Subject|2|||
94365009|NCT00819091|323120557|FG000|Overall Study|Other|1|||
94365010|NCT00819091|323120558|FG001|Overall Study|Other|2|||
94365011|NCT03286426|323120559|FG000|Overall Study|Physician Decision|3|||
94365012|NCT02411110|323120573|FG000|Treatment Period 1|Adverse Event|4|||
94365013|NCT02411110|323120574|FG001|Treatment Period 1|Adverse Event|2|||
94365014|NCT02411110|323120573|FG000|Treatment Period 1|Lost to Follow-up|1|||
94365015|NCT02411110|323120574|FG001|Treatment Period 1|Lost to Follow-up|0|||
94365016|NCT02411110|323120573|FG000|Treatment Period 1|Personal Reasons|2|||
94365017|NCT02411110|323120574|FG001|Treatment Period 1|Personal Reasons|5|||
94365018|NCT02411110|323120573|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
94365019|NCT02411110|323120574|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
94365020|NCT02411110|323120573|FG000|Treatment Period 2|Adverse Event|1|||
94365021|NCT02411110|323120574|FG001|Treatment Period 2|Adverse Event|0|||
94365022|NCT02411110|323120573|FG000|Treatment Period 2|Lost to Follow-up|0|||
94365023|NCT02411110|323120574|FG001|Treatment Period 2|Lost to Follow-up|2|||
94365024|NCT02411110|323120573|FG000|Treatment Period 2|Personal Reasons|0|||
94365025|NCT02411110|323120574|FG001|Treatment Period 2|Personal Reasons|2|||
94365026|NCT03692078|323120576|FG000|Overall Study|Adverse Event|0|||
94365027|NCT03692078|323120577|FG001|Overall Study|Adverse Event|0|||
94365028|NCT03692078|323120578|FG002|Overall Study|Adverse Event|0|||
94365029|NCT03692078|323120579|FG003|Overall Study|Adverse Event|0|||
94365030|NCT03692078|323120580|FG004|Overall Study|Adverse Event|0|||
94365031|NCT03692078|323120581|FG005|Overall Study|Adverse Event|1|||
94365032|NCT03692078|323120582|FG006|Overall Study|Adverse Event|0|||
94365033|NCT03692078|323120576|FG000|Overall Study|Enrollment Closed|5|||
94365034|NCT03692078|323120577|FG001|Overall Study|Enrollment Closed|0|||
94365035|NCT03692078|323120578|FG002|Overall Study|Enrollment Closed|0|||
94365036|NCT03692078|323120579|FG003|Overall Study|Enrollment Closed|0|||
94365037|NCT03692078|323120580|FG004|Overall Study|Enrollment Closed|0|||
94365038|NCT03692078|323120581|FG005|Overall Study|Enrollment Closed|0|||
94365039|NCT03692078|323120582|FG006|Overall Study|Enrollment Closed|0|||
94365040|NCT03692078|323120576|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
94365041|NCT03692078|323120577|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
94365042|NCT03692078|323120578|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
94365043|NCT03692078|323120579|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
94365044|NCT03692078|323120580|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
94365045|NCT03692078|323120581|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
94365046|NCT03692078|323120582|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
94365047|NCT03692078|323120576|FG000|Overall Study|Withdrawal by Subject|0|||
94365048|NCT03692078|323120577|FG001|Overall Study|Withdrawal by Subject|2|||
94365049|NCT03692078|323120578|FG002|Overall Study|Withdrawal by Subject|0|||
94365050|NCT03692078|323120579|FG003|Overall Study|Withdrawal by Subject|1|||
94365051|NCT03692078|323120580|FG004|Overall Study|Withdrawal by Subject|5|||
94365052|NCT03692078|323120581|FG005|Overall Study|Withdrawal by Subject|3|||
94465272|NCT01524783|323492606|FG001|Blinded Period|Disease Progression|75|||
94465273|NCT01524783|323492607|FG002|Blinded Period|Disease Progression|0|||
94465274|NCT01524783|323492605|FG000|Blinded Period|Withdrawal by Subject|19|||
94465275|NCT01524783|323492606|FG001|Blinded Period|Withdrawal by Subject|6|||
94465276|NCT01524783|323492607|FG002|Blinded Period|Withdrawal by Subject|0|||
94465277|NCT01524783|323492605|FG000|Blinded Period|Protocol deviation|2|||
94465278|NCT01524783|323492606|FG001|Blinded Period|Protocol deviation|1|||
94465279|NCT01524783|323492607|FG002|Blinded Period|Protocol deviation|0|||
94465280|NCT01524783|323492605|FG000|Blinded Period|Death|5|||
94465281|NCT01524783|323492606|FG001|Blinded Period|Death|2|||
94465282|NCT01524783|323492607|FG002|Blinded Period|Death|0|||
94465283|NCT01524783|323492605|FG000|Open-label Period|Disease progression|13|||
94465284|NCT01524783|323492606|FG001|Open-label Period|Disease progression|0|||
94465285|NCT01524783|323492607|FG002|Open-label Period|Disease progression|2|||
94465286|NCT01524783|323492605|FG000|Open-label Period|Administrative problems|5|||
94465287|NCT01524783|323492606|FG001|Open-label Period|Administrative problems|0|||
94650981|NCT01573624|324179682|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
94650982|NCT01573624|324179683|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
94650983|NCT01573624|324179684|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
94650984|NCT01573624|324179685|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
94650985|NCT01573624|324179686|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
94650986|NCT01573624|324179680|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
94650987|NCT01573624|324179681|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
94650988|NCT01573624|324179682|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
94650989|NCT01573624|324179683|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
94650990|NCT01573624|324179684|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
94650991|NCT01573624|324179685|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
94650992|NCT01573624|324179686|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
94650993|NCT01573624|324179680|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
94650994|NCT01573624|324179681|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
94650995|NCT01573624|324179682|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
94650996|NCT01573624|324179683|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
94650997|NCT01573624|324179684|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
94650998|NCT01573624|324179685|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
94650999|NCT01573624|324179686|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
94651000|NCT01573624|324179680|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
94651001|NCT01573624|324179681|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
94651002|NCT01573624|324179682|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
94651003|NCT01573624|324179683|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
94465288|NCT01524783|323492607|FG002|Open-label Period|Administrative problems|2|||
94465289|NCT01524783|323492605|FG000|Open-label Period|Adverse Event|5|||
94465290|NCT01524783|323492606|FG001|Open-label Period|Adverse Event|0|||
94465291|NCT01524783|323492607|FG002|Open-label Period|Adverse Event|1|||
94465292|NCT01524783|323492605|FG000|Open-label Period|Withdrawal by Subject|2|||
94465293|NCT01524783|323492606|FG001|Open-label Period|Withdrawal by Subject|0|||
94465294|NCT01524783|323492607|FG002|Open-label Period|Withdrawal by Subject|1|||
94465295|NCT01524783|323492605|FG000|Open-label Period|Protocol deviation|1|||
94465296|NCT01524783|323492606|FG001|Open-label Period|Protocol deviation|0|||
94465297|NCT01524783|323492607|FG002|Open-label Period|Protocol deviation|0|||
94465298|NCT03233204|323492608|FG000|Overall Study|Adverse Event|1|||
94465299|NCT03233204|323492608|FG000|Overall Study|Death|1|||
94465300|NCT03233204|323492608|FG000|Overall Study|Withdrawal by Subject|1|||
94465301|NCT03233204|323492608|FG000|Overall Study|Progressive Disease|3|||
94465302|NCT03673345|323492609|FG000|Overall Study|Lost to Follow-up|1|||
94465303|NCT03673345|323492610|FG001|Overall Study|Lost to Follow-up|0|||
94465304|NCT03673345|323492611|FG002|Overall Study|Lost to Follow-up|3|||
94465305|NCT03673345|323492612|FG003|Overall Study|Lost to Follow-up|3|||
94465306|NCT03673345|323492613|FG004|Overall Study|Lost to Follow-up|2|||
94465307|NCT03673345|323492614|FG005|Overall Study|Lost to Follow-up|1|||
94651004|NCT01573624|324179684|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
94651005|NCT01573624|324179685|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
94651006|NCT01573624|324179686|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
94651007|NCT01573624|324179680|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
94651008|NCT01573624|324179681|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
94651009|NCT01573624|324179682|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
94465308|NCT03673345|323492615|FG006|Overall Study|Lost to Follow-up|0|||
94465309|NCT03673345|323492616|FG007|Overall Study|Lost to Follow-up|0|||
94465310|NCT03673345|323492609|FG000|Overall Study|Withdrawal by Subject|1|||
94465311|NCT03673345|323492610|FG001|Overall Study|Withdrawal by Subject|0|||
94465312|NCT03673345|323492611|FG002|Overall Study|Withdrawal by Subject|4|||
94465313|NCT03673345|323492612|FG003|Overall Study|Withdrawal by Subject|2|||
94465314|NCT03673345|323492613|FG004|Overall Study|Withdrawal by Subject|0|||
94465315|NCT03673345|323492614|FG005|Overall Study|Withdrawal by Subject|0|||
94465316|NCT03673345|323492615|FG006|Overall Study|Withdrawal by Subject|0|||
94263940|NCT02877927|322759990|FG001|Overall Study|Withdrawal by Subject|12|||
94263941|NCT02877927|322759989|FG000|Overall Study|Physician Decision|0|||
94263942|NCT02877927|322759990|FG001|Overall Study|Physician Decision|1|||
94263943|NCT02877927|322759989|FG000|Overall Study|Missed EOT/PTE Visit|5|||
94263944|NCT02877927|322759990|FG001|Overall Study|Missed EOT/PTE Visit|6|||
94263945|NCT01572922|322759992|FG000|Overall Study|Adverse Event|1|||
94263946|NCT01572922|322759992|FG000|Overall Study|Protocol Violation|1|||
94263947|NCT01572922|322759992|FG000|Overall Study|Death|1|||
94263948|NCT03040622|322759993|FG000|Overall Study|unable to implant device|3|||
94263949|NCT00928564|322761768|FG000|Overall Study|Lost to Follow-up|6|||
94263950|NCT00928564|322761769|FG001|Overall Study|Lost to Follow-up|0|||
94263951|NCT00929656|322761770|FG000|Overall Study|Lost to Follow-up|0|||
94263952|NCT00929656|322761771|FG001|Overall Study|Lost to Follow-up|1|||
94263953|NCT00908583|322761772|FG000|Phase 1|Withdrawal by Subject|1|||
94465317|NCT03673345|323492616|FG007|Overall Study|Withdrawal by Subject|0|||
94465318|NCT03673345|323492609|FG000|Overall Study|Physician Decision|0|||
94465319|NCT03673345|323492610|FG001|Overall Study|Physician Decision|0|||
94465320|NCT03673345|323492611|FG002|Overall Study|Physician Decision|2|||
94465321|NCT03673345|323492612|FG003|Overall Study|Physician Decision|0|||
94465322|NCT03673345|323492613|FG004|Overall Study|Physician Decision|0|||
94465323|NCT03673345|323492614|FG005|Overall Study|Physician Decision|0|||
94465324|NCT03673345|323492615|FG006|Overall Study|Physician Decision|0|||
94465325|NCT03673345|323492616|FG007|Overall Study|Physician Decision|0|||
94465326|NCT01362244|323492617|FG000|Overall Study|Adverse Event|3|||
94465327|NCT01362244|323492618|FG001|Overall Study|Adverse Event|5|||
94465328|NCT01362244|323492617|FG000|Overall Study|Lack of Efficacy|5|||
94465329|NCT01362244|323492618|FG001|Overall Study|Lack of Efficacy|11|||
94465330|NCT01362244|323492617|FG000|Overall Study|Lost to Follow-up|0|||
94465331|NCT01362244|323492618|FG001|Overall Study|Lost to Follow-up|2|||
94465332|NCT01362244|323492617|FG000|Overall Study|Protocol Violation|5|||
94651010|NCT01573624|324179683|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
94651011|NCT01573624|324179684|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
94651012|NCT01573624|324179685|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
94651013|NCT01573624|324179686|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
94263954|NCT00908583|322761772|FG000|Phase 1|Adverse Event|4|||
94263955|NCT00908583|322761772|FG000|Phase 2|Physician Decision|1|||
94263956|NCT00908583|322761772|FG000|Phase 2|Adverse Event|1|||
94263957|NCT00908583|322761772|FG000|Phase 3|Adverse Event|2|||
94465333|NCT01362244|323492618|FG001|Overall Study|Protocol Violation|1|||
94465334|NCT01362244|323492617|FG000|Overall Study|Withdrawal by Subject|2|||
94465335|NCT01362244|323492618|FG001|Overall Study|Withdrawal by Subject|1|||
94465336|NCT01362244|323492617|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
94465337|NCT01362244|323492618|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
94465338|NCT01362244|323492617|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
94263958|NCT00908583|322761772|FG000|Phase 4|Adverse Event|1|||
94263959|NCT00908583|322761772|FG000|Phase 4|Physician Decision|1|||
94263960|NCT00908583|322761772|FG000|Phase 5|Adverse Event|3|||
94263961|NCT04004429|322761776|FG000|Overall Study|Protocol Violation|1|||
94263962|NCT04004429|322761777|FG001|Overall Study|Protocol Violation|0|||
94263963|NCT04004429|322761778|FG002|Overall Study|Protocol Violation|0|||
94263964|NCT04004429|322761776|FG000|Overall Study|Physician Decision|0|||
94263965|NCT04004429|322761777|FG001|Overall Study|Physician Decision|1|||
94263966|NCT04004429|322761778|FG002|Overall Study|Physician Decision|1|||
94263967|NCT04004429|322761776|FG000|Overall Study|Withdrawal by Subject|1|||
94263968|NCT04004429|322761777|FG001|Overall Study|Withdrawal by Subject|1|||
94263969|NCT04004429|322761778|FG002|Overall Study|Withdrawal by Subject|1|||
94263970|NCT02606461|322761780|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
94263971|NCT02606461|322761781|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
94263972|NCT02606461|322761782|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
94263973|NCT02606461|322761783|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
94263974|NCT02606461|322761784|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
94263975|NCT02606461|322761785|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
94263976|NCT03974334|322761786|FG000|Overall Study|Lost to Follow-up|1|||
94263977|NCT01303965|322761787|FG000|Overall Study|Adverse Event|1|||
94263978|NCT01303965|322761788|FG001|Overall Study|Adverse Event|1|||
94263979|NCT01303965|322761787|FG000|Overall Study|Death|0|||
94465339|NCT01362244|323492618|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
94465340|NCT00474786|323492621|FG000|Overall Study|Not Meeting Study Criteria|0|||
94465341|NCT00474786|323492622|FG001|Overall Study|Not Meeting Study Criteria|1|||
94465342|NCT00474786|323492621|FG000|Overall Study|Investigator Request|2|||
94465343|NCT00474786|323492622|FG001|Overall Study|Investigator Request|1|||
94465344|NCT00474786|323492621|FG000|Overall Study|Death|189|||
94465345|NCT00474786|323492622|FG001|Overall Study|Death|170|||
94465346|NCT00474786|323492621|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
94465347|NCT00474786|323492622|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
94465348|NCT00474786|323492621|FG000|Overall Study|Lost to Follow-up|4|||
94465349|NCT00474786|323492622|FG001|Overall Study|Lost to Follow-up|7|||
94465350|NCT00474786|323492621|FG000|Overall Study|Protocol Violation|2|||
94465351|NCT00474786|323492622|FG001|Overall Study|Protocol Violation|0|||
94465352|NCT00474786|323492621|FG000|Overall Study|Withdrawal by Subject|15|||
94465353|NCT00474786|323492622|FG001|Overall Study|Withdrawal by Subject|15|||
94465354|NCT00474786|323492621|FG000|Overall Study|Other|5|||
94263980|NCT01303965|322761788|FG001|Overall Study|Death|3|||
94465355|NCT00474786|323492622|FG001|Overall Study|Other|0|||
94465356|NCT03806231|323492623|FG000|Overall Study|Physician Decision|1|||
94465357|NCT03806231|323492624|FG001|Overall Study|Physician Decision|0|||
94465358|NCT03806231|323492623|FG000|Overall Study|Withdrawal by Subject|1|||
94465359|NCT03806231|323492624|FG001|Overall Study|Withdrawal by Subject|0|||
94465360|NCT00900731|323492625|FG000|Overall Study|Adverse Event|31|||
94465361|NCT00900731|323492626|FG001|Overall Study|Adverse Event|27|||
94465362|NCT00900731|323492625|FG000|Overall Study|Withdrawal by Subject|8|||
94465363|NCT00900731|323492626|FG001|Overall Study|Withdrawal by Subject|7|||
94465364|NCT00900731|323492625|FG000|Overall Study|Protocol Deviation|8|||
94465365|NCT00900731|323492626|FG001|Overall Study|Protocol Deviation|11|||
94465366|NCT00900731|323492625|FG000|Overall Study|Administrative Problems|5|||
94465367|NCT00900731|323492626|FG001|Overall Study|Administrative Problems|4|||
94465368|NCT00900731|323492625|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
94465369|NCT00900731|323492626|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
94465370|NCT00900731|323492625|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
94465371|NCT00900731|323492626|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
94465372|NCT00900731|323492625|FG000|Overall Study|Lost to Follow-up|2|||
94465373|NCT00900731|323492626|FG001|Overall Study|Lost to Follow-up|3|||
94465374|NCT00900731|323492625|FG000|Overall Study|Lack of Efficacy|1|||
94465375|NCT00900731|323492626|FG001|Overall Study|Lack of Efficacy|3|||
94465376|NCT00900731|323492625|FG000|Overall Study|Death|0|||
94465377|NCT00900731|323492626|FG001|Overall Study|Death|2|||
94465378|NCT02919267|323492627|FG000|Overall Study|Protocol Violation|0|||
94465379|NCT02919267|323492628|FG001|Overall Study|Protocol Violation|3|||
94465380|NCT02919267|323492629|FG002|Overall Study|Protocol Violation|3|||
94465381|NCT02919267|323492630|FG003|Overall Study|Protocol Violation|4|||
94465382|NCT00932698|323492631|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
94465383|NCT00932698|323492632|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
94263981|NCT01303965|322761787|FG000|Overall Study|Withdrawal by Subject|1|||
94263982|NCT01303965|322761788|FG001|Overall Study|Withdrawal by Subject|0|||
94263983|NCT01303965|322761787|FG000|Overall Study|Disease Progression|1|||
94263984|NCT01303965|322761788|FG001|Overall Study|Disease Progression|6|||
94263985|NCT03740997|322761791|FG000|Overall Study|Withdrawal by Subject|1|||
94465384|NCT00932698|323492633|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
94465385|NCT00932698|323492634|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
94465386|NCT00932698|323492635|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
94465387|NCT00932698|323492636|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
94263986|NCT03740997|322761792|FG001|Overall Study|Withdrawal by Subject|0|||
94465388|NCT00932698|323492637|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
94465389|NCT00932698|323492638|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
94465390|NCT00932698|323492639|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
94465391|NCT00932698|323492640|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
94365053|NCT03692078|323120582|FG006|Overall Study|Withdrawal by Subject|3|||
94365054|NCT03130777|323120587|FG000|Overall Study|Death|0|||
94365055|NCT03130777|323120588|FG001|Overall Study|Death|1|||
94365056|NCT03130777|323120587|FG000|Overall Study|Did not meet eligibility criteria|1|||
94365057|NCT03130777|323120588|FG001|Overall Study|Did not meet eligibility criteria|0|||
94365058|NCT00422058|323120589|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
94365059|NCT00422058|323120590|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
94365060|NCT00422058|323120591|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
94365061|NCT00422058|323120592|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
94365062|NCT00422058|323120593|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
94365063|NCT00422058|323120594|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
94365064|NCT00422058|323120589|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
94365065|NCT00422058|323120590|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
94365066|NCT00422058|323120591|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
94686683|NCT01320735|324307721|FG000|Overall Study|Administrative Reason|6|||
94686684|NCT01320735|324307721|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
94686685|NCT01320735|324307721|FG000|Overall Study|Protocol Violation|1|||
94686686|NCT01320735|324307721|FG000|Overall Study|Other|1|||
94686687|NCT01320735|324307721|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
94686688|NCT01320735|324307721|FG000|Overall Study|Investigator Unable to be Contacted|17|||
94686689|NCT03856996|324307726|FG000|Overall Study|Withdrawal by Subject|1|||
94686690|NCT03856996|324307727|FG001|Overall Study|Withdrawal by Subject|0|||
94686691|NCT03856996|324307726|FG000|Overall Study|Lost to Follow-up|0|||
94686692|NCT03856996|324307727|FG001|Overall Study|Lost to Follow-up|1|||
94686693|NCT03856996|324307726|FG000|Overall Study|Adverse Event|1|||
94686694|NCT03856996|324307727|FG001|Overall Study|Adverse Event|1|||
94686695|NCT03856996|324307726|FG000|Overall Study|Other|1|||
94686696|NCT03856996|324307727|FG001|Overall Study|Other|0|||
94686697|NCT01003639|324307730|FG000|Overall Study|Lost to Follow-up|6|||
94686698|NCT01003639|324307731|FG001|Overall Study|Lost to Follow-up|9|||
94686699|NCT01003639|324307730|FG000|Overall Study|Withdrawal by Subject|9|||
94686700|NCT01003639|324307731|FG001|Overall Study|Withdrawal by Subject|5|||
94686701|NCT01003639|324307730|FG000|Overall Study|Lack of Efficacy|1|||
94686702|NCT01003639|324307731|FG001|Overall Study|Lack of Efficacy|6|||
94686703|NCT01003639|324307730|FG000|Overall Study|Adverse Event|0|||
94686704|NCT01003639|324307731|FG001|Overall Study|Adverse Event|1|||
94686705|NCT01003639|324307730|FG000|Overall Study|Protocol Violation|0|||
94686706|NCT01003639|324307731|FG001|Overall Study|Protocol Violation|1|||
94686707|NCT01003639|324307730|FG000|Overall Study|Physician Decision|1|||
94686708|NCT01003639|324307731|FG001|Overall Study|Physician Decision|0|||
94686709|NCT05284019|324307732|FG000|Overall Study|Study terminated|2|||
94686710|NCT05284019|324307733|FG001|Overall Study|Study terminated|2|||
94686711|NCT05284019|324307734|FG002|Overall Study|Study terminated|2|||
94686712|NCT05284019|324307735|FG003|Overall Study|Study terminated|5|||
94686713|NCT05284019|324307736|FG004|Overall Study|Study terminated|15|||
94686714|NCT05284019|324307732|FG000|Overall Study|Withdrawal by Subject|0|||
94686715|NCT05284019|324307733|FG001|Overall Study|Withdrawal by Subject|0|||
94686716|NCT05284019|324307734|FG002|Overall Study|Withdrawal by Subject|0|||
94686717|NCT05284019|324307735|FG003|Overall Study|Withdrawal by Subject|1|||
94686718|NCT05284019|324307736|FG004|Overall Study|Withdrawal by Subject|1|||
94686719|NCT05284019|324307732|FG000|Overall Study|Lost to Follow-up|1|||
94686720|NCT05284019|324307733|FG001|Overall Study|Lost to Follow-up|0|||
94686721|NCT05284019|324307734|FG002|Overall Study|Lost to Follow-up|0|||
94686722|NCT05284019|324307735|FG003|Overall Study|Lost to Follow-up|2|||
94686723|NCT05284019|324307736|FG004|Overall Study|Lost to Follow-up|1|||
94365067|NCT00422058|323120592|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
94365068|NCT00422058|323120593|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
94365069|NCT00422058|323120594|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
94365070|NCT00422058|323120589|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
94686724|NCT01231503|324307737|FG000|Overall Study|Adverse Event|0|||
94686725|NCT01231503|324307738|FG001|Overall Study|Adverse Event|0|||
94686726|NCT01231503|324307739|FG002|Overall Study|Adverse Event|0|||
94686727|NCT01231503|324307740|FG003|Overall Study|Adverse Event|0|||
94686728|NCT01231503|324307741|FG004|Overall Study|Adverse Event|0|||
94686729|NCT01231503|324307742|FG005|Overall Study|Adverse Event|1|||
94686730|NCT01231503|324307743|FG006|Overall Study|Adverse Event|0|||
94686731|NCT01231503|324307744|FG007|Overall Study|Adverse Event|0|||
94686732|NCT01231503|324307737|FG000|Overall Study|Adverse event, serious fatal|0|||
94686733|NCT01231503|324307738|FG001|Overall Study|Adverse event, serious fatal|0|||
94465392|NCT00932698|323492641|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
94465393|NCT00932698|323492631|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
94465394|NCT00932698|323492632|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
94465395|NCT00932698|323492633|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
94465396|NCT00932698|323492634|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
94465397|NCT00932698|323492635|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
94465398|NCT00932698|323492636|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
94465399|NCT00932698|323492637|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
94465400|NCT00932698|323492638|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
94465401|NCT00932698|323492639|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
94465402|NCT00932698|323492640|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
94465403|NCT00932698|323492641|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
94465404|NCT00932698|323492631|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
94465405|NCT00932698|323492632|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
94465406|NCT00932698|323492633|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
94465407|NCT00932698|323492634|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
94465408|NCT00932698|323492635|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
94465409|NCT00932698|323492636|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
94465410|NCT00932698|323492637|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
94465411|NCT00932698|323492638|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
94465412|NCT00932698|323492639|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
94465413|NCT00932698|323492640|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
94465414|NCT00932698|323492641|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
94465415|NCT00932698|323492631|FG000|Part 1 (Dose Escalation)|Other|0|||
94465416|NCT00932698|323492632|FG001|Part 1 (Dose Escalation)|Other|0|||
94465417|NCT00932698|323492633|FG002|Part 1 (Dose Escalation)|Other|1|||
94465418|NCT00932698|323492634|FG003|Part 1 (Dose Escalation)|Other|0|||
94465419|NCT00932698|323492635|FG004|Part 1 (Dose Escalation)|Other|0|||
94465420|NCT00932698|323492636|FG005|Part 1 (Dose Escalation)|Other|0|||
94465421|NCT00932698|323492637|FG006|Part 1 (Dose Escalation)|Other|1|||
94465422|NCT00932698|323492638|FG007|Part 1 (Dose Escalation)|Other|0|||
94465423|NCT00932698|323492639|FG008|Part 1 (Dose Escalation)|Other|0|||
94465424|NCT00932698|323492640|FG009|Part 1 (Dose Escalation)|Other|0|||
94465425|NCT00932698|323492641|FG010|Part 1 (Dose Escalation)|Other|0|||
94263987|NCT03740997|322761791|FG000|Overall Study|Participant was unable to complete study procedures|1|||
94263988|NCT03740997|322761792|FG001|Overall Study|Participant was unable to complete study procedures|0|||
94263989|NCT01829425|322761794|FG000|Overall Study|Withdrawal by Subject|4|||
94263990|NCT01829425|322761795|FG001|Overall Study|Withdrawal by Subject|3|||
94263991|NCT01829425|322761794|FG000|Overall Study|Lost to Follow-up|2|||
94263992|NCT01829425|322761795|FG001|Overall Study|Lost to Follow-up|1|||
94263993|NCT03681951|322761796|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
94263994|NCT03681951|322761797|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
94263995|NCT03681951|322761798|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
94263996|NCT03681951|322761799|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
94263997|NCT03681951|322761800|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
94263998|NCT03681951|322761801|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
94263999|NCT03681951|322761802|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
94264000|NCT03681951|322761803|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
94264001|NCT03681951|322761796|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
94465426|NCT00932698|323492631|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
94465427|NCT00932698|323492632|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
94465428|NCT00932698|323492633|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
94465429|NCT00932698|323492634|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
94465430|NCT00932698|323492635|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
94264002|NCT03681951|322761797|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
94264003|NCT03681951|322761798|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
94465431|NCT00932698|323492636|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
94465432|NCT00932698|323492637|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
94465433|NCT00932698|323492638|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
94465434|NCT00932698|323492639|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
94465435|NCT00932698|323492640|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
94465436|NCT00932698|323492641|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
94465437|NCT00932698|323492631|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
94465438|NCT00932698|323492632|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
94465439|NCT00932698|323492633|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
94465440|NCT00932698|323492634|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
94465441|NCT00932698|323492635|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
94465442|NCT00932698|323492636|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
94465443|NCT00932698|323492637|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
94465444|NCT00932698|323492638|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
94465445|NCT00932698|323492639|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
94465446|NCT00932698|323492640|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
94465447|NCT00932698|323492641|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
94465448|NCT00932698|323492631|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
94465449|NCT00932698|323492632|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
94465450|NCT00932698|323492633|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
94465451|NCT00932698|323492634|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
94465452|NCT00932698|323492635|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
94465453|NCT00932698|323492636|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
94465454|NCT00932698|323492637|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
94465455|NCT00932698|323492638|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
94465456|NCT00932698|323492639|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
94465457|NCT00932698|323492640|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
94465458|NCT00932698|323492641|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
94365071|NCT00422058|323120590|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
94365072|NCT00422058|323120591|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
94365073|NCT00422058|323120592|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
94365074|NCT00422058|323120593|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
94365075|NCT00422058|323120594|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
94365076|NCT00422058|323120589|FG000|Double-Blind, Week 0-20|Other|11|||
94365077|NCT00422058|323120590|FG001|Double-Blind, Week 0-20|Other|3|||
94365078|NCT00422058|323120591|FG002|Double-Blind, Week 0-20|Other|8|||
94365079|NCT00422058|323120592|FG003|Double-Blind, Week 0-20|Other|8|||
94365080|NCT00422058|323120593|FG004|Double-Blind, Week 0-20|Other|4|||
94365081|NCT00422058|323120594|FG005|Double-Blind, Week 0-20|Other|10|||
94365082|NCT00422058|323120589|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
94365083|NCT00422058|323120590|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
94465459|NCT00432276|323492642|FG000|Overall Study|Hyperglycemic Rescue|44|||
94465460|NCT00432276|323492643|FG001|Overall Study|Hyperglycemic Rescue|87|||
94465461|NCT00432276|323492642|FG000|Overall Study|Adverse Event|13|||
94465462|NCT00432276|323492643|FG001|Overall Study|Adverse Event|16|||
94465463|NCT00432276|323492642|FG000|Overall Study|Protocol Violation|25|||
94465464|NCT00432276|323492643|FG001|Overall Study|Protocol Violation|20|||
94465465|NCT00432276|323492642|FG000|Overall Study|Lost to Follow-up|6|||
94465466|NCT00432276|323492643|FG001|Overall Study|Lost to Follow-up|2|||
94465467|NCT00432276|323492642|FG000|Overall Study|Withdrawal by Subject|25|||
94465468|NCT00432276|323492643|FG001|Overall Study|Withdrawal by Subject|20|||
94365084|NCT00422058|323120591|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
94365085|NCT00422058|323120592|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
94465469|NCT00432276|323492642|FG000|Overall Study|Physician Decision|6|||
94465470|NCT00432276|323492643|FG001|Overall Study|Physician Decision|8|||
94465471|NCT00432276|323492642|FG000|Overall Study|Other|2|||
94465472|NCT00432276|323492643|FG001|Overall Study|Other|3|||
94465473|NCT00131365|323492644|FG000|Overall Study|Withdrawal by Subject|1|||
94465474|NCT00131365|323492644|FG000|Overall Study|Alternative treatment|3|||
94465475|NCT01085136|323492646|FG000|Part A|Other Adverse event|223|||
94465476|NCT01085136|323492647|FG001|Part A|Other Adverse event|0|||
94465477|NCT01085136|323492648|FG002|Part A|Other Adverse event|0|||
94465478|NCT01085136|323492646|FG000|Part A|Protocol Violation|3|||
94465479|NCT01085136|323492647|FG001|Part A|Protocol Violation|0|||
94465480|NCT01085136|323492648|FG002|Part A|Protocol Violation|0|||
94465481|NCT01085136|323492646|FG000|Part A|Lost to Follow-up|3|||
94465482|NCT01085136|323492647|FG001|Part A|Lost to Follow-up|0|||
94465483|NCT01085136|323492648|FG002|Part A|Lost to Follow-up|0|||
94465484|NCT01085136|323492646|FG000|Part A|Refusal to continue trial medication|64|||
94465485|NCT01085136|323492647|FG001|Part A|Refusal to continue trial medication|0|||
94465486|NCT01085136|323492648|FG002|Part A|Refusal to continue trial medication|0|||
94465487|NCT01085136|323492646|FG000|Part A|Other reason not defined above|30|||
94465488|NCT01085136|323492647|FG001|Part A|Other reason not defined above|0|||
94465489|NCT01085136|323492648|FG002|Part A|Other reason not defined above|0|||
94465490|NCT01085136|323492646|FG000|Part B|Other AE|0|||
94465491|NCT01085136|323492647|FG001|Part B|Other AE|29|||
94465492|NCT01085136|323492648|FG002|Part B|Other AE|8|||
94465493|NCT01085136|323492646|FG000|Part B|Refusal to continue trial medication|0|||
94465494|NCT01085136|323492647|FG001|Part B|Refusal to continue trial medication|12|||
94465495|NCT01085136|323492648|FG002|Part B|Refusal to continue trial medication|7|||
94465496|NCT01085136|323492646|FG000|Part B|Not treated|0|||
94465497|NCT01085136|323492647|FG001|Part B|Not treated|4|||
94465498|NCT01085136|323492648|FG002|Part B|Not treated|8|||
94465499|NCT01085136|323492646|FG000|Part B|Other reason not defined above|0|||
94465500|NCT01085136|323492647|FG001|Part B|Other reason not defined above|6|||
94465501|NCT01085136|323492648|FG002|Part B|Other reason not defined above|3|||
94465502|NCT02172040|323492649|FG000|Overall Study|Adverse Event|0|||
94465503|NCT02172040|323492650|FG001|Overall Study|Adverse Event|2|||
94465504|NCT02172040|323492651|FG002|Overall Study|Adverse Event|0|||
94465505|NCT02172040|323492652|FG003|Overall Study|Adverse Event|0|||
94465506|NCT02172040|323492649|FG000|Overall Study|Protocol Violation|0|||
94365086|NCT00422058|323120593|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
94365087|NCT00422058|323120594|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
94465507|NCT02172040|323492650|FG001|Overall Study|Protocol Violation|1|||
94465508|NCT02172040|323492651|FG002|Overall Study|Protocol Violation|0|||
94465509|NCT02172040|323492652|FG003|Overall Study|Protocol Violation|0|||
94465510|NCT02172040|323492649|FG000|Overall Study|Withdrawal by Subject|0|||
94465511|NCT02172040|323492650|FG001|Overall Study|Withdrawal by Subject|0|||
94365088|NCT00422058|323120589|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
94465512|NCT02172040|323492651|FG002|Overall Study|Withdrawal by Subject|1|||
94465513|NCT02172040|323492652|FG003|Overall Study|Withdrawal by Subject|0|||
94465514|NCT02172040|323492649|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
94465515|NCT02172040|323492650|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
94465516|NCT02172040|323492651|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
94365089|NCT00422058|323120590|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
94264004|NCT03681951|322761799|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
94264005|NCT03681951|322761800|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
94264006|NCT03681951|322761801|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
94264007|NCT03681951|322761802|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
94264008|NCT03681951|322761803|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
94264009|NCT03681951|322761796|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
94264010|NCT03681951|322761797|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
94264011|NCT03681951|322761798|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
94264012|NCT03681951|322761799|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
94264013|NCT03681951|322761800|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
94264014|NCT03681951|322761801|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
94264015|NCT03681951|322761802|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
94264016|NCT03681951|322761803|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
94264017|NCT00041067|322761804|FG000|Overall Study|Adverse Event|20|||
94264018|NCT00041067|322761804|FG000|Overall Study|Progression|19|||
94264019|NCT00041067|322761804|FG000|Overall Study|Patient refusal|12|||
94264020|NCT00041067|322761804|FG000|Overall Study|Other reasons|23|||
94365090|NCT00422058|323120591|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
94365091|NCT00422058|323120592|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
94365092|NCT00422058|323120593|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
94365093|NCT00422058|323120594|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
94365094|NCT00422058|323120589|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
94365095|NCT00422058|323120590|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
94365096|NCT00422058|323120591|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
94365097|NCT00422058|323120592|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
94365098|NCT00422058|323120593|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
94365099|NCT00422058|323120594|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
94365100|NCT00422058|323120589|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
94365101|NCT00422058|323120590|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
94365102|NCT00422058|323120591|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
94365103|NCT00422058|323120592|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
94365104|NCT00422058|323120593|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
94365105|NCT00422058|323120594|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
94365106|NCT00422058|323120589|FG000|Open-Label Extension, Week 20-104|Other|13|||
94365107|NCT00422058|323120590|FG001|Open-Label Extension, Week 20-104|Other|14|||
94365108|NCT00422058|323120591|FG002|Open-Label Extension, Week 20-104|Other|6|||
94365109|NCT00422058|323120592|FG003|Open-Label Extension, Week 20-104|Other|13|||
94365110|NCT00422058|323120593|FG004|Open-Label Extension, Week 20-104|Other|16|||
94365111|NCT00422058|323120594|FG005|Open-Label Extension, Week 20-104|Other|18|||
94365112|NCT02780115|323120595|FG000|Overall Study|Withdrawal by Subject|0|||
94365113|NCT02780115|323120596|FG001|Overall Study|Withdrawal by Subject|1|||
94365114|NCT02780115|323120597|FG002|Overall Study|Withdrawal by Subject|1|||
94365115|NCT02780115|323120598|FG003|Overall Study|Withdrawal by Subject|0|||
94365116|NCT02780115|323120599|FG004|Overall Study|Withdrawal by Subject|0|||
94365117|NCT02780115|323120595|FG000|Overall Study|Adverse Event|0|||
94365118|NCT02780115|323120596|FG001|Overall Study|Adverse Event|0|||
94365119|NCT02780115|323120597|FG002|Overall Study|Adverse Event|0|||
94365120|NCT02780115|323120598|FG003|Overall Study|Adverse Event|1|||
94365121|NCT02780115|323120599|FG004|Overall Study|Adverse Event|1|||
94365122|NCT00499252|323120601|FG000|Overall Study|Adverse Event|3|||
94365123|NCT00499252|323120601|FG000|Overall Study|Refused further treatment|2|||
94365124|NCT00499252|323120601|FG000|Overall Study|Ineligible|4|||
94365125|NCT00499252|323120601|FG000|Overall Study|<no further label>|3|||
94365126|NCT00457418|323120602|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
94365127|NCT00457418|323120602|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
94365128|NCT00457418|323120602|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
94365129|NCT00457418|323120602|FG000|Post PK Maintenance|Adverse Event|10|||
94365130|NCT00457418|323120602|FG000|Post PK Maintenance|Progression of Disease|6|||
94365131|NCT00457418|323120602|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
94365132|NCT00457418|323120602|FG000|Post PK Maintenance|Lost to Follow-up|1|||
94365133|NCT02628418|323120603|FG000|Overall Study|Lost to Follow-up|1|||
94365134|NCT02628418|323120604|FG001|Overall Study|Lost to Follow-up|2|||
94365135|NCT04732728|323120612|FG000|Overall Study|Death|12|||
94365136|NCT04732728|323120612|FG000|Overall Study|Withdrawn|136|||
94365137|NCT01447628|323120613|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
94365138|NCT01447628|323120614|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
94365139|NCT01447628|323120615|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
94365140|NCT01447628|323120616|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
94365141|NCT05144477|323120619|FG000|Overall Study|Withdrawal by Subject|1|||
94365142|NCT05144477|323120620|FG001|Overall Study|Withdrawal by Subject|1|||
94686734|NCT01231503|324307739|FG002|Overall Study|Adverse event, serious fatal|1|||
94686735|NCT01231503|324307740|FG003|Overall Study|Adverse event, serious fatal|1|||
94686736|NCT01231503|324307741|FG004|Overall Study|Adverse event, serious fatal|0|||
94686737|NCT01231503|324307742|FG005|Overall Study|Adverse event, serious fatal|1|||
94686738|NCT01231503|324307743|FG006|Overall Study|Adverse event, serious fatal|0|||
94686739|NCT01231503|324307744|FG007|Overall Study|Adverse event, serious fatal|0|||
94686740|NCT01231503|324307737|FG000|Overall Study|Withdrawal by Subject|6|||
94686741|NCT01231503|324307738|FG001|Overall Study|Withdrawal by Subject|3|||
94686742|NCT01231503|324307739|FG002|Overall Study|Withdrawal by Subject|3|||
94686743|NCT01231503|324307740|FG003|Overall Study|Withdrawal by Subject|1|||
94686744|NCT01231503|324307741|FG004|Overall Study|Withdrawal by Subject|3|||
94686745|NCT01231503|324307742|FG005|Overall Study|Withdrawal by Subject|5|||
94686746|NCT01231503|324307743|FG006|Overall Study|Withdrawal by Subject|1|||
94686747|NCT01231503|324307744|FG007|Overall Study|Withdrawal by Subject|2|||
94686748|NCT01231503|324307737|FG000|Overall Study|Lost to Follow-up|8|||
94686749|NCT01231503|324307738|FG001|Overall Study|Lost to Follow-up|10|||
94686750|NCT01231503|324307739|FG002|Overall Study|Lost to Follow-up|8|||
94686751|NCT01231503|324307740|FG003|Overall Study|Lost to Follow-up|5|||
94686752|NCT01231503|324307741|FG004|Overall Study|Lost to Follow-up|7|||
94686753|NCT01231503|324307742|FG005|Overall Study|Lost to Follow-up|9|||
94686754|NCT01231503|324307743|FG006|Overall Study|Lost to Follow-up|6|||
94686755|NCT01231503|324307744|FG007|Overall Study|Lost to Follow-up|6|||
94686756|NCT01231503|324307737|FG000|Overall Study|Protocol Violation|0|||
94686757|NCT01231503|324307738|FG001|Overall Study|Protocol Violation|0|||
94686758|NCT01231503|324307739|FG002|Overall Study|Protocol Violation|0|||
94686759|NCT01231503|324307740|FG003|Overall Study|Protocol Violation|1|||
94686760|NCT01231503|324307741|FG004|Overall Study|Protocol Violation|0|||
94686761|NCT01231503|324307742|FG005|Overall Study|Protocol Violation|0|||
94686762|NCT01231503|324307743|FG006|Overall Study|Protocol Violation|0|||
94686763|NCT01231503|324307744|FG007|Overall Study|Protocol Violation|0|||
94686764|NCT01586338|324307745|FG000|Overall Study|Adverse Event|3|||
94686765|NCT01586338|324307745|FG000|Overall Study|Lost to Follow-up|1|||
94686766|NCT01586338|324307745|FG000|Overall Study|Withdrawal by participant|3|||
94686767|NCT01586338|324307745|FG000|Overall Study|Other|1|||
94686768|NCT00284089|324307748|FG000|Multiple Dose Phase|Adverse Event|1|||
94686769|NCT00284089|324307749|FG001|Multiple Dose Phase|Adverse Event|0|||
94686770|NCT00284089|324307750|FG002|Multiple Dose Phase|Adverse Event|1|||
94686771|NCT00284089|324307751|FG003|Multiple Dose Phase|Adverse Event|1|||
94686772|NCT00284089|324307748|FG000|Multiple Dose Phase|Protocol Violation|0|||
94686773|NCT00284089|324307749|FG001|Multiple Dose Phase|Protocol Violation|0|||
94686774|NCT00284089|324307750|FG002|Multiple Dose Phase|Protocol Violation|1|||
94686775|NCT00284089|324307751|FG003|Multiple Dose Phase|Protocol Violation|0|||
94686776|NCT00284089|324307748|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
94686777|NCT00284089|324307749|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
94686778|NCT00284089|324307750|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
94686779|NCT00284089|324307751|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
94686780|NCT00284089|324307748|FG000|Multiple Dose Phase|Death|0|||
94686781|NCT00284089|324307749|FG001|Multiple Dose Phase|Death|0|||
94686782|NCT00284089|324307750|FG002|Multiple Dose Phase|Death|1|||
94686783|NCT00284089|324307751|FG003|Multiple Dose Phase|Death|1|||
94686784|NCT00284089|324307748|FG000|Extension Phase|Adverse Event|0|||
94686785|NCT00284089|324307749|FG001|Extension Phase|Adverse Event|0|||
94686786|NCT00284089|324307750|FG002|Extension Phase|Adverse Event|2|||
94686787|NCT00284089|324307751|FG003|Extension Phase|Adverse Event|2|||
94686788|NCT00284089|324307748|FG000|Extension Phase|condition no longer requires study drug|2|||
94686789|NCT00284089|324307749|FG001|Extension Phase|condition no longer requires study drug|0|||
94686790|NCT00284089|324307750|FG002|Extension Phase|condition no longer requires study drug|2|||
94686791|NCT00284089|324307751|FG003|Extension Phase|condition no longer requires study drug|7|||
94686792|NCT00284089|324307748|FG000|Extension Phase|Protocol Violation|0|||
94686793|NCT00284089|324307749|FG001|Extension Phase|Protocol Violation|0|||
94686794|NCT00284089|324307750|FG002|Extension Phase|Protocol Violation|1|||
94686795|NCT00284089|324307751|FG003|Extension Phase|Protocol Violation|0|||
94686796|NCT00284089|324307748|FG000|Extension Phase|Withdrawal by Subject|0|||
94365143|NCT01339000|323120621|FG000|Overall Study|study closed due to lack of drug supply|1|||
94686797|NCT00284089|324307749|FG001|Extension Phase|Withdrawal by Subject|0|||
94365144|NCT01339000|323120622|FG001|Overall Study|study closed due to lack of drug supply|0|||
94365145|NCT00728988|323120623|FG000|Overall Study|Not Treated|2|||
94365146|NCT00728988|323120624|FG001|Overall Study|Not Treated|2|||
94686798|NCT00284089|324307750|FG002|Extension Phase|Withdrawal by Subject|1|||
94686799|NCT00284089|324307751|FG003|Extension Phase|Withdrawal by Subject|3|||
94686800|NCT03051659|324307752|FG000|Treatment Period|Withdrawal by Subject|0|||
94686801|NCT03051659|324307753|FG001|Treatment Period|Withdrawal by Subject|2|||
94686802|NCT03051659|324307752|FG000|Survival Follow-up|Lost to Follow-up|23|||
94686803|NCT03051659|324307753|FG001|Survival Follow-up|Lost to Follow-up|22|||
94686804|NCT02494206|324307754|FG000|Overall Study|Adverse Event|1|||
94686805|NCT02494206|324307754|FG000|Overall Study|Disease Progression|1|||
94686806|NCT00318149|324307755|FG000|Overall Study|Adverse Event|0|||
94686807|NCT00318149|324307756|FG001|Overall Study|Adverse Event|0|||
94686808|NCT00318149|324307757|FG002|Overall Study|Adverse Event|0|||
94686809|NCT00318149|324307758|FG003|Overall Study|Adverse Event|0|||
94686810|NCT00318149|324307759|FG004|Overall Study|Adverse Event|0|||
94686811|NCT00318149|324307760|FG005|Overall Study|Adverse Event|2|||
94686812|NCT01088529|324307761|FG000|Overall Study|Did not receive study treatment|0|||
94686813|NCT01088529|324307762|FG001|Overall Study|Did not receive study treatment|1|||
94686814|NCT02778399|324307768|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
94686815|NCT02778399|324307769|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
94686816|NCT02778399|324307770|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
94686817|NCT02778399|324307771|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
94686818|NCT02778399|324307772|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
94686819|NCT02778399|324307773|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
94686820|NCT02778399|324307768|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
94686821|NCT02778399|324307769|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
94686822|NCT02778399|324307770|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
94686823|NCT02778399|324307771|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
94686824|NCT02778399|324307772|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
94686825|NCT02778399|324307773|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
94686826|NCT02778399|324307768|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
94686827|NCT02778399|324307769|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
94686828|NCT02778399|324307770|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
94686829|NCT02778399|324307771|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
94686830|NCT02778399|324307772|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
94686831|NCT02778399|324307773|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
94686832|NCT02778399|324307768|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
94686833|NCT02778399|324307769|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
94686834|NCT02778399|324307770|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
94686835|NCT02778399|324307771|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
94686836|NCT02778399|324307772|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
94686837|NCT02778399|324307773|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
94686838|NCT02778399|324307768|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
94686839|NCT02778399|324307769|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
94686840|NCT02778399|324307770|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
94686841|NCT02778399|324307771|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
94686842|NCT02778399|324307772|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
94686843|NCT02778399|324307773|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
94686844|NCT02778399|324307768|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
94686845|NCT02778399|324307769|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
94686846|NCT02778399|324307770|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
94686847|NCT02778399|324307771|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
94686848|NCT02778399|324307772|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
94686849|NCT02778399|324307773|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
94686850|NCT02778399|324307768|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
94686851|NCT02778399|324307769|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
94686852|NCT02778399|324307770|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
94686853|NCT02778399|324307771|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
94686854|NCT02778399|324307772|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
94686855|NCT02778399|324307773|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
94686856|NCT02778399|324307768|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
94686857|NCT02778399|324307769|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
94686858|NCT02778399|324307770|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
94686859|NCT02778399|324307771|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
94686860|NCT02778399|324307772|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
94686861|NCT02778399|324307773|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
94686862|NCT02778399|324307768|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
94686863|NCT02778399|324307769|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
94686864|NCT02778399|324307770|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
94686865|NCT02778399|324307771|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
94686866|NCT02778399|324307772|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
94686867|NCT02778399|324307773|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
94686868|NCT02778399|324307768|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
94686869|NCT02778399|324307769|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
94686870|NCT02778399|324307770|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
94686871|NCT02778399|324307771|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
94686872|NCT02778399|324307772|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
94686873|NCT02778399|324307773|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
94686874|NCT02778399|324307768|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
94686875|NCT02778399|324307769|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
94686876|NCT02778399|324307770|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
94686877|NCT02778399|324307771|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
94686878|NCT02778399|324307772|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
94686879|NCT02778399|324307773|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
94686880|NCT03560245|324307775|FG000|Overall Study|Withdrawal by Subject|3|||
94686881|NCT03560245|324307776|FG001|Overall Study|Withdrawal by Subject|2|||
94686882|NCT03560245|324307775|FG000|Overall Study|Adverse Event|1|||
94686883|NCT03560245|324307776|FG001|Overall Study|Adverse Event|1|||
94686884|NCT03560245|324307775|FG000|Overall Study|Protocol Violation|1|||
94686885|NCT03560245|324307776|FG001|Overall Study|Protocol Violation|0|||
94686886|NCT03560245|324307775|FG000|Overall Study|Death|0|||
94686887|NCT03560245|324307776|FG001|Overall Study|Death|1|||
94686888|NCT03560245|324307775|FG000|Overall Study|Lost to Follow-up|0|||
94686889|NCT03560245|324307776|FG001|Overall Study|Lost to Follow-up|1|||
94686890|NCT03560245|324307775|FG000|Overall Study|Physician Decision|0|||
94465517|NCT02172040|323492652|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
94465518|NCT02172040|323492649|FG000|Overall Study|Family emergency abroad|0|||
94365147|NCT00728988|323120623|FG000|Overall Study|Death|1|||
94365148|NCT00728988|323120624|FG001|Overall Study|Death|1|||
94365149|NCT00728988|323120623|FG000|Overall Study|Adverse Event|3|||
94365150|NCT00728988|323120624|FG001|Overall Study|Adverse Event|2|||
94365151|NCT00728988|323120623|FG000|Overall Study|Other|85|||
94365152|NCT00728988|323120624|FG001|Overall Study|Other|77|||
94365153|NCT00728988|323120623|FG000|Overall Study|Withdrawal by Subject|2|||
94365154|NCT00728988|323120624|FG001|Overall Study|Withdrawal by Subject|6|||
94465519|NCT02172040|323492650|FG001|Overall Study|Family emergency abroad|0|||
94465520|NCT02172040|323492651|FG002|Overall Study|Family emergency abroad|0|||
94465521|NCT02172040|323492652|FG003|Overall Study|Family emergency abroad|1|||
94465522|NCT01900431|323492653|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
94465523|NCT01900431|323492654|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
94465524|NCT01900431|323492655|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
94465525|NCT01900431|323492653|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
94686891|NCT03560245|324307776|FG001|Overall Study|Physician Decision|1|||
94686892|NCT03560245|324307775|FG000|Overall Study|Other|0|||
94686893|NCT03560245|324307776|FG001|Overall Study|Other|1|||
94686894|NCT00337662|324307783|FG000|Study Period II|Lost to Follow-up|0|||
94686895|NCT00337662|324307784|FG001|Study Period II|Lost to Follow-up|0|||
94686896|NCT00337662|324307785|FG002|Study Period II|Lost to Follow-up|0|||
94686897|NCT00337662|324307786|FG003|Study Period II|Lost to Follow-up|35|||
94686898|NCT00337662|324307783|FG000|Study Period II|Withdrawal by Subject|0|||
94686899|NCT00337662|324307784|FG001|Study Period II|Withdrawal by Subject|0|||
94686900|NCT00337662|324307785|FG002|Study Period II|Withdrawal by Subject|0|||
94686901|NCT00337662|324307786|FG003|Study Period II|Withdrawal by Subject|20|||
94686902|NCT00337662|324307783|FG000|Study Period II|Adverse Event|0|||
94686903|NCT00337662|324307784|FG001|Study Period II|Adverse Event|0|||
94686904|NCT00337662|324307785|FG002|Study Period II|Adverse Event|0|||
94686905|NCT00337662|324307786|FG003|Study Period II|Adverse Event|16|||
94686906|NCT00337662|324307783|FG000|Study Period II|Physician Decision|0|||
94686907|NCT00337662|324307784|FG001|Study Period II|Physician Decision|0|||
94686908|NCT00337662|324307785|FG002|Study Period II|Physician Decision|0|||
94686909|NCT00337662|324307786|FG003|Study Period II|Physician Decision|13|||
94686910|NCT00337662|324307783|FG000|Study Period II|Entry Criteria Not Met|0|||
94686911|NCT00337662|324307784|FG001|Study Period II|Entry Criteria Not Met|0|||
94686912|NCT00337662|324307785|FG002|Study Period II|Entry Criteria Not Met|0|||
94686913|NCT00337662|324307786|FG003|Study Period II|Entry Criteria Not Met|6|||
94686914|NCT00337662|324307783|FG000|Study Period II|Protocol Violation|0|||
94686915|NCT00337662|324307784|FG001|Study Period II|Protocol Violation|0|||
94686916|NCT00337662|324307785|FG002|Study Period II|Protocol Violation|0|||
94686917|NCT00337662|324307786|FG003|Study Period II|Protocol Violation|6|||
94686918|NCT00337662|324307783|FG000|Study Period II|Lack of Efficacy|0|||
94686919|NCT00337662|324307784|FG001|Study Period II|Lack of Efficacy|0|||
94365155|NCT01984229|323120627|FG000|Safety Follow-up Period|Adverse Event|1|||
94365156|NCT01984229|323120628|FG001|Safety Follow-up Period|Adverse Event|1|||
94686920|NCT00337662|324307785|FG002|Study Period II|Lack of Efficacy|0|||
94686921|NCT00337662|324307786|FG003|Study Period II|Lack of Efficacy|7|||
94686922|NCT00337662|324307783|FG000|Study Period II|Sponsor Decision|0|||
94686923|NCT00337662|324307784|FG001|Study Period II|Sponsor Decision|0|||
94686924|NCT00337662|324307785|FG002|Study Period II|Sponsor Decision|0|||
94686925|NCT00337662|324307786|FG003|Study Period II|Sponsor Decision|2|||
94365157|NCT01984229|323120627|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
94365158|NCT01984229|323120628|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
94686926|NCT00337662|324307783|FG000|Study Period II|Parent/Caregiver Decision|0|||
94686927|NCT00337662|324307784|FG001|Study Period II|Parent/Caregiver Decision|0|||
94686928|NCT00337662|324307785|FG002|Study Period II|Parent/Caregiver Decision|0|||
94365159|NCT05674721|323120629|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
94686929|NCT00337662|324307786|FG003|Study Period II|Parent/Caregiver Decision|1|||
94686930|NCT00337662|324307783|FG000|Study Period III|Lost to Follow-up|14|||
94686931|NCT00337662|324307784|FG001|Study Period III|Lost to Follow-up|16|||
94686932|NCT00337662|324307785|FG002|Study Period III|Lost to Follow-up|14|||
94686933|NCT00337662|324307786|FG003|Study Period III|Lost to Follow-up|0|||
94686934|NCT00337662|324307783|FG000|Study Period III|Withdrawal by Subject|18|||
94686935|NCT00337662|324307784|FG001|Study Period III|Withdrawal by Subject|14|||
94686936|NCT00337662|324307785|FG002|Study Period III|Withdrawal by Subject|12|||
94686937|NCT00337662|324307786|FG003|Study Period III|Withdrawal by Subject|0|||
94686938|NCT00337662|324307783|FG000|Study Period III|Adverse Event|9|||
94686939|NCT00337662|324307784|FG001|Study Period III|Adverse Event|10|||
94686940|NCT00337662|324307785|FG002|Study Period III|Adverse Event|8|||
94686941|NCT00337662|324307786|FG003|Study Period III|Adverse Event|0|||
94686942|NCT00337662|324307783|FG000|Study Period III|Protocol Violation|3|||
94686943|NCT00337662|324307784|FG001|Study Period III|Protocol Violation|8|||
94686944|NCT00337662|324307785|FG002|Study Period III|Protocol Violation|2|||
94686945|NCT00337662|324307786|FG003|Study Period III|Protocol Violation|0|||
94686946|NCT00337662|324307783|FG000|Study Period III|Physician Decision|6|||
94686947|NCT00337662|324307784|FG001|Study Period III|Physician Decision|5|||
94686948|NCT00337662|324307785|FG002|Study Period III|Physician Decision|0|||
94686949|NCT00337662|324307786|FG003|Study Period III|Physician Decision|0|||
94686950|NCT00337662|324307783|FG000|Study Period III|Entry Criteria Not Met|4|||
94686951|NCT00337662|324307784|FG001|Study Period III|Entry Criteria Not Met|1|||
94686952|NCT00337662|324307785|FG002|Study Period III|Entry Criteria Not Met|3|||
94686953|NCT00337662|324307786|FG003|Study Period III|Entry Criteria Not Met|0|||
94686954|NCT00337662|324307783|FG000|Study Period III|Lack of Efficacy|4|||
94686955|NCT00337662|324307784|FG001|Study Period III|Lack of Efficacy|4|||
94686956|NCT00337662|324307785|FG002|Study Period III|Lack of Efficacy|2|||
94686957|NCT00337662|324307786|FG003|Study Period III|Lack of Efficacy|0|||
94686958|NCT00337662|324307783|FG000|Study Period III|Parent/Caregiver Decision|0|||
94686959|NCT00337662|324307784|FG001|Study Period III|Parent/Caregiver Decision|0|||
94686960|NCT00337662|324307785|FG002|Study Period III|Parent/Caregiver Decision|2|||
94686961|NCT00337662|324307786|FG003|Study Period III|Parent/Caregiver Decision|0|||
94686962|NCT00337662|324307783|FG000|Study Period III|Sponsor Decision|1|||
94686963|NCT00337662|324307784|FG001|Study Period III|Sponsor Decision|0|||
94686964|NCT00337662|324307785|FG002|Study Period III|Sponsor Decision|1|||
94686965|NCT00337662|324307786|FG003|Study Period III|Sponsor Decision|0|||
94686966|NCT00337662|324307783|FG000|Study Period III|Clinical Relapse|1|||
94686967|NCT00337662|324307784|FG001|Study Period III|Clinical Relapse|0|||
94686968|NCT00337662|324307785|FG002|Study Period III|Clinical Relapse|0|||
94686969|NCT00337662|324307786|FG003|Study Period III|Clinical Relapse|0|||
94686970|NCT00882921|324307788|FG000|Overall Study|Death|2|||
94686971|NCT00882921|324307788|FG000|Overall Study|Other|3|||
94686972|NCT00882921|324307788|FG000|Overall Study|Lost to Follow-up|2|||
94686973|NCT00882921|324307788|FG000|Overall Study|Termination By Investigator|3|||
94686974|NCT00882921|324307788|FG000|Overall Study|Withdrawal Of Consent|1|||
94686975|NCT01263106|324307789|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
94686976|NCT01263106|324307790|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
94686977|NCT02058290|324307798|FG000|Overall Study|Protocol Violation|2|||
94686978|NCT02058290|324307799|FG001|Overall Study|Protocol Violation|1|||
94686979|NCT02058290|324307798|FG000|Overall Study|Physician Decision|1|||
94686980|NCT02058290|324307799|FG001|Overall Study|Physician Decision|0|||
94686981|NCT02058290|324307798|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
94686982|NCT02058290|324307799|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
94686983|NCT02058290|324307798|FG000|Overall Study|Withdrawal by Subject|0|||
94686984|NCT02058290|324307799|FG001|Overall Study|Withdrawal by Subject|1|||
94686985|NCT03012061|324307808|FG000|Overall Study|Withdrawal by Subject|1|||
94686986|NCT03012061|324307809|FG001|Overall Study|Withdrawal by Subject|5|||
94686987|NCT03012061|324307810|FG002|Overall Study|Withdrawal by Subject|4|||
94686988|NCT03012061|324307808|FG000|Overall Study|Investigator Site Closed|1|||
94686989|NCT03012061|324307809|FG001|Overall Study|Investigator Site Closed|2|||
94686990|NCT03012061|324307810|FG002|Overall Study|Investigator Site Closed|0|||
94686991|NCT03012061|324307808|FG000|Overall Study|Lost to Follow-up|2|||
94686992|NCT03012061|324307809|FG001|Overall Study|Lost to Follow-up|1|||
94686993|NCT03012061|324307810|FG002|Overall Study|Lost to Follow-up|0|||
94686994|NCT03012061|324307808|FG000|Overall Study|Study closed/ Terminated|0|||
94686995|NCT03012061|324307809|FG001|Overall Study|Study closed/ Terminated|0|||
94686996|NCT03012061|324307810|FG002|Overall Study|Study closed/ Terminated|1|||
94686997|NCT03012061|324307808|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
94686998|NCT03012061|324307809|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
94686999|NCT03012061|324307810|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
94687000|NCT03012061|324307808|FG000|Overall Study|Protocol Violation|0|||
94687001|NCT03012061|324307809|FG001|Overall Study|Protocol Violation|0|||
94687002|NCT03012061|324307810|FG002|Overall Study|Protocol Violation|2|||
94687003|NCT03012061|324307808|FG000|Overall Study|Lack of Efficacy|0|||
94687004|NCT03012061|324307809|FG001|Overall Study|Lack of Efficacy|1|||
94687005|NCT03012061|324307810|FG002|Overall Study|Lack of Efficacy|0|||
94687006|NCT03012061|324307808|FG000|Overall Study|Adverse Event|2|||
94687007|NCT03012061|324307809|FG001|Overall Study|Adverse Event|0|||
94365160|NCT05674721|323120630|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
94365161|NCT05674721|323120629|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
94365162|NCT05674721|323120630|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
94365163|NCT03891875|323120631|FG000|Overall Study|Withdrawal by Subject|20|||
94365164|NCT03891875|323120632|FG001|Overall Study|Withdrawal by Subject|3|||
94365165|NCT03891875|323120631|FG000|Overall Study|Adverse Event|10|||
94687008|NCT03012061|324307810|FG002|Overall Study|Adverse Event|0|||
94687009|NCT02696902|324307811|FG000|Overall Study|Lost to Follow-up|0|||
94687010|NCT02696902|324307812|FG001|Overall Study|Lost to Follow-up|1|||
94687011|NCT02696902|324307813|FG002|Overall Study|Lost to Follow-up|1|||
94687012|NCT02696902|324307811|FG000|Overall Study|Withdrawal by Subject|0|||
94687013|NCT02696902|324307812|FG001|Overall Study|Withdrawal by Subject|0|||
94687014|NCT02696902|324307813|FG002|Overall Study|Withdrawal by Subject|1|||
94687015|NCT02696902|324307811|FG000|Overall Study|Death|19|||
94687016|NCT02696902|324307812|FG001|Overall Study|Death|3|||
94687017|NCT02696902|324307813|FG002|Overall Study|Death|24|||
94687018|NCT02696902|324307811|FG000|Overall Study|Participant not fit post-randomization|0|||
94687019|NCT02696902|324307812|FG001|Overall Study|Participant not fit post-randomization|0|||
94687020|NCT02696902|324307813|FG002|Overall Study|Participant not fit post-randomization|1|||
94687021|NCT02696902|324307811|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
94687022|NCT02696902|324307812|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
94687023|NCT02696902|324307813|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
94687024|NCT02696902|324307811|FG000|Overall Study|Principal investigator's decision|1|||
94687025|NCT02696902|324307812|FG001|Overall Study|Principal investigator's decision|0|||
94687026|NCT02696902|324307813|FG002|Overall Study|Principal investigator's decision|0|||
94687027|NCT02696902|324307811|FG000|Overall Study|Sponsor's decision|1|||
94687028|NCT02696902|324307812|FG001|Overall Study|Sponsor's decision|0|||
94687029|NCT02696902|324307813|FG002|Overall Study|Sponsor's decision|0|||
94687030|NCT02696902|324307811|FG000|Overall Study|Transferred to other hospital|1|||
94687031|NCT02696902|324307812|FG001|Overall Study|Transferred to other hospital|0|||
94687032|NCT02696902|324307813|FG002|Overall Study|Transferred to other hospital|0|||
94687033|NCT02401308|324307820|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
94687034|NCT02401308|324307821|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
94687035|NCT04318093|324307822|FG000|Overall Study|Adverse Event|2|||
94687036|NCT04318093|324307823|FG001|Overall Study|Adverse Event|2|||
94687037|NCT04318093|324307822|FG000|Overall Study|Participant withdrew consent|1|||
94687038|NCT04318093|324307823|FG001|Overall Study|Participant withdrew consent|0|||
94687039|NCT04318093|324307822|FG000|Overall Study|Other reasons|0|||
94687040|NCT04318093|324307823|FG001|Overall Study|Other reasons|1|||
94687041|NCT01233609|324307824|FG000|Overall Study|Death|1|||
94687042|NCT01233609|324307825|FG001|Overall Study|Death|0|||
94687043|NCT01233609|324307824|FG000|Overall Study|Lost to Follow-up|3|||
94687044|NCT01233609|324307825|FG001|Overall Study|Lost to Follow-up|1|||
94687045|NCT01233609|324307824|FG000|Overall Study|Adverse Event|2|||
94365166|NCT03891875|323120632|FG001|Overall Study|Adverse Event|4|||
94365167|NCT03891875|323120631|FG000|Overall Study|Physician Decision|1|||
94365168|NCT03891875|323120632|FG001|Overall Study|Physician Decision|1|||
94687046|NCT01233609|324307825|FG001|Overall Study|Adverse Event|1|||
94687047|NCT01233609|324307824|FG000|Overall Study|Withdrawal by Subject|3|||
94687048|NCT01233609|324307825|FG001|Overall Study|Withdrawal by Subject|0|||
94687049|NCT02294474|324307826|FG000|Overall Study|Adverse Event|7|||
94687050|NCT02294474|324307827|FG001|Overall Study|Adverse Event|7|||
94687051|NCT02294474|324307826|FG000|Overall Study|Lack of Efficacy|2|||
94365169|NCT03891875|323120631|FG000|Overall Study|Protocol Violation|1|||
94365170|NCT03891875|323120632|FG001|Overall Study|Protocol Violation|0|||
94687052|NCT02294474|324307827|FG001|Overall Study|Lack of Efficacy|1|||
94687053|NCT02294474|324307826|FG000|Overall Study|Protocol Violation|4|||
94687054|NCT02294474|324307827|FG001|Overall Study|Protocol Violation|2|||
94687055|NCT02294474|324307826|FG000|Overall Study|Other than specified above|12|||
94687056|NCT02294474|324307827|FG001|Overall Study|Other than specified above|12|||
94465526|NCT01900431|323492654|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
94465527|NCT01900431|323492655|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
94465528|NCT01900431|323492653|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
94465529|NCT01900431|323492654|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
94465530|NCT01900431|323492655|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
94465531|NCT01900431|323492653|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
94465532|NCT01900431|323492654|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
94465533|NCT01900431|323492655|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
94465534|NCT01900431|323492653|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
94465535|NCT01900431|323492654|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
94465536|NCT01900431|323492655|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
94465537|NCT01900431|323492653|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
94465538|NCT01900431|323492654|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
94465539|NCT01900431|323492655|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
94465540|NCT01900431|323492653|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
94465541|NCT01900431|323492654|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
94465542|NCT01900431|323492655|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
94465543|NCT01900431|323492653|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
94465544|NCT01900431|323492654|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
94465545|NCT01900431|323492655|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
94465546|NCT01900431|323492653|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
94465547|NCT01900431|323492654|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
94465548|NCT01900431|323492655|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
94465549|NCT04226495|323492656|FG000|Overall Study|Withdrawal by Subject|3|||
94465550|NCT04226495|323492657|FG001|Overall Study|Withdrawal by Subject|3|||
94465551|NCT04226495|323492656|FG000|Overall Study|PI discretion|3|||
94465552|NCT04226495|323492657|FG001|Overall Study|PI discretion|4|||
94465553|NCT01876979|323492661|FG000|Overall Study|Physician Decision|2|||
94465554|NCT01876979|323492662|FG001|Overall Study|Physician Decision|3|||
94465555|NCT04438499|323492663|FG000|Overall Study|Lack of Efficacy|3|||
94465556|NCT02093390|323492664|FG000|Overall Study|Withdrawal by Subject|0|||
94465557|NCT02093390|323492665|FG001|Overall Study|Withdrawal by Subject|1|||
94465558|NCT02560623|323494856|FG000|Overall Study|Unable to swallow sponge|0|||
94465559|NCT02560623|323494857|FG001|Overall Study|Unable to swallow sponge|1|||
94465560|NCT02560623|323494858|FG002|Overall Study|Unable to swallow sponge|0|||
94465561|NCT02560623|323494859|FG003|Overall Study|Unable to swallow sponge|0|||
94465562|NCT02560623|323494856|FG000|Overall Study|Intervention prior to sponge administration|0|||
94465563|NCT02560623|323494857|FG001|Overall Study|Intervention prior to sponge administration|1|||
94465564|NCT02560623|323494858|FG002|Overall Study|Intervention prior to sponge administration|0|||
94465565|NCT02560623|323494859|FG003|Overall Study|Intervention prior to sponge administration|0|||
94465566|NCT01125813|323494860|FG000|Overall Study|Death|1|||
94465567|NCT01125813|323494860|FG000|Overall Study|Withdrawal by Subject|1|||
94465568|NCT01125813|323494860|FG000|Overall Study|Screen Failures|4|||
94465569|NCT02539134|323494861|FG000|Overall Study|Lost to Follow-up|1|||
94465570|NCT02539134|323494862|FG001|Overall Study|Lost to Follow-up|0|||
94465571|NCT02539134|323494863|FG002|Overall Study|Lost to Follow-up|0|||
94465572|NCT02539134|323494864|FG003|Overall Study|Lost to Follow-up|0|||
94465573|NCT02539134|323494865|FG004|Overall Study|Lost to Follow-up|0|||
94465574|NCT02539134|323494866|FG005|Overall Study|Lost to Follow-up|0|||
94465575|NCT01069419|323494869|FG000|Overall Study|Adverse Event|233|||
94465576|NCT01069419|323494869|FG000|Overall Study|Lack of Efficacy|332|||
94465577|NCT01069419|323494869|FG000|Overall Study|Lost to Follow-up|49|||
94465578|NCT01069419|323494869|FG000|Overall Study|Remission of disease|11|||
94465579|NCT01069419|323494869|FG000|Overall Study|Withdrawal by Subject|34|||
94465580|NCT01069419|323494869|FG000|Overall Study|Other Reason|43|||
94465581|NCT01069419|323494869|FG000|Overall Study|Missing termination information|13|||
94465582|NCT02382796|323494870|FG000|Overall Study|Global deterioration of health status|1|||
94465583|NCT02382796|323494870|FG000|Overall Study|Objective progression or relapse|3|||
94465584|NCT02382796|323494870|FG000|Overall Study|Commercial dacomitinib became available|3|||
94465585|NCT04007107|323494871|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
94465586|NCT04007107|323494872|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
94465587|NCT04007107|323494873|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
94465588|NCT04007107|323494874|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
94465589|NCT04679051|323494875|FG000|Overall Study|felt tired after restricted time in bed|3|||
94465590|NCT04679051|323494876|FG001|Overall Study|felt tired after restricted time in bed|0|||
94465591|NCT04679051|323494875|FG000|Overall Study|discomfort with blood pressure cuff|2|||
94465592|NCT04679051|323494876|FG001|Overall Study|discomfort with blood pressure cuff|0|||
94465593|NCT04679051|323494875|FG000|Overall Study|scheduling conflict|1|||
94465594|NCT04679051|323494876|FG001|Overall Study|scheduling conflict|1|||
94465595|NCT04679051|323494875|FG000|Overall Study|Protocol Violation|0|||
94465596|NCT04679051|323494876|FG001|Overall Study|Protocol Violation|4|||
94687057|NCT01567865|324307830|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
94687058|NCT01567865|324307831|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
94687059|NCT01567865|324307832|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
94687060|NCT01567865|324307833|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
94687061|NCT01567865|324307830|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
94687062|NCT01567865|324307831|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
94687063|NCT01567865|324307832|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
94687064|NCT01567865|324307833|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
94687065|NCT00663117|324309537|FG000|Overall Study|Lack of Efficacy|1|||
94687066|NCT00663117|324309538|FG001|Overall Study|Lack of Efficacy|0|||
94687067|NCT00311155|324309539|FG000|Overall Study|Adverse Event|21|||
94687068|NCT00311155|324309539|FG000|Overall Study|Withdrawal by Subject|17|||
94687069|NCT00311155|324309539|FG000|Overall Study|Did not meet entry criteria|55|||
94687070|NCT03017235|324309540|FG000|Overall Study|Withdrawal by Subject|4|||
94687071|NCT03017235|324309541|FG001|Overall Study|Withdrawal by Subject|3|||
94687072|NCT03017235|324309540|FG000|Overall Study|Lost to Follow-up|2|||
94687073|NCT03017235|324309541|FG001|Overall Study|Lost to Follow-up|7|||
94687074|NCT03017235|324309540|FG000|Overall Study|Adverse Event|0|||
94687075|NCT03017235|324309541|FG001|Overall Study|Adverse Event|1|||
94687076|NCT03017235|324309540|FG000|Overall Study|Protocol Violation|2|||
94687077|NCT03017235|324309541|FG001|Overall Study|Protocol Violation|1|||
94687078|NCT03017235|324309540|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
94687079|NCT03017235|324309541|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
94687080|NCT02764775|324309542|FG000|Overall Study|Death|1|||
94687081|NCT02764775|324309542|FG000|Overall Study|Lost to Follow-up|2|||
94687082|NCT02764775|324309542|FG000|Overall Study|Withdrawal by Subject|3|||
94687083|NCT00437125|324309554|FG000|Overall Study|Adverse Event|12|||
94687084|NCT00437125|324309554|FG000|Overall Study|Death|1|||
94687085|NCT00437125|324309554|FG000|Overall Study|Clinical Relapse|1|||
94687086|NCT00437125|324309554|FG000|Overall Study|Lack of Efficacy|1|||
94687087|NCT00437125|324309554|FG000|Overall Study|Lost to Follow-up|1|||
94687088|NCT00437125|324309554|FG000|Overall Study|Withdrawal by Subject|13|||
94687089|NCT00437125|324309554|FG000|Overall Study|Withdrawal by Caregiver|2|||
94687090|NCT00437125|324309554|FG000|Overall Study|Physician Decision|1|||
94687091|NCT02248961|324309557|FG000|Overall Study|Adverse Event|1|||
94687092|NCT02248961|324309558|FG001|Overall Study|Adverse Event|0|||
94687093|NCT02248961|324309557|FG000|Overall Study|Withdrawal by Subject|1|||
94687094|NCT02248961|324309558|FG001|Overall Study|Withdrawal by Subject|2|||
94687095|NCT02248961|324309557|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
94687096|NCT02248961|324309558|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
94687097|NCT03029247|324309568|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
94687098|NCT03029247|324309569|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
94687099|NCT03029247|324309568|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
94687100|NCT03029247|324309569|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
94687101|NCT03029247|324309568|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
94687102|NCT03029247|324309569|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
94687103|NCT03029247|324309568|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
94687104|NCT03029247|324309569|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
94687105|NCT02593305|324309572|FG000|Post 1|Comparison only group. No intervention.|0|||
94687106|NCT02593305|324309573|FG001|Post 1|Comparison only group. No intervention.|0|||
94687107|NCT02593305|324309574|FG002|Post 1|Comparison only group. No intervention.|10|||
94687108|NCT00068380|324309576|FG000|Overall Study|Withdrawal by Subject|3|||
94687109|NCT00068380|324309576|FG000|Overall Study|Adverse Event|2|||
94687110|NCT02757521|324309577|FG000|Overall Study|Adverse Event|1|||
94687111|NCT02757521|324309578|FG001|Overall Study|Adverse Event|0|||
94687112|NCT03239873|324309579|FG000|Overall Study|Lost to Follow-up|15|||
94687113|NCT03239873|324309580|FG001|Overall Study|Lost to Follow-up|16|||
94687114|NCT03239873|324309579|FG000|Overall Study|Physician Decision|1|||
94687115|NCT03239873|324309580|FG001|Overall Study|Physician Decision|0|||
94687116|NCT03239873|324309579|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
94687117|NCT03239873|324309580|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
94687118|NCT03239873|324309579|FG000|Overall Study|Withdrawal by Subject|2|||
94687119|NCT03239873|324309580|FG001|Overall Study|Withdrawal by Subject|0|||
94687120|NCT03239873|324309579|FG000|Overall Study|Contraindication to study medication|1|||
94687121|NCT03239873|324309580|FG001|Overall Study|Contraindication to study medication|0|||
94687122|NCT03239873|324309579|FG000|Overall Study|Protocol Violation|1|||
94687123|NCT03239873|324309580|FG001|Overall Study|Protocol Violation|0|||
94687124|NCT01317875|324309581|FG000|Overall Study|Other|0|||
94687125|NCT01317875|324309582|FG001|Overall Study|Other|0|||
94687126|NCT01317875|324309583|FG002|Overall Study|Other|1|||
94687127|NCT01317875|324309584|FG003|Overall Study|Other|0|||
94687128|NCT01317875|324309585|FG004|Overall Study|Other|0|||
94687129|NCT01317875|324309586|FG005|Overall Study|Other|0|||
94687130|NCT01317875|324309587|FG006|Overall Study|Other|0|||
94687131|NCT01317875|324309588|FG007|Overall Study|Other|0|||
94465597|NCT02332239|323494877|FG000|Overall Study|Lost to Follow-up|4|||
94687132|NCT01317875|324309589|FG008|Overall Study|Other|0|||
94687133|NCT01317875|324309590|FG009|Overall Study|Other|0|||
94687134|NCT01317875|324309581|FG000|Overall Study|Noncompliance with study drug|0|||
94687135|NCT01317875|324309582|FG001|Overall Study|Noncompliance with study drug|0|||
94687136|NCT01317875|324309583|FG002|Overall Study|Noncompliance with study drug|1|||
94687137|NCT01317875|324309584|FG003|Overall Study|Noncompliance with study drug|0|||
94687138|NCT01317875|324309585|FG004|Overall Study|Noncompliance with study drug|0|||
94687139|NCT01317875|324309586|FG005|Overall Study|Noncompliance with study drug|0|||
94687140|NCT01317875|324309587|FG006|Overall Study|Noncompliance with study drug|0|||
94687141|NCT01317875|324309588|FG007|Overall Study|Noncompliance with study drug|0|||
94687142|NCT01317875|324309589|FG008|Overall Study|Noncompliance with study drug|0|||
94687143|NCT01317875|324309590|FG009|Overall Study|Noncompliance with study drug|0|||
94365171|NCT03891875|323120631|FG000|Overall Study|Lost to Follow-up|1|||
94365172|NCT03891875|323120632|FG001|Overall Study|Lost to Follow-up|0|||
94365173|NCT03891875|323120631|FG000|Overall Study|COVID-19 infection|1|||
94365174|NCT03891875|323120632|FG001|Overall Study|COVID-19 infection|0|||
94365175|NCT00664066|323120637|FG000|Overall Study|Study terminated|3|||
94365176|NCT03332212|323120638|FG000|Overall Study|Not treated|0|||
94365177|NCT03332212|323120639|FG001|Overall Study|Not treated|1|||
94365178|NCT03332212|323120640|FG002|Overall Study|Not treated|0|||
94365179|NCT03332212|323120641|FG003|Overall Study|Not treated|0|||
94365180|NCT03332212|323120638|FG000|Overall Study|Adverse Event|0|||
94365181|NCT03332212|323120639|FG001|Overall Study|Adverse Event|0|||
94365182|NCT03332212|323120640|FG002|Overall Study|Adverse Event|0|||
94365183|NCT03332212|323120641|FG003|Overall Study|Adverse Event|1|||
94365184|NCT03332212|323120638|FG000|Overall Study|worsening of disease under study|1|||
94365185|NCT03332212|323120639|FG001|Overall Study|worsening of disease under study|1|||
94365186|NCT03332212|323120640|FG002|Overall Study|worsening of disease under study|0|||
94365187|NCT03332212|323120641|FG003|Overall Study|worsening of disease under study|0|||
94365188|NCT01591499|323120642|FG000|Baseline Visit|Withdrawal by Subject|0|||
94365189|NCT01591499|323120643|FG001|Baseline Visit|Withdrawal by Subject|2|||
94365190|NCT01591499|323120644|FG002|Baseline Visit|Withdrawal by Subject|0|||
94365191|NCT01591499|323120645|FG003|Baseline Visit|Withdrawal by Subject|2|||
94365192|NCT01591499|323120642|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
94365193|NCT01591499|323120643|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
94365194|NCT01591499|323120644|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
94365195|NCT01591499|323120645|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
94365196|NCT01591499|323120642|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
94365197|NCT01591499|323120643|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
94365198|NCT01591499|323120644|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
94365199|NCT01591499|323120645|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
94365200|NCT00646282|323120646|FG000|Overall Study|Protocol terminated|4|||
94365201|NCT00646282|323120647|FG001|Overall Study|Protocol terminated|4|||
94365202|NCT00960687|323120648|FG000|Washout Period of 7 Days|Adverse Event|3|||
94365203|NCT00960687|323120649|FG001|Washout Period of 7 Days|Adverse Event|2|||
94365204|NCT00960687|323120648|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
94365205|NCT00960687|323120649|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
94365206|NCT05789420|323120657|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
94365207|NCT05789420|323120657|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
94365208|NCT05899218|323120658|FG000|Overall Study|Lost to Follow-up|2|||
94365209|NCT05899218|323120659|FG001|Overall Study|Lost to Follow-up|2|||
94365210|NCT05899218|323120658|FG000|Overall Study|deemed ineligible out of country|1|||
94365211|NCT05899218|323120659|FG001|Overall Study|deemed ineligible out of country|0|||
94365212|NCT01500434|323120664|FG000|Overall Study|Death|1|||
94365213|NCT01500434|323120664|FG000|Overall Study|Withdrawal by Subject|1|||
94365214|NCT01500434|323120664|FG000|Overall Study|Missed 12-month follow-up|5|||
94365215|NCT03690206|323120666|FG000|Overall Study|Withdrawal by Subject|2|||
94365216|NCT03690206|323120667|FG001|Overall Study|Withdrawal by Subject|0|||
94365217|NCT03690206|323120668|FG002|Overall Study|Withdrawal by Subject|0|||
94365218|NCT03690206|323120666|FG000|Overall Study|ICF withdrawal|2|||
94365219|NCT03690206|323120667|FG001|Overall Study|ICF withdrawal|0|||
94365220|NCT03690206|323120668|FG002|Overall Study|ICF withdrawal|0|||
94365221|NCT01721200|323122310|FG000|Overall Study|Lost to Follow-up|3|||
94365222|NCT01721200|323122311|FG001|Overall Study|Lost to Follow-up|5|||
94365223|NCT00891527|323122312|FG000|Overall Study|Withdrawal by Subject|2|||
94365224|NCT03993288|323122315|FG000|Overall Study|Lost to Follow-up|2|||
94365225|NCT03993288|323122316|FG001|Overall Study|Lost to Follow-up|1|||
94365226|NCT03993288|323122315|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
94365227|NCT03993288|323122316|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
94365228|NCT03993288|323122315|FG000|Overall Study|wrong randomization|0|||
94365229|NCT03993288|323122316|FG001|Overall Study|wrong randomization|1|||
94365230|NCT03993288|323122315|FG000|Overall Study|improper enrollment|0|||
94365231|NCT03993288|323122316|FG001|Overall Study|improper enrollment|1|||
94687144|NCT01317875|324309581|FG000|Overall Study|Progressive Disease|1|||
94687145|NCT01317875|324309582|FG001|Overall Study|Progressive Disease|0|||
94687146|NCT01317875|324309583|FG002|Overall Study|Progressive Disease|2|||
94687147|NCT01317875|324309584|FG003|Overall Study|Progressive Disease|0|||
94687148|NCT01317875|324309585|FG004|Overall Study|Progressive Disease|1|||
94687149|NCT01317875|324309586|FG005|Overall Study|Progressive Disease|0|||
94687150|NCT01317875|324309587|FG006|Overall Study|Progressive Disease|0|||
94687151|NCT01317875|324309588|FG007|Overall Study|Progressive Disease|1|||
94687152|NCT01317875|324309589|FG008|Overall Study|Progressive Disease|0|||
94687153|NCT01317875|324309590|FG009|Overall Study|Progressive Disease|0|||
94687154|NCT01317875|324309581|FG000|Overall Study|Withdrawal by Subject|0|||
94687155|NCT01317875|324309582|FG001|Overall Study|Withdrawal by Subject|0|||
94687156|NCT01317875|324309583|FG002|Overall Study|Withdrawal by Subject|0|||
94687157|NCT01317875|324309584|FG003|Overall Study|Withdrawal by Subject|0|||
94687158|NCT01317875|324309585|FG004|Overall Study|Withdrawal by Subject|1|||
94687159|NCT01317875|324309586|FG005|Overall Study|Withdrawal by Subject|0|||
94687160|NCT01317875|324309587|FG006|Overall Study|Withdrawal by Subject|0|||
94687161|NCT01317875|324309588|FG007|Overall Study|Withdrawal by Subject|3|||
94687162|NCT01317875|324309589|FG008|Overall Study|Withdrawal by Subject|0|||
94687163|NCT01317875|324309590|FG009|Overall Study|Withdrawal by Subject|0|||
94687164|NCT01317875|324309581|FG000|Overall Study|Physician Decision|0|||
94687165|NCT01317875|324309582|FG001|Overall Study|Physician Decision|1|||
94687166|NCT01317875|324309583|FG002|Overall Study|Physician Decision|1|||
94687167|NCT01317875|324309584|FG003|Overall Study|Physician Decision|0|||
94687168|NCT01317875|324309585|FG004|Overall Study|Physician Decision|2|||
94687169|NCT01317875|324309586|FG005|Overall Study|Physician Decision|0|||
94687170|NCT01317875|324309587|FG006|Overall Study|Physician Decision|0|||
94687171|NCT01317875|324309588|FG007|Overall Study|Physician Decision|2|||
94687172|NCT01317875|324309589|FG008|Overall Study|Physician Decision|0|||
94687173|NCT01317875|324309590|FG009|Overall Study|Physician Decision|0|||
94687174|NCT01317875|324309581|FG000|Overall Study|Death|0|||
94687175|NCT01317875|324309582|FG001|Overall Study|Death|0|||
94687176|NCT01317875|324309583|FG002|Overall Study|Death|2|||
94687177|NCT01317875|324309584|FG003|Overall Study|Death|1|||
94687178|NCT01317875|324309585|FG004|Overall Study|Death|0|||
94687179|NCT01317875|324309586|FG005|Overall Study|Death|1|||
94687180|NCT01317875|324309587|FG006|Overall Study|Death|0|||
94687181|NCT01317875|324309588|FG007|Overall Study|Death|4|||
94687182|NCT01317875|324309589|FG008|Overall Study|Death|0|||
94687183|NCT01317875|324309590|FG009|Overall Study|Death|0|||
94687184|NCT01317875|324309581|FG000|Overall Study|Adverse Event|2|||
94687185|NCT01317875|324309582|FG001|Overall Study|Adverse Event|1|||
94687186|NCT01317875|324309583|FG002|Overall Study|Adverse Event|2|||
94687187|NCT01317875|324309584|FG003|Overall Study|Adverse Event|1|||
94687188|NCT01317875|324309585|FG004|Overall Study|Adverse Event|5|||
94687189|NCT01317875|324309586|FG005|Overall Study|Adverse Event|1|||
94687190|NCT01317875|324309587|FG006|Overall Study|Adverse Event|2|||
94687191|NCT01317875|324309588|FG007|Overall Study|Adverse Event|5|||
94687192|NCT01317875|324309589|FG008|Overall Study|Adverse Event|0|||
94687193|NCT01317875|324309590|FG009|Overall Study|Adverse Event|0|||
94687194|NCT01868035|324309593|FG000|Overall Study|Lost to Follow-up|3|||
94687195|NCT01868035|324309593|FG000|Overall Study|Withdrawal by Subject|1|||
94687196|NCT01868035|324309593|FG000|Overall Study|Progressive Disease|2|||
94687197|NCT01868035|324309593|FG000|Overall Study|Non-compliance|1|||
94687198|NCT02318719|324309594|FG000|Double-blind Phase|Adverse Event|7|||
94687199|NCT02318719|324309595|FG001|Double-blind Phase|Adverse Event|6|||
94687200|NCT02318719|324309596|FG002|Double-blind Phase|Adverse Event|12|||
94687201|NCT02318719|324309597|FG003|Double-blind Phase|Adverse Event|4|||
94365232|NCT03993288|323122315|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
94365233|NCT03993288|323122316|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
94365234|NCT03993288|323122315|FG000|Overall Study|developed SAE|2|||
94365235|NCT03993288|323122316|FG001|Overall Study|developed SAE|0|||
94365236|NCT03993288|323122315|FG000|Overall Study|consent withdrawal|1|||
94365237|NCT03993288|323122316|FG001|Overall Study|consent withdrawal|0|||
94365238|NCT03993288|323122315|FG000|Overall Study|did not follow the treatment schedule|1|||
94365239|NCT03993288|323122316|FG001|Overall Study|did not follow the treatment schedule|0|||
94365240|NCT03993288|323122315|FG000|Overall Study|did not follow the treatment regimen|1|||
94365241|NCT03993288|323122316|FG001|Overall Study|did not follow the treatment regimen|0|||
94687202|NCT02318719|324309598|FG004|Double-blind Phase|Adverse Event|0|||
94687203|NCT02318719|324309594|FG000|Double-blind Phase|Lack of Efficacy|5|||
94365242|NCT03993288|323122315|FG000|Overall Study|Adverse Event|1|||
94365243|NCT03993288|323122316|FG001|Overall Study|Adverse Event|0|||
94365244|NCT03993288|323122315|FG000|Overall Study|Withdrawal by Subject|1|||
94687204|NCT02318719|324309595|FG001|Double-blind Phase|Lack of Efficacy|0|||
94687205|NCT02318719|324309596|FG002|Double-blind Phase|Lack of Efficacy|1|||
94687206|NCT02318719|324309597|FG003|Double-blind Phase|Lack of Efficacy|1|||
94687207|NCT02318719|324309598|FG004|Double-blind Phase|Lack of Efficacy|0|||
94687208|NCT02318719|324309594|FG000|Double-blind Phase|Protocol Violation|0|||
94687209|NCT02318719|324309595|FG001|Double-blind Phase|Protocol Violation|1|||
94687210|NCT02318719|324309596|FG002|Double-blind Phase|Protocol Violation|3|||
94687211|NCT02318719|324309597|FG003|Double-blind Phase|Protocol Violation|0|||
94687212|NCT02318719|324309598|FG004|Double-blind Phase|Protocol Violation|0|||
94687213|NCT02318719|324309594|FG000|Double-blind Phase|Withdrawal by Subject|25|||
94687214|NCT02318719|324309595|FG001|Double-blind Phase|Withdrawal by Subject|7|||
94687215|NCT02318719|324309596|FG002|Double-blind Phase|Withdrawal by Subject|9|||
94687216|NCT02318719|324309597|FG003|Double-blind Phase|Withdrawal by Subject|10|||
94687217|NCT02318719|324309598|FG004|Double-blind Phase|Withdrawal by Subject|0|||
94687218|NCT02318719|324309594|FG000|Double-blind Phase|Other|1|||
94687219|NCT02318719|324309595|FG001|Double-blind Phase|Other|2|||
94687220|NCT02318719|324309596|FG002|Double-blind Phase|Other|0|||
94687221|NCT02318719|324309597|FG003|Double-blind Phase|Other|0|||
94687222|NCT02318719|324309598|FG004|Double-blind Phase|Other|0|||
94687223|NCT02318719|324309594|FG000|Open-label Extension Phase|Adverse Event|0|||
94687224|NCT02318719|324309595|FG001|Open-label Extension Phase|Adverse Event|0|||
94687225|NCT02318719|324309596|FG002|Open-label Extension Phase|Adverse Event|0|||
94687226|NCT02318719|324309597|FG003|Open-label Extension Phase|Adverse Event|0|||
94687227|NCT02318719|324309598|FG004|Open-label Extension Phase|Adverse Event|15|||
94687228|NCT02318719|324309594|FG000|Open-label Extension Phase|Death|0|||
94687229|NCT02318719|324309595|FG001|Open-label Extension Phase|Death|0|||
94687230|NCT02318719|324309596|FG002|Open-label Extension Phase|Death|0|||
94687231|NCT02318719|324309597|FG003|Open-label Extension Phase|Death|0|||
94687232|NCT02318719|324309598|FG004|Open-label Extension Phase|Death|1|||
94687233|NCT02318719|324309594|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
94687234|NCT02318719|324309595|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
94687235|NCT02318719|324309596|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
94687236|NCT02318719|324309597|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
94687237|NCT02318719|324309598|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
94687238|NCT02318719|324309594|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
94687239|NCT02318719|324309595|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
94687240|NCT02318719|324309596|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
94687241|NCT02318719|324309597|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
94687242|NCT02318719|324309598|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
94687243|NCT02318719|324309594|FG000|Open-label Extension Phase|Other|0|||
94687244|NCT02318719|324309595|FG001|Open-label Extension Phase|Other|0|||
94687245|NCT02318719|324309596|FG002|Open-label Extension Phase|Other|0|||
94687246|NCT02318719|324309597|FG003|Open-label Extension Phase|Other|0|||
94687247|NCT02318719|324309598|FG004|Open-label Extension Phase|Other|7|||
94687248|NCT00423293|324309599|FG000|Overall Study|Ineligible / No protocol treatment|11|||
94687249|NCT02045433|324309602|FG000|Overall Study|Withdrawal by Subject|1|||
94687250|NCT04399551|324309603|FG000|Overall Study|Adverse Event|15|||
94687251|NCT04399551|324309603|FG000|Overall Study|Withdrawal by Subject|6|||
94687252|NCT04399551|324309603|FG000|Overall Study|Physician Decision|3|||
94687253|NCT04399551|324309603|FG000|Overall Study|Lost to Follow-up|2|||
94687254|NCT04399551|324309603|FG000|Overall Study|Protocol Deviation|2|||
94687255|NCT02254421|324309604|FG000|Overall Study|Randomized but Not Treated|1|||
94687256|NCT02254421|324309605|FG001|Overall Study|Randomized but Not Treated|0|||
94687257|NCT02254421|324309604|FG000|Overall Study|Death|0|||
94687258|NCT02254421|324309605|FG001|Overall Study|Death|2|||
94687259|NCT02254421|324309604|FG000|Overall Study|Withdrew Consent|1|||
94687260|NCT02254421|324309605|FG001|Overall Study|Withdrew Consent|1|||
94687261|NCT01928225|324309609|FG000|Overall Study|Pregnancy|1|||
94687262|NCT01928225|324309610|FG001|Overall Study|Pregnancy|0|||
94687263|NCT01928225|324309609|FG000|Overall Study|basaloid cervical cancer|1|||
94687264|NCT01928225|324309610|FG001|Overall Study|basaloid cervical cancer|0|||
94687265|NCT01928225|324309609|FG000|Overall Study|Lost to Follow-up|1|||
94687266|NCT01928225|324309610|FG001|Overall Study|Lost to Follow-up|3|||
94687267|NCT01965158|324309612|FG000|Overall Study|Adverse Event|14|||
94687268|NCT01965158|324309613|FG001|Overall Study|Adverse Event|5|||
94687269|NCT01965158|324309612|FG000|Overall Study|Withdrawal by Subject|16|||
94687270|NCT01965158|324309613|FG001|Overall Study|Withdrawal by Subject|24|||
94687271|NCT01965158|324309612|FG000|Overall Study|Lost to Follow-up|7|||
94687272|NCT01965158|324309613|FG001|Overall Study|Lost to Follow-up|5|||
94687273|NCT01965158|324309612|FG000|Overall Study|Protocol Violation|1|||
94687274|NCT01965158|324309613|FG001|Overall Study|Protocol Violation|1|||
94687275|NCT01965158|324309612|FG000|Overall Study|Other - Miscellaneous|3|||
94687276|NCT01965158|324309613|FG001|Overall Study|Other - Miscellaneous|0|||
94687277|NCT00474175|324309614|FG000|Overall Study|Lack of Efficacy|0|||
94687278|NCT00474175|324309615|FG001|Overall Study|Lack of Efficacy|0|||
94687279|NCT00474175|324309616|FG002|Overall Study|Lack of Efficacy|1|||
94687280|NCT00474175|324309614|FG000|Overall Study|Withdrawal by Subject|0|||
94687281|NCT00474175|324309615|FG001|Overall Study|Withdrawal by Subject|1|||
94687282|NCT00474175|324309616|FG002|Overall Study|Withdrawal by Subject|1|||
94687283|NCT00474175|324309614|FG000|Overall Study|Ineligible|1|||
94687284|NCT00474175|324309615|FG001|Overall Study|Ineligible|3|||
94687285|NCT00474175|324309616|FG002|Overall Study|Ineligible|1|||
94687286|NCT00474175|324309614|FG000|Overall Study|Protocol Violation|0|||
94365245|NCT03993288|323122316|FG001|Overall Study|Withdrawal by Subject|1|||
94365246|NCT02729545|323122317|FG000|Overall Study|Pregnancy|1|||
94365247|NCT02729545|323122318|FG001|Overall Study|Pregnancy|1|||
94365248|NCT02729545|323122317|FG000|Overall Study|Lost to Follow-up|0|||
94365249|NCT02729545|323122318|FG001|Overall Study|Lost to Follow-up|1|||
94365250|NCT02729545|323122317|FG000|Overall Study|Withdrawal by Subject|2|||
94365251|NCT02729545|323122318|FG001|Overall Study|Withdrawal by Subject|3|||
94365252|NCT02499406|323122322|FG000|Overall Study|missed 3 treatment sessions|4|||
94365253|NCT03976076|323122323|FG000|Overall Study|Withdrawal by Subject|2|||
94365254|NCT04651218|323122324|FG000|Overall Study|Withdrawal by Subject|0|||
94365255|NCT04651218|323122325|FG001|Overall Study|Withdrawal by Subject|2|||
94365256|NCT02476851|323122330|FG000|Overall Study|Protocol Violation|1|||
94365257|NCT02476851|323122331|FG001|Overall Study|Protocol Violation|1|||
94365258|NCT00647426|323122334|FG000|Overall Study|Withdrawal by Subject|2|||
94365259|NCT00759174|323122339|FG000|Overall Study|Other|0|||
94365260|NCT00759174|323122340|FG001|Overall Study|Other|2|||
94365261|NCT00883740|323122341|FG000|First Intervention|Lost to Follow-up|1|||
94365262|NCT00883740|323122342|FG001|First Intervention|Lost to Follow-up|0|||
94365263|NCT00883740|323122341|FG000|First Intervention|No longer willing to participate|2|||
94365264|NCT00883740|323122342|FG001|First Intervention|No longer willing to participate|0|||
94365265|NCT00883740|323122341|FG000|First Intervention|Protocol Violation|3|||
94365266|NCT00883740|323122342|FG001|First Intervention|Protocol Violation|6|||
94365267|NCT00883740|323122341|FG000|First Intervention|Adverse Event|1|||
94365268|NCT00883740|323122342|FG001|First Intervention|Adverse Event|2|||
94365269|NCT00883740|323122341|FG000|Second Intervention|Protocol Violation|1|||
94365270|NCT00883740|323122342|FG001|Second Intervention|Protocol Violation|0|||
94365271|NCT00883740|323122341|FG000|Second Intervention|No longer willing to participate|0|||
94365272|NCT00883740|323122342|FG001|Second Intervention|No longer willing to participate|1|||
94365273|NCT00568776|323122344|FG000|Overall Study|Adverse Event|8|||
94365274|NCT00568776|323122345|FG001|Overall Study|Adverse Event|8|||
94365275|NCT00568776|323122346|FG002|Overall Study|Adverse Event|10|||
94465598|NCT02332239|323494878|FG001|Overall Study|Lost to Follow-up|6|||
94465599|NCT00628095|323494879|FG000|Overall Study|Adverse Event|5|||
94465600|NCT00628095|323494880|FG001|Overall Study|Adverse Event|3|||
94465601|NCT00628095|323494879|FG000|Overall Study|Lack of Efficacy|0|||
94465602|NCT00628095|323494880|FG001|Overall Study|Lack of Efficacy|3|||
94465603|NCT00628095|323494879|FG000|Overall Study|Withdrawal by Subject|2|||
94465604|NCT00628095|323494880|FG001|Overall Study|Withdrawal by Subject|0|||
94465605|NCT00628095|323494879|FG000|Overall Study|Other|0|||
94465606|NCT00628095|323494880|FG001|Overall Study|Other|1|||
94651014|NCT01573624|324179680|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
94651015|NCT01573624|324179681|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
94651016|NCT01573624|324179682|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
94651017|NCT01573624|324179683|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
94651018|NCT01573624|324179684|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
94651019|NCT01573624|324179685|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
94651020|NCT01573624|324179686|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
94651021|NCT01573624|324179680|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
94651022|NCT01573624|324179681|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
94651023|NCT01573624|324179682|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
94651024|NCT01573624|324179683|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
94651025|NCT01573624|324179684|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
94651026|NCT01573624|324179685|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
94651027|NCT01573624|324179686|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
94651028|NCT01573624|324179680|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
94651029|NCT01573624|324179681|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
94651030|NCT01573624|324179682|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
94651031|NCT01573624|324179683|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
94651032|NCT01573624|324179684|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
94651033|NCT01573624|324179685|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
94651034|NCT01573624|324179686|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
94365276|NCT00568776|323122347|FG003|Overall Study|Adverse Event|8|||
94365277|NCT00568776|323122344|FG000|Overall Study|Death|0|||
94365278|NCT00568776|323122345|FG001|Overall Study|Death|1|||
94365279|NCT00568776|323122346|FG002|Overall Study|Death|4|||
94365280|NCT00568776|323122347|FG003|Overall Study|Death|3|||
94365281|NCT00568776|323122344|FG000|Overall Study|Physician Decision|0|||
94465607|NCT01546038|323494881|FG000|Overall Study|Death|15|||
94465608|NCT01546038|323494882|FG001|Overall Study|Death|6|||
94465609|NCT01546038|323494883|FG002|Overall Study|Death|4|||
94465610|NCT01546038|323494884|FG003|Overall Study|Death|2|||
94651035|NCT01573624|324179680|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
94687287|NCT00474175|324309615|FG001|Overall Study|Protocol Violation|2|||
94687288|NCT00474175|324309616|FG002|Overall Study|Protocol Violation|1|||
94687289|NCT00474175|324309614|FG000|Overall Study|Administrative|0|||
94687290|NCT00474175|324309615|FG001|Overall Study|Administrative|1|||
94687291|NCT00474175|324309616|FG002|Overall Study|Administrative|0|||
94687292|NCT00885352|324309629|FG000|Overall Study|Adverse Event|2|||
94687293|NCT00885352|324309630|FG001|Overall Study|Adverse Event|3|||
94687294|NCT00885352|324309629|FG000|Overall Study|Lost to Follow-up|2|||
94687295|NCT00885352|324309630|FG001|Overall Study|Lost to Follow-up|2|||
94687296|NCT00885352|324309629|FG000|Overall Study|Physician Decision|0|||
94687297|NCT00885352|324309630|FG001|Overall Study|Physician Decision|3|||
94687298|NCT00885352|324309629|FG000|Overall Study|Protocol Violation|0|||
94687299|NCT00885352|324309630|FG001|Overall Study|Protocol Violation|2|||
94687300|NCT00885352|324309629|FG000|Overall Study|Withdrawal by Subject|1|||
94687301|NCT00885352|324309630|FG001|Overall Study|Withdrawal by Subject|5|||
94687302|NCT00885352|324309629|FG000|Overall Study|Contradiction to study medication|0|||
94687303|NCT00885352|324309630|FG001|Overall Study|Contradiction to study medication|2|||
94687304|NCT00885352|324309629|FG000|Overall Study|Excluded medication|2|||
94687305|NCT00885352|324309630|FG001|Overall Study|Excluded medication|2|||
94687306|NCT00885352|324309629|FG000|Overall Study|Lab abnormalities|1|||
94687307|NCT00885352|324309630|FG001|Overall Study|Lab abnormalities|1|||
94687308|NCT02306265|324309639|FG000|Overall Study|Withdrawal by Subject|1|||
94687309|NCT03000673|324309649|FG000|Overall Study|Withdrawal by Subject|1|||
94687310|NCT03000673|324309650|FG001|Overall Study|Withdrawal by Subject|0|||
94687311|NCT03000673|324309651|FG002|Overall Study|Withdrawal by Subject|0|||
94687312|NCT03000673|324309652|FG003|Overall Study|Withdrawal by Subject|0|||
94687313|NCT01121484|324309654|FG000|Overall Study|Adverse Event|12|||
94687314|NCT01121484|324309655|FG001|Overall Study|Adverse Event|5|||
94687315|NCT01121484|324309654|FG000|Overall Study|Lack of Efficacy|3|||
94687316|NCT01121484|324309655|FG001|Overall Study|Lack of Efficacy|11|||
94687317|NCT01121484|324309654|FG000|Overall Study|Lost to Follow-up|5|||
94687318|NCT01121484|324309655|FG001|Overall Study|Lost to Follow-up|9|||
94687319|NCT01121484|324309654|FG000|Overall Study|Physician Decision|0|||
94687320|NCT01121484|324309655|FG001|Overall Study|Physician Decision|3|||
94687321|NCT01121484|324309654|FG000|Overall Study|Protocol Violation|1|||
94687322|NCT01121484|324309655|FG001|Overall Study|Protocol Violation|0|||
94264021|NCT00041067|322761804|FG000|Overall Study|Ineligible|2|||
94264022|NCT01387230|322761806|FG000|Overall Study|Adverse Event|0|||
94264023|NCT01387230|322761807|FG001|Overall Study|Adverse Event|1|||
94264024|NCT01387230|322761808|FG002|Overall Study|Adverse Event|3|||
94264025|NCT01387230|322761806|FG000|Overall Study|Lack of Efficacy|8|||
94264026|NCT01387230|322761807|FG001|Overall Study|Lack of Efficacy|5|||
94264027|NCT01387230|322761808|FG002|Overall Study|Lack of Efficacy|4|||
94264028|NCT01387230|322761806|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
94264029|NCT01387230|322761807|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
94264030|NCT01387230|322761808|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
94264031|NCT01387230|322761806|FG000|Overall Study|Lost to Follow-up|0|||
94264032|NCT01387230|322761807|FG001|Overall Study|Lost to Follow-up|0|||
94264033|NCT01387230|322761808|FG002|Overall Study|Lost to Follow-up|1|||
94264034|NCT01387230|322761806|FG000|Overall Study|Withdrawal by Subject|4|||
94264035|NCT01387230|322761807|FG001|Overall Study|Withdrawal by Subject|1|||
94264036|NCT01387230|322761808|FG002|Overall Study|Withdrawal by Subject|0|||
94264037|NCT02558231|322761809|FG000|Overall Study|Death|4|||
94264038|NCT02558231|322761810|FG001|Overall Study|Death|12|||
94264039|NCT02558231|322761809|FG000|Overall Study|Lost to Follow-up|7|||
94264040|NCT02558231|322761810|FG001|Overall Study|Lost to Follow-up|4|||
94264041|NCT02558231|322761809|FG000|Overall Study|Withdrawal by Subject|7|||
94264042|NCT02558231|322761810|FG001|Overall Study|Withdrawal by Subject|4|||
94264043|NCT02558231|322761809|FG000|Overall Study|Physician Decision|7|||
94264044|NCT02558231|322761810|FG001|Overall Study|Physician Decision|5|||
94264045|NCT02558231|322761809|FG000|Overall Study|Sponsor Decision|0|||
94687323|NCT01121484|324309654|FG000|Overall Study|Withdrawal by Subject|8|||
94687324|NCT01121484|324309655|FG001|Overall Study|Withdrawal by Subject|7|||
94687325|NCT01121484|324309654|FG000|Overall Study|Discontinuation of study by sponsor|0|||
94687326|NCT01121484|324309655|FG001|Overall Study|Discontinuation of study by sponsor|1|||
94687327|NCT01121484|324309654|FG000|Overall Study|Other|3|||
94687328|NCT01121484|324309655|FG001|Overall Study|Other|3|||
94687329|NCT01121484|324309654|FG000|Overall Study|Randomized, not treated|1|||
94264046|NCT02558231|322761810|FG001|Overall Study|Sponsor Decision|1|||
94264047|NCT01237340|322761811|FG000|Overall Study|Adverse Event|3|||
94264048|NCT01237340|322761811|FG000|Overall Study|Withdrawal by Subject|1|||
94264049|NCT01237340|322761811|FG000|Overall Study|Early termination of the trial|36|||
94264050|NCT02019420|322761813|FG000|Overall Study|Did not receive study drug|2|||
94687330|NCT01121484|324309655|FG001|Overall Study|Randomized, not treated|4|||
94687331|NCT01512745|324309656|FG000|Overall Study|Adverse Event|22|||
94687332|NCT01512745|324309657|FG001|Overall Study|Adverse Event|3|||
94687333|NCT01512745|324309656|FG000|Overall Study|Death|9|||
94264051|NCT02019420|322761814|FG001|Overall Study|Did not receive study drug|2|||
94687334|NCT01512745|324309657|FG001|Overall Study|Death|13|||
94687335|NCT01512745|324309656|FG000|Overall Study|Withdrawal by Subject|2|||
94687336|NCT01512745|324309657|FG001|Overall Study|Withdrawal by Subject|2|||
94687337|NCT01512745|324309656|FG000|Overall Study|Lost to Follow-up|4|||
94687338|NCT01512745|324309657|FG001|Overall Study|Lost to Follow-up|0|||
94687339|NCT01512745|324309656|FG000|Overall Study|Lack of Efficacy|2|||
94687340|NCT01512745|324309657|FG001|Overall Study|Lack of Efficacy|2|||
94687341|NCT01512745|324309656|FG000|Overall Study|Protocol Violation|1|||
94687342|NCT01512745|324309657|FG001|Overall Study|Protocol Violation|0|||
94687343|NCT00562978|324309658|FG000|Overall Study|Patient had imaging dose only|1|||
94687344|NCT00562978|324309659|FG001|Overall Study|Patient had imaging dose only|11|||
94687345|NCT00758160|324309664|FG000|Overall Study|No Longer Requires Study Medication|4|||
94687346|NCT00758160|324309664|FG000|Overall Study|Administration Problems|3|||
94687347|NCT00758160|324309664|FG000|Overall Study|Adverse Event|15|||
94687348|NCT00758160|324309664|FG000|Overall Study|Lack of Efficacy|10|||
94687349|NCT00758160|324309664|FG000|Overall Study|Lost to Follow-up|14|||
94687350|NCT00758160|324309664|FG000|Overall Study|Protocol Violation|12|||
94687351|NCT00758160|324309664|FG000|Overall Study|Withdrawal by Subject|8|||
94687352|NCT04422639|324309667|FG000|Overall Study|Death|1|||
94687353|NCT04422639|324309668|FG001|Overall Study|Death|0|||
94687354|NCT04422639|324309667|FG000|Overall Study|study closed prior to completion of FU visits|0|||
94687355|NCT04422639|324309668|FG001|Overall Study|study closed prior to completion of FU visits|2|||
94687356|NCT01348776|324309669|FG000|Overall Study|Lost to Follow-up|3|||
94687357|NCT01372605|324309670|FG000|Overall Study|Death|1|||
94687358|NCT01372605|324309671|FG001|Overall Study|Death|2|||
94687359|NCT01372605|324309670|FG000|Overall Study|Lost to Follow-up|2|||
94687360|NCT01372605|324309671|FG001|Overall Study|Lost to Follow-up|1|||
94687361|NCT01372605|324309670|FG000|Overall Study|Withdrawal by Subject|4|||
94687362|NCT01372605|324309671|FG001|Overall Study|Withdrawal by Subject|7|||
94687363|NCT01372605|324309670|FG000|Overall Study|Moved|3|||
94687364|NCT01372605|324309671|FG001|Overall Study|Moved|0|||
94687365|NCT01372605|324309670|FG000|Overall Study|Changed medical home|2|||
94687366|NCT01372605|324309671|FG001|Overall Study|Changed medical home|0|||
94687367|NCT01463293|324309672|FG000|Overall Study|Lost to Follow-up|1|||
94687368|NCT01463293|324309673|FG001|Overall Study|Lost to Follow-up|4|||
94687369|NCT01463293|324309674|FG002|Overall Study|Lost to Follow-up|5|||
94687370|NCT01463293|324309672|FG000|Overall Study|Adverse Event|1|||
94687371|NCT01463293|324309673|FG001|Overall Study|Adverse Event|2|||
94687372|NCT01463293|324309674|FG002|Overall Study|Adverse Event|0|||
94687373|NCT01463293|324309672|FG000|Overall Study|Withdrawal by Subject|4|||
94687374|NCT01463293|324309673|FG001|Overall Study|Withdrawal by Subject|10|||
94264052|NCT02019420|322761813|FG000|Overall Study|Withdrawal by Subject|1|||
94264053|NCT02019420|322761814|FG001|Overall Study|Withdrawal by Subject|3|||
94264054|NCT02019420|322761813|FG000|Overall Study|At request of sponsor or investigator|0|||
94264055|NCT02019420|322761814|FG001|Overall Study|At request of sponsor or investigator|1|||
94264056|NCT02019420|322761813|FG000|Overall Study|Death|104|||
94264057|NCT02019420|322761814|FG001|Overall Study|Death|99|||
94264058|NCT02019420|322761813|FG000|Overall Study|Transferred to other care facility|1|||
94264059|NCT02019420|322761814|FG001|Overall Study|Transferred to other care facility|1|||
94264060|NCT00986440|322761815|FG000|Overall Study|Progressive disease|27|||
94264061|NCT00986440|322761816|FG001|Overall Study|Progressive disease|37|||
94264062|NCT00986440|322761815|FG000|Overall Study|Serious adverse event or adverse event|9|||
94264063|NCT00986440|322761816|FG001|Overall Study|Serious adverse event or adverse event|2|||
94264064|NCT00986440|322761815|FG000|Overall Study|Withdrawal by Subject|1|||
94264065|NCT00986440|322761816|FG001|Overall Study|Withdrawal by Subject|2|||
94264066|NCT00986440|322761815|FG000|Overall Study|Screen failure (not dosed)|4|||
94264067|NCT00986440|322761816|FG001|Overall Study|Screen failure (not dosed)|2|||
94264068|NCT01093625|322761821|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
94264069|NCT01093625|322761822|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
94264070|NCT01093625|322761821|FG000|2-Week Visit|Withdrawal by Subject|1|||
94264071|NCT01093625|322761822|FG001|2-Week Visit|Withdrawal by Subject|0|||
94264072|NCT01093625|322761821|FG000|1-Month Visit|Lost to Follow-up|2|||
94264073|NCT01093625|322761822|FG001|1-Month Visit|Lost to Follow-up|0|||
94264074|NCT01093625|322761821|FG000|3-Month Visit|Lost to Follow-up|2|||
94264075|NCT01093625|322761822|FG001|3-Month Visit|Lost to Follow-up|0|||
94687375|NCT01463293|324309674|FG002|Overall Study|Withdrawal by Subject|5|||
94687376|NCT01463293|324309672|FG000|Overall Study|Other|0|||
94687377|NCT01463293|324309673|FG001|Overall Study|Other|0|||
94687378|NCT01463293|324309674|FG002|Overall Study|Other|2|||
94687379|NCT02796963|324309675|FG000|Overall Study|Lost to Follow-up|89|||
94687380|NCT02796963|324309676|FG001|Overall Study|Lost to Follow-up|76|||
94687381|NCT02796963|324309677|FG002|Overall Study|Lost to Follow-up|69|||
94687382|NCT02796963|324309678|FG003|Overall Study|Lost to Follow-up|72|||
94687383|NCT00119262|324309681|FG000|Overall Study|Lack of Efficacy|0|||
94687384|NCT00119262|324309682|FG001|Overall Study|Lack of Efficacy|3|||
94687385|NCT00119262|324309681|FG000|Overall Study|Withdrawal by Subject|12|||
94687386|NCT00119262|324309682|FG001|Overall Study|Withdrawal by Subject|11|||
94687387|NCT00119262|324309681|FG000|Overall Study|Adverse Event|33|||
94687388|NCT00119262|324309682|FG001|Overall Study|Adverse Event|35|||
94687389|NCT00119262|324309681|FG000|Overall Study|other disease|0|||
94687390|NCT00119262|324309682|FG001|Overall Study|other disease|2|||
94687391|NCT00119262|324309681|FG000|Overall Study|ineligble|1|||
94687392|NCT00119262|324309682|FG001|Overall Study|ineligble|2|||
94687393|NCT00119262|324309681|FG000|Overall Study|others|0|||
94687394|NCT00119262|324309682|FG001|Overall Study|others|5|||
94687395|NCT00582491|324309683|FG000|Overall Study|Withdrawal by Subject|1|||
94687396|NCT00582491|324309684|FG001|Overall Study|Withdrawal by Subject|0|||
94687397|NCT01193582|324309685|FG000|Vaccination Series|Withdrawal by Subject|11|||
94687398|NCT01193582|324309686|FG001|Vaccination Series|Withdrawal by Subject|13|||
94687399|NCT01193582|324309687|FG002|Vaccination Series|Withdrawal by Subject|8|||
94687400|NCT01193582|324309688|FG003|Vaccination Series|Withdrawal by Subject|3|||
94687401|NCT01193582|324309685|FG000|12 Month Follow-up|Death|0|||
94687402|NCT01193582|324309686|FG001|12 Month Follow-up|Death|0|||
94687403|NCT01193582|324309687|FG002|12 Month Follow-up|Death|1|||
94687404|NCT01193582|324309688|FG003|12 Month Follow-up|Death|0|||
94687405|NCT01193582|324309685|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
94687406|NCT01193582|324309686|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
94687407|NCT01193582|324309687|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
94687408|NCT01193582|324309688|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
94687409|NCT02533258|324309695|FG000|Overall Study|Adverse Event|1|||
94687410|NCT02533258|324309695|FG000|Overall Study|Death|2|||
94687411|NCT02533258|324309695|FG000|Overall Study|Other|1|||
94687412|NCT02533258|324309695|FG000|Overall Study|Economic factor|1|||
94687413|NCT02533258|324309695|FG000|Overall Study|Progression of pleural effusion|1|||
94687414|NCT02533258|324309695|FG000|Overall Study|Lack of Efficacy|2|||
94687415|NCT00924469|324309698|FG000|Overall Study|Adverse Event|2|||
94687416|NCT00924469|324309699|FG001|Overall Study|Adverse Event|0|||
94687417|NCT00924469|324309698|FG000|Overall Study|Withdrawal by Subject|0|||
94687418|NCT00924469|324309699|FG001|Overall Study|Withdrawal by Subject|1|||
94687419|NCT00924469|324309698|FG000|Overall Study|Lost to Follow-up|0|||
94687420|NCT00924469|324309699|FG001|Overall Study|Lost to Follow-up|1|||
94687421|NCT02743793|324309703|FG000|Overall Study|Death|1|||
94687422|NCT02743793|324309704|FG001|Overall Study|Death|1|||
94687423|NCT02743793|324309703|FG000|Overall Study|Withdrawal by Subject|0|||
94687424|NCT02743793|324309704|FG001|Overall Study|Withdrawal by Subject|1|||
94687425|NCT02743793|324309703|FG000|Overall Study|Screen Failure|4|||
94687426|NCT02743793|324309704|FG001|Overall Study|Screen Failure|0|||
94687427|NCT02743793|324309703|FG000|Overall Study|No Primary Care Physician|0|||
94687428|NCT02743793|324309704|FG001|Overall Study|No Primary Care Physician|1|||
94687429|NCT02743793|324309703|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
94687430|NCT02743793|324309704|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
94687431|NCT02743793|324309703|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
94687432|NCT02743793|324309704|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
94687433|NCT00089895|324309705|FG000|Overall Study|Consent Withdrawn|11|||
94687434|NCT00089895|324309706|FG001|Overall Study|Consent Withdrawn|14|||
94687435|NCT00089895|324309705|FG000|Overall Study|Technical reason|7|||
94264076|NCT01093625|322761821|FG000|6-Month Visit|Withdrawal by Subject|6|||
94687436|NCT00089895|324309706|FG001|Overall Study|Technical reason|2|||
94687437|NCT00089895|324309705|FG000|Overall Study|Surgery|0|||
94687438|NCT00089895|324309706|FG001|Overall Study|Surgery|1|||
94687439|NCT00089895|324309705|FG000|Overall Study|Bleeding|0|||
94687440|NCT00089895|324309706|FG001|Overall Study|Bleeding|2|||
94687441|NCT00089895|324309705|FG000|Overall Study|Physician Decision|3|||
94687442|NCT00089895|324309706|FG001|Overall Study|Physician Decision|7|||
94687443|NCT00089895|324309705|FG000|Overall Study|Exclusion criteria met|6|||
94687444|NCT00089895|324309706|FG001|Overall Study|Exclusion criteria met|6|||
94687445|NCT00089895|324309705|FG000|Overall Study|Not otherwise specified|4|||
94687446|NCT00089895|324309706|FG001|Overall Study|Not otherwise specified|8|||
94687447|NCT00089895|324309705|FG000|Overall Study|Missing|4|||
94687448|NCT00089895|324309706|FG001|Overall Study|Missing|2|||
94687449|NCT04362137|324309707|FG000|Overall Study|Death|9|||
94687450|NCT04362137|324309708|FG001|Overall Study|Death|3|||
94687451|NCT04362137|324309707|FG000|Overall Study|Patient decision|6|||
94687452|NCT04362137|324309708|FG001|Overall Study|Patient decision|3|||
94687453|NCT04362137|324309707|FG000|Overall Study|Adverse Event|1|||
94687454|NCT04362137|324309708|FG001|Overall Study|Adverse Event|0|||
94687455|NCT04362137|324309707|FG000|Overall Study|Lost to Follow-up|1|||
94687456|NCT04362137|324309708|FG001|Overall Study|Lost to Follow-up|0|||
94687457|NCT04362137|324309707|FG000|Overall Study|Protocol deviation|1|||
94687458|NCT04362137|324309708|FG001|Overall Study|Protocol deviation|0|||
94687459|NCT01821898|324309709|FG000|Overall Study|Withdrawal by Subject|2|||
94687460|NCT01821898|324309710|FG001|Overall Study|Withdrawal by Subject|1|||
94687461|NCT05033080|324309715|FG000|Overall Study|Adverse Event|4|||
94687462|NCT05033080|324309716|FG001|Overall Study|Adverse Event|4|||
94687463|NCT05033080|324309715|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
94687464|NCT05033080|324309716|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
94687465|NCT05033080|324309715|FG000|Overall Study|Lost to Follow-up|1|||
94687466|NCT05033080|324309716|FG001|Overall Study|Lost to Follow-up|0|||
94687467|NCT05033080|324309715|FG000|Overall Study|Other non-compliance|0|||
94687468|NCT05033080|324309716|FG001|Overall Study|Other non-compliance|1|||
94687469|NCT05033080|324309715|FG000|Overall Study|Physician Decision|0|||
94687470|NCT05033080|324309716|FG001|Overall Study|Physician Decision|1|||
94687471|NCT05033080|324309715|FG000|Overall Study|Other|1|||
94687472|NCT05033080|324309716|FG001|Overall Study|Other|1|||
94687473|NCT00735644|324309717|FG000|Overall Study|Did not receive study vaccine|0|||
94687474|NCT00735644|324309718|FG001|Overall Study|Did not receive study vaccine|1|||
94687475|NCT00735644|324309719|FG002|Overall Study|Did not receive study vaccine|0|||
94687476|NCT00735644|324309720|FG003|Overall Study|Did not receive study vaccine|0|||
94687477|NCT00735644|324309721|FG004|Overall Study|Did not receive study vaccine|0|||
94687478|NCT00735644|324309717|FG000|Overall Study|Withdrawal by Subject|0|||
94687479|NCT00735644|324309718|FG001|Overall Study|Withdrawal by Subject|1|||
94687480|NCT00735644|324309719|FG002|Overall Study|Withdrawal by Subject|1|||
94687481|NCT00735644|324309720|FG003|Overall Study|Withdrawal by Subject|1|||
94687482|NCT00735644|324309721|FG004|Overall Study|Withdrawal by Subject|0|||
94687483|NCT02388074|324309723|FG000|Overall Study|Lost in Transit|2|||
94687484|NCT02388074|324309723|FG000|Overall Study|Sample Not Returned|1|||
94687485|NCT00003458|324309724|FG000|Overall Study|Not evaluable|4|||
94687486|NCT02769065|324311633|FG000|Overall Study|Voluntary Withdrawal|1|||
94687487|NCT02769065|324311634|FG001|Overall Study|Voluntary Withdrawal|0|||
94687488|NCT02769065|324311635|FG002|Overall Study|Voluntary Withdrawal|0|||
94687489|NCT02769065|324311636|FG003|Overall Study|Voluntary Withdrawal|0|||
94687490|NCT02769065|324311637|FG004|Overall Study|Voluntary Withdrawal|0|||
94687491|NCT02769065|324311638|FG005|Overall Study|Voluntary Withdrawal|0|||
94687492|NCT02769065|324311639|FG006|Overall Study|Voluntary Withdrawal|0|||
94687493|NCT02769065|324311640|FG007|Overall Study|Voluntary Withdrawal|0|||
94687494|NCT02769065|324311641|FG008|Overall Study|Voluntary Withdrawal|0|||
94687495|NCT02769065|324311642|FG009|Overall Study|Voluntary Withdrawal|0|||
94687496|NCT02769065|324311643|FG010|Overall Study|Voluntary Withdrawal|0|||
94687497|NCT02769065|324311644|FG011|Overall Study|Voluntary Withdrawal|0|||
94687498|NCT02769065|324311645|FG012|Overall Study|Voluntary Withdrawal|0|||
94687499|NCT02769065|324311646|FG013|Overall Study|Voluntary Withdrawal|0|||
94687500|NCT02769065|324311647|FG014|Overall Study|Voluntary Withdrawal|0|||
94687501|NCT02769065|324311648|FG015|Overall Study|Voluntary Withdrawal|0|||
94687502|NCT02769065|324311649|FG016|Overall Study|Voluntary Withdrawal|0|||
94687503|NCT02769065|324311650|FG017|Overall Study|Voluntary Withdrawal|0|||
94687504|NCT02769065|324311651|FG018|Overall Study|Voluntary Withdrawal|0|||
94687505|NCT02769065|324311652|FG019|Overall Study|Voluntary Withdrawal|0|||
94687506|NCT02769065|324311653|FG020|Overall Study|Voluntary Withdrawal|0|||
94687507|NCT02769065|324311654|FG021|Overall Study|Voluntary Withdrawal|0|||
94687508|NCT02769065|324311655|FG022|Overall Study|Voluntary Withdrawal|0|||
94687509|NCT02769065|324311656|FG023|Overall Study|Voluntary Withdrawal|0|||
94687510|NCT02769065|324311657|FG024|Overall Study|Voluntary Withdrawal|0|||
94687511|NCT02769065|324311658|FG025|Overall Study|Voluntary Withdrawal|0|||
94687512|NCT02769065|324311659|FG026|Overall Study|Voluntary Withdrawal|0|||
94687513|NCT02769065|324311660|FG027|Overall Study|Voluntary Withdrawal|0|||
94687514|NCT02769065|324311661|FG028|Overall Study|Voluntary Withdrawal|0|||
94687515|NCT02769065|324311662|FG029|Overall Study|Voluntary Withdrawal|0|||
94687516|NCT02769065|324311633|FG000|Overall Study|Reason Not Specified|0|||
94687517|NCT02769065|324311634|FG001|Overall Study|Reason Not Specified|0|||
94687518|NCT02769065|324311635|FG002|Overall Study|Reason Not Specified|0|||
94687519|NCT02769065|324311636|FG003|Overall Study|Reason Not Specified|0|||
94687520|NCT02769065|324311637|FG004|Overall Study|Reason Not Specified|0|||
94687521|NCT02769065|324311638|FG005|Overall Study|Reason Not Specified|0|||
94687522|NCT02769065|324311639|FG006|Overall Study|Reason Not Specified|1|||
94687523|NCT02769065|324311640|FG007|Overall Study|Reason Not Specified|0|||
94687524|NCT02769065|324311641|FG008|Overall Study|Reason Not Specified|0|||
94687525|NCT02769065|324311642|FG009|Overall Study|Reason Not Specified|0|||
94687526|NCT02769065|324311643|FG010|Overall Study|Reason Not Specified|0|||
94687527|NCT02769065|324311644|FG011|Overall Study|Reason Not Specified|0|||
94687528|NCT02769065|324311645|FG012|Overall Study|Reason Not Specified|0|||
94687529|NCT02769065|324311646|FG013|Overall Study|Reason Not Specified|0|||
94687530|NCT02769065|324311647|FG014|Overall Study|Reason Not Specified|0|||
94687531|NCT02769065|324311648|FG015|Overall Study|Reason Not Specified|0|||
94687532|NCT02769065|324311649|FG016|Overall Study|Reason Not Specified|0|||
94687533|NCT02769065|324311650|FG017|Overall Study|Reason Not Specified|0|||
94687534|NCT02769065|324311651|FG018|Overall Study|Reason Not Specified|0|||
94687535|NCT02769065|324311652|FG019|Overall Study|Reason Not Specified|0|||
94687536|NCT02769065|324311653|FG020|Overall Study|Reason Not Specified|0|||
94687537|NCT02769065|324311654|FG021|Overall Study|Reason Not Specified|0|||
94687538|NCT02769065|324311655|FG022|Overall Study|Reason Not Specified|0|||
94687539|NCT02769065|324311656|FG023|Overall Study|Reason Not Specified|0|||
94687540|NCT02769065|324311657|FG024|Overall Study|Reason Not Specified|0|||
94687541|NCT02769065|324311658|FG025|Overall Study|Reason Not Specified|0|||
94687542|NCT02769065|324311659|FG026|Overall Study|Reason Not Specified|0|||
94687543|NCT02769065|324311660|FG027|Overall Study|Reason Not Specified|0|||
94687544|NCT02769065|324311661|FG028|Overall Study|Reason Not Specified|0|||
94687545|NCT02769065|324311662|FG029|Overall Study|Reason Not Specified|0|||
94687546|NCT02769065|324311633|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687547|NCT02769065|324311634|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687548|NCT02769065|324311635|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687549|NCT02769065|324311636|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687550|NCT02769065|324311637|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687551|NCT02769065|324311638|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687552|NCT02769065|324311639|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687553|NCT02769065|324311640|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687554|NCT02769065|324311641|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687555|NCT02769065|324311642|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687556|NCT02769065|324311643|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
94687557|NCT02769065|324311644|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687558|NCT02769065|324311645|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687559|NCT02769065|324311646|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687560|NCT02769065|324311647|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687561|NCT02769065|324311648|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687562|NCT02769065|324311649|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687563|NCT02769065|324311650|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687564|NCT02769065|324311651|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687565|NCT02769065|324311652|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687566|NCT02769065|324311653|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687567|NCT02769065|324311654|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687568|NCT02769065|324311655|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687569|NCT02769065|324311656|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687570|NCT02769065|324311657|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687571|NCT02769065|324311658|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687572|NCT02769065|324311659|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687573|NCT02769065|324311660|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687574|NCT02769065|324311661|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687575|NCT02769065|324311662|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
94687576|NCT01340482|324311665|FG000|Overall Study|Adverse Event|2|||
94687577|NCT01340482|324311666|FG001|Overall Study|Adverse Event|0|||
94687578|NCT01340482|324311667|FG002|Overall Study|Adverse Event|0|||
94687579|NCT02593539|324311668|FG000|Overall Study|Adverse Event|1|||
94687580|NCT00871351|324311669|FG000|Overall Study|Withdrawal by Subject|1|||
94687581|NCT00871351|324311670|FG001|Overall Study|Withdrawal by Subject|0|||
94687582|NCT00871351|324311671|FG002|Overall Study|Withdrawal by Subject|0|||
94365282|NCT00568776|323122345|FG001|Overall Study|Physician Decision|2|||
94365283|NCT00568776|323122346|FG002|Overall Study|Physician Decision|0|||
94687583|NCT00871351|324311669|FG000|Overall Study|Adverse Event|3|||
94687584|NCT00871351|324311670|FG001|Overall Study|Adverse Event|1|||
94687585|NCT00871351|324311671|FG002|Overall Study|Adverse Event|0|||
94365284|NCT00568776|323122347|FG003|Overall Study|Physician Decision|0|||
94687586|NCT00720902|324311672|FG000|Overall Study|Withdrawal by Subject|1|||
94687587|NCT00720902|324311673|FG001|Overall Study|Withdrawal by Subject|0|||
94687588|NCT00720902|324311672|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
94687589|NCT00720902|324311673|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
94687590|NCT02959671|324311675|FG000|Overall Study|Adverse Event|2|||
94688668|NCT00363896|324315566|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
94651036|NCT01573624|324179681|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
94651037|NCT01573624|324179682|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
94651038|NCT01573624|324179683|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
94651039|NCT01573624|324179684|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
94651040|NCT01573624|324179685|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
94651041|NCT01573624|324179686|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
94651042|NCT01573624|324179680|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
94651043|NCT01573624|324179681|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
94651044|NCT01573624|324179682|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
94651045|NCT01573624|324179683|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
94651046|NCT01573624|324179684|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
94651047|NCT01573624|324179685|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
94651048|NCT01573624|324179686|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
94651049|NCT01573624|324179680|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
94651050|NCT01573624|324179681|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
94651051|NCT01573624|324179682|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
94651052|NCT01573624|324179683|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
94651053|NCT01573624|324179684|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
94651054|NCT01573624|324179685|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
94651055|NCT01573624|324179686|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
94651056|NCT01573624|324179680|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
94651057|NCT01573624|324179681|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
94651058|NCT01573624|324179682|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
94651059|NCT01573624|324179683|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
94651060|NCT01573624|324179684|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
94651061|NCT01573624|324179685|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
94651062|NCT01573624|324179686|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
94651063|NCT01573624|324179680|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
94651064|NCT01573624|324179681|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
94651065|NCT01573624|324179682|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
94651066|NCT01573624|324179683|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
94651067|NCT01573624|324179684|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
94651068|NCT01573624|324179685|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
94651069|NCT01573624|324179686|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
94651070|NCT01573624|324179680|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
94651071|NCT01573624|324179681|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
94651072|NCT01573624|324179682|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
94651073|NCT01573624|324179683|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
94651074|NCT01573624|324179684|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
94651075|NCT01573624|324179685|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
94651076|NCT01573624|324179686|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
94651077|NCT01573624|324179680|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
94651078|NCT01573624|324179681|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
94651079|NCT01573624|324179682|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
94651080|NCT01573624|324179683|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
94651081|NCT01573624|324179684|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
94651082|NCT01573624|324179685|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
94651083|NCT01573624|324179686|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
94651084|NCT01573624|324179680|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
94651085|NCT01573624|324179681|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
94651086|NCT01573624|324179682|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
94651087|NCT01573624|324179683|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
94651088|NCT01573624|324179684|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
94687591|NCT02959671|324311675|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
94687592|NCT00077636|324311676|FG000|Overall Study|Refused Treatment|9|||
94687593|NCT00077636|324311677|FG001|Overall Study|Refused Treatment|31|||
94651089|NCT01573624|324179685|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
94651090|NCT01573624|324179686|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
94651091|NCT01573624|324179680|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
94651092|NCT01573624|324179681|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
94651093|NCT01573624|324179682|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
94651094|NCT01573624|324179683|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
94687594|NCT00077636|324311676|FG000|Overall Study|Admin|3|||
94687595|NCT00077636|324311677|FG001|Overall Study|Admin|3|||
94687596|NCT00077636|324311676|FG000|Overall Study|Withdrawal by Subject|2|||
94687597|NCT00077636|324311677|FG001|Overall Study|Withdrawal by Subject|2|||
94687598|NCT00077636|324311676|FG000|Overall Study|Adverse Event|17|||
94687599|NCT00077636|324311677|FG001|Overall Study|Adverse Event|34|||
94687600|NCT00077636|324311676|FG000|Overall Study|Protocol Violation|0|||
94687601|NCT00077636|324311677|FG001|Overall Study|Protocol Violation|2|||
94687602|NCT00077636|324311676|FG000|Overall Study|Lost to Follow-up|10|||
94687603|NCT00077636|324311677|FG001|Overall Study|Lost to Follow-up|18|||
94687604|NCT00077636|324311676|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
94687605|NCT00077636|324311677|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
94687606|NCT03377790|324311688|FG000|Overall Study|Withdrawal by Subject|1|||
94687607|NCT03377790|324311689|FG001|Overall Study|Withdrawal by Subject|0|||
94687608|NCT03377790|324311688|FG000|Overall Study|Adverse Event|1|||
94687609|NCT03377790|324311689|FG001|Overall Study|Adverse Event|0|||
94687610|NCT03377790|324311688|FG000|Overall Study|Lost to Follow-up|0|||
94687611|NCT03377790|324311689|FG001|Overall Study|Lost to Follow-up|2|||
94687612|NCT03377790|324311688|FG000|Overall Study|Randomized but not treated|1|||
94687613|NCT03377790|324311689|FG001|Overall Study|Randomized but not treated|0|||
94687614|NCT03377790|324311688|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
94687615|NCT03377790|324311689|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
94687616|NCT01533714|324311690|FG000|Overall Study|Adverse Event|0|||
94687617|NCT01533714|324311691|FG001|Overall Study|Adverse Event|1|||
94687618|NCT01533714|324311692|FG002|Overall Study|Adverse Event|2|||
94687619|NCT01533714|324311693|FG003|Overall Study|Adverse Event|2|||
94687620|NCT01533714|324311694|FG004|Overall Study|Adverse Event|2|||
94687621|NCT01533714|324311695|FG005|Overall Study|Adverse Event|1|||
94687622|NCT01533714|324311690|FG000|Overall Study|Lack of Efficacy|0|||
94687623|NCT01533714|324311691|FG001|Overall Study|Lack of Efficacy|0|||
94687624|NCT01533714|324311692|FG002|Overall Study|Lack of Efficacy|0|||
94687625|NCT01533714|324311693|FG003|Overall Study|Lack of Efficacy|0|||
94687626|NCT01533714|324311694|FG004|Overall Study|Lack of Efficacy|0|||
94687627|NCT01533714|324311695|FG005|Overall Study|Lack of Efficacy|1|||
94687628|NCT01533714|324311690|FG000|Overall Study|Withdrawal by Subject|0|||
94687629|NCT01533714|324311691|FG001|Overall Study|Withdrawal by Subject|1|||
94687630|NCT01533714|324311692|FG002|Overall Study|Withdrawal by Subject|0|||
94687631|NCT01533714|324311693|FG003|Overall Study|Withdrawal by Subject|1|||
94687632|NCT01533714|324311694|FG004|Overall Study|Withdrawal by Subject|1|||
94687633|NCT01533714|324311695|FG005|Overall Study|Withdrawal by Subject|0|||
94687634|NCT01533714|324311690|FG000|Overall Study|Exclusion criteria|0|||
94687635|NCT01533714|324311691|FG001|Overall Study|Exclusion criteria|1|||
94687636|NCT01533714|324311692|FG002|Overall Study|Exclusion criteria|0|||
94687637|NCT01533714|324311693|FG003|Overall Study|Exclusion criteria|0|||
94687638|NCT01533714|324311694|FG004|Overall Study|Exclusion criteria|0|||
94687639|NCT01533714|324311695|FG005|Overall Study|Exclusion criteria|0|||
94687640|NCT01533714|324311690|FG000|Overall Study|Positive for purified protein derivative|0|||
94687641|NCT01533714|324311691|FG001|Overall Study|Positive for purified protein derivative|0|||
94687642|NCT01533714|324311692|FG002|Overall Study|Positive for purified protein derivative|1|||
94687643|NCT01533714|324311693|FG003|Overall Study|Positive for purified protein derivative|0|||
94687644|NCT01533714|324311694|FG004|Overall Study|Positive for purified protein derivative|1|||
94687645|NCT01533714|324311695|FG005|Overall Study|Positive for purified protein derivative|0|||
94687646|NCT01533714|324311690|FG000|Overall Study|Withdrawal criteria|0|||
94687647|NCT01533714|324311691|FG001|Overall Study|Withdrawal criteria|0|||
94687648|NCT01533714|324311692|FG002|Overall Study|Withdrawal criteria|1|||
94687649|NCT01533714|324311693|FG003|Overall Study|Withdrawal criteria|0|||
94687650|NCT01533714|324311694|FG004|Overall Study|Withdrawal criteria|3|||
94687651|NCT01533714|324311695|FG005|Overall Study|Withdrawal criteria|1|||
94687652|NCT01533714|324311690|FG000|Overall Study|Ineligibility reason|0|||
94687653|NCT01533714|324311691|FG001|Overall Study|Ineligibility reason|0|||
94687654|NCT01533714|324311692|FG002|Overall Study|Ineligibility reason|0|||
94687655|NCT01533714|324311693|FG003|Overall Study|Ineligibility reason|1|||
94687656|NCT01533714|324311694|FG004|Overall Study|Ineligibility reason|0|||
94687657|NCT01533714|324311695|FG005|Overall Study|Ineligibility reason|0|||
94687658|NCT05033743|324311697|FG000|Overall Study|Lost to Follow-up|1|||
94687659|NCT05033743|324311697|FG000|Overall Study|Protocol Violation|2|||
94687660|NCT05033743|324311697|FG000|Overall Study|Withdrawal by Subject|1|||
94687661|NCT00791921|324311700|FG000|Overall Study|Protocol planed|24|||
94687662|NCT00791921|324311701|FG001|Overall Study|Protocol planed|88|||
94687663|NCT00791921|324311700|FG000|Overall Study|Withdrawal by Subject|1|||
94687664|NCT00791921|324311701|FG001|Overall Study|Withdrawal by Subject|2|||
94687665|NCT00791921|324311700|FG000|Overall Study|Adverse Event|8|||
94687666|NCT00791921|324311701|FG001|Overall Study|Adverse Event|2|||
94687667|NCT00791921|324311700|FG000|Overall Study|Lack of Efficacy|0|||
94687668|NCT00791921|324311701|FG001|Overall Study|Lack of Efficacy|2|||
94687669|NCT00791921|324311700|FG000|Overall Study|Lack of study drug administration|1|||
94687670|NCT00791921|324311701|FG001|Overall Study|Lack of study drug administration|1|||
94687671|NCT00791921|324311700|FG000|Overall Study|Reason other than those above|0|||
94687672|NCT00791921|324311701|FG001|Overall Study|Reason other than those above|1|||
94687673|NCT04537897|324311702|FG000|Overall Study|Other than listed|0|||
94687674|NCT04537897|324311703|FG001|Overall Study|Other than listed|0|||
94687675|NCT04537897|324311704|FG002|Overall Study|Other than listed|0|||
94687676|NCT04537897|324311705|FG003|Overall Study|Other than listed|0|||
94687677|NCT04537897|324311706|FG004|Overall Study|Other than listed|0|||
94687678|NCT04537897|324311707|FG005|Overall Study|Other than listed|0|||
94687679|NCT04537897|324311708|FG006|Overall Study|Other than listed|1|||
94687680|NCT04537897|324311709|FG007|Overall Study|Other than listed|0|||
94687681|NCT04537897|324311710|FG008|Overall Study|Other than listed|0|||
94687682|NCT04537897|324311702|FG000|Overall Study|Adverse Event|0|||
94687683|NCT04537897|324311703|FG001|Overall Study|Adverse Event|0|||
94687684|NCT04537897|324311704|FG002|Overall Study|Adverse Event|0|||
94687685|NCT04537897|324311705|FG003|Overall Study|Adverse Event|1|||
94687686|NCT04537897|324311706|FG004|Overall Study|Adverse Event|0|||
94687687|NCT04537897|324311707|FG005|Overall Study|Adverse Event|0|||
94687688|NCT04537897|324311708|FG006|Overall Study|Adverse Event|0|||
94687689|NCT04537897|324311709|FG007|Overall Study|Adverse Event|0|||
94687690|NCT04537897|324311710|FG008|Overall Study|Adverse Event|0|||
94687691|NCT04537897|324311702|FG000|Overall Study|Withdrawal by Subject|0|||
94687692|NCT04537897|324311703|FG001|Overall Study|Withdrawal by Subject|1|||
94687693|NCT04537897|324311704|FG002|Overall Study|Withdrawal by Subject|0|||
94687694|NCT04537897|324311705|FG003|Overall Study|Withdrawal by Subject|0|||
94687695|NCT04537897|324311706|FG004|Overall Study|Withdrawal by Subject|0|||
94687696|NCT04537897|324311707|FG005|Overall Study|Withdrawal by Subject|0|||
94687697|NCT04537897|324311708|FG006|Overall Study|Withdrawal by Subject|0|||
94687698|NCT04537897|324311709|FG007|Overall Study|Withdrawal by Subject|0|||
94687699|NCT04537897|324311710|FG008|Overall Study|Withdrawal by Subject|0|||
94687700|NCT01130883|324311711|FG000|Overall Study|Patient Noncompliance|6|||
94687701|NCT01130883|324311711|FG000|Overall Study|Reason Unknown|1|||
94687702|NCT01130883|324311711|FG000|Overall Study|Adverse Event|3|||
94687703|NCT03029780|324311712|FG000|Overall Study|Disease Progression|20|||
94687704|NCT03029780|324311713|FG001|Overall Study|Disease Progression|22|||
94687705|NCT03029780|324311712|FG000|Overall Study|Study Drug Toxicity|15|||
94687706|NCT03029780|324311713|FG001|Overall Study|Study Drug Toxicity|11|||
94687707|NCT03029780|324311712|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
94687708|NCT03029780|324311713|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
94687709|NCT03029780|324311712|FG000|Overall Study|Participant request to discontinue study treatment|4|||
94687710|NCT03029780|324311713|FG001|Overall Study|Participant request to discontinue study treatment|1|||
94687711|NCT03029780|324311712|FG000|Overall Study|Maximum clinical benefit|1|||
94687712|NCT03029780|324311713|FG001|Overall Study|Maximum clinical benefit|0|||
94687713|NCT03029780|324311712|FG000|Overall Study|Participant no longer meets study criteria|0|||
94687714|NCT03029780|324311713|FG001|Overall Study|Participant no longer meets study criteria|1|||
94687715|NCT03029780|324311712|FG000|Overall Study|Other reasons|6|||
94687716|NCT03029780|324311713|FG001|Overall Study|Other reasons|6|||
94687717|NCT03029780|324311712|FG000|Overall Study|Not reported|1|||
94687718|NCT03029780|324311713|FG001|Overall Study|Not reported|1|||
94687719|NCT03029780|324311712|FG000|Overall Study|Death|2|||
94687720|NCT03029780|324311713|FG001|Overall Study|Death|6|||
94687721|NCT03321006|324311714|FG000|Overall Study|Death|1|||
94687722|NCT03321006|324311715|FG001|Overall Study|Death|0|||
94687723|NCT03321006|324311714|FG000|Overall Study|Lack of Efficacy|1|||
94687724|NCT03321006|324311715|FG001|Overall Study|Lack of Efficacy|0|||
94687725|NCT04161807|324311718|FG000|Overall Study|Withdrawal by Subject|2|||
94687726|NCT04161807|324311718|FG000|Overall Study|Performed only 1 treatment|2|||
94687727|NCT02091739|324311723|FG000|MP: 16 Weeks|Adverse Event|1|||
94687728|NCT02091739|324311724|FG001|MP: 16 Weeks|Adverse Event|1|||
94687729|NCT02091739|324311725|FG002|MP: 16 Weeks|Adverse Event|1|||
94687730|NCT02091739|324311726|FG003|MP: 16 Weeks|Adverse Event|0|||
94687731|NCT02091739|324311727|FG004|MP: 16 Weeks|Adverse Event|0|||
94687732|NCT02091739|324311723|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
94687733|NCT02091739|324311724|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
94687734|NCT02091739|324311725|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
94687735|NCT02091739|324311726|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
94687736|NCT02091739|324311727|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
94687737|NCT02091739|324311723|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
94687738|NCT02091739|324311724|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
94687739|NCT02091739|324311725|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
94687740|NCT02091739|324311726|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
94687741|NCT02091739|324311727|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
94687742|NCT02091739|324311723|FG000|EP: 48 Weeks|Other|0|||
94687743|NCT02091739|324311724|FG001|EP: 48 Weeks|Other|0|||
94687744|NCT02091739|324311725|FG002|EP: 48 Weeks|Other|0|||
94687745|NCT02091739|324311726|FG003|EP: 48 Weeks|Other|1|||
94687746|NCT02091739|324311727|FG004|EP: 48 Weeks|Other|0|||
94687747|NCT02091739|324311723|FG000|EP: 48 Weeks|Death|0|||
94687748|NCT02091739|324311724|FG001|EP: 48 Weeks|Death|0|||
94687749|NCT02091739|324311725|FG002|EP: 48 Weeks|Death|0|||
94687750|NCT02091739|324311726|FG003|EP: 48 Weeks|Death|3|||
94687751|NCT02091739|324311727|FG004|EP: 48 Weeks|Death|2|||
94687752|NCT02091739|324311723|FG000|EP: 48 Weeks|Adverse Event|0|||
94687753|NCT02091739|324311724|FG001|EP: 48 Weeks|Adverse Event|0|||
94687754|NCT02091739|324311725|FG002|EP: 48 Weeks|Adverse Event|0|||
94687755|NCT02091739|324311726|FG003|EP: 48 Weeks|Adverse Event|2|||
94687756|NCT02091739|324311727|FG004|EP: 48 Weeks|Adverse Event|6|||
94687757|NCT02091739|324311723|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
94687758|NCT02091739|324311724|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
94687759|NCT02091739|324311725|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
94687760|NCT02091739|324311726|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
94687761|NCT02091739|324311727|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
94687762|NCT02086552|324311728|FG000|Overall Study|Withdrawal by Subject|1|||
94687763|NCT00708305|324311729|FG000|Period 1|Protocol Violation|1|||
94687764|NCT00708305|324311730|FG001|Period 1|Protocol Violation|0|||
94687765|NCT00708305|324311731|FG002|Period 1|Protocol Violation|1|||
94687766|NCT00708305|324311732|FG003|Period 1|Protocol Violation|0|||
94687767|NCT00708305|324311729|FG000|Period 1|Other Reason|0|||
94687768|NCT00708305|324311730|FG001|Period 1|Other Reason|0|||
94687769|NCT00708305|324311731|FG002|Period 1|Other Reason|0|||
94687770|NCT00708305|324311732|FG003|Period 1|Other Reason|2|||
94687771|NCT00708305|324311729|FG000|Period 2|Lost to Follow-up|0|||
94687772|NCT00708305|324311730|FG001|Period 2|Lost to Follow-up|1|||
94687773|NCT00708305|324311731|FG002|Period 2|Lost to Follow-up|0|||
94687774|NCT00708305|324311732|FG003|Period 2|Lost to Follow-up|0|||
94687775|NCT00708305|324311729|FG000|Period 2|Protocol Violation|0|||
94687776|NCT00708305|324311730|FG001|Period 2|Protocol Violation|1|||
94687777|NCT00708305|324311731|FG002|Period 2|Protocol Violation|0|||
94687778|NCT00708305|324311732|FG003|Period 2|Protocol Violation|0|||
94687779|NCT00708305|324311729|FG000|Period 2|Other Reason|1|||
94687780|NCT00708305|324311730|FG001|Period 2|Other Reason|0|||
94687781|NCT00708305|324311731|FG002|Period 2|Other Reason|0|||
94687782|NCT00708305|324311732|FG003|Period 2|Other Reason|1|||
94687783|NCT00708305|324311729|FG000|Period 3|Protocol Violation|0|||
94687784|NCT00708305|324311730|FG001|Period 3|Protocol Violation|2|||
94687785|NCT00708305|324311731|FG002|Period 3|Protocol Violation|0|||
94687786|NCT00708305|324311732|FG003|Period 3|Protocol Violation|0|||
94687787|NCT00708305|324311729|FG000|Period 3|Other Reason|1|||
94687788|NCT00708305|324311730|FG001|Period 3|Other Reason|0|||
94687789|NCT00708305|324311731|FG002|Period 3|Other Reason|0|||
94687790|NCT00708305|324311732|FG003|Period 3|Other Reason|0|||
94687791|NCT02823964|324311733|FG000|Overall Study|Adverse Event|2|||
94687792|NCT02823964|324311733|FG000|Overall Study|Physician Decision|1|||
94687793|NCT02823964|324311733|FG000|Overall Study|Lack of Efficacy|1|||
94687794|NCT02823964|324311733|FG000|Overall Study|Withdrawal by Subject|1|||
94687795|NCT04789577|324311737|FG000|Overall Study|Withdrawal by Subject|1|||
94687796|NCT04789577|324311738|FG001|Overall Study|Withdrawal by Subject|1|||
94687797|NCT04789577|324311739|FG002|Overall Study|Withdrawal by Subject|1|||
94687798|NCT04789577|324311740|FG003|Overall Study|Withdrawal by Subject|3|||
94687799|NCT04789577|324311741|FG004|Overall Study|Withdrawal by Subject|1|||
94687800|NCT04789577|324311742|FG005|Overall Study|Withdrawal by Subject|7|||
94687801|NCT04789577|324311743|FG006|Overall Study|Withdrawal by Subject|1|||
94687802|NCT04789577|324311737|FG000|Overall Study|Lost to Follow-up|7|||
94687803|NCT04789577|324311738|FG001|Overall Study|Lost to Follow-up|12|||
94687804|NCT04789577|324311739|FG002|Overall Study|Lost to Follow-up|7|||
94687805|NCT04789577|324311740|FG003|Overall Study|Lost to Follow-up|10|||
94687806|NCT04789577|324311741|FG004|Overall Study|Lost to Follow-up|8|||
94687807|NCT04789577|324311742|FG005|Overall Study|Lost to Follow-up|6|||
94687808|NCT04789577|324311743|FG006|Overall Study|Lost to Follow-up|10|||
94687809|NCT04789577|324311737|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
94687810|NCT04789577|324311738|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
94687811|NCT04789577|324311739|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
94687812|NCT04789577|324311740|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
94687813|NCT04789577|324311741|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
94687814|NCT04789577|324311742|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
94687815|NCT04789577|324311743|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
94687816|NCT04789577|324311737|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
94687817|NCT04789577|324311738|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
94687818|NCT04789577|324311739|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
94687819|NCT04789577|324311740|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
94687820|NCT04789577|324311741|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
94365285|NCT00568776|323122344|FG000|Overall Study|Lack of Efficacy|2|||
94687821|NCT04789577|324311742|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
94687822|NCT04789577|324311743|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
94687823|NCT01827254|324311744|FG000|Overall Study|Death|10|||
94687824|NCT01827254|324311744|FG000|Overall Study|Case report form not completed|4|||
94365286|NCT00568776|323122345|FG001|Overall Study|Lack of Efficacy|2|||
94365287|NCT00568776|323122346|FG002|Overall Study|Lack of Efficacy|2|||
94365288|NCT00568776|323122347|FG003|Overall Study|Lack of Efficacy|4|||
94365289|NCT00568776|323122344|FG000|Overall Study|Lost to Follow-up|1|||
94365290|NCT00568776|323122345|FG001|Overall Study|Lost to Follow-up|1|||
94365291|NCT00568776|323122346|FG002|Overall Study|Lost to Follow-up|1|||
94687825|NCT01827254|324311744|FG000|Overall Study|Invalidated centre|3|||
94365292|NCT00568776|323122347|FG003|Overall Study|Lost to Follow-up|1|||
94365293|NCT00568776|323122344|FG000|Overall Study|Protocol Violation|1|||
94365294|NCT00568776|323122345|FG001|Overall Study|Protocol Violation|0|||
94365295|NCT00568776|323122346|FG002|Overall Study|Protocol Violation|1|||
94365296|NCT00568776|323122347|FG003|Overall Study|Protocol Violation|1|||
94365297|NCT00568776|323122344|FG000|Overall Study|Withdrawal by Subject|13|||
94365298|NCT00568776|323122345|FG001|Overall Study|Withdrawal by Subject|15|||
94365299|NCT00568776|323122346|FG002|Overall Study|Withdrawal by Subject|13|||
94365300|NCT00568776|323122347|FG003|Overall Study|Withdrawal by Subject|7|||
94365301|NCT00568776|323122344|FG000|Overall Study|Loss of Caregiver|0|||
94365302|NCT00568776|323122345|FG001|Overall Study|Loss of Caregiver|2|||
94365303|NCT00568776|323122346|FG002|Overall Study|Loss of Caregiver|1|||
94365304|NCT00568776|323122347|FG003|Overall Study|Loss of Caregiver|2|||
94365305|NCT00568776|323122344|FG000|Overall Study|Sponsor Decision|2|||
94365306|NCT00568776|323122345|FG001|Overall Study|Sponsor Decision|2|||
94365307|NCT00568776|323122346|FG002|Overall Study|Sponsor Decision|41|||
94365308|NCT00568776|323122347|FG003|Overall Study|Sponsor Decision|42|||
94365309|NCT00568776|323122344|FG000|Overall Study|Miscellaeneous|3|||
94365310|NCT00568776|323122345|FG001|Overall Study|Miscellaeneous|3|||
94365311|NCT00568776|323122346|FG002|Overall Study|Miscellaeneous|1|||
94365312|NCT00568776|323122347|FG003|Overall Study|Miscellaeneous|4|||
94365313|NCT03869684|323122350|FG000|Overall Study|Adverse Event|0|||
94365314|NCT03869684|323122351|FG001|Overall Study|Adverse Event|3|||
94687826|NCT01827254|324311744|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
94687827|NCT01827254|324311744|FG000|Overall Study|Did not complete re-challenge|1|||
94687828|NCT01827254|324311744|FG000|Overall Study|Disease progression|36|||
94687829|NCT01827254|324311744|FG000|Overall Study|Intolerance to treatment|4|||
94687830|NCT02222896|324311749|FG000|Abdomen|Did not qualify|34|||
94687831|NCT02222896|324311750|FG001|Abdomen|Did not qualify|10|||
94687832|NCT02222896|324311751|FG002|Abdomen|Did not qualify|32|||
94687833|NCT02222896|324311749|FG000|Groin|Did not qualify|43|||
94687834|NCT02222896|324311750|FG001|Groin|Did not qualify|9|||
94687835|NCT02222896|324311751|FG002|Groin|Did not qualify|40|||
94687836|NCT04848662|324311752|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
94687837|NCT04848662|324311753|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
94687838|NCT01844115|324311756|FG000|Overall Study|Adverse Event|4|||
94687839|NCT01844115|324311757|FG001|Overall Study|Adverse Event|22|||
94687840|NCT01844115|324311756|FG000|Overall Study|Lack of Efficacy|1|||
94687841|NCT01844115|324311757|FG001|Overall Study|Lack of Efficacy|4|||
94687842|NCT01844115|324311756|FG000|Overall Study|Protocol Violation|12|||
94687843|NCT01844115|324311757|FG001|Overall Study|Protocol Violation|10|||
94687844|NCT01844115|324311756|FG000|Overall Study|Withdrawal by Subject|11|||
94687845|NCT01844115|324311757|FG001|Overall Study|Withdrawal by Subject|11|||
94687846|NCT01844115|324311756|FG000|Overall Study|Lost to Follow-up|11|||
94687847|NCT01844115|324311757|FG001|Overall Study|Lost to Follow-up|10|||
94687848|NCT01844115|324311756|FG000|Overall Study|Pregnancy|0|||
94687849|NCT01844115|324311757|FG001|Overall Study|Pregnancy|1|||
94687850|NCT00993317|324311758|FG000|Overall Study|Adverse Event|2|||
94687851|NCT00993317|324311759|FG001|Overall Study|Adverse Event|4|||
94687852|NCT00993317|324311758|FG000|Overall Study|Lack of Efficacy|18|||
94687853|NCT00993317|324311759|FG001|Overall Study|Lack of Efficacy|18|||
94687854|NCT00993317|324311758|FG000|Overall Study|Withdrawal by Subject|0|||
94687855|NCT00993317|324311759|FG001|Overall Study|Withdrawal by Subject|2|||
94687856|NCT00993317|324311758|FG000|Overall Study|Investigator's opinion|0|||
94365315|NCT03869684|323122352|FG002|Overall Study|Adverse Event|1|||
94365316|NCT03869684|323122350|FG000|Overall Study|Withdrawal by Subject|1|||
94465611|NCT01546038|323494885|FG004|Overall Study|Death|9|||
94687857|NCT00993317|324311759|FG001|Overall Study|Investigator's opinion|1|||
94687858|NCT00993317|324311758|FG000|Overall Study|Early study termination at the site|1|||
94465612|NCT01546038|323494886|FG005|Overall Study|Death|3|||
94365317|NCT03869684|323122351|FG001|Overall Study|Withdrawal by Subject|0|||
94365318|NCT03869684|323122352|FG002|Overall Study|Withdrawal by Subject|0|||
94687859|NCT00993317|324311759|FG001|Overall Study|Early study termination at the site|0|||
94687860|NCT00366301|324311760|FG000|Overall Study|Lost to Follow-up|4|||
94687861|NCT00366301|324311761|FG001|Overall Study|Lost to Follow-up|4|||
94465613|NCT01546038|323494887|FG006|Overall Study|Death|46|||
94465614|NCT01546038|323494888|FG007|Overall Study|Death|76|||
94465615|NCT01546038|323494889|FG008|Overall Study|Death|39|||
94365319|NCT03869684|323122350|FG000|Overall Study|Lost to Follow-up|1|||
94465616|NCT01546038|323494881|FG000|Overall Study|Lost to Follow-up|0|||
94687862|NCT00366301|324311762|FG002|Overall Study|Lost to Follow-up|3|||
94687863|NCT00366301|324311763|FG003|Overall Study|Lost to Follow-up|7|||
94687864|NCT00366301|324311760|FG000|Overall Study|Withdrawal by Subject|4|||
94687865|NCT00366301|324311761|FG001|Overall Study|Withdrawal by Subject|2|||
94687866|NCT00366301|324311762|FG002|Overall Study|Withdrawal by Subject|1|||
94687867|NCT00366301|324311763|FG003|Overall Study|Withdrawal by Subject|1|||
94687868|NCT01830881|324311769|FG000|Overall Study|Changed decision to have an abortion|0|||
94687869|NCT01830881|324311770|FG001|Overall Study|Changed decision to have an abortion|1|||
94687870|NCT02838628|324311779|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
94687871|NCT02838628|324311780|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
94687872|NCT02838628|324311779|FG000|Recurrence Follow-up Period|Adverse Event|1|||
94687873|NCT02838628|324311780|FG001|Recurrence Follow-up Period|Adverse Event|0|||
94687874|NCT02838628|324311779|FG000|Recurrence Follow-up Period|Non-compliance|0|||
94687875|NCT02838628|324311780|FG001|Recurrence Follow-up Period|Non-compliance|1|||
94687876|NCT02838628|324311779|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
94687877|NCT02838628|324311780|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
94687878|NCT02838628|324311779|FG000|Recurrence Follow-up Period|Other un-specified|1|||
94687879|NCT02838628|324311780|FG001|Recurrence Follow-up Period|Other un-specified|1|||
94687880|NCT02611830|324311782|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
94687881|NCT02611830|324311783|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
94687882|NCT02611830|324311784|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
94687883|NCT02611830|324311785|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
94687884|NCT02611830|324311782|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
94687885|NCT02611830|324311783|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
94687886|NCT02611830|324311784|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
94687887|NCT02611830|324311785|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
94687888|NCT02611830|324311782|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
94687889|NCT02611830|324311783|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
94687890|NCT02611830|324311784|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
94687891|NCT02611830|324311785|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
94687892|NCT02611830|324311782|FG000|OL Induction Phase|Lack of Efficacy|9|||
94687893|NCT02611830|324311783|FG001|OL Induction Phase|Lack of Efficacy|0|||
94687894|NCT02611830|324311784|FG002|OL Induction Phase|Lack of Efficacy|0|||
94687895|NCT02611830|324311785|FG003|OL Induction Phase|Lack of Efficacy|0|||
94687896|NCT02611830|324311782|FG000|OL Induction Phase|Reason not specified|3|||
94687897|NCT02611830|324311783|FG001|OL Induction Phase|Reason not specified|0|||
94687898|NCT02611830|324311784|FG002|OL Induction Phase|Reason not specified|0|||
94687899|NCT02611830|324311785|FG003|OL Induction Phase|Reason not specified|0|||
94687900|NCT02611830|324311782|FG000|Maintenance Phase|Lack of Efficacy|0|||
94687901|NCT02611830|324311783|FG001|Maintenance Phase|Lack of Efficacy|29|||
94687902|NCT02611830|324311784|FG002|Maintenance Phase|Lack of Efficacy|18|||
94687903|NCT02611830|324311785|FG003|Maintenance Phase|Lack of Efficacy|6|||
94687904|NCT02611830|324311782|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
94687905|NCT02611830|324311783|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
94687906|NCT02611830|324311784|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
94687907|NCT02611830|324311785|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
94687908|NCT02611830|324311782|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
94687909|NCT02611830|324311783|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
94687910|NCT02611830|324311784|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
94687911|NCT02611830|324311785|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
94687912|NCT02611830|324311782|FG000|Maintenance Phase|Lost to Follow-up|0|||
94687913|NCT02611830|324311783|FG001|Maintenance Phase|Lost to Follow-up|0|||
94687914|NCT02611830|324311784|FG002|Maintenance Phase|Lost to Follow-up|0|||
94687915|NCT02611830|324311785|FG003|Maintenance Phase|Lost to Follow-up|1|||
94687916|NCT02611830|324311782|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
94687917|NCT02611830|324311783|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
94687918|NCT02611830|324311784|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
94687919|NCT02611830|324311785|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
94687920|NCT02611830|324311782|FG000|Maintenance Phase|Pregnancy|0|||
94687921|NCT02611830|324311783|FG001|Maintenance Phase|Pregnancy|0|||
94687922|NCT02611830|324311784|FG002|Maintenance Phase|Pregnancy|1|||
94687923|NCT02611830|324311785|FG003|Maintenance Phase|Pregnancy|0|||
94687924|NCT02611830|324311782|FG000|Maintenance Phase|Reason not specified|0|||
94687925|NCT02611830|324311783|FG001|Maintenance Phase|Reason not specified|1|||
94687926|NCT02611830|324311784|FG002|Maintenance Phase|Reason not specified|4|||
94687927|NCT02611830|324311785|FG003|Maintenance Phase|Reason not specified|0|||
94687928|NCT01794117|324311788|FG000|Overall Study|Adverse Event|1|||
94687929|NCT01794117|324311789|FG001|Overall Study|Adverse Event|0|||
94687930|NCT01794117|324311790|FG002|Overall Study|Adverse Event|0|||
94687931|NCT01794117|324311791|FG003|Overall Study|Adverse Event|0|||
94687932|NCT01794117|324311788|FG000|Overall Study|Participant noncompliance|0|||
94687933|NCT01794117|324311789|FG001|Overall Study|Participant noncompliance|1|||
94687934|NCT01794117|324311790|FG002|Overall Study|Participant noncompliance|0|||
94687935|NCT01794117|324311791|FG003|Overall Study|Participant noncompliance|0|||
94687936|NCT01794117|324311788|FG000|Overall Study|Refused further treatment|0|||
94687937|NCT01794117|324311789|FG001|Overall Study|Refused further treatment|2|||
94687938|NCT01794117|324311790|FG002|Overall Study|Refused further treatment|0|||
94687939|NCT01794117|324311791|FG003|Overall Study|Refused further treatment|0|||
94687940|NCT00195715|324311792|FG000|Overall Study|Adverse Event|122|||
94687941|NCT00195715|324311792|FG000|Overall Study|Withdrawal by Subject|58|||
94687942|NCT00195715|324311792|FG000|Overall Study|Lost to Follow-up|27|||
94687943|NCT00195715|324311792|FG000|Overall Study|Protocol Violation|13|||
94687944|NCT00195715|324311792|FG000|Overall Study|Lack of Efficacy|93|||
94687945|NCT00195715|324311792|FG000|Overall Study|Pregnancy|14|||
94687946|NCT00195715|324311792|FG000|Overall Study|Investigative site closure|8|||
94687947|NCT00195715|324311792|FG000|Overall Study|Subject moved/relocated|7|||
94687948|NCT00195715|324311792|FG000|Overall Study|Subject non-compliance|6|||
94687949|NCT00195715|324311792|FG000|Overall Study|Subject started commercial Humira|5|||
94687950|NCT00195715|324311792|FG000|Overall Study|Subject choice|3|||
94365320|NCT03869684|323122351|FG001|Overall Study|Lost to Follow-up|0|||
94365321|NCT03869684|323122352|FG002|Overall Study|Lost to Follow-up|0|||
94687951|NCT00195715|324311792|FG000|Overall Study|Loss of response/no improvement|3|||
94687952|NCT00195715|324311792|FG000|Overall Study|Sponsor stopped study|1|||
94687953|NCT00195715|324311792|FG000|Overall Study|Administrative reasons|2|||
94687954|NCT00195715|324311792|FG000|Overall Study|Investigator's decision|2|||
94687955|NCT00195715|324311792|FG000|Overall Study|Subject wants to get pregnant|4|||
94687956|NCT00195715|324311792|FG000|Overall Study|Use of prohibited medication|2|||
94365322|NCT03869684|323122350|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
94365323|NCT03869684|323122351|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
94365324|NCT03869684|323122352|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
94365325|NCT01005680|323122353|FG000|Overall Study|Lost to Follow-up|4|||
94365326|NCT01005680|323122354|FG001|Overall Study|Lost to Follow-up|6|||
94365327|NCT01005680|323122353|FG000|Overall Study|Withdrawal by Subject|1|||
94365328|NCT01005680|323122354|FG001|Overall Study|Withdrawal by Subject|4|||
94365329|NCT01005680|323122353|FG000|Overall Study|Physician Decision|1|||
94365330|NCT01005680|323122354|FG001|Overall Study|Physician Decision|1|||
94365331|NCT03576131|323122355|FG000|Overall Study|Investigator decision|0|||
94365332|NCT03576131|323122356|FG001|Overall Study|Investigator decision|0|||
94365333|NCT03576131|323122357|FG002|Overall Study|Investigator decision|0|||
94365334|NCT03576131|323122358|FG003|Overall Study|Investigator decision|1|||
94365335|NCT03576131|323122359|FG004|Overall Study|Investigator decision|0|||
94365336|NCT03576131|323122360|FG005|Overall Study|Investigator decision|1|||
94365337|NCT03576131|323122361|FG006|Overall Study|Investigator decision|0|||
94365338|NCT03576131|323122362|FG007|Overall Study|Investigator decision|0|||
94365339|NCT03576131|323122355|FG000|Overall Study|Withdrawal by Subject|1|||
94365340|NCT03576131|323122356|FG001|Overall Study|Withdrawal by Subject|1|||
94365341|NCT03576131|323122357|FG002|Overall Study|Withdrawal by Subject|0|||
94365342|NCT03576131|323122358|FG003|Overall Study|Withdrawal by Subject|1|||
94365343|NCT03576131|323122359|FG004|Overall Study|Withdrawal by Subject|2|||
94365344|NCT03576131|323122360|FG005|Overall Study|Withdrawal by Subject|3|||
94365345|NCT03576131|323122361|FG006|Overall Study|Withdrawal by Subject|1|||
94365346|NCT03576131|323122362|FG007|Overall Study|Withdrawal by Subject|0|||
94365347|NCT03576131|323122355|FG000|Overall Study|Death|3|||
94365348|NCT03576131|323122356|FG001|Overall Study|Death|3|||
94365349|NCT03576131|323122357|FG002|Overall Study|Death|1|||
94365350|NCT03576131|323122358|FG003|Overall Study|Death|5|||
94365351|NCT03576131|323122359|FG004|Overall Study|Death|4|||
94365352|NCT03576131|323122360|FG005|Overall Study|Death|1|||
94365353|NCT03576131|323122361|FG006|Overall Study|Death|0|||
94365354|NCT03576131|323122362|FG007|Overall Study|Death|1|||
94365355|NCT03576131|323122355|FG000|Overall Study|New anti-cancer treatment|5|||
94365356|NCT03576131|323122356|FG001|Overall Study|New anti-cancer treatment|1|||
94687957|NCT00195715|324311792|FG000|Overall Study|Planned surgery|2|||
94687958|NCT00195715|324311792|FG000|Overall Study|Increased infection rate|1|||
94687959|NCT00195715|324311792|FG000|Overall Study|Ineligible|1|||
94687960|NCT00195715|324311792|FG000|Overall Study|Colonic stricture|1|||
94687961|NCT00195715|324311792|FG000|Overall Study|Sponsor discontinued trial|1|||
94687962|NCT00195715|324311792|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
94687963|NCT02961374|324311793|FG000|Overall Study|Adverse Event|4|||
94687964|NCT00514046|324311794|FG000|Overall Study|transferred to another protocol|2|||
94687965|NCT00514046|324311795|FG001|Overall Study|transferred to another protocol|1|||
94687966|NCT00514046|324311796|FG002|Overall Study|transferred to another protocol|3|||
94365357|NCT03576131|323122357|FG002|Overall Study|New anti-cancer treatment|2|||
94365358|NCT03576131|323122358|FG003|Overall Study|New anti-cancer treatment|3|||
94365359|NCT03576131|323122359|FG004|Overall Study|New anti-cancer treatment|0|||
94365360|NCT03576131|323122360|FG005|Overall Study|New anti-cancer treatment|0|||
94687967|NCT00514046|324311797|FG003|Overall Study|transferred to another protocol|0|||
94365361|NCT03576131|323122361|FG006|Overall Study|New anti-cancer treatment|0|||
94365362|NCT03576131|323122362|FG007|Overall Study|New anti-cancer treatment|0|||
94687968|NCT00514046|324311798|FG004|Overall Study|transferred to another protocol|1|||
94365363|NCT03576131|323122355|FG000|Overall Study|Unspecified reason|0|||
94687969|NCT00514046|324311799|FG005|Overall Study|transferred to another protocol|0|||
94687970|NCT00514046|324311800|FG006|Overall Study|transferred to another protocol|0|||
94687971|NCT00514046|324311801|FG007|Overall Study|transferred to another protocol|0|||
94687972|NCT00514046|324311802|FG008|Overall Study|transferred to another protocol|0|||
94687973|NCT00514046|324311794|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
94687974|NCT00514046|324311795|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
94687975|NCT00514046|324311796|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
94687976|NCT00514046|324311797|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
94687977|NCT00514046|324311798|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
94687978|NCT00514046|324311799|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
94687979|NCT00514046|324311800|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
94687980|NCT00514046|324311801|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
94687981|NCT00514046|324311802|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
94687982|NCT00514046|324311794|FG000|Overall Study|Disease progression on study|0|||
94687983|NCT00514046|324311795|FG001|Overall Study|Disease progression on study|0|||
94687984|NCT00514046|324311796|FG002|Overall Study|Disease progression on study|2|||
94687985|NCT00514046|324311797|FG003|Overall Study|Disease progression on study|0|||
94687986|NCT00514046|324311798|FG004|Overall Study|Disease progression on study|0|||
94687987|NCT00514046|324311799|FG005|Overall Study|Disease progression on study|1|||
94687988|NCT00514046|324311800|FG006|Overall Study|Disease progression on study|0|||
94687989|NCT00514046|324311801|FG007|Overall Study|Disease progression on study|0|||
94687990|NCT00514046|324311802|FG008|Overall Study|Disease progression on study|0|||
94687991|NCT01734434|324311803|FG000|Overall Study|Death Infant|3|||
94687992|NCT01734434|324311804|FG001|Overall Study|Death Infant|1|||
94687993|NCT01734434|324311805|FG002|Overall Study|Death Infant|17|||
94687994|NCT01734434|324311806|FG003|Overall Study|Death Infant|5|||
94687995|NCT01734434|324311803|FG000|Overall Study|Lost to Follow-up|2|||
94687996|NCT01734434|324311804|FG001|Overall Study|Lost to Follow-up|9|||
94687997|NCT01734434|324311805|FG002|Overall Study|Lost to Follow-up|67|||
94687998|NCT01734434|324311806|FG003|Overall Study|Lost to Follow-up|11|||
94687999|NCT01734434|324311803|FG000|Overall Study|No Live Birth|1|||
94688000|NCT01734434|324311804|FG001|Overall Study|No Live Birth|2|||
94688001|NCT01734434|324311805|FG002|Overall Study|No Live Birth|32|||
94688002|NCT01734434|324311806|FG003|Overall Study|No Live Birth|6|||
94688003|NCT01734434|324311803|FG000|Overall Study|Withdrawal by Subject|4|||
94688004|NCT01734434|324311804|FG001|Overall Study|Withdrawal by Subject|0|||
94688005|NCT01734434|324311805|FG002|Overall Study|Withdrawal by Subject|8|||
94688006|NCT01734434|324311806|FG003|Overall Study|Withdrawal by Subject|1|||
94688007|NCT01734434|324311803|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
94688008|NCT01734434|324311804|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
94688009|NCT01734434|324311805|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
94688010|NCT01734434|324311806|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
94688011|NCT01734434|324311803|FG000|Overall Study|Subject Not Reachable|0|||
94688012|NCT01734434|324311804|FG001|Overall Study|Subject Not Reachable|0|||
94688013|NCT01734434|324311805|FG002|Overall Study|Subject Not Reachable|1|||
94688014|NCT01734434|324311806|FG003|Overall Study|Subject Not Reachable|0|||
94688015|NCT01734434|324311803|FG000|Overall Study|Treatment Defaulter|0|||
94688016|NCT01734434|324311804|FG001|Overall Study|Treatment Defaulter|0|||
94688017|NCT01734434|324311805|FG002|Overall Study|Treatment Defaulter|1|||
94688018|NCT01734434|324311806|FG003|Overall Study|Treatment Defaulter|0|||
94688019|NCT01734434|324311803|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
94688020|NCT01734434|324311804|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
94688021|NCT01734434|324311805|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
94688022|NCT01734434|324311806|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
94688023|NCT01734434|324311803|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
94688024|NCT01734434|324311804|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
94688025|NCT01734434|324311805|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
94688026|NCT01734434|324311806|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
94688027|NCT01051063|324311807|FG000|Overall Study|Death|2|||
94688028|NCT01051063|324311808|FG001|Overall Study|Death|2|||
94688029|NCT01051063|324311807|FG000|Overall Study|Withdrawal by Subject|1|||
94688030|NCT01051063|324311808|FG001|Overall Study|Withdrawal by Subject|1|||
94688031|NCT01051063|324311807|FG000|Overall Study|Termination of the study|5|||
94688032|NCT01051063|324311808|FG001|Overall Study|Termination of the study|0|||
94688033|NCT01051063|324311807|FG000|Overall Study|Moved from the study site area|1|||
94688034|NCT01051063|324311808|FG001|Overall Study|Moved from the study site area|0|||
94688035|NCT01051063|324311807|FG000|Overall Study|Other|1|||
94688036|NCT01051063|324311808|FG001|Overall Study|Other|0|||
94688037|NCT01051063|324311807|FG000|Overall Study|Lost to Follow-up|0|||
94688038|NCT01051063|324311808|FG001|Overall Study|Lost to Follow-up|1|||
94688039|NCT00547911|324311812|FG000|Overall Study|Adverse Event|0|||
94688040|NCT00547911|324311813|FG001|Overall Study|Adverse Event|0|||
94688041|NCT00547911|324311814|FG002|Overall Study|Adverse Event|0|||
94688042|NCT00547911|324311815|FG003|Overall Study|Adverse Event|1|||
94365364|NCT03576131|323122356|FG001|Overall Study|Unspecified reason|0|||
94365365|NCT03576131|323122357|FG002|Overall Study|Unspecified reason|1|||
94365366|NCT03576131|323122358|FG003|Overall Study|Unspecified reason|1|||
94365367|NCT03576131|323122359|FG004|Overall Study|Unspecified reason|1|||
94365368|NCT03576131|323122360|FG005|Overall Study|Unspecified reason|1|||
94365369|NCT03576131|323122361|FG006|Overall Study|Unspecified reason|0|||
94365370|NCT03576131|323122362|FG007|Overall Study|Unspecified reason|0|||
94365371|NCT03576131|323122355|FG000|Overall Study|Subject non-compliance|0|||
94365372|NCT03576131|323122356|FG001|Overall Study|Subject non-compliance|0|||
94365373|NCT03576131|323122357|FG002|Overall Study|Subject non-compliance|0|||
94365374|NCT03576131|323122358|FG003|Overall Study|Subject non-compliance|0|||
94365375|NCT03576131|323122359|FG004|Overall Study|Subject non-compliance|0|||
94365376|NCT03576131|323122360|FG005|Overall Study|Subject non-compliance|1|||
94365377|NCT03576131|323122361|FG006|Overall Study|Subject non-compliance|0|||
94365378|NCT03576131|323122362|FG007|Overall Study|Subject non-compliance|0|||
94365379|NCT02216214|323122375|FG000|Overall Study|Randomized Never Received Study Drug|1|||
94365380|NCT02216214|323122376|FG001|Overall Study|Randomized Never Received Study Drug|0|||
94365381|NCT02216214|323122375|FG000|Overall Study|Adverse Event|10|||
94688043|NCT00547911|324311816|FG004|Overall Study|Adverse Event|0|||
94688044|NCT00547911|324311817|FG005|Overall Study|Adverse Event|0|||
94688045|NCT01254890|324311819|FG000|Overall Study|Ineligible|0|||
94688046|NCT01254890|324311820|FG001|Overall Study|Ineligible|3|||
94688047|NCT01254890|324311819|FG000|Overall Study|Withdrawal by Subject|1|||
94688048|NCT01254890|324311820|FG001|Overall Study|Withdrawal by Subject|2|||
94688049|NCT01254890|324311819|FG000|Overall Study|Disease Progression|0|||
94688050|NCT01254890|324311820|FG001|Overall Study|Disease Progression|5|||
94688051|NCT01078662|324311821|FG000|Overall Study|Death|41|||
94688052|NCT01078662|324311822|FG001|Overall Study|Death|103|||
94688053|NCT01078662|324311823|FG002|Overall Study|Death|18|||
94688054|NCT01078662|324311824|FG003|Overall Study|Death|5|||
94688055|NCT01078662|324311825|FG004|Overall Study|Death|8|||
94688056|NCT01078662|324311821|FG000|Overall Study|Patients reached data cut-off|12|||
94688057|NCT01078662|324311822|FG001|Overall Study|Patients reached data cut-off|53|||
94688058|NCT01078662|324311823|FG002|Overall Study|Patients reached data cut-off|2|||
94688059|NCT01078662|324311824|FG003|Overall Study|Patients reached data cut-off|2|||
94688060|NCT01078662|324311825|FG004|Overall Study|Patients reached data cut-off|3|||
94688061|NCT01078662|324311821|FG000|Overall Study|Withdrawal by Subject|4|||
94688062|NCT01078662|324311822|FG001|Overall Study|Withdrawal by Subject|11|||
94688063|NCT01078662|324311823|FG002|Overall Study|Withdrawal by Subject|1|||
94688064|NCT01078662|324311824|FG003|Overall Study|Withdrawal by Subject|0|||
94688065|NCT01078662|324311825|FG004|Overall Study|Withdrawal by Subject|0|||
94688066|NCT01078662|324311821|FG000|Overall Study|Protocol Violation|0|||
94688067|NCT01078662|324311822|FG001|Overall Study|Protocol Violation|1|||
94688068|NCT01078662|324311823|FG002|Overall Study|Protocol Violation|0|||
94688069|NCT01078662|324311824|FG003|Overall Study|Protocol Violation|0|||
94688070|NCT01078662|324311825|FG004|Overall Study|Protocol Violation|0|||
94688071|NCT01078662|324311821|FG000|Overall Study|Lost to Follow-up|1|||
94688072|NCT01078662|324311822|FG001|Overall Study|Lost to Follow-up|0|||
94688073|NCT01078662|324311823|FG002|Overall Study|Lost to Follow-up|0|||
94688074|NCT01078662|324311824|FG003|Overall Study|Lost to Follow-up|0|||
94688075|NCT01078662|324311825|FG004|Overall Study|Lost to Follow-up|0|||
94365382|NCT02216214|323122376|FG001|Overall Study|Adverse Event|8|||
94365383|NCT02216214|323122375|FG000|Overall Study|Lack of Efficacy|2|||
94688076|NCT04157686|324311827|FG000|Overall Study|Adverse Event|1|||
94688077|NCT04157686|324311828|FG001|Overall Study|Adverse Event|0|||
94688078|NCT04157686|324311829|FG002|Overall Study|Adverse Event|1|||
94688079|NCT04157686|324311830|FG003|Overall Study|Adverse Event|0|||
94688080|NCT04157686|324311831|FG004|Overall Study|Adverse Event|1|||
94688081|NCT04157686|324311832|FG005|Overall Study|Adverse Event|0|||
94688082|NCT04157686|324311833|FG006|Overall Study|Adverse Event|0|||
94688083|NCT04157686|324311834|FG007|Overall Study|Adverse Event|0|||
94365384|NCT02216214|323122376|FG001|Overall Study|Lack of Efficacy|2|||
94365385|NCT02216214|323122375|FG000|Overall Study|Lost to Follow-up|3|||
94365386|NCT02216214|323122376|FG001|Overall Study|Lost to Follow-up|2|||
94688084|NCT04157686|324311827|FG000|Overall Study|Pregnancy|0|||
94688085|NCT04157686|324311828|FG001|Overall Study|Pregnancy|1|||
94365387|NCT02216214|323122375|FG000|Overall Study|Protocol Violation|4|||
94365388|NCT02216214|323122376|FG001|Overall Study|Protocol Violation|2|||
94365389|NCT02216214|323122375|FG000|Overall Study|Withdrawal by Subject|22|||
94365390|NCT02216214|323122376|FG001|Overall Study|Withdrawal by Subject|20|||
94688086|NCT04157686|324311829|FG002|Overall Study|Pregnancy|3|||
94688087|NCT04157686|324311830|FG003|Overall Study|Pregnancy|0|||
94688088|NCT04157686|324311831|FG004|Overall Study|Pregnancy|0|||
94688089|NCT04157686|324311832|FG005|Overall Study|Pregnancy|0|||
94688090|NCT04157686|324311833|FG006|Overall Study|Pregnancy|3|||
94688091|NCT04157686|324311834|FG007|Overall Study|Pregnancy|0|||
94688092|NCT04157686|324311827|FG000|Overall Study|Lost to Follow-up|1|||
94688093|NCT04157686|324311828|FG001|Overall Study|Lost to Follow-up|2|||
94688094|NCT04157686|324311829|FG002|Overall Study|Lost to Follow-up|8|||
94688095|NCT04157686|324311830|FG003|Overall Study|Lost to Follow-up|6|||
94688096|NCT04157686|324311831|FG004|Overall Study|Lost to Follow-up|6|||
94688097|NCT04157686|324311832|FG005|Overall Study|Lost to Follow-up|3|||
94688098|NCT04157686|324311833|FG006|Overall Study|Lost to Follow-up|7|||
94688099|NCT04157686|324311834|FG007|Overall Study|Lost to Follow-up|9|||
94688100|NCT04157686|324311827|FG000|Overall Study|Lack of Efficacy|0|||
94688101|NCT04157686|324311828|FG001|Overall Study|Lack of Efficacy|0|||
94688102|NCT04157686|324311829|FG002|Overall Study|Lack of Efficacy|0|||
94688103|NCT04157686|324311830|FG003|Overall Study|Lack of Efficacy|0|||
94688104|NCT04157686|324311831|FG004|Overall Study|Lack of Efficacy|0|||
94688105|NCT04157686|324311832|FG005|Overall Study|Lack of Efficacy|2|||
94688106|NCT04157686|324311833|FG006|Overall Study|Lack of Efficacy|0|||
94688107|NCT04157686|324311834|FG007|Overall Study|Lack of Efficacy|1|||
94688108|NCT04157686|324311827|FG000|Overall Study|Withdrawal by Subject|10|||
94688109|NCT04157686|324311828|FG001|Overall Study|Withdrawal by Subject|10|||
94688110|NCT04157686|324311829|FG002|Overall Study|Withdrawal by Subject|12|||
94688111|NCT04157686|324311830|FG003|Overall Study|Withdrawal by Subject|20|||
94688112|NCT04157686|324311831|FG004|Overall Study|Withdrawal by Subject|12|||
94688113|NCT04157686|324311832|FG005|Overall Study|Withdrawal by Subject|11|||
94688114|NCT04157686|324311833|FG006|Overall Study|Withdrawal by Subject|18|||
94688115|NCT04157686|324311834|FG007|Overall Study|Withdrawal by Subject|24|||
94688116|NCT04157686|324311827|FG000|Overall Study|Physician Decision|0|||
94688117|NCT04157686|324311828|FG001|Overall Study|Physician Decision|0|||
94688118|NCT04157686|324311829|FG002|Overall Study|Physician Decision|1|||
94688119|NCT04157686|324311830|FG003|Overall Study|Physician Decision|0|||
94688120|NCT04157686|324311831|FG004|Overall Study|Physician Decision|1|||
94688121|NCT04157686|324311832|FG005|Overall Study|Physician Decision|0|||
94688122|NCT04157686|324311833|FG006|Overall Study|Physician Decision|3|||
94688123|NCT04157686|324311834|FG007|Overall Study|Physician Decision|0|||
94688124|NCT04157686|324311827|FG000|Overall Study|Death|0|||
94688125|NCT04157686|324311828|FG001|Overall Study|Death|0|||
94688126|NCT04157686|324311829|FG002|Overall Study|Death|0|||
94688127|NCT04157686|324311830|FG003|Overall Study|Death|2|||
94688128|NCT04157686|324311831|FG004|Overall Study|Death|0|||
94688129|NCT04157686|324311832|FG005|Overall Study|Death|0|||
94688130|NCT04157686|324311833|FG006|Overall Study|Death|0|||
94688131|NCT04157686|324311834|FG007|Overall Study|Death|0|||
94688132|NCT04157686|324311827|FG000|Overall Study|Protocol Violation|0|||
94688133|NCT04157686|324311828|FG001|Overall Study|Protocol Violation|0|||
94688134|NCT04157686|324311829|FG002|Overall Study|Protocol Violation|0|||
94688135|NCT04157686|324311830|FG003|Overall Study|Protocol Violation|0|||
94688136|NCT04157686|324311831|FG004|Overall Study|Protocol Violation|1|||
94688137|NCT04157686|324311832|FG005|Overall Study|Protocol Violation|0|||
94688138|NCT04157686|324311833|FG006|Overall Study|Protocol Violation|0|||
94688139|NCT04157686|324311834|FG007|Overall Study|Protocol Violation|0|||
94688140|NCT04157686|324311827|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
94688141|NCT04157686|324311828|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
94688142|NCT04157686|324311829|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
94688143|NCT04157686|324311830|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
94688144|NCT04157686|324311831|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
94688145|NCT04157686|324311832|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
94688146|NCT04157686|324311833|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
94688147|NCT04157686|324311834|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
94688148|NCT04022889|324313574|FG000|Stage 1: Period 1|Adverse Event|1|||
94688149|NCT04022889|324313575|FG001|Stage 1: Period 1|Adverse Event|0|||
94688150|NCT04022889|324313576|FG002|Stage 1: Period 1|Adverse Event|0|||
94688151|NCT04022889|324313574|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
94688152|NCT04022889|324313575|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
94688153|NCT04022889|324313576|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
94688154|NCT04022889|324313574|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
94688155|NCT04022889|324313575|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
94688156|NCT04022889|324313576|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
94688157|NCT04022889|324313574|FG000|Stage 2|Screen Failure|0|||
94688158|NCT04022889|324313575|FG001|Stage 2|Screen Failure|0|||
94688159|NCT04022889|324313576|FG002|Stage 2|Screen Failure|3|||
94688160|NCT04022889|324313574|FG000|Stage 2|Ineligible for apheresis donation|0|||
94688161|NCT04022889|324313575|FG001|Stage 2|Ineligible for apheresis donation|0|||
94688162|NCT04022889|324313576|FG002|Stage 2|Ineligible for apheresis donation|2|||
94688163|NCT04022889|324313574|FG000|Stage 2|Adverse Event|0|||
94688164|NCT04022889|324313575|FG001|Stage 2|Adverse Event|0|||
94688165|NCT04022889|324313576|FG002|Stage 2|Adverse Event|2|||
94688166|NCT04022889|324313574|FG000|Stage 2|Protocol Violation|0|||
94688167|NCT04022889|324313575|FG001|Stage 2|Protocol Violation|0|||
94688168|NCT04022889|324313576|FG002|Stage 2|Protocol Violation|1|||
94688169|NCT04022889|324313574|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
94688170|NCT04022889|324313575|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
94688171|NCT04022889|324313576|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
94688172|NCT01973491|324313583|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
94688173|NCT01973491|324313583|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
94688174|NCT01973491|324313583|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
94688175|NCT01863043|324313585|FG000|Overall Study|Death|6|||
94688176|NCT01863043|324313586|FG001|Overall Study|Death|1|||
94688177|NCT01863043|324313585|FG000|Overall Study|Withdrawal by Subject|0|||
94688178|NCT01863043|324313586|FG001|Overall Study|Withdrawal by Subject|2|||
94688179|NCT01863043|324313585|FG000|Overall Study|Adverse Event|7|||
94688180|NCT01863043|324313586|FG001|Overall Study|Adverse Event|8|||
94688181|NCT01863043|324313585|FG000|Overall Study|exclusion criteria found after enrollment|0|||
94688182|NCT01863043|324313586|FG001|Overall Study|exclusion criteria found after enrollment|1|||
94688183|NCT00313911|324313587|FG000|Overall Study|Serious adverse event|6|||
94688184|NCT00313911|324313588|FG001|Overall Study|Serious adverse event|1|||
94688185|NCT00313911|324313587|FG000|Overall Study|Adverse Event|2|||
94688186|NCT00313911|324313588|FG001|Overall Study|Adverse Event|3|||
94688187|NCT00313911|324313587|FG000|Overall Study|Protocol Violation|19|||
94688188|NCT00313911|324313588|FG001|Overall Study|Protocol Violation|10|||
94688189|NCT00313911|324313587|FG000|Overall Study|Lost to Follow-up|27|||
94688190|NCT00313911|324313588|FG001|Overall Study|Lost to Follow-up|14|||
94688191|NCT00313911|324313587|FG000|Overall Study|Withdrawal by Subject|39|||
94688192|NCT00313911|324313588|FG001|Overall Study|Withdrawal by Subject|12|||
94688193|NCT00313911|324313587|FG000|Overall Study|Did not meet age criteria|1|||
94688194|NCT00313911|324313588|FG001|Overall Study|Did not meet age criteria|1|||
94688195|NCT01912781|324313589|FG000|Overall Study|Withdrawal by Subject|2|||
94688196|NCT01912781|324313590|FG001|Overall Study|Withdrawal by Subject|0|||
94688197|NCT01987596|324313591|FG000|Overall Study|Physician Decision|1|||
94688198|NCT01987596|324313592|FG001|Overall Study|Physician Decision|0|||
94688199|NCT01987596|324313591|FG000|Overall Study|Progressive Disease; missing all period|0|||
94688200|NCT01987596|324313592|FG001|Overall Study|Progressive Disease; missing all period|1|||
94688201|NCT00854295|324313593|FG000|Overall Study|Death|7|||
94688202|NCT00854295|324313594|FG001|Overall Study|Death|0|||
94688203|NCT00854295|324313595|FG002|Overall Study|Death|1|||
94688204|NCT00854295|324313596|FG003|Overall Study|Death|1|||
94688205|NCT00854295|324313593|FG000|Overall Study|Adverse Event|6|||
94688206|NCT00854295|324313594|FG001|Overall Study|Adverse Event|1|||
94688207|NCT00854295|324313595|FG002|Overall Study|Adverse Event|1|||
94688208|NCT00854295|324313596|FG003|Overall Study|Adverse Event|3|||
94688209|NCT00854295|324313593|FG000|Overall Study|Lost to Follow-up|18|||
94688210|NCT00854295|324313594|FG001|Overall Study|Lost to Follow-up|5|||
94688211|NCT00854295|324313595|FG002|Overall Study|Lost to Follow-up|21|||
94688212|NCT00854295|324313596|FG003|Overall Study|Lost to Follow-up|21|||
94688213|NCT00854295|324313593|FG000|Overall Study|Physician Decision|10|||
94688214|NCT00854295|324313594|FG001|Overall Study|Physician Decision|0|||
94688215|NCT00854295|324313595|FG002|Overall Study|Physician Decision|0|||
94688216|NCT00854295|324313596|FG003|Overall Study|Physician Decision|0|||
94688217|NCT00467142|324313602|FG000|Overall Study|Withdrawal by Subject|1|||
94688218|NCT00467142|324313602|FG000|Overall Study|Adverse Event|1|||
94688219|NCT00467142|324313602|FG000|Overall Study|Protocol Violation|1|||
94688220|NCT01619787|324313603|FG000|Overall Study|Lost to Follow-up|5|||
94688221|NCT01763788|324313604|FG000|Overall Study|Lost to Follow-up|0|||
94688222|NCT01763788|324313605|FG001|Overall Study|Lost to Follow-up|0|||
94688223|NCT01763788|324313606|FG002|Overall Study|Lost to Follow-up|1|||
94688224|NCT01763788|324313607|FG003|Overall Study|Lost to Follow-up|0|||
94688225|NCT02771210|324313610|FG000|Period 1|Adverse Event|5|||
94688226|NCT02771210|324313611|FG001|Period 1|Adverse Event|3|||
94688227|NCT02771210|324313610|FG000|Period 1|Lack of Efficacy|3|||
94688228|NCT02771210|324313611|FG001|Period 1|Lack of Efficacy|6|||
94688229|NCT02771210|324313610|FG000|Period 1|Lost to Follow-up|2|||
94688230|NCT02771210|324313611|FG001|Period 1|Lost to Follow-up|0|||
94688231|NCT02771210|324313610|FG000|Period 1|Physician Decision|0|||
94688232|NCT02771210|324313611|FG001|Period 1|Physician Decision|1|||
94688233|NCT02771210|324313610|FG000|Period 1|Withdrawal by Subject|0|||
94688234|NCT02771210|324313611|FG001|Period 1|Withdrawal by Subject|3|||
94688235|NCT02771210|324313610|FG000|Period 1|Withdrawal of informed consent|1|||
94688236|NCT02771210|324313611|FG001|Period 1|Withdrawal of informed consent|5|||
94688237|NCT02771210|324313610|FG000|Period 2|Adverse Event|1|||
94688238|NCT02771210|324313611|FG001|Period 2|Adverse Event|0|||
94688239|NCT02771210|324313610|FG000|Period 2|Lack of Efficacy|0|||
94688240|NCT02771210|324313611|FG001|Period 2|Lack of Efficacy|1|||
94688241|NCT02771210|324313610|FG000|Period 2|Withdrawal by Subject|1|||
94688242|NCT02771210|324313611|FG001|Period 2|Withdrawal by Subject|0|||
94688243|NCT02771210|324313610|FG000|Period 2|Withdrawal of informed consent|0|||
94688244|NCT02771210|324313611|FG001|Period 2|Withdrawal of informed consent|2|||
94688245|NCT01275196|324313622|FG000|Overall Study|Adverse Event|3|||
94688246|NCT01275196|324313623|FG001|Overall Study|Adverse Event|5|||
94688247|NCT01275196|324313622|FG000|Overall Study|Withdrawal by Subject|4|||
94688248|NCT01275196|324313623|FG001|Overall Study|Withdrawal by Subject|5|||
94688249|NCT01275196|324313622|FG000|Overall Study|Lost to Follow-up|1|||
94465617|NCT01546038|323494882|FG001|Overall Study|Lost to Follow-up|0|||
94465618|NCT01546038|323494883|FG002|Overall Study|Lost to Follow-up|0|||
94651095|NCT01573624|324179684|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
94651096|NCT01573624|324179685|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
94651097|NCT01573624|324179686|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
94651098|NCT01573624|324179680|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
94651099|NCT01573624|324179681|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
94651100|NCT01573624|324179682|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
94651101|NCT01573624|324179683|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
94651102|NCT01573624|324179684|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
94651103|NCT01573624|324179685|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
94651104|NCT01573624|324179686|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
94651105|NCT01573624|324179680|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
94651106|NCT01573624|324179681|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
94651107|NCT01573624|324179682|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
94651108|NCT01573624|324179683|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
94651109|NCT01573624|324179684|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
94651110|NCT01573624|324179685|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
94651111|NCT01573624|324179686|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
94651112|NCT01573624|324179680|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
94651113|NCT01573624|324179681|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
94651114|NCT01573624|324179682|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
94651115|NCT01573624|324179683|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
94651116|NCT01573624|324179684|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
94651117|NCT01573624|324179685|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
94651118|NCT01573624|324179686|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
94651119|NCT01573624|324179680|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
94651120|NCT01573624|324179681|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
94651121|NCT01573624|324179682|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
94651122|NCT01573624|324179683|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
94651123|NCT01573624|324179684|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
94651124|NCT01573624|324179685|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
94651125|NCT01573624|324179686|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
94651126|NCT01573624|324179680|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
94651127|NCT01573624|324179681|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
94651128|NCT01573624|324179682|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
94651129|NCT01573624|324179683|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
94651130|NCT01573624|324179684|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
94651131|NCT01573624|324179685|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
94651132|NCT01573624|324179686|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
94651133|NCT01573624|324179680|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
94651134|NCT01573624|324179681|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
94651135|NCT01573624|324179682|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
94651136|NCT01573624|324179683|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
94651137|NCT01573624|324179684|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
94651138|NCT01573624|324179685|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
94651139|NCT01573624|324179686|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
94651140|NCT01573624|324179680|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
94651141|NCT01573624|324179681|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
94651142|NCT01573624|324179682|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
94651143|NCT01573624|324179683|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
94651144|NCT01573624|324179684|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
94651145|NCT01573624|324179685|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
94465619|NCT01546038|323494884|FG003|Overall Study|Lost to Follow-up|0|||
94651146|NCT01573624|324179686|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
94651147|NCT03417141|324179687|FG000|Overall Study|Withdrawal by Subject|1|||
94651148|NCT03417141|324179687|FG000|Overall Study|Protocol Violation|3|||
94651149|NCT02550652|324179688|FG000|Overall Study|Death|1|||
94651150|NCT02550652|324179689|FG001|Overall Study|Death|4|||
94651151|NCT02550652|324179688|FG000|Overall Study|Lack of Efficacy|1|||
94651152|NCT02550652|324179689|FG001|Overall Study|Lack of Efficacy|0|||
94651153|NCT02550652|324179688|FG000|Overall Study|Withdrawal by Subject|4|||
94651154|NCT02550652|324179689|FG001|Overall Study|Withdrawal by Subject|7|||
94651155|NCT02550652|324179688|FG000|Overall Study|Post Trial Access|1|||
94465620|NCT01546038|323494885|FG004|Overall Study|Lost to Follow-up|1|||
94651156|NCT02550652|324179689|FG001|Overall Study|Post Trial Access|0|||
94651157|NCT02550652|324179688|FG000|Overall Study|Lost to Follow-up|1|||
94651158|NCT02550652|324179689|FG001|Overall Study|Lost to Follow-up|3|||
94651159|NCT02550652|324179688|FG000|Overall Study|Physician Decision|0|||
94651160|NCT02550652|324179689|FG001|Overall Study|Physician Decision|2|||
94651161|NCT02550652|324179688|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
94651162|NCT02550652|324179689|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
94651163|NCT03921411|324179690|FG000|Overall Study|Withdrawal by Subject|1|||
94651164|NCT03921411|324179690|FG000|Overall Study|Protocol Deviation|2|||
94651165|NCT03921411|324179690|FG000|Overall Study|Enrolled, but never treated|2|||
94651166|NCT04587193|324179705|FG000|Overall Study|Screen failure after consent|3|||
94651167|NCT04587193|324179706|FG001|Overall Study|Screen failure after consent|0|||
94651168|NCT04587193|324179705|FG000|Overall Study|Device broke during study|3|||
94651169|NCT04587193|324179706|FG001|Overall Study|Device broke during study|2|||
94651170|NCT00437034|324179707|FG000|Overall Study|Adverse Event|1|||
94651171|NCT00437034|324179707|FG000|Overall Study|Disease progression during treatment|5|||
94651172|NCT01451424|324179708|FG000|Overall Study|Withdrawal by Subject|1|||
94651173|NCT01451424|324179709|FG001|Overall Study|Withdrawal by Subject|1|||
94651174|NCT01451424|324179710|FG002|Overall Study|Withdrawal by Subject|0|||
94651175|NCT01451424|324179711|FG003|Overall Study|Withdrawal by Subject|2|||
94651176|NCT01451424|324179708|FG000|Overall Study|Lost to Follow-up|0|||
94651177|NCT01451424|324179709|FG001|Overall Study|Lost to Follow-up|1|||
94651178|NCT01451424|324179710|FG002|Overall Study|Lost to Follow-up|0|||
94651179|NCT01451424|324179711|FG003|Overall Study|Lost to Follow-up|1|||
94651180|NCT01451424|324179708|FG000|Overall Study|Physician Decision|0|||
94651181|NCT01451424|324179709|FG001|Overall Study|Physician Decision|0|||
94651182|NCT01451424|324179710|FG002|Overall Study|Physician Decision|1|||
94651183|NCT01451424|324179711|FG003|Overall Study|Physician Decision|1|||
94651184|NCT01451424|324179708|FG000|Overall Study|Adverse Event|0|||
94651185|NCT01451424|324179709|FG001|Overall Study|Adverse Event|0|||
94651186|NCT01451424|324179710|FG002|Overall Study|Adverse Event|0|||
94651187|NCT01451424|324179711|FG003|Overall Study|Adverse Event|1|||
94651188|NCT03878134|324179714|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
94651189|NCT02460224|324179715|FG000|Overall Study|Adverse Event|0|||
94651190|NCT02460224|324179716|FG001|Overall Study|Adverse Event|0|||
94651191|NCT02460224|324179717|FG002|Overall Study|Adverse Event|0|||
94651192|NCT02460224|324179718|FG003|Overall Study|Adverse Event|0|||
94651193|NCT02460224|324179719|FG004|Overall Study|Adverse Event|0|||
94651194|NCT02460224|324179720|FG005|Overall Study|Adverse Event|0|||
94651195|NCT02460224|324179721|FG006|Overall Study|Adverse Event|1|||
94651196|NCT02460224|324179722|FG007|Overall Study|Adverse Event|0|||
94651197|NCT02460224|324179723|FG008|Overall Study|Adverse Event|0|||
94651198|NCT02460224|324179724|FG009|Overall Study|Adverse Event|0|||
94651199|NCT02460224|324179725|FG010|Overall Study|Adverse Event|0|||
94651200|NCT02460224|324179726|FG011|Overall Study|Adverse Event|0|||
94651201|NCT02460224|324179727|FG012|Overall Study|Adverse Event|1|||
94651202|NCT02460224|324179728|FG013|Overall Study|Adverse Event|0|||
94651203|NCT02460224|324179729|FG014|Overall Study|Adverse Event|0|||
94651204|NCT02460224|324179730|FG015|Overall Study|Adverse Event|0|||
94651205|NCT02460224|324179731|FG016|Overall Study|Adverse Event|1|||
94465621|NCT01546038|323494886|FG005|Overall Study|Lost to Follow-up|0|||
94465622|NCT01546038|323494887|FG006|Overall Study|Lost to Follow-up|2|||
94465623|NCT01546038|323494888|FG007|Overall Study|Lost to Follow-up|1|||
94465624|NCT01546038|323494889|FG008|Overall Study|Lost to Follow-up|0|||
94465625|NCT01546038|323494881|FG000|Overall Study|Withdrawal by Subject|1|||
94465626|NCT01546038|323494882|FG001|Overall Study|Withdrawal by Subject|0|||
94651206|NCT02460224|324179732|FG017|Overall Study|Adverse Event|0|||
94651207|NCT02460224|324179733|FG018|Overall Study|Adverse Event|1|||
94651208|NCT02460224|324179734|FG019|Overall Study|Adverse Event|0|||
94651209|NCT02460224|324179735|FG020|Overall Study|Adverse Event|1|||
94651210|NCT02460224|324179736|FG021|Overall Study|Adverse Event|1|||
94651211|NCT02460224|324179737|FG022|Overall Study|Adverse Event|1|||
94651212|NCT02460224|324179738|FG023|Overall Study|Adverse Event|0|||
94651213|NCT02460224|324179739|FG024|Overall Study|Adverse Event|0|||
94651214|NCT02460224|324179740|FG025|Overall Study|Adverse Event|0|||
94651215|NCT02460224|324179741|FG026|Overall Study|Adverse Event|11|||
94651216|NCT02460224|324179742|FG027|Overall Study|Adverse Event|1|||
94651217|NCT02460224|324179743|FG028|Overall Study|Adverse Event|6|||
94651218|NCT02460224|324179715|FG000|Overall Study|Death|0|||
94651219|NCT02460224|324179716|FG001|Overall Study|Death|0|||
94651220|NCT02460224|324179717|FG002|Overall Study|Death|0|||
94651221|NCT02460224|324179718|FG003|Overall Study|Death|0|||
94651222|NCT02460224|324179719|FG004|Overall Study|Death|0|||
94651223|NCT02460224|324179720|FG005|Overall Study|Death|2|||
94651224|NCT02460224|324179721|FG006|Overall Study|Death|1|||
94651225|NCT02460224|324179722|FG007|Overall Study|Death|0|||
94651226|NCT02460224|324179723|FG008|Overall Study|Death|0|||
94651227|NCT02460224|324179724|FG009|Overall Study|Death|1|||
94651228|NCT02460224|324179725|FG010|Overall Study|Death|0|||
94365391|NCT02216214|323122375|FG000|Overall Study|Study Terminated By Sponsor|0|||
94365392|NCT02216214|323122376|FG001|Overall Study|Study Terminated By Sponsor|1|||
94365393|NCT02216214|323122375|FG000|Overall Study|Miscellaneous|1|||
94365394|NCT02216214|323122376|FG001|Overall Study|Miscellaneous|1|||
94365395|NCT01414062|323122377|FG000|Overall Study|Lost to Follow-up|3|||
94365396|NCT01414062|323122378|FG001|Overall Study|Lost to Follow-up|2|||
94365397|NCT01414062|323122377|FG000|Overall Study|Left Country|1|||
94365398|NCT01414062|323122378|FG001|Overall Study|Left Country|1|||
94365399|NCT01414062|323122377|FG000|Overall Study|Family Disapproval|1|||
94365400|NCT01414062|323122378|FG001|Overall Study|Family Disapproval|0|||
94365401|NCT01414062|323122377|FG000|Overall Study|Withdrawal by Subject|0|||
94365402|NCT01414062|323122378|FG001|Overall Study|Withdrawal by Subject|1|||
94365403|NCT04936334|323122379|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
94365404|NCT01563029|323122380|FG000|Overall Study|Adverse Event|1|||
94365405|NCT01563029|323122381|FG001|Overall Study|Adverse Event|0|||
94365406|NCT01563029|323122382|FG002|Overall Study|Adverse Event|1|||
94365407|NCT01563029|323122383|FG003|Overall Study|Adverse Event|2|||
94365408|NCT01563029|323122384|FG004|Overall Study|Adverse Event|1|||
94365409|NCT01563029|323122380|FG000|Overall Study|Lack of Efficacy|42|||
94651229|NCT02460224|324179726|FG011|Overall Study|Death|0|||
94651230|NCT02460224|324179727|FG012|Overall Study|Death|0|||
94651231|NCT02460224|324179728|FG013|Overall Study|Death|1|||
94651232|NCT02460224|324179729|FG014|Overall Study|Death|0|||
94651233|NCT02460224|324179730|FG015|Overall Study|Death|0|||
94651234|NCT02460224|324179731|FG016|Overall Study|Death|2|||
94651235|NCT02460224|324179732|FG017|Overall Study|Death|1|||
94651236|NCT02460224|324179733|FG018|Overall Study|Death|0|||
94651237|NCT02460224|324179734|FG019|Overall Study|Death|2|||
94365410|NCT01563029|323122381|FG001|Overall Study|Lack of Efficacy|16|||
94365411|NCT01563029|323122382|FG002|Overall Study|Lack of Efficacy|23|||
94365412|NCT01563029|323122383|FG003|Overall Study|Lack of Efficacy|21|||
94365413|NCT01563029|323122384|FG004|Overall Study|Lack of Efficacy|19|||
94365414|NCT01563029|323122380|FG000|Overall Study|Protocol Violation|1|||
94365415|NCT01563029|323122381|FG001|Overall Study|Protocol Violation|2|||
94365416|NCT01563029|323122382|FG002|Overall Study|Protocol Violation|3|||
94365417|NCT01563029|323122383|FG003|Overall Study|Protocol Violation|1|||
94365418|NCT01563029|323122384|FG004|Overall Study|Protocol Violation|3|||
94365419|NCT01563029|323122380|FG000|Overall Study|Protocol defined stopping criteria|1|||
94365420|NCT01563029|323122381|FG001|Overall Study|Protocol defined stopping criteria|0|||
94365421|NCT01563029|323122382|FG002|Overall Study|Protocol defined stopping criteria|0|||
94365422|NCT01563029|323122383|FG003|Overall Study|Protocol defined stopping criteria|0|||
94365423|NCT01563029|323122384|FG004|Overall Study|Protocol defined stopping criteria|0|||
94365424|NCT01563029|323122380|FG000|Overall Study|Lost to Follow-up|1|||
94365425|NCT01563029|323122381|FG001|Overall Study|Lost to Follow-up|0|||
94365426|NCT01563029|323122382|FG002|Overall Study|Lost to Follow-up|1|||
94365427|NCT01563029|323122383|FG003|Overall Study|Lost to Follow-up|1|||
94365428|NCT01563029|323122384|FG004|Overall Study|Lost to Follow-up|1|||
94365429|NCT01563029|323122380|FG000|Overall Study|Physician Decision|3|||
94365430|NCT01563029|323122381|FG001|Overall Study|Physician Decision|5|||
94365431|NCT01563029|323122382|FG002|Overall Study|Physician Decision|2|||
94365432|NCT01563029|323122383|FG003|Overall Study|Physician Decision|4|||
94365433|NCT01563029|323122384|FG004|Overall Study|Physician Decision|2|||
94365434|NCT01563029|323122380|FG000|Overall Study|Withdrawal by Subject|4|||
94365435|NCT01563029|323122381|FG001|Overall Study|Withdrawal by Subject|1|||
94365436|NCT01563029|323122382|FG002|Overall Study|Withdrawal by Subject|3|||
94365437|NCT01563029|323122383|FG003|Overall Study|Withdrawal by Subject|4|||
94365438|NCT01563029|323122384|FG004|Overall Study|Withdrawal by Subject|3|||
94365439|NCT04701658|323122385|FG000|Overall Study|Lost to Follow-up|6|||
94365440|NCT01060007|323122387|FG000|Overall Study|Withdrawal by Subject|1|||
94365441|NCT01060007|323122387|FG000|Overall Study|Inevaluable for response at surgery|3|||
94365442|NCT04101721|323122388|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
94365443|NCT04101721|323122389|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
94365444|NCT04101721|323122388|FG000|Overall Study|Death|0|||
94365445|NCT04101721|323122389|FG001|Overall Study|Death|1|||
94365446|NCT04101721|323122388|FG000|Overall Study|Lost to Follow-up|0|||
94365447|NCT04101721|323122389|FG001|Overall Study|Lost to Follow-up|3|||
94365448|NCT01215955|323122390|FG000|Overall Study|Adverse Event|1|||
94365449|NCT01215955|323122391|FG001|Overall Study|Adverse Event|4|||
94365450|NCT01215955|323122392|FG002|Overall Study|Adverse Event|2|||
94365451|NCT01215955|323122393|FG003|Overall Study|Adverse Event|3|||
94365452|NCT01215955|323122390|FG000|Overall Study|Death|2|||
94365453|NCT01215955|323122391|FG001|Overall Study|Death|0|||
94365454|NCT01215955|323122392|FG002|Overall Study|Death|1|||
94365455|NCT01215955|323122393|FG003|Overall Study|Death|3|||
94365456|NCT01215955|323122390|FG000|Overall Study|Entry Criteria Not Met|1|||
94651238|NCT02460224|324179735|FG020|Overall Study|Death|0|||
94651239|NCT02460224|324179736|FG021|Overall Study|Death|0|||
94651240|NCT02460224|324179737|FG022|Overall Study|Death|0|||
94651241|NCT02460224|324179738|FG023|Overall Study|Death|0|||
94651242|NCT02460224|324179739|FG024|Overall Study|Death|1|||
94688250|NCT01275196|324313623|FG001|Overall Study|Lost to Follow-up|0|||
94688251|NCT01275196|324313622|FG000|Overall Study|Disease Progression|6|||
94688252|NCT01275196|324313623|FG001|Overall Study|Disease Progression|5|||
94688253|NCT01275196|324313622|FG000|Overall Study|Protocol Violation|1|||
94688254|NCT01275196|324313623|FG001|Overall Study|Protocol Violation|0|||
94688255|NCT01275196|324313622|FG000|Overall Study|Suboptimal response/treatment failure|5|||
94688256|NCT01275196|324313623|FG001|Overall Study|Suboptimal response/treatment failure|6|||
94688257|NCT02406261|324313624|FG000|Period 1|Lost to Follow-up|2|||
94365457|NCT01215955|323122391|FG001|Overall Study|Entry Criteria Not Met|3|||
94688258|NCT02406261|324313625|FG001|Period 1|Lost to Follow-up|0|||
94688259|NCT02406261|324313624|FG000|Period 1|Adverse Event|1|||
94688260|NCT02406261|324313625|FG001|Period 1|Adverse Event|0|||
94688261|NCT02406261|324313624|FG000|Period 2|Physician Decision|0|||
94688262|NCT02406261|324313625|FG001|Period 2|Physician Decision|1|||
94688263|NCT02406261|324313624|FG000|Period 2|Protocol Violation|0|||
94688264|NCT02406261|324313625|FG001|Period 2|Protocol Violation|1|||
94688265|NCT02406261|324313624|FG000|Period 2|Withdrawal by Subject|0|||
94688266|NCT02406261|324313625|FG001|Period 2|Withdrawal by Subject|1|||
94688267|NCT02310126|324313628|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
94688268|NCT02310126|324313629|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
94688269|NCT02310126|324313628|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
94688270|NCT02310126|324313629|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
94688271|NCT02111213|324313635|FG000|Overall Study|Withdrawal by Subject|3|||
94688272|NCT02111213|324313636|FG001|Overall Study|Withdrawal by Subject|2|||
94688273|NCT02111213|324313635|FG000|Overall Study|Lost to Follow-up|3|||
94688274|NCT02111213|324313636|FG001|Overall Study|Lost to Follow-up|4|||
94688275|NCT02226172|324313639|FG000|Overall Study|Participant refused further follow-up|4|||
94688276|NCT02226172|324313639|FG000|Overall Study|Other|5|||
94688277|NCT02226172|324313639|FG000|Overall Study|Death|1|||
94688278|NCT02226172|324313639|FG000|Overall Study|Study terminated by sponsor|1|||
94688279|NCT02226172|324313639|FG000|Overall Study|Adverse Event|6|||
94688280|NCT01865617|324313640|FG000|Overall Study|Death|27|||
94688281|NCT01865617|324313641|FG001|Overall Study|Death|3|||
94688282|NCT01865617|324313642|FG002|Overall Study|Death|1|||
94688283|NCT01865617|324313643|FG003|Overall Study|Death|1|||
94688284|NCT01865617|324313644|FG004|Overall Study|Death|5|||
94688285|NCT01865617|324313645|FG005|Overall Study|Death|1|||
94688286|NCT01865617|324313646|FG006|Overall Study|Death|11|||
94688287|NCT01865617|324313647|FG007|Overall Study|Death|1|||
94688288|NCT01865617|324313648|FG008|Overall Study|Death|11|||
94688289|NCT01865617|324313649|FG009|Overall Study|Death|3|||
94688290|NCT01865617|324313650|FG010|Overall Study|Death|32|||
94688291|NCT01865617|324313651|FG011|Overall Study|Death|6|||
94688292|NCT01865617|324313652|FG012|Overall Study|Death|13|||
94688293|NCT01865617|324313640|FG000|Overall Study|Lost to Follow-up|2|||
94688294|NCT01865617|324313641|FG001|Overall Study|Lost to Follow-up|0|||
94688295|NCT01865617|324313642|FG002|Overall Study|Lost to Follow-up|0|||
94688296|NCT01865617|324313643|FG003|Overall Study|Lost to Follow-up|0|||
94688297|NCT01865617|324313644|FG004|Overall Study|Lost to Follow-up|0|||
94688298|NCT01865617|324313645|FG005|Overall Study|Lost to Follow-up|0|||
94688299|NCT01865617|324313646|FG006|Overall Study|Lost to Follow-up|0|||
94688300|NCT01865617|324313647|FG007|Overall Study|Lost to Follow-up|0|||
94688301|NCT01865617|324313648|FG008|Overall Study|Lost to Follow-up|0|||
94688302|NCT01865617|324313649|FG009|Overall Study|Lost to Follow-up|0|||
94688303|NCT01865617|324313650|FG010|Overall Study|Lost to Follow-up|0|||
94688304|NCT01865617|324313651|FG011|Overall Study|Lost to Follow-up|0|||
94688305|NCT01865617|324313652|FG012|Overall Study|Lost to Follow-up|0|||
94688306|NCT01865617|324313640|FG000|Overall Study|Withdrawal by Subject|1|||
94688307|NCT01865617|324313641|FG001|Overall Study|Withdrawal by Subject|0|||
94688308|NCT01865617|324313642|FG002|Overall Study|Withdrawal by Subject|0|||
94688309|NCT01865617|324313643|FG003|Overall Study|Withdrawal by Subject|0|||
94688310|NCT01865617|324313644|FG004|Overall Study|Withdrawal by Subject|0|||
94688311|NCT01865617|324313645|FG005|Overall Study|Withdrawal by Subject|0|||
94688312|NCT01865617|324313646|FG006|Overall Study|Withdrawal by Subject|0|||
94688313|NCT01865617|324313647|FG007|Overall Study|Withdrawal by Subject|0|||
94688314|NCT01865617|324313648|FG008|Overall Study|Withdrawal by Subject|0|||
94688315|NCT01865617|324313649|FG009|Overall Study|Withdrawal by Subject|0|||
94688316|NCT01865617|324313650|FG010|Overall Study|Withdrawal by Subject|0|||
94688317|NCT01865617|324313651|FG011|Overall Study|Withdrawal by Subject|0|||
94688318|NCT01865617|324313652|FG012|Overall Study|Withdrawal by Subject|0|||
94688319|NCT01865617|324313640|FG000|Overall Study|Patient proceeded to new therapy|0|||
94688320|NCT01865617|324313641|FG001|Overall Study|Patient proceeded to new therapy|0|||
94688321|NCT01865617|324313642|FG002|Overall Study|Patient proceeded to new therapy|0|||
94688322|NCT01865617|324313643|FG003|Overall Study|Patient proceeded to new therapy|0|||
94688323|NCT01865617|324313644|FG004|Overall Study|Patient proceeded to new therapy|2|||
94688324|NCT01865617|324313645|FG005|Overall Study|Patient proceeded to new therapy|0|||
94688325|NCT01865617|324313646|FG006|Overall Study|Patient proceeded to new therapy|0|||
94688326|NCT01865617|324313647|FG007|Overall Study|Patient proceeded to new therapy|0|||
94688327|NCT01865617|324313648|FG008|Overall Study|Patient proceeded to new therapy|0|||
94688328|NCT01865617|324313649|FG009|Overall Study|Patient proceeded to new therapy|0|||
94688329|NCT01865617|324313650|FG010|Overall Study|Patient proceeded to new therapy|0|||
94688330|NCT01865617|324313651|FG011|Overall Study|Patient proceeded to new therapy|0|||
94688331|NCT01865617|324313652|FG012|Overall Study|Patient proceeded to new therapy|0|||
94688332|NCT01865617|324313640|FG000|Overall Study|Other|0|||
94688333|NCT01865617|324313641|FG001|Overall Study|Other|0|||
94688334|NCT01865617|324313642|FG002|Overall Study|Other|0|||
94688335|NCT01865617|324313643|FG003|Overall Study|Other|0|||
94688336|NCT01865617|324313644|FG004|Overall Study|Other|0|||
94688337|NCT01865617|324313645|FG005|Overall Study|Other|0|||
94688338|NCT01865617|324313646|FG006|Overall Study|Other|1|||
94688339|NCT01865617|324313647|FG007|Overall Study|Other|0|||
94688340|NCT01865617|324313648|FG008|Overall Study|Other|0|||
94688341|NCT01865617|324313649|FG009|Overall Study|Other|0|||
94688342|NCT01865617|324313650|FG010|Overall Study|Other|0|||
94688343|NCT01865617|324313651|FG011|Overall Study|Other|0|||
94688344|NCT01865617|324313652|FG012|Overall Study|Other|0|||
94688345|NCT00258440|324313658|FG000|Overall Study|Withdrawal by Subject|0|||
94688346|NCT00258440|324313659|FG001|Overall Study|Withdrawal by Subject|0|||
94688347|NCT00258440|324313660|FG002|Overall Study|Withdrawal by Subject|1|||
94688348|NCT01729728|324313661|FG000|Overall Study|Adverse Event|0|||
94688349|NCT01729728|324313662|FG001|Overall Study|Adverse Event|6|||
94688350|NCT01729728|324313663|FG002|Overall Study|Adverse Event|0|||
94688351|NCT01729728|324313661|FG000|Overall Study|Protocol Violation|1|||
94688352|NCT01729728|324313662|FG001|Overall Study|Protocol Violation|0|||
94688353|NCT01729728|324313663|FG002|Overall Study|Protocol Violation|1|||
94688354|NCT02500979|324313664|FG000|Period 1|Hyperglycemia|1|||
94688355|NCT02500979|324313665|FG001|Period 1|Hyperglycemia|0|||
94688356|NCT02500979|324313664|FG000|Period 1|Severe non-compliance to protocol|0|||
94688357|NCT02500979|324313665|FG001|Period 1|Severe non-compliance to protocol|1|||
94688358|NCT02500979|324313664|FG000|Period 1|Adverse Event|1|||
94688359|NCT02500979|324313665|FG001|Period 1|Adverse Event|0|||
94688360|NCT02500979|324313664|FG000|Period 1|Subject decision|2|||
94688361|NCT02500979|324313665|FG001|Period 1|Subject decision|0|||
94688362|NCT02500979|324313664|FG000|Period 2|Change in risk|1|||
94688363|NCT02500979|324313665|FG001|Period 2|Change in risk|0|||
94688364|NCT02878213|324313671|FG000|Overall Study|Withdrawal by Subject|2|||
94688365|NCT02878213|324313671|FG000|Overall Study|Adverse Event|1|||
94688366|NCT01076088|324313685|FG000|Overall Study|Adverse Event|1|||
94688367|NCT01076088|324313686|FG001|Overall Study|Adverse Event|6|||
94688368|NCT01076088|324313687|FG002|Overall Study|Adverse Event|3|||
94688369|NCT01076088|324313688|FG003|Overall Study|Adverse Event|2|||
94264077|NCT01093625|322761822|FG001|6-Month Visit|Withdrawal by Subject|7|||
94264078|NCT01093625|322761821|FG000|6-Month Visit|Lost to Follow-up|2|||
94264079|NCT01093625|322761822|FG001|6-Month Visit|Lost to Follow-up|2|||
94264080|NCT01093625|322761821|FG000|1-Year Visit|Lost to Follow-up|5|||
94264081|NCT01093625|322761822|FG001|1-Year Visit|Lost to Follow-up|3|||
94264082|NCT03684642|322761828|FG000|Overall Study|Adverse Event|6|||
94264083|NCT03684642|322761829|FG001|Overall Study|Adverse Event|15|||
94264084|NCT03684642|322761830|FG002|Overall Study|Adverse Event|11|||
94264085|NCT03684642|322761828|FG000|Overall Study|Withdrawal by Subject|35|||
94264086|NCT03684642|322761829|FG001|Overall Study|Withdrawal by Subject|53|||
94688370|NCT01076088|324313689|FG004|Overall Study|Adverse Event|3|||
94688371|NCT01076088|324313690|FG005|Overall Study|Adverse Event|3|||
94688372|NCT01076088|324313685|FG000|Overall Study|Lost to Follow-up|1|||
94688373|NCT01076088|324313686|FG001|Overall Study|Lost to Follow-up|1|||
94688374|NCT01076088|324313687|FG002|Overall Study|Lost to Follow-up|0|||
94688375|NCT01076088|324313688|FG003|Overall Study|Lost to Follow-up|1|||
94688376|NCT01076088|324313689|FG004|Overall Study|Lost to Follow-up|1|||
94688377|NCT01076088|324313690|FG005|Overall Study|Lost to Follow-up|2|||
94688378|NCT01076088|324313685|FG000|Overall Study|Non-compliance with study drug|0|||
94264087|NCT03684642|322761830|FG002|Overall Study|Withdrawal by Subject|23|||
94688379|NCT01076088|324313686|FG001|Overall Study|Non-compliance with study drug|0|||
94688380|NCT01076088|324313687|FG002|Overall Study|Non-compliance with study drug|0|||
94688381|NCT01076088|324313688|FG003|Overall Study|Non-compliance with study drug|1|||
94688382|NCT01076088|324313689|FG004|Overall Study|Non-compliance with study drug|0|||
94688383|NCT01076088|324313690|FG005|Overall Study|Non-compliance with study drug|0|||
94688384|NCT01076088|324313685|FG000|Overall Study|Physician Decision|1|||
94688385|NCT01076088|324313686|FG001|Overall Study|Physician Decision|3|||
94688386|NCT01076088|324313687|FG002|Overall Study|Physician Decision|0|||
94688387|NCT01076088|324313688|FG003|Overall Study|Physician Decision|1|||
94688388|NCT01076088|324313689|FG004|Overall Study|Physician Decision|1|||
94688389|NCT01076088|324313690|FG005|Overall Study|Physician Decision|0|||
94688390|NCT01076088|324313685|FG000|Overall Study|Withdrawal by Subject|8|||
94688391|NCT01076088|324313686|FG001|Overall Study|Withdrawal by Subject|8|||
94688392|NCT01076088|324313687|FG002|Overall Study|Withdrawal by Subject|14|||
94688393|NCT01076088|324313688|FG003|Overall Study|Withdrawal by Subject|10|||
94688394|NCT01076088|324313689|FG004|Overall Study|Withdrawal by Subject|11|||
94688395|NCT01076088|324313690|FG005|Overall Study|Withdrawal by Subject|17|||
94688396|NCT01076088|324313685|FG000|Overall Study|Other protocol specified criteria|0|||
94688397|NCT01076088|324313686|FG001|Overall Study|Other protocol specified criteria|0|||
94688398|NCT01076088|324313687|FG002|Overall Study|Other protocol specified criteria|0|||
94688399|NCT01076088|324313688|FG003|Overall Study|Other protocol specified criteria|0|||
94688400|NCT01076088|324313689|FG004|Overall Study|Other protocol specified criteria|0|||
94688401|NCT01076088|324313690|FG005|Overall Study|Other protocol specified criteria|1|||
94688402|NCT00849680|324313691|FG000|Overall Study|Adverse Event|0|||
94688403|NCT00849680|324313692|FG001|Overall Study|Adverse Event|0|||
94688404|NCT00849680|324313693|FG002|Overall Study|Adverse Event|0|||
94688405|NCT00849680|324313694|FG003|Overall Study|Adverse Event|0|||
94688406|NCT00849680|324313695|FG004|Overall Study|Adverse Event|0|||
94688407|NCT00849680|324313696|FG005|Overall Study|Adverse Event|0|||
94688408|NCT00849680|324313697|FG006|Overall Study|Adverse Event|2|||
94365458|NCT01215955|323122392|FG002|Overall Study|Entry Criteria Not Met|4|||
94365459|NCT01215955|323122393|FG003|Overall Study|Entry Criteria Not Met|7|||
94365460|NCT01215955|323122390|FG000|Overall Study|Lack of Efficacy|1|||
94365461|NCT01215955|323122391|FG001|Overall Study|Lack of Efficacy|2|||
94365462|NCT01215955|323122392|FG002|Overall Study|Lack of Efficacy|1|||
94365463|NCT01215955|323122393|FG003|Overall Study|Lack of Efficacy|0|||
94365464|NCT01215955|323122390|FG000|Overall Study|Lost to Follow-up|4|||
94365465|NCT01215955|323122391|FG001|Overall Study|Lost to Follow-up|4|||
94688409|NCT00849680|324313698|FG007|Overall Study|Adverse Event|0|||
94688410|NCT00849680|324313691|FG000|Overall Study|Lost to Follow-up|7|||
94688411|NCT00849680|324313692|FG001|Overall Study|Lost to Follow-up|3|||
94688412|NCT00849680|324313693|FG002|Overall Study|Lost to Follow-up|12|||
94688413|NCT00849680|324313694|FG003|Overall Study|Lost to Follow-up|11|||
94688414|NCT00849680|324313695|FG004|Overall Study|Lost to Follow-up|8|||
94688415|NCT00849680|324313696|FG005|Overall Study|Lost to Follow-up|11|||
94688416|NCT00849680|324313697|FG006|Overall Study|Lost to Follow-up|12|||
94688417|NCT00849680|324313698|FG007|Overall Study|Lost to Follow-up|5|||
94688418|NCT00849680|324313691|FG000|Overall Study|Subject moved|1|||
94688419|NCT00849680|324313692|FG001|Overall Study|Subject moved|0|||
94688420|NCT00849680|324313693|FG002|Overall Study|Subject moved|3|||
94688421|NCT00849680|324313694|FG003|Overall Study|Subject moved|1|||
94688422|NCT00849680|324313695|FG004|Overall Study|Subject moved|0|||
94688423|NCT00849680|324313696|FG005|Overall Study|Subject moved|2|||
94688424|NCT00849680|324313697|FG006|Overall Study|Subject moved|2|||
94688425|NCT00849680|324313698|FG007|Overall Study|Subject moved|2|||
94688426|NCT00849680|324313691|FG000|Overall Study|Withdrawal by Subject|2|||
94688427|NCT00849680|324313692|FG001|Overall Study|Withdrawal by Subject|0|||
94688428|NCT00849680|324313693|FG002|Overall Study|Withdrawal by Subject|0|||
94688429|NCT00849680|324313694|FG003|Overall Study|Withdrawal by Subject|2|||
94688430|NCT00849680|324313695|FG004|Overall Study|Withdrawal by Subject|2|||
94688431|NCT00849680|324313696|FG005|Overall Study|Withdrawal by Subject|2|||
94688432|NCT00849680|324313697|FG006|Overall Study|Withdrawal by Subject|1|||
94688433|NCT00849680|324313698|FG007|Overall Study|Withdrawal by Subject|1|||
94688434|NCT00849680|324313691|FG000|Overall Study|Subject unable to comply with protocol|1|||
94688435|NCT00849680|324313692|FG001|Overall Study|Subject unable to comply with protocol|0|||
94688436|NCT00849680|324313693|FG002|Overall Study|Subject unable to comply with protocol|0|||
94688437|NCT00849680|324313694|FG003|Overall Study|Subject unable to comply with protocol|0|||
94688438|NCT00849680|324313695|FG004|Overall Study|Subject unable to comply with protocol|0|||
94688439|NCT00849680|324313696|FG005|Overall Study|Subject unable to comply with protocol|0|||
94688440|NCT00849680|324313697|FG006|Overall Study|Subject unable to comply with protocol|0|||
94688441|NCT00849680|324313698|FG007|Overall Study|Subject unable to comply with protocol|0|||
94688442|NCT04078035|324313699|FG000|Session 2|Lost to Follow-up|3|||
94688443|NCT04078035|324313700|FG001|Session 2|Lost to Follow-up|1|||
94688444|NCT04078035|324313699|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
94688445|NCT04078035|324313700|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
94688446|NCT03567993|324313727|FG000|Overall Study|Lost to Follow-up|4|||
94688447|NCT03567993|324313728|FG001|Overall Study|Lost to Follow-up|2|||
94688448|NCT03567993|324313727|FG000|Overall Study|Death|1|||
94264088|NCT03684642|322761828|FG000|Overall Study|Lack of Efficacy|0|||
94264089|NCT03684642|322761829|FG001|Overall Study|Lack of Efficacy|0|||
94264090|NCT03684642|322761830|FG002|Overall Study|Lack of Efficacy|1|||
94264091|NCT03684642|322761828|FG000|Overall Study|Poor compliance to protocol|0|||
94465627|NCT01546038|323494883|FG002|Overall Study|Withdrawal by Subject|0|||
94465628|NCT01546038|323494884|FG003|Overall Study|Withdrawal by Subject|1|||
94465629|NCT01546038|323494885|FG004|Overall Study|Withdrawal by Subject|0|||
94465630|NCT01546038|323494886|FG005|Overall Study|Withdrawal by Subject|1|||
94465631|NCT01546038|323494887|FG006|Overall Study|Withdrawal by Subject|3|||
94465632|NCT01546038|323494888|FG007|Overall Study|Withdrawal by Subject|3|||
94465633|NCT01546038|323494889|FG008|Overall Study|Withdrawal by Subject|1|||
94465634|NCT01546038|323494881|FG000|Overall Study|: Randomized, not treated|0|||
94465635|NCT01546038|323494882|FG001|Overall Study|: Randomized, not treated|0|||
94465636|NCT01546038|323494883|FG002|Overall Study|: Randomized, not treated|0|||
94465637|NCT01546038|323494884|FG003|Overall Study|: Randomized, not treated|0|||
94465638|NCT01546038|323494885|FG004|Overall Study|: Randomized, not treated|0|||
94465639|NCT01546038|323494886|FG005|Overall Study|: Randomized, not treated|0|||
94651243|NCT02460224|324179740|FG025|Overall Study|Death|1|||
94651244|NCT02460224|324179741|FG026|Overall Study|Death|5|||
94651245|NCT02460224|324179742|FG027|Overall Study|Death|0|||
94651246|NCT02460224|324179743|FG028|Overall Study|Death|1|||
94651247|NCT02460224|324179715|FG000|Overall Study|Lost to Follow-up|0|||
94651248|NCT02460224|324179716|FG001|Overall Study|Lost to Follow-up|0|||
94651249|NCT02460224|324179717|FG002|Overall Study|Lost to Follow-up|0|||
94651250|NCT02460224|324179718|FG003|Overall Study|Lost to Follow-up|0|||
94651251|NCT02460224|324179719|FG004|Overall Study|Lost to Follow-up|0|||
94651252|NCT02460224|324179720|FG005|Overall Study|Lost to Follow-up|0|||
94651253|NCT02460224|324179721|FG006|Overall Study|Lost to Follow-up|0|||
94651254|NCT02460224|324179722|FG007|Overall Study|Lost to Follow-up|0|||
94651255|NCT02460224|324179723|FG008|Overall Study|Lost to Follow-up|0|||
94651256|NCT02460224|324179724|FG009|Overall Study|Lost to Follow-up|0|||
94651257|NCT02460224|324179725|FG010|Overall Study|Lost to Follow-up|0|||
94651258|NCT02460224|324179726|FG011|Overall Study|Lost to Follow-up|0|||
94651259|NCT02460224|324179727|FG012|Overall Study|Lost to Follow-up|0|||
94651260|NCT02460224|324179728|FG013|Overall Study|Lost to Follow-up|0|||
94651261|NCT02460224|324179729|FG014|Overall Study|Lost to Follow-up|0|||
94651262|NCT02460224|324179730|FG015|Overall Study|Lost to Follow-up|0|||
94651263|NCT02460224|324179731|FG016|Overall Study|Lost to Follow-up|0|||
94651264|NCT02460224|324179732|FG017|Overall Study|Lost to Follow-up|0|||
94651265|NCT02460224|324179733|FG018|Overall Study|Lost to Follow-up|0|||
94651266|NCT02460224|324179734|FG019|Overall Study|Lost to Follow-up|0|||
94651267|NCT02460224|324179735|FG020|Overall Study|Lost to Follow-up|0|||
94651268|NCT02460224|324179736|FG021|Overall Study|Lost to Follow-up|0|||
94651269|NCT02460224|324179737|FG022|Overall Study|Lost to Follow-up|1|||
94651270|NCT02460224|324179738|FG023|Overall Study|Lost to Follow-up|0|||
94651271|NCT02460224|324179739|FG024|Overall Study|Lost to Follow-up|0|||
94651272|NCT02460224|324179740|FG025|Overall Study|Lost to Follow-up|0|||
94465640|NCT01546038|323494887|FG006|Overall Study|: Randomized, not treated|2|||
94465641|NCT01546038|323494888|FG007|Overall Study|: Randomized, not treated|4|||
94465642|NCT01546038|323494889|FG008|Overall Study|: Randomized, not treated|3|||
94465643|NCT00772005|323494891|FG000|Overall Study|Adverse Event|9|||
94465644|NCT00772005|323494892|FG001|Overall Study|Adverse Event|14|||
94465645|NCT00772005|323494893|FG002|Overall Study|Adverse Event|10|||
94465646|NCT00772005|323494894|FG003|Overall Study|Adverse Event|13|||
94465647|NCT00772005|323494891|FG000|Overall Study|Lack of Efficacy|0|||
94465648|NCT00772005|323494892|FG001|Overall Study|Lack of Efficacy|1|||
94465649|NCT00772005|323494893|FG002|Overall Study|Lack of Efficacy|0|||
94651273|NCT02460224|324179741|FG026|Overall Study|Lost to Follow-up|0|||
94651274|NCT02460224|324179742|FG027|Overall Study|Lost to Follow-up|0|||
94651275|NCT02460224|324179743|FG028|Overall Study|Lost to Follow-up|0|||
94651276|NCT02460224|324179715|FG000|Overall Study|Physician Decision|0|||
94651277|NCT02460224|324179716|FG001|Overall Study|Physician Decision|1|||
94651278|NCT02460224|324179717|FG002|Overall Study|Physician Decision|0|||
94651279|NCT02460224|324179718|FG003|Overall Study|Physician Decision|0|||
94651280|NCT02460224|324179719|FG004|Overall Study|Physician Decision|1|||
94651281|NCT02460224|324179720|FG005|Overall Study|Physician Decision|0|||
94651282|NCT02460224|324179721|FG006|Overall Study|Physician Decision|0|||
94651283|NCT02460224|324179722|FG007|Overall Study|Physician Decision|1|||
94651284|NCT02460224|324179723|FG008|Overall Study|Physician Decision|0|||
94651285|NCT02460224|324179724|FG009|Overall Study|Physician Decision|0|||
94651286|NCT02460224|324179725|FG010|Overall Study|Physician Decision|0|||
94651287|NCT02460224|324179726|FG011|Overall Study|Physician Decision|1|||
94688449|NCT03567993|324313728|FG001|Overall Study|Death|1|||
94688450|NCT03567993|324313727|FG000|Overall Study|Withdrawal by Subject|1|||
94688451|NCT03567993|324313728|FG001|Overall Study|Withdrawal by Subject|0|||
94688452|NCT05822921|324313732|FG000|Overall Study|Lost to Follow-up|1|||
94688453|NCT05822921|324313733|FG001|Overall Study|Lost to Follow-up|1|||
94688454|NCT01857622|324313735|FG000|Overall Study|Adverse Event|5|||
94688455|NCT01857622|324313736|FG001|Overall Study|Adverse Event|0|||
94365466|NCT01215955|323122392|FG002|Overall Study|Lost to Follow-up|8|||
94365467|NCT01215955|323122393|FG003|Overall Study|Lost to Follow-up|9|||
94365468|NCT01215955|323122390|FG000|Overall Study|Physician Decision|4|||
94688456|NCT01857622|324313737|FG002|Overall Study|Adverse Event|2|||
94688457|NCT01857622|324313735|FG000|Overall Study|Physician Decision|1|||
94688458|NCT01857622|324313736|FG001|Overall Study|Physician Decision|0|||
94688459|NCT01857622|324313737|FG002|Overall Study|Physician Decision|0|||
94688460|NCT01857622|324313735|FG000|Overall Study|Protocol Violation|4|||
94688461|NCT01857622|324313736|FG001|Overall Study|Protocol Violation|1|||
94688462|NCT01857622|324313737|FG002|Overall Study|Protocol Violation|0|||
94688463|NCT01857622|324313735|FG000|Overall Study|Withdrawal by Subject|1|||
94365469|NCT01215955|323122391|FG001|Overall Study|Physician Decision|10|||
94365470|NCT01215955|323122392|FG002|Overall Study|Physician Decision|8|||
94365471|NCT01215955|323122393|FG003|Overall Study|Physician Decision|11|||
94365472|NCT01215955|323122390|FG000|Overall Study|Protocol Violation|17|||
94365473|NCT01215955|323122391|FG001|Overall Study|Protocol Violation|13|||
94365474|NCT01215955|323122392|FG002|Overall Study|Protocol Violation|8|||
94365475|NCT01215955|323122393|FG003|Overall Study|Protocol Violation|8|||
94688464|NCT01857622|324313736|FG001|Overall Study|Withdrawal by Subject|0|||
94688465|NCT01857622|324313737|FG002|Overall Study|Withdrawal by Subject|0|||
94688466|NCT02998021|324313738|FG000|Overall Study|Withdrawal by Subject|3|||
94688467|NCT02998021|324313739|FG001|Overall Study|Withdrawal by Subject|1|||
94688468|NCT02998021|324313738|FG000|Overall Study|unsafe home|0|||
94688469|NCT02998021|324313739|FG001|Overall Study|unsafe home|1|||
94688470|NCT01370603|324313749|FG000|Period 1|Adverse Event|5|||
94688471|NCT01370603|324313750|FG001|Period 1|Adverse Event|3|||
94688472|NCT01370603|324313749|FG000|Period 1|Lost to Follow-up|2|||
94688473|NCT01370603|324313750|FG001|Period 1|Lost to Follow-up|0|||
94688474|NCT01370603|324313749|FG000|Period 1|Protocol Violation|2|||
94688475|NCT01370603|324313750|FG001|Period 1|Protocol Violation|2|||
94688476|NCT01370603|324313749|FG000|Period 1|Withdrawal by Subject|5|||
94688477|NCT01370603|324313750|FG001|Period 1|Withdrawal by Subject|5|||
94688478|NCT01370603|324313749|FG000|Crossover Washout|Adverse Event|2|||
94688479|NCT01370603|324313750|FG001|Crossover Washout|Adverse Event|1|||
94688480|NCT01370603|324313749|FG000|Crossover Washout|Lost to Follow-up|2|||
94688481|NCT01370603|324313750|FG001|Crossover Washout|Lost to Follow-up|0|||
94688482|NCT01370603|324313749|FG000|Crossover Washout|Protocol Violation|1|||
94688483|NCT01370603|324313750|FG001|Crossover Washout|Protocol Violation|0|||
94688484|NCT01370603|324313749|FG000|Crossover Washout|Withdrawal by Subject|4|||
94688485|NCT01370603|324313750|FG001|Crossover Washout|Withdrawal by Subject|1|||
94688486|NCT01370603|324313749|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
94688487|NCT01370603|324313750|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
94688488|NCT01370603|324313749|FG000|Period 2|Adverse Event|1|||
94688489|NCT01370603|324313750|FG001|Period 2|Adverse Event|4|||
94688490|NCT01370603|324313749|FG000|Period 2|Lost to Follow-up|1|||
94688491|NCT01370603|324313750|FG001|Period 2|Lost to Follow-up|0|||
94688492|NCT01370603|324313749|FG000|Period 2|Withdrawal by Subject|1|||
94688493|NCT01370603|324313750|FG001|Period 2|Withdrawal by Subject|0|||
94688494|NCT04424290|324315476|FG000|Overall Study|Not treated|0|||
94688495|NCT04424290|324315477|FG001|Overall Study|Not treated|0|||
94688496|NCT04424290|324315478|FG002|Overall Study|Not treated|1|||
94688497|NCT04424290|324315479|FG003|Overall Study|Not treated|0|||
94688498|NCT04424290|324315480|FG004|Overall Study|Not treated|1|||
94688499|NCT04424290|324315476|FG000|Overall Study|Adverse Event|0|||
94688500|NCT04424290|324315477|FG001|Overall Study|Adverse Event|0|||
94688501|NCT04424290|324315478|FG002|Overall Study|Adverse Event|0|||
94688502|NCT04424290|324315479|FG003|Overall Study|Adverse Event|2|||
94688503|NCT04424290|324315480|FG004|Overall Study|Adverse Event|0|||
94688504|NCT04424290|324315476|FG000|Overall Study|Withdrawal by Subject|0|||
94688505|NCT04424290|324315477|FG001|Overall Study|Withdrawal by Subject|0|||
94688506|NCT04424290|324315478|FG002|Overall Study|Withdrawal by Subject|0|||
94688507|NCT04424290|324315479|FG003|Overall Study|Withdrawal by Subject|0|||
94688508|NCT04424290|324315480|FG004|Overall Study|Withdrawal by Subject|1|||
94688509|NCT04424290|324315476|FG000|Overall Study|Other than listed|0|||
94688510|NCT04424290|324315477|FG001|Overall Study|Other than listed|0|||
94688511|NCT04424290|324315478|FG002|Overall Study|Other than listed|0|||
94688512|NCT04424290|324315479|FG003|Overall Study|Other than listed|1|||
94688513|NCT04424290|324315480|FG004|Overall Study|Other than listed|0|||
94688514|NCT01267825|324315481|FG000|Overall Study|study terminated. no data collected.|1|||
94688515|NCT01267825|324315482|FG001|Overall Study|study terminated. no data collected.|0|||
94688516|NCT00605319|324315486|FG000|Overall Study|Adverse Event|6|||
94688517|NCT02960763|324315504|FG000|Step 1|Withdrawal by Subject|10|||
94688518|NCT02960763|324315505|FG001|Step 1|Withdrawal by Subject|8|||
94688519|NCT02960763|324315506|FG002|Step 1|Withdrawal by Subject|13|||
94688520|NCT02960763|324315507|FG003|Step 1|Withdrawal by Subject|0|||
94688521|NCT02960763|324315508|FG004|Step 1|Withdrawal by Subject|0|||
94688522|NCT02960763|324315504|FG000|Step 1|Lost to Follow-up|7|||
94688523|NCT02960763|324315505|FG001|Step 1|Lost to Follow-up|9|||
94688524|NCT02960763|324315506|FG002|Step 1|Lost to Follow-up|12|||
94688525|NCT02960763|324315507|FG003|Step 1|Lost to Follow-up|0|||
94688526|NCT02960763|324315508|FG004|Step 1|Lost to Follow-up|0|||
94688527|NCT02960763|324315504|FG000|Step 1|Death|1|||
94688528|NCT02960763|324315505|FG001|Step 1|Death|1|||
94688529|NCT02960763|324315506|FG002|Step 1|Death|1|||
94688530|NCT02960763|324315507|FG003|Step 1|Death|0|||
94688531|NCT02960763|324315508|FG004|Step 1|Death|0|||
94264092|NCT03684642|322761829|FG001|Overall Study|Poor compliance to protocol|4|||
94688532|NCT02960763|324315504|FG000|Step 1|Investigator discretion|1|||
94688533|NCT02960763|324315505|FG001|Step 1|Investigator discretion|0|||
94688534|NCT02960763|324315506|FG002|Step 1|Investigator discretion|1|||
94264093|NCT03684642|322761830|FG002|Overall Study|Poor compliance to protocol|1|||
94264094|NCT03684642|322761828|FG000|Overall Study|Other than specified|62|||
94688535|NCT02960763|324315507|FG003|Step 1|Investigator discretion|0|||
94688536|NCT02960763|324315508|FG004|Step 1|Investigator discretion|0|||
94688537|NCT02960763|324315504|FG000|Step 1|Other|0|||
94688538|NCT02960763|324315505|FG001|Step 1|Other|0|||
94688539|NCT02960763|324315506|FG002|Step 1|Other|1|||
94688540|NCT02960763|324315507|FG003|Step 1|Other|0|||
94688541|NCT02960763|324315508|FG004|Step 1|Other|0|||
94688542|NCT02960763|324315504|FG000|Step 2|Withdrawal by Subject|0|||
94688543|NCT02960763|324315505|FG001|Step 2|Withdrawal by Subject|0|||
94688544|NCT02960763|324315506|FG002|Step 2|Withdrawal by Subject|0|||
94688545|NCT02960763|324315507|FG003|Step 2|Withdrawal by Subject|7|||
94688546|NCT02960763|324315508|FG004|Step 2|Withdrawal by Subject|3|||
94688547|NCT02960763|324315504|FG000|Step 2|Lost to Follow-up|0|||
94688548|NCT02960763|324315505|FG001|Step 2|Lost to Follow-up|0|||
94365476|NCT01215955|323122390|FG000|Overall Study|Sponsor Decision|1|||
94365477|NCT01215955|323122391|FG001|Overall Study|Sponsor Decision|2|||
94365478|NCT01215955|323122392|FG002|Overall Study|Sponsor Decision|0|||
94365479|NCT01215955|323122393|FG003|Overall Study|Sponsor Decision|1|||
94365480|NCT01215955|323122390|FG000|Overall Study|Withdrawal by Subject|14|||
94365481|NCT01215955|323122391|FG001|Overall Study|Withdrawal by Subject|15|||
94365482|NCT01215955|323122392|FG002|Overall Study|Withdrawal by Subject|13|||
94365483|NCT01215955|323122393|FG003|Overall Study|Withdrawal by Subject|9|||
94365484|NCT01215955|323122390|FG000|Overall Study|Quality Issues|0|||
94365485|NCT01215955|323122391|FG001|Overall Study|Quality Issues|0|||
94365486|NCT01215955|323122392|FG002|Overall Study|Quality Issues|3|||
94365487|NCT01215955|323122393|FG003|Overall Study|Quality Issues|2|||
94365488|NCT05013749|323122397|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
94365489|NCT05013749|323122398|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
94365490|NCT05013749|323122397|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
94365491|NCT05013749|323122398|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
94365492|NCT02756078|323122399|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
94365493|NCT02756078|323122400|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
94365494|NCT02756078|323122399|FG000|Period 1|Lost to Follow-up|0|||
94365495|NCT02756078|323122400|FG001|Period 1|Lost to Follow-up|2|||
94365496|NCT02756078|323122399|FG000|Period 1|Protocol Violation|0|||
94365497|NCT02756078|323122400|FG001|Period 1|Protocol Violation|1|||
94365498|NCT02756078|323122399|FG000|Period 1|Adverse Event|1|||
94365499|NCT02756078|323122400|FG001|Period 1|Adverse Event|10|||
94365500|NCT02756078|323122399|FG000|Period 1|Withdrawal by Subject|6|||
94365501|NCT02756078|323122400|FG001|Period 1|Withdrawal by Subject|6|||
94365502|NCT02756078|323122399|FG000|Period 1|Lens Discomfort|2|||
94365503|NCT02756078|323122400|FG001|Period 1|Lens Discomfort|2|||
94365504|NCT02756078|323122399|FG000|Period 2|Adverse Event|3|||
94365505|NCT02756078|323122400|FG001|Period 2|Adverse Event|5|||
94365506|NCT02756078|323122399|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
94365507|NCT02756078|323122400|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
94365508|NCT02756078|323122399|FG000|Period 2|Withdrawal by Subject|3|||
94365509|NCT02756078|323122400|FG001|Period 2|Withdrawal by Subject|1|||
94365510|NCT03151707|323122403|FG000|Overall Study|Lost to Follow-up|6|||
94365511|NCT03083639|323122404|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
94365512|NCT03083639|323122405|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
94365513|NCT03083639|323122404|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
94365514|NCT03083639|323122405|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
94365515|NCT00605839|323122406|FG000|Overall Study|Protocol Violation|1|||
94365516|NCT00605839|323122407|FG001|Overall Study|Protocol Violation|0|||
94365517|NCT00605839|323122408|FG002|Overall Study|Protocol Violation|0|||
94365518|NCT00390572|323122411|FG000|Overall Study|Lost to Follow-up|8|||
94365519|NCT00390572|323122412|FG001|Overall Study|Lost to Follow-up|4|||
94365520|NCT00390572|323122411|FG000|Overall Study|health condition|0|||
94365521|NCT00390572|323122412|FG001|Overall Study|health condition|1|||
94365522|NCT00391118|323122415|FG000|Overall Study|Adverse Event|3|||
94365523|NCT00391118|323122416|FG001|Overall Study|Adverse Event|10|||
94365524|NCT00391118|323122417|FG002|Overall Study|Adverse Event|7|||
94365525|NCT00391118|323122415|FG000|Overall Study|Lost to Follow-up|0|||
94365526|NCT00391118|323122416|FG001|Overall Study|Lost to Follow-up|2|||
94365527|NCT00391118|323122417|FG002|Overall Study|Lost to Follow-up|3|||
94365528|NCT00391118|323122415|FG000|Overall Study|Withdrawal by Subject|0|||
94365529|NCT00391118|323122416|FG001|Overall Study|Withdrawal by Subject|9|||
94365530|NCT00391118|323122417|FG002|Overall Study|Withdrawal by Subject|1|||
94365531|NCT00391118|323122415|FG000|Overall Study|Death|0|||
94365532|NCT00391118|323122416|FG001|Overall Study|Death|1|||
94365533|NCT00391118|323122417|FG002|Overall Study|Death|0|||
94365534|NCT00391118|323122415|FG000|Overall Study|Physician Decision|0|||
94365535|NCT00391118|323122416|FG001|Overall Study|Physician Decision|3|||
94365536|NCT00391118|323122417|FG002|Overall Study|Physician Decision|0|||
94365537|NCT00391118|323122415|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
94365538|NCT00391118|323122416|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
94365539|NCT00391118|323122417|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
94365540|NCT00391118|323122415|FG000|Overall Study|Progressive Disease|7|||
94365541|NCT00391118|323122416|FG001|Overall Study|Progressive Disease|26|||
94365542|NCT00391118|323122417|FG002|Overall Study|Progressive Disease|43|||
94365543|NCT00391118|323122415|FG000|Overall Study|Sponsor Decision|0|||
94365544|NCT00391118|323122416|FG001|Overall Study|Sponsor Decision|1|||
94365545|NCT00391118|323122417|FG002|Overall Study|Sponsor Decision|3|||
94365546|NCT00391118|323122415|FG000|Overall Study|Protocol Violation|1|||
94365547|NCT00391118|323122416|FG001|Overall Study|Protocol Violation|0|||
94365548|NCT00391118|323122417|FG002|Overall Study|Protocol Violation|0|||
94365549|NCT01345058|323122418|FG000|Overall Study|Withdrawal by Subject|1|||
94365550|NCT01345058|323122419|FG001|Overall Study|Withdrawal by Subject|0|||
94365551|NCT01345058|323122418|FG000|Overall Study|Participant Reported Increase in Events|1|||
94365552|NCT01345058|323122419|FG001|Overall Study|Participant Reported Increase in Events|0|||
94688675|NCT00630058|324315570|FG000|Overall Study|Withdrawal by Subject|0|||
94688676|NCT00630058|324315571|FG001|Overall Study|Withdrawal by Subject|1|||
94688677|NCT00630058|324315570|FG000|Overall Study|stopping criteria|3|||
94688678|NCT00630058|324315571|FG001|Overall Study|stopping criteria|2|||
94688679|NCT01651936|324315572|FG000|Base Study|Adverse Event|3|||
94688680|NCT01651936|324315573|FG001|Base Study|Adverse Event|0|||
94688681|NCT01651936|324315574|FG002|Base Study|Adverse Event|0|||
94688682|NCT01651936|324315572|FG000|Base Study|Withdrawal by Subject|1|||
94688683|NCT01651936|324315573|FG001|Base Study|Withdrawal by Subject|1|||
94688684|NCT01651936|324315574|FG002|Base Study|Withdrawal by Subject|0|||
94688685|NCT01651936|324315572|FG000|Base Study|Early Escape|2|||
94688686|NCT01651936|324315573|FG001|Base Study|Early Escape|8|||
94688687|NCT01651936|324315574|FG002|Base Study|Early Escape|0|||
94688688|NCT01651936|324315572|FG000|Base Study|Study terminated by sponsor|21|||
94688689|NCT01651936|324315573|FG001|Base Study|Study terminated by sponsor|16|||
94688690|NCT01651936|324315574|FG002|Base Study|Study terminated by sponsor|0|||
94688691|NCT01651936|324315572|FG000|Extension Study|Lack of Efficacy|0|||
94688692|NCT01651936|324315573|FG001|Extension Study|Lack of Efficacy|0|||
94688693|NCT01651936|324315574|FG002|Extension Study|Lack of Efficacy|1|||
94688694|NCT01651936|324315572|FG000|Extension Study|Study terminated by sponsor|0|||
94688695|NCT01651936|324315573|FG001|Extension Study|Study terminated by sponsor|0|||
94688696|NCT01651936|324315574|FG002|Extension Study|Study terminated by sponsor|13|||
94688697|NCT01868074|324315587|FG000|Overall Study|Lost to Follow-up|3|||
94688698|NCT01868074|324315588|FG001|Overall Study|Lost to Follow-up|2|||
94688699|NCT01868074|324315587|FG000|Overall Study|Withdrawal by Subject|4|||
94688700|NCT01868074|324315588|FG001|Overall Study|Withdrawal by Subject|2|||
94688701|NCT00967018|324315589|FG000|Overall Study|Adverse Event|2|||
94688702|NCT00967018|324315589|FG000|Overall Study|Physician Decision|7|||
94688703|NCT00967018|324315589|FG000|Overall Study|Lost to Follow-up|2|||
94688704|NCT00967018|324315589|FG000|Overall Study|Withdrawal by Subject|1|||
94688705|NCT00967018|324315589|FG000|Overall Study|Miscellaneous Reasons|9|||
94688706|NCT04642469|324315591|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
94688707|NCT04642469|324315592|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
94688708|NCT04642469|324315591|FG000|Overall Study|Death|1|||
94688709|NCT04642469|324315592|FG001|Overall Study|Death|2|||
94688710|NCT04642469|324315591|FG000|Overall Study|Study/site closed following amendment 1|11|||
94688711|NCT04642469|324315592|FG001|Overall Study|Study/site closed following amendment 1|11|||
94688712|NCT04642469|324315591|FG000|Overall Study|Other|1|||
94465953|NCT04769739|323494962|FG003|Overall Study|Poor bowel preparation|1|||
94465954|NCT00932451|323494963|FG000|Overall Study|Withdrawal by Subject|69|||
94465955|NCT00932451|323494963|FG000|Overall Study|Lost to Follow-up|22|||
94465956|NCT00932451|323494963|FG000|Overall Study|Death|726|||
94465957|NCT00932451|323494963|FG000|Overall Study|Other reasons|5|||
94465958|NCT02431806|323494964|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
94465959|NCT02431806|323494965|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
94465960|NCT02431806|323494966|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
94465961|NCT02431806|323494967|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
94465962|NCT02431806|323494964|FG000|Double-blind Treatment Period|Adverse Event|4|||
94465963|NCT02431806|323494965|FG001|Double-blind Treatment Period|Adverse Event|7|||
94465964|NCT02431806|323494966|FG002|Double-blind Treatment Period|Adverse Event|11|||
94465965|NCT02431806|323494967|FG003|Double-blind Treatment Period|Adverse Event|7|||
94465966|NCT02431806|323494964|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
94465967|NCT02431806|323494965|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
94465968|NCT02431806|323494966|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
94465969|NCT02431806|323494967|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
94465970|NCT02431806|323494964|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
94465971|NCT02431806|323494965|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
94465972|NCT02431806|323494966|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
94465973|NCT02431806|323494967|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
94465974|NCT02431806|323494964|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
94465975|NCT02431806|323494965|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
94465976|NCT02431806|323494966|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
94688713|NCT04642469|324315592|FG001|Overall Study|Other|1|||
94465977|NCT02431806|323494967|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
94465978|NCT02431806|323494964|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
94465979|NCT02431806|323494965|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
94688714|NCT04642469|324315591|FG000|Overall Study|Withdrawal by Subject|1|||
94688715|NCT04642469|324315592|FG001|Overall Study|Withdrawal by Subject|0|||
94688716|NCT02733042|324315600|FG000|Overall Study|Adverse Event|1|||
94688717|NCT02733042|324315601|FG001|Overall Study|Adverse Event|0|||
94688718|NCT02733042|324315602|FG002|Overall Study|Adverse Event|1|||
94688719|NCT02733042|324315603|FG003|Overall Study|Adverse Event|1|||
94688720|NCT02733042|324315604|FG004|Overall Study|Adverse Event|0|||
94688721|NCT02733042|324315605|FG005|Overall Study|Adverse Event|0|||
94688722|NCT02733042|324315606|FG006|Overall Study|Adverse Event|0|||
94688723|NCT02733042|324315607|FG007|Overall Study|Adverse Event|0|||
94688724|NCT02733042|324315608|FG008|Overall Study|Adverse Event|0|||
94688725|NCT02733042|324315609|FG009|Overall Study|Adverse Event|0|||
94688726|NCT02733042|324315610|FG010|Overall Study|Adverse Event|2|||
94688727|NCT02733042|324315611|FG011|Overall Study|Adverse Event|2|||
94688728|NCT02733042|324315612|FG012|Overall Study|Adverse Event|0|||
94688729|NCT02733042|324315613|FG013|Overall Study|Adverse Event|2|||
94688730|NCT02733042|324315614|FG014|Overall Study|Adverse Event|0|||
94688731|NCT02733042|324315615|FG015|Overall Study|Adverse Event|0|||
94688732|NCT02733042|324315616|FG016|Overall Study|Adverse Event|0|||
94688733|NCT02733042|324315617|FG017|Overall Study|Adverse Event|1|||
94688734|NCT02733042|324315618|FG018|Overall Study|Adverse Event|0|||
94688735|NCT02733042|324315600|FG000|Overall Study|Progressive Disease|2|||
94688736|NCT02733042|324315601|FG001|Overall Study|Progressive Disease|1|||
94688737|NCT02733042|324315602|FG002|Overall Study|Progressive Disease|3|||
94688738|NCT02733042|324315603|FG003|Overall Study|Progressive Disease|1|||
94688739|NCT02733042|324315604|FG004|Overall Study|Progressive Disease|2|||
94688740|NCT02733042|324315605|FG005|Overall Study|Progressive Disease|3|||
94688741|NCT02733042|324315606|FG006|Overall Study|Progressive Disease|0|||
94688742|NCT02733042|324315607|FG007|Overall Study|Progressive Disease|3|||
94688743|NCT02733042|324315608|FG008|Overall Study|Progressive Disease|3|||
94688744|NCT02733042|324315609|FG009|Overall Study|Progressive Disease|2|||
94688745|NCT02733042|324315610|FG010|Overall Study|Progressive Disease|2|||
94688746|NCT02733042|324315611|FG011|Overall Study|Progressive Disease|2|||
94688747|NCT02733042|324315612|FG012|Overall Study|Progressive Disease|8|||
94688748|NCT02733042|324315613|FG013|Overall Study|Progressive Disease|1|||
94688749|NCT02733042|324315614|FG014|Overall Study|Progressive Disease|4|||
94688750|NCT02733042|324315615|FG015|Overall Study|Progressive Disease|7|||
94688751|NCT02733042|324315616|FG016|Overall Study|Progressive Disease|2|||
94688752|NCT02733042|324315617|FG017|Overall Study|Progressive Disease|3|||
94688753|NCT02733042|324315618|FG018|Overall Study|Progressive Disease|4|||
94688754|NCT02733042|324315600|FG000|Overall Study|Withdrawal by Subject|0|||
94688755|NCT02733042|324315601|FG001|Overall Study|Withdrawal by Subject|1|||
94688756|NCT02733042|324315602|FG002|Overall Study|Withdrawal by Subject|2|||
94688757|NCT02733042|324315603|FG003|Overall Study|Withdrawal by Subject|1|||
94688758|NCT02733042|324315604|FG004|Overall Study|Withdrawal by Subject|1|||
94688759|NCT02733042|324315605|FG005|Overall Study|Withdrawal by Subject|0|||
94688760|NCT02733042|324315606|FG006|Overall Study|Withdrawal by Subject|0|||
94688761|NCT02733042|324315607|FG007|Overall Study|Withdrawal by Subject|0|||
94688762|NCT02733042|324315608|FG008|Overall Study|Withdrawal by Subject|1|||
94688763|NCT02733042|324315609|FG009|Overall Study|Withdrawal by Subject|1|||
94688764|NCT02733042|324315610|FG010|Overall Study|Withdrawal by Subject|0|||
94688765|NCT02733042|324315611|FG011|Overall Study|Withdrawal by Subject|2|||
94688766|NCT02733042|324315612|FG012|Overall Study|Withdrawal by Subject|1|||
94688767|NCT02733042|324315613|FG013|Overall Study|Withdrawal by Subject|1|||
94688768|NCT02733042|324315614|FG014|Overall Study|Withdrawal by Subject|0|||
94688769|NCT02733042|324315615|FG015|Overall Study|Withdrawal by Subject|0|||
94688770|NCT02733042|324315616|FG016|Overall Study|Withdrawal by Subject|0|||
94688771|NCT02733042|324315617|FG017|Overall Study|Withdrawal by Subject|0|||
94688772|NCT02733042|324315618|FG018|Overall Study|Withdrawal by Subject|0|||
94688773|NCT02733042|324315600|FG000|Overall Study|Other Reasons|0|||
94688774|NCT02733042|324315601|FG001|Overall Study|Other Reasons|0|||
94365717|NCT05553600|323124754|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
94365718|NCT05553600|323124751|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
94365719|NCT05553600|323124752|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
94365720|NCT05553600|323124753|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
94365721|NCT05553600|323124754|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
94688775|NCT02733042|324315602|FG002|Overall Study|Other Reasons|1|||
94688776|NCT02733042|324315603|FG003|Overall Study|Other Reasons|0|||
94688777|NCT02733042|324315604|FG004|Overall Study|Other Reasons|0|||
94688778|NCT02733042|324315605|FG005|Overall Study|Other Reasons|0|||
94688779|NCT02733042|324315606|FG006|Overall Study|Other Reasons|0|||
94688780|NCT02733042|324315607|FG007|Overall Study|Other Reasons|0|||
94688781|NCT02733042|324315608|FG008|Overall Study|Other Reasons|0|||
94688782|NCT02733042|324315609|FG009|Overall Study|Other Reasons|1|||
94688783|NCT02733042|324315610|FG010|Overall Study|Other Reasons|1|||
94688784|NCT02733042|324315611|FG011|Overall Study|Other Reasons|0|||
94688785|NCT02733042|324315612|FG012|Overall Study|Other Reasons|0|||
94688786|NCT02733042|324315613|FG013|Overall Study|Other Reasons|0|||
94688787|NCT02733042|324315614|FG014|Overall Study|Other Reasons|0|||
94688788|NCT02733042|324315615|FG015|Overall Study|Other Reasons|1|||
94688789|NCT02733042|324315616|FG016|Overall Study|Other Reasons|0|||
94688790|NCT02733042|324315617|FG017|Overall Study|Other Reasons|1|||
94688791|NCT02733042|324315618|FG018|Overall Study|Other Reasons|0|||
94688792|NCT02733042|324315600|FG000|Overall Study|Death|0|||
94688793|NCT02733042|324315601|FG001|Overall Study|Death|0|||
94688794|NCT02733042|324315602|FG002|Overall Study|Death|0|||
94688795|NCT02733042|324315603|FG003|Overall Study|Death|0|||
94688796|NCT02733042|324315604|FG004|Overall Study|Death|0|||
94688797|NCT02733042|324315605|FG005|Overall Study|Death|0|||
94688798|NCT02733042|324315606|FG006|Overall Study|Death|1|||
94688799|NCT02733042|324315607|FG007|Overall Study|Death|0|||
94688800|NCT02733042|324315608|FG008|Overall Study|Death|1|||
94688801|NCT02733042|324315609|FG009|Overall Study|Death|0|||
94688802|NCT02733042|324315610|FG010|Overall Study|Death|1|||
94688803|NCT02733042|324315611|FG011|Overall Study|Death|0|||
94688804|NCT02733042|324315612|FG012|Overall Study|Death|0|||
94688805|NCT02733042|324315613|FG013|Overall Study|Death|0|||
94688806|NCT02733042|324315614|FG014|Overall Study|Death|1|||
94688807|NCT02733042|324315615|FG015|Overall Study|Death|2|||
94688808|NCT02733042|324315616|FG016|Overall Study|Death|0|||
94688809|NCT02733042|324315617|FG017|Overall Study|Death|0|||
94688810|NCT02733042|324315618|FG018|Overall Study|Death|0|||
94688811|NCT02397460|324315619|FG000|Treatment Period 2|Adverse Event|0|||
94688812|NCT02397460|324315620|FG001|Treatment Period 2|Adverse Event|0|||
94688813|NCT02397460|324315621|FG002|Treatment Period 2|Adverse Event|0|||
94688814|NCT02397460|324315622|FG003|Treatment Period 2|Adverse Event|0|||
94688815|NCT02397460|324315623|FG004|Treatment Period 2|Adverse Event|0|||
94688816|NCT02397460|324315624|FG005|Treatment Period 2|Adverse Event|0|||
94688817|NCT02397460|324315625|FG006|Treatment Period 2|Adverse Event|0|||
94688818|NCT02397460|324315626|FG007|Treatment Period 2|Adverse Event|1|||
94688819|NCT02397460|324315619|FG000|Treatment Period 4|Adverse Event|0|||
94688820|NCT02397460|324315620|FG001|Treatment Period 4|Adverse Event|1|||
94688821|NCT02397460|324315621|FG002|Treatment Period 4|Adverse Event|0|||
94688822|NCT02397460|324315622|FG003|Treatment Period 4|Adverse Event|0|||
94688823|NCT02397460|324315623|FG004|Treatment Period 4|Adverse Event|0|||
94688824|NCT02397460|324315624|FG005|Treatment Period 4|Adverse Event|0|||
94688825|NCT02397460|324315625|FG006|Treatment Period 4|Adverse Event|0|||
94688826|NCT02397460|324315626|FG007|Treatment Period 4|Adverse Event|0|||
94688827|NCT02397460|324315619|FG000|Treatment Period 4|Physician Decision|0|||
94688828|NCT02397460|324315620|FG001|Treatment Period 4|Physician Decision|0|||
94688829|NCT02397460|324315621|FG002|Treatment Period 4|Physician Decision|0|||
94688830|NCT02397460|324315622|FG003|Treatment Period 4|Physician Decision|0|||
94688831|NCT02397460|324315623|FG004|Treatment Period 4|Physician Decision|1|||
94688832|NCT02397460|324315624|FG005|Treatment Period 4|Physician Decision|0|||
94688833|NCT02397460|324315625|FG006|Treatment Period 4|Physician Decision|0|||
94688834|NCT02397460|324315626|FG007|Treatment Period 4|Physician Decision|0|||
94688835|NCT02066532|324315629|FG000|Phase II|Withdrawal by Subject|1|||
94688836|NCT02066532|324315630|FG001|Phase II|Withdrawal by Subject|0|||
94688837|NCT02066532|324315631|FG002|Phase II|Withdrawal by Subject|0|||
94688838|NCT02066532|324315632|FG003|Phase II|Withdrawal by Subject|0|||
94688839|NCT01265823|324315633|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
94688840|NCT01265823|324315633|FG000|Overall Study|Failure to Return|4|||
94688841|NCT01265823|324315633|FG000|Overall Study|Protocol Violation|1|||
94688842|NCT01265823|324315633|FG000|Overall Study|Participant Request|1|||
94688843|NCT03406702|324315639|FG000|Overall Study|Missed Day 27 Dosing|1|||
94688844|NCT00845871|324315642|FG000|Assessment Period|Adverse Event|2|||
94688845|NCT00845871|324315642|FG000|Assessment Period|Abnormal laboratory values|1|||
94688846|NCT00845871|324315642|FG000|Assessment Period|Abnormal test procedure results|1|||
94688847|NCT00845871|324315642|FG000|Assessment Period|Patient withdrew consent|3|||
94688848|NCT00383240|324315649|FG000|Overall Study|Adverse Event|4|||
94688849|NCT00383240|324315650|FG001|Overall Study|Adverse Event|6|||
94688850|NCT00383240|324315651|FG002|Overall Study|Adverse Event|9|||
94688851|NCT00383240|324315652|FG003|Overall Study|Adverse Event|7|||
94688852|NCT00383240|324315649|FG000|Overall Study|Treatment Failure|8|||
94688853|NCT00383240|324315650|FG001|Overall Study|Treatment Failure|13|||
94688854|NCT00383240|324315651|FG002|Overall Study|Treatment Failure|47|||
94264162|NCT02876835|322761861|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
94688855|NCT00383240|324315652|FG003|Overall Study|Treatment Failure|46|||
94688856|NCT00383240|324315649|FG000|Overall Study|Lost to Follow-up|3|||
94688857|NCT00383240|324315650|FG001|Overall Study|Lost to Follow-up|0|||
94688858|NCT00383240|324315651|FG002|Overall Study|Lost to Follow-up|0|||
94688859|NCT00383240|324315652|FG003|Overall Study|Lost to Follow-up|2|||
94688860|NCT00383240|324315649|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
94688861|NCT00383240|324315650|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
94688862|NCT00383240|324315651|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
94688863|NCT00383240|324315652|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
94688864|NCT00383240|324315649|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
94688865|NCT00383240|324315650|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
94688866|NCT00383240|324315651|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
94688867|NCT00383240|324315652|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
94688868|NCT00383240|324315649|FG000|Overall Study|Protocol Violation|4|||
94688869|NCT00383240|324315650|FG001|Overall Study|Protocol Violation|5|||
94688870|NCT00383240|324315651|FG002|Overall Study|Protocol Violation|9|||
94688871|NCT00383240|324315652|FG003|Overall Study|Protocol Violation|6|||
94688872|NCT00383240|324315649|FG000|Overall Study|Did not meet protocol eligibility|9|||
94688873|NCT00383240|324315650|FG001|Overall Study|Did not meet protocol eligibility|4|||
94688874|NCT00383240|324315651|FG002|Overall Study|Did not meet protocol eligibility|9|||
94688875|NCT00383240|324315652|FG003|Overall Study|Did not meet protocol eligibility|3|||
94688876|NCT00383240|324315649|FG000|Overall Study|Administrative|1|||
94688877|NCT00383240|324315650|FG001|Overall Study|Administrative|1|||
94688878|NCT00383240|324315651|FG002|Overall Study|Administrative|0|||
94688879|NCT00383240|324315652|FG003|Overall Study|Administrative|0|||
94688880|NCT02044458|324315653|FG000|Overall Study|Protocol Violation|3|||
94688881|NCT02044458|324315654|FG001|Overall Study|Protocol Violation|8|||
94688882|NCT03363659|324315655|FG000|Overall Study|Adverse Event|1|||
94688883|NCT03363659|324315655|FG000|Overall Study|Screen fail|1|||
94688884|NCT03363659|324315655|FG000|Overall Study|Withdrawal by Subject|1|||
94688885|NCT01216293|324315656|FG000|Main Study|Adverse Event|1|||
94688886|NCT01216293|324315657|FG001|Main Study|Adverse Event|4|||
94688887|NCT01216293|324315658|FG002|Main Study|Adverse Event|2|||
94688888|NCT01216293|324315656|FG000|Main Study|Major Protocol Deviation|1|||
94688889|NCT01216293|324315657|FG001|Main Study|Major Protocol Deviation|0|||
94688890|NCT01216293|324315658|FG002|Main Study|Major Protocol Deviation|1|||
94688891|NCT01216293|324315656|FG000|Main Study|Lost to Follow-up|3|||
94688892|NCT01216293|324315657|FG001|Main Study|Lost to Follow-up|1|||
94688893|NCT01216293|324315658|FG002|Main Study|Lost to Follow-up|0|||
94688894|NCT01216293|324315656|FG000|Main Study|Voluntary Withdrawal|2|||
94688895|NCT01216293|324315657|FG001|Main Study|Voluntary Withdrawal|2|||
94688896|NCT01216293|324315658|FG002|Main Study|Voluntary Withdrawal|2|||
94688897|NCT01216293|324315656|FG000|Main Study|Other Reason Not Specified|0|||
94688898|NCT01216293|324315657|FG001|Main Study|Other Reason Not Specified|1|||
94688899|NCT01216293|324315658|FG002|Main Study|Other Reason Not Specified|1|||
94688900|NCT01216293|324315656|FG000|Main Study|Randomized, Not Treated|1|||
94688901|NCT01216293|324315657|FG001|Main Study|Randomized, Not Treated|0|||
94688902|NCT01216293|324315658|FG002|Main Study|Randomized, Not Treated|0|||
94688903|NCT01216293|324315656|FG000|Calcium Absorption Substudy|Adverse Event|0|||
94688904|NCT01216293|324315657|FG001|Calcium Absorption Substudy|Adverse Event|2|||
94688905|NCT01216293|324315658|FG002|Calcium Absorption Substudy|Adverse Event|0|||
94688906|NCT01216293|324315656|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
94688907|NCT01216293|324315657|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
94688908|NCT01216293|324315658|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
94688909|NCT01216293|324315656|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
94688910|NCT01216293|324315657|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
94688911|NCT01216293|324315658|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
94688912|NCT03857841|324315659|FG000|Overall Study|Death|1|||
94688913|NCT03857841|324315660|FG001|Overall Study|Death|0|||
94688914|NCT03857841|324315661|FG002|Overall Study|Death|0|||
94688915|NCT03857841|324315662|FG003|Overall Study|Death|0|||
94688916|NCT03857841|324315659|FG000|Overall Study|Study Terminated by Sponsor|1|||
94688917|NCT03857841|324315660|FG001|Overall Study|Study Terminated by Sponsor|0|||
94688918|NCT03857841|324315661|FG002|Overall Study|Study Terminated by Sponsor|0|||
94688919|NCT03857841|324315662|FG003|Overall Study|Study Terminated by Sponsor|0|||
94688920|NCT01671748|324315663|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
94688921|NCT01671748|324315664|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
94365722|NCT03443973|323124755|FG000|Double-blind Treatment Period|Adverse Event|5|||
94365723|NCT03443973|323124756|FG001|Double-blind Treatment Period|Adverse Event|19|||
94365724|NCT03443973|323124757|FG002|Double-blind Treatment Period|Adverse Event|0|||
94365725|NCT03443973|323124758|FG003|Double-blind Treatment Period|Adverse Event|0|||
94365726|NCT03443973|323124755|FG000|Double-blind Treatment Period|Death|5|||
94365727|NCT03443973|323124756|FG001|Double-blind Treatment Period|Death|7|||
94365728|NCT03443973|323124757|FG002|Double-blind Treatment Period|Death|0|||
94365729|NCT03443973|323124758|FG003|Double-blind Treatment Period|Death|0|||
94688922|NCT01671748|324315663|FG000|4 Week run-in Phase|Adverse Event|1|||
94688923|NCT01671748|324315664|FG001|4 Week run-in Phase|Adverse Event|0|||
94688924|NCT01671748|324315663|FG000|4 Week run-in Phase|Not eligible|9|||
94688925|NCT01671748|324315664|FG001|4 Week run-in Phase|Not eligible|0|||
94688926|NCT01091428|324317109|FG000|Phase 1|Progressive Disease|24|||
94688927|NCT01091428|324317110|FG001|Phase 1|Progressive Disease|8|||
94688928|NCT01091428|324317111|FG002|Phase 1|Progressive Disease|0|||
94688929|NCT01091428|324317112|FG003|Phase 1|Progressive Disease|0|||
94688930|NCT01091428|324317109|FG000|Phase 1|Symptomatic Deterioration|3|||
94688931|NCT01091428|324317110|FG001|Phase 1|Symptomatic Deterioration|2|||
94688932|NCT01091428|324317111|FG002|Phase 1|Symptomatic Deterioration|0|||
94688933|NCT01091428|324317112|FG003|Phase 1|Symptomatic Deterioration|0|||
94688934|NCT01091428|324317109|FG000|Phase 1|Adverse Event|2|||
94688935|NCT01091428|324317110|FG001|Phase 1|Adverse Event|0|||
94688936|NCT01091428|324317111|FG002|Phase 1|Adverse Event|0|||
94688937|NCT01091428|324317112|FG003|Phase 1|Adverse Event|0|||
94688938|NCT01091428|324317109|FG000|Phase 1|Withdrawal by Subject|7|||
94688939|NCT01091428|324317110|FG001|Phase 1|Withdrawal by Subject|0|||
94688940|NCT01091428|324317111|FG002|Phase 1|Withdrawal by Subject|0|||
94688941|NCT01091428|324317112|FG003|Phase 1|Withdrawal by Subject|0|||
94688942|NCT01091428|324317109|FG000|Phase 1|Reason not specified|0|||
94688943|NCT01091428|324317110|FG001|Phase 1|Reason not specified|1|||
94688944|NCT01091428|324317111|FG002|Phase 1|Reason not specified|0|||
94688945|NCT01091428|324317112|FG003|Phase 1|Reason not specified|0|||
94688946|NCT01091428|324317109|FG000|Phase 1|Single-Patient IND|2|||
94688947|NCT01091428|324317110|FG001|Phase 1|Single-Patient IND|0|||
94688948|NCT01091428|324317111|FG002|Phase 1|Single-Patient IND|0|||
94688949|NCT01091428|324317112|FG003|Phase 1|Single-Patient IND|0|||
94688950|NCT01091428|324317109|FG000|Phase 2|Progressive Disease|0|||
94688951|NCT01091428|324317110|FG001|Phase 2|Progressive Disease|0|||
94688952|NCT01091428|324317111|FG002|Phase 2|Progressive Disease|44|||
94688953|NCT01091428|324317112|FG003|Phase 2|Progressive Disease|46|||
94688954|NCT01091428|324317109|FG000|Phase 2|Symptomatic Deterioration|0|||
94688955|NCT01091428|324317110|FG001|Phase 2|Symptomatic Deterioration|0|||
94688956|NCT01091428|324317111|FG002|Phase 2|Symptomatic Deterioration|1|||
94688957|NCT01091428|324317112|FG003|Phase 2|Symptomatic Deterioration|6|||
94688958|NCT01091428|324317109|FG000|Phase 2|Adverse Event|0|||
94688959|NCT01091428|324317110|FG001|Phase 2|Adverse Event|0|||
94688960|NCT01091428|324317111|FG002|Phase 2|Adverse Event|12|||
94688961|NCT01091428|324317112|FG003|Phase 2|Adverse Event|5|||
94688962|NCT01091428|324317109|FG000|Phase 2|Withdrawal by Subject|0|||
94688963|NCT01091428|324317110|FG001|Phase 2|Withdrawal by Subject|0|||
94688964|NCT01091428|324317111|FG002|Phase 2|Withdrawal by Subject|9|||
94688965|NCT01091428|324317112|FG003|Phase 2|Withdrawal by Subject|8|||
94688966|NCT01091428|324317109|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
94688967|NCT01091428|324317110|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
94688968|NCT01091428|324317111|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
94688969|NCT01091428|324317112|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
94688970|NCT01091428|324317109|FG000|Phase 2|Reason not specified|0|||
94688971|NCT01091428|324317110|FG001|Phase 2|Reason not specified|0|||
94688972|NCT01091428|324317111|FG002|Phase 2|Reason not specified|4|||
94688973|NCT01091428|324317112|FG003|Phase 2|Reason not specified|3|||
94688974|NCT01091428|324317109|FG000|Phase 2|Physician Decision|0|||
94688975|NCT01091428|324317110|FG001|Phase 2|Physician Decision|0|||
94688976|NCT01091428|324317111|FG002|Phase 2|Physician Decision|2|||
94688977|NCT01091428|324317112|FG003|Phase 2|Physician Decision|0|||
94688978|NCT01282476|324317113|FG000|Overall Study|Death|11|||
94688979|NCT04249336|324317118|FG000|Overall Study|Lost to Follow-up|3|||
94688980|NCT04249336|324317119|FG001|Overall Study|Lost to Follow-up|3|||
94688981|NCT04249336|324317120|FG002|Overall Study|Lost to Follow-up|3|||
94688982|NCT04249336|324317121|FG003|Overall Study|Lost to Follow-up|3|||
94688983|NCT01242176|324317122|FG000|Washout Period of 7 Days|Adverse Event|0|||
94688984|NCT01242176|324317123|FG001|Washout Period of 7 Days|Adverse Event|2|||
94688985|NCT01242176|324317122|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
94688986|NCT01242176|324317123|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
94688987|NCT03722264|324317125|FG000|Overall Study|Physician Decision|3|||
94688988|NCT02032173|324317128|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
94688989|NCT01683994|324317135|FG000|Overall Study|Withdrawal by Subject|1|||
94688990|NCT01683994|324317136|FG001|Overall Study|Withdrawal by Subject|0|||
94688991|NCT01683994|324317137|FG002|Overall Study|Withdrawal by Subject|0|||
94688992|NCT01683994|324317138|FG003|Overall Study|Withdrawal by Subject|1|||
94688993|NCT01683994|324317139|FG004|Overall Study|Withdrawal by Subject|0|||
94688994|NCT01683994|324317135|FG000|Overall Study|Intercurrent illness|0|||
94688995|NCT01683994|324317136|FG001|Overall Study|Intercurrent illness|0|||
94688996|NCT01683994|324317137|FG002|Overall Study|Intercurrent illness|0|||
94688997|NCT01683994|324317138|FG003|Overall Study|Intercurrent illness|2|||
94688998|NCT01683994|324317139|FG004|Overall Study|Intercurrent illness|1|||
94688999|NCT00802659|324317144|FG000|Overall Study|Physician Decision|0|||
94689000|NCT00802659|324317145|FG001|Overall Study|Physician Decision|1|||
94689001|NCT00802659|324317146|FG002|Overall Study|Physician Decision|0|||
94689002|NCT00802659|324317147|FG003|Overall Study|Physician Decision|0|||
94689003|NCT00289770|324317148|FG000|Year 15|Withdrawal by Subject|1|||
94689004|NCT01912222|324317149|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
94689005|NCT01912222|324317150|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
94689006|NCT01912222|324317151|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
94689007|NCT01912222|324317149|FG000|Part B: Treatment Period|Progressive disease|10|||
94689008|NCT01912222|324317150|FG001|Part B: Treatment Period|Progressive disease|12|||
94365730|NCT03443973|323124755|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
94365731|NCT03443973|323124756|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
94689009|NCT01912222|324317151|FG002|Part B: Treatment Period|Progressive disease|15|||
94689010|NCT01912222|324317149|FG000|Part B: Treatment Period|Adverse Event|1|||
94689011|NCT01912222|324317150|FG001|Part B: Treatment Period|Adverse Event|2|||
94689012|NCT01912222|324317151|FG002|Part B: Treatment Period|Adverse Event|3|||
94689013|NCT01912222|324317149|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
94689014|NCT01912222|324317150|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
94689015|NCT01912222|324317151|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
94689016|NCT00154063|324317152|FG000|Overall Study|Adverse Event|4|||
94689017|NCT00154063|324317153|FG001|Overall Study|Adverse Event|8|||
94689018|NCT00154063|324317152|FG000|Overall Study|Protocol Violation|1|||
94689019|NCT00154063|324317153|FG001|Overall Study|Protocol Violation|1|||
94689020|NCT00154063|324317152|FG000|Overall Study|Investigator or Sponsor Request|0|||
94689021|NCT00154063|324317153|FG001|Overall Study|Investigator or Sponsor Request|1|||
94689022|NCT00154063|324317152|FG000|Overall Study|Withdrawal by Subject|4|||
94689023|NCT00154063|324317153|FG001|Overall Study|Withdrawal by Subject|9|||
94689024|NCT00154063|324317152|FG000|Overall Study|Other|3|||
94689025|NCT00154063|324317153|FG001|Overall Study|Other|3|||
94689026|NCT04747275|324317154|FG000|Overall Study|Study terminated|0|||
94689027|NCT04747275|324317155|FG001|Overall Study|Study terminated|1|||
94689028|NCT00531011|324317156|FG000|Overall Study|Withdrawal by Subject|2|||
94689029|NCT00531011|324317157|FG001|Overall Study|Withdrawal by Subject|4|||
94689030|NCT00531011|324317156|FG000|Overall Study|Death|1|||
94689031|NCT00531011|324317157|FG001|Overall Study|Death|0|||
94689032|NCT00531011|324317156|FG000|Overall Study|Lost to Follow-up|1|||
94689033|NCT00531011|324317157|FG001|Overall Study|Lost to Follow-up|0|||
94689034|NCT00531011|324317156|FG000|Overall Study|Physician Decision|0|||
94689035|NCT00531011|324317157|FG001|Overall Study|Physician Decision|3|||
94689036|NCT03893825|324317182|FG000|Overall Study|Death|2|||
94689037|NCT03893825|324317183|FG001|Overall Study|Death|1|||
94689038|NCT03893825|324317182|FG000|Overall Study|Adverse Event|0|||
94689039|NCT03893825|324317183|FG001|Overall Study|Adverse Event|2|||
94689040|NCT03893825|324317182|FG000|Overall Study|Withdrawal by Subject|19|||
94689041|NCT03893825|324317183|FG001|Overall Study|Withdrawal by Subject|21|||
94689042|NCT03893825|324317182|FG000|Overall Study|Protocol deviation|1|||
94689043|NCT03893825|324317183|FG001|Overall Study|Protocol deviation|0|||
94689044|NCT03893825|324317182|FG000|Overall Study|Lost to Follow-up|10|||
94689045|NCT03893825|324317183|FG001|Overall Study|Lost to Follow-up|10|||
94689046|NCT03893825|324317182|FG000|Overall Study|Other than specified|7|||
94689047|NCT03893825|324317183|FG001|Overall Study|Other than specified|6|||
94689048|NCT00672958|324317196|FG000|Overall Study|Adverse Event|11|||
94689049|NCT00672958|324317197|FG001|Overall Study|Adverse Event|9|||
94689050|NCT00672958|324317196|FG000|Overall Study|Lack of Efficacy|6|||
94689051|NCT00672958|324317197|FG001|Overall Study|Lack of Efficacy|11|||
94689052|NCT00672958|324317196|FG000|Overall Study|Non-compliance with study drug|2|||
94689053|NCT00672958|324317197|FG001|Overall Study|Non-compliance with study drug|3|||
94689054|NCT00672958|324317196|FG000|Overall Study|Protocol deviations|11|||
94689055|NCT00672958|324317197|FG001|Overall Study|Protocol deviations|5|||
94365732|NCT03443973|323124757|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
94365733|NCT03443973|323124758|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
94365734|NCT03443973|323124755|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
94365735|NCT03443973|323124756|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
94365736|NCT03443973|323124757|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
94465980|NCT02431806|323494966|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
94465981|NCT02431806|323494967|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
94465982|NCT02431806|323494964|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
94465983|NCT02431806|323494965|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
94689056|NCT00672958|324317196|FG000|Overall Study|Voluntary withdrawal|12|||
94689057|NCT00672958|324317197|FG001|Overall Study|Voluntary withdrawal|8|||
94689058|NCT00672958|324317196|FG000|Overall Study|Lost to Follow-up|22|||
94689059|NCT00672958|324317197|FG001|Overall Study|Lost to Follow-up|17|||
94689060|NCT00672958|324317196|FG000|Overall Study|Reason not specified|0|||
94365737|NCT03443973|323124758|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
94365738|NCT03443973|323124755|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
94465984|NCT02431806|323494966|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
94689061|NCT00672958|324317197|FG001|Overall Study|Reason not specified|3|||
94689062|NCT01425632|324317198|FG000|Overall Study|Adverse Event|0|||
94689063|NCT01425632|324317199|FG001|Overall Study|Adverse Event|1|||
94689064|NCT01425632|324317200|FG002|Overall Study|Adverse Event|1|||
94689065|NCT01425632|324317198|FG000|Overall Study|Physician Decision|1|||
94689066|NCT01425632|324317199|FG001|Overall Study|Physician Decision|0|||
94689067|NCT01425632|324317200|FG002|Overall Study|Physician Decision|0|||
94689068|NCT01425632|324317198|FG000|Overall Study|Protocol Violation|0|||
94689069|NCT01425632|324317199|FG001|Overall Study|Protocol Violation|0|||
94365739|NCT03443973|323124756|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
94689070|NCT01425632|324317200|FG002|Overall Study|Protocol Violation|2|||
94689071|NCT01425632|324317198|FG000|Overall Study|Withdrawal by Subject|0|||
94689072|NCT01425632|324317199|FG001|Overall Study|Withdrawal by Subject|0|||
94689073|NCT01425632|324317200|FG002|Overall Study|Withdrawal by Subject|1|||
94689074|NCT04716881|324317203|FG000|Overall Study|Adverse Event|1|||
94689075|NCT04716881|324317203|FG000|Overall Study|Lost to Follow-up|1|||
94689076|NCT01115491|324317204|FG000|Overall Study|Death|22|||
94689077|NCT01115491|324317204|FG000|Overall Study|Adverse Event|3|||
94689078|NCT01115491|324317204|FG000|Overall Study|Lost to Follow-up|3|||
94689079|NCT01115491|324317204|FG000|Overall Study|Withdrawal by Subject|1|||
94689080|NCT01115491|324317204|FG000|Overall Study|Physician Decision|1|||
94689081|NCT04297241|324317205|FG000|Overall Study|Withdrawal by Subject|1|||
94689082|NCT04297241|324317205|FG000|Overall Study|Adverse Event|1|||
94689083|NCT04297241|324317205|FG000|Overall Study|Physician Decision|3|||
94689084|NCT03044353|324317206|FG000|Overall Study|Adverse Event|0|||
94689085|NCT03044353|324317207|FG001|Overall Study|Adverse Event|1|||
94689086|NCT03044353|324317208|FG002|Overall Study|Adverse Event|0|||
94689087|NCT02141659|324317211|FG000|Overall Study|Major Protocol Deviation|0|||
94689088|NCT02141659|324317212|FG001|Overall Study|Major Protocol Deviation|1|||
94689089|NCT02141659|324317213|FG002|Overall Study|Major Protocol Deviation|0|||
94689090|NCT02141659|324317214|FG003|Overall Study|Major Protocol Deviation|0|||
94689091|NCT02141659|324317215|FG004|Overall Study|Major Protocol Deviation|0|||
94689092|NCT02141659|324317216|FG005|Overall Study|Major Protocol Deviation|0|||
94689093|NCT02141659|324317211|FG000|Overall Study|Lack of Efficacy|0|||
94689094|NCT02141659|324317212|FG001|Overall Study|Lack of Efficacy|0|||
94689095|NCT02141659|324317213|FG002|Overall Study|Lack of Efficacy|0|||
94689096|NCT02141659|324317214|FG003|Overall Study|Lack of Efficacy|0|||
94689097|NCT02141659|324317215|FG004|Overall Study|Lack of Efficacy|0|||
94689098|NCT02141659|324317216|FG005|Overall Study|Lack of Efficacy|1|||
94689099|NCT02141659|324317211|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
94689100|NCT02141659|324317212|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
94689101|NCT02141659|324317213|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
94689102|NCT02141659|324317214|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
94689103|NCT02141659|324317215|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
94689104|NCT02141659|324317216|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
94689105|NCT02471404|324317217|FG000|Overall Study|Adverse Event|7|||
94689106|NCT02471404|324317218|FG001|Overall Study|Adverse Event|1|||
94689107|NCT02471404|324317219|FG002|Overall Study|Adverse Event|2|||
94689108|NCT02471404|324317217|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
94689109|NCT02471404|324317218|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
94689110|NCT02471404|324317219|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
94689111|NCT02471404|324317217|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
94689112|NCT02471404|324317218|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
94689113|NCT02471404|324317219|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
94689114|NCT02471404|324317217|FG000|Overall Study|Lost to Follow-up|1|||
94689115|NCT02471404|324317218|FG001|Overall Study|Lost to Follow-up|1|||
94689116|NCT02471404|324317219|FG002|Overall Study|Lost to Follow-up|3|||
94689117|NCT02471404|324317217|FG000|Overall Study|Protocol Violation|1|||
94689118|NCT02471404|324317218|FG001|Overall Study|Protocol Violation|0|||
94689119|NCT02471404|324317219|FG002|Overall Study|Protocol Violation|0|||
94689120|NCT02471404|324317217|FG000|Overall Study|Withdrawal by Subject|8|||
94689121|NCT02471404|324317218|FG001|Overall Study|Withdrawal by Subject|4|||
94689122|NCT02471404|324317219|FG002|Overall Study|Withdrawal by Subject|5|||
94689123|NCT02471404|324317217|FG000|Overall Study|Other reasons not specified|10|||
94689124|NCT02471404|324317218|FG001|Overall Study|Other reasons not specified|7|||
94365740|NCT03443973|323124757|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
94365741|NCT03443973|323124758|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
94365742|NCT03443973|323124755|FG000|Double-blind Treatment Period|Physician Decision|5|||
94365743|NCT03443973|323124756|FG001|Double-blind Treatment Period|Physician Decision|6|||
94689125|NCT02471404|324317219|FG002|Overall Study|Other reasons not specified|12|||
94689126|NCT01388530|324317220|FG000|Overall Study|Lost to Follow-up|5|||
94689127|NCT01018563|324317226|FG000|Overall Study|Termination of the study by Sponsor|2|||
94689128|NCT01018563|324317227|FG001|Overall Study|Termination of the study by Sponsor|1|||
94689129|NCT02337478|324317228|FG000|Overall Study|Lack of Efficacy|5|||
94689130|NCT00932646|324317229|FG000|Overall Study|Adverse Event|2|||
94689131|NCT00932646|324317230|FG001|Overall Study|Adverse Event|1|||
94689132|NCT00932646|324317231|FG002|Overall Study|Adverse Event|1|||
94689133|NCT00932646|324317232|FG003|Overall Study|Adverse Event|1|||
94689134|NCT00932646|324317229|FG000|Overall Study|Lost to Follow-up|2|||
94689135|NCT00932646|324317230|FG001|Overall Study|Lost to Follow-up|1|||
94689136|NCT00932646|324317231|FG002|Overall Study|Lost to Follow-up|0|||
94689137|NCT00932646|324317232|FG003|Overall Study|Lost to Follow-up|0|||
94689138|NCT00932646|324317229|FG000|Overall Study|Withdrawal by Subject|1|||
94689139|NCT00932646|324317230|FG001|Overall Study|Withdrawal by Subject|1|||
94689140|NCT00932646|324317231|FG002|Overall Study|Withdrawal by Subject|3|||
94689141|NCT00932646|324317232|FG003|Overall Study|Withdrawal by Subject|0|||
94365744|NCT03443973|323124757|FG002|Double-blind Treatment Period|Physician Decision|0|||
94365745|NCT03443973|323124758|FG003|Double-blind Treatment Period|Physician Decision|0|||
94365746|NCT03443973|323124755|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
94365747|NCT03443973|323124756|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
94365748|NCT03443973|323124757|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
94365749|NCT03443973|323124758|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
94689142|NCT00653263|324317234|FG000|Overall Study|Withdrawal by Subject|1|||
94689143|NCT00653263|324317234|FG000|Overall Study|Physician Decision|1|||
94689144|NCT02262260|324317238|FG000|Overall Study|Adverse Event|4|||
94689145|NCT02262260|324317239|FG001|Overall Study|Adverse Event|1|||
94689146|NCT02262260|324317238|FG000|Overall Study|Withdrawal of consent|4|||
94689147|NCT02262260|324317239|FG001|Overall Study|Withdrawal of consent|2|||
94689148|NCT02262260|324317238|FG000|Overall Study|Lost to Follow-up|1|||
94689149|NCT02262260|324317239|FG001|Overall Study|Lost to Follow-up|2|||
94689150|NCT02262260|324317238|FG000|Overall Study|Protocol deviation|2|||
94689151|NCT02262260|324317239|FG001|Overall Study|Protocol deviation|5|||
94689152|NCT00180713|324317240|FG000|Overall Study|Withdrawal by Subject|2|||
94689153|NCT00180713|324317241|FG001|Overall Study|Withdrawal by Subject|0|||
94689154|NCT00180713|324317240|FG000|Overall Study|Adverse Event|3|||
94689155|NCT00180713|324317241|FG001|Overall Study|Adverse Event|3|||
94689156|NCT01267253|324317242|FG000|Overall Study|Ineligible - required test not done|1|||
94689157|NCT01267253|324317242|FG000|Overall Study|Inevaluable-never received study treatme|2|||
94689158|NCT00655551|324317243|FG000|All Periods Combined|Adverse Event|0|||
94689159|NCT00655551|324317244|FG001|All Periods Combined|Adverse Event|3|||
94689160|NCT00655551|324317245|FG002|All Periods Combined|Adverse Event|4|||
94689161|NCT00655551|324317243|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
94689162|NCT00655551|324317244|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
94689163|NCT00655551|324317245|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
94689164|NCT00655551|324317243|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
94689165|NCT00655551|324317244|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
94689166|NCT00655551|324317245|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
94689167|NCT00655551|324317243|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
94689168|NCT00655551|324317244|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
94689169|NCT00655551|324317245|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
94689170|NCT00309608|324317246|FG000|Overall Study|Adverse Event|1|||
94689171|NCT00309608|324317247|FG001|Overall Study|Adverse Event|5|||
94689172|NCT00309608|324317248|FG002|Overall Study|Adverse Event|3|||
94689173|NCT00309608|324317249|FG003|Overall Study|Adverse Event|2|||
94689174|NCT00309608|324317250|FG004|Overall Study|Adverse Event|3|||
94689175|NCT00309608|324317246|FG000|Overall Study|Protocol Violation|2|||
94689176|NCT00309608|324317247|FG001|Overall Study|Protocol Violation|0|||
94689177|NCT00309608|324317248|FG002|Overall Study|Protocol Violation|0|||
94689178|NCT00309608|324317249|FG003|Overall Study|Protocol Violation|0|||
94689179|NCT00309608|324317250|FG004|Overall Study|Protocol Violation|0|||
94689180|NCT00309608|324317246|FG000|Overall Study|Lost to Follow-up|0|||
94689181|NCT00309608|324317247|FG001|Overall Study|Lost to Follow-up|0|||
94689182|NCT00309608|324317248|FG002|Overall Study|Lost to Follow-up|2|||
94689183|NCT00309608|324317249|FG003|Overall Study|Lost to Follow-up|0|||
94689184|NCT00309608|324317250|FG004|Overall Study|Lost to Follow-up|1|||
94689185|NCT00309608|324317246|FG000|Overall Study|Withdrawal by Subject|1|||
94689186|NCT00309608|324317247|FG001|Overall Study|Withdrawal by Subject|4|||
94689187|NCT00309608|324317248|FG002|Overall Study|Withdrawal by Subject|2|||
94689188|NCT00309608|324317249|FG003|Overall Study|Withdrawal by Subject|0|||
94689189|NCT00309608|324317250|FG004|Overall Study|Withdrawal by Subject|0|||
94689190|NCT00309608|324317246|FG000|Overall Study|Other incl. Lack of efficacy|10|||
94689191|NCT00309608|324317247|FG001|Overall Study|Other incl. Lack of efficacy|4|||
94689192|NCT00309608|324317248|FG002|Overall Study|Other incl. Lack of efficacy|3|||
94689193|NCT00309608|324317249|FG003|Overall Study|Other incl. Lack of efficacy|4|||
94689194|NCT00309608|324317250|FG004|Overall Study|Other incl. Lack of efficacy|0|||
94689195|NCT00127413|324317251|FG000|Overall Study|Lost to Follow-up|6|||
94689196|NCT00127413|324317252|FG001|Overall Study|Lost to Follow-up|4|||
94689197|NCT00127413|324317253|FG002|Overall Study|Lost to Follow-up|8|||
94689198|NCT00127413|324317254|FG003|Overall Study|Lost to Follow-up|2|||
94365750|NCT03443973|323124755|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
94689199|NCT00641186|324317259|FG000|Overall Study|Adverse Event|3|||
94689200|NCT05221749|324317260|FG000|Overall Study|Lost to Follow-up|2|||
94689201|NCT05221749|324317261|FG001|Overall Study|Lost to Follow-up|3|||
94689202|NCT01644474|324317264|FG000|Overall Study|Poor compliance to protocol|1|||
94689203|NCT01644474|324317265|FG001|Overall Study|Poor compliance to protocol|0|||
94689204|NCT01644474|324317264|FG000|Overall Study|Consent withdrawn by participant|0|||
94689205|NCT01644474|324317265|FG001|Overall Study|Consent withdrawn by participant|1|||
94689206|NCT01644474|324317264|FG000|Overall Study|Participant moved|0|||
94689207|NCT01644474|324317265|FG001|Overall Study|Participant moved|1|||
94689208|NCT01644474|324317264|FG000|Overall Study|Adverse Event|4|||
94689209|NCT01644474|324317265|FG001|Overall Study|Adverse Event|5|||
94689210|NCT01644474|324317264|FG000|Overall Study|Site scheduling error|1|||
94689211|NCT01644474|324317265|FG001|Overall Study|Site scheduling error|1|||
94689212|NCT01644474|324317264|FG000|Overall Study|Protocol Violation|1|||
94264163|NCT02876835|322761860|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
94689213|NCT01644474|324317265|FG001|Overall Study|Protocol Violation|0|||
94689214|NCT02023879|324317266|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
94689215|NCT02023879|324317267|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
94689216|NCT02023879|324317268|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
94689217|NCT02023879|324317266|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
94689218|NCT02023879|324317267|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
94689219|NCT02023879|324317268|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
94689220|NCT02023879|324317266|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
94689221|NCT02023879|324317267|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
94689222|NCT02023879|324317268|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
94689223|NCT02023879|324317266|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
94689224|NCT02023879|324317267|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
94689225|NCT02023879|324317268|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
94365751|NCT03443973|323124756|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
94365752|NCT03443973|323124757|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
94365753|NCT03443973|323124758|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
94365754|NCT03443973|323124755|FG000|Open-label Extension Period|Reason Not Specified|0|||
94365755|NCT03443973|323124756|FG001|Open-label Extension Period|Reason Not Specified|0|||
94689226|NCT02023879|324317266|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
94689227|NCT02023879|324317267|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
94689228|NCT02023879|324317268|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
94689229|NCT02023879|324317266|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
94689230|NCT02023879|324317267|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
94689231|NCT02023879|324317268|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
94689232|NCT02023879|324317266|FG000|Extension Open Label Treatment|Adverse Event|1|||
94689233|NCT02023879|324317267|FG001|Extension Open Label Treatment|Adverse Event|7|||
94689234|NCT02023879|324317268|FG002|Extension Open Label Treatment|Adverse Event|3|||
94689235|NCT02023879|324317266|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
94689236|NCT02023879|324317267|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
94689237|NCT02023879|324317268|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
94689238|NCT02023879|324317266|FG000|Extension Open Label Treatment|Participant moved|1|||
94689239|NCT02023879|324317267|FG001|Extension Open Label Treatment|Participant moved|2|||
94689240|NCT02023879|324317268|FG002|Extension Open Label Treatment|Participant moved|0|||
94689241|NCT02023879|324317266|FG000|Extension Open Label Treatment|Other than specified above|2|||
94689242|NCT02023879|324317267|FG001|Extension Open Label Treatment|Other than specified above|7|||
94689243|NCT02023879|324317268|FG002|Extension Open Label Treatment|Other than specified above|2|||
94689244|NCT01167179|324319178|FG000|Overall Study|disease recurrence|4|||
94689245|NCT01167179|324319179|FG001|Overall Study|disease recurrence|4|||
94689246|NCT01167179|324319178|FG000|Overall Study|Death|4|||
94689247|NCT01167179|324319179|FG001|Overall Study|Death|10|||
94689248|NCT01167179|324319178|FG000|Overall Study|Withdrawal by Subject|1|||
94689249|NCT01167179|324319179|FG001|Overall Study|Withdrawal by Subject|2|||
94689250|NCT01167179|324319178|FG000|Overall Study|diverse|6|||
94689251|NCT01167179|324319179|FG001|Overall Study|diverse|5|||
94689252|NCT00581113|324319180|FG000|Overall Study|Withdrawal by Subject|0|||
94689253|NCT00581113|324319181|FG001|Overall Study|Withdrawal by Subject|1|||
94689254|NCT01818141|324319182|FG000|Overall Study|Withdrawal by Subject|2|||
94689255|NCT01818141|324319183|FG001|Overall Study|Withdrawal by Subject|0|||
94689256|NCT01818141|324319182|FG000|Overall Study|No baseline C.diff colonies|1|||
94689257|NCT01818141|324319183|FG001|Overall Study|No baseline C.diff colonies|1|||
94689258|NCT01818141|324319182|FG000|Overall Study|Lost to Follow-up|0|||
94689259|NCT01818141|324319183|FG001|Overall Study|Lost to Follow-up|2|||
94689260|NCT03518658|324319184|FG000|Overall Study|Other|51|||
94689261|NCT03518658|324319185|FG001|Overall Study|Other|0|||
94689262|NCT04781647|324319186|FG000|Overall Study|Study terminated by Sponsor|11|||
94689263|NCT04781647|324319187|FG001|Overall Study|Study terminated by Sponsor|9|||
94689264|NCT04781647|324319188|FG002|Overall Study|Study terminated by Sponsor|9|||
94689265|NCT04781647|324319186|FG000|Overall Study|Withdrawal by Subject|1|||
94689266|NCT04781647|324319187|FG001|Overall Study|Withdrawal by Subject|2|||
94689267|NCT04781647|324319188|FG002|Overall Study|Withdrawal by Subject|0|||
94689268|NCT04781647|324319186|FG000|Overall Study|Adverse Event|0|||
94689269|NCT04781647|324319187|FG001|Overall Study|Adverse Event|1|||
94689270|NCT04781647|324319188|FG002|Overall Study|Adverse Event|1|||
94689271|NCT04781647|324319186|FG000|Overall Study|Protocol Violation|1|||
94689272|NCT04781647|324319187|FG001|Overall Study|Protocol Violation|0|||
94689273|NCT04781647|324319188|FG002|Overall Study|Protocol Violation|0|||
94689274|NCT04781647|324319186|FG000|Overall Study|Pregnancy|0|||
94689275|NCT04781647|324319187|FG001|Overall Study|Pregnancy|0|||
94365756|NCT03443973|323124757|FG002|Open-label Extension Period|Reason Not Specified|3|||
94689276|NCT04781647|324319188|FG002|Overall Study|Pregnancy|1|||
94689277|NCT04781647|324319186|FG000|Overall Study|Virology rebounded|1|||
94689278|NCT04781647|324319187|FG001|Overall Study|Virology rebounded|0|||
94689279|NCT04781647|324319188|FG002|Overall Study|Virology rebounded|0|||
94365757|NCT03443973|323124758|FG003|Open-label Extension Period|Reason Not Specified|0|||
94689280|NCT04213989|324319191|FG000|Overall Study|Withdrawal by Subject|3|||
94689281|NCT04213989|324319192|FG001|Overall Study|Withdrawal by Subject|2|||
94365758|NCT03443973|323124755|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
94365759|NCT03443973|323124756|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
94689282|NCT04213989|324319191|FG000|Overall Study|Physician Decision|1|||
94689283|NCT04213989|324319192|FG001|Overall Study|Physician Decision|0|||
94689284|NCT04213989|324319191|FG000|Overall Study|Lost to Follow-up|0|||
94689285|NCT04213989|324319192|FG001|Overall Study|Lost to Follow-up|4|||
94689286|NCT00744237|324319195|FG000|Overall Study|Lack of Efficacy|1|||
94689287|NCT00744237|324319196|FG001|Overall Study|Lack of Efficacy|1|||
94689288|NCT00744237|324319197|FG002|Overall Study|Lack of Efficacy|0|||
94689289|NCT00744237|324319195|FG000|Overall Study|Withdrawal by Subject|9|||
94689290|NCT00744237|324319196|FG001|Overall Study|Withdrawal by Subject|5|||
94689291|NCT00744237|324319197|FG002|Overall Study|Withdrawal by Subject|3|||
94689292|NCT00744237|324319195|FG000|Overall Study|Lost to Follow-up|1|||
94365760|NCT03443973|323124757|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
94365761|NCT03443973|323124758|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
94365762|NCT01956123|323124759|FG000|COS Cycle 2|Protocol Violation|8|||
94365763|NCT01956123|323124760|FG001|COS Cycle 2|Protocol Violation|3|||
94365764|NCT01956123|323124761|FG002|COS Cycle 2|Protocol Violation|0|||
94365765|NCT01956123|323124762|FG003|COS Cycle 2|Protocol Violation|0|||
94365766|NCT01956123|323124759|FG000|COS Cycle 2|Adverse Event|3|||
94365767|NCT01956123|323124760|FG001|COS Cycle 2|Adverse Event|4|||
94365768|NCT01956123|323124761|FG002|COS Cycle 2|Adverse Event|0|||
94365769|NCT01956123|323124762|FG003|COS Cycle 2|Adverse Event|0|||
94365770|NCT01956123|323124759|FG000|COS Cycle 2|Personal Reasons|2|||
94365771|NCT01956123|323124760|FG001|COS Cycle 2|Personal Reasons|0|||
94365772|NCT01956123|323124761|FG002|COS Cycle 2|Personal Reasons|0|||
94365773|NCT01956123|323124762|FG003|COS Cycle 2|Personal Reasons|0|||
94365774|NCT01956123|323124759|FG000|COS Cycle 2|Withdrawal by Subject|1|||
94365775|NCT01956123|323124760|FG001|COS Cycle 2|Withdrawal by Subject|0|||
94365776|NCT01956123|323124761|FG002|COS Cycle 2|Withdrawal by Subject|0|||
94365777|NCT01956123|323124762|FG003|COS Cycle 2|Withdrawal by Subject|0|||
94365778|NCT01956123|323124759|FG000|COS Cycle 3|Protocol Violation|0|||
94365779|NCT01956123|323124760|FG001|COS Cycle 3|Protocol Violation|0|||
94365780|NCT01956123|323124761|FG002|COS Cycle 3|Protocol Violation|2|||
94365781|NCT01956123|323124762|FG003|COS Cycle 3|Protocol Violation|1|||
94365782|NCT01956123|323124759|FG000|COS Cycle 3|Adverse Event|0|||
94365783|NCT01956123|323124760|FG001|COS Cycle 3|Adverse Event|0|||
94689293|NCT00744237|324319196|FG001|Overall Study|Lost to Follow-up|1|||
94689294|NCT00744237|324319197|FG002|Overall Study|Lost to Follow-up|1|||
94689295|NCT00744237|324319195|FG000|Overall Study|Protocol Violation|3|||
94689296|NCT00744237|324319196|FG001|Overall Study|Protocol Violation|4|||
94689297|NCT00744237|324319197|FG002|Overall Study|Protocol Violation|3|||
94689298|NCT00744237|324319195|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
94689299|NCT00744237|324319196|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
94689300|NCT00744237|324319197|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
94689301|NCT00744237|324319195|FG000|Overall Study|Dosing Error|1|||
94689302|NCT00744237|324319196|FG001|Overall Study|Dosing Error|0|||
94689303|NCT00744237|324319197|FG002|Overall Study|Dosing Error|1|||
94689304|NCT00744237|324319195|FG000|Overall Study|Study Drug Error|1|||
94689305|NCT00744237|324319196|FG001|Overall Study|Study Drug Error|0|||
94689306|NCT00744237|324319197|FG002|Overall Study|Study Drug Error|0|||
94689307|NCT00744237|324319195|FG000|Overall Study|Prohibited Concomitant Medication|0|||
94689308|NCT00744237|324319196|FG001|Overall Study|Prohibited Concomitant Medication|0|||
94689309|NCT00744237|324319197|FG002|Overall Study|Prohibited Concomitant Medication|1|||
94689310|NCT00744237|324319195|FG000|Overall Study|Poor Compliance|0|||
94689311|NCT00744237|324319196|FG001|Overall Study|Poor Compliance|2|||
94689312|NCT00744237|324319197|FG002|Overall Study|Poor Compliance|0|||
94689313|NCT00744237|324319195|FG000|Overall Study|Administrative. Site Closed|1|||
94689314|NCT00744237|324319196|FG001|Overall Study|Administrative. Site Closed|1|||
94689315|NCT00744237|324319197|FG002|Overall Study|Administrative. Site Closed|1|||
94689316|NCT00744237|324319195|FG000|Overall Study|Adverse Event|9|||
94689317|NCT00744237|324319196|FG001|Overall Study|Adverse Event|13|||
94689318|NCT00744237|324319197|FG002|Overall Study|Adverse Event|5|||
94689319|NCT00179010|324319201|FG000|Overall Study|Muscle probe defective|1|||
94689320|NCT00179010|324319202|FG001|Overall Study|Muscle probe defective|1|||
94689321|NCT00179010|324319201|FG000|Overall Study|Failure to place arterial line|0|||
94689322|NCT00179010|324319202|FG001|Overall Study|Failure to place arterial line|1|||
94689323|NCT00919893|324319211|FG000|Overall Study|Protocol Violation|19|||
94689324|NCT00919893|324319212|FG001|Overall Study|Protocol Violation|9|||
94689325|NCT04397523|324319215|FG000|Overall Study|Lost to Follow-up|3|||
94689326|NCT04397523|324319215|FG000|Overall Study|Transfer from/to other hospital|8|||
94689327|NCT00794820|324319216|FG000|Overall Study|Adverse Event|11|||
94689328|NCT00794820|324319216|FG000|Overall Study|Secondary Malignancies|2|||
94689329|NCT00794820|324319216|FG000|Overall Study|Resistant Disease|2|||
94689330|NCT00794820|324319216|FG000|Overall Study|Ineligible/Screen Failure|1|||
94689331|NCT01923389|324319219|FG000|Overall Study|Protocol Violation|1|||
94365784|NCT01956123|323124761|FG002|COS Cycle 3|Adverse Event|3|||
94365785|NCT01956123|323124762|FG003|COS Cycle 3|Adverse Event|0|||
94365786|NCT01956123|323124759|FG000|COS Cycle 3|Personal Reasons|0|||
94365787|NCT01956123|323124760|FG001|COS Cycle 3|Personal Reasons|0|||
94365788|NCT01956123|323124761|FG002|COS Cycle 3|Personal Reasons|1|||
94365789|NCT01956123|323124762|FG003|COS Cycle 3|Personal Reasons|0|||
94365790|NCT01956123|323124759|FG000|COS Cycle 3|Withdrawal by Subject|0|||
94689332|NCT01923389|324319220|FG001|Overall Study|Protocol Violation|0|||
94689333|NCT04467840|324319223|FG000|Overall Study|Death|35|||
94689334|NCT04467840|324319224|FG001|Overall Study|Death|39|||
94689335|NCT04467840|324319223|FG000|Overall Study|Withdrawal by Subject|8|||
94689336|NCT04467840|324319224|FG001|Overall Study|Withdrawal by Subject|4|||
94689337|NCT04467840|324319223|FG000|Overall Study|Adverse Event|2|||
94689338|NCT04467840|324319224|FG001|Overall Study|Adverse Event|0|||
94689339|NCT04467840|324319223|FG000|Overall Study|Lost to Follow-up|1|||
94689340|NCT04467840|324319224|FG001|Overall Study|Lost to Follow-up|3|||
94689341|NCT04467840|324319223|FG000|Overall Study|Physician Decision|1|||
94689342|NCT04467840|324319224|FG001|Overall Study|Physician Decision|0|||
94689343|NCT04467840|324319223|FG000|Overall Study|Other|1|||
94689344|NCT04467840|324319224|FG001|Overall Study|Other|5|||
94689345|NCT04467840|324319223|FG000|Overall Study|Missing study completion status|3|||
94689346|NCT04467840|324319224|FG001|Overall Study|Missing study completion status|1|||
94689347|NCT03537261|324319229|FG000|Overall Study|Lost to Follow-up|4|||
94689348|NCT03537261|324319230|FG001|Overall Study|Lost to Follow-up|5|||
94689349|NCT03537261|324319229|FG000|Overall Study|Withdrawal by Subject|4|||
94689350|NCT03537261|324319230|FG001|Overall Study|Withdrawal by Subject|6|||
94689351|NCT03537261|324319229|FG000|Overall Study|Did not return study questionnaires|0|||
94689352|NCT03537261|324319230|FG001|Overall Study|Did not return study questionnaires|1|||
94689353|NCT00502996|324319233|FG000|Overall Study|Lost to Follow-up|9|||
94689354|NCT00502996|324319233|FG000|Overall Study|Protocol Violation|2|||
94689355|NCT00502996|324319233|FG000|Overall Study|Treatment failure|25|||
94689356|NCT00502996|324319233|FG000|Overall Study|Withdrawal Informed Consent|6|||
94689357|NCT00502996|324319233|FG000|Overall Study|Adverse Event|2|||
94689358|NCT01380990|324319236|FG000|Overall Study|Treatment Failure|1|||
94689359|NCT01380990|324319237|FG001|Overall Study|Treatment Failure|0|||
94689360|NCT01380990|324319236|FG000|Overall Study|Death|0|||
94689361|NCT01380990|324319237|FG001|Overall Study|Death|1|||
94689362|NCT01284140|324319238|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
94689363|NCT01284140|324319239|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
94689364|NCT01284140|324319238|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
94689365|NCT01284140|324319239|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
94689366|NCT04827134|324319240|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
94689367|NCT04827134|324319241|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
94689368|NCT04827134|324319242|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
94689369|NCT04827134|324319243|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
94689370|NCT03125941|324319246|FG000|Overall Study|did not receive intervention|1|||
94689371|NCT03125941|324319247|FG001|Overall Study|did not receive intervention|2|||
94689372|NCT00988351|324319248|FG000|Overall Study|Withdrawal by Subject|8|||
94689373|NCT00988351|324319249|FG001|Overall Study|Withdrawal by Subject|0|||
94689374|NCT00988351|324319248|FG000|Overall Study|Lost to Follow-up|6|||
94689375|NCT00988351|324319249|FG001|Overall Study|Lost to Follow-up|9|||
94689376|NCT00988351|324319248|FG000|Overall Study|not using CPAP|5|||
94689377|NCT00988351|324319249|FG001|Overall Study|not using CPAP|3|||
94689378|NCT01551303|324319255|FG000|Overall Study|failed awareness check on vision test|4|||
94689379|NCT01551303|324319256|FG001|Overall Study|failed awareness check on vision test|7|||
94689380|NCT01208415|324319257|FG000|Overall Study|Death|1|||
94689381|NCT01208415|324319257|FG000|Overall Study|Lost to Follow-up|2|||
94689382|NCT01208415|324319257|FG000|Overall Study|Withdrawal by Subject|3|||
94689383|NCT01208415|324319257|FG000|Overall Study|Device not placed|1|||
94689384|NCT01208415|324319257|FG000|Overall Study|Still be eligible for follow-up|33|||
94689385|NCT01927731|324319262|FG000|Overall Study|Graft Failure|1|||
94689386|NCT01927731|324319263|FG001|Overall Study|Graft Failure|2|||
94689387|NCT01927731|324319262|FG000|Overall Study|Physician Decision|2|||
94689388|NCT01927731|324319263|FG001|Overall Study|Physician Decision|3|||
94689389|NCT01927731|324319262|FG000|Overall Study|Withdrawal by Subject|0|||
94264164|NCT02876835|322761861|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
94264165|NCT02876835|322761860|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
94264166|NCT02876835|322761861|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
94264167|NCT02301936|322761862|FG000|Overall Study|Lost to Follow-up|1|||
94264168|NCT02301936|322761863|FG001|Overall Study|Lost to Follow-up|0|||
94264169|NCT01174238|322761864|FG000|Overall Study|Lost to Follow-up|2|||
94689390|NCT01927731|324319263|FG001|Overall Study|Withdrawal by Subject|2|||
94689391|NCT01927731|324319262|FG000|Overall Study|Death|0|||
94689392|NCT01927731|324319263|FG001|Overall Study|Death|3|||
94689393|NCT02982720|324319264|FG000|Overall Study|Adverse Event|3|||
94689394|NCT02982720|324319264|FG000|Overall Study|Death|1|||
94689395|NCT02340520|324319267|FG000|Overall Study|Lost to Follow-up|1|||
94689396|NCT02340520|324319267|FG000|Overall Study|Patient did not take drug as specified|1|||
94689397|NCT02340520|324319267|FG000|Overall Study|Withdrawal by Subject|1|||
94689398|NCT01464255|324319268|FG000|Overall Study|unresolve corneal staining|0|||
94689399|NCT01464255|324319269|FG001|Overall Study|unresolve corneal staining|1|||
94689400|NCT03881059|324319270|FG000|Treatment Period - Part A|Adverse Event|1|||
94689401|NCT03881059|324319271|FG001|Treatment Period - Part A|Adverse Event|3|||
94689402|NCT03881059|324319272|FG002|Treatment Period - Part A|Adverse Event|4|||
94264170|NCT02540538|322761866|FG000|Overall Study|Pregnancy|0|||
94689403|NCT03881059|324319270|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
94689404|NCT03881059|324319271|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
94689405|NCT03881059|324319272|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
94689406|NCT03881059|324319270|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
94689407|NCT03881059|324319271|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
94689408|NCT03881059|324319272|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
94689409|NCT03881059|324319270|FG000|Treatment Period - Part A|Other reasons|2|||
94689410|NCT03881059|324319271|FG001|Treatment Period - Part A|Other reasons|1|||
94689411|NCT03881059|324319272|FG002|Treatment Period - Part A|Other reasons|0|||
94689412|NCT03881059|324319270|FG000|Treatment Period - Part B|Adverse Event|0|||
94689413|NCT03881059|324319271|FG001|Treatment Period - Part B|Adverse Event|0|||
94689414|NCT03881059|324319272|FG002|Treatment Period - Part B|Adverse Event|3|||
94689415|NCT03881059|324319270|FG000|Treatment Period - Part B|Death|0|||
94689416|NCT03881059|324319271|FG001|Treatment Period - Part B|Death|1|||
94689417|NCT03881059|324319272|FG002|Treatment Period - Part B|Death|1|||
94689418|NCT03881059|324319270|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
94689419|NCT03881059|324319271|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
94689420|NCT03881059|324319272|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
94689421|NCT03881059|324319270|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
94689422|NCT03881059|324319271|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
94689423|NCT03881059|324319272|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
94689424|NCT03881059|324319270|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
94689425|NCT03881059|324319271|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
94689426|NCT03881059|324319272|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
94689427|NCT03881059|324319270|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
94689428|NCT03881059|324319271|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
94689429|NCT03881059|324319272|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
94689430|NCT03881059|324319270|FG000|Treatment Period - Part B|Other reasons|4|||
94689431|NCT03881059|324319271|FG001|Treatment Period - Part B|Other reasons|3|||
94689432|NCT03881059|324319272|FG002|Treatment Period - Part B|Other reasons|3|||
94689433|NCT01146574|324319273|FG000|Overall Study|Death|0|||
94689434|NCT01146574|324319274|FG001|Overall Study|Death|1|||
94689435|NCT01146574|324319275|FG002|Overall Study|Death|1|||
94689436|NCT01146574|324319276|FG003|Overall Study|Death|0|||
94689437|NCT01146574|324319277|FG004|Overall Study|Death|0|||
94689438|NCT01146574|324319278|FG005|Overall Study|Death|0|||
94689439|NCT01146574|324319279|FG006|Overall Study|Death|0|||
94689440|NCT01146574|324319273|FG000|Overall Study|Other reasons|0|||
94689441|NCT01146574|324319274|FG001|Overall Study|Other reasons|0|||
94689442|NCT01146574|324319275|FG002|Overall Study|Other reasons|3|||
94689443|NCT01146574|324319276|FG003|Overall Study|Other reasons|0|||
94689444|NCT01146574|324319277|FG004|Overall Study|Other reasons|0|||
94689445|NCT01146574|324319278|FG005|Overall Study|Other reasons|0|||
94689446|NCT01146574|324319279|FG006|Overall Study|Other reasons|0|||
94689447|NCT01146574|324319273|FG000|Overall Study|Kidney transplant|0|||
94689448|NCT01146574|324319274|FG001|Overall Study|Kidney transplant|0|||
94689449|NCT01146574|324319275|FG002|Overall Study|Kidney transplant|1|||
94689450|NCT01146574|324319276|FG003|Overall Study|Kidney transplant|1|||
94689451|NCT01146574|324319277|FG004|Overall Study|Kidney transplant|0|||
94689452|NCT01146574|324319278|FG005|Overall Study|Kidney transplant|0|||
94689453|NCT01146574|324319279|FG006|Overall Study|Kidney transplant|0|||
94689454|NCT01146574|324319273|FG000|Overall Study|Withdrew consent|0|||
94689455|NCT01146574|324319274|FG001|Overall Study|Withdrew consent|0|||
94689456|NCT01146574|324319275|FG002|Overall Study|Withdrew consent|1|||
94689457|NCT01146574|324319276|FG003|Overall Study|Withdrew consent|1|||
94689458|NCT01146574|324319277|FG004|Overall Study|Withdrew consent|2|||
94689459|NCT01146574|324319278|FG005|Overall Study|Withdrew consent|1|||
94689460|NCT01146574|324319279|FG006|Overall Study|Withdrew consent|1|||
94689461|NCT02293837|324319282|FG000|Overall Study|Lost to Follow-up|0|||
94689462|NCT02293837|324319283|FG001|Overall Study|Lost to Follow-up|2|||
94689463|NCT02293837|324319284|FG002|Overall Study|Lost to Follow-up|1|||
94689464|NCT02293837|324319285|FG003|Overall Study|Lost to Follow-up|0|||
94689465|NCT02293837|324319282|FG000|Overall Study|Withdrawal by Subject|2|||
94689466|NCT02293837|324319283|FG001|Overall Study|Withdrawal by Subject|1|||
94689467|NCT02293837|324319284|FG002|Overall Study|Withdrawal by Subject|2|||
94689468|NCT02293837|324319285|FG003|Overall Study|Withdrawal by Subject|1|||
94689469|NCT02293837|324319282|FG000|Overall Study|COVID-19 Related|1|||
94689470|NCT02293837|324319283|FG001|Overall Study|COVID-19 Related|1|||
94689471|NCT02293837|324319284|FG002|Overall Study|COVID-19 Related|0|||
94689472|NCT02293837|324319285|FG003|Overall Study|COVID-19 Related|0|||
94689473|NCT02293837|324319282|FG000|Overall Study|Participant ill and could not be infused|0|||
94689474|NCT02293837|324319283|FG001|Overall Study|Participant ill and could not be infused|0|||
94689475|NCT02293837|324319284|FG002|Overall Study|Participant ill and could not be infused|1|||
94689476|NCT02293837|324319285|FG003|Overall Study|Participant ill and could not be infused|0|||
94689477|NCT04779242|324319288|FG000|Overall Study|Adverse Event|1|||
94689478|NCT04779242|324319289|FG001|Overall Study|Adverse Event|1|||
94689479|NCT04779242|324319288|FG000|Overall Study|Lost to Follow-up|2|||
94689480|NCT04779242|324319289|FG001|Overall Study|Lost to Follow-up|4|||
94689481|NCT04779242|324319288|FG000|Overall Study|Withdrawal by Subject|7|||
94689482|NCT04779242|324319289|FG001|Overall Study|Withdrawal by Subject|9|||
94689483|NCT04779242|324319288|FG000|Overall Study|Death|6|||
94689484|NCT04779242|324319289|FG001|Overall Study|Death|6|||
94689485|NCT04779242|324319288|FG000|Overall Study|COVID-19 related reasons|2|||
94689486|NCT04779242|324319289|FG001|Overall Study|COVID-19 related reasons|1|||
94689487|NCT04779242|324319288|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
94689488|NCT04779242|324319289|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
94689489|NCT04779242|324319288|FG000|Overall Study|Martial Law in Ukraine|2|||
94689490|NCT04779242|324319289|FG001|Overall Study|Martial Law in Ukraine|3|||
94689491|NCT00786474|324319294|FG000|Overall Study|Death|5|||
94689492|NCT00786474|324319295|FG001|Overall Study|Death|4|||
94689493|NCT00786474|324319294|FG000|Overall Study|Withdrawal by Subject|23|||
94689494|NCT00786474|324319295|FG001|Overall Study|Withdrawal by Subject|31|||
94689495|NCT00786474|324319294|FG000|Overall Study|Lost to Follow-up|3|||
94689496|NCT00786474|324319295|FG001|Overall Study|Lost to Follow-up|3|||
94689497|NCT00786474|324319294|FG000|Overall Study|Physician Decision|2|||
94689498|NCT00786474|324319295|FG001|Overall Study|Physician Decision|1|||
94689499|NCT00786474|324319294|FG000|Overall Study|Other|4|||
94689500|NCT00786474|324319295|FG001|Overall Study|Other|4|||
94689501|NCT03053492|324319296|FG000|Overall Study|Adverse Event|1|||
94689502|NCT03053492|324319297|FG001|Overall Study|Adverse Event|1|||
94689503|NCT03053492|324319296|FG000|Overall Study|Withdrawal by Subject|7|||
94689504|NCT03053492|324319297|FG001|Overall Study|Withdrawal by Subject|5|||
94689505|NCT02942004|324319298|FG000|Overall Study|Withdrawal by Subject|0|||
94689506|NCT02942004|324319299|FG001|Overall Study|Withdrawal by Subject|2|||
94689507|NCT02942004|324319300|FG002|Overall Study|Withdrawal by Subject|3|||
94689508|NCT02942004|324319298|FG000|Overall Study|Lost to Follow-up|1|||
94689509|NCT02942004|324319299|FG001|Overall Study|Lost to Follow-up|1|||
94689510|NCT02942004|324319300|FG002|Overall Study|Lost to Follow-up|2|||
94689511|NCT02942004|324319298|FG000|Overall Study|Randomized but not dosed|3|||
94689512|NCT02942004|324319299|FG001|Overall Study|Randomized but not dosed|9|||
94689513|NCT02942004|324319300|FG002|Overall Study|Randomized but not dosed|4|||
94689514|NCT03306043|324319302|FG000|Overall Study|Adverse Event|1|||
94689515|NCT03306043|324319302|FG000|Overall Study|Lost to Follow-up|1|||
94689516|NCT03306043|324319302|FG000|Overall Study|Withdrawal by Subject|2|||
94689517|NCT01544491|324319303|FG000|Overall Study|Withdrawal by Subject|3|||
94689518|NCT01544491|324319304|FG001|Overall Study|Withdrawal by Subject|2|||
94689519|NCT01544491|324319303|FG000|Overall Study|Lost to Follow-up|0|||
94689520|NCT01544491|324319304|FG001|Overall Study|Lost to Follow-up|1|||
94689521|NCT01544491|324319303|FG000|Overall Study|administrative problems|2|||
94689522|NCT01544491|324319304|FG001|Overall Study|administrative problems|0|||
94689523|NCT02207374|324319305|FG000|Overall Study|Withdrawal by Subject|5|||
94689524|NCT02207374|324319306|FG001|Overall Study|Withdrawal by Subject|9|||
94689525|NCT02207374|324319307|FG002|Overall Study|Withdrawal by Subject|4|||
94689526|NCT02207374|324319305|FG000|Overall Study|Death|1|||
94689527|NCT02207374|324319306|FG001|Overall Study|Death|0|||
94689528|NCT02207374|324319307|FG002|Overall Study|Death|1|||
94689529|NCT02207374|324319305|FG000|Overall Study|Missing follow-up information|0|||
94689530|NCT02207374|324319306|FG001|Overall Study|Missing follow-up information|1|||
94689531|NCT02207374|324319307|FG002|Overall Study|Missing follow-up information|1|||
94689532|NCT02087150|324319308|FG000|Overall Study|Death|0|||
94689533|NCT02087150|324319309|FG001|Overall Study|Death|1|||
94689534|NCT02087150|324319310|FG002|Overall Study|Death|0|||
94689535|NCT02087150|324319308|FG000|Overall Study|Lost to Follow-up|6|||
94689536|NCT02087150|324319309|FG001|Overall Study|Lost to Follow-up|13|||
94689537|NCT02087150|324319310|FG002|Overall Study|Lost to Follow-up|7|||
94689538|NCT02087150|324319308|FG000|Overall Study|Withdrawal by Subject|2|||
94689539|NCT02087150|324319309|FG001|Overall Study|Withdrawal by Subject|5|||
94689540|NCT02087150|324319310|FG002|Overall Study|Withdrawal by Subject|3|||
94689541|NCT02087150|324319308|FG000|Overall Study|Physician Decision|0|||
94689542|NCT02087150|324319309|FG001|Overall Study|Physician Decision|1|||
94689543|NCT02087150|324319310|FG002|Overall Study|Physician Decision|0|||
94689544|NCT02087150|324319308|FG000|Overall Study|Procedure not done|1|||
94689545|NCT02087150|324319309|FG001|Overall Study|Procedure not done|13|||
94689546|NCT02087150|324319310|FG002|Overall Study|Procedure not done|0|||
94689547|NCT02087150|324319308|FG000|Overall Study|F/U not completed w/in study window|0|||
94689548|NCT02087150|324319309|FG001|Overall Study|F/U not completed w/in study window|0|||
94689549|NCT02087150|324319310|FG002|Overall Study|F/U not completed w/in study window|1|||
94689550|NCT02087150|324319308|FG000|Overall Study|Other|1|||
94689551|NCT02087150|324319309|FG001|Overall Study|Other|0|||
94689552|NCT02087150|324319310|FG002|Overall Study|Other|0|||
94689553|NCT02087150|324319308|FG000|Overall Study|Pt moved out of town|0|||
94689554|NCT02087150|324319309|FG001|Overall Study|Pt moved out of town|1|||
94689555|NCT02087150|324319310|FG002|Overall Study|Pt moved out of town|0|||
94689556|NCT00393094|324319313|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
94365791|NCT01956123|323124760|FG001|COS Cycle 3|Withdrawal by Subject|0|||
94365792|NCT01956123|323124761|FG002|COS Cycle 3|Withdrawal by Subject|0|||
94365793|NCT01956123|323124762|FG003|COS Cycle 3|Withdrawal by Subject|1|||
94689557|NCT00393094|324319313|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
94689558|NCT03382600|324319314|FG000|Overall Study|Adverse Event|3|||
94689559|NCT03382600|324319315|FG001|Overall Study|Adverse Event|3|||
94689560|NCT03382600|324319314|FG000|Overall Study|Clinical Disease Progression|2|||
94689561|NCT03382600|324319315|FG001|Overall Study|Clinical Disease Progression|4|||
94689562|NCT03382600|324319314|FG000|Overall Study|Radiological Progression|40|||
94689563|NCT03382600|324319315|FG001|Overall Study|Radiological Progression|31|||
94689564|NCT03382600|324319314|FG000|Overall Study|Withdrawal by Subject|0|||
94689565|NCT03382600|324319315|FG001|Overall Study|Withdrawal by Subject|1|||
94689566|NCT03382600|324319314|FG000|Overall Study|Other|9|||
94689567|NCT03382600|324319315|FG001|Overall Study|Other|7|||
94365794|NCT01432600|323124763|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
94365795|NCT01432600|323124764|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
94365796|NCT01432600|323124765|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
94689568|NCT01448044|324319318|FG000|Treatment Period|Adverse Event|4|||
94689569|NCT01448044|324319319|FG001|Treatment Period|Adverse Event|3|||
94689570|NCT01448044|324319318|FG000|Treatment Period|Lack of Efficacy|5|||
94689571|NCT01448044|324319319|FG001|Treatment Period|Lack of Efficacy|12|||
94689572|NCT01448044|324319318|FG000|Treatment Period|Subject requested discontinue study drug|1|||
94689573|NCT01448044|324319319|FG001|Treatment Period|Subject requested discontinue study drug|0|||
94689574|NCT01448044|324319318|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
94689575|NCT01448044|324319319|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
94689576|NCT01448044|324319318|FG000|Treatment Period|Participant does not meet study criteria|1|||
94689577|NCT01448044|324319319|FG001|Treatment Period|Participant does not meet study criteria|0|||
94689578|NCT01448044|324319318|FG000|Treatment Period|Lost to Follow-up|2|||
94689579|NCT01448044|324319319|FG001|Treatment Period|Lost to Follow-up|1|||
94689580|NCT01448044|324319318|FG000|Treatment Period|Other reason|2|||
94689581|NCT01448044|324319319|FG001|Treatment Period|Other reason|0|||
94689582|NCT01448044|324319318|FG000|Follow Up Period|Withdrawal by Subject|1|||
94689583|NCT01448044|324319319|FG001|Follow Up Period|Withdrawal by Subject|1|||
94689584|NCT01448044|324319318|FG000|Follow Up Period|Lost to Follow-up|6|||
94689585|NCT01448044|324319319|FG001|Follow Up Period|Lost to Follow-up|2|||
94689586|NCT01448044|324319318|FG000|Follow Up Period|Other|5|||
94689587|NCT01448044|324319319|FG001|Follow Up Period|Other|11|||
94689588|NCT01799720|324319321|FG000|Overall Study|Withdrawal by Subject|3|||
94689589|NCT01799720|324319322|FG001|Overall Study|Withdrawal by Subject|0|||
94689590|NCT01799720|324319323|FG002|Overall Study|Withdrawal by Subject|0|||
94689591|NCT01799720|324319321|FG000|Overall Study|Protocol Violation|0|||
94689592|NCT01799720|324319322|FG001|Overall Study|Protocol Violation|1|||
94689593|NCT01799720|324319323|FG002|Overall Study|Protocol Violation|0|||
94689594|NCT01799720|324319321|FG000|Overall Study|Pregnancy|0|||
94689595|NCT01799720|324319322|FG001|Overall Study|Pregnancy|0|||
94689596|NCT01799720|324319323|FG002|Overall Study|Pregnancy|1|||
94689597|NCT04276090|324319324|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
94689598|NCT04276090|324319325|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
94689599|NCT01000376|324319326|FG000|Cycle 1 Day 1|Adverse Event|1|||
94689600|NCT01000376|324319327|FG001|Cycle 1 Day 1|Adverse Event|0|||
94689601|NCT01000376|324319326|FG000|Cycle 1 Day 1|Progressive Disease|1|||
94689602|NCT01000376|324319327|FG001|Cycle 1 Day 1|Progressive Disease|0|||
94689603|NCT00681187|324319328|FG000|Overall Study|Withdrawal by Subject|1|||
94689604|NCT00681187|324319329|FG001|Overall Study|Withdrawal by Subject|0|||
94689605|NCT00681187|324319328|FG000|Overall Study|Death|0|||
94689606|NCT00681187|324319329|FG001|Overall Study|Death|1|||
94689607|NCT00681187|324319328|FG000|Overall Study|Adverse Event|0|||
94689608|NCT00681187|324319329|FG001|Overall Study|Adverse Event|1|||
94689609|NCT00896454|324319330|FG000|Overall Study|Death|10|||
94689610|NCT00896454|324319330|FG000|Overall Study|Adverse Event|8|||
94689611|NCT00896454|324319330|FG000|Overall Study|Disease Progression|5|||
94689612|NCT00896454|324319330|FG000|Overall Study|Other|4|||
94689613|NCT00896454|324319330|FG000|Overall Study|Requirement for alternative therapy|3|||
94689614|NCT00896454|324319330|FG000|Overall Study|Ongoing in study|2|||
94365797|NCT03079869|323124772|FG000|Overall Study|Adverse Event|6|||
94365798|NCT03079869|323124773|FG001|Overall Study|Adverse Event|8|||
94365799|NCT03079869|323124772|FG000|Overall Study|Withdrawal by Subject|4|||
94689615|NCT00896454|324319330|FG000|Overall Study|Withdrawal by Subject|1|||
94689616|NCT00680056|324319333|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
94689617|NCT00680056|324319334|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
94689618|NCT00680056|324319333|FG000|Second Intervention|Protocol Violation|3|||
94689619|NCT00680056|324319334|FG001|Second Intervention|Protocol Violation|1|||
94689620|NCT02584855|324319336|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
94689621|NCT02584855|324319337|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
94365800|NCT03079869|323124773|FG001|Overall Study|Withdrawal by Subject|1|||
94689622|NCT02584855|324319338|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
94689623|NCT02584855|324319339|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
94689624|NCT02584855|324319340|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
94689625|NCT02584855|324319341|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
94689626|NCT02584855|324319336|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
94689627|NCT02584855|324319337|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
94689628|NCT02584855|324319338|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
94689629|NCT02584855|324319339|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
94689630|NCT02584855|324319340|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
94689631|NCT02584855|324319341|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
94689632|NCT02584855|324319336|FG000|Open-Label Treatment Period|Adverse Event|14|||
94689633|NCT02584855|324319337|FG001|Open-Label Treatment Period|Adverse Event|0|||
94689634|NCT02584855|324319338|FG002|Open-Label Treatment Period|Adverse Event|0|||
94689635|NCT02584855|324319339|FG003|Open-Label Treatment Period|Adverse Event|0|||
94689636|NCT02584855|324319340|FG004|Open-Label Treatment Period|Adverse Event|0|||
94689637|NCT02584855|324319341|FG005|Open-Label Treatment Period|Adverse Event|0|||
94689638|NCT02584855|324319336|FG000|Open-Label Treatment Period|Death|2|||
94689639|NCT02584855|324319337|FG001|Open-Label Treatment Period|Death|0|||
94689640|NCT02584855|324319338|FG002|Open-Label Treatment Period|Death|0|||
94689641|NCT02584855|324319339|FG003|Open-Label Treatment Period|Death|0|||
94689642|NCT02584855|324319340|FG004|Open-Label Treatment Period|Death|0|||
94689643|NCT02584855|324319341|FG005|Open-Label Treatment Period|Death|0|||
94689644|NCT02584855|324319336|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
94689645|NCT02584855|324319337|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
94689646|NCT02584855|324319338|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
94689647|NCT02584855|324319339|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
94689648|NCT02584855|324319340|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
94689649|NCT02584855|324319341|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
94689650|NCT02584855|324319336|FG000|Open-Label Treatment Period|Protocol Violation|1|||
94689651|NCT02584855|324319337|FG001|Open-Label Treatment Period|Protocol Violation|0|||
94689652|NCT02584855|324319338|FG002|Open-Label Treatment Period|Protocol Violation|0|||
94689653|NCT02584855|324319339|FG003|Open-Label Treatment Period|Protocol Violation|0|||
94689654|NCT02584855|324319340|FG004|Open-Label Treatment Period|Protocol Violation|0|||
94689655|NCT02584855|324319341|FG005|Open-Label Treatment Period|Protocol Violation|0|||
94689656|NCT02584855|324319336|FG000|Open-Label Treatment Period|No PI Available|2|||
94689657|NCT02584855|324319337|FG001|Open-Label Treatment Period|No PI Available|0|||
94689658|NCT02584855|324319338|FG002|Open-Label Treatment Period|No PI Available|0|||
94689659|NCT02584855|324319339|FG003|Open-Label Treatment Period|No PI Available|0|||
94689660|NCT02584855|324319340|FG004|Open-Label Treatment Period|No PI Available|0|||
94689661|NCT02584855|324319341|FG005|Open-Label Treatment Period|No PI Available|0|||
94689662|NCT02584855|324319336|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
94689663|NCT02584855|324319337|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
94689664|NCT02584855|324319338|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
94689665|NCT02584855|324319339|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
94689666|NCT02584855|324319340|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
94689667|NCT02584855|324319341|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
94689668|NCT02584855|324319336|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
94689669|NCT02584855|324319337|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
94689670|NCT02584855|324319338|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
94689671|NCT02584855|324319339|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
94689672|NCT02584855|324319340|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
94689673|NCT02584855|324319341|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
94689674|NCT02584855|324319336|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
94689675|NCT02584855|324319337|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
94689676|NCT02584855|324319338|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
94689677|NCT02584855|324319339|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
94365801|NCT03079869|323124772|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
94365802|NCT03079869|323124773|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
94365803|NCT01643928|323124780|FG000|Overall Study|Lost to Follow-up|1|||
94365804|NCT01643928|323124781|FG001|Overall Study|Lost to Follow-up|0|||
94365805|NCT01643928|323124782|FG002|Overall Study|Lost to Follow-up|2|||
94365806|NCT01643928|323124783|FG003|Overall Study|Lost to Follow-up|0|||
94365807|NCT01643928|323124784|FG004|Overall Study|Lost to Follow-up|0|||
94365808|NCT01643928|323124780|FG000|Overall Study|Withdrawal by Subject|2|||
94365809|NCT01643928|323124781|FG001|Overall Study|Withdrawal by Subject|0|||
94365810|NCT01643928|323124782|FG002|Overall Study|Withdrawal by Subject|0|||
94689678|NCT02584855|324319340|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
94689679|NCT02584855|324319341|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
94365811|NCT01643928|323124783|FG003|Overall Study|Withdrawal by Subject|1|||
94365812|NCT01643928|323124784|FG004|Overall Study|Withdrawal by Subject|0|||
94365813|NCT01643928|323124780|FG000|Overall Study|Pregnancy|0|||
94365814|NCT01643928|323124781|FG001|Overall Study|Pregnancy|0|||
94689680|NCT02584855|324319336|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
94689681|NCT02584855|324319337|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
94689682|NCT02584855|324319338|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
94689683|NCT02584855|324319339|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
94689684|NCT02584855|324319340|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
94689685|NCT02584855|324319341|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
94689686|NCT02584855|324319336|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
94689687|NCT02584855|324319337|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
94689688|NCT02584855|324319338|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
94689689|NCT02584855|324319339|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
94689690|NCT02584855|324319340|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
94689691|NCT02584855|324319341|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
94689692|NCT02584855|324319336|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
94689693|NCT02584855|324319337|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
94689694|NCT02584855|324319338|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
94689695|NCT02584855|324319339|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
94689696|NCT02584855|324319340|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
94689697|NCT02584855|324319341|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
94689698|NCT02584855|324319336|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
94689699|NCT02584855|324319337|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
94689700|NCT02584855|324319338|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
94689701|NCT02584855|324319339|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
94689702|NCT02584855|324319340|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
94689703|NCT02584855|324319341|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
94689704|NCT01556763|324319342|FG000|Overall Study|Withdrawal by Subject|0|||
94689705|NCT01556763|324319343|FG001|Overall Study|Withdrawal by Subject|1|||
94689706|NCT01556763|324319344|FG002|Overall Study|Withdrawal by Subject|0|||
94689707|NCT02258464|324319345|FG000|Overall Study|Progressive disease (PD)|9|||
94689708|NCT02258464|324319346|FG001|Overall Study|Progressive disease (PD)|17|||
94689709|NCT02258464|324319345|FG000|Overall Study|Study drug never administered|1|||
94689710|NCT02258464|324319346|FG001|Overall Study|Study drug never administered|1|||
94689711|NCT02258464|324319345|FG000|Overall Study|AE not related to clinical PD|1|||
94689712|NCT02258464|324319346|FG001|Overall Study|AE not related to clinical PD|3|||
94689713|NCT02258464|324319345|FG000|Overall Study|Withdrawal by Subject|5|||
94689714|NCT02258464|324319346|FG001|Overall Study|Withdrawal by Subject|4|||
94689715|NCT02258464|324319345|FG000|Overall Study|AE related to clinical PD|1|||
94689716|NCT02258464|324319346|FG001|Overall Study|AE related to clinical PD|0|||
94689717|NCT04170296|324319347|FG000|Overall Study|Adverse Event|1|||
94689718|NCT04170296|324319348|FG001|Overall Study|Adverse Event|0|||
94689719|NCT04170296|324319347|FG000|Overall Study|Withdrawal by Subject|3|||
94689720|NCT04170296|324319348|FG001|Overall Study|Withdrawal by Subject|2|||
94689721|NCT04170296|324319347|FG000|Overall Study|Lost to Follow-up|4|||
94689722|NCT04170296|324319348|FG001|Overall Study|Lost to Follow-up|2|||
94689723|NCT00556374|324319354|FG000|Overall Study|Withdrawal by Subject|235|||
94689724|NCT00556374|324319355|FG001|Overall Study|Withdrawal by Subject|205|||
94689725|NCT00556374|324319354|FG000|Overall Study|Death|158|||
94689726|NCT00556374|324319355|FG001|Overall Study|Death|127|||
94689727|NCT00556374|324319354|FG000|Overall Study|Lost to Follow-up|24|||
94689728|NCT00556374|324319355|FG001|Overall Study|Lost to Follow-up|17|||
94689729|NCT00556374|324319354|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
94689730|NCT00556374|324319355|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
94689731|NCT00544544|324319356|FG000|Overall Study|Withdrawal by Subject|1|||
94689732|NCT00544544|324319356|FG000|Overall Study|Adverse Event|1|||
94689733|NCT00544544|324319356|FG000|Overall Study|Lost to Follow-up|1|||
94689734|NCT01291225|324319359|FG000|Overall Study|Lost to Follow-up|85|||
94689735|NCT01291225|324319360|FG001|Overall Study|Lost to Follow-up|39|||
94689736|NCT02781506|324321209|FG000|Overall Study|Adverse Event|5|||
94689737|NCT01158378|324321210|FG000|Overall Study|Death|4|||
94689738|NCT01158378|324321211|FG001|Overall Study|Death|5|||
94689739|NCT01158378|324321210|FG000|Overall Study|Lost to Follow-up|2|||
94365815|NCT01643928|323124782|FG002|Overall Study|Pregnancy|0|||
94689740|NCT01158378|324321211|FG001|Overall Study|Lost to Follow-up|4|||
94689741|NCT01158378|324321210|FG000|Overall Study|Withdrawal by Subject|4|||
94689742|NCT01158378|324321211|FG001|Overall Study|Withdrawal by Subject|0|||
94689743|NCT03864926|324321212|FG000|Overall Study|Death|0|||
94689744|NCT03864926|324321213|FG001|Overall Study|Death|2|||
94689745|NCT03918239|324321218|FG000|Overall Study|Lost to Follow-up|3|||
94689746|NCT03918239|324321219|FG001|Overall Study|Lost to Follow-up|1|||
94689747|NCT03918239|324321218|FG000|Overall Study|Pregnancy|0|||
94689748|NCT03918239|324321219|FG001|Overall Study|Pregnancy|2|||
94689749|NCT03918239|324321218|FG000|Overall Study|Withdrawal by Subject|3|||
94365816|NCT01643928|323124783|FG003|Overall Study|Pregnancy|1|||
94689750|NCT03918239|324321219|FG001|Overall Study|Withdrawal by Subject|3|||
94689751|NCT03918239|324321218|FG000|Overall Study|positive urine drug screening results|4|||
94689752|NCT03918239|324321219|FG001|Overall Study|positive urine drug screening results|1|||
94689753|NCT02105636|324321220|FG000|Pre-Treatment|Disease Progression|1|||
94689754|NCT02105636|324321221|FG001|Pre-Treatment|Disease Progression|0|||
94689755|NCT02105636|324321220|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
94689756|NCT02105636|324321221|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
94689757|NCT02105636|324321220|FG000|Pre-Treatment|Participant withdrew consent|0|||
94689758|NCT02105636|324321221|FG001|Pre-Treatment|Participant withdrew consent|6|||
94689759|NCT02105636|324321220|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
94689760|NCT02105636|324321221|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
94689761|NCT02105636|324321220|FG000|Treatment|Study Drug Toxicity|14|||
94689762|NCT02105636|324321221|FG001|Treatment|Study Drug Toxicity|10|||
94689763|NCT02105636|324321220|FG000|Treatment|Adverse event unrelated to study drug|19|||
94689764|NCT02105636|324321221|FG001|Treatment|Adverse event unrelated to study drug|3|||
94689765|NCT02105636|324321220|FG000|Treatment|Participant request to discontinue study treatment|8|||
94689766|NCT02105636|324321221|FG001|Treatment|Participant request to discontinue study treatment|6|||
94689767|NCT02105636|324321220|FG000|Treatment|Participant withdrew consent|5|||
94689768|NCT02105636|324321221|FG001|Treatment|Participant withdrew consent|1|||
94689769|NCT02105636|324321220|FG000|Treatment|Lost to Follow-up|1|||
94689770|NCT02105636|324321221|FG001|Treatment|Lost to Follow-up|0|||
94689771|NCT02105636|324321220|FG000|Treatment|Maximum Clinical Benefit|1|||
94689772|NCT02105636|324321221|FG001|Treatment|Maximum Clinical Benefit|3|||
94689773|NCT02105636|324321220|FG000|Treatment|Poor/Non-compliance|0|||
94689774|NCT02105636|324321221|FG001|Treatment|Poor/Non-compliance|1|||
94689775|NCT02105636|324321220|FG000|Treatment|Participant no longer meets study criteria|1|||
94689776|NCT02105636|324321221|FG001|Treatment|Participant no longer meets study criteria|0|||
94689777|NCT02105636|324321220|FG000|Treatment|Other reasons|1|||
94689778|NCT02105636|324321221|FG001|Treatment|Other reasons|0|||
94689779|NCT02105636|324321220|FG000|Treatment|Disease Progression|185|||
94689780|NCT02105636|324321221|FG001|Treatment|Disease Progression|87|||
94689781|NCT00358215|324321222|FG000|Overall Study|Ineligibility determined|4|||
94689782|NCT00358215|324321223|FG001|Overall Study|Ineligibility determined|3|||
94689783|NCT00358215|324321222|FG000|Overall Study|Adverse Event|83|||
94689784|NCT00358215|324321223|FG001|Overall Study|Adverse Event|65|||
94689785|NCT00358215|324321222|FG000|Overall Study|Withdrawal by Subject|111|||
94689786|NCT00358215|324321223|FG001|Overall Study|Withdrawal by Subject|102|||
94689787|NCT00358215|324321222|FG000|Overall Study|Participant request|65|||
94689788|NCT00358215|324321223|FG001|Overall Study|Participant request|64|||
94689789|NCT00358215|324321222|FG000|Overall Study|Physician Decision|47|||
94689790|NCT00358215|324321223|FG001|Overall Study|Physician Decision|39|||
94689791|NCT00358215|324321222|FG000|Overall Study|Lost to Follow-up|16|||
94689792|NCT00358215|324321223|FG001|Overall Study|Lost to Follow-up|22|||
94689793|NCT00358215|324321222|FG000|Overall Study|Death|265|||
94689794|NCT00358215|324321223|FG001|Overall Study|Death|281|||
94689795|NCT00358215|324321222|FG000|Overall Study|Protocol Violation|64|||
94689796|NCT00358215|324321223|FG001|Overall Study|Protocol Violation|59|||
94689797|NCT00358215|324321222|FG000|Overall Study|Pregnancy|1|||
94689798|NCT00358215|324321223|FG001|Overall Study|Pregnancy|0|||
94689799|NCT00358215|324321222|FG000|Overall Study|Other|21|||
94465985|NCT02431806|323494967|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
94689800|NCT00358215|324321223|FG001|Overall Study|Other|14|||
94689801|NCT00358215|324321222|FG000|Overall Study|Did not receive investigational product|2|||
94689802|NCT00358215|324321223|FG001|Overall Study|Did not receive investigational product|3|||
94689803|NCT02609659|324321224|FG000|Overall Study|Adverse Event|1|||
94689804|NCT02609659|324321224|FG000|Overall Study|Lost to Follow-up|6|||
94689805|NCT02609659|324321224|FG000|Overall Study|Other|1|||
94689806|NCT03545113|324321225|FG000|Overall Study|Surgery Cancelled|1|||
94689807|NCT03545113|324321226|FG001|Overall Study|Surgery Cancelled|0|||
94689808|NCT03545113|324321225|FG000|Overall Study|Death|1|||
94689809|NCT03545113|324321226|FG001|Overall Study|Death|0|||
94689810|NCT03545113|324321225|FG000|Overall Study|Adverse Event|2|||
94689811|NCT03545113|324321226|FG001|Overall Study|Adverse Event|0|||
94689812|NCT03545113|324321225|FG000|Overall Study|Received different surgery|1|||
94689813|NCT03545113|324321226|FG001|Overall Study|Received different surgery|0|||
94689814|NCT00312858|324321232|FG000|Overall Study|Adverse Event|0|||
94689815|NCT00312858|324321233|FG001|Overall Study|Adverse Event|1|||
94689816|NCT00312858|324321232|FG000|Overall Study|Lost to Follow-up|25|||
94689817|NCT00312858|324321233|FG001|Overall Study|Lost to Follow-up|42|||
94689818|NCT00312858|324321232|FG000|Overall Study|Protocol Violation|3|||
94689819|NCT00312858|324321233|FG001|Overall Study|Protocol Violation|8|||
94689820|NCT00312858|324321232|FG000|Overall Study|Withdraw by Participant|20|||
94689821|NCT00312858|324321233|FG001|Overall Study|Withdraw by Participant|20|||
94689822|NCT00312858|324321232|FG000|Overall Study|Participant Moved|11|||
94689823|NCT00312858|324321233|FG001|Overall Study|Participant Moved|10|||
94689824|NCT00312858|324321232|FG000|Overall Study|Other|9|||
94689825|NCT00312858|324321233|FG001|Overall Study|Other|12|||
94689826|NCT01087723|324321235|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
94689827|NCT01087723|324321236|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
94689828|NCT01087723|324321235|FG000|Overall Study|Withdrawal by Subject|10|||
94689829|NCT01087723|324321236|FG001|Overall Study|Withdrawal by Subject|13|||
94689830|NCT01087723|324321235|FG000|Overall Study|Physician Decision|2|||
94689831|NCT01087723|324321236|FG001|Overall Study|Physician Decision|0|||
94689832|NCT01087723|324321235|FG000|Overall Study|Lost to Follow-up|1|||
94689833|NCT01087723|324321236|FG001|Overall Study|Lost to Follow-up|4|||
94689834|NCT01087723|324321235|FG000|Overall Study|Reason Not Specified|1|||
94689835|NCT01087723|324321236|FG001|Overall Study|Reason Not Specified|2|||
94689836|NCT00432835|324321240|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
94689837|NCT00432835|324321241|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
94689838|NCT00806624|324321242|FG000|Overall Study|Adverse Event|2|||
94689839|NCT00806624|324321243|FG001|Overall Study|Adverse Event|8|||
94689840|NCT00806624|324321244|FG002|Overall Study|Adverse Event|0|||
94689841|NCT00806624|324321242|FG000|Overall Study|Death|0|||
94689842|NCT00806624|324321243|FG001|Overall Study|Death|1|||
94689843|NCT00806624|324321244|FG002|Overall Study|Death|1|||
94689844|NCT00806624|324321242|FG000|Overall Study|Lost to Follow-up|1|||
94689845|NCT00806624|324321243|FG001|Overall Study|Lost to Follow-up|0|||
94689846|NCT00806624|324321244|FG002|Overall Study|Lost to Follow-up|1|||
94689847|NCT00806624|324321242|FG000|Overall Study|Withdrawal by Subject|6|||
94689848|NCT00806624|324321243|FG001|Overall Study|Withdrawal by Subject|3|||
94689849|NCT00806624|324321244|FG002|Overall Study|Withdrawal by Subject|3|||
94689850|NCT00806624|324321242|FG000|Overall Study|discontinued before start of treatment|0|||
94689851|NCT00806624|324321243|FG001|Overall Study|discontinued before start of treatment|0|||
94689852|NCT00806624|324321244|FG002|Overall Study|discontinued before start of treatment|1|||
94689853|NCT00962585|324321247|FG000|Overall Study|Adverse Event|0|||
94689854|NCT00962585|324321248|FG001|Overall Study|Adverse Event|2|||
94689855|NCT00962585|324321249|FG002|Overall Study|Adverse Event|1|||
94689856|NCT00962585|324321250|FG003|Overall Study|Adverse Event|0|||
94689857|NCT00962585|324321247|FG000|Overall Study|Lost to Follow-up|3|||
94689858|NCT00962585|324321248|FG001|Overall Study|Lost to Follow-up|0|||
94689859|NCT00962585|324321249|FG002|Overall Study|Lost to Follow-up|1|||
94689860|NCT00962585|324321250|FG003|Overall Study|Lost to Follow-up|0|||
94264171|NCT02540538|322761867|FG001|Overall Study|Pregnancy|1|||
94264172|NCT02540538|322761868|FG002|Overall Study|Pregnancy|0|||
94264173|NCT03250832|322761870|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
94264174|NCT03250832|322761871|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
94264175|NCT03250832|322761872|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
94264176|NCT03250832|322761873|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
94689861|NCT00962585|324321247|FG000|Overall Study|Protocol Violation|0|||
94689862|NCT00962585|324321248|FG001|Overall Study|Protocol Violation|0|||
94689863|NCT00962585|324321249|FG002|Overall Study|Protocol Violation|1|||
94689864|NCT00962585|324321250|FG003|Overall Study|Protocol Violation|0|||
94689865|NCT00962585|324321247|FG000|Overall Study|Withdrawal by Subject|1|||
94689866|NCT00962585|324321248|FG001|Overall Study|Withdrawal by Subject|0|||
94689867|NCT00962585|324321249|FG002|Overall Study|Withdrawal by Subject|0|||
94689868|NCT00962585|324321250|FG003|Overall Study|Withdrawal by Subject|0|||
94689869|NCT00962585|324321247|FG000|Overall Study|Withdrew Consent|2|||
94264177|NCT03250832|322761874|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
94264178|NCT03250832|322761875|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
94264179|NCT03250832|322761876|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
94264180|NCT03250832|322761877|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
94689870|NCT00962585|324321248|FG001|Overall Study|Withdrew Consent|0|||
94689871|NCT00962585|324321249|FG002|Overall Study|Withdrew Consent|0|||
94689872|NCT00962585|324321250|FG003|Overall Study|Withdrew Consent|0|||
94689873|NCT02091869|324321251|FG000|Overall Study|Withdrawal by Subject|0|||
94689874|NCT02091869|324321252|FG001|Overall Study|Withdrawal by Subject|3|||
94689875|NCT01024959|324321253|FG000|Overall Study|ineligible|12|||
94689876|NCT01024959|324321253|FG000|Overall Study|results not evaluable|12|||
94689877|NCT01024959|324321253|FG000|Overall Study|missing results required for analysis|17|||
94689878|NCT00594906|324321258|FG000|Overall Study|Physician Decision|1|||
94689879|NCT00594906|324321259|FG001|Overall Study|Physician Decision|0|||
94689880|NCT00594906|324321258|FG000|Overall Study|Physician Decision|0|||
94689881|NCT00594906|324321259|FG001|Overall Study|Physician Decision|1|||
94689882|NCT00594906|324321258|FG000|Overall Study|Death|0|||
94689883|NCT00594906|324321259|FG001|Overall Study|Death|1|||
94689884|NCT00709592|324321260|FG000|Overall Study|Unable to proceed to transplant|0|||
94689885|NCT00709592|324321261|FG001|Overall Study|Unable to proceed to transplant|1|||
94689886|NCT01254565|324321262|FG000|Overall Study|Non-compliance to Study Procedures|0|||
94689887|NCT01254565|324321263|FG001|Overall Study|Non-compliance to Study Procedures|0|||
94689888|NCT01254565|324321264|FG002|Overall Study|Non-compliance to Study Procedures|0|||
94689889|NCT01254565|324321265|FG003|Overall Study|Non-compliance to Study Procedures|0|||
94689890|NCT01254565|324321266|FG004|Overall Study|Non-compliance to Study Procedures|1|||
94689891|NCT01254565|324321267|FG005|Overall Study|Non-compliance to Study Procedures|0|||
94689892|NCT01254565|324321262|FG000|Overall Study|Did not Receive Treatment|1|||
94689893|NCT01254565|324321263|FG001|Overall Study|Did not Receive Treatment|1|||
94689894|NCT01254565|324321264|FG002|Overall Study|Did not Receive Treatment|0|||
94689895|NCT01254565|324321265|FG003|Overall Study|Did not Receive Treatment|0|||
94689896|NCT01254565|324321266|FG004|Overall Study|Did not Receive Treatment|3|||
94689897|NCT01254565|324321267|FG005|Overall Study|Did not Receive Treatment|4|||
94689898|NCT01254565|324321262|FG000|Overall Study|Other|0|||
94689899|NCT01254565|324321263|FG001|Overall Study|Other|0|||
94365817|NCT01643928|323124784|FG004|Overall Study|Pregnancy|0|||
94365818|NCT01643928|323124780|FG000|Overall Study|Other|5|||
94689900|NCT01254565|324321264|FG002|Overall Study|Other|0|||
94689901|NCT01254565|324321265|FG003|Overall Study|Other|1|||
94689902|NCT01254565|324321266|FG004|Overall Study|Other|0|||
94689903|NCT01254565|324321267|FG005|Overall Study|Other|0|||
94689904|NCT00472186|324321268|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
94689905|NCT00472186|324321269|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
94689906|NCT03354637|324321270|FG000|Double-blind Period|Protocol Violation|2|||
94689907|NCT03354637|324321271|FG001|Double-blind Period|Protocol Violation|0|||
94689908|NCT03354637|324321272|FG002|Double-blind Period|Protocol Violation|0|||
94689909|NCT03354637|324321270|FG000|Double-blind Period|Adverse Event|1|||
94689910|NCT03354637|324321271|FG001|Double-blind Period|Adverse Event|2|||
94689911|NCT03354637|324321272|FG002|Double-blind Period|Adverse Event|0|||
94689912|NCT03354637|324321270|FG000|Double-blind Period|Lost to Follow-up|3|||
94689913|NCT03354637|324321271|FG001|Double-blind Period|Lost to Follow-up|4|||
94689914|NCT03354637|324321272|FG002|Double-blind Period|Lost to Follow-up|3|||
94689915|NCT03354637|324321270|FG000|Double-blind Period|Withdrawal by Subject|10|||
94689916|NCT03354637|324321271|FG001|Double-blind Period|Withdrawal by Subject|6|||
94689917|NCT03354637|324321272|FG002|Double-blind Period|Withdrawal by Subject|4|||
94689918|NCT03354637|324321270|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
94689919|NCT03354637|324321271|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
94689920|NCT03354637|324321272|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
94689921|NCT03354637|324321270|FG000|Open Label Extension|Adverse Event|0|||
94689922|NCT03354637|324321271|FG001|Open Label Extension|Adverse Event|0|||
94689923|NCT03354637|324321272|FG002|Open Label Extension|Adverse Event|1|||
94689924|NCT03354637|324321270|FG000|Open Label Extension|Lost to Follow-up|0|||
94689925|NCT03354637|324321271|FG001|Open Label Extension|Lost to Follow-up|0|||
94689926|NCT03354637|324321272|FG002|Open Label Extension|Lost to Follow-up|2|||
94689927|NCT03354637|324321270|FG000|Open Label Extension|Withdrawal by Subject|0|||
94689928|NCT03354637|324321271|FG001|Open Label Extension|Withdrawal by Subject|0|||
94689929|NCT03354637|324321272|FG002|Open Label Extension|Withdrawal by Subject|5|||
94689930|NCT03354637|324321270|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
94689931|NCT03354637|324321271|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
94689932|NCT03354637|324321272|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
94689933|NCT03354637|324321270|FG000|Open Label Extension|Subject Noncompliance|0|||
94689934|NCT03354637|324321271|FG001|Open Label Extension|Subject Noncompliance|0|||
94689935|NCT03354637|324321272|FG002|Open Label Extension|Subject Noncompliance|1|||
94689936|NCT03354637|324321270|FG000|Open Label Extension|Lack of Efficacy|0|||
94689937|NCT03354637|324321271|FG001|Open Label Extension|Lack of Efficacy|0|||
94689938|NCT03354637|324321272|FG002|Open Label Extension|Lack of Efficacy|1|||
94689939|NCT03354637|324321270|FG000|Open Label Extension|Physician Decision|0|||
94689940|NCT03354637|324321271|FG001|Open Label Extension|Physician Decision|0|||
94689941|NCT03354637|324321272|FG002|Open Label Extension|Physician Decision|1|||
94689942|NCT00197028|324321273|FG000|Overall Study|Adverse Event|2|||
94689943|NCT00197028|324321274|FG001|Overall Study|Adverse Event|2|||
94689944|NCT00197028|324321273|FG000|Overall Study|Protocol Violation|2|||
94689945|NCT00197028|324321274|FG001|Overall Study|Protocol Violation|1|||
94365819|NCT01643928|323124781|FG001|Overall Study|Other|1|||
94689946|NCT00197028|324321273|FG000|Overall Study|Withdrawal by Subject|8|||
94689947|NCT00197028|324321274|FG001|Overall Study|Withdrawal by Subject|12|||
94689948|NCT00197028|324321273|FG000|Overall Study|Lost to Follow-up|1|||
94689949|NCT00197028|324321274|FG001|Overall Study|Lost to Follow-up|0|||
94689950|NCT00197028|324321273|FG000|Overall Study|Other|3|||
94689951|NCT00197028|324321274|FG001|Overall Study|Other|6|||
94689952|NCT00737061|324321284|FG000|Waiting Period|Lost to Follow-up|6|||
94689953|NCT00737061|324321284|FG000|Waiting Period|Withdrawal by Subject|1|||
94689954|NCT00737061|324321284|FG000|Waiting Period|Bilateral placement failure|34|||
94689955|NCT00737061|324321284|FG000|Waiting Period|Deemed patent following HSG|26|||
94689956|NCT00737061|324321284|FG000|Waiting Period|Alternative contraception failure|3|||
94689957|NCT00737061|324321284|FG000|Waiting Period|Elected surgical tubal ligation|5|||
94689958|NCT00737061|324321284|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
94689959|NCT00737061|324321284|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
94689960|NCT00737061|324321284|FG000|1 Year Wearing Period|Discontinued reilance|3|||
94689961|NCT00737061|324321284|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
94689962|NCT02374593|324321286|FG000|Overall Study|non-compliant|2|||
94689963|NCT02374593|324321287|FG001|Overall Study|non-compliant|0|||
94689964|NCT04267614|324321288|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
94689965|NCT04267614|324321288|FG000|Overall Study|Lost to Follow-up|115|||
94689966|NCT00210119|324321289|FG000|Overall Study|Protocol Violation|1|||
94689967|NCT00210119|324321289|FG000|Overall Study|Withdrawal by Subject|1|||
94689968|NCT02038764|324321290|FG000|Overall Study|Adverse Event|0|||
94689969|NCT02038764|324321291|FG001|Overall Study|Adverse Event|0|||
94689970|NCT02038764|324321292|FG002|Overall Study|Adverse Event|1|||
94689971|NCT02038764|324321293|FG003|Overall Study|Adverse Event|0|||
94689972|NCT02038764|324321294|FG004|Overall Study|Adverse Event|0|||
94689973|NCT02038764|324321290|FG000|Overall Study|Lost to Follow-up|0|||
94689974|NCT02038764|324321291|FG001|Overall Study|Lost to Follow-up|1|||
94689975|NCT02038764|324321292|FG002|Overall Study|Lost to Follow-up|0|||
94689976|NCT02038764|324321293|FG003|Overall Study|Lost to Follow-up|0|||
94689977|NCT02038764|324321294|FG004|Overall Study|Lost to Follow-up|0|||
94689978|NCT02038764|324321290|FG000|Overall Study|Withdrawal by Subject|0|||
94689979|NCT02038764|324321291|FG001|Overall Study|Withdrawal by Subject|0|||
94689980|NCT02038764|324321292|FG002|Overall Study|Withdrawal by Subject|0|||
94689981|NCT02038764|324321293|FG003|Overall Study|Withdrawal by Subject|0|||
94264181|NCT03250832|322761878|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
94264182|NCT03250832|322761879|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
94264183|NCT03250832|322761880|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
94264184|NCT03250832|322761881|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
94264185|NCT03250832|322761870|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
94264186|NCT03250832|322761871|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
94264187|NCT03250832|322761872|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
94264188|NCT03250832|322761873|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
94264189|NCT03250832|322761874|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
94264190|NCT03250832|322761875|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
94264191|NCT03250832|322761876|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
94264192|NCT03250832|322761877|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
94264193|NCT03250832|322761878|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
94264194|NCT03250832|322761879|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
94264195|NCT03250832|322761880|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
94264196|NCT03250832|322761881|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
94264197|NCT03250832|322761870|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
94264198|NCT03250832|322761871|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
94264199|NCT03250832|322761872|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
94264200|NCT03250832|322761873|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
94264201|NCT03250832|322761874|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
94264202|NCT03250832|322761875|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
94264203|NCT03250832|322761876|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
94264204|NCT03250832|322761877|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
94264205|NCT03250832|322761878|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
94264206|NCT03250832|322761879|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
94264207|NCT03250832|322761880|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
94365820|NCT01643928|323124782|FG002|Overall Study|Other|1|||
94365821|NCT01643928|323124783|FG003|Overall Study|Other|0|||
94365822|NCT01643928|323124784|FG004|Overall Study|Other|0|||
94365823|NCT01643928|323124780|FG000|Overall Study|Adverse Event|2|||
94365824|NCT01643928|323124781|FG001|Overall Study|Adverse Event|1|||
94689982|NCT02038764|324321294|FG004|Overall Study|Withdrawal by Subject|1|||
94689983|NCT02038764|324321290|FG000|Overall Study|Other|1|||
94689984|NCT02038764|324321291|FG001|Overall Study|Other|0|||
94689985|NCT02038764|324321292|FG002|Overall Study|Other|1|||
94689986|NCT02038764|324321293|FG003|Overall Study|Other|0|||
94689987|NCT02038764|324321294|FG004|Overall Study|Other|0|||
94689988|NCT04844918|324321297|FG000|Overall Study|Adverse Event|7|||
94689989|NCT04844918|324321298|FG001|Overall Study|Adverse Event|8|||
94689990|NCT04844918|324321299|FG002|Overall Study|Adverse Event|5|||
94689991|NCT04844918|324321297|FG000|Overall Study|Physician Decision|0|||
94689992|NCT04844918|324321298|FG001|Overall Study|Physician Decision|1|||
94689993|NCT04844918|324321299|FG002|Overall Study|Physician Decision|0|||
94689994|NCT04844918|324321297|FG000|Overall Study|Withdrawal by Subject|6|||
94689995|NCT04844918|324321298|FG001|Overall Study|Withdrawal by Subject|3|||
94689996|NCT04844918|324321299|FG002|Overall Study|Withdrawal by Subject|3|||
94689997|NCT04844918|324321297|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
94689998|NCT04844918|324321298|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
94689999|NCT04844918|324321299|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
94690000|NCT04192630|324321301|FG000|Overall Study|Discontinued before surgery|2|||
94690001|NCT04192630|324321302|FG001|Overall Study|Discontinued before surgery|0|||
94690002|NCT04192630|324321301|FG000|Overall Study|Discontinued after surgery|5|||
94690003|NCT04192630|324321302|FG001|Overall Study|Discontinued after surgery|3|||
94690004|NCT01009047|324321303|FG000|Overall Study|Adverse Event|5|||
94690005|NCT01009047|324321304|FG001|Overall Study|Adverse Event|0|||
94690006|NCT01009047|324321303|FG000|Overall Study|Lost to Follow-up|0|||
94690007|NCT01009047|324321304|FG001|Overall Study|Lost to Follow-up|2|||
94690008|NCT01009047|324321303|FG000|Overall Study|Lack of Efficacy|4|||
94690009|NCT01009047|324321304|FG001|Overall Study|Lack of Efficacy|11|||
94690010|NCT01009047|324321303|FG000|Overall Study|Withdrawal by consent|16|||
94690011|NCT01009047|324321304|FG001|Overall Study|Withdrawal by consent|11|||
94690012|NCT01009047|324321303|FG000|Overall Study|Other|3|||
94690013|NCT01009047|324321304|FG001|Overall Study|Other|2|||
94690014|NCT02366936|324321305|FG000|Overall Study|Withdrawal by Subject|2|||
94690015|NCT02366936|324321305|FG000|Overall Study|Lost to Follow-up|4|||
94690016|NCT02366936|324321305|FG000|Overall Study|Physician Decision|2|||
94690017|NCT03358329|324321306|FG000|Overall Study|Lost to Follow-up|2|||
94690018|NCT03358329|324321306|FG000|Overall Study|Withdrawal by Subject|2|||
94690019|NCT03875911|324321307|FG000|Overall Study|Lost to Follow-up|3|||
94690020|NCT03875911|324321308|FG001|Overall Study|Lost to Follow-up|6|||
94690021|NCT03875911|324321309|FG002|Overall Study|Lost to Follow-up|2|||
94690022|NCT03875911|324321307|FG000|Overall Study|Surgery cancelled|1|||
94690023|NCT03875911|324321308|FG001|Overall Study|Surgery cancelled|0|||
94690024|NCT03875911|324321309|FG002|Overall Study|Surgery cancelled|1|||
94690025|NCT03875911|324321307|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
94690026|NCT03875911|324321308|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
94690027|NCT03875911|324321309|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
94690028|NCT03824938|324321314|FG000|Overall Study|Withdrawal by Subject|2|||
94690029|NCT03824938|324321315|FG001|Overall Study|Withdrawal by Subject|1|||
94690030|NCT03824938|324321316|FG002|Overall Study|Withdrawal by Subject|0|||
94690031|NCT03824938|324321317|FG003|Overall Study|Withdrawal by Subject|2|||
94690032|NCT03824938|324321318|FG004|Overall Study|Withdrawal by Subject|0|||
94690033|NCT03824938|324321319|FG005|Overall Study|Withdrawal by Subject|1|||
94690034|NCT03824938|324321314|FG000|Overall Study|Lost to Follow-up|0|||
94690035|NCT03824938|324321315|FG001|Overall Study|Lost to Follow-up|1|||
94690036|NCT03824938|324321316|FG002|Overall Study|Lost to Follow-up|0|||
94690037|NCT03824938|324321317|FG003|Overall Study|Lost to Follow-up|0|||
94690038|NCT03824938|324321318|FG004|Overall Study|Lost to Follow-up|1|||
94690039|NCT03824938|324321319|FG005|Overall Study|Lost to Follow-up|0|||
94690040|NCT02836613|324321320|FG000|Overall Study|Accidental drowning|1|||
94690041|NCT02836613|324321321|FG001|Overall Study|Accidental drowning|0|||
94690042|NCT02836613|324321320|FG000|Overall Study|Lost to Follow-up|0|||
94690043|NCT02836613|324321321|FG001|Overall Study|Lost to Follow-up|1|||
94690044|NCT02836613|324321320|FG000|Overall Study|Withdrawal by Subject|0|||
94690045|NCT02836613|324321321|FG001|Overall Study|Withdrawal by Subject|2|||
94690046|NCT00507026|324321322|FG000|Overall Study|Lack of Efficacy|6|||
94690047|NCT00507026|324321323|FG001|Overall Study|Lack of Efficacy|4|||
94690048|NCT00507026|324321324|FG002|Overall Study|Lack of Efficacy|21|||
94690049|NCT00507026|324321322|FG000|Overall Study|Withdrawal by Subject|2|||
94690050|NCT00507026|324321323|FG001|Overall Study|Withdrawal by Subject|0|||
94690051|NCT00507026|324321324|FG002|Overall Study|Withdrawal by Subject|0|||
94690052|NCT00507026|324321322|FG000|Overall Study|Investigator Decision|1|||
94690053|NCT00507026|324321323|FG001|Overall Study|Investigator Decision|0|||
94690054|NCT00507026|324321324|FG002|Overall Study|Investigator Decision|0|||
94690055|NCT00507026|324321322|FG000|Overall Study|Adverse Event|2|||
94690056|NCT00507026|324321323|FG001|Overall Study|Adverse Event|0|||
94690057|NCT00507026|324321324|FG002|Overall Study|Adverse Event|0|||
94690058|NCT00507026|324321322|FG000|Overall Study|Protocol Violation|1|||
94690059|NCT00507026|324321323|FG001|Overall Study|Protocol Violation|0|||
94690060|NCT00507026|324321324|FG002|Overall Study|Protocol Violation|0|||
94690061|NCT00507026|324321322|FG000|Overall Study|Other|1|||
94690062|NCT00507026|324321323|FG001|Overall Study|Other|0|||
94690063|NCT00507026|324321324|FG002|Overall Study|Other|0|||
94690064|NCT02269943|324321325|FG000|Treatment Period|Death|0|||
94690065|NCT02269943|324321326|FG001|Treatment Period|Death|1|||
94690066|NCT02269943|324321325|FG000|Treatment Period|Adverse Event|1|||
94690067|NCT02269943|324321326|FG001|Treatment Period|Adverse Event|10|||
94690068|NCT02269943|324321325|FG000|Treatment Period|Progressive Disease|5|||
94690069|NCT02269943|324321326|FG001|Treatment Period|Progressive Disease|17|||
94690070|NCT02269943|324321325|FG000|Treatment Period|Symptomatic Deterioration|0|||
94690071|NCT02269943|324321326|FG001|Treatment Period|Symptomatic Deterioration|2|||
94690072|NCT02269943|324321325|FG000|Follow-Up Survival Period|Death|3|||
94690073|NCT02269943|324321326|FG001|Follow-Up Survival Period|Death|16|||
94690074|NCT02269943|324321325|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
94690075|NCT02269943|324321326|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
94690076|NCT02269943|324321325|FG000|Follow-Up Survival Period|Alive|2|||
94690077|NCT02269943|324321326|FG001|Follow-Up Survival Period|Alive|8|||
94690078|NCT00972179|324321327|FG000|Overall Study|Noncompliance|1|||
94690079|NCT00972179|324321328|FG001|Overall Study|Noncompliance|0|||
94690080|NCT00972179|324321329|FG002|Overall Study|Noncompliance|0|||
94690081|NCT00972179|324321330|FG003|Overall Study|Noncompliance|0|||
94690082|NCT00972179|324321331|FG004|Overall Study|Noncompliance|1|||
94690083|NCT00972179|324321332|FG005|Overall Study|Noncompliance|0|||
94690084|NCT00972179|324321333|FG006|Overall Study|Noncompliance|1|||
94690085|NCT00972179|324321327|FG000|Overall Study|Withdrawal by Subject|0|||
94690086|NCT00972179|324321328|FG001|Overall Study|Withdrawal by Subject|3|||
94690087|NCT00972179|324321329|FG002|Overall Study|Withdrawal by Subject|0|||
94690088|NCT00972179|324321330|FG003|Overall Study|Withdrawal by Subject|1|||
94690089|NCT00972179|324321331|FG004|Overall Study|Withdrawal by Subject|0|||
94690090|NCT00972179|324321332|FG005|Overall Study|Withdrawal by Subject|0|||
94690091|NCT00972179|324321333|FG006|Overall Study|Withdrawal by Subject|2|||
94690092|NCT00972179|324321327|FG000|Overall Study|Administrative Decision|0|||
94690093|NCT00972179|324321328|FG001|Overall Study|Administrative Decision|0|||
94690094|NCT00972179|324321329|FG002|Overall Study|Administrative Decision|0|||
94690095|NCT00972179|324321330|FG003|Overall Study|Administrative Decision|0|||
94690096|NCT00972179|324321331|FG004|Overall Study|Administrative Decision|1|||
94690097|NCT00972179|324321332|FG005|Overall Study|Administrative Decision|0|||
94690098|NCT00972179|324321333|FG006|Overall Study|Administrative Decision|0|||
94690099|NCT00972179|324321327|FG000|Overall Study|Lost to Follow-up|0|||
94690100|NCT00972179|324321328|FG001|Overall Study|Lost to Follow-up|0|||
94690101|NCT00972179|324321329|FG002|Overall Study|Lost to Follow-up|1|||
94690102|NCT00972179|324321330|FG003|Overall Study|Lost to Follow-up|0|||
94690103|NCT00972179|324321331|FG004|Overall Study|Lost to Follow-up|0|||
94690104|NCT00972179|324321332|FG005|Overall Study|Lost to Follow-up|3|||
94690105|NCT00972179|324321333|FG006|Overall Study|Lost to Follow-up|1|||
94690106|NCT02138747|324321336|FG000|Treatment Period 1|Adverse Event|10|||
94690107|NCT02138747|324321337|FG001|Treatment Period 1|Adverse Event|14|||
94690108|NCT02138747|324321338|FG002|Treatment Period 1|Adverse Event|2|||
94690109|NCT02138747|324321339|FG003|Treatment Period 1|Adverse Event|1|||
94690110|NCT02138747|324321336|FG000|Treatment Period 1|Lost to Follow-up|0|||
94690111|NCT02138747|324321337|FG001|Treatment Period 1|Lost to Follow-up|1|||
94690112|NCT02138747|324321338|FG002|Treatment Period 1|Lost to Follow-up|1|||
94690113|NCT02138747|324321339|FG003|Treatment Period 1|Lost to Follow-up|0|||
94690114|NCT02138747|324321336|FG000|Treatment Period 1|Protocol Violation|0|||
94690115|NCT02138747|324321337|FG001|Treatment Period 1|Protocol Violation|2|||
94690116|NCT02138747|324321338|FG002|Treatment Period 1|Protocol Violation|0|||
94690117|NCT02138747|324321339|FG003|Treatment Period 1|Protocol Violation|0|||
94690118|NCT02138747|324321336|FG000|Treatment Period 1|Withdrawal by Subject|8|||
94690119|NCT02138747|324321337|FG001|Treatment Period 1|Withdrawal by Subject|4|||
94690120|NCT02138747|324321338|FG002|Treatment Period 1|Withdrawal by Subject|1|||
94690121|NCT02138747|324321339|FG003|Treatment Period 1|Withdrawal by Subject|3|||
94690122|NCT02138747|324321336|FG000|Treatment Period 1|Other - Miscellaneous|2|||
94690123|NCT02138747|324321337|FG001|Treatment Period 1|Other - Miscellaneous|4|||
94690124|NCT02138747|324321338|FG002|Treatment Period 1|Other - Miscellaneous|0|||
94690125|NCT02138747|324321339|FG003|Treatment Period 1|Other - Miscellaneous|0|||
94690126|NCT02138747|324321336|FG000|Treatment Period 2|Adverse Event|6|||
94690127|NCT02138747|324321337|FG001|Treatment Period 2|Adverse Event|3|||
94690128|NCT02138747|324321338|FG002|Treatment Period 2|Adverse Event|1|||
94690129|NCT02138747|324321339|FG003|Treatment Period 2|Adverse Event|1|||
94690130|NCT02138747|324321336|FG000|Treatment Period 2|Lost to Follow-up|2|||
94690131|NCT02138747|324321337|FG001|Treatment Period 2|Lost to Follow-up|0|||
94690132|NCT02138747|324321338|FG002|Treatment Period 2|Lost to Follow-up|0|||
94690133|NCT02138747|324321339|FG003|Treatment Period 2|Lost to Follow-up|0|||
94690134|NCT02138747|324321336|FG000|Treatment Period 2|Protocol Violation|1|||
94690135|NCT02138747|324321337|FG001|Treatment Period 2|Protocol Violation|0|||
94690136|NCT02138747|324321338|FG002|Treatment Period 2|Protocol Violation|0|||
94690137|NCT02138747|324321339|FG003|Treatment Period 2|Protocol Violation|0|||
94690138|NCT02138747|324321336|FG000|Treatment Period 2|Withdrawal by Subject|5|||
94690139|NCT02138747|324321337|FG001|Treatment Period 2|Withdrawal by Subject|4|||
94690140|NCT02138747|324321338|FG002|Treatment Period 2|Withdrawal by Subject|1|||
94690141|NCT02138747|324321339|FG003|Treatment Period 2|Withdrawal by Subject|2|||
94690142|NCT02138747|324321336|FG000|Treatment Period 2|Other - Miscellaneous|3|||
94690143|NCT02138747|324321337|FG001|Treatment Period 2|Other - Miscellaneous|0|||
94690144|NCT02138747|324321338|FG002|Treatment Period 2|Other - Miscellaneous|0|||
94690145|NCT02138747|324321339|FG003|Treatment Period 2|Other - Miscellaneous|0|||
94690146|NCT02855164|324321341|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
94690147|NCT02855164|324321342|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
94690148|NCT02855164|324321343|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
94690149|NCT02855164|324321344|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
94690150|NCT02855164|324321345|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
94690151|NCT02855164|324321346|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
94690152|NCT02855164|324321347|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
94690153|NCT02855164|324321348|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
94690154|NCT02855164|324321341|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
94690155|NCT02855164|324321342|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
94690156|NCT02855164|324321343|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
94690157|NCT02855164|324321344|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
94690158|NCT02855164|324321345|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
94690159|NCT02855164|324321346|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
94690160|NCT02855164|324321347|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
94690161|NCT02855164|324321348|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
94690162|NCT02855164|324321341|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
94690163|NCT02855164|324321342|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
94690164|NCT02855164|324321343|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
94690165|NCT02855164|324321344|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
94690166|NCT02855164|324321345|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
94690167|NCT02855164|324321346|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
94690168|NCT02855164|324321347|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
94690169|NCT02855164|324321348|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
94690170|NCT02855164|324321341|FG000|Part C (Randomized Set)|Adverse Event|0|||
94690171|NCT02855164|324321342|FG001|Part C (Randomized Set)|Adverse Event|0|||
94690172|NCT02855164|324321343|FG002|Part C (Randomized Set)|Adverse Event|0|||
94690173|NCT02855164|324321344|FG003|Part C (Randomized Set)|Adverse Event|0|||
94690174|NCT02855164|324321345|FG004|Part C (Randomized Set)|Adverse Event|0|||
94690175|NCT02855164|324321346|FG005|Part C (Randomized Set)|Adverse Event|5|||
94690176|NCT02855164|324321347|FG006|Part C (Randomized Set)|Adverse Event|9|||
94690177|NCT02855164|324321348|FG007|Part C (Randomized Set)|Adverse Event|2|||
94690178|NCT02855164|324321341|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
94690179|NCT02855164|324321342|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
94690180|NCT02855164|324321343|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
94690181|NCT02855164|324321344|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
94690182|NCT02855164|324321345|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
94690183|NCT02855164|324321346|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
94690184|NCT02855164|324321347|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
94690185|NCT02855164|324321348|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
94690186|NCT02855164|324321341|FG000|Part C (Randomized Set)|Physician Decision|0|||
94690187|NCT02855164|324321342|FG001|Part C (Randomized Set)|Physician Decision|0|||
94465986|NCT00561470|323494968|FG000|Overall Study|Adverse Event|74|||
94690188|NCT02855164|324321343|FG002|Part C (Randomized Set)|Physician Decision|0|||
94690189|NCT02855164|324321344|FG003|Part C (Randomized Set)|Physician Decision|0|||
94690190|NCT02855164|324321345|FG004|Part C (Randomized Set)|Physician Decision|0|||
94690191|NCT02855164|324321346|FG005|Part C (Randomized Set)|Physician Decision|1|||
94690192|NCT02855164|324321347|FG006|Part C (Randomized Set)|Physician Decision|0|||
94690193|NCT02855164|324321348|FG007|Part C (Randomized Set)|Physician Decision|1|||
94690194|NCT02855164|324321341|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
94690195|NCT02855164|324321342|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
94690196|NCT02855164|324321343|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
94690197|NCT02855164|324321344|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
94690198|NCT02855164|324321345|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
94690199|NCT02855164|324321346|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
94690200|NCT02855164|324321347|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
94264208|NCT03250832|322761881|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
94264209|NCT03250832|322761870|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
94264210|NCT03250832|322761871|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
94264211|NCT03250832|322761872|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
94264212|NCT03250832|322761873|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
94264213|NCT03250832|322761874|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
94465987|NCT00561470|323494969|FG001|Overall Study|Adverse Event|163|||
94365825|NCT01643928|323124782|FG002|Overall Study|Adverse Event|0|||
94365826|NCT01643928|323124783|FG003|Overall Study|Adverse Event|1|||
94365827|NCT01643928|323124784|FG004|Overall Study|Adverse Event|2|||
94365828|NCT00996632|323124787|FG000|Overall Study|Physician Decision|0|||
94365829|NCT00996632|323124788|FG001|Overall Study|Physician Decision|0|||
94365830|NCT04840901|323124789|FG000|Overall Study|Lost to Follow-up|3|||
94365831|NCT04840901|323124790|FG001|Overall Study|Lost to Follow-up|1|||
94365832|NCT04840901|323124789|FG000|Overall Study|Moved|1|||
94365833|NCT04840901|323124790|FG001|Overall Study|Moved|0|||
94365834|NCT04840901|323124789|FG000|Overall Study|Unable to comply with study schedule|0|||
94365835|NCT04840901|323124790|FG001|Overall Study|Unable to comply with study schedule|1|||
94365836|NCT04840901|323124789|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
94365837|NCT04840901|323124790|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
94365838|NCT01260194|323124791|FG000|Overall Study|Withdrawal of Consent|1|||
94365839|NCT03387735|323124792|FG000|Overall Study|Lost to Follow-up|4|||
94365840|NCT03387735|323124793|FG001|Overall Study|Lost to Follow-up|8|||
94365841|NCT03387735|323124792|FG000|Overall Study|Death|4|||
94365842|NCT03387735|323124793|FG001|Overall Study|Death|8|||
94365843|NCT01036594|323124796|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
94365844|NCT01036594|323124797|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
94365845|NCT01036594|323124796|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
94365846|NCT01036594|323124797|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
94365847|NCT01036594|323124796|FG000|Week 12 Evaluation|Adverse Event|5|||
94365848|NCT01036594|323124797|FG001|Week 12 Evaluation|Adverse Event|0|||
94264214|NCT03250832|322761875|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
94264215|NCT03250832|322761876|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
94264216|NCT03250832|322761877|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
94264217|NCT03250832|322761878|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
94264218|NCT03250832|322761879|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
94264219|NCT03250832|322761880|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
94264220|NCT03250832|322761881|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
94264221|NCT03250832|322761870|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
94264222|NCT03250832|322761871|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
94264223|NCT03250832|322761872|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
94365849|NCT01036594|323124796|FG000|Week 12 Evaluation|Physician Decision|1|||
94365850|NCT01036594|323124797|FG001|Week 12 Evaluation|Physician Decision|0|||
94365851|NCT01036594|323124796|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
94365852|NCT01036594|323124797|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
94365853|NCT01036594|323124796|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
94690201|NCT02855164|324321348|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
94690202|NCT00064025|324321349|FG000|Overall Study|Ineligible|4|||
94690203|NCT00064025|324321349|FG000|Overall Study|Inevaluable|3|||
94690204|NCT02468934|324321350|FG000|Overall Study|Withdrawal by Subject|4|||
94690205|NCT02468934|324321350|FG000|Overall Study|Screen Failure|3|||
94690206|NCT02102464|324321355|FG000|Randomized Study|Withdrawal by Subject|0|||
94690207|NCT02102464|324321356|FG001|Randomized Study|Withdrawal by Subject|1|||
94690208|NCT02102464|324321357|FG002|Randomized Study|Withdrawal by Subject|0|||
94690209|NCT02404493|324321358|FG000|Overall Study|Adverse Event|1|||
94690210|NCT02404493|324321359|FG001|Overall Study|Adverse Event|1|||
94690211|NCT02133924|324321360|FG000|Overall Study|Death|38|||
94690212|NCT02133924|324321360|FG000|Overall Study|Physician Decision|1|||
94690213|NCT02133924|324321360|FG000|Overall Study|Withdrawal by Subject|3|||
94690214|NCT02846558|324321368|FG000|Overall Study|Adverse Event|1|||
94690215|NCT02846558|324321369|FG001|Overall Study|Adverse Event|0|||
94690216|NCT02846558|324321370|FG002|Overall Study|Adverse Event|0|||
94690217|NCT02846558|324321371|FG003|Overall Study|Adverse Event|0|||
94690218|NCT02846558|324321368|FG000|Overall Study|Withdrawal by Subject|5|||
94690219|NCT02846558|324321369|FG001|Overall Study|Withdrawal by Subject|4|||
94690220|NCT02846558|324321370|FG002|Overall Study|Withdrawal by Subject|2|||
94690221|NCT02846558|324321371|FG003|Overall Study|Withdrawal by Subject|2|||
94690222|NCT02846558|324321368|FG000|Overall Study|Lost to Follow-up|2|||
94690223|NCT02846558|324321369|FG001|Overall Study|Lost to Follow-up|0|||
94690224|NCT02846558|324321370|FG002|Overall Study|Lost to Follow-up|0|||
94690225|NCT02846558|324321371|FG003|Overall Study|Lost to Follow-up|0|||
94690226|NCT03204695|324323192|FG000|Overall Study|Death|1|||
94690227|NCT03204695|324323192|FG000|Overall Study|Participant was treated with another device|1|||
94690228|NCT03204695|324323192|FG000|Overall Study|Physician Decision|2|||
94690229|NCT02531295|324323193|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
94690230|NCT02531295|324323194|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
94690231|NCT02531295|324323195|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
94690232|NCT02531295|324323196|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
94690233|NCT02531295|324323197|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
94690234|NCT02531295|324323198|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
94690235|NCT03390036|324323201|FG000|Overall Study|Lost to Follow-up|1|||
94690236|NCT03390036|324323202|FG001|Overall Study|Lost to Follow-up|0|||
94690237|NCT03390036|324323203|FG002|Overall Study|Lost to Follow-up|0|||
94690238|NCT03390036|324323201|FG000|Overall Study|Lack of Efficacy|1|||
94690239|NCT03390036|324323202|FG001|Overall Study|Lack of Efficacy|0|||
94690240|NCT03390036|324323203|FG002|Overall Study|Lack of Efficacy|0|||
94690241|NCT02802319|324323207|FG000|Overall Study|Physician Decision|2|||
94690242|NCT02802319|324323208|FG001|Overall Study|Physician Decision|1|||
94690243|NCT02802319|324323207|FG000|Overall Study|Lost to Follow-up|0|||
94690244|NCT02802319|324323208|FG001|Overall Study|Lost to Follow-up|4|||
94690245|NCT03268590|324323224|FG000|Overall Study|Previously unknown exclusion criteria|1|||
94690246|NCT02139982|324323225|FG000|Overall Study|Lack of Efficacy|0|||
94690247|NCT02139982|324323226|FG001|Overall Study|Lack of Efficacy|1|||
94690248|NCT02139982|324323227|FG002|Overall Study|Lack of Efficacy|0|||
94690249|NCT02139982|324323228|FG003|Overall Study|Lack of Efficacy|1|||
94690250|NCT02139982|324323229|FG004|Overall Study|Lack of Efficacy|0|||
94690251|NCT02139982|324323230|FG005|Overall Study|Lack of Efficacy|0|||
94365854|NCT01036594|323124797|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
94365855|NCT01036594|323124796|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
94365856|NCT01036594|323124797|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
94365857|NCT01036594|323124796|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
94690252|NCT02139982|324323231|FG006|Overall Study|Lack of Efficacy|0|||
94690253|NCT02139982|324323232|FG007|Overall Study|Lack of Efficacy|0|||
94690254|NCT02139982|324323233|FG008|Overall Study|Lack of Efficacy|0|||
94690255|NCT02139982|324323234|FG009|Overall Study|Lack of Efficacy|0|||
94690256|NCT04254679|324323235|FG000|Overall Study|Protocol Violation|1|||
94690257|NCT04254679|324323236|FG001|Overall Study|Protocol Violation|1|||
94365858|NCT01036594|323124797|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
94690258|NCT04254679|324323235|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
94690259|NCT04254679|324323236|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
94690260|NCT00478608|324323243|FG000|Overall Study|Adverse Event|1|||
94690261|NCT00478608|324323243|FG000|Overall Study|Serious Adverse Event|14|||
94690262|NCT00478608|324323243|FG000|Overall Study|Withdrawal by Subject|2|||
94690263|NCT00478608|324323243|FG000|Overall Study|Protocol Violation|3|||
94690264|NCT02080520|324323244|FG000|Overall Study|Self-reported symptoms|5|||
94690265|NCT02080520|324323245|FG001|Overall Study|Self-reported symptoms|6|||
94690266|NCT02080520|324323244|FG000|Overall Study|Unable to contact|2|||
94690267|NCT02080520|324323245|FG001|Overall Study|Unable to contact|1|||
94690268|NCT02080520|324323244|FG000|Overall Study|Initiated aspirin|2|||
94690269|NCT02080520|324323245|FG001|Overall Study|Initiated aspirin|0|||
94690270|NCT02080520|324323244|FG000|Overall Study|Atrial fibrillation|1|||
94690271|NCT02080520|324323245|FG001|Overall Study|Atrial fibrillation|1|||
94690272|NCT02080520|324323244|FG000|Overall Study|Cancer|1|||
94690273|NCT02080520|324323245|FG001|Overall Study|Cancer|2|||
94690274|NCT02080520|324323244|FG000|Overall Study|Not interested in study|1|||
94690275|NCT02080520|324323245|FG001|Overall Study|Not interested in study|3|||
94690276|NCT02080520|324323244|FG000|Overall Study|Too busy|1|||
94690277|NCT02080520|324323245|FG001|Overall Study|Too busy|1|||
94690278|NCT02080520|324323244|FG000|Overall Study|Work-related injury|1|||
94690279|NCT02080520|324323245|FG001|Overall Study|Work-related injury|0|||
94690280|NCT02080520|324323244|FG000|Overall Study|Personal reasons|0|||
94690281|NCT02080520|324323245|FG001|Overall Study|Personal reasons|3|||
94690282|NCT04012814|324323246|FG000|Overall Study|Lost to Follow-up|4|||
94690283|NCT04012814|324323246|FG000|Overall Study|Withdrawal by Subject|2|||
94690284|NCT04012814|324323246|FG000|Overall Study|Protocol Violation|1|||
94690285|NCT04012814|324323246|FG000|Overall Study|Adverse Event|1|||
94690286|NCT01591460|324323251|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
94690287|NCT01591460|324323251|FG000|Overall Study|Futility Rule (Week 12)|7|||
94690288|NCT01591460|324323251|FG000|Overall Study|Futility Rule (Week 24)|3|||
94690289|NCT01591460|324323251|FG000|Overall Study|Rebound or Breakthrough|3|||
94690290|NCT01591460|324323251|FG000|Overall Study|Treatment Discontinued by Error|1|||
94690291|NCT01591460|324323251|FG000|Overall Study|Lost to Follow-up|1|||
94690292|NCT01591460|324323251|FG000|Overall Study|Noncompliance|1|||
94690293|NCT01591460|324323251|FG000|Overall Study|Participant Refusal|3|||
94690294|NCT01591460|324323251|FG000|Overall Study|Withdrawal by Subject|1|||
94690295|NCT01591460|324323251|FG000|Overall Study|Protocol Violation|1|||
94690296|NCT03230864|324323252|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
94690297|NCT03230864|324323253|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
94690298|NCT03230864|324323254|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
94690299|NCT03230864|324323255|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
94690300|NCT03230864|324323252|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
94690301|NCT03230864|324323253|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
94690302|NCT03230864|324323254|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
94690303|NCT03230864|324323255|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
94690304|NCT03230864|324323252|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
94690305|NCT03230864|324323253|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
94690306|NCT03230864|324323254|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
94690307|NCT03230864|324323255|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
94690308|NCT03230864|324323252|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
94690309|NCT03230864|324323253|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
94690310|NCT03230864|324323254|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
94690311|NCT03230864|324323255|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
94690312|NCT03230864|324323252|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
94690313|NCT03230864|324323253|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
94690314|NCT03230864|324323254|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
94690315|NCT03230864|324323255|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
94690316|NCT03230864|324323252|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
94690317|NCT03230864|324323253|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
94690318|NCT03230864|324323254|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
94690319|NCT03230864|324323255|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
94690320|NCT03230864|324323252|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
94690321|NCT03230864|324323253|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
94690322|NCT03230864|324323254|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
94690323|NCT03230864|324323255|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
94690324|NCT03230864|324323252|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
94690325|NCT03230864|324323253|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
94690326|NCT03230864|324323254|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
94690327|NCT03230864|324323255|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
94690328|NCT03230864|324323252|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
94690329|NCT03230864|324323253|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
94690330|NCT03230864|324323254|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
94365859|NCT01036594|323124796|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
94690331|NCT03230864|324323255|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
94690332|NCT03230864|324323252|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
94690333|NCT03230864|324323253|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
94690334|NCT03230864|324323254|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
94690335|NCT03230864|324323255|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
94690336|NCT00432679|324323263|FG000|Overall Study|Adverse Event|2|||
94690337|NCT00432679|324323264|FG001|Overall Study|Adverse Event|1|||
94690338|NCT00432679|324323263|FG000|Overall Study|Withdrawal by Subject|3|||
94690339|NCT00432679|324323264|FG001|Overall Study|Withdrawal by Subject|2|||
94690340|NCT01744496|324323265|FG000|Titration Period|Adverse Event|2|||
94690341|NCT01744496|324323266|FG001|Titration Period|Adverse Event|1|||
94690342|NCT01744496|324323265|FG000|Titration Period|Personal reasons|0|||
94690343|NCT01744496|324323266|FG001|Titration Period|Personal reasons|1|||
94690344|NCT01744496|324323265|FG000|Maintenance Period|Adverse Event|1|||
94690345|NCT01744496|324323266|FG001|Maintenance Period|Adverse Event|3|||
94690346|NCT01744496|324323265|FG000|Maintenance Period|Protocol Violation|1|||
94690347|NCT01744496|324323266|FG001|Maintenance Period|Protocol Violation|0|||
94690348|NCT01744496|324323265|FG000|Maintenance Period|Withdrawal by Subject|1|||
94690349|NCT01744496|324323266|FG001|Maintenance Period|Withdrawal by Subject|1|||
94690350|NCT01744496|324323265|FG000|Maintenance Period|Subject left town|1|||
94690351|NCT01744496|324323266|FG001|Maintenance Period|Subject left town|0|||
94690352|NCT03237013|324323267|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
94690353|NCT03237013|324323268|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
94690354|NCT03237013|324323269|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
94690355|NCT00109928|324323271|FG000|Overall Study|Adverse Event|2|||
94690356|NCT00109928|324323271|FG000|Overall Study|Progression|6|||
94690357|NCT00109928|324323271|FG000|Overall Study|Death|2|||
94690358|NCT00109928|324323271|FG000|Overall Study|not protocol specified|2|||
94690359|NCT00109928|324323271|FG000|Overall Study|not eligible|1|||
94690360|NCT01196104|324323272|FG000|Overall Study|Lost to Follow-up|1|||
94690361|NCT01196104|324323273|FG001|Overall Study|Lost to Follow-up|0|||
94690362|NCT01196104|324323272|FG000|Overall Study|Physician Decision|0|||
94690363|NCT01196104|324323273|FG001|Overall Study|Physician Decision|1|||
94690364|NCT01196104|324323272|FG000|Overall Study|Withdrawal by Subject|3|||
94690365|NCT01196104|324323273|FG001|Overall Study|Withdrawal by Subject|3|||
94690366|NCT01196104|324323272|FG000|Overall Study|Various|0|||
94690367|NCT01196104|324323273|FG001|Overall Study|Various|1|||
94690368|NCT02761629|324323274|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
94690369|NCT02761629|324323275|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
94690370|NCT02761629|324323274|FG000|Overall Study|Insufficient Therapeutic Response|2|||
94690371|NCT02761629|324323275|FG001|Overall Study|Insufficient Therapeutic Response|7|||
94690372|NCT02761629|324323274|FG000|Overall Study|Failure to Return|2|||
94690373|NCT02761629|324323275|FG001|Overall Study|Failure to Return|4|||
94690374|NCT02761629|324323274|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
94690375|NCT02761629|324323275|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
94690376|NCT02761629|324323274|FG000|Overall Study|Protocol Violation|2|||
94690377|NCT02761629|324323275|FG001|Overall Study|Protocol Violation|2|||
94690378|NCT02761629|324323274|FG000|Overall Study|Withdrawal by Subject|0|||
94690379|NCT02761629|324323275|FG001|Overall Study|Withdrawal by Subject|3|||
94690380|NCT02761629|324323274|FG000|Overall Study|Other|0|||
94690381|NCT02761629|324323275|FG001|Overall Study|Other|2|||
94690382|NCT02761629|324323274|FG000|Overall Study|Lost to Follow-up|4|||
94690383|NCT02761629|324323275|FG001|Overall Study|Lost to Follow-up|1|||
94690384|NCT02761629|324323274|FG000|Overall Study|Randomized But Not Treated|8|||
94690385|NCT02761629|324323275|FG001|Overall Study|Randomized But Not Treated|4|||
94690386|NCT01536145|324323282|FG000|Overall Study|Progressive disease|3|||
94690387|NCT01536145|324323283|FG001|Overall Study|Progressive disease|4|||
94690388|NCT01536145|324323284|FG002|Overall Study|Progressive disease|1|||
94690389|NCT01536145|324323285|FG003|Overall Study|Progressive disease|2|||
94690390|NCT01536145|324323286|FG004|Overall Study|Progressive disease|1|||
94690391|NCT01536145|324323287|FG005|Overall Study|Progressive disease|2|||
94690392|NCT01536145|324323288|FG006|Overall Study|Progressive disease|1|||
94690393|NCT01536145|324323289|FG007|Overall Study|Progressive disease|2|||
94465988|NCT00561470|323494968|FG000|Overall Study|Disease progression|437|||
94690394|NCT01536145|324323290|FG008|Overall Study|Progressive disease|1|||
94690395|NCT01536145|324323291|FG009|Overall Study|Progressive disease|3|||
94690396|NCT01536145|324323292|FG010|Overall Study|Progressive disease|3|||
94690397|NCT01536145|324323282|FG000|Overall Study|Withdrawal by Subject|0|||
94690398|NCT01536145|324323283|FG001|Overall Study|Withdrawal by Subject|0|||
94690399|NCT01536145|324323284|FG002|Overall Study|Withdrawal by Subject|1|||
94690400|NCT01536145|324323285|FG003|Overall Study|Withdrawal by Subject|0|||
94690401|NCT01536145|324323286|FG004|Overall Study|Withdrawal by Subject|0|||
94690402|NCT01536145|324323287|FG005|Overall Study|Withdrawal by Subject|1|||
94690403|NCT01536145|324323288|FG006|Overall Study|Withdrawal by Subject|0|||
94690404|NCT01536145|324323289|FG007|Overall Study|Withdrawal by Subject|0|||
94690405|NCT01536145|324323290|FG008|Overall Study|Withdrawal by Subject|2|||
94690406|NCT01536145|324323291|FG009|Overall Study|Withdrawal by Subject|0|||
94690407|NCT01536145|324323292|FG010|Overall Study|Withdrawal by Subject|2|||
94690408|NCT01536145|324323282|FG000|Overall Study|Other|0|||
94690409|NCT01536145|324323283|FG001|Overall Study|Other|0|||
94690410|NCT01536145|324323284|FG002|Overall Study|Other|0|||
94690411|NCT01536145|324323285|FG003|Overall Study|Other|0|||
94690412|NCT01536145|324323286|FG004|Overall Study|Other|1|||
94690413|NCT01536145|324323287|FG005|Overall Study|Other|0|||
94690414|NCT01536145|324323288|FG006|Overall Study|Other|0|||
94690415|NCT01536145|324323289|FG007|Overall Study|Other|0|||
94690416|NCT01536145|324323290|FG008|Overall Study|Other|0|||
94690417|NCT01536145|324323291|FG009|Overall Study|Other|3|||
94690418|NCT01536145|324323292|FG010|Overall Study|Other|2|||
94690419|NCT01536145|324323282|FG000|Overall Study|Death|0|||
94690420|NCT01536145|324323283|FG001|Overall Study|Death|0|||
94690421|NCT01536145|324323284|FG002|Overall Study|Death|0|||
94690422|NCT01536145|324323285|FG003|Overall Study|Death|0|||
94690423|NCT01536145|324323286|FG004|Overall Study|Death|0|||
94690424|NCT01536145|324323287|FG005|Overall Study|Death|0|||
94690425|NCT01536145|324323288|FG006|Overall Study|Death|1|||
94690426|NCT01536145|324323289|FG007|Overall Study|Death|0|||
94690427|NCT01536145|324323290|FG008|Overall Study|Death|0|||
94690428|NCT01536145|324323291|FG009|Overall Study|Death|0|||
94690429|NCT01536145|324323292|FG010|Overall Study|Death|0|||
94690430|NCT01536145|324323282|FG000|Overall Study|Adverse Event|0|||
94690431|NCT01536145|324323283|FG001|Overall Study|Adverse Event|0|||
94690432|NCT01536145|324323284|FG002|Overall Study|Adverse Event|0|||
94690433|NCT01536145|324323285|FG003|Overall Study|Adverse Event|0|||
94690434|NCT01536145|324323286|FG004|Overall Study|Adverse Event|0|||
94690435|NCT01536145|324323287|FG005|Overall Study|Adverse Event|0|||
94690436|NCT01536145|324323288|FG006|Overall Study|Adverse Event|0|||
94690437|NCT01536145|324323289|FG007|Overall Study|Adverse Event|2|||
94690438|NCT01536145|324323290|FG008|Overall Study|Adverse Event|0|||
94690439|NCT01536145|324323291|FG009|Overall Study|Adverse Event|0|||
94690440|NCT01536145|324323292|FG010|Overall Study|Adverse Event|3|||
94690441|NCT02001974|324323297|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
94690442|NCT02001974|324323298|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
94690443|NCT02001974|324323299|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
94690444|NCT02001974|324323297|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
94690445|NCT02001974|324323298|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
94690446|NCT02001974|324323299|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
94690447|NCT02001974|324323297|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
94690448|NCT02001974|324323298|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
94690449|NCT02001974|324323299|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
94690450|NCT02001974|324323297|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
94690451|NCT02001974|324323298|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
94690452|NCT02001974|324323299|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
94690453|NCT01313923|324323302|FG000|Overall Study|Physician Decision|3|||
94690454|NCT01990300|324323307|FG000|Overall Study|Case Report Forms Uncollected|89|||
94690455|NCT01990300|324323307|FG000|Overall Study|Protocol Deviation|53|||
94690456|NCT02065570|324323308|FG000|Induction Study|Adverse Event|5|||
94690457|NCT02065570|324323309|FG001|Induction Study|Adverse Event|12|||
94690458|NCT02065570|324323310|FG002|Induction Study|Adverse Event|0|||
94690459|NCT02065570|324323311|FG003|Induction Study|Adverse Event|0|||
94690460|NCT02065570|324323308|FG000|Induction Study|Withdrawal by Subject|2|||
94690461|NCT02065570|324323309|FG001|Induction Study|Withdrawal by Subject|3|||
94690462|NCT02065570|324323310|FG002|Induction Study|Withdrawal by Subject|0|||
94690463|NCT02065570|324323311|FG003|Induction Study|Withdrawal by Subject|0|||
94690464|NCT02065570|324323308|FG000|Induction Study|Lost to Follow-up|1|||
94690465|NCT02065570|324323309|FG001|Induction Study|Lost to Follow-up|1|||
94690466|NCT02065570|324323310|FG002|Induction Study|Lost to Follow-up|0|||
94690467|NCT02065570|324323311|FG003|Induction Study|Lost to Follow-up|0|||
94690468|NCT02065570|324323308|FG000|Induction Study|Other, Not Specified|6|||
94690469|NCT02065570|324323309|FG001|Induction Study|Other, Not Specified|5|||
94690470|NCT02065570|324323310|FG002|Induction Study|Other, Not Specified|0|||
94690471|NCT02065570|324323311|FG003|Induction Study|Other, Not Specified|0|||
94690472|NCT02065570|324323308|FG000|Maintenance Study|Adverse Event|0|||
94690473|NCT02065570|324323309|FG001|Maintenance Study|Adverse Event|0|||
94690474|NCT02065570|324323310|FG002|Maintenance Study|Adverse Event|8|||
94690475|NCT02065570|324323311|FG003|Maintenance Study|Adverse Event|8|||
94690476|NCT02065570|324323308|FG000|Maintenance Study|Withdrawal by Subject|0|||
94690477|NCT02065570|324323309|FG001|Maintenance Study|Withdrawal by Subject|0|||
94690478|NCT02065570|324323310|FG002|Maintenance Study|Withdrawal by Subject|1|||
94690479|NCT02065570|324323311|FG003|Maintenance Study|Withdrawal by Subject|4|||
94690480|NCT02065570|324323308|FG000|Maintenance Study|Lost to Follow-up|0|||
94690481|NCT02065570|324323309|FG001|Maintenance Study|Lost to Follow-up|0|||
94690482|NCT02065570|324323310|FG002|Maintenance Study|Lost to Follow-up|2|||
94690483|NCT02065570|324323311|FG003|Maintenance Study|Lost to Follow-up|2|||
94690484|NCT02065570|324323308|FG000|Maintenance Study|Other, Not Specified|0|||
94690485|NCT02065570|324323309|FG001|Maintenance Study|Other, Not Specified|0|||
94690486|NCT02065570|324323310|FG002|Maintenance Study|Other, Not Specified|11|||
94690487|NCT02065570|324323311|FG003|Maintenance Study|Other, Not Specified|5|||
94690488|NCT00287469|324323313|FG000|Overall Study|serious adverse event|1|||
94690489|NCT00287469|324323314|FG001|Overall Study|serious adverse event|6|||
94690490|NCT00287469|324323313|FG000|Overall Study|Adverse Event|1|||
94690491|NCT00287469|324323314|FG001|Overall Study|Adverse Event|1|||
94690492|NCT00287469|324323313|FG000|Overall Study|moved from area|144|||
94690493|NCT00287469|324323314|FG001|Overall Study|moved from area|138|||
94690494|NCT00287469|324323313|FG000|Overall Study|Lost to Follow-up|74|||
94690495|NCT00287469|324323314|FG001|Overall Study|Lost to Follow-up|69|||
94690496|NCT01266993|324323315|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
94690497|NCT01266993|324323316|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
94690498|NCT01266993|324323315|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
94690499|NCT01266993|324323316|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
94690500|NCT03285113|324323317|FG000|Overall Study|Unable to implant leads|2|||
94690501|NCT02213055|324323318|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
94690502|NCT02213055|324323319|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
94690503|NCT02213055|324323318|FG000|Overall Study|Protocol was not Followed during Study|1|||
94690504|NCT02213055|324323319|FG001|Overall Study|Protocol was not Followed during Study|0|||
94690505|NCT02213055|324323318|FG000|Overall Study|Documentation Issue at Enrollment|1|||
94690506|NCT02213055|324323319|FG001|Overall Study|Documentation Issue at Enrollment|0|||
94690507|NCT02213055|324323318|FG000|Overall Study|Documentation Issue during Study|10|||
94690508|NCT02213055|324323319|FG001|Overall Study|Documentation Issue during Study|0|||
94690509|NCT02213055|324323318|FG000|Overall Study|Did not have Live Lice|8|||
94690510|NCT02213055|324323319|FG001|Overall Study|Did not have Live Lice|0|||
94690511|NCT02213055|324323318|FG000|Overall Study|Had another Treatment during the Study|3|||
94690512|NCT02213055|324323319|FG001|Overall Study|Had another Treatment during the Study|0|||
94690513|NCT02213055|324323318|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
94690514|NCT02213055|324323319|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
94690515|NCT02213055|324323318|FG000|Overall Study|Did not Return to School|5|||
94690516|NCT02213055|324323319|FG001|Overall Study|Did not Return to School|0|||
94690517|NCT00231894|324323320|FG000|Overall Study|Withdrawal by Subject|1|||
94690518|NCT00231894|324323321|FG001|Overall Study|Withdrawal by Subject|1|||
94690519|NCT01767129|324323322|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
94690520|NCT01767129|324323323|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
94690521|NCT01932996|324323326|FG000|Overall Study|Protocol Violation|2|||
94690522|NCT01932996|324323327|FG001|Overall Study|Protocol Violation|0|||
94690523|NCT02500316|324323328|FG000|Overall Study|Adverse Event|3|||
94690524|NCT02500316|324323328|FG000|Overall Study|Lost to Follow-up|2|||
94690525|NCT02500316|324323328|FG000|Overall Study|Protocol Violation|1|||
94690526|NCT02500316|324323328|FG000|Overall Study|Withdrawal by Subject|15|||
94690527|NCT02500316|324323328|FG000|Overall Study|Final height achieved|5|||
94690528|NCT02500316|324323328|FG000|Overall Study|Due to war activity|1|||
94690529|NCT01848834|324323329|FG000|Overall Study|Adverse Event|3|||
94690530|NCT01848834|324323330|FG001|Overall Study|Adverse Event|11|||
94690531|NCT01848834|324323331|FG002|Overall Study|Adverse Event|3|||
94690532|NCT01848834|324323332|FG003|Overall Study|Adverse Event|5|||
94690533|NCT01848834|324323333|FG004|Overall Study|Adverse Event|9|||
94690534|NCT01848834|324323329|FG000|Overall Study|Death|2|||
94690535|NCT01848834|324323330|FG001|Overall Study|Death|11|||
94690536|NCT01848834|324323331|FG002|Overall Study|Death|1|||
94690537|NCT01848834|324323332|FG003|Overall Study|Death|8|||
94690538|NCT01848834|324323333|FG004|Overall Study|Death|27|||
94690539|NCT01848834|324323329|FG000|Overall Study|Excluded Medication|5|||
94690540|NCT01848834|324323330|FG001|Overall Study|Excluded Medication|4|||
94690541|NCT01848834|324323331|FG002|Overall Study|Excluded Medication|3|||
94690542|NCT01848834|324323332|FG003|Overall Study|Excluded Medication|6|||
94690543|NCT01848834|324323333|FG004|Overall Study|Excluded Medication|6|||
94690544|NCT01848834|324323329|FG000|Overall Study|Lost to Follow-up|5|||
94690545|NCT01848834|324323330|FG001|Overall Study|Lost to Follow-up|5|||
94690546|NCT01848834|324323331|FG002|Overall Study|Lost to Follow-up|3|||
94690547|NCT01848834|324323332|FG003|Overall Study|Lost to Follow-up|0|||
94690548|NCT01848834|324323333|FG004|Overall Study|Lost to Follow-up|3|||
94690549|NCT01848834|324323329|FG000|Overall Study|Physician Decision|1|||
94690550|NCT01848834|324323330|FG001|Overall Study|Physician Decision|3|||
94690551|NCT01848834|324323331|FG002|Overall Study|Physician Decision|4|||
94690552|NCT01848834|324323332|FG003|Overall Study|Physician Decision|0|||
94690553|NCT01848834|324323333|FG004|Overall Study|Physician Decision|11|||
94690554|NCT01848834|324323329|FG000|Overall Study|Protocol Violation|0|||
94690555|NCT01848834|324323330|FG001|Overall Study|Protocol Violation|0|||
94690556|NCT01848834|324323331|FG002|Overall Study|Protocol Violation|0|||
94690557|NCT01848834|324323332|FG003|Overall Study|Protocol Violation|0|||
94690558|NCT01848834|324323333|FG004|Overall Study|Protocol Violation|1|||
94690559|NCT01848834|324323329|FG000|Overall Study|Sponsor Decision|1|||
94690560|NCT01848834|324323330|FG001|Overall Study|Sponsor Decision|1|||
94690561|NCT01848834|324323331|FG002|Overall Study|Sponsor Decision|0|||
94690562|NCT01848834|324323332|FG003|Overall Study|Sponsor Decision|1|||
94690563|NCT01848834|324323333|FG004|Overall Study|Sponsor Decision|1|||
94690564|NCT01848834|324323329|FG000|Overall Study|Withdrawal by Subject|2|||
94690565|NCT01848834|324323330|FG001|Overall Study|Withdrawal by Subject|13|||
94690566|NCT01848834|324323331|FG002|Overall Study|Withdrawal by Subject|10|||
94690567|NCT01848834|324323332|FG003|Overall Study|Withdrawal by Subject|6|||
94690568|NCT01848834|324323333|FG004|Overall Study|Withdrawal by Subject|36|||
94690569|NCT02040090|324323334|FG000|Overall Study|Adverse Event|2|||
94690570|NCT02040090|324323335|FG001|Overall Study|Adverse Event|0|||
94264224|NCT03250832|322761873|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
94264225|NCT03250832|322761874|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
94264226|NCT03250832|322761875|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
94264227|NCT03250832|322761876|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
94264228|NCT03250832|322761877|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
94264229|NCT03250832|322761878|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
94264230|NCT03250832|322761879|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
94264231|NCT03250832|322761880|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
94264232|NCT03250832|322761881|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
94264233|NCT03250832|322761870|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
94264234|NCT03250832|322761871|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
94264235|NCT03250832|322761872|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
94264236|NCT03250832|322761873|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
94264237|NCT03250832|322761874|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
94264238|NCT03250832|322761875|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
94264239|NCT03250832|322761876|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
94264240|NCT03250832|322761877|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
94264241|NCT03250832|322761878|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
94264242|NCT03250832|322761879|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
94264243|NCT03250832|322761880|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
94264244|NCT03250832|322761881|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
94264245|NCT03250832|322761870|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
94690571|NCT02040090|324323334|FG000|Overall Study|Physician Decision|1|||
94690572|NCT02040090|324323335|FG001|Overall Study|Physician Decision|0|||
94690573|NCT02040090|324323334|FG000|Overall Study|Withdrawal by Subject|0|||
94690574|NCT02040090|324323335|FG001|Overall Study|Withdrawal by Subject|1|||
94690575|NCT02040090|324323334|FG000|Overall Study|Lost to Follow-up|0|||
94690576|NCT02040090|324323335|FG001|Overall Study|Lost to Follow-up|1|||
94690577|NCT03257995|324323336|FG000|Overall Study|Adverse Event|0|||
94690578|NCT03257995|324323337|FG001|Overall Study|Adverse Event|1|||
94690579|NCT03257995|324323338|FG002|Overall Study|Adverse Event|0|||
94690580|NCT03257995|324323339|FG003|Overall Study|Adverse Event|0|||
94690581|NCT03257995|324323340|FG004|Overall Study|Adverse Event|0|||
94690582|NCT03257995|324323341|FG005|Overall Study|Adverse Event|0|||
94690583|NCT03257995|324323336|FG000|Overall Study|Protocol deviation|0|||
94690584|NCT03257995|324323337|FG001|Overall Study|Protocol deviation|0|||
94690585|NCT03257995|324323338|FG002|Overall Study|Protocol deviation|0|||
94690586|NCT03257995|324323339|FG003|Overall Study|Protocol deviation|0|||
94690587|NCT03257995|324323340|FG004|Overall Study|Protocol deviation|0|||
94690588|NCT03257995|324323341|FG005|Overall Study|Protocol deviation|2|||
94690589|NCT01680458|324323342|FG000|Overall Study|Protocol Violation|3|||
94690590|NCT02550873|324323344|FG000|Randomized Double Blind|Adverse Event|3|||
94690591|NCT02550873|324323345|FG001|Randomized Double Blind|Adverse Event|1|||
94690592|NCT02550873|324323346|FG002|Randomized Double Blind|Adverse Event|0|||
94690593|NCT02550873|324323344|FG000|Randomized Double Blind|Disease progression|1|||
94690594|NCT02550873|324323345|FG001|Randomized Double Blind|Disease progression|1|||
94690595|NCT02550873|324323346|FG002|Randomized Double Blind|Disease progression|0|||
94690596|NCT02550873|324323344|FG000|Open Label Extension|Study ongoing|0|||
94690597|NCT02550873|324323345|FG001|Open Label Extension|Study ongoing|0|||
94690598|NCT02550873|324323346|FG002|Open Label Extension|Study ongoing|111|||
94690599|NCT00519636|324323357|FG000|Treatment Period 1|Adverse Event|1|||
94690600|NCT00519636|324323358|FG001|Treatment Period 1|Adverse Event|0|||
94690601|NCT00519636|324323359|FG002|Treatment Period 1|Adverse Event|1|||
94690602|NCT00519636|324323360|FG003|Treatment Period 1|Adverse Event|0|||
94690603|NCT00519636|324323357|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
94690604|NCT00519636|324323358|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
94690605|NCT00519636|324323359|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
94690606|NCT00519636|324323360|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
94690607|NCT00519636|324323357|FG000|Washout Period|Adverse Event|2|||
94690608|NCT00519636|324323358|FG001|Washout Period|Adverse Event|1|||
94690609|NCT00519636|324323359|FG002|Washout Period|Adverse Event|1|||
94690610|NCT00519636|324323360|FG003|Washout Period|Adverse Event|0|||
94690611|NCT00519636|324323357|FG000|Washout Period|Lost to Follow-up|1|||
94690612|NCT00519636|324323358|FG001|Washout Period|Lost to Follow-up|0|||
94690613|NCT00519636|324323359|FG002|Washout Period|Lost to Follow-up|0|||
94690614|NCT00519636|324323360|FG003|Washout Period|Lost to Follow-up|0|||
94690615|NCT00519636|324323357|FG000|Washout Period|Protocol Violation|0|||
94690616|NCT00519636|324323358|FG001|Washout Period|Protocol Violation|0|||
94690617|NCT00519636|324323359|FG002|Washout Period|Protocol Violation|1|||
94690618|NCT00519636|324323360|FG003|Washout Period|Protocol Violation|2|||
94690619|NCT00519636|324323357|FG000|Washout Period|Withdrawal by Subject|1|||
94690620|NCT00519636|324323358|FG001|Washout Period|Withdrawal by Subject|0|||
94690621|NCT00519636|324323359|FG002|Washout Period|Withdrawal by Subject|1|||
94690622|NCT00519636|324323360|FG003|Washout Period|Withdrawal by Subject|0|||
94690623|NCT00519636|324323357|FG000|Washout Period|Failed to meet continuation criteria|14|||
94690624|NCT00519636|324323358|FG001|Washout Period|Failed to meet continuation criteria|11|||
94690625|NCT00519636|324323359|FG002|Washout Period|Failed to meet continuation criteria|9|||
94690626|NCT00519636|324323360|FG003|Washout Period|Failed to meet continuation criteria|3|||
94690627|NCT00519636|324323357|FG000|Washout Period|Out of pollen area > 48 hours|1|||
94690628|NCT00519636|324323358|FG001|Washout Period|Out of pollen area > 48 hours|0|||
94690629|NCT00519636|324323359|FG002|Washout Period|Out of pollen area > 48 hours|0|||
94690630|NCT00519636|324323360|FG003|Washout Period|Out of pollen area > 48 hours|0|||
94690631|NCT00519636|324323357|FG000|Washout Period|Participating in study at another site|1|||
94690632|NCT00519636|324323358|FG001|Washout Period|Participating in study at another site|0|||
94690633|NCT00519636|324323359|FG002|Washout Period|Participating in study at another site|0|||
94690634|NCT00519636|324323360|FG003|Washout Period|Participating in study at another site|0|||
94690635|NCT00519636|324323357|FG000|Washout Period|Non-compliant|0|||
94690636|NCT00519636|324323358|FG001|Washout Period|Non-compliant|1|||
94690637|NCT00519636|324323359|FG002|Washout Period|Non-compliant|0|||
94690638|NCT00519636|324323360|FG003|Washout Period|Non-compliant|0|||
94690639|NCT00519636|324323357|FG000|Washout Period|Per doctors request|0|||
94690640|NCT00519636|324323358|FG001|Washout Period|Per doctors request|1|||
94690641|NCT00519636|324323359|FG002|Washout Period|Per doctors request|0|||
94690642|NCT00519636|324323360|FG003|Washout Period|Per doctors request|0|||
94690643|NCT00519636|324323357|FG000|Washout Period|Subject randomized in error|0|||
94264246|NCT03250832|322761871|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
94465989|NCT00561470|323494969|FG001|Overall Study|Disease progression|305|||
94465990|NCT00561470|323494968|FG000|Overall Study|poor compliance to protocol|4|||
94690644|NCT00519636|324323358|FG001|Washout Period|Subject randomized in error|0|||
94690645|NCT00519636|324323359|FG002|Washout Period|Subject randomized in error|1|||
94465991|NCT00561470|323494969|FG001|Overall Study|poor compliance to protocol|4|||
94690646|NCT00519636|324323360|FG003|Washout Period|Subject randomized in error|0|||
94690647|NCT00519636|324323357|FG000|Washout Period|Prohibited medications|0|||
94690648|NCT00519636|324323358|FG001|Washout Period|Prohibited medications|0|||
94690649|NCT00519636|324323359|FG002|Washout Period|Prohibited medications|1|||
94690650|NCT00519636|324323360|FG003|Washout Period|Prohibited medications|0|||
94690651|NCT00519636|324323357|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
94690652|NCT00519636|324323358|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
94690653|NCT00519636|324323359|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
94690654|NCT00519636|324323360|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
94690655|NCT00519636|324323357|FG000|Treatment Period 2|Subject randomized in error|0|||
94690656|NCT00519636|324323358|FG001|Treatment Period 2|Subject randomized in error|1|||
94690657|NCT00519636|324323359|FG002|Treatment Period 2|Subject randomized in error|0|||
94690658|NCT00519636|324323360|FG003|Treatment Period 2|Subject randomized in error|0|||
94690659|NCT00519636|324323357|FG000|Treatment Period 2|Per doctors request|0|||
94690660|NCT00519636|324323358|FG001|Treatment Period 2|Per doctors request|0|||
94690661|NCT00519636|324323359|FG002|Treatment Period 2|Per doctors request|1|||
94690662|NCT00519636|324323360|FG003|Treatment Period 2|Per doctors request|0|||
94690663|NCT00519636|324323357|FG000|Treatment Period 2|Subject misrandomized|0|||
94690664|NCT00519636|324323358|FG001|Treatment Period 2|Subject misrandomized|0|||
94690665|NCT00519636|324323359|FG002|Treatment Period 2|Subject misrandomized|0|||
94690666|NCT00519636|324323360|FG003|Treatment Period 2|Subject misrandomized|1|||
94690667|NCT00519636|324323357|FG000|Post Study Period|Subject randomized in error|0|||
94690668|NCT00519636|324323358|FG001|Post Study Period|Subject randomized in error|0|||
94690669|NCT00519636|324323359|FG002|Post Study Period|Subject randomized in error|0|||
94690670|NCT00519636|324323360|FG003|Post Study Period|Subject randomized in error|1|||
94690671|NCT04039503|324323363|FG000|Overall Study|Adverse Event|3|||
94690672|NCT04039503|324323364|FG001|Overall Study|Adverse Event|0|||
94690673|NCT04039503|324323365|FG002|Overall Study|Adverse Event|2|||
94690674|NCT04039503|324323366|FG003|Overall Study|Adverse Event|0|||
94690675|NCT04039503|324323363|FG000|Overall Study|Lost to Follow-up|0|||
94690676|NCT04039503|324323364|FG001|Overall Study|Lost to Follow-up|0|||
94690677|NCT04039503|324323365|FG002|Overall Study|Lost to Follow-up|1|||
94690678|NCT04039503|324323366|FG003|Overall Study|Lost to Follow-up|0|||
94690679|NCT04039503|324323363|FG000|Overall Study|Protocol Violation|0|||
94690680|NCT04039503|324323364|FG001|Overall Study|Protocol Violation|1|||
94690681|NCT04039503|324323365|FG002|Overall Study|Protocol Violation|2|||
94690682|NCT04039503|324323366|FG003|Overall Study|Protocol Violation|1|||
94690683|NCT04039503|324323363|FG000|Overall Study|Withdrawal by Subject|4|||
94690684|NCT04039503|324323364|FG001|Overall Study|Withdrawal by Subject|3|||
94690685|NCT04039503|324323365|FG002|Overall Study|Withdrawal by Subject|5|||
94690686|NCT04039503|324323366|FG003|Overall Study|Withdrawal by Subject|2|||
94690687|NCT01163747|324323367|FG000|Overall Study|Adverse Event|0|||
94690688|NCT01163747|324323368|FG001|Overall Study|Adverse Event|5|||
94690689|NCT01163747|324323367|FG000|Overall Study|Insufficient Therapeutic Response|0|||
94690690|NCT01163747|324323368|FG001|Overall Study|Insufficient Therapeutic Response|1|||
94690691|NCT01163747|324323367|FG000|Overall Study|Protocol Violation|0|||
94690692|NCT01163747|324323368|FG001|Overall Study|Protocol Violation|1|||
94365860|NCT01036594|323124797|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
94365861|NCT02866695|323124800|FG000|Overall Study|Adverse Event|1|||
94365862|NCT02866695|323124800|FG000|Overall Study|Lost to Follow-up|1|||
94365863|NCT05016765|323124801|FG000|Overall Study|Lost to Follow-up|4|||
94365864|NCT01612780|323124802|FG000|Overall Study|Treatment not completed|1|||
94365865|NCT01612780|323124802|FG000|Overall Study|Withdrawal by Subject|5|||
94365866|NCT03020966|323124803|FG000|Overall Study|Withdrawal by Subject|2|||
94690693|NCT01163747|324323367|FG000|Overall Study|Refused Treatment|6|||
94690694|NCT01163747|324323368|FG001|Overall Study|Refused Treatment|4|||
94690695|NCT00245011|324323369|FG000|Overall Study|Lack of Efficacy|1|||
94690696|NCT02684903|324323376|FG000|Overall Study|COVID-19 shutdown of lab|4|||
94690697|NCT02684903|324323377|FG001|Overall Study|COVID-19 shutdown of lab|6|||
94690698|NCT02684903|324323376|FG000|Overall Study|Lost to Follow-up|31|||
94690699|NCT02684903|324323377|FG001|Overall Study|Lost to Follow-up|41|||
94690700|NCT04880161|324323378|FG000|Overall Study|Withdrawal by Subject|1|||
94690701|NCT04880161|324323379|FG001|Overall Study|Withdrawal by Subject|0|||
94690702|NCT04880161|324323378|FG000|Overall Study|Lack of Compliance|1|||
94690703|NCT04880161|324323379|FG001|Overall Study|Lack of Compliance|1|||
94690704|NCT04880161|324323378|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
94690705|NCT04880161|324323379|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
94690706|NCT04880161|324323378|FG000|Overall Study|Screen Failure|0|||
94690707|NCT04880161|324323379|FG001|Overall Study|Screen Failure|1|||
94690708|NCT00386308|324325169|FG000|Overall Study|Adverse Event|3|||
94690709|NCT00386308|324325170|FG001|Overall Study|Adverse Event|3|||
94690710|NCT00386308|324325169|FG000|Overall Study|Protocol Violation|2|||
94690711|NCT00386308|324325170|FG001|Overall Study|Protocol Violation|5|||
94690712|NCT00386308|324325169|FG000|Overall Study|Lack of Efficacy|0|||
94690713|NCT00386308|324325170|FG001|Overall Study|Lack of Efficacy|2|||
94690714|NCT00386308|324325169|FG000|Overall Study|Lost to Follow-up|10|||
94690715|NCT00386308|324325170|FG001|Overall Study|Lost to Follow-up|6|||
94690716|NCT00386308|324325169|FG000|Overall Study|Withdrawal by Subject|6|||
94690717|NCT00386308|324325170|FG001|Overall Study|Withdrawal by Subject|2|||
94690718|NCT00386308|324325169|FG000|Overall Study|Other Event|8|||
94690719|NCT00386308|324325170|FG001|Overall Study|Other Event|1|||
94690720|NCT03095599|324325176|FG000|Overall Study|Withdrawal by Subject|1|||
94690721|NCT03095599|324325177|FG001|Overall Study|Withdrawal by Subject|0|||
94690722|NCT03095599|324325176|FG000|Overall Study|Lost to Follow-up|1|||
94690723|NCT03095599|324325177|FG001|Overall Study|Lost to Follow-up|0|||
94690724|NCT03095599|324325176|FG000|Overall Study|Withdrawal prior to vaccination|1|||
94690725|NCT03095599|324325177|FG001|Overall Study|Withdrawal prior to vaccination|0|||
94690726|NCT01189890|324325178|FG000|Overall Study|Adverse Event|3|||
94690727|NCT01189890|324325179|FG001|Overall Study|Adverse Event|4|||
94690728|NCT01189890|324325178|FG000|Overall Study|Lack of Efficacy|7|||
94690729|NCT01189890|324325179|FG001|Overall Study|Lack of Efficacy|2|||
94690730|NCT01189890|324325178|FG000|Overall Study|Lost to Follow-up|1|||
94690731|NCT01189890|324325179|FG001|Overall Study|Lost to Follow-up|7|||
94690732|NCT01189890|324325178|FG000|Overall Study|Protocol Violation|1|||
94690733|NCT01189890|324325179|FG001|Overall Study|Protocol Violation|5|||
94690734|NCT01189890|324325178|FG000|Overall Study|Withdrawal by Subject|15|||
94690735|NCT01189890|324325179|FG001|Overall Study|Withdrawal by Subject|11|||
94690736|NCT01189890|324325178|FG000|Overall Study|Non Compliance|0|||
94690737|NCT01189890|324325179|FG001|Overall Study|Non Compliance|1|||
94690738|NCT01189890|324325178|FG000|Overall Study|Physician Decision|5|||
94690739|NCT01189890|324325179|FG001|Overall Study|Physician Decision|4|||
94690740|NCT01189890|324325178|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
94690741|NCT01189890|324325179|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
94690742|NCT01995357|324325180|FG000|Period 5|Lack of Efficacy|1|||
94690743|NCT01995357|324325181|FG001|Period 5|Lack of Efficacy|0|||
94690744|NCT01995357|324325182|FG002|Period 5|Lack of Efficacy|0|||
94690745|NCT01995357|324325183|FG003|Period 5|Lack of Efficacy|0|||
94365867|NCT03020966|323124804|FG001|Overall Study|Withdrawal by Subject|0|||
94365868|NCT03664024|323124807|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
94690746|NCT01995357|324325184|FG004|Period 5|Lack of Efficacy|0|||
94690747|NCT01995357|324325185|FG005|Period 5|Lack of Efficacy|0|||
94365869|NCT03664024|323124807|FG000|Overall Study|Lost to Follow-up|2|||
94365870|NCT03664024|323124807|FG000|Overall Study|Withdrawal by Subject|2|||
94365871|NCT03664024|323124807|FG000|Overall Study|Death|80|||
94690748|NCT01995357|324325180|FG000|Period 5|Adverse Event|1|||
94690749|NCT01995357|324325181|FG001|Period 5|Adverse Event|0|||
94690750|NCT01995357|324325182|FG002|Period 5|Adverse Event|1|||
94690751|NCT01995357|324325183|FG003|Period 5|Adverse Event|0|||
94690752|NCT01995357|324325184|FG004|Period 5|Adverse Event|0|||
94690753|NCT01995357|324325185|FG005|Period 5|Adverse Event|0|||
94690754|NCT01383993|324325186|FG000|Overall Study|Adverse Event|1|||
94690755|NCT01383993|324325187|FG001|Overall Study|Adverse Event|1|||
94690756|NCT01383993|324325188|FG002|Overall Study|Adverse Event|0|||
94690757|NCT01383993|324325186|FG000|Overall Study|Withdrawal by Subject|0|||
94690758|NCT01383993|324325187|FG001|Overall Study|Withdrawal by Subject|0|||
94690759|NCT01383993|324325188|FG002|Overall Study|Withdrawal by Subject|1|||
94690760|NCT01383993|324325186|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
94690761|NCT01383993|324325187|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
94690762|NCT01383993|324325188|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
94690763|NCT01017120|324325193|FG000|Overall Study|Adverse Event|9|||
94690764|NCT01017120|324325194|FG001|Overall Study|Adverse Event|0|||
94690765|NCT01017120|324325193|FG000|Overall Study|Lost to Follow-up|13|||
94690766|NCT01017120|324325194|FG001|Overall Study|Lost to Follow-up|11|||
94690767|NCT01017120|324325193|FG000|Overall Study|Lack of Efficacy|1|||
94690768|NCT01017120|324325194|FG001|Overall Study|Lack of Efficacy|0|||
94690769|NCT01017120|324325193|FG000|Overall Study|Withdrawal by Subject|39|||
94690770|NCT01017120|324325194|FG001|Overall Study|Withdrawal by Subject|21|||
94690771|NCT01017120|324325193|FG000|Overall Study|Pregnancy|1|||
94690772|NCT01017120|324325194|FG001|Overall Study|Pregnancy|1|||
94690773|NCT01017120|324325193|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
94690774|NCT01017120|324325194|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
94690775|NCT01017120|324325193|FG000|Overall Study|Relocated Out of Town|0|||
94690776|NCT01017120|324325194|FG001|Overall Study|Relocated Out of Town|2|||
94690777|NCT01017120|324325193|FG000|Overall Study|Protocol Violation|1|||
94651437|NCT03603964|324181656|FG000|Overall Study|Study terminated by Sponsor|19|||
94690778|NCT01017120|324325194|FG001|Overall Study|Protocol Violation|0|||
94690779|NCT01017120|324325193|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
94690780|NCT01017120|324325194|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
94690781|NCT01702428|324325200|FG000|Overall Study|Adverse Event|2|||
94690782|NCT01702428|324325201|FG001|Overall Study|Adverse Event|0|||
94690783|NCT01702428|324325202|FG002|Overall Study|Adverse Event|0|||
94690784|NCT01702428|324325203|FG003|Overall Study|Adverse Event|0|||
94651438|NCT00226941|324181657|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
94651439|NCT00226941|324181658|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
94651440|NCT00226941|324181659|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
94651441|NCT00226941|324181660|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
94651442|NCT00226941|324181657|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
94651443|NCT00226941|324181658|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
94651444|NCT00226941|324181659|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
94651445|NCT00226941|324181660|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
94651446|NCT01034397|324181661|FG000|Overall Study|Lack of compliance|0|||
94651447|NCT01034397|324181662|FG001|Overall Study|Lack of compliance|1|||
94651448|NCT01034397|324181661|FG000|Overall Study|Lack of Efficacy|3|||
94651449|NCT01034397|324181662|FG001|Overall Study|Lack of Efficacy|0|||
94651450|NCT01034397|324181661|FG000|Overall Study|Adverse Event|4|||
94651451|NCT01034397|324181662|FG001|Overall Study|Adverse Event|0|||
94651452|NCT01034397|324181661|FG000|Overall Study|Other|0|||
94651453|NCT01034397|324181662|FG001|Overall Study|Other|1|||
94651454|NCT00812929|324181663|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
94651455|NCT00812929|324181664|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
94651456|NCT00812929|324181665|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
94651457|NCT00812929|324181666|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
94651458|NCT00812929|324181667|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
94651459|NCT00812929|324181668|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
94651460|NCT00812929|324181669|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
94651461|NCT00812929|324181670|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
94651462|NCT00812929|324181671|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
94651463|NCT00812929|324181672|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
94651464|NCT00812929|324181663|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
94651465|NCT00812929|324181664|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
94651466|NCT00812929|324181665|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
94651467|NCT00812929|324181666|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
94651468|NCT00812929|324181667|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
94651469|NCT00812929|324181668|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
94651470|NCT00812929|324181669|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
94651471|NCT00812929|324181670|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
94651472|NCT00812929|324181671|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
94651473|NCT00812929|324181672|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
94651474|NCT00812929|324181663|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
94690785|NCT01702428|324325200|FG000|Overall Study|Lost to Follow-up|33|||
94690786|NCT01702428|324325201|FG001|Overall Study|Lost to Follow-up|41|||
94651475|NCT00812929|324181664|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
94651476|NCT00812929|324181665|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
94651477|NCT00812929|324181666|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
94651478|NCT00812929|324181667|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
94690787|NCT01702428|324325202|FG002|Overall Study|Lost to Follow-up|37|||
94690788|NCT01702428|324325203|FG003|Overall Study|Lost to Follow-up|44|||
94690789|NCT01702428|324325200|FG000|Overall Study|Parents cannot assist to site|1|||
94690790|NCT01702428|324325201|FG001|Overall Study|Parents cannot assist to site|0|||
94690791|NCT01702428|324325202|FG002|Overall Study|Parents cannot assist to site|1|||
94690792|NCT01702428|324325203|FG003|Overall Study|Parents cannot assist to site|0|||
94690793|NCT01702428|324325200|FG000|Overall Study|Lost Coverage|0|||
94690794|NCT01702428|324325201|FG001|Overall Study|Lost Coverage|0|||
94690795|NCT01702428|324325202|FG002|Overall Study|Lost Coverage|0|||
94690796|NCT01702428|324325203|FG003|Overall Study|Lost Coverage|1|||
94690797|NCT01702428|324325200|FG000|Overall Study|Lost Health Plan|3|||
94690798|NCT01702428|324325201|FG001|Overall Study|Lost Health Plan|5|||
94690799|NCT01702428|324325202|FG002|Overall Study|Lost Health Plan|0|||
94690800|NCT01702428|324325203|FG003|Overall Study|Lost Health Plan|2|||
94690801|NCT01702428|324325200|FG000|Overall Study|Mother transferred care|0|||
94690802|NCT01702428|324325201|FG001|Overall Study|Mother transferred care|1|||
94690803|NCT01702428|324325202|FG002|Overall Study|Mother transferred care|0|||
94690804|NCT01702428|324325203|FG003|Overall Study|Mother transferred care|0|||
94690805|NCT01702428|324325200|FG000|Overall Study|Parents too busy|1|||
94690806|NCT01702428|324325201|FG001|Overall Study|Parents too busy|0|||
94690807|NCT01702428|324325202|FG002|Overall Study|Parents too busy|0|||
94690808|NCT01702428|324325203|FG003|Overall Study|Parents too busy|0|||
94690809|NCT01702428|324325200|FG000|Overall Study|Protocol Violation|3|||
94690810|NCT01702428|324325201|FG001|Overall Study|Protocol Violation|0|||
94690811|NCT01702428|324325202|FG002|Overall Study|Protocol Violation|1|||
94690812|NCT01702428|324325203|FG003|Overall Study|Protocol Violation|0|||
94690813|NCT01702428|324325200|FG000|Overall Study|Withdrawal by Subject|21|||
94690814|NCT01702428|324325201|FG001|Overall Study|Withdrawal by Subject|23|||
94690815|NCT01702428|324325202|FG002|Overall Study|Withdrawal by Subject|14|||
94690816|NCT01702428|324325203|FG003|Overall Study|Withdrawal by Subject|10|||
94690817|NCT01804673|324325206|FG000|Overall Study|Adverse Event|4|||
94690818|NCT01804673|324325206|FG000|Overall Study|Withdrawal by Subject|1|||
94690819|NCT01804673|324325206|FG000|Overall Study|Lack of Efficacy|9|||
94690820|NCT01804673|324325206|FG000|Overall Study|Change to Oral Therapy|37|||
94690821|NCT01804673|324325206|FG000|Overall Study|No Further Therapy Required|84|||
94690822|NCT01804673|324325206|FG000|Overall Study|Use of Prohibited Medication|1|||
94690823|NCT01804673|324325206|FG000|Overall Study|Other|4|||
94690824|NCT00839917|324325217|FG000|Overall Study|Lost to Follow-up|1|||
94690825|NCT00839917|324325218|FG001|Overall Study|Lost to Follow-up|0|||
94690826|NCT00839917|324325217|FG000|Overall Study|Did not receive vaccine|0|||
94690827|NCT00839917|324325218|FG001|Overall Study|Did not receive vaccine|1|||
94690828|NCT00867490|324325219|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
94690829|NCT00867490|324325219|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
94690830|NCT00867490|324325219|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
94690831|NCT00867490|324325219|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
94690832|NCT00867490|324325219|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
94690833|NCT01129336|324325220|FG000|Overall Study|Protocol Violation|1|||
94690834|NCT01129336|324325221|FG001|Overall Study|Protocol Violation|0|||
94690835|NCT01129336|324325220|FG000|Overall Study|Disease Progression|1|||
94690836|NCT01129336|324325221|FG001|Overall Study|Disease Progression|4|||
94690837|NCT01129336|324325220|FG000|Overall Study|Lost to Follow-up|1|||
94690838|NCT01129336|324325221|FG001|Overall Study|Lost to Follow-up|0|||
94690839|NCT01129336|324325220|FG000|Overall Study|Withdrawal by Subject|7|||
94690840|NCT01129336|324325221|FG001|Overall Study|Withdrawal by Subject|4|||
94690841|NCT01129336|324325220|FG000|Overall Study|Adverse Event|0|||
94690842|NCT01129336|324325221|FG001|Overall Study|Adverse Event|1|||
94690843|NCT01129336|324325220|FG000|Overall Study|Missing Study Completion Status|2|||
94690844|NCT01129336|324325221|FG001|Overall Study|Missing Study Completion Status|3|||
94690845|NCT01129336|324325220|FG000|Overall Study|Death|0|||
94690846|NCT01129336|324325221|FG001|Overall Study|Death|4|||
94690847|NCT01950273|324325222|FG000|Overall Study|Protocol Violation|1|||
94690848|NCT01950273|324325223|FG001|Overall Study|Protocol Violation|0|||
94690849|NCT01950273|324325222|FG000|Overall Study|Withdrawal by Subject|2|||
94690850|NCT01950273|324325223|FG001|Overall Study|Withdrawal by Subject|0|||
94690851|NCT01950273|324325222|FG000|Overall Study|Other not defined above|1|||
94690852|NCT01950273|324325223|FG001|Overall Study|Other not defined above|0|||
94690853|NCT00305864|324325248|FG000|Overall Study|Ineligible / No protocol treatment|0|||
94690854|NCT00305864|324325249|FG001|Overall Study|Ineligible / No protocol treatment|1|||
94465992|NCT00561470|323494968|FG000|Overall Study|Lost to Follow-up|2|||
94690855|NCT00305864|324325250|FG002|Overall Study|Ineligible / No protocol treatment|1|||
94690856|NCT00305864|324325251|FG003|Overall Study|Ineligible / No protocol treatment|13|||
94690857|NCT01734850|324325252|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
94690858|NCT01734850|324325253|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
94690859|NCT01734850|324325254|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
94690860|NCT01734850|324325252|FG000|Overall Study|Not infused due to manufacturing failure|0|||
94690861|NCT01734850|324325253|FG001|Overall Study|Not infused due to manufacturing failure|0|||
94690862|NCT01734850|324325254|FG002|Overall Study|Not infused due to manufacturing failure|1|||
94690863|NCT00750893|324325255|FG000|Overall Study|Adverse Event|5|||
94690864|NCT00750893|324325255|FG000|Overall Study|Withdrawal by Subject|10|||
94690865|NCT00750893|324325255|FG000|Overall Study|Lost to Follow-up|510|||
94690866|NCT00750893|324325255|FG000|Overall Study|Other|17|||
94690867|NCT02420327|324325262|FG000|Overall Study|Adverse Event|7|||
94690868|NCT02420327|324325262|FG000|Overall Study|Pregnancy|1|||
94690869|NCT02420327|324325262|FG000|Overall Study|Withdrawal by Subject|6|||
94690870|NCT02420327|324325262|FG000|Overall Study|Lost to Follow-up|1|||
94690871|NCT02420327|324325262|FG000|Overall Study|Protocol Violation|1|||
94690872|NCT02204293|324325263|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
94690873|NCT02204293|324325264|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
94690874|NCT02204293|324325265|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
94690875|NCT02204293|324325266|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
94690876|NCT02204293|324325267|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
94690877|NCT02204293|324325268|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
94690878|NCT02204293|324325263|FG000|Core Study Part I|Adverse Event|1|||
94690879|NCT02204293|324325264|FG001|Core Study Part I|Adverse Event|0|||
94690880|NCT02204293|324325265|FG002|Core Study Part I|Adverse Event|0|||
94690881|NCT02204293|324325266|FG003|Core Study Part I|Adverse Event|0|||
94690882|NCT02204293|324325267|FG004|Core Study Part I|Adverse Event|0|||
94690883|NCT02204293|324325268|FG005|Core Study Part I|Adverse Event|0|||
94690884|NCT02204293|324325263|FG000|Core Study Part I|Physician Decision|0|||
94690885|NCT02204293|324325264|FG001|Core Study Part I|Physician Decision|3|||
94690886|NCT02204293|324325265|FG002|Core Study Part I|Physician Decision|0|||
94690887|NCT02204293|324325266|FG003|Core Study Part I|Physician Decision|0|||
94690888|NCT02204293|324325267|FG004|Core Study Part I|Physician Decision|0|||
94690889|NCT02204293|324325268|FG005|Core Study Part I|Physician Decision|0|||
94690890|NCT02204293|324325263|FG000|LTE Phase|Study Suspended|0|||
94690891|NCT02204293|324325264|FG001|LTE Phase|Study Suspended|0|||
94690892|NCT02204293|324325265|FG002|LTE Phase|Study Suspended|0|||
94690893|NCT02204293|324325266|FG003|LTE Phase|Study Suspended|0|||
94690894|NCT02204293|324325267|FG004|LTE Phase|Study Suspended|0|||
94690895|NCT02204293|324325268|FG005|LTE Phase|Study Suspended|7|||
94690896|NCT00065468|324325271|FG000|Overall Study|Death|172|||
94690897|NCT00065468|324325272|FG001|Overall Study|Death|169|||
94690898|NCT00065468|324325273|FG002|Overall Study|Death|171|||
94690899|NCT00065468|324325271|FG000|Overall Study|Withdrawal by Subject|3|||
94690900|NCT00065468|324325272|FG001|Overall Study|Withdrawal by Subject|4|||
94690901|NCT00065468|324325273|FG002|Overall Study|Withdrawal by Subject|5|||
94690902|NCT00065468|324325271|FG000|Overall Study|Lost to Follow-up|5|||
94690903|NCT00065468|324325272|FG001|Overall Study|Lost to Follow-up|3|||
94690904|NCT00065468|324325273|FG002|Overall Study|Lost to Follow-up|2|||
94690905|NCT00065468|324325271|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
94690906|NCT00065468|324325272|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
94690907|NCT00065468|324325273|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
94690908|NCT00065468|324325271|FG000|Overall Study|Disease progression|0|||
94365872|NCT04736576|323124816|FG000|Overall Study|Progressive disease|3|||
94365873|NCT04736576|323124817|FG001|Overall Study|Progressive disease|1|||
94365874|NCT04736576|323124816|FG000|Overall Study|Death|1|||
94365875|NCT04736576|323124817|FG001|Overall Study|Death|0|||
94365876|NCT03747939|323124818|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
94365877|NCT03747939|323124819|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
94365878|NCT03747939|323124820|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
94365879|NCT03747939|323124821|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
94365880|NCT03747939|323124818|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
94365881|NCT03747939|323124819|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
94365882|NCT03747939|323124820|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
94365883|NCT03747939|323124821|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
94365884|NCT03747939|323124818|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
94365885|NCT03747939|323124819|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
94365886|NCT03747939|323124820|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
94690909|NCT00065468|324325272|FG001|Overall Study|Disease progression|0|||
94690910|NCT00065468|324325273|FG002|Overall Study|Disease progression|1|||
94365887|NCT03747939|323124821|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
94690911|NCT00065468|324325271|FG000|Overall Study|Other|14|||
94690912|NCT00065468|324325272|FG001|Overall Study|Other|24|||
94690913|NCT00065468|324325273|FG002|Overall Study|Other|18|||
94690914|NCT00661258|324325274|FG000|Overall Study|Death|1|||
94690915|NCT00661258|324325275|FG001|Overall Study|Death|0|||
94690916|NCT00661258|324325274|FG000|Overall Study|caught by police and in detox center|2|||
94690917|NCT00661258|324325275|FG001|Overall Study|caught by police and in detox center|1|||
94690918|NCT01225835|324325276|FG000|Overall Study|Completed protocol|2|||
94690919|NCT01225835|324325277|FG001|Overall Study|Completed protocol|1|||
94690920|NCT01225835|324325276|FG000|Overall Study|Did not meet hCG criterion|2|||
94365888|NCT03747939|323124818|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
94690921|NCT01225835|324325277|FG001|Overall Study|Did not meet hCG criterion|0|||
94690922|NCT01225835|324325276|FG000|Overall Study|Adverse Event|2|||
94465993|NCT00561470|323494969|FG001|Overall Study|Lost to Follow-up|0|||
94690923|NCT01225835|324325277|FG001|Overall Study|Adverse Event|1|||
94690924|NCT01225835|324325276|FG000|Overall Study|Other|1|||
94690925|NCT01225835|324325277|FG001|Overall Study|Other|1|||
94690926|NCT02019602|324325279|FG000|Screening Period|Ineligibility|4|||
94690927|NCT02019602|324325280|FG001|Screening Period|Ineligibility|0|||
94690928|NCT02019602|324325279|FG000|Screening Period|Adverse Event|1|||
94690929|NCT02019602|324325280|FG001|Screening Period|Adverse Event|0|||
94690930|NCT02372058|324325285|FG000|Overall Study|Withdrawal by Subject|3|||
94690931|NCT02788006|324325287|FG000|Overall Study|Patient not treated|1|||
94690932|NCT00598481|324325288|FG000|Treatment|Physician Decision|1|||
94690933|NCT01461993|324325289|FG000|Overall Study|Withdrawal by Subject|60|||
94690934|NCT01461993|324325290|FG001|Overall Study|Withdrawal by Subject|53|||
94690935|NCT01461993|324325291|FG002|Overall Study|Withdrawal by Subject|16|||
94690936|NCT01461993|324325289|FG000|Overall Study|Lost to Follow-up|44|||
94690937|NCT01461993|324325290|FG001|Overall Study|Lost to Follow-up|48|||
94690938|NCT01461993|324325291|FG002|Overall Study|Lost to Follow-up|22|||
94690939|NCT01461993|324325289|FG000|Overall Study|Protocol Violation|10|||
94690940|NCT01461993|324325290|FG001|Overall Study|Protocol Violation|9|||
94690941|NCT01461993|324325291|FG002|Overall Study|Protocol Violation|7|||
94690942|NCT01461993|324325289|FG000|Overall Study|Adverse Event|9|||
94690943|NCT01461993|324325290|FG001|Overall Study|Adverse Event|11|||
94690944|NCT01461993|324325291|FG002|Overall Study|Adverse Event|3|||
94690945|NCT01461993|324325289|FG000|Overall Study|No longer met eligibility criteria|13|||
94690946|NCT01461993|324325290|FG001|Overall Study|No longer met eligibility criteria|18|||
94690947|NCT01461993|324325291|FG002|Overall Study|No longer met eligibility criteria|10|||
94690948|NCT01461993|324325289|FG000|Overall Study|Did not meet entrance criteria|2|||
94690949|NCT01461993|324325290|FG001|Overall Study|Did not meet entrance criteria|3|||
94690950|NCT01461993|324325291|FG002|Overall Study|Did not meet entrance criteria|0|||
94690951|NCT01461993|324325289|FG000|Overall Study|Other|13|||
94690952|NCT01461993|324325290|FG001|Overall Study|Other|15|||
94690953|NCT01461993|324325291|FG002|Overall Study|Other|6|||
94690954|NCT01951092|324325292|FG000|Overall Study|Lost to Follow-up|10|||
94690955|NCT01951092|324325292|FG000|Overall Study|Incarceration|1|||
94690956|NCT01951092|324325292|FG000|Overall Study|Transfer of Care|1|||
94690957|NCT03688711|324325293|FG000|Overall Study|Withdrawal by Subject|0|||
94690958|NCT03688711|324325294|FG001|Overall Study|Withdrawal by Subject|1|||
94690959|NCT03018106|324325295|FG000|Overall Study|Lost to Follow-up|0|||
94690960|NCT03018106|324325296|FG001|Overall Study|Lost to Follow-up|1|||
94690961|NCT03055832|324325297|FG000|Week 2|Withdrawal by Subject|1|||
94690962|NCT03055832|324325298|FG001|Week 2|Withdrawal by Subject|0|||
94690963|NCT01152554|324325299|FG000|Overall Study|Withdrawal by Subject|73|||
94690964|NCT01152554|324325300|FG001|Overall Study|Withdrawal by Subject|28|||
94690965|NCT01152554|324325299|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
94690966|NCT01152554|324325300|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
94690967|NCT01152554|324325299|FG000|Overall Study|Adverse Event|67|||
94690968|NCT01152554|324325300|FG001|Overall Study|Adverse Event|14|||
94690969|NCT01152554|324325299|FG000|Overall Study|Severe non-compliance to protocol|36|||
94690970|NCT01152554|324325300|FG001|Overall Study|Severe non-compliance to protocol|14|||
94690971|NCT01152554|324325299|FG000|Overall Study|Condition under investigation worsened|5|||
94690972|NCT01152554|324325300|FG001|Overall Study|Condition under investigation worsened|2|||
94690973|NCT01152554|324325299|FG000|Overall Study|Lack of Efficacy|20|||
94690974|NCT01152554|324325300|FG001|Overall Study|Lack of Efficacy|3|||
94690975|NCT01152554|324325299|FG000|Overall Study|Study-specific withdrawal criteria|17|||
94690976|NCT01152554|324325300|FG001|Overall Study|Study-specific withdrawal criteria|8|||
94690977|NCT01152554|324325299|FG000|Overall Study|Lost to Follow-up|87|||
94690978|NCT01152554|324325300|FG001|Overall Study|Lost to Follow-up|32|||
94690979|NCT01152554|324325299|FG000|Overall Study|Other|28|||
94690980|NCT01152554|324325300|FG001|Overall Study|Other|8|||
94690981|NCT01152554|324325299|FG000|Overall Study|Death|1|||
94690982|NCT01152554|324325300|FG001|Overall Study|Death|1|||
94690983|NCT01818700|324325303|FG000|Overall Study|Adverse Event|67|||
94690984|NCT01818700|324325303|FG000|Overall Study|Lack of Efficacy|2|||
94690985|NCT01818700|324325303|FG000|Overall Study|Lost to Follow-up|5|||
94690986|NCT01818700|324325303|FG000|Overall Study|Withdrawal by Subject|27|||
94690987|NCT01818700|324325303|FG000|Overall Study|Protocol Violation|2|||
94690988|NCT01818700|324325303|FG000|Overall Study|Other|1|||
94690989|NCT02061761|324325304|FG000|Overall Study|Disease progression|2|||
94690990|NCT02061761|324325305|FG001|Overall Study|Disease progression|8|||
94690991|NCT02061761|324325306|FG002|Overall Study|Disease progression|4|||
94690992|NCT02061761|324325307|FG003|Overall Study|Disease progression|5|||
94690993|NCT02061761|324325308|FG004|Overall Study|Disease progression|9|||
94690994|NCT02061761|324325309|FG005|Overall Study|Disease progression|3|||
94690995|NCT02061761|324325310|FG006|Overall Study|Disease progression|1|||
94365889|NCT03747939|323124819|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
94365890|NCT03747939|323124820|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
94365891|NCT03747939|323124821|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
94690996|NCT02061761|324325311|FG007|Overall Study|Disease progression|2|||
94690997|NCT02061761|324325312|FG008|Overall Study|Disease progression|28|||
94690998|NCT02061761|324325304|FG000|Overall Study|Study Drug toxicity|0|||
94690999|NCT02061761|324325305|FG001|Overall Study|Study Drug toxicity|0|||
94691000|NCT02061761|324325306|FG002|Overall Study|Study Drug toxicity|0|||
94691001|NCT02061761|324325307|FG003|Overall Study|Study Drug toxicity|0|||
94691002|NCT02061761|324325308|FG004|Overall Study|Study Drug toxicity|0|||
94691003|NCT02061761|324325309|FG005|Overall Study|Study Drug toxicity|1|||
94691004|NCT02061761|324325310|FG006|Overall Study|Study Drug toxicity|0|||
94691005|NCT02061761|324325311|FG007|Overall Study|Study Drug toxicity|2|||
94691006|NCT02061761|324325312|FG008|Overall Study|Study Drug toxicity|6|||
94691007|NCT02061761|324325304|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
94691008|NCT02061761|324325305|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
94691009|NCT02061761|324325306|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
94691010|NCT02061761|324325307|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
94691011|NCT02061761|324325308|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
94691012|NCT02061761|324325309|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
94691013|NCT02061761|324325310|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
94691014|NCT02061761|324325311|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
94691015|NCT02061761|324325312|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
94691016|NCT02061761|324325304|FG000|Overall Study|Participant request to discontinue study treatment|0|||
94691017|NCT02061761|324325305|FG001|Overall Study|Participant request to discontinue study treatment|0|||
94691018|NCT02061761|324325306|FG002|Overall Study|Participant request to discontinue study treatment|2|||
94691019|NCT02061761|324325307|FG003|Overall Study|Participant request to discontinue study treatment|2|||
94691020|NCT02061761|324325308|FG004|Overall Study|Participant request to discontinue study treatment|0|||
94691021|NCT02061761|324325309|FG005|Overall Study|Participant request to discontinue study treatment|1|||
94691022|NCT02061761|324325310|FG006|Overall Study|Participant request to discontinue study treatment|0|||
94691023|NCT02061761|324325311|FG007|Overall Study|Participant request to discontinue study treatment|0|||
94691024|NCT02061761|324325312|FG008|Overall Study|Participant request to discontinue study treatment|2|||
94691025|NCT02061761|324325304|FG000|Overall Study|Withdrawal by Subject|0|||
94691026|NCT02061761|324325305|FG001|Overall Study|Withdrawal by Subject|0|||
94691027|NCT02061761|324325306|FG002|Overall Study|Withdrawal by Subject|0|||
94691028|NCT02061761|324325307|FG003|Overall Study|Withdrawal by Subject|0|||
94691029|NCT02061761|324325308|FG004|Overall Study|Withdrawal by Subject|0|||
94691030|NCT02061761|324325309|FG005|Overall Study|Withdrawal by Subject|0|||
94691031|NCT02061761|324325310|FG006|Overall Study|Withdrawal by Subject|0|||
94691032|NCT02061761|324325311|FG007|Overall Study|Withdrawal by Subject|0|||
94691033|NCT02061761|324325312|FG008|Overall Study|Withdrawal by Subject|2|||
94691034|NCT02061761|324325304|FG000|Overall Study|Maximum clinical benefit|0|||
94691035|NCT02061761|324325305|FG001|Overall Study|Maximum clinical benefit|0|||
94691036|NCT02061761|324325306|FG002|Overall Study|Maximum clinical benefit|0|||
94691037|NCT02061761|324325307|FG003|Overall Study|Maximum clinical benefit|1|||
94691038|NCT02061761|324325308|FG004|Overall Study|Maximum clinical benefit|0|||
94691039|NCT02061761|324325309|FG005|Overall Study|Maximum clinical benefit|0|||
94691040|NCT02061761|324325310|FG006|Overall Study|Maximum clinical benefit|0|||
94691041|NCT02061761|324325311|FG007|Overall Study|Maximum clinical benefit|0|||
94691042|NCT02061761|324325312|FG008|Overall Study|Maximum clinical benefit|6|||
94691043|NCT02061761|324325304|FG000|Overall Study|Participant no longer meets study criteria|0|||
94691044|NCT02061761|324325305|FG001|Overall Study|Participant no longer meets study criteria|0|||
94691045|NCT02061761|324325306|FG002|Overall Study|Participant no longer meets study criteria|0|||
94691046|NCT02061761|324325307|FG003|Overall Study|Participant no longer meets study criteria|0|||
94691047|NCT02061761|324325308|FG004|Overall Study|Participant no longer meets study criteria|0|||
94691048|NCT02061761|324325309|FG005|Overall Study|Participant no longer meets study criteria|0|||
94691049|NCT02061761|324325310|FG006|Overall Study|Participant no longer meets study criteria|0|||
94691050|NCT02061761|324325311|FG007|Overall Study|Participant no longer meets study criteria|0|||
94691051|NCT02061761|324325312|FG008|Overall Study|Participant no longer meets study criteria|1|||
94691052|NCT02061761|324325304|FG000|Overall Study|Other reasons|0|||
94691053|NCT02061761|324325305|FG001|Overall Study|Other reasons|0|||
94691054|NCT02061761|324325306|FG002|Overall Study|Other reasons|0|||
94691055|NCT02061761|324325307|FG003|Overall Study|Other reasons|0|||
94691056|NCT02061761|324325308|FG004|Overall Study|Other reasons|2|||
94691057|NCT02061761|324325309|FG005|Overall Study|Other reasons|0|||
94691058|NCT02061761|324325310|FG006|Overall Study|Other reasons|0|||
94691059|NCT02061761|324325311|FG007|Overall Study|Other reasons|0|||
94691060|NCT02061761|324325312|FG008|Overall Study|Other reasons|6|||
94691061|NCT02285595|324325321|FG000|Overall Study|Lost to Follow-up|14|||
94691062|NCT02285595|324325321|FG000|Overall Study|Withdrawal by Subject|1|||
94691063|NCT01987830|324325322|FG000|Overall Study|Never received baseline scan|1|||
94691064|NCT03990363|324325323|FG000|Overall Study|Withdrawal by Subject|10|||
94691065|NCT03990363|324325324|FG001|Overall Study|Withdrawal by Subject|9|||
94691066|NCT03990363|324325325|FG002|Overall Study|Withdrawal by Subject|18|||
94465994|NCT00561470|323494968|FG000|Overall Study|Physician Decision|21|||
94691067|NCT03990363|324325326|FG003|Overall Study|Withdrawal by Subject|11|||
94691068|NCT03990363|324325327|FG004|Overall Study|Withdrawal by Subject|9|||
94691069|NCT03990363|324325323|FG000|Overall Study|Physician Decision|1|||
94691070|NCT03990363|324325324|FG001|Overall Study|Physician Decision|0|||
94691071|NCT03990363|324325325|FG002|Overall Study|Physician Decision|0|||
94691072|NCT03990363|324325326|FG003|Overall Study|Physician Decision|0|||
94691073|NCT03990363|324325327|FG004|Overall Study|Physician Decision|0|||
94691074|NCT03990363|324325323|FG000|Overall Study|Adverse Event|1|||
94691075|NCT03990363|324325324|FG001|Overall Study|Adverse Event|3|||
94691076|NCT03990363|324325325|FG002|Overall Study|Adverse Event|2|||
94691077|NCT03990363|324325326|FG003|Overall Study|Adverse Event|2|||
94691078|NCT03990363|324325327|FG004|Overall Study|Adverse Event|0|||
94691079|NCT03990363|324325323|FG000|Overall Study|Death|14|||
94691080|NCT03990363|324325324|FG001|Overall Study|Death|8|||
94691081|NCT03990363|324325325|FG002|Overall Study|Death|14|||
94691082|NCT03990363|324325326|FG003|Overall Study|Death|10|||
94691083|NCT03990363|324325327|FG004|Overall Study|Death|11|||
94691084|NCT03990363|324325323|FG000|Overall Study|Failure to meet randomization criteria|0|||
94691085|NCT03990363|324325324|FG001|Overall Study|Failure to meet randomization criteria|1|||
94691086|NCT03990363|324325325|FG002|Overall Study|Failure to meet randomization criteria|1|||
94691087|NCT03990363|324325326|FG003|Overall Study|Failure to meet randomization criteria|0|||
94691088|NCT03990363|324325327|FG004|Overall Study|Failure to meet randomization criteria|0|||
94691089|NCT03990363|324325323|FG000|Overall Study|Lost to Follow-up|0|||
94691090|NCT03990363|324325324|FG001|Overall Study|Lost to Follow-up|0|||
94691091|NCT03990363|324325325|FG002|Overall Study|Lost to Follow-up|0|||
94691092|NCT03990363|324325326|FG003|Overall Study|Lost to Follow-up|1|||
94691093|NCT03990363|324325327|FG004|Overall Study|Lost to Follow-up|2|||
94691094|NCT03990363|324325323|FG000|Overall Study|Non-compliance with study drug|2|||
94691095|NCT03990363|324325324|FG001|Overall Study|Non-compliance with study drug|1|||
94691096|NCT03990363|324325325|FG002|Overall Study|Non-compliance with study drug|2|||
94691097|NCT03990363|324325326|FG003|Overall Study|Non-compliance with study drug|0|||
94691098|NCT03990363|324325327|FG004|Overall Study|Non-compliance with study drug|0|||
94691099|NCT03990363|324325323|FG000|Overall Study|Study terminated by sponsor|0|||
94691100|NCT03990363|324325324|FG001|Overall Study|Study terminated by sponsor|1|||
94691101|NCT03990363|324325325|FG002|Overall Study|Study terminated by sponsor|0|||
94691102|NCT03990363|324325326|FG003|Overall Study|Study terminated by sponsor|0|||
94691103|NCT03990363|324325327|FG004|Overall Study|Study terminated by sponsor|0|||
94691104|NCT03990363|324325323|FG000|Overall Study|Site terminated by sponsor|2|||
94691105|NCT03990363|324325324|FG001|Overall Study|Site terminated by sponsor|1|||
94691106|NCT03990363|324325325|FG002|Overall Study|Site terminated by sponsor|2|||
94691107|NCT03990363|324325326|FG003|Overall Study|Site terminated by sponsor|0|||
94691108|NCT03990363|324325327|FG004|Overall Study|Site terminated by sponsor|2|||
94691109|NCT03990363|324325323|FG000|Overall Study|Not categorized|5|||
94691110|NCT03990363|324325324|FG001|Overall Study|Not categorized|5|||
94691111|NCT03990363|324325325|FG002|Overall Study|Not categorized|3|||
94691112|NCT03990363|324325326|FG003|Overall Study|Not categorized|2|||
94691113|NCT03990363|324325327|FG004|Overall Study|Not categorized|2|||
94691114|NCT01349660|324325331|FG000|Overall Study|Still Receiving Study Treatment|0|||
94691115|NCT01349660|324325332|FG001|Overall Study|Still Receiving Study Treatment|0|||
94691116|NCT01349660|324325333|FG002|Overall Study|Still Receiving Study Treatment|1|||
94691117|NCT01349660|324325331|FG000|Overall Study|Disease Progression|2|||
94691118|NCT01349660|324325332|FG001|Overall Study|Disease Progression|4|||
94691119|NCT01349660|324325333|FG002|Overall Study|Disease Progression|50|||
94691120|NCT01349660|324325331|FG000|Overall Study|Adverse Event|1|||
94691121|NCT01349660|324325332|FG001|Overall Study|Adverse Event|1|||
94691122|NCT01349660|324325333|FG002|Overall Study|Adverse Event|12|||
94691123|NCT01349660|324325331|FG000|Overall Study|Withdrawal by Subject|2|||
94691124|NCT01349660|324325332|FG001|Overall Study|Withdrawal by Subject|0|||
94691125|NCT01349660|324325333|FG002|Overall Study|Withdrawal by Subject|9|||
94691126|NCT01349660|324325331|FG000|Overall Study|Death|1|||
94691127|NCT01349660|324325332|FG001|Overall Study|Death|1|||
94691128|NCT01349660|324325333|FG002|Overall Study|Death|0|||
94691129|NCT01349660|324325331|FG000|Overall Study|Non-Permitted Interventions|0|||
94691130|NCT01349660|324325332|FG001|Overall Study|Non-Permitted Interventions|0|||
94691131|NCT01349660|324325333|FG002|Overall Study|Non-Permitted Interventions|2|||
94691132|NCT01349660|324325331|FG000|Overall Study|Study Compliance|0|||
94691133|NCT01349660|324325332|FG001|Overall Study|Study Compliance|0|||
94691134|NCT01349660|324325333|FG002|Overall Study|Study Compliance|1|||
94691135|NCT01349660|324325331|FG000|Overall Study|Declining Performance Status|0|||
94691136|NCT01349660|324325332|FG001|Overall Study|Declining Performance Status|0|||
94691137|NCT01349660|324325333|FG002|Overall Study|Declining Performance Status|1|||
94691138|NCT05764239|324325335|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
94691139|NCT05764239|324325335|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
94691140|NCT05764239|324325335|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
94691141|NCT05764239|324325335|FG000|DEP (Part 1)|Adverse Event|1|||
94691142|NCT05764239|324325335|FG000|DEP (Part 1)|Lost to Follow-up|1|||
94691143|NCT05764239|324325335|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
94691144|NCT05764239|324325335|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
94691145|NCT05764239|324325335|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
94691146|NCT05764239|324325335|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
94691147|NCT00057811|324325336|FG000|Overall Study|Lack of Efficacy|1|||
94691148|NCT00057811|324325337|FG001|Overall Study|Lack of Efficacy|4|||
94691149|NCT00057811|324325336|FG000|Overall Study|Physician Decision|1|||
94691150|NCT00057811|324325337|FG001|Overall Study|Physician Decision|0|||
94691151|NCT00057811|324325336|FG000|Overall Study|Withdrawal by Subject|3|||
94691152|NCT00057811|324325337|FG001|Overall Study|Withdrawal by Subject|4|||
94691153|NCT00057811|324325336|FG000|Overall Study|Ineligible|4|||
94465995|NCT00561470|323494969|FG001|Overall Study|Physician Decision|20|||
94465996|NCT00561470|323494968|FG000|Overall Study|Consent Withdrawn|2|||
94465997|NCT00561470|323494969|FG001|Overall Study|Consent Withdrawn|6|||
94465998|NCT00561470|323494968|FG000|Overall Study|Subject request|43|||
94465999|NCT00561470|323494969|FG001|Overall Study|Subject request|77|||
94466000|NCT00561470|323494968|FG000|Overall Study|Metastatic surgery|10|||
94466001|NCT00561470|323494969|FG001|Overall Study|Metastatic surgery|12|||
94466002|NCT00561470|323494968|FG000|Overall Study|Unauthorized procedure|3|||
94466003|NCT00561470|323494969|FG001|Overall Study|Unauthorized procedure|1|||
94466004|NCT00561470|323494968|FG000|Overall Study|Randomized but not treated|5|||
94466005|NCT00561470|323494969|FG001|Overall Study|Randomized but not treated|5|||
94466006|NCT00561470|323494968|FG000|Overall Study|Missed visit window|1|||
94466007|NCT00561470|323494969|FG001|Overall Study|Missed visit window|4|||
94466008|NCT00561470|323494968|FG000|Overall Study|Planning surgery|1|||
94466009|NCT00561470|323494969|FG001|Overall Study|Planning surgery|1|||
94466010|NCT00561470|323494968|FG000|Overall Study|Ongoing Treatment|11|||
94691154|NCT00057811|324325337|FG001|Overall Study|Ineligible|2|||
94691155|NCT00057811|324325336|FG000|Overall Study|Inevaluable|1|||
94691156|NCT00057811|324325337|FG001|Overall Study|Inevaluable|2|||
94691157|NCT02353832|324325338|FG000|Overall Study|Ineligible after enrollment|1|||
94691158|NCT02353832|324325338|FG000|Overall Study|Lost to Follow-up|1|||
94691159|NCT00904150|324325339|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
94691160|NCT00904150|324325340|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
94691161|NCT00904150|324325339|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
94691162|NCT00904150|324325340|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
94691163|NCT01354106|324325341|FG000|Overall Study|Withdrawal by Subject|2|||
94691164|NCT00445601|324327084|FG000|Overall Study|Withdrawal by Subject|11|||
94691165|NCT00445601|324327085|FG001|Overall Study|Withdrawal by Subject|11|||
94691166|NCT00445601|324327084|FG000|Overall Study|TURBT Complication|12|||
94691167|NCT00445601|324327085|FG001|Overall Study|TURBT Complication|8|||
94691168|NCT00445601|324327084|FG000|Overall Study|Incorrect Disease Status|6|||
94691169|NCT00445601|324327085|FG001|Overall Study|Incorrect Disease Status|6|||
94691170|NCT00445601|324327084|FG000|Overall Study|Drug Delivery Issue|2|||
94691171|NCT00445601|324327085|FG001|Overall Study|Drug Delivery Issue|2|||
94691172|NCT00445601|324327084|FG000|Overall Study|Adverse Event|2|||
94691173|NCT00445601|324327085|FG001|Overall Study|Adverse Event|0|||
94691174|NCT00445601|324327084|FG000|Overall Study|Death prior to TURBT|0|||
94691175|NCT00445601|324327085|FG001|Overall Study|Death prior to TURBT|1|||
94691176|NCT02391038|324327089|FG000|Overall Study|Progressive disease|3|||
94691177|NCT02391038|324327090|FG001|Overall Study|Progressive disease|3|||
94691178|NCT02391038|324327091|FG002|Overall Study|Progressive disease|6|||
94691179|NCT02959138|324327092|FG000|Overall Study|Enrolled but Never Treated|0|||
94691180|NCT02959138|324327093|FG001|Overall Study|Enrolled but Never Treated|1|||
94691181|NCT02959138|324327094|FG002|Overall Study|Enrolled but Never Treated|0|||
94691182|NCT01811563|324327095|FG000|Overall Study|Lost to Follow-up|5|||
94691183|NCT01811563|324327096|FG001|Overall Study|Lost to Follow-up|2|||
94466011|NCT00561470|323494969|FG001|Overall Study|Ongoing Treatment|14|||
94466012|NCT05079230|323494972|FG000|Overall Study|Study Terminated by Sponsor|101|||
94466013|NCT05079230|323494973|FG001|Overall Study|Study Terminated by Sponsor|102|||
94466014|NCT05079230|323494972|FG000|Overall Study|Death|72|||
94466015|NCT05079230|323494973|FG001|Overall Study|Death|66|||
94466016|NCT05079230|323494972|FG000|Overall Study|Withdrew Consent|16|||
94466017|NCT05079230|323494973|FG001|Overall Study|Withdrew Consent|18|||
94466018|NCT05079230|323494972|FG000|Overall Study|Lost to Follow-up|0|||
94466019|NCT05079230|323494973|FG001|Overall Study|Lost to Follow-up|3|||
94466020|NCT02054910|323494975|FG000|Overall Study|Lost to Follow-up|4|||
94691184|NCT01811563|324327095|FG000|Overall Study|Incorrect Randomization procedure|0|||
94466021|NCT02054910|323494976|FG001|Overall Study|Lost to Follow-up|1|||
94466022|NCT03723070|323494977|FG000|Overall Study|Lost to Follow-up|2|||
94466023|NCT03723070|323494977|FG000|Overall Study|Physician Decision|1|||
94466024|NCT03723070|323494977|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
94466025|NCT00477607|323494978|FG000|Overall Study|Lost to Follow-up|7|||
94466026|NCT00477607|323494979|FG001|Overall Study|Lost to Follow-up|7|||
94466027|NCT04102865|323494982|FG000|Overall Study|Adverse Event|4|||
94691185|NCT01811563|324327096|FG001|Overall Study|Incorrect Randomization procedure|1|||
94691186|NCT01807221|324327099|FG000|Overall Study|Progressive disease|1|||
94691187|NCT01807221|324327100|FG001|Overall Study|Progressive disease|0|||
94466028|NCT04102865|323494983|FG001|Overall Study|Adverse Event|0|||
94691188|NCT01807221|324327101|FG002|Overall Study|Progressive disease|1|||
94691189|NCT01807221|324327102|FG003|Overall Study|Progressive disease|0|||
94691190|NCT01807221|324327103|FG004|Overall Study|Progressive disease|0|||
94691191|NCT01807221|324327104|FG005|Overall Study|Progressive disease|0|||
94691192|NCT01807221|324327099|FG000|Overall Study|Death|7|||
94691193|NCT01807221|324327100|FG001|Overall Study|Death|9|||
94691194|NCT01807221|324327101|FG002|Overall Study|Death|4|||
94691195|NCT01807221|324327102|FG003|Overall Study|Death|2|||
94691196|NCT01807221|324327103|FG004|Overall Study|Death|1|||
94691197|NCT01807221|324327104|FG005|Overall Study|Death|6|||
94691198|NCT01807221|324327099|FG000|Overall Study|Physician Decision|2|||
94691199|NCT01807221|324327100|FG001|Overall Study|Physician Decision|1|||
94691200|NCT01807221|324327101|FG002|Overall Study|Physician Decision|0|||
94691201|NCT01807221|324327102|FG003|Overall Study|Physician Decision|0|||
94691202|NCT01807221|324327103|FG004|Overall Study|Physician Decision|0|||
94691203|NCT01807221|324327104|FG005|Overall Study|Physician Decision|0|||
94691204|NCT01807221|324327099|FG000|Overall Study|Adverse Event|33|||
94691205|NCT01807221|324327100|FG001|Overall Study|Adverse Event|22|||
94691206|NCT01807221|324327101|FG002|Overall Study|Adverse Event|26|||
94691207|NCT01807221|324327102|FG003|Overall Study|Adverse Event|25|||
94691208|NCT01807221|324327103|FG004|Overall Study|Adverse Event|18|||
94691209|NCT01807221|324327104|FG005|Overall Study|Adverse Event|21|||
94691210|NCT01807221|324327099|FG000|Overall Study|Protocol Violation|0|||
94691211|NCT01807221|324327100|FG001|Overall Study|Protocol Violation|2|||
94691212|NCT01807221|324327101|FG002|Overall Study|Protocol Violation|1|||
94691213|NCT01807221|324327102|FG003|Overall Study|Protocol Violation|2|||
94691214|NCT01807221|324327103|FG004|Overall Study|Protocol Violation|0|||
94691215|NCT01807221|324327104|FG005|Overall Study|Protocol Violation|1|||
94691216|NCT01807221|324327099|FG000|Overall Study|Non-compliance|1|||
94691217|NCT01807221|324327100|FG001|Overall Study|Non-compliance|2|||
94691218|NCT01807221|324327101|FG002|Overall Study|Non-compliance|0|||
94691219|NCT01807221|324327102|FG003|Overall Study|Non-compliance|1|||
94691220|NCT01807221|324327103|FG004|Overall Study|Non-compliance|0|||
94691221|NCT01807221|324327104|FG005|Overall Study|Non-compliance|0|||
94691222|NCT01807221|324327099|FG000|Overall Study|Logistical difficulties|0|||
94691223|NCT01807221|324327100|FG001|Overall Study|Logistical difficulties|1|||
94691224|NCT01807221|324327101|FG002|Overall Study|Logistical difficulties|0|||
94691225|NCT01807221|324327102|FG003|Overall Study|Logistical difficulties|0|||
94691226|NCT01807221|324327103|FG004|Overall Study|Logistical difficulties|1|||
94691227|NCT01807221|324327104|FG005|Overall Study|Logistical difficulties|0|||
94691228|NCT01807221|324327099|FG000|Overall Study|Withdrawal by Subject|33|||
94691229|NCT01807221|324327100|FG001|Overall Study|Withdrawal by Subject|15|||
94691230|NCT01807221|324327101|FG002|Overall Study|Withdrawal by Subject|8|||
94691231|NCT01807221|324327102|FG003|Overall Study|Withdrawal by Subject|14|||
94691232|NCT01807221|324327103|FG004|Overall Study|Withdrawal by Subject|16|||
94691233|NCT01807221|324327104|FG005|Overall Study|Withdrawal by Subject|13|||
94691234|NCT01807221|324327099|FG000|Overall Study|Sponsor decision|2|||
94691235|NCT01807221|324327100|FG001|Overall Study|Sponsor decision|0|||
94691236|NCT01807221|324327101|FG002|Overall Study|Sponsor decision|1|||
94691237|NCT01807221|324327102|FG003|Overall Study|Sponsor decision|1|||
94691238|NCT01807221|324327103|FG004|Overall Study|Sponsor decision|0|||
94691239|NCT01807221|324327104|FG005|Overall Study|Sponsor decision|0|||
94691240|NCT01807221|324327099|FG000|Overall Study|Lost to Follow-up|1|||
94691241|NCT01807221|324327100|FG001|Overall Study|Lost to Follow-up|0|||
94691242|NCT01807221|324327101|FG002|Overall Study|Lost to Follow-up|2|||
94691243|NCT01807221|324327102|FG003|Overall Study|Lost to Follow-up|1|||
94691244|NCT01807221|324327103|FG004|Overall Study|Lost to Follow-up|0|||
94691245|NCT01807221|324327104|FG005|Overall Study|Lost to Follow-up|0|||
94691246|NCT01155388|324327105|FG000|Overall Study|Adverse Event|1|||
94691247|NCT01155388|324327106|FG001|Overall Study|Adverse Event|0|||
94691248|NCT01004250|324327107|FG000|Induction Therapy Period|Adverse Event|10|||
94691249|NCT01004250|324327107|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
94691250|NCT01004250|324327107|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
94691251|NCT01004250|324327107|FG000|Induction Therapy Period|Physician Decision|2|||
94691252|NCT01004250|324327107|FG000|Maintenance Therapy Period|Adverse Event|15|||
94691253|NCT01004250|324327107|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
94691254|NCT01004250|324327107|FG000|Maintenance Therapy Period|Protocol Violation|1|||
94691255|NCT01004250|324327107|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
94691256|NCT01004250|324327107|FG000|Maintenance Therapy Period|Physician Decision|4|||
94691257|NCT01004250|324327107|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
94691258|NCT02291289|324327108|FG000|Induction Treatment|Withdrawal by Subject|0|||
94691259|NCT02291289|324327109|FG001|Induction Treatment|Withdrawal by Subject|0|||
94691260|NCT02291289|324327110|FG002|Induction Treatment|Withdrawal by Subject|0|||
94691261|NCT02291289|324327111|FG003|Induction Treatment|Withdrawal by Subject|24|||
94691262|NCT02291289|324327112|FG004|Induction Treatment|Withdrawal by Subject|0|||
94691263|NCT02291289|324327113|FG005|Induction Treatment|Withdrawal by Subject|0|||
94691264|NCT02291289|324327114|FG006|Induction Treatment|Withdrawal by Subject|0|||
94691265|NCT02291289|324327115|FG007|Induction Treatment|Withdrawal by Subject|0|||
94691266|NCT02291289|324327116|FG008|Induction Treatment|Withdrawal by Subject|0|||
94691267|NCT02291289|324327117|FG009|Induction Treatment|Withdrawal by Subject|18|||
94466029|NCT04102865|323494982|FG000|Overall Study|Lost to Follow-up|1|||
94466030|NCT04102865|323494983|FG001|Overall Study|Lost to Follow-up|0|||
94466031|NCT04102865|323494982|FG000|Overall Study|Withdrawal by Subject|2|||
94466032|NCT04102865|323494983|FG001|Overall Study|Withdrawal by Subject|0|||
94365892|NCT03747939|323124818|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
94691268|NCT02291289|324327118|FG010|Induction Treatment|Withdrawal by Subject|0|||
94691269|NCT02291289|324327119|FG011|Induction Treatment|Withdrawal by Subject|0|||
94691270|NCT02291289|324327120|FG012|Induction Treatment|Withdrawal by Subject|0|||
94691271|NCT02291289|324327108|FG000|Induction Treatment|Adverse Event|0|||
94691272|NCT02291289|324327109|FG001|Induction Treatment|Adverse Event|0|||
94691273|NCT02291289|324327110|FG002|Induction Treatment|Adverse Event|0|||
94691274|NCT02291289|324327111|FG003|Induction Treatment|Adverse Event|3|||
94691275|NCT02291289|324327112|FG004|Induction Treatment|Adverse Event|0|||
94691276|NCT02291289|324327113|FG005|Induction Treatment|Adverse Event|0|||
94691277|NCT02291289|324327114|FG006|Induction Treatment|Adverse Event|0|||
94691278|NCT02291289|324327115|FG007|Induction Treatment|Adverse Event|0|||
94691279|NCT02291289|324327116|FG008|Induction Treatment|Adverse Event|0|||
94691280|NCT02291289|324327117|FG009|Induction Treatment|Adverse Event|1|||
94691281|NCT02291289|324327118|FG010|Induction Treatment|Adverse Event|0|||
94691282|NCT02291289|324327119|FG011|Induction Treatment|Adverse Event|0|||
94691283|NCT02291289|324327120|FG012|Induction Treatment|Adverse Event|0|||
94691284|NCT02291289|324327108|FG000|Induction Treatment|Death|25|||
94691285|NCT02291289|324327109|FG001|Induction Treatment|Death|0|||
94691286|NCT02291289|324327110|FG002|Induction Treatment|Death|0|||
94691287|NCT02291289|324327111|FG003|Induction Treatment|Death|111|||
94691288|NCT02291289|324327112|FG004|Induction Treatment|Death|0|||
94691289|NCT02291289|324327113|FG005|Induction Treatment|Death|0|||
94691290|NCT02291289|324327114|FG006|Induction Treatment|Death|1|||
94691291|NCT02291289|324327115|FG007|Induction Treatment|Death|0|||
94691292|NCT02291289|324327116|FG008|Induction Treatment|Death|0|||
94691293|NCT02291289|324327117|FG009|Induction Treatment|Death|82|||
94691294|NCT02291289|324327118|FG010|Induction Treatment|Death|0|||
94691295|NCT02291289|324327119|FG011|Induction Treatment|Death|0|||
94691296|NCT02291289|324327120|FG012|Induction Treatment|Death|0|||
94691297|NCT02291289|324327108|FG000|Induction Treatment|Lost to Follow-up|1|||
94691298|NCT02291289|324327109|FG001|Induction Treatment|Lost to Follow-up|0|||
94691299|NCT02291289|324327110|FG002|Induction Treatment|Lost to Follow-up|0|||
94691300|NCT02291289|324327111|FG003|Induction Treatment|Lost to Follow-up|12|||
94691301|NCT02291289|324327112|FG004|Induction Treatment|Lost to Follow-up|0|||
94691302|NCT02291289|324327113|FG005|Induction Treatment|Lost to Follow-up|0|||
94691303|NCT02291289|324327114|FG006|Induction Treatment|Lost to Follow-up|0|||
94691304|NCT02291289|324327115|FG007|Induction Treatment|Lost to Follow-up|0|||
94691305|NCT02291289|324327116|FG008|Induction Treatment|Lost to Follow-up|0|||
94691306|NCT02291289|324327117|FG009|Induction Treatment|Lost to Follow-up|9|||
94691307|NCT02291289|324327118|FG010|Induction Treatment|Lost to Follow-up|0|||
94691308|NCT02291289|324327119|FG011|Induction Treatment|Lost to Follow-up|0|||
94691309|NCT02291289|324327120|FG012|Induction Treatment|Lost to Follow-up|0|||
94691310|NCT02291289|324327108|FG000|Induction Treatment|Non-Compliance|0|||
94691311|NCT02291289|324327109|FG001|Induction Treatment|Non-Compliance|0|||
94691312|NCT02291289|324327110|FG002|Induction Treatment|Non-Compliance|0|||
94691313|NCT02291289|324327111|FG003|Induction Treatment|Non-Compliance|1|||
94691314|NCT02291289|324327112|FG004|Induction Treatment|Non-Compliance|0|||
94691315|NCT02291289|324327113|FG005|Induction Treatment|Non-Compliance|0|||
94691316|NCT02291289|324327114|FG006|Induction Treatment|Non-Compliance|0|||
94691317|NCT02291289|324327115|FG007|Induction Treatment|Non-Compliance|0|||
94691318|NCT02291289|324327116|FG008|Induction Treatment|Non-Compliance|0|||
94691319|NCT02291289|324327117|FG009|Induction Treatment|Non-Compliance|1|||
94691320|NCT02291289|324327118|FG010|Induction Treatment|Non-Compliance|0|||
94691321|NCT02291289|324327119|FG011|Induction Treatment|Non-Compliance|0|||
94691322|NCT02291289|324327120|FG012|Induction Treatment|Non-Compliance|0|||
94691323|NCT02291289|324327108|FG000|Induction Treatment|Reason Not Specified|0|||
94691324|NCT02291289|324327109|FG001|Induction Treatment|Reason Not Specified|0|||
94691325|NCT02291289|324327110|FG002|Induction Treatment|Reason Not Specified|0|||
94691326|NCT02291289|324327111|FG003|Induction Treatment|Reason Not Specified|4|||
94691327|NCT02291289|324327112|FG004|Induction Treatment|Reason Not Specified|0|||
94691328|NCT02291289|324327113|FG005|Induction Treatment|Reason Not Specified|0|||
94691329|NCT02291289|324327114|FG006|Induction Treatment|Reason Not Specified|0|||
94691330|NCT02291289|324327115|FG007|Induction Treatment|Reason Not Specified|0|||
94691331|NCT02291289|324327116|FG008|Induction Treatment|Reason Not Specified|0|||
94691332|NCT02291289|324327117|FG009|Induction Treatment|Reason Not Specified|7|||
94691333|NCT02291289|324327118|FG010|Induction Treatment|Reason Not Specified|0|||
94691334|NCT02291289|324327119|FG011|Induction Treatment|Reason Not Specified|0|||
94691335|NCT02291289|324327120|FG012|Induction Treatment|Reason Not Specified|0|||
94691336|NCT02291289|324327108|FG000|Induction Treatment|Physician Decision|0|||
94691337|NCT02291289|324327109|FG001|Induction Treatment|Physician Decision|0|||
94691338|NCT02291289|324327110|FG002|Induction Treatment|Physician Decision|0|||
94691339|NCT02291289|324327111|FG003|Induction Treatment|Physician Decision|3|||
94365893|NCT03747939|323124819|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
94691340|NCT02291289|324327112|FG004|Induction Treatment|Physician Decision|0|||
94691341|NCT02291289|324327113|FG005|Induction Treatment|Physician Decision|0|||
94691342|NCT02291289|324327114|FG006|Induction Treatment|Physician Decision|0|||
94691343|NCT02291289|324327115|FG007|Induction Treatment|Physician Decision|0|||
94691344|NCT02291289|324327116|FG008|Induction Treatment|Physician Decision|0|||
94691345|NCT02291289|324327117|FG009|Induction Treatment|Physician Decision|1|||
94691346|NCT02291289|324327118|FG010|Induction Treatment|Physician Decision|0|||
94691347|NCT02291289|324327119|FG011|Induction Treatment|Physician Decision|0|||
94691348|NCT02291289|324327120|FG012|Induction Treatment|Physician Decision|0|||
94691349|NCT02291289|324327108|FG000|Induction Treatment|Protocol Violation|0|||
94691350|NCT02291289|324327109|FG001|Induction Treatment|Protocol Violation|0|||
94691351|NCT02291289|324327110|FG002|Induction Treatment|Protocol Violation|0|||
94691352|NCT02291289|324327111|FG003|Induction Treatment|Protocol Violation|3|||
94691353|NCT02291289|324327112|FG004|Induction Treatment|Protocol Violation|0|||
94691354|NCT02291289|324327113|FG005|Induction Treatment|Protocol Violation|0|||
94691355|NCT02291289|324327114|FG006|Induction Treatment|Protocol Violation|0|||
94691356|NCT02291289|324327115|FG007|Induction Treatment|Protocol Violation|0|||
94691357|NCT02291289|324327116|FG008|Induction Treatment|Protocol Violation|0|||
94691358|NCT02291289|324327117|FG009|Induction Treatment|Protocol Violation|2|||
94691359|NCT02291289|324327118|FG010|Induction Treatment|Protocol Violation|0|||
94691360|NCT02291289|324327119|FG011|Induction Treatment|Protocol Violation|0|||
94691361|NCT02291289|324327120|FG012|Induction Treatment|Protocol Violation|0|||
94691362|NCT02291289|324327108|FG000|Induction Treatment|Missing|4|||
94691363|NCT02291289|324327109|FG001|Induction Treatment|Missing|0|||
94691364|NCT02291289|324327110|FG002|Induction Treatment|Missing|0|||
94691365|NCT02291289|324327111|FG003|Induction Treatment|Missing|14|||
94691366|NCT02291289|324327112|FG004|Induction Treatment|Missing|0|||
94691367|NCT02291289|324327113|FG005|Induction Treatment|Missing|0|||
94691368|NCT02291289|324327114|FG006|Induction Treatment|Missing|0|||
94691369|NCT02291289|324327115|FG007|Induction Treatment|Missing|0|||
94691370|NCT02291289|324327116|FG008|Induction Treatment|Missing|0|||
94691371|NCT02291289|324327117|FG009|Induction Treatment|Missing|54|||
94691372|NCT02291289|324327118|FG010|Induction Treatment|Missing|0|||
94691373|NCT02291289|324327119|FG011|Induction Treatment|Missing|0|||
94691374|NCT02291289|324327120|FG012|Induction Treatment|Missing|0|||
94651479|NCT00812929|324181668|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
94651480|NCT00812929|324181669|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
94651481|NCT00812929|324181670|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
94651482|NCT00812929|324181671|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
94651483|NCT00812929|324181672|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
94651484|NCT00211081|324181673|FG000|Overall Study|Withdrawal by Subject|2|||
94651485|NCT04027686|324181674|FG000|Overall Study|Lost to Follow-up|2|||
94651486|NCT04027686|324181675|FG001|Overall Study|Lost to Follow-up|0|||
94651487|NCT04027686|324181674|FG000|Overall Study|Withdrawal by Subject|0|||
94651488|NCT04027686|324181675|FG001|Overall Study|Withdrawal by Subject|1|||
94651489|NCT04713748|324181676|FG000|Overall Study|Not enough kits allocated|35|||
94651490|NCT00113516|324181677|FG000|Part 1|Adverse Event|6|||
94651491|NCT00113516|324181678|FG001|Part 1|Adverse Event|0|||
94651492|NCT00113516|324181677|FG000|Part 1|Death|3|||
94651493|NCT00113516|324181678|FG001|Part 1|Death|0|||
94651494|NCT00113516|324181677|FG000|Part 1|Other|3|||
94651495|NCT00113516|324181678|FG001|Part 1|Other|0|||
94651496|NCT00113516|324181677|FG000|Part 1|Withdrawal by Subject|2|||
94651497|NCT00113516|324181678|FG001|Part 1|Withdrawal by Subject|0|||
94651498|NCT00113516|324181677|FG000|Part 1|Lack of Efficacy|2|||
94651499|NCT00113516|324181678|FG001|Part 1|Lack of Efficacy|0|||
94651500|NCT00113516|324181677|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
94651501|NCT00113516|324181678|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
94651502|NCT00113516|324181677|FG000|Part 1|Laboratory Abnormality|1|||
94651503|NCT00113516|324181678|FG001|Part 1|Laboratory Abnormality|0|||
94651504|NCT00113516|324181677|FG000|Part 1|Ongoing|1|||
94651505|NCT00113516|324181678|FG001|Part 1|Ongoing|0|||
94651506|NCT00113516|324181677|FG000|Part 1|Missing|65|||
94651507|NCT00113516|324181678|FG001|Part 1|Missing|0|||
94651508|NCT00113516|324181677|FG000|Part 2|Adverse Event|0|||
94651509|NCT00113516|324181678|FG001|Part 2|Adverse Event|16|||
94651510|NCT00113516|324181677|FG000|Part 2|Death|0|||
94651511|NCT00113516|324181678|FG001|Part 2|Death|5|||
94651512|NCT00113516|324181677|FG000|Part 2|Lack of Efficacy|0|||
94651513|NCT00113516|324181678|FG001|Part 2|Lack of Efficacy|37|||
94651514|NCT00113516|324181677|FG000|Part 2|Withdrawal by Subject|0|||
94651515|NCT00113516|324181678|FG001|Part 2|Withdrawal by Subject|3|||
94651516|NCT00113516|324181677|FG000|Part 2|Other|0|||
94651517|NCT00113516|324181678|FG001|Part 2|Other|3|||
94651518|NCT00113516|324181677|FG000|Part 2|Laboratory Abnormality|0|||
94651519|NCT00113516|324181678|FG001|Part 2|Laboratory Abnormality|1|||
94651520|NCT00113516|324181677|FG000|Part 2|Ongoing|0|||
94651521|NCT00113516|324181678|FG001|Part 2|Ongoing|1|||
94651522|NCT00047463|324181679|FG000|Overall Study|Withdrawal by Subject|0|||
94651523|NCT00047463|324181680|FG001|Overall Study|Withdrawal by Subject|3|||
94651524|NCT03217136|324181689|FG000|Overall Study|Lost to Follow-up|2|||
94651525|NCT03217136|324181690|FG001|Overall Study|Lost to Follow-up|1|||
94651526|NCT03217136|324181689|FG000|Overall Study|Site Randomized Participant in Error|0|||
94691375|NCT02291289|324327108|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
94691376|NCT02291289|324327109|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
94691377|NCT02291289|324327110|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
94691378|NCT02291289|324327111|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
94691379|NCT02291289|324327112|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
94691380|NCT02291289|324327113|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
94691381|NCT02291289|324327114|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
94691382|NCT02291289|324327115|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
94691383|NCT02291289|324327116|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
94691384|NCT02291289|324327117|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
94691385|NCT02291289|324327118|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
94691386|NCT02291289|324327119|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
94691387|NCT02291289|324327120|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
94691388|NCT02291289|324327108|FG000|Maintenance Treatment Phase|Death|0|||
94691389|NCT02291289|324327109|FG001|Maintenance Treatment Phase|Death|29|||
94691390|NCT02291289|324327110|FG002|Maintenance Treatment Phase|Death|16|||
94691391|NCT02291289|324327111|FG003|Maintenance Treatment Phase|Death|0|||
94691392|NCT02291289|324327112|FG004|Maintenance Treatment Phase|Death|188|||
94691393|NCT02291289|324327113|FG005|Maintenance Treatment Phase|Death|107|||
94691394|NCT02291289|324327114|FG006|Maintenance Treatment Phase|Death|0|||
94691395|NCT02291289|324327115|FG007|Maintenance Treatment Phase|Death|1|||
94691396|NCT02291289|324327116|FG008|Maintenance Treatment Phase|Death|1|||
94691397|NCT02291289|324327117|FG009|Maintenance Treatment Phase|Death|0|||
94691398|NCT02291289|324327118|FG010|Maintenance Treatment Phase|Death|46|||
94691399|NCT02291289|324327119|FG011|Maintenance Treatment Phase|Death|19|||
94691400|NCT02291289|324327120|FG012|Maintenance Treatment Phase|Death|0|||
94691401|NCT02291289|324327108|FG000|Maintenance Treatment Phase|Adverse Event|0|||
94691402|NCT02291289|324327109|FG001|Maintenance Treatment Phase|Adverse Event|0|||
94691403|NCT02291289|324327110|FG002|Maintenance Treatment Phase|Adverse Event|0|||
94691404|NCT02291289|324327111|FG003|Maintenance Treatment Phase|Adverse Event|0|||
94691405|NCT02291289|324327112|FG004|Maintenance Treatment Phase|Adverse Event|1|||
94691406|NCT02291289|324327113|FG005|Maintenance Treatment Phase|Adverse Event|1|||
94691407|NCT02291289|324327114|FG006|Maintenance Treatment Phase|Adverse Event|0|||
94691408|NCT02291289|324327115|FG007|Maintenance Treatment Phase|Adverse Event|0|||
94691409|NCT02291289|324327116|FG008|Maintenance Treatment Phase|Adverse Event|0|||
94691410|NCT02291289|324327117|FG009|Maintenance Treatment Phase|Adverse Event|0|||
94691411|NCT02291289|324327118|FG010|Maintenance Treatment Phase|Adverse Event|0|||
94691412|NCT02291289|324327119|FG011|Maintenance Treatment Phase|Adverse Event|0|||
94691413|NCT02291289|324327120|FG012|Maintenance Treatment Phase|Adverse Event|0|||
94691414|NCT02291289|324327108|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
94691415|NCT02291289|324327109|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
94691416|NCT02291289|324327110|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
94691417|NCT02291289|324327111|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
94691418|NCT02291289|324327112|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
94691419|NCT02291289|324327113|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
94691420|NCT02291289|324327114|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
94691421|NCT02291289|324327115|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
94691422|NCT02291289|324327116|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
94691423|NCT02291289|324327117|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
94691424|NCT02291289|324327118|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
94691425|NCT02291289|324327119|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
94691426|NCT02291289|324327120|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
94691427|NCT02291289|324327108|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
94691428|NCT02291289|324327109|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
94691429|NCT02291289|324327110|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
94691430|NCT02291289|324327111|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
94691431|NCT02291289|324327112|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
94691432|NCT02291289|324327113|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
94691433|NCT02291289|324327114|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
94691434|NCT02291289|324327115|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
94365894|NCT03747939|323124820|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
94466033|NCT00435019|323494985|FG000|Overall Study|Adverse Event|1|||
94691435|NCT02291289|324327116|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
94691436|NCT02291289|324327117|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
94691437|NCT02291289|324327118|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
94691438|NCT02291289|324327119|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
94691439|NCT02291289|324327120|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
94691440|NCT02291289|324327108|FG000|Maintenance Treatment Phase|Physician Decision|0|||
94691441|NCT02291289|324327109|FG001|Maintenance Treatment Phase|Physician Decision|2|||
94691442|NCT02291289|324327110|FG002|Maintenance Treatment Phase|Physician Decision|0|||
94691443|NCT02291289|324327111|FG003|Maintenance Treatment Phase|Physician Decision|0|||
94691444|NCT02291289|324327112|FG004|Maintenance Treatment Phase|Physician Decision|3|||
94691445|NCT02291289|324327113|FG005|Maintenance Treatment Phase|Physician Decision|0|||
94691446|NCT02291289|324327114|FG006|Maintenance Treatment Phase|Physician Decision|0|||
94691447|NCT02291289|324327115|FG007|Maintenance Treatment Phase|Physician Decision|0|||
94691448|NCT02291289|324327116|FG008|Maintenance Treatment Phase|Physician Decision|0|||
94691449|NCT02291289|324327117|FG009|Maintenance Treatment Phase|Physician Decision|0|||
94691450|NCT02291289|324327118|FG010|Maintenance Treatment Phase|Physician Decision|1|||
94691451|NCT02291289|324327119|FG011|Maintenance Treatment Phase|Physician Decision|3|||
94691452|NCT02291289|324327120|FG012|Maintenance Treatment Phase|Physician Decision|0|||
94691453|NCT02291289|324327108|FG000|Maintenance Treatment Phase|Not Treated|0|||
94691454|NCT02291289|324327109|FG001|Maintenance Treatment Phase|Not Treated|0|||
94691455|NCT02291289|324327110|FG002|Maintenance Treatment Phase|Not Treated|2|||
94691456|NCT02291289|324327111|FG003|Maintenance Treatment Phase|Not Treated|0|||
94691457|NCT02291289|324327112|FG004|Maintenance Treatment Phase|Not Treated|0|||
94691458|NCT02291289|324327113|FG005|Maintenance Treatment Phase|Not Treated|0|||
94691459|NCT02291289|324327114|FG006|Maintenance Treatment Phase|Not Treated|0|||
94691460|NCT02291289|324327115|FG007|Maintenance Treatment Phase|Not Treated|0|||
94691461|NCT02291289|324327116|FG008|Maintenance Treatment Phase|Not Treated|0|||
94691462|NCT02291289|324327117|FG009|Maintenance Treatment Phase|Not Treated|0|||
94691463|NCT02291289|324327118|FG010|Maintenance Treatment Phase|Not Treated|0|||
94691464|NCT02291289|324327119|FG011|Maintenance Treatment Phase|Not Treated|0|||
94691465|NCT02291289|324327120|FG012|Maintenance Treatment Phase|Not Treated|0|||
94691466|NCT02291289|324327108|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
94691467|NCT02291289|324327109|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
94691468|NCT02291289|324327110|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
94691469|NCT02291289|324327111|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
94691470|NCT02291289|324327112|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
94691471|NCT02291289|324327113|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
94691472|NCT02291289|324327114|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
94691473|NCT02291289|324327115|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
94691474|NCT02291289|324327116|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
94691475|NCT02291289|324327117|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
94691476|NCT02291289|324327118|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
94691477|NCT02291289|324327119|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
94264247|NCT03250832|322761872|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
94264248|NCT03250832|322761873|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
94264249|NCT03250832|322761874|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
94264250|NCT03250832|322761875|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
94264251|NCT03250832|322761876|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
94264252|NCT03250832|322761877|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
94264253|NCT03250832|322761878|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
94264254|NCT03250832|322761879|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
94264255|NCT03250832|322761880|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
94264256|NCT03250832|322761881|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
94264257|NCT03250832|322761870|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
94264258|NCT03250832|322761871|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
94264259|NCT03250832|322761872|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
94264260|NCT03250832|322761873|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
94264261|NCT03250832|322761874|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
94264262|NCT03250832|322761875|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
94264263|NCT03250832|322761876|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
94264264|NCT03250832|322761877|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
94264265|NCT03250832|322761878|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
94264266|NCT03250832|322761879|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
94264267|NCT03250832|322761880|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
94264268|NCT03250832|322761881|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
94264269|NCT03250832|322761870|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
94264270|NCT03250832|322761871|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
94264271|NCT03250832|322761872|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
94264272|NCT03250832|322761873|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
94264273|NCT03250832|322761874|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
94264274|NCT03250832|322761875|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
94691478|NCT02291289|324327120|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
94691479|NCT02291289|324327108|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
94691480|NCT02291289|324327109|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
94691481|NCT02291289|324327110|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
94691482|NCT02291289|324327111|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
94691483|NCT02291289|324327112|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
94691484|NCT02291289|324327113|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
94691485|NCT02291289|324327114|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
94691486|NCT02291289|324327115|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
94691487|NCT02291289|324327116|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
94691488|NCT02291289|324327117|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
94691489|NCT02291289|324327118|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
94691490|NCT02291289|324327119|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
94691491|NCT02291289|324327120|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
94691492|NCT02291289|324327108|FG000|Early Disease Progression|Death|0|||
94691493|NCT02291289|324327109|FG001|Early Disease Progression|Death|0|||
94691494|NCT02291289|324327110|FG002|Early Disease Progression|Death|0|||
94691495|NCT02291289|324327111|FG003|Early Disease Progression|Death|0|||
94691496|NCT02291289|324327112|FG004|Early Disease Progression|Death|0|||
94691497|NCT02291289|324327113|FG005|Early Disease Progression|Death|0|||
94691498|NCT02291289|324327114|FG006|Early Disease Progression|Death|0|||
94691499|NCT02291289|324327115|FG007|Early Disease Progression|Death|0|||
94691500|NCT02291289|324327116|FG008|Early Disease Progression|Death|0|||
94691501|NCT02291289|324327117|FG009|Early Disease Progression|Death|0|||
94691502|NCT02291289|324327118|FG010|Early Disease Progression|Death|0|||
94691503|NCT02291289|324327119|FG011|Early Disease Progression|Death|0|||
94691504|NCT02291289|324327120|FG012|Early Disease Progression|Death|10|||
94691505|NCT02291289|324327108|FG000|Early Disease Progression|Lost to Follow-up|0|||
94691506|NCT02291289|324327109|FG001|Early Disease Progression|Lost to Follow-up|0|||
94691507|NCT02291289|324327110|FG002|Early Disease Progression|Lost to Follow-up|0|||
94691508|NCT02291289|324327111|FG003|Early Disease Progression|Lost to Follow-up|0|||
94691509|NCT02291289|324327112|FG004|Early Disease Progression|Lost to Follow-up|0|||
94691510|NCT02291289|324327113|FG005|Early Disease Progression|Lost to Follow-up|0|||
94264275|NCT03250832|322761876|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
94264276|NCT03250832|322761877|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
94264277|NCT03250832|322761878|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
94264278|NCT03250832|322761879|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
94264279|NCT03250832|322761880|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
94691511|NCT02291289|324327114|FG006|Early Disease Progression|Lost to Follow-up|0|||
94691512|NCT02291289|324327115|FG007|Early Disease Progression|Lost to Follow-up|0|||
94691513|NCT02291289|324327116|FG008|Early Disease Progression|Lost to Follow-up|0|||
94691514|NCT02291289|324327117|FG009|Early Disease Progression|Lost to Follow-up|0|||
94691515|NCT02291289|324327118|FG010|Early Disease Progression|Lost to Follow-up|0|||
94691516|NCT02291289|324327119|FG011|Early Disease Progression|Lost to Follow-up|0|||
94691517|NCT02291289|324327120|FG012|Early Disease Progression|Lost to Follow-up|1|||
94691518|NCT01500226|324327121|FG000|Overall Study|Adverse Event|31|||
94691519|NCT01500226|324327122|FG001|Overall Study|Adverse Event|38|||
94691520|NCT01500226|324327121|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
94691521|NCT01500226|324327122|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
94691522|NCT01500226|324327121|FG000|Overall Study|Withdrawal by Subject|93|||
94691523|NCT01500226|324327122|FG001|Overall Study|Withdrawal by Subject|96|||
94691524|NCT01500226|324327121|FG000|Overall Study|Death|12|||
94691525|NCT01500226|324327122|FG001|Overall Study|Death|4|||
94691526|NCT01500226|324327121|FG000|Overall Study|Disease Progression|16|||
94691527|NCT01500226|324327122|FG001|Overall Study|Disease Progression|14|||
94691528|NCT01500226|324327121|FG000|Overall Study|Protocol Violation|53|||
94691529|NCT01500226|324327122|FG001|Overall Study|Protocol Violation|39|||
94691530|NCT01500226|324327121|FG000|Overall Study|Physician Decision|17|||
94691531|NCT01500226|324327122|FG001|Overall Study|Physician Decision|15|||
94691532|NCT01500226|324327121|FG000|Overall Study|Lack of Efficacy|14|||
94691533|NCT01500226|324327122|FG001|Overall Study|Lack of Efficacy|30|||
94691534|NCT01500226|324327121|FG000|Overall Study|Lost to Follow-up|9|||
94691535|NCT01500226|324327122|FG001|Overall Study|Lost to Follow-up|5|||
94691536|NCT01500226|324327121|FG000|Overall Study|Other Reasons|19|||
94691537|NCT01500226|324327122|FG001|Overall Study|Other Reasons|16|||
94691538|NCT03699124|324327123|FG000|Overall Study|Adverse Event|6|||
94691539|NCT03699124|324327124|FG001|Overall Study|Adverse Event|5|||
94691540|NCT03699124|324327125|FG002|Overall Study|Adverse Event|2|||
94691541|NCT03699124|324327123|FG000|Overall Study|Death|0|||
94691542|NCT03699124|324327124|FG001|Overall Study|Death|2|||
94691543|NCT03699124|324327125|FG002|Overall Study|Death|0|||
94691544|NCT03699124|324327123|FG000|Overall Study|Lost to Follow-up|20|||
94691545|NCT03699124|324327124|FG001|Overall Study|Lost to Follow-up|16|||
94691546|NCT03699124|324327125|FG002|Overall Study|Lost to Follow-up|15|||
94691547|NCT03699124|324327123|FG000|Overall Study|Protocol Violation|1|||
94691548|NCT03699124|324327124|FG001|Overall Study|Protocol Violation|0|||
94691549|NCT03699124|324327125|FG002|Overall Study|Protocol Violation|0|||
94691550|NCT03699124|324327123|FG000|Overall Study|Withdrawal by Subject|13|||
94691551|NCT03699124|324327124|FG001|Overall Study|Withdrawal by Subject|14|||
94691552|NCT03699124|324327125|FG002|Overall Study|Withdrawal by Subject|13|||
94691553|NCT03699124|324327123|FG000|Overall Study|Other reasons|5|||
94691554|NCT03699124|324327124|FG001|Overall Study|Other reasons|3|||
94691555|NCT03699124|324327125|FG002|Overall Study|Other reasons|10|||
94691556|NCT00999661|324327126|FG000|Overall Study|Lost to Follow-up|59|||
94691557|NCT00999661|324327126|FG000|Overall Study|Adverse Event|1|||
94691558|NCT00999661|324327126|FG000|Overall Study|Withdrawal by Subject|1|||
94691559|NCT00999661|324327126|FG000|Overall Study|Not meeting eligibility criteria|9|||
94691560|NCT00593554|324327127|FG000|Overall Study|Death|1|||
94691561|NCT00593554|324327128|FG001|Overall Study|Death|2|||
94691562|NCT00593554|324327127|FG000|Overall Study|Physician Decision|0|||
94691563|NCT00593554|324327128|FG001|Overall Study|Physician Decision|1|||
94691564|NCT00593554|324327127|FG000|Overall Study|Withdrawal by Subject|1|||
94691565|NCT00593554|324327128|FG001|Overall Study|Withdrawal by Subject|0|||
94691566|NCT00593554|324327127|FG000|Overall Study|Disease Progression|1|||
94691567|NCT00593554|324327128|FG001|Overall Study|Disease Progression|2|||
94691568|NCT03638635|324327129|FG000|Initial Hospitalization|Study terminated prematurely|0|||
94691569|NCT03638635|324327130|FG001|Initial Hospitalization|Study terminated prematurely|1|||
94691570|NCT03638635|324327129|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
94365895|NCT03747939|323124821|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
94365896|NCT03747939|323124818|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
94365897|NCT03747939|323124819|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
94365898|NCT03747939|323124820|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
94691571|NCT03638635|324327130|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
94691572|NCT03638635|324327129|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
94691573|NCT03638635|324327130|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
94691574|NCT01592695|324327137|FG000|Overall Study|Lost to Follow-up|8|||
94691575|NCT01592695|324327138|FG001|Overall Study|Lost to Follow-up|4|||
94691576|NCT00627042|324327139|FG000|Overall Study|Withdrawal by Subject|2|||
94365899|NCT03747939|323124821|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
94365900|NCT03747939|323124818|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
94691577|NCT02564055|324327140|FG000|Overall Study|Adverse Event|1|||
94691578|NCT02564055|324327141|FG001|Overall Study|Adverse Event|0|||
94691579|NCT02564055|324327142|FG002|Overall Study|Adverse Event|4|||
94691580|NCT02564055|324327143|FG003|Overall Study|Adverse Event|1|||
94691581|NCT02564055|324327144|FG004|Overall Study|Adverse Event|4|||
94691582|NCT02564055|324327145|FG005|Overall Study|Adverse Event|1|||
94691583|NCT02564055|324327140|FG000|Overall Study|Protocol Violation|1|||
94691584|NCT02564055|324327141|FG001|Overall Study|Protocol Violation|0|||
94691585|NCT02564055|324327142|FG002|Overall Study|Protocol Violation|0|||
94691586|NCT02564055|324327143|FG003|Overall Study|Protocol Violation|0|||
94691587|NCT02564055|324327144|FG004|Overall Study|Protocol Violation|0|||
94691588|NCT02564055|324327145|FG005|Overall Study|Protocol Violation|0|||
94691589|NCT02564055|324327140|FG000|Overall Study|Reached stopping criteria|0|||
94691590|NCT02564055|324327141|FG001|Overall Study|Reached stopping criteria|0|||
94691591|NCT02564055|324327142|FG002|Overall Study|Reached stopping criteria|0|||
94691592|NCT02564055|324327143|FG003|Overall Study|Reached stopping criteria|0|||
94691593|NCT02564055|324327144|FG004|Overall Study|Reached stopping criteria|0|||
94691594|NCT02564055|324327145|FG005|Overall Study|Reached stopping criteria|1|||
94691595|NCT02564055|324327140|FG000|Overall Study|Lost to Follow-up|0|||
94691596|NCT02564055|324327141|FG001|Overall Study|Lost to Follow-up|1|||
94691597|NCT02564055|324327142|FG002|Overall Study|Lost to Follow-up|4|||
94691598|NCT02564055|324327143|FG003|Overall Study|Lost to Follow-up|2|||
94691599|NCT02564055|324327144|FG004|Overall Study|Lost to Follow-up|1|||
94691600|NCT02564055|324327145|FG005|Overall Study|Lost to Follow-up|0|||
94691601|NCT02564055|324327140|FG000|Overall Study|Physician Decision|0|||
94691602|NCT02564055|324327141|FG001|Overall Study|Physician Decision|0|||
94691603|NCT02564055|324327142|FG002|Overall Study|Physician Decision|1|||
94691604|NCT02564055|324327143|FG003|Overall Study|Physician Decision|0|||
94691605|NCT02564055|324327144|FG004|Overall Study|Physician Decision|0|||
94691606|NCT02564055|324327145|FG005|Overall Study|Physician Decision|0|||
94691607|NCT02564055|324327140|FG000|Overall Study|Withdrawal by Subject|4|||
94691608|NCT02564055|324327141|FG001|Overall Study|Withdrawal by Subject|4|||
94691609|NCT02564055|324327142|FG002|Overall Study|Withdrawal by Subject|3|||
94691610|NCT02564055|324327143|FG003|Overall Study|Withdrawal by Subject|3|||
94691611|NCT02564055|324327144|FG004|Overall Study|Withdrawal by Subject|10|||
94691612|NCT02564055|324327145|FG005|Overall Study|Withdrawal by Subject|10|||
94691613|NCT00178256|324327147|FG000|Overall Study|Adverse Event|2|||
94691614|NCT00178256|324327148|FG001|Overall Study|Adverse Event|0|||
94691615|NCT00178256|324327149|FG002|Overall Study|Adverse Event|0|||
94691616|NCT00178256|324327150|FG003|Overall Study|Adverse Event|0|||
94691617|NCT00178256|324327147|FG000|Overall Study|Death|0|||
94691618|NCT00178256|324327148|FG001|Overall Study|Death|1|||
94691619|NCT00178256|324327149|FG002|Overall Study|Death|0|||
94691620|NCT00178256|324327150|FG003|Overall Study|Death|1|||
94691621|NCT00178256|324327147|FG000|Overall Study|Cancer progression|2|||
94691622|NCT00178256|324327148|FG001|Overall Study|Cancer progression|0|||
94691623|NCT00178256|324327149|FG002|Overall Study|Cancer progression|0|||
94691624|NCT00178256|324327150|FG003|Overall Study|Cancer progression|1|||
94691625|NCT03583541|324327152|FG000|Overall Study|Lost to Follow-up|31|||
94691626|NCT03583541|324327153|FG001|Overall Study|Lost to Follow-up|65|||
94691627|NCT04102540|324327154|FG000|Overall Study|Withdrawn by PI|2|||
94691628|NCT04102540|324327154|FG000|Overall Study|Lost to Follow-up|6|||
94691629|NCT01477749|324327157|FG000|Overall Study|Physician Decision|4|||
94691630|NCT01567163|324327158|FG000|Overall Study|Progressive Disease|2|||
94691631|NCT01567163|324327158|FG000|Overall Study|Lost to Follow-up|2|||
94691632|NCT03405662|324327159|FG000|Overall Study|COVID-19 restriction|1|||
94691633|NCT03405662|324327160|FG001|Overall Study|COVID-19 restriction|0|||
94691634|NCT03405662|324327159|FG000|Overall Study|unblinding|0|||
94691635|NCT03405662|324327160|FG001|Overall Study|unblinding|1|||
94691636|NCT03405662|324327159|FG000|Overall Study|placement in memory care facility|0|||
94264280|NCT03250832|322761881|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
94264281|NCT03250832|322761870|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
94264282|NCT03250832|322761871|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
94264283|NCT03250832|322761872|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
94691637|NCT03405662|324327160|FG001|Overall Study|placement in memory care facility|2|||
94691638|NCT00280293|324327161|FG000|Overall Study|Protocol Violation|3|||
94691639|NCT00280293|324327162|FG001|Overall Study|Protocol Violation|0|||
94691640|NCT00280293|324327161|FG000|Overall Study|Physician Decision|5|||
94691641|NCT00280293|324327162|FG001|Overall Study|Physician Decision|4|||
94691642|NCT00280293|324327161|FG000|Overall Study|Lost to Follow-up|14|||
94691643|NCT00280293|324327162|FG001|Overall Study|Lost to Follow-up|12|||
94691644|NCT00280293|324327161|FG000|Overall Study|Withdrawal by Subject|3|||
94691645|NCT00280293|324327162|FG001|Overall Study|Withdrawal by Subject|5|||
94691646|NCT00280293|324327161|FG000|Overall Study|Incarceration/Legal Reasons|1|||
94264284|NCT03250832|322761873|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
94264285|NCT03250832|322761874|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
94466034|NCT00435019|323494986|FG001|Overall Study|Adverse Event|0|||
94691647|NCT00280293|324327162|FG001|Overall Study|Incarceration/Legal Reasons|1|||
94691648|NCT00280293|324327161|FG000|Overall Study|Adverse Event|0|||
94691649|NCT00280293|324327162|FG001|Overall Study|Adverse Event|1|||
94691650|NCT01177813|324327163|FG000|Overall Study|Adverse Event|8|||
94691651|NCT01177813|324327164|FG001|Overall Study|Adverse Event|2|||
94691652|NCT01177813|324327165|FG002|Overall Study|Adverse Event|4|||
94691653|NCT01177813|324327166|FG003|Overall Study|Adverse Event|6|||
94691654|NCT01177813|324327167|FG004|Overall Study|Adverse Event|3|||
94691655|NCT01177813|324327163|FG000|Overall Study|Lack of Efficacy|1|||
94691656|NCT01177813|324327164|FG001|Overall Study|Lack of Efficacy|0|||
94691657|NCT01177813|324327165|FG002|Overall Study|Lack of Efficacy|0|||
94691658|NCT01177813|324327166|FG003|Overall Study|Lack of Efficacy|0|||
94691659|NCT01177813|324327167|FG004|Overall Study|Lack of Efficacy|0|||
94691660|NCT01177813|324327163|FG000|Overall Study|Protocol Violation|3|||
94691661|NCT01177813|324327164|FG001|Overall Study|Protocol Violation|2|||
94691662|NCT01177813|324327165|FG002|Overall Study|Protocol Violation|2|||
94691663|NCT01177813|324327166|FG003|Overall Study|Protocol Violation|0|||
94691664|NCT01177813|324327167|FG004|Overall Study|Protocol Violation|1|||
94691665|NCT01177813|324327163|FG000|Overall Study|Lost to Follow-up|12|||
94691666|NCT01177813|324327164|FG001|Overall Study|Lost to Follow-up|5|||
94691667|NCT01177813|324327165|FG002|Overall Study|Lost to Follow-up|6|||
94691668|NCT01177813|324327166|FG003|Overall Study|Lost to Follow-up|3|||
94691669|NCT01177813|324327167|FG004|Overall Study|Lost to Follow-up|0|||
94691670|NCT01177813|324327163|FG000|Overall Study|Withdrawal by Subject|12|||
94691671|NCT01177813|324327164|FG001|Overall Study|Withdrawal by Subject|7|||
94691672|NCT01177813|324327165|FG002|Overall Study|Withdrawal by Subject|6|||
94691673|NCT01177813|324327166|FG003|Overall Study|Withdrawal by Subject|5|||
94691674|NCT01177813|324327167|FG004|Overall Study|Withdrawal by Subject|3|||
94691675|NCT01177813|324327163|FG000|Overall Study|Other reason not defined above|5|||
94691676|NCT01177813|324327164|FG001|Overall Study|Other reason not defined above|2|||
94691677|NCT01177813|324327165|FG002|Overall Study|Other reason not defined above|2|||
94691678|NCT01177813|324327166|FG003|Overall Study|Other reason not defined above|3|||
94691679|NCT01177813|324327167|FG004|Overall Study|Other reason not defined above|2|||
94691680|NCT01316692|324327170|FG000|Overall Study|Adverse Event|5|||
94691681|NCT01316692|324327170|FG000|Overall Study|Disease Progression|7|||
94691682|NCT03220737|324327171|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
94691683|NCT03220737|324327172|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
94691684|NCT03220737|324327173|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
94691685|NCT03220737|324327174|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
94691686|NCT03220737|324327175|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
94691687|NCT03220737|324327176|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
94691688|NCT03220737|324327177|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
94691689|NCT03220737|324327171|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
94691690|NCT03220737|324327172|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
94691691|NCT03220737|324327173|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
94691692|NCT03220737|324327174|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
94691693|NCT03220737|324327175|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
94691694|NCT03220737|324327176|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
94691695|NCT03220737|324327177|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
94691696|NCT03220737|324327171|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
94691697|NCT03220737|324327172|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
94691698|NCT03220737|324327173|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
94691699|NCT03220737|324327174|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
94691700|NCT03220737|324327175|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
94691701|NCT03220737|324327176|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
94691702|NCT03220737|324327177|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
94691703|NCT03220737|324327171|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
94691704|NCT03220737|324327172|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
94691705|NCT03220737|324327173|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
94365901|NCT03747939|323124819|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
94691706|NCT03220737|324327174|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
94691707|NCT03220737|324327175|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
94691708|NCT03220737|324327176|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
94691709|NCT03220737|324327177|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
94691710|NCT03220737|324327171|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
94691711|NCT03220737|324327172|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
94691712|NCT03220737|324327173|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
94691713|NCT03220737|324327174|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
94691714|NCT03220737|324327175|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
94691715|NCT03220737|324327176|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
94691716|NCT03220737|324327177|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
94691717|NCT03220737|324327171|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
94691718|NCT03220737|324327172|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
94691719|NCT03220737|324327173|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
94691720|NCT03220737|324327174|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
94691721|NCT03220737|324327175|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
94691722|NCT03220737|324327176|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
94691723|NCT03220737|324327177|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
94691724|NCT03220737|324327171|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
94691725|NCT03220737|324327172|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
94691726|NCT03220737|324327173|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
94691727|NCT03220737|324327174|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
94691728|NCT03220737|324327175|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
94691729|NCT03220737|324327176|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
94691730|NCT03220737|324327177|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
94691731|NCT03220737|324327171|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
94691732|NCT03220737|324327172|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
94691733|NCT03220737|324327173|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
94691734|NCT03220737|324327174|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
94691735|NCT03220737|324327175|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
94691736|NCT03220737|324327176|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
94691737|NCT03220737|324327177|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
94691738|NCT03772314|324327178|FG000|Overall Study|Adverse Event|7|||
94691739|NCT03772314|324327179|FG001|Overall Study|Adverse Event|2|||
94691740|NCT00579982|324327180|FG000|Overall Study|Adverse Event|4|||
94691741|NCT00579982|324327180|FG000|Overall Study|Protocol Violation|4|||
94691742|NCT03050398|324327189|FG000|Overall Study|Study terminated by sponsor|8|||
94691743|NCT00219141|324327192|FG000|Overall Study|Adverse Event|4|||
94691744|NCT00219141|324327193|FG001|Overall Study|Adverse Event|10|||
94691745|NCT00219141|324327194|FG002|Overall Study|Adverse Event|5|||
94691746|NCT00219141|324327192|FG000|Overall Study|Lack of Efficacy|3|||
94691747|NCT00219141|324327193|FG001|Overall Study|Lack of Efficacy|2|||
94691748|NCT00219141|324327194|FG002|Overall Study|Lack of Efficacy|0|||
94691749|NCT00219141|324327192|FG000|Overall Study|Administrative problems|0|||
94691750|NCT00219141|324327193|FG001|Overall Study|Administrative problems|1|||
94691751|NCT00219141|324327194|FG002|Overall Study|Administrative problems|0|||
94691752|NCT00219141|324327192|FG000|Overall Study|Lost to Follow-up|2|||
94691753|NCT00219141|324327193|FG001|Overall Study|Lost to Follow-up|4|||
94691754|NCT00219141|324327194|FG002|Overall Study|Lost to Follow-up|1|||
94691755|NCT00219141|324327192|FG000|Overall Study|Protocol Violation|3|||
94691756|NCT00219141|324327193|FG001|Overall Study|Protocol Violation|1|||
94466035|NCT00435019|323494985|FG000|Overall Study|Lack of Efficacy|1|||
94691757|NCT00219141|324327194|FG002|Overall Study|Protocol Violation|1|||
94691758|NCT00219141|324327192|FG000|Overall Study|Withdrawal by Subject|1|||
94691759|NCT00219141|324327193|FG001|Overall Study|Withdrawal by Subject|3|||
94691760|NCT00219141|324327194|FG002|Overall Study|Withdrawal by Subject|5|||
94691761|NCT00219141|324327192|FG000|Overall Study|Condition no longer requires study drug|1|||
94691762|NCT00219141|324327193|FG001|Overall Study|Condition no longer requires study drug|0|||
94691763|NCT00219141|324327194|FG002|Overall Study|Condition no longer requires study drug|0|||
94691764|NCT04285229|324327195|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
94691765|NCT04285229|324327196|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
94691766|NCT04285229|324327197|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
94691767|NCT04285229|324327198|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
94691768|NCT04285229|324327199|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
94691769|NCT04285229|324327200|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
94691770|NCT04285229|324327195|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
94691771|NCT04285229|324327196|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
94691772|NCT04285229|324327197|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
94691773|NCT04285229|324327198|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
94691774|NCT04285229|324327199|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
94691775|NCT04285229|324327200|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
94691776|NCT04285229|324327195|FG000|Extended Treatment Period|Adverse Event|0|||
94691777|NCT04285229|324327196|FG001|Extended Treatment Period|Adverse Event|0|||
94691778|NCT04285229|324327197|FG002|Extended Treatment Period|Adverse Event|0|||
94691779|NCT04285229|324327198|FG003|Extended Treatment Period|Adverse Event|1|||
94691780|NCT04285229|324327199|FG004|Extended Treatment Period|Adverse Event|0|||
94691781|NCT04285229|324327200|FG005|Extended Treatment Period|Adverse Event|0|||
94691782|NCT04285229|324327195|FG000|Extended Treatment Period|Physician Decision|0|||
94691783|NCT04285229|324327196|FG001|Extended Treatment Period|Physician Decision|0|||
94691784|NCT04285229|324327197|FG002|Extended Treatment Period|Physician Decision|1|||
94691785|NCT04285229|324327198|FG003|Extended Treatment Period|Physician Decision|0|||
94691786|NCT04285229|324327199|FG004|Extended Treatment Period|Physician Decision|0|||
94691787|NCT04285229|324327200|FG005|Extended Treatment Period|Physician Decision|0|||
94691788|NCT04285229|324327195|FG000|Follow-up Period|Adverse Event|0|||
94691789|NCT04285229|324327196|FG001|Follow-up Period|Adverse Event|0|||
94691790|NCT04285229|324327197|FG002|Follow-up Period|Adverse Event|0|||
94691791|NCT04285229|324327198|FG003|Follow-up Period|Adverse Event|0|||
94691792|NCT04285229|324327199|FG004|Follow-up Period|Adverse Event|1|||
94691793|NCT04285229|324327200|FG005|Follow-up Period|Adverse Event|4|||
94691794|NCT04285229|324327195|FG000|Follow-up Period|Withdrawal by Subject|0|||
94691795|NCT04285229|324327196|FG001|Follow-up Period|Withdrawal by Subject|0|||
94691796|NCT04285229|324327197|FG002|Follow-up Period|Withdrawal by Subject|0|||
94691797|NCT04285229|324327198|FG003|Follow-up Period|Withdrawal by Subject|0|||
94691798|NCT04285229|324327199|FG004|Follow-up Period|Withdrawal by Subject|0|||
94691799|NCT04285229|324327200|FG005|Follow-up Period|Withdrawal by Subject|5|||
94691800|NCT04285229|324327195|FG000|Follow-up Period|Covid-19|0|||
94691801|NCT04285229|324327196|FG001|Follow-up Period|Covid-19|0|||
94691802|NCT04285229|324327197|FG002|Follow-up Period|Covid-19|0|||
94691803|NCT04285229|324327198|FG003|Follow-up Period|Covid-19|0|||
94691804|NCT04285229|324327199|FG004|Follow-up Period|Covid-19|0|||
94691805|NCT04285229|324327200|FG005|Follow-up Period|Covid-19|2|||
94691806|NCT04285229|324327195|FG000|Follow-up Period|Physician Decision|0|||
94691807|NCT04285229|324327196|FG001|Follow-up Period|Physician Decision|0|||
94691808|NCT04285229|324327197|FG002|Follow-up Period|Physician Decision|0|||
94691809|NCT04285229|324327198|FG003|Follow-up Period|Physician Decision|0|||
94691810|NCT04285229|324327199|FG004|Follow-up Period|Physician Decision|0|||
94691811|NCT04285229|324327200|FG005|Follow-up Period|Physician Decision|1|||
94691812|NCT01406717|324327203|FG000|Overall Study|Subject non-compliance|4|||
94691813|NCT01406717|324327204|FG001|Overall Study|Subject non-compliance|3|||
94691814|NCT01406717|324327203|FG000|Overall Study|Protocol Violation|5|||
94691815|NCT01406717|324327204|FG001|Overall Study|Protocol Violation|1|||
94691816|NCT01406717|324327203|FG000|Overall Study|Lost to Follow-up|14|||
94691817|NCT01406717|324327204|FG001|Overall Study|Lost to Follow-up|8|||
94691818|NCT01406717|324327203|FG000|Overall Study|Withdrawal by Subject|19|||
94691819|NCT01406717|324327204|FG001|Overall Study|Withdrawal by Subject|15|||
94691820|NCT01406717|324327203|FG000|Overall Study|Adverse Event|1|||
94691821|NCT01406717|324327204|FG001|Overall Study|Adverse Event|2|||
94691822|NCT01406717|324327203|FG000|Overall Study|Lack of Efficacy|0|||
94691823|NCT01406717|324327204|FG001|Overall Study|Lack of Efficacy|1|||
94691824|NCT01406717|324327203|FG000|Overall Study|Non-completion of visit activity|0|||
94691825|NCT01406717|324327204|FG001|Overall Study|Non-completion of visit activity|1|||
94691826|NCT00776100|324327211|FG000|Overall Study|Disease Progression|1|||
94691827|NCT00776100|324327212|FG001|Overall Study|Disease Progression|0|||
94691828|NCT04963062|324327217|FG000|Overall Study|withdrew by the study team|4|||
94691829|NCT04963062|324327218|FG001|Overall Study|withdrew by the study team|2|||
94691830|NCT01857323|324327219|FG000|Overall Study|Adverse Event|1|||
94691831|NCT01857323|324327219|FG000|Overall Study|Withdrawal by Subject|3|||
94691832|NCT01857323|324327219|FG000|Overall Study|Non-compliance|1|||
94691833|NCT01857323|324327219|FG000|Overall Study|Protocol Violation|6|||
94691834|NCT01857323|324327219|FG000|Overall Study|Lost to Follow-up|1|||
94691835|NCT01857323|324327219|FG000|Overall Study|Other|4|||
94691836|NCT01857323|324327219|FG000|Overall Study|Did not complete 180 doses|48|||
94691837|NCT02431533|324327224|FG000|Overall Study|Withdrawal by Subject|1|||
94691838|NCT02431533|324327225|FG001|Overall Study|Withdrawal by Subject|3|||
94691839|NCT02431533|324327224|FG000|Overall Study|Developed Exclusionary criteria|1|||
94691840|NCT02431533|324327225|FG001|Overall Study|Developed Exclusionary criteria|0|||
94691841|NCT02107443|324327226|FG000|Overall Study|Death|42|||
94691842|NCT02107443|324327227|FG001|Overall Study|Death|30|||
94691843|NCT02107443|324327226|FG000|Overall Study|Study Protocol Violation|3|||
94691844|NCT02107443|324327227|FG001|Overall Study|Study Protocol Violation|1|||
94691845|NCT02107443|324327226|FG000|Overall Study|Registered but Not Eligible|0|||
94691846|NCT02107443|324327227|FG001|Overall Study|Registered but Not Eligible|1|||
94691847|NCT02107443|324327226|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
94691848|NCT02107443|324327227|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
94691849|NCT02107443|324327226|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
94691850|NCT02107443|324327227|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
94691851|NCT02107443|324327226|FG000|Overall Study|Withdrawal: Changed Mind|2|||
94691852|NCT02107443|324327227|FG001|Overall Study|Withdrawal: Changed Mind|0|||
94691853|NCT02107443|324327226|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
94691854|NCT02107443|324327227|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
94691855|NCT02107443|324327226|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
94691856|NCT02107443|324327227|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
94691857|NCT02107443|324327226|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
94691858|NCT02107443|324327227|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
94691859|NCT02107443|324327226|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
94691860|NCT02107443|324327227|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
94691861|NCT02107443|324327226|FG000|Overall Study|Withdrawal: Other Medical|9|||
94691862|NCT02107443|324327227|FG001|Overall Study|Withdrawal: Other Medical|5|||
94691863|NCT02107443|324327226|FG000|Overall Study|Withdrawal: Disease Progression|4|||
94691864|NCT02107443|324327227|FG001|Overall Study|Withdrawal: Disease Progression|2|||
94691865|NCT02107443|324327226|FG000|Overall Study|Withdrawal: Personal Issues|0|||
94691866|NCT02107443|324327227|FG001|Overall Study|Withdrawal: Personal Issues|3|||
94691867|NCT00946647|324327231|FG000|Phase 1 Part|Adverse Event|2|||
94691868|NCT00946647|324327232|FG001|Phase 1 Part|Adverse Event|5|||
94691869|NCT00946647|324327233|FG002|Phase 1 Part|Adverse Event|3|||
94691870|NCT00946647|324327234|FG003|Phase 1 Part|Adverse Event|0|||
94691871|NCT00946647|324327235|FG004|Phase 1 Part|Adverse Event|0|||
94691872|NCT00946647|324327231|FG000|Phase 1 Part|Disease progression|3|||
94691873|NCT00946647|324327232|FG001|Phase 1 Part|Disease progression|6|||
94691874|NCT00946647|324327233|FG002|Phase 1 Part|Disease progression|1|||
94691875|NCT00946647|324327234|FG003|Phase 1 Part|Disease progression|0|||
94691876|NCT00946647|324327235|FG004|Phase 1 Part|Disease progression|0|||
94691877|NCT00946647|324327231|FG000|Phase 1 Part|Withdrawal by Subject|1|||
94691878|NCT00946647|324327232|FG001|Phase 1 Part|Withdrawal by Subject|4|||
94691879|NCT00946647|324327233|FG002|Phase 1 Part|Withdrawal by Subject|3|||
94691880|NCT00946647|324327234|FG003|Phase 1 Part|Withdrawal by Subject|0|||
94691881|NCT00946647|324327235|FG004|Phase 1 Part|Withdrawal by Subject|0|||
94691882|NCT00946647|324327231|FG000|Phase 1 Part|Abnormal values|0|||
94691883|NCT00946647|324327232|FG001|Phase 1 Part|Abnormal values|2|||
94691884|NCT00946647|324327233|FG002|Phase 1 Part|Abnormal values|0|||
94691885|NCT00946647|324327234|FG003|Phase 1 Part|Abnormal values|0|||
94691886|NCT00946647|324327235|FG004|Phase 1 Part|Abnormal values|0|||
94691887|NCT00946647|324327231|FG000|Phase 1 Part|Reason missing|0|||
94691888|NCT00946647|324327232|FG001|Phase 1 Part|Reason missing|1|||
94691889|NCT00946647|324327233|FG002|Phase 1 Part|Reason missing|0|||
94691890|NCT00946647|324327234|FG003|Phase 1 Part|Reason missing|0|||
94691891|NCT00946647|324327235|FG004|Phase 1 Part|Reason missing|0|||
94691892|NCT00946647|324327231|FG000|Phase ll Part|Untreated|0|||
94691893|NCT00946647|324327232|FG001|Phase ll Part|Untreated|0|||
94466036|NCT00435019|323494986|FG001|Overall Study|Lack of Efficacy|2|||
94691894|NCT00946647|324327233|FG002|Phase ll Part|Untreated|0|||
94691895|NCT00946647|324327234|FG003|Phase ll Part|Untreated|0|||
94691896|NCT00946647|324327235|FG004|Phase ll Part|Untreated|2|||
94691897|NCT00946647|324327231|FG000|Phase ll Part|Adverse Event|0|||
94691898|NCT00946647|324327232|FG001|Phase ll Part|Adverse Event|0|||
94691899|NCT00946647|324327233|FG002|Phase ll Part|Adverse Event|0|||
94691900|NCT00946647|324327234|FG003|Phase ll Part|Adverse Event|10|||
94691901|NCT00946647|324327235|FG004|Phase ll Part|Adverse Event|6|||
94691902|NCT00946647|324327231|FG000|Phase ll Part|Withdrawal by Subject|0|||
94691903|NCT00946647|324327232|FG001|Phase ll Part|Withdrawal by Subject|0|||
94691904|NCT00946647|324327233|FG002|Phase ll Part|Withdrawal by Subject|0|||
94691905|NCT00946647|324327234|FG003|Phase ll Part|Withdrawal by Subject|8|||
94691906|NCT00946647|324327235|FG004|Phase ll Part|Withdrawal by Subject|6|||
94691907|NCT00946647|324327231|FG000|Phase ll Part|Administrative problems|0|||
94691908|NCT00946647|324327232|FG001|Phase ll Part|Administrative problems|0|||
94691909|NCT00946647|324327233|FG002|Phase ll Part|Administrative problems|0|||
94691910|NCT00946647|324327234|FG003|Phase ll Part|Administrative problems|3|||
94691911|NCT00946647|324327235|FG004|Phase ll Part|Administrative problems|8|||
94691912|NCT00946647|324327231|FG000|Phase ll Part|Death|0|||
94691913|NCT00946647|324327232|FG001|Phase ll Part|Death|0|||
94691914|NCT00946647|324327233|FG002|Phase ll Part|Death|0|||
94691915|NCT00946647|324327234|FG003|Phase ll Part|Death|7|||
94691916|NCT00946647|324327235|FG004|Phase ll Part|Death|4|||
94691917|NCT00946647|324327231|FG000|Phase ll Part|Disease progression|0|||
94691918|NCT00946647|324327232|FG001|Phase ll Part|Disease progression|0|||
94691919|NCT00946647|324327233|FG002|Phase ll Part|Disease progression|0|||
94691920|NCT00946647|324327234|FG003|Phase ll Part|Disease progression|6|||
94691921|NCT00946647|324327235|FG004|Phase ll Part|Disease progression|14|||
94691922|NCT00946647|324327231|FG000|Phase ll Part|Protocol Violation|0|||
94691923|NCT00946647|324327232|FG001|Phase ll Part|Protocol Violation|0|||
94691924|NCT00946647|324327233|FG002|Phase ll Part|Protocol Violation|0|||
94691925|NCT00946647|324327234|FG003|Phase ll Part|Protocol Violation|4|||
94691926|NCT00946647|324327235|FG004|Phase ll Part|Protocol Violation|2|||
94691927|NCT00946647|324327231|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
94691928|NCT00946647|324327232|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
94691929|NCT00946647|324327233|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
94691930|NCT00946647|324327234|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
94691931|NCT00946647|324327235|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
94691932|NCT01368211|324327236|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
94691933|NCT01368211|324327237|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
94691934|NCT01563978|324327239|FG000|Overall Study|Physician Decision|1|||
94691935|NCT01563978|324327240|FG001|Overall Study|Physician Decision|0|||
94691936|NCT01563978|324327239|FG000|Overall Study|Lost to Follow-up|1|||
94691937|NCT01563978|324327240|FG001|Overall Study|Lost to Follow-up|0|||
94691938|NCT01563978|324327239|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
94691939|NCT01563978|324327240|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
94691940|NCT01563978|324327239|FG000|Overall Study|Adverse Event|1|||
94691941|NCT01563978|324327240|FG001|Overall Study|Adverse Event|2|||
94691942|NCT00663962|324327244|FG000|Overall Study|somnolence|1|||
94691943|NCT00663962|324327245|FG001|Overall Study|somnolence|0|||
94691944|NCT02218489|324327246|FG000|Overall Study|Withdrawal by Subject|4|||
94691945|NCT02218489|324327247|FG001|Overall Study|Withdrawal by Subject|3|||
94691946|NCT02218489|324327246|FG000|Overall Study|Lost to Follow-up|1|||
94691947|NCT02218489|324327247|FG001|Overall Study|Lost to Follow-up|0|||
94691948|NCT01815736|324327248|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
94691949|NCT01815736|324327249|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
94691950|NCT01815736|324327248|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
94691951|NCT01815736|324327249|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
94691952|NCT01815736|324327248|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
94691953|NCT01815736|324327249|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
94691954|NCT01815736|324327248|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
94691955|NCT01815736|324327249|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
94691956|NCT01815736|324327248|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
94691957|NCT01815736|324327249|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
94691958|NCT01815736|324327248|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
94691959|NCT01815736|324327249|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
94691960|NCT01815736|324327248|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
94691961|NCT01815736|324327249|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
94691962|NCT01815736|324327248|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
94691963|NCT01815736|324327249|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
94691964|NCT01815736|324327248|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
94691965|NCT01815736|324327249|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
94691966|NCT01815736|324327248|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
94691967|NCT01815736|324327249|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
94691968|NCT01815736|324327248|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
94691969|NCT01815736|324327249|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
94691970|NCT01815736|324327248|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
94691971|NCT01815736|324327249|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
94691972|NCT01815736|324327248|FG000|Extension Treatment Phase- After Week 96|Death|1|||
94691973|NCT01815736|324327249|FG001|Extension Treatment Phase- After Week 96|Death|0|||
94691974|NCT04329104|324328918|FG000|Efficacy Study|Withdrawal by Subject|0|||
94691975|NCT04329104|324328919|FG001|Efficacy Study|Withdrawal by Subject|0|||
94691976|NCT04329104|324328920|FG002|Efficacy Study|Withdrawal by Subject|0|||
94691977|NCT04329104|324328921|FG003|Efficacy Study|Withdrawal by Subject|5|||
94691978|NCT04329104|324328922|FG004|Efficacy Study|Withdrawal by Subject|6|||
94691979|NCT04329104|324328923|FG005|Efficacy Study|Withdrawal by Subject|8|||
94691980|NCT03884231|324328924|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
94691981|NCT03884231|324328924|FG000|Overall Study|Subject Withdrew Consent|1|||
94691982|NCT03884231|324328924|FG000|Overall Study|MRI Scan Not Performed|1|||
94691983|NCT01023308|324328930|FG000|Overall Study|Abnormal test proceedure results|3|||
94691984|NCT01023308|324328931|FG001|Overall Study|Abnormal test proceedure results|8|||
94691985|NCT01023308|324328930|FG000|Overall Study|Administrative problems|2|||
94691986|NCT01023308|324328931|FG001|Overall Study|Administrative problems|1|||
94691987|NCT01023308|324328930|FG000|Overall Study|Adverse Event|130|||
94691988|NCT01023308|324328931|FG001|Overall Study|Adverse Event|66|||
94691989|NCT01023308|324328930|FG000|Overall Study|Death|21|||
94691990|NCT01023308|324328931|FG001|Overall Study|Death|17|||
94691991|NCT01023308|324328930|FG000|Overall Study|Disease progression|82|||
94691992|NCT01023308|324328931|FG001|Overall Study|Disease progression|153|||
94691993|NCT01023308|324328930|FG000|Overall Study|New Cancer therapy|4|||
94691994|NCT01023308|324328931|FG001|Overall Study|New Cancer therapy|7|||
94691995|NCT01023308|324328930|FG000|Overall Study|Protocol Violation|3|||
94691996|NCT01023308|324328931|FG001|Overall Study|Protocol Violation|4|||
94691997|NCT01023308|324328930|FG000|Overall Study|Untreated|5|||
94691998|NCT01023308|324328931|FG001|Overall Study|Untreated|5|||
94691999|NCT01023308|324328930|FG000|Overall Study|Lost to Follow-up|1|||
94692000|NCT01023308|324328931|FG001|Overall Study|Lost to Follow-up|0|||
94692001|NCT01023308|324328930|FG000|Overall Study|Withdrawal by Subject|34|||
94692002|NCT01023308|324328931|FG001|Overall Study|Withdrawal by Subject|18|||
94692003|NCT01238575|324328932|FG000|Overall Study|Lack of Efficacy|2|||
94692004|NCT01238575|324328933|FG001|Overall Study|Lack of Efficacy|4|||
94692005|NCT01238575|324328932|FG000|Overall Study|Adverse Event|2|||
94692006|NCT01238575|324328933|FG001|Overall Study|Adverse Event|0|||
94692007|NCT03525574|324328934|FG000|Overall Study|Adverse Event|15|||
94692008|NCT03525574|324328935|FG001|Overall Study|Adverse Event|0|||
94692009|NCT03525574|324328934|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
94692010|NCT03525574|324328935|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
94692011|NCT03525574|324328934|FG000|Overall Study|Lost to Follow-up|4|||
94365902|NCT03747939|323124820|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
94365903|NCT03747939|323124821|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
94365904|NCT03747939|323124818|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
94365905|NCT03747939|323124819|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
94365906|NCT03747939|323124820|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
94365907|NCT03747939|323124821|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
94365908|NCT03747939|323124818|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
94692012|NCT03525574|324328935|FG001|Overall Study|Lost to Follow-up|0|||
94692013|NCT03525574|324328934|FG000|Overall Study|Commercial drug is Available for participant|48|||
94692014|NCT03525574|324328935|FG001|Overall Study|Commercial drug is Available for participant|0|||
94692015|NCT03525574|324328934|FG000|Overall Study|Death|1|||
94692016|NCT03525574|324328935|FG001|Overall Study|Death|0|||
94692017|NCT03525574|324328934|FG000|Overall Study|Other non-compliance|2|||
94692018|NCT03525574|324328935|FG001|Overall Study|Other non-compliance|0|||
94692019|NCT03525574|324328934|FG000|Overall Study|Physician Decision|6|||
94692020|NCT03525574|324328935|FG001|Overall Study|Physician Decision|0|||
94692021|NCT03525574|324328934|FG000|Overall Study|Other|58|||
94692022|NCT03525574|324328935|FG001|Overall Study|Other|0|||
94692023|NCT03525574|324328934|FG000|Overall Study|Enrolled but never dosed|1|||
94692024|NCT03525574|324328935|FG001|Overall Study|Enrolled but never dosed|0|||
94692025|NCT03525574|324328934|FG000|Overall Study|Not enrolled in 105 study|0|||
94692026|NCT03525574|324328935|FG001|Overall Study|Not enrolled in 105 study|3|||
94692027|NCT02726399|324328936|FG000|Overall Study|Participant Non-Compliance|1|||
94692028|NCT02726399|324328936|FG000|Overall Study|Adverse Event|2|||
94692029|NCT02726399|324328936|FG000|Overall Study|Progression of disease|4|||
94692030|NCT03685708|324328937|FG000|Overall Study|Withdrawal by Subject|0|||
94692031|NCT03685708|324328938|FG001|Overall Study|Withdrawal by Subject|0|||
94692032|NCT03685708|324328939|FG002|Overall Study|Withdrawal by Subject|1|||
94692033|NCT03685708|324328937|FG000|Overall Study|Screen Fail|0|||
94692034|NCT03685708|324328938|FG001|Overall Study|Screen Fail|1|||
94692035|NCT03685708|324328939|FG002|Overall Study|Screen Fail|1|||
94692036|NCT03685708|324328937|FG000|Overall Study|COVID 19 Pandemic|1|||
94692037|NCT03685708|324328938|FG001|Overall Study|COVID 19 Pandemic|1|||
94692038|NCT03685708|324328939|FG002|Overall Study|COVID 19 Pandemic|6|||
94692039|NCT03685708|324328937|FG000|Overall Study|Disease Progression|0|||
94692040|NCT03685708|324328938|FG001|Overall Study|Disease Progression|0|||
94692041|NCT03685708|324328939|FG002|Overall Study|Disease Progression|1|||
94692042|NCT04668989|324328940|FG000|First Intervention|Covid-19 related self-isolation|0|||
94692043|NCT04668989|324328941|FG001|First Intervention|Covid-19 related self-isolation|1|||
94692044|NCT04668989|324328940|FG000|Second Intervention|Adverse Event|0|||
94692045|NCT04668989|324328941|FG001|Second Intervention|Adverse Event|1|||
94692046|NCT01349907|324328948|FG000|Overall Study|Adverse Event|37|||
94692047|NCT01349907|324328949|FG001|Overall Study|Adverse Event|11|||
94692048|NCT01349907|324328948|FG000|Overall Study|Treatment failure|13|||
94692049|NCT01349907|324328949|FG001|Overall Study|Treatment failure|4|||
94692050|NCT01349907|324328948|FG000|Overall Study|Lost to Follow-up|25|||
94692051|NCT01349907|324328949|FG001|Overall Study|Lost to Follow-up|6|||
94692052|NCT01349907|324328948|FG000|Overall Study|Withdrawal by Subject|30|||
94692053|NCT01349907|324328949|FG001|Overall Study|Withdrawal by Subject|8|||
94692054|NCT01349907|324328948|FG000|Overall Study|Protocol Violation|33|||
94692055|NCT01349907|324328949|FG001|Overall Study|Protocol Violation|13|||
94692056|NCT01349907|324328948|FG000|Overall Study|Administrative|1|||
94692057|NCT01349907|324328949|FG001|Overall Study|Administrative|1|||
94692058|NCT00610675|324328954|FG000|Overall Study|Untreated|4|||
94692059|NCT00610675|324328954|FG000|Overall Study|Adverse Event|67|||
94692060|NCT00610675|324328954|FG000|Overall Study|Insufficient Effect|31|||
94692061|NCT00610675|324328954|FG000|Overall Study|Withdrawal by Subject|28|||
94692062|NCT00610675|324328954|FG000|Overall Study|Reasons unrelated to trial|27|||
94692063|NCT00610675|324328954|FG000|Overall Study|Lack of Compliance|7|||
94692064|NCT00610675|324328954|FG000|Overall Study|Lost to Follow-up|31|||
94692065|NCT00610675|324328954|FG000|Overall Study|Other reason (not specified)|25|||
94692066|NCT01348854|324328955|FG000|Overall Study|Lost to Follow-up|2|||
94692067|NCT01348854|324328956|FG001|Overall Study|Lost to Follow-up|1|||
94692068|NCT01348854|324328955|FG000|Overall Study|Withdrawal by Subject|1|||
94692069|NCT01348854|324328956|FG001|Overall Study|Withdrawal by Subject|0|||
94692070|NCT04011384|324328966|FG000|Overall Study|Withdrawal by Subject|2|||
94692071|NCT04011384|324328967|FG001|Overall Study|Withdrawal by Subject|0|||
94692072|NCT03192215|324328968|FG000|Overall Study|Death|28|||
94692073|NCT03192215|324328969|FG001|Overall Study|Death|23|||
94692074|NCT03192215|324328968|FG000|Overall Study|Lost to Follow-up|10|||
94692075|NCT03192215|324328969|FG001|Overall Study|Lost to Follow-up|15|||
94692076|NCT03192215|324328968|FG000|Overall Study|Withdrawal by Subject|49|||
94692077|NCT03192215|324328969|FG001|Overall Study|Withdrawal by Subject|48|||
94692078|NCT03192215|324328968|FG000|Overall Study|Other as reported in analysis|4|||
94692079|NCT03192215|324328969|FG001|Overall Study|Other as reported in analysis|1|||
94692080|NCT01364727|324328972|FG000|Overall Study|Not Eligible|2|||
94692081|NCT00688259|324328973|FG000|Overall Study|Lost to Follow-up|2|||
94692082|NCT00688259|324328974|FG001|Overall Study|Lost to Follow-up|4|||
94692083|NCT00688259|324328973|FG000|Overall Study|Physician Decision|1|||
94692084|NCT00688259|324328974|FG001|Overall Study|Physician Decision|0|||
94692085|NCT00688259|324328973|FG000|Overall Study|Withdrawal by Subject|2|||
94692086|NCT00688259|324328974|FG001|Overall Study|Withdrawal by Subject|0|||
94692087|NCT00688259|324328973|FG000|Overall Study|Declined Interview|2|||
94692088|NCT00688259|324328974|FG001|Overall Study|Declined Interview|3|||
94692089|NCT00688259|324328973|FG000|Overall Study|Hospitalized at Follow-up|0|||
94692090|NCT00688259|324328974|FG001|Overall Study|Hospitalized at Follow-up|1|||
94692091|NCT01676220|324328975|FG000|Overall Study|Randomized But Not Treated|4|||
94692092|NCT01676220|324328976|FG001|Overall Study|Randomized But Not Treated|1|||
94692093|NCT01676220|324328975|FG000|Overall Study|Adverse Event|10|||
94692094|NCT01676220|324328976|FG001|Overall Study|Adverse Event|8|||
94692095|NCT01676220|324328975|FG000|Overall Study|Lack of Efficacy|2|||
94692096|NCT01676220|324328976|FG001|Overall Study|Lack of Efficacy|5|||
94692097|NCT01676220|324328975|FG000|Overall Study|Protocol Violation|11|||
94692098|NCT01676220|324328976|FG001|Overall Study|Protocol Violation|12|||
94692099|NCT01676220|324328975|FG000|Overall Study|Received Rescue Therapy|14|||
94692100|NCT01676220|324328976|FG001|Overall Study|Received Rescue Therapy|22|||
94692101|NCT01676220|324328975|FG000|Overall Study|Personal Reason|34|||
94692102|NCT01676220|324328976|FG001|Overall Study|Personal Reason|45|||
94692103|NCT01676220|324328975|FG000|Overall Study|Lost to Follow-up|11|||
94692104|NCT01676220|324328976|FG001|Overall Study|Lost to Follow-up|18|||
94692105|NCT01676220|324328975|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
94692106|NCT01676220|324328976|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
94692107|NCT01676220|324328975|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
94692108|NCT01676220|324328976|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
94692109|NCT01676220|324328975|FG000|Overall Study|Perceived Lack of Efficacy|3|||
94692110|NCT01676220|324328976|FG001|Overall Study|Perceived Lack of Efficacy|1|||
94692111|NCT01676220|324328975|FG000|Overall Study|Non Serious Hypoglycemia|2|||
94692112|NCT01676220|324328976|FG001|Overall Study|Non Serious Hypoglycemia|0|||
94692113|NCT01676220|324328975|FG000|Overall Study|No More Need of Insulin|1|||
94692114|NCT01676220|324328976|FG001|Overall Study|No More Need of Insulin|0|||
94692115|NCT01310868|324328977|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
94692116|NCT02491892|324328978|FG000|Overall Study|Adverse Event|1|||
94692117|NCT02491892|324328979|FG001|Overall Study|Adverse Event|1|||
94692118|NCT02491892|324328978|FG000|Overall Study|Death|1|||
94692119|NCT02491892|324328979|FG001|Overall Study|Death|1|||
94692120|NCT02491892|324328978|FG000|Overall Study|Lack of Efficacy|37|||
94692121|NCT02491892|324328979|FG001|Overall Study|Lack of Efficacy|36|||
94692122|NCT02491892|324328978|FG000|Overall Study|Refused Treatment|1|||
94692123|NCT02491892|324328979|FG001|Overall Study|Refused Treatment|0|||
94692124|NCT02491892|324328978|FG000|Overall Study|Lost to Follow-up|1|||
94692125|NCT02491892|324328979|FG001|Overall Study|Lost to Follow-up|0|||
94692126|NCT00322374|324328984|FG000|Starting Dose|Physician Decision|2|||
94692127|NCT00322374|324328985|FG001|Starting Dose|Physician Decision|0|||
94692128|NCT00322374|324328986|FG002|Starting Dose|Physician Decision|0|||
94692129|NCT00322374|324328987|FG003|Starting Dose|Physician Decision|0|||
94692130|NCT00322374|324328984|FG000|Starting Dose|Study Drug Toxicity|4|||
94692131|NCT00322374|324328985|FG001|Starting Dose|Study Drug Toxicity|0|||
94692132|NCT00322374|324328986|FG002|Starting Dose|Study Drug Toxicity|0|||
94692133|NCT00322374|324328987|FG003|Starting Dose|Study Drug Toxicity|0|||
94692134|NCT00322374|324328984|FG000|First Escalation|Documented Disease Progression|0|||
94692135|NCT00322374|324328985|FG001|First Escalation|Documented Disease Progression|6|||
94692136|NCT00322374|324328986|FG002|First Escalation|Documented Disease Progression|0|||
94692137|NCT00322374|324328987|FG003|First Escalation|Documented Disease Progression|0|||
94692138|NCT00322374|324328984|FG000|First Escalation|Physician Decision|0|||
94692139|NCT00322374|324328985|FG001|First Escalation|Physician Decision|12|||
94692140|NCT00322374|324328986|FG002|First Escalation|Physician Decision|0|||
94692141|NCT00322374|324328987|FG003|First Escalation|Physician Decision|0|||
94692142|NCT00322374|324328984|FG000|First Escalation|Study Drug Toxicity|0|||
94692143|NCT00322374|324328985|FG001|First Escalation|Study Drug Toxicity|11|||
94692144|NCT00322374|324328986|FG002|First Escalation|Study Drug Toxicity|0|||
94692145|NCT00322374|324328987|FG003|First Escalation|Study Drug Toxicity|0|||
94692146|NCT00322374|324328984|FG000|First Escalation|Participant Request|0|||
94692147|NCT00322374|324328985|FG001|First Escalation|Participant Request|1|||
94692148|NCT00322374|324328986|FG002|First Escalation|Participant Request|0|||
94692149|NCT00322374|324328987|FG003|First Escalation|Participant Request|0|||
94692150|NCT00322374|324328984|FG000|Second Escalation|Physician Decision|0|||
94692151|NCT00322374|324328985|FG001|Second Escalation|Physician Decision|0|||
94692152|NCT00322374|324328986|FG002|Second Escalation|Physician Decision|5|||
94692153|NCT00322374|324328987|FG003|Second Escalation|Physician Decision|0|||
94692154|NCT00322374|324328984|FG000|Second Escalation|Study Drug Toxicity|0|||
94692155|NCT00322374|324328985|FG001|Second Escalation|Study Drug Toxicity|0|||
94692156|NCT00322374|324328986|FG002|Second Escalation|Study Drug Toxicity|1|||
94692157|NCT00322374|324328987|FG003|Second Escalation|Study Drug Toxicity|0|||
94692158|NCT01058863|324328988|FG000|Overall Study|Lost to Follow-up|1|||
94692159|NCT01058863|324328988|FG000|Overall Study|Withdrawal by Subject|1|||
94692160|NCT01058863|324328988|FG000|Overall Study|Sponsor requested withdrawal|1|||
94692161|NCT01058863|324328988|FG000|Overall Study|Randomized in error|1|||
94692162|NCT03619174|324328989|FG000|Overall Study|Lost to Follow-up|3|||
94692163|NCT03619174|324328990|FG001|Overall Study|Lost to Follow-up|0|||
94692164|NCT03619174|324328989|FG000|Overall Study|Withdrawal by Subject|4|||
94692165|NCT03619174|324328990|FG001|Overall Study|Withdrawal by Subject|3|||
94692166|NCT03619174|324328989|FG000|Overall Study|Pregnancy|1|||
94692167|NCT03619174|324328990|FG001|Overall Study|Pregnancy|1|||
94692168|NCT03619174|324328989|FG000|Overall Study|Discomfort during treatment|1|||
94692169|NCT03619174|324328990|FG001|Overall Study|Discomfort during treatment|0|||
94692170|NCT01991197|324328991|FG000|Overall Study|Lost to Follow-up|1|||
94692171|NCT01991197|324328992|FG001|Overall Study|Lost to Follow-up|1|||
94692172|NCT01991197|324328991|FG000|Overall Study|Physician Decision|0|||
94692173|NCT01991197|324328992|FG001|Overall Study|Physician Decision|2|||
94692174|NCT01991197|324328991|FG000|Overall Study|Withdrawal by Subject|2|||
94692175|NCT01991197|324328992|FG001|Overall Study|Withdrawal by Subject|0|||
94466037|NCT00435019|323494985|FG000|Overall Study|Protocol Violation|3|||
94692176|NCT01012973|324328993|FG000|Overall Study|Adverse Event|5|||
94692177|NCT01012973|324328994|FG001|Overall Study|Adverse Event|5|||
94692178|NCT01012973|324328993|FG000|Overall Study|Lack of Efficacy|0|||
94692179|NCT01012973|324328994|FG001|Overall Study|Lack of Efficacy|5|||
94692180|NCT01012973|324328993|FG000|Overall Study|Lost to Follow-up|1|||
94692181|NCT01012973|324328994|FG001|Overall Study|Lost to Follow-up|0|||
94692182|NCT01012973|324328993|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
94692183|NCT01012973|324328994|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
94692184|NCT01012973|324328993|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
94692185|NCT01012973|324328994|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
94692186|NCT01012973|324328993|FG000|Overall Study|Protocol Violation|5|||
94692187|NCT01012973|324328994|FG001|Overall Study|Protocol Violation|2|||
94692188|NCT01012973|324328993|FG000|Overall Study|Withdrawal by Subject|4|||
94692189|NCT01012973|324328994|FG001|Overall Study|Withdrawal by Subject|6|||
94692190|NCT02025205|324328996|FG000|Overall Study|Withdrawal by Subject|1|||
94692191|NCT02025205|324328997|FG001|Overall Study|Withdrawal by Subject|1|||
94692192|NCT02025205|324328996|FG000|Overall Study|Protocol Violation|2|||
94692193|NCT02025205|324328997|FG001|Overall Study|Protocol Violation|1|||
94692194|NCT02025205|324328996|FG000|Overall Study|Death|0|||
94692195|NCT02025205|324328997|FG001|Overall Study|Death|1|||
94692196|NCT02448719|324328998|FG000|Overall Study|Withdrawal by Subject|0|||
94692197|NCT02448719|324328999|FG001|Overall Study|Withdrawal by Subject|0|||
94692198|NCT02448719|324329000|FG002|Overall Study|Withdrawal by Subject|0|||
94692199|NCT02448719|324329001|FG003|Overall Study|Withdrawal by Subject|0|||
94692200|NCT02448719|324329002|FG004|Overall Study|Withdrawal by Subject|1|||
94692201|NCT02448719|324329003|FG005|Overall Study|Withdrawal by Subject|0|||
94692202|NCT02448719|324329004|FG006|Overall Study|Withdrawal by Subject|0|||
94692203|NCT02448719|324329005|FG007|Overall Study|Withdrawal by Subject|0|||
94692204|NCT02448719|324329006|FG008|Overall Study|Withdrawal by Subject|0|||
94692205|NCT02448719|324329007|FG009|Overall Study|Withdrawal by Subject|0|||
94692206|NCT02448719|324329008|FG010|Overall Study|Withdrawal by Subject|0|||
94692207|NCT01473420|324329010|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
94692208|NCT01473420|324329011|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
94692209|NCT01473420|324329010|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
94692210|NCT01473420|324329011|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
94692211|NCT01473420|324329010|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
94692212|NCT01473420|324329011|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
94692213|NCT01473420|324329010|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
94692214|NCT01473420|324329011|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
94692215|NCT01473420|324329010|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
94692216|NCT01473420|324329011|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
94692217|NCT01473420|324329010|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
94692218|NCT01473420|324329011|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
94692219|NCT01473420|324329010|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
94692220|NCT01473420|324329011|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
94692221|NCT01473420|324329010|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
94692222|NCT01473420|324329011|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
94692223|NCT01473420|324329010|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
94692224|NCT01473420|324329011|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
94692225|NCT01473420|324329010|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
94692226|NCT01473420|324329011|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
94692227|NCT01473420|324329010|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
94692228|NCT01473420|324329011|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
94692229|NCT01473420|324329010|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
94692230|NCT01473420|324329011|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
94692231|NCT01473420|324329010|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
94692232|NCT01473420|324329011|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
94692233|NCT04894903|324329018|FG000|Overall Study|Death|1|||
94692234|NCT04894903|324329019|FG001|Overall Study|Death|0|||
94692235|NCT04894903|324329018|FG000|Overall Study|Pregnancy|1|||
94692236|NCT04894903|324329019|FG001|Overall Study|Pregnancy|0|||
94692237|NCT04894903|324329018|FG000|Overall Study|Withdrawal by Subject|1|||
94692238|NCT04894903|324329019|FG001|Overall Study|Withdrawal by Subject|1|||
94692239|NCT04894903|324329018|FG000|Overall Study|moved or exited health system|1|||
94692240|NCT04894903|324329019|FG001|Overall Study|moved or exited health system|3|||
94692241|NCT03714022|324329021|FG000|Overall Study|Adverse Event|1|||
94692242|NCT03714022|324329022|FG001|Overall Study|Adverse Event|0|||
94692243|NCT03714022|324329021|FG000|Overall Study|Consent withdrawal|0|||
94692244|NCT03714022|324329022|FG001|Overall Study|Consent withdrawal|1|||
94692245|NCT03714022|324329021|FG000|Overall Study|Lost to Follow-up|3|||
94692246|NCT03714022|324329022|FG001|Overall Study|Lost to Follow-up|2|||
94692247|NCT01923428|324329025|FG000|Overall Study|Adverse Event|8|||
94692248|NCT01923428|324329026|FG001|Overall Study|Adverse Event|6|||
94692249|NCT01923428|324329027|FG002|Overall Study|Adverse Event|3|||
94692250|NCT01923428|324329028|FG003|Overall Study|Adverse Event|3|||
94692251|NCT01923428|324329025|FG000|Overall Study|Withdrawal by Subject|5|||
94692252|NCT01923428|324329026|FG001|Overall Study|Withdrawal by Subject|3|||
94692253|NCT01923428|324329027|FG002|Overall Study|Withdrawal by Subject|0|||
94692254|NCT01923428|324329028|FG003|Overall Study|Withdrawal by Subject|4|||
94692255|NCT01923428|324329025|FG000|Overall Study|Lost to Follow-up|2|||
94692256|NCT01923428|324329026|FG001|Overall Study|Lost to Follow-up|1|||
94692257|NCT01923428|324329027|FG002|Overall Study|Lost to Follow-up|5|||
94692258|NCT01923428|324329028|FG003|Overall Study|Lost to Follow-up|0|||
94692259|NCT01923428|324329025|FG000|Overall Study|Protocol Violation|3|||
94692260|NCT01923428|324329026|FG001|Overall Study|Protocol Violation|0|||
94692261|NCT01923428|324329027|FG002|Overall Study|Protocol Violation|2|||
94692262|NCT01923428|324329028|FG003|Overall Study|Protocol Violation|1|||
94692263|NCT01923428|324329025|FG000|Overall Study|Non Compliance to treatment|1|||
94692264|NCT01923428|324329026|FG001|Overall Study|Non Compliance to treatment|2|||
94692265|NCT01923428|324329027|FG002|Overall Study|Non Compliance to treatment|0|||
94692266|NCT01923428|324329028|FG003|Overall Study|Non Compliance to treatment|1|||
94692267|NCT01923428|324329025|FG000|Overall Study|Lack of Efficacy|0|||
94692268|NCT01923428|324329026|FG001|Overall Study|Lack of Efficacy|0|||
94692269|NCT01923428|324329027|FG002|Overall Study|Lack of Efficacy|1|||
94692270|NCT01923428|324329028|FG003|Overall Study|Lack of Efficacy|1|||
94692271|NCT01822353|324329029|FG000|Overall Study|Adverse Event|1|||
94692272|NCT01822353|324329030|FG001|Overall Study|Adverse Event|3|||
94692273|NCT01822353|324329031|FG002|Overall Study|Adverse Event|1|||
94692274|NCT01822353|324329029|FG000|Overall Study|Pregnancy|0|||
94692275|NCT01822353|324329030|FG001|Overall Study|Pregnancy|1|||
94692276|NCT01822353|324329031|FG002|Overall Study|Pregnancy|0|||
94692277|NCT01822353|324329029|FG000|Overall Study|Withdrawal by Subject|3|||
94692278|NCT01822353|324329030|FG001|Overall Study|Withdrawal by Subject|1|||
94692279|NCT01822353|324329031|FG002|Overall Study|Withdrawal by Subject|0|||
94692280|NCT04320615|324329032|FG000|Overall Study|Withdrawal by Subject|4|||
94692281|NCT04320615|324329033|FG001|Overall Study|Withdrawal by Subject|10|||
94692282|NCT04320615|324329032|FG000|Overall Study|Physician Decision|2|||
94692283|NCT04320615|324329033|FG001|Overall Study|Physician Decision|0|||
94692284|NCT04320615|324329032|FG000|Overall Study|Other|2|||
94692285|NCT04320615|324329033|FG001|Overall Study|Other|0|||
94692286|NCT04320615|324329032|FG000|Overall Study|Lost to Follow-up|5|||
94692287|NCT04320615|324329033|FG001|Overall Study|Lost to Follow-up|23|||
94692288|NCT04320615|324329032|FG000|Overall Study|Death|35|||
94692289|NCT04320615|324329033|FG001|Overall Study|Death|71|||
94692290|NCT00895843|324329034|FG000|Overall Study|Protocol Violation|12|||
94692291|NCT00895843|324329035|FG001|Overall Study|Protocol Violation|12|||
94692292|NCT01602380|324329038|FG000|Overall Study|Death|147|||
94692293|NCT01602380|324329039|FG001|Overall Study|Death|145|||
94692294|NCT01602380|324329038|FG000|Overall Study|Withdrawal by Subject|39|||
94692295|NCT01602380|324329039|FG001|Overall Study|Withdrawal by Subject|41|||
94692296|NCT01602380|324329038|FG000|Overall Study|Lost to Follow-up|15|||
94692297|NCT01602380|324329039|FG001|Overall Study|Lost to Follow-up|12|||
94692298|NCT01602380|324329038|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
94692299|NCT01602380|324329039|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
94692300|NCT01602380|324329038|FG000|Overall Study|Other|2|||
94692301|NCT01602380|324329039|FG001|Overall Study|Other|0|||
94692302|NCT02036515|324329043|FG000|Overall Study|Adverse Event|1|||
94692303|NCT02036515|324329044|FG001|Overall Study|Adverse Event|1|||
94692304|NCT02036515|324329045|FG002|Overall Study|Adverse Event|2|||
94692305|NCT02036515|324329043|FG000|Overall Study|Lost to Follow-up|0|||
94692306|NCT02036515|324329044|FG001|Overall Study|Lost to Follow-up|2|||
94692307|NCT02036515|324329045|FG002|Overall Study|Lost to Follow-up|0|||
94692308|NCT02036515|324329043|FG000|Overall Study|Non-compliance with study drug|0|||
94692309|NCT02036515|324329044|FG001|Overall Study|Non-compliance with study drug|0|||
94692310|NCT02036515|324329045|FG002|Overall Study|Non-compliance with study drug|2|||
94692311|NCT02036515|324329043|FG000|Overall Study|Screen failure|0|||
94365909|NCT03747939|323124819|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
94365910|NCT03747939|323124820|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
94365911|NCT03747939|323124821|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
94365912|NCT03747939|323124818|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
94365913|NCT03747939|323124819|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
94692312|NCT02036515|324329044|FG001|Overall Study|Screen failure|2|||
94692313|NCT02036515|324329045|FG002|Overall Study|Screen failure|0|||
94692314|NCT02036515|324329043|FG000|Overall Study|Withdrawal by Subject|4|||
94692315|NCT02036515|324329044|FG001|Overall Study|Withdrawal by Subject|7|||
94692316|NCT02036515|324329045|FG002|Overall Study|Withdrawal by Subject|9|||
94692317|NCT02036515|324329043|FG000|Overall Study|Hyperglycemia|0|||
94692318|NCT02036515|324329044|FG001|Overall Study|Hyperglycemia|0|||
94692319|NCT02036515|324329045|FG002|Overall Study|Hyperglycemia|1|||
94692320|NCT01342887|324329046|FG000|Overall Study|Death|2|||
94692321|NCT03428815|324329047|FG000|Overall Study|Lost to Follow-up|2|||
94692322|NCT03428815|324329048|FG001|Overall Study|Lost to Follow-up|2|||
94692323|NCT03428815|324329047|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
94692324|NCT03428815|324329048|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
94692325|NCT03428815|324329047|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
94692326|NCT03428815|324329048|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
94692327|NCT03387514|324329050|FG000|Overall Study|Withdrawal by Subject|2|||
94692328|NCT03387514|324329050|FG000|Overall Study|Physician Decision|1|||
94692329|NCT03387514|324329050|FG000|Overall Study|Lost to Follow-up|2|||
94692330|NCT03040687|324329061|FG000|Overall Study|Withdrawal by Subject|1|||
94692331|NCT03040687|324329062|FG001|Overall Study|Withdrawal by Subject|0|||
94692332|NCT03040687|324329063|FG002|Overall Study|Withdrawal by Subject|0|||
94692333|NCT00550173|324329064|FG000|Overall Study|Death|45|||
94692334|NCT00550173|324329065|FG001|Overall Study|Death|38|||
94692335|NCT00550173|324329066|FG002|Overall Study|Death|50|||
94692336|NCT00550173|324329064|FG000|Overall Study|Physician Decision|1|||
94692337|NCT00550173|324329065|FG001|Overall Study|Physician Decision|2|||
94692338|NCT00550173|324329066|FG002|Overall Study|Physician Decision|2|||
94692339|NCT00550173|324329064|FG000|Overall Study|Withdrawal by Subject|9|||
94692340|NCT00550173|324329065|FG001|Overall Study|Withdrawal by Subject|12|||
94692341|NCT00550173|324329066|FG002|Overall Study|Withdrawal by Subject|17|||
94692342|NCT00550173|324329064|FG000|Overall Study|Sponsor Decision|13|||
94692343|NCT00550173|324329065|FG001|Overall Study|Sponsor Decision|7|||
94692344|NCT00550173|324329066|FG002|Overall Study|Sponsor Decision|1|||
94692345|NCT00550173|324329064|FG000|Overall Study|Lost to Follow-up|4|||
94692346|NCT00550173|324329065|FG001|Overall Study|Lost to Follow-up|4|||
94692347|NCT00550173|324329066|FG002|Overall Study|Lost to Follow-up|3|||
94692348|NCT00810641|324329073|FG000|Overall Study|Withdrawal by Subject|0|||
94692349|NCT00810641|324329074|FG001|Overall Study|Withdrawal by Subject|1|||
94692350|NCT00810641|324329075|FG002|Overall Study|Withdrawal by Subject|2|||
94692351|NCT02325713|324329082|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
94692352|NCT02325713|324329083|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
94692353|NCT02325713|324329084|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
94692354|NCT02325713|324329085|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
94692355|NCT02325713|324329086|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
94692356|NCT02325713|324329087|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
94692357|NCT02325713|324329088|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
94692358|NCT02325713|324329089|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
94692359|NCT02325713|324329090|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
94692360|NCT02325713|324329091|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
94692361|NCT02325713|324329092|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
94692362|NCT02325713|324329093|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
94692363|NCT02325713|324329094|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
94692364|NCT02325713|324329095|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
94692365|NCT02325713|324329096|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
94692366|NCT02325713|324329097|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
94692367|NCT02325713|324329082|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
94692368|NCT02325713|324329083|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
94692369|NCT02325713|324329084|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
94692370|NCT02325713|324329085|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
94692371|NCT02325713|324329086|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
94692372|NCT02325713|324329087|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
94692373|NCT02325713|324329088|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
94692374|NCT02325713|324329089|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
94692375|NCT02325713|324329090|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
94692376|NCT02325713|324329091|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
94692377|NCT02325713|324329092|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
94692378|NCT02325713|324329093|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
94692379|NCT02325713|324329094|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
94692380|NCT02325713|324329095|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
94692381|NCT02325713|324329096|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
94692382|NCT02325713|324329097|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
94692383|NCT02325713|324329082|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
94692384|NCT02325713|324329083|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
94692385|NCT02325713|324329084|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
94692386|NCT02325713|324329085|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
94692387|NCT02325713|324329086|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
94692388|NCT02325713|324329087|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
94692389|NCT02325713|324329088|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
94692390|NCT02325713|324329089|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
94692391|NCT02325713|324329090|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
94692392|NCT02325713|324329091|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
94692393|NCT02325713|324329092|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
94692394|NCT02325713|324329093|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
94692395|NCT02325713|324329094|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
94692396|NCT02325713|324329095|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
94692397|NCT02325713|324329096|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
94692398|NCT02325713|324329097|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
94692399|NCT01213173|324329099|FG000|Overall Study|Protocol Violation|2|||
94692400|NCT01213173|324329100|FG001|Overall Study|Protocol Violation|0|||
94692401|NCT01213173|324329099|FG000|Overall Study|Adverse Event|4|||
94692402|NCT01213173|324329100|FG001|Overall Study|Adverse Event|8|||
94692403|NCT01213173|324329099|FG000|Overall Study|Withdrawal by Subject|5|||
94692404|NCT01213173|324329100|FG001|Overall Study|Withdrawal by Subject|5|||
94692405|NCT01213173|324329099|FG000|Overall Study|Incorrect Enrollment|1|||
94692406|NCT01213173|324329100|FG001|Overall Study|Incorrect Enrollment|3|||
94692407|NCT00654940|324330644|FG000|Period 1|Adverse Event|0|||
94692408|NCT00654940|324330645|FG001|Period 1|Adverse Event|1|||
94692409|NCT00654940|324330644|FG000|Period 1|Intolerable Pain Level|1|||
94692410|NCT00654940|324330645|FG001|Period 1|Intolerable Pain Level|0|||
94692411|NCT00802737|324330646|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
94692412|NCT00802737|324330647|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
94692413|NCT00802737|324330648|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
94692414|NCT00802737|324330646|FG000|Overall Study|Death|6|||
94692415|NCT00802737|324330647|FG001|Overall Study|Death|5|||
94692416|NCT00802737|324330648|FG002|Overall Study|Death|1|||
94692417|NCT00802737|324330646|FG000|Overall Study|Adverse Event|1|||
94692418|NCT00802737|324330647|FG001|Overall Study|Adverse Event|0|||
94692419|NCT00802737|324330648|FG002|Overall Study|Adverse Event|0|||
94692420|NCT00802737|324330646|FG000|Overall Study|Received Prohibited Therapy|1|||
94692421|NCT00802737|324330647|FG001|Overall Study|Received Prohibited Therapy|0|||
94692422|NCT00802737|324330648|FG002|Overall Study|Received Prohibited Therapy|0|||
94692423|NCT00802737|324330646|FG000|Overall Study|Ongoing CLL-Treatment|0|||
94692424|NCT00802737|324330647|FG001|Overall Study|Ongoing CLL-Treatment|1|||
94692425|NCT00802737|324330648|FG002|Overall Study|Ongoing CLL-Treatment|0|||
94692426|NCT00802737|324330646|FG000|Overall Study|Participant too Unwell|0|||
94692427|NCT00802737|324330647|FG001|Overall Study|Participant too Unwell|2|||
94692428|NCT00802737|324330648|FG002|Overall Study|Participant too Unwell|0|||
94692429|NCT02930122|324330651|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
94692430|NCT02930122|324330652|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
94692431|NCT01681368|324330654|FG000|Overall Study|Refused further treatment|1|||
94692432|NCT01681368|324330654|FG000|Overall Study|Refused further follow up|1|||
94692433|NCT03943589|324330655|FG000|Overall Study|Death|1|||
94692434|NCT03943589|324330655|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
94692435|NCT01853254|324330656|FG000|Overall Study|Abnormal Laboratory Test|1|||
94692436|NCT01853254|324330656|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
94692437|NCT01853254|324330656|FG000|Overall Study|Death|1|||
94692438|NCT01853254|324330656|FG000|Overall Study|Failure to Return|43|||
94692439|NCT01853254|324330656|FG000|Overall Study|Insufficient Therapeutic Response|22|||
94692440|NCT01853254|324330656|FG000|Overall Study|Refusal of Treatment|1|||
94692441|NCT01853254|324330656|FG000|Overall Study|Other Protocol Violation|1|||
94692442|NCT01853254|324330656|FG000|Overall Study|Withdrawal of Consent|16|||
94692443|NCT01853254|324330656|FG000|Overall Study|Administrative/Other|16|||
94692444|NCT00506285|324330657|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
94692445|NCT00506285|324330658|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
94692446|NCT00506285|324330657|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
94692447|NCT00506285|324330658|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
94692448|NCT00506285|324330657|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
94365914|NCT03747939|323124820|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
94365915|NCT03747939|323124821|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
94365916|NCT03747939|323124818|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
94692449|NCT00506285|324330658|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
94692450|NCT00506285|324330657|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
94692451|NCT00506285|324330658|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
94692452|NCT00506285|324330657|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
94692453|NCT00506285|324330658|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
94692454|NCT00551213|324330659|FG000|Overall Study|Adverse Event|6|||
94692455|NCT00551213|324330660|FG001|Overall Study|Adverse Event|3|||
94692456|NCT00551213|324330659|FG000|Overall Study|Progressive Disease|41|||
94692457|NCT00551213|324330660|FG001|Overall Study|Progressive Disease|12|||
94692458|NCT00551213|324330659|FG000|Overall Study|Withdrawal by Subject|2|||
94692459|NCT00551213|324330660|FG001|Overall Study|Withdrawal by Subject|0|||
94692460|NCT00551213|324330659|FG000|Overall Study|Not Treated|1|||
94692461|NCT00551213|324330660|FG001|Overall Study|Not Treated|2|||
94692462|NCT04430335|324330665|FG000|Overall Study|Withdrawal by Subject|1|||
94692463|NCT01558674|324330666|FG000|Part 1|Study Terminated by Sponsor|10|||
94692464|NCT01558674|324330667|FG001|Part 1|Study Terminated by Sponsor|0|||
94692465|NCT01558674|324330666|FG000|Part 1|Withdrawal by Subject|1|||
94692466|NCT01558674|324330667|FG001|Part 1|Withdrawal by Subject|0|||
94692467|NCT02411591|324330668|FG000|Overall Study|Adverse Event|0|||
94692468|NCT02411591|324330669|FG001|Overall Study|Adverse Event|4|||
94692469|NCT02411591|324330670|FG002|Overall Study|Adverse Event|2|||
94692470|NCT02411591|324330668|FG000|Overall Study|Withdrawal by Subject|0|||
94692471|NCT02411591|324330669|FG001|Overall Study|Withdrawal by Subject|3|||
94692472|NCT02411591|324330670|FG002|Overall Study|Withdrawal by Subject|0|||
94692473|NCT02411591|324330668|FG000|Overall Study|Physician Decision|0|||
94692474|NCT02411591|324330669|FG001|Overall Study|Physician Decision|3|||
94692475|NCT02411591|324330670|FG002|Overall Study|Physician Decision|1|||
94692476|NCT02954575|324330671|FG000|Overall Study|Withdrawal by Subject|2|||
94692477|NCT02954575|324330671|FG000|Overall Study|Adverse Event|1|||
94692478|NCT01734382|324330672|FG000|Part 1|Adverse Event|2|||
94692479|NCT01734382|324330673|FG001|Part 1|Adverse Event|0|||
94692480|NCT01734382|324330674|FG002|Part 1|Adverse Event|0|||
94692481|NCT01734382|324330672|FG000|Part 2|Adverse Event|0|||
94692482|NCT01734382|324330673|FG001|Part 2|Adverse Event|0|||
94692483|NCT01734382|324330674|FG002|Part 2|Adverse Event|1|||
94692484|NCT01734382|324330672|FG000|Part 2|Lack of Efficacy|0|||
94692485|NCT01734382|324330673|FG001|Part 2|Lack of Efficacy|1|||
94692486|NCT01734382|324330674|FG002|Part 2|Lack of Efficacy|1|||
94692487|NCT01734382|324330672|FG000|Part 2|Other|0|||
94692488|NCT01734382|324330673|FG001|Part 2|Other|0|||
94692489|NCT01734382|324330674|FG002|Part 2|Other|1|||
94692490|NCT01734382|324330672|FG000|Part 2|Physician Decision|0|||
94692491|NCT01734382|324330673|FG001|Part 2|Physician Decision|0|||
94692492|NCT01734382|324330674|FG002|Part 2|Physician Decision|3|||
94692493|NCT01734382|324330672|FG000|Part 2|Protocol Violation|0|||
94692494|NCT01734382|324330673|FG001|Part 2|Protocol Violation|1|||
94692495|NCT01734382|324330674|FG002|Part 2|Protocol Violation|0|||
94692496|NCT01734382|324330672|FG000|Part 2|Withdrawal by Subject|0|||
94692497|NCT01734382|324330673|FG001|Part 2|Withdrawal by Subject|0|||
94692498|NCT01734382|324330674|FG002|Part 2|Withdrawal by Subject|1|||
94692499|NCT04496167|324330676|FG000|Overall Study|Adverse Event|6|||
94692500|NCT04496167|324330677|FG001|Overall Study|Adverse Event|2|||
94692501|NCT04496167|324330676|FG000|Overall Study|Withdrawal by Subject|7|||
94692502|NCT04496167|324330677|FG001|Overall Study|Withdrawal by Subject|6|||
94692503|NCT04496167|324330676|FG000|Overall Study|Lost to Follow-up|3|||
94692504|NCT04496167|324330677|FG001|Overall Study|Lost to Follow-up|5|||
94692505|NCT04496167|324330676|FG000|Overall Study|Not Treated|1|||
94692506|NCT04496167|324330677|FG001|Overall Study|Not Treated|2|||
94692507|NCT04496167|324330676|FG000|Overall Study|Other Than Specified|1|||
94692508|NCT04496167|324330677|FG001|Overall Study|Other Than Specified|1|||
94692509|NCT00683449|324330678|FG000|Overall Study|Lost to Follow-up|0|||
94692510|NCT00683449|324330679|FG001|Overall Study|Lost to Follow-up|1|||
94692511|NCT00683449|324330680|FG002|Overall Study|Lost to Follow-up|0|||
94692512|NCT00683449|324330681|FG003|Overall Study|Lost to Follow-up|0|||
94692513|NCT00683449|324330682|FG004|Overall Study|Lost to Follow-up|0|||
94692514|NCT03653416|324330683|FG000|Overall Study|Protocol Violation|6|||
94692515|NCT03653416|324330684|FG001|Overall Study|Protocol Violation|1|||
94692516|NCT04230980|324330685|FG000|Overall Study|Lost to Follow-up|1|||
94692517|NCT04230980|324330686|FG001|Overall Study|Lost to Follow-up|2|||
94692518|NCT04230980|324330685|FG000|Overall Study|Adverse Event|0|||
94692519|NCT04230980|324330686|FG001|Overall Study|Adverse Event|1|||
94692520|NCT03541642|324330691|FG000|Overall Study|Withdrawal by Subject|1|||
94692521|NCT03541642|324330692|FG001|Overall Study|Withdrawal by Subject|2|||
94692522|NCT03541642|324330691|FG000|Overall Study|Lost to Follow-up|16|||
94692523|NCT03541642|324330692|FG001|Overall Study|Lost to Follow-up|12|||
94692524|NCT03541642|324330691|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
94692525|NCT03541642|324330692|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
94692526|NCT01083160|324330693|FG000|Overall Study|Adverse Event|1|||
94692527|NCT00918749|324330694|FG000|Overall Study|Adverse Event|1|||
94692528|NCT00918749|324330695|FG001|Overall Study|Adverse Event|0|||
94692529|NCT00918749|324330696|FG002|Overall Study|Adverse Event|1|||
94692530|NCT00918749|324330694|FG000|Overall Study|Lost to Follow-up|0|||
94692531|NCT00918749|324330695|FG001|Overall Study|Lost to Follow-up|0|||
94692532|NCT00918749|324330696|FG002|Overall Study|Lost to Follow-up|1|||
94692533|NCT00918749|324330694|FG000|Overall Study|Withdrawal by Subject|5|||
94692534|NCT00918749|324330695|FG001|Overall Study|Withdrawal by Subject|3|||
94692535|NCT00918749|324330696|FG002|Overall Study|Withdrawal by Subject|5|||
94692536|NCT00918749|324330694|FG000|Overall Study|No Study Medication Taken|1|||
94692537|NCT00918749|324330695|FG001|Overall Study|No Study Medication Taken|0|||
94692538|NCT00918749|324330696|FG002|Overall Study|No Study Medication Taken|0|||
94692539|NCT01712789|324330697|FG000|Overall Study|Lack of Efficacy|2|||
94692540|NCT01712789|324330697|FG000|Overall Study|Lost to Follow-up|1|||
94692541|NCT01712789|324330697|FG000|Overall Study|Progressive Disease|504|||
94692542|NCT01712789|324330697|FG000|Overall Study|Death|57|||
94692543|NCT01712789|324330697|FG000|Overall Study|Adverse Event|52|||
94692544|NCT01712789|324330697|FG000|Overall Study|Miscellaneous|31|||
94692545|NCT01712789|324330697|FG000|Overall Study|Withdrawal by Subject|21|||
94692546|NCT01712789|324330697|FG000|Overall Study|Transition to Commercial Treatment|8|||
94692547|NCT01712789|324330697|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
94692548|NCT01708187|324330698|FG000|Overall Study|Lost to Follow-up|0|||
94692549|NCT01708187|324330699|FG001|Overall Study|Lost to Follow-up|1|||
94692550|NCT00873093|324330700|FG000|Overall Study|Adverse Event|0|||
94692551|NCT00873093|324330701|FG001|Overall Study|Adverse Event|2|||
94692552|NCT00873093|324330702|FG002|Overall Study|Adverse Event|0|||
94692553|NCT00873093|324330703|FG003|Overall Study|Adverse Event|0|||
94692554|NCT00873093|324330704|FG004|Overall Study|Adverse Event|0|||
94692555|NCT00873093|324330700|FG000|Overall Study|Death|0|||
94692556|NCT00873093|324330701|FG001|Overall Study|Death|3|||
94692557|NCT00873093|324330702|FG002|Overall Study|Death|2|||
94692558|NCT00873093|324330703|FG003|Overall Study|Death|0|||
94692559|NCT00873093|324330704|FG004|Overall Study|Death|0|||
94692560|NCT00873093|324330700|FG000|Overall Study|Physician Decision|0|||
94692561|NCT00873093|324330701|FG001|Overall Study|Physician Decision|17|||
94692562|NCT00873093|324330702|FG002|Overall Study|Physician Decision|10|||
94692563|NCT00873093|324330703|FG003|Overall Study|Physician Decision|10|||
94692564|NCT00873093|324330704|FG004|Overall Study|Physician Decision|2|||
94692565|NCT00873093|324330700|FG000|Overall Study|Withdrawal by Subject|1|||
94692566|NCT00873093|324330701|FG001|Overall Study|Withdrawal by Subject|4|||
94692567|NCT00873093|324330702|FG002|Overall Study|Withdrawal by Subject|4|||
94692568|NCT00873093|324330703|FG003|Overall Study|Withdrawal by Subject|0|||
94692569|NCT00873093|324330704|FG004|Overall Study|Withdrawal by Subject|0|||
94692570|NCT00873093|324330700|FG000|Overall Study|Ineligible|0|||
94692571|NCT00873093|324330701|FG001|Overall Study|Ineligible|1|||
94692572|NCT00873093|324330702|FG002|Overall Study|Ineligible|0|||
94692573|NCT00873093|324330703|FG003|Overall Study|Ineligible|1|||
94692574|NCT00873093|324330704|FG004|Overall Study|Ineligible|0|||
94692575|NCT01994720|324330708|FG000|Overall Study|Withdrawal by Subject|46|||
94466038|NCT00435019|323494986|FG001|Overall Study|Protocol Violation|1|||
94692576|NCT01994720|324330709|FG001|Overall Study|Withdrawal by Subject|56|||
94692577|NCT00479674|324330710|FG000|Overall Study|Adverse Event|18|||
94692578|NCT00479674|324330710|FG000|Overall Study|Withdrawal by Subject|6|||
94692579|NCT00479674|324330710|FG000|Overall Study|Physician Decision|14|||
94692580|NCT00479674|324330710|FG000|Overall Study|none provided|3|||
94692581|NCT01232556|324330714|FG000|Overall Study|Withdrawal by Subject|21|||
94692582|NCT01232556|324330715|FG001|Overall Study|Withdrawal by Subject|17|||
94692583|NCT01232556|324330714|FG000|Overall Study|Death|97|||
94692584|NCT01232556|324330715|FG001|Overall Study|Death|97|||
94692585|NCT01232556|324330714|FG000|Overall Study|Lost to Follow-up|0|||
94692586|NCT01232556|324330715|FG001|Overall Study|Lost to Follow-up|2|||
94692587|NCT01232556|324330714|FG000|Overall Study|Terminated by Sponsor|35|||
94692588|NCT01232556|324330715|FG001|Overall Study|Terminated by Sponsor|51|||
94692589|NCT01232556|324330714|FG000|Overall Study|Other|6|||
94692590|NCT01232556|324330715|FG001|Overall Study|Other|4|||
94692591|NCT00388362|324330716|FG000|Enrolled|Ineligible|1|||
94692592|NCT00388362|324330716|FG000|Enrolled|Adverse Event|9|||
94692593|NCT00388362|324330716|FG000|Enrolled|Death|1|||
94692594|NCT00388362|324330716|FG000|Enrolled|Loss insurance|1|||
94692595|NCT00388362|324330716|FG000|Enrolled|Withdrawal by Subject|1|||
94692596|NCT00388362|324330716|FG000|Remained on Study Median of 514 Days|Death|2|||
94692597|NCT01141660|324330717|FG000|Overall Study|Physician Decision|0|||
94692598|NCT01141660|324330718|FG001|Overall Study|Physician Decision|12|||
94692599|NCT00209027|324330719|FG000|Overall Study|study terminated|10|||
94692600|NCT00209027|324330720|FG001|Overall Study|study terminated|0|||
94692601|NCT01163149|324330721|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
94692602|NCT01163149|324330722|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
94692603|NCT01163149|324330723|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
94692604|NCT01163149|324330721|FG000|Extension Treatment Period|Adverse Event|0|||
94365917|NCT03747939|323124819|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
94365918|NCT03747939|323124820|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
94365919|NCT03747939|323124821|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
94365920|NCT03747939|323124818|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
94365921|NCT03747939|323124819|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
94692605|NCT01163149|324330722|FG001|Extension Treatment Period|Adverse Event|1|||
94692606|NCT01163149|324330723|FG002|Extension Treatment Period|Adverse Event|0|||
94692607|NCT01163149|324330721|FG000|Extension Treatment Period|Noncompliance|0|||
94692608|NCT01163149|324330722|FG001|Extension Treatment Period|Noncompliance|0|||
94692609|NCT01163149|324330723|FG002|Extension Treatment Period|Noncompliance|1|||
94692610|NCT02806336|324330724|FG000|Overall Study|Physician Decision|1|||
94692611|NCT02806336|324330725|FG001|Overall Study|Physician Decision|0|||
94692612|NCT02806336|324330724|FG000|Overall Study|Withdrawal by Subject|2|||
94692613|NCT02806336|324330725|FG001|Overall Study|Withdrawal by Subject|4|||
94692614|NCT02806336|324330724|FG000|Overall Study|COVID-19 research shut down|3|||
94692615|NCT02806336|324330725|FG001|Overall Study|COVID-19 research shut down|4|||
94692616|NCT02806336|324330724|FG000|Overall Study|Lack of Efficacy|0|||
94692617|NCT02806336|324330725|FG001|Overall Study|Lack of Efficacy|1|||
94692618|NCT03259373|324330730|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
94692619|NCT03259373|324330731|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
94692620|NCT03259373|324330730|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
94692621|NCT03259373|324330731|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
94692622|NCT03259373|324330730|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
94692623|NCT03259373|324330731|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
94692624|NCT03259373|324330730|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
94692625|NCT03259373|324330731|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
94692626|NCT03259373|324330730|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
94692627|NCT03259373|324330731|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
94692628|NCT03259373|324330730|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
94692629|NCT03259373|324330731|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
94692630|NCT02322775|324330735|FG000|Overall Study|Adverse Event|1|||
94692631|NCT02322775|324330736|FG001|Overall Study|Adverse Event|0|||
94692632|NCT02322775|324330735|FG000|Overall Study|Lost to Follow-up|0|||
94692633|NCT02322775|324330736|FG001|Overall Study|Lost to Follow-up|1|||
94692634|NCT02322775|324330735|FG000|Overall Study|Protocol Violation|1|||
94692635|NCT02322775|324330736|FG001|Overall Study|Protocol Violation|0|||
94692636|NCT02322775|324330735|FG000|Overall Study|Withdrawal by Subject|3|||
94692637|NCT02322775|324330736|FG001|Overall Study|Withdrawal by Subject|4|||
94692638|NCT02322775|324330735|FG000|Overall Study|Not willing to perform all FU visits|0|||
94692639|NCT02322775|324330736|FG001|Overall Study|Not willing to perform all FU visits|1|||
94692640|NCT02906202|324330737|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
94692641|NCT01960790|324330738|FG000|Overall Study|Survey forms could not be recovered|3|||
94692642|NCT01960790|324330738|FG000|Overall Study|Treat with Humira outside survey period|3|||
94692643|NCT01960790|324330738|FG000|Overall Study|Transferred to another hospital|4|||
94692644|NCT01960790|324330738|FG000|Overall Study|Unevaluable for safety|1|||
94692645|NCT02169219|324330740|FG000|Overall Study|Lack of Efficacy|6|||
94692646|NCT00333138|324330743|FG000|Core Study (6 Months)|Adverse Event|4|||
94692647|NCT00333138|324330744|FG001|Core Study (6 Months)|Adverse Event|5|||
94692648|NCT00333138|324330745|FG002|Core Study (6 Months)|Adverse Event|8|||
94692649|NCT00333138|324330743|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
94692650|NCT00333138|324330744|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
94692651|NCT00333138|324330745|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
94692652|NCT00333138|324330743|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
94692653|NCT00333138|324330744|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
94692654|NCT00333138|324330745|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
94692655|NCT00333138|324330743|FG000|Core Study (6 Months)|Protocol Violation|1|||
94692656|NCT00333138|324330744|FG001|Core Study (6 Months)|Protocol Violation|0|||
94692657|NCT00333138|324330745|FG002|Core Study (6 Months)|Protocol Violation|1|||
94692658|NCT00333138|324330743|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
94692659|NCT00333138|324330744|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
94692660|NCT00333138|324330745|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
94692661|NCT00333138|324330743|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
94692662|NCT00333138|324330744|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
94692663|NCT00333138|324330745|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
94466039|NCT00435019|323494985|FG000|Overall Study|Personal reasons for withdrawal|8|||
94692664|NCT00333138|324330743|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
94692665|NCT00333138|324330744|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
94692666|NCT00333138|324330745|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
94692667|NCT00333138|324330743|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
94692668|NCT00333138|324330744|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
94692669|NCT00333138|324330745|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
94692670|NCT00333138|324330743|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
94692671|NCT00333138|324330744|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
94692672|NCT00333138|324330745|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
94692673|NCT00333138|324330743|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
94692674|NCT00333138|324330744|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
94692675|NCT00333138|324330745|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
94692676|NCT00333138|324330743|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
94692677|NCT00333138|324330744|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
94692678|NCT00333138|324330745|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
94692679|NCT00333138|324330743|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
94692680|NCT00333138|324330744|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
94692681|NCT00333138|324330745|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
94692682|NCT00333138|324330743|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
94692683|NCT00333138|324330744|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
94692684|NCT00333138|324330745|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
94692685|NCT00333138|324330743|FG000|Extension Study (Month6 to End of Study)|Death|0|||
94692686|NCT00333138|324330744|FG001|Extension Study (Month6 to End of Study)|Death|1|||
94692687|NCT00333138|324330745|FG002|Extension Study (Month6 to End of Study)|Death|0|||
94692688|NCT02320721|324330746|FG000|Overall Study|Adverse Event|6|||
94692689|NCT02320721|324330747|FG001|Overall Study|Adverse Event|6|||
94692690|NCT02320721|324330746|FG000|Overall Study|Lack of Efficacy|2|||
94692691|NCT02320721|324330747|FG001|Overall Study|Lack of Efficacy|0|||
94692692|NCT02320721|324330746|FG000|Overall Study|Poor compliance to protocol|3|||
94692693|NCT02320721|324330747|FG001|Overall Study|Poor compliance to protocol|7|||
94692694|NCT02320721|324330746|FG000|Overall Study|Randomized but not treated|0|||
94692695|NCT02320721|324330747|FG001|Overall Study|Randomized but not treated|1|||
94692696|NCT02320721|324330746|FG000|Overall Study|Hypoglycemia|1|||
94692697|NCT02320721|324330747|FG001|Overall Study|Hypoglycemia|0|||
94692698|NCT02320721|324330746|FG000|Overall Study|Other than specified above|15|||
94692699|NCT02320721|324330747|FG001|Overall Study|Other than specified above|20|||
94692700|NCT00847301|324330748|FG000|Overall Study|Adverse Event|35|||
94692701|NCT00847301|324330748|FG000|Overall Study|Switch to other anticoagulants|16|||
94692702|NCT00847301|324330748|FG000|Overall Study|Lost to Follow-up|1|||
94692703|NCT00847301|324330748|FG000|Overall Study|No prescription after hospital discharge|1|||
94692704|NCT00847301|324330748|FG000|Overall Study|Other reason not defined above|1|||
94692705|NCT05593211|324330749|FG000|Overall Study|Withdrawal by Subject|1|||
94692706|NCT03077620|324330750|FG000|Overall Study|Unable to place lumbar catheter|1|||
94692707|NCT03077620|324330751|FG001|Overall Study|Unable to place lumbar catheter|0|||
94692708|NCT03077620|324330752|FG002|Overall Study|Unable to place lumbar catheter|1|||
94692709|NCT03077620|324330753|FG003|Overall Study|Unable to place lumbar catheter|0|||
94692710|NCT03077620|324330750|FG000|Overall Study|Withdrawal by Subject|0|||
94692711|NCT03077620|324330751|FG001|Overall Study|Withdrawal by Subject|1|||
94692712|NCT03077620|324330752|FG002|Overall Study|Withdrawal by Subject|0|||
94692713|NCT03077620|324330753|FG003|Overall Study|Withdrawal by Subject|0|||
94692714|NCT03077620|324330750|FG000|Overall Study|Physician Decision|0|||
94692715|NCT03077620|324330751|FG001|Overall Study|Physician Decision|0|||
94692716|NCT03077620|324330752|FG002|Overall Study|Physician Decision|1|||
94692717|NCT03077620|324330753|FG003|Overall Study|Physician Decision|0|||
94692718|NCT03225846|324330754|FG000|Overall Study|Adverse Event|0|||
94692719|NCT03225846|324330755|FG001|Overall Study|Adverse Event|0|||
94692720|NCT03225846|324330756|FG002|Overall Study|Adverse Event|0|||
94692721|NCT03225846|324330757|FG003|Overall Study|Adverse Event|0|||
94692722|NCT03225846|324330758|FG004|Overall Study|Adverse Event|0|||
94692723|NCT03225846|324330759|FG005|Overall Study|Adverse Event|0|||
94692724|NCT03225846|324330760|FG006|Overall Study|Adverse Event|6|||
94692725|NCT03225846|324330754|FG000|Overall Study|Withdrawal by Subject|0|||
94692726|NCT03225846|324330755|FG001|Overall Study|Withdrawal by Subject|1|||
94692727|NCT03225846|324330756|FG002|Overall Study|Withdrawal by Subject|0|||
94692728|NCT03225846|324330757|FG003|Overall Study|Withdrawal by Subject|0|||
94692729|NCT03225846|324330758|FG004|Overall Study|Withdrawal by Subject|0|||
94692730|NCT03225846|324330759|FG005|Overall Study|Withdrawal by Subject|0|||
94692731|NCT03225846|324330760|FG006|Overall Study|Withdrawal by Subject|0|||
94692732|NCT03225846|324330754|FG000|Overall Study|Death|0|||
94692733|NCT03225846|324330755|FG001|Overall Study|Death|1|||
94692734|NCT03225846|324330756|FG002|Overall Study|Death|0|||
94692735|NCT03225846|324330757|FG003|Overall Study|Death|0|||
94692736|NCT03225846|324330758|FG004|Overall Study|Death|0|||
94692737|NCT03225846|324330759|FG005|Overall Study|Death|0|||
94264286|NCT03250832|322761875|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
94264287|NCT03250832|322761876|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
94264288|NCT03250832|322761877|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
94264289|NCT03250832|322761878|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
94264290|NCT03250832|322761879|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
94264291|NCT03250832|322761880|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
94264292|NCT03250832|322761881|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
94264293|NCT03250832|322761870|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
94264294|NCT03250832|322761871|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
94264295|NCT03250832|322761872|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
94264296|NCT03250832|322761873|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
94365922|NCT03747939|323124820|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
94365923|NCT03747939|323124821|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
94365924|NCT03747939|323124818|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
94692738|NCT03225846|324330760|FG006|Overall Study|Death|0|||
94692739|NCT03225846|324330754|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
94692740|NCT03225846|324330755|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
94692741|NCT03225846|324330756|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
94692742|NCT03225846|324330757|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
94692743|NCT03225846|324330758|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
94692744|NCT03225846|324330759|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
94692745|NCT03225846|324330760|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
94692746|NCT03225846|324330754|FG000|Overall Study|Patient decision|0|||
94692747|NCT03225846|324330755|FG001|Overall Study|Patient decision|0|||
94692748|NCT03225846|324330756|FG002|Overall Study|Patient decision|0|||
94692749|NCT03225846|324330757|FG003|Overall Study|Patient decision|0|||
94692750|NCT03225846|324330758|FG004|Overall Study|Patient decision|0|||
94692751|NCT03225846|324330759|FG005|Overall Study|Patient decision|0|||
94692752|NCT03225846|324330760|FG006|Overall Study|Patient decision|1|||
94692753|NCT00924560|324330761|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
94692754|NCT00924560|324330762|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
94692755|NCT00924560|324330763|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
94692756|NCT00924560|324330761|FG000|Overall Study|Non Compliance with the Protocol|20|||
94692757|NCT00924560|324330762|FG001|Overall Study|Non Compliance with the Protocol|15|||
94692758|NCT00924560|324330763|FG002|Overall Study|Non Compliance with the Protocol|4|||
94692759|NCT00924560|324330761|FG000|Overall Study|Physician Decision|2|||
94692760|NCT00924560|324330762|FG001|Overall Study|Physician Decision|3|||
94692761|NCT00924560|324330763|FG002|Overall Study|Physician Decision|4|||
94692762|NCT00924560|324330761|FG000|Overall Study|Withdrawal by Subject|50|||
94692763|NCT00924560|324330762|FG001|Overall Study|Withdrawal by Subject|44|||
94692764|NCT00924560|324330763|FG002|Overall Study|Withdrawal by Subject|18|||
94692765|NCT00924560|324330761|FG000|Overall Study|Adverse Event|39|||
94365925|NCT03747939|323124819|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
94365926|NCT03747939|323124820|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
94692766|NCT00924560|324330762|FG001|Overall Study|Adverse Event|33|||
94692767|NCT00924560|324330763|FG002|Overall Study|Adverse Event|0|||
94692768|NCT00924560|324330761|FG000|Overall Study|Pregnancy|5|||
94692769|NCT00924560|324330762|FG001|Overall Study|Pregnancy|7|||
94692770|NCT00924560|324330763|FG002|Overall Study|Pregnancy|1|||
94692771|NCT00924560|324330761|FG000|Overall Study|Lost to Follow-up|78|||
94692772|NCT00924560|324330762|FG001|Overall Study|Lost to Follow-up|94|||
94692773|NCT00924560|324330763|FG002|Overall Study|Lost to Follow-up|45|||
94692774|NCT00924560|324330761|FG000|Overall Study|Miscellaneous Reasons|13|||
94692775|NCT00924560|324330762|FG001|Overall Study|Miscellaneous Reasons|10|||
94692776|NCT00924560|324330763|FG002|Overall Study|Miscellaneous Reasons|10|||
94692777|NCT05708846|324330766|FG000|Overall Study|Death|5|||
94692778|NCT05708846|324330766|FG000|Overall Study|Withdrawal by Subject|20|||
94692779|NCT04140890|324330767|FG000|Overall Study|Withdrawal by Subject|0|||
94692780|NCT04140890|324330768|FG001|Overall Study|Withdrawal by Subject|1|||
94692781|NCT01700348|324330769|FG000|Overall Study|Withdrawal by Subject|22|||
94692782|NCT01700348|324330769|FG000|Overall Study|Lost to Follow-up|1|||
94692783|NCT00026312|324330776|FG000|Overall Study|Adverse Event|0|||
94692784|NCT00026312|324330777|FG001|Overall Study|Adverse Event|32|||
94692785|NCT00026312|324330776|FG000|Overall Study|Death|1|||
94692786|NCT00026312|324330777|FG001|Overall Study|Death|7|||
94692787|NCT00026312|324330776|FG000|Overall Study|Lack of Efficacy|19|||
94692788|NCT00026312|324330777|FG001|Overall Study|Lack of Efficacy|114|||
94692789|NCT00026312|324330776|FG000|Overall Study|Lost to Follow-up|0|||
94692790|NCT00026312|324330777|FG001|Overall Study|Lost to Follow-up|5|||
94692791|NCT00026312|324330776|FG000|Overall Study|Physician Decision|1|||
94692792|NCT00026312|324330777|FG001|Overall Study|Physician Decision|37|||
94692793|NCT00026312|324330776|FG000|Overall Study|Protocol Violation|0|||
94692794|NCT00026312|324330777|FG001|Overall Study|Protocol Violation|3|||
94692795|NCT00026312|324330776|FG000|Overall Study|Withdrawal by Subject|1|||
94692796|NCT00026312|324330777|FG001|Overall Study|Withdrawal by Subject|6|||
94692797|NCT00026312|324330776|FG000|Overall Study|Ineligible|4|||
94692798|NCT00026312|324330777|FG001|Overall Study|Ineligible|5|||
94692799|NCT00026312|324330776|FG000|Overall Study|Entry onto another COG study|0|||
94692800|NCT00026312|324330777|FG001|Overall Study|Entry onto another COG study|1|||
94692801|NCT00026312|324330776|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
94692802|NCT00026312|324330777|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
94692803|NCT01475786|324330778|FG000|Overall Study|Adverse Event|0|||
94692804|NCT01475786|324330779|FG001|Overall Study|Adverse Event|1|||
94692805|NCT01475786|324330780|FG002|Overall Study|Adverse Event|0|||
94692806|NCT01475786|324330778|FG000|Overall Study|Lost to Follow-up|1|||
94692807|NCT01475786|324330779|FG001|Overall Study|Lost to Follow-up|2|||
94692808|NCT01475786|324330780|FG002|Overall Study|Lost to Follow-up|1|||
94692809|NCT01475786|324330778|FG000|Overall Study|Withdrawal by Subject|0|||
94692810|NCT01475786|324330779|FG001|Overall Study|Withdrawal by Subject|1|||
94692811|NCT01475786|324330780|FG002|Overall Study|Withdrawal by Subject|1|||
94692812|NCT01475786|324330778|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
94692813|NCT01475786|324330779|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
94692814|NCT01475786|324330780|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
94692815|NCT00619476|324332897|FG000|Overall Study|Adverse Event|12|||
94692816|NCT00619476|324332898|FG001|Overall Study|Adverse Event|6|||
94365927|NCT03747939|323124821|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
94692817|NCT00619476|324332899|FG002|Overall Study|Adverse Event|12|||
94692818|NCT00619476|324332900|FG003|Overall Study|Adverse Event|16|||
94692819|NCT00619476|324332897|FG000|Overall Study|Lack of Efficacy|6|||
94692820|NCT00619476|324332898|FG001|Overall Study|Lack of Efficacy|1|||
94692821|NCT00619476|324332899|FG002|Overall Study|Lack of Efficacy|1|||
94692822|NCT00619476|324332900|FG003|Overall Study|Lack of Efficacy|4|||
94692823|NCT00619476|324332897|FG000|Overall Study|Protocol Violation|5|||
94692824|NCT00619476|324332898|FG001|Overall Study|Protocol Violation|4|||
94692825|NCT00619476|324332899|FG002|Overall Study|Protocol Violation|4|||
94692826|NCT00619476|324332900|FG003|Overall Study|Protocol Violation|9|||
94692827|NCT00619476|324332897|FG000|Overall Study|Lost to Follow-up|1|||
94692828|NCT00619476|324332898|FG001|Overall Study|Lost to Follow-up|2|||
94692829|NCT00619476|324332899|FG002|Overall Study|Lost to Follow-up|0|||
94692830|NCT00619476|324332900|FG003|Overall Study|Lost to Follow-up|1|||
94692831|NCT00619476|324332897|FG000|Overall Study|Investigator Discretion|2|||
94692832|NCT00619476|324332898|FG001|Overall Study|Investigator Discretion|2|||
94692833|NCT00619476|324332899|FG002|Overall Study|Investigator Discretion|2|||
94692834|NCT00619476|324332900|FG003|Overall Study|Investigator Discretion|0|||
94692835|NCT00619476|324332897|FG000|Overall Study|Withdrawal by Subject|5|||
94692836|NCT00619476|324332898|FG001|Overall Study|Withdrawal by Subject|7|||
94692837|NCT00619476|324332899|FG002|Overall Study|Withdrawal by Subject|5|||
94692838|NCT00619476|324332900|FG003|Overall Study|Withdrawal by Subject|4|||
94692839|NCT04834362|324332901|FG000|Overall Study|Death|1|||
94692840|NCT04834362|324332902|FG001|Overall Study|Death|2|||
94692841|NCT01349829|324332905|FG000|Overall Study|Lost to Follow-up|4|||
94692842|NCT01349829|324332906|FG001|Overall Study|Lost to Follow-up|8|||
94692843|NCT01349829|324332905|FG000|Overall Study|Consent withdrawal|3|||
94692844|NCT01349829|324332906|FG001|Overall Study|Consent withdrawal|8|||
94692845|NCT01349829|324332905|FG000|Overall Study|Migrated/moved|2|||
94692846|NCT01349829|324332906|FG001|Overall Study|Migrated/moved|7|||
94692847|NCT02555371|324332907|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
94692848|NCT02555371|324332908|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
94692849|NCT02555371|324332909|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
94692850|NCT02555371|324332910|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
94692851|NCT02555371|324332911|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
94692852|NCT02555371|324332907|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
94692853|NCT02555371|324332908|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
94692854|NCT02555371|324332909|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
94692855|NCT02555371|324332910|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
94692856|NCT02555371|324332911|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
94692857|NCT02555371|324332907|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
94692858|NCT02555371|324332908|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
94692859|NCT02555371|324332909|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
94692860|NCT02555371|324332910|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
94692861|NCT02555371|324332911|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
94692862|NCT02555371|324332907|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
94692863|NCT02555371|324332908|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
94692864|NCT02555371|324332909|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
94692865|NCT02555371|324332910|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
94692866|NCT02555371|324332911|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
94692867|NCT02555371|324332907|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
94692868|NCT02555371|324332908|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
94692869|NCT02555371|324332909|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
94692870|NCT02555371|324332910|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
94365928|NCT03747939|323124818|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
94365929|NCT03747939|323124819|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
94365930|NCT03747939|323124820|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
94692871|NCT02555371|324332911|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
94692872|NCT02555371|324332907|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
94692873|NCT02555371|324332908|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
94692874|NCT02555371|324332909|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
94692875|NCT02555371|324332910|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
94692876|NCT02555371|324332911|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
94692877|NCT02555371|324332907|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
94692878|NCT02555371|324332908|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
94692879|NCT02555371|324332909|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
94692880|NCT02555371|324332910|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
94692881|NCT02555371|324332911|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
94692882|NCT02555371|324332907|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
94692883|NCT02555371|324332908|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
94692884|NCT02555371|324332909|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
94692885|NCT02555371|324332910|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
94692886|NCT02555371|324332911|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
94692887|NCT02555371|324332907|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
94692888|NCT02555371|324332908|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
94692889|NCT02555371|324332909|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
94692890|NCT02555371|324332910|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
94692891|NCT02555371|324332911|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
94692892|NCT02555371|324332907|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
94692893|NCT02555371|324332908|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
94692894|NCT02555371|324332909|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
94692895|NCT02555371|324332910|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
94692896|NCT02555371|324332911|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
94692897|NCT02555371|324332907|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
94692898|NCT02555371|324332908|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
94692899|NCT02555371|324332909|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
94692900|NCT02555371|324332910|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
94692901|NCT02555371|324332911|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
94692902|NCT02555371|324332907|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
94692903|NCT02555371|324332908|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
94692904|NCT02555371|324332909|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
94692905|NCT02555371|324332910|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
94692906|NCT02555371|324332911|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
94692907|NCT02555371|324332907|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
94692908|NCT02555371|324332908|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
94692909|NCT02555371|324332909|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
94692910|NCT02555371|324332910|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
94692911|NCT02555371|324332911|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
94692912|NCT02555371|324332907|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
94692913|NCT02555371|324332908|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
94692914|NCT02555371|324332909|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
94692915|NCT02555371|324332910|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
94692916|NCT02555371|324332911|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
94692917|NCT01625910|324332912|FG000|Overall Study|Lost to Follow-up|3|||
94692918|NCT01625910|324332913|FG001|Overall Study|Lost to Follow-up|4|||
94692919|NCT00513019|324332914|FG000|Overall Study|Adverse Event|1|||
94692920|NCT00513019|324332915|FG001|Overall Study|Adverse Event|0|||
94692921|NCT00513019|324332914|FG000|Overall Study|Withdrawal by Subject|4|||
94692922|NCT00513019|324332915|FG001|Overall Study|Withdrawal by Subject|5|||
94692923|NCT00742885|324332918|FG000|Overall Study|Lost to Follow-up|1|||
94692924|NCT00742885|324332919|FG001|Overall Study|Lost to Follow-up|0|||
94692925|NCT01755689|324332925|FG000|Overall Study|Withdrawal by Subject|1|||
94692926|NCT01755689|324332926|FG001|Overall Study|Withdrawal by Subject|3|||
94692927|NCT01755689|324332927|FG002|Overall Study|Withdrawal by Subject|2|||
94692928|NCT01755689|324332928|FG003|Overall Study|Withdrawal by Subject|1|||
94692929|NCT01755689|324332929|FG004|Overall Study|Withdrawal by Subject|1|||
94692930|NCT01755689|324332925|FG000|Overall Study|Migrated/moved from study area|0|||
94692931|NCT01755689|324332926|FG001|Overall Study|Migrated/moved from study area|1|||
94692932|NCT01755689|324332927|FG002|Overall Study|Migrated/moved from study area|1|||
94692933|NCT01755689|324332928|FG003|Overall Study|Migrated/moved from study area|1|||
94692934|NCT01755689|324332929|FG004|Overall Study|Migrated/moved from study area|1|||
94692935|NCT01755689|324332925|FG000|Overall Study|Lost to Follow-up|1|||
94692936|NCT01755689|324332926|FG001|Overall Study|Lost to Follow-up|0|||
94692937|NCT01755689|324332927|FG002|Overall Study|Lost to Follow-up|1|||
94692938|NCT01755689|324332928|FG003|Overall Study|Lost to Follow-up|0|||
94692939|NCT01755689|324332929|FG004|Overall Study|Lost to Follow-up|2|||
94692940|NCT01755689|324332925|FG000|Overall Study|Pregnancy|1|||
94692941|NCT01755689|324332926|FG001|Overall Study|Pregnancy|1|||
94692942|NCT01755689|324332927|FG002|Overall Study|Pregnancy|2|||
94692943|NCT01755689|324332928|FG003|Overall Study|Pregnancy|4|||
94692944|NCT01755689|324332929|FG004|Overall Study|Pregnancy|2|||
94692945|NCT01327547|324332930|FG000|Overall Study|Adverse Event|4|||
94692946|NCT01327547|324332931|FG001|Overall Study|Adverse Event|1|||
94692947|NCT01327547|324332930|FG000|Overall Study|Death|1|||
94692948|NCT01327547|324332931|FG001|Overall Study|Death|2|||
94692949|NCT01327547|324332930|FG000|Overall Study|Lost to Follow-up|6|||
94692950|NCT01327547|324332931|FG001|Overall Study|Lost to Follow-up|6|||
94692951|NCT01327547|324332930|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
94692952|NCT01327547|324332931|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
94692953|NCT01327547|324332930|FG000|Overall Study|Withdrawal by Subject|3|||
94692954|NCT01327547|324332931|FG001|Overall Study|Withdrawal by Subject|7|||
94692955|NCT01327547|324332930|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
94692956|NCT01327547|324332931|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
94692957|NCT01327547|324332930|FG000|Overall Study|Protocol Violation|1|||
94692958|NCT01327547|324332931|FG001|Overall Study|Protocol Violation|0|||
94692959|NCT01327547|324332930|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
94692960|NCT01327547|324332931|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
94692961|NCT01327547|324332930|FG000|Overall Study|Required prohibited medication|2|||
94692962|NCT01327547|324332931|FG001|Overall Study|Required prohibited medication|0|||
94692963|NCT01327547|324332930|FG000|Overall Study|Non-compliance with study procedures|1|||
94692964|NCT01327547|324332931|FG001|Overall Study|Non-compliance with study procedures|0|||
94692965|NCT01327547|324332930|FG000|Overall Study|By investigator in subject's interest|0|||
94692966|NCT01327547|324332931|FG001|Overall Study|By investigator in subject's interest|1|||
94692967|NCT00373295|324332932|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
94692968|NCT00373295|324332933|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
94692969|NCT00373295|324332934|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
94692970|NCT00373295|324332935|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
94264297|NCT03250832|322761874|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
94692971|NCT00373295|324332936|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
94692972|NCT00373295|324332937|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
94692973|NCT02176928|324332938|FG000|Overall Study|Lost to Follow-up|2|||
94692974|NCT02176928|324332939|FG001|Overall Study|Lost to Follow-up|4|||
94692975|NCT02718417|324332942|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
94692976|NCT02718417|324332943|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
94264298|NCT03250832|322761875|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
94692977|NCT02718417|324332944|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
94692978|NCT02718417|324332942|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
94692979|NCT02718417|324332943|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
94692980|NCT02718417|324332944|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
94692981|NCT02718417|324332942|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
94692982|NCT02718417|324332943|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
94692983|NCT02718417|324332944|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
94692984|NCT02718417|324332942|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
94692985|NCT02718417|324332943|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
94692986|NCT02718417|324332944|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
94692987|NCT02718417|324332942|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
94692988|NCT02718417|324332943|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
94692989|NCT02718417|324332944|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
94692990|NCT02718417|324332942|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
94692991|NCT02718417|324332943|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
94692992|NCT02718417|324332944|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
94692993|NCT02718417|324332942|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
94692994|NCT02718417|324332943|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
94692995|NCT02718417|324332944|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
94692996|NCT02718417|324332942|FG000|Chemotherapy Phase (CP)|Other|2|||
94692997|NCT02718417|324332943|FG001|Chemotherapy Phase (CP)|Other|0|||
94692998|NCT02718417|324332944|FG002|Chemotherapy Phase (CP)|Other|1|||
94692999|NCT02718417|324332942|FG000|Maintenance Phase (MP)|Adverse Event|21|||
94693000|NCT02718417|324332943|FG001|Maintenance Phase (MP)|Adverse Event|26|||
94693001|NCT02718417|324332944|FG002|Maintenance Phase (MP)|Adverse Event|0|||
94693002|NCT02718417|324332942|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
94693003|NCT02718417|324332943|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
94693004|NCT02718417|324332944|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
94693005|NCT02718417|324332942|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
94693006|NCT02718417|324332943|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
94693007|NCT02718417|324332944|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
94693008|NCT02718417|324332942|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
94693009|NCT02718417|324332943|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
94365931|NCT03747939|323124821|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
94693010|NCT02718417|324332944|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
94693011|NCT02718417|324332942|FG000|Maintenance Phase (MP)|Physician's decision|6|||
94693012|NCT02718417|324332943|FG001|Maintenance Phase (MP)|Physician's decision|7|||
94693013|NCT02718417|324332944|FG002|Maintenance Phase (MP)|Physician's decision|0|||
94693014|NCT02718417|324332942|FG000|Maintenance Phase (MP)|Progressive disease|100|||
94693015|NCT02718417|324332943|FG001|Maintenance Phase (MP)|Progressive disease|88|||
94693016|NCT02718417|324332944|FG002|Maintenance Phase (MP)|Progressive disease|0|||
94693017|NCT02718417|324332942|FG000|Maintenance Phase (MP)|Other|2|||
94693018|NCT02718417|324332943|FG001|Maintenance Phase (MP)|Other|1|||
94693019|NCT02718417|324332944|FG002|Maintenance Phase (MP)|Other|0|||
94693020|NCT02718417|324332942|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
94693021|NCT02718417|324332943|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
94693022|NCT02718417|324332944|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
94693023|NCT02718417|324332942|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
94693024|NCT02718417|324332943|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
94693025|NCT02718417|324332944|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
94693026|NCT02718417|324332942|FG000|Observation Phase (OP)|Adverse Event|0|||
94693027|NCT02718417|324332943|FG001|Observation Phase (OP)|Adverse Event|0|||
94693028|NCT02718417|324332944|FG002|Observation Phase (OP)|Adverse Event|1|||
94693029|NCT02718417|324332942|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
94693030|NCT02718417|324332943|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
94693031|NCT02718417|324332944|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
94693032|NCT02718417|324332942|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
94693033|NCT02718417|324332943|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
94693034|NCT02718417|324332944|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
94693035|NCT02718417|324332942|FG000|Observation Phase (OP)|Physician Decision|0|||
94693036|NCT02718417|324332943|FG001|Observation Phase (OP)|Physician Decision|0|||
94693037|NCT02718417|324332944|FG002|Observation Phase (OP)|Physician Decision|9|||
94693038|NCT02718417|324332942|FG000|Observation Phase (OP)|Progressive disease|0|||
94693039|NCT02718417|324332943|FG001|Observation Phase (OP)|Progressive disease|0|||
94693040|NCT02718417|324332944|FG002|Observation Phase (OP)|Progressive disease|92|||
94693041|NCT02718417|324332942|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
94693042|NCT02718417|324332943|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
94693043|NCT02718417|324332944|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
94693044|NCT02718417|324332942|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
94693045|NCT02718417|324332943|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
94693046|NCT02718417|324332944|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
94693047|NCT02718417|324332942|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
94693048|NCT02718417|324332943|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
94693049|NCT02718417|324332944|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
94693050|NCT02718417|324332942|FG000|Observation Phase (OP)|Other|0|||
94693051|NCT02718417|324332943|FG001|Observation Phase (OP)|Other|0|||
94693052|NCT02718417|324332944|FG002|Observation Phase (OP)|Other|7|||
94693053|NCT02718417|324332942|FG000|Follow-up Phase|Adverse Event|3|||
94693054|NCT02718417|324332943|FG001|Follow-up Phase|Adverse Event|1|||
94693055|NCT02718417|324332944|FG002|Follow-up Phase|Adverse Event|1|||
94693056|NCT02718417|324332942|FG000|Follow-up Phase|Other|4|||
94693057|NCT02718417|324332943|FG001|Follow-up Phase|Other|6|||
94693058|NCT02718417|324332944|FG002|Follow-up Phase|Other|4|||
94693059|NCT02718417|324332942|FG000|Follow-up Phase|Withdrawal by Subject|19|||
94693060|NCT02718417|324332943|FG001|Follow-up Phase|Withdrawal by Subject|17|||
94693061|NCT02718417|324332944|FG002|Follow-up Phase|Withdrawal by Subject|5|||
94693062|NCT02718417|324332942|FG000|Follow-up Phase|Study terminated by sponsor|100|||
94693063|NCT02718417|324332943|FG001|Follow-up Phase|Study terminated by sponsor|138|||
94693064|NCT02718417|324332944|FG002|Follow-up Phase|Study terminated by sponsor|6|||
94693065|NCT02718417|324332942|FG000|Follow-up Phase|Lost to Follow-up|2|||
94693066|NCT02718417|324332943|FG001|Follow-up Phase|Lost to Follow-up|3|||
94693067|NCT02718417|324332944|FG002|Follow-up Phase|Lost to Follow-up|0|||
94693068|NCT02718417|324332942|FG000|Follow-up Phase|Death leading to discontinuation|7|||
94693069|NCT02718417|324332943|FG001|Follow-up Phase|Death leading to discontinuation|7|||
94693070|NCT02718417|324332944|FG002|Follow-up Phase|Death leading to discontinuation|3|||
94693071|NCT02718417|324332942|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
94693072|NCT02718417|324332943|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
94693073|NCT02718417|324332944|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
94693074|NCT02718417|324332942|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
94693075|NCT02718417|324332943|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
94693076|NCT02718417|324332944|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
94693077|NCT02718417|324332942|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
94693078|NCT02718417|324332943|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
94693079|NCT02718417|324332944|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
94651527|NCT03217136|324181690|FG001|Overall Study|Site Randomized Participant in Error|1|||
94651528|NCT03217136|324181689|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
94651529|NCT03217136|324181690|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
94651530|NCT03217136|324181689|FG000|Overall Study|Dispensing Error|1|||
94651531|NCT03217136|324181690|FG001|Overall Study|Dispensing Error|0|||
94651532|NCT03217136|324181689|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
94651533|NCT03217136|324181690|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94651534|NCT01401530|324181691|FG000|Overall Study|Disease Progression|1|||
94651535|NCT01401530|324181692|FG001|Overall Study|Disease Progression|2|||
94651536|NCT01401530|324181693|FG002|Overall Study|Disease Progression|1|||
94651537|NCT01401530|324181691|FG000|Overall Study|Adverse Event|1|||
94651538|NCT01401530|324181692|FG001|Overall Study|Adverse Event|1|||
94651539|NCT01401530|324181693|FG002|Overall Study|Adverse Event|1|||
94651540|NCT01401530|324181691|FG000|Overall Study|Participant Choice|1|||
94651541|NCT01401530|324181692|FG001|Overall Study|Participant Choice|2|||
94651542|NCT01401530|324181693|FG002|Overall Study|Participant Choice|1|||
94651543|NCT01401530|324181691|FG000|Overall Study|Physician Decision|0|||
94651544|NCT01401530|324181692|FG001|Overall Study|Physician Decision|1|||
94651545|NCT01401530|324181693|FG002|Overall Study|Physician Decision|0|||
94651546|NCT02104557|324181694|FG000|Overall Study|Adverse Event|24|||
94651547|NCT02104557|324181694|FG000|Overall Study|Lost to Follow-up|34|||
94651548|NCT02104557|324181694|FG000|Overall Study|Violated the usage and dosage|14|||
94651549|NCT02104557|324181694|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
94651550|NCT02104557|324181694|FG000|Overall Study|Administered Sayana prior to the contract|1|||
94651551|NCT02104557|324181694|FG000|Overall Study|Other|17|||
94651552|NCT02104557|324181694|FG000|Overall Study|Change to other contraception methods|5|||
94651553|NCT02104557|324181694|FG000|Overall Study|Discontinuation due to no pain|1|||
94651554|NCT02104557|324181694|FG000|Overall Study|Withdrawal consent|2|||
94651555|NCT02104557|324181694|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
94651556|NCT02104557|324181694|FG000|Overall Study|Discontinuation of contraception|9|||
94651557|NCT01859715|324181697|FG000|Overall Study|No 2nd VAS|16|||
94651558|NCT01859715|324181698|FG001|Overall Study|No 2nd VAS|8|||
94651559|NCT01859715|324181699|FG002|Overall Study|No 2nd VAS|23|||
94651560|NCT00261716|324181700|FG000|Overall Study|Withdrawal by Subject|6|||
94651561|NCT00261716|324181701|FG001|Overall Study|Withdrawal by Subject|8|||
94651562|NCT00261716|324181700|FG000|Overall Study|Lost to Follow-up|0|||
94651563|NCT00261716|324181701|FG001|Overall Study|Lost to Follow-up|2|||
94651564|NCT01000051|324181703|FG000|Overall Study|Withdrawal by Subject|1|||
94651565|NCT01000051|324181704|FG001|Overall Study|Withdrawal by Subject|1|||
94651566|NCT01000051|324181703|FG000|Overall Study|Disease Progression|1|||
94651567|NCT01000051|324181704|FG001|Overall Study|Disease Progression|0|||
94651568|NCT01000051|324181703|FG000|Overall Study|Serious noncompliance|1|||
94651569|NCT01000051|324181704|FG001|Overall Study|Serious noncompliance|0|||
94651570|NCT03304379|324181705|FG000|Overall Study|Protocol Violation|8|||
94651571|NCT03304379|324181706|FG001|Overall Study|Protocol Violation|10|||
94651572|NCT03304379|324181707|FG002|Overall Study|Protocol Violation|5|||
94651573|NCT03304379|324181708|FG003|Overall Study|Protocol Violation|0|||
94651574|NCT03304379|324181709|FG004|Overall Study|Protocol Violation|2|||
94651575|NCT03304379|324181705|FG000|Overall Study|Adverse Event|4|||
94651576|NCT03304379|324181706|FG001|Overall Study|Adverse Event|20|||
94651577|NCT03304379|324181707|FG002|Overall Study|Adverse Event|17|||
94651578|NCT03304379|324181708|FG003|Overall Study|Adverse Event|1|||
94651579|NCT03304379|324181709|FG004|Overall Study|Adverse Event|0|||
94651580|NCT03304379|324181705|FG000|Overall Study|Lack of Efficacy|17|||
94651581|NCT03304379|324181706|FG001|Overall Study|Lack of Efficacy|16|||
94651582|NCT03304379|324181707|FG002|Overall Study|Lack of Efficacy|20|||
94651583|NCT03304379|324181708|FG003|Overall Study|Lack of Efficacy|0|||
94651584|NCT03304379|324181709|FG004|Overall Study|Lack of Efficacy|0|||
94651585|NCT03304379|324181705|FG000|Overall Study|Physician Decision|6|||
94651586|NCT03304379|324181706|FG001|Overall Study|Physician Decision|10|||
94651587|NCT03304379|324181707|FG002|Overall Study|Physician Decision|6|||
94651588|NCT03304379|324181708|FG003|Overall Study|Physician Decision|9|||
94651589|NCT03304379|324181709|FG004|Overall Study|Physician Decision|10|||
94651590|NCT03304379|324181705|FG000|Overall Study|Withdrawal by Subject|26|||
94651591|NCT03304379|324181706|FG001|Overall Study|Withdrawal by Subject|58|||
94651592|NCT03304379|324181707|FG002|Overall Study|Withdrawal by Subject|66|||
94651593|NCT03304379|324181708|FG003|Overall Study|Withdrawal by Subject|3|||
94651594|NCT03304379|324181709|FG004|Overall Study|Withdrawal by Subject|5|||
94651595|NCT03304379|324181705|FG000|Overall Study|Lost to Follow-up|8|||
94651596|NCT03304379|324181706|FG001|Overall Study|Lost to Follow-up|24|||
94651597|NCT03304379|324181707|FG002|Overall Study|Lost to Follow-up|35|||
94651598|NCT03304379|324181708|FG003|Overall Study|Lost to Follow-up|4|||
94651599|NCT03304379|324181709|FG004|Overall Study|Lost to Follow-up|0|||
94651600|NCT03304379|324181705|FG000|Overall Study|Death|1|||
94651601|NCT03304379|324181706|FG001|Overall Study|Death|2|||
94651602|NCT03304379|324181707|FG002|Overall Study|Death|0|||
94651603|NCT03304379|324181708|FG003|Overall Study|Death|0|||
94651604|NCT03304379|324181709|FG004|Overall Study|Death|0|||
94651605|NCT03304379|324181705|FG000|Overall Study|Other|0|||
94365932|NCT01850108|323124822|FG000|Overall Study|Lost to Follow-up|4|||
94365933|NCT01850108|323124822|FG000|Overall Study|Not eligible|1|||
94651606|NCT03304379|324181706|FG001|Overall Study|Other|1|||
94651607|NCT03304379|324181707|FG002|Overall Study|Other|0|||
94651608|NCT03304379|324181708|FG003|Overall Study|Other|0|||
94651609|NCT03304379|324181709|FG004|Overall Study|Other|0|||
94651610|NCT03773757|324181716|FG000|Overall Study|Withdrawal by Subject|2|||
94651611|NCT03773757|324181717|FG001|Overall Study|Withdrawal by Subject|4|||
94651612|NCT01147653|324181718|FG000|Year 2|Withdrawal by Subject|2|||
94651613|NCT01147653|324181719|FG001|Year 2|Withdrawal by Subject|3|||
94651614|NCT01440946|324181723|FG000|Overall Study|Lost to Follow-up|1|||
94651615|NCT01440946|324181724|FG001|Overall Study|Lost to Follow-up|1|||
94651616|NCT01440946|324181723|FG000|Overall Study|Physician Decision|1|||
94651617|NCT01440946|324181724|FG001|Overall Study|Physician Decision|0|||
94651618|NCT03286140|324181725|FG000|Overall Study|Withdrawal by Subject|10|||
94651619|NCT03286140|324181726|FG001|Overall Study|Withdrawal by Subject|5|||
94651620|NCT03286140|324181725|FG000|Overall Study|Lost to Follow-up|5|||
94651621|NCT03286140|324181726|FG001|Overall Study|Lost to Follow-up|10|||
94651622|NCT03286140|324181725|FG000|Overall Study|Failure to comply|0|||
94651623|NCT03286140|324181726|FG001|Overall Study|Failure to comply|1|||
94651624|NCT03299192|324181734|FG000|Overall Study|Fell before classes started|1|||
94651625|NCT03299192|324181735|FG001|Overall Study|Fell before classes started|0|||
94651626|NCT03299192|324181736|FG002|Overall Study|Fell before classes started|0|||
94651627|NCT03299192|324181734|FG000|Overall Study|Other|0|||
94651628|NCT03299192|324181735|FG001|Overall Study|Other|2|||
94651629|NCT03299192|324181736|FG002|Overall Study|Other|1|||
94651630|NCT02253810|324181738|FG000|Overall Study|Withdrawal by Subject|2|||
94651631|NCT02253810|324181739|FG001|Overall Study|Withdrawal by Subject|1|||
94651632|NCT02253810|324181738|FG000|Overall Study|Unknown concomitant procedure|3|||
94651633|NCT02253810|324181739|FG001|Overall Study|Unknown concomitant procedure|2|||
94651634|NCT00205712|324181741|FG000|Overall Study|Lost to Follow-up|0|||
94651635|NCT00205712|324181742|FG001|Overall Study|Lost to Follow-up|1|||
94651636|NCT01418209|324181746|FG000|Overall Study|Withdrawal by Subject|1|||
94365934|NCT01850108|323124822|FG000|Overall Study|Failed engraftment|2|||
94365935|NCT01850108|323124822|FG000|Overall Study|Physician Decision|1|||
94693080|NCT02718417|324332942|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
94693081|NCT02718417|324332943|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
94693082|NCT02718417|324332944|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
94693083|NCT02718417|324332942|FG000|Long-term Follow-up Phase|Other|0|||
94693084|NCT02718417|324332943|FG001|Long-term Follow-up Phase|Other|2|||
94693085|NCT02718417|324332944|FG002|Long-term Follow-up Phase|Other|0|||
94693086|NCT01089556|324332945|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
94693087|NCT01089556|324332946|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
94693088|NCT01089556|324332947|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
94693089|NCT01089556|324332948|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
94693090|NCT01089556|324332949|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
94693091|NCT01089556|324332950|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
94693092|NCT01089556|324332945|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
94693093|NCT01089556|324332946|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
94693094|NCT01089556|324332947|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
94693095|NCT01089556|324332948|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
94693096|NCT01089556|324332949|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
94693097|NCT01089556|324332950|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
94693098|NCT01089556|324332945|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
94693099|NCT01089556|324332946|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
94693100|NCT01089556|324332947|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
94693101|NCT01089556|324332948|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
94693102|NCT01089556|324332949|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
94693103|NCT01089556|324332950|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
94693104|NCT01089556|324332945|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
94693105|NCT01089556|324332946|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
94693106|NCT01089556|324332947|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
94693107|NCT01089556|324332948|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
94693108|NCT01089556|324332949|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
94693109|NCT01089556|324332950|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
94693110|NCT01089556|324332945|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
94693111|NCT01089556|324332946|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
94693112|NCT01089556|324332947|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
94693113|NCT01089556|324332948|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
94693114|NCT01089556|324332949|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
94693115|NCT01089556|324332950|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
94693116|NCT01089556|324332945|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
94693117|NCT01089556|324332946|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
94693118|NCT01089556|324332947|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
94693119|NCT01089556|324332948|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
94693120|NCT01089556|324332949|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
94693121|NCT01089556|324332950|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
94693122|NCT01089556|324332945|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
94693123|NCT01089556|324332946|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
94693124|NCT01089556|324332947|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
94693125|NCT01089556|324332948|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
94693126|NCT01089556|324332949|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
94693127|NCT01089556|324332950|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
94693128|NCT01089556|324332945|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
94693129|NCT01089556|324332946|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
94693130|NCT01089556|324332947|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
94693131|NCT01089556|324332948|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
94693132|NCT01089556|324332949|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
94693133|NCT01089556|324332950|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
94693134|NCT01089556|324332945|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
94693135|NCT01089556|324332946|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
94693136|NCT01089556|324332947|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
94693137|NCT01089556|324332948|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
94693138|NCT01089556|324332949|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
94693139|NCT01089556|324332950|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
94693140|NCT01089556|324332945|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
94693141|NCT01089556|324332946|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
94693142|NCT01089556|324332947|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
94693143|NCT01089556|324332948|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
94693144|NCT01089556|324332949|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
94693145|NCT01089556|324332950|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
94693146|NCT01089556|324332945|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
94693147|NCT01089556|324332946|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
94693148|NCT01089556|324332947|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
94693149|NCT01089556|324332948|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
94693150|NCT01089556|324332949|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
94693151|NCT01089556|324332950|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
94693152|NCT01089556|324332945|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
94693153|NCT01089556|324332946|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
94693154|NCT01089556|324332947|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
94693155|NCT01089556|324332948|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
94693156|NCT01089556|324332949|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
94693157|NCT01089556|324332950|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
94693158|NCT01089556|324332945|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
94693159|NCT01089556|324332946|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
94693160|NCT01089556|324332947|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
94693161|NCT01089556|324332948|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
94693162|NCT01089556|324332949|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
94693163|NCT01089556|324332950|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
94693164|NCT01089556|324332945|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
94693165|NCT01089556|324332946|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
94693166|NCT01089556|324332947|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
94693167|NCT01089556|324332948|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
94693168|NCT01089556|324332949|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
94693169|NCT01089556|324332950|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
94693170|NCT01089556|324332945|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
94693171|NCT01089556|324332946|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
94693172|NCT01089556|324332947|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
94693173|NCT01089556|324332948|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
94693174|NCT01089556|324332949|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
94693175|NCT01089556|324332950|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
94693176|NCT01890967|324332953|FG000|Overall Study|Adverse Event|3|||
94693177|NCT01890967|324332954|FG001|Overall Study|Adverse Event|3|||
94693178|NCT01890967|324332955|FG002|Overall Study|Adverse Event|3|||
94693179|NCT01890967|324332956|FG003|Overall Study|Adverse Event|2|||
94693180|NCT01890967|324332957|FG004|Overall Study|Adverse Event|1|||
94693181|NCT01890967|324332958|FG005|Overall Study|Adverse Event|7|||
94693182|NCT01890967|324332953|FG000|Overall Study|Death|1|||
94693183|NCT01890967|324332954|FG001|Overall Study|Death|0|||
94693184|NCT01890967|324332955|FG002|Overall Study|Death|0|||
94693185|NCT01890967|324332956|FG003|Overall Study|Death|0|||
94693186|NCT01890967|324332957|FG004|Overall Study|Death|0|||
94693187|NCT01890967|324332958|FG005|Overall Study|Death|0|||
94693188|NCT01890967|324332953|FG000|Overall Study|Lost to Follow-up|1|||
94693189|NCT01890967|324332954|FG001|Overall Study|Lost to Follow-up|1|||
94693190|NCT01890967|324332955|FG002|Overall Study|Lost to Follow-up|1|||
94693191|NCT01890967|324332956|FG003|Overall Study|Lost to Follow-up|1|||
94693192|NCT01890967|324332957|FG004|Overall Study|Lost to Follow-up|0|||
94693193|NCT01890967|324332958|FG005|Overall Study|Lost to Follow-up|1|||
94365936|NCT02494583|323124825|FG000|Overall Study|Death|224|||
94365937|NCT02494583|323124826|FG001|Overall Study|Death|214|||
94693194|NCT01890967|324332953|FG000|Overall Study|Protocol Violation|0|||
94693195|NCT01890967|324332954|FG001|Overall Study|Protocol Violation|3|||
94693196|NCT01890967|324332955|FG002|Overall Study|Protocol Violation|3|||
94693197|NCT01890967|324332956|FG003|Overall Study|Protocol Violation|2|||
94693198|NCT01890967|324332957|FG004|Overall Study|Protocol Violation|4|||
94693199|NCT01890967|324332958|FG005|Overall Study|Protocol Violation|1|||
94693200|NCT01890967|324332953|FG000|Overall Study|Sponsor Decision|2|||
94693201|NCT01890967|324332954|FG001|Overall Study|Sponsor Decision|0|||
94693202|NCT01890967|324332955|FG002|Overall Study|Sponsor Decision|1|||
94693203|NCT01890967|324332956|FG003|Overall Study|Sponsor Decision|3|||
94693204|NCT01890967|324332957|FG004|Overall Study|Sponsor Decision|2|||
94693205|NCT01890967|324332958|FG005|Overall Study|Sponsor Decision|3|||
94693206|NCT01890967|324332953|FG000|Overall Study|Withdrawal by Subject|3|||
94693207|NCT01890967|324332954|FG001|Overall Study|Withdrawal by Subject|4|||
94693208|NCT01890967|324332955|FG002|Overall Study|Withdrawal by Subject|2|||
94693209|NCT01890967|324332956|FG003|Overall Study|Withdrawal by Subject|3|||
94693210|NCT01890967|324332957|FG004|Overall Study|Withdrawal by Subject|3|||
94693211|NCT01890967|324332958|FG005|Overall Study|Withdrawal by Subject|1|||
94693212|NCT01646320|324332964|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
94693213|NCT01646320|324332965|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
94693214|NCT01646320|324332964|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
94693215|NCT01646320|324332965|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
94693216|NCT01646320|324332964|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
94693217|NCT01646320|324332965|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
94693218|NCT01646320|324332964|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
94693219|NCT01646320|324332965|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
94693220|NCT01646320|324332964|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
94693221|NCT01646320|324332965|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
94693222|NCT01646320|324332964|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
94693223|NCT01646320|324332965|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
94693224|NCT01646320|324332964|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
94693225|NCT01646320|324332965|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
94693226|NCT01646320|324332964|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
94693227|NCT01646320|324332965|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
94693228|NCT01646320|324332964|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
94693229|NCT01646320|324332965|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
94693230|NCT01646320|324332964|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
94693231|NCT01646320|324332965|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
94693232|NCT01646320|324332964|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
94693233|NCT01646320|324332965|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
94693234|NCT04006366|324332966|FG000|Overall Study|Withdrawal by Subject|1|||
94693235|NCT01375959|324332968|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
94693236|NCT01375959|324332969|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
94693237|NCT01375959|324332968|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
94693238|NCT01375959|324332969|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
94693239|NCT01375959|324332968|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
94693240|NCT01375959|324332969|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
94693241|NCT02056119|324332975|FG000|Overall Study|Death|1|||
94693242|NCT02056119|324332976|FG001|Overall Study|Death|2|||
94693243|NCT02056119|324332975|FG000|Overall Study|Intubated for less than 24 hrs|2|||
94693244|NCT02056119|324332976|FG001|Overall Study|Intubated for less than 24 hrs|7|||
94693245|NCT02056119|324332975|FG000|Overall Study|No aerosol treatments were given.|3|||
94693246|NCT02056119|324332976|FG001|Overall Study|No aerosol treatments were given.|2|||
94693247|NCT02056119|324332975|FG000|Overall Study|Received Metaneb treatment|0|||
94693248|NCT02056119|324332976|FG001|Overall Study|Received Metaneb treatment|2|||
94693249|NCT02056119|324332975|FG000|Overall Study|Protocol Violation|4|||
94693250|NCT02056119|324332976|FG001|Overall Study|Protocol Violation|7|||
94693251|NCT01720797|324332977|FG000|Overall Study|Withdrawal by Subject|3|||
94693252|NCT01720797|324332978|FG001|Overall Study|Withdrawal by Subject|0|||
94693253|NCT00983619|324332982|FG000|Overall Study|Lost to Follow-up|0|||
94693254|NCT00983619|324332983|FG001|Overall Study|Lost to Follow-up|1|||
94693255|NCT00983619|324332984|FG002|Overall Study|Lost to Follow-up|0|||
94693256|NCT00983619|324332985|FG003|Overall Study|Lost to Follow-up|0|||
94693257|NCT00983619|324332986|FG004|Overall Study|Lost to Follow-up|0|||
94693258|NCT00983619|324332987|FG005|Overall Study|Lost to Follow-up|2|||
94693259|NCT00983619|324332988|FG006|Overall Study|Lost to Follow-up|0|||
94693260|NCT00983619|324332989|FG007|Overall Study|Lost to Follow-up|0|||
94693261|NCT00983619|324332990|FG008|Overall Study|Lost to Follow-up|0|||
94693262|NCT00983619|324332991|FG009|Overall Study|Lost to Follow-up|0|||
94365938|NCT02494583|323124827|FG002|Overall Study|Death|225|||
94365939|NCT02494583|323124825|FG000|Overall Study|Lost to Follow-up|1|||
94693263|NCT00983619|324332992|FG010|Overall Study|Lost to Follow-up|0|||
94365940|NCT02494583|323124826|FG001|Overall Study|Lost to Follow-up|0|||
94693264|NCT00983619|324332993|FG011|Overall Study|Lost to Follow-up|2|||
94693265|NCT00983619|324332982|FG000|Overall Study|Withdrawal by Subject|2|||
94693266|NCT00983619|324332983|FG001|Overall Study|Withdrawal by Subject|1|||
94693267|NCT00983619|324332984|FG002|Overall Study|Withdrawal by Subject|1|||
94693268|NCT00983619|324332985|FG003|Overall Study|Withdrawal by Subject|3|||
94693269|NCT00983619|324332986|FG004|Overall Study|Withdrawal by Subject|1|||
94693270|NCT00983619|324332987|FG005|Overall Study|Withdrawal by Subject|23|||
94693271|NCT00983619|324332988|FG006|Overall Study|Withdrawal by Subject|0|||
94693272|NCT00983619|324332989|FG007|Overall Study|Withdrawal by Subject|0|||
94693273|NCT00983619|324332990|FG008|Overall Study|Withdrawal by Subject|0|||
94693274|NCT00983619|324332991|FG009|Overall Study|Withdrawal by Subject|0|||
94693275|NCT00983619|324332992|FG010|Overall Study|Withdrawal by Subject|1|||
94693276|NCT00983619|324332993|FG011|Overall Study|Withdrawal by Subject|1|||
94693277|NCT00983619|324332982|FG000|Overall Study|Death|0|||
94693278|NCT00983619|324332983|FG001|Overall Study|Death|2|||
94693279|NCT00983619|324332984|FG002|Overall Study|Death|2|||
94693280|NCT00983619|324332985|FG003|Overall Study|Death|1|||
94693281|NCT00983619|324332986|FG004|Overall Study|Death|2|||
94693282|NCT00983619|324332987|FG005|Overall Study|Death|30|||
94693283|NCT00983619|324332988|FG006|Overall Study|Death|1|||
94693284|NCT00983619|324332989|FG007|Overall Study|Death|0|||
94693285|NCT00983619|324332990|FG008|Overall Study|Death|1|||
94693286|NCT00983619|324332991|FG009|Overall Study|Death|2|||
94693287|NCT00983619|324332992|FG010|Overall Study|Death|9|||
94693288|NCT00983619|324332993|FG011|Overall Study|Death|8|||
94693289|NCT00983619|324332982|FG000|Overall Study|Other|1|||
94693290|NCT00983619|324332983|FG001|Overall Study|Other|0|||
94693291|NCT00983619|324332984|FG002|Overall Study|Other|0|||
94693292|NCT00983619|324332985|FG003|Overall Study|Other|1|||
94693293|NCT00983619|324332986|FG004|Overall Study|Other|0|||
94693294|NCT00983619|324332987|FG005|Overall Study|Other|12|||
94693295|NCT00983619|324332988|FG006|Overall Study|Other|2|||
94693296|NCT00983619|324332989|FG007|Overall Study|Other|2|||
94693297|NCT00983619|324332990|FG008|Overall Study|Other|0|||
94693298|NCT00983619|324332991|FG009|Overall Study|Other|1|||
94693299|NCT00983619|324332992|FG010|Overall Study|Other|1|||
94693300|NCT00983619|324332993|FG011|Overall Study|Other|0|||
94693301|NCT00088205|324332994|FG000|Overall Study|Adverse Event|4|||
94693302|NCT00088205|324332994|FG000|Overall Study|Progressive Disease|51|||
94693303|NCT00088205|324332994|FG000|Overall Study|Physician Decision|1|||
94693304|NCT00088205|324332994|FG000|Overall Study|Death Due to Study Disease|4|||
94693305|NCT05199233|324332997|FG000|Overall Study|Lack of Efficacy|1|||
94693306|NCT04147260|324332999|FG000|Overall Study|Adverse Event|1|||
94693307|NCT04147260|324333000|FG001|Overall Study|Adverse Event|0|||
94693308|NCT04147260|324333001|FG002|Overall Study|Adverse Event|1|||
94693309|NCT04147260|324333002|FG003|Overall Study|Adverse Event|2|||
94693310|NCT04147260|324333003|FG004|Overall Study|Adverse Event|0|||
94693311|NCT04147260|324332999|FG000|Overall Study|Withdrawal by Subject|0|||
94693312|NCT04147260|324333000|FG001|Overall Study|Withdrawal by Subject|0|||
94693313|NCT04147260|324333001|FG002|Overall Study|Withdrawal by Subject|1|||
94693314|NCT04147260|324333002|FG003|Overall Study|Withdrawal by Subject|1|||
94693315|NCT04147260|324333003|FG004|Overall Study|Withdrawal by Subject|0|||
94365941|NCT02494583|323124827|FG002|Overall Study|Lost to Follow-up|0|||
94365942|NCT02494583|323124825|FG000|Overall Study|Protocol Violation|1|||
94365943|NCT02494583|323124826|FG001|Overall Study|Protocol Violation|2|||
94365944|NCT02494583|323124827|FG002|Overall Study|Protocol Violation|0|||
94693316|NCT01555021|324333004|FG000|Overall Study|Lost to Follow-up|1|||
94693317|NCT01555021|324333005|FG001|Overall Study|Lost to Follow-up|2|||
94693318|NCT04227340|324333006|FG000|Overall Study|Withdrawal by Subject|3|||
94693319|NCT03890120|324333007|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
94693320|NCT03890120|324333008|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
94693321|NCT03890120|324333009|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
94693322|NCT03890120|324333010|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
94693323|NCT03890120|324333007|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
94693324|NCT03890120|324333008|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
94365945|NCT02494583|323124825|FG000|Overall Study|Screen Failure|0|||
94693325|NCT03890120|324333009|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
94693326|NCT03890120|324333010|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
94693327|NCT03890120|324333007|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
94693328|NCT03890120|324333008|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
94693329|NCT03890120|324333009|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
94693330|NCT03890120|324333010|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
94693331|NCT03890120|324333007|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
94693332|NCT03890120|324333008|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
94693333|NCT03890120|324333009|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
94693334|NCT03890120|324333010|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
94693335|NCT03890120|324333007|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
94693336|NCT03890120|324333008|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
94693337|NCT03890120|324333009|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
94693338|NCT03890120|324333010|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
94693339|NCT03890120|324333007|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
94693340|NCT03890120|324333008|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
94693341|NCT03890120|324333009|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
94693342|NCT03890120|324333010|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
94693343|NCT03890120|324333007|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
94693344|NCT03890120|324333008|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
94693345|NCT03890120|324333009|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
94693346|NCT03890120|324333010|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
94693347|NCT03890120|324333007|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
94693348|NCT03890120|324333008|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
94693349|NCT03890120|324333009|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
94693350|NCT03890120|324333010|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
94693351|NCT03890120|324333007|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
94693352|NCT03890120|324333008|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
94693353|NCT03890120|324333009|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
94693354|NCT03890120|324333010|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
94693355|NCT03890120|324333007|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
94693356|NCT03890120|324333008|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
94693357|NCT03890120|324333009|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
94693358|NCT03890120|324333010|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
94693359|NCT03890120|324333007|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
94693360|NCT03890120|324333008|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
94693361|NCT03890120|324333009|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
94693362|NCT03890120|324333010|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
94693363|NCT03890120|324333007|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
94693364|NCT03890120|324333008|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
94693365|NCT03890120|324333009|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
94693366|NCT03890120|324333010|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
94693367|NCT03890120|324333007|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
94693368|NCT03890120|324333008|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
94693369|NCT03890120|324333009|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
94693370|NCT03890120|324333010|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
94693371|NCT02589392|324333011|FG000|Overall Study|Adverse Event|1|||
94693372|NCT02589392|324333012|FG001|Overall Study|Adverse Event|1|||
94693373|NCT02589392|324333011|FG000|Overall Study|Withdrawal by Subject|1|||
94693374|NCT02589392|324333012|FG001|Overall Study|Withdrawal by Subject|2|||
94693375|NCT02589392|324333011|FG000|Overall Study|Protocol Violation|1|||
94693376|NCT02589392|324333012|FG001|Overall Study|Protocol Violation|1|||
94693377|NCT02589392|324333011|FG000|Overall Study|Lost to Follow-up|2|||
94693378|NCT02589392|324333012|FG001|Overall Study|Lost to Follow-up|2|||
94693379|NCT02589392|324333011|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
94693380|NCT02589392|324333012|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
94693381|NCT02117544|324333013|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
94693382|NCT02117544|324333014|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
94693383|NCT03486899|324333015|FG000|Overall Study|Lost to Follow-up|4|||
94693384|NCT03486899|324333016|FG001|Overall Study|Lost to Follow-up|1|||
94693385|NCT03486899|324333017|FG002|Overall Study|Lost to Follow-up|4|||
94693386|NCT03486899|324333018|FG003|Overall Study|Lost to Follow-up|3|||
94693387|NCT03486899|324333015|FG000|Overall Study|Death|1|||
94693388|NCT03486899|324333016|FG001|Overall Study|Death|0|||
94693389|NCT03486899|324333017|FG002|Overall Study|Death|0|||
94693390|NCT03486899|324333018|FG003|Overall Study|Death|1|||
94693391|NCT03486899|324333015|FG000|Overall Study|Adverse Event|0|||
94693392|NCT03486899|324333016|FG001|Overall Study|Adverse Event|2|||
94693393|NCT03486899|324333017|FG002|Overall Study|Adverse Event|0|||
94693394|NCT03486899|324333018|FG003|Overall Study|Adverse Event|2|||
94693395|NCT03486899|324333015|FG000|Overall Study|Withdrawal by Subject|3|||
94693396|NCT03486899|324333016|FG001|Overall Study|Withdrawal by Subject|7|||
94693397|NCT03486899|324333017|FG002|Overall Study|Withdrawal by Subject|4|||
94693398|NCT03486899|324333018|FG003|Overall Study|Withdrawal by Subject|3|||
94693399|NCT03486899|324333015|FG000|Overall Study|Other Reasons|0|||
94693400|NCT03486899|324333016|FG001|Overall Study|Other Reasons|1|||
94693401|NCT03486899|324333017|FG002|Overall Study|Other Reasons|0|||
94693402|NCT03486899|324333018|FG003|Overall Study|Other Reasons|1|||
94693403|NCT01010217|324333019|FG000|Overall Study|Lost to Follow-up|4|||
94693404|NCT01010217|324333020|FG001|Overall Study|Lost to Follow-up|5|||
94693405|NCT01010217|324333021|FG002|Overall Study|Lost to Follow-up|1|||
94693406|NCT01010217|324333022|FG003|Overall Study|Lost to Follow-up|0|||
94693407|NCT01010217|324333023|FG004|Overall Study|Lost to Follow-up|0|||
94693408|NCT01010217|324333019|FG000|Overall Study|Withdrawal by Subject|1|||
94693409|NCT01010217|324333020|FG001|Overall Study|Withdrawal by Subject|0|||
94693410|NCT01010217|324333021|FG002|Overall Study|Withdrawal by Subject|0|||
94693411|NCT01010217|324333022|FG003|Overall Study|Withdrawal by Subject|0|||
94693412|NCT01010217|324333023|FG004|Overall Study|Withdrawal by Subject|0|||
94693413|NCT01010217|324333019|FG000|Overall Study|Physician Decision|0|||
94693414|NCT01010217|324333020|FG001|Overall Study|Physician Decision|0|||
94693415|NCT01010217|324333021|FG002|Overall Study|Physician Decision|0|||
94693416|NCT01010217|324333022|FG003|Overall Study|Physician Decision|6|||
94693417|NCT01010217|324333023|FG004|Overall Study|Physician Decision|3|||
94693418|NCT01439711|324333024|FG000|Overall Study|Ineligible|13|||
94693419|NCT01439711|324333024|FG000|Overall Study|Cancel|3|||
94693420|NCT01439711|324333024|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
94693421|NCT01439711|324333024|FG000|Overall Study|Adverse Event|5|||
94693422|NCT01439711|324333024|FG000|Overall Study|Withdrawal by Subject|3|||
94693423|NCT01439711|324333024|FG000|Overall Study|Progression During Active Tx|3|||
94693424|NCT01439711|324333024|FG000|Overall Study|Noncompliance|3|||
94693425|NCT01439711|324333024|FG000|Overall Study|No MRI|9|||
94693426|NCT04242875|324333025|FG000|Overall Study|Adverse Event|2|||
94693427|NCT03389893|324333026|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
94693428|NCT03389893|324333027|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
94693429|NCT03389893|324333028|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
94693430|NCT03389893|324333029|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
94693431|NCT03389893|324333026|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
94693432|NCT03389893|324333027|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
94693433|NCT03389893|324333028|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
94693434|NCT03389893|324333029|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
94693435|NCT03389893|324333026|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
94693436|NCT03389893|324333027|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
94693437|NCT03389893|324333028|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
94693438|NCT03389893|324333029|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
94693439|NCT03389893|324333026|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
94693440|NCT03389893|324333027|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
94693441|NCT03389893|324333028|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
94693442|NCT03389893|324333029|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
94693443|NCT01024751|324333030|FG000|Enrolled Participants|Ineligible at baseline|3|||
94693444|NCT01024751|324333031|FG001|Enrolled Participants|Ineligible at baseline|4|||
94693445|NCT01024751|324333030|FG000|Eligible Participants|Withdrawal by Subject|0|||
94693446|NCT01024751|324333031|FG001|Eligible Participants|Withdrawal by Subject|1|||
94693447|NCT01024751|324333030|FG000|Eligible Participants|Lost to Follow-up|0|||
94693448|NCT01024751|324333031|FG001|Eligible Participants|Lost to Follow-up|1|||
94693449|NCT01024751|324333030|FG000|Eligible Participants|Ineligible|0|||
94693450|NCT01024751|324333031|FG001|Eligible Participants|Ineligible|1|||
94693451|NCT00801242|324333047|FG000|Overall Study|Adverse Event|10|||
94693452|NCT00801242|324333047|FG000|Overall Study|Withdrawal by Subject|13|||
94693453|NCT00801242|324333047|FG000|Overall Study|Protocol Violation|5|||
94693454|NCT00801242|324333047|FG000|Overall Study|Physician Decision|3|||
94693455|NCT00801242|324333047|FG000|Overall Study|Lost to Follow-up|1|||
94693456|NCT00801242|324333047|FG000|Overall Study|Miscellaneous reasons|20|||
94693457|NCT01347645|324333051|FG000|Overall Study|Death|1|||
94693458|NCT01347645|324333052|FG001|Overall Study|Death|5|||
94693459|NCT01347645|324333053|FG002|Overall Study|Death|2|||
94693460|NCT01347645|324333054|FG003|Overall Study|Death|7|||
94693461|NCT01347645|324333055|FG004|Overall Study|Death|7|||
94693462|NCT01347645|324333051|FG000|Overall Study|Lost to Follow-up|1|||
94693463|NCT01347645|324333052|FG001|Overall Study|Lost to Follow-up|1|||
94693464|NCT01347645|324333053|FG002|Overall Study|Lost to Follow-up|0|||
94693465|NCT01347645|324333054|FG003|Overall Study|Lost to Follow-up|1|||
94693466|NCT01347645|324333055|FG004|Overall Study|Lost to Follow-up|1|||
94693467|NCT01347645|324333051|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
94365946|NCT02494583|323124826|FG001|Overall Study|Screen Failure|1|||
94365947|NCT02494583|323124827|FG002|Overall Study|Screen Failure|0|||
94693468|NCT01347645|324333052|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
94693469|NCT01347645|324333053|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
94693470|NCT01347645|324333054|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
94693471|NCT01347645|324333055|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
94693472|NCT01347645|324333051|FG000|Overall Study|Other|1|||
94693473|NCT01347645|324333052|FG001|Overall Study|Other|0|||
94693474|NCT01347645|324333053|FG002|Overall Study|Other|0|||
94693475|NCT01347645|324333054|FG003|Overall Study|Other|0|||
94693476|NCT01347645|324333055|FG004|Overall Study|Other|1|||
94693477|NCT01347645|324333051|FG000|Overall Study|Withdrawal by Subject|0|||
94693478|NCT01347645|324333052|FG001|Overall Study|Withdrawal by Subject|0|||
94693479|NCT01347645|324333053|FG002|Overall Study|Withdrawal by Subject|0|||
94693480|NCT01347645|324333054|FG003|Overall Study|Withdrawal by Subject|3|||
94693481|NCT01347645|324333055|FG004|Overall Study|Withdrawal by Subject|3|||
94693482|NCT01347645|324333051|FG000|Overall Study|Physician Decision|0|||
94693483|NCT01347645|324333052|FG001|Overall Study|Physician Decision|0|||
94693484|NCT01347645|324333053|FG002|Overall Study|Physician Decision|0|||
94693485|NCT01347645|324333054|FG003|Overall Study|Physician Decision|0|||
94693486|NCT01347645|324333055|FG004|Overall Study|Physician Decision|1|||
94693487|NCT01347645|324333051|FG000|Overall Study|Adverse Event|0|||
94693488|NCT01347645|324333052|FG001|Overall Study|Adverse Event|0|||
94693489|NCT01347645|324333053|FG002|Overall Study|Adverse Event|0|||
94693490|NCT01347645|324333054|FG003|Overall Study|Adverse Event|1|||
94693491|NCT01347645|324333055|FG004|Overall Study|Adverse Event|1|||
94693492|NCT00162942|324333056|FG000|Overall Study|Adverse Event|10|||
94693493|NCT00162942|324333057|FG001|Overall Study|Adverse Event|6|||
94693494|NCT00162942|324333056|FG000|Overall Study|Death|1|||
94693495|NCT00162942|324333057|FG001|Overall Study|Death|0|||
94693496|NCT00162942|324333056|FG000|Overall Study|Withdrawal by Subject|3|||
94693497|NCT00162942|324333057|FG001|Overall Study|Withdrawal by Subject|6|||
94264299|NCT03250832|322761876|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
94264300|NCT03250832|322761877|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
94264301|NCT03250832|322761878|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
94264302|NCT03250832|322761879|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
94264303|NCT03250832|322761880|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
94264304|NCT03250832|322761881|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
94264305|NCT03250832|322761870|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
94264306|NCT03250832|322761871|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
94264307|NCT03250832|322761872|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
94264308|NCT03250832|322761873|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
94466040|NCT00435019|323494986|FG001|Overall Study|Personal reasons for withdrawal|7|||
94466041|NCT02360475|323494995|FG000|Overall Study|Lost to Follow-up|4|||
94693498|NCT00162942|324333056|FG000|Overall Study|Physician Decision|1|||
94693499|NCT00162942|324333057|FG001|Overall Study|Physician Decision|0|||
94693500|NCT00162942|324333056|FG000|Overall Study|Enter Open-Label Study|76|||
94693501|NCT00162942|324333057|FG001|Overall Study|Enter Open-Label Study|35|||
94693502|NCT00162942|324333056|FG000|Overall Study|Alternate Therapy|6|||
94693503|NCT00162942|324333057|FG001|Overall Study|Alternate Therapy|2|||
94693504|NCT00162942|324333056|FG000|Overall Study|Lack of Efficacy|1|||
94693505|NCT00162942|324333057|FG001|Overall Study|Lack of Efficacy|0|||
94693506|NCT00162942|324333056|FG000|Overall Study|Flare During Active Treatment|7|||
94693507|NCT00162942|324333057|FG001|Overall Study|Flare During Active Treatment|3|||
94693508|NCT00162942|324333056|FG000|Overall Study|2 or more consecutive treatments missed|1|||
94693509|NCT00162942|324333057|FG001|Overall Study|2 or more consecutive treatments missed|0|||
94693510|NCT01192295|324333058|FG000|Overall Study|Adverse Event|3|||
94693511|NCT01192295|324333059|FG001|Overall Study|Adverse Event|7|||
94693512|NCT01192295|324333058|FG000|Overall Study|Withdrawal by Subject|3|||
94693513|NCT01192295|324333059|FG001|Overall Study|Withdrawal by Subject|4|||
94693514|NCT01192295|324333058|FG000|Overall Study|Lost to Follow-up|0|||
94693515|NCT01192295|324333059|FG001|Overall Study|Lost to Follow-up|1|||
94693516|NCT01192295|324333058|FG000|Overall Study|Lack of Efficacy|0|||
94693517|NCT01192295|324333059|FG001|Overall Study|Lack of Efficacy|5|||
94693518|NCT01192295|324333058|FG000|Overall Study|Administrative|4|||
94693519|NCT01192295|324333059|FG001|Overall Study|Administrative|6|||
94693520|NCT04562779|324333068|FG000|Overall Study|Lost to Follow-up|7|||
94693521|NCT04562779|324333069|FG001|Overall Study|Lost to Follow-up|5|||
94693522|NCT04562779|324333070|FG002|Overall Study|Lost to Follow-up|10|||
94693523|NCT04562779|324333068|FG000|Overall Study|Protocol Violation|2|||
94693524|NCT04562779|324333069|FG001|Overall Study|Protocol Violation|2|||
94693525|NCT04562779|324333070|FG002|Overall Study|Protocol Violation|0|||
94693526|NCT05174065|324333071|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
94693527|NCT05174065|324333072|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
94693528|NCT05174065|324333073|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
94693529|NCT05174065|324333071|FG000|Placebo-controlled Period|Other|0|||
94693530|NCT05174065|324333072|FG001|Placebo-controlled Period|Other|1|||
94693531|NCT05174065|324333073|FG002|Placebo-controlled Period|Other|0|||
94693532|NCT05174065|324333071|FG000|Placebo-controlled Period|Adverse Event|1|||
94693533|NCT05174065|324333072|FG001|Placebo-controlled Period|Adverse Event|1|||
94693534|NCT05174065|324333073|FG002|Placebo-controlled Period|Adverse Event|0|||
94693535|NCT05174065|324333071|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
94693536|NCT05174065|324333072|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
94693537|NCT05174065|324333073|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
94693538|NCT05174065|324333071|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
94693539|NCT05174065|324333072|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
94693540|NCT05174065|324333073|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
94693541|NCT05174065|324333071|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
94693542|NCT05174065|324333072|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
94693543|NCT05174065|324333073|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
94365948|NCT02494583|323124825|FG000|Overall Study|Transferred to Extension Study|15|||
94365949|NCT02494583|323124826|FG001|Overall Study|Transferred to Extension Study|15|||
94365950|NCT02494583|323124827|FG002|Overall Study|Transferred to Extension Study|6|||
94365951|NCT02494583|323124825|FG000|Overall Study|Did Not Continue on Extension Study|8|||
94365952|NCT02494583|323124826|FG001|Overall Study|Did Not Continue on Extension Study|10|||
94365953|NCT02494583|323124827|FG002|Overall Study|Did Not Continue on Extension Study|4|||
94365954|NCT02494583|323124825|FG000|Overall Study|Withdrawal by Subject|7|||
94365955|NCT02494583|323124826|FG001|Overall Study|Withdrawal by Subject|15|||
94365956|NCT02494583|323124827|FG002|Overall Study|Withdrawal by Subject|15|||
94365957|NCT04088734|323124828|FG000|Overall Study|Other, Not Specified|5|||
94365958|NCT00835068|323124829|FG000|Overall Study|Death|1|||
94365959|NCT00835068|323124830|FG001|Overall Study|Death|0|||
94365960|NCT00835068|323124829|FG000|Overall Study|Adverse Event|0|||
94365961|NCT00835068|323124830|FG001|Overall Study|Adverse Event|1|||
94365962|NCT00835068|323124829|FG000|Overall Study|Other|8|||
94365963|NCT00835068|323124830|FG001|Overall Study|Other|0|||
94365964|NCT00835068|323124829|FG000|Overall Study|Withdrawal by Subject|1|||
94365965|NCT00835068|323124830|FG001|Overall Study|Withdrawal by Subject|0|||
94365966|NCT00530088|323124832|FG000|Overall Study|Disease Progression|4|||
94365967|NCT00530088|323124832|FG000|Overall Study|Physician Decision|4|||
94365968|NCT00530088|323124832|FG000|Overall Study|Other Not Specified|2|||
94365969|NCT02058368|323124833|FG000|Overall Study|Adverse Event|15|||
94365970|NCT02058368|323124834|FG001|Overall Study|Adverse Event|20|||
94365971|NCT02058368|323124833|FG000|Overall Study|Lack of Efficacy|0|||
94365972|NCT02058368|323124834|FG001|Overall Study|Lack of Efficacy|1|||
94365973|NCT02058368|323124833|FG000|Overall Study|Protocol Violation|0|||
94365974|NCT02058368|323124834|FG001|Overall Study|Protocol Violation|4|||
94693544|NCT04131907|324333074|FG000|Overall Study|Adverse Event|2|||
94693545|NCT04131907|324333075|FG001|Overall Study|Adverse Event|0|||
94693546|NCT04131907|324333076|FG002|Overall Study|Adverse Event|0|||
94693547|NCT04131907|324333074|FG000|Overall Study|Physician Decision|4|||
94693548|NCT04131907|324333075|FG001|Overall Study|Physician Decision|22|||
94693549|NCT04131907|324333076|FG002|Overall Study|Physician Decision|0|||
94693550|NCT04131907|324333074|FG000|Overall Study|Withdrawal by Subject|2|||
94693551|NCT04131907|324333075|FG001|Overall Study|Withdrawal by Subject|0|||
94693552|NCT04131907|324333076|FG002|Overall Study|Withdrawal by Subject|1|||
94365975|NCT02058368|323124833|FG000|Overall Study|Lost to Follow-up|2|||
94365976|NCT02058368|323124834|FG001|Overall Study|Lost to Follow-up|0|||
94693553|NCT04131907|324333074|FG000|Overall Study|Treatment failure|2|||
94693554|NCT04131907|324333075|FG001|Overall Study|Treatment failure|0|||
94693555|NCT04131907|324333076|FG002|Overall Study|Treatment failure|1|||
94693556|NCT00996580|324333077|FG000|Overall Study|Adverse Event|466|||
94693557|NCT00996580|324333077|FG000|Overall Study|Lost to Follow-up|480|||
94693558|NCT00996580|324333077|FG000|Overall Study|Noncompliance with the protocol|137|||
94693559|NCT00996580|324333077|FG000|Overall Study|Physician Decision|5|||
94693560|NCT00996580|324333077|FG000|Overall Study|Pregnancy|68|||
94365977|NCT02058368|323124833|FG000|Overall Study|Physician Decision|2|||
94693561|NCT00996580|324333077|FG000|Overall Study|Protocol Violation|16|||
94693562|NCT00996580|324333077|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
94693563|NCT00996580|324333077|FG000|Overall Study|Withdrawal by Subject|217|||
94693564|NCT00996580|324333077|FG000|Overall Study|Other|29|||
94693565|NCT01040780|324334946|FG000|Overall Study|Protocol Violation|1|||
94693566|NCT01040780|324334947|FG001|Overall Study|Protocol Violation|3|||
94693567|NCT03681639|324334948|FG000|Overall Study|Death|4|||
94693568|NCT03681639|324334948|FG000|Overall Study|Lost to Follow-up|2|||
94693569|NCT03681639|324334948|FG000|Overall Study|Withdrawal by Subject|1|||
94693570|NCT03681639|324334948|FG000|Overall Study|Adverse Event|2|||
94693571|NCT02906683|324334949|FG000|Overall Study|Adverse Event|0|||
94693572|NCT02906683|324334950|FG001|Overall Study|Adverse Event|1|||
94693573|NCT02906683|324334951|FG002|Overall Study|Adverse Event|0|||
94693574|NCT02906683|324334949|FG000|Overall Study|Physician Decision|0|||
94693575|NCT02906683|324334950|FG001|Overall Study|Physician Decision|1|||
94693576|NCT02906683|324334951|FG002|Overall Study|Physician Decision|1|||
94693577|NCT02906683|324334949|FG000|Overall Study|Withdrawal by Subject|0|||
94693578|NCT02906683|324334950|FG001|Overall Study|Withdrawal by Subject|2|||
94693579|NCT02906683|324334951|FG002|Overall Study|Withdrawal by Subject|1|||
94693580|NCT02906683|324334949|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
94693581|NCT02906683|324334950|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
94693582|NCT02906683|324334951|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
94693583|NCT02906683|324334949|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
94693584|NCT02906683|324334950|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
94693585|NCT02906683|324334951|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
94693586|NCT04714216|324334952|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
94693587|NCT04714216|324334952|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
94693588|NCT00394095|324334955|FG000|Screening|Withdrawal by Subject|1|||
94693589|NCT00394095|324334956|FG001|Screening|Withdrawal by Subject|0|||
94693590|NCT00394095|324334955|FG000|Randomized|Withdrawal by Subject|5|||
94693591|NCT00394095|324334956|FG001|Randomized|Withdrawal by Subject|1|||
94693592|NCT00394095|324334955|FG000|Randomized|Adverse Event|1|||
94693593|NCT00394095|324334956|FG001|Randomized|Adverse Event|1|||
94693594|NCT00394095|324334955|FG000|Randomized|Overdose|1|||
94693595|NCT00394095|324334956|FG001|Randomized|Overdose|0|||
94693596|NCT00394095|324334955|FG000|Randomized|Lost to Follow-up|1|||
94693597|NCT00394095|324334956|FG001|Randomized|Lost to Follow-up|2|||
94693598|NCT00777803|324334960|FG000|Overall Study|Lost to Follow-up|12|||
94693599|NCT00777803|324334961|FG001|Overall Study|Lost to Follow-up|5|||
94693600|NCT00777803|324334960|FG000|Overall Study|Adverse Event|1|||
94693601|NCT00777803|324334961|FG001|Overall Study|Adverse Event|0|||
94693602|NCT00777803|324334960|FG000|Overall Study|Non-compliance|2|||
94693603|NCT00777803|324334961|FG001|Overall Study|Non-compliance|2|||
94693604|NCT02955277|324334965|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
94693605|NCT02955277|324334966|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
94693606|NCT02955277|324334965|FG000|Post to Follow-up|Lost to Follow-up|8|||
94693607|NCT02955277|324334966|FG001|Post to Follow-up|Lost to Follow-up|11|||
94693608|NCT01809210|324334970|FG000|Overall Study|Withdrawal by Subject|0|||
94693609|NCT01809210|324334971|FG001|Overall Study|Withdrawal by Subject|0|||
94693610|NCT01809210|324334972|FG002|Overall Study|Withdrawal by Subject|1|||
94693611|NCT01809210|324334973|FG003|Overall Study|Withdrawal by Subject|1|||
94365978|NCT02058368|323124834|FG001|Overall Study|Physician Decision|3|||
94365979|NCT02058368|323124833|FG000|Overall Study|Withdrawal by Subject|22|||
94365980|NCT02058368|323124834|FG001|Overall Study|Withdrawal by Subject|26|||
94365981|NCT05083559|323124837|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
94365982|NCT05083559|323124838|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
94365983|NCT05083559|323124837|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
94693612|NCT01809210|324334974|FG004|Overall Study|Withdrawal by Subject|1|||
94693613|NCT01809210|324334975|FG005|Overall Study|Withdrawal by Subject|0|||
94693614|NCT01809210|324334976|FG006|Overall Study|Withdrawal by Subject|4|||
94693615|NCT01809210|324334970|FG000|Overall Study|Death|1|||
94693616|NCT01809210|324334971|FG001|Overall Study|Death|1|||
94693617|NCT01809210|324334972|FG002|Overall Study|Death|2|||
94693618|NCT01809210|324334973|FG003|Overall Study|Death|0|||
94693619|NCT01809210|324334974|FG004|Overall Study|Death|1|||
94693620|NCT01809210|324334975|FG005|Overall Study|Death|3|||
94693621|NCT01809210|324334976|FG006|Overall Study|Death|1|||
94693622|NCT01155726|324334981|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
94693623|NCT01155726|324334982|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
94693624|NCT01155726|324334983|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
94693625|NCT01155726|324334984|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
94693626|NCT01489020|324334985|FG000|Overall Study|Withdrawal by Subject|1|||
94693627|NCT01489020|324334986|FG001|Overall Study|Withdrawal by Subject|0|||
94693628|NCT01489020|324334987|FG002|Overall Study|Withdrawal by Subject|0|||
94693629|NCT01489020|324334988|FG003|Overall Study|Withdrawal by Subject|0|||
94693630|NCT01489020|324334989|FG004|Overall Study|Withdrawal by Subject|0|||
94693631|NCT01489020|324334990|FG005|Overall Study|Withdrawal by Subject|0|||
94693632|NCT01489020|324334985|FG000|Overall Study|Adverse Event|0|||
94693633|NCT01489020|324334986|FG001|Overall Study|Adverse Event|0|||
94693634|NCT01489020|324334987|FG002|Overall Study|Adverse Event|3|||
94693635|NCT01489020|324334988|FG003|Overall Study|Adverse Event|0|||
94693636|NCT01489020|324334989|FG004|Overall Study|Adverse Event|3|||
94693637|NCT01489020|324334990|FG005|Overall Study|Adverse Event|0|||
94693638|NCT01489020|324334985|FG000|Overall Study|Concomitant disease|0|||
94693639|NCT01489020|324334986|FG001|Overall Study|Concomitant disease|0|||
94693640|NCT01489020|324334987|FG002|Overall Study|Concomitant disease|0|||
94693641|NCT01489020|324334988|FG003|Overall Study|Concomitant disease|0|||
94693642|NCT01489020|324334989|FG004|Overall Study|Concomitant disease|3|||
94693643|NCT01489020|324334990|FG005|Overall Study|Concomitant disease|0|||
94693644|NCT01254305|324334997|FG000|Overall Study|Adverse Event|6|||
94693645|NCT01254305|324334998|FG001|Overall Study|Adverse Event|3|||
94693646|NCT01254305|324334999|FG002|Overall Study|Adverse Event|2|||
94693647|NCT01254305|324334997|FG000|Overall Study|Lack of Efficacy|1|||
94693648|NCT01254305|324334998|FG001|Overall Study|Lack of Efficacy|0|||
94693649|NCT01254305|324334999|FG002|Overall Study|Lack of Efficacy|1|||
94693650|NCT01254305|324334997|FG000|Overall Study|Protocol Violation|1|||
94693651|NCT01254305|324334998|FG001|Overall Study|Protocol Violation|7|||
94693652|NCT01254305|324334999|FG002|Overall Study|Protocol Violation|3|||
94693653|NCT01254305|324334997|FG000|Overall Study|Withdrawal by Subject|4|||
94693654|NCT01254305|324334998|FG001|Overall Study|Withdrawal by Subject|2|||
94693655|NCT01254305|324334999|FG002|Overall Study|Withdrawal by Subject|4|||
94693656|NCT01254305|324334997|FG000|Overall Study|Lost to Follow-up|10|||
94693657|NCT01254305|324334998|FG001|Overall Study|Lost to Follow-up|6|||
94693658|NCT01254305|324334999|FG002|Overall Study|Lost to Follow-up|5|||
94693659|NCT01254305|324334997|FG000|Overall Study|Other Reasons|0|||
94693660|NCT01254305|324334998|FG001|Overall Study|Other Reasons|0|||
94693661|NCT01254305|324334999|FG002|Overall Study|Other Reasons|2|||
94693662|NCT01154036|324335000|FG000|Phase I|Physician Decision|0|||
94693663|NCT01154036|324335001|FG001|Phase I|Physician Decision|1|||
94693664|NCT01154036|324335002|FG002|Phase I|Physician Decision|0|||
94693665|NCT01154036|324335003|FG003|Phase I|Physician Decision|0|||
94693666|NCT01154036|324335004|FG004|Phase I|Physician Decision|0|||
94693667|NCT01154036|324335005|FG005|Phase I|Physician Decision|0|||
94693668|NCT01154036|324335006|FG006|Phase I|Physician Decision|0|||
94693669|NCT01154036|324335007|FG007|Phase I|Physician Decision|0|||
94693670|NCT01154036|324335000|FG000|Phase I|Lost to Follow-up|0|||
94693671|NCT01154036|324335001|FG001|Phase I|Lost to Follow-up|3|||
94693672|NCT01154036|324335002|FG002|Phase I|Lost to Follow-up|6|||
94693673|NCT01154036|324335003|FG003|Phase I|Lost to Follow-up|0|||
94693674|NCT01154036|324335004|FG004|Phase I|Lost to Follow-up|0|||
94693675|NCT01154036|324335005|FG005|Phase I|Lost to Follow-up|0|||
94693676|NCT01154036|324335006|FG006|Phase I|Lost to Follow-up|0|||
94693677|NCT01154036|324335007|FG007|Phase I|Lost to Follow-up|0|||
94693678|NCT01154036|324335000|FG000|Phase I|Protocol Violation|0|||
94693679|NCT01154036|324335001|FG001|Phase I|Protocol Violation|3|||
94693680|NCT01154036|324335002|FG002|Phase I|Protocol Violation|9|||
94693681|NCT01154036|324335003|FG003|Phase I|Protocol Violation|0|||
94693682|NCT01154036|324335004|FG004|Phase I|Protocol Violation|0|||
94693683|NCT01154036|324335005|FG005|Phase I|Protocol Violation|0|||
94693684|NCT01154036|324335006|FG006|Phase I|Protocol Violation|0|||
94693685|NCT01154036|324335007|FG007|Phase I|Protocol Violation|0|||
94693686|NCT01154036|324335000|FG000|Phase I|Withdrawal by Subject|2|||
94693687|NCT01154036|324335001|FG001|Phase I|Withdrawal by Subject|10|||
94693688|NCT01154036|324335002|FG002|Phase I|Withdrawal by Subject|29|||
94693689|NCT01154036|324335003|FG003|Phase I|Withdrawal by Subject|0|||
94693690|NCT01154036|324335004|FG004|Phase I|Withdrawal by Subject|0|||
94693691|NCT01154036|324335005|FG005|Phase I|Withdrawal by Subject|0|||
94693692|NCT01154036|324335006|FG006|Phase I|Withdrawal by Subject|0|||
94693693|NCT01154036|324335007|FG007|Phase I|Withdrawal by Subject|0|||
94693694|NCT01154036|324335000|FG000|Phase I|Adverse Event|1|||
94693695|NCT01154036|324335001|FG001|Phase I|Adverse Event|11|||
94693696|NCT01154036|324335002|FG002|Phase I|Adverse Event|12|||
94693697|NCT01154036|324335003|FG003|Phase I|Adverse Event|0|||
94693698|NCT01154036|324335004|FG004|Phase I|Adverse Event|0|||
94693699|NCT01154036|324335005|FG005|Phase I|Adverse Event|0|||
94693700|NCT01154036|324335006|FG006|Phase I|Adverse Event|0|||
94693701|NCT01154036|324335007|FG007|Phase I|Adverse Event|0|||
94693702|NCT01154036|324335000|FG000|Phase II|Adverse Event|0|||
94693703|NCT01154036|324335001|FG001|Phase II|Adverse Event|0|||
94693704|NCT01154036|324335002|FG002|Phase II|Adverse Event|0|||
94693705|NCT01154036|324335003|FG003|Phase II|Adverse Event|0|||
94693706|NCT01154036|324335004|FG004|Phase II|Adverse Event|1|||
94693707|NCT01154036|324335005|FG005|Phase II|Adverse Event|1|||
94693708|NCT01154036|324335006|FG006|Phase II|Adverse Event|1|||
94693709|NCT01154036|324335007|FG007|Phase II|Adverse Event|1|||
94693710|NCT01154036|324335000|FG000|Phase II|Physician Decision|0|||
94693711|NCT01154036|324335001|FG001|Phase II|Physician Decision|0|||
94693712|NCT01154036|324335002|FG002|Phase II|Physician Decision|0|||
94693713|NCT01154036|324335003|FG003|Phase II|Physician Decision|0|||
94693714|NCT01154036|324335004|FG004|Phase II|Physician Decision|0|||
94693715|NCT01154036|324335005|FG005|Phase II|Physician Decision|0|||
94693716|NCT01154036|324335006|FG006|Phase II|Physician Decision|1|||
94693717|NCT01154036|324335007|FG007|Phase II|Physician Decision|0|||
94693718|NCT01154036|324335000|FG000|Phase II|Lost to Follow-up|0|||
94693719|NCT01154036|324335001|FG001|Phase II|Lost to Follow-up|0|||
94693720|NCT01154036|324335002|FG002|Phase II|Lost to Follow-up|0|||
94693721|NCT01154036|324335003|FG003|Phase II|Lost to Follow-up|1|||
94693722|NCT01154036|324335004|FG004|Phase II|Lost to Follow-up|2|||
94693723|NCT01154036|324335005|FG005|Phase II|Lost to Follow-up|0|||
94693724|NCT01154036|324335006|FG006|Phase II|Lost to Follow-up|2|||
94693725|NCT01154036|324335007|FG007|Phase II|Lost to Follow-up|1|||
94693726|NCT01154036|324335000|FG000|Phase II|Protocol Violation|0|||
94693727|NCT01154036|324335001|FG001|Phase II|Protocol Violation|0|||
94693728|NCT01154036|324335002|FG002|Phase II|Protocol Violation|0|||
94693729|NCT01154036|324335003|FG003|Phase II|Protocol Violation|0|||
94693730|NCT01154036|324335004|FG004|Phase II|Protocol Violation|1|||
94693731|NCT01154036|324335005|FG005|Phase II|Protocol Violation|2|||
94693732|NCT01154036|324335006|FG006|Phase II|Protocol Violation|0|||
94693733|NCT01154036|324335007|FG007|Phase II|Protocol Violation|0|||
94693734|NCT01154036|324335000|FG000|Phase II|Withdrawal by Subject|0|||
94693735|NCT01154036|324335001|FG001|Phase II|Withdrawal by Subject|0|||
94693736|NCT01154036|324335002|FG002|Phase II|Withdrawal by Subject|0|||
94693737|NCT01154036|324335003|FG003|Phase II|Withdrawal by Subject|0|||
94693738|NCT01154036|324335004|FG004|Phase II|Withdrawal by Subject|4|||
94693739|NCT01154036|324335005|FG005|Phase II|Withdrawal by Subject|2|||
94693740|NCT01154036|324335006|FG006|Phase II|Withdrawal by Subject|5|||
94264309|NCT03250832|322761874|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
94693741|NCT01154036|324335007|FG007|Phase II|Withdrawal by Subject|4|||
94693742|NCT00997243|324335008|FG000|Overall Study|Early termination of study by sponsor|7|||
94693743|NCT04466618|324335011|FG000|Overall Study|Withdrawal by Subject|0|||
94693744|NCT04466618|324335012|FG001|Overall Study|Withdrawal by Subject|1|||
94693745|NCT02206152|324335013|FG000|Pre-Randomization|Withdrawal by Subject|2|||
94693746|NCT03302910|324335017|FG000|Overall Study|Protocol Violation|1|||
94693747|NCT03302910|324335018|FG001|Overall Study|Protocol Violation|0|||
94693748|NCT02800928|324335020|FG000|Overall Study|Withdrawal by Subject|1|||
94693749|NCT02800928|324335021|FG001|Overall Study|Withdrawal by Subject|1|||
94693750|NCT02800928|324335020|FG000|Overall Study|Protocol Violation|1|||
94693751|NCT02800928|324335021|FG001|Overall Study|Protocol Violation|1|||
94693752|NCT00594932|324335029|FG000|First 3 Months|Withdrawal by Subject|1|||
94693753|NCT00594932|324335030|FG001|First 3 Months|Withdrawal by Subject|3|||
94693754|NCT00594932|324335029|FG000|Final 3 Months|Withdrawal by Subject|4|||
94693755|NCT00594932|324335030|FG001|Final 3 Months|Withdrawal by Subject|3|||
94693756|NCT01723826|324335031|FG000|Overall Study|Adverse Event|4|||
94264310|NCT03250832|322761875|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
94466042|NCT02360475|323494996|FG001|Overall Study|Lost to Follow-up|12|||
94693757|NCT01723826|324335032|FG001|Overall Study|Adverse Event|1|||
94693758|NCT01723826|324335033|FG002|Overall Study|Adverse Event|4|||
94693759|NCT01723826|324335034|FG003|Overall Study|Adverse Event|5|||
94693760|NCT01723826|324335031|FG000|Overall Study|Death according to AE eCRF|2|||
94693761|NCT01723826|324335032|FG001|Overall Study|Death according to AE eCRF|3|||
94693762|NCT01723826|324335033|FG002|Overall Study|Death according to AE eCRF|3|||
94693763|NCT01723826|324335034|FG003|Overall Study|Death according to AE eCRF|7|||
94693764|NCT01723826|324335031|FG000|Overall Study|Lost to Follow-up|1|||
94693765|NCT01723826|324335032|FG001|Overall Study|Lost to Follow-up|3|||
94693766|NCT01723826|324335033|FG002|Overall Study|Lost to Follow-up|1|||
94693767|NCT01723826|324335034|FG003|Overall Study|Lost to Follow-up|1|||
94693768|NCT01723826|324335031|FG000|Overall Study|Non-compliance|0|||
94693769|NCT01723826|324335032|FG001|Overall Study|Non-compliance|1|||
94693770|NCT01723826|324335033|FG002|Overall Study|Non-compliance|3|||
94693771|NCT01723826|324335034|FG003|Overall Study|Non-compliance|3|||
94693772|NCT01723826|324335031|FG000|Overall Study|Non-compliance With Study Drug|0|||
94693773|NCT01723826|324335032|FG001|Overall Study|Non-compliance With Study Drug|1|||
94693774|NCT01723826|324335033|FG002|Overall Study|Non-compliance With Study Drug|0|||
94693775|NCT01723826|324335034|FG003|Overall Study|Non-compliance With Study Drug|0|||
94693776|NCT01723826|324335031|FG000|Overall Study|Other Reason|8|||
94693777|NCT01723826|324335032|FG001|Overall Study|Other Reason|6|||
94693778|NCT01723826|324335033|FG002|Overall Study|Other Reason|12|||
94693779|NCT01723826|324335034|FG003|Overall Study|Other Reason|14|||
94693780|NCT01723826|324335031|FG000|Overall Study|Physician Decision|1|||
94693781|NCT01723826|324335032|FG001|Overall Study|Physician Decision|3|||
94693782|NCT01723826|324335033|FG002|Overall Study|Physician Decision|4|||
94693783|NCT01723826|324335034|FG003|Overall Study|Physician Decision|11|||
94693784|NCT01723826|324335031|FG000|Overall Study|Protocol Violation|1|||
94693785|NCT01723826|324335032|FG001|Overall Study|Protocol Violation|1|||
94693786|NCT01723826|324335033|FG002|Overall Study|Protocol Violation|3|||
94693787|NCT01723826|324335034|FG003|Overall Study|Protocol Violation|1|||
94693788|NCT01723826|324335031|FG000|Overall Study|Withdrawal by Subject|10|||
94693789|NCT01723826|324335032|FG001|Overall Study|Withdrawal by Subject|17|||
94693790|NCT01723826|324335033|FG002|Overall Study|Withdrawal by Subject|27|||
94693791|NCT01723826|324335034|FG003|Overall Study|Withdrawal by Subject|48|||
94693792|NCT00131911|324335035|FG000|Overall Study|Withdrawal by Subject|1|||
94693793|NCT00131911|324335036|FG001|Overall Study|Withdrawal by Subject|0|||
94693794|NCT01253200|324335039|FG000|Overall Study|Death|1|||
94264311|NCT03250832|322761876|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
94693795|NCT01253200|324335040|FG001|Overall Study|Death|0|||
94693796|NCT01253200|324335041|FG002|Overall Study|Death|0|||
94693797|NCT01253200|324335042|FG003|Overall Study|Death|0|||
94693798|NCT01253200|324335043|FG004|Overall Study|Death|0|||
94693799|NCT01253200|324335039|FG000|Overall Study|Lost to Follow-up|1|||
94693800|NCT01253200|324335040|FG001|Overall Study|Lost to Follow-up|1|||
94693801|NCT01253200|324335041|FG002|Overall Study|Lost to Follow-up|0|||
94693802|NCT01253200|324335042|FG003|Overall Study|Lost to Follow-up|0|||
94693803|NCT01253200|324335043|FG004|Overall Study|Lost to Follow-up|0|||
94693804|NCT01253200|324335039|FG000|Overall Study|Withdrawal by Subject|2|||
94693805|NCT01253200|324335040|FG001|Overall Study|Withdrawal by Subject|0|||
94693806|NCT01253200|324335041|FG002|Overall Study|Withdrawal by Subject|0|||
94693807|NCT01253200|324335042|FG003|Overall Study|Withdrawal by Subject|0|||
94693808|NCT01253200|324335043|FG004|Overall Study|Withdrawal by Subject|0|||
94693809|NCT01253200|324335039|FG000|Overall Study|Protocol Violation|1|||
94693810|NCT01253200|324335040|FG001|Overall Study|Protocol Violation|4|||
94693811|NCT01253200|324335041|FG002|Overall Study|Protocol Violation|0|||
94693812|NCT01253200|324335042|FG003|Overall Study|Protocol Violation|0|||
94693813|NCT01253200|324335043|FG004|Overall Study|Protocol Violation|5|||
94693814|NCT01253200|324335039|FG000|Overall Study|intents|10|||
94693815|NCT01253200|324335040|FG001|Overall Study|intents|10|||
94693816|NCT01253200|324335041|FG002|Overall Study|intents|1|||
94693817|NCT01253200|324335042|FG003|Overall Study|intents|3|||
94693818|NCT01253200|324335043|FG004|Overall Study|intents|0|||
94693819|NCT01253200|324335039|FG000|Overall Study|Attempts|6|||
94693820|NCT01253200|324335040|FG001|Overall Study|Attempts|4|||
94693821|NCT01253200|324335041|FG002|Overall Study|Attempts|1|||
94693822|NCT01253200|324335042|FG003|Overall Study|Attempts|2|||
94693823|NCT01253200|324335043|FG004|Overall Study|Attempts|0|||
94693824|NCT03785340|324335047|FG000|Overall Study|Lost to Follow-up|2|||
94693825|NCT03785340|324335048|FG001|Overall Study|Lost to Follow-up|0|||
94693826|NCT03785340|324335047|FG000|Overall Study|Adverse Event|1|||
94693827|NCT03785340|324335048|FG001|Overall Study|Adverse Event|0|||
94693828|NCT03008122|324335052|FG000|Overall Study|Physician Decision|3|||
94693829|NCT03008122|324335053|FG001|Overall Study|Physician Decision|2|||
94693830|NCT03008122|324335054|FG002|Overall Study|Physician Decision|0|||
94693831|NCT03008122|324335052|FG000|Overall Study|Withdrawal by Subject|1|||
94693832|NCT03008122|324335053|FG001|Overall Study|Withdrawal by Subject|3|||
94693833|NCT03008122|324335054|FG002|Overall Study|Withdrawal by Subject|0|||
94693834|NCT03008122|324335052|FG000|Overall Study|Lost to Follow-up|4|||
94693835|NCT03008122|324335053|FG001|Overall Study|Lost to Follow-up|8|||
94693836|NCT03008122|324335054|FG002|Overall Study|Lost to Follow-up|3|||
94693837|NCT03008122|324335052|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
94693838|NCT03008122|324335053|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
94693839|NCT03008122|324335054|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
94693840|NCT03008122|324335052|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
94693841|NCT03008122|324335053|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
94693842|NCT03008122|324335054|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
94693843|NCT03008122|324335052|FG000|Overall Study|Death|0|||
94693844|NCT03008122|324335053|FG001|Overall Study|Death|0|||
94264312|NCT03250832|322761877|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
94693845|NCT03008122|324335054|FG002|Overall Study|Death|1|||
94693846|NCT01670500|324335063|FG000|Overall Study|Withdrawal by Subject|1|||
94693847|NCT01670500|324335064|FG001|Overall Study|Withdrawal by Subject|0|||
94466043|NCT02360475|323494997|FG002|Overall Study|Lost to Follow-up|6|||
94693848|NCT03473756|324335065|FG000|Overall Study|Withdrawal by Subject|1|||
94693849|NCT03473756|324335066|FG001|Overall Study|Withdrawal by Subject|4|||
94693850|NCT03473756|324335065|FG000|Overall Study|Adverse Event|6|||
94693851|NCT03473756|324335066|FG001|Overall Study|Adverse Event|7|||
94693852|NCT03473756|324335065|FG000|Overall Study|Lack of Efficacy|3|||
94693853|NCT03473756|324335066|FG001|Overall Study|Lack of Efficacy|10|||
94693854|NCT03473756|324335065|FG000|Overall Study|Physician Decision|0|||
94693855|NCT03473756|324335066|FG001|Overall Study|Physician Decision|2|||
94693856|NCT03473756|324335065|FG000|Overall Study|End of study treatment|0|||
94693857|NCT03473756|324335066|FG001|Overall Study|End of study treatment|2|||
94693858|NCT03473756|324335065|FG000|Overall Study|Lost to Follow-up|0|||
94693859|NCT03473756|324335066|FG001|Overall Study|Lost to Follow-up|1|||
94693860|NCT02192359|324335069|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
94693861|NCT02192359|324335070|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
94693862|NCT02192359|324335071|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
94693863|NCT02192359|324335072|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
94693864|NCT02192359|324335069|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
94693865|NCT02192359|324335070|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
94693866|NCT02192359|324335071|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
94693867|NCT02192359|324335072|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
94693868|NCT02192359|324335069|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
94693869|NCT02192359|324335070|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
94693870|NCT02192359|324335071|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
94693871|NCT02192359|324335072|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
94693872|NCT04951479|324335073|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
94693873|NCT00729690|324335077|FG000|Overall Study|IT Catheter Malfunction|0|||
94693874|NCT00729690|324335078|FG001|Overall Study|IT Catheter Malfunction|2|||
94693875|NCT00729690|324335079|FG002|Overall Study|IT Catheter Malfunction|2|||
94693876|NCT02507219|324335083|FG000|Overall Study|Physician Decision|1|||
94693877|NCT02507219|324335084|FG001|Overall Study|Physician Decision|0|||
94693878|NCT02507219|324335085|FG002|Overall Study|Physician Decision|0|||
94693879|NCT02507219|324335086|FG003|Overall Study|Physician Decision|0|||
94693880|NCT02507219|324335087|FG004|Overall Study|Physician Decision|0|||
94693881|NCT02507219|324335088|FG005|Overall Study|Physician Decision|0|||
94693882|NCT02507219|324335083|FG000|Overall Study|Withdrawal by Subject|0|||
94693883|NCT02507219|324335084|FG001|Overall Study|Withdrawal by Subject|0|||
94693884|NCT02507219|324335085|FG002|Overall Study|Withdrawal by Subject|0|||
94693885|NCT02507219|324335086|FG003|Overall Study|Withdrawal by Subject|0|||
94693886|NCT02507219|324335087|FG004|Overall Study|Withdrawal by Subject|1|||
94693887|NCT02507219|324335088|FG005|Overall Study|Withdrawal by Subject|0|||
94693888|NCT04248465|324335089|FG000|Randomized-Controlled Period|Death|12|||
94693889|NCT04248465|324335090|FG001|Randomized-Controlled Period|Death|5|||
94693890|NCT04248465|324335089|FG000|Randomized-Controlled Period|Adverse Event|2|||
94693891|NCT04248465|324335090|FG001|Randomized-Controlled Period|Adverse Event|0|||
94693892|NCT04248465|324335089|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
94693893|NCT04248465|324335090|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
94693894|NCT04248465|324335089|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
94693895|NCT04248465|324335090|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
94693896|NCT04248465|324335089|FG000|Randomized-Controlled Period|Physician Decision|1|||
94693897|NCT04248465|324335090|FG001|Randomized-Controlled Period|Physician Decision|1|||
94693898|NCT04248465|324335089|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
94693899|NCT04248465|324335090|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
94693900|NCT04248465|324335089|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
94693901|NCT04248465|324335090|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
94693902|NCT04248465|324335089|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
94693903|NCT04248465|324335090|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
94693904|NCT00238420|324335091|FG000|Overall Study|Protocol Violation|1|||
94693905|NCT00238420|324335092|FG001|Overall Study|Protocol Violation|1|||
94693906|NCT01544582|324335095|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
94693907|NCT01544582|324335096|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
94693908|NCT01544582|324335097|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
94693909|NCT01544582|324335098|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
94693910|NCT01544582|324335095|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
94693911|NCT01544582|324335096|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
94693912|NCT01544582|324335097|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
94693913|NCT01544582|324335098|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
94693914|NCT01544582|324335095|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
94365984|NCT05083559|323124838|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
94466044|NCT02360475|323494998|FG003|Overall Study|Lost to Follow-up|4|||
94693915|NCT01544582|324335096|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
94693916|NCT01544582|324335097|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
94693917|NCT01544582|324335098|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
94693918|NCT01544582|324335095|FG000|Analysis Population|Physician Decision|0|||
94693919|NCT01544582|324335096|FG001|Analysis Population|Physician Decision|13|||
94693920|NCT01544582|324335097|FG002|Analysis Population|Physician Decision|10|||
94693921|NCT01544582|324335098|FG003|Analysis Population|Physician Decision|9|||
94693922|NCT01544582|324335095|FG000|Analysis Population|Safety Reason|0|||
94693923|NCT01544582|324335096|FG001|Analysis Population|Safety Reason|33|||
94693924|NCT01544582|324335097|FG002|Analysis Population|Safety Reason|31|||
94693925|NCT01544582|324335098|FG003|Analysis Population|Safety Reason|8|||
94693926|NCT01544582|324335095|FG000|Analysis Population|Effectiveness Reason|0|||
94693927|NCT01544582|324335096|FG001|Analysis Population|Effectiveness Reason|48|||
94693928|NCT01544582|324335097|FG002|Analysis Population|Effectiveness Reason|29|||
94693929|NCT01544582|324335098|FG003|Analysis Population|Effectiveness Reason|12|||
94693930|NCT01544582|324335095|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
94693931|NCT01544582|324335096|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
94693932|NCT01544582|324335097|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
94693933|NCT01544582|324335098|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
94693934|NCT01544582|324335095|FG000|Analysis Population|Lost to Follow-up|0|||
94693935|NCT01544582|324335096|FG001|Analysis Population|Lost to Follow-up|6|||
94693936|NCT01544582|324335097|FG002|Analysis Population|Lost to Follow-up|6|||
94693937|NCT01544582|324335098|FG003|Analysis Population|Lost to Follow-up|5|||
94693938|NCT01544582|324335095|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
94693939|NCT01544582|324335096|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
94693940|NCT01544582|324335097|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
94693941|NCT01544582|324335098|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
94693942|NCT01544582|324335095|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
94693943|NCT01544582|324335096|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
94693944|NCT01544582|324335097|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
94693945|NCT01544582|324335098|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
94693946|NCT01544582|324335095|FG000|Analysis Population|Intolerance|0|||
94693947|NCT01544582|324335096|FG001|Analysis Population|Intolerance|1|||
94693948|NCT01544582|324335097|FG002|Analysis Population|Intolerance|0|||
94693949|NCT01544582|324335098|FG003|Analysis Population|Intolerance|0|||
94693950|NCT01544582|324335095|FG000|Analysis Population|Liver Transplantation|0|||
94693951|NCT01544582|324335096|FG001|Analysis Population|Liver Transplantation|0|||
94693952|NCT01544582|324335097|FG002|Analysis Population|Liver Transplantation|1|||
94693953|NCT01544582|324335098|FG003|Analysis Population|Liver Transplantation|0|||
94693954|NCT01544582|324335095|FG000|Analysis Population|No Social Insurance|0|||
94693955|NCT01544582|324335096|FG001|Analysis Population|No Social Insurance|0|||
94693956|NCT01544582|324335097|FG002|Analysis Population|No Social Insurance|1|||
94693957|NCT01544582|324335098|FG003|Analysis Population|No Social Insurance|0|||
94693958|NCT01544582|324335095|FG000|Analysis Population|Poor Adherence|0|||
94693959|NCT01544582|324335096|FG001|Analysis Population|Poor Adherence|0|||
94693960|NCT01544582|324335097|FG002|Analysis Population|Poor Adherence|1|||
94693961|NCT01544582|324335098|FG003|Analysis Population|Poor Adherence|0|||
94693962|NCT01544582|324335095|FG000|Analysis Population|Poor Participant Compliance|0|||
94693963|NCT01544582|324335096|FG001|Analysis Population|Poor Participant Compliance|1|||
94693964|NCT01544582|324335097|FG002|Analysis Population|Poor Participant Compliance|0|||
94693965|NCT01544582|324335098|FG003|Analysis Population|Poor Participant Compliance|0|||
94693966|NCT01544582|324335095|FG000|Analysis Population|Programmed Surgery|0|||
94693967|NCT01544582|324335096|FG001|Analysis Population|Programmed Surgery|1|||
94693968|NCT01544582|324335097|FG002|Analysis Population|Programmed Surgery|0|||
94693969|NCT01544582|324335098|FG003|Analysis Population|Programmed Surgery|0|||
94693970|NCT01544582|324335095|FG000|Analysis Population|Participant in Jail|0|||
94693971|NCT01544582|324335096|FG001|Analysis Population|Participant in Jail|0|||
94693972|NCT01544582|324335097|FG002|Analysis Population|Participant in Jail|1|||
94693973|NCT01544582|324335098|FG003|Analysis Population|Participant in Jail|0|||
94693974|NCT00209274|324335099|FG000|Overall Study|Missed visit|3|||
94693975|NCT00209274|324335100|FG001|Overall Study|Missed visit|2|||
94693976|NCT00209274|324335099|FG000|Overall Study|Death|32|||
94693977|NCT00209274|324335100|FG001|Overall Study|Death|15|||
94693978|NCT00209274|324335099|FG000|Overall Study|Withdrawal by Subject|30|||
94693979|NCT00209274|324335100|FG001|Overall Study|Withdrawal by Subject|15|||
94693980|NCT00209274|324335099|FG000|Overall Study|Randomized not treated (RNT)|6|||
94693981|NCT00209274|324335100|FG001|Overall Study|Randomized not treated (RNT)|15|||
94693982|NCT01778062|324335101|FG000|Overall Study|Adverse Event|1|||
94693983|NCT01778062|324335102|FG001|Overall Study|Adverse Event|3|||
94693984|NCT01778062|324335101|FG000|Overall Study|Consent Withdrawal|1|||
94693985|NCT01778062|324335102|FG001|Overall Study|Consent Withdrawal|5|||
94693986|NCT01778062|324335101|FG000|Overall Study|major protocol deviation|4|||
94693987|NCT01778062|324335102|FG001|Overall Study|major protocol deviation|3|||
94693988|NCT03958630|324335103|FG000|Overall Study|Withdrawal by Subject|0|||
94693989|NCT03958630|324335104|FG001|Overall Study|Withdrawal by Subject|0|||
94693990|NCT03958630|324335105|FG002|Overall Study|Withdrawal by Subject|1|||
94693991|NCT03958630|324335103|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
94693992|NCT03958630|324335104|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
94693993|NCT03958630|324335105|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
94693994|NCT01824472|324335108|FG000|Overall Study|Lost to Follow-up|0|||
94693995|NCT01824472|324335109|FG001|Overall Study|Lost to Follow-up|0|||
94693996|NCT01824472|324335110|FG002|Overall Study|Lost to Follow-up|1|||
94693997|NCT01824472|324335108|FG000|Overall Study|Withdrawal by Subject|1|||
94693998|NCT01824472|324335109|FG001|Overall Study|Withdrawal by Subject|5|||
94693999|NCT01824472|324335110|FG002|Overall Study|Withdrawal by Subject|3|||
94694000|NCT01824472|324335108|FG000|Overall Study|Ineligible post randomization&screening|0|||
94694001|NCT01824472|324335109|FG001|Overall Study|Ineligible post randomization&screening|2|||
94694002|NCT01824472|324335110|FG002|Overall Study|Ineligible post randomization&screening|0|||
94694003|NCT03317379|324335111|FG000|Overall Study|Lost to Follow-up|0|||
94694004|NCT03317379|324335112|FG001|Overall Study|Lost to Follow-up|3|||
94694005|NCT03317379|324335113|FG002|Overall Study|Lost to Follow-up|2|||
94694006|NCT04445155|324335114|FG000|Overall Study|Lost to Follow-up|11|||
94694007|NCT04445155|324335115|FG001|Overall Study|Lost to Follow-up|2|||
94694008|NCT04445155|324335116|FG002|Overall Study|Lost to Follow-up|3|||
94694009|NCT04445155|324335117|FG003|Overall Study|Lost to Follow-up|0|||
94694010|NCT04445155|324335114|FG000|Overall Study|Withdrawal by Subject|8|||
94694011|NCT04445155|324335115|FG001|Overall Study|Withdrawal by Subject|0|||
94694012|NCT04445155|324335116|FG002|Overall Study|Withdrawal by Subject|0|||
94694013|NCT04445155|324335117|FG003|Overall Study|Withdrawal by Subject|0|||
94694014|NCT04445155|324335114|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
94694015|NCT04445155|324335115|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
94694016|NCT04445155|324335116|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
94694017|NCT04445155|324335117|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
94694018|NCT04445155|324335114|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
94694019|NCT04445155|324335115|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
94694020|NCT04445155|324335116|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
94694021|NCT04445155|324335117|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
94694022|NCT00900627|324337027|FG000|Overall Study|Condition under investigation worsened|4|||
94694023|NCT00900627|324337028|FG001|Overall Study|Condition under investigation worsened|0|||
94694024|NCT00900627|324337029|FG002|Overall Study|Condition under investigation worsened|5|||
94694025|NCT00900627|324337030|FG003|Overall Study|Condition under investigation worsened|3|||
94694026|NCT00900627|324337031|FG004|Overall Study|Condition under investigation worsened|0|||
94694027|NCT00900627|324337032|FG005|Overall Study|Condition under investigation worsened|0|||
94694028|NCT00900627|324337027|FG000|Overall Study|Withdrawal by Subject|1|||
94694029|NCT00900627|324337028|FG001|Overall Study|Withdrawal by Subject|0|||
94694030|NCT00900627|324337029|FG002|Overall Study|Withdrawal by Subject|1|||
94694031|NCT00900627|324337030|FG003|Overall Study|Withdrawal by Subject|0|||
94694032|NCT00900627|324337031|FG004|Overall Study|Withdrawal by Subject|1|||
94694033|NCT00900627|324337032|FG005|Overall Study|Withdrawal by Subject|2|||
94694034|NCT00900627|324337027|FG000|Overall Study|Adverse Event|1|||
94365985|NCT05083559|323124837|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
94694035|NCT00900627|324337028|FG001|Overall Study|Adverse Event|2|||
94365986|NCT05083559|323124838|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
94694036|NCT00900627|324337029|FG002|Overall Study|Adverse Event|0|||
94694037|NCT00900627|324337030|FG003|Overall Study|Adverse Event|3|||
94694038|NCT00900627|324337031|FG004|Overall Study|Adverse Event|0|||
94694039|NCT00900627|324337032|FG005|Overall Study|Adverse Event|0|||
94694040|NCT00900627|324337027|FG000|Overall Study|Death|0|||
94694041|NCT00900627|324337028|FG001|Overall Study|Death|0|||
94694042|NCT00900627|324337029|FG002|Overall Study|Death|0|||
94694043|NCT00900627|324337030|FG003|Overall Study|Death|0|||
94694044|NCT00900627|324337031|FG004|Overall Study|Death|28|||
94694045|NCT00900627|324337032|FG005|Overall Study|Death|24|||
94694046|NCT02692235|324337033|FG000|Overall Study|Withdrawal by Subject|2|||
94694047|NCT02692235|324337034|FG001|Overall Study|Withdrawal by Subject|1|||
94694048|NCT02692235|324337033|FG000|Overall Study|Adverse Event|1|||
94694049|NCT02692235|324337034|FG001|Overall Study|Adverse Event|2|||
94694050|NCT00830947|324337035|FG000|Overall Study|Lost to Follow-up|4|||
94694051|NCT00830947|324337036|FG001|Overall Study|Lost to Follow-up|4|||
94694052|NCT02462083|324337037|FG000|Overall Study|Sponsor request|39|||
94694053|NCT02462083|324337037|FG000|Overall Study|Withdrawal by Subject|87|||
94694054|NCT02462083|324337037|FG000|Overall Study|Lost to Follow-up|41|||
94694055|NCT02462083|324337037|FG000|Overall Study|Lack of Efficacy|151|||
94694056|NCT02462083|324337037|FG000|Overall Study|Pregnancy|1|||
94694057|NCT02462083|324337037|FG000|Overall Study|Protocol Violation|6|||
94694058|NCT02462083|324337037|FG000|Overall Study|Adverse Event|33|||
94694059|NCT02462083|324337037|FG000|Overall Study|Worsening condition|16|||
94694060|NCT02462083|324337037|FG000|Overall Study|Other than specified|45|||
94694061|NCT00802841|324337038|FG000|Overall Study|Administrative problems|1|||
94694062|NCT00802841|324337039|FG001|Overall Study|Administrative problems|0|||
94694063|NCT00802841|324337038|FG000|Overall Study|Lost to Follow-up|2|||
94694064|NCT00802841|324337039|FG001|Overall Study|Lost to Follow-up|1|||
94694065|NCT00802841|324337038|FG000|Overall Study|Death|1|||
94694066|NCT00802841|324337039|FG001|Overall Study|Death|2|||
94694067|NCT00802841|324337038|FG000|Overall Study|Adverse Event|8|||
94694068|NCT00802841|324337039|FG001|Overall Study|Adverse Event|2|||
94694069|NCT00802841|324337038|FG000|Overall Study|Disease progression|7|||
94694070|NCT00802841|324337039|FG001|Overall Study|Disease progression|3|||
94694071|NCT00802841|324337038|FG000|Overall Study|Withdrawal by Subject|9|||
94694072|NCT00802841|324337039|FG001|Overall Study|Withdrawal by Subject|5|||
94694073|NCT00802841|324337038|FG000|Overall Study|Protocol deviation|2|||
94694074|NCT00802841|324337039|FG001|Overall Study|Protocol deviation|6|||
94694075|NCT00802841|324337038|FG000|Overall Study|Treatment duration completed|66|||
94694076|NCT00802841|324337039|FG001|Overall Study|Treatment duration completed|76|||
94694077|NCT03615482|324337042|FG000|Overall Study|Death|1|||
94694078|NCT03615482|324337043|FG001|Overall Study|Death|0|||
94694079|NCT03615482|324337042|FG000|Overall Study|Lost to Follow-up|7|||
94694080|NCT03615482|324337043|FG001|Overall Study|Lost to Follow-up|7|||
94694081|NCT03615482|324337042|FG000|Overall Study|Physician Decision|2|||
94694082|NCT03615482|324337043|FG001|Overall Study|Physician Decision|3|||
94694083|NCT03615482|324337042|FG000|Overall Study|Withdrawal by Subject|7|||
94694084|NCT03615482|324337043|FG001|Overall Study|Withdrawal by Subject|7|||
94694085|NCT00322868|324337044|FG000|Overall Study|disease progression|1|||
94694086|NCT04212169|324337045|FG000|Overall Study|Adverse Event|0|||
94694087|NCT04212169|324337046|FG001|Overall Study|Adverse Event|0|||
94694088|NCT04212169|324337047|FG002|Overall Study|Adverse Event|0|||
94694089|NCT04212169|324337048|FG003|Overall Study|Adverse Event|2|||
94694090|NCT04212169|324337045|FG000|Overall Study|Lost to Follow-up|1|||
94694091|NCT04212169|324337046|FG001|Overall Study|Lost to Follow-up|0|||
94694092|NCT04212169|324337047|FG002|Overall Study|Lost to Follow-up|0|||
94694093|NCT04212169|324337048|FG003|Overall Study|Lost to Follow-up|2|||
94694094|NCT04212169|324337045|FG000|Overall Study|Withdrawal by Subject|10|||
94694095|NCT04212169|324337046|FG001|Overall Study|Withdrawal by Subject|2|||
94694096|NCT04212169|324337047|FG002|Overall Study|Withdrawal by Subject|5|||
94694097|NCT04212169|324337048|FG003|Overall Study|Withdrawal by Subject|7|||
94694098|NCT04212169|324337045|FG000|Overall Study|Other reason, unspecified|3|||
94694099|NCT04212169|324337046|FG001|Overall Study|Other reason, unspecified|1|||
94694100|NCT04212169|324337047|FG002|Overall Study|Other reason, unspecified|0|||
94694101|NCT04212169|324337048|FG003|Overall Study|Other reason, unspecified|2|||
94694102|NCT02018861|324337054|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
94264313|NCT03250832|322761878|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
94264314|NCT03250832|322761879|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
94264315|NCT03250832|322761880|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
94264316|NCT03250832|322761881|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
94694103|NCT02018861|324337055|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
94694104|NCT02018861|324337056|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
94694105|NCT02018861|324337057|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
94694106|NCT02018861|324337058|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
94694107|NCT02018861|324337059|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
94694108|NCT02018861|324337060|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
94694109|NCT02018861|324337061|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
94694110|NCT02018861|324337062|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
94694111|NCT02018861|324337063|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
94694112|NCT02018861|324337054|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
94694113|NCT02018861|324337055|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
94694114|NCT02018861|324337056|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
94694115|NCT02018861|324337057|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
94365987|NCT02704130|323124839|FG000|Overall Study|Physician Decision|5|||
94694116|NCT02018861|324337058|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
94694117|NCT02018861|324337059|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
94694118|NCT02018861|324337060|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
94694119|NCT02018861|324337061|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
94694120|NCT02018861|324337062|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
94694121|NCT02018861|324337063|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
94694122|NCT02018861|324337054|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
94694123|NCT02018861|324337055|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
94694124|NCT02018861|324337056|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
94694125|NCT02018861|324337057|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
94694126|NCT02018861|324337058|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
94694127|NCT02018861|324337059|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
94694128|NCT02018861|324337060|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
94694129|NCT02018861|324337061|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
94694130|NCT02018861|324337062|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
94694131|NCT02018861|324337063|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
94694132|NCT02018861|324337054|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
94694133|NCT02018861|324337055|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
94694134|NCT02018861|324337056|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
94694135|NCT02018861|324337057|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
94694136|NCT02018861|324337058|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
94694137|NCT02018861|324337059|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
94694138|NCT02018861|324337060|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
94694139|NCT02018861|324337061|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
94694140|NCT02018861|324337062|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
94694141|NCT02018861|324337063|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
94694142|NCT02018861|324337054|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
94694143|NCT02018861|324337055|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
94694144|NCT02018861|324337056|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
94694145|NCT02018861|324337057|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
94694146|NCT02018861|324337058|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
94694147|NCT02018861|324337059|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
94694148|NCT02018861|324337060|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
94694149|NCT02018861|324337061|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
94694150|NCT02018861|324337062|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
94694151|NCT02018861|324337063|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
94694152|NCT02018861|324337054|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
94694153|NCT02018861|324337055|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
94694154|NCT02018861|324337056|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
94694155|NCT02018861|324337057|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
94466045|NCT02360475|323494995|FG000|Overall Study|Withdrawal by Subject|0|||
94466046|NCT02360475|323494996|FG001|Overall Study|Withdrawal by Subject|1|||
94466047|NCT02360475|323494997|FG002|Overall Study|Withdrawal by Subject|2|||
94694156|NCT02018861|324337058|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
94694157|NCT02018861|324337059|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
94694158|NCT02018861|324337060|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
94694159|NCT02018861|324337061|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
94694160|NCT02018861|324337062|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
94694161|NCT02018861|324337063|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
94694162|NCT02018861|324337054|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
94694163|NCT02018861|324337055|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
94694164|NCT02018861|324337056|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
94694165|NCT02018861|324337057|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
94694166|NCT02018861|324337058|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
94694167|NCT02018861|324337059|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
94694168|NCT02018861|324337060|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
94694169|NCT02018861|324337061|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
94466048|NCT02360475|323494998|FG003|Overall Study|Withdrawal by Subject|0|||
94466049|NCT02360475|323494995|FG000|Overall Study|Migrated/moved from study area|0|||
94466050|NCT02360475|323494996|FG001|Overall Study|Migrated/moved from study area|0|||
94694170|NCT02018861|324337062|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
94694171|NCT02018861|324337063|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
94694172|NCT02018861|324337054|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
94694173|NCT02018861|324337055|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
94365988|NCT02704130|323124840|FG001|Overall Study|Physician Decision|3|||
94365989|NCT01216319|323124844|FG000|Overall Study|Lost to Follow-up|2|||
94365990|NCT01216319|323124844|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
94365991|NCT00995488|323124845|FG000|Overall Study|Withdrawal by Subject|1|||
94365992|NCT01174368|323124851|FG000|Overall Study|Withdrawal by Subject|1|||
94365993|NCT03728257|323124852|FG000|Overall Study|Death|3|||
94365994|NCT03728257|323124853|FG001|Overall Study|Death|0|||
94365995|NCT03985293|323124854|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
94365996|NCT03985293|323124855|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
94365997|NCT03985293|323124856|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
94365998|NCT03985293|323124857|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
94365999|NCT03985293|323124858|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
94366000|NCT03985293|323124859|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
94366001|NCT03985293|323124854|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
94366002|NCT03985293|323124855|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
94366003|NCT03985293|323124856|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
94366004|NCT03985293|323124857|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
94366005|NCT03985293|323124858|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
94366006|NCT03985293|323124859|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
94366007|NCT03985293|323124854|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
94366008|NCT03985293|323124855|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
94366009|NCT03985293|323124856|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
94366010|NCT03985293|323124857|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
94366011|NCT03985293|323124858|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
94366012|NCT03985293|323124859|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
94366013|NCT03985293|323124854|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
94366014|NCT03985293|323124855|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
94366015|NCT03985293|323124856|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
94366016|NCT03985293|323124857|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
94366017|NCT03985293|323124858|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
94366018|NCT03985293|323124859|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
94366019|NCT03985293|323124854|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
94366020|NCT03985293|323124855|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
94366021|NCT03985293|323124856|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
94366022|NCT03985293|323124857|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
94366023|NCT03985293|323124858|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
94366024|NCT03985293|323124859|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
94366025|NCT03985293|323124854|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
94366026|NCT03985293|323124855|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
94366027|NCT03985293|323124856|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
94366028|NCT03985293|323124857|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
94366029|NCT03985293|323124858|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
94366030|NCT03985293|323124859|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
94366031|NCT03985293|323124854|FG000|FOLLOW-UP|Lost to Follow-up|0|||
94366032|NCT03985293|323124855|FG001|FOLLOW-UP|Lost to Follow-up|0|||
94366033|NCT03985293|323124856|FG002|FOLLOW-UP|Lost to Follow-up|1|||
94366034|NCT03985293|323124857|FG003|FOLLOW-UP|Lost to Follow-up|0|||
94366035|NCT03985293|323124858|FG004|FOLLOW-UP|Lost to Follow-up|0|||
94366036|NCT03985293|323124859|FG005|FOLLOW-UP|Lost to Follow-up|0|||
94366037|NCT01311505|323124860|FG000|First Intervention Period|Protocol Violation|0|||
94366038|NCT01311505|323124861|FG001|First Intervention Period|Protocol Violation|1|||
94366039|NCT03273257|323124865|FG000|Overall Study|Death|0|||
94366040|NCT03273257|323124866|FG001|Overall Study|Death|1|||
94366041|NCT03273257|323124865|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
94366042|NCT03273257|323124866|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
94366043|NCT03273257|323124865|FG000|Overall Study|Study terminated|3|||
94366044|NCT03273257|323124866|FG001|Overall Study|Study terminated|2|||
94466051|NCT02360475|323494997|FG002|Overall Study|Migrated/moved from study area|0|||
94694174|NCT02018861|324337056|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
94694175|NCT02018861|324337057|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
94694176|NCT02018861|324337058|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
94694177|NCT02018861|324337059|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
94366045|NCT01898884|323124867|FG000|Multiple Dose Period|Adverse Event|0|||
94466052|NCT02360475|323494998|FG003|Overall Study|Migrated/moved from study area|1|||
94466053|NCT03759366|323494999|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
94366046|NCT01898884|323124868|FG001|Multiple Dose Period|Adverse Event|0|||
94366047|NCT01898884|323124869|FG002|Multiple Dose Period|Adverse Event|0|||
94366048|NCT01898884|323124870|FG003|Multiple Dose Period|Adverse Event|0|||
94366049|NCT01898884|323124871|FG004|Multiple Dose Period|Adverse Event|0|||
94366050|NCT01898884|323124872|FG005|Multiple Dose Period|Adverse Event|0|||
94366051|NCT01898884|323124873|FG006|Multiple Dose Period|Adverse Event|1|||
94366052|NCT01898884|323124874|FG007|Multiple Dose Period|Adverse Event|0|||
94694178|NCT02018861|324337060|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
94694179|NCT02018861|324337061|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
94694180|NCT02018861|324337062|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
94694181|NCT02018861|324337063|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
94694182|NCT02018861|324337054|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
94694183|NCT02018861|324337055|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
94694184|NCT02018861|324337056|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
94694185|NCT02018861|324337057|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
94694186|NCT02018861|324337058|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
94694187|NCT02018861|324337059|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
94694188|NCT02018861|324337060|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
94694189|NCT02018861|324337061|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
94694190|NCT02018861|324337062|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
94694191|NCT02018861|324337063|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
94694192|NCT02018861|324337054|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
94694193|NCT02018861|324337055|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
94694194|NCT02018861|324337056|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
94694195|NCT02018861|324337057|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
94694196|NCT02018861|324337058|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
94694197|NCT02018861|324337059|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
94694198|NCT02018861|324337060|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
94694199|NCT02018861|324337061|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
94694200|NCT02018861|324337062|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
94694201|NCT02018861|324337063|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
94694202|NCT02018861|324337054|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
94694203|NCT02018861|324337055|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
94694204|NCT02018861|324337056|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
94694205|NCT02018861|324337057|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
94694206|NCT02018861|324337058|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
94694207|NCT02018861|324337059|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
94694208|NCT02018861|324337060|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
94694209|NCT02018861|324337061|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
94694210|NCT02018861|324337062|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
94694211|NCT02018861|324337063|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
94694212|NCT02018861|324337054|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
94694213|NCT02018861|324337055|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
94694214|NCT02018861|324337056|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
94694215|NCT02018861|324337057|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
94694216|NCT02018861|324337058|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
94694217|NCT02018861|324337059|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
94694218|NCT02018861|324337060|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
94694219|NCT02018861|324337061|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
94694220|NCT02018861|324337062|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
94694221|NCT02018861|324337063|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
94694222|NCT02018861|324337054|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
94694223|NCT02018861|324337055|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
94694224|NCT02018861|324337056|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
94694225|NCT02018861|324337057|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
94694226|NCT02018861|324337058|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
94694227|NCT02018861|324337059|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
94694228|NCT02018861|324337060|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
94694229|NCT02018861|324337061|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
94694230|NCT02018861|324337062|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
94694231|NCT02018861|324337063|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
94694232|NCT01668147|324337064|FG000|Overall Study|Withdrawal by Subject|6|||
94694233|NCT01268059|324337065|FG000|Overall Study|Lost to Follow-up|0|||
94694234|NCT01268059|324337066|FG001|Overall Study|Lost to Follow-up|1|||
94694235|NCT01268059|324337067|FG002|Overall Study|Lost to Follow-up|0|||
94694236|NCT01268059|324337068|FG003|Overall Study|Lost to Follow-up|0|||
94694237|NCT01268059|324337065|FG000|Overall Study|Withdrawal by Subject|7|||
94694238|NCT01268059|324337066|FG001|Overall Study|Withdrawal by Subject|4|||
94694239|NCT01268059|324337067|FG002|Overall Study|Withdrawal by Subject|0|||
94694240|NCT01268059|324337068|FG003|Overall Study|Withdrawal by Subject|0|||
94694241|NCT01268059|324337065|FG000|Overall Study|Death|20|||
94694242|NCT01268059|324337066|FG001|Overall Study|Death|30|||
94694243|NCT01268059|324337067|FG002|Overall Study|Death|3|||
94694244|NCT01268059|324337068|FG003|Overall Study|Death|5|||
94694245|NCT01268059|324337065|FG000|Overall Study|Progression of disease|1|||
94694246|NCT01268059|324337066|FG001|Overall Study|Progression of disease|0|||
94694247|NCT01268059|324337067|FG002|Overall Study|Progression of disease|0|||
94694248|NCT01268059|324337068|FG003|Overall Study|Progression of disease|0|||
94694249|NCT02819479|324337069|FG000|Overall Study|Adverse Event|2|||
94366053|NCT01898884|323124875|FG008|Multiple Dose Period|Adverse Event|0|||
94694250|NCT00504348|324337070|FG000|Overall Study|Adverse Event|3|||
94694251|NCT00504348|324337070|FG000|Overall Study|Lack of Efficacy|4|||
94694252|NCT00504348|324337070|FG000|Overall Study|Physician Decision|1|||
94694253|NCT01474512|324337071|FG000|Induction Period|Adverse Event|6|||
94694254|NCT01474512|324337072|FG001|Induction Period|Adverse Event|10|||
94694255|NCT01474512|324337073|FG002|Induction Period|Adverse Event|10|||
94694256|NCT01474512|324337074|FG003|Induction Period|Adverse Event|0|||
94694257|NCT01474512|324337075|FG004|Induction Period|Adverse Event|0|||
94694258|NCT01474512|324337076|FG005|Induction Period|Adverse Event|0|||
94694259|NCT01474512|324337077|FG006|Induction Period|Adverse Event|0|||
94694260|NCT01474512|324337078|FG007|Induction Period|Adverse Event|0|||
94694261|NCT01474512|324337079|FG008|Induction Period|Adverse Event|0|||
94694262|NCT01474512|324337080|FG009|Induction Period|Adverse Event|0|||
94694263|NCT01474512|324337081|FG010|Induction Period|Adverse Event|0|||
94694264|NCT01474512|324337082|FG011|Induction Period|Adverse Event|0|||
94694265|NCT01474512|324337083|FG012|Induction Period|Adverse Event|0|||
94694266|NCT01474512|324337084|FG013|Induction Period|Adverse Event|0|||
94694267|NCT01474512|324337085|FG014|Induction Period|Adverse Event|0|||
94694268|NCT01474512|324337086|FG015|Induction Period|Adverse Event|0|||
94694269|NCT01474512|324337087|FG016|Induction Period|Adverse Event|0|||
94694270|NCT01474512|324337088|FG017|Induction Period|Adverse Event|0|||
94694271|NCT01474512|324337071|FG000|Induction Period|Lack of Efficacy|7|||
94694272|NCT01474512|324337072|FG001|Induction Period|Lack of Efficacy|1|||
94694273|NCT01474512|324337073|FG002|Induction Period|Lack of Efficacy|0|||
94694274|NCT01474512|324337074|FG003|Induction Period|Lack of Efficacy|0|||
94694275|NCT01474512|324337075|FG004|Induction Period|Lack of Efficacy|0|||
94694276|NCT01474512|324337076|FG005|Induction Period|Lack of Efficacy|0|||
94694277|NCT01474512|324337077|FG006|Induction Period|Lack of Efficacy|0|||
94694278|NCT01474512|324337078|FG007|Induction Period|Lack of Efficacy|0|||
94694279|NCT01474512|324337079|FG008|Induction Period|Lack of Efficacy|0|||
94694280|NCT01474512|324337080|FG009|Induction Period|Lack of Efficacy|0|||
94694281|NCT01474512|324337081|FG010|Induction Period|Lack of Efficacy|0|||
94694282|NCT01474512|324337082|FG011|Induction Period|Lack of Efficacy|0|||
94694283|NCT01474512|324337083|FG012|Induction Period|Lack of Efficacy|0|||
94694284|NCT01474512|324337084|FG013|Induction Period|Lack of Efficacy|0|||
94694285|NCT01474512|324337085|FG014|Induction Period|Lack of Efficacy|0|||
94694286|NCT01474512|324337086|FG015|Induction Period|Lack of Efficacy|0|||
94694287|NCT01474512|324337087|FG016|Induction Period|Lack of Efficacy|0|||
94694288|NCT01474512|324337088|FG017|Induction Period|Lack of Efficacy|0|||
94694289|NCT01474512|324337071|FG000|Induction Period|Withdrawal by Subject|6|||
94694290|NCT01474512|324337072|FG001|Induction Period|Withdrawal by Subject|6|||
94694291|NCT01474512|324337073|FG002|Induction Period|Withdrawal by Subject|5|||
94694292|NCT01474512|324337074|FG003|Induction Period|Withdrawal by Subject|0|||
94694293|NCT01474512|324337075|FG004|Induction Period|Withdrawal by Subject|0|||
94694294|NCT01474512|324337076|FG005|Induction Period|Withdrawal by Subject|0|||
94694295|NCT01474512|324337077|FG006|Induction Period|Withdrawal by Subject|0|||
94694296|NCT01474512|324337078|FG007|Induction Period|Withdrawal by Subject|0|||
94694297|NCT01474512|324337079|FG008|Induction Period|Withdrawal by Subject|0|||
94694298|NCT01474512|324337080|FG009|Induction Period|Withdrawal by Subject|0|||
94694299|NCT01474512|324337081|FG010|Induction Period|Withdrawal by Subject|0|||
94694300|NCT01474512|324337082|FG011|Induction Period|Withdrawal by Subject|0|||
94694301|NCT01474512|324337083|FG012|Induction Period|Withdrawal by Subject|0|||
94694302|NCT01474512|324337084|FG013|Induction Period|Withdrawal by Subject|0|||
94694303|NCT01474512|324337085|FG014|Induction Period|Withdrawal by Subject|0|||
94694304|NCT01474512|324337086|FG015|Induction Period|Withdrawal by Subject|0|||
94694305|NCT01474512|324337087|FG016|Induction Period|Withdrawal by Subject|0|||
94694306|NCT01474512|324337088|FG017|Induction Period|Withdrawal by Subject|0|||
94366054|NCT01898884|323124867|FG000|Multiple Dose Period|Randomized Not Treated|0|||
94694307|NCT01474512|324337071|FG000|Induction Period|Protocol Violation|3|||
94694308|NCT01474512|324337072|FG001|Induction Period|Protocol Violation|6|||
94694309|NCT01474512|324337073|FG002|Induction Period|Protocol Violation|0|||
94694310|NCT01474512|324337074|FG003|Induction Period|Protocol Violation|0|||
94694311|NCT01474512|324337075|FG004|Induction Period|Protocol Violation|0|||
94694312|NCT01474512|324337076|FG005|Induction Period|Protocol Violation|0|||
94694313|NCT01474512|324337077|FG006|Induction Period|Protocol Violation|0|||
94694314|NCT01474512|324337078|FG007|Induction Period|Protocol Violation|0|||
94694315|NCT01474512|324337079|FG008|Induction Period|Protocol Violation|0|||
94694316|NCT01474512|324337080|FG009|Induction Period|Protocol Violation|0|||
94694317|NCT01474512|324337081|FG010|Induction Period|Protocol Violation|0|||
94694318|NCT01474512|324337082|FG011|Induction Period|Protocol Violation|0|||
94694319|NCT01474512|324337083|FG012|Induction Period|Protocol Violation|0|||
94694320|NCT01474512|324337084|FG013|Induction Period|Protocol Violation|0|||
94694321|NCT01474512|324337085|FG014|Induction Period|Protocol Violation|0|||
94694322|NCT01474512|324337086|FG015|Induction Period|Protocol Violation|0|||
94694323|NCT01474512|324337087|FG016|Induction Period|Protocol Violation|0|||
94694324|NCT01474512|324337088|FG017|Induction Period|Protocol Violation|0|||
94694325|NCT01474512|324337071|FG000|Induction Period|Sponsor Decision|1|||
94694326|NCT01474512|324337072|FG001|Induction Period|Sponsor Decision|1|||
94694327|NCT01474512|324337073|FG002|Induction Period|Sponsor Decision|1|||
94694328|NCT01474512|324337074|FG003|Induction Period|Sponsor Decision|0|||
94694329|NCT01474512|324337075|FG004|Induction Period|Sponsor Decision|0|||
94694330|NCT01474512|324337076|FG005|Induction Period|Sponsor Decision|0|||
94694331|NCT01474512|324337077|FG006|Induction Period|Sponsor Decision|0|||
94694332|NCT01474512|324337078|FG007|Induction Period|Sponsor Decision|0|||
94694333|NCT01474512|324337079|FG008|Induction Period|Sponsor Decision|0|||
94694334|NCT01474512|324337080|FG009|Induction Period|Sponsor Decision|0|||
94694335|NCT01474512|324337081|FG010|Induction Period|Sponsor Decision|0|||
94694336|NCT01474512|324337082|FG011|Induction Period|Sponsor Decision|0|||
94694337|NCT01474512|324337083|FG012|Induction Period|Sponsor Decision|0|||
94694338|NCT01474512|324337084|FG013|Induction Period|Sponsor Decision|0|||
94694339|NCT01474512|324337085|FG014|Induction Period|Sponsor Decision|0|||
94694340|NCT01474512|324337086|FG015|Induction Period|Sponsor Decision|0|||
94694341|NCT01474512|324337087|FG016|Induction Period|Sponsor Decision|0|||
94694342|NCT01474512|324337088|FG017|Induction Period|Sponsor Decision|0|||
94694343|NCT01474512|324337071|FG000|Induction Period|Lost to Follow-up|1|||
94694344|NCT01474512|324337072|FG001|Induction Period|Lost to Follow-up|0|||
94694345|NCT01474512|324337073|FG002|Induction Period|Lost to Follow-up|2|||
94694346|NCT01474512|324337074|FG003|Induction Period|Lost to Follow-up|0|||
94694347|NCT01474512|324337075|FG004|Induction Period|Lost to Follow-up|0|||
94694348|NCT01474512|324337076|FG005|Induction Period|Lost to Follow-up|0|||
94694349|NCT01474512|324337077|FG006|Induction Period|Lost to Follow-up|0|||
94694350|NCT01474512|324337078|FG007|Induction Period|Lost to Follow-up|0|||
94694351|NCT01474512|324337079|FG008|Induction Period|Lost to Follow-up|0|||
94694352|NCT01474512|324337080|FG009|Induction Period|Lost to Follow-up|0|||
94694353|NCT01474512|324337081|FG010|Induction Period|Lost to Follow-up|0|||
94694354|NCT01474512|324337082|FG011|Induction Period|Lost to Follow-up|0|||
94694355|NCT01474512|324337083|FG012|Induction Period|Lost to Follow-up|0|||
94694356|NCT01474512|324337084|FG013|Induction Period|Lost to Follow-up|0|||
94694357|NCT01474512|324337085|FG014|Induction Period|Lost to Follow-up|0|||
94694358|NCT01474512|324337086|FG015|Induction Period|Lost to Follow-up|0|||
94694359|NCT01474512|324337087|FG016|Induction Period|Lost to Follow-up|0|||
94694360|NCT01474512|324337088|FG017|Induction Period|Lost to Follow-up|0|||
94694361|NCT01474512|324337071|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
94694362|NCT01474512|324337072|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
94694363|NCT01474512|324337073|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
94694364|NCT01474512|324337074|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
94694365|NCT01474512|324337075|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
94694366|NCT01474512|324337076|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
94694367|NCT01474512|324337077|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
94694368|NCT01474512|324337078|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
94694369|NCT01474512|324337079|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
94694370|NCT01474512|324337080|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
94694371|NCT01474512|324337081|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
94694372|NCT01474512|324337082|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
94694373|NCT01474512|324337083|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
94694374|NCT01474512|324337084|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
94694375|NCT01474512|324337085|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
94694376|NCT01474512|324337086|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
94694377|NCT01474512|324337087|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
94694378|NCT01474512|324337088|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
94694379|NCT01474512|324337071|FG000|Maintenance Period|Adverse Event|0|||
94694380|NCT01474512|324337072|FG001|Maintenance Period|Adverse Event|0|||
94366055|NCT01898884|323124868|FG001|Multiple Dose Period|Randomized Not Treated|0|||
94694381|NCT01474512|324337073|FG002|Maintenance Period|Adverse Event|0|||
94694382|NCT01474512|324337074|FG003|Maintenance Period|Adverse Event|4|||
94694383|NCT01474512|324337075|FG004|Maintenance Period|Adverse Event|2|||
94694384|NCT01474512|324337076|FG005|Maintenance Period|Adverse Event|7|||
94694385|NCT01474512|324337077|FG006|Maintenance Period|Adverse Event|0|||
94694386|NCT01474512|324337078|FG007|Maintenance Period|Adverse Event|19|||
94694387|NCT01474512|324337079|FG008|Maintenance Period|Adverse Event|1|||
94694388|NCT01474512|324337080|FG009|Maintenance Period|Adverse Event|3|||
94694389|NCT01474512|324337081|FG010|Maintenance Period|Adverse Event|0|||
94694390|NCT01474512|324337082|FG011|Maintenance Period|Adverse Event|0|||
94694391|NCT01474512|324337083|FG012|Maintenance Period|Adverse Event|0|||
94694392|NCT01474512|324337084|FG013|Maintenance Period|Adverse Event|0|||
94694393|NCT01474512|324337085|FG014|Maintenance Period|Adverse Event|0|||
94694394|NCT01474512|324337086|FG015|Maintenance Period|Adverse Event|0|||
94694395|NCT01474512|324337087|FG016|Maintenance Period|Adverse Event|0|||
94694396|NCT01474512|324337088|FG017|Maintenance Period|Adverse Event|0|||
94694397|NCT01474512|324337071|FG000|Maintenance Period|Withdrawal by Subject|0|||
94694398|NCT01474512|324337072|FG001|Maintenance Period|Withdrawal by Subject|0|||
94694399|NCT01474512|324337073|FG002|Maintenance Period|Withdrawal by Subject|0|||
94694400|NCT01474512|324337074|FG003|Maintenance Period|Withdrawal by Subject|6|||
94694401|NCT01474512|324337075|FG004|Maintenance Period|Withdrawal by Subject|2|||
94694402|NCT01474512|324337076|FG005|Maintenance Period|Withdrawal by Subject|3|||
94694403|NCT01474512|324337077|FG006|Maintenance Period|Withdrawal by Subject|1|||
94694404|NCT01474512|324337078|FG007|Maintenance Period|Withdrawal by Subject|6|||
94694405|NCT01474512|324337079|FG008|Maintenance Period|Withdrawal by Subject|3|||
94694406|NCT01474512|324337080|FG009|Maintenance Period|Withdrawal by Subject|1|||
94694407|NCT01474512|324337081|FG010|Maintenance Period|Withdrawal by Subject|0|||
94694408|NCT01474512|324337082|FG011|Maintenance Period|Withdrawal by Subject|0|||
94694409|NCT01474512|324337083|FG012|Maintenance Period|Withdrawal by Subject|0|||
94694410|NCT01474512|324337084|FG013|Maintenance Period|Withdrawal by Subject|0|||
94694411|NCT01474512|324337085|FG014|Maintenance Period|Withdrawal by Subject|0|||
94694412|NCT01474512|324337086|FG015|Maintenance Period|Withdrawal by Subject|0|||
94694413|NCT01474512|324337087|FG016|Maintenance Period|Withdrawal by Subject|0|||
94694414|NCT01474512|324337088|FG017|Maintenance Period|Withdrawal by Subject|0|||
94694415|NCT01474512|324337071|FG000|Maintenance Period|Lost to Follow-up|0|||
94694416|NCT01474512|324337072|FG001|Maintenance Period|Lost to Follow-up|0|||
94694417|NCT01474512|324337073|FG002|Maintenance Period|Lost to Follow-up|0|||
94694418|NCT01474512|324337074|FG003|Maintenance Period|Lost to Follow-up|3|||
94694419|NCT01474512|324337075|FG004|Maintenance Period|Lost to Follow-up|3|||
94694420|NCT01474512|324337076|FG005|Maintenance Period|Lost to Follow-up|0|||
94694421|NCT01474512|324337077|FG006|Maintenance Period|Lost to Follow-up|0|||
94694422|NCT01474512|324337078|FG007|Maintenance Period|Lost to Follow-up|2|||
94694423|NCT01474512|324337079|FG008|Maintenance Period|Lost to Follow-up|1|||
94694424|NCT01474512|324337080|FG009|Maintenance Period|Lost to Follow-up|1|||
94694425|NCT01474512|324337081|FG010|Maintenance Period|Lost to Follow-up|0|||
94694426|NCT01474512|324337082|FG011|Maintenance Period|Lost to Follow-up|0|||
94694427|NCT01474512|324337083|FG012|Maintenance Period|Lost to Follow-up|0|||
94694428|NCT01474512|324337084|FG013|Maintenance Period|Lost to Follow-up|0|||
94694429|NCT01474512|324337085|FG014|Maintenance Period|Lost to Follow-up|0|||
94694430|NCT01474512|324337086|FG015|Maintenance Period|Lost to Follow-up|0|||
94694431|NCT01474512|324337087|FG016|Maintenance Period|Lost to Follow-up|0|||
94694432|NCT01474512|324337088|FG017|Maintenance Period|Lost to Follow-up|0|||
94694433|NCT01474512|324337071|FG000|Maintenance Period|Death|0|||
94694434|NCT01474512|324337072|FG001|Maintenance Period|Death|0|||
94694435|NCT01474512|324337073|FG002|Maintenance Period|Death|0|||
94694436|NCT01474512|324337074|FG003|Maintenance Period|Death|0|||
94694437|NCT01474512|324337075|FG004|Maintenance Period|Death|0|||
94694438|NCT01474512|324337076|FG005|Maintenance Period|Death|2|||
94694439|NCT01474512|324337077|FG006|Maintenance Period|Death|0|||
94694440|NCT01474512|324337078|FG007|Maintenance Period|Death|0|||
94694441|NCT01474512|324337079|FG008|Maintenance Period|Death|0|||
94694442|NCT01474512|324337080|FG009|Maintenance Period|Death|0|||
94694443|NCT01474512|324337081|FG010|Maintenance Period|Death|0|||
94694444|NCT01474512|324337082|FG011|Maintenance Period|Death|0|||
94694445|NCT01474512|324337083|FG012|Maintenance Period|Death|0|||
94694446|NCT01474512|324337084|FG013|Maintenance Period|Death|0|||
94694447|NCT01474512|324337085|FG014|Maintenance Period|Death|0|||
94694448|NCT01474512|324337086|FG015|Maintenance Period|Death|0|||
94694449|NCT01474512|324337087|FG016|Maintenance Period|Death|0|||
94694450|NCT01474512|324337088|FG017|Maintenance Period|Death|0|||
94694451|NCT01474512|324337071|FG000|Maintenance Period|Physician Decision|0|||
94694452|NCT01474512|324337072|FG001|Maintenance Period|Physician Decision|0|||
94694453|NCT01474512|324337073|FG002|Maintenance Period|Physician Decision|0|||
94694454|NCT01474512|324337074|FG003|Maintenance Period|Physician Decision|0|||
94694455|NCT01474512|324337075|FG004|Maintenance Period|Physician Decision|0|||
94694456|NCT01474512|324337076|FG005|Maintenance Period|Physician Decision|1|||
94694457|NCT01474512|324337077|FG006|Maintenance Period|Physician Decision|0|||
94694458|NCT01474512|324337078|FG007|Maintenance Period|Physician Decision|2|||
94694459|NCT01474512|324337079|FG008|Maintenance Period|Physician Decision|0|||
94694460|NCT01474512|324337080|FG009|Maintenance Period|Physician Decision|0|||
94694461|NCT01474512|324337081|FG010|Maintenance Period|Physician Decision|0|||
94264317|NCT02511678|322761882|FG000|Overall Study|Withdrawal by Subject|2|||
94264318|NCT02511678|322761882|FG000|Overall Study|Lost to Follow-up|4|||
94264319|NCT02511678|322761882|FG000|Overall Study|Death|19|||
94264320|NCT02511678|322761882|FG000|Overall Study|Adverse Event|1|||
94264321|NCT02511678|322761882|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
94264322|NCT02511678|322761882|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
94694462|NCT01474512|324337082|FG011|Maintenance Period|Physician Decision|0|||
94694463|NCT01474512|324337083|FG012|Maintenance Period|Physician Decision|0|||
94694464|NCT01474512|324337084|FG013|Maintenance Period|Physician Decision|0|||
94694465|NCT01474512|324337085|FG014|Maintenance Period|Physician Decision|0|||
94694466|NCT01474512|324337086|FG015|Maintenance Period|Physician Decision|0|||
94264323|NCT02511678|322761882|FG000|Overall Study|Required Radiofrequency Ablation|1|||
94264324|NCT02511678|322761882|FG000|Overall Study|Biopsy was Negative|1|||
94694467|NCT01474512|324337087|FG016|Maintenance Period|Physician Decision|0|||
94694468|NCT01474512|324337088|FG017|Maintenance Period|Physician Decision|0|||
94694469|NCT01474512|324337071|FG000|Maintenance Period|Clinical Relapse|0|||
94694470|NCT01474512|324337072|FG001|Maintenance Period|Clinical Relapse|0|||
94694471|NCT01474512|324337073|FG002|Maintenance Period|Clinical Relapse|0|||
94694472|NCT01474512|324337074|FG003|Maintenance Period|Clinical Relapse|1|||
94694473|NCT01474512|324337075|FG004|Maintenance Period|Clinical Relapse|0|||
94694474|NCT01474512|324337076|FG005|Maintenance Period|Clinical Relapse|0|||
94694475|NCT01474512|324337077|FG006|Maintenance Period|Clinical Relapse|0|||
94694476|NCT01474512|324337078|FG007|Maintenance Period|Clinical Relapse|0|||
94694477|NCT01474512|324337079|FG008|Maintenance Period|Clinical Relapse|0|||
94694478|NCT01474512|324337080|FG009|Maintenance Period|Clinical Relapse|0|||
94694479|NCT01474512|324337081|FG010|Maintenance Period|Clinical Relapse|0|||
94694480|NCT01474512|324337082|FG011|Maintenance Period|Clinical Relapse|0|||
94694481|NCT01474512|324337083|FG012|Maintenance Period|Clinical Relapse|0|||
94694482|NCT01474512|324337084|FG013|Maintenance Period|Clinical Relapse|0|||
94694483|NCT01474512|324337085|FG014|Maintenance Period|Clinical Relapse|0|||
94694484|NCT01474512|324337086|FG015|Maintenance Period|Clinical Relapse|0|||
94694485|NCT01474512|324337087|FG016|Maintenance Period|Clinical Relapse|0|||
94694486|NCT01474512|324337088|FG017|Maintenance Period|Clinical Relapse|0|||
94694487|NCT01474512|324337071|FG000|Maintenance Period|Lack of Efficacy|0|||
94694488|NCT01474512|324337072|FG001|Maintenance Period|Lack of Efficacy|0|||
94694489|NCT01474512|324337073|FG002|Maintenance Period|Lack of Efficacy|0|||
94694490|NCT01474512|324337074|FG003|Maintenance Period|Lack of Efficacy|1|||
94694491|NCT01474512|324337075|FG004|Maintenance Period|Lack of Efficacy|0|||
94694492|NCT01474512|324337076|FG005|Maintenance Period|Lack of Efficacy|0|||
94694493|NCT01474512|324337077|FG006|Maintenance Period|Lack of Efficacy|0|||
94694494|NCT01474512|324337078|FG007|Maintenance Period|Lack of Efficacy|11|||
94694495|NCT01474512|324337079|FG008|Maintenance Period|Lack of Efficacy|11|||
94694496|NCT01474512|324337080|FG009|Maintenance Period|Lack of Efficacy|12|||
94694497|NCT01474512|324337081|FG010|Maintenance Period|Lack of Efficacy|0|||
94694498|NCT01474512|324337082|FG011|Maintenance Period|Lack of Efficacy|0|||
94694499|NCT01474512|324337083|FG012|Maintenance Period|Lack of Efficacy|0|||
94694500|NCT01474512|324337084|FG013|Maintenance Period|Lack of Efficacy|0|||
94694501|NCT01474512|324337085|FG014|Maintenance Period|Lack of Efficacy|0|||
94694502|NCT01474512|324337086|FG015|Maintenance Period|Lack of Efficacy|0|||
94694503|NCT01474512|324337087|FG016|Maintenance Period|Lack of Efficacy|0|||
94694504|NCT01474512|324337088|FG017|Maintenance Period|Lack of Efficacy|0|||
94694505|NCT01474512|324337071|FG000|Maintenance Period|Protocol Violation|0|||
94694506|NCT01474512|324337072|FG001|Maintenance Period|Protocol Violation|0|||
94694507|NCT01474512|324337073|FG002|Maintenance Period|Protocol Violation|0|||
94694508|NCT01474512|324337074|FG003|Maintenance Period|Protocol Violation|1|||
94694509|NCT01474512|324337075|FG004|Maintenance Period|Protocol Violation|0|||
94694510|NCT01474512|324337076|FG005|Maintenance Period|Protocol Violation|0|||
94694511|NCT01474512|324337077|FG006|Maintenance Period|Protocol Violation|0|||
94694512|NCT01474512|324337078|FG007|Maintenance Period|Protocol Violation|1|||
94694513|NCT01474512|324337079|FG008|Maintenance Period|Protocol Violation|0|||
94694514|NCT01474512|324337080|FG009|Maintenance Period|Protocol Violation|1|||
94694515|NCT01474512|324337081|FG010|Maintenance Period|Protocol Violation|0|||
94694516|NCT01474512|324337082|FG011|Maintenance Period|Protocol Violation|0|||
94694517|NCT01474512|324337083|FG012|Maintenance Period|Protocol Violation|0|||
94694518|NCT01474512|324337084|FG013|Maintenance Period|Protocol Violation|0|||
94694519|NCT01474512|324337085|FG014|Maintenance Period|Protocol Violation|0|||
94694520|NCT01474512|324337086|FG015|Maintenance Period|Protocol Violation|0|||
94694521|NCT01474512|324337087|FG016|Maintenance Period|Protocol Violation|0|||
94264325|NCT02511678|322761882|FG000|Overall Study|Protocol Violation|1|||
94264326|NCT02511678|322761882|FG000|Overall Study|Received Radiation Treatment|1|||
94264327|NCT04448756|322761889|FG000|Overall Study|Adverse Event|0|||
94264328|NCT04448756|322761890|FG001|Overall Study|Adverse Event|1|||
94264329|NCT04448756|322761891|FG002|Overall Study|Adverse Event|0|||
94264330|NCT04448756|322761889|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
94264331|NCT04448756|322761890|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
94264332|NCT04448756|322761891|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
94694522|NCT01474512|324337088|FG017|Maintenance Period|Protocol Violation|0|||
94694523|NCT01474512|324337071|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
94694524|NCT01474512|324337072|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
94694525|NCT01474512|324337073|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
94694526|NCT01474512|324337074|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
94694527|NCT01474512|324337075|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
94694528|NCT01474512|324337076|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
94694529|NCT01474512|324337077|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
94694530|NCT01474512|324337078|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
94694531|NCT01474512|324337079|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
94264333|NCT04448756|322761889|FG000|Overall Study|Withdrawal by Subject|0|||
94264334|NCT04448756|322761890|FG001|Overall Study|Withdrawal by Subject|3|||
94694532|NCT01474512|324337080|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
94694533|NCT01474512|324337081|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
94694534|NCT01474512|324337082|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
94694535|NCT01474512|324337083|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
94694536|NCT01474512|324337084|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
94694537|NCT01474512|324337085|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
94694538|NCT01474512|324337086|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
94694539|NCT01474512|324337087|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
94694540|NCT01474512|324337088|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
94694541|NCT01474512|324337071|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
94694542|NCT01474512|324337072|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
94694543|NCT01474512|324337073|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
94694544|NCT01474512|324337074|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
94694545|NCT01474512|324337075|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
94694546|NCT01474512|324337076|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
94694547|NCT01474512|324337077|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
94694548|NCT01474512|324337078|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
94694549|NCT01474512|324337079|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
94694550|NCT01474512|324337080|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
94694551|NCT01474512|324337081|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
94694552|NCT01474512|324337082|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
94694553|NCT01474512|324337083|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
94694554|NCT01474512|324337084|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
94694555|NCT01474512|324337085|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
94694556|NCT01474512|324337086|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
94694557|NCT01474512|324337087|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
94694558|NCT01474512|324337088|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
94694559|NCT01474512|324337071|FG000|Long-Term Extension Period|Adverse Event|0|||
94694560|NCT01474512|324337072|FG001|Long-Term Extension Period|Adverse Event|0|||
94694561|NCT01474512|324337073|FG002|Long-Term Extension Period|Adverse Event|0|||
94694562|NCT01474512|324337074|FG003|Long-Term Extension Period|Adverse Event|0|||
94694563|NCT01474512|324337075|FG004|Long-Term Extension Period|Adverse Event|0|||
94694564|NCT01474512|324337076|FG005|Long-Term Extension Period|Adverse Event|0|||
94694565|NCT01474512|324337077|FG006|Long-Term Extension Period|Adverse Event|0|||
94694566|NCT01474512|324337078|FG007|Long-Term Extension Period|Adverse Event|0|||
94694567|NCT01474512|324337079|FG008|Long-Term Extension Period|Adverse Event|0|||
94694568|NCT01474512|324337080|FG009|Long-Term Extension Period|Adverse Event|0|||
94694569|NCT01474512|324337081|FG010|Long-Term Extension Period|Adverse Event|0|||
94694570|NCT01474512|324337082|FG011|Long-Term Extension Period|Adverse Event|1|||
94694571|NCT01474512|324337083|FG012|Long-Term Extension Period|Adverse Event|57|||
94694572|NCT01474512|324337084|FG013|Long-Term Extension Period|Adverse Event|58|||
94694573|NCT01474512|324337085|FG014|Long-Term Extension Period|Adverse Event|0|||
94694574|NCT01474512|324337086|FG015|Long-Term Extension Period|Adverse Event|0|||
94694575|NCT01474512|324337087|FG016|Long-Term Extension Period|Adverse Event|0|||
94694576|NCT01474512|324337088|FG017|Long-Term Extension Period|Adverse Event|0|||
94694577|NCT01474512|324337071|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
94694578|NCT01474512|324337072|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
94694579|NCT01474512|324337073|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
94694580|NCT01474512|324337074|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
94694581|NCT01474512|324337075|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
94694582|NCT01474512|324337076|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
94694583|NCT01474512|324337077|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
94694584|NCT01474512|324337078|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
94694585|NCT01474512|324337079|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
94694586|NCT01474512|324337080|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
94694587|NCT01474512|324337081|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
94694588|NCT01474512|324337082|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
94694589|NCT01474512|324337083|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
94694590|NCT01474512|324337084|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
94694591|NCT01474512|324337085|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
94694592|NCT01474512|324337086|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
94694593|NCT01474512|324337087|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
94694594|NCT01474512|324337088|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
94694595|NCT01474512|324337071|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
94694596|NCT01474512|324337072|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
94694597|NCT01474512|324337073|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
94694598|NCT01474512|324337074|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
94694599|NCT01474512|324337075|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
94694600|NCT01474512|324337076|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
94694601|NCT01474512|324337077|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
94694602|NCT01474512|324337078|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
94694603|NCT01474512|324337079|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
94694604|NCT01474512|324337080|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
94694605|NCT01474512|324337081|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
94694606|NCT01474512|324337082|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
94694607|NCT01474512|324337083|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
94694608|NCT01474512|324337084|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
94694609|NCT01474512|324337085|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
94694610|NCT01474512|324337086|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
94694611|NCT01474512|324337087|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
94694612|NCT01474512|324337088|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
94694613|NCT01474512|324337071|FG000|Long-Term Extension Period|Physician Decision|0|||
94694614|NCT01474512|324337072|FG001|Long-Term Extension Period|Physician Decision|0|||
94694615|NCT01474512|324337073|FG002|Long-Term Extension Period|Physician Decision|0|||
94694616|NCT01474512|324337074|FG003|Long-Term Extension Period|Physician Decision|0|||
94694617|NCT01474512|324337075|FG004|Long-Term Extension Period|Physician Decision|0|||
94694618|NCT01474512|324337076|FG005|Long-Term Extension Period|Physician Decision|0|||
94694619|NCT01474512|324337077|FG006|Long-Term Extension Period|Physician Decision|0|||
94694620|NCT01474512|324337078|FG007|Long-Term Extension Period|Physician Decision|0|||
94694621|NCT01474512|324337079|FG008|Long-Term Extension Period|Physician Decision|0|||
94694622|NCT01474512|324337080|FG009|Long-Term Extension Period|Physician Decision|0|||
94694623|NCT01474512|324337081|FG010|Long-Term Extension Period|Physician Decision|0|||
94694624|NCT01474512|324337082|FG011|Long-Term Extension Period|Physician Decision|0|||
94694625|NCT01474512|324337083|FG012|Long-Term Extension Period|Physician Decision|21|||
94694626|NCT01474512|324337084|FG013|Long-Term Extension Period|Physician Decision|21|||
94694627|NCT01474512|324337085|FG014|Long-Term Extension Period|Physician Decision|0|||
94694628|NCT01474512|324337086|FG015|Long-Term Extension Period|Physician Decision|0|||
94694629|NCT01474512|324337087|FG016|Long-Term Extension Period|Physician Decision|0|||
94694630|NCT01474512|324337088|FG017|Long-Term Extension Period|Physician Decision|0|||
94694631|NCT01474512|324337071|FG000|Long-Term Extension Period|Clinical Relapse|0|||
94694632|NCT01474512|324337072|FG001|Long-Term Extension Period|Clinical Relapse|0|||
94694633|NCT01474512|324337073|FG002|Long-Term Extension Period|Clinical Relapse|0|||
94694634|NCT01474512|324337074|FG003|Long-Term Extension Period|Clinical Relapse|0|||
94694635|NCT01474512|324337075|FG004|Long-Term Extension Period|Clinical Relapse|0|||
94694636|NCT01474512|324337076|FG005|Long-Term Extension Period|Clinical Relapse|0|||
94694637|NCT01474512|324337077|FG006|Long-Term Extension Period|Clinical Relapse|0|||
94694638|NCT01474512|324337078|FG007|Long-Term Extension Period|Clinical Relapse|0|||
94694639|NCT01474512|324337079|FG008|Long-Term Extension Period|Clinical Relapse|0|||
94694640|NCT01474512|324337080|FG009|Long-Term Extension Period|Clinical Relapse|0|||
94694641|NCT01474512|324337081|FG010|Long-Term Extension Period|Clinical Relapse|0|||
94694642|NCT01474512|324337082|FG011|Long-Term Extension Period|Clinical Relapse|0|||
94694643|NCT01474512|324337083|FG012|Long-Term Extension Period|Clinical Relapse|9|||
94694644|NCT01474512|324337084|FG013|Long-Term Extension Period|Clinical Relapse|9|||
94694645|NCT01474512|324337085|FG014|Long-Term Extension Period|Clinical Relapse|0|||
94694646|NCT01474512|324337086|FG015|Long-Term Extension Period|Clinical Relapse|0|||
94694647|NCT01474512|324337087|FG016|Long-Term Extension Period|Clinical Relapse|0|||
94694648|NCT01474512|324337088|FG017|Long-Term Extension Period|Clinical Relapse|0|||
94694649|NCT01474512|324337071|FG000|Long-Term Extension Period|Death|0|||
94694650|NCT01474512|324337072|FG001|Long-Term Extension Period|Death|0|||
94694651|NCT01474512|324337073|FG002|Long-Term Extension Period|Death|0|||
94694652|NCT01474512|324337074|FG003|Long-Term Extension Period|Death|0|||
94694653|NCT01474512|324337075|FG004|Long-Term Extension Period|Death|0|||
94694654|NCT01474512|324337076|FG005|Long-Term Extension Period|Death|0|||
94694655|NCT01474512|324337077|FG006|Long-Term Extension Period|Death|0|||
94694656|NCT01474512|324337078|FG007|Long-Term Extension Period|Death|0|||
94694657|NCT01474512|324337079|FG008|Long-Term Extension Period|Death|0|||
94694658|NCT01474512|324337080|FG009|Long-Term Extension Period|Death|0|||
94694659|NCT01474512|324337081|FG010|Long-Term Extension Period|Death|0|||
94694660|NCT01474512|324337082|FG011|Long-Term Extension Period|Death|0|||
94694661|NCT01474512|324337083|FG012|Long-Term Extension Period|Death|9|||
94694662|NCT01474512|324337084|FG013|Long-Term Extension Period|Death|9|||
94694663|NCT01474512|324337085|FG014|Long-Term Extension Period|Death|0|||
94694664|NCT01474512|324337086|FG015|Long-Term Extension Period|Death|0|||
94694665|NCT01474512|324337087|FG016|Long-Term Extension Period|Death|0|||
94264335|NCT04448756|322761891|FG002|Overall Study|Withdrawal by Subject|1|||
94694666|NCT01474512|324337088|FG017|Long-Term Extension Period|Death|0|||
94694667|NCT01474512|324337071|FG000|Long-Term Extension Period|Sponsor Decision|0|||
94694668|NCT01474512|324337072|FG001|Long-Term Extension Period|Sponsor Decision|0|||
94694669|NCT01474512|324337073|FG002|Long-Term Extension Period|Sponsor Decision|0|||
94694670|NCT01474512|324337074|FG003|Long-Term Extension Period|Sponsor Decision|0|||
94694671|NCT01474512|324337075|FG004|Long-Term Extension Period|Sponsor Decision|0|||
94694672|NCT01474512|324337076|FG005|Long-Term Extension Period|Sponsor Decision|0|||
94694673|NCT01474512|324337077|FG006|Long-Term Extension Period|Sponsor Decision|0|||
94694674|NCT01474512|324337078|FG007|Long-Term Extension Period|Sponsor Decision|0|||
94694675|NCT01474512|324337079|FG008|Long-Term Extension Period|Sponsor Decision|0|||
94694676|NCT01474512|324337080|FG009|Long-Term Extension Period|Sponsor Decision|0|||
94694677|NCT01474512|324337081|FG010|Long-Term Extension Period|Sponsor Decision|0|||
94694678|NCT01474512|324337082|FG011|Long-Term Extension Period|Sponsor Decision|0|||
94694679|NCT01474512|324337083|FG012|Long-Term Extension Period|Sponsor Decision|6|||
94694680|NCT01474512|324337084|FG013|Long-Term Extension Period|Sponsor Decision|6|||
94694681|NCT01474512|324337085|FG014|Long-Term Extension Period|Sponsor Decision|0|||
94694682|NCT01474512|324337086|FG015|Long-Term Extension Period|Sponsor Decision|0|||
94694683|NCT01474512|324337087|FG016|Long-Term Extension Period|Sponsor Decision|0|||
94694684|NCT01474512|324337088|FG017|Long-Term Extension Period|Sponsor Decision|0|||
94694685|NCT01474512|324337071|FG000|Long-Term Extension Period|Protocol Violation|0|||
94694686|NCT01474512|324337072|FG001|Long-Term Extension Period|Protocol Violation|0|||
94694687|NCT01474512|324337073|FG002|Long-Term Extension Period|Protocol Violation|0|||
94694688|NCT01474512|324337074|FG003|Long-Term Extension Period|Protocol Violation|0|||
94694689|NCT01474512|324337075|FG004|Long-Term Extension Period|Protocol Violation|0|||
94694690|NCT01474512|324337076|FG005|Long-Term Extension Period|Protocol Violation|0|||
94694691|NCT01474512|324337077|FG006|Long-Term Extension Period|Protocol Violation|0|||
94694692|NCT01474512|324337078|FG007|Long-Term Extension Period|Protocol Violation|0|||
94694693|NCT01474512|324337079|FG008|Long-Term Extension Period|Protocol Violation|0|||
94694694|NCT01474512|324337080|FG009|Long-Term Extension Period|Protocol Violation|0|||
94694695|NCT01474512|324337081|FG010|Long-Term Extension Period|Protocol Violation|0|||
94694696|NCT01474512|324337082|FG011|Long-Term Extension Period|Protocol Violation|0|||
94694697|NCT01474512|324337083|FG012|Long-Term Extension Period|Protocol Violation|5|||
94694698|NCT01474512|324337084|FG013|Long-Term Extension Period|Protocol Violation|5|||
94694699|NCT01474512|324337085|FG014|Long-Term Extension Period|Protocol Violation|0|||
94694700|NCT01474512|324337086|FG015|Long-Term Extension Period|Protocol Violation|0|||
94694701|NCT01474512|324337087|FG016|Long-Term Extension Period|Protocol Violation|0|||
94694702|NCT01474512|324337088|FG017|Long-Term Extension Period|Protocol Violation|0|||
94694703|NCT01474512|324337071|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
94694704|NCT01474512|324337072|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
94366056|NCT01898884|323124869|FG002|Multiple Dose Period|Randomized Not Treated|0|||
94366057|NCT01898884|323124870|FG003|Multiple Dose Period|Randomized Not Treated|0|||
94366058|NCT01898884|323124871|FG004|Multiple Dose Period|Randomized Not Treated|0|||
94366059|NCT01898884|323124872|FG005|Multiple Dose Period|Randomized Not Treated|0|||
94694705|NCT01474512|324337073|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
94694706|NCT01474512|324337074|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
94694707|NCT01474512|324337075|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
94366060|NCT01898884|323124873|FG006|Multiple Dose Period|Randomized Not Treated|0|||
94694708|NCT01474512|324337076|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
94694709|NCT01474512|324337077|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
94366061|NCT01898884|323124874|FG007|Multiple Dose Period|Randomized Not Treated|0|||
94366062|NCT01898884|323124875|FG008|Multiple Dose Period|Randomized Not Treated|1|||
94694710|NCT01474512|324337078|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
94694711|NCT01474512|324337079|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
94694712|NCT01474512|324337080|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
94694713|NCT01474512|324337081|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
94694714|NCT01474512|324337082|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
94694715|NCT01474512|324337083|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
94694716|NCT01474512|324337084|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
94694717|NCT01474512|324337085|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
94694718|NCT01474512|324337086|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
94694719|NCT01474512|324337087|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
94694720|NCT01474512|324337088|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
94694721|NCT01474512|324337071|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
94694722|NCT01474512|324337072|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
94694723|NCT01474512|324337073|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
94694724|NCT01474512|324337074|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
94694725|NCT01474512|324337075|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
94694726|NCT01474512|324337076|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
94694727|NCT01474512|324337077|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
94694728|NCT01474512|324337078|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
94694729|NCT01474512|324337079|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
94694730|NCT01474512|324337080|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
94694731|NCT01474512|324337081|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
94694732|NCT01474512|324337082|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
94694733|NCT01474512|324337083|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
94694734|NCT01474512|324337084|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
94694735|NCT01474512|324337085|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
94694736|NCT01474512|324337086|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
94694737|NCT01474512|324337087|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
94694738|NCT01474512|324337088|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
94694739|NCT01474512|324337071|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
94694740|NCT01474512|324337072|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
94694741|NCT01474512|324337073|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
94694742|NCT01474512|324337074|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
94694743|NCT01474512|324337075|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
94694744|NCT01474512|324337076|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
94694745|NCT01474512|324337077|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
94694746|NCT01474512|324337078|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
94694747|NCT01474512|324337079|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
94694748|NCT01474512|324337080|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
94694749|NCT01474512|324337081|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
94694750|NCT01474512|324337082|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
94694751|NCT01474512|324337083|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
94694752|NCT01474512|324337084|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
94694753|NCT01474512|324337085|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
94694754|NCT01474512|324337086|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
94694755|NCT01474512|324337087|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
94694756|NCT01474512|324337088|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
94694757|NCT01474512|324337071|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
94694758|NCT01474512|324337072|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
94694759|NCT01474512|324337073|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
94694760|NCT01474512|324337074|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
94694761|NCT01474512|324337075|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
94694762|NCT01474512|324337076|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
94694763|NCT01474512|324337077|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
94694764|NCT01474512|324337078|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
94694765|NCT01474512|324337079|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
94694766|NCT01474512|324337080|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
94694767|NCT01474512|324337081|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
94694768|NCT01474512|324337082|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
94694769|NCT01474512|324337083|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
94694770|NCT01474512|324337084|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
94694771|NCT01474512|324337085|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
94694772|NCT01474512|324337086|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
94694773|NCT01474512|324337087|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
94694774|NCT01474512|324337088|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
94694775|NCT01474512|324337071|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
94694776|NCT01474512|324337072|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
94694777|NCT01474512|324337073|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
94694778|NCT01474512|324337074|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
94694779|NCT01474512|324337075|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
94694780|NCT01474512|324337076|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
94694781|NCT01474512|324337077|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
94694782|NCT01474512|324337078|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
94694783|NCT01474512|324337079|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
94694784|NCT01474512|324337080|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
94694785|NCT01474512|324337081|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
94694786|NCT01474512|324337082|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
94694787|NCT01474512|324337083|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
94694788|NCT01474512|324337084|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
94694789|NCT01474512|324337085|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
94694790|NCT01474512|324337086|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
94694791|NCT01474512|324337087|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
94694792|NCT01474512|324337088|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
94694793|NCT01474512|324337071|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
94694794|NCT01474512|324337072|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
94694795|NCT01474512|324337073|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
94694796|NCT01474512|324337074|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
94694797|NCT01474512|324337075|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
94694798|NCT01474512|324337076|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
94694799|NCT01474512|324337077|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
94694800|NCT01474512|324337078|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
94694801|NCT01474512|324337079|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
94694802|NCT01474512|324337080|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
94694803|NCT01474512|324337081|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
94694804|NCT01474512|324337082|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
94694805|NCT01474512|324337083|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
94694806|NCT01474512|324337084|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
94694807|NCT01474512|324337085|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
94694808|NCT01474512|324337086|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
94694809|NCT01474512|324337087|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
94694810|NCT01474512|324337088|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
94694811|NCT01474512|324337071|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
94694812|NCT01474512|324337072|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
94694813|NCT01474512|324337073|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
94694814|NCT01474512|324337074|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
94694815|NCT01474512|324337075|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
94694816|NCT01474512|324337076|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
94694817|NCT01474512|324337077|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
94694818|NCT01474512|324337078|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
94694819|NCT01474512|324337079|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
94694820|NCT01474512|324337080|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
94694821|NCT01474512|324337081|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
94694822|NCT01474512|324337082|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
94694823|NCT01474512|324337083|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
94694824|NCT01474512|324337084|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
94694825|NCT01474512|324337085|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
94694826|NCT01474512|324337086|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
94694827|NCT01474512|324337087|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
94694828|NCT01474512|324337088|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
94694829|NCT01474512|324337071|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
94694830|NCT01474512|324337072|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
94694831|NCT01474512|324337073|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
94694832|NCT01474512|324337074|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
94694833|NCT01474512|324337075|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
94694834|NCT01474512|324337076|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
94694835|NCT01474512|324337077|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
94694836|NCT01474512|324337078|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
94694837|NCT01474512|324337079|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
94694838|NCT01474512|324337080|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
94694839|NCT01474512|324337081|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
94694840|NCT01474512|324337082|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
94694841|NCT01474512|324337083|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
94694842|NCT01474512|324337084|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
94694843|NCT01474512|324337085|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
94694844|NCT01474512|324337086|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
94694845|NCT01474512|324337087|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
94694846|NCT01474512|324337088|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
94694847|NCT01474512|324337071|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
94694848|NCT01474512|324337072|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
94694849|NCT01474512|324337073|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
94694850|NCT01474512|324337074|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
94694851|NCT01474512|324337075|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
94694852|NCT01474512|324337076|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
94694853|NCT01474512|324337077|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
94694854|NCT01474512|324337078|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
94694855|NCT01474512|324337079|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
94694856|NCT01474512|324337080|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
94694857|NCT01474512|324337081|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
94694858|NCT01474512|324337082|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
94694859|NCT01474512|324337083|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
94694860|NCT01474512|324337084|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
94694861|NCT01474512|324337085|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
94694862|NCT01474512|324337086|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
94694863|NCT01474512|324337087|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
94694864|NCT01474512|324337088|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
94694865|NCT01474512|324337071|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
94694866|NCT01474512|324337072|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
94694867|NCT01474512|324337073|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
94694868|NCT01474512|324337074|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
94694869|NCT01474512|324337075|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
94694870|NCT01474512|324337076|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
94694871|NCT01474512|324337077|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
94694872|NCT01474512|324337078|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
94694873|NCT01474512|324337079|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
94694874|NCT01474512|324337080|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
94694875|NCT01474512|324337081|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
94694876|NCT01474512|324337082|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
94694877|NCT01474512|324337083|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
94694878|NCT01474512|324337084|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
94694879|NCT01474512|324337085|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
94694880|NCT01474512|324337086|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
94694881|NCT01474512|324337087|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
94694882|NCT01474512|324337088|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
94694883|NCT01474512|324337071|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
94694884|NCT01474512|324337072|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
94694885|NCT01474512|324337073|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
94694886|NCT01474512|324337074|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
94694887|NCT01474512|324337075|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
94694888|NCT01474512|324337076|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
94694889|NCT01474512|324337077|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
94694890|NCT01474512|324337078|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
94694891|NCT01474512|324337079|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
94694892|NCT01474512|324337080|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
94694893|NCT01474512|324337081|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
94694894|NCT01474512|324337082|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
94694895|NCT01474512|324337083|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
94694896|NCT01474512|324337084|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
94694897|NCT01474512|324337085|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
94694898|NCT01474512|324337086|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
94366063|NCT01861717|323124884|FG000|Overall Study|Lost to Follow-up|1|||
94366064|NCT01861717|323124884|FG000|Overall Study|Withdrawal by Subject|1|||
94694899|NCT01474512|324337087|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
94694900|NCT01474512|324337088|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
94694901|NCT01474512|324337071|FG000|Post-Treatment Follow-Up|Death|0|||
94694902|NCT01474512|324337072|FG001|Post-Treatment Follow-Up|Death|0|||
94366065|NCT01389024|323126430|FG000|Overall Study|Withdrawal by Subject|0|||
94694903|NCT01474512|324337073|FG002|Post-Treatment Follow-Up|Death|0|||
94694904|NCT01474512|324337074|FG003|Post-Treatment Follow-Up|Death|0|||
94694905|NCT01474512|324337075|FG004|Post-Treatment Follow-Up|Death|0|||
94264336|NCT04448756|322761889|FG000|Overall Study|Death|2|||
94264337|NCT04448756|322761890|FG001|Overall Study|Death|1|||
94466054|NCT03759366|323494999|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
94694906|NCT01474512|324337076|FG005|Post-Treatment Follow-Up|Death|0|||
94264338|NCT04448756|322761891|FG002|Overall Study|Death|0|||
94264339|NCT02593786|322761892|FG000|Overall Study|Disease progression|12|||
94694907|NCT01474512|324337077|FG006|Post-Treatment Follow-Up|Death|0|||
94694908|NCT01474512|324337078|FG007|Post-Treatment Follow-Up|Death|0|||
94694909|NCT01474512|324337079|FG008|Post-Treatment Follow-Up|Death|0|||
94694910|NCT01474512|324337080|FG009|Post-Treatment Follow-Up|Death|0|||
94694911|NCT01474512|324337081|FG010|Post-Treatment Follow-Up|Death|0|||
94694912|NCT01474512|324337082|FG011|Post-Treatment Follow-Up|Death|0|||
94694913|NCT01474512|324337083|FG012|Post-Treatment Follow-Up|Death|0|||
94694914|NCT01474512|324337084|FG013|Post-Treatment Follow-Up|Death|0|||
94694915|NCT01474512|324337085|FG014|Post-Treatment Follow-Up|Death|0|||
94694916|NCT01474512|324337086|FG015|Post-Treatment Follow-Up|Death|0|||
94694917|NCT01474512|324337087|FG016|Post-Treatment Follow-Up|Death|1|||
94694918|NCT01474512|324337088|FG017|Post-Treatment Follow-Up|Death|0|||
94694919|NCT05406791|324337091|FG000|Overall Study|Lost to Follow-up|13|||
94694920|NCT05406791|324337092|FG001|Overall Study|Lost to Follow-up|10|||
94694921|NCT01625338|324337096|FG000|Overall Study|Enrolled but not Treated|0|||
94694922|NCT01625338|324337097|FG001|Overall Study|Enrolled but not Treated|0|||
94694923|NCT01625338|324337098|FG002|Overall Study|Enrolled but not Treated|1|||
94694924|NCT01625338|324337096|FG000|Overall Study|Efficacy Failure|27|||
94694925|NCT01625338|324337097|FG001|Overall Study|Efficacy Failure|39|||
94694926|NCT01625338|324337098|FG002|Overall Study|Efficacy Failure|31|||
94694927|NCT01625338|324337096|FG000|Overall Study|Lost to Follow-up|3|||
94694928|NCT01625338|324337097|FG001|Overall Study|Lost to Follow-up|3|||
94694929|NCT01625338|324337098|FG002|Overall Study|Lost to Follow-up|2|||
94694930|NCT01625338|324337096|FG000|Overall Study|Investigator Decision|0|||
94694931|NCT01625338|324337097|FG001|Overall Study|Investigator Decision|2|||
94694932|NCT01625338|324337098|FG002|Overall Study|Investigator Decision|1|||
94694933|NCT01625338|324337096|FG000|Overall Study|Subject Withdrew Consent|1|||
94694934|NCT01625338|324337097|FG001|Overall Study|Subject Withdrew Consent|0|||
94694935|NCT01625338|324337098|FG002|Overall Study|Subject Withdrew Consent|2|||
94694936|NCT01625338|324337096|FG000|Overall Study|Adverse Event|1|||
94694937|NCT01625338|324337097|FG001|Overall Study|Adverse Event|0|||
94694938|NCT01625338|324337098|FG002|Overall Study|Adverse Event|1|||
94694939|NCT01625338|324337096|FG000|Overall Study|Study Discontinued by Sponsor|0|||
94694940|NCT01625338|324337097|FG001|Overall Study|Study Discontinued by Sponsor|0|||
94694941|NCT01625338|324337098|FG002|Overall Study|Study Discontinued by Sponsor|1|||
94694942|NCT01440049|324337099|FG000|Overall Study|Adverse Event|5|||
94694943|NCT02118714|324337104|FG000|Overall Study|Lost to Follow-up|2|||
94694944|NCT02118714|324337104|FG000|Overall Study|Protocol Violation|1|||
94694945|NCT02059161|324337114|FG000|Overall Study|Pregnancy|0|||
94694946|NCT02059161|324337115|FG001|Overall Study|Pregnancy|2|||
94694947|NCT02059161|324337114|FG000|Overall Study|Adverse Event|2|||
94694948|NCT02059161|324337115|FG001|Overall Study|Adverse Event|6|||
94694949|NCT02059161|324337114|FG000|Overall Study|Lost to Follow-up|20|||
94694950|NCT02059161|324337115|FG001|Overall Study|Lost to Follow-up|12|||
94694951|NCT02059161|324337114|FG000|Overall Study|Physician Decision|4|||
94694952|NCT02059161|324337115|FG001|Overall Study|Physician Decision|4|||
94694953|NCT02059161|324337114|FG000|Overall Study|Protocol Violation|1|||
94694954|NCT02059161|324337115|FG001|Overall Study|Protocol Violation|1|||
94694955|NCT02059161|324337114|FG000|Overall Study|Withdrawal by Subject|16|||
94694956|NCT02059161|324337115|FG001|Overall Study|Withdrawal by Subject|13|||
94694957|NCT02059161|324337114|FG000|Overall Study|Randomized in error, no study drug|0|||
94694958|NCT02059161|324337115|FG001|Overall Study|Randomized in error, no study drug|1|||
94694959|NCT02059161|324337114|FG000|Overall Study|Non-compliance with study drug|6|||
94694960|NCT02059161|324337115|FG001|Overall Study|Non-compliance with study drug|2|||
94694961|NCT03293485|324337117|FG000|Overall Study|Death|1|||
94694962|NCT03293485|324337117|FG000|Overall Study|Screen Failure|2|||
94694963|NCT03293485|324337117|FG000|Overall Study|Withdrawal by Subject|2|||
94694964|NCT03023332|324337118|FG000|Overall Study|Withdrawal by Subject|10|||
94694965|NCT03023332|324337119|FG001|Overall Study|Withdrawal by Subject|5|||
94694966|NCT03023332|324337120|FG002|Overall Study|Withdrawal by Subject|4|||
94694967|NCT03023332|324337121|FG003|Overall Study|Withdrawal by Subject|7|||
94694968|NCT03023332|324337118|FG000|Overall Study|Lost to Follow-up|13|||
94694969|NCT03023332|324337119|FG001|Overall Study|Lost to Follow-up|16|||
94694970|NCT03023332|324337120|FG002|Overall Study|Lost to Follow-up|8|||
94694971|NCT03023332|324337121|FG003|Overall Study|Lost to Follow-up|13|||
94694972|NCT03023332|324337118|FG000|Overall Study|Death|1|||
94694973|NCT03023332|324337119|FG001|Overall Study|Death|0|||
94694974|NCT03023332|324337120|FG002|Overall Study|Death|0|||
94694975|NCT03023332|324337121|FG003|Overall Study|Death|0|||
94366066|NCT01389024|323126431|FG001|Overall Study|Withdrawal by Subject|1|||
94366067|NCT01389024|323126430|FG000|Overall Study|Lost to Follow-up|1|||
94694976|NCT02408549|324337122|FG000|Overall Study|Adverse Event|15|||
94694977|NCT02408549|324337122|FG000|Overall Study|Death|4|||
94694978|NCT02408549|324337122|FG000|Overall Study|Lack of Efficacy|17|||
94694979|NCT02408549|324337122|FG000|Overall Study|Protocol Violation|4|||
94694980|NCT02408549|324337122|FG000|Overall Study|Lost to Follow-up|6|||
94694981|NCT02408549|324337122|FG000|Overall Study|Consent withdrawn|30|||
94694982|NCT02408549|324337122|FG000|Overall Study|Neurology research program closing at site|1|||
94694983|NCT02408549|324337122|FG000|Overall Study|Site closure|1|||
94694984|NCT02408549|324337122|FG000|Overall Study|Pregnancy|1|||
94694985|NCT02408549|324337122|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
94694986|NCT02408549|324337122|FG000|Overall Study|Subject moved to another place, far from site|1|||
94694987|NCT02408549|324337122|FG000|Overall Study|Study terminated at site|1|||
94694989|NCT02013687|324337124|FG000|Overall Study|Lost to Follow-up|0|||
94694990|NCT02013687|324337125|FG001|Overall Study|Lost to Follow-up|0|||
94694991|NCT02013687|324337126|FG002|Overall Study|Lost to Follow-up|1|||
94694992|NCT02013687|324337127|FG003|Overall Study|Lost to Follow-up|0|||
94694993|NCT02013687|324337124|FG000|Overall Study|Protocol Violation|0|||
94694994|NCT02013687|324337125|FG001|Overall Study|Protocol Violation|0|||
94694995|NCT02013687|324337126|FG002|Overall Study|Protocol Violation|0|||
94694996|NCT02013687|324337127|FG003|Overall Study|Protocol Violation|1|||
94694997|NCT02013687|324337124|FG000|Overall Study|Withdrawal by Subject|0|||
94694998|NCT02013687|324337125|FG001|Overall Study|Withdrawal by Subject|0|||
94694999|NCT02013687|324337126|FG002|Overall Study|Withdrawal by Subject|0|||
94695000|NCT02013687|324337127|FG003|Overall Study|Withdrawal by Subject|1|||
94695001|NCT02013687|324337124|FG000|Overall Study|Missed visits due to patient travel|0|||
94695002|NCT02013687|324337125|FG001|Overall Study|Missed visits due to patient travel|0|||
94695003|NCT02013687|324337126|FG002|Overall Study|Missed visits due to patient travel|1|||
94695004|NCT02013687|324337127|FG003|Overall Study|Missed visits due to patient travel|0|||
94695005|NCT01782326|324337128|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
94695006|NCT01782326|324337129|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
94695007|NCT01782326|324337128|FG000|Planned Treatment Epoch|Death|29|||
94695008|NCT01782326|324337129|FG001|Planned Treatment Epoch|Death|30|||
94695009|NCT01782326|324337128|FG000|Planned Treatment Epoch|Physician Decision|18|||
94695010|NCT01782326|324337129|FG001|Planned Treatment Epoch|Physician Decision|16|||
94695011|NCT01782326|324337128|FG000|Planned Treatment Epoch|Protocol deviation|2|||
94695012|NCT01782326|324337129|FG001|Planned Treatment Epoch|Protocol deviation|3|||
94695013|NCT01782326|324337128|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
94695014|NCT01782326|324337129|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
94695015|NCT01782326|324337128|FG000|Planned Treatment Epoch|Technical problems|0|||
94695016|NCT01782326|324337129|FG001|Planned Treatment Epoch|Technical problems|4|||
94695017|NCT01782326|324337128|FG000|Double-blind Treatment|Adverse Event|129|||
94695018|NCT01782326|324337129|FG001|Double-blind Treatment|Adverse Event|145|||
94695019|NCT01782326|324337128|FG000|Double-blind Treatment|Subject/guardian decision|111|||
94695020|NCT01782326|324337129|FG001|Double-blind Treatment|Subject/guardian decision|125|||
94695021|NCT01782326|324337128|FG000|Double-blind Treatment|Lack of Efficacy|17|||
94695022|NCT01782326|324337129|FG001|Double-blind Treatment|Lack of Efficacy|22|||
94695023|NCT01782326|324337128|FG000|Double-blind Treatment|Physician Decision|13|||
94695024|NCT01782326|324337129|FG001|Double-blind Treatment|Physician Decision|16|||
94695025|NCT01782326|324337128|FG000|Double-blind Treatment|Protocol deviation|8|||
94695026|NCT01782326|324337129|FG001|Double-blind Treatment|Protocol deviation|7|||
94695027|NCT01782326|324337128|FG000|Double-blind Treatment|Technical problems|0|||
94695028|NCT01782326|324337129|FG001|Double-blind Treatment|Technical problems|5|||
94695029|NCT05968482|324337130|FG000|First Crossover Period|Withdrawal by Subject|0|||
94695030|NCT05968482|324337131|FG001|First Crossover Period|Withdrawal by Subject|0|||
94695031|NCT05968482|324337132|FG002|First Crossover Period|Withdrawal by Subject|1|||
94695032|NCT05968482|324337133|FG003|First Crossover Period|Withdrawal by Subject|0|||
94695033|NCT05968482|324337134|FG004|First Crossover Period|Withdrawal by Subject|0|||
94695034|NCT05968482|324337135|FG005|First Crossover Period|Withdrawal by Subject|0|||
94695035|NCT05968482|324337130|FG000|First Crossover Period|Adverse Event|0|||
94695036|NCT05968482|324337131|FG001|First Crossover Period|Adverse Event|0|||
94695037|NCT05968482|324337132|FG002|First Crossover Period|Adverse Event|0|||
94695038|NCT05968482|324337133|FG003|First Crossover Period|Adverse Event|0|||
94695039|NCT05968482|324337134|FG004|First Crossover Period|Adverse Event|0|||
94695040|NCT05968482|324337135|FG005|First Crossover Period|Adverse Event|1|||
94695041|NCT05968482|324337130|FG000|Second Crossover Period|Withdrawal by Subject|0|||
94695042|NCT05968482|324337131|FG001|Second Crossover Period|Withdrawal by Subject|0|||
94695043|NCT05968482|324337132|FG002|Second Crossover Period|Withdrawal by Subject|0|||
94695044|NCT05968482|324337133|FG003|Second Crossover Period|Withdrawal by Subject|0|||
94695045|NCT05968482|324337134|FG004|Second Crossover Period|Withdrawal by Subject|1|||
94695046|NCT05968482|324337135|FG005|Second Crossover Period|Withdrawal by Subject|0|||
94695047|NCT05968482|324337130|FG000|Third Crossover Period|Adverse Event|0|||
94695048|NCT05968482|324337131|FG001|Third Crossover Period|Adverse Event|0|||
94695049|NCT05968482|324337132|FG002|Third Crossover Period|Adverse Event|0|||
94695050|NCT05968482|324337133|FG003|Third Crossover Period|Adverse Event|0|||
94695051|NCT05968482|324337134|FG004|Third Crossover Period|Adverse Event|1|||
94695052|NCT05968482|324337135|FG005|Third Crossover Period|Adverse Event|0|||
94695053|NCT05968482|324337130|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
94695054|NCT05968482|324337131|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
94695055|NCT05968482|324337132|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
94695056|NCT05968482|324337133|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
94695057|NCT05968482|324337134|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
94695058|NCT05968482|324337135|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
94695059|NCT02559817|324337136|FG000|Treatment Period|Adverse Event|1|||
94695060|NCT02559817|324337137|FG001|Treatment Period|Adverse Event|0|||
94695061|NCT02559817|324337138|FG002|Treatment Period|Adverse Event|1|||
94695062|NCT02559817|324337139|FG003|Treatment Period|Adverse Event|0|||
94695063|NCT02559817|324337140|FG004|Treatment Period|Adverse Event|0|||
94695064|NCT02559817|324337136|FG000|Treatment Period|Lack of Efficacy|0|||
94695065|NCT02559817|324337137|FG001|Treatment Period|Lack of Efficacy|1|||
94695066|NCT02559817|324337138|FG002|Treatment Period|Lack of Efficacy|0|||
94695067|NCT02559817|324337139|FG003|Treatment Period|Lack of Efficacy|0|||
94695068|NCT02559817|324337140|FG004|Treatment Period|Lack of Efficacy|0|||
94695069|NCT02559817|324337136|FG000|Treatment Period|Lost to Follow-up|0|||
94695070|NCT02559817|324337137|FG001|Treatment Period|Lost to Follow-up|1|||
94695071|NCT02559817|324337138|FG002|Treatment Period|Lost to Follow-up|0|||
94695072|NCT02559817|324337139|FG003|Treatment Period|Lost to Follow-up|1|||
94695073|NCT02559817|324337140|FG004|Treatment Period|Lost to Follow-up|0|||
94695074|NCT02559817|324337136|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
94695075|NCT02559817|324337137|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
94695076|NCT02559817|324337138|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
94695077|NCT02559817|324337139|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
94695078|NCT02559817|324337140|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
94695079|NCT02559817|324337136|FG000|Treatment Period|Protocol Violation|0|||
94695080|NCT02559817|324337137|FG001|Treatment Period|Protocol Violation|0|||
94695081|NCT02559817|324337138|FG002|Treatment Period|Protocol Violation|0|||
94695082|NCT02559817|324337139|FG003|Treatment Period|Protocol Violation|1|||
94695083|NCT02559817|324337140|FG004|Treatment Period|Protocol Violation|0|||
94695084|NCT04172987|324337141|FG000|Lead In Period|Adverse Event|1|||
94695085|NCT04172987|324337141|FG000|Lead In Period|Protocol Violation|1|||
94695086|NCT04172987|324337141|FG000|Period 1|Physician Decision|1|||
94695087|NCT04172987|324337141|FG000|Period 2|Adverse Event|5|||
94695088|NCT04172987|324337141|FG000|Period 2|Dosing Termination by Sponsor|4|||
94695089|NCT02839681|324337142|FG000|Overall Study|Death|2|||
94695090|NCT00738530|324337143|FG000|Overall Study|Death|220|||
94695091|NCT00738530|324337144|FG001|Overall Study|Death|224|||
94695092|NCT00738530|324337143|FG000|Overall Study|Lost to Follow-up|8|||
94695093|NCT00738530|324337144|FG001|Overall Study|Lost to Follow-up|6|||
94695094|NCT00738530|324337143|FG000|Overall Study|Withdrawal by Subject|6|||
94695095|NCT00738530|324337144|FG001|Overall Study|Withdrawal by Subject|8|||
94695096|NCT01628510|324337145|FG000|Overall Study|Withdrawal by Subject|0|||
94695097|NCT01628510|324337146|FG001|Overall Study|Withdrawal by Subject|4|||
94695098|NCT01628510|324337145|FG000|Overall Study|Death|3|||
94695099|NCT01628510|324337146|FG001|Overall Study|Death|1|||
94695100|NCT02687919|324337147|FG000|Overall Study|Withdrawal by Subject|6|||
94695101|NCT02687919|324337148|FG001|Overall Study|Withdrawal by Subject|6|||
94695102|NCT02687919|324337147|FG000|Overall Study|Protocol Violation|2|||
94695103|NCT02687919|324337148|FG001|Overall Study|Protocol Violation|0|||
94695104|NCT04179461|324337149|FG000|Overall Study|Lost to Follow-up|4|||
94695105|NCT00772928|324337150|FG000|Overall Study|Lost to Follow-up|9|||
94695106|NCT00772928|324337151|FG001|Overall Study|Lost to Follow-up|6|||
94695107|NCT00772928|324337150|FG000|Overall Study|Protocol Violation|10|||
94695108|NCT00772928|324337151|FG001|Overall Study|Protocol Violation|12|||
94695109|NCT00772928|324337150|FG000|Overall Study|Withdrawal by Subject|25|||
94695110|NCT00772928|324337151|FG001|Overall Study|Withdrawal by Subject|22|||
94695111|NCT00772928|324337150|FG000|Overall Study|Did not receive vaccine|0|||
94695112|NCT00772928|324337151|FG001|Overall Study|Did not receive vaccine|1|||
94695113|NCT01653847|324337152|FG000|Overall Study|Withdrawal by Subject|1|||
94695114|NCT01653847|324337153|FG001|Overall Study|Withdrawal by Subject|0|||
94695115|NCT03100838|324337155|FG000|Overall Study|Adverse Event|1|||
94695116|NCT03100838|324337156|FG001|Overall Study|Adverse Event|0|||
94695117|NCT03100838|324337157|FG002|Overall Study|Adverse Event|0|||
94695118|NCT03100838|324337158|FG003|Overall Study|Adverse Event|0|||
94695119|NCT03100838|324337155|FG000|Overall Study|Physician Decision|1|||
94695120|NCT03100838|324337156|FG001|Overall Study|Physician Decision|1|||
94695121|NCT03100838|324337157|FG002|Overall Study|Physician Decision|1|||
94695122|NCT03100838|324337158|FG003|Overall Study|Physician Decision|1|||
94695123|NCT03100838|324337155|FG000|Overall Study|Pregnancy|0|||
94695124|NCT03100838|324337156|FG001|Overall Study|Pregnancy|1|||
94695125|NCT03100838|324337157|FG002|Overall Study|Pregnancy|0|||
94695126|NCT03100838|324337158|FG003|Overall Study|Pregnancy|0|||
94695127|NCT03100838|324337155|FG000|Overall Study|Lost to Follow-up|0|||
94695128|NCT03100838|324337156|FG001|Overall Study|Lost to Follow-up|0|||
94695129|NCT03100838|324337157|FG002|Overall Study|Lost to Follow-up|1|||
94695130|NCT03100838|324337158|FG003|Overall Study|Lost to Follow-up|0|||
94695131|NCT04707391|324337159|FG000|Overall Study|Adverse Event|5|||
94695132|NCT04707391|324337160|FG001|Overall Study|Adverse Event|8|||
94695133|NCT04707391|324337159|FG000|Overall Study|Lost to Follow-up|44|||
94695134|NCT04707391|324337160|FG001|Overall Study|Lost to Follow-up|31|||
94695135|NCT04707391|324337159|FG000|Overall Study|Protocol Violation|1|||
94695136|NCT04707391|324337160|FG001|Overall Study|Protocol Violation|5|||
94264340|NCT02593786|322761893|FG001|Overall Study|Disease progression|16|||
94264341|NCT02593786|322761894|FG002|Overall Study|Disease progression|10|||
94264342|NCT02593786|322761895|FG003|Overall Study|Disease progression|7|||
94264343|NCT02593786|322761892|FG000|Overall Study|Study drug toxicity|1|||
94264344|NCT02593786|322761893|FG001|Overall Study|Study drug toxicity|0|||
94264345|NCT02593786|322761894|FG002|Overall Study|Study drug toxicity|0|||
94264346|NCT02593786|322761895|FG003|Overall Study|Study drug toxicity|0|||
94264347|NCT02593786|322761892|FG000|Overall Study|Adverse event unrelated to study drug|1|||
94264348|NCT02593786|322761893|FG001|Overall Study|Adverse event unrelated to study drug|1|||
94695137|NCT04707391|324337159|FG000|Overall Study|Withdrawal by Subject|27|||
94695138|NCT04707391|324337160|FG001|Overall Study|Withdrawal by Subject|25|||
94695139|NCT04707391|324337159|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
94695140|NCT04707391|324337160|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
94695141|NCT04707391|324337159|FG000|Overall Study|Other|0|||
94695142|NCT04707391|324337160|FG001|Overall Study|Other|2|||
94264349|NCT02593786|322761894|FG002|Overall Study|Adverse event unrelated to study drug|1|||
94264350|NCT02593786|322761895|FG003|Overall Study|Adverse event unrelated to study drug|0|||
94264351|NCT02593786|322761892|FG000|Overall Study|Participant request to discontinue study therapy|0|||
94264352|NCT02593786|322761893|FG001|Overall Study|Participant request to discontinue study therapy|2|||
94264353|NCT02593786|322761894|FG002|Overall Study|Participant request to discontinue study therapy|0|||
94264354|NCT02593786|322761895|FG003|Overall Study|Participant request to discontinue study therapy|0|||
94264355|NCT02593786|322761892|FG000|Overall Study|Other reasons|1|||
94264356|NCT02593786|322761893|FG001|Overall Study|Other reasons|1|||
94264357|NCT02593786|322761894|FG002|Overall Study|Other reasons|0|||
94264358|NCT02593786|322761895|FG003|Overall Study|Other reasons|5|||
94264359|NCT04252287|322761896|FG000|Overall Study|Death|5|||
94264360|NCT04252287|322761897|FG001|Overall Study|Death|3|||
94264361|NCT04252287|322761896|FG000|Overall Study|Lost to Follow-up|4|||
94264362|NCT04252287|322761897|FG001|Overall Study|Lost to Follow-up|6|||
94264363|NCT04252287|322761896|FG000|Overall Study|Withdrawal by Subject|19|||
94264364|NCT04252287|322761897|FG001|Overall Study|Withdrawal by Subject|16|||
94264365|NCT04252287|322761896|FG000|Overall Study|Protocol Violation|3|||
94264366|NCT04252287|322761897|FG001|Overall Study|Protocol Violation|4|||
94264367|NCT02383589|322761899|FG000|Treatment Period|Adverse Event|1|||
94264368|NCT02383589|322761900|FG001|Treatment Period|Adverse Event|3|||
94264369|NCT02383589|322761899|FG000|Treatment Period|Lost to Follow-up|0|||
94264370|NCT02383589|322761900|FG001|Treatment Period|Lost to Follow-up|1|||
94264371|NCT02383589|322761899|FG000|Treatment Period|Withdrawal by Subject|0|||
94264372|NCT02383589|322761900|FG001|Treatment Period|Withdrawal by Subject|5|||
94264373|NCT02383589|322761899|FG000|Treatment Period|Non-compliance with study drug|0|||
94264374|NCT02383589|322761900|FG001|Treatment Period|Non-compliance with study drug|1|||
94264375|NCT02383589|322761899|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
94264376|NCT02383589|322761900|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
94264377|NCT02383589|322761899|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
94264378|NCT02383589|322761900|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
94264379|NCT02383589|322761899|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
94264380|NCT02383589|322761900|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
94264381|NCT02906787|322761901|FG000|Overall Study|Withdrawal by Subject|12|||
94264382|NCT02906787|322761902|FG001|Overall Study|Withdrawal by Subject|10|||
94264383|NCT02906787|322761901|FG000|Overall Study|Missed|24|||
94264384|NCT02906787|322761902|FG001|Overall Study|Missed|22|||
94264385|NCT02818920|322761903|FG000|Overall Study|Unresectable|4|||
94264386|NCT02818920|322761903|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
94264387|NCT02818920|322761903|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
94264388|NCT02818920|322761903|FG000|Overall Study|Adverse Event|3|||
94264389|NCT02818920|322761903|FG000|Overall Study|Developed Other Disease|1|||
94264390|NCT02818920|322761903|FG000|Overall Study|Refused Further Treatment|1|||
94264391|NCT04275297|322761904|FG000|Overall Study|Lost to Follow-up|1|||
94264392|NCT04275297|322761905|FG001|Overall Study|Lost to Follow-up|1|||
94264393|NCT01335009|322761906|FG000|Overall Study|Too ill to travel to study sites|1|||
94264394|NCT01335009|322761907|FG001|Overall Study|Too ill to travel to study sites|0|||
94264395|NCT01335009|322761906|FG000|Overall Study|Death|28|||
94264396|NCT01335009|322761907|FG001|Overall Study|Death|32|||
94264397|NCT01335009|322761906|FG000|Overall Study|Withdrawal by Subject|1|||
94264398|NCT01335009|322761907|FG001|Overall Study|Withdrawal by Subject|1|||
94264399|NCT01335009|322761906|FG000|Overall Study|Lost to Follow-up|1|||
94264400|NCT01335009|322761907|FG001|Overall Study|Lost to Follow-up|0|||
94264401|NCT04572854|322761908|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
94264402|NCT04572854|322761909|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
94264403|NCT04572854|322761910|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
94264404|NCT04572854|322761911|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
94264405|NCT04572854|322761908|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
94264406|NCT04572854|322761909|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
94695143|NCT02015195|324337161|FG000|Overall Study|Adverse Event|0|||
94264407|NCT04572854|322761910|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
94264408|NCT04572854|322761911|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
94264409|NCT00972777|322761912|FG000|Overall Study|Adverse Event|3|||
94264410|NCT00972777|322761913|FG001|Overall Study|Adverse Event|2|||
94264411|NCT00972777|322761912|FG000|Overall Study|Lost to Follow-up|0|||
94264412|NCT00972777|322761913|FG001|Overall Study|Lost to Follow-up|4|||
94264413|NCT00972777|322761912|FG000|Overall Study|Withdrawal by Subject|4|||
94695144|NCT02015195|324337162|FG001|Overall Study|Adverse Event|0|||
94695145|NCT02015195|324337163|FG002|Overall Study|Adverse Event|0|||
94695146|NCT02015195|324337164|FG003|Overall Study|Adverse Event|1|||
94695147|NCT02015195|324337165|FG004|Overall Study|Adverse Event|0|||
94695148|NCT02015195|324337166|FG005|Overall Study|Adverse Event|0|||
94695149|NCT02015195|324337167|FG006|Overall Study|Adverse Event|0|||
94695150|NCT01318811|324337168|FG000|Overall Study|Physician Decision|1|||
94695151|NCT01318811|324337169|FG001|Overall Study|Physician Decision|1|||
94695152|NCT01318811|324337168|FG000|Overall Study|CRRT stopped for head CT|0|||
94695153|NCT01318811|324337169|FG001|Overall Study|CRRT stopped for head CT|1|||
94695154|NCT01318811|324337168|FG000|Overall Study|Death|0|||
94695155|NCT01318811|324337169|FG001|Overall Study|Death|1|||
94695156|NCT01318811|324337168|FG000|Overall Study|CRRT stopped for head MRI|0|||
94695157|NCT01318811|324337169|FG001|Overall Study|CRRT stopped for head MRI|1|||
94695158|NCT03246672|324337170|FG000|Overall Study|Lost to Follow-up|2|||
94695159|NCT00994279|324337171|FG000|Overall Study|Withdrawal by Subject|2|||
94695160|NCT00994279|324337172|FG001|Overall Study|Withdrawal by Subject|2|||
94695161|NCT00994279|324337171|FG000|Overall Study|Toxicity|1|||
94695162|NCT00994279|324337172|FG001|Overall Study|Toxicity|0|||
94695163|NCT00994279|324337171|FG000|Overall Study|Multiple reasons|1|||
94695164|NCT00994279|324337172|FG001|Overall Study|Multiple reasons|3|||
94695165|NCT01700530|324337173|FG000|Overall Study|Withdrawal by Subject|0|||
94695166|NCT01700530|324337174|FG001|Overall Study|Withdrawal by Subject|3|||
94695167|NCT01700530|324337175|FG002|Overall Study|Withdrawal by Subject|1|||
94695168|NCT04833855|324337181|FG000|Overall Study|Decision by sponsor|0|||
94695169|NCT04833855|324337182|FG001|Overall Study|Decision by sponsor|1|||
94695170|NCT04833855|324337183|FG002|Overall Study|Decision by sponsor|0|||
94695171|NCT04833855|324337184|FG003|Overall Study|Decision by sponsor|0|||
94695172|NCT04833855|324337181|FG000|Overall Study|Withdrawal by Subject|4|||
94695173|NCT04833855|324337182|FG001|Overall Study|Withdrawal by Subject|1|||
94695174|NCT04833855|324337183|FG002|Overall Study|Withdrawal by Subject|3|||
94695175|NCT04833855|324337184|FG003|Overall Study|Withdrawal by Subject|1|||
94695176|NCT04833855|324337181|FG000|Overall Study|Lost to Follow-up|1|||
94695177|NCT04833855|324337182|FG001|Overall Study|Lost to Follow-up|0|||
94695178|NCT04833855|324337183|FG002|Overall Study|Lost to Follow-up|2|||
94695179|NCT04833855|324337184|FG003|Overall Study|Lost to Follow-up|2|||
94695180|NCT04833855|324337181|FG000|Overall Study|Protocol specified criteria|0|||
94695181|NCT04833855|324337182|FG001|Overall Study|Protocol specified criteria|0|||
94695182|NCT04833855|324337183|FG002|Overall Study|Protocol specified criteria|2|||
94695183|NCT04833855|324337184|FG003|Overall Study|Protocol specified criteria|1|||
94695184|NCT04159896|324337186|FG000|Overall Study|Lack of Efficacy|7|||
94695185|NCT04159896|324337186|FG000|Overall Study|Withdrawal by Subject|1|||
94695186|NCT04159896|324337186|FG000|Overall Study|Adverse Event|1|||
94695187|NCT04159896|324337186|FG000|Overall Study|A transient ischaemic attack|1|||
94695188|NCT00003509|324337187|FG000|Overall Study|Not evaluable|5|||
94695189|NCT03873246|324337188|FG000|Overall Study|Adverse Event|1|||
94695190|NCT03873246|324337189|FG001|Overall Study|Adverse Event|3|||
94695191|NCT03873246|324337190|FG002|Overall Study|Adverse Event|3|||
94695192|NCT03873246|324337188|FG000|Overall Study|Lost to Follow-up|4|||
94695193|NCT03873246|324337189|FG001|Overall Study|Lost to Follow-up|4|||
94695194|NCT03873246|324337190|FG002|Overall Study|Lost to Follow-up|5|||
94695195|NCT03873246|324337188|FG000|Overall Study|Protocol Violation|0|||
94695196|NCT03873246|324337189|FG001|Overall Study|Protocol Violation|1|||
94695197|NCT03873246|324337190|FG002|Overall Study|Protocol Violation|0|||
94695198|NCT03873246|324337188|FG000|Overall Study|Withdrawal by Subject|0|||
94264414|NCT00972777|322761913|FG001|Overall Study|Withdrawal by Subject|5|||
94264415|NCT00972777|322761912|FG000|Overall Study|Physician Decision|4|||
94264416|NCT00972777|322761913|FG001|Overall Study|Physician Decision|0|||
94264417|NCT00972777|322761912|FG000|Overall Study|Protocol Violation|0|||
94264418|NCT00972777|322761913|FG001|Overall Study|Protocol Violation|2|||
94264419|NCT00972777|322761912|FG000|Overall Study|Screening Failure|2|||
94264420|NCT00972777|322761913|FG001|Overall Study|Screening Failure|1|||
94264421|NCT00972777|322761912|FG000|Overall Study|Missed visit|1|||
94264422|NCT00972777|322761913|FG001|Overall Study|Missed visit|0|||
94264423|NCT03672461|322761914|FG000|Overall Study|COVID Related|4|||
94264424|NCT03672461|322761915|FG001|Overall Study|COVID Related|2|||
94264425|NCT03672461|322761914|FG000|Overall Study|Adverse Event|2|||
94264426|NCT03672461|322761915|FG001|Overall Study|Adverse Event|0|||
94695199|NCT03873246|324337189|FG001|Overall Study|Withdrawal by Subject|4|||
94695200|NCT03873246|324337190|FG002|Overall Study|Withdrawal by Subject|1|||
94695201|NCT01400893|324337191|FG000|Overall Study|Death|27|||
94695202|NCT01400893|324337192|FG001|Overall Study|Death|21|||
94695203|NCT01400893|324337191|FG000|Overall Study|Lost to Follow-up|0|||
94695204|NCT01400893|324337192|FG001|Overall Study|Lost to Follow-up|6|||
94695205|NCT02886936|324337195|FG000|Overall Study|Lost to Follow-up|4|||
94264427|NCT03672461|322761914|FG000|Overall Study|Serious Adverse Event|0|||
94264428|NCT03672461|322761915|FG001|Overall Study|Serious Adverse Event|1|||
94366068|NCT01389024|323126431|FG001|Overall Study|Lost to Follow-up|0|||
94695206|NCT02886936|324337196|FG001|Overall Study|Lost to Follow-up|3|||
94695207|NCT02886936|324337197|FG002|Overall Study|Lost to Follow-up|0|||
94695208|NCT04630756|324337202|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
94695209|NCT04630756|324337203|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
94695210|NCT04630756|324337204|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
94695211|NCT04426006|324337208|FG000|Inclusion|Protocol Violation|1|||
94695212|NCT04426006|324337208|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
94695213|NCT04426006|324337208|FG000|Inclusion|Blood sample at inclusion not done|1|||
94695214|NCT04426006|324337208|FG000|3 Months|Lost to Follow-up|17|||
94695215|NCT04426006|324337208|FG000|12 Months|Lost to Follow-up|38|||
94695216|NCT03621982|324337209|FG000|Overall Study|Withdrawal by Subject|1|||
94695217|NCT03621982|324337210|FG001|Overall Study|Withdrawal by Subject|0|||
94695218|NCT03621982|324337211|FG002|Overall Study|Withdrawal by Subject|0|||
94695219|NCT03621982|324337212|FG003|Overall Study|Withdrawal by Subject|1|||
94695220|NCT03621982|324337213|FG004|Overall Study|Withdrawal by Subject|0|||
94695221|NCT03621982|324337214|FG005|Overall Study|Withdrawal by Subject|1|||
94695222|NCT03621982|324337215|FG006|Overall Study|Withdrawal by Subject|1|||
94695223|NCT03621982|324337216|FG007|Overall Study|Withdrawal by Subject|0|||
94695224|NCT03621982|324337217|FG008|Overall Study|Withdrawal by Subject|1|||
94695225|NCT03621982|324337218|FG009|Overall Study|Withdrawal by Subject|0|||
94695226|NCT03621982|324337219|FG010|Overall Study|Withdrawal by Subject|2|||
94695227|NCT03621982|324337220|FG011|Overall Study|Withdrawal by Subject|1|||
94695228|NCT03621982|324337221|FG012|Overall Study|Withdrawal by Subject|2|||
94695229|NCT03621982|324337222|FG013|Overall Study|Withdrawal by Subject|2|||
94695230|NCT03621982|324337209|FG000|Overall Study|Investigator/Sponsor decision|0|||
94695231|NCT03621982|324337210|FG001|Overall Study|Investigator/Sponsor decision|0|||
94695232|NCT03621982|324337211|FG002|Overall Study|Investigator/Sponsor decision|0|||
94695233|NCT03621982|324337212|FG003|Overall Study|Investigator/Sponsor decision|0|||
94695234|NCT03621982|324337213|FG004|Overall Study|Investigator/Sponsor decision|0|||
94695235|NCT03621982|324337214|FG005|Overall Study|Investigator/Sponsor decision|0|||
94695236|NCT03621982|324337215|FG006|Overall Study|Investigator/Sponsor decision|0|||
94695237|NCT03621982|324337216|FG007|Overall Study|Investigator/Sponsor decision|0|||
94695238|NCT03621982|324337217|FG008|Overall Study|Investigator/Sponsor decision|0|||
94695239|NCT03621982|324337218|FG009|Overall Study|Investigator/Sponsor decision|0|||
94695240|NCT03621982|324337219|FG010|Overall Study|Investigator/Sponsor decision|0|||
94695241|NCT03621982|324337220|FG011|Overall Study|Investigator/Sponsor decision|4|||
94695242|NCT03621982|324337221|FG012|Overall Study|Investigator/Sponsor decision|0|||
94695243|NCT03621982|324337222|FG013|Overall Study|Investigator/Sponsor decision|2|||
94695244|NCT03621982|324337209|FG000|Overall Study|Death|2|||
94695245|NCT03621982|324337210|FG001|Overall Study|Death|4|||
94695246|NCT03621982|324337211|FG002|Overall Study|Death|4|||
94695247|NCT03621982|324337212|FG003|Overall Study|Death|3|||
94695248|NCT03621982|324337213|FG004|Overall Study|Death|8|||
94695249|NCT03621982|324337214|FG005|Overall Study|Death|4|||
94695250|NCT03621982|324337215|FG006|Overall Study|Death|6|||
94695251|NCT03621982|324337216|FG007|Overall Study|Death|3|||
94695252|NCT03621982|324337217|FG008|Overall Study|Death|0|||
94695253|NCT03621982|324337218|FG009|Overall Study|Death|3|||
94695254|NCT03621982|324337219|FG010|Overall Study|Death|8|||
94695255|NCT03621982|324337220|FG011|Overall Study|Death|4|||
94695256|NCT03621982|324337221|FG012|Overall Study|Death|2|||
94695257|NCT03621982|324337222|FG013|Overall Study|Death|2|||
94695258|NCT03621982|324337209|FG000|Overall Study|Lost to Follow-up|0|||
94695259|NCT03621982|324337210|FG001|Overall Study|Lost to Follow-up|0|||
94695260|NCT03621982|324337211|FG002|Overall Study|Lost to Follow-up|1|||
94695261|NCT03621982|324337212|FG003|Overall Study|Lost to Follow-up|0|||
94695262|NCT03621982|324337213|FG004|Overall Study|Lost to Follow-up|0|||
94695263|NCT03621982|324337214|FG005|Overall Study|Lost to Follow-up|0|||
94695264|NCT03621982|324337215|FG006|Overall Study|Lost to Follow-up|1|||
94695265|NCT03621982|324337216|FG007|Overall Study|Lost to Follow-up|0|||
94695266|NCT03621982|324337217|FG008|Overall Study|Lost to Follow-up|0|||
94695267|NCT03621982|324337218|FG009|Overall Study|Lost to Follow-up|1|||
94695268|NCT03621982|324337219|FG010|Overall Study|Lost to Follow-up|0|||
94695269|NCT03621982|324337220|FG011|Overall Study|Lost to Follow-up|0|||
94695270|NCT03621982|324337221|FG012|Overall Study|Lost to Follow-up|0|||
94695271|NCT03621982|324337222|FG013|Overall Study|Lost to Follow-up|0|||
94695272|NCT00442286|324337223|FG000|Overall Study|Death|2|||
94695273|NCT00442286|324337224|FG001|Overall Study|Death|2|||
94695274|NCT00442286|324337223|FG000|Overall Study|Lost to Follow-up|1|||
94695275|NCT00442286|324337224|FG001|Overall Study|Lost to Follow-up|0|||
94695276|NCT00442286|324337223|FG000|Overall Study|Withdrawal by Subject|2|||
94695277|NCT00442286|324337224|FG001|Overall Study|Withdrawal by Subject|0|||
94695278|NCT00442286|324337223|FG000|Overall Study|System explanted|1|||
94695279|NCT00442286|324337224|FG001|Overall Study|System explanted|0|||
94695280|NCT00442286|324337223|FG000|Overall Study|Patient Injury|1|||
94695281|NCT00442286|324337224|FG001|Overall Study|Patient Injury|0|||
94695282|NCT00429793|324337226|FG000|Overall Study|Improper pre-protocol treatment|3|||
94695283|NCT00429793|324337226|FG000|Overall Study|Required test not done|1|||
94695284|NCT00429793|324337226|FG000|Overall Study|Never treated|1|||
94695285|NCT00429793|324337226|FG000|Overall Study|Non-measurable|1|||
94695286|NCT00097370|324337227|FG000|Stage 1|Adverse Event|3|||
94695287|NCT00097370|324337227|FG000|Stage 1|Withdrawal by Subject|1|||
94695288|NCT00097370|324337227|FG000|Stage 1|Lack of Efficacy|2|||
94695289|NCT00097370|324337227|FG000|Stage 2|Adverse Event|5|||
94695290|NCT00097370|324337227|FG000|Stage 2|Withdrawal by Subject|1|||
94695291|NCT00097370|324337227|FG000|Stage 2|Lack of Efficacy|3|||
94695292|NCT00097370|324337227|FG000|Stage 2|Pregnancy|1|||
94695293|NCT00097370|324337227|FG000|Stage 2|Sponsor Terminated Study|2|||
94695294|NCT00097370|324337227|FG000|Stage 2|Lost to Follow-up|1|||
94695295|NCT00097370|324337227|FG000|Stage 3|Adverse Event|2|||
94695296|NCT00097370|324337227|FG000|Stage 3|Withdrawal by Subject|3|||
94695297|NCT00097370|324337227|FG000|Stage 3|Lack of Efficacy|1|||
94695298|NCT00097370|324337227|FG000|Stage 3|Sponsor Terminated Study|52|||
94695299|NCT00097370|324337227|FG000|Stage 3|Lost to Follow-up|1|||
94695300|NCT04129580|324338387|FG000|Overall Study|Lost to Follow-up|14|||
94695301|NCT04129580|324338388|FG001|Overall Study|Lost to Follow-up|25|||
94695302|NCT00107380|324338391|FG000|Overall Study|Adverse Event|7|||
94695303|NCT00107380|324338391|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
94695304|NCT00107380|324338391|FG000|Overall Study|Progression/relapse|4|||
94695305|NCT00107380|324338391|FG000|Overall Study|Death|3|||
94695306|NCT00107380|324338391|FG000|Overall Study|Other - not protocol specified|7|||
94695307|NCT00107380|324338391|FG000|Overall Study|Ineligible|2|||
94695308|NCT01642186|324338399|FG000|Overall Study|Death|0|||
94695309|NCT01642186|324338400|FG001|Overall Study|Death|2|||
94695310|NCT01642186|324338401|FG002|Overall Study|Death|2|||
94695311|NCT01642186|324338399|FG000|Overall Study|Lost to Follow-up|0|||
94695312|NCT01642186|324338400|FG001|Overall Study|Lost to Follow-up|0|||
94695313|NCT01642186|324338401|FG002|Overall Study|Lost to Follow-up|1|||
94695314|NCT02268396|324338402|FG000|Overall Study|Adverse Event|3|||
94695315|NCT02268396|324338402|FG000|Overall Study|Administrative|2|||
94695316|NCT02268396|324338402|FG000|Overall Study|Withdrawal by Subject|1|||
94695317|NCT02268396|324338402|FG000|Overall Study|Lost to Follow-up|2|||
94695318|NCT02268396|324338402|FG000|Overall Study|Protocol-Specified Criteria|2|||
94695319|NCT02268396|324338402|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
94695320|NCT00163215|324338403|FG000|Overall Study|Lack of Efficacy|3|||
94695321|NCT00163215|324338403|FG000|Overall Study|Withdrawal by Subject|5|||
94695322|NCT00163215|324338403|FG000|Overall Study|Other|7|||
94695323|NCT00224133|324338408|FG000|Overall Study|Adverse Event|93|||
94695324|NCT00224133|324338408|FG000|Overall Study|Protocol Violation|6|||
94695325|NCT00224133|324338408|FG000|Overall Study|Withdrawal by Subject|33|||
94695326|NCT00224133|324338408|FG000|Overall Study|Lack of Efficacy|58|||
94695327|NCT00224133|324338408|FG000|Overall Study|Lost to Follow-up|21|||
94695328|NCT00224133|324338408|FG000|Overall Study|Physician Decision|1|||
94695329|NCT00224133|324338408|FG000|Overall Study|Other|14|||
94695330|NCT00231179|324338409|FG000|Overall Study|Lost to Follow-up|21|||
94695331|NCT00231179|324338410|FG001|Overall Study|Lost to Follow-up|21|||
94695332|NCT00231179|324338409|FG000|Overall Study|Withdrawal by Subject|3|||
94695333|NCT00231179|324338410|FG001|Overall Study|Withdrawal by Subject|3|||
94695334|NCT02424344|324338411|FG000|Overall Study|Lack of Efficacy|0|||
94695335|NCT02424344|324338412|FG001|Overall Study|Lack of Efficacy|1|||
94264429|NCT03672461|322761914|FG000|Overall Study|Too Busy|3|||
94264430|NCT03672461|322761915|FG001|Overall Study|Too Busy|1|||
94466055|NCT03759366|323494999|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
94695336|NCT02424344|324338411|FG000|Overall Study|Withdrawal by Subject|2|||
94695337|NCT02424344|324338412|FG001|Overall Study|Withdrawal by Subject|1|||
94695338|NCT02424344|324338411|FG000|Overall Study|Lost to Follow-up|1|||
94466056|NCT03759366|323494999|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
94695339|NCT02424344|324338412|FG001|Overall Study|Lost to Follow-up|0|||
94264431|NCT03672461|322761914|FG000|Overall Study|Lost to Follow-up|1|||
94695340|NCT02424344|324338411|FG000|Overall Study|Adverse Event|4|||
94695341|NCT02424344|324338412|FG001|Overall Study|Adverse Event|8|||
94695342|NCT00795132|324338413|FG000|Overall Study|Death|1|||
94695343|NCT00795132|324338413|FG000|Overall Study|Relapse|2|||
94695344|NCT04822298|324338417|FG000|Overall Study|Death|3|||
94695345|NCT02561455|324338418|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
94695346|NCT02561455|324338419|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
94695347|NCT02561455|324338420|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
94466057|NCT03759366|323494999|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
94695348|NCT02561455|324338421|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
94695349|NCT02561455|324338418|FG000|Overall Study|Withdrawal by Subject|1|||
94695350|NCT02561455|324338419|FG001|Overall Study|Withdrawal by Subject|0|||
94695351|NCT02561455|324338420|FG002|Overall Study|Withdrawal by Subject|1|||
94695352|NCT02561455|324338421|FG003|Overall Study|Withdrawal by Subject|0|||
94695353|NCT02561455|324338418|FG000|Overall Study|Disease Progression|0|||
94695354|NCT02561455|324338419|FG001|Overall Study|Disease Progression|1|||
94695355|NCT02561455|324338420|FG002|Overall Study|Disease Progression|0|||
94695356|NCT02561455|324338421|FG003|Overall Study|Disease Progression|0|||
94695357|NCT02451930|324338422|FG000|Overall Study|Death|0|||
94695358|NCT02451930|324338423|FG001|Overall Study|Death|15|||
94695359|NCT02451930|324338422|FG000|Overall Study|Lost to Follow-up|0|||
94695360|NCT02451930|324338423|FG001|Overall Study|Lost to Follow-up|3|||
94695361|NCT02451930|324338422|FG000|Overall Study|Sponsor Decision|2|||
94695362|NCT02451930|324338423|FG001|Overall Study|Sponsor Decision|10|||
94695363|NCT02451930|324338422|FG000|Overall Study|Withdrawal by Subject|0|||
94695364|NCT02451930|324338423|FG001|Overall Study|Withdrawal by Subject|1|||
94695365|NCT02451930|324338422|FG000|Overall Study|Other|0|||
94695366|NCT02451930|324338423|FG001|Overall Study|Other|1|||
94695367|NCT03639675|324338424|FG000|Overall Study|Withdrawal by Subject|1|||
94695368|NCT02459587|324338427|FG000|3-Month Follow-up Assessment|Death|0|||
94695369|NCT02459587|324338428|FG001|3-Month Follow-up Assessment|Death|2|||
94695370|NCT02459587|324338427|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
94695371|NCT02459587|324338428|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
94695372|NCT02459587|324338427|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
94695373|NCT02459587|324338428|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
94695374|NCT02459587|324338427|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
94695375|NCT02459587|324338428|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
94695376|NCT02459587|324338427|FG000|6-month Follow-up Assessment|Death|2|||
94695377|NCT02459587|324338428|FG001|6-month Follow-up Assessment|Death|1|||
94695378|NCT02459587|324338427|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
94695379|NCT02459587|324338428|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
94695380|NCT02459587|324338427|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
94695381|NCT02459587|324338428|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
94695382|NCT02459587|324338427|FG000|12-month Follow-up Assessment|Death|2|||
94695383|NCT02459587|324338428|FG001|12-month Follow-up Assessment|Death|0|||
94695384|NCT02459587|324338427|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
94695385|NCT02459587|324338428|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
94695386|NCT02459587|324338427|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
94695387|NCT02459587|324338428|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
94695388|NCT02459587|324338427|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
94695389|NCT02459587|324338428|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
94695390|NCT02403674|324338431|FG000|Base Study|Death|1|||
94695391|NCT02403674|324338432|FG001|Base Study|Death|4|||
94695392|NCT02403674|324338431|FG000|Base Study|Adverse Event|11|||
94695393|NCT02403674|324338432|FG001|Base Study|Adverse Event|26|||
94695394|NCT02403674|324338431|FG000|Base Study|Lack of Efficacy|31|||
94695395|NCT02403674|324338432|FG001|Base Study|Lack of Efficacy|23|||
94695396|NCT02403674|324338431|FG000|Base Study|Lost to Follow-up|6|||
94695397|NCT02403674|324338432|FG001|Base Study|Lost to Follow-up|8|||
94695398|NCT02403674|324338431|FG000|Base Study|Withdrawal by Subject|10|||
94695399|NCT02403674|324338432|FG001|Base Study|Withdrawal by Subject|17|||
94695400|NCT02403674|324338431|FG000|Base Study|Physician Decision|2|||
94695401|NCT02403674|324338432|FG001|Base Study|Physician Decision|2|||
94695402|NCT02403674|324338431|FG000|Base Study|Pregnancy|2|||
94695403|NCT02403674|324338432|FG001|Base Study|Pregnancy|2|||
94695404|NCT02403674|324338431|FG000|Base Study|Protocol Violation|8|||
94695405|NCT02403674|324338432|FG001|Base Study|Protocol Violation|4|||
94695406|NCT02403674|324338431|FG000|Base Study|Non-Compliance with study drug|1|||
94695407|NCT02403674|324338432|FG001|Base Study|Non-Compliance with study drug|4|||
94695408|NCT02403674|324338431|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
94695409|NCT02403674|324338432|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
94695410|NCT02403674|324338431|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
94466058|NCT03759366|323494999|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
94695411|NCT02403674|324338432|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
94695412|NCT02403674|324338431|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
94695413|NCT02403674|324338432|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
94695414|NCT02403674|324338431|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
94695415|NCT02403674|324338432|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
94695416|NCT02403674|324338431|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
94695417|NCT02403674|324338432|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
94695418|NCT02403674|324338431|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
94695419|NCT02403674|324338432|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
94695420|NCT02403674|324338431|FG000|Study Extension 1 (Open-Label)|Death|1|||
94695421|NCT02403674|324338432|FG001|Study Extension 1 (Open-Label)|Death|0|||
94695422|NCT02403674|324338431|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
94695423|NCT02403674|324338432|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
94695424|NCT02403674|324338431|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
94695425|NCT02403674|324338432|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
94695426|NCT02403674|324338431|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
94695427|NCT02403674|324338432|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
94695428|NCT02403674|324338431|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
94695429|NCT02403674|324338432|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
94695430|NCT02403674|324338431|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
94695431|NCT02403674|324338432|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
94695432|NCT02403674|324338431|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
94695433|NCT02403674|324338432|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
94695434|NCT02403674|324338431|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
94695435|NCT02403674|324338432|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
94695436|NCT02403674|324338431|FG000|Study Extension 2 (Open-Label)|Death|2|||
94695437|NCT02403674|324338432|FG001|Study Extension 2 (Open-Label)|Death|2|||
94695438|NCT02403674|324338431|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
94695439|NCT02403674|324338432|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
94695440|NCT02403674|324338431|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
94695441|NCT02403674|324338432|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
94695442|NCT02403674|324338431|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
94695443|NCT02403674|324338432|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
94695444|NCT02403674|324338431|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
94695445|NCT02403674|324338432|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
94695446|NCT02403674|324338431|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
94695447|NCT02403674|324338432|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
94695448|NCT02403674|324338431|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
94695449|NCT02403674|324338432|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
94695450|NCT02403674|324338431|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
94695451|NCT02403674|324338432|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
94695452|NCT00826280|324338433|FG000|Overall Study|Randomized but drug not received|1|||
94695453|NCT00826280|324338434|FG001|Overall Study|Randomized but drug not received|0|||
94695454|NCT00826280|324338435|FG002|Overall Study|Randomized but drug not received|1|||
94695455|NCT00826280|324338433|FG000|Overall Study|Adverse Event|1|||
94264432|NCT03672461|322761915|FG001|Overall Study|Lost to Follow-up|2|||
94695456|NCT00826280|324338434|FG001|Overall Study|Adverse Event|3|||
94695457|NCT00826280|324338435|FG002|Overall Study|Adverse Event|0|||
94695458|NCT00826280|324338433|FG000|Overall Study|Lost to Follow-up|0|||
94695459|NCT00826280|324338434|FG001|Overall Study|Lost to Follow-up|1|||
94695460|NCT00826280|324338435|FG002|Overall Study|Lost to Follow-up|0|||
94695461|NCT00826280|324338433|FG000|Overall Study|Sponsor discontinued subject or study|1|||
94695462|NCT00826280|324338434|FG001|Overall Study|Sponsor discontinued subject or study|0|||
94695463|NCT00826280|324338435|FG002|Overall Study|Sponsor discontinued subject or study|0|||
94695464|NCT00826280|324338433|FG000|Overall Study|Reversible ischemic defect not present|43|||
94695465|NCT00826280|324338434|FG001|Overall Study|Reversible ischemic defect not present|40|||
94695466|NCT00826280|324338435|FG002|Overall Study|Reversible ischemic defect not present|44|||
94695467|NCT00826280|324338433|FG000|Overall Study|Interpretation Failure|1|||
94695468|NCT00826280|324338434|FG001|Overall Study|Interpretation Failure|0|||
94695469|NCT00826280|324338435|FG002|Overall Study|Interpretation Failure|0|||
94695470|NCT00826280|324338433|FG000|Overall Study|Machine Failure|1|||
94695471|NCT00826280|324338434|FG001|Overall Study|Machine Failure|1|||
94695472|NCT00826280|324338435|FG002|Overall Study|Machine Failure|0|||
94695473|NCT00826280|324338433|FG000|Overall Study|One or more non-interpretable scan|0|||
94695474|NCT00826280|324338434|FG001|Overall Study|One or more non-interpretable scan|1|||
94695475|NCT00826280|324338435|FG002|Overall Study|One or more non-interpretable scan|1|||
94695476|NCT02268552|324338445|FG000|Part 1|Death|1|||
94695477|NCT02268552|324338446|FG001|Part 1|Death|1|||
94695478|NCT02268552|324338447|FG002|Part 1|Death|1|||
94695479|NCT02268552|324338448|FG003|Part 1|Death|2|||
94695480|NCT02268552|324338449|FG004|Part 1|Death|0|||
94695481|NCT02268552|324338450|FG005|Part 1|Death|0|||
94695482|NCT02268552|324338451|FG006|Part 1|Death|0|||
94264433|NCT03672461|322761914|FG000|Overall Study|Family|2|||
94264434|NCT03672461|322761915|FG001|Overall Study|Family|2|||
94264435|NCT03672461|322761914|FG000|Overall Study|No remote technology access|0|||
94264436|NCT03672461|322761915|FG001|Overall Study|No remote technology access|1|||
94264437|NCT03672461|322761914|FG000|Overall Study|Withdrawal by Subject|1|||
94264438|NCT03672461|322761915|FG001|Overall Study|Withdrawal by Subject|0|||
94264439|NCT03672461|322761914|FG000|Overall Study|Cannot tolerate intervention|1|||
94264440|NCT03672461|322761915|FG001|Overall Study|Cannot tolerate intervention|0|||
94264441|NCT03672461|322761914|FG000|Overall Study|Incomplete outcome data|6|||
94466059|NCT03759366|323494999|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
94466060|NCT04907227|323495000|FG000|Overall Study|Death|12|||
94466061|NCT04907227|323495001|FG001|Overall Study|Death|8|||
94695483|NCT02268552|324338445|FG000|Part 1|Subject/guardian decision|0|||
94695484|NCT02268552|324338446|FG001|Part 1|Subject/guardian decision|0|||
94264442|NCT03672461|322761915|FG001|Overall Study|Incomplete outcome data|1|||
94466062|NCT04907227|323495000|FG000|Overall Study|Withdrawal by Subject|2|||
94264443|NCT03144804|322761916|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
94264444|NCT04223791|322761917|FG000|Overall Study|Lost to Follow-up|0|||
94466063|NCT04907227|323495001|FG001|Overall Study|Withdrawal by Subject|2|||
94695485|NCT02268552|324338447|FG002|Part 1|Subject/guardian decision|0|||
94695486|NCT02268552|324338448|FG003|Part 1|Subject/guardian decision|1|||
94695487|NCT02268552|324338449|FG004|Part 1|Subject/guardian decision|0|||
94695488|NCT02268552|324338450|FG005|Part 1|Subject/guardian decision|0|||
94695489|NCT02268552|324338451|FG006|Part 1|Subject/guardian decision|0|||
94695490|NCT02268552|324338445|FG000|Part 2|Death|0|||
94695491|NCT02268552|324338446|FG001|Part 2|Death|0|||
94695492|NCT02268552|324338447|FG002|Part 2|Death|0|||
94695493|NCT02268552|324338448|FG003|Part 2|Death|0|||
94695494|NCT02268552|324338449|FG004|Part 2|Death|0|||
94695495|NCT02268552|324338450|FG005|Part 2|Death|0|||
94695496|NCT02268552|324338451|FG006|Part 2|Death|2|||
94695497|NCT02268552|324338445|FG000|Part 2|Subject/guardian decision|0|||
94695498|NCT02268552|324338446|FG001|Part 2|Subject/guardian decision|0|||
94695499|NCT02268552|324338447|FG002|Part 2|Subject/guardian decision|0|||
94695500|NCT02268552|324338448|FG003|Part 2|Subject/guardian decision|0|||
94695501|NCT02268552|324338449|FG004|Part 2|Subject/guardian decision|0|||
94695502|NCT02268552|324338450|FG005|Part 2|Subject/guardian decision|0|||
94695503|NCT02268552|324338451|FG006|Part 2|Subject/guardian decision|1|||
94695504|NCT02268552|324338445|FG000|Part 3 Extension|Death|0|||
94695505|NCT02268552|324338446|FG001|Part 3 Extension|Death|1|||
94695506|NCT02268552|324338447|FG002|Part 3 Extension|Death|1|||
94695507|NCT02268552|324338448|FG003|Part 3 Extension|Death|1|||
94695508|NCT02268552|324338449|FG004|Part 3 Extension|Death|1|||
94695509|NCT02268552|324338450|FG005|Part 3 Extension|Death|1|||
94695510|NCT02268552|324338451|FG006|Part 3 Extension|Death|0|||
94695511|NCT02268552|324338445|FG000|Part 3 Extension|Early termination of trial|1|||
94695512|NCT02268552|324338446|FG001|Part 3 Extension|Early termination of trial|0|||
94695513|NCT02268552|324338447|FG002|Part 3 Extension|Early termination of trial|0|||
94695514|NCT02268552|324338448|FG003|Part 3 Extension|Early termination of trial|0|||
94695515|NCT02268552|324338449|FG004|Part 3 Extension|Early termination of trial|2|||
94695516|NCT02268552|324338450|FG005|Part 3 Extension|Early termination of trial|9|||
94695517|NCT02268552|324338451|FG006|Part 3 Extension|Early termination of trial|11|||
94695518|NCT02268552|324338445|FG000|Part 3 Extension|Subject/guardian decision|0|||
94695519|NCT02268552|324338446|FG001|Part 3 Extension|Subject/guardian decision|0|||
94695520|NCT02268552|324338447|FG002|Part 3 Extension|Subject/guardian decision|0|||
94695521|NCT02268552|324338448|FG003|Part 3 Extension|Subject/guardian decision|0|||
94695522|NCT02268552|324338449|FG004|Part 3 Extension|Subject/guardian decision|0|||
94695523|NCT02268552|324338450|FG005|Part 3 Extension|Subject/guardian decision|0|||
94695524|NCT02268552|324338451|FG006|Part 3 Extension|Subject/guardian decision|1|||
94695525|NCT00765362|324338452|FG000|Overall Study|Death|9|||
94695526|NCT00765362|324338452|FG000|Overall Study|Adverse Event|2|||
94695527|NCT00765362|324338452|FG000|Overall Study|Protocol Violation|18|||
94695528|NCT00765362|324338452|FG000|Overall Study|Withdrawal by Subject|13|||
94695529|NCT00765362|324338452|FG000|Overall Study|Lost to Follow-up|95|||
94695530|NCT03930186|324338453|FG000|Weeks 0 to 16|Adverse Event|6|||
94695531|NCT03930186|324338453|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
94695532|NCT03930186|324338453|FG000|Weeks 16 to 32|Adverse Event|1|||
94695533|NCT03930186|324338453|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
94695534|NCT03019458|324338456|FG000|Overall Study|Death|0|||
94695535|NCT03019458|324338457|FG001|Overall Study|Death|1|||
94695536|NCT00031447|324338460|FG000|Overall Study|Lost to Follow-up|0|||
94695537|NCT00031447|324338461|FG001|Overall Study|Lost to Follow-up|1|||
94695538|NCT00031447|324338460|FG000|Overall Study|Non-compliant|1|||
94695539|NCT00031447|324338461|FG001|Overall Study|Non-compliant|1|||
94695540|NCT00031447|324338460|FG000|Overall Study|Re-activation of Disease|2|||
94695541|NCT00031447|324338461|FG001|Overall Study|Re-activation of Disease|1|||
94695542|NCT00031447|324338460|FG000|Overall Study|Disruption of blinded study drug supply|7|||
94695543|NCT00031447|324338461|FG001|Overall Study|Disruption of blinded study drug supply|4|||
94695544|NCT01636362|324338462|FG000|Overall Study|Physician Decision|6|||
94695545|NCT01636362|324338462|FG000|Overall Study|Subject healed, not returning|1|||
94695546|NCT01636362|324338462|FG000|Overall Study|Withdrawal by Subject|1|||
94695547|NCT00884286|324338467|FG000|Overall Study|Progressive disease|21|||
94695548|NCT00884286|324338468|FG001|Overall Study|Progressive disease|28|||
94695549|NCT00884286|324338467|FG000|Overall Study|Toxicity|4|||
94695550|NCT00884286|324338468|FG001|Overall Study|Toxicity|1|||
94695551|NCT00884286|324338467|FG000|Overall Study|Death|2|||
94695552|NCT00884286|324338468|FG001|Overall Study|Death|2|||
94695553|NCT00884286|324338467|FG000|Overall Study|Physician Decision|1|||
94695554|NCT00884286|324338468|FG001|Overall Study|Physician Decision|0|||
94695555|NCT00884286|324338467|FG000|Overall Study|Septic shock|1|||
94695556|NCT00884286|324338468|FG001|Overall Study|Septic shock|0|||
94695557|NCT00884286|324338467|FG000|Overall Study|Thrombus in right auricle|1|||
94695558|NCT00884286|324338468|FG001|Overall Study|Thrombus in right auricle|0|||
94695559|NCT00884286|324338467|FG000|Overall Study|Not treated|2|||
94695560|NCT00884286|324338468|FG001|Overall Study|Not treated|1|||
94695561|NCT00884286|324338467|FG000|Overall Study|Comprised lung carcinoma|0|||
94695562|NCT00884286|324338468|FG001|Overall Study|Comprised lung carcinoma|1|||
94695563|NCT03712098|324338469|FG000|Overall Study|Lost to Follow-up|3|||
94695564|NCT03712098|324338470|FG001|Overall Study|Lost to Follow-up|7|||
94695565|NCT03712098|324338469|FG000|Overall Study|Withdrawal by Subject|9|||
94695566|NCT03712098|324338470|FG001|Overall Study|Withdrawal by Subject|4|||
94695567|NCT03712098|324338469|FG000|Overall Study|Protocol Violation|2|||
94695568|NCT03712098|324338470|FG001|Overall Study|Protocol Violation|1|||
94695569|NCT01094171|324338473|FG000|Overall Study|Lost to Follow-up|2|||
94695570|NCT01094171|324338473|FG000|Overall Study|Informed consent withdrawal|4|||
94695571|NCT01094171|324338473|FG000|Overall Study|Migration from the study area|3|||
94695572|NCT01094171|324338473|FG000|Overall Study|Other|1|||
94695573|NCT00136916|324338474|FG000|Overall Study|Never received study treatment|3|||
94695574|NCT00136916|324338475|FG001|Overall Study|Never received study treatment|5|||
94695575|NCT00136916|324338474|FG000|Overall Study|Death|1|||
94264445|NCT04223791|322761918|FG001|Overall Study|Lost to Follow-up|4|||
94264446|NCT04223791|322761917|FG000|Overall Study|Physician Decision|5|||
94264447|NCT04223791|322761918|FG001|Overall Study|Physician Decision|1|||
94264448|NCT04223791|322761917|FG000|Overall Study|Protocol Violation|1|||
94264449|NCT04223791|322761918|FG001|Overall Study|Protocol Violation|1|||
94264450|NCT04223791|322761917|FG000|Overall Study|Withdrawal by Subject|10|||
94264451|NCT04223791|322761918|FG001|Overall Study|Withdrawal by Subject|12|||
94264452|NCT04223791|322761917|FG000|Overall Study|Pregnancy|1|||
94264453|NCT04223791|322761918|FG001|Overall Study|Pregnancy|1|||
94264454|NCT04223791|322761917|FG000|Overall Study|Ongoing in Study|305|||
94264455|NCT04223791|322761918|FG001|Overall Study|Ongoing in Study|302|||
94264456|NCT01306890|322763452|FG000|Overall Study|Adverse Event|2|||
94264457|NCT01306890|322763452|FG000|Overall Study|Death|1223|||
94264458|NCT01306890|322763452|FG000|Overall Study|Lost to Follow-up|58|||
94264459|NCT01306890|322763452|FG000|Overall Study|Withdrawal by Subject|88|||
94264460|NCT01306890|322763452|FG000|Overall Study|Unspecified reasons|104|||
94264461|NCT01306890|322763452|FG000|Overall Study|Study Termination|3|||
94264462|NCT01306890|322763452|FG000|Overall Study|No discontinuation documentation|41|||
94264463|NCT01436071|322763453|FG000|Overall Study|Adverse Event|1|||
94264464|NCT01436071|322763454|FG001|Overall Study|Adverse Event|0|||
94264465|NCT01436071|322763453|FG000|Overall Study|Lack of Efficacy|16|||
94264466|NCT01436071|322763454|FG001|Overall Study|Lack of Efficacy|7|||
94264467|NCT01436071|322763453|FG000|Overall Study|Protocol Violation|0|||
94264468|NCT01436071|322763454|FG001|Overall Study|Protocol Violation|1|||
94264469|NCT01436071|322763453|FG000|Overall Study|Lost to Follow-up|3|||
94264470|NCT01436071|322763454|FG001|Overall Study|Lost to Follow-up|1|||
94264471|NCT01436071|322763453|FG000|Overall Study|Physician Decision|1|||
94264472|NCT01436071|322763454|FG001|Overall Study|Physician Decision|0|||
94264473|NCT01436071|322763453|FG000|Overall Study|Withdrawal by Subject|2|||
94264474|NCT01436071|322763454|FG001|Overall Study|Withdrawal by Subject|2|||
94264475|NCT01436071|322763453|FG000|Overall Study|Did Not Receive Trial Medication|3|||
94695576|NCT00136916|324338475|FG001|Overall Study|Death|3|||
94695577|NCT00136916|324338474|FG000|Overall Study|Adverse Event|27|||
94264476|NCT01436071|322763454|FG001|Overall Study|Did Not Receive Trial Medication|3|||
94695578|NCT00136916|324338475|FG001|Overall Study|Adverse Event|8|||
94695579|NCT00136916|324338474|FG000|Overall Study|Laboratory abnormality|0|||
94695580|NCT00136916|324338475|FG001|Overall Study|Laboratory abnormality|1|||
94695581|NCT00136916|324338474|FG000|Overall Study|Lack of Efficacy|13|||
94695582|NCT00136916|324338475|FG001|Overall Study|Lack of Efficacy|3|||
94695583|NCT00136916|324338474|FG000|Overall Study|Lost to Follow-up|12|||
94695584|NCT00136916|324338475|FG001|Overall Study|Lost to Follow-up|14|||
94695585|NCT00136916|324338474|FG000|Overall Study|Withdrawal by Subject|44|||
94695586|NCT00136916|324338475|FG001|Overall Study|Withdrawal by Subject|46|||
94695587|NCT00136916|324338474|FG000|Overall Study|Other|22|||
94695588|NCT00136916|324338475|FG001|Overall Study|Other|24|||
94695589|NCT00136916|324338474|FG000|Overall Study|Discontinued in follow up period|3|||
94695590|NCT00136916|324338475|FG001|Overall Study|Discontinued in follow up period|0|||
94695591|NCT03285711|324338480|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
94695592|NCT03285711|324338481|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
94695593|NCT03285711|324338482|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
94695594|NCT03285711|324338483|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
94695595|NCT03285711|324338480|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
94695596|NCT03285711|324338481|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
94695597|NCT03285711|324338482|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
94695598|NCT03285711|324338483|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
94695599|NCT03285711|324338480|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
94695600|NCT03285711|324338481|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
94695601|NCT03285711|324338482|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
94695602|NCT03285711|324338483|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
94695603|NCT03285711|324338480|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
94695604|NCT03285711|324338481|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
94695605|NCT03285711|324338482|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
94695606|NCT03285711|324338483|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
94695607|NCT03658811|324338489|FG000|Overall Study|Lost to Follow-up|3|||
94695608|NCT00885495|324338490|FG000|Overall Study|Adverse Event|1|||
94695609|NCT00885495|324338491|FG001|Overall Study|Adverse Event|2|||
94695610|NCT00885495|324338490|FG000|Overall Study|Protocol Violation|0|||
94695611|NCT00885495|324338491|FG001|Overall Study|Protocol Violation|1|||
94695612|NCT00885495|324338490|FG000|Overall Study|Withdrawal by Subject|1|||
94695613|NCT00885495|324338491|FG001|Overall Study|Withdrawal by Subject|0|||
94695614|NCT01513967|324338492|FG000|Overall Study|Pregnancy|0|||
94695615|NCT01513967|324338493|FG001|Overall Study|Pregnancy|0|||
94695616|NCT01513967|324338494|FG002|Overall Study|Pregnancy|0|||
94695617|NCT01513967|324338495|FG003|Overall Study|Pregnancy|0|||
94366069|NCT01458132|323126432|FG000|Overall Study|Other|15|||
94695618|NCT01513967|324338496|FG004|Overall Study|Pregnancy|0|||
94695619|NCT01513967|324338497|FG005|Overall Study|Pregnancy|0|||
94695620|NCT01513967|324338498|FG006|Overall Study|Pregnancy|1|||
94695621|NCT01513967|324338499|FG007|Overall Study|Pregnancy|0|||
94695622|NCT01513967|324338492|FG000|Overall Study|missed a study visit|0|||
94695623|NCT01513967|324338493|FG001|Overall Study|missed a study visit|0|||
94695624|NCT01513967|324338494|FG002|Overall Study|missed a study visit|0|||
94695625|NCT01513967|324338495|FG003|Overall Study|missed a study visit|0|||
94695626|NCT01513967|324338496|FG004|Overall Study|missed a study visit|0|||
94695627|NCT01513967|324338497|FG005|Overall Study|missed a study visit|0|||
94695628|NCT01513967|324338498|FG006|Overall Study|missed a study visit|1|||
94695629|NCT01513967|324338499|FG007|Overall Study|missed a study visit|0|||
94695630|NCT01513967|324338492|FG000|Overall Study|excluded due to positive drug screen|0|||
94695631|NCT01513967|324338493|FG001|Overall Study|excluded due to positive drug screen|0|||
94695632|NCT01513967|324338494|FG002|Overall Study|excluded due to positive drug screen|0|||
94695633|NCT01513967|324338495|FG003|Overall Study|excluded due to positive drug screen|0|||
94695634|NCT01513967|324338496|FG004|Overall Study|excluded due to positive drug screen|0|||
94695635|NCT01513967|324338497|FG005|Overall Study|excluded due to positive drug screen|0|||
94695636|NCT01513967|324338498|FG006|Overall Study|excluded due to positive drug screen|0|||
94695637|NCT01513967|324338499|FG007|Overall Study|excluded due to positive drug screen|2|||
94695638|NCT01513967|324338492|FG000|Overall Study|Physician Decision|0|||
94695639|NCT01513967|324338493|FG001|Overall Study|Physician Decision|0|||
94695640|NCT01513967|324338494|FG002|Overall Study|Physician Decision|0|||
94695641|NCT01513967|324338495|FG003|Overall Study|Physician Decision|0|||
94695642|NCT01513967|324338496|FG004|Overall Study|Physician Decision|0|||
94695643|NCT01513967|324338497|FG005|Overall Study|Physician Decision|1|||
94695644|NCT01513967|324338498|FG006|Overall Study|Physician Decision|0|||
94695645|NCT01513967|324338499|FG007|Overall Study|Physician Decision|0|||
94695646|NCT02711826|324338500|FG000|Overall Study|Physician Decision|0|||
94695647|NCT02711826|324338501|FG001|Overall Study|Physician Decision|0|||
94695648|NCT02711826|324338502|FG002|Overall Study|Physician Decision|0|||
94695649|NCT02711826|324338503|FG003|Overall Study|Physician Decision|1|||
94695650|NCT02711826|324338504|FG004|Overall Study|Physician Decision|0|||
94695651|NCT02711826|324338500|FG000|Overall Study|Withdrawal by Subject|0|||
94695652|NCT02711826|324338501|FG001|Overall Study|Withdrawal by Subject|1|||
94695653|NCT02711826|324338502|FG002|Overall Study|Withdrawal by Subject|0|||
94695654|NCT02711826|324338503|FG003|Overall Study|Withdrawal by Subject|4|||
94695655|NCT02711826|324338504|FG004|Overall Study|Withdrawal by Subject|0|||
94695656|NCT02711826|324338500|FG000|Overall Study|Failure to manufacture cellular product|0|||
94695657|NCT02711826|324338501|FG001|Overall Study|Failure to manufacture cellular product|0|||
94695658|NCT02711826|324338502|FG002|Overall Study|Failure to manufacture cellular product|5|||
94695659|NCT02711826|324338503|FG003|Overall Study|Failure to manufacture cellular product|0|||
94695660|NCT02711826|324338504|FG004|Overall Study|Failure to manufacture cellular product|0|||
94695661|NCT02711826|324338500|FG000|Overall Study|Infusion canceled for active infection|0|||
94695662|NCT02711826|324338501|FG001|Overall Study|Infusion canceled for active infection|1|||
94695663|NCT02711826|324338502|FG002|Overall Study|Infusion canceled for active infection|0|||
94695664|NCT02711826|324338503|FG003|Overall Study|Infusion canceled for active infection|0|||
94695665|NCT02711826|324338504|FG004|Overall Study|Infusion canceled for active infection|0|||
94695666|NCT02711826|324338500|FG000|Overall Study|Screen failures|0|||
94695667|NCT02711826|324338501|FG001|Overall Study|Screen failures|0|||
94695668|NCT02711826|324338502|FG002|Overall Study|Screen failures|0|||
94695669|NCT02711826|324338503|FG003|Overall Study|Screen failures|4|||
94695670|NCT02711826|324338504|FG004|Overall Study|Screen failures|0|||
94695671|NCT01007552|324338505|FG000|Overall Study|Withdrawal by Subject|1|||
94695672|NCT02169830|324340017|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
94695673|NCT02169830|324340018|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
94695674|NCT02169830|324340019|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
94695675|NCT02169830|324340017|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
94695676|NCT02169830|324340018|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
94695677|NCT02169830|324340019|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
94695678|NCT02169830|324340017|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
94695679|NCT02169830|324340018|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
94695680|NCT02169830|324340019|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
94695681|NCT02169830|324340017|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
94695682|NCT02169830|324340018|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
94695683|NCT02169830|324340019|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
94695684|NCT02169830|324340017|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
94695685|NCT02169830|324340018|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
94695686|NCT02169830|324340019|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
94695687|NCT00329719|324340020|FG000|Overall Study|Lost to Follow-up|0|||
94695688|NCT00329719|324340021|FG001|Overall Study|Lost to Follow-up|0|||
94695689|NCT00329719|324340022|FG002|Overall Study|Lost to Follow-up|0|||
94366070|NCT01458132|323126433|FG001|Overall Study|Other|3|||
94366071|NCT00833976|323126435|FG000|Overall Study|Withdrawal by Subject|5|||
94695690|NCT00329719|324340023|FG003|Overall Study|Lost to Follow-up|1|||
94695691|NCT02711995|324340024|FG000|Washout (90 Days)|Conflicting medication|1|||
94695692|NCT03673098|324340025|FG000|Overall Study|Lost to Follow-up|2|||
94695693|NCT03673098|324340026|FG001|Overall Study|Lost to Follow-up|3|||
94695694|NCT03673098|324340025|FG000|Overall Study|Withdrawal by Subject|6|||
94695695|NCT03673098|324340026|FG001|Overall Study|Withdrawal by Subject|1|||
94695696|NCT03673098|324340025|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
94695697|NCT03673098|324340026|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
94695698|NCT03850444|324340032|FG000|Overall Study|Adverse Event|16|||
94695699|NCT03850444|324340033|FG001|Overall Study|Adverse Event|10|||
94695700|NCT03850444|324340032|FG000|Overall Study|Death|87|||
94695701|NCT03850444|324340033|FG001|Overall Study|Death|107|||
94695702|NCT03850444|324340032|FG000|Overall Study|Lost to Follow-up|1|||
94695703|NCT03850444|324340033|FG001|Overall Study|Lost to Follow-up|1|||
94695704|NCT03850444|324340032|FG000|Overall Study|Withdrawal by Subject|1|||
94695705|NCT03850444|324340033|FG001|Overall Study|Withdrawal by Subject|5|||
94695706|NCT03850444|324340032|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
94695707|NCT03850444|324340033|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
94695708|NCT02123966|324340034|FG000|Overall Study|Intercurrent Illness|1|||
94695709|NCT01536262|324340035|FG000|Overall Study|Adverse Event|6|||
94695710|NCT01536262|324340036|FG001|Overall Study|Adverse Event|1|||
94695711|NCT01536262|324340037|FG002|Overall Study|Adverse Event|2|||
94695712|NCT01536262|324340035|FG000|Overall Study|Withdrawal by Subject|1|||
94695713|NCT01536262|324340036|FG001|Overall Study|Withdrawal by Subject|1|||
94695714|NCT01536262|324340037|FG002|Overall Study|Withdrawal by Subject|0|||
94695715|NCT01536262|324340035|FG000|Overall Study|Other than stated above|1|||
94695716|NCT01536262|324340036|FG001|Overall Study|Other than stated above|0|||
94695717|NCT01536262|324340037|FG002|Overall Study|Other than stated above|0|||
94695718|NCT01781611|324340039|FG000|Overall Study|Adverse Event|4|||
94695719|NCT01781611|324340040|FG001|Overall Study|Adverse Event|0|||
94695720|NCT01333943|324340041|FG000|Overall Study|Known neuropathy|1|||
94695721|NCT01333943|324340042|FG001|Overall Study|Known neuropathy|0|||
94695722|NCT00262743|324340043|FG000|Overall Study|Adverse Event|0|||
94695723|NCT00262743|324340044|FG001|Overall Study|Adverse Event|9|||
94695724|NCT00262743|324340043|FG000|Overall Study|Disease progression|0|||
94695725|NCT00262743|324340044|FG001|Overall Study|Disease progression|3|||
94695726|NCT01244763|324340046|FG000|Overall Study|Adverse Event|1|||
94695727|NCT01244763|324340047|FG001|Overall Study|Adverse Event|0|||
94695728|NCT01244763|324340048|FG002|Overall Study|Adverse Event|0|||
94695729|NCT01244763|324340049|FG003|Overall Study|Adverse Event|0|||
94695730|NCT01244763|324340050|FG004|Overall Study|Adverse Event|0|||
94695731|NCT01244763|324340051|FG005|Overall Study|Adverse Event|1|||
94695732|NCT01244763|324340046|FG000|Overall Study|Death|1|||
94695733|NCT01244763|324340047|FG001|Overall Study|Death|0|||
94695734|NCT01244763|324340048|FG002|Overall Study|Death|1|||
94695735|NCT01244763|324340049|FG003|Overall Study|Death|0|||
94695736|NCT01244763|324340050|FG004|Overall Study|Death|2|||
94695737|NCT01244763|324340051|FG005|Overall Study|Death|0|||
94695738|NCT01244763|324340046|FG000|Overall Study|Physician Decision|0|||
94695739|NCT01244763|324340047|FG001|Overall Study|Physician Decision|0|||
94695740|NCT01244763|324340048|FG002|Overall Study|Physician Decision|1|||
94695741|NCT01244763|324340049|FG003|Overall Study|Physician Decision|0|||
94695742|NCT01244763|324340050|FG004|Overall Study|Physician Decision|0|||
94695743|NCT01244763|324340051|FG005|Overall Study|Physician Decision|0|||
94695744|NCT01244763|324340046|FG000|Overall Study|Withdrawal by Subject|1|||
94695745|NCT01244763|324340047|FG001|Overall Study|Withdrawal by Subject|2|||
94695746|NCT01244763|324340048|FG002|Overall Study|Withdrawal by Subject|0|||
94695747|NCT01244763|324340049|FG003|Overall Study|Withdrawal by Subject|1|||
94695748|NCT01244763|324340050|FG004|Overall Study|Withdrawal by Subject|1|||
94695749|NCT01244763|324340051|FG005|Overall Study|Withdrawal by Subject|2|||
94695750|NCT01244763|324340046|FG000|Overall Study|Lost to Follow-up|0|||
94695751|NCT01244763|324340047|FG001|Overall Study|Lost to Follow-up|1|||
94695752|NCT01244763|324340048|FG002|Overall Study|Lost to Follow-up|0|||
94366072|NCT00833976|323126435|FG000|Overall Study|Lost to Follow-up|4|||
94366073|NCT00833976|323126435|FG000|Overall Study|Did not meet eligibility criteria|41|||
94366074|NCT00833976|323126435|FG000|Overall Study|Physician Decision|1|||
94695753|NCT01244763|324340049|FG003|Overall Study|Lost to Follow-up|0|||
94695754|NCT01244763|324340050|FG004|Overall Study|Lost to Follow-up|0|||
94695755|NCT01244763|324340051|FG005|Overall Study|Lost to Follow-up|0|||
94695756|NCT01244763|324340046|FG000|Overall Study|Enrolled into the Extension Study|0|||
94695757|NCT01244763|324340047|FG001|Overall Study|Enrolled into the Extension Study|0|||
94695758|NCT01244763|324340048|FG002|Overall Study|Enrolled into the Extension Study|0|||
94695759|NCT01244763|324340049|FG003|Overall Study|Enrolled into the Extension Study|0|||
94695760|NCT01244763|324340050|FG004|Overall Study|Enrolled into the Extension Study|0|||
94695761|NCT01244763|324340051|FG005|Overall Study|Enrolled into the Extension Study|1|||
94695762|NCT02264574|324340052|FG000|Overall Study|Death|21|||
94695763|NCT02264574|324340053|FG001|Overall Study|Death|21|||
94695764|NCT02264574|324340052|FG000|Overall Study|Withdrawal by Subject|8|||
94695765|NCT02264574|324340053|FG001|Overall Study|Withdrawal by Subject|6|||
94695766|NCT02264574|324340052|FG000|Overall Study|Other, Not Specified|0|||
94695767|NCT02264574|324340053|FG001|Overall Study|Other, Not Specified|3|||
94695768|NCT03330119|324340058|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
94695769|NCT03330119|324340059|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
94695770|NCT00664521|324340060|FG000|Overall Study|Adverse Event|4|||
94695771|NCT00664521|324340061|FG001|Overall Study|Adverse Event|1|||
94695772|NCT00664521|324340060|FG000|Overall Study|Lost to Follow-up|1|||
94695773|NCT00664521|324340061|FG001|Overall Study|Lost to Follow-up|0|||
94695774|NCT00664521|324340060|FG000|Overall Study|Other|1|||
94695775|NCT00664521|324340061|FG001|Overall Study|Other|0|||
94695776|NCT01403987|324340062|FG000|Overall Study|Residents forgot their secret PIN|18|||
94695777|NCT01403987|324340063|FG001|Overall Study|Residents forgot their secret PIN|17|||
94695778|NCT01403987|324340064|FG002|Overall Study|Residents forgot their secret PIN|18|||
94695779|NCT00278564|324340071|FG000|Overall Study|Lack of Efficacy|4|||
94695780|NCT02886728|324340072|FG000|Overall Study|Withdrew Consent|31|||
94695781|NCT02886728|324340073|FG001|Overall Study|Withdrew Consent|13|||
94695782|NCT02886728|324340074|FG002|Overall Study|Withdrew Consent|11|||
94695783|NCT02886728|324340075|FG003|Overall Study|Withdrew Consent|47|||
94695784|NCT02886728|324340072|FG000|Overall Study|Lost to Follow-up|12|||
94695785|NCT02886728|324340073|FG001|Overall Study|Lost to Follow-up|6|||
94695786|NCT02886728|324340074|FG002|Overall Study|Lost to Follow-up|13|||
94695787|NCT02886728|324340075|FG003|Overall Study|Lost to Follow-up|12|||
94695788|NCT02886728|324340072|FG000|Overall Study|Adverse Event|13|||
94695789|NCT02886728|324340073|FG001|Overall Study|Adverse Event|5|||
94695790|NCT02886728|324340074|FG002|Overall Study|Adverse Event|5|||
94695791|NCT02886728|324340075|FG003|Overall Study|Adverse Event|11|||
94695792|NCT02886728|324340072|FG000|Overall Study|Investigator's Discretion|11|||
94695793|NCT02886728|324340073|FG001|Overall Study|Investigator's Discretion|7|||
94695794|NCT02886728|324340074|FG002|Overall Study|Investigator's Discretion|5|||
94695795|NCT02886728|324340075|FG003|Overall Study|Investigator's Discretion|11|||
94695796|NCT02886728|324340072|FG000|Overall Study|Death|3|||
94366075|NCT01325701|323126438|FG000|Overall Study|Adverse Event|12|||
94695797|NCT02886728|324340073|FG001|Overall Study|Death|1|||
94695798|NCT02886728|324340074|FG002|Overall Study|Death|0|||
94695799|NCT02886728|324340075|FG003|Overall Study|Death|0|||
94695800|NCT02886728|324340072|FG000|Overall Study|Protocol Violation|0|||
94695801|NCT02886728|324340073|FG001|Overall Study|Protocol Violation|0|||
94695802|NCT02886728|324340074|FG002|Overall Study|Protocol Violation|0|||
94695803|NCT02886728|324340075|FG003|Overall Study|Protocol Violation|4|||
94695804|NCT02886728|324340072|FG000|Overall Study|Non-Compliance with Study Drug|1|||
94695805|NCT02886728|324340073|FG001|Overall Study|Non-Compliance with Study Drug|0|||
94366076|NCT01325701|323126439|FG001|Overall Study|Adverse Event|0|||
94366077|NCT01325701|323126438|FG000|Overall Study|Protocol Violation|1|||
94695806|NCT02886728|324340074|FG002|Overall Study|Non-Compliance with Study Drug|1|||
94695807|NCT02886728|324340075|FG003|Overall Study|Non-Compliance with Study Drug|0|||
94695808|NCT02886728|324340072|FG000|Overall Study|Pregnancy|0|||
94695809|NCT02886728|324340073|FG001|Overall Study|Pregnancy|0|||
94695810|NCT02886728|324340074|FG002|Overall Study|Pregnancy|1|||
94695811|NCT02886728|324340075|FG003|Overall Study|Pregnancy|0|||
94695812|NCT02886728|324340072|FG000|Overall Study|Randomized but Not Dosed|1|||
94695813|NCT02886728|324340073|FG001|Overall Study|Randomized but Not Dosed|0|||
94695814|NCT02886728|324340074|FG002|Overall Study|Randomized but Not Dosed|0|||
94695815|NCT02886728|324340075|FG003|Overall Study|Randomized but Not Dosed|2|||
94695816|NCT04004208|324340080|FG000|Overall Study|Withdrawal by parent/guardian|1|||
94695817|NCT04004208|324340081|FG001|Overall Study|Withdrawal by parent/guardian|1|||
94695818|NCT04004208|324340080|FG000|Overall Study|Death|3|||
94695819|NCT04004208|324340081|FG001|Overall Study|Death|0|||
94695820|NCT04004208|324340080|FG000|Overall Study|COVID-19 pandemic|1|||
94695821|NCT04004208|324340081|FG001|Overall Study|COVID-19 pandemic|0|||
94695822|NCT04004208|324340080|FG000|Overall Study|Physician Decision|1|||
94695823|NCT04004208|324340081|FG001|Overall Study|Physician Decision|0|||
94695824|NCT04004208|324340080|FG000|Overall Study|Adverse Event|1|||
94695825|NCT04004208|324340081|FG001|Overall Study|Adverse Event|1|||
94695826|NCT01458249|324340082|FG000|Overall Study|Not treated|1|||
94695827|NCT01458249|324340082|FG000|Overall Study|Adverse Event|4|||
94695828|NCT01458249|324340082|FG000|Overall Study|Other|2|||
94695829|NCT01458249|324340082|FG000|Overall Study|Ongoing|1|||
94695830|NCT04990440|324340083|FG000|Overall Study|Sponsor's Decision|0|||
94695831|NCT04990440|324340084|FG001|Overall Study|Sponsor's Decision|0|||
94695832|NCT04990440|324340085|FG002|Overall Study|Sponsor's Decision|1|||
94695833|NCT02724020|324340088|FG000|Overall Study|Death|16|||
94695834|NCT02724020|324340089|FG001|Overall Study|Death|18|||
94695835|NCT02724020|324340090|FG002|Overall Study|Death|19|||
94695836|NCT02724020|324340088|FG000|Overall Study|Lost to Follow-up|0|||
94695837|NCT02724020|324340089|FG001|Overall Study|Lost to Follow-up|3|||
94695838|NCT02724020|324340090|FG002|Overall Study|Lost to Follow-up|0|||
94695839|NCT02724020|324340088|FG000|Overall Study|Site Terminated by Sponsor|15|||
94695840|NCT02724020|324340089|FG001|Overall Study|Site Terminated by Sponsor|8|||
94695841|NCT02724020|324340090|FG002|Overall Study|Site Terminated by Sponsor|8|||
94695842|NCT02724020|324340088|FG000|Overall Study|Withdrawal by Subject|1|||
94695843|NCT02724020|324340089|FG001|Overall Study|Withdrawal by Subject|3|||
94695844|NCT02724020|324340090|FG002|Overall Study|Withdrawal by Subject|5|||
94695845|NCT01686932|324340091|FG000|Period 1|Adverse Event|1|||
94695846|NCT01686932|324340092|FG001|Period 1|Adverse Event|1|||
94695847|NCT00570661|324340093|FG000|Overall Study|Disease worsening|5|||
94695848|NCT00570661|324340093|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
94695849|NCT00570661|324340093|FG000|Overall Study|Adverse Event|1|||
94695850|NCT01628874|324340094|FG000|Overall Study|Physician Decision|1|||
94695851|NCT01628874|324340095|FG001|Overall Study|Physician Decision|1|||
94695852|NCT01628874|324340094|FG000|Overall Study|Age >4 months|4|||
94695853|NCT01628874|324340095|FG001|Overall Study|Age >4 months|2|||
94695854|NCT01052662|324340098|FG000|Overall Study|Lost to Follow-up|15|||
94695855|NCT01052662|324340099|FG001|Overall Study|Lost to Follow-up|13|||
94695856|NCT01052662|324340100|FG002|Overall Study|Lost to Follow-up|18|||
94695857|NCT01052662|324340098|FG000|Overall Study|Withdrawal by Subject|3|||
94695858|NCT01052662|324340099|FG001|Overall Study|Withdrawal by Subject|2|||
94695859|NCT01052662|324340100|FG002|Overall Study|Withdrawal by Subject|1|||
94695860|NCT01052662|324340098|FG000|Overall Study|Pharmacy issue|1|||
94695861|NCT01052662|324340099|FG001|Overall Study|Pharmacy issue|3|||
94695862|NCT01052662|324340100|FG002|Overall Study|Pharmacy issue|3|||
94695863|NCT01052662|324340098|FG000|Overall Study|Adverse Event|1|||
94695864|NCT01052662|324340099|FG001|Overall Study|Adverse Event|1|||
94695865|NCT01052662|324340100|FG002|Overall Study|Adverse Event|0|||
94695866|NCT01052662|324340098|FG000|Overall Study|Legal Problem|2|||
94695867|NCT01052662|324340099|FG001|Overall Study|Legal Problem|0|||
94695868|NCT01052662|324340100|FG002|Overall Study|Legal Problem|0|||
94695869|NCT01052662|324340098|FG000|Overall Study|Administrative|0|||
94695870|NCT01052662|324340099|FG001|Overall Study|Administrative|3|||
94695871|NCT01052662|324340100|FG002|Overall Study|Administrative|0|||
94695872|NCT03523871|324340101|FG000|Overall Study|Death|1|||
94695873|NCT01113463|324340102|FG000|Overall Study|Physician Decision|5|||
94695874|NCT00146640|324340103|FG000|Overall Study|Adverse Event|12|||
94695875|NCT00146640|324340104|FG001|Overall Study|Adverse Event|10|||
94695876|NCT00146640|324340103|FG000|Overall Study|Medical Reasons|3|||
94695877|NCT00146640|324340104|FG001|Overall Study|Medical Reasons|0|||
94695878|NCT00146640|324340103|FG000|Overall Study|Non-Medical Reasons|8|||
94695879|NCT00146640|324340104|FG001|Overall Study|Non-Medical Reasons|4|||
94695880|NCT01603121|324340107|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
94695881|NCT01603121|324340108|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
94695882|NCT00577720|324340109|FG000|Overall Study|Adverse Event|2|||
94695883|NCT00577720|324340110|FG001|Overall Study|Adverse Event|1|||
94695884|NCT00577720|324340111|FG002|Overall Study|Adverse Event|0|||
94695885|NCT00577720|324340112|FG003|Overall Study|Adverse Event|4|||
94264477|NCT00726622|322763455|FG000|Overall Study|Withdrawal by Subject|16|||
94264478|NCT00726622|322763456|FG001|Overall Study|Withdrawal by Subject|2|||
94264479|NCT00726622|322763455|FG000|Overall Study|Physician Decision|0|||
94264480|NCT00726622|322763456|FG001|Overall Study|Physician Decision|1|||
94264481|NCT00726622|322763455|FG000|Overall Study|Metastasis|2|||
94264482|NCT00726622|322763456|FG001|Overall Study|Metastasis|0|||
94264483|NCT02462928|322763457|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
94264484|NCT02462928|322763458|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
94264485|NCT02462928|322763459|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
94264486|NCT02462928|322763457|FG000|Overall Study|Adverse Event|47|||
94264487|NCT02462928|322763458|FG001|Overall Study|Adverse Event|51|||
94264488|NCT02462928|322763459|FG002|Overall Study|Adverse Event|25|||
94264489|NCT02462928|322763457|FG000|Overall Study|Lack of Efficacy|3|||
94264490|NCT02462928|322763458|FG001|Overall Study|Lack of Efficacy|8|||
94264491|NCT02462928|322763459|FG002|Overall Study|Lack of Efficacy|3|||
94264492|NCT02462928|322763457|FG000|Overall Study|Lost to Follow-up|4|||
94264493|NCT02462928|322763458|FG001|Overall Study|Lost to Follow-up|4|||
94264494|NCT02462928|322763459|FG002|Overall Study|Lost to Follow-up|1|||
94264495|NCT02462928|322763457|FG000|Overall Study|Withdrawal by Patient|31|||
94264496|NCT02462928|322763458|FG001|Overall Study|Withdrawal by Patient|21|||
94264497|NCT02462928|322763459|FG002|Overall Study|Withdrawal by Patient|21|||
94264498|NCT02462928|322763457|FG000|Overall Study|Protocol Violation|0|||
94264499|NCT02462928|322763458|FG001|Overall Study|Protocol Violation|1|||
94264500|NCT02462928|322763459|FG002|Overall Study|Protocol Violation|0|||
94264501|NCT02462928|322763457|FG000|Overall Study|Reason not Specified|4|||
94264502|NCT02462928|322763458|FG001|Overall Study|Reason not Specified|6|||
94264503|NCT02462928|322763459|FG002|Overall Study|Reason not Specified|5|||
94264504|NCT01493557|322763460|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
94264505|NCT01493557|322763461|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
94264506|NCT01493557|322763462|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
94264507|NCT01493557|322763460|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
94264508|NCT01493557|322763461|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
94264509|NCT01493557|322763462|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
94264510|NCT01493557|322763460|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
94264511|NCT01493557|322763461|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
94264512|NCT01493557|322763462|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
94264513|NCT01493557|322763460|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
94264514|NCT01493557|322763461|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
94695886|NCT00577720|324340109|FG000|Overall Study|Lost to Follow-up|0|||
94695887|NCT00577720|324340110|FG001|Overall Study|Lost to Follow-up|0|||
94695888|NCT00577720|324340111|FG002|Overall Study|Lost to Follow-up|1|||
94695889|NCT00577720|324340112|FG003|Overall Study|Lost to Follow-up|0|||
94695890|NCT00577720|324340109|FG000|Overall Study|Protocol Violation|0|||
94695891|NCT00577720|324340110|FG001|Overall Study|Protocol Violation|0|||
94695892|NCT00577720|324340111|FG002|Overall Study|Protocol Violation|0|||
94695893|NCT00577720|324340112|FG003|Overall Study|Protocol Violation|1|||
94695894|NCT00577720|324340109|FG000|Overall Study|Withdrawal by Subject|2|||
94695895|NCT00577720|324340110|FG001|Overall Study|Withdrawal by Subject|0|||
94695896|NCT00577720|324340111|FG002|Overall Study|Withdrawal by Subject|0|||
94695897|NCT00577720|324340112|FG003|Overall Study|Withdrawal by Subject|2|||
94695898|NCT01449721|324340113|FG000|Overall Study|Physician Decision|0|||
94695899|NCT01449721|324340114|FG001|Overall Study|Physician Decision|1|||
94695900|NCT01449721|324340113|FG000|Overall Study|Physician Decision|0|||
94695901|NCT01449721|324340114|FG001|Overall Study|Physician Decision|1|||
94695902|NCT02148718|324340115|FG000|Overall Study|Protocol Violation|26|||
94264515|NCT01493557|322763462|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
94264516|NCT01493557|322763460|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
94264517|NCT01493557|322763461|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
94264518|NCT01493557|322763462|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
94264519|NCT01493557|322763460|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
94264520|NCT01493557|322763461|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
94264521|NCT01493557|322763462|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
94264522|NCT01493557|322763460|FG000|Not Randomized to Management Strategies|Early termination|0|||
94264523|NCT01493557|322763461|FG001|Not Randomized to Management Strategies|Early termination|0|||
94264524|NCT01493557|322763462|FG002|Not Randomized to Management Strategies|Early termination|34|||
94264525|NCT01493557|322763460|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
94264526|NCT01493557|322763461|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
94264527|NCT01493557|322763462|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
94264528|NCT01493557|322763460|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
94264529|NCT01493557|322763461|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
94264530|NCT01493557|322763462|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
94264531|NCT01493557|322763460|FG000|Randomized to Management Strategies|Other adverse event|8|||
94264532|NCT01493557|322763461|FG001|Randomized to Management Strategies|Other adverse event|5|||
94264533|NCT01493557|322763462|FG002|Randomized to Management Strategies|Other adverse event|0|||
94264534|NCT01493557|322763460|FG000|Randomized to Management Strategies|Protocol Violation|3|||
94264535|NCT01493557|322763461|FG001|Randomized to Management Strategies|Protocol Violation|0|||
94264536|NCT01493557|322763462|FG002|Randomized to Management Strategies|Protocol Violation|0|||
94264537|NCT01493557|322763460|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
94264538|NCT01493557|322763461|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
94264539|NCT01493557|322763462|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
94264540|NCT01493557|322763460|FG000|Randomized to Management Strategies|Other than stated above|1|||
94264541|NCT01493557|322763461|FG001|Randomized to Management Strategies|Other than stated above|3|||
94264542|NCT01493557|322763462|FG002|Randomized to Management Strategies|Other than stated above|0|||
94264543|NCT01493557|322763460|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
94264544|NCT01493557|322763461|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
94264545|NCT01493557|322763462|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
94264546|NCT01493557|322763460|FG000|Adding the Second Strategy|Other adverse event|1|||
94264547|NCT01493557|322763461|FG001|Adding the Second Strategy|Other adverse event|2|||
94264548|NCT01493557|322763462|FG002|Adding the Second Strategy|Other adverse event|0|||
94264549|NCT01493557|322763460|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
94264550|NCT01493557|322763461|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
94264551|NCT01493557|322763462|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
94264552|NCT03872453|322763465|FG000|Overall Study|Adverse Event|1|||
94264553|NCT03872453|322763466|FG001|Overall Study|Adverse Event|1|||
94264554|NCT03872453|322763467|FG002|Overall Study|Adverse Event|0|||
94264555|NCT03872453|322763468|FG003|Overall Study|Adverse Event|0|||
94264556|NCT03872453|322763465|FG000|Overall Study|Lost to Follow-up|8|||
94264557|NCT03872453|322763466|FG001|Overall Study|Lost to Follow-up|7|||
94264558|NCT03872453|322763467|FG002|Overall Study|Lost to Follow-up|4|||
94264559|NCT03872453|322763468|FG003|Overall Study|Lost to Follow-up|4|||
94264560|NCT03872453|322763465|FG000|Overall Study|Never Treated Migraine|19|||
94264561|NCT03872453|322763466|FG001|Overall Study|Never Treated Migraine|17|||
94264562|NCT03872453|322763467|FG002|Overall Study|Never Treated Migraine|13|||
94264563|NCT03872453|322763468|FG003|Overall Study|Never Treated Migraine|12|||
94264564|NCT03872453|322763465|FG000|Overall Study|Pregnancy|1|||
94264565|NCT03872453|322763466|FG001|Overall Study|Pregnancy|0|||
94264566|NCT03872453|322763467|FG002|Overall Study|Pregnancy|0|||
94264567|NCT03872453|322763468|FG003|Overall Study|Pregnancy|0|||
94264568|NCT03872453|322763465|FG000|Overall Study|Protocol Deviation|2|||
94264569|NCT03872453|322763466|FG001|Overall Study|Protocol Deviation|0|||
94264570|NCT03872453|322763467|FG002|Overall Study|Protocol Deviation|0|||
94264571|NCT03872453|322763468|FG003|Overall Study|Protocol Deviation|2|||
94264572|NCT03872453|322763465|FG000|Overall Study|Withdrawal by Subject|0|||
94264573|NCT03872453|322763466|FG001|Overall Study|Withdrawal by Subject|1|||
94264574|NCT03872453|322763467|FG002|Overall Study|Withdrawal by Subject|2|||
94264575|NCT03872453|322763468|FG003|Overall Study|Withdrawal by Subject|0|||
94264576|NCT03872453|322763465|FG000|Overall Study|Other Than Specified|1|||
94264577|NCT03872453|322763466|FG001|Overall Study|Other Than Specified|0|||
94264578|NCT03872453|322763467|FG002|Overall Study|Other Than Specified|0|||
94264579|NCT03872453|322763468|FG003|Overall Study|Other Than Specified|0|||
94366078|NCT01325701|323126439|FG001|Overall Study|Protocol Violation|0|||
94695903|NCT02148718|324340115|FG000|Overall Study|Discontinued Study Prematurely|5|||
94695904|NCT04793464|324340116|FG000|Overall Study|Lost to Follow-up|458|||
94695905|NCT04793464|324340117|FG001|Overall Study|Lost to Follow-up|168|||
94695906|NCT04793464|324340118|FG002|Overall Study|Lost to Follow-up|5|||
94695907|NCT04793464|324340116|FG000|Overall Study|Withdrawal by Subject|43|||
94695908|NCT04793464|324340117|FG001|Overall Study|Withdrawal by Subject|15|||
94695909|NCT04793464|324340118|FG002|Overall Study|Withdrawal by Subject|0|||
94695910|NCT02234310|324340120|FG000|Overall Study|Physician Decision|1|||
94695911|NCT02234310|324340120|FG000|Overall Study|Adverse Event|1|||
94695912|NCT02234310|324340120|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
94695913|NCT02234310|324340120|FG000|Overall Study|Withdrawal by Subject|2|||
94695914|NCT03289455|324340122|FG000|Overall Study|Death|1|||
94695915|NCT03289455|324340123|FG001|Overall Study|Death|0|||
94695916|NCT03289455|324340124|FG002|Overall Study|Death|0|||
94695917|NCT03289455|324340122|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
94695918|NCT03289455|324340123|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
94695919|NCT03289455|324340124|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
94695920|NCT03289455|324340122|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
94695921|NCT03289455|324340123|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
94695922|NCT03289455|324340124|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
94695923|NCT03289455|324340122|FG000|Overall Study|Progressive disease|3|||
94695924|NCT03289455|324340123|FG001|Overall Study|Progressive disease|4|||
94695925|NCT03289455|324340124|FG002|Overall Study|Progressive disease|5|||
94695926|NCT02956967|324340126|FG000|Overall Study|Adverse Event|3|||
94695927|NCT02956967|324340126|FG000|Overall Study|Reason non-related to neutropenia|10|||
94695928|NCT02956967|324340126|FG000|Overall Study|Lost to Follow-up|5|||
94695929|NCT02956967|324340126|FG000|Overall Study|Missing|1|||
94695930|NCT02956967|324340126|FG000|Overall Study|Termination of Nivestim administration|29|||
94366079|NCT01325701|323126438|FG000|Overall Study|Physician Decision|2|||
94366080|NCT01325701|323126439|FG001|Overall Study|Physician Decision|2|||
94366081|NCT01325701|323126438|FG000|Overall Study|Withdrawal by Subject|2|||
94366082|NCT01325701|323126439|FG001|Overall Study|Withdrawal by Subject|1|||
94366083|NCT01325701|323126438|FG000|Overall Study|Rollerover Extension Study|4|||
94366084|NCT01325701|323126439|FG001|Overall Study|Rollerover Extension Study|0|||
94695931|NCT05114590|324340134|FG000|Overall Study|Adverse Event|1|||
94695932|NCT05114590|324340134|FG000|Overall Study|Investigator decision|1|||
94695933|NCT05114590|324340134|FG000|Overall Study|Lost to Follow-up|5|||
94366085|NCT02962739|323126441|FG000|Overall Study|Withdrawal by Subject|0|||
94366086|NCT02962739|323126442|FG001|Overall Study|Withdrawal by Subject|1|||
94695934|NCT05114590|324340134|FG000|Overall Study|Withdrawal by Subject|5|||
94695935|NCT05114590|324340134|FG000|Overall Study|Other|2|||
94366087|NCT02962739|323126443|FG002|Overall Study|Withdrawal by Subject|0|||
94366088|NCT02962739|323126444|FG003|Overall Study|Withdrawal by Subject|0|||
94366089|NCT02962739|323126445|FG004|Overall Study|Withdrawal by Subject|0|||
94366090|NCT02962739|323126446|FG005|Overall Study|Withdrawal by Subject|0|||
94366091|NCT02962739|323126441|FG000|Overall Study|Protocol Violation|0|||
94366092|NCT02962739|323126442|FG001|Overall Study|Protocol Violation|0|||
94366093|NCT02962739|323126443|FG002|Overall Study|Protocol Violation|1|||
94366094|NCT02962739|323126444|FG003|Overall Study|Protocol Violation|0|||
94366095|NCT02962739|323126445|FG004|Overall Study|Protocol Violation|1|||
94366096|NCT02962739|323126446|FG005|Overall Study|Protocol Violation|0|||
94366097|NCT00734617|323126447|FG000|Overall Study|Adverse Event|4|||
94366098|NCT00734617|323126448|FG001|Overall Study|Adverse Event|7|||
94366099|NCT00734617|323126447|FG000|Overall Study|Withdrawal by Subject|103|||
94366100|NCT00734617|323126448|FG001|Overall Study|Withdrawal by Subject|95|||
94366101|NCT00552617|323126449|FG000|Overall Study|Not Treated|0|||
94695936|NCT02753530|324340135|FG000|Overall Study|Adverse Event|7|||
94366102|NCT00552617|323126450|FG001|Overall Study|Not Treated|0|||
94366103|NCT00552617|323126451|FG002|Overall Study|Not Treated|1|||
94366104|NCT00552617|323126452|FG003|Overall Study|Not Treated|0|||
94366105|NCT00552617|323126453|FG004|Overall Study|Not Treated|0|||
94366106|NCT00552617|323126454|FG005|Overall Study|Not Treated|0|||
94695937|NCT02753530|324340136|FG001|Overall Study|Adverse Event|1|||
94695938|NCT02753530|324340135|FG000|Overall Study|Death|0|||
94695939|NCT02753530|324340136|FG001|Overall Study|Death|1|||
94695940|NCT02753530|324340135|FG000|Overall Study|Physician Decision|0|||
94695941|NCT02753530|324340136|FG001|Overall Study|Physician Decision|1|||
94695942|NCT02753530|324340135|FG000|Overall Study|Protocol Violation|1|||
94695943|NCT02753530|324340136|FG001|Overall Study|Protocol Violation|0|||
94695944|NCT02753530|324340135|FG000|Overall Study|Withdrawal by Subject|4|||
94695945|NCT02753530|324340136|FG001|Overall Study|Withdrawal by Subject|3|||
94695946|NCT03590743|324340137|FG000|Overall Study|Withdrawal by Subject|0|||
94695947|NCT03590743|324340138|FG001|Overall Study|Withdrawal by Subject|1|||
94695948|NCT00604786|324340139|FG000|Overall Study|Lost to Follow-up|2|||
94695949|NCT00604786|324340140|FG001|Overall Study|Lost to Follow-up|0|||
94695950|NCT01641861|324340148|FG000|Overall Study|Lost to Follow-up|21|||
94695951|NCT01641861|324340149|FG001|Overall Study|Lost to Follow-up|16|||
94695952|NCT01641861|324340148|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
94695953|NCT01641861|324340149|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
94695954|NCT01641861|324340148|FG000|Overall Study|Died due to drowning|0|||
94695955|NCT01641861|324340149|FG001|Overall Study|Died due to drowning|1|||
94695956|NCT01556243|324340150|FG000|Overall Study|Ineligible|34|||
94695957|NCT01556243|324340150|FG000|Overall Study|Converted to mastectomy|14|||
94695958|NCT01556243|324340150|FG000|Overall Study|Unable to achieve negative margins|2|||
94695959|NCT01556243|324340150|FG000|Overall Study|Withdrawal by Subject|16|||
94695960|NCT01388543|324340151|FG000|Day 14|Adverse Event|1|||
94695961|NCT01388543|324340152|FG001|Day 14|Adverse Event|4|||
94695962|NCT00701311|324340153|FG000|Overall Study|Lack of Efficacy|3|||
94695963|NCT00701311|324340153|FG000|Overall Study|Adverse Event|3|||
94695964|NCT00701311|324340153|FG000|Overall Study|Withdrawal by Subject|2|||
94695965|NCT00901485|324340154|FG000|Overall Study|Lack of Efficacy|0|||
94695966|NCT00901485|324340155|FG001|Overall Study|Lack of Efficacy|2|||
94695967|NCT00901485|324340154|FG000|Overall Study|Withdrawal by Subject|1|||
94695968|NCT00901485|324340155|FG001|Overall Study|Withdrawal by Subject|2|||
94695969|NCT01852162|324341661|FG000|Overall Study|Adverse Event|1|||
94695970|NCT01852162|324341662|FG001|Overall Study|Adverse Event|0|||
94695971|NCT01852162|324341661|FG000|Overall Study|Withdrawal by Subject|3|||
94695972|NCT01852162|324341662|FG001|Overall Study|Withdrawal by Subject|1|||
94695973|NCT00590980|324341665|FG000|Overall Study|Did not meet all inclusion criteria|10|||
94695974|NCT04096365|324341666|FG000|Overall Study|Adverse Event|1|||
94695975|NCT01118962|324341668|FG000|Overall Study|Adverse Event|2|||
94695976|NCT01118962|324341668|FG000|Overall Study|Lack of Efficacy|1|||
94695977|NCT01118962|324341668|FG000|Overall Study|Protocol Violation|1|||
94695978|NCT01118962|324341668|FG000|Overall Study|Withdrawal by Subject|4|||
94695979|NCT01118962|324341668|FG000|Overall Study|Pregnancy|1|||
94695980|NCT01118962|324341668|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
94695981|NCT01036087|324341671|FG000|Overall Study|Adverse Event|2|||
94695982|NCT01036087|324341671|FG000|Overall Study|Lack of Efficacy|1|||
94695983|NCT05257837|324341674|FG000|Overall Study|Excluded (did not find the guns)|4|||
94695984|NCT05257837|324341675|FG001|Overall Study|Excluded (did not find the guns)|2|||
94695985|NCT05257837|324341676|FG002|Overall Study|Excluded (did not find the guns)|4|||
94695986|NCT05257837|324341677|FG003|Overall Study|Excluded (did not find the guns)|0|||
94695987|NCT00465361|324341678|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
94695988|NCT02373813|324341679|FG000|Run-In Period|Other, Not Specified|5|||
94695989|NCT02373813|324341680|FG001|Run-In Period|Other, Not Specified|0|||
94695990|NCT02373813|324341681|FG002|Run-In Period|Other, Not Specified|0|||
94695991|NCT02373813|324341682|FG003|Run-In Period|Other, Not Specified|0|||
94695992|NCT02373813|324341679|FG000|Run-In Period|Withdrawal by Subject|16|||
94695993|NCT02373813|324341680|FG001|Run-In Period|Withdrawal by Subject|0|||
94695994|NCT02373813|324341681|FG002|Run-In Period|Withdrawal by Subject|0|||
94695995|NCT02373813|324341682|FG003|Run-In Period|Withdrawal by Subject|0|||
94695996|NCT02373813|324341679|FG000|Run-In Period|Decision by Sponsor|11|||
94366107|NCT00552617|323126455|FG006|Overall Study|Not Treated|0|||
94695997|NCT02373813|324341680|FG001|Run-In Period|Decision by Sponsor|0|||
94695998|NCT02373813|324341681|FG002|Run-In Period|Decision by Sponsor|0|||
94695999|NCT02373813|324341682|FG003|Run-In Period|Decision by Sponsor|0|||
94696000|NCT02373813|324341679|FG000|Run-In Period|Protocol Violation|75|||
94696001|NCT02373813|324341680|FG001|Run-In Period|Protocol Violation|0|||
94696002|NCT02373813|324341681|FG002|Run-In Period|Protocol Violation|0|||
94366108|NCT00552617|323126456|FG007|Overall Study|Not Treated|0|||
94696003|NCT02373813|324341682|FG003|Run-In Period|Protocol Violation|0|||
94696004|NCT02373813|324341679|FG000|Run-In Period|Lost to Follow-up|2|||
94696005|NCT02373813|324341680|FG001|Run-In Period|Lost to Follow-up|0|||
94696006|NCT02373813|324341681|FG002|Run-In Period|Lost to Follow-up|0|||
94696007|NCT02373813|324341682|FG003|Run-In Period|Lost to Follow-up|0|||
94696008|NCT02373813|324341679|FG000|Run-In Period|Adverse Event|3|||
94696009|NCT02373813|324341680|FG001|Run-In Period|Adverse Event|0|||
94696010|NCT02373813|324341681|FG002|Run-In Period|Adverse Event|0|||
94696011|NCT02373813|324341682|FG003|Run-In Period|Adverse Event|0|||
94696012|NCT02373813|324341679|FG000|Run-In Period|Noncompliance|1|||
94264580|NCT00702845|322763470|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
94264581|NCT00702845|322763471|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
94264582|NCT00702845|322763470|FG000|Overall Study|Too high ovarian response|5|||
94264583|NCT00702845|322763471|FG001|Overall Study|Too high ovarian response|1|||
94264584|NCT00702845|322763470|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
94264585|NCT00702845|322763471|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
94264586|NCT00702845|322763470|FG000|Overall Study|Insufficient ovarian response|1|||
94264587|NCT00702845|322763471|FG001|Overall Study|Insufficient ovarian response|0|||
94264588|NCT00702845|322763470|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
94264589|NCT00702845|322763471|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
94264590|NCT00702845|322763470|FG000|Overall Study|No or abnormal fertilization|4|||
94264591|NCT00702845|322763471|FG001|Overall Study|No or abnormal fertilization|2|||
94264592|NCT00702845|322763470|FG000|Overall Study|Patient's decision|2|||
94264593|NCT00702845|322763471|FG001|Overall Study|Patient's decision|1|||
94264594|NCT00702845|322763470|FG000|Overall Study|Not randomized|0|||
94264595|NCT00702845|322763471|FG001|Overall Study|Not randomized|1|||
94264596|NCT02973425|322763472|FG000|Overall Study|Lost to Follow-up|49|||
94264597|NCT02973425|322763473|FG001|Overall Study|Lost to Follow-up|53|||
94264598|NCT01399190|322763474|FG000|Overall Study|Not Eligible for Final Analysis|5|||
94264599|NCT01399190|322763474|FG000|Overall Study|Adverse Event|8|||
94264600|NCT01399190|322763474|FG000|Overall Study|Participant's Request|5|||
94264601|NCT01399190|322763474|FG000|Overall Study|Physician Decision|2|||
94264602|NCT00059839|322763475|FG000|Overall Study|Death|1|||
94264603|NCT00059839|322763476|FG001|Overall Study|Death|1|||
94264604|NCT00059839|322763475|FG000|Overall Study|Lack of Efficacy|6|||
94264605|NCT00059839|322763476|FG001|Overall Study|Lack of Efficacy|5|||
94264606|NCT00059839|322763475|FG000|Overall Study|Lost to Follow-up|2|||
94264607|NCT00059839|322763476|FG001|Overall Study|Lost to Follow-up|0|||
94264608|NCT00059839|322763475|FG000|Overall Study|Physician Decision|1|||
94264609|NCT00059839|322763476|FG001|Overall Study|Physician Decision|2|||
94264610|NCT00059839|322763475|FG000|Overall Study|Withdrawal by Subject|1|||
94264611|NCT00059839|322763476|FG001|Overall Study|Withdrawal by Subject|6|||
94264612|NCT00059839|322763475|FG000|Overall Study|Ineligible|1|||
94264613|NCT00059839|322763476|FG001|Overall Study|Ineligible|3|||
94264614|NCT02596620|322763477|FG000|Overall Study|Lost to Follow-up|1|||
94264615|NCT02596620|322763478|FG001|Overall Study|Lost to Follow-up|1|||
94264616|NCT01054144|322763479|FG000|Overall Study|Death|2|||
94264617|NCT02616614|322763480|FG000|Overall Study|Withdrawal by Subject|10|||
94264618|NCT02616614|322763481|FG001|Overall Study|Withdrawal by Subject|5|||
94264619|NCT02616614|322763482|FG002|Overall Study|Withdrawal by Subject|6|||
94264620|NCT02616614|322763480|FG000|Overall Study|Physician Decision|2|||
94264621|NCT02616614|322763481|FG001|Overall Study|Physician Decision|1|||
94264622|NCT02616614|322763482|FG002|Overall Study|Physician Decision|0|||
94264623|NCT02616614|322763480|FG000|Overall Study|Adverse Event|1|||
94264624|NCT02616614|322763481|FG001|Overall Study|Adverse Event|4|||
94264625|NCT02616614|322763482|FG002|Overall Study|Adverse Event|1|||
94264626|NCT02616614|322763480|FG000|Overall Study|Protocol Violation|0|||
94264627|NCT02616614|322763481|FG001|Overall Study|Protocol Violation|3|||
94264628|NCT02616614|322763482|FG002|Overall Study|Protocol Violation|1|||
94264629|NCT02616614|322763480|FG000|Overall Study|Prohibited Medication|12|||
94264630|NCT02616614|322763481|FG001|Overall Study|Prohibited Medication|9|||
94264631|NCT02616614|322763482|FG002|Overall Study|Prohibited Medication|5|||
94264632|NCT02616614|322763480|FG000|Overall Study|More than 3 applications missed|6|||
94264633|NCT02616614|322763481|FG001|Overall Study|More than 3 applications missed|8|||
94264634|NCT02616614|322763482|FG002|Overall Study|More than 3 applications missed|1|||
94264635|NCT02616614|322763480|FG000|Overall Study|Lost to Follow-up|31|||
94264636|NCT02616614|322763481|FG001|Overall Study|Lost to Follow-up|28|||
94264637|NCT02616614|322763482|FG002|Overall Study|Lost to Follow-up|13|||
94264638|NCT02616614|322763480|FG000|Overall Study|Pregnancy|2|||
94264639|NCT02616614|322763481|FG001|Overall Study|Pregnancy|0|||
94264640|NCT02616614|322763482|FG002|Overall Study|Pregnancy|1|||
94264641|NCT02616614|322763480|FG000|Overall Study|Other|1|||
94264642|NCT02616614|322763481|FG001|Overall Study|Other|2|||
94264643|NCT02616614|322763482|FG002|Overall Study|Other|1|||
94264644|NCT00596934|322763483|FG000|Overall Study|Protocol Violation|1|||
94264645|NCT00596934|322763483|FG000|Overall Study|Withdrawal by Subject|1|||
94264646|NCT00974090|322763490|FG000|Period 1: Double Blind Period|Adverse Event|2|||
94264647|NCT00974090|322763491|FG001|Period 1: Double Blind Period|Adverse Event|1|||
94264648|NCT00974090|322763490|FG000|Period 1: Double Blind Period|Physician Decision|1|||
94366109|NCT00552617|323126457|FG008|Overall Study|Not Treated|0|||
94264649|NCT00974090|322763491|FG001|Period 1: Double Blind Period|Physician Decision|0|||
94264650|NCT00974090|322763490|FG000|Period 2: Open-label Period|Adverse Event|4|||
94264651|NCT00974090|322763491|FG001|Period 2: Open-label Period|Adverse Event|6|||
94264652|NCT00974090|322763490|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
94264653|NCT00974090|322763491|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
94264654|NCT00974090|322763490|FG000|Period 2: Open-label Period|Physician Decision|0|||
94264655|NCT00974090|322763491|FG001|Period 2: Open-label Period|Physician Decision|3|||
94264656|NCT00974090|322763490|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
94264657|NCT00974090|322763491|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
94264658|NCT03189862|322763492|FG000|Overall Study|Withdrawal by Subject|1|||
94264659|NCT03189862|322763493|FG001|Overall Study|Withdrawal by Subject|0|||
94264660|NCT03189862|322763492|FG000|Overall Study|Lost to Follow-up|54|||
94264661|NCT03189862|322763493|FG001|Overall Study|Lost to Follow-up|62|||
94264662|NCT01122576|322763494|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
94264663|NCT01122576|322763495|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
94264664|NCT01122576|322763496|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
94264665|NCT01122576|322763494|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
94264666|NCT01122576|322763495|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
94264667|NCT01122576|322763496|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
94264668|NCT01122576|322763494|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
94264669|NCT01122576|322763495|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
94264670|NCT01122576|322763496|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
94366110|NCT00552617|323126458|FG009|Overall Study|Not Treated|1|||
94696013|NCT02373813|324341680|FG001|Run-In Period|Noncompliance|0|||
94696014|NCT02373813|324341681|FG002|Run-In Period|Noncompliance|0|||
94696015|NCT02373813|324341682|FG003|Run-In Period|Noncompliance|0|||
94696016|NCT02373813|324341679|FG000|Run-In Period|Ineligibility Determined|3|||
94696017|NCT02373813|324341680|FG001|Run-In Period|Ineligibility Determined|0|||
94696018|NCT02373813|324341681|FG002|Run-In Period|Ineligibility Determined|0|||
94696019|NCT02373813|324341682|FG003|Run-In Period|Ineligibility Determined|0|||
94696020|NCT02373813|324341679|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
94696021|NCT02373813|324341680|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
94696022|NCT02373813|324341681|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
94696023|NCT02373813|324341682|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
94696024|NCT02373813|324341679|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
94696025|NCT02373813|324341680|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
94696026|NCT02373813|324341681|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
94696027|NCT02373813|324341682|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
94696028|NCT02373813|324341679|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
94696029|NCT02373813|324341680|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
94696030|NCT02373813|324341681|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
94696031|NCT02373813|324341682|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
94696032|NCT02373813|324341679|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
94696033|NCT02373813|324341680|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
94696034|NCT02373813|324341681|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
94696035|NCT02373813|324341682|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
94696036|NCT03487666|324341683|FG000|Overall Study|Disease progression|4|||
94696037|NCT03487666|324341684|FG001|Overall Study|Disease progression|2|||
94696038|NCT03487666|324341685|FG002|Overall Study|Disease progression|0|||
94696039|NCT03487666|324341683|FG000|Overall Study|Adverse Event|0|||
94696040|NCT03487666|324341684|FG001|Overall Study|Adverse Event|0|||
94264671|NCT01829360|322763497|FG000|Overall Study|Protocol Violation|0|||
94264672|NCT01829360|322763498|FG001|Overall Study|Protocol Violation|0|||
94366111|NCT00552617|323126449|FG000|Overall Study|Lost to Follow-up|0|||
94366112|NCT00552617|323126450|FG001|Overall Study|Lost to Follow-up|0|||
94366113|NCT00552617|323126451|FG002|Overall Study|Lost to Follow-up|0|||
94366114|NCT00552617|323126452|FG003|Overall Study|Lost to Follow-up|1|||
94366115|NCT00552617|323126453|FG004|Overall Study|Lost to Follow-up|0|||
94366116|NCT00552617|323126454|FG005|Overall Study|Lost to Follow-up|2|||
94366117|NCT00552617|323126455|FG006|Overall Study|Lost to Follow-up|0|||
94366118|NCT00552617|323126456|FG007|Overall Study|Lost to Follow-up|0|||
94366119|NCT00552617|323126457|FG008|Overall Study|Lost to Follow-up|2|||
94366120|NCT00552617|323126458|FG009|Overall Study|Lost to Follow-up|0|||
94366121|NCT02406742|323126459|FG000|Overall Study|Progression of Disease|5|||
94366122|NCT02406742|323126460|FG001|Overall Study|Progression of Disease|1|||
94366123|NCT02406742|323126461|FG002|Overall Study|Progression of Disease|6|||
94366124|NCT02406742|323126459|FG000|Overall Study|Adverse Event|3|||
94696041|NCT03487666|324341685|FG002|Overall Study|Adverse Event|1|||
94696042|NCT02297503|324341686|FG000|Overall Study|Withdrawal by Subject|1|||
94264673|NCT01829360|322763499|FG002|Overall Study|Protocol Violation|1|||
94264674|NCT01829360|322763500|FG003|Overall Study|Protocol Violation|0|||
94264675|NCT01970488|322763508|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
94696043|NCT02297503|324341687|FG001|Overall Study|Withdrawal by Subject|1|||
94696044|NCT02297503|324341686|FG000|Overall Study|Protocol Violation|1|||
94696045|NCT02297503|324341687|FG001|Overall Study|Protocol Violation|0|||
94696046|NCT02297503|324341686|FG000|Overall Study|Pregnancy|0|||
94264676|NCT01970488|322763509|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
94264677|NCT01970488|322763510|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
94366125|NCT02406742|323126460|FG001|Overall Study|Adverse Event|0|||
94366126|NCT02406742|323126461|FG002|Overall Study|Adverse Event|2|||
94366127|NCT02406742|323126459|FG000|Overall Study|Death|1|||
94366128|NCT02406742|323126460|FG001|Overall Study|Death|0|||
94264678|NCT01970488|322763511|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
94264679|NCT01970488|322763512|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
94264680|NCT01970488|322763508|FG000|Part 1: Through Week 16|Protocol Violation|1|||
94264681|NCT01970488|322763509|FG001|Part 1: Through Week 16|Protocol Violation|2|||
94264682|NCT01970488|322763510|FG002|Part 1: Through Week 16|Protocol Violation|0|||
94264683|NCT01970488|322763511|FG003|Part 1: Through Week 16|Protocol Violation|0|||
94264684|NCT01970488|322763512|FG004|Part 1: Through Week 16|Protocol Violation|0|||
94264685|NCT01970488|322763508|FG000|Part 1: Through Week 16|Adverse Event|6|||
94264686|NCT01970488|322763509|FG001|Part 1: Through Week 16|Adverse Event|5|||
94264687|NCT01970488|322763510|FG002|Part 1: Through Week 16|Adverse Event|0|||
94264688|NCT01970488|322763511|FG003|Part 1: Through Week 16|Adverse Event|0|||
94264689|NCT01970488|322763512|FG004|Part 1: Through Week 16|Adverse Event|0|||
94264690|NCT01970488|322763508|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
94264691|NCT01970488|322763509|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
94264692|NCT01970488|322763510|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
94264693|NCT01970488|322763511|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
94264694|NCT01970488|322763512|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
94264695|NCT01970488|322763508|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
94264696|NCT01970488|322763509|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
94264697|NCT01970488|322763510|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
94264698|NCT01970488|322763511|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
94264699|NCT01970488|322763512|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
94696047|NCT02297503|324341687|FG001|Overall Study|Pregnancy|1|||
94696048|NCT02297503|324341686|FG000|Overall Study|Lost to Follow-up|0|||
94696049|NCT02297503|324341687|FG001|Overall Study|Lost to Follow-up|1|||
94696050|NCT02297503|324341686|FG000|Overall Study|Medical reason|0|||
94696051|NCT02297503|324341687|FG001|Overall Study|Medical reason|1|||
94696052|NCT02703532|324341688|FG000|Overall Study|Withdrawal by Subject|0|||
94696053|NCT02703532|324341689|FG001|Overall Study|Withdrawal by Subject|1|||
94696054|NCT02703532|324341690|FG002|Overall Study|Withdrawal by Subject|0|||
94696055|NCT02703532|324341691|FG003|Overall Study|Withdrawal by Subject|1|||
94696056|NCT02703532|324341688|FG000|Overall Study|Lost to Follow-up|2|||
94696057|NCT02703532|324341689|FG001|Overall Study|Lost to Follow-up|0|||
94696058|NCT02703532|324341690|FG002|Overall Study|Lost to Follow-up|2|||
94696059|NCT02703532|324341691|FG003|Overall Study|Lost to Follow-up|0|||
94696060|NCT00557505|324341693|FG000|Overall Study|Death|0|||
94696061|NCT00557505|324341694|FG001|Overall Study|Death|0|||
94696062|NCT00557505|324341695|FG002|Overall Study|Death|0|||
94696063|NCT00557505|324341696|FG003|Overall Study|Death|0|||
94696064|NCT00557505|324341697|FG004|Overall Study|Death|0|||
94696065|NCT00557505|324341698|FG005|Overall Study|Death|0|||
94696066|NCT00557505|324341699|FG006|Overall Study|Death|0|||
94696067|NCT00557505|324341700|FG007|Overall Study|Death|0|||
94696068|NCT00557505|324341701|FG008|Overall Study|Death|1|||
94696069|NCT00557505|324341693|FG000|Overall Study|Adverse Event|0|||
94696070|NCT00557505|324341694|FG001|Overall Study|Adverse Event|0|||
94696071|NCT00557505|324341695|FG002|Overall Study|Adverse Event|1|||
94696072|NCT00557505|324341696|FG003|Overall Study|Adverse Event|0|||
94696073|NCT00557505|324341697|FG004|Overall Study|Adverse Event|0|||
94696074|NCT00557505|324341698|FG005|Overall Study|Adverse Event|0|||
94696075|NCT00557505|324341699|FG006|Overall Study|Adverse Event|1|||
94696076|NCT00557505|324341700|FG007|Overall Study|Adverse Event|0|||
94696077|NCT00557505|324341701|FG008|Overall Study|Adverse Event|0|||
94696078|NCT00557505|324341693|FG000|Overall Study|Global deterioration of health|1|||
94696079|NCT00557505|324341694|FG001|Overall Study|Global deterioration of health|0|||
94696080|NCT00557505|324341695|FG002|Overall Study|Global deterioration of health|0|||
94696081|NCT00557505|324341696|FG003|Overall Study|Global deterioration of health|0|||
94696082|NCT00557505|324341697|FG004|Overall Study|Global deterioration of health|0|||
94696083|NCT00557505|324341698|FG005|Overall Study|Global deterioration of health|0|||
94696084|NCT00557505|324341699|FG006|Overall Study|Global deterioration of health|0|||
94696085|NCT00557505|324341700|FG007|Overall Study|Global deterioration of health|0|||
94696086|NCT00557505|324341701|FG008|Overall Study|Global deterioration of health|0|||
94696087|NCT00557505|324341693|FG000|Overall Study|Objective progression or relapse|2|||
94696088|NCT00557505|324341694|FG001|Overall Study|Objective progression or relapse|3|||
94696089|NCT00557505|324341695|FG002|Overall Study|Objective progression or relapse|3|||
94696090|NCT00557505|324341696|FG003|Overall Study|Objective progression or relapse|2|||
94696091|NCT00557505|324341697|FG004|Overall Study|Objective progression or relapse|2|||
94696092|NCT00557505|324341698|FG005|Overall Study|Objective progression or relapse|3|||
94696093|NCT00557505|324341699|FG006|Overall Study|Objective progression or relapse|2|||
94696094|NCT00557505|324341700|FG007|Overall Study|Objective progression or relapse|5|||
94696095|NCT00557505|324341701|FG008|Overall Study|Objective progression or relapse|15|||
94696096|NCT00557505|324341693|FG000|Overall Study|Withdrawal by Subject|0|||
94696097|NCT00557505|324341694|FG001|Overall Study|Withdrawal by Subject|0|||
94696098|NCT00557505|324341695|FG002|Overall Study|Withdrawal by Subject|0|||
94696099|NCT00557505|324341696|FG003|Overall Study|Withdrawal by Subject|1|||
94696100|NCT00557505|324341697|FG004|Overall Study|Withdrawal by Subject|0|||
94696101|NCT00557505|324341698|FG005|Overall Study|Withdrawal by Subject|0|||
94696102|NCT00557505|324341699|FG006|Overall Study|Withdrawal by Subject|0|||
94696103|NCT00557505|324341700|FG007|Overall Study|Withdrawal by Subject|0|||
94696104|NCT00557505|324341701|FG008|Overall Study|Withdrawal by Subject|1|||
94696105|NCT02459964|324341711|FG000|Overall Study|Withdrawal by Subject|0|||
94696106|NCT02459964|324341712|FG001|Overall Study|Withdrawal by Subject|0|||
94696107|NCT02459964|324341713|FG002|Overall Study|Withdrawal by Subject|1|||
94696108|NCT02459964|324341711|FG000|Overall Study|Abnormal EKG changes|0|||
94696109|NCT02459964|324341712|FG001|Overall Study|Abnormal EKG changes|0|||
94696110|NCT02459964|324341713|FG002|Overall Study|Abnormal EKG changes|1|||
94696111|NCT00550732|324341714|FG000|Overall Study|Death|4|||
94696112|NCT00550732|324341714|FG000|Overall Study|Withdrawal by Subject|2|||
94696113|NCT00550732|324341714|FG000|Overall Study|Physician Decision|2|||
94696114|NCT00550732|324341714|FG000|Overall Study|Lost to Follow-up|1|||
94696115|NCT00550732|324341714|FG000|Overall Study|Palliative care|1|||
94696116|NCT00550732|324341714|FG000|Overall Study|Adverse Event|1|||
94696117|NCT03415022|324341715|FG000|Overall Study|Withdrawal by Subject|1|||
94696118|NCT03415022|324341716|FG001|Overall Study|Withdrawal by Subject|2|||
94696119|NCT03415022|324341715|FG000|Overall Study|COVID-19 Suspension|2|||
94696120|NCT03415022|324341716|FG001|Overall Study|COVID-19 Suspension|3|||
94696121|NCT03415022|324341715|FG000|Overall Study|Lost to Follow-up|2|||
94696122|NCT03415022|324341716|FG001|Overall Study|Lost to Follow-up|0|||
94696123|NCT00425503|324341719|FG000|Overall Study|Adverse Event|2|||
94696124|NCT00425503|324341719|FG000|Overall Study|Protocol Violation|1|||
94264700|NCT01970488|322763508|FG000|Part 2: Post Week 16|Physician Decision|0|||
94264701|NCT01970488|322763509|FG001|Part 2: Post Week 16|Physician Decision|0|||
94696125|NCT01657032|324341725|FG000|Overall Study|Lost to Follow-up|0|||
94696126|NCT01657032|324341726|FG001|Overall Study|Lost to Follow-up|7|||
94696127|NCT01925170|324341727|FG000|Overall Study|Unverified cancer status|53|||
94696128|NCT00965484|324341728|FG000|Overall Study|Protocol Violation|1|||
94696129|NCT00965484|324341728|FG000|Overall Study|Withdrawal by Subject|1|||
94696130|NCT00619151|324341734|FG000|Overall Study|Study terminated prior to followup|1|||
94696131|NCT00619151|324341735|FG001|Overall Study|Study terminated prior to followup|0|||
94696132|NCT00329303|324341736|FG000|Overall Study|Lack of Efficacy|1|||
94696133|NCT00329303|324341737|FG001|Overall Study|Lack of Efficacy|0|||
94696134|NCT00329303|324341736|FG000|Overall Study|Decision of the sponsor|0|||
94696135|NCT00329303|324341737|FG001|Overall Study|Decision of the sponsor|1|||
94696136|NCT00329303|324341736|FG000|Overall Study|Patient no longer available|1|||
94696137|NCT00329303|324341737|FG001|Overall Study|Patient no longer available|0|||
94696138|NCT00329303|324341736|FG000|Overall Study|Patient relocated|0|||
94696139|NCT00329303|324341737|FG001|Overall Study|Patient relocated|1|||
94696140|NCT00859014|324341740|FG000|Overall Study|Death|4|||
94696141|NCT00859014|324341740|FG000|Overall Study|Lost to Follow-up|1|||
94696142|NCT02335268|324341741|FG000|Overall Study|Physician Decision|5|||
94696143|NCT02335268|324341742|FG001|Overall Study|Physician Decision|1|||
94696144|NCT02335268|324341741|FG000|Overall Study|Lack of Efficacy|2|||
94696145|NCT02335268|324341742|FG001|Overall Study|Lack of Efficacy|1|||
94696146|NCT02335268|324341741|FG000|Overall Study|Adverse Event|5|||
94696147|NCT02335268|324341742|FG001|Overall Study|Adverse Event|2|||
94696148|NCT02335268|324341741|FG000|Overall Study|increase blasts|2|||
94696149|NCT02335268|324341742|FG001|Overall Study|increase blasts|0|||
94696150|NCT02335268|324341741|FG000|Overall Study|Withdrawal by Subject|3|||
94696151|NCT02335268|324341742|FG001|Overall Study|Withdrawal by Subject|2|||
94696152|NCT01767909|324341748|FG000|Overall Study|Withdrawal by Subject|4|||
94696153|NCT01767909|324341749|FG001|Overall Study|Withdrawal by Subject|7|||
94696154|NCT01767909|324341748|FG000|Overall Study|Adverse Event|3|||
94696155|NCT01767909|324341749|FG001|Overall Study|Adverse Event|1|||
94696156|NCT01767909|324341748|FG000|Overall Study|Withdrawal by Study Partner|3|||
94696157|NCT01767909|324341749|FG001|Overall Study|Withdrawal by Study Partner|1|||
94696158|NCT01767909|324341748|FG000|Overall Study|Non-Compliance|2|||
94696159|NCT01767909|324341749|FG001|Overall Study|Non-Compliance|0|||
94366129|NCT02406742|323126461|FG002|Overall Study|Death|0|||
94366130|NCT02406742|323126459|FG000|Overall Study|Lack of Efficacy|0|||
94366131|NCT02406742|323126460|FG001|Overall Study|Lack of Efficacy|0|||
94366132|NCT02406742|323126461|FG002|Overall Study|Lack of Efficacy|1|||
94696160|NCT01767909|324341748|FG000|Overall Study|Perceived Lack of Efficacy|1|||
94366133|NCT02406742|323126459|FG000|Overall Study|Withdrawal by Participant|1|||
94696161|NCT01767909|324341749|FG001|Overall Study|Perceived Lack of Efficacy|0|||
94264702|NCT01970488|322763510|FG002|Part 2: Post Week 16|Physician Decision|0|||
94264703|NCT01970488|322763511|FG003|Part 2: Post Week 16|Physician Decision|0|||
94264704|NCT01970488|322763512|FG004|Part 2: Post Week 16|Physician Decision|1|||
94264705|NCT01970488|322763508|FG000|Part 2: Post Week 16|Non-compliance|0|||
94696162|NCT01767909|324341748|FG000|Overall Study|Investigator Recommendation|0|||
94696163|NCT01767909|324341749|FG001|Overall Study|Investigator Recommendation|1|||
94696164|NCT01767909|324341748|FG000|Overall Study|Lost to Follow-up|0|||
94696165|NCT01767909|324341749|FG001|Overall Study|Lost to Follow-up|1|||
94696166|NCT01767909|324341748|FG000|Overall Study|LP uncessessful|0|||
94696167|NCT01767909|324341749|FG001|Overall Study|LP uncessessful|1|||
94696168|NCT04529538|324341751|FG000|Overall Study|Lost to Follow-up|3|||
94696169|NCT04529538|324341752|FG001|Overall Study|Lost to Follow-up|2|||
94696170|NCT04529538|324341753|FG002|Overall Study|Lost to Follow-up|1|||
94696171|NCT04529538|324341754|FG003|Overall Study|Lost to Follow-up|0|||
94696172|NCT04529538|324341755|FG004|Overall Study|Lost to Follow-up|1|||
94696173|NCT04529538|324341756|FG005|Overall Study|Lost to Follow-up|1|||
94696174|NCT04529538|324341757|FG006|Overall Study|Lost to Follow-up|2|||
94696175|NCT04529538|324341758|FG007|Overall Study|Lost to Follow-up|0|||
94696176|NCT04529538|324341751|FG000|Overall Study|Not eligible at enrollment|0|||
94696177|NCT04529538|324341752|FG001|Overall Study|Not eligible at enrollment|1|||
94696178|NCT04529538|324341753|FG002|Overall Study|Not eligible at enrollment|2|||
94696179|NCT04529538|324341754|FG003|Overall Study|Not eligible at enrollment|1|||
94696180|NCT04529538|324341755|FG004|Overall Study|Not eligible at enrollment|0|||
94696181|NCT04529538|324341756|FG005|Overall Study|Not eligible at enrollment|0|||
94696182|NCT04529538|324341757|FG006|Overall Study|Not eligible at enrollment|0|||
94696183|NCT04529538|324341758|FG007|Overall Study|Not eligible at enrollment|1|||
94696184|NCT04529538|324341751|FG000|Overall Study|Withdrawal by Subject|0|||
94696185|NCT04529538|324341752|FG001|Overall Study|Withdrawal by Subject|1|||
94696186|NCT04529538|324341753|FG002|Overall Study|Withdrawal by Subject|1|||
94696187|NCT04529538|324341754|FG003|Overall Study|Withdrawal by Subject|2|||
94696188|NCT04529538|324341755|FG004|Overall Study|Withdrawal by Subject|0|||
94696189|NCT04529538|324341756|FG005|Overall Study|Withdrawal by Subject|2|||
94696190|NCT04529538|324341757|FG006|Overall Study|Withdrawal by Subject|3|||
94696191|NCT04529538|324341758|FG007|Overall Study|Withdrawal by Subject|0|||
94696192|NCT04529538|324341751|FG000|Overall Study|Other|0|||
94696193|NCT04529538|324341752|FG001|Overall Study|Other|1|||
94696194|NCT04529538|324341753|FG002|Overall Study|Other|0|||
94696195|NCT04529538|324341754|FG003|Overall Study|Other|0|||
94696196|NCT04529538|324341755|FG004|Overall Study|Other|0|||
94696197|NCT04529538|324341756|FG005|Overall Study|Other|0|||
94696198|NCT04529538|324341757|FG006|Overall Study|Other|0|||
94264706|NCT01970488|322763509|FG001|Part 2: Post Week 16|Non-compliance|0|||
94264707|NCT01970488|322763510|FG002|Part 2: Post Week 16|Non-compliance|1|||
94264708|NCT01970488|322763511|FG003|Part 2: Post Week 16|Non-compliance|0|||
94264709|NCT01970488|322763512|FG004|Part 2: Post Week 16|Non-compliance|0|||
94264710|NCT01970488|322763508|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
94264711|NCT01970488|322763509|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
94264712|NCT01970488|322763510|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
94264713|NCT01970488|322763511|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
94264714|NCT01970488|322763512|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
94696199|NCT04529538|324341758|FG007|Overall Study|Other|0|||
94696200|NCT04529538|324341751|FG000|Overall Study|Adverse Event|0|||
94696201|NCT04529538|324341752|FG001|Overall Study|Adverse Event|0|||
94264715|NCT01970488|322763508|FG000|Part 2: Post Week 16|Adverse Event|0|||
94264716|NCT01970488|322763509|FG001|Part 2: Post Week 16|Adverse Event|0|||
94264717|NCT01970488|322763510|FG002|Part 2: Post Week 16|Adverse Event|5|||
94264718|NCT01970488|322763511|FG003|Part 2: Post Week 16|Adverse Event|1|||
94264719|NCT01970488|322763512|FG004|Part 2: Post Week 16|Adverse Event|1|||
94264720|NCT01970488|322763508|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
94264721|NCT01970488|322763509|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
94264722|NCT01970488|322763510|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
94366134|NCT02406742|323126460|FG001|Overall Study|Withdrawal by Participant|2|||
94366135|NCT02406742|323126461|FG002|Overall Study|Withdrawal by Participant|0|||
94366136|NCT02406742|323126459|FG000|Overall Study|Physician Decision|1|||
94366137|NCT02406742|323126460|FG001|Overall Study|Physician Decision|2|||
94696202|NCT04529538|324341753|FG002|Overall Study|Adverse Event|0|||
94696203|NCT04529538|324341754|FG003|Overall Study|Adverse Event|1|||
94696204|NCT04529538|324341755|FG004|Overall Study|Adverse Event|0|||
94696205|NCT04529538|324341756|FG005|Overall Study|Adverse Event|0|||
94696206|NCT04529538|324341757|FG006|Overall Study|Adverse Event|0|||
94696207|NCT04529538|324341758|FG007|Overall Study|Adverse Event|0|||
94696208|NCT04529538|324341751|FG000|Overall Study|Protocol Deviation|0|||
94696209|NCT04529538|324341752|FG001|Overall Study|Protocol Deviation|0|||
94264723|NCT01970488|322763511|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
94264724|NCT01970488|322763512|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
94264725|NCT01970488|322763508|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
94264726|NCT01970488|322763509|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
94696210|NCT04529538|324341753|FG002|Overall Study|Protocol Deviation|0|||
94466064|NCT04907227|323495000|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
94696211|NCT04529538|324341754|FG003|Overall Study|Protocol Deviation|1|||
94696212|NCT04529538|324341755|FG004|Overall Study|Protocol Deviation|0|||
94696213|NCT04529538|324341756|FG005|Overall Study|Protocol Deviation|0|||
94696214|NCT04529538|324341757|FG006|Overall Study|Protocol Deviation|0|||
94696215|NCT04529538|324341758|FG007|Overall Study|Protocol Deviation|0|||
94696216|NCT04529538|324341751|FG000|Overall Study|Physician Decision|0|||
94696217|NCT04529538|324341752|FG001|Overall Study|Physician Decision|0|||
94696218|NCT04529538|324341753|FG002|Overall Study|Physician Decision|0|||
94696219|NCT04529538|324341754|FG003|Overall Study|Physician Decision|0|||
94696220|NCT04529538|324341755|FG004|Overall Study|Physician Decision|0|||
94696221|NCT04529538|324341756|FG005|Overall Study|Physician Decision|1|||
94696222|NCT04529538|324341757|FG006|Overall Study|Physician Decision|0|||
94696223|NCT04529538|324341758|FG007|Overall Study|Physician Decision|1|||
94696224|NCT00333788|324341761|FG000|Overall Study|Adverse Event|44|||
94696225|NCT00333788|324341761|FG000|Overall Study|Lack of Efficacy|80|||
94696226|NCT00333788|324341761|FG000|Overall Study|Lost to Follow-up|2|||
94696227|NCT00333788|324341761|FG000|Overall Study|Withdrawal by Subject|24|||
94696228|NCT00333788|324341761|FG000|Overall Study|Other: Non-compliance|2|||
94696229|NCT00333788|324341761|FG000|Overall Study|Other: Moved|2|||
94696230|NCT00333788|324341761|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
94696231|NCT00333788|324341761|FG000|Overall Study|Other: Investigator decision|1|||
94696232|NCT00333788|324341761|FG000|Overall Study|Other: Quality of life concern|1|||
94696233|NCT00333788|324341761|FG000|Overall Study|Other: Sponsor decision|1|||
94696234|NCT00333788|324341761|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
94696235|NCT00333788|324341761|FG000|Overall Study|Other: Medical monitor decision|1|||
94696236|NCT00333788|324341761|FG000|Overall Study|Other: Physician decision|1|||
94696237|NCT00333788|324341761|FG000|Overall Study|Other: Signed consent for another study|1|||
94696238|NCT00114959|324341762|FG000|Overall Study|Lack of Efficacy|6|||
94696239|NCT00114959|324341762|FG000|Overall Study|Physician Decision|1|||
94696240|NCT00114959|324341762|FG000|Overall Study|Death|1|||
94696241|NCT03251378|324341765|FG000|Overall Study|Death|3|||
94696242|NCT03251378|324341766|FG001|Overall Study|Death|2|||
94696243|NCT03251378|324341767|FG002|Overall Study|Death|3|||
94696244|NCT03251378|324341768|FG003|Overall Study|Death|30|||
94696245|NCT03251378|324341769|FG004|Overall Study|Death|24|||
94696246|NCT03251378|324341770|FG005|Overall Study|Death|12|||
94696247|NCT03251378|324341771|FG006|Overall Study|Death|12|||
94466065|NCT04907227|323495001|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
94466066|NCT04907227|323495000|FG000|Overall Study|Sponsor Decision|25|||
94696248|NCT03251378|324341765|FG000|Overall Study|Lost to Follow-up|0|||
94696249|NCT03251378|324341766|FG001|Overall Study|Lost to Follow-up|0|||
94696250|NCT03251378|324341767|FG002|Overall Study|Lost to Follow-up|1|||
94696251|NCT03251378|324341768|FG003|Overall Study|Lost to Follow-up|3|||
94696252|NCT03251378|324341769|FG004|Overall Study|Lost to Follow-up|0|||
94696253|NCT03251378|324341770|FG005|Overall Study|Lost to Follow-up|0|||
94696254|NCT03251378|324341771|FG006|Overall Study|Lost to Follow-up|0|||
94696255|NCT03251378|324341765|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
94696256|NCT03251378|324341766|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
94466067|NCT04907227|323495001|FG001|Overall Study|Sponsor Decision|30|||
94264727|NCT01970488|322763510|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
94264728|NCT01970488|322763511|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
94264729|NCT01970488|322763512|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
94264730|NCT01109173|322763513|FG000|Overall Study|Adverse Event|15|||
94264731|NCT01109173|322763514|FG001|Overall Study|Adverse Event|17|||
94264732|NCT01109173|322763515|FG002|Overall Study|Adverse Event|9|||
94264733|NCT01109173|322763516|FG003|Overall Study|Adverse Event|6|||
94264734|NCT01109173|322763513|FG000|Overall Study|Lost to Follow-up|0|||
94264735|NCT01109173|322763514|FG001|Overall Study|Lost to Follow-up|1|||
94264736|NCT01109173|322763515|FG002|Overall Study|Lost to Follow-up|0|||
94264737|NCT01109173|322763516|FG003|Overall Study|Lost to Follow-up|0|||
94264738|NCT01109173|322763513|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
94264739|NCT01109173|322763514|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
94264740|NCT01109173|322763515|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
94264741|NCT01109173|322763516|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
94264742|NCT01109173|322763513|FG000|Overall Study|Noncompliance|0|||
94264743|NCT01109173|322763514|FG001|Overall Study|Noncompliance|1|||
94264744|NCT01109173|322763515|FG002|Overall Study|Noncompliance|0|||
94264745|NCT01109173|322763516|FG003|Overall Study|Noncompliance|0|||
94264746|NCT01109173|322763513|FG000|Overall Study|Treatment Failure|25|||
94264747|NCT01109173|322763514|FG001|Overall Study|Treatment Failure|32|||
94264748|NCT01109173|322763515|FG002|Overall Study|Treatment Failure|69|||
94264749|NCT01109173|322763516|FG003|Overall Study|Treatment Failure|64|||
94264750|NCT01109173|322763513|FG000|Overall Study|Protocol Violation|4|||
94264751|NCT01109173|322763514|FG001|Overall Study|Protocol Violation|5|||
94264752|NCT01109173|322763515|FG002|Overall Study|Protocol Violation|1|||
94264753|NCT01109173|322763516|FG003|Overall Study|Protocol Violation|2|||
94264754|NCT01109173|322763513|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
94264755|NCT01109173|322763514|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
94264756|NCT01109173|322763515|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
94264757|NCT01109173|322763516|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
94264758|NCT01109173|322763513|FG000|Overall Study|Not Specifiied|5|||
94264759|NCT01109173|322763514|FG001|Overall Study|Not Specifiied|4|||
94264760|NCT01109173|322763515|FG002|Overall Study|Not Specifiied|9|||
94264761|NCT01109173|322763516|FG003|Overall Study|Not Specifiied|14|||
94264762|NCT02448225|322763523|FG000|Overall Study|Withdrawal by Subject|1|||
94264763|NCT02448225|322763523|FG000|Overall Study|Did not get FSPG scan|18|||
94264764|NCT02448225|322763523|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
94264765|NCT02178553|322763529|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
94264766|NCT02178553|322763530|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
94264767|NCT02178553|322763529|FG000|Overall Study|Physician Decision|0|||
94264768|NCT02178553|322763530|FG001|Overall Study|Physician Decision|4|||
94264769|NCT02178553|322763529|FG000|Overall Study|Technical problem with injection|1|||
94264770|NCT02178553|322763530|FG001|Overall Study|Technical problem with injection|3|||
94696257|NCT03251378|324341767|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
94696258|NCT03251378|324341768|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
94696259|NCT03251378|324341769|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
94696260|NCT03251378|324341770|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
94696261|NCT03251378|324341771|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
94696262|NCT03251378|324341765|FG000|Overall Study|Progressive disease|2|||
94696263|NCT03251378|324341766|FG001|Overall Study|Progressive disease|0|||
94696264|NCT03251378|324341767|FG002|Overall Study|Progressive disease|0|||
94696265|NCT03251378|324341768|FG003|Overall Study|Progressive disease|1|||
94696266|NCT03251378|324341769|FG004|Overall Study|Progressive disease|0|||
94696267|NCT03251378|324341770|FG005|Overall Study|Progressive disease|0|||
94696268|NCT03251378|324341771|FG006|Overall Study|Progressive disease|0|||
94696269|NCT03251378|324341765|FG000|Overall Study|Physician Decision|0|||
94264771|NCT05085665|322763531|FG000|Overall Study|Physician Decision|2|||
94264772|NCT01251120|322763534|FG000|Overall Study|Lack of Efficacy|0|||
94264773|NCT01251120|322763535|FG001|Overall Study|Lack of Efficacy|1|||
94264774|NCT01807923|322763540|FG000|Overall Study|Adverse Event|2|||
94264775|NCT01807923|322763541|FG001|Overall Study|Adverse Event|1|||
94264776|NCT01807923|322763542|FG002|Overall Study|Adverse Event|2|||
94264777|NCT01807923|322763540|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
94264778|NCT01807923|322763541|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
94264779|NCT01807923|322763542|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
94264780|NCT01807923|322763540|FG000|Overall Study|Physician Decision|0|||
94696270|NCT03251378|324341766|FG001|Overall Study|Physician Decision|2|||
94264781|NCT01807923|322763541|FG001|Overall Study|Physician Decision|0|||
94264782|NCT01807923|322763542|FG002|Overall Study|Physician Decision|1|||
94264783|NCT01807923|322763540|FG000|Overall Study|Not Eligible (Genotype)|0|||
94264784|NCT01807923|322763541|FG001|Overall Study|Not Eligible (Genotype)|0|||
94264785|NCT01807923|322763542|FG002|Overall Study|Not Eligible (Genotype)|1|||
94264786|NCT01807923|322763540|FG000|Overall Study|Randomized But Not Treated|3|||
94696271|NCT03251378|324341767|FG002|Overall Study|Physician Decision|0|||
94696272|NCT03251378|324341768|FG003|Overall Study|Physician Decision|0|||
94264787|NCT01807923|322763541|FG001|Overall Study|Randomized But Not Treated|2|||
94264788|NCT01807923|322763542|FG002|Overall Study|Randomized But Not Treated|5|||
94264789|NCT00890929|322763543|FG000|Overall Study|Death before treatment|2|||
94264790|NCT00890929|322763543|FG000|Overall Study|Withdrawal by Subject|3|||
94264791|NCT00890929|322763543|FG000|Overall Study|Physician Decision|1|||
94264792|NCT03933397|322763546|FG000|Overall Study|No emergency department visit|65|||
94264793|NCT03933397|322763547|FG001|Overall Study|No emergency department visit|71|||
94696273|NCT03251378|324341769|FG004|Overall Study|Physician Decision|0|||
94696274|NCT03251378|324341770|FG005|Overall Study|Physician Decision|0|||
94696275|NCT03251378|324341771|FG006|Overall Study|Physician Decision|0|||
94696276|NCT03251378|324341765|FG000|Overall Study|Other|2|||
94696277|NCT03251378|324341766|FG001|Overall Study|Other|3|||
94696278|NCT03251378|324341767|FG002|Overall Study|Other|2|||
94696279|NCT03251378|324341768|FG003|Overall Study|Other|0|||
94696280|NCT03251378|324341769|FG004|Overall Study|Other|1|||
94696281|NCT03251378|324341770|FG005|Overall Study|Other|1|||
94696282|NCT03251378|324341771|FG006|Overall Study|Other|1|||
94696283|NCT03251378|324341765|FG000|Overall Study|Other|0|||
94696284|NCT03251378|324341766|FG001|Overall Study|Other|0|||
94696285|NCT03251378|324341767|FG002|Overall Study|Other|0|||
94696286|NCT03251378|324341768|FG003|Overall Study|Other|4|||
94696287|NCT03251378|324341769|FG004|Overall Study|Other|13|||
94696288|NCT03251378|324341770|FG005|Overall Study|Other|0|||
94696289|NCT03251378|324341771|FG006|Overall Study|Other|0|||
94696290|NCT04060680|324341772|FG000|Overall Study|Unsuccessful implant|17|||
94696291|NCT04060680|324341773|FG001|Overall Study|Unsuccessful implant|2|||
94696292|NCT04060680|324341772|FG000|Overall Study|Adverse Event|3|||
94696293|NCT04060680|324341773|FG001|Overall Study|Adverse Event|0|||
94696294|NCT04060680|324341772|FG000|Overall Study|Death|2|||
94696295|NCT04060680|324341773|FG001|Overall Study|Death|0|||
94696296|NCT04060680|324341772|FG000|Overall Study|Study product no longer in use|1|||
94696297|NCT04060680|324341773|FG001|Overall Study|Study product no longer in use|0|||
94696298|NCT04060680|324341772|FG000|Overall Study|Withdrawal by Subject|1|||
94696299|NCT04060680|324341773|FG001|Overall Study|Withdrawal by Subject|0|||
94696300|NCT01221181|324341782|FG000|Overall Study|Lost to Follow-up|1|||
94696301|NCT02698436|324341783|FG000|Overall Study|Adverse Event|1|||
94696302|NCT02698436|324341784|FG001|Overall Study|Adverse Event|0|||
94696303|NCT02698436|324341783|FG000|Overall Study|Withdrawal by Subject|3|||
94696304|NCT02698436|324341784|FG001|Overall Study|Withdrawal by Subject|3|||
94696305|NCT02698436|324341783|FG000|Overall Study|Lost to Follow-up|2|||
94696306|NCT02698436|324341784|FG001|Overall Study|Lost to Follow-up|4|||
94696307|NCT02698436|324341783|FG000|Overall Study|Non-compliance with study regimen|1|||
94696308|NCT02698436|324341784|FG001|Overall Study|Non-compliance with study regimen|0|||
94696309|NCT01394991|324341785|FG000|Overall Study|Adverse Event|0|||
94696310|NCT01394991|324341786|FG001|Overall Study|Adverse Event|4|||
94696311|NCT01394991|324341785|FG000|Overall Study|Lack of Efficacy|5|||
94696312|NCT01394991|324341786|FG001|Overall Study|Lack of Efficacy|7|||
94696313|NCT01394991|324341785|FG000|Overall Study|Lost to Follow-up|6|||
94696314|NCT01394991|324341786|FG001|Overall Study|Lost to Follow-up|8|||
94696315|NCT01394991|324341785|FG000|Overall Study|Physician Decision|1|||
94264794|NCT03933397|322763546|FG000|Overall Study|Missed emergency department visit|25|||
94264795|NCT03933397|322763547|FG001|Overall Study|Missed emergency department visit|30|||
94264796|NCT03933397|322763546|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
94696316|NCT01394991|324341786|FG001|Overall Study|Physician Decision|3|||
94696317|NCT01394991|324341785|FG000|Overall Study|Protocol Violation|1|||
94696318|NCT01394991|324341786|FG001|Overall Study|Protocol Violation|1|||
94696319|NCT01394991|324341785|FG000|Overall Study|Withdrawal by Subject|20|||
94696320|NCT01394991|324341786|FG001|Overall Study|Withdrawal by Subject|17|||
94696321|NCT01394991|324341785|FG000|Overall Study|Chemotherapy Termination|10|||
94696322|NCT01394991|324341786|FG001|Overall Study|Chemotherapy Termination|15|||
94696323|NCT01394991|324341785|FG000|Overall Study|Disease Progression|7|||
94696324|NCT01394991|324341786|FG001|Overall Study|Disease Progression|7|||
94696325|NCT01394991|324341785|FG000|Overall Study|Prematurely Termination of Trial|9|||
94696326|NCT01394991|324341786|FG001|Overall Study|Prematurely Termination of Trial|10|||
94696327|NCT02419755|324341787|FG000|Overall Study|Death|1|||
94366138|NCT02406742|323126461|FG002|Overall Study|Physician Decision|1|||
94366139|NCT02406742|323126459|FG000|Overall Study|Transition to other treatment|2|||
94366140|NCT02406742|323126460|FG001|Overall Study|Transition to other treatment|0|||
94696328|NCT02419755|324341788|FG001|Overall Study|Death|3|||
94696329|NCT02419755|324341787|FG000|Overall Study|Relapse|0|||
94696330|NCT02419755|324341788|FG001|Overall Study|Relapse|1|||
94696331|NCT02419755|324341787|FG000|Overall Study|Ineligible|1|||
94696332|NCT02419755|324341788|FG001|Overall Study|Ineligible|0|||
94696333|NCT02419755|324341787|FG000|Overall Study|Withdrawal by Subject|1|||
94696334|NCT02419755|324341788|FG001|Overall Study|Withdrawal by Subject|0|||
94696335|NCT02337361|324341790|FG000|3-month Follow-up|Lost to Follow-up|19|||
94696336|NCT02337361|324341791|FG001|3-month Follow-up|Lost to Follow-up|14|||
94264797|NCT03933397|322763547|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
94264798|NCT03933397|322763546|FG000|Overall Study|Withdrawal by Subject|1|||
94264799|NCT03933397|322763547|FG001|Overall Study|Withdrawal by Subject|0|||
94264800|NCT03933397|322763546|FG000|Overall Study|Physician Decision|1|||
94264801|NCT03933397|322763547|FG001|Overall Study|Physician Decision|1|||
94264802|NCT03933397|322763546|FG000|Overall Study|missing pain score|1|||
94264803|NCT03933397|322763547|FG001|Overall Study|missing pain score|1|||
94264804|NCT03933397|322763546|FG000|Overall Study|Confirmed COVID-19|1|||
94264805|NCT03933397|322763547|FG001|Overall Study|Confirmed COVID-19|2|||
94264806|NCT01910116|322763548|FG000|Overall Study|Adverse Event|0|||
94264807|NCT01910116|322763549|FG001|Overall Study|Adverse Event|3|||
94264808|NCT01910116|322763548|FG000|Overall Study|Lack of Efficacy|3|||
94264809|NCT01910116|322763549|FG001|Overall Study|Lack of Efficacy|4|||
94264810|NCT01910116|322763548|FG000|Overall Study|Lost to Follow-up|1|||
94264811|NCT01910116|322763549|FG001|Overall Study|Lost to Follow-up|0|||
94264812|NCT01910116|322763548|FG000|Overall Study|Protocol Violation|1|||
94264813|NCT01910116|322763549|FG001|Overall Study|Protocol Violation|2|||
94264814|NCT01910116|322763548|FG000|Overall Study|Withdrawal by Subject|8|||
94264815|NCT01910116|322763549|FG001|Overall Study|Withdrawal by Subject|3|||
94264816|NCT01910116|322763548|FG000|Overall Study|uncertain allocation|1|||
94264817|NCT01910116|322763549|FG001|Overall Study|uncertain allocation|3|||
94264818|NCT01910116|322763548|FG000|Overall Study|incomplete data|0|||
94264819|NCT01910116|322763549|FG001|Overall Study|incomplete data|1|||
94264820|NCT03836807|322763550|FG000|Overall Study|Physician Decision|1|||
94264821|NCT03836807|322763551|FG001|Overall Study|Physician Decision|0|||
94264822|NCT03606980|322763552|FG000|Overall Study|Lost to Follow-up|3|||
94264823|NCT03606980|322763553|FG001|Overall Study|Lost to Follow-up|2|||
94264824|NCT03606980|322763554|FG002|Overall Study|Lost to Follow-up|3|||
94264825|NCT03606980|322763552|FG000|Overall Study|Withdrawal by Subject|1|||
94264826|NCT03606980|322763553|FG001|Overall Study|Withdrawal by Subject|0|||
94264827|NCT03606980|322763554|FG002|Overall Study|Withdrawal by Subject|4|||
94264828|NCT03675776|322763557|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
94264829|NCT03675776|322763558|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
94264830|NCT03675776|322763559|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
94264831|NCT03675776|322763557|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
94264832|NCT03675776|322763558|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
94264833|NCT03675776|322763559|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
94264834|NCT02401412|322763560|FG000|Overall Study|Lost to Follow-up|1|||
94264835|NCT02401412|322763561|FG001|Overall Study|Lost to Follow-up|0|||
94264836|NCT02401412|322763560|FG000|Overall Study|Discontinued Intervention|15|||
94264837|NCT02401412|322763561|FG001|Overall Study|Discontinued Intervention|21|||
94264838|NCT02401412|322763560|FG000|Overall Study|Withdrawal by Subject|4|||
94264839|NCT02401412|322763561|FG001|Overall Study|Withdrawal by Subject|4|||
94264840|NCT02401412|322763560|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
94264841|NCT02401412|322763561|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
94264842|NCT02401412|322763560|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
94264843|NCT02401412|322763561|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
94264844|NCT01009034|322763562|FG000|Overall Study|Lost to Follow-up|2|||
94264845|NCT01009034|322763562|FG000|Overall Study|Withdrawal by Subject|2|||
94264846|NCT01494350|322763563|FG000|Overall Study|Worsening of lesion|1|||
94264847|NCT02608879|322763577|FG000|Overall Study|Lost to Follow-up|1|||
94264848|NCT02608879|322763578|FG001|Overall Study|Lost to Follow-up|0|||
94264849|NCT02608879|322763579|FG002|Overall Study|Lost to Follow-up|0|||
94264850|NCT02608879|322763577|FG000|Overall Study|Did not meet continuation criteria|0|||
94264851|NCT02608879|322763578|FG001|Overall Study|Did not meet continuation criteria|0|||
94264852|NCT02608879|322763579|FG002|Overall Study|Did not meet continuation criteria|3|||
94264853|NCT04246801|322763580|FG000|Overall Study|Adverse Event|1|||
94264854|NCT04246801|322763581|FG001|Overall Study|Adverse Event|1|||
94264855|NCT04246801|322763580|FG000|Overall Study|Protocol Violation|1|||
94264856|NCT04246801|322763581|FG001|Overall Study|Protocol Violation|1|||
94264857|NCT04246801|322763580|FG000|Overall Study|Lack of Efficacy|0|||
94264858|NCT04246801|322763581|FG001|Overall Study|Lack of Efficacy|2|||
94264859|NCT04246801|322763580|FG000|Overall Study|Lost to Follow-up|1|||
94264860|NCT04246801|322763581|FG001|Overall Study|Lost to Follow-up|1|||
94264861|NCT04246801|322763580|FG000|Overall Study|Withdrawal by Subject|2|||
94264862|NCT04246801|322763581|FG001|Overall Study|Withdrawal by Subject|1|||
94264863|NCT01326728|322763587|FG000|Overall Study|Death|13|||
94264864|NCT01326728|322763588|FG001|Overall Study|Death|0|||
94264865|NCT01326728|322763587|FG000|Overall Study|Early closure of study|34|||
94264866|NCT01326728|322763588|FG001|Overall Study|Early closure of study|9|||
94264867|NCT00651157|322763590|FG000|Overall Study|Death|1|||
94264868|NCT00651157|322763590|FG000|Overall Study|Protocol Violation|1|||
94264869|NCT02322229|322763591|FG000|Overall Study|Physician Decision|2|||
94264870|NCT03431350|322763594|FG000|Overall Study|ONGOING|0|||
94264871|NCT03431350|322763595|FG001|Overall Study|ONGOING|0|||
94264872|NCT03431350|322763596|FG002|Overall Study|ONGOING|2|||
94264873|NCT03431350|322763597|FG003|Overall Study|ONGOING|0|||
94696337|NCT02337361|324341790|FG000|6-month Follow-up|Lost to Follow-up|2|||
94696338|NCT02337361|324341791|FG001|6-month Follow-up|Lost to Follow-up|4|||
94696339|NCT02427646|324341792|FG000|Overall Study|Lack of Efficacy|2|||
94696340|NCT02427646|324341793|FG001|Overall Study|Lack of Efficacy|3|||
94696341|NCT02427646|324341792|FG000|Overall Study|Physician Decision|1|||
94696342|NCT02427646|324341793|FG001|Overall Study|Physician Decision|4|||
94696343|NCT02427646|324341792|FG000|Overall Study|Protocol Violation|3|||
94696344|NCT02427646|324341793|FG001|Overall Study|Protocol Violation|3|||
94696345|NCT02427646|324341792|FG000|Overall Study|Bothersome hand weakness|2|||
94696346|NCT02427646|324341793|FG001|Overall Study|Bothersome hand weakness|4|||
94696347|NCT01929993|324343468|FG000|Overall Study|Protocol Violation|4|||
94696348|NCT01929993|324343469|FG001|Overall Study|Protocol Violation|6|||
94696349|NCT01929993|324343468|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
94696350|NCT01929993|324343469|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
94696351|NCT01115998|324343476|FG000|Overall Study|Lost to Follow-up|6|||
94696352|NCT01115998|324343477|FG001|Overall Study|Lost to Follow-up|6|||
94696353|NCT03531905|324343478|FG000|Overall Study|Withdrawal by Subject|3|||
94696354|NCT03531905|324343479|FG001|Overall Study|Withdrawal by Subject|3|||
94696355|NCT03531905|324343480|FG002|Overall Study|Withdrawal by Subject|2|||
94696356|NCT03531905|324343478|FG000|Overall Study|Lost to Follow-up|2|||
94696357|NCT03531905|324343479|FG001|Overall Study|Lost to Follow-up|2|||
94696358|NCT03531905|324343480|FG002|Overall Study|Lost to Follow-up|1|||
94696359|NCT03531905|324343478|FG000|Overall Study|Participant was out of town|1|||
94696360|NCT03531905|324343479|FG001|Overall Study|Participant was out of town|0|||
94696361|NCT03531905|324343480|FG002|Overall Study|Participant was out of town|0|||
94696362|NCT03531905|324343478|FG000|Overall Study|Could not speak with the participant|1|||
94696363|NCT03531905|324343479|FG001|Overall Study|Could not speak with the participant|0|||
94696364|NCT03531905|324343480|FG002|Overall Study|Could not speak with the participant|0|||
94696365|NCT01174550|324343485|FG000|Overall Study|Death|75|||
94696366|NCT01174550|324343486|FG001|Overall Study|Death|74|||
94696367|NCT01174550|324343485|FG000|Overall Study|Lost to Follow-up|652|||
94696368|NCT01174550|324343486|FG001|Overall Study|Lost to Follow-up|510|||
94696369|NCT01174550|324343485|FG000|Overall Study|Withdrawal by Subject|543|||
94696370|NCT01174550|324343486|FG001|Overall Study|Withdrawal by Subject|289|||
94696371|NCT00515086|324343491|FG000|Overall Study|Adverse Event|1|||
94696372|NCT00515086|324343492|FG001|Overall Study|Adverse Event|1|||
94696373|NCT00515086|324343493|FG002|Overall Study|Adverse Event|2|||
94696374|NCT00515086|324343494|FG003|Overall Study|Adverse Event|3|||
94696375|NCT00515086|324343491|FG000|Overall Study|Administrative|1|||
94696376|NCT00515086|324343492|FG001|Overall Study|Administrative|1|||
94696377|NCT00515086|324343493|FG002|Overall Study|Administrative|0|||
94696378|NCT00515086|324343494|FG003|Overall Study|Administrative|0|||
94696379|NCT00515086|324343491|FG000|Overall Study|Withdrawal by Subject|1|||
94696380|NCT00515086|324343492|FG001|Overall Study|Withdrawal by Subject|0|||
94696381|NCT00515086|324343493|FG002|Overall Study|Withdrawal by Subject|0|||
94696382|NCT00515086|324343494|FG003|Overall Study|Withdrawal by Subject|1|||
94696383|NCT00515086|324343491|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
94696384|NCT00515086|324343492|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
94696385|NCT00515086|324343493|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
94696386|NCT00515086|324343494|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
94696387|NCT00515086|324343491|FG000|Overall Study|Lost to Follow-up|1|||
94696388|NCT00515086|324343492|FG001|Overall Study|Lost to Follow-up|0|||
94696389|NCT00515086|324343493|FG002|Overall Study|Lost to Follow-up|0|||
94696390|NCT00515086|324343494|FG003|Overall Study|Lost to Follow-up|0|||
94696391|NCT00515086|324343491|FG000|Overall Study|Study drug no longer required|0|||
94696392|NCT00515086|324343492|FG001|Overall Study|Study drug no longer required|1|||
94696393|NCT00515086|324343493|FG002|Overall Study|Study drug no longer required|0|||
94696394|NCT00515086|324343494|FG003|Overall Study|Study drug no longer required|0|||
94696395|NCT00515086|324343491|FG000|Overall Study|Death|2|||
94264874|NCT03431350|322763598|FG004|Overall Study|ONGOING|1|||
94264875|NCT03431350|322763599|FG005|Overall Study|ONGOING|3|||
94264876|NCT03431350|322763600|FG006|Overall Study|ONGOING|0|||
94696396|NCT00515086|324343492|FG001|Overall Study|Death|0|||
94696397|NCT00515086|324343493|FG002|Overall Study|Death|0|||
94696398|NCT00515086|324343494|FG003|Overall Study|Death|0|||
94696399|NCT01021332|324343495|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
94696400|NCT01021332|324343495|FG000|Overall Study|Adverse Event|43|||
94696401|NCT01021332|324343495|FG000|Overall Study|Lack of Efficacy|19|||
94696402|NCT01021332|324343495|FG000|Overall Study|Withdrawal of Consent|23|||
94696403|NCT01021332|324343495|FG000|Overall Study|Lost to Follow-up|4|||
94696404|NCT01021332|324343495|FG000|Overall Study|Protocol Violation|9|||
94696405|NCT01021332|324343495|FG000|Overall Study|Miscellaneous|3|||
94696406|NCT05343455|324343498|FG000|Overall Study|Withdrawal by Subject|4|||
94264877|NCT03431350|322763601|FG007|Overall Study|ONGOING|1|||
94696407|NCT05343455|324343499|FG001|Overall Study|Withdrawal by Subject|9|||
94696408|NCT05343455|324343500|FG002|Overall Study|Withdrawal by Subject|7|||
94696409|NCT05343455|324343498|FG000|Overall Study|Adverse Event|2|||
94264878|NCT03431350|322763602|FG008|Overall Study|ONGOING|3|||
94264879|NCT03431350|322763603|FG009|Overall Study|ONGOING|4|||
94264880|NCT03431350|322763604|FG010|Overall Study|ONGOING|2|||
94264881|NCT03431350|322763605|FG011|Overall Study|ONGOING|1|||
94264882|NCT03431350|322763594|FG000|Overall Study|Death|6|||
94264883|NCT03431350|322763595|FG001|Overall Study|Death|5|||
94264884|NCT03431350|322763596|FG002|Overall Study|Death|18|||
94696410|NCT05343455|324343499|FG001|Overall Study|Adverse Event|1|||
94696411|NCT05343455|324343500|FG002|Overall Study|Adverse Event|2|||
94696412|NCT05343455|324343498|FG000|Overall Study|Lost to Follow-up|1|||
94696413|NCT05343455|324343499|FG001|Overall Study|Lost to Follow-up|1|||
94696414|NCT05343455|324343500|FG002|Overall Study|Lost to Follow-up|3|||
94696415|NCT05343455|324343498|FG000|Overall Study|Pregnancy|1|||
94696416|NCT05343455|324343499|FG001|Overall Study|Pregnancy|0|||
94696417|NCT05343455|324343500|FG002|Overall Study|Pregnancy|0|||
94696418|NCT05343455|324343498|FG000|Overall Study|Physician Decision|0|||
94696419|NCT05343455|324343499|FG001|Overall Study|Physician Decision|0|||
94696420|NCT05343455|324343500|FG002|Overall Study|Physician Decision|1|||
94696421|NCT05343455|324343498|FG000|Overall Study|Protocol Violation|0|||
94696422|NCT05343455|324343499|FG001|Overall Study|Protocol Violation|1|||
94696423|NCT05343455|324343500|FG002|Overall Study|Protocol Violation|1|||
94696424|NCT02748512|324343503|FG000|Overall Study|Lost to Follow-up|1|||
94696425|NCT02748512|324343504|FG001|Overall Study|Lost to Follow-up|1|||
94696426|NCT01066156|324343514|FG000|Overall Study|ineligible|2|||
94696427|NCT01066156|324343514|FG000|Overall Study|Lost to Follow-up|7|||
94696428|NCT01066156|324343514|FG000|Overall Study|Withdrawal by Subject|1|||
94696429|NCT04537949|324343517|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
94696430|NCT04537949|324343518|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
94696431|NCT04537949|324343519|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
94696432|NCT04537949|324343520|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
94696433|NCT04537949|324343521|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
94696434|NCT04537949|324343522|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
94696435|NCT04537949|324343523|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
94696436|NCT04537949|324343524|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
94696437|NCT04537949|324343517|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
94696438|NCT04537949|324343518|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
94696439|NCT04537949|324343519|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
94696440|NCT04537949|324343520|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
94696441|NCT04537949|324343521|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
94696442|NCT04537949|324343522|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
94696443|NCT04537949|324343523|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
94696444|NCT04537949|324343524|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
94696445|NCT04537949|324343517|FG000|Follow-up Phase|Lost to Follow-up|0|||
94696446|NCT04537949|324343518|FG001|Follow-up Phase|Lost to Follow-up|3|||
94696447|NCT04537949|324343519|FG002|Follow-up Phase|Lost to Follow-up|0|||
94696448|NCT04537949|324343520|FG003|Follow-up Phase|Lost to Follow-up|0|||
94696449|NCT04537949|324343521|FG004|Follow-up Phase|Lost to Follow-up|0|||
94696450|NCT04537949|324343522|FG005|Follow-up Phase|Lost to Follow-up|0|||
94696451|NCT04537949|324343523|FG006|Follow-up Phase|Lost to Follow-up|0|||
94696452|NCT04537949|324343524|FG007|Follow-up Phase|Lost to Follow-up|0|||
94696453|NCT04537949|324343517|FG000|Follow-up Phase|personal reasons|0|||
94696454|NCT04537949|324343518|FG001|Follow-up Phase|personal reasons|0|||
94696455|NCT04537949|324343519|FG002|Follow-up Phase|personal reasons|0|||
94696456|NCT04537949|324343520|FG003|Follow-up Phase|personal reasons|1|||
94696457|NCT04537949|324343521|FG004|Follow-up Phase|personal reasons|1|||
94696458|NCT04537949|324343522|FG005|Follow-up Phase|personal reasons|0|||
94696459|NCT04537949|324343523|FG006|Follow-up Phase|personal reasons|0|||
94696460|NCT04537949|324343524|FG007|Follow-up Phase|personal reasons|0|||
94696461|NCT04537949|324343517|FG000|Follow-up Phase|Withdrawal by Subject|0|||
94696462|NCT04537949|324343518|FG001|Follow-up Phase|Withdrawal by Subject|0|||
94696463|NCT04537949|324343519|FG002|Follow-up Phase|Withdrawal by Subject|0|||
94696464|NCT04537949|324343520|FG003|Follow-up Phase|Withdrawal by Subject|0|||
94264885|NCT03431350|322763597|FG003|Overall Study|Death|7|||
94264886|NCT03431350|322763598|FG004|Overall Study|Death|4|||
94264887|NCT03431350|322763599|FG005|Overall Study|Death|3|||
94696465|NCT04537949|324343521|FG004|Follow-up Phase|Withdrawal by Subject|1|||
94696466|NCT04537949|324343522|FG005|Follow-up Phase|Withdrawal by Subject|0|||
94696467|NCT04537949|324343523|FG006|Follow-up Phase|Withdrawal by Subject|0|||
94264888|NCT03431350|322763600|FG006|Overall Study|Death|2|||
94264889|NCT03431350|322763601|FG007|Overall Study|Death|0|||
94264890|NCT03431350|322763602|FG008|Overall Study|Death|0|||
94696468|NCT04537949|324343524|FG007|Follow-up Phase|Withdrawal by Subject|0|||
94696469|NCT02400307|324343525|FG000|Overall Study|Enrolled and Never Dosed|1|||
94264891|NCT03431350|322763603|FG009|Overall Study|Death|0|||
94264892|NCT03431350|322763604|FG010|Overall Study|Death|4|||
94696470|NCT02400307|324343526|FG001|Overall Study|Enrolled and Never Dosed|0|||
94696471|NCT02015663|324343527|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
94696472|NCT02015663|324343528|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
94696473|NCT02015663|324343527|FG000|Overall Study|Withdrawal by Subject|1|||
94366141|NCT02406742|323126461|FG002|Overall Study|Transition to other treatment|1|||
94366142|NCT02406742|323126459|FG000|Overall Study|Other Reasons|1|||
94366143|NCT02406742|323126460|FG001|Overall Study|Other Reasons|11|||
94696474|NCT02015663|324343528|FG001|Overall Study|Withdrawal by Subject|0|||
94696475|NCT02015663|324343527|FG000|Overall Study|Protocol Violation|0|||
94696476|NCT02015663|324343528|FG001|Overall Study|Protocol Violation|1|||
94696477|NCT02015663|324343527|FG000|Overall Study|Adverse Event|3|||
94696478|NCT02015663|324343528|FG001|Overall Study|Adverse Event|0|||
94696479|NCT02015663|324343527|FG000|Overall Study|Administrative problems|10|||
94696480|NCT02015663|324343528|FG001|Overall Study|Administrative problems|11|||
94696481|NCT00372528|324343531|FG000|Overall Study|Lack of Efficacy|1|||
94696482|NCT00372528|324343531|FG000|Overall Study|Adverse Event|1|||
94696483|NCT00372528|324343531|FG000|Overall Study|Study Terminated by Sponsor|18|||
94696484|NCT00372528|324343531|FG000|Overall Study|Other|1|||
94696485|NCT01719861|324343535|FG000|Cycle 1|Death|4|||
94696486|NCT01719861|324343535|FG000|Cycle 2|Death|1|||
94696487|NCT00087490|324343536|FG000|Overall Study|Death|6|||
94696488|NCT00087490|324343537|FG001|Overall Study|Death|4|||
94696489|NCT00087490|324343536|FG000|Overall Study|Adverse Event|3|||
94696490|NCT00087490|324343537|FG001|Overall Study|Adverse Event|8|||
94696491|NCT00087490|324343536|FG000|Overall Study|Lack of Efficacy|0|||
94696492|NCT00087490|324343537|FG001|Overall Study|Lack of Efficacy|2|||
94696493|NCT00087490|324343536|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
94696494|NCT00087490|324343537|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
94696495|NCT00087490|324343536|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
94696496|NCT00087490|324343537|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
94696497|NCT00087490|324343536|FG000|Overall Study|Randomized but not treated|7|||
94696498|NCT00087490|324343537|FG001|Overall Study|Randomized but not treated|18|||
94696499|NCT03379233|324343538|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
94696500|NCT03379233|324343539|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
94696501|NCT00848211|324343540|FG000|Overall Study|Protocol Violation|0|||
94696502|NCT00848211|324343541|FG001|Overall Study|Protocol Violation|1|||
94696503|NCT00848211|324343542|FG002|Overall Study|Protocol Violation|1|||
94696504|NCT00848211|324343543|FG003|Overall Study|Protocol Violation|0|||
94696505|NCT00848211|324343540|FG000|Overall Study|Adverse Event|0|||
94366144|NCT02406742|323126461|FG002|Overall Study|Other Reasons|5|||
94366145|NCT00414011|323126463|FG000|Overall Study|Physician Decision|3|||
94366146|NCT00414011|323126463|FG000|Overall Study|Withdrawal by Subject|2|||
94366147|NCT02367729|323126466|FG000|Overall Study|Organic disorder diagnosed|2|||
94466068|NCT04907227|323495000|FG000|Overall Study|Physician Decision|1|||
94466069|NCT04907227|323495001|FG001|Overall Study|Physician Decision|0|||
94466070|NCT04852276|323495002|FG000|Overall Study|Death|2|||
94466071|NCT04852276|323495003|FG001|Overall Study|Death|0|||
94466072|NCT04852276|323495002|FG000|Overall Study|Lost to Follow-up|15|||
94466073|NCT04852276|323495003|FG001|Overall Study|Lost to Follow-up|9|||
94466074|NCT04852276|323495002|FG000|Overall Study|Withdrawal by Subject|26|||
94466075|NCT04852276|323495003|FG001|Overall Study|Withdrawal by Subject|6|||
94466076|NCT04529850|323496930|FG000|Overall Study|Death|2|||
94466077|NCT04529850|323496930|FG000|Overall Study|Physician Decision|1|||
94466078|NCT04529850|323496930|FG000|Overall Study|Withdrawal by Subject|2|||
94466079|NCT01458951|323496933|FG000|Overall Study|Other|1|||
94466080|NCT01458951|323496934|FG001|Overall Study|Other|0|||
94466081|NCT01458951|323496935|FG002|Overall Study|Other|0|||
94466082|NCT01458951|323496933|FG000|Overall Study|Protocol Violation|5|||
94466083|NCT01458951|323496934|FG001|Overall Study|Protocol Violation|1|||
94466084|NCT01458951|323496935|FG002|Overall Study|Protocol Violation|0|||
94466085|NCT01458951|323496933|FG000|Overall Study|Withdrawal by Subject|2|||
94466086|NCT01458951|323496934|FG001|Overall Study|Withdrawal by Subject|0|||
94466087|NCT01458951|323496935|FG002|Overall Study|Withdrawal by Subject|2|||
94466088|NCT01458951|323496933|FG000|Overall Study|Adverse Event|7|||
94366148|NCT02367729|323126467|FG001|Overall Study|Organic disorder diagnosed|1|||
94366149|NCT02367729|323126466|FG000|Overall Study|Adverse Event|1|||
94466089|NCT01458951|323496934|FG001|Overall Study|Adverse Event|0|||
94366150|NCT02367729|323126467|FG001|Overall Study|Adverse Event|2|||
94366151|NCT02367729|323126466|FG000|Overall Study|Withdrawal by Subject|0|||
94366152|NCT02367729|323126467|FG001|Overall Study|Withdrawal by Subject|5|||
94466090|NCT01458951|323496935|FG002|Overall Study|Adverse Event|2|||
94466091|NCT01458951|323496933|FG000|Overall Study|Insufficient Clinical Response|17|||
94466092|NCT01458951|323496934|FG001|Overall Study|Insufficient Clinical Response|0|||
94466093|NCT01458951|323496935|FG002|Overall Study|Insufficient Clinical Response|11|||
94466094|NCT01473394|323496936|FG000|Overall Study|Adverse Event|13|||
94466095|NCT01473394|323496937|FG001|Overall Study|Adverse Event|16|||
94696506|NCT00848211|324343541|FG001|Overall Study|Adverse Event|0|||
94696507|NCT00848211|324343542|FG002|Overall Study|Adverse Event|0|||
94696508|NCT00848211|324343543|FG003|Overall Study|Adverse Event|0|||
94696509|NCT02049437|324343547|FG000|Period 1|Adverse Event|1|||
94696510|NCT02049437|324343548|FG001|Period 1|Adverse Event|1|||
94696511|NCT02049437|324343547|FG000|Period 1|Adverse Event|1|||
94696512|NCT02049437|324343548|FG001|Period 1|Adverse Event|0|||
94696513|NCT03782727|324343551|FG000|Overall Study|Lost to Follow-up|32|||
94696514|NCT03682536|324343552|FG000|Randomization|Withdrawal by Subject|0|||
94696515|NCT03682536|324343553|FG001|Randomization|Withdrawal by Subject|2|||
94696516|NCT03682536|324343552|FG000|Treatment|Other Reasons|8|||
94696517|NCT03682536|324343553|FG001|Treatment|Other Reasons|7|||
94696518|NCT03682536|324343552|FG000|Treatment|Physician Decision|5|||
94696519|NCT03682536|324343553|FG001|Treatment|Physician Decision|5|||
94696520|NCT03682536|324343552|FG000|Treatment|Protocol Violation|1|||
94696521|NCT03682536|324343553|FG001|Treatment|Protocol Violation|0|||
94696522|NCT03682536|324343552|FG000|Treatment|Study Terminated by Sponsor|1|||
94696523|NCT03682536|324343553|FG001|Treatment|Study Terminated by Sponsor|2|||
94696524|NCT03682536|324343552|FG000|Treatment|Lost to Follow-up|0|||
94696525|NCT03682536|324343553|FG001|Treatment|Lost to Follow-up|1|||
94696526|NCT03682536|324343552|FG000|Treatment|Withdrawal by Subject|16|||
94696527|NCT03682536|324343553|FG001|Treatment|Withdrawal by Subject|18|||
94696528|NCT03682536|324343552|FG000|Treatment|Lack of Efficacy|41|||
94696529|NCT03682536|324343553|FG001|Treatment|Lack of Efficacy|68|||
94696530|NCT03682536|324343552|FG000|Treatment|Disease Progression|9|||
94696531|NCT03682536|324343553|FG001|Treatment|Disease Progression|7|||
94696532|NCT03682536|324343552|FG000|Treatment|Adverse Event|9|||
94696533|NCT03682536|324343553|FG001|Treatment|Adverse Event|5|||
94696534|NCT03682536|324343552|FG000|Treatment|Death|14|||
94696535|NCT03682536|324343553|FG001|Treatment|Death|13|||
94696536|NCT03909165|324343554|FG000|Overall Study|Physician Decision|0|||
94696537|NCT03909165|324343555|FG001|Overall Study|Physician Decision|1|||
94696538|NCT03909165|324343556|FG002|Overall Study|Physician Decision|0|||
94696539|NCT03909165|324343557|FG003|Overall Study|Physician Decision|0|||
94696540|NCT03909165|324343558|FG004|Overall Study|Physician Decision|0|||
94696541|NCT03909165|324343554|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94696542|NCT03909165|324343555|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94696543|NCT03909165|324343556|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94696544|NCT03909165|324343557|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94696545|NCT03909165|324343558|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
94696546|NCT03909165|324343554|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
94696547|NCT03909165|324343555|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
94696548|NCT03909165|324343556|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
94696549|NCT03909165|324343557|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
94696550|NCT03909165|324343558|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
94696551|NCT03909165|324343554|FG000|Overall Study|Previous Drug Exposure|0|||
94696552|NCT03909165|324343555|FG001|Overall Study|Previous Drug Exposure|0|||
94696553|NCT03909165|324343556|FG002|Overall Study|Previous Drug Exposure|1|||
94696554|NCT03909165|324343557|FG003|Overall Study|Previous Drug Exposure|0|||
94696555|NCT03909165|324343558|FG004|Overall Study|Previous Drug Exposure|0|||
94696556|NCT03909165|324343554|FG000|Overall Study|Early Discharge|1|||
94696557|NCT03909165|324343555|FG001|Overall Study|Early Discharge|0|||
94696558|NCT03909165|324343556|FG002|Overall Study|Early Discharge|0|||
94264893|NCT03431350|322763605|FG011|Overall Study|Death|0|||
94264894|NCT03431350|322763594|FG000|Overall Study|Lost to Follow-up|0|||
94264895|NCT03431350|322763595|FG001|Overall Study|Lost to Follow-up|1|||
94264896|NCT03431350|322763596|FG002|Overall Study|Lost to Follow-up|0|||
94264897|NCT03431350|322763597|FG003|Overall Study|Lost to Follow-up|0|||
94264898|NCT03431350|322763598|FG004|Overall Study|Lost to Follow-up|0|||
94264899|NCT03431350|322763599|FG005|Overall Study|Lost to Follow-up|0|||
94264900|NCT03431350|322763600|FG006|Overall Study|Lost to Follow-up|0|||
94264901|NCT03431350|322763601|FG007|Overall Study|Lost to Follow-up|0|||
94264902|NCT03431350|322763602|FG008|Overall Study|Lost to Follow-up|0|||
94264903|NCT03431350|322763603|FG009|Overall Study|Lost to Follow-up|0|||
94264904|NCT03431350|322763604|FG010|Overall Study|Lost to Follow-up|0|||
94264905|NCT03431350|322763605|FG011|Overall Study|Lost to Follow-up|0|||
94264906|NCT03431350|322763594|FG000|Overall Study|Withdrawal by Subject|0|||
94264907|NCT03431350|322763595|FG001|Overall Study|Withdrawal by Subject|0|||
94264908|NCT03431350|322763596|FG002|Overall Study|Withdrawal by Subject|0|||
94264909|NCT03431350|322763597|FG003|Overall Study|Withdrawal by Subject|1|||
94264910|NCT03431350|322763598|FG004|Overall Study|Withdrawal by Subject|1|||
94264911|NCT03431350|322763599|FG005|Overall Study|Withdrawal by Subject|1|||
94264912|NCT03431350|322763600|FG006|Overall Study|Withdrawal by Subject|0|||
94366153|NCT00388674|323126468|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
94696559|NCT03909165|324343557|FG003|Overall Study|Early Discharge|0|||
94696560|NCT03909165|324343558|FG004|Overall Study|Early Discharge|0|||
94696561|NCT04640571|324343559|FG000|Overall Study|Withdrawal by Subject|0|||
94696562|NCT04640571|324343560|FG001|Overall Study|Withdrawal by Subject|0|||
94696563|NCT04640571|324343561|FG002|Overall Study|Withdrawal by Subject|0|||
94264913|NCT03431350|322763601|FG007|Overall Study|Withdrawal by Subject|0|||
94264914|NCT03431350|322763602|FG008|Overall Study|Withdrawal by Subject|0|||
94264915|NCT03431350|322763603|FG009|Overall Study|Withdrawal by Subject|2|||
94366154|NCT00388674|323126469|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
94696564|NCT04640571|324343562|FG003|Overall Study|Withdrawal by Subject|0|||
94696565|NCT04640571|324343563|FG004|Overall Study|Withdrawal by Subject|0|||
94696566|NCT04640571|324343564|FG005|Overall Study|Withdrawal by Subject|2|||
94264916|NCT03431350|322763604|FG010|Overall Study|Withdrawal by Subject|0|||
94264917|NCT03431350|322763605|FG011|Overall Study|Withdrawal by Subject|1|||
94264918|NCT03431350|322763594|FG000|Overall Study|Other|0|||
94264919|NCT03431350|322763595|FG001|Overall Study|Other|0|||
94264920|NCT03431350|322763596|FG002|Overall Study|Other|1|||
94264921|NCT03431350|322763597|FG003|Overall Study|Other|3|||
94264922|NCT03431350|322763598|FG004|Overall Study|Other|2|||
94264923|NCT03431350|322763599|FG005|Overall Study|Other|2|||
94264924|NCT03431350|322763600|FG006|Overall Study|Other|4|||
94264925|NCT03431350|322763601|FG007|Overall Study|Other|0|||
94264926|NCT03431350|322763602|FG008|Overall Study|Other|14|||
94264927|NCT03431350|322763603|FG009|Overall Study|Other|11|||
94264928|NCT03431350|322763604|FG010|Overall Study|Other|11|||
94264929|NCT03431350|322763605|FG011|Overall Study|Other|15|||
94264930|NCT01130051|322763606|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
94264931|NCT01130051|322763607|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
94264932|NCT01130051|322763606|FG000|Washout Period of 14 Days|Protocol Violation|1|||
94264933|NCT01130051|322763607|FG001|Washout Period of 14 Days|Protocol Violation|1|||
94264934|NCT04376060|322763610|FG000|Overall Study|Physician Decision|1|||
94264935|NCT00445068|322763611|FG000|Overall Study|Disease progression|26|||
94264936|NCT00445068|322763611|FG000|Overall Study|Adverse Event|5|||
94264937|NCT00445068|322763611|FG000|Overall Study|Abnormal laboratory value|2|||
94264938|NCT00445068|322763611|FG000|Overall Study|Withdrawal by Subject|2|||
94264939|NCT00445068|322763611|FG000|Overall Study|Death|1|||
94264940|NCT00583024|322763612|FG000|Overall Study|Lost to Follow-up|4|||
94264941|NCT05514873|322763616|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
94264942|NCT05514873|322763616|FG000|Main Treatment Period|Adverse Event|2|||
94264943|NCT05514873|322763616|FG000|Extension Treatment Period|Lost to Follow-up|3|||
94264944|NCT04376827|322763617|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
94264945|NCT04376827|322763618|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
94264946|NCT04376827|322763617|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
94264947|NCT04376827|322763618|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
94264948|NCT04376827|322763617|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
94264949|NCT04376827|322763618|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
94264950|NCT04376827|322763617|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
94264951|NCT04376827|322763618|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
94264952|NCT04376827|322763617|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
94264953|NCT04376827|322763618|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
94264954|NCT03047551|322765596|FG000|Overall Study|Did not receive TAS|1|||
94264955|NCT03047551|322765597|FG001|Overall Study|Did not receive TAS|0|||
94264956|NCT03047551|322765596|FG000|Overall Study|Physician Decision|1|||
94264957|NCT03047551|322765597|FG001|Overall Study|Physician Decision|0|||
94264958|NCT03047551|322765596|FG000|Overall Study|Withdrawal by Subject|0|||
94264959|NCT03047551|322765597|FG001|Overall Study|Withdrawal by Subject|1|||
94264960|NCT03047551|322765596|FG000|Overall Study|Probe malfunction|0|||
94264961|NCT03047551|322765597|FG001|Overall Study|Probe malfunction|1|||
94264962|NCT03047551|322765596|FG000|Overall Study|Ineligible|0|||
94264963|NCT03047551|322765597|FG001|Overall Study|Ineligible|1|||
94264964|NCT00826111|322765598|FG000|Overall Study|Lost to Follow-up|0|||
94264965|NCT00826111|322765599|FG001|Overall Study|Lost to Follow-up|1|||
94264966|NCT00826111|322765598|FG000|Overall Study|Protocol Violation|1|||
94264967|NCT00826111|322765599|FG001|Overall Study|Protocol Violation|0|||
94264968|NCT00826111|322765598|FG000|Overall Study|Withdrawal by Subject|5|||
94264969|NCT00826111|322765599|FG001|Overall Study|Withdrawal by Subject|0|||
94264970|NCT00826111|322765598|FG000|Overall Study|Physician Decision|1|||
94696567|NCT03176134|324343565|FG000|Overall Study|Lost to Follow-up|0|||
94696568|NCT03176134|324343566|FG001|Overall Study|Lost to Follow-up|2|||
94696569|NCT03176134|324343567|FG002|Overall Study|Lost to Follow-up|0|||
94696570|NCT03176134|324343568|FG003|Overall Study|Lost to Follow-up|0|||
94696571|NCT03176134|324343569|FG004|Overall Study|Lost to Follow-up|0|||
94696572|NCT03176134|324343570|FG005|Overall Study|Lost to Follow-up|0|||
94696573|NCT03176134|324343571|FG006|Overall Study|Lost to Follow-up|0|||
94696574|NCT03176134|324343572|FG007|Overall Study|Lost to Follow-up|0|||
94264971|NCT00826111|322765599|FG001|Overall Study|Physician Decision|1|||
94264972|NCT01672788|322765600|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
94264973|NCT01672788|322765601|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
94264974|NCT01672788|322765602|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
94366155|NCT00388674|323126468|FG000|Initial Treatment|Adverse Event|22|||
94366156|NCT00388674|323126469|FG001|Initial Treatment|Adverse Event|87|||
94696575|NCT03176134|324343565|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
94264975|NCT01672788|322765603|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
94264976|NCT03426787|322765606|FG000|Overall Study|Withdrawal by Subject|6|||
94696576|NCT03176134|324343566|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94366157|NCT00388674|323126468|FG000|Initial Treatment|Death|215|||
94366158|NCT00388674|323126469|FG001|Initial Treatment|Death|216|||
94366159|NCT00388674|323126468|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
94366160|NCT00388674|323126469|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
94366161|NCT00388674|323126468|FG000|Initial Treatment|HCC|12|||
94366162|NCT00388674|323126469|FG001|Initial Treatment|HCC|20|||
94366163|NCT00388674|323126468|FG000|Initial Treatment|Lost to Follow-up|526|||
94366164|NCT00388674|323126469|FG001|Initial Treatment|Lost to Follow-up|624|||
94366165|NCT00388674|323126468|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
94366166|NCT00388674|323126469|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
94366167|NCT00388674|323126468|FG000|Initial Treatment|Never Treated with Study Medication|1|||
94366168|NCT00388674|323126469|FG001|Initial Treatment|Never Treated with Study Medication|7|||
94366169|NCT00388674|323126468|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
94366170|NCT00388674|323126469|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
94366171|NCT00388674|323126468|FG000|Initial Treatment|Not Defined|125|||
94366172|NCT00388674|323126469|FG001|Initial Treatment|Not Defined|172|||
94366173|NCT00388674|323126468|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
94366174|NCT00388674|323126469|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
94366175|NCT00388674|323126468|FG000|Initial Treatment|Pregnancy|26|||
94366176|NCT00388674|323126469|FG001|Initial Treatment|Pregnancy|16|||
94366177|NCT00388674|323126468|FG000|Initial Treatment|Study Drug Toxicity|5|||
94366178|NCT00388674|323126469|FG001|Initial Treatment|Study Drug Toxicity|92|||
94366179|NCT00388674|323126468|FG000|Initial Treatment|Participant Request|501|||
94366180|NCT00388674|323126469|FG001|Initial Treatment|Participant Request|673|||
94366181|NCT00388674|323126468|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
94366182|NCT00388674|323126469|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
94366183|NCT00388674|323126468|FG000|Initial Treatment|Not Reported|10|||
94366184|NCT00388674|323126469|FG001|Initial Treatment|Not Reported|12|||
94366185|NCT00388674|323126468|FG000|End of Study|Administrative Reason By Sponsor|299|||
94366186|NCT00388674|323126469|FG001|End of Study|Administrative Reason By Sponsor|253|||
94366187|NCT00388674|323126468|FG000|End of Study|Death|239|||
94366188|NCT00388674|323126469|FG001|End of Study|Death|262|||
94366189|NCT00388674|323126468|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
94366190|NCT00388674|323126469|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
94366191|NCT00388674|323126468|FG000|End of Study|HCC|8|||
94366192|NCT00388674|323126469|FG001|End of Study|HCC|7|||
94366193|NCT00388674|323126468|FG000|End of Study|Lost to Follow-up|587|||
94366194|NCT00388674|323126469|FG001|End of Study|Lost to Follow-up|715|||
94366195|NCT00388674|323126468|FG000|End of Study|Malignancy (Non-HCC)|1|||
94366196|NCT00388674|323126469|FG001|End of Study|Malignancy (Non-HCC)|1|||
94366197|NCT00388674|323126468|FG000|End of Study|Non-Study Related Comorbidities|3|||
94366198|NCT00388674|323126469|FG001|End of Study|Non-Study Related Comorbidities|4|||
94366199|NCT00388674|323126468|FG000|End of Study|Not Defined|135|||
94366200|NCT00388674|323126469|FG001|End of Study|Not Defined|214|||
94366201|NCT00388674|323126468|FG000|End of Study|Participant Withdrew Consent|437|||
94366202|NCT00388674|323126469|FG001|End of Study|Participant Withdrew Consent|673|||
94366203|NCT00388674|323126468|FG000|End of Study|No Off-Treatment Status Data|22|||
94366204|NCT00388674|323126469|FG001|End of Study|No Off-Treatment Status Data|30|||
94366205|NCT00388674|323126468|FG000|End of Study|Not Reported|0|||
94366206|NCT00388674|323126469|FG001|End of Study|Not Reported|1|||
94366207|NCT00306852|323126473|FG000|Overall Study|Death|14|||
94366208|NCT00306852|323126474|FG001|Overall Study|Death|14|||
94366209|NCT00306852|323126473|FG000|Overall Study|Lost to Follow-up|15|||
94264977|NCT03426787|322765606|FG000|Overall Study|Lost to Follow-up|7|||
94264978|NCT03426787|322765606|FG000|Overall Study|Unrelated to intervention death|1|||
94366210|NCT00306852|323126474|FG001|Overall Study|Lost to Follow-up|24|||
94366211|NCT00078312|323126477|FG000|Overall Study|Adverse Event|43|||
94366212|NCT00078312|323126477|FG000|Overall Study|Lack of Efficacy|15|||
94264979|NCT03808688|322765607|FG000|Overall Study|Adverse Event|13|||
94264980|NCT03808688|322765608|FG001|Overall Study|Adverse Event|17|||
94264981|NCT03808688|322765607|FG000|Overall Study|Lack of Efficacy|2|||
94264982|NCT03808688|322765608|FG001|Overall Study|Lack of Efficacy|0|||
94264983|NCT03808688|322765607|FG000|Overall Study|Lost to Follow-up|0|||
94264984|NCT03808688|322765608|FG001|Overall Study|Lost to Follow-up|2|||
94264985|NCT03808688|322765607|FG000|Overall Study|Withdrawal by Subject|1|||
94366213|NCT00078312|323126477|FG000|Overall Study|Lost to Follow-up|41|||
94366214|NCT00078312|323126477|FG000|Overall Study|Physician Decision|9|||
94366215|NCT00078312|323126477|FG000|Overall Study|Protocol Violation|3|||
94366216|NCT00078312|323126477|FG000|Overall Study|Withdrawal by Subject|33|||
94366217|NCT00078312|323126477|FG000|Overall Study|Miscellaneous|33|||
94264986|NCT03808688|322765608|FG001|Overall Study|Withdrawal by Subject|0|||
94264987|NCT03808688|322765607|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
94264988|NCT03808688|322765608|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
94366218|NCT02610842|323126483|FG000|Overall Study|Lost to Follow-up|5|||
94366219|NCT00756652|323126484|FG000|Original Phase|Withdrawal by Subject|864|||
94366220|NCT00756652|323126485|FG001|Original Phase|Withdrawal by Subject|23|||
94366221|NCT00756652|323126484|FG000|Original Phase|Lost to Follow-up|601|||
94696577|NCT03176134|324343567|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
94696578|NCT03176134|324343568|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
94696579|NCT03176134|324343569|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
94696580|NCT03176134|324343570|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
94696581|NCT03176134|324343571|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
94696582|NCT03176134|324343572|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
94696583|NCT00235495|324343575|FG000|Overall Study|Death|52|||
94696584|NCT00235495|324343576|FG001|Overall Study|Death|42|||
94696585|NCT00235495|324343575|FG000|Overall Study|Withdrawal by Subject|5|||
94696586|NCT00235495|324343576|FG001|Overall Study|Withdrawal by Subject|3|||
94696587|NCT00235495|324343575|FG000|Overall Study|Lost to Follow-up|11|||
94696588|NCT00235495|324343576|FG001|Overall Study|Lost to Follow-up|13|||
94696589|NCT00235495|324343575|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
94696590|NCT00235495|324343576|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
94696591|NCT02696226|324343581|FG000|Overall Study|Study terminated - lack of enrollment|1|||
94264989|NCT03808688|322765607|FG000|Overall Study|IOP Too High|1|||
94264990|NCT03808688|322765608|FG001|Overall Study|IOP Too High|1|||
94264991|NCT03808688|322765607|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
94264992|NCT03808688|322765608|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
94264993|NCT03808688|322765607|FG000|Overall Study|Visit Out of Window|0|||
94264994|NCT03808688|322765608|FG001|Overall Study|Visit Out of Window|1|||
94264995|NCT03808688|322765607|FG000|Overall Study|Medication Non-Compliance|0|||
94264996|NCT03808688|322765608|FG001|Overall Study|Medication Non-Compliance|1|||
94264997|NCT03329196|322765609|FG000|Overall Study|Adverse Event|10|||
94264998|NCT03329196|322765610|FG001|Overall Study|Adverse Event|5|||
94264999|NCT03329196|322765609|FG000|Overall Study|Physician Decision|2|||
94265000|NCT03329196|322765610|FG001|Overall Study|Physician Decision|2|||
94265001|NCT03329196|322765609|FG000|Overall Study|Withdrawal by Subject|11|||
94265002|NCT03329196|322765610|FG001|Overall Study|Withdrawal by Subject|3|||
94265003|NCT03329196|322765609|FG000|Overall Study|Hepatic function abnormalities|0|||
94265004|NCT03329196|322765610|FG001|Overall Study|Hepatic function abnormalities|1|||
94265005|NCT03329196|322765609|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
94265006|NCT03329196|322765610|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
94265007|NCT03329196|322765609|FG000|Overall Study|Difficult to control Hb|2|||
94265008|NCT03329196|322765610|FG001|Overall Study|Difficult to control Hb|3|||
94265009|NCT03329196|322765609|FG000|Overall Study|Dialysis or renal transplant|13|||
94265010|NCT03329196|322765610|FG001|Overall Study|Dialysis or renal transplant|15|||
94265011|NCT01128361|322765616|FG000|Overall Study|Lost to Follow-up|0|||
94265012|NCT01128361|322765617|FG001|Overall Study|Lost to Follow-up|1|||
94265013|NCT01128361|322765616|FG000|Overall Study|Withdrawal by Subject|5|||
94265014|NCT01128361|322765617|FG001|Overall Study|Withdrawal by Subject|2|||
94265015|NCT01890148|322765618|FG000|Overall Study|Adverse Event|1|||
94265016|NCT01215175|322765619|FG000|Overall Study|Lost to Follow-up|0|||
94265017|NCT01215175|322765620|FG001|Overall Study|Lost to Follow-up|1|||
94265018|NCT01215175|322765621|FG002|Overall Study|Lost to Follow-up|0|||
94265019|NCT01215175|322765622|FG003|Overall Study|Lost to Follow-up|1|||
94265020|NCT01215175|322765623|FG004|Overall Study|Lost to Follow-up|0|||
94265021|NCT01678209|322765624|FG000|Overall Study|could not scan twice|1|||
94265022|NCT01678209|322765625|FG001|Overall Study|could not scan twice|1|||
94265023|NCT01678209|322765626|FG002|Overall Study|could not scan twice|1|||
94265024|NCT01678209|322765624|FG000|Overall Study|scheduling conflicts|0|||
94265025|NCT01678209|322765625|FG001|Overall Study|scheduling conflicts|0|||
94265026|NCT01678209|322765626|FG002|Overall Study|scheduling conflicts|1|||
94265027|NCT01678209|322765624|FG000|Overall Study|screen fail|16|||
94265028|NCT01678209|322765625|FG001|Overall Study|screen fail|17|||
94265029|NCT01678209|322765626|FG002|Overall Study|screen fail|16|||
94265030|NCT03873493|322765627|FG000|Overall Study|Withdrawal by Subject|1|||
94265031|NCT03873493|322765627|FG000|Overall Study|Death|9|||
94265032|NCT03873493|322765627|FG000|Overall Study|Lost to Follow-up|1|||
94265033|NCT03873493|322765627|FG000|Overall Study|Study Terminated by Sponsor|1|||
94265034|NCT03873493|322765627|FG000|Overall Study|Other|2|||
94265035|NCT03756350|322765632|FG000|Overall Study|Lost to Follow-up|1|||
94265036|NCT03876171|322765636|FG000|Overall Study|Withdrawal by Subject|3|||
94265037|NCT03876171|322765637|FG001|Overall Study|Withdrawal by Subject|3|||
94265038|NCT03876171|322765636|FG000|Overall Study|Re-arrest|0|||
94265039|NCT03876171|322765637|FG001|Overall Study|Re-arrest|4|||
94265040|NCT02012296|322765638|FG000|Overall Study|Lack of Efficacy|0|||
94265041|NCT02012296|322765639|FG001|Overall Study|Lack of Efficacy|0|||
94265042|NCT02012296|322765640|FG002|Overall Study|Lack of Efficacy|15|||
94265043|NCT02012296|322765638|FG000|Overall Study|Adverse Event|0|||
94265044|NCT02012296|322765639|FG001|Overall Study|Adverse Event|0|||
94265045|NCT02012296|322765640|FG002|Overall Study|Adverse Event|2|||
94265046|NCT02012296|322765638|FG000|Overall Study|Early study closure|0|||
94696592|NCT02696226|324343582|FG001|Overall Study|Study terminated - lack of enrollment|0|||
94696593|NCT02696226|324343583|FG002|Overall Study|Study terminated - lack of enrollment|2|||
94265047|NCT02012296|322765639|FG001|Overall Study|Early study closure|0|||
94265048|NCT02012296|322765640|FG002|Overall Study|Early study closure|5|||
94265049|NCT02012296|322765638|FG000|Overall Study|Protocol Violation|0|||
94265050|NCT02012296|322765639|FG001|Overall Study|Protocol Violation|1|||
94265051|NCT02012296|322765640|FG002|Overall Study|Protocol Violation|0|||
94265052|NCT01330914|322765641|FG000|Overall Study|Withdrawal by Subject|4|||
94265053|NCT01330914|322765641|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
94265054|NCT03503513|322765642|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
94265055|NCT03503513|322765642|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
94265056|NCT03503513|322765642|FG000|Overall Study|Physician Decision|3|||
94265057|NCT03503513|322765642|FG000|Overall Study|Withdrawal by Subject|2|||
94265058|NCT03503513|322765642|FG000|Overall Study|Lost to Follow-up|1|||
94265059|NCT02615470|322765647|FG000|Overall Study|Lost to Follow-up|21|||
94265060|NCT02615470|322765648|FG001|Overall Study|Lost to Follow-up|32|||
94265061|NCT01650285|322765649|FG000|Overall Study|Adverse Event|1|||
94265062|NCT00283049|322765653|FG000|Overall Study|Adverse Event|6|||
94265063|NCT00283049|322765654|FG001|Overall Study|Adverse Event|1|||
94265064|NCT00283049|322765655|FG002|Overall Study|Adverse Event|4|||
94265065|NCT00283049|322765653|FG000|Overall Study|Protocol Violation|3|||
94265066|NCT00283049|322765654|FG001|Overall Study|Protocol Violation|0|||
94265067|NCT00283049|322765655|FG002|Overall Study|Protocol Violation|3|||
94265068|NCT00283049|322765653|FG000|Overall Study|Death|1|||
94265069|NCT00283049|322765654|FG001|Overall Study|Death|1|||
94265070|NCT00283049|322765655|FG002|Overall Study|Death|1|||
94265071|NCT00283049|322765653|FG000|Overall Study|Lack of Efficacy|0|||
94265072|NCT00283049|322765654|FG001|Overall Study|Lack of Efficacy|1|||
94265073|NCT00283049|322765655|FG002|Overall Study|Lack of Efficacy|1|||
94265074|NCT00283049|322765653|FG000|Overall Study|Lost to Follow-up|4|||
94265075|NCT00283049|322765654|FG001|Overall Study|Lost to Follow-up|2|||
94265076|NCT00283049|322765655|FG002|Overall Study|Lost to Follow-up|5|||
94265077|NCT00283049|322765653|FG000|Overall Study|Withdrawal by Subject|26|||
94265078|NCT00283049|322765654|FG001|Overall Study|Withdrawal by Subject|24|||
94265079|NCT00283049|322765655|FG002|Overall Study|Withdrawal by Subject|19|||
94265080|NCT00283049|322765653|FG000|Overall Study|Discontinuation of Study|18|||
94265081|NCT00283049|322765654|FG001|Overall Study|Discontinuation of Study|16|||
94265082|NCT00283049|322765655|FG002|Overall Study|Discontinuation of Study|20|||
94265083|NCT00283049|322765653|FG000|Overall Study|No longer requires study treatment|0|||
94265084|NCT00283049|322765654|FG001|Overall Study|No longer requires study treatment|0|||
94265085|NCT00283049|322765655|FG002|Overall Study|No longer requires study treatment|1|||
94265086|NCT00385203|322765656|FG000|Overall Study|Adverse Event|5|||
94265087|NCT00385203|322765657|FG001|Overall Study|Adverse Event|4|||
94265088|NCT00385203|322765656|FG000|Overall Study|Death|1|||
94265089|NCT00385203|322765657|FG001|Overall Study|Death|0|||
94265090|NCT00385203|322765656|FG000|Overall Study|Condition under investigation worsened|18|||
94265091|NCT00385203|322765657|FG001|Overall Study|Condition under investigation worsened|3|||
94265092|NCT00385203|322765656|FG000|Overall Study|Incorrect enrollment|2|||
94265093|NCT00385203|322765657|FG001|Overall Study|Incorrect enrollment|0|||
94265094|NCT03422172|322765658|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
94265095|NCT03422172|322765658|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
94265096|NCT03422172|322765658|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
94265097|NCT00436618|322765662|FG000|Overall Study|Withdrawal by Subject|5|||
94265098|NCT00436618|322765663|FG001|Overall Study|Withdrawal by Subject|8|||
94265099|NCT00436618|322765664|FG002|Overall Study|Withdrawal by Subject|11|||
94265100|NCT00436618|322765662|FG000|Overall Study|Adverse Event|8|||
94265101|NCT00436618|322765663|FG001|Overall Study|Adverse Event|8|||
94265102|NCT00436618|322765664|FG002|Overall Study|Adverse Event|9|||
94265103|NCT00436618|322765662|FG000|Overall Study|Alternate Treatment|3|||
94265104|NCT00436618|322765663|FG001|Overall Study|Alternate Treatment|4|||
94265105|NCT00436618|322765664|FG002|Overall Study|Alternate Treatment|12|||
94265106|NCT00436618|322765662|FG000|Overall Study|Other Medical Problems|3|||
94265107|NCT00436618|322765663|FG001|Overall Study|Other Medical Problems|1|||
94265108|NCT00436618|322765664|FG002|Overall Study|Other Medical Problems|7|||
94265109|NCT00436618|322765662|FG000|Overall Study|Death|4|||
94265110|NCT00436618|322765663|FG001|Overall Study|Death|2|||
94265111|NCT00436618|322765664|FG002|Overall Study|Death|3|||
94265112|NCT00436618|322765662|FG000|Overall Study|New Primary or Other Reasons|6|||
94265113|NCT00436618|322765663|FG001|Overall Study|New Primary or Other Reasons|2|||
94265114|NCT00436618|322765664|FG002|Overall Study|New Primary or Other Reasons|12|||
94265115|NCT00436618|322765662|FG000|Overall Study|Still on treatment|1|||
94265116|NCT00436618|322765663|FG001|Overall Study|Still on treatment|2|||
94265117|NCT00436618|322765664|FG002|Overall Study|Still on treatment|7|||
94265118|NCT03829241|322765665|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
94265119|NCT03829241|322765666|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
94265120|NCT03829241|322765665|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
94265121|NCT03829241|322765666|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
94265122|NCT03829241|322765665|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
94265123|NCT03829241|322765666|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
94265124|NCT03829241|322765665|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
94265125|NCT03829241|322765666|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
94265126|NCT03829241|322765665|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
94265127|NCT03829241|322765666|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
94265128|NCT03829241|322765665|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
94265129|NCT03829241|322765666|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
94265130|NCT03829241|322765665|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
94265131|NCT03829241|322765666|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
94265132|NCT03829241|322765665|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
94265133|NCT03829241|322765666|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
94265134|NCT03829241|322765665|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
94265135|NCT03829241|322765666|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
94265136|NCT03829241|322765665|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
94265137|NCT03829241|322765666|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
94265138|NCT03829241|322765665|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
94265139|NCT03829241|322765666|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
94265140|NCT03829241|322765665|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
94265141|NCT03829241|322765666|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
94265142|NCT03829241|322765665|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
94265143|NCT03829241|322765666|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
94265144|NCT03829241|322765665|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
94265145|NCT03829241|322765666|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
94265146|NCT00698451|322765667|FG000|Overall Study|Adverse Event|22|||
94265147|NCT00698451|322765667|FG000|Overall Study|Physician Decision|2|||
94265148|NCT00698451|322765667|FG000|Overall Study|Protocol Violation|6|||
94265149|NCT00698451|322765667|FG000|Overall Study|Withdrawal by Subject|6|||
94265150|NCT00698451|322765667|FG000|Overall Study|Disease progression|3|||
94265151|NCT00698204|322765668|FG000|Overall Study|Withdrawal by Subject|1|||
94265152|NCT00698204|322765669|FG001|Overall Study|Withdrawal by Subject|0|||
94265153|NCT01179672|322765670|FG000|Overall Study|Adverse Event|17|||
94265154|NCT01179672|322765671|FG001|Overall Study|Adverse Event|8|||
94265155|NCT01179672|322765670|FG000|Overall Study|Withdrawal by Subject|10|||
94265156|NCT01179672|322765671|FG001|Overall Study|Withdrawal by Subject|12|||
94265157|NCT01179672|322765670|FG000|Overall Study|Entry Criteria Not Met|0|||
94265158|NCT01179672|322765671|FG001|Overall Study|Entry Criteria Not Met|2|||
94265159|NCT01179672|322765670|FG000|Overall Study|Lost to Follow-up|0|||
94265160|NCT01179672|322765671|FG001|Overall Study|Lost to Follow-up|1|||
94265161|NCT01179672|322765670|FG000|Overall Study|Protocol Violation|2|||
94265162|NCT01179672|322765671|FG001|Overall Study|Protocol Violation|2|||
94265163|NCT01179672|322765670|FG000|Overall Study|Physician Decision|1|||
94265164|NCT01179672|322765671|FG001|Overall Study|Physician Decision|1|||
94265165|NCT02224599|322765674|FG000|Overall Study|Physician Decision|1|||
94265166|NCT02224599|322765674|FG000|Overall Study|Progression of Disease|1|||
94265167|NCT00314249|322765676|FG000|Overall Study|Adverse Event|73|||
94265168|NCT00314249|322765677|FG001|Overall Study|Adverse Event|94|||
94265169|NCT00314249|322765676|FG000|Overall Study|Lack of Efficacy|33|||
94265170|NCT00314249|322765677|FG001|Overall Study|Lack of Efficacy|24|||
94265171|NCT00314249|322765676|FG000|Overall Study|Withdrawal by Subject|21|||
94265172|NCT00314249|322765677|FG001|Overall Study|Withdrawal by Subject|28|||
94265173|NCT00314249|322765676|FG000|Overall Study|Lost to Follow-up|15|||
94366222|NCT00756652|323126485|FG001|Original Phase|Lost to Follow-up|0|||
94366223|NCT00756652|323126484|FG000|Original Phase|Other Discontinuation|797|||
94366224|NCT00756652|323126485|FG001|Original Phase|Other Discontinuation|5|||
94366225|NCT00756652|323126484|FG000|Original Phase|Participant Noncompliance|18622|||
94265174|NCT00314249|322765677|FG001|Overall Study|Lost to Follow-up|9|||
94265175|NCT00314249|322765676|FG000|Overall Study|Physician Decision|1|||
94265176|NCT00314249|322765677|FG001|Overall Study|Physician Decision|1|||
94265177|NCT00314249|322765676|FG000|Overall Study|Withdrawn for other reasons|4|||
94366226|NCT00756652|323126485|FG001|Original Phase|Participant Noncompliance|424|||
94265178|NCT00314249|322765677|FG001|Overall Study|Withdrawn for other reasons|1|||
94265179|NCT00314249|322765676|FG000|Overall Study|Non-Compliant|5|||
94265180|NCT00314249|322765677|FG001|Overall Study|Non-Compliant|6|||
94265181|NCT01949155|322765678|FG000|Overall Study|Lost to Follow-up|1|||
94265182|NCT01949155|322765679|FG001|Overall Study|Lost to Follow-up|0|||
94265183|NCT01949155|322765678|FG000|Overall Study|Protocol Violation|1|||
94366227|NCT00756652|323126484|FG000|Original Phase|Unknown Discontinuation Reason|2|||
94696594|NCT02696226|324343584|FG003|Overall Study|Study terminated - lack of enrollment|0|||
94696595|NCT02909101|324343592|FG000|Overall Study|Lost to Follow-up|1|||
94696596|NCT02909101|324343593|FG001|Overall Study|Lost to Follow-up|1|||
94696597|NCT03073005|324343598|FG000|Overall Study|Death|6|||
94696598|NCT03073005|324343599|FG001|Overall Study|Death|0|||
94696599|NCT03073005|324343600|FG002|Overall Study|Death|7|||
94696600|NCT03073005|324343601|FG003|Overall Study|Death|0|||
94696601|NCT03073005|324343598|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
94696602|NCT03073005|324343599|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
94696603|NCT03073005|324343600|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
94696604|NCT03073005|324343601|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
94696605|NCT03073005|324343598|FG000|Overall Study|Lost to Follow-up|2|||
94696606|NCT03073005|324343599|FG001|Overall Study|Lost to Follow-up|2|||
94696607|NCT03073005|324343600|FG002|Overall Study|Lost to Follow-up|1|||
94696608|NCT03073005|324343601|FG003|Overall Study|Lost to Follow-up|2|||
94696609|NCT03073005|324343598|FG000|Overall Study|Withdrawal by Subject|0|||
94696610|NCT03073005|324343599|FG001|Overall Study|Withdrawal by Subject|4|||
94696611|NCT03073005|324343600|FG002|Overall Study|Withdrawal by Subject|4|||
94696612|NCT03073005|324343601|FG003|Overall Study|Withdrawal by Subject|4|||
94696613|NCT02414828|324343602|FG000|Overall Study|Lost to Follow-up|0|||
94696614|NCT02414828|324343603|FG001|Overall Study|Lost to Follow-up|1|||
94696615|NCT02414828|324343604|FG002|Overall Study|Lost to Follow-up|1|||
94696616|NCT02414828|324343605|FG003|Overall Study|Lost to Follow-up|2|||
94696617|NCT01101542|324343606|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
94696618|NCT01101542|324343606|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
94696619|NCT01101542|324343606|FG000|Year 4 Surveillance Period|Other|287|||
94696620|NCT01101542|324343606|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
94696621|NCT01101542|324343606|FG000|Year 5 Surveillance Period|Pregnancy|1|||
94696622|NCT01101542|324343606|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
94696623|NCT01101542|324343606|FG000|Year 6 Surveillance Period|Pregnancy|1|||
94265184|NCT01949155|322765679|FG001|Overall Study|Protocol Violation|0|||
94696624|NCT01101542|324343606|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
94696625|NCT00814489|324343609|FG000|Overall Study|Other|2|||
94696626|NCT00814489|324343610|FG001|Overall Study|Other|0|||
94696627|NCT00814489|324343611|FG002|Overall Study|Other|1|||
94696628|NCT03253653|324343637|FG000|Overall Study|Withdrawal by Subject|4|||
94696629|NCT03253653|324343638|FG001|Overall Study|Withdrawal by Subject|1|||
94696630|NCT03253653|324343637|FG000|Overall Study|Protocol Violation|0|||
94265185|NCT01187550|322765682|FG000|Overall Study|Protocol Violation|3|||
94265186|NCT01187550|322765683|FG001|Overall Study|Protocol Violation|1|||
94265187|NCT01187550|322765682|FG000|Overall Study|Other|3|||
94265188|NCT01187550|322765683|FG001|Overall Study|Other|0|||
94265189|NCT01187550|322765682|FG000|Overall Study|Randomized but not treated|8|||
94265190|NCT01187550|322765683|FG001|Overall Study|Randomized but not treated|0|||
94366228|NCT00756652|323126485|FG001|Original Phase|Unknown Discontinuation Reason|0|||
94366229|NCT00756652|323126484|FG000|Original Phase|Participants without data|3259|||
94366230|NCT00756652|323126485|FG001|Original Phase|Participants without data|466|||
94366231|NCT00756652|323126484|FG000|Original Phase|Death|168|||
94366232|NCT00756652|323126485|FG001|Original Phase|Death|1|||
94366233|NCT00756652|323126484|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
94366234|NCT00756652|323126485|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
94265191|NCT00129623|322765684|FG000|Overall Study|Adverse Event|3|||
94265192|NCT00129623|322765685|FG001|Overall Study|Adverse Event|7|||
94366235|NCT00756652|323126484|FG000|Re-Op Phase|Withdrawal by Subject|62|||
94265193|NCT00129623|322765684|FG000|Overall Study|Refused Treatment|5|||
94265194|NCT00129623|322765685|FG001|Overall Study|Refused Treatment|3|||
94366236|NCT00756652|323126485|FG001|Re-Op Phase|Withdrawal by Subject|0|||
94366237|NCT00756652|323126484|FG000|Re-Op Phase|Death|6|||
94366238|NCT00756652|323126485|FG001|Re-Op Phase|Death|0|||
94366239|NCT00756652|323126484|FG000|Re-Op Phase|Lost to Follow-up|340|||
94366240|NCT00756652|323126485|FG001|Re-Op Phase|Lost to Follow-up|0|||
94366241|NCT00756652|323126484|FG000|Re-Op Phase|Site Closed|2454|||
94366242|NCT00756652|323126485|FG001|Re-Op Phase|Site Closed|0|||
94366243|NCT00756652|323126484|FG000|Re-Op Phase|Withdrawn after explant|14|||
94366244|NCT00756652|323126485|FG001|Re-Op Phase|Withdrawn after explant|0|||
94366245|NCT02564952|323126486|FG000|Overall Study|Adverse Event|6|||
94366246|NCT02564952|323126486|FG000|Overall Study|Lost to Follow-up|1|||
94366247|NCT02564952|323126486|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
94366248|NCT02564952|323126486|FG000|Overall Study|Withdrawal by Subject|1|||
94466096|NCT01473394|323496936|FG000|Overall Study|Insufficient Therapeutic Response|4|||
94466097|NCT01473394|323496937|FG001|Overall Study|Insufficient Therapeutic Response|1|||
94265195|NCT00129623|322765684|FG000|Overall Study|Failure to Return|1|||
94265196|NCT00129623|322765685|FG001|Overall Study|Failure to Return|1|||
94265197|NCT00129623|322765684|FG000|Overall Study|Relocated job out of state|1|||
94696631|NCT03253653|324343638|FG001|Overall Study|Protocol Violation|5|||
94696632|NCT00731042|324345188|FG000|Second Intervention|Did not meet inclusion criteria|0|||
94366249|NCT02564952|323126486|FG000|Overall Study|Low Efficacy|1|||
94366250|NCT02564952|323126486|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
94696633|NCT00731042|324345189|FG001|Second Intervention|Did not meet inclusion criteria|2|||
94696634|NCT01021878|324345192|FG000|Overall Study|Lost to Follow-up|4|||
94265198|NCT00129623|322765685|FG001|Overall Study|Relocated job out of state|0|||
94265199|NCT00129623|322765684|FG000|Overall Study|Uncertainty to return|0|||
94265200|NCT00129623|322765685|FG001|Overall Study|Uncertainty to return|1|||
94696635|NCT01021878|324345193|FG001|Overall Study|Lost to Follow-up|3|||
94696636|NCT01021878|324345192|FG000|Overall Study|Death|0|||
94696637|NCT01021878|324345193|FG001|Overall Study|Death|1|||
94265201|NCT03781323|322765686|FG000|Overall Study|Withdrawal by Subject|1|||
94366251|NCT00038467|323126487|FG000|Overall Study|Adverse Event|170|||
94366252|NCT00038467|323126488|FG001|Overall Study|Adverse Event|145|||
94366253|NCT00038467|323126487|FG000|Overall Study|Withdrawal by Subject|150|||
94265202|NCT02308007|322765687|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
94265203|NCT02308007|322765688|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
94265204|NCT02308007|322765689|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
94265205|NCT02308007|322765687|FG000|Overall Study|Positive for STD at Baseline|7|||
94265206|NCT02308007|322765688|FG001|Overall Study|Positive for STD at Baseline|11|||
94265207|NCT02308007|322765689|FG002|Overall Study|Positive for STD at Baseline|7|||
94265208|NCT02308007|322765687|FG000|Overall Study|Lost to Follow-up|3|||
94265209|NCT02308007|322765688|FG001|Overall Study|Lost to Follow-up|0|||
94265210|NCT02308007|322765689|FG002|Overall Study|Lost to Follow-up|1|||
94265211|NCT01233869|322765690|FG000|Initial Treatment Period (24 Months)|Death|1|||
94265212|NCT01233869|322765691|FG001|Initial Treatment Period (24 Months)|Death|0|||
94265213|NCT01233869|322765692|FG002|Initial Treatment Period (24 Months)|Death|0|||
94265214|NCT01233869|322765693|FG003|Initial Treatment Period (24 Months)|Death|0|||
94265215|NCT01233869|322765690|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
94265216|NCT01233869|322765691|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
94265217|NCT01233869|322765692|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
94265218|NCT01233869|322765693|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
94265219|NCT01233869|322765690|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
94265220|NCT01233869|322765691|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
94265221|NCT01233869|322765692|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
94265222|NCT01233869|322765693|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
94265223|NCT01233869|322765690|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
94265224|NCT01233869|322765691|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
94265225|NCT01233869|322765692|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
94265226|NCT01233869|322765693|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
94265227|NCT01233869|322765690|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
94265228|NCT01233869|322765691|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
94265229|NCT01233869|322765692|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
94265230|NCT01233869|322765693|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
94265231|NCT01233869|322765690|FG000|Extended Treatment Period (46 Months)|Other|3|||
94265232|NCT01233869|322765691|FG001|Extended Treatment Period (46 Months)|Other|0|||
94265233|NCT01233869|322765692|FG002|Extended Treatment Period (46 Months)|Other|0|||
94265234|NCT01233869|322765693|FG003|Extended Treatment Period (46 Months)|Other|3|||
94265235|NCT01233869|322765690|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
94265236|NCT01233869|322765691|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
94265237|NCT01233869|322765692|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
94265238|NCT01233869|322765693|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
94265239|NCT03334409|322765694|FG000|Overall Study|Did not meet inclusion criteria|1|||
94265240|NCT03334409|322765695|FG001|Overall Study|Did not meet inclusion criteria|0|||
94265241|NCT03678103|322765696|FG000|Overall Study|Withdrawn prior to completion|4|||
94265242|NCT01296035|322765701|FG000|Overall Study|Withdrawal by Subject|1|||
94265243|NCT00528567|322765702|FG000|Overall Study|Death|4|||
94265244|NCT00528567|322765703|FG001|Overall Study|Death|5|||
94265245|NCT00528567|322765702|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
94265246|NCT00528567|322765703|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
94265247|NCT00528567|322765702|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
94265248|NCT00528567|322765703|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
94265249|NCT00528567|322765702|FG000|Overall Study|Violation Criteria at Entry|3|||
94265250|NCT00528567|322765703|FG001|Overall Study|Violation Criteria at Entry|17|||
94265251|NCT00528567|322765702|FG000|Overall Study|Withdrew Consent|59|||
94265252|NCT00528567|322765703|FG001|Overall Study|Withdrew Consent|55|||
94265253|NCT00528567|322765702|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
94265254|NCT00528567|322765703|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
94265255|NCT00528567|322765702|FG000|Overall Study|Failure to Return|1|||
94265256|NCT00528567|322765703|FG001|Overall Study|Failure to Return|4|||
94265257|NCT00528567|322765702|FG000|Overall Study|Other Protocol Violation|5|||
94265258|NCT00528567|322765703|FG001|Overall Study|Other Protocol Violation|21|||
94265259|NCT00528567|322765702|FG000|Overall Study|Administrative/Other|22|||
94265260|NCT00528567|322765703|FG001|Overall Study|Administrative/Other|75|||
94265261|NCT03085758|322765709|FG000|Overall Study|Death|26|||
94366254|NCT00038467|323126488|FG001|Overall Study|Withdrawal by Subject|107|||
94366255|NCT00038467|323126487|FG000|Overall Study|Protocol Violation|19|||
94366256|NCT00038467|323126488|FG001|Overall Study|Protocol Violation|22|||
94265262|NCT03085758|322765710|FG001|Overall Study|Death|24|||
94265263|NCT03085758|322765711|FG002|Overall Study|Death|53|||
94366257|NCT00038467|323126487|FG000|Overall Study|Death|22|||
94366258|NCT00038467|323126488|FG001|Overall Study|Death|16|||
94265264|NCT03085758|322765709|FG000|Overall Study|Lost to Follow-up|1|||
94265265|NCT03085758|322765710|FG001|Overall Study|Lost to Follow-up|1|||
94265266|NCT03085758|322765711|FG002|Overall Study|Lost to Follow-up|1|||
94366259|NCT00038467|323126487|FG000|Overall Study|Lost to Follow-up|15|||
94366260|NCT00038467|323126488|FG001|Overall Study|Lost to Follow-up|10|||
94696638|NCT01021878|324345192|FG000|Overall Study|Adverse Event|6|||
94696639|NCT01021878|324345193|FG001|Overall Study|Adverse Event|5|||
94696640|NCT01021878|324345192|FG000|Overall Study|Transplantation|6|||
94696641|NCT01021878|324345193|FG001|Overall Study|Transplantation|1|||
94265267|NCT03085758|322765709|FG000|Overall Study|Withdrawal by Subject|2|||
94265268|NCT03085758|322765710|FG001|Overall Study|Withdrawal by Subject|2|||
94265269|NCT03085758|322765711|FG002|Overall Study|Withdrawal by Subject|1|||
94466098|NCT01473394|323496936|FG000|Overall Study|Protocol Violation|7|||
94696642|NCT00367237|324345194|FG000|Overall Study|Adverse Event|7|||
94696643|NCT00367237|324345195|FG001|Overall Study|Adverse Event|2|||
94696644|NCT00367237|324345194|FG000|Overall Study|Lost to Follow-up|1|||
94696645|NCT00367237|324345195|FG001|Overall Study|Lost to Follow-up|0|||
94696646|NCT00367237|324345194|FG000|Overall Study|Withdrawal by Subject|0|||
94696647|NCT00367237|324345195|FG001|Overall Study|Withdrawal by Subject|4|||
94696648|NCT00367237|324345194|FG000|Overall Study|Protocol Violation|2|||
94696649|NCT00367237|324345195|FG001|Overall Study|Protocol Violation|5|||
94696650|NCT02688621|324345199|FG000|Overall Study|Pregnancy|1|||
94696651|NCT02688621|324345200|FG001|Overall Study|Pregnancy|3|||
94696652|NCT02688621|324345199|FG000|Overall Study|Lost to Follow-up|38|||
94696653|NCT02688621|324345200|FG001|Overall Study|Lost to Follow-up|15|||
94696654|NCT02688621|324345199|FG000|Overall Study|Withdrawal by Subject|1|||
94696655|NCT02688621|324345200|FG001|Overall Study|Withdrawal by Subject|0|||
94696656|NCT01575860|324345201|FG000|Overall Study|Withdrawal by Subject|1|||
94696657|NCT01575860|324345201|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
94696658|NCT03606460|324345210|FG000|Overall Study|Lost to Follow-up|1|||
94696659|NCT03606460|324345211|FG001|Overall Study|Lost to Follow-up|8|||
94696660|NCT04170023|324345212|FG000|LTE Period|Withdrawal by Subject|1|||
94696661|NCT04170023|324345213|FG001|LTE Period|Withdrawal by Subject|0|||
94696662|NCT04170023|324345214|FG002|LTE Period|Withdrawal by Subject|0|||
94696663|NCT04170023|324345212|FG000|LTE Period|Study Termination|11|||
94696664|NCT04170023|324345213|FG001|LTE Period|Study Termination|11|||
94696665|NCT04170023|324345214|FG002|LTE Period|Study Termination|5|||
94696666|NCT00724061|324345222|FG000|Dose Escalation Phase|Adverse Event|2|||
94696667|NCT00724061|324345222|FG000|Dose Escalation Phase|Disease Progression|3|||
94696668|NCT00372567|324345225|FG000|Phase 3 Study|Adverse Event|5|||
94696669|NCT00372567|324345226|FG001|Phase 3 Study|Adverse Event|1|||
94696670|NCT00372567|324345227|FG002|Phase 3 Study|Adverse Event|1|||
94696671|NCT00372567|324345225|FG000|Phase 3 Study|Death|1|||
94696672|NCT00372567|324345226|FG001|Phase 3 Study|Death|1|||
94696673|NCT00372567|324345227|FG002|Phase 3 Study|Death|0|||
94696674|NCT00372567|324345225|FG000|Phase 3 Study|Protocol Violation|0|||
94696675|NCT00372567|324345226|FG001|Phase 3 Study|Protocol Violation|0|||
94696676|NCT00372567|324345227|FG002|Phase 3 Study|Protocol Violation|1|||
94696677|NCT00372567|324345225|FG000|Phase 3 Study|Objective progression or relapse|10|||
94696678|NCT00372567|324345226|FG001|Phase 3 Study|Objective progression or relapse|13|||
94696679|NCT00372567|324345227|FG002|Phase 3 Study|Objective progression or relapse|4|||
94696680|NCT00372567|324345225|FG000|Phase 3 Study|Global deterioration of health status|0|||
94696681|NCT00372567|324345226|FG001|Phase 3 Study|Global deterioration of health status|1|||
94696682|NCT00372567|324345227|FG002|Phase 3 Study|Global deterioration of health status|0|||
94696683|NCT00372567|324345225|FG000|Phase 3 Study|Other|2|||
94696684|NCT00372567|324345226|FG001|Phase 3 Study|Other|2|||
94265270|NCT03085758|322765709|FG000|Overall Study|Refusal to recall it up to day 90|0|||
94265271|NCT03085758|322765710|FG001|Overall Study|Refusal to recall it up to day 90|0|||
94265272|NCT03085758|322765711|FG002|Overall Study|Refusal to recall it up to day 90|1|||
94265273|NCT03085758|322765709|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
94265274|NCT03085758|322765710|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
94265275|NCT03085758|322765711|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
94265276|NCT00874770|322765712|FG000|Overall Study|Lack of Efficacy|2|||
94265277|NCT00874770|322765713|FG001|Overall Study|Lack of Efficacy|0|||
94265278|NCT00874770|322765714|FG002|Overall Study|Lack of Efficacy|0|||
94265279|NCT00874770|322765715|FG003|Overall Study|Lack of Efficacy|2|||
94265280|NCT00874770|322765712|FG000|Overall Study|Adverse Event|1|||
94265281|NCT00874770|322765713|FG001|Overall Study|Adverse Event|1|||
94265282|NCT00874770|322765714|FG002|Overall Study|Adverse Event|4|||
94265283|NCT00874770|322765715|FG003|Overall Study|Adverse Event|2|||
94265284|NCT00874770|322765712|FG000|Overall Study|Lost to Follow-up|1|||
94265285|NCT00874770|322765713|FG001|Overall Study|Lost to Follow-up|0|||
94265286|NCT00874770|322765714|FG002|Overall Study|Lost to Follow-up|0|||
94696685|NCT00372567|324345227|FG002|Phase 3 Study|Other|1|||
94466099|NCT01473394|323496937|FG001|Overall Study|Protocol Violation|5|||
94696686|NCT00372567|324345225|FG000|Phase 3 Study|study terminated by sponsor|13|||
94696687|NCT00372567|324345226|FG001|Phase 3 Study|study terminated by sponsor|8|||
94696688|NCT00372567|324345227|FG002|Phase 3 Study|study terminated by sponsor|5|||
94696689|NCT00953160|324345228|FG000|Overall Study|Lost to Follow-up|23|||
94696690|NCT00953160|324345228|FG000|Overall Study|Withdrawal by Subject|4|||
94265287|NCT00874770|322765715|FG003|Overall Study|Lost to Follow-up|1|||
94265288|NCT00874770|322765712|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
94265289|NCT00874770|322765713|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
94265290|NCT00874770|322765714|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
94696691|NCT02179918|324345236|FG000|Overall Study|Death|0|||
94696692|NCT02179918|324345237|FG001|Overall Study|Death|0|||
94696693|NCT02179918|324345238|FG002|Overall Study|Death|0|||
94265291|NCT00874770|322765715|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
94696694|NCT02179918|324345239|FG003|Overall Study|Death|1|||
94696695|NCT02179918|324345240|FG004|Overall Study|Death|0|||
94696696|NCT02179918|324345236|FG000|Overall Study|Lost to Follow-up|0|||
94696697|NCT02179918|324345237|FG001|Overall Study|Lost to Follow-up|0|||
94696698|NCT02179918|324345238|FG002|Overall Study|Lost to Follow-up|1|||
94696699|NCT02179918|324345239|FG003|Overall Study|Lost to Follow-up|0|||
94696700|NCT02179918|324345240|FG004|Overall Study|Lost to Follow-up|0|||
94696701|NCT02179918|324345236|FG000|Overall Study|Progressive Disease|4|||
94696702|NCT02179918|324345237|FG001|Overall Study|Progressive Disease|1|||
94696703|NCT02179918|324345238|FG002|Overall Study|Progressive Disease|1|||
94696704|NCT02179918|324345239|FG003|Overall Study|Progressive Disease|2|||
94696705|NCT02179918|324345240|FG004|Overall Study|Progressive Disease|6|||
94696706|NCT02179918|324345236|FG000|Overall Study|Other|0|||
94696707|NCT02179918|324345237|FG001|Overall Study|Other|1|||
94696708|NCT02179918|324345238|FG002|Overall Study|Other|0|||
94696709|NCT02179918|324345239|FG003|Overall Study|Other|0|||
94696710|NCT02179918|324345240|FG004|Overall Study|Other|1|||
94696711|NCT02179918|324345236|FG000|Overall Study|Subject refused further follow-up|0|||
94696712|NCT02179918|324345237|FG001|Overall Study|Subject refused further follow-up|1|||
94696713|NCT02179918|324345238|FG002|Overall Study|Subject refused further follow-up|0|||
94696714|NCT02179918|324345239|FG003|Overall Study|Subject refused further follow-up|0|||
94696715|NCT02179918|324345240|FG004|Overall Study|Subject refused further follow-up|1|||
94696716|NCT00463151|324345245|FG000|Overall Study|Adverse Event|0|||
94696717|NCT00463151|324345246|FG001|Overall Study|Adverse Event|0|||
94696718|NCT00463151|324345247|FG002|Overall Study|Adverse Event|1|||
94265292|NCT04464265|322765716|FG000|Overall Study|Physician Decision|2|||
94265293|NCT04880447|322765718|FG000|Overall Study|No vaccination information|1|||
94265294|NCT04880447|322765718|FG000|Overall Study|No adverse event information (missing information)|1|||
94265295|NCT04880447|322765718|FG000|Overall Study|Disease not covered in this study|35|||
94265296|NCT00381563|322765719|FG000|Overall Study|Withdrawal by Subject|5|||
94265297|NCT00381563|322765720|FG001|Overall Study|Withdrawal by Subject|5|||
94265298|NCT00381563|322765719|FG000|Overall Study|Lost to Follow-up|2|||
94265299|NCT00381563|322765720|FG001|Overall Study|Lost to Follow-up|0|||
94265300|NCT00381563|322765719|FG000|Overall Study|Protocol Violation|0|||
94696719|NCT00463151|324345248|FG003|Overall Study|Adverse Event|0|||
94696720|NCT00463151|324345245|FG000|Overall Study|Lack of Efficacy|2|||
94696721|NCT00463151|324345246|FG001|Overall Study|Lack of Efficacy|5|||
94696722|NCT00463151|324345247|FG002|Overall Study|Lack of Efficacy|2|||
94696723|NCT00463151|324345248|FG003|Overall Study|Lack of Efficacy|5|||
94696724|NCT00463151|324345245|FG000|Overall Study|Protocol Violation|0|||
94696725|NCT00463151|324345246|FG001|Overall Study|Protocol Violation|0|||
94696726|NCT00463151|324345247|FG002|Overall Study|Protocol Violation|0|||
94696727|NCT00463151|324345248|FG003|Overall Study|Protocol Violation|1|||
94696728|NCT00463151|324345245|FG000|Overall Study|Withdrawal by Subject|0|||
94696729|NCT00463151|324345246|FG001|Overall Study|Withdrawal by Subject|0|||
94696730|NCT00463151|324345247|FG002|Overall Study|Withdrawal by Subject|0|||
94696731|NCT00463151|324345248|FG003|Overall Study|Withdrawal by Subject|1|||
94696732|NCT01880554|324345249|FG000|Overall Study|Protocol Violation|14|||
94696733|NCT01880554|324345249|FG000|Overall Study|Simon's design requirements|2|||
94696734|NCT00972543|324345250|FG000|Overall Study|Adverse Event|1|||
94696735|NCT00972543|324345251|FG001|Overall Study|Adverse Event|0|||
94696736|NCT00972543|324345250|FG000|Overall Study|Early study termination by sponsor|4|||
94696737|NCT00972543|324345251|FG001|Overall Study|Early study termination by sponsor|1|||
94696738|NCT01579578|324345252|FG000|Overall Study|Death|4|||
94696739|NCT01579578|324345253|FG001|Overall Study|Death|1|||
94696740|NCT01579578|324345252|FG000|Overall Study|Lost to Follow-up|1|||
94696741|NCT01579578|324345253|FG001|Overall Study|Lost to Follow-up|1|||
94696742|NCT01579578|324345252|FG000|Overall Study|Withdrawal by Subject|2|||
94696743|NCT01579578|324345253|FG001|Overall Study|Withdrawal by Subject|1|||
94265301|NCT00381563|322765720|FG001|Overall Study|Protocol Violation|1|||
94265302|NCT00239226|322765721|FG000|Overall Study|permAF during stabilization period|0|||
94265303|NCT00239226|322765722|FG001|Overall Study|permAF during stabilization period|0|||
94265304|NCT00239226|322765723|FG002|Overall Study|permAF during stabilization period|0|||
94265305|NCT00239226|322765724|FG003|Overall Study|permAF during stabilization period|3|||
94265306|NCT00239226|322765721|FG000|Overall Study|Lost to Follow-up|1|||
94265307|NCT00239226|322765722|FG001|Overall Study|Lost to Follow-up|0|||
94265308|NCT00239226|322765723|FG002|Overall Study|Lost to Follow-up|1|||
94265309|NCT00239226|322765724|FG003|Overall Study|Lost to Follow-up|0|||
94265310|NCT00851682|322765725|FG000|Overall Study|screen failure|5|||
94265311|NCT00851682|322765726|FG001|Overall Study|screen failure|0|||
94265312|NCT04060563|322765727|FG000|Overall Study|Lost to Follow-up|1|||
94265313|NCT04060563|322765728|FG001|Overall Study|Lost to Follow-up|1|||
94265314|NCT04060563|322765727|FG000|Overall Study|Physician Decision|0|||
94265315|NCT04060563|322765728|FG001|Overall Study|Physician Decision|1|||
94265316|NCT01287364|322765733|FG000|Overall Study|Adverse Event|0|||
94696744|NCT01579578|324345252|FG000|Overall Study|Eligibility criteria|3|||
94265317|NCT01287364|322765734|FG001|Overall Study|Adverse Event|3|||
94265318|NCT01287364|322765733|FG000|Overall Study|Protocol Violation|5|||
94265319|NCT01287364|322765734|FG001|Overall Study|Protocol Violation|5|||
94265320|NCT01287364|322765733|FG000|Overall Study|Other Reason|4|||
94265321|NCT01287364|322765734|FG001|Overall Study|Other Reason|2|||
94696745|NCT01579578|324345253|FG001|Overall Study|Eligibility criteria|9|||
94696746|NCT01579578|324345252|FG000|Overall Study|Ongoing|3|||
94696747|NCT01579578|324345253|FG001|Overall Study|Ongoing|0|||
94265322|NCT02378220|322765735|FG000|Overall Study|Death|6|||
94265323|NCT02378220|322765736|FG001|Overall Study|Death|1|||
94696748|NCT03111095|324345256|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
94265324|NCT00962390|322765737|FG000|Overall Study|Adverse Event|0|||
94265325|NCT00962390|322765738|FG001|Overall Study|Adverse Event|0|||
94265326|NCT00962390|322765739|FG002|Overall Study|Adverse Event|3|||
94265327|NCT00962390|322765740|FG003|Overall Study|Adverse Event|1|||
94265328|NCT00962390|322765737|FG000|Overall Study|Lost to Follow-up|2|||
94265329|NCT00962390|322765738|FG001|Overall Study|Lost to Follow-up|2|||
94265330|NCT00962390|322765739|FG002|Overall Study|Lost to Follow-up|0|||
94265331|NCT00962390|322765740|FG003|Overall Study|Lost to Follow-up|0|||
94265332|NCT00962390|322765737|FG000|Overall Study|Protocol Violation|1|||
94265333|NCT00962390|322765738|FG001|Overall Study|Protocol Violation|0|||
94265334|NCT00962390|322765739|FG002|Overall Study|Protocol Violation|0|||
94265335|NCT00962390|322765740|FG003|Overall Study|Protocol Violation|0|||
94265336|NCT00962390|322765737|FG000|Overall Study|Withdrawal by Subject|1|||
94265337|NCT00962390|322765738|FG001|Overall Study|Withdrawal by Subject|1|||
94265338|NCT00962390|322765739|FG002|Overall Study|Withdrawal by Subject|1|||
94265339|NCT00962390|322765740|FG003|Overall Study|Withdrawal by Subject|0|||
94265340|NCT04344301|322765744|FG000|Overall Study|Withdrawal by Subject|1|||
94265341|NCT04344301|322765745|FG001|Overall Study|Withdrawal by Subject|0|||
94265342|NCT04344301|322765744|FG000|Overall Study|Death|0|||
94265343|NCT04344301|322765745|FG001|Overall Study|Death|1|||
94265344|NCT05105789|322765746|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
94265345|NCT01026142|322765750|FG000|Overall Study|Death|136|||
94265346|NCT01026142|322765751|FG001|Overall Study|Death|134|||
94265347|NCT01026142|322765750|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
94265348|NCT01026142|322765751|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
94265349|NCT04178967|322765752|FG000|Induction Period|Adverse Event|4|||
94265350|NCT04178967|322765753|FG001|Induction Period|Adverse Event|6|||
94265351|NCT04178967|322765754|FG002|Induction Period|Adverse Event|0|||
94265352|NCT04178967|322765755|FG003|Induction Period|Adverse Event|0|||
94265353|NCT04178967|322765756|FG004|Induction Period|Adverse Event|0|||
94265354|NCT04178967|322765757|FG005|Induction Period|Adverse Event|0|||
94265355|NCT04178967|322765758|FG006|Induction Period|Adverse Event|0|||
94265356|NCT04178967|322765759|FG007|Induction Period|Adverse Event|0|||
94265357|NCT04178967|322765760|FG008|Induction Period|Adverse Event|0|||
94265358|NCT04178967|322765761|FG009|Induction Period|Adverse Event|0|||
94265359|NCT04178967|322765762|FG010|Induction Period|Adverse Event|0|||
94265360|NCT04178967|322765752|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
94265361|NCT04178967|322765753|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
94265362|NCT04178967|322765754|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
94265363|NCT04178967|322765755|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
94265364|NCT04178967|322765756|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
94265365|NCT04178967|322765757|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
94265366|NCT04178967|322765758|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
94265367|NCT04178967|322765759|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
94265368|NCT04178967|322765760|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
94265369|NCT04178967|322765761|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
94265370|NCT04178967|322765762|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
94265371|NCT04178967|322765752|FG000|Induction Period|Lack of Efficacy|4|||
94265372|NCT04178967|322765753|FG001|Induction Period|Lack of Efficacy|1|||
94265373|NCT04178967|322765754|FG002|Induction Period|Lack of Efficacy|0|||
94265374|NCT04178967|322765755|FG003|Induction Period|Lack of Efficacy|0|||
94265375|NCT04178967|322765756|FG004|Induction Period|Lack of Efficacy|0|||
94265376|NCT04178967|322765757|FG005|Induction Period|Lack of Efficacy|0|||
94265377|NCT04178967|322765758|FG006|Induction Period|Lack of Efficacy|0|||
94265378|NCT04178967|322765759|FG007|Induction Period|Lack of Efficacy|0|||
94265379|NCT04178967|322765760|FG008|Induction Period|Lack of Efficacy|0|||
94265380|NCT04178967|322765761|FG009|Induction Period|Lack of Efficacy|0|||
94265381|NCT04178967|322765762|FG010|Induction Period|Lack of Efficacy|0|||
94265382|NCT04178967|322765752|FG000|Induction Period|Protocol Violation|0|||
94265383|NCT04178967|322765753|FG001|Induction Period|Protocol Violation|6|||
94265384|NCT04178967|322765754|FG002|Induction Period|Protocol Violation|0|||
94265385|NCT04178967|322765755|FG003|Induction Period|Protocol Violation|0|||
94265386|NCT04178967|322765756|FG004|Induction Period|Protocol Violation|0|||
94265387|NCT04178967|322765757|FG005|Induction Period|Protocol Violation|0|||
94265388|NCT04178967|322765758|FG006|Induction Period|Protocol Violation|0|||
94265389|NCT04178967|322765759|FG007|Induction Period|Protocol Violation|0|||
94265390|NCT04178967|322765760|FG008|Induction Period|Protocol Violation|0|||
94265391|NCT04178967|322765761|FG009|Induction Period|Protocol Violation|0|||
94265392|NCT04178967|322765762|FG010|Induction Period|Protocol Violation|0|||
94265393|NCT04178967|322765752|FG000|Induction Period|Withdrawal by Subject|6|||
94265394|NCT04178967|322765753|FG001|Induction Period|Withdrawal by Subject|4|||
94265395|NCT04178967|322765754|FG002|Induction Period|Withdrawal by Subject|0|||
94265396|NCT04178967|322765755|FG003|Induction Period|Withdrawal by Subject|0|||
94265397|NCT04178967|322765756|FG004|Induction Period|Withdrawal by Subject|0|||
94265398|NCT04178967|322765757|FG005|Induction Period|Withdrawal by Subject|0|||
94265399|NCT04178967|322765758|FG006|Induction Period|Withdrawal by Subject|0|||
94696749|NCT03111095|324345257|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
94696750|NCT03111095|324345256|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
94696751|NCT03111095|324345257|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
94696752|NCT00761774|324345258|FG000|Overall Study|Adverse Event|17|||
94696753|NCT00761774|324345258|FG000|Overall Study|Lack of Efficacy|37|||
94696754|NCT00761774|324345258|FG000|Overall Study|Lost to Follow-up|2|||
94696755|NCT00761774|324345258|FG000|Overall Study|Withdrawal by Subject|9|||
94696756|NCT00761774|324345258|FG000|Overall Study|Non-compliance|4|||
94696757|NCT00761774|324345258|FG000|Overall Study|End of study|2|||
94696758|NCT00761774|324345258|FG000|Overall Study|Reclassification of seizures|1|||
94696759|NCT00761774|324345258|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
94696760|NCT00761774|324345258|FG000|Overall Study|Sponsor decision|1|||
94696761|NCT00761774|324345258|FG000|Overall Study|Investigator clinical judgement|1|||
94696762|NCT00761774|324345258|FG000|Overall Study|Patient moved out of study area|1|||
94696763|NCT00761774|324345258|FG000|Overall Study|Coordinator leaving site|1|||
94696764|NCT00761774|324345258|FG000|Overall Study|Subject IP non-compliance|1|||
94696765|NCT00761774|324345258|FG000|Overall Study|IP stopped by hospital physician|1|||
94696766|NCT01656759|324345261|FG000|Overall Study|Protocol Violation|2|||
94696767|NCT01656759|324345262|FG001|Overall Study|Protocol Violation|3|||
94696768|NCT00811187|324345263|FG000|Overall Study|Unable to place device / procedure abort|3|||
94696769|NCT00811187|324345264|FG001|Overall Study|Unable to place device / procedure abort|3|||
94696770|NCT02303574|324345265|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
94696771|NCT02303574|324345266|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
94696772|NCT02303574|324345267|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
94696773|NCT02303574|324345268|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
94696774|NCT02303574|324345269|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
94696775|NCT02303574|324345270|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
94696776|NCT02303574|324345271|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
94696777|NCT02303574|324345272|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
94696778|NCT02303574|324345273|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
94696779|NCT02303574|324345274|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
94696780|NCT02303574|324345265|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
94696781|NCT02303574|324345266|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
94696782|NCT02303574|324345267|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
94696783|NCT02303574|324345268|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
94696784|NCT02303574|324345269|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
94696785|NCT02303574|324345270|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
94696786|NCT02303574|324345271|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
94696787|NCT02303574|324345272|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
94696788|NCT02303574|324345273|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
94696789|NCT02303574|324345274|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
94696790|NCT00184028|324345277|FG000|Overall Study|Death|1|||
94696791|NCT00184028|324345277|FG000|Overall Study|Lack of Efficacy|4|||
94366261|NCT00038467|323126487|FG000|Overall Study|Recurrence|109|||
94366262|NCT00038467|323126488|FG001|Overall Study|Recurrence|179|||
94366263|NCT00038467|323126487|FG000|Overall Study|Randomized, but not treated|31|||
94366264|NCT00038467|323126488|FG001|Overall Study|Randomized, but not treated|35|||
94366265|NCT00038467|323126487|FG000|Overall Study|Other|26|||
94366266|NCT00038467|323126488|FG001|Overall Study|Other|28|||
94696792|NCT00184028|324345277|FG000|Overall Study|Adverse Event|2|||
94696793|NCT00184028|324345277|FG000|Overall Study|Withdrawal by Subject|1|||
94696794|NCT00184028|324345277|FG000|Overall Study|Non-compliance|2|||
94696795|NCT01606189|324345282|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
94696796|NCT01606189|324345283|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
94696797|NCT01606189|324345284|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
94696798|NCT01606189|324345285|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
94696799|NCT01606189|324345286|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
94696800|NCT01606189|324345287|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
94696801|NCT01606189|324345282|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
94696802|NCT01606189|324345283|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
94696803|NCT01606189|324345284|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
94696804|NCT01606189|324345285|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
94696805|NCT01606189|324345286|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
94696806|NCT01606189|324345287|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
94696807|NCT04796935|324345288|FG000|Overall Study|Withdrawal by Subject|0|||
94696808|NCT04796935|324345289|FG001|Overall Study|Withdrawal by Subject|1|||
94696809|NCT04796935|324345288|FG000|Overall Study|Physician Decision|0|||
94696810|NCT04796935|324345289|FG001|Overall Study|Physician Decision|1|||
94696811|NCT04796935|324345288|FG000|Overall Study|Device not available|1|||
94696812|NCT04796935|324345289|FG001|Overall Study|Device not available|0|||
94696813|NCT04796935|324345288|FG000|Overall Study|Trained provider not available|1|||
94696814|NCT04796935|324345289|FG001|Overall Study|Trained provider not available|0|||
94696815|NCT01354938|324345290|FG000|Overall Study|Lost to Follow-up|1|||
94696816|NCT00410384|324345291|FG000|Overall Study|Withdrawal by Subject|28|||
94696817|NCT00410384|324345292|FG001|Overall Study|Withdrawal by Subject|17|||
94696818|NCT00410384|324345293|FG002|Overall Study|Withdrawal by Subject|20|||
94696819|NCT00410384|324345291|FG000|Overall Study|Adverse Event|23|||
94696820|NCT00410384|324345292|FG001|Overall Study|Adverse Event|18|||
94696821|NCT00410384|324345293|FG002|Overall Study|Adverse Event|23|||
94696822|NCT00410384|324345291|FG000|Overall Study|Lack of Efficacy|20|||
94696823|NCT00410384|324345292|FG001|Overall Study|Lack of Efficacy|12|||
94696824|NCT00410384|324345293|FG002|Overall Study|Lack of Efficacy|17|||
94265400|NCT04178967|322765759|FG007|Induction Period|Withdrawal by Subject|0|||
94265401|NCT04178967|322765760|FG008|Induction Period|Withdrawal by Subject|0|||
94265402|NCT04178967|322765761|FG009|Induction Period|Withdrawal by Subject|0|||
94265403|NCT04178967|322765762|FG010|Induction Period|Withdrawal by Subject|0|||
94265404|NCT04178967|322765752|FG000|Induction Period|Lost to Follow-up|2|||
94265405|NCT04178967|322765753|FG001|Induction Period|Lost to Follow-up|0|||
94265406|NCT04178967|322765754|FG002|Induction Period|Lost to Follow-up|0|||
94265407|NCT04178967|322765755|FG003|Induction Period|Lost to Follow-up|0|||
94265408|NCT04178967|322765756|FG004|Induction Period|Lost to Follow-up|0|||
94265409|NCT04178967|322765757|FG005|Induction Period|Lost to Follow-up|0|||
94265410|NCT04178967|322765758|FG006|Induction Period|Lost to Follow-up|0|||
94265411|NCT04178967|322765759|FG007|Induction Period|Lost to Follow-up|0|||
94265412|NCT04178967|322765760|FG008|Induction Period|Lost to Follow-up|0|||
94265413|NCT04178967|322765761|FG009|Induction Period|Lost to Follow-up|0|||
94265414|NCT04178967|322765762|FG010|Induction Period|Lost to Follow-up|0|||
94265415|NCT04178967|322765752|FG000|Induction Period|Participant Missed Study Visits|0|||
94265416|NCT04178967|322765753|FG001|Induction Period|Participant Missed Study Visits|1|||
94265417|NCT04178967|322765754|FG002|Induction Period|Participant Missed Study Visits|0|||
94265418|NCT04178967|322765755|FG003|Induction Period|Participant Missed Study Visits|0|||
94265419|NCT04178967|322765756|FG004|Induction Period|Participant Missed Study Visits|0|||
94265420|NCT04178967|322765757|FG005|Induction Period|Participant Missed Study Visits|0|||
94265421|NCT04178967|322765758|FG006|Induction Period|Participant Missed Study Visits|0|||
94265422|NCT04178967|322765759|FG007|Induction Period|Participant Missed Study Visits|0|||
94265423|NCT04178967|322765760|FG008|Induction Period|Participant Missed Study Visits|0|||
94265424|NCT04178967|322765761|FG009|Induction Period|Participant Missed Study Visits|0|||
94265425|NCT04178967|322765762|FG010|Induction Period|Participant Missed Study Visits|0|||
94265426|NCT04178967|322765752|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
94265427|NCT04178967|322765753|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
94265428|NCT04178967|322765754|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
94265429|NCT04178967|322765755|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
94265430|NCT04178967|322765756|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
94696825|NCT00410384|324345291|FG000|Overall Study|Lack of Compliance|2|||
94696826|NCT00410384|324345292|FG001|Overall Study|Lack of Compliance|2|||
94696827|NCT00410384|324345293|FG002|Overall Study|Lack of Compliance|2|||
94696828|NCT00410384|324345291|FG000|Overall Study|Lost to Follow-up|4|||
94696829|NCT00410384|324345292|FG001|Overall Study|Lost to Follow-up|6|||
94265431|NCT04178967|322765757|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
94265432|NCT04178967|322765758|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
94265433|NCT04178967|322765759|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
94265434|NCT04178967|322765760|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
94265435|NCT04178967|322765761|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
94265436|NCT04178967|322765762|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
94265437|NCT04178967|322765752|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94265438|NCT04178967|322765753|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94366267|NCT01988493|323126489|FG000|Overall Study|Randomized but not treated|0|||
94696830|NCT00410384|324345293|FG002|Overall Study|Lost to Follow-up|6|||
94366268|NCT01988493|323126490|FG001|Overall Study|Randomized but not treated|0|||
94696831|NCT00410384|324345291|FG000|Overall Study|Protocol Violation|6|||
94696832|NCT00410384|324345292|FG001|Overall Study|Protocol Violation|6|||
94696833|NCT00410384|324345293|FG002|Overall Study|Protocol Violation|6|||
94696834|NCT00410384|324345291|FG000|Overall Study|Physician Decision|3|||
94696835|NCT00410384|324345292|FG001|Overall Study|Physician Decision|3|||
94696836|NCT00410384|324345293|FG002|Overall Study|Physician Decision|4|||
94696837|NCT00410384|324345291|FG000|Overall Study|Other|3|||
94696838|NCT00410384|324345292|FG001|Overall Study|Other|8|||
94265439|NCT04178967|322765754|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94265440|NCT04178967|322765755|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94265441|NCT04178967|322765756|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94265442|NCT04178967|322765757|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
94696839|NCT00410384|324345293|FG002|Overall Study|Other|4|||
94696840|NCT01167023|324345294|FG000|Overall Study|Lost to Follow-up|0|||
94696841|NCT01167023|324345295|FG001|Overall Study|Lost to Follow-up|1|||
94696842|NCT01167023|324345296|FG002|Overall Study|Lost to Follow-up|1|||
94696843|NCT01167023|324345294|FG000|Overall Study|Screen Failure|0|||
94696844|NCT01167023|324345295|FG001|Overall Study|Screen Failure|1|||
94696845|NCT01167023|324345296|FG002|Overall Study|Screen Failure|0|||
94696846|NCT01167023|324345294|FG000|Overall Study|Sponsor Decision|0|||
94696847|NCT01167023|324345295|FG001|Overall Study|Sponsor Decision|1|||
94696848|NCT01167023|324345296|FG002|Overall Study|Sponsor Decision|0|||
94696849|NCT01167023|324345294|FG000|Overall Study|Withdrawal by Subject|0|||
94696850|NCT01167023|324345295|FG001|Overall Study|Withdrawal by Subject|0|||
94696851|NCT01167023|324345296|FG002|Overall Study|Withdrawal by Subject|1|||
94696852|NCT00783718|324345297|FG000|Induction Phase|Adverse Event|4|||
94696853|NCT00783718|324345298|FG001|Induction Phase|Adverse Event|0|||
94696854|NCT00783718|324345299|FG002|Induction Phase|Adverse Event|7|||
94696855|NCT00783718|324345300|FG003|Induction Phase|Adverse Event|0|||
94696856|NCT00783718|324345301|FG004|Induction Phase|Adverse Event|0|||
94696857|NCT00783718|324345302|FG005|Induction Phase|Adverse Event|0|||
94696858|NCT00783718|324345303|FG006|Induction Phase|Adverse Event|0|||
94696859|NCT00783718|324345297|FG000|Induction Phase|Protocol Violation|1|||
94696860|NCT00783718|324345298|FG001|Induction Phase|Protocol Violation|1|||
94696861|NCT00783718|324345299|FG002|Induction Phase|Protocol Violation|6|||
94696862|NCT00783718|324345300|FG003|Induction Phase|Protocol Violation|0|||
94696863|NCT00783718|324345301|FG004|Induction Phase|Protocol Violation|0|||
94696864|NCT00783718|324345302|FG005|Induction Phase|Protocol Violation|0|||
94696865|NCT00783718|324345303|FG006|Induction Phase|Protocol Violation|0|||
94696866|NCT00783718|324345297|FG000|Induction Phase|Lack of Efficacy|5|||
94696867|NCT00783718|324345298|FG001|Induction Phase|Lack of Efficacy|2|||
94696868|NCT00783718|324345299|FG002|Induction Phase|Lack of Efficacy|14|||
94696869|NCT00783718|324345300|FG003|Induction Phase|Lack of Efficacy|0|||
94696870|NCT00783718|324345301|FG004|Induction Phase|Lack of Efficacy|0|||
94696871|NCT00783718|324345302|FG005|Induction Phase|Lack of Efficacy|0|||
94696872|NCT00783718|324345303|FG006|Induction Phase|Lack of Efficacy|0|||
94696873|NCT00783718|324345297|FG000|Induction Phase|Withdrawal by Subject|3|||
94696874|NCT00783718|324345298|FG001|Induction Phase|Withdrawal by Subject|4|||
94696875|NCT00783718|324345299|FG002|Induction Phase|Withdrawal by Subject|8|||
94265443|NCT04178967|322765758|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94265444|NCT04178967|322765759|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94265445|NCT04178967|322765760|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94265446|NCT04178967|322765761|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94265447|NCT04178967|322765762|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94265448|NCT04178967|322765752|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94265449|NCT04178967|322765753|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94265450|NCT04178967|322765754|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94466100|NCT01473394|323496936|FG000|Overall Study|Withdrew Consent|12|||
94466101|NCT01473394|323496937|FG001|Overall Study|Withdrew Consent|10|||
94466102|NCT01473394|323496936|FG000|Overall Study|Lost to Follow-up|9|||
94466103|NCT01473394|323496937|FG001|Overall Study|Lost to Follow-up|11|||
94696876|NCT00783718|324345300|FG003|Induction Phase|Withdrawal by Subject|0|||
94696877|NCT00783718|324345301|FG004|Induction Phase|Withdrawal by Subject|0|||
94696878|NCT00783718|324345302|FG005|Induction Phase|Withdrawal by Subject|0|||
94696879|NCT00783718|324345303|FG006|Induction Phase|Withdrawal by Subject|0|||
94696880|NCT00783718|324345297|FG000|Induction Phase|Lost to Follow-up|1|||
94696881|NCT00783718|324345298|FG001|Induction Phase|Lost to Follow-up|0|||
94696882|NCT00783718|324345299|FG002|Induction Phase|Lost to Follow-up|1|||
94696883|NCT00783718|324345300|FG003|Induction Phase|Lost to Follow-up|0|||
94696884|NCT00783718|324345301|FG004|Induction Phase|Lost to Follow-up|0|||
94696885|NCT00783718|324345302|FG005|Induction Phase|Lost to Follow-up|0|||
94696886|NCT00783718|324345303|FG006|Induction Phase|Lost to Follow-up|0|||
94696887|NCT00783718|324345297|FG000|Maintenance Phase|Adverse Event|12|||
94696888|NCT00783718|324345298|FG001|Maintenance Phase|Adverse Event|0|||
94696889|NCT00783718|324345299|FG002|Maintenance Phase|Adverse Event|0|||
94696890|NCT00783718|324345300|FG003|Maintenance Phase|Adverse Event|15|||
94696891|NCT00783718|324345301|FG004|Maintenance Phase|Adverse Event|7|||
94696892|NCT00783718|324345302|FG005|Maintenance Phase|Adverse Event|6|||
94696893|NCT00783718|324345303|FG006|Maintenance Phase|Adverse Event|16|||
94696894|NCT00783718|324345297|FG000|Maintenance Phase|Protocol Violation|1|||
94696895|NCT00783718|324345298|FG001|Maintenance Phase|Protocol Violation|0|||
94696896|NCT00783718|324345299|FG002|Maintenance Phase|Protocol Violation|0|||
94696897|NCT00783718|324345300|FG003|Maintenance Phase|Protocol Violation|0|||
94696898|NCT00783718|324345301|FG004|Maintenance Phase|Protocol Violation|0|||
94696899|NCT00783718|324345302|FG005|Maintenance Phase|Protocol Violation|0|||
94696900|NCT00783718|324345303|FG006|Maintenance Phase|Protocol Violation|2|||
94696901|NCT00783718|324345297|FG000|Maintenance Phase|Lack of Efficacy|83|||
94696902|NCT00783718|324345298|FG001|Maintenance Phase|Lack of Efficacy|0|||
94696903|NCT00783718|324345299|FG002|Maintenance Phase|Lack of Efficacy|0|||
94696904|NCT00783718|324345300|FG003|Maintenance Phase|Lack of Efficacy|61|||
94696905|NCT00783718|324345301|FG004|Maintenance Phase|Lack of Efficacy|31|||
94696906|NCT00783718|324345302|FG005|Maintenance Phase|Lack of Efficacy|33|||
94696907|NCT00783718|324345303|FG006|Maintenance Phase|Lack of Efficacy|155|||
94696908|NCT00783718|324345297|FG000|Maintenance Phase|Withdrawal by Subject|6|||
94696909|NCT00783718|324345298|FG001|Maintenance Phase|Withdrawal by Subject|0|||
94696910|NCT00783718|324345299|FG002|Maintenance Phase|Withdrawal by Subject|0|||
94696911|NCT00783718|324345300|FG003|Maintenance Phase|Withdrawal by Subject|2|||
94696912|NCT00783718|324345301|FG004|Maintenance Phase|Withdrawal by Subject|5|||
94696913|NCT00783718|324345302|FG005|Maintenance Phase|Withdrawal by Subject|2|||
94696914|NCT00783718|324345303|FG006|Maintenance Phase|Withdrawal by Subject|20|||
94696915|NCT00783718|324345297|FG000|Maintenance Phase|Lost to Follow-up|3|||
94696916|NCT00783718|324345298|FG001|Maintenance Phase|Lost to Follow-up|0|||
94696917|NCT00783718|324345299|FG002|Maintenance Phase|Lost to Follow-up|0|||
94696918|NCT00783718|324345300|FG003|Maintenance Phase|Lost to Follow-up|0|||
94696919|NCT00783718|324345301|FG004|Maintenance Phase|Lost to Follow-up|2|||
94696920|NCT00783718|324345302|FG005|Maintenance Phase|Lost to Follow-up|0|||
94696921|NCT00783718|324345303|FG006|Maintenance Phase|Lost to Follow-up|2|||
94696922|NCT00630539|324345306|FG000|Overall Study|Adverse Event|1|||
94696923|NCT00630539|324345307|FG001|Overall Study|Adverse Event|3|||
94696924|NCT00630539|324345308|FG002|Overall Study|Adverse Event|1|||
94696925|NCT00630539|324345309|FG003|Overall Study|Adverse Event|2|||
94696926|NCT00630539|324345306|FG000|Overall Study|Withdrawal by Subject|0|||
94696927|NCT00630539|324345307|FG001|Overall Study|Withdrawal by Subject|1|||
94366269|NCT01988493|323126491|FG002|Overall Study|Randomized but not treated|0|||
94366270|NCT01988493|323126492|FG003|Overall Study|Randomized but not treated|0|||
94366271|NCT01988493|323126493|FG004|Overall Study|Randomized but not treated|1|||
94366272|NCT01523301|323126494|FG000|Overall Study|Adverse Event|25|||
94366273|NCT01523301|323126495|FG001|Overall Study|Adverse Event|16|||
94366274|NCT01523301|323126494|FG000|Overall Study|Lack of Efficacy|0|||
94366275|NCT01523301|323126495|FG001|Overall Study|Lack of Efficacy|2|||
94366276|NCT01523301|323126494|FG000|Overall Study|Protocol Violation|3|||
94366277|NCT01523301|323126495|FG001|Overall Study|Protocol Violation|4|||
94366278|NCT01523301|323126494|FG000|Overall Study|Lost to Follow-up|1|||
94366279|NCT01523301|323126495|FG001|Overall Study|Lost to Follow-up|0|||
94366280|NCT01523301|323126494|FG000|Overall Study|Withdrawal by Subject|6|||
94366281|NCT01523301|323126495|FG001|Overall Study|Withdrawal by Subject|8|||
94366282|NCT01523301|323126494|FG000|Overall Study|Other Reason|0|||
94366283|NCT01523301|323126495|FG001|Overall Study|Other Reason|2|||
94366284|NCT00720304|323126496|FG000|Overall Study|Withdrawal by Subject|14|||
94366285|NCT00720304|323126497|FG001|Overall Study|Withdrawal by Subject|1|||
94366286|NCT00720304|323126496|FG000|Overall Study|Death|1|||
94366287|NCT00720304|323126497|FG001|Overall Study|Death|0|||
94366288|NCT00720304|323126496|FG000|Overall Study|Physician Decision|5|||
94366289|NCT00720304|323126497|FG001|Overall Study|Physician Decision|2|||
94696928|NCT00630539|324345308|FG002|Overall Study|Withdrawal by Subject|0|||
94696929|NCT00630539|324345309|FG003|Overall Study|Withdrawal by Subject|1|||
94696930|NCT00577629|324345310|FG000|Treatment Period|Death|1|||
94696931|NCT00577629|324345310|FG000|Long Term Follow-Up|Death|15|||
94696932|NCT00577629|324345310|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
94696933|NCT00577629|324345310|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
94366290|NCT00720304|323126496|FG000|Overall Study|Adverse Event|3|||
94366291|NCT00720304|323126497|FG001|Overall Study|Adverse Event|1|||
94366292|NCT00720304|323126496|FG000|Overall Study|Disease progression|6|||
94366293|NCT00720304|323126497|FG001|Overall Study|Disease progression|1|||
94366294|NCT00996918|323126498|FG000|Overall Study|Lack of Efficacy|1|||
94366295|NCT00996918|323126499|FG001|Overall Study|Lack of Efficacy|1|||
94366296|NCT00996918|323126500|FG002|Overall Study|Lack of Efficacy|2|||
94366297|NCT00996918|323126501|FG003|Overall Study|Lack of Efficacy|2|||
94696934|NCT00577629|324345310|FG000|Long Term Follow-Up|Physician Decision|1|||
94696935|NCT04939428|324345315|FG000|Overall Study|Death|0|||
94696936|NCT04939428|324345316|FG001|Overall Study|Death|1|||
94366298|NCT00996918|323126502|FG004|Overall Study|Lack of Efficacy|0|||
94366299|NCT00996918|323126498|FG000|Overall Study|Adverse Event|2|||
94366300|NCT00996918|323126499|FG001|Overall Study|Adverse Event|5|||
94366301|NCT00996918|323126500|FG002|Overall Study|Adverse Event|2|||
94366302|NCT00996918|323126501|FG003|Overall Study|Adverse Event|6|||
94366303|NCT00996918|323126502|FG004|Overall Study|Adverse Event|0|||
94366304|NCT00996918|323126498|FG000|Overall Study|Withdrawal by Subject|1|||
94696937|NCT04939428|324345317|FG002|Overall Study|Death|0|||
94696938|NCT04939428|324345315|FG000|Overall Study|Lost to Follow-up|0|||
94696939|NCT04939428|324345316|FG001|Overall Study|Lost to Follow-up|5|||
94696940|NCT04939428|324345317|FG002|Overall Study|Lost to Follow-up|0|||
94696941|NCT04939428|324345315|FG000|Overall Study|Physician Decision|1|||
94696942|NCT04939428|324345316|FG001|Overall Study|Physician Decision|0|||
94696943|NCT04939428|324345317|FG002|Overall Study|Physician Decision|0|||
94696944|NCT04939428|324345315|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
94696945|NCT04939428|324345316|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94696946|NCT04939428|324345317|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94696947|NCT04939428|324345315|FG000|Overall Study|Withdrawal by Subject|10|||
94696948|NCT04939428|324345316|FG001|Overall Study|Withdrawal by Subject|11|||
94696949|NCT04939428|324345317|FG002|Overall Study|Withdrawal by Subject|0|||
94696950|NCT04939428|324345315|FG000|Overall Study|Unkown|6|||
94696951|NCT04939428|324345316|FG001|Overall Study|Unkown|3|||
94696952|NCT04939428|324345317|FG002|Overall Study|Unkown|0|||
94696953|NCT04939428|324345315|FG000|Overall Study|Discotinued per protocol|0|||
94696954|NCT04939428|324345316|FG001|Overall Study|Discotinued per protocol|0|||
94696955|NCT04939428|324345317|FG002|Overall Study|Discotinued per protocol|902|||
94696956|NCT04319094|324345320|FG000|Baseline|Lost to Follow-up|4|||
94696957|NCT04319094|324345321|FG001|Baseline|Lost to Follow-up|5|||
94696958|NCT04319094|324345320|FG000|Baseline|Protocol Violation|0|||
94696959|NCT04319094|324345321|FG001|Baseline|Protocol Violation|3|||
94696960|NCT04319094|324345320|FG000|Baseline|Withdrawal by Subject|2|||
94696961|NCT04319094|324345321|FG001|Baseline|Withdrawal by Subject|1|||
94696962|NCT04319094|324345320|FG000|Post-Intervention|Death|0|||
94696963|NCT04319094|324345321|FG001|Post-Intervention|Death|1|||
94696964|NCT04319094|324345320|FG000|Post-Intervention|Lost to Follow-up|4|||
94696965|NCT04319094|324345321|FG001|Post-Intervention|Lost to Follow-up|4|||
94696966|NCT04319094|324345320|FG000|Post-Intervention|Withdrawal by Subject|8|||
94696967|NCT04319094|324345321|FG001|Post-Intervention|Withdrawal by Subject|5|||
94696968|NCT04319094|324345320|FG000|Post-Intervention|Incomplete Data Collection|1|||
94696969|NCT04319094|324345321|FG001|Post-Intervention|Incomplete Data Collection|3|||
94696970|NCT04319094|324345320|FG000|3-month|Death|1|||
94696971|NCT04319094|324345321|FG001|3-month|Death|0|||
94696972|NCT04319094|324345320|FG000|3-month|Lost to Follow-up|2|||
94696973|NCT04319094|324345321|FG001|3-month|Lost to Follow-up|2|||
94265451|NCT04178967|322765755|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
94265452|NCT04178967|322765756|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94265453|NCT04178967|322765757|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94265454|NCT04178967|322765758|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94265455|NCT04178967|322765759|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94696974|NCT04319094|324345320|FG000|3-month|Withdrawal by Subject|0|||
94696975|NCT04319094|324345321|FG001|3-month|Withdrawal by Subject|3|||
94696976|NCT04319094|324345320|FG000|3-month|Incomplete data collection|9|||
94696977|NCT04319094|324345321|FG001|3-month|Incomplete data collection|7|||
94696978|NCT04319094|324345320|FG000|6-month|Lost to Follow-up|1|||
94696979|NCT04319094|324345321|FG001|6-month|Lost to Follow-up|1|||
94696980|NCT04319094|324345320|FG000|6-month|Withdrawal by Subject|0|||
94696981|NCT04319094|324345321|FG001|6-month|Withdrawal by Subject|3|||
94265456|NCT04178967|322765760|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94265457|NCT04178967|322765761|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94265458|NCT04178967|322765762|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94265459|NCT04178967|322765752|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
94265460|NCT04178967|322765753|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
94265461|NCT04178967|322765754|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
94265462|NCT04178967|322765755|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
94265463|NCT04178967|322765756|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
94265464|NCT04178967|322765757|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
94265465|NCT04178967|322765758|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
94265466|NCT04178967|322765759|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
94265467|NCT04178967|322765760|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
94265468|NCT04178967|322765761|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
94265469|NCT04178967|322765762|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
94265470|NCT04178967|322765752|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
94265471|NCT04178967|322765753|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
94265472|NCT04178967|322765754|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
94265473|NCT04178967|322765755|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
94696982|NCT04319094|324345320|FG000|6-month|Incomplete data collection|14|||
94265474|NCT04178967|322765756|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
94265475|NCT04178967|322765757|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
94265476|NCT04178967|322765758|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
94265477|NCT04178967|322765759|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
94265478|NCT04178967|322765760|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
94265479|NCT04178967|322765761|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
94265480|NCT04178967|322765762|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
94265481|NCT04178967|322765752|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
94265482|NCT04178967|322765753|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
94265483|NCT04178967|322765754|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
94265484|NCT04178967|322765755|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
94265485|NCT04178967|322765756|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
94265486|NCT04178967|322765757|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
94265487|NCT04178967|322765758|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
94265488|NCT04178967|322765759|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
94265489|NCT04178967|322765760|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
94265490|NCT04178967|322765761|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
94265491|NCT04178967|322765762|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
94265492|NCT04178967|322765752|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
94265493|NCT04178967|322765753|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
94265494|NCT04178967|322765754|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
94265495|NCT04178967|322765755|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
94265496|NCT04178967|322765756|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
94265497|NCT04178967|322765757|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
94696983|NCT04319094|324345321|FG001|6-month|Incomplete data collection|9|||
94696984|NCT04319094|324345320|FG000|9-month|Lost to Follow-up|8|||
94696985|NCT04319094|324345321|FG001|9-month|Lost to Follow-up|4|||
94696986|NCT04319094|324345320|FG000|9-month|Withdrawal by Subject|0|||
94265498|NCT04178967|322765758|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
94265499|NCT04178967|322765759|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
94265500|NCT04178967|322765760|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
94696987|NCT04319094|324345321|FG001|9-month|Withdrawal by Subject|1|||
94696988|NCT04319094|324345320|FG000|9-month|Incomplete data collection|8|||
94696989|NCT04319094|324345321|FG001|9-month|Incomplete data collection|5|||
94696990|NCT04319094|324345320|FG000|12-month|Lost to Follow-up|11|||
94696991|NCT04319094|324345321|FG001|12-month|Lost to Follow-up|8|||
94696992|NCT02696785|324345322|FG000|Blinded Treatment Period|Adverse Event|0|||
94696993|NCT02696785|324345323|FG001|Blinded Treatment Period|Adverse Event|1|||
94696994|NCT02696785|324345324|FG002|Blinded Treatment Period|Adverse Event|3|||
94696995|NCT02696785|324345325|FG003|Blinded Treatment Period|Adverse Event|0|||
94696996|NCT02696785|324345322|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
94696997|NCT02696785|324345323|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
94696998|NCT02696785|324345324|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
94696999|NCT02696785|324345325|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
94697000|NCT02696785|324345322|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
94697001|NCT02696785|324345323|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
94697002|NCT02696785|324345324|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
94697003|NCT02696785|324345325|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
94697004|NCT02696785|324345322|FG000|Blinded Treatment Period|Screen Failure|1|||
94697005|NCT02696785|324345323|FG001|Blinded Treatment Period|Screen Failure|0|||
94697006|NCT02696785|324345324|FG002|Blinded Treatment Period|Screen Failure|0|||
94697007|NCT02696785|324345325|FG003|Blinded Treatment Period|Screen Failure|0|||
94697008|NCT02696785|324345322|FG000|Washout Period|Withdrawal by Subject|0|||
94697009|NCT02696785|324345323|FG001|Washout Period|Withdrawal by Subject|1|||
94697010|NCT02696785|324345324|FG002|Washout Period|Withdrawal by Subject|0|||
94697011|NCT02696785|324345325|FG003|Washout Period|Withdrawal by Subject|0|||
94697012|NCT02696785|324345322|FG000|Washout Period|Lack of Efficacy|0|||
94697013|NCT02696785|324345323|FG001|Washout Period|Lack of Efficacy|1|||
94697014|NCT02696785|324345324|FG002|Washout Period|Lack of Efficacy|0|||
94697015|NCT02696785|324345325|FG003|Washout Period|Lack of Efficacy|0|||
94697016|NCT02696785|324345322|FG000|Extended Treatment Period|Adverse Event|2|||
94697017|NCT02696785|324345323|FG001|Extended Treatment Period|Adverse Event|3|||
94697018|NCT02696785|324345324|FG002|Extended Treatment Period|Adverse Event|2|||
94697019|NCT02696785|324345325|FG003|Extended Treatment Period|Adverse Event|1|||
94697020|NCT02696785|324345322|FG000|Extended Treatment Period|Lack of Efficacy|0|||
94697021|NCT02696785|324345323|FG001|Extended Treatment Period|Lack of Efficacy|1|||
94697022|NCT02696785|324345324|FG002|Extended Treatment Period|Lack of Efficacy|0|||
94366305|NCT00996918|323126499|FG001|Overall Study|Withdrawal by Subject|4|||
94366306|NCT00996918|323126500|FG002|Overall Study|Withdrawal by Subject|3|||
94366307|NCT00996918|323126501|FG003|Overall Study|Withdrawal by Subject|3|||
94697023|NCT02696785|324345325|FG003|Extended Treatment Period|Lack of Efficacy|0|||
94697024|NCT02696785|324345322|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
94697025|NCT02696785|324345323|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
94697026|NCT02696785|324345324|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
94697027|NCT02696785|324345325|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
94697028|NCT02696785|324345322|FG000|Follow-up Period|Adverse Event|0|||
94697029|NCT02696785|324345323|FG001|Follow-up Period|Adverse Event|0|||
94697030|NCT02696785|324345324|FG002|Follow-up Period|Adverse Event|8|||
94697031|NCT02696785|324345325|FG003|Follow-up Period|Adverse Event|2|||
94697032|NCT02696785|324345322|FG000|Follow-up Period|Lost to Follow-up|0|||
94697033|NCT02696785|324345323|FG001|Follow-up Period|Lost to Follow-up|0|||
94697034|NCT02696785|324345324|FG002|Follow-up Period|Lost to Follow-up|0|||
94697035|NCT02696785|324345325|FG003|Follow-up Period|Lost to Follow-up|1|||
94697036|NCT02696785|324345322|FG000|Follow-up Period|Lack of Efficacy|0|||
94697037|NCT02696785|324345323|FG001|Follow-up Period|Lack of Efficacy|0|||
94697038|NCT02696785|324345324|FG002|Follow-up Period|Lack of Efficacy|0|||
94697039|NCT02696785|324345325|FG003|Follow-up Period|Lack of Efficacy|1|||
94697040|NCT02696785|324345322|FG000|Follow-up Period|Withdrawal by Subject|1|||
94697041|NCT02696785|324345323|FG001|Follow-up Period|Withdrawal by Subject|0|||
94697042|NCT02696785|324345324|FG002|Follow-up Period|Withdrawal by Subject|5|||
94697043|NCT02696785|324345325|FG003|Follow-up Period|Withdrawal by Subject|4|||
94697044|NCT02487446|324345326|FG000|Period 1|Physician Decision|0|||
94697045|NCT02487446|324345327|FG001|Period 1|Physician Decision|1|||
94697046|NCT02487446|324345326|FG000|Period 1|Lack of Efficacy|1|||
94697047|NCT02487446|324345327|FG001|Period 1|Lack of Efficacy|0|||
94697048|NCT02487446|324345326|FG000|Period 1|Protocol deviation|3|||
94697049|NCT02487446|324345327|FG001|Period 1|Protocol deviation|2|||
94697050|NCT02487446|324345326|FG000|Period 1|Lost to Follow-up|2|||
94697051|NCT02487446|324345327|FG001|Period 1|Lost to Follow-up|0|||
94697052|NCT02487446|324345326|FG000|Period 1|Withdrawal by Subject|2|||
94697053|NCT02487446|324345327|FG001|Period 1|Withdrawal by Subject|0|||
94697054|NCT02487446|324345326|FG000|Period 1|Adverse Event|5|||
94697055|NCT02487446|324345327|FG001|Period 1|Adverse Event|5|||
94697056|NCT02487446|324345326|FG000|Washout|Lost to Follow-up|0|||
94697057|NCT02487446|324345327|FG001|Washout|Lost to Follow-up|2|||
94697058|NCT02487446|324345326|FG000|Washout|Withdrawal by Subject|1|||
94697059|NCT02487446|324345327|FG001|Washout|Withdrawal by Subject|4|||
94366308|NCT00996918|323126502|FG004|Overall Study|Withdrawal by Subject|2|||
94697060|NCT02487446|324345326|FG000|Washout|Adverse Event|2|||
94697061|NCT02487446|324345327|FG001|Washout|Adverse Event|2|||
94697062|NCT02487446|324345326|FG000|Period 2|Protocol deviation|0|||
94697063|NCT02487446|324345327|FG001|Period 2|Protocol deviation|1|||
94366309|NCT00996918|323126498|FG000|Overall Study|Physician Decision|1|||
94697064|NCT02487446|324345326|FG000|Period 2|Lost to Follow-up|1|||
94697065|NCT02487446|324345327|FG001|Period 2|Lost to Follow-up|1|||
94697066|NCT02487446|324345326|FG000|Period 2|Withdrawal by Subject|1|||
94697067|NCT02487446|324345327|FG001|Period 2|Withdrawal by Subject|1|||
94697068|NCT02487446|324345326|FG000|Period 2|Adverse Event|6|||
94697069|NCT02487446|324345327|FG001|Period 2|Adverse Event|2|||
94697070|NCT04482855|324345328|FG000|Overall Study|Lost to Follow-up|1|||
94697071|NCT04482855|324345329|FG001|Overall Study|Lost to Follow-up|0|||
94697072|NCT04482855|324345328|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
94697073|NCT04482855|324345329|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
94697074|NCT04482855|324345328|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
94697075|NCT04482855|324345329|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
94697076|NCT03660943|324347517|FG000|Overall Study|Adverse Event|5|||
94697077|NCT03660943|324347518|FG001|Overall Study|Adverse Event|3|||
94697078|NCT03660943|324347517|FG000|Overall Study|Death|0|||
94697079|NCT03660943|324347518|FG001|Overall Study|Death|2|||
94697080|NCT03660943|324347517|FG000|Overall Study|Lost to Follow-up|7|||
94697081|NCT03660943|324347518|FG001|Overall Study|Lost to Follow-up|3|||
94697082|NCT03660943|324347517|FG000|Overall Study|Protocol Violation|3|||
94697083|NCT03660943|324347518|FG001|Overall Study|Protocol Violation|5|||
94697084|NCT03660943|324347517|FG000|Overall Study|Withdrawal by Subject|8|||
94697085|NCT03660943|324347518|FG001|Overall Study|Withdrawal by Subject|15|||
94697086|NCT03660943|324347517|FG000|Overall Study|Lack of Efficacy|9|||
94697087|NCT03660943|324347518|FG001|Overall Study|Lack of Efficacy|12|||
94697088|NCT03660943|324347517|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
94697089|NCT03660943|324347518|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
94697090|NCT02107274|324347519|FG000|Treatment vs. Placebo|Adverse Event|3|||
94697091|NCT02107274|324347520|FG001|Treatment vs. Placebo|Adverse Event|0|||
94697092|NCT02107274|324347519|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
94697093|NCT02107274|324347520|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
94697094|NCT02107274|324347519|FG000|Control Phase|Lost to Follow-up|1|||
94697095|NCT02107274|324347520|FG001|Control Phase|Lost to Follow-up|1|||
94697096|NCT02107274|324347519|FG000|Control Phase|Death|2|||
94697097|NCT02107274|324347520|FG001|Control Phase|Death|0|||
94697098|NCT02107274|324347519|FG000|Control Phase|Adverse Event|0|||
94697099|NCT02107274|324347520|FG001|Control Phase|Adverse Event|1|||
94697100|NCT02892409|324347523|FG000|Overall Study|Adverse Event|1|||
94697101|NCT02892409|324347524|FG001|Overall Study|Adverse Event|0|||
94697102|NCT02892409|324347523|FG000|Overall Study|Withdrawal by Subject|2|||
94697103|NCT02892409|324347524|FG001|Overall Study|Withdrawal by Subject|1|||
94697104|NCT01876043|324347525|FG000|Overall Study|Death|1|||
94697105|NCT01876043|324347525|FG000|Overall Study|Withdrawal by Subject|1|||
94697106|NCT01616563|324347526|FG000|Overall Study|Lost to Follow-up|40|||
94697107|NCT01033643|324347529|FG000|Overall Study|Withdrew Consent|0|||
94697108|NCT01033643|324347530|FG001|Overall Study|Withdrew Consent|3|||
94697109|NCT01033643|324347531|FG002|Overall Study|Withdrew Consent|0|||
94697110|NCT01033643|324347532|FG003|Overall Study|Withdrew Consent|0|||
94697111|NCT01033643|324347533|FG004|Overall Study|Withdrew Consent|0|||
94697112|NCT01033643|324347534|FG005|Overall Study|Withdrew Consent|1|||
94697113|NCT00852475|324347545|FG000|Overall Study|Lost to Follow-up|3|||
94697114|NCT00852475|324347546|FG001|Overall Study|Lost to Follow-up|4|||
94697115|NCT02485353|324347547|FG000|Overall Study|Death|1|||
94697116|NCT02485353|324347547|FG000|Overall Study|Disease Progression|1|||
94697117|NCT02652130|324347548|FG000|Overall Study|Death|1|||
94697118|NCT00354029|324347549|FG000|Overall Study|Protocol Violation|4|||
94697119|NCT00354029|324347550|FG001|Overall Study|Protocol Violation|2|||
94697120|NCT00723294|324347551|FG000|Overall Study|Lobular histology|2|||
94697121|NCT00723294|324347551|FG000|Overall Study|>25% intraductal component|1|||
94697122|NCT00723294|324347551|FG000|Overall Study|No MRI tumor enhancement|1|||
94697123|NCT00723294|324347551|FG000|Overall Study|1.0-Tesla MRI|1|||
94697124|NCT00723294|324347551|FG000|Overall Study|No cryoabalation|2|||
94697125|NCT00723294|324347551|FG000|Overall Study|Did not undergo surgery|1|||
94697126|NCT00723294|324347551|FG000|Overall Study|Treated prior to registration|1|||
94697127|NCT00723294|324347551|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
94697128|NCT00723294|324347551|FG000|Overall Study|Benign lesion|1|||
94697129|NCT00723294|324347551|FG000|Overall Study|Withdrawal by Subject|1|||
94265501|NCT04178967|322765761|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
94265502|NCT04178967|322765762|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
94265503|NCT04178967|322765752|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
94265504|NCT04178967|322765753|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
94265505|NCT04178967|322765754|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
94265506|NCT04178967|322765755|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
94265507|NCT04178967|322765756|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
94697130|NCT00723294|324347551|FG000|Overall Study|No treatment due to probe failure|1|||
94697131|NCT01511536|324347557|FG000|Phase 1|Other|0|||
94697132|NCT01511536|324347558|FG001|Phase 1|Other|1|||
94697133|NCT01511536|324347559|FG002|Phase 1|Other|0|||
94697134|NCT01511536|324347557|FG000|Phase 2|Other|0|||
94697135|NCT01511536|324347558|FG001|Phase 2|Other|0|||
94697136|NCT01511536|324347559|FG002|Phase 2|Other|9|||
94697137|NCT01764386|324347563|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
94265508|NCT04178967|322765757|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
94265509|NCT04178967|322765758|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
94265510|NCT04178967|322765759|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
94265511|NCT04178967|322765760|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
94265512|NCT04178967|322765761|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
94265513|NCT04178967|322765762|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
94265514|NCT04178967|322765752|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94265515|NCT04178967|322765753|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94265516|NCT04178967|322765754|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94265517|NCT04178967|322765755|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94265518|NCT04178967|322765756|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94265519|NCT04178967|322765757|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94265520|NCT04178967|322765758|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94265521|NCT04178967|322765759|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94265522|NCT04178967|322765760|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
94265523|NCT04178967|322765761|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
94265524|NCT04178967|322765762|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
94265525|NCT04178967|322765752|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94265526|NCT04178967|322765753|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94265527|NCT04178967|322765754|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94265528|NCT04178967|322765755|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94265529|NCT04178967|322765756|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94265530|NCT04178967|322765757|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94265531|NCT04178967|322765758|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94265532|NCT04178967|322765759|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94265533|NCT04178967|322765760|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94265534|NCT04178967|322765761|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
94697138|NCT01764386|324347564|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
94697139|NCT01764386|324347563|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
94265535|NCT04178967|322765762|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94697140|NCT01764386|324347564|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
94697141|NCT01764386|324347563|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
94697142|NCT01764386|324347564|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
94697143|NCT01764386|324347563|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
94697144|NCT01764386|324347564|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
94697145|NCT01764386|324347563|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
94697146|NCT01764386|324347564|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
94697147|NCT01764386|324347563|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
94697148|NCT01764386|324347564|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
94697149|NCT01764386|324347563|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
94697150|NCT01764386|324347564|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
94697151|NCT01764386|324347563|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
94697152|NCT01764386|324347564|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
94697153|NCT03738241|324347568|FG000|Overall Study|Withdrawal by Subject|0|||
94697154|NCT03738241|324347569|FG001|Overall Study|Withdrawal by Subject|0|||
94697155|NCT03738241|324347570|FG002|Overall Study|Withdrawal by Subject|0|||
94697156|NCT03738241|324347571|FG003|Overall Study|Withdrawal by Subject|0|||
94697157|NCT03738241|324347572|FG004|Overall Study|Withdrawal by Subject|0|||
94697158|NCT03738241|324347573|FG005|Overall Study|Withdrawal by Subject|0|||
94697159|NCT03738241|324347574|FG006|Overall Study|Withdrawal by Subject|0|||
94697160|NCT03738241|324347575|FG007|Overall Study|Withdrawal by Subject|0|||
94697161|NCT03738241|324347576|FG008|Overall Study|Withdrawal by Subject|0|||
94697162|NCT03738241|324347577|FG009|Overall Study|Withdrawal by Subject|1|||
94697163|NCT03738241|324347568|FG000|Overall Study|Physician Decision|0|||
94697164|NCT03738241|324347569|FG001|Overall Study|Physician Decision|0|||
94697165|NCT03738241|324347570|FG002|Overall Study|Physician Decision|0|||
94697166|NCT03738241|324347571|FG003|Overall Study|Physician Decision|0|||
94697167|NCT03738241|324347572|FG004|Overall Study|Physician Decision|0|||
94697168|NCT03738241|324347573|FG005|Overall Study|Physician Decision|0|||
94697169|NCT03738241|324347574|FG006|Overall Study|Physician Decision|0|||
94697170|NCT03738241|324347575|FG007|Overall Study|Physician Decision|0|||
94697171|NCT03738241|324347576|FG008|Overall Study|Physician Decision|1|||
94697172|NCT03738241|324347577|FG009|Overall Study|Physician Decision|0|||
94697173|NCT03738241|324347568|FG000|Overall Study|Adverse Event|1|||
94697174|NCT03738241|324347569|FG001|Overall Study|Adverse Event|0|||
94697175|NCT03738241|324347570|FG002|Overall Study|Adverse Event|0|||
94697176|NCT03738241|324347571|FG003|Overall Study|Adverse Event|0|||
94697177|NCT03738241|324347572|FG004|Overall Study|Adverse Event|0|||
94697178|NCT03738241|324347573|FG005|Overall Study|Adverse Event|0|||
94697179|NCT03738241|324347574|FG006|Overall Study|Adverse Event|0|||
94697180|NCT03738241|324347575|FG007|Overall Study|Adverse Event|0|||
94697181|NCT03738241|324347576|FG008|Overall Study|Adverse Event|0|||
94697182|NCT03738241|324347577|FG009|Overall Study|Adverse Event|0|||
94697183|NCT02788656|324347578|FG000|Overall Study|Withdrawal by Subject|1|||
94697184|NCT02788656|324347579|FG001|Overall Study|Withdrawal by Subject|0|||
94697185|NCT03169361|324347580|FG000|Overall Study|Protocol Violation|32|||
94697186|NCT02271594|324347581|FG000|Overall Study|Study closed; recruiting failure|19|||
94697187|NCT02271594|324347582|FG001|Overall Study|Study closed; recruiting failure|12|||
94697188|NCT00088465|324347583|FG000|Overall Study|Withdrawal by Subject|290|||
94697189|NCT00088465|324347583|FG000|Overall Study|Adverse Event|77|||
94697190|NCT00088465|324347583|FG000|Overall Study|Lost to Follow-up|57|||
94697191|NCT00088465|324347583|FG000|Overall Study|Physician Decision|45|||
94697192|NCT00088465|324347583|FG000|Overall Study|Sponsor Decision|37|||
94697193|NCT00088465|324347583|FG000|Overall Study|Lack of Efficacy|27|||
94697194|NCT00088465|324347583|FG000|Overall Study|Protocol Violation|17|||
94697195|NCT00088465|324347583|FG000|Overall Study|Death|11|||
94697196|NCT01561079|324347584|FG000|Overall Study|Physician Decision|17|||
94697197|NCT01561079|324347584|FG000|Overall Study|Withdrawal by Subject|59|||
94697198|NCT01561079|324347584|FG000|Overall Study|Protocol Violation|2|||
94697199|NCT03929302|324347585|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
94697200|NCT03929302|324347586|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
94697201|NCT03929302|324347587|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
94697202|NCT03929302|324347585|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
94697203|NCT03929302|324347586|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
94697204|NCT03929302|324347587|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
94697205|NCT03929302|324347585|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
94697206|NCT03929302|324347586|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
94697207|NCT03929302|324347587|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
94697208|NCT00003377|324347592|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
94697209|NCT00003377|324347593|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
94697210|NCT00003377|324347594|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
94697211|NCT00003377|324347595|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
94697212|NCT00003377|324347596|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
94697213|NCT00003377|324347592|FG000|Period II|Ureteral stent complications|0|||
94697214|NCT00003377|324347593|FG001|Period II|Ureteral stent complications|0|||
94697215|NCT00003377|324347594|FG002|Period II|Ureteral stent complications|0|||
94697216|NCT00003377|324347595|FG003|Period II|Ureteral stent complications|0|||
94697217|NCT00003377|324347596|FG004|Period II|Ureteral stent complications|1|||
94697218|NCT01077024|324347597|FG000|Overall Study|Lost to Follow-up|20|||
94697219|NCT01077024|324347598|FG001|Overall Study|Lost to Follow-up|14|||
94697220|NCT01077024|324347597|FG000|Overall Study|Withdrawal by Subject|0|||
94697221|NCT01077024|324347598|FG001|Overall Study|Withdrawal by Subject|2|||
94697222|NCT01077024|324347597|FG000|Overall Study|Incarcerated|7|||
94466104|NCT00869557|323496938|FG000|Randomized Phase|Lost to Follow-up|2|||
94466105|NCT00869557|323496939|FG001|Randomized Phase|Lost to Follow-up|1|||
94651637|NCT01418209|324181747|FG001|Overall Study|Withdrawal by Subject|0|||
94651638|NCT01418209|324181748|FG002|Overall Study|Withdrawal by Subject|1|||
94651639|NCT01418209|324181746|FG000|Overall Study|Did not provide hot flash diary data|1|||
94651640|NCT01418209|324181747|FG001|Overall Study|Did not provide hot flash diary data|3|||
94651641|NCT01418209|324181748|FG002|Overall Study|Did not provide hot flash diary data|3|||
94651642|NCT01462357|324181749|FG000|Overall Study|Death|0|||
94651643|NCT01462357|324181750|FG001|Overall Study|Death|0|||
94651644|NCT01462357|324181751|FG002|Overall Study|Death|1|||
94651645|NCT01462357|324181749|FG000|Overall Study|Withdrawal by Subject|3|||
94651646|NCT01462357|324181750|FG001|Overall Study|Withdrawal by Subject|11|||
94651647|NCT01462357|324181751|FG002|Overall Study|Withdrawal by Subject|3|||
94651648|NCT01462357|324181749|FG000|Overall Study|Migrated/moved from study area|2|||
94651649|NCT01462357|324181750|FG001|Overall Study|Migrated/moved from study area|3|||
94651650|NCT01462357|324181751|FG002|Overall Study|Migrated/moved from study area|1|||
94651651|NCT01462357|324181749|FG000|Overall Study|Lost to Follow-up|3|||
94651652|NCT01462357|324181750|FG001|Overall Study|Lost to Follow-up|5|||
94651653|NCT01462357|324181751|FG002|Overall Study|Lost to Follow-up|7|||
94651654|NCT01334866|324181755|FG000|Overall Study|Withdrawal by Subject|10|||
94651655|NCT01334866|324181755|FG000|Overall Study|Lost to Follow-up|3|||
94651656|NCT01334866|324181755|FG000|Overall Study|Physician Decision|3|||
94651657|NCT01334866|324181755|FG000|Overall Study|medically necessary prior to procedure|2|||
94651658|NCT01334866|324181755|FG000|Overall Study|medically necessary post-procedure|1|||
94651659|NCT04292730|324181756|FG000|Overall Study|Lost to Follow-up|8|||
94651660|NCT04292730|324181757|FG001|Overall Study|Lost to Follow-up|12|||
94651661|NCT04292730|324181758|FG002|Overall Study|Lost to Follow-up|12|||
94651662|NCT04292730|324181759|FG003|Overall Study|Lost to Follow-up|48|||
94651663|NCT04292730|324181756|FG000|Overall Study|Death|2|||
94651664|NCT04292730|324181757|FG001|Overall Study|Death|2|||
94651665|NCT04292730|324181758|FG002|Overall Study|Death|4|||
94651666|NCT04292730|324181759|FG003|Overall Study|Death|12|||
94651667|NCT04292730|324181756|FG000|Overall Study|Withdrew Consent|2|||
94651668|NCT04292730|324181757|FG001|Overall Study|Withdrew Consent|2|||
94651669|NCT04292730|324181758|FG002|Overall Study|Withdrew Consent|5|||
94651670|NCT04292730|324181759|FG003|Overall Study|Withdrew Consent|6|||
94651671|NCT04292730|324181756|FG000|Overall Study|Non-Compliance with Study Drug|0|||
94651672|NCT04292730|324181757|FG001|Overall Study|Non-Compliance with Study Drug|1|||
94651673|NCT04292730|324181758|FG002|Overall Study|Non-Compliance with Study Drug|0|||
94651674|NCT04292730|324181759|FG003|Overall Study|Non-Compliance with Study Drug|0|||
94651675|NCT04292730|324181756|FG000|Overall Study|Protocol Violation|0|||
94651676|NCT04292730|324181757|FG001|Overall Study|Protocol Violation|0|||
94651677|NCT04292730|324181758|FG002|Overall Study|Protocol Violation|1|||
94651678|NCT04292730|324181759|FG003|Overall Study|Protocol Violation|0|||
94651679|NCT04292730|324181756|FG000|Overall Study|Randomized but not Treated|8|||
94651680|NCT04292730|324181757|FG001|Overall Study|Randomized but not Treated|4|||
94651681|NCT04292730|324181758|FG002|Overall Study|Randomized but not Treated|0|||
94651682|NCT04292730|324181759|FG003|Overall Study|Randomized but not Treated|14|||
94651683|NCT00983580|324181762|FG000|Overall Study|Cancel Prior to treatment|1|||
94651684|NCT00983580|324181763|FG001|Overall Study|Cancel Prior to treatment|3|||
94651685|NCT00983580|324181762|FG000|Overall Study|Protocol Violation|1|||
94651686|NCT00983580|324181763|FG001|Overall Study|Protocol Violation|1|||
94651687|NCT00983580|324181762|FG000|Overall Study|Ineligible|3|||
94651688|NCT00983580|324181763|FG001|Overall Study|Ineligible|0|||
94651689|NCT01856543|324181771|FG000|Overall Study|Treatment discontinued|6|||
94651690|NCT01856543|324181772|FG001|Overall Study|Treatment discontinued|3|||
94651691|NCT01856543|324181771|FG000|Overall Study|Withdrawn before start|7|||
94651692|NCT01856543|324181772|FG001|Overall Study|Withdrawn before start|3|||
94651693|NCT01247090|324181775|FG000|Overall Study|Physician Decision|1|||
94651694|NCT01247090|324181776|FG001|Overall Study|Physician Decision|0|||
94651695|NCT01247090|324181777|FG002|Overall Study|Physician Decision|0|||
94651696|NCT01247090|324181775|FG000|Overall Study|Withdrawal by Subject|0|||
94651697|NCT01247090|324181776|FG001|Overall Study|Withdrawal by Subject|1|||
94651698|NCT01247090|324181777|FG002|Overall Study|Withdrawal by Subject|0|||
94651699|NCT04545515|324181779|FG000|Overall Study|Adverse Event|1|||
94651700|NCT04545515|324181779|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
94651701|NCT04545515|324181779|FG000|Overall Study|Commercial drug is available for participant|7|||
94651702|NCT02501096|324181780|FG000|Overall Study|Lost to Follow-up|0|||
94651703|NCT02501096|324181781|FG001|Overall Study|Lost to Follow-up|0|||
94651704|NCT02501096|324181782|FG002|Overall Study|Lost to Follow-up|0|||
94651705|NCT02501096|324181783|FG003|Overall Study|Lost to Follow-up|0|||
94651706|NCT02501096|324181784|FG004|Overall Study|Lost to Follow-up|1|||
94651707|NCT02501096|324181785|FG005|Overall Study|Lost to Follow-up|1|||
94265536|NCT04178967|322765752|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94265537|NCT04178967|322765753|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94265538|NCT04178967|322765754|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94265539|NCT04178967|322765755|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94697223|NCT01077024|324347598|FG001|Overall Study|Incarcerated|8|||
94697224|NCT01077024|324347597|FG000|Overall Study|Other|4|||
94697225|NCT01077024|324347598|FG001|Overall Study|Other|4|||
94697226|NCT02034435|324347599|FG000|Overall Study|Withdrawal by Subject|1|||
94697227|NCT02034435|324347600|FG001|Overall Study|Withdrawal by Subject|0|||
94265540|NCT04178967|322765756|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94265541|NCT04178967|322765757|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94265542|NCT04178967|322765758|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94697228|NCT02034435|324347601|FG002|Overall Study|Withdrawal by Subject|0|||
94697229|NCT02034435|324347602|FG003|Overall Study|Withdrawal by Subject|0|||
94697230|NCT02034435|324347599|FG000|Overall Study|Illness|0|||
94697231|NCT02034435|324347600|FG001|Overall Study|Illness|2|||
94697232|NCT02034435|324347601|FG002|Overall Study|Illness|0|||
94697233|NCT02034435|324347602|FG003|Overall Study|Illness|0|||
94697234|NCT02034435|324347599|FG000|Overall Study|Inadequate IV access|1|||
94697235|NCT02034435|324347600|FG001|Overall Study|Inadequate IV access|0|||
94697236|NCT02034435|324347601|FG002|Overall Study|Inadequate IV access|0|||
94697237|NCT02034435|324347602|FG003|Overall Study|Inadequate IV access|1|||
94697238|NCT02300311|324347605|FG000|Overall Study|Other than the reason specified|1|||
94697239|NCT02300311|324347606|FG001|Overall Study|Other than the reason specified|0|||
94697240|NCT02300311|324347605|FG000|Overall Study|Refused to continue taking medication|18|||
94697241|NCT02300311|324347606|FG001|Overall Study|Refused to continue taking medication|0|||
94697242|NCT00419003|324347607|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
94697243|NCT00419003|324347608|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
94697244|NCT00419003|324347607|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
94697245|NCT00419003|324347608|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
94697246|NCT02531438|324347609|FG000|Overall Study|Adverse Event|7|||
94697247|NCT02531438|324347610|FG001|Overall Study|Adverse Event|9|||
94697248|NCT02531438|324347609|FG000|Overall Study|Lost to Follow-up|0|||
94697249|NCT02531438|324347610|FG001|Overall Study|Lost to Follow-up|3|||
94697250|NCT02531438|324347609|FG000|Overall Study|Withdrawal by Subject|7|||
94697251|NCT02531438|324347610|FG001|Overall Study|Withdrawal by Subject|8|||
94697252|NCT02531438|324347609|FG000|Overall Study|Physician Decision|0|||
94697253|NCT02531438|324347610|FG001|Overall Study|Physician Decision|1|||
94697254|NCT02531438|324347609|FG000|Overall Study|Death|6|||
94697255|NCT02531438|324347610|FG001|Overall Study|Death|3|||
94697256|NCT02531438|324347609|FG000|Overall Study|Randomized, but Not Treated|4|||
94697257|NCT02531438|324347610|FG001|Overall Study|Randomized, but Not Treated|0|||
94697258|NCT02531438|324347609|FG000|Overall Study|Missed EOT/PTE Visit|5|||
94697259|NCT02531438|324347610|FG001|Overall Study|Missed EOT/PTE Visit|2|||
94697260|NCT02531438|324347609|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
94697261|NCT02531438|324347610|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
94697262|NCT01124617|324347611|FG000|Overall Study|Adverse Event|5|||
94697263|NCT01124617|324347612|FG001|Overall Study|Adverse Event|2|||
94697264|NCT01124617|324347611|FG000|Overall Study|Lack of Efficacy|2|||
94697265|NCT01124617|324347612|FG001|Overall Study|Lack of Efficacy|1|||
94697266|NCT01124617|324347611|FG000|Overall Study|Protocol Violation|1|||
94697267|NCT01124617|324347612|FG001|Overall Study|Protocol Violation|1|||
94697268|NCT01124617|324347611|FG000|Overall Study|Withdrawal by Subject|9|||
94265543|NCT04178967|322765759|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94265544|NCT04178967|322765760|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
94265545|NCT04178967|322765761|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
94265546|NCT04178967|322765762|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
94265547|NCT04178967|322765752|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
94265548|NCT04178967|322765753|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
94265549|NCT04178967|322765754|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
94366310|NCT00996918|323126499|FG001|Overall Study|Physician Decision|0|||
94366311|NCT00996918|323126500|FG002|Overall Study|Physician Decision|0|||
94366312|NCT00996918|323126501|FG003|Overall Study|Physician Decision|0|||
94697269|NCT01124617|324347612|FG001|Overall Study|Withdrawal by Subject|1|||
94697270|NCT01124617|324347611|FG000|Overall Study|Other|2|||
94697271|NCT01124617|324347612|FG001|Overall Study|Other|1|||
94697272|NCT00945477|324347613|FG000|Overall Study|Adverse Event|3|||
94697273|NCT00945477|324347613|FG000|Overall Study|Lack of Efficacy|2|||
94697274|NCT00945477|324347613|FG000|Overall Study|Withdrawal by Subject|1|||
94697275|NCT03582137|324347617|FG000|Overall Study|Adverse Event|1|||
94366313|NCT00996918|323126502|FG004|Overall Study|Physician Decision|0|||
94697276|NCT03582137|324347618|FG001|Overall Study|Adverse Event|0|||
94697277|NCT02554513|324347619|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
94697278|NCT02554513|324347620|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
94697279|NCT01982760|324347621|FG000|Overall Study|Physician Decision|1|||
94697280|NCT01982760|324347622|FG001|Overall Study|Physician Decision|0|||
94697281|NCT00578227|324347624|FG000|Overall Study|Lost to Follow-up|0|||
94697282|NCT00578227|324347625|FG001|Overall Study|Lost to Follow-up|1|||
94697283|NCT00578227|324347626|FG002|Overall Study|Lost to Follow-up|1|||
94697284|NCT00578227|324347624|FG000|Overall Study|Withdrawal by Subject|5|||
94697285|NCT00578227|324347625|FG001|Overall Study|Withdrawal by Subject|1|||
94697286|NCT00578227|324347626|FG002|Overall Study|Withdrawal by Subject|3|||
94697287|NCT02096003|324347627|FG000|Overall Study|Protocol Violation|0|||
94697288|NCT02096003|324347628|FG001|Overall Study|Protocol Violation|2|||
94697289|NCT02096003|324347627|FG000|Overall Study|additional surgery|2|||
94697290|NCT02096003|324347628|FG001|Overall Study|additional surgery|1|||
94697291|NCT04668144|324347629|FG000|Overall Study|Protocol Violation|0|||
94697292|NCT04668144|324347630|FG001|Overall Study|Protocol Violation|1|||
94697293|NCT04668144|324347631|FG002|Overall Study|Protocol Violation|2|||
94265550|NCT04178967|322765755|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
94265551|NCT04178967|322765756|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
94697294|NCT01072929|324347637|FG000|Overall Study|Adverse Event|8|||
94697295|NCT01072929|324347638|FG001|Overall Study|Adverse Event|11|||
94697296|NCT01072929|324347639|FG002|Overall Study|Adverse Event|2|||
94697297|NCT01072929|324347637|FG000|Overall Study|Lack of Efficacy|7|||
94697298|NCT01072929|324347638|FG001|Overall Study|Lack of Efficacy|4|||
94697299|NCT01072929|324347639|FG002|Overall Study|Lack of Efficacy|0|||
94697300|NCT01072929|324347637|FG000|Overall Study|Withdrawal by Subject|7|||
94697301|NCT01072929|324347638|FG001|Overall Study|Withdrawal by Subject|15|||
94697302|NCT01072929|324347639|FG002|Overall Study|Withdrawal by Subject|3|||
94697303|NCT01072929|324347637|FG000|Overall Study|Protocol Violation|13|||
94697304|NCT01072929|324347638|FG001|Overall Study|Protocol Violation|11|||
94697305|NCT01072929|324347639|FG002|Overall Study|Protocol Violation|2|||
94697306|NCT01072929|324347637|FG000|Overall Study|Lost to Follow-up|8|||
94697307|NCT01072929|324347638|FG001|Overall Study|Lost to Follow-up|4|||
94697308|NCT01072929|324347639|FG002|Overall Study|Lost to Follow-up|1|||
94697309|NCT01072929|324347637|FG000|Overall Study|Noncompliance with study medication|0|||
94697310|NCT01072929|324347638|FG001|Overall Study|Noncompliance with study medication|3|||
94697311|NCT01072929|324347639|FG002|Overall Study|Noncompliance with study medication|0|||
94697312|NCT01072929|324347637|FG000|Overall Study|Noncompliance with study procedures|1|||
94697313|NCT01072929|324347638|FG001|Overall Study|Noncompliance with study procedures|0|||
94697314|NCT01072929|324347639|FG002|Overall Study|Noncompliance with study procedures|1|||
94697315|NCT01072929|324347637|FG000|Overall Study|Other|0|||
94697316|NCT01072929|324347638|FG001|Overall Study|Other|3|||
94697317|NCT01072929|324347639|FG002|Overall Study|Other|0|||
94697318|NCT01027871|324347640|FG000|Overall Study|Physician Decision|1|||
94697319|NCT01027871|324347641|FG001|Overall Study|Physician Decision|5|||
94697320|NCT01027871|324347642|FG002|Overall Study|Physician Decision|0|||
94697321|NCT01027871|324347640|FG000|Overall Study|Protocol Violation|0|||
94697322|NCT01027871|324347641|FG001|Overall Study|Protocol Violation|2|||
94697323|NCT01027871|324347642|FG002|Overall Study|Protocol Violation|2|||
94697324|NCT01027871|324347640|FG000|Overall Study|Withdrawal by Subject|1|||
94697325|NCT01027871|324347641|FG001|Overall Study|Withdrawal by Subject|2|||
94697326|NCT01027871|324347642|FG002|Overall Study|Withdrawal by Subject|2|||
94697327|NCT01027871|324347640|FG000|Overall Study|Adverse Event|0|||
94697328|NCT01027871|324347641|FG001|Overall Study|Adverse Event|2|||
94697329|NCT01027871|324347642|FG002|Overall Study|Adverse Event|2|||
94697330|NCT01027871|324347640|FG000|Overall Study|Sponsor Decision|0|||
94697331|NCT01027871|324347641|FG001|Overall Study|Sponsor Decision|2|||
94697332|NCT01027871|324347642|FG002|Overall Study|Sponsor Decision|0|||
94265552|NCT04178967|322765757|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
94265553|NCT04178967|322765758|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
94265554|NCT04178967|322765759|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
94265555|NCT04178967|322765760|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
94265556|NCT04178967|322765761|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
94265557|NCT04178967|322765762|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
94265558|NCT04178967|322765752|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
94265559|NCT04178967|322765753|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
94697333|NCT01027871|324347640|FG000|Overall Study|Discontinued Prior to Treatment|0|||
94265560|NCT04178967|322765754|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
94265561|NCT04178967|322765755|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
94265562|NCT04178967|322765756|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
94697334|NCT01027871|324347641|FG001|Overall Study|Discontinued Prior to Treatment|0|||
94697335|NCT01027871|324347642|FG002|Overall Study|Discontinued Prior to Treatment|1|||
94697336|NCT01222247|324347646|FG000|Overall Study|Lost to Follow-up|2|||
94697337|NCT01222247|324347647|FG001|Overall Study|Lost to Follow-up|2|||
94697338|NCT02338609|324347648|FG000|Overall Study|Physician Decision|1|||
94697339|NCT02338609|324347648|FG000|Overall Study|Death|1|||
94697340|NCT04530344|324347649|FG000|Overall Study|Lost to Follow-up|3|||
94697341|NCT04530344|324347650|FG001|Overall Study|Lost to Follow-up|3|||
94697342|NCT04530344|324347651|FG002|Overall Study|Lost to Follow-up|3|||
94697343|NCT04530344|324347652|FG003|Overall Study|Lost to Follow-up|10|||
94697344|NCT04530344|324347649|FG000|Overall Study|Withdrawal by Subject|14|||
94697345|NCT04530344|324347650|FG001|Overall Study|Withdrawal by Subject|5|||
94697346|NCT04530344|324347651|FG002|Overall Study|Withdrawal by Subject|18|||
94697347|NCT04530344|324347652|FG003|Overall Study|Withdrawal by Subject|33|||
94697348|NCT04530344|324347649|FG000|Overall Study|Adverse Event|0|||
94697349|NCT04530344|324347650|FG001|Overall Study|Adverse Event|0|||
94697350|NCT04530344|324347651|FG002|Overall Study|Adverse Event|0|||
94697351|NCT04530344|324347652|FG003|Overall Study|Adverse Event|1|||
94697352|NCT04530344|324347649|FG000|Overall Study|Lack of Efficacy|0|||
94697353|NCT04530344|324347650|FG001|Overall Study|Lack of Efficacy|0|||
94697354|NCT04530344|324347651|FG002|Overall Study|Lack of Efficacy|0|||
94697355|NCT04530344|324347652|FG003|Overall Study|Lack of Efficacy|1|||
94697356|NCT04530344|324347649|FG000|Overall Study|Physician Decision|0|||
94697357|NCT04530344|324347650|FG001|Overall Study|Physician Decision|0|||
94697358|NCT04530344|324347651|FG002|Overall Study|Physician Decision|1|||
94697359|NCT04530344|324347652|FG003|Overall Study|Physician Decision|1|||
94697360|NCT04530344|324347649|FG000|Overall Study|Pregnancy|0|||
94697361|NCT04530344|324347650|FG001|Overall Study|Pregnancy|0|||
94697362|NCT04530344|324347651|FG002|Overall Study|Pregnancy|2|||
94697363|NCT04530344|324347652|FG003|Overall Study|Pregnancy|1|||
94697364|NCT04530344|324347649|FG000|Overall Study|Protocol Violation|0|||
94697365|NCT04530344|324347650|FG001|Overall Study|Protocol Violation|0|||
94697366|NCT04530344|324347651|FG002|Overall Study|Protocol Violation|0|||
94697367|NCT04530344|324347652|FG003|Overall Study|Protocol Violation|1|||
94697368|NCT04530344|324347649|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
94697369|NCT04530344|324347650|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
94697370|NCT04530344|324347651|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
94697371|NCT04530344|324347652|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
94697372|NCT04530344|324347649|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
94697373|NCT04530344|324347650|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
94697374|NCT04530344|324347651|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
94697375|NCT04530344|324347652|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
94697376|NCT04530344|324347649|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
94697377|NCT04530344|324347650|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
94697378|NCT04530344|324347651|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
94697379|NCT04530344|324347652|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
94697380|NCT04530344|324347649|FG000|Overall Study|Personal Reasons|0|||
94697381|NCT04530344|324347650|FG001|Overall Study|Personal Reasons|0|||
94697382|NCT04530344|324347651|FG002|Overall Study|Personal Reasons|0|||
94697383|NCT04530344|324347652|FG003|Overall Study|Personal Reasons|1|||
94697384|NCT04530344|324347649|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
94697385|NCT04530344|324347650|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
94697386|NCT04530344|324347651|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
94697387|NCT04530344|324347652|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
94697388|NCT05705167|324347653|FG000|Overall Study|Randomised but not Treated|0|||
94697389|NCT05705167|324347654|FG001|Overall Study|Randomised but not Treated|2|||
94697390|NCT05705167|324347655|FG002|Overall Study|Randomised but not Treated|0|||
94697391|NCT05705167|324347656|FG003|Overall Study|Randomised but not Treated|7|||
94697392|NCT05705167|324347657|FG004|Overall Study|Randomised but not Treated|0|||
94697393|NCT05705167|324347658|FG005|Overall Study|Randomised but not Treated|0|||
94697394|NCT05705167|324347659|FG006|Overall Study|Randomised but not Treated|0|||
94697395|NCT05705167|324347653|FG000|Overall Study|Death|0|||
94697396|NCT05705167|324347654|FG001|Overall Study|Death|0|||
94697397|NCT05705167|324347655|FG002|Overall Study|Death|3|||
94697398|NCT05705167|324347656|FG003|Overall Study|Death|0|||
94697399|NCT05705167|324347657|FG004|Overall Study|Death|1|||
94697400|NCT05705167|324347658|FG005|Overall Study|Death|1|||
94697401|NCT05705167|324347659|FG006|Overall Study|Death|1|||
94697402|NCT05705167|324347653|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
94697403|NCT05705167|324347654|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
94697404|NCT05705167|324347655|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
94697405|NCT05705167|324347656|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
94697406|NCT05705167|324347657|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
94697407|NCT05705167|324347658|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
94697408|NCT05705167|324347659|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
94697409|NCT04736056|324347660|FG000|Overall Study|Death|0|||
94697410|NCT04736056|324347661|FG001|Overall Study|Death|0|||
94697411|NCT04736056|324347662|FG002|Overall Study|Death|0|||
94697412|NCT04736056|324347663|FG003|Overall Study|Death|1|||
94697413|NCT04736056|324347660|FG000|Overall Study|Lost to Follow-up|1|||
94697414|NCT04736056|324347661|FG001|Overall Study|Lost to Follow-up|0|||
94697415|NCT04736056|324347662|FG002|Overall Study|Lost to Follow-up|1|||
94697416|NCT04736056|324347663|FG003|Overall Study|Lost to Follow-up|1|||
94697417|NCT04736056|324347660|FG000|Overall Study|Withdrawal by Subject|2|||
94697418|NCT04736056|324347661|FG001|Overall Study|Withdrawal by Subject|0|||
94697419|NCT04736056|324347662|FG002|Overall Study|Withdrawal by Subject|0|||
94697420|NCT04736056|324347663|FG003|Overall Study|Withdrawal by Subject|0|||
94697421|NCT04736056|324347660|FG000|Overall Study|Physician Decision|1|||
94697422|NCT04736056|324347661|FG001|Overall Study|Physician Decision|0|||
94697423|NCT04736056|324347662|FG002|Overall Study|Physician Decision|1|||
94697424|NCT04736056|324347663|FG003|Overall Study|Physician Decision|0|||
94697425|NCT02223182|324347664|FG000|Double-Blind Period|Adverse Event|0|||
94697426|NCT02223182|324347665|FG001|Double-Blind Period|Adverse Event|2|||
94697427|NCT02223182|324347666|FG002|Double-Blind Period|Adverse Event|1|||
94697428|NCT02223182|324347667|FG003|Double-Blind Period|Adverse Event|0|||
94697429|NCT02223182|324347664|FG000|Double-Blind Period|Withdrawal by Subject|1|||
94697430|NCT02223182|324347665|FG001|Double-Blind Period|Withdrawal by Subject|1|||
94697431|NCT02223182|324347666|FG002|Double-Blind Period|Withdrawal by Subject|1|||
94697432|NCT02223182|324347667|FG003|Double-Blind Period|Withdrawal by Subject|0|||
94697433|NCT02223182|324347664|FG000|Double-Blind Period|Lost to Follow-up|0|||
94697434|NCT02223182|324347665|FG001|Double-Blind Period|Lost to Follow-up|1|||
94697435|NCT02223182|324347666|FG002|Double-Blind Period|Lost to Follow-up|0|||
94697436|NCT02223182|324347667|FG003|Double-Blind Period|Lost to Follow-up|0|||
94697437|NCT02223182|324347664|FG000|Double-Blind Period|Non Compliance|0|||
94697438|NCT02223182|324347665|FG001|Double-Blind Period|Non Compliance|0|||
94697439|NCT02223182|324347666|FG002|Double-Blind Period|Non Compliance|0|||
94697440|NCT02223182|324347667|FG003|Double-Blind Period|Non Compliance|1|||
94697441|NCT02223182|324347664|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
94697442|NCT02223182|324347665|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
94697443|NCT02223182|324347666|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
94697444|NCT02223182|324347667|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
94697445|NCT02223182|324347664|FG000|Open-Label 500 Period|Adverse Event|1|||
94697446|NCT02223182|324347665|FG001|Open-Label 500 Period|Adverse Event|0|||
94697447|NCT02223182|324347666|FG002|Open-Label 500 Period|Adverse Event|2|||
94697448|NCT02223182|324347667|FG003|Open-Label 500 Period|Adverse Event|1|||
94697449|NCT02223182|324347664|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
94697450|NCT02223182|324347665|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
94697451|NCT02223182|324347666|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
94697452|NCT02223182|324347667|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
94697453|NCT02223182|324347664|FG000|Open-Label 500 Period|Physician Decision|0|||
94697454|NCT02223182|324347665|FG001|Open-Label 500 Period|Physician Decision|0|||
94697455|NCT02223182|324347666|FG002|Open-Label 500 Period|Physician Decision|0|||
94697456|NCT02223182|324347667|FG003|Open-Label 500 Period|Physician Decision|1|||
94697457|NCT02223182|324347664|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
94697458|NCT02223182|324347665|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
94697459|NCT02223182|324347666|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
94697460|NCT02223182|324347667|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
94697461|NCT02223182|324347664|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
94697462|NCT02223182|324347665|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
94697463|NCT02223182|324347666|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
94697464|NCT02223182|324347667|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
94697465|NCT02223182|324347664|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
94697466|NCT02223182|324347665|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
94697467|NCT02223182|324347666|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
94697468|NCT02223182|324347667|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
94697469|NCT02223182|324347664|FG000|Open-Label 300 Period|Non Compliance|0|||
94697470|NCT02223182|324347665|FG001|Open-Label 300 Period|Non Compliance|2|||
94697471|NCT02223182|324347666|FG002|Open-Label 300 Period|Non Compliance|1|||
94697472|NCT02223182|324347667|FG003|Open-Label 300 Period|Non Compliance|0|||
94697473|NCT01321073|324347671|FG000|Overall Study|Did not attempt implant|4|||
94697474|NCT01321073|324347671|FG000|Overall Study|Death|3|||
94697475|NCT00877851|324347676|FG000|Overall Study|Lost to Follow-up|5|||
94697476|NCT00877851|324347677|FG001|Overall Study|Lost to Follow-up|5|||
94697477|NCT00877851|324347676|FG000|Overall Study|computer problem|3|||
94697478|NCT00877851|324347677|FG001|Overall Study|computer problem|0|||
94697479|NCT00877851|324347676|FG000|Overall Study|no longer interested in participating|1|||
94697480|NCT00877851|324347677|FG001|Overall Study|no longer interested in participating|0|||
94697481|NCT01712685|324347685|FG000|Overall Study|pt declined to participate before trmt|1|||
94697482|NCT01515319|324347686|FG000|Overall Study|Withdrawal by Subject|0|||
94697483|NCT01515319|324347687|FG001|Overall Study|Withdrawal by Subject|0|||
94697484|NCT01515319|324347688|FG002|Overall Study|Withdrawal by Subject|0|||
94697485|NCT01515319|324347689|FG003|Overall Study|Withdrawal by Subject|0|||
94697486|NCT01515319|324347690|FG004|Overall Study|Withdrawal by Subject|0|||
94697487|NCT01515319|324347691|FG005|Overall Study|Withdrawal by Subject|0|||
94697488|NCT01515319|324347692|FG006|Overall Study|Withdrawal by Subject|1|||
94697489|NCT01515319|324347693|FG007|Overall Study|Withdrawal by Subject|0|||
94697490|NCT01515319|324347694|FG008|Overall Study|Withdrawal by Subject|0|||
94697491|NCT01515319|324347695|FG009|Overall Study|Withdrawal by Subject|0|||
94697492|NCT01515319|324347686|FG000|Overall Study|Adverse Event|0|||
94697493|NCT01515319|324347687|FG001|Overall Study|Adverse Event|0|||
94697494|NCT01515319|324347688|FG002|Overall Study|Adverse Event|0|||
94697495|NCT01515319|324347689|FG003|Overall Study|Adverse Event|0|||
94697496|NCT01515319|324347690|FG004|Overall Study|Adverse Event|0|||
94697497|NCT01515319|324347691|FG005|Overall Study|Adverse Event|0|||
94697498|NCT01515319|324347692|FG006|Overall Study|Adverse Event|0|||
94697499|NCT01515319|324347693|FG007|Overall Study|Adverse Event|0|||
94697500|NCT01515319|324347694|FG008|Overall Study|Adverse Event|3|||
94697501|NCT01515319|324347695|FG009|Overall Study|Adverse Event|0|||
94697502|NCT01515319|324347686|FG000|Overall Study|Protocol Violation|0|||
94697503|NCT01515319|324347687|FG001|Overall Study|Protocol Violation|0|||
94697504|NCT01515319|324347688|FG002|Overall Study|Protocol Violation|0|||
94697505|NCT01515319|324347689|FG003|Overall Study|Protocol Violation|0|||
94697506|NCT01515319|324347690|FG004|Overall Study|Protocol Violation|0|||
94697507|NCT01515319|324347691|FG005|Overall Study|Protocol Violation|0|||
94697508|NCT01515319|324347692|FG006|Overall Study|Protocol Violation|0|||
94697509|NCT01515319|324347693|FG007|Overall Study|Protocol Violation|0|||
94697510|NCT01515319|324347694|FG008|Overall Study|Protocol Violation|2|||
94697511|NCT01515319|324347695|FG009|Overall Study|Protocol Violation|0|||
94697512|NCT01871285|324347696|FG000|First Intervention (1 Day)|Adverse Event|1|||
94697513|NCT01871285|324347697|FG001|First Intervention (1 Day)|Adverse Event|0|||
94697514|NCT01871285|324347698|FG002|First Intervention (1 Day)|Adverse Event|0|||
94697515|NCT01871285|324347699|FG003|First Intervention (1 Day)|Adverse Event|0|||
94697516|NCT01871285|324347696|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
94697517|NCT01871285|324347697|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
94697518|NCT01871285|324347698|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
94697519|NCT01871285|324347699|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
94697520|NCT01959880|324347700|FG000|Overall Study|Withdrawal by Subject|11|||
94697521|NCT01959880|324347701|FG001|Overall Study|Withdrawal by Subject|13|||
94697522|NCT01959880|324347702|FG002|Overall Study|Withdrawal by Subject|8|||
94697523|NCT01959880|324347703|FG003|Overall Study|Withdrawal by Subject|7|||
94697524|NCT01959880|324347700|FG000|Overall Study|Death|1|||
94697525|NCT01959880|324347701|FG001|Overall Study|Death|10|||
94697526|NCT01959880|324347702|FG002|Overall Study|Death|1|||
94697527|NCT01959880|324347703|FG003|Overall Study|Death|2|||
94697528|NCT01959880|324347700|FG000|Overall Study|Lost to Follow-up|95|||
94697529|NCT01959880|324347701|FG001|Overall Study|Lost to Follow-up|18|||
94697530|NCT01959880|324347702|FG002|Overall Study|Lost to Follow-up|15|||
94697531|NCT01959880|324347703|FG003|Overall Study|Lost to Follow-up|8|||
94697532|NCT01959880|324347700|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
94697533|NCT01959880|324347701|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
94697534|NCT01959880|324347702|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
94697535|NCT01959880|324347703|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
94697536|NCT01959880|324347700|FG000|Overall Study|Study completed early-FDA approved|1003|||
94697537|NCT01959880|324347701|FG001|Overall Study|Study completed early-FDA approved|311|||
94697538|NCT01959880|324347702|FG002|Overall Study|Study completed early-FDA approved|179|||
94697539|NCT01959880|324347703|FG003|Overall Study|Study completed early-FDA approved|152|||
94697540|NCT00662909|324347704|FG000|Overall Study|Adverse Event|17|||
94697541|NCT00662909|324347705|FG001|Overall Study|Adverse Event|18|||
94697542|NCT00662909|324347706|FG002|Overall Study|Adverse Event|19|||
94697543|NCT00662909|324347704|FG000|Overall Study|Lack of Efficacy|9|||
94697544|NCT00662909|324347705|FG001|Overall Study|Lack of Efficacy|1|||
94697545|NCT00662909|324347706|FG002|Overall Study|Lack of Efficacy|5|||
94697546|NCT00662909|324347704|FG000|Overall Study|Withdrawal by Subject|29|||
94697547|NCT00662909|324347705|FG001|Overall Study|Withdrawal by Subject|22|||
94697548|NCT00662909|324347706|FG002|Overall Study|Withdrawal by Subject|16|||
94366314|NCT00996918|323126498|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
94697549|NCT00662909|324347704|FG000|Overall Study|Lost to Follow-up|2|||
94697550|NCT00662909|324347705|FG001|Overall Study|Lost to Follow-up|9|||
94697551|NCT00662909|324347706|FG002|Overall Study|Lost to Follow-up|3|||
94697552|NCT00662909|324347704|FG000|Overall Study|Protocol Violation|7|||
94697553|NCT00662909|324347705|FG001|Overall Study|Protocol Violation|4|||
94697554|NCT00662909|324347706|FG002|Overall Study|Protocol Violation|5|||
94697555|NCT00662909|324347704|FG000|Overall Study|Randomized- never received study drug|1|||
94697556|NCT00662909|324347705|FG001|Overall Study|Randomized- never received study drug|0|||
94697557|NCT00662909|324347706|FG002|Overall Study|Randomized- never received study drug|0|||
94697558|NCT00662909|324347704|FG000|Overall Study|Non-compliance with study procedures|3|||
94697559|NCT00662909|324347705|FG001|Overall Study|Non-compliance with study procedures|3|||
94697560|NCT00662909|324347706|FG002|Overall Study|Non-compliance with study procedures|2|||
94697561|NCT00662909|324347704|FG000|Overall Study|Physician Decision|1|||
94697562|NCT00662909|324347705|FG001|Overall Study|Physician Decision|1|||
94697563|NCT00662909|324347706|FG002|Overall Study|Physician Decision|2|||
94697564|NCT00662909|324347704|FG000|Overall Study|Eligibility criterion not met|0|||
94697565|NCT00662909|324347705|FG001|Overall Study|Eligibility criterion not met|1|||
94697566|NCT00662909|324347706|FG002|Overall Study|Eligibility criterion not met|1|||
94697567|NCT00432159|324349328|FG000|Overall Study|Death|0|||
94697568|NCT00432159|324349329|FG001|Overall Study|Death|1|||
94697569|NCT00432159|324349330|FG002|Overall Study|Death|0|||
94697570|NCT00432159|324349331|FG003|Overall Study|Death|0|||
94697571|NCT00432159|324349332|FG004|Overall Study|Death|0|||
94697572|NCT00432159|324349328|FG000|Overall Study|Failure|9|||
94697573|NCT00432159|324349329|FG001|Overall Study|Failure|5|||
94697574|NCT00432159|324349330|FG002|Overall Study|Failure|3|||
94697575|NCT00432159|324349331|FG003|Overall Study|Failure|2|||
94697576|NCT00432159|324349332|FG004|Overall Study|Failure|3|||
94697577|NCT00432159|324349328|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
94697578|NCT00432159|324349329|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
94697579|NCT00432159|324349330|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
94697580|NCT00432159|324349331|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
94697581|NCT00432159|324349332|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
94697582|NCT01256476|324349333|FG000|Overall Study|Adverse Event|2|||
94697583|NCT01256476|324349334|FG001|Overall Study|Adverse Event|1|||
94697584|NCT01256476|324349333|FG000|Overall Study|Withdrawal by Subject|2|||
94697585|NCT01256476|324349334|FG001|Overall Study|Withdrawal by Subject|1|||
94697586|NCT01256476|324349333|FG000|Overall Study|Lost to Follow-up|1|||
94697587|NCT01256476|324349334|FG001|Overall Study|Lost to Follow-up|2|||
94697588|NCT01256476|324349333|FG000|Overall Study|Persistent ALT or AST elevation|1|||
94697589|NCT01256476|324349334|FG001|Overall Study|Persistent ALT or AST elevation|0|||
94697590|NCT01256476|324349333|FG000|Overall Study|Physician Decision|0|||
94697591|NCT01256476|324349334|FG001|Overall Study|Physician Decision|1|||
94697592|NCT01256476|324349333|FG000|Overall Study|Subject non-compliance|0|||
94697593|NCT01256476|324349334|FG001|Overall Study|Subject non-compliance|1|||
94697594|NCT01256476|324349333|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
94697595|NCT01256476|324349334|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
94697596|NCT02491411|324349335|FG000|Overall Study|Physician Decision|4|||
94697597|NCT05310084|324349338|FG000|Overall Study|Withdrawal by Subject|2|||
94697598|NCT05310084|324349339|FG001|Overall Study|Withdrawal by Subject|3|||
94697599|NCT05310084|324349338|FG000|Overall Study|Participant availability|0|||
94697600|NCT05310084|324349339|FG001|Overall Study|Participant availability|4|||
94697601|NCT05310084|324349338|FG000|Overall Study|Lost to Follow-up|1|||
94697602|NCT05310084|324349339|FG001|Overall Study|Lost to Follow-up|1|||
94265563|NCT04178967|322765757|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
94265564|NCT04178967|322765758|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
94265565|NCT04178967|322765759|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
94265566|NCT04178967|322765760|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
94697603|NCT05310084|324349338|FG000|Overall Study|Adverse Event|1|||
94697604|NCT05310084|324349339|FG001|Overall Study|Adverse Event|1|||
94697605|NCT05310084|324349338|FG000|Overall Study|Randomized but not vaccinated|4|||
94697606|NCT05310084|324349339|FG001|Overall Study|Randomized but not vaccinated|2|||
94697607|NCT02065245|324349340|FG000|Infusion 1|Lost to Follow-up|0|||
94697608|NCT02065245|324349341|FG001|Infusion 1|Lost to Follow-up|0|||
94697609|NCT02065245|324349342|FG002|Infusion 1|Lost to Follow-up|0|||
94697610|NCT02065245|324349343|FG003|Infusion 1|Lost to Follow-up|0|||
94697611|NCT02065245|324349344|FG004|Infusion 1|Lost to Follow-up|0|||
94697612|NCT02065245|324349345|FG005|Infusion 1|Lost to Follow-up|0|||
94697613|NCT02065245|324349346|FG006|Infusion 1|Lost to Follow-up|1|||
94697614|NCT02065245|324349340|FG000|Infusion 1|Death|0|||
94697615|NCT02065245|324349341|FG001|Infusion 1|Death|0|||
94697616|NCT02065245|324349342|FG002|Infusion 1|Death|1|||
94697617|NCT02065245|324349343|FG003|Infusion 1|Death|0|||
94697618|NCT02065245|324349344|FG004|Infusion 1|Death|1|||
94697619|NCT02065245|324349345|FG005|Infusion 1|Death|0|||
94697620|NCT02065245|324349346|FG006|Infusion 1|Death|0|||
94697621|NCT02065245|324349340|FG000|Infusion 2|Death|0|||
94697622|NCT02065245|324349341|FG001|Infusion 2|Death|0|||
94697623|NCT02065245|324349342|FG002|Infusion 2|Death|0|||
94697624|NCT02065245|324349343|FG003|Infusion 2|Death|0|||
94697625|NCT02065245|324349344|FG004|Infusion 2|Death|0|||
94697626|NCT02065245|324349345|FG005|Infusion 2|Death|0|||
94697627|NCT02065245|324349346|FG006|Infusion 2|Death|1|||
94697628|NCT02065245|324349340|FG000|Infusion 3|Lost to Follow-up|1|||
94697629|NCT02065245|324349341|FG001|Infusion 3|Lost to Follow-up|1|||
94697630|NCT02065245|324349342|FG002|Infusion 3|Lost to Follow-up|0|||
94697631|NCT02065245|324349343|FG003|Infusion 3|Lost to Follow-up|0|||
94697632|NCT02065245|324349344|FG004|Infusion 3|Lost to Follow-up|0|||
94697633|NCT02065245|324349345|FG005|Infusion 3|Lost to Follow-up|0|||
94697634|NCT02065245|324349346|FG006|Infusion 3|Lost to Follow-up|0|||
94697635|NCT02263885|324349347|FG000|Overall Study|Withdrawal by Subject|7|||
94697636|NCT02263885|324349347|FG000|Overall Study|Alternative Treatment|3|||
94697637|NCT00519779|324349348|FG000|Overall Study|Withdrawal by Subject|0|||
94697638|NCT00519779|324349349|FG001|Overall Study|Withdrawal by Subject|1|||
94697639|NCT04531540|324349356|FG000|Overall Study|Adverse Event|1|||
94697640|NCT04531540|324349356|FG000|Overall Study|Protocol Violation|3|||
94697641|NCT04531540|324349356|FG000|Overall Study|Withdrawal by Subject|4|||
94697642|NCT04531540|324349356|FG000|Overall Study|Found to be Ineligible|1|||
94697643|NCT03239210|324349357|FG000|Overall Study|Lost to Follow-up|2|||
94697644|NCT03239210|324349358|FG001|Overall Study|Lost to Follow-up|2|||
94697645|NCT03239210|324349357|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
94697646|NCT03239210|324349358|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
94697647|NCT03239210|324349357|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
94697648|NCT03239210|324349358|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
94697649|NCT00180674|324349360|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
94697650|NCT00180674|324349360|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
94697651|NCT01106976|324349361|FG000|Overall Study|Lost to Follow-up|8|||
94697652|NCT01094743|324349362|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
94265567|NCT04178967|322765761|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
94265568|NCT04178967|322765762|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
94265569|NCT02187809|322765763|FG000|Overall Study|The study was terminated|3|||
94265570|NCT00628251|322765764|FG000|Randomised Part|Withdrawal by Subject|0|||
94265571|NCT00628251|322765765|FG001|Randomised Part|Withdrawal by Subject|0|||
94265572|NCT00628251|322765766|FG002|Randomised Part|Withdrawal by Subject|1|||
94265573|NCT00628251|322765764|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
94265574|NCT00628251|322765765|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
94265575|NCT00628251|322765766|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
94265576|NCT00628251|322765764|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
94265577|NCT00628251|322765765|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
94265578|NCT00628251|322765766|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
94265579|NCT00628251|322765764|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
94265580|NCT00628251|322765765|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
94265581|NCT00628251|322765766|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
94265582|NCT00628251|322765764|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
94265583|NCT00628251|322765765|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
94265584|NCT00628251|322765766|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
94265585|NCT00628251|322765764|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
94265586|NCT00628251|322765765|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
94265587|NCT00628251|322765766|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
94265588|NCT01822522|322765768|FG000|Overall Study|Adverse Event|1|||
94265589|NCT01822522|322765769|FG001|Overall Study|Adverse Event|1|||
94265590|NCT01822522|322765770|FG002|Overall Study|Adverse Event|1|||
94265591|NCT01822522|322765771|FG003|Overall Study|Adverse Event|0|||
94265592|NCT01822522|322765772|FG004|Overall Study|Adverse Event|0|||
94265593|NCT01822522|322765773|FG005|Overall Study|Adverse Event|1|||
94697653|NCT02851511|324349363|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
94697654|NCT02851511|324349364|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
94697655|NCT02851511|324349365|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
94697656|NCT02851511|324349366|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
94265594|NCT01822522|322765768|FG000|Overall Study|Death|3|||
94651708|NCT02501096|324181786|FG006|Overall Study|Lost to Follow-up|3|||
94651709|NCT02501096|324181787|FG007|Overall Study|Lost to Follow-up|0|||
94651710|NCT02501096|324181788|FG008|Overall Study|Lost to Follow-up|0|||
94651711|NCT02501096|324181780|FG000|Overall Study|Withdrawal by Subject|1|||
94651712|NCT02501096|324181781|FG001|Overall Study|Withdrawal by Subject|0|||
94651713|NCT02501096|324181782|FG002|Overall Study|Withdrawal by Subject|7|||
94651714|NCT02501096|324181783|FG003|Overall Study|Withdrawal by Subject|13|||
94651715|NCT02501096|324181784|FG004|Overall Study|Withdrawal by Subject|2|||
94651716|NCT02501096|324181785|FG005|Overall Study|Withdrawal by Subject|2|||
94651717|NCT02501096|324181786|FG006|Overall Study|Withdrawal by Subject|2|||
94651718|NCT02501096|324181787|FG007|Overall Study|Withdrawal by Subject|3|||
94651719|NCT02501096|324181788|FG008|Overall Study|Withdrawal by Subject|0|||
94651720|NCT02501096|324181780|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
94651721|NCT02501096|324181781|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
94651722|NCT02501096|324181782|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
94651723|NCT02501096|324181783|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
94651724|NCT02501096|324181784|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
94651725|NCT02501096|324181785|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
94651726|NCT02501096|324181786|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
94651727|NCT02501096|324181787|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
94651728|NCT02501096|324181788|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
94651729|NCT02501096|324181780|FG000|Overall Study|Death|1|||
94651730|NCT02501096|324181781|FG001|Overall Study|Death|1|||
94651731|NCT02501096|324181782|FG002|Overall Study|Death|88|||
94651732|NCT02501096|324181783|FG003|Overall Study|Death|74|||
94651733|NCT02501096|324181784|FG004|Overall Study|Death|15|||
94651734|NCT02501096|324181785|FG005|Overall Study|Death|16|||
94651735|NCT02501096|324181786|FG006|Overall Study|Death|15|||
94651736|NCT02501096|324181787|FG007|Overall Study|Death|16|||
94651737|NCT02501096|324181788|FG008|Overall Study|Death|1|||
94651738|NCT00308711|324181791|FG000|Overall Study|Withdrawal by Subject|1|||
94651739|NCT00308711|324181792|FG001|Overall Study|Withdrawal by Subject|0|||
94651740|NCT00308711|324181793|FG002|Overall Study|Withdrawal by Subject|1|||
94651741|NCT00308711|324181791|FG000|Overall Study|Protocol Violation|0|||
94651742|NCT00308711|324181792|FG001|Overall Study|Protocol Violation|1|||
94651743|NCT00308711|324181793|FG002|Overall Study|Protocol Violation|1|||
94651744|NCT00308711|324181791|FG000|Overall Study|Lost to Follow-up|0|||
94651745|NCT00308711|324181792|FG001|Overall Study|Lost to Follow-up|1|||
94651746|NCT00308711|324181793|FG002|Overall Study|Lost to Follow-up|0|||
94651747|NCT00308711|324181791|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
94651748|NCT00308711|324181792|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
94651749|NCT00308711|324181793|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
94651750|NCT00308711|324181791|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
94651751|NCT00308711|324181792|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
94651752|NCT00308711|324181793|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
94651753|NCT02296112|324181794|FG000|Overall Study|Disease progression|7|||
94651754|NCT02296112|324181794|FG000|Overall Study|Toxicity|1|||
94651755|NCT02296112|324181794|FG000|Overall Study|Began an alternate therapy|1|||
94651756|NCT03139916|324181795|FG000|Overall Study|Withdrawal by Subject|2|||
94651757|NCT03139916|324181795|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
94651758|NCT00183872|324181796|FG000|Overall Study|Death|3|||
94651759|NCT00183872|324181796|FG000|Overall Study|Adverse Event|9|||
94651760|NCT00183872|324181796|FG000|Overall Study|Withdrawal by Subject|2|||
94651761|NCT00183872|324181796|FG000|Overall Study|Drug delayed more than 28 days|2|||
94651762|NCT01466192|324181797|FG000|Overall Study|Physician Decision|1|||
94651763|NCT01466192|324181797|FG000|Overall Study|Withdrawal by Subject|3|||
94651764|NCT00508742|324181800|FG000|Period 1: Infant Series|Adverse Event|5|||
94651765|NCT00508742|324181801|FG001|Period 1: Infant Series|Adverse Event|4|||
94651766|NCT00508742|324181800|FG000|Period 1: Infant Series|Protocol Violation|1|||
94651767|NCT00508742|324181801|FG001|Period 1: Infant Series|Protocol Violation|0|||
94651768|NCT00508742|324181800|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
94651769|NCT00508742|324181801|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
94651770|NCT00508742|324181800|FG000|Period 1: Infant Series|Physician Decision|1|||
94651771|NCT00508742|324181801|FG001|Period 1: Infant Series|Physician Decision|0|||
94651772|NCT00508742|324181800|FG000|Period 1: Infant Series|Other|4|||
94697657|NCT02851511|324349363|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
94697658|NCT02851511|324349364|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
94697659|NCT02851511|324349365|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
94697660|NCT02851511|324349366|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
94697661|NCT02851511|324349363|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
94697662|NCT02851511|324349364|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
94697663|NCT02851511|324349365|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
94697664|NCT02851511|324349366|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
94697665|NCT02851511|324349363|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
94697666|NCT02851511|324349364|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
94697667|NCT02851511|324349365|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
94697668|NCT02851511|324349366|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
94697669|NCT02851511|324349363|FG000|Phase I|Physician Decision|0|||
94697670|NCT02851511|324349364|FG001|Phase I|Physician Decision|0|||
94697671|NCT02851511|324349365|FG002|Phase I|Physician Decision|0|||
94697672|NCT02851511|324349366|FG003|Phase I|Physician Decision|1|||
94697673|NCT02851511|324349363|FG000|Phase I|Withdrawal by Subject|2|||
94697674|NCT02851511|324349364|FG001|Phase I|Withdrawal by Subject|1|||
94697675|NCT02851511|324349365|FG002|Phase I|Withdrawal by Subject|0|||
94366315|NCT00996918|323126499|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
94366316|NCT00996918|323126500|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
94366317|NCT00996918|323126501|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
94366318|NCT00996918|323126502|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
94366319|NCT00996918|323126498|FG000|Overall Study|Loss of Caregiver|0|||
94697676|NCT02851511|324349366|FG003|Phase I|Withdrawal by Subject|3|||
94697677|NCT02851511|324349363|FG000|Phase II|Physician Decision|18|||
94697678|NCT02851511|324349364|FG001|Phase II|Physician Decision|16|||
94697679|NCT02851511|324349365|FG002|Phase II|Physician Decision|0|||
94697680|NCT02851511|324349366|FG003|Phase II|Physician Decision|0|||
94697681|NCT02851511|324349363|FG000|Phase II|Withdrawal by Subject|18|||
94697682|NCT02851511|324349364|FG001|Phase II|Withdrawal by Subject|16|||
94697683|NCT02851511|324349365|FG002|Phase II|Withdrawal by Subject|0|||
94697684|NCT02851511|324349366|FG003|Phase II|Withdrawal by Subject|0|||
94697685|NCT02851511|324349363|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
94697686|NCT02851511|324349364|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
94697687|NCT02851511|324349365|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
94697688|NCT02851511|324349366|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
94366320|NCT00996918|323126499|FG001|Overall Study|Loss of Caregiver|1|||
94697689|NCT02851511|324349363|FG000|Phase II|Lost to Follow-up|0|||
94697690|NCT02851511|324349364|FG001|Phase II|Lost to Follow-up|1|||
94697691|NCT02851511|324349365|FG002|Phase II|Lost to Follow-up|0|||
94697692|NCT02851511|324349366|FG003|Phase II|Lost to Follow-up|0|||
94697693|NCT03836664|324349368|FG000|Overall Study|Didn't complete forms and lost drug|3|||
94697694|NCT03836664|324349369|FG001|Overall Study|Didn't complete forms and lost drug|3|||
94697695|NCT00688688|324349370|FG000|Overall Study|Eligibility criterion not met|7|||
94697696|NCT00688688|324349371|FG001|Overall Study|Eligibility criterion not met|7|||
94697697|NCT00688688|324349372|FG002|Overall Study|Eligibility criterion not met|10|||
94697698|NCT00688688|324349370|FG000|Overall Study|Adverse Event|52|||
94697699|NCT00688688|324349371|FG001|Overall Study|Adverse Event|51|||
94697700|NCT00688688|324349372|FG002|Overall Study|Adverse Event|50|||
94697701|NCT00688688|324349370|FG000|Overall Study|Lack of Efficacy|34|||
94697702|NCT00688688|324349371|FG001|Overall Study|Lack of Efficacy|25|||
94697703|NCT00688688|324349372|FG002|Overall Study|Lack of Efficacy|45|||
94366321|NCT00996918|323126500|FG002|Overall Study|Loss of Caregiver|0|||
94697704|NCT00688688|324349370|FG000|Overall Study|Withdrawal by Subject|66|||
94697705|NCT00688688|324349371|FG001|Overall Study|Withdrawal by Subject|75|||
94697706|NCT00688688|324349372|FG002|Overall Study|Withdrawal by Subject|65|||
94697707|NCT00688688|324349370|FG000|Overall Study|Lost to Follow-up|14|||
94366322|NCT00996918|323126501|FG003|Overall Study|Loss of Caregiver|0|||
94366323|NCT00996918|323126502|FG004|Overall Study|Loss of Caregiver|0|||
94366324|NCT00996918|323126498|FG000|Overall Study|Other|3|||
94466106|NCT00869557|323496938|FG000|Randomized Phase|Investigator's Discretion|1|||
94466107|NCT00869557|323496939|FG001|Randomized Phase|Investigator's Discretion|0|||
94466108|NCT00869557|323496938|FG000|Randomized Phase|Withdrew Consent|0|||
94697708|NCT00688688|324349371|FG001|Overall Study|Lost to Follow-up|7|||
94697709|NCT00688688|324349372|FG002|Overall Study|Lost to Follow-up|7|||
94697710|NCT00688688|324349370|FG000|Overall Study|Protocol Violation|6|||
94697711|NCT00688688|324349371|FG001|Overall Study|Protocol Violation|9|||
94697712|NCT00688688|324349372|FG002|Overall Study|Protocol Violation|11|||
94697713|NCT00688688|324349370|FG000|Overall Study|Randomized but never received study drug|1|||
94697714|NCT00688688|324349371|FG001|Overall Study|Randomized but never received study drug|0|||
94366325|NCT00996918|323126499|FG001|Overall Study|Other|1|||
94366326|NCT00996918|323126500|FG002|Overall Study|Other|0|||
94366327|NCT00996918|323126501|FG003|Overall Study|Other|0|||
94697715|NCT00688688|324349372|FG002|Overall Study|Randomized but never received study drug|0|||
94697716|NCT00688688|324349370|FG000|Overall Study|Non-compliance with study procedures|5|||
94697717|NCT00688688|324349371|FG001|Overall Study|Non-compliance with study procedures|3|||
94697718|NCT00688688|324349372|FG002|Overall Study|Non-compliance with study procedures|4|||
94697719|NCT00688688|324349370|FG000|Overall Study|Taking exclusionary medications|1|||
94697720|NCT00688688|324349371|FG001|Overall Study|Taking exclusionary medications|0|||
94697721|NCT00688688|324349372|FG002|Overall Study|Taking exclusionary medications|0|||
94697722|NCT00688688|324349370|FG000|Overall Study|Site closure|0|||
94697723|NCT00688688|324349371|FG001|Overall Study|Site closure|1|||
94697724|NCT00688688|324349372|FG002|Overall Study|Site closure|0|||
94697725|NCT00688688|324349370|FG000|Overall Study|Violation of exclusion criterion|0|||
94697726|NCT00688688|324349371|FG001|Overall Study|Violation of exclusion criterion|1|||
94697727|NCT00688688|324349372|FG002|Overall Study|Violation of exclusion criterion|0|||
94697728|NCT03283553|324349374|FG000|Patient Participant Flow|Death|5|||
94697729|NCT03283553|324349375|FG001|Patient Participant Flow|Death|10|||
94697730|NCT03283553|324349374|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
94697731|NCT03283553|324349375|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
94697732|NCT03283553|324349374|FG000|Patient Participant Flow|Lost to Follow-up|1|||
94697733|NCT03283553|324349375|FG001|Patient Participant Flow|Lost to Follow-up|1|||
94697734|NCT03283553|324349374|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
94697735|NCT03283553|324349375|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
94697736|NCT03283553|324349374|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
94697737|NCT03283553|324349375|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
94697738|NCT03283553|324349374|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
94697739|NCT03283553|324349375|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
94697740|NCT04003974|324349376|FG000|Overall Study|Missing|1|||
94697741|NCT04003974|324349377|FG001|Overall Study|Missing|0|||
94697742|NCT04003974|324349376|FG000|Overall Study|Withdrawal by Subject|0|||
94697743|NCT04003974|324349377|FG001|Overall Study|Withdrawal by Subject|2|||
94697744|NCT04296942|324349378|FG000|Overall Study|Study closure by sponsor|1|||
94697745|NCT04296942|324349379|FG001|Overall Study|Study closure by sponsor|0|||
94697746|NCT04296942|324349380|FG002|Overall Study|Study closure by sponsor|0|||
94697747|NCT02478359|324349381|FG000|Overall Study|Disenrolled from health plan|106|||
94697748|NCT02478359|324349382|FG001|Overall Study|Disenrolled from health plan|65|||
94697749|NCT01237678|324349383|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
94697750|NCT01237678|324349384|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
94697751|NCT01237678|324349385|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
94697752|NCT01237678|324349383|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
94697753|NCT01237678|324349384|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
94697754|NCT01237678|324349385|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
94697755|NCT01237678|324349383|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
94697756|NCT01237678|324349384|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
94697757|NCT01237678|324349385|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
94697758|NCT01237678|324349383|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
94697759|NCT01237678|324349384|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
94697760|NCT01237678|324349385|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
94697761|NCT01237678|324349383|FG000|Phase II|Adverse Event|0|||
94697762|NCT01237678|324349384|FG001|Phase II|Adverse Event|39|||
94697763|NCT01237678|324349385|FG002|Phase II|Adverse Event|9|||
94697764|NCT01237678|324349383|FG000|Phase II|Death|0|||
94697765|NCT01237678|324349384|FG001|Phase II|Death|0|||
94697766|NCT01237678|324349385|FG002|Phase II|Death|2|||
94697767|NCT01237678|324349383|FG000|Phase II|Lack of Efficacy|0|||
94697768|NCT01237678|324349384|FG001|Phase II|Lack of Efficacy|25|||
94697769|NCT01237678|324349385|FG002|Phase II|Lack of Efficacy|3|||
94697770|NCT01237678|324349383|FG000|Phase II|Withdrawal by Subject|0|||
94697771|NCT01237678|324349384|FG001|Phase II|Withdrawal by Subject|1|||
94697772|NCT01237678|324349385|FG002|Phase II|Withdrawal by Subject|5|||
94697773|NCT01237678|324349383|FG000|Phase II|Completed Cycles 4-6|0|||
94697774|NCT01237678|324349384|FG001|Phase II|Completed Cycles 4-6|11|||
94697775|NCT01237678|324349385|FG002|Phase II|Completed Cycles 4-6|21|||
94697776|NCT01237678|324349383|FG000|Phase II|Sponsor Decision/Study Closed|0|||
94697777|NCT01237678|324349384|FG001|Phase II|Sponsor Decision/Study Closed|18|||
94366328|NCT00996918|323126502|FG004|Overall Study|Other|0|||
94466109|NCT00869557|323496939|FG001|Randomized Phase|Withdrew Consent|1|||
94697778|NCT01237678|324349385|FG002|Phase II|Sponsor Decision/Study Closed|7|||
94697779|NCT01237678|324349383|FG000|Phase II|Randomized but were not treated|0|||
94697780|NCT01237678|324349384|FG001|Phase II|Randomized but were not treated|4|||
94697781|NCT01237678|324349385|FG002|Phase II|Randomized but were not treated|3|||
94697782|NCT01627340|324349390|FG000|Overall Study|Adverse Event|1|||
94697783|NCT01627340|324349391|FG001|Overall Study|Adverse Event|0|||
94697784|NCT01627340|324349390|FG000|Overall Study|Lost to Follow-up|8|||
94697785|NCT01627340|324349391|FG001|Overall Study|Lost to Follow-up|4|||
94697786|NCT01627340|324349390|FG000|Overall Study|Pregnancy|1|||
94697787|NCT01627340|324349391|FG001|Overall Study|Pregnancy|0|||
94697788|NCT01627340|324349390|FG000|Overall Study|Withdrawal by Subject|2|||
94697789|NCT01627340|324349391|FG001|Overall Study|Withdrawal by Subject|0|||
94697790|NCT01272011|324349392|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
94697791|NCT01272011|324349393|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
94697792|NCT01272011|324349394|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
94697793|NCT03633903|324349395|FG000|Overall Study|Withdrawal by Subject|1|||
94697794|NCT03633903|324349396|FG001|Overall Study|Withdrawal by Subject|2|||
94697795|NCT03633903|324349395|FG000|Overall Study|Lost to Follow-up|5|||
94697796|NCT03633903|324349396|FG001|Overall Study|Lost to Follow-up|5|||
94697797|NCT00562965|324349397|FG000|Overall Study|Withdrawal by Subject|0|||
94697798|NCT00562965|324349398|FG001|Overall Study|Withdrawal by Subject|1|||
94697799|NCT00562965|324349397|FG000|Overall Study|Death|2|||
94697800|NCT00562965|324349398|FG001|Overall Study|Death|4|||
94697801|NCT00562965|324349397|FG000|Overall Study|Lost to Follow-up|1|||
94697802|NCT00562965|324349398|FG001|Overall Study|Lost to Follow-up|0|||
94697803|NCT00562965|324349397|FG000|Overall Study|Other|0|||
94697804|NCT00562965|324349398|FG001|Overall Study|Other|1|||
94697805|NCT02084082|324349403|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
94697806|NCT02084082|324349404|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
94697807|NCT02084082|324349405|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
94697808|NCT02084082|324349406|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
94697809|NCT02084082|324349403|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
94697810|NCT02084082|324349404|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
94697811|NCT02084082|324349405|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
94697812|NCT02084082|324349406|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
94697813|NCT00832780|324349407|FG000|Overall Study|Death|16|||
94697814|NCT00832780|324349407|FG000|Overall Study|Lost to Follow-up|4|||
94697815|NCT00832780|324349407|FG000|Overall Study|no reason given|2|||
94697816|NCT00832780|324349407|FG000|Overall Study|other complicating condition|2|||
94697817|NCT00832780|324349407|FG000|Overall Study|Physician Decision|1|||
94697818|NCT04956692|324349413|FG000|Overall Study|Death|115|||
94697819|NCT04956692|324349414|FG001|Overall Study|Death|47|||
94697820|NCT04956692|324349413|FG000|Overall Study|Lost to Follow-up|0|||
94697821|NCT04956692|324349414|FG001|Overall Study|Lost to Follow-up|1|||
94697822|NCT04956692|324349413|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
94697823|NCT04956692|324349414|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94697824|NCT04956692|324349413|FG000|Overall Study|Withdrawal by Subject|5|||
94697825|NCT04956692|324349414|FG001|Overall Study|Withdrawal by Subject|2|||
94697826|NCT04956692|324349413|FG000|Overall Study|Ongoing in Study|236|||
94697827|NCT04956692|324349414|FG001|Overall Study|Ongoing in Study|123|||
94697828|NCT04639947|324349417|FG000|Overall Study|Screen fail|1|||
94697829|NCT00654238|324349423|FG000|Overall Study|Screen Failures|4|||
94697830|NCT00614744|324349424|FG000|Overall Study|Lost to Follow-up|5|||
94697831|NCT00614744|324349425|FG001|Overall Study|Lost to Follow-up|4|||
94697832|NCT00614744|324349424|FG000|Overall Study|Incomplete for Behavior Issues|0|||
94697833|NCT00614744|324349425|FG001|Overall Study|Incomplete for Behavior Issues|2|||
94265595|NCT01822522|322765769|FG001|Overall Study|Death|0|||
94265596|NCT01822522|322765770|FG002|Overall Study|Death|2|||
94265597|NCT01822522|322765771|FG003|Overall Study|Death|0|||
94265598|NCT01822522|322765772|FG004|Overall Study|Death|0|||
94265599|NCT01822522|322765773|FG005|Overall Study|Death|0|||
94265600|NCT01822522|322765768|FG000|Overall Study|Lost to Follow-up|0|||
94265601|NCT01822522|322765769|FG001|Overall Study|Lost to Follow-up|0|||
94265602|NCT01822522|322765770|FG002|Overall Study|Lost to Follow-up|1|||
94265603|NCT01822522|322765771|FG003|Overall Study|Lost to Follow-up|1|||
94265604|NCT01822522|322765772|FG004|Overall Study|Lost to Follow-up|0|||
94265605|NCT01822522|322765773|FG005|Overall Study|Lost to Follow-up|1|||
94697834|NCT01822821|324349428|FG000|Overall Study|Eligible surgery cancelled|1|||
94697835|NCT01822821|324349429|FG001|Overall Study|Eligible surgery cancelled|1|||
94697836|NCT01822821|324349428|FG000|Overall Study|Other reasons|1|||
94697837|NCT01822821|324349429|FG001|Overall Study|Other reasons|0|||
94697838|NCT03115346|324349431|FG000|Overall Study|Did not have AAA surgery|28|||
94697839|NCT03115346|324349432|FG001|Overall Study|Did not have AAA surgery|15|||
94697840|NCT03115346|324349431|FG000|Overall Study|Death|3|||
94697841|NCT03115346|324349432|FG001|Overall Study|Death|1|||
94697842|NCT03115346|324349431|FG000|Overall Study|Withdrawal by Subject|0|||
94697843|NCT03115346|324349432|FG001|Overall Study|Withdrawal by Subject|3|||
94697844|NCT03115346|324349431|FG000|Overall Study|Lost to Follow-up|0|||
94697845|NCT03115346|324349432|FG001|Overall Study|Lost to Follow-up|3|||
94697846|NCT00689104|324349433|FG000|Overall Study|Eligibility criterion not met|5|||
94697847|NCT00689104|324349434|FG001|Overall Study|Eligibility criterion not met|8|||
94697848|NCT00689104|324349435|FG002|Overall Study|Eligibility criterion not met|0|||
94697849|NCT00689104|324349436|FG003|Overall Study|Eligibility criterion not met|4|||
94265606|NCT01822522|322765768|FG000|Overall Study|Withdrawal by Subject|0|||
94697850|NCT00689104|324349433|FG000|Overall Study|Adverse Event|13|||
94697851|NCT00689104|324349434|FG001|Overall Study|Adverse Event|25|||
94697852|NCT00689104|324349435|FG002|Overall Study|Adverse Event|16|||
94697853|NCT00689104|324349436|FG003|Overall Study|Adverse Event|24|||
94697854|NCT00689104|324349433|FG000|Overall Study|Lack of Efficacy|5|||
94697855|NCT00689104|324349434|FG001|Overall Study|Lack of Efficacy|6|||
94697856|NCT00689104|324349435|FG002|Overall Study|Lack of Efficacy|2|||
94697857|NCT00689104|324349436|FG003|Overall Study|Lack of Efficacy|3|||
94697858|NCT00689104|324349433|FG000|Overall Study|Withdrawal by Subject|12|||
94697859|NCT00689104|324349434|FG001|Overall Study|Withdrawal by Subject|11|||
94697860|NCT00689104|324349435|FG002|Overall Study|Withdrawal by Subject|18|||
94697861|NCT00689104|324349436|FG003|Overall Study|Withdrawal by Subject|11|||
94697862|NCT00689104|324349433|FG000|Overall Study|Lost to Follow-up|4|||
94697863|NCT00689104|324349434|FG001|Overall Study|Lost to Follow-up|3|||
94697864|NCT00689104|324349435|FG002|Overall Study|Lost to Follow-up|2|||
94697865|NCT00689104|324349436|FG003|Overall Study|Lost to Follow-up|5|||
94697866|NCT00689104|324349433|FG000|Overall Study|Protocol Violation|2|||
94697867|NCT00689104|324349434|FG001|Overall Study|Protocol Violation|3|||
94697868|NCT00689104|324349435|FG002|Overall Study|Protocol Violation|5|||
94697869|NCT00689104|324349436|FG003|Overall Study|Protocol Violation|3|||
94697870|NCT00689104|324349433|FG000|Overall Study|Randomized but never received study drug|2|||
94697871|NCT00689104|324349434|FG001|Overall Study|Randomized but never received study drug|1|||
94697872|NCT00689104|324349435|FG002|Overall Study|Randomized but never received study drug|1|||
94697873|NCT00689104|324349436|FG003|Overall Study|Randomized but never received study drug|0|||
94697874|NCT00689104|324349433|FG000|Overall Study|Physician Decision|1|||
94697875|NCT00689104|324349434|FG001|Overall Study|Physician Decision|0|||
94697876|NCT00689104|324349435|FG002|Overall Study|Physician Decision|0|||
94697877|NCT00689104|324349436|FG003|Overall Study|Physician Decision|0|||
94697878|NCT00689104|324349433|FG000|Overall Study|Non-compliance with study procedures|0|||
94697879|NCT00689104|324349434|FG001|Overall Study|Non-compliance with study procedures|0|||
94697880|NCT00689104|324349435|FG002|Overall Study|Non-compliance with study procedures|1|||
94697881|NCT00689104|324349436|FG003|Overall Study|Non-compliance with study procedures|0|||
94697882|NCT01836458|324349437|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
94697883|NCT01836458|324349438|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
94697884|NCT01836458|324349439|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
94697885|NCT01836458|324349440|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
94697886|NCT02189863|324349441|FG000|First 2 Weeks|Motion Sickness|4|||
94697887|NCT02189863|324349442|FG001|First 2 Weeks|Motion Sickness|2|||
94697888|NCT03697460|324349443|FG000|Overall Study|Withdrawal by Subject|3|||
94697889|NCT00062868|324349448|FG000|Dose Level 1|Death|2|||
94697890|NCT00062868|324349449|FG001|Dose Level 1|Death|0|||
94697891|NCT00062868|324349450|FG002|Dose Level 1|Death|0|||
94697892|NCT00062868|324349451|FG003|Dose Level 1|Death|2|||
94697893|NCT00062868|324349452|FG004|Dose Level 1|Death|0|||
94697894|NCT00062868|324349453|FG005|Dose Level 1|Death|0|||
94697895|NCT00062868|324349454|FG006|Dose Level 1|Death|3|||
94697896|NCT00062868|324349455|FG007|Dose Level 1|Death|0|||
94697897|NCT00062868|324349456|FG008|Dose Level 1|Death|0|||
94697898|NCT00062868|324349457|FG009|Dose Level 1|Death|0|||
94697899|NCT00062868|324349458|FG010|Dose Level 1|Death|0|||
94697900|NCT00062868|324349459|FG011|Dose Level 1|Death|0|||
94697901|NCT00062868|324349460|FG012|Dose Level 1|Death|0|||
94697902|NCT00062868|324349461|FG013|Dose Level 1|Death|0|||
94697903|NCT00062868|324349462|FG014|Dose Level 1|Death|0|||
94697904|NCT00062868|324349463|FG015|Dose Level 1|Death|0|||
94697905|NCT00062868|324349464|FG016|Dose Level 1|Death|0|||
94697906|NCT00062868|324349465|FG017|Dose Level 1|Death|0|||
94697907|NCT00062868|324349466|FG018|Dose Level 1|Death|7|||
94697908|NCT00062868|324349467|FG019|Dose Level 1|Death|0|||
94697909|NCT00062868|324349468|FG020|Dose Level 1|Death|1|||
94265607|NCT01822522|322765769|FG001|Overall Study|Withdrawal by Subject|0|||
94265608|NCT01822522|322765770|FG002|Overall Study|Withdrawal by Subject|0|||
94265609|NCT01822522|322765771|FG003|Overall Study|Withdrawal by Subject|1|||
94265610|NCT01822522|322765772|FG004|Overall Study|Withdrawal by Subject|0|||
94466110|NCT00869557|323496938|FG000|Extension Phase|Adverse Event|2|||
94697910|NCT00062868|324349448|FG000|Dose Level 1|Lost to Follow-up|0|||
94697911|NCT00062868|324349449|FG001|Dose Level 1|Lost to Follow-up|0|||
94697912|NCT00062868|324349450|FG002|Dose Level 1|Lost to Follow-up|0|||
94697913|NCT00062868|324349451|FG003|Dose Level 1|Lost to Follow-up|0|||
94697914|NCT00062868|324349452|FG004|Dose Level 1|Lost to Follow-up|0|||
94697915|NCT00062868|324349453|FG005|Dose Level 1|Lost to Follow-up|0|||
94697916|NCT00062868|324349454|FG006|Dose Level 1|Lost to Follow-up|0|||
94697917|NCT00062868|324349455|FG007|Dose Level 1|Lost to Follow-up|0|||
94697918|NCT00062868|324349456|FG008|Dose Level 1|Lost to Follow-up|0|||
94697919|NCT00062868|324349457|FG009|Dose Level 1|Lost to Follow-up|0|||
94697920|NCT00062868|324349458|FG010|Dose Level 1|Lost to Follow-up|0|||
94697921|NCT00062868|324349459|FG011|Dose Level 1|Lost to Follow-up|0|||
94697922|NCT00062868|324349460|FG012|Dose Level 1|Lost to Follow-up|1|||
94697923|NCT00062868|324349461|FG013|Dose Level 1|Lost to Follow-up|0|||
94697924|NCT00062868|324349462|FG014|Dose Level 1|Lost to Follow-up|0|||
94466111|NCT00869557|323496939|FG001|Extension Phase|Adverse Event|2|||
94466112|NCT00869557|323496938|FG000|Extension Phase|Lack of Efficacy|1|||
94466113|NCT00869557|323496939|FG001|Extension Phase|Lack of Efficacy|0|||
94466114|NCT00869557|323496938|FG000|Extension Phase|Lost to Follow-up|3|||
94651773|NCT00508742|324181801|FG001|Period 1: Infant Series|Other|1|||
94651774|NCT00508742|324181800|FG000|Period 2: After Infant Series|Adverse Event|2|||
94651775|NCT00508742|324181801|FG001|Period 2: After Infant Series|Adverse Event|6|||
94651776|NCT00508742|324181800|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
94651777|NCT00508742|324181801|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
94651778|NCT00508742|324181800|FG000|Period 2: After Infant Series|Protocol Violation|1|||
94651779|NCT00508742|324181801|FG001|Period 2: After Infant Series|Protocol Violation|0|||
94651780|NCT00508742|324181800|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
94651781|NCT00508742|324181801|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
94651782|NCT00508742|324181800|FG000|Period 2: After Infant Series|Failed to Return|1|||
94651783|NCT00508742|324181801|FG001|Period 2: After Infant Series|Failed to Return|0|||
94651784|NCT00508742|324181800|FG000|Period 2: After Infant Series|Other|2|||
94651785|NCT00508742|324181801|FG001|Period 2: After Infant Series|Other|1|||
94651786|NCT00508742|324181800|FG000|Period 3: Toddler Dose|Adverse Event|1|||
94651787|NCT00508742|324181801|FG001|Period 3: Toddler Dose|Adverse Event|0|||
94651788|NCT00508742|324181800|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
94651789|NCT00508742|324181801|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
94651790|NCT00508742|324181800|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
94651791|NCT00508742|324181801|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
94651792|NCT00508742|324181800|FG000|Period 3: Toddler Dose|Other|5|||
94651793|NCT00508742|324181801|FG001|Period 3: Toddler Dose|Other|4|||
94651794|NCT03851016|324181805|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
94651795|NCT03851016|324181806|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
94651796|NCT01976845|324181808|FG000|Overall Study|Physician Decision|8|||
94651797|NCT01976845|324181809|FG001|Overall Study|Physician Decision|8|||
94651798|NCT01976845|324181810|FG002|Overall Study|Physician Decision|3|||
94651799|NCT02383758|324183741|FG000|Overall Study|Withdrawal by Subject|0|||
94651800|NCT02383758|324183742|FG001|Overall Study|Withdrawal by Subject|2|||
94651801|NCT03085927|324183743|FG000|Overall Study|Withdrawal by Subject|1|||
94651802|NCT03085927|324183744|FG001|Overall Study|Withdrawal by Subject|4|||
94651803|NCT03085927|324183743|FG000|Overall Study|Lost to Follow-up|3|||
94651804|NCT03085927|324183744|FG001|Overall Study|Lost to Follow-up|1|||
94651805|NCT03085927|324183743|FG000|Overall Study|Death|1|||
94651806|NCT03085927|324183744|FG001|Overall Study|Death|0|||
94651807|NCT03085927|324183743|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
94651808|NCT03085927|324183744|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
94651809|NCT03085927|324183743|FG000|Overall Study|Dyad Became Ineligible|0|||
94651810|NCT03085927|324183744|FG001|Overall Study|Dyad Became Ineligible|1|||
94651811|NCT02573324|324183745|FG000|Overall Study|Withdrawal by Subject|26|||
94651812|NCT02573324|324183746|FG001|Overall Study|Withdrawal by Subject|23|||
94651813|NCT02573324|324183747|FG002|Overall Study|Withdrawal by Subject|3|||
94651814|NCT02573324|324183745|FG000|Overall Study|Lost to Follow-up|4|||
94651815|NCT02573324|324183746|FG001|Overall Study|Lost to Follow-up|5|||
94651816|NCT02573324|324183747|FG002|Overall Study|Lost to Follow-up|0|||
94651817|NCT02573324|324183745|FG000|Overall Study|Study Terminated by Sponsor|107|||
94651818|NCT02573324|324183746|FG001|Overall Study|Study Terminated by Sponsor|89|||
94651819|NCT02573324|324183747|FG002|Overall Study|Study Terminated by Sponsor|2|||
94651820|NCT02573324|324183745|FG000|Overall Study|Death|182|||
94651821|NCT02573324|324183746|FG001|Overall Study|Death|200|||
94651822|NCT02573324|324183747|FG002|Overall Study|Death|1|||
94651823|NCT02573324|324183745|FG000|Overall Study|Other, Not Specified|20|||
94651824|NCT02573324|324183746|FG001|Overall Study|Other, Not Specified|27|||
94651825|NCT02573324|324183747|FG002|Overall Study|Other, Not Specified|0|||
94651826|NCT02573324|324183745|FG000|Overall Study|Unknown Reason|2|||
94651827|NCT02573324|324183746|FG001|Overall Study|Unknown Reason|0|||
94651828|NCT02573324|324183747|FG002|Overall Study|Unknown Reason|0|||
94651829|NCT00938431|324183748|FG000|Overall Study|Adverse Event|5|||
94651830|NCT00938431|324183749|FG001|Overall Study|Adverse Event|8|||
94651831|NCT00938431|324183750|FG002|Overall Study|Adverse Event|6|||
94651832|NCT00938431|324183748|FG000|Overall Study|Lack of Efficacy|0|||
94651833|NCT00938431|324183749|FG001|Overall Study|Lack of Efficacy|1|||
94651834|NCT00938431|324183750|FG002|Overall Study|Lack of Efficacy|0|||
94651835|NCT00938431|324183748|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
94651836|NCT00938431|324183749|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
94651837|NCT00938431|324183750|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
94651838|NCT00938431|324183748|FG000|Overall Study|Dosing compliance issue|0|||
94651839|NCT00938431|324183749|FG001|Overall Study|Dosing compliance issue|0|||
94651840|NCT00938431|324183750|FG002|Overall Study|Dosing compliance issue|1|||
94697925|NCT00062868|324349463|FG015|Dose Level 1|Lost to Follow-up|0|||
94697926|NCT00062868|324349464|FG016|Dose Level 1|Lost to Follow-up|0|||
94697927|NCT00062868|324349465|FG017|Dose Level 1|Lost to Follow-up|0|||
94697928|NCT00062868|324349466|FG018|Dose Level 1|Lost to Follow-up|2|||
94697929|NCT00062868|324349467|FG019|Dose Level 1|Lost to Follow-up|0|||
94697930|NCT00062868|324349468|FG020|Dose Level 1|Lost to Follow-up|1|||
94697931|NCT00062868|324349448|FG000|Dose Level 2|Death|0|||
94697932|NCT00062868|324349449|FG001|Dose Level 2|Death|3|||
94697933|NCT00062868|324349450|FG002|Dose Level 2|Death|0|||
94697934|NCT00062868|324349451|FG003|Dose Level 2|Death|0|||
94697935|NCT00062868|324349452|FG004|Dose Level 2|Death|2|||
94697936|NCT00062868|324349453|FG005|Dose Level 2|Death|0|||
94697937|NCT00062868|324349454|FG006|Dose Level 2|Death|0|||
94697938|NCT00062868|324349455|FG007|Dose Level 2|Death|0|||
94697939|NCT00062868|324349456|FG008|Dose Level 2|Death|0|||
94697940|NCT00062868|324349457|FG009|Dose Level 2|Death|0|||
94697941|NCT00062868|324349458|FG010|Dose Level 2|Death|1|||
94697942|NCT00062868|324349459|FG011|Dose Level 2|Death|0|||
94697943|NCT00062868|324349460|FG012|Dose Level 2|Death|0|||
94697944|NCT00062868|324349461|FG013|Dose Level 2|Death|0|||
94697945|NCT00062868|324349462|FG014|Dose Level 2|Death|0|||
94697946|NCT00062868|324349463|FG015|Dose Level 2|Death|0|||
94697947|NCT00062868|324349464|FG016|Dose Level 2|Death|2|||
94697948|NCT00062868|324349465|FG017|Dose Level 2|Death|0|||
94697949|NCT00062868|324349466|FG018|Dose Level 2|Death|0|||
94697950|NCT00062868|324349467|FG019|Dose Level 2|Death|0|||
94697951|NCT00062868|324349468|FG020|Dose Level 2|Death|0|||
94697952|NCT00062868|324349448|FG000|Dose Level 2|Lost to Follow-up|0|||
94697953|NCT00062868|324349449|FG001|Dose Level 2|Lost to Follow-up|0|||
94697954|NCT00062868|324349450|FG002|Dose Level 2|Lost to Follow-up|0|||
94697955|NCT00062868|324349451|FG003|Dose Level 2|Lost to Follow-up|0|||
94697956|NCT00062868|324349452|FG004|Dose Level 2|Lost to Follow-up|0|||
94697957|NCT00062868|324349453|FG005|Dose Level 2|Lost to Follow-up|0|||
94697958|NCT00062868|324349454|FG006|Dose Level 2|Lost to Follow-up|0|||
94697959|NCT00062868|324349455|FG007|Dose Level 2|Lost to Follow-up|0|||
94697960|NCT00062868|324349456|FG008|Dose Level 2|Lost to Follow-up|0|||
94697961|NCT00062868|324349457|FG009|Dose Level 2|Lost to Follow-up|0|||
94697962|NCT00062868|324349458|FG010|Dose Level 2|Lost to Follow-up|0|||
94697963|NCT00062868|324349459|FG011|Dose Level 2|Lost to Follow-up|0|||
94697964|NCT00062868|324349460|FG012|Dose Level 2|Lost to Follow-up|0|||
94697965|NCT00062868|324349461|FG013|Dose Level 2|Lost to Follow-up|1|||
94697966|NCT00062868|324349462|FG014|Dose Level 2|Lost to Follow-up|0|||
94697967|NCT00062868|324349463|FG015|Dose Level 2|Lost to Follow-up|0|||
94697968|NCT00062868|324349464|FG016|Dose Level 2|Lost to Follow-up|1|||
94697969|NCT00062868|324349465|FG017|Dose Level 2|Lost to Follow-up|0|||
94697970|NCT00062868|324349466|FG018|Dose Level 2|Lost to Follow-up|0|||
94697971|NCT00062868|324349467|FG019|Dose Level 2|Lost to Follow-up|0|||
94697972|NCT00062868|324349468|FG020|Dose Level 2|Lost to Follow-up|0|||
94697973|NCT00062868|324349448|FG000|Dose Level 3|Death|0|||
94697974|NCT00062868|324349449|FG001|Dose Level 3|Death|0|||
94697975|NCT00062868|324349450|FG002|Dose Level 3|Death|0|||
94697976|NCT00062868|324349451|FG003|Dose Level 3|Death|0|||
94697977|NCT00062868|324349452|FG004|Dose Level 3|Death|0|||
94697978|NCT00062868|324349453|FG005|Dose Level 3|Death|0|||
94697979|NCT00062868|324349454|FG006|Dose Level 3|Death|0|||
94697980|NCT00062868|324349455|FG007|Dose Level 3|Death|0|||
94697981|NCT00062868|324349456|FG008|Dose Level 3|Death|0|||
94697982|NCT00062868|324349457|FG009|Dose Level 3|Death|0|||
94697983|NCT00062868|324349458|FG010|Dose Level 3|Death|0|||
94697984|NCT00062868|324349459|FG011|Dose Level 3|Death|1|||
94697985|NCT00062868|324349460|FG012|Dose Level 3|Death|0|||
94697986|NCT00062868|324349461|FG013|Dose Level 3|Death|0|||
94697987|NCT00062868|324349462|FG014|Dose Level 3|Death|0|||
94697988|NCT00062868|324349463|FG015|Dose Level 3|Death|0|||
94697989|NCT00062868|324349464|FG016|Dose Level 3|Death|0|||
94697990|NCT00062868|324349465|FG017|Dose Level 3|Death|1|||
94697991|NCT00062868|324349466|FG018|Dose Level 3|Death|0|||
94697992|NCT00062868|324349467|FG019|Dose Level 3|Death|0|||
94697993|NCT00062868|324349468|FG020|Dose Level 3|Death|0|||
94697994|NCT00062868|324349448|FG000|Dose Level 3|Lost to Follow-up|0|||
94697995|NCT00062868|324349449|FG001|Dose Level 3|Lost to Follow-up|0|||
94697996|NCT00062868|324349450|FG002|Dose Level 3|Lost to Follow-up|0|||
94697997|NCT00062868|324349451|FG003|Dose Level 3|Lost to Follow-up|0|||
94697998|NCT00062868|324349452|FG004|Dose Level 3|Lost to Follow-up|0|||
94697999|NCT00062868|324349453|FG005|Dose Level 3|Lost to Follow-up|0|||
94698000|NCT00062868|324349454|FG006|Dose Level 3|Lost to Follow-up|0|||
94698001|NCT00062868|324349455|FG007|Dose Level 3|Lost to Follow-up|0|||
94698002|NCT00062868|324349456|FG008|Dose Level 3|Lost to Follow-up|0|||
94698003|NCT00062868|324349457|FG009|Dose Level 3|Lost to Follow-up|0|||
94698004|NCT00062868|324349458|FG010|Dose Level 3|Lost to Follow-up|0|||
94698005|NCT00062868|324349459|FG011|Dose Level 3|Lost to Follow-up|0|||
94698006|NCT00062868|324349460|FG012|Dose Level 3|Lost to Follow-up|0|||
94698007|NCT00062868|324349461|FG013|Dose Level 3|Lost to Follow-up|0|||
94698008|NCT00062868|324349462|FG014|Dose Level 3|Lost to Follow-up|1|||
94698009|NCT00062868|324349463|FG015|Dose Level 3|Lost to Follow-up|0|||
94698010|NCT00062868|324349464|FG016|Dose Level 3|Lost to Follow-up|0|||
94698011|NCT00062868|324349465|FG017|Dose Level 3|Lost to Follow-up|0|||
94698012|NCT00062868|324349466|FG018|Dose Level 3|Lost to Follow-up|0|||
94698013|NCT00062868|324349467|FG019|Dose Level 3|Lost to Follow-up|0|||
94698014|NCT00062868|324349468|FG020|Dose Level 3|Lost to Follow-up|0|||
94698015|NCT00062868|324349448|FG000|Dose Level 3|Withdrew|0|||
94698016|NCT00062868|324349449|FG001|Dose Level 3|Withdrew|0|||
94698017|NCT00062868|324349450|FG002|Dose Level 3|Withdrew|2|||
94698018|NCT00062868|324349451|FG003|Dose Level 3|Withdrew|0|||
94698019|NCT00062868|324349452|FG004|Dose Level 3|Withdrew|0|||
94698020|NCT00062868|324349453|FG005|Dose Level 3|Withdrew|0|||
94698021|NCT00062868|324349454|FG006|Dose Level 3|Withdrew|0|||
94698022|NCT00062868|324349455|FG007|Dose Level 3|Withdrew|0|||
94698023|NCT00062868|324349456|FG008|Dose Level 3|Withdrew|0|||
94698024|NCT00062868|324349457|FG009|Dose Level 3|Withdrew|0|||
94698025|NCT00062868|324349458|FG010|Dose Level 3|Withdrew|0|||
94698026|NCT00062868|324349459|FG011|Dose Level 3|Withdrew|0|||
94698027|NCT00062868|324349460|FG012|Dose Level 3|Withdrew|0|||
94698028|NCT00062868|324349461|FG013|Dose Level 3|Withdrew|0|||
94698029|NCT00062868|324349462|FG014|Dose Level 3|Withdrew|0|||
94698030|NCT00062868|324349463|FG015|Dose Level 3|Withdrew|0|||
94698031|NCT00062868|324349464|FG016|Dose Level 3|Withdrew|0|||
94698032|NCT00062868|324349465|FG017|Dose Level 3|Withdrew|0|||
94698033|NCT00062868|324349466|FG018|Dose Level 3|Withdrew|0|||
94698034|NCT00062868|324349467|FG019|Dose Level 3|Withdrew|0|||
94698035|NCT00062868|324349468|FG020|Dose Level 3|Withdrew|0|||
94698036|NCT00725010|324349469|FG000|Overall Study|Toxicity|9|||
94698037|NCT00725010|324349469|FG000|Overall Study|Tumor Progression|7|||
94698038|NCT00725010|324349469|FG000|Overall Study|Withdrawal by Subject|2|||
94698039|NCT00725010|324349469|FG000|Overall Study|Death|1|||
94698040|NCT00725010|324349469|FG000|Overall Study|Lost to Follow-up|1|||
94698041|NCT00725010|324349469|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
94698042|NCT00725010|324349469|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
94698043|NCT00725010|324349469|FG000|Overall Study|No further documentation|1|||
94698044|NCT00725010|324349469|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
94698045|NCT03425539|324349470|FG000|Overall Study|Randomized but not treated|0|||
94698046|NCT03425539|324349471|FG001|Overall Study|Randomized but not treated|1|||
94698047|NCT03425539|324349470|FG000|Overall Study|Adverse Event|2|||
94698048|NCT03425539|324349471|FG001|Overall Study|Adverse Event|2|||
94698049|NCT03425539|324349470|FG000|Overall Study|Withdrawal by Subject|3|||
94698050|NCT03425539|324349471|FG001|Overall Study|Withdrawal by Subject|0|||
94698051|NCT03425539|324349470|FG000|Overall Study|Lost to Follow-up|0|||
94698052|NCT03425539|324349471|FG001|Overall Study|Lost to Follow-up|1|||
94698053|NCT01140347|324349475|FG000|Overall Study|Lost to Follow-up|5|||
94698054|NCT01140347|324349476|FG001|Overall Study|Lost to Follow-up|6|||
94698055|NCT01140347|324349475|FG000|Overall Study|Withdrawal by Subject|13|||
94698056|NCT01140347|324349476|FG001|Overall Study|Withdrawal by Subject|8|||
94698057|NCT01449929|324349477|FG000|Randomization Phase 96 Week|Adverse Event|5|||
94698058|NCT01449929|324349478|FG001|Randomization Phase 96 Week|Adverse Event|13|||
94698059|NCT01449929|324349479|FG002|Randomization Phase 96 Week|Adverse Event|0|||
94698060|NCT01449929|324349477|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
94698061|NCT01449929|324349478|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
94698062|NCT01449929|324349479|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
94698063|NCT01449929|324349477|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
94698064|NCT01449929|324349478|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
94698065|NCT01449929|324349479|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
94698066|NCT01449929|324349477|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
94366329|NCT02072174|323126503|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
94366330|NCT02072174|323126504|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
94698067|NCT01449929|324349478|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
94698068|NCT01449929|324349479|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
94698069|NCT01449929|324349477|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
94698070|NCT01449929|324349478|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
94698071|NCT01449929|324349479|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
94698072|NCT01449929|324349477|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
94698073|NCT01449929|324349478|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
94698074|NCT01449929|324349479|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
94698075|NCT01449929|324349477|FG000|Randomization Phase 96 Week|Physician Decision|2|||
94698076|NCT01449929|324349478|FG001|Randomization Phase 96 Week|Physician Decision|3|||
94698077|NCT01449929|324349479|FG002|Randomization Phase 96 Week|Physician Decision|0|||
94698078|NCT01449929|324349477|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
94698079|NCT01449929|324349478|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
94698080|NCT01449929|324349479|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
94698081|NCT01449929|324349477|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
94698082|NCT01449929|324349478|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
94698083|NCT01449929|324349479|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
94698084|NCT01449929|324349477|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
94698085|NCT01449929|324349478|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
94698086|NCT01449929|324349479|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
94698087|NCT01449929|324349477|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
94698088|NCT01449929|324349478|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
94698089|NCT01449929|324349479|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
94698090|NCT01919619|324349480|FG000|Overall Study|Physician Decision|1|||
94698091|NCT01919619|324349481|FG001|Overall Study|Physician Decision|1|||
94698092|NCT02501811|324349482|FG000|Overall Study|Death|1|||
94698093|NCT02501811|324349483|FG001|Overall Study|Death|3|||
94698094|NCT02501811|324349484|FG002|Overall Study|Death|2|||
94698095|NCT02501811|324349485|FG003|Overall Study|Death|3|||
94698096|NCT02501811|324349482|FG000|Overall Study|Withdrawal by Subject|3|||
94698097|NCT02501811|324349483|FG001|Overall Study|Withdrawal by Subject|3|||
94698098|NCT02501811|324349484|FG002|Overall Study|Withdrawal by Subject|2|||
94698099|NCT02501811|324349485|FG003|Overall Study|Withdrawal by Subject|3|||
94698100|NCT02501811|324349482|FG000|Overall Study|Lost to Follow-up|0|||
94698101|NCT02501811|324349483|FG001|Overall Study|Lost to Follow-up|0|||
94466115|NCT00869557|323496939|FG001|Extension Phase|Lost to Follow-up|1|||
94698102|NCT02501811|324349484|FG002|Overall Study|Lost to Follow-up|2|||
94698103|NCT02501811|324349485|FG003|Overall Study|Lost to Follow-up|1|||
94698104|NCT00924664|324351098|FG000|Overall Study|Adverse Event|23|||
94698105|NCT00924664|324351099|FG001|Overall Study|Adverse Event|39|||
94698106|NCT00924664|324351098|FG000|Overall Study|Lack of Efficacy|10|||
94698107|NCT00924664|324351099|FG001|Overall Study|Lack of Efficacy|15|||
94698108|NCT00924664|324351098|FG000|Overall Study|Lost to Follow-up|10|||
94698109|NCT00924664|324351099|FG001|Overall Study|Lost to Follow-up|12|||
94698110|NCT00924664|324351098|FG000|Overall Study|Withdrawal by Subject|47|||
94698111|NCT00924664|324351099|FG001|Overall Study|Withdrawal by Subject|71|||
94698112|NCT00924664|324351098|FG000|Overall Study|Protocol Violation|2|||
94698113|NCT00924664|324351099|FG001|Overall Study|Protocol Violation|5|||
94698114|NCT00924664|324351098|FG000|Overall Study|Pregnancy|1|||
94698115|NCT00924664|324351099|FG001|Overall Study|Pregnancy|1|||
94698116|NCT00924664|324351098|FG000|Overall Study|Death|0|||
94698117|NCT00924664|324351099|FG001|Overall Study|Death|2|||
94698118|NCT00924664|324351098|FG000|Overall Study|Study terminated by sponsor|199|||
94698119|NCT00924664|324351099|FG001|Overall Study|Study terminated by sponsor|330|||
94698120|NCT00924664|324351098|FG000|Overall Study|Other|29|||
94698121|NCT00924664|324351099|FG001|Overall Study|Other|52|||
94698122|NCT00924664|324351098|FG000|Overall Study|Randomized but not Treated|1|||
94698123|NCT00924664|324351099|FG001|Overall Study|Randomized but not Treated|0|||
94698124|NCT01598987|324351100|FG000|Baseline to Month 12|Administrative problems|2|||
94366331|NCT02072174|323126503|FG000|Overall Study|Protocol Violation|16|||
94366332|NCT02072174|323126504|FG001|Overall Study|Protocol Violation|23|||
94366333|NCT02072174|323126503|FG000|Overall Study|Physician Decision|0|||
94366334|NCT02072174|323126504|FG001|Overall Study|Physician Decision|1|||
94366335|NCT02072174|323126503|FG000|Overall Study|Non-compliance with protocol requirement|2|||
94366336|NCT02072174|323126504|FG001|Overall Study|Non-compliance with protocol requirement|0|||
94366337|NCT02017535|323126508|FG000|Overall Study|Withdrawal by Subject|1|||
94366338|NCT02017535|323126509|FG001|Overall Study|Withdrawal by Subject|0|||
94366339|NCT02017535|323126510|FG002|Overall Study|Withdrawal by Subject|0|||
94366340|NCT02017535|323126511|FG003|Overall Study|Withdrawal by Subject|0|||
94366341|NCT01393626|323126512|FG000|Overall Study|Adverse Event|2|||
94366342|NCT01393626|323126513|FG001|Overall Study|Adverse Event|1|||
94366343|NCT01393626|323126514|FG002|Overall Study|Adverse Event|5|||
94466116|NCT00869557|323496938|FG000|Extension Phase|Investigator's Discretion|2|||
94366344|NCT01393626|323126515|FG003|Overall Study|Adverse Event|0|||
94466117|NCT00869557|323496939|FG001|Extension Phase|Investigator's Discretion|0|||
94366345|NCT01393626|323126512|FG000|Overall Study|Did not meet entrance criteria|1|||
94466118|NCT00869557|323496938|FG000|Extension Phase|Withdrew Consent|2|||
94698125|NCT01598987|324351100|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
94698126|NCT01598987|324351100|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
94698127|NCT01598987|324351100|FG000|Baseline to 24 Month|Administrative problems|2|||
94698128|NCT01598987|324351100|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
94698129|NCT05305040|324351101|FG000|Overall Study|Not Dosed|37|||
94698130|NCT05305040|324351102|FG001|Overall Study|Not Dosed|37|||
94698131|NCT05305040|324351101|FG000|Overall Study|Study Closure|34|||
94265611|NCT01822522|322765773|FG005|Overall Study|Withdrawal by Subject|0|||
94265612|NCT01822522|322765768|FG000|Overall Study|Lack of Efficacy|0|||
94265613|NCT01822522|322765769|FG001|Overall Study|Lack of Efficacy|0|||
94265614|NCT01822522|322765770|FG002|Overall Study|Lack of Efficacy|0|||
94265615|NCT01822522|322765771|FG003|Overall Study|Lack of Efficacy|0|||
94265616|NCT01822522|322765772|FG004|Overall Study|Lack of Efficacy|0|||
94698132|NCT05305040|324351102|FG001|Overall Study|Study Closure|46|||
94698133|NCT05305040|324351101|FG000|Overall Study|Death|14|||
94698134|NCT05305040|324351102|FG001|Overall Study|Death|13|||
94698135|NCT05305040|324351101|FG000|Overall Study|Withdrawal by Subject|15|||
94698136|NCT05305040|324351102|FG001|Overall Study|Withdrawal by Subject|10|||
94698137|NCT05305040|324351101|FG000|Overall Study|Other|13|||
94698138|NCT05305040|324351102|FG001|Overall Study|Other|10|||
94265617|NCT01822522|322765773|FG005|Overall Study|Lack of Efficacy|2|||
94265618|NCT02941926|322765776|FG000|Core Phase|Progressive disease|1109|||
94265619|NCT02941926|322765776|FG000|Core Phase|Adverse Event|504|||
94265620|NCT02941926|322765776|FG000|Core Phase|Subject/guardian decision|127|||
94265621|NCT02941926|322765776|FG000|Core Phase|Physician Decision|112|||
94265622|NCT02941926|322765776|FG000|Core Phase|Death|46|||
94265623|NCT02941926|322765776|FG000|Core Phase|Protocol deviation|34|||
94265624|NCT02941926|322765776|FG000|Core Phase|Lost to Follow-up|8|||
94265625|NCT02941926|322765776|FG000|Core Phase|Technical problems|5|||
94265626|NCT02941926|322765776|FG000|Extension Phase|Physician Decision|155|||
94265627|NCT02941926|322765776|FG000|Extension Phase|Progressive disease|115|||
94265628|NCT02941926|322765776|FG000|Extension Phase|Adverse Event|13|||
94265629|NCT02941926|322765776|FG000|Extension Phase|Subject/Guardian decision|12|||
94265630|NCT02941926|322765776|FG000|Extension Phase|Death|6|||
94265631|NCT00307333|322765777|FG000|Overall Study|Lost to Follow-up|11|||
94265632|NCT00307333|322765778|FG001|Overall Study|Lost to Follow-up|3|||
94265633|NCT03065023|322765780|FG000|Overall Study|Progressive Disease|0|||
94265634|NCT03065023|322765781|FG001|Overall Study|Progressive Disease|1|||
94366346|NCT01393626|323126513|FG001|Overall Study|Did not meet entrance criteria|0|||
94366347|NCT01393626|323126514|FG002|Overall Study|Did not meet entrance criteria|0|||
94366348|NCT01393626|323126515|FG003|Overall Study|Did not meet entrance criteria|0|||
94366349|NCT01393626|323126512|FG000|Overall Study|Lack of Efficacy|6|||
94366350|NCT01393626|323126513|FG001|Overall Study|Lack of Efficacy|6|||
94366351|NCT01393626|323126514|FG002|Overall Study|Lack of Efficacy|4|||
94366352|NCT01393626|323126515|FG003|Overall Study|Lack of Efficacy|1|||
94366353|NCT01393626|323126512|FG000|Overall Study|Lost to Follow-up|1|||
94366354|NCT01393626|323126513|FG001|Overall Study|Lost to Follow-up|1|||
94366355|NCT01393626|323126514|FG002|Overall Study|Lost to Follow-up|1|||
94366356|NCT01393626|323126515|FG003|Overall Study|Lost to Follow-up|0|||
94366357|NCT01393626|323126512|FG000|Overall Study|Withdrawal by Subject|6|||
94366358|NCT01393626|323126513|FG001|Overall Study|Withdrawal by Subject|4|||
94366359|NCT01393626|323126514|FG002|Overall Study|Withdrawal by Subject|0|||
94366360|NCT01393626|323126515|FG003|Overall Study|Withdrawal by Subject|0|||
94698139|NCT05305040|324351101|FG000|Overall Study|Primary Malignancy Relapse|3|||
94698140|NCT05305040|324351102|FG001|Overall Study|Primary Malignancy Relapse|4|||
94698141|NCT05305040|324351101|FG000|Overall Study|Adverse Event|3|||
94698142|NCT05305040|324351102|FG001|Overall Study|Adverse Event|3|||
94698143|NCT05305040|324351101|FG000|Overall Study|Lost to Follow-up|2|||
94698144|NCT05305040|324351102|FG001|Overall Study|Lost to Follow-up|1|||
94698145|NCT05305040|324351101|FG000|Overall Study|Graft versus host disease|2|||
94698146|NCT05305040|324351102|FG001|Overall Study|Graft versus host disease|0|||
94698147|NCT05305040|324351101|FG000|Overall Study|Investigator's Decision|1|||
94698148|NCT05305040|324351102|FG001|Overall Study|Investigator's Decision|1|||
94698149|NCT05305040|324351101|FG000|Overall Study|COVID-19 Reasons|1|||
94698150|NCT05305040|324351102|FG001|Overall Study|COVID-19 Reasons|0|||
94698151|NCT02028884|324351105|FG000|Double-blind Period|Adverse Event|5|||
94698152|NCT02028884|324351106|FG001|Double-blind Period|Adverse Event|3|||
94265635|NCT03065023|322765782|FG002|Overall Study|Progressive Disease|0|||
94265636|NCT03065023|322765783|FG003|Overall Study|Progressive Disease|0|||
94265637|NCT03065023|322765784|FG004|Overall Study|Progressive Disease|0|||
94366361|NCT01393626|323126512|FG000|Overall Study|Other|1|||
94366362|NCT01393626|323126513|FG001|Overall Study|Other|0|||
94366363|NCT01393626|323126514|FG002|Overall Study|Other|0|||
94366364|NCT01393626|323126515|FG003|Overall Study|Other|0|||
94265638|NCT03065023|322765780|FG000|Overall Study|Death|2|||
94265639|NCT03065023|322765781|FG001|Overall Study|Death|0|||
94265640|NCT03065023|322765782|FG002|Overall Study|Death|1|||
94366365|NCT01393626|323126512|FG000|Overall Study|Protocol Violation|1|||
94366366|NCT01393626|323126513|FG001|Overall Study|Protocol Violation|0|||
94466119|NCT00869557|323496939|FG001|Extension Phase|Withdrew Consent|0|||
94698153|NCT02028884|324351107|FG002|Double-blind Period|Adverse Event|0|||
94698154|NCT02028884|324351105|FG000|Double-blind Period|Eligibility Violation|1|||
94366367|NCT01393626|323126514|FG002|Overall Study|Protocol Violation|2|||
94265641|NCT03065023|322765783|FG003|Overall Study|Death|1|||
94698155|NCT02028884|324351106|FG001|Double-blind Period|Eligibility Violation|0|||
94265642|NCT03065023|322765784|FG004|Overall Study|Death|0|||
94366368|NCT01393626|323126515|FG003|Overall Study|Protocol Violation|0|||
94698156|NCT02028884|324351107|FG002|Double-blind Period|Eligibility Violation|0|||
94698157|NCT02028884|324351105|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
94698158|NCT02028884|324351106|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
94698159|NCT02028884|324351107|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
94698160|NCT02028884|324351105|FG000|Double-blind Period|Withdrawal by Subject|2|||
94698161|NCT02028884|324351106|FG001|Double-blind Period|Withdrawal by Subject|0|||
94698162|NCT02028884|324351107|FG002|Double-blind Period|Withdrawal by Subject|0|||
94698163|NCT02028884|324351105|FG000|Open-label Extension Period|Adverse Event|3|||
94698164|NCT02028884|324351106|FG001|Open-label Extension Period|Adverse Event|1|||
94698165|NCT02028884|324351107|FG002|Open-label Extension Period|Adverse Event|0|||
94698166|NCT02028884|324351105|FG000|Open-label Extension Period|Lack of Efficacy|3|||
94698167|NCT02028884|324351106|FG001|Open-label Extension Period|Lack of Efficacy|0|||
94698168|NCT02028884|324351107|FG002|Open-label Extension Period|Lack of Efficacy|0|||
94698169|NCT02028884|324351105|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
94698170|NCT02028884|324351106|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
94698171|NCT02028884|324351107|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
94698172|NCT02028884|324351105|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
94698173|NCT02028884|324351106|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
94698174|NCT02028884|324351107|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
94698175|NCT02028884|324351105|FG000|Open-label Extension Period|Switched to another treatment option|3|||
94698176|NCT02028884|324351106|FG001|Open-label Extension Period|Switched to another treatment option|0|||
94698177|NCT02028884|324351107|FG002|Open-label Extension Period|Switched to another treatment option|0|||
94698178|NCT02256969|324351108|FG000|Overall Study|Screenfailed or withdrew|2|||
94698179|NCT02256969|324351109|FG001|Overall Study|Screenfailed or withdrew|1|||
94698180|NCT02256969|324351110|FG002|Overall Study|Screenfailed or withdrew|1|||
94698181|NCT00691028|324351114|FG000|Open-label Period|Adverse Event|0|||
94698182|NCT00691028|324351115|FG001|Open-label Period|Adverse Event|0|||
94698183|NCT00691028|324351116|FG002|Open-label Period|Adverse Event|0|||
94698184|NCT00691028|324351117|FG003|Open-label Period|Adverse Event|16|||
94698185|NCT00691028|324351114|FG000|Open-label Period|Withdrawal by Subject|0|||
94698186|NCT00691028|324351115|FG001|Open-label Period|Withdrawal by Subject|0|||
94698187|NCT00691028|324351116|FG002|Open-label Period|Withdrawal by Subject|0|||
94698188|NCT00691028|324351117|FG003|Open-label Period|Withdrawal by Subject|3|||
94698189|NCT00691028|324351114|FG000|Open-label Period|not come to a hospital|0|||
94698190|NCT00691028|324351115|FG001|Open-label Period|not come to a hospital|0|||
94698191|NCT00691028|324351116|FG002|Open-label Period|not come to a hospital|0|||
94698192|NCT00691028|324351117|FG003|Open-label Period|not come to a hospital|1|||
94698193|NCT00691028|324351114|FG000|Double-blind Period|Adverse Event|8|||
94698194|NCT00691028|324351115|FG001|Double-blind Period|Adverse Event|9|||
94698195|NCT00691028|324351116|FG002|Double-blind Period|Adverse Event|6|||
94698196|NCT00691028|324351117|FG003|Double-blind Period|Adverse Event|0|||
94698197|NCT00691028|324351114|FG000|Double-blind Period|Lack of Efficacy|4|||
94698198|NCT00691028|324351115|FG001|Double-blind Period|Lack of Efficacy|3|||
94698199|NCT00691028|324351116|FG002|Double-blind Period|Lack of Efficacy|2|||
94698200|NCT00691028|324351117|FG003|Double-blind Period|Lack of Efficacy|0|||
94698201|NCT00691028|324351114|FG000|Double-blind Period|Withdrawal by Subject|1|||
94698202|NCT00691028|324351115|FG001|Double-blind Period|Withdrawal by Subject|0|||
94698203|NCT00691028|324351116|FG002|Double-blind Period|Withdrawal by Subject|1|||
94698204|NCT00691028|324351117|FG003|Double-blind Period|Withdrawal by Subject|0|||
94698205|NCT00691028|324351114|FG000|Double-blind Period|not come to a hospital.|0|||
94698206|NCT00691028|324351115|FG001|Double-blind Period|not come to a hospital.|1|||
94698207|NCT00691028|324351116|FG002|Double-blind Period|not come to a hospital.|0|||
94698208|NCT00691028|324351117|FG003|Double-blind Period|not come to a hospital.|0|||
94698209|NCT03566680|324351130|FG000|Overall Study|Pregnancy|1|||
94698210|NCT03566680|324351130|FG000|Overall Study|Lost to Follow-up|13|||
94698211|NCT03566680|324351130|FG000|Overall Study|Withdrawal by Subject|3|||
94698212|NCT01427907|324351134|FG000|Overall Study|Withdrawal by Subject|3|||
94698213|NCT01427907|324351135|FG001|Overall Study|Withdrawal by Subject|4|||
94698214|NCT00582790|324351138|FG000|Overall Study|Rapid progression of disease|1|||
94698215|NCT00480441|324351140|FG000|Screening|Not Eligible|37|||
94698216|NCT00480441|324351141|FG001|Screening|Not Eligible|0|||
94698217|NCT00480441|324351142|FG002|Screening|Not Eligible|0|||
94698218|NCT00480441|324351140|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
94698219|NCT00480441|324351141|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
94698220|NCT00480441|324351142|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
94698221|NCT00480441|324351140|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
94698222|NCT00480441|324351141|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
94698223|NCT00480441|324351142|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
94698224|NCT00480441|324351140|FG000|Baseline Functional MRI|physical contraindication|4|||
94698225|NCT00480441|324351141|FG001|Baseline Functional MRI|physical contraindication|0|||
94698226|NCT00480441|324351142|FG002|Baseline Functional MRI|physical contraindication|0|||
94265643|NCT03065023|322765780|FG000|Overall Study|Lost to Follow-up|0|||
94265644|NCT03065023|322765781|FG001|Overall Study|Lost to Follow-up|1|||
94265645|NCT03065023|322765782|FG002|Overall Study|Lost to Follow-up|0|||
94265646|NCT03065023|322765783|FG003|Overall Study|Lost to Follow-up|0|||
94265647|NCT03065023|322765784|FG004|Overall Study|Lost to Follow-up|0|||
94265648|NCT03065023|322765780|FG000|Overall Study|Participant Decision|0|||
94265649|NCT03065023|322765781|FG001|Overall Study|Participant Decision|0|||
94265650|NCT03065023|322765782|FG002|Overall Study|Participant Decision|0|||
94265651|NCT03065023|322765783|FG003|Overall Study|Participant Decision|1|||
94265652|NCT03065023|322765784|FG004|Overall Study|Participant Decision|0|||
94265653|NCT03065023|322765780|FG000|Overall Study|Withdrawal by Subject|0|||
94265654|NCT03065023|322765781|FG001|Overall Study|Withdrawal by Subject|0|||
94265655|NCT03065023|322765782|FG002|Overall Study|Withdrawal by Subject|0|||
94265656|NCT03065023|322765783|FG003|Overall Study|Withdrawal by Subject|1|||
94265657|NCT03065023|322765784|FG004|Overall Study|Withdrawal by Subject|0|||
94265658|NCT00705432|322765785|FG000|Treatment Period|Adverse Event|45|||
94265659|NCT00705432|322765786|FG001|Treatment Period|Adverse Event|37|||
94698227|NCT00480441|324351140|FG000|Randomization|Lost to Follow-up|0|||
94698228|NCT00480441|324351141|FG001|Randomization|Lost to Follow-up|7|||
94698229|NCT00480441|324351142|FG002|Randomization|Lost to Follow-up|2|||
94698230|NCT00748969|324351143|FG000|Overall Study|Withdrawal by Subject|1|||
94698231|NCT00748969|324351144|FG001|Overall Study|Withdrawal by Subject|0|||
94698232|NCT00748969|324351143|FG000|Overall Study|Withdrawal by Subject|0|||
94698233|NCT00748969|324351144|FG001|Overall Study|Withdrawal by Subject|1|||
94698234|NCT02334306|324351145|FG000|Double-blind Period|Adverse Event|0|||
94698235|NCT02334306|324351146|FG001|Double-blind Period|Adverse Event|1|||
94698236|NCT02334306|324351145|FG000|Double-blind Period|Withdrawal by Subject|1|||
94698237|NCT02334306|324351146|FG001|Double-blind Period|Withdrawal by Subject|1|||
94698238|NCT01360840|324351151|FG000|Overall Study|Ongoing at data cut-off|10|||
94698239|NCT01360840|324351152|FG001|Overall Study|Ongoing at data cut-off|10|||
94698240|NCT01360840|324351153|FG002|Overall Study|Ongoing at data cut-off|9|||
94698241|NCT04337489|324351154|FG000|Overall Study|Withdrawal by Subject|1|||
94698242|NCT00293462|324351155|FG000|Overall Study|Withdrawal by Subject|4|||
94698243|NCT00293462|324351156|FG001|Overall Study|Withdrawal by Subject|3|||
94698244|NCT00293462|324351157|FG002|Overall Study|Withdrawal by Subject|8|||
94698245|NCT00293462|324351155|FG000|Overall Study|Death|1|||
94698246|NCT00293462|324351156|FG001|Overall Study|Death|0|||
94698247|NCT00293462|324351157|FG002|Overall Study|Death|0|||
94698248|NCT00293462|324351155|FG000|Overall Study|Lost to Follow-up|0|||
94698249|NCT00293462|324351156|FG001|Overall Study|Lost to Follow-up|1|||
94698250|NCT00293462|324351157|FG002|Overall Study|Lost to Follow-up|0|||
94698251|NCT00293462|324351155|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
94698252|NCT00293462|324351156|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
94698253|NCT00293462|324351157|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
94698254|NCT00293462|324351155|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
94698255|NCT00293462|324351156|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
94698256|NCT00293462|324351157|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
94698257|NCT00293462|324351155|FG000|Overall Study|Refuse Radiation Treatment|1|||
94698258|NCT00293462|324351156|FG001|Overall Study|Refuse Radiation Treatment|0|||
94698259|NCT00293462|324351157|FG002|Overall Study|Refuse Radiation Treatment|0|||
94698260|NCT00293462|324351155|FG000|Overall Study|No Show|0|||
94698261|NCT00293462|324351156|FG001|Overall Study|No Show|0|||
94698262|NCT00293462|324351157|FG002|Overall Study|No Show|1|||
94698263|NCT00293462|324351155|FG000|Overall Study|Went back to his home country|0|||
94698264|NCT00293462|324351156|FG001|Overall Study|Went back to his home country|0|||
94698265|NCT00293462|324351157|FG002|Overall Study|Went back to his home country|1|||
94698266|NCT00293462|324351155|FG000|Overall Study|Blood clot after chemotherapy|0|||
94698267|NCT00293462|324351156|FG001|Overall Study|Blood clot after chemotherapy|0|||
94698268|NCT00293462|324351157|FG002|Overall Study|Blood clot after chemotherapy|1|||
94698269|NCT00293462|324351155|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
94698270|NCT00293462|324351156|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
94698271|NCT00293462|324351157|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
94698272|NCT00293462|324351155|FG000|Overall Study|Possible Tracheostomy leakage|0|||
94698273|NCT00293462|324351156|FG001|Overall Study|Possible Tracheostomy leakage|1|||
94698274|NCT00293462|324351157|FG002|Overall Study|Possible Tracheostomy leakage|0|||
94698275|NCT00293462|324351155|FG000|Overall Study|Low radiation dose in oral cavity|0|||
94698276|NCT00293462|324351156|FG001|Overall Study|Low radiation dose in oral cavity|1|||
94698277|NCT00293462|324351157|FG002|Overall Study|Low radiation dose in oral cavity|0|||
94265660|NCT00705432|322765787|FG002|Treatment Period|Adverse Event|51|||
94265661|NCT00705432|322765788|FG003|Treatment Period|Adverse Event|12|||
94265662|NCT00705432|322765789|FG004|Treatment Period|Adverse Event|8|||
94265663|NCT00705432|322765790|FG005|Treatment Period|Adverse Event|9|||
94698278|NCT00293462|324351155|FG000|Overall Study|Physician Decision|0|||
94698279|NCT00293462|324351156|FG001|Overall Study|Physician Decision|1|||
94698280|NCT00293462|324351157|FG002|Overall Study|Physician Decision|0|||
94698281|NCT03255941|324351158|FG000|Overall Study|Not eligible or refused injection|37|||
94698282|NCT03255941|324351159|FG001|Overall Study|Not eligible or refused injection|44|||
94698283|NCT03255941|324351160|FG002|Overall Study|Not eligible or refused injection|5|||
94698284|NCT03255941|324351161|FG003|Overall Study|Not eligible or refused injection|6|||
94698285|NCT03255941|324351158|FG000|Overall Study|Did not complete exit interview|1|||
94698286|NCT03255941|324351159|FG001|Overall Study|Did not complete exit interview|2|||
94698287|NCT03255941|324351160|FG002|Overall Study|Did not complete exit interview|0|||
94698288|NCT03255941|324351161|FG003|Overall Study|Did not complete exit interview|0|||
94698289|NCT00372060|324351162|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
94698290|NCT00372060|324351163|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
94698291|NCT00372060|324351162|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
94698292|NCT00372060|324351163|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
94698293|NCT00372060|324351162|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
94698294|NCT00372060|324351163|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
94698295|NCT00372060|324351162|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
94698296|NCT00372060|324351163|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
94698297|NCT00372060|324351162|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
94698298|NCT00372060|324351163|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
94698299|NCT00372060|324351162|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
94698300|NCT00372060|324351163|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
94698301|NCT00335153|324351175|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
94698302|NCT00335153|324351175|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
94698303|NCT00335153|324351175|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
94698304|NCT00335153|324351175|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
94698305|NCT00335153|324351175|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
94698306|NCT00335153|324351175|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
94698307|NCT00335153|324351175|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
94698308|NCT00335153|324351175|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
94698309|NCT00335153|324351175|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
94698310|NCT00335153|324351175|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
94698311|NCT01004263|324351178|FG000|Overall Study|Adverse Event|15|||
94698312|NCT01004263|324351178|FG000|Overall Study|Withdrawal by Subject|58|||
94698313|NCT01004263|324351178|FG000|Overall Study|Protocol Violation|10|||
94698314|NCT01004263|324351178|FG000|Overall Study|Lost to Follow-up|64|||
94698315|NCT01004263|324351178|FG000|Overall Study|Lack of Efficacy|13|||
94698316|NCT01004263|324351178|FG000|Overall Study|Pregnancy|2|||
94698317|NCT01004263|324351178|FG000|Overall Study|Physician Decision|15|||
94698318|NCT01004263|324351178|FG000|Overall Study|Lack of Qualifying Event|2|||
94698319|NCT01528709|324351179|FG000|Overall Study|Death|2|||
94698320|NCT01528709|324351180|FG001|Overall Study|Death|0|||
94698321|NCT01528709|324351179|FG000|Overall Study|Withdrawal by Subject|10|||
94698322|NCT01528709|324351180|FG001|Overall Study|Withdrawal by Subject|15|||
94698323|NCT01528709|324351179|FG000|Overall Study|allergy|1|||
94698324|NCT01528709|324351180|FG001|Overall Study|allergy|0|||
94698325|NCT02240680|324351184|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
94698326|NCT02240680|324351185|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
94698327|NCT02240680|324351186|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
94698328|NCT02240680|324351187|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
94698329|NCT02240680|324351184|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
94698330|NCT02240680|324351185|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
94698331|NCT02240680|324351186|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
94698332|NCT02240680|324351187|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
94698333|NCT02240680|324351184|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
94698334|NCT02240680|324351185|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
94698335|NCT02240680|324351186|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
94698336|NCT02240680|324351187|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
94698337|NCT02240680|324351184|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
94698338|NCT02240680|324351185|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
94698339|NCT02240680|324351186|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
94366369|NCT02858076|323126516|FG000|Overall Study|Death|6|||
94698340|NCT02240680|324351187|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
94698341|NCT02240680|324351184|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
94698342|NCT02240680|324351185|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
94698343|NCT02240680|324351186|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
94698344|NCT02240680|324351187|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
94698345|NCT02240680|324351184|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
94698346|NCT02240680|324351185|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
94698347|NCT02240680|324351186|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
94698348|NCT02240680|324351187|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
94698349|NCT02240680|324351184|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
94698350|NCT02240680|324351185|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
94698351|NCT02240680|324351186|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
94466120|NCT02949908|323496940|FG000|Overall Study|Study termination|2|||
94466121|NCT01472939|323496941|FG000|Overall Study|Adverse Event|3|||
94698352|NCT02240680|324351187|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
94698353|NCT02240680|324351184|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
94698354|NCT02240680|324351185|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
94698355|NCT02240680|324351186|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
94698356|NCT02240680|324351187|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
94698357|NCT02162732|324351188|FG000|Overall Study|Biopsy not performed.|18|||
94698358|NCT01605136|324351192|FG000|Study Period|Withdrawal by Subject|2|||
94698359|NCT01605136|324351193|FG001|Study Period|Withdrawal by Subject|0|||
94698360|NCT01605136|324351192|FG000|Study Period|Physician Decision|1|||
94698361|NCT01605136|324351193|FG001|Study Period|Physician Decision|1|||
94698362|NCT01605136|324351192|FG000|Study Period|Lost to Follow-up|0|||
94698363|NCT01605136|324351193|FG001|Study Period|Lost to Follow-up|2|||
94698364|NCT01605136|324351192|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
94698365|NCT01605136|324351193|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
94698366|NCT01008748|324351196|FG000|Overall Study|Lost to Follow-up|80|||
94698367|NCT01008748|324351196|FG000|Overall Study|Other|1|||
94698368|NCT04824131|324351198|FG000|CAB LA Oral Phase|Adverse Event|1|||
94698369|NCT04824131|324351198|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
94698370|NCT04824131|324351198|FG000|Step 3|Withdrawal by Subject|2|||
94698371|NCT04887285|324351199|FG000|Overall Study|Lost to Follow-up|0|||
94698372|NCT04887285|324351200|FG001|Overall Study|Lost to Follow-up|2|||
94698373|NCT04887285|324351201|FG002|Overall Study|Lost to Follow-up|3|||
94698374|NCT02820051|324351205|FG000|Overall Study|Lost to Follow-up|7|||
94698375|NCT02820051|324351206|FG001|Overall Study|Lost to Follow-up|4|||
94698376|NCT04863898|324351210|FG000|Overall Study|Away from study clinic during intervention training period|2|||
94698377|NCT04863898|324351210|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
94698378|NCT04863898|324351210|FG000|Overall Study|Lost to Follow-up|3|||
94698379|NCT04863898|324351210|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
94698380|NCT04863898|324351210|FG000|Overall Study|No longer employed at clinic|3|||
94698381|NCT03424239|324351211|FG000|Overall Study|Withdrawal by Subject|2|||
94698382|NCT00770211|324351212|FG000|Overall Study|Lost to Follow-up|1|||
94698383|NCT00770211|324351213|FG001|Overall Study|Lost to Follow-up|0|||
94698384|NCT00770211|324351212|FG000|Overall Study|Withdrawal by Subject|0|||
94698385|NCT00770211|324351213|FG001|Overall Study|Withdrawal by Subject|2|||
94698386|NCT02042443|324351215|FG000|Overall Study|Adverse Event|2|||
94698387|NCT02042443|324351216|FG001|Overall Study|Adverse Event|1|||
94698388|NCT02042443|324351215|FG000|Overall Study|Withdrawal by Subject|0|||
94466122|NCT01472939|323496942|FG001|Overall Study|Adverse Event|7|||
94698389|NCT02042443|324351216|FG001|Overall Study|Withdrawal by Subject|1|||
94698390|NCT02042443|324351215|FG000|Overall Study|Progression|21|||
94698391|NCT02042443|324351216|FG001|Overall Study|Progression|17|||
94698392|NCT02042443|324351215|FG000|Overall Study|not protocol specified|1|||
94698393|NCT02042443|324351216|FG001|Overall Study|not protocol specified|1|||
94698394|NCT02042443|324351215|FG000|Overall Study|Not eligible/not analyzable|3|||
94698395|NCT02042443|324351216|FG001|Overall Study|Not eligible/not analyzable|6|||
94698396|NCT01649427|324351217|FG000|Overall Study|Adverse Event|1|||
94698397|NCT01649427|324351218|FG001|Overall Study|Adverse Event|1|||
94698398|NCT01649427|324351217|FG000|Overall Study|Withdrawal by Subject|8|||
94698399|NCT01649427|324351218|FG001|Overall Study|Withdrawal by Subject|7|||
94698400|NCT01649427|324351217|FG000|Overall Study|Lost to Follow-up|0|||
94698401|NCT01649427|324351218|FG001|Overall Study|Lost to Follow-up|1|||
94698402|NCT01649427|324351217|FG000|Overall Study|Graft loss|0|||
94698403|NCT01649427|324351218|FG001|Overall Study|Graft loss|1|||
94698404|NCT01649427|324351217|FG000|Overall Study|Surgical problems during nephrectomy|2|||
94698405|NCT01649427|324351218|FG001|Overall Study|Surgical problems during nephrectomy|2|||
94698406|NCT02320253|324351222|FG000|Overall Study|Withdrawal by Subject|3|||
94698407|NCT02320253|324351223|FG001|Overall Study|Withdrawal by Subject|0|||
94698408|NCT02320253|324351224|FG002|Overall Study|Withdrawal by Subject|0|||
94698409|NCT02320253|324351222|FG000|Overall Study|Lost to Follow-up|2|||
94698410|NCT02320253|324351223|FG001|Overall Study|Lost to Follow-up|2|||
94698411|NCT02320253|324351224|FG002|Overall Study|Lost to Follow-up|1|||
94698412|NCT02320253|324351222|FG000|Overall Study|Death|1|||
94698413|NCT02320253|324351223|FG001|Overall Study|Death|0|||
94698414|NCT02320253|324351224|FG002|Overall Study|Death|1|||
94698415|NCT05750745|324351225|FG000|Overall Study|Adverse Event|1|||
94698416|NCT05750745|324351226|FG001|Overall Study|Adverse Event|0|||
94698417|NCT05750745|324351227|FG002|Overall Study|Adverse Event|0|||
94698418|NCT05750745|324351225|FG000|Overall Study|Protocol Violation|1|||
94698419|NCT05750745|324351226|FG001|Overall Study|Protocol Violation|0|||
94698420|NCT05750745|324351227|FG002|Overall Study|Protocol Violation|0|||
94698421|NCT05750745|324351225|FG000|Overall Study|Withdrawal by Subject|0|||
94698422|NCT05750745|324351226|FG001|Overall Study|Withdrawal by Subject|1|||
94698423|NCT05750745|324351227|FG002|Overall Study|Withdrawal by Subject|0|||
94698424|NCT04794179|324351228|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
94698425|NCT04794179|324351229|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
94698426|NCT04739423|324351232|FG000|Overall Study|Protocol Violation|0|||
94698427|NCT04739423|324351233|FG001|Overall Study|Protocol Violation|1|||
94698428|NCT04739423|324351234|FG002|Overall Study|Protocol Violation|0|||
94698429|NCT04739423|324351235|FG003|Overall Study|Protocol Violation|0|||
94698430|NCT04739423|324351236|FG004|Overall Study|Protocol Violation|0|||
94698431|NCT04739423|324351237|FG005|Overall Study|Protocol Violation|0|||
94698432|NCT04739423|324351232|FG000|Overall Study|Adverse Event|0|||
94698433|NCT04739423|324351233|FG001|Overall Study|Adverse Event|0|||
94698434|NCT04739423|324351234|FG002|Overall Study|Adverse Event|1|||
94698435|NCT04739423|324351235|FG003|Overall Study|Adverse Event|0|||
94698436|NCT04739423|324351236|FG004|Overall Study|Adverse Event|1|||
94698437|NCT04739423|324351237|FG005|Overall Study|Adverse Event|0|||
94698438|NCT04739423|324351232|FG000|Overall Study|Withdrawal by Subject|0|||
94698439|NCT04739423|324351233|FG001|Overall Study|Withdrawal by Subject|0|||
94698440|NCT04739423|324351234|FG002|Overall Study|Withdrawal by Subject|0|||
94698441|NCT04739423|324351235|FG003|Overall Study|Withdrawal by Subject|0|||
94698442|NCT04739423|324351236|FG004|Overall Study|Withdrawal by Subject|0|||
94698443|NCT04739423|324351237|FG005|Overall Study|Withdrawal by Subject|1|||
94698444|NCT03717194|324351241|FG000|Overall Study|Withdrawal by Subject|2|||
94698445|NCT03717194|324351242|FG001|Overall Study|Withdrawal by Subject|4|||
94698446|NCT03717194|324351241|FG000|Overall Study|Adverse Event|1|||
94698447|NCT03717194|324351242|FG001|Overall Study|Adverse Event|1|||
94698448|NCT01734811|324351243|FG000|Overall Study|Lost to Follow-up|2|||
94698449|NCT01734811|324351244|FG001|Overall Study|Lost to Follow-up|3|||
94698450|NCT01734811|324351243|FG000|Overall Study|Withdrawal by Subject|2|||
94698451|NCT01734811|324351244|FG001|Overall Study|Withdrawal by Subject|0|||
94698452|NCT01290094|324351247|FG000|Overall Study|Withdrawal by Subject|1|||
94698453|NCT01290094|324351247|FG000|Overall Study|Lost to Follow-up|5|||
94698454|NCT00445692|324351248|FG000|Overall Study|Adverse Event|11|||
94698455|NCT00445692|324351248|FG000|Overall Study|Lack of Efficacy|5|||
94698456|NCT04949399|324351253|FG000|Overall Study|Lost to Follow-up|11|||
94698457|NCT04949399|324351254|FG001|Overall Study|Lost to Follow-up|6|||
94698458|NCT04949399|324351253|FG000|Overall Study|Withdrawal by Subject|2|||
94698459|NCT04949399|324351254|FG001|Overall Study|Withdrawal by Subject|3|||
94698460|NCT00670540|324351255|FG000|Overall Study|ineligible|17|||
94698461|NCT00670540|324351255|FG000|Overall Study|not living in France|348|||
94698462|NCT00670540|324351255|FG000|Overall Study|refused to participate|189|||
94698463|NCT00670540|324351255|FG000|Overall Study|controls randomised for no follow up|2770|||
94698464|NCT00670540|324351255|FG000|Overall Study|missing information inclusion criteria|1|||
94698465|NCT04159506|324351256|FG000|Overall Study|Lost to Follow-up|2|||
94698466|NCT04159506|324351257|FG001|Overall Study|Lost to Follow-up|5|||
94698467|NCT03201757|324352304|FG000|Overall Study|Withdrawal by Subject|133|||
94698468|NCT03201757|324352304|FG000|Overall Study|Adverse Event|44|||
94698469|NCT03201757|324352304|FG000|Overall Study|Lost to Follow-up|37|||
94698470|NCT03201757|324352304|FG000|Overall Study|Pregnancy|2|||
94698471|NCT03201757|324352304|FG000|Overall Study|Lack of Efficacy|1|||
94698472|NCT03201757|324352304|FG000|Overall Study|Protocol Violation|20|||
94698473|NCT03201757|324352304|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
94698474|NCT03201757|324352304|FG000|Overall Study|Not Yet Determined|5|||
94698475|NCT03201757|324352304|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
94698476|NCT03201757|324352304|FG000|Overall Study|Other|20|||
94698477|NCT01323660|324352310|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
94698478|NCT01323660|324352311|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
94698479|NCT01323660|324352312|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
94698480|NCT01323660|324352313|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
94698481|NCT01323660|324352314|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
94698482|NCT01323660|324352315|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
94698483|NCT01323660|324352310|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
94698484|NCT01323660|324352311|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
94698485|NCT01323660|324352312|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
94698486|NCT01323660|324352313|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
94698487|NCT01323660|324352314|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
94698488|NCT01323660|324352315|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
94698489|NCT01323660|324352310|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
94698490|NCT01323660|324352311|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
94698491|NCT01323660|324352312|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
94698492|NCT01323660|324352313|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
94698493|NCT01323660|324352314|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
94698494|NCT01323660|324352315|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
94698495|NCT01323660|324352310|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
94698496|NCT01323660|324352311|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
94698497|NCT01323660|324352312|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
94698498|NCT01323660|324352313|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
94698499|NCT01323660|324352314|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
94698500|NCT01323660|324352315|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
94698501|NCT01323660|324352310|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
94698502|NCT01323660|324352311|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
94698503|NCT01323660|324352312|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
94698504|NCT01323660|324352313|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
94698505|NCT01323660|324352314|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
94698506|NCT01323660|324352315|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
94698507|NCT01323660|324352310|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
94698508|NCT01323660|324352311|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
94698509|NCT01323660|324352312|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
94698510|NCT01323660|324352313|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
94698511|NCT01323660|324352314|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
94698512|NCT01323660|324352315|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
94698513|NCT01323660|324352310|FG000|Washout Period (14 Days)|Adverse Event|0|||
94698514|NCT01323660|324352311|FG001|Washout Period (14 Days)|Adverse Event|0|||
94698515|NCT01323660|324352312|FG002|Washout Period (14 Days)|Adverse Event|0|||
94698516|NCT01323660|324352313|FG003|Washout Period (14 Days)|Adverse Event|0|||
94698517|NCT01323660|324352314|FG004|Washout Period (14 Days)|Adverse Event|1|||
94698518|NCT01323660|324352315|FG005|Washout Period (14 Days)|Adverse Event|0|||
94698519|NCT01323660|324352310|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
94698520|NCT01323660|324352311|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
94698521|NCT01323660|324352312|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
94698522|NCT01323660|324352313|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
94698523|NCT01323660|324352314|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
94698524|NCT01323660|324352315|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
94698525|NCT01323660|324352310|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
94698526|NCT01323660|324352311|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
94698527|NCT01323660|324352312|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
94698528|NCT01323660|324352313|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
94698529|NCT01323660|324352314|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
94698530|NCT01323660|324352315|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
94698531|NCT01323660|324352310|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
94698532|NCT01323660|324352311|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
94698533|NCT01323660|324352312|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
94698534|NCT01323660|324352313|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
94698535|NCT01323660|324352314|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
94698536|NCT01323660|324352315|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
94698537|NCT01323660|324352310|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
94698538|NCT01323660|324352311|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
94698539|NCT01323660|324352312|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
94698540|NCT01323660|324352313|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
94698541|NCT01323660|324352314|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
94698542|NCT01323660|324352315|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
94698543|NCT01323660|324352310|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
94698544|NCT01323660|324352311|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
94698545|NCT01323660|324352312|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
94698546|NCT01323660|324352313|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
94698547|NCT01323660|324352314|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
94698548|NCT01323660|324352315|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
94698549|NCT01323660|324352310|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
94698550|NCT01323660|324352311|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
94698551|NCT01323660|324352312|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
94698552|NCT01323660|324352313|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
94698553|NCT01323660|324352314|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
94698554|NCT01323660|324352315|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
94698555|NCT00751790|324352322|FG000|Overall Study|Lost to Follow-up|1|||
94698556|NCT00751790|324352322|FG000|Overall Study|Death|3|||
94698557|NCT00751790|324352322|FG000|Overall Study|Withdrawal by Subject|1|||
94698558|NCT04541186|324352325|FG000|Main Study|Adverse Event|0|||
94698559|NCT04541186|324352326|FG001|Main Study|Adverse Event|0|||
94698560|NCT04541186|324352327|FG002|Main Study|Adverse Event|4|||
94698561|NCT04541186|324352328|FG003|Main Study|Adverse Event|0|||
94698562|NCT04541186|324352329|FG004|Main Study|Adverse Event|0|||
94698563|NCT04541186|324352325|FG000|Main Study|Investigator Decision|0|||
94698564|NCT04541186|324352326|FG001|Main Study|Investigator Decision|0|||
94698565|NCT04541186|324352327|FG002|Main Study|Investigator Decision|1|||
94698566|NCT04541186|324352328|FG003|Main Study|Investigator Decision|1|||
94698567|NCT04541186|324352329|FG004|Main Study|Investigator Decision|0|||
94698568|NCT04541186|324352325|FG000|Main Study|Withdrawal by Subject|1|||
94698569|NCT04541186|324352326|FG001|Main Study|Withdrawal by Subject|1|||
94698570|NCT04541186|324352327|FG002|Main Study|Withdrawal by Subject|0|||
94698571|NCT04541186|324352328|FG003|Main Study|Withdrawal by Subject|0|||
94698572|NCT04541186|324352329|FG004|Main Study|Withdrawal by Subject|0|||
94698573|NCT04541186|324352325|FG000|Main Study|COVID-19-related Dose Interruption|0|||
94698574|NCT04541186|324352326|FG001|Main Study|COVID-19-related Dose Interruption|0|||
94698575|NCT04541186|324352327|FG002|Main Study|COVID-19-related Dose Interruption|0|||
94698576|NCT04541186|324352328|FG003|Main Study|COVID-19-related Dose Interruption|0|||
94698577|NCT04541186|324352329|FG004|Main Study|COVID-19-related Dose Interruption|1|||
94698578|NCT04541186|324352325|FG000|Main Study|Randomized in Error Not Treated|0|||
94698579|NCT04541186|324352326|FG001|Main Study|Randomized in Error Not Treated|0|||
94265664|NCT00705432|322765785|FG000|Treatment Period|Treatment failure|92|||
94265665|NCT00705432|322765786|FG001|Treatment Period|Treatment failure|42|||
94698580|NCT04541186|324352327|FG002|Main Study|Randomized in Error Not Treated|1|||
94698581|NCT04541186|324352328|FG003|Main Study|Randomized in Error Not Treated|0|||
94698582|NCT04541186|324352329|FG004|Main Study|Randomized in Error Not Treated|0|||
94698583|NCT04541186|324352325|FG000|Fibrate Expansion Study|Other than Specified|0|||
94698584|NCT04541186|324352326|FG001|Fibrate Expansion Study|Other than Specified|0|||
94698585|NCT04541186|324352327|FG002|Fibrate Expansion Study|Other than Specified|0|||
94698586|NCT04541186|324352328|FG003|Fibrate Expansion Study|Other than Specified|0|||
94698587|NCT04541186|324352329|FG004|Fibrate Expansion Study|Other than Specified|1|||
94698588|NCT02374957|324352333|FG000|Overall Study|Patient did not complete forms correctly|1|||
94698589|NCT02374957|324352334|FG001|Overall Study|Patient did not complete forms correctly|0|||
94698590|NCT02390557|324352335|FG000|Wave 2|Survey non-respondent|72|||
94698591|NCT02390557|324352336|FG001|Wave 2|Survey non-respondent|41|||
94698592|NCT02390557|324352337|FG002|Wave 2|Survey non-respondent|23|||
94698593|NCT05349084|324352341|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
94698594|NCT02950545|324352344|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
94698595|NCT02950545|324352345|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
94698596|NCT02950545|324352346|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
94698597|NCT02950545|324352347|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
94698598|NCT02950545|324352348|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
94698599|NCT02950545|324352349|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
94698600|NCT02950545|324352344|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
94698601|NCT02950545|324352345|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
94698602|NCT02950545|324352346|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
94698603|NCT02950545|324352347|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
94698604|NCT02950545|324352348|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
94698605|NCT02950545|324352349|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
94698606|NCT02950545|324352344|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
94698607|NCT02950545|324352345|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
94698608|NCT02950545|324352346|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
94698609|NCT02950545|324352347|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
94698610|NCT02950545|324352348|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
94698611|NCT02950545|324352349|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
94698612|NCT02950545|324352344|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
94698613|NCT02950545|324352345|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
94698614|NCT02950545|324352346|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
94698615|NCT02950545|324352347|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
94698616|NCT02950545|324352348|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
94698617|NCT02950545|324352349|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
94698618|NCT02950545|324352344|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
94698619|NCT02950545|324352345|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
94698620|NCT02950545|324352346|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
94698621|NCT02950545|324352347|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
94698622|NCT02950545|324352348|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
94698623|NCT02950545|324352349|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
94698624|NCT03101592|324352350|FG000|Overall Study|participant files could not be located|111|||
94698625|NCT03101592|324352351|FG001|Overall Study|participant files could not be located|170|||
94698626|NCT03101592|324352352|FG002|Overall Study|participant files could not be located|118|||
94698627|NCT03398356|324352355|FG000|Before Treatment|Lost to Follow-up|1|||
94698628|NCT03398356|324352356|FG001|Before Treatment|Lost to Follow-up|2|||
94698629|NCT03398356|324352357|FG002|Before Treatment|Lost to Follow-up|0|||
94698630|NCT03398356|324352355|FG000|Before Treatment|drug intolerance|2|||
94698631|NCT03398356|324352356|FG001|Before Treatment|drug intolerance|1|||
94698632|NCT03398356|324352357|FG002|Before Treatment|drug intolerance|0|||
94698633|NCT03398356|324352355|FG000|Before Treatment|Withdrawal by Subject|0|||
94698634|NCT03398356|324352356|FG001|Before Treatment|Withdrawal by Subject|5|||
94698635|NCT03398356|324352357|FG002|Before Treatment|Withdrawal by Subject|0|||
94698636|NCT03398356|324352355|FG000|Before Treatment|Physician Decision|0|||
94698637|NCT03398356|324352356|FG001|Before Treatment|Physician Decision|0|||
94698638|NCT03398356|324352357|FG002|Before Treatment|Physician Decision|11|||
94698639|NCT03398356|324352355|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
94698640|NCT03398356|324352356|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
94698641|NCT03398356|324352357|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
94698642|NCT02412761|324352359|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
94698643|NCT02412761|324352360|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
94698644|NCT02412761|324352361|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
94698645|NCT02412761|324352362|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
94698646|NCT02412761|324352363|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
94698647|NCT02412761|324352364|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
94698648|NCT00647348|324352371|FG000|Overall Study|Lost to Follow-up|3|||
94698649|NCT00647348|324352372|FG001|Overall Study|Lost to Follow-up|6|||
94698650|NCT01648283|324352373|FG000|Overall Study|Withdrawal by Subject|14|||
94698651|NCT01653743|324352374|FG000|Overall Study|Withdrawal by Subject|1|||
94698652|NCT01653743|324352375|FG001|Overall Study|Withdrawal by Subject|0|||
94698653|NCT01653743|324352374|FG000|Overall Study|Investigator discretion|3|||
94698654|NCT01653743|324352375|FG001|Overall Study|Investigator discretion|0|||
94698655|NCT02825043|324352377|FG000|Overall Study|Lost to Follow-up|4|||
94698656|NCT03704298|324352380|FG000|Overall Study|Death|3|||
94698657|NCT03704298|324352381|FG001|Overall Study|Death|1|||
94698658|NCT03704298|324352382|FG002|Overall Study|Death|1|||
94698659|NCT03704298|324352383|FG003|Overall Study|Death|0|||
94698660|NCT03704298|324352380|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
94698661|NCT03704298|324352381|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
94698662|NCT03704298|324352382|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
94698663|NCT03704298|324352383|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
94698664|NCT03704298|324352380|FG000|Overall Study|Withdrawal by Subject|1|||
94698665|NCT03704298|324352381|FG001|Overall Study|Withdrawal by Subject|0|||
94698666|NCT03704298|324352382|FG002|Overall Study|Withdrawal by Subject|0|||
94698667|NCT03704298|324352383|FG003|Overall Study|Withdrawal by Subject|0|||
94698668|NCT03704298|324352380|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
94698669|NCT03704298|324352381|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
94698670|NCT03704298|324352382|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
94698671|NCT03704298|324352383|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
94698672|NCT00558753|324352384|FG000|Overall Study|Lost to Follow-up|5|||
94698673|NCT00558753|324352385|FG001|Overall Study|Lost to Follow-up|7|||
94698674|NCT00821236|324352386|FG000|Overall Study|Lost to Follow-up|3|||
94698675|NCT01582243|324352388|FG000|Overall Study|Withdrawal by Subject|1|||
94698676|NCT01582243|324352388|FG000|Overall Study|Adverse Event|1|||
94698677|NCT01582243|324352388|FG000|Overall Study|Lost to Follow-up|1|||
94698678|NCT00282438|324352390|FG000|Overall Study|Lack of Efficacy|1|||
94698679|NCT00282438|324352391|FG001|Overall Study|Lack of Efficacy|0|||
94698680|NCT00282438|324352390|FG000|Overall Study|Death|0|||
94698681|NCT00282438|324352391|FG001|Overall Study|Death|1|||
94698682|NCT02929108|324352392|FG000|Overall Study|Hospice patient death|100|||
94698683|NCT02929108|324352393|FG001|Overall Study|Hospice patient death|64|||
94698684|NCT02929108|324352394|FG002|Overall Study|Hospice patient death|28|||
94698685|NCT02929108|324352395|FG003|Overall Study|Hospice patient death|46|||
94698686|NCT02929108|324352396|FG004|Overall Study|Hospice patient death|55|||
94698687|NCT02929108|324352397|FG005|Overall Study|Hospice patient death|28|||
94698688|NCT02929108|324352398|FG006|Overall Study|Hospice patient death|78|||
94698689|NCT00052962|324352399|FG000|Overall Study|Not evaluable|0|||
94698690|NCT00052962|324352400|FG001|Overall Study|Not evaluable|2|||
94698691|NCT00052962|324352399|FG000|Overall Study|Not randomized/not evaluable|1|||
94698692|NCT00052962|324352400|FG001|Overall Study|Not randomized/not evaluable|0|||
94698693|NCT05489224|324352405|FG000|Treatment Period I|Withdrawal by Subject|6|||
94698694|NCT05489224|324352406|FG001|Treatment Period I|Withdrawal by Subject|5|||
94698695|NCT05489224|324352407|FG002|Treatment Period I|Withdrawal by Subject|0|||
94698696|NCT05489224|324352405|FG000|Treatment Period I|Adverse Event|3|||
94698697|NCT05489224|324352406|FG001|Treatment Period I|Adverse Event|11|||
94698698|NCT05489224|324352407|FG002|Treatment Period I|Adverse Event|0|||
94698699|NCT05489224|324352405|FG000|Treatment Period I|Lost to Follow-up|0|||
94698700|NCT05489224|324352406|FG001|Treatment Period I|Lost to Follow-up|1|||
94698701|NCT05489224|324352407|FG002|Treatment Period I|Lost to Follow-up|0|||
94698702|NCT05489224|324352405|FG000|Treatment Period I|Physician Decision|0|||
94698703|NCT05489224|324352406|FG001|Treatment Period I|Physician Decision|1|||
94698704|NCT05489224|324352407|FG002|Treatment Period I|Physician Decision|0|||
94698705|NCT05489224|324352405|FG000|Treatment Period II up to Week 32|Ongoing|222|||
94698706|NCT05489224|324352406|FG001|Treatment Period II up to Week 32|Ongoing|107|||
94698707|NCT05489224|324352407|FG002|Treatment Period II up to Week 32|Ongoing|107|||
94366370|NCT02858076|323126517|FG001|Overall Study|Death|3|||
94366371|NCT02858076|323126516|FG000|Overall Study|Withdrawal by Subject|1|||
94366372|NCT02858076|323126517|FG001|Overall Study|Withdrawal by Subject|5|||
94698708|NCT05489224|324352405|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
94366373|NCT02858076|323126516|FG000|Overall Study|Lost to Follow-up|2|||
94366374|NCT02858076|323126517|FG001|Overall Study|Lost to Follow-up|7|||
94366375|NCT02858076|323126516|FG000|Overall Study|Completed Out of Window|1|||
94366376|NCT02858076|323126517|FG001|Overall Study|Completed Out of Window|3|||
94366377|NCT03506425|323126518|FG000|Overall Study|Adverse Event|1|||
94698709|NCT05489224|324352406|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
94698710|NCT05489224|324352407|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
94698711|NCT05489224|324352405|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
94698712|NCT05489224|324352406|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
94698713|NCT05489224|324352407|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
94698714|NCT00121199|324352409|FG000|Overall Study|Adverse Event|11|||
94698715|NCT00121199|324352409|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
94698716|NCT00121199|324352409|FG000|Overall Study|Progression/Relapse|1|||
94698717|NCT00121199|324352409|FG000|Overall Study|Death|3|||
94698718|NCT00121199|324352409|FG000|Overall Study|Other - Not Protocol Specified|3|||
94698719|NCT00121199|324352409|FG000|Overall Study|Ineligible|9|||
94698720|NCT01723774|324352410|FG000|Neoadjuvant|Ki67 > 10%|4|||
94698721|NCT01723774|324352411|FG001|Neoadjuvant|Ki67 > 10%|0|||
94698722|NCT01723774|324352412|FG002|Neoadjuvant|Ki67 > 10%|10|||
94698723|NCT01723774|324352413|FG003|Neoadjuvant|Ki67 > 10%|0|||
94698724|NCT01723774|324352410|FG000|Neoadjuvant|Withdrawal by Subject|3|||
94698725|NCT01723774|324352411|FG001|Neoadjuvant|Withdrawal by Subject|1|||
94698726|NCT01723774|324352412|FG002|Neoadjuvant|Withdrawal by Subject|0|||
94698727|NCT01723774|324352413|FG003|Neoadjuvant|Withdrawal by Subject|0|||
94366378|NCT03506425|323126519|FG001|Overall Study|Adverse Event|3|||
94366379|NCT03506425|323126520|FG002|Overall Study|Adverse Event|0|||
94366380|NCT03506425|323126518|FG000|Overall Study|Death|1|||
94366381|NCT03506425|323126519|FG001|Overall Study|Death|0|||
94366382|NCT03506425|323126520|FG002|Overall Study|Death|0|||
94366383|NCT03506425|323126518|FG000|Overall Study|Withdrawal by Subject|0|||
94366384|NCT03506425|323126519|FG001|Overall Study|Withdrawal by Subject|0|||
94366385|NCT03506425|323126520|FG002|Overall Study|Withdrawal by Subject|1|||
94366386|NCT05349188|323126521|FG000|Overall Study|Withdrawal by Subject|1|||
94366387|NCT05349188|323126522|FG001|Overall Study|Withdrawal by Subject|0|||
94366388|NCT02643394|323126523|FG000|Overall Study|Protocol Violation|4|||
94366389|NCT02643394|323126524|FG001|Overall Study|Protocol Violation|5|||
94366390|NCT00096200|323126525|FG000|Overall Study|Adverse Event|0|||
94366391|NCT00096200|323126526|FG001|Overall Study|Adverse Event|4|||
94366392|NCT00096200|323126527|FG002|Overall Study|Adverse Event|0|||
94366393|NCT00096200|323126525|FG000|Overall Study|Withdrawal by Subject|1|||
94366394|NCT00096200|323126526|FG001|Overall Study|Withdrawal by Subject|2|||
94366395|NCT00096200|323126527|FG002|Overall Study|Withdrawal by Subject|0|||
94366396|NCT00096200|323126525|FG000|Overall Study|Ineligible pathology|0|||
94366397|NCT00096200|323126526|FG001|Overall Study|Ineligible pathology|1|||
94366398|NCT00096200|323126527|FG002|Overall Study|Ineligible pathology|0|||
94366399|NCT01766310|323126528|FG000|Overall Study|Lost to Follow-up|1|||
94366400|NCT01766310|323126529|FG001|Overall Study|Lost to Follow-up|3|||
94366401|NCT00478673|323126530|FG000|30-Days Post-Procedure|Death|2|||
94366402|NCT00478673|323126530|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
94366403|NCT00478673|323126530|FG000|30-Days Post-Procedure|Missed Visit|7|||
94366404|NCT00478673|323126530|FG000|12-Months Post-Procedure|Death|23|||
94366405|NCT00478673|323126530|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
94366406|NCT00478673|323126530|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
94366407|NCT00478673|323126530|FG000|12-Months Post-Procedure|Missed Visit|25|||
94366408|NCT00478673|323126530|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
94366409|NCT02617446|323126531|FG000|Overall Study|Withdrawal by Subject|0|||
94366410|NCT02617446|323126532|FG001|Overall Study|Withdrawal by Subject|2|||
94366411|NCT02617446|323126533|FG002|Overall Study|Withdrawal by Subject|0|||
94698728|NCT01723774|324352410|FG000|Neoadjuvant|Disease progression|0|||
94698729|NCT01723774|324352411|FG001|Neoadjuvant|Disease progression|1|||
94698730|NCT01723774|324352412|FG002|Neoadjuvant|Disease progression|1|||
94698731|NCT01723774|324352413|FG003|Neoadjuvant|Disease progression|0|||
94698732|NCT01723774|324352410|FG000|Neoadjuvant|Adverse Event|0|||
94698733|NCT01723774|324352411|FG001|Neoadjuvant|Adverse Event|1|||
94698734|NCT01723774|324352412|FG002|Neoadjuvant|Adverse Event|2|||
94698735|NCT01723774|324352413|FG003|Neoadjuvant|Adverse Event|0|||
94698736|NCT01723774|324352410|FG000|Neoadjuvant|High estradiol|0|||
94698737|NCT01723774|324352411|FG001|Neoadjuvant|High estradiol|1|||
94698738|NCT01723774|324352412|FG002|Neoadjuvant|High estradiol|0|||
94698739|NCT01723774|324352413|FG003|Neoadjuvant|High estradiol|0|||
94698740|NCT02099539|324352414|FG000|Overall Study|Progressive Disease|3|||
94698741|NCT02099539|324352415|FG001|Overall Study|Progressive Disease|2|||
94698742|NCT02099539|324352416|FG002|Overall Study|Progressive Disease|2|||
94698743|NCT02099539|324352417|FG003|Overall Study|Progressive Disease|1|||
94698744|NCT02099539|324352418|FG004|Overall Study|Progressive Disease|4|||
94698745|NCT02099539|324352419|FG005|Overall Study|Progressive Disease|2|||
94698746|NCT02099539|324352420|FG006|Overall Study|Progressive Disease|0|||
94698747|NCT02099539|324352414|FG000|Overall Study|Adverse Event|0|||
94698748|NCT02099539|324352415|FG001|Overall Study|Adverse Event|0|||
94698749|NCT02099539|324352416|FG002|Overall Study|Adverse Event|1|||
94698750|NCT02099539|324352417|FG003|Overall Study|Adverse Event|1|||
94366412|NCT02617446|323126531|FG000|Overall Study|Adverse Event|1|||
94366413|NCT02617446|323126532|FG001|Overall Study|Adverse Event|0|||
94366414|NCT02617446|323126533|FG002|Overall Study|Adverse Event|5|||
94366415|NCT02617446|323126531|FG000|Overall Study|Lost to Follow-up|3|||
94366416|NCT02617446|323126532|FG001|Overall Study|Lost to Follow-up|0|||
94698751|NCT02099539|324352418|FG004|Overall Study|Adverse Event|0|||
94698752|NCT02099539|324352419|FG005|Overall Study|Adverse Event|0|||
94698753|NCT02099539|324352420|FG006|Overall Study|Adverse Event|0|||
94698754|NCT02099539|324352414|FG000|Overall Study|Physician Decision|0|||
94698755|NCT02099539|324352415|FG001|Overall Study|Physician Decision|0|||
94366417|NCT02617446|323126533|FG002|Overall Study|Lost to Follow-up|0|||
94366418|NCT02617446|323126531|FG000|Overall Study|Death|0|||
94366419|NCT02617446|323126532|FG001|Overall Study|Death|0|||
94698756|NCT02099539|324352416|FG002|Overall Study|Physician Decision|0|||
94698757|NCT02099539|324352417|FG003|Overall Study|Physician Decision|0|||
94698758|NCT02099539|324352418|FG004|Overall Study|Physician Decision|0|||
94698759|NCT02099539|324352419|FG005|Overall Study|Physician Decision|1|||
94698760|NCT02099539|324352420|FG006|Overall Study|Physician Decision|0|||
94698761|NCT05780047|324352425|FG000|Overall Study|Did not submit baseline urine test kit|226|||
94698762|NCT05780047|324352425|FG000|Overall Study|Lost to Follow-up|34|||
94698763|NCT05780047|324352425|FG000|Overall Study|Did not submit second urine test kit|124|||
94698764|NCT03212365|324352428|FG000|Overall Study|Discharged prior to Xa level|12|||
94698765|NCT03212365|324352429|FG001|Overall Study|Discharged prior to Xa level|8|||
94698766|NCT03212365|324352428|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
94698767|NCT03212365|324352429|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
94698768|NCT03212365|324352428|FG000|Overall Study|Refused study medication|3|||
94698769|NCT03212365|324352429|FG001|Overall Study|Refused study medication|0|||
94698770|NCT03212365|324352428|FG000|Overall Study|Initiated heparin infusion on floor|1|||
94698771|NCT03212365|324352429|FG001|Overall Study|Initiated heparin infusion on floor|1|||
94698772|NCT03212365|324352428|FG000|Overall Study|Unexpected return to OR|1|||
94698773|NCT03212365|324352429|FG001|Overall Study|Unexpected return to OR|1|||
94698774|NCT03212365|324352428|FG000|Overall Study|Medication distribution error|1|||
94698775|NCT03212365|324352429|FG001|Overall Study|Medication distribution error|0|||
94698776|NCT03212365|324352428|FG000|Overall Study|Required epidural placement|1|||
94698777|NCT03212365|324352429|FG001|Overall Study|Required epidural placement|0|||
94698778|NCT03212365|324352428|FG000|Overall Study|Withdrawal by Subject|0|||
94698779|NCT03212365|324352429|FG001|Overall Study|Withdrawal by Subject|1|||
94698780|NCT03212365|324352428|FG000|Overall Study|developed acute renal failure|0|||
94698781|NCT03212365|324352429|FG001|Overall Study|developed acute renal failure|1|||
94698782|NCT04873817|324352431|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
94698783|NCT04873817|324352431|FG000|Overall Study|Lost to Follow-up|4|||
94698784|NCT04873817|324352431|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
94698785|NCT04873817|324352431|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
94698786|NCT04873817|324352431|FG000|Overall Study|Other Reasons|3|||
94698787|NCT02926937|324352432|FG000|Overall Study|Adverse Event|0|||
94698788|NCT02926937|324352433|FG001|Overall Study|Adverse Event|1|||
94698789|NCT02926937|324352434|FG002|Overall Study|Adverse Event|1|||
94698790|NCT02926937|324352432|FG000|Overall Study|Poor Compliance to Protocol|1|||
94698791|NCT02926937|324352433|FG001|Overall Study|Poor Compliance to Protocol|0|||
94698792|NCT02926937|324352434|FG002|Overall Study|Poor Compliance to Protocol|0|||
94698793|NCT02926937|324352432|FG000|Overall Study|Lost to Follow-up|4|||
94698794|NCT02926937|324352433|FG001|Overall Study|Lost to Follow-up|5|||
94698795|NCT02926937|324352434|FG002|Overall Study|Lost to Follow-up|0|||
94698796|NCT02926937|324352432|FG000|Overall Study|At the Participant's own Request|11|||
94698797|NCT02926937|324352433|FG001|Overall Study|At the Participant's own Request|5|||
94698798|NCT02926937|324352434|FG002|Overall Study|At the Participant's own Request|8|||
94698799|NCT02926937|324352432|FG000|Overall Study|Reason not Specified|3|||
94698800|NCT02926937|324352433|FG001|Overall Study|Reason not Specified|4|||
94698801|NCT02926937|324352434|FG002|Overall Study|Reason not Specified|2|||
94698802|NCT00681811|324352435|FG000|Overall Study|Adverse Event|1|||
94265666|NCT00705432|322765787|FG002|Treatment Period|Treatment failure|33|||
94698803|NCT00681811|324352436|FG001|Overall Study|Adverse Event|1|||
94698804|NCT00681811|324352435|FG000|Overall Study|Withdrawal by Subject|2|||
94698805|NCT00681811|324352436|FG001|Overall Study|Withdrawal by Subject|2|||
94265667|NCT00705432|322765788|FG003|Treatment Period|Treatment failure|25|||
94698806|NCT00681811|324352435|FG000|Overall Study|Non-compliance|0|||
94698807|NCT00681811|324352436|FG001|Overall Study|Non-compliance|1|||
94698808|NCT02449044|324352437|FG000|Overall Study|Lost to Follow-up|2|||
94698809|NCT02449044|324352437|FG000|Overall Study|Withdrawal by Subject|13|||
94698810|NCT02449044|324352437|FG000|Overall Study|Adverse Event|30|||
94698811|NCT02449044|324352437|FG000|Overall Study|Met Withdrawal Criteria|7|||
94698812|NCT02449044|324352437|FG000|Overall Study|Physician Decision|9|||
94698813|NCT02449044|324352437|FG000|Overall Study|Sponsor Discontinued Trial|3|||
94698814|NCT02401529|324354166|FG000|Overall Study|Lost to Follow-up|2|||
94698815|NCT02401529|324354167|FG001|Overall Study|Lost to Follow-up|1|||
94698816|NCT02401529|324354166|FG000|Overall Study|Physician Decision|2|||
94698817|NCT02401529|324354167|FG001|Overall Study|Physician Decision|6|||
94698818|NCT02401529|324354166|FG000|Overall Study|Protocol Violation|5|||
94698819|NCT02401529|324354167|FG001|Overall Study|Protocol Violation|0|||
94698820|NCT04610684|324354169|FG000|Study Treatment|Withdrawal by Subject|1|||
94698821|NCT04610684|324354169|FG000|Study Treatment|Disease Progression|2|||
94698822|NCT04610684|324354169|FG000|Follow up|Death|2|||
94698823|NCT04610684|324354169|FG000|Follow up|Withdrawal by Subject|1|||
94698824|NCT04978363|324354171|FG000|Overall Study|Other medical issues unrelated to the study|0|||
94698825|NCT04978363|324354172|FG001|Overall Study|Other medical issues unrelated to the study|0|||
94698826|NCT04978363|324354173|FG002|Overall Study|Other medical issues unrelated to the study|0|||
94698827|NCT04978363|324354174|FG003|Overall Study|Other medical issues unrelated to the study|0|||
94698828|NCT04978363|324354175|FG004|Overall Study|Other medical issues unrelated to the study|1|||
94698829|NCT04978363|324354176|FG005|Overall Study|Other medical issues unrelated to the study|0|||
94698830|NCT04978363|324354177|FG006|Overall Study|Other medical issues unrelated to the study|0|||
94698831|NCT04978363|324354178|FG007|Overall Study|Other medical issues unrelated to the study|0|||
94698832|NCT04978363|324354179|FG008|Overall Study|Other medical issues unrelated to the study|0|||
94698833|NCT04978363|324354180|FG009|Overall Study|Other medical issues unrelated to the study|0|||
94698834|NCT04978363|324354181|FG010|Overall Study|Other medical issues unrelated to the study|0|||
94698835|NCT04978363|324354171|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
94698836|NCT04978363|324354172|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
94698837|NCT04978363|324354173|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
94698838|NCT04978363|324354174|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
94698839|NCT04978363|324354175|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
94698840|NCT04978363|324354176|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
94698841|NCT04978363|324354177|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
94698842|NCT04978363|324354178|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
94698843|NCT04978363|324354179|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
94698844|NCT04978363|324354180|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
94698845|NCT04978363|324354181|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
94698846|NCT04978363|324354171|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
94698847|NCT04978363|324354172|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
94698848|NCT04978363|324354173|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
94698849|NCT04978363|324354174|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
94698850|NCT04978363|324354175|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
94698851|NCT04978363|324354176|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
94265668|NCT00705432|322765789|FG004|Treatment Period|Treatment failure|13|||
94265669|NCT00705432|322765790|FG005|Treatment Period|Treatment failure|14|||
94265670|NCT00705432|322765785|FG000|Treatment Period|Non medical reason|26|||
94265671|NCT00705432|322765786|FG001|Treatment Period|Non medical reason|32|||
94265672|NCT00705432|322765787|FG002|Treatment Period|Non medical reason|37|||
94265673|NCT00705432|322765788|FG003|Treatment Period|Non medical reason|4|||
94265674|NCT00705432|322765789|FG004|Treatment Period|Non medical reason|7|||
94265675|NCT00705432|322765790|FG005|Treatment Period|Non medical reason|7|||
94698852|NCT04978363|324354177|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
94698853|NCT04978363|324354178|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
94698854|NCT04978363|324354179|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
94698855|NCT04978363|324354180|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
94698856|NCT04978363|324354181|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
94698857|NCT01251614|324354182|FG000|Overall Study|Adverse Event|1|||
94698858|NCT01251614|324354183|FG001|Overall Study|Adverse Event|0|||
94698859|NCT01251614|324354184|FG002|Overall Study|Adverse Event|1|||
94698860|NCT01251614|324354182|FG000|Overall Study|Lack of Efficacy|1|||
94698861|NCT01251614|324354183|FG001|Overall Study|Lack of Efficacy|9|||
94698862|NCT01251614|324354184|FG002|Overall Study|Lack of Efficacy|4|||
94698863|NCT01251614|324354182|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
94698864|NCT01251614|324354183|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
94698865|NCT01251614|324354184|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
94698866|NCT01251614|324354182|FG000|Overall Study|Pregnancy|0|||
94698867|NCT01251614|324354183|FG001|Overall Study|Pregnancy|0|||
94698868|NCT01251614|324354184|FG002|Overall Study|Pregnancy|2|||
94698869|NCT01251614|324354182|FG000|Overall Study|Loss of Disease Control|0|||
94698870|NCT01251614|324354183|FG001|Overall Study|Loss of Disease Control|1|||
94698871|NCT01251614|324354184|FG002|Overall Study|Loss of Disease Control|0|||
94698872|NCT01251614|324354182|FG000|Overall Study|Withdrawal by Subject|0|||
94698873|NCT01251614|324354183|FG001|Overall Study|Withdrawal by Subject|2|||
94698874|NCT01251614|324354184|FG002|Overall Study|Withdrawal by Subject|1|||
94698875|NCT01251614|324354182|FG000|Overall Study|Lost to Follow-up|0|||
94698876|NCT01251614|324354183|FG001|Overall Study|Lost to Follow-up|1|||
94698877|NCT01251614|324354184|FG002|Overall Study|Lost to Follow-up|0|||
94698878|NCT00079937|324354185|FG000|Overall Study|Adverse Event|2|||
94698879|NCT00079937|324354186|FG001|Overall Study|Adverse Event|1|||
94698880|NCT00079937|324354185|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94698881|NCT00079937|324354186|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
94698882|NCT00079937|324354185|FG000|Overall Study|Subject no longer requires study drug|3|||
94698883|NCT00079937|324354186|FG001|Overall Study|Subject no longer requires study drug|0|||
94698884|NCT00079937|324354185|FG000|Overall Study|Protocol Violation|8|||
94698885|NCT00079937|324354186|FG001|Overall Study|Protocol Violation|6|||
94698886|NCT00079937|324354185|FG000|Overall Study|Withdrawal by Subject|21|||
94698887|NCT00079937|324354186|FG001|Overall Study|Withdrawal by Subject|7|||
94698888|NCT00079937|324354185|FG000|Overall Study|Lost to Follow-up|12|||
94698889|NCT00079937|324354186|FG001|Overall Study|Lost to Follow-up|5|||
94698890|NCT00079937|324354185|FG000|Overall Study|Administrative problems|22|||
94698891|NCT00079937|324354186|FG001|Overall Study|Administrative problems|11|||
94698892|NCT01460381|324354187|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
94698893|NCT01460381|324354188|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
94698894|NCT01684046|324354189|FG000|Period 1, First 30 Days|Adverse Event|0|||
94698895|NCT01684046|324354190|FG001|Period 1, First 30 Days|Adverse Event|2|||
94698896|NCT01345292|324354191|FG000|Overall Study|Withdrawal by Subject|2|||
94698897|NCT01345292|324354192|FG001|Overall Study|Withdrawal by Subject|0|||
94698898|NCT01345292|324354193|FG002|Overall Study|Withdrawal by Subject|1|||
94698899|NCT05458102|324354195|FG000|Overall Study|Withdrew consent|2|||
94698900|NCT05458102|324354196|FG001|Overall Study|Withdrew consent|0|||
94698901|NCT05458102|324354195|FG000|Overall Study|Adverse Event|1|||
94698902|NCT05458102|324354196|FG001|Overall Study|Adverse Event|0|||
94698903|NCT05458102|324354195|FG000|Overall Study|Enrolled but never treated|1|||
94698904|NCT05458102|324354196|FG001|Overall Study|Enrolled but never treated|0|||
94698905|NCT05458102|324354195|FG000|Overall Study|Protocol Violation|1|||
94698906|NCT05458102|324354196|FG001|Overall Study|Protocol Violation|0|||
94698907|NCT02790606|324354201|FG000|Overall Study|Death|27|||
94698908|NCT02790606|324354201|FG000|Overall Study|Lost to Follow-up|4|||
94698909|NCT02790606|324354201|FG000|Overall Study|Physician Decision|3|||
94698910|NCT02790606|324354201|FG000|Overall Study|Withdrawal by Subject|1|||
94698911|NCT02735915|324354202|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
94698912|NCT02735915|324354202|FG000|Overall Study|Withdrawal following SAE|2|||
94265676|NCT00705432|322765785|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
94265677|NCT00705432|322765786|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
94265678|NCT00705432|322765787|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
94698913|NCT02735915|324354202|FG000|Overall Study|Withdrawal by Subject|1|||
94698914|NCT01789203|324354203|FG000|Overall Study|Adverse Event|2|||
94698915|NCT01789203|324354204|FG001|Overall Study|Adverse Event|2|||
94698916|NCT01789203|324354203|FG000|Overall Study|Withdrawal by Subject|1|||
94698917|NCT01789203|324354204|FG001|Overall Study|Withdrawal by Subject|0|||
94698918|NCT01789203|324354203|FG000|Overall Study|Death|1|||
94698919|NCT01789203|324354204|FG001|Overall Study|Death|0|||
94698920|NCT01789203|324354203|FG000|Overall Study|Protocol Violation|2|||
94698921|NCT01789203|324354204|FG001|Overall Study|Protocol Violation|1|||
94698922|NCT01789203|324354203|FG000|Overall Study|Other|1|||
94698923|NCT01789203|324354204|FG001|Overall Study|Other|1|||
94698924|NCT01789203|324354203|FG000|Overall Study|patient non-adherent|2|||
94366420|NCT02617446|323126533|FG002|Overall Study|Death|2|||
94366421|NCT01289990|323126537|FG000|Overall Study|Death|0|||
94366422|NCT01289990|323126538|FG001|Overall Study|Death|0|||
94366423|NCT01289990|323126539|FG002|Overall Study|Death|0|||
94366424|NCT01289990|323126540|FG003|Overall Study|Death|1|||
94698925|NCT01789203|324354204|FG001|Overall Study|patient non-adherent|0|||
94698926|NCT01687270|324354209|FG000|Overall Study|Lack of Efficacy|11|||
94698927|NCT01687270|324354209|FG000|Overall Study|Lost to Follow-up|1|||
94698928|NCT03302156|324354210|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
94698929|NCT03302156|324354211|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
94698930|NCT03302156|324354212|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
94698931|NCT03532178|324354213|FG000|First Period|Withdrawal by Subject|1|||
94698932|NCT03532178|324354214|FG001|First Period|Withdrawal by Subject|3|||
94698933|NCT03532178|324354213|FG000|First Period|technical issues in data collection Technical issues|0|||
94698934|NCT03532178|324354214|FG001|First Period|technical issues in data collection Technical issues|1|||
94698935|NCT03532178|324354213|FG000|Second Period|Withdrawal by Subject|1|||
94698936|NCT03532178|324354214|FG001|Second Period|Withdrawal by Subject|1|||
94698937|NCT03532178|324354213|FG000|Second Period|Technical issues|0|||
94698938|NCT03532178|324354214|FG001|Second Period|Technical issues|1|||
94698939|NCT01417000|324354215|FG000|Overall Study|Death|59|||
94698940|NCT01417000|324354216|FG001|Overall Study|Death|28|||
94698941|NCT01417000|324354215|FG000|Overall Study|Lost to Follow-up|1|||
94698942|NCT01417000|324354216|FG001|Overall Study|Lost to Follow-up|0|||
94698943|NCT01417000|324354215|FG000|Overall Study|Study Terminated by Sponsor|1|||
94698944|NCT01417000|324354216|FG001|Overall Study|Study Terminated by Sponsor|1|||
94698945|NCT04889118|324354217|FG000|Overall Study|Death|33|||
94698946|NCT04889118|324354218|FG001|Overall Study|Death|37|||
94698947|NCT04889118|324354217|FG000|Overall Study|Ongoing in Study|31|||
94698948|NCT04889118|324354218|FG001|Overall Study|Ongoing in Study|30|||
94698949|NCT00601640|324354222|FG000|Overall Study|Withdrawal by Subject|3|||
94698950|NCT00601640|324354223|FG001|Overall Study|Withdrawal by Subject|0|||
94698951|NCT00601640|324354224|FG002|Overall Study|Withdrawal by Subject|7|||
94698952|NCT00601640|324354222|FG000|Overall Study|Death|1|||
94698953|NCT00601640|324354223|FG001|Overall Study|Death|0|||
94698954|NCT00601640|324354224|FG002|Overall Study|Death|0|||
94698955|NCT00601640|324354222|FG000|Overall Study|Adverse Event|0|||
94366425|NCT01289990|323126541|FG004|Overall Study|Death|2|||
94366426|NCT01289990|323126542|FG005|Overall Study|Death|1|||
94366427|NCT01289990|323126543|FG006|Overall Study|Death|0|||
94698956|NCT00601640|324354223|FG001|Overall Study|Adverse Event|4|||
94698957|NCT00601640|324354224|FG002|Overall Study|Adverse Event|2|||
94698958|NCT00601640|324354222|FG000|Overall Study|intercurrent illness|1|||
94698959|NCT00601640|324354223|FG001|Overall Study|intercurrent illness|0|||
94366428|NCT01289990|323126544|FG007|Overall Study|Death|0|||
94366429|NCT01289990|323126545|FG008|Overall Study|Death|0|||
94366430|NCT01289990|323126546|FG009|Overall Study|Death|0|||
94698960|NCT00601640|324354224|FG002|Overall Study|intercurrent illness|0|||
94698961|NCT00601640|324354222|FG000|Overall Study|change in eligibility status|0|||
94698962|NCT00601640|324354223|FG001|Overall Study|change in eligibility status|1|||
94698963|NCT00601640|324354224|FG002|Overall Study|change in eligibility status|1|||
94698964|NCT00530777|324354225|FG000|Overall Study|Lost to Follow-up|0|||
94698965|NCT00530777|324354226|FG001|Overall Study|Lost to Follow-up|1|||
94698966|NCT00530777|324354225|FG000|Overall Study|Death|1|||
94698967|NCT00530777|324354226|FG001|Overall Study|Death|2|||
94698968|NCT00530777|324354225|FG000|Overall Study|Physician Decision|1|||
94698969|NCT00530777|324354226|FG001|Overall Study|Physician Decision|0|||
94698970|NCT00530777|324354225|FG000|Overall Study|Withdrawal by Subject|0|||
94698971|NCT00530777|324354226|FG001|Overall Study|Withdrawal by Subject|1|||
94698972|NCT00530777|324354225|FG000|Overall Study|Unable to adhere to visit schedule|5|||
94698973|NCT00530777|324354226|FG001|Overall Study|Unable to adhere to visit schedule|1|||
94698974|NCT02775435|324354235|FG000|Overall Study|Adverse Event|32|||
94698975|NCT02775435|324354236|FG001|Overall Study|Adverse Event|27|||
94698976|NCT02775435|324354235|FG000|Overall Study|Lost to Follow-up|2|||
94698977|NCT02775435|324354236|FG001|Overall Study|Lost to Follow-up|2|||
94698978|NCT02775435|324354235|FG000|Overall Study|Sponsor decision|44|||
94698979|NCT02775435|324354236|FG001|Overall Study|Sponsor decision|19|||
94698980|NCT02775435|324354235|FG000|Overall Study|Withdrawal by Subject|4|||
94698981|NCT02775435|324354236|FG001|Overall Study|Withdrawal by Subject|9|||
94698982|NCT02775435|324354235|FG000|Overall Study|Death|196|||
94698983|NCT02775435|324354236|FG001|Overall Study|Death|224|||
94698984|NCT01872611|324354237|FG000|Overall Study|Adverse Event|3|||
94698985|NCT01872611|324354238|FG001|Overall Study|Adverse Event|1|||
94698986|NCT01872611|324354237|FG000|Overall Study|Adverse Event, prior to treatment|0|||
94698987|NCT01872611|324354238|FG001|Overall Study|Adverse Event, prior to treatment|1|||
94698988|NCT01872611|324354237|FG000|Overall Study|Death|0|||
94698989|NCT01872611|324354238|FG001|Overall Study|Death|1|||
94265679|NCT00705432|322765788|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
94265680|NCT00705432|322765789|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
94265681|NCT00705432|322765790|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
94265682|NCT00705432|322765785|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
94265683|NCT00705432|322765786|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
94265684|NCT00705432|322765787|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
94265685|NCT00705432|322765788|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
94698990|NCT01872611|324354237|FG000|Overall Study|Death, prior to treatment|0|||
94698991|NCT01872611|324354238|FG001|Overall Study|Death, prior to treatment|1|||
94698992|NCT01872611|324354237|FG000|Overall Study|Lost to Follow-up|8|||
94698993|NCT01872611|324354238|FG001|Overall Study|Lost to Follow-up|1|||
94698994|NCT01872611|324354237|FG000|Overall Study|Physician Decision|1|||
94698995|NCT01872611|324354238|FG001|Overall Study|Physician Decision|0|||
94698996|NCT01872611|324354237|FG000|Overall Study|Withdrawal by Subject|6|||
94698997|NCT01872611|324354238|FG001|Overall Study|Withdrawal by Subject|1|||
94698998|NCT01872611|324354237|FG000|Overall Study|Reason not provided|6|||
94698999|NCT01872611|324354238|FG001|Overall Study|Reason not provided|6|||
94699000|NCT04088188|324354246|FG000|Overall Study|Withdrawal by Subject|2|||
94699001|NCT04088188|324354247|FG001|Overall Study|Withdrawal by Subject|0|||
94699002|NCT04088188|324354246|FG000|Overall Study|Adverse Event|2|||
94699003|NCT04088188|324354247|FG001|Overall Study|Adverse Event|0|||
94699004|NCT01414166|324354248|FG000|Overall Study|Adverse Event|10|||
94699005|NCT01414166|324354249|FG001|Overall Study|Adverse Event|2|||
94699006|NCT01414166|324354248|FG000|Overall Study|Lost to Follow-up|4|||
94699007|NCT01414166|324354249|FG001|Overall Study|Lost to Follow-up|1|||
94699008|NCT01414166|324354248|FG000|Overall Study|Non-compliance with study drug|2|||
94699009|NCT01414166|324354249|FG001|Overall Study|Non-compliance with study drug|0|||
94699010|NCT01414166|324354248|FG000|Overall Study|Physician Decision|2|||
94699011|NCT01414166|324354249|FG001|Overall Study|Physician Decision|0|||
94699012|NCT01414166|324354248|FG000|Overall Study|Protocol Violation|2|||
94699013|NCT01414166|324354249|FG001|Overall Study|Protocol Violation|0|||
94699014|NCT01414166|324354248|FG000|Overall Study|Study terminated by Sponsor|68|||
94699015|NCT01414166|324354249|FG001|Overall Study|Study terminated by Sponsor|75|||
94699016|NCT01414166|324354248|FG000|Overall Study|Withdrawal by Subject|3|||
94699017|NCT01414166|324354249|FG001|Overall Study|Withdrawal by Subject|5|||
94699018|NCT03124108|324354250|FG000|Overall Study|Adverse Event|0|||
94699019|NCT03124108|324354251|FG001|Overall Study|Adverse Event|1|||
94699020|NCT03124108|324354252|FG002|Overall Study|Adverse Event|0|||
94699021|NCT00631917|324354253|FG000|Overall Study|Adverse Event|34|||
94699022|NCT00631917|324354254|FG001|Overall Study|Adverse Event|45|||
94699023|NCT00631917|324354253|FG000|Overall Study|Abnormal laboratory value(s)|2|||
94699024|NCT00631917|324354254|FG001|Overall Study|Abnormal laboratory value(s)|1|||
94699025|NCT00631917|324354253|FG000|Overall Study|Abnormal test procedure result(s)|3|||
94699026|NCT00631917|324354254|FG001|Overall Study|Abnormal test procedure result(s)|2|||
94699027|NCT00631917|324354253|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
94699028|NCT00631917|324354254|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
94699029|NCT00631917|324354253|FG000|Overall Study|No longer required study drug|0|||
94699030|NCT00631917|324354254|FG001|Overall Study|No longer required study drug|1|||
94699031|NCT00631917|324354253|FG000|Overall Study|Protocol deviation|6|||
94699032|NCT00631917|324354254|FG001|Overall Study|Protocol deviation|5|||
94466123|NCT01472939|323496943|FG002|Overall Study|Adverse Event|7|||
94466124|NCT01472939|323496944|FG003|Overall Study|Adverse Event|14|||
94466125|NCT01472939|323496941|FG000|Overall Study|Lack of Efficacy|1|||
94466126|NCT01472939|323496942|FG001|Overall Study|Lack of Efficacy|0|||
94699033|NCT00631917|324354253|FG000|Overall Study|Subject withdrew consent|25|||
94699034|NCT00631917|324354254|FG001|Overall Study|Subject withdrew consent|33|||
94699035|NCT00631917|324354253|FG000|Overall Study|Lost to Follow-up|7|||
94699036|NCT00631917|324354254|FG001|Overall Study|Lost to Follow-up|7|||
94699037|NCT00631917|324354253|FG000|Overall Study|Administrative problems|2|||
94699038|NCT00631917|324354254|FG001|Overall Study|Administrative problems|0|||
94699039|NCT00631917|324354253|FG000|Overall Study|Death|1|||
94699040|NCT00631917|324354254|FG001|Overall Study|Death|0|||
94699041|NCT02403323|324354257|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
94699042|NCT02403323|324354258|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
94699043|NCT02403323|324354259|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
94699044|NCT02403323|324354257|FG000|Part 1: Open Label Extension Period|Death|3|||
94699045|NCT02403323|324354258|FG001|Part 1: Open Label Extension Period|Death|0|||
94699046|NCT02403323|324354259|FG002|Part 1: Open Label Extension Period|Death|0|||
94699047|NCT02403323|324354257|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
94699048|NCT02403323|324354258|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
94699049|NCT02403323|324354259|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
94699050|NCT02403323|324354257|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
94699051|NCT02403323|324354258|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
94699052|NCT02403323|324354259|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
94699053|NCT02403323|324354257|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
94699054|NCT02403323|324354258|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
94699055|NCT02403323|324354259|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
94699056|NCT02403323|324354257|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
94699057|NCT02403323|324354258|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
94699058|NCT02403323|324354259|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
94699059|NCT02403323|324354257|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
94699060|NCT02403323|324354258|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
94699061|NCT02403323|324354259|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
94699062|NCT02403323|324354257|FG000|Part 1: Open Label Extension Period|Other|1|||
94699063|NCT02403323|324354258|FG001|Part 1: Open Label Extension Period|Other|0|||
94699064|NCT02403323|324354259|FG002|Part 1: Open Label Extension Period|Other|0|||
94699065|NCT02403323|324354257|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
94699066|NCT02403323|324354258|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
94699067|NCT02403323|324354259|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
94699068|NCT02403323|324354257|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
94699069|NCT02403323|324354258|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
94699070|NCT02403323|324354259|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
94699071|NCT02403323|324354257|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
94699072|NCT02403323|324354258|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
94699073|NCT02403323|324354259|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
94699074|NCT02403323|324354257|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
94699075|NCT02403323|324354258|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
94699076|NCT02403323|324354259|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
94699077|NCT02403323|324354257|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
94699078|NCT02403323|324354258|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
94699079|NCT02403323|324354259|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
94699080|NCT02403323|324354257|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
94699081|NCT02403323|324354258|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
94699082|NCT02403323|324354259|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
94699083|NCT02403323|324354257|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
94699084|NCT02403323|324354258|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
94699085|NCT02403323|324354259|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
94699086|NCT02403323|324354257|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
94699087|NCT02403323|324354258|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
94699088|NCT02403323|324354259|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
94699089|NCT02403323|324354257|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
94699090|NCT02403323|324354258|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
94699091|NCT02403323|324354259|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
94699092|NCT02403323|324354257|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
94699093|NCT02403323|324354258|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
94699094|NCT02403323|324354259|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
94699095|NCT02138916|324354260|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
94366431|NCT01289990|323126547|FG010|Overall Study|Death|0|||
94366432|NCT01289990|323126548|FG011|Overall Study|Death|1|||
94366433|NCT01289990|323126549|FG012|Overall Study|Death|0|||
94366434|NCT01289990|323126537|FG000|Overall Study|Lost to Follow-up|3|||
94366435|NCT01289990|323126538|FG001|Overall Study|Lost to Follow-up|2|||
94366436|NCT01289990|323126539|FG002|Overall Study|Lost to Follow-up|5|||
94366437|NCT01289990|323126540|FG003|Overall Study|Lost to Follow-up|5|||
94699096|NCT02138916|324354261|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
94699097|NCT02138916|324354262|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
94699098|NCT02138916|324354260|FG000|Overall Study|Death|14|||
94699099|NCT02138916|324354261|FG001|Overall Study|Death|11|||
94699100|NCT02138916|324354262|FG002|Overall Study|Death|12|||
94699101|NCT02138916|324354260|FG000|Overall Study|Withdrawal by Subject|27|||
94699102|NCT02138916|324354261|FG001|Overall Study|Withdrawal by Subject|31|||
94699103|NCT02138916|324354262|FG002|Overall Study|Withdrawal by Subject|32|||
94699104|NCT02138916|324354260|FG000|Overall Study|Study specific withdrawal criteria|0|||
94699105|NCT02138916|324354261|FG001|Overall Study|Study specific withdrawal criteria|0|||
94699106|NCT02138916|324354262|FG002|Overall Study|Study specific withdrawal criteria|1|||
94699107|NCT02138916|324354260|FG000|Overall Study|incorrect enrolment|1|||
94699108|NCT02138916|324354261|FG001|Overall Study|incorrect enrolment|1|||
94699109|NCT02138916|324354262|FG002|Overall Study|incorrect enrolment|0|||
94699110|NCT02138916|324354260|FG000|Overall Study|Severe non-compliance|1|||
94699111|NCT02138916|324354261|FG001|Overall Study|Severe non-compliance|2|||
94699112|NCT02138916|324354262|FG002|Overall Study|Severe non-compliance|1|||
94699113|NCT02138916|324354260|FG000|Overall Study|Lost to Follow-up|4|||
94699114|NCT02138916|324354261|FG001|Overall Study|Lost to Follow-up|2|||
94699115|NCT02138916|324354262|FG002|Overall Study|Lost to Follow-up|3|||
94699116|NCT02138916|324354260|FG000|Overall Study|Adverse Event|4|||
94699117|NCT02138916|324354261|FG001|Overall Study|Adverse Event|4|||
94699118|NCT02138916|324354262|FG002|Overall Study|Adverse Event|3|||
94699119|NCT00764868|324354263|FG000|Overall Study|Adverse Event|18|||
94699120|NCT00764868|324354263|FG000|Overall Study|Withdrawal by Subject|31|||
94699121|NCT00764868|324354263|FG000|Overall Study|Non-compliance|16|||
94699122|NCT00764868|324354263|FG000|Overall Study|Lost to Follow-up|25|||
94699123|NCT00764868|324354263|FG000|Overall Study|Lack of Efficacy|5|||
94699124|NCT00764868|324354263|FG000|Overall Study|Subject moved|7|||
94699125|NCT00764868|324354263|FG000|Overall Study|Pregnancy|3|||
94699126|NCT00764868|324354263|FG000|Overall Study|Prohibited medication|1|||
94699127|NCT00764868|324354263|FG000|Overall Study|Out of town|1|||
94699128|NCT00764868|324354263|FG000|Overall Study|Misuse and compliance of study drug|1|||
94699129|NCT00764868|324354263|FG000|Overall Study|Subject sent to boarding school|1|||
94699130|NCT00764868|324354263|FG000|Overall Study|Met an exclusion criteria|1|||
94699131|NCT00764868|324354263|FG000|Overall Study|Positive drug screen|2|||
94699132|NCT00764868|324354263|FG000|Overall Study|Sponsor requested withdrawal|1|||
94699133|NCT00819234|324354264|FG000|Overall Study|Withdrawal by Subject|8|||
94699134|NCT00819234|324354265|FG001|Overall Study|Withdrawal by Subject|13|||
94699135|NCT00819234|324354266|FG002|Overall Study|Withdrawal by Subject|6|||
94699136|NCT00819234|324354267|FG003|Overall Study|Withdrawal by Subject|3|||
94699137|NCT00819234|324354268|FG004|Overall Study|Withdrawal by Subject|0|||
94699138|NCT00819234|324354269|FG005|Overall Study|Withdrawal by Subject|4|||
94699139|NCT00819234|324354270|FG006|Overall Study|Withdrawal by Subject|4|||
94699140|NCT00819234|324354271|FG007|Overall Study|Withdrawal by Subject|8|||
94699141|NCT00819234|324354272|FG008|Overall Study|Withdrawal by Subject|5|||
94699142|NCT00819234|324354273|FG009|Overall Study|Withdrawal by Subject|3|||
94699143|NCT00819234|324354264|FG000|Overall Study|Adverse Event|0|||
94699144|NCT00819234|324354265|FG001|Overall Study|Adverse Event|0|||
94699145|NCT00819234|324354266|FG002|Overall Study|Adverse Event|1|||
94699146|NCT00819234|324354267|FG003|Overall Study|Adverse Event|0|||
94699147|NCT00819234|324354268|FG004|Overall Study|Adverse Event|0|||
94699148|NCT00819234|324354269|FG005|Overall Study|Adverse Event|2|||
94699149|NCT00819234|324354270|FG006|Overall Study|Adverse Event|0|||
94699150|NCT00819234|324354271|FG007|Overall Study|Adverse Event|0|||
94699151|NCT00819234|324354272|FG008|Overall Study|Adverse Event|0|||
94699152|NCT00819234|324354273|FG009|Overall Study|Adverse Event|0|||
94699153|NCT00819234|324354264|FG000|Overall Study|Physician Decision|0|||
94699154|NCT00819234|324354265|FG001|Overall Study|Physician Decision|0|||
94699155|NCT00819234|324354266|FG002|Overall Study|Physician Decision|0|||
94699156|NCT00819234|324354267|FG003|Overall Study|Physician Decision|1|||
94699157|NCT00819234|324354268|FG004|Overall Study|Physician Decision|0|||
94699158|NCT00819234|324354269|FG005|Overall Study|Physician Decision|0|||
94699159|NCT00819234|324354270|FG006|Overall Study|Physician Decision|0|||
94699160|NCT00819234|324354271|FG007|Overall Study|Physician Decision|0|||
94699161|NCT00819234|324354272|FG008|Overall Study|Physician Decision|0|||
94699162|NCT00819234|324354273|FG009|Overall Study|Physician Decision|2|||
94699163|NCT00819234|324354264|FG000|Overall Study|Protocol Violation|0|||
94699164|NCT00819234|324354265|FG001|Overall Study|Protocol Violation|0|||
94699165|NCT00819234|324354266|FG002|Overall Study|Protocol Violation|1|||
94699166|NCT00819234|324354267|FG003|Overall Study|Protocol Violation|0|||
94699167|NCT00819234|324354268|FG004|Overall Study|Protocol Violation|0|||
94699168|NCT00819234|324354269|FG005|Overall Study|Protocol Violation|0|||
94699169|NCT00819234|324354270|FG006|Overall Study|Protocol Violation|0|||
94699170|NCT00819234|324354271|FG007|Overall Study|Protocol Violation|0|||
94699171|NCT00819234|324354272|FG008|Overall Study|Protocol Violation|0|||
94699172|NCT00819234|324354273|FG009|Overall Study|Protocol Violation|0|||
94699173|NCT00819234|324354264|FG000|Overall Study|Lost to Follow-up|2|||
94699174|NCT00819234|324354265|FG001|Overall Study|Lost to Follow-up|2|||
94699175|NCT00819234|324354266|FG002|Overall Study|Lost to Follow-up|0|||
94699176|NCT00819234|324354267|FG003|Overall Study|Lost to Follow-up|2|||
94699177|NCT00819234|324354268|FG004|Overall Study|Lost to Follow-up|1|||
94699178|NCT00819234|324354269|FG005|Overall Study|Lost to Follow-up|1|||
94699179|NCT00819234|324354270|FG006|Overall Study|Lost to Follow-up|1|||
94699180|NCT00819234|324354271|FG007|Overall Study|Lost to Follow-up|1|||
94699181|NCT00819234|324354272|FG008|Overall Study|Lost to Follow-up|1|||
94651841|NCT00938431|324183748|FG000|Overall Study|Reached maximum dose early|0|||
94651842|NCT00938431|324183749|FG001|Overall Study|Reached maximum dose early|0|||
94651843|NCT00938431|324183750|FG002|Overall Study|Reached maximum dose early|1|||
94651844|NCT02086591|324183751|FG000|Overall Study|Adverse Event|1|||
94651845|NCT02086591|324183751|FG000|Overall Study|Withdrawal by Subject|1|||
94651846|NCT02086591|324183751|FG000|Overall Study|protocol terminated|3|||
94651847|NCT02984020|324183752|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
94651848|NCT02984020|324183752|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
94651849|NCT02984020|324183752|FG000|Overall Study|Other significant protocol violation|2|||
94651850|NCT01774903|324183758|FG000|Overall Study|Adverse Event|7|||
94651851|NCT01774903|324183758|FG000|Overall Study|Withdrawal by Subject|2|||
94651852|NCT01774903|324183758|FG000|Overall Study|Lack of Efficacy|1|||
94651853|NCT01774903|324183758|FG000|Overall Study|Ineligible to continue the trial|1|||
94651854|NCT02610192|324183766|FG000|Overall Study|Received other treatment|8|||
94651855|NCT02610192|324183766|FG000|Overall Study|Physician Decision|1|||
94651856|NCT04101526|324183770|FG000|Overall Study|Did not complete all sleep diary entries|0|||
94651857|NCT04101526|324183771|FG001|Overall Study|Did not complete all sleep diary entries|1|||
94651858|NCT03228680|324183774|FG000|Overall Study|Adverse Event|13|||
94651859|NCT03228680|324183775|FG001|Overall Study|Adverse Event|18|||
94651860|NCT03228680|324183774|FG000|Overall Study|Randomization failure|0|||
94699182|NCT00819234|324354273|FG009|Overall Study|Lost to Follow-up|2|||
94699183|NCT04438785|324354274|FG000|Overall Study|change of weight, give up intervention|2|||
94699184|NCT04438785|324354275|FG001|Overall Study|change of weight, give up intervention|10|||
94699185|NCT05550337|324354276|FG000|Overall Study|Lack of Efficacy|0|||
94699186|NCT05550337|324354277|FG001|Overall Study|Lack of Efficacy|0|||
94699187|NCT05550337|324354278|FG002|Overall Study|Lack of Efficacy|1|||
94699188|NCT05550337|324354276|FG000|Overall Study|Adverse Event|1|||
94699189|NCT05550337|324354277|FG001|Overall Study|Adverse Event|5|||
94699190|NCT05550337|324354278|FG002|Overall Study|Adverse Event|0|||
94699191|NCT05550337|324354276|FG000|Overall Study|Withdrawal by Subject|8|||
94699192|NCT05550337|324354277|FG001|Overall Study|Withdrawal by Subject|14|||
94699193|NCT05550337|324354278|FG002|Overall Study|Withdrawal by Subject|10|||
94699194|NCT05550337|324354276|FG000|Overall Study|Pregnancy|0|||
94699195|NCT05550337|324354277|FG001|Overall Study|Pregnancy|0|||
94699196|NCT05550337|324354278|FG002|Overall Study|Pregnancy|1|||
94699197|NCT05550337|324354276|FG000|Overall Study|Protocol Violation|1|||
94699198|NCT05550337|324354277|FG001|Overall Study|Protocol Violation|3|||
94699199|NCT05550337|324354278|FG002|Overall Study|Protocol Violation|4|||
94699200|NCT05550337|324354276|FG000|Overall Study|Physician Decision|2|||
94699201|NCT05550337|324354277|FG001|Overall Study|Physician Decision|1|||
94699202|NCT05550337|324354278|FG002|Overall Study|Physician Decision|1|||
94699203|NCT05550337|324354276|FG000|Overall Study|Lost to Follow-up|16|||
94699204|NCT05550337|324354277|FG001|Overall Study|Lost to Follow-up|11|||
94699205|NCT05550337|324354278|FG002|Overall Study|Lost to Follow-up|11|||
94699206|NCT02027935|324354279|FG000|Overall Study|Death|1|||
94699207|NCT02027935|324354279|FG000|Overall Study|Lack of Efficacy|5|||
94699208|NCT02027935|324354279|FG000|Overall Study|Study Closure|1|||
94699209|NCT01737268|324354280|FG000|Overall Study|Adverse Event|6|||
94699210|NCT01737268|324354280|FG000|Overall Study|Worsening of Target Disease|2|||
94699211|NCT01737268|324354280|FG000|Overall Study|In consideration of the patient's safety|1|||
94699212|NCT01559090|324354281|FG000|Stage I|Withdrawal by Subject|2|||
94699213|NCT01559090|324354282|FG001|Stage I|Withdrawal by Subject|2|||
94699214|NCT01559090|324354283|FG002|Stage I|Withdrawal by Subject|3|||
94699215|NCT01559090|324354281|FG000|Stage II|Withdrawal by Subject|1|||
94699216|NCT01559090|324354282|FG001|Stage II|Withdrawal by Subject|0|||
94699217|NCT01559090|324354283|FG002|Stage II|Withdrawal by Subject|0|||
94699218|NCT00389519|324354289|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
94699219|NCT00389519|324354290|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
94699220|NCT00389519|324354291|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
94699221|NCT00389519|324354292|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
94699222|NCT00389519|324354289|FG000|Placebo Run-In|Withdrawal by Subject|19|||
94699223|NCT00389519|324354290|FG001|Placebo Run-In|Withdrawal by Subject|0|||
94699224|NCT00389519|324354291|FG002|Placebo Run-In|Withdrawal by Subject|0|||
94699225|NCT00389519|324354292|FG003|Placebo Run-In|Withdrawal by Subject|0|||
94699226|NCT00389519|324354289|FG000|Placebo Run-In|Reason not specified|40|||
94699227|NCT00389519|324354290|FG001|Placebo Run-In|Reason not specified|0|||
94699228|NCT00389519|324354291|FG002|Placebo Run-In|Reason not specified|0|||
94699229|NCT00389519|324354292|FG003|Placebo Run-In|Reason not specified|0|||
94699230|NCT00389519|324354289|FG000|Randomized|Did not receive study drug|2|||
94699231|NCT00389519|324354290|FG001|Randomized|Did not receive study drug|0|||
94699232|NCT00389519|324354291|FG002|Randomized|Did not receive study drug|0|||
94699233|NCT00389519|324354292|FG003|Randomized|Did not receive study drug|0|||
94699234|NCT00389519|324354289|FG000|Treated|Adverse Event|1|||
94699235|NCT00389519|324354290|FG001|Treated|Adverse Event|0|||
94699236|NCT00389519|324354291|FG002|Treated|Adverse Event|0|||
94699237|NCT00389519|324354292|FG003|Treated|Adverse Event|2|||
94699238|NCT00389519|324354289|FG000|Treated|Reason not specified|1|||
94366438|NCT01289990|323126541|FG004|Overall Study|Lost to Follow-up|3|||
94699239|NCT00389519|324354290|FG001|Treated|Reason not specified|1|||
94699240|NCT00389519|324354291|FG002|Treated|Reason not specified|0|||
94699241|NCT00389519|324354292|FG003|Treated|Reason not specified|2|||
94699242|NCT02014558|324354293|FG000|Overall Study|Never Received Study Drug|0|||
94699243|NCT02014558|324354294|FG001|Overall Study|Never Received Study Drug|0|||
94699244|NCT02014558|324354295|FG002|Overall Study|Never Received Study Drug|0|||
94699245|NCT02014558|324354296|FG003|Overall Study|Never Received Study Drug|0|||
94699246|NCT02014558|324354297|FG004|Overall Study|Never Received Study Drug|1|||
94699247|NCT02014558|324354298|FG005|Overall Study|Never Received Study Drug|0|||
94699248|NCT02014558|324354299|FG006|Overall Study|Never Received Study Drug|1|||
94699249|NCT02014558|324354300|FG007|Overall Study|Never Received Study Drug|0|||
94699250|NCT02014558|324354301|FG008|Overall Study|Never Received Study Drug|2|||
94699251|NCT02014558|324354302|FG009|Overall Study|Never Received Study Drug|0|||
94699252|NCT02014558|324354303|FG010|Overall Study|Never Received Study Drug|2|||
94699253|NCT02014558|324354304|FG011|Overall Study|Never Received Study Drug|2|||
94699254|NCT02014558|324354305|FG012|Overall Study|Never Received Study Drug|0|||
94699255|NCT02014558|324354293|FG000|Overall Study|Adverse Event|0|||
94699256|NCT02014558|324354294|FG001|Overall Study|Adverse Event|0|||
94699257|NCT02014558|324354295|FG002|Overall Study|Adverse Event|0|||
94699258|NCT02014558|324354296|FG003|Overall Study|Adverse Event|0|||
94699259|NCT02014558|324354297|FG004|Overall Study|Adverse Event|1|||
94699260|NCT02014558|324354298|FG005|Overall Study|Adverse Event|0|||
94699261|NCT02014558|324354299|FG006|Overall Study|Adverse Event|0|||
94699262|NCT02014558|324354300|FG007|Overall Study|Adverse Event|0|||
94699263|NCT02014558|324354301|FG008|Overall Study|Adverse Event|2|||
94699264|NCT02014558|324354302|FG009|Overall Study|Adverse Event|2|||
94699265|NCT02014558|324354303|FG010|Overall Study|Adverse Event|5|||
94699266|NCT02014558|324354304|FG011|Overall Study|Adverse Event|21|||
94699267|NCT02014558|324354305|FG012|Overall Study|Adverse Event|3|||
94699268|NCT02014558|324354293|FG000|Overall Study|Death|1|||
94699269|NCT02014558|324354294|FG001|Overall Study|Death|0|||
94699270|NCT02014558|324354295|FG002|Overall Study|Death|0|||
94699271|NCT02014558|324354296|FG003|Overall Study|Death|0|||
94699272|NCT02014558|324354297|FG004|Overall Study|Death|0|||
94699273|NCT02014558|324354298|FG005|Overall Study|Death|0|||
94699274|NCT02014558|324354299|FG006|Overall Study|Death|1|||
94699275|NCT02014558|324354300|FG007|Overall Study|Death|1|||
94699276|NCT02014558|324354301|FG008|Overall Study|Death|2|||
94699277|NCT02014558|324354302|FG009|Overall Study|Death|5|||
94699278|NCT02014558|324354303|FG010|Overall Study|Death|5|||
94699279|NCT02014558|324354304|FG011|Overall Study|Death|19|||
94699280|NCT02014558|324354305|FG012|Overall Study|Death|2|||
94699281|NCT02014558|324354293|FG000|Overall Study|Lack of Efficacy|1|||
94699282|NCT02014558|324354294|FG001|Overall Study|Lack of Efficacy|2|||
94699283|NCT02014558|324354295|FG002|Overall Study|Lack of Efficacy|1|||
94699284|NCT02014558|324354296|FG003|Overall Study|Lack of Efficacy|1|||
94699285|NCT02014558|324354297|FG004|Overall Study|Lack of Efficacy|0|||
94699286|NCT02014558|324354298|FG005|Overall Study|Lack of Efficacy|0|||
94699287|NCT02014558|324354299|FG006|Overall Study|Lack of Efficacy|1|||
94699288|NCT02014558|324354300|FG007|Overall Study|Lack of Efficacy|3|||
94699289|NCT02014558|324354301|FG008|Overall Study|Lack of Efficacy|3|||
94699290|NCT02014558|324354302|FG009|Overall Study|Lack of Efficacy|3|||
94699291|NCT02014558|324354303|FG010|Overall Study|Lack of Efficacy|16|||
94699292|NCT02014558|324354304|FG011|Overall Study|Lack of Efficacy|8|||
94699293|NCT02014558|324354305|FG012|Overall Study|Lack of Efficacy|5|||
94699294|NCT02014558|324354293|FG000|Overall Study|Lost to Follow-up|0|||
94699295|NCT02014558|324354294|FG001|Overall Study|Lost to Follow-up|0|||
94699296|NCT02014558|324354295|FG002|Overall Study|Lost to Follow-up|0|||
94699297|NCT02014558|324354296|FG003|Overall Study|Lost to Follow-up|0|||
94699298|NCT02014558|324354297|FG004|Overall Study|Lost to Follow-up|0|||
94699299|NCT02014558|324354298|FG005|Overall Study|Lost to Follow-up|0|||
94699300|NCT02014558|324354299|FG006|Overall Study|Lost to Follow-up|0|||
94699301|NCT02014558|324354300|FG007|Overall Study|Lost to Follow-up|0|||
94699302|NCT02014558|324354301|FG008|Overall Study|Lost to Follow-up|0|||
94699303|NCT02014558|324354302|FG009|Overall Study|Lost to Follow-up|0|||
94366439|NCT01289990|323126542|FG005|Overall Study|Lost to Follow-up|4|||
94699304|NCT02014558|324354303|FG010|Overall Study|Lost to Follow-up|1|||
94699305|NCT02014558|324354304|FG011|Overall Study|Lost to Follow-up|0|||
94699306|NCT02014558|324354305|FG012|Overall Study|Lost to Follow-up|0|||
94699307|NCT02014558|324354293|FG000|Overall Study|Progressive Disease|1|||
94699308|NCT02014558|324354294|FG001|Overall Study|Progressive Disease|0|||
94699309|NCT02014558|324354295|FG002|Overall Study|Progressive Disease|1|||
94699310|NCT02014558|324354296|FG003|Overall Study|Progressive Disease|1|||
94699311|NCT02014558|324354297|FG004|Overall Study|Progressive Disease|1|||
94699312|NCT02014558|324354298|FG005|Overall Study|Progressive Disease|2|||
94366440|NCT01289990|323126543|FG006|Overall Study|Lost to Follow-up|2|||
94699313|NCT02014558|324354299|FG006|Overall Study|Progressive Disease|1|||
94699314|NCT02014558|324354300|FG007|Overall Study|Progressive Disease|6|||
94699315|NCT02014558|324354301|FG008|Overall Study|Progressive Disease|5|||
94699316|NCT02014558|324354302|FG009|Overall Study|Progressive Disease|6|||
94699317|NCT02014558|324354303|FG010|Overall Study|Progressive Disease|22|||
94699318|NCT02014558|324354304|FG011|Overall Study|Progressive Disease|31|||
94699319|NCT02014558|324354305|FG012|Overall Study|Progressive Disease|6|||
94699320|NCT02014558|324354293|FG000|Overall Study|Withdrawal by Subject|0|||
94699321|NCT02014558|324354294|FG001|Overall Study|Withdrawal by Subject|0|||
94699322|NCT02014558|324354295|FG002|Overall Study|Withdrawal by Subject|0|||
94699323|NCT02014558|324354296|FG003|Overall Study|Withdrawal by Subject|0|||
94699324|NCT02014558|324354297|FG004|Overall Study|Withdrawal by Subject|1|||
94699325|NCT02014558|324354298|FG005|Overall Study|Withdrawal by Subject|0|||
94699326|NCT02014558|324354299|FG006|Overall Study|Withdrawal by Subject|0|||
94699327|NCT02014558|324354300|FG007|Overall Study|Withdrawal by Subject|0|||
94699328|NCT02014558|324354301|FG008|Overall Study|Withdrawal by Subject|0|||
94699329|NCT02014558|324354302|FG009|Overall Study|Withdrawal by Subject|2|||
94699330|NCT02014558|324354303|FG010|Overall Study|Withdrawal by Subject|6|||
94699331|NCT02014558|324354304|FG011|Overall Study|Withdrawal by Subject|10|||
94699332|NCT02014558|324354305|FG012|Overall Study|Withdrawal by Subject|0|||
94699333|NCT02014558|324354293|FG000|Overall Study|Miscellaneous|2|||
94699334|NCT02014558|324354294|FG001|Overall Study|Miscellaneous|1|||
94699335|NCT02014558|324354295|FG002|Overall Study|Miscellaneous|1|||
94699336|NCT02014558|324354296|FG003|Overall Study|Miscellaneous|1|||
94699337|NCT02014558|324354297|FG004|Overall Study|Miscellaneous|0|||
94699338|NCT02014558|324354298|FG005|Overall Study|Miscellaneous|1|||
94699339|NCT02014558|324354299|FG006|Overall Study|Miscellaneous|0|||
94699340|NCT02014558|324354300|FG007|Overall Study|Miscellaneous|1|||
94699341|NCT02014558|324354301|FG008|Overall Study|Miscellaneous|1|||
94699342|NCT02014558|324354302|FG009|Overall Study|Miscellaneous|3|||
94699343|NCT02014558|324354303|FG010|Overall Study|Miscellaneous|12|||
94699344|NCT02014558|324354304|FG011|Overall Study|Miscellaneous|11|||
94699345|NCT02014558|324354305|FG012|Overall Study|Miscellaneous|1|||
94699346|NCT01866917|324354306|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
94699347|NCT01866917|324354307|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
94699348|NCT04155424|324354311|FG000|Overall Study|Other than specified|3|||
94699349|NCT04155424|324354311|FG000|Overall Study|Withdrawal by Subject|1|||
94699350|NCT04155424|324354311|FG000|Overall Study|Adverse Event|1|||
94699351|NCT01939158|324355493|FG000|Overall Study|Adverse Event|1|||
94699352|NCT01939158|324355494|FG001|Overall Study|Adverse Event|0|||
94699353|NCT01939158|324355495|FG002|Overall Study|Adverse Event|0|||
94699354|NCT01939158|324355496|FG003|Overall Study|Adverse Event|0|||
94699355|NCT01939158|324355493|FG000|Overall Study|Withdrawal by Subject|22|||
94699356|NCT01939158|324355494|FG001|Overall Study|Withdrawal by Subject|25|||
94699357|NCT01939158|324355495|FG002|Overall Study|Withdrawal by Subject|15|||
94699358|NCT01939158|324355496|FG003|Overall Study|Withdrawal by Subject|17|||
94699359|NCT01939158|324355493|FG000|Overall Study|Migrated/moved from study area|5|||
94699360|NCT01939158|324355494|FG001|Overall Study|Migrated/moved from study area|7|||
94699361|NCT01939158|324355495|FG002|Overall Study|Migrated/moved from study area|3|||
94699362|NCT01939158|324355496|FG003|Overall Study|Migrated/moved from study area|6|||
94699363|NCT01939158|324355493|FG000|Overall Study|Lost to Follow-up|18|||
94699364|NCT01939158|324355494|FG001|Overall Study|Lost to Follow-up|17|||
94699365|NCT01939158|324355495|FG002|Overall Study|Lost to Follow-up|17|||
94699366|NCT01939158|324355496|FG003|Overall Study|Lost to Follow-up|17|||
94699367|NCT01939158|324355493|FG000|Overall Study|Death|0|||
94699368|NCT01939158|324355494|FG001|Overall Study|Death|0|||
94699369|NCT01939158|324355495|FG002|Overall Study|Death|1|||
94699370|NCT01939158|324355496|FG003|Overall Study|Death|1|||
94699371|NCT01939158|324355493|FG000|Overall Study|No longer meets eligibility criteria|0|||
94699372|NCT01939158|324355494|FG001|Overall Study|No longer meets eligibility criteria|0|||
94699373|NCT01939158|324355495|FG002|Overall Study|No longer meets eligibility criteria|1|||
94699374|NCT01939158|324355496|FG003|Overall Study|No longer meets eligibility criteria|0|||
94699375|NCT01939158|324355493|FG000|Overall Study|Other|1|||
94699376|NCT01939158|324355494|FG001|Overall Study|Other|3|||
94699377|NCT01939158|324355495|FG002|Overall Study|Other|4|||
94699378|NCT01939158|324355496|FG003|Overall Study|Other|3|||
94699379|NCT01304706|324355497|FG000|Overall Study|Adverse Event|2|||
94699380|NCT01304706|324355497|FG000|Overall Study|Lack of Efficacy|1|||
94699381|NCT01304706|324355497|FG000|Overall Study|Death|3|||
94699382|NCT01304706|324355497|FG000|Overall Study|Withdrawal by Subject|3|||
94699383|NCT01304706|324355497|FG000|Overall Study|Lost to Follow-up|7|||
94699384|NCT01304706|324355497|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
94699385|NCT04672460|324355500|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
94699386|NCT04672460|324355501|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
94699387|NCT04672460|324355500|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
94699388|NCT04672460|324355501|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
94699389|NCT04672460|324355500|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
94699390|NCT04672460|324355501|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
94699391|NCT04672460|324355500|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
94699392|NCT04672460|324355501|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
94699393|NCT04672460|324355500|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
94699394|NCT04672460|324355501|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
94699395|NCT04672460|324355500|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
94699396|NCT04672460|324355501|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
94699397|NCT04672460|324355500|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
94699398|NCT04672460|324355501|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
94699399|NCT04672460|324355500|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
94699400|NCT04672460|324355501|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
94699401|NCT04672460|324355500|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
94699402|NCT04672460|324355501|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
94699403|NCT04672460|324355500|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
94699404|NCT04672460|324355501|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
94699405|NCT04672460|324355500|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
94699406|NCT04672460|324355501|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
94699407|NCT04672460|324355500|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
94699408|NCT04672460|324355501|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
94699409|NCT04672460|324355500|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
94699410|NCT04672460|324355501|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
94699411|NCT04672460|324355500|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
94699412|NCT04672460|324355501|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
94699413|NCT04672460|324355500|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
94699414|NCT04672460|324355501|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
94699415|NCT04672460|324355500|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
94699416|NCT04672460|324355501|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
94699417|NCT04672460|324355500|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
94699418|NCT04672460|324355501|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
94699419|NCT01106287|324355502|FG000|Overall Study|Adverse Event|1|||
94699420|NCT01106287|324355503|FG001|Overall Study|Adverse Event|0|||
94699421|NCT01106287|324355504|FG002|Overall Study|Adverse Event|0|||
94699422|NCT01106287|324355505|FG003|Overall Study|Adverse Event|0|||
94699423|NCT01450943|324355506|FG000|Overall Study|Screen failure, loss to follow-up|2|||
94699424|NCT01450943|324355507|FG001|Overall Study|Screen failure, loss to follow-up|7|||
94699425|NCT01450943|324355508|FG002|Overall Study|Screen failure, loss to follow-up|6|||
94699426|NCT01097655|324355511|FG000|Overall Study|Withdrawal by Subject|1|||
94699427|NCT01097655|324355511|FG000|Overall Study|Subject Documented Twice|1|||
94699428|NCT01097655|324355511|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
94699429|NCT05074498|324355512|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
94699430|NCT05074498|324355513|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
94699431|NCT05074498|324355514|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
94699432|NCT05074498|324355515|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
94699433|NCT05074498|324355516|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
94699434|NCT05074498|324355517|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
94699435|NCT05074498|324355512|FG000|Part 1 (Upto Day 104)|Other|1|||
94699436|NCT05074498|324355513|FG001|Part 1 (Upto Day 104)|Other|0|||
94699437|NCT05074498|324355514|FG002|Part 1 (Upto Day 104)|Other|0|||
94699438|NCT05074498|324355515|FG003|Part 1 (Upto Day 104)|Other|0|||
94699439|NCT05074498|324355516|FG004|Part 1 (Upto Day 104)|Other|0|||
94699440|NCT05074498|324355517|FG005|Part 1 (Upto Day 104)|Other|0|||
94699441|NCT05074498|324355512|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
94699442|NCT05074498|324355513|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
94699443|NCT05074498|324355514|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
94699444|NCT05074498|324355515|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
94699445|NCT05074498|324355516|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
94699446|NCT05074498|324355517|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
94699447|NCT05074498|324355512|FG000|Part 2 (Upto Day 104)|Death|0|||
94699448|NCT05074498|324355513|FG001|Part 2 (Upto Day 104)|Death|0|||
94699449|NCT05074498|324355514|FG002|Part 2 (Upto Day 104)|Death|0|||
94699450|NCT05074498|324355515|FG003|Part 2 (Upto Day 104)|Death|0|||
94699451|NCT05074498|324355516|FG004|Part 2 (Upto Day 104)|Death|1|||
94699452|NCT05074498|324355517|FG005|Part 2 (Upto Day 104)|Death|0|||
94699453|NCT05074498|324355512|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
94699454|NCT05074498|324355513|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
94699455|NCT05074498|324355514|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
94699456|NCT05074498|324355515|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
94699457|NCT05074498|324355516|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
94699458|NCT05074498|324355517|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
94699459|NCT05074498|324355512|FG000|Part 2 (Upto Day 104)|Other|0|||
94699460|NCT05074498|324355513|FG001|Part 2 (Upto Day 104)|Other|0|||
94699461|NCT05074498|324355514|FG002|Part 2 (Upto Day 104)|Other|0|||
94699462|NCT05074498|324355515|FG003|Part 2 (Upto Day 104)|Other|0|||
94699463|NCT05074498|324355516|FG004|Part 2 (Upto Day 104)|Other|1|||
94699464|NCT05074498|324355517|FG005|Part 2 (Upto Day 104)|Other|0|||
94699465|NCT05328973|324355524|FG000|Overall Study|Withdrawal by Subject|0|||
94699466|NCT05328973|324355525|FG001|Overall Study|Withdrawal by Subject|1|||
94699467|NCT00946114|324355526|FG000|Overall Study|Death|5|||
94699468|NCT00946114|324355527|FG001|Overall Study|Death|2|||
94699469|NCT00946114|324355526|FG000|Overall Study|Other|1|||
94699470|NCT00946114|324355527|FG001|Overall Study|Other|0|||
94699471|NCT00946114|324355526|FG000|Overall Study|Withdrawal by Subject|2|||
94699472|NCT00946114|324355527|FG001|Overall Study|Withdrawal by Subject|0|||
94699473|NCT00498186|324355528|FG000|Overall Study|Protocol Violation|10|||
94699474|NCT00498186|324355528|FG000|Overall Study|Lack of Efficacy|31|||
94699475|NCT00498186|324355528|FG000|Overall Study|Adverse Event|89|||
94699476|NCT00498186|324355528|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
94699477|NCT00498186|324355528|FG000|Overall Study|Withdrawal by Subject|18|||
94699478|NCT00498186|324355528|FG000|Overall Study|Lost to Follow-up|3|||
94699479|NCT00498186|324355528|FG000|Overall Study|Other|10|||
94699480|NCT01175707|324355533|FG000|Overall Study|Adverse Event|4|||
94699481|NCT01175707|324355534|FG001|Overall Study|Adverse Event|6|||
94699482|NCT02347943|324355541|FG000|Overall Study|Study was cancelled|140|||
94699483|NCT02347943|324355542|FG001|Overall Study|Study was cancelled|67|||
94699484|NCT02347943|324355543|FG002|Overall Study|Study was cancelled|45|||
94699485|NCT00303303|324355545|FG000|Overall Study|Withdrawal by Subject|0|||
94699486|NCT00303303|324355546|FG001|Overall Study|Withdrawal by Subject|0|||
94699487|NCT00303303|324355547|FG002|Overall Study|Withdrawal by Subject|1|||
94699488|NCT05124899|324355548|FG000|Overall Study|Lost to Follow-up|3|||
94699489|NCT01813422|324355550|FG000|Overall Study|Withdrawal by Subject|14|||
94699490|NCT01813422|324355551|FG001|Overall Study|Withdrawal by Subject|8|||
94699491|NCT01813422|324355550|FG000|Overall Study|Death|2|||
94699492|NCT01813422|324355551|FG001|Overall Study|Death|3|||
94699493|NCT01813422|324355550|FG000|Overall Study|Sponsor Decision|2|||
94699494|NCT01813422|324355551|FG001|Overall Study|Sponsor Decision|1|||
94699495|NCT01813422|324355550|FG000|Overall Study|Lost to Follow-up|2|||
94699496|NCT01813422|324355551|FG001|Overall Study|Lost to Follow-up|4|||
94699497|NCT01763047|324355560|FG000|Period 1|Test Article Not Available|4|||
94699498|NCT01763047|324355561|FG001|Period 1|Test Article Not Available|1|||
94699499|NCT01763047|324355560|FG000|Period 1|Protocol Violation|4|||
94699500|NCT01763047|324355561|FG001|Period 1|Protocol Violation|4|||
94699501|NCT01763047|324355560|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
94699502|NCT01763047|324355561|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
94699503|NCT01763047|324355560|FG000|Period 1|Adverse Event|0|||
94699504|NCT01763047|324355561|FG001|Period 1|Adverse Event|1|||
94699505|NCT01763047|324355560|FG000|Period 1|Unsatisfactory Visual Response|0|||
94699506|NCT01763047|324355561|FG001|Period 1|Unsatisfactory Visual Response|3|||
94699507|NCT01763047|324355560|FG000|Period 1|Lens Power Not Available|0|||
94699508|NCT01763047|324355561|FG001|Period 1|Lens Power Not Available|1|||
94699509|NCT01763047|324355560|FG000|Period 1|Study Site office Closed|0|||
94699510|NCT01763047|324355561|FG001|Period 1|Study Site office Closed|1|||
94699511|NCT01763047|324355560|FG000|Period 2|Lens Discomfort|1|||
94466127|NCT01472939|323496943|FG002|Overall Study|Lack of Efficacy|0|||
94699512|NCT01763047|324355561|FG001|Period 2|Lens Discomfort|0|||
94699513|NCT01763047|324355560|FG000|Period 2|No longer meets Eligibility Criteria|1|||
94699514|NCT01763047|324355561|FG001|Period 2|No longer meets Eligibility Criteria|0|||
94699515|NCT01763047|324355560|FG000|Period 2|Study Site office Closed|1|||
94699516|NCT01763047|324355561|FG001|Period 2|Study Site office Closed|1|||
94699517|NCT01763047|324355560|FG000|Period 2|Unsatisfactory Visual Response|1|||
94699518|NCT01763047|324355561|FG001|Period 2|Unsatisfactory Visual Response|1|||
94699519|NCT01763047|324355560|FG000|Period 2|Protocol Violation|0|||
94699520|NCT01763047|324355561|FG001|Period 2|Protocol Violation|2|||
94699521|NCT01763047|324355560|FG000|Period 2|Unsatisfactory lens Fitting|0|||
94699522|NCT01763047|324355561|FG001|Period 2|Unsatisfactory lens Fitting|1|||
94699523|NCT00916006|324355565|FG000|Overall Study|Adverse Event|1|||
94699524|NCT00916006|324355566|FG001|Overall Study|Adverse Event|1|||
94699525|NCT00916006|324355565|FG000|Overall Study|Withdrawal by Subject|2|||
94699526|NCT00916006|324355566|FG001|Overall Study|Withdrawal by Subject|5|||
94699527|NCT00916006|324355565|FG000|Overall Study|Protocol Violation|0|||
94699528|NCT00916006|324355566|FG001|Overall Study|Protocol Violation|1|||
94699529|NCT03404843|324355569|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
94699530|NCT03404843|324355570|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
94699531|NCT05650333|324355579|FG000|Treatment Period (7 Days)|Adverse Event|1|||
94699532|NCT03852433|324355580|FG000|Overall Study|Withdrawal of consent|5|||
94699533|NCT03852433|324355581|FG001|Overall Study|Withdrawal of consent|8|||
94699534|NCT03852433|324355582|FG002|Overall Study|Withdrawal of consent|1|||
94699535|NCT03852433|324355583|FG003|Overall Study|Withdrawal of consent|1|||
94699536|NCT03852433|324355580|FG000|Overall Study|Adverse Event|1|||
94699537|NCT03852433|324355581|FG001|Overall Study|Adverse Event|1|||
94699538|NCT03852433|324355582|FG002|Overall Study|Adverse Event|1|||
94699539|NCT03852433|324355583|FG003|Overall Study|Adverse Event|1|||
94699540|NCT03852433|324355580|FG000|Overall Study|Lost to Follow-up|0|||
94699541|NCT03852433|324355581|FG001|Overall Study|Lost to Follow-up|1|||
94699542|NCT03852433|324355582|FG002|Overall Study|Lost to Follow-up|0|||
94699543|NCT03852433|324355583|FG003|Overall Study|Lost to Follow-up|1|||
94699544|NCT03852433|324355580|FG000|Overall Study|Pregnancy|0|||
94699545|NCT03852433|324355581|FG001|Overall Study|Pregnancy|1|||
94699546|NCT03852433|324355582|FG002|Overall Study|Pregnancy|1|||
94699547|NCT03852433|324355583|FG003|Overall Study|Pregnancy|0|||
94699548|NCT03852433|324355580|FG000|Overall Study|Protocol Violation|0|||
94699549|NCT03852433|324355581|FG001|Overall Study|Protocol Violation|0|||
94699550|NCT03852433|324355582|FG002|Overall Study|Protocol Violation|1|||
94699551|NCT03852433|324355583|FG003|Overall Study|Protocol Violation|1|||
94699552|NCT03852433|324355580|FG000|Overall Study|Death|0|||
94699553|NCT03852433|324355581|FG001|Overall Study|Death|0|||
94699554|NCT03852433|324355582|FG002|Overall Study|Death|1|||
94699555|NCT03852433|324355583|FG003|Overall Study|Death|0|||
94699556|NCT03852433|324355580|FG000|Overall Study|Lack of Efficacy|0|||
94699557|NCT03852433|324355581|FG001|Overall Study|Lack of Efficacy|1|||
94699558|NCT03852433|324355582|FG002|Overall Study|Lack of Efficacy|0|||
94699559|NCT03852433|324355583|FG003|Overall Study|Lack of Efficacy|0|||
94699560|NCT03852433|324355580|FG000|Overall Study|Non-compliance with study drug|0|||
94699561|NCT03852433|324355581|FG001|Overall Study|Non-compliance with study drug|0|||
94699562|NCT03852433|324355582|FG002|Overall Study|Non-compliance with study drug|0|||
94265686|NCT00705432|322765789|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
94265687|NCT00705432|322765790|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
94699563|NCT03852433|324355583|FG003|Overall Study|Non-compliance with study drug|1|||
94265688|NCT01667107|322765791|FG000|Overall Study|Adverse Event|4|||
94699564|NCT03852433|324355580|FG000|Overall Study|Physician Decision|1|||
94699565|NCT03852433|324355581|FG001|Overall Study|Physician Decision|0|||
94699566|NCT03852433|324355582|FG002|Overall Study|Physician Decision|0|||
94699567|NCT03852433|324355583|FG003|Overall Study|Physician Decision|0|||
94699568|NCT03852433|324355580|FG000|Overall Study|Randomized but never treated|1|||
94699569|NCT03852433|324355581|FG001|Overall Study|Randomized but never treated|0|||
94699570|NCT03852433|324355582|FG002|Overall Study|Randomized but never treated|0|||
94699571|NCT03852433|324355583|FG003|Overall Study|Randomized but never treated|0|||
94699572|NCT01446003|324355584|FG000|Period 1|Protocol Violation|2|||
94699573|NCT01446003|324355585|FG001|Period 1|Protocol Violation|0|||
94699574|NCT01446003|324355584|FG000|Period 2|Adverse Event|1|||
94699575|NCT01446003|324355585|FG001|Period 2|Adverse Event|0|||
94699576|NCT00490555|324355586|FG000|Overall Study|noncompliant with drug administration|0|||
94699577|NCT00490555|324355587|FG001|Overall Study|noncompliant with drug administration|0|||
94699578|NCT00490555|324355588|FG002|Overall Study|noncompliant with drug administration|2|||
94699579|NCT00490555|324355589|FG003|Overall Study|noncompliant with drug administration|0|||
94699580|NCT00783692|324355598|FG000|Induction Phase|Adverse Event|7|||
94699581|NCT00783692|324355599|FG001|Induction Phase|Adverse Event|9|||
94466128|NCT01472939|323496944|FG003|Overall Study|Lack of Efficacy|1|||
94699582|NCT00783692|324355600|FG002|Induction Phase|Adverse Event|24|||
94699583|NCT00783692|324355601|FG003|Induction Phase|Adverse Event|0|||
94699584|NCT00783692|324355602|FG004|Induction Phase|Adverse Event|0|||
94699585|NCT00783692|324355603|FG005|Induction Phase|Adverse Event|0|||
94699586|NCT00783692|324355604|FG006|Induction Phase|Adverse Event|0|||
94699587|NCT00783692|324355598|FG000|Induction Phase|Protocol Violation|0|||
94699588|NCT00783692|324355599|FG001|Induction Phase|Protocol Violation|0|||
94699589|NCT00783692|324355600|FG002|Induction Phase|Protocol Violation|1|||
94699590|NCT00783692|324355601|FG003|Induction Phase|Protocol Violation|0|||
94699591|NCT00783692|324355602|FG004|Induction Phase|Protocol Violation|0|||
94699592|NCT00783692|324355603|FG005|Induction Phase|Protocol Violation|0|||
94699593|NCT00783692|324355604|FG006|Induction Phase|Protocol Violation|0|||
94699594|NCT00783692|324355598|FG000|Induction Phase|Lack of Efficacy|1|||
94699595|NCT00783692|324355599|FG001|Induction Phase|Lack of Efficacy|3|||
94699596|NCT00783692|324355600|FG002|Induction Phase|Lack of Efficacy|28|||
94699597|NCT00783692|324355601|FG003|Induction Phase|Lack of Efficacy|0|||
94699598|NCT00783692|324355602|FG004|Induction Phase|Lack of Efficacy|0|||
94699599|NCT00783692|324355603|FG005|Induction Phase|Lack of Efficacy|0|||
94699600|NCT00783692|324355604|FG006|Induction Phase|Lack of Efficacy|0|||
94699601|NCT00783692|324355598|FG000|Induction Phase|Withdrawal by Subject|3|||
94699602|NCT00783692|324355599|FG001|Induction Phase|Withdrawal by Subject|9|||
94699603|NCT00783692|324355600|FG002|Induction Phase|Withdrawal by Subject|16|||
94699604|NCT00783692|324355601|FG003|Induction Phase|Withdrawal by Subject|0|||
94699605|NCT00783692|324355602|FG004|Induction Phase|Withdrawal by Subject|0|||
94699606|NCT00783692|324355603|FG005|Induction Phase|Withdrawal by Subject|0|||
94699607|NCT00783692|324355604|FG006|Induction Phase|Withdrawal by Subject|0|||
94699608|NCT00783692|324355598|FG000|Induction Phase|Lost to Follow-up|0|||
94699609|NCT00783692|324355599|FG001|Induction Phase|Lost to Follow-up|0|||
94699610|NCT00783692|324355600|FG002|Induction Phase|Lost to Follow-up|3|||
94699611|NCT00783692|324355601|FG003|Induction Phase|Lost to Follow-up|0|||
94699612|NCT00783692|324355602|FG004|Induction Phase|Lost to Follow-up|0|||
94699613|NCT00783692|324355603|FG005|Induction Phase|Lost to Follow-up|0|||
94699614|NCT00783692|324355604|FG006|Induction Phase|Lost to Follow-up|0|||
94699615|NCT00783692|324355598|FG000|Induction Phase|Other|0|||
94699616|NCT00783692|324355599|FG001|Induction Phase|Other|0|||
94699617|NCT00783692|324355600|FG002|Induction Phase|Other|2|||
94699618|NCT00783692|324355601|FG003|Induction Phase|Other|0|||
94699619|NCT00783692|324355602|FG004|Induction Phase|Other|0|||
94699620|NCT00783692|324355603|FG005|Induction Phase|Other|0|||
94699621|NCT00783692|324355604|FG006|Induction Phase|Other|0|||
94699622|NCT00783692|324355598|FG000|Maintenance Phase|Adverse Event|7|||
94699623|NCT00783692|324355599|FG001|Maintenance Phase|Adverse Event|0|||
94699624|NCT00783692|324355600|FG002|Maintenance Phase|Adverse Event|0|||
94699625|NCT00783692|324355601|FG003|Maintenance Phase|Adverse Event|15|||
94699626|NCT00783692|324355602|FG004|Maintenance Phase|Adverse Event|12|||
94699627|NCT00783692|324355603|FG005|Maintenance Phase|Adverse Event|9|||
94699628|NCT00783692|324355604|FG006|Maintenance Phase|Adverse Event|38|||
94699629|NCT00783692|324355598|FG000|Maintenance Phase|Protocol Violation|0|||
94699630|NCT00783692|324355599|FG001|Maintenance Phase|Protocol Violation|0|||
94699631|NCT00783692|324355600|FG002|Maintenance Phase|Protocol Violation|0|||
94699632|NCT00783692|324355601|FG003|Maintenance Phase|Protocol Violation|1|||
94699633|NCT00783692|324355602|FG004|Maintenance Phase|Protocol Violation|2|||
94699634|NCT00783692|324355603|FG005|Maintenance Phase|Protocol Violation|3|||
94699635|NCT00783692|324355604|FG006|Maintenance Phase|Protocol Violation|4|||
94699636|NCT00783692|324355598|FG000|Maintenance Phase|Lack of Efficacy|79|||
94699637|NCT00783692|324355599|FG001|Maintenance Phase|Lack of Efficacy|0|||
94699638|NCT00783692|324355600|FG002|Maintenance Phase|Lack of Efficacy|0|||
94699639|NCT00783692|324355601|FG003|Maintenance Phase|Lack of Efficacy|64|||
94699640|NCT00783692|324355602|FG004|Maintenance Phase|Lack of Efficacy|58|||
94699641|NCT00783692|324355603|FG005|Maintenance Phase|Lack of Efficacy|48|||
94699642|NCT00783692|324355604|FG006|Maintenance Phase|Lack of Efficacy|177|||
94699643|NCT00783692|324355598|FG000|Maintenance Phase|Withdrawal by Subject|7|||
94699644|NCT00783692|324355599|FG001|Maintenance Phase|Withdrawal by Subject|0|||
94699645|NCT00783692|324355600|FG002|Maintenance Phase|Withdrawal by Subject|0|||
94699646|NCT00783692|324355601|FG003|Maintenance Phase|Withdrawal by Subject|7|||
94699647|NCT00783692|324355602|FG004|Maintenance Phase|Withdrawal by Subject|6|||
94699648|NCT00783692|324355603|FG005|Maintenance Phase|Withdrawal by Subject|9|||
94699649|NCT00783692|324355604|FG006|Maintenance Phase|Withdrawal by Subject|24|||
94699650|NCT00783692|324355598|FG000|Maintenance Phase|Lost to Follow-up|2|||
94699651|NCT00783692|324355599|FG001|Maintenance Phase|Lost to Follow-up|0|||
94699652|NCT00783692|324355600|FG002|Maintenance Phase|Lost to Follow-up|0|||
94699653|NCT00783692|324355601|FG003|Maintenance Phase|Lost to Follow-up|1|||
94699654|NCT00783692|324355602|FG004|Maintenance Phase|Lost to Follow-up|3|||
94699655|NCT00783692|324355603|FG005|Maintenance Phase|Lost to Follow-up|2|||
94699656|NCT00783692|324355604|FG006|Maintenance Phase|Lost to Follow-up|5|||
94699657|NCT00783692|324355598|FG000|Maintenance Phase|Other|0|||
94699658|NCT00783692|324355599|FG001|Maintenance Phase|Other|0|||
94699659|NCT00783692|324355600|FG002|Maintenance Phase|Other|0|||
94699660|NCT00783692|324355601|FG003|Maintenance Phase|Other|1|||
94699661|NCT00783692|324355602|FG004|Maintenance Phase|Other|0|||
94699662|NCT00783692|324355603|FG005|Maintenance Phase|Other|1|||
94699663|NCT00783692|324355604|FG006|Maintenance Phase|Other|1|||
94699664|NCT02040844|324355611|FG000|Overall Study|Adverse Event|0|||
94699665|NCT02040844|324355612|FG001|Overall Study|Adverse Event|0|||
94699666|NCT02040844|324355613|FG002|Overall Study|Adverse Event|1|||
94699667|NCT02040844|324355611|FG000|Overall Study|Withdrawal by Subject|16|||
94699668|NCT02040844|324355612|FG001|Overall Study|Withdrawal by Subject|22|||
94699669|NCT02040844|324355613|FG002|Overall Study|Withdrawal by Subject|25|||
94699670|NCT02040844|324355611|FG000|Overall Study|Lost to Follow-up|12|||
94699671|NCT02040844|324355612|FG001|Overall Study|Lost to Follow-up|9|||
94699672|NCT02040844|324355613|FG002|Overall Study|Lost to Follow-up|13|||
94699673|NCT02040844|324355611|FG000|Overall Study|Missing|13|||
94699674|NCT02040844|324355612|FG001|Overall Study|Missing|3|||
94699675|NCT02040844|324355613|FG002|Overall Study|Missing|2|||
94699676|NCT02040844|324355611|FG000|Overall Study|Non-specified|8|||
94699677|NCT02040844|324355612|FG001|Overall Study|Non-specified|2|||
94699678|NCT02040844|324355613|FG002|Overall Study|Non-specified|5|||
94699679|NCT02040844|324355611|FG000|Overall Study|Concomitant medication|1|||
94699680|NCT02040844|324355612|FG001|Overall Study|Concomitant medication|3|||
94699681|NCT02040844|324355613|FG002|Overall Study|Concomitant medication|1|||
94699682|NCT04213846|324357332|FG000|Overall Study|Withdrawal by Subject|7|||
94366441|NCT01289990|323126544|FG007|Overall Study|Lost to Follow-up|2|||
94699683|NCT04213846|324357333|FG001|Overall Study|Withdrawal by Subject|6|||
94699684|NCT04213846|324357332|FG000|Overall Study|Lost to Follow-up|15|||
94699685|NCT04213846|324357333|FG001|Overall Study|Lost to Follow-up|21|||
94699686|NCT04091672|324357336|FG000|Overall Study|Death|6|||
94699687|NCT04091672|324357337|FG001|Overall Study|Death|6|||
94699688|NCT04091672|324357336|FG000|Overall Study|Lost to Follow-up|7|||
94699689|NCT04091672|324357337|FG001|Overall Study|Lost to Follow-up|7|||
94366442|NCT01289990|323126545|FG008|Overall Study|Lost to Follow-up|1|||
94366443|NCT01289990|323126546|FG009|Overall Study|Lost to Follow-up|4|||
94366444|NCT01289990|323126547|FG010|Overall Study|Lost to Follow-up|2|||
94366445|NCT01289990|323126548|FG011|Overall Study|Lost to Follow-up|1|||
94366446|NCT01289990|323126549|FG012|Overall Study|Lost to Follow-up|2|||
94699690|NCT04091672|324357336|FG000|Overall Study|Withdrawal by Subject|3|||
94699691|NCT04091672|324357337|FG001|Overall Study|Withdrawal by Subject|3|||
94699692|NCT04091672|324357336|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
94699693|NCT04091672|324357337|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
94366447|NCT01289990|323126537|FG000|Overall Study|Withdrawal by Subject|15|||
94699694|NCT05296629|324357338|FG000|Overall Study|Withdrawal by Subject|3|||
94699695|NCT05296629|324357339|FG001|Overall Study|Withdrawal by Subject|10|||
94699696|NCT05296629|324357340|FG002|Overall Study|Withdrawal by Subject|4|||
94699697|NCT05296629|324357338|FG000|Overall Study|Lost to Follow-up|2|||
94699698|NCT05296629|324357339|FG001|Overall Study|Lost to Follow-up|7|||
94699699|NCT05296629|324357340|FG002|Overall Study|Lost to Follow-up|1|||
94699700|NCT05296629|324357338|FG000|Overall Study|Adverse Event|0|||
94699701|NCT05296629|324357339|FG001|Overall Study|Adverse Event|4|||
94699702|NCT05296629|324357340|FG002|Overall Study|Adverse Event|2|||
94699703|NCT05296629|324357338|FG000|Overall Study|Protocol Violation|0|||
94699704|NCT05296629|324357339|FG001|Overall Study|Protocol Violation|2|||
94699705|NCT05296629|324357340|FG002|Overall Study|Protocol Violation|0|||
94699706|NCT04034238|324357341|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
94699707|NCT04034238|324357342|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
94699708|NCT04034238|324357343|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
94699709|NCT04034238|324357344|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
94699710|NCT04034238|324357341|FG000|Dose Escalation Phase|Screen failures|0|||
94699711|NCT04034238|324357342|FG001|Dose Escalation Phase|Screen failures|0|||
94699712|NCT04034238|324357343|FG002|Dose Escalation Phase|Screen failures|0|||
94699713|NCT04034238|324357344|FG003|Dose Escalation Phase|Screen failures|2|||
94699714|NCT04034238|324357341|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
94699715|NCT04034238|324357342|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
94699716|NCT04034238|324357343|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
94699717|NCT04034238|324357344|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
94699718|NCT04034238|324357341|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
94699719|NCT04034238|324357342|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
94699720|NCT04034238|324357343|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
94699721|NCT04034238|324357344|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
94699722|NCT00049517|324357349|FG000|Induction|Disease progression|0|||
94699723|NCT00049517|324357350|FG001|Induction|Disease progression|0|||
94699724|NCT00049517|324357351|FG002|Induction|Disease progression|0|||
94699725|NCT00049517|324357352|FG003|Induction|Disease progression|0|||
94699726|NCT00049517|324357353|FG004|Induction|Disease progression|18|||
94366448|NCT01289990|323126538|FG001|Overall Study|Withdrawal by Subject|14|||
94699727|NCT00049517|324357354|FG005|Induction|Disease progression|11|||
94699728|NCT00049517|324357349|FG000|Induction|Adverse Event|0|||
94699729|NCT00049517|324357350|FG001|Induction|Adverse Event|0|||
94699730|NCT00049517|324357351|FG002|Induction|Adverse Event|0|||
94699731|NCT00049517|324357352|FG003|Induction|Adverse Event|0|||
94699732|NCT00049517|324357353|FG004|Induction|Adverse Event|5|||
94699733|NCT00049517|324357354|FG005|Induction|Adverse Event|7|||
94699734|NCT00049517|324357349|FG000|Induction|Death|0|||
94699735|NCT00049517|324357350|FG001|Induction|Death|0|||
94699736|NCT00049517|324357351|FG002|Induction|Death|0|||
94699737|NCT00049517|324357352|FG003|Induction|Death|0|||
94699738|NCT00049517|324357353|FG004|Induction|Death|9|||
94699739|NCT00049517|324357354|FG005|Induction|Death|6|||
94699740|NCT00049517|324357349|FG000|Induction|Withdrawal by Subject|0|||
94699741|NCT00049517|324357350|FG001|Induction|Withdrawal by Subject|0|||
94466129|NCT01472939|323496941|FG000|Overall Study|Lost to Follow-up|3|||
94699742|NCT00049517|324357351|FG002|Induction|Withdrawal by Subject|0|||
94699743|NCT00049517|324357352|FG003|Induction|Withdrawal by Subject|0|||
94699744|NCT00049517|324357353|FG004|Induction|Withdrawal by Subject|1|||
94699745|NCT00049517|324357354|FG005|Induction|Withdrawal by Subject|3|||
94699746|NCT00049517|324357349|FG000|Induction|Alternative therapy|0|||
94699747|NCT00049517|324357350|FG001|Induction|Alternative therapy|0|||
94699748|NCT00049517|324357351|FG002|Induction|Alternative therapy|0|||
94699749|NCT00049517|324357352|FG003|Induction|Alternative therapy|0|||
94699750|NCT00049517|324357353|FG004|Induction|Alternative therapy|2|||
94699751|NCT00049517|324357354|FG005|Induction|Alternative therapy|2|||
94699752|NCT00049517|324357349|FG000|Induction|Other complicating disease|0|||
94699753|NCT00049517|324357350|FG001|Induction|Other complicating disease|0|||
94699754|NCT00049517|324357351|FG002|Induction|Other complicating disease|0|||
94699755|NCT00049517|324357352|FG003|Induction|Other complicating disease|0|||
94699756|NCT00049517|324357353|FG004|Induction|Other complicating disease|3|||
94699757|NCT00049517|324357354|FG005|Induction|Other complicating disease|0|||
94699758|NCT00049517|324357349|FG000|Induction|Reasons not reported|0|||
94699759|NCT00049517|324357350|FG001|Induction|Reasons not reported|0|||
94699760|NCT00049517|324357351|FG002|Induction|Reasons not reported|0|||
94699761|NCT00049517|324357352|FG003|Induction|Reasons not reported|0|||
94699762|NCT00049517|324357353|FG004|Induction|Reasons not reported|22|||
94699763|NCT00049517|324357354|FG005|Induction|Reasons not reported|25|||
94466130|NCT01472939|323496942|FG001|Overall Study|Lost to Follow-up|0|||
94699764|NCT00049517|324357349|FG000|Conditioning/Transplant|Disease progression|14|||
94699765|NCT00049517|324357350|FG001|Conditioning/Transplant|Disease progression|6|||
94699766|NCT00049517|324357351|FG002|Conditioning/Transplant|Disease progression|10|||
94699767|NCT00049517|324357352|FG003|Conditioning/Transplant|Disease progression|6|||
94699768|NCT00049517|324357353|FG004|Conditioning/Transplant|Disease progression|0|||
94699769|NCT00049517|324357354|FG005|Conditioning/Transplant|Disease progression|0|||
94699770|NCT00049517|324357349|FG000|Conditioning/Transplant|Adverse Event|2|||
94699771|NCT00049517|324357350|FG001|Conditioning/Transplant|Adverse Event|1|||
94699772|NCT00049517|324357351|FG002|Conditioning/Transplant|Adverse Event|4|||
94699773|NCT00049517|324357352|FG003|Conditioning/Transplant|Adverse Event|8|||
94699774|NCT00049517|324357353|FG004|Conditioning/Transplant|Adverse Event|0|||
94699775|NCT00049517|324357354|FG005|Conditioning/Transplant|Adverse Event|0|||
94699776|NCT00049517|324357349|FG000|Conditioning/Transplant|Death|1|||
94699777|NCT00049517|324357350|FG001|Conditioning/Transplant|Death|0|||
94699778|NCT00049517|324357351|FG002|Conditioning/Transplant|Death|0|||
94699779|NCT00049517|324357352|FG003|Conditioning/Transplant|Death|2|||
94699780|NCT00049517|324357353|FG004|Conditioning/Transplant|Death|0|||
94699781|NCT00049517|324357354|FG005|Conditioning/Transplant|Death|0|||
94699782|NCT00049517|324357349|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
94699783|NCT00049517|324357350|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
94699784|NCT00049517|324357351|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
94699785|NCT00049517|324357352|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
94699786|NCT00049517|324357353|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
94699787|NCT00049517|324357354|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
94699788|NCT00049517|324357349|FG000|Conditioning/Transplant|Alternative therapy|4|||
94699789|NCT00049517|324357350|FG001|Conditioning/Transplant|Alternative therapy|4|||
94699790|NCT00049517|324357351|FG002|Conditioning/Transplant|Alternative therapy|2|||
94699791|NCT00049517|324357352|FG003|Conditioning/Transplant|Alternative therapy|1|||
94699792|NCT00049517|324357353|FG004|Conditioning/Transplant|Alternative therapy|1|||
94699793|NCT00049517|324357354|FG005|Conditioning/Transplant|Alternative therapy|0|||
94699794|NCT00049517|324357349|FG000|Conditioning/Transplant|Other complicating disease|2|||
94699795|NCT00049517|324357350|FG001|Conditioning/Transplant|Other complicating disease|0|||
94699796|NCT00049517|324357351|FG002|Conditioning/Transplant|Other complicating disease|0|||
94699797|NCT00049517|324357352|FG003|Conditioning/Transplant|Other complicating disease|4|||
94699798|NCT00049517|324357353|FG004|Conditioning/Transplant|Other complicating disease|0|||
94699799|NCT00049517|324357354|FG005|Conditioning/Transplant|Other complicating disease|1|||
94699800|NCT00049517|324357349|FG000|Conditioning/Transplant|Reasons not reported|25|||
94699801|NCT00049517|324357350|FG001|Conditioning/Transplant|Reasons not reported|31|||
94699802|NCT00049517|324357351|FG002|Conditioning/Transplant|Reasons not reported|18|||
94699803|NCT00049517|324357352|FG003|Conditioning/Transplant|Reasons not reported|15|||
94699804|NCT00049517|324357353|FG004|Conditioning/Transplant|Reasons not reported|5|||
94699805|NCT00049517|324357354|FG005|Conditioning/Transplant|Reasons not reported|5|||
94699806|NCT02206685|324357355|FG000|Overall Study|Surgery cancelled/changed|2|||
94699807|NCT02206685|324357356|FG001|Overall Study|Surgery cancelled/changed|3|||
94699808|NCT02206685|324357355|FG000|Overall Study|Withdrawal by Subject|1|||
94699809|NCT02206685|324357356|FG001|Overall Study|Withdrawal by Subject|2|||
94699810|NCT02206685|324357355|FG000|Overall Study|Protocol Violation|2|||
94699811|NCT02206685|324357356|FG001|Overall Study|Protocol Violation|2|||
94699812|NCT00093795|324357357|FG000|Overall Study|No follow up data|20|||
94366449|NCT01289990|323126539|FG002|Overall Study|Withdrawal by Subject|12|||
94366450|NCT01289990|323126540|FG003|Overall Study|Withdrawal by Subject|13|||
94366451|NCT01289990|323126541|FG004|Overall Study|Withdrawal by Subject|8|||
94699813|NCT00093795|324357358|FG001|Overall Study|No follow up data|16|||
94699814|NCT00093795|324357359|FG002|Overall Study|No follow up data|17|||
94699815|NCT04730947|324357360|FG000|Overall Study|Withdrawal by Subject|0|||
94366452|NCT01289990|323126542|FG005|Overall Study|Withdrawal by Subject|7|||
94699816|NCT04730947|324357361|FG001|Overall Study|Withdrawal by Subject|1|||
94699817|NCT01211665|324357367|FG000|Overall Study|Withdrawal by Subject|1|||
94699818|NCT01211665|324357368|FG001|Overall Study|Withdrawal by Subject|0|||
94699819|NCT01211665|324357367|FG000|Overall Study|Death|1|||
94699820|NCT01211665|324357368|FG001|Overall Study|Death|0|||
94699821|NCT04454567|324357371|FG000|Overall Study|Study Terminated by Sponsor|1|||
94699822|NCT04454567|324357372|FG001|Overall Study|Study Terminated by Sponsor|1|||
94699823|NCT00051311|324357373|FG000|Overall Study|Starting new study|0|||
94699824|NCT00051311|324357374|FG001|Overall Study|Starting new study|1|||
94699825|NCT00051311|324357373|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
94699826|NCT00051311|324357374|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
94699827|NCT00051311|324357373|FG000|Overall Study|Death of recipient|8|||
94699828|NCT00051311|324357374|FG001|Overall Study|Death of recipient|8|||
94699829|NCT00051311|324357373|FG000|Overall Study|Recipient taken off study|4|||
94699830|NCT00051311|324357374|FG001|Overall Study|Recipient taken off study|4|||
94699831|NCT03278028|324357375|FG000|Overall Study|Lost to Follow-up|1|||
94699832|NCT03278028|324357376|FG001|Overall Study|Lost to Follow-up|0|||
94699833|NCT03278028|324357375|FG000|Overall Study|Withdrawal by Subject|3|||
94699834|NCT03278028|324357376|FG001|Overall Study|Withdrawal by Subject|1|||
94699835|NCT03278028|324357375|FG000|Overall Study|Pregnancy|0|||
94699836|NCT03278028|324357376|FG001|Overall Study|Pregnancy|1|||
94699837|NCT01657682|324357377|FG000|Overall Study|Lost to Follow-up|1|||
94699838|NCT01657682|324357378|FG001|Overall Study|Lost to Follow-up|0|||
94699839|NCT01657682|324357379|FG002|Overall Study|Lost to Follow-up|0|||
94699840|NCT01657682|324357377|FG000|Overall Study|Withdrawal by Subject|0|||
94699841|NCT01657682|324357378|FG001|Overall Study|Withdrawal by Subject|1|||
94699842|NCT01657682|324357379|FG002|Overall Study|Withdrawal by Subject|1|||
94699843|NCT01657682|324357377|FG000|Overall Study|Adverse Event|0|||
94699844|NCT01657682|324357378|FG001|Overall Study|Adverse Event|1|||
94699845|NCT01657682|324357379|FG002|Overall Study|Adverse Event|0|||
94699846|NCT00958009|324357384|FG000|Overall Study|Adverse Event|1|||
94699847|NCT00958009|324357384|FG000|Overall Study|Subject found device difficult to use|1|||
94699848|NCT03432533|324357385|FG000|Overall Study|Lost to Follow-up|1|||
94699849|NCT03432533|324357386|FG001|Overall Study|Lost to Follow-up|2|||
94699850|NCT03432533|324357385|FG000|Overall Study|Withdrawal by Subject|14|||
94699851|NCT03432533|324357386|FG001|Overall Study|Withdrawal by Subject|9|||
94699852|NCT02365298|324357389|FG000|Period 2|incorrect Rx dispensed|1|||
94699853|NCT02365298|324357390|FG001|Period 2|incorrect Rx dispensed|0|||
94699854|NCT02365298|324357389|FG000|Period 2|Discontinued at request of Sponsor|1|||
94699855|NCT02365298|324357390|FG001|Period 2|Discontinued at request of Sponsor|0|||
94699856|NCT02365298|324357389|FG000|Period 2|Test Article longer available|0|||
94699857|NCT02365298|324357390|FG001|Period 2|Test Article longer available|1|||
94699858|NCT02365298|324357389|FG000|Period 2|Protocol Violation|0|||
94699859|NCT02365298|324357390|FG001|Period 2|Protocol Violation|1|||
94699860|NCT03593070|324357392|FG000|Overall Study|administrative withdrawal|1|||
94699861|NCT03593070|324357393|FG001|Overall Study|administrative withdrawal|1|||
94699862|NCT02939183|324357394|FG000|Overall Study|Death|0|||
94699863|NCT02939183|324357395|FG001|Overall Study|Death|0|||
94699864|NCT02939183|324357396|FG002|Overall Study|Death|1|||
94699865|NCT02939183|324357397|FG003|Overall Study|Death|0|||
94699866|NCT02939183|324357398|FG004|Overall Study|Death|0|||
94699867|NCT02939183|324357399|FG005|Overall Study|Death|2|||
94699868|NCT02939183|324357400|FG006|Overall Study|Death|1|||
94699869|NCT02939183|324357401|FG007|Overall Study|Death|0|||
94265689|NCT01667107|322765792|FG001|Overall Study|Adverse Event|3|||
94466131|NCT01472939|323496943|FG002|Overall Study|Lost to Follow-up|2|||
94699870|NCT02939183|324357402|FG008|Overall Study|Death|0|||
94699871|NCT02939183|324357394|FG000|Overall Study|Sponsor decision|0|||
94699872|NCT02939183|324357395|FG001|Overall Study|Sponsor decision|1|||
94699873|NCT02939183|324357396|FG002|Overall Study|Sponsor decision|0|||
94699874|NCT02939183|324357397|FG003|Overall Study|Sponsor decision|1|||
94699875|NCT02939183|324357398|FG004|Overall Study|Sponsor decision|2|||
94699876|NCT02939183|324357399|FG005|Overall Study|Sponsor decision|0|||
94265690|NCT01667107|322765791|FG000|Overall Study|Tolerability issues|0|||
94265691|NCT01667107|322765792|FG001|Overall Study|Tolerability issues|2|||
94265692|NCT01667107|322765791|FG000|Overall Study|Protocol Violation|0|||
94366453|NCT01289990|323126543|FG006|Overall Study|Withdrawal by Subject|13|||
94699877|NCT02939183|324357400|FG006|Overall Study|Sponsor decision|3|||
94699878|NCT02939183|324357401|FG007|Overall Study|Sponsor decision|1|||
94699879|NCT02939183|324357402|FG008|Overall Study|Sponsor decision|4|||
94699880|NCT02939183|324357394|FG000|Overall Study|Withdrawal by Subject|0|||
94699881|NCT02939183|324357395|FG001|Overall Study|Withdrawal by Subject|2|||
94699882|NCT02939183|324357396|FG002|Overall Study|Withdrawal by Subject|0|||
94699883|NCT02939183|324357397|FG003|Overall Study|Withdrawal by Subject|1|||
94699884|NCT02939183|324357398|FG004|Overall Study|Withdrawal by Subject|0|||
94699885|NCT02939183|324357399|FG005|Overall Study|Withdrawal by Subject|0|||
94699886|NCT02939183|324357400|FG006|Overall Study|Withdrawal by Subject|2|||
94699887|NCT02939183|324357401|FG007|Overall Study|Withdrawal by Subject|2|||
94699888|NCT02939183|324357402|FG008|Overall Study|Withdrawal by Subject|2|||
94699889|NCT02939183|324357394|FG000|Overall Study|Not treated due to adverse event|0|||
94699890|NCT02939183|324357395|FG001|Overall Study|Not treated due to adverse event|0|||
94699891|NCT02939183|324357396|FG002|Overall Study|Not treated due to adverse event|0|||
94699892|NCT02939183|324357397|FG003|Overall Study|Not treated due to adverse event|1|||
94699893|NCT02939183|324357398|FG004|Overall Study|Not treated due to adverse event|0|||
94699894|NCT02939183|324357399|FG005|Overall Study|Not treated due to adverse event|0|||
94699895|NCT02939183|324357400|FG006|Overall Study|Not treated due to adverse event|1|||
94699896|NCT02939183|324357401|FG007|Overall Study|Not treated due to adverse event|0|||
94699897|NCT02939183|324357402|FG008|Overall Study|Not treated due to adverse event|0|||
94699898|NCT05015478|324357403|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
94699899|NCT05015478|324357404|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
94699900|NCT05015478|324357405|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
94699901|NCT05015478|324357406|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
94699902|NCT00318656|324357407|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
94699903|NCT00318656|324357408|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
94699904|NCT00318656|324357407|FG000|Overall Study|Did not receive any treatment|0|||
94699905|NCT00318656|324357408|FG001|Overall Study|Did not receive any treatment|1|||
94699906|NCT03905135|324357409|FG000|Dose Escalation|Adverse Event|1|||
94699907|NCT03905135|324357410|FG001|Dose Escalation|Adverse Event|1|||
94699908|NCT03905135|324357409|FG000|Dose Escalation|Progressive disease|3|||
94699909|NCT03905135|324357410|FG001|Dose Escalation|Progressive disease|1|||
94699910|NCT03905135|324357409|FG000|Dose Escalation|Intercurrent illness|1|||
94699911|NCT03905135|324357410|FG001|Dose Escalation|Intercurrent illness|0|||
94699912|NCT04550039|324357417|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
94699913|NCT04550039|324357418|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
94699914|NCT04550039|324357417|FG000|Overall Study|patient self-withdrew from study|0|||
94699915|NCT04550039|324357418|FG001|Overall Study|patient self-withdrew from study|1|||
94699916|NCT03396913|324357419|FG000|Overall Study|Lost to Follow-up|0|||
94699917|NCT03396913|324357420|FG001|Overall Study|Lost to Follow-up|6|||
94699918|NCT00881335|324357421|FG000|Overall Study|Lost to Follow-up|3|||
94699919|NCT00881335|324357422|FG001|Overall Study|Lost to Follow-up|2|||
94699920|NCT00828945|324357423|FG000|Overall Study|Death|4|||
94699921|NCT00828945|324357423|FG000|Overall Study|Participant was missing|1|||
94699922|NCT00828945|324357423|FG000|Overall Study|Other|36|||
94699923|NCT03005288|324357426|FG000|Overall Study|Withdrawal by Subject|7|||
94366454|NCT01289990|323126544|FG007|Overall Study|Withdrawal by Subject|9|||
94366455|NCT01289990|323126545|FG008|Overall Study|Withdrawal by Subject|12|||
94366456|NCT01289990|323126546|FG009|Overall Study|Withdrawal by Subject|13|||
94366457|NCT01289990|323126547|FG010|Overall Study|Withdrawal by Subject|11|||
94366458|NCT01289990|323126548|FG011|Overall Study|Withdrawal by Subject|13|||
94366459|NCT01289990|323126549|FG012|Overall Study|Withdrawal by Subject|16|||
94366460|NCT01289990|323126537|FG000|Overall Study|discontinued in preceding trial|18|||
94366461|NCT01289990|323126538|FG001|Overall Study|discontinued in preceding trial|20|||
94366462|NCT01289990|323126539|FG002|Overall Study|discontinued in preceding trial|41|||
94699924|NCT03005288|324357427|FG001|Overall Study|Withdrawal by Subject|5|||
94699925|NCT03005288|324357426|FG000|Overall Study|Lost to Follow-up|0|||
94366463|NCT01289990|323126540|FG003|Overall Study|discontinued in preceding trial|17|||
94699926|NCT03005288|324357427|FG001|Overall Study|Lost to Follow-up|1|||
94699927|NCT03005288|324357426|FG000|Overall Study|Adverse Event|5|||
94699928|NCT03005288|324357427|FG001|Overall Study|Adverse Event|0|||
94699929|NCT03005288|324357426|FG000|Overall Study|Protocol deviation|0|||
94699930|NCT03005288|324357427|FG001|Overall Study|Protocol deviation|1|||
94699931|NCT03005288|324357426|FG000|Overall Study|Physician Decision|0|||
94699932|NCT03005288|324357427|FG001|Overall Study|Physician Decision|1|||
94699933|NCT00462943|324357428|FG000|Overall Study|Failure to achieve a response|5|||
94699934|NCT00462943|324357429|FG001|Overall Study|Failure to achieve a response|5|||
94699935|NCT00462943|324357430|FG002|Overall Study|Failure to achieve a response|1|||
94699936|NCT00462943|324357428|FG000|Overall Study|Adverse Event|6|||
94699937|NCT00462943|324357429|FG001|Overall Study|Adverse Event|4|||
94699938|NCT00462943|324357430|FG002|Overall Study|Adverse Event|1|||
94699939|NCT00462943|324357428|FG000|Overall Study|Protocol Violation|1|||
94699940|NCT00462943|324357429|FG001|Overall Study|Protocol Violation|0|||
94699941|NCT00462943|324357430|FG002|Overall Study|Protocol Violation|0|||
94699942|NCT00462943|324357428|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
94699943|NCT00462943|324357429|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
94699944|NCT00462943|324357430|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
94699945|NCT00462943|324357428|FG000|Overall Study|Disease Progression|15|||
94699946|NCT00462943|324357429|FG001|Overall Study|Disease Progression|15|||
94699947|NCT00462943|324357430|FG002|Overall Study|Disease Progression|9|||
94699948|NCT00462943|324357428|FG000|Overall Study|Death|5|||
94699949|NCT00462943|324357429|FG001|Overall Study|Death|2|||
94699950|NCT00462943|324357430|FG002|Overall Study|Death|7|||
94699951|NCT00462943|324357428|FG000|Overall Study|Stem Cell Transplant|1|||
94699952|NCT00462943|324357429|FG001|Overall Study|Stem Cell Transplant|1|||
94699953|NCT00462943|324357430|FG002|Overall Study|Stem Cell Transplant|0|||
94699954|NCT00462943|324357428|FG000|Overall Study|Bone Marrow Transplant|1|||
94699955|NCT00462943|324357429|FG001|Overall Study|Bone Marrow Transplant|0|||
94699956|NCT00462943|324357430|FG002|Overall Study|Bone Marrow Transplant|0|||
94699957|NCT00462943|324357428|FG000|Overall Study|Required Lymphocyte Infusion|1|||
94699958|NCT00462943|324357429|FG001|Overall Study|Required Lymphocyte Infusion|0|||
94699959|NCT00462943|324357430|FG002|Overall Study|Required Lymphocyte Infusion|0|||
94699960|NCT00462943|324357428|FG000|Overall Study|Transplant - not specified|1|||
94699961|NCT00462943|324357429|FG001|Overall Study|Transplant - not specified|0|||
94699962|NCT00462943|324357430|FG002|Overall Study|Transplant - not specified|1|||
94699963|NCT00462943|324357428|FG000|Overall Study|Physician Decision|1|||
94699964|NCT00462943|324357429|FG001|Overall Study|Physician Decision|0|||
94699965|NCT00462943|324357430|FG002|Overall Study|Physician Decision|0|||
94699966|NCT00462943|324357428|FG000|Overall Study|Withdrawal by Subject|0|||
94699967|NCT00462943|324357429|FG001|Overall Study|Withdrawal by Subject|1|||
94699968|NCT00462943|324357430|FG002|Overall Study|Withdrawal by Subject|0|||
94699969|NCT01096056|324357431|FG000|Overall Study|Lost to Follow-up|0|||
94699970|NCT01096056|324357432|FG001|Overall Study|Lost to Follow-up|1|||
94699971|NCT04011033|324357439|FG000|Overall Study|Physician Decision|2|||
94699972|NCT04011033|324357440|FG001|Overall Study|Physician Decision|3|||
94699973|NCT04011033|324357439|FG000|Overall Study|Withdrawal by Subject|1|||
94699974|NCT04011033|324357440|FG001|Overall Study|Withdrawal by Subject|0|||
94699975|NCT00768066|324357441|FG000|Overall Study|Did not receive study product injection.|3|||
94699976|NCT00768066|324357442|FG001|Overall Study|Did not receive study product injection.|3|||
94699977|NCT00768066|324357443|FG002|Overall Study|Did not receive study product injection.|0|||
94699978|NCT01823341|324357444|FG000|Overall Study|Failed run-in|7|||
94699979|NCT01823341|324357444|FG000|Overall Study|Withdrawal by Subject|7|||
94699980|NCT01823341|324357444|FG000|Overall Study|Adverse Event|1|||
94699981|NCT01190176|324357450|FG000|Overall Study|Withdrawal by Subject|1|||
94699982|NCT01190176|324357450|FG000|Overall Study|Lost to Follow-up|1|||
94699983|NCT02081391|324357451|FG000|12-hour Treatment|Withdrawal by Subject|3|||
94699984|NCT02081391|324357452|FG001|12-hour Treatment|Withdrawal by Subject|2|||
94699985|NCT02081391|324357453|FG002|12-hour Treatment|Withdrawal by Subject|0|||
94699986|NCT02081391|324357454|FG003|12-hour Treatment|Withdrawal by Subject|0|||
94699987|NCT02081391|324357451|FG000|12-hour Treatment|Physician Decision|4|||
94699988|NCT02081391|324357452|FG001|12-hour Treatment|Physician Decision|1|||
94699989|NCT02081391|324357453|FG002|12-hour Treatment|Physician Decision|0|||
94699990|NCT02081391|324357454|FG003|12-hour Treatment|Physician Decision|0|||
94699991|NCT02081391|324357451|FG000|12-hour Treatment|Lack of Efficacy|3|||
94699992|NCT02081391|324357452|FG001|12-hour Treatment|Lack of Efficacy|0|||
94699993|NCT02081391|324357453|FG002|12-hour Treatment|Lack of Efficacy|0|||
94699994|NCT02081391|324357454|FG003|12-hour Treatment|Lack of Efficacy|0|||
94699995|NCT02081391|324357451|FG000|12-hour Treatment|Adverse Event|4|||
94366464|NCT01289990|323126541|FG004|Overall Study|discontinued in preceding trial|11|||
94699996|NCT02081391|324357452|FG001|12-hour Treatment|Adverse Event|2|||
94699997|NCT02081391|324357453|FG002|12-hour Treatment|Adverse Event|0|||
94699998|NCT02081391|324357454|FG003|12-hour Treatment|Adverse Event|0|||
94466132|NCT01472939|323496944|FG003|Overall Study|Lost to Follow-up|0|||
94699999|NCT02081391|324357451|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
94700000|NCT02081391|324357452|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
94700001|NCT02081391|324357453|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
94700002|NCT02081391|324357454|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
94700003|NCT02081391|324357451|FG000|12-hour Treatment|Further reasons|2|||
94700004|NCT02081391|324357452|FG001|12-hour Treatment|Further reasons|1|||
94700005|NCT02081391|324357453|FG002|12-hour Treatment|Further reasons|0|||
94700006|NCT02081391|324357454|FG003|12-hour Treatment|Further reasons|0|||
94700007|NCT02081391|324357451|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
94700008|NCT02081391|324357452|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
94700009|NCT02081391|324357453|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
94700010|NCT02081391|324357454|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
94700011|NCT02081391|324357451|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
94700012|NCT02081391|324357452|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
94700013|NCT02081391|324357453|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
94700014|NCT02081391|324357454|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
94700015|NCT02081391|324357451|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
94700016|NCT02081391|324357452|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
94700017|NCT02081391|324357453|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
94700018|NCT02081391|324357454|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
94700019|NCT02081391|324357451|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
94700020|NCT02081391|324357452|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
94700021|NCT02081391|324357453|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
94700022|NCT02081391|324357454|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
94700023|NCT02081391|324357451|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
94700024|NCT02081391|324357452|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
94700025|NCT02081391|324357453|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
94700026|NCT02081391|324357454|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
94700027|NCT02081391|324357451|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
94700028|NCT02081391|324357452|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
94700029|NCT02081391|324357453|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
94700030|NCT02081391|324357454|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
94700031|NCT01458275|324357455|FG000|Overall Study|Adverse Event|3|||
94700032|NCT01458275|324357456|FG001|Overall Study|Adverse Event|4|||
94700033|NCT01458275|324357457|FG002|Overall Study|Adverse Event|1|||
94700034|NCT01458275|324357455|FG000|Overall Study|Lost to Follow-up|3|||
94700035|NCT01458275|324357456|FG001|Overall Study|Lost to Follow-up|2|||
94700036|NCT01458275|324357457|FG002|Overall Study|Lost to Follow-up|5|||
94700037|NCT01458275|324357455|FG000|Overall Study|Protocol Violation|5|||
94700038|NCT01458275|324357456|FG001|Overall Study|Protocol Violation|5|||
94700039|NCT01458275|324357457|FG002|Overall Study|Protocol Violation|2|||
94700040|NCT01458275|324357455|FG000|Overall Study|Withdrawal by Subject|3|||
94700041|NCT01458275|324357456|FG001|Overall Study|Withdrawal by Subject|2|||
94700042|NCT01458275|324357457|FG002|Overall Study|Withdrawal by Subject|1|||
94700043|NCT00665561|324357459|FG000|Overall Study|Death recorded on subject summary pages|75|||
94700044|NCT00665561|324357460|FG001|Overall Study|Death recorded on subject summary pages|75|||
94700045|NCT00665561|324357459|FG000|Overall Study|Does not meet entrance criteria|19|||
94700046|NCT00665561|324357460|FG001|Overall Study|Does not meet entrance criteria|21|||
94700047|NCT00665561|324357459|FG000|Overall Study|Lost to Follow-up|203|||
94700048|NCT00665561|324357460|FG001|Overall Study|Lost to Follow-up|264|||
94700049|NCT00665561|324357459|FG000|Overall Study|Withdrawal by Subject|74|||
94700050|NCT00665561|324357460|FG001|Overall Study|Withdrawal by Subject|65|||
94700051|NCT00665561|324357459|FG000|Overall Study|Other|123|||
94700052|NCT00665561|324357460|FG001|Overall Study|Other|108|||
94700053|NCT00665561|324357459|FG000|Overall Study|Site closed|8|||
94700054|NCT00665561|324357460|FG001|Overall Study|Site closed|0|||
94700055|NCT00665561|324357459|FG000|Overall Study|Withdrawn due to pregnancy|0|||
94700056|NCT00665561|324357460|FG001|Overall Study|Withdrawn due to pregnancy|1|||
94700057|NCT03677375|324357461|FG000|Overall Study|Incomplete procedure|8|||
94700058|NCT03677375|324357461|FG000|Overall Study|Adverse Event|3|||
94700059|NCT03677375|324357461|FG000|Overall Study|Physician Decision|1|||
94700060|NCT03824236|324357465|FG000|Overall Study|Lost to Follow-up|0|||
94366465|NCT01289990|323126542|FG005|Overall Study|discontinued in preceding trial|12|||
94366466|NCT01289990|323126543|FG006|Overall Study|discontinued in preceding trial|18|||
94366467|NCT01289990|323126544|FG007|Overall Study|discontinued in preceding trial|8|||
94366468|NCT01289990|323126545|FG008|Overall Study|discontinued in preceding trial|17|||
94366469|NCT01289990|323126546|FG009|Overall Study|discontinued in preceding trial|21|||
94700061|NCT03824236|324357466|FG001|Overall Study|Lost to Follow-up|0|||
94700062|NCT03824236|324357467|FG002|Overall Study|Lost to Follow-up|1|||
94700063|NCT01143077|324357471|FG000|Overall Study|Lack of Efficacy|0|||
94700064|NCT01143077|324357472|FG001|Overall Study|Lack of Efficacy|2|||
94700065|NCT01143077|324357473|FG002|Overall Study|Lack of Efficacy|1|||
94366470|NCT01289990|323126547|FG010|Overall Study|discontinued in preceding trial|17|||
94366471|NCT01289990|323126548|FG011|Overall Study|discontinued in preceding trial|17|||
94366472|NCT01289990|323126549|FG012|Overall Study|discontinued in preceding trial|24|||
94700066|NCT01143077|324357471|FG000|Overall Study|Adverse Event|5|||
94700067|NCT01143077|324357472|FG001|Overall Study|Adverse Event|6|||
94700068|NCT01143077|324357473|FG002|Overall Study|Adverse Event|5|||
94700069|NCT01143077|324357471|FG000|Overall Study|Lost to Follow-up|2|||
94700070|NCT01143077|324357472|FG001|Overall Study|Lost to Follow-up|3|||
94700071|NCT01143077|324357473|FG002|Overall Study|Lost to Follow-up|4|||
94700072|NCT01143077|324357471|FG000|Overall Study|Protocol Violation|2|||
94700073|NCT01143077|324357472|FG001|Overall Study|Protocol Violation|0|||
94700074|NCT01143077|324357473|FG002|Overall Study|Protocol Violation|0|||
94700075|NCT01143077|324357471|FG000|Overall Study|Withdrawal by Subject|4|||
94700076|NCT01143077|324357472|FG001|Overall Study|Withdrawal by Subject|3|||
94700077|NCT01143077|324357473|FG002|Overall Study|Withdrawal by Subject|3|||
94700078|NCT01143077|324357471|FG000|Overall Study|Non-compliance with study drug|0|||
94700079|NCT01143077|324357472|FG001|Overall Study|Non-compliance with study drug|1|||
94700080|NCT01143077|324357473|FG002|Overall Study|Non-compliance with study drug|1|||
94700081|NCT01143077|324357471|FG000|Overall Study|Administrative|1|||
94700082|NCT01143077|324357472|FG001|Overall Study|Administrative|0|||
94700083|NCT01143077|324357473|FG002|Overall Study|Administrative|0|||
94700084|NCT01143077|324357471|FG000|Overall Study|Principal Investigator Decision|2|||
94700085|NCT01143077|324357472|FG001|Overall Study|Principal Investigator Decision|0|||
94700086|NCT01143077|324357473|FG002|Overall Study|Principal Investigator Decision|1|||
94700087|NCT01333514|324357476|FG000|Overall Study|Withdrawal by Subject|1|||
94700088|NCT01333514|324357477|FG001|Overall Study|Withdrawal by Subject|0|||
94700089|NCT00836810|324357478|FG000|Overall Study|New diagnosis|1|||
94700090|NCT00836810|324357479|FG001|Overall Study|New diagnosis|0|||
94700091|NCT00871429|324357482|FG000|Overall Study|Lost to Follow-up|6|||
94700092|NCT00871429|324357482|FG000|Overall Study|Withdrawal by Subject|17|||
94700093|NCT00871429|324357482|FG000|Overall Study|Questionnaire not completed|1|||
94700094|NCT00946192|324357483|FG000|Overall Study|Lost to Follow-up|6|||
94700095|NCT00946192|324357484|FG001|Overall Study|Lost to Follow-up|11|||
94700096|NCT00946192|324357485|FG002|Overall Study|Lost to Follow-up|9|||
94700097|NCT00946192|324357483|FG000|Overall Study|Withdrawal by Subject|10|||
94700098|NCT00946192|324357484|FG001|Overall Study|Withdrawal by Subject|7|||
94700099|NCT00946192|324357485|FG002|Overall Study|Withdrawal by Subject|3|||
94700100|NCT00946192|324357483|FG000|Overall Study|Did not start medication|2|||
94700101|NCT00946192|324357484|FG001|Overall Study|Did not start medication|0|||
94700102|NCT00946192|324357485|FG002|Overall Study|Did not start medication|0|||
94700103|NCT02451943|324359414|FG000|Overall Study|On Treatment|4|||
94700104|NCT02451943|324359415|FG001|Overall Study|On Treatment|4|||
94700105|NCT02451943|324359414|FG000|Overall Study|Withdrawal by Subject|13|||
94700106|NCT02451943|324359415|FG001|Overall Study|Withdrawal by Subject|16|||
94700107|NCT02451943|324359414|FG000|Overall Study|Lost to Follow-up|3|||
94700108|NCT02451943|324359415|FG001|Overall Study|Lost to Follow-up|4|||
94700109|NCT04423393|324359417|FG000|Overall Study|Withdrawal by Subject|0|||
94700110|NCT04423393|324359418|FG001|Overall Study|Withdrawal by Subject|0|||
94700111|NCT04423393|324359419|FG002|Overall Study|Withdrawal by Subject|0|||
94700112|NCT04423393|324359420|FG003|Overall Study|Withdrawal by Subject|0|||
94700113|NCT04423393|324359421|FG004|Overall Study|Withdrawal by Subject|0|||
94700114|NCT04423393|324359422|FG005|Overall Study|Withdrawal by Subject|1|||
94700115|NCT04423393|324359423|FG006|Overall Study|Withdrawal by Subject|0|||
94700116|NCT04423393|324359424|FG007|Overall Study|Withdrawal by Subject|0|||
94700117|NCT04423393|324359425|FG008|Overall Study|Withdrawal by Subject|0|||
94700118|NCT04423393|324359426|FG009|Overall Study|Withdrawal by Subject|0|||
94700119|NCT04423393|324359427|FG010|Overall Study|Withdrawal by Subject|0|||
94700120|NCT04423393|324359428|FG011|Overall Study|Withdrawal by Subject|0|||
94700121|NCT04423393|324359429|FG012|Overall Study|Withdrawal by Subject|0|||
94700122|NCT04423393|324359430|FG013|Overall Study|Withdrawal by Subject|1|||
94700123|NCT04423393|324359431|FG014|Overall Study|Withdrawal by Subject|0|||
94700124|NCT04423393|324359432|FG015|Overall Study|Withdrawal by Subject|0|||
94700125|NCT04423393|324359433|FG016|Overall Study|Withdrawal by Subject|0|||
94700126|NCT04423393|324359434|FG017|Overall Study|Withdrawal by Subject|0|||
94700127|NCT04423393|324359417|FG000|Overall Study|Sponsor Decision|0|||
94700128|NCT04423393|324359418|FG001|Overall Study|Sponsor Decision|0|||
94700129|NCT04423393|324359419|FG002|Overall Study|Sponsor Decision|0|||
94265693|NCT01667107|322765792|FG001|Overall Study|Protocol Violation|1|||
94265694|NCT01667107|322765791|FG000|Overall Study|Lack of Efficacy|0|||
94265695|NCT01667107|322765792|FG001|Overall Study|Lack of Efficacy|1|||
94265696|NCT02708095|322765796|FG000|Overall Study|Adverse Event|4|||
94265697|NCT02708095|322765797|FG001|Overall Study|Adverse Event|10|||
94265698|NCT02708095|322765798|FG002|Overall Study|Adverse Event|11|||
94700130|NCT04423393|324359420|FG003|Overall Study|Sponsor Decision|0|||
94700131|NCT04423393|324359421|FG004|Overall Study|Sponsor Decision|0|||
94700132|NCT04423393|324359422|FG005|Overall Study|Sponsor Decision|0|||
94700133|NCT04423393|324359423|FG006|Overall Study|Sponsor Decision|0|||
94700134|NCT04423393|324359424|FG007|Overall Study|Sponsor Decision|0|||
94700135|NCT04423393|324359425|FG008|Overall Study|Sponsor Decision|0|||
94265699|NCT02708095|322765796|FG000|Overall Study|Lack of Efficacy|9|||
94700136|NCT04423393|324359426|FG009|Overall Study|Sponsor Decision|0|||
94700137|NCT04423393|324359427|FG010|Overall Study|Sponsor Decision|0|||
94700138|NCT04423393|324359428|FG011|Overall Study|Sponsor Decision|0|||
94700139|NCT04423393|324359429|FG012|Overall Study|Sponsor Decision|0|||
94700140|NCT04423393|324359430|FG013|Overall Study|Sponsor Decision|1|||
94700141|NCT04423393|324359431|FG014|Overall Study|Sponsor Decision|0|||
94700142|NCT04423393|324359432|FG015|Overall Study|Sponsor Decision|0|||
94700143|NCT04423393|324359433|FG016|Overall Study|Sponsor Decision|0|||
94700144|NCT04423393|324359434|FG017|Overall Study|Sponsor Decision|0|||
94700145|NCT01518257|324359442|FG000|Overall Study|Lost to Follow-up|1|||
94700146|NCT01518257|324359443|FG001|Overall Study|Lost to Follow-up|0|||
94700147|NCT01518257|324359442|FG000|Overall Study|Other Miscellaneous Reason|1|||
94700148|NCT01518257|324359443|FG001|Overall Study|Other Miscellaneous Reason|0|||
94700149|NCT02153788|324359444|FG000|Overall Study|Physician Decision|2|||
94700150|NCT02153788|324359445|FG001|Overall Study|Physician Decision|1|||
94700151|NCT00256308|324359448|FG000|Overall Study|Death|2|||
94700152|NCT01195675|324359452|FG000|Overall Study|Adverse Event|1|||
94700153|NCT01195675|324359452|FG000|Overall Study|Withdrawal by Subject|2|||
94700154|NCT04476043|324359453|FG000|Overall Study|Withdrawal by Subject|1|||
94700155|NCT04476043|324359454|FG001|Overall Study|Withdrawal by Subject|3|||
94700156|NCT04476043|324359455|FG002|Overall Study|Withdrawal by Subject|4|||
94700157|NCT04476043|324359456|FG003|Overall Study|Withdrawal by Subject|1|||
94700158|NCT04476043|324359453|FG000|Overall Study|Lost to Follow-up|1|||
94700159|NCT04476043|324359454|FG001|Overall Study|Lost to Follow-up|1|||
94700160|NCT04476043|324359455|FG002|Overall Study|Lost to Follow-up|2|||
94700161|NCT04476043|324359456|FG003|Overall Study|Lost to Follow-up|1|||
94700162|NCT04476043|324359453|FG000|Overall Study|Adverse Event|2|||
94700163|NCT04476043|324359454|FG001|Overall Study|Adverse Event|0|||
94700164|NCT04476043|324359455|FG002|Overall Study|Adverse Event|1|||
94700165|NCT04476043|324359456|FG003|Overall Study|Adverse Event|0|||
94700166|NCT04476043|324359453|FG000|Overall Study|Protocol Violation|0|||
94700167|NCT04476043|324359454|FG001|Overall Study|Protocol Violation|1|||
94700168|NCT04476043|324359455|FG002|Overall Study|Protocol Violation|0|||
94700169|NCT04476043|324359456|FG003|Overall Study|Protocol Violation|0|||
94700170|NCT00940017|324359457|FG000|Overall Study|did not meet entrance criteria|3|||
94700171|NCT00940017|324359457|FG000|Overall Study|Adverse Event|1|||
94700172|NCT02949271|324359460|FG000|Overall Study|Lack of Efficacy|5|||
94700173|NCT02949271|324359461|FG001|Overall Study|Lack of Efficacy|4|||
94700174|NCT02949271|324359460|FG000|Overall Study|Lost to Follow-up|3|||
94700175|NCT02949271|324359461|FG001|Overall Study|Lost to Follow-up|6|||
94700176|NCT02949271|324359460|FG000|Overall Study|Physician Decision|5|||
94700177|NCT02949271|324359461|FG001|Overall Study|Physician Decision|5|||
94700178|NCT02949271|324359460|FG000|Overall Study|Protocol Violation|6|||
94700179|NCT02949271|324359461|FG001|Overall Study|Protocol Violation|3|||
94700180|NCT02949271|324359460|FG000|Overall Study|Withdrawal by Subject|1|||
94700181|NCT02949271|324359461|FG001|Overall Study|Withdrawal by Subject|0|||
94700182|NCT02949271|324359460|FG000|Overall Study|Delivered prior to intervention|7|||
94700183|NCT02949271|324359461|FG001|Overall Study|Delivered prior to intervention|9|||
94700184|NCT02949271|324359460|FG000|Overall Study|Outside the window for cervical dilation|2|||
94700185|NCT02949271|324359461|FG001|Overall Study|Outside the window for cervical dilation|3|||
94700186|NCT00531479|324359462|FG000|Overall Study|Death|68|||
94700187|NCT00531479|324359463|FG001|Overall Study|Death|71|||
94700188|NCT00531479|324359462|FG000|Overall Study|Lost to Follow-up|0|||
94700189|NCT00531479|324359463|FG001|Overall Study|Lost to Follow-up|2|||
94700190|NCT00531479|324359462|FG000|Overall Study|Other|0|||
94700191|NCT00531479|324359463|FG001|Overall Study|Other|1|||
94700192|NCT00531479|324359462|FG000|Overall Study|Withdrawal by Subject|6|||
94700193|NCT00531479|324359463|FG001|Overall Study|Withdrawal by Subject|6|||
94700194|NCT00531479|324359462|FG000|Overall Study|Did not receive treatment|2|||
94700195|NCT00531479|324359463|FG001|Overall Study|Did not receive treatment|3|||
94700196|NCT00409708|324359464|FG000|Treatment|Abnormal test procedure result(s)|1|||
94700197|NCT00409708|324359465|FG001|Treatment|Abnormal test procedure result(s)|0|||
94700198|NCT00409708|324359464|FG000|Treatment|Lack of Efficacy|0|||
94700199|NCT00409708|324359465|FG001|Treatment|Lack of Efficacy|1|||
94700200|NCT00409708|324359464|FG000|Treatment|Protocol Violation|6|||
94700201|NCT00409708|324359465|FG001|Treatment|Protocol Violation|2|||
94700202|NCT00409708|324359464|FG000|Treatment|Withdrawal by Subject|3|||
94700203|NCT00409708|324359465|FG001|Treatment|Withdrawal by Subject|8|||
94466133|NCT01472939|323496941|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
94700204|NCT00409708|324359464|FG000|Treatment|Lost to Follow-up|0|||
94700205|NCT00409708|324359465|FG001|Treatment|Lost to Follow-up|6|||
94700206|NCT00409708|324359464|FG000|Treatment|Administrative problems|5|||
94700207|NCT00409708|324359465|FG001|Treatment|Administrative problems|0|||
94700208|NCT00409708|324359464|FG000|Washout|Lack of Efficacy|9|||
94700209|NCT00409708|324359465|FG001|Washout|Lack of Efficacy|1|||
94700210|NCT00409708|324359464|FG000|Washout|Protocol Violation|0|||
94700211|NCT00409708|324359465|FG001|Washout|Protocol Violation|1|||
94700212|NCT00409708|324359464|FG000|Washout|Withdrawal by Subject|11|||
94700213|NCT00409708|324359465|FG001|Washout|Withdrawal by Subject|5|||
94700214|NCT00409708|324359464|FG000|Washout|Lost to Follow-up|1|||
94700215|NCT00409708|324359465|FG001|Washout|Lost to Follow-up|3|||
94700216|NCT00495469|324359466|FG000|Overall Study|Adverse Event|0|||
94700217|NCT00495469|324359467|FG001|Overall Study|Adverse Event|1|||
94700218|NCT00495469|324359468|FG002|Overall Study|Adverse Event|3|||
94700219|NCT00495469|324359469|FG003|Overall Study|Adverse Event|0|||
94700220|NCT00495469|324359470|FG004|Overall Study|Adverse Event|1|||
94700221|NCT00495469|324359471|FG005|Overall Study|Adverse Event|1|||
94700222|NCT00495469|324359472|FG006|Overall Study|Adverse Event|1|||
94700223|NCT00495469|324359466|FG000|Overall Study|Lost to Follow-up|1|||
94700224|NCT00495469|324359467|FG001|Overall Study|Lost to Follow-up|1|||
94700225|NCT00495469|324359468|FG002|Overall Study|Lost to Follow-up|3|||
94700226|NCT00495469|324359469|FG003|Overall Study|Lost to Follow-up|1|||
94700227|NCT00495469|324359470|FG004|Overall Study|Lost to Follow-up|0|||
94700228|NCT00495469|324359471|FG005|Overall Study|Lost to Follow-up|0|||
94700229|NCT00495469|324359472|FG006|Overall Study|Lost to Follow-up|0|||
94700230|NCT00495469|324359466|FG000|Overall Study|Protocol Violation|0|||
94700231|NCT00495469|324359467|FG001|Overall Study|Protocol Violation|0|||
94700232|NCT00495469|324359468|FG002|Overall Study|Protocol Violation|0|||
94700233|NCT00495469|324359469|FG003|Overall Study|Protocol Violation|0|||
94700234|NCT00495469|324359470|FG004|Overall Study|Protocol Violation|1|||
94700235|NCT00495469|324359471|FG005|Overall Study|Protocol Violation|2|||
94700236|NCT00495469|324359472|FG006|Overall Study|Protocol Violation|0|||
94700237|NCT00495469|324359466|FG000|Overall Study|Withdrawal by Subject|5|||
94700238|NCT00495469|324359467|FG001|Overall Study|Withdrawal by Subject|3|||
94700239|NCT00495469|324359468|FG002|Overall Study|Withdrawal by Subject|1|||
94700240|NCT00495469|324359469|FG003|Overall Study|Withdrawal by Subject|3|||
94700241|NCT00495469|324359470|FG004|Overall Study|Withdrawal by Subject|3|||
94700242|NCT00495469|324359471|FG005|Overall Study|Withdrawal by Subject|2|||
94700243|NCT00495469|324359472|FG006|Overall Study|Withdrawal by Subject|3|||
94700244|NCT00495469|324359466|FG000|Overall Study|Lack of Efficacy|0|||
94700245|NCT00495469|324359467|FG001|Overall Study|Lack of Efficacy|0|||
94700246|NCT00495469|324359468|FG002|Overall Study|Lack of Efficacy|0|||
94700247|NCT00495469|324359469|FG003|Overall Study|Lack of Efficacy|0|||
94700248|NCT00495469|324359470|FG004|Overall Study|Lack of Efficacy|0|||
94700249|NCT00495469|324359471|FG005|Overall Study|Lack of Efficacy|0|||
94700250|NCT00495469|324359472|FG006|Overall Study|Lack of Efficacy|1|||
94700251|NCT00495469|324359466|FG000|Overall Study|Liver function test abnormality|0|||
94700252|NCT00495469|324359467|FG001|Overall Study|Liver function test abnormality|1|||
94700253|NCT00495469|324359468|FG002|Overall Study|Liver function test abnormality|0|||
94700254|NCT00495469|324359469|FG003|Overall Study|Liver function test abnormality|0|||
94700255|NCT00495469|324359470|FG004|Overall Study|Liver function test abnormality|0|||
94700256|NCT00495469|324359471|FG005|Overall Study|Liver function test abnormality|0|||
94700257|NCT00495469|324359472|FG006|Overall Study|Liver function test abnormality|0|||
94700258|NCT00495469|324359466|FG000|Overall Study|ST depression at randomisation in ECG|0|||
94700259|NCT00495469|324359467|FG001|Overall Study|ST depression at randomisation in ECG|1|||
94265700|NCT02708095|322765797|FG001|Overall Study|Lack of Efficacy|3|||
94265701|NCT02708095|322765798|FG002|Overall Study|Lack of Efficacy|0|||
94265702|NCT02708095|322765796|FG000|Overall Study|Lost to Follow-up|2|||
94265703|NCT02708095|322765797|FG001|Overall Study|Lost to Follow-up|0|||
94265704|NCT02708095|322765798|FG002|Overall Study|Lost to Follow-up|0|||
94265705|NCT02708095|322765796|FG000|Overall Study|Physician Decision|2|||
94265706|NCT02708095|322765797|FG001|Overall Study|Physician Decision|3|||
94700260|NCT00495469|324359468|FG002|Overall Study|ST depression at randomisation in ECG|0|||
94700261|NCT00495469|324359469|FG003|Overall Study|ST depression at randomisation in ECG|0|||
94700262|NCT00495469|324359470|FG004|Overall Study|ST depression at randomisation in ECG|0|||
94700263|NCT00495469|324359471|FG005|Overall Study|ST depression at randomisation in ECG|0|||
94700264|NCT00495469|324359472|FG006|Overall Study|ST depression at randomisation in ECG|0|||
94700265|NCT05349864|324359476|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
94700266|NCT05349864|324359477|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
94466134|NCT01472939|323496942|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
94466135|NCT01472939|323496943|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
94466136|NCT01472939|323496944|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
94700267|NCT02333630|324359478|FG000|Overall Study|Lost to Follow-up|5|||
94700268|NCT02333630|324359479|FG001|Overall Study|Lost to Follow-up|2|||
94700269|NCT00465985|324359485|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
94700270|NCT00465985|324359486|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
94700271|NCT00465985|324359485|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
94700272|NCT00465985|324359486|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
94700273|NCT00465985|324359485|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
94700274|NCT00465985|324359486|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
94700275|NCT00465985|324359485|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
94700276|NCT00465985|324359486|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
94700277|NCT03382821|324359493|FG000|Overall Study|Did not receive allocated intervention.|0|||
94700278|NCT03382821|324359494|FG001|Overall Study|Did not receive allocated intervention.|3|||
94700279|NCT01674569|324359502|FG000|Overall Study|Adverse Event|0|||
94700280|NCT01674569|324359503|FG001|Overall Study|Adverse Event|2|||
94700281|NCT01674569|324359504|FG002|Overall Study|Adverse Event|0|||
94700282|NCT01674569|324359505|FG003|Overall Study|Adverse Event|1|||
94700283|NCT01674569|324359506|FG004|Overall Study|Adverse Event|2|||
94700284|NCT01674569|324359507|FG005|Overall Study|Adverse Event|2|||
94700285|NCT01674569|324359502|FG000|Overall Study|Protocol Violation|0|||
94700286|NCT01674569|324359503|FG001|Overall Study|Protocol Violation|1|||
94700287|NCT01674569|324359504|FG002|Overall Study|Protocol Violation|1|||
94700288|NCT01674569|324359505|FG003|Overall Study|Protocol Violation|0|||
94700289|NCT01674569|324359506|FG004|Overall Study|Protocol Violation|0|||
94700290|NCT01674569|324359507|FG005|Overall Study|Protocol Violation|0|||
94700291|NCT01674569|324359502|FG000|Overall Study|Withdrawal by Subject|0|||
94700292|NCT01674569|324359503|FG001|Overall Study|Withdrawal by Subject|0|||
94700293|NCT01674569|324359504|FG002|Overall Study|Withdrawal by Subject|1|||
94700294|NCT01674569|324359505|FG003|Overall Study|Withdrawal by Subject|0|||
94700295|NCT01674569|324359506|FG004|Overall Study|Withdrawal by Subject|0|||
94700296|NCT01674569|324359507|FG005|Overall Study|Withdrawal by Subject|0|||
94700297|NCT01928940|324359508|FG000|Overall Study|Adverse Event|0|||
94700298|NCT01928940|324359509|FG001|Overall Study|Adverse Event|1|||
94700299|NCT01599325|324359514|FG000|Primary Parent Phase|Adverse Event|5|||
94700300|NCT01599325|324359514|FG000|Primary Parent Phase|Disease Progression|7|||
94700301|NCT01599325|324359514|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
94700302|NCT01599325|324359514|FG000|Primary Parent Phase|Death|13|||
94700303|NCT01599325|324359514|FG000|Primary Parent Phase|Protocol Violation|1|||
94700304|NCT01599325|324359514|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
94700305|NCT01599325|324359514|FG000|Primary Parent Phase|Other|2|||
94700306|NCT01599325|324359514|FG000|Extension Phase|Study Closure|1|||
94700307|NCT01599325|324359514|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
94700308|NCT01599325|324359514|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
94700309|NCT01599325|324359514|FG000|Extension Phase|Disease Progression|1|||
94700310|NCT01599325|324359514|FG000|Extension Phase|Withdrawal by Subject|8|||
94700311|NCT03168438|324359517|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
94700312|NCT03168438|324359518|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
94700313|NCT01007149|324359519|FG000|Overall Study|Administrative problems|0|||
94700314|NCT01007149|324359520|FG001|Overall Study|Administrative problems|1|||
94700315|NCT01729871|324359522|FG000|Overall Study|Adverse Event|7|||
94700316|NCT01729871|324359523|FG001|Overall Study|Adverse Event|7|||
94700317|NCT01729871|324359522|FG000|Overall Study|Death|0|||
94700318|NCT01729871|324359523|FG001|Overall Study|Death|1|||
94700319|NCT01729871|324359522|FG000|Overall Study|Lack of Efficacy|0|||
94265707|NCT02708095|322765798|FG002|Overall Study|Physician Decision|2|||
94466137|NCT01472939|323496941|FG000|Overall Study|Prohibited Medication|0|||
94700320|NCT01729871|324359523|FG001|Overall Study|Lack of Efficacy|1|||
94700321|NCT01729871|324359522|FG000|Overall Study|Physician Decision|0|||
94700322|NCT01729871|324359523|FG001|Overall Study|Physician Decision|2|||
94700323|NCT01729871|324359522|FG000|Overall Study|Protocol Violation|1|||
94700324|NCT01729871|324359523|FG001|Overall Study|Protocol Violation|0|||
94700325|NCT01729871|324359522|FG000|Overall Study|Withdrawal by Subject|0|||
94700326|NCT01729871|324359523|FG001|Overall Study|Withdrawal by Subject|3|||
94700327|NCT01729871|324359522|FG000|Overall Study|Other|4|||
94700328|NCT01729871|324359523|FG001|Overall Study|Other|9|||
94700329|NCT00630864|324359525|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
94700330|NCT00630864|324359525|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
94700331|NCT03722446|324359526|FG000|Overall Study|Protocol Violation|15|||
94700332|NCT03722446|324359527|FG001|Overall Study|Protocol Violation|2|||
94466138|NCT01472939|323496942|FG001|Overall Study|Prohibited Medication|1|||
94466139|NCT01472939|323496943|FG002|Overall Study|Prohibited Medication|0|||
94700333|NCT00430677|324359528|FG000|Short-term Period|Death|1|||
94700334|NCT00430677|324359529|FG001|Short-term Period|Death|1|||
94700335|NCT00430677|324359530|FG002|Short-term Period|Death|5|||
94700336|NCT00430677|324359528|FG000|Short-term Period|Adverse Event|15|||
94700337|NCT00430677|324359529|FG001|Short-term Period|Adverse Event|13|||
94700338|NCT00430677|324359530|FG002|Short-term Period|Adverse Event|9|||
94700339|NCT00430677|324359528|FG000|Short-term Period|Lack of Efficacy|5|||
94700340|NCT00430677|324359529|FG001|Short-term Period|Lack of Efficacy|6|||
94700341|NCT00430677|324359530|FG002|Short-term Period|Lack of Efficacy|4|||
94700342|NCT00430677|324359528|FG000|Short-term Period|Withdrawal by Subject|1|||
94700343|NCT00430677|324359529|FG001|Short-term Period|Withdrawal by Subject|1|||
94700344|NCT00430677|324359530|FG002|Short-term Period|Withdrawal by Subject|2|||
94265708|NCT02708095|322765796|FG000|Overall Study|Protocol Violation|0|||
94466140|NCT01472939|323496944|FG003|Overall Study|Prohibited Medication|0|||
94466141|NCT01472939|323496941|FG000|Overall Study|Withdrawal By PI|1|||
94700345|NCT00430677|324359528|FG000|Short-term Period|Participant no longer met study criteria|1|||
94700346|NCT00430677|324359529|FG001|Short-term Period|Participant no longer met study criteria|1|||
94700347|NCT00430677|324359530|FG002|Short-term Period|Participant no longer met study criteria|2|||
94700348|NCT00430677|324359528|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
94700349|NCT00430677|324359529|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
94700350|NCT00430677|324359530|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
94700351|NCT00430677|324359528|FG000|Short-term Period|Pregnancy|0|||
94700352|NCT00430677|324359529|FG001|Short-term Period|Pregnancy|2|||
94700353|NCT00430677|324359530|FG002|Short-term Period|Pregnancy|0|||
94700354|NCT00430677|324359528|FG000|Long-term Extension Period|Death|1|||
94700355|NCT00430677|324359529|FG001|Long-term Extension Period|Death|0|||
94700356|NCT00430677|324359530|FG002|Long-term Extension Period|Death|0|||
94700357|NCT00430677|324359528|FG000|Long-term Extension Period|Adverse Event|3|||
94700358|NCT00430677|324359529|FG001|Long-term Extension Period|Adverse Event|2|||
94700359|NCT00430677|324359530|FG002|Long-term Extension Period|Adverse Event|5|||
94700360|NCT00430677|324359528|FG000|Long-term Extension Period|Lack of Efficacy|5|||
94700361|NCT00430677|324359529|FG001|Long-term Extension Period|Lack of Efficacy|3|||
94700362|NCT00430677|324359530|FG002|Long-term Extension Period|Lack of Efficacy|8|||
94700363|NCT00430677|324359528|FG000|Long-term Extension Period|Lost to Follow-up|1|||
94700364|NCT00430677|324359529|FG001|Long-term Extension Period|Lost to Follow-up|1|||
94700365|NCT00430677|324359530|FG002|Long-term Extension Period|Lost to Follow-up|1|||
94700366|NCT00430677|324359528|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
94700367|NCT00430677|324359529|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
94700368|NCT00430677|324359530|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
94700369|NCT00430677|324359528|FG000|Long-term Extension Period|Pregnancy|1|||
94700370|NCT00430677|324359529|FG001|Long-term Extension Period|Pregnancy|1|||
94700371|NCT00430677|324359530|FG002|Long-term Extension Period|Pregnancy|0|||
94700372|NCT00430677|324359528|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
94700373|NCT00430677|324359529|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
94700374|NCT00430677|324359530|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
94700375|NCT00430677|324359528|FG000|Long-term Extension Period|Other|2|||
94700376|NCT00430677|324359529|FG001|Long-term Extension Period|Other|1|||
94700377|NCT00430677|324359530|FG002|Long-term Extension Period|Other|1|||
94700378|NCT00430677|324359528|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
94700379|NCT00430677|324359529|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
94700380|NCT00430677|324359530|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
94700381|NCT01555762|324359531|FG000|Overall Study|No information on Bevacizumab intake|11|||
94700382|NCT01555762|324359531|FG000|Overall Study|Missing start date of infusion|8|||
94700383|NCT01555762|324359531|FG000|Overall Study|75 years old or more ticked No|1|||
94700384|NCT01555762|324359531|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
94700385|NCT01555762|324359531|FG000|Overall Study|Death linked to progression of disease|165|||
94700386|NCT01555762|324359531|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
94700387|NCT01555762|324359531|FG000|Overall Study|Investigator's decision|10|||
94700388|NCT01555762|324359531|FG000|Overall Study|Participant not wishing to continue|5|||
94700389|NCT01555762|324359531|FG000|Overall Study|Missing data|1|||
94700390|NCT01555762|324359531|FG000|Overall Study|Death linked to an adverse event|14|||
94700391|NCT00819910|324359532|FG000|Overall Study|Adverse Event|0|||
94700392|NCT00819910|324359533|FG001|Overall Study|Adverse Event|0|||
94700393|NCT00819910|324359534|FG002|Overall Study|Adverse Event|2|||
94700394|NCT00819910|324359535|FG003|Overall Study|Adverse Event|1|||
94700395|NCT00819910|324359532|FG000|Overall Study|Withdrawal by Subject|1|||
94700396|NCT00819910|324359533|FG001|Overall Study|Withdrawal by Subject|1|||
94700397|NCT00819910|324359534|FG002|Overall Study|Withdrawal by Subject|1|||
94700398|NCT00819910|324359535|FG003|Overall Study|Withdrawal by Subject|0|||
94700399|NCT00819910|324359532|FG000|Overall Study|Lost to Follow-up|1|||
94700400|NCT00819910|324359533|FG001|Overall Study|Lost to Follow-up|0|||
94700401|NCT00819910|324359534|FG002|Overall Study|Lost to Follow-up|0|||
94700402|NCT00819910|324359535|FG003|Overall Study|Lost to Follow-up|0|||
94700403|NCT00477412|324359536|FG000|Overall Study|Death|0|||
94700404|NCT00477412|324359537|FG001|Overall Study|Death|0|||
94700405|NCT00477412|324359538|FG002|Overall Study|Death|0|||
94700406|NCT00477412|324359539|FG003|Overall Study|Death|4|||
94700407|NCT00477412|324359536|FG000|Overall Study|Lost to Follow-up|0|||
94700408|NCT00477412|324359537|FG001|Overall Study|Lost to Follow-up|0|||
94700409|NCT00477412|324359538|FG002|Overall Study|Lost to Follow-up|0|||
94700410|NCT00477412|324359539|FG003|Overall Study|Lost to Follow-up|1|||
94700411|NCT00477412|324359536|FG000|Overall Study|Withdrawal by Subject|0|||
94700412|NCT00477412|324359537|FG001|Overall Study|Withdrawal by Subject|0|||
94700413|NCT00477412|324359538|FG002|Overall Study|Withdrawal by Subject|0|||
94700414|NCT00477412|324359539|FG003|Overall Study|Withdrawal by Subject|2|||
94700415|NCT00477412|324359536|FG000|Overall Study|Second Malignancy|0|||
94700416|NCT00477412|324359537|FG001|Overall Study|Second Malignancy|0|||
94700417|NCT00477412|324359538|FG002|Overall Study|Second Malignancy|0|||
94700418|NCT00477412|324359539|FG003|Overall Study|Second Malignancy|1|||
94700419|NCT00477412|324359536|FG000|Overall Study|Adverse Event|1|||
94700420|NCT00477412|324359537|FG001|Overall Study|Adverse Event|0|||
94700421|NCT00477412|324359538|FG002|Overall Study|Adverse Event|1|||
94700422|NCT00477412|324359539|FG003|Overall Study|Adverse Event|0|||
94700423|NCT04580407|324359540|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
94700424|NCT02068885|324359545|FG000|Overall Study|Withdrew|3|||
94700425|NCT02068885|324359546|FG001|Overall Study|Withdrew|5|||
94700426|NCT02068885|324359547|FG002|Overall Study|Withdrew|8|||
94700427|NCT05273801|324359553|FG000|Overall Study|Physician Decision|1|||
94700428|NCT03820986|324359554|FG000|Overall Study|Death|177|||
94700429|NCT03820986|324359555|FG001|Overall Study|Death|156|||
94700430|NCT03820986|324359554|FG000|Overall Study|Lost to Follow-up|0|||
94700431|NCT03820986|324359555|FG001|Overall Study|Lost to Follow-up|1|||
94700432|NCT03820986|324359554|FG000|Overall Study|Withdrawal by Subject|8|||
94265709|NCT02708095|322765797|FG001|Overall Study|Protocol Violation|0|||
94265710|NCT02708095|322765798|FG002|Overall Study|Protocol Violation|1|||
94265711|NCT02708095|322765796|FG000|Overall Study|Withdrawal by Subject|5|||
94700433|NCT03820986|324359555|FG001|Overall Study|Withdrawal by Subject|3|||
94265712|NCT02708095|322765797|FG001|Overall Study|Withdrawal by Subject|3|||
94265713|NCT02708095|322765798|FG002|Overall Study|Withdrawal by Subject|4|||
94700434|NCT03820986|324359554|FG000|Overall Study|Ongoing|149|||
94700435|NCT03820986|324359555|FG001|Overall Study|Ongoing|180|||
94700436|NCT00828919|324359556|FG000|Overall Study|Death|0|||
94466142|NCT01472939|323496942|FG001|Overall Study|Withdrawal By PI|0|||
94466143|NCT01472939|323496943|FG002|Overall Study|Withdrawal By PI|0|||
94700437|NCT00828919|324359557|FG001|Overall Study|Death|1|||
94700438|NCT00828919|324359558|FG002|Overall Study|Death|2|||
94700439|NCT00828919|324359559|FG003|Overall Study|Death|0|||
94700440|NCT00828919|324359560|FG004|Overall Study|Death|0|||
94700441|NCT00828919|324359556|FG000|Overall Study|Adverse Event|2|||
94700442|NCT00828919|324359557|FG001|Overall Study|Adverse Event|2|||
94700443|NCT00828919|324359558|FG002|Overall Study|Adverse Event|2|||
94700444|NCT00828919|324359559|FG003|Overall Study|Adverse Event|1|||
94700445|NCT00828919|324359560|FG004|Overall Study|Adverse Event|3|||
94700446|NCT00828919|324359556|FG000|Overall Study|Objective progression or relapse|4|||
94700447|NCT00828919|324359557|FG001|Overall Study|Objective progression or relapse|4|||
94700448|NCT00828919|324359558|FG002|Overall Study|Objective progression or relapse|11|||
94700449|NCT00828919|324359559|FG003|Overall Study|Objective progression or relapse|0|||
94700450|NCT00828919|324359560|FG004|Overall Study|Objective progression or relapse|5|||
94700451|NCT00828919|324359556|FG000|Overall Study|No longer willing to participate in study|0|||
94700452|NCT00828919|324359557|FG001|Overall Study|No longer willing to participate in study|0|||
94700453|NCT00828919|324359558|FG002|Overall Study|No longer willing to participate in study|2|||
94700454|NCT00828919|324359559|FG003|Overall Study|No longer willing to participate in study|0|||
94700455|NCT00828919|324359560|FG004|Overall Study|No longer willing to participate in study|0|||
94700456|NCT00828919|324359556|FG000|Overall Study|Insufficient Clinical Response|0|||
94700457|NCT00828919|324359557|FG001|Overall Study|Insufficient Clinical Response|1|||
94700458|NCT00828919|324359558|FG002|Overall Study|Insufficient Clinical Response|2|||
94700459|NCT00828919|324359559|FG003|Overall Study|Insufficient Clinical Response|0|||
94700460|NCT00828919|324359560|FG004|Overall Study|Insufficient Clinical Response|0|||
94466144|NCT01472939|323496944|FG003|Overall Study|Withdrawal By PI|0|||
94466145|NCT01472939|323496941|FG000|Overall Study|Protocol Violation|3|||
94700461|NCT00828919|324359556|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
94265714|NCT01162239|322765799|FG000|Treatment Phase|Withdrawal by Subject|1|||
94265715|NCT01162239|322765800|FG001|Treatment Phase|Withdrawal by Subject|3|||
94265716|NCT01162239|322765801|FG002|Treatment Phase|Withdrawal by Subject|2|||
94265717|NCT01162239|322765802|FG003|Treatment Phase|Withdrawal by Subject|3|||
94265718|NCT01162239|322765799|FG000|Treatment Phase|Death|0|||
94265719|NCT01162239|322765800|FG001|Treatment Phase|Death|0|||
94265720|NCT01162239|322765801|FG002|Treatment Phase|Death|0|||
94265721|NCT01162239|322765802|FG003|Treatment Phase|Death|1|||
94265722|NCT01162239|322765799|FG000|Treatment Phase|Lost to Follow-up|5|||
94265723|NCT01162239|322765800|FG001|Treatment Phase|Lost to Follow-up|4|||
94366473|NCT01289990|323126537|FG000|Overall Study|did not continue in extension|41|||
94700462|NCT00828919|324359557|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
94700463|NCT00828919|324359558|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
94700464|NCT00828919|324359559|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
94700465|NCT00828919|324359560|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
94700466|NCT00828919|324359556|FG000|Overall Study|Other|1|||
94700467|NCT00828919|324359557|FG001|Overall Study|Other|0|||
94700468|NCT00828919|324359558|FG002|Overall Study|Other|1|||
94700469|NCT00828919|324359559|FG003|Overall Study|Other|1|||
94700470|NCT00828919|324359560|FG004|Overall Study|Other|0|||
94700471|NCT00828919|324359556|FG000|Overall Study|Lost to Follow-up|0|||
94700472|NCT00828919|324359557|FG001|Overall Study|Lost to Follow-up|1|||
94700473|NCT00828919|324359558|FG002|Overall Study|Lost to Follow-up|0|||
94700474|NCT00828919|324359559|FG003|Overall Study|Lost to Follow-up|0|||
94700475|NCT00828919|324359560|FG004|Overall Study|Lost to Follow-up|0|||
94700476|NCT01562743|324359563|FG000|Overall Study|Adverse Event|29|||
94700477|NCT01562743|324359563|FG000|Overall Study|Lack of Efficacy|3|||
94700478|NCT01562743|324359563|FG000|Overall Study|Withdrawal by Subject|13|||
94700479|NCT01562743|324359563|FG000|Overall Study|Protocol Violation|1|||
94700480|NCT01562743|324359563|FG000|Overall Study|Discontinuation criteria|2|||
94700481|NCT01562743|324359563|FG000|Overall Study|Lost to Follow-up|2|||
94700482|NCT01562743|324359563|FG000|Overall Study|Physician Decision|2|||
94700483|NCT05567159|324359564|FG000|Overall Study|Adverse Event|4|||
94700484|NCT05567159|324359564|FG000|Overall Study|Physician Decision|3|||
94700485|NCT05567159|324359564|FG000|Overall Study|Protocol deviation|1|||
94700486|NCT02465359|324359567|FG000|Overall Study|Lack of Efficacy|1|||
94700487|NCT02465359|324359567|FG000|Overall Study|Withdrawal by Subject|1|||
94700488|NCT02465359|324359567|FG000|Overall Study|Adverse Event|1|||
94700489|NCT03015740|324359568|FG000|Overall Study|Adverse Event|1|||
94700490|NCT03015740|324359569|FG001|Overall Study|Adverse Event|0|||
94700491|NCT03015740|324359570|FG002|Overall Study|Adverse Event|0|||
94700492|NCT03015740|324359568|FG000|Overall Study|Death|3|||
94700493|NCT03015740|324359569|FG001|Overall Study|Death|5|||
94700494|NCT03015740|324359570|FG002|Overall Study|Death|0|||
94700495|NCT03015740|324359568|FG000|Overall Study|Withdrawal by Subject|2|||
94700496|NCT03015740|324359569|FG001|Overall Study|Withdrawal by Subject|0|||
94700497|NCT03015740|324359570|FG002|Overall Study|Withdrawal by Subject|0|||
94700498|NCT05233085|324359571|FG000|Overall Study|Adverse Event|1|||
94700499|NCT05233085|324359572|FG001|Overall Study|Adverse Event|0|||
94700500|NCT05233085|324359573|FG002|Overall Study|Adverse Event|0|||
94700501|NCT05233085|324359574|FG003|Overall Study|Adverse Event|0|||
94700502|NCT05567952|324361650|FG000|Overall Study|Lost to Follow-up|3|||
94700503|NCT05567952|324361651|FG001|Overall Study|Lost to Follow-up|2|||
94700504|NCT05567952|324361650|FG000|Overall Study|Withdrawal by Subject|6|||
94700505|NCT05567952|324361651|FG001|Overall Study|Withdrawal by Subject|3|||
94700506|NCT05567952|324361650|FG000|Overall Study|Other|3|||
94700507|NCT05567952|324361651|FG001|Overall Study|Other|1|||
94700508|NCT00072475|324361654|FG000|Overall Study|Adverse Event|44|||
94700509|NCT00072475|324361654|FG000|Overall Study|Death|3|||
94700510|NCT00072475|324361654|FG000|Overall Study|Withdrawal by Subject|46|||
94700511|NCT00072475|324361654|FG000|Overall Study|Patient/Investigator Decision|4|||
94700512|NCT03303105|324361657|FG000|Overall Study|Adverse Event|0|||
94700513|NCT03303105|324361658|FG001|Overall Study|Adverse Event|2|||
94700514|NCT03303105|324361657|FG000|Overall Study|Lack of Efficacy|1|||
94700515|NCT03303105|324361658|FG001|Overall Study|Lack of Efficacy|0|||
94700516|NCT03303105|324361657|FG000|Overall Study|Protocol Violation|1|||
94700517|NCT03303105|324361658|FG001|Overall Study|Protocol Violation|0|||
94265724|NCT01162239|322765801|FG002|Treatment Phase|Lost to Follow-up|2|||
94366474|NCT01289990|323126538|FG001|Overall Study|did not continue in extension|45|||
94366475|NCT01289990|323126539|FG002|Overall Study|did not continue in extension|51|||
94265725|NCT01162239|322765802|FG003|Treatment Phase|Lost to Follow-up|1|||
94700518|NCT03303105|324361657|FG000|Overall Study|Withdrawal by Subject|0|||
94700519|NCT03303105|324361658|FG001|Overall Study|Withdrawal by Subject|2|||
94700520|NCT00797862|324361661|FG000|Overall Study|Adverse Event|86|||
94700521|NCT00797862|324361662|FG001|Overall Study|Adverse Event|44|||
94700522|NCT00797862|324361663|FG002|Overall Study|Adverse Event|58|||
94700523|NCT00797862|324361661|FG000|Overall Study|Abnormal Test Procedure Result|0|||
94366476|NCT01289990|323126540|FG003|Overall Study|did not continue in extension|51|||
94700524|NCT00797862|324361662|FG001|Overall Study|Abnormal Test Procedure Result|1|||
94700525|NCT00797862|324361663|FG002|Overall Study|Abnormal Test Procedure Result|1|||
94700526|NCT00797862|324361661|FG000|Overall Study|Lack of Efficacy|1|||
94700527|NCT00797862|324361662|FG001|Overall Study|Lack of Efficacy|7|||
94700528|NCT00797862|324361663|FG002|Overall Study|Lack of Efficacy|6|||
94700529|NCT00797862|324361661|FG000|Overall Study|No longer required study medication|1|||
94651861|NCT03228680|324183775|FG001|Overall Study|Randomization failure|1|||
94651862|NCT03228680|324183774|FG000|Overall Study|Withdrawal by Subject|1|||
94651863|NCT03228680|324183775|FG001|Overall Study|Withdrawal by Subject|0|||
94651864|NCT03228680|324183774|FG000|Overall Study|Other|9|||
94651865|NCT03228680|324183775|FG001|Overall Study|Other|16|||
94651866|NCT00529386|324183792|FG000|Overall Study|Lost to Follow-up|1|||
94651867|NCT03592641|324183793|FG000|Overall Study|Withdrawal by Subject|1|||
94651868|NCT00436280|324183794|FG000|Period 1: Induction|Adverse Event|8|||
94651869|NCT00436280|324183794|FG000|Period 1: Induction|Progressive Disease|12|||
94651870|NCT00436280|324183794|FG000|Period 1: Induction|Stable Disease|6|||
94651871|NCT00436280|324183794|FG000|Period 1: Induction|Withdrawal by Subject|1|||
94651872|NCT00436280|324183794|FG000|Period 1: Induction|Death|1|||
94651873|NCT00436280|324183794|FG000|Period 2: Consolidation|Adverse Event|1|||
94651874|NCT00436280|324183794|FG000|Period 2: Consolidation|Progressive Disease|10|||
94651875|NCT00436280|324183794|FG000|Period 2: Consolidation|Stable Disease|1|||
94651876|NCT00436280|324183794|FG000|Period 2: Consolidation|Physician Decision|2|||
94651877|NCT00436280|324183794|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
94651878|NCT00436280|324183794|FG000|Period 2: Consolidation|Death|1|||
94651879|NCT00436280|324183794|FG000|Period 3: Maintenance|Adverse Event|6|||
94651880|NCT00436280|324183794|FG000|Period 3: Maintenance|Progressive Disease|12|||
94651881|NCT02103478|324183796|FG000|Overall Study|Adverse Event|0|||
94651882|NCT02103478|324183797|FG001|Overall Study|Adverse Event|0|||
94651883|NCT02103478|324183798|FG002|Overall Study|Adverse Event|1|||
94651884|NCT02103478|324183799|FG003|Overall Study|Adverse Event|1|||
94651885|NCT02103478|324183800|FG004|Overall Study|Adverse Event|2|||
94651886|NCT02103478|324183801|FG005|Overall Study|Adverse Event|1|||
94651887|NCT02103478|324183802|FG006|Overall Study|Adverse Event|0|||
94651888|NCT02103478|324183803|FG007|Overall Study|Adverse Event|0|||
94651889|NCT02103478|324183804|FG008|Overall Study|Adverse Event|0|||
94651890|NCT02103478|324183796|FG000|Overall Study|Death|2|||
94651891|NCT02103478|324183797|FG001|Overall Study|Death|2|||
94651892|NCT02103478|324183798|FG002|Overall Study|Death|1|||
94651893|NCT02103478|324183799|FG003|Overall Study|Death|1|||
94651894|NCT02103478|324183800|FG004|Overall Study|Death|5|||
94651895|NCT02103478|324183801|FG005|Overall Study|Death|15|||
94651896|NCT02103478|324183802|FG006|Overall Study|Death|14|||
94651897|NCT02103478|324183803|FG007|Overall Study|Death|10|||
94651898|NCT02103478|324183804|FG008|Overall Study|Death|11|||
94651899|NCT02103478|324183796|FG000|Overall Study|Progressive Disease|2|||
94651900|NCT02103478|324183797|FG001|Overall Study|Progressive Disease|1|||
94651901|NCT02103478|324183798|FG002|Overall Study|Progressive Disease|2|||
94651902|NCT02103478|324183799|FG003|Overall Study|Progressive Disease|0|||
94651903|NCT02103478|324183800|FG004|Overall Study|Progressive Disease|9|||
94651904|NCT02103478|324183801|FG005|Overall Study|Progressive Disease|1|||
94651905|NCT02103478|324183802|FG006|Overall Study|Progressive Disease|2|||
94651906|NCT02103478|324183803|FG007|Overall Study|Progressive Disease|0|||
94651907|NCT02103478|324183804|FG008|Overall Study|Progressive Disease|1|||
94651908|NCT02103478|324183796|FG000|Overall Study|Withdrawal by Subject|2|||
94651909|NCT02103478|324183797|FG001|Overall Study|Withdrawal by Subject|0|||
94651910|NCT02103478|324183798|FG002|Overall Study|Withdrawal by Subject|0|||
94651911|NCT02103478|324183799|FG003|Overall Study|Withdrawal by Subject|4|||
94651912|NCT02103478|324183800|FG004|Overall Study|Withdrawal by Subject|0|||
94651913|NCT02103478|324183801|FG005|Overall Study|Withdrawal by Subject|0|||
94651914|NCT02103478|324183802|FG006|Overall Study|Withdrawal by Subject|1|||
94651915|NCT02103478|324183803|FG007|Overall Study|Withdrawal by Subject|1|||
94651916|NCT02103478|324183804|FG008|Overall Study|Withdrawal by Subject|0|||
94651917|NCT02103478|324183796|FG000|Overall Study|Lost to Follow-up|0|||
94651918|NCT02103478|324183797|FG001|Overall Study|Lost to Follow-up|0|||
94651919|NCT02103478|324183798|FG002|Overall Study|Lost to Follow-up|0|||
94651920|NCT02103478|324183799|FG003|Overall Study|Lost to Follow-up|0|||
94651921|NCT02103478|324183800|FG004|Overall Study|Lost to Follow-up|0|||
94651922|NCT02103478|324183801|FG005|Overall Study|Lost to Follow-up|0|||
94651923|NCT02103478|324183802|FG006|Overall Study|Lost to Follow-up|0|||
94651924|NCT02103478|324183803|FG007|Overall Study|Lost to Follow-up|1|||
94651925|NCT02103478|324183804|FG008|Overall Study|Lost to Follow-up|0|||
94651926|NCT02103478|324183796|FG000|Overall Study|Other|1|||
94651927|NCT02103478|324183797|FG001|Overall Study|Other|3|||
94651928|NCT02103478|324183798|FG002|Overall Study|Other|2|||
94651929|NCT02103478|324183799|FG003|Overall Study|Other|0|||
94700530|NCT00797862|324361662|FG001|Overall Study|No longer required study medication|0|||
94700531|NCT00797862|324361663|FG002|Overall Study|No longer required study medication|0|||
94700532|NCT00797862|324361661|FG000|Overall Study|Withdrawal by Subject|14|||
94700533|NCT00797862|324361662|FG001|Overall Study|Withdrawal by Subject|7|||
94700534|NCT00797862|324361663|FG002|Overall Study|Withdrawal by Subject|7|||
94700535|NCT00797862|324361661|FG000|Overall Study|Lost to Follow-up|11|||
94700536|NCT00797862|324361662|FG001|Overall Study|Lost to Follow-up|0|||
94700537|NCT00797862|324361663|FG002|Overall Study|Lost to Follow-up|5|||
94700538|NCT00797862|324361661|FG000|Overall Study|Administrative Problem|4|||
94700539|NCT00797862|324361662|FG001|Overall Study|Administrative Problem|0|||
94700540|NCT00797862|324361663|FG002|Overall Study|Administrative Problem|0|||
94700541|NCT00797862|324361661|FG000|Overall Study|Protocol Violation|4|||
94700542|NCT00797862|324361662|FG001|Overall Study|Protocol Violation|6|||
94700543|NCT00797862|324361663|FG002|Overall Study|Protocol Violation|8|||
94700544|NCT00797862|324361661|FG000|Overall Study|Mis-randomized|3|||
94700545|NCT00797862|324361662|FG001|Overall Study|Mis-randomized|3|||
94700546|NCT00797862|324361663|FG002|Overall Study|Mis-randomized|1|||
94700547|NCT01240356|324361667|FG000|Overall Study|Withdrawal by Subject|2|||
94700548|NCT01240356|324361668|FG001|Overall Study|Withdrawal by Subject|0|||
94700549|NCT01240356|324361667|FG000|Overall Study|MRI contraindication|1|||
94700550|NCT01240356|324361668|FG001|Overall Study|MRI contraindication|0|||
94700551|NCT01306331|324361669|FG000|Overall Study|Adverse Event|28|||
94700552|NCT01306331|324361670|FG001|Overall Study|Adverse Event|25|||
94700553|NCT01306331|324361669|FG000|Overall Study|Lost to Follow-up|321|||
94700554|NCT01306331|324361670|FG001|Overall Study|Lost to Follow-up|323|||
94700555|NCT01306331|324361669|FG000|Overall Study|Physician Decision|26|||
94700556|NCT01306331|324361670|FG001|Overall Study|Physician Decision|22|||
94700557|NCT01306331|324361669|FG000|Overall Study|Pregnancy|136|||
94700558|NCT01306331|324361670|FG001|Overall Study|Pregnancy|151|||
94700559|NCT01306331|324361669|FG000|Overall Study|Protocol Violation|154|||
94700560|NCT01306331|324361670|FG001|Overall Study|Protocol Violation|124|||
94700561|NCT01306331|324361669|FG000|Overall Study|Withdrawal by Subject|163|||
94700562|NCT01306331|324361670|FG001|Overall Study|Withdrawal by Subject|152|||
94700563|NCT01306331|324361669|FG000|Overall Study|Not sexually active|29|||
94700564|NCT01306331|324361670|FG001|Overall Study|Not sexually active|28|||
94700565|NCT01306331|324361669|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
94700566|NCT01306331|324361670|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
94700567|NCT01306331|324361669|FG000|Overall Study|Other|34|||
94700568|NCT01306331|324361670|FG001|Overall Study|Other|32|||
94700569|NCT01257503|324361674|FG000|Overall Study|Lost to Follow-up|7|||
94700570|NCT01257503|324361675|FG001|Overall Study|Lost to Follow-up|10|||
94700571|NCT01257503|324361674|FG000|Overall Study|Over 5 years old at enrollment|0|||
94700572|NCT01257503|324361675|FG001|Overall Study|Over 5 years old at enrollment|1|||
94700573|NCT01257503|324361674|FG000|Overall Study|strep culture positive at enrollment|1|||
94700574|NCT01257503|324361675|FG001|Overall Study|strep culture positive at enrollment|0|||
94700575|NCT00448864|324361679|FG000|Overall Study|Death|1|||
94366477|NCT01289990|323126541|FG004|Overall Study|did not continue in extension|48|||
94366478|NCT01289990|323126542|FG005|Overall Study|did not continue in extension|50|||
94700576|NCT00448864|324361680|FG001|Overall Study|Death|0|||
94700577|NCT00448864|324361681|FG002|Overall Study|Death|0|||
94700578|NCT00448864|324361679|FG000|Overall Study|Lost to Follow-up|3|||
94366479|NCT01289990|323126543|FG006|Overall Study|did not continue in extension|54|||
94466146|NCT01472939|323496942|FG001|Overall Study|Protocol Violation|3|||
94700579|NCT00448864|324361680|FG001|Overall Study|Lost to Follow-up|1|||
94700580|NCT00448864|324361681|FG002|Overall Study|Lost to Follow-up|0|||
94700581|NCT00448864|324361679|FG000|Overall Study|Physician Decision|1|||
94700582|NCT00448864|324361680|FG001|Overall Study|Physician Decision|0|||
94700583|NCT00448864|324361681|FG002|Overall Study|Physician Decision|1|||
94700584|NCT00448864|324361679|FG000|Overall Study|Withdrawal by Subject|0|||
94700585|NCT00448864|324361680|FG001|Overall Study|Withdrawal by Subject|2|||
94700586|NCT00448864|324361681|FG002|Overall Study|Withdrawal by Subject|0|||
94700587|NCT00448864|324361679|FG000|Overall Study|Protocol Violation|0|||
94700588|NCT00448864|324361680|FG001|Overall Study|Protocol Violation|2|||
94700589|NCT00448864|324361681|FG002|Overall Study|Protocol Violation|0|||
94700590|NCT01390857|324361682|FG000|Overall Study|Protocol Violation|2|||
94700591|NCT01390857|324361682|FG000|Overall Study|Lost to Follow-up|1|||
94700592|NCT01390857|324361682|FG000|Overall Study|No Visit after the First Visit|7|||
94700593|NCT01123161|324361683|FG000|Overall Study|Lost to Follow-up|1|||
94700594|NCT01123161|324361684|FG001|Overall Study|Lost to Follow-up|0|||
94700595|NCT01123161|324361683|FG000|Overall Study|Withdrawal by Subject|1|||
94700596|NCT01123161|324361684|FG001|Overall Study|Withdrawal by Subject|0|||
94700597|NCT02757885|324361685|FG000|Overall Study|Screen Failures|4|||
94700598|NCT02501629|324361687|FG000|Overall Study|Death|0|||
94700599|NCT02501629|324361688|FG001|Overall Study|Death|1|||
94700600|NCT02501629|324361687|FG000|Overall Study|Withdrawn from study by sponsor|1|||
94700601|NCT02501629|324361688|FG001|Overall Study|Withdrawn from study by sponsor|0|||
94700602|NCT02501629|324361687|FG000|Overall Study|Early termination by sponsor|1|||
94700603|NCT02501629|324361688|FG001|Overall Study|Early termination by sponsor|0|||
94700604|NCT02501629|324361687|FG000|Overall Study|Withdrawal by Subject|3|||
94700605|NCT02501629|324361688|FG001|Overall Study|Withdrawal by Subject|5|||
94265726|NCT01162239|322765799|FG000|Extended Follow-up|Lost to Follow-up|8|||
94265727|NCT01162239|322765800|FG001|Extended Follow-up|Lost to Follow-up|13|||
94700606|NCT02501629|324361687|FG000|Overall Study|Subject did not return to site|0|||
94700607|NCT02501629|324361688|FG001|Overall Study|Subject did not return to site|1|||
94700608|NCT00984282|324361689|FG000|Double Blind Treatment|Adverse Event|40|||
94700609|NCT00984282|324361690|FG001|Double Blind Treatment|Adverse Event|6|||
94700610|NCT00984282|324361689|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
94700611|NCT00984282|324361690|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
94466147|NCT01472939|323496943|FG002|Overall Study|Protocol Violation|0|||
94265728|NCT01162239|322765801|FG002|Extended Follow-up|Lost to Follow-up|8|||
94466148|NCT01472939|323496944|FG003|Overall Study|Protocol Violation|1|||
94700612|NCT00984282|324361689|FG000|Double Blind Treatment|Physician Decision|1|||
94700613|NCT00984282|324361690|FG001|Double Blind Treatment|Physician Decision|2|||
94700614|NCT00984282|324361689|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
94700615|NCT00984282|324361690|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
94700616|NCT00984282|324361689|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
94700617|NCT00984282|324361690|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
94700618|NCT00984282|324361689|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
94700619|NCT00984282|324361690|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
94700620|NCT00984282|324361689|FG000|Double Blind Treatment|Lost to Follow-up|3|||
94700621|NCT00984282|324361690|FG001|Double Blind Treatment|Lost to Follow-up|0|||
94700622|NCT00984282|324361689|FG000|Double Blind Treatment|Death|8|||
94700623|NCT00984282|324361690|FG001|Double Blind Treatment|Death|4|||
94700624|NCT00984282|324361689|FG000|Double Blind Treatment|Not treated|0|||
94700625|NCT00984282|324361690|FG001|Double Blind Treatment|Not treated|1|||
94700626|NCT00984282|324361689|FG000|Double Blind Treatment|Switched to commercial drug|6|||
94700627|NCT00984282|324361690|FG001|Double Blind Treatment|Switched to commercial drug|1|||
94700628|NCT00984282|324361689|FG000|Double Blind Treatment|protocol driven decision point|1|||
94700629|NCT00984282|324361690|FG001|Double Blind Treatment|protocol driven decision point|1|||
94700630|NCT00984282|324361689|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
94700631|NCT00984282|324361690|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
94700632|NCT00984282|324361689|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
94700633|NCT00984282|324361690|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
94700634|NCT00984282|324361689|FG000|Open-label Treatment|Adverse Event|20|||
94700635|NCT00984282|324361690|FG001|Open-label Treatment|Adverse Event|30|||
94700636|NCT00984282|324361689|FG000|Open-label Treatment|Withdrawal by Subject|6|||
94700637|NCT00984282|324361690|FG001|Open-label Treatment|Withdrawal by Subject|21|||
94700638|NCT00984282|324361689|FG000|Open-label Treatment|Death|7|||
94700639|NCT00984282|324361690|FG001|Open-label Treatment|Death|15|||
94700640|NCT00984282|324361689|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
94700641|NCT00984282|324361690|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
94700642|NCT00984282|324361689|FG000|Open-label Treatment|Lost to Follow-up|1|||
94700643|NCT00984282|324361690|FG001|Open-label Treatment|Lost to Follow-up|1|||
94700644|NCT00984282|324361689|FG000|Open-label Treatment|Patient convenience|1|||
94700645|NCT00984282|324361690|FG001|Open-label Treatment|Patient convenience|0|||
94700646|NCT00984282|324361689|FG000|Open-label Treatment|Non-compliant with study medication|1|||
94700647|NCT00984282|324361690|FG001|Open-label Treatment|Non-compliant with study medication|0|||
94700648|NCT00984282|324361689|FG000|Open-label Treatment|Target lesion removed|0|||
94700649|NCT00984282|324361690|FG001|Open-label Treatment|Target lesion removed|1|||
94700650|NCT00984282|324361689|FG000|Open-label Treatment|Protocol driven decision point|1|||
94700651|NCT00984282|324361690|FG001|Open-label Treatment|Protocol driven decision point|1|||
94700652|NCT00984282|324361689|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
94700653|NCT00984282|324361690|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
94700654|NCT00984282|324361689|FG000|Open-label Treatment|Switched to commercial drug|6|||
94700655|NCT00984282|324361690|FG001|Open-label Treatment|Switched to commercial drug|7|||
94700656|NCT00984282|324361689|FG000|Open-label Treatment|Physician Decision|1|||
94700657|NCT00984282|324361690|FG001|Open-label Treatment|Physician Decision|0|||
94700658|NCT00984282|324361689|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
94700659|NCT00984282|324361690|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
94700660|NCT00984282|324361689|FG000|Long Term Follow-up|Death|27|||
94700661|NCT00984282|324361690|FG001|Long Term Follow-up|Death|68|||
94700662|NCT00984282|324361689|FG000|Long Term Follow-up|Lost to Follow-up|3|||
94700663|NCT00984282|324361690|FG001|Long Term Follow-up|Lost to Follow-up|6|||
94700664|NCT00984282|324361689|FG000|Long Term Follow-up|Protocol driven decision point|25|||
94700665|NCT00984282|324361690|FG001|Long Term Follow-up|Protocol driven decision point|26|||
94700666|NCT00984282|324361689|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
94700667|NCT00984282|324361690|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
94700668|NCT00984282|324361689|FG000|Long Term Follow-up|Switched to commercial drug|4|||
94700669|NCT00984282|324361690|FG001|Long Term Follow-up|Switched to commercial drug|2|||
94466149|NCT01472939|323496941|FG000|Overall Study|Withdrawal by Subject|9|||
94466150|NCT01472939|323496942|FG001|Overall Study|Withdrawal by Subject|3|||
94700670|NCT00984282|324361689|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
94700671|NCT00984282|324361690|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
94700672|NCT00530335|324361692|FG000|Overall Study|Adverse Event|3|||
94700673|NCT00530335|324361692|FG000|Overall Study|Protocol Violation|1|||
94700674|NCT00530335|324361692|FG000|Overall Study|Withdrawal by Subject|1|||
94466151|NCT01472939|323496943|FG002|Overall Study|Withdrawal by Subject|1|||
94265729|NCT01162239|322765802|FG003|Extended Follow-up|Lost to Follow-up|6|||
94265730|NCT00671554|322765808|FG000|Overall Study|Disease progression|3|||
94265731|NCT01479829|322765809|FG000|Overall Study|Withdrawal by Subject|8|||
94265732|NCT01479829|322765810|FG001|Overall Study|Withdrawal by Subject|10|||
94265733|NCT03511053|322766754|FG000|Overall Study|Withdrawal by Subject|1|||
94265734|NCT01448213|322766755|FG000|Overall Study|Lost to Follow-up|12|||
94265735|NCT01448213|322766756|FG001|Overall Study|Lost to Follow-up|10|||
94265736|NCT01448213|322766755|FG000|Overall Study|Adverse Event|4|||
94651930|NCT02103478|324183800|FG004|Overall Study|Other|3|||
94651931|NCT02103478|324183801|FG005|Overall Study|Other|8|||
94651932|NCT02103478|324183802|FG006|Overall Study|Other|8|||
94651933|NCT02103478|324183803|FG007|Overall Study|Other|4|||
94651934|NCT02103478|324183804|FG008|Overall Study|Other|2|||
94651935|NCT03219333|324183805|FG000|Overall Study|Withdrawal by Subject|9|||
94651936|NCT03219333|324183806|FG001|Overall Study|Withdrawal by Subject|4|||
94651937|NCT03219333|324183805|FG000|Overall Study|Lost to Follow-up|1|||
94651938|NCT03219333|324183806|FG001|Overall Study|Lost to Follow-up|1|||
94651939|NCT03219333|324183805|FG000|Overall Study|Death|104|||
94651940|NCT03219333|324183806|FG001|Overall Study|Death|72|||
94651941|NCT03219333|324183805|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
94651942|NCT03219333|324183806|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
94651943|NCT03219333|324183805|FG000|Overall Study|Other|2|||
94651944|NCT03219333|324183806|FG001|Overall Study|Other|2|||
94651945|NCT02566759|324183807|FG000|All Parts|Withdrawal by Subject|0|||
94651946|NCT02566759|324183808|FG001|All Parts|Withdrawal by Subject|1|||
94651947|NCT02566759|324183809|FG002|All Parts|Withdrawal by Subject|0|||
94651948|NCT02566759|324183810|FG003|All Parts|Withdrawal by Subject|0|||
94651949|NCT02566759|324183811|FG004|All Parts|Withdrawal by Subject|0|||
94651950|NCT02566759|324183812|FG005|All Parts|Withdrawal by Subject|0|||
94651951|NCT02566759|324183813|FG006|All Parts|Withdrawal by Subject|0|||
94651952|NCT02566759|324183814|FG007|All Parts|Withdrawal by Subject|0|||
94651953|NCT02566759|324183815|FG008|All Parts|Withdrawal by Subject|0|||
94651954|NCT02566759|324183816|FG009|All Parts|Withdrawal by Subject|0|||
94651955|NCT02566759|324183817|FG010|All Parts|Withdrawal by Subject|0|||
94651956|NCT02566759|324183818|FG011|All Parts|Withdrawal by Subject|0|||
94651957|NCT02566759|324183819|FG012|All Parts|Withdrawal by Subject|0|||
94651958|NCT02566759|324183820|FG013|All Parts|Withdrawal by Subject|0|||
94651959|NCT02566759|324183821|FG014|All Parts|Withdrawal by Subject|0|||
94651960|NCT02566759|324183822|FG015|All Parts|Withdrawal by Subject|0|||
94651961|NCT02566759|324183823|FG016|All Parts|Withdrawal by Subject|0|||
94651962|NCT02566759|324183807|FG000|All Parts|Adverse Event|0|||
94651963|NCT02566759|324183808|FG001|All Parts|Adverse Event|0|||
94651964|NCT02566759|324183809|FG002|All Parts|Adverse Event|0|||
94651965|NCT02566759|324183810|FG003|All Parts|Adverse Event|0|||
94651966|NCT02566759|324183811|FG004|All Parts|Adverse Event|0|||
94651967|NCT02566759|324183812|FG005|All Parts|Adverse Event|0|||
94651968|NCT02566759|324183813|FG006|All Parts|Adverse Event|0|||
94651969|NCT02566759|324183814|FG007|All Parts|Adverse Event|0|||
94651970|NCT02566759|324183815|FG008|All Parts|Adverse Event|0|||
94651971|NCT02566759|324183816|FG009|All Parts|Adverse Event|0|||
94651972|NCT02566759|324183817|FG010|All Parts|Adverse Event|0|||
94651973|NCT02566759|324183818|FG011|All Parts|Adverse Event|0|||
94651974|NCT02566759|324183819|FG012|All Parts|Adverse Event|1|||
94651975|NCT02566759|324183820|FG013|All Parts|Adverse Event|3|||
94651976|NCT02566759|324183821|FG014|All Parts|Adverse Event|0|||
94651977|NCT02566759|324183822|FG015|All Parts|Adverse Event|0|||
94651978|NCT02566759|324183823|FG016|All Parts|Adverse Event|0|||
94651979|NCT02566759|324183807|FG000|All Parts|Other|0|||
94651980|NCT02566759|324183808|FG001|All Parts|Other|0|||
94651981|NCT02566759|324183809|FG002|All Parts|Other|0|||
94651982|NCT02566759|324183810|FG003|All Parts|Other|0|||
94651983|NCT02566759|324183811|FG004|All Parts|Other|0|||
94651984|NCT02566759|324183812|FG005|All Parts|Other|0|||
94700675|NCT00530335|324361692|FG000|Overall Study|Physician Decision|1|||
94700676|NCT03646669|324361693|FG000|Overall Study|Withdrawal by Subject|5|||
94700677|NCT03646669|324361694|FG001|Overall Study|Withdrawal by Subject|0|||
94700678|NCT01688973|324361696|FG000|Overall Study|Ineligible|2|||
94700679|NCT01688973|324361697|FG001|Overall Study|Ineligible|3|||
94700680|NCT04582877|324361698|FG000|Overall Study|Did not use device measurement|5|||
94700681|NCT04582877|324361698|FG000|Overall Study|No fractional flow reserve test results|2|||
94700682|NCT04582877|324361698|FG000|Overall Study|Protocol Violation|1|||
94700683|NCT00003656|324361699|FG000|Overall Study|Adverse Event|0|||
94700684|NCT00003656|324361700|FG001|Overall Study|Adverse Event|1|||
94700685|NCT03055767|324361701|FG000|Open-Label Period|Lost to Follow-up|0|||
94700686|NCT03055767|324361702|FG001|Open-Label Period|Lost to Follow-up|0|||
94700687|NCT03055767|324361703|FG002|Open-Label Period|Lost to Follow-up|2|||
94700688|NCT03055767|324361704|FG003|Open-Label Period|Lost to Follow-up|0|||
94700689|NCT03055767|324361701|FG000|Open-Label Period|Withdrawal by Subject|0|||
94700690|NCT03055767|324361702|FG001|Open-Label Period|Withdrawal by Subject|0|||
94700691|NCT03055767|324361703|FG002|Open-Label Period|Withdrawal by Subject|0|||
94700692|NCT03055767|324361704|FG003|Open-Label Period|Withdrawal by Subject|1|||
94700693|NCT03686683|324361705|FG000|Overall Study|Withdrawal by Subject|52|||
94700694|NCT03686683|324361706|FG001|Overall Study|Withdrawal by Subject|32|||
94700695|NCT03686683|324361705|FG000|Overall Study|Lost to Follow-up|23|||
94700696|NCT03686683|324361706|FG001|Overall Study|Lost to Follow-up|19|||
94700697|NCT03686683|324361705|FG000|Overall Study|Adverse Event|1|||
94700698|NCT03686683|324361706|FG001|Overall Study|Adverse Event|0|||
94700699|NCT03686683|324361705|FG000|Overall Study|Death|10|||
94700700|NCT03686683|324361706|FG001|Overall Study|Death|5|||
94700701|NCT03686683|324361705|FG000|Overall Study|Progressive Disease|1|||
94700702|NCT03686683|324361706|FG001|Overall Study|Progressive Disease|1|||
94700703|NCT03686683|324361705|FG000|Overall Study|Noncompliance|1|||
94700704|NCT03686683|324361706|FG001|Overall Study|Noncompliance|0|||
94700705|NCT03686683|324361705|FG000|Overall Study|Physician Decision|1|||
94700706|NCT03686683|324361706|FG001|Overall Study|Physician Decision|1|||
94700707|NCT03686683|324361705|FG000|Overall Study|Screen fail post-randomization|1|||
94700708|NCT03686683|324361706|FG001|Overall Study|Screen fail post-randomization|0|||
94700709|NCT03686683|324361705|FG000|Overall Study|Protocol Violation|3|||
94700710|NCT03686683|324361706|FG001|Overall Study|Protocol Violation|0|||
94700711|NCT03686683|324361705|FG000|Overall Study|No data available|1|||
94700712|NCT03686683|324361706|FG001|Overall Study|No data available|0|||
94700713|NCT00763282|324361709|FG000|Overall Study|Withdrawal by Subject|6|||
94700714|NCT00763282|324361710|FG001|Overall Study|Withdrawal by Subject|5|||
94700715|NCT00763282|324361709|FG000|Overall Study|Death|4|||
94700716|NCT00763282|324361710|FG001|Overall Study|Death|3|||
94700717|NCT00763282|324361709|FG000|Overall Study|Lost to Follow-up|22|||
94700718|NCT00763282|324361710|FG001|Overall Study|Lost to Follow-up|26|||
94700719|NCT00742274|324361711|FG000|Overall Study|Death|1|||
94700720|NCT00742274|324361712|FG001|Overall Study|Death|0|||
94700721|NCT00742274|324361711|FG000|Overall Study|Withdrawal by Subject|1|||
94700722|NCT00742274|324361712|FG001|Overall Study|Withdrawal by Subject|2|||
94265737|NCT01448213|322766756|FG001|Overall Study|Adverse Event|10|||
94700723|NCT00742274|324361711|FG000|Overall Study|Removed for medical reasons|1|||
94700724|NCT00742274|324361712|FG001|Overall Study|Removed for medical reasons|1|||
94700725|NCT01770860|324361713|FG000|Overall Study|Withdrawal by Subject|4|||
94700726|NCT01770860|324361713|FG000|Overall Study|Lost to Follow-up|1|||
94700727|NCT01770860|324361713|FG000|Overall Study|Administrative decision made by the PI|1|||
94700728|NCT01878890|324361722|FG000|Overall Study|Protocol Violation|0|||
94700729|NCT01878890|324361723|FG001|Overall Study|Protocol Violation|1|||
94700730|NCT01878890|324361724|FG002|Overall Study|Protocol Violation|0|||
94700731|NCT01878890|324361725|FG003|Overall Study|Protocol Violation|0|||
94700732|NCT01511250|324361726|FG000|Overall Study|Withdrawal of Consent|1|||
94700733|NCT01511250|324361727|FG001|Overall Study|Withdrawal of Consent|0|||
94700734|NCT01511250|324361728|FG002|Overall Study|Withdrawal of Consent|0|||
94700735|NCT01511250|324361729|FG003|Overall Study|Withdrawal of Consent|0|||
94700736|NCT01511250|324361730|FG004|Overall Study|Withdrawal of Consent|0|||
94700737|NCT01511250|324361731|FG005|Overall Study|Withdrawal of Consent|0|||
94700738|NCT01511250|324361732|FG006|Overall Study|Withdrawal of Consent|0|||
94700739|NCT01511250|324361733|FG007|Overall Study|Withdrawal of Consent|1|||
94700740|NCT01511250|324361734|FG008|Overall Study|Withdrawal of Consent|1|||
94700741|NCT01511250|324361735|FG009|Overall Study|Withdrawal of Consent|0|||
94700742|NCT01511250|324361726|FG000|Overall Study|Sponsor/Investigator Decision|1|||
94700743|NCT01511250|324361727|FG001|Overall Study|Sponsor/Investigator Decision|0|||
94700744|NCT01511250|324361728|FG002|Overall Study|Sponsor/Investigator Decision|0|||
94700745|NCT01511250|324361729|FG003|Overall Study|Sponsor/Investigator Decision|0|||
94700746|NCT01511250|324361730|FG004|Overall Study|Sponsor/Investigator Decision|0|||
94700747|NCT01511250|324361731|FG005|Overall Study|Sponsor/Investigator Decision|0|||
94700748|NCT01511250|324361732|FG006|Overall Study|Sponsor/Investigator Decision|0|||
94700749|NCT01511250|324361733|FG007|Overall Study|Sponsor/Investigator Decision|0|||
94265738|NCT01448213|322766755|FG000|Overall Study|Protocol Violation|1|||
94265739|NCT01448213|322766756|FG001|Overall Study|Protocol Violation|2|||
94265740|NCT04163900|322766757|FG000|Overall Study|Radiological disease progression|112|||
94265741|NCT04163900|322766758|FG001|Overall Study|Radiological disease progression|127|||
94265742|NCT04163900|322766757|FG000|Overall Study|Study closure|98|||
94265743|NCT04163900|322766758|FG001|Overall Study|Study closure|133|||
94265744|NCT04163900|322766757|FG000|Overall Study|Adverse Event|78|||
94265745|NCT04163900|322766758|FG001|Overall Study|Adverse Event|32|||
94265746|NCT04163900|322766757|FG000|Overall Study|Withdrawal by Subject|37|||
94265747|NCT04163900|322766758|FG001|Overall Study|Withdrawal by Subject|34|||
94265748|NCT04163900|322766757|FG000|Overall Study|Death|29|||
94265749|NCT04163900|322766758|FG001|Overall Study|Death|16|||
94265750|NCT04163900|322766757|FG000|Overall Study|Physician Decision|17|||
94265751|NCT04163900|322766758|FG001|Overall Study|Physician Decision|25|||
94265752|NCT04163900|322766757|FG000|Overall Study|Clinical disease progression|14|||
94265753|NCT04163900|322766758|FG001|Overall Study|Clinical disease progression|13|||
94700750|NCT01511250|324361734|FG008|Overall Study|Sponsor/Investigator Decision|0|||
94700751|NCT01511250|324361735|FG009|Overall Study|Sponsor/Investigator Decision|0|||
94700752|NCT01511250|324361726|FG000|Overall Study|Lost to Follow-up|7|||
94700753|NCT01511250|324361727|FG001|Overall Study|Lost to Follow-up|3|||
94700754|NCT01511250|324361728|FG002|Overall Study|Lost to Follow-up|3|||
94700755|NCT01511250|324361729|FG003|Overall Study|Lost to Follow-up|3|||
94700756|NCT01511250|324361730|FG004|Overall Study|Lost to Follow-up|0|||
94700757|NCT01511250|324361731|FG005|Overall Study|Lost to Follow-up|0|||
94700758|NCT01511250|324361732|FG006|Overall Study|Lost to Follow-up|2|||
94265754|NCT04163900|322766757|FG000|Overall Study|Protocol Violation|3|||
94265755|NCT04163900|322766758|FG001|Overall Study|Protocol Violation|4|||
94700759|NCT01511250|324361733|FG007|Overall Study|Lost to Follow-up|3|||
94700760|NCT01511250|324361734|FG008|Overall Study|Lost to Follow-up|13|||
94700761|NCT01511250|324361735|FG009|Overall Study|Lost to Follow-up|5|||
94265756|NCT04163900|322766757|FG000|Overall Study|Lost to Follow-up|0|||
94265757|NCT04163900|322766758|FG001|Overall Study|Lost to Follow-up|1|||
94265758|NCT03823404|322766759|FG000|Overall Study|Lost to Follow-up|1|||
94700762|NCT01511250|324361726|FG000|Overall Study|Protocol Violation|0|||
94700763|NCT01511250|324361727|FG001|Overall Study|Protocol Violation|2|||
94700764|NCT01511250|324361728|FG002|Overall Study|Protocol Violation|1|||
94265759|NCT03823404|322766760|FG001|Overall Study|Lost to Follow-up|2|||
94700765|NCT01511250|324361729|FG003|Overall Study|Protocol Violation|0|||
94700766|NCT01511250|324361730|FG004|Overall Study|Protocol Violation|0|||
94700767|NCT01511250|324361731|FG005|Overall Study|Protocol Violation|0|||
94700768|NCT01511250|324361732|FG006|Overall Study|Protocol Violation|0|||
94700769|NCT01511250|324361733|FG007|Overall Study|Protocol Violation|0|||
94700770|NCT01511250|324361734|FG008|Overall Study|Protocol Violation|0|||
94700771|NCT01511250|324361735|FG009|Overall Study|Protocol Violation|0|||
94700772|NCT00567164|324361737|FG000|Overall Study|Withdrawal by Subject|171|||
94700773|NCT00567164|324361738|FG001|Overall Study|Withdrawal by Subject|21|||
94700774|NCT00567164|324361739|FG002|Overall Study|Withdrawal by Subject|17|||
94700775|NCT00567164|324361737|FG000|Overall Study|Protocol Violation|23|||
94700776|NCT00567164|324361738|FG001|Overall Study|Protocol Violation|4|||
94700777|NCT00567164|324361739|FG002|Overall Study|Protocol Violation|2|||
94700778|NCT00567164|324361737|FG000|Overall Study|Adverse Event|92|||
94700779|NCT00567164|324361738|FG001|Overall Study|Adverse Event|13|||
94700780|NCT00567164|324361739|FG002|Overall Study|Adverse Event|9|||
94700781|NCT00567164|324361737|FG000|Overall Study|Death|0|||
94700782|NCT00567164|324361738|FG001|Overall Study|Death|0|||
94700783|NCT00567164|324361739|FG002|Overall Study|Death|1|||
94700784|NCT00567164|324361737|FG000|Overall Study|Lost to Follow-up|202|||
94700785|NCT00567164|324361738|FG001|Overall Study|Lost to Follow-up|23|||
94700786|NCT00567164|324361739|FG002|Overall Study|Lost to Follow-up|21|||
94700787|NCT00567164|324361737|FG000|Overall Study|Pregnancy|20|||
94700788|NCT00567164|324361738|FG001|Overall Study|Pregnancy|4|||
94700789|NCT00567164|324361739|FG002|Overall Study|Pregnancy|6|||
94700790|NCT00567164|324361737|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
94700791|NCT00567164|324361738|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
94700792|NCT00567164|324361739|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
94700793|NCT00567164|324361737|FG000|Overall Study|Missing|1|||
94700794|NCT00567164|324361738|FG001|Overall Study|Missing|0|||
94700795|NCT00567164|324361739|FG002|Overall Study|Missing|0|||
94700796|NCT02974010|324361740|FG000|Overall Study|Lost to Follow-up|3|||
94700797|NCT02974010|324361741|FG001|Overall Study|Lost to Follow-up|1|||
94700798|NCT02974010|324361742|FG002|Overall Study|Lost to Follow-up|0|||
94700799|NCT02974010|324361743|FG003|Overall Study|Lost to Follow-up|0|||
94700800|NCT02974010|324361740|FG000|Overall Study|Withdrawal by Subject|2|||
94700801|NCT02974010|324361741|FG001|Overall Study|Withdrawal by Subject|1|||
94700802|NCT02974010|324361742|FG002|Overall Study|Withdrawal by Subject|0|||
94700803|NCT02974010|324361743|FG003|Overall Study|Withdrawal by Subject|0|||
94700804|NCT02974010|324361740|FG000|Overall Study|Adverse Event|0|||
94700805|NCT02974010|324361741|FG001|Overall Study|Adverse Event|1|||
94700806|NCT02974010|324361742|FG002|Overall Study|Adverse Event|0|||
94700807|NCT02974010|324361743|FG003|Overall Study|Adverse Event|0|||
94700808|NCT02974010|324361740|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
94700809|NCT02974010|324361741|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
94700810|NCT02974010|324361742|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
94700811|NCT02974010|324361743|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
94700812|NCT02974010|324361740|FG000|Overall Study|Lack of Efficacy|0|||
94700813|NCT02974010|324361741|FG001|Overall Study|Lack of Efficacy|0|||
94700814|NCT02974010|324361742|FG002|Overall Study|Lack of Efficacy|1|||
94700815|NCT02974010|324361743|FG003|Overall Study|Lack of Efficacy|0|||
94700816|NCT02282527|324361744|FG000|Overall Study|Lost to Follow-up|0|||
94700817|NCT02282527|324361745|FG001|Overall Study|Lost to Follow-up|1|||
94700818|NCT02282527|324361744|FG000|Overall Study|Lack of home health aid|1|||
94700819|NCT02282527|324361745|FG001|Overall Study|Lack of home health aid|0|||
94700820|NCT03441984|324361746|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
94700821|NCT03441984|324361747|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
94700822|NCT03441984|324361748|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
94700823|NCT03441984|324361749|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
94700824|NCT03441984|324361750|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
94700825|NCT03441984|324361751|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
94700826|NCT03441984|324361752|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
94700827|NCT03441984|324361753|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
94700828|NCT03441984|324361754|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
94700829|NCT03441984|324361755|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
94265760|NCT03823404|322766761|FG002|Overall Study|Lost to Follow-up|3|||
94366480|NCT01289990|323126544|FG007|Overall Study|did not continue in extension|36|||
94366481|NCT01289990|323126545|FG008|Overall Study|did not continue in extension|44|||
94366482|NCT01289990|323126546|FG009|Overall Study|did not continue in extension|48|||
94651985|NCT02566759|324183813|FG006|All Parts|Other|0|||
94366483|NCT01289990|323126547|FG010|Overall Study|did not continue in extension|45|||
94700830|NCT03441984|324361756|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
94700831|NCT03441984|324361757|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
94700832|NCT02107014|324361758|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
94700833|NCT03761784|324361759|FG000|Overall Study|Adverse Event|4|||
94700834|NCT03761784|324361760|FG001|Overall Study|Adverse Event|0|||
94700835|NCT03761784|324361759|FG000|Overall Study|Lost to Follow-up|10|||
94700836|NCT03761784|324361760|FG001|Overall Study|Lost to Follow-up|7|||
94700837|NCT03761784|324361759|FG000|Overall Study|Pregnancy|1|||
94700838|NCT03761784|324361760|FG001|Overall Study|Pregnancy|0|||
94700839|NCT03761784|324361759|FG000|Overall Study|Protocol Violation|2|||
94700840|NCT03761784|324361760|FG001|Overall Study|Protocol Violation|0|||
94700841|NCT03761784|324361759|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
94700842|NCT03761784|324361760|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
94700843|NCT03761784|324361759|FG000|Overall Study|Withdrawal by Subject|9|||
94700844|NCT03761784|324361760|FG001|Overall Study|Withdrawal by Subject|4|||
94700845|NCT03761784|324361759|FG000|Overall Study|Physician Decision|1|||
94700846|NCT03761784|324361760|FG001|Overall Study|Physician Decision|0|||
94700847|NCT03761784|324361759|FG000|Overall Study|Other Than Specified|1|||
94700848|NCT03761784|324361760|FG001|Overall Study|Other Than Specified|0|||
94700849|NCT03686384|324361761|FG000|Overall Study|Lack of Efficacy|4|||
94700850|NCT03686384|324361762|FG001|Overall Study|Lack of Efficacy|13|||
94700851|NCT03686384|324361761|FG000|Overall Study|Lost to Follow-up|3|||
94700852|NCT03686384|324361762|FG001|Overall Study|Lost to Follow-up|0|||
94700853|NCT03686384|324361761|FG000|Overall Study|Physician Decision|0|||
94700854|NCT03686384|324361762|FG001|Overall Study|Physician Decision|1|||
94700855|NCT03686384|324361761|FG000|Overall Study|Took prohibited medication|0|||
94700856|NCT03686384|324361762|FG001|Overall Study|Took prohibited medication|1|||
94700857|NCT01018511|324361771|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
94700858|NCT01018511|324361772|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
94700859|NCT01018511|324361773|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
94700860|NCT01018511|324361774|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
94700861|NCT01018511|324361771|FG000|Overall Study|Adverse Event|5|||
94700862|NCT01018511|324361772|FG001|Overall Study|Adverse Event|9|||
94700863|NCT01018511|324361773|FG002|Overall Study|Adverse Event|13|||
94700864|NCT01018511|324361774|FG003|Overall Study|Adverse Event|10|||
94700865|NCT01018511|324361771|FG000|Overall Study|Lack of Efficacy|4|||
94700866|NCT01018511|324361772|FG001|Overall Study|Lack of Efficacy|1|||
94700867|NCT01018511|324361773|FG002|Overall Study|Lack of Efficacy|1|||
94700868|NCT01018511|324361774|FG003|Overall Study|Lack of Efficacy|2|||
94700869|NCT01018511|324361771|FG000|Overall Study|Withdrawal by Subject|6|||
94700870|NCT01018511|324361772|FG001|Overall Study|Withdrawal by Subject|5|||
94700871|NCT01018511|324361773|FG002|Overall Study|Withdrawal by Subject|11|||
94700872|NCT01018511|324361774|FG003|Overall Study|Withdrawal by Subject|9|||
94700873|NCT01018511|324361771|FG000|Overall Study|Lost to Follow-up|0|||
94700874|NCT01018511|324361772|FG001|Overall Study|Lost to Follow-up|0|||
94700875|NCT01018511|324361773|FG002|Overall Study|Lost to Follow-up|1|||
94700876|NCT01018511|324361774|FG003|Overall Study|Lost to Follow-up|0|||
94700877|NCT01018511|324361771|FG000|Overall Study|Protocol Violation|5|||
94700878|NCT01018511|324361772|FG001|Overall Study|Protocol Violation|8|||
94700879|NCT01018511|324361773|FG002|Overall Study|Protocol Violation|7|||
94700880|NCT01018511|324361774|FG003|Overall Study|Protocol Violation|9|||
94700881|NCT01018511|324361771|FG000|Overall Study|Miscellaneous|0|||
94700882|NCT01018511|324361772|FG001|Overall Study|Miscellaneous|2|||
94700883|NCT01018511|324361773|FG002|Overall Study|Miscellaneous|0|||
94700884|NCT01018511|324361774|FG003|Overall Study|Miscellaneous|0|||
94700885|NCT01348087|324361777|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
94700886|NCT01348087|324361777|FG000|Overall Study|Administrative problems|79|||
94700887|NCT01348087|324361777|FG000|Overall Study|protocol deviation|1|||
94700888|NCT01348087|324361777|FG000|Overall Study|Lost to Follow-up|1|||
94700889|NCT01348087|324361777|FG000|Overall Study|Subject withdrew consent|7|||
94700890|NCT01348087|324361777|FG000|Overall Study|Adverse Event|25|||
94700891|NCT05196737|324361778|FG000|Non-intervention Week|Lost to Follow-up|2|||
94700892|NCT05196737|324361778|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
94700893|NCT03822351|324361779|FG000|Overall Study|Death|27|||
94700894|NCT03822351|324361780|FG001|Overall Study|Death|23|||
94700895|NCT03822351|324361781|FG002|Overall Study|Death|24|||
94700896|NCT03822351|324361779|FG000|Overall Study|Lost to Follow-up|6|||
94700897|NCT03822351|324361780|FG001|Overall Study|Lost to Follow-up|2|||
94700898|NCT03822351|324361781|FG002|Overall Study|Lost to Follow-up|1|||
94700899|NCT03822351|324361779|FG000|Overall Study|Withdrawal by Subject|10|||
94700900|NCT03822351|324361780|FG001|Overall Study|Withdrawal by Subject|4|||
94700901|NCT03822351|324361781|FG002|Overall Study|Withdrawal by Subject|6|||
94700902|NCT03822351|324361779|FG000|Overall Study|Progressive Disease|2|||
94700903|NCT03822351|324361780|FG001|Overall Study|Progressive Disease|1|||
94700904|NCT03822351|324361781|FG002|Overall Study|Progressive Disease|0|||
94700905|NCT03822351|324361779|FG000|Overall Study|Not Treated|1|||
94700906|NCT03822351|324361780|FG001|Overall Study|Not Treated|1|||
94700907|NCT03822351|324361781|FG002|Overall Study|Not Treated|1|||
94700908|NCT03568162|324361782|FG000|Overall Study|Adverse Event|0|||
94700909|NCT03568162|324361783|FG001|Overall Study|Adverse Event|1|||
94700910|NCT03568162|324361784|FG002|Overall Study|Adverse Event|2|||
94700911|NCT03568162|324361785|FG003|Overall Study|Adverse Event|0|||
94700912|NCT03568162|324361786|FG004|Overall Study|Adverse Event|0|||
94700913|NCT03568162|324361787|FG005|Overall Study|Adverse Event|1|||
94700914|NCT03568162|324361782|FG000|Overall Study|Death|0|||
94700915|NCT03568162|324361783|FG001|Overall Study|Death|0|||
94700916|NCT03568162|324361784|FG002|Overall Study|Death|0|||
94700917|NCT03568162|324361785|FG003|Overall Study|Death|0|||
94700918|NCT03568162|324361786|FG004|Overall Study|Death|1|||
94700919|NCT03568162|324361787|FG005|Overall Study|Death|0|||
94700920|NCT03568162|324361782|FG000|Overall Study|Lost to Follow-up|3|||
94700921|NCT03568162|324361783|FG001|Overall Study|Lost to Follow-up|2|||
94700922|NCT03568162|324361784|FG002|Overall Study|Lost to Follow-up|4|||
94700923|NCT03568162|324361785|FG003|Overall Study|Lost to Follow-up|2|||
94700924|NCT03568162|324361786|FG004|Overall Study|Lost to Follow-up|3|||
94700925|NCT03568162|324361787|FG005|Overall Study|Lost to Follow-up|2|||
94700926|NCT03568162|324361782|FG000|Overall Study|Physician Decision|0|||
94700927|NCT03568162|324361783|FG001|Overall Study|Physician Decision|1|||
94700928|NCT03568162|324361784|FG002|Overall Study|Physician Decision|1|||
94700929|NCT03568162|324361785|FG003|Overall Study|Physician Decision|0|||
94265761|NCT03823404|322766759|FG000|Overall Study|Protocol Violation|2|||
94265762|NCT03823404|322766760|FG001|Overall Study|Protocol Violation|0|||
94700930|NCT03568162|324361786|FG004|Overall Study|Physician Decision|1|||
94700931|NCT03568162|324361787|FG005|Overall Study|Physician Decision|0|||
94700932|NCT03568162|324361782|FG000|Overall Study|Pregnancy|0|||
94700933|NCT03568162|324361783|FG001|Overall Study|Pregnancy|0|||
94265763|NCT03823404|322766761|FG002|Overall Study|Protocol Violation|2|||
94265764|NCT03823404|322766759|FG000|Overall Study|Adverse Event|35|||
94700934|NCT03568162|324361784|FG002|Overall Study|Pregnancy|0|||
94700935|NCT03568162|324361785|FG003|Overall Study|Pregnancy|1|||
94700936|NCT03568162|324361786|FG004|Overall Study|Pregnancy|0|||
94700937|NCT03568162|324361787|FG005|Overall Study|Pregnancy|0|||
94700938|NCT03568162|324361782|FG000|Overall Study|Protocol Violation|1|||
94700939|NCT03568162|324361783|FG001|Overall Study|Protocol Violation|0|||
94700940|NCT03568162|324361784|FG002|Overall Study|Protocol Violation|1|||
94700941|NCT03568162|324361785|FG003|Overall Study|Protocol Violation|1|||
94700942|NCT03568162|324361786|FG004|Overall Study|Protocol Violation|1|||
94700943|NCT03568162|324361787|FG005|Overall Study|Protocol Violation|1|||
94700944|NCT03568162|324361782|FG000|Overall Study|Withdrawal by Subject|15|||
94700945|NCT03568162|324361783|FG001|Overall Study|Withdrawal by Subject|15|||
94700946|NCT03568162|324361784|FG002|Overall Study|Withdrawal by Subject|26|||
94700947|NCT03568162|324361785|FG003|Overall Study|Withdrawal by Subject|22|||
94700948|NCT03568162|324361786|FG004|Overall Study|Withdrawal by Subject|6|||
94700949|NCT03568162|324361787|FG005|Overall Study|Withdrawal by Subject|9|||
94700950|NCT03568162|324361782|FG000|Overall Study|Others|3|||
94700951|NCT03568162|324361783|FG001|Overall Study|Others|4|||
94700952|NCT03568162|324361784|FG002|Overall Study|Others|1|||
94700953|NCT03568162|324361785|FG003|Overall Study|Others|4|||
94700954|NCT03568162|324361786|FG004|Overall Study|Others|2|||
94700955|NCT03568162|324361787|FG005|Overall Study|Others|1|||
94700956|NCT04831775|324361788|FG000|Overall Study|Lost to Follow-up|11|||
94700957|NCT04831775|324361789|FG001|Overall Study|Lost to Follow-up|13|||
94700958|NCT03563053|324361790|FG000|Overall Study|Withdrawal by Subject|17|||
94700959|NCT03563053|324361790|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
94700960|NCT03563053|324361790|FG000|Overall Study|Adverse Event|3|||
94700961|NCT03563053|324361790|FG000|Overall Study|Physician Decision|1|||
94700962|NCT03563053|324361790|FG000|Overall Study|study terminated by sponsor|71|||
94700963|NCT03369951|324361791|FG000|Overall Study|Withdrawal by Subject|3|||
94700964|NCT03369951|324361791|FG000|Overall Study|Death|1|||
94700965|NCT03369951|324361791|FG000|Overall Study|Lost to Follow-up|1|||
94700966|NCT03369951|324361791|FG000|Overall Study|Protocol Violation|1|||
94700967|NCT00813488|324361792|FG000|Titration Period 1|Adverse Event|6|||
94700968|NCT00813488|324361793|FG001|Titration Period 1|Adverse Event|1|||
94700969|NCT00813488|324361792|FG000|Titration Period 1|Lack of Efficacy|9|||
94700970|NCT00813488|324361793|FG001|Titration Period 1|Lack of Efficacy|7|||
94700971|NCT00813488|324361792|FG000|Titration Period 1|Withdrawal by Subject|2|||
94700972|NCT00813488|324361793|FG001|Titration Period 1|Withdrawal by Subject|2|||
94700973|NCT00813488|324361792|FG000|Titration Period 1|Protocol Violation|4|||
94700974|NCT00813488|324361793|FG001|Titration Period 1|Protocol Violation|3|||
94700975|NCT00813488|324361792|FG000|Titration Period 1|Non-compliance to study medication|4|||
94700976|NCT00813488|324361793|FG001|Titration Period 1|Non-compliance to study medication|1|||
94700977|NCT00813488|324361792|FG000|Titration Period 1|Non-compliance to study procedures|2|||
94700978|NCT00813488|324361793|FG001|Titration Period 1|Non-compliance to study procedures|2|||
94700979|NCT00813488|324361792|FG000|Titration Period 1|Technical Difficulties|0|||
94700980|NCT00813488|324361793|FG001|Titration Period 1|Technical Difficulties|1|||
94700981|NCT00813488|324361792|FG000|Titration Period 2|Adverse Event|2|||
94700982|NCT00813488|324361793|FG001|Titration Period 2|Adverse Event|3|||
94700983|NCT00813488|324361792|FG000|Titration Period 2|Lack of Efficacy|8|||
94700984|NCT00813488|324361793|FG001|Titration Period 2|Lack of Efficacy|4|||
94700985|NCT00813488|324361792|FG000|Titration Period 2|Protocol Violation|3|||
94700986|NCT00813488|324361793|FG001|Titration Period 2|Protocol Violation|2|||
94700987|NCT00813488|324361792|FG000|Titration Period 2|Lost to Follow-up|1|||
94700988|NCT00813488|324361793|FG001|Titration Period 2|Lost to Follow-up|0|||
94700989|NCT00813488|324361792|FG000|Titration Period 2|Non-compliance with study procedures|2|||
94700990|NCT00813488|324361793|FG001|Titration Period 2|Non-compliance with study procedures|1|||
94700991|NCT00813488|324361792|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
94700992|NCT00813488|324361793|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
94700993|NCT00813488|324361792|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
94700994|NCT00813488|324361793|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
94700995|NCT00813488|324361792|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
94700996|NCT00813488|324361793|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
94700997|NCT00813488|324361792|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
94700998|NCT00813488|324361793|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
94700999|NCT00813488|324361792|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
94366484|NCT01289990|323126548|FG011|Overall Study|did not continue in extension|34|||
94366485|NCT01289990|323126549|FG012|Overall Study|did not continue in extension|56|||
94366486|NCT01289990|323126537|FG000|Overall Study|Not treated|0|||
94366487|NCT01289990|323126538|FG001|Overall Study|Not treated|0|||
94366488|NCT01289990|323126539|FG002|Overall Study|Not treated|0|||
94701000|NCT00813488|324361793|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
94701001|NCT00813488|324361792|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
94701002|NCT00813488|324361793|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
94701003|NCT00813488|324361792|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
94701004|NCT00813488|324361793|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
94366489|NCT01289990|323126540|FG003|Overall Study|Not treated|0|||
94701005|NCT00813488|324361792|FG000|Double-blind Treatment Period 2|Other|1|||
94701006|NCT00813488|324361793|FG001|Double-blind Treatment Period 2|Other|0|||
94701007|NCT00813488|324361792|FG000|Open-label Extension|Adverse Event|1|||
94701008|NCT00813488|324361793|FG001|Open-label Extension|Adverse Event|2|||
94701009|NCT00813488|324361792|FG000|Open-label Extension|Lack of Efficacy|3|||
94701010|NCT00813488|324361793|FG001|Open-label Extension|Lack of Efficacy|0|||
94701011|NCT00813488|324361792|FG000|Open-label Extension|Withdrawal by Subject|0|||
94701012|NCT00813488|324361793|FG001|Open-label Extension|Withdrawal by Subject|2|||
94701013|NCT00813488|324361792|FG000|Open-label Extension|Protocol Violation|1|||
94701014|NCT00813488|324361793|FG001|Open-label Extension|Protocol Violation|2|||
94701015|NCT00813488|324361792|FG000|Open-label Extension|Non-compliance study medication|4|||
94701016|NCT00813488|324361793|FG001|Open-label Extension|Non-compliance study medication|0|||
94701017|NCT00813488|324361792|FG000|Open-label Extension|Non-compliance study procedures|2|||
94701018|NCT00813488|324361793|FG001|Open-label Extension|Non-compliance study procedures|1|||
94701019|NCT00813488|324361792|FG000|Open-label Extension|Other|1|||
94701020|NCT00813488|324361793|FG001|Open-label Extension|Other|0|||
94701021|NCT03499600|324361795|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
94701022|NCT03499600|324361796|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
94701023|NCT02952261|324361797|FG000|Overall Study|Withdrawal by Subject|4|||
94701024|NCT02952261|324361798|FG001|Overall Study|Withdrawal by Subject|5|||
94701025|NCT02952261|324361797|FG000|Overall Study|Protocol Violation|1|||
94701026|NCT02952261|324361798|FG001|Overall Study|Protocol Violation|0|||
94701027|NCT03158948|324364145|FG000|Overall Study|Death|1|||
94701028|NCT03158948|324364146|FG001|Overall Study|Death|1|||
94701029|NCT03158948|324364147|FG002|Overall Study|Death|3|||
94701030|NCT03158948|324364148|FG003|Overall Study|Death|2|||
94701031|NCT03158948|324364145|FG000|Overall Study|Physician Decision|0|||
94701032|NCT03158948|324364146|FG001|Overall Study|Physician Decision|0|||
94701033|NCT03158948|324364147|FG002|Overall Study|Physician Decision|0|||
94701034|NCT03158948|324364148|FG003|Overall Study|Physician Decision|1|||
94701035|NCT00868231|324364159|FG000|Treatment Period 1|Adverse Event|0|||
94701036|NCT00868231|324364160|FG001|Treatment Period 1|Adverse Event|0|||
94701037|NCT00868231|324364161|FG002|Treatment Period 1|Adverse Event|0|||
94701038|NCT00868231|324364162|FG003|Treatment Period 1|Adverse Event|0|||
94701039|NCT00868231|324364163|FG004|Treatment Period 1|Adverse Event|1|||
94701040|NCT00868231|324364164|FG005|Treatment Period 1|Adverse Event|0|||
94701041|NCT00868231|324364159|FG000|Treatment Period 2|Adverse Event|1|||
94701042|NCT00868231|324364160|FG001|Treatment Period 2|Adverse Event|0|||
94701043|NCT00868231|324364161|FG002|Treatment Period 2|Adverse Event|0|||
94701044|NCT00868231|324364162|FG003|Treatment Period 2|Adverse Event|0|||
94701045|NCT00868231|324364163|FG004|Treatment Period 2|Adverse Event|0|||
94701046|NCT00868231|324364164|FG005|Treatment Period 2|Adverse Event|0|||
94701047|NCT00868231|324364159|FG000|Treatment Period 3|Adverse Event|0|||
94701048|NCT00868231|324364160|FG001|Treatment Period 3|Adverse Event|0|||
94701049|NCT00868231|324364161|FG002|Treatment Period 3|Adverse Event|1|||
94701050|NCT00868231|324364162|FG003|Treatment Period 3|Adverse Event|0|||
94701051|NCT00868231|324364163|FG004|Treatment Period 3|Adverse Event|0|||
94701052|NCT00868231|324364164|FG005|Treatment Period 3|Adverse Event|0|||
94701053|NCT00926393|324364167|FG000|Overall Study|Withdrawal by Subject|1|||
94701054|NCT00926393|324364168|FG001|Overall Study|Withdrawal by Subject|2|||
94701055|NCT00926393|324364167|FG000|Overall Study|Adverse Event|1|||
94701056|NCT00926393|324364168|FG001|Overall Study|Adverse Event|1|||
94701057|NCT00886613|324364169|FG000|Overall Study|Protocol deviation (Part B)|1|||
94701058|NCT00886613|324364170|FG001|Overall Study|Protocol deviation (Part B)|0|||
94701059|NCT00886613|324364171|FG002|Overall Study|Protocol deviation (Part B)|0|||
94701060|NCT00886613|324364169|FG000|Overall Study|Lost to follow-up (Part B)|1|||
94701061|NCT00886613|324364170|FG001|Overall Study|Lost to follow-up (Part B)|0|||
94701062|NCT00886613|324364171|FG002|Overall Study|Lost to follow-up (Part B)|1|||
94701063|NCT00886613|324364169|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
94701064|NCT00886613|324364170|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
94701065|NCT00886613|324364171|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
94701066|NCT02223793|324364172|FG000|Overall Study|Lost to Follow-up|10|||
94701067|NCT02223793|324364173|FG001|Overall Study|Lost to Follow-up|1|||
94701068|NCT02223793|324364174|FG002|Overall Study|Lost to Follow-up|2|||
94701069|NCT02223793|324364172|FG000|Overall Study|Withdrawal by Subject|3|||
94701070|NCT02223793|324364173|FG001|Overall Study|Withdrawal by Subject|2|||
94701071|NCT02223793|324364174|FG002|Overall Study|Withdrawal by Subject|3|||
94701072|NCT02223793|324364172|FG000|Overall Study|Moved/studycenter unable to participate|4|||
94701073|NCT02223793|324364173|FG001|Overall Study|Moved/studycenter unable to participate|6|||
94701074|NCT02223793|324364174|FG002|Overall Study|Moved/studycenter unable to participate|8|||
94701075|NCT00151996|324364175|FG000|Overall Study|Adverse Event|3|||
94701076|NCT00151996|324364176|FG001|Overall Study|Adverse Event|2|||
94701077|NCT00151996|324364175|FG000|Overall Study|Withdrawal by Subject|1|||
94701078|NCT00151996|324364176|FG001|Overall Study|Withdrawal by Subject|1|||
94701079|NCT00151996|324364175|FG000|Overall Study|Protocol Violation|1|||
94701080|NCT00151996|324364176|FG001|Overall Study|Protocol Violation|2|||
94701081|NCT00151996|324364175|FG000|Overall Study|Sponsor's decision|0|||
94701082|NCT00151996|324364176|FG001|Overall Study|Sponsor's decision|2|||
94265765|NCT03823404|322766760|FG001|Overall Study|Adverse Event|38|||
94265766|NCT03823404|322766761|FG002|Overall Study|Adverse Event|8|||
94265767|NCT03823404|322766759|FG000|Overall Study|Withdrawal by Subject|38|||
94265768|NCT03823404|322766760|FG001|Overall Study|Withdrawal by Subject|40|||
94701083|NCT01289119|324364177|FG000|Overall Study|Adverse Event|2|||
94701084|NCT01289119|324364178|FG001|Overall Study|Adverse Event|1|||
94701085|NCT01289119|324364179|FG002|Overall Study|Adverse Event|0|||
94701086|NCT01289119|324364180|FG003|Overall Study|Adverse Event|2|||
94701087|NCT01289119|324364181|FG004|Overall Study|Adverse Event|1|||
94701088|NCT01289119|324364182|FG005|Overall Study|Adverse Event|0|||
94701089|NCT01289119|324364177|FG000|Overall Study|Major Protocol Deviation|2|||
94701090|NCT01289119|324364178|FG001|Overall Study|Major Protocol Deviation|1|||
94701091|NCT01289119|324364179|FG002|Overall Study|Major Protocol Deviation|3|||
94701092|NCT01289119|324364180|FG003|Overall Study|Major Protocol Deviation|0|||
94701093|NCT01289119|324364181|FG004|Overall Study|Major Protocol Deviation|2|||
94701094|NCT01289119|324364182|FG005|Overall Study|Major Protocol Deviation|1|||
94701095|NCT01289119|324364177|FG000|Overall Study|Lost to Follow-up|0|||
94701096|NCT01289119|324364178|FG001|Overall Study|Lost to Follow-up|3|||
94701097|NCT01289119|324364179|FG002|Overall Study|Lost to Follow-up|0|||
94701098|NCT01289119|324364180|FG003|Overall Study|Lost to Follow-up|0|||
94265769|NCT03823404|322766761|FG002|Overall Study|Withdrawal by Subject|35|||
94265770|NCT03823404|322766759|FG000|Overall Study|Death|4|||
94265771|NCT03823404|322766760|FG001|Overall Study|Death|0|||
94265772|NCT03823404|322766761|FG002|Overall Study|Death|0|||
94265773|NCT03823404|322766759|FG000|Overall Study|Other: Various reasons provided|5|||
94265774|NCT03823404|322766760|FG001|Overall Study|Other: Various reasons provided|5|||
94265775|NCT03823404|322766761|FG002|Overall Study|Other: Various reasons provided|6|||
94265776|NCT00832117|322766762|FG000|Overall Study|Death|1|||
94265777|NCT00832117|322766762|FG000|Overall Study|Disease Progression|11|||
94701099|NCT01289119|324364181|FG004|Overall Study|Lost to Follow-up|0|||
94701100|NCT01289119|324364182|FG005|Overall Study|Lost to Follow-up|1|||
94701101|NCT01289119|324364177|FG000|Overall Study|Withdrawal by Subject|4|||
94265778|NCT04439071|322766763|FG000|Overall Study|Lost to Follow-up|0|||
94265779|NCT04439071|322766764|FG001|Overall Study|Lost to Follow-up|3|||
94701102|NCT01289119|324364178|FG001|Overall Study|Withdrawal by Subject|2|||
94701103|NCT01289119|324364179|FG002|Overall Study|Withdrawal by Subject|4|||
94701104|NCT01289119|324364180|FG003|Overall Study|Withdrawal by Subject|3|||
94701105|NCT01289119|324364181|FG004|Overall Study|Withdrawal by Subject|1|||
94701106|NCT01289119|324364182|FG005|Overall Study|Withdrawal by Subject|1|||
94701107|NCT01289119|324364177|FG000|Overall Study|Pregnancy|0|||
94701108|NCT01289119|324364178|FG001|Overall Study|Pregnancy|1|||
94701109|NCT01289119|324364179|FG002|Overall Study|Pregnancy|0|||
94701110|NCT01289119|324364180|FG003|Overall Study|Pregnancy|0|||
94701111|NCT01289119|324364181|FG004|Overall Study|Pregnancy|0|||
94701112|NCT01289119|324364182|FG005|Overall Study|Pregnancy|0|||
94701113|NCT01289119|324364177|FG000|Overall Study|Lack of Efficacy|0|||
94701114|NCT01289119|324364178|FG001|Overall Study|Lack of Efficacy|1|||
94701115|NCT01289119|324364179|FG002|Overall Study|Lack of Efficacy|1|||
94701116|NCT01289119|324364180|FG003|Overall Study|Lack of Efficacy|1|||
94701117|NCT01289119|324364181|FG004|Overall Study|Lack of Efficacy|1|||
94701118|NCT01289119|324364182|FG005|Overall Study|Lack of Efficacy|1|||
94701119|NCT01289119|324364177|FG000|Overall Study|Other|1|||
94701120|NCT01289119|324364178|FG001|Overall Study|Other|0|||
94701121|NCT01289119|324364179|FG002|Overall Study|Other|1|||
94701122|NCT01289119|324364180|FG003|Overall Study|Other|0|||
94701123|NCT01289119|324364181|FG004|Overall Study|Other|0|||
94701124|NCT01289119|324364182|FG005|Overall Study|Other|0|||
94701125|NCT02321540|324364183|FG000|Overall Study|Death|0|||
94701126|NCT02321540|324364184|FG001|Overall Study|Death|1|||
94701127|NCT02321540|324364183|FG000|Overall Study|Progression|3|||
94701128|NCT02321540|324364184|FG001|Overall Study|Progression|9|||
94701129|NCT01649791|324364185|FG000|Overall Study|Disease Progression|2|||
94701130|NCT01649791|324364185|FG000|Overall Study|Adverse Event|1|||
94701131|NCT04577183|324364186|FG000|Overall Study|Death|1|||
94701132|NCT04577183|324364186|FG000|Overall Study|Withdrawal by Subject|3|||
94701133|NCT04577183|324364186|FG000|Overall Study|Early termination|2|||
94701134|NCT01168401|324364187|FG000|Overall Study|Lost to Follow-up|1|||
94701135|NCT01168401|324364188|FG001|Overall Study|Lost to Follow-up|1|||
94701136|NCT01168401|324364189|FG002|Overall Study|Lost to Follow-up|2|||
94701137|NCT01168401|324364190|FG003|Overall Study|Lost to Follow-up|1|||
94701138|NCT01168401|324364191|FG004|Overall Study|Lost to Follow-up|0|||
94701139|NCT01168401|324364192|FG005|Overall Study|Lost to Follow-up|0|||
94701140|NCT01168401|324364193|FG006|Overall Study|Lost to Follow-up|0|||
94701141|NCT01168401|324364194|FG007|Overall Study|Lost to Follow-up|0|||
94701142|NCT01168401|324364195|FG008|Overall Study|Lost to Follow-up|0|||
94701143|NCT01168401|324364196|FG009|Overall Study|Lost to Follow-up|0|||
94701144|NCT01168401|324364197|FG010|Overall Study|Lost to Follow-up|0|||
94701145|NCT01168401|324364187|FG000|Overall Study|Withdrawal by Subject|0|||
94701146|NCT01168401|324364188|FG001|Overall Study|Withdrawal by Subject|0|||
94701147|NCT01168401|324364189|FG002|Overall Study|Withdrawal by Subject|0|||
94701148|NCT01168401|324364190|FG003|Overall Study|Withdrawal by Subject|1|||
94701149|NCT01168401|324364191|FG004|Overall Study|Withdrawal by Subject|0|||
94701150|NCT01168401|324364192|FG005|Overall Study|Withdrawal by Subject|0|||
94701151|NCT01168401|324364193|FG006|Overall Study|Withdrawal by Subject|0|||
94701152|NCT01168401|324364194|FG007|Overall Study|Withdrawal by Subject|0|||
94701153|NCT01168401|324364195|FG008|Overall Study|Withdrawal by Subject|0|||
94701154|NCT01168401|324364196|FG009|Overall Study|Withdrawal by Subject|0|||
94701155|NCT01168401|324364197|FG010|Overall Study|Withdrawal by Subject|0|||
94701156|NCT00672256|324364198|FG000|Overall Study|PI dropped, bad data|44|||
94701157|NCT00058058|324364200|FG000|Overall Study|Withdrawal by Subject|4|||
94701158|NCT00058058|324364200|FG000|Overall Study|Ineligible|20|||
94701159|NCT00058058|324364200|FG000|Overall Study|Claustrophobic|5|||
94701160|NCT00058058|324364200|FG000|Overall Study|technical issues|6|||
94701161|NCT00058058|324364200|FG000|Overall Study|Poor positioning, illness,pain|3|||
94701162|NCT03085017|324364201|FG000|Overall Study|Death|0|||
94701163|NCT03085017|324364202|FG001|Overall Study|Death|3|||
94701164|NCT00991276|324364214|FG000|First Intervention Period|Adverse Event|0|||
94466152|NCT01472939|323496944|FG003|Overall Study|Withdrawal by Subject|4|||
94701165|NCT00991276|324364215|FG001|First Intervention Period|Adverse Event|1|||
94466153|NCT00114738|323496945|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
94701166|NCT00991276|324364216|FG002|First Intervention Period|Adverse Event|0|||
94701167|NCT00991276|324364217|FG003|First Intervention Period|Adverse Event|1|||
94701168|NCT00991276|324364218|FG004|First Intervention Period|Adverse Event|0|||
94701169|NCT00991276|324364219|FG005|First Intervention Period|Adverse Event|0|||
94701170|NCT00991276|324364214|FG000|First Intervention Period|Protocol Violation|0|||
94701171|NCT00991276|324364215|FG001|First Intervention Period|Protocol Violation|0|||
94701172|NCT00991276|324364216|FG002|First Intervention Period|Protocol Violation|0|||
94701173|NCT00991276|324364217|FG003|First Intervention Period|Protocol Violation|0|||
94701174|NCT00991276|324364218|FG004|First Intervention Period|Protocol Violation|2|||
94701175|NCT00991276|324364219|FG005|First Intervention Period|Protocol Violation|0|||
94701176|NCT00991276|324364214|FG000|First Intervention Period|Insufficient clinical response|0|||
94701177|NCT00991276|324364215|FG001|First Intervention Period|Insufficient clinical response|0|||
94701178|NCT00991276|324364216|FG002|First Intervention Period|Insufficient clinical response|0|||
94701179|NCT00991276|324364217|FG003|First Intervention Period|Insufficient clinical response|0|||
94701180|NCT00991276|324364218|FG004|First Intervention Period|Insufficient clinical response|1|||
94701181|NCT00991276|324364219|FG005|First Intervention Period|Insufficient clinical response|0|||
94701182|NCT00991276|324364214|FG000|First Intervention Period|Other|0|||
94701183|NCT00991276|324364215|FG001|First Intervention Period|Other|0|||
94701184|NCT00991276|324364216|FG002|First Intervention Period|Other|0|||
94701185|NCT00991276|324364217|FG003|First Intervention Period|Other|1|||
94701186|NCT00991276|324364218|FG004|First Intervention Period|Other|1|||
94701187|NCT00991276|324364219|FG005|First Intervention Period|Other|0|||
94701188|NCT00991276|324364214|FG000|First Intervention Period|Withdrawal by Subject|0|||
94701189|NCT00991276|324364215|FG001|First Intervention Period|Withdrawal by Subject|1|||
94701190|NCT00991276|324364216|FG002|First Intervention Period|Withdrawal by Subject|0|||
94701191|NCT00991276|324364217|FG003|First Intervention Period|Withdrawal by Subject|1|||
94701192|NCT00991276|324364218|FG004|First Intervention Period|Withdrawal by Subject|0|||
94701193|NCT00991276|324364219|FG005|First Intervention Period|Withdrawal by Subject|1|||
94701194|NCT00991276|324364214|FG000|First Intervention Period|Lost to Follow-up|0|||
94701195|NCT00991276|324364215|FG001|First Intervention Period|Lost to Follow-up|1|||
94701196|NCT00991276|324364216|FG002|First Intervention Period|Lost to Follow-up|0|||
94701197|NCT00991276|324364217|FG003|First Intervention Period|Lost to Follow-up|1|||
94701198|NCT00991276|324364218|FG004|First Intervention Period|Lost to Follow-up|0|||
94701199|NCT00991276|324364219|FG005|First Intervention Period|Lost to Follow-up|0|||
94701200|NCT00991276|324364214|FG000|Second Intervention Period|Adverse Event|0|||
94701201|NCT00991276|324364215|FG001|Second Intervention Period|Adverse Event|2|||
94701202|NCT00991276|324364216|FG002|Second Intervention Period|Adverse Event|0|||
94701203|NCT00991276|324364217|FG003|Second Intervention Period|Adverse Event|1|||
94701204|NCT00991276|324364218|FG004|Second Intervention Period|Adverse Event|1|||
94701205|NCT00991276|324364219|FG005|Second Intervention Period|Adverse Event|0|||
94701206|NCT00991276|324364214|FG000|Second Intervention Period|Protocol Violation|1|||
94701207|NCT00991276|324364215|FG001|Second Intervention Period|Protocol Violation|0|||
94701208|NCT00991276|324364216|FG002|Second Intervention Period|Protocol Violation|0|||
94701209|NCT00991276|324364217|FG003|Second Intervention Period|Protocol Violation|0|||
94701210|NCT00991276|324364218|FG004|Second Intervention Period|Protocol Violation|0|||
94701211|NCT00991276|324364219|FG005|Second Intervention Period|Protocol Violation|0|||
94701212|NCT00991276|324364214|FG000|Second Intervention Period|Other|0|||
94701213|NCT00991276|324364215|FG001|Second Intervention Period|Other|0|||
94701214|NCT00991276|324364216|FG002|Second Intervention Period|Other|0|||
94701215|NCT00991276|324364217|FG003|Second Intervention Period|Other|1|||
94701216|NCT00991276|324364218|FG004|Second Intervention Period|Other|0|||
94701217|NCT00991276|324364219|FG005|Second Intervention Period|Other|1|||
94701218|NCT00991276|324364214|FG000|Third Intervention Period|Protocol Violation|1|||
94701219|NCT00991276|324364215|FG001|Third Intervention Period|Protocol Violation|0|||
94701220|NCT00991276|324364216|FG002|Third Intervention Period|Protocol Violation|0|||
94701221|NCT00991276|324364217|FG003|Third Intervention Period|Protocol Violation|0|||
94701222|NCT00991276|324364218|FG004|Third Intervention Period|Protocol Violation|0|||
94701223|NCT00991276|324364219|FG005|Third Intervention Period|Protocol Violation|0|||
94701224|NCT00991276|324364214|FG000|Third Intervention Period|Other|0|||
94701225|NCT00991276|324364215|FG001|Third Intervention Period|Other|0|||
94701226|NCT00991276|324364216|FG002|Third Intervention Period|Other|0|||
94701227|NCT00991276|324364217|FG003|Third Intervention Period|Other|0|||
94701228|NCT00991276|324364218|FG004|Third Intervention Period|Other|0|||
94701229|NCT00991276|324364219|FG005|Third Intervention Period|Other|1|||
94701230|NCT00991276|324364214|FG000|Third Intervention Period|Adverse Event|0|||
94701231|NCT00991276|324364215|FG001|Third Intervention Period|Adverse Event|0|||
94701232|NCT00991276|324364216|FG002|Third Intervention Period|Adverse Event|1|||
94701233|NCT00991276|324364217|FG003|Third Intervention Period|Adverse Event|0|||
94701234|NCT00991276|324364218|FG004|Third Intervention Period|Adverse Event|0|||
94701235|NCT00991276|324364219|FG005|Third Intervention Period|Adverse Event|0|||
94701236|NCT00991276|324364214|FG000|Third Intervention Period|Withdrawal by Subject|0|||
94701237|NCT00991276|324364215|FG001|Third Intervention Period|Withdrawal by Subject|0|||
94701238|NCT00991276|324364216|FG002|Third Intervention Period|Withdrawal by Subject|0|||
94701239|NCT00991276|324364217|FG003|Third Intervention Period|Withdrawal by Subject|1|||
94701240|NCT00991276|324364218|FG004|Third Intervention Period|Withdrawal by Subject|0|||
94701241|NCT00991276|324364219|FG005|Third Intervention Period|Withdrawal by Subject|0|||
94701242|NCT03255018|324364222|FG000|Overall Study|Death on study|0|||
94701243|NCT03255018|324364223|FG001|Overall Study|Death on study|5|||
94701244|NCT03255018|324364222|FG000|Overall Study|Withdrawal by Subject|0|||
94701245|NCT03255018|324364223|FG001|Overall Study|Withdrawal by Subject|2|||
94701246|NCT04759131|324364226|FG000|Overall Study|Investigator's discretion|1|||
94701247|NCT04759131|324364227|FG001|Overall Study|Investigator's discretion|0|||
94701248|NCT04759131|324364226|FG000|Overall Study|Subject withdrawal|1|||
94701249|NCT04759131|324364227|FG001|Overall Study|Subject withdrawal|0|||
94701250|NCT01720043|324364228|FG000|Overall Study|Withdrawal by Subject|1|||
94701251|NCT01124162|324364229|FG000|First Intervention|Adverse Event|2|||
94701252|NCT01124162|324364230|FG001|First Intervention|Adverse Event|0|||
94701253|NCT01124162|324364229|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
94701254|NCT01124162|324364230|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
94701255|NCT03681691|324364231|FG000|Overall Study|COVID|1|||
94701256|NCT03681691|324364232|FG001|Overall Study|COVID|0|||
94701257|NCT03681691|324364231|FG000|Overall Study|prolonged bleeding|1|||
94701258|NCT03681691|324364232|FG001|Overall Study|prolonged bleeding|0|||
94701259|NCT03681691|324364231|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
94701260|NCT03681691|324364232|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
94701261|NCT01516892|324364233|FG000|Overall Study|Adverse Event|25|||
94701262|NCT01516892|324364233|FG000|Overall Study|Lack of Efficacy|35|||
94701263|NCT01516892|324364233|FG000|Overall Study|Pregnancy|5|||
94701264|NCT01516892|324364233|FG000|Overall Study|Lost to Follow-up|82|||
94701265|NCT01516892|324364233|FG000|Overall Study|Subject Withdrew Consent|92|||
94701266|NCT01516892|324364233|FG000|Overall Study|Protocol Violation|60|||
94701267|NCT01516892|324364233|FG000|Overall Study|Other Miscellaneous Reasons|43|||
94701268|NCT01516892|324364233|FG000|Overall Study|Missing|1|||
94701269|NCT00938340|324364234|FG000|Overall Study|Withdrawal by Subject|3|||
94701270|NCT00938340|324364234|FG000|Overall Study|Protocol Violation|1|||
94701271|NCT00938340|324364234|FG000|Overall Study|Adverse Event|1|||
94701272|NCT01149681|324364235|FG000|Overall Study|Withdrawal by Subject|7|||
94701273|NCT01149681|324364235|FG000|Overall Study|Progressive disease|1|||
94701274|NCT01149681|324364235|FG000|Overall Study|Physician Decision|2|||
94701275|NCT01149681|324364235|FG000|Overall Study|adverse events nonrelated study drug|2|||
94701276|NCT03710564|324364236|FG000|Overall Study|Study Terminated by Sponsor|104|||
94701277|NCT03710564|324364237|FG001|Overall Study|Study Terminated by Sponsor|55|||
94701278|NCT03710564|324364236|FG000|Overall Study|Withdrawal by Subject|57|||
94701279|NCT03710564|324364237|FG001|Overall Study|Withdrawal by Subject|25|||
94701280|NCT03710564|324364236|FG000|Overall Study|Death|10|||
94701281|NCT03710564|324364237|FG001|Overall Study|Death|4|||
94701282|NCT03710564|324364236|FG000|Overall Study|Lost to Follow-up|5|||
94701283|NCT03710564|324364237|FG001|Overall Study|Lost to Follow-up|4|||
94701284|NCT03710564|324364236|FG000|Overall Study|Protocol Violation|3|||
94701285|NCT03710564|324364237|FG001|Overall Study|Protocol Violation|2|||
94701286|NCT03710564|324364236|FG000|Overall Study|Adverse Event|3|||
94701287|NCT03710564|324364237|FG001|Overall Study|Adverse Event|0|||
94701288|NCT03710564|324364236|FG000|Overall Study|Physician Decision|2|||
94701289|NCT03710564|324364237|FG001|Overall Study|Physician Decision|3|||
94701290|NCT02993471|324364240|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
94701291|NCT02993471|324364240|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
94701292|NCT00930813|324364241|FG000|Overall Study|Death|4|||
94701293|NCT00930813|324364242|FG001|Overall Study|Death|5|||
94701294|NCT00930813|324364241|FG000|Overall Study|Withdrawal by Subject|2|||
94701295|NCT00930813|324364242|FG001|Overall Study|Withdrawal by Subject|5|||
94701296|NCT00930813|324364241|FG000|Overall Study|Lost to Follow-up|2|||
94701297|NCT00930813|324364242|FG001|Overall Study|Lost to Follow-up|4|||
94701298|NCT03999554|324364247|FG000|Overall Study|Lost to Follow-up|4|||
94701299|NCT03999554|324364248|FG001|Overall Study|Lost to Follow-up|5|||
94701300|NCT03999554|324364249|FG002|Overall Study|Lost to Follow-up|4|||
94701301|NCT03999554|324364250|FG003|Overall Study|Lost to Follow-up|5|||
94701302|NCT03999554|324364251|FG004|Overall Study|Lost to Follow-up|8|||
94701303|NCT03999554|324364247|FG000|Overall Study|Protocol Violation|0|||
94701304|NCT03999554|324364248|FG001|Overall Study|Protocol Violation|0|||
94701305|NCT03999554|324364249|FG002|Overall Study|Protocol Violation|5|||
94701306|NCT03999554|324364250|FG003|Overall Study|Protocol Violation|0|||
94701307|NCT03999554|324364251|FG004|Overall Study|Protocol Violation|0|||
94366490|NCT01289990|323126541|FG004|Overall Study|Not treated|0|||
94701308|NCT03999554|324364247|FG000|Overall Study|Pregnancy|0|||
94701309|NCT03999554|324364248|FG001|Overall Study|Pregnancy|0|||
94701310|NCT03999554|324364249|FG002|Overall Study|Pregnancy|1|||
94701311|NCT03999554|324364250|FG003|Overall Study|Pregnancy|0|||
94701312|NCT03999554|324364251|FG004|Overall Study|Pregnancy|0|||
94701313|NCT03999554|324364247|FG000|Overall Study|Withdrawal by Subject|2|||
94701314|NCT03999554|324364248|FG001|Overall Study|Withdrawal by Subject|2|||
94701315|NCT03999554|324364249|FG002|Overall Study|Withdrawal by Subject|2|||
94701316|NCT03999554|324364250|FG003|Overall Study|Withdrawal by Subject|1|||
94701317|NCT03999554|324364251|FG004|Overall Study|Withdrawal by Subject|1|||
94701318|NCT03999554|324364247|FG000|Overall Study|failure to comply with protocol requirements|0|||
94701319|NCT03999554|324364248|FG001|Overall Study|failure to comply with protocol requirements|0|||
94701320|NCT03999554|324364249|FG002|Overall Study|failure to comply with protocol requirements|0|||
94701321|NCT03999554|324364250|FG003|Overall Study|failure to comply with protocol requirements|1|||
94701322|NCT03999554|324364251|FG004|Overall Study|failure to comply with protocol requirements|0|||
94701323|NCT03006341|324364252|FG000|Overall Study|Not linked in the EMR|25069|||
94701324|NCT03006341|324364253|FG001|Overall Study|Not linked in the EMR|67505|||
94701325|NCT03006341|324364254|FG002|Overall Study|Not linked in the EMR|30993|||
94701326|NCT03006341|324364255|FG003|Overall Study|Not linked in the EMR|10685|||
94701327|NCT02397889|324364260|FG000|Overall Study|Physician Decision|1|||
94701328|NCT02397889|324364261|FG001|Overall Study|Physician Decision|0|||
94701329|NCT00797225|324364263|FG000|Weeks 1 to 12|Adverse Event|0|||
94701330|NCT00797225|324364264|FG001|Weeks 1 to 12|Adverse Event|0|||
94701331|NCT00797225|324364265|FG002|Weeks 1 to 12|Adverse Event|1|||
94701332|NCT00797225|324364266|FG003|Weeks 1 to 12|Adverse Event|0|||
94701333|NCT00797225|324364267|FG004|Weeks 1 to 12|Adverse Event|0|||
94701334|NCT00797225|324364268|FG005|Weeks 1 to 12|Adverse Event|0|||
94701335|NCT00797225|324364269|FG006|Weeks 1 to 12|Adverse Event|0|||
94701336|NCT00797225|324364270|FG007|Weeks 1 to 12|Adverse Event|0|||
94701337|NCT00797225|324364263|FG000|Weeks 1 to 12|Non-compliance|0|||
94701338|NCT00797225|324364264|FG001|Weeks 1 to 12|Non-compliance|1|||
94701339|NCT00797225|324364265|FG002|Weeks 1 to 12|Non-compliance|0|||
94701340|NCT00797225|324364266|FG003|Weeks 1 to 12|Non-compliance|0|||
94701341|NCT00797225|324364267|FG004|Weeks 1 to 12|Non-compliance|0|||
94701342|NCT00797225|324364268|FG005|Weeks 1 to 12|Non-compliance|0|||
94701343|NCT00797225|324364269|FG006|Weeks 1 to 12|Non-compliance|0|||
94701344|NCT00797225|324364270|FG007|Weeks 1 to 12|Non-compliance|0|||
94701345|NCT00797225|324364263|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
94701346|NCT00797225|324364264|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
94701347|NCT00797225|324364265|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
94701348|NCT00797225|324364266|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
94701349|NCT00797225|324364267|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
94701350|NCT00797225|324364268|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
94701351|NCT00797225|324364269|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
94701352|NCT00797225|324364270|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
94701353|NCT00797225|324364263|FG000|Weeks 1 to 12|Sponsor Decision|1|||
94265780|NCT04439071|322766763|FG000|Overall Study|Withdrawal by Subject|3|||
94265781|NCT04439071|322766764|FG001|Overall Study|Withdrawal by Subject|8|||
94265782|NCT04439071|322766763|FG000|Overall Study|Death|6|||
94265783|NCT04439071|322766764|FG001|Overall Study|Death|4|||
94265784|NCT04439071|322766763|FG000|Overall Study|Other than specified|3|||
94265785|NCT04439071|322766764|FG001|Overall Study|Other than specified|3|||
94265786|NCT04439071|322766763|FG000|Overall Study|Randomized but not treated|2|||
94265787|NCT04439071|322766764|FG001|Overall Study|Randomized but not treated|0|||
94265788|NCT00404066|322766765|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
94265789|NCT00404066|322766765|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
94265790|NCT01186939|322766766|FG000|Overall Study|Death|7|||
94265791|NCT01186939|322766766|FG000|Overall Study|Withdrawal by Subject|2|||
94265792|NCT01186939|322766766|FG000|Overall Study|No longer receiving clinical benefit|17|||
94265793|NCT01186939|322766766|FG000|Overall Study|Program closed|5|||
94265794|NCT01186939|322766766|FG000|Overall Study|Sponsor decision|4|||
94265795|NCT01186939|322766766|FG000|Overall Study|Started additional treatment|1|||
94265796|NCT01186939|322766766|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
94265797|NCT01186939|322766766|FG000|Overall Study|Myocardial infarction|1|||
94265798|NCT01186939|322766766|FG000|Overall Study|Bone marrow transplant|1|||
94265799|NCT01186939|322766766|FG000|Overall Study|Transformation to AML|1|||
94265800|NCT03155373|322766767|FG000|Overall Study|No longer required surgery|1|||
94265801|NCT03155373|322766767|FG000|Overall Study|Protocol Violation|1|||
94265802|NCT03155373|322766767|FG000|Overall Study|Death|2|||
94265803|NCT03155373|322766767|FG000|Overall Study|Withdrawal by Subject|3|||
94265804|NCT00068588|322766768|FG000|Overall Study|Adverse Event|0|||
94265805|NCT00068588|322766769|FG001|Overall Study|Adverse Event|0|||
94265806|NCT00068588|322766770|FG002|Overall Study|Adverse Event|2|||
94265807|NCT00068588|322766768|FG000|Overall Study|Withdrawal by Subject|0|||
94265808|NCT00068588|322766769|FG001|Overall Study|Withdrawal by Subject|0|||
94265809|NCT00068588|322766770|FG002|Overall Study|Withdrawal by Subject|1|||
94265810|NCT00068588|322766768|FG000|Overall Study|Poor KPS|0|||
94265811|NCT00068588|322766769|FG001|Overall Study|Poor KPS|0|||
94265812|NCT00068588|322766770|FG002|Overall Study|Poor KPS|1|||
94265813|NCT01118325|322766771|FG000|Overall Study|Adverse Event|1|||
94265814|NCT01118325|322766772|FG001|Overall Study|Adverse Event|0|||
94701354|NCT00797225|324364264|FG001|Weeks 1 to 12|Sponsor Decision|0|||
94701355|NCT00797225|324364265|FG002|Weeks 1 to 12|Sponsor Decision|0|||
94701356|NCT00797225|324364266|FG003|Weeks 1 to 12|Sponsor Decision|0|||
94701357|NCT00797225|324364267|FG004|Weeks 1 to 12|Sponsor Decision|0|||
94701358|NCT00797225|324364268|FG005|Weeks 1 to 12|Sponsor Decision|0|||
94701359|NCT00797225|324364269|FG006|Weeks 1 to 12|Sponsor Decision|0|||
94701360|NCT00797225|324364270|FG007|Weeks 1 to 12|Sponsor Decision|0|||
94701361|NCT00797225|324364263|FG000|Weeks 13 to 24|Non-compliance|0|||
94701362|NCT00797225|324364264|FG001|Weeks 13 to 24|Non-compliance|2|||
94701363|NCT00797225|324364265|FG002|Weeks 13 to 24|Non-compliance|0|||
94701364|NCT00797225|324364266|FG003|Weeks 13 to 24|Non-compliance|0|||
94701365|NCT00797225|324364267|FG004|Weeks 13 to 24|Non-compliance|0|||
94701366|NCT00797225|324364268|FG005|Weeks 13 to 24|Non-compliance|0|||
94701367|NCT00797225|324364269|FG006|Weeks 13 to 24|Non-compliance|0|||
94701368|NCT00797225|324364270|FG007|Weeks 13 to 24|Non-compliance|0|||
94701369|NCT00797225|324364263|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
94701370|NCT00797225|324364264|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
94701371|NCT00797225|324364265|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
94701372|NCT00797225|324364266|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
94701373|NCT00797225|324364267|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
94701374|NCT00797225|324364268|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
94701375|NCT00797225|324364269|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
94701376|NCT00797225|324364270|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
94701377|NCT00797225|324364263|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
94701378|NCT00797225|324364264|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
94701379|NCT00797225|324364265|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
94701380|NCT00797225|324364266|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
94701381|NCT00797225|324364267|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
94701382|NCT00797225|324364268|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
94701383|NCT00797225|324364269|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
94701384|NCT00797225|324364270|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
94701385|NCT00797225|324364263|FG000|Weeks 13 to 24|Adverse Event|0|||
94701386|NCT00797225|324364264|FG001|Weeks 13 to 24|Adverse Event|1|||
94701387|NCT00797225|324364265|FG002|Weeks 13 to 24|Adverse Event|0|||
94701388|NCT00797225|324364266|FG003|Weeks 13 to 24|Adverse Event|0|||
94701389|NCT00797225|324364267|FG004|Weeks 13 to 24|Adverse Event|0|||
94701390|NCT00797225|324364268|FG005|Weeks 13 to 24|Adverse Event|0|||
94701391|NCT00797225|324364269|FG006|Weeks 13 to 24|Adverse Event|1|||
94701392|NCT00797225|324364270|FG007|Weeks 13 to 24|Adverse Event|0|||
94701393|NCT00797225|324364263|FG000|Weeks 13 to 24|Sponsor Decision|0|||
94701394|NCT00797225|324364264|FG001|Weeks 13 to 24|Sponsor Decision|0|||
94701395|NCT00797225|324364265|FG002|Weeks 13 to 24|Sponsor Decision|0|||
94701396|NCT00797225|324364266|FG003|Weeks 13 to 24|Sponsor Decision|0|||
94701397|NCT00797225|324364267|FG004|Weeks 13 to 24|Sponsor Decision|0|||
94701398|NCT00797225|324364268|FG005|Weeks 13 to 24|Sponsor Decision|0|||
94701399|NCT00797225|324364269|FG006|Weeks 13 to 24|Sponsor Decision|1|||
94701400|NCT00797225|324364270|FG007|Weeks 13 to 24|Sponsor Decision|0|||
94701401|NCT01352507|324364271|FG000|Treatment Period 1|Adverse Event|3|||
94701402|NCT01352507|324364272|FG001|Treatment Period 1|Adverse Event|0|||
94701403|NCT01352507|324364271|FG000|Treatment Period 1|Lost to Follow-up|3|||
94701404|NCT01352507|324364272|FG001|Treatment Period 1|Lost to Follow-up|4|||
94701405|NCT01352507|324364271|FG000|Treatment Period 1|Withdrawal by Subject|7|||
94701406|NCT01352507|324364272|FG001|Treatment Period 1|Withdrawal by Subject|5|||
94701407|NCT01352507|324364271|FG000|Treatment Period 1|Physician Decision|1|||
94701408|NCT01352507|324364272|FG001|Treatment Period 1|Physician Decision|0|||
94701409|NCT01352507|324364271|FG000|Washout Period|Withdrawal by Subject|0|||
94701410|NCT01352507|324364272|FG001|Washout Period|Withdrawal by Subject|1|||
94701411|NCT01352507|324364271|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
94701412|NCT01352507|324364272|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
94701413|NCT01352507|324364271|FG000|Treatment Period 2|Withdrawal by Subject|4|||
94366491|NCT01289990|323126542|FG005|Overall Study|Not treated|0|||
94366492|NCT01289990|323126543|FG006|Overall Study|Not treated|1|||
94701414|NCT01352507|324364272|FG001|Treatment Period 2|Withdrawal by Subject|3|||
94701415|NCT01352507|324364271|FG000|Treatment Period 2|Lack of Efficacy|1|||
94701416|NCT01352507|324364272|FG001|Treatment Period 2|Lack of Efficacy|0|||
94701417|NCT01119703|324364273|FG000|Overall Study|Adverse Event|0|||
94701418|NCT01119703|324364274|FG001|Overall Study|Adverse Event|1|||
94701419|NCT02095158|324364275|FG000|Overall Study|Adverse Event|14|||
94366493|NCT01289990|323126544|FG007|Overall Study|Not treated|0|||
94366494|NCT01289990|323126545|FG008|Overall Study|Not treated|1|||
94701420|NCT02095158|324364275|FG000|Overall Study|Lack of Efficacy|3|||
94701421|NCT02095158|324364275|FG000|Overall Study|Pregnancy|1|||
94701422|NCT02095158|324364275|FG000|Overall Study|Lost to Follow-up|20|||
94701423|NCT02095158|324364275|FG000|Overall Study|Personal Reasons|35|||
94701424|NCT02095158|324364275|FG000|Overall Study|Protocol Violation|1|||
94701425|NCT02095158|324364275|FG000|Overall Study|Other Miscellaneous Reasons|1|||
94701426|NCT01941316|324364276|FG000|Overall Study|Adverse Event|0|||
94701427|NCT01941316|324364277|FG001|Overall Study|Adverse Event|1|||
94701428|NCT01941316|324364278|FG002|Overall Study|Adverse Event|0|||
94701429|NCT01941316|324364279|FG003|Overall Study|Adverse Event|7|||
94701430|NCT01941316|324364276|FG000|Overall Study|Progressive Disease|3|||
94701431|NCT01941316|324364277|FG001|Overall Study|Progressive Disease|6|||
94701432|NCT01941316|324364278|FG002|Overall Study|Progressive Disease|2|||
94701433|NCT01941316|324364279|FG003|Overall Study|Progressive Disease|29|||
94701434|NCT01941316|324364276|FG000|Overall Study|Withdrawal by Subject|0|||
94701435|NCT01941316|324364277|FG001|Overall Study|Withdrawal by Subject|2|||
94701436|NCT01941316|324364278|FG002|Overall Study|Withdrawal by Subject|1|||
94701437|NCT01941316|324364279|FG003|Overall Study|Withdrawal by Subject|8|||
94701438|NCT01941316|324364276|FG000|Overall Study|Death|0|||
94701439|NCT01941316|324364277|FG001|Overall Study|Death|0|||
94701440|NCT01941316|324364278|FG002|Overall Study|Death|0|||
94701441|NCT01941316|324364279|FG003|Overall Study|Death|3|||
94701442|NCT01941316|324364276|FG000|Overall Study|Physician Decision|0|||
94701443|NCT01941316|324364277|FG001|Overall Study|Physician Decision|0|||
94701444|NCT01941316|324364278|FG002|Overall Study|Physician Decision|0|||
94701445|NCT01941316|324364279|FG003|Overall Study|Physician Decision|3|||
94701446|NCT01941316|324364276|FG000|Overall Study|Protocol Violation|0|||
94701447|NCT01941316|324364277|FG001|Overall Study|Protocol Violation|0|||
94701448|NCT01941316|324364278|FG002|Overall Study|Protocol Violation|0|||
94701449|NCT01941316|324364279|FG003|Overall Study|Protocol Violation|3|||
94701450|NCT01941316|324364276|FG000|Overall Study|Intercurrent illness|0|||
94701451|NCT01941316|324364277|FG001|Overall Study|Intercurrent illness|0|||
94701452|NCT01941316|324364278|FG002|Overall Study|Intercurrent illness|0|||
94701453|NCT01941316|324364279|FG003|Overall Study|Intercurrent illness|1|||
94701454|NCT01941316|324364276|FG000|Overall Study|Other, not specified|0|||
94701455|NCT01941316|324364277|FG001|Overall Study|Other, not specified|0|||
94701456|NCT01941316|324364278|FG002|Overall Study|Other, not specified|0|||
94701457|NCT01941316|324364279|FG003|Overall Study|Other, not specified|1|||
94701458|NCT00502593|324364285|FG000|Overall Study|Withdrawn unspecified reason|1|||
94701459|NCT00502593|324364286|FG001|Overall Study|Withdrawn unspecified reason|1|||
94701460|NCT00502593|324364287|FG002|Overall Study|Withdrawn unspecified reason|3|||
94701461|NCT00502593|324364288|FG003|Overall Study|Withdrawn unspecified reason|1|||
94701462|NCT00502593|324364289|FG004|Overall Study|Withdrawn unspecified reason|2|||
94701463|NCT00502593|324364290|FG005|Overall Study|Withdrawn unspecified reason|0|||
94701464|NCT00502593|324364291|FG006|Overall Study|Withdrawn unspecified reason|2|||
94701465|NCT00502593|324364292|FG007|Overall Study|Withdrawn unspecified reason|0|||
94701466|NCT00502593|324364293|FG008|Overall Study|Withdrawn unspecified reason|0|||
94701467|NCT00502593|324364294|FG009|Overall Study|Withdrawn unspecified reason|0|||
94701468|NCT00502593|324364295|FG010|Overall Study|Withdrawn unspecified reason|0|||
94701469|NCT00502593|324364296|FG011|Overall Study|Withdrawn unspecified reason|0|||
94701470|NCT00502593|324364285|FG000|Overall Study|Withdrawal by Subject|0|||
94701471|NCT00502593|324364286|FG001|Overall Study|Withdrawal by Subject|0|||
94701472|NCT00502593|324364287|FG002|Overall Study|Withdrawal by Subject|6|||
94701473|NCT00502593|324364288|FG003|Overall Study|Withdrawal by Subject|2|||
94701474|NCT00502593|324364289|FG004|Overall Study|Withdrawal by Subject|2|||
94701475|NCT00502593|324364290|FG005|Overall Study|Withdrawal by Subject|0|||
94701476|NCT00502593|324364291|FG006|Overall Study|Withdrawal by Subject|3|||
94701477|NCT00502593|324364292|FG007|Overall Study|Withdrawal by Subject|0|||
94701478|NCT00502593|324364293|FG008|Overall Study|Withdrawal by Subject|3|||
94701479|NCT00502593|324364294|FG009|Overall Study|Withdrawal by Subject|0|||
94701480|NCT00502593|324364295|FG010|Overall Study|Withdrawal by Subject|1|||
94701481|NCT00502593|324364296|FG011|Overall Study|Withdrawal by Subject|0|||
94701482|NCT00502593|324364285|FG000|Overall Study|Lost to Follow-up|2|||
94701483|NCT00502593|324364286|FG001|Overall Study|Lost to Follow-up|1|||
94701484|NCT00502593|324364287|FG002|Overall Study|Lost to Follow-up|1|||
94701485|NCT00502593|324364288|FG003|Overall Study|Lost to Follow-up|1|||
94701486|NCT00502593|324364289|FG004|Overall Study|Lost to Follow-up|0|||
94701487|NCT00502593|324364290|FG005|Overall Study|Lost to Follow-up|0|||
94701488|NCT00502593|324364291|FG006|Overall Study|Lost to Follow-up|0|||
94701489|NCT00502593|324364292|FG007|Overall Study|Lost to Follow-up|0|||
94701490|NCT00502593|324364293|FG008|Overall Study|Lost to Follow-up|3|||
94701491|NCT00502593|324364294|FG009|Overall Study|Lost to Follow-up|0|||
94701492|NCT00502593|324364295|FG010|Overall Study|Lost to Follow-up|1|||
94701493|NCT00502593|324364296|FG011|Overall Study|Lost to Follow-up|0|||
94701494|NCT01664104|324364297|FG000|Overall Study|Adverse Event|6|||
94701495|NCT01664104|324364297|FG000|Overall Study|Lack of Efficacy|2|||
94701496|NCT01664104|324364297|FG000|Overall Study|Withdrawal by Subject|1|||
94701497|NCT01664104|324364297|FG000|Overall Study|Lost to Follow-up|4|||
94701498|NCT01664104|324364297|FG000|Overall Study|Other|1|||
94701499|NCT01664104|324364297|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
94701500|NCT02616263|324364301|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
94701501|NCT02616263|324364302|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
94701502|NCT02616263|324364301|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
94701503|NCT02616263|324364302|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
94701504|NCT02616263|324364301|FG000|6 Month to 1.5 Year|Death|1|||
94701505|NCT02616263|324364302|FG001|6 Month to 1.5 Year|Death|0|||
94701506|NCT02616263|324364301|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
94701507|NCT02616263|324364302|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
94701508|NCT02616263|324364301|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
94701509|NCT02616263|324364302|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
94701510|NCT02616263|324364301|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
94701511|NCT02616263|324364302|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
94701512|NCT03643211|324364303|FG000|Overall Study|Contract violation/deficiency|12|||
94701513|NCT03643211|324364303|FG000|Overall Study|Invalid registration|3|||
94701514|NCT03643211|324364303|FG000|Overall Study|No treatment information|2|||
94701515|NCT03643211|324364303|FG000|Overall Study|No adverse event information - No revisit|4|||
94701516|NCT01244828|324364306|FG000|Overall Study|Adverse Event|37|||
94701517|NCT01244828|324364306|FG000|Overall Study|Withdrawal by Subject|31|||
94701518|NCT01244828|324364306|FG000|Overall Study|Lack of Efficacy|7|||
94701519|NCT01244828|324364306|FG000|Overall Study|Lost to Follow-up|2|||
94701520|NCT01244828|324364306|FG000|Overall Study|Other reason (not specified)|1|||
94701521|NCT00603447|324364307|FG000|Overall Study|Adverse Event|0|||
94701522|NCT00603447|324364308|FG001|Overall Study|Adverse Event|1|||
94701523|NCT00603447|324364309|FG002|Overall Study|Adverse Event|1|||
94701524|NCT00603447|324364310|FG003|Overall Study|Adverse Event|2|||
94701525|NCT00603447|324364311|FG004|Overall Study|Adverse Event|1|||
94701526|NCT00603447|324364312|FG005|Overall Study|Adverse Event|2|||
94701527|NCT00603447|324364313|FG006|Overall Study|Adverse Event|10|||
94701528|NCT00603447|324364307|FG000|Overall Study|Other|0|||
94701529|NCT00603447|324364308|FG001|Overall Study|Other|0|||
94701530|NCT00603447|324364309|FG002|Overall Study|Other|1|||
94701531|NCT00603447|324364310|FG003|Overall Study|Other|0|||
94701532|NCT00603447|324364311|FG004|Overall Study|Other|3|||
94701533|NCT00603447|324364312|FG005|Overall Study|Other|0|||
94701534|NCT00603447|324364313|FG006|Overall Study|Other|13|||
94701535|NCT00603447|324364307|FG000|Overall Study|Withdrew Consent|0|||
94701536|NCT00603447|324364308|FG001|Overall Study|Withdrew Consent|2|||
94701537|NCT00603447|324364309|FG002|Overall Study|Withdrew Consent|0|||
94701538|NCT00603447|324364310|FG003|Overall Study|Withdrew Consent|0|||
94701539|NCT00603447|324364311|FG004|Overall Study|Withdrew Consent|1|||
94701540|NCT00603447|324364312|FG005|Overall Study|Withdrew Consent|0|||
94701541|NCT00603447|324364313|FG006|Overall Study|Withdrew Consent|1|||
94701542|NCT02624778|324365536|FG000|Overall Study|Lost to Follow-up|0|||
94701543|NCT02624778|324365537|FG001|Overall Study|Lost to Follow-up|0|||
94701544|NCT02624778|324365538|FG002|Overall Study|Lost to Follow-up|1|||
94701545|NCT02624778|324365539|FG003|Overall Study|Lost to Follow-up|0|||
94701546|NCT02624778|324365540|FG004|Overall Study|Lost to Follow-up|0|||
94701547|NCT02624778|324365541|FG005|Overall Study|Lost to Follow-up|0|||
94701548|NCT02624778|324365542|FG006|Overall Study|Lost to Follow-up|0|||
94701549|NCT02624778|324365543|FG007|Overall Study|Lost to Follow-up|0|||
94701550|NCT02624778|324365544|FG008|Overall Study|Lost to Follow-up|0|||
94701551|NCT02624778|324365536|FG000|Overall Study|Withdrawal by Subject|0|||
94701552|NCT02624778|324365537|FG001|Overall Study|Withdrawal by Subject|1|||
94701553|NCT02624778|324365538|FG002|Overall Study|Withdrawal by Subject|0|||
94701554|NCT02624778|324365539|FG003|Overall Study|Withdrawal by Subject|0|||
94701555|NCT02624778|324365540|FG004|Overall Study|Withdrawal by Subject|0|||
94701556|NCT02624778|324365541|FG005|Overall Study|Withdrawal by Subject|1|||
94701557|NCT02624778|324365542|FG006|Overall Study|Withdrawal by Subject|1|||
94701558|NCT02624778|324365543|FG007|Overall Study|Withdrawal by Subject|1|||
94701559|NCT02624778|324365544|FG008|Overall Study|Withdrawal by Subject|1|||
94701560|NCT02624778|324365536|FG000|Overall Study|Adverse Event|0|||
94701561|NCT02624778|324365537|FG001|Overall Study|Adverse Event|0|||
94701562|NCT02624778|324365538|FG002|Overall Study|Adverse Event|0|||
94701563|NCT02624778|324365539|FG003|Overall Study|Adverse Event|0|||
94701564|NCT02624778|324365540|FG004|Overall Study|Adverse Event|0|||
94701565|NCT02624778|324365541|FG005|Overall Study|Adverse Event|0|||
94701566|NCT02624778|324365542|FG006|Overall Study|Adverse Event|0|||
94701567|NCT02624778|324365543|FG007|Overall Study|Adverse Event|0|||
94701568|NCT02624778|324365544|FG008|Overall Study|Adverse Event|2|||
94701569|NCT02624778|324365536|FG000|Overall Study|Death|0|||
94701570|NCT02624778|324365537|FG001|Overall Study|Death|0|||
94701571|NCT02624778|324365538|FG002|Overall Study|Death|0|||
94701572|NCT02624778|324365539|FG003|Overall Study|Death|0|||
94701573|NCT02624778|324365540|FG004|Overall Study|Death|0|||
94701574|NCT02624778|324365541|FG005|Overall Study|Death|0|||
94701575|NCT02624778|324365542|FG006|Overall Study|Death|1|||
94701576|NCT02624778|324365543|FG007|Overall Study|Death|0|||
94701577|NCT02624778|324365544|FG008|Overall Study|Death|0|||
94701578|NCT02624778|324365536|FG000|Overall Study|Physician Decision|0|||
94701579|NCT02624778|324365537|FG001|Overall Study|Physician Decision|0|||
94701580|NCT02624778|324365538|FG002|Overall Study|Physician Decision|0|||
94701581|NCT02624778|324365539|FG003|Overall Study|Physician Decision|0|||
94701582|NCT02624778|324365540|FG004|Overall Study|Physician Decision|0|||
94701583|NCT02624778|324365541|FG005|Overall Study|Physician Decision|0|||
94701584|NCT02624778|324365542|FG006|Overall Study|Physician Decision|0|||
94701585|NCT02624778|324365543|FG007|Overall Study|Physician Decision|3|||
94701586|NCT02624778|324365544|FG008|Overall Study|Physician Decision|3|||
94701587|NCT00359619|324365545|FG000|Overall Study|Adverse Event|0|||
94701588|NCT00359619|324365546|FG001|Overall Study|Adverse Event|0|||
94701589|NCT00359619|324365547|FG002|Overall Study|Adverse Event|1|||
94701590|NCT00359619|324365548|FG003|Overall Study|Adverse Event|0|||
94701591|NCT00359619|324365549|FG004|Overall Study|Adverse Event|0|||
94701592|NCT00359619|324365550|FG005|Overall Study|Adverse Event|0|||
94701593|NCT00359619|324365551|FG006|Overall Study|Adverse Event|1|||
94701594|NCT00359619|324365545|FG000|Overall Study|Withdrawal by Subject|3|||
94701595|NCT00359619|324365546|FG001|Overall Study|Withdrawal by Subject|1|||
94701596|NCT00359619|324365547|FG002|Overall Study|Withdrawal by Subject|4|||
94701597|NCT00359619|324365548|FG003|Overall Study|Withdrawal by Subject|2|||
94701598|NCT00359619|324365549|FG004|Overall Study|Withdrawal by Subject|2|||
94701599|NCT00359619|324365550|FG005|Overall Study|Withdrawal by Subject|0|||
94701600|NCT00359619|324365551|FG006|Overall Study|Withdrawal by Subject|3|||
94701601|NCT00359619|324365545|FG000|Overall Study|Other|1|||
94701602|NCT00359619|324365546|FG001|Overall Study|Other|0|||
94701603|NCT00359619|324365547|FG002|Overall Study|Other|0|||
94701604|NCT00359619|324365548|FG003|Overall Study|Other|0|||
94701605|NCT00359619|324365549|FG004|Overall Study|Other|0|||
94701606|NCT00359619|324365550|FG005|Overall Study|Other|0|||
94701607|NCT00359619|324365551|FG006|Overall Study|Other|0|||
94701608|NCT00359619|324365545|FG000|Overall Study|Lost to Follow-up|4|||
94701609|NCT00359619|324365546|FG001|Overall Study|Lost to Follow-up|4|||
94701610|NCT00359619|324365547|FG002|Overall Study|Lost to Follow-up|2|||
94701611|NCT00359619|324365548|FG003|Overall Study|Lost to Follow-up|1|||
94701612|NCT00359619|324365549|FG004|Overall Study|Lost to Follow-up|1|||
94701613|NCT00359619|324365550|FG005|Overall Study|Lost to Follow-up|5|||
94701614|NCT00359619|324365551|FG006|Overall Study|Lost to Follow-up|0|||
94701615|NCT01419717|324365552|FG000|Overall Study|Protocol-specified Criteria|62|||
94701616|NCT01419717|324365552|FG000|Overall Study|Adverse Event|19|||
94701617|NCT01419717|324365552|FG000|Overall Study|Death|17|||
94701618|NCT01419717|324365552|FG000|Overall Study|Withdrawal by Subject|10|||
94701619|NCT01419717|324365552|FG000|Overall Study|Disease Progression|9|||
94701620|NCT01419717|324365552|FG000|Overall Study|Other|4|||
94701621|NCT01419717|324365552|FG000|Overall Study|Lost to Follow-up|2|||
94701622|NCT01419717|324365552|FG000|Overall Study|Administrative Decision|1|||
94701623|NCT01419717|324365552|FG000|Overall Study|Noncompliance|1|||
94701624|NCT00587288|324365553|FG000|Overall Study|Adverse Event|0|||
94701625|NCT00587288|324365554|FG001|Overall Study|Adverse Event|1|||
94701626|NCT00587288|324365553|FG000|Overall Study|Lack of Efficacy|2|||
94701627|NCT00587288|324365554|FG001|Overall Study|Lack of Efficacy|8|||
94701628|NCT00587288|324365553|FG000|Overall Study|Protocol Violation|1|||
94701629|NCT00587288|324365554|FG001|Overall Study|Protocol Violation|0|||
94701630|NCT01474538|324365559|FG000|Treatment Period 1|Death|1|||
94701631|NCT01474538|324365560|FG001|Treatment Period 1|Death|0|||
94701632|NCT01474538|324365559|FG000|Treatment Period 1|Physician Decision|1|||
94701633|NCT01474538|324365560|FG001|Treatment Period 1|Physician Decision|0|||
94701634|NCT01474538|324365559|FG000|Treatment Period 1|Withdrawal by Subject|1|||
94701635|NCT01474538|324365560|FG001|Treatment Period 1|Withdrawal by Subject|3|||
94701636|NCT01474538|324365559|FG000|Treatment Period 1|Protocol Violation|0|||
94701637|NCT01474538|324365560|FG001|Treatment Period 1|Protocol Violation|1|||
94701638|NCT01474538|324365559|FG000|Treatment Period 2|Death|1|||
94701639|NCT01474538|324365560|FG001|Treatment Period 2|Death|0|||
94701640|NCT01474538|324365559|FG000|Treatment Period 2|Adverse Event|1|||
94701641|NCT01474538|324365560|FG001|Treatment Period 2|Adverse Event|1|||
94701642|NCT01474538|324365559|FG000|Treatment Period 2|Withdrawal by Subject|2|||
94701643|NCT01474538|324365560|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94701644|NCT01474538|324365559|FG000|Treatment Period 2|Sponsor decision|1|||
94701645|NCT01474538|324365560|FG001|Treatment Period 2|Sponsor decision|0|||
94701646|NCT01474538|324365559|FG000|Treatment Period 2|Physician Decision|0|||
94701647|NCT01474538|324365560|FG001|Treatment Period 2|Physician Decision|1|||
94701648|NCT01474538|324365559|FG000|Treatment Period 2|Protocol Violation|1|||
94701649|NCT01474538|324365560|FG001|Treatment Period 2|Protocol Violation|0|||
94701650|NCT01456780|324365561|FG000|Overall Study|Lost to Follow-up|3|||
94701651|NCT01456780|324365562|FG001|Overall Study|Lost to Follow-up|3|||
94701652|NCT01456780|324365563|FG002|Overall Study|Lost to Follow-up|0|||
94701653|NCT04565249|324365569|FG000|Overall Study|Death|0|||
94701654|NCT04565249|324365570|FG001|Overall Study|Death|0|||
94701655|NCT04565249|324365571|FG002|Overall Study|Death|0|||
94701656|NCT04565249|324365572|FG003|Overall Study|Death|1|||
94701657|NCT00315055|324365573|FG000|Overall Study|Protocol Violation|2|||
94701658|NCT00315055|324365574|FG001|Overall Study|Protocol Violation|4|||
94701659|NCT00315055|324365573|FG000|Overall Study|Lost to Follow-up|1|||
94701660|NCT00315055|324365574|FG001|Overall Study|Lost to Follow-up|1|||
94701661|NCT01704846|324365575|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94701662|NCT01704846|324365576|FG001|Treatment Period 2|Withdrawal by Subject|1|||
94701663|NCT02680756|324365581|FG000|Overall Study|Adverse Event|10|||
94701664|NCT02680756|324365582|FG001|Overall Study|Adverse Event|2|||
94701665|NCT02680756|324365581|FG000|Overall Study|Lost to Follow-up|7|||
94701666|NCT02680756|324365582|FG001|Overall Study|Lost to Follow-up|6|||
94701667|NCT02680756|324365581|FG000|Overall Study|Withdrawal by Subject|5|||
94701668|NCT02680756|324365582|FG001|Overall Study|Withdrawal by Subject|5|||
94701669|NCT02680756|324365581|FG000|Overall Study|Physician Decision|4|||
94701670|NCT02680756|324365582|FG001|Overall Study|Physician Decision|1|||
94701671|NCT02680756|324365581|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
94701672|NCT02680756|324365582|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
94701673|NCT02680756|324365581|FG000|Overall Study|Blood transfusion for any reason|0|||
94701674|NCT02680756|324365582|FG001|Overall Study|Blood transfusion for any reason|1|||
94701675|NCT02680756|324365581|FG000|Overall Study|Death|1|||
94701676|NCT02680756|324365582|FG001|Overall Study|Death|0|||
94701677|NCT02680756|324365581|FG000|Overall Study|Protocol Violation|1|||
94701678|NCT02680756|324365582|FG001|Overall Study|Protocol Violation|0|||
94701679|NCT02680756|324365581|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
94701680|NCT02680756|324365582|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
94701681|NCT02680756|324365581|FG000|Overall Study|None of above or not recorded|3|||
94701682|NCT02680756|324365582|FG001|Overall Study|None of above or not recorded|2|||
94701683|NCT00335556|324365583|FG000|Overall Study|Death|0|||
94701684|NCT00335556|324365584|FG001|Overall Study|Death|5|||
94701685|NCT00335556|324365585|FG002|Overall Study|Death|0|||
94701686|NCT00335556|324365586|FG003|Overall Study|Death|0|||
94701687|NCT00335556|324365587|FG004|Overall Study|Death|1|||
94701688|NCT00335556|324365588|FG005|Overall Study|Death|0|||
94701689|NCT00335556|324365583|FG000|Overall Study|Lack of Efficacy|0|||
94701690|NCT00335556|324365584|FG001|Overall Study|Lack of Efficacy|19|||
94701691|NCT00335556|324365585|FG002|Overall Study|Lack of Efficacy|3|||
94701692|NCT00335556|324365586|FG003|Overall Study|Lack of Efficacy|3|||
94701693|NCT00335556|324365587|FG004|Overall Study|Lack of Efficacy|0|||
94701694|NCT00335556|324365588|FG005|Overall Study|Lack of Efficacy|1|||
94701695|NCT00335556|324365583|FG000|Overall Study|Physician Decision|0|||
94701696|NCT00335556|324365584|FG001|Overall Study|Physician Decision|6|||
94701697|NCT00335556|324365585|FG002|Overall Study|Physician Decision|2|||
94701698|NCT00335556|324365586|FG003|Overall Study|Physician Decision|1|||
94701699|NCT00335556|324365587|FG004|Overall Study|Physician Decision|0|||
94701700|NCT00335556|324365588|FG005|Overall Study|Physician Decision|0|||
94265815|NCT01118325|322766773|FG002|Overall Study|Adverse Event|1|||
94701701|NCT00335556|324365583|FG000|Overall Study|Ineligible|2|||
94701702|NCT00335556|324365584|FG001|Overall Study|Ineligible|0|||
94701703|NCT00335556|324365585|FG002|Overall Study|Ineligible|0|||
94701704|NCT00335556|324365586|FG003|Overall Study|Ineligible|0|||
94701705|NCT00335556|324365587|FG004|Overall Study|Ineligible|0|||
94701706|NCT00335556|324365588|FG005|Overall Study|Ineligible|0|||
94701707|NCT00335556|324365583|FG000|Overall Study|Refusal of further protocol therapy|0|||
94701708|NCT00335556|324365584|FG001|Overall Study|Refusal of further protocol therapy|4|||
94701709|NCT00335556|324365585|FG002|Overall Study|Refusal of further protocol therapy|0|||
94701710|NCT00335556|324365586|FG003|Overall Study|Refusal of further protocol therapy|1|||
94701711|NCT00335556|324365587|FG004|Overall Study|Refusal of further protocol therapy|0|||
94701712|NCT00335556|324365588|FG005|Overall Study|Refusal of further protocol therapy|0|||
94701713|NCT00320489|324365593|FG000|Overall Study|Adverse Event|26|||
94701714|NCT00320489|324365594|FG001|Overall Study|Adverse Event|25|||
94701715|NCT00320489|324365593|FG000|Overall Study|Clinical Relapse|26|||
94265816|NCT00975715|322766774|FG000|Titration Period|Adverse Event|6|||
94265817|NCT00975715|322766775|FG001|Titration Period|Adverse Event|0|||
94265818|NCT00975715|322766774|FG000|Titration Period|Protocol Violation|1|||
94265819|NCT00975715|322766775|FG001|Titration Period|Protocol Violation|0|||
94265820|NCT00975715|322766774|FG000|Maintenance Period|Adverse Event|2|||
94265821|NCT00975715|322766775|FG001|Maintenance Period|Adverse Event|1|||
94265822|NCT01674712|322766776|FG000|Overall Study|Adverse Event|5|||
94265823|NCT01674712|322766777|FG001|Overall Study|Adverse Event|6|||
94265824|NCT01674712|322766778|FG002|Overall Study|Adverse Event|3|||
94265825|NCT01674712|322766779|FG003|Overall Study|Adverse Event|4|||
94265826|NCT01674712|322766780|FG004|Overall Study|Adverse Event|6|||
94265827|NCT01674712|322766776|FG000|Overall Study|Lost to Follow-up|1|||
94265828|NCT01674712|322766777|FG001|Overall Study|Lost to Follow-up|0|||
94265829|NCT01674712|322766778|FG002|Overall Study|Lost to Follow-up|0|||
94265830|NCT01674712|322766779|FG003|Overall Study|Lost to Follow-up|0|||
94265831|NCT01674712|322766780|FG004|Overall Study|Lost to Follow-up|0|||
94265832|NCT01674712|322766776|FG000|Overall Study|Protocol Violation|2|||
94265833|NCT01674712|322766777|FG001|Overall Study|Protocol Violation|0|||
94265834|NCT01674712|322766778|FG002|Overall Study|Protocol Violation|0|||
94265835|NCT01674712|322766779|FG003|Overall Study|Protocol Violation|0|||
94265836|NCT01674712|322766780|FG004|Overall Study|Protocol Violation|0|||
94265837|NCT01674712|322766776|FG000|Overall Study|Withdrawal by Subject|2|||
94651986|NCT02566759|324183814|FG007|All Parts|Other|0|||
94651987|NCT02566759|324183815|FG008|All Parts|Other|0|||
94651988|NCT02566759|324183816|FG009|All Parts|Other|0|||
94651989|NCT02566759|324183817|FG010|All Parts|Other|0|||
94651990|NCT02566759|324183818|FG011|All Parts|Other|0|||
94651991|NCT02566759|324183819|FG012|All Parts|Other|0|||
94651992|NCT02566759|324183820|FG013|All Parts|Other|2|||
94651993|NCT02566759|324183821|FG014|All Parts|Other|0|||
94651994|NCT02566759|324183822|FG015|All Parts|Other|0|||
94651995|NCT02566759|324183823|FG016|All Parts|Other|0|||
94651996|NCT02566759|324183807|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
94701716|NCT00320489|324365594|FG001|Overall Study|Clinical Relapse|20|||
94701717|NCT00320489|324365593|FG000|Overall Study|Death|0|||
94701718|NCT00320489|324365594|FG001|Overall Study|Death|2|||
94701719|NCT00320489|324365593|FG000|Overall Study|Entry Criteria Exclusion|2|||
94701720|NCT00320489|324365594|FG001|Overall Study|Entry Criteria Exclusion|4|||
94701721|NCT00320489|324365593|FG000|Overall Study|Lack of Efficacy|16|||
94701722|NCT00320489|324365594|FG001|Overall Study|Lack of Efficacy|7|||
94701723|NCT00320489|324365593|FG000|Overall Study|Lost to Follow-up|21|||
94701724|NCT00320489|324365594|FG001|Overall Study|Lost to Follow-up|22|||
94701725|NCT00320489|324365593|FG000|Overall Study|Physician Decision|8|||
94701726|NCT00320489|324365594|FG001|Overall Study|Physician Decision|8|||
94701727|NCT00320489|324365593|FG000|Overall Study|Protocol Violation|4|||
94701728|NCT00320489|324365594|FG001|Overall Study|Protocol Violation|4|||
94701729|NCT00320489|324365593|FG000|Overall Study|Sponsor Decision|3|||
94701730|NCT00320489|324365594|FG001|Overall Study|Sponsor Decision|3|||
94701731|NCT00320489|324365593|FG000|Overall Study|Withdrawal by Subject|39|||
94701732|NCT00320489|324365594|FG001|Overall Study|Withdrawal by Subject|41|||
94701733|NCT00941031|324365595|FG000|Induction Period|Lack of Efficacy|2|||
94701734|NCT00941031|324365596|FG001|Induction Period|Lack of Efficacy|1|||
94701735|NCT00941031|324365597|FG002|Induction Period|Lack of Efficacy|0|||
94651997|NCT02566759|324183808|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
94651998|NCT02566759|324183809|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
94651999|NCT02566759|324183810|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
94652000|NCT02566759|324183811|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
94652001|NCT02566759|324183812|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
94701736|NCT00941031|324365598|FG003|Induction Period|Lack of Efficacy|5|||
94701737|NCT00941031|324365599|FG004|Induction Period|Lack of Efficacy|0|||
94701738|NCT00941031|324365600|FG005|Induction Period|Lack of Efficacy|0|||
94701739|NCT00941031|324365601|FG006|Induction Period|Lack of Efficacy|0|||
94701740|NCT00941031|324365595|FG000|Induction Period|Withdrawal by Subject|1|||
94701741|NCT00941031|324365596|FG001|Induction Period|Withdrawal by Subject|2|||
94265838|NCT01674712|322766777|FG001|Overall Study|Withdrawal by Subject|2|||
94265839|NCT01674712|322766778|FG002|Overall Study|Withdrawal by Subject|5|||
94265840|NCT01674712|322766779|FG003|Overall Study|Withdrawal by Subject|4|||
94265841|NCT01674712|322766780|FG004|Overall Study|Withdrawal by Subject|3|||
94652002|NCT02566759|324183813|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
94701742|NCT00941031|324365597|FG002|Induction Period|Withdrawal by Subject|2|||
94701743|NCT00941031|324365598|FG003|Induction Period|Withdrawal by Subject|2|||
94701744|NCT00941031|324365599|FG004|Induction Period|Withdrawal by Subject|0|||
94701745|NCT00941031|324365600|FG005|Induction Period|Withdrawal by Subject|0|||
94701746|NCT00941031|324365601|FG006|Induction Period|Withdrawal by Subject|0|||
94366495|NCT01289990|323126546|FG009|Overall Study|Not treated|0|||
94366496|NCT01289990|323126547|FG010|Overall Study|Not treated|1|||
94366497|NCT01289990|323126548|FG011|Overall Study|Not treated|2|||
94366498|NCT01289990|323126549|FG012|Overall Study|Not treated|0|||
94366499|NCT04529499|323126550|FG000|Overall Study|Withdrawal by Subject|9|||
94366500|NCT04529499|323126551|FG001|Overall Study|Withdrawal by Subject|11|||
94366501|NCT04529499|323126550|FG000|Overall Study|Physician Decision|1|||
94366502|NCT04529499|323126551|FG001|Overall Study|Physician Decision|2|||
94366503|NCT04529499|323126550|FG000|Overall Study|Adverse Event|4|||
94366504|NCT04529499|323126551|FG001|Overall Study|Adverse Event|4|||
94366505|NCT04529499|323126550|FG000|Overall Study|Death|14|||
94366506|NCT04529499|323126551|FG001|Overall Study|Death|11|||
94366507|NCT04529499|323126550|FG000|Overall Study|Lost to Follow-up|1|||
94366508|NCT04529499|323126551|FG001|Overall Study|Lost to Follow-up|1|||
94366509|NCT04529499|323126550|FG000|Overall Study|Others|7|||
94366510|NCT04529499|323126551|FG001|Overall Study|Others|11|||
94366511|NCT00683904|323126552|FG000|Dose Level 1|Disease progression|2|||
94366512|NCT00683904|323126553|FG001|Dose Level 1|Disease progression|0|||
94366513|NCT00683904|323126552|FG000|Dose Level 1|Adverse Event|1|||
94366514|NCT00683904|323126553|FG001|Dose Level 1|Adverse Event|0|||
94366515|NCT00683904|323126552|FG000|Dose Level 2|Adverse Event|0|||
94366516|NCT00683904|323126553|FG001|Dose Level 2|Adverse Event|2|||
94366517|NCT05166512|323126563|FG000|Randomized|Lost to Follow-up|2|||
94366518|NCT05166512|323126564|FG001|Randomized|Lost to Follow-up|0|||
94366519|NCT05166512|323126563|FG000|Randomized|Withdrawal by Subject|1|||
94366520|NCT05166512|323126564|FG001|Randomized|Withdrawal by Subject|0|||
94701747|NCT00941031|324365595|FG000|Induction Period|Adminstative Problems|1|||
94701748|NCT00941031|324365596|FG001|Induction Period|Adminstative Problems|1|||
94701749|NCT00941031|324365597|FG002|Induction Period|Adminstative Problems|1|||
94701750|NCT00941031|324365598|FG003|Induction Period|Adminstative Problems|0|||
94701751|NCT00941031|324365599|FG004|Induction Period|Adminstative Problems|0|||
94701752|NCT00941031|324365600|FG005|Induction Period|Adminstative Problems|0|||
94701753|NCT00941031|324365601|FG006|Induction Period|Adminstative Problems|0|||
94701754|NCT00941031|324365595|FG000|Induction Period|Adverse Event|1|||
94701755|NCT00941031|324365596|FG001|Induction Period|Adverse Event|0|||
94701756|NCT00941031|324365597|FG002|Induction Period|Adverse Event|3|||
94701757|NCT00941031|324365598|FG003|Induction Period|Adverse Event|2|||
94701758|NCT00941031|324365599|FG004|Induction Period|Adverse Event|0|||
94701759|NCT00941031|324365600|FG005|Induction Period|Adverse Event|0|||
94701760|NCT00941031|324365601|FG006|Induction Period|Adverse Event|0|||
94701761|NCT00941031|324365595|FG000|Maintenance Period|Withdrawal by Subject|0|||
94701762|NCT00941031|324365596|FG001|Maintenance Period|Withdrawal by Subject|0|||
94701763|NCT00941031|324365597|FG002|Maintenance Period|Withdrawal by Subject|0|||
94701764|NCT00941031|324365598|FG003|Maintenance Period|Withdrawal by Subject|0|||
94701765|NCT00941031|324365599|FG004|Maintenance Period|Withdrawal by Subject|6|||
94701766|NCT00941031|324365600|FG005|Maintenance Period|Withdrawal by Subject|2|||
94701767|NCT00941031|324365601|FG006|Maintenance Period|Withdrawal by Subject|13|||
94701768|NCT00941031|324365595|FG000|Maintenance Period|Administrative Problems|0|||
94701769|NCT00941031|324365596|FG001|Maintenance Period|Administrative Problems|0|||
94701770|NCT00941031|324365597|FG002|Maintenance Period|Administrative Problems|0|||
94701771|NCT00941031|324365598|FG003|Maintenance Period|Administrative Problems|0|||
94701772|NCT00941031|324365599|FG004|Maintenance Period|Administrative Problems|1|||
94701773|NCT00941031|324365600|FG005|Maintenance Period|Administrative Problems|0|||
94701774|NCT00941031|324365601|FG006|Maintenance Period|Administrative Problems|1|||
94701775|NCT00941031|324365595|FG000|Maintenance Period|Protocol Violation|0|||
94701776|NCT00941031|324365596|FG001|Maintenance Period|Protocol Violation|0|||
94701777|NCT00941031|324365597|FG002|Maintenance Period|Protocol Violation|0|||
94701778|NCT00941031|324365598|FG003|Maintenance Period|Protocol Violation|0|||
94701779|NCT00941031|324365599|FG004|Maintenance Period|Protocol Violation|0|||
94701780|NCT00941031|324365600|FG005|Maintenance Period|Protocol Violation|0|||
94701781|NCT00941031|324365601|FG006|Maintenance Period|Protocol Violation|1|||
94701782|NCT00941031|324365595|FG000|Maintenance Period|Adverse Event|0|||
94701783|NCT00941031|324365596|FG001|Maintenance Period|Adverse Event|0|||
94366521|NCT05166512|323126563|FG000|Baseline Data Collection|Lost to Follow-up|0|||
94466154|NCT00114738|323496946|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
94701784|NCT00941031|324365597|FG002|Maintenance Period|Adverse Event|0|||
94701785|NCT00941031|324365598|FG003|Maintenance Period|Adverse Event|0|||
94366522|NCT05166512|323126564|FG001|Baseline Data Collection|Lost to Follow-up|3|||
94366523|NCT05166512|323126563|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
94701786|NCT00941031|324365599|FG004|Maintenance Period|Adverse Event|0|||
94701787|NCT00941031|324365600|FG005|Maintenance Period|Adverse Event|2|||
94366524|NCT05166512|323126564|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
94366525|NCT05166512|323126563|FG000|Baseline Data Collection|Protocol Violation|2|||
94366526|NCT05166512|323126564|FG001|Baseline Data Collection|Protocol Violation|0|||
94265842|NCT01674712|322766776|FG000|Overall Study|Administrative|0|||
94265843|NCT01674712|322766777|FG001|Overall Study|Administrative|1|||
94652003|NCT02566759|324183814|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
94652004|NCT02566759|324183815|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
94652005|NCT02566759|324183816|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
94652006|NCT02566759|324183817|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
94652007|NCT02566759|324183818|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
94652008|NCT02566759|324183819|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
94652009|NCT02566759|324183820|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
94652010|NCT02566759|324183821|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
94652011|NCT02566759|324183822|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
94652012|NCT02566759|324183823|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
94652013|NCT00807092|324183824|FG000|Overall Study|Adverse Event|0|||
94652014|NCT00807092|324183825|FG001|Overall Study|Adverse Event|1|||
94652015|NCT00807092|324183824|FG000|Overall Study|Protocol Violation|0|||
94652016|NCT00807092|324183825|FG001|Overall Study|Protocol Violation|2|||
94652017|NCT00807092|324183824|FG000|Overall Study|Withdrawal by Subject|1|||
94652018|NCT00807092|324183825|FG001|Overall Study|Withdrawal by Subject|0|||
94652019|NCT00807092|324183824|FG000|Overall Study|CGMS data collection failed|0|||
94652020|NCT00807092|324183825|FG001|Overall Study|CGMS data collection failed|1|||
94652021|NCT03160703|324183826|FG000|Overall Study|Withdrawal by Subject|0|||
94652022|NCT03160703|324183827|FG001|Overall Study|Withdrawal by Subject|0|||
94652023|NCT03160703|324183828|FG002|Overall Study|Withdrawal by Subject|0|||
94652024|NCT03160703|324183829|FG003|Overall Study|Withdrawal by Subject|1|||
94652025|NCT00087568|324183836|FG000|Overall Study|Adverse Event|4|||
94652026|NCT00087568|324183837|FG001|Overall Study|Adverse Event|0|||
94652027|NCT00087568|324183836|FG000|Overall Study|Withdrawal by Subject|1|||
94652028|NCT00087568|324183837|FG001|Overall Study|Withdrawal by Subject|1|||
94652029|NCT00087568|324183836|FG000|Overall Study|Lost to Follow-up|1|||
94652030|NCT00087568|324183837|FG001|Overall Study|Lost to Follow-up|0|||
94652031|NCT00087568|324183836|FG000|Overall Study|Lack of Efficacy|24|||
94652032|NCT00087568|324183837|FG001|Overall Study|Lack of Efficacy|1|||
94652033|NCT01358981|324183838|FG000|Period 1|Withdrawal by Subject|0|||
94652034|NCT01358981|324183839|FG001|Period 1|Withdrawal by Subject|0|||
94652035|NCT01358981|324183840|FG002|Period 1|Withdrawal by Subject|0|||
94652036|NCT01358981|324183841|FG003|Period 1|Withdrawal by Subject|1|||
94652037|NCT01358981|324183842|FG004|Period 1|Withdrawal by Subject|0|||
94652038|NCT01358981|324183843|FG005|Period 1|Withdrawal by Subject|0|||
94652039|NCT01358981|324183844|FG006|Period 1|Withdrawal by Subject|0|||
94652040|NCT04354831|324183845|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
94652041|NCT04354831|324183846|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
94652042|NCT02732847|324183847|FG000|Overall Study|some filled early|42|||
94652043|NCT02732847|324183848|FG001|Overall Study|some filled early|42|||
94652044|NCT01785524|324183849|FG000|Overall Study|Withdrawal by Subject|2|||
94652045|NCT01785524|324183850|FG001|Overall Study|Withdrawal by Subject|2|||
94652046|NCT02863354|324183855|FG000|Year 1|Lost to Follow-up|1|||
94652047|NCT02863354|324183856|FG001|Year 1|Lost to Follow-up|1|||
94652048|NCT02863354|324183855|FG000|Year 1|Withdrawal by Subject|3|||
94652049|NCT02863354|324183856|FG001|Year 1|Withdrawal by Subject|0|||
94652050|NCT02863354|324183855|FG000|Year 1|Death|0|||
94652051|NCT02863354|324183856|FG001|Year 1|Death|1|||
94652052|NCT02863354|324183855|FG000|Year 2|Lost to Follow-up|2|||
94652053|NCT02863354|324183856|FG001|Year 2|Lost to Follow-up|2|||
94652054|NCT03296696|324183857|FG000|Overall Study|Started Other Antitumor Therapy|1|||
94652055|NCT03296696|324183858|FG001|Overall Study|Started Other Antitumor Therapy|2|||
94652056|NCT03296696|324183859|FG002|Overall Study|Started Other Antitumor Therapy|1|||
94652057|NCT03296696|324183860|FG003|Overall Study|Started Other Antitumor Therapy|2|||
94652058|NCT03296696|324183861|FG004|Overall Study|Started Other Antitumor Therapy|1|||
94652059|NCT03296696|324183862|FG005|Overall Study|Started Other Antitumor Therapy|1|||
94652060|NCT03296696|324183863|FG006|Overall Study|Started Other Antitumor Therapy|2|||
94652061|NCT03296696|324183864|FG007|Overall Study|Started Other Antitumor Therapy|3|||
94652062|NCT03296696|324183865|FG008|Overall Study|Started Other Antitumor Therapy|1|||
94652063|NCT03296696|324183866|FG009|Overall Study|Started Other Antitumor Therapy|0|||
94652064|NCT03296696|324183857|FG000|Overall Study|Death|0|||
94652065|NCT03296696|324183858|FG001|Overall Study|Death|1|||
94652066|NCT03296696|324183859|FG002|Overall Study|Death|1|||
94652067|NCT03296696|324183860|FG003|Overall Study|Death|2|||
94652068|NCT03296696|324183861|FG004|Overall Study|Death|2|||
94652069|NCT03296696|324183862|FG005|Overall Study|Death|3|||
94652070|NCT03296696|324183863|FG006|Overall Study|Death|1|||
94652071|NCT03296696|324183864|FG007|Overall Study|Death|2|||
94652072|NCT03296696|324183865|FG008|Overall Study|Death|0|||
94652073|NCT03296696|324183866|FG009|Overall Study|Death|0|||
94652074|NCT03296696|324183857|FG000|Overall Study|Withdrawal by Subject|0|||
94652075|NCT03296696|324183858|FG001|Overall Study|Withdrawal by Subject|0|||
94265844|NCT01674712|322766778|FG002|Overall Study|Administrative|0|||
94265845|NCT01674712|322766779|FG003|Overall Study|Administrative|0|||
94265846|NCT01674712|322766780|FG004|Overall Study|Administrative|1|||
94265847|NCT01674712|322766776|FG000|Overall Study|Lack of Efficacy|0|||
94265848|NCT01674712|322766777|FG001|Overall Study|Lack of Efficacy|0|||
94265849|NCT01674712|322766778|FG002|Overall Study|Lack of Efficacy|1|||
94265850|NCT01674712|322766779|FG003|Overall Study|Lack of Efficacy|0|||
94466155|NCT00114738|323496947|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
94466156|NCT00114738|323496945|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
94466157|NCT00114738|323496946|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
94466158|NCT00114738|323496947|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
94466159|NCT00114738|323496945|FG000|Screening for Randomization|Neuropathy|17|||
94466160|NCT00114738|323496946|FG001|Screening for Randomization|Neuropathy|0|||
94466161|NCT00114738|323496947|FG002|Screening for Randomization|Neuropathy|0|||
94466162|NCT00114738|323496945|FG000|Screening for Randomization|Progressive disease|2|||
94466163|NCT00114738|323496946|FG001|Screening for Randomization|Progressive disease|0|||
94466164|NCT00114738|323496947|FG002|Screening for Randomization|Progressive disease|0|||
94466165|NCT00114738|323496945|FG000|Screening for Randomization|CNS Hemorrhage|1|||
94466166|NCT00114738|323496946|FG001|Screening for Randomization|CNS Hemorrhage|0|||
94466167|NCT00114738|323496947|FG002|Screening for Randomization|CNS Hemorrhage|0|||
94466168|NCT00114738|323496945|FG000|Screening for Randomization|Other|1|||
94466169|NCT00114738|323496946|FG001|Screening for Randomization|Other|0|||
94466170|NCT00114738|323496947|FG002|Screening for Randomization|Other|0|||
94466171|NCT00308750|323496948|FG000|Overall Study|Adverse Event|9|||
94466172|NCT00308750|323496949|FG001|Overall Study|Adverse Event|9|||
94466173|NCT00308750|323496950|FG002|Overall Study|Adverse Event|13|||
94466174|NCT00308750|323496948|FG000|Overall Study|Withdrawal by Subject|6|||
94466175|NCT00308750|323496949|FG001|Overall Study|Withdrawal by Subject|2|||
94466176|NCT00308750|323496950|FG002|Overall Study|Withdrawal by Subject|3|||
94466177|NCT00308750|323496948|FG000|Overall Study|Physician Decision|3|||
94466178|NCT00308750|323496949|FG001|Overall Study|Physician Decision|4|||
94466179|NCT00308750|323496950|FG002|Overall Study|Physician Decision|3|||
94466180|NCT00308750|323496948|FG000|Overall Study|Sponsor Decision|1|||
94466181|NCT00308750|323496949|FG001|Overall Study|Sponsor Decision|0|||
94466182|NCT00308750|323496950|FG002|Overall Study|Sponsor Decision|0|||
94466183|NCT00308750|323496948|FG000|Overall Study|Disease Progression|47|||
94466184|NCT00308750|323496949|FG001|Overall Study|Disease Progression|24|||
94466185|NCT00308750|323496950|FG002|Overall Study|Disease Progression|28|||
94652076|NCT03296696|324183859|FG002|Overall Study|Withdrawal by Subject|1|||
94652077|NCT03296696|324183860|FG003|Overall Study|Withdrawal by Subject|0|||
94652078|NCT03296696|324183861|FG004|Overall Study|Withdrawal by Subject|1|||
94652079|NCT03296696|324183862|FG005|Overall Study|Withdrawal by Subject|0|||
94652080|NCT03296696|324183863|FG006|Overall Study|Withdrawal by Subject|0|||
94652081|NCT03296696|324183864|FG007|Overall Study|Withdrawal by Subject|0|||
94652082|NCT03296696|324183865|FG008|Overall Study|Withdrawal by Subject|0|||
94652083|NCT03296696|324183866|FG009|Overall Study|Withdrawal by Subject|1|||
94652084|NCT04456699|324183867|FG000|Overall Study|Death|48|||
94652085|NCT04456699|324183868|FG001|Overall Study|Death|50|||
94652086|NCT04456699|324183869|FG002|Overall Study|Death|52|||
94652087|NCT04456699|324183867|FG000|Overall Study|Physician Decision|0|||
94652088|NCT04456699|324183868|FG001|Overall Study|Physician Decision|0|||
94652089|NCT04456699|324183869|FG002|Overall Study|Physician Decision|2|||
94652090|NCT04456699|324183867|FG000|Overall Study|Sponsor Decision|55|||
94652091|NCT04456699|324183868|FG001|Overall Study|Sponsor Decision|61|||
94652092|NCT04456699|324183869|FG002|Overall Study|Sponsor Decision|50|||
94652093|NCT04456699|324183867|FG000|Overall Study|Withdrawal by Subject|8|||
94652094|NCT04456699|324183868|FG001|Overall Study|Withdrawal by Subject|4|||
94652095|NCT04456699|324183869|FG002|Overall Study|Withdrawal by Subject|5|||
94652096|NCT02047110|324183872|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
94652097|NCT02047110|324183873|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
94652098|NCT02047110|324183874|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
94652099|NCT02047110|324183875|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
94652100|NCT02047110|324183872|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
94652101|NCT02047110|324183873|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
94652102|NCT02047110|324183874|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
94652103|NCT02047110|324183875|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
94652104|NCT02047110|324183872|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
94652105|NCT02047110|324183873|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
94652106|NCT02047110|324183874|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
94652107|NCT02047110|324183875|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
94652108|NCT02047110|324183872|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
94652109|NCT02047110|324183873|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
94652110|NCT02047110|324183874|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
94652111|NCT02047110|324183875|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
94652112|NCT02047110|324183872|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
94652113|NCT02047110|324183873|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
94466186|NCT00308750|323496948|FG000|Overall Study|Unrelated Complication|3|||
94466187|NCT00308750|323496949|FG001|Overall Study|Unrelated Complication|0|||
94466188|NCT00308750|323496950|FG002|Overall Study|Unrelated Complication|1|||
94466189|NCT00308750|323496948|FG000|Overall Study|Death|1|||
94466190|NCT00308750|323496949|FG001|Overall Study|Death|0|||
94466191|NCT00308750|323496950|FG002|Overall Study|Death|1|||
94466192|NCT00308750|323496948|FG000|Overall Study|Protocol Violation|1|||
94466193|NCT00308750|323496949|FG001|Overall Study|Protocol Violation|0|||
94466194|NCT00308750|323496950|FG002|Overall Study|Protocol Violation|0|||
94466195|NCT00308750|323496948|FG000|Overall Study|New Primary Disease Identified|1|||
94466196|NCT00308750|323496949|FG001|Overall Study|New Primary Disease Identified|1|||
94466197|NCT00308750|323496950|FG002|Overall Study|New Primary Disease Identified|0|||
94466198|NCT01358578|323496951|FG000|Induction Period|Adverse Event|2|||
94466199|NCT01358578|323496952|FG001|Induction Period|Adverse Event|4|||
94701788|NCT00941031|324365601|FG006|Maintenance Period|Adverse Event|8|||
94701789|NCT00941031|324365595|FG000|Maintenance Period|Lost to Follow-up|0|||
94701790|NCT00941031|324365596|FG001|Maintenance Period|Lost to Follow-up|0|||
94701791|NCT00941031|324365597|FG002|Maintenance Period|Lost to Follow-up|0|||
94701792|NCT00941031|324365598|FG003|Maintenance Period|Lost to Follow-up|0|||
94701793|NCT00941031|324365599|FG004|Maintenance Period|Lost to Follow-up|2|||
94701794|NCT00941031|324365600|FG005|Maintenance Period|Lost to Follow-up|2|||
94701795|NCT00941031|324365601|FG006|Maintenance Period|Lost to Follow-up|7|||
94701796|NCT00941031|324365595|FG000|Maintenance Period|Lack of Efficacy|0|||
94701797|NCT00941031|324365596|FG001|Maintenance Period|Lack of Efficacy|0|||
94701798|NCT00941031|324365597|FG002|Maintenance Period|Lack of Efficacy|0|||
94701799|NCT00941031|324365598|FG003|Maintenance Period|Lack of Efficacy|0|||
94701800|NCT00941031|324365599|FG004|Maintenance Period|Lack of Efficacy|0|||
94701801|NCT00941031|324365600|FG005|Maintenance Period|Lack of Efficacy|0|||
94701802|NCT00941031|324365601|FG006|Maintenance Period|Lack of Efficacy|13|||
94701803|NCT01190150|324365602|FG000|First Treatment|Withdrawal by Subject|1|||
94701804|NCT01190150|324365603|FG001|First Treatment|Withdrawal by Subject|0|||
94701805|NCT01190150|324365602|FG000|Washout|Withdrawal by Subject|0|||
94701806|NCT01190150|324365603|FG001|Washout|Withdrawal by Subject|1|||
94701807|NCT01190150|324365602|FG000|Washout|Difficulty in adherence|0|||
94701808|NCT01190150|324365603|FG001|Washout|Difficulty in adherence|1|||
94701809|NCT04511650|324365606|FG000|Overall Study|Lost to Follow-up|1|||
94701810|NCT04511650|324365607|FG001|Overall Study|Lost to Follow-up|0|||
94701811|NCT04511650|324365608|FG002|Overall Study|Lost to Follow-up|0|||
94701812|NCT04511650|324365606|FG000|Overall Study|Withdrawal by Subject|1|||
94701813|NCT04511650|324365607|FG001|Overall Study|Withdrawal by Subject|0|||
94701814|NCT04511650|324365608|FG002|Overall Study|Withdrawal by Subject|0|||
94701815|NCT04511650|324365606|FG000|Overall Study|reason not provided|0|||
94701816|NCT04511650|324365607|FG001|Overall Study|reason not provided|0|||
94701817|NCT04511650|324365608|FG002|Overall Study|reason not provided|1|||
94701818|NCT04511650|324365606|FG000|Overall Study|Death|1|||
94701819|NCT04511650|324365607|FG001|Overall Study|Death|1|||
94701820|NCT04511650|324365608|FG002|Overall Study|Death|1|||
94701821|NCT03601507|324365609|FG000|Overall Study|Adverse Event|1|||
94701822|NCT03971357|324365613|FG000|Overall Study|Lack of Efficacy|0|||
94701823|NCT03971357|324365614|FG001|Overall Study|Lack of Efficacy|1|||
94701824|NCT00124982|324365615|FG000|Short-term Period|Death|1|||
94701825|NCT00124982|324365616|FG001|Short-term Period|Death|1|||
94701826|NCT00124982|324365617|FG002|Short-term Period|Death|0|||
94701827|NCT00124982|324365615|FG000|Short-term Period|Adverse Event|17|||
94701828|NCT00124982|324365616|FG001|Short-term Period|Adverse Event|22|||
94701829|NCT00124982|324365617|FG002|Short-term Period|Adverse Event|0|||
94701830|NCT00124982|324365615|FG000|Short-term Period|Lack of Efficacy|32|||
94701831|NCT00124982|324365616|FG001|Short-term Period|Lack of Efficacy|73|||
94701832|NCT00124982|324365617|FG002|Short-term Period|Lack of Efficacy|0|||
94701833|NCT00124982|324365615|FG000|Short-term Period|Lost to Follow-up|8|||
94466200|NCT01358578|323496953|FG002|Induction Period|Adverse Event|2|||
94701834|NCT00124982|324365616|FG001|Short-term Period|Lost to Follow-up|5|||
94701835|NCT00124982|324365617|FG002|Short-term Period|Lost to Follow-up|0|||
94701836|NCT00124982|324365615|FG000|Short-term Period|Withdrawal of Consent|7|||
94701837|NCT00124982|324365616|FG001|Short-term Period|Withdrawal of Consent|9|||
94466201|NCT01358578|323496954|FG003|Induction Period|Adverse Event|6|||
94466202|NCT01358578|323496955|FG004|Induction Period|Adverse Event|0|||
94701838|NCT00124982|324365617|FG002|Short-term Period|Withdrawal of Consent|0|||
94701839|NCT00124982|324365615|FG000|Short-term Period|Poor/Non-compliance|3|||
94701840|NCT00124982|324365616|FG001|Short-term Period|Poor/Non-compliance|1|||
94701841|NCT00124982|324365617|FG002|Short-term Period|Poor/Non-compliance|0|||
94701842|NCT00124982|324365615|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
94701843|NCT00124982|324365616|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
94701844|NCT00124982|324365617|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
94701845|NCT00124982|324365615|FG000|Short-term Period|Participant Decision|1|||
94701846|NCT00124982|324365616|FG001|Short-term Period|Participant Decision|0|||
94701847|NCT00124982|324365617|FG002|Short-term Period|Participant Decision|0|||
94701848|NCT00124982|324365615|FG000|Short-term Period|Participant Chose Own Doctor|0|||
94701849|NCT00124982|324365616|FG001|Short-term Period|Participant Chose Own Doctor|1|||
94701850|NCT00124982|324365617|FG002|Short-term Period|Participant Chose Own Doctor|0|||
94701851|NCT00124982|324365615|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
94701852|NCT00124982|324365616|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
94701853|NCT00124982|324365617|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
94701854|NCT00124982|324365615|FG000|Short-term Period|Participant Had Lymphopenia|1|||
94701855|NCT00124982|324365616|FG001|Short-term Period|Participant Had Lymphopenia|0|||
94701856|NCT00124982|324365617|FG002|Short-term Period|Participant Had Lymphopenia|0|||
94701857|NCT00124982|324365615|FG000|Long-term Period|Death|0|||
94701858|NCT00124982|324365616|FG001|Long-term Period|Death|0|||
94701859|NCT00124982|324365617|FG002|Long-term Period|Death|1|||
94701860|NCT00124982|324365615|FG000|Long-term Period|Adverse Event|0|||
94701861|NCT00124982|324365616|FG001|Long-term Period|Adverse Event|0|||
94701862|NCT00124982|324365617|FG002|Long-term Period|Adverse Event|17|||
94701863|NCT00124982|324365615|FG000|Long-term Period|Lack of Efficacy|0|||
94701864|NCT00124982|324365616|FG001|Long-term Period|Lack of Efficacy|0|||
94701865|NCT00124982|324365617|FG002|Long-term Period|Lack of Efficacy|46|||
94701866|NCT00124982|324365615|FG000|Long-term Period|Lost to Follow-up|0|||
94701867|NCT00124982|324365616|FG001|Long-term Period|Lost to Follow-up|0|||
94701868|NCT00124982|324365617|FG002|Long-term Period|Lost to Follow-up|4|||
94701869|NCT00124982|324365615|FG000|Long-term Period|Withdrawal by Subject|0|||
94701870|NCT00124982|324365616|FG001|Long-term Period|Withdrawal by Subject|0|||
94701871|NCT00124982|324365617|FG002|Long-term Period|Withdrawal by Subject|16|||
94701872|NCT00124982|324365615|FG000|Long-term Period|Pregnancy|0|||
94701873|NCT00124982|324365616|FG001|Long-term Period|Pregnancy|0|||
94701874|NCT00124982|324365617|FG002|Long-term Period|Pregnancy|1|||
94701875|NCT00124982|324365615|FG000|Long-term Period|Poor/Non-compliance|0|||
94701876|NCT00124982|324365616|FG001|Long-term Period|Poor/Non-compliance|0|||
94701877|NCT00124982|324365617|FG002|Long-term Period|Poor/Non-compliance|2|||
94701878|NCT00124982|324365615|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
94701879|NCT00124982|324365616|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
94701880|NCT00124982|324365617|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
94701881|NCT00124982|324365615|FG000|Long-term Period|Neurologist Recommendation|0|||
94701882|NCT00124982|324365616|FG001|Long-term Period|Neurologist Recommendation|0|||
94701883|NCT00124982|324365617|FG002|Long-term Period|Neurologist Recommendation|1|||
94701884|NCT03102242|324365622|FG000|Overall Study|Adverse Event|2|||
94701885|NCT01137292|324365625|FG000|Overall Study|Death|30|||
94701886|NCT01137292|324365625|FG000|Overall Study|Adverse Event|3|||
94701887|NCT01137292|324365625|FG000|Overall Study|Lack of Efficacy|13|||
94701888|NCT01137292|324365625|FG000|Overall Study|Lost to Follow-up|1|||
94701889|NCT01137292|324365625|FG000|Overall Study|Other|7|||
94701890|NCT01311713|324365630|FG000|Overall Study|Death|0|||
94701891|NCT01311713|324365631|FG001|Overall Study|Death|0|||
94701892|NCT01311713|324365632|FG002|Overall Study|Death|1|||
94701893|NCT01311713|324365633|FG003|Overall Study|Death|1|||
94701894|NCT01311713|324365634|FG004|Overall Study|Death|0|||
94701895|NCT01311713|324365635|FG005|Overall Study|Death|1|||
94701896|NCT01311713|324365636|FG006|Overall Study|Death|0|||
94701897|NCT01311713|324365630|FG000|Overall Study|Adverse Event|0|||
94701898|NCT01311713|324365631|FG001|Overall Study|Adverse Event|1|||
94701899|NCT01311713|324365632|FG002|Overall Study|Adverse Event|0|||
94701900|NCT01311713|324365633|FG003|Overall Study|Adverse Event|2|||
94701901|NCT01311713|324365634|FG004|Overall Study|Adverse Event|0|||
94701902|NCT01311713|324365635|FG005|Overall Study|Adverse Event|0|||
94701903|NCT01311713|324365636|FG006|Overall Study|Adverse Event|2|||
94701904|NCT01311713|324365630|FG000|Overall Study|Withdrawal by Subject|0|||
94701905|NCT01311713|324365631|FG001|Overall Study|Withdrawal by Subject|1|||
94701906|NCT01311713|324365632|FG002|Overall Study|Withdrawal by Subject|1|||
94701907|NCT01311713|324365633|FG003|Overall Study|Withdrawal by Subject|0|||
94701908|NCT01311713|324365634|FG004|Overall Study|Withdrawal by Subject|0|||
94701909|NCT01311713|324365635|FG005|Overall Study|Withdrawal by Subject|1|||
94701910|NCT01311713|324365636|FG006|Overall Study|Withdrawal by Subject|2|||
94701911|NCT01311713|324365630|FG000|Overall Study|Disease progression|3|||
94701912|NCT01311713|324365631|FG001|Overall Study|Disease progression|4|||
94701913|NCT01311713|324365632|FG002|Overall Study|Disease progression|3|||
94701914|NCT01311713|324365633|FG003|Overall Study|Disease progression|2|||
94701915|NCT01311713|324365634|FG004|Overall Study|Disease progression|4|||
94701916|NCT01311713|324365635|FG005|Overall Study|Disease progression|4|||
94701917|NCT01311713|324365636|FG006|Overall Study|Disease progression|5|||
94701918|NCT01311713|324365630|FG000|Overall Study|Lost to Follow-up|0|||
94701919|NCT01311713|324365631|FG001|Overall Study|Lost to Follow-up|0|||
94701920|NCT01311713|324365632|FG002|Overall Study|Lost to Follow-up|1|||
94701921|NCT01311713|324365633|FG003|Overall Study|Lost to Follow-up|0|||
94701922|NCT01311713|324365634|FG004|Overall Study|Lost to Follow-up|0|||
94701923|NCT01311713|324365635|FG005|Overall Study|Lost to Follow-up|0|||
94701924|NCT01311713|324365636|FG006|Overall Study|Lost to Follow-up|0|||
94701925|NCT01311713|324365630|FG000|Overall Study|Stopped taking study medication|0|||
94701926|NCT01311713|324365631|FG001|Overall Study|Stopped taking study medication|0|||
94701927|NCT01311713|324365632|FG002|Overall Study|Stopped taking study medication|0|||
94701928|NCT01311713|324365633|FG003|Overall Study|Stopped taking study medication|1|||
94701929|NCT01311713|324365634|FG004|Overall Study|Stopped taking study medication|1|||
94701930|NCT01311713|324365635|FG005|Overall Study|Stopped taking study medication|0|||
94701931|NCT01311713|324365636|FG006|Overall Study|Stopped taking study medication|0|||
94701932|NCT01311713|324365630|FG000|Overall Study|Enrolled but not treated|0|||
94701933|NCT01311713|324365631|FG001|Overall Study|Enrolled but not treated|0|||
94701934|NCT01311713|324365632|FG002|Overall Study|Enrolled but not treated|1|||
94701935|NCT01311713|324365633|FG003|Overall Study|Enrolled but not treated|0|||
94701936|NCT01311713|324365634|FG004|Overall Study|Enrolled but not treated|0|||
94701937|NCT01311713|324365635|FG005|Overall Study|Enrolled but not treated|0|||
94701938|NCT01311713|324365636|FG006|Overall Study|Enrolled but not treated|0|||
94701939|NCT01311713|324365630|FG000|Overall Study|Other than specified|0|||
94701940|NCT01311713|324365631|FG001|Overall Study|Other than specified|1|||
94265851|NCT01674712|322766780|FG004|Overall Study|Lack of Efficacy|1|||
94265852|NCT01438151|322766783|FG000|Overall Study|study terminated|8|||
94265853|NCT01886313|322766787|FG000|Overall Study|Adverse Event|1|||
94265854|NCT01886313|322766788|FG001|Overall Study|Adverse Event|1|||
94265855|NCT00006392|322766790|FG000|Overall Study|Ineligible|11|||
94466203|NCT01358578|323496956|FG005|Induction Period|Adverse Event|0|||
94466204|NCT01358578|323496951|FG000|Induction Period|Lack of Efficacy|0|||
94466205|NCT01358578|323496952|FG001|Induction Period|Lack of Efficacy|0|||
94466206|NCT01358578|323496953|FG002|Induction Period|Lack of Efficacy|9|||
94466207|NCT01358578|323496954|FG003|Induction Period|Lack of Efficacy|1|||
94466208|NCT01358578|323496955|FG004|Induction Period|Lack of Efficacy|0|||
94265856|NCT00006392|322766791|FG001|Overall Study|Ineligible|3|||
94265857|NCT00006392|322766792|FG002|Overall Study|Ineligible|5|||
94265858|NCT00006392|322766793|FG003|Overall Study|Ineligible|5|||
94265859|NCT00006392|322766790|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
94466209|NCT01358578|323496956|FG005|Induction Period|Lack of Efficacy|0|||
94466210|NCT01358578|323496951|FG000|Induction Period|Lost to Follow-up|0|||
94466211|NCT01358578|323496952|FG001|Induction Period|Lost to Follow-up|0|||
94466212|NCT01358578|323496953|FG002|Induction Period|Lost to Follow-up|1|||
94265860|NCT00006392|322766791|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
94265861|NCT00006392|322766792|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
94466213|NCT01358578|323496954|FG003|Induction Period|Lost to Follow-up|4|||
94466214|NCT01358578|323496955|FG004|Induction Period|Lost to Follow-up|0|||
94466215|NCT01358578|323496956|FG005|Induction Period|Lost to Follow-up|0|||
94466216|NCT01358578|323496951|FG000|Induction Period|Physician Decision|2|||
94466217|NCT01358578|323496952|FG001|Induction Period|Physician Decision|1|||
94466218|NCT01358578|323496953|FG002|Induction Period|Physician Decision|2|||
94466219|NCT01358578|323496954|FG003|Induction Period|Physician Decision|0|||
94466220|NCT01358578|323496955|FG004|Induction Period|Physician Decision|0|||
94652114|NCT02047110|324183874|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
94652115|NCT02047110|324183875|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
94652116|NCT02047110|324183872|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
94652117|NCT02047110|324183873|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
94652118|NCT02047110|324183874|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
94652119|NCT02047110|324183875|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
94652120|NCT02047110|324183872|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
94652121|NCT02047110|324183873|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
94652122|NCT02047110|324183874|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
94652123|NCT02047110|324183875|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
94652124|NCT02047110|324183872|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
94652125|NCT02047110|324183873|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
94652126|NCT02047110|324183874|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
94652127|NCT02047110|324183875|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
94652128|NCT02047110|324183872|FG000|Escape Treatment Period|Adverse Event|1|||
94701941|NCT01311713|324365632|FG002|Overall Study|Other than specified|2|||
94701942|NCT01311713|324365633|FG003|Overall Study|Other than specified|0|||
94701943|NCT01311713|324365634|FG004|Overall Study|Other than specified|0|||
94701944|NCT01311713|324365635|FG005|Overall Study|Other than specified|0|||
94701945|NCT01311713|324365636|FG006|Overall Study|Other than specified|0|||
94701946|NCT01981356|324365637|FG000|Overall Study|Lost to Follow-up|4|||
94701947|NCT01981356|324365638|FG001|Overall Study|Lost to Follow-up|1|||
94701948|NCT01981356|324365637|FG000|Overall Study|Withdrawal by Subject|1|||
94701949|NCT01981356|324365638|FG001|Overall Study|Withdrawal by Subject|1|||
94701950|NCT01981356|324365637|FG000|Overall Study|Protocol Violation|2|||
94701951|NCT01981356|324365638|FG001|Overall Study|Protocol Violation|0|||
94701952|NCT04248829|324365639|FG000|Overall Study|Disease progression|44|||
94701953|NCT04248829|324365640|FG001|Overall Study|Disease progression|109|||
94701954|NCT04248829|324365639|FG000|Overall Study|Adverse Event|19|||
94701955|NCT04248829|324365640|FG001|Overall Study|Adverse Event|18|||
94701956|NCT04248829|324365639|FG000|Overall Study|Withdrawal by Subject|11|||
94701957|NCT04248829|324365640|FG001|Overall Study|Withdrawal by Subject|2|||
94701958|NCT04248829|324365639|FG000|Overall Study|Lost to Follow-up|0|||
94701959|NCT04248829|324365640|FG001|Overall Study|Lost to Follow-up|1|||
94701960|NCT04248829|324365639|FG000|Overall Study|Death|12|||
94701961|NCT04248829|324365640|FG001|Overall Study|Death|14|||
94701962|NCT04248829|324365639|FG000|Overall Study|Physician Decision|2|||
94701963|NCT04248829|324365640|FG001|Overall Study|Physician Decision|4|||
94701964|NCT04248829|324365639|FG000|Overall Study|Any reason not specifically recorded|0|||
94701965|NCT04248829|324365640|FG001|Overall Study|Any reason not specifically recorded|2|||
94701966|NCT02931396|324365641|FG000|Overall Study|Lost to Follow-up|3|||
94701967|NCT02931396|324365642|FG001|Overall Study|Lost to Follow-up|0|||
94701968|NCT02931396|324365641|FG000|Overall Study|Withdrawal by Subject|2|||
94701969|NCT02931396|324365642|FG001|Overall Study|Withdrawal by Subject|0|||
94701970|NCT05460663|324365643|FG000|Overall Study|Withdrawal by Subject|2|||
94701971|NCT05460663|324365644|FG001|Overall Study|Withdrawal by Subject|5|||
94701972|NCT02013037|324365647|FG000|Overall Study|Death|6|||
94701973|NCT02013037|324365647|FG000|Overall Study|Withdrawal by Subject|1|||
94701974|NCT02013037|324365647|FG000|Overall Study|Awaiting Transplantation|7|||
94701975|NCT02013037|324365647|FG000|Overall Study|Transplanted without DSA|2|||
94701976|NCT01867580|324365648|FG000|Overall Study|Withdrawal by Subject|2|||
94701977|NCT01867580|324365649|FG001|Overall Study|Withdrawal by Subject|3|||
94701978|NCT01867580|324365648|FG000|Overall Study|Physician Decision|17|||
94701979|NCT01867580|324365649|FG001|Overall Study|Physician Decision|12|||
94701980|NCT01867580|324365648|FG000|Overall Study|Lost to Follow-up|3|||
94701981|NCT01867580|324365649|FG001|Overall Study|Lost to Follow-up|5|||
94701982|NCT01867580|324365648|FG000|Overall Study|Sponsor terminated study|1|||
94701983|NCT01867580|324365649|FG001|Overall Study|Sponsor terminated study|0|||
94701984|NCT01867580|324365648|FG000|Overall Study|Missed follow-up assessment|2|||
94701985|NCT01867580|324365649|FG001|Overall Study|Missed follow-up assessment|1|||
94701986|NCT01867580|324365648|FG000|Overall Study|Interruption to therapy|3|||
94701987|NCT01867580|324365649|FG001|Overall Study|Interruption to therapy|0|||
94701988|NCT01867580|324365648|FG000|Overall Study|Osteomyelitis|0|||
94701989|NCT01867580|324365649|FG001|Overall Study|Osteomyelitis|1|||
94701990|NCT01867580|324365648|FG000|Overall Study|Continuation of therapy|0|||
94701991|NCT01867580|324365649|FG001|Overall Study|Continuation of therapy|1|||
94701992|NCT01867580|324365648|FG000|Overall Study|Wound recurrence|0|||
94701993|NCT01867580|324365649|FG001|Overall Study|Wound recurrence|1|||
94701994|NCT01304147|324365650|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
94701995|NCT01304147|324365651|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
94701996|NCT00708097|324365652|FG000|Period 1|Protocol Violation|0|||
94701997|NCT00708097|324365653|FG001|Period 1|Protocol Violation|1|||
94701998|NCT00708097|324365654|FG002|Period 1|Protocol Violation|0|||
94701999|NCT00708097|324365655|FG003|Period 1|Protocol Violation|2|||
94702000|NCT00708097|324365656|FG004|Period 1|Protocol Violation|0|||
94702001|NCT00708097|324365652|FG000|Period 1|Other Reason|0|||
94265862|NCT00006392|322766793|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
94366527|NCT05166512|323126563|FG000|4 Month Data Collection|Lost to Follow-up|1|||
94366528|NCT05166512|323126564|FG001|4 Month Data Collection|Lost to Follow-up|0|||
94265863|NCT02459769|322766797|FG000|Overall Study|Withdrawal by Subject|7|||
94265864|NCT02459769|322766798|FG001|Overall Study|Withdrawal by Subject|4|||
94265865|NCT02459769|322766799|FG002|Overall Study|Withdrawal by Subject|8|||
94265866|NCT02459769|322766800|FG003|Overall Study|Withdrawal by Subject|5|||
94265867|NCT02459769|322766797|FG000|Overall Study|Lost to Follow-up|1|||
94265868|NCT02459769|322766798|FG001|Overall Study|Lost to Follow-up|0|||
94265869|NCT02459769|322766799|FG002|Overall Study|Lost to Follow-up|1|||
94265870|NCT02459769|322766800|FG003|Overall Study|Lost to Follow-up|0|||
94265871|NCT03838198|322766801|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
94366529|NCT05166512|323126563|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
94702002|NCT00708097|324365653|FG001|Period 1|Other Reason|0|||
94702003|NCT00708097|324365654|FG002|Period 1|Other Reason|0|||
94702004|NCT00708097|324365655|FG003|Period 1|Other Reason|0|||
94702005|NCT00708097|324365656|FG004|Period 1|Other Reason|1|||
94702006|NCT00708097|324365652|FG000|Period 2|Protocol Violation|0|||
94702007|NCT00708097|324365653|FG001|Period 2|Protocol Violation|1|||
94702008|NCT00708097|324365654|FG002|Period 2|Protocol Violation|1|||
94702009|NCT00708097|324365655|FG003|Period 2|Protocol Violation|1|||
94702010|NCT00708097|324365656|FG004|Period 2|Protocol Violation|0|||
94702011|NCT00798265|324365657|FG000|Overall Study|Lost to Follow-up|1|||
94702012|NCT00798265|324365658|FG001|Overall Study|Lost to Follow-up|10|||
94702013|NCT00798265|324365657|FG000|Overall Study|Study closing|7|||
94702014|NCT00798265|324365658|FG001|Overall Study|Study closing|6|||
94702015|NCT00798265|324365657|FG000|Overall Study|Withdrawal by Subject|0|||
94702016|NCT00798265|324365658|FG001|Overall Study|Withdrawal by Subject|1|||
94702017|NCT00798265|324365657|FG000|Overall Study|Screen failure|0|||
94702018|NCT00798265|324365658|FG001|Overall Study|Screen failure|1|||
94702019|NCT03613129|324367322|FG000|Pre-treatment Assessment|Protocol Violation|2|||
94702020|NCT03613129|324367323|FG001|Pre-treatment Assessment|Protocol Violation|0|||
94702021|NCT03613129|324367324|FG002|Pre-treatment Assessment|Protocol Violation|0|||
94702022|NCT03613129|324367325|FG003|Pre-treatment Assessment|Protocol Violation|0|||
94702023|NCT03613129|324367326|FG004|Pre-treatment Assessment|Protocol Violation|0|||
94702024|NCT03613129|324367322|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
94702025|NCT03613129|324367323|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
94702026|NCT03613129|324367324|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
94702027|NCT03613129|324367325|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
94702028|NCT03613129|324367326|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
94702029|NCT01838200|324367329|FG000|Overall Study|Adverse Event|0|||
94265872|NCT03838198|322766802|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
94265873|NCT03838198|322766803|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
94265874|NCT03838198|322766804|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
94265875|NCT03838198|322766801|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
94265876|NCT03838198|322766802|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
94265877|NCT03838198|322766803|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
94265878|NCT03838198|322766804|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
94265879|NCT01379573|322766805|FG000|Overall Study|Lost to Follow-up|1|||
94265880|NCT01379573|322766805|FG000|Overall Study|Screen Failure|10|||
94265881|NCT00312221|322766810|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
94265882|NCT00312221|322766811|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
94265883|NCT00312221|322766812|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
94265884|NCT00312221|322766813|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
94265885|NCT00312221|322766810|FG000|Open-label Run-in Period|Adverse Event|74|||
94265886|NCT00312221|322766811|FG001|Open-label Run-in Period|Adverse Event|0|||
94265887|NCT00312221|322766812|FG002|Open-label Run-in Period|Adverse Event|0|||
94265888|NCT00312221|322766813|FG003|Open-label Run-in Period|Adverse Event|0|||
94265889|NCT00312221|322766810|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
94265890|NCT00312221|322766811|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
94265891|NCT00312221|322766812|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
94265892|NCT00312221|322766813|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
94265893|NCT00312221|322766810|FG000|Open-label Run-in Period|Administrative|42|||
94265894|NCT00312221|322766811|FG001|Open-label Run-in Period|Administrative|0|||
94265895|NCT00312221|322766812|FG002|Open-label Run-in Period|Administrative|0|||
94265896|NCT00312221|322766813|FG003|Open-label Run-in Period|Administrative|0|||
94265897|NCT00312221|322766810|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
94265898|NCT00312221|322766811|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
94265899|NCT00312221|322766812|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
94265900|NCT00312221|322766813|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
94265901|NCT00312221|322766810|FG000|Open-label Run-in Period|Did not qualify|5|||
94265902|NCT00312221|322766811|FG001|Open-label Run-in Period|Did not qualify|0|||
94265903|NCT00312221|322766812|FG002|Open-label Run-in Period|Did not qualify|0|||
94265904|NCT00312221|322766813|FG003|Open-label Run-in Period|Did not qualify|0|||
94265905|NCT00312221|322766810|FG000|Double-blind Phase|Withdrawal by Subject|0|||
94265906|NCT00312221|322766811|FG001|Double-blind Phase|Withdrawal by Subject|6|||
94265907|NCT00312221|322766812|FG002|Double-blind Phase|Withdrawal by Subject|8|||
94265908|NCT00312221|322766813|FG003|Double-blind Phase|Withdrawal by Subject|7|||
94265909|NCT00312221|322766810|FG000|Double-blind Phase|Adverse Event|0|||
94265910|NCT00312221|322766811|FG001|Double-blind Phase|Adverse Event|10|||
94265911|NCT00312221|322766812|FG002|Double-blind Phase|Adverse Event|19|||
94265912|NCT00312221|322766813|FG003|Double-blind Phase|Adverse Event|18|||
94265913|NCT00312221|322766810|FG000|Double-blind Phase|Lost to Follow-up|0|||
94265914|NCT00312221|322766811|FG001|Double-blind Phase|Lost to Follow-up|0|||
94265915|NCT00312221|322766812|FG002|Double-blind Phase|Lost to Follow-up|2|||
94265916|NCT00312221|322766813|FG003|Double-blind Phase|Lost to Follow-up|2|||
94366530|NCT05166512|323126564|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
94366531|NCT05166512|323126563|FG000|12 Month Data Collection|Lost to Follow-up|3|||
94366532|NCT05166512|323126564|FG001|12 Month Data Collection|Lost to Follow-up|1|||
94702030|NCT01838200|324367330|FG001|Overall Study|Adverse Event|2|||
94702031|NCT01838200|324367329|FG000|Overall Study|Progressive disease|3|||
94702032|NCT01838200|324367330|FG001|Overall Study|Progressive disease|0|||
94265917|NCT00312221|322766810|FG000|Double-blind Phase|Administrative|0|||
94265918|NCT00312221|322766811|FG001|Double-blind Phase|Administrative|26|||
94265919|NCT00312221|322766812|FG002|Double-blind Phase|Administrative|37|||
94265920|NCT00312221|322766813|FG003|Double-blind Phase|Administrative|33|||
94265921|NCT00312221|322766810|FG000|Double-blind Phase|Lack of Efficacy|0|||
94265922|NCT00312221|322766811|FG001|Double-blind Phase|Lack of Efficacy|17|||
94265923|NCT00312221|322766812|FG002|Double-blind Phase|Lack of Efficacy|6|||
94265924|NCT00312221|322766813|FG003|Double-blind Phase|Lack of Efficacy|10|||
94265925|NCT00770770|322766815|FG000|Overall Study|Lost to Follow-up|1|||
94265926|NCT00770770|322766816|FG001|Overall Study|Lost to Follow-up|0|||
94265927|NCT00770770|322766815|FG000|Overall Study|Withdrawal by Subject|1|||
94265928|NCT00770770|322766816|FG001|Overall Study|Withdrawal by Subject|0|||
94265929|NCT00770770|322766815|FG000|Overall Study|Death|0|||
94265930|NCT00770770|322766816|FG001|Overall Study|Death|1|||
94265931|NCT00770770|322766815|FG000|Overall Study|Study Terminated|8|||
94265932|NCT00770770|322766816|FG001|Overall Study|Study Terminated|0|||
94265933|NCT00117507|322766817|FG000|Overall Study|Adverse Event|4|||
94265934|NCT00117507|322766817|FG000|Overall Study|Abnormal laboratory values|3|||
94265935|NCT00117507|322766817|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94265936|NCT00117507|322766817|FG000|Overall Study|Patient withdrew consent|4|||
94265937|NCT00117507|322766817|FG000|Overall Study|Death|3|||
94265938|NCT01106027|322766823|FG000|Overall Study|Lost graft early, discontinued|1|||
94265939|NCT00529451|322766826|FG000|Overall Study|Subject withdrew consent|16|||
94265940|NCT00529451|322766827|FG001|Overall Study|Subject withdrew consent|21|||
94265941|NCT00529451|322766828|FG002|Overall Study|Subject withdrew consent|13|||
94265942|NCT00529451|322766829|FG003|Overall Study|Subject withdrew consent|12|||
94265943|NCT00529451|322766826|FG000|Overall Study|Adverse Event|9|||
94265944|NCT00529451|322766827|FG001|Overall Study|Adverse Event|16|||
94265945|NCT00529451|322766828|FG002|Overall Study|Adverse Event|14|||
94265946|NCT00529451|322766829|FG003|Overall Study|Adverse Event|8|||
94265947|NCT00529451|322766826|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
94265948|NCT00529451|322766827|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
94265949|NCT00529451|322766828|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
94265950|NCT00529451|322766829|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
94265951|NCT00529451|322766826|FG000|Overall Study|Lost to Follow-up|4|||
94265952|NCT00529451|322766827|FG001|Overall Study|Lost to Follow-up|7|||
94265953|NCT00529451|322766828|FG002|Overall Study|Lost to Follow-up|4|||
94265954|NCT00529451|322766829|FG003|Overall Study|Lost to Follow-up|4|||
94652129|NCT02047110|324183873|FG001|Escape Treatment Period|Adverse Event|2|||
94652130|NCT02047110|324183874|FG002|Escape Treatment Period|Adverse Event|2|||
94652131|NCT02047110|324183875|FG003|Escape Treatment Period|Adverse Event|0|||
94652132|NCT02047110|324183872|FG000|Escape Treatment Period|Other than specified|1|||
94652133|NCT02047110|324183873|FG001|Escape Treatment Period|Other than specified|2|||
94652134|NCT02047110|324183874|FG002|Escape Treatment Period|Other than specified|0|||
94652135|NCT02047110|324183875|FG003|Escape Treatment Period|Other than specified|1|||
94652136|NCT02047110|324183872|FG000|OLE Treatment Period|Other than specified|0|||
94652137|NCT02047110|324183873|FG001|OLE Treatment Period|Other than specified|0|||
94652138|NCT02047110|324183874|FG002|OLE Treatment Period|Other than specified|1|||
94652139|NCT02047110|324183875|FG003|OLE Treatment Period|Other than specified|0|||
94652140|NCT04439240|324183878|FG000|Overall Study|Ineligible|2|||
94652141|NCT04439240|324183878|FG000|Overall Study|Never started treatment|2|||
94652142|NCT04439240|324183878|FG000|Overall Study|Adverse Event|12|||
94652143|NCT04439240|324183878|FG000|Overall Study|Death|2|||
94652144|NCT04439240|324183878|FG000|Overall Study|Disease progression|25|||
94652145|NCT04439240|324183878|FG000|Overall Study|Other diseases|2|||
94652146|NCT04439240|324183878|FG000|Overall Study|Withdrawal by Subject|3|||
94652147|NCT04439240|324183878|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
94652148|NCT04439240|324183878|FG000|Overall Study|Symptomatic decline|1|||
94652149|NCT04439240|324183878|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
94652150|NCT04439240|324183878|FG000|Overall Study|Clinical progression|1|||
94652151|NCT00813124|324183880|FG000|Overall Study|Death|2|||
94652152|NCT00813124|324183880|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
94652153|NCT00813124|324183880|FG000|Overall Study|Withdrawal by Subject|1|||
94652154|NCT00767676|324183881|FG000|Overall Study|Investigator error|54|||
94652155|NCT00057746|324183884|FG000|Overall Study|Withdrawal by Subject|0|||
94652156|NCT00057746|324183885|FG001|Overall Study|Withdrawal by Subject|0|||
94652157|NCT00057746|324183886|FG002|Overall Study|Withdrawal by Subject|1|||
94652158|NCT00670228|324183887|FG000|Overall Study|Adverse Event|1|||
94652159|NCT00670228|324183888|FG001|Overall Study|Adverse Event|0|||
94652160|NCT00670228|324183887|FG000|Overall Study|Death or MACE|0|||
94652161|NCT00670228|324183888|FG001|Overall Study|Death or MACE|1|||
94652162|NCT00670228|324183887|FG000|Overall Study|Not treated|2|||
94652163|NCT00670228|324183888|FG001|Overall Study|Not treated|2|||
94652164|NCT00670228|324183887|FG000|Overall Study|Not meeting the selection criteria|2|||
94652165|NCT00670228|324183888|FG001|Overall Study|Not meeting the selection criteria|0|||
94652166|NCT04542070|324183893|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
94702033|NCT00711646|324367331|FG000|Overall Study|Adverse Event|6|||
94702034|NCT00711646|324367332|FG001|Overall Study|Adverse Event|1|||
94702035|NCT00711646|324367331|FG000|Overall Study|Withdrawal by Subject|4|||
94702036|NCT00711646|324367332|FG001|Overall Study|Withdrawal by Subject|0|||
94702037|NCT00711646|324367331|FG000|Overall Study|Protocol Violation|0|||
94702038|NCT00711646|324367332|FG001|Overall Study|Protocol Violation|1|||
94702039|NCT00711646|324367331|FG000|Overall Study|Lost to Follow-up|1|||
94702040|NCT00711646|324367332|FG001|Overall Study|Lost to Follow-up|0|||
94702041|NCT00711646|324367331|FG000|Overall Study|administrative decision|0|||
94702042|NCT00711646|324367332|FG001|Overall Study|administrative decision|1|||
94702043|NCT00711646|324367331|FG000|Overall Study|patient non-compliance|1|||
94702044|NCT00711646|324367332|FG001|Overall Study|patient non-compliance|0|||
94702045|NCT01107626|324367333|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
94702046|NCT01107626|324367334|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
94702047|NCT01107626|324367335|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
94702048|NCT01107626|324367336|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
94702049|NCT01107626|324367333|FG000|Step 1: Induction Therapy|Adverse Event|198|||
94702050|NCT01107626|324367334|FG001|Step 1: Induction Therapy|Adverse Event|0|||
94702051|NCT01107626|324367335|FG002|Step 1: Induction Therapy|Adverse Event|0|||
94702052|NCT01107626|324367336|FG003|Step 1: Induction Therapy|Adverse Event|0|||
94702053|NCT01107626|324367333|FG000|Step 1: Induction Therapy|Death|62|||
94702054|NCT01107626|324367334|FG001|Step 1: Induction Therapy|Death|0|||
94702055|NCT01107626|324367335|FG002|Step 1: Induction Therapy|Death|0|||
94702056|NCT01107626|324367336|FG003|Step 1: Induction Therapy|Death|0|||
94702057|NCT01107626|324367333|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
94702058|NCT01107626|324367334|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
94702059|NCT01107626|324367335|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
94702060|NCT01107626|324367336|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
94702061|NCT01107626|324367333|FG000|Step 1: Induction Therapy|Complicating disease|13|||
94702062|NCT01107626|324367334|FG001|Step 1: Induction Therapy|Complicating disease|0|||
94702063|NCT01107626|324367335|FG002|Step 1: Induction Therapy|Complicating disease|0|||
94702064|NCT01107626|324367336|FG003|Step 1: Induction Therapy|Complicating disease|0|||
94702065|NCT01107626|324367333|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
94702066|NCT01107626|324367334|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
94702067|NCT01107626|324367335|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
94265955|NCT00529451|322766826|FG000|Overall Study|Protocol deviation|1|||
94265956|NCT00529451|322766827|FG001|Overall Study|Protocol deviation|1|||
94265957|NCT00529451|322766828|FG002|Overall Study|Protocol deviation|4|||
94265958|NCT00529451|322766829|FG003|Overall Study|Protocol deviation|1|||
94265959|NCT00529451|322766826|FG000|Overall Study|Administrative problems|1|||
94265960|NCT00529451|322766827|FG001|Overall Study|Administrative problems|1|||
94265961|NCT00529451|322766828|FG002|Overall Study|Administrative problems|0|||
94265962|NCT00529451|322766829|FG003|Overall Study|Administrative problems|2|||
94265963|NCT01289821|322766830|FG000|Treatment Period|Withdrawal by Subject|1|||
94265964|NCT01289821|322766830|FG000|Treatment Period|Physician Decision|3|||
94265965|NCT01289821|322766830|FG000|Treatment Period|Adverse Event|4|||
94265966|NCT01289821|322766830|FG000|Treatment Period|Radiological Progression|43|||
94265967|NCT01289821|322766830|FG000|Treatment Period|Clinical Progression|2|||
94265968|NCT01289821|322766830|FG000|Treatment Period|Therapeutic procedure required|1|||
94265969|NCT01289821|322766830|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
94265970|NCT01289821|322766830|FG000|Safety Follow-up Period|Protocol Violation|3|||
94265971|NCT01289821|322766830|FG000|Safety Follow-up Period|Unspecified reason|1|||
94702068|NCT01107626|324367336|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
94702069|NCT01107626|324367333|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
94702070|NCT01107626|324367334|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
94702071|NCT01107626|324367335|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
94702072|NCT01107626|324367336|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
94702073|NCT01107626|324367333|FG000|Step 1: Induction Therapy|Non-compliance|4|||
94702074|NCT01107626|324367334|FG001|Step 1: Induction Therapy|Non-compliance|0|||
94265972|NCT01289821|322766830|FG000|Survival Follow-up Period|Protocol Violation|1|||
94702075|NCT01107626|324367335|FG002|Step 1: Induction Therapy|Non-compliance|0|||
94265973|NCT01289821|322766830|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
94265974|NCT01289821|322766830|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
94265975|NCT01294150|322766831|FG000|Overall Study|Physician Decision|2|||
94265976|NCT01294150|322766832|FG001|Overall Study|Physician Decision|2|||
94265977|NCT01010633|322766833|FG000|Overall Study|Adverse Event|1|||
94265978|NCT01010633|322766834|FG001|Overall Study|Adverse Event|1|||
94265979|NCT01010633|322766833|FG000|Overall Study|Protocol Violation|1|||
94265980|NCT01010633|322766834|FG001|Overall Study|Protocol Violation|2|||
94265981|NCT01010633|322766833|FG000|Overall Study|Withdrawal by Subject|2|||
94265982|NCT01010633|322766834|FG001|Overall Study|Withdrawal by Subject|1|||
94265983|NCT01010633|322766833|FG000|Overall Study|Investigator decision|0|||
94265984|NCT01010633|322766834|FG001|Overall Study|Investigator decision|1|||
94265985|NCT02729740|322766835|FG000|Overall Study|Early Termination|130|||
94265986|NCT02729740|322766835|FG000|Overall Study|Other|1|||
94702076|NCT01107626|324367336|FG003|Step 1: Induction Therapy|Non-compliance|0|||
94702077|NCT01107626|324367333|FG000|Step 1: Induction Therapy|Pain|4|||
94702078|NCT01107626|324367334|FG001|Step 1: Induction Therapy|Pain|0|||
94702079|NCT01107626|324367335|FG002|Step 1: Induction Therapy|Pain|0|||
94702080|NCT01107626|324367336|FG003|Step 1: Induction Therapy|Pain|0|||
94702081|NCT01107626|324367333|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
94702082|NCT01107626|324367334|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
94702083|NCT01107626|324367335|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
94702084|NCT01107626|324367336|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
94702085|NCT01107626|324367333|FG000|Step 1: Induction Therapy|Hospice care|1|||
94702086|NCT01107626|324367334|FG001|Step 1: Induction Therapy|Hospice care|0|||
94702087|NCT01107626|324367335|FG002|Step 1: Induction Therapy|Hospice care|0|||
94702088|NCT01107626|324367336|FG003|Step 1: Induction Therapy|Hospice care|0|||
94702089|NCT01107626|324367333|FG000|Step 1: Induction Therapy|Physician Decision|1|||
94702090|NCT01107626|324367334|FG001|Step 1: Induction Therapy|Physician Decision|0|||
94702091|NCT01107626|324367335|FG002|Step 1: Induction Therapy|Physician Decision|0|||
94702092|NCT01107626|324367336|FG003|Step 1: Induction Therapy|Physician Decision|0|||
94702093|NCT01107626|324367333|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
94702094|NCT01107626|324367334|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
94702095|NCT01107626|324367335|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
94702096|NCT01107626|324367336|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
94702097|NCT01107626|324367333|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
94702098|NCT01107626|324367334|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
94702099|NCT01107626|324367335|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
94702100|NCT01107626|324367336|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
94702101|NCT01107626|324367333|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
94702102|NCT01107626|324367334|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
94702103|NCT01107626|324367335|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
94702104|NCT01107626|324367336|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
94702105|NCT01107626|324367333|FG000|Step 2: Maintenance Therapy|Death|0|||
94702106|NCT01107626|324367334|FG001|Step 2: Maintenance Therapy|Death|8|||
94702107|NCT01107626|324367335|FG002|Step 2: Maintenance Therapy|Death|2|||
94702108|NCT01107626|324367336|FG003|Step 2: Maintenance Therapy|Death|13|||
94702109|NCT01107626|324367333|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
94702110|NCT01107626|324367334|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
94702111|NCT01107626|324367335|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
94702112|NCT01107626|324367336|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
94702113|NCT01107626|324367333|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
94702114|NCT01107626|324367334|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
94702115|NCT01107626|324367335|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
94702116|NCT01107626|324367336|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
94702117|NCT01107626|324367333|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
94702118|NCT01107626|324367334|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
94702119|NCT01107626|324367335|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
94702120|NCT01107626|324367336|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
94702121|NCT01107626|324367333|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
94702122|NCT01107626|324367334|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
94702123|NCT01107626|324367335|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
94702124|NCT01107626|324367336|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
94702125|NCT01107626|324367333|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
94702126|NCT01107626|324367334|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
94702127|NCT01107626|324367335|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
94702128|NCT01107626|324367336|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
94702129|NCT01107626|324367333|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
94265987|NCT00882310|322766836|FG000|Overall Study|Screen Failure|10|||
94702130|NCT01107626|324367334|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
94702131|NCT01107626|324367335|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
94702132|NCT01107626|324367336|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
94702133|NCT01107626|324367333|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
94702134|NCT01107626|324367334|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
94702135|NCT01107626|324367335|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
94702136|NCT01107626|324367336|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
94702137|NCT01107626|324367333|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
94702138|NCT01107626|324367334|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
94702139|NCT01107626|324367335|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
94702140|NCT01107626|324367336|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
94702141|NCT01107626|324367333|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
94702142|NCT01107626|324367334|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
94702143|NCT01107626|324367335|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
94702144|NCT01107626|324367336|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
94702145|NCT01107626|324367333|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
94702146|NCT01107626|324367334|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
94702147|NCT01107626|324367335|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
94702148|NCT01107626|324367336|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
94702149|NCT01107626|324367333|FG000|Step 2: Maintenance Therapy|Pain|0|||
94702150|NCT01107626|324367334|FG001|Step 2: Maintenance Therapy|Pain|0|||
94702151|NCT01107626|324367335|FG002|Step 2: Maintenance Therapy|Pain|0|||
94702152|NCT01107626|324367336|FG003|Step 2: Maintenance Therapy|Pain|1|||
94702153|NCT01107626|324367333|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
94702154|NCT01107626|324367334|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
94702155|NCT01107626|324367335|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
94702156|NCT01107626|324367336|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
94702157|NCT04148937|324367337|FG000|Overall Study|Withdrawal by Subject|0|||
94702158|NCT04148937|324367338|FG001|Overall Study|Withdrawal by Subject|0|||
94702159|NCT04148937|324367339|FG002|Overall Study|Withdrawal by Subject|0|||
94702160|NCT04148937|324367340|FG003|Overall Study|Withdrawal by Subject|1|||
94702161|NCT04148937|324367341|FG004|Overall Study|Withdrawal by Subject|0|||
94702162|NCT04148937|324367342|FG005|Overall Study|Withdrawal by Subject|1|||
94702163|NCT04148937|324367343|FG006|Overall Study|Withdrawal by Subject|1|||
94702164|NCT04148937|324367344|FG007|Overall Study|Withdrawal by Subject|0|||
94702165|NCT04148937|324367337|FG000|Overall Study|Lost to Follow-up|0|||
94702166|NCT04148937|324367338|FG001|Overall Study|Lost to Follow-up|0|||
94702167|NCT04148937|324367339|FG002|Overall Study|Lost to Follow-up|1|||
94702168|NCT04148937|324367340|FG003|Overall Study|Lost to Follow-up|0|||
94702169|NCT04148937|324367341|FG004|Overall Study|Lost to Follow-up|0|||
94702170|NCT04148937|324367342|FG005|Overall Study|Lost to Follow-up|2|||
94702171|NCT04148937|324367343|FG006|Overall Study|Lost to Follow-up|0|||
94702172|NCT04148937|324367344|FG007|Overall Study|Lost to Follow-up|0|||
94702173|NCT03357341|324367346|FG000|Overall Study|Withdrawal by Subject|3|||
94702174|NCT03357341|324367347|FG001|Overall Study|Withdrawal by Subject|6|||
94702175|NCT03357341|324367346|FG000|Overall Study|Lost to Follow-up|4|||
94702176|NCT03357341|324367347|FG001|Overall Study|Lost to Follow-up|5|||
94702177|NCT03357341|324367346|FG000|Overall Study|Death|0|||
94702178|NCT03357341|324367347|FG001|Overall Study|Death|1|||
94702179|NCT03635112|324367348|FG000|Overall Study|Adverse Event|5|||
94702180|NCT03635112|324367349|FG001|Overall Study|Adverse Event|9|||
94702181|NCT03635112|324367350|FG002|Overall Study|Adverse Event|14|||
94702182|NCT03635112|324367348|FG000|Overall Study|Lost to Follow-up|1|||
94702183|NCT03635112|324367349|FG001|Overall Study|Lost to Follow-up|0|||
94702184|NCT03635112|324367350|FG002|Overall Study|Lost to Follow-up|1|||
94702185|NCT03635112|324367348|FG000|Overall Study|Physician Decision|5|||
94702186|NCT03635112|324367349|FG001|Overall Study|Physician Decision|7|||
94702187|NCT03635112|324367350|FG002|Overall Study|Physician Decision|5|||
94702188|NCT03635112|324367348|FG000|Overall Study|Protocol Violation|0|||
94702189|NCT03635112|324367349|FG001|Overall Study|Protocol Violation|0|||
94702190|NCT03635112|324367350|FG002|Overall Study|Protocol Violation|1|||
94702191|NCT03635112|324367348|FG000|Overall Study|Study Terminated by Sponsor|11|||
94702192|NCT03635112|324367349|FG001|Overall Study|Study Terminated by Sponsor|17|||
94702193|NCT03635112|324367350|FG002|Overall Study|Study Terminated by Sponsor|21|||
94702194|NCT03635112|324367348|FG000|Overall Study|Withdrawal by Subject|4|||
94702195|NCT03635112|324367349|FG001|Overall Study|Withdrawal by Subject|9|||
94702196|NCT03635112|324367350|FG002|Overall Study|Withdrawal by Subject|7|||
94702197|NCT03635112|324367348|FG000|Overall Study|Miscellaneous|0|||
94265988|NCT00882310|322766836|FG000|Overall Study|Never received treatment|1|||
94265989|NCT00882310|322766836|FG000|Overall Study|Death|6|||
94265990|NCT00882310|322766836|FG000|Overall Study|Progression of disease|4|||
94702198|NCT03635112|324367349|FG001|Overall Study|Miscellaneous|0|||
94702199|NCT03635112|324367350|FG002|Overall Study|Miscellaneous|1|||
94702200|NCT01876511|324367351|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
94702201|NCT01876511|324367352|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
94702202|NCT01876511|324367353|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
94702203|NCT01876511|324367351|FG000|Overall Study|Death (unrelated)|3|||
94702204|NCT01876511|324367352|FG001|Overall Study|Death (unrelated)|0|||
94702205|NCT01876511|324367353|FG002|Overall Study|Death (unrelated)|2|||
94265991|NCT00882310|322766836|FG000|Overall Study|Adverse Event|1|||
94265992|NCT00698932|322766837|FG000|Overall Study|Adverse Event|0|||
94265993|NCT00698932|322766838|FG001|Overall Study|Adverse Event|2|||
94265994|NCT00698932|322766837|FG000|Overall Study|Incorrect enrollment|0|||
94265995|NCT00698932|322766838|FG001|Overall Study|Incorrect enrollment|2|||
94265996|NCT00698932|322766837|FG000|Overall Study|Study specific discontinuation criteria|3|||
94265997|NCT00698932|322766838|FG001|Overall Study|Study specific discontinuation criteria|4|||
94265998|NCT00698932|322766837|FG000|Overall Study|Withdrawal by Subject|11|||
94265999|NCT00698932|322766838|FG001|Overall Study|Withdrawal by Subject|23|||
94266000|NCT00698932|322766837|FG000|Overall Study|Lost to Follow-up|6|||
94266001|NCT00698932|322766838|FG001|Overall Study|Lost to Follow-up|1|||
94266002|NCT00698932|322766837|FG000|Overall Study|Severe non-compliance to protocol|1|||
94266003|NCT00698932|322766838|FG001|Overall Study|Severe non-compliance to protocol|2|||
94266004|NCT00698932|322766837|FG000|Overall Study|Safety reasons|0|||
94266005|NCT00698932|322766838|FG001|Overall Study|Safety reasons|2|||
94266006|NCT00698932|322766837|FG000|Overall Study|Death|1|||
94266007|NCT00698932|322766838|FG001|Overall Study|Death|0|||
94266008|NCT00601705|322766839|FG000|Overall Study|Withdrawal by Subject|1|||
94266009|NCT02014740|322766840|FG000|Overall Study|Lost to Follow-up|4|||
94266010|NCT02014740|322766841|FG001|Overall Study|Lost to Follow-up|4|||
94266011|NCT02014740|322766840|FG000|Overall Study|Withdrawal by Subject|2|||
94266012|NCT02014740|322766841|FG001|Overall Study|Withdrawal by Subject|1|||
94266013|NCT03346057|322766846|FG000|Overall Study|Death|1|||
94266014|NCT03346057|322766847|FG001|Overall Study|Death|2|||
94266015|NCT03346057|322766848|FG002|Overall Study|Death|0|||
94266016|NCT03346057|322766849|FG003|Overall Study|Death|0|||
94266017|NCT03346057|322766846|FG000|Overall Study|Lost to Follow-up|0|||
94266018|NCT03346057|322766847|FG001|Overall Study|Lost to Follow-up|2|||
94266019|NCT03346057|322766848|FG002|Overall Study|Lost to Follow-up|1|||
94266020|NCT03346057|322766849|FG003|Overall Study|Lost to Follow-up|0|||
94266021|NCT03346057|322766846|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
94266022|NCT03346057|322766847|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
94266023|NCT03346057|322766848|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
94266024|NCT03346057|322766849|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
94266025|NCT03346057|322766846|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
94266026|NCT03346057|322766847|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
94266027|NCT03346057|322766848|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
94266028|NCT03346057|322766849|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
94266029|NCT03346057|322766846|FG000|Overall Study|Physician Decision|3|||
94266030|NCT03346057|322766847|FG001|Overall Study|Physician Decision|2|||
94266031|NCT03346057|322766848|FG002|Overall Study|Physician Decision|0|||
94266032|NCT03346057|322766849|FG003|Overall Study|Physician Decision|2|||
94266033|NCT03346057|322766846|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
94266034|NCT03346057|322766847|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
94266035|NCT03346057|322766848|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
94266036|NCT03346057|322766849|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
94266037|NCT03346057|322766846|FG000|Overall Study|Withdrawal by Subject|1|||
94266038|NCT03346057|322766847|FG001|Overall Study|Withdrawal by Subject|0|||
94266039|NCT03346057|322766848|FG002|Overall Study|Withdrawal by Subject|0|||
94266040|NCT03346057|322766849|FG003|Overall Study|Withdrawal by Subject|0|||
94266041|NCT02003014|322766850|FG000|Overall Study|Case report forms uncollected|9|||
94266042|NCT02003014|322766850|FG000|Overall Study|Treatment started after contract period|1|||
94266043|NCT02003014|322766850|FG000|Overall Study|Patient did not visit the study site|5|||
94266044|NCT02003014|322766850|FG000|Overall Study|Investigator's transfer|4|||
94266045|NCT01159912|322766851|FG000|Overall Study|Adverse Event|2|||
94266046|NCT01159912|322766852|FG001|Overall Study|Adverse Event|2|||
94266047|NCT01159912|322766853|FG002|Overall Study|Adverse Event|3|||
94266048|NCT01159912|322766851|FG000|Overall Study|Lack of Efficacy|23|||
94266049|NCT01159912|322766852|FG001|Overall Study|Lack of Efficacy|15|||
94266050|NCT01159912|322766853|FG002|Overall Study|Lack of Efficacy|14|||
94266051|NCT01159912|322766851|FG000|Overall Study|Protocol Violation|1|||
94266052|NCT01159912|322766852|FG001|Overall Study|Protocol Violation|2|||
94266053|NCT01159912|322766853|FG002|Overall Study|Protocol Violation|3|||
94266054|NCT01159912|322766851|FG000|Overall Study|Lost to Follow-up|4|||
94266055|NCT01159912|322766852|FG001|Overall Study|Lost to Follow-up|0|||
94266056|NCT01159912|322766853|FG002|Overall Study|Lost to Follow-up|0|||
94266057|NCT01159912|322766851|FG000|Overall Study|Physician Decision|0|||
94266058|NCT01159912|322766852|FG001|Overall Study|Physician Decision|0|||
94266059|NCT01159912|322766853|FG002|Overall Study|Physician Decision|3|||
94266060|NCT01159912|322766851|FG000|Overall Study|Withdrawal by Subject|10|||
94266061|NCT01159912|322766852|FG001|Overall Study|Withdrawal by Subject|3|||
94266062|NCT01159912|322766853|FG002|Overall Study|Withdrawal by Subject|3|||
94266063|NCT00617604|322766854|FG000|Overall Study|Death|2|||
94366533|NCT05166512|323126563|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
94266064|NCT00617604|322766855|FG001|Overall Study|Death|1|||
94266065|NCT00617604|322766854|FG000|Overall Study|Lost to Follow-up|1|||
94266066|NCT00617604|322766855|FG001|Overall Study|Lost to Follow-up|0|||
94266067|NCT00617604|322766854|FG000|Overall Study|Miscellaneous Reasons|8|||
94366534|NCT05166512|323126564|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
94366535|NCT04449354|323126565|FG000|Overall Study|Withdrawal by Subject|1|||
94366536|NCT02720094|323126566|FG000|Overall Study|Scheduled exit visit/end of study|2|||
94702206|NCT01876511|324367351|FG000|Overall Study|Drug-related Toxicity|5|||
94702207|NCT01876511|324367352|FG001|Overall Study|Drug-related Toxicity|1|||
94702208|NCT01876511|324367353|FG002|Overall Study|Drug-related Toxicity|6|||
94702209|NCT01876511|324367351|FG000|Overall Study|Patient Decision|3|||
94702210|NCT01876511|324367352|FG001|Overall Study|Patient Decision|0|||
94702211|NCT01876511|324367353|FG002|Overall Study|Patient Decision|6|||
94702212|NCT01876511|324367351|FG000|Overall Study|Physician Decision|1|||
94702213|NCT01876511|324367352|FG001|Overall Study|Physician Decision|0|||
94702214|NCT01876511|324367353|FG002|Overall Study|Physician Decision|1|||
94702215|NCT01313182|324367354|FG000|Overall Study|Protocol Violation|66|||
94702216|NCT01313182|324367355|FG001|Overall Study|Protocol Violation|92|||
94702217|NCT02759731|324367356|FG000|Overall Study|Did not complete treatment.|8|||
94702218|NCT00957229|324367357|FG000|Study Start|Adverse Event|0|||
94702219|NCT00957229|324367358|FG001|Study Start|Adverse Event|3|||
94702220|NCT00957229|324367357|FG000|Study Start|Disease Progression|1|||
94702221|NCT00957229|324367358|FG001|Study Start|Disease Progression|0|||
94702222|NCT00957229|324367357|FG000|Reallocated to or Continued Vismodegib|Death|1|||
94702223|NCT00957229|324367358|FG001|Reallocated to or Continued Vismodegib|Death|1|||
94702224|NCT00957229|324367357|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
94702225|NCT00957229|324367358|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
94702226|NCT05193318|324367359|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
94702227|NCT05193318|324367359|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
94702228|NCT00828672|324367361|FG000|Study Treatment|Lost to Follow-up|1|||
94702229|NCT00828672|324367362|FG001|Study Treatment|Lost to Follow-up|0|||
94702230|NCT00828672|324367361|FG000|Study Treatment|Adverse Event|0|||
94702231|NCT00828672|324367362|FG001|Study Treatment|Adverse Event|1|||
94702232|NCT00828672|324367361|FG000|Study Treatment|Complete response, no surgery|1|||
94702233|NCT00828672|324367362|FG001|Study Treatment|Complete response, no surgery|1|||
94702234|NCT00828672|324367361|FG000|Post-surgery (<30 Days)|No central review materials|0|||
94702235|NCT00828672|324367362|FG001|Post-surgery (<30 Days)|No central review materials|1|||
94702236|NCT00015457|324367366|FG000|First Intervention|Adverse Event|0|||
94702237|NCT00015457|324367367|FG001|First Intervention|Adverse Event|2|||
94702238|NCT00015457|324367366|FG000|First Intervention|Lack of Efficacy|0|||
94702239|NCT00015457|324367367|FG001|First Intervention|Lack of Efficacy|1|||
94702240|NCT00015457|324367366|FG000|Second Intervention|Withdrawal by Subject|1|||
94702241|NCT00015457|324367367|FG001|Second Intervention|Withdrawal by Subject|0|||
94702242|NCT01250002|324367368|FG000|Overall Study|Change to open surgical procedure|4|||
94702243|NCT01250002|324367369|FG001|Overall Study|Change to open surgical procedure|3|||
94702244|NCT03095508|324367370|FG000|Overall Study|Adverse Event|0|||
94702245|NCT03095508|324367371|FG001|Overall Study|Adverse Event|1|||
94702246|NCT02317705|324367372|FG000|Overall Study|Withdrawal by Subject|3|||
94702247|NCT02317705|324367372|FG000|Overall Study|Physician Decision|1|||
94702248|NCT02317705|324367372|FG000|Overall Study|Drug not usable|1|||
94702249|NCT02219490|324367373|FG000|Overall Study|Adverse Event|24|||
94702250|NCT02219490|324367373|FG000|Overall Study|Withdrew consent|96|||
94702251|NCT02219490|324367373|FG000|Overall Study|Lost to Follow-up|126|||
94702252|NCT02219490|324367373|FG000|Overall Study|COVID-19 infection|2|||
94702253|NCT02219490|324367373|FG000|Overall Study|COVID-19 logistical restrictions|33|||
94702254|NCT02219490|324367373|FG000|Overall Study|Other, not specified|57|||
94702255|NCT02954055|324367381|FG000|Overall Study|Did not initiate therapy|6|||
94702256|NCT02954055|324367382|FG001|Overall Study|Did not initiate therapy|1|||
94702257|NCT03178201|324367385|FG000|Overall Study|Off study|5|||
94702258|NCT04555044|324367386|FG000|Overall Study|Adverse Event|0|||
94366537|NCT02720094|323126567|FG001|Overall Study|Scheduled exit visit/end of study|1|||
94366538|NCT02720094|323126566|FG000|Overall Study|Death|4|||
94366539|NCT02720094|323126567|FG001|Overall Study|Death|7|||
94366540|NCT02720094|323126566|FG000|Overall Study|Withdrawal by Subject|55|||
94366541|NCT02720094|323126567|FG001|Overall Study|Withdrawal by Subject|56|||
94702259|NCT04555044|324367387|FG001|Overall Study|Adverse Event|1|||
94702260|NCT01670019|324367393|FG000|Overall Study|Adverse Event|3|||
94702261|NCT01670019|324367394|FG001|Overall Study|Adverse Event|0|||
94702262|NCT01670019|324367393|FG000|Overall Study|Withdrawal by Subject|6|||
94702263|NCT01670019|324367394|FG001|Overall Study|Withdrawal by Subject|0|||
94366542|NCT02720094|323126566|FG000|Overall Study|Lost to Follow-up|2|||
94702264|NCT00843193|324367395|FG000|Overall Study|Adverse Event|2|||
94702265|NCT00843193|324367396|FG001|Overall Study|Adverse Event|4|||
94366543|NCT02720094|323126567|FG001|Overall Study|Lost to Follow-up|7|||
94702266|NCT00843193|324367395|FG000|Overall Study|Lack of Efficacy|1|||
94702267|NCT00843193|324367396|FG001|Overall Study|Lack of Efficacy|1|||
94702268|NCT00843193|324367395|FG000|Overall Study|Protocol Violation|1|||
94702269|NCT00843193|324367396|FG001|Overall Study|Protocol Violation|2|||
94702270|NCT00843193|324367395|FG000|Overall Study|Lost to Follow-up|1|||
94702271|NCT00843193|324367396|FG001|Overall Study|Lost to Follow-up|0|||
94702272|NCT00843193|324367395|FG000|Overall Study|Physician Decision|0|||
94702273|NCT00843193|324367396|FG001|Overall Study|Physician Decision|1|||
94702274|NCT00843193|324367395|FG000|Overall Study|Withdrawal by Subject|3|||
94702275|NCT00843193|324367396|FG001|Overall Study|Withdrawal by Subject|3|||
94702276|NCT01191788|324367399|FG000|Overall Study|Lost to Follow-up|21|||
94702277|NCT01191788|324367400|FG001|Overall Study|Lost to Follow-up|22|||
94702278|NCT03537651|324367402|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
94702279|NCT03537651|324367402|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
94702280|NCT03537651|324367402|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
94702281|NCT03537651|324367402|FG000|Part A (Up to 96 Weeks)|Other|1|||
94702282|NCT03537651|324367402|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
94702283|NCT03537651|324367402|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
94702284|NCT03537651|324367402|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
94702285|NCT03537651|324367402|FG000|Part B (Up to 192 Weeks)|Other|1|||
94702286|NCT05487703|324367403|FG000|Overall Study|Other|19|||
94702287|NCT05487703|324367403|FG000|Overall Study|Participant not well|5|||
94702288|NCT05487703|324367403|FG000|Overall Study|Insurance Reasons|6|||
94702289|NCT05487703|324367403|FG000|Overall Study|Physician Decision|19|||
94702290|NCT05487703|324367403|FG000|Overall Study|Lack of Efficacy|60|||
94702291|NCT00197236|324367407|FG000|Overall Study|Adverse Event|1|||
94702292|NCT00197236|324367408|FG001|Overall Study|Adverse Event|0|||
94702293|NCT00197236|324367409|FG002|Overall Study|Adverse Event|1|||
94702294|NCT00197236|324367407|FG000|Overall Study|Lost to Follow-up|5|||
94702295|NCT00197236|324367408|FG001|Overall Study|Lost to Follow-up|14|||
94702296|NCT00197236|324367409|FG002|Overall Study|Lost to Follow-up|6|||
94266068|NCT00617604|322766855|FG001|Overall Study|Miscellaneous Reasons|10|||
94266069|NCT00617604|322766854|FG000|Overall Study|Withdrawal by Subject|4|||
94266070|NCT00617604|322766855|FG001|Overall Study|Withdrawal by Subject|6|||
94266071|NCT00617604|322766854|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
94266072|NCT00617604|322766855|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
94266073|NCT00493220|322766856|FG000|Third Intervention|Withdrawal by Subject|1|||
94266074|NCT00493220|322766857|FG001|Third Intervention|Withdrawal by Subject|0|||
94266075|NCT00493220|322766858|FG002|Third Intervention|Withdrawal by Subject|0|||
94266076|NCT00493220|322766859|FG003|Third Intervention|Withdrawal by Subject|0|||
94266077|NCT00493220|322766860|FG004|Third Intervention|Withdrawal by Subject|0|||
94266078|NCT00493220|322766861|FG005|Third Intervention|Withdrawal by Subject|0|||
94366544|NCT02720094|323126566|FG000|Overall Study|Physician Decision|1|||
94366545|NCT02720094|323126567|FG001|Overall Study|Physician Decision|3|||
94366546|NCT02720094|323126566|FG000|Overall Study|Inappropriate enrollment|1|||
94366547|NCT02720094|323126567|FG001|Overall Study|Inappropriate enrollment|3|||
94366548|NCT02720094|323126566|FG000|Overall Study|Ongoing|2210|||
94366549|NCT02720094|323126567|FG001|Overall Study|Ongoing|2203|||
94366550|NCT02720094|323126566|FG000|Overall Study|Relocation|1|||
94366551|NCT02720094|323126567|FG001|Overall Study|Relocation|1|||
94366552|NCT04881448|323126568|FG000|Overall Study|Study cancelled by sponsor|220|||
94702297|NCT00197236|324367407|FG000|Overall Study|Protocol Violation|0|||
94702298|NCT00197236|324367408|FG001|Overall Study|Protocol Violation|0|||
94702299|NCT00197236|324367409|FG002|Overall Study|Protocol Violation|1|||
94702300|NCT00197236|324367407|FG000|Overall Study|Withdrawal by Subject|7|||
94366553|NCT04881448|323126568|FG000|Overall Study|Withdrawal by Subject|2|||
94702301|NCT00197236|324367408|FG001|Overall Study|Withdrawal by Subject|3|||
94702302|NCT00197236|324367409|FG002|Overall Study|Withdrawal by Subject|11|||
94702303|NCT00197236|324367407|FG000|Overall Study|Study drug/medication expiration|1|||
94702304|NCT00197236|324367408|FG001|Overall Study|Study drug/medication expiration|0|||
94702305|NCT00197236|324367409|FG002|Overall Study|Study drug/medication expiration|3|||
94702306|NCT00197236|324367407|FG000|Overall Study|Returned out of specified time window|0|||
94702307|NCT00197236|324367408|FG001|Overall Study|Returned out of specified time window|0|||
94702308|NCT00197236|324367409|FG002|Overall Study|Returned out of specified time window|1|||
94702309|NCT03885596|324367410|FG000|Overall Study|Withdrawal by Subject|2|||
94702310|NCT03885596|324367411|FG001|Overall Study|Withdrawal by Subject|1|||
94702311|NCT03885596|324367412|FG002|Overall Study|Withdrawal by Subject|0|||
94702312|NCT03885596|324367413|FG003|Overall Study|Withdrawal by Subject|0|||
94702313|NCT01076335|324367414|FG000|Overall Study|Withdrawal by Subject|3|||
94702314|NCT01076335|324367414|FG000|Overall Study|Withdrawal without treatment|1|||
94702315|NCT01467700|324367415|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
94702316|NCT01467700|324367416|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
94702317|NCT01467700|324367417|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
94702318|NCT01467700|324367418|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
94702319|NCT01467700|324367415|FG000|Overall Study|Major Protocol Deviation|3|||
94702320|NCT01467700|324367416|FG001|Overall Study|Major Protocol Deviation|3|||
94702321|NCT01467700|324367417|FG002|Overall Study|Major Protocol Deviation|2|||
94702322|NCT01467700|324367418|FG003|Overall Study|Major Protocol Deviation|3|||
94702323|NCT01467700|324367415|FG000|Overall Study|Lost to Follow-up|6|||
94702324|NCT01467700|324367416|FG001|Overall Study|Lost to Follow-up|5|||
94702325|NCT01467700|324367417|FG002|Overall Study|Lost to Follow-up|2|||
94702326|NCT01467700|324367418|FG003|Overall Study|Lost to Follow-up|3|||
94702327|NCT01467700|324367415|FG000|Overall Study|Voluntary Withdrawal|5|||
94702328|NCT01467700|324367416|FG001|Overall Study|Voluntary Withdrawal|7|||
94702329|NCT01467700|324367417|FG002|Overall Study|Voluntary Withdrawal|6|||
94702330|NCT01467700|324367418|FG003|Overall Study|Voluntary Withdrawal|2|||
94702331|NCT01467700|324367415|FG000|Overall Study|Study Termination|6|||
94702332|NCT01467700|324367416|FG001|Overall Study|Study Termination|5|||
94702333|NCT01467700|324367417|FG002|Overall Study|Study Termination|10|||
94702334|NCT01467700|324367418|FG003|Overall Study|Study Termination|7|||
94702335|NCT01467700|324367415|FG000|Overall Study|Pregnancy|0|||
94702336|NCT01467700|324367416|FG001|Overall Study|Pregnancy|1|||
94702337|NCT01467700|324367417|FG002|Overall Study|Pregnancy|1|||
94702338|NCT01467700|324367418|FG003|Overall Study|Pregnancy|0|||
94702339|NCT01467700|324367415|FG000|Overall Study|Lack of Efficacy|2|||
94702340|NCT01467700|324367416|FG001|Overall Study|Lack of Efficacy|0|||
94266079|NCT02568475|322766862|FG000|Overall Study|Lost to Follow-up|40|||
94702341|NCT01467700|324367417|FG002|Overall Study|Lack of Efficacy|2|||
94702342|NCT01467700|324367418|FG003|Overall Study|Lack of Efficacy|1|||
94702343|NCT01467700|324367415|FG000|Overall Study|Reason not Specified|1|||
94702344|NCT01467700|324367416|FG001|Overall Study|Reason not Specified|3|||
94702345|NCT01467700|324367417|FG002|Overall Study|Reason not Specified|2|||
94702346|NCT01467700|324367418|FG003|Overall Study|Reason not Specified|8|||
94702347|NCT01582945|324367419|FG000|Overall Study|Intolerable side-effects|1|||
94702348|NCT01582945|324367419|FG000|Overall Study|Scheduling conflicts|1|||
94702349|NCT04109118|324367420|FG000|Overall Study|Lost to Follow-up|3|||
94702350|NCT03235349|324367421|FG000|Overall Study|Adverse Event|1|||
94702351|NCT03235349|324367421|FG000|Overall Study|Other|1|||
94702352|NCT01740557|324367425|FG000|Overall Study|Ineligible|1|||
94702353|NCT01740557|324367425|FG000|Overall Study|Screen failure|1|||
94702354|NCT04305912|324367428|FG000|First Intervention|COVID-19 Suspension|2|||
94702355|NCT04305912|324367429|FG001|First Intervention|COVID-19 Suspension|0|||
94702356|NCT04305912|324367428|FG000|First Intervention|Withdrawal by Subject|0|||
94702357|NCT04305912|324367429|FG001|First Intervention|Withdrawal by Subject|1|||
94702358|NCT04305912|324367428|FG000|Second Intervention|Adverse Event|0|||
94702359|NCT04305912|324367429|FG001|Second Intervention|Adverse Event|1|||
94702360|NCT01268566|324367430|FG000|Overall Study|Lost to Follow-up|1|||
94702361|NCT01268566|324367430|FG000|Overall Study|Withdrawal by Subject|12|||
94702362|NCT01268566|324367430|FG000|Overall Study|Death|30|||
94702363|NCT02784704|324367431|FG000|Overall Study|Adverse Event|4|||
94702364|NCT02784704|324367432|FG001|Overall Study|Adverse Event|2|||
94702365|NCT02784704|324367431|FG000|Overall Study|Lost to Follow-up|6|||
94702366|NCT02784704|324367432|FG001|Overall Study|Lost to Follow-up|4|||
94702367|NCT02784704|324367431|FG000|Overall Study|Withdrawal by Subject|1|||
94702368|NCT02784704|324367432|FG001|Overall Study|Withdrawal by Subject|3|||
94702369|NCT02784704|324367431|FG000|Overall Study|Subject Non Compliance|2|||
94702370|NCT02784704|324367432|FG001|Overall Study|Subject Non Compliance|0|||
94702371|NCT01913340|324367433|FG000|Overall Study|Death|2|||
94702372|NCT01913340|324367434|FG001|Overall Study|Death|5|||
94702373|NCT01913340|324367433|FG000|Overall Study|Lost to Follow-up|1|||
94702374|NCT01913340|324367434|FG001|Overall Study|Lost to Follow-up|1|||
94702375|NCT00603538|324367435|FG000|Overall Study|Adverse Event|0|||
94702376|NCT00603538|324367436|FG001|Overall Study|Adverse Event|4|||
94702377|NCT00603538|324367437|FG002|Overall Study|Adverse Event|2|||
94702378|NCT00603538|324367435|FG000|Overall Study|Objective progression or relapse|3|||
94702379|NCT00603538|324367436|FG001|Overall Study|Objective progression or relapse|0|||
94702380|NCT00603538|324367437|FG002|Overall Study|Objective progression or relapse|0|||
94702381|NCT00117988|324367439|FG000|Overall Study|Death|3|||
94702382|NCT00117988|324367439|FG000|Overall Study|Adverse Event|1|||
94702383|NCT04888585|324367443|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
94702384|NCT04888585|324367444|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
94702385|NCT04888585|324367445|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
94702386|NCT04888585|324367446|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
94702387|NCT04888585|324367447|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
94702388|NCT04888585|324367448|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
94702389|NCT04888585|324367449|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
94702390|NCT04888585|324367450|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
94702391|NCT04888585|324367451|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
94702392|NCT04888585|324367452|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
94702393|NCT04888585|324367453|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
94702394|NCT04888585|324367443|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
94702395|NCT04888585|324367444|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
94702396|NCT04888585|324367445|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
94702397|NCT04888585|324367446|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
94702398|NCT04888585|324367447|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
94266080|NCT02568475|322766863|FG001|Overall Study|Lost to Follow-up|39|||
94702399|NCT04888585|324367448|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
94702400|NCT04888585|324367449|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
94702401|NCT04888585|324367450|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
94702402|NCT04888585|324367451|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
94702403|NCT04888585|324367452|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
94702404|NCT04888585|324367453|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
94702405|NCT04888585|324367443|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
94702406|NCT04888585|324367444|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
94702407|NCT04888585|324367445|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
94702408|NCT04888585|324367446|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
94702409|NCT04888585|324367447|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
94702410|NCT04888585|324367448|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
94702411|NCT04888585|324367449|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
94702412|NCT04888585|324367450|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
94702413|NCT04888585|324367451|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
94702414|NCT04888585|324367452|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
94702415|NCT04888585|324367453|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
94702416|NCT04888585|324367443|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
94702417|NCT04888585|324367444|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
94702418|NCT04888585|324367445|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
94702419|NCT04888585|324367446|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
94702420|NCT04888585|324367447|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
94702421|NCT04888585|324367448|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
94702422|NCT04888585|324367449|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
94702423|NCT04888585|324367450|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
94702424|NCT04888585|324367451|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
94702425|NCT04888585|324367452|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
94702426|NCT04888585|324367453|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
94702427|NCT04888585|324367443|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
94702428|NCT04888585|324367444|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
94702429|NCT04888585|324367445|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
94266081|NCT02568475|322766862|FG000|Overall Study|Withdrawal by Subject|2|||
94266082|NCT02568475|322766863|FG001|Overall Study|Withdrawal by Subject|0|||
94266083|NCT02568475|322766862|FG000|Overall Study|Discharged home|4|||
94266084|NCT02568475|322766863|FG001|Overall Study|Discharged home|4|||
94266085|NCT02568475|322766862|FG000|Overall Study|Short-term: Discharge location unknown|4|||
94266086|NCT02568475|322766863|FG001|Overall Study|Short-term: Discharge location unknown|0|||
94266087|NCT02568475|322766862|FG000|Overall Study|Transferred to another facility|1|||
94266088|NCT02568475|322766863|FG001|Overall Study|Transferred to another facility|0|||
94266089|NCT01200238|322766864|FG000|Overall Study|Adverse Event|2|||
94266090|NCT01200238|322766865|FG001|Overall Study|Adverse Event|1|||
94266091|NCT01200238|322766864|FG000|Overall Study|Progressive Disease|5|||
94266092|NCT01200238|322766865|FG001|Overall Study|Progressive Disease|8|||
94266093|NCT01200238|322766864|FG000|Overall Study|Withdrawal by Subject|0|||
94266094|NCT01200238|322766865|FG001|Overall Study|Withdrawal by Subject|1|||
94266095|NCT00667823|322766866|FG000|Overall Study|Lost to Follow-up|5|||
94266096|NCT00667823|322766866|FG000|Overall Study|Adverse Event|7|||
94266097|NCT00667823|322766866|FG000|Overall Study|Death|182|||
94266098|NCT00667823|322766866|FG000|Overall Study|Withdrawal by Subject|12|||
94266099|NCT00667823|322766866|FG000|Overall Study|Other|8|||
94266100|NCT00667823|322766866|FG000|Overall Study|Missing (completion page missing)|2|||
94266101|NCT00860951|322768307|FG000|Overall Study|Withdrawal by Subject|2|||
94266102|NCT00860951|322768307|FG000|Overall Study|Lost to Follow-up|5|||
94266103|NCT01809132|322768309|FG000|Overall Study|Withdrawal by Subject|0|||
94266104|NCT01809132|322768310|FG001|Overall Study|Withdrawal by Subject|0|||
94266105|NCT01809132|322768311|FG002|Overall Study|Withdrawal by Subject|1|||
94266106|NCT01383096|322768312|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
94266107|NCT01383096|322768313|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
94702430|NCT04888585|324367446|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
94702431|NCT04888585|324367447|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
94702432|NCT04888585|324367448|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
94702433|NCT04888585|324367449|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
94702434|NCT04888585|324367450|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
94702435|NCT04888585|324367451|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
94702436|NCT04888585|324367452|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
94702437|NCT04888585|324367453|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
94702438|NCT04888585|324367443|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
94702439|NCT04888585|324367444|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
94702440|NCT04888585|324367445|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
94702441|NCT04888585|324367446|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
94702442|NCT04888585|324367447|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
94702443|NCT04888585|324367448|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
94702444|NCT04888585|324367449|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
94702445|NCT04888585|324367450|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
94702446|NCT04888585|324367451|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
94702447|NCT04888585|324367452|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
94702448|NCT04888585|324367453|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
94702449|NCT04888585|324367443|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
94702450|NCT04888585|324367444|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
94702451|NCT04888585|324367445|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
94366554|NCT04881448|323126568|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
94702452|NCT04888585|324367446|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
94702453|NCT04888585|324367447|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
94702454|NCT04888585|324367448|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
94702455|NCT04888585|324367449|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
94702456|NCT04888585|324367450|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
94702457|NCT04888585|324367451|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
94702458|NCT04888585|324367452|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
94702459|NCT04888585|324367453|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
94702460|NCT04888585|324367443|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
94702461|NCT04888585|324367444|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
94702462|NCT04888585|324367445|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
94702463|NCT04888585|324367446|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
94702464|NCT04888585|324367447|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
94702465|NCT04888585|324367448|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
94366555|NCT02531698|323126569|FG000|Overall Study|Adverse Event|2|||
94366556|NCT02531698|323126570|FG001|Overall Study|Adverse Event|1|||
94366557|NCT02531698|323126569|FG000|Overall Study|Withdrawal by Subject|6|||
94366558|NCT02531698|323126570|FG001|Overall Study|Withdrawal by Subject|1|||
94366559|NCT02531698|323126569|FG000|Overall Study|Protocol Violation|2|||
94366560|NCT02531698|323126570|FG001|Overall Study|Protocol Violation|0|||
94366561|NCT02531698|323126569|FG000|Overall Study|Lost to Follow-up|1|||
94702466|NCT04888585|324367449|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
94702467|NCT04888585|324367450|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
94702468|NCT04888585|324367451|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
94702469|NCT04888585|324367452|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
94702470|NCT04888585|324367453|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
94366562|NCT02531698|323126570|FG001|Overall Study|Lost to Follow-up|0|||
94366563|NCT03033069|323126571|FG000|Overall Study|Adverse Event|6|||
94702471|NCT01543685|324367456|FG000|Overall Study|Lack of Efficacy|1|||
94702472|NCT01543685|324367457|FG001|Overall Study|Lack of Efficacy|2|||
94702473|NCT01543685|324367458|FG002|Overall Study|Lack of Efficacy|2|||
94702474|NCT01543685|324367459|FG003|Overall Study|Lack of Efficacy|0|||
94702475|NCT01543685|324367460|FG004|Overall Study|Lack of Efficacy|2|||
94702476|NCT01543685|324367456|FG000|Overall Study|Adverse Event|2|||
94702477|NCT01543685|324367457|FG001|Overall Study|Adverse Event|1|||
94702478|NCT01543685|324367458|FG002|Overall Study|Adverse Event|0|||
94702479|NCT01543685|324367459|FG003|Overall Study|Adverse Event|0|||
94702480|NCT01543685|324367460|FG004|Overall Study|Adverse Event|2|||
94702481|NCT02540213|324367461|FG000|Overall Study|Death/adverse event|18|||
94702482|NCT02540213|324367461|FG000|Overall Study|Administrative reasons|3|||
94366564|NCT03033069|323126572|FG001|Overall Study|Adverse Event|7|||
94366565|NCT03033069|323126573|FG002|Overall Study|Adverse Event|4|||
94366566|NCT03033069|323126574|FG003|Overall Study|Adverse Event|6|||
94702483|NCT02540213|324367461|FG000|Overall Study|Kidney transplant|3|||
94702484|NCT02540213|324367461|FG000|Overall Study|Lack of Efficacy|6|||
94702485|NCT02540213|324367461|FG000|Overall Study|Consent withdrawn|7|||
94366567|NCT03033069|323126571|FG000|Overall Study|Lack of Efficacy|0|||
94366568|NCT03033069|323126572|FG001|Overall Study|Lack of Efficacy|0|||
94366569|NCT03033069|323126573|FG002|Overall Study|Lack of Efficacy|1|||
94366570|NCT03033069|323126574|FG003|Overall Study|Lack of Efficacy|0|||
94366571|NCT03033069|323126571|FG000|Overall Study|Lost to Follow-up|6|||
94366572|NCT03033069|323126572|FG001|Overall Study|Lost to Follow-up|5|||
94366573|NCT03033069|323126573|FG002|Overall Study|Lost to Follow-up|5|||
94366574|NCT03033069|323126574|FG003|Overall Study|Lost to Follow-up|6|||
94366575|NCT03033069|323126571|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94366576|NCT03033069|323126572|FG001|Overall Study|Non-Compliance With Study Drug|1|||
94702486|NCT02540213|324367461|FG000|Overall Study|Enrolled but not treated|2|||
94702487|NCT02908464|324367462|FG000|Overall Study|Withdrawal by Subject|2|||
94702488|NCT02908464|324367463|FG001|Overall Study|Withdrawal by Subject|1|||
94702489|NCT02908464|324367462|FG000|Overall Study|Found ineligible after randomization|0|||
94702490|NCT02908464|324367463|FG001|Overall Study|Found ineligible after randomization|2|||
94702491|NCT04084769|324367464|FG000|Overall Study|Protocol Violation|1|||
94702492|NCT04084769|324367465|FG001|Overall Study|Protocol Violation|3|||
94702493|NCT04084769|324367466|FG002|Overall Study|Protocol Violation|0|||
94702494|NCT04084769|324367467|FG003|Overall Study|Protocol Violation|1|||
94702495|NCT04084769|324367464|FG000|Overall Study|Withdrawal by Subject|0|||
94702496|NCT04084769|324367465|FG001|Overall Study|Withdrawal by Subject|1|||
94702497|NCT04084769|324367466|FG002|Overall Study|Withdrawal by Subject|0|||
94702498|NCT04084769|324367467|FG003|Overall Study|Withdrawal by Subject|0|||
94702499|NCT04084769|324367464|FG000|Overall Study|Withdrawal by parent/guardian|1|||
94702500|NCT04084769|324367465|FG001|Overall Study|Withdrawal by parent/guardian|0|||
94702501|NCT04084769|324367466|FG002|Overall Study|Withdrawal by parent/guardian|0|||
94702502|NCT04084769|324367467|FG003|Overall Study|Withdrawal by parent/guardian|1|||
94702503|NCT04084769|324367464|FG000|Overall Study|Lost to Follow-up|2|||
94702504|NCT04084769|324367465|FG001|Overall Study|Lost to Follow-up|0|||
94702505|NCT04084769|324367466|FG002|Overall Study|Lost to Follow-up|0|||
94702506|NCT04084769|324367467|FG003|Overall Study|Lost to Follow-up|0|||
94702507|NCT01772719|324367472|FG000|Overall Study|Withdrawal by Subject|3|||
94702508|NCT01772719|324367472|FG000|Overall Study|Adverse Event|2|||
94702509|NCT01772719|324367472|FG000|Overall Study|Protocol Violation|1|||
94702510|NCT01772719|324367472|FG000|Overall Study|Lost to Follow-up|1|||
94702511|NCT02317016|324367477|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
94702512|NCT02317016|324367477|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
94702513|NCT02317016|324367477|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
94702514|NCT02317016|324367477|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
94366577|NCT03033069|323126573|FG002|Overall Study|Non-Compliance With Study Drug|1|||
94366578|NCT03033069|323126574|FG003|Overall Study|Non-Compliance With Study Drug|0|||
94366579|NCT03033069|323126571|FG000|Overall Study|Protocol Deviation|0|||
94702515|NCT02317016|324367477|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
94366580|NCT03033069|323126572|FG001|Overall Study|Protocol Deviation|1|||
94702516|NCT02317016|324367477|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
94702517|NCT02317016|324367477|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
94702518|NCT01080131|324367479|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
94702519|NCT01080131|324367480|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
94702520|NCT01080131|324367479|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
94702521|NCT01080131|324367480|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
94702522|NCT01080131|324367479|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
94702523|NCT01080131|324367480|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
94702524|NCT01080131|324367479|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
94702525|NCT01080131|324367480|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
94366581|NCT03033069|323126573|FG002|Overall Study|Protocol Deviation|0|||
94366582|NCT03033069|323126574|FG003|Overall Study|Protocol Deviation|0|||
94366583|NCT03033069|323126571|FG000|Overall Study|Withdrawal by Subject|10|||
94466221|NCT01358578|323496956|FG005|Induction Period|Physician Decision|0|||
94466222|NCT01358578|323496951|FG000|Induction Period|Protocol Deviation|3|||
94702526|NCT01080131|324367479|FG000|Core Study (0- 12 Weeks)|Death|1|||
94702527|NCT01080131|324367480|FG001|Core Study (0- 12 Weeks)|Death|0|||
94702528|NCT01080131|324367479|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
94702529|NCT01080131|324367480|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
94702530|NCT01080131|324367479|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
94702531|NCT01080131|324367480|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
94702532|NCT01080131|324367479|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
94702533|NCT01080131|324367480|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
94702534|NCT01080131|324367479|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
94702535|NCT01080131|324367480|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
94702536|NCT01080131|324367479|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
94702537|NCT01080131|324367480|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
94702538|NCT01080131|324367479|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
94702539|NCT01080131|324367480|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
94702540|NCT01080131|324367479|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
94702541|NCT01080131|324367480|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
94702542|NCT01080131|324367479|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
94702543|NCT01080131|324367480|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
94702544|NCT01560949|324367484|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
94702545|NCT01560949|324367484|FG000|Surgery Phase|Physician Decision|3|||
94702546|NCT02486588|324367485|FG000|Overall Study|Randomized in error- ineligible|738|||
94702547|NCT02486588|324367486|FG001|Overall Study|Randomized in error- ineligible|750|||
94702548|NCT02486588|324367487|FG002|Overall Study|Randomized in error- ineligible|755|||
94702549|NCT02486588|324367488|FG003|Overall Study|Randomized in error- ineligible|738|||
94702550|NCT02486588|324367489|FG004|Overall Study|Randomized in error- ineligible|746|||
94702551|NCT02486588|324367490|FG005|Overall Study|Randomized in error- ineligible|746|||
94702552|NCT00751036|324367493|FG000|Overall Study|Disease Progression|28|||
94702553|NCT00751036|324367494|FG001|Overall Study|Disease Progression|29|||
94702554|NCT00751036|324367493|FG000|Overall Study|Adverse Event|6|||
94702555|NCT00751036|324367494|FG001|Overall Study|Adverse Event|4|||
94702556|NCT00751036|324367493|FG000|Overall Study|Administrative Problems|3|||
94702557|NCT00751036|324367494|FG001|Overall Study|Administrative Problems|4|||
94702558|NCT00751036|324367493|FG000|Overall Study|Withdrawal by Subject|5|||
94702559|NCT00751036|324367494|FG001|Overall Study|Withdrawal by Subject|2|||
94702560|NCT00751036|324367493|FG000|Overall Study|Death|3|||
94702561|NCT00751036|324367494|FG001|Overall Study|Death|3|||
94702562|NCT00751036|324367493|FG000|Overall Study|Lost to Follow-up|0|||
94702563|NCT00751036|324367494|FG001|Overall Study|Lost to Follow-up|1|||
94702564|NCT00751036|324367493|FG000|Overall Study|Protocol Violation|1|||
94702565|NCT00751036|324367494|FG001|Overall Study|Protocol Violation|0|||
94702566|NCT00751036|324367493|FG000|Overall Study|Missing end of Treatment Page|2|||
94702567|NCT00751036|324367494|FG001|Overall Study|Missing end of Treatment Page|3|||
94702568|NCT02685033|324367495|FG000|Overall Study|Withdrawal of Consent|0|||
94702569|NCT02685033|324367496|FG001|Overall Study|Withdrawal of Consent|1|||
94702570|NCT02685033|324367495|FG000|Overall Study|Lost to Follow-up|2|||
94702571|NCT02685033|324367496|FG001|Overall Study|Lost to Follow-up|1|||
94702572|NCT02685033|324367495|FG000|Overall Study|Adverse Event|1|||
94702573|NCT02685033|324367496|FG001|Overall Study|Adverse Event|0|||
94702574|NCT02132702|324367497|FG000|Overall Study|Protocol Violation|2|||
94702575|NCT02132702|324367497|FG000|Overall Study|Adverse Event|3|||
94466223|NCT01358578|323496952|FG001|Induction Period|Protocol Deviation|5|||
94466224|NCT01358578|323496953|FG002|Induction Period|Protocol Deviation|0|||
94702576|NCT02132702|324367497|FG000|Overall Study|Withdrawal by Subject|3|||
94702577|NCT04697069|324367498|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
94702578|NCT04697069|324367499|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
94702579|NCT04697069|324367498|FG000|Overall Study|Study termination|2|||
94702580|NCT04697069|324367499|FG001|Overall Study|Study termination|1|||
94702581|NCT03120676|324369119|FG000|Overall Study|Not treated|1|||
94702582|NCT02359435|324369120|FG000|Overall Study|Lost to Follow-up|4|||
94702583|NCT02359435|324369121|FG001|Overall Study|Lost to Follow-up|4|||
94702584|NCT01729819|324369128|FG000|Overall Study|Adverse Event|2|||
94702585|NCT01729819|324369129|FG001|Overall Study|Adverse Event|4|||
94702586|NCT01729819|324369128|FG000|Overall Study|Lack of Efficacy|1|||
94702587|NCT01729819|324369129|FG001|Overall Study|Lack of Efficacy|0|||
94702588|NCT01729819|324369128|FG000|Overall Study|Lost to Follow-up|2|||
94702589|NCT01729819|324369129|FG001|Overall Study|Lost to Follow-up|0|||
94702590|NCT01729819|324369128|FG000|Overall Study|Other reason|1|||
94702591|NCT01729819|324369129|FG001|Overall Study|Other reason|0|||
94702592|NCT01729819|324369128|FG000|Overall Study|Protocol Violation|0|||
94702593|NCT01729819|324369129|FG001|Overall Study|Protocol Violation|1|||
94702594|NCT01729819|324369128|FG000|Overall Study|Withdrawal by Subject|0|||
94702595|NCT01729819|324369129|FG001|Overall Study|Withdrawal by Subject|2|||
94702596|NCT01244984|324369130|FG000|Overall Study|Adverse Event|2|||
94702597|NCT01244984|324369131|FG001|Overall Study|Adverse Event|11|||
94702598|NCT01244984|324369132|FG002|Overall Study|Adverse Event|2|||
94702599|NCT01244984|324369130|FG000|Overall Study|Protocol Violation|1|||
94702600|NCT01244984|324369131|FG001|Overall Study|Protocol Violation|0|||
94702601|NCT01244984|324369132|FG002|Overall Study|Protocol Violation|0|||
94702602|NCT01244984|324369130|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
94702603|NCT01244984|324369131|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
94702604|NCT01244984|324369132|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
94702605|NCT01244984|324369130|FG000|Overall Study|Withdrawal by Subject|1|||
94702606|NCT01244984|324369131|FG001|Overall Study|Withdrawal by Subject|2|||
94702607|NCT01244984|324369132|FG002|Overall Study|Withdrawal by Subject|2|||
94702608|NCT02534896|324369137|FG000|Overall Study|Adverse Event|2|||
94702609|NCT02534896|324369138|FG001|Overall Study|Adverse Event|1|||
94702610|NCT02534896|324369139|FG002|Overall Study|Adverse Event|1|||
94702611|NCT02534896|324369137|FG000|Overall Study|Insufficient therapeutic response|2|||
94702612|NCT02534896|324369138|FG001|Overall Study|Insufficient therapeutic response|0|||
94702613|NCT02534896|324369139|FG002|Overall Study|Insufficient therapeutic response|0|||
94702614|NCT00269399|324369142|FG000|Overall Study|Lack of Efficacy|27|||
94702615|NCT00269399|324369143|FG001|Overall Study|Lack of Efficacy|10|||
94702616|NCT00269399|324369142|FG000|Overall Study|Adverse Event|10|||
94702617|NCT00269399|324369143|FG001|Overall Study|Adverse Event|4|||
94702618|NCT00269399|324369142|FG000|Overall Study|Withdrawal by Subject|2|||
94702619|NCT00269399|324369143|FG001|Overall Study|Withdrawal by Subject|5|||
94702620|NCT00269399|324369142|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
94266108|NCT01383096|322768314|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
94266109|NCT01383096|322768312|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
94266110|NCT01383096|322768313|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
94266111|NCT01383096|322768314|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
94466225|NCT01358578|323496954|FG003|Induction Period|Protocol Deviation|3|||
94466226|NCT01358578|323496955|FG004|Induction Period|Protocol Deviation|0|||
94652167|NCT04542070|324183894|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
94652168|NCT04542070|324183895|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
94652169|NCT04542070|324183896|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
94652170|NCT04542070|324183893|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
94652171|NCT04542070|324183894|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
94652172|NCT04542070|324183895|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
94652173|NCT04542070|324183896|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
94652174|NCT04542070|324183893|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
94652175|NCT04542070|324183894|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
94652176|NCT04542070|324183895|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
94652177|NCT04542070|324183896|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
94652178|NCT04542070|324183893|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
94652179|NCT04542070|324183894|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
94652180|NCT04542070|324183895|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
94652181|NCT04542070|324183896|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
94652182|NCT04542070|324183893|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
94702621|NCT00269399|324369143|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
94702622|NCT00269399|324369142|FG000|Overall Study|Other|0|||
94702623|NCT00269399|324369143|FG001|Overall Study|Other|4|||
94702624|NCT00269399|324369142|FG000|Overall Study|Development of exclusion criteria|0|||
94702625|NCT00269399|324369143|FG001|Overall Study|Development of exclusion criteria|1|||
94702626|NCT03721016|324369151|FG000|Overall Study|Adverse Event|0|||
94702627|NCT03721016|324369152|FG001|Overall Study|Adverse Event|1|||
94702628|NCT03721016|324369153|FG002|Overall Study|Adverse Event|1|||
94702629|NCT03721016|324369151|FG000|Overall Study|Withdrawal by Subject|8|||
94702630|NCT03721016|324369152|FG001|Overall Study|Withdrawal by Subject|16|||
94702631|NCT03721016|324369153|FG002|Overall Study|Withdrawal by Subject|13|||
94702632|NCT03721016|324369151|FG000|Overall Study|Lost to Follow-up|4|||
94702633|NCT03721016|324369152|FG001|Overall Study|Lost to Follow-up|6|||
94702634|NCT03721016|324369153|FG002|Overall Study|Lost to Follow-up|5|||
94702635|NCT03721016|324369151|FG000|Overall Study|Physician Decision|0|||
94702636|NCT03721016|324369152|FG001|Overall Study|Physician Decision|1|||
94702637|NCT03721016|324369153|FG002|Overall Study|Physician Decision|2|||
94702638|NCT03721016|324369151|FG000|Overall Study|Protocol Violation|0|||
94702639|NCT03721016|324369152|FG001|Overall Study|Protocol Violation|1|||
94702640|NCT03721016|324369153|FG002|Overall Study|Protocol Violation|0|||
94702641|NCT03721016|324369151|FG000|Overall Study|Site terminated by sponsor|3|||
94702642|NCT03721016|324369152|FG001|Overall Study|Site terminated by sponsor|7|||
94702643|NCT03721016|324369153|FG002|Overall Study|Site terminated by sponsor|6|||
94702644|NCT03721016|324369151|FG000|Overall Study|Subject exited early due to COVID-19|1|||
94702645|NCT03721016|324369152|FG001|Overall Study|Subject exited early due to COVID-19|0|||
94702646|NCT03721016|324369153|FG002|Overall Study|Subject exited early due to COVID-19|0|||
94702647|NCT02145182|324369154|FG000|Overall Study|Adverse Event|4|||
94702648|NCT02145182|324369155|FG001|Overall Study|Adverse Event|1|||
94702649|NCT02145182|324369154|FG000|Overall Study|Death|7|||
94702650|NCT02145182|324369155|FG001|Overall Study|Death|7|||
94702651|NCT02145182|324369154|FG000|Overall Study|Lost to Follow-up|2|||
94702652|NCT02145182|324369155|FG001|Overall Study|Lost to Follow-up|2|||
94702653|NCT02145182|324369154|FG000|Overall Study|Pre-transplant Withdrawal|0|||
94702654|NCT02145182|324369155|FG001|Overall Study|Pre-transplant Withdrawal|2|||
94702655|NCT02145182|324369154|FG000|Overall Study|Withdrawal by Subject|5|||
94702656|NCT02145182|324369155|FG001|Overall Study|Withdrawal by Subject|4|||
94702657|NCT01233050|324369156|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
94702658|NCT01233050|324369157|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
94702659|NCT02281318|324369158|FG000|Overall Study|Adverse Event|2|||
94702660|NCT02281318|324369159|FG001|Overall Study|Adverse Event|2|||
94702661|NCT02281318|324369158|FG000|Overall Study|Lack of Efficacy|2|||
94702662|NCT02281318|324369159|FG001|Overall Study|Lack of Efficacy|0|||
94702663|NCT02281318|324369158|FG000|Overall Study|Lost to Follow-up|2|||
94702664|NCT02281318|324369159|FG001|Overall Study|Lost to Follow-up|1|||
94702665|NCT02281318|324369158|FG000|Overall Study|Physician Decision|2|||
94702666|NCT02281318|324369159|FG001|Overall Study|Physician Decision|0|||
94702667|NCT02281318|324369158|FG000|Overall Study|Withdrawal by Subject|6|||
94702668|NCT02281318|324369159|FG001|Overall Study|Withdrawal by Subject|2|||
94702669|NCT01368406|324369161|FG000|Overall Study|Lost to Follow-up|8|||
94702670|NCT01368406|324369162|FG001|Overall Study|Lost to Follow-up|4|||
94702671|NCT01368406|324369161|FG000|Overall Study|Withdrawal by Subject|8|||
94702672|NCT01368406|324369162|FG001|Overall Study|Withdrawal by Subject|4|||
94702673|NCT01368406|324369161|FG000|Overall Study|relapse of the disease|3|||
94702674|NCT01368406|324369162|FG001|Overall Study|relapse of the disease|2|||
94702675|NCT01368406|324369161|FG000|Overall Study|started working|2|||
94702676|NCT01368406|324369162|FG001|Overall Study|started working|3|||
94702677|NCT04304534|324369163|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
94702678|NCT04304534|324369164|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
94702679|NCT04304534|324369165|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
94466227|NCT01358578|323496956|FG005|Induction Period|Protocol Deviation|0|||
94702680|NCT04304534|324369166|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
94702681|NCT04304534|324369163|FG000|Overall Study|Non-Compliance with study drug|0|||
94702682|NCT04304534|324369164|FG001|Overall Study|Non-Compliance with study drug|1|||
94702683|NCT04304534|324369165|FG002|Overall Study|Non-Compliance with study drug|1|||
94702684|NCT04304534|324369166|FG003|Overall Study|Non-Compliance with study drug|1|||
94702685|NCT04304534|324369163|FG000|Overall Study|Lost to Follow-up|0|||
94702686|NCT04304534|324369164|FG001|Overall Study|Lost to Follow-up|1|||
94702687|NCT04304534|324369165|FG002|Overall Study|Lost to Follow-up|2|||
94702688|NCT04304534|324369166|FG003|Overall Study|Lost to Follow-up|3|||
94702689|NCT04304534|324369163|FG000|Overall Study|Unspecific|4|||
94702690|NCT04304534|324369164|FG001|Overall Study|Unspecific|2|||
94702691|NCT04304534|324369165|FG002|Overall Study|Unspecific|2|||
94702692|NCT04304534|324369166|FG003|Overall Study|Unspecific|2|||
94702693|NCT04304534|324369163|FG000|Overall Study|Technical Problems|2|||
94702694|NCT04304534|324369164|FG001|Overall Study|Technical Problems|2|||
94702695|NCT04304534|324369165|FG002|Overall Study|Technical Problems|3|||
94702696|NCT04304534|324369166|FG003|Overall Study|Technical Problems|4|||
94702697|NCT04304534|324369163|FG000|Overall Study|Death|7|||
94702698|NCT04304534|324369164|FG001|Overall Study|Death|2|||
94702699|NCT04304534|324369165|FG002|Overall Study|Death|4|||
94702700|NCT04304534|324369166|FG003|Overall Study|Death|3|||
94702701|NCT04304534|324369163|FG000|Overall Study|Withdrawal by Subject|7|||
94702702|NCT04304534|324369164|FG001|Overall Study|Withdrawal by Subject|2|||
94702703|NCT04304534|324369165|FG002|Overall Study|Withdrawal by Subject|7|||
94702704|NCT04304534|324369166|FG003|Overall Study|Withdrawal by Subject|4|||
94702705|NCT04304534|324369163|FG000|Overall Study|Physician Decision|4|||
94702706|NCT04304534|324369164|FG001|Overall Study|Physician Decision|9|||
94702707|NCT04304534|324369165|FG002|Overall Study|Physician Decision|9|||
94702708|NCT04304534|324369166|FG003|Overall Study|Physician Decision|5|||
94702709|NCT04304534|324369163|FG000|Overall Study|Subject Decision|34|||
94702710|NCT04304534|324369164|FG001|Overall Study|Subject Decision|25|||
94702711|NCT04304534|324369165|FG002|Overall Study|Subject Decision|25|||
94702712|NCT04304534|324369166|FG003|Overall Study|Subject Decision|26|||
94702713|NCT04304534|324369163|FG000|Overall Study|Adverse Event|35|||
94702714|NCT04304534|324369164|FG001|Overall Study|Adverse Event|40|||
94702715|NCT04304534|324369165|FG002|Overall Study|Adverse Event|39|||
94702716|NCT04304534|324369166|FG003|Overall Study|Adverse Event|44|||
94702717|NCT04012853|324369167|FG000|Overall Study|Withdrawal by Subject|1|||
94702718|NCT04012853|324369168|FG001|Overall Study|Withdrawal by Subject|1|||
94702719|NCT04012853|324369167|FG000|Overall Study|Protocol Violation|1|||
94702720|NCT04012853|324369168|FG001|Overall Study|Protocol Violation|0|||
94702721|NCT04012853|324369167|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
94702722|NCT04012853|324369168|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
94702723|NCT01466881|324369169|FG000|Overall Study|Ineligible|5|||
94702724|NCT01466881|324369169|FG000|Overall Study|Adverse Event|6|||
94702725|NCT01466881|324369169|FG000|Overall Study|Progression/relapse|20|||
94702726|NCT01466881|324369169|FG000|Overall Study|Death|4|||
94702727|NCT01466881|324369169|FG000|Overall Study|Other reason not protocol specified|5|||
94702728|NCT02299635|324369170|FG000|Overall Study|Adverse Event|2|||
94702729|NCT02299635|324369170|FG000|Overall Study|Death|1|||
94702730|NCT02299635|324369170|FG000|Overall Study|Global deterioration of health status|1|||
94702731|NCT02299635|324369170|FG000|Overall Study|Objective progression or relapse|10|||
94702732|NCT02299635|324369170|FG000|Overall Study|Withdrawal by Subject|2|||
94702733|NCT02299635|324369170|FG000|Overall Study|Other|3|||
94702734|NCT01710514|324369172|FG000|Overall Study|Adverse Event|6|||
94702735|NCT01710514|324369173|FG001|Overall Study|Adverse Event|7|||
94702736|NCT01710514|324369172|FG000|Overall Study|Withdrawal by Subject|1|||
94702737|NCT01710514|324369173|FG001|Overall Study|Withdrawal by Subject|0|||
94702738|NCT02846415|324369174|FG000|Overall Study|Lost to Follow-up|2|||
94702739|NCT02846415|324369175|FG001|Overall Study|Lost to Follow-up|0|||
94702740|NCT02846415|324369174|FG000|Overall Study|Withdrawal by Subject|1|||
94702741|NCT02846415|324369175|FG001|Overall Study|Withdrawal by Subject|1|||
94702742|NCT02430532|324369185|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
94702743|NCT02430532|324369186|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
94702744|NCT02430532|324369185|FG000|Overall Study|Consent Withdrawn|0|||
94702745|NCT02430532|324369186|FG001|Overall Study|Consent Withdrawn|2|||
94702746|NCT02430532|324369185|FG000|Overall Study|Adverse Event|0|||
94702747|NCT02430532|324369186|FG001|Overall Study|Adverse Event|1|||
94702748|NCT01806714|324369188|FG000|Overall Study|No functioning phone number|200|||
94702749|NCT01806714|324369189|FG001|Overall Study|No functioning phone number|170|||
94702750|NCT00404079|324369190|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
94702751|NCT00404079|324369191|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
94702752|NCT00580801|324369193|FG000|Overall Study|Physician Decision|1|||
94702753|NCT00580801|324369194|FG001|Overall Study|Physician Decision|0|||
94702754|NCT00580801|324369195|FG002|Overall Study|Physician Decision|0|||
94702755|NCT00580801|324369193|FG000|Overall Study|Adverse Event|2|||
94702756|NCT00580801|324369194|FG001|Overall Study|Adverse Event|0|||
94702757|NCT00580801|324369195|FG002|Overall Study|Adverse Event|0|||
94702758|NCT00580801|324369193|FG000|Overall Study|Lost to Follow-up|2|||
94702759|NCT00580801|324369194|FG001|Overall Study|Lost to Follow-up|0|||
94702760|NCT00580801|324369195|FG002|Overall Study|Lost to Follow-up|0|||
94702761|NCT00580801|324369193|FG000|Overall Study|Reached a virologic endpoint|0|||
94702762|NCT00580801|324369194|FG001|Overall Study|Reached a virologic endpoint|1|||
94702763|NCT00580801|324369195|FG002|Overall Study|Reached a virologic endpoint|2|||
94702764|NCT00580801|324369193|FG000|Overall Study|Participant non-compliant|0|||
94702765|NCT00580801|324369194|FG001|Overall Study|Participant non-compliant|0|||
94702766|NCT00580801|324369195|FG002|Overall Study|Participant non-compliant|1|||
94702767|NCT00580801|324369193|FG000|Overall Study|Travel|1|||
94702768|NCT00580801|324369194|FG001|Overall Study|Travel|0|||
94702769|NCT00580801|324369195|FG002|Overall Study|Travel|0|||
94702770|NCT00383188|324369196|FG000|Overall Study|Adverse Event|4|||
94702771|NCT00383188|324369197|FG001|Overall Study|Adverse Event|7|||
94702772|NCT00383188|324369198|FG002|Overall Study|Adverse Event|9|||
94702773|NCT00383188|324369199|FG003|Overall Study|Adverse Event|8|||
94702774|NCT00383188|324369200|FG004|Overall Study|Adverse Event|8|||
94702775|NCT00383188|324369196|FG000|Overall Study|Lack of Efficacy|9|||
94702776|NCT00383188|324369197|FG001|Overall Study|Lack of Efficacy|3|||
94702777|NCT00383188|324369198|FG002|Overall Study|Lack of Efficacy|3|||
94702778|NCT00383188|324369199|FG003|Overall Study|Lack of Efficacy|2|||
94702779|NCT00383188|324369200|FG004|Overall Study|Lack of Efficacy|6|||
94702780|NCT00383188|324369196|FG000|Overall Study|Other|3|||
94702781|NCT00383188|324369197|FG001|Overall Study|Other|1|||
94702782|NCT00383188|324369198|FG002|Overall Study|Other|0|||
94702783|NCT00383188|324369199|FG003|Overall Study|Other|2|||
94702784|NCT00383188|324369200|FG004|Overall Study|Other|6|||
94702785|NCT00383188|324369196|FG000|Overall Study|No longer willing to participate|1|||
94702786|NCT00383188|324369197|FG001|Overall Study|No longer willing to participate|0|||
94702787|NCT00383188|324369198|FG002|Overall Study|No longer willing to participate|1|||
94702788|NCT00383188|324369199|FG003|Overall Study|No longer willing to participate|0|||
94702789|NCT00383188|324369200|FG004|Overall Study|No longer willing to participate|2|||
94702790|NCT00383188|324369196|FG000|Overall Study|Lost to Follow-up|0|||
94702791|NCT00383188|324369197|FG001|Overall Study|Lost to Follow-up|0|||
94702792|NCT00383188|324369198|FG002|Overall Study|Lost to Follow-up|0|||
94702793|NCT00383188|324369199|FG003|Overall Study|Lost to Follow-up|0|||
94702794|NCT00383188|324369200|FG004|Overall Study|Lost to Follow-up|1|||
94702795|NCT01981850|324369201|FG000|Main Phase Stage 1|Death|2|||
94702796|NCT01981850|324369202|FG001|Main Phase Stage 1|Death|0|||
94702797|NCT01981850|324369203|FG002|Main Phase Stage 1|Death|0|||
94266112|NCT01383096|322768312|FG000|Third Intervention (8 Days)|Elevated AST|0|||
94266113|NCT01383096|322768313|FG001|Third Intervention (8 Days)|Elevated AST|1|||
94266114|NCT01383096|322768314|FG002|Third Intervention (8 Days)|Elevated AST|0|||
94266115|NCT01383096|322768312|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
94266116|NCT01383096|322768313|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
94266117|NCT01383096|322768314|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
94266118|NCT01383096|322768312|FG000|Third Intervention (8 Days)|Adverse Event|1|||
94266119|NCT01383096|322768313|FG001|Third Intervention (8 Days)|Adverse Event|0|||
94266120|NCT01383096|322768314|FG002|Third Intervention (8 Days)|Adverse Event|0|||
94266121|NCT01383096|322768312|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
94266122|NCT01383096|322768313|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
94266123|NCT01383096|322768314|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
94266124|NCT01383096|322768312|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
94266125|NCT01383096|322768313|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
94266126|NCT01383096|322768314|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
94266127|NCT01383096|322768312|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
94266128|NCT01383096|322768313|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
94266129|NCT01383096|322768314|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
94266130|NCT01383096|322768312|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
94266131|NCT01383096|322768313|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
94266132|NCT01383096|322768314|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
94266133|NCT01383096|322768312|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
94266134|NCT01383096|322768313|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
94266135|NCT01383096|322768314|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
94266136|NCT01383096|322768312|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
94266137|NCT01383096|322768313|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
94266138|NCT01383096|322768314|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
94266139|NCT01524133|322768317|FG000|Treatment Phase|Withdrawal by Subject|13|||
94266140|NCT01524133|322768318|FG001|Treatment Phase|Withdrawal by Subject|28|||
94266141|NCT01524133|322768319|FG002|Treatment Phase|Withdrawal by Subject|31|||
94266142|NCT01524133|322768317|FG000|Treatment Phase|Physician Decision|6|||
94266143|NCT01524133|322768318|FG001|Treatment Phase|Physician Decision|3|||
94266144|NCT01524133|322768319|FG002|Treatment Phase|Physician Decision|3|||
94266145|NCT01524133|322768317|FG000|Treatment Phase|Lost to Follow-up|0|||
94266146|NCT01524133|322768318|FG001|Treatment Phase|Lost to Follow-up|1|||
94266147|NCT01524133|322768319|FG002|Treatment Phase|Lost to Follow-up|2|||
94652183|NCT04542070|324183894|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
94652184|NCT04542070|324183895|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
94652185|NCT04542070|324183896|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
94652186|NCT04542070|324183893|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
94652187|NCT04542070|324183894|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
94652188|NCT04542070|324183895|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
94652189|NCT04542070|324183896|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
94652190|NCT04542070|324183893|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
94652191|NCT04542070|324183894|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
94652192|NCT04542070|324183895|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
94652193|NCT04542070|324183896|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
94652194|NCT04542070|324183893|FG000|Maintenance + Extension Period|Adverse Event|10|||
94652195|NCT04542070|324183894|FG001|Maintenance + Extension Period|Adverse Event|2|||
94652196|NCT04542070|324183895|FG002|Maintenance + Extension Period|Adverse Event|0|||
94652197|NCT04542070|324183896|FG003|Maintenance + Extension Period|Adverse Event|0|||
94652198|NCT04542070|324183893|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
94652199|NCT04542070|324183894|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
94652200|NCT04542070|324183895|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
94652201|NCT04542070|324183896|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
94652202|NCT04542070|324183893|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
94652203|NCT04542070|324183894|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
94652204|NCT04542070|324183895|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
94652205|NCT04542070|324183896|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
94652206|NCT04542070|324183893|FG000|Maintenance + Extension Period|Physician Decision|1|||
94652207|NCT04542070|324183894|FG001|Maintenance + Extension Period|Physician Decision|1|||
94652208|NCT04542070|324183895|FG002|Maintenance + Extension Period|Physician Decision|0|||
94652209|NCT04542070|324183896|FG003|Maintenance + Extension Period|Physician Decision|0|||
94652210|NCT04542070|324183893|FG000|Maintenance + Extension Period|Protocol Violation|2|||
94652211|NCT04542070|324183894|FG001|Maintenance + Extension Period|Protocol Violation|5|||
94652212|NCT04542070|324183895|FG002|Maintenance + Extension Period|Protocol Violation|0|||
94652213|NCT04542070|324183896|FG003|Maintenance + Extension Period|Protocol Violation|0|||
94702798|NCT01981850|324369204|FG003|Main Phase Stage 1|Death|0|||
94702799|NCT01981850|324369205|FG004|Main Phase Stage 1|Death|0|||
94702800|NCT01981850|324369206|FG005|Main Phase Stage 1|Death|0|||
94702801|NCT01981850|324369207|FG006|Main Phase Stage 1|Death|0|||
94702802|NCT01981850|324369208|FG007|Main Phase Stage 1|Death|0|||
94702803|NCT01981850|324369209|FG008|Main Phase Stage 1|Death|0|||
94702804|NCT01981850|324369210|FG009|Main Phase Stage 1|Death|0|||
94702805|NCT01981850|324369201|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
94702806|NCT01981850|324369202|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
94702807|NCT01981850|324369203|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
94702808|NCT01981850|324369204|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
94702809|NCT01981850|324369205|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
94702810|NCT01981850|324369206|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
94702811|NCT01981850|324369207|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
94702812|NCT01981850|324369208|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
94702813|NCT01981850|324369209|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
94702814|NCT01981850|324369210|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
94702815|NCT01981850|324369201|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
94702816|NCT01981850|324369202|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
94702817|NCT01981850|324369203|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
94702818|NCT01981850|324369204|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
94702819|NCT01981850|324369205|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
94702820|NCT01981850|324369206|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
94702821|NCT01981850|324369207|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
94266148|NCT01524133|322768317|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
94266149|NCT01524133|322768318|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
94266150|NCT01524133|322768319|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
94266151|NCT01524133|322768317|FG000|Overall Study 52 Weeks|Physician Decision|1|||
94266152|NCT01524133|322768318|FG001|Overall Study 52 Weeks|Physician Decision|0|||
94266153|NCT01524133|322768319|FG002|Overall Study 52 Weeks|Physician Decision|2|||
94266154|NCT01524133|322768317|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
94266155|NCT01524133|322768318|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
94266156|NCT01524133|322768319|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
94266157|NCT01087957|322768320|FG000|Overall Study|Death|2|||
94266158|NCT01087957|322768321|FG001|Overall Study|Death|2|||
94266159|NCT01087957|322768320|FG000|Overall Study|Lost to Follow-up|3|||
94266160|NCT01087957|322768321|FG001|Overall Study|Lost to Follow-up|4|||
94266161|NCT01087957|322768320|FG000|Overall Study|Protocol Violation|13|||
94702822|NCT01981850|324369208|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
94702823|NCT01981850|324369209|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
94702824|NCT01981850|324369210|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
94702825|NCT01981850|324369201|FG000|Main Phase Stage 1|Various reasons|0|||
94702826|NCT01981850|324369202|FG001|Main Phase Stage 1|Various reasons|0|||
94266162|NCT01087957|322768321|FG001|Overall Study|Protocol Violation|25|||
94266163|NCT01087957|322768320|FG000|Overall Study|Withdrawal by Subject|18|||
94702827|NCT01981850|324369203|FG002|Main Phase Stage 1|Various reasons|2|||
94266164|NCT01087957|322768321|FG001|Overall Study|Withdrawal by Subject|15|||
94266165|NCT01087957|322768320|FG000|Overall Study|Physician Decision|5|||
94266166|NCT01087957|322768321|FG001|Overall Study|Physician Decision|9|||
94266167|NCT00616434|322768326|FG000|Overall Study|Adverse Event|5|||
94702828|NCT01981850|324369204|FG003|Main Phase Stage 1|Various reasons|0|||
94702829|NCT01981850|324369205|FG004|Main Phase Stage 1|Various reasons|0|||
94266168|NCT00616434|322768327|FG001|Overall Study|Adverse Event|2|||
94266169|NCT00616434|322768326|FG000|Overall Study|Physician Decision|0|||
94266170|NCT00616434|322768327|FG001|Overall Study|Physician Decision|4|||
94266171|NCT00616434|322768326|FG000|Overall Study|Withdrawal by Subject|1|||
94266172|NCT00616434|322768327|FG001|Overall Study|Withdrawal by Subject|1|||
94266173|NCT00616434|322768326|FG000|Overall Study|Protocol deviation|0|||
94266174|NCT00616434|322768327|FG001|Overall Study|Protocol deviation|1|||
94266175|NCT01509079|322768328|FG000|Overall Study|Lack of Efficacy|0|||
94266176|NCT01509079|322768329|FG001|Overall Study|Lack of Efficacy|2|||
94266177|NCT01509079|322768328|FG000|Overall Study|started an excluded medication|0|||
94266178|NCT01509079|322768329|FG001|Overall Study|started an excluded medication|1|||
94266179|NCT03945591|322768330|FG000|Overall Study|Participant not transplanted|1|||
94266180|NCT03945591|322768330|FG000|Overall Study|Change in treatment plan|3|||
94266181|NCT03945591|322768330|FG000|Overall Study|Adverse Event|1|||
94266182|NCT03842163|322768333|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
94266183|NCT03842163|322768333|FG000|Overall Study|Scintigraphy was not performed|44|||
94702830|NCT01981850|324369206|FG005|Main Phase Stage 1|Various reasons|0|||
94702831|NCT01981850|324369207|FG006|Main Phase Stage 1|Various reasons|0|||
94702832|NCT01981850|324369208|FG007|Main Phase Stage 1|Various reasons|0|||
94702833|NCT01981850|324369209|FG008|Main Phase Stage 1|Various reasons|0|||
94702834|NCT01981850|324369210|FG009|Main Phase Stage 1|Various reasons|0|||
94702835|NCT01981850|324369201|FG000|Main Phase Stage 2|Adverse Event|0|||
94702836|NCT01981850|324369202|FG001|Main Phase Stage 2|Adverse Event|0|||
94266184|NCT00733304|322768334|FG000|Overall Study|Adverse Event|3|||
94266185|NCT00733304|322768335|FG001|Overall Study|Adverse Event|0|||
94266186|NCT00733304|322768336|FG002|Overall Study|Adverse Event|0|||
94266187|NCT00733304|322768334|FG000|Overall Study|Lack of Efficacy|0|||
94266188|NCT00733304|322768335|FG001|Overall Study|Lack of Efficacy|0|||
94266189|NCT00733304|322768336|FG002|Overall Study|Lack of Efficacy|2|||
94266190|NCT00733304|322768334|FG000|Overall Study|Lost to Follow-up|0|||
94266191|NCT00733304|322768335|FG001|Overall Study|Lost to Follow-up|1|||
94266192|NCT00733304|322768336|FG002|Overall Study|Lost to Follow-up|0|||
94266193|NCT00733304|322768334|FG000|Overall Study|Physician Decision|3|||
94266194|NCT00733304|322768335|FG001|Overall Study|Physician Decision|1|||
94266195|NCT00733304|322768336|FG002|Overall Study|Physician Decision|3|||
94266196|NCT00733304|322768334|FG000|Overall Study|Withdrawal by Subject|1|||
94266197|NCT00733304|322768335|FG001|Overall Study|Withdrawal by Subject|1|||
94266198|NCT00733304|322768336|FG002|Overall Study|Withdrawal by Subject|0|||
94266199|NCT00056862|322768339|FG000|Overall Study|Protocol Violation|1|||
94266200|NCT00056862|322768340|FG001|Overall Study|Protocol Violation|0|||
94266201|NCT02545322|322768347|FG000|Overall Study|Withdrawal by Subject|3|||
94266202|NCT03690141|322768348|FG000|Overall Study|Adverse Event|5|||
94266203|NCT03690141|322768348|FG000|Overall Study|Withdrawal by Subject|3|||
94266204|NCT03690141|322768348|FG000|Overall Study|Physician Decision|4|||
94266205|NCT03690141|322768348|FG000|Overall Study|Disease progression|4|||
94266206|NCT01230554|322768350|FG000|Overall Study|Lost to Follow-up|2|||
94266207|NCT01230554|322768350|FG000|Overall Study|Inability to maintain visit schedule|1|||
94266208|NCT02653300|322768351|FG000|Overall Study|Withdrawal by Subject|2|||
94266209|NCT00448435|322768352|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
94266210|NCT00448435|322768353|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
94266211|NCT04195581|322768356|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
94266212|NCT04195581|322768356|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
94702837|NCT01981850|324369203|FG002|Main Phase Stage 2|Adverse Event|0|||
94266213|NCT04195581|322768356|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
94266214|NCT04195581|322768356|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
94702838|NCT01981850|324369204|FG003|Main Phase Stage 2|Adverse Event|0|||
94702839|NCT01981850|324369205|FG004|Main Phase Stage 2|Adverse Event|6|||
94702840|NCT01981850|324369206|FG005|Main Phase Stage 2|Adverse Event|5|||
94702841|NCT01981850|324369207|FG006|Main Phase Stage 2|Adverse Event|7|||
94702842|NCT01981850|324369208|FG007|Main Phase Stage 2|Adverse Event|0|||
94702843|NCT01981850|324369209|FG008|Main Phase Stage 2|Adverse Event|0|||
94266215|NCT04195581|322768356|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
94266216|NCT04195581|322768356|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
94266217|NCT02678416|322768359|FG000|Part 1|Withdrawal by Subject|1|||
94702844|NCT01981850|324369210|FG009|Main Phase Stage 2|Adverse Event|0|||
94266218|NCT02678416|322768359|FG000|Part 2|Adverse Event|2|||
94266219|NCT02678416|322768359|FG000|Part 2|Withdrawal by Subject|1|||
94266220|NCT00108069|322768360|FG000|Overall Study|Never rec'd study drug|0|||
94266221|NCT00108069|322768361|FG001|Overall Study|Never rec'd study drug|1|||
94266222|NCT00108069|322768360|FG000|Overall Study|Adverse Event|1|||
94702845|NCT01981850|324369201|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
94266223|NCT00108069|322768361|FG001|Overall Study|Adverse Event|1|||
94266224|NCT00108069|322768360|FG000|Overall Study|Withdrawal by Subject|1|||
94266225|NCT00108069|322768361|FG001|Overall Study|Withdrawal by Subject|0|||
94266226|NCT00108069|322768360|FG000|Overall Study|Death|1|||
94266227|NCT00108069|322768361|FG001|Overall Study|Death|0|||
94266228|NCT00108069|322768360|FG000|Overall Study|Progessive disease|27|||
94266229|NCT00108069|322768361|FG001|Overall Study|Progessive disease|11|||
94266230|NCT04556136|322768362|FG000|Overall Study|Lost to Follow-up|6|||
94266231|NCT04556136|322768363|FG001|Overall Study|Lost to Follow-up|6|||
94266232|NCT04556136|322768362|FG000|Overall Study|Physician Decision|2|||
94266233|NCT04556136|322768363|FG001|Overall Study|Physician Decision|1|||
94266234|NCT04556136|322768362|FG000|Overall Study|Withdrawal by Subject|2|||
94266235|NCT04556136|322768363|FG001|Overall Study|Withdrawal by Subject|1|||
94266236|NCT01478360|322768372|FG000|Overall Study|Lost to Follow-up|1|||
94266237|NCT01478360|322768373|FG001|Overall Study|Lost to Follow-up|0|||
94266238|NCT01478360|322768372|FG000|Overall Study|Adverse Event|0|||
94266239|NCT01478360|322768373|FG001|Overall Study|Adverse Event|1|||
94266240|NCT01478360|322768372|FG000|Overall Study|Administrative problems|1|||
94266241|NCT01478360|322768373|FG001|Overall Study|Administrative problems|2|||
94652214|NCT04542070|324183893|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
94652215|NCT04542070|324183894|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
94652216|NCT04542070|324183895|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
94652217|NCT04542070|324183896|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
94652218|NCT04542070|324183893|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
94652219|NCT04542070|324183894|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
94652220|NCT04542070|324183895|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
94652221|NCT04542070|324183896|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
94652222|NCT04542070|324183893|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
94652223|NCT04542070|324183894|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
94652224|NCT04542070|324183895|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
94652225|NCT04542070|324183896|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
94652226|NCT04542070|324183893|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
94652227|NCT04542070|324183894|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
94652228|NCT04542070|324183895|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
94652229|NCT04542070|324183896|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
94652230|NCT04542070|324183893|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
94652231|NCT04542070|324183894|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
94652232|NCT04542070|324183895|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
94652233|NCT04542070|324183896|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
94652234|NCT04542070|324183893|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
94652235|NCT04542070|324183894|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
94652236|NCT04542070|324183895|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
94652237|NCT04542070|324183896|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
94652238|NCT04542070|324183893|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
94652239|NCT04542070|324183894|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
94652240|NCT04542070|324183895|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
94652241|NCT04542070|324183896|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
94652242|NCT03511560|324183897|FG000|Overall Study|Death|0|||
94652243|NCT03511560|324183898|FG001|Overall Study|Death|1|||
94652244|NCT03511560|324183897|FG000|Overall Study|Adverse Event|0|||
94652245|NCT03511560|324183898|FG001|Overall Study|Adverse Event|2|||
94652246|NCT03511560|324183897|FG000|Overall Study|Transplant cancelled|0|||
94652247|NCT03511560|324183898|FG001|Overall Study|Transplant cancelled|1|||
94652248|NCT03511560|324183897|FG000|Overall Study|Patient switched to another drug|1|||
94652249|NCT03511560|324183898|FG001|Overall Study|Patient switched to another drug|0|||
94652250|NCT02141516|324183899|FG000|Overall Study|Adverse Event|0|||
94652251|NCT02141516|324183900|FG001|Overall Study|Adverse Event|1|||
94652252|NCT02141516|324183901|FG002|Overall Study|Adverse Event|0|||
94652253|NCT02141516|324183899|FG000|Overall Study|Lost to Follow-up|0|||
94652254|NCT02141516|324183900|FG001|Overall Study|Lost to Follow-up|1|||
94652255|NCT02141516|324183901|FG002|Overall Study|Lost to Follow-up|0|||
94652256|NCT02141516|324183899|FG000|Overall Study|Other|0|||
94652257|NCT02141516|324183900|FG001|Overall Study|Other|3|||
94652258|NCT02141516|324183901|FG002|Overall Study|Other|0|||
94652259|NCT00179413|324183902|FG000|Overall Study|Adverse Event|38|||
94652260|NCT00179413|324183903|FG001|Overall Study|Adverse Event|20|||
94652261|NCT00179413|324183902|FG000|Overall Study|Withdrawal by Subject|87|||
94266242|NCT00685685|322768374|FG000|Washout Period of 7 Days|Adverse Event|2|||
94266243|NCT00685685|322768375|FG001|Washout Period of 7 Days|Adverse Event|0|||
94266244|NCT00685685|322768374|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
94266245|NCT00685685|322768375|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
94652262|NCT00179413|324183903|FG001|Overall Study|Withdrawal by Subject|95|||
94266246|NCT00132496|322768379|FG000|Overall Study|Withdrawal by Subject|1|||
94266247|NCT00132496|322768380|FG001|Overall Study|Withdrawal by Subject|2|||
94266248|NCT00132496|322768379|FG000|Overall Study|Physician Decision|1|||
94266249|NCT00132496|322768380|FG001|Overall Study|Physician Decision|0|||
94266250|NCT00175877|322768381|FG000|Overall Study|Adverse Event|136|||
94266251|NCT00175877|322768381|FG000|Overall Study|Withdrawal by Subject|141|||
94266252|NCT00175877|322768381|FG000|Overall Study|Lost to Follow-up|9|||
94266253|NCT00175877|322768381|FG000|Overall Study|Lack of Efficacy|26|||
94266254|NCT00175877|322768381|FG000|Overall Study|Protocol Violation|15|||
94266255|NCT00175877|322768381|FG000|Overall Study|Other Reason|20|||
94266256|NCT00175877|322768381|FG000|Overall Study|AE & Other|1|||
94266257|NCT00175877|322768381|FG000|Overall Study|Withdrawal by subject & Other|1|||
94266258|NCT02243865|322768389|FG000|Overall Study|Protocol Violation|1|||
94266259|NCT02243865|322768390|FG001|Overall Study|Protocol Violation|3|||
94266260|NCT02243865|322768389|FG000|Overall Study|Lost to Follow-up|1|||
94266261|NCT02243865|322768390|FG001|Overall Study|Lost to Follow-up|1|||
94702846|NCT01981850|324369202|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
94702847|NCT01981850|324369203|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
94702848|NCT01981850|324369204|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
94702849|NCT01981850|324369205|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
94702850|NCT01981850|324369206|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
94702851|NCT01981850|324369207|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
94702852|NCT01981850|324369208|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
94702853|NCT01981850|324369209|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
94266262|NCT02243865|322768389|FG000|Overall Study|Withdrawal by Subject|1|||
94266263|NCT02243865|322768390|FG001|Overall Study|Withdrawal by Subject|0|||
94702854|NCT01981850|324369210|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
94702855|NCT01981850|324369201|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
94702856|NCT01981850|324369202|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
94702857|NCT01981850|324369203|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
94702858|NCT01981850|324369204|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
94702859|NCT01981850|324369205|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
94702860|NCT01981850|324369206|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
94702861|NCT01981850|324369207|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
94702862|NCT01981850|324369208|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
94702863|NCT01981850|324369209|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
94702864|NCT01981850|324369210|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
94702865|NCT01981850|324369201|FG000|Main Phase Stage 2|Various reasons|0|||
94702866|NCT01981850|324369202|FG001|Main Phase Stage 2|Various reasons|0|||
94702867|NCT01981850|324369203|FG002|Main Phase Stage 2|Various reasons|0|||
94702868|NCT01981850|324369204|FG003|Main Phase Stage 2|Various reasons|0|||
94702869|NCT01981850|324369205|FG004|Main Phase Stage 2|Various reasons|2|||
94702870|NCT01981850|324369206|FG005|Main Phase Stage 2|Various reasons|0|||
94702871|NCT01981850|324369207|FG006|Main Phase Stage 2|Various reasons|1|||
94702872|NCT01981850|324369208|FG007|Main Phase Stage 2|Various reasons|0|||
94702873|NCT01981850|324369209|FG008|Main Phase Stage 2|Various reasons|0|||
94702874|NCT01981850|324369210|FG009|Main Phase Stage 2|Various reasons|0|||
94702875|NCT01981850|324369201|FG000|Main Phase Stage 2|Progressive Disease|0|||
94702876|NCT01981850|324369202|FG001|Main Phase Stage 2|Progressive Disease|0|||
94702877|NCT01981850|324369203|FG002|Main Phase Stage 2|Progressive Disease|0|||
94702878|NCT01981850|324369204|FG003|Main Phase Stage 2|Progressive Disease|0|||
94702879|NCT01981850|324369205|FG004|Main Phase Stage 2|Progressive Disease|0|||
94702880|NCT01981850|324369206|FG005|Main Phase Stage 2|Progressive Disease|6|||
94702881|NCT01981850|324369207|FG006|Main Phase Stage 2|Progressive Disease|6|||
94702882|NCT01981850|324369208|FG007|Main Phase Stage 2|Progressive Disease|0|||
94702883|NCT01981850|324369209|FG008|Main Phase Stage 2|Progressive Disease|0|||
94702884|NCT01981850|324369210|FG009|Main Phase Stage 2|Progressive Disease|0|||
94702885|NCT01981850|324369201|FG000|Open Label Extension (OLE)|Adverse Event|0|||
94702886|NCT01981850|324369202|FG001|Open Label Extension (OLE)|Adverse Event|0|||
94702887|NCT01981850|324369203|FG002|Open Label Extension (OLE)|Adverse Event|0|||
94702888|NCT01981850|324369204|FG003|Open Label Extension (OLE)|Adverse Event|0|||
94702889|NCT01981850|324369205|FG004|Open Label Extension (OLE)|Adverse Event|0|||
94702890|NCT01981850|324369206|FG005|Open Label Extension (OLE)|Adverse Event|0|||
94702891|NCT01981850|324369207|FG006|Open Label Extension (OLE)|Adverse Event|0|||
94702892|NCT01981850|324369208|FG007|Open Label Extension (OLE)|Adverse Event|2|||
94702893|NCT01981850|324369209|FG008|Open Label Extension (OLE)|Adverse Event|1|||
94702894|NCT01981850|324369210|FG009|Open Label Extension (OLE)|Adverse Event|8|||
94266264|NCT02243865|322768389|FG000|Overall Study|Adverse Event|1|||
94266265|NCT02243865|322768390|FG001|Overall Study|Adverse Event|1|||
94266266|NCT02663271|322768391|FG000|Overall Study|Withdrawal by Subject|5|||
94702895|NCT01981850|324369201|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
94702896|NCT01981850|324369202|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
94702897|NCT01981850|324369203|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
94266267|NCT02663271|322768391|FG000|Overall Study|Lack of Efficacy|1|||
94702898|NCT01981850|324369204|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
94702899|NCT01981850|324369205|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
94702900|NCT01981850|324369206|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
94702901|NCT01981850|324369207|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
94702902|NCT01981850|324369208|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
94702903|NCT01981850|324369209|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
94702904|NCT01981850|324369210|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
94702905|NCT01981850|324369201|FG000|Open Label Extension (OLE)|Various reasons|0|||
94702906|NCT01981850|324369202|FG001|Open Label Extension (OLE)|Various reasons|0|||
94702907|NCT01981850|324369203|FG002|Open Label Extension (OLE)|Various reasons|0|||
94702908|NCT01981850|324369204|FG003|Open Label Extension (OLE)|Various reasons|0|||
94702909|NCT01981850|324369205|FG004|Open Label Extension (OLE)|Various reasons|0|||
94702910|NCT01981850|324369206|FG005|Open Label Extension (OLE)|Various reasons|0|||
94702911|NCT01981850|324369207|FG006|Open Label Extension (OLE)|Various reasons|0|||
94702912|NCT01981850|324369208|FG007|Open Label Extension (OLE)|Various reasons|3|||
94702913|NCT01981850|324369209|FG008|Open Label Extension (OLE)|Various reasons|1|||
94702914|NCT01981850|324369210|FG009|Open Label Extension (OLE)|Various reasons|3|||
94702915|NCT01981850|324369201|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
94702916|NCT01981850|324369202|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
94702917|NCT01981850|324369203|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
94702918|NCT01981850|324369204|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
94702919|NCT01981850|324369205|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
94702920|NCT01981850|324369206|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
94702921|NCT01981850|324369207|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
94702922|NCT01981850|324369208|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
94702923|NCT01981850|324369209|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
94702924|NCT01981850|324369210|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
94702925|NCT01981850|324369201|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
94702926|NCT01981850|324369202|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
94702927|NCT01981850|324369203|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
94702928|NCT01981850|324369204|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
94702929|NCT01981850|324369205|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
94702930|NCT01981850|324369206|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
94702931|NCT01981850|324369207|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
94702932|NCT01981850|324369208|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
94702933|NCT01981850|324369209|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
94702934|NCT01981850|324369210|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
94702935|NCT01981850|324369201|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
94702936|NCT01981850|324369202|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
94702937|NCT01981850|324369203|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
94702938|NCT01981850|324369204|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
94702939|NCT01981850|324369205|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
94702940|NCT01981850|324369206|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
94702941|NCT01981850|324369207|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
94702942|NCT01981850|324369208|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
94702943|NCT01981850|324369209|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
94702944|NCT01981850|324369210|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
94702945|NCT02524288|324369212|FG000|Overall Study|Adverse Event|115|||
94702946|NCT02524288|324369212|FG000|Overall Study|Lost to Follow-up|216|||
94702947|NCT02524288|324369212|FG000|Overall Study|Non-Compliance With Protocol|32|||
94702948|NCT02524288|324369212|FG000|Overall Study|Non-Compliance With Study Drug|14|||
94702949|NCT02524288|324369212|FG000|Overall Study|Pregnancy Wish|6|||
94702950|NCT02524288|324369212|FG000|Overall Study|Protocol Violation|6|||
94702951|NCT02524288|324369212|FG000|Overall Study|Screen Failure|2|||
94702952|NCT02524288|324369212|FG000|Overall Study|Site Discontinued Study Participation|1|||
94702953|NCT02524288|324369212|FG000|Overall Study|Study Terminated By Sponsor|1417|||
94702954|NCT02524288|324369212|FG000|Overall Study|Subject Moved|32|||
94702955|NCT02524288|324369212|FG000|Overall Study|Withdrawal by Subject|76|||
94702956|NCT02524288|324369212|FG000|Overall Study|Pregnancy|22|||
94702957|NCT02524288|324369212|FG000|Overall Study|Physician Decision|2|||
94702958|NCT00517933|324369213|FG000|Period 1|Death|2|||
94702959|NCT00517933|324369214|FG001|Period 1|Death|1|||
94702960|NCT00517933|324369213|FG000|Period 1|Adverse Event|4|||
94702961|NCT00517933|324369214|FG001|Period 1|Adverse Event|4|||
94702962|NCT00517933|324369213|FG000|Period 1|Lost to Follow-up|2|||
94702963|NCT00517933|324369214|FG001|Period 1|Lost to Follow-up|0|||
94702964|NCT00517933|324369213|FG000|Period 1|Underwent lung transplant|0|||
94702965|NCT00517933|324369214|FG001|Period 1|Underwent lung transplant|1|||
94702966|NCT00517933|324369213|FG000|Period 2|Death|2|||
94702967|NCT00517933|324369214|FG001|Period 2|Death|4|||
94702968|NCT00517933|324369213|FG000|Period 2|Adverse Event|2|||
94702969|NCT00517933|324369214|FG001|Period 2|Adverse Event|4|||
94702970|NCT00517933|324369213|FG000|Period 2|Physician Decision|1|||
94702971|NCT00517933|324369214|FG001|Period 2|Physician Decision|0|||
94702972|NCT00517933|324369213|FG000|Period 2|Withdrawal by Subject|1|||
94702973|NCT00517933|324369214|FG001|Period 2|Withdrawal by Subject|3|||
94702974|NCT00517933|324369213|FG000|Period 2|Underwent lung transplant|0|||
94702975|NCT00517933|324369214|FG001|Period 2|Underwent lung transplant|2|||
94702976|NCT03523962|324369216|FG000|Closed Fractures|Death|86|||
94702977|NCT03523962|324369217|FG001|Closed Fractures|Death|71|||
94702978|NCT03523962|324369218|FG002|Closed Fractures|Death|0|||
94702979|NCT03523962|324369219|FG003|Closed Fractures|Death|0|||
94702980|NCT03523962|324369216|FG000|Closed Fractures|Lost to Follow-up|62|||
94702981|NCT03523962|324369217|FG001|Closed Fractures|Lost to Follow-up|36|||
94702982|NCT03523962|324369218|FG002|Closed Fractures|Lost to Follow-up|0|||
94702983|NCT03523962|324369219|FG003|Closed Fractures|Lost to Follow-up|0|||
94702984|NCT03523962|324369216|FG000|Closed Fractures|Withdrawal by Subject|19|||
94702985|NCT03523962|324369217|FG001|Closed Fractures|Withdrawal by Subject|29|||
94702986|NCT03523962|324369218|FG002|Closed Fractures|Withdrawal by Subject|0|||
94702987|NCT03523962|324369219|FG003|Closed Fractures|Withdrawal by Subject|0|||
94702988|NCT03523962|324369216|FG000|Closed Fractures|Incarceration|1|||
94702989|NCT03523962|324369217|FG001|Closed Fractures|Incarceration|4|||
94702990|NCT03523962|324369218|FG002|Closed Fractures|Incarceration|0|||
94702991|NCT03523962|324369219|FG003|Closed Fractures|Incarceration|0|||
94702992|NCT03523962|324369216|FG000|Open Fractures|Death|0|||
94702993|NCT03523962|324369217|FG001|Open Fractures|Death|0|||
94702994|NCT03523962|324369218|FG002|Open Fractures|Death|11|||
94702995|NCT03523962|324369219|FG003|Open Fractures|Death|6|||
94702996|NCT03523962|324369216|FG000|Open Fractures|Lost to Follow-up|0|||
94702997|NCT03523962|324369217|FG001|Open Fractures|Lost to Follow-up|0|||
94702998|NCT03523962|324369218|FG002|Open Fractures|Lost to Follow-up|15|||
94702999|NCT03523962|324369219|FG003|Open Fractures|Lost to Follow-up|8|||
94703000|NCT03523962|324369216|FG000|Open Fractures|Withdrawal by Subject|0|||
94703001|NCT03523962|324369217|FG001|Open Fractures|Withdrawal by Subject|0|||
94703002|NCT03523962|324369218|FG002|Open Fractures|Withdrawal by Subject|6|||
94703003|NCT03523962|324369219|FG003|Open Fractures|Withdrawal by Subject|2|||
94703004|NCT03523962|324369216|FG000|Open Fractures|Incarceration|0|||
94703005|NCT03523962|324369217|FG001|Open Fractures|Incarceration|0|||
94703006|NCT03523962|324369218|FG002|Open Fractures|Incarceration|1|||
94703007|NCT03523962|324369219|FG003|Open Fractures|Incarceration|0|||
94703008|NCT01835899|324369220|FG000|Overall Study|Adverse Event|0|||
94703009|NCT01835899|324369221|FG001|Overall Study|Adverse Event|0|||
94703010|NCT01835899|324369222|FG002|Overall Study|Adverse Event|1|||
94703011|NCT01835899|324369220|FG000|Overall Study|Other than stated above|0|||
94703012|NCT01835899|324369221|FG001|Overall Study|Other than stated above|1|||
94703013|NCT01835899|324369222|FG002|Overall Study|Other than stated above|0|||
94703014|NCT04523181|324369227|FG000|Overall Study|Withdrawal by Subject|4|||
94703015|NCT04523181|324369228|FG001|Overall Study|Withdrawal by Subject|5|||
94703016|NCT04523181|324369227|FG000|Overall Study|Lost to Follow-up|2|||
94703017|NCT04523181|324369228|FG001|Overall Study|Lost to Follow-up|3|||
94703018|NCT04523181|324369227|FG000|Overall Study|Physician Decision|1|||
94703019|NCT04523181|324369228|FG001|Overall Study|Physician Decision|0|||
94703020|NCT04523181|324369227|FG000|Overall Study|Transferred to external facility.|1|||
94703021|NCT04523181|324369228|FG001|Overall Study|Transferred to external facility.|1|||
94703022|NCT01656304|324369230|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
94703023|NCT04886596|324369233|FG000|Overall Study|Adverse Event|73|||
94703024|NCT04886596|324369234|FG001|Overall Study|Adverse Event|78|||
94703025|NCT04886596|324369233|FG000|Overall Study|Lost to Follow-up|104|||
94703026|NCT04886596|324369234|FG001|Overall Study|Lost to Follow-up|104|||
94703027|NCT04886596|324369233|FG000|Overall Study|Ongoing|12095|||
94703028|NCT04886596|324369234|FG001|Overall Study|Ongoing|12107|||
94703029|NCT04886596|324369233|FG000|Overall Study|Consent withdrawal, not due to an (S)AE|162|||
94703030|NCT04886596|324369234|FG001|Overall Study|Consent withdrawal, not due to an (S)AE|173|||
94703031|NCT04886596|324369233|FG000|Overall Study|Migrated / Moved from the study area|17|||
94703032|NCT04886596|324369234|FG001|Overall Study|Migrated / Moved from the study area|14|||
94703033|NCT04886596|324369233|FG000|Overall Study|Unknown reason|16|||
94703034|NCT04886596|324369234|FG001|Overall Study|Unknown reason|23|||
94703035|NCT05096884|324369235|FG000|Overall Study|Excluded based on negative tilt table test|4|||
94703036|NCT05824351|324369236|FG000|Overall Study|Adverse Event|6|||
94703037|NCT04927975|324369237|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
94703038|NCT04927975|324369238|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
94703039|NCT04927975|324369239|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
94703040|NCT04927975|324369240|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
94703041|NCT04927975|324369241|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
94703042|NCT04927975|324369242|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
94703043|NCT04927975|324369237|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
94703044|NCT04927975|324369238|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
94703045|NCT04927975|324369239|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
94703046|NCT04927975|324369240|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
94703047|NCT04927975|324369241|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
94703048|NCT04927975|324369242|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
94703049|NCT04927975|324369237|FG000|Period 1 (Baseline-Week 24)|Death|0|||
94703050|NCT04927975|324369238|FG001|Period 1 (Baseline-Week 24)|Death|0|||
94703051|NCT04927975|324369239|FG002|Period 1 (Baseline-Week 24)|Death|0|||
94703052|NCT04927975|324369240|FG003|Period 1 (Baseline-Week 24)|Death|0|||
94703053|NCT04927975|324369241|FG004|Period 1 (Baseline-Week 24)|Death|0|||
94703054|NCT04927975|324369242|FG005|Period 1 (Baseline-Week 24)|Death|1|||
94703055|NCT04927975|324369237|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
94703056|NCT04927975|324369238|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
94703057|NCT04927975|324369239|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
94703058|NCT04927975|324369240|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
94703059|NCT04927975|324369241|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
94703060|NCT04927975|324369242|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
94703061|NCT04927975|324369237|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
94703062|NCT04927975|324369238|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
94703063|NCT04927975|324369239|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
94703064|NCT04927975|324369240|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
94703065|NCT04927975|324369241|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
94703066|NCT04927975|324369242|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
94703067|NCT03781804|324369243|FG000|Overall Study|Adverse Event|2|||
94703068|NCT03781804|324369244|FG001|Overall Study|Adverse Event|2|||
94703069|NCT03781804|324369245|FG002|Overall Study|Adverse Event|3|||
94703070|NCT03781804|324369243|FG000|Overall Study|Lost to Follow-up|1|||
94703071|NCT03781804|324369244|FG001|Overall Study|Lost to Follow-up|1|||
94703072|NCT03781804|324369245|FG002|Overall Study|Lost to Follow-up|2|||
94703073|NCT03781804|324369243|FG000|Overall Study|Lack of Efficacy|4|||
94703074|NCT03781804|324369244|FG001|Overall Study|Lack of Efficacy|2|||
94703075|NCT03781804|324369245|FG002|Overall Study|Lack of Efficacy|9|||
94703076|NCT03781804|324369243|FG000|Overall Study|Protocol Violation|0|||
94703077|NCT03781804|324369244|FG001|Overall Study|Protocol Violation|0|||
94703078|NCT03781804|324369245|FG002|Overall Study|Protocol Violation|1|||
94703079|NCT03781804|324369243|FG000|Overall Study|Withdrawal by Subject|0|||
94703080|NCT03781804|324369244|FG001|Overall Study|Withdrawal by Subject|1|||
94703081|NCT03781804|324369245|FG002|Overall Study|Withdrawal by Subject|1|||
94703082|NCT03781804|324369243|FG000|Overall Study|Reason not provided|2|||
94703083|NCT03781804|324369244|FG001|Overall Study|Reason not provided|2|||
94703084|NCT03781804|324369245|FG002|Overall Study|Reason not provided|0|||
94703085|NCT00337818|324369246|FG000|Overall Study|Lost to Follow-up|289|||
94703086|NCT00337818|324369247|FG001|Overall Study|Lost to Follow-up|91|||
94703087|NCT00337818|324369248|FG002|Overall Study|Lost to Follow-up|107|||
94703088|NCT04678830|324369249|FG000|Overall Study|Lack of Efficacy|2|||
94703089|NCT04678830|324369250|FG001|Overall Study|Lack of Efficacy|0|||
94703090|NCT04678830|324369249|FG000|Overall Study|Withdrawal by Subject|0|||
94703091|NCT04678830|324369250|FG001|Overall Study|Withdrawal by Subject|1|||
94703092|NCT00604721|324369253|FG000|Overall Study|Physician Decision|1|||
94703093|NCT00604721|324369253|FG000|Overall Study|Withdrawal by Subject|1|||
94703094|NCT04776213|324369254|FG000|Overall Study|Other|1|||
94703095|NCT04776213|324369254|FG000|Overall Study|Withdrawal by Subject|7|||
94703096|NCT04776213|324369254|FG000|Overall Study|Protocol Violation|1|||
94703097|NCT04776213|324369254|FG000|Overall Study|Lost to Follow-up|2|||
94703098|NCT00561574|324369256|FG000|Overall Study|Adverse Event|21|||
94703099|NCT00561574|324369257|FG001|Overall Study|Adverse Event|24|||
94703100|NCT00561574|324369256|FG000|Overall Study|Lack of Efficacy|11|||
94266268|NCT03044886|322768392|FG000|Overall Study|Lost to Follow-up|15|||
94703101|NCT00561574|324369257|FG001|Overall Study|Lack of Efficacy|21|||
94703102|NCT00561574|324369256|FG000|Overall Study|Withdrawal by Subject|4|||
94703103|NCT00561574|324369257|FG001|Overall Study|Withdrawal by Subject|4|||
94703104|NCT00561574|324369256|FG000|Overall Study|Reason Unrelated to Trial|6|||
94266269|NCT03044886|322768393|FG001|Overall Study|Lost to Follow-up|10|||
94703105|NCT00561574|324369257|FG001|Overall Study|Reason Unrelated to Trial|2|||
94703106|NCT00561574|324369256|FG000|Overall Study|Lost to Follow-up|1|||
94703107|NCT00561574|324369257|FG001|Overall Study|Lost to Follow-up|0|||
94703108|NCT00561574|324369256|FG000|Overall Study|Other|5|||
94266270|NCT03044886|322768394|FG002|Overall Study|Lost to Follow-up|12|||
94266271|NCT02921269|322768395|FG000|Overall Study|Did not complete DLT period|1|||
94266272|NCT02054325|322768406|FG000|Overall Study|Lost to Follow-up|8|||
94266273|NCT02054325|322768407|FG001|Overall Study|Lost to Follow-up|5|||
94703109|NCT00561574|324369257|FG001|Overall Study|Other|7|||
94703110|NCT01838551|324369258|FG000|Overall Study|Adverse Event|16|||
94703111|NCT01838551|324369258|FG000|Overall Study|Death|1|||
94703112|NCT01838551|324369258|FG000|Overall Study|Lack of Efficacy|10|||
94266274|NCT02966223|322768408|FG000|Overall Study|Physician Decision|3|||
94652263|NCT00550836|324183904|FG000|Overall Study|Withdrawal by Subject|3|||
94652264|NCT00550836|324183905|FG001|Overall Study|Withdrawal by Subject|9|||
94652265|NCT01813019|324183906|FG000|Overall Study|Adverse Event|0|||
94652266|NCT01813019|324183907|FG001|Overall Study|Adverse Event|3|||
94652267|NCT01813019|324183906|FG000|Overall Study|Withdrawal by Subject|3|||
94652268|NCT01813019|324183907|FG001|Overall Study|Withdrawal by Subject|2|||
94652269|NCT01813019|324183906|FG000|Overall Study|administrative problems|2|||
94652270|NCT01813019|324183907|FG001|Overall Study|administrative problems|0|||
94652271|NCT01813019|324183906|FG000|Overall Study|Protocol Deviation|2|||
94652272|NCT01813019|324183907|FG001|Overall Study|Protocol Deviation|1|||
94652273|NCT01723904|324183908|FG000|Overall Study|Noncompliant|3|||
94652274|NCT01723904|324183908|FG000|Overall Study|Adverse Event|5|||
94652275|NCT01723904|324183908|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
94652276|NCT03027466|324183915|FG000|Overall Study|Opting out of the app|1869|||
94652277|NCT03027466|324183916|FG001|Overall Study|Opting out of the app|1819|||
94652278|NCT03027466|324183917|FG002|Overall Study|Opting out of the app|1743|||
94652279|NCT03027466|324183918|FG003|Overall Study|Opting out of the app|1821|||
94652280|NCT00235989|324183920|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
94652281|NCT00235989|324183921|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
94652282|NCT00235989|324183922|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
94652283|NCT00235989|324183923|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
94652284|NCT00235989|324183924|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
94652285|NCT00235989|324183925|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
94652286|NCT00235989|324183920|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
94652287|NCT00235989|324183921|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
94652288|NCT00235989|324183922|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
94652289|NCT00235989|324183923|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
94652290|NCT00235989|324183924|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
94652291|NCT00235989|324183925|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
94652292|NCT00235989|324183920|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
94652293|NCT00235989|324183921|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
94652294|NCT00235989|324183922|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
94652295|NCT00235989|324183923|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
94652296|NCT00235989|324183924|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
94652297|NCT00235989|324183925|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
94652298|NCT00235989|324183920|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
94652299|NCT00235989|324183921|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
94652300|NCT00235989|324183922|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
94652301|NCT00235989|324183923|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
94652302|NCT00235989|324183924|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
94652303|NCT00235989|324183925|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
94652304|NCT00235989|324183920|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
94652305|NCT00235989|324183921|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
94652306|NCT00235989|324183922|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
94652307|NCT00235989|324183923|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
94652308|NCT00235989|324183924|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
94652309|NCT00235989|324183925|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
94652310|NCT03385239|324183927|FG000|Overall Study|Voluntary Withdrawal|2|||
94652311|NCT03385239|324183928|FG001|Overall Study|Voluntary Withdrawal|3|||
94652312|NCT03385239|324183929|FG002|Overall Study|Voluntary Withdrawal|2|||
94652313|NCT03385239|324183930|FG003|Overall Study|Voluntary Withdrawal|3|||
94652314|NCT03385239|324183931|FG004|Overall Study|Voluntary Withdrawal|0|||
94652315|NCT03385239|324183927|FG000|Overall Study|Adverse Event|0|||
94652316|NCT03385239|324183928|FG001|Overall Study|Adverse Event|0|||
94652317|NCT03385239|324183929|FG002|Overall Study|Adverse Event|1|||
94652318|NCT03385239|324183930|FG003|Overall Study|Adverse Event|0|||
94652319|NCT03385239|324183931|FG004|Overall Study|Adverse Event|0|||
94652320|NCT03385239|324183927|FG000|Overall Study|Other|0|||
94652321|NCT03385239|324183928|FG001|Overall Study|Other|0|||
94652322|NCT03385239|324183929|FG002|Overall Study|Other|0|||
94652323|NCT03385239|324183930|FG003|Overall Study|Other|1|||
94652324|NCT03385239|324183931|FG004|Overall Study|Other|0|||
94652325|NCT03042312|324186046|FG000|Overall Study|Administrative Reason|1|||
94652326|NCT03042312|324186047|FG001|Overall Study|Administrative Reason|1|||
94652327|NCT03042312|324186046|FG000|Overall Study|Adverse Event|0|||
94652328|NCT03042312|324186047|FG001|Overall Study|Adverse Event|1|||
94652329|NCT03042312|324186046|FG000|Overall Study|Lost to Follow-up|1|||
94652330|NCT03042312|324186047|FG001|Overall Study|Lost to Follow-up|3|||
94652331|NCT03042312|324186046|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
94703113|NCT01838551|324369258|FG000|Overall Study|Physician Decision|4|||
94703114|NCT01838551|324369258|FG000|Overall Study|Withdrawal by Subject|10|||
94703115|NCT01838551|324369258|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
94703116|NCT00712166|324369259|FG000|Overall Study|Noncompliance|0|||
94703117|NCT00712166|324369260|FG001|Overall Study|Noncompliance|1|||
94703118|NCT01773122|324369261|FG000|Overall Study|Due to amended age eligibility criteria|3|||
94703119|NCT01773122|324369262|FG001|Overall Study|Due to amended age eligibility criteria|1|||
94703120|NCT01773122|324369263|FG002|Overall Study|Due to amended age eligibility criteria|0|||
94703121|NCT01773122|324369264|FG003|Overall Study|Due to amended age eligibility criteria|1|||
94703122|NCT02289560|324369265|FG000|Overall Study|Lost to Follow-up|6|||
94703123|NCT02289560|324369265|FG000|Overall Study|Alternative Treatment|4|||
94703124|NCT02289560|324369265|FG000|Overall Study|Inadequate Treatment|2|||
94703125|NCT02289560|324369265|FG000|Overall Study|Withdrawal by Subject|23|||
94703126|NCT03538054|324369267|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
94703127|NCT03538054|324369267|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
94703128|NCT03538054|324369267|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
94703129|NCT03254394|324369268|FG000|Overall Study|Withdrawal by Subject|0|||
94703130|NCT03254394|324369269|FG001|Overall Study|Withdrawal by Subject|2|||
94703131|NCT02163915|324369270|FG000|Overall Study|Withdrawal by Subject|2|||
94703132|NCT02163915|324369271|FG001|Overall Study|Withdrawal by Subject|0|||
94703133|NCT02163915|324369272|FG002|Overall Study|Withdrawal by Subject|2|||
94703134|NCT02163915|324369273|FG003|Overall Study|Withdrawal by Subject|2|||
94703135|NCT02163915|324369274|FG004|Overall Study|Withdrawal by Subject|2|||
94703136|NCT02163915|324369270|FG000|Overall Study|Study termination|1|||
94703137|NCT02163915|324369271|FG001|Overall Study|Study termination|0|||
94703138|NCT02163915|324369272|FG002|Overall Study|Study termination|0|||
94703139|NCT02163915|324369273|FG003|Overall Study|Study termination|0|||
94703140|NCT02163915|324369274|FG004|Overall Study|Study termination|2|||
94703141|NCT02163915|324369270|FG000|Overall Study|Physician Decision|0|||
94703142|NCT02163915|324369271|FG001|Overall Study|Physician Decision|0|||
94703143|NCT02163915|324369272|FG002|Overall Study|Physician Decision|0|||
94703144|NCT02163915|324369273|FG003|Overall Study|Physician Decision|1|||
94703145|NCT02163915|324369274|FG004|Overall Study|Physician Decision|0|||
94703146|NCT00536380|324369275|FG000|Overall Study|Adverse Event|0|||
94703147|NCT00536380|324369276|FG001|Overall Study|Adverse Event|2|||
94703148|NCT00536380|324369277|FG002|Overall Study|Adverse Event|2|||
94703149|NCT00536380|324369275|FG000|Overall Study|Lost to Follow-up|0|||
94703150|NCT00536380|324369276|FG001|Overall Study|Lost to Follow-up|0|||
94703151|NCT00536380|324369277|FG002|Overall Study|Lost to Follow-up|1|||
94703152|NCT00536380|324369275|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
94703153|NCT00536380|324369276|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
94703154|NCT00536380|324369277|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
94703155|NCT00536380|324369275|FG000|Overall Study|Withdrawal related to study drug|7|||
94703156|NCT00536380|324369276|FG001|Overall Study|Withdrawal related to study drug|5|||
94703157|NCT00536380|324369277|FG002|Overall Study|Withdrawal related to study drug|2|||
94703158|NCT00536380|324369275|FG000|Overall Study|Noncompliance with protocol|3|||
94703159|NCT00536380|324369276|FG001|Overall Study|Noncompliance with protocol|2|||
94703160|NCT00536380|324369277|FG002|Overall Study|Noncompliance with protocol|2|||
94703161|NCT00536380|324369275|FG000|Overall Study|Did not meet protocol eligibility|0|||
94703162|NCT00536380|324369276|FG001|Overall Study|Did not meet protocol eligibility|0|||
94703163|NCT00536380|324369277|FG002|Overall Study|Did not meet protocol eligibility|1|||
94703164|NCT00536380|324369275|FG000|Overall Study|Administrative|0|||
94703165|NCT00536380|324369276|FG001|Overall Study|Administrative|0|||
94703166|NCT00536380|324369277|FG002|Overall Study|Administrative|1|||
94703167|NCT01278862|324369278|FG000|Overall Study|Lost to Follow-up|1|||
94703168|NCT01278862|324369279|FG001|Overall Study|Lost to Follow-up|1|||
94703169|NCT00849147|324369280|FG000|Overall Study|Withdrawal by Subject|1|||
94703170|NCT00849147|324369280|FG000|Overall Study|Protocol Violation|2|||
94703171|NCT00849147|324369280|FG000|Overall Study|Disease Relapse/Progression|2|||
94703172|NCT01268891|324370716|FG000|Overall Study|Adverse Event|3|||
94703173|NCT01268891|324370717|FG001|Overall Study|Adverse Event|7|||
94703174|NCT01268891|324370716|FG000|Overall Study|Lack of Efficacy|1|||
94703175|NCT01268891|324370717|FG001|Overall Study|Lack of Efficacy|0|||
94703176|NCT01268891|324370716|FG000|Overall Study|Withdrawal of Consent|3|||
94703177|NCT01268891|324370717|FG001|Overall Study|Withdrawal of Consent|1|||
94703178|NCT01268891|324370716|FG000|Overall Study|Administrative or other reason(s)|1|||
94703179|NCT01268891|324370717|FG001|Overall Study|Administrative or other reason(s)|0|||
94703180|NCT04381494|324370720|FG000|Overall Study|Early termination of trial|19|||
94266275|NCT02966223|322768408|FG000|Overall Study|Withdrawal by Subject|11|||
94266276|NCT02966223|322768408|FG000|Overall Study|Lost to Follow-up|1|||
94703181|NCT04381494|324370720|FG000|Overall Study|Investigator's discretion|1|||
94703182|NCT04381494|324370720|FG000|Overall Study|Withdrawal by Subject|9|||
94703183|NCT04381494|324370720|FG000|Overall Study|NSCLC disease progression|4|||
94703184|NCT04381494|324370720|FG000|Overall Study|Device-Related Adverse Event|2|||
94703185|NCT03441360|324370721|FG000|Overall Study|Radiological disease progression|5|||
94703186|NCT03441360|324370722|FG001|Overall Study|Radiological disease progression|6|||
94703187|NCT03441360|324370723|FG002|Overall Study|Radiological disease progression|4|||
94703188|NCT03441360|324370721|FG000|Overall Study|Clinical disease progression|2|||
94703189|NCT03441360|324370722|FG001|Overall Study|Clinical disease progression|2|||
94703190|NCT03441360|324370723|FG002|Overall Study|Clinical disease progression|0|||
94703191|NCT03441360|324370721|FG000|Overall Study|Adverse Event|1|||
94703192|NCT03441360|324370722|FG001|Overall Study|Adverse Event|0|||
94703193|NCT03441360|324370723|FG002|Overall Study|Adverse Event|1|||
94703194|NCT03467724|324370724|FG000|Overall Study|Lost to Follow-up|5|||
94703195|NCT03467724|324370724|FG000|Overall Study|Withdrawal by Subject|1|||
94703196|NCT03467724|324370724|FG000|Overall Study|Protocol Violation|1|||
94703197|NCT03467724|324370724|FG000|Overall Study|Adverse Event|1|||
94703198|NCT01280591|324370729|FG000|Overall Study|Withdrawal by Subject|0|||
94703199|NCT01280591|324370730|FG001|Overall Study|Withdrawal by Subject|0|||
94703200|NCT01280591|324370731|FG002|Overall Study|Withdrawal by Subject|0|||
94703201|NCT01280591|324370732|FG003|Overall Study|Withdrawal by Subject|2|||
94703202|NCT01280591|324370729|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
94703203|NCT01280591|324370730|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
94703204|NCT01280591|324370731|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
94703205|NCT01280591|324370732|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
94703206|NCT02232178|324370733|FG000|Overall Study|Lost to Follow-up|0|||
94703207|NCT02232178|324370734|FG001|Overall Study|Lost to Follow-up|1|||
94703208|NCT02232178|324370735|FG002|Overall Study|Lost to Follow-up|0|||
94703209|NCT02232178|324370733|FG000|Overall Study|ineligibility|0|||
94703210|NCT02232178|324370734|FG001|Overall Study|ineligibility|0|||
94703211|NCT02232178|324370735|FG002|Overall Study|ineligibility|1|||
94703212|NCT02232178|324370733|FG000|Overall Study|surgical complication|1|||
94703213|NCT02232178|324370734|FG001|Overall Study|surgical complication|0|||
94703214|NCT02232178|324370735|FG002|Overall Study|surgical complication|0|||
94703215|NCT03107611|324370737|FG000|Overall Study|Adverse Event|1|||
94703216|NCT03107611|324370738|FG001|Overall Study|Adverse Event|0|||
94703217|NCT03107611|324370739|FG002|Overall Study|Adverse Event|2|||
94703218|NCT03107611|324370737|FG000|Overall Study|Lost to Follow-up|3|||
94703219|NCT03107611|324370738|FG001|Overall Study|Lost to Follow-up|3|||
94703220|NCT03107611|324370739|FG002|Overall Study|Lost to Follow-up|3|||
94703221|NCT03107611|324370737|FG000|Overall Study|Protocol Violation|0|||
94703222|NCT03107611|324370738|FG001|Overall Study|Protocol Violation|0|||
94703223|NCT03107611|324370739|FG002|Overall Study|Protocol Violation|1|||
94703224|NCT03107611|324370737|FG000|Overall Study|Withdrawal by Subject|1|||
94703225|NCT03107611|324370738|FG001|Overall Study|Withdrawal by Subject|0|||
94703226|NCT03107611|324370739|FG002|Overall Study|Withdrawal by Subject|1|||
94703227|NCT03107611|324370737|FG000|Overall Study|Worsening signs/symptoms|2|||
94703228|NCT03107611|324370738|FG001|Overall Study|Worsening signs/symptoms|1|||
94703229|NCT03107611|324370739|FG002|Overall Study|Worsening signs/symptoms|2|||
94703230|NCT01720446|324370740|FG000|Overall Study|Lost to Follow-up|12|||
94703231|NCT01720446|324370741|FG001|Overall Study|Lost to Follow-up|6|||
94703232|NCT01720446|324370742|FG002|Overall Study|Lost to Follow-up|16|||
94703233|NCT01720446|324370743|FG003|Overall Study|Lost to Follow-up|16|||
94703234|NCT01720446|324370740|FG000|Overall Study|Withdrawal by Subject|2|||
94703235|NCT01720446|324370741|FG001|Overall Study|Withdrawal by Subject|5|||
94703236|NCT01720446|324370742|FG002|Overall Study|Withdrawal by Subject|4|||
94703237|NCT01720446|324370743|FG003|Overall Study|Withdrawal by Subject|4|||
94703238|NCT01020838|324370744|FG000|Overall Study|Death|90|||
94703239|NCT01020838|324370744|FG000|Overall Study|Adverse Event|1|||
94703240|NCT01020838|324370744|FG000|Overall Study|Withdrawal by Subject|9|||
94703241|NCT01020838|324370744|FG000|Overall Study|Lost to Follow-up|6|||
94703242|NCT01020838|324370744|FG000|Overall Study|Most common: Study ended by sponsor|77|||
94703243|NCT05790408|324370745|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
94703244|NCT01048788|324370746|FG000|Overall Study|Adverse Event|5|||
94703245|NCT01048788|324370747|FG001|Overall Study|Adverse Event|1|||
94703246|NCT01048788|324370748|FG002|Overall Study|Adverse Event|1|||
94703247|NCT01048788|324370746|FG000|Overall Study|Lack of Efficacy|0|||
94703248|NCT01048788|324370747|FG001|Overall Study|Lack of Efficacy|0|||
94703249|NCT01048788|324370748|FG002|Overall Study|Lack of Efficacy|1|||
94703250|NCT01048788|324370746|FG000|Overall Study|Withdrawal by Subject|0|||
94266277|NCT03785678|322768409|FG000|Overall Study|Death|44|||
94266278|NCT03785678|322768410|FG001|Overall Study|Death|42|||
94266279|NCT03785678|322768409|FG000|Overall Study|Lost to Follow-up|4|||
94266280|NCT03785678|322768410|FG001|Overall Study|Lost to Follow-up|2|||
94703251|NCT01048788|324370747|FG001|Overall Study|Withdrawal by Subject|1|||
94703252|NCT01048788|324370748|FG002|Overall Study|Withdrawal by Subject|0|||
94266281|NCT03785678|322768409|FG000|Overall Study|Physician Decision|0|||
94266282|NCT03785678|322768410|FG001|Overall Study|Physician Decision|2|||
94703253|NCT00420316|324370750|FG000|Overall Study|Withdrawal by Subject|0|||
94703254|NCT00420316|324370751|FG001|Overall Study|Withdrawal by Subject|1|||
94703255|NCT00420316|324370750|FG000|Overall Study|Lost to Follow-up|12|||
94703256|NCT00420316|324370751|FG001|Overall Study|Lost to Follow-up|8|||
94703257|NCT05419557|324370752|FG000|Overall Study|Lost to Follow-up|11|||
94703258|NCT05419557|324370753|FG001|Overall Study|Lost to Follow-up|4|||
94703259|NCT00588666|324370755|FG000|Overall Study|Adverse Event|4|||
94703260|NCT02274493|324370760|FG000|Overall Study|Withdrawal by Subject|1|||
94703261|NCT00558363|324370761|FG000|Overall Study|Physician Decision|18|||
94703262|NCT00558363|324370762|FG001|Overall Study|Physician Decision|4|||
94703263|NCT00558363|324370761|FG000|Overall Study|Withdrawal by Subject|11|||
94703264|NCT00558363|324370762|FG001|Overall Study|Withdrawal by Subject|4|||
94703265|NCT00558363|324370761|FG000|Overall Study|Adverse Event|5|||
94703266|NCT00558363|324370762|FG001|Overall Study|Adverse Event|5|||
94703267|NCT00558363|324370761|FG000|Overall Study|Lack of Efficacy|2|||
94703268|NCT00558363|324370762|FG001|Overall Study|Lack of Efficacy|2|||
94703269|NCT00558363|324370761|FG000|Overall Study|Protocol Violation|2|||
94703270|NCT00558363|324370762|FG001|Overall Study|Protocol Violation|1|||
94703271|NCT00558363|324370761|FG000|Overall Study|Lost to Follow-up|0|||
94703272|NCT00558363|324370762|FG001|Overall Study|Lost to Follow-up|1|||
94703273|NCT00558363|324370761|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
94703274|NCT00558363|324370762|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
94703275|NCT00558363|324370761|FG000|Overall Study|Randomized in Error|1|||
94703276|NCT00558363|324370762|FG001|Overall Study|Randomized in Error|2|||
94703277|NCT00558363|324370761|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
94703278|NCT00558363|324370762|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
94703279|NCT03102710|324370763|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
94703280|NCT03102710|324370764|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
94703281|NCT03102710|324370765|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
94703282|NCT03102710|324370763|FG000|Overall Study|Technical issues during final MRI scan|0|||
94703283|NCT03102710|324370764|FG001|Overall Study|Technical issues during final MRI scan|1|||
94703284|NCT03102710|324370765|FG002|Overall Study|Technical issues during final MRI scan|0|||
94703285|NCT03102710|324370763|FG000|Overall Study|Nausea during MRI scan|0|||
94703286|NCT03102710|324370764|FG001|Overall Study|Nausea during MRI scan|1|||
94703287|NCT03102710|324370765|FG002|Overall Study|Nausea during MRI scan|0|||
94703288|NCT03102710|324370763|FG000|Overall Study|Subject unable to attend final session|0|||
94703289|NCT03102710|324370764|FG001|Overall Study|Subject unable to attend final session|1|||
94703290|NCT03102710|324370765|FG002|Overall Study|Subject unable to attend final session|0|||
94703291|NCT00920686|324370766|FG000|Overall Study|Lost to Follow-up|2|||
94703292|NCT00920686|324370767|FG001|Overall Study|Lost to Follow-up|3|||
94703293|NCT00920686|324370768|FG002|Overall Study|Lost to Follow-up|1|||
94703294|NCT00920686|324370766|FG000|Overall Study|Study drug dosing criteria not met|17|||
94703295|NCT00920686|324370767|FG001|Overall Study|Study drug dosing criteria not met|19|||
94703296|NCT00920686|324370768|FG002|Overall Study|Study drug dosing criteria not met|12|||
94703297|NCT01695317|324370770|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
94703298|NCT01695317|324370771|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
94703299|NCT01695317|324370770|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
94703300|NCT01695317|324370771|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
94703301|NCT00606580|324370773|FG000|Overall Study|Lost to Follow-up|1|||
94703302|NCT00606580|324370774|FG001|Overall Study|Lost to Follow-up|1|||
94703303|NCT00606580|324370775|FG002|Overall Study|Lost to Follow-up|4|||
94703304|NCT00606580|324370773|FG000|Overall Study|Clinical failures|1|||
94703305|NCT00606580|324370774|FG001|Overall Study|Clinical failures|0|||
94703306|NCT00606580|324370775|FG002|Overall Study|Clinical failures|12|||
94703307|NCT00606580|324370773|FG000|Overall Study|Withdrawal by investigator|0|||
94703308|NCT00606580|324370774|FG001|Overall Study|Withdrawal by investigator|1|||
94703309|NCT00606580|324370775|FG002|Overall Study|Withdrawal by investigator|6|||
94703310|NCT00606580|324370773|FG000|Overall Study|Withdrawal by Subject|0|||
94703311|NCT00606580|324370774|FG001|Overall Study|Withdrawal by Subject|1|||
94703312|NCT00606580|324370775|FG002|Overall Study|Withdrawal by Subject|0|||
94703313|NCT01101165|324370776|FG000|Period 1|Adverse Event|1|||
94703314|NCT01101165|324370777|FG001|Period 1|Adverse Event|2|||
94703315|NCT01101165|324370776|FG000|Period 1|Withdrawal by Subject|0|||
94703316|NCT01101165|324370777|FG001|Period 1|Withdrawal by Subject|2|||
94703317|NCT01101165|324370776|FG000|Period 1|Positive Drug Screen|0|||
94703318|NCT01101165|324370777|FG001|Period 1|Positive Drug Screen|1|||
94703319|NCT01101165|324370776|FG000|Period 1|Lost to Follow-up|1|||
94703320|NCT01101165|324370777|FG001|Period 1|Lost to Follow-up|0|||
94703321|NCT01101165|324370776|FG000|Period 2|Withdrawal by Subject|3|||
94703322|NCT01101165|324370777|FG001|Period 2|Withdrawal by Subject|1|||
94703323|NCT01101165|324370776|FG000|Period 2|Adverse Event|1|||
94703324|NCT01101165|324370777|FG001|Period 2|Adverse Event|0|||
94703325|NCT00798096|324370779|FG000|Overall Study|Ongoing|2|||
94703326|NCT01833065|324370780|FG000|Overall Study|Adverse Event|6|||
94703327|NCT01833065|324370781|FG001|Overall Study|Adverse Event|1|||
94703328|NCT01833065|324370782|FG002|Overall Study|Adverse Event|0|||
94703329|NCT01833065|324370783|FG003|Overall Study|Adverse Event|2|||
94703330|NCT01833065|324370784|FG004|Overall Study|Adverse Event|3|||
94703331|NCT01833065|324370780|FG000|Overall Study|Protocol Violation|1|||
94703332|NCT01833065|324370781|FG001|Overall Study|Protocol Violation|0|||
94703333|NCT01833065|324370782|FG002|Overall Study|Protocol Violation|0|||
94703334|NCT01833065|324370783|FG003|Overall Study|Protocol Violation|0|||
94703335|NCT01833065|324370784|FG004|Overall Study|Protocol Violation|2|||
94703336|NCT01833065|324370780|FG000|Overall Study|Lost to Follow-up|1|||
94652332|NCT03042312|324186047|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
94652333|NCT03042312|324186046|FG000|Overall Study|Withdrawal by Subject|4|||
94652334|NCT03042312|324186047|FG001|Overall Study|Withdrawal by Subject|5|||
94652335|NCT02349711|324186049|FG000|Overall Study|Withdrawal by Subject|2|||
94652336|NCT02349711|324186050|FG001|Overall Study|Withdrawal by Subject|1|||
94652337|NCT02349711|324186049|FG000|Overall Study|Lost to Follow-up|1|||
94652338|NCT02349711|324186050|FG001|Overall Study|Lost to Follow-up|1|||
94652339|NCT02564471|324186051|FG000|Overall Study|Adverse Event|1|||
94652340|NCT02564471|324186052|FG001|Overall Study|Adverse Event|0|||
94652341|NCT02564471|324186053|FG002|Overall Study|Adverse Event|0|||
94652342|NCT02564471|324186054|FG003|Overall Study|Adverse Event|0|||
94652343|NCT02564471|324186051|FG000|Overall Study|Withdrawal by Subject|2|||
94652344|NCT02564471|324186052|FG001|Overall Study|Withdrawal by Subject|1|||
94652345|NCT02564471|324186053|FG002|Overall Study|Withdrawal by Subject|3|||
94652346|NCT02564471|324186054|FG003|Overall Study|Withdrawal by Subject|0|||
94652347|NCT02564471|324186051|FG000|Overall Study|Lost to Follow-up|0|||
94652348|NCT02564471|324186052|FG001|Overall Study|Lost to Follow-up|2|||
94652349|NCT02564471|324186053|FG002|Overall Study|Lost to Follow-up|0|||
94652350|NCT02564471|324186054|FG003|Overall Study|Lost to Follow-up|0|||
94652351|NCT00941733|324186055|FG000|Overall Study|Death|24|||
94652352|NCT00941733|324186056|FG001|Overall Study|Death|10|||
94652353|NCT00941733|324186055|FG000|Overall Study|Withdrawal by Subject|14|||
94652354|NCT00941733|324186056|FG001|Overall Study|Withdrawal by Subject|6|||
94652355|NCT00941733|324186055|FG000|Overall Study|Adverse Event|20|||
94652356|NCT00941733|324186056|FG001|Overall Study|Adverse Event|4|||
94652357|NCT00941733|324186055|FG000|Overall Study|Lost to Follow-up|1|||
94652358|NCT00941733|324186056|FG001|Overall Study|Lost to Follow-up|2|||
94652359|NCT00941733|324186055|FG000|Overall Study|Protocol Violation|15|||
94652360|NCT00941733|324186056|FG001|Overall Study|Protocol Violation|6|||
94652361|NCT00194012|324186057|FG000|Randomized Phase|Lack of Efficacy|8|||
94652362|NCT00194012|324186058|FG001|Randomized Phase|Lack of Efficacy|18|||
94652363|NCT00194012|324186057|FG000|Randomized Phase|Study nonadherence|2|||
94652364|NCT00194012|324186058|FG001|Randomized Phase|Study nonadherence|1|||
94652365|NCT00194012|324186057|FG000|Randomized Phase|Withdrawal by Subject|3|||
94652366|NCT00194012|324186058|FG001|Randomized Phase|Withdrawal by Subject|3|||
94652367|NCT00194012|324186057|FG000|Randomized Phase|Adverse Event|2|||
94652368|NCT00194012|324186058|FG001|Randomized Phase|Adverse Event|1|||
94652369|NCT00194012|324186057|FG000|Randomized Phase|Participant reported having a rash|1|||
94652370|NCT00194012|324186058|FG001|Randomized Phase|Participant reported having a rash|0|||
94652371|NCT00194012|324186057|FG000|Randomized Phase|Emesis and enuresis|0|||
94652372|NCT00194012|324186058|FG001|Randomized Phase|Emesis and enuresis|1|||
94652373|NCT00194012|324186057|FG000|Randomized Phase|Oral/nasal twitching|0|||
94652374|NCT00194012|324186058|FG001|Randomized Phase|Oral/nasal twitching|1|||
94652375|NCT00194012|324186057|FG000|Open Label Extension (OLE)|Weight Gain|1|||
94652376|NCT00194012|324186058|FG001|Open Label Extension (OLE)|Weight Gain|0|||
94652377|NCT00194012|324186057|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
94652378|NCT00194012|324186058|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
94652379|NCT00194012|324186057|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
94652380|NCT00194012|324186058|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
94703337|NCT01833065|324370781|FG001|Overall Study|Lost to Follow-up|0|||
94652381|NCT00194012|324186057|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
94652382|NCT00194012|324186058|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
94652383|NCT04260191|324186061|FG000|Overall Study|Decision by Sponsor|0|||
94652384|NCT04260191|324186062|FG001|Overall Study|Decision by Sponsor|1|||
94652385|NCT04260191|324186063|FG002|Overall Study|Decision by Sponsor|0|||
94652386|NCT04260191|324186061|FG000|Overall Study|Withdrawal by Subject|1|||
94652387|NCT04260191|324186062|FG001|Overall Study|Withdrawal by Subject|0|||
94652388|NCT04260191|324186063|FG002|Overall Study|Withdrawal by Subject|3|||
94652389|NCT04260191|324186061|FG000|Overall Study|Death|4|||
94652390|NCT04260191|324186062|FG001|Overall Study|Death|3|||
94652391|NCT04260191|324186063|FG002|Overall Study|Death|2|||
94652392|NCT01643473|324186064|FG000|Overall Study|Lost to Follow-up|1|||
94652393|NCT01643473|324186065|FG001|Overall Study|Lost to Follow-up|0|||
94652394|NCT01312909|324186066|FG000|Overall Study|Randomized but not treated|1|||
94652395|NCT01312909|324186067|FG001|Overall Study|Randomized but not treated|3|||
94652396|NCT01312909|324186068|FG002|Overall Study|Randomized but not treated|1|||
94652397|NCT01312909|324186066|FG000|Overall Study|Adverse Event|1|||
94652398|NCT01312909|324186067|FG001|Overall Study|Adverse Event|0|||
94652399|NCT01312909|324186068|FG002|Overall Study|Adverse Event|3|||
94652400|NCT01312909|324186066|FG000|Overall Study|Protocol Violation|2|||
94652401|NCT01312909|324186067|FG001|Overall Study|Protocol Violation|0|||
94652402|NCT01312909|324186068|FG002|Overall Study|Protocol Violation|2|||
94652403|NCT01312909|324186066|FG000|Overall Study|Other|9|||
94652404|NCT01312909|324186067|FG001|Overall Study|Other|6|||
94652405|NCT01312909|324186068|FG002|Overall Study|Other|11|||
94652406|NCT01312909|324186066|FG000|Overall Study|Withdrawal by Subject|8|||
94652407|NCT01312909|324186067|FG001|Overall Study|Withdrawal by Subject|10|||
94652408|NCT01312909|324186068|FG002|Overall Study|Withdrawal by Subject|7|||
94652409|NCT01312909|324186066|FG000|Overall Study|Lost to Follow-up|21|||
94652410|NCT01312909|324186067|FG001|Overall Study|Lost to Follow-up|17|||
94652411|NCT01312909|324186068|FG002|Overall Study|Lost to Follow-up|20|||
94652412|NCT01312909|324186066|FG000|Overall Study|Insufficient clinical response|0|||
94652413|NCT01312909|324186067|FG001|Overall Study|Insufficient clinical response|0|||
94652414|NCT01312909|324186068|FG002|Overall Study|Insufficient clinical response|1|||
94652415|NCT01312909|324186066|FG000|Overall Study|Entrance criteria not met|0|||
94652416|NCT01312909|324186067|FG001|Overall Study|Entrance criteria not met|0|||
94652417|NCT01312909|324186068|FG002|Overall Study|Entrance criteria not met|2|||
94652418|NCT02564198|324186070|FG000|Overall Study|Withdrawal by Subject|2|||
94652419|NCT02564198|324186071|FG001|Overall Study|Withdrawal by Subject|4|||
94652420|NCT02564198|324186072|FG002|Overall Study|Withdrawal by Subject|0|||
94652421|NCT02564198|324186070|FG000|Overall Study|Adverse Event|0|||
94652422|NCT02564198|324186071|FG001|Overall Study|Adverse Event|1|||
94652423|NCT02564198|324186072|FG002|Overall Study|Adverse Event|0|||
94652424|NCT00672477|324186076|FG000|Overall Study|Adverse Event|10|||
94652425|NCT00672477|324186077|FG001|Overall Study|Adverse Event|7|||
94652426|NCT00672477|324186076|FG000|Overall Study|Death|7|||
94652427|NCT00672477|324186077|FG001|Overall Study|Death|11|||
94652428|NCT00672477|324186076|FG000|Overall Study|Physician Decision|2|||
94652429|NCT00672477|324186077|FG001|Overall Study|Physician Decision|0|||
94652430|NCT00672477|324186076|FG000|Overall Study|Protocol Violation|1|||
94652431|NCT00672477|324186077|FG001|Overall Study|Protocol Violation|1|||
94652432|NCT00672477|324186076|FG000|Overall Study|Withdrawal by Subject|5|||
94652433|NCT00672477|324186077|FG001|Overall Study|Withdrawal by Subject|3|||
94652434|NCT00672477|324186076|FG000|Overall Study|Lack of Efficacy|1|||
94652435|NCT00672477|324186077|FG001|Overall Study|Lack of Efficacy|1|||
94652436|NCT00672477|324186076|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
94652437|NCT00672477|324186077|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
94652438|NCT03394391|324186084|FG000|Overall Study|Lost to Follow-up|1|||
94652439|NCT03394391|324186085|FG001|Overall Study|Lost to Follow-up|2|||
94652440|NCT00451282|324186086|FG000|Overall Study|Lost to Follow-up|6|||
94652441|NCT00451282|324186087|FG001|Overall Study|Lost to Follow-up|5|||
94652442|NCT00501540|324186088|FG000|Overall Study|Death|5|||
94652443|NCT01797536|324186089|FG000|Overall Study|Adverse Event|0|||
94652444|NCT01797536|324186090|FG001|Overall Study|Adverse Event|1|||
94652445|NCT01797536|324186091|FG002|Overall Study|Adverse Event|0|||
94652446|NCT01797536|324186092|FG003|Overall Study|Adverse Event|0|||
94652447|NCT00098839|324186093|FG000|Overall Study|Adverse Event|5|||
94652448|NCT00098839|324186094|FG001|Overall Study|Adverse Event|2|||
94652449|NCT00098839|324186093|FG000|Overall Study|Death|1|||
94652450|NCT00098839|324186094|FG001|Overall Study|Death|2|||
94652451|NCT00098839|324186093|FG000|Overall Study|Physician Decision|4|||
94652452|NCT00098839|324186094|FG001|Overall Study|Physician Decision|14|||
94652453|NCT00098839|324186093|FG000|Overall Study|Withdrawal by Subject|1|||
94652454|NCT00098839|324186094|FG001|Overall Study|Withdrawal by Subject|0|||
94652455|NCT00098839|324186093|FG000|Overall Study|Refusal of further protocol therapy|3|||
94652456|NCT00098839|324186094|FG001|Overall Study|Refusal of further protocol therapy|1|||
94652457|NCT00098839|324186093|FG000|Overall Study|Relapse|6|||
94652458|NCT00098839|324186094|FG001|Overall Study|Relapse|3|||
94652459|NCT00098839|324186093|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
94703338|NCT01833065|324370782|FG002|Overall Study|Lost to Follow-up|0|||
94703339|NCT01833065|324370783|FG003|Overall Study|Lost to Follow-up|0|||
94703340|NCT01833065|324370784|FG004|Overall Study|Lost to Follow-up|3|||
94703341|NCT01833065|324370780|FG000|Overall Study|Withdrawal by Subject|6|||
94703342|NCT01833065|324370781|FG001|Overall Study|Withdrawal by Subject|2|||
94703343|NCT01833065|324370782|FG002|Overall Study|Withdrawal by Subject|4|||
94703344|NCT01833065|324370783|FG003|Overall Study|Withdrawal by Subject|3|||
94703345|NCT01833065|324370784|FG004|Overall Study|Withdrawal by Subject|11|||
94703346|NCT01833065|324370780|FG000|Overall Study|Subject's substantial non-compliance|0|||
94703347|NCT01833065|324370781|FG001|Overall Study|Subject's substantial non-compliance|1|||
94703348|NCT01833065|324370782|FG002|Overall Study|Subject's substantial non-compliance|0|||
94703349|NCT01833065|324370783|FG003|Overall Study|Subject's substantial non-compliance|0|||
94703350|NCT01833065|324370784|FG004|Overall Study|Subject's substantial non-compliance|0|||
94703351|NCT01833065|324370780|FG000|Overall Study|Trial terminated by sponsor|8|||
94703352|NCT01833065|324370781|FG001|Overall Study|Trial terminated by sponsor|8|||
94703353|NCT01833065|324370782|FG002|Overall Study|Trial terminated by sponsor|7|||
94703354|NCT01833065|324370783|FG003|Overall Study|Trial terminated by sponsor|3|||
94703355|NCT01833065|324370784|FG004|Overall Study|Trial terminated by sponsor|13|||
94703356|NCT01833065|324370780|FG000|Overall Study|Others|2|||
94703357|NCT01833065|324370781|FG001|Overall Study|Others|1|||
94703358|NCT01833065|324370782|FG002|Overall Study|Others|1|||
94703359|NCT01833065|324370783|FG003|Overall Study|Others|1|||
94703360|NCT01833065|324370784|FG004|Overall Study|Others|4|||
94703361|NCT03670602|324370791|FG000|Overall Study|Lost to Follow-up|1|||
94703362|NCT03670602|324370792|FG001|Overall Study|Lost to Follow-up|0|||
94703363|NCT03670602|324370791|FG000|Overall Study|Withdrawal by Subject|0|||
94703364|NCT03670602|324370792|FG001|Overall Study|Withdrawal by Subject|3|||
94703365|NCT00001575|324370797|FG000|Overall Study|Screening failures-Ph I portion|22|||
94703366|NCT00001575|324370797|FG000|Overall Study|Withdrawn/deaths|23|||
94703367|NCT00831792|324370798|FG000|Overall Study|Not Eligible|3|||
94703368|NCT00831792|324370798|FG000|Overall Study|Adverse Event|1|||
94703369|NCT00831792|324370798|FG000|Overall Study|Death|1|||
94703370|NCT00831792|324370798|FG000|Overall Study|Lack of Efficacy|1|||
94703371|NCT02469064|324370801|FG000|Overall Study|Request not to receive intervention.|1|||
94703372|NCT02469064|324370802|FG001|Overall Study|Request not to receive intervention.|3|||
94703373|NCT00678795|324370803|FG000|Overall Study|Adverse Event|7|||
94703374|NCT00678795|324370804|FG001|Overall Study|Adverse Event|3|||
94703375|NCT00678795|324370803|FG000|Overall Study|Withdrawal by Subject|3|||
94703376|NCT00678795|324370804|FG001|Overall Study|Withdrawal by Subject|0|||
94703377|NCT00678795|324370803|FG000|Overall Study|Protocol Violation|0|||
94703378|NCT00678795|324370804|FG001|Overall Study|Protocol Violation|1|||
94703379|NCT00678795|324370803|FG000|Overall Study|Lost to Follow-up|0|||
94703380|NCT00678795|324370804|FG001|Overall Study|Lost to Follow-up|1|||
94703381|NCT00678795|324370803|FG000|Overall Study|Lack of Efficacy|1|||
94703382|NCT00678795|324370804|FG001|Overall Study|Lack of Efficacy|1|||
94703383|NCT01120275|324370805|FG000|Overall Study|Adverse Event|3|||
94703384|NCT01120275|324370805|FG000|Overall Study|Progression|27|||
94703385|NCT01120275|324370805|FG000|Overall Study|Ineligible|3|||
94703386|NCT01120275|324370805|FG000|Overall Study|Withdrawal by Subject|1|||
94703387|NCT01120275|324370805|FG000|Overall Study|Refusal|1|||
94703388|NCT01120275|324370805|FG000|Overall Study|Not specific|1|||
94703389|NCT01253226|324370817|FG000|Overall Study|Adverse Event|0|||
94703390|NCT01253226|324370818|FG001|Overall Study|Adverse Event|0|||
94703391|NCT01253226|324370819|FG002|Overall Study|Adverse Event|1|||
94703392|NCT01253226|324370820|FG003|Overall Study|Adverse Event|0|||
94703393|NCT01253226|324370821|FG004|Overall Study|Adverse Event|0|||
94703394|NCT01253226|324370817|FG000|Overall Study|Death|0|||
94703395|NCT01253226|324370818|FG001|Overall Study|Death|1|||
94703396|NCT01253226|324370819|FG002|Overall Study|Death|0|||
94703397|NCT01253226|324370820|FG003|Overall Study|Death|0|||
94703398|NCT01253226|324370821|FG004|Overall Study|Death|0|||
94703399|NCT01253226|324370817|FG000|Overall Study|Physician Decision|0|||
94703400|NCT01253226|324370818|FG001|Overall Study|Physician Decision|0|||
94703401|NCT01253226|324370819|FG002|Overall Study|Physician Decision|0|||
94703402|NCT01253226|324370820|FG003|Overall Study|Physician Decision|0|||
94703403|NCT01253226|324370821|FG004|Overall Study|Physician Decision|2|||
94703404|NCT01253226|324370817|FG000|Overall Study|Withdrawal by Subject|0|||
94703405|NCT01253226|324370818|FG001|Overall Study|Withdrawal by Subject|0|||
94703406|NCT01253226|324370819|FG002|Overall Study|Withdrawal by Subject|0|||
94703407|NCT01253226|324370820|FG003|Overall Study|Withdrawal by Subject|1|||
94703408|NCT01253226|324370821|FG004|Overall Study|Withdrawal by Subject|0|||
94703409|NCT01839877|324370823|FG000|Overall Study|Protocol Violation|1|||
94703410|NCT02781584|324370824|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
94703411|NCT02781584|324370825|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
94703412|NCT02781584|324370826|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
94703413|NCT02781584|324370827|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
94703414|NCT02781584|324370828|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
94703415|NCT02781584|324370829|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
94703416|NCT02781584|324370830|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
94703417|NCT02781584|324370831|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
94703418|NCT02781584|324370832|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
94703419|NCT02781584|324370833|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
94703420|NCT02781584|324370834|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
94703421|NCT02781584|324370835|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
94703422|NCT02781584|324370836|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
94703423|NCT02781584|324370824|FG000|Pre-treatment Phase|Adverse Event|0|||
94703424|NCT02781584|324370825|FG001|Pre-treatment Phase|Adverse Event|0|||
94703425|NCT02781584|324370826|FG002|Pre-treatment Phase|Adverse Event|0|||
94266283|NCT03785678|322768409|FG000|Overall Study|Withdrawal by Subject|5|||
94266284|NCT03785678|322768410|FG001|Overall Study|Withdrawal by Subject|3|||
94266285|NCT00898443|322768411|FG000|Overall Study|Withdrawal by Subject|1|||
94703426|NCT02781584|324370827|FG003|Pre-treatment Phase|Adverse Event|0|||
94703427|NCT02781584|324370828|FG004|Pre-treatment Phase|Adverse Event|0|||
94703428|NCT02781584|324370829|FG005|Pre-treatment Phase|Adverse Event|0|||
94703429|NCT02781584|324370830|FG006|Pre-treatment Phase|Adverse Event|0|||
94703430|NCT02781584|324370831|FG007|Pre-treatment Phase|Adverse Event|0|||
94703431|NCT02781584|324370832|FG008|Pre-treatment Phase|Adverse Event|0|||
94266286|NCT00898443|322768412|FG001|Overall Study|Withdrawal by Subject|0|||
94703432|NCT02781584|324370833|FG009|Pre-treatment Phase|Adverse Event|0|||
94703433|NCT02781584|324370834|FG010|Pre-treatment Phase|Adverse Event|0|||
94703434|NCT02781584|324370835|FG011|Pre-treatment Phase|Adverse Event|1|||
94703435|NCT02781584|324370836|FG012|Pre-treatment Phase|Adverse Event|0|||
94703436|NCT02781584|324370824|FG000|Treatment Phase|Withdrew Consent|0|||
94703437|NCT02781584|324370825|FG001|Treatment Phase|Withdrew Consent|0|||
94703438|NCT02781584|324370826|FG002|Treatment Phase|Withdrew Consent|0|||
94703439|NCT02781584|324370827|FG003|Treatment Phase|Withdrew Consent|0|||
94703440|NCT02781584|324370828|FG004|Treatment Phase|Withdrew Consent|0|||
94703441|NCT02781584|324370829|FG005|Treatment Phase|Withdrew Consent|1|||
94703442|NCT02781584|324370830|FG006|Treatment Phase|Withdrew Consent|0|||
94703443|NCT02781584|324370831|FG007|Treatment Phase|Withdrew Consent|0|||
94703444|NCT02781584|324370832|FG008|Treatment Phase|Withdrew Consent|0|||
94703445|NCT02781584|324370833|FG009|Treatment Phase|Withdrew Consent|0|||
94703446|NCT02781584|324370834|FG010|Treatment Phase|Withdrew Consent|1|||
94703447|NCT02781584|324370835|FG011|Treatment Phase|Withdrew Consent|2|||
94703448|NCT02781584|324370836|FG012|Treatment Phase|Withdrew Consent|0|||
94703449|NCT02781584|324370824|FG000|Treatment Phase|Adverse Event|0|||
94703450|NCT02781584|324370825|FG001|Treatment Phase|Adverse Event|0|||
94703451|NCT02781584|324370826|FG002|Treatment Phase|Adverse Event|0|||
94703452|NCT02781584|324370827|FG003|Treatment Phase|Adverse Event|0|||
94703453|NCT02781584|324370828|FG004|Treatment Phase|Adverse Event|0|||
94703454|NCT02781584|324370829|FG005|Treatment Phase|Adverse Event|0|||
94703455|NCT02781584|324370830|FG006|Treatment Phase|Adverse Event|0|||
94703456|NCT02781584|324370831|FG007|Treatment Phase|Adverse Event|1|||
94703457|NCT02781584|324370832|FG008|Treatment Phase|Adverse Event|0|||
94703458|NCT02781584|324370833|FG009|Treatment Phase|Adverse Event|0|||
94703459|NCT02781584|324370834|FG010|Treatment Phase|Adverse Event|0|||
94703460|NCT02781584|324370835|FG011|Treatment Phase|Adverse Event|0|||
94703461|NCT02781584|324370836|FG012|Treatment Phase|Adverse Event|0|||
94703462|NCT00554801|324370837|FG000|Overall Study|left area before completion|5|||
94703463|NCT00554801|324370838|FG001|Overall Study|left area before completion|0|||
94703464|NCT00554801|324370837|FG000|Overall Study|Withdrawal by Subject|14|||
94703465|NCT00554801|324370838|FG001|Overall Study|Withdrawal by Subject|0|||
94703466|NCT01093534|324370839|FG000|Overall Study|Adverse Event|2|||
94703467|NCT01093534|324370840|FG001|Overall Study|Adverse Event|5|||
94703468|NCT01093534|324370841|FG002|Overall Study|Adverse Event|2|||
94703469|NCT01093534|324370839|FG000|Overall Study|Lack of Efficacy|2|||
94703470|NCT01093534|324370840|FG001|Overall Study|Lack of Efficacy|1|||
94703471|NCT01093534|324370841|FG002|Overall Study|Lack of Efficacy|1|||
94703472|NCT01093534|324370839|FG000|Overall Study|Withdrawal by Subject|5|||
94703473|NCT01093534|324370840|FG001|Overall Study|Withdrawal by Subject|7|||
94703474|NCT01093534|324370841|FG002|Overall Study|Withdrawal by Subject|2|||
94703475|NCT01093534|324370839|FG000|Overall Study|Other|1|||
94703476|NCT01093534|324370840|FG001|Overall Study|Other|3|||
94703477|NCT01093534|324370841|FG002|Overall Study|Other|4|||
94703478|NCT04340362|324370842|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
94703479|NCT00811057|324370843|FG000|Overall Study|Protocol Violation|5|||
94703480|NCT00811057|324370844|FG001|Overall Study|Protocol Violation|10|||
94703481|NCT00811057|324370845|FG002|Overall Study|Protocol Violation|10|||
94703482|NCT00768651|324370850|FG000|Overall Study|Withdrawal by Subject|1|||
94703483|NCT04436120|324370851|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
94703484|NCT04436120|324370852|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
94703485|NCT04436120|324370853|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
94703486|NCT04436120|324370854|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
94703487|NCT04436120|324370855|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
94703488|NCT04436120|324370856|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
94703489|NCT04436120|324370857|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
94266287|NCT01708291|322768419|FG000|Overall Study|fighting|2|||
94266288|NCT01708291|322768420|FG001|Overall Study|fighting|1|||
94266289|NCT00521053|322768421|FG000|Observation Phase|Disease Progression|55|||
94266290|NCT00521053|322768421|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
94266291|NCT00521053|322768421|FG000|Observation Phase|Death|2|||
94266292|NCT00521053|322768421|FG000|Observation Phase|Adverse Event|1|||
94266293|NCT00521053|322768421|FG000|Observation Phase|Other non-study melanoma treatment|1|||
94266294|NCT00521053|322768421|FG000|Observation Phase|Physician Decision|1|||
94266295|NCT05293743|322768423|FG000|Overall Study|Withdrawal by Subject|1|||
94266296|NCT05293743|322768424|FG001|Overall Study|Withdrawal by Subject|0|||
94266297|NCT03734016|322768427|FG000|Overall Study|Sponsor Ended Study|225|||
94266298|NCT03734016|322768428|FG001|Overall Study|Sponsor Ended Study|200|||
94266299|NCT03734016|322768427|FG000|Overall Study|Death|69|||
94266300|NCT03734016|322768428|FG001|Overall Study|Death|83|||
94652460|NCT00098839|324186094|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
94652461|NCT00098839|324186093|FG000|Overall Study|Ineligible|2|||
94652462|NCT00098839|324186094|FG001|Overall Study|Ineligible|0|||
94652463|NCT01465802|324186095|FG000|Overall Study|Study terminated by sponsor|1|||
94652464|NCT01465802|324186096|FG001|Overall Study|Study terminated by sponsor|0|||
94652465|NCT01465802|324186097|FG002|Overall Study|Study terminated by sponsor|0|||
94652466|NCT01465802|324186098|FG003|Overall Study|Study terminated by sponsor|1|||
94652467|NCT01465802|324186099|FG004|Overall Study|Study terminated by sponsor|7|||
94652468|NCT01465802|324186095|FG000|Overall Study|Withdrawal by Subject|7|||
94652469|NCT01465802|324186096|FG001|Overall Study|Withdrawal by Subject|7|||
94652470|NCT01465802|324186097|FG002|Overall Study|Withdrawal by Subject|0|||
94652471|NCT01465802|324186098|FG003|Overall Study|Withdrawal by Subject|8|||
94652472|NCT01465802|324186099|FG004|Overall Study|Withdrawal by Subject|1|||
94652473|NCT01465802|324186095|FG000|Overall Study|Lost to Follow-up|1|||
94652474|NCT01465802|324186096|FG001|Overall Study|Lost to Follow-up|1|||
94652475|NCT01465802|324186097|FG002|Overall Study|Lost to Follow-up|0|||
94652476|NCT01465802|324186098|FG003|Overall Study|Lost to Follow-up|0|||
94652477|NCT01465802|324186099|FG004|Overall Study|Lost to Follow-up|0|||
94652478|NCT01465802|324186095|FG000|Overall Study|Reason not specified|9|||
94652479|NCT01465802|324186096|FG001|Overall Study|Reason not specified|4|||
94652480|NCT01465802|324186097|FG002|Overall Study|Reason not specified|0|||
94652481|NCT01465802|324186098|FG003|Overall Study|Reason not specified|10|||
94652482|NCT01465802|324186099|FG004|Overall Study|Reason not specified|2|||
94652483|NCT01465802|324186095|FG000|Overall Study|Death|15|||
94652484|NCT01465802|324186096|FG001|Overall Study|Death|12|||
94652485|NCT01465802|324186097|FG002|Overall Study|Death|0|||
94652486|NCT01465802|324186098|FG003|Overall Study|Death|10|||
94652487|NCT01465802|324186099|FG004|Overall Study|Death|2|||
94652488|NCT00796861|324186100|FG000|Overall Study|Withdrawal by Subject|2|||
94652489|NCT00796861|324186100|FG000|Overall Study|Death|2|||
94652490|NCT01532687|324186102|FG000|Overall Study|Death|2|||
94652491|NCT01532687|324186103|FG001|Overall Study|Death|0|||
94652492|NCT01532687|324186102|FG000|Overall Study|Adverse Event|6|||
94652493|NCT01532687|324186103|FG001|Overall Study|Adverse Event|1|||
94652494|NCT01532687|324186102|FG000|Overall Study|Withdrawal by Subject|1|||
94652495|NCT01532687|324186103|FG001|Overall Study|Withdrawal by Subject|0|||
94652496|NCT01532687|324186102|FG000|Overall Study|Physician Decision|2|||
94652497|NCT01532687|324186103|FG001|Overall Study|Physician Decision|1|||
94652498|NCT01532687|324186102|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
94652499|NCT01532687|324186103|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
94652500|NCT02809976|324186104|FG000|Overall Study|Lost to Follow-up|1|||
94652501|NCT02809976|324186104|FG000|Overall Study|Withdrawal by Subject|1|||
94652502|NCT04394351|324186105|FG000|Part A (16 Weeks)|Adverse Event|1|||
94652503|NCT04394351|324186106|FG001|Part A (16 Weeks)|Adverse Event|0|||
94652504|NCT04394351|324186107|FG002|Part A (16 Weeks)|Adverse Event|0|||
94652505|NCT04394351|324186108|FG003|Part A (16 Weeks)|Adverse Event|0|||
94652506|NCT04394351|324186109|FG004|Part A (16 Weeks)|Adverse Event|0|||
94652507|NCT04394351|324186110|FG005|Part A (16 Weeks)|Adverse Event|0|||
94652508|NCT04394351|324186111|FG006|Part A (16 Weeks)|Adverse Event|0|||
94652509|NCT04394351|324186112|FG007|Part A (16 Weeks)|Adverse Event|0|||
94652510|NCT04394351|324186105|FG000|Part A (16 Weeks)|Physician Decision|0|||
94652511|NCT04394351|324186106|FG001|Part A (16 Weeks)|Physician Decision|1|||
94652512|NCT04394351|324186107|FG002|Part A (16 Weeks)|Physician Decision|0|||
94652513|NCT04394351|324186108|FG003|Part A (16 Weeks)|Physician Decision|0|||
94652514|NCT04394351|324186109|FG004|Part A (16 Weeks)|Physician Decision|0|||
94652515|NCT04394351|324186110|FG005|Part A (16 Weeks)|Physician Decision|0|||
94652516|NCT04394351|324186111|FG006|Part A (16 Weeks)|Physician Decision|0|||
94652517|NCT04394351|324186112|FG007|Part A (16 Weeks)|Physician Decision|0|||
94652518|NCT04394351|324186105|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
94652519|NCT04394351|324186106|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
94652520|NCT04394351|324186107|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
94266301|NCT03734016|322768427|FG000|Overall Study|Withdrawal by Subject|21|||
94652521|NCT04394351|324186108|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
94652522|NCT04394351|324186109|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
94652523|NCT04394351|324186110|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
94652524|NCT04394351|324186111|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
94652525|NCT04394351|324186112|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
94652526|NCT04394351|324186105|FG000|Part B (36 Weeks)|Adverse Event|0|||
94652527|NCT04394351|324186106|FG001|Part B (36 Weeks)|Adverse Event|0|||
94652528|NCT04394351|324186107|FG002|Part B (36 Weeks)|Adverse Event|0|||
94652529|NCT04394351|324186108|FG003|Part B (36 Weeks)|Adverse Event|0|||
94652530|NCT04394351|324186109|FG004|Part B (36 Weeks)|Adverse Event|0|||
94652531|NCT04394351|324186110|FG005|Part B (36 Weeks)|Adverse Event|0|||
94652532|NCT04394351|324186111|FG006|Part B (36 Weeks)|Adverse Event|1|||
94652533|NCT04394351|324186112|FG007|Part B (36 Weeks)|Adverse Event|0|||
94652534|NCT01060384|324186113|FG000|Overall Study|Withdrawal by Subject|0|||
94652535|NCT01060384|324186114|FG001|Overall Study|Withdrawal by Subject|1|||
94652536|NCT01060384|324186115|FG002|Overall Study|Withdrawal by Subject|0|||
94652537|NCT01060384|324186116|FG003|Overall Study|Withdrawal by Subject|0|||
94652538|NCT01060384|324186117|FG004|Overall Study|Withdrawal by Subject|0|||
94652539|NCT01060384|324186113|FG000|Overall Study|Death|0|||
94652540|NCT01060384|324186114|FG001|Overall Study|Death|0|||
94652541|NCT01060384|324186115|FG002|Overall Study|Death|0|||
94652542|NCT01060384|324186116|FG003|Overall Study|Death|0|||
94652543|NCT01060384|324186117|FG004|Overall Study|Death|1|||
94652544|NCT01060384|324186113|FG000|Overall Study|Intercurrent illness|0|||
94652545|NCT01060384|324186114|FG001|Overall Study|Intercurrent illness|0|||
94652546|NCT01060384|324186115|FG002|Overall Study|Intercurrent illness|0|||
94652547|NCT01060384|324186116|FG003|Overall Study|Intercurrent illness|0|||
94652548|NCT01060384|324186117|FG004|Overall Study|Intercurrent illness|1|||
94652549|NCT01600040|324186123|FG000|Overall Study|Withdrawal by Subject|1|||
94652550|NCT01263873|324186124|FG000|Overall Study|One provider unable to complete numbers|1|||
94652551|NCT01263873|324186125|FG001|Overall Study|One provider unable to complete numbers|1|||
94652552|NCT00642304|324186128|FG000|Overall Study|Adverse Event|1|||
94652553|NCT00642304|324186128|FG000|Overall Study|Death|1|||
94652554|NCT00642304|324186128|FG000|Overall Study|Blood transfusion|2|||
94652555|NCT00642304|324186128|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
94652556|NCT00642304|324186128|FG000|Overall Study|Transplantation|1|||
94652557|NCT01412424|324186131|FG000|Core Treatment Period|Treatment Failure|24|||
94652558|NCT01412424|324186131|FG000|Core Treatment Period|Adverse Event|21|||
94652559|NCT01412424|324186131|FG000|Core Treatment Period|Patient Request|5|||
94652560|NCT01412424|324186131|FG000|Core Treatment Period|Lost to Follow-up|2|||
94652561|NCT01412424|324186131|FG000|Core Treatment Period|Sponsor Request|1|||
94652562|NCT01412424|324186131|FG000|Extension Treatment Period|Adverse Event|2|||
94652563|NCT01412424|324186131|FG000|Extension Treatment Period|Treatment Failure|2|||
94652564|NCT01412424|324186131|FG000|Extension Treatment Period|Patient Request|2|||
94652565|NCT00673452|324186136|FG000|Acute Double-Blind Phase|Adverse Event|41|||
94652566|NCT00673452|324186137|FG001|Acute Double-Blind Phase|Adverse Event|24|||
94652567|NCT00673452|324186136|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
94652568|NCT00673452|324186137|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
94652569|NCT00673452|324186136|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
94652570|NCT00673452|324186137|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
94652571|NCT00673452|324186136|FG000|Acute Double-Blind Phase|Physician Decision|0|||
94652572|NCT00673452|324186137|FG001|Acute Double-Blind Phase|Physician Decision|6|||
94652573|NCT00673452|324186136|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
94652574|NCT00673452|324186137|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
94652575|NCT00673452|324186136|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
94652576|NCT00673452|324186137|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
94652577|NCT00673452|324186136|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
94652578|NCT00673452|324186137|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
94652579|NCT00673452|324186136|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
94652580|NCT00673452|324186137|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
94652581|NCT00673452|324186136|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
94652582|NCT00673452|324186137|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
94652583|NCT00673452|324186136|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
94652584|NCT00673452|324186137|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
94652585|NCT00673452|324186136|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
94652586|NCT00673452|324186137|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
94652587|NCT00673452|324186136|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
94652588|NCT00673452|324186137|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
94652589|NCT00673452|324186136|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
94652590|NCT00673452|324186137|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
94652591|NCT00673452|324186136|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
94652592|NCT00673452|324186137|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
94652593|NCT00673452|324186136|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
94266302|NCT03734016|322768428|FG001|Overall Study|Withdrawal by Subject|27|||
94266303|NCT03734016|322768427|FG000|Overall Study|Physician Decision|1|||
94266304|NCT03734016|322768428|FG001|Overall Study|Physician Decision|12|||
94703490|NCT05576662|324370858|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
94703491|NCT05576662|324370859|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
94703492|NCT05576662|324370858|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
94703493|NCT05576662|324370859|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
94703494|NCT05576662|324370858|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
94703495|NCT05576662|324370859|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
94703496|NCT05576662|324370858|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
94703497|NCT05576662|324370859|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
94703498|NCT02482233|324370864|FG000|Overall Study|Lost to Follow-up|1|||
94703499|NCT02482233|324370865|FG001|Overall Study|Lost to Follow-up|1|||
94703500|NCT00299702|324370871|FG000|Overall Study|Death|1|||
94703501|NCT00299702|324370872|FG001|Overall Study|Death|0|||
94703502|NCT00299702|324370871|FG000|Overall Study|Adverse Event|0|||
94703503|NCT00299702|324370872|FG001|Overall Study|Adverse Event|4|||
94703504|NCT00299702|324370871|FG000|Overall Study|Lost to Follow-up|18|||
94703505|NCT00299702|324370872|FG001|Overall Study|Lost to Follow-up|10|||
94703506|NCT00299702|324370871|FG000|Overall Study|Withdrawal by Subject|25|||
94703507|NCT00299702|324370872|FG001|Overall Study|Withdrawal by Subject|23|||
94703508|NCT00299702|324370871|FG000|Overall Study|Pregnancy|0|||
94703509|NCT00299702|324370872|FG001|Overall Study|Pregnancy|1|||
94703510|NCT00299702|324370871|FG000|Overall Study|Insufficient Response|4|||
94703511|NCT00299702|324370872|FG001|Overall Study|Insufficient Response|3|||
94703512|NCT00299702|324370871|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
94703513|NCT00299702|324370872|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
94703514|NCT05052983|324370873|FG000|Overall Study|Lack of Efficacy|3|||
94703515|NCT05052983|324370874|FG001|Overall Study|Lack of Efficacy|12|||
94703516|NCT05052983|324370873|FG000|Overall Study|Adverse Event|1|||
94703517|NCT05052983|324370874|FG001|Overall Study|Adverse Event|0|||
94703518|NCT03141788|324370875|FG000|Overall Study|Lost to Follow-up|1|||
94703519|NCT03141788|324370875|FG000|Overall Study|Protocol Violation|3|||
94703520|NCT03141788|324370875|FG000|Overall Study|Withdrawal by Subject|4|||
94703521|NCT03354390|324370876|FG000|Level 1|Death|2|||
94703522|NCT03354390|324370877|FG001|Level 1|Death|0|||
94703523|NCT03354390|324370878|FG002|Level 1|Death|0|||
94703524|NCT03354390|324370879|FG003|Level 1|Death|0|||
94703525|NCT03354390|324370876|FG000|Level 1|Physician Decision|1|||
94703526|NCT03354390|324370877|FG001|Level 1|Physician Decision|0|||
94703527|NCT03354390|324370878|FG002|Level 1|Physician Decision|0|||
94703528|NCT03354390|324370879|FG003|Level 1|Physician Decision|0|||
94703529|NCT03354390|324370876|FG000|Level 2|Physician Decision|0|||
94703530|NCT03354390|324370877|FG001|Level 2|Physician Decision|2|||
94703531|NCT03354390|324370878|FG002|Level 2|Physician Decision|0|||
94703532|NCT03354390|324370879|FG003|Level 2|Physician Decision|0|||
94703533|NCT03354390|324370876|FG000|Level 2|Lack of Efficacy|0|||
94703534|NCT03354390|324370877|FG001|Level 2|Lack of Efficacy|1|||
94703535|NCT03354390|324370878|FG002|Level 2|Lack of Efficacy|0|||
94703536|NCT03354390|324370879|FG003|Level 2|Lack of Efficacy|0|||
94703537|NCT03354390|324370876|FG000|Level 2|Lost to Follow-up|0|||
94703538|NCT03354390|324370877|FG001|Level 2|Lost to Follow-up|1|||
94703539|NCT03354390|324370878|FG002|Level 2|Lost to Follow-up|0|||
94703540|NCT03354390|324370879|FG003|Level 2|Lost to Follow-up|0|||
94703541|NCT03354390|324370876|FG000|Level 3|Death|0|||
94703542|NCT03354390|324370877|FG001|Level 3|Death|0|||
94703543|NCT03354390|324370878|FG002|Level 3|Death|1|||
94703544|NCT03354390|324370879|FG003|Level 3|Death|0|||
94703545|NCT03354390|324370876|FG000|Level 3|Physician Decision|0|||
94703546|NCT03354390|324370877|FG001|Level 3|Physician Decision|0|||
94703547|NCT03354390|324370878|FG002|Level 3|Physician Decision|2|||
94703548|NCT03354390|324370879|FG003|Level 3|Physician Decision|0|||
94703549|NCT03354390|324370876|FG000|Level 4|Death|0|||
94703550|NCT03354390|324370877|FG001|Level 4|Death|0|||
94703551|NCT03354390|324370878|FG002|Level 4|Death|0|||
94703552|NCT03354390|324370879|FG003|Level 4|Death|3|||
94703553|NCT02857283|324372436|FG000|First Exposure|Withdrawal by Subject|1|||
94703554|NCT02857283|324372437|FG001|First Exposure|Withdrawal by Subject|0|||
94703555|NCT04358549|324372439|FG000|Overall Study|Adverse Event|0|||
94703556|NCT04358549|324372440|FG001|Overall Study|Adverse Event|1|||
94703557|NCT04358549|324372439|FG000|Overall Study|Death|1|||
94703558|NCT04358549|324372440|FG001|Overall Study|Death|0|||
94703559|NCT04358549|324372439|FG000|Overall Study|Lost to Follow-up|2|||
94703560|NCT04358549|324372440|FG001|Overall Study|Lost to Follow-up|1|||
94703561|NCT04358549|324372439|FG000|Overall Study|Withdrawal by Subject|6|||
94703562|NCT04358549|324372440|FG001|Overall Study|Withdrawal by Subject|6|||
94703563|NCT04358549|324372439|FG000|Overall Study|Start remdesivir|1|||
94703564|NCT04358549|324372440|FG001|Overall Study|Start remdesivir|0|||
94703565|NCT00349908|324372447|FG000|Overall Study|Withdrawal by Subject|0|||
94703566|NCT00349908|324372448|FG001|Overall Study|Withdrawal by Subject|4|||
94703567|NCT00777556|324372449|FG000|Overall Study|Inappropriate self-selection|34|||
94703568|NCT00777556|324372449|FG000|Overall Study|Dispensed but did not use product|12|||
94703569|NCT00777556|324372449|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
94703570|NCT02072226|324372452|FG000|Overall Study|Lost to Follow-up|11|||
94703571|NCT02072226|324372453|FG001|Overall Study|Lost to Follow-up|7|||
94703572|NCT02072226|324372452|FG000|Overall Study|Patient Non-compliance|2|||
94703573|NCT02072226|324372453|FG001|Overall Study|Patient Non-compliance|3|||
94703574|NCT02072226|324372452|FG000|Overall Study|Death|1|||
94703575|NCT02072226|324372453|FG001|Overall Study|Death|0|||
94703576|NCT02072226|324372452|FG000|Overall Study|Patient Withdrawal of Consent|1|||
94703577|NCT02072226|324372453|FG001|Overall Study|Patient Withdrawal of Consent|0|||
94703578|NCT03396835|324372455|FG000|Overall Study|Withdrawn prior to completion|1|||
94703579|NCT03396835|324372455|FG000|Overall Study|Did not meet criteria for data analysis|1|||
94703580|NCT04310579|324372456|FG000|Overall Study|Adverse Event|0|||
94703581|NCT04310579|324372457|FG001|Overall Study|Adverse Event|0|||
94703582|NCT04310579|324372458|FG002|Overall Study|Adverse Event|0|||
94703583|NCT04310579|324372459|FG003|Overall Study|Adverse Event|0|||
94703584|NCT04310579|324372460|FG004|Overall Study|Adverse Event|0|||
94703585|NCT04310579|324372461|FG005|Overall Study|Adverse Event|0|||
94703586|NCT04310579|324372462|FG006|Overall Study|Adverse Event|2|||
94703587|NCT04310579|324372463|FG007|Overall Study|Adverse Event|0|||
94703588|NCT04310579|324372464|FG008|Overall Study|Adverse Event|1|||
94703589|NCT04310579|324372465|FG009|Overall Study|Adverse Event|1|||
94703590|NCT04310579|324372466|FG010|Overall Study|Adverse Event|0|||
94703591|NCT04310579|324372456|FG000|Overall Study|Withdrawal by Subject|0|||
94703592|NCT04310579|324372457|FG001|Overall Study|Withdrawal by Subject|0|||
94703593|NCT04310579|324372458|FG002|Overall Study|Withdrawal by Subject|0|||
94703594|NCT04310579|324372459|FG003|Overall Study|Withdrawal by Subject|0|||
94703595|NCT04310579|324372460|FG004|Overall Study|Withdrawal by Subject|0|||
94703596|NCT04310579|324372461|FG005|Overall Study|Withdrawal by Subject|1|||
94703597|NCT04310579|324372462|FG006|Overall Study|Withdrawal by Subject|0|||
94703598|NCT04310579|324372463|FG007|Overall Study|Withdrawal by Subject|0|||
94703599|NCT04310579|324372464|FG008|Overall Study|Withdrawal by Subject|0|||
94703600|NCT04310579|324372465|FG009|Overall Study|Withdrawal by Subject|0|||
94703601|NCT04310579|324372466|FG010|Overall Study|Withdrawal by Subject|0|||
94703602|NCT04310579|324372456|FG000|Overall Study|Positive COVID-19 test|0|||
94703603|NCT04310579|324372457|FG001|Overall Study|Positive COVID-19 test|0|||
94703604|NCT04310579|324372458|FG002|Overall Study|Positive COVID-19 test|0|||
94703605|NCT04310579|324372459|FG003|Overall Study|Positive COVID-19 test|0|||
94703606|NCT04310579|324372460|FG004|Overall Study|Positive COVID-19 test|0|||
94703607|NCT04310579|324372461|FG005|Overall Study|Positive COVID-19 test|0|||
94703608|NCT04310579|324372462|FG006|Overall Study|Positive COVID-19 test|0|||
94703609|NCT04310579|324372463|FG007|Overall Study|Positive COVID-19 test|0|||
94703610|NCT04310579|324372464|FG008|Overall Study|Positive COVID-19 test|0|||
94703611|NCT04310579|324372465|FG009|Overall Study|Positive COVID-19 test|0|||
94703612|NCT04310579|324372466|FG010|Overall Study|Positive COVID-19 test|1|||
94703613|NCT02049866|324372467|FG000|Overall Study|Withdrawal by Subject|1|||
94703614|NCT02955069|324372469|FG000|Overall Study|Adverse Event|7|||
94703615|NCT02955069|324372470|FG001|Overall Study|Adverse Event|2|||
94703616|NCT02955069|324372469|FG000|Overall Study|Death|7|||
94703617|NCT02955069|324372470|FG001|Overall Study|Death|3|||
94703618|NCT02955069|324372469|FG000|Overall Study|Physician Decision|10|||
94703619|NCT02955069|324372470|FG001|Overall Study|Physician Decision|2|||
94703620|NCT02955069|324372469|FG000|Overall Study|Progressive disease|64|||
94703621|NCT02955069|324372470|FG001|Overall Study|Progressive disease|13|||
94703622|NCT02955069|324372469|FG000|Overall Study|Study terminated by sponsor|4|||
94703623|NCT02955069|324372470|FG001|Overall Study|Study terminated by sponsor|0|||
94703624|NCT02955069|324372469|FG000|Overall Study|Subject/Guardian decision|3|||
94703625|NCT02955069|324372470|FG001|Overall Study|Subject/Guardian decision|1|||
94703626|NCT01883492|324372474|FG000|Overall Study|Lost to Follow-up|3|||
94703627|NCT01883492|324372475|FG001|Overall Study|Lost to Follow-up|4|||
94703628|NCT01883492|324372474|FG000|Overall Study|Surgery on contra-lateral hip|0|||
94703629|NCT01883492|324372475|FG001|Overall Study|Surgery on contra-lateral hip|1|||
94703630|NCT01883492|324372474|FG000|Overall Study|Poor X-ray quality|7|||
94703631|NCT01883492|324372475|FG001|Overall Study|Poor X-ray quality|4|||
94703632|NCT01883492|324372474|FG000|Overall Study|Withdrawal by Subject|1|||
94703633|NCT01883492|324372475|FG001|Overall Study|Withdrawal by Subject|0|||
94703634|NCT01883492|324372474|FG000|Overall Study|inappropriate implant used|1|||
94703635|NCT01883492|324372475|FG001|Overall Study|inappropriate implant used|1|||
94703636|NCT01883492|324372474|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
94703637|NCT01883492|324372475|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
94703638|NCT00817635|324372476|FG000|Overall Study|Adverse Event|1|||
94703639|NCT00817635|324372477|FG001|Overall Study|Adverse Event|0|||
94703640|NCT00817635|324372478|FG002|Overall Study|Adverse Event|0|||
94703641|NCT00817635|324372479|FG003|Overall Study|Adverse Event|1|||
94703642|NCT00817635|324372480|FG004|Overall Study|Adverse Event|1|||
94266305|NCT03734016|322768427|FG000|Overall Study|Lost to Follow-up|6|||
94266306|NCT03734016|322768428|FG001|Overall Study|Lost to Follow-up|2|||
94266307|NCT03734016|322768427|FG000|Overall Study|Miscellaneous|5|||
94266308|NCT03734016|322768428|FG001|Overall Study|Miscellaneous|1|||
94703643|NCT00817635|324372476|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
94703644|NCT00817635|324372477|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
94703645|NCT00817635|324372478|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
94703646|NCT00817635|324372479|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
94703647|NCT00817635|324372480|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
94703648|NCT00817635|324372476|FG000|Overall Study|Withdrawal by Subject|2|||
94703649|NCT00817635|324372477|FG001|Overall Study|Withdrawal by Subject|1|||
94703650|NCT00817635|324372478|FG002|Overall Study|Withdrawal by Subject|0|||
94703651|NCT00817635|324372479|FG003|Overall Study|Withdrawal by Subject|1|||
94703652|NCT00817635|324372480|FG004|Overall Study|Withdrawal by Subject|2|||
94703653|NCT00817635|324372476|FG000|Overall Study|Lost to Follow-up|0|||
94703654|NCT00817635|324372477|FG001|Overall Study|Lost to Follow-up|1|||
94703655|NCT00817635|324372478|FG002|Overall Study|Lost to Follow-up|0|||
94703656|NCT00817635|324372479|FG003|Overall Study|Lost to Follow-up|1|||
94703657|NCT00817635|324372480|FG004|Overall Study|Lost to Follow-up|0|||
94703658|NCT00817635|324372476|FG000|Overall Study|Administrative Problems|0|||
94703659|NCT00817635|324372477|FG001|Overall Study|Administrative Problems|0|||
94703660|NCT00817635|324372478|FG002|Overall Study|Administrative Problems|0|||
94703661|NCT00817635|324372479|FG003|Overall Study|Administrative Problems|0|||
94703662|NCT00817635|324372480|FG004|Overall Study|Administrative Problems|1|||
94703663|NCT00817635|324372476|FG000|Overall Study|Protocol Violation|5|||
94703664|NCT00817635|324372477|FG001|Overall Study|Protocol Violation|1|||
94703665|NCT00817635|324372478|FG002|Overall Study|Protocol Violation|3|||
94703666|NCT00817635|324372479|FG003|Overall Study|Protocol Violation|2|||
94703667|NCT00817635|324372480|FG004|Overall Study|Protocol Violation|3|||
94703668|NCT04353037|324372481|FG000|Overall Study|Lost to Follow-up|0|||
94703669|NCT04353037|324372482|FG001|Overall Study|Lost to Follow-up|1|||
94703670|NCT04353037|324372483|FG002|Overall Study|Lost to Follow-up|2|||
94703671|NCT04353037|324372484|FG003|Overall Study|Lost to Follow-up|3|||
94266309|NCT01624259|322768429|FG000|Overall Study|Adverse Event|18|||
94266310|NCT01624259|322768430|FG001|Overall Study|Adverse Event|18|||
94266311|NCT01624259|322768429|FG000|Overall Study|Protocol Violation|1|||
94266312|NCT01624259|322768430|FG001|Overall Study|Protocol Violation|2|||
94266313|NCT01624259|322768429|FG000|Overall Study|Withdrawal by Subject|5|||
94266314|NCT01624259|322768430|FG001|Overall Study|Withdrawal by Subject|7|||
94266315|NCT01624259|322768429|FG000|Overall Study|Physician Decision|1|||
94266316|NCT01624259|322768430|FG001|Overall Study|Physician Decision|1|||
94266317|NCT01624259|322768429|FG000|Overall Study|Lost to Follow-up|2|||
94266318|NCT01624259|322768430|FG001|Overall Study|Lost to Follow-up|3|||
94266319|NCT01624259|322768429|FG000|Overall Study|Abnormal laboratory measure|3|||
94266320|NCT01624259|322768430|FG001|Overall Study|Abnormal laboratory measure|0|||
94266321|NCT01016964|322769903|FG000|Overall Study|Lost to Follow-up|3|||
94266322|NCT01016964|322769904|FG001|Overall Study|Lost to Follow-up|3|||
94266323|NCT00607880|322769909|FG000|Overall Study|Unable to place port due to occlusion|1|||
94266324|NCT00607880|322769910|FG001|Overall Study|Unable to place port due to occlusion|0|||
94266325|NCT01170039|322769911|FG000|Overall Study|Withdrawal by Subject|5|||
94266326|NCT01170039|322769912|FG001|Overall Study|Withdrawal by Subject|3|||
94266327|NCT01170039|322769911|FG000|Overall Study|Lack of funding, drug not available|3|||
94266328|NCT01170039|322769912|FG001|Overall Study|Lack of funding, drug not available|3|||
94266329|NCT00727649|322769917|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
94266330|NCT00727649|322769918|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
94266331|NCT00727649|322769917|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
94266332|NCT00727649|322769918|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
94266333|NCT00727649|322769917|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
94266334|NCT00727649|322769918|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
94266335|NCT00727649|322769917|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
94266336|NCT00727649|322769918|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
94266337|NCT00727649|322769917|FG000|Second Intervention (4-weeks)|Death|1|||
94266338|NCT00727649|322769918|FG001|Second Intervention (4-weeks)|Death|0|||
94266339|NCT00727649|322769917|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
94266340|NCT00727649|322769918|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
94266341|NCT00727649|322769917|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
94703672|NCT04353037|324372481|FG000|Overall Study|Withdrawal by Subject|0|||
94703673|NCT04353037|324372482|FG001|Overall Study|Withdrawal by Subject|2|||
94703674|NCT04353037|324372483|FG002|Overall Study|Withdrawal by Subject|3|||
94266342|NCT00727649|322769918|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
94266343|NCT01641237|322769926|FG000|Period II|Withdrawal by Subject|1|||
94266344|NCT01641237|322769927|FG001|Period II|Withdrawal by Subject|0|||
94266345|NCT01641237|322769928|FG002|Period II|Withdrawal by Subject|0|||
94266346|NCT01641237|322769929|FG003|Period II|Withdrawal by Subject|0|||
94266347|NCT01641237|322769926|FG000|Period III|Lost to Follow-up|1|||
94266348|NCT01641237|322769927|FG001|Period III|Lost to Follow-up|0|||
94266349|NCT01641237|322769928|FG002|Period III|Lost to Follow-up|0|||
94266350|NCT01641237|322769929|FG003|Period III|Lost to Follow-up|0|||
94703675|NCT04353037|324372484|FG003|Overall Study|Withdrawal by Subject|5|||
94703676|NCT04353037|324372481|FG000|Overall Study|Adverse Event|0|||
94703677|NCT04353037|324372482|FG001|Overall Study|Adverse Event|0|||
94703678|NCT04353037|324372483|FG002|Overall Study|Adverse Event|2|||
94703679|NCT04353037|324372484|FG003|Overall Study|Adverse Event|0|||
94703680|NCT04353037|324372481|FG000|Overall Study|Exposure Change|0|||
94703681|NCT04353037|324372482|FG001|Overall Study|Exposure Change|0|||
94703682|NCT04353037|324372483|FG002|Overall Study|Exposure Change|0|||
94703683|NCT04353037|324372484|FG003|Overall Study|Exposure Change|2|||
94703684|NCT01803646|324372485|FG000|Overall Study|Protocol Violation|1|||
94703685|NCT01803646|324372486|FG001|Overall Study|Protocol Violation|0|||
94703686|NCT01803646|324372485|FG000|Overall Study|Adverse Event|1|||
94703687|NCT01803646|324372486|FG001|Overall Study|Adverse Event|1|||
94703688|NCT01803646|324372485|FG000|Overall Study|Withdrawal by Subject|9|||
94703689|NCT01803646|324372486|FG001|Overall Study|Withdrawal by Subject|6|||
94266351|NCT01754857|322769930|FG000|Overall Study|Adverse Event|7|||
94266352|NCT01754857|322769930|FG000|Overall Study|Disease progression|3|||
94266353|NCT01754857|322769930|FG000|Overall Study|Physician Decision|2|||
94266354|NCT01754857|322769930|FG000|Overall Study|Withdrawal by Subject|3|||
94266355|NCT01754857|322769930|FG000|Overall Study|other complicating disease|1|||
94266356|NCT01754857|322769930|FG000|Overall Study|ineligible to continue onto maintenance|1|||
94266357|NCT01754857|322769930|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
94266358|NCT01754857|322769930|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
94266359|NCT00041080|322769931|FG000|Overall Study|Adverse Event|21|||
94266360|NCT00041080|322769932|FG001|Overall Study|Adverse Event|1|||
94266361|NCT00041080|322769931|FG000|Overall Study|Withdrawal by Subject|6|||
94266362|NCT00041080|322769932|FG001|Overall Study|Withdrawal by Subject|6|||
94266363|NCT00041080|322769931|FG000|Overall Study|Concommitant Illness/Other|1|||
94266364|NCT00041080|322769932|FG001|Overall Study|Concommitant Illness/Other|2|||
94266365|NCT00041080|322769931|FG000|Overall Study|Did not start therapy|1|||
94266366|NCT00041080|322769932|FG001|Overall Study|Did not start therapy|1|||
94266367|NCT00041080|322769931|FG000|Overall Study|Ineligible|1|||
94266368|NCT00041080|322769932|FG001|Overall Study|Ineligible|0|||
94266369|NCT04784897|322769933|FG000|Overall Study|Death|4|||
94266370|NCT04784897|322769934|FG001|Overall Study|Death|2|||
94266371|NCT04784897|322769935|FG002|Overall Study|Death|1|||
94266372|NCT04784897|322769933|FG000|Overall Study|Withdrawal by Subject|0|||
94266373|NCT04784897|322769934|FG001|Overall Study|Withdrawal by Subject|0|||
94266374|NCT04784897|322769935|FG002|Overall Study|Withdrawal by Subject|1|||
94266375|NCT00210184|322769936|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
94266376|NCT03239483|322769937|FG000|Overall Study|Lost to Follow-up|1|||
94266377|NCT03239483|322769938|FG001|Overall Study|Lost to Follow-up|0|||
94266378|NCT03239483|322769937|FG000|Overall Study|Withdrawal by Subject|1|||
94266379|NCT03239483|322769938|FG001|Overall Study|Withdrawal by Subject|0|||
94266380|NCT02252536|322769947|FG000|Overall Study|Lost to Follow-up|5|||
94266381|NCT02252536|322769948|FG001|Overall Study|Lost to Follow-up|3|||
94266382|NCT03492554|322769966|FG000|Overall Study|Protocol Violation|0|||
94266383|NCT03492554|322769967|FG001|Overall Study|Protocol Violation|14|||
94266384|NCT04340557|322769970|FG000|Overall Study|Transferred to ICU and/or death|1|||
94266385|NCT04340557|322769971|FG001|Overall Study|Transferred to ICU and/or death|2|||
94266386|NCT01177384|322769972|FG000|Overall Study|Adverse Event|6|||
94266387|NCT01177384|322769973|FG001|Overall Study|Adverse Event|4|||
94266388|NCT01177384|322769972|FG000|Overall Study|Lack of Efficacy|0|||
94266389|NCT01177384|322769973|FG001|Overall Study|Lack of Efficacy|1|||
94266390|NCT01177384|322769972|FG000|Overall Study|Lost to Follow-up|3|||
94266391|NCT01177384|322769973|FG001|Overall Study|Lost to Follow-up|4|||
94266392|NCT01177384|322769972|FG000|Overall Study|Physician Decision|0|||
94266393|NCT01177384|322769973|FG001|Overall Study|Physician Decision|3|||
94266394|NCT01177384|322769972|FG000|Overall Study|Protocol Violation|0|||
94266395|NCT01177384|322769973|FG001|Overall Study|Protocol Violation|2|||
94266396|NCT01177384|322769972|FG000|Overall Study|Withdrawal by Subject|5|||
94266397|NCT01177384|322769973|FG001|Overall Study|Withdrawal by Subject|12|||
94266398|NCT04029116|322769974|FG000|Overall Study|Adverse Event|0|||
94703690|NCT01803646|324372485|FG000|Overall Study|Randomization error|1|||
94266399|NCT04029116|322769975|FG001|Overall Study|Adverse Event|2|||
94266400|NCT04029116|322769974|FG000|Overall Study|Lost to Follow-up|3|||
94266401|NCT04029116|322769975|FG001|Overall Study|Lost to Follow-up|5|||
94266402|NCT04029116|322769974|FG000|Overall Study|Physician Decision|2|||
94266403|NCT04029116|322769975|FG001|Overall Study|Physician Decision|0|||
94266404|NCT04029116|322769974|FG000|Overall Study|Pregnancy|1|||
94266405|NCT04029116|322769975|FG001|Overall Study|Pregnancy|2|||
94266406|NCT04029116|322769974|FG000|Overall Study|Withdrawal by Subject|4|||
94266407|NCT04029116|322769975|FG001|Overall Study|Withdrawal by Subject|6|||
94266408|NCT04029116|322769974|FG000|Overall Study|Other|2|||
94266409|NCT04029116|322769975|FG001|Overall Study|Other|1|||
94266410|NCT01849497|322769976|FG000|Overall Study|Withdrawal by Subject|1|||
94266411|NCT01849497|322769977|FG001|Overall Study|Withdrawal by Subject|2|||
94703691|NCT01803646|324372486|FG001|Overall Study|Randomization error|2|||
94703692|NCT01803646|324372485|FG000|Overall Study|Lost to Follow-up|5|||
94703693|NCT01803646|324372486|FG001|Overall Study|Lost to Follow-up|1|||
94366584|NCT03033069|323126572|FG001|Overall Study|Withdrawal by Subject|10|||
94366585|NCT03033069|323126573|FG002|Overall Study|Withdrawal by Subject|11|||
94366586|NCT03033069|323126574|FG003|Overall Study|Withdrawal by Subject|6|||
94366587|NCT03033069|323126571|FG000|Overall Study|Withdrawal By Caregiver|1|||
94366588|NCT03033069|323126572|FG001|Overall Study|Withdrawal By Caregiver|0|||
94366589|NCT03033069|323126573|FG002|Overall Study|Withdrawal By Caregiver|0|||
94366590|NCT03033069|323126574|FG003|Overall Study|Withdrawal By Caregiver|0|||
94366591|NCT03033069|323126571|FG000|Overall Study|Reason not Specified|0|||
94366592|NCT03033069|323126572|FG001|Overall Study|Reason not Specified|1|||
94703694|NCT01167426|324372489|FG000|Overall Study|Lost to Follow-up|6|||
94703695|NCT01167426|324372489|FG000|Overall Study|Protocol Violation|1|||
94703696|NCT01167426|324372489|FG000|Overall Study|Withdrawal by Subject|2|||
94703697|NCT01167426|324372489|FG000|Overall Study|Sponsor Decision|1|||
94703698|NCT04176458|324372492|FG000|Overall Study|Covid 19|4|||
94703699|NCT01072357|324372493|FG000|Overall Study|Lost to Follow-up|0|||
94703700|NCT01072357|324372494|FG001|Overall Study|Lost to Follow-up|1|||
94703701|NCT01693614|324372495|FG000|Overall Study|Adverse Event|7|||
94703702|NCT01693614|324372496|FG001|Overall Study|Adverse Event|11|||
94703703|NCT01693614|324372497|FG002|Overall Study|Adverse Event|5|||
94703704|NCT01693614|324372495|FG000|Overall Study|Disease progression|11|||
94703705|NCT01693614|324372496|FG001|Overall Study|Disease progression|8|||
94703706|NCT01693614|324372497|FG002|Overall Study|Disease progression|7|||
94703707|NCT01693614|324372495|FG000|Overall Study|Protocol Violation|5|||
94703708|NCT01693614|324372496|FG001|Overall Study|Protocol Violation|2|||
94703709|NCT01693614|324372497|FG002|Overall Study|Protocol Violation|1|||
94703710|NCT01693614|324372495|FG000|Overall Study|Death|1|||
94703711|NCT01693614|324372496|FG001|Overall Study|Death|0|||
94703712|NCT01693614|324372497|FG002|Overall Study|Death|0|||
94703713|NCT01693614|324372495|FG000|Overall Study|Physician Decision|1|||
94703714|NCT01693614|324372496|FG001|Overall Study|Physician Decision|1|||
94703715|NCT01693614|324372497|FG002|Overall Study|Physician Decision|4|||
94703716|NCT01693614|324372495|FG000|Overall Study|Withdrawal by subject/guardian|0|||
94703717|NCT01693614|324372496|FG001|Overall Study|Withdrawal by subject/guardian|0|||
94703718|NCT01693614|324372497|FG002|Overall Study|Withdrawal by subject/guardian|2|||
94703719|NCT01693614|324372495|FG000|Overall Study|Withdrawal by Subject|1|||
94703720|NCT01693614|324372496|FG001|Overall Study|Withdrawal by Subject|0|||
94703721|NCT01693614|324372497|FG002|Overall Study|Withdrawal by Subject|5|||
94703722|NCT01196988|324372498|FG000|Overall Study|Adverse Event|1|||
94703723|NCT01196988|324372499|FG001|Overall Study|Adverse Event|2|||
94703724|NCT01196988|324372500|FG002|Overall Study|Adverse Event|0|||
94703725|NCT01196988|324372501|FG003|Overall Study|Adverse Event|0|||
94703726|NCT01196988|324372498|FG000|Overall Study|Withdrawal by Subject|5|||
94703727|NCT01196988|324372499|FG001|Overall Study|Withdrawal by Subject|1|||
94703728|NCT01196988|324372500|FG002|Overall Study|Withdrawal by Subject|4|||
94703729|NCT01196988|324372501|FG003|Overall Study|Withdrawal by Subject|0|||
94703730|NCT01196988|324372498|FG000|Overall Study|Lost to Follow-up|16|||
94703731|NCT01196988|324372499|FG001|Overall Study|Lost to Follow-up|29|||
94703732|NCT01196988|324372500|FG002|Overall Study|Lost to Follow-up|21|||
94703733|NCT01196988|324372501|FG003|Overall Study|Lost to Follow-up|1|||
94703734|NCT01196988|324372498|FG000|Overall Study|Other|2|||
94703735|NCT01196988|324372499|FG001|Overall Study|Other|0|||
94703736|NCT01196988|324372500|FG002|Overall Study|Other|0|||
94703737|NCT01196988|324372501|FG003|Overall Study|Other|0|||
94703738|NCT00927823|324372502|FG000|Continuous Dosing Period|Death|0|||
94703739|NCT00927823|324372503|FG001|Continuous Dosing Period|Death|0|||
94703740|NCT00927823|324372504|FG002|Continuous Dosing Period|Death|6|||
94703741|NCT00927823|324372505|FG003|Continuous Dosing Period|Death|0|||
94703742|NCT00927823|324372502|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
94703743|NCT00927823|324372503|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
94366593|NCT03033069|323126573|FG002|Overall Study|Reason not Specified|0|||
94703744|NCT00927823|324372504|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
94703745|NCT00927823|324372505|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
94703746|NCT00927823|324372502|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
94703747|NCT00927823|324372503|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
94366594|NCT03033069|323126574|FG003|Overall Study|Reason not Specified|1|||
94366595|NCT03185949|323126575|FG000|ITT Analysis|Withdrawal by Subject|4|||
94366596|NCT03185949|323126576|FG001|ITT Analysis|Withdrawal by Subject|3|||
94366597|NCT03185949|323126575|FG000|PP Analysis|Protocol Violation|2|||
94366598|NCT03185949|323126576|FG001|PP Analysis|Protocol Violation|2|||
94366599|NCT03185949|323126575|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
94703748|NCT00927823|324372504|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
94703749|NCT00927823|324372505|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
94703750|NCT00927823|324372502|FG000|Continuous Dosing Period|Other|1|||
94703751|NCT00927823|324372503|FG001|Continuous Dosing Period|Other|2|||
94703752|NCT00927823|324372504|FG002|Continuous Dosing Period|Other|9|||
94703753|NCT00927823|324372505|FG003|Continuous Dosing Period|Other|3|||
94703754|NCT00241644|324372506|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
94703755|NCT00241644|324372507|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
94703756|NCT00241644|324372508|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
94703757|NCT00241644|324372509|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
94703758|NCT00241644|324372506|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
94703759|NCT00241644|324372507|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
94703760|NCT00241644|324372508|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
94703761|NCT00241644|324372509|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
94703762|NCT00241644|324372506|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
94703763|NCT00241644|324372507|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
94703764|NCT00241644|324372508|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
94703765|NCT00241644|324372509|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
94703766|NCT00241644|324372506|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
94703767|NCT00241644|324372507|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
94703768|NCT00241644|324372508|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
94703769|NCT00241644|324372509|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
94703770|NCT00241644|324372506|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
94703771|NCT00241644|324372507|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
94703772|NCT00241644|324372508|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
94703773|NCT00241644|324372509|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
94703774|NCT00241644|324372506|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
94703775|NCT00241644|324372507|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
94703776|NCT00241644|324372508|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
94703777|NCT00241644|324372509|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
94703778|NCT00241644|324372506|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
94703779|NCT00241644|324372507|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
94703780|NCT00241644|324372508|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
94703781|NCT00241644|324372509|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
94703782|NCT00241644|324372506|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
94703783|NCT00241644|324372507|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
94703784|NCT00241644|324372508|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
94703785|NCT00241644|324372509|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
94703786|NCT00241644|324372506|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
94703787|NCT00241644|324372507|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
94703788|NCT00241644|324372508|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
94703789|NCT00241644|324372509|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
94703790|NCT00241644|324372506|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
94703791|NCT00241644|324372507|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
94703792|NCT00241644|324372508|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
94703793|NCT00241644|324372509|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
94703794|NCT00241644|324372506|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
94703795|NCT00241644|324372507|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
94703796|NCT00241644|324372508|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
94703797|NCT00241644|324372509|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
94703798|NCT00241644|324372506|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
94703799|NCT00241644|324372507|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
94703800|NCT00241644|324372508|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
94703801|NCT00241644|324372509|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
94703802|NCT00241644|324372506|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
94703803|NCT00241644|324372507|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
94703804|NCT00241644|324372508|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
94703805|NCT00241644|324372509|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
94703806|NCT00543725|324372510|FG000|Overall Study|Adverse Event|18|||
94703807|NCT00543725|324372511|FG001|Overall Study|Adverse Event|27|||
94703808|NCT00543725|324372510|FG000|Overall Study|Sponsor's Decision|0|||
94703809|NCT00543725|324372511|FG001|Overall Study|Sponsor's Decision|1|||
94703810|NCT00543725|324372510|FG000|Overall Study|Subject Non-Compliant|4|||
94703811|NCT00543725|324372511|FG001|Overall Study|Subject Non-Compliant|4|||
94703812|NCT00543725|324372510|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
94703813|NCT00543725|324372511|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
94703814|NCT00543725|324372510|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
94703815|NCT00543725|324372511|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
94703816|NCT00543725|324372510|FG000|Overall Study|Protocol Violation|0|||
94703817|NCT00543725|324372511|FG001|Overall Study|Protocol Violation|1|||
94703818|NCT00543725|324372510|FG000|Overall Study|Withdrawal by Subject|4|||
94703819|NCT00543725|324372511|FG001|Overall Study|Withdrawal by Subject|13|||
94703820|NCT00543725|324372510|FG000|Overall Study|Lost to Follow-up|15|||
94703821|NCT00543725|324372511|FG001|Overall Study|Lost to Follow-up|11|||
94703822|NCT00543725|324372510|FG000|Overall Study|Other|3|||
94703823|NCT00543725|324372511|FG001|Overall Study|Other|3|||
94703824|NCT00906698|324372512|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
94703825|NCT00906698|324372513|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
94703826|NCT00906698|324372514|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
94703827|NCT00906698|324372515|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
94703828|NCT00906698|324372516|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
94703829|NCT00906698|324372517|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
94703830|NCT00906698|324372512|FG000|Overall Study|Adverse Event|0|||
94703831|NCT00906698|324372513|FG001|Overall Study|Adverse Event|0|||
94703832|NCT00906698|324372514|FG002|Overall Study|Adverse Event|2|||
94703833|NCT00906698|324372515|FG003|Overall Study|Adverse Event|0|||
94703834|NCT00906698|324372516|FG004|Overall Study|Adverse Event|4|||
94703835|NCT00906698|324372517|FG005|Overall Study|Adverse Event|1|||
94703836|NCT00906698|324372512|FG000|Overall Study|Disease progression|3|||
94703837|NCT00906698|324372513|FG001|Overall Study|Disease progression|12|||
94703838|NCT00906698|324372514|FG002|Overall Study|Disease progression|4|||
94703839|NCT00906698|324372515|FG003|Overall Study|Disease progression|4|||
94703840|NCT00906698|324372516|FG004|Overall Study|Disease progression|12|||
94703841|NCT00906698|324372517|FG005|Overall Study|Disease progression|4|||
94703842|NCT00906698|324372512|FG000|Overall Study|Withdrawal by Subject|0|||
94703843|NCT00906698|324372513|FG001|Overall Study|Withdrawal by Subject|0|||
94703844|NCT00906698|324372514|FG002|Overall Study|Withdrawal by Subject|0|||
94703845|NCT00906698|324372515|FG003|Overall Study|Withdrawal by Subject|0|||
94703846|NCT00906698|324372516|FG004|Overall Study|Withdrawal by Subject|1|||
94703847|NCT00906698|324372517|FG005|Overall Study|Withdrawal by Subject|0|||
94703848|NCT00906698|324372512|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
94703849|NCT00906698|324372513|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
94703850|NCT00906698|324372514|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
94703851|NCT00906698|324372515|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
94703852|NCT00906698|324372516|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
94703853|NCT00906698|324372517|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
94703854|NCT03201809|324372518|FG000|Overall Study|Lost to Follow-up|2|||
94703855|NCT03201809|324372519|FG001|Overall Study|Lost to Follow-up|0|||
94703856|NCT04044664|324372524|FG000|Stage 1|Adverse Event|3|||
94703857|NCT04044664|324372525|FG001|Stage 1|Adverse Event|3|||
94703858|NCT04044664|324372526|FG002|Stage 1|Adverse Event|1|||
94703859|NCT04044664|324372524|FG000|Stage 1|Lost to Follow-up|3|||
94703860|NCT04044664|324372525|FG001|Stage 1|Lost to Follow-up|2|||
94703861|NCT04044664|324372526|FG002|Stage 1|Lost to Follow-up|2|||
94703862|NCT04044664|324372524|FG000|Stage 1|Withdrawal by Subject|9|||
94703863|NCT04044664|324372525|FG001|Stage 1|Withdrawal by Subject|1|||
94703864|NCT04044664|324372526|FG002|Stage 1|Withdrawal by Subject|0|||
94703865|NCT04044664|324372524|FG000|Stage 1|noncompliance, personal reason|2|||
94703866|NCT04044664|324372525|FG001|Stage 1|noncompliance, personal reason|0|||
94703867|NCT04044664|324372526|FG002|Stage 1|noncompliance, personal reason|0|||
94703868|NCT04044664|324372524|FG000|Stage 1|randomization error|0|||
94703869|NCT04044664|324372525|FG001|Stage 1|randomization error|1|||
94703870|NCT04044664|324372526|FG002|Stage 1|randomization error|0|||
94703871|NCT04044664|324372524|FG000|Stage 2|Adverse Event|2|||
94703872|NCT04044664|324372525|FG001|Stage 2|Adverse Event|0|||
94703873|NCT04044664|324372526|FG002|Stage 2|Adverse Event|0|||
94703874|NCT04044664|324372524|FG000|Stage 2|Lost to Follow-up|3|||
94703875|NCT04044664|324372525|FG001|Stage 2|Lost to Follow-up|2|||
94703876|NCT04044664|324372526|FG002|Stage 2|Lost to Follow-up|1|||
94703877|NCT04044664|324372524|FG000|Stage 2|Withdrawal by Subject|3|||
94703878|NCT04044664|324372525|FG001|Stage 2|Withdrawal by Subject|0|||
94703879|NCT04044664|324372526|FG002|Stage 2|Withdrawal by Subject|0|||
94703880|NCT04044664|324372524|FG000|Stage 2|protocol deviation|1|||
94703881|NCT04044664|324372525|FG001|Stage 2|protocol deviation|0|||
94703882|NCT04044664|324372526|FG002|Stage 2|protocol deviation|0|||
94703883|NCT00545844|324372527|FG000|Overall Study|Lost to Follow-up|9|||
94703884|NCT00545844|324372527|FG000|Overall Study|Protocol Violation|1|||
94703885|NCT00545844|324372527|FG000|Overall Study|Withdrawal by Subject|2|||
94703886|NCT03736785|324372529|FG000|Overall Study|Adverse Event|1|||
94703887|NCT03736785|324372530|FG001|Overall Study|Adverse Event|1|||
94703888|NCT03736785|324372531|FG002|Overall Study|Adverse Event|1|||
94703889|NCT03736785|324372529|FG000|Overall Study|Death|1|||
94703890|NCT03736785|324372530|FG001|Overall Study|Death|0|||
94703891|NCT03736785|324372531|FG002|Overall Study|Death|1|||
94703892|NCT03736785|324372529|FG000|Overall Study|Lost to Follow-up|0|||
94703893|NCT03736785|324372530|FG001|Overall Study|Lost to Follow-up|2|||
94703894|NCT03736785|324372531|FG002|Overall Study|Lost to Follow-up|3|||
94703895|NCT03736785|324372529|FG000|Overall Study|Non compliance with study drug|1|||
94703896|NCT03736785|324372530|FG001|Overall Study|Non compliance with study drug|1|||
94703897|NCT03736785|324372531|FG002|Overall Study|Non compliance with study drug|0|||
94703898|NCT03736785|324372529|FG000|Overall Study|Physician Decision|0|||
94703899|NCT03736785|324372530|FG001|Overall Study|Physician Decision|1|||
94703900|NCT03736785|324372531|FG002|Overall Study|Physician Decision|1|||
94703901|NCT03736785|324372529|FG000|Overall Study|Protocol Violation|1|||
94703902|NCT03736785|324372530|FG001|Overall Study|Protocol Violation|4|||
94703903|NCT03736785|324372531|FG002|Overall Study|Protocol Violation|3|||
94703904|NCT03736785|324372529|FG000|Overall Study|Sponsor Decision|1|||
94703905|NCT03736785|324372530|FG001|Overall Study|Sponsor Decision|0|||
94703906|NCT03736785|324372531|FG002|Overall Study|Sponsor Decision|0|||
94703907|NCT03736785|324372529|FG000|Overall Study|Unknown/Missing data|3|||
94703908|NCT03736785|324372530|FG001|Overall Study|Unknown/Missing data|2|||
94703909|NCT03736785|324372531|FG002|Overall Study|Unknown/Missing data|1|||
94703910|NCT03736785|324372529|FG000|Overall Study|Withdrawal by Subject|9|||
94703911|NCT03736785|324372530|FG001|Overall Study|Withdrawal by Subject|6|||
94703912|NCT03736785|324372531|FG002|Overall Study|Withdrawal by Subject|4|||
94703913|NCT01744691|324372534|FG000|Overall Study|Progressive Disease|18|||
94703914|NCT01744691|324372534|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
94703915|NCT01744691|324372534|FG000|Overall Study|Withdrawal of consent for treatment|3|||
94703916|NCT01744691|324372534|FG000|Overall Study|Physician Decision|4|||
94703917|NCT02701361|324372538|FG000|Overall Study|Lost to Follow-up|5|||
94703918|NCT02701361|324372539|FG001|Overall Study|Lost to Follow-up|2|||
94703919|NCT02701361|324372540|FG002|Overall Study|Lost to Follow-up|1|||
94703920|NCT02701361|324372538|FG000|Overall Study|Withdrawal by Subject|4|||
94703921|NCT02701361|324372539|FG001|Overall Study|Withdrawal by Subject|0|||
94703922|NCT02701361|324372540|FG002|Overall Study|Withdrawal by Subject|0|||
94703923|NCT02701361|324372538|FG000|Overall Study|timed out in rehab center|0|||
94703924|NCT02701361|324372539|FG001|Overall Study|timed out in rehab center|1|||
94703925|NCT02701361|324372540|FG002|Overall Study|timed out in rehab center|0|||
94703926|NCT02701361|324372538|FG000|Overall Study|incarceration|0|||
94703927|NCT02701361|324372539|FG001|Overall Study|incarceration|0|||
94703928|NCT02701361|324372540|FG002|Overall Study|incarceration|1|||
94703929|NCT00975806|324372541|FG000|Overall Study|Adverse Event|2|||
94703930|NCT00975806|324372542|FG001|Overall Study|Adverse Event|1|||
94703931|NCT00975806|324372543|FG002|Overall Study|Adverse Event|2|||
94703932|NCT00975806|324372541|FG000|Overall Study|Disease Progression|1|||
94703933|NCT00975806|324372542|FG001|Overall Study|Disease Progression|5|||
94703934|NCT00975806|324372543|FG002|Overall Study|Disease Progression|1|||
94703935|NCT00975806|324372541|FG000|Overall Study|Withdrawal by Subject|1|||
94703936|NCT00975806|324372542|FG001|Overall Study|Withdrawal by Subject|0|||
94703937|NCT00975806|324372543|FG002|Overall Study|Withdrawal by Subject|0|||
94703938|NCT00975806|324372541|FG000|Overall Study|Death|0|||
94703939|NCT00975806|324372542|FG001|Overall Study|Death|1|||
94703940|NCT00975806|324372543|FG002|Overall Study|Death|0|||
94703941|NCT00975806|324372541|FG000|Overall Study|Physician decision and disease related|1|||
94703942|NCT00975806|324372542|FG001|Overall Study|Physician decision and disease related|0|||
94703943|NCT00975806|324372543|FG002|Overall Study|Physician decision and disease related|1|||
94703944|NCT04588480|324372544|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
94703945|NCT04588480|324372545|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
94703946|NCT04588480|324372546|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
94703947|NCT04588480|324372544|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
94703948|NCT04588480|324372545|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
94703949|NCT04588480|324372546|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
94703950|NCT01242085|324372547|FG000|Overall Study|Withdrawal by Subject|4|||
94703951|NCT01242085|324372548|FG001|Overall Study|Withdrawal by Subject|2|||
94703952|NCT01242085|324372549|FG002|Overall Study|Withdrawal by Subject|0|||
94703953|NCT01242085|324372547|FG000|Overall Study|medically unable to have surgery|4|||
94703954|NCT01242085|324372548|FG001|Overall Study|medically unable to have surgery|5|||
94703955|NCT01242085|324372549|FG002|Overall Study|medically unable to have surgery|0|||
94703956|NCT01178762|324372550|FG000|Overall Study|Lost to Follow-up|15|||
94703957|NCT00094809|324372551|FG000|Overall Study|Protocol deviation|2|||
94703958|NCT00094809|324372552|FG001|Overall Study|Protocol deviation|2|||
94366600|NCT03185949|323126576|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
94366601|NCT01020773|323128070|FG000|Overall Study|Withdrawal by Subject|4|||
94703959|NCT00094809|324372551|FG000|Overall Study|Noncompliance|1|||
94703960|NCT00094809|324372552|FG001|Overall Study|Noncompliance|0|||
94703961|NCT00094809|324372551|FG000|Overall Study|Adverse Event|3|||
94703962|NCT00094809|324372552|FG001|Overall Study|Adverse Event|1|||
94703963|NCT00094809|324372551|FG000|Overall Study|Withdrawal by Subject|8|||
94703964|NCT00094809|324372552|FG001|Overall Study|Withdrawal by Subject|9|||
94703965|NCT00094809|324372551|FG000|Overall Study|Disease progression|3|||
94703966|NCT00094809|324372552|FG001|Overall Study|Disease progression|3|||
94703967|NCT00094809|324372551|FG000|Overall Study|Physician Decision|3|||
94703968|NCT00094809|324372552|FG001|Overall Study|Physician Decision|5|||
94703969|NCT00094809|324372551|FG000|Overall Study|Lost to Follow-up|6|||
94703970|NCT00094809|324372552|FG001|Overall Study|Lost to Follow-up|6|||
94703971|NCT00094809|324372551|FG000|Overall Study|Death|19|||
94703972|NCT00094809|324372552|FG001|Overall Study|Death|25|||
94703973|NCT00094809|324372551|FG000|Overall Study|Protocol-specified criteria|1|||
94703974|NCT00094809|324372552|FG001|Overall Study|Protocol-specified criteria|1|||
94703975|NCT00094809|324372551|FG000|Overall Study|Other|2|||
94703976|NCT00094809|324372552|FG001|Overall Study|Other|4|||
94703977|NCT00094809|324372551|FG000|Overall Study|Informed consent signed after treatment|1|||
94703978|NCT00094809|324372552|FG001|Overall Study|Informed consent signed after treatment|0|||
94703979|NCT00094809|324372551|FG000|Overall Study|Study drug not received|2|||
94703980|NCT00094809|324372552|FG001|Overall Study|Study drug not received|8|||
94703981|NCT00094809|324372551|FG000|Overall Study|Other|1|||
94703982|NCT00094809|324372552|FG001|Overall Study|Other|1|||
94703983|NCT02322216|324372557|FG000|Overall Study|Adverse Event|1|||
94703984|NCT02322216|324372558|FG001|Overall Study|Adverse Event|0|||
94703985|NCT02322216|324372557|FG000|Overall Study|Withdrawal by Subject|1|||
94703986|NCT02322216|324372558|FG001|Overall Study|Withdrawal by Subject|4|||
94703987|NCT01651949|324372559|FG000|Overall Study|Unknown status|4|||
94703988|NCT01651949|324372560|FG001|Overall Study|Unknown status|4|||
94703989|NCT01651949|324372561|FG002|Overall Study|Unknown status|0|||
94703990|NCT01651949|324372559|FG000|Overall Study|Lost to Follow-up|30|||
94703991|NCT01651949|324372560|FG001|Overall Study|Lost to Follow-up|56|||
94703992|NCT01651949|324372561|FG002|Overall Study|Lost to Follow-up|20|||
94703993|NCT01651949|324372559|FG000|Overall Study|Protocol Violation|0|||
94703994|NCT01651949|324372560|FG001|Overall Study|Protocol Violation|2|||
94703995|NCT01651949|324372561|FG002|Overall Study|Protocol Violation|1|||
94703996|NCT01651949|324372559|FG000|Overall Study|Physician Decision|0|||
94703997|NCT01651949|324372560|FG001|Overall Study|Physician Decision|2|||
94703998|NCT01651949|324372561|FG002|Overall Study|Physician Decision|0|||
94703999|NCT01651949|324372559|FG000|Overall Study|Adverse Event|0|||
94704000|NCT01651949|324372560|FG001|Overall Study|Adverse Event|2|||
94704001|NCT01651949|324372561|FG002|Overall Study|Adverse Event|1|||
94704002|NCT01651949|324372559|FG000|Overall Study|Screen failure|2|||
94704003|NCT01651949|324372560|FG001|Overall Study|Screen failure|2|||
94704004|NCT01651949|324372561|FG002|Overall Study|Screen failure|0|||
94704005|NCT01651949|324372559|FG000|Overall Study|Withdrawal by Subject|17|||
94704006|NCT01651949|324372560|FG001|Overall Study|Withdrawal by Subject|18|||
94704007|NCT01651949|324372561|FG002|Overall Study|Withdrawal by Subject|9|||
94704008|NCT01549652|324372562|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
94704009|NCT01549652|324372563|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
94704010|NCT01549652|324372564|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
94704011|NCT01549652|324372565|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
94704012|NCT01549652|324372562|FG000|Overall Study|Study Drug Titration Failure|5|||
94704013|NCT01549652|324372563|FG001|Overall Study|Study Drug Titration Failure|6|||
94704014|NCT01549652|324372564|FG002|Overall Study|Study Drug Titration Failure|0|||
94704015|NCT01549652|324372565|FG003|Overall Study|Study Drug Titration Failure|0|||
94704016|NCT01549652|324372562|FG000|Overall Study|Withdrawal Effect|0|||
94704017|NCT01549652|324372563|FG001|Overall Study|Withdrawal Effect|2|||
94704018|NCT01549652|324372564|FG002|Overall Study|Withdrawal Effect|0|||
94704019|NCT01549652|324372565|FG003|Overall Study|Withdrawal Effect|0|||
94704020|NCT01549652|324372562|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
94704021|NCT01549652|324372563|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
94704022|NCT01549652|324372564|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
94704023|NCT01549652|324372565|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
94704024|NCT01549652|324372562|FG000|Overall Study|Problem with Infusion|1|||
94704025|NCT01549652|324372563|FG001|Overall Study|Problem with Infusion|0|||
94704026|NCT01549652|324372564|FG002|Overall Study|Problem with Infusion|0|||
94704027|NCT01549652|324372565|FG003|Overall Study|Problem with Infusion|0|||
94704028|NCT01549652|324372562|FG000|Overall Study|Titration Non-Compliance|1|||
94704029|NCT01549652|324372563|FG001|Overall Study|Titration Non-Compliance|3|||
94704030|NCT01549652|324372564|FG002|Overall Study|Titration Non-Compliance|4|||
94704031|NCT01549652|324372565|FG003|Overall Study|Titration Non-Compliance|5|||
94704032|NCT01549652|324372562|FG000|Overall Study|Titration Side Effects|0|||
94704033|NCT01549652|324372563|FG001|Overall Study|Titration Side Effects|0|||
94704034|NCT01549652|324372564|FG002|Overall Study|Titration Side Effects|6|||
94704035|NCT01549652|324372565|FG003|Overall Study|Titration Side Effects|3|||
94704036|NCT01549652|324372562|FG000|Overall Study|Withdrawal by Subject|0|||
94366602|NCT01020773|323128071|FG001|Overall Study|Withdrawal by Subject|3|||
94652594|NCT00673452|324186137|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
94652595|NCT00439140|324186139|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
94652596|NCT00439140|324186140|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
94652597|NCT00439140|324186141|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
94652598|NCT00439140|324186139|FG000|Treatment Cycle 1|Personal reasons|0|||
94652599|NCT00439140|324186140|FG001|Treatment Cycle 1|Personal reasons|2|||
94652600|NCT00439140|324186141|FG002|Treatment Cycle 1|Personal reasons|0|||
94652601|NCT00439140|324186139|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
94652602|NCT00439140|324186140|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
94652603|NCT00439140|324186141|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
94652604|NCT00439140|324186139|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
94652605|NCT00439140|324186140|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
94652606|NCT00439140|324186141|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
94652607|NCT00439140|324186139|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
94652608|NCT00439140|324186140|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
94652609|NCT00439140|324186141|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
94652610|NCT01458171|324186142|FG000|Overall Study|Adverse Event|1|||
94652611|NCT00153101|324186144|FG000|Overall Study|Lost to Follow-up|14|||
94652612|NCT00153101|324186145|FG001|Overall Study|Lost to Follow-up|14|||
94652613|NCT00153101|324186146|FG002|Overall Study|Lost to Follow-up|12|||
94652614|NCT00153101|324186147|FG003|Overall Study|Lost to Follow-up|5|||
94652615|NCT00153101|324186148|FG004|Overall Study|Lost to Follow-up|5|||
94652616|NCT00153101|324186144|FG000|Overall Study|Withdrawal by Subject|3|||
94652617|NCT00153101|324186145|FG001|Overall Study|Withdrawal by Subject|4|||
94652618|NCT00153101|324186146|FG002|Overall Study|Withdrawal by Subject|3|||
94652619|NCT00153101|324186147|FG003|Overall Study|Withdrawal by Subject|3|||
94652620|NCT00153101|324186148|FG004|Overall Study|Withdrawal by Subject|5|||
94652621|NCT01193556|324186149|FG000|Overall Study|Study termination|26|||
94652622|NCT01193556|324186150|FG001|Overall Study|Study termination|25|||
94652623|NCT03169153|324186151|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
94652624|NCT03169153|324186152|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
94652625|NCT03169153|324186151|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
94652626|NCT03169153|324186152|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
94652627|NCT03169153|324186151|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
94652628|NCT03169153|324186152|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
94652629|NCT03169153|324186151|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
94652630|NCT03169153|324186152|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
94652631|NCT00887341|324186153|FG000|Overall Study|Refused treatment|1|||
94652632|NCT00887341|324186154|FG001|Overall Study|Refused treatment|0|||
94652633|NCT00887341|324186153|FG000|Overall Study|Withdrawal by Subject|1|||
94652634|NCT00887341|324186154|FG001|Overall Study|Withdrawal by Subject|1|||
94652635|NCT00887341|324186153|FG000|Overall Study|Adverse Event|0|||
94652636|NCT00887341|324186154|FG001|Overall Study|Adverse Event|1|||
94652637|NCT00887341|324186153|FG000|Overall Study|Lost to Follow-up|0|||
94652638|NCT00887341|324186154|FG001|Overall Study|Lost to Follow-up|1|||
94652639|NCT02617589|324186155|FG000|Randomization|Request to Discontinue Study Treatment|1|||
94652640|NCT02617589|324186156|FG001|Randomization|Request to Discontinue Study Treatment|3|||
94652641|NCT02617589|324186155|FG000|Randomization|Participant Withdrew Consent|1|||
94652642|NCT02617589|324186156|FG001|Randomization|Participant Withdrew Consent|2|||
94652643|NCT02617589|324186155|FG000|Treatment|Other Reasons|3|||
94652644|NCT02617589|324186156|FG001|Treatment|Other Reasons|3|||
94652645|NCT02617589|324186155|FG000|Treatment|Poor/Non Compliance|1|||
94652646|NCT02617589|324186156|FG001|Treatment|Poor/Non Compliance|1|||
94652647|NCT02617589|324186155|FG000|Treatment|Maximum Clinical Benefit|0|||
94652648|NCT02617589|324186156|FG001|Treatment|Maximum Clinical Benefit|2|||
94652649|NCT02617589|324186155|FG000|Treatment|Participant Withdrew Consent|2|||
94652650|NCT02617589|324186156|FG001|Treatment|Participant Withdrew Consent|6|||
94652651|NCT02617589|324186155|FG000|Treatment|Participant Request to Discontinue|12|||
94652652|NCT02617589|324186156|FG001|Treatment|Participant Request to Discontinue|21|||
94652653|NCT02617589|324186155|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
94652654|NCT02617589|324186156|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
94652655|NCT02617589|324186155|FG000|Treatment|Death|1|||
94652656|NCT02617589|324186156|FG001|Treatment|Death|1|||
94652657|NCT02617589|324186155|FG000|Treatment|Study Drug Toxicity|27|||
94652658|NCT02617589|324186156|FG001|Treatment|Study Drug Toxicity|20|||
94652659|NCT02617589|324186155|FG000|Treatment|Disease Progression|216|||
94652660|NCT02617589|324186156|FG001|Treatment|Disease Progression|136|||
94652661|NCT01696032|324186159|FG000|Overall Study|Withdrawal by Subject|0|||
94652662|NCT01696032|324186160|FG001|Overall Study|Withdrawal by Subject|0|||
94652663|NCT01696032|324186161|FG002|Overall Study|Withdrawal by Subject|1|||
94652664|NCT01696032|324186162|FG003|Overall Study|Withdrawal by Subject|2|||
94652665|NCT01696032|324186159|FG000|Overall Study|Death|14|||
94652666|NCT01696032|324186160|FG001|Overall Study|Death|4|||
94652667|NCT01696032|324186161|FG002|Overall Study|Death|43|||
94652668|NCT01696032|324186162|FG003|Overall Study|Death|18|||
94652669|NCT01696032|324186159|FG000|Overall Study|Lost to Follow-up|0|||
94704037|NCT01549652|324372563|FG001|Overall Study|Withdrawal by Subject|0|||
94704038|NCT01549652|324372564|FG002|Overall Study|Withdrawal by Subject|5|||
94704039|NCT01549652|324372565|FG003|Overall Study|Withdrawal by Subject|3|||
94704040|NCT02512042|324372566|FG000|Overall Study|Adverse Event|0|||
94704041|NCT02512042|324372567|FG001|Overall Study|Adverse Event|4|||
94704042|NCT02512042|324372566|FG000|Overall Study|Withdrawal by Subject|6|||
94704043|NCT02512042|324372567|FG001|Overall Study|Withdrawal by Subject|6|||
94704044|NCT02512042|324372566|FG000|Overall Study|Non-compliance with study drug|1|||
94704045|NCT02512042|324372567|FG001|Overall Study|Non-compliance with study drug|2|||
94704046|NCT02512042|324372566|FG000|Overall Study|Lost to Follow-up|5|||
94704047|NCT02512042|324372567|FG001|Overall Study|Lost to Follow-up|2|||
94704048|NCT02512042|324372566|FG000|Overall Study|Other|11|||
94704049|NCT02512042|324372567|FG001|Overall Study|Other|11|||
94704050|NCT04163458|324372568|FG000|Overall Study|Protocol Deviation|7|||
94704051|NCT04163458|324372569|FG001|Overall Study|Protocol Deviation|13|||
94704052|NCT04163458|324372568|FG000|Overall Study|Adverse Event|5|||
94704053|NCT04163458|324372569|FG001|Overall Study|Adverse Event|8|||
94704054|NCT04163458|324372568|FG000|Overall Study|Due to COVID-19 pandemic|4|||
94704055|NCT04163458|324372569|FG001|Overall Study|Due to COVID-19 pandemic|2|||
94704056|NCT04163458|324372568|FG000|Overall Study|Participant withdrew consent|2|||
94704057|NCT04163458|324372569|FG001|Overall Study|Participant withdrew consent|3|||
94704058|NCT04163458|324372568|FG000|Overall Study|Randomization failure|2|||
94704059|NCT04163458|324372569|FG001|Overall Study|Randomization failure|2|||
94704060|NCT04163458|324372568|FG000|Overall Study|Other|4|||
94704061|NCT04163458|324372569|FG001|Overall Study|Other|2|||
94704062|NCT02596035|324372570|FG000|Overall Study|Disease Progression|64|||
94704063|NCT02596035|324372571|FG001|Overall Study|Disease Progression|32|||
94704064|NCT02596035|324372572|FG002|Overall Study|Disease Progression|1|||
94704065|NCT02596035|324372570|FG000|Overall Study|study drug toxicity|12|||
94704066|NCT02596035|324372571|FG001|Overall Study|study drug toxicity|3|||
94704067|NCT02596035|324372572|FG002|Overall Study|study drug toxicity|0|||
94704068|NCT02596035|324372570|FG000|Overall Study|AE unrelated to study drug|5|||
94704069|NCT02596035|324372571|FG001|Overall Study|AE unrelated to study drug|2|||
94704070|NCT02596035|324372572|FG002|Overall Study|AE unrelated to study drug|0|||
94704071|NCT02596035|324372570|FG000|Overall Study|participant request to discontinue study treatment|2|||
94704072|NCT02596035|324372571|FG001|Overall Study|participant request to discontinue study treatment|0|||
94704073|NCT02596035|324372572|FG002|Overall Study|participant request to discontinue study treatment|0|||
94704074|NCT02596035|324372570|FG000|Overall Study|participant withdrew consent|2|||
94704075|NCT02596035|324372571|FG001|Overall Study|participant withdrew consent|2|||
94704076|NCT02596035|324372572|FG002|Overall Study|participant withdrew consent|0|||
94704077|NCT02596035|324372570|FG000|Overall Study|Poor/Non Comlpiance|0|||
94704078|NCT02596035|324372571|FG001|Overall Study|Poor/Non Comlpiance|1|||
94704079|NCT02596035|324372572|FG002|Overall Study|Poor/Non Comlpiance|0|||
94704080|NCT02596035|324372570|FG000|Overall Study|participant no longer meets study criteria|1|||
94704081|NCT02596035|324372571|FG001|Overall Study|participant no longer meets study criteria|0|||
94704082|NCT02596035|324372572|FG002|Overall Study|participant no longer meets study criteria|0|||
94704083|NCT02596035|324372570|FG000|Overall Study|other reasons|11|||
94704084|NCT02596035|324372571|FG001|Overall Study|other reasons|4|||
94704085|NCT02596035|324372572|FG002|Overall Study|other reasons|0|||
94704086|NCT00746330|324372575|FG000|Period 1|Abnormal test procedure result|0|||
94704087|NCT00746330|324372576|FG001|Period 1|Abnormal test procedure result|0|||
94704088|NCT00746330|324372577|FG002|Period 1|Abnormal test procedure result|1|||
94704089|NCT00746330|324372578|FG003|Period 1|Abnormal test procedure result|0|||
94704090|NCT03098030|324372592|FG000|Overall Study|Death|10|||
94704091|NCT03098030|324372593|FG001|Overall Study|Death|156|||
94704092|NCT03098030|324372594|FG002|Overall Study|Death|156|||
94704093|NCT03098030|324372595|FG003|Overall Study|Death|82|||
94704094|NCT03098030|324372592|FG000|Overall Study|Withdrawal by Subject|0|||
94704095|NCT03098030|324372593|FG001|Overall Study|Withdrawal by Subject|7|||
94704096|NCT03098030|324372594|FG002|Overall Study|Withdrawal by Subject|8|||
94704097|NCT03098030|324372595|FG003|Overall Study|Withdrawal by Subject|2|||
94704098|NCT03098030|324372592|FG000|Overall Study|Lost to Follow-up|0|||
94704099|NCT03098030|324372593|FG001|Overall Study|Lost to Follow-up|0|||
94466228|NCT01358578|323496951|FG000|Induction Period|technical problems|0|||
94266412|NCT01849497|322769976|FG000|Overall Study|Sponsor Decision|0|||
94466229|NCT01358578|323496952|FG001|Induction Period|technical problems|0|||
94466230|NCT01358578|323496953|FG002|Induction Period|technical problems|1|||
94652670|NCT01696032|324186160|FG001|Overall Study|Lost to Follow-up|1|||
94652671|NCT01696032|324186161|FG002|Overall Study|Lost to Follow-up|0|||
94652672|NCT01696032|324186162|FG003|Overall Study|Lost to Follow-up|0|||
94652673|NCT01696032|324186159|FG000|Overall Study|Database lock|0|||
94652674|NCT01696032|324186160|FG001|Overall Study|Database lock|1|||
94652675|NCT01696032|324186161|FG002|Overall Study|Database lock|7|||
94652676|NCT01696032|324186162|FG003|Overall Study|Database lock|2|||
94652677|NCT00578565|324186165|FG000|Overall Study|Adverse Event|3|||
94652678|NCT01752933|324186168|FG000|Treatment|Disease Progression|3|||
94652679|NCT01752933|324186169|FG001|Treatment|Disease Progression|29|||
94704100|NCT03098030|324372594|FG002|Overall Study|Lost to Follow-up|2|||
94704101|NCT03098030|324372595|FG003|Overall Study|Lost to Follow-up|1|||
94704102|NCT04716933|324372596|FG000|Overall Study|Ongoing|46|||
94704103|NCT04716933|324372597|FG001|Overall Study|Ongoing|37|||
94704104|NCT04716933|324372596|FG000|Overall Study|Sponsor Decision|55|||
94704105|NCT04716933|324372597|FG001|Overall Study|Sponsor Decision|63|||
94704106|NCT01537133|324374303|FG000|Overall Study|Withdrawal by Subject|2|||
94704107|NCT01537133|324374304|FG001|Overall Study|Withdrawal by Subject|0|||
94704108|NCT01537133|324374305|FG002|Overall Study|Withdrawal by Subject|0|||
94704109|NCT01537133|324374306|FG003|Overall Study|Withdrawal by Subject|0|||
94704110|NCT01537133|324374303|FG000|Overall Study|Lost to Follow-up|1|||
94704111|NCT01537133|324374304|FG001|Overall Study|Lost to Follow-up|0|||
94704112|NCT01537133|324374305|FG002|Overall Study|Lost to Follow-up|0|||
94704113|NCT01537133|324374306|FG003|Overall Study|Lost to Follow-up|0|||
94704114|NCT00613301|324374307|FG000|Overall Study|Adverse Event|49|||
94704115|NCT00613301|324374307|FG000|Overall Study|Lost to Follow-up|88|||
94704116|NCT00613301|324374307|FG000|Overall Study|Withdrawal by Subject|5|||
94704117|NCT00613301|324374307|FG000|Overall Study|Death|6|||
94704118|NCT00613301|324374307|FG000|Overall Study|Lack of Efficacy|13|||
94704119|NCT00613301|324374307|FG000|Overall Study|Physician Decision|2|||
94704120|NCT00613301|324374307|FG000|Overall Study|No data was collected|53|||
94704121|NCT00613301|324374307|FG000|Overall Study|Irregularly enrolled patients|12|||
94704122|NCT04057196|324374308|FG000|Overall Study|Withdrawal by Subject|3|||
94704123|NCT04057196|324374308|FG000|Overall Study|Death|3|||
94704124|NCT03068468|324374311|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
94704125|NCT03068468|324374312|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
94704126|NCT03068468|324374313|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
94704127|NCT03068468|324374314|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
94704128|NCT03068468|324374311|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
94704129|NCT03068468|324374312|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
94704130|NCT03068468|324374313|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
94704131|NCT03068468|324374314|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
94704132|NCT03068468|324374311|FG000|Placebo-Controlled Period|Adverse Event|16|||
94704133|NCT03068468|324374312|FG001|Placebo-Controlled Period|Adverse Event|21|||
94704134|NCT03068468|324374313|FG002|Placebo-Controlled Period|Adverse Event|0|||
94704135|NCT03068468|324374314|FG003|Placebo-Controlled Period|Adverse Event|0|||
94704136|NCT03068468|324374311|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
94704137|NCT03068468|324374312|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
94704138|NCT03068468|324374313|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
94704139|NCT03068468|324374314|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
94704140|NCT03068468|324374311|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
94704141|NCT03068468|324374312|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
94704142|NCT03068468|324374313|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
94704143|NCT03068468|324374314|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
94704144|NCT03068468|324374311|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
94704145|NCT03068468|324374312|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
94704146|NCT03068468|324374313|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
94704147|NCT03068468|324374314|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
94704148|NCT03068468|324374311|FG000|Placebo-Controlled Period|Death|0|||
94704149|NCT03068468|324374312|FG001|Placebo-Controlled Period|Death|1|||
94704150|NCT03068468|324374313|FG002|Placebo-Controlled Period|Death|0|||
94704151|NCT03068468|324374314|FG003|Placebo-Controlled Period|Death|0|||
94704152|NCT03068468|324374311|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
94704153|NCT03068468|324374312|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
94704154|NCT03068468|324374313|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
94704155|NCT03068468|324374314|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
94704156|NCT03068468|324374311|FG000|Open-Label Extension Period|Adverse Event|0|||
94704157|NCT03068468|324374312|FG001|Open-Label Extension Period|Adverse Event|0|||
94704158|NCT03068468|324374313|FG002|Open-Label Extension Period|Adverse Event|13|||
94704159|NCT03068468|324374314|FG003|Open-Label Extension Period|Adverse Event|17|||
94704160|NCT03068468|324374311|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
94704161|NCT03068468|324374312|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
94704162|NCT03068468|324374313|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
94704163|NCT03068468|324374314|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
94704164|NCT03068468|324374311|FG000|Open-Label Extension Period|Death|0|||
94704165|NCT03068468|324374312|FG001|Open-Label Extension Period|Death|0|||
94704166|NCT03068468|324374313|FG002|Open-Label Extension Period|Death|0|||
94704167|NCT03068468|324374314|FG003|Open-Label Extension Period|Death|1|||
94704168|NCT03068468|324374311|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
94704169|NCT03068468|324374312|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
94704170|NCT03068468|324374313|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
94704171|NCT03068468|324374314|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
94704172|NCT03068468|324374311|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
94704173|NCT03068468|324374312|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
94704174|NCT03068468|324374313|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
94704175|NCT03068468|324374314|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
94704176|NCT03068468|324374311|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
94704177|NCT03068468|324374312|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
94704178|NCT03068468|324374313|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
94704179|NCT03068468|324374314|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
94704180|NCT03068468|324374311|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
94704181|NCT03068468|324374312|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
94704182|NCT03068468|324374313|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
94704183|NCT03068468|324374314|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
94704184|NCT03068468|324374311|FG000|Open-Label Extension Period|Reason not Specified|0|||
94704185|NCT03068468|324374312|FG001|Open-Label Extension Period|Reason not Specified|0|||
94704186|NCT03068468|324374313|FG002|Open-Label Extension Period|Reason not Specified|1|||
94704187|NCT03068468|324374314|FG003|Open-Label Extension Period|Reason not Specified|4|||
94704188|NCT01118377|324374315|FG000|Overall Study|Did Not Receive Study Medication|1|||
94704189|NCT01118377|324374315|FG000|Overall Study|Death|38|||
94704190|NCT01118377|324374315|FG000|Overall Study|Failure to Return|3|||
94704191|NCT01510912|324374317|FG000|Overall Study|Adverse Event|99|||
94704192|NCT01510912|324374317|FG000|Overall Study|Lack of Efficacy|12|||
94704193|NCT01510912|324374317|FG000|Overall Study|Non-compliance with trial drug|23|||
94704194|NCT01510912|324374317|FG000|Overall Study|Withdrawal by Subject|49|||
94704195|NCT01510912|324374317|FG000|Overall Study|Physician Decision|1|||
94704196|NCT01510912|324374317|FG000|Overall Study|Protocol Violation|27|||
94704197|NCT01510912|324374317|FG000|Overall Study|Lost to Follow-up|26|||
94704198|NCT01510912|324374317|FG000|Overall Study|Other, including joint replacement|5|||
94704199|NCT00157014|324374318|FG000|Overall Study|Death|4|||
94704200|NCT00157014|324374319|FG001|Overall Study|Death|2|||
94704201|NCT00157014|324374320|FG002|Overall Study|Death|1|||
94704202|NCT00157014|324374321|FG003|Overall Study|Death|1|||
94704203|NCT00157014|324374318|FG000|Overall Study|Physician Decision|0|||
94704204|NCT00157014|324374319|FG001|Overall Study|Physician Decision|1|||
94704205|NCT00157014|324374320|FG002|Overall Study|Physician Decision|0|||
94704206|NCT00157014|324374321|FG003|Overall Study|Physician Decision|0|||
94704207|NCT00157014|324374318|FG000|Overall Study|Medications withdrawn on family request|0|||
94704208|NCT00157014|324374319|FG001|Overall Study|Medications withdrawn on family request|1|||
94704209|NCT00157014|324374320|FG002|Overall Study|Medications withdrawn on family request|0|||
94704210|NCT00157014|324374321|FG003|Overall Study|Medications withdrawn on family request|0|||
94704211|NCT00157014|324374318|FG000|Overall Study|Patient withdrawn by investigator|1|||
94704212|NCT00157014|324374319|FG001|Overall Study|Patient withdrawn by investigator|0|||
94704213|NCT00157014|324374320|FG002|Overall Study|Patient withdrawn by investigator|0|||
94704214|NCT00157014|324374321|FG003|Overall Study|Patient withdrawn by investigator|0|||
94704215|NCT00157014|324374318|FG000|Overall Study|Patient unable to return in nursing home|1|||
94704216|NCT00157014|324374319|FG001|Overall Study|Patient unable to return in nursing home|0|||
94704217|NCT00157014|324374320|FG002|Overall Study|Patient unable to return in nursing home|0|||
94704218|NCT00157014|324374321|FG003|Overall Study|Patient unable to return in nursing home|0|||
94704219|NCT00157014|324374318|FG000|Overall Study|Patient would not receive transplant|0|||
94704220|NCT00157014|324374319|FG001|Overall Study|Patient would not receive transplant|1|||
94704221|NCT00157014|324374320|FG002|Overall Study|Patient would not receive transplant|0|||
94704222|NCT00157014|324374321|FG003|Overall Study|Patient would not receive transplant|0|||
94704223|NCT00157014|324374318|FG000|Overall Study|Withdrawal by Subject|1|||
94704224|NCT00157014|324374319|FG001|Overall Study|Withdrawal by Subject|0|||
94704225|NCT00157014|324374320|FG002|Overall Study|Withdrawal by Subject|0|||
94704226|NCT00157014|324374321|FG003|Overall Study|Withdrawal by Subject|0|||
94704227|NCT03181958|324374322|FG000|Overall Study|Lost to Follow-up|17|||
94704228|NCT03181958|324374323|FG001|Overall Study|Lost to Follow-up|21|||
94704229|NCT03181958|324374324|FG002|Overall Study|Lost to Follow-up|15|||
94704230|NCT00567879|324374326|FG000|Overall Study|Adverse Event|2|||
94704231|NCT00567879|324374327|FG001|Overall Study|Adverse Event|0|||
94704232|NCT00567879|324374328|FG002|Overall Study|Adverse Event|1|||
94704233|NCT00567879|324374329|FG003|Overall Study|Adverse Event|0|||
94704234|NCT00567879|324374330|FG004|Overall Study|Adverse Event|1|||
94704235|NCT00567879|324374331|FG005|Overall Study|Adverse Event|0|||
94704236|NCT00567879|324374326|FG000|Overall Study|Abnormal test procedure(s)|0|||
94704237|NCT00567879|324374327|FG001|Overall Study|Abnormal test procedure(s)|0|||
94704238|NCT00567879|324374328|FG002|Overall Study|Abnormal test procedure(s)|1|||
94704239|NCT00567879|324374329|FG003|Overall Study|Abnormal test procedure(s)|0|||
94704240|NCT00567879|324374330|FG004|Overall Study|Abnormal test procedure(s)|0|||
94704241|NCT00567879|324374331|FG005|Overall Study|Abnormal test procedure(s)|0|||
94704242|NCT00567879|324374326|FG000|Overall Study|Withdrawal by Subject|0|||
94704243|NCT00567879|324374327|FG001|Overall Study|Withdrawal by Subject|0|||
94704244|NCT00567879|324374328|FG002|Overall Study|Withdrawal by Subject|3|||
94704245|NCT00567879|324374329|FG003|Overall Study|Withdrawal by Subject|1|||
94704246|NCT00567879|324374330|FG004|Overall Study|Withdrawal by Subject|0|||
94704247|NCT00567879|324374331|FG005|Overall Study|Withdrawal by Subject|0|||
94704248|NCT00567879|324374326|FG000|Overall Study|New cancer therapy|0|||
94704249|NCT00567879|324374327|FG001|Overall Study|New cancer therapy|0|||
94704250|NCT00567879|324374328|FG002|Overall Study|New cancer therapy|1|||
94704251|NCT00567879|324374329|FG003|Overall Study|New cancer therapy|0|||
94704252|NCT00567879|324374330|FG004|Overall Study|New cancer therapy|0|||
94704253|NCT00567879|324374331|FG005|Overall Study|New cancer therapy|0|||
94704254|NCT00567879|324374326|FG000|Overall Study|Disease progression|5|||
94704255|NCT00567879|324374327|FG001|Overall Study|Disease progression|7|||
94704256|NCT00567879|324374328|FG002|Overall Study|Disease progression|15|||
94704257|NCT00567879|324374329|FG003|Overall Study|Disease progression|5|||
94704258|NCT00567879|324374330|FG004|Overall Study|Disease progression|11|||
94704259|NCT00567879|324374331|FG005|Overall Study|Disease progression|3|||
94704260|NCT00470626|324374332|FG000|Overall Study|Lost to Follow-up|10|||
94704261|NCT00470626|324374332|FG000|Overall Study|Withdrawal by Subject|7|||
94704262|NCT03518112|324374333|FG000|Overall Study|Withdrawal by Subject|1|||
94704263|NCT02987543|324374334|FG000|Overall Study|Ongoing study at data cut off|49|||
94704264|NCT02987543|324374335|FG001|Overall Study|Ongoing study at data cut off|21|||
94704265|NCT02987543|324374336|FG002|Overall Study|Ongoing study at data cut off|19|||
94704266|NCT02987543|324374337|FG003|Overall Study|Ongoing study at data cut off|12|||
94704267|NCT02987543|324374334|FG000|Overall Study|Death|88|||
94704268|NCT02987543|324374335|FG001|Overall Study|Death|54|||
94704269|NCT02987543|324374336|FG002|Overall Study|Death|67|||
94704270|NCT02987543|324374337|FG003|Overall Study|Death|28|||
94704271|NCT02987543|324374334|FG000|Overall Study|Lost to Follow-up|3|||
94704272|NCT02987543|324374335|FG001|Overall Study|Lost to Follow-up|0|||
94704273|NCT02987543|324374336|FG002|Overall Study|Lost to Follow-up|1|||
94704274|NCT02987543|324374337|FG003|Overall Study|Lost to Follow-up|0|||
94704275|NCT02987543|324374334|FG000|Overall Study|Screen failure|0|||
94704276|NCT02987543|324374335|FG001|Overall Study|Screen failure|0|||
94704277|NCT02987543|324374336|FG002|Overall Study|Screen failure|0|||
94704278|NCT02987543|324374337|FG003|Overall Study|Screen failure|1|||
94704279|NCT02987543|324374334|FG000|Overall Study|Withdrawal by Subject|21|||
94704280|NCT02987543|324374335|FG001|Overall Study|Withdrawal by Subject|7|||
94704281|NCT02987543|324374336|FG002|Overall Study|Withdrawal by Subject|7|||
94704282|NCT02987543|324374337|FG003|Overall Study|Withdrawal by Subject|6|||
94704283|NCT02987543|324374334|FG000|Overall Study|Study terminated by sponsor|1|||
94704284|NCT02987543|324374335|FG001|Overall Study|Study terminated by sponsor|0|||
94704285|NCT02987543|324374336|FG002|Overall Study|Study terminated by sponsor|0|||
94704286|NCT02987543|324374337|FG003|Overall Study|Study terminated by sponsor|0|||
94704287|NCT02987543|324374334|FG000|Overall Study|Investigator decision|0|||
94704288|NCT02987543|324374335|FG001|Overall Study|Investigator decision|1|||
94704289|NCT02987543|324374336|FG002|Overall Study|Investigator decision|0|||
94704290|NCT02987543|324374337|FG003|Overall Study|Investigator decision|0|||
94704291|NCT02987543|324374334|FG000|Overall Study|Disease progression|0|||
94704292|NCT02987543|324374335|FG001|Overall Study|Disease progression|0|||
94366603|NCT03911960|323128072|FG000|Overall Study|Lost to Follow-up|5|||
94704293|NCT02987543|324374336|FG002|Overall Study|Disease progression|0|||
94266413|NCT01849497|322769977|FG001|Overall Study|Sponsor Decision|1|||
94266414|NCT01849497|322769976|FG000|Overall Study|Lost to Follow-up|0|||
94266415|NCT01849497|322769977|FG001|Overall Study|Lost to Follow-up|1|||
94266416|NCT00911625|322770003|FG000|Overall Study|Lost to Follow-up|7|||
94266417|NCT00911625|322770004|FG001|Overall Study|Lost to Follow-up|0|||
94266418|NCT00773136|322770011|FG000|Overall Study|Physician Decision|2|||
94266419|NCT02146599|322770012|FG000|Overall Study|Failed to meet inclusion criteria|5|||
94266420|NCT01368042|322770013|FG000|Overall Study|Death|14|||
94266421|NCT01368042|322770013|FG000|Overall Study|Protocol Violation|11|||
94266422|NCT01368042|322770013|FG000|Overall Study|Lost to Follow-up|4|||
94266423|NCT01368042|322770013|FG000|Overall Study|Transplanted|1|||
94266424|NCT01572675|322770015|FG000|Overall Study|End of prescribed treatment|140|||
94704294|NCT02987543|324374337|FG003|Overall Study|Disease progression|1|||
94704295|NCT01801930|324374338|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
94266425|NCT01572675|322770016|FG001|Overall Study|End of prescribed treatment|118|||
94266426|NCT01572675|322770015|FG000|Overall Study|Recovery|16|||
94266427|NCT01572675|322770016|FG001|Overall Study|Recovery|23|||
94266428|NCT01572675|322770015|FG000|Overall Study|Lack of Efficacy|31|||
94266429|NCT01572675|322770016|FG001|Overall Study|Lack of Efficacy|31|||
94266430|NCT01572675|322770015|FG000|Overall Study|Intolerance|6|||
94266431|NCT01572675|322770016|FG001|Overall Study|Intolerance|5|||
94266432|NCT01572675|322770015|FG000|Overall Study|Improved symptoms|8|||
94266433|NCT01572675|322770016|FG001|Overall Study|Improved symptoms|2|||
94266434|NCT01572675|322770015|FG000|Overall Study|Surgical intervention|3|||
94266435|NCT01572675|322770016|FG001|Overall Study|Surgical intervention|6|||
94266436|NCT01572675|322770015|FG000|Overall Study|Withdrawal by Subject|5|||
94266437|NCT01572675|322770016|FG001|Overall Study|Withdrawal by Subject|1|||
94266438|NCT01572675|322770015|FG000|Overall Study|Physician Decision|2|||
94266439|NCT01572675|322770016|FG001|Overall Study|Physician Decision|2|||
94266440|NCT01572675|322770015|FG000|Overall Study|Death unrelated to coxibs|1|||
94266441|NCT01572675|322770016|FG001|Overall Study|Death unrelated to coxibs|1|||
94266442|NCT01572675|322770015|FG000|Overall Study|Other disease detected|1|||
94704296|NCT01801930|324374339|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
94704297|NCT01801930|324374340|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
94704298|NCT01801930|324374341|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
94704299|NCT01801930|324374338|FG000|Overall Study|DLT occurs|0|||
94704300|NCT01801930|324374339|FG001|Overall Study|DLT occurs|1|||
94704301|NCT01801930|324374340|FG002|Overall Study|DLT occurs|0|||
94704302|NCT01801930|324374341|FG003|Overall Study|DLT occurs|0|||
94704303|NCT00309452|324374342|FG000|Overall Study|Withdrawal by Subject|3|||
94266443|NCT01572675|322770016|FG001|Overall Study|Other disease detected|1|||
94266444|NCT01572675|322770015|FG000|Overall Study|Unknown reason|1|||
94266445|NCT01572675|322770016|FG001|Overall Study|Unknown reason|1|||
94266446|NCT01572675|322770015|FG000|Overall Study|Rheumatologist new evaluation|0|||
94266447|NCT01572675|322770016|FG001|Overall Study|Rheumatologist new evaluation|1|||
94266448|NCT01572675|322770015|FG000|Overall Study|Missing data|1|||
94266449|NCT01572675|322770016|FG001|Overall Study|Missing data|4|||
94266450|NCT01572675|322770015|FG000|Overall Study|Lost to Follow-up|22|||
94266451|NCT01572675|322770016|FG001|Overall Study|Lost to Follow-up|27|||
94366604|NCT03911960|323128073|FG001|Overall Study|Lost to Follow-up|3|||
94366605|NCT00424515|323128080|FG000|Overall Study|Progressive Disease|10|||
94704304|NCT00309452|324374343|FG001|Overall Study|Withdrawal by Subject|0|||
94704305|NCT00943605|324374344|FG000|Overall Study|Study termination|30|||
94704306|NCT00943605|324374345|FG001|Overall Study|Study termination|30|||
94704307|NCT04464421|324374348|FG000|Overall Study|Lost to Follow-up|2|||
94704308|NCT04464421|324374349|FG001|Overall Study|Lost to Follow-up|2|||
94704309|NCT01908634|324374352|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
94704310|NCT01908634|324374352|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
94704311|NCT01027286|324374356|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
94704312|NCT01027286|324374357|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
94704313|NCT01027286|324374356|FG000|Overall Study|Lost to Follow-up|0|||
94704314|NCT01027286|324374357|FG001|Overall Study|Lost to Follow-up|1|||
94704315|NCT02377362|324374362|FG000|Part A Second Treatment|Protocol Violation|0|||
94704316|NCT02377362|324374363|FG001|Part A Second Treatment|Protocol Violation|0|||
94704317|NCT02377362|324374364|FG002|Part A Second Treatment|Protocol Violation|0|||
94704318|NCT02377362|324374365|FG003|Part A Second Treatment|Protocol Violation|0|||
94266452|NCT04166383|322770017|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
94266453|NCT04166383|322770017|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
94266454|NCT04166383|322770017|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
94266455|NCT01660451|322770020|FG000|Overall Study|Protocol Violation|0|||
94266456|NCT01660451|322770021|FG001|Overall Study|Protocol Violation|1|||
94704319|NCT02377362|324374366|FG004|Part A Second Treatment|Protocol Violation|1|||
94704320|NCT02377362|324374367|FG005|Part A Second Treatment|Protocol Violation|0|||
94266457|NCT01660451|322770022|FG002|Overall Study|Protocol Violation|1|||
94266458|NCT01660451|322770020|FG000|Overall Study|AE not associated with clinical disease progression|13|||
94266459|NCT01660451|322770021|FG001|Overall Study|AE not associated with clinical disease progression|10|||
94266460|NCT01660451|322770022|FG002|Overall Study|AE not associated with clinical disease progression|40|||
94266461|NCT01660451|322770020|FG000|Overall Study|AE associated with clinical disease progression|1|||
94266462|NCT01660451|322770021|FG001|Overall Study|AE associated with clinical disease progression|3|||
94266463|NCT01660451|322770022|FG002|Overall Study|AE associated with clinical disease progression|11|||
94266464|NCT01660451|322770020|FG000|Overall Study|Sponsor Decision|0|||
94266465|NCT01660451|322770021|FG001|Overall Study|Sponsor Decision|0|||
94704321|NCT02377362|324374368|FG006|Part A Second Treatment|Protocol Violation|0|||
94704322|NCT02377362|324374369|FG007|Part A Second Treatment|Protocol Violation|0|||
94704323|NCT02377362|324374370|FG008|Part A Second Treatment|Protocol Violation|0|||
94704324|NCT02377362|324374371|FG009|Part A Second Treatment|Protocol Violation|0|||
94704325|NCT02377362|324374372|FG010|Part A Second Treatment|Protocol Violation|0|||
94704326|NCT02377362|324374373|FG011|Part A Second Treatment|Protocol Violation|0|||
94704327|NCT02377362|324374374|FG012|Part A Second Treatment|Protocol Violation|0|||
94704328|NCT02377362|324374362|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
94704329|NCT02377362|324374363|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
94704330|NCT02377362|324374364|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
94704331|NCT02377362|324374365|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
94704332|NCT02377362|324374366|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
94704333|NCT02377362|324374367|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
94704334|NCT02377362|324374368|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
94704335|NCT02377362|324374369|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
94704336|NCT02377362|324374370|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
94704337|NCT02377362|324374371|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
94704338|NCT02377362|324374372|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
94704339|NCT02377362|324374373|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
94704340|NCT02377362|324374374|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
94704341|NCT02377362|324374362|FG000|Part B Overall|Protocol Violation|0|||
94704342|NCT02377362|324374363|FG001|Part B Overall|Protocol Violation|0|||
94704343|NCT02377362|324374364|FG002|Part B Overall|Protocol Violation|0|||
94704344|NCT02377362|324374365|FG003|Part B Overall|Protocol Violation|0|||
94704345|NCT02377362|324374366|FG004|Part B Overall|Protocol Violation|0|||
94704346|NCT02377362|324374367|FG005|Part B Overall|Protocol Violation|0|||
94704347|NCT02377362|324374368|FG006|Part B Overall|Protocol Violation|0|||
94704348|NCT02377362|324374369|FG007|Part B Overall|Protocol Violation|0|||
94704349|NCT02377362|324374370|FG008|Part B Overall|Protocol Violation|0|||
94704350|NCT02377362|324374371|FG009|Part B Overall|Protocol Violation|1|||
94704351|NCT02377362|324374372|FG010|Part B Overall|Protocol Violation|0|||
94704352|NCT02377362|324374373|FG011|Part B Overall|Protocol Violation|0|||
94704353|NCT02377362|324374374|FG012|Part B Overall|Protocol Violation|0|||
94704354|NCT02377362|324374362|FG000|Part B Overall|Adverse Event|0|||
94704355|NCT02377362|324374363|FG001|Part B Overall|Adverse Event|0|||
94704356|NCT02377362|324374364|FG002|Part B Overall|Adverse Event|0|||
94704357|NCT02377362|324374365|FG003|Part B Overall|Adverse Event|0|||
94704358|NCT02377362|324374366|FG004|Part B Overall|Adverse Event|0|||
94704359|NCT02377362|324374367|FG005|Part B Overall|Adverse Event|0|||
94704360|NCT02377362|324374368|FG006|Part B Overall|Adverse Event|1|||
94704361|NCT02377362|324374369|FG007|Part B Overall|Adverse Event|1|||
94704362|NCT02377362|324374370|FG008|Part B Overall|Adverse Event|0|||
94704363|NCT02377362|324374371|FG009|Part B Overall|Adverse Event|0|||
94704364|NCT02377362|324374372|FG010|Part B Overall|Adverse Event|0|||
94704365|NCT02377362|324374373|FG011|Part B Overall|Adverse Event|0|||
94704366|NCT02377362|324374374|FG012|Part B Overall|Adverse Event|0|||
94704367|NCT02377362|324374362|FG000|Part B Overall|Withdrawal by Subject|0|||
94704368|NCT02377362|324374363|FG001|Part B Overall|Withdrawal by Subject|0|||
94266466|NCT01660451|322770022|FG002|Overall Study|Sponsor Decision|1|||
94266467|NCT01660451|322770020|FG000|Overall Study|Protocol Deviation|0|||
94266468|NCT01660451|322770021|FG001|Overall Study|Protocol Deviation|0|||
94266469|NCT01660451|322770022|FG002|Overall Study|Protocol Deviation|1|||
94704369|NCT02377362|324374364|FG002|Part B Overall|Withdrawal by Subject|0|||
94704370|NCT02377362|324374365|FG003|Part B Overall|Withdrawal by Subject|0|||
94266470|NCT01660451|322770020|FG000|Overall Study|Physician Decision|1|||
94366606|NCT00424515|323128081|FG001|Overall Study|Progressive Disease|11|||
94366607|NCT00424515|323128080|FG000|Overall Study|Adverse Event|0|||
94366608|NCT00424515|323128081|FG001|Overall Study|Adverse Event|1|||
94366609|NCT00424515|323128080|FG000|Overall Study|Intercurrent Illness|0|||
94266471|NCT01660451|322770021|FG001|Overall Study|Physician Decision|2|||
94266472|NCT01660451|322770022|FG002|Overall Study|Physician Decision|5|||
94366610|NCT00424515|323128081|FG001|Overall Study|Intercurrent Illness|1|||
94704371|NCT02377362|324374366|FG004|Part B Overall|Withdrawal by Subject|0|||
94704372|NCT02377362|324374367|FG005|Part B Overall|Withdrawal by Subject|0|||
94704373|NCT02377362|324374368|FG006|Part B Overall|Withdrawal by Subject|1|||
94704374|NCT02377362|324374369|FG007|Part B Overall|Withdrawal by Subject|0|||
94704375|NCT02377362|324374370|FG008|Part B Overall|Withdrawal by Subject|0|||
94266473|NCT01660451|322770020|FG000|Overall Study|Withdrawal by Subject|1|||
94266474|NCT01660451|322770021|FG001|Overall Study|Withdrawal by Subject|1|||
94266475|NCT01660451|322770022|FG002|Overall Study|Withdrawal by Subject|20|||
94266476|NCT01660451|322770020|FG000|Overall Study|Trial closure.|0|||
94266477|NCT01660451|322770021|FG001|Overall Study|Trial closure.|0|||
94266478|NCT01660451|322770022|FG002|Overall Study|Trial closure.|1|||
94266479|NCT01660451|322770020|FG000|Overall Study|Switching to other therapy|0|||
94266480|NCT01660451|322770021|FG001|Overall Study|Switching to other therapy|1|||
94266481|NCT01660451|322770022|FG002|Overall Study|Switching to other therapy|1|||
94266482|NCT01660451|322770020|FG000|Overall Study|Progressive disease - clinical progression|4|||
94266483|NCT01660451|322770021|FG001|Overall Study|Progressive disease - clinical progression|10|||
94266484|NCT01660451|322770022|FG002|Overall Study|Progressive disease - clinical progression|9|||
94266485|NCT01660451|322770020|FG000|Overall Study|Progressive disease - radiological progression|12|||
94266486|NCT01660451|322770021|FG001|Overall Study|Progressive disease - radiological progression|23|||
94266487|NCT01660451|322770022|FG002|Overall Study|Progressive disease - radiological progression|50|||
94266488|NCT01660451|322770020|FG000|Overall Study|Death|1|||
94266489|NCT01660451|322770021|FG001|Overall Study|Death|0|||
94266490|NCT01660451|322770022|FG002|Overall Study|Death|1|||
94266491|NCT01660451|322770020|FG000|Overall Study|Other|0|||
94266492|NCT01660451|322770021|FG001|Overall Study|Other|0|||
94266493|NCT01660451|322770022|FG002|Overall Study|Other|1|||
94266494|NCT02456662|322770023|FG000|Overall Study|Lost to Follow-up|2|||
94266495|NCT02456662|322770024|FG001|Overall Study|Lost to Follow-up|1|||
94266496|NCT00805025|322770029|FG000|Overall Study|Screened but not enrolled/treated|42|||
94266497|NCT00805025|322770029|FG000|Overall Study|Adverse Event|4|||
94266498|NCT00805025|322770029|FG000|Overall Study|Withdrawal by Subject|2|||
94266499|NCT00805025|322770029|FG000|Overall Study|Physician Decision|1|||
94266500|NCT01854645|322770035|FG000|Overall Study|Protocol-Specified Criteria|13|||
94266501|NCT01854645|322770036|FG001|Overall Study|Protocol-Specified Criteria|10|||
94266502|NCT01854645|322770037|FG002|Overall Study|Protocol-Specified Criteria|8|||
94266503|NCT01854645|322770038|FG003|Overall Study|Protocol-Specified Criteria|5|||
94266504|NCT01854645|322770039|FG004|Overall Study|Protocol-Specified Criteria|7|||
94266505|NCT01854645|322770035|FG000|Overall Study|Administrative Reasons / Missing|0|||
94266506|NCT01854645|322770036|FG001|Overall Study|Administrative Reasons / Missing|0|||
94266507|NCT01854645|322770037|FG002|Overall Study|Administrative Reasons / Missing|0|||
94266508|NCT01854645|322770038|FG003|Overall Study|Administrative Reasons / Missing|1|||
94266509|NCT01854645|322770039|FG004|Overall Study|Administrative Reasons / Missing|1|||
94266510|NCT01854645|322770035|FG000|Overall Study|Protocol Violation|3|||
94266511|NCT01854645|322770036|FG001|Overall Study|Protocol Violation|0|||
94266512|NCT01854645|322770037|FG002|Overall Study|Protocol Violation|5|||
94266513|NCT01854645|322770038|FG003|Overall Study|Protocol Violation|4|||
94266514|NCT01854645|322770039|FG004|Overall Study|Protocol Violation|1|||
94266515|NCT01854645|322770035|FG000|Overall Study|Lost to Follow-up|10|||
94266516|NCT01854645|322770036|FG001|Overall Study|Lost to Follow-up|7|||
94266517|NCT01854645|322770037|FG002|Overall Study|Lost to Follow-up|8|||
94266518|NCT01854645|322770038|FG003|Overall Study|Lost to Follow-up|5|||
94266519|NCT01854645|322770039|FG004|Overall Study|Lost to Follow-up|0|||
94266520|NCT01854645|322770035|FG000|Overall Study|Physician Decision|1|||
94266521|NCT01854645|322770036|FG001|Overall Study|Physician Decision|5|||
94266522|NCT01854645|322770037|FG002|Overall Study|Physician Decision|3|||
94266523|NCT01854645|322770038|FG003|Overall Study|Physician Decision|3|||
94266524|NCT01854645|322770039|FG004|Overall Study|Physician Decision|7|||
94266525|NCT01854645|322770035|FG000|Overall Study|Withdrawal by Subject|31|||
94266526|NCT01854645|322770036|FG001|Overall Study|Withdrawal by Subject|41|||
94266527|NCT01854645|322770037|FG002|Overall Study|Withdrawal by Subject|30|||
94266528|NCT01854645|322770038|FG003|Overall Study|Withdrawal by Subject|21|||
94266529|NCT01854645|322770039|FG004|Overall Study|Withdrawal by Subject|24|||
94266530|NCT01854645|322770035|FG000|Overall Study|Lack of Efficacy|7|||
94266531|NCT01854645|322770036|FG001|Overall Study|Lack of Efficacy|12|||
94266532|NCT01854645|322770037|FG002|Overall Study|Lack of Efficacy|9|||
94266533|NCT01854645|322770038|FG003|Overall Study|Lack of Efficacy|3|||
94266534|NCT01854645|322770039|FG004|Overall Study|Lack of Efficacy|9|||
94266535|NCT01854645|322770035|FG000|Overall Study|Adverse Event|33|||
94266536|NCT01854645|322770036|FG001|Overall Study|Adverse Event|31|||
94266537|NCT01854645|322770037|FG002|Overall Study|Adverse Event|19|||
94266538|NCT01854645|322770038|FG003|Overall Study|Adverse Event|20|||
94266539|NCT01854645|322770039|FG004|Overall Study|Adverse Event|11|||
94266540|NCT00475722|322770042|FG000|Overall Study|Withdrawal by Subject|12|||
94266541|NCT00475722|322770043|FG001|Overall Study|Withdrawal by Subject|12|||
94266542|NCT00475722|322770042|FG000|Overall Study|Protocol Violation|3|||
94266543|NCT00475722|322770043|FG001|Overall Study|Protocol Violation|0|||
94266544|NCT03348631|322770044|FG000|Overall Study|Not Eligible, No treatment|0|||
94266545|NCT03348631|322770045|FG001|Overall Study|Not Eligible, No treatment|1|||
94266546|NCT03348631|322770044|FG000|Overall Study|Not Eligible, Treated|2|||
94266547|NCT03348631|322770045|FG001|Overall Study|Not Eligible, Treated|0|||
94266548|NCT03348631|322770044|FG000|Overall Study|Eligible, No Treatment|1|||
94266549|NCT03348631|322770045|FG001|Overall Study|Eligible, No Treatment|0|||
94366611|NCT00424515|323128080|FG000|Overall Study|Withdrawal by Subject|1|||
94366612|NCT00424515|323128081|FG001|Overall Study|Withdrawal by Subject|0|||
94366613|NCT02953262|323128082|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
94366614|NCT02953262|323128083|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
94366615|NCT02953262|323128084|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
94366616|NCT02953262|323128085|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
94366617|NCT00934622|323128086|FG000|Overall Study|Lost to Follow-up|7|||
94366618|NCT00934622|323128086|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
94366619|NCT01396161|323128090|FG000|Overall Study|Withdrawal by Subject|0|||
94366620|NCT01396161|323128091|FG001|Overall Study|Withdrawal by Subject|0|||
94366621|NCT01396161|323128092|FG002|Overall Study|Withdrawal by Subject|0|||
94366622|NCT01396161|323128093|FG003|Overall Study|Withdrawal by Subject|0|||
94466231|NCT01358578|323496954|FG003|Induction Period|technical problems|1|||
94466232|NCT01358578|323496955|FG004|Induction Period|technical problems|0|||
94466233|NCT01358578|323496956|FG005|Induction Period|technical problems|0|||
94466234|NCT01358578|323496951|FG000|Induction Period|Withdrawal by Subject|5|||
94466235|NCT01358578|323496952|FG001|Induction Period|Withdrawal by Subject|5|||
94704376|NCT02377362|324374371|FG009|Part B Overall|Withdrawal by Subject|0|||
94704377|NCT02377362|324374372|FG010|Part B Overall|Withdrawal by Subject|0|||
94704378|NCT02377362|324374373|FG011|Part B Overall|Withdrawal by Subject|1|||
94704379|NCT02377362|324374374|FG012|Part B Overall|Withdrawal by Subject|0|||
94704380|NCT03586167|324374379|FG000|Overall Study|Other|1|||
94704381|NCT03586167|324374380|FG001|Overall Study|Other|0|||
94704382|NCT03631199|324374381|FG000|Overall Study|Progressive disease|9|||
94704383|NCT03631199|324374382|FG001|Overall Study|Progressive disease|5|||
94704384|NCT03631199|324374383|FG002|Overall Study|Progressive disease|5|||
94704385|NCT03631199|324374384|FG003|Overall Study|Progressive disease|149|||
94704386|NCT03631199|324374385|FG004|Overall Study|Progressive disease|148|||
94704387|NCT03631199|324374381|FG000|Overall Study|Physician Decision|0|||
94704388|NCT03631199|324374382|FG001|Overall Study|Physician Decision|2|||
94704389|NCT03631199|324374383|FG002|Overall Study|Physician Decision|3|||
94704390|NCT03631199|324374384|FG003|Overall Study|Physician Decision|19|||
94704391|NCT03631199|324374385|FG004|Overall Study|Physician Decision|13|||
94704392|NCT03631199|324374381|FG000|Overall Study|Adverse Event|1|||
94704393|NCT03631199|324374382|FG001|Overall Study|Adverse Event|1|||
94704394|NCT03631199|324374383|FG002|Overall Study|Adverse Event|0|||
94704395|NCT03631199|324374384|FG003|Overall Study|Adverse Event|28|||
94704396|NCT03631199|324374385|FG004|Overall Study|Adverse Event|29|||
94704397|NCT03631199|324374381|FG000|Overall Study|Death|0|||
94704398|NCT03631199|324374382|FG001|Overall Study|Death|1|||
94704399|NCT03631199|324374383|FG002|Overall Study|Death|0|||
94704400|NCT03631199|324374384|FG003|Overall Study|Death|35|||
94704401|NCT03631199|324374385|FG004|Overall Study|Death|48|||
94704402|NCT03631199|324374381|FG000|Overall Study|Subject decision|0|||
94704403|NCT03631199|324374382|FG001|Overall Study|Subject decision|1|||
94704404|NCT03631199|324374383|FG002|Overall Study|Subject decision|0|||
94466236|NCT01358578|323496953|FG002|Induction Period|Withdrawal by Subject|10|||
94704405|NCT03631199|324374384|FG003|Overall Study|Subject decision|12|||
94704406|NCT03631199|324374385|FG004|Overall Study|Subject decision|12|||
94704407|NCT03631199|324374381|FG000|Overall Study|No treated|0|||
94704408|NCT03631199|324374382|FG001|Overall Study|No treated|0|||
94704409|NCT03631199|324374383|FG002|Overall Study|No treated|0|||
94266550|NCT04085523|322770046|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
94266551|NCT04085523|322770047|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
94266552|NCT04085523|322770048|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
94266553|NCT04085523|322770049|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
94266554|NCT04085523|322770050|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
94266555|NCT04085523|322770051|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
94266556|NCT04313153|322771923|FG000|Overall Study|Adverse Event (includes Death)|14|||
94266557|NCT04313153|322771924|FG001|Overall Study|Adverse Event (includes Death)|19|||
94266558|NCT04313153|322771925|FG002|Overall Study|Adverse Event (includes Death)|10|||
94266559|NCT04313153|322771923|FG000|Overall Study|Physician Decision|4|||
94266560|NCT04313153|322771924|FG001|Overall Study|Physician Decision|2|||
94266561|NCT04313153|322771925|FG002|Overall Study|Physician Decision|1|||
94266562|NCT04313153|322771923|FG000|Overall Study|Withdrawal by Subject|7|||
94266563|NCT04313153|322771924|FG001|Overall Study|Withdrawal by Subject|6|||
94266564|NCT04313153|322771925|FG002|Overall Study|Withdrawal by Subject|2|||
94266565|NCT04313153|322771923|FG000|Overall Study|Lack of Efficacy|3|||
94266566|NCT04313153|322771924|FG001|Overall Study|Lack of Efficacy|3|||
94266567|NCT04313153|322771925|FG002|Overall Study|Lack of Efficacy|0|||
94266568|NCT04313153|322771923|FG000|Overall Study|Lost to Follow-up|1|||
94266569|NCT04313153|322771924|FG001|Overall Study|Lost to Follow-up|0|||
94266570|NCT04313153|322771925|FG002|Overall Study|Lost to Follow-up|2|||
94652680|NCT01752933|324186168|FG000|Treatment|Withdrawal by Subject|0|||
94652681|NCT01752933|324186169|FG001|Treatment|Withdrawal by Subject|5|||
94652682|NCT01752933|324186168|FG000|Treatment|Adverse Event|1|||
94652683|NCT01752933|324186169|FG001|Treatment|Adverse Event|4|||
94652684|NCT01752933|324186168|FG000|Treatment|Physician Decision|0|||
94652685|NCT01752933|324186169|FG001|Treatment|Physician Decision|3|||
94652686|NCT01752933|324186168|FG000|Treatment|Death|0|||
94652687|NCT01752933|324186169|FG001|Treatment|Death|2|||
94652688|NCT01752933|324186168|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
94652689|NCT01752933|324186169|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
94652690|NCT01752933|324186168|FG000|Treatment|Patient noncompliant|0|||
94652691|NCT01752933|324186169|FG001|Treatment|Patient noncompliant|1|||
94652692|NCT01752933|324186168|FG000|Treatment|Patient unable to travel to appointments|0|||
94652693|NCT01752933|324186169|FG001|Treatment|Patient unable to travel to appointments|1|||
94652694|NCT01752933|324186168|FG000|Overall Study and Follow-up|Death|4|||
94652695|NCT01752933|324186169|FG001|Overall Study and Follow-up|Death|34|||
94652696|NCT01752933|324186168|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
94652697|NCT01752933|324186169|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
94652698|NCT01752933|324186168|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
94652699|NCT01752933|324186169|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
94652700|NCT01752933|324186168|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
94652701|NCT01752933|324186169|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
94652702|NCT01649856|324186171|FG000|Overall Study|Withdrawal by Subject|14|||
94652703|NCT01649856|324186172|FG001|Overall Study|Withdrawal by Subject|14|||
94652704|NCT01649856|324186171|FG000|Overall Study|Protocol Violation|4|||
94652705|NCT01649856|324186172|FG001|Overall Study|Protocol Violation|4|||
94652706|NCT01649856|324186171|FG000|Overall Study|Treatment Failure|1|||
94652707|NCT01649856|324186172|FG001|Overall Study|Treatment Failure|1|||
94652708|NCT01649856|324186171|FG000|Overall Study|Death|69|||
94652709|NCT01649856|324186172|FG001|Overall Study|Death|34|||
94652710|NCT01649856|324186171|FG000|Overall Study|Stable or Progressed Disease|5|||
94652711|NCT01649856|324186172|FG001|Overall Study|Stable or Progressed Disease|3|||
94652712|NCT01649856|324186171|FG000|Overall Study|Lost to Follow-up|20|||
94652713|NCT01649856|324186172|FG001|Overall Study|Lost to Follow-up|16|||
94652714|NCT01649856|324186171|FG000|Overall Study|Lack of Compliance|6|||
94652715|NCT01649856|324186172|FG001|Overall Study|Lack of Compliance|1|||
94652716|NCT01649856|324186171|FG000|Overall Study|Other|20|||
94652717|NCT01649856|324186172|FG001|Overall Study|Other|5|||
94652718|NCT02203591|324186173|FG000|Overall Study|Did not meet treatment day baseline|147|||
94652719|NCT02203591|324186174|FG001|Overall Study|Did not meet treatment day baseline|141|||
94652720|NCT02203591|324186175|FG002|Overall Study|Did not meet treatment day baseline|150|||
94652721|NCT02203591|324186176|FG003|Overall Study|Did not meet treatment day baseline|45|||
94652722|NCT02203591|324186177|FG004|Overall Study|Did not meet treatment day baseline|33|||
94652723|NCT02203591|324186178|FG005|Overall Study|Did not meet treatment day baseline|35|||
94652724|NCT02203591|324186179|FG006|Overall Study|Did not meet treatment day baseline|29|||
94652725|NCT02203591|324186180|FG007|Overall Study|Did not meet treatment day baseline|12|||
94652726|NCT02203591|324186173|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
94652727|NCT02203591|324186174|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
94652728|NCT02203591|324186175|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
94652729|NCT02203591|324186176|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
94652730|NCT02203591|324186177|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
94652731|NCT02203591|324186178|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
94652732|NCT02203591|324186179|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
94704410|NCT03631199|324374384|FG003|Overall Study|No treated|0|||
94704411|NCT03631199|324374385|FG004|Overall Study|No treated|1|||
94704412|NCT03631199|324374381|FG000|Overall Study|Treatment ongoing|0|||
94704413|NCT03631199|324374382|FG001|Overall Study|Treatment ongoing|1|||
94704414|NCT03631199|324374383|FG002|Overall Study|Treatment ongoing|1|||
94704415|NCT03631199|324374384|FG003|Overall Study|Treatment ongoing|76|||
94704416|NCT03631199|324374385|FG004|Overall Study|Treatment ongoing|71|||
94704417|NCT03631199|324374381|FG000|Overall Study|Guardian decision|0|||
94704418|NCT03631199|324374382|FG001|Overall Study|Guardian decision|0|||
94704419|NCT03631199|324374383|FG002|Overall Study|Guardian decision|0|||
94704420|NCT03631199|324374384|FG003|Overall Study|Guardian decision|1|||
94704421|NCT03631199|324374385|FG004|Overall Study|Guardian decision|1|||
94704422|NCT01227707|324374391|FG000|Overall Study|Adverse Event|10|||
94704423|NCT01227707|324374391|FG000|Overall Study|Progression of disease|3|||
94704424|NCT01227707|324374391|FG000|Overall Study|Withdrawal by Subject|1|||
94704425|NCT01227707|324374391|FG000|Overall Study|Patient non-compliance|3|||
94704426|NCT01227707|324374391|FG000|Overall Study|Medical decision|6|||
94704427|NCT01227707|324374391|FG000|Overall Study|Death|1|||
94704428|NCT01726023|324374392|FG000|Overall Study|Death|1|||
94704429|NCT01726023|324374393|FG001|Overall Study|Death|1|||
94704430|NCT01726023|324374392|FG000|Overall Study|Lost to Follow-up|5|||
94704431|NCT01726023|324374393|FG001|Overall Study|Lost to Follow-up|10|||
94704432|NCT01726023|324374392|FG000|Overall Study|Other Eligibility criteria|7|||
94704433|NCT01726023|324374393|FG001|Overall Study|Other Eligibility criteria|7|||
94704434|NCT01726023|324374392|FG000|Overall Study|Withdrawal by Subject|16|||
94704435|NCT01726023|324374393|FG001|Overall Study|Withdrawal by Subject|8|||
94704436|NCT03310983|324374394|FG000|Overall Study|Lost to Follow-up|15|||
94704437|NCT03310983|324374395|FG001|Overall Study|Lost to Follow-up|17|||
94704438|NCT02104765|324374400|FG000|Overall Study|Lost to Follow-up|0|||
94704439|NCT02104765|324374401|FG001|Overall Study|Lost to Follow-up|0|||
94704440|NCT02104765|324374402|FG002|Overall Study|Lost to Follow-up|1|||
94704441|NCT02104765|324374403|FG003|Overall Study|Lost to Follow-up|0|||
94704442|NCT02104765|324374404|FG004|Overall Study|Lost to Follow-up|0|||
94704443|NCT02104765|324374405|FG005|Overall Study|Lost to Follow-up|0|||
94704444|NCT02104765|324374406|FG006|Overall Study|Lost to Follow-up|0|||
94704445|NCT02104765|324374400|FG000|Overall Study|Withdrawal by Subject|0|||
94704446|NCT02104765|324374401|FG001|Overall Study|Withdrawal by Subject|0|||
94704447|NCT02104765|324374402|FG002|Overall Study|Withdrawal by Subject|0|||
94704448|NCT02104765|324374403|FG003|Overall Study|Withdrawal by Subject|1|||
94704449|NCT02104765|324374404|FG004|Overall Study|Withdrawal by Subject|1|||
94704450|NCT02104765|324374405|FG005|Overall Study|Withdrawal by Subject|0|||
94704451|NCT02104765|324374406|FG006|Overall Study|Withdrawal by Subject|1|||
94704452|NCT04771273|324374407|FG000|Dose Escalation Period|Not treated with trial medication|0|||
94704453|NCT04771273|324374408|FG001|Dose Escalation Period|Not treated with trial medication|1|||
94704454|NCT04771273|324374409|FG002|Dose Escalation Period|Not treated with trial medication|1|||
94704455|NCT04771273|324374410|FG003|Dose Escalation Period|Not treated with trial medication|0|||
94704456|NCT04771273|324374407|FG000|Dose Escalation Period|Other reasons than listed|2|||
94704457|NCT04771273|324374408|FG001|Dose Escalation Period|Other reasons than listed|0|||
94704458|NCT04771273|324374409|FG002|Dose Escalation Period|Other reasons than listed|2|||
94704459|NCT04771273|324374410|FG003|Dose Escalation Period|Other reasons than listed|1|||
94704460|NCT04771273|324374407|FG000|Dose Escalation Period|Protocol Violation|0|||
94704461|NCT04771273|324374408|FG001|Dose Escalation Period|Protocol Violation|0|||
94704462|NCT04771273|324374409|FG002|Dose Escalation Period|Protocol Violation|3|||
94704463|NCT04771273|324374410|FG003|Dose Escalation Period|Protocol Violation|1|||
94704464|NCT04771273|324374407|FG000|Dose Escalation Period|Burden of study procedures|1|||
94704465|NCT04771273|324374408|FG001|Dose Escalation Period|Burden of study procedures|0|||
94266571|NCT04313153|322771923|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
94266572|NCT04313153|322771924|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
94266573|NCT04313153|322771925|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
94704466|NCT04771273|324374409|FG002|Dose Escalation Period|Burden of study procedures|0|||
94266574|NCT04313153|322771923|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
94266575|NCT04313153|322771924|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
94704467|NCT04771273|324374410|FG003|Dose Escalation Period|Burden of study procedures|0|||
94704468|NCT04771273|324374407|FG000|Dose Escalation Period|Change of residence|0|||
94704469|NCT04771273|324374408|FG001|Dose Escalation Period|Change of residence|0|||
94704470|NCT04771273|324374409|FG002|Dose Escalation Period|Change of residence|0|||
94704471|NCT04771273|324374410|FG003|Dose Escalation Period|Change of residence|1|||
94704472|NCT04771273|324374407|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
94704473|NCT04771273|324374408|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
94704474|NCT04771273|324374409|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
94704475|NCT04771273|324374410|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
94704476|NCT04771273|324374407|FG000|Dose Escalation Period|Adverse Event|8|||
94704477|NCT04771273|324374408|FG001|Dose Escalation Period|Adverse Event|9|||
94704478|NCT04771273|324374409|FG002|Dose Escalation Period|Adverse Event|12|||
94704479|NCT04771273|324374410|FG003|Dose Escalation Period|Adverse Event|2|||
94704480|NCT04771273|324374407|FG000|Maintenance Period|Other than listed|4|||
94704481|NCT04771273|324374408|FG001|Maintenance Period|Other than listed|2|||
94704482|NCT04771273|324374409|FG002|Maintenance Period|Other than listed|0|||
94704483|NCT04771273|324374410|FG003|Maintenance Period|Other than listed|3|||
94704484|NCT04771273|324374407|FG000|Maintenance Period|Burden of study procedures|1|||
94704485|NCT04771273|324374408|FG001|Maintenance Period|Burden of study procedures|0|||
94704486|NCT04771273|324374409|FG002|Maintenance Period|Burden of study procedures|0|||
94704487|NCT04771273|324374410|FG003|Maintenance Period|Burden of study procedures|0|||
94704488|NCT04771273|324374407|FG000|Maintenance Period|Change of residence|0|||
94704489|NCT04771273|324374408|FG001|Maintenance Period|Change of residence|1|||
94704490|NCT04771273|324374409|FG002|Maintenance Period|Change of residence|3|||
94704491|NCT04771273|324374410|FG003|Maintenance Period|Change of residence|0|||
94704492|NCT04771273|324374407|FG000|Maintenance Period|Perceived lack of efficacy|0|||
94704493|NCT04771273|324374408|FG001|Maintenance Period|Perceived lack of efficacy|0|||
94704494|NCT04771273|324374409|FG002|Maintenance Period|Perceived lack of efficacy|0|||
94704495|NCT04771273|324374410|FG003|Maintenance Period|Perceived lack of efficacy|1|||
94704496|NCT04771273|324374407|FG000|Maintenance Period|Adverse Event|4|||
94704497|NCT04771273|324374408|FG001|Maintenance Period|Adverse Event|5|||
94704498|NCT04771273|324374409|FG002|Maintenance Period|Adverse Event|5|||
94704499|NCT04771273|324374410|FG003|Maintenance Period|Adverse Event|0|||
94704500|NCT00995709|324374414|FG000|Overall Study|Adverse Event|4|||
94704501|NCT00995709|324374415|FG001|Overall Study|Adverse Event|2|||
94704502|NCT00995709|324374416|FG002|Overall Study|Adverse Event|0|||
94704503|NCT00995709|324374414|FG000|Overall Study|Lack of Efficacy|0|||
94704504|NCT00995709|324374415|FG001|Overall Study|Lack of Efficacy|1|||
94704505|NCT00995709|324374416|FG002|Overall Study|Lack of Efficacy|4|||
94704506|NCT00995709|324374414|FG000|Overall Study|Withdrawal by Subject|0|||
94704507|NCT00995709|324374415|FG001|Overall Study|Withdrawal by Subject|4|||
94704508|NCT00995709|324374416|FG002|Overall Study|Withdrawal by Subject|1|||
94704509|NCT00995709|324374414|FG000|Overall Study|Lost to Follow-up|1|||
94704510|NCT00995709|324374415|FG001|Overall Study|Lost to Follow-up|0|||
94704511|NCT00995709|324374416|FG002|Overall Study|Lost to Follow-up|0|||
94704512|NCT00995709|324374414|FG000|Overall Study|Death|0|||
94704513|NCT00995709|324374415|FG001|Overall Study|Death|1|||
94704514|NCT00995709|324374416|FG002|Overall Study|Death|0|||
94704515|NCT00995709|324374414|FG000|Overall Study|Protocol Violation|2|||
94704516|NCT00995709|324374415|FG001|Overall Study|Protocol Violation|1|||
94704517|NCT00995709|324374416|FG002|Overall Study|Protocol Violation|0|||
94704518|NCT02770248|324374423|FG000|Overall Study|Adverse Event|0|||
94704519|NCT02770248|324374424|FG001|Overall Study|Adverse Event|1|||
94704520|NCT02770248|324374423|FG000|Overall Study|Randomized in error, prior to treatment|0|||
94704521|NCT02770248|324374424|FG001|Overall Study|Randomized in error, prior to treatment|1|||
94704522|NCT02698241|324374425|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
94704523|NCT02698241|324374425|FG000|Overall Study|Screening not met|7|||
94704524|NCT02698241|324374425|FG000|Overall Study|Withdrawal by Subject|7|||
94704525|NCT02698241|324374425|FG000|Overall Study|Physician Decision|2|||
94704526|NCT02698241|324374425|FG000|Overall Study|Subject underwent system modification|2|||
94704527|NCT02698241|324374425|FG000|Overall Study|Lost to Follow-up|3|||
94704528|NCT02698241|324374425|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
94704529|NCT02698241|324374425|FG000|Overall Study|geographic and licensing issue|1|||
94704530|NCT02698241|324374425|FG000|Overall Study|Death|2|||
94704531|NCT01837641|324374426|FG000|Overall Study|Sponsor decision|1|||
94704532|NCT01837641|324374427|FG001|Overall Study|Sponsor decision|0|||
94704533|NCT01837641|324374428|FG002|Overall Study|Sponsor decision|0|||
94704534|NCT01837641|324374429|FG003|Overall Study|Sponsor decision|0|||
94704535|NCT01837641|324374430|FG004|Overall Study|Sponsor decision|0|||
94704536|NCT01837641|324374431|FG005|Overall Study|Sponsor decision|1|||
94704537|NCT01837641|324374432|FG006|Overall Study|Sponsor decision|0|||
94266576|NCT04313153|322771925|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
94266577|NCT04313153|322771923|FG000|Overall Study|Change in Dialysis Modality|0|||
94704538|NCT01837641|324374433|FG007|Overall Study|Sponsor decision|0|||
94704539|NCT01837641|324374426|FG000|Overall Study|Adverse Event|0|||
94704540|NCT01837641|324374427|FG001|Overall Study|Adverse Event|0|||
94704541|NCT01837641|324374428|FG002|Overall Study|Adverse Event|0|||
94704542|NCT01837641|324374429|FG003|Overall Study|Adverse Event|0|||
94704543|NCT01837641|324374430|FG004|Overall Study|Adverse Event|0|||
94704544|NCT01837641|324374431|FG005|Overall Study|Adverse Event|1|||
94704545|NCT01837641|324374432|FG006|Overall Study|Adverse Event|0|||
94704546|NCT01837641|324374433|FG007|Overall Study|Adverse Event|0|||
94704547|NCT01837641|324374426|FG000|Overall Study|Withdrawal by Subject|0|||
94704548|NCT01837641|324374427|FG001|Overall Study|Withdrawal by Subject|0|||
94704549|NCT01837641|324374428|FG002|Overall Study|Withdrawal by Subject|0|||
94704550|NCT01837641|324374429|FG003|Overall Study|Withdrawal by Subject|0|||
94704551|NCT01837641|324374430|FG004|Overall Study|Withdrawal by Subject|1|||
94704552|NCT01837641|324374431|FG005|Overall Study|Withdrawal by Subject|0|||
94704553|NCT01837641|324374432|FG006|Overall Study|Withdrawal by Subject|1|||
94704554|NCT01837641|324374433|FG007|Overall Study|Withdrawal by Subject|0|||
94704555|NCT00906282|324374436|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
94704556|NCT00906282|324374436|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
94704557|NCT00906282|324374436|FG000|Preoperative Chemotherapy|Progressive disease|6|||
94704558|NCT00906282|324374436|FG000|Preoperative Chemotherapy|Toxicity|1|||
94704559|NCT01264718|324374439|FG000|Overall Study|Lost to Follow-up|3|||
94704560|NCT01264718|324374440|FG001|Overall Study|Lost to Follow-up|2|||
94704561|NCT01264718|324374439|FG000|Overall Study|Withdrawal by Subject|9|||
94704562|NCT01264718|324374440|FG001|Overall Study|Withdrawal by Subject|15|||
94704563|NCT01264718|324374439|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
94704564|NCT01264718|324374440|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
94704565|NCT03386929|324374443|FG000|Overall Study|Death|0|||
94704566|NCT03386929|324374444|FG001|Overall Study|Death|0|||
94704567|NCT03386929|324374445|FG002|Overall Study|Death|1|||
94704568|NCT03386929|324374443|FG000|Overall Study|Withdrawal by Subject|0|||
94704569|NCT03386929|324374444|FG001|Overall Study|Withdrawal by Subject|1|||
94704570|NCT03386929|324374445|FG002|Overall Study|Withdrawal by Subject|0|||
94704571|NCT03386929|324374443|FG000|Overall Study|Physician Decision|0|||
94704572|NCT03386929|324374444|FG001|Overall Study|Physician Decision|0|||
94704573|NCT03386929|324374445|FG002|Overall Study|Physician Decision|1|||
94704574|NCT03386929|324374443|FG000|Overall Study|Progression|4|||
94704575|NCT03386929|324374444|FG001|Overall Study|Progression|4|||
94704576|NCT03386929|324374445|FG002|Overall Study|Progression|0|||
94704577|NCT03386929|324374443|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
94704578|NCT03386929|324374444|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
94704579|NCT03386929|324374445|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
94704580|NCT03386929|324374443|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
94704581|NCT03386929|324374444|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
94704582|NCT03386929|324374445|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
94704583|NCT01144182|324374449|FG000|Overall Study|Death|5|||
94704584|NCT01144182|324374450|FG001|Overall Study|Death|6|||
94704585|NCT01144182|324374449|FG000|Overall Study|Withdrawal by Subject|3|||
94704586|NCT01144182|324374450|FG001|Overall Study|Withdrawal by Subject|6|||
94704587|NCT01144182|324374449|FG000|Overall Study|Lost to Follow-up|9|||
94704588|NCT01144182|324374450|FG001|Overall Study|Lost to Follow-up|9|||
94704589|NCT03264456|324374451|FG000|Overall Study|Withdrawal by Subject|3|||
94704590|NCT03264456|324374451|FG000|Overall Study|Lost to Follow-up|1|||
94704591|NCT03121950|324374464|FG000|Overall Study|Withdrawal by Subject|11|||
94704592|NCT03121950|324374465|FG001|Overall Study|Withdrawal by Subject|2|||
94704593|NCT05025449|324375921|FG000|Overall Study|Withdrawal by Subject|1|||
94704594|NCT05025449|324375921|FG000|Overall Study|Patient emergently taken to operating room|1|||
94704595|NCT00569946|324375922|FG000|Overall Study|Adverse Event|16|||
94704596|NCT00569946|324375922|FG000|Overall Study|Objective Progression or Relapse|42|||
94704597|NCT00569946|324375922|FG000|Overall Study|Global Deterioration of Health Status|1|||
94704598|NCT00762463|324375923|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
94704599|NCT00762463|324375924|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
94704600|NCT00762463|324375925|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
94704601|NCT00762463|324375926|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
94704602|NCT00762463|324375923|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
94704603|NCT00762463|324375924|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
94704604|NCT00762463|324375925|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
94704605|NCT00762463|324375926|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
94704606|NCT00762463|324375923|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
94704607|NCT00762463|324375924|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
94704608|NCT00762463|324375925|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
94704609|NCT00762463|324375926|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
94704610|NCT00762463|324375923|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
94704611|NCT00762463|324375924|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
94704612|NCT00762463|324375925|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
94704613|NCT00762463|324375926|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
94704614|NCT00762463|324375923|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
94704615|NCT00762463|324375924|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
94704616|NCT00762463|324375925|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
94704617|NCT00762463|324375926|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
94704618|NCT00762463|324375923|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
94704619|NCT00762463|324375924|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
94704620|NCT00762463|324375925|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
94704621|NCT00762463|324375926|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
94704622|NCT00762463|324375923|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
94704623|NCT00762463|324375924|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
94704624|NCT00762463|324375925|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
94704625|NCT00762463|324375926|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
94704626|NCT00762463|324375923|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
94704627|NCT00762463|324375924|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
94704628|NCT00762463|324375925|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
94704629|NCT00762463|324375926|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
94704630|NCT03895034|324375927|FG000|Overall Study|Lost to Follow-up|2|||
94704631|NCT03140176|324375935|FG000|Overall Study|Reason missing|23|||
94704632|NCT03140176|324375935|FG000|Overall Study|Death|33|||
94704633|NCT03140176|324375935|FG000|Overall Study|Disease progression|1|||
94704634|NCT03140176|324375935|FG000|Overall Study|Physician Decision|1|||
94704635|NCT03140176|324375935|FG000|Overall Study|Withdrawal by Subject|1|||
94704636|NCT03140176|324375935|FG000|Overall Study|Lost to Follow-up|15|||
94704637|NCT00739102|324375936|FG000|Overall Study|Death|5|||
94704638|NCT00739102|324375936|FG000|Overall Study|Withdrawal by Subject|10|||
94704639|NCT01331824|324375938|FG000|Overall Study|Adverse Event|2|||
94704640|NCT01331824|324375938|FG000|Overall Study|Death|1|||
94704641|NCT01331824|324375938|FG000|Overall Study|Disease Progression|9|||
94704642|NCT01331824|324375938|FG000|Overall Study|Withdrawal by Subject|1|||
94704643|NCT00646451|324375939|FG000|Overall Study|Adverse Event|3|||
94704644|NCT00646451|324375940|FG001|Overall Study|Adverse Event|0|||
94704645|NCT00646451|324375939|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
94704646|NCT00646451|324375940|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
94704647|NCT03784963|324375941|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
94704648|NCT03784963|324375942|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
94704649|NCT03784963|324375943|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
94704650|NCT03784963|324375944|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
94704651|NCT03179787|324375945|FG000|Overall Study|Lost to Follow-up|15|||
94704652|NCT03179787|324375945|FG000|Overall Study|Case report failures|2|||
94704653|NCT03179787|324375945|FG000|Overall Study|Treatment not administered|1|||
94704654|NCT01362491|324375946|FG000|Overall Study|Ineligible|1|||
94704655|NCT01362491|324375947|FG001|Overall Study|Ineligible|0|||
94704656|NCT01362491|324375948|FG002|Overall Study|Ineligible|0|||
94704657|NCT02030028|324375949|FG000|Overall Study|Withdrawal by Subject|4|||
94704658|NCT02030028|324375949|FG000|Overall Study|lack of transportation|1|||
94704659|NCT01090024|324375950|FG000|Period 1|Met exclusion criteria|0|||
94704660|NCT01090024|324375951|FG001|Period 1|Met exclusion criteria|0|||
94704661|NCT01090024|324375952|FG002|Period 1|Met exclusion criteria|0|||
94704662|NCT01090024|324375953|FG003|Period 1|Met exclusion criteria|0|||
94704663|NCT01090024|324375954|FG004|Period 1|Met exclusion criteria|0|||
94704664|NCT01090024|324375955|FG005|Period 1|Met exclusion criteria|0|||
94704665|NCT01090024|324375956|FG006|Period 1|Met exclusion criteria|0|||
94704666|NCT01090024|324375957|FG007|Period 1|Met exclusion criteria|0|||
94704667|NCT01090024|324375958|FG008|Period 1|Met exclusion criteria|0|||
94704668|NCT01090024|324375959|FG009|Period 1|Met exclusion criteria|0|||
94704669|NCT01090024|324375960|FG010|Period 1|Met exclusion criteria|0|||
94704670|NCT01090024|324375961|FG011|Period 1|Met exclusion criteria|0|||
94704671|NCT01090024|324375962|FG012|Period 1|Met exclusion criteria|0|||
94704672|NCT01090024|324375963|FG013|Period 1|Met exclusion criteria|0|||
94704673|NCT01090024|324375964|FG014|Period 1|Met exclusion criteria|1|||
94266578|NCT04313153|322771924|FG001|Overall Study|Change in Dialysis Modality|1|||
94266579|NCT04313153|322771925|FG002|Overall Study|Change in Dialysis Modality|2|||
94266580|NCT04313153|322771923|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
94266581|NCT04313153|322771924|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
94704674|NCT01090024|324375965|FG015|Period 1|Met exclusion criteria|0|||
94704675|NCT01090024|324375966|FG016|Period 1|Met exclusion criteria|0|||
94704676|NCT01090024|324375967|FG017|Period 1|Met exclusion criteria|0|||
94704677|NCT01090024|324375950|FG000|Period 1|Adverse Event|0|||
94704678|NCT01090024|324375951|FG001|Period 1|Adverse Event|0|||
94704679|NCT01090024|324375952|FG002|Period 1|Adverse Event|0|||
94704680|NCT01090024|324375953|FG003|Period 1|Adverse Event|0|||
94704681|NCT01090024|324375954|FG004|Period 1|Adverse Event|0|||
94704682|NCT01090024|324375955|FG005|Period 1|Adverse Event|0|||
94704683|NCT01090024|324375956|FG006|Period 1|Adverse Event|0|||
94704684|NCT01090024|324375957|FG007|Period 1|Adverse Event|0|||
94704685|NCT01090024|324375958|FG008|Period 1|Adverse Event|0|||
94704686|NCT01090024|324375959|FG009|Period 1|Adverse Event|1|||
94704687|NCT01090024|324375960|FG010|Period 1|Adverse Event|0|||
94704688|NCT01090024|324375961|FG011|Period 1|Adverse Event|1|||
94704689|NCT01090024|324375962|FG012|Period 1|Adverse Event|0|||
94704690|NCT01090024|324375963|FG013|Period 1|Adverse Event|0|||
94704691|NCT01090024|324375964|FG014|Period 1|Adverse Event|0|||
94704692|NCT01090024|324375965|FG015|Period 1|Adverse Event|0|||
94704693|NCT01090024|324375966|FG016|Period 1|Adverse Event|0|||
94704694|NCT01090024|324375967|FG017|Period 1|Adverse Event|1|||
94704695|NCT01090024|324375950|FG000|Period 1|Withdrawal by Subject|0|||
94704696|NCT01090024|324375951|FG001|Period 1|Withdrawal by Subject|0|||
94704697|NCT01090024|324375952|FG002|Period 1|Withdrawal by Subject|0|||
94704698|NCT01090024|324375953|FG003|Period 1|Withdrawal by Subject|1|||
94704699|NCT01090024|324375954|FG004|Period 1|Withdrawal by Subject|0|||
94704700|NCT01090024|324375955|FG005|Period 1|Withdrawal by Subject|0|||
94704701|NCT01090024|324375956|FG006|Period 1|Withdrawal by Subject|0|||
94704702|NCT01090024|324375957|FG007|Period 1|Withdrawal by Subject|0|||
94704703|NCT01090024|324375958|FG008|Period 1|Withdrawal by Subject|0|||
94366623|NCT01396161|323128094|FG004|Overall Study|Withdrawal by Subject|1|||
94366624|NCT01396161|323128095|FG005|Overall Study|Withdrawal by Subject|0|||
94366625|NCT01396161|323128096|FG006|Overall Study|Withdrawal by Subject|0|||
94366626|NCT01396161|323128090|FG000|Overall Study|Other|0|||
94704704|NCT01090024|324375959|FG009|Period 1|Withdrawal by Subject|0|||
94704705|NCT01090024|324375960|FG010|Period 1|Withdrawal by Subject|0|||
94704706|NCT01090024|324375961|FG011|Period 1|Withdrawal by Subject|0|||
94704707|NCT01090024|324375962|FG012|Period 1|Withdrawal by Subject|0|||
94704708|NCT01090024|324375963|FG013|Period 1|Withdrawal by Subject|0|||
94704709|NCT01090024|324375964|FG014|Period 1|Withdrawal by Subject|0|||
94704710|NCT01090024|324375965|FG015|Period 1|Withdrawal by Subject|0|||
94704711|NCT01090024|324375966|FG016|Period 1|Withdrawal by Subject|0|||
94704712|NCT01090024|324375967|FG017|Period 1|Withdrawal by Subject|0|||
94704713|NCT01090024|324375950|FG000|Period 1|Lost to Follow-up|0|||
94704714|NCT01090024|324375951|FG001|Period 1|Lost to Follow-up|1|||
94704715|NCT01090024|324375952|FG002|Period 1|Lost to Follow-up|0|||
94704716|NCT01090024|324375953|FG003|Period 1|Lost to Follow-up|0|||
94704717|NCT01090024|324375954|FG004|Period 1|Lost to Follow-up|0|||
94704718|NCT01090024|324375955|FG005|Period 1|Lost to Follow-up|0|||
94704719|NCT01090024|324375956|FG006|Period 1|Lost to Follow-up|0|||
94704720|NCT01090024|324375957|FG007|Period 1|Lost to Follow-up|0|||
94704721|NCT01090024|324375958|FG008|Period 1|Lost to Follow-up|0|||
94704722|NCT01090024|324375959|FG009|Period 1|Lost to Follow-up|0|||
94704723|NCT01090024|324375960|FG010|Period 1|Lost to Follow-up|0|||
94704724|NCT01090024|324375961|FG011|Period 1|Lost to Follow-up|0|||
94704725|NCT01090024|324375962|FG012|Period 1|Lost to Follow-up|0|||
94704726|NCT01090024|324375963|FG013|Period 1|Lost to Follow-up|0|||
94704727|NCT01090024|324375964|FG014|Period 1|Lost to Follow-up|0|||
94366627|NCT01396161|323128091|FG001|Overall Study|Other|0|||
94366628|NCT01396161|323128092|FG002|Overall Study|Other|0|||
94704728|NCT01090024|324375965|FG015|Period 1|Lost to Follow-up|0|||
94704729|NCT01090024|324375966|FG016|Period 1|Lost to Follow-up|0|||
94704730|NCT01090024|324375967|FG017|Period 1|Lost to Follow-up|0|||
94704731|NCT01090024|324375950|FG000|Period 2|Lost to Follow-up|0|||
94704732|NCT01090024|324375951|FG001|Period 2|Lost to Follow-up|0|||
94704733|NCT01090024|324375952|FG002|Period 2|Lost to Follow-up|0|||
94704734|NCT01090024|324375953|FG003|Period 2|Lost to Follow-up|1|||
94704735|NCT01090024|324375954|FG004|Period 2|Lost to Follow-up|0|||
94704736|NCT01090024|324375955|FG005|Period 2|Lost to Follow-up|0|||
94704737|NCT01090024|324375956|FG006|Period 2|Lost to Follow-up|0|||
94704738|NCT01090024|324375957|FG007|Period 2|Lost to Follow-up|0|||
94704739|NCT01090024|324375958|FG008|Period 2|Lost to Follow-up|0|||
94704740|NCT01090024|324375959|FG009|Period 2|Lost to Follow-up|0|||
94704741|NCT01090024|324375960|FG010|Period 2|Lost to Follow-up|0|||
94704742|NCT01090024|324375961|FG011|Period 2|Lost to Follow-up|0|||
94704743|NCT01090024|324375962|FG012|Period 2|Lost to Follow-up|0|||
94704744|NCT01090024|324375963|FG013|Period 2|Lost to Follow-up|0|||
94704745|NCT01090024|324375964|FG014|Period 2|Lost to Follow-up|0|||
94704746|NCT01090024|324375965|FG015|Period 2|Lost to Follow-up|0|||
94704747|NCT01090024|324375966|FG016|Period 2|Lost to Follow-up|0|||
94704748|NCT01090024|324375967|FG017|Period 2|Lost to Follow-up|0|||
94704749|NCT01090024|324375950|FG000|Period 2|Adverse Event|1|||
94704750|NCT01090024|324375951|FG001|Period 2|Adverse Event|0|||
94704751|NCT01090024|324375952|FG002|Period 2|Adverse Event|0|||
94704752|NCT01090024|324375953|FG003|Period 2|Adverse Event|0|||
94704753|NCT01090024|324375954|FG004|Period 2|Adverse Event|0|||
94704754|NCT01090024|324375955|FG005|Period 2|Adverse Event|0|||
94704755|NCT01090024|324375956|FG006|Period 2|Adverse Event|0|||
94704756|NCT01090024|324375957|FG007|Period 2|Adverse Event|0|||
94704757|NCT01090024|324375958|FG008|Period 2|Adverse Event|0|||
94704758|NCT01090024|324375959|FG009|Period 2|Adverse Event|0|||
94704759|NCT01090024|324375960|FG010|Period 2|Adverse Event|0|||
94704760|NCT01090024|324375961|FG011|Period 2|Adverse Event|0|||
94704761|NCT01090024|324375962|FG012|Period 2|Adverse Event|0|||
94704762|NCT01090024|324375963|FG013|Period 2|Adverse Event|0|||
94704763|NCT01090024|324375964|FG014|Period 2|Adverse Event|0|||
94704764|NCT01090024|324375965|FG015|Period 2|Adverse Event|0|||
94704765|NCT01090024|324375966|FG016|Period 2|Adverse Event|0|||
94704766|NCT01090024|324375967|FG017|Period 2|Adverse Event|0|||
94704767|NCT01090024|324375950|FG000|Period 3|Withdrawal by Subject|0|||
94704768|NCT01090024|324375951|FG001|Period 3|Withdrawal by Subject|0|||
94704769|NCT01090024|324375952|FG002|Period 3|Withdrawal by Subject|0|||
94704770|NCT01090024|324375953|FG003|Period 3|Withdrawal by Subject|0|||
94704771|NCT01090024|324375954|FG004|Period 3|Withdrawal by Subject|0|||
94704772|NCT01090024|324375955|FG005|Period 3|Withdrawal by Subject|0|||
94704773|NCT01090024|324375956|FG006|Period 3|Withdrawal by Subject|0|||
94704774|NCT01090024|324375957|FG007|Period 3|Withdrawal by Subject|0|||
94704775|NCT01090024|324375958|FG008|Period 3|Withdrawal by Subject|0|||
94704776|NCT01090024|324375959|FG009|Period 3|Withdrawal by Subject|0|||
94704777|NCT01090024|324375960|FG010|Period 3|Withdrawal by Subject|0|||
94704778|NCT01090024|324375961|FG011|Period 3|Withdrawal by Subject|0|||
94704779|NCT01090024|324375962|FG012|Period 3|Withdrawal by Subject|0|||
94704780|NCT01090024|324375963|FG013|Period 3|Withdrawal by Subject|0|||
94704781|NCT01090024|324375964|FG014|Period 3|Withdrawal by Subject|0|||
94704782|NCT01090024|324375965|FG015|Period 3|Withdrawal by Subject|1|||
94704783|NCT01090024|324375966|FG016|Period 3|Withdrawal by Subject|0|||
94704784|NCT01090024|324375967|FG017|Period 3|Withdrawal by Subject|0|||
94704785|NCT01090024|324375950|FG000|Period 3|Protocol Violation|0|||
94704786|NCT01090024|324375951|FG001|Period 3|Protocol Violation|0|||
94704787|NCT01090024|324375952|FG002|Period 3|Protocol Violation|0|||
94704788|NCT01090024|324375953|FG003|Period 3|Protocol Violation|0|||
94704789|NCT01090024|324375954|FG004|Period 3|Protocol Violation|0|||
94704790|NCT01090024|324375955|FG005|Period 3|Protocol Violation|0|||
94704791|NCT01090024|324375956|FG006|Period 3|Protocol Violation|0|||
94704792|NCT01090024|324375957|FG007|Period 3|Protocol Violation|0|||
94704793|NCT01090024|324375958|FG008|Period 3|Protocol Violation|1|||
94704794|NCT01090024|324375959|FG009|Period 3|Protocol Violation|0|||
94704795|NCT01090024|324375960|FG010|Period 3|Protocol Violation|0|||
94704796|NCT01090024|324375961|FG011|Period 3|Protocol Violation|0|||
94704797|NCT01090024|324375962|FG012|Period 3|Protocol Violation|0|||
94704798|NCT01090024|324375963|FG013|Period 3|Protocol Violation|0|||
94704799|NCT01090024|324375964|FG014|Period 3|Protocol Violation|0|||
94704800|NCT01090024|324375965|FG015|Period 3|Protocol Violation|0|||
94466237|NCT01358578|323496954|FG003|Induction Period|Withdrawal by Subject|6|||
94704801|NCT01090024|324375966|FG016|Period 3|Protocol Violation|0|||
94704802|NCT01090024|324375967|FG017|Period 3|Protocol Violation|0|||
94704803|NCT01090024|324375950|FG000|Period 3|Adverse Event|0|||
94704804|NCT01090024|324375951|FG001|Period 3|Adverse Event|0|||
94704805|NCT01090024|324375952|FG002|Period 3|Adverse Event|0|||
94704806|NCT01090024|324375953|FG003|Period 3|Adverse Event|0|||
94704807|NCT01090024|324375954|FG004|Period 3|Adverse Event|0|||
94704808|NCT01090024|324375955|FG005|Period 3|Adverse Event|1|||
94704809|NCT01090024|324375956|FG006|Period 3|Adverse Event|0|||
94704810|NCT01090024|324375957|FG007|Period 3|Adverse Event|0|||
94704811|NCT01090024|324375958|FG008|Period 3|Adverse Event|0|||
94704812|NCT01090024|324375959|FG009|Period 3|Adverse Event|0|||
94704813|NCT01090024|324375960|FG010|Period 3|Adverse Event|0|||
94704814|NCT01090024|324375961|FG011|Period 3|Adverse Event|0|||
94704815|NCT01090024|324375962|FG012|Period 3|Adverse Event|0|||
94704816|NCT01090024|324375963|FG013|Period 3|Adverse Event|0|||
94704817|NCT01090024|324375964|FG014|Period 3|Adverse Event|0|||
94704818|NCT01090024|324375965|FG015|Period 3|Adverse Event|0|||
94704819|NCT01090024|324375966|FG016|Period 3|Adverse Event|0|||
94704820|NCT01090024|324375967|FG017|Period 3|Adverse Event|0|||
94704821|NCT05298111|324375971|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
94704822|NCT05298111|324375972|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
94704823|NCT01249092|324375975|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
94704824|NCT01249092|324375975|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
94704825|NCT02380742|324375976|FG000|Overall Study|Withdrawal by Subject|1|||
94704826|NCT02380742|324375977|FG001|Overall Study|Withdrawal by Subject|0|||
94704827|NCT02689349|324375980|FG000|Overall Study|Not implanted|4|||
94704828|NCT02689349|324375981|FG001|Overall Study|Not implanted|0|||
94704829|NCT02689349|324375980|FG000|Overall Study|Withdrawal by Subject|9|||
94704830|NCT02689349|324375981|FG001|Overall Study|Withdrawal by Subject|0|||
94704831|NCT01546155|324375983|FG000|Overall Study|could not tolerate long scan duration|3|||
94704832|NCT02930343|324375984|FG000|Overall Study|Lost to Follow-up|9|||
94704833|NCT02930343|324375985|FG001|Overall Study|Lost to Follow-up|7|||
94704834|NCT02236559|324375986|FG000|Overall Study|Met Exclusion|3|||
94704835|NCT02236559|324375987|FG001|Overall Study|Met Exclusion|6|||
94704836|NCT02236559|324375986|FG000|Overall Study|Did not Meet Inclusion|3|||
94704837|NCT02236559|324375987|FG001|Overall Study|Did not Meet Inclusion|3|||
94704838|NCT02236559|324375986|FG000|Overall Study|Subject Did Not Consent|4|||
94704839|NCT02236559|324375987|FG001|Overall Study|Subject Did Not Consent|2|||
94704840|NCT02236559|324375986|FG000|Overall Study|Physician Decision|1|||
94704841|NCT02236559|324375987|FG001|Overall Study|Physician Decision|1|||
94704842|NCT02236559|324375986|FG000|Overall Study|Withdrawal by Subject|1|||
94366629|NCT01396161|323128093|FG003|Overall Study|Other|0|||
94366630|NCT01396161|323128094|FG004|Overall Study|Other|0|||
94366631|NCT01396161|323128095|FG005|Overall Study|Other|0|||
94366632|NCT01396161|323128096|FG006|Overall Study|Other|1|||
94704843|NCT02236559|324375987|FG001|Overall Study|Withdrawal by Subject|0|||
94704844|NCT01570751|324375988|FG000|Period A (16 Weeks)|Protocol Violation|1|||
94704845|NCT01570751|324375989|FG001|Period A (16 Weeks)|Protocol Violation|1|||
94704846|NCT01570751|324375988|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
94704847|NCT01570751|324375989|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
94366633|NCT00450177|323128099|FG000|Overall Study|Adverse Event|7|||
94366634|NCT00450177|323128100|FG001|Overall Study|Adverse Event|4|||
94704848|NCT01570751|324375988|FG000|Period A (16 Weeks)|Unclassified|2|||
94704849|NCT01570751|324375989|FG001|Period A (16 Weeks)|Unclassified|3|||
94704850|NCT01570751|324375988|FG000|Period B (16 Weeks)|Adverse Event|1|||
94704851|NCT01570751|324375989|FG001|Period B (16 Weeks)|Adverse Event|0|||
94704852|NCT01570751|324375988|FG000|Period B (16 Weeks)|Protocol Violation|0|||
94704853|NCT01570751|324375989|FG001|Period B (16 Weeks)|Protocol Violation|1|||
94704854|NCT02614560|324375990|FG000|Overall Study|Death|6|||
94704855|NCT02614560|324375991|FG001|Overall Study|Death|2|||
94704856|NCT00464672|324375992|FG000|Overall Study|withdrawal of consent|0|||
94704857|NCT00464672|324375993|FG001|Overall Study|withdrawal of consent|0|||
94704858|NCT00464672|324375994|FG002|Overall Study|withdrawal of consent|0|||
94704859|NCT00464672|324375995|FG003|Overall Study|withdrawal of consent|1|||
94704860|NCT00464672|324375996|FG004|Overall Study|withdrawal of consent|9|||
94704861|NCT00464672|324375997|FG005|Overall Study|withdrawal of consent|4|||
94704862|NCT00464672|324375992|FG000|Overall Study|Lost to Follow-up|25|||
94704863|NCT00464672|324375993|FG001|Overall Study|Lost to Follow-up|10|||
94704864|NCT00464672|324375994|FG002|Overall Study|Lost to Follow-up|0|||
94704865|NCT00464672|324375995|FG003|Overall Study|Lost to Follow-up|0|||
94704866|NCT00464672|324375996|FG004|Overall Study|Lost to Follow-up|1|||
94704867|NCT00464672|324375997|FG005|Overall Study|Lost to Follow-up|0|||
94704868|NCT04889664|324375998|FG000|Screen|Lost to Follow-up|1|||
94704869|NCT04889664|324375998|FG000|Screen|Failed to meet screening criteria|1|||
94704870|NCT04889664|324375998|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
94704871|NCT02155829|324376000|FG000|Overall Study|Adverse Event|1|||
94704872|NCT02155829|324376001|FG001|Overall Study|Adverse Event|0|||
94704873|NCT02155829|324376000|FG000|Overall Study|Withdrawal by Subject|3|||
94704874|NCT02155829|324376001|FG001|Overall Study|Withdrawal by Subject|3|||
94704875|NCT02155829|324376000|FG000|Overall Study|Protocol Violation|2|||
94704876|NCT02155829|324376001|FG001|Overall Study|Protocol Violation|0|||
94704877|NCT02057718|324376009|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
94704878|NCT02057718|324376010|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
94704879|NCT02057718|324376009|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
94704880|NCT02057718|324376010|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
94704881|NCT02057718|324376009|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
94704882|NCT02057718|324376010|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
94704883|NCT02057718|324376009|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
94704884|NCT02057718|324376010|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
94704885|NCT02057718|324376009|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
94704886|NCT02057718|324376010|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
94704887|NCT02057718|324376009|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
94704888|NCT02057718|324376010|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
94704889|NCT02057718|324376009|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
94704890|NCT02057718|324376010|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
94704891|NCT02057718|324376009|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
94704892|NCT02057718|324376010|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
94704893|NCT02057718|324376009|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
94704894|NCT02057718|324376010|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
94704895|NCT02057718|324376009|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
94704896|NCT02057718|324376010|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
94704897|NCT02057718|324376009|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
94704898|NCT02057718|324376010|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
94704899|NCT00197015|324376011|FG000|Overall Study|Adverse Event|3|||
94704900|NCT00197015|324376012|FG001|Overall Study|Adverse Event|0|||
94704901|NCT00197015|324376013|FG002|Overall Study|Adverse Event|1|||
94704902|NCT00197015|324376011|FG000|Overall Study|Protocol Violation|0|||
94704903|NCT00197015|324376012|FG001|Overall Study|Protocol Violation|3|||
94704904|NCT00197015|324376013|FG002|Overall Study|Protocol Violation|3|||
94704905|NCT00197015|324376011|FG000|Overall Study|Withdrawal by Subject|17|||
94704906|NCT00197015|324376012|FG001|Overall Study|Withdrawal by Subject|37|||
94704907|NCT00197015|324376013|FG002|Overall Study|Withdrawal by Subject|34|||
94704908|NCT00197015|324376011|FG000|Overall Study|Lost to Follow-up|28|||
94704909|NCT00197015|324376012|FG001|Overall Study|Lost to Follow-up|46|||
94704910|NCT00197015|324376013|FG002|Overall Study|Lost to Follow-up|37|||
94266582|NCT04313153|322771925|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
94266583|NCT04313153|322771923|FG000|Overall Study|Other|5|||
94266584|NCT04313153|322771924|FG001|Overall Study|Other|3|||
94704911|NCT00197015|324376011|FG000|Overall Study|Other|2|||
94266585|NCT04313153|322771925|FG002|Overall Study|Other|2|||
94704912|NCT00197015|324376012|FG001|Overall Study|Other|3|||
94266586|NCT02060383|322771931|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
94704913|NCT00197015|324376013|FG002|Overall Study|Other|2|||
94704914|NCT00823979|324376019|FG000|Overall Study|Lack of Efficacy|13|||
94704915|NCT00823979|324376020|FG001|Overall Study|Lack of Efficacy|16|||
94704916|NCT00823979|324376021|FG002|Overall Study|Lack of Efficacy|9|||
94704917|NCT00823979|324376019|FG000|Overall Study|Lost to Follow-up|2|||
94704918|NCT00823979|324376020|FG001|Overall Study|Lost to Follow-up|1|||
94704919|NCT00823979|324376021|FG002|Overall Study|Lost to Follow-up|0|||
94704920|NCT00823979|324376019|FG000|Overall Study|Withdrawal by Subject|2|||
94704921|NCT00823979|324376020|FG001|Overall Study|Withdrawal by Subject|3|||
94704922|NCT00823979|324376021|FG002|Overall Study|Withdrawal by Subject|2|||
94704923|NCT00823979|324376019|FG000|Overall Study|Protocol Violation|1|||
94704924|NCT00823979|324376020|FG001|Overall Study|Protocol Violation|1|||
94704925|NCT00823979|324376021|FG002|Overall Study|Protocol Violation|0|||
94704926|NCT00823979|324376019|FG000|Overall Study|Pregnancy|0|||
94704927|NCT00823979|324376020|FG001|Overall Study|Pregnancy|1|||
94704928|NCT00823979|324376021|FG002|Overall Study|Pregnancy|0|||
94704929|NCT00823979|324376019|FG000|Overall Study|Adverse Event|0|||
94704930|NCT00823979|324376020|FG001|Overall Study|Adverse Event|2|||
94704931|NCT00823979|324376021|FG002|Overall Study|Adverse Event|4|||
94704932|NCT00823979|324376019|FG000|Overall Study|Other|2|||
94704933|NCT00823979|324376020|FG001|Overall Study|Other|0|||
94704934|NCT00823979|324376021|FG002|Overall Study|Other|1|||
94704935|NCT00823979|324376019|FG000|Overall Study|Randomized but not Treated|4|||
94704936|NCT00823979|324376020|FG001|Overall Study|Randomized but not Treated|3|||
94704937|NCT00823979|324376021|FG002|Overall Study|Randomized but not Treated|1|||
94704938|NCT00823979|324376019|FG000|Overall Study|Study Terminated by Sponsor|5|||
94704939|NCT00823979|324376020|FG001|Overall Study|Study Terminated by Sponsor|5|||
94704940|NCT00823979|324376021|FG002|Overall Study|Study Terminated by Sponsor|7|||
94704941|NCT04391309|324376022|FG000|Overall Study|Death|1|||
94704942|NCT04391309|324376023|FG001|Overall Study|Death|1|||
94704943|NCT04391309|324376022|FG000|Overall Study|Lost to Follow-up|3|||
94704944|NCT04391309|324376023|FG001|Overall Study|Lost to Follow-up|2|||
94704945|NCT04391309|324376022|FG000|Overall Study|Withdrawal by Subject|2|||
94704946|NCT04391309|324376023|FG001|Overall Study|Withdrawal by Subject|2|||
94704947|NCT01155869|324376029|FG000|Overall Study|Lost to Follow-up|3|||
94704948|NCT01155869|324376030|FG001|Overall Study|Lost to Follow-up|1|||
94704949|NCT02824432|324376031|FG000|Overall Study|Major Protocol Deviation|1|||
94704950|NCT02824432|324376032|FG001|Overall Study|Major Protocol Deviation|0|||
94704951|NCT05826431|324376033|FG000|Overall Study|Withdrawal by Subject|1|||
94704952|NCT02357784|324376034|FG000|Overall Study|Withdrawal by Subject|1|||
94704953|NCT01769391|324376039|FG000|Overall Study|Death|10|||
94704954|NCT01769391|324376040|FG001|Overall Study|Death|1|||
94704955|NCT01769391|324376039|FG000|Overall Study|Adverse Event|0|||
94704956|NCT01769391|324376040|FG001|Overall Study|Adverse Event|3|||
94704957|NCT01769391|324376039|FG000|Overall Study|Progressive Disease|1|||
94704958|NCT01769391|324376040|FG001|Overall Study|Progressive Disease|2|||
94704959|NCT01769391|324376039|FG000|Overall Study|Withdrawal by Subject|4|||
94704960|NCT01769391|324376040|FG001|Overall Study|Withdrawal by Subject|3|||
94704961|NCT01769391|324376039|FG000|Overall Study|Investigator Decision|2|||
94704962|NCT01769391|324376040|FG001|Overall Study|Investigator Decision|0|||
94704963|NCT02351180|324376041|FG000|Overall Study|Withdrawal by Subject|1|||
94704964|NCT02351180|324376042|FG001|Overall Study|Withdrawal by Subject|0|||
94704965|NCT00208767|324376043|FG000|Overall Study|Adverse Event|9|||
94704966|NCT00208767|324376044|FG001|Overall Study|Adverse Event|1|||
94704967|NCT00208767|324376043|FG000|Overall Study|Withdrawal by Subject|14|||
94704968|NCT00208767|324376044|FG001|Overall Study|Withdrawal by Subject|3|||
94704969|NCT00208767|324376043|FG000|Overall Study|Death|1|||
94704970|NCT00208767|324376044|FG001|Overall Study|Death|0|||
94704971|NCT00208767|324376043|FG000|Overall Study|Lost to Follow-up|3|||
94704972|NCT00208767|324376044|FG001|Overall Study|Lost to Follow-up|3|||
94704973|NCT03418324|324376045|FG000|Overall Study|Death|0|||
94704974|NCT03418324|324376046|FG001|Overall Study|Death|1|||
94704975|NCT03418324|324376045|FG000|Overall Study|Physician Decision|1|||
94704976|NCT03418324|324376046|FG001|Overall Study|Physician Decision|1|||
94704977|NCT01768676|324376047|FG000|Overall Study|Adverse Event|3|||
94704978|NCT01768676|324376048|FG001|Overall Study|Adverse Event|3|||
94704979|NCT01768676|324376047|FG000|Overall Study|Lost to Follow-up|13|||
94704980|NCT01768676|324376048|FG001|Overall Study|Lost to Follow-up|16|||
94704981|NCT01768676|324376047|FG000|Overall Study|Protocol Violation|1|||
94704982|NCT01768676|324376048|FG001|Overall Study|Protocol Violation|1|||
94704983|NCT01768676|324376047|FG000|Overall Study|Physician Decision|4|||
94704984|NCT01768676|324376048|FG001|Overall Study|Physician Decision|1|||
94704985|NCT01768676|324376047|FG000|Overall Study|Withdrawal by Subject|3|||
94704986|NCT01768676|324376048|FG001|Overall Study|Withdrawal by Subject|10|||
94704987|NCT03768206|324376049|FG000|Overall Study|Lost to Follow-up|2|||
94266587|NCT02060383|322771932|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
94266588|NCT02060383|322771933|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
94704988|NCT03768206|324376050|FG001|Overall Study|Lost to Follow-up|1|||
94704989|NCT03768206|324376049|FG000|Overall Study|Withdrawal by Subject|0|||
94704990|NCT03768206|324376050|FG001|Overall Study|Withdrawal by Subject|1|||
94704991|NCT01390402|324376051|FG000|Overall Study|Death|1|||
94704992|NCT01390402|324376051|FG000|Overall Study|Disease Progression|4|||
94704993|NCT01212757|324376052|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
94704994|NCT01212757|324376053|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
94704995|NCT01212757|324376054|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
94704996|NCT01212757|324376055|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
94704997|NCT01212757|324376056|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
94704998|NCT01212757|324376057|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
94704999|NCT01212757|324376058|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
94705000|NCT01212757|324376059|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
94705001|NCT01212757|324376060|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
94705002|NCT01212757|324376052|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
94705003|NCT01212757|324376053|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
94705004|NCT01212757|324376054|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
94705005|NCT01212757|324376055|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
94705006|NCT01212757|324376056|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
94705007|NCT01212757|324376057|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
94705008|NCT01212757|324376058|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
94705009|NCT01212757|324376059|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
94266589|NCT02060383|322771934|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
94705010|NCT01212757|324376060|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
94705011|NCT01212757|324376052|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
94705012|NCT01212757|324376053|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
94705013|NCT01212757|324376054|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
94705014|NCT01212757|324376055|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
94705015|NCT01212757|324376056|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
94705016|NCT01212757|324376057|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
94705017|NCT01212757|324376058|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
94705018|NCT01212757|324376059|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
94705019|NCT01212757|324376060|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
94705020|NCT01212757|324376052|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
94705021|NCT01212757|324376053|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
94705022|NCT01212757|324376054|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
94705023|NCT01212757|324376055|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
94705024|NCT01212757|324376056|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
94705025|NCT01212757|324376057|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
94705026|NCT01212757|324376058|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
94705027|NCT01212757|324376059|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
94705028|NCT01212757|324376060|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
94705029|NCT01212757|324376052|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
94705030|NCT01212757|324376053|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
94705031|NCT01212757|324376054|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
94705032|NCT01212757|324376055|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94705033|NCT01212757|324376056|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94705034|NCT01212757|324376057|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94705035|NCT01212757|324376058|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94705036|NCT01212757|324376059|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94705037|NCT01212757|324376060|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94266590|NCT02060383|322771935|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
94266591|NCT02060383|322771931|FG000|Core Phase|Adverse Event|2|||
94705038|NCT01212757|324376052|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94705039|NCT01212757|324376053|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
94705040|NCT01212757|324376054|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
94705041|NCT01212757|324376055|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94266592|NCT02060383|322771932|FG001|Core Phase|Adverse Event|0|||
94266593|NCT02060383|322771933|FG002|Core Phase|Adverse Event|0|||
94266594|NCT02060383|322771934|FG003|Core Phase|Adverse Event|2|||
94266595|NCT02060383|322771935|FG004|Core Phase|Adverse Event|6|||
94266596|NCT02060383|322771931|FG000|Core Phase|Administrative problems|0|||
94266597|NCT02060383|322771932|FG001|Core Phase|Administrative problems|1|||
94266598|NCT02060383|322771933|FG002|Core Phase|Administrative problems|0|||
94266599|NCT02060383|322771934|FG003|Core Phase|Administrative problems|0|||
94266600|NCT02060383|322771935|FG004|Core Phase|Administrative problems|0|||
94266601|NCT02060383|322771931|FG000|Core Phase|Protocol Violation|0|||
94366635|NCT00450177|323128099|FG000|Overall Study|Withdrawal by Subject|1|||
94705042|NCT01212757|324376056|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94705043|NCT01212757|324376057|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94705044|NCT01212757|324376058|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94705045|NCT01212757|324376059|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94705046|NCT01212757|324376060|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94705047|NCT01212757|324376052|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
94705048|NCT01212757|324376053|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
94705049|NCT01212757|324376054|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
94705050|NCT01212757|324376055|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
94705051|NCT01212757|324376056|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
94705052|NCT01212757|324376057|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
94705053|NCT01212757|324376058|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
94705054|NCT01212757|324376059|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
94705055|NCT01212757|324376060|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
94705056|NCT01212757|324376052|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
94705057|NCT01212757|324376053|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
94705058|NCT01212757|324376054|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
94705059|NCT01212757|324376055|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
94705060|NCT01212757|324376056|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
94705061|NCT01212757|324376057|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
94705062|NCT01212757|324376058|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
94705063|NCT01212757|324376059|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
94705064|NCT01212757|324376060|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
94705065|NCT01212757|324376052|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
94705066|NCT01212757|324376053|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
94705067|NCT01212757|324376054|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
94705068|NCT01212757|324376055|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
94705069|NCT01212757|324376056|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
94705070|NCT01212757|324376057|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
94705071|NCT01212757|324376058|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
94705072|NCT01212757|324376059|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
94705073|NCT01212757|324376060|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
94705074|NCT01212757|324376052|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
94705075|NCT01212757|324376053|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
94705076|NCT01212757|324376054|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
94705077|NCT01212757|324376055|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
94705078|NCT01212757|324376056|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
94705079|NCT01212757|324376057|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
94705080|NCT01212757|324376058|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
94705081|NCT01212757|324376059|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
94705082|NCT01212757|324376060|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
94705083|NCT01212757|324376052|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
94705084|NCT01212757|324376053|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
94705085|NCT01212757|324376054|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
94705086|NCT01212757|324376055|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
94705087|NCT01212757|324376056|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
94705088|NCT01212757|324376057|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
94705089|NCT01212757|324376058|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
94705090|NCT01212757|324376059|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
94705091|NCT01212757|324376060|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
94705092|NCT01212757|324376052|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
94705093|NCT01212757|324376053|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
94705094|NCT01212757|324376054|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
94705095|NCT01212757|324376055|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
94705096|NCT01212757|324376056|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
94705097|NCT01212757|324376057|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
94705098|NCT01212757|324376058|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
94705099|NCT01212757|324376059|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
94705100|NCT01212757|324376060|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
94705101|NCT01212757|324376052|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
94705102|NCT01212757|324376053|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
94705103|NCT01212757|324376054|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
94705104|NCT01212757|324376055|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
94705105|NCT01212757|324376056|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
94705106|NCT01212757|324376057|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
94705107|NCT01212757|324376058|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
94705108|NCT01212757|324376059|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
94705109|NCT01212757|324376060|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
94705110|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
94705111|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
94705112|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
94705113|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
94705114|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
94705115|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
94705116|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
94705117|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
94705118|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
94705119|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
94705120|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
94705121|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
94705122|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
94705123|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
94705124|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
94705125|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
94705126|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
94705127|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
94705128|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
94705129|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
94705130|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
94705131|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
94705132|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
94705133|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
94705134|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
94705135|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
94705136|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
94705137|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
94705138|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
94705139|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
94705140|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
94705141|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
94705142|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
94705143|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
94705144|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
94705145|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
94705146|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
94705147|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
94705148|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
94705149|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
94705150|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
94705151|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
94705152|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
94705153|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
94705154|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
94705155|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
94705156|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
94705157|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
94705158|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
94705159|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
94705160|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
94705161|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
94705162|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
94705163|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
94705164|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
94705165|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
94705166|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
94705167|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
94705168|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
94705169|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
94705170|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
94705171|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
94705172|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
94705173|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
94705174|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
94705175|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
94705176|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
94705177|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
94705178|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
94705179|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
94705180|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
94705181|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
94705182|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
94705183|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
94705184|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
94705185|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
94705186|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
94705187|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
94705188|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
94705189|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
94705190|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
94705191|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
94705192|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
94705193|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
94705194|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
94705195|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
94705196|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
94705197|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
94705198|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
94705199|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
94705200|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
94705201|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
94705202|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
94705203|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
94705204|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
94705205|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
94705206|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
94705207|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
94705208|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
94705209|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
94705210|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
94705211|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
94705212|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
94705213|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
94705214|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
94705215|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
94705216|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
94705217|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
94705218|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
94705219|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
94266602|NCT02060383|322771932|FG001|Core Phase|Protocol Violation|0|||
94705220|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
94705221|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
94705222|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
94705223|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
94705224|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
94705225|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
94705226|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
94705227|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
94705228|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
94705229|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
94705230|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
94705231|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
94705232|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
94705233|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
94705234|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
94705235|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
94705236|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
94705237|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
94705238|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
94705239|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
94705240|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
94705241|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
94705242|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
94705243|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
94705244|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
94705245|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
94705246|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
94705247|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
94705248|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
94705249|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
94705250|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
94705251|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
94705252|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
94705253|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
94705254|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
94705255|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
94705256|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
94705257|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
94705258|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
94705259|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
94705260|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
94705261|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
94705262|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
94705263|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
94705264|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
94705265|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
94266603|NCT02060383|322771933|FG002|Core Phase|Protocol Violation|0|||
94266604|NCT02060383|322771934|FG003|Core Phase|Protocol Violation|1|||
94266605|NCT02060383|322771935|FG004|Core Phase|Protocol Violation|0|||
94705266|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
94705267|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
94705268|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
94705269|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
94705270|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
94705271|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
94705272|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
94705273|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
94705274|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
94705275|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
94705276|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
94705277|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
94705278|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
94705279|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
94705280|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
94705281|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
94705282|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
94705283|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
94705284|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
94705285|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
94705286|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
94705287|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
94705288|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
94705289|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
94705290|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
94705291|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
94705292|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
94705293|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
94705294|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
94705295|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
94705296|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
94705297|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
94705298|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
94705299|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
94705300|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
94705301|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
94705302|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
94705303|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
94705304|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
94705305|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
94705306|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
94705307|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
94705308|NCT01212757|324376052|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
94705309|NCT01212757|324376053|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
94705310|NCT01212757|324376054|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
94705311|NCT01212757|324376055|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
94705312|NCT01212757|324376056|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
94705313|NCT01212757|324376057|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
94705314|NCT01212757|324376058|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
94705315|NCT01212757|324376059|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
94705316|NCT01212757|324376060|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
94705317|NCT03425643|324376061|FG000|Overall Study|Withdrawal by Subject|10|||
94705318|NCT03425643|324376062|FG001|Overall Study|Withdrawal by Subject|12|||
94705319|NCT03425643|324376061|FG000|Overall Study|Lost to Follow-up|2|||
94705320|NCT03425643|324376062|FG001|Overall Study|Lost to Follow-up|0|||
94705321|NCT03425643|324376061|FG000|Overall Study|Death|109|||
94705322|NCT03425643|324376062|FG001|Overall Study|Death|141|||
94705323|NCT03425643|324376061|FG000|Overall Study|Ongoing in study|276|||
94705324|NCT03425643|324376062|FG001|Overall Study|Ongoing in study|247|||
94705325|NCT04133363|324376063|FG000|Overall Study|Lost to Follow-up|2|||
94705326|NCT04133363|324376064|FG001|Overall Study|Lost to Follow-up|1|||
94705327|NCT04133363|324376065|FG002|Overall Study|Lost to Follow-up|4|||
94705328|NCT02812966|324376066|FG000|Overall Study|Death|1|||
94705329|NCT02812966|324376067|FG001|Overall Study|Death|0|||
94705330|NCT00954707|324377061|FG000|Overall Study|Death|34|||
94705331|NCT00954707|324377061|FG000|Overall Study|Withdrawal by Subject|100|||
94705332|NCT00954707|324377061|FG000|Overall Study|Lost to Follow-up|33|||
94705333|NCT04580303|324377066|FG000|Overall Study|Adverse Event|0|||
94705334|NCT04580303|324377067|FG001|Overall Study|Adverse Event|1|||
94705335|NCT04580303|324377068|FG002|Overall Study|Adverse Event|0|||
94705336|NCT04580303|324377069|FG003|Overall Study|Adverse Event|0|||
94705337|NCT04580303|324377066|FG000|Overall Study|Withdrawal by Subject|0|||
94705338|NCT04580303|324377067|FG001|Overall Study|Withdrawal by Subject|0|||
94705339|NCT04580303|324377068|FG002|Overall Study|Withdrawal by Subject|1|||
94705340|NCT04580303|324377069|FG003|Overall Study|Withdrawal by Subject|0|||
94705341|NCT03383887|324377071|FG000|Overall Study|Lost to Follow-up|0|||
94705342|NCT03383887|324377072|FG001|Overall Study|Lost to Follow-up|1|||
94705343|NCT02750709|324377073|FG000|Treatment Period 1|Adverse Event|0|||
94705344|NCT02750709|324377074|FG001|Treatment Period 1|Adverse Event|0|||
94705345|NCT02750709|324377075|FG002|Treatment Period 1|Adverse Event|0|||
94705346|NCT02750709|324377076|FG003|Treatment Period 1|Adverse Event|0|||
94705347|NCT02750709|324377077|FG004|Treatment Period 1|Adverse Event|0|||
94705348|NCT02750709|324377078|FG005|Treatment Period 1|Adverse Event|1|||
94705349|NCT03256344|324377079|FG000|Overall Study|Death|6|||
94705350|NCT03256344|324377080|FG001|Overall Study|Death|22|||
94705351|NCT03256344|324377079|FG000|Overall Study|Withdrawal by Subject|3|||
94705352|NCT03256344|324377080|FG001|Overall Study|Withdrawal by Subject|3|||
94705353|NCT03256344|324377079|FG000|Overall Study|Sponsor Decision|1|||
94705354|NCT03256344|324377080|FG001|Overall Study|Sponsor Decision|0|||
94705355|NCT00542386|324377084|FG000|Overall Study|Adverse Event|1|||
94705356|NCT00542386|324377085|FG001|Overall Study|Adverse Event|7|||
94705357|NCT00542386|324377086|FG002|Overall Study|Adverse Event|7|||
94705358|NCT00542386|324377087|FG003|Overall Study|Adverse Event|8|||
94705359|NCT00542386|324377088|FG004|Overall Study|Adverse Event|13|||
94705360|NCT00542386|324377089|FG005|Overall Study|Adverse Event|4|||
94705361|NCT00542386|324377084|FG000|Overall Study|Death|0|||
94705362|NCT00542386|324377085|FG001|Overall Study|Death|0|||
94705363|NCT00542386|324377086|FG002|Overall Study|Death|1|||
94705364|NCT00542386|324377087|FG003|Overall Study|Death|2|||
94705365|NCT00542386|324377088|FG004|Overall Study|Death|1|||
94266606|NCT02060383|322771931|FG000|Core Phase|Withdrawal by Subject|0|||
94266607|NCT02060383|322771932|FG001|Core Phase|Withdrawal by Subject|0|||
94266608|NCT02060383|322771933|FG002|Core Phase|Withdrawal by Subject|0|||
94266609|NCT02060383|322771934|FG003|Core Phase|Withdrawal by Subject|4|||
94266610|NCT02060383|322771935|FG004|Core Phase|Withdrawal by Subject|2|||
94266611|NCT02060383|322771931|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
94266612|NCT02060383|322771932|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
94366636|NCT00450177|323128100|FG001|Overall Study|Withdrawal by Subject|6|||
94366637|NCT00450177|323128099|FG000|Overall Study|Withdrawal by Primary Team|1|||
94366638|NCT00450177|323128100|FG001|Overall Study|Withdrawal by Primary Team|1|||
94366639|NCT01296152|323128103|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
94705366|NCT00542386|324377089|FG005|Overall Study|Death|2|||
94705367|NCT00542386|324377084|FG000|Overall Study|Lack of Efficacy|32|||
94705368|NCT00542386|324377085|FG001|Overall Study|Lack of Efficacy|12|||
94705369|NCT00542386|324377086|FG002|Overall Study|Lack of Efficacy|10|||
94366640|NCT01128153|323128108|FG000|Overall Study|Adverse Event|1|||
94366641|NCT01128153|323128109|FG001|Overall Study|Adverse Event|3|||
94705370|NCT00542386|324377087|FG003|Overall Study|Lack of Efficacy|13|||
94705371|NCT00542386|324377088|FG004|Overall Study|Lack of Efficacy|7|||
94705372|NCT00542386|324377089|FG005|Overall Study|Lack of Efficacy|31|||
94705373|NCT00542386|324377084|FG000|Overall Study|Physician Decision|1|||
94705374|NCT00542386|324377085|FG001|Overall Study|Physician Decision|0|||
94705375|NCT00542386|324377086|FG002|Overall Study|Physician Decision|0|||
94705376|NCT00542386|324377087|FG003|Overall Study|Physician Decision|1|||
94705377|NCT00542386|324377088|FG004|Overall Study|Physician Decision|0|||
94705378|NCT00542386|324377089|FG005|Overall Study|Physician Decision|0|||
94705379|NCT00542386|324377084|FG000|Overall Study|Protocol Violation|0|||
94705380|NCT00542386|324377085|FG001|Overall Study|Protocol Violation|0|||
94705381|NCT00542386|324377086|FG002|Overall Study|Protocol Violation|1|||
94705382|NCT00542386|324377087|FG003|Overall Study|Protocol Violation|0|||
94705383|NCT00542386|324377088|FG004|Overall Study|Protocol Violation|0|||
94266613|NCT02060383|322771933|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
94366642|NCT01128153|323128108|FG000|Overall Study|Condition under investigation worsened|8|||
94366643|NCT01128153|323128109|FG001|Overall Study|Condition under investigation worsened|7|||
94366644|NCT01128153|323128108|FG000|Overall Study|Withdrawal by Subject|2|||
94366645|NCT01128153|323128109|FG001|Overall Study|Withdrawal by Subject|3|||
94366646|NCT01128153|323128108|FG000|Overall Study|Incorrect enrolment to study|2|||
94366647|NCT01128153|323128109|FG001|Overall Study|Incorrect enrolment to study|1|||
94705384|NCT00542386|324377089|FG005|Overall Study|Protocol Violation|4|||
94705385|NCT00542386|324377084|FG000|Overall Study|Withdrawal by Subject|5|||
94705386|NCT00542386|324377085|FG001|Overall Study|Withdrawal by Subject|8|||
94705387|NCT00542386|324377086|FG002|Overall Study|Withdrawal by Subject|10|||
94705388|NCT00542386|324377087|FG003|Overall Study|Withdrawal by Subject|11|||
94705389|NCT00542386|324377088|FG004|Overall Study|Withdrawal by Subject|15|||
94705390|NCT00542386|324377089|FG005|Overall Study|Withdrawal by Subject|7|||
94705391|NCT00542386|324377084|FG000|Overall Study|Other Reasons|4|||
94705392|NCT00542386|324377085|FG001|Overall Study|Other Reasons|1|||
94705393|NCT00542386|324377086|FG002|Overall Study|Other Reasons|4|||
94705394|NCT00542386|324377087|FG003|Overall Study|Other Reasons|3|||
94266614|NCT02060383|322771934|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
94366648|NCT01128153|323128108|FG000|Overall Study|Protocol Violation|2|||
94366649|NCT01128153|323128109|FG001|Overall Study|Protocol Violation|0|||
94366650|NCT01128153|323128108|FG000|Overall Study|Developed discontinuation criteria|1|||
94366651|NCT01128153|323128109|FG001|Overall Study|Developed discontinuation criteria|1|||
94366652|NCT00755937|323128112|FG000|Recruitment|Unknown if infliximab received|164|||
94366653|NCT00755937|323128112|FG000|Observational Follow-up|Lost to Follow-up|148|||
94366654|NCT02742818|323128120|FG000|Overall Study|Adverse Event|0|||
94366655|NCT02742818|323128121|FG001|Overall Study|Adverse Event|1|||
94366656|NCT02742818|323128120|FG000|Overall Study|Protocol Violation|0|||
94366657|NCT02742818|323128121|FG001|Overall Study|Protocol Violation|1|||
94366658|NCT00566631|323128122|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
94705395|NCT00542386|324377088|FG004|Overall Study|Other Reasons|4|||
94705396|NCT00542386|324377089|FG005|Overall Study|Other Reasons|2|||
94705397|NCT00880906|324377091|FG000|Overall Study|Lost to Follow-up|0|||
94705398|NCT00880906|324377092|FG001|Overall Study|Lost to Follow-up|1|||
94705399|NCT00880906|324377091|FG000|Overall Study|Did not meet criteria following patholog|12|||
94705400|NCT00880906|324377092|FG001|Overall Study|Did not meet criteria following patholog|6|||
94705401|NCT00544440|324377097|FG000|Overall Study|Other|1|||
94705402|NCT00544440|324377097|FG000|Overall Study|Adverse Event|1|||
94705403|NCT00544440|324377097|FG000|Overall Study|Withdrawal by Subject|2|||
94705404|NCT00544440|324377097|FG000|Overall Study|Subject Non-compliance|1|||
94705405|NCT00544440|324377097|FG000|Overall Study|Progressive Disease|47|||
94705406|NCT00544440|324377097|FG000|Overall Study|Other|5|||
94705407|NCT00591838|324377107|FG000|Overall Study|Withdrawal by Subject|0|||
94705408|NCT00591838|324377108|FG001|Overall Study|Withdrawal by Subject|0|||
94705409|NCT00591838|324377109|FG002|Overall Study|Withdrawal by Subject|0|||
94705410|NCT00591838|324377110|FG003|Overall Study|Withdrawal by Subject|1|||
94705411|NCT00591838|324377111|FG004|Overall Study|Withdrawal by Subject|0|||
94705412|NCT02982213|324377112|FG000|Overall Study|Did not complete follow up questionnaire|5|||
94705413|NCT02982213|324377113|FG001|Overall Study|Did not complete follow up questionnaire|1|||
94705414|NCT03525119|324377114|FG000|Overall Study|Adverse Event|0|||
94705415|NCT03525119|324377115|FG001|Overall Study|Adverse Event|1|||
94705416|NCT03525119|324377116|FG002|Overall Study|Adverse Event|0|||
94705417|NCT03525119|324377114|FG000|Overall Study|Lost to Follow-up|32|||
94705418|NCT03525119|324377115|FG001|Overall Study|Lost to Follow-up|33|||
94705419|NCT03525119|324377116|FG002|Overall Study|Lost to Follow-up|37|||
94705420|NCT03525119|324377114|FG000|Overall Study|Withdrawal by Subject|5|||
94705421|NCT03525119|324377115|FG001|Overall Study|Withdrawal by Subject|4|||
94705422|NCT03525119|324377116|FG002|Overall Study|Withdrawal by Subject|2|||
94705423|NCT03525119|324377114|FG000|Overall Study|Reason not Specified|2|||
94705424|NCT03525119|324377115|FG001|Overall Study|Reason not Specified|1|||
94705425|NCT03525119|324377116|FG002|Overall Study|Reason not Specified|2|||
94705426|NCT03525119|324377114|FG000|Overall Study|Randomized but not Vaccinated|1|||
94705427|NCT03525119|324377115|FG001|Overall Study|Randomized but not Vaccinated|0|||
94705428|NCT03525119|324377116|FG002|Overall Study|Randomized but not Vaccinated|2|||
94705429|NCT03939819|324377117|FG000|Overall Study|Death|2|||
94705430|NCT03939819|324377118|FG001|Overall Study|Death|0|||
94705431|NCT00586339|324377119|FG000|Overall Study|Withdrawal by Subject|1|||
94705432|NCT00586339|324377120|FG001|Overall Study|Withdrawal by Subject|3|||
94705433|NCT00586339|324377121|FG002|Overall Study|Withdrawal by Subject|1|||
94705434|NCT00586339|324377119|FG000|Overall Study|Migrated/moved from study area|3|||
94705435|NCT00586339|324377120|FG001|Overall Study|Migrated/moved from study area|2|||
94705436|NCT00586339|324377121|FG002|Overall Study|Migrated/moved from study area|4|||
94705437|NCT00586339|324377119|FG000|Overall Study|Lost to Follow-up|3|||
94705438|NCT00586339|324377120|FG001|Overall Study|Lost to Follow-up|2|||
94705439|NCT00586339|324377121|FG002|Overall Study|Lost to Follow-up|1|||
94705440|NCT01972152|324377122|FG000|First Treatment Visit|Lost to Follow-up|0|||
94705441|NCT01972152|324377123|FG001|First Treatment Visit|Lost to Follow-up|1|||
94705442|NCT01972152|324377124|FG002|First Treatment Visit|Lost to Follow-up|0|||
94705443|NCT01972152|324377125|FG003|First Treatment Visit|Lost to Follow-up|0|||
94705444|NCT01972152|324377126|FG004|First Treatment Visit|Lost to Follow-up|0|||
94705445|NCT01972152|324377127|FG005|First Treatment Visit|Lost to Follow-up|0|||
94705446|NCT01972152|324377122|FG000|Second Treatment Visit|Protocol Violation|0|||
94705447|NCT01972152|324377123|FG001|Second Treatment Visit|Protocol Violation|1|||
94705448|NCT01972152|324377124|FG002|Second Treatment Visit|Protocol Violation|0|||
94366659|NCT00566631|323128122|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
94366660|NCT00566631|323128122|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
94366661|NCT00566631|323128122|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
94705449|NCT01972152|324377125|FG003|Second Treatment Visit|Protocol Violation|0|||
94705450|NCT01972152|324377126|FG004|Second Treatment Visit|Protocol Violation|0|||
94705451|NCT01972152|324377127|FG005|Second Treatment Visit|Protocol Violation|0|||
94705452|NCT01959412|324377128|FG000|Overall Study|Protocol deviation|1|||
94705453|NCT01959412|324377129|FG001|Overall Study|Protocol deviation|1|||
94705454|NCT01959412|324377130|FG002|Overall Study|Protocol deviation|0|||
94705455|NCT01959412|324377131|FG003|Overall Study|Protocol deviation|1|||
94705456|NCT01959412|324377132|FG004|Overall Study|Protocol deviation|3|||
94705457|NCT01959412|324377133|FG005|Overall Study|Protocol deviation|0|||
94705458|NCT01959412|324377128|FG000|Overall Study|Adverse Event|0|||
94705459|NCT01959412|324377129|FG001|Overall Study|Adverse Event|0|||
94705460|NCT01959412|324377130|FG002|Overall Study|Adverse Event|0|||
94705461|NCT01959412|324377131|FG003|Overall Study|Adverse Event|1|||
94705462|NCT01959412|324377132|FG004|Overall Study|Adverse Event|0|||
94705463|NCT01959412|324377133|FG005|Overall Study|Adverse Event|0|||
94705464|NCT01186848|324377134|FG000|Overall Study|Lost to Follow-up|4|||
94705465|NCT01186848|324377134|FG000|Overall Study|Withdrawal by Subject|2|||
94705466|NCT01186848|324377134|FG000|Overall Study|Adverse Event|2|||
94705467|NCT00770965|324377151|FG000|Safety Set|Withdrawal by Subject|0|||
94705468|NCT00770965|324377152|FG001|Safety Set|Withdrawal by Subject|0|||
94705469|NCT00770965|324377153|FG002|Safety Set|Withdrawal by Subject|0|||
94705470|NCT00770965|324377154|FG003|Safety Set|Withdrawal by Subject|1|||
94705471|NCT00770965|324377151|FG000|Safety Set|Protocol deviation|0|||
94705472|NCT00770965|324377152|FG001|Safety Set|Protocol deviation|0|||
94705473|NCT00770965|324377153|FG002|Safety Set|Protocol deviation|1|||
94705474|NCT00770965|324377154|FG003|Safety Set|Protocol deviation|0|||
94705475|NCT00770965|324377151|FG000|Excluded Set|Administrative problems|14|||
94705476|NCT00770965|324377152|FG001|Excluded Set|Administrative problems|12|||
94705477|NCT00770965|324377153|FG002|Excluded Set|Administrative problems|12|||
94705478|NCT00770965|324377154|FG003|Excluded Set|Administrative problems|10|||
94705479|NCT00770965|324377151|FG000|Excluded Set|Withdrawal by Subject|1|||
94705480|NCT00770965|324377152|FG001|Excluded Set|Withdrawal by Subject|1|||
94705481|NCT00770965|324377153|FG002|Excluded Set|Withdrawal by Subject|2|||
94705482|NCT00770965|324377154|FG003|Excluded Set|Withdrawal by Subject|3|||
94705483|NCT00509769|324377155|FG000|Overall Study|Progressive disease|77|||
94705484|NCT00509769|324377155|FG000|Overall Study|Adverse Event|4|||
94705485|NCT00509769|324377155|FG000|Overall Study|Patient's decision|1|||
94705486|NCT00509769|324377155|FG000|Overall Study|Physician Decision|8|||
94705487|NCT00509769|324377155|FG000|Overall Study|Use of prohibited therapies during study|1|||
94705488|NCT00371566|324377156|FG000|Treatment Phase|Withdrawal by Subject|0|||
94705489|NCT00371566|324377157|FG001|Treatment Phase|Withdrawal by Subject|1|||
94705490|NCT00371566|324377156|FG000|Treatment Phase|Adverse Event|0|||
94705491|NCT00371566|324377157|FG001|Treatment Phase|Adverse Event|1|||
94705492|NCT00371566|324377156|FG000|Treatment Phase|Protocol Violation|0|||
94705493|NCT00371566|324377157|FG001|Treatment Phase|Protocol Violation|1|||
94705494|NCT00371566|324377156|FG000|Chemoradiation Phase|Physician Decision|2|||
94705495|NCT00371566|324377157|FG001|Chemoradiation Phase|Physician Decision|0|||
94705496|NCT00371566|324377156|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
94705497|NCT00371566|324377157|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
94705498|NCT00371566|324377156|FG000|Chemoradiation Phase|Non compliant|0|||
94705499|NCT00371566|324377157|FG001|Chemoradiation Phase|Non compliant|1|||
94705500|NCT00371566|324377156|FG000|Chemoradiation Phase|Progressive Disease|1|||
94705501|NCT00371566|324377157|FG001|Chemoradiation Phase|Progressive Disease|1|||
94705502|NCT00371566|324377156|FG000|Chemoradiation Phase|Death|2|||
94705503|NCT00371566|324377157|FG001|Chemoradiation Phase|Death|0|||
94705504|NCT00371566|324377156|FG000|Follow Up Phase|Death|0|||
94705505|NCT00371566|324377157|FG001|Follow Up Phase|Death|5|||
94705506|NCT00371566|324377156|FG000|Follow Up Phase|Disease progression|1|||
94705507|NCT00371566|324377157|FG001|Follow Up Phase|Disease progression|0|||
94705508|NCT00371566|324377156|FG000|Follow Up Phase|Withdrawal by Subject|0|||
94705509|NCT00371566|324377157|FG001|Follow Up Phase|Withdrawal by Subject|1|||
94705510|NCT00371566|324377156|FG000|Follow Up Phase|Physician Decision|1|||
94705511|NCT00371566|324377157|FG001|Follow Up Phase|Physician Decision|1|||
94705512|NCT00371566|324377156|FG000|Follow Up Phase|Lost to Follow-up|1|||
94705513|NCT00371566|324377157|FG001|Follow Up Phase|Lost to Follow-up|0|||
94705514|NCT00597519|324377158|FG000|Overall Study|Death|1|||
94266615|NCT02060383|322771935|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
94266616|NCT02060383|322771931|FG000|Extension Phase|Adverse Event|1|||
94266617|NCT02060383|322771932|FG001|Extension Phase|Adverse Event|1|||
94705515|NCT00988637|324377161|FG000|Overall Study|Lost to Follow-up|2|||
94266618|NCT02060383|322771933|FG002|Extension Phase|Adverse Event|2|||
94266619|NCT02060383|322771934|FG003|Extension Phase|Adverse Event|0|||
94266620|NCT02060383|322771935|FG004|Extension Phase|Adverse Event|1|||
94266621|NCT02060383|322771931|FG000|Extension Phase|Withdrawal by Subject|0|||
94266622|NCT02060383|322771932|FG001|Extension Phase|Withdrawal by Subject|1|||
94705516|NCT00988637|324377162|FG001|Overall Study|Lost to Follow-up|1|||
94705517|NCT00988637|324377161|FG000|Overall Study|Withdrawal by Subject|1|||
94705518|NCT00988637|324377162|FG001|Overall Study|Withdrawal by Subject|1|||
94705519|NCT00988637|324377161|FG000|Overall Study|non-compliance with study drug|0|||
94705520|NCT00988637|324377162|FG001|Overall Study|non-compliance with study drug|1|||
94705521|NCT04858425|324377166|FG000|Overall Study|Adverse Event|2|||
94705522|NCT04858425|324377167|FG001|Overall Study|Adverse Event|2|||
94705523|NCT04858425|324377166|FG000|Overall Study|Withdrawal by Subject|3|||
94705524|NCT04858425|324377167|FG001|Overall Study|Withdrawal by Subject|1|||
94705525|NCT04858425|324377166|FG000|Overall Study|Lost to Follow-up|4|||
94705526|NCT04858425|324377167|FG001|Overall Study|Lost to Follow-up|2|||
94266623|NCT02060383|322771933|FG002|Extension Phase|Withdrawal by Subject|0|||
94266624|NCT02060383|322771934|FG003|Extension Phase|Withdrawal by Subject|0|||
94266625|NCT02060383|322771935|FG004|Extension Phase|Withdrawal by Subject|2|||
94266626|NCT02060383|322771931|FG000|Extension Phase|Administrative problems|1|||
94266627|NCT02060383|322771932|FG001|Extension Phase|Administrative problems|0|||
94266628|NCT02060383|322771933|FG002|Extension Phase|Administrative problems|0|||
94266629|NCT02060383|322771934|FG003|Extension Phase|Administrative problems|0|||
94266630|NCT02060383|322771935|FG004|Extension Phase|Administrative problems|0|||
94266631|NCT02060383|322771931|FG000|Extension Phase|Death|0|||
94266632|NCT02060383|322771932|FG001|Extension Phase|Death|0|||
94266633|NCT02060383|322771933|FG002|Extension Phase|Death|1|||
94266634|NCT02060383|322771934|FG003|Extension Phase|Death|0|||
94266635|NCT02060383|322771935|FG004|Extension Phase|Death|1|||
94266636|NCT02060383|322771931|FG000|Extension Phase|Protocol Violation|0|||
94266637|NCT02060383|322771932|FG001|Extension Phase|Protocol Violation|0|||
94266638|NCT02060383|322771933|FG002|Extension Phase|Protocol Violation|0|||
94266639|NCT02060383|322771934|FG003|Extension Phase|Protocol Violation|0|||
94266640|NCT02060383|322771935|FG004|Extension Phase|Protocol Violation|1|||
94266641|NCT00088907|322771936|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
94266642|NCT00088907|322771937|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
94266643|NCT00088907|322771936|FG000|Randomized Study (Step 1)|Adverse Event|14|||
94266644|NCT00088907|322771937|FG001|Randomized Study (Step 1)|Adverse Event|19|||
94266645|NCT00088907|322771936|FG000|Randomized Study (Step 1)|Death|11|||
94266646|NCT00088907|322771937|FG001|Randomized Study (Step 1)|Death|12|||
94266647|NCT00088907|322771936|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
94266648|NCT00088907|322771937|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
94266649|NCT00088907|322771936|FG000|Randomized Study (Step 1)|complicating disease|3|||
94266650|NCT00088907|322771937|FG001|Randomized Study (Step 1)|complicating disease|1|||
94266651|NCT00088907|322771936|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
94266652|NCT00088907|322771937|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
94266653|NCT00088907|322771936|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
94266654|NCT00088907|322771937|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
94266655|NCT00088907|322771936|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
94266656|NCT00088907|322771937|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
94266657|NCT00088907|322771936|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
94266658|NCT00088907|322771937|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
94266659|NCT00088907|322771936|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
94705527|NCT04858425|324377166|FG000|Overall Study|Lost to Follow-up|1|||
94705528|NCT04858425|324377167|FG001|Overall Study|Lost to Follow-up|0|||
94705529|NCT03586544|324377170|FG000|First Intervention|Adverse Event|0|||
94705530|NCT03586544|324377171|FG001|First Intervention|Adverse Event|1|||
94705531|NCT03586544|324377170|FG000|Second Intervention|Withdrawal by Subject|0|||
94705532|NCT03586544|324377171|FG001|Second Intervention|Withdrawal by Subject|1|||
94705533|NCT00741988|324377172|FG000|Overall Study|Adverse Event|2|||
94705534|NCT00741988|324377173|FG001|Overall Study|Adverse Event|4|||
94705535|NCT00741988|324377172|FG000|Overall Study|Lack of Efficacy|2|||
94705536|NCT00741988|324377173|FG001|Overall Study|Lack of Efficacy|0|||
94705537|NCT05019729|324377174|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
94705538|NCT05019729|324377175|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
94705539|NCT05019729|324377176|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
94705540|NCT05019729|324377177|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
94705541|NCT05019729|324377178|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
94705542|NCT05019729|324377179|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
94705543|NCT01311648|324378944|FG000|Main Study|Protocol Violation|0|||
94705544|NCT01311648|324378945|FG001|Main Study|Protocol Violation|1|||
94705545|NCT01311648|324378944|FG000|Main Study|Adverse Event|0|||
94705546|NCT01311648|324378945|FG001|Main Study|Adverse Event|1|||
94266660|NCT00088907|322771937|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
94266661|NCT00088907|322771936|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
94266662|NCT00088907|322771937|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
94266663|NCT02020863|322771938|FG000|Overall Study|Discovery of Metastatic disease|4|||
94266664|NCT02020863|322771938|FG000|Overall Study|Team chose not to place an a line|1|||
94366662|NCT00566631|323128122|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
94266665|NCT02460497|322771941|FG000|Overall Study|Participant Requested Withdrawal|4|||
94366663|NCT00566631|323128122|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
94266666|NCT02460497|322771941|FG000|Overall Study|Non-Compliance|1|||
94266667|NCT02460497|322771941|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
94366664|NCT00566631|323128122|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
94705547|NCT01311648|324378944|FG000|Main Study|Inhibitor management|0|||
94705548|NCT01311648|324378945|FG001|Main Study|Inhibitor management|17|||
94266668|NCT02460497|322771941|FG000|Overall Study|Lost to Follow-up|2|||
94705549|NCT01311648|324378944|FG000|Main Study|Withdrawal by Subject|0|||
94705550|NCT01311648|324378945|FG001|Main Study|Withdrawal by Subject|2|||
94705551|NCT01311648|324378944|FG000|Extension Study|Physician Decision|0|||
94705552|NCT01311648|324378945|FG001|Extension Study|Physician Decision|1|||
94705553|NCT01311648|324378944|FG000|Extension Study|ITI therapy with marketed product|0|||
94705554|NCT01311648|324378945|FG001|Extension Study|ITI therapy with marketed product|1|||
94705555|NCT01311648|324378944|FG000|Extension Study|Incorrect visit planning|0|||
94705556|NCT01311648|324378945|FG001|Extension Study|Incorrect visit planning|1|||
94705557|NCT01311648|324378944|FG000|Extension Study|Family's decision|0|||
94705558|NCT01311648|324378945|FG001|Extension Study|Family's decision|1|||
94705559|NCT01311648|324378944|FG000|Extension Study|Failure of ITI therapy|0|||
94705560|NCT01311648|324378945|FG001|Extension Study|Failure of ITI therapy|3|||
94705561|NCT01311648|324378944|FG000|Extension Study|Long travel|0|||
94705562|NCT01311648|324378945|FG001|Extension Study|Long travel|1|||
94705563|NCT01311648|324378944|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
94705564|NCT01311648|324378945|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
94705565|NCT01311648|324378944|FG000|Extension Study|Withdrawal by Subject|0|||
94705566|NCT01311648|324378945|FG001|Extension Study|Withdrawal by Subject|1|||
94705567|NCT01311648|324378944|FG000|Extension Study|Inhibitor management|0|||
94705568|NCT01311648|324378945|FG001|Extension Study|Inhibitor management|2|||
94705569|NCT01645111|324378946|FG000|Overall Study|Did not require Clevidipine|15|||
94705570|NCT05526911|324378947|FG000|Overall Study|Adverse Event|2|||
94705571|NCT05355116|324378948|FG000|Overall Study|Withdrawal by Subject|2|||
94705572|NCT00149630|324378949|FG000|Overall Study|Incarceration|2|||
94705573|NCT00149630|324378950|FG001|Overall Study|Incarceration|0|||
94705574|NCT00149630|324378949|FG000|Overall Study|Treatment Programs|4|||
94705575|NCT00149630|324378950|FG001|Overall Study|Treatment Programs|5|||
94705576|NCT00149630|324378949|FG000|Overall Study|Adverse Event|2|||
94705577|NCT00149630|324378950|FG001|Overall Study|Adverse Event|0|||
94705578|NCT01977612|324378956|FG000|Overall Study|Lost to Follow-up|1|||
94705579|NCT01977612|324378957|FG001|Overall Study|Lost to Follow-up|1|||
94705580|NCT01451814|324378958|FG000|Overall Study|Withdrawal by Subject|1|||
94705581|NCT01451814|324378959|FG001|Overall Study|Withdrawal by Subject|1|||
94705582|NCT01451814|324378958|FG000|Overall Study|Lost to Follow-up|5|||
94705583|NCT01451814|324378959|FG001|Overall Study|Lost to Follow-up|4|||
94705584|NCT03439124|324378960|FG000|Overall Study|Adverse Event|2|||
94705585|NCT03439124|324378961|FG001|Overall Study|Adverse Event|0|||
94705586|NCT03439124|324378960|FG000|Overall Study|Lost to Follow-up|1|||
94705587|NCT03439124|324378961|FG001|Overall Study|Lost to Follow-up|0|||
94705588|NCT03439124|324378960|FG000|Overall Study|Other reasons|1|||
94705589|NCT03439124|324378961|FG001|Overall Study|Other reasons|0|||
94705590|NCT03646123|324378962|FG000|Overall Study|Patient transferred and not able to get testing completed|0|||
94705591|NCT03646123|324378963|FG001|Overall Study|Patient transferred and not able to get testing completed|1|||
94705592|NCT03646123|324378964|FG002|Overall Study|Patient transferred and not able to get testing completed|0|||
94705593|NCT03646123|324378962|FG000|Overall Study|Participant no longer met inclusion criteria and never received treatment|1|||
94705594|NCT03646123|324378963|FG001|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
94705595|NCT03646123|324378964|FG002|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
94705596|NCT03646123|324378962|FG000|Overall Study|Non-compliance to study protocol|1|||
94705597|NCT03646123|324378963|FG001|Overall Study|Non-compliance to study protocol|0|||
94705598|NCT03646123|324378964|FG002|Overall Study|Non-compliance to study protocol|0|||
94705599|NCT03646123|324378962|FG000|Overall Study|Ineligible due to progression during screening|0|||
94705600|NCT03646123|324378963|FG001|Overall Study|Ineligible due to progression during screening|0|||
94705601|NCT03646123|324378964|FG002|Overall Study|Ineligible due to progression during screening|1|||
94705602|NCT03646123|324378962|FG000|Overall Study|Withdrawal by Subject|2|||
94705603|NCT03646123|324378963|FG001|Overall Study|Withdrawal by Subject|1|||
94705604|NCT03646123|324378964|FG002|Overall Study|Withdrawal by Subject|3|||
94705605|NCT03646123|324378962|FG000|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
94705606|NCT03646123|324378963|FG001|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
94705607|NCT03646123|324378964|FG002|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|1|||
94705608|NCT03646123|324378962|FG000|Overall Study|Death|2|||
94705609|NCT03646123|324378963|FG001|Overall Study|Death|1|||
94705610|NCT03646123|324378964|FG002|Overall Study|Death|1|||
94705611|NCT03646123|324378962|FG000|Overall Study|Lost to Follow-up|4|||
94705612|NCT03646123|324378963|FG001|Overall Study|Lost to Follow-up|7|||
94705613|NCT03646123|324378964|FG002|Overall Study|Lost to Follow-up|6|||
94705614|NCT03646123|324378962|FG000|Overall Study|Participants in long term follow-up|0|||
94705615|NCT03646123|324378963|FG001|Overall Study|Participants in long term follow-up|48|||
94705616|NCT03646123|324378964|FG002|Overall Study|Participants in long term follow-up|144|||
94705617|NCT04860258|324378965|FG000|Overall Study|Withdrawal by Subject|0|||
94705618|NCT04860258|324378966|FG001|Overall Study|Withdrawal by Subject|0|||
94705619|NCT04860258|324378967|FG002|Overall Study|Withdrawal by Subject|4|||
94705620|NCT04860258|324378968|FG003|Overall Study|Withdrawal by Subject|1|||
94705621|NCT04860258|324378969|FG004|Overall Study|Withdrawal by Subject|4|||
94705622|NCT04860258|324378970|FG005|Overall Study|Withdrawal by Subject|1|||
94705623|NCT04860258|324378971|FG006|Overall Study|Withdrawal by Subject|0|||
94705624|NCT01259102|324378974|FG000|Overall Study|Adverse Event|1|||
94705625|NCT01259102|324378975|FG001|Overall Study|Adverse Event|0|||
94705626|NCT01259102|324378976|FG002|Overall Study|Adverse Event|1|||
94705627|NCT01259102|324378977|FG003|Overall Study|Adverse Event|1|||
94705628|NCT01259102|324378978|FG004|Overall Study|Adverse Event|0|||
94705629|NCT01259102|324378974|FG000|Overall Study|Other|0|||
94705630|NCT01259102|324378975|FG001|Overall Study|Other|0|||
94705631|NCT01259102|324378976|FG002|Overall Study|Other|1|||
94705632|NCT01259102|324378977|FG003|Overall Study|Other|1|||
94705633|NCT01259102|324378978|FG004|Overall Study|Other|1|||
94705634|NCT00357396|324378981|FG000|Overall Study|Adverse Event|1|||
94705635|NCT00357396|324378982|FG001|Overall Study|Adverse Event|0|||
94705636|NCT01956669|324378983|FG000|Overall Study|Disease Progression|12|||
94705637|NCT01956669|324378984|FG001|Overall Study|Disease Progression|7|||
94705638|NCT01956669|324378985|FG002|Overall Study|Disease Progression|7|||
94705639|NCT01956669|324378986|FG003|Overall Study|Disease Progression|8|||
94705640|NCT01956669|324378987|FG004|Overall Study|Disease Progression|4|||
94705641|NCT01956669|324378988|FG005|Overall Study|Disease Progression|3|||
94705642|NCT01956669|324378989|FG006|Overall Study|Disease Progression|5|||
94705643|NCT01956669|324378983|FG000|Overall Study|Adverse Event|0|||
94705644|NCT01956669|324378984|FG001|Overall Study|Adverse Event|2|||
94705645|NCT01956669|324378985|FG002|Overall Study|Adverse Event|2|||
94705646|NCT01956669|324378986|FG003|Overall Study|Adverse Event|1|||
94705647|NCT01956669|324378987|FG004|Overall Study|Adverse Event|0|||
94705648|NCT01956669|324378988|FG005|Overall Study|Adverse Event|0|||
94705649|NCT01956669|324378989|FG006|Overall Study|Adverse Event|0|||
94705650|NCT01956669|324378983|FG000|Overall Study|Physician Decision|0|||
94705651|NCT01956669|324378984|FG001|Overall Study|Physician Decision|2|||
94705652|NCT01956669|324378985|FG002|Overall Study|Physician Decision|0|||
94705653|NCT01956669|324378986|FG003|Overall Study|Physician Decision|0|||
94705654|NCT01956669|324378987|FG004|Overall Study|Physician Decision|0|||
94705655|NCT01956669|324378988|FG005|Overall Study|Physician Decision|1|||
94705656|NCT01956669|324378989|FG006|Overall Study|Physician Decision|0|||
94705657|NCT01956669|324378983|FG000|Overall Study|Withdrawal by Subject|0|||
94705658|NCT01956669|324378984|FG001|Overall Study|Withdrawal by Subject|0|||
94705659|NCT01956669|324378985|FG002|Overall Study|Withdrawal by Subject|1|||
94705660|NCT01956669|324378986|FG003|Overall Study|Withdrawal by Subject|1|||
94705661|NCT01956669|324378987|FG004|Overall Study|Withdrawal by Subject|0|||
94705662|NCT01956669|324378988|FG005|Overall Study|Withdrawal by Subject|0|||
94705663|NCT01956669|324378989|FG006|Overall Study|Withdrawal by Subject|1|||
94705664|NCT00864682|324378993|FG000|Overall Study|Protocol Violation|2|||
94705665|NCT00864682|324378994|FG001|Overall Study|Protocol Violation|1|||
94705666|NCT00864682|324378995|FG002|Overall Study|Protocol Violation|2|||
94705667|NCT01585038|324378996|FG000|Overall Study|Adverse Event|2|||
94705668|NCT01585038|324378997|FG001|Overall Study|Adverse Event|2|||
94705669|NCT04107805|324378998|FG000|Overall Study|Adverse Event|0|||
94705670|NCT04107805|324378999|FG001|Overall Study|Adverse Event|0|||
94705671|NCT04107805|324379000|FG002|Overall Study|Adverse Event|0|||
94705672|NCT04107805|324379001|FG003|Overall Study|Adverse Event|1|||
94705673|NCT04107805|324379002|FG004|Overall Study|Adverse Event|0|||
94705674|NCT04107805|324379003|FG005|Overall Study|Adverse Event|1|||
94705675|NCT04107805|324379004|FG006|Overall Study|Adverse Event|0|||
94705676|NCT04107805|324379005|FG007|Overall Study|Adverse Event|0|||
94705677|NCT04107805|324379006|FG008|Overall Study|Adverse Event|1|||
94705678|NCT01370694|324379018|FG000|Overall Study|Switched to rituximab|4|||
94705679|NCT01370694|324379018|FG000|Overall Study|Progressive disease|2|||
94705680|NCT02736799|324379019|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
94705681|NCT02736799|324379020|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
94705682|NCT02736799|324379021|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
94705683|NCT02736799|324379022|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
94705684|NCT02595398|324379023|FG000|Overall Study|Non-compliance|1|||
94705685|NCT02595398|324379024|FG001|Overall Study|Non-compliance|0|||
94705686|NCT02595398|324379023|FG000|Overall Study|Withdrawal by Subject|2|||
94705687|NCT02595398|324379024|FG001|Overall Study|Withdrawal by Subject|1|||
94705688|NCT02595398|324379023|FG000|Overall Study|Lost to Follow-up|1|||
94705689|NCT02595398|324379024|FG001|Overall Study|Lost to Follow-up|0|||
94705690|NCT01833832|324379025|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
94705691|NCT01156116|324379026|FG000|Overall Study|Withdrawal by Subject|3|||
94266669|NCT02460497|322771941|FG000|Overall Study|Investigator Decision|1|||
94266670|NCT00659529|322771942|FG000|Overall Study|Withdrawal by Subject|4|||
94266671|NCT00659529|322771942|FG000|Overall Study|Protocol Violation|3|||
94266672|NCT00659529|322771942|FG000|Overall Study|Screen failure|9|||
94266673|NCT03627767|322771945|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
94266674|NCT03627767|322771946|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
94266675|NCT03627767|322771947|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
94266676|NCT03627767|322771948|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
94266677|NCT03627767|322771949|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
94266678|NCT03627767|322771945|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
94266679|NCT03627767|322771946|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
94266680|NCT03627767|322771947|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
94266681|NCT03627767|322771948|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
94266682|NCT03627767|322771949|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
94266683|NCT03627767|322771945|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
94266684|NCT03627767|322771946|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
94266685|NCT03627767|322771947|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
94266686|NCT03627767|322771948|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
94266687|NCT03627767|322771949|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
94705692|NCT01156116|324379027|FG001|Overall Study|Withdrawal by Subject|1|||
94705693|NCT01156116|324379026|FG000|Overall Study|CPAP intolerance|2|||
94705694|NCT01156116|324379027|FG001|Overall Study|CPAP intolerance|0|||
94705695|NCT01193153|324379028|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
94705696|NCT01193153|324379029|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
94705697|NCT01193153|324379028|FG000|Open-label Lead in Period|Pregnancy|1|||
94705698|NCT01193153|324379029|FG001|Open-label Lead in Period|Pregnancy|0|||
94705699|NCT01193153|324379028|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
94705700|NCT01193153|324379029|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
94705701|NCT01193153|324379028|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
94705702|NCT01193153|324379029|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
94705703|NCT01193153|324379028|FG000|Open-label Lead in Period|Other|14|||
94705704|NCT01193153|324379029|FG001|Open-label Lead in Period|Other|0|||
94705705|NCT01193153|324379028|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
94705706|NCT01193153|324379029|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
94705707|NCT01193153|324379028|FG000|Open-label Lead in Period|Adverse Event|41|||
94705708|NCT01193153|324379029|FG001|Open-label Lead in Period|Adverse Event|0|||
94705709|NCT01193153|324379028|FG000|Open-label Lead in Period|Death|1|||
94705710|NCT01193153|324379029|FG001|Open-label Lead in Period|Death|0|||
94705711|NCT01193153|324379028|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
94705712|NCT01193153|324379029|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
94705713|NCT01193153|324379028|FG000|Open-label Stabilization Period|Adverse Event|9|||
94705714|NCT01193153|324379029|FG001|Open-label Stabilization Period|Adverse Event|0|||
94705715|NCT01193153|324379028|FG000|Open-label Stabilization Period|Death|2|||
94705716|NCT01193153|324379029|FG001|Open-label Stabilization Period|Death|0|||
94705717|NCT01193153|324379028|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
94705718|NCT01193153|324379029|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
94705719|NCT01193153|324379028|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
94705720|NCT01193153|324379029|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
94705721|NCT01193153|324379028|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
94705722|NCT01193153|324379029|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
94705723|NCT01193153|324379028|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
94705724|NCT01193153|324379029|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
94705725|NCT01193153|324379028|FG000|Open-label Stabilization Period|Other|8|||
94705726|NCT01193153|324379029|FG001|Open-label Stabilization Period|Other|0|||
94705727|NCT01193153|324379028|FG000|Double Blind Relapse Prevention Period|Other|2|||
94705728|NCT01193153|324379029|FG001|Double Blind Relapse Prevention Period|Other|3|||
94705729|NCT01193153|324379028|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
94705730|NCT01193153|324379029|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
94705731|NCT01193153|324379028|FG000|Double Blind Relapse Prevention Period|Death|2|||
94705732|NCT01193153|324379029|FG001|Double Blind Relapse Prevention Period|Death|0|||
94705733|NCT01193153|324379028|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
94266688|NCT03627767|322771945|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
94705734|NCT01193153|324379029|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
94705735|NCT01193153|324379028|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
94705736|NCT01193153|324379029|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
94705737|NCT01193153|324379028|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
94705738|NCT01193153|324379029|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
94266689|NCT03627767|322771946|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
94266690|NCT03627767|322771947|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
94705739|NCT01193153|324379028|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
94705740|NCT01193153|324379029|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
94705741|NCT01193153|324379028|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
94705742|NCT01193153|324379029|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
94705743|NCT01648140|324379030|FG000|Overall Study|Physician Decision|1|||
94705744|NCT01648140|324379031|FG001|Overall Study|Physician Decision|0|||
94705745|NCT01648140|324379032|FG002|Overall Study|Physician Decision|0|||
94705746|NCT01648140|324379033|FG003|Overall Study|Physician Decision|0|||
94705747|NCT01648140|324379030|FG000|Overall Study|Lack of Efficacy|4|||
94705748|NCT01648140|324379031|FG001|Overall Study|Lack of Efficacy|7|||
94705749|NCT01648140|324379032|FG002|Overall Study|Lack of Efficacy|1|||
94705750|NCT01648140|324379033|FG003|Overall Study|Lack of Efficacy|0|||
94705751|NCT01648140|324379030|FG000|Overall Study|Adverse Event|3|||
94705752|NCT01648140|324379031|FG001|Overall Study|Adverse Event|1|||
94705753|NCT01648140|324379032|FG002|Overall Study|Adverse Event|2|||
94705754|NCT01648140|324379033|FG003|Overall Study|Adverse Event|0|||
94705755|NCT01648140|324379030|FG000|Overall Study|Withdrawal by Subject|2|||
94705756|NCT01648140|324379031|FG001|Overall Study|Withdrawal by Subject|3|||
94705757|NCT01648140|324379032|FG002|Overall Study|Withdrawal by Subject|3|||
94705758|NCT01648140|324379033|FG003|Overall Study|Withdrawal by Subject|2|||
94705759|NCT01648140|324379030|FG000|Overall Study|Lost to Follow-up|2|||
94705760|NCT01648140|324379031|FG001|Overall Study|Lost to Follow-up|1|||
94705761|NCT01648140|324379032|FG002|Overall Study|Lost to Follow-up|2|||
94705762|NCT01648140|324379033|FG003|Overall Study|Lost to Follow-up|0|||
94705763|NCT00906035|324379036|FG000|Overall Study|Withdrawal by Subject|2|||
94705764|NCT00906035|324379037|FG001|Overall Study|Withdrawal by Subject|3|||
94705765|NCT00906035|324379038|FG002|Overall Study|Withdrawal by Subject|0|||
94705766|NCT03058991|324379039|FG000|Overall Study|Lost to Follow-up|17|||
94705767|NCT03058991|324379040|FG001|Overall Study|Lost to Follow-up|12|||
94705768|NCT03058991|324379041|FG002|Overall Study|Lost to Follow-up|12|||
94705769|NCT03058991|324379039|FG000|Overall Study|Withdrawal by Subject|1|||
94705770|NCT03058991|324379040|FG001|Overall Study|Withdrawal by Subject|0|||
94705771|NCT03058991|324379041|FG002|Overall Study|Withdrawal by Subject|0|||
94705772|NCT00130637|324379042|FG000|Overall Study|Adverse Event|2|||
94705773|NCT00130637|324379042|FG000|Overall Study|Withdrawal by Subject|1|||
94705774|NCT00414648|324379046|FG000|Overall Study|Adverse Event|5|||
94705775|NCT00414648|324379047|FG001|Overall Study|Adverse Event|5|||
94705776|NCT00414648|324379046|FG000|Overall Study|Death|0|||
94705777|NCT00414648|324379047|FG001|Overall Study|Death|1|||
94705778|NCT00414648|324379046|FG000|Overall Study|Lack of Efficacy|0|||
94705779|NCT00414648|324379047|FG001|Overall Study|Lack of Efficacy|2|||
94705780|NCT00414648|324379046|FG000|Overall Study|Withdrawal by Subject|0|||
94705781|NCT00414648|324379047|FG001|Overall Study|Withdrawal by Subject|1|||
94705782|NCT00972504|324379049|FG000|Overall Study|Adverse Event|2|||
94705783|NCT00972504|324379049|FG000|Overall Study|Investigator discretion|1|||
94705784|NCT04246762|324379050|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
94705785|NCT02954848|324379051|FG000|Overall Study|Randomized but Not Treated|0|||
94705786|NCT02954848|324379052|FG001|Overall Study|Randomized but Not Treated|1|||
94705787|NCT02954848|324379051|FG000|Overall Study|Adverse Event|2|||
94705788|NCT02954848|324379052|FG001|Overall Study|Adverse Event|3|||
94705789|NCT02954848|324379051|FG000|Overall Study|Withdrawal by Participant|0|||
94705790|NCT02954848|324379052|FG001|Overall Study|Withdrawal by Participant|1|||
94705791|NCT03247543|324379053|FG000|Overall Study|Adverse Event|3|||
94705792|NCT03247543|324379054|FG001|Overall Study|Adverse Event|6|||
94705793|NCT03247543|324379055|FG002|Overall Study|Adverse Event|4|||
94705794|NCT03247543|324379053|FG000|Overall Study|Lost to Follow-up|10|||
94705795|NCT03247543|324379054|FG001|Overall Study|Lost to Follow-up|7|||
94705796|NCT03247543|324379055|FG002|Overall Study|Lost to Follow-up|8|||
94705797|NCT03247543|324379053|FG000|Overall Study|Consent withdrawn by caregiver|2|||
94705798|NCT03247543|324379054|FG001|Overall Study|Consent withdrawn by caregiver|2|||
94705799|NCT03247543|324379055|FG002|Overall Study|Consent withdrawn by caregiver|9|||
94705800|NCT03247543|324379053|FG000|Overall Study|Withdrawal by Subject|0|||
94705801|NCT03247543|324379054|FG001|Overall Study|Withdrawal by Subject|0|||
94705802|NCT03247543|324379055|FG002|Overall Study|Withdrawal by Subject|1|||
94705803|NCT03247543|324379053|FG000|Overall Study|Failure to Follow study procedures|1|||
94705804|NCT03247543|324379054|FG001|Overall Study|Failure to Follow study procedures|3|||
94705805|NCT03247543|324379055|FG002|Overall Study|Failure to Follow study procedures|1|||
94705806|NCT03247543|324379053|FG000|Overall Study|Lack of Efficacy|1|||
94705807|NCT03247543|324379054|FG001|Overall Study|Lack of Efficacy|0|||
94705808|NCT03247543|324379055|FG002|Overall Study|Lack of Efficacy|0|||
94705809|NCT03247543|324379053|FG000|Overall Study|Non-compliance with study visits|0|||
94705810|NCT03247543|324379054|FG001|Overall Study|Non-compliance with study visits|1|||
94705811|NCT03247543|324379055|FG002|Overall Study|Non-compliance with study visits|0|||
94705812|NCT02914522|324379056|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
94705813|NCT02914522|324379057|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
94705814|NCT02914522|324379058|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
94705815|NCT02914522|324379059|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
94705816|NCT02914522|324379060|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
94705817|NCT02914522|324379061|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
94705818|NCT02914522|324379062|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
94705819|NCT02914522|324379063|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
94705820|NCT02914522|324379064|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
94705821|NCT02914522|324379065|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
94705822|NCT02914522|324379066|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
94705823|NCT02914522|324379056|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
94705824|NCT02914522|324379057|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
94705825|NCT02914522|324379058|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
94705826|NCT02914522|324379059|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
94705827|NCT02914522|324379060|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
94705828|NCT02914522|324379061|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
94705829|NCT02914522|324379062|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
94705830|NCT02914522|324379063|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
94705831|NCT02914522|324379064|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
94705832|NCT02914522|324379065|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
94705833|NCT02914522|324379066|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
94705834|NCT02914522|324379056|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
94705835|NCT02914522|324379057|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
94705836|NCT02914522|324379058|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
94705837|NCT02914522|324379059|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
94705838|NCT02914522|324379060|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
94705839|NCT02914522|324379061|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
94705840|NCT02914522|324379062|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
94705841|NCT02914522|324379063|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
94705842|NCT02914522|324379064|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
94705843|NCT02914522|324379065|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
94705844|NCT02914522|324379066|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
94705845|NCT02914522|324379056|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
94705846|NCT02914522|324379057|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
94705847|NCT02914522|324379058|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
94705848|NCT02914522|324379059|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
94705849|NCT02914522|324379060|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
94266691|NCT03627767|322771948|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
94266692|NCT03627767|322771949|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
94266693|NCT03627767|322771945|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
94266694|NCT03627767|322771946|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
94266695|NCT03627767|322771947|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
94266696|NCT03627767|322771948|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
94266697|NCT03627767|322771949|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
94266698|NCT03627767|322771945|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
94266699|NCT03627767|322771946|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
94266700|NCT03627767|322771947|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
94266701|NCT03627767|322771948|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
94266702|NCT03627767|322771949|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
94266703|NCT03627767|322771945|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
94266704|NCT03627767|322771946|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
94266705|NCT03627767|322771947|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
94266706|NCT03627767|322771948|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
94266707|NCT03627767|322771949|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
94266708|NCT03627767|322771945|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
94266709|NCT03627767|322771946|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
94266710|NCT03627767|322771947|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
94266711|NCT03627767|322771948|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
94705850|NCT02914522|324379061|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
94705851|NCT02914522|324379062|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
94705852|NCT02914522|324379063|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
94705853|NCT02914522|324379064|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
94705854|NCT02914522|324379065|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
94705855|NCT02914522|324379066|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
94705856|NCT02914522|324379056|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
94705857|NCT02914522|324379057|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
94705858|NCT02914522|324379058|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
94705859|NCT02914522|324379059|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
94705860|NCT02914522|324379060|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
94705861|NCT02914522|324379061|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
94705862|NCT02914522|324379062|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
94705863|NCT02914522|324379063|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
94705864|NCT02914522|324379064|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
94705865|NCT02914522|324379065|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
94705866|NCT02914522|324379066|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
94705867|NCT02914522|324379056|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
94705868|NCT02914522|324379057|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
94705869|NCT02914522|324379058|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
94705870|NCT02914522|324379059|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
94705871|NCT02914522|324379060|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
94705872|NCT02914522|324379061|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
94705873|NCT02914522|324379062|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
94705874|NCT02914522|324379063|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
94705875|NCT02914522|324379064|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
94705876|NCT02914522|324379065|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
94705877|NCT02914522|324379066|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
94705878|NCT02914522|324379056|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
94705879|NCT02914522|324379057|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
94705880|NCT02914522|324379058|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
94705881|NCT02914522|324379059|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
94705882|NCT02914522|324379060|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
94705883|NCT02914522|324379061|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
94705884|NCT02914522|324379062|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
94705885|NCT02914522|324379063|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
94705886|NCT02914522|324379064|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
94705887|NCT02914522|324379065|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
94705888|NCT02914522|324379066|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
94705889|NCT02914522|324379056|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
94705890|NCT02914522|324379057|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
94705891|NCT02914522|324379058|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
94705892|NCT02914522|324379059|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
94705893|NCT02914522|324379060|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
94705894|NCT02914522|324379061|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
94705895|NCT02914522|324379062|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
94705896|NCT02914522|324379063|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
94705897|NCT02914522|324379064|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
94705898|NCT02914522|324379065|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
94705899|NCT02914522|324379066|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
94705900|NCT02914522|324379056|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
94705901|NCT02914522|324379057|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
94705902|NCT02914522|324379058|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
94705903|NCT02914522|324379059|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
94705904|NCT02914522|324379060|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
94705905|NCT02914522|324379061|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
94705906|NCT02914522|324379062|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
94705907|NCT02914522|324379063|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
94705908|NCT02914522|324379064|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
94705909|NCT02914522|324379065|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
94705910|NCT02914522|324379066|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
94705911|NCT02914522|324379056|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
94705912|NCT02914522|324379057|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
94705913|NCT02914522|324379058|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
94705914|NCT02914522|324379059|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
94705915|NCT02914522|324379060|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
94705916|NCT02914522|324379061|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
94705917|NCT02914522|324379062|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
94705918|NCT02914522|324379063|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
94366665|NCT00566631|323128122|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
94366666|NCT00566631|323128122|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
94705919|NCT02914522|324379064|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
94705920|NCT02914522|324379065|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
94705921|NCT02914522|324379066|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
94705922|NCT02914522|324379056|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
94705923|NCT02914522|324379057|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
94705924|NCT02914522|324379058|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
94705925|NCT02914522|324379059|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
94705926|NCT02914522|324379060|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
94705927|NCT02914522|324379061|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
94705928|NCT02914522|324379062|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
94705929|NCT02914522|324379063|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
94705930|NCT02914522|324379064|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
94705931|NCT02914522|324379065|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
94705932|NCT02914522|324379066|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
94705933|NCT02914522|324379056|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
94705934|NCT02914522|324379057|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
94705935|NCT02914522|324379058|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
94705936|NCT02914522|324379059|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
94705937|NCT02914522|324379060|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
94705938|NCT02914522|324379061|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
94705939|NCT02914522|324379062|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
94705940|NCT02914522|324379063|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
94705941|NCT02914522|324379064|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
94705942|NCT02914522|324379065|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
94705943|NCT02914522|324379066|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
94705944|NCT02914522|324379056|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
94705945|NCT02914522|324379057|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
94705946|NCT02914522|324379058|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
94705947|NCT02914522|324379059|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
94705948|NCT02914522|324379060|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
94705949|NCT02914522|324379061|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
94705950|NCT02914522|324379062|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
94705951|NCT02914522|324379063|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
94705952|NCT02914522|324379064|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
94705953|NCT02914522|324379065|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
94705954|NCT02914522|324379066|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
94705955|NCT02914522|324379056|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
94705956|NCT02914522|324379057|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
94705957|NCT02914522|324379058|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
94705958|NCT02914522|324379059|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
94705959|NCT02914522|324379060|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
94705960|NCT02914522|324379061|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
94705961|NCT02914522|324379062|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
94705962|NCT02914522|324379063|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
94705963|NCT02914522|324379064|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
94705964|NCT02914522|324379065|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
94705965|NCT02914522|324379066|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
94705966|NCT02914522|324379056|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
94705967|NCT02914522|324379057|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
94705968|NCT02914522|324379058|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
94705969|NCT02914522|324379059|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
94705970|NCT02914522|324379060|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
94705971|NCT02914522|324379061|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
94705972|NCT02914522|324379062|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
94705973|NCT02914522|324379063|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
94705974|NCT02914522|324379064|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
94266712|NCT03627767|322771949|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
94266713|NCT03627767|322771945|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
94266714|NCT03627767|322771946|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
94266715|NCT03627767|322771947|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
94266716|NCT03627767|322771948|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
94266717|NCT03627767|322771949|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
94266718|NCT03627767|322771945|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
94705975|NCT02914522|324379065|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
94705976|NCT02914522|324379066|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
94266719|NCT03627767|322771946|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
94266720|NCT03627767|322771947|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
94266721|NCT03627767|322771948|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
94266722|NCT03627767|322771949|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
94266723|NCT03627767|322771945|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
94266724|NCT03627767|322771946|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
94266725|NCT03627767|322771947|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
94266726|NCT03627767|322771948|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
94266727|NCT03627767|322771949|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
94266728|NCT03627767|322771945|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
94266729|NCT03627767|322771946|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
94266730|NCT03627767|322771947|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
94266731|NCT03627767|322771948|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
94266732|NCT03627767|322771949|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
94705977|NCT02914522|324379056|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
94705978|NCT02914522|324379057|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
94705979|NCT02914522|324379058|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
94705980|NCT02914522|324379059|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
94705981|NCT02914522|324379060|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
94705982|NCT02914522|324379061|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
94705983|NCT02914522|324379062|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
94705984|NCT02914522|324379063|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
94705985|NCT02914522|324379064|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
94705986|NCT02914522|324379065|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
94705987|NCT02914522|324379066|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
94705988|NCT01161498|324379067|FG000|Overall Study|Disease Progression|0|||
94705989|NCT01161498|324379068|FG001|Overall Study|Disease Progression|1|||
94705990|NCT03394027|324379076|FG000|Overall Study|Ineligible|3|||
94705991|NCT03394027|324379077|FG001|Overall Study|Ineligible|1|||
94705992|NCT03394027|324379078|FG002|Overall Study|Ineligible|3|||
94705993|NCT03394027|324379076|FG000|Overall Study|Participant declined to participate before treatment started|0|||
94705994|NCT03394027|324379077|FG001|Overall Study|Participant declined to participate before treatment started|0|||
94705995|NCT03394027|324379078|FG002|Overall Study|Participant declined to participate before treatment started|1|||
94705996|NCT04536077|324379081|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
94705997|NCT04536077|324379082|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
94705998|NCT04536077|324379081|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
94705999|NCT04536077|324379082|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
94706000|NCT03368001|324379084|FG000|Allocation|Lost to Pretest|16|||
94706001|NCT03368001|324379085|FG001|Allocation|Lost to Pretest|25|||
94706002|NCT03368001|324379084|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
94706003|NCT03368001|324379085|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
94706004|NCT03368001|324379084|FG000|Posttest|Lost to Posttest|7|||
94706005|NCT03368001|324379085|FG001|Posttest|Lost to Posttest|11|||
94706006|NCT03368001|324379084|FG000|Posttest|Discontinued Intervention|6|||
94706007|NCT03368001|324379085|FG001|Posttest|Discontinued Intervention|19|||
94706008|NCT03368001|324379084|FG000|Follow-up|Lost to Follow-up|6|||
94706009|NCT03368001|324379085|FG001|Follow-up|Lost to Follow-up|3|||
94706010|NCT02197234|324379086|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
94706011|NCT02197234|324379086|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
94706012|NCT02197234|324379086|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
94706013|NCT02197234|324379086|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
94706014|NCT02197234|324379086|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
94706015|NCT02197234|324379086|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
94706016|NCT02517307|324379088|FG000|Overall Study|Withdrawal by Subject|1|||
94706017|NCT02517307|324379089|FG001|Overall Study|Withdrawal by Subject|0|||
94706018|NCT02517307|324379090|FG002|Overall Study|Withdrawal by Subject|1|||
94706019|NCT02517307|324379091|FG003|Overall Study|Withdrawal by Subject|0|||
94706020|NCT02517307|324379088|FG000|Overall Study|Protocol Violation|0|||
94706021|NCT02517307|324379089|FG001|Overall Study|Protocol Violation|0|||
94706022|NCT02517307|324379090|FG002|Overall Study|Protocol Violation|1|||
94706023|NCT02517307|324379091|FG003|Overall Study|Protocol Violation|1|||
94706024|NCT05484726|324379092|FG000|Overall Study|Protocol Violation|3|||
94706025|NCT05484726|324379093|FG001|Overall Study|Protocol Violation|3|||
94706026|NCT05484726|324379092|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
94706027|NCT05484726|324379093|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
94706028|NCT05484726|324379092|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
94706029|NCT05484726|324379093|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
94706030|NCT05484726|324379092|FG000|Overall Study|continued need of mechanical ventilation|2|||
94706031|NCT05484726|324379093|FG001|Overall Study|continued need of mechanical ventilation|3|||
94706032|NCT05484726|324379092|FG000|Overall Study|Withdrawal by Subject|2|||
94706033|NCT05484726|324379093|FG001|Overall Study|Withdrawal by Subject|3|||
94706034|NCT05484726|324379092|FG000|Overall Study|IVH (G III & IV)|2|||
94706035|NCT05484726|324379093|FG001|Overall Study|IVH (G III & IV)|1|||
94706036|NCT05484726|324379092|FG000|Overall Study|NEC (stage II & III)|2|||
94706037|NCT05484726|324379093|FG001|Overall Study|NEC (stage II & III)|3|||
94706038|NCT03523091|324379103|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
94706039|NCT03523091|324379104|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
94706040|NCT03523091|324379103|FG000|Overall Study|Withdrawal by Subject|0|||
94706041|NCT03523091|324379104|FG001|Overall Study|Withdrawal by Subject|3|||
94706042|NCT03523091|324379103|FG000|Overall Study|Increase Botox dose|0|||
94706043|NCT03523091|324379104|FG001|Overall Study|Increase Botox dose|1|||
94706044|NCT01697319|324379110|FG000|Primary Phase|Withdrawal by Subject|1|||
94706045|NCT01697319|324379110|FG000|Extension Phase|Terminated by Sponsor|15|||
94706046|NCT04222959|324379112|FG000|Overall Study|Lost to Follow-up|76|||
94706047|NCT04222959|324379113|FG001|Overall Study|Lost to Follow-up|28|||
94706048|NCT00038103|324379114|FG000|Overall Study|Adverse Event|5|||
94706049|NCT00038103|324379115|FG001|Overall Study|Adverse Event|6|||
94706050|NCT00038103|324379114|FG000|Overall Study|Lack of Efficacy|48|||
94706051|NCT00038103|324379115|FG001|Overall Study|Lack of Efficacy|41|||
94706052|NCT00038103|324379114|FG000|Overall Study|Withdrawal by Subject|0|||
94706053|NCT00038103|324379115|FG001|Overall Study|Withdrawal by Subject|3|||
94706054|NCT00038103|324379114|FG000|Overall Study|Lost to Follow-up|0|||
94706055|NCT00038103|324379115|FG001|Overall Study|Lost to Follow-up|3|||
94706056|NCT00038103|324379114|FG000|Overall Study|Protocol Violation|0|||
94706057|NCT00038103|324379115|FG001|Overall Study|Protocol Violation|2|||
94706058|NCT00038103|324379114|FG000|Overall Study|Sponsor Decision|0|||
94706059|NCT00038103|324379115|FG001|Overall Study|Sponsor Decision|1|||
94706060|NCT00038103|324379114|FG000|Overall Study|Randomized/never treated|2|||
94706061|NCT00038103|324379115|FG001|Overall Study|Randomized/never treated|0|||
94706062|NCT03545984|324379118|FG000|Overall Study|CSF cases not present during rotation|11|||
94706063|NCT03545984|324379119|FG001|Overall Study|CSF cases not present during rotation|9|||
94706064|NCT00387465|324379120|FG000|Overall Study|Withdrawal by Subject|0|||
94706065|NCT00387465|324379121|FG001|Overall Study|Withdrawal by Subject|1|||
94706066|NCT00387465|324379122|FG002|Overall Study|Withdrawal by Subject|0|||
94706067|NCT00290706|324379123|FG000|Overall Study|Withdrawal by Subject|2|||
94706068|NCT00290706|324379124|FG001|Overall Study|Withdrawal by Subject|0|||
94706069|NCT00290706|324379125|FG002|Overall Study|Withdrawal by Subject|0|||
94706070|NCT00290706|324379126|FG003|Overall Study|Withdrawal by Subject|0|||
94706071|NCT00290706|324379123|FG000|Overall Study|Progressive Disease|3|||
94266733|NCT03627767|322771945|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
94266734|NCT03627767|322771946|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
94266735|NCT03627767|322771947|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
94266736|NCT03627767|322771948|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
94266737|NCT03627767|322771949|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
94466238|NCT01358578|323496955|FG004|Induction Period|Withdrawal by Subject|0|||
94706072|NCT00290706|324379124|FG001|Overall Study|Progressive Disease|5|||
94706073|NCT00290706|324379125|FG002|Overall Study|Progressive Disease|4|||
94706074|NCT00290706|324379126|FG003|Overall Study|Progressive Disease|10|||
94706075|NCT00290706|324379123|FG000|Overall Study|Adverse Event|0|||
94706076|NCT00290706|324379124|FG001|Overall Study|Adverse Event|1|||
94706077|NCT00290706|324379125|FG002|Overall Study|Adverse Event|2|||
94706078|NCT00290706|324379126|FG003|Overall Study|Adverse Event|0|||
94706079|NCT00290706|324379123|FG000|Overall Study|Receive auto transplant or radiation|0|||
94706080|NCT00290706|324379124|FG001|Overall Study|Receive auto transplant or radiation|0|||
94706081|NCT00290706|324379125|FG002|Overall Study|Receive auto transplant or radiation|0|||
94706082|NCT00290706|324379126|FG003|Overall Study|Receive auto transplant or radiation|1|||
94706083|NCT00290706|324379123|FG000|Overall Study|Physician Decision|0|||
94706084|NCT00290706|324379124|FG001|Overall Study|Physician Decision|0|||
94706085|NCT00290706|324379125|FG002|Overall Study|Physician Decision|0|||
94706086|NCT00290706|324379126|FG003|Overall Study|Physician Decision|1|||
94706087|NCT01196429|324379127|FG000|Overall Study|Ineligible - inadequate pathology|1|||
94706088|NCT01196429|324379128|FG001|Overall Study|Ineligible - inadequate pathology|0|||
94706089|NCT01196429|324379127|FG000|Overall Study|Ineligible - wrong cell type|1|||
94706090|NCT01196429|324379128|FG001|Overall Study|Ineligible - wrong cell type|0|||
94706091|NCT01196429|324379127|FG000|Overall Study|Refused - Never Treated|1|||
94706092|NCT01196429|324379128|FG001|Overall Study|Refused - Never Treated|0|||
94706093|NCT00172185|324380503|FG000|Overall Study|Adverse Event|0|||
94706094|NCT00172185|324380504|FG001|Overall Study|Adverse Event|1|||
94706095|NCT00172185|324380505|FG002|Overall Study|Adverse Event|3|||
94706096|NCT00172185|324380506|FG003|Overall Study|Adverse Event|4|||
94706097|NCT00172185|324380503|FG000|Overall Study|Physician Decision|0|||
94706098|NCT00172185|324380504|FG001|Overall Study|Physician Decision|0|||
94706099|NCT00172185|324380505|FG002|Overall Study|Physician Decision|1|||
94706100|NCT00172185|324380506|FG003|Overall Study|Physician Decision|0|||
94706101|NCT00172185|324380503|FG000|Overall Study|SPONSOR Decision|0|||
94706102|NCT00172185|324380504|FG001|Overall Study|SPONSOR Decision|1|||
94706103|NCT00172185|324380505|FG002|Overall Study|SPONSOR Decision|0|||
94706104|NCT00172185|324380506|FG003|Overall Study|SPONSOR Decision|0|||
94706105|NCT00172185|324380503|FG000|Overall Study|Withdrawal by Subject|0|||
94706106|NCT00172185|324380504|FG001|Overall Study|Withdrawal by Subject|0|||
94706107|NCT00172185|324380505|FG002|Overall Study|Withdrawal by Subject|1|||
94706108|NCT00172185|324380506|FG003|Overall Study|Withdrawal by Subject|0|||
94706109|NCT02968004|324380507|FG000|Overall Study|Adverse Event|1|||
94706110|NCT02968004|324380508|FG001|Overall Study|Adverse Event|0|||
94706111|NCT02968004|324380507|FG000|Overall Study|Withdrawal by Subject|0|||
94706112|NCT02968004|324380508|FG001|Overall Study|Withdrawal by Subject|1|||
94706113|NCT01185522|324380509|FG000|Overall Study|Lack of Efficacy|28|||
94706114|NCT01185522|324380509|FG000|Overall Study|Lost to Follow-up|19|||
94706115|NCT01185522|324380509|FG000|Overall Study|Withdrawal by Subject|10|||
94706116|NCT01185522|324380509|FG000|Overall Study|Poor tolerance|39|||
94706117|NCT01185522|324380509|FG000|Overall Study|Other reasons|12|||
94706118|NCT00109967|324380510|FG000|Overall Study|Cancel Prior to Treatment|2|||
94706119|NCT00109967|324380511|FG001|Overall Study|Cancel Prior to Treatment|0|||
94706120|NCT00109967|324380510|FG000|Overall Study|Adverse Event|12|||
94706121|NCT00109967|324380511|FG001|Overall Study|Adverse Event|1|||
94706122|NCT00109967|324380510|FG000|Overall Study|Withdrawal by Subject|5|||
94706123|NCT00109967|324380511|FG001|Overall Study|Withdrawal by Subject|0|||
94706124|NCT00109967|324380510|FG000|Overall Study|Physician Decision|1|||
94706125|NCT00109967|324380511|FG001|Overall Study|Physician Decision|3|||
94706126|NCT00109967|324380510|FG000|Overall Study|Death|0|||
94706127|NCT00109967|324380511|FG001|Overall Study|Death|2|||
94706128|NCT01897233|324380512|FG000|Part B (24 Weeks)|Adverse Event|1|||
94706129|NCT01897233|324380512|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
94706130|NCT01897233|324380512|FG000|Part B (24 Weeks)|Physician Decision|1|||
94706131|NCT01117480|324380513|FG000|Overall Study|Protocol Violation|8|||
94466239|NCT01358578|323496956|FG005|Induction Period|Withdrawal by Subject|0|||
94466240|NCT01358578|323496951|FG000|Maintenance Period|Adverse Event|2|||
94706132|NCT01117480|324380513|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
94706133|NCT02131324|324380514|FG000|Overall Study|Withdrawal by Subject|1|||
94706134|NCT02131324|324380515|FG001|Overall Study|Withdrawal by Subject|2|||
94706135|NCT02131324|324380514|FG000|Overall Study|Lost to Follow-up|1|||
94706136|NCT02131324|324380515|FG001|Overall Study|Lost to Follow-up|1|||
94706137|NCT00891618|324380516|FG000|Overall Study|Withdrawal by Subject|1|||
94706138|NCT01131494|324380517|FG000|Overall Study|Withdrawal by Subject|2|||
94706139|NCT00868192|324380518|FG000|Overall Study|Ineligible|4|||
94706140|NCT01191086|324380520|FG000|Overall Study|Adverse Event|20|||
94706141|NCT01191086|324380520|FG000|Overall Study|Lack of Efficacy|10|||
94706142|NCT01191086|324380520|FG000|Overall Study|Lost to Follow-up|4|||
94706143|NCT01191086|324380520|FG000|Overall Study|Physician Decision|2|||
94706144|NCT01191086|324380520|FG000|Overall Study|Withdrawal by Subject|24|||
94706145|NCT01191086|324380520|FG000|Overall Study|Discontinuation criterion met|1|||
94706146|NCT01191086|324380520|FG000|Overall Study|Other|1|||
94706147|NCT00290732|324380523|FG000|Overall Study|Inability to instill drug intraductally.|0|||
94706148|NCT00290732|324380524|FG001|Overall Study|Inability to instill drug intraductally.|1|||
94706149|NCT00290732|324380525|FG002|Overall Study|Inability to instill drug intraductally.|1|||
94706150|NCT00290732|324380526|FG003|Overall Study|Inability to instill drug intraductally.|0|||
94706151|NCT00290732|324380527|FG004|Overall Study|Inability to instill drug intraductally.|0|||
94706152|NCT02393716|324380528|FG000|Overall Study|Death|29|||
94706153|NCT02393716|324380528|FG000|Overall Study|Withdrawal by Subject|8|||
94706154|NCT02393716|324380528|FG000|Overall Study|Device Explanted|8|||
94706155|NCT02393716|324380528|FG000|Overall Study|Missed visit|16|||
94706156|NCT02046616|324380529|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
94706157|NCT02046616|324380529|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
94706158|NCT02046616|324380529|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
94706159|NCT02046616|324380529|FG000|24-Week Treatment Period|Physician Decision|3|||
94706160|NCT02046616|324380529|FG000|24-Week Treatment Period|Other|1|||
94706161|NCT02046616|324380529|FG000|8-Week FU Period|Lost to Follow-up|1|||
94706162|NCT02503202|324380533|FG000|Base Study: Up to Month 6|Death|1|||
94706163|NCT02503202|324380534|FG001|Base Study: Up to Month 6|Death|1|||
94706164|NCT02503202|324380535|FG002|Base Study: Up to Month 6|Death|0|||
94706165|NCT02503202|324380536|FG003|Base Study: Up to Month 6|Death|0|||
94706166|NCT02503202|324380537|FG004|Base Study: Up to Month 6|Death|0|||
94706167|NCT02503202|324380533|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
94706168|NCT02503202|324380534|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
94706169|NCT02503202|324380535|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
94706170|NCT02503202|324380536|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
94706171|NCT02503202|324380537|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
94706172|NCT02503202|324380533|FG000|Base Study: Up to Month 6|Physician Decision|0|||
94706173|NCT02503202|324380534|FG001|Base Study: Up to Month 6|Physician Decision|0|||
94706174|NCT02503202|324380535|FG002|Base Study: Up to Month 6|Physician Decision|0|||
94706175|NCT02503202|324380536|FG003|Base Study: Up to Month 6|Physician Decision|0|||
94706176|NCT02503202|324380537|FG004|Base Study: Up to Month 6|Physician Decision|1|||
94706177|NCT02503202|324380533|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
94706178|NCT02503202|324380534|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
94706179|NCT02503202|324380535|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
94706180|NCT02503202|324380536|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
94706181|NCT02503202|324380537|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
94706182|NCT02503202|324380533|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
94706183|NCT02503202|324380534|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
94706184|NCT02503202|324380535|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
94706185|NCT02503202|324380536|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
94706186|NCT02503202|324380537|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
94706187|NCT02503202|324380533|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
94706188|NCT02503202|324380534|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
94706189|NCT02503202|324380535|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
94706190|NCT02503202|324380536|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
94706191|NCT02503202|324380537|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
94706192|NCT02503202|324380533|FG000|Extension: Month 6 to 24|Death|1|||
94706193|NCT02503202|324380534|FG001|Extension: Month 6 to 24|Death|0|||
94706194|NCT02503202|324380535|FG002|Extension: Month 6 to 24|Death|0|||
94706195|NCT02503202|324380536|FG003|Extension: Month 6 to 24|Death|0|||
94706196|NCT02503202|324380537|FG004|Extension: Month 6 to 24|Death|0|||
94706197|NCT02503202|324380533|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
94706198|NCT02503202|324380534|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
94706199|NCT02503202|324380535|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
94706200|NCT02503202|324380536|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
94706201|NCT02503202|324380537|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
94706202|NCT02503202|324380533|FG000|Extension: Month 6 to 24|Physician Decision|1|||
94706203|NCT02503202|324380534|FG001|Extension: Month 6 to 24|Physician Decision|0|||
94706204|NCT02503202|324380535|FG002|Extension: Month 6 to 24|Physician Decision|1|||
94706205|NCT02503202|324380536|FG003|Extension: Month 6 to 24|Physician Decision|3|||
94706206|NCT02503202|324380537|FG004|Extension: Month 6 to 24|Physician Decision|0|||
94706207|NCT02503202|324380533|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
94266738|NCT03627767|322771945|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
94266739|NCT03627767|322771946|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
94266740|NCT03627767|322771947|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
94266741|NCT03627767|322771948|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
94266742|NCT03627767|322771949|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
94266743|NCT03627767|322771945|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
94266744|NCT03627767|322771946|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
94266745|NCT03627767|322771947|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
94266746|NCT03627767|322771948|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
94266747|NCT03627767|322771949|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
94266748|NCT03627767|322771945|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
94266749|NCT03627767|322771946|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
94266750|NCT03627767|322771947|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
94266751|NCT03627767|322771948|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
94266752|NCT03627767|322771949|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
94266753|NCT03627767|322771945|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
94266754|NCT03627767|322771946|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
94266755|NCT03627767|322771947|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
94266756|NCT03627767|322771948|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
94266757|NCT03627767|322771949|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
94266758|NCT03627767|322771945|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
94266759|NCT03627767|322771946|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
94266760|NCT03627767|322771947|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
94266761|NCT03627767|322771948|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
94266762|NCT03627767|322771949|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
94266763|NCT03627767|322771945|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
94266764|NCT03627767|322771946|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
94266765|NCT03627767|322771947|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
94266766|NCT03627767|322771948|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
94266767|NCT03627767|322771949|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
94266768|NCT03627767|322771945|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
94266769|NCT03627767|322771946|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
94266770|NCT03627767|322771947|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
94266771|NCT03627767|322771948|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
94266772|NCT03627767|322771949|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
94266773|NCT01873417|322771950|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
94266774|NCT01873417|322771950|FG000|Overall Study|Adverse Event|24|||
94266775|NCT01873417|322771950|FG000|Overall Study|Lost to Follow-up|2|||
94266776|NCT01873417|322771950|FG000|Overall Study|Withdrawal by Subject|2|||
94266777|NCT01873417|322771950|FG000|Overall Study|Physician Decision|3|||
94266778|NCT01798992|322771951|FG000|Overall Study|Administrative withdrawal|0|||
94266779|NCT01798992|322771952|FG001|Overall Study|Administrative withdrawal|1|||
94266780|NCT01798992|322771953|FG002|Overall Study|Administrative withdrawal|0|||
94266781|NCT01798992|322771954|FG003|Overall Study|Administrative withdrawal|1|||
94266782|NCT01798992|322771951|FG000|Overall Study|Lost to Follow-up|0|||
94266783|NCT01798992|322771952|FG001|Overall Study|Lost to Follow-up|1|||
94266784|NCT01798992|322771953|FG002|Overall Study|Lost to Follow-up|1|||
94266785|NCT01798992|322771954|FG003|Overall Study|Lost to Follow-up|0|||
94466241|NCT01358578|323496952|FG001|Maintenance Period|Adverse Event|7|||
94466242|NCT01358578|323496953|FG002|Maintenance Period|Adverse Event|0|||
94466243|NCT01358578|323496954|FG003|Maintenance Period|Adverse Event|6|||
94706208|NCT02503202|324380534|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
94706209|NCT02503202|324380535|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
94266786|NCT01798992|322771951|FG000|Overall Study|Insufficient biopsy tissue|0|||
94266787|NCT01798992|322771952|FG001|Overall Study|Insufficient biopsy tissue|0|||
94266788|NCT01798992|322771953|FG002|Overall Study|Insufficient biopsy tissue|1|||
94266789|NCT01798992|322771954|FG003|Overall Study|Insufficient biopsy tissue|0|||
94266790|NCT01688466|322771955|FG000|Overall Study|Withdrawal by Subject|2|||
94266791|NCT01688466|322771956|FG001|Overall Study|Withdrawal by Subject|1|||
94266792|NCT01688466|322771955|FG000|Overall Study|Death|0|||
94266793|NCT01688466|322771956|FG001|Overall Study|Death|1|||
94266794|NCT01688466|322771955|FG000|Overall Study|Adverse Event|0|||
94266795|NCT01688466|322771956|FG001|Overall Study|Adverse Event|4|||
94266796|NCT01688466|322771955|FG000|Overall Study|Not evaluable|0|||
94266797|NCT01688466|322771956|FG001|Overall Study|Not evaluable|1|||
94266798|NCT01205438|322771957|FG000|Overall Study|Adverse Event|19|||
94266799|NCT01205438|322771958|FG001|Overall Study|Adverse Event|17|||
94266800|NCT01205438|322771959|FG002|Overall Study|Adverse Event|24|||
94266801|NCT01205438|322771957|FG000|Overall Study|Death|1|||
94266802|NCT01205438|322771958|FG001|Overall Study|Death|1|||
94266803|NCT01205438|322771959|FG002|Overall Study|Death|3|||
94466244|NCT01358578|323496955|FG004|Maintenance Period|Adverse Event|4|||
94706210|NCT02503202|324380536|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
94706211|NCT02503202|324380537|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
94706212|NCT01050569|324380548|FG000|Overall Study|Lost to Follow-up|20|||
94706213|NCT01050569|324380549|FG001|Overall Study|Lost to Follow-up|14|||
94706214|NCT01050569|324380550|FG002|Overall Study|Lost to Follow-up|16|||
94706215|NCT01050569|324380548|FG000|Overall Study|Withdrawal by Subject|9|||
94706216|NCT01050569|324380549|FG001|Overall Study|Withdrawal by Subject|3|||
94706217|NCT01050569|324380550|FG002|Overall Study|Withdrawal by Subject|11|||
94706218|NCT01050569|324380548|FG000|Overall Study|Lack of Efficacy|5|||
94706219|NCT01050569|324380549|FG001|Overall Study|Lack of Efficacy|4|||
94706220|NCT01050569|324380550|FG002|Overall Study|Lack of Efficacy|3|||
94706221|NCT01050569|324380548|FG000|Overall Study|Adverse Event|1|||
94706222|NCT01050569|324380549|FG001|Overall Study|Adverse Event|0|||
94706223|NCT01050569|324380550|FG002|Overall Study|Adverse Event|0|||
94706224|NCT01050569|324380548|FG000|Overall Study|Physician Decision|3|||
94706225|NCT01050569|324380549|FG001|Overall Study|Physician Decision|3|||
94706226|NCT01050569|324380550|FG002|Overall Study|Physician Decision|3|||
94706227|NCT04493242|324380554|FG000|Overall Study|Death|10|||
94706228|NCT04493242|324380555|FG001|Overall Study|Death|14|||
94706229|NCT04493242|324380556|FG002|Overall Study|Death|16|||
94706230|NCT04493242|324380554|FG000|Overall Study|Lost to Follow-up|1|||
94706231|NCT04493242|324380555|FG001|Overall Study|Lost to Follow-up|1|||
94706232|NCT04493242|324380556|FG002|Overall Study|Lost to Follow-up|0|||
94706233|NCT04493242|324380554|FG000|Overall Study|Withdrawal by Subject|1|||
94706234|NCT04493242|324380555|FG001|Overall Study|Withdrawal by Subject|0|||
94706235|NCT04493242|324380556|FG002|Overall Study|Withdrawal by Subject|0|||
94706236|NCT04493242|324380554|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
94706237|NCT04493242|324380555|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
94706238|NCT04493242|324380556|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
94706239|NCT04493242|324380554|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
94706240|NCT04493242|324380555|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
94706241|NCT04493242|324380556|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
94706242|NCT04379713|324380559|FG000|Overall Study|Adverse Event|2|||
94706243|NCT04379713|324380560|FG001|Overall Study|Adverse Event|0|||
94706244|NCT04379713|324380559|FG000|Overall Study|Physician Decision|2|||
94706245|NCT04379713|324380560|FG001|Overall Study|Physician Decision|1|||
94706246|NCT04379713|324380559|FG000|Overall Study|Protocol Violation|11|||
94706247|NCT04379713|324380560|FG001|Overall Study|Protocol Violation|6|||
94706248|NCT04379713|324380559|FG000|Overall Study|No longer met eligibility criteria|14|||
94706249|NCT04379713|324380560|FG001|Overall Study|No longer met eligibility criteria|11|||
94706250|NCT04379713|324380559|FG000|Overall Study|Withdrawal by parent/guardian|36|||
94706251|NCT04379713|324380560|FG001|Overall Study|Withdrawal by parent/guardian|15|||
94706252|NCT04379713|324380559|FG000|Overall Study|Lost to Follow-up|31|||
94706253|NCT04379713|324380560|FG001|Overall Study|Lost to Follow-up|21|||
94706254|NCT02148133|324380563|FG000|Overall Study|Investigator discretion|1|||
94706255|NCT02148133|324380563|FG000|Overall Study|Lack of Efficacy|1|||
94706256|NCT02148133|324380563|FG000|Overall Study|Protocol deviation|1|||
94706257|NCT02148133|324380563|FG000|Overall Study|Protocol-defined stopping criteria|2|||
94706258|NCT03808883|324380564|FG000|Overall Study|Withdrawal by Subject|2|||
94706259|NCT03808883|324380565|FG001|Overall Study|Withdrawal by Subject|0|||
94706260|NCT03808883|324380564|FG000|Overall Study|Did not complete pre test or post test survey|4|||
94706261|NCT03808883|324380565|FG001|Overall Study|Did not complete pre test or post test survey|3|||
94706262|NCT02371746|324380567|FG000|Overall Study|Consent withdrawn|0|||
94706263|NCT02371746|324380568|FG001|Overall Study|Consent withdrawn|0|||
94706264|NCT02371746|324380569|FG002|Overall Study|Consent withdrawn|0|||
94706265|NCT02371746|324380570|FG003|Overall Study|Consent withdrawn|0|||
94706266|NCT02371746|324380571|FG004|Overall Study|Consent withdrawn|0|||
94706267|NCT02371746|324380572|FG005|Overall Study|Consent withdrawn|0|||
94706268|NCT02371746|324380573|FG006|Overall Study|Consent withdrawn|1|||
94706269|NCT00612586|324380575|FG000|Overall Study|Adverse Event|6|||
94706270|NCT00612586|324380576|FG001|Overall Study|Adverse Event|2|||
94706271|NCT00612586|324380575|FG000|Overall Study|Death|1|||
94706272|NCT00612586|324380576|FG001|Overall Study|Death|0|||
94706273|NCT00612586|324380575|FG000|Overall Study|Entry Criteria Not Met|0|||
94706274|NCT00612586|324380576|FG001|Overall Study|Entry Criteria Not Met|2|||
94706275|NCT00612586|324380575|FG000|Overall Study|Withdrawal by Subject|7|||
94706276|NCT00612586|324380576|FG001|Overall Study|Withdrawal by Subject|9|||
94706277|NCT00612586|324380575|FG000|Overall Study|Physician Decision|1|||
94706278|NCT00612586|324380576|FG001|Overall Study|Physician Decision|2|||
94706279|NCT00612586|324380575|FG000|Overall Study|Sponsor Decision|1|||
94706280|NCT00612586|324380576|FG001|Overall Study|Sponsor Decision|1|||
94706281|NCT00612586|324380575|FG000|Overall Study|Progressive Disease|26|||
94706282|NCT00612586|324380576|FG001|Overall Study|Progressive Disease|24|||
94706283|NCT00612586|324380575|FG000|Overall Study|Randomized and Not Treated|1|||
94706284|NCT00612586|324380576|FG001|Overall Study|Randomized and Not Treated|1|||
94706285|NCT02613364|324380581|FG000|Overall Study|Other|19|||
94266804|NCT01205438|322771957|FG000|Overall Study|Entry Criteria Not Met|16|||
94266805|NCT01205438|322771958|FG001|Overall Study|Entry Criteria Not Met|15|||
94266806|NCT01205438|322771959|FG002|Overall Study|Entry Criteria Not Met|13|||
94266807|NCT01205438|322771957|FG000|Overall Study|Lack of Efficacy|14|||
94266808|NCT01205438|322771958|FG001|Overall Study|Lack of Efficacy|11|||
94266809|NCT01205438|322771959|FG002|Overall Study|Lack of Efficacy|14|||
94266810|NCT01205438|322771957|FG000|Overall Study|Lost to Follow-up|6|||
94266811|NCT01205438|322771958|FG001|Overall Study|Lost to Follow-up|7|||
94266812|NCT01205438|322771959|FG002|Overall Study|Lost to Follow-up|8|||
94266813|NCT01205438|322771957|FG000|Overall Study|Withdrawal by Subject|19|||
94266814|NCT01205438|322771958|FG001|Overall Study|Withdrawal by Subject|25|||
94266815|NCT01205438|322771959|FG002|Overall Study|Withdrawal by Subject|19|||
94266816|NCT01205438|322771957|FG000|Overall Study|Physician Decision|0|||
94266817|NCT01205438|322771958|FG001|Overall Study|Physician Decision|3|||
94266818|NCT01205438|322771959|FG002|Overall Study|Physician Decision|2|||
94266819|NCT01205438|322771957|FG000|Overall Study|Protocol Violation|2|||
94266820|NCT01205438|322771958|FG001|Overall Study|Protocol Violation|7|||
94266821|NCT01205438|322771959|FG002|Overall Study|Protocol Violation|4|||
94266822|NCT01205438|322771957|FG000|Overall Study|Sponsor Decision|0|||
94266823|NCT01205438|322771958|FG001|Overall Study|Sponsor Decision|1|||
94266824|NCT01205438|322771959|FG002|Overall Study|Sponsor Decision|1|||
94266825|NCT03631667|322771962|FG000|Overall Study|Withdrawal by Subject|3|||
94266826|NCT01480284|322771963|FG000|Overall Study|Withdrawal by Subject|2|||
94266827|NCT01480284|322771964|FG001|Overall Study|Withdrawal by Subject|0|||
94266828|NCT01480284|322771963|FG000|Overall Study|Adverse Event|1|||
94266829|NCT01480284|322771964|FG001|Overall Study|Adverse Event|0|||
94266830|NCT01480284|322771963|FG000|Overall Study|Study closed/terminated|3|||
94266831|NCT01480284|322771964|FG001|Overall Study|Study closed/terminated|0|||
94266832|NCT01480284|322771963|FG000|Overall Study|Lost to Follow-up|1|||
94266833|NCT01480284|322771964|FG001|Overall Study|Lost to Follow-up|0|||
94266834|NCT01480284|322771963|FG000|Overall Study|Physician Decision|1|||
94366667|NCT00566631|323128122|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
94706286|NCT02613364|324380582|FG001|Overall Study|Other|29|||
94706287|NCT02613364|324380583|FG002|Overall Study|Other|17|||
94706288|NCT02613364|324380581|FG000|Overall Study|Too time consuming|21|||
94706289|NCT02613364|324380582|FG001|Overall Study|Too time consuming|26|||
94706290|NCT02613364|324380583|FG002|Overall Study|Too time consuming|26|||
94706291|NCT02613364|324380581|FG000|Overall Study|Withdrawal by Subject|13|||
94706292|NCT02613364|324380582|FG001|Overall Study|Withdrawal by Subject|18|||
94706293|NCT02613364|324380583|FG002|Overall Study|Withdrawal by Subject|17|||
94706294|NCT02613364|324380581|FG000|Overall Study|Medical|12|||
94706295|NCT02613364|324380582|FG001|Overall Study|Medical|13|||
94706296|NCT02613364|324380583|FG002|Overall Study|Medical|9|||
94706297|NCT02613364|324380581|FG000|Overall Study|Disliked Study Procedure|1|||
94706298|NCT02613364|324380582|FG001|Overall Study|Disliked Study Procedure|1|||
94706299|NCT02613364|324380583|FG002|Overall Study|Disliked Study Procedure|4|||
94706300|NCT02613364|324380581|FG000|Overall Study|Disliked Intervention|0|||
94706301|NCT02613364|324380582|FG001|Overall Study|Disliked Intervention|3|||
94706302|NCT02613364|324380583|FG002|Overall Study|Disliked Intervention|3|||
94706303|NCT04364269|324380584|FG000|Overall Study|Adverse Event|1|||
94706304|NCT04364269|324380585|FG001|Overall Study|Adverse Event|0|||
94706305|NCT04364269|324380586|FG002|Overall Study|Adverse Event|0|||
94706306|NCT04364269|324380584|FG000|Overall Study|Withdrawal by Subject|0|||
94706307|NCT04364269|324380585|FG001|Overall Study|Withdrawal by Subject|1|||
94706308|NCT04364269|324380586|FG002|Overall Study|Withdrawal by Subject|0|||
94366668|NCT00566631|323128122|FG000|Part 2: Extension Phase|Adverse Event|11|||
94366669|NCT00566631|323128122|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
94706309|NCT02873754|324380587|FG000|Overall Study|Lost to Follow-up|5|||
94706310|NCT02873754|324380587|FG000|Overall Study|Couldn't complete study procedures|1|||
94706311|NCT05641311|324380588|FG000|Dosing Period 1|Adverse Event|1|||
94706312|NCT05641311|324380589|FG001|Dosing Period 1|Adverse Event|0|||
94706313|NCT00082810|324380595|FG000|Overall Study|Adverse Event|3|||
94706314|NCT00082810|324380595|FG000|Overall Study|Progressive disease|24|||
94706315|NCT00082810|324380595|FG000|Overall Study|Withdrawal by Subject|4|||
94266835|NCT01480284|322771964|FG001|Overall Study|Physician Decision|0|||
94266836|NCT00884325|322771965|FG000|Overall Study|Lost to Follow-up|1|||
94706316|NCT00835380|324380596|FG000|Overall Study|Withdrawal by Subject|2|||
94706317|NCT02950558|324380597|FG000|Overall Study|Lost to Follow-up|2|||
94706318|NCT02950558|324380598|FG001|Overall Study|Lost to Follow-up|0|||
94706319|NCT02059980|324380601|FG000|Overall Study|Lost to Follow-up|2|||
94266837|NCT00884325|322771966|FG001|Overall Study|Lost to Follow-up|2|||
94266838|NCT00884325|322771965|FG000|Overall Study|Lack of Efficacy|0|||
94266839|NCT00884325|322771966|FG001|Overall Study|Lack of Efficacy|1|||
94266840|NCT00884325|322771965|FG000|Overall Study|Withdrawal by Subject|1|||
94266841|NCT00884325|322771966|FG001|Overall Study|Withdrawal by Subject|1|||
94266842|NCT00884325|322771965|FG000|Overall Study|Not provided|1|||
94706320|NCT02059980|324380602|FG001|Overall Study|Lost to Follow-up|1|||
94706321|NCT01321606|324380603|FG000|Overall Study|Lost to Follow-up|0|||
94706322|NCT01321606|324380604|FG001|Overall Study|Lost to Follow-up|0|||
94706323|NCT01321606|324380605|FG002|Overall Study|Lost to Follow-up|0|||
94706324|NCT01321606|324380606|FG003|Overall Study|Lost to Follow-up|1|||
94706325|NCT03920215|324380607|FG000|Overall Study|Lost to Follow-up|1|||
94706326|NCT03920215|324380608|FG001|Overall Study|Lost to Follow-up|2|||
94706327|NCT03920215|324380609|FG002|Overall Study|Lost to Follow-up|0|||
94706328|NCT03920215|324380610|FG003|Overall Study|Lost to Follow-up|0|||
94706329|NCT03920215|324380607|FG000|Overall Study|Death|0|||
94706330|NCT03920215|324380608|FG001|Overall Study|Death|0|||
94706331|NCT03920215|324380609|FG002|Overall Study|Death|0|||
94706332|NCT03920215|324380610|FG003|Overall Study|Death|1|||
94706333|NCT00177216|324380612|FG000|Overall Study|Withdrawal by Subject|6|||
94706334|NCT00177216|324380613|FG001|Overall Study|Withdrawal by Subject|3|||
94706335|NCT00177216|324380614|FG002|Overall Study|Withdrawal by Subject|1|||
94706336|NCT01081145|324380615|FG000|Open-Label Phase|Lack of Efficacy|56|||
94706337|NCT01081145|324380616|FG001|Open-Label Phase|Lack of Efficacy|0|||
94706338|NCT01081145|324380615|FG000|Open-Label Phase|Response criteria not met|46|||
94706339|NCT01081145|324380616|FG001|Open-Label Phase|Response criteria not met|0|||
94706340|NCT01081145|324380615|FG000|Open-Label Phase|Adverse Event|42|||
94706341|NCT01081145|324380616|FG001|Open-Label Phase|Adverse Event|0|||
94706342|NCT01081145|324380615|FG000|Open-Label Phase|Withdrawal by Subject|41|||
94706343|NCT01081145|324380616|FG001|Open-Label Phase|Withdrawal by Subject|0|||
94706344|NCT01081145|324380615|FG000|Open-Label Phase|Other|12|||
94706345|NCT01081145|324380616|FG001|Open-Label Phase|Other|0|||
94706346|NCT01081145|324380615|FG000|Open-Label Phase|Lost to Follow-up|11|||
94706347|NCT01081145|324380616|FG001|Open-Label Phase|Lost to Follow-up|0|||
94706348|NCT01081145|324380615|FG000|Open-Label Phase|Protocol Violation|4|||
94706349|NCT01081145|324380616|FG001|Open-Label Phase|Protocol Violation|0|||
94706350|NCT01081145|324380615|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
94706351|NCT01081145|324380616|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
94706352|NCT01081145|324380615|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
94706353|NCT01081145|324380616|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
94706354|NCT01081145|324380615|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
94706355|NCT01081145|324380616|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
94706356|NCT01081145|324380615|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
94706357|NCT01081145|324380616|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
94706358|NCT01081145|324380615|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
94706359|NCT01081145|324380616|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
94706360|NCT01081145|324380615|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
94706361|NCT01081145|324380616|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
94706362|NCT01081145|324380615|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
94706363|NCT01081145|324380616|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
94706364|NCT00367055|324380620|FG000|Overall Study|Adverse Event|6|||
94706365|NCT00367055|324380621|FG001|Overall Study|Adverse Event|3|||
94706366|NCT00367055|324380620|FG000|Overall Study|Patient's Willing|3|||
94706367|NCT00367055|324380621|FG001|Overall Study|Patient's Willing|2|||
94706368|NCT00367055|324380620|FG000|Overall Study|Lack of Efficacy|1|||
94706369|NCT00367055|324380621|FG001|Overall Study|Lack of Efficacy|2|||
94706370|NCT00367055|324380620|FG000|Overall Study|Lost to Follow-up|1|||
94706371|NCT00367055|324380621|FG001|Overall Study|Lost to Follow-up|1|||
94706372|NCT00367055|324380620|FG000|Overall Study|Protocol Violation|0|||
94706373|NCT00367055|324380621|FG001|Overall Study|Protocol Violation|1|||
94706374|NCT00367055|324380620|FG000|Overall Study|Stopping Criterion Met|0|||
94706375|NCT00367055|324380621|FG001|Overall Study|Stopping Criterion Met|1|||
94706376|NCT00367055|324380620|FG000|Overall Study|Participant Living too Far from Hospital|0|||
94706377|NCT00367055|324380621|FG001|Overall Study|Participant Living too Far from Hospital|1|||
94706378|NCT02459899|324380622|FG000|Overall Study|Adverse Event|1|||
94706379|NCT02459899|324380623|FG001|Overall Study|Adverse Event|1|||
94706380|NCT02459899|324380624|FG002|Overall Study|Adverse Event|0|||
94706381|NCT02459899|324380625|FG003|Overall Study|Adverse Event|0|||
94706382|NCT02459899|324380622|FG000|Overall Study|Lost to Follow-up|1|||
94706383|NCT02459899|324380623|FG001|Overall Study|Lost to Follow-up|2|||
94706384|NCT02459899|324380624|FG002|Overall Study|Lost to Follow-up|0|||
94706385|NCT02459899|324380625|FG003|Overall Study|Lost to Follow-up|1|||
94706386|NCT02459899|324380622|FG000|Overall Study|Non-compliance with the treatment|0|||
94706387|NCT02459899|324380623|FG001|Overall Study|Non-compliance with the treatment|0|||
94706388|NCT02459899|324380624|FG002|Overall Study|Non-compliance with the treatment|0|||
94706389|NCT02459899|324380625|FG003|Overall Study|Non-compliance with the treatment|1|||
94706390|NCT02459899|324380622|FG000|Overall Study|Withdrawal by Subject|1|||
94706391|NCT02459899|324380623|FG001|Overall Study|Withdrawal by Subject|3|||
94706392|NCT02459899|324380624|FG002|Overall Study|Withdrawal by Subject|0|||
94706393|NCT02459899|324380625|FG003|Overall Study|Withdrawal by Subject|0|||
94706394|NCT00547118|324380638|FG000|Overall Study|Did not qualify prior to starting drug|1|||
94706395|NCT00547118|324380639|FG001|Overall Study|Did not qualify prior to starting drug|1|||
94706396|NCT00547118|324380638|FG000|Overall Study|Study suspended|7|||
94706397|NCT00547118|324380639|FG001|Overall Study|Study suspended|8|||
94706398|NCT00324038|324380645|FG000|Overall Study|Adverse Event|38|||
94706399|NCT00324038|324380646|FG001|Overall Study|Adverse Event|23|||
94706400|NCT00324038|324380645|FG000|Overall Study|Lack of Efficacy|5|||
94706401|NCT00324038|324380646|FG001|Overall Study|Lack of Efficacy|13|||
94706402|NCT00324038|324380645|FG000|Overall Study|Lost to Follow-up|0|||
94706403|NCT00324038|324380646|FG001|Overall Study|Lost to Follow-up|2|||
94706404|NCT00324038|324380645|FG000|Overall Study|Other|6|||
94706405|NCT00324038|324380646|FG001|Overall Study|Other|13|||
94706406|NCT01123083|324380649|FG000|Overall Study|Investigator recommendation|1|||
94706407|NCT01123083|324380650|FG001|Overall Study|Investigator recommendation|1|||
94706408|NCT01123083|324380649|FG000|Overall Study|Administrative reasons|0|||
94706409|NCT01123083|324380650|FG001|Overall Study|Administrative reasons|4|||
94706410|NCT01123083|324380649|FG000|Overall Study|Lost to Follow-up|2|||
94706411|NCT01123083|324380650|FG001|Overall Study|Lost to Follow-up|6|||
94706412|NCT01123083|324380649|FG000|Overall Study|Adverse Event|1|||
94706413|NCT01123083|324380650|FG001|Overall Study|Adverse Event|0|||
94706414|NCT01123083|324380649|FG000|Overall Study|Withdrew for another reason not covered|0|||
94706415|NCT01123083|324380650|FG001|Overall Study|Withdrew for another reason not covered|1|||
94706416|NCT01123083|324380649|FG000|Overall Study|Participant/legal representative request|7|||
94706417|NCT01123083|324380650|FG001|Overall Study|Participant/legal representative request|3|||
94706418|NCT01751724|324380653|FG000|Overall Study|extubated bef.start assigned treatment|1|||
94706419|NCT01751724|324380654|FG001|Overall Study|extubated bef.start assigned treatment|0|||
94706420|NCT01751724|324380653|FG000|Overall Study|withdrawn by parent|0|||
94706421|NCT01751724|324380654|FG001|Overall Study|withdrawn by parent|2|||
94706422|NCT02974634|324382894|FG000|Overall Study|Advanced disease|12|||
94706423|NCT02974634|324382895|FG001|Overall Study|Advanced disease|3|||
94706424|NCT02974634|324382894|FG000|Overall Study|Noncompliance|3|||
94706425|NCT02974634|324382895|FG001|Overall Study|Noncompliance|7|||
94706426|NCT02974634|324382894|FG000|Overall Study|intervention technology related issues|5|||
94706427|NCT02974634|324382895|FG001|Overall Study|intervention technology related issues|0|||
94706428|NCT02974634|324382894|FG000|Overall Study|Death|8|||
94706429|NCT02974634|324382895|FG001|Overall Study|Death|11|||
94706430|NCT04867902|324382896|FG000|Overall Study|Lost to Follow-up|1|||
94706431|NCT04867902|324382896|FG000|Overall Study|Withdrawal by Subject|2|||
94706432|NCT04867902|324382896|FG000|Overall Study|Protocol Violation|1|||
94706433|NCT01025843|324382898|FG000|Washout 4|Withdrawal by Subject|0|||
94706434|NCT01025843|324382899|FG001|Washout 4|Withdrawal by Subject|0|||
94706435|NCT01025843|324382900|FG002|Washout 4|Withdrawal by Subject|1|||
94706436|NCT01025843|324382901|FG003|Washout 4|Withdrawal by Subject|1|||
94706437|NCT01025843|324382902|FG004|Washout 4|Withdrawal by Subject|0|||
94706438|NCT01025843|324382903|FG005|Washout 4|Withdrawal by Subject|0|||
94706439|NCT01025843|324382904|FG006|Washout 4|Withdrawal by Subject|0|||
94706440|NCT01025843|324382905|FG007|Washout 4|Withdrawal by Subject|0|||
94706441|NCT01025843|324382906|FG008|Washout 4|Withdrawal by Subject|0|||
94706442|NCT01025843|324382907|FG009|Washout 4|Withdrawal by Subject|0|||
94706443|NCT00377455|324382912|FG000|Overall Study|Withdrawal by Subject|1|||
94706444|NCT02001623|324382913|FG000|Overall Study|Disease Progression|2|||
94706445|NCT02001623|324382914|FG001|Overall Study|Disease Progression|2|||
94706446|NCT02001623|324382915|FG002|Overall Study|Disease Progression|3|||
94706447|NCT02001623|324382916|FG003|Overall Study|Disease Progression|2|||
94706448|NCT02001623|324382917|FG004|Overall Study|Disease Progression|3|||
94706449|NCT02001623|324382918|FG005|Overall Study|Disease Progression|2|||
94706450|NCT02001623|324382919|FG006|Overall Study|Disease Progression|3|||
94706451|NCT02001623|324382920|FG007|Overall Study|Disease Progression|3|||
94706452|NCT02001623|324382921|FG008|Overall Study|Disease Progression|7|||
94706453|NCT02001623|324382922|FG009|Overall Study|Disease Progression|40|||
94706454|NCT02001623|324382923|FG010|Overall Study|Disease Progression|5|||
94706455|NCT02001623|324382924|FG011|Overall Study|Disease Progression|9|||
94706456|NCT02001623|324382925|FG012|Overall Study|Disease Progression|9|||
94706457|NCT02001623|324382926|FG013|Overall Study|Disease Progression|20|||
94706458|NCT02001623|324382927|FG014|Overall Study|Disease Progression|9|||
94706459|NCT02001623|324382913|FG000|Overall Study|Physician Decision|0|||
94706460|NCT02001623|324382914|FG001|Overall Study|Physician Decision|0|||
94706461|NCT02001623|324382915|FG002|Overall Study|Physician Decision|0|||
94706462|NCT02001623|324382916|FG003|Overall Study|Physician Decision|0|||
94706463|NCT02001623|324382917|FG004|Overall Study|Physician Decision|0|||
94706464|NCT02001623|324382918|FG005|Overall Study|Physician Decision|0|||
94706465|NCT02001623|324382919|FG006|Overall Study|Physician Decision|0|||
94706466|NCT02001623|324382920|FG007|Overall Study|Physician Decision|0|||
94706467|NCT02001623|324382921|FG008|Overall Study|Physician Decision|3|||
94706468|NCT02001623|324382922|FG009|Overall Study|Physician Decision|2|||
94706469|NCT02001623|324382923|FG010|Overall Study|Physician Decision|3|||
94706470|NCT02001623|324382924|FG011|Overall Study|Physician Decision|3|||
94706471|NCT02001623|324382925|FG012|Overall Study|Physician Decision|1|||
94706472|NCT02001623|324382926|FG013|Overall Study|Physician Decision|2|||
94706473|NCT02001623|324382927|FG014|Overall Study|Physician Decision|1|||
94706474|NCT02001623|324382913|FG000|Overall Study|Death|0|||
94706475|NCT02001623|324382914|FG001|Overall Study|Death|1|||
94706476|NCT02001623|324382915|FG002|Overall Study|Death|0|||
94706477|NCT02001623|324382916|FG003|Overall Study|Death|0|||
94706478|NCT02001623|324382917|FG004|Overall Study|Death|0|||
94706479|NCT02001623|324382918|FG005|Overall Study|Death|0|||
94706480|NCT02001623|324382919|FG006|Overall Study|Death|0|||
94706481|NCT02001623|324382920|FG007|Overall Study|Death|0|||
94706482|NCT02001623|324382921|FG008|Overall Study|Death|0|||
94706483|NCT02001623|324382922|FG009|Overall Study|Death|0|||
94706484|NCT02001623|324382923|FG010|Overall Study|Death|0|||
94706485|NCT02001623|324382924|FG011|Overall Study|Death|0|||
94706486|NCT02001623|324382925|FG012|Overall Study|Death|0|||
94706487|NCT02001623|324382926|FG013|Overall Study|Death|0|||
94706488|NCT02001623|324382927|FG014|Overall Study|Death|0|||
94706489|NCT02001623|324382913|FG000|Overall Study|Adverse Event|0|||
94706490|NCT02001623|324382914|FG001|Overall Study|Adverse Event|0|||
94706491|NCT02001623|324382915|FG002|Overall Study|Adverse Event|0|||
94706492|NCT02001623|324382916|FG003|Overall Study|Adverse Event|0|||
94706493|NCT02001623|324382917|FG004|Overall Study|Adverse Event|0|||
94706494|NCT02001623|324382918|FG005|Overall Study|Adverse Event|1|||
94706495|NCT02001623|324382919|FG006|Overall Study|Adverse Event|0|||
94706496|NCT02001623|324382920|FG007|Overall Study|Adverse Event|3|||
94706497|NCT02001623|324382921|FG008|Overall Study|Adverse Event|4|||
94706498|NCT02001623|324382922|FG009|Overall Study|Adverse Event|6|||
94706499|NCT02001623|324382923|FG010|Overall Study|Adverse Event|4|||
94706500|NCT02001623|324382924|FG011|Overall Study|Adverse Event|0|||
94706501|NCT02001623|324382925|FG012|Overall Study|Adverse Event|3|||
94706502|NCT02001623|324382926|FG013|Overall Study|Adverse Event|5|||
94706503|NCT02001623|324382927|FG014|Overall Study|Adverse Event|6|||
94706504|NCT02001623|324382913|FG000|Overall Study|Other - Miscellaneous|0|||
94706505|NCT02001623|324382914|FG001|Overall Study|Other - Miscellaneous|0|||
94706506|NCT02001623|324382915|FG002|Overall Study|Other - Miscellaneous|0|||
94706507|NCT02001623|324382916|FG003|Overall Study|Other - Miscellaneous|0|||
94706508|NCT02001623|324382917|FG004|Overall Study|Other - Miscellaneous|0|||
94706509|NCT02001623|324382918|FG005|Overall Study|Other - Miscellaneous|0|||
94706510|NCT02001623|324382919|FG006|Overall Study|Other - Miscellaneous|0|||
94706511|NCT02001623|324382920|FG007|Overall Study|Other - Miscellaneous|0|||
94706512|NCT02001623|324382921|FG008|Overall Study|Other - Miscellaneous|0|||
94706513|NCT02001623|324382922|FG009|Overall Study|Other - Miscellaneous|1|||
94706514|NCT02001623|324382923|FG010|Overall Study|Other - Miscellaneous|0|||
94706515|NCT02001623|324382924|FG011|Overall Study|Other - Miscellaneous|0|||
94706516|NCT02001623|324382925|FG012|Overall Study|Other - Miscellaneous|0|||
94706517|NCT02001623|324382926|FG013|Overall Study|Other - Miscellaneous|1|||
94706518|NCT02001623|324382927|FG014|Overall Study|Other - Miscellaneous|0|||
94706519|NCT02001623|324382913|FG000|Overall Study|Withdrawal by Subject|1|||
94706520|NCT02001623|324382914|FG001|Overall Study|Withdrawal by Subject|0|||
94706521|NCT02001623|324382915|FG002|Overall Study|Withdrawal by Subject|0|||
94706522|NCT02001623|324382916|FG003|Overall Study|Withdrawal by Subject|0|||
94706523|NCT02001623|324382917|FG004|Overall Study|Withdrawal by Subject|0|||
94706524|NCT02001623|324382918|FG005|Overall Study|Withdrawal by Subject|0|||
94706525|NCT02001623|324382919|FG006|Overall Study|Withdrawal by Subject|0|||
94706526|NCT02001623|324382920|FG007|Overall Study|Withdrawal by Subject|0|||
94706527|NCT02001623|324382921|FG008|Overall Study|Withdrawal by Subject|1|||
94706528|NCT02001623|324382922|FG009|Overall Study|Withdrawal by Subject|3|||
94706529|NCT02001623|324382923|FG010|Overall Study|Withdrawal by Subject|2|||
94706530|NCT02001623|324382924|FG011|Overall Study|Withdrawal by Subject|2|||
94706531|NCT02001623|324382925|FG012|Overall Study|Withdrawal by Subject|1|||
94706532|NCT02001623|324382926|FG013|Overall Study|Withdrawal by Subject|5|||
94706533|NCT02001623|324382927|FG014|Overall Study|Withdrawal by Subject|2|||
94706534|NCT02001623|324382913|FG000|Overall Study|Lost to Follow-up|0|||
94706535|NCT02001623|324382914|FG001|Overall Study|Lost to Follow-up|0|||
94706536|NCT02001623|324382915|FG002|Overall Study|Lost to Follow-up|0|||
94706537|NCT02001623|324382916|FG003|Overall Study|Lost to Follow-up|0|||
94706538|NCT02001623|324382917|FG004|Overall Study|Lost to Follow-up|0|||
94706539|NCT02001623|324382918|FG005|Overall Study|Lost to Follow-up|0|||
94706540|NCT02001623|324382919|FG006|Overall Study|Lost to Follow-up|0|||
94706541|NCT02001623|324382920|FG007|Overall Study|Lost to Follow-up|0|||
94706542|NCT02001623|324382921|FG008|Overall Study|Lost to Follow-up|0|||
94706543|NCT02001623|324382922|FG009|Overall Study|Lost to Follow-up|1|||
94706544|NCT02001623|324382923|FG010|Overall Study|Lost to Follow-up|0|||
94706545|NCT02001623|324382924|FG011|Overall Study|Lost to Follow-up|0|||
94706546|NCT02001623|324382925|FG012|Overall Study|Lost to Follow-up|0|||
94706547|NCT02001623|324382926|FG013|Overall Study|Lost to Follow-up|0|||
94706548|NCT02001623|324382927|FG014|Overall Study|Lost to Follow-up|0|||
94706549|NCT02001623|324382913|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
94706550|NCT02001623|324382914|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
94706551|NCT02001623|324382915|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
94706552|NCT02001623|324382916|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
94706553|NCT02001623|324382917|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
94706554|NCT02001623|324382918|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
94706555|NCT02001623|324382919|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
94706556|NCT02001623|324382920|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
94706557|NCT02001623|324382921|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
94706558|NCT02001623|324382922|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
94706559|NCT02001623|324382923|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
94706560|NCT02001623|324382924|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
94706561|NCT02001623|324382925|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
94706562|NCT02001623|324382926|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
94706563|NCT02001623|324382927|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
94706564|NCT02001623|324382913|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
94706565|NCT02001623|324382914|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
94706566|NCT02001623|324382915|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
94706567|NCT02001623|324382916|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
94706568|NCT02001623|324382917|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
94706569|NCT02001623|324382918|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
94706570|NCT02001623|324382919|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
94706571|NCT02001623|324382920|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
94706572|NCT02001623|324382921|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
94706573|NCT02001623|324382922|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
94706574|NCT02001623|324382923|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
94706575|NCT02001623|324382924|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
94706576|NCT02001623|324382925|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
94706577|NCT02001623|324382926|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
94706578|NCT02001623|324382927|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
94706579|NCT00771667|324382928|FG000|Induction Phase|Adverse Event|5|||
94706580|NCT00771667|324382929|FG001|Induction Phase|Adverse Event|2|||
94706581|NCT00771667|324382930|FG002|Induction Phase|Adverse Event|4|||
94706582|NCT00771667|324382931|FG003|Induction Phase|Adverse Event|1|||
94706583|NCT00771667|324382932|FG004|Induction Phase|Adverse Event|0|||
94706584|NCT00771667|324382933|FG005|Induction Phase|Adverse Event|0|||
94706585|NCT00771667|324382934|FG006|Induction Phase|Adverse Event|0|||
94706586|NCT00771667|324382935|FG007|Induction Phase|Adverse Event|0|||
94706587|NCT00771667|324382936|FG008|Induction Phase|Adverse Event|0|||
94706588|NCT00771667|324382937|FG009|Induction Phase|Adverse Event|0|||
94706589|NCT00771667|324382928|FG000|Induction Phase|Lack of Efficacy|9|||
94706590|NCT00771667|324382929|FG001|Induction Phase|Lack of Efficacy|2|||
94706591|NCT00771667|324382930|FG002|Induction Phase|Lack of Efficacy|4|||
94706592|NCT00771667|324382931|FG003|Induction Phase|Lack of Efficacy|3|||
94706593|NCT00771667|324382932|FG004|Induction Phase|Lack of Efficacy|0|||
94706594|NCT00771667|324382933|FG005|Induction Phase|Lack of Efficacy|0|||
94706595|NCT00771667|324382934|FG006|Induction Phase|Lack of Efficacy|0|||
94706596|NCT00771667|324382935|FG007|Induction Phase|Lack of Efficacy|0|||
94706597|NCT00771667|324382936|FG008|Induction Phase|Lack of Efficacy|0|||
94706598|NCT00771667|324382937|FG009|Induction Phase|Lack of Efficacy|0|||
94706599|NCT00771667|324382928|FG000|Induction Phase|Lost to Follow-up|1|||
94706600|NCT00771667|324382929|FG001|Induction Phase|Lost to Follow-up|0|||
94706601|NCT00771667|324382930|FG002|Induction Phase|Lost to Follow-up|1|||
94706602|NCT00771667|324382931|FG003|Induction Phase|Lost to Follow-up|0|||
94706603|NCT00771667|324382932|FG004|Induction Phase|Lost to Follow-up|0|||
94706604|NCT00771667|324382933|FG005|Induction Phase|Lost to Follow-up|0|||
94706605|NCT00771667|324382934|FG006|Induction Phase|Lost to Follow-up|0|||
94706606|NCT00771667|324382935|FG007|Induction Phase|Lost to Follow-up|0|||
94706607|NCT00771667|324382936|FG008|Induction Phase|Lost to Follow-up|0|||
94706608|NCT00771667|324382937|FG009|Induction Phase|Lost to Follow-up|0|||
94706609|NCT00771667|324382928|FG000|Induction Phase|Other|4|||
94706610|NCT00771667|324382929|FG001|Induction Phase|Other|6|||
94706611|NCT00771667|324382930|FG002|Induction Phase|Other|3|||
94706612|NCT00771667|324382931|FG003|Induction Phase|Other|4|||
94706613|NCT00771667|324382932|FG004|Induction Phase|Other|0|||
94706614|NCT00771667|324382933|FG005|Induction Phase|Other|0|||
94706615|NCT00771667|324382934|FG006|Induction Phase|Other|0|||
94706616|NCT00771667|324382935|FG007|Induction Phase|Other|0|||
94706617|NCT00771667|324382936|FG008|Induction Phase|Other|0|||
94706618|NCT00771667|324382937|FG009|Induction Phase|Other|0|||
94706619|NCT00771667|324382928|FG000|Maintenance Phase|Adverse Event|0|||
94706620|NCT00771667|324382929|FG001|Maintenance Phase|Adverse Event|0|||
94366670|NCT00566631|323128122|FG000|Part 2: Extension Phase|Death|1|||
94706621|NCT00771667|324382930|FG002|Maintenance Phase|Adverse Event|0|||
94706622|NCT00771667|324382931|FG003|Maintenance Phase|Adverse Event|0|||
94706623|NCT00771667|324382932|FG004|Maintenance Phase|Adverse Event|1|||
94706624|NCT00771667|324382933|FG005|Maintenance Phase|Adverse Event|3|||
94706625|NCT00771667|324382934|FG006|Maintenance Phase|Adverse Event|5|||
94706626|NCT00771667|324382935|FG007|Maintenance Phase|Adverse Event|1|||
94706627|NCT00771667|324382936|FG008|Maintenance Phase|Adverse Event|8|||
94706628|NCT00771667|324382937|FG009|Maintenance Phase|Adverse Event|7|||
94706629|NCT00771667|324382928|FG000|Maintenance Phase|Lack of Efficacy|0|||
94706630|NCT00771667|324382929|FG001|Maintenance Phase|Lack of Efficacy|0|||
94706631|NCT00771667|324382930|FG002|Maintenance Phase|Lack of Efficacy|0|||
94706632|NCT00771667|324382931|FG003|Maintenance Phase|Lack of Efficacy|0|||
94706633|NCT00771667|324382932|FG004|Maintenance Phase|Lack of Efficacy|1|||
94706634|NCT00771667|324382933|FG005|Maintenance Phase|Lack of Efficacy|3|||
94706635|NCT00771667|324382934|FG006|Maintenance Phase|Lack of Efficacy|3|||
94706636|NCT00771667|324382935|FG007|Maintenance Phase|Lack of Efficacy|2|||
94706637|NCT00771667|324382936|FG008|Maintenance Phase|Lack of Efficacy|11|||
94706638|NCT00771667|324382937|FG009|Maintenance Phase|Lack of Efficacy|7|||
94706639|NCT00771667|324382928|FG000|Maintenance Phase|Other|0|||
94706640|NCT00771667|324382929|FG001|Maintenance Phase|Other|0|||
94706641|NCT00771667|324382930|FG002|Maintenance Phase|Other|0|||
94706642|NCT00771667|324382931|FG003|Maintenance Phase|Other|0|||
94706643|NCT00771667|324382932|FG004|Maintenance Phase|Other|0|||
94706644|NCT00771667|324382933|FG005|Maintenance Phase|Other|1|||
94706645|NCT00771667|324382934|FG006|Maintenance Phase|Other|2|||
94706646|NCT00771667|324382935|FG007|Maintenance Phase|Other|2|||
94706647|NCT00771667|324382936|FG008|Maintenance Phase|Other|3|||
94706648|NCT00771667|324382937|FG009|Maintenance Phase|Other|3|||
94706649|NCT01063036|324382946|FG000|Participants Treated With Study Drug|Adverse Event|1|||
94706650|NCT01063036|324382946|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
94706651|NCT01063036|324382946|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
94706652|NCT01063036|324382946|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
94706653|NCT01063036|324382946|FG000|Participants Treated With Study Drug|Pregnancy|1|||
94706654|NCT01063036|324382946|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
94706655|NCT01063036|324382946|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
94706656|NCT01063036|324382946|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
94706657|NCT02263508|324382947|FG000|Overall Study|Withdrawal by Subject|1|||
94706658|NCT02263508|324382948|FG001|Overall Study|Withdrawal by Subject|23|||
94706659|NCT02263508|324382949|FG002|Overall Study|Withdrawal by Subject|17|||
94706660|NCT02263508|324382947|FG000|Overall Study|Sponsor Decision|12|||
94706661|NCT02263508|324382948|FG001|Overall Study|Sponsor Decision|165|||
94706662|NCT02263508|324382949|FG002|Overall Study|Sponsor Decision|182|||
94706663|NCT02263508|324382947|FG000|Overall Study|Lost to Follow-up|2|||
94706664|NCT02263508|324382948|FG001|Overall Study|Lost to Follow-up|7|||
94706665|NCT02263508|324382949|FG002|Overall Study|Lost to Follow-up|7|||
94706666|NCT02263508|324382947|FG000|Overall Study|Death|6|||
94706667|NCT02263508|324382948|FG001|Overall Study|Death|151|||
94706668|NCT02263508|324382949|FG002|Overall Study|Death|140|||
94706669|NCT02577523|324382950|FG000|Overall Study|Adverse Event|1|||
94706670|NCT02577523|324382951|FG001|Overall Study|Adverse Event|1|||
94706671|NCT02577523|324382950|FG000|Overall Study|Lack of Efficacy|1|||
94706672|NCT02577523|324382951|FG001|Overall Study|Lack of Efficacy|1|||
94706673|NCT02577523|324382950|FG000|Overall Study|Withdrawal by Subject|1|||
94706674|NCT02577523|324382951|FG001|Overall Study|Withdrawal by Subject|0|||
94706675|NCT03265210|324382955|FG000|Overall Study|Withdrawal by Subject|7|||
94706676|NCT03265210|324382956|FG001|Overall Study|Withdrawal by Subject|9|||
94706677|NCT03265210|324382955|FG000|Overall Study|Lost to Follow-up|2|||
94706678|NCT03265210|324382956|FG001|Overall Study|Lost to Follow-up|0|||
94706679|NCT03265210|324382955|FG000|Overall Study|Physician Decision|2|||
94706680|NCT03265210|324382956|FG001|Overall Study|Physician Decision|0|||
94706681|NCT03265210|324382955|FG000|Overall Study|Adverse Event|1|||
94706682|NCT03265210|324382956|FG001|Overall Study|Adverse Event|0|||
94706683|NCT00918957|324382957|FG000|Overall Study|Adverse Event|2|||
94706684|NCT00918957|324382958|FG001|Overall Study|Adverse Event|0|||
94706685|NCT00918957|324382957|FG000|Overall Study|Withdrawal by Subject|1|||
94706686|NCT00918957|324382958|FG001|Overall Study|Withdrawal by Subject|0|||
94706687|NCT00686517|324382959|FG000|Treatment|Serious Adverse Event|1|||
94706688|NCT00686517|324382960|FG001|Treatment|Serious Adverse Event|2|||
94706689|NCT00686517|324382961|FG002|Treatment|Serious Adverse Event|1|||
94706690|NCT00686517|324382959|FG000|Treatment|Adverse Event|2|||
94706691|NCT00686517|324382960|FG001|Treatment|Adverse Event|0|||
94706692|NCT00686517|324382961|FG002|Treatment|Adverse Event|0|||
94706693|NCT00686517|324382959|FG000|Treatment|Poor Protocol Compliance|1|||
94706694|NCT00686517|324382960|FG001|Treatment|Poor Protocol Compliance|0|||
94706695|NCT00686517|324382961|FG002|Treatment|Poor Protocol Compliance|0|||
94706696|NCT00686517|324382959|FG000|Treatment|Protocol Violation|2|||
94706697|NCT00686517|324382960|FG001|Treatment|Protocol Violation|1|||
94706698|NCT00686517|324382961|FG002|Treatment|Protocol Violation|0|||
94706699|NCT01499134|324382962|FG000|Overall Study|Withdrawal by Subject|0|||
94706700|NCT01499134|324382963|FG001|Overall Study|Withdrawal by Subject|1|||
94706701|NCT02320123|324382964|FG000|Overall Study|Lost to Follow-up|4|||
94706702|NCT02320123|324382965|FG001|Overall Study|Lost to Follow-up|6|||
94706703|NCT02320123|324382964|FG000|Overall Study|Death|6|||
94706704|NCT02320123|324382965|FG001|Overall Study|Death|5|||
94706705|NCT01616654|324382975|FG000|Overall Study|Lack of Efficacy|1|||
94706706|NCT01616654|324382976|FG001|Overall Study|Lack of Efficacy|0|||
94706707|NCT01616654|324382977|FG002|Overall Study|Lack of Efficacy|0|||
94706708|NCT01616654|324382978|FG003|Overall Study|Lack of Efficacy|0|||
94706709|NCT01616654|324382979|FG004|Overall Study|Lack of Efficacy|1|||
94706710|NCT01616654|324382975|FG000|Overall Study|Adverse Event|0|||
94706711|NCT01616654|324382976|FG001|Overall Study|Adverse Event|1|||
94706712|NCT01616654|324382977|FG002|Overall Study|Adverse Event|2|||
94706713|NCT01616654|324382978|FG003|Overall Study|Adverse Event|1|||
94706714|NCT01616654|324382979|FG004|Overall Study|Adverse Event|0|||
94706715|NCT01616654|324382975|FG000|Overall Study|Withdrawal by Subject|2|||
94706716|NCT01616654|324382976|FG001|Overall Study|Withdrawal by Subject|2|||
94706717|NCT01616654|324382977|FG002|Overall Study|Withdrawal by Subject|3|||
94706718|NCT01616654|324382978|FG003|Overall Study|Withdrawal by Subject|1|||
94706719|NCT01616654|324382979|FG004|Overall Study|Withdrawal by Subject|5|||
94706720|NCT01616654|324382975|FG000|Overall Study|Protocol Violation|0|||
94706721|NCT01616654|324382976|FG001|Overall Study|Protocol Violation|5|||
94706722|NCT01616654|324382977|FG002|Overall Study|Protocol Violation|2|||
94706723|NCT01616654|324382978|FG003|Overall Study|Protocol Violation|4|||
94706724|NCT01616654|324382979|FG004|Overall Study|Protocol Violation|4|||
94706725|NCT01616654|324382975|FG000|Overall Study|Lost to Follow-up|1|||
94706726|NCT01616654|324382976|FG001|Overall Study|Lost to Follow-up|0|||
94706727|NCT01616654|324382977|FG002|Overall Study|Lost to Follow-up|3|||
94706728|NCT01616654|324382978|FG003|Overall Study|Lost to Follow-up|2|||
94706729|NCT01616654|324382979|FG004|Overall Study|Lost to Follow-up|1|||
94706730|NCT01616654|324382975|FG000|Overall Study|Pregnancy|1|||
94706731|NCT01616654|324382976|FG001|Overall Study|Pregnancy|0|||
94706732|NCT01616654|324382977|FG002|Overall Study|Pregnancy|0|||
94706733|NCT01616654|324382978|FG003|Overall Study|Pregnancy|0|||
94706734|NCT01616654|324382979|FG004|Overall Study|Pregnancy|1|||
94706735|NCT01988233|324382989|FG000|Overall Study|Lost to Follow-up|64|||
94706736|NCT01988233|324382990|FG001|Overall Study|Lost to Follow-up|51|||
94706737|NCT03621761|324382991|FG000|Overall Study|Lost to Follow-up|1|||
94706738|NCT03621761|324382992|FG001|Overall Study|Lost to Follow-up|1|||
94706739|NCT03621761|324382993|FG002|Overall Study|Lost to Follow-up|2|||
94706740|NCT03621761|324382991|FG000|Overall Study|Withdrawal by Subject|2|||
94706741|NCT03621761|324382992|FG001|Overall Study|Withdrawal by Subject|1|||
94706742|NCT03621761|324382993|FG002|Overall Study|Withdrawal by Subject|1|||
94706743|NCT03621761|324382991|FG000|Overall Study|Became Ineligible|0|||
94706744|NCT03621761|324382992|FG001|Overall Study|Became Ineligible|2|||
94706745|NCT03621761|324382993|FG002|Overall Study|Became Ineligible|0|||
94706746|NCT01689519|324382994|FG000|Intent to Treat|Death|157|||
94706747|NCT01689519|324382995|FG001|Intent to Treat|Death|167|||
94706748|NCT01689519|324382994|FG000|Intent to Treat|Lost to Follow-up|4|||
94706749|NCT01689519|324382995|FG001|Intent to Treat|Lost to Follow-up|8|||
94706750|NCT01689519|324382994|FG000|Intent to Treat|Other|2|||
94706751|NCT01689519|324382995|FG001|Intent to Treat|Other|4|||
94706752|NCT01689519|324382994|FG000|Intent to Treat|Physician Decision|4|||
94706753|NCT01689519|324382995|FG001|Intent to Treat|Physician Decision|1|||
94706754|NCT01689519|324382994|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
94706755|NCT01689519|324382995|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
94706756|NCT01689519|324382994|FG000|Intent to Treat|Withdrawal by Subject|21|||
94706757|NCT01689519|324382995|FG001|Intent to Treat|Withdrawal by Subject|20|||
94706758|NCT01689519|324382994|FG000|Safety Population|Death|158|||
94706759|NCT01689519|324382995|FG001|Safety Population|Death|165|||
94706760|NCT01689519|324382994|FG000|Safety Population|Lost to Follow-up|4|||
94706761|NCT01689519|324382995|FG001|Safety Population|Lost to Follow-up|8|||
94706762|NCT01689519|324382994|FG000|Safety Population|Other|2|||
94706763|NCT01689519|324382995|FG001|Safety Population|Other|4|||
94706764|NCT01689519|324382994|FG000|Safety Population|Physician Decision|4|||
94706765|NCT01689519|324382995|FG001|Safety Population|Physician Decision|1|||
94706766|NCT01689519|324382994|FG000|Safety Population|Study Terminated By Sponsor|60|||
94706767|NCT01689519|324382995|FG001|Safety Population|Study Terminated By Sponsor|47|||
94706768|NCT01689519|324382994|FG000|Safety Population|Withdrawal by Subject|20|||
94706769|NCT01689519|324382995|FG001|Safety Population|Withdrawal by Subject|20|||
94706770|NCT00559949|324382998|FG000|Overall Study|Progressive Disease during cycle 1|1|||
94706771|NCT00559949|324382998|FG000|Overall Study|Adverse Event|1|||
94706772|NCT00559949|324382998|FG000|Overall Study|Withdrawal by Subject|4|||
94706773|NCT00559949|324382998|FG000|Overall Study|No disease evaluation per protocol|1|||
94706774|NCT01183780|324382999|FG000|Overall Study|Withdrawal by Subject|25|||
94706775|NCT01183780|324383000|FG001|Overall Study|Withdrawal by Subject|14|||
94706776|NCT01183780|324382999|FG000|Overall Study|Lost to Follow-up|6|||
94706777|NCT01183780|324383000|FG001|Overall Study|Lost to Follow-up|11|||
94706778|NCT00855465|324383003|FG000|Treatment Period|Adverse Event|4|||
94706779|NCT00855465|324383004|FG001|Treatment Period|Adverse Event|2|||
94706780|NCT00855465|324383003|FG000|Treatment Period|Death|2|||
94706781|NCT00855465|324383004|FG001|Treatment Period|Death|2|||
94706782|NCT00855465|324383003|FG000|Treatment Period|Lack of Efficacy|2|||
94706783|NCT00855465|324383004|FG001|Treatment Period|Lack of Efficacy|1|||
94706784|NCT00855465|324383003|FG000|Treatment Period|Non-compliance|1|||
94706785|NCT00855465|324383004|FG001|Treatment Period|Non-compliance|0|||
94706786|NCT00855465|324383003|FG000|Treatment Period|Protocol Violation|2|||
94706787|NCT00855465|324383004|FG001|Treatment Period|Protocol Violation|0|||
94706788|NCT00855465|324383003|FG000|Treatment Period|Withdrawal by Subject|2|||
94706789|NCT00855465|324383004|FG001|Treatment Period|Withdrawal by Subject|0|||
94706790|NCT00855465|324383003|FG000|Treatment Period|Not treated|1|||
94706791|NCT00855465|324383004|FG001|Treatment Period|Not treated|0|||
94706792|NCT00855465|324383003|FG000|Follow-up Period (FUP)|Adverse Event|0|||
94706793|NCT00855465|324383004|FG001|Follow-up Period (FUP)|Adverse Event|1|||
94706794|NCT00855465|324383003|FG000|Follow-up Period (FUP)|Death|0|||
94706795|NCT00855465|324383004|FG001|Follow-up Period (FUP)|Death|1|||
94706796|NCT00855465|324383003|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
94706797|NCT00855465|324383004|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
94706798|NCT00855465|324383003|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
94706799|NCT00855465|324383004|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
94706800|NCT00855465|324383003|FG000|Follow-up Period (FUP)|Missing|1|||
94706801|NCT00855465|324383004|FG001|Follow-up Period (FUP)|Missing|0|||
94706802|NCT00079183|324383016|FG000|Overall Study|Withdrawal by Subject|4|||
94706803|NCT00079183|324383016|FG000|Overall Study|Study medication non-compliance|2|||
94706804|NCT00079183|324383016|FG000|Overall Study|Specimen collection non-compliance|1|||
94706805|NCT04567888|324383017|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
94706806|NCT04567888|324383018|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
94706807|NCT04567888|324383017|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
94706808|NCT04567888|324383018|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
94706809|NCT04567888|324383017|FG000|Overall Study|Reported Unusual Birth Year|2|||
94706810|NCT04567888|324383018|FG001|Overall Study|Reported Unusual Birth Year|3|||
94706811|NCT04567888|324383017|FG000|Overall Study|Duplicate Responses|0|||
94706812|NCT04567888|324383018|FG001|Overall Study|Duplicate Responses|1|||
94706813|NCT01194258|324383019|FG000|Titration Period|Withdrawal by Subject|6|||
94706814|NCT01194258|324383020|FG001|Titration Period|Withdrawal by Subject|0|||
94706815|NCT01194258|324383021|FG002|Titration Period|Withdrawal by Subject|0|||
94706816|NCT01194258|324383022|FG003|Titration Period|Withdrawal by Subject|0|||
94706817|NCT01194258|324383023|FG004|Titration Period|Withdrawal by Subject|0|||
94706818|NCT01194258|324383019|FG000|Titration Period|Lost to Follow-up|2|||
94706819|NCT01194258|324383020|FG001|Titration Period|Lost to Follow-up|0|||
94706820|NCT01194258|324383021|FG002|Titration Period|Lost to Follow-up|0|||
94706821|NCT01194258|324383022|FG003|Titration Period|Lost to Follow-up|0|||
94706822|NCT01194258|324383023|FG004|Titration Period|Lost to Follow-up|0|||
94706823|NCT01194258|324383019|FG000|Titration Period|Titration failure|3|||
94706824|NCT01194258|324383020|FG001|Titration Period|Titration failure|0|||
94706825|NCT01194258|324383021|FG002|Titration Period|Titration failure|0|||
94706826|NCT01194258|324383022|FG003|Titration Period|Titration failure|0|||
94706827|NCT01194258|324383023|FG004|Titration Period|Titration failure|0|||
94706828|NCT01194258|324383019|FG000|Period 1 (12 Weeks)|Death|0|||
94706829|NCT01194258|324383020|FG001|Period 1 (12 Weeks)|Death|0|||
94706830|NCT01194258|324383021|FG002|Period 1 (12 Weeks)|Death|0|||
94706831|NCT01194258|324383022|FG003|Period 1 (12 Weeks)|Death|0|||
94706832|NCT01194258|324383023|FG004|Period 1 (12 Weeks)|Death|1|||
94706833|NCT01194258|324383019|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
94706834|NCT01194258|324383020|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
94706835|NCT01194258|324383021|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
94706836|NCT01194258|324383022|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
94706837|NCT01194258|324383023|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
94706838|NCT01194258|324383019|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
94706839|NCT01194258|324383020|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
94706840|NCT01194258|324383021|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
94706841|NCT01194258|324383022|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
94706842|NCT01194258|324383023|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
94706843|NCT01194258|324383019|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
94706844|NCT01194258|324383020|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
94706845|NCT01194258|324383021|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
94706846|NCT01194258|324383022|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
94706847|NCT01194258|324383023|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
94706848|NCT01235949|324383024|FG000|Primary Phase|Migrated/moved from study area|1|||
94706849|NCT01235949|324383025|FG001|Primary Phase|Migrated/moved from study area|1|||
94706850|NCT01235949|324383026|FG002|Primary Phase|Migrated/moved from study area|0|||
94706851|NCT01235949|324383027|FG003|Primary Phase|Migrated/moved from study area|0|||
94706852|NCT01235949|324383028|FG004|Primary Phase|Migrated/moved from study area|1|||
94706853|NCT01235949|324383029|FG005|Primary Phase|Migrated/moved from study area|2|||
94706854|NCT01235949|324383030|FG006|Primary Phase|Migrated/moved from study area|0|||
94706855|NCT01235949|324383031|FG007|Primary Phase|Migrated/moved from study area|0|||
94706856|NCT01235949|324383032|FG008|Primary Phase|Migrated/moved from study area|0|||
94706857|NCT01235949|324383033|FG009|Primary Phase|Migrated/moved from study area|0|||
94706858|NCT01235949|324383034|FG010|Primary Phase|Migrated/moved from study area|0|||
94706859|NCT01235949|324383035|FG011|Primary Phase|Migrated/moved from study area|0|||
94706860|NCT01235949|324383036|FG012|Primary Phase|Migrated/moved from study area|0|||
94706861|NCT01235949|324383037|FG013|Primary Phase|Migrated/moved from study area|0|||
94706862|NCT01235949|324383038|FG014|Primary Phase|Migrated/moved from study area|0|||
94706863|NCT01235949|324383039|FG015|Primary Phase|Migrated/moved from study area|0|||
94706864|NCT01235949|324383040|FG016|Primary Phase|Migrated/moved from study area|0|||
94706865|NCT01235949|324383041|FG017|Primary Phase|Migrated/moved from study area|0|||
94706866|NCT01235949|324383024|FG000|Primary Phase|Adverse Event|0|||
94706867|NCT01235949|324383025|FG001|Primary Phase|Adverse Event|0|||
94706868|NCT01235949|324383026|FG002|Primary Phase|Adverse Event|0|||
94706869|NCT01235949|324383027|FG003|Primary Phase|Adverse Event|1|||
94706870|NCT01235949|324383028|FG004|Primary Phase|Adverse Event|0|||
94706871|NCT01235949|324383029|FG005|Primary Phase|Adverse Event|0|||
94706872|NCT01235949|324383030|FG006|Primary Phase|Adverse Event|0|||
94706873|NCT01235949|324383031|FG007|Primary Phase|Adverse Event|0|||
94706874|NCT01235949|324383032|FG008|Primary Phase|Adverse Event|0|||
94706875|NCT01235949|324383033|FG009|Primary Phase|Adverse Event|0|||
94706876|NCT01235949|324383034|FG010|Primary Phase|Adverse Event|0|||
94706877|NCT01235949|324383035|FG011|Primary Phase|Adverse Event|0|||
94706878|NCT01235949|324383036|FG012|Primary Phase|Adverse Event|0|||
94706879|NCT01235949|324383037|FG013|Primary Phase|Adverse Event|0|||
94706880|NCT01235949|324383038|FG014|Primary Phase|Adverse Event|0|||
94706881|NCT01235949|324383039|FG015|Primary Phase|Adverse Event|0|||
94706882|NCT01235949|324383040|FG016|Primary Phase|Adverse Event|0|||
94706883|NCT01235949|324383041|FG017|Primary Phase|Adverse Event|0|||
94706884|NCT01235949|324383024|FG000|Primary Phase|Withdrawal by Subject|3|||
94706885|NCT01235949|324383025|FG001|Primary Phase|Withdrawal by Subject|2|||
94706886|NCT01235949|324383026|FG002|Primary Phase|Withdrawal by Subject|2|||
94706887|NCT01235949|324383027|FG003|Primary Phase|Withdrawal by Subject|0|||
94706888|NCT01235949|324383028|FG004|Primary Phase|Withdrawal by Subject|0|||
94706889|NCT01235949|324383029|FG005|Primary Phase|Withdrawal by Subject|3|||
94706890|NCT01235949|324383030|FG006|Primary Phase|Withdrawal by Subject|0|||
94706891|NCT01235949|324383031|FG007|Primary Phase|Withdrawal by Subject|0|||
94706892|NCT01235949|324383032|FG008|Primary Phase|Withdrawal by Subject|0|||
94706893|NCT01235949|324383033|FG009|Primary Phase|Withdrawal by Subject|0|||
94706894|NCT01235949|324383034|FG010|Primary Phase|Withdrawal by Subject|0|||
94706895|NCT01235949|324383035|FG011|Primary Phase|Withdrawal by Subject|0|||
94706896|NCT01235949|324383036|FG012|Primary Phase|Withdrawal by Subject|0|||
94706897|NCT01235949|324383037|FG013|Primary Phase|Withdrawal by Subject|0|||
94706898|NCT01235949|324383038|FG014|Primary Phase|Withdrawal by Subject|0|||
94706899|NCT01235949|324383039|FG015|Primary Phase|Withdrawal by Subject|0|||
94706900|NCT01235949|324383040|FG016|Primary Phase|Withdrawal by Subject|0|||
94706901|NCT01235949|324383041|FG017|Primary Phase|Withdrawal by Subject|0|||
94706902|NCT01235949|324383024|FG000|Primary Phase|Lost to Follow-up|0|||
94706903|NCT01235949|324383025|FG001|Primary Phase|Lost to Follow-up|0|||
94706904|NCT01235949|324383026|FG002|Primary Phase|Lost to Follow-up|1|||
94706905|NCT01235949|324383027|FG003|Primary Phase|Lost to Follow-up|1|||
94706906|NCT01235949|324383028|FG004|Primary Phase|Lost to Follow-up|0|||
94706907|NCT01235949|324383029|FG005|Primary Phase|Lost to Follow-up|2|||
94706908|NCT01235949|324383030|FG006|Primary Phase|Lost to Follow-up|0|||
94706909|NCT01235949|324383031|FG007|Primary Phase|Lost to Follow-up|0|||
94706910|NCT01235949|324383032|FG008|Primary Phase|Lost to Follow-up|0|||
94706911|NCT01235949|324383033|FG009|Primary Phase|Lost to Follow-up|0|||
94706912|NCT01235949|324383034|FG010|Primary Phase|Lost to Follow-up|0|||
94706913|NCT01235949|324383035|FG011|Primary Phase|Lost to Follow-up|0|||
94706914|NCT01235949|324383036|FG012|Primary Phase|Lost to Follow-up|0|||
94706915|NCT01235949|324383037|FG013|Primary Phase|Lost to Follow-up|0|||
94706916|NCT01235949|324383038|FG014|Primary Phase|Lost to Follow-up|0|||
94706917|NCT01235949|324383039|FG015|Primary Phase|Lost to Follow-up|0|||
94706918|NCT01235949|324383040|FG016|Primary Phase|Lost to Follow-up|0|||
94706919|NCT01235949|324383041|FG017|Primary Phase|Lost to Follow-up|0|||
94706920|NCT01235949|324383024|FG000|Booster Phase|Migrated/moved from study area|0|||
94706921|NCT01235949|324383025|FG001|Booster Phase|Migrated/moved from study area|0|||
94706922|NCT01235949|324383026|FG002|Booster Phase|Migrated/moved from study area|0|||
94706923|NCT01235949|324383027|FG003|Booster Phase|Migrated/moved from study area|0|||
94706924|NCT01235949|324383028|FG004|Booster Phase|Migrated/moved from study area|0|||
94366671|NCT00566631|323128122|FG000|Part 2: Extension Phase|Other|5|||
94706925|NCT01235949|324383029|FG005|Booster Phase|Migrated/moved from study area|0|||
94706926|NCT01235949|324383030|FG006|Booster Phase|Migrated/moved from study area|0|||
94706927|NCT01235949|324383031|FG007|Booster Phase|Migrated/moved from study area|0|||
94366672|NCT00127192|323128123|FG000|Overall Study|Adverse Event|0|||
94706928|NCT01235949|324383032|FG008|Booster Phase|Migrated/moved from study area|0|||
94706929|NCT01235949|324383033|FG009|Booster Phase|Migrated/moved from study area|0|||
94706930|NCT01235949|324383034|FG010|Booster Phase|Migrated/moved from study area|0|||
94706931|NCT01235949|324383035|FG011|Booster Phase|Migrated/moved from study area|1|||
94706932|NCT01235949|324383036|FG012|Booster Phase|Migrated/moved from study area|1|||
94266843|NCT00884325|322771966|FG001|Overall Study|Not provided|0|||
94266844|NCT00709111|322771967|FG000|Overall Study|Withdrawal by Subject|1|||
94266845|NCT00709111|322771967|FG000|Overall Study|Unable to attend clinic visits|1|||
94266846|NCT00915772|322771972|FG000|Overall Study|Adverse Event|12|||
94266847|NCT00915772|322771973|FG001|Overall Study|Adverse Event|13|||
94266848|NCT00915772|322771974|FG002|Overall Study|Adverse Event|11|||
94266849|NCT00915772|322771972|FG000|Overall Study|Protocol Violation|4|||
94266850|NCT00915772|322771973|FG001|Overall Study|Protocol Violation|1|||
94266851|NCT00915772|322771974|FG002|Overall Study|Protocol Violation|2|||
94266852|NCT00915772|322771972|FG000|Overall Study|Lost to Follow-up|1|||
94266853|NCT00915772|322771973|FG001|Overall Study|Lost to Follow-up|2|||
94266854|NCT00915772|322771974|FG002|Overall Study|Lost to Follow-up|2|||
94266855|NCT00915772|322771972|FG000|Overall Study|Lack of Efficacy|9|||
94266856|NCT00915772|322771973|FG001|Overall Study|Lack of Efficacy|15|||
94266857|NCT00915772|322771974|FG002|Overall Study|Lack of Efficacy|3|||
94266858|NCT00915772|322771972|FG000|Overall Study|Refused to continue trial medication|6|||
94266859|NCT00915772|322771973|FG001|Overall Study|Refused to continue trial medication|8|||
94266860|NCT00915772|322771974|FG002|Overall Study|Refused to continue trial medication|4|||
94266861|NCT00915772|322771972|FG000|Overall Study|Any other reason|4|||
94266862|NCT00915772|322771973|FG001|Overall Study|Any other reason|7|||
94266863|NCT00915772|322771974|FG002|Overall Study|Any other reason|7|||
94706933|NCT01235949|324383037|FG013|Booster Phase|Migrated/moved from study area|0|||
94706934|NCT01235949|324383038|FG014|Booster Phase|Migrated/moved from study area|0|||
94706935|NCT01235949|324383039|FG015|Booster Phase|Migrated/moved from study area|0|||
94706936|NCT01235949|324383040|FG016|Booster Phase|Migrated/moved from study area|0|||
94706937|NCT01235949|324383041|FG017|Booster Phase|Migrated/moved from study area|1|||
94706938|NCT01235949|324383024|FG000|Booster Phase|Adverse Event|0|||
94706939|NCT01235949|324383025|FG001|Booster Phase|Adverse Event|0|||
94706940|NCT01235949|324383026|FG002|Booster Phase|Adverse Event|0|||
94706941|NCT01235949|324383027|FG003|Booster Phase|Adverse Event|0|||
94706942|NCT01235949|324383028|FG004|Booster Phase|Adverse Event|0|||
94706943|NCT01235949|324383029|FG005|Booster Phase|Adverse Event|0|||
94706944|NCT01235949|324383030|FG006|Booster Phase|Adverse Event|0|||
94706945|NCT01235949|324383031|FG007|Booster Phase|Adverse Event|0|||
94706946|NCT01235949|324383032|FG008|Booster Phase|Adverse Event|0|||
94706947|NCT01235949|324383033|FG009|Booster Phase|Adverse Event|0|||
94706948|NCT01235949|324383034|FG010|Booster Phase|Adverse Event|0|||
94706949|NCT01235949|324383035|FG011|Booster Phase|Adverse Event|0|||
94706950|NCT01235949|324383036|FG012|Booster Phase|Adverse Event|0|||
94706951|NCT01235949|324383037|FG013|Booster Phase|Adverse Event|0|||
94706952|NCT01235949|324383038|FG014|Booster Phase|Adverse Event|0|||
94706953|NCT01235949|324383039|FG015|Booster Phase|Adverse Event|1|||
94706954|NCT01235949|324383040|FG016|Booster Phase|Adverse Event|0|||
94706955|NCT01235949|324383041|FG017|Booster Phase|Adverse Event|0|||
94706956|NCT01235949|324383024|FG000|Booster Phase|Withdrawal by Subject|0|||
94706957|NCT01235949|324383025|FG001|Booster Phase|Withdrawal by Subject|0|||
94706958|NCT01235949|324383026|FG002|Booster Phase|Withdrawal by Subject|0|||
94706959|NCT01235949|324383027|FG003|Booster Phase|Withdrawal by Subject|0|||
94706960|NCT01235949|324383028|FG004|Booster Phase|Withdrawal by Subject|0|||
94706961|NCT01235949|324383029|FG005|Booster Phase|Withdrawal by Subject|0|||
94706962|NCT01235949|324383030|FG006|Booster Phase|Withdrawal by Subject|0|||
94706963|NCT01235949|324383031|FG007|Booster Phase|Withdrawal by Subject|1|||
94706964|NCT01235949|324383032|FG008|Booster Phase|Withdrawal by Subject|1|||
94706965|NCT01235949|324383033|FG009|Booster Phase|Withdrawal by Subject|0|||
94706966|NCT01235949|324383034|FG010|Booster Phase|Withdrawal by Subject|1|||
94706967|NCT01235949|324383035|FG011|Booster Phase|Withdrawal by Subject|1|||
94706968|NCT01235949|324383036|FG012|Booster Phase|Withdrawal by Subject|2|||
94266864|NCT01446016|322771977|FG000|Overall Study|Lost to Follow-up|3|||
94706969|NCT01235949|324383037|FG013|Booster Phase|Withdrawal by Subject|0|||
94706970|NCT01235949|324383038|FG014|Booster Phase|Withdrawal by Subject|2|||
94706971|NCT01235949|324383039|FG015|Booster Phase|Withdrawal by Subject|0|||
94266865|NCT01446016|322771977|FG000|Overall Study|Withdrawal by Subject|1|||
94266866|NCT01446016|322771977|FG000|Overall Study|Toxicity|3|||
94266867|NCT00791258|322771986|FG000|Overall Study|Adverse Event|87|||
94706972|NCT01235949|324383040|FG016|Booster Phase|Withdrawal by Subject|0|||
94706973|NCT01235949|324383041|FG017|Booster Phase|Withdrawal by Subject|0|||
94266868|NCT00791258|322771986|FG000|Overall Study|Lost to Follow-up|18|||
94266869|NCT00791258|322771986|FG000|Overall Study|Protocol Violation|109|||
94706974|NCT01235949|324383024|FG000|Booster Phase|Lost to Follow-up|0|||
94706975|NCT01235949|324383025|FG001|Booster Phase|Lost to Follow-up|0|||
94706976|NCT01235949|324383026|FG002|Booster Phase|Lost to Follow-up|0|||
94706977|NCT01235949|324383027|FG003|Booster Phase|Lost to Follow-up|0|||
94706978|NCT01235949|324383028|FG004|Booster Phase|Lost to Follow-up|0|||
94706979|NCT01235949|324383029|FG005|Booster Phase|Lost to Follow-up|0|||
94706980|NCT01235949|324383030|FG006|Booster Phase|Lost to Follow-up|0|||
94266870|NCT00791258|322771986|FG000|Overall Study|Withdrawal by Subject|40|||
94266871|NCT00791258|322771986|FG000|Overall Study|Did not take medication for >3 days|1|||
94266872|NCT00791258|322771986|FG000|Overall Study|subject left area|2|||
94266873|NCT00791258|322771986|FG000|Overall Study|non-compliance|3|||
94706981|NCT01235949|324383031|FG007|Booster Phase|Lost to Follow-up|0|||
94706982|NCT01235949|324383032|FG008|Booster Phase|Lost to Follow-up|1|||
94706983|NCT01235949|324383033|FG009|Booster Phase|Lost to Follow-up|1|||
94706984|NCT01235949|324383034|FG010|Booster Phase|Lost to Follow-up|1|||
94706985|NCT01235949|324383035|FG011|Booster Phase|Lost to Follow-up|1|||
94266874|NCT00791258|322771986|FG000|Overall Study|Subject incarcerated|1|||
94266875|NCT00791258|322771986|FG000|Overall Study|Subject required restricted medication|1|||
94706986|NCT01235949|324383036|FG012|Booster Phase|Lost to Follow-up|0|||
94706987|NCT01235949|324383037|FG013|Booster Phase|Lost to Follow-up|0|||
94706988|NCT01235949|324383038|FG014|Booster Phase|Lost to Follow-up|0|||
94706989|NCT01235949|324383039|FG015|Booster Phase|Lost to Follow-up|0|||
94706990|NCT01235949|324383040|FG016|Booster Phase|Lost to Follow-up|0|||
94706991|NCT01235949|324383041|FG017|Booster Phase|Lost to Follow-up|1|||
94706992|NCT00754936|324383042|FG000|Overall Study|Lost to Follow-up|3|||
94706993|NCT00754936|324383042|FG000|Overall Study|Physician Decision|1|||
94706994|NCT00754936|324383042|FG000|Overall Study|Withdrawal by Subject|2|||
94706995|NCT00754936|324383042|FG000|Overall Study|Side Effects|3|||
94266876|NCT00791258|322771986|FG000|Overall Study|Lack of Efficacy|1|||
94266877|NCT01423812|322771987|FG000|Overall Study|Lost to Follow-up|2|||
94266878|NCT01423812|322771988|FG001|Overall Study|Lost to Follow-up|2|||
94266879|NCT01423812|322771987|FG000|Overall Study|Withdrawal by Subject|1|||
94266880|NCT01423812|322771988|FG001|Overall Study|Withdrawal by Subject|2|||
94266881|NCT02445755|322772001|FG000|Overall Study|Withdrawal by Subject|2|||
94266882|NCT02445755|322772001|FG000|Overall Study|Protocol Violation|6|||
94266883|NCT02445755|322772001|FG000|Overall Study|Screen Failure|5|||
94266884|NCT01241552|322772002|FG000|Overall Study|Lack of Efficacy|1|||
94706996|NCT00754936|324383042|FG000|Overall Study|Inter-current medical events|3|||
94706997|NCT00436644|324383043|FG000|Overall Study|Adverse Event|2|||
94706998|NCT00436644|324383043|FG000|Overall Study|Death|1|||
94706999|NCT00619645|324383045|FG000|Overall Study|Adverse Event|1|||
94707000|NCT03743246|324383046|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
94707001|NCT03743246|324383047|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
94707002|NCT03743246|324383048|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
94707003|NCT03743246|324383049|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
94707004|NCT03743246|324383046|FG000|Pre-Treatment Period|Death|0|||
94707005|NCT03743246|324383047|FG001|Pre-Treatment Period|Death|1|||
94707006|NCT03743246|324383048|FG002|Pre-Treatment Period|Death|0|||
94707007|NCT03743246|324383049|FG003|Pre-Treatment Period|Death|1|||
94707008|NCT03743246|324383046|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
94707009|NCT03743246|324383047|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
94707010|NCT03743246|324383048|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
94707011|NCT03743246|324383049|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
94707012|NCT03743246|324383046|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
94707013|NCT03743246|324383047|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
94707014|NCT03743246|324383048|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
94707015|NCT03743246|324383049|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
94707016|NCT03743246|324383046|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
94707017|NCT03743246|324383047|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
94707018|NCT03743246|324383048|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
94707019|NCT03743246|324383049|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
94707020|NCT03743246|324383046|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
94707021|NCT03743246|324383047|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
94707022|NCT03743246|324383048|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
94707023|NCT03743246|324383049|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
94707024|NCT03743246|324383046|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
94707025|NCT03743246|324383047|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
94707026|NCT03743246|324383048|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
94707027|NCT03743246|324383049|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
94707028|NCT03743246|324383046|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
94266885|NCT01241552|322772003|FG001|Overall Study|Lack of Efficacy|0|||
94266886|NCT01241552|322772004|FG002|Overall Study|Lack of Efficacy|0|||
94266887|NCT01241552|322772005|FG003|Overall Study|Lack of Efficacy|0|||
94707029|NCT03743246|324383047|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
94707030|NCT03743246|324383048|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
94707031|NCT03743246|324383049|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
94707032|NCT03743246|324383046|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
94707033|NCT03743246|324383047|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
94707034|NCT03743246|324383048|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
94707035|NCT03743246|324383049|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
94707036|NCT04173572|324383050|FG000|Overall Study|Withdrawal by Subject|1|||
94707037|NCT04173572|324383051|FG001|Overall Study|Withdrawal by Subject|5|||
94266888|NCT01241552|322772002|FG000|Overall Study|Death|26|||
94266889|NCT01241552|322772003|FG001|Overall Study|Death|30|||
94707038|NCT04173572|324383050|FG000|Overall Study|Lost to Follow-up|3|||
94707039|NCT04173572|324383051|FG001|Overall Study|Lost to Follow-up|1|||
94707040|NCT00949975|324383052|FG000|Overall Study|Voluntary discontinuation|6|||
94707041|NCT00949975|324383053|FG001|Overall Study|Voluntary discontinuation|5|||
94707042|NCT00949975|324383054|FG002|Overall Study|Voluntary discontinuation|3|||
94707043|NCT00949975|324383055|FG003|Overall Study|Voluntary discontinuation|6|||
94707044|NCT00949975|324383052|FG000|Overall Study|Adverse Event|11|||
94707045|NCT00949975|324383053|FG001|Overall Study|Adverse Event|11|||
94707046|NCT00949975|324383054|FG002|Overall Study|Adverse Event|10|||
94707047|NCT00949975|324383055|FG003|Overall Study|Adverse Event|10|||
94707048|NCT00949975|324383052|FG000|Overall Study|Safety reason|0|||
94707049|NCT00949975|324383053|FG001|Overall Study|Safety reason|1|||
94707050|NCT00949975|324383054|FG002|Overall Study|Safety reason|0|||
94707051|NCT00949975|324383055|FG003|Overall Study|Safety reason|0|||
94707052|NCT00949975|324383052|FG000|Overall Study|Study-specific criteria|0|||
94707053|NCT00949975|324383053|FG001|Overall Study|Study-specific criteria|1|||
94707054|NCT00949975|324383054|FG002|Overall Study|Study-specific criteria|1|||
94707055|NCT00949975|324383055|FG003|Overall Study|Study-specific criteria|0|||
94707056|NCT00949975|324383052|FG000|Overall Study|Incorrect enrolment|5|||
94707057|NCT00949975|324383053|FG001|Overall Study|Incorrect enrolment|10|||
94707058|NCT00949975|324383054|FG002|Overall Study|Incorrect enrolment|4|||
94707059|NCT00949975|324383055|FG003|Overall Study|Incorrect enrolment|7|||
94707060|NCT00949975|324383052|FG000|Overall Study|Severe non-compliance|3|||
94707061|NCT00949975|324383053|FG001|Overall Study|Severe non-compliance|1|||
94707062|NCT00949975|324383054|FG002|Overall Study|Severe non-compliance|0|||
94707063|NCT00949975|324383055|FG003|Overall Study|Severe non-compliance|2|||
94707064|NCT00949975|324383052|FG000|Overall Study|Lost to Follow-up|1|||
94707065|NCT00949975|324383053|FG001|Overall Study|Lost to Follow-up|0|||
94707066|NCT00949975|324383054|FG002|Overall Study|Lost to Follow-up|1|||
94707067|NCT00949975|324383055|FG003|Overall Study|Lost to Follow-up|3|||
94707068|NCT00949975|324383052|FG000|Overall Study|Other|1|||
94707069|NCT00949975|324383053|FG001|Overall Study|Other|0|||
94707070|NCT00949975|324383054|FG002|Overall Study|Other|0|||
94707071|NCT00949975|324383055|FG003|Overall Study|Other|0|||
94707072|NCT00410124|324383068|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
94707073|NCT00410124|324383069|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
94707074|NCT00410124|324383068|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
94707075|NCT00410124|324383069|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
94707076|NCT00410124|324383068|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
94707077|NCT00410124|324383069|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
94707078|NCT00410124|324383068|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
94707079|NCT00410124|324383069|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
94707080|NCT00410124|324383068|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
94707081|NCT00410124|324383069|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
94707082|NCT00410124|324383068|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
94707083|NCT00410124|324383069|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
94707084|NCT00410124|324383068|FG000|Core Phase Double Blind (15 Months)|Death|7|||
94707085|NCT00410124|324383069|FG001|Core Phase Double Blind (15 Months)|Death|4|||
94707086|NCT00410124|324383068|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
94707087|NCT00410124|324383069|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
94707088|NCT00410124|324383068|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
94707089|NCT00410124|324383069|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
94707090|NCT00410124|324383068|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
94707091|NCT00410124|324383069|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
94707092|NCT00410124|324383068|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
94707093|NCT00410124|324383069|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
94707094|NCT00410124|324383068|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
94707095|NCT00410124|324383069|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
94707096|NCT00410124|324383068|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
94707097|NCT00410124|324383069|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
94707098|NCT00410124|324383068|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
94707099|NCT00410124|324383069|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
94707100|NCT00410124|324383068|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
94707101|NCT00410124|324383069|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
94707102|NCT00410124|324383068|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
94707103|NCT00410124|324383069|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
94707104|NCT00716144|324383070|FG000|Overall Study|Withdrawal by Subject|4|||
94707105|NCT00716144|324383071|FG001|Overall Study|Withdrawal by Subject|2|||
94707106|NCT00716144|324383072|FG002|Overall Study|Withdrawal by Subject|6|||
94707107|NCT00716144|324383073|FG003|Overall Study|Withdrawal by Subject|6|||
94707108|NCT00716144|324383070|FG000|Overall Study|Lost to Follow-up|2|||
94707109|NCT00716144|324383071|FG001|Overall Study|Lost to Follow-up|2|||
94707110|NCT00716144|324383072|FG002|Overall Study|Lost to Follow-up|1|||
94707111|NCT00716144|324383073|FG003|Overall Study|Lost to Follow-up|2|||
94707112|NCT00716144|324383070|FG000|Overall Study|Adverse Event|0|||
94707113|NCT00716144|324383071|FG001|Overall Study|Adverse Event|0|||
94707114|NCT00716144|324383072|FG002|Overall Study|Adverse Event|0|||
94707115|NCT00716144|324383073|FG003|Overall Study|Adverse Event|2|||
94707116|NCT00716144|324383070|FG000|Overall Study|Non-compliance|1|||
94707117|NCT00716144|324383071|FG001|Overall Study|Non-compliance|0|||
94707118|NCT00716144|324383072|FG002|Overall Study|Non-compliance|0|||
94707119|NCT00716144|324383073|FG003|Overall Study|Non-compliance|0|||
94707120|NCT00716144|324383070|FG000|Overall Study|Protocol Violation|2|||
94707121|NCT00716144|324383071|FG001|Overall Study|Protocol Violation|0|||
94707122|NCT00716144|324383072|FG002|Overall Study|Protocol Violation|1|||
94707123|NCT00716144|324383073|FG003|Overall Study|Protocol Violation|0|||
94707124|NCT00716144|324383070|FG000|Overall Study|Physician Decision|0|||
94707125|NCT00716144|324383071|FG001|Overall Study|Physician Decision|1|||
94707126|NCT00716144|324383072|FG002|Overall Study|Physician Decision|2|||
94707127|NCT00716144|324383073|FG003|Overall Study|Physician Decision|2|||
94707128|NCT00716144|324383070|FG000|Overall Study|Intercurrent illness|0|||
94707129|NCT00716144|324383071|FG001|Overall Study|Intercurrent illness|0|||
94707130|NCT00716144|324383072|FG002|Overall Study|Intercurrent illness|1|||
94707131|NCT00716144|324383073|FG003|Overall Study|Intercurrent illness|0|||
94707132|NCT00716144|324383070|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
94707133|NCT00716144|324383071|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
94707134|NCT00716144|324383072|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
94707135|NCT00716144|324383073|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
94707136|NCT00716144|324383070|FG000|Overall Study|Adverse event: left foot pain|0|||
94707137|NCT00716144|324383071|FG001|Overall Study|Adverse event: left foot pain|1|||
94707138|NCT00716144|324383072|FG002|Overall Study|Adverse event: left foot pain|0|||
94707139|NCT00716144|324383073|FG003|Overall Study|Adverse event: left foot pain|0|||
94707140|NCT00716144|324383070|FG000|Overall Study|Clinical Depression|0|||
94707141|NCT00716144|324383071|FG001|Overall Study|Clinical Depression|1|||
94707142|NCT00716144|324383072|FG002|Overall Study|Clinical Depression|0|||
94707143|NCT00716144|324383073|FG003|Overall Study|Clinical Depression|0|||
94707144|NCT01802632|324383074|FG000|Overall Study|Death|28|||
94707145|NCT01802632|324383075|FG001|Overall Study|Death|1|||
94707146|NCT01802632|324383076|FG002|Overall Study|Death|38|||
94707147|NCT01802632|324383077|FG003|Overall Study|Death|0|||
94707148|NCT01802632|324383078|FG004|Overall Study|Death|2|||
94707149|NCT01802632|324383079|FG005|Overall Study|Death|0|||
94707150|NCT01802632|324383074|FG000|Overall Study|Withdrawal by Subject|4|||
94707151|NCT01802632|324383075|FG001|Overall Study|Withdrawal by Subject|2|||
94707152|NCT01802632|324383076|FG002|Overall Study|Withdrawal by Subject|7|||
94707153|NCT01802632|324383077|FG003|Overall Study|Withdrawal by Subject|3|||
94707154|NCT01802632|324383078|FG004|Overall Study|Withdrawal by Subject|0|||
94707155|NCT01802632|324383079|FG005|Overall Study|Withdrawal by Subject|1|||
94707156|NCT01802632|324383074|FG000|Overall Study|Objective Disease Progression|1|||
94707157|NCT01802632|324383075|FG001|Overall Study|Objective Disease Progression|12|||
94707158|NCT01802632|324383076|FG002|Overall Study|Objective Disease Progression|104|||
94707159|NCT01802632|324383077|FG003|Overall Study|Objective Disease Progression|6|||
94707160|NCT01802632|324383078|FG004|Overall Study|Objective Disease Progression|4|||
94707161|NCT01802632|324383079|FG005|Overall Study|Objective Disease Progression|4|||
94707162|NCT01802632|324383074|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
94707163|NCT01802632|324383075|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
94366673|NCT00127192|323128124|FG001|Overall Study|Adverse Event|1|||
94707164|NCT01802632|324383076|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
94707165|NCT01802632|324383077|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
94707166|NCT01802632|324383078|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
94707167|NCT01802632|324383079|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
94707168|NCT01802632|324383074|FG000|Overall Study|Other (not specified)|0|||
94707169|NCT01802632|324383075|FG001|Overall Study|Other (not specified)|0|||
94707170|NCT01802632|324383076|FG002|Overall Study|Other (not specified)|7|||
94707171|NCT01802632|324383077|FG003|Overall Study|Other (not specified)|1|||
94707172|NCT01802632|324383078|FG004|Overall Study|Other (not specified)|0|||
94707173|NCT01802632|324383079|FG005|Overall Study|Other (not specified)|1|||
94707174|NCT00756730|324383082|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
94707175|NCT00756730|324383083|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
94707176|NCT00756730|324383082|FG000|Overall Study|persistent low-level viremmia|0|||
94707177|NCT00756730|324383083|FG001|Overall Study|persistent low-level viremmia|1|||
94707178|NCT03227757|324385105|FG000|Overall Study|Death|25|||
94707179|NCT03227757|324385105|FG000|Overall Study|Withdrawal|10|||
94707180|NCT03227757|324385105|FG000|Overall Study|Missed visits|1|||
94707181|NCT03227757|324385105|FG000|Overall Study|Lost to Follow-up|2|||
94707182|NCT02738840|324385106|FG000|Overall Study|MRI Scan not Performed|5|||
94707183|NCT02738840|324385106|FG000|Overall Study|Lost to Follow-up|1|||
94707184|NCT02738840|324385106|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
94707185|NCT02738840|324385106|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
94707186|NCT04048135|324385111|FG000|Overall Study|Withdrawal by Subject|1|||
94707187|NCT04048135|324385112|FG001|Overall Study|Withdrawal by Subject|1|||
94707188|NCT04048135|324385113|FG002|Overall Study|Withdrawal by Subject|1|||
94707189|NCT04048135|324385114|FG003|Overall Study|Withdrawal by Subject|2|||
94707190|NCT04048135|324385115|FG004|Overall Study|Withdrawal by Subject|0|||
94707191|NCT04048135|324385116|FG005|Overall Study|Withdrawal by Subject|0|||
94707192|NCT04048135|324385117|FG006|Overall Study|Withdrawal by Subject|1|||
94707193|NCT04048135|324385118|FG007|Overall Study|Withdrawal by Subject|1|||
94707194|NCT04048135|324385111|FG000|Overall Study|Adverse Event|0|||
94707195|NCT04048135|324385112|FG001|Overall Study|Adverse Event|0|||
94707196|NCT04048135|324385113|FG002|Overall Study|Adverse Event|0|||
94707197|NCT04048135|324385114|FG003|Overall Study|Adverse Event|1|||
94707198|NCT04048135|324385115|FG004|Overall Study|Adverse Event|1|||
94707199|NCT04048135|324385116|FG005|Overall Study|Adverse Event|0|||
94707200|NCT04048135|324385117|FG006|Overall Study|Adverse Event|0|||
94707201|NCT04048135|324385118|FG007|Overall Study|Adverse Event|0|||
94707202|NCT04048135|324385111|FG000|Overall Study|Protocol Violation|0|||
94707203|NCT04048135|324385112|FG001|Overall Study|Protocol Violation|0|||
94707204|NCT04048135|324385113|FG002|Overall Study|Protocol Violation|0|||
94707205|NCT04048135|324385114|FG003|Overall Study|Protocol Violation|0|||
94707206|NCT04048135|324385115|FG004|Overall Study|Protocol Violation|0|||
94707207|NCT04048135|324385116|FG005|Overall Study|Protocol Violation|1|||
94707208|NCT04048135|324385117|FG006|Overall Study|Protocol Violation|0|||
94707209|NCT04048135|324385118|FG007|Overall Study|Protocol Violation|0|||
94707210|NCT01677936|324385119|FG000|Overall Study|Lost to Follow-up|4|||
94707211|NCT01677936|324385120|FG001|Overall Study|Lost to Follow-up|1|||
94707212|NCT01677936|324385119|FG000|Overall Study|Protocol Violation|3|||
94707213|NCT01677936|324385120|FG001|Overall Study|Protocol Violation|0|||
94707214|NCT01677936|324385119|FG000|Overall Study|Adverse Event|1|||
94707215|NCT01677936|324385120|FG001|Overall Study|Adverse Event|0|||
94707216|NCT01677936|324385119|FG000|Overall Study|Lost to Follow-up|1|||
94707217|NCT01677936|324385120|FG001|Overall Study|Lost to Follow-up|0|||
94707218|NCT01677936|324385119|FG000|Overall Study|Protocol Violation|0|||
94707219|NCT01677936|324385120|FG001|Overall Study|Protocol Violation|4|||
94707220|NCT01091454|324385123|FG000|Overall Study|Ineligible|1|||
94707221|NCT03837028|324385124|FG000|Overall Study|Lost to Follow-up|4|||
94707222|NCT03837028|324385125|FG001|Overall Study|Lost to Follow-up|0|||
94707223|NCT03837028|324385126|FG002|Overall Study|Lost to Follow-up|2|||
94707224|NCT03837028|324385127|FG003|Overall Study|Lost to Follow-up|0|||
94707225|NCT03837028|324385124|FG000|Overall Study|Withdrawal by Subject|12|||
94707226|NCT03837028|324385125|FG001|Overall Study|Withdrawal by Subject|11|||
94707227|NCT03837028|324385126|FG002|Overall Study|Withdrawal by Subject|11|||
94707228|NCT03837028|324385127|FG003|Overall Study|Withdrawal by Subject|7|||
94707229|NCT00486759|324385131|FG000|Treatment|Adverse event/intercurrent illness|86|||
94707230|NCT00486759|324385132|FG001|Treatment|Adverse event/intercurrent illness|39|||
94707231|NCT00486759|324385131|FG000|Treatment|Insufficient therapeutic response|37|||
94707232|NCT00486759|324385132|FG001|Treatment|Insufficient therapeutic response|39|||
94707233|NCT00486759|324385131|FG000|Treatment|Death|17|||
94707234|NCT00486759|324385132|FG001|Treatment|Death|10|||
94707235|NCT00486759|324385131|FG000|Treatment|Withdrew consent|15|||
94707236|NCT00486759|324385132|FG001|Treatment|Withdrew consent|12|||
94707237|NCT00486759|324385131|FG000|Treatment|Administrative/reason not specified|17|||
94707238|NCT00486759|324385132|FG001|Treatment|Administrative/reason not specified|21|||
94707239|NCT00486759|324385131|FG000|Treatment|Refused treatment|10|||
94707240|NCT00486759|324385132|FG001|Treatment|Refused treatment|7|||
94707241|NCT00486759|324385131|FG000|Treatment|Violation of selection criteria at entry|3|||
94707242|NCT00486759|324385132|FG001|Treatment|Violation of selection criteria at entry|3|||
94707243|NCT00486759|324385131|FG000|Treatment|Other protocol violation|1|||
94707244|NCT00486759|324385132|FG001|Treatment|Other protocol violation|5|||
94707245|NCT00486759|324385131|FG000|Treatment|Failure to return|1|||
94707246|NCT00486759|324385132|FG001|Treatment|Failure to return|1|||
94707247|NCT00486759|324385131|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
94707248|NCT00486759|324385132|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
94707249|NCT00486759|324385131|FG000|Safety Follow-up|Death|40|||
94707250|NCT00486759|324385132|FG001|Safety Follow-up|Death|29|||
94707251|NCT00486759|324385131|FG000|Safety Follow-up|Withdrew consent|32|||
94707252|NCT00486759|324385132|FG001|Safety Follow-up|Withdrew consent|23|||
94707253|NCT00486759|324385131|FG000|Safety Follow-up|Failure to return|9|||
94707254|NCT00486759|324385132|FG001|Safety Follow-up|Failure to return|6|||
94707255|NCT00486759|324385131|FG000|Safety Follow-up|Administrative/not specified|8|||
94707256|NCT00486759|324385132|FG001|Safety Follow-up|Administrative/not specified|6|||
94707257|NCT00486759|324385131|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
94707258|NCT00486759|324385132|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
94707259|NCT00486759|324385131|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
94707260|NCT00486759|324385132|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
94707261|NCT02715258|324385136|FG000|Overall Study|Withdrawal by Subject|6|||
94707262|NCT02715258|324385137|FG001|Overall Study|Withdrawal by Subject|1|||
94707263|NCT02715258|324385136|FG000|Overall Study|Lost to Follow-up|7|||
94707264|NCT02715258|324385137|FG001|Overall Study|Lost to Follow-up|1|||
94707265|NCT02715258|324385136|FG000|Overall Study|Terminated by Sponsor|0|||
94707266|NCT02715258|324385137|FG001|Overall Study|Terminated by Sponsor|1|||
94707267|NCT02715258|324385136|FG000|Overall Study|Death|0|||
94707268|NCT02715258|324385137|FG001|Overall Study|Death|1|||
94707269|NCT02715258|324385136|FG000|Overall Study|Subject non-compliant|1|||
94707270|NCT02715258|324385137|FG001|Overall Study|Subject non-compliant|1|||
94707271|NCT02715258|324385136|FG000|Overall Study|GCP violation|2|||
94707272|NCT02715258|324385137|FG001|Overall Study|GCP violation|1|||
94707273|NCT00487578|324385138|FG000|Overall Study|Adverse Event|1|||
94707274|NCT00487578|324385139|FG001|Overall Study|Adverse Event|2|||
94707275|NCT00487578|324385138|FG000|Overall Study|Lack of Efficacy|0|||
94707276|NCT00487578|324385139|FG001|Overall Study|Lack of Efficacy|1|||
94707277|NCT00487578|324385138|FG000|Overall Study|Lost to Follow-up|0|||
94707278|NCT00487578|324385139|FG001|Overall Study|Lost to Follow-up|1|||
94707279|NCT00708032|324385142|FG000|Overall Study|Adverse Event|0|||
94707280|NCT00708032|324385143|FG001|Overall Study|Adverse Event|2|||
94707281|NCT00708032|324385142|FG000|Overall Study|Lost to Follow-up|1|||
94707282|NCT00708032|324385143|FG001|Overall Study|Lost to Follow-up|2|||
94707283|NCT00708032|324385142|FG000|Overall Study|Pregnancy|0|||
94707284|NCT00708032|324385143|FG001|Overall Study|Pregnancy|1|||
94707285|NCT00708032|324385142|FG000|Overall Study|Poor vision|0|||
94707286|NCT00708032|324385143|FG001|Overall Study|Poor vision|6|||
94707287|NCT00708032|324385142|FG000|Overall Study|Visit out of range at month 12|4|||
94707288|NCT00708032|324385143|FG001|Overall Study|Visit out of range at month 12|1|||
94707289|NCT00708032|324385142|FG000|Overall Study|Did not meet protocol criteria|1|||
94707290|NCT00708032|324385143|FG001|Overall Study|Did not meet protocol criteria|2|||
94707291|NCT00708032|324385142|FG000|Overall Study|Protocol Violation|4|||
94707292|NCT00708032|324385143|FG001|Overall Study|Protocol Violation|1|||
94707293|NCT00708032|324385142|FG000|Overall Study|Withdrawal by Subject|0|||
94707294|NCT00708032|324385143|FG001|Overall Study|Withdrawal by Subject|1|||
94707295|NCT01227278|324385144|FG000|Overall Study|Withdrawal by Subject|4|||
94707296|NCT01227278|324385145|FG001|Overall Study|Withdrawal by Subject|4|||
94707297|NCT01227278|324385144|FG000|Overall Study|Death|0|||
94707298|NCT01227278|324385145|FG001|Overall Study|Death|2|||
94707299|NCT01227278|324385144|FG000|Overall Study|Other|1|||
94707300|NCT01227278|324385145|FG001|Overall Study|Other|2|||
94707301|NCT00941655|324385146|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
94707302|NCT00941655|324385147|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
94707303|NCT00941655|324385146|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
94707304|NCT00941655|324385147|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
94707305|NCT00941655|324385146|FG000|Overall Study|progressed while on chemo|0|||
94707306|NCT00941655|324385147|FG001|Overall Study|progressed while on chemo|2|||
94266890|NCT01241552|322772004|FG002|Overall Study|Death|20|||
94707307|NCT00941655|324385146|FG000|Overall Study|refused further treatment|0|||
94707308|NCT00941655|324385147|FG001|Overall Study|refused further treatment|1|||
94707309|NCT00941655|324385146|FG000|Overall Study|withdrew consent|0|||
94707310|NCT00941655|324385147|FG001|Overall Study|withdrew consent|1|||
94707311|NCT00941655|324385146|FG000|Overall Study|non-compliant|0|||
94707312|NCT00941655|324385147|FG001|Overall Study|non-compliant|1|||
94707313|NCT02385669|324385148|FG000|Overall Study|Adverse Event|2|||
94707314|NCT02477670|324385149|FG000|Stage 1|Adverse Event|2|||
94707315|NCT02477670|324385150|FG001|Stage 1|Adverse Event|7|||
94707316|NCT02477670|324385151|FG002|Stage 1|Adverse Event|0|||
94707317|NCT02477670|324385152|FG003|Stage 1|Adverse Event|0|||
94707318|NCT02477670|324385153|FG004|Stage 1|Adverse Event|0|||
94707319|NCT02477670|324385154|FG005|Stage 1|Adverse Event|0|||
94707320|NCT02477670|324385155|FG006|Stage 1|Adverse Event|0|||
94707321|NCT02477670|324385149|FG000|Stage 1|Lost to Follow-up|0|||
94707322|NCT02477670|324385150|FG001|Stage 1|Lost to Follow-up|2|||
94707323|NCT02477670|324385151|FG002|Stage 1|Lost to Follow-up|0|||
94707324|NCT02477670|324385152|FG003|Stage 1|Lost to Follow-up|0|||
94707325|NCT02477670|324385153|FG004|Stage 1|Lost to Follow-up|0|||
94707326|NCT02477670|324385154|FG005|Stage 1|Lost to Follow-up|0|||
94707327|NCT02477670|324385155|FG006|Stage 1|Lost to Follow-up|0|||
94707328|NCT02477670|324385149|FG000|Stage 1|Withdrawal by Subject|1|||
94707329|NCT02477670|324385150|FG001|Stage 1|Withdrawal by Subject|2|||
94707330|NCT02477670|324385151|FG002|Stage 1|Withdrawal by Subject|0|||
94707331|NCT02477670|324385152|FG003|Stage 1|Withdrawal by Subject|0|||
94707332|NCT02477670|324385153|FG004|Stage 1|Withdrawal by Subject|0|||
94707333|NCT02477670|324385154|FG005|Stage 1|Withdrawal by Subject|0|||
94707334|NCT02477670|324385155|FG006|Stage 1|Withdrawal by Subject|0|||
94707335|NCT02477670|324385149|FG000|Stage 1|Non-compliance with Study Drug|1|||
94707336|NCT02477670|324385150|FG001|Stage 1|Non-compliance with Study Drug|2|||
94707337|NCT02477670|324385151|FG002|Stage 1|Non-compliance with Study Drug|0|||
94707338|NCT02477670|324385152|FG003|Stage 1|Non-compliance with Study Drug|0|||
94707339|NCT02477670|324385153|FG004|Stage 1|Non-compliance with Study Drug|0|||
94707340|NCT02477670|324385154|FG005|Stage 1|Non-compliance with Study Drug|0|||
94707341|NCT02477670|324385155|FG006|Stage 1|Non-compliance with Study Drug|0|||
94707342|NCT02477670|324385149|FG000|Stage 2|Adverse Event|0|||
94707343|NCT02477670|324385150|FG001|Stage 2|Adverse Event|0|||
94707344|NCT02477670|324385151|FG002|Stage 2|Adverse Event|1|||
94707345|NCT02477670|324385152|FG003|Stage 2|Adverse Event|0|||
94707346|NCT02477670|324385153|FG004|Stage 2|Adverse Event|0|||
94707347|NCT02477670|324385154|FG005|Stage 2|Adverse Event|0|||
94707348|NCT02477670|324385155|FG006|Stage 2|Adverse Event|0|||
94707349|NCT02477670|324385149|FG000|Stage 2|Antipsychotic Medication Changed|0|||
94707350|NCT02477670|324385150|FG001|Stage 2|Antipsychotic Medication Changed|0|||
94707351|NCT02477670|324385151|FG002|Stage 2|Antipsychotic Medication Changed|1|||
94707352|NCT02477670|324385152|FG003|Stage 2|Antipsychotic Medication Changed|0|||
94707353|NCT02477670|324385153|FG004|Stage 2|Antipsychotic Medication Changed|0|||
94707354|NCT02477670|324385154|FG005|Stage 2|Antipsychotic Medication Changed|0|||
94707355|NCT02477670|324385155|FG006|Stage 2|Antipsychotic Medication Changed|0|||
94707356|NCT02477670|324385149|FG000|Stage 2|Withdrawal by Subject|0|||
94707357|NCT02477670|324385150|FG001|Stage 2|Withdrawal by Subject|0|||
94707358|NCT02477670|324385151|FG002|Stage 2|Withdrawal by Subject|0|||
94707359|NCT02477670|324385152|FG003|Stage 2|Withdrawal by Subject|1|||
94707360|NCT02477670|324385153|FG004|Stage 2|Withdrawal by Subject|0|||
94707361|NCT02477670|324385154|FG005|Stage 2|Withdrawal by Subject|0|||
94707362|NCT02477670|324385155|FG006|Stage 2|Withdrawal by Subject|0|||
94707363|NCT01281813|324385162|FG000|Overall Study|Adverse Event|0|||
94707364|NCT01281813|324385163|FG001|Overall Study|Adverse Event|0|||
94707365|NCT01281813|324385164|FG002|Overall Study|Adverse Event|10|||
94707366|NCT01281813|324385162|FG000|Overall Study|Lost to Follow-up|0|||
94707367|NCT01281813|324385163|FG001|Overall Study|Lost to Follow-up|0|||
94707368|NCT01281813|324385164|FG002|Overall Study|Lost to Follow-up|31|||
94707369|NCT01281813|324385162|FG000|Overall Study|Withdrawal by Subject|0|||
94707370|NCT01281813|324385163|FG001|Overall Study|Withdrawal by Subject|0|||
94707371|NCT01281813|324385164|FG002|Overall Study|Withdrawal by Subject|13|||
94707372|NCT01281813|324385162|FG000|Overall Study|Subject Non-Compliant|0|||
94707373|NCT01281813|324385163|FG001|Overall Study|Subject Non-Compliant|0|||
94707374|NCT01281813|324385164|FG002|Overall Study|Subject Non-Compliant|6|||
94707375|NCT01281813|324385162|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
94707376|NCT01281813|324385163|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
94707377|NCT01281813|324385164|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
94707378|NCT01281813|324385162|FG000|Overall Study|Sponsor's Decision|4|||
94266891|NCT01241552|322772005|FG003|Overall Study|Death|25|||
94266892|NCT01241552|322772002|FG000|Overall Study|Adverse Event|1|||
94266893|NCT01241552|322772003|FG001|Overall Study|Adverse Event|1|||
94707379|NCT01281813|324385163|FG001|Overall Study|Sponsor's Decision|3|||
94707380|NCT01281813|324385164|FG002|Overall Study|Sponsor's Decision|7|||
94707381|NCT01281813|324385162|FG000|Overall Study|Switched to Commercially Available Medication|0|||
94707382|NCT01281813|324385163|FG001|Overall Study|Switched to Commercially Available Medication|0|||
94707383|NCT01281813|324385164|FG002|Overall Study|Switched to Commercially Available Medication|26|||
94707384|NCT01281813|324385162|FG000|Overall Study|Other|0|||
94707385|NCT01281813|324385163|FG001|Overall Study|Other|1|||
94707386|NCT01281813|324385164|FG002|Overall Study|Other|39|||
94266894|NCT01241552|322772004|FG002|Overall Study|Adverse Event|0|||
94707387|NCT03546907|324385165|FG000|Overall Study|Lack of Efficacy|1|||
94707388|NCT03546907|324385166|FG001|Overall Study|Lack of Efficacy|1|||
94707389|NCT03546907|324385165|FG000|Overall Study|Withdrawal by Subject|8|||
94707390|NCT03546907|324385166|FG001|Overall Study|Withdrawal by Subject|9|||
94707391|NCT03546907|324385165|FG000|Overall Study|Adverse events (AEs)|7|||
94707392|NCT03546907|324385166|FG001|Overall Study|Adverse events (AEs)|10|||
94266895|NCT01241552|322772005|FG003|Overall Study|Adverse Event|0|||
94266896|NCT01241552|322772002|FG000|Overall Study|Technical Problems|2|||
94707393|NCT03546907|324385165|FG000|Overall Study|Other-unspecified|1|||
94707394|NCT03546907|324385166|FG001|Overall Study|Other-unspecified|1|||
94707395|NCT00970307|324385167|FG000|Overall Study|Serious Adverse Event|1|||
94707396|NCT00970307|324385168|FG001|Overall Study|Serious Adverse Event|0|||
94707397|NCT00970307|324385169|FG002|Overall Study|Serious Adverse Event|0|||
94707398|NCT00970307|324385167|FG000|Overall Study|Withdrawal by Subject|2|||
94707399|NCT00970307|324385168|FG001|Overall Study|Withdrawal by Subject|3|||
94707400|NCT00970307|324385169|FG002|Overall Study|Withdrawal by Subject|2|||
94707401|NCT02937831|324385170|FG000|Overall Study|Protocol Violation|4|||
94707402|NCT02810080|324385171|FG000|Overall Study|Adverse Event|3|||
94707403|NCT02810080|324385172|FG001|Overall Study|Adverse Event|0|||
94707404|NCT02810080|324385171|FG000|Overall Study|Death|0|||
94707405|NCT02810080|324385172|FG001|Overall Study|Death|2|||
94707406|NCT02810080|324385171|FG000|Overall Study|Physician Decision|4|||
94707407|NCT02810080|324385172|FG001|Overall Study|Physician Decision|0|||
94707408|NCT02810080|324385171|FG000|Overall Study|Withdrawal by Subject|0|||
94707409|NCT02810080|324385172|FG001|Overall Study|Withdrawal by Subject|2|||
94707410|NCT05257798|324385173|FG000|Follow-up Phase|Lost to Follow-up|1|||
94707411|NCT05257798|324385174|FG001|Follow-up Phase|Lost to Follow-up|0|||
94707412|NCT03125382|324385175|FG000|Randomization|screening failure|1|||
94707413|NCT03125382|324385176|FG001|Randomization|screening failure|4|||
94707414|NCT03125382|324385177|FG002|Randomization|screening failure|2|||
94707415|NCT03125382|324385178|FG003|Randomization|screening failure|0|||
94707416|NCT03125382|324385175|FG000|Follow-up|Death|1|||
94707417|NCT03125382|324385176|FG001|Follow-up|Death|2|||
94707418|NCT03125382|324385177|FG002|Follow-up|Death|1|||
94707419|NCT03125382|324385178|FG003|Follow-up|Death|2|||
94707420|NCT03125382|324385175|FG000|Follow-up|Lost to Follow-up|1|||
94707421|NCT03125382|324385176|FG001|Follow-up|Lost to Follow-up|4|||
94707422|NCT03125382|324385177|FG002|Follow-up|Lost to Follow-up|3|||
94707423|NCT03125382|324385178|FG003|Follow-up|Lost to Follow-up|1|||
94707424|NCT02174562|324385181|FG000|Overall Study|Withdrawal by Subject|7|||
94707425|NCT02174562|324385182|FG001|Overall Study|Withdrawal by Subject|2|||
94707426|NCT02174562|324385181|FG000|Overall Study|Death|2|||
94707427|NCT02174562|324385182|FG001|Overall Study|Death|0|||
94707428|NCT02174562|324385181|FG000|Overall Study|Lost to Follow-up|0|||
94707429|NCT02174562|324385182|FG001|Overall Study|Lost to Follow-up|3|||
94707430|NCT00486330|324385183|FG000|Overall Study|Adverse Event|2|||
94707431|NCT01290224|324385184|FG000|Overall Study|Adverse Event|1|||
94707432|NCT01290224|324385184|FG000|Overall Study|Refused Further Treatment|4|||
94707433|NCT00853827|324385185|FG000|Single Blind Period (1 Week)|Other|4|||
94707434|NCT00853827|324385186|FG001|Single Blind Period (1 Week)|Other|0|||
94707435|NCT00853827|324385185|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
94707436|NCT00853827|324385186|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
94707437|NCT00853827|324385185|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
94707438|NCT00853827|324385186|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
94707439|NCT00853827|324385185|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
94707440|NCT00853827|324385186|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
94707441|NCT00853827|324385185|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
94707442|NCT00853827|324385186|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
94707443|NCT00853827|324385185|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
94707444|NCT00853827|324385186|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
94707445|NCT00853827|324385185|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
94707446|NCT00853827|324385186|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
94707447|NCT00853827|324385185|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
94707448|NCT00853827|324385186|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
94707449|NCT00853827|324385185|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
94707450|NCT00853827|324385186|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
94707451|NCT00853827|324385185|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
94707452|NCT00853827|324385186|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
94707453|NCT00853827|324385185|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
94707454|NCT00853827|324385186|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
94707455|NCT00853827|324385185|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
94707456|NCT00853827|324385186|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
94707457|NCT00853827|324385185|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
94707458|NCT00853827|324385186|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
94707459|NCT00853827|324385185|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
94707460|NCT00853827|324385186|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
94707461|NCT00853827|324385185|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
94707462|NCT00853827|324385186|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
94707463|NCT00853827|324385185|FG000|Double Blind Period (103 Weeks)|Death|1|||
94266897|NCT01241552|322772003|FG001|Overall Study|Technical Problems|0|||
94707464|NCT00853827|324385186|FG001|Double Blind Period (103 Weeks)|Death|6|||
94707465|NCT02957539|324385187|FG000|Baseline to Week 16|Lost to Follow-up|8|||
94707466|NCT02957539|324385188|FG001|Baseline to Week 16|Lost to Follow-up|10|||
94707467|NCT02957539|324385189|FG002|Baseline to Week 16|Lost to Follow-up|16|||
94707468|NCT02957539|324385187|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
94707469|NCT02957539|324385188|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
94707470|NCT02957539|324385189|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
94707471|NCT02957539|324385187|FG000|Week 16 to 32|Withdrawal by Subject|3|||
94707472|NCT02957539|324385188|FG001|Week 16 to 32|Withdrawal by Subject|3|||
94707473|NCT02957539|324385189|FG002|Week 16 to 32|Withdrawal by Subject|1|||
94707474|NCT02957539|324385187|FG000|Week 16 to 32|Lost to Follow-up|8|||
94707475|NCT02957539|324385188|FG001|Week 16 to 32|Lost to Follow-up|7|||
94707476|NCT02957539|324385189|FG002|Week 16 to 32|Lost to Follow-up|5|||
94707477|NCT02957539|324385187|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
94707478|NCT02957539|324385188|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
94707479|NCT02957539|324385189|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
94707480|NCT02957539|324385187|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
94707481|NCT02957539|324385188|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
94707482|NCT02957539|324385189|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
94707483|NCT00344019|324385190|FG000|Overall Study|did not meet final inclusion criteria|0|||
94707484|NCT00344019|324385191|FG001|Overall Study|did not meet final inclusion criteria|0|||
94707485|NCT00344019|324385192|FG002|Overall Study|did not meet final inclusion criteria|74|||
94707486|NCT01591616|324385197|FG000|Overall Study|Withdrawal by Subject|1|||
94707487|NCT01713530|324385198|FG000|Overall Study|Adverse Event|0|||
94707488|NCT01713530|324385199|FG001|Overall Study|Adverse Event|5|||
94707489|NCT01713530|324385198|FG000|Overall Study|Withdrawal criteria|21|||
94707490|NCT01713530|324385199|FG001|Overall Study|Withdrawal criteria|12|||
94707491|NCT01713530|324385198|FG000|Overall Study|Unclassified|4|||
94707492|NCT01713530|324385199|FG001|Overall Study|Unclassified|2|||
94707493|NCT00758602|324385200|FG000|Overall Study|Adverse Event|11|||
94707494|NCT00758602|324385201|FG001|Overall Study|Adverse Event|10|||
94707495|NCT00758602|324385200|FG000|Overall Study|Lost to Follow-up|4|||
94707496|NCT00758602|324385201|FG001|Overall Study|Lost to Follow-up|3|||
94707497|NCT00758602|324385200|FG000|Overall Study|Withdrawal by Subject|1|||
94707498|NCT00758602|324385201|FG001|Overall Study|Withdrawal by Subject|3|||
94707499|NCT00758602|324385200|FG000|Overall Study|Protocol Violation|0|||
94707500|NCT00758602|324385201|FG001|Overall Study|Protocol Violation|2|||
94707501|NCT00758602|324385200|FG000|Overall Study|Death|0|||
94707502|NCT00758602|324385201|FG001|Overall Study|Death|1|||
94707503|NCT00758602|324385200|FG000|Overall Study|Reason not specified|3|||
94707504|NCT00758602|324385201|FG001|Overall Study|Reason not specified|3|||
94707505|NCT03781336|324385202|FG000|Overall Study|Withdrawal by Subject|2|||
94707506|NCT03781336|324385203|FG001|Overall Study|Withdrawal by Subject|2|||
94707507|NCT00158054|324385204|FG000|Overall Study|Refused to continue|3|||
94707508|NCT00158054|324385205|FG001|Overall Study|Refused to continue|0|||
94707509|NCT00158054|324385204|FG000|Overall Study|Unavailable for follow up|7|||
94707510|NCT00158054|324385205|FG001|Overall Study|Unavailable for follow up|3|||
94707511|NCT00909363|324385206|FG000|Overall Study|Withdrawal by Subject|1|||
94707512|NCT00909363|324385207|FG001|Overall Study|Withdrawal by Subject|0|||
94707513|NCT00909363|324385208|FG002|Overall Study|Withdrawal by Subject|0|||
94707514|NCT00909363|324385206|FG000|Overall Study|Lack of Efficacy|1|||
94707515|NCT00909363|324385207|FG001|Overall Study|Lack of Efficacy|0|||
94707516|NCT00909363|324385208|FG002|Overall Study|Lack of Efficacy|0|||
94707517|NCT01069341|324385211|FG000|Overall Study|Lost to Follow-up|1|||
94707518|NCT02880241|324385214|FG000|Overall Study|Lack of Efficacy|1|||
94707519|NCT02880241|324385215|FG001|Overall Study|Lack of Efficacy|0|||
94707520|NCT02880241|324385216|FG002|Overall Study|Lack of Efficacy|0|||
94707521|NCT02880241|324385217|FG003|Overall Study|Lack of Efficacy|0|||
94707522|NCT02880241|324385218|FG004|Overall Study|Lack of Efficacy|0|||
94707523|NCT02880241|324385219|FG005|Overall Study|Lack of Efficacy|0|||
94707524|NCT02194933|324385220|FG000|Overall Study|Lost to Follow-up|1|||
94707525|NCT02194933|324385221|FG001|Overall Study|Lost to Follow-up|2|||
94707526|NCT02194933|324385220|FG000|Overall Study|Participant met withdrawal criteria|1|||
94366674|NCT00127192|323128125|FG002|Overall Study|Adverse Event|1|||
94707527|NCT02194933|324385221|FG001|Overall Study|Participant met withdrawal criteria|3|||
94707528|NCT02194933|324385220|FG000|Overall Study|Withdrawal by Subject|0|||
94707529|NCT02194933|324385221|FG001|Overall Study|Withdrawal by Subject|2|||
94707530|NCT02194933|324385220|FG000|Overall Study|Lack of Efficacy|1|||
94707531|NCT02194933|324385221|FG001|Overall Study|Lack of Efficacy|2|||
94366675|NCT00127192|323128126|FG003|Overall Study|Adverse Event|1|||
94707532|NCT02045836|324385222|FG000|Overall Study|Adverse Event|4|||
94707533|NCT02045836|324385223|FG001|Overall Study|Adverse Event|4|||
94707534|NCT02045836|324385222|FG000|Overall Study|Withdrawal by Subject|1|||
94707535|NCT02045836|324385223|FG001|Overall Study|Withdrawal by Subject|1|||
94707536|NCT02045836|324385222|FG000|Overall Study|Lost to Follow-up|4|||
94707537|NCT02045836|324385223|FG001|Overall Study|Lost to Follow-up|7|||
94707538|NCT02045836|324385222|FG000|Overall Study|Migrated from study area|0|||
94707539|NCT02045836|324385223|FG001|Overall Study|Migrated from study area|2|||
94707540|NCT02341625|324385224|FG000|Overall Study|Disease Progression|2|||
94707541|NCT02341625|324385225|FG001|Overall Study|Disease Progression|2|||
94707542|NCT02341625|324385226|FG002|Overall Study|Disease Progression|3|||
94707543|NCT02341625|324385227|FG003|Overall Study|Disease Progression|6|||
94707544|NCT02341625|324385228|FG004|Overall Study|Disease Progression|7|||
94707545|NCT02341625|324385229|FG005|Overall Study|Disease Progression|7|||
94707546|NCT02341625|324385230|FG006|Overall Study|Disease Progression|28|||
94707547|NCT02341625|324385231|FG007|Overall Study|Disease Progression|5|||
94707548|NCT02341625|324385232|FG008|Overall Study|Disease Progression|4|||
94707549|NCT02341625|324385233|FG009|Overall Study|Disease Progression|19|||
94707550|NCT02341625|324385224|FG000|Overall Study|Study Drug Toxicity|0|||
94707551|NCT02341625|324385225|FG001|Overall Study|Study Drug Toxicity|0|||
94707552|NCT02341625|324385226|FG002|Overall Study|Study Drug Toxicity|0|||
94707553|NCT02341625|324385227|FG003|Overall Study|Study Drug Toxicity|1|||
94707554|NCT02341625|324385228|FG004|Overall Study|Study Drug Toxicity|0|||
94707555|NCT02341625|324385229|FG005|Overall Study|Study Drug Toxicity|3|||
94707556|NCT02341625|324385230|FG006|Overall Study|Study Drug Toxicity|10|||
94707557|NCT02341625|324385231|FG007|Overall Study|Study Drug Toxicity|0|||
94707558|NCT02341625|324385232|FG008|Overall Study|Study Drug Toxicity|0|||
94707559|NCT02341625|324385233|FG009|Overall Study|Study Drug Toxicity|3|||
94707560|NCT02341625|324385224|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
94707561|NCT02341625|324385225|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
94707562|NCT02341625|324385226|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
94707563|NCT02341625|324385227|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
94707564|NCT02341625|324385228|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
94707565|NCT02341625|324385229|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
94707566|NCT02341625|324385230|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
94707567|NCT02341625|324385231|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
94707568|NCT02341625|324385232|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
94707569|NCT02341625|324385233|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
94707570|NCT02341625|324385224|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
94707571|NCT02341625|324385225|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
94707572|NCT02341625|324385226|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
94707573|NCT02341625|324385227|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
94707574|NCT02341625|324385228|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
94707575|NCT02341625|324385229|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
94707576|NCT02341625|324385230|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
94707577|NCT02341625|324385231|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
94707578|NCT02341625|324385232|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
94707579|NCT02341625|324385233|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
94707580|NCT02341625|324385224|FG000|Overall Study|Participant Withdrew Consent|0|||
94707581|NCT02341625|324385225|FG001|Overall Study|Participant Withdrew Consent|0|||
94707582|NCT02341625|324385226|FG002|Overall Study|Participant Withdrew Consent|0|||
94707583|NCT02341625|324385227|FG003|Overall Study|Participant Withdrew Consent|1|||
94707584|NCT02341625|324385228|FG004|Overall Study|Participant Withdrew Consent|0|||
94707585|NCT02341625|324385229|FG005|Overall Study|Participant Withdrew Consent|0|||
94707586|NCT02341625|324385230|FG006|Overall Study|Participant Withdrew Consent|0|||
94707587|NCT02341625|324385231|FG007|Overall Study|Participant Withdrew Consent|0|||
94707588|NCT02341625|324385232|FG008|Overall Study|Participant Withdrew Consent|0|||
94707589|NCT02341625|324385233|FG009|Overall Study|Participant Withdrew Consent|0|||
94707590|NCT02341625|324385224|FG000|Overall Study|Completed Treatment as per Protocol|0|||
94707591|NCT02341625|324385225|FG001|Overall Study|Completed Treatment as per Protocol|0|||
94707592|NCT02341625|324385226|FG002|Overall Study|Completed Treatment as per Protocol|0|||
94707593|NCT02341625|324385227|FG003|Overall Study|Completed Treatment as per Protocol|0|||
94707594|NCT02341625|324385228|FG004|Overall Study|Completed Treatment as per Protocol|0|||
94707595|NCT02341625|324385229|FG005|Overall Study|Completed Treatment as per Protocol|0|||
94707596|NCT02341625|324385230|FG006|Overall Study|Completed Treatment as per Protocol|0|||
94707597|NCT02341625|324385231|FG007|Overall Study|Completed Treatment as per Protocol|0|||
94707598|NCT02341625|324385232|FG008|Overall Study|Completed Treatment as per Protocol|0|||
94707599|NCT02341625|324385233|FG009|Overall Study|Completed Treatment as per Protocol|1|||
94707600|NCT02341625|324385224|FG000|Overall Study|Other Reasons|0|||
94707601|NCT02341625|324385225|FG001|Overall Study|Other Reasons|0|||
94707602|NCT02341625|324385226|FG002|Overall Study|Other Reasons|0|||
94707603|NCT02341625|324385227|FG003|Overall Study|Other Reasons|0|||
94707604|NCT02341625|324385228|FG004|Overall Study|Other Reasons|1|||
94707605|NCT02341625|324385229|FG005|Overall Study|Other Reasons|0|||
94707606|NCT02341625|324385230|FG006|Overall Study|Other Reasons|5|||
94707607|NCT02341625|324385231|FG007|Overall Study|Other Reasons|0|||
94707608|NCT02341625|324385232|FG008|Overall Study|Other Reasons|0|||
94707609|NCT02341625|324385233|FG009|Overall Study|Other Reasons|2|||
94707610|NCT02341625|324385224|FG000|Overall Study|Not Reported|0|||
94707611|NCT02341625|324385225|FG001|Overall Study|Not Reported|0|||
94707612|NCT02341625|324385226|FG002|Overall Study|Not Reported|0|||
94707613|NCT02341625|324385227|FG003|Overall Study|Not Reported|0|||
94707614|NCT02341625|324385228|FG004|Overall Study|Not Reported|0|||
94707615|NCT02341625|324385229|FG005|Overall Study|Not Reported|0|||
94707616|NCT02341625|324385230|FG006|Overall Study|Not Reported|0|||
94707617|NCT02341625|324385231|FG007|Overall Study|Not Reported|0|||
94707618|NCT02341625|324385232|FG008|Overall Study|Not Reported|0|||
94707619|NCT02341625|324385233|FG009|Overall Study|Not Reported|3|||
94707620|NCT05686421|324385237|FG000|Overall Study|Screen failure|22|||
94707621|NCT05686421|324385238|FG001|Overall Study|Screen failure|0|||
94707622|NCT05686421|324385239|FG002|Overall Study|Screen failure|0|||
94707623|NCT05686421|324385240|FG003|Overall Study|Screen failure|0|||
94707624|NCT02739035|324385243|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
94707625|NCT02739035|324385244|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
94707626|NCT02739035|324385243|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
94707627|NCT02739035|324385244|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
94707628|NCT02739035|324385243|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
94707629|NCT02739035|324385244|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
94707630|NCT02739035|324385243|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
94707631|NCT02739035|324385244|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
94707632|NCT03210402|324385245|FG000|Overall Study|Withdrawal by Subject|0|||
94707633|NCT03210402|324385246|FG001|Overall Study|Withdrawal by Subject|1|||
94707634|NCT03612804|324385249|FG000|Overall Study|Death|0|||
94707635|NCT03612804|324385250|FG001|Overall Study|Death|7|||
94707636|NCT03612804|324385251|FG002|Overall Study|Death|0|||
94707637|NCT03612804|324385252|FG003|Overall Study|Death|8|||
94707638|NCT03612804|324385249|FG000|Overall Study|Medication copay coverage issues|0|||
94707639|NCT03612804|324385250|FG001|Overall Study|Medication copay coverage issues|0|||
94707640|NCT03612804|324385251|FG002|Overall Study|Medication copay coverage issues|0|||
94707641|NCT03612804|324385252|FG003|Overall Study|Medication copay coverage issues|17|||
94707642|NCT03612804|324385249|FG000|Overall Study|Not current smoker at time of screening|0|||
94707643|NCT03612804|324385250|FG001|Overall Study|Not current smoker at time of screening|1|||
94707644|NCT03612804|324385251|FG002|Overall Study|Not current smoker at time of screening|0|||
94707645|NCT03612804|324385252|FG003|Overall Study|Not current smoker at time of screening|3|||
94707646|NCT03612804|324385249|FG000|Overall Study|Non-veteran status|0|||
94707647|NCT03612804|324385250|FG001|Overall Study|Non-veteran status|1|||
94707648|NCT03612804|324385251|FG002|Overall Study|Non-veteran status|0|||
94707649|NCT03612804|324385252|FG003|Overall Study|Non-veteran status|0|||
94707650|NCT03612804|324385249|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
94707651|NCT03612804|324385250|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
94707652|NCT03612804|324385251|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
94707653|NCT03612804|324385252|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
94707654|NCT03612804|324385249|FG000|Overall Study|Provider retired from VA|0|||
94707655|NCT03612804|324385250|FG001|Overall Study|Provider retired from VA|0|||
94707656|NCT03612804|324385251|FG002|Overall Study|Provider retired from VA|2|||
94707657|NCT03612804|324385252|FG003|Overall Study|Provider retired from VA|0|||
94707658|NCT03612804|324385249|FG000|Overall Study|Withdrawal by Subject|0|||
94707659|NCT03612804|324385250|FG001|Overall Study|Withdrawal by Subject|0|||
94707660|NCT03612804|324385251|FG002|Overall Study|Withdrawal by Subject|7|||
94707661|NCT03612804|324385252|FG003|Overall Study|Withdrawal by Subject|0|||
94707662|NCT03612804|324385249|FG000|Overall Study|Provider involved with study activities|1|||
94707663|NCT03612804|324385250|FG001|Overall Study|Provider involved with study activities|0|||
94707664|NCT03612804|324385251|FG002|Overall Study|Provider involved with study activities|0|||
94707665|NCT03612804|324385252|FG003|Overall Study|Provider involved with study activities|0|||
94707666|NCT02041104|324385263|FG000|Overall Study|Lost to Follow-up|1|||
94707667|NCT02041104|324385264|FG001|Overall Study|Lost to Follow-up|4|||
94707668|NCT02041104|324385263|FG000|Overall Study|discomfort during OGTT|0|||
94707669|NCT02041104|324385264|FG001|Overall Study|discomfort during OGTT|3|||
94707670|NCT01063517|324385265|FG000|Overall Study|Consent withdrawal|1|||
94707671|NCT01063517|324385266|FG001|Overall Study|Consent withdrawal|0|||
94707672|NCT01063517|324385265|FG000|Overall Study|Study reached data cut-off|19|||
94707673|NCT01063517|324385266|FG001|Overall Study|Study reached data cut-off|7|||
94707674|NCT01063517|324385265|FG000|Overall Study|Lost to Follow-up|4|||
94707675|NCT01063517|324385266|FG001|Overall Study|Lost to Follow-up|3|||
94707676|NCT01063517|324385265|FG000|Overall Study|Withdrawal by Subject|1|||
94707677|NCT01063517|324385266|FG001|Overall Study|Withdrawal by Subject|2|||
94366676|NCT00127192|323128127|FG004|Overall Study|Adverse Event|0|||
94366677|NCT00127192|323128123|FG000|Overall Study|Lack of Efficacy|2|||
94707678|NCT01063517|324385265|FG000|Overall Study|Death|33|||
94707679|NCT01063517|324385266|FG001|Overall Study|Death|48|||
94707680|NCT00546871|324385267|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
94707681|NCT00546871|324385268|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
94707682|NCT00546871|324385267|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
94707683|NCT00546871|324385268|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
94707684|NCT00546871|324385267|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
94707685|NCT00546871|324385268|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
94707686|NCT00546871|324385267|FG000|Study Extension Period|Protocol Violation|1|||
94707687|NCT00546871|324385268|FG001|Study Extension Period|Protocol Violation|0|||
94707688|NCT00546871|324385267|FG000|Study Extension Period|Withdrawal by Subject|0|||
94707689|NCT00546871|324385268|FG001|Study Extension Period|Withdrawal by Subject|1|||
94707690|NCT02106442|324385271|FG000|Overall Study|Case Report Forms Uncollected|7|||
94707691|NCT02106442|324385271|FG000|Overall Study|Protocol Deviation|30|||
94707692|NCT02698891|324386991|FG000|Overall Study|Withdrawal by Subject|2|||
94707693|NCT02698891|324386991|FG000|Overall Study|deemed ineligible|1|||
94707694|NCT02698891|324386991|FG000|Overall Study|Adverse Event|9|||
94707695|NCT02139046|324386992|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
94707696|NCT02139046|324386993|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
94707697|NCT02139046|324386994|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
94707698|NCT02139046|324386995|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
94707699|NCT02139046|324386996|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
94707700|NCT02139046|324386992|FG000|Overall Study|Major Protocol Deviation|9|||
94707701|NCT02139046|324386993|FG001|Overall Study|Major Protocol Deviation|10|||
94707702|NCT02139046|324386994|FG002|Overall Study|Major Protocol Deviation|16|||
94707703|NCT02139046|324386995|FG003|Overall Study|Major Protocol Deviation|12|||
94707704|NCT02139046|324386996|FG004|Overall Study|Major Protocol Deviation|6|||
94707705|NCT02139046|324386992|FG000|Overall Study|Lost to Follow-up|13|||
94707706|NCT02139046|324386993|FG001|Overall Study|Lost to Follow-up|16|||
94707707|NCT02139046|324386994|FG002|Overall Study|Lost to Follow-up|16|||
94707708|NCT02139046|324386995|FG003|Overall Study|Lost to Follow-up|18|||
94707709|NCT02139046|324386996|FG004|Overall Study|Lost to Follow-up|13|||
94707710|NCT02139046|324386992|FG000|Overall Study|Voluntary Withdrawal|20|||
94707711|NCT02139046|324386993|FG001|Overall Study|Voluntary Withdrawal|8|||
94707712|NCT02139046|324386994|FG002|Overall Study|Voluntary Withdrawal|10|||
94707713|NCT02139046|324386995|FG003|Overall Study|Voluntary Withdrawal|15|||
94707714|NCT02139046|324386996|FG004|Overall Study|Voluntary Withdrawal|16|||
94707715|NCT02139046|324386992|FG000|Overall Study|Lack of Efficacy|0|||
94707716|NCT02139046|324386993|FG001|Overall Study|Lack of Efficacy|1|||
94707717|NCT02139046|324386994|FG002|Overall Study|Lack of Efficacy|2|||
94707718|NCT02139046|324386995|FG003|Overall Study|Lack of Efficacy|1|||
94707719|NCT02139046|324386996|FG004|Overall Study|Lack of Efficacy|2|||
94707720|NCT02139046|324386992|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
94707721|NCT02139046|324386993|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
94707722|NCT02139046|324386994|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
94707723|NCT02139046|324386995|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
94707724|NCT02139046|324386996|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
94707725|NCT02139046|324386992|FG000|Overall Study|Other Miscellaneous Reasons|10|||
94707726|NCT02139046|324386993|FG001|Overall Study|Other Miscellaneous Reasons|9|||
94707727|NCT02139046|324386994|FG002|Overall Study|Other Miscellaneous Reasons|4|||
94707728|NCT02139046|324386995|FG003|Overall Study|Other Miscellaneous Reasons|9|||
94707729|NCT02139046|324386996|FG004|Overall Study|Other Miscellaneous Reasons|12|||
94707730|NCT04033432|324386997|FG000|Overall Study|Progressive Disease|8|||
94707731|NCT04033432|324386997|FG000|Overall Study|Adverse Event|4|||
94707732|NCT04033432|324386997|FG000|Overall Study|Death|1|||
94707733|NCT02192606|324386998|FG000|Overall Study|surgery type was changed|1|||
94707734|NCT02192606|324386999|FG001|Overall Study|surgery type was changed|1|||
94707735|NCT02192606|324386998|FG000|Overall Study|Physician Decision|1|||
94707736|NCT02192606|324386999|FG001|Overall Study|Physician Decision|2|||
94707737|NCT02192606|324386998|FG000|Overall Study|3D equipment rep unable to join|0|||
94707738|NCT02192606|324386999|FG001|Overall Study|3D equipment rep unable to join|1|||
94707739|NCT03923491|324387005|FG000|Overall Study|Lost to Follow-up|5|||
94707740|NCT03923491|324387006|FG001|Overall Study|Lost to Follow-up|8|||
94707741|NCT03923491|324387005|FG000|Overall Study|Withdrawal by Subject|4|||
94707742|NCT03923491|324387006|FG001|Overall Study|Withdrawal by Subject|6|||
94707743|NCT02613871|324387009|FG000|Overall Study|Death|2|||
94707744|NCT02613871|324387009|FG000|Overall Study|Withdrew Consent|1|||
94707745|NCT00753012|324387010|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
94707746|NCT00753012|324387011|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
94707747|NCT00753012|324387010|FG000|Overall Study|Adverse Event|2|||
94707748|NCT00753012|324387011|FG001|Overall Study|Adverse Event|0|||
94707749|NCT00753012|324387010|FG000|Overall Study|Withdrawal by Subject|0|||
94707750|NCT00753012|324387011|FG001|Overall Study|Withdrawal by Subject|1|||
94366678|NCT00127192|323128124|FG001|Overall Study|Lack of Efficacy|0|||
94366679|NCT00127192|323128125|FG002|Overall Study|Lack of Efficacy|0|||
94366680|NCT00127192|323128126|FG003|Overall Study|Lack of Efficacy|0|||
94366681|NCT00127192|323128127|FG004|Overall Study|Lack of Efficacy|2|||
94707751|NCT00753012|324387010|FG000|Overall Study|Lost to Follow-up|4|||
94707752|NCT00753012|324387011|FG001|Overall Study|Lost to Follow-up|0|||
94707753|NCT00753012|324387010|FG000|Overall Study|Confounded endpoint data|1|||
94707754|NCT00753012|324387011|FG001|Overall Study|Confounded endpoint data|0|||
94707755|NCT01456936|324387012|FG000|Overall Study|Other reason|41|||
94707756|NCT01456936|324387013|FG001|Overall Study|Other reason|30|||
94707757|NCT01456936|324387014|FG002|Overall Study|Other reason|36|||
94707758|NCT01456936|324387015|FG003|Overall Study|Other reason|33|||
94707759|NCT01456936|324387012|FG000|Overall Study|No longer meets eligibility criteria|4|||
94707760|NCT01456936|324387013|FG001|Overall Study|No longer meets eligibility criteria|8|||
94707761|NCT01456936|324387014|FG002|Overall Study|No longer meets eligibility criteria|6|||
94707762|NCT01456936|324387015|FG003|Overall Study|No longer meets eligibility criteria|5|||
94707763|NCT01456936|324387012|FG000|Overall Study|Protocol Violation|4|||
94707764|NCT01456936|324387013|FG001|Overall Study|Protocol Violation|2|||
94707765|NCT01456936|324387014|FG002|Overall Study|Protocol Violation|5|||
94707766|NCT01456936|324387015|FG003|Overall Study|Protocol Violation|5|||
94707767|NCT01456936|324387012|FG000|Overall Study|Pregnancy|1|||
94707768|NCT01456936|324387013|FG001|Overall Study|Pregnancy|0|||
94707769|NCT01456936|324387014|FG002|Overall Study|Pregnancy|0|||
94707770|NCT01456936|324387015|FG003|Overall Study|Pregnancy|1|||
94707771|NCT01456936|324387012|FG000|Overall Study|Insufficient clinical response|4|||
94707772|NCT01456936|324387013|FG001|Overall Study|Insufficient clinical response|4|||
94707773|NCT01456936|324387014|FG002|Overall Study|Insufficient clinical response|14|||
94707774|NCT01456936|324387015|FG003|Overall Study|Insufficient clinical response|13|||
94707775|NCT01456936|324387012|FG000|Overall Study|No longer willing to participate|195|||
94707776|NCT01456936|324387013|FG001|Overall Study|No longer willing to participate|218|||
94707777|NCT01456936|324387014|FG002|Overall Study|No longer willing to participate|224|||
94707778|NCT01456936|324387015|FG003|Overall Study|No longer willing to participate|248|||
94707779|NCT01456936|324387012|FG000|Overall Study|Lost to Follow-up|135|||
94707780|NCT01456936|324387013|FG001|Overall Study|Lost to Follow-up|126|||
94707781|NCT01456936|324387014|FG002|Overall Study|Lost to Follow-up|144|||
94707782|NCT01456936|324387015|FG003|Overall Study|Lost to Follow-up|127|||
94707783|NCT01456936|324387012|FG000|Overall Study|Medication error|0|||
94707784|NCT01456936|324387013|FG001|Overall Study|Medication error|1|||
94707785|NCT01456936|324387014|FG002|Overall Study|Medication error|0|||
94707786|NCT01456936|324387015|FG003|Overall Study|Medication error|1|||
94707787|NCT01456936|324387012|FG000|Overall Study|Adverse event (study drug)|25|||
94707788|NCT01456936|324387013|FG001|Overall Study|Adverse event (study drug)|21|||
94707789|NCT01456936|324387014|FG002|Overall Study|Adverse event (study drug)|26|||
94707790|NCT01456936|324387015|FG003|Overall Study|Adverse event (study drug)|17|||
94707791|NCT01456936|324387012|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
94707792|NCT01456936|324387013|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
94707793|NCT01456936|324387014|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
94707794|NCT01456936|324387015|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
94707795|NCT01456936|324387012|FG000|Overall Study|Death|0|||
94707796|NCT01456936|324387013|FG001|Overall Study|Death|3|||
94707797|NCT01456936|324387014|FG002|Overall Study|Death|1|||
94707798|NCT01456936|324387015|FG003|Overall Study|Death|3|||
94707799|NCT01456936|324387012|FG000|Overall Study|Randomized but not treated|21|||
94707800|NCT01456936|324387013|FG001|Overall Study|Randomized but not treated|28|||
94707801|NCT01456936|324387014|FG002|Overall Study|Randomized but not treated|16|||
94707802|NCT01456936|324387015|FG003|Overall Study|Randomized but not treated|21|||
94707803|NCT00957658|324387016|FG000|Overall Study|Death|1|||
94707804|NCT00957658|324387016|FG000|Overall Study|Lost to Follow-up|4|||
94707805|NCT00957658|324387016|FG000|Overall Study|Withdrawal by Subject|12|||
94707806|NCT00957658|324387016|FG000|Overall Study|Revision|1|||
94707807|NCT00957658|324387016|FG000|Overall Study|Incomplete 2 yr data|28|||
94707808|NCT00957658|324387016|FG000|Overall Study|Site termination|10|||
94707809|NCT00957658|324387016|FG000|Overall Study|unwilling/unable to return|2|||
94707810|NCT00957658|324387016|FG000|Overall Study|surgery cancelled|2|||
94707811|NCT00957658|324387016|FG000|Overall Study|Protocol Violation|5|||
94707812|NCT00246012|324387017|FG000|Overall Study|Adverse Event|0|||
94707813|NCT00246012|324387018|FG001|Overall Study|Adverse Event|0|||
94707814|NCT00246012|324387019|FG002|Overall Study|Adverse Event|0|||
94707815|NCT00246012|324387020|FG003|Overall Study|Adverse Event|0|||
94707816|NCT00246012|324387021|FG004|Overall Study|Adverse Event|0|||
94707817|NCT00246012|324387022|FG005|Overall Study|Adverse Event|1|||
94707818|NCT00246012|324387023|FG006|Overall Study|Adverse Event|0|||
94707819|NCT00246012|324387024|FG007|Overall Study|Adverse Event|0|||
94707820|NCT00246012|324387025|FG008|Overall Study|Adverse Event|2|||
94707821|NCT00246012|324387017|FG000|Overall Study|Withdrawal by Subject|0|||
94707822|NCT00246012|324387018|FG001|Overall Study|Withdrawal by Subject|0|||
94707823|NCT00246012|324387019|FG002|Overall Study|Withdrawal by Subject|0|||
94707824|NCT00246012|324387020|FG003|Overall Study|Withdrawal by Subject|0|||
94707825|NCT00246012|324387021|FG004|Overall Study|Withdrawal by Subject|0|||
94707826|NCT00246012|324387022|FG005|Overall Study|Withdrawal by Subject|1|||
94707827|NCT00246012|324387023|FG006|Overall Study|Withdrawal by Subject|0|||
94707828|NCT00246012|324387024|FG007|Overall Study|Withdrawal by Subject|0|||
94707829|NCT00246012|324387025|FG008|Overall Study|Withdrawal by Subject|0|||
94707830|NCT00246012|324387017|FG000|Overall Study|Disease progression|3|||
94707831|NCT00246012|324387018|FG001|Overall Study|Disease progression|1|||
94707832|NCT00246012|324387019|FG002|Overall Study|Disease progression|2|||
94707833|NCT00246012|324387020|FG003|Overall Study|Disease progression|3|||
94707834|NCT00246012|324387021|FG004|Overall Study|Disease progression|3|||
94707835|NCT00246012|324387022|FG005|Overall Study|Disease progression|25|||
94707836|NCT00246012|324387023|FG006|Overall Study|Disease progression|30|||
94707837|NCT00246012|324387024|FG007|Overall Study|Disease progression|27|||
94707838|NCT00246012|324387025|FG008|Overall Study|Disease progression|26|||
94707839|NCT00246012|324387017|FG000|Overall Study|Other|0|||
94707840|NCT00246012|324387018|FG001|Overall Study|Other|0|||
94707841|NCT00246012|324387019|FG002|Overall Study|Other|0|||
94707842|NCT00246012|324387020|FG003|Overall Study|Other|0|||
94707843|NCT00246012|324387021|FG004|Overall Study|Other|0|||
94707844|NCT00246012|324387022|FG005|Overall Study|Other|0|||
94707845|NCT00246012|324387023|FG006|Overall Study|Other|0|||
94707846|NCT00246012|324387024|FG007|Overall Study|Other|1|||
94707847|NCT00246012|324387025|FG008|Overall Study|Other|0|||
94707848|NCT00246012|324387017|FG000|Overall Study|Randomly assigned but not treated|0|||
94707849|NCT00246012|324387018|FG001|Overall Study|Randomly assigned but not treated|0|||
94707850|NCT00246012|324387019|FG002|Overall Study|Randomly assigned but not treated|0|||
94707851|NCT00246012|324387020|FG003|Overall Study|Randomly assigned but not treated|0|||
94707852|NCT00246012|324387021|FG004|Overall Study|Randomly assigned but not treated|0|||
94707853|NCT00246012|324387022|FG005|Overall Study|Randomly assigned but not treated|1|||
94707854|NCT00246012|324387023|FG006|Overall Study|Randomly assigned but not treated|1|||
94707855|NCT00246012|324387024|FG007|Overall Study|Randomly assigned but not treated|0|||
94707856|NCT00246012|324387025|FG008|Overall Study|Randomly assigned but not treated|0|||
94707857|NCT03691428|324387027|FG000|Overall Study|Withdrawal by Subject|6|||
94707858|NCT03691428|324387028|FG001|Overall Study|Withdrawal by Subject|8|||
94707859|NCT00771849|324387029|FG000|Overall Study|Lost to Follow-up|1|||
94707860|NCT00771849|324387030|FG001|Overall Study|Lost to Follow-up|2|||
94707861|NCT00771849|324387029|FG000|Overall Study|Withdrawal by Subject|1|||
94707862|NCT00771849|324387030|FG001|Overall Study|Withdrawal by Subject|1|||
94707863|NCT00771849|324387029|FG000|Overall Study|Not vaccinated|0|||
94707864|NCT00771849|324387030|FG001|Overall Study|Not vaccinated|1|||
94707865|NCT03184558|324387031|FG000|Overall Study|Withdrawal by Subject|2|||
94707866|NCT03184558|324387031|FG000|Overall Study|Death|16|||
94707867|NCT03184558|324387031|FG000|Overall Study|Lost to Follow-up|2|||
94707868|NCT03184558|324387031|FG000|Overall Study|Other|9|||
94707869|NCT04842604|324387033|FG000|Overall Study|Death|1|||
94707870|NCT04842604|324387034|FG001|Overall Study|Death|0|||
94707871|NCT04842604|324387033|FG000|Overall Study|Other|4|||
94707872|NCT04842604|324387034|FG001|Overall Study|Other|4|||
94707873|NCT04842604|324387033|FG000|Overall Study|Randomized but not treated|1|||
94707874|NCT04842604|324387034|FG001|Overall Study|Randomized but not treated|0|||
94707875|NCT01565928|324387036|FG000|Overall Study|Adverse Event|3|||
94707876|NCT01565928|324387036|FG000|Overall Study|Other|3|||
94707877|NCT01565928|324387036|FG000|Overall Study|Progressive Disease|13|||
94707878|NCT01565928|324387036|FG000|Overall Study|Withdrawal by Subject|1|||
94707879|NCT01565928|324387036|FG000|Overall Study|Death|2|||
94707880|NCT01119950|324387037|FG000|Overall Study|Adverse Event|25|||
94707881|NCT01119950|324387037|FG000|Overall Study|Withdrawal by Subject|9|||
94707882|NCT01119950|324387037|FG000|Overall Study|Protocol Violation|5|||
94707883|NCT01119950|324387037|FG000|Overall Study|Lost to Follow-up|4|||
94707884|NCT01119950|324387037|FG000|Overall Study|Administrative|2|||
94707885|NCT01119950|324387037|FG000|Overall Study|Abnormal lab value|1|||
94707886|NCT01119950|324387037|FG000|Overall Study|Death|1|||
94707887|NCT00608907|324387040|FG000|Overall Study|Adverse Event|6|||
94707888|NCT00608907|324387041|FG001|Overall Study|Adverse Event|0|||
94707889|NCT00608907|324387042|FG002|Overall Study|Adverse Event|1|||
94652733|NCT02203591|324186180|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
94652734|NCT00622635|324186181|FG000|Treatment Period 1|Adverse Event|0|||
94652735|NCT00622635|324186182|FG001|Treatment Period 1|Adverse Event|0|||
94652736|NCT00622635|324186183|FG002|Treatment Period 1|Adverse Event|1|||
94652737|NCT00622635|324186184|FG003|Treatment Period 1|Adverse Event|0|||
94652738|NCT00622635|324186185|FG004|Treatment Period 1|Adverse Event|0|||
94652739|NCT00622635|324186186|FG005|Treatment Period 1|Adverse Event|0|||
94652740|NCT00622635|324186181|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94652741|NCT00622635|324186182|FG001|Treatment Period 1|Withdrawal by Subject|1|||
94652742|NCT00622635|324186183|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94652743|NCT00622635|324186184|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94652744|NCT00622635|324186185|FG004|Treatment Period 1|Withdrawal by Subject|0|||
94652745|NCT00622635|324186186|FG005|Treatment Period 1|Withdrawal by Subject|0|||
94652746|NCT00622635|324186181|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
94707890|NCT00608907|324387040|FG000|Overall Study|Death|1|||
94707891|NCT00608907|324387041|FG001|Overall Study|Death|0|||
94707892|NCT00608907|324387042|FG002|Overall Study|Death|0|||
94707893|NCT00608907|324387040|FG000|Overall Study|Withdrawal by Subject|4|||
94707894|NCT00608907|324387041|FG001|Overall Study|Withdrawal by Subject|0|||
94707895|NCT00608907|324387042|FG002|Overall Study|Withdrawal by Subject|0|||
94707896|NCT00608907|324387040|FG000|Overall Study|Progressive Disease|1|||
94652747|NCT00622635|324186182|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
94707897|NCT00608907|324387041|FG001|Overall Study|Progressive Disease|0|||
94707898|NCT00608907|324387042|FG002|Overall Study|Progressive Disease|0|||
94707899|NCT00139737|324387045|FG000|Overall Study|Withdrawal by Subject|190|||
94707900|NCT00139737|324387045|FG000|Overall Study|Adverse Event|58|||
94707901|NCT00139737|324387045|FG000|Overall Study|Lack of Efficacy|40|||
94707902|NCT00139737|324387045|FG000|Overall Study|Lost to Follow-up|8|||
94707903|NCT00139737|324387045|FG000|Overall Study|Death|3|||
94707904|NCT00139737|324387045|FG000|Overall Study|Laboratory Abnormality|2|||
94707905|NCT00139737|324387045|FG000|Overall Study|Protocol Violation|18|||
94707906|NCT00139737|324387045|FG000|Overall Study|Withdrew During Screening Phase|8|||
94707907|NCT00139737|324387045|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
94707908|NCT00139737|324387045|FG000|Overall Study|Screened, Not Treated|13|||
94707909|NCT01460342|324387048|FG000|Overall Study|Adverse Event|5|||
94707910|NCT01460342|324387049|FG001|Overall Study|Adverse Event|4|||
94707911|NCT01460342|324387048|FG000|Overall Study|Lost to Follow-up|1|||
94707912|NCT01460342|324387049|FG001|Overall Study|Lost to Follow-up|2|||
94707913|NCT01460342|324387048|FG000|Overall Study|Protocol Violation|0|||
94707914|NCT01460342|324387049|FG001|Overall Study|Protocol Violation|1|||
94707915|NCT01460342|324387048|FG000|Overall Study|Withdrawal by Subject|3|||
94707916|NCT01460342|324387049|FG001|Overall Study|Withdrawal by Subject|4|||
94707917|NCT01460342|324387048|FG000|Overall Study|Physician Decision|1|||
94707918|NCT01460342|324387049|FG001|Overall Study|Physician Decision|3|||
94707919|NCT01460342|324387048|FG000|Overall Study|Lack of Efficacy|1|||
94707920|NCT01460342|324387049|FG001|Overall Study|Lack of Efficacy|0|||
94707921|NCT00217672|324387050|FG000|Allocation|Ineligible|2|||
94707922|NCT00217672|324387051|FG001|Allocation|Ineligible|0|||
94707923|NCT00217672|324387050|FG000|Treatment|disease progression|33|||
94707924|NCT00217672|324387051|FG001|Treatment|disease progression|4|||
94707925|NCT00217672|324387050|FG000|Treatment|Adverse Event|18|||
94707926|NCT00217672|324387051|FG001|Treatment|Adverse Event|2|||
94707927|NCT00217672|324387050|FG000|Treatment|reqd treatment not permitted by protocol|6|||
94707928|NCT00217672|324387051|FG001|Treatment|reqd treatment not permitted by protocol|0|||
94707929|NCT00217672|324387050|FG000|Treatment|Physician Decision|6|||
94266898|NCT01241552|322772004|FG002|Overall Study|Technical Problems|2|||
94707930|NCT00217672|324387051|FG001|Treatment|Physician Decision|0|||
94707931|NCT00217672|324387050|FG000|Treatment|insurance issues|1|||
94707932|NCT00217672|324387051|FG001|Treatment|insurance issues|1|||
94707933|NCT00217672|324387050|FG000|Treatment|Death|2|||
94707934|NCT00217672|324387051|FG001|Treatment|Death|0|||
94707935|NCT00217672|324387050|FG000|Treatment|secondary malignancy|1|||
94707936|NCT00217672|324387051|FG001|Treatment|secondary malignancy|0|||
94707937|NCT00217672|324387050|FG000|Follow-up|Withdrawal by Subject|4|||
94707938|NCT00217672|324387051|FG001|Follow-up|Withdrawal by Subject|0|||
94707939|NCT00217672|324387050|FG000|Follow-up|Lost to Follow-up|1|||
94707940|NCT00217672|324387051|FG001|Follow-up|Lost to Follow-up|0|||
94707941|NCT03987451|324387055|FG000|Overall Study|Lost to Follow-up|1|||
94707942|NCT03987451|324387056|FG001|Overall Study|Lost to Follow-up|0|||
94707943|NCT03987451|324387055|FG000|Overall Study|Withdrawal by Subject|1|||
94707944|NCT03987451|324387056|FG001|Overall Study|Withdrawal by Subject|1|||
94707945|NCT00762606|324387058|FG000|Overall Study|Lost to Follow-up|18|||
94707946|NCT00762606|324387059|FG001|Overall Study|Lost to Follow-up|13|||
94707947|NCT00842257|324387062|FG000|Overall Study|Adverse Event|1|||
94707948|NCT01596504|324387063|FG000|Overall Study|Participant's Private Reason|0|||
94707949|NCT01596504|324387064|FG001|Overall Study|Participant's Private Reason|1|||
94707950|NCT01596504|324387065|FG002|Overall Study|Participant's Private Reason|0|||
94707951|NCT01596504|324387063|FG000|Overall Study|Adverse Event|1|||
94707952|NCT01596504|324387064|FG001|Overall Study|Adverse Event|2|||
94707953|NCT01596504|324387065|FG002|Overall Study|Adverse Event|1|||
94707954|NCT01596504|324387063|FG000|Overall Study|Withdrawal by Subject|1|||
94707955|NCT01596504|324387064|FG001|Overall Study|Withdrawal by Subject|0|||
94266899|NCT01241552|322772005|FG003|Overall Study|Technical Problems|2|||
94266900|NCT01241552|322772002|FG000|Overall Study|Progressive Disease|0|||
94707956|NCT01596504|324387065|FG002|Overall Study|Withdrawal by Subject|0|||
94707957|NCT01901276|324387066|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
94707958|NCT01901276|324387067|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
94707959|NCT01490580|324387068|FG000|Overall Study|Parents withdrew consent|0|||
94707960|NCT01490580|324387069|FG001|Overall Study|Parents withdrew consent|2|||
94707961|NCT04347954|324387070|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
94707962|NCT04347954|324387071|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
94266901|NCT01241552|322772003|FG001|Overall Study|Progressive Disease|0|||
94707963|NCT04347954|324387072|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
94707964|NCT04347954|324387070|FG000|Overall Study|Lost to Follow-up|0|||
94707965|NCT04347954|324387071|FG001|Overall Study|Lost to Follow-up|1|||
94266902|NCT01241552|322772004|FG002|Overall Study|Progressive Disease|1|||
94707966|NCT04347954|324387072|FG002|Overall Study|Lost to Follow-up|0|||
94707967|NCT00880048|324387073|FG000|Overall Study|Adverse Event|2|||
94707968|NCT00880048|324387074|FG001|Overall Study|Adverse Event|3|||
94266903|NCT01241552|322772005|FG003|Overall Study|Progressive Disease|2|||
94707969|NCT00880048|324387075|FG002|Overall Study|Adverse Event|5|||
94707970|NCT00880048|324387073|FG000|Overall Study|Lack of Efficacy|1|||
94707971|NCT00880048|324387074|FG001|Overall Study|Lack of Efficacy|2|||
94707972|NCT00880048|324387075|FG002|Overall Study|Lack of Efficacy|2|||
94707973|NCT00880048|324387073|FG000|Overall Study|Protocol Violation|4|||
94707974|NCT00880048|324387074|FG001|Overall Study|Protocol Violation|6|||
94707975|NCT00880048|324387075|FG002|Overall Study|Protocol Violation|5|||
94707976|NCT00880048|324387073|FG000|Overall Study|Lost to Follow-up|6|||
94707977|NCT00880048|324387074|FG001|Overall Study|Lost to Follow-up|6|||
94707978|NCT00880048|324387075|FG002|Overall Study|Lost to Follow-up|5|||
94707979|NCT00880048|324387073|FG000|Overall Study|Physician Decision|1|||
94707980|NCT00880048|324387074|FG001|Overall Study|Physician Decision|1|||
94707981|NCT00880048|324387075|FG002|Overall Study|Physician Decision|7|||
94707982|NCT00880048|324387073|FG000|Overall Study|Withdrawal by Subject|5|||
94707983|NCT00880048|324387074|FG001|Overall Study|Withdrawal by Subject|8|||
94707984|NCT00880048|324387075|FG002|Overall Study|Withdrawal by Subject|5|||
94707985|NCT00880048|324387073|FG000|Overall Study|Study closed/terminated|9|||
94707986|NCT00880048|324387074|FG001|Overall Study|Study closed/terminated|7|||
94707987|NCT00880048|324387075|FG002|Overall Study|Study closed/terminated|6|||
94707988|NCT00922207|324387076|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
94707989|NCT00922207|324387077|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
94707990|NCT00922207|324387078|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
94707991|NCT00922207|324387076|FG000|Overall Study|Insufficient Therapeutic Response|0|||
94707992|NCT00922207|324387077|FG001|Overall Study|Insufficient Therapeutic Response|0|||
94707993|NCT00922207|324387078|FG002|Overall Study|Insufficient Therapeutic Response|1|||
94707994|NCT00922207|324387076|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
94707995|NCT00922207|324387077|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
94707996|NCT00922207|324387078|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
94707997|NCT00922207|324387076|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
94707998|NCT00922207|324387077|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
94707999|NCT00922207|324387078|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
94708000|NCT00922207|324387076|FG000|Overall Study|Withdrew Consent|2|||
94708001|NCT00922207|324387077|FG001|Overall Study|Withdrew Consent|5|||
94708002|NCT00922207|324387078|FG002|Overall Study|Withdrew Consent|2|||
94708003|NCT00922207|324387076|FG000|Overall Study|Abnormality of Laboratory Test|0|||
94708004|NCT00922207|324387077|FG001|Overall Study|Abnormality of Laboratory Test|1|||
94708005|NCT00922207|324387078|FG002|Overall Study|Abnormality of Laboratory Test|1|||
94708006|NCT00367991|324387079|FG000|Overall Study|Withdrawal by Subject|1|||
94708007|NCT00367991|324387080|FG001|Overall Study|Withdrawal by Subject|1|||
94708008|NCT00367991|324387079|FG000|Overall Study|Adverse Event|1|||
94708009|NCT00367991|324387080|FG001|Overall Study|Adverse Event|1|||
94708010|NCT00319436|324387083|FG000|Overall Study|Withdrawal by Subject|6|||
94708011|NCT00319436|324387084|FG001|Overall Study|Withdrawal by Subject|7|||
94708012|NCT00790790|324387085|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
94708013|NCT00790790|324387086|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
94708014|NCT00790790|324387087|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
94708015|NCT00790790|324387085|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
94708016|NCT00790790|324387086|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
94708017|NCT00790790|324387087|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
94708018|NCT00790790|324387085|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
94708019|NCT00790790|324387086|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
94708020|NCT00790790|324387087|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
94708021|NCT00790790|324387085|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
94708022|NCT00790790|324387086|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
94708023|NCT00790790|324387087|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
94708024|NCT00790790|324387085|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
94708025|NCT00790790|324387086|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
94708026|NCT00790790|324387087|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
94708027|NCT01104415|324387094|FG000|Core Phase|Consent withdrawn by subjects|1|||
94708028|NCT01104415|324387095|FG001|Core Phase|Consent withdrawn by subjects|0|||
94708029|NCT01104415|324387094|FG000|Extension Period|Progressive disease|0|||
94708030|NCT01104415|324387095|FG001|Extension Period|Progressive disease|4|||
94708031|NCT01104415|324387094|FG000|Extension Period|Death|0|||
94708032|NCT01104415|324387095|FG001|Extension Period|Death|1|||
94708033|NCT01104415|324387094|FG000|Extension Period|Physician Decision|0|||
94708034|NCT01104415|324387095|FG001|Extension Period|Physician Decision|1|||
94708035|NCT01104415|324387094|FG000|Extension Period|Transition to Study LX1606.302|0|||
94708036|NCT01104415|324387095|FG001|Extension Period|Transition to Study LX1606.302|4|||
94708037|NCT01104415|324387094|FG000|Extension Period|Heart surgery/feeling miserable|0|||
94708038|NCT01104415|324387095|FG001|Extension Period|Heart surgery/feeling miserable|1|||
94708039|NCT03024606|324387099|FG000|Overall Study|Withdrawal by Subject|9|||
94708040|NCT03024606|324387100|FG001|Overall Study|Withdrawal by Subject|10|||
94708041|NCT00919763|324387101|FG000|Overall Study|Adverse Event|7|||
94708042|NCT00919763|324387102|FG001|Overall Study|Adverse Event|1|||
94708043|NCT00919763|324387101|FG000|Overall Study|Lost to Follow-up|1|||
94708044|NCT00919763|324387102|FG001|Overall Study|Lost to Follow-up|0|||
94708045|NCT00919763|324387101|FG000|Overall Study|Protocol Violation|1|||
94708046|NCT00919763|324387102|FG001|Overall Study|Protocol Violation|1|||
94708047|NCT00919763|324387101|FG000|Overall Study|Withdrawal by Subject|3|||
94708048|NCT00919763|324387102|FG001|Overall Study|Withdrawal by Subject|1|||
94708049|NCT00919763|324387101|FG000|Overall Study|Non-compliance|0|||
94708050|NCT00919763|324387102|FG001|Overall Study|Non-compliance|1|||
94708051|NCT00940992|324387104|FG000|Overall Study|Adverse Event|2|||
94708052|NCT00940992|324387105|FG001|Overall Study|Adverse Event|0|||
94708053|NCT00940992|324387106|FG002|Overall Study|Adverse Event|1|||
94708054|NCT00940992|324387104|FG000|Overall Study|subject request|2|||
94708055|NCT00940992|324387105|FG001|Overall Study|subject request|1|||
94708056|NCT00940992|324387106|FG002|Overall Study|subject request|0|||
94708057|NCT00940992|324387104|FG000|Overall Study|Lost to Follow-up|0|||
94708058|NCT00940992|324387105|FG001|Overall Study|Lost to Follow-up|1|||
94708059|NCT00940992|324387106|FG002|Overall Study|Lost to Follow-up|1|||
94708060|NCT03008915|324387107|FG000|Treatment 1|Withdrawal by Subject|0|||
94708061|NCT03008915|324387108|FG001|Treatment 1|Withdrawal by Subject|1|||
94708062|NCT03603717|324387113|FG000|Overall Study|Lost to Follow-up|20|||
94708063|NCT03603717|324387114|FG001|Overall Study|Lost to Follow-up|20|||
94708064|NCT03603717|324387113|FG000|Overall Study|Withdrawal by Subject|16|||
94708065|NCT03603717|324387114|FG001|Overall Study|Withdrawal by Subject|10|||
94708066|NCT00605033|324387115|FG000|Overall Study|Adverse Event|2|||
94708067|NCT00605033|324387116|FG001|Overall Study|Adverse Event|2|||
94708068|NCT00605033|324387115|FG000|Overall Study|Lost to Follow-up|1|||
94708069|NCT00605033|324387116|FG001|Overall Study|Lost to Follow-up|1|||
94708070|NCT00605033|324387115|FG000|Overall Study|Withdrawal by Subject|3|||
94708071|NCT00605033|324387116|FG001|Overall Study|Withdrawal by Subject|4|||
94708072|NCT00605033|324387115|FG000|Overall Study|Protocol Violation|1|||
94708073|NCT00605033|324387116|FG001|Overall Study|Protocol Violation|1|||
94708074|NCT03395353|324387117|FG000|Overall Study|Adverse Event|20|||
94708075|NCT03395353|324387117|FG000|Overall Study|Protocol Violation|1|||
94708076|NCT03395353|324387117|FG000|Overall Study|Lack of Efficacy|3|||
94708077|NCT03395353|324387117|FG000|Overall Study|Withdrawal by Subject|24|||
94708078|NCT03395353|324387117|FG000|Overall Study|Discontinued visit|1|||
94708079|NCT03395353|324387117|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
94708080|NCT03395353|324387117|FG000|Overall Study|Physician Decision|4|||
94708081|NCT03395353|324387117|FG000|Overall Study|Early termination of overall study|33|||
94708082|NCT00430300|324387120|FG000|Overall Study|Adverse Event|0|||
94708083|NCT00430300|324387121|FG001|Overall Study|Adverse Event|2|||
94466245|NCT01358578|323496956|FG005|Maintenance Period|Adverse Event|3|||
94708084|NCT00430300|324387122|FG002|Overall Study|Adverse Event|1|||
94708085|NCT00430300|324387123|FG003|Overall Study|Adverse Event|1|||
94708086|NCT00430300|324387120|FG000|Overall Study|Withdrawal by Subject|1|||
94708087|NCT00430300|324387121|FG001|Overall Study|Withdrawal by Subject|0|||
94708088|NCT00430300|324387122|FG002|Overall Study|Withdrawal by Subject|5|||
94708089|NCT00430300|324387123|FG003|Overall Study|Withdrawal by Subject|0|||
94708090|NCT00430300|324387120|FG000|Overall Study|Laboratory abnormality|1|||
94266904|NCT01241552|322772002|FG000|Overall Study|Protocol Violation|0|||
94266905|NCT01241552|322772003|FG001|Overall Study|Protocol Violation|2|||
94266906|NCT01241552|322772004|FG002|Overall Study|Protocol Violation|6|||
94266907|NCT01241552|322772005|FG003|Overall Study|Protocol Violation|1|||
94266908|NCT01241552|322772002|FG000|Overall Study|Withdrawal by Subject|7|||
94266909|NCT01241552|322772003|FG001|Overall Study|Withdrawal by Subject|15|||
94266910|NCT01241552|322772004|FG002|Overall Study|Withdrawal by Subject|14|||
94266911|NCT01241552|322772005|FG003|Overall Study|Withdrawal by Subject|15|||
94266912|NCT01241552|322772002|FG000|Overall Study|Physician Decision|2|||
94266913|NCT01241552|322772003|FG001|Overall Study|Physician Decision|4|||
94266914|NCT01241552|322772004|FG002|Overall Study|Physician Decision|2|||
94266915|NCT01241552|322772005|FG003|Overall Study|Physician Decision|3|||
94266916|NCT01241552|322772002|FG000|Overall Study|Lost to Follow-up|2|||
94266917|NCT01241552|322772003|FG001|Overall Study|Lost to Follow-up|11|||
94266918|NCT01241552|322772004|FG002|Overall Study|Lost to Follow-up|15|||
94266919|NCT01241552|322772005|FG003|Overall Study|Lost to Follow-up|16|||
94266920|NCT01353508|322772010|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
94266921|NCT01353508|322772011|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
94266922|NCT01353508|322772012|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
94266923|NCT01353508|322772013|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
94266924|NCT01353508|322772010|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
94266925|NCT01353508|322772011|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
94266926|NCT01353508|322772012|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
94266927|NCT01353508|322772013|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
94266928|NCT00728481|322772016|FG000|Overall Study|Withdrawal by Subject|0|||
94266929|NCT00728481|322772017|FG001|Overall Study|Withdrawal by Subject|1|||
94266930|NCT00728481|322772016|FG000|Overall Study|Adverse Event|0|||
94266931|NCT00728481|322772017|FG001|Overall Study|Adverse Event|1|||
94266932|NCT00728481|322772016|FG000|Overall Study|Study medication non-compliance|0|||
94266933|NCT00728481|322772017|FG001|Overall Study|Study medication non-compliance|2|||
94266934|NCT00728481|322772016|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
94266935|NCT00728481|322772017|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
94266936|NCT01034540|322772036|FG000|Overall Study|Adverse Event|0|||
94266937|NCT01034540|322772037|FG001|Overall Study|Adverse Event|1|||
94266938|NCT01843972|322772038|FG000|Overall Study|Withdrawal by Subject|0|||
94266939|NCT01843972|322772039|FG001|Overall Study|Withdrawal by Subject|0|||
94266940|NCT01843972|322772040|FG002|Overall Study|Withdrawal by Subject|0|||
94266941|NCT01843972|322772041|FG003|Overall Study|Withdrawal by Subject|0|||
94708091|NCT00430300|324387121|FG001|Overall Study|Laboratory abnormality|0|||
94708092|NCT00430300|324387122|FG002|Overall Study|Laboratory abnormality|0|||
94708093|NCT00430300|324387123|FG003|Overall Study|Laboratory abnormality|0|||
94708094|NCT00430300|324387120|FG000|Overall Study|Other|0|||
94266942|NCT01843972|322772042|FG004|Overall Study|Withdrawal by Subject|1|||
94266943|NCT01843972|322772043|FG005|Overall Study|Withdrawal by Subject|0|||
94266944|NCT01843972|322772044|FG006|Overall Study|Withdrawal by Subject|0|||
94266945|NCT01843972|322772045|FG007|Overall Study|Withdrawal by Subject|0|||
94266946|NCT01843972|322772046|FG008|Overall Study|Withdrawal by Subject|0|||
94708095|NCT00430300|324387121|FG001|Overall Study|Other|0|||
94708096|NCT00430300|324387122|FG002|Overall Study|Other|0|||
94708097|NCT00430300|324387123|FG003|Overall Study|Other|1|||
94708098|NCT02754479|324387124|FG000|Overall Study|Lost to Follow-up|1|||
94708099|NCT01121549|324387125|FG000|Overall Study|Adverse Event|10|||
94708100|NCT01121549|324387125|FG000|Overall Study|Lack of Efficacy|11|||
94708101|NCT01121549|324387125|FG000|Overall Study|Lost to Follow-up|12|||
94708102|NCT01121549|324387125|FG000|Overall Study|Did not meet entrance criteria|9|||
94708103|NCT01121549|324387125|FG000|Overall Study|Study terminated by sponsor|197|||
94708104|NCT01121549|324387125|FG000|Overall Study|Pregnancy|1|||
94708105|NCT01121549|324387125|FG000|Overall Study|Protocol Violation|33|||
94708106|NCT01121549|324387125|FG000|Overall Study|Withdrawal by Subject|16|||
94708107|NCT01121549|324387125|FG000|Overall Study|Other|58|||
94708108|NCT03183518|324387126|FG000|Overall Study|Other (Not specified)|2|||
94708109|NCT03183518|324387126|FG000|Overall Study|Other (Withdrawal of consent)|1|||
94708110|NCT02960659|324388503|FG000|Overall Study|Withdrawal by Subject|1|||
94708111|NCT02960659|324388504|FG001|Overall Study|Withdrawal by Subject|0|||
94266947|NCT01843972|322772047|FG009|Overall Study|Withdrawal by Subject|0|||
94266948|NCT00932425|322772050|FG000|Overall Study|Lost to Follow-up|0|||
94266949|NCT00932425|322772051|FG001|Overall Study|Lost to Follow-up|1|||
94266950|NCT00932425|322772050|FG000|Overall Study|Withdrawal by Subject|0|||
94266951|NCT00932425|322772051|FG001|Overall Study|Withdrawal by Subject|1|||
94266952|NCT02064920|322772053|FG000|Overall Study|Adverse Event|0|||
94266953|NCT02064920|322772054|FG001|Overall Study|Adverse Event|4|||
94266954|NCT02064920|322772053|FG000|Overall Study|Physician Decision|0|||
94708112|NCT02960659|324388503|FG000|Overall Study|Poor compliance|0|||
94708113|NCT02960659|324388504|FG001|Overall Study|Poor compliance|1|||
94708114|NCT00661778|324388508|FG000|Overall Study|Disease Progression|23|||
94708115|NCT00661778|324388508|FG000|Overall Study|Adverse Event|18|||
94708116|NCT00661778|324388508|FG000|Overall Study|Reason not Specified|6|||
94708117|NCT00661778|324388508|FG000|Overall Study|Protocol Violation|2|||
94708118|NCT00661778|324388508|FG000|Overall Study|Withdrawal of Consent|1|||
94708119|NCT01070888|324388516|FG000|First Intervention (14 Days)|Adverse Event|0|||
94708120|NCT01070888|324388517|FG001|First Intervention (14 Days)|Adverse Event|1|||
94708121|NCT01070888|324388516|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
94708122|NCT01070888|324388517|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
94708123|NCT01070888|324388516|FG000|Washout (14 Days)|Physician Decision|1|||
94708124|NCT01070888|324388517|FG001|Washout (14 Days)|Physician Decision|0|||
94708125|NCT02962674|324388518|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
94708126|NCT01580293|324388519|FG000|Part A_Main Trial|Adverse Event|0|||
94708127|NCT01580293|324388520|FG001|Part A_Main Trial|Adverse Event|2|||
94708128|NCT01580293|324388521|FG002|Part A_Main Trial|Adverse Event|0|||
94708129|NCT01580293|324388519|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
94708130|NCT01580293|324388520|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
94708131|NCT01580293|324388521|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
94708132|NCT01580293|324388519|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
94708133|NCT01580293|324388520|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
94708134|NCT01580293|324388521|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
94708135|NCT01580293|324388519|FG000|Part A_Extension|Adverse Event|0|||
94708136|NCT01580293|324388520|FG001|Part A_Extension|Adverse Event|2|||
94708137|NCT01580293|324388521|FG002|Part A_Extension|Adverse Event|0|||
94708138|NCT01580293|324388519|FG000|Part A_Extension|Withdrawal by Subject|0|||
94708139|NCT01580293|324388520|FG001|Part A_Extension|Withdrawal by Subject|3|||
94708140|NCT01580293|324388521|FG002|Part A_Extension|Withdrawal by Subject|0|||
94708141|NCT01580293|324388519|FG000|Part A_Extension|Lost to Follow-up|0|||
94708142|NCT01580293|324388520|FG001|Part A_Extension|Lost to Follow-up|1|||
94708143|NCT01580293|324388521|FG002|Part A_Extension|Lost to Follow-up|0|||
94708144|NCT01580293|324388519|FG000|Part A_Extension|Other Reason|0|||
94708145|NCT01580293|324388520|FG001|Part A_Extension|Other Reason|1|||
94708146|NCT01580293|324388521|FG002|Part A_Extension|Other Reason|0|||
94266955|NCT02064920|322772054|FG001|Overall Study|Physician Decision|1|||
94266956|NCT02064920|322772053|FG000|Overall Study|Technical Problems|0|||
94266957|NCT02064920|322772054|FG001|Overall Study|Technical Problems|1|||
94266958|NCT02064920|322772053|FG000|Overall Study|Withdrawal by Subject|1|||
94266959|NCT02064920|322772054|FG001|Overall Study|Withdrawal by Subject|3|||
94266960|NCT04136184|322772055|FG000|Overall Study|Lost to Follow-up|0|||
94266961|NCT04136184|322772056|FG001|Overall Study|Lost to Follow-up|3|||
94266962|NCT04136184|322772055|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
94266963|NCT04136184|322772056|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
94266964|NCT02783274|322772057|FG000|Overall Study|Withdrawal by Subject|16|||
94266965|NCT02783274|322772057|FG000|Overall Study|Physician Decision|6|||
94266966|NCT02783274|322772057|FG000|Overall Study|Death|9|||
94266967|NCT02783274|322772057|FG000|Overall Study|Lost to Follow-up|22|||
94266968|NCT02783274|322772057|FG000|Overall Study|Other|22|||
94266969|NCT03318978|322772058|FG000|Overall Study|Withdrawal by Subject|1|||
94266970|NCT04552288|322772059|FG000|Overall Study|Death|3|||
94266971|NCT04552288|322772059|FG000|Overall Study|Lost to Follow-up|6|||
94708147|NCT01580293|324388519|FG000|Part A_Extension|Completed Japan only|0|||
94708148|NCT01580293|324388520|FG001|Part A_Extension|Completed Japan only|5|||
94266972|NCT04552288|322772059|FG000|Overall Study|Physician Decision|3|||
94708149|NCT01580293|324388521|FG002|Part A_Extension|Completed Japan only|0|||
94266973|NCT04552288|322772059|FG000|Overall Study|Protocol Violation|9|||
94708150|NCT01580293|324388519|FG000|Part B|Withdrawal by Subject|0|||
94708151|NCT01580293|324388520|FG001|Part B|Withdrawal by Subject|0|||
94708152|NCT01580293|324388521|FG002|Part B|Withdrawal by Subject|1|||
94708153|NCT01580293|324388519|FG000|Part B|Other reason|0|||
94708154|NCT01580293|324388520|FG001|Part B|Other reason|0|||
94708155|NCT01580293|324388521|FG002|Part B|Other reason|1|||
94708156|NCT00028769|324388522|FG000|Overall Study|Adverse Event|2|||
94708157|NCT00028769|324388522|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
94708158|NCT00028769|324388522|FG000|Overall Study|Progression or Death|31|||
94708159|NCT00028769|324388522|FG000|Overall Study|Other - Not Protocol Specified|1|||
94708160|NCT00028769|324388522|FG000|Overall Study|Ineligible|5|||
94708161|NCT00028769|324388522|FG000|Overall Study|Not Analyzable|1|||
94708162|NCT02496702|324388524|FG000|Overall Study|Lost to Follow-up|8|||
94708163|NCT02496702|324388525|FG001|Overall Study|Lost to Follow-up|6|||
94708164|NCT02496702|324388524|FG000|Overall Study|Only partially tested|0|||
94708165|NCT02496702|324388525|FG001|Overall Study|Only partially tested|2|||
94708166|NCT04035668|324388526|FG000|Overall Study|Adverse Event|3|||
94708167|NCT04035668|324388527|FG001|Overall Study|Adverse Event|4|||
94708168|NCT04035668|324388528|FG002|Overall Study|Adverse Event|2|||
94708169|NCT04035668|324388526|FG000|Overall Study|Lost to Follow-up|0|||
94708170|NCT04035668|324388527|FG001|Overall Study|Lost to Follow-up|1|||
94708171|NCT04035668|324388528|FG002|Overall Study|Lost to Follow-up|0|||
94708172|NCT04035668|324388526|FG000|Overall Study|Physician Decision|2|||
94708173|NCT04035668|324388527|FG001|Overall Study|Physician Decision|1|||
94708174|NCT04035668|324388528|FG002|Overall Study|Physician Decision|1|||
94708175|NCT04035668|324388526|FG000|Overall Study|Subject Decision|2|||
94708176|NCT04035668|324388527|FG001|Overall Study|Subject Decision|2|||
94708177|NCT04035668|324388528|FG002|Overall Study|Subject Decision|0|||
94708178|NCT04480827|324388531|FG000|Overall Study|Adverse Event|0|||
94708179|NCT04480827|324388532|FG001|Overall Study|Adverse Event|0|||
94708180|NCT04480827|324388533|FG002|Overall Study|Adverse Event|0|||
94708181|NCT04480827|324388534|FG003|Overall Study|Adverse Event|0|||
94708182|NCT04480827|324388535|FG004|Overall Study|Adverse Event|0|||
94708183|NCT04480827|324388536|FG005|Overall Study|Adverse Event|1|||
94708184|NCT04480827|324388537|FG006|Overall Study|Adverse Event|0|||
94708185|NCT00465816|324388538|FG000|Overall Study|Lost to Follow-up|0|||
94708186|NCT00465816|324388539|FG001|Overall Study|Lost to Follow-up|0|||
94708187|NCT00465816|324388540|FG002|Overall Study|Lost to Follow-up|2|||
94708188|NCT02983617|324388549|FG000|Overall Study|Adverse Event|0|||
94708189|NCT02983617|324388550|FG001|Overall Study|Adverse Event|7|||
94708190|NCT02983617|324388549|FG000|Overall Study|Death|0|||
94708191|NCT02983617|324388550|FG001|Overall Study|Death|1|||
94708192|NCT02983617|324388549|FG000|Overall Study|Investigator's Discretion|0|||
94708193|NCT02983617|324388550|FG001|Overall Study|Investigator's Discretion|1|||
94708194|NCT03720210|324388551|FG000|Overall Study|Lost to Follow-up|1|||
94708195|NCT00703911|324388554|FG000|Overall Study|Death|1|||
94708196|NCT00703911|324388554|FG000|Overall Study|Physician Decision|6|||
94708197|NCT00703911|324388554|FG000|Overall Study|Lost to Follow-up|1|||
94708198|NCT00703911|324388554|FG000|Overall Study|Withdrawal by Subject|2|||
94708199|NCT01064817|324388556|FG000|Study Completion|Physician Decision|1|||
94708200|NCT01064817|324388557|FG001|Study Completion|Physician Decision|0|||
94708201|NCT01064817|324388556|FG000|Study Completion|Withdrawal by Subject|1|||
94708202|NCT01064817|324388557|FG001|Study Completion|Withdrawal by Subject|0|||
94708203|NCT01066923|324388560|FG000|Overall Study|Withdrawal by Subject|3|||
94708204|NCT01066923|324388561|FG001|Overall Study|Withdrawal by Subject|3|||
94708205|NCT01066923|324388562|FG002|Overall Study|Withdrawal by Subject|8|||
94708206|NCT01066923|324388563|FG003|Overall Study|Withdrawal by Subject|8|||
94708207|NCT00738699|324388567|FG000|Overall Study|Withdrawal by Subject|5|||
94708208|NCT00738699|324388568|FG001|Overall Study|Withdrawal by Subject|0|||
94708209|NCT00738699|324388567|FG000|Overall Study|Lost to Follow-up|1|||
94366682|NCT00127192|323128123|FG000|Overall Study|Withdrawal by Subject|0|||
94366683|NCT00127192|323128124|FG001|Overall Study|Withdrawal by Subject|0|||
94708210|NCT00738699|324388568|FG001|Overall Study|Lost to Follow-up|0|||
94708211|NCT00738699|324388567|FG000|Overall Study|Death|144|||
94708212|NCT00738699|324388568|FG001|Overall Study|Death|68|||
94708213|NCT00738699|324388567|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
94366684|NCT00127192|323128125|FG002|Overall Study|Withdrawal by Subject|1|||
94366685|NCT00127192|323128126|FG003|Overall Study|Withdrawal by Subject|0|||
94708214|NCT00738699|324388568|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
94708215|NCT00738699|324388567|FG000|Overall Study|Other|2|||
94708216|NCT00738699|324388568|FG001|Overall Study|Other|0|||
94708217|NCT01171625|324388571|FG000|Overall Study|On-Protocol|67|||
94708218|NCT01171625|324388571|FG000|Overall Study|Death|38|||
94708219|NCT01171625|324388571|FG000|Overall Study|Withdrawal by Subject|31|||
94708220|NCT01171625|324388571|FG000|Overall Study|Explanted|10|||
94366686|NCT00127192|323128127|FG004|Overall Study|Withdrawal by Subject|3|||
94366687|NCT00127192|323128123|FG000|Overall Study|Adverse event in pre-treatment period|1|||
94708221|NCT01171625|324388571|FG000|Overall Study|Lost to Follow-up|5|||
94708222|NCT01171625|324388571|FG000|Overall Study|Patient received valve-in-valve|3|||
94708223|NCT01171625|324388571|FG000|Overall Study|Other|1|||
94708224|NCT01171625|324388571|FG000|Overall Study|Consented but did not receive device|25|||
94708225|NCT00419094|324388576|FG000|Overall Study|Adverse Event|3|||
94708226|NCT00419094|324388577|FG001|Overall Study|Adverse Event|7|||
94708227|NCT00419094|324388576|FG000|Overall Study|Lack of Efficacy|1|||
94708228|NCT00419094|324388577|FG001|Overall Study|Lack of Efficacy|0|||
94708229|NCT00419094|324388576|FG000|Overall Study|Lost to Follow-up|0|||
94708230|NCT00419094|324388577|FG001|Overall Study|Lost to Follow-up|2|||
94708231|NCT00419094|324388576|FG000|Overall Study|Protocol Violation|1|||
94708232|NCT00419094|324388577|FG001|Overall Study|Protocol Violation|14|||
94708233|NCT00419094|324388576|FG000|Overall Study|Withdrawal of consent|1|||
94708234|NCT00419094|324388577|FG001|Overall Study|Withdrawal of consent|5|||
94708235|NCT00419094|324388576|FG000|Overall Study|Other: Error determining exit criteria|1|||
94708236|NCT00419094|324388577|FG001|Overall Study|Other: Error determining exit criteria|0|||
94708237|NCT00419094|324388576|FG000|Overall Study|Other: Patient non-compliant|0|||
94708238|NCT00419094|324388577|FG001|Overall Study|Other: Patient non-compliant|1|||
94708239|NCT00419094|324388576|FG000|Overall Study|Other: No contact for extended period|0|||
94708240|NCT00419094|324388577|FG001|Overall Study|Other: No contact for extended period|1|||
94708241|NCT00943735|324388584|FG000|Overall Study|Adverse Event|12|||
94708242|NCT00943735|324388584|FG000|Overall Study|Withdrawal by Subject|8|||
94708243|NCT00943735|324388584|FG000|Overall Study|Death|1|||
94708244|NCT00943735|324388584|FG000|Overall Study|Other|8|||
94708245|NCT00943735|324388584|FG000|Overall Study|Other|3|||
94708246|NCT02705586|324388603|FG000|Overall Study|Health Issues|2|||
94708247|NCT02705586|324388603|FG000|Overall Study|Transportation Difficulties|5|||
94708248|NCT02705586|324388603|FG000|Overall Study|Vacation/Planned Absence|1|||
94708249|NCT02000817|324388606|FG000|Overall Study|Withdrawal by Subject|2|||
94708250|NCT02000817|324388607|FG001|Overall Study|Withdrawal by Subject|0|||
94708251|NCT02000817|324388608|FG002|Overall Study|Withdrawal by Subject|0|||
94708252|NCT02000817|324388609|FG003|Overall Study|Withdrawal by Subject|0|||
94708253|NCT02000817|324388606|FG000|Overall Study|Adverse Event|0|||
94708254|NCT02000817|324388607|FG001|Overall Study|Adverse Event|1|||
94708255|NCT02000817|324388608|FG002|Overall Study|Adverse Event|0|||
94708256|NCT02000817|324388609|FG003|Overall Study|Adverse Event|0|||
94708257|NCT02000817|324388606|FG000|Overall Study|Lost to Follow-up|0|||
94708258|NCT02000817|324388607|FG001|Overall Study|Lost to Follow-up|0|||
94708259|NCT02000817|324388608|FG002|Overall Study|Lost to Follow-up|1|||
94708260|NCT02000817|324388609|FG003|Overall Study|Lost to Follow-up|0|||
94708261|NCT03383146|324388611|FG000|Overall Study|Screen Failure|1|||
94708262|NCT03383146|324388612|FG001|Overall Study|Screen Failure|0|||
94708263|NCT03383146|324388611|FG000|Overall Study|Adverse Event|6|||
94708264|NCT03383146|324388612|FG001|Overall Study|Adverse Event|18|||
94708265|NCT03383146|324388611|FG000|Overall Study|Lack of Efficacy|0|||
94708266|NCT03383146|324388612|FG001|Overall Study|Lack of Efficacy|3|||
94708267|NCT03383146|324388611|FG000|Overall Study|Withdrawal by Subject|20|||
94708268|NCT03383146|324388612|FG001|Overall Study|Withdrawal by Subject|36|||
94708269|NCT03383146|324388611|FG000|Overall Study|Lost to Follow-up|5|||
94708270|NCT03383146|324388612|FG001|Overall Study|Lost to Follow-up|15|||
94708271|NCT03383146|324388611|FG000|Overall Study|Death|0|||
94708272|NCT03383146|324388612|FG001|Overall Study|Death|2|||
94708273|NCT03383146|324388611|FG000|Overall Study|Physician Decision|0|||
94708274|NCT03383146|324388612|FG001|Overall Study|Physician Decision|1|||
94708275|NCT03383146|324388611|FG000|Overall Study|Protocol Deviation|1|||
94708276|NCT03383146|324388612|FG001|Overall Study|Protocol Deviation|8|||
94708277|NCT03383146|324388611|FG000|Overall Study|Study Terminated by the Sponsor|48|||
94708278|NCT03383146|324388612|FG001|Overall Study|Study Terminated by the Sponsor|95|||
94708279|NCT03383146|324388611|FG000|Overall Study|Reason not Specified|4|||
94708280|NCT03383146|324388612|FG001|Overall Study|Reason not Specified|6|||
94708281|NCT01968226|324388614|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
94708282|NCT00102063|324388615|FG000|Overall Study|Lack of Efficacy|5|||
94708283|NCT00102063|324388616|FG001|Overall Study|Lack of Efficacy|1|||
94708284|NCT00102063|324388617|FG002|Overall Study|Lack of Efficacy|1|||
94708285|NCT00102063|324388615|FG000|Overall Study|Adverse Event|7|||
94708286|NCT00102063|324388616|FG001|Overall Study|Adverse Event|4|||
94708287|NCT00102063|324388617|FG002|Overall Study|Adverse Event|2|||
94708288|NCT00102063|324388615|FG000|Overall Study|Withdrawal by Subject|4|||
94708289|NCT00102063|324388616|FG001|Overall Study|Withdrawal by Subject|12|||
94708290|NCT00102063|324388617|FG002|Overall Study|Withdrawal by Subject|5|||
94708291|NCT00102063|324388615|FG000|Overall Study|Lost to Follow-up|0|||
94708292|NCT00102063|324388616|FG001|Overall Study|Lost to Follow-up|0|||
94708293|NCT00102063|324388617|FG002|Overall Study|Lost to Follow-up|1|||
94708294|NCT00102063|324388615|FG000|Overall Study|Protocol Violation|0|||
94708295|NCT00102063|324388616|FG001|Overall Study|Protocol Violation|1|||
94708296|NCT00102063|324388617|FG002|Overall Study|Protocol Violation|1|||
94708297|NCT00256243|324388623|FG000|Overall Study|Lost to Follow-up|2|||
94708298|NCT00256243|324388623|FG000|Overall Study|Death|7|||
94708299|NCT00256243|324388623|FG000|Overall Study|Not treated|1|||
94708300|NCT01585558|324388625|FG000|Overall Study|Withdrawal by Subject|4|||
94708301|NCT01585558|324388626|FG001|Overall Study|Withdrawal by Subject|5|||
94708302|NCT01585558|324388627|FG002|Overall Study|Withdrawal by Subject|8|||
94708303|NCT01585558|324388625|FG000|Overall Study|Lost to Follow-up|2|||
94708304|NCT01585558|324388626|FG001|Overall Study|Lost to Follow-up|0|||
94708305|NCT01585558|324388627|FG002|Overall Study|Lost to Follow-up|3|||
94708306|NCT01585558|324388625|FG000|Overall Study|Adverse Event|3|||
94708307|NCT01585558|324388626|FG001|Overall Study|Adverse Event|4|||
94708308|NCT01585558|324388627|FG002|Overall Study|Adverse Event|1|||
94708309|NCT01585558|324388625|FG000|Overall Study|Protocol Violation|4|||
94708310|NCT01585558|324388626|FG001|Overall Study|Protocol Violation|3|||
94708311|NCT01585558|324388627|FG002|Overall Study|Protocol Violation|2|||
94708312|NCT01585558|324388625|FG000|Overall Study|Lack of Efficacy|0|||
94708313|NCT01585558|324388626|FG001|Overall Study|Lack of Efficacy|0|||
94708314|NCT01585558|324388627|FG002|Overall Study|Lack of Efficacy|1|||
94708315|NCT02994654|324388628|FG000|Overall Study|Lost to Follow-up|1|||
94708316|NCT01144468|324390410|FG000|Overall Study|Lost to Follow-up|4|||
94708317|NCT01144468|324390411|FG001|Overall Study|Lost to Follow-up|7|||
94708318|NCT01144468|324390410|FG000|Overall Study|Adverse Event|3|||
94708319|NCT01144468|324390411|FG001|Overall Study|Adverse Event|2|||
94708320|NCT01144468|324390410|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
94708321|NCT01144468|324390411|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
94708322|NCT04199728|324390412|FG000|Overall Study|Adverse Event|1|||
94708323|NCT04199728|324390413|FG001|Overall Study|Adverse Event|0|||
94708324|NCT04199728|324390412|FG000|Overall Study|Withdrawal by Subject|8|||
94708325|NCT04199728|324390413|FG001|Overall Study|Withdrawal by Subject|3|||
94708326|NCT04199728|324390412|FG000|Overall Study|Screen fail after consent|0|||
94708327|NCT04199728|324390413|FG001|Overall Study|Screen fail after consent|1|||
94708328|NCT04199728|324390412|FG000|Overall Study|Early withdraw criteria met|0|||
94708329|NCT04199728|324390413|FG001|Overall Study|Early withdraw criteria met|1|||
94708330|NCT04199728|324390412|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
94708331|NCT04199728|324390413|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
94708332|NCT01875250|324390414|FG000|Overall Study|Adverse Event|2|||
94708333|NCT01875250|324390415|FG001|Overall Study|Adverse Event|0|||
94708334|NCT03712930|324390416|FG000|Overall Study|Death|7|||
94708335|NCT03712930|324390416|FG000|Overall Study|Physician Decision|1|||
94708336|NCT03712930|324390416|FG000|Overall Study|Study Terminated by Sponsor|3|||
94708337|NCT03712930|324390416|FG000|Overall Study|Progressive Disease|2|||
94708338|NCT01134562|324390422|FG000|Overall Study|Adverse Event|0|||
94708339|NCT01134562|324390423|FG001|Overall Study|Adverse Event|1|||
94708340|NCT01134562|324390424|FG002|Overall Study|Adverse Event|0|||
94708341|NCT01134562|324390425|FG003|Overall Study|Adverse Event|0|||
94708342|NCT01134562|324390426|FG004|Overall Study|Adverse Event|0|||
94708343|NCT00726999|324390429|FG000|Overall Study|Physician Decision|0|||
94708344|NCT00726999|324390430|FG001|Overall Study|Physician Decision|1|||
94708345|NCT00726999|324390429|FG000|Overall Study|Withdrawal by Subject|2|||
94708346|NCT00726999|324390430|FG001|Overall Study|Withdrawal by Subject|0|||
94708347|NCT00726999|324390429|FG000|Overall Study|Protocol Violation|1|||
94708348|NCT00726999|324390430|FG001|Overall Study|Protocol Violation|0|||
94708349|NCT02488980|324390431|FG000|Overall Study|Protocol Violation|2|||
94708350|NCT02488980|324390432|FG001|Overall Study|Protocol Violation|2|||
94708351|NCT02488980|324390433|FG002|Overall Study|Protocol Violation|2|||
94708352|NCT00446550|324390437|FG000|Overall Study|Adverse Event|1|||
94708353|NCT00446550|324390438|FG001|Overall Study|Adverse Event|0|||
94708354|NCT00516386|324390440|FG000|Overall Study|not interested in the study|4|||
94708355|NCT00516386|324390440|FG000|Overall Study|Lost to Follow-up|2|||
94708356|NCT00393848|324390441|FG000|Overall Study|Surgical schedule|0|||
94708357|NCT00393848|324390442|FG001|Overall Study|Surgical schedule|0|||
94708358|NCT00393848|324390443|FG002|Overall Study|Surgical schedule|0|||
94708359|NCT00393848|324390444|FG003|Overall Study|Surgical schedule|1|||
94466246|NCT01358578|323496951|FG000|Maintenance Period|Lack of Efficacy|10|||
94466247|NCT01358578|323496952|FG001|Maintenance Period|Lack of Efficacy|2|||
94708360|NCT00393848|324390441|FG000|Overall Study|Personal reasons|0|||
94708361|NCT00393848|324390442|FG001|Overall Study|Personal reasons|0|||
94708362|NCT00393848|324390443|FG002|Overall Study|Personal reasons|2|||
94708363|NCT00393848|324390444|FG003|Overall Study|Personal reasons|0|||
94708364|NCT02082158|324390447|FG000|Overall Study|Withdrawal by Subject|0|||
94708365|NCT02082158|324390448|FG001|Overall Study|Withdrawal by Subject|0|||
94708366|NCT02082158|324390449|FG002|Overall Study|Withdrawal by Subject|0|||
94708367|NCT02082158|324390450|FG003|Overall Study|Withdrawal by Subject|0|||
94708368|NCT02082158|324390451|FG004|Overall Study|Withdrawal by Subject|1|||
94708369|NCT02082158|324390452|FG005|Overall Study|Withdrawal by Subject|0|||
94708370|NCT02082158|324390447|FG000|Overall Study|Failed Fit-testing|8|||
94708371|NCT02082158|324390448|FG001|Overall Study|Failed Fit-testing|8|||
94708372|NCT02082158|324390449|FG002|Overall Study|Failed Fit-testing|14|||
94708373|NCT02082158|324390450|FG003|Overall Study|Failed Fit-testing|4|||
94708374|NCT02082158|324390451|FG004|Overall Study|Failed Fit-testing|3|||
94708375|NCT02082158|324390452|FG005|Overall Study|Failed Fit-testing|7|||
94708376|NCT00549848|324390454|FG000|Overall Study|Death|1|||
94708377|NCT00549848|324390455|FG001|Overall Study|Death|4|||
94708378|NCT00549848|324390456|FG002|Overall Study|Death|13|||
94708379|NCT00549848|324390454|FG000|Overall Study|Physician Decision|0|||
94708380|NCT00549848|324390455|FG001|Overall Study|Physician Decision|0|||
94708381|NCT00549848|324390456|FG002|Overall Study|Physician Decision|4|||
94708382|NCT00549848|324390454|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
94708383|NCT00549848|324390455|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
94708384|NCT00549848|324390456|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
94708385|NCT00549848|324390454|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
94708386|NCT00549848|324390455|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
94708387|NCT00549848|324390456|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
94708388|NCT00549848|324390454|FG000|Overall Study|Participant/Family Withdraw|2|||
94708389|NCT00549848|324390455|FG001|Overall Study|Participant/Family Withdraw|3|||
94708390|NCT00549848|324390456|FG002|Overall Study|Participant/Family Withdraw|5|||
94708391|NCT00549848|324390454|FG000|Overall Study|Second Malignancy|1|||
94708392|NCT00549848|324390455|FG001|Overall Study|Second Malignancy|0|||
94708393|NCT00549848|324390456|FG002|Overall Study|Second Malignancy|0|||
94708394|NCT00549848|324390454|FG000|Overall Study|Transplant|3|||
94708395|NCT00549848|324390455|FG001|Overall Study|Transplant|3|||
94708396|NCT00549848|324390456|FG002|Overall Study|Transplant|18|||
94708397|NCT00549848|324390454|FG000|Overall Study|Unacceptable Toxicity|1|||
94708398|NCT00549848|324390455|FG001|Overall Study|Unacceptable Toxicity|6|||
94708399|NCT00549848|324390456|FG002|Overall Study|Unacceptable Toxicity|6|||
94708400|NCT01458210|324390459|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
94708401|NCT01458210|324390459|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
94708402|NCT01458210|324390459|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
94708403|NCT01458210|324390459|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
94708404|NCT01786564|324390460|FG000|Overall Study|Lost to Follow-up|47|||
94708405|NCT01786564|324390460|FG000|Overall Study|Ineligible|17|||
94708406|NCT00494442|324390461|FG000|Overall Study|Death|1|||
94708407|NCT00494442|324390462|FG001|Overall Study|Death|1|||
94708408|NCT00494442|324390461|FG000|Overall Study|Lack of Efficacy|16|||
94708409|NCT00494442|324390462|FG001|Overall Study|Lack of Efficacy|10|||
94708410|NCT00494442|324390461|FG000|Overall Study|Adverse Event|0|||
94708411|NCT00494442|324390462|FG001|Overall Study|Adverse Event|2|||
94708412|NCT00494442|324390461|FG000|Overall Study|Physician Decision|0|||
94708413|NCT00494442|324390462|FG001|Overall Study|Physician Decision|1|||
94708414|NCT00494442|324390461|FG000|Overall Study|Non-compliance|0|||
94708415|NCT00494442|324390462|FG001|Overall Study|Non-compliance|1|||
94708416|NCT00494442|324390461|FG000|Overall Study|Intercurrent illness|0|||
94708417|NCT00494442|324390462|FG001|Overall Study|Intercurrent illness|1|||
94708418|NCT01241292|324390463|FG000|Overall Study|Administrative Reason by Sponsor|1|||
94708419|NCT01241292|324390464|FG001|Overall Study|Administrative Reason by Sponsor|0|||
94708420|NCT01241292|324390463|FG000|Overall Study|Disease Progression|2|||
94708421|NCT01241292|324390464|FG001|Overall Study|Disease Progression|0|||
94708422|NCT01241292|324390463|FG000|Overall Study|Study Drug Toxicity|0|||
94708423|NCT01241292|324390464|FG001|Overall Study|Study Drug Toxicity|1|||
94708424|NCT01241292|324390463|FG000|Overall Study|Participant Discontinued Treatment|0|||
94708425|NCT01241292|324390464|FG001|Overall Study|Participant Discontinued Treatment|2|||
94708426|NCT00424762|324390465|FG000|Overall Study|Withdrawal by Subject|18|||
94708427|NCT00424762|324390466|FG001|Overall Study|Withdrawal by Subject|19|||
94708428|NCT00424762|324390465|FG000|Overall Study|Lost to Follow-up|2|||
94708429|NCT00424762|324390466|FG001|Overall Study|Lost to Follow-up|3|||
94708430|NCT01329328|324390467|FG000|Overall Study|Withdrawal by Subject|2|||
94708431|NCT01329328|324390468|FG001|Overall Study|Withdrawal by Subject|4|||
94708432|NCT01329328|324390469|FG002|Overall Study|Withdrawal by Subject|3|||
94708433|NCT01145885|324390470|FG000|Overall Study|Progressive Disease|7|||
94708434|NCT00964366|324390471|FG000|Overall Study|Did not qualify at Day 1|1|||
94708435|NCT00964366|324390472|FG001|Overall Study|Did not qualify at Day 1|0|||
94708436|NCT00964366|324390471|FG000|Overall Study|Withdrawal by Subject|0|||
94708437|NCT00964366|324390472|FG001|Overall Study|Withdrawal by Subject|1|||
94708438|NCT01563354|324390473|FG000|Core Phase|Adverse Event|5|||
94708439|NCT01563354|324390474|FG001|Core Phase|Adverse Event|15|||
94708440|NCT01563354|324390475|FG002|Core Phase|Adverse Event|13|||
94466248|NCT01358578|323496953|FG002|Maintenance Period|Lack of Efficacy|0|||
94708441|NCT01563354|324390473|FG000|Core Phase|Withdrawal by Subject|1|||
94708442|NCT01563354|324390474|FG001|Core Phase|Withdrawal by Subject|0|||
94708443|NCT01563354|324390475|FG002|Core Phase|Withdrawal by Subject|3|||
94466249|NCT01358578|323496954|FG003|Maintenance Period|Lack of Efficacy|11|||
94466250|NCT01358578|323496955|FG004|Maintenance Period|Lack of Efficacy|3|||
94708444|NCT01563354|324390473|FG000|Core Phase|Lost to Follow-up|1|||
94708445|NCT01563354|324390474|FG001|Core Phase|Lost to Follow-up|0|||
94466251|NCT01358578|323496956|FG005|Maintenance Period|Lack of Efficacy|0|||
94466252|NCT01358578|323496951|FG000|Maintenance Period|Lost to Follow-up|4|||
94708446|NCT01563354|324390475|FG002|Core Phase|Lost to Follow-up|0|||
94708447|NCT01563354|324390473|FG000|Core Phase|Death|1|||
94708448|NCT01563354|324390474|FG001|Core Phase|Death|5|||
94708449|NCT01563354|324390475|FG002|Core Phase|Death|2|||
94708450|NCT01563354|324390473|FG000|Core Phase|Diseasse progression|18|||
94708451|NCT01563354|324390474|FG001|Core Phase|Diseasse progression|7|||
94708452|NCT01563354|324390475|FG002|Core Phase|Diseasse progression|8|||
94708453|NCT01563354|324390473|FG000|Core Phase|Protocol deviation|2|||
94708454|NCT01563354|324390474|FG001|Core Phase|Protocol deviation|0|||
94708455|NCT01563354|324390475|FG002|Core Phase|Protocol deviation|0|||
94708456|NCT01563354|324390473|FG000|Core Phase|PI decision - did not enter extension|0|||
94708457|NCT01563354|324390474|FG001|Core Phase|PI decision - did not enter extension|1|||
94708458|NCT01563354|324390475|FG002|Core Phase|PI decision - did not enter extension|0|||
94708459|NCT01563354|324390473|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
94708460|NCT01563354|324390474|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
94708461|NCT01563354|324390475|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
94708462|NCT01563354|324390473|FG000|Extension Phase|Adverse Event|0|||
94708463|NCT01563354|324390474|FG001|Extension Phase|Adverse Event|3|||
94708464|NCT01563354|324390475|FG002|Extension Phase|Adverse Event|2|||
94708465|NCT01563354|324390473|FG000|Extension Phase|Withdrawal by Subject|0|||
94708466|NCT01563354|324390474|FG001|Extension Phase|Withdrawal by Subject|1|||
94708467|NCT01563354|324390475|FG002|Extension Phase|Withdrawal by Subject|0|||
94708468|NCT01563354|324390473|FG000|Extension Phase|Administration problems|3|||
94708469|NCT01563354|324390474|FG001|Extension Phase|Administration problems|2|||
94708470|NCT01563354|324390475|FG002|Extension Phase|Administration problems|3|||
94708471|NCT01563354|324390473|FG000|Extension Phase|Disease progression|9|||
94708472|NCT01563354|324390474|FG001|Extension Phase|Disease progression|8|||
94708473|NCT01563354|324390475|FG002|Extension Phase|Disease progression|10|||
94708474|NCT01831791|324390476|FG000|Overall Study|Withdrawal by Subject|10|||
94708475|NCT01505881|324390477|FG000|Overall Study|Adverse Event|0|||
94708476|NCT01505881|324390478|FG001|Overall Study|Adverse Event|1|||
94708477|NCT01505881|324390477|FG000|Overall Study|Lost to Follow-up|2|||
94708478|NCT01505881|324390478|FG001|Overall Study|Lost to Follow-up|0|||
94708479|NCT01505881|324390477|FG000|Overall Study|Withdrawal by Subject|2|||
94708480|NCT01505881|324390478|FG001|Overall Study|Withdrawal by Subject|0|||
94708481|NCT01194154|324390479|FG000|Overall Study|Adverse Event|12|||
94708482|NCT01194154|324390480|FG001|Overall Study|Adverse Event|7|||
94708483|NCT01194154|324390479|FG000|Overall Study|Lost to Follow-up|2|||
94708484|NCT01194154|324390480|FG001|Overall Study|Lost to Follow-up|3|||
94708485|NCT01194154|324390479|FG000|Overall Study|Protocol Violation|0|||
94708486|NCT01194154|324390480|FG001|Overall Study|Protocol Violation|1|||
94708487|NCT01194154|324390479|FG000|Overall Study|Withdrawal by Subject|5|||
94708488|NCT01194154|324390480|FG001|Overall Study|Withdrawal by Subject|6|||
94708489|NCT01194154|324390479|FG000|Overall Study|Blood pressure increase|5|||
94708490|NCT01194154|324390480|FG001|Overall Study|Blood pressure increase|3|||
94708491|NCT01194154|324390479|FG000|Overall Study|Hemoglobin decrease|0|||
94708492|NCT01194154|324390480|FG001|Overall Study|Hemoglobin decrease|1|||
94708493|NCT01194154|324390479|FG000|Overall Study|Hemoglobin increase|12|||
94708494|NCT01194154|324390480|FG001|Overall Study|Hemoglobin increase|3|||
94708495|NCT01194154|324390479|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
94708496|NCT01194154|324390480|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
94708497|NCT01194154|324390479|FG000|Overall Study|Treatment with prohibited medication|4|||
94708498|NCT01194154|324390480|FG001|Overall Study|Treatment with prohibited medication|5|||
94708499|NCT01194154|324390479|FG000|Overall Study|Other|4|||
94708500|NCT01194154|324390480|FG001|Overall Study|Other|0|||
94708501|NCT01194154|324390479|FG000|Overall Study|Did not receive study medication|2|||
94708502|NCT01194154|324390480|FG001|Overall Study|Did not receive study medication|4|||
94366688|NCT00127192|323128124|FG001|Overall Study|Adverse event in pre-treatment period|0|||
94708503|NCT02026258|324390481|FG000|Randomized|Did not start treatment|2|||
94708504|NCT02026258|324390482|FG001|Randomized|Did not start treatment|1|||
94708505|NCT02026258|324390481|FG000|Randomized|Change in treatment plan|1|||
94708506|NCT02026258|324390482|FG001|Randomized|Change in treatment plan|0|||
94708507|NCT02026258|324390481|FG000|Randomized|Presence of periodontal disease|1|||
94708508|NCT02026258|324390482|FG001|Randomized|Presence of periodontal disease|1|||
94708509|NCT02026258|324390481|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
94708510|NCT02026258|324390482|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
94708511|NCT02026258|324390481|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
94708512|NCT02026258|324390482|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
94708513|NCT00878722|324390485|FG000|Overall Study|Progressive disease|3|||
94708514|NCT00878722|324390486|FG001|Overall Study|Progressive disease|3|||
94708515|NCT00878722|324390487|FG002|Overall Study|Progressive disease|3|||
94708516|NCT00878722|324390488|FG003|Overall Study|Progressive disease|7|||
94708517|NCT00878722|324390489|FG004|Overall Study|Progressive disease|7|||
94708518|NCT00878722|324390490|FG005|Overall Study|Progressive disease|1|||
94708519|NCT00878722|324390491|FG006|Overall Study|Progressive disease|4|||
94708520|NCT00878722|324390492|FG007|Overall Study|Progressive disease|3|||
94708521|NCT00878722|324390485|FG000|Overall Study|Death|0|||
94708522|NCT00878722|324390486|FG001|Overall Study|Death|0|||
94708523|NCT00878722|324390487|FG002|Overall Study|Death|0|||
94708524|NCT00878722|324390488|FG003|Overall Study|Death|1|||
94708525|NCT00878722|324390489|FG004|Overall Study|Death|0|||
94708526|NCT00878722|324390490|FG005|Overall Study|Death|1|||
94708527|NCT00878722|324390491|FG006|Overall Study|Death|0|||
94708528|NCT00878722|324390492|FG007|Overall Study|Death|2|||
94708529|NCT00878722|324390485|FG000|Overall Study|Adverse Event|0|||
94708530|NCT00878722|324390486|FG001|Overall Study|Adverse Event|0|||
94708531|NCT00878722|324390487|FG002|Overall Study|Adverse Event|0|||
94708532|NCT00878722|324390488|FG003|Overall Study|Adverse Event|0|||
94708533|NCT00878722|324390489|FG004|Overall Study|Adverse Event|0|||
94708534|NCT00878722|324390490|FG005|Overall Study|Adverse Event|0|||
94708535|NCT00878722|324390491|FG006|Overall Study|Adverse Event|2|||
94708536|NCT00878722|324390492|FG007|Overall Study|Adverse Event|0|||
94708537|NCT00878722|324390485|FG000|Overall Study|Withdrawal by Subject|0|||
94708538|NCT00878722|324390486|FG001|Overall Study|Withdrawal by Subject|0|||
94708539|NCT00878722|324390487|FG002|Overall Study|Withdrawal by Subject|0|||
94708540|NCT00878722|324390488|FG003|Overall Study|Withdrawal by Subject|0|||
94708541|NCT00878722|324390489|FG004|Overall Study|Withdrawal by Subject|0|||
94708542|NCT00878722|324390490|FG005|Overall Study|Withdrawal by Subject|0|||
94708543|NCT00878722|324390491|FG006|Overall Study|Withdrawal by Subject|0|||
94708544|NCT00878722|324390492|FG007|Overall Study|Withdrawal by Subject|2|||
94366689|NCT00127192|323128125|FG002|Overall Study|Adverse event in pre-treatment period|0|||
94366690|NCT00127192|323128126|FG003|Overall Study|Adverse event in pre-treatment period|0|||
94366691|NCT00127192|323128127|FG004|Overall Study|Adverse event in pre-treatment period|0|||
94366692|NCT01346501|323128132|FG000|Overall Study|Initiated Other Biological Agents|3|||
94366693|NCT01346501|323128133|FG001|Overall Study|Initiated Other Biological Agents|1|||
94366694|NCT01346501|323128132|FG000|Overall Study|Other|8|||
94366695|NCT01346501|323128133|FG001|Overall Study|Other|12|||
94366696|NCT05180630|323128136|FG000|First Intervention|Physician Decision|0|||
94366697|NCT05180630|323128137|FG001|First Intervention|Physician Decision|0|||
94366698|NCT05180630|323128138|FG002|First Intervention|Physician Decision|3|||
94366699|NCT01787188|323128141|FG000|Overall Study|Adverse Event|2|||
94366700|NCT01787188|323128142|FG001|Overall Study|Adverse Event|4|||
94366701|NCT01787188|323128143|FG002|Overall Study|Adverse Event|6|||
94366702|NCT01787188|323128141|FG000|Overall Study|Lack of Efficacy|7|||
94366703|NCT01787188|323128142|FG001|Overall Study|Lack of Efficacy|3|||
94366704|NCT01787188|323128143|FG002|Overall Study|Lack of Efficacy|5|||
94366705|NCT01787188|323128141|FG000|Overall Study|Non-compliance with Study Drug|0|||
94366706|NCT01787188|323128142|FG001|Overall Study|Non-compliance with Study Drug|1|||
94366707|NCT01787188|323128143|FG002|Overall Study|Non-compliance with Study Drug|0|||
94366708|NCT01787188|323128141|FG000|Overall Study|Withdrawal by Subject|4|||
94366709|NCT01787188|323128142|FG001|Overall Study|Withdrawal by Subject|3|||
94366710|NCT01787188|323128143|FG002|Overall Study|Withdrawal by Subject|2|||
94366711|NCT01787188|323128141|FG000|Overall Study|Protocol Violation|3|||
94366712|NCT01787188|323128142|FG001|Overall Study|Protocol Violation|2|||
94366713|NCT01787188|323128143|FG002|Overall Study|Protocol Violation|3|||
94366714|NCT01787188|323128141|FG000|Overall Study|Lost to Follow-up|1|||
94366715|NCT01787188|323128142|FG001|Overall Study|Lost to Follow-up|2|||
94366716|NCT01787188|323128143|FG002|Overall Study|Lost to Follow-up|2|||
94366717|NCT01787188|323128141|FG000|Overall Study|Other, including patient moved|0|||
94366718|NCT01787188|323128142|FG001|Overall Study|Other, including patient moved|3|||
94366719|NCT01787188|323128143|FG002|Overall Study|Other, including patient moved|0|||
94366720|NCT02268045|323128148|FG000|Overall Study|Death|4|||
94366721|NCT02268045|323128149|FG001|Overall Study|Death|4|||
94366722|NCT02268045|323128148|FG000|Overall Study|Disease Progression|2|||
94366723|NCT02268045|323128149|FG001|Overall Study|Disease Progression|1|||
94366724|NCT02268045|323128148|FG000|Overall Study|Adverse Event|7|||
94366725|NCT02268045|323128149|FG001|Overall Study|Adverse Event|7|||
94708545|NCT00878722|324390485|FG000|Overall Study|Relapse|0|||
94708546|NCT00878722|324390486|FG001|Overall Study|Relapse|0|||
94708547|NCT00878722|324390487|FG002|Overall Study|Relapse|0|||
94708548|NCT00878722|324390488|FG003|Overall Study|Relapse|1|||
94708549|NCT00878722|324390489|FG004|Overall Study|Relapse|0|||
94708550|NCT00878722|324390490|FG005|Overall Study|Relapse|0|||
94708551|NCT00878722|324390491|FG006|Overall Study|Relapse|0|||
94708552|NCT00878722|324390492|FG007|Overall Study|Relapse|0|||
94708553|NCT03299816|324390493|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
94708554|NCT03299816|324390494|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
94708555|NCT03299816|324390493|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
94708556|NCT03299816|324390494|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
94708557|NCT03299816|324390493|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
94708558|NCT03299816|324390494|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
94708559|NCT02798835|324390497|FG000|Overall Study|Protocol Violation|0|||
94708560|NCT02798835|324390498|FG001|Overall Study|Protocol Violation|0|||
94708561|NCT02798835|324390499|FG002|Overall Study|Protocol Violation|3|||
94708562|NCT00639002|324390506|FG000|Overall Study|Death|1|||
94708563|NCT00639002|324390506|FG000|Overall Study|Adverse Event|1|||
94708564|NCT00639002|324390506|FG000|Overall Study|Protocol Violation|1|||
94708565|NCT00639002|324390506|FG000|Overall Study|Disease progression|3|||
94708566|NCT00639002|324390506|FG000|Overall Study|Physician Decision|6|||
94708567|NCT00639002|324390506|FG000|Overall Study|Lack of Efficacy|1|||
94708568|NCT00712335|324390509|FG000|Overall Study|Withdrawal by Subject|0|||
94708569|NCT00712335|324390510|FG001|Overall Study|Withdrawal by Subject|7|||
94708570|NCT00712335|324390511|FG002|Overall Study|Withdrawal by Subject|2|||
94708571|NCT00712335|324390512|FG003|Overall Study|Withdrawal by Subject|3|||
94708572|NCT00712335|324390513|FG004|Overall Study|Withdrawal by Subject|0|||
94708573|NCT00712335|324390509|FG000|Overall Study|Lost to Follow-up|2|||
94708574|NCT00712335|324390510|FG001|Overall Study|Lost to Follow-up|5|||
94708575|NCT00712335|324390511|FG002|Overall Study|Lost to Follow-up|0|||
94708576|NCT00712335|324390512|FG003|Overall Study|Lost to Follow-up|1|||
94708577|NCT00712335|324390513|FG004|Overall Study|Lost to Follow-up|0|||
94708578|NCT00712335|324390509|FG000|Overall Study|Protocol Violation|1|||
94708579|NCT00712335|324390510|FG001|Overall Study|Protocol Violation|2|||
94708580|NCT00712335|324390511|FG002|Overall Study|Protocol Violation|1|||
94708581|NCT00712335|324390512|FG003|Overall Study|Protocol Violation|0|||
94708582|NCT00712335|324390513|FG004|Overall Study|Protocol Violation|0|||
94708583|NCT00712335|324390509|FG000|Overall Study|Lack of Efficacy|0|||
94708584|NCT00712335|324390510|FG001|Overall Study|Lack of Efficacy|0|||
94708585|NCT00712335|324390511|FG002|Overall Study|Lack of Efficacy|1|||
94708586|NCT00712335|324390512|FG003|Overall Study|Lack of Efficacy|1|||
94708587|NCT00712335|324390513|FG004|Overall Study|Lack of Efficacy|0|||
94708588|NCT00712335|324390509|FG000|Overall Study|Other Reason|0|||
94708589|NCT00712335|324390510|FG001|Overall Study|Other Reason|3|||
94708590|NCT00712335|324390511|FG002|Overall Study|Other Reason|1|||
94708591|NCT00712335|324390512|FG003|Overall Study|Other Reason|0|||
94708592|NCT00712335|324390513|FG004|Overall Study|Other Reason|0|||
94708593|NCT01909778|324390518|FG000|Overall Study|failed screening|1|||
94708594|NCT02248480|324390519|FG000|Overall Study|Lack of Efficacy|4|||
94708595|NCT02248480|324390520|FG001|Overall Study|Lack of Efficacy|6|||
94708596|NCT02248480|324390519|FG000|Overall Study|Adverse Event|11|||
94708597|NCT02248480|324390520|FG001|Overall Study|Adverse Event|2|||
94708598|NCT02248480|324390519|FG000|Overall Study|Withdrawal by Subject|2|||
94708599|NCT02248480|324390520|FG001|Overall Study|Withdrawal by Subject|4|||
94708600|NCT02248480|324390519|FG000|Overall Study|Entry Criteria Not Met|0|||
94708601|NCT02248480|324390520|FG001|Overall Study|Entry Criteria Not Met|1|||
94708602|NCT02248480|324390519|FG000|Overall Study|Other:Physician Decision|0|||
94708603|NCT02248480|324390520|FG001|Overall Study|Other:Physician Decision|1|||
94708604|NCT03863834|324390522|FG000|Overall Study|Lost to Follow-up|3|||
94708605|NCT02020616|324390523|FG000|Overall Study|Adverse Event|0|||
94708606|NCT02020616|324390524|FG001|Overall Study|Adverse Event|0|||
94708607|NCT02020616|324390525|FG002|Overall Study|Adverse Event|0|||
94708608|NCT02020616|324390526|FG003|Overall Study|Adverse Event|0|||
94708609|NCT02020616|324390527|FG004|Overall Study|Adverse Event|0|||
94708610|NCT02020616|324390528|FG005|Overall Study|Adverse Event|1|||
94708611|NCT02020616|324390529|FG006|Overall Study|Adverse Event|1|||
94708612|NCT02020616|324390523|FG000|Overall Study|Physician Decision|0|||
94708613|NCT02020616|324390524|FG001|Overall Study|Physician Decision|0|||
94708614|NCT02020616|324390525|FG002|Overall Study|Physician Decision|0|||
94708615|NCT02020616|324390526|FG003|Overall Study|Physician Decision|0|||
94708616|NCT02020616|324390527|FG004|Overall Study|Physician Decision|0|||
94708617|NCT02020616|324390528|FG005|Overall Study|Physician Decision|1|||
94708618|NCT02020616|324390529|FG006|Overall Study|Physician Decision|2|||
94708619|NCT02020616|324390523|FG000|Overall Study|Withdrawal by Subject|0|||
94266974|NCT04552288|322772059|FG000|Overall Study|Withdrawal by Subject|6|||
94266975|NCT04552288|322772059|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
94266976|NCT02844816|322772060|FG000|Overall Study|No protocol treatment received|5|||
94266977|NCT02844816|322772061|FG001|Overall Study|No protocol treatment received|1|||
94266978|NCT02844816|322772060|FG000|Overall Study|Ineligible|22|||
94708620|NCT02020616|324390524|FG001|Overall Study|Withdrawal by Subject|0|||
94708621|NCT02020616|324390525|FG002|Overall Study|Withdrawal by Subject|1|||
94708622|NCT02020616|324390526|FG003|Overall Study|Withdrawal by Subject|0|||
94708623|NCT02020616|324390527|FG004|Overall Study|Withdrawal by Subject|0|||
94708624|NCT02020616|324390528|FG005|Overall Study|Withdrawal by Subject|1|||
94708625|NCT02020616|324390529|FG006|Overall Study|Withdrawal by Subject|1|||
94708626|NCT02020616|324390523|FG000|Overall Study|Lost to Follow-up|0|||
94708627|NCT02020616|324390524|FG001|Overall Study|Lost to Follow-up|1|||
94708628|NCT02020616|324390525|FG002|Overall Study|Lost to Follow-up|0|||
94708629|NCT02020616|324390526|FG003|Overall Study|Lost to Follow-up|1|||
94708630|NCT02020616|324390527|FG004|Overall Study|Lost to Follow-up|1|||
94708631|NCT02020616|324390528|FG005|Overall Study|Lost to Follow-up|1|||
94708632|NCT02020616|324390529|FG006|Overall Study|Lost to Follow-up|0|||
94708633|NCT02020616|324390523|FG000|Overall Study|Early Termination Criteria Met|0|||
94708634|NCT02020616|324390524|FG001|Overall Study|Early Termination Criteria Met|0|||
94708635|NCT02020616|324390525|FG002|Overall Study|Early Termination Criteria Met|1|||
94708636|NCT02020616|324390526|FG003|Overall Study|Early Termination Criteria Met|0|||
94708637|NCT02020616|324390527|FG004|Overall Study|Early Termination Criteria Met|0|||
94708638|NCT02020616|324390528|FG005|Overall Study|Early Termination Criteria Met|1|||
94708639|NCT02020616|324390529|FG006|Overall Study|Early Termination Criteria Met|0|||
94708640|NCT02020616|324390523|FG000|Overall Study|Randomized in Error|0|||
94708641|NCT02020616|324390524|FG001|Overall Study|Randomized in Error|0|||
94708642|NCT02020616|324390525|FG002|Overall Study|Randomized in Error|0|||
94708643|NCT02020616|324390526|FG003|Overall Study|Randomized in Error|1|||
94708644|NCT02020616|324390527|FG004|Overall Study|Randomized in Error|0|||
94708645|NCT02020616|324390528|FG005|Overall Study|Randomized in Error|0|||
94708646|NCT02020616|324390529|FG006|Overall Study|Randomized in Error|0|||
94708647|NCT02020616|324390523|FG000|Overall Study|Lack of Efficacy|0|||
94708648|NCT02020616|324390524|FG001|Overall Study|Lack of Efficacy|0|||
94708649|NCT02020616|324390525|FG002|Overall Study|Lack of Efficacy|0|||
94708650|NCT02020616|324390526|FG003|Overall Study|Lack of Efficacy|0|||
94708651|NCT02020616|324390527|FG004|Overall Study|Lack of Efficacy|1|||
94708652|NCT02020616|324390528|FG005|Overall Study|Lack of Efficacy|0|||
94708653|NCT02020616|324390529|FG006|Overall Study|Lack of Efficacy|0|||
94708654|NCT02621424|324390532|FG000|Overall Study|Withdrawal by Subject|1|||
94708655|NCT02621424|324390533|FG001|Overall Study|Withdrawal by Subject|2|||
94708656|NCT02031471|324390536|FG000|24 Week Treatment Period|Adverse Event|6|||
94708657|NCT02031471|324390536|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
94708658|NCT02031471|324390536|FG000|24 Week Treatment Period|Protocol Violation|1|||
94708659|NCT02031471|324390536|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
94708660|NCT02031471|324390536|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
94708661|NCT02031471|324390536|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
94708662|NCT02031471|324390536|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
94708663|NCT00841035|324390539|FG000|Phase 1 Overall Study|Physician Decision|13|||
94708664|NCT00094575|324390544|FG000|Overall Study|Death|146|||
94708665|NCT00094575|324390545|FG001|Overall Study|Death|146|||
94708666|NCT00961636|324390549|FG000|Overall Study|Adverse Event|35|||
94708667|NCT00961636|324390550|FG001|Overall Study|Adverse Event|54|||
94708668|NCT00961636|324390551|FG002|Overall Study|Adverse Event|13|||
94708669|NCT00961636|324390549|FG000|Overall Study|Flushing Symptoms|29|||
94708670|NCT00961636|324390550|FG001|Overall Study|Flushing Symptoms|46|||
94708671|NCT00961636|324390551|FG002|Overall Study|Flushing Symptoms|3|||
94708672|NCT00961636|324390549|FG000|Overall Study|Lost to Follow-up|2|||
94708673|NCT00961636|324390550|FG001|Overall Study|Lost to Follow-up|3|||
94708674|NCT00961636|324390551|FG002|Overall Study|Lost to Follow-up|1|||
94708675|NCT00961636|324390549|FG000|Overall Study|Physician Decision|3|||
94708676|NCT00961636|324390550|FG001|Overall Study|Physician Decision|1|||
94708677|NCT00961636|324390551|FG002|Overall Study|Physician Decision|1|||
94708678|NCT00961636|324390549|FG000|Overall Study|Protocol Violation|9|||
94708679|NCT00961636|324390550|FG001|Overall Study|Protocol Violation|5|||
94266979|NCT02844816|322772061|FG001|Overall Study|Ineligible|15|||
94266980|NCT02844816|322772060|FG000|Overall Study|Participant refusal|5|||
94266981|NCT02844816|322772061|FG001|Overall Study|Participant refusal|5|||
94266982|NCT02844816|322772060|FG000|Overall Study|Adverse Event|5|||
94266983|NCT02844816|322772061|FG001|Overall Study|Adverse Event|4|||
94266984|NCT02844816|322772060|FG000|Overall Study|Death|0|||
94266985|NCT02844816|322772061|FG001|Overall Study|Death|1|||
94266986|NCT02844816|322772060|FG000|Overall Study|Disease progression/recurrence|50|||
94366726|NCT02268045|323128148|FG000|Overall Study|Withdrawal by Subject|2|||
94708680|NCT00961636|324390551|FG002|Overall Study|Protocol Violation|1|||
94708681|NCT00961636|324390549|FG000|Overall Study|Withdrawal by Subject|29|||
94708682|NCT00961636|324390550|FG001|Overall Study|Withdrawal by Subject|22|||
94366727|NCT02268045|323128149|FG001|Overall Study|Withdrawal by Subject|6|||
94708683|NCT00961636|324390551|FG002|Overall Study|Withdrawal by Subject|13|||
94708684|NCT00457691|324390553|FG000|Overall Study|Adverse Event|4|||
94708685|NCT00457691|324390554|FG001|Overall Study|Adverse Event|1|||
94708686|NCT00457691|324390553|FG000|Overall Study|Death|163|||
94708687|NCT00457691|324390554|FG001|Overall Study|Death|148|||
94708688|NCT00457691|324390553|FG000|Overall Study|Protocol Violation|1|||
94708689|NCT00457691|324390554|FG001|Overall Study|Protocol Violation|3|||
94266987|NCT02844816|322772061|FG001|Overall Study|Disease progression/recurrence|24|||
94266988|NCT02844816|322772060|FG000|Overall Study|Physician Decision|1|||
94708690|NCT00457691|324390553|FG000|Overall Study|Lost to Follow-up|23|||
94708691|NCT00457691|324390554|FG001|Overall Study|Lost to Follow-up|14|||
94708692|NCT00457691|324390553|FG000|Overall Study|Study terminated by Sponsor|1|||
94708693|NCT00457691|324390554|FG001|Overall Study|Study terminated by Sponsor|1|||
94708694|NCT00457691|324390553|FG000|Overall Study|Subject refused (reason other than AE)|14|||
94708695|NCT00457691|324390554|FG001|Overall Study|Subject refused (reason other than AE)|19|||
94708696|NCT00457691|324390553|FG000|Overall Study|Disease progression, study terminated|180|||
94708697|NCT00457691|324390554|FG001|Overall Study|Disease progression, study terminated|196|||
94708698|NCT02551055|324390555|FG000|Overall Study|Death|2|||
94708699|NCT02551055|324390556|FG001|Overall Study|Death|4|||
94708700|NCT02551055|324390557|FG002|Overall Study|Death|2|||
94708701|NCT02551055|324390558|FG003|Overall Study|Death|2|||
94708702|NCT02551055|324390559|FG004|Overall Study|Death|2|||
94708703|NCT02551055|324390560|FG005|Overall Study|Death|1|||
94708704|NCT02551055|324390561|FG006|Overall Study|Death|2|||
94708705|NCT02551055|324390562|FG007|Overall Study|Death|0|||
94708706|NCT02551055|324390555|FG000|Overall Study|Study Terminated by Sponsor|1|||
94708707|NCT02551055|324390556|FG001|Overall Study|Study Terminated by Sponsor|1|||
94708708|NCT02551055|324390557|FG002|Overall Study|Study Terminated by Sponsor|0|||
94708709|NCT02551055|324390558|FG003|Overall Study|Study Terminated by Sponsor|2|||
94708710|NCT02551055|324390559|FG004|Overall Study|Study Terminated by Sponsor|2|||
94708711|NCT02551055|324390560|FG005|Overall Study|Study Terminated by Sponsor|0|||
94708712|NCT02551055|324390561|FG006|Overall Study|Study Terminated by Sponsor|0|||
94708713|NCT02551055|324390562|FG007|Overall Study|Study Terminated by Sponsor|0|||
94708714|NCT02551055|324390555|FG000|Overall Study|Withdrawal by Subject|1|||
94708715|NCT02551055|324390556|FG001|Overall Study|Withdrawal by Subject|1|||
94708716|NCT02551055|324390557|FG002|Overall Study|Withdrawal by Subject|0|||
94708717|NCT02551055|324390558|FG003|Overall Study|Withdrawal by Subject|1|||
94708718|NCT02551055|324390559|FG004|Overall Study|Withdrawal by Subject|2|||
94708719|NCT02551055|324390560|FG005|Overall Study|Withdrawal by Subject|0|||
94708720|NCT02551055|324390561|FG006|Overall Study|Withdrawal by Subject|0|||
94708721|NCT02551055|324390562|FG007|Overall Study|Withdrawal by Subject|0|||
94708722|NCT02551055|324390555|FG000|Overall Study|Reason not specified|0|||
94708723|NCT02551055|324390556|FG001|Overall Study|Reason not specified|0|||
94708724|NCT02551055|324390557|FG002|Overall Study|Reason not specified|0|||
94708725|NCT02551055|324390558|FG003|Overall Study|Reason not specified|0|||
94708726|NCT02551055|324390559|FG004|Overall Study|Reason not specified|1|||
94708727|NCT02551055|324390560|FG005|Overall Study|Reason not specified|0|||
94708728|NCT02551055|324390561|FG006|Overall Study|Reason not specified|1|||
94708729|NCT02551055|324390562|FG007|Overall Study|Reason not specified|0|||
94708730|NCT00617201|324390565|FG000|Overall Study|Lost to Follow-up|9|||
94708731|NCT00617201|324390566|FG001|Overall Study|Lost to Follow-up|13|||
94708732|NCT01350804|324390567|FG000|Core Study|Withdrawal by Subject|11|||
94708733|NCT01350804|324390568|FG001|Core Study|Withdrawal by Subject|17|||
94708734|NCT01350804|324390569|FG002|Core Study|Withdrawal by Subject|16|||
94708735|NCT01350804|324390570|FG003|Core Study|Withdrawal by Subject|7|||
94708736|NCT01350804|324390567|FG000|Core Study|Study terminated by Sponsor|0|||
94708737|NCT01350804|324390568|FG001|Core Study|Study terminated by Sponsor|0|||
94708738|NCT01350804|324390569|FG002|Core Study|Study terminated by Sponsor|0|||
94708739|NCT01350804|324390570|FG003|Core Study|Study terminated by Sponsor|2|||
94708740|NCT01350804|324390567|FG000|Core Study|Protocol deviation|1|||
94708741|NCT01350804|324390568|FG001|Core Study|Protocol deviation|0|||
94708742|NCT01350804|324390569|FG002|Core Study|Protocol deviation|1|||
94708743|NCT01350804|324390570|FG003|Core Study|Protocol deviation|0|||
94708744|NCT01350804|324390567|FG000|Core Study|Physician Decision|1|||
94708745|NCT01350804|324390568|FG001|Core Study|Physician Decision|0|||
94708746|NCT01350804|324390569|FG002|Core Study|Physician Decision|1|||
94708747|NCT01350804|324390570|FG003|Core Study|Physician Decision|3|||
94266989|NCT02844816|322772061|FG001|Overall Study|Physician Decision|1|||
94266990|NCT01877915|322772064|FG000|Overall Study|Lost to Follow-up|10|||
94266991|NCT01877915|322772065|FG001|Overall Study|Lost to Follow-up|9|||
94266992|NCT01877915|322772064|FG000|Overall Study|Withdrawal by Subject|42|||
94708748|NCT01350804|324390567|FG000|Core Study|Lost to Follow-up|3|||
94708749|NCT01350804|324390568|FG001|Core Study|Lost to Follow-up|0|||
94708750|NCT01350804|324390569|FG002|Core Study|Lost to Follow-up|2|||
94708751|NCT01350804|324390570|FG003|Core Study|Lost to Follow-up|1|||
94708752|NCT01350804|324390567|FG000|Core Study|Lack of Efficacy|16|||
94708753|NCT01350804|324390568|FG001|Core Study|Lack of Efficacy|19|||
94708754|NCT01350804|324390569|FG002|Core Study|Lack of Efficacy|18|||
94708755|NCT01350804|324390570|FG003|Core Study|Lack of Efficacy|5|||
94708756|NCT01350804|324390567|FG000|Core Study|Death|1|||
94708757|NCT01350804|324390568|FG001|Core Study|Death|1|||
94708758|NCT01350804|324390569|FG002|Core Study|Death|1|||
94708759|NCT01350804|324390570|FG003|Core Study|Death|0|||
94266993|NCT01877915|322772065|FG001|Overall Study|Withdrawal by Subject|55|||
94266994|NCT01877915|322772064|FG000|Overall Study|Other|2|||
94708760|NCT01350804|324390567|FG000|Core Study|Adverse Event|8|||
94708761|NCT01350804|324390568|FG001|Core Study|Adverse Event|10|||
94266995|NCT01877915|322772065|FG001|Overall Study|Other|4|||
94708762|NCT01350804|324390569|FG002|Core Study|Adverse Event|8|||
94708763|NCT01350804|324390570|FG003|Core Study|Adverse Event|8|||
94708764|NCT01350804|324390567|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
94708765|NCT01350804|324390568|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
94708766|NCT01350804|324390569|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
94708767|NCT01350804|324390570|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
94266996|NCT03509467|322772066|FG000|Overall Study|Withdrawal by Subject|5|||
94266997|NCT03509467|322772067|FG001|Overall Study|Withdrawal by Subject|1|||
94266998|NCT03509467|322772068|FG002|Overall Study|Withdrawal by Subject|6|||
94266999|NCT03509467|322772069|FG003|Overall Study|Withdrawal by Subject|7|||
94267000|NCT03509467|322772070|FG004|Overall Study|Withdrawal by Subject|10|||
94267001|NCT03509467|322772071|FG005|Overall Study|Withdrawal by Subject|10|||
94267002|NCT03509467|322772072|FG006|Overall Study|Withdrawal by Subject|10|||
94267003|NCT03509467|322772073|FG007|Overall Study|Withdrawal by Subject|10|||
94267004|NCT03509467|322772066|FG000|Overall Study|Death|0|||
94267005|NCT03509467|322772067|FG001|Overall Study|Death|0|||
94267006|NCT03509467|322772068|FG002|Overall Study|Death|2|||
94267007|NCT03509467|322772069|FG003|Overall Study|Death|2|||
94267008|NCT03509467|322772070|FG004|Overall Study|Death|1|||
94267009|NCT03509467|322772071|FG005|Overall Study|Death|0|||
94267010|NCT03509467|322772072|FG006|Overall Study|Death|1|||
94267011|NCT03509467|322772073|FG007|Overall Study|Death|0|||
94267012|NCT03509467|322772066|FG000|Overall Study|Proxy Withdrawal|0|||
94267013|NCT03509467|322772067|FG001|Overall Study|Proxy Withdrawal|0|||
94267014|NCT03509467|322772068|FG002|Overall Study|Proxy Withdrawal|0|||
94267015|NCT03509467|322772069|FG003|Overall Study|Proxy Withdrawal|0|||
94267016|NCT03509467|322772070|FG004|Overall Study|Proxy Withdrawal|0|||
94267017|NCT03509467|322772071|FG005|Overall Study|Proxy Withdrawal|0|||
94267018|NCT03509467|322772072|FG006|Overall Study|Proxy Withdrawal|0|||
94267019|NCT03509467|322772073|FG007|Overall Study|Proxy Withdrawal|1|||
94267020|NCT02717754|322772074|FG000|Overall Study|Incorrect Infusion Duration|0|||
94267021|NCT02717754|322772075|FG001|Overall Study|Incorrect Infusion Duration|0|||
94267022|NCT02717754|322772076|FG002|Overall Study|Incorrect Infusion Duration|0|||
94267023|NCT02717754|322772077|FG003|Overall Study|Incorrect Infusion Duration|10|||
94267024|NCT02717754|322772078|FG004|Overall Study|Incorrect Infusion Duration|20|||
94267025|NCT02717754|322772079|FG005|Overall Study|Incorrect Infusion Duration|20|||
94267026|NCT00482703|322772080|FG000|Overall Study|Poor compliance|1|||
94267027|NCT00482703|322772081|FG001|Overall Study|Poor compliance|0|||
94267028|NCT01428661|322772089|FG000|Double-Masked Phase|Protocol Violation|9|||
94267029|NCT01428661|322772090|FG001|Double-Masked Phase|Protocol Violation|4|||
94267030|NCT01428661|322772091|FG002|Double-Masked Phase|Protocol Violation|0|||
94267031|NCT01428661|322772089|FG000|Double-Masked Phase|Adverse Event|13|||
94267032|NCT01428661|322772090|FG001|Double-Masked Phase|Adverse Event|4|||
94267033|NCT01428661|322772091|FG002|Double-Masked Phase|Adverse Event|0|||
94267034|NCT01428661|322772089|FG000|Double-Masked Phase|Lost to Follow-up|14|||
94267035|NCT01428661|322772090|FG001|Double-Masked Phase|Lost to Follow-up|14|||
94267036|NCT01428661|322772091|FG002|Double-Masked Phase|Lost to Follow-up|0|||
94267037|NCT01428661|322772089|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
94267038|NCT01428661|322772090|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
94267039|NCT01428661|322772091|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
94267040|NCT01428661|322772089|FG000|Double-Masked Phase|Lack of Efficacy|2|||
94267041|NCT01428661|322772090|FG001|Double-Masked Phase|Lack of Efficacy|1|||
94267042|NCT01428661|322772091|FG002|Double-Masked Phase|Lack of Efficacy|0|||
94267043|NCT01428661|322772089|FG000|Double-Masked Phase|*Various|1|||
94267044|NCT01428661|322772090|FG001|Double-Masked Phase|*Various|6|||
94267045|NCT01428661|322772091|FG002|Double-Masked Phase|*Various|0|||
94267046|NCT01428661|322772089|FG000|Open Label Extension|Protocol Violation|0|||
94267047|NCT01428661|322772090|FG001|Open Label Extension|Protocol Violation|0|||
94267048|NCT01428661|322772091|FG002|Open Label Extension|Protocol Violation|9|||
94267049|NCT01428661|322772089|FG000|Open Label Extension|Adverse Event|0|||
94267050|NCT01428661|322772090|FG001|Open Label Extension|Adverse Event|0|||
94267051|NCT01428661|322772091|FG002|Open Label Extension|Adverse Event|15|||
94267052|NCT01428661|322772089|FG000|Open Label Extension|Lost to Follow-up|0|||
94267053|NCT01428661|322772090|FG001|Open Label Extension|Lost to Follow-up|0|||
94267054|NCT01428661|322772091|FG002|Open Label Extension|Lost to Follow-up|38|||
94267055|NCT01428661|322772089|FG000|Open Label Extension|Withdrawal by Subject|0|||
94267056|NCT01428661|322772090|FG001|Open Label Extension|Withdrawal by Subject|0|||
94267057|NCT01428661|322772091|FG002|Open Label Extension|Withdrawal by Subject|49|||
94267058|NCT01428661|322772089|FG000|Open Label Extension|Lack of Efficacy|0|||
94267059|NCT01428661|322772090|FG001|Open Label Extension|Lack of Efficacy|0|||
94267060|NCT01428661|322772091|FG002|Open Label Extension|Lack of Efficacy|24|||
94267061|NCT01428661|322772089|FG000|Open Label Extension|**Various|0|||
94267062|NCT01428661|322772090|FG001|Open Label Extension|**Various|0|||
94267063|NCT01428661|322772091|FG002|Open Label Extension|**Various|185|||
94267064|NCT00591214|322772092|FG000|Overall Study|Physician Decision|7|||
94267065|NCT00591214|322772092|FG000|Overall Study|Withdrawal by Subject|1|||
94267066|NCT01129921|322772093|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
94708768|NCT01350804|324390567|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
94708769|NCT01350804|324390568|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
94708770|NCT01350804|324390569|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
94708771|NCT01350804|324390570|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
94708772|NCT01350804|324390567|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
94708773|NCT01350804|324390568|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
94708774|NCT01350804|324390569|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
94708775|NCT01350804|324390570|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
94708776|NCT01350804|324390567|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
94708777|NCT01350804|324390568|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
94708778|NCT01350804|324390569|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
94708779|NCT01350804|324390570|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
94708780|NCT01350804|324390567|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
94708781|NCT01350804|324390568|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
94708782|NCT01350804|324390569|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
94708783|NCT01350804|324390570|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
94708784|NCT01350804|324390567|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
94708785|NCT01350804|324390568|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
94708786|NCT01350804|324390569|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
94708787|NCT01350804|324390570|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
94708788|NCT02299336|324390571|FG000|Overall Study|Withdrawal by Subject|11|||
94708789|NCT02299336|324390571|FG000|Overall Study|Adverse Event|1|||
94708790|NCT02299336|324390571|FG000|Overall Study|Death|1|||
94708791|NCT02299336|324390571|FG000|Overall Study|Lost to Follow-up|1|||
94708792|NCT00573833|324390579|FG000|Overall Study|Not Treated|2|||
94708793|NCT02466516|324392040|FG000|Overall Study|Adverse Event|1|||
94708794|NCT02466516|324392041|FG001|Overall Study|Adverse Event|1|||
94708795|NCT02466516|324392042|FG002|Overall Study|Adverse Event|0|||
94708796|NCT02466516|324392043|FG003|Overall Study|Adverse Event|0|||
94708797|NCT02466516|324392044|FG004|Overall Study|Adverse Event|0|||
94708798|NCT02466516|324392040|FG000|Overall Study|Withdrew Consent|1|||
94708799|NCT02466516|324392041|FG001|Overall Study|Withdrew Consent|0|||
94708800|NCT02466516|324392042|FG002|Overall Study|Withdrew Consent|0|||
94708801|NCT02466516|324392043|FG003|Overall Study|Withdrew Consent|0|||
94708802|NCT02466516|324392044|FG004|Overall Study|Withdrew Consent|0|||
94708803|NCT02466516|324392040|FG000|Overall Study|Lost to Follow-up|2|||
94708804|NCT02466516|324392041|FG001|Overall Study|Lost to Follow-up|0|||
94708805|NCT02466516|324392042|FG002|Overall Study|Lost to Follow-up|1|||
94708806|NCT02466516|324392043|FG003|Overall Study|Lost to Follow-up|0|||
94708807|NCT02466516|324392044|FG004|Overall Study|Lost to Follow-up|0|||
94708808|NCT00482729|324392045|FG000|Overall Study|Adverse Event|29|||
94708809|NCT00482729|324392046|FG001|Overall Study|Adverse Event|33|||
94708810|NCT00482729|324392045|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
94708811|NCT00482729|324392046|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
94708812|NCT00482729|324392045|FG000|Overall Study|Hyperglycemia Criteria|7|||
94708813|NCT00482729|324392046|FG001|Overall Study|Hyperglycemia Criteria|5|||
94267067|NCT01129921|322772094|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
94267068|NCT01129921|322772093|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
94267069|NCT01129921|322772094|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
94267070|NCT01129921|322772093|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
94267071|NCT01129921|322772094|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
94267072|NCT01129921|322772093|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
94267073|NCT01129921|322772094|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
94267074|NCT05586269|322773291|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
94267075|NCT05586269|322773292|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
94267076|NCT05586269|322773293|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
94267077|NCT05586269|322773294|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
94267078|NCT05586269|322773291|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
94267079|NCT05586269|322773292|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
94708814|NCT00482729|324392045|FG000|Overall Study|Lack of Efficacy|4|||
94708815|NCT00482729|324392046|FG001|Overall Study|Lack of Efficacy|16|||
94708816|NCT00482729|324392045|FG000|Overall Study|Lost to Follow-up|86|||
94708817|NCT00482729|324392046|FG001|Overall Study|Lost to Follow-up|66|||
94708818|NCT00482729|324392045|FG000|Overall Study|Physician Decision|10|||
94708819|NCT00482729|324392046|FG001|Overall Study|Physician Decision|7|||
94708820|NCT00482729|324392045|FG000|Overall Study|Pregnancy|4|||
94708821|NCT00482729|324392046|FG001|Overall Study|Pregnancy|2|||
94466253|NCT01358578|323496952|FG001|Maintenance Period|Lost to Follow-up|0|||
94708822|NCT00482729|324392045|FG000|Overall Study|Protocol Violation|10|||
94708823|NCT00482729|324392046|FG001|Overall Study|Protocol Violation|18|||
94708824|NCT00482729|324392045|FG000|Overall Study|Withdrawal by Subject|67|||
94708825|NCT00482729|324392046|FG001|Overall Study|Withdrawal by Subject|69|||
94708826|NCT00364286|324392047|FG000|Overall Study|Withdrawal by Subject|1|||
94708827|NCT00364286|324392047|FG000|Overall Study|Adverse Event|2|||
94708828|NCT00628862|324392048|FG000|Overall Study|Adverse Event|6|||
94708829|NCT00628862|324392049|FG001|Overall Study|Adverse Event|8|||
94708830|NCT00628862|324392050|FG002|Overall Study|Adverse Event|10|||
94708831|NCT00628862|324392048|FG000|Overall Study|Withdrawal by Subject|4|||
94708832|NCT00628862|324392049|FG001|Overall Study|Withdrawal by Subject|6|||
94708833|NCT00628862|324392050|FG002|Overall Study|Withdrawal by Subject|11|||
94708834|NCT00628862|324392048|FG000|Overall Study|Lost to Follow-up|0|||
94708835|NCT00628862|324392049|FG001|Overall Study|Lost to Follow-up|2|||
94708836|NCT00628862|324392050|FG002|Overall Study|Lost to Follow-up|1|||
94708837|NCT00628862|324392048|FG000|Overall Study|Protocol Violation|1|||
94708838|NCT00628862|324392049|FG001|Overall Study|Protocol Violation|0|||
94708839|NCT00628862|324392050|FG002|Overall Study|Protocol Violation|0|||
94708840|NCT00628862|324392048|FG000|Overall Study|COPD Exacerbation|0|||
94708841|NCT00628862|324392049|FG001|Overall Study|COPD Exacerbation|1|||
94708842|NCT00628862|324392050|FG002|Overall Study|COPD Exacerbation|0|||
94708843|NCT00768664|324392051|FG000|Overall Study|Death|57|||
94708844|NCT00768664|324392051|FG000|Overall Study|Lost to Follow-up|2|||
94708845|NCT00768664|324392051|FG000|Overall Study|Other|9|||
94708846|NCT00768664|324392051|FG000|Overall Study|Participant refused|1|||
94708847|NCT02525796|324392056|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
94708848|NCT02525796|324392057|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
94708849|NCT02525796|324392058|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
94708850|NCT02525796|324392056|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
94708851|NCT02525796|324392057|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
94708852|NCT02525796|324392058|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
94708853|NCT02525796|324392056|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
94267080|NCT05586269|322773293|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
94267081|NCT05586269|322773294|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
94267082|NCT04752475|322773295|FG000|Overall Study|Withdrawal by Subject|1|||
94267083|NCT04752475|322773296|FG001|Overall Study|Withdrawal by Subject|1|||
94267084|NCT00523718|322773299|FG000|Overall Study|Withdrawal by Subject|1|||
94267085|NCT00523718|322773300|FG001|Overall Study|Withdrawal by Subject|0|||
94267086|NCT00523718|322773299|FG000|Overall Study|Protocol Violation|2|||
94267087|NCT00523718|322773300|FG001|Overall Study|Protocol Violation|0|||
94267088|NCT00332839|322773301|FG000|Core (Months 0 - 12)|Administrative problems|1|||
94267089|NCT00332839|322773302|FG001|Core (Months 0 - 12)|Administrative problems|1|||
94267090|NCT00332839|322773301|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
94267091|NCT00332839|322773302|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
94267092|NCT00332839|322773301|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
94267093|NCT00332839|322773302|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
94267094|NCT00332839|322773301|FG000|Core (Months 0 - 12)|Adverse Event|5|||
94267095|NCT00332839|322773302|FG001|Core (Months 0 - 12)|Adverse Event|15|||
94267096|NCT00332839|322773301|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
94267097|NCT00332839|322773302|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
94267098|NCT00332839|322773301|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
94267099|NCT00332839|322773302|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
94267100|NCT00332839|322773301|FG000|Follow-up (Months 12 - 60)|Death|1|||
94267101|NCT00332839|322773302|FG001|Follow-up (Months 12 - 60)|Death|1|||
94267102|NCT04641299|322773307|FG000|Overall Study|Adverse Event|0|||
94267103|NCT04641299|322773308|FG001|Overall Study|Adverse Event|0|||
94267104|NCT04641299|322773309|FG002|Overall Study|Adverse Event|2|||
94267105|NCT04641299|322773310|FG003|Overall Study|Adverse Event|0|||
94366728|NCT02268045|323128148|FG000|Overall Study|Physician Decision|0|||
94708854|NCT02525796|324392057|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
94708855|NCT02525796|324392058|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
94708856|NCT02525796|324392056|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
94708857|NCT02525796|324392057|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
94708858|NCT02525796|324392058|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
94708859|NCT02525796|324392056|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
94708860|NCT02525796|324392057|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
94708861|NCT02525796|324392058|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
94708862|NCT01400776|324392059|FG000|Overall Study|Adverse Event|7|||
94708863|NCT01400776|324392060|FG001|Overall Study|Adverse Event|2|||
94708864|NCT01400776|324392061|FG002|Overall Study|Adverse Event|9|||
94708865|NCT01400776|324392062|FG003|Overall Study|Adverse Event|2|||
94708866|NCT01400776|324392059|FG000|Overall Study|Lost to Follow-up|1|||
94708867|NCT01400776|324392060|FG001|Overall Study|Lost to Follow-up|0|||
94708868|NCT01400776|324392061|FG002|Overall Study|Lost to Follow-up|4|||
94708869|NCT01400776|324392062|FG003|Overall Study|Lost to Follow-up|1|||
94708870|NCT01400776|324392059|FG000|Overall Study|Withdrew Consent|4|||
94708871|NCT01400776|324392060|FG001|Overall Study|Withdrew Consent|2|||
94708872|NCT01400776|324392061|FG002|Overall Study|Withdrew Consent|6|||
94708873|NCT01400776|324392062|FG003|Overall Study|Withdrew Consent|1|||
94708874|NCT01400776|324392059|FG000|Overall Study|Protocol Deviation|6|||
94708875|NCT01400776|324392060|FG001|Overall Study|Protocol Deviation|1|||
94708876|NCT01400776|324392061|FG002|Overall Study|Protocol Deviation|5|||
94708877|NCT01400776|324392062|FG003|Overall Study|Protocol Deviation|2|||
94708878|NCT01400776|324392059|FG000|Overall Study|Reason not Specified|3|||
94708879|NCT01400776|324392060|FG001|Overall Study|Reason not Specified|0|||
94708880|NCT01400776|324392061|FG002|Overall Study|Reason not Specified|4|||
94708881|NCT01400776|324392062|FG003|Overall Study|Reason not Specified|3|||
94708882|NCT01198275|324392063|FG000|Overall Study|Adverse Event|2|||
94708883|NCT01198275|324392064|FG001|Overall Study|Adverse Event|3|||
94708884|NCT01198275|324392063|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
94708885|NCT01198275|324392064|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
94708886|NCT00391846|324392065|FG000|Overall Study|Adverse Event|4|||
94708887|NCT00391846|324392066|FG001|Overall Study|Adverse Event|1|||
94708888|NCT00391846|324392065|FG000|Overall Study|Did not meet the required elig. crit|2|||
94708889|NCT00391846|324392066|FG001|Overall Study|Did not meet the required elig. crit|2|||
94708890|NCT00391846|324392065|FG000|Overall Study|Withdrawal by Subject|2|||
94708891|NCT00391846|324392066|FG001|Overall Study|Withdrawal by Subject|3|||
94708892|NCT00391846|324392065|FG000|Overall Study|Developed study specific DC criteria|0|||
94708893|NCT00391846|324392066|FG001|Overall Study|Developed study specific DC criteria|1|||
94708894|NCT00150176|324392067|FG000|Overall Study|Adverse Event|16|||
94708895|NCT00150176|324392068|FG001|Overall Study|Adverse Event|53|||
94708896|NCT00150176|324392067|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
94708897|NCT00150176|324392068|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
94708898|NCT00150176|324392067|FG000|Overall Study|Withdrawal by Subject|19|||
94708899|NCT00150176|324392068|FG001|Overall Study|Withdrawal by Subject|12|||
94708900|NCT00150176|324392067|FG000|Overall Study|Lost to Follow-up|3|||
94708901|NCT00150176|324392068|FG001|Overall Study|Lost to Follow-up|3|||
94708902|NCT00150176|324392067|FG000|Overall Study|OTHER|11|||
94708903|NCT00150176|324392068|FG001|Overall Study|OTHER|13|||
94708904|NCT00423098|324392069|FG000|Overall Study|Adverse Event|1|||
94708905|NCT00423098|324392070|FG001|Overall Study|Adverse Event|2|||
94708906|NCT00423098|324392069|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94708907|NCT00423098|324392070|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
94708908|NCT00423098|324392069|FG000|Overall Study|Administrative problems|0|||
94708909|NCT00423098|324392070|FG001|Overall Study|Administrative problems|1|||
94708910|NCT00423098|324392069|FG000|Overall Study|Death|2|||
94708911|NCT00423098|324392070|FG001|Overall Study|Death|0|||
94708912|NCT00004124|324392078|FG000|Overall Study|Received no protocol therapy|12|||
94708913|NCT00004124|324392079|FG001|Overall Study|Received no protocol therapy|20|||
94708914|NCT02027558|324392080|FG000|Overall Study|Death|0|||
94708915|NCT02027558|324392081|FG001|Overall Study|Death|1|||
94708916|NCT02027558|324392080|FG000|Overall Study|Withdrawal by Subject|2|||
94708917|NCT02027558|324392081|FG001|Overall Study|Withdrawal by Subject|0|||
94708918|NCT02027558|324392080|FG000|Overall Study|Lost to Follow-up|4|||
94708919|NCT02027558|324392081|FG001|Overall Study|Lost to Follow-up|1|||
94708920|NCT02027558|324392080|FG000|Overall Study|Refused assessment|3|||
94708921|NCT02027558|324392081|FG001|Overall Study|Refused assessment|0|||
94708922|NCT01930045|324392084|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
94708923|NCT01930045|324392085|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
94708924|NCT01930045|324392086|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
94708925|NCT01930045|324392087|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
94708926|NCT01930045|324392088|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
94708927|NCT01930045|324392089|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
94708928|NCT01930045|324392084|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
94708929|NCT01930045|324392085|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
94708930|NCT01930045|324392086|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
94708931|NCT01930045|324392087|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
94708932|NCT01930045|324392088|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
94267106|NCT04641299|322773307|FG000|Overall Study|Lost to Follow-up|0|||
94267107|NCT04641299|322773308|FG001|Overall Study|Lost to Follow-up|1|||
94267108|NCT04641299|322773309|FG002|Overall Study|Lost to Follow-up|0|||
94267109|NCT04641299|322773310|FG003|Overall Study|Lost to Follow-up|0|||
94267110|NCT04641299|322773307|FG000|Overall Study|Withdrawal by Subject|1|||
94267111|NCT04641299|322773308|FG001|Overall Study|Withdrawal by Subject|0|||
94267112|NCT04641299|322773309|FG002|Overall Study|Withdrawal by Subject|0|||
94267113|NCT04641299|322773310|FG003|Overall Study|Withdrawal by Subject|0|||
94267114|NCT04641299|322773307|FG000|Overall Study|Reason not given|1|||
94267115|NCT04641299|322773308|FG001|Overall Study|Reason not given|0|||
94267116|NCT04641299|322773309|FG002|Overall Study|Reason not given|0|||
94267117|NCT04641299|322773310|FG003|Overall Study|Reason not given|0|||
94267118|NCT04042740|322773311|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
94267119|NCT04042740|322773311|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
94267120|NCT03739762|322773312|FG000|Overall Study|Lost to Follow-up|1|||
94267121|NCT03739762|322773313|FG001|Overall Study|Lost to Follow-up|1|||
94267122|NCT03739762|322773312|FG000|Overall Study|Withdrawal by Subject|2|||
94267123|NCT03739762|322773313|FG001|Overall Study|Withdrawal by Subject|6|||
94267124|NCT03713034|322773316|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
94267125|NCT03713034|322773317|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
94267126|NCT00785044|322773321|FG000|Overall Study|Dosed at non-participating sites|152|||
94267127|NCT00785044|322773321|FG000|Overall Study|Death|77|||
94267128|NCT00785044|322773321|FG000|Overall Study|Lost to Follow-up|266|||
94267129|NCT00785044|322773321|FG000|Overall Study|Withdrawal by Subject|1|||
94267130|NCT01086410|322773322|FG000|Overall Study|Adverse Event|1|||
94267131|NCT01086410|322773323|FG001|Overall Study|Adverse Event|0|||
94267132|NCT01086410|322773324|FG002|Overall Study|Adverse Event|0|||
94267133|NCT01086410|322773325|FG003|Overall Study|Adverse Event|2|||
94267134|NCT01086410|322773322|FG000|Overall Study|Lack of Efficacy|1|||
94267135|NCT01086410|322773323|FG001|Overall Study|Lack of Efficacy|1|||
94267136|NCT01086410|322773324|FG002|Overall Study|Lack of Efficacy|0|||
94267137|NCT01086410|322773325|FG003|Overall Study|Lack of Efficacy|0|||
94267138|NCT01086410|322773322|FG000|Overall Study|Protocol Violation|1|||
94267139|NCT01086410|322773323|FG001|Overall Study|Protocol Violation|1|||
94267140|NCT01086410|322773324|FG002|Overall Study|Protocol Violation|0|||
94267141|NCT01086410|322773325|FG003|Overall Study|Protocol Violation|0|||
94267142|NCT01086410|322773322|FG000|Overall Study|Lost to Follow-up|0|||
94267143|NCT01086410|322773323|FG001|Overall Study|Lost to Follow-up|0|||
94267144|NCT01086410|322773324|FG002|Overall Study|Lost to Follow-up|1|||
94267145|NCT01086410|322773325|FG003|Overall Study|Lost to Follow-up|0|||
94267146|NCT00621751|322773327|FG000|Overall Study|Adverse Event|0|||
94267147|NCT00621751|322773328|FG001|Overall Study|Adverse Event|1|||
94267148|NCT00295633|322773329|FG000|Overall Study|Lack of Efficacy|19|||
94267149|NCT00295633|322773330|FG001|Overall Study|Lack of Efficacy|7|||
94267150|NCT00295633|322773331|FG002|Overall Study|Lack of Efficacy|16|||
94267151|NCT00295633|322773329|FG000|Overall Study|Withdrawal of consent by subject|16|||
94267152|NCT00295633|322773330|FG001|Overall Study|Withdrawal of consent by subject|16|||
94267153|NCT00295633|322773331|FG002|Overall Study|Withdrawal of consent by subject|26|||
94267154|NCT00295633|322773329|FG000|Overall Study|Adverse Event|9|||
94708933|NCT01930045|324392089|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
94708934|NCT00507689|324392090|FG000|Pre-Randomization Period|Adverse Event|1|||
94708935|NCT00507689|324392091|FG001|Pre-Randomization Period|Adverse Event|0|||
94708936|NCT00507689|324392090|FG000|Pre-Randomization Period|Physician Decision|1|||
94708937|NCT00507689|324392091|FG001|Pre-Randomization Period|Physician Decision|0|||
94708938|NCT00507689|324392090|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
94708939|NCT00507689|324392091|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
94708940|NCT00507689|324392090|FG000|Randomized Period|Adverse Event|1|||
94708941|NCT00507689|324392091|FG001|Randomized Period|Adverse Event|1|||
94267155|NCT00295633|322773330|FG001|Overall Study|Adverse Event|17|||
94708942|NCT00507689|324392090|FG000|Randomized Period|Withdrawal by Subject|0|||
94708943|NCT00507689|324392091|FG001|Randomized Period|Withdrawal by Subject|1|||
94708944|NCT01405924|324392092|FG000|Overall Study|Protocol Violation|8|||
94708945|NCT01405924|324392092|FG000|Overall Study|Missing/Incomplete Data|2|||
94708946|NCT01924767|324392093|FG000|Overall Study|Adverse Event|1|||
94267156|NCT00295633|322773331|FG002|Overall Study|Adverse Event|9|||
94708947|NCT01924767|324392094|FG001|Overall Study|Adverse Event|0|||
94708948|NCT01924767|324392095|FG002|Overall Study|Adverse Event|1|||
94708949|NCT01924767|324392096|FG003|Overall Study|Adverse Event|0|||
94267157|NCT00295633|322773329|FG000|Overall Study|Lost to Follow-up|6|||
94267158|NCT00295633|322773330|FG001|Overall Study|Lost to Follow-up|11|||
94708950|NCT01924767|324392097|FG004|Overall Study|Adverse Event|0|||
94267159|NCT00295633|322773331|FG002|Overall Study|Lost to Follow-up|7|||
94267160|NCT00295633|322773329|FG000|Overall Study|Physician Decision|9|||
94267161|NCT00295633|322773330|FG001|Overall Study|Physician Decision|10|||
94267162|NCT00295633|322773331|FG002|Overall Study|Physician Decision|8|||
94267163|NCT00295633|322773329|FG000|Overall Study|Poor/Noncompliance|2|||
94708951|NCT05046132|324392098|FG000|Overall Study|Adverse Event|4|||
94708952|NCT05046132|324392099|FG001|Overall Study|Adverse Event|0|||
94708953|NCT05046132|324392100|FG002|Overall Study|Adverse Event|0|||
94708954|NCT05046132|324392098|FG000|Overall Study|Withdrawal by Subject|3|||
94708955|NCT05046132|324392099|FG001|Overall Study|Withdrawal by Subject|0|||
94708956|NCT05046132|324392100|FG002|Overall Study|Withdrawal by Subject|0|||
94708957|NCT05046132|324392098|FG000|Overall Study|Positive Covid19 Result.|0|||
94708958|NCT05046132|324392099|FG001|Overall Study|Positive Covid19 Result.|1|||
94267164|NCT00295633|322773330|FG001|Overall Study|Poor/Noncompliance|2|||
94267165|NCT00295633|322773331|FG002|Overall Study|Poor/Noncompliance|6|||
94267166|NCT00295633|322773329|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
94267167|NCT00295633|322773330|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
94267168|NCT00295633|322773331|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
94267169|NCT00295633|322773329|FG000|Overall Study|Death|1|||
94267170|NCT00295633|322773330|FG001|Overall Study|Death|1|||
94267171|NCT00295633|322773331|FG002|Overall Study|Death|0|||
94267172|NCT00295633|322773329|FG000|Overall Study|Administrative reason by sponsor|0|||
94267173|NCT00295633|322773330|FG001|Overall Study|Administrative reason by sponsor|0|||
94267174|NCT00295633|322773331|FG002|Overall Study|Administrative reason by sponsor|1|||
94267175|NCT00419120|322773332|FG000|Long Term Follow up Period|study ongoing|10|||
94267176|NCT02357134|322773335|FG000|Overall Study|Lost to Follow-up|1|||
94267177|NCT02357134|322773336|FG001|Overall Study|Lost to Follow-up|0|||
94267178|NCT02357134|322773337|FG002|Overall Study|Lost to Follow-up|0|||
94267179|NCT02357134|322773338|FG003|Overall Study|Lost to Follow-up|0|||
94267180|NCT05097716|322773341|FG000|Period 1|Adverse Event|1|||
94267181|NCT05097716|322773341|FG000|Period 1|Close contact with highly-transmissible infection|1|||
94267182|NCT00536809|322773345|FG000|Phase II|Adverse Event|1|||
94267183|NCT00536809|322773345|FG000|Phase II|Referred for surgical resection|1|||
94267184|NCT01132612|322773351|FG000|Overall Study|Death|0|||
94267185|NCT01132612|322773352|FG001|Overall Study|Death|0|||
94267186|NCT01132612|322773353|FG002|Overall Study|Death|1|||
94267187|NCT01132612|322773351|FG000|Overall Study|Protocol deviation|0|||
94267188|NCT01132612|322773352|FG001|Overall Study|Protocol deviation|0|||
94267189|NCT01132612|322773353|FG002|Overall Study|Protocol deviation|3|||
94267190|NCT01132612|322773351|FG000|Overall Study|Lost to Follow-up|2|||
94267191|NCT01132612|322773352|FG001|Overall Study|Lost to Follow-up|2|||
94267192|NCT01132612|322773353|FG002|Overall Study|Lost to Follow-up|7|||
94267193|NCT01132612|322773351|FG000|Overall Study|Adverse Event|5|||
94267194|NCT01132612|322773352|FG001|Overall Study|Adverse Event|2|||
94267195|NCT01132612|322773353|FG002|Overall Study|Adverse Event|15|||
94267196|NCT01132612|322773351|FG000|Overall Study|Withdrawal by Subject|5|||
94267197|NCT01132612|322773352|FG001|Overall Study|Withdrawal by Subject|8|||
94267198|NCT01132612|322773353|FG002|Overall Study|Withdrawal by Subject|19|||
94267199|NCT01132612|322773351|FG000|Overall Study|Administrative problems|5|||
94267200|NCT01132612|322773352|FG001|Overall Study|Administrative problems|1|||
94267201|NCT01132612|322773353|FG002|Overall Study|Administrative problems|52|||
94267202|NCT01132612|322773351|FG000|Overall Study|Lack of Efficacy|23|||
94267203|NCT01132612|322773352|FG001|Overall Study|Lack of Efficacy|22|||
94267204|NCT01132612|322773353|FG002|Overall Study|Lack of Efficacy|73|||
94267205|NCT01848353|322773354|FG000|Phase 1|Withdrawal by Subject|3|||
94267206|NCT01848353|322773355|FG001|Phase 1|Withdrawal by Subject|1|||
94267207|NCT01848353|322773356|FG002|Phase 1|Withdrawal by Subject|0|||
94267208|NCT01848353|322773357|FG003|Phase 1|Withdrawal by Subject|0|||
94267209|NCT01848353|322773354|FG000|Phase 2|Withdrawal by Subject|3|||
94267210|NCT01848353|322773355|FG001|Phase 2|Withdrawal by Subject|2|||
94267211|NCT01848353|322773356|FG002|Phase 2|Withdrawal by Subject|0|||
94267212|NCT01848353|322773357|FG003|Phase 2|Withdrawal by Subject|0|||
94267213|NCT01848353|322773354|FG000|Phase 3|Withdrawal by Subject|1|||
94267214|NCT01848353|322773355|FG001|Phase 3|Withdrawal by Subject|1|||
94267215|NCT01848353|322773356|FG002|Phase 3|Withdrawal by Subject|0|||
94366729|NCT02268045|323128149|FG001|Overall Study|Physician Decision|1|||
94366730|NCT02268045|323128148|FG000|Overall Study|Protocol Violation|1|||
94366731|NCT02268045|323128149|FG001|Overall Study|Protocol Violation|1|||
94366732|NCT01154673|323128150|FG000|Overall Study|Lost to Follow-up|1|||
94366733|NCT01154673|323128151|FG001|Overall Study|Lost to Follow-up|0|||
94366734|NCT01154673|323128150|FG000|Overall Study|moved out of province|1|||
94267216|NCT01848353|322773357|FG003|Phase 3|Withdrawal by Subject|0|||
94267217|NCT01245387|322773361|FG000|Overall Study|Lost to Follow-up|106|||
94267218|NCT01245387|322773361|FG000|Overall Study|Lack of Efficacy|195|||
94267219|NCT01245387|322773361|FG000|Overall Study|Adverse Event|9|||
94267220|NCT01245387|322773361|FG000|Overall Study|Death|3|||
94267221|NCT01245387|322773361|FG000|Overall Study|Other|131|||
94267222|NCT01245387|322773361|FG000|Overall Study|Missing discontinuation status|369|||
94267223|NCT00757003|322773362|FG000|Overall Study|Death|33|||
94267224|NCT00757003|322773362|FG000|Overall Study|Lost to Follow-up|9|||
94267225|NCT00757003|322773362|FG000|Overall Study|Withdrawal by Subject|4|||
94267226|NCT00757003|322773362|FG000|Overall Study|Surgically explanted|2|||
94267227|NCT00757003|322773362|FG000|Overall Study|Not implanted|1|||
94267228|NCT02790138|322773365|FG000|Overall Study|Adverse Event|5|||
94267229|NCT02790138|322773366|FG001|Overall Study|Adverse Event|2|||
94267230|NCT02790138|322773365|FG000|Overall Study|Significant Protocol Deviation|0|||
94267231|NCT02790138|322773366|FG001|Overall Study|Significant Protocol Deviation|1|||
94267232|NCT02790138|322773365|FG000|Overall Study|Lost to Follow-up|1|||
94267233|NCT02790138|322773366|FG001|Overall Study|Lost to Follow-up|0|||
94267234|NCT02790138|322773365|FG000|Overall Study|Voluntary Withdrawal|8|||
94267235|NCT02790138|322773366|FG001|Overall Study|Voluntary Withdrawal|9|||
94267236|NCT02790138|322773365|FG000|Overall Study|Lack of Efficacy|6|||
94267237|NCT02790138|322773366|FG001|Overall Study|Lack of Efficacy|7|||
94267238|NCT02790138|322773365|FG000|Overall Study|Reason not Specified|1|||
94267239|NCT02790138|322773366|FG001|Overall Study|Reason not Specified|0|||
94267240|NCT01092143|322773367|FG000|Overall Study|Adverse Event|10|||
94267241|NCT01092143|322773368|FG001|Overall Study|Adverse Event|5|||
94267242|NCT01092143|322773369|FG002|Overall Study|Adverse Event|1|||
94267243|NCT01092143|322773370|FG003|Overall Study|Adverse Event|4|||
94267244|NCT01092143|322773371|FG004|Overall Study|Adverse Event|3|||
94267245|NCT01092143|322773367|FG000|Overall Study|Lost to Follow-up|1|||
94267246|NCT01092143|322773368|FG001|Overall Study|Lost to Follow-up|0|||
94267247|NCT01092143|322773369|FG002|Overall Study|Lost to Follow-up|1|||
94267248|NCT01092143|322773370|FG003|Overall Study|Lost to Follow-up|0|||
94267249|NCT01092143|322773371|FG004|Overall Study|Lost to Follow-up|0|||
94267250|NCT01092143|322773367|FG000|Overall Study|Consent withdrawn|2|||
94267251|NCT01092143|322773368|FG001|Overall Study|Consent withdrawn|1|||
94267252|NCT01092143|322773369|FG002|Overall Study|Consent withdrawn|0|||
94267253|NCT01092143|322773370|FG003|Overall Study|Consent withdrawn|1|||
94267254|NCT01092143|322773371|FG004|Overall Study|Consent withdrawn|3|||
94267255|NCT01092143|322773367|FG000|Overall Study|Not treated|0|||
94267256|NCT01092143|322773368|FG001|Overall Study|Not treated|0|||
94267257|NCT01092143|322773369|FG002|Overall Study|Not treated|1|||
94267258|NCT01092143|322773370|FG003|Overall Study|Not treated|0|||
94267259|NCT01092143|322773371|FG004|Overall Study|Not treated|0|||
94267260|NCT01092143|322773367|FG000|Overall Study|did not reversibility criteria|0|||
94267261|NCT01092143|322773368|FG001|Overall Study|did not reversibility criteria|0|||
94267262|NCT01092143|322773369|FG002|Overall Study|did not reversibility criteria|1|||
94267263|NCT01092143|322773370|FG003|Overall Study|did not reversibility criteria|0|||
94366735|NCT01154673|323128151|FG001|Overall Study|moved out of province|0|||
94366736|NCT00481871|323128159|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
94267264|NCT01092143|322773371|FG004|Overall Study|did not reversibility criteria|0|||
94267265|NCT01092143|322773367|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
94267266|NCT01092143|322773368|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
94267267|NCT01092143|322773369|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
94267268|NCT01092143|322773370|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
94267269|NCT01092143|322773371|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
94267270|NCT01092143|322773367|FG000|Overall Study|Ineligible patient|1|||
94267271|NCT01092143|322773368|FG001|Overall Study|Ineligible patient|0|||
94267272|NCT01092143|322773369|FG002|Overall Study|Ineligible patient|0|||
94267273|NCT01092143|322773370|FG003|Overall Study|Ineligible patient|0|||
94267274|NCT01092143|322773371|FG004|Overall Study|Ineligible patient|0|||
94267275|NCT01092143|322773367|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
94267276|NCT01092143|322773368|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
94267277|NCT01092143|322773369|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
94267278|NCT01092143|322773370|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
94267279|NCT01092143|322773371|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
94267280|NCT01092143|322773367|FG000|Overall Study|Patient travel|0|||
94267281|NCT01092143|322773368|FG001|Overall Study|Patient travel|0|||
94267282|NCT01092143|322773369|FG002|Overall Study|Patient travel|0|||
94267283|NCT01092143|322773370|FG003|Overall Study|Patient travel|0|||
94267284|NCT01092143|322773371|FG004|Overall Study|Patient travel|1|||
94267285|NCT01092143|322773367|FG000|Overall Study|Non compliance with study medication|0|||
94267286|NCT01092143|322773368|FG001|Overall Study|Non compliance with study medication|0|||
94267287|NCT01092143|322773369|FG002|Overall Study|Non compliance with study medication|0|||
94267288|NCT01092143|322773370|FG003|Overall Study|Non compliance with study medication|0|||
94267289|NCT01092143|322773371|FG004|Overall Study|Non compliance with study medication|1|||
94267290|NCT01092143|322773367|FG000|Overall Study|Randomized by mistake|0|||
94267291|NCT01092143|322773368|FG001|Overall Study|Randomized by mistake|0|||
94267292|NCT01092143|322773369|FG002|Overall Study|Randomized by mistake|0|||
94267293|NCT01092143|322773370|FG003|Overall Study|Randomized by mistake|1|||
94267294|NCT01092143|322773371|FG004|Overall Study|Randomized by mistake|0|||
94267295|NCT01092143|322773367|FG000|Overall Study|Pregnancy|0|||
94267296|NCT01092143|322773368|FG001|Overall Study|Pregnancy|0|||
94366737|NCT00481871|323128160|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
94267297|NCT01092143|322773369|FG002|Overall Study|Pregnancy|0|||
94267298|NCT01092143|322773370|FG003|Overall Study|Pregnancy|1|||
94366738|NCT00481871|323128161|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
94708959|NCT05046132|324392100|FG002|Overall Study|Positive Covid19 Result.|0|||
94267299|NCT01092143|322773371|FG004|Overall Study|Pregnancy|0|||
94267300|NCT03044249|322773372|FG000|Overall Study|Adverse Event|4|||
94267301|NCT03044249|322773373|FG001|Overall Study|Adverse Event|9|||
94267302|NCT03044249|322773372|FG000|Overall Study|Lost to Follow-up|1|||
94267303|NCT03044249|322773373|FG001|Overall Study|Lost to Follow-up|0|||
94267304|NCT03044249|322773372|FG000|Overall Study|Non-compliance with Study Drug|1|||
94267305|NCT03044249|322773373|FG001|Overall Study|Non-compliance with Study Drug|0|||
94267306|NCT03044249|322773372|FG000|Overall Study|Study Terminated by Sponsor|2|||
94267307|NCT03044249|322773373|FG001|Overall Study|Study Terminated by Sponsor|0|||
94267308|NCT03044249|322773372|FG000|Overall Study|Withdrawal by Subject|2|||
94267309|NCT03044249|322773373|FG001|Overall Study|Withdrawal by Subject|5|||
94267310|NCT00760669|322773374|FG000|Overall Study|Not assessed for overall improvement|18|||
94267311|NCT00760669|322773374|FG000|Overall Study|Participants missing efficacy assessment|6|||
94267312|NCT00760669|322773374|FG000|Overall Study|Participants with overlapping cases|1|||
94267313|NCT00760669|322773374|FG000|Overall Study|Took drug before entering in contract|5|||
94267314|NCT00504153|322773382|FG000|Overall Study|Withdrawal by Subject|1|||
94267315|NCT00504153|322773382|FG000|Overall Study|Adverse Event|4|||
94267316|NCT00504153|322773382|FG000|Overall Study|Death|1|||
94267317|NCT02303704|322773383|FG000|Overall Study|Protocol Violation|5|||
94267318|NCT02303704|322773384|FG001|Overall Study|Protocol Violation|9|||
94267319|NCT04411628|322773386|FG000|Overall Study|Withdrawal by Subject|1|||
94267320|NCT04411628|322773387|FG001|Overall Study|Withdrawal by Subject|1|||
94267321|NCT04411628|322773388|FG002|Overall Study|Withdrawal by Subject|2|||
94267322|NCT04411628|322773389|FG003|Overall Study|Withdrawal by Subject|0|||
94267323|NCT04411628|322773386|FG000|Overall Study|Lost to Follow-up|0|||
94267324|NCT04411628|322773387|FG001|Overall Study|Lost to Follow-up|1|||
94267325|NCT04411628|322773388|FG002|Overall Study|Lost to Follow-up|0|||
94267326|NCT04411628|322773389|FG003|Overall Study|Lost to Follow-up|0|||
94267327|NCT00732251|322773390|FG000|Overall Study|Lost to Follow-up|3|||
94267328|NCT00732251|322773390|FG000|Overall Study|Withdrawal by Subject|3|||
94267329|NCT00732251|322773390|FG000|Overall Study|Early Term due to Site Closure|1|||
94267330|NCT00688155|322773393|FG000|Overall Study|Withdrawal by Subject|2|||
94267331|NCT00688155|322773394|FG001|Overall Study|Withdrawal by Subject|2|||
94267332|NCT00688155|322773395|FG002|Overall Study|Withdrawal by Subject|1|||
94267333|NCT00688155|322773396|FG003|Overall Study|Withdrawal by Subject|1|||
94267334|NCT03007979|322773400|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
94267335|NCT01005745|322773401|FG000|Overall Study|No TIL growth|1|||
94267336|NCT01005745|322773401|FG000|Overall Study|Disease progressed during TIL growth|3|||
94267337|NCT01005745|322773401|FG000|Overall Study|Death prior to treatment|1|||
94267338|NCT01005745|322773401|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
94267339|NCT01659151|322773402|FG000|Overall Study|Inadequate TIL growth|1|||
94267340|NCT00597753|322773405|FG000|Overall Study|Adverse Event|6|||
94267341|NCT00597753|322773406|FG001|Overall Study|Adverse Event|2|||
94267342|NCT00597753|322773405|FG000|Overall Study|Death|55|||
94267343|NCT00597753|322773406|FG001|Overall Study|Death|29|||
94267344|NCT00597753|322773405|FG000|Overall Study|Lack of Efficacy|2|||
94267345|NCT00597753|322773406|FG001|Overall Study|Lack of Efficacy|0|||
94267346|NCT00597753|322773405|FG000|Overall Study|Lost to Follow-up|10|||
94267347|NCT00597753|322773406|FG001|Overall Study|Lost to Follow-up|3|||
94267348|NCT00597753|322773405|FG000|Overall Study|Physician Decision|5|||
94267349|NCT00597753|322773406|FG001|Overall Study|Physician Decision|1|||
94267350|NCT00597753|322773405|FG000|Overall Study|Pregnancy|1|||
94267351|NCT00597753|322773406|FG001|Overall Study|Pregnancy|0|||
94267352|NCT00597753|322773405|FG000|Overall Study|Withdrawal by Subject|35|||
94267353|NCT00597753|322773406|FG001|Overall Study|Withdrawal by Subject|12|||
94267354|NCT00597753|322773405|FG000|Overall Study|Discontinued Dialysis|0|||
94267355|NCT00597753|322773406|FG001|Overall Study|Discontinued Dialysis|1|||
94267356|NCT00597753|322773405|FG000|Overall Study|Never dosed|2|||
94267357|NCT00597753|322773406|FG001|Overall Study|Never dosed|0|||
94267358|NCT00597753|322773405|FG000|Overall Study|Noncompliance|2|||
94267359|NCT00597753|322773406|FG001|Overall Study|Noncompliance|1|||
94267360|NCT00597753|322773405|FG000|Overall Study|Relocation|17|||
94267361|NCT00597753|322773406|FG001|Overall Study|Relocation|6|||
94267362|NCT00597753|322773405|FG000|Overall Study|Renal transplant|10|||
94267363|NCT00597753|322773406|FG001|Overall Study|Renal transplant|3|||
94267364|NCT00597753|322773405|FG000|Overall Study|Site closed by sponsor|19|||
94267365|NCT00597753|322773406|FG001|Overall Study|Site closed by sponsor|7|||
94267366|NCT00597753|322773405|FG000|Overall Study|Site elected to close|2|||
94267367|NCT00597753|322773406|FG001|Overall Study|Site elected to close|4|||
94267368|NCT03416153|322773412|FG000|Overall Study|Physician Decision|1|||
94267369|NCT03416153|322773413|FG001|Overall Study|Physician Decision|1|||
94267370|NCT03416153|322773412|FG000|Overall Study|Withdrawal by Subject|1|||
94267371|NCT03416153|322773413|FG001|Overall Study|Withdrawal by Subject|0|||
94267372|NCT03441334|322774794|FG000|Overall Study|Withdrawal by Subject|1|||
94267373|NCT03441334|322774795|FG001|Overall Study|Withdrawal by Subject|0|||
94267374|NCT02217436|322774800|FG000|Overall Study|Protocol Violation|1|||
94267375|NCT02217436|322774801|FG001|Overall Study|Protocol Violation|1|||
94267376|NCT02217436|322774800|FG000|Overall Study|Incomplete data|0|||
94267377|NCT02217436|322774801|FG001|Overall Study|Incomplete data|1|||
94267378|NCT01920594|322774807|FG000|Overall Study|Adverse Event|4|||
94267379|NCT01920594|322774808|FG001|Overall Study|Adverse Event|2|||
94267380|NCT01920594|322774807|FG000|Overall Study|Lost to Follow-up|1|||
94267381|NCT01920594|322774808|FG001|Overall Study|Lost to Follow-up|0|||
94267382|NCT01920594|322774807|FG000|Overall Study|Recovery|2|||
94708960|NCT02441036|324392103|FG000|Overall Study|No tissue resected|0|||
94708961|NCT02441036|324392104|FG001|Overall Study|No tissue resected|1|||
94708962|NCT02441036|324392105|FG002|Overall Study|No tissue resected|0|||
94708963|NCT02441036|324392106|FG003|Overall Study|No tissue resected|1|||
94708964|NCT02441036|324392107|FG004|Overall Study|No tissue resected|0|||
94708965|NCT00723450|324392109|FG000|Open-Label Phase|Adverse Event|26|||
94708966|NCT00723450|324392110|FG001|Open-Label Phase|Adverse Event|0|||
94708967|NCT00723450|324392111|FG002|Open-Label Phase|Adverse Event|0|||
94708968|NCT00723450|324392109|FG000|Open-Label Phase|Lack of Efficacy|18|||
94708969|NCT00723450|324392110|FG001|Open-Label Phase|Lack of Efficacy|0|||
94708970|NCT00723450|324392111|FG002|Open-Label Phase|Lack of Efficacy|0|||
94708971|NCT00723450|324392109|FG000|Open-Label Phase|Protocol Violation|35|||
94708972|NCT00723450|324392110|FG001|Open-Label Phase|Protocol Violation|0|||
94708973|NCT00723450|324392111|FG002|Open-Label Phase|Protocol Violation|0|||
94708974|NCT00723450|324392109|FG000|Open-Label Phase|Lost to Follow-up|7|||
94708975|NCT00723450|324392110|FG001|Open-Label Phase|Lost to Follow-up|0|||
94708976|NCT00723450|324392111|FG002|Open-Label Phase|Lost to Follow-up|0|||
94708977|NCT00723450|324392109|FG000|Open-Label Phase|Physician Decision|2|||
94708978|NCT00723450|324392110|FG001|Open-Label Phase|Physician Decision|0|||
94708979|NCT00723450|324392111|FG002|Open-Label Phase|Physician Decision|0|||
94708980|NCT00723450|324392109|FG000|Open-Label Phase|Withdrawal by Subject|37|||
94708981|NCT00723450|324392110|FG001|Open-Label Phase|Withdrawal by Subject|0|||
94708982|NCT00723450|324392111|FG002|Open-Label Phase|Withdrawal by Subject|0|||
94708983|NCT00723450|324392109|FG000|Randomized Phase|Adverse Event|0|||
94708984|NCT00723450|324392110|FG001|Randomized Phase|Adverse Event|26|||
94708985|NCT00723450|324392111|FG002|Randomized Phase|Adverse Event|17|||
94708986|NCT00723450|324392109|FG000|Randomized Phase|Lack of Efficacy|0|||
94708987|NCT00723450|324392110|FG001|Randomized Phase|Lack of Efficacy|11|||
94708988|NCT00723450|324392111|FG002|Randomized Phase|Lack of Efficacy|11|||
94708989|NCT00723450|324392109|FG000|Randomized Phase|Protocol Violation|0|||
94708990|NCT00723450|324392110|FG001|Randomized Phase|Protocol Violation|9|||
94708991|NCT00723450|324392111|FG002|Randomized Phase|Protocol Violation|13|||
94708992|NCT00723450|324392109|FG000|Randomized Phase|Lost to Follow-up|0|||
94708993|NCT00723450|324392110|FG001|Randomized Phase|Lost to Follow-up|2|||
94708994|NCT00723450|324392111|FG002|Randomized Phase|Lost to Follow-up|3|||
94708995|NCT00723450|324392109|FG000|Randomized Phase|Physician Decision|0|||
94708996|NCT00723450|324392110|FG001|Randomized Phase|Physician Decision|3|||
94708997|NCT00723450|324392111|FG002|Randomized Phase|Physician Decision|1|||
94708998|NCT00723450|324392109|FG000|Randomized Phase|Withdrawal by Subject|0|||
94708999|NCT00723450|324392110|FG001|Randomized Phase|Withdrawal by Subject|14|||
94709000|NCT00723450|324392111|FG002|Randomized Phase|Withdrawal by Subject|22|||
94709001|NCT01909336|324392112|FG000|Overall Study|Lost to Follow-up|4|||
94709002|NCT01909336|324392113|FG001|Overall Study|Lost to Follow-up|2|||
94709003|NCT01909336|324392114|FG002|Overall Study|Lost to Follow-up|2|||
94709004|NCT01909336|324392112|FG000|Overall Study|Physician Decision|0|||
94709005|NCT01909336|324392113|FG001|Overall Study|Physician Decision|1|||
94709006|NCT01909336|324392114|FG002|Overall Study|Physician Decision|1|||
94709007|NCT00530842|324392121|FG000|Overall Study|Adverse Event|10|||
94709008|NCT00530842|324392122|FG001|Overall Study|Adverse Event|6|||
94709009|NCT00530842|324392121|FG000|Overall Study|Lack of Efficacy|2|||
94709010|NCT00530842|324392122|FG001|Overall Study|Lack of Efficacy|1|||
94709011|NCT00530842|324392121|FG000|Overall Study|Lost to Follow-up|0|||
94709012|NCT00530842|324392122|FG001|Overall Study|Lost to Follow-up|4|||
94709013|NCT00530842|324392121|FG000|Overall Study|Protocol Violation|3|||
94709014|NCT00530842|324392122|FG001|Overall Study|Protocol Violation|2|||
94709015|NCT00530842|324392121|FG000|Overall Study|Withdrawal by Subject|4|||
94709016|NCT00530842|324392122|FG001|Overall Study|Withdrawal by Subject|5|||
94709017|NCT00530842|324392121|FG000|Overall Study|Individual different reasons|4|||
94709018|NCT00530842|324392122|FG001|Overall Study|Individual different reasons|3|||
94709019|NCT00530842|324392121|FG000|Period 1|Adverse Event|7|||
94709020|NCT00530842|324392122|FG001|Period 1|Adverse Event|3|||
94709021|NCT00530842|324392121|FG000|Period 1|Lack of Efficacy|1|||
94709022|NCT00530842|324392122|FG001|Period 1|Lack of Efficacy|1|||
94709023|NCT00530842|324392121|FG000|Period 1|Protocol Violation|2|||
94709024|NCT00530842|324392122|FG001|Period 1|Protocol Violation|1|||
94709025|NCT00530842|324392121|FG000|Period 1|Withdrawal by Subject|2|||
94709026|NCT00530842|324392122|FG001|Period 1|Withdrawal by Subject|3|||
94709027|NCT00530842|324392121|FG000|Period 1|Individual different reasons|2|||
94709028|NCT00530842|324392122|FG001|Period 1|Individual different reasons|3|||
94709029|NCT00530842|324392121|FG000|Period 2|Adverse Event|3|||
94709030|NCT00530842|324392122|FG001|Period 2|Adverse Event|3|||
94709031|NCT00530842|324392121|FG000|Period 2|Lack of Efficacy|1|||
94709032|NCT00530842|324392122|FG001|Period 2|Lack of Efficacy|0|||
94709033|NCT00530842|324392121|FG000|Period 2|Lost to Follow-up|0|||
94709034|NCT00530842|324392122|FG001|Period 2|Lost to Follow-up|4|||
94709035|NCT00530842|324392121|FG000|Period 2|Protocol Violation|1|||
94709036|NCT00530842|324392122|FG001|Period 2|Protocol Violation|0|||
94709037|NCT00530842|324392121|FG000|Period 2|Withdrawal by Subject|1|||
94709038|NCT00530842|324392122|FG001|Period 2|Withdrawal by Subject|2|||
94709039|NCT00530842|324392121|FG000|Period 2|Individual different reasons|2|||
94709040|NCT00530842|324392122|FG001|Period 2|Individual different reasons|0|||
94709041|NCT02534350|324392123|FG000|Overall Study|Randomized But Not Treated|1|||
94709042|NCT02534350|324392124|FG001|Overall Study|Randomized But Not Treated|0|||
94709043|NCT02534350|324392123|FG000|Overall Study|Protocol Violation|1|||
94709044|NCT02534350|324392124|FG001|Overall Study|Protocol Violation|0|||
94709045|NCT02534350|324392123|FG000|Overall Study|Withdrew Consent|2|||
94709046|NCT02534350|324392124|FG001|Overall Study|Withdrew Consent|0|||
94709047|NCT03478696|324392125|FG000|Overall Study|Adverse Event|1|||
94709048|NCT03478696|324392126|FG001|Overall Study|Adverse Event|5|||
94709049|NCT03478696|324392125|FG000|Overall Study|Lost to Follow-up|1|||
94709050|NCT03478696|324392126|FG001|Overall Study|Lost to Follow-up|0|||
94709051|NCT03478696|324392125|FG000|Overall Study|Physician Decision|6|||
94709052|NCT03478696|324392126|FG001|Overall Study|Physician Decision|3|||
94709053|NCT03478696|324392125|FG000|Overall Study|Withdrawal by Subject|9|||
94709054|NCT03478696|324392126|FG001|Overall Study|Withdrawal by Subject|4|||
94709055|NCT00545077|324392128|FG000|Overall Study|Treatment not received|5|||
94709056|NCT00545077|324392129|FG001|Overall Study|Treatment not received|1|||
94709057|NCT00545077|324392128|FG000|Overall Study|Disease Progression|131|||
94709058|NCT00545077|324392129|FG001|Overall Study|Disease Progression|98|||
94267383|NCT01920594|322774808|FG001|Overall Study|Recovery|0|||
94267384|NCT01920594|322774807|FG000|Overall Study|Investigator discretion|0|||
94267385|NCT01920594|322774808|FG001|Overall Study|Investigator discretion|1|||
94267386|NCT00880555|322774809|FG000|Overall Study|Physician Decision|0|||
94267387|NCT00880555|322774810|FG001|Overall Study|Physician Decision|8|||
94267388|NCT00880555|322774811|FG002|Overall Study|Physician Decision|0|||
94267389|NCT00880555|322774812|FG003|Overall Study|Physician Decision|2|||
94267390|NCT00880555|322774813|FG004|Overall Study|Physician Decision|1|||
94267391|NCT00880555|322774814|FG005|Overall Study|Physician Decision|0|||
94267392|NCT00880555|322774809|FG000|Overall Study|Withdrawal by Subject|1|||
94267393|NCT00880555|322774810|FG001|Overall Study|Withdrawal by Subject|1|||
94267394|NCT00880555|322774811|FG002|Overall Study|Withdrawal by Subject|0|||
94267395|NCT00880555|322774812|FG003|Overall Study|Withdrawal by Subject|0|||
94267396|NCT00880555|322774813|FG004|Overall Study|Withdrawal by Subject|0|||
94267397|NCT00880555|322774814|FG005|Overall Study|Withdrawal by Subject|0|||
94267398|NCT00880555|322774809|FG000|Overall Study|Lack of resources (hired rater)|9|||
94267399|NCT00880555|322774810|FG001|Overall Study|Lack of resources (hired rater)|7|||
94267400|NCT00880555|322774811|FG002|Overall Study|Lack of resources (hired rater)|5|||
94267401|NCT00880555|322774812|FG003|Overall Study|Lack of resources (hired rater)|0|||
94267402|NCT00880555|322774813|FG004|Overall Study|Lack of resources (hired rater)|0|||
94267403|NCT00880555|322774814|FG005|Overall Study|Lack of resources (hired rater)|0|||
94267404|NCT00880555|322774809|FG000|Overall Study|Death|0|||
94267405|NCT00880555|322774810|FG001|Overall Study|Death|0|||
94267406|NCT00880555|322774811|FG002|Overall Study|Death|0|||
94267407|NCT00880555|322774812|FG003|Overall Study|Death|0|||
94267408|NCT00880555|322774813|FG004|Overall Study|Death|0|||
94267409|NCT00880555|322774814|FG005|Overall Study|Death|1|||
94267410|NCT00880555|322774809|FG000|Overall Study|Lost to Follow-up|0|||
94267411|NCT00880555|322774810|FG001|Overall Study|Lost to Follow-up|1|||
94267412|NCT00880555|322774811|FG002|Overall Study|Lost to Follow-up|0|||
94267413|NCT00880555|322774812|FG003|Overall Study|Lost to Follow-up|0|||
94267414|NCT00880555|322774813|FG004|Overall Study|Lost to Follow-up|0|||
94267415|NCT00880555|322774814|FG005|Overall Study|Lost to Follow-up|0|||
94267416|NCT03034460|322774815|FG000|Overall Study|Adverse Event|0|||
94267417|NCT03034460|322774816|FG001|Overall Study|Adverse Event|1|||
94267418|NCT03034460|322774815|FG000|Overall Study|Withdrawal by Subject|2|||
94267419|NCT03034460|322774816|FG001|Overall Study|Withdrawal by Subject|2|||
94267420|NCT03034460|322774815|FG000|Overall Study|Personal Reasons|1|||
94267421|NCT03034460|322774816|FG001|Overall Study|Personal Reasons|0|||
94267422|NCT01950247|322774818|FG000|Overall Study|Withdrawal by Subject|28|||
94267423|NCT01950247|322774819|FG001|Overall Study|Withdrawal by Subject|13|||
94267424|NCT01950247|322774818|FG000|Overall Study|Lost to Follow-up|18|||
94267425|NCT01950247|322774819|FG001|Overall Study|Lost to Follow-up|16|||
94267426|NCT01950247|322774818|FG000|Overall Study|Physician Decision|3|||
94267427|NCT01950247|322774819|FG001|Overall Study|Physician Decision|4|||
94267428|NCT01950247|322774818|FG000|Overall Study|Adverse Event|3|||
94267429|NCT01950247|322774819|FG001|Overall Study|Adverse Event|2|||
94267430|NCT01950247|322774818|FG000|Overall Study|Death|1|||
94267431|NCT01950247|322774819|FG001|Overall Study|Death|1|||
94267432|NCT01950247|322774818|FG000|Overall Study|Not Defined|4|||
94267433|NCT01950247|322774819|FG001|Overall Study|Not Defined|10|||
94267434|NCT01069120|322774820|FG000|Overall Study|Study prematurely terminated|27|||
94709059|NCT00545077|324392128|FG000|Overall Study|Withdrawal by Subject|3|||
94709060|NCT00545077|324392129|FG001|Overall Study|Withdrawal by Subject|14|||
94709061|NCT00545077|324392128|FG000|Overall Study|Physician Decision|6|||
94709062|NCT00545077|324392129|FG001|Overall Study|Physician Decision|3|||
94709063|NCT00545077|324392128|FG000|Overall Study|Lost to Follow-up|2|||
94267435|NCT00388505|322774821|FG000|Overall Study|Adverse Event or Death|43|||
94267436|NCT00388505|322774822|FG001|Overall Study|Adverse Event or Death|17|||
94267437|NCT00388505|322774821|FG000|Overall Study|Withdrawal by Subject|24|||
94267438|NCT00388505|322774822|FG001|Overall Study|Withdrawal by Subject|9|||
94267439|NCT00388505|322774821|FG000|Overall Study|Lost to Follow-up|5|||
94267440|NCT00388505|322774822|FG001|Overall Study|Lost to Follow-up|3|||
94267441|NCT00388505|322774821|FG000|Overall Study|Inappropriate Enrollment|0|||
94267442|NCT00388505|322774822|FG001|Overall Study|Inappropriate Enrollment|1|||
94267443|NCT00388505|322774821|FG000|Overall Study|Administrative Reason|1|||
94267444|NCT00388505|322774822|FG001|Overall Study|Administrative Reason|0|||
94267445|NCT00388505|322774821|FG000|Overall Study|Protocol Violation|6|||
94267446|NCT00388505|322774822|FG001|Overall Study|Protocol Violation|5|||
94267447|NCT00388505|322774821|FG000|Overall Study|Unable to classify|4|||
94267448|NCT00388505|322774822|FG001|Overall Study|Unable to classify|3|||
94267449|NCT01942148|322774828|FG000|Overall Study|Adverse Event|4|||
94267450|NCT01942148|322774828|FG000|Overall Study|Lack of Efficacy|2|||
94267451|NCT01942148|322774828|FG000|Overall Study|Physician Decision|11|||
94267452|NCT01942148|322774828|FG000|Overall Study|Protocol Violation|1|||
94267453|NCT01942148|322774828|FG000|Overall Study|Withdrawal by Subject|8|||
94267454|NCT01942148|322774828|FG000|Overall Study|Use of the prohibition medicine|1|||
94267455|NCT00066742|322774829|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
94267456|NCT00066742|322774829|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
94267457|NCT00066742|322774829|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
94267458|NCT00066742|322774829|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
94267459|NCT00066742|322774829|FG000|Induction Chemoradiotherapy|Ineligible|3|||
94267460|NCT00066742|322774829|FG000|Consolidation Chemotherapy|not protocol specified|1|||
94267461|NCT00066742|322774829|FG000|Consolidation Chemotherapy|Ineligible|2|||
94267462|NCT03794583|322774830|FG000|Overall Study|Death|8|||
94267463|NCT03794583|322774830|FG000|Overall Study|Study Terminated by Sponsor|24|||
94267464|NCT03794583|322774830|FG000|Overall Study|Withdrawal by Subject|9|||
94709064|NCT00545077|324392129|FG001|Overall Study|Lost to Follow-up|0|||
94709065|NCT00545077|324392128|FG000|Overall Study|Protocol Violation|1|||
94267465|NCT03814746|322774832|FG000|Overall Study|Participant decision|9|||
94267466|NCT03814746|322774833|FG001|Overall Study|Participant decision|6|||
94267467|NCT03814746|322774834|FG002|Overall Study|Participant decision|15|||
94267468|NCT03814746|322774832|FG000|Overall Study|Physician Decision|2|||
94267469|NCT03814746|322774833|FG001|Overall Study|Physician Decision|2|||
94267470|NCT03814746|322774834|FG002|Overall Study|Physician Decision|4|||
94267471|NCT03814746|322774832|FG000|Overall Study|Death|2|||
94267472|NCT03814746|322774833|FG001|Overall Study|Death|2|||
94267473|NCT03814746|322774834|FG002|Overall Study|Death|2|||
94267474|NCT03814746|322774832|FG000|Overall Study|Adverse Event|2|||
94267475|NCT03814746|322774833|FG001|Overall Study|Adverse Event|2|||
94267476|NCT03814746|322774834|FG002|Overall Study|Adverse Event|1|||
94267477|NCT03814746|322774832|FG000|Overall Study|Lost to Follow-up|2|||
94709066|NCT00545077|324392129|FG001|Overall Study|Protocol Violation|0|||
94709067|NCT00545077|324392128|FG000|Overall Study|Adverse Event|0|||
94709068|NCT00545077|324392129|FG001|Overall Study|Adverse Event|31|||
94709069|NCT00545077|324392128|FG000|Overall Study|Death|0|||
94709070|NCT00545077|324392129|FG001|Overall Study|Death|8|||
94709071|NCT02471755|324392143|FG000|Overall Study|Withdrawal by Subject|1|||
94709072|NCT02471755|324392144|FG001|Overall Study|Withdrawal by Subject|0|||
94709073|NCT02471755|324392143|FG000|Overall Study|Lost to Follow-up|0|||
94709074|NCT02471755|324392144|FG001|Overall Study|Lost to Follow-up|1|||
94709075|NCT01152190|324392149|FG000|Overall Study|Adverse Event|2|||
94709076|NCT01152190|324392150|FG001|Overall Study|Adverse Event|4|||
94709077|NCT01152190|324392149|FG000|Overall Study|Death|1|||
94709078|NCT01152190|324392150|FG001|Overall Study|Death|0|||
94709079|NCT01152190|324392149|FG000|Overall Study|Protocol Violation|1|||
94709080|NCT01152190|324392150|FG001|Overall Study|Protocol Violation|1|||
94709081|NCT01152190|324392149|FG000|Overall Study|Withdrawal by Subject|1|||
94709082|NCT01152190|324392150|FG001|Overall Study|Withdrawal by Subject|3|||
94709083|NCT00258895|324392151|FG000|Overall Study|Lost to Follow-up|3|||
94709084|NCT00258895|324392152|FG001|Overall Study|Lost to Follow-up|1|||
94709085|NCT00258895|324392151|FG000|Overall Study|Protocol Violation|6|||
94709086|NCT00258895|324392152|FG001|Overall Study|Protocol Violation|2|||
94709087|NCT00258895|324392151|FG000|Overall Study|Withdrawal by Subject|1|||
94709088|NCT00258895|324392152|FG001|Overall Study|Withdrawal by Subject|0|||
94709089|NCT02685488|324392153|FG000|Overall Study|Withdrawal by Subject|0|||
94709090|NCT02685488|324392154|FG001|Overall Study|Withdrawal by Subject|1|||
94267478|NCT03814746|322774833|FG001|Overall Study|Lost to Follow-up|1|||
94267479|NCT03814746|322774834|FG002|Overall Study|Lost to Follow-up|2|||
94267480|NCT03814746|322774832|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94267481|NCT03814746|322774833|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
94267482|NCT03814746|322774834|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
94267483|NCT03814746|322774832|FG000|Overall Study|Pregnancy|0|||
94709091|NCT00305695|324392155|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
94709092|NCT00305695|324392156|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
94267484|NCT03814746|322774833|FG001|Overall Study|Pregnancy|1|||
94267485|NCT03814746|322774834|FG002|Overall Study|Pregnancy|1|||
94267486|NCT03814746|322774832|FG000|Overall Study|Protocol Violation|1|||
94267487|NCT03814746|322774833|FG001|Overall Study|Protocol Violation|0|||
94267488|NCT03814746|322774834|FG002|Overall Study|Protocol Violation|0|||
94267489|NCT01195090|322774838|FG000|Overall Study|Adverse Event|1|||
94267490|NCT01195090|322774839|FG001|Overall Study|Adverse Event|2|||
94267491|NCT01195090|322774838|FG000|Overall Study|Lost to Follow-up|2|||
94709093|NCT00305695|324392155|FG000|Overall Study|Did not have baseline scan|1|||
94709094|NCT00305695|324392156|FG001|Overall Study|Did not have baseline scan|1|||
94709095|NCT03070483|324392157|FG000|Overall Study|Lost to Follow-up|2|||
94709096|NCT00837616|324392160|FG000|Overall Study|Withdrawal by Subject|0|||
94709097|NCT00837616|324392161|FG001|Overall Study|Withdrawal by Subject|1|||
94709098|NCT00732381|324392166|FG000|Overall Study|Adverse Event|1|||
94709099|NCT00732381|324392167|FG001|Overall Study|Adverse Event|0|||
94709100|NCT00732381|324392166|FG000|Overall Study|Treatment Failure|1|||
94709101|NCT00732381|324392167|FG001|Overall Study|Treatment Failure|1|||
94709102|NCT01713946|324392174|FG000|Overall Study|Death|0|||
94709103|NCT01713946|324392175|FG001|Overall Study|Death|2|||
94709104|NCT01713946|324392176|FG002|Overall Study|Death|2|||
94709105|NCT01713946|324392174|FG000|Overall Study|Adverse Event|19|||
94709106|NCT01713946|324392175|FG001|Overall Study|Adverse Event|14|||
94709107|NCT01713946|324392176|FG002|Overall Study|Adverse Event|13|||
94709108|NCT01713946|324392174|FG000|Overall Study|Withdrawal by Subject|12|||
94709109|NCT01713946|324392175|FG001|Overall Study|Withdrawal by Subject|12|||
94709110|NCT01713946|324392176|FG002|Overall Study|Withdrawal by Subject|8|||
94709111|NCT01713946|324392174|FG000|Overall Study|Lack of Efficacy|8|||
94709112|NCT01713946|324392175|FG001|Overall Study|Lack of Efficacy|8|||
94709113|NCT01713946|324392176|FG002|Overall Study|Lack of Efficacy|14|||
94709114|NCT01713946|324392174|FG000|Overall Study|Protocol Violation|2|||
94709115|NCT01713946|324392175|FG001|Overall Study|Protocol Violation|4|||
94709116|NCT01713946|324392176|FG002|Overall Study|Protocol Violation|1|||
94709117|NCT01713946|324392174|FG000|Overall Study|Lost to Follow-up|0|||
94709118|NCT01713946|324392175|FG001|Overall Study|Lost to Follow-up|0|||
94709119|NCT01713946|324392176|FG002|Overall Study|Lost to Follow-up|1|||
94709120|NCT01713946|324392174|FG000|Overall Study|Administrative problems|1|||
94709121|NCT01713946|324392175|FG001|Overall Study|Administrative problems|0|||
94709122|NCT01713946|324392176|FG002|Overall Study|Administrative problems|0|||
94709123|NCT01713946|324392174|FG000|Overall Study|Did not continue in Ext|0|||
94709124|NCT01713946|324392175|FG001|Overall Study|Did not continue in Ext|3|||
94709125|NCT01713946|324392176|FG002|Overall Study|Did not continue in Ext|0|||
94709126|NCT01713946|324392174|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
94709127|NCT01713946|324392175|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
94709128|NCT01713946|324392176|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
94709129|NCT01713946|324392174|FG000|Overall Study|Patients never switched to everolimus|0|||
94709130|NCT01713946|324392175|FG001|Overall Study|Patients never switched to everolimus|0|||
94709131|NCT01713946|324392176|FG002|Overall Study|Patients never switched to everolimus|5|||
94709132|NCT02631148|324393952|FG000|Overall Study|8 were ineligible|8|||
94709133|NCT02631148|324393953|FG001|Overall Study|8 were ineligible|0|||
94709134|NCT02631148|324393952|FG000|Overall Study|Withdrawal by Subject|1|||
94709135|NCT02631148|324393953|FG001|Overall Study|Withdrawal by Subject|0|||
94709136|NCT02631148|324393952|FG000|Overall Study|PAH not available to study participant|1|||
94709137|NCT02631148|324393953|FG001|Overall Study|PAH not available to study participant|0|||
94709138|NCT01393119|324393954|FG000|Overall Study|Adverse Event|1|||
94709139|NCT01393119|324393955|FG001|Overall Study|Adverse Event|1|||
94709140|NCT01393119|324393956|FG002|Overall Study|Adverse Event|0|||
94709141|NCT01393119|324393957|FG003|Overall Study|Adverse Event|1|||
94709142|NCT01393119|324393954|FG000|Overall Study|Withdrawal by Subject|0|||
94709143|NCT01393119|324393955|FG001|Overall Study|Withdrawal by Subject|1|||
94267492|NCT01195090|322774839|FG001|Overall Study|Lost to Follow-up|2|||
94267493|NCT01195090|322774838|FG000|Overall Study|Protocol Violation|3|||
94709144|NCT01393119|324393956|FG002|Overall Study|Withdrawal by Subject|1|||
94267494|NCT01195090|322774839|FG001|Overall Study|Protocol Violation|4|||
94267495|NCT01205230|322774840|FG000|Overall Study|Adverse Event|4|||
94709145|NCT01393119|324393957|FG003|Overall Study|Withdrawal by Subject|0|||
94709146|NCT01393119|324393954|FG000|Overall Study|Lack of Efficacy|1|||
94709147|NCT01393119|324393955|FG001|Overall Study|Lack of Efficacy|0|||
94709148|NCT01393119|324393956|FG002|Overall Study|Lack of Efficacy|2|||
94709149|NCT01393119|324393957|FG003|Overall Study|Lack of Efficacy|1|||
94709150|NCT01393119|324393954|FG000|Overall Study|Protocol Violation|0|||
94709151|NCT01393119|324393955|FG001|Overall Study|Protocol Violation|0|||
94709152|NCT01393119|324393956|FG002|Overall Study|Protocol Violation|1|||
94267496|NCT01205230|322774841|FG001|Overall Study|Adverse Event|0|||
94267497|NCT01205230|322774840|FG000|Overall Study|Physician Decision|1|||
94709153|NCT01393119|324393957|FG003|Overall Study|Protocol Violation|0|||
94709154|NCT01393119|324393954|FG000|Overall Study|Death|0|||
94709155|NCT01393119|324393955|FG001|Overall Study|Death|0|||
94267498|NCT01205230|322774841|FG001|Overall Study|Physician Decision|0|||
94709156|NCT01393119|324393956|FG002|Overall Study|Death|0|||
94709157|NCT01393119|324393957|FG003|Overall Study|Death|1|||
94709158|NCT01393119|324393954|FG000|Overall Study|Randomized but Not treated|1|||
94709159|NCT01393119|324393955|FG001|Overall Study|Randomized but Not treated|0|||
94267499|NCT01701674|322774842|FG000|Overall Study|Unable to safely complete treatment|1|||
94267500|NCT01368536|322774847|FG000|Overall Study|Adverse Event|5|||
94267501|NCT01368536|322774848|FG001|Overall Study|Adverse Event|6|||
94267502|NCT01368536|322774849|FG002|Overall Study|Adverse Event|8|||
94267503|NCT01368536|322774847|FG000|Overall Study|Abnormal laboratory value(s)|0|||
94267504|NCT01368536|322774848|FG001|Overall Study|Abnormal laboratory value(s)|1|||
94267505|NCT01368536|322774849|FG002|Overall Study|Abnormal laboratory value(s)|2|||
94267506|NCT01368536|322774847|FG000|Overall Study|Abnormal test procedure result(s)|0|||
94267507|NCT01368536|322774848|FG001|Overall Study|Abnormal test procedure result(s)|0|||
94267508|NCT01368536|322774849|FG002|Overall Study|Abnormal test procedure result(s)|1|||
94267509|NCT01368536|322774847|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
94267510|NCT01368536|322774848|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
94267511|NCT01368536|322774849|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
94267512|NCT01368536|322774847|FG000|Overall Study|No longer required study medication|0|||
94267513|NCT01368536|322774848|FG001|Overall Study|No longer required study medication|0|||
94267514|NCT01368536|322774849|FG002|Overall Study|No longer required study medication|1|||
94267515|NCT01368536|322774847|FG000|Overall Study|Withdrawal by Subject|2|||
94267516|NCT01368536|322774848|FG001|Overall Study|Withdrawal by Subject|5|||
94267517|NCT01368536|322774849|FG002|Overall Study|Withdrawal by Subject|4|||
94267518|NCT01368536|322774847|FG000|Overall Study|Lost to Follow-up|3|||
94267519|NCT01368536|322774848|FG001|Overall Study|Lost to Follow-up|3|||
94366739|NCT00481871|323128162|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
94709160|NCT01393119|324393956|FG002|Overall Study|Randomized but Not treated|1|||
94709161|NCT01393119|324393957|FG003|Overall Study|Randomized but Not treated|1|||
94709162|NCT01393119|324393954|FG000|Overall Study|Sponsor Termination of Study|11|||
94709163|NCT01393119|324393955|FG001|Overall Study|Sponsor Termination of Study|12|||
94709164|NCT01393119|324393956|FG002|Overall Study|Sponsor Termination of Study|9|||
94709165|NCT01393119|324393957|FG003|Overall Study|Sponsor Termination of Study|12|||
94709166|NCT01266265|324393958|FG000|Overall Study|Death|95|||
94709167|NCT01266265|324393959|FG001|Overall Study|Death|73|||
94709168|NCT01266265|324393958|FG000|Overall Study|Lost to Follow-up|23|||
94709169|NCT01266265|324393959|FG001|Overall Study|Lost to Follow-up|28|||
94709170|NCT01266265|324393958|FG000|Overall Study|Withdrawal by Subject|13|||
94709171|NCT01266265|324393959|FG001|Overall Study|Withdrawal by Subject|11|||
94709172|NCT01266265|324393958|FG000|Overall Study|Respiratory-related adverse event|2|||
94709173|NCT01266265|324393959|FG001|Overall Study|Respiratory-related adverse event|1|||
94709174|NCT01266265|324393958|FG000|Overall Study|Transferred care to another provider|22|||
94709175|NCT01266265|324393959|FG001|Overall Study|Transferred care to another provider|28|||
94709176|NCT01266265|324393958|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
94709177|NCT01266265|324393959|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
94709178|NCT01266265|324393958|FG000|Overall Study|Enrolled in another clinical study|15|||
94709179|NCT01266265|324393959|FG001|Overall Study|Enrolled in another clinical study|26|||
94709180|NCT01266265|324393958|FG000|Overall Study|Non-compliance|8|||
94709181|NCT01266265|324393959|FG001|Overall Study|Non-compliance|5|||
94709182|NCT01266265|324393958|FG000|Overall Study|Lung transplant|6|||
94267520|NCT01368536|322774849|FG002|Overall Study|Lost to Follow-up|5|||
94267521|NCT01368536|322774847|FG000|Overall Study|Administrative problems|34|||
94366740|NCT00481871|323128163|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
94366741|NCT01556490|323128177|FG000|Randomized Patients Summary|Protocol Violation|22|||
94652748|NCT00622635|324186183|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
94652749|NCT00622635|324186184|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
94652750|NCT00622635|324186185|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
94652751|NCT00622635|324186186|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
94652752|NCT00622635|324186181|FG000|Treatment Period 2|Adverse Event|1|||
94652753|NCT00622635|324186182|FG001|Treatment Period 2|Adverse Event|0|||
94652754|NCT00622635|324186183|FG002|Treatment Period 2|Adverse Event|0|||
94652755|NCT00622635|324186184|FG003|Treatment Period 2|Adverse Event|0|||
94652756|NCT00622635|324186185|FG004|Treatment Period 2|Adverse Event|0|||
94652757|NCT00622635|324186186|FG005|Treatment Period 2|Adverse Event|0|||
94652758|NCT00622635|324186181|FG000|Treatment Period 3|Adverse Event|0|||
94652759|NCT00622635|324186182|FG001|Treatment Period 3|Adverse Event|0|||
94652760|NCT00622635|324186183|FG002|Treatment Period 3|Adverse Event|0|||
94652761|NCT00622635|324186184|FG003|Treatment Period 3|Adverse Event|2|||
94652762|NCT00622635|324186185|FG004|Treatment Period 3|Adverse Event|0|||
94652763|NCT00622635|324186186|FG005|Treatment Period 3|Adverse Event|0|||
94709183|NCT01266265|324393959|FG001|Overall Study|Lung transplant|5|||
94709184|NCT01266265|324393958|FG000|Overall Study|Site closed early|4|||
94709185|NCT01266265|324393959|FG001|Overall Study|Site closed early|3|||
94366742|NCT01556490|323128178|FG001|Randomized Patients Summary|Protocol Violation|23|||
94652764|NCT00622635|324186181|FG000|Treatment Period 3|Withdrawal by Subject|0|||
94652765|NCT00622635|324186182|FG001|Treatment Period 3|Withdrawal by Subject|0|||
94267522|NCT01368536|322774848|FG001|Overall Study|Administrative problems|39|||
94267523|NCT01368536|322774849|FG002|Overall Study|Administrative problems|35|||
94267524|NCT01368536|322774847|FG000|Overall Study|Protocol deviation|0|||
94267525|NCT01368536|322774848|FG001|Overall Study|Protocol deviation|3|||
94267526|NCT01368536|322774849|FG002|Overall Study|Protocol deviation|1|||
94267527|NCT00233363|322774850|FG000|Overall Study|Adverse Event|1|||
94267528|NCT00233363|322774851|FG001|Overall Study|Adverse Event|2|||
94267529|NCT00233363|322774850|FG000|Overall Study|Lack of Efficacy|0|||
94267530|NCT00233363|322774851|FG001|Overall Study|Lack of Efficacy|2|||
94267531|NCT00233363|322774850|FG000|Overall Study|Withdrawal by Subject|1|||
94267532|NCT00233363|322774851|FG001|Overall Study|Withdrawal by Subject|1|||
94267533|NCT00233363|322774850|FG000|Overall Study|Aggravation of complication|1|||
94267534|NCT00233363|322774851|FG001|Overall Study|Aggravation of complication|0|||
94267535|NCT05215262|322774852|FG000|Overall Study|Lost to Follow-up|12|||
94709186|NCT01266265|324393958|FG000|Overall Study|Clinical worsening|1|||
94709187|NCT01266265|324393959|FG001|Overall Study|Clinical worsening|1|||
94709188|NCT00711958|324393964|FG000|Overall Study|Withdrawal by Subject|6|||
94709189|NCT00711958|324393965|FG001|Overall Study|Withdrawal by Subject|8|||
94709190|NCT00711958|324393964|FG000|Overall Study|Lack of Efficacy|3|||
94709191|NCT00711958|324393965|FG001|Overall Study|Lack of Efficacy|1|||
94709192|NCT00711958|324393964|FG000|Overall Study|Clinical deterioration|1|||
94709193|NCT00711958|324393965|FG001|Overall Study|Clinical deterioration|0|||
94709194|NCT00711958|324393964|FG000|Overall Study|Adverse Event|9|||
94709195|NCT00711958|324393965|FG001|Overall Study|Adverse Event|7|||
94709196|NCT00711958|324393964|FG000|Overall Study|Protocol Violation|1|||
94709197|NCT00711958|324393965|FG001|Overall Study|Protocol Violation|0|||
94709198|NCT00711958|324393964|FG000|Overall Study|Lost to Follow-up|2|||
94709199|NCT00711958|324393965|FG001|Overall Study|Lost to Follow-up|2|||
94709200|NCT00711958|324393964|FG000|Overall Study|Death|10|||
94709201|NCT00711958|324393965|FG001|Overall Study|Death|5|||
94709202|NCT00711958|324393964|FG000|Overall Study|Progression of disease|1|||
94709203|NCT00711958|324393965|FG001|Overall Study|Progression of disease|0|||
94709204|NCT02013830|324393966|FG000|Overall Study|Adverse Event|3|||
94709205|NCT02013830|324393966|FG000|Overall Study|Death|1|||
94709206|NCT02013830|324393966|FG000|Overall Study|Insufficient therapeutic response|25|||
94709207|NCT02013830|324393966|FG000|Overall Study|Refused treatment|1|||
94709208|NCT02015546|324393967|FG000|Overall Study|Withdrawal by Subject|1|||
94709209|NCT02015546|324393968|FG001|Overall Study|Withdrawal by Subject|1|||
94709210|NCT02015546|324393969|FG002|Overall Study|Withdrawal by Subject|1|||
94709211|NCT02015546|324393967|FG000|Overall Study|Screem Failure|2|||
94709212|NCT02015546|324393968|FG001|Overall Study|Screem Failure|1|||
94709213|NCT02015546|324393969|FG002|Overall Study|Screem Failure|3|||
94709214|NCT03020745|324393970|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
94709215|NCT03020745|324393971|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
94709216|NCT03020745|324393972|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
94709217|NCT03020745|324393973|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
94709218|NCT03020745|324393974|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
94709219|NCT03020745|324393975|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
94267536|NCT05215262|322774853|FG001|Overall Study|Lost to Follow-up|0|||
94267537|NCT00646906|322774854|FG000|Crossover Period 1|Withdrawal by Subject|1|||
94267538|NCT00646906|322774855|FG001|Crossover Period 1|Withdrawal by Subject|0|||
94709220|NCT03020745|324393976|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
94709221|NCT03020745|324393977|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
94709222|NCT03020745|324393978|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
94709223|NCT03020745|324393979|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
94709224|NCT03020745|324393970|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
94267539|NCT00646906|322774856|FG002|Crossover Period 1|Withdrawal by Subject|0|||
94709225|NCT03020745|324393971|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
94709226|NCT03020745|324393972|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
94709227|NCT03020745|324393973|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
94709228|NCT03020745|324393974|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
94709229|NCT03020745|324393975|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
94709230|NCT03020745|324393976|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
94709231|NCT03020745|324393977|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
94709232|NCT03020745|324393978|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
94709233|NCT03020745|324393979|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
94709234|NCT03020745|324393970|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
94709235|NCT03020745|324393971|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
94709236|NCT03020745|324393972|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
94709237|NCT03020745|324393973|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
94709238|NCT03020745|324393974|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
94709239|NCT03020745|324393975|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
94709240|NCT03020745|324393976|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
94709241|NCT03020745|324393977|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
94709242|NCT03020745|324393978|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
94709243|NCT03020745|324393979|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
94709244|NCT03020745|324393970|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
94709245|NCT03020745|324393971|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
94709246|NCT03020745|324393972|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
94709247|NCT03020745|324393973|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
94709248|NCT03020745|324393974|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
94709249|NCT03020745|324393975|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
94709250|NCT03020745|324393976|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
94709251|NCT03020745|324393977|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
94709252|NCT03020745|324393978|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
94709253|NCT03020745|324393979|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
94709254|NCT00186186|324393980|FG000|Overall Study|Lack of Efficacy|3|||
94709255|NCT00186186|324393980|FG000|Overall Study|Withdrawal by Subject|3|||
94709256|NCT00186186|324393980|FG000|Overall Study|Not reported as to reason|2|||
94709257|NCT01337635|324393981|FG000|Overall Study|Lost to Follow-up|0|||
94709258|NCT01337635|324393982|FG001|Overall Study|Lost to Follow-up|1|||
94709259|NCT04956575|324393984|FG000|Overall Study|Death|1|||
94709260|NCT04956575|324393985|FG001|Overall Study|Death|0|||
94709261|NCT04956575|324393986|FG002|Overall Study|Death|0|||
94709262|NCT04956575|324393987|FG003|Overall Study|Death|0|||
94709263|NCT04956575|324393988|FG004|Overall Study|Death|0|||
94709264|NCT04956575|324393989|FG005|Overall Study|Death|0|||
94709265|NCT04956575|324393990|FG006|Overall Study|Death|0|||
94709266|NCT04956575|324393991|FG007|Overall Study|Death|1|||
94709267|NCT04956575|324393992|FG008|Overall Study|Death|0|||
94709268|NCT04956575|324393993|FG009|Overall Study|Death|1|||
94709269|NCT04956575|324393994|FG010|Overall Study|Death|0|||
94709270|NCT04956575|324393995|FG011|Overall Study|Death|0|||
94709271|NCT04956575|324393984|FG000|Overall Study|Lost to Follow-up|3|||
94709272|NCT04956575|324393985|FG001|Overall Study|Lost to Follow-up|4|||
94709273|NCT04956575|324393986|FG002|Overall Study|Lost to Follow-up|2|||
94709274|NCT04956575|324393987|FG003|Overall Study|Lost to Follow-up|3|||
94709275|NCT04956575|324393988|FG004|Overall Study|Lost to Follow-up|1|||
94709276|NCT04956575|324393989|FG005|Overall Study|Lost to Follow-up|10|||
94709277|NCT04956575|324393990|FG006|Overall Study|Lost to Follow-up|11|||
94709278|NCT04956575|324393991|FG007|Overall Study|Lost to Follow-up|7|||
94709279|NCT04956575|324393992|FG008|Overall Study|Lost to Follow-up|4|||
94709280|NCT04956575|324393993|FG009|Overall Study|Lost to Follow-up|2|||
94709281|NCT04956575|324393994|FG010|Overall Study|Lost to Follow-up|3|||
94709282|NCT04956575|324393995|FG011|Overall Study|Lost to Follow-up|8|||
94709283|NCT04956575|324393984|FG000|Overall Study|Withdrawal by Subject|1|||
94709284|NCT04956575|324393985|FG001|Overall Study|Withdrawal by Subject|2|||
94709285|NCT04956575|324393986|FG002|Overall Study|Withdrawal by Subject|1|||
94709286|NCT04956575|324393987|FG003|Overall Study|Withdrawal by Subject|4|||
94709287|NCT04956575|324393988|FG004|Overall Study|Withdrawal by Subject|2|||
94709288|NCT04956575|324393989|FG005|Overall Study|Withdrawal by Subject|8|||
94709289|NCT04956575|324393990|FG006|Overall Study|Withdrawal by Subject|5|||
94709290|NCT04956575|324393991|FG007|Overall Study|Withdrawal by Subject|1|||
94709291|NCT04956575|324393992|FG008|Overall Study|Withdrawal by Subject|1|||
94709292|NCT04956575|324393993|FG009|Overall Study|Withdrawal by Subject|0|||
94709293|NCT04956575|324393994|FG010|Overall Study|Withdrawal by Subject|3|||
94709294|NCT04956575|324393995|FG011|Overall Study|Withdrawal by Subject|1|||
94709295|NCT02057692|324394001|FG000|Overall Study|Adverse Event|1|||
94709296|NCT02057692|324394002|FG001|Overall Study|Adverse Event|0|||
94709297|NCT02057692|324394003|FG002|Overall Study|Adverse Event|0|||
94709298|NCT02057692|324394004|FG003|Overall Study|Adverse Event|0|||
94709299|NCT02057692|324394001|FG000|Overall Study|Lost to Follow-up|0|||
94709300|NCT02057692|324394002|FG001|Overall Study|Lost to Follow-up|0|||
94709301|NCT02057692|324394003|FG002|Overall Study|Lost to Follow-up|0|||
94709302|NCT02057692|324394004|FG003|Overall Study|Lost to Follow-up|1|||
94709303|NCT00854906|324394005|FG000|Overall Study|One person had no ocular history|1|||
94709304|NCT03959241|324394017|FG000|Overall Study|Withdrawal by Subject|7|||
94709305|NCT03959241|324394018|FG001|Overall Study|Withdrawal by Subject|8|||
94709306|NCT03959241|324394017|FG000|Overall Study|Lost to Follow-up|1|||
94709307|NCT03959241|324394018|FG001|Overall Study|Lost to Follow-up|0|||
94709308|NCT03959241|324394017|FG000|Overall Study|Move to Hospice Care|1|||
94709309|NCT03959241|324394018|FG001|Overall Study|Move to Hospice Care|0|||
94709310|NCT03959241|324394017|FG000|Overall Study|Screen Failure|1|||
94709311|NCT03959241|324394018|FG001|Overall Study|Screen Failure|0|||
94709312|NCT03959241|324394017|FG000|Overall Study|Disease Relapse|0|||
94709313|NCT03959241|324394018|FG001|Overall Study|Disease Relapse|1|||
94709314|NCT03959241|324394017|FG000|Overall Study|Off Study|1|||
94709315|NCT03959241|324394018|FG001|Overall Study|Off Study|0|||
94709316|NCT00831415|324394023|FG000|Overall Study|Adverse Event|14|||
94709317|NCT00831415|324394023|FG000|Overall Study|Failed to return|3|||
94709318|NCT00831415|324394023|FG000|Overall Study|Physician Decision|6|||
94709319|NCT00831415|324394023|FG000|Overall Study|Lost to Follow-up|9|||
94709320|NCT00831415|324394023|FG000|Overall Study|Protocol Violation|3|||
94709321|NCT00831415|324394023|FG000|Overall Study|Withdrawal by Subject|35|||
94709322|NCT00831415|324394023|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
94709323|NCT00831415|324394023|FG000|Overall Study|Death|1|||
94709324|NCT03804918|324394024|FG000|Overall Study|Participant did not use the app|1|||
94709325|NCT03034915|324394027|FG000|Overall Study|Adverse Event|29|||
94709326|NCT03034915|324394028|FG001|Overall Study|Adverse Event|32|||
94709327|NCT03034915|324394029|FG002|Overall Study|Adverse Event|22|||
94709328|NCT03034915|324394027|FG000|Overall Study|Lost to Follow-up|5|||
94709329|NCT03034915|324394028|FG001|Overall Study|Lost to Follow-up|13|||
94709330|NCT03034915|324394029|FG002|Overall Study|Lost to Follow-up|3|||
94709331|NCT03034915|324394027|FG000|Overall Study|Withdrawal by Subject|29|||
94709332|NCT03034915|324394028|FG001|Overall Study|Withdrawal by Subject|46|||
94709333|NCT03034915|324394029|FG002|Overall Study|Withdrawal by Subject|41|||
94709334|NCT03034915|324394027|FG000|Overall Study|Protocol Deviation|2|||
94709335|NCT03034915|324394028|FG001|Overall Study|Protocol Deviation|14|||
94709336|NCT03034915|324394029|FG002|Overall Study|Protocol Deviation|7|||
94709337|NCT03034915|324394027|FG000|Overall Study|Lack of Efficacy|8|||
94709338|NCT03034915|324394028|FG001|Overall Study|Lack of Efficacy|16|||
94709339|NCT03034915|324394029|FG002|Overall Study|Lack of Efficacy|18|||
94709340|NCT03034915|324394027|FG000|Overall Study|Site closed|2|||
94709341|NCT03034915|324394028|FG001|Overall Study|Site closed|2|||
94709342|NCT03034915|324394029|FG002|Overall Study|Site closed|4|||
94709343|NCT03034915|324394027|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
94709344|NCT03034915|324394028|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
94709345|NCT03034915|324394029|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
94709346|NCT03034915|324394027|FG000|Overall Study|Physician Decision|1|||
94709347|NCT03034915|324394028|FG001|Overall Study|Physician Decision|5|||
94709348|NCT03034915|324394029|FG002|Overall Study|Physician Decision|2|||
94709349|NCT03861767|324394032|FG000|Overall Study|Withdrawal by Subject|2|||
94709350|NCT03861767|324394033|FG001|Overall Study|Withdrawal by Subject|1|||
94709351|NCT03861767|324394034|FG002|Overall Study|Withdrawal by Subject|0|||
94709352|NCT03861767|324394035|FG003|Overall Study|Withdrawal by Subject|5|||
94709353|NCT03861767|324394036|FG004|Overall Study|Withdrawal by Subject|2|||
94709354|NCT03861767|324394037|FG005|Overall Study|Withdrawal by Subject|1|||
94709355|NCT03861767|324394038|FG006|Overall Study|Withdrawal by Subject|3|||
94709356|NCT03861767|324394039|FG007|Overall Study|Withdrawal by Subject|1|||
94709357|NCT03861767|324394040|FG008|Overall Study|Withdrawal by Subject|0|||
94709358|NCT03861767|324394041|FG009|Overall Study|Withdrawal by Subject|5|||
94709359|NCT00813904|324394042|FG000|Overall Study|Death|1|||
94709360|NCT00346333|324394043|FG000|Overall Study|Death|1|||
94709361|NCT00346333|324394044|FG001|Overall Study|Death|0|||
94709362|NCT00346333|324394043|FG000|Overall Study|unwilling or unable to continue|4|||
94709363|NCT00346333|324394044|FG001|Overall Study|unwilling or unable to continue|8|||
94709364|NCT02506257|324394045|FG000|Overall Study|Adverse Event|0|||
94709365|NCT02506257|324394046|FG001|Overall Study|Adverse Event|2|||
94709366|NCT02506257|324394047|FG002|Overall Study|Adverse Event|3|||
94709367|NCT02506257|324394048|FG003|Overall Study|Adverse Event|0|||
94709368|NCT02506257|324394045|FG000|Overall Study|Protocol Violation|0|||
94709369|NCT02506257|324394046|FG001|Overall Study|Protocol Violation|0|||
94709370|NCT02506257|324394047|FG002|Overall Study|Protocol Violation|1|||
94709371|NCT02506257|324394048|FG003|Overall Study|Protocol Violation|0|||
94709372|NCT03460756|324394052|FG000|Overall Study|Adverse Event|0|||
94709373|NCT03460756|324394053|FG001|Overall Study|Adverse Event|0|||
94709374|NCT03460756|324394054|FG002|Overall Study|Adverse Event|0|||
94709375|NCT03460756|324394055|FG003|Overall Study|Adverse Event|1|||
94709376|NCT03460756|324394052|FG000|Overall Study|Lack of Efficacy|0|||
94709377|NCT03460756|324394053|FG001|Overall Study|Lack of Efficacy|0|||
94709378|NCT03460756|324394054|FG002|Overall Study|Lack of Efficacy|0|||
94709379|NCT03460756|324394055|FG003|Overall Study|Lack of Efficacy|2|||
94709380|NCT03460756|324394052|FG000|Overall Study|Lost to Follow-up|0|||
94709381|NCT03460756|324394053|FG001|Overall Study|Lost to Follow-up|1|||
94652766|NCT00622635|324186183|FG002|Treatment Period 3|Withdrawal by Subject|0|||
94652767|NCT00622635|324186184|FG003|Treatment Period 3|Withdrawal by Subject|1|||
94652768|NCT00622635|324186185|FG004|Treatment Period 3|Withdrawal by Subject|0|||
94652769|NCT00622635|324186186|FG005|Treatment Period 3|Withdrawal by Subject|0|||
94652770|NCT02138214|324186189|FG000|Overall Study|Withdrawal by Subject|0|||
94652771|NCT02138214|324186190|FG001|Overall Study|Withdrawal by Subject|1|||
94652772|NCT02138214|324186191|FG002|Overall Study|Withdrawal by Subject|0|||
94652773|NCT02138214|324186189|FG000|Overall Study|Lost to Follow-up|0|||
94652774|NCT02138214|324186190|FG001|Overall Study|Lost to Follow-up|2|||
94652775|NCT02138214|324186191|FG002|Overall Study|Lost to Follow-up|4|||
94652776|NCT02138214|324186189|FG000|Overall Study|Screen Failure|0|||
94652777|NCT02138214|324186190|FG001|Overall Study|Screen Failure|1|||
94652778|NCT02138214|324186191|FG002|Overall Study|Screen Failure|0|||
94652779|NCT01706250|324186194|FG000|Overall Study|Lost to Follow-up|2|||
94652780|NCT01858194|324186199|FG000|Overall Study|Total Artificial Heart Implant|0|||
94652781|NCT01858194|324186200|FG001|Overall Study|Total Artificial Heart Implant|1|||
94652782|NCT01858194|324186199|FG000|Overall Study|Lost to Follow-up|0|||
94652783|NCT01858194|324186200|FG001|Overall Study|Lost to Follow-up|1|||
94652784|NCT03062891|324186212|FG000|Overall Study|Withdrawal by Subject|2|||
94652785|NCT03062891|324186213|FG001|Overall Study|Withdrawal by Subject|0|||
94652786|NCT03062891|324186212|FG000|Overall Study|Lost to Follow-up|50|||
94652787|NCT03062891|324186213|FG001|Overall Study|Lost to Follow-up|38|||
94652788|NCT02127307|324186214|FG000|Overall Study|Protocol Violation|36|||
94652789|NCT02127307|324186214|FG000|Overall Study|Lost to Follow-up|2|||
94652790|NCT02127307|324186214|FG000|Overall Study|Death|101|||
94652791|NCT02127307|324186214|FG000|Overall Study|Other than specified above|169|||
94652792|NCT01079234|324186215|FG000|Main: Week 0 to 26|Adverse Event|5|||
94652793|NCT01079234|324186216|FG001|Main: Week 0 to 26|Adverse Event|4|||
94652794|NCT01079234|324186217|FG002|Main: Week 0 to 26|Adverse Event|1|||
94652795|NCT01079234|324186218|FG003|Main: Week 0 to 26|Adverse Event|0|||
94652796|NCT01079234|324186215|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
94652797|NCT01079234|324186216|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
94652798|NCT01079234|324186217|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
94652799|NCT01079234|324186218|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
94652800|NCT01079234|324186215|FG000|Main: Week 0 to 26|Protocol Violation|6|||
94652801|NCT01079234|324186216|FG001|Main: Week 0 to 26|Protocol Violation|2|||
94652802|NCT01079234|324186217|FG002|Main: Week 0 to 26|Protocol Violation|4|||
94652803|NCT01079234|324186218|FG003|Main: Week 0 to 26|Protocol Violation|0|||
94652804|NCT01079234|324186215|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
94652805|NCT01079234|324186216|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
94652806|NCT01079234|324186217|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
94652807|NCT01079234|324186218|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
94652808|NCT01079234|324186215|FG000|Main: Week 0 to 26|Unclassified|7|||
94652809|NCT01079234|324186216|FG001|Main: Week 0 to 26|Unclassified|13|||
94652810|NCT01079234|324186217|FG002|Main: Week 0 to 26|Unclassified|4|||
94652811|NCT01079234|324186218|FG003|Main: Week 0 to 26|Unclassified|0|||
94652812|NCT01079234|324186215|FG000|Extension: Week 27 to 52|Adverse Event|0|||
94652813|NCT01079234|324186216|FG001|Extension: Week 27 to 52|Adverse Event|0|||
94652814|NCT01079234|324186217|FG002|Extension: Week 27 to 52|Adverse Event|1|||
94652815|NCT01079234|324186218|FG003|Extension: Week 27 to 52|Adverse Event|0|||
94652816|NCT01079234|324186215|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
94652817|NCT01079234|324186216|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
94652818|NCT01079234|324186217|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
94652819|NCT01079234|324186218|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
94652820|NCT01079234|324186215|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
94652821|NCT01079234|324186216|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
94652822|NCT01079234|324186217|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
94652823|NCT01079234|324186218|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
94652824|NCT01079234|324186215|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
94652825|NCT01079234|324186216|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
94652826|NCT01079234|324186217|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
94652827|NCT01079234|324186218|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
94652828|NCT01079234|324186215|FG000|Extension: Week 27 to 52|Unclassified|0|||
94652829|NCT01079234|324186216|FG001|Extension: Week 27 to 52|Unclassified|0|||
94652830|NCT01079234|324186217|FG002|Extension: Week 27 to 52|Unclassified|4|||
94652831|NCT01079234|324186218|FG003|Extension: Week 27 to 52|Unclassified|7|||
94652832|NCT00101101|324186220|FG000|Overall Study|never received vaccine|20|||
94652833|NCT01603875|324186223|FG000|Overall Study|Preexisting rabies antibody|3|||
94709382|NCT03460756|324394054|FG002|Overall Study|Lost to Follow-up|2|||
94709383|NCT03460756|324394055|FG003|Overall Study|Lost to Follow-up|1|||
94709384|NCT03460756|324394052|FG000|Overall Study|Pregnancy|0|||
94709385|NCT03460756|324394053|FG001|Overall Study|Pregnancy|0|||
94709386|NCT03460756|324394054|FG002|Overall Study|Pregnancy|0|||
94709387|NCT03460756|324394055|FG003|Overall Study|Pregnancy|1|||
94709388|NCT03460756|324394052|FG000|Overall Study|Protocol Violation|0|||
94709389|NCT03460756|324394053|FG001|Overall Study|Protocol Violation|0|||
94709390|NCT03460756|324394054|FG002|Overall Study|Protocol Violation|0|||
94709391|NCT03460756|324394055|FG003|Overall Study|Protocol Violation|1|||
94709392|NCT03460756|324394052|FG000|Overall Study|Withdrawal by Subject|0|||
94709393|NCT03460756|324394053|FG001|Overall Study|Withdrawal by Subject|4|||
94709394|NCT03460756|324394054|FG002|Overall Study|Withdrawal by Subject|7|||
94709395|NCT03460756|324394055|FG003|Overall Study|Withdrawal by Subject|3|||
94709396|NCT03192046|324394058|FG000|Overall Study|Withdrawal by Subject|1|||
94709397|NCT03192046|324394059|FG001|Overall Study|Withdrawal by Subject|1|||
94709398|NCT02314117|324394060|FG000|Overall Study|Lost to Follow-up|9|||
94709399|NCT02314117|324394061|FG001|Overall Study|Lost to Follow-up|14|||
94709400|NCT02314117|324394060|FG000|Overall Study|Withdrawal by Subject|3|||
94709401|NCT02314117|324394061|FG001|Overall Study|Withdrawal by Subject|2|||
94709402|NCT01391130|324394062|FG000|Overall Study|Withdrawal by Subject|3|||
94709403|NCT01391130|324394063|FG001|Overall Study|Withdrawal by Subject|2|||
94709404|NCT01391130|324394062|FG000|Overall Study|Physician Decision|2|||
94709405|NCT01391130|324394063|FG001|Overall Study|Physician Decision|3|||
94709406|NCT01391130|324394062|FG000|Overall Study|Did not Receive Drug|1|||
94709407|NCT01391130|324394063|FG001|Overall Study|Did not Receive Drug|1|||
94709408|NCT03257813|324394064|FG000|Overall Study|Protocol Violation|6|||
94709409|NCT03257813|324394065|FG001|Overall Study|Protocol Violation|3|||
94709410|NCT00666276|324394076|FG000|Overall Study|Protocol Violation|34|||
94709411|NCT03520413|324394077|FG000|Overall Study|Lost to Follow-up|1|||
94709412|NCT03520413|324394078|FG001|Overall Study|Lost to Follow-up|1|||
94709413|NCT03520413|324394077|FG000|Overall Study|Withdrawal by Subject|1|||
94709414|NCT03520413|324394078|FG001|Overall Study|Withdrawal by Subject|2|||
94709415|NCT03520413|324394077|FG000|Overall Study|Death|0|||
94709416|NCT03520413|324394078|FG001|Overall Study|Death|1|||
94709417|NCT03520413|324394077|FG000|Overall Study|Physician Decision|3|||
94709418|NCT03520413|324394078|FG001|Overall Study|Physician Decision|3|||
94267540|NCT00646906|322774857|FG003|Crossover Period 1|Withdrawal by Subject|0|||
94267541|NCT00646906|322774858|FG004|Crossover Period 1|Withdrawal by Subject|0|||
94709419|NCT03520413|324394077|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
94709420|NCT03520413|324394078|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
94709421|NCT04054635|324394081|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
94709422|NCT04054635|324394082|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
94709423|NCT04054635|324394083|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
94709424|NCT04054635|324394081|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
94709425|NCT04054635|324394082|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
94709426|NCT04054635|324394083|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
94709427|NCT00891930|324394085|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
94709428|NCT00891930|324394085|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
94709429|NCT00891930|324394085|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
94709430|NCT00891930|324394085|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
94709431|NCT00891930|324394085|FG000|Part 2 Panitumumab + AMG479|Death|30|||
94709432|NCT02537522|324394086|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
94709433|NCT02537522|324394087|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
94709434|NCT02537522|324394088|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
94709435|NCT02537522|324394089|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
94709436|NCT02537522|324394086|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
94709437|NCT02537522|324394087|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
94709438|NCT02537522|324394088|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
94709439|NCT02537522|324394089|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
94709440|NCT02537522|324394086|FG000|Phase I - Contralateral|incorrect randomization|0|||
94267542|NCT00646906|322774859|FG005|Crossover Period 1|Withdrawal by Subject|1|||
94267543|NCT00646906|322774860|FG006|Crossover Period 1|Withdrawal by Subject|0|||
94709441|NCT02537522|324394087|FG001|Phase I - Contralateral|incorrect randomization|1|||
94709442|NCT02537522|324394088|FG002|Phase I - Contralateral|incorrect randomization|0|||
94709443|NCT02537522|324394089|FG003|Phase I - Contralateral|incorrect randomization|0|||
94709444|NCT02537522|324394086|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
94709445|NCT02537522|324394087|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
94709446|NCT02537522|324394088|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
94709447|NCT02537522|324394089|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
94709448|NCT02537522|324394086|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
94267544|NCT00646906|322774854|FG000|Crossover Period 2|Withdrawal by Subject|0|||
94709449|NCT02537522|324394087|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
94709450|NCT02537522|324394088|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
94267545|NCT00646906|322774855|FG001|Crossover Period 2|Withdrawal by Subject|1|||
94267546|NCT00646906|322774856|FG002|Crossover Period 2|Withdrawal by Subject|2|||
94267547|NCT00646906|322774857|FG003|Crossover Period 2|Withdrawal by Subject|1|||
94267548|NCT00646906|322774858|FG004|Crossover Period 2|Withdrawal by Subject|0|||
94267549|NCT00646906|322774859|FG005|Crossover Period 2|Withdrawal by Subject|0|||
94267550|NCT00646906|322774860|FG006|Crossover Period 2|Withdrawal by Subject|0|||
94267551|NCT00646906|322774854|FG000|Crossover Period 2|Physician Decision|0|||
94267552|NCT00646906|322774855|FG001|Crossover Period 2|Physician Decision|0|||
94267553|NCT00646906|322774856|FG002|Crossover Period 2|Physician Decision|0|||
94267554|NCT00646906|322774857|FG003|Crossover Period 2|Physician Decision|0|||
94267555|NCT00646906|322774858|FG004|Crossover Period 2|Physician Decision|0|||
94267556|NCT00646906|322774859|FG005|Crossover Period 2|Physician Decision|0|||
94267557|NCT00646906|322774860|FG006|Crossover Period 2|Physician Decision|1|||
94267558|NCT04422990|322774866|FG000|Overall Study|Withdrawal by Subject|0|||
94267559|NCT04422990|322774867|FG001|Overall Study|Withdrawal by Subject|1|||
94267560|NCT04422990|322774866|FG000|Overall Study|Travel|3|||
94267561|NCT04422990|322774867|FG001|Overall Study|Travel|0|||
94267562|NCT01490814|322774874|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
94267563|NCT01490814|322774875|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
94267564|NCT01490814|322774874|FG000|Overall Study|Physician Decision|1|||
94267565|NCT01490814|322774875|FG001|Overall Study|Physician Decision|0|||
94267566|NCT01490814|322774874|FG000|Overall Study|Withdrawal by Subject|0|||
94267567|NCT01490814|322774875|FG001|Overall Study|Withdrawal by Subject|5|||
94267568|NCT00935272|322774887|FG000|Overall Study|Lost to Follow-up|10|||
94267569|NCT00935272|322774888|FG001|Overall Study|Lost to Follow-up|3|||
94267570|NCT00935272|322774887|FG000|Overall Study|Withdrawal by Subject|8|||
94267571|NCT00935272|322774888|FG001|Overall Study|Withdrawal by Subject|2|||
94267572|NCT00935272|322774887|FG000|Overall Study|Physician Decision|1|||
94267573|NCT00935272|322774888|FG001|Overall Study|Physician Decision|0|||
94267574|NCT00935272|322774887|FG000|Overall Study|Protocol Violation|0|||
94267575|NCT00935272|322774888|FG001|Overall Study|Protocol Violation|1|||
94267576|NCT00736034|322774889|FG000|Overall Study|Adverse Event|2|||
94267577|NCT02289352|322774890|FG000|Overall Study|Withdrawal by Subject|1|||
94267578|NCT02289352|322774891|FG001|Overall Study|Withdrawal by Subject|1|||
94267579|NCT02289352|322774892|FG002|Overall Study|Withdrawal by Subject|0|||
94267580|NCT01022502|322774896|FG000|Overall Study|Adverse Event|1|||
94267581|NCT01022502|322774896|FG000|Overall Study|employment related reasons|1|||
94267582|NCT01022502|322774896|FG000|Overall Study|Withdrawal by Subject|1|||
94267583|NCT03716050|322774897|FG000|Overall Study|Lost to Follow-up|0|||
94267584|NCT03716050|322774898|FG001|Overall Study|Lost to Follow-up|0|||
94267585|NCT03716050|322774899|FG002|Overall Study|Lost to Follow-up|1|||
94267586|NCT03716050|322774900|FG003|Overall Study|Lost to Follow-up|0|||
94267587|NCT03716050|322774901|FG004|Overall Study|Lost to Follow-up|0|||
94267588|NCT03716050|322774902|FG005|Overall Study|Lost to Follow-up|0|||
94267589|NCT03716050|322774903|FG006|Overall Study|Lost to Follow-up|0|||
94267590|NCT03716050|322774904|FG007|Overall Study|Lost to Follow-up|0|||
94267591|NCT03716050|322774897|FG000|Overall Study|Physician Decision|0|||
94267592|NCT03716050|322774898|FG001|Overall Study|Physician Decision|0|||
94267593|NCT03716050|322774899|FG002|Overall Study|Physician Decision|0|||
94267594|NCT03716050|322774900|FG003|Overall Study|Physician Decision|1|||
94267595|NCT03716050|322774901|FG004|Overall Study|Physician Decision|0|||
94267596|NCT03716050|322774902|FG005|Overall Study|Physician Decision|0|||
94267597|NCT03716050|322774903|FG006|Overall Study|Physician Decision|0|||
94267598|NCT03716050|322774904|FG007|Overall Study|Physician Decision|0|||
94267599|NCT03716050|322774897|FG000|Overall Study|Protocol Violation|0|||
94267600|NCT03716050|322774898|FG001|Overall Study|Protocol Violation|0|||
94267601|NCT03716050|322774899|FG002|Overall Study|Protocol Violation|0|||
94652834|NCT01603875|324186224|FG001|Overall Study|Preexisting rabies antibody|4|||
94652835|NCT01603875|324186225|FG002|Overall Study|Preexisting rabies antibody|3|||
94652836|NCT01603875|324186223|FG000|Overall Study|Lost to Follow-up|4|||
94652837|NCT01603875|324186224|FG001|Overall Study|Lost to Follow-up|3|||
94652838|NCT01603875|324186225|FG002|Overall Study|Lost to Follow-up|6|||
94652839|NCT01603875|324186223|FG000|Overall Study|Protocol Violation|0|||
94652840|NCT01603875|324186224|FG001|Overall Study|Protocol Violation|1|||
94652841|NCT01603875|324186225|FG002|Overall Study|Protocol Violation|0|||
94652842|NCT01071512|324186226|FG000|Overall Study|Adverse Event|1|||
94652843|NCT01071512|324186226|FG000|Overall Study|Development of antibodies to drug|2|||
94652844|NCT01071512|324186226|FG000|Overall Study|positive anti-JC virus antibody test|2|||
94652845|NCT01720069|324186233|FG000|Overall Study|Could not use e-diary correctly|0|||
94652846|NCT01720069|324186234|FG001|Overall Study|Could not use e-diary correctly|1|||
94652847|NCT01720069|324186235|FG002|Overall Study|Could not use e-diary correctly|1|||
94652848|NCT01720069|324186233|FG000|Overall Study|Randomised without baseline values|0|||
94652849|NCT01720069|324186234|FG001|Overall Study|Randomised without baseline values|0|||
94652850|NCT01720069|324186235|FG002|Overall Study|Randomised without baseline values|1|||
94652851|NCT01720069|324186233|FG000|Overall Study|Adverse Event|0|||
94652852|NCT01720069|324186234|FG001|Overall Study|Adverse Event|0|||
94267602|NCT03716050|322774900|FG003|Overall Study|Protocol Violation|1|||
94267603|NCT03716050|322774901|FG004|Overall Study|Protocol Violation|0|||
94267604|NCT03716050|322774902|FG005|Overall Study|Protocol Violation|0|||
94267605|NCT03716050|322774903|FG006|Overall Study|Protocol Violation|0|||
94267606|NCT03716050|322774904|FG007|Overall Study|Protocol Violation|2|||
94267607|NCT02361944|322774905|FG000|Overall Study|surgery cancellation|0|||
94267608|NCT02361944|322774906|FG001|Overall Study|surgery cancellation|1|||
94267609|NCT02566577|322774908|FG000|Overall Study|Withdrawal by Subject|1|||
94267610|NCT02566577|322774909|FG001|Overall Study|Withdrawal by Subject|1|||
94267611|NCT02566577|322774908|FG000|Overall Study|Equipment failure|1|||
94267612|NCT02566577|322774909|FG001|Overall Study|Equipment failure|1|||
94267613|NCT02566577|322774908|FG000|Overall Study|Physical limitation|1|||
94267614|NCT02566577|322774909|FG001|Overall Study|Physical limitation|0|||
94267615|NCT04513665|322774910|FG000|Overall Study|Adverse Event|2|||
94267616|NCT04513665|322774911|FG001|Overall Study|Adverse Event|0|||
94267617|NCT04513665|322774910|FG000|Overall Study|Lack of Efficacy|14|||
94267618|NCT04513665|322774911|FG001|Overall Study|Lack of Efficacy|0|||
94267619|NCT04233164|322774912|FG000|Overall Study|Unable to obtain specimen|0|||
94267620|NCT04233164|322774913|FG001|Overall Study|Unable to obtain specimen|1|||
94267621|NCT03654976|322774918|FG000|Overall Study|Withdrawal by Subject|12|||
94267622|NCT03654976|322774919|FG001|Overall Study|Withdrawal by Subject|11|||
94267623|NCT03654976|322774918|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
94267624|NCT03654976|322774919|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
94267625|NCT03654976|322774918|FG000|Overall Study|Adverse Event|5|||
94267626|NCT03654976|322774919|FG001|Overall Study|Adverse Event|0|||
94267627|NCT03654976|322774918|FG000|Overall Study|Lost to Follow-up|2|||
94267628|NCT03654976|322774919|FG001|Overall Study|Lost to Follow-up|0|||
94267629|NCT03654976|322774918|FG000|Overall Study|Lack of Efficacy|0|||
94267630|NCT03654976|322774919|FG001|Overall Study|Lack of Efficacy|1|||
94267631|NCT02101021|322774920|FG000|Overall Study|Death|4|||
94267632|NCT02101021|322774921|FG001|Overall Study|Death|3|||
94267633|NCT02101021|322774922|FG002|Overall Study|Death|6|||
94267634|NCT02101021|322774923|FG003|Overall Study|Death|0|||
94267635|NCT02101021|322774924|FG004|Overall Study|Death|3|||
94267636|NCT02101021|322774920|FG000|Overall Study|Withdrew Consent from study|1|||
94267637|NCT02101021|322774921|FG001|Overall Study|Withdrew Consent from study|1|||
94267638|NCT02101021|322774922|FG002|Overall Study|Withdrew Consent from study|0|||
94267639|NCT02101021|322774923|FG003|Overall Study|Withdrew Consent from study|2|||
94267640|NCT02101021|322774924|FG004|Overall Study|Withdrew Consent from study|0|||
94267641|NCT02101021|322774920|FG000|Overall Study|Lost to Follow-up|1|||
94267642|NCT02101021|322774921|FG001|Overall Study|Lost to Follow-up|0|||
94267643|NCT02101021|322774922|FG002|Overall Study|Lost to Follow-up|0|||
94267644|NCT02101021|322774923|FG003|Overall Study|Lost to Follow-up|0|||
94267645|NCT02101021|322774924|FG004|Overall Study|Lost to Follow-up|0|||
94267646|NCT02101021|322774920|FG000|Overall Study|Study Terminated by Sponsor|1|||
94267647|NCT02101021|322774921|FG001|Overall Study|Study Terminated by Sponsor|0|||
94267648|NCT02101021|322774922|FG002|Overall Study|Study Terminated by Sponsor|1|||
94267649|NCT02101021|322774923|FG003|Overall Study|Study Terminated by Sponsor|1|||
94267650|NCT02101021|322774924|FG004|Overall Study|Study Terminated by Sponsor|1|||
94267651|NCT00955279|322774925|FG000|Overall Study|Other|0|||
94267652|NCT00955279|322774926|FG001|Overall Study|Other|0|||
94267653|NCT00955279|322774927|FG002|Overall Study|Other|3|||
94267654|NCT00955279|322774925|FG000|Overall Study|Death|1|||
94267655|NCT00955279|322774926|FG001|Overall Study|Death|1|||
94267656|NCT00955279|322774927|FG002|Overall Study|Death|1|||
94267657|NCT00955279|322774925|FG000|Overall Study|Lost to Follow-up|0|||
94267658|NCT00955279|322774926|FG001|Overall Study|Lost to Follow-up|3|||
94267659|NCT00955279|322774927|FG002|Overall Study|Lost to Follow-up|1|||
94267660|NCT00955279|322774925|FG000|Overall Study|Withdrawal by Subject|2|||
94267661|NCT00955279|322774926|FG001|Overall Study|Withdrawal by Subject|0|||
94267662|NCT00955279|322774927|FG002|Overall Study|Withdrawal by Subject|3|||
94267663|NCT02632721|322774930|FG000|Overall Study|Adverse Event|0|||
94267664|NCT02632721|322774931|FG001|Overall Study|Adverse Event|0|||
94267665|NCT02632721|322774932|FG002|Overall Study|Adverse Event|2|||
94267666|NCT02632721|322774933|FG003|Overall Study|Adverse Event|5|||
94267667|NCT02632721|322774934|FG004|Overall Study|Adverse Event|3|||
94267668|NCT02632721|322774930|FG000|Overall Study|Dose limiting toxicity|0|||
94267669|NCT02632721|322774931|FG001|Overall Study|Dose limiting toxicity|0|||
94267670|NCT02632721|322774932|FG002|Overall Study|Dose limiting toxicity|0|||
94267671|NCT02632721|322774933|FG003|Overall Study|Dose limiting toxicity|1|||
94267672|NCT02632721|322774934|FG004|Overall Study|Dose limiting toxicity|0|||
94366743|NCT01556490|323128177|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
94652853|NCT01720069|324186235|FG002|Overall Study|Adverse Event|1|||
94267673|NCT02632721|322774930|FG000|Overall Study|Progressive disease|3|||
94267674|NCT02632721|322774931|FG001|Overall Study|Progressive disease|0|||
94267675|NCT02632721|322774932|FG002|Overall Study|Progressive disease|4|||
94267676|NCT02632721|322774933|FG003|Overall Study|Progressive disease|6|||
94267677|NCT02632721|322774934|FG004|Overall Study|Progressive disease|5|||
94267678|NCT02632721|322774930|FG000|Overall Study|Refused to continue taking trial medication|0|||
94267679|NCT02632721|322774931|FG001|Overall Study|Refused to continue taking trial medication|1|||
94267680|NCT02632721|322774932|FG002|Overall Study|Refused to continue taking trial medication|1|||
94267681|NCT02632721|322774933|FG003|Overall Study|Refused to continue taking trial medication|1|||
94267682|NCT02632721|322774934|FG004|Overall Study|Refused to continue taking trial medication|2|||
94267683|NCT02632721|322774930|FG000|Overall Study|Inadequate clinical condition|0|||
94267684|NCT02632721|322774931|FG001|Overall Study|Inadequate clinical condition|0|||
94267685|NCT02632721|322774932|FG002|Overall Study|Inadequate clinical condition|0|||
94267686|NCT02632721|322774933|FG003|Overall Study|Inadequate clinical condition|0|||
94267687|NCT02632721|322774934|FG004|Overall Study|Inadequate clinical condition|1|||
94267688|NCT02632721|322774930|FG000|Overall Study|No meet eligibility|0|||
94267689|NCT02632721|322774931|FG001|Overall Study|No meet eligibility|0|||
94267690|NCT02632721|322774932|FG002|Overall Study|No meet eligibility|0|||
94267691|NCT02632721|322774933|FG003|Overall Study|No meet eligibility|0|||
94267692|NCT02632721|322774934|FG004|Overall Study|No meet eligibility|1|||
94267693|NCT02632721|322774930|FG000|Overall Study|Allergic reaction|0|||
94267694|NCT02632721|322774931|FG001|Overall Study|Allergic reaction|0|||
94267695|NCT02632721|322774932|FG002|Overall Study|Allergic reaction|0|||
94267696|NCT02632721|322774933|FG003|Overall Study|Allergic reaction|1|||
94267697|NCT02632721|322774934|FG004|Overall Study|Allergic reaction|0|||
94267698|NCT02632721|322774930|FG000|Overall Study|Receiving Decitabine locally|0|||
94709451|NCT02537522|324394089|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
94709452|NCT02423291|324394090|FG000|Overall Study|Lack of Efficacy|14|||
94709453|NCT02423291|324394090|FG000|Overall Study|Adverse Event|1|||
94709454|NCT01430611|324394092|FG000|Overall Study|Adverse Event|0|||
94709455|NCT01430611|324394093|FG001|Overall Study|Adverse Event|1|||
94709456|NCT01430611|324394092|FG000|Overall Study|Protocol Violation|1|||
94709457|NCT01430611|324394093|FG001|Overall Study|Protocol Violation|0|||
94709458|NCT01430611|324394092|FG000|Overall Study|Lost to Follow-up|1|||
94709459|NCT01430611|324394093|FG001|Overall Study|Lost to Follow-up|0|||
94709460|NCT01430611|324394092|FG000|Overall Study|Withdrawal by Subject|15|||
94709461|NCT01430611|324394093|FG001|Overall Study|Withdrawal by Subject|14|||
94709462|NCT03194958|324394094|FG000|Overall Study|Death|0|||
94709463|NCT03194958|324394095|FG001|Overall Study|Death|1|||
94709464|NCT03194958|324394096|FG002|Overall Study|Death|1|||
94709465|NCT03194958|324394097|FG003|Overall Study|Death|1|||
94709466|NCT03194958|324394094|FG000|Overall Study|Withdrawal by Subject|24|||
94709467|NCT03194958|324394095|FG001|Overall Study|Withdrawal by Subject|27|||
94709468|NCT03194958|324394096|FG002|Overall Study|Withdrawal by Subject|7|||
94709469|NCT03194958|324394097|FG003|Overall Study|Withdrawal by Subject|22|||
94267699|NCT02632721|322774931|FG001|Overall Study|Receiving Decitabine locally|0|||
94267700|NCT02632721|322774932|FG002|Overall Study|Receiving Decitabine locally|1|||
94267701|NCT02632721|322774933|FG003|Overall Study|Receiving Decitabine locally|0|||
94267702|NCT02632721|322774934|FG004|Overall Study|Receiving Decitabine locally|0|||
94267703|NCT02632721|322774930|FG000|Overall Study|No benefit from study treatment|1|||
94267704|NCT02632721|322774931|FG001|Overall Study|No benefit from study treatment|1|||
94267705|NCT02632721|322774932|FG002|Overall Study|No benefit from study treatment|0|||
94267706|NCT02632721|322774933|FG003|Overall Study|No benefit from study treatment|0|||
94267707|NCT02632721|322774934|FG004|Overall Study|No benefit from study treatment|1|||
94267708|NCT02632721|322774930|FG000|Overall Study|Patient wish for other treatment|0|||
94267709|NCT02632721|322774931|FG001|Overall Study|Patient wish for other treatment|1|||
94267710|NCT02632721|322774932|FG002|Overall Study|Patient wish for other treatment|0|||
94267711|NCT02632721|322774933|FG003|Overall Study|Patient wish for other treatment|0|||
94267712|NCT02632721|322774934|FG004|Overall Study|Patient wish for other treatment|0|||
94267713|NCT02632721|322774930|FG000|Overall Study|Relapsed Pneumonia|0|||
94267714|NCT02632721|322774931|FG001|Overall Study|Relapsed Pneumonia|0|||
94267715|NCT02632721|322774932|FG002|Overall Study|Relapsed Pneumonia|0|||
94267716|NCT02632721|322774933|FG003|Overall Study|Relapsed Pneumonia|0|||
94267717|NCT02632721|322774934|FG004|Overall Study|Relapsed Pneumonia|1|||
94267718|NCT02632721|322774930|FG000|Overall Study|Therapy refractory AML|0|||
94267719|NCT02632721|322774931|FG001|Overall Study|Therapy refractory AML|0|||
94267720|NCT02632721|322774932|FG002|Overall Study|Therapy refractory AML|0|||
94267721|NCT02632721|322774933|FG003|Overall Study|Therapy refractory AML|0|||
94267722|NCT02632721|322774934|FG004|Overall Study|Therapy refractory AML|1|||
94709470|NCT03194958|324394094|FG000|Overall Study|Lost to Follow-up|168|||
94709471|NCT03194958|324394095|FG001|Overall Study|Lost to Follow-up|196|||
94267723|NCT02632721|322774930|FG000|Overall Study|Increase of white blood cell count|0|||
94267724|NCT02632721|322774931|FG001|Overall Study|Increase of white blood cell count|0|||
94267725|NCT02632721|322774932|FG002|Overall Study|Increase of white blood cell count|0|||
94267726|NCT02632721|322774933|FG003|Overall Study|Increase of white blood cell count|0|||
94709472|NCT03194958|324394096|FG002|Overall Study|Lost to Follow-up|174|||
94709473|NCT03194958|324394097|FG003|Overall Study|Lost to Follow-up|186|||
94267727|NCT02632721|322774934|FG004|Overall Study|Increase of white blood cell count|1|||
94267728|NCT02632721|322774930|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
94267729|NCT02632721|322774931|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
94709474|NCT02807493|324394100|FG000|Overall Study|Adverse Event|5|||
94709475|NCT02807493|324394101|FG001|Overall Study|Adverse Event|2|||
94709476|NCT02807493|324394100|FG000|Overall Study|Lost to Follow-up|6|||
94709477|NCT02807493|324394101|FG001|Overall Study|Lost to Follow-up|0|||
94709478|NCT02807493|324394100|FG000|Overall Study|Physician Decision|4|||
94709479|NCT02807493|324394101|FG001|Overall Study|Physician Decision|1|||
94709480|NCT02807493|324394100|FG000|Overall Study|Protocol Violation|7|||
94709481|NCT02807493|324394101|FG001|Overall Study|Protocol Violation|0|||
94709482|NCT02807493|324394100|FG000|Overall Study|Withdrawal by Subject|17|||
94709483|NCT02807493|324394101|FG001|Overall Study|Withdrawal by Subject|10|||
94709484|NCT02807493|324394100|FG000|Overall Study|Other withdrawal|17|||
94709485|NCT02807493|324394101|FG001|Overall Study|Other withdrawal|0|||
94709486|NCT02807493|324394100|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
94709487|NCT02807493|324394101|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
94709488|NCT05190419|324394102|FG000|Overall Study|Lack of Efficacy|8|||
94709489|NCT05190419|324394103|FG001|Overall Study|Lack of Efficacy|0|||
94709490|NCT05190419|324394104|FG002|Overall Study|Lack of Efficacy|1|||
94709491|NCT05190419|324394105|FG003|Overall Study|Lack of Efficacy|0|||
94709492|NCT05190419|324394102|FG000|Overall Study|Withdrawal by Subject|7|||
94709493|NCT05190419|324394103|FG001|Overall Study|Withdrawal by Subject|1|||
94709494|NCT05190419|324394104|FG002|Overall Study|Withdrawal by Subject|2|||
94709495|NCT05190419|324394105|FG003|Overall Study|Withdrawal by Subject|2|||
94709496|NCT05190419|324394102|FG000|Overall Study|Adverse Event|2|||
94709497|NCT05190419|324394103|FG001|Overall Study|Adverse Event|10|||
94709498|NCT05190419|324394104|FG002|Overall Study|Adverse Event|11|||
94267730|NCT02632721|322774932|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
94267731|NCT02632721|322774933|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
94267732|NCT02632721|322774934|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
94267733|NCT00544648|322774935|FG000|Overall Study|Withdrawal by Subject|1|||
94267734|NCT00544648|322774936|FG001|Overall Study|Withdrawal by Subject|0|||
94267735|NCT00544648|322774935|FG000|Overall Study|Adverse Event|1|||
94267736|NCT00544648|322774936|FG001|Overall Study|Adverse Event|1|||
94267737|NCT00544648|322774935|FG000|Overall Study|progression of disease|1|||
94267738|NCT00544648|322774936|FG001|Overall Study|progression of disease|0|||
94267739|NCT00074581|322774937|FG000|Overall Study|Death|15|||
94267740|NCT00074581|322774938|FG001|Overall Study|Death|16|||
94267741|NCT00074581|322774937|FG000|Overall Study|Withdrawal by Subject|50|||
94267742|NCT00074581|322774938|FG001|Overall Study|Withdrawal by Subject|49|||
94267743|NCT00074581|322774937|FG000|Overall Study|Unable to adhere to visit schedule|13|||
94267744|NCT00074581|322774938|FG001|Overall Study|Unable to adhere to visit schedule|14|||
94267745|NCT00074581|322774937|FG000|Overall Study|Relocated|14|||
94267746|NCT00074581|322774938|FG001|Overall Study|Relocated|9|||
94267747|NCT00074581|322774937|FG000|Overall Study|Were withdrawn by investigator|5|||
94267748|NCT00074581|322774938|FG001|Overall Study|Were withdrawn by investigator|2|||
94267749|NCT00074581|322774937|FG000|Overall Study|Lost to Follow-up|16|||
94267750|NCT00074581|322774938|FG001|Overall Study|Lost to Follow-up|11|||
94267751|NCT00074581|322774937|FG000|Overall Study|Ended relationship w. index participant|117|||
94267752|NCT00074581|322774938|FG001|Overall Study|Ended relationship w. index participant|106|||
94267753|NCT00074581|322774937|FG000|Overall Study|Other|14|||
94267754|NCT00074581|322774938|FG001|Overall Study|Other|19|||
94267755|NCT01202279|322774940|FG000|Overall Study|Adverse Event|8|||
94267756|NCT01202279|322774941|FG001|Overall Study|Adverse Event|6|||
94267757|NCT01202279|322774940|FG000|Overall Study|Withdrawal by Subject|13|||
94267758|NCT01202279|322774941|FG001|Overall Study|Withdrawal by Subject|10|||
94267759|NCT01202279|322774940|FG000|Overall Study|Physician Decision|0|||
94267760|NCT01202279|322774941|FG001|Overall Study|Physician Decision|1|||
94267761|NCT01202279|322774940|FG000|Overall Study|Lost to Follow-up|10|||
94267762|NCT01202279|322774941|FG001|Overall Study|Lost to Follow-up|7|||
94267763|NCT01202279|322774940|FG000|Overall Study|Protocol Violation|1|||
94267764|NCT01202279|322774941|FG001|Overall Study|Protocol Violation|1|||
94267765|NCT01202279|322774940|FG000|Overall Study|study compliance|5|||
94267766|NCT01202279|322774941|FG001|Overall Study|study compliance|2|||
94267767|NCT02546765|322774942|FG000|Overall Study|Withdrawal by Subject|0|||
94267768|NCT02546765|322774943|FG001|Overall Study|Withdrawal by Subject|1|||
94267769|NCT02546765|322774944|FG002|Overall Study|Withdrawal by Subject|0|||
94267770|NCT02546765|322774945|FG003|Overall Study|Withdrawal by Subject|0|||
94709499|NCT05190419|324394105|FG003|Overall Study|Adverse Event|21|||
94709500|NCT05190419|324394102|FG000|Overall Study|Lost to Follow-up|1|||
94267771|NCT00228566|322774946|FG000|Overall Study|Adverse Event|31|||
94267772|NCT00228566|322774946|FG000|Overall Study|Lack of Efficacy|14|||
94267773|NCT00228566|322774946|FG000|Overall Study|Lost to Follow-up|16|||
94267774|NCT00228566|322774946|FG000|Overall Study|Physician Decision|5|||
94267775|NCT00228566|322774946|FG000|Overall Study|Withdrawal by Subject|4|||
94267776|NCT00228566|322774946|FG000|Overall Study|Miscellaneous|1|||
94267777|NCT00290186|322774951|FG000|Overall Study|Adverse Event|1|||
94267778|NCT00290186|322774952|FG001|Overall Study|Adverse Event|1|||
94267779|NCT00290186|322774951|FG000|Overall Study|Lost to Follow-up|3|||
94267780|NCT00290186|322774952|FG001|Overall Study|Lost to Follow-up|2|||
94267781|NCT00290186|322774951|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
94709501|NCT05190419|324394103|FG001|Overall Study|Lost to Follow-up|2|||
94709502|NCT05190419|324394104|FG002|Overall Study|Lost to Follow-up|3|||
94709503|NCT05190419|324394105|FG003|Overall Study|Lost to Follow-up|1|||
94709504|NCT05190419|324394102|FG000|Overall Study|Other|1|||
94709505|NCT05190419|324394103|FG001|Overall Study|Other|1|||
94709506|NCT05190419|324394104|FG002|Overall Study|Other|0|||
94267782|NCT00290186|322774952|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
94267783|NCT00290186|322774951|FG000|Overall Study|Withdrawal by Subject|0|||
94267784|NCT00290186|322774952|FG001|Overall Study|Withdrawal by Subject|1|||
94267785|NCT01979835|322774953|FG000|Primary Outcome SA Measurment|failed insertion|18|||
94267786|NCT01979835|322774953|FG000|Follow-up|Lost to Follow-up|32|||
94267787|NCT02592018|322774954|FG000|Overall Study|Adverse Event|1|||
94267788|NCT02592018|322774954|FG000|Overall Study|Lost to Follow-up|1|||
94267789|NCT02113579|322776550|FG000|Overall Study|Adverse Event|1|||
94267790|NCT02113579|322776551|FG001|Overall Study|Adverse Event|0|||
94267791|NCT02113579|322776550|FG000|Overall Study|Withdrawal by Subject|3|||
94267792|NCT02113579|322776551|FG001|Overall Study|Withdrawal by Subject|2|||
94267793|NCT02113579|322776550|FG000|Overall Study|Lost to Follow-up|6|||
94267794|NCT02113579|322776551|FG001|Overall Study|Lost to Follow-up|2|||
94267795|NCT00574145|322776554|FG000|Overall Study|Withdrawal by Subject|2|||
94267796|NCT00574145|322776555|FG001|Overall Study|Withdrawal by Subject|1|||
94267797|NCT00382720|322776556|FG000|Overall Study|Adverse Event|21|||
94267798|NCT00382720|322776557|FG001|Overall Study|Adverse Event|23|||
94267799|NCT00382720|322776558|FG002|Overall Study|Adverse Event|15|||
94267800|NCT00382720|322776556|FG000|Overall Study|Protocol Violation|2|||
94267801|NCT00382720|322776557|FG001|Overall Study|Protocol Violation|5|||
94267802|NCT00382720|322776558|FG002|Overall Study|Protocol Violation|1|||
94267803|NCT00382720|322776556|FG000|Overall Study|Death|0|||
94267804|NCT00382720|322776557|FG001|Overall Study|Death|1|||
94267805|NCT00382720|322776558|FG002|Overall Study|Death|2|||
94267806|NCT00382720|322776556|FG000|Overall Study|Progressive disease|37|||
94267807|NCT00382720|322776557|FG001|Overall Study|Progressive disease|28|||
94267808|NCT00382720|322776558|FG002|Overall Study|Progressive disease|38|||
94267809|NCT00382720|322776556|FG000|Overall Study|Withdrew consent|1|||
94267810|NCT00382720|322776557|FG001|Overall Study|Withdrew consent|1|||
94267811|NCT00382720|322776558|FG002|Overall Study|Withdrew consent|2|||
94267812|NCT00382720|322776556|FG000|Overall Study|Withdrawal by Subject|11|||
94267813|NCT00382720|322776557|FG001|Overall Study|Withdrawal by Subject|20|||
94267814|NCT00382720|322776558|FG002|Overall Study|Withdrawal by Subject|12|||
94267815|NCT00382720|322776556|FG000|Overall Study|Surgery|1|||
94267816|NCT00382720|322776557|FG001|Overall Study|Surgery|1|||
94267817|NCT00382720|322776558|FG002|Overall Study|Surgery|4|||
94267818|NCT00382720|322776556|FG000|Overall Study|Patient did not receive study medication|1|||
94267819|NCT00382720|322776557|FG001|Overall Study|Patient did not receive study medication|1|||
94267820|NCT00382720|322776558|FG002|Overall Study|Patient did not receive study medication|4|||
94267821|NCT00382720|322776556|FG000|Overall Study|Clinically progressive disease|0|||
94267822|NCT00382720|322776557|FG001|Overall Study|Clinically progressive disease|1|||
94267823|NCT00382720|322776558|FG002|Overall Study|Clinically progressive disease|0|||
94267824|NCT00382720|322776556|FG000|Overall Study|Good prognosis|0|||
94709507|NCT05190419|324394105|FG003|Overall Study|Other|3|||
94709508|NCT04707313|324394106|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
94709509|NCT04707313|324394107|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
94709510|NCT04707313|324394108|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
94709511|NCT04707313|324394109|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
94709512|NCT04707313|324394110|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
94709513|NCT04707313|324394111|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
94709514|NCT04707313|324394112|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
94709515|NCT04707313|324394113|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
94709516|NCT04707313|324394114|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
94709517|NCT04707313|324394115|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
94709518|NCT04707313|324394116|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
94709519|NCT04707313|324394117|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
94709520|NCT04707313|324394118|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
94709521|NCT04707313|324394106|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
94709522|NCT04707313|324394107|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
94709523|NCT04707313|324394108|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
94709524|NCT04707313|324394109|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
94267825|NCT00382720|322776557|FG001|Overall Study|Good prognosis|1|||
94267826|NCT00382720|322776558|FG002|Overall Study|Good prognosis|0|||
94267827|NCT00382720|322776556|FG000|Overall Study|Investigator/Clinical decision|5|||
94267828|NCT00382720|322776557|FG001|Overall Study|Investigator/Clinical decision|6|||
94267829|NCT00382720|322776558|FG002|Overall Study|Investigator/Clinical decision|6|||
94267830|NCT00382720|322776556|FG000|Overall Study|Discontinued at end of study|0|||
94466254|NCT01358578|323496953|FG002|Maintenance Period|Lost to Follow-up|0|||
94267831|NCT00382720|322776557|FG001|Overall Study|Discontinued at end of study|1|||
94466255|NCT01358578|323496954|FG003|Maintenance Period|Lost to Follow-up|5|||
94652854|NCT01720069|324186233|FG000|Overall Study|Lack of Efficacy|0|||
94652855|NCT01720069|324186234|FG001|Overall Study|Lack of Efficacy|4|||
94652856|NCT01720069|324186235|FG002|Overall Study|Lack of Efficacy|0|||
94652857|NCT01720069|324186233|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
94652858|NCT01720069|324186234|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
94652859|NCT01720069|324186235|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
94652860|NCT01720069|324186233|FG000|Overall Study|Withdrawal by Subject|0|||
94652861|NCT01720069|324186234|FG001|Overall Study|Withdrawal by Subject|2|||
94652862|NCT01720069|324186235|FG002|Overall Study|Withdrawal by Subject|1|||
94652863|NCT01720069|324186233|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
94652864|NCT01720069|324186234|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
94652865|NCT01720069|324186235|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
94652866|NCT01720069|324186233|FG000|Overall Study|Non-compliance on using e-diary|0|||
94652867|NCT01720069|324186234|FG001|Overall Study|Non-compliance on using e-diary|0|||
94652868|NCT01720069|324186235|FG002|Overall Study|Non-compliance on using e-diary|1|||
94652869|NCT01720069|324186233|FG000|Overall Study|Lost to Follow-up|0|||
94652870|NCT01720069|324186234|FG001|Overall Study|Lost to Follow-up|0|||
94652871|NCT01720069|324186235|FG002|Overall Study|Lost to Follow-up|1|||
94652872|NCT00360334|324186236|FG000|Overall Study|Adverse Event|7|||
94652873|NCT00360334|324186237|FG001|Overall Study|Adverse Event|4|||
94709525|NCT04707313|324394110|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
94709526|NCT04707313|324394111|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
94709527|NCT04707313|324394112|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
94709528|NCT04707313|324394113|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
94709529|NCT04707313|324394114|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
94709530|NCT04707313|324394115|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
94709531|NCT04707313|324394116|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
94709532|NCT04707313|324394117|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
94709533|NCT04707313|324394118|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
94709534|NCT04707313|324394106|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
94709535|NCT04707313|324394107|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
94709536|NCT04707313|324394108|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
94709537|NCT04707313|324394109|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
94709538|NCT04707313|324394110|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
94709539|NCT04707313|324394111|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
94709540|NCT04707313|324394112|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
94709541|NCT04707313|324394113|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
94709542|NCT04707313|324394114|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
94709543|NCT04707313|324394115|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
94709544|NCT04707313|324394116|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
94709545|NCT04707313|324394117|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
94709546|NCT04707313|324394118|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
94709547|NCT04707313|324394106|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
94709548|NCT04707313|324394107|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
94709549|NCT04707313|324394108|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
94709550|NCT04707313|324394109|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
94709551|NCT04707313|324394110|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
94709552|NCT04707313|324394111|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
94709553|NCT04707313|324394112|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
94709554|NCT04707313|324394113|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
94709555|NCT04707313|324394114|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
94709556|NCT04707313|324394115|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
94709557|NCT04707313|324394116|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
94709558|NCT04707313|324394117|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
94709559|NCT04707313|324394118|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
94709560|NCT04707313|324394106|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
94709561|NCT04707313|324394107|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
94709562|NCT04707313|324394108|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
94709563|NCT04707313|324394109|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
94709564|NCT04707313|324394110|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
94709565|NCT04707313|324394111|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
94709566|NCT04707313|324394112|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
94709567|NCT04707313|324394113|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
94709568|NCT04707313|324394114|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
94709569|NCT04707313|324394115|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
94709570|NCT04707313|324394116|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
94709571|NCT04707313|324394117|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
94709572|NCT04707313|324394118|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
94267832|NCT00382720|322776558|FG002|Overall Study|Discontinued at end of study|2|||
94709573|NCT04707313|324394106|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
94709574|NCT04707313|324394107|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
94267833|NCT00710879|322776559|FG000|Overall Study|Lost to Follow-up|2|||
94267834|NCT00710879|322776560|FG001|Overall Study|Lost to Follow-up|1|||
94267835|NCT00710879|322776559|FG000|Overall Study|Protocol Violation|0|||
94267836|NCT00710879|322776560|FG001|Overall Study|Protocol Violation|3|||
94267837|NCT02248259|322776561|FG000|Treatment Period 1|Adverse Event|0|||
94267838|NCT02248259|322776562|FG001|Treatment Period 1|Adverse Event|0|||
94267839|NCT02248259|322776563|FG002|Treatment Period 1|Adverse Event|1|||
94267840|NCT02248259|322776564|FG003|Treatment Period 1|Adverse Event|0|||
94267841|NCT01301456|322776580|FG000|Stage 1|Withdrawal by Subject|0|||
94267842|NCT01301456|322776581|FG001|Stage 1|Withdrawal by Subject|0|||
94267843|NCT01301456|322776582|FG002|Stage 1|Withdrawal by Subject|1|||
94267844|NCT01301456|322776583|FG003|Stage 1|Withdrawal by Subject|0|||
94267845|NCT01301456|322776584|FG004|Stage 1|Withdrawal by Subject|1|||
94267846|NCT01301456|322776585|FG005|Stage 1|Withdrawal by Subject|0|||
94267847|NCT01301456|322776586|FG006|Stage 1|Withdrawal by Subject|0|||
94267848|NCT01301456|322776587|FG007|Stage 1|Withdrawal by Subject|0|||
94267849|NCT01301456|322776588|FG008|Stage 1|Withdrawal by Subject|0|||
94267850|NCT01301456|322776589|FG009|Stage 1|Withdrawal by Subject|0|||
94267851|NCT01301456|322776590|FG010|Stage 1|Withdrawal by Subject|0|||
94267852|NCT01301456|322776591|FG011|Stage 1|Withdrawal by Subject|0|||
94267853|NCT01301456|322776580|FG000|Stage 1|Randomized but not treated|0|||
94267854|NCT01301456|322776581|FG001|Stage 1|Randomized but not treated|0|||
94267855|NCT01301456|322776582|FG002|Stage 1|Randomized but not treated|0|||
94267856|NCT01301456|322776583|FG003|Stage 1|Randomized but not treated|0|||
94267857|NCT01301456|322776584|FG004|Stage 1|Randomized but not treated|0|||
94267858|NCT01301456|322776585|FG005|Stage 1|Randomized but not treated|0|||
94267859|NCT01301456|322776586|FG006|Stage 1|Randomized but not treated|1|||
94267860|NCT01301456|322776587|FG007|Stage 1|Randomized but not treated|0|||
94267861|NCT01301456|322776588|FG008|Stage 1|Randomized but not treated|0|||
94267862|NCT01301456|322776589|FG009|Stage 1|Randomized but not treated|0|||
94267863|NCT01301456|322776590|FG010|Stage 1|Randomized but not treated|0|||
94267864|NCT01301456|322776591|FG011|Stage 1|Randomized but not treated|0|||
94267865|NCT01301456|322776580|FG000|Stage 2|Adverse Event|0|||
94267866|NCT01301456|322776581|FG001|Stage 2|Adverse Event|0|||
94267867|NCT01301456|322776582|FG002|Stage 2|Adverse Event|0|||
94267868|NCT01301456|322776583|FG003|Stage 2|Adverse Event|0|||
94267869|NCT01301456|322776584|FG004|Stage 2|Adverse Event|0|||
94267870|NCT01301456|322776585|FG005|Stage 2|Adverse Event|0|||
94267871|NCT01301456|322776586|FG006|Stage 2|Adverse Event|0|||
94267872|NCT01301456|322776587|FG007|Stage 2|Adverse Event|0|||
94267873|NCT01301456|322776588|FG008|Stage 2|Adverse Event|0|||
94267874|NCT01301456|322776589|FG009|Stage 2|Adverse Event|0|||
94267875|NCT01301456|322776590|FG010|Stage 2|Adverse Event|1|||
94267876|NCT01301456|322776591|FG011|Stage 2|Adverse Event|0|||
94267877|NCT03374995|322776592|FG000|Overall Study|Withdrawal by Subject|0|||
94267878|NCT03374995|322776593|FG001|Overall Study|Withdrawal by Subject|1|||
94267879|NCT00823823|322776596|FG000|Overall Study|Lost to Follow-up|3|||
94267880|NCT00823823|322776597|FG001|Overall Study|Lost to Follow-up|1|||
94267881|NCT00823823|322776596|FG000|Overall Study|Protocol Violation|5|||
94267882|NCT00823823|322776597|FG001|Overall Study|Protocol Violation|5|||
94267883|NCT01986920|322776598|FG000|A- 101 25%|Withdrawal by Subject|1|||
94267884|NCT01986920|322776599|FG001|A- 101 25%|Withdrawal by Subject|0|||
94267885|NCT01986920|322776600|FG002|A- 101 25%|Withdrawal by Subject|0|||
94267886|NCT01986920|322776601|FG003|A- 101 25%|Withdrawal by Subject|0|||
94267887|NCT01986920|322776598|FG000|A-101 32.5%|Withdrawal by Subject|0|||
94267888|NCT01986920|322776599|FG001|A-101 32.5%|Withdrawal by Subject|1|||
94267889|NCT01986920|322776600|FG002|A-101 32.5%|Withdrawal by Subject|0|||
94267890|NCT01986920|322776601|FG003|A-101 32.5%|Withdrawal by Subject|0|||
94366744|NCT01556490|323128178|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
94652874|NCT00360334|324186236|FG000|Overall Study|Protocol Violation|1|||
94652875|NCT00360334|324186237|FG001|Overall Study|Protocol Violation|1|||
94652876|NCT00360334|324186236|FG000|Overall Study|Physician Decision|2|||
94652877|NCT00360334|324186237|FG001|Overall Study|Physician Decision|3|||
94652878|NCT00360334|324186236|FG000|Overall Study|Lack of Efficacy|0|||
94652879|NCT00360334|324186237|FG001|Overall Study|Lack of Efficacy|1|||
94652880|NCT00360334|324186236|FG000|Overall Study|Entry criterion not met|1|||
94652881|NCT00360334|324186237|FG001|Overall Study|Entry criterion not met|2|||
94652882|NCT00360334|324186236|FG000|Overall Study|Subject decision|8|||
94652883|NCT00360334|324186237|FG001|Overall Study|Subject decision|2|||
94267891|NCT01986920|322776598|FG000|A-101 40%|Withdrawal by Subject|0|||
94267892|NCT01986920|322776599|FG001|A-101 40%|Withdrawal by Subject|0|||
94267893|NCT01986920|322776600|FG002|A-101 40%|Withdrawal by Subject|1|||
94652884|NCT00595582|324186240|FG000|Overall Study|Pilot study that PI terminated|2|||
94709575|NCT04707313|324394108|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
94709576|NCT04707313|324394109|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
94709577|NCT04707313|324394110|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
94709578|NCT04707313|324394111|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
94709579|NCT04707313|324394112|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
94709580|NCT04707313|324394113|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
94709581|NCT04707313|324394114|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
94709582|NCT04707313|324394115|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
94709583|NCT04707313|324394116|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
94709584|NCT04707313|324394117|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
94709585|NCT04707313|324394118|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
94709586|NCT04707313|324394106|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
94709587|NCT04707313|324394107|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
94709588|NCT04707313|324394108|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
94709589|NCT04707313|324394109|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
94709590|NCT04707313|324394110|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
94709591|NCT04707313|324394111|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
94709592|NCT04707313|324394112|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
94709593|NCT04707313|324394113|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
94709594|NCT04707313|324394114|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
94709595|NCT04707313|324394115|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
94709596|NCT04707313|324394116|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
94709597|NCT04707313|324394117|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
94709598|NCT04707313|324394118|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
94709599|NCT04707313|324394106|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
94709600|NCT04707313|324394107|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
94709601|NCT04707313|324394108|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
94709602|NCT04707313|324394109|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
94709603|NCT04707313|324394110|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
94709604|NCT04707313|324394111|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
94709605|NCT04707313|324394112|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
94709606|NCT04707313|324394113|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
94709607|NCT04707313|324394114|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
94709608|NCT04707313|324394115|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
94709609|NCT04707313|324394116|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
94709610|NCT04707313|324394117|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
94709611|NCT04707313|324394118|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
94709612|NCT04707313|324394106|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
94709613|NCT04707313|324394107|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
94709614|NCT04707313|324394108|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
94709615|NCT04707313|324394109|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
94709616|NCT04707313|324394110|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
94709617|NCT04707313|324394111|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
94709618|NCT04707313|324394112|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
94709619|NCT04707313|324394113|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
94709620|NCT04707313|324394114|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
94709621|NCT04707313|324394115|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
94709622|NCT04707313|324394116|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
94709623|NCT04707313|324394117|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
94709624|NCT04707313|324394118|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
94709625|NCT04707313|324394106|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
94709626|NCT04707313|324394107|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
94709627|NCT04707313|324394108|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
94709628|NCT04707313|324394109|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
94709629|NCT04707313|324394110|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
94709630|NCT04707313|324394111|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
94709631|NCT04707313|324394112|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
94709632|NCT04707313|324394113|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
94709633|NCT04707313|324394114|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
94709634|NCT04707313|324394115|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
94709635|NCT04707313|324394116|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
94709636|NCT04707313|324394117|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
94709637|NCT04707313|324394118|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
94709638|NCT04707313|324394106|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
94709639|NCT04707313|324394107|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
94709640|NCT04707313|324394108|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
94709641|NCT04707313|324394109|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
94709642|NCT04707313|324394110|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
94366745|NCT00981019|323128179|FG000|Overall Study|Did not respond|65|||
94366746|NCT00981019|323128179|FG000|Overall Study|Did not match target population|94|||
94366747|NCT00981019|323128179|FG000|Overall Study|Inadvertent exclusion|239|||
94366748|NCT00981019|323128179|FG000|Overall Study|Hit the survey after closure|79|||
94366749|NCT00902278|323128180|FG000|Overall Study|Physician Decision|1|||
94366750|NCT00902278|323128181|FG001|Overall Study|Physician Decision|0|||
94366751|NCT00902278|323128182|FG002|Overall Study|Physician Decision|2|||
94366752|NCT00902278|323128183|FG003|Overall Study|Physician Decision|0|||
94366753|NCT00902278|323128184|FG004|Overall Study|Physician Decision|1|||
94366754|NCT00902278|323128180|FG000|Overall Study|Lost to Follow-up|3|||
94366755|NCT00902278|323128181|FG001|Overall Study|Lost to Follow-up|2|||
94366756|NCT00902278|323128182|FG002|Overall Study|Lost to Follow-up|3|||
94466256|NCT01358578|323496955|FG004|Maintenance Period|Lost to Follow-up|1|||
94709643|NCT04707313|324394111|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
94709644|NCT04707313|324394112|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
94709645|NCT04707313|324394113|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
94709646|NCT04707313|324394114|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
94709647|NCT04707313|324394115|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
94709648|NCT04707313|324394116|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
94709649|NCT04707313|324394117|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
94709650|NCT04707313|324394118|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
94709651|NCT04707313|324394106|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
94709652|NCT04707313|324394107|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
94709653|NCT04707313|324394108|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
94709654|NCT04707313|324394109|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
94709655|NCT04707313|324394110|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
94709656|NCT04707313|324394111|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
94709657|NCT04707313|324394112|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
94709658|NCT04707313|324394113|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
94709659|NCT04707313|324394114|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
94709660|NCT04707313|324394115|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
94709661|NCT04707313|324394116|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
94709662|NCT04707313|324394117|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
94709663|NCT04707313|324394118|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
94709664|NCT04707313|324394106|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
94709665|NCT04707313|324394107|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
94709666|NCT04707313|324394108|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
94709667|NCT04707313|324394109|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
94366757|NCT00902278|323128183|FG003|Overall Study|Lost to Follow-up|0|||
94709668|NCT04707313|324394110|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
94366758|NCT00902278|323128184|FG004|Overall Study|Lost to Follow-up|1|||
94366759|NCT02362646|323128185|FG000|Overall Study|Death|15|||
94709669|NCT04707313|324394111|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
94709670|NCT04707313|324394112|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
94709671|NCT04707313|324394113|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
94709672|NCT04707313|324394114|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
94709673|NCT04707313|324394115|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
94709674|NCT04707313|324394116|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
94709675|NCT04707313|324394117|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
94709676|NCT04707313|324394118|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
94709677|NCT04707313|324394106|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
94709678|NCT04707313|324394107|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
94709679|NCT04707313|324394108|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
94709680|NCT04707313|324394109|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
94709681|NCT04707313|324394110|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
94709682|NCT04707313|324394111|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
94709683|NCT04707313|324394112|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
94709684|NCT04707313|324394113|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
94709685|NCT04707313|324394114|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
94709686|NCT04707313|324394115|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
94709687|NCT04707313|324394116|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
94709688|NCT04707313|324394117|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
94709689|NCT04707313|324394118|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
94709690|NCT00539292|324394119|FG000|Overall Study|Physician Decision|1|||
94709691|NCT00539292|324394120|FG001|Overall Study|Physician Decision|0|||
94709692|NCT00361283|324394121|FG000|Overall Study|Lost to Follow-up|27|||
94709693|NCT02999477|324394128|FG000|Overall Study|found ineligible after first dose|0|||
94709694|NCT02999477|324394129|FG001|Overall Study|found ineligible after first dose|1|||
94709695|NCT02999477|324394128|FG000|Overall Study|Withdrawal by Subject|1|||
94709696|NCT02999477|324394129|FG001|Overall Study|Withdrawal by Subject|1|||
94709697|NCT04722003|324395708|FG000|Overall Study|Lost to Follow-up|2|||
94709698|NCT04722003|324395709|FG001|Overall Study|Lost to Follow-up|0|||
94709699|NCT04722003|324395708|FG000|Overall Study|Physician Decision|1|||
94709700|NCT04722003|324395709|FG001|Overall Study|Physician Decision|0|||
94709701|NCT00925899|324395710|FG000|Part 1|Death|1|||
94709702|NCT00925899|324395711|FG001|Part 1|Death|2|||
94709703|NCT00925899|324395710|FG000|Part 1|Withdrawal by Subject|10|||
94709704|NCT00925899|324395711|FG001|Part 1|Withdrawal by Subject|9|||
94709705|NCT01062126|324395714|FG000|Overall Study|Death|209|||
94709706|NCT01062126|324395714|FG000|Overall Study|All Withdrawals|324|||
94709707|NCT01662336|324395715|FG000|Overall Study|Adverse Event|1|||
94709708|NCT01662336|324395715|FG000|Overall Study|No longer on LPV/r|30|||
94709709|NCT01662336|324395715|FG000|Overall Study|Other|29|||
94709710|NCT01662336|324395715|FG000|Overall Study|Withdrawal by Subject|6|||
94709711|NCT00178399|324395716|FG000|Overall Study|Physician Decision|4|||
94709712|NCT00178399|324395716|FG000|Overall Study|Withdrawal by Subject|8|||
94709713|NCT00178399|324395716|FG000|Overall Study|Lost to Follow-up|1|||
94709714|NCT02814643|324395717|FG000|Overall Study|Lost to Follow-up|0|||
94709715|NCT02814643|324395718|FG001|Overall Study|Lost to Follow-up|1|||
94709716|NCT02814643|324395717|FG000|Overall Study|Withdrawal by Subject|1|||
94709717|NCT02814643|324395718|FG001|Overall Study|Withdrawal by Subject|2|||
94709718|NCT01759264|324395719|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
94709719|NCT01759264|324395719|FG000|Overall Study|Adverse Event|1|||
94709720|NCT01759264|324395719|FG000|Overall Study|Other|2|||
94709721|NCT01759264|324395719|FG000|Overall Study|Lost to Follow-up|2|||
94709722|NCT01759264|324395719|FG000|Overall Study|Withdrawal by Subject|3|||
94709723|NCT01759264|324395719|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
94709724|NCT00114244|324395720|FG000|Overall Study|Adverse Event|2|||
94709725|NCT00114244|324395721|FG001|Overall Study|Adverse Event|5|||
94709726|NCT00114244|324395720|FG000|Overall Study|Withdrawal by Subject|0|||
94709727|NCT00114244|324395721|FG001|Overall Study|Withdrawal by Subject|2|||
94709728|NCT01111526|324395722|FG000|Overall Study|GVHD Disease Progression|0|||
94709729|NCT01111526|324395723|FG001|Overall Study|GVHD Disease Progression|1|||
94709730|NCT01111526|324395724|FG002|Overall Study|GVHD Disease Progression|2|||
94709731|NCT02694978|324395729|FG000|Overall Study|Adverse Event|10|||
94709732|NCT02694978|324395730|FG001|Overall Study|Adverse Event|9|||
94709733|NCT02694978|324395729|FG000|Overall Study|Withdrawal by Subject|22|||
94709734|NCT02694978|324395730|FG001|Overall Study|Withdrawal by Subject|19|||
94709735|NCT02694978|324395729|FG000|Overall Study|Lost to Follow-up|14|||
94267894|NCT01986920|322776601|FG003|A-101 40%|Withdrawal by Subject|0|||
94267895|NCT01986920|322776598|FG000|Placebo|Withdrawal by Subject|0|||
94267896|NCT01986920|322776599|FG001|Placebo|Withdrawal by Subject|0|||
94267897|NCT01986920|322776600|FG002|Placebo|Withdrawal by Subject|0|||
94267898|NCT01986920|322776601|FG003|Placebo|Withdrawal by Subject|1|||
94267899|NCT00701090|322776602|FG000|Overall Study|Adverse Event|11|||
94267900|NCT00701090|322776603|FG001|Overall Study|Adverse Event|2|||
94267901|NCT00701090|322776602|FG000|Overall Study|Death|0|||
94267902|NCT00701090|322776603|FG001|Overall Study|Death|1|||
94267903|NCT00701090|322776602|FG000|Overall Study|Lack of Efficacy|5|||
94267904|NCT00701090|322776603|FG001|Overall Study|Lack of Efficacy|4|||
94366760|NCT02362646|323128186|FG001|Overall Study|Death|8|||
94366761|NCT02362646|323128185|FG000|Overall Study|Withdrawal by Subject|2|||
94267905|NCT00701090|322776602|FG000|Overall Study|Lost to Follow-up|9|||
94267906|NCT00701090|322776603|FG001|Overall Study|Lost to Follow-up|9|||
94267907|NCT00701090|322776602|FG000|Overall Study|Physician Decision|3|||
94267908|NCT00701090|322776603|FG001|Overall Study|Physician Decision|4|||
94267909|NCT00701090|322776602|FG000|Overall Study|Protocol Violation|2|||
94267910|NCT00701090|322776603|FG001|Overall Study|Protocol Violation|3|||
94267911|NCT00701090|322776602|FG000|Overall Study|Withdrawal by Subject|11|||
94267912|NCT00701090|322776603|FG001|Overall Study|Withdrawal by Subject|16|||
94366762|NCT02362646|323128186|FG001|Overall Study|Withdrawal by Subject|2|||
94366763|NCT02362646|323128185|FG000|Overall Study|received transplant|21|||
94366764|NCT02362646|323128186|FG001|Overall Study|received transplant|14|||
94709736|NCT02694978|324395730|FG001|Overall Study|Lost to Follow-up|17|||
94709737|NCT02694978|324395729|FG000|Overall Study|Death|4|||
94709738|NCT02694978|324395730|FG001|Overall Study|Death|1|||
94709739|NCT02694978|324395729|FG000|Overall Study|Other-Decision of Participant|6|||
94709740|NCT02694978|324395730|FG001|Overall Study|Other-Decision of Participant|1|||
94709741|NCT02694978|324395729|FG000|Overall Study|Other-Investigator's decision|1|||
94267913|NCT00701090|322776602|FG000|Overall Study|Other|7|||
94267914|NCT00701090|322776603|FG001|Overall Study|Other|12|||
94267915|NCT00873366|322776604|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
94267916|NCT00873366|322776604|FG000|Overall Study|Off tamoxifen due to side effects|2|||
94267917|NCT00873366|322776604|FG000|Overall Study|Refused to continue DM-BT testing|3|||
94267918|NCT03962738|322776610|FG000|Overall Study|Protocol Deviation|3|||
94267919|NCT03962738|322776611|FG001|Overall Study|Protocol Deviation|0|||
94267920|NCT03962738|322776612|FG002|Overall Study|Protocol Deviation|1|||
94267921|NCT03962738|322776613|FG003|Overall Study|Protocol Deviation|1|||
94267922|NCT03962738|322776610|FG000|Overall Study|Withdrawal by Subject|4|||
94267923|NCT03962738|322776611|FG001|Overall Study|Withdrawal by Subject|0|||
94267924|NCT03962738|322776612|FG002|Overall Study|Withdrawal by Subject|0|||
94267925|NCT03962738|322776613|FG003|Overall Study|Withdrawal by Subject|0|||
94267926|NCT03962738|322776610|FG000|Overall Study|Lost to Follow-up|0|||
94267927|NCT03962738|322776611|FG001|Overall Study|Lost to Follow-up|0|||
94267928|NCT03962738|322776612|FG002|Overall Study|Lost to Follow-up|1|||
94267929|NCT03962738|322776613|FG003|Overall Study|Lost to Follow-up|0|||
94267930|NCT00509067|322776614|FG000|Overall Study|Lost to Follow-up|1|||
94366765|NCT02181842|323128187|FG000|Overall Study|Case Report Forms Uncollected|2|||
94366766|NCT01652872|323128188|FG000|Overall Study|Death|36|||
94366767|NCT01652872|323128189|FG001|Overall Study|Death|39|||
94366768|NCT01652872|323128188|FG000|Overall Study|Lost to Follow-up|28|||
94366769|NCT01652872|323128189|FG001|Overall Study|Lost to Follow-up|23|||
94709742|NCT02694978|324395730|FG001|Overall Study|Other-Investigator's decision|0|||
94709743|NCT02694978|324395729|FG000|Overall Study|Other-Unable to be reached|0|||
94709744|NCT02694978|324395730|FG001|Overall Study|Other-Unable to be reached|1|||
94709745|NCT02694978|324395729|FG000|Overall Study|Other-Protocol noncompliant|2|||
94709746|NCT02694978|324395730|FG001|Overall Study|Other-Protocol noncompliant|1|||
94709747|NCT02694978|324395729|FG000|Overall Study|Other-Personal reasons|3|||
94709748|NCT02694978|324395730|FG001|Overall Study|Other-Personal reasons|3|||
94709749|NCT02694978|324395729|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
94709750|NCT02694978|324395730|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
94709751|NCT01376089|324395731|FG000|Overall Study|Patient received no contrast media|3|||
94709752|NCT01376089|324395732|FG001|Overall Study|Patient received no contrast media|4|||
94709753|NCT02224924|324395733|FG000|Overall Study|Withdrawal by Subject|7|||
94709754|NCT02224924|324395734|FG001|Overall Study|Withdrawal by Subject|6|||
94709755|NCT02224924|324395733|FG000|Overall Study|Biopsy cancelled|20|||
94709756|NCT02224924|324395734|FG001|Overall Study|Biopsy cancelled|14|||
94709757|NCT02224924|324395733|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
94709758|NCT02224924|324395734|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
94709759|NCT02224924|324395733|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
94709760|NCT02224924|324395734|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
94709761|NCT00814346|324395735|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
94709762|NCT00814346|324395736|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
94709763|NCT00814346|324395735|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
94709764|NCT00814346|324395736|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
94709765|NCT00814346|324395735|FG000|Open Phase (17 Months)|Adverse Event|5|||
94709766|NCT00814346|324395736|FG001|Open Phase (17 Months)|Adverse Event|0|||
94709767|NCT00814346|324395735|FG000|Open Phase (17 Months)|Consent|2|||
94709768|NCT00814346|324395736|FG001|Open Phase (17 Months)|Consent|0|||
94709769|NCT00814346|324395735|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
94709770|NCT00814346|324395736|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
94709771|NCT00814346|324395735|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
94709772|NCT00814346|324395736|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
94709773|NCT05136443|324395737|FG000|Overall Study|Lost to Follow-up|2|||
94709774|NCT05136443|324395737|FG000|Overall Study|Adverse Event|2|||
94709775|NCT01157182|324395742|FG000|Washout of 28 Days|Adverse Event|2|||
94709776|NCT01157182|324395743|FG001|Washout of 28 Days|Adverse Event|0|||
94709777|NCT01184508|324395746|FG000|Overall Study|Adverse Event|4|||
94709778|NCT01184508|324395747|FG001|Overall Study|Adverse Event|6|||
94709779|NCT01184508|324395746|FG000|Overall Study|Lack of Efficacy|1|||
94709780|NCT01184508|324395747|FG001|Overall Study|Lack of Efficacy|1|||
94709781|NCT01184508|324395746|FG000|Overall Study|Lost to Follow-up|1|||
94709782|NCT01184508|324395747|FG001|Overall Study|Lost to Follow-up|1|||
94267931|NCT00509067|322776615|FG001|Overall Study|Lost to Follow-up|1|||
94267932|NCT00509067|322776614|FG000|Overall Study|Adverse Event|3|||
94267933|NCT00509067|322776615|FG001|Overall Study|Adverse Event|1|||
94709783|NCT01184508|324395746|FG000|Overall Study|Physician Decision|1|||
94709784|NCT01184508|324395747|FG001|Overall Study|Physician Decision|0|||
94709785|NCT01184508|324395746|FG000|Overall Study|Protocol Violation|3|||
94267934|NCT00509067|322776614|FG000|Overall Study|Protocol Violation|0|||
94267935|NCT00509067|322776615|FG001|Overall Study|Protocol Violation|3|||
94267936|NCT00702325|322776616|FG000|Overall Study|Adverse Event|1|||
94366770|NCT01652872|323128188|FG000|Overall Study|Decision by sponsor|5|||
94709786|NCT01184508|324395747|FG001|Overall Study|Protocol Violation|1|||
94709787|NCT01184508|324395746|FG000|Overall Study|Sponsor Decision|5|||
94267937|NCT00702325|322776617|FG001|Overall Study|Adverse Event|0|||
94267938|NCT00702325|322776616|FG000|Overall Study|Withdrawal by Subject|7|||
94267939|NCT00702325|322776617|FG001|Overall Study|Withdrawal by Subject|7|||
94267940|NCT00702325|322776616|FG000|Overall Study|Lost to Follow-up|3|||
94267941|NCT00702325|322776617|FG001|Overall Study|Lost to Follow-up|4|||
94267942|NCT00702325|322776616|FG000|Overall Study|Incorrect enrollment|5|||
94267943|NCT00702325|322776617|FG001|Overall Study|Incorrect enrollment|7|||
94267944|NCT00702325|322776616|FG000|Overall Study|Developed study discontinuation criteria|18|||
94267945|NCT00702325|322776617|FG001|Overall Study|Developed study discontinuation criteria|28|||
94267946|NCT00702325|322776616|FG000|Overall Study|Severe noncompliance to protocol|3|||
94267947|NCT00702325|322776617|FG001|Overall Study|Severe noncompliance to protocol|3|||
94267948|NCT00702325|322776616|FG000|Overall Study|Termination due to lab results|1|||
94267949|NCT00702325|322776617|FG001|Overall Study|Termination due to lab results|0|||
94267950|NCT00702325|322776616|FG000|Overall Study|Didn't follow study medication dosage|0|||
94267951|NCT00702325|322776617|FG001|Overall Study|Didn't follow study medication dosage|2|||
94267952|NCT00702325|322776616|FG000|Overall Study|Withdrew consent|0|||
94267953|NCT00702325|322776617|FG001|Overall Study|Withdrew consent|1|||
94267954|NCT00702325|322776616|FG000|Overall Study|Incorrectly Discontinued|0|||
94267955|NCT00702325|322776617|FG001|Overall Study|Incorrectly Discontinued|1|||
94267956|NCT03123250|322776620|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
94267957|NCT00073528|322776626|FG000|Overall Study|Death|488|||
94709788|NCT01184508|324395747|FG001|Overall Study|Sponsor Decision|2|||
94709789|NCT01184508|324395746|FG000|Overall Study|Withdrawal by Subject|1|||
94709790|NCT01184508|324395747|FG001|Overall Study|Withdrawal by Subject|3|||
94709791|NCT01184508|324395746|FG000|Overall Study|Randomized, Not Treated|0|||
94709792|NCT01184508|324395747|FG001|Overall Study|Randomized, Not Treated|1|||
94709793|NCT00869323|324395748|FG000|Maintenance Therapy|concurrent illness|1|||
94709794|NCT02808338|324395758|FG000|Screening|Screen Failure|10|||
94709795|NCT02808338|324395758|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
94709796|NCT02808338|324395758|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
94709797|NCT00057837|324395762|FG000|Overall Study|Progression/relapse|12|||
94709798|NCT00057837|324395763|FG001|Overall Study|Progression/relapse|14|||
94709799|NCT00057837|324395762|FG000|Overall Study|Adverse Event|2|||
94709800|NCT00057837|324395763|FG001|Overall Study|Adverse Event|12|||
94709801|NCT00057837|324395762|FG000|Overall Study|Death|5|||
94709802|NCT00057837|324395763|FG001|Overall Study|Death|4|||
94709803|NCT00057837|324395762|FG000|Overall Study|Withdrawal by Subject|5|||
94709804|NCT00057837|324395763|FG001|Overall Study|Withdrawal by Subject|3|||
94709805|NCT00057837|324395762|FG000|Overall Study|Alternative therapy|0|||
94709806|NCT00057837|324395763|FG001|Overall Study|Alternative therapy|1|||
94709807|NCT00057837|324395762|FG000|Overall Study|Other complicating disease|2|||
94709808|NCT00057837|324395763|FG001|Overall Study|Other complicating disease|1|||
94709809|NCT00057837|324395762|FG000|Overall Study|Physician Decision|1|||
94709810|NCT00057837|324395763|FG001|Overall Study|Physician Decision|0|||
94709811|NCT00057837|324395762|FG000|Overall Study|Ineligible|3|||
94709812|NCT00057837|324395763|FG001|Overall Study|Ineligible|3|||
94709813|NCT00057837|324395762|FG000|Overall Study|Never started treatment|1|||
94709814|NCT00057837|324395763|FG001|Overall Study|Never started treatment|1|||
94709815|NCT02570711|324395768|FG000|Overall Study|Death|1|||
94709816|NCT02570711|324395769|FG001|Overall Study|Death|0|||
94709817|NCT02570711|324395768|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
94709818|NCT02570711|324395769|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
94709819|NCT05001945|324395770|FG000|Overall Study|Adverse Event|0|||
94709820|NCT05001945|324395771|FG001|Overall Study|Adverse Event|0|||
94709821|NCT05001945|324395772|FG002|Overall Study|Adverse Event|0|||
94709822|NCT05001945|324395773|FG003|Overall Study|Adverse Event|1|||
94709823|NCT05001945|324395774|FG004|Overall Study|Adverse Event|0|||
94709824|NCT05001945|324395775|FG005|Overall Study|Adverse Event|0|||
94709825|NCT05001945|324395776|FG006|Overall Study|Adverse Event|0|||
94709826|NCT05001945|324395777|FG007|Overall Study|Adverse Event|0|||
94709827|NCT05001945|324395770|FG000|Overall Study|Lost to Follow-up|0|||
94709828|NCT05001945|324395771|FG001|Overall Study|Lost to Follow-up|1|||
94709829|NCT05001945|324395772|FG002|Overall Study|Lost to Follow-up|1|||
94709830|NCT05001945|324395773|FG003|Overall Study|Lost to Follow-up|2|||
94709831|NCT05001945|324395774|FG004|Overall Study|Lost to Follow-up|0|||
94709832|NCT05001945|324395775|FG005|Overall Study|Lost to Follow-up|1|||
94267958|NCT00073528|322776627|FG001|Overall Study|Death|473|||
94267959|NCT00073528|322776626|FG000|Overall Study|Lost to Follow-up|52|||
94267960|NCT00073528|322776627|FG001|Overall Study|Lost to Follow-up|45|||
94267961|NCT00073528|322776626|FG000|Overall Study|Withdrawal by Subject|50|||
94267962|NCT00073528|322776627|FG001|Overall Study|Withdrawal by Subject|45|||
94267963|NCT00073528|322776626|FG000|Overall Study|Study terminated by Sponsor|10|||
94267964|NCT00073528|322776627|FG001|Overall Study|Study terminated by Sponsor|29|||
94709833|NCT05001945|324395776|FG006|Overall Study|Lost to Follow-up|0|||
94267965|NCT00073528|322776626|FG000|Overall Study|Other|18|||
94709834|NCT05001945|324395777|FG007|Overall Study|Lost to Follow-up|0|||
94709835|NCT05001945|324395770|FG000|Overall Study|Protocol Violation|1|||
94709836|NCT05001945|324395771|FG001|Overall Study|Protocol Violation|0|||
94709837|NCT05001945|324395772|FG002|Overall Study|Protocol Violation|1|||
94709838|NCT05001945|324395773|FG003|Overall Study|Protocol Violation|1|||
94709839|NCT05001945|324395774|FG004|Overall Study|Protocol Violation|0|||
94709840|NCT05001945|324395775|FG005|Overall Study|Protocol Violation|1|||
94709841|NCT05001945|324395776|FG006|Overall Study|Protocol Violation|0|||
94709842|NCT05001945|324395777|FG007|Overall Study|Protocol Violation|0|||
94709843|NCT05001945|324395770|FG000|Overall Study|Withdrawal by Subject|0|||
94709844|NCT05001945|324395771|FG001|Overall Study|Withdrawal by Subject|0|||
94709845|NCT05001945|324395772|FG002|Overall Study|Withdrawal by Subject|0|||
94709846|NCT05001945|324395773|FG003|Overall Study|Withdrawal by Subject|1|||
94709847|NCT05001945|324395774|FG004|Overall Study|Withdrawal by Subject|1|||
94709848|NCT05001945|324395775|FG005|Overall Study|Withdrawal by Subject|1|||
94709849|NCT05001945|324395776|FG006|Overall Study|Withdrawal by Subject|0|||
94709850|NCT05001945|324395777|FG007|Overall Study|Withdrawal by Subject|1|||
94709851|NCT05001945|324395770|FG000|Overall Study|Not specified by Investigator|0|||
94709852|NCT05001945|324395771|FG001|Overall Study|Not specified by Investigator|3|||
94709853|NCT05001945|324395772|FG002|Overall Study|Not specified by Investigator|0|||
94709854|NCT05001945|324395773|FG003|Overall Study|Not specified by Investigator|0|||
94709855|NCT05001945|324395774|FG004|Overall Study|Not specified by Investigator|1|||
94709856|NCT05001945|324395775|FG005|Overall Study|Not specified by Investigator|0|||
94709857|NCT05001945|324395776|FG006|Overall Study|Not specified by Investigator|0|||
94709858|NCT05001945|324395777|FG007|Overall Study|Not specified by Investigator|0|||
94709859|NCT02448446|324395778|FG000|Overall Study|Withdrawal by Subject|1|||
94709860|NCT02448446|324395779|FG001|Overall Study|Withdrawal by Subject|0|||
94709861|NCT01490086|324395783|FG000|Overall Study|Consent withdrawn|4|||
94709862|NCT01490086|324395784|FG001|Overall Study|Consent withdrawn|4|||
94709863|NCT01490086|324395785|FG002|Overall Study|Consent withdrawn|3|||
94709864|NCT01490086|324395786|FG003|Overall Study|Consent withdrawn|0|||
94709865|NCT01490086|324395787|FG004|Overall Study|Consent withdrawn|1|||
94709866|NCT01490086|324395783|FG000|Overall Study|Non-compliance|0|||
94709867|NCT01490086|324395784|FG001|Overall Study|Non-compliance|1|||
94709868|NCT01490086|324395785|FG002|Overall Study|Non-compliance|0|||
94709869|NCT01490086|324395786|FG003|Overall Study|Non-compliance|0|||
94709870|NCT01490086|324395787|FG004|Overall Study|Non-compliance|0|||
94709871|NCT01490086|324395783|FG000|Overall Study|Abnormal laboratory findings|1|||
94709872|NCT01490086|324395784|FG001|Overall Study|Abnormal laboratory findings|0|||
94709873|NCT01490086|324395785|FG002|Overall Study|Abnormal laboratory findings|0|||
94709874|NCT01490086|324395786|FG003|Overall Study|Abnormal laboratory findings|0|||
94709875|NCT01490086|324395787|FG004|Overall Study|Abnormal laboratory findings|0|||
94709876|NCT01490086|324395783|FG000|Overall Study|Lost to Follow-up|0|||
94709877|NCT01490086|324395784|FG001|Overall Study|Lost to Follow-up|0|||
94709878|NCT01490086|324395785|FG002|Overall Study|Lost to Follow-up|0|||
94709879|NCT01490086|324395786|FG003|Overall Study|Lost to Follow-up|0|||
94709880|NCT01490086|324395787|FG004|Overall Study|Lost to Follow-up|1|||
94709881|NCT01490086|324395783|FG000|Overall Study|Physician Decision|3|||
94709882|NCT01490086|324395784|FG001|Overall Study|Physician Decision|4|||
94709883|NCT01490086|324395785|FG002|Overall Study|Physician Decision|2|||
94709884|NCT01490086|324395786|FG003|Overall Study|Physician Decision|3|||
94709885|NCT01490086|324395787|FG004|Overall Study|Physician Decision|1|||
94709886|NCT01490086|324395783|FG000|Overall Study|Adverse Event|0|||
94709887|NCT01490086|324395784|FG001|Overall Study|Adverse Event|0|||
94709888|NCT01490086|324395785|FG002|Overall Study|Adverse Event|1|||
94709889|NCT01490086|324395786|FG003|Overall Study|Adverse Event|2|||
94709890|NCT01490086|324395787|FG004|Overall Study|Adverse Event|0|||
94709891|NCT01490086|324395783|FG000|Overall Study|Lack of Efficacy|0|||
94709892|NCT01490086|324395784|FG001|Overall Study|Lack of Efficacy|3|||
94709893|NCT01490086|324395785|FG002|Overall Study|Lack of Efficacy|1|||
94709894|NCT01490086|324395786|FG003|Overall Study|Lack of Efficacy|0|||
94709895|NCT01490086|324395787|FG004|Overall Study|Lack of Efficacy|8|||
94709896|NCT01490086|324395783|FG000|Overall Study|Worsening of symptoms|0|||
94709897|NCT01490086|324395784|FG001|Overall Study|Worsening of symptoms|1|||
94709898|NCT01490086|324395785|FG002|Overall Study|Worsening of symptoms|0|||
94709899|NCT01490086|324395786|FG003|Overall Study|Worsening of symptoms|1|||
94709900|NCT01490086|324395787|FG004|Overall Study|Worsening of symptoms|0|||
94709901|NCT01490086|324395783|FG000|Overall Study|Subject uncontrollable and abusive|0|||
94709902|NCT01490086|324395784|FG001|Overall Study|Subject uncontrollable and abusive|1|||
94709903|NCT01490086|324395785|FG002|Overall Study|Subject uncontrollable and abusive|0|||
94709904|NCT01490086|324395786|FG003|Overall Study|Subject uncontrollable and abusive|0|||
94709905|NCT01490086|324395787|FG004|Overall Study|Subject uncontrollable and abusive|0|||
94709906|NCT01490086|324395783|FG000|Overall Study|Subject left hospital|0|||
94709907|NCT01490086|324395784|FG001|Overall Study|Subject left hospital|1|||
94709908|NCT01490086|324395785|FG002|Overall Study|Subject left hospital|0|||
94709909|NCT01490086|324395786|FG003|Overall Study|Subject left hospital|1|||
94709910|NCT01490086|324395787|FG004|Overall Study|Subject left hospital|0|||
94709911|NCT05082935|324395792|FG000|Overall Study|Lost to Follow-up|549|||
94709912|NCT05082935|324395793|FG001|Overall Study|Lost to Follow-up|631|||
94709913|NCT05082935|324395792|FG000|Overall Study|Withdrawal by Subject|27|||
94709914|NCT05082935|324395793|FG001|Overall Study|Withdrawal by Subject|58|||
94709915|NCT05382104|324395795|FG000|Period 2 (2 Days)|Adverse Event|0|||
94709916|NCT05382104|324395796|FG001|Period 2 (2 Days)|Adverse Event|1|||
94709917|NCT05382104|324395797|FG002|Period 2 (2 Days)|Adverse Event|0|||
94709918|NCT05382104|324395798|FG003|Period 2 (2 Days)|Adverse Event|0|||
94709919|NCT05382104|324395799|FG004|Period 2 (2 Days)|Adverse Event|0|||
94709920|NCT05382104|324395800|FG005|Period 2 (2 Days)|Adverse Event|0|||
94709921|NCT02547922|324395803|FG000|Overall Study|Withdrawal by Subject|9|||
94709922|NCT02547922|324395804|FG001|Overall Study|Withdrawal by Subject|6|||
94709923|NCT02547922|324395805|FG002|Overall Study|Withdrawal by Subject|10|||
94709924|NCT02547922|324395803|FG000|Overall Study|Adverse Event|3|||
94709925|NCT02547922|324395804|FG001|Overall Study|Adverse Event|1|||
94709926|NCT02547922|324395805|FG002|Overall Study|Adverse Event|2|||
94709927|NCT02547922|324395803|FG000|Overall Study|Lost to Follow-up|1|||
94709928|NCT02547922|324395804|FG001|Overall Study|Lost to Follow-up|0|||
94709929|NCT02547922|324395805|FG002|Overall Study|Lost to Follow-up|0|||
94709930|NCT02547922|324395803|FG000|Overall Study|Lack of Efficacy|5|||
94709931|NCT02547922|324395804|FG001|Overall Study|Lack of Efficacy|7|||
94709932|NCT02547922|324395805|FG002|Overall Study|Lack of Efficacy|4|||
94709933|NCT02547922|324395803|FG000|Overall Study|Death|1|||
94709934|NCT02547922|324395804|FG001|Overall Study|Death|0|||
94709935|NCT02547922|324395805|FG002|Overall Study|Death|0|||
94709936|NCT02547922|324395803|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
94709937|NCT02547922|324395804|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
94709938|NCT02547922|324395805|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
94709939|NCT02547922|324395803|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
94709940|NCT02547922|324395804|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
94709941|NCT02547922|324395805|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
94709942|NCT02547922|324395803|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
94709943|NCT02547922|324395804|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
94709944|NCT02547922|324395805|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
94709945|NCT02547922|324395803|FG000|Overall Study|Physician Decision|2|||
94709946|NCT02547922|324395804|FG001|Overall Study|Physician Decision|1|||
94709947|NCT02547922|324395805|FG002|Overall Study|Physician Decision|2|||
94267966|NCT00073528|322776627|FG001|Overall Study|Other|19|||
94267967|NCT00073528|322776626|FG000|Overall Study|Other|9|||
94267968|NCT00073528|322776627|FG001|Overall Study|Other|12|||
94267969|NCT00073528|322776626|FG000|Overall Study|Protocol Violation|3|||
94267970|NCT00073528|322776627|FG001|Overall Study|Protocol Violation|5|||
94267971|NCT02463071|322776628|FG000|Overall Study|Adverse Event|3|||
94267972|NCT02463071|322776629|FG001|Overall Study|Adverse Event|5|||
94267973|NCT02463071|322776630|FG002|Overall Study|Adverse Event|1|||
94267974|NCT02463071|322776628|FG000|Overall Study|Death|1|||
94267975|NCT02463071|322776629|FG001|Overall Study|Death|0|||
94267976|NCT02463071|322776630|FG002|Overall Study|Death|0|||
94267977|NCT02463071|322776628|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
94267978|NCT02463071|322776629|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
94267979|NCT02463071|322776630|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
94267980|NCT02463071|322776628|FG000|Overall Study|Reason not specified|7|||
94267981|NCT02463071|322776629|FG001|Overall Study|Reason not specified|9|||
94267982|NCT02463071|322776630|FG002|Overall Study|Reason not specified|4|||
94267983|NCT02463071|322776628|FG000|Overall Study|Protocol Violation|0|||
94267984|NCT02463071|322776629|FG001|Overall Study|Protocol Violation|2|||
94267985|NCT02463071|322776630|FG002|Overall Study|Protocol Violation|0|||
94267986|NCT02463071|322776628|FG000|Overall Study|Lost to Follow-up|0|||
94267987|NCT02463071|322776629|FG001|Overall Study|Lost to Follow-up|0|||
94267988|NCT02463071|322776630|FG002|Overall Study|Lost to Follow-up|1|||
94709948|NCT02547922|324395803|FG000|Overall Study|Patients did not receive IP|1|||
94709949|NCT02547922|324395804|FG001|Overall Study|Patients did not receive IP|1|||
94709950|NCT02547922|324395805|FG002|Overall Study|Patients did not receive IP|0|||
94709951|NCT02200770|324395806|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
94267989|NCT00888381|322776633|FG000|Overall Study|Lost to Follow-up|0|||
94366771|NCT01652872|323128189|FG001|Overall Study|Decision by sponsor|7|||
94709952|NCT02200770|324395807|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
94709953|NCT02200770|324395806|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
94709954|NCT02200770|324395807|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
94267990|NCT00888381|322776634|FG001|Overall Study|Lost to Follow-up|1|||
94267991|NCT00097773|322776635|FG000|Overall Study|Lost to Follow-up|2|||
94267992|NCT00097773|322776636|FG001|Overall Study|Lost to Follow-up|2|||
94267993|NCT00097773|322776637|FG002|Overall Study|Lost to Follow-up|0|||
94267994|NCT00097773|322776638|FG003|Overall Study|Lost to Follow-up|1|||
94267995|NCT00097773|322776635|FG000|Overall Study|Physician Decision|2|||
94267996|NCT00097773|322776636|FG001|Overall Study|Physician Decision|2|||
94267997|NCT00097773|322776637|FG002|Overall Study|Physician Decision|3|||
94267998|NCT00097773|322776638|FG003|Overall Study|Physician Decision|1|||
94267999|NCT00097773|322776635|FG000|Overall Study|Withdrawal by Subject|3|||
94268000|NCT00097773|322776636|FG001|Overall Study|Withdrawal by Subject|3|||
94268001|NCT00097773|322776637|FG002|Overall Study|Withdrawal by Subject|3|||
94268002|NCT00097773|322776638|FG003|Overall Study|Withdrawal by Subject|1|||
94268003|NCT00097773|322776635|FG000|Overall Study|Adverse Event|0|||
94268004|NCT00097773|322776636|FG001|Overall Study|Adverse Event|1|||
94268005|NCT00097773|322776637|FG002|Overall Study|Adverse Event|0|||
94268006|NCT00097773|322776638|FG003|Overall Study|Adverse Event|0|||
94268007|NCT00097773|322776635|FG000|Overall Study|Other|1|||
94268008|NCT00097773|322776636|FG001|Overall Study|Other|0|||
94268009|NCT00097773|322776637|FG002|Overall Study|Other|2|||
94268010|NCT00097773|322776638|FG003|Overall Study|Other|0|||
94268011|NCT00003702|322776639|FG000|Overall Study|Ineligible cell types|2|||
94268012|NCT00003702|322776640|FG001|Overall Study|Ineligible cell types|2|||
94268013|NCT00003702|322776639|FG000|Overall Study|Did not meet criteria for persistence|8|||
94268014|NCT00003702|322776640|FG001|Overall Study|Did not meet criteria for persistence|5|||
94268015|NCT00003702|322776639|FG000|Overall Study|WHO score > 6|2|||
94268016|NCT00003702|322776640|FG001|Overall Study|WHO score > 6|1|||
94268017|NCT00003702|322776639|FG000|Overall Study|Inadequate documentation of disease|1|||
94268018|NCT00003702|322776640|FG001|Overall Study|Inadequate documentation of disease|3|||
94268019|NCT03061175|322776646|FG000|Baseline|Participant was deemed ineligible|1|||
94268020|NCT03061175|322776647|FG001|Baseline|Participant was deemed ineligible|0|||
94268021|NCT03061175|322776646|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
94268022|NCT03061175|322776647|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
94268023|NCT03061175|322776646|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
94268024|NCT03061175|322776647|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
94268025|NCT03061175|322776646|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
94268026|NCT03061175|322776647|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
94268027|NCT01621542|322776648|FG000|Overall Study|Adverse Event|0|||
94268028|NCT01621542|322776649|FG001|Overall Study|Adverse Event|0|||
94268029|NCT01621542|322776650|FG002|Overall Study|Adverse Event|1|||
94268030|NCT01621542|322776651|FG003|Overall Study|Adverse Event|3|||
94268031|NCT01621542|322776652|FG004|Overall Study|Adverse Event|0|||
94268032|NCT01621542|322776653|FG005|Overall Study|Adverse Event|0|||
94268033|NCT01621542|322776648|FG000|Overall Study|Death|0|||
94268034|NCT01621542|322776649|FG001|Overall Study|Death|1|||
94268035|NCT01621542|322776650|FG002|Overall Study|Death|0|||
94268036|NCT01621542|322776651|FG003|Overall Study|Death|0|||
94268037|NCT01621542|322776652|FG004|Overall Study|Death|0|||
94268038|NCT01621542|322776653|FG005|Overall Study|Death|0|||
94268039|NCT01621542|322776648|FG000|Overall Study|Physician Decision|1|||
94268040|NCT01621542|322776649|FG001|Overall Study|Physician Decision|0|||
94268041|NCT01621542|322776650|FG002|Overall Study|Physician Decision|1|||
94268042|NCT01621542|322776651|FG003|Overall Study|Physician Decision|13|||
94268043|NCT01621542|322776652|FG004|Overall Study|Physician Decision|3|||
94268044|NCT01621542|322776653|FG005|Overall Study|Physician Decision|1|||
94268045|NCT01621542|322776648|FG000|Overall Study|Withdrawal by Subject|2|||
94268046|NCT01621542|322776649|FG001|Overall Study|Withdrawal by Subject|0|||
94268047|NCT01621542|322776650|FG002|Overall Study|Withdrawal by Subject|1|||
94268048|NCT01621542|322776651|FG003|Overall Study|Withdrawal by Subject|3|||
94268049|NCT01621542|322776652|FG004|Overall Study|Withdrawal by Subject|3|||
94268050|NCT01621542|322776653|FG005|Overall Study|Withdrawal by Subject|3|||
94268051|NCT01621542|322776648|FG000|Overall Study|progression/treatment failure|2|||
94268052|NCT01621542|322776649|FG001|Overall Study|progression/treatment failure|4|||
94268053|NCT01621542|322776650|FG002|Overall Study|progression/treatment failure|3|||
94268054|NCT01621542|322776651|FG003|Overall Study|progression/treatment failure|7|||
94268055|NCT01621542|322776652|FG004|Overall Study|progression/treatment failure|3|||
94268056|NCT01621542|322776653|FG005|Overall Study|progression/treatment failure|5|||
94268057|NCT01621542|322776648|FG000|Overall Study|Protocol Violation|0|||
94268058|NCT01621542|322776649|FG001|Overall Study|Protocol Violation|0|||
94268059|NCT01621542|322776650|FG002|Overall Study|Protocol Violation|0|||
94268060|NCT01621542|322776651|FG003|Overall Study|Protocol Violation|1|||
94268061|NCT01621542|322776652|FG004|Overall Study|Protocol Violation|0|||
94268062|NCT01621542|322776653|FG005|Overall Study|Protocol Violation|0|||
94268063|NCT01621542|322776648|FG000|Overall Study|study stopped by sponsor|0|||
94268064|NCT01621542|322776649|FG001|Overall Study|study stopped by sponsor|0|||
94268065|NCT01621542|322776650|FG002|Overall Study|study stopped by sponsor|0|||
94268066|NCT01621542|322776651|FG003|Overall Study|study stopped by sponsor|1|||
94268067|NCT01621542|322776652|FG004|Overall Study|study stopped by sponsor|0|||
94268068|NCT01621542|322776653|FG005|Overall Study|study stopped by sponsor|0|||
94268069|NCT01235793|322776654|FG000|Overall Study|Death|6|||
94268070|NCT04695392|322776655|FG000|Overall Study|Withdrawn by parent/guardian|0|||
94268071|NCT04695392|322776656|FG001|Overall Study|Withdrawn by parent/guardian|1|||
94268072|NCT04695392|322776655|FG000|Overall Study|Withdrawn by physician|0|||
94709955|NCT02200770|324395806|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
94709956|NCT02200770|324395807|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
94709957|NCT02200770|324395806|FG000|Randomized-controlled Period (RCP)|Other|1|||
94709958|NCT02200770|324395807|FG001|Randomized-controlled Period (RCP)|Other|2|||
94268073|NCT04695392|322776656|FG001|Overall Study|Withdrawn by physician|1|||
94268074|NCT00382018|322776661|FG000|Overall Study|Progression|0|||
94268075|NCT00382018|322776662|FG001|Overall Study|Progression|136|||
94709959|NCT02200770|324395806|FG000|Open-label Period (OLP)|Adverse Event|1|||
94709960|NCT02200770|324395807|FG001|Open-label Period (OLP)|Adverse Event|2|||
94709961|NCT02200770|324395806|FG000|Open-label Period (OLP)|Death|1|||
94709962|NCT02200770|324395807|FG001|Open-label Period (OLP)|Death|2|||
94709963|NCT02200770|324395806|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
94709964|NCT02200770|324395807|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
94709965|NCT02200770|324395806|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
94709966|NCT02200770|324395807|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
94709967|NCT02200770|324395806|FG000|Open-label Period (OLP)|Other|6|||
94709968|NCT02200770|324395807|FG001|Open-label Period (OLP)|Other|15|||
94709969|NCT03475316|324395810|FG000|6 Month Intervention|Adverse Event|2|||
94709970|NCT03475316|324395811|FG001|6 Month Intervention|Adverse Event|1|||
94709971|NCT03475316|324395810|FG000|6 Month Intervention|Withdrawal by Subject|2|||
94709972|NCT03475316|324395811|FG001|6 Month Intervention|Withdrawal by Subject|0|||
94709973|NCT03475316|324395810|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
94709974|NCT03475316|324395811|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
94709975|NCT03475316|324395810|FG000|9 Months|Study stopped due to COVID pandemic|3|||
94709976|NCT03475316|324395811|FG001|9 Months|Study stopped due to COVID pandemic|4|||
94709977|NCT00959946|324395812|FG000|Overall Study|Adverse Event|0|||
94709978|NCT00959946|324395813|FG001|Overall Study|Adverse Event|0|||
94709979|NCT00959946|324395814|FG002|Overall Study|Adverse Event|2|||
94709980|NCT00959946|324395815|FG003|Overall Study|Adverse Event|1|||
94709981|NCT00959946|324395816|FG004|Overall Study|Adverse Event|0|||
94709982|NCT00959946|324395817|FG005|Overall Study|Adverse Event|1|||
94709983|NCT00959946|324395818|FG006|Overall Study|Adverse Event|0|||
94709984|NCT00959946|324395819|FG007|Overall Study|Adverse Event|0|||
94709985|NCT00959946|324395812|FG000|Overall Study|Death|0|||
94709986|NCT00959946|324395813|FG001|Overall Study|Death|0|||
94709987|NCT00959946|324395814|FG002|Overall Study|Death|0|||
94709988|NCT00959946|324395815|FG003|Overall Study|Death|0|||
94709989|NCT00959946|324395816|FG004|Overall Study|Death|0|||
94709990|NCT00959946|324395817|FG005|Overall Study|Death|1|||
94268076|NCT00382018|322776663|FG002|Overall Study|Progression|51|||
94268077|NCT00382018|322776664|FG003|Overall Study|Progression|43|||
94268078|NCT00382018|322776661|FG000|Overall Study|Death|0|||
94268079|NCT00382018|322776662|FG001|Overall Study|Death|9|||
94268080|NCT00382018|322776663|FG002|Overall Study|Death|7|||
94268081|NCT00382018|322776664|FG003|Overall Study|Death|11|||
94268082|NCT00382018|322776661|FG000|Overall Study|Withdrawal by Subject|0|||
94268083|NCT00382018|322776662|FG001|Overall Study|Withdrawal by Subject|4|||
94268084|NCT00382018|322776663|FG002|Overall Study|Withdrawal by Subject|3|||
94268085|NCT00382018|322776664|FG003|Overall Study|Withdrawal by Subject|4|||
94268086|NCT00382018|322776661|FG000|Overall Study|Other, not protocol specified|0|||
94268087|NCT00382018|322776662|FG001|Overall Study|Other, not protocol specified|16|||
94268088|NCT00382018|322776663|FG002|Overall Study|Other, not protocol specified|3|||
94268089|NCT00382018|322776664|FG003|Overall Study|Other, not protocol specified|1|||
94268090|NCT03805750|322776665|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
94268091|NCT03805750|322776666|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
94268092|NCT01436084|322776669|FG000|Overall Study|Disease Progression|2|||
94268093|NCT01436084|322776669|FG000|Overall Study|Withdrawal by Subject|1|||
94268094|NCT01436084|322776669|FG000|Overall Study|Early Closure of Study|1|||
94268095|NCT00916279|322776670|FG000|Overall Study|Death|2|||
94268096|NCT00916279|322776670|FG000|Overall Study|Lost to Follow-up|2|||
94366772|NCT01652872|323128188|FG000|Overall Study|Withdrawal by Subject|76|||
94366773|NCT01652872|323128189|FG001|Overall Study|Withdrawal by Subject|84|||
94709991|NCT00959946|324395818|FG006|Overall Study|Death|0|||
94709992|NCT00959946|324395819|FG007|Overall Study|Death|0|||
94709993|NCT00959946|324395812|FG000|Overall Study|Disease Progression|2|||
94366774|NCT00758706|323128190|FG000|Overall Study|Adverse Event|4|||
94366775|NCT00758706|323128191|FG001|Overall Study|Adverse Event|4|||
94709994|NCT00959946|324395813|FG001|Overall Study|Disease Progression|4|||
94268097|NCT02109562|322776671|FG000|Overall Study|Insufficient clinical response|2|||
94268098|NCT02109562|322776672|FG001|Overall Study|Insufficient clinical response|0|||
94268099|NCT02109562|322776673|FG002|Overall Study|Insufficient clinical response|4|||
94268100|NCT02109562|322776671|FG000|Overall Study|Adverse Event|0|||
94366776|NCT01039584|323128192|FG000|Overall Study|Withdrawal by Subject|4|||
94709995|NCT00959946|324395814|FG002|Overall Study|Disease Progression|2|||
94709996|NCT00959946|324395815|FG003|Overall Study|Disease Progression|4|||
94709997|NCT00959946|324395816|FG004|Overall Study|Disease Progression|4|||
94709998|NCT00959946|324395817|FG005|Overall Study|Disease Progression|6|||
94709999|NCT00959946|324395818|FG006|Overall Study|Disease Progression|2|||
94710000|NCT00959946|324395819|FG007|Overall Study|Disease Progression|2|||
94710001|NCT00959946|324395812|FG000|Overall Study|Withdrawal by Subject|0|||
94710002|NCT00959946|324395813|FG001|Overall Study|Withdrawal by Subject|0|||
94710003|NCT00959946|324395814|FG002|Overall Study|Withdrawal by Subject|0|||
94710004|NCT00959946|324395815|FG003|Overall Study|Withdrawal by Subject|0|||
94710005|NCT00959946|324395816|FG004|Overall Study|Withdrawal by Subject|0|||
94710006|NCT00959946|324395817|FG005|Overall Study|Withdrawal by Subject|1|||
94710007|NCT00959946|324395818|FG006|Overall Study|Withdrawal by Subject|0|||
94710008|NCT00959946|324395819|FG007|Overall Study|Withdrawal by Subject|0|||
94710009|NCT02709655|324395820|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
94710010|NCT02709655|324395821|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
94710011|NCT02709655|324395822|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
94710012|NCT02709655|324395823|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
94710013|NCT02709655|324395824|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
94710014|NCT02709655|324395820|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
94710015|NCT02709655|324395821|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
94710016|NCT02709655|324395822|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
94710017|NCT02709655|324395823|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
94268101|NCT02109562|322776672|FG001|Overall Study|Adverse Event|2|||
94268102|NCT02109562|322776673|FG002|Overall Study|Adverse Event|3|||
94268103|NCT02109562|322776671|FG000|Overall Study|Lost to Follow-up|1|||
94268104|NCT02109562|322776672|FG001|Overall Study|Lost to Follow-up|0|||
94268105|NCT02109562|322776673|FG002|Overall Study|Lost to Follow-up|1|||
94268106|NCT02109562|322776671|FG000|Overall Study|Protocol Violation|0|||
94268107|NCT02109562|322776672|FG001|Overall Study|Protocol Violation|3|||
94268108|NCT02109562|322776673|FG002|Overall Study|Protocol Violation|1|||
94268109|NCT02109562|322776671|FG000|Overall Study|Withdrawal by Subject|20|||
94268110|NCT02109562|322776672|FG001|Overall Study|Withdrawal by Subject|25|||
94268111|NCT02109562|322776673|FG002|Overall Study|Withdrawal by Subject|21|||
94268112|NCT02109562|322776671|FG000|Overall Study|Physician Decision|3|||
94268113|NCT02109562|322776672|FG001|Overall Study|Physician Decision|4|||
94268114|NCT02109562|322776673|FG002|Overall Study|Physician Decision|5|||
94268115|NCT00310804|322776674|FG000|Overall Study|Lost to Follow-up|2|||
94268116|NCT00310804|322776675|FG001|Overall Study|Lost to Follow-up|0|||
94268117|NCT00310804|322776674|FG000|Overall Study|Withdrawal by Subject|3|||
94268118|NCT00310804|322776675|FG001|Overall Study|Withdrawal by Subject|0|||
94268119|NCT04669535|322776677|FG000|Overall Study|Death|1|||
94268120|NCT04669535|322776678|FG001|Overall Study|Death|1|||
94366777|NCT01039584|323128193|FG001|Overall Study|Withdrawal by Subject|2|||
94366778|NCT01039584|323128194|FG002|Overall Study|Withdrawal by Subject|1|||
94268121|NCT04669535|322776679|FG002|Overall Study|Death|0|||
94268122|NCT04669535|322776680|FG003|Overall Study|Death|0|||
94268123|NCT00943579|322776681|FG000|Overall Study|Adverse Event|4|||
94268124|NCT00943579|322776682|FG001|Overall Study|Adverse Event|3|||
94268125|NCT00943579|322776681|FG000|Overall Study|Lack of Efficacy|2|||
94268126|NCT00943579|322776682|FG001|Overall Study|Lack of Efficacy|2|||
94268127|NCT02710136|322776683|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
94268128|NCT02710136|322776684|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
94268129|NCT00418665|322776685|FG000|Treatment Period|Ineligibility determined|1|||
94268130|NCT00418665|322776686|FG001|Treatment Period|Ineligibility determined|1|||
94268131|NCT00418665|322776687|FG002|Treatment Period|Ineligibility determined|0|||
94268132|NCT00418665|322776685|FG000|Treatment Period|Adverse Event|2|||
94268133|NCT00418665|322776686|FG001|Treatment Period|Adverse Event|2|||
94268134|NCT00418665|322776687|FG002|Treatment Period|Adverse Event|0|||
94268135|NCT00418665|322776685|FG000|Treatment Period|Withdrawal by Subject|0|||
94268136|NCT00418665|322776686|FG001|Treatment Period|Withdrawal by Subject|3|||
94268137|NCT00418665|322776687|FG002|Treatment Period|Withdrawal by Subject|1|||
94268138|NCT00418665|322776685|FG000|Treatment Period|Requirement for alternative therapy|1|||
94268139|NCT00418665|322776686|FG001|Treatment Period|Requirement for alternative therapy|0|||
94268140|NCT00418665|322776687|FG002|Treatment Period|Requirement for alternative therapy|0|||
94268141|NCT00418665|322776685|FG000|Treatment Period|Physician Decision|1|||
94268142|NCT00418665|322776686|FG001|Treatment Period|Physician Decision|0|||
94268143|NCT00418665|322776687|FG002|Treatment Period|Physician Decision|3|||
94268144|NCT00418665|322776685|FG000|Treatment Extension|Adverse Event|1|||
94268145|NCT00418665|322776686|FG001|Treatment Extension|Adverse Event|0|||
94268146|NCT00418665|322776687|FG002|Treatment Extension|Adverse Event|0|||
94268147|NCT00418665|322776685|FG000|Treatment Extension|Withdrawal by Subject|1|||
94268148|NCT00418665|322776686|FG001|Treatment Extension|Withdrawal by Subject|0|||
94268149|NCT00418665|322776687|FG002|Treatment Extension|Withdrawal by Subject|0|||
94268150|NCT00418665|322776685|FG000|Treatment Extension|Requirement for alternative therapy|2|||
94268151|NCT00418665|322776686|FG001|Treatment Extension|Requirement for alternative therapy|2|||
94268152|NCT00418665|322776687|FG002|Treatment Extension|Requirement for alternative therapy|0|||
94268153|NCT00418665|322776685|FG000|Treatment Extension|Physician Decision|2|||
94268154|NCT00418665|322776686|FG001|Treatment Extension|Physician Decision|2|||
94268155|NCT00418665|322776687|FG002|Treatment Extension|Physician Decision|1|||
94268156|NCT00418665|322776685|FG000|Treatment Extension|Death|0|||
94268157|NCT00418665|322776686|FG001|Treatment Extension|Death|0|||
94268158|NCT00418665|322776687|FG002|Treatment Extension|Death|1|||
94268159|NCT01133379|322776688|FG000|Overall Study|Withdrawal by Subject|0|||
94268160|NCT01133379|322776689|FG001|Overall Study|Withdrawal by Subject|1|||
94268161|NCT01133379|322776690|FG002|Overall Study|Withdrawal by Subject|1|||
94710018|NCT02709655|324395824|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
94268162|NCT01133379|322776688|FG000|Overall Study|Lost to Follow-up|1|||
94268163|NCT01133379|322776689|FG001|Overall Study|Lost to Follow-up|1|||
94268164|NCT01133379|322776690|FG002|Overall Study|Lost to Follow-up|1|||
94268165|NCT00121108|322776691|FG000|Overall Study|Lost to Follow-up|10|||
94268166|NCT00121108|322776692|FG001|Overall Study|Lost to Follow-up|22|||
94268167|NCT00121108|322776691|FG000|Overall Study|Withdrawal by Subject|106|||
94268168|NCT00121108|322776692|FG001|Overall Study|Withdrawal by Subject|195|||
94268169|NCT00121108|322776691|FG000|Overall Study|Death|5|||
94268170|NCT00121108|322776692|FG001|Overall Study|Death|8|||
94268171|NCT01357577|322776699|FG000|Overall Study|Lost to Follow-up|20|||
94710019|NCT02709655|324395820|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
94268172|NCT01357577|322776700|FG001|Overall Study|Lost to Follow-up|16|||
94268173|NCT01357577|322776699|FG000|Overall Study|Withdrawal by Subject|16|||
94268174|NCT01357577|322776700|FG001|Overall Study|Withdrawal by Subject|8|||
94268175|NCT01357577|322776699|FG000|Overall Study|look at data in database?|1|||
94268176|NCT01357577|322776700|FG001|Overall Study|look at data in database?|2|||
94268177|NCT02779855|322776701|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
94268178|NCT02779855|322776702|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
94268179|NCT02779855|322776703|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
94268180|NCT04998812|322776704|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
94268181|NCT04998812|322776705|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
94268182|NCT04998812|322776704|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
94268183|NCT04998812|322776705|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
94710020|NCT02709655|324395821|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
94710021|NCT02709655|324395822|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
94710022|NCT02709655|324395823|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
94268184|NCT04998812|322776704|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
94268185|NCT04998812|322776705|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
94268186|NCT04998812|322776704|FG000|Vaccination Period|Ongoing in study|23|||
94268187|NCT04998812|322776705|FG001|Vaccination Period|Ongoing in study|23|||
94268188|NCT00729378|322778429|FG000|Baseline|Did not complete study measurements|72|||
94268189|NCT00729378|322778430|FG001|Baseline|Did not complete study measurements|33|||
94268190|NCT00729378|322778429|FG000|Baseline|Withdrawal by Subject|66|||
94268191|NCT00729378|322778430|FG001|Baseline|Withdrawal by Subject|59|||
94268192|NCT00729378|322778429|FG000|12-months|Lost to Follow-up|100|||
94268193|NCT00729378|322778430|FG001|12-months|Lost to Follow-up|65|||
94268194|NCT00729378|322778429|FG000|24-months|Lost to Follow-up|72|||
94268195|NCT00729378|322778430|FG001|24-months|Lost to Follow-up|51|||
94268196|NCT00729378|322778429|FG000|36-months|Lost to Follow-up|15|||
94268197|NCT00729378|322778430|FG001|36-months|Lost to Follow-up|6|||
94268198|NCT00395863|322778431|FG000|Overall Study|Patients did not complete both exams|2|||
94268199|NCT00395863|322778432|FG001|Overall Study|Patients did not complete both exams|3|||
94268200|NCT00682448|322778435|FG000|Overall Study|Adverse Event|1|||
94268201|NCT00682448|322778436|FG001|Overall Study|Adverse Event|2|||
94268202|NCT00682448|322778435|FG000|Overall Study|Lack of Efficacy|1|||
94268203|NCT00682448|322778436|FG001|Overall Study|Lack of Efficacy|0|||
94268204|NCT00682448|322778435|FG000|Overall Study|Lost to Follow-up|1|||
94268205|NCT00682448|322778436|FG001|Overall Study|Lost to Follow-up|3|||
94268206|NCT00682448|322778435|FG000|Overall Study|Pregnancy|0|||
94268207|NCT00682448|322778436|FG001|Overall Study|Pregnancy|1|||
94268208|NCT00682448|322778435|FG000|Overall Study|Withdrawal by Subject|2|||
94268209|NCT00682448|322778436|FG001|Overall Study|Withdrawal by Subject|0|||
94268210|NCT02737852|322778437|FG000|Overall Study|Withdrawal by Subject|2|||
94268211|NCT02592551|322778438|FG000|Overall Study|Not evaluable|1|||
94268212|NCT02592551|322778439|FG001|Overall Study|Not evaluable|3|||
94268213|NCT02592551|322778440|FG002|Overall Study|Not evaluable|0|||
94268214|NCT01704287|322778441|FG000|Initial Treatment Period|Death|139|||
94268215|NCT01704287|322778442|FG001|Initial Treatment Period|Death|129|||
94268216|NCT01704287|322778443|FG002|Initial Treatment Period|Death|71|||
94268217|NCT01704287|322778444|FG003|Initial Treatment Period|Death|0|||
94268218|NCT01704287|322778445|FG004|Initial Treatment Period|Death|0|||
94268219|NCT01704287|322778441|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
94268220|NCT01704287|322778442|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
94268221|NCT01704287|322778443|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
94268222|NCT01704287|322778444|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
94268223|NCT01704287|322778445|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
94268224|NCT01704287|322778441|FG000|Initial Treatment Period|Lost to Follow-up|5|||
94268225|NCT01704287|322778442|FG001|Initial Treatment Period|Lost to Follow-up|3|||
94268226|NCT01704287|322778443|FG002|Initial Treatment Period|Lost to Follow-up|0|||
94268227|NCT01704287|322778444|FG003|Initial Treatment Period|Lost to Follow-up|0|||
94268228|NCT01704287|322778445|FG004|Initial Treatment Period|Lost to Follow-up|0|||
94268229|NCT01704287|322778441|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
94268230|NCT01704287|322778442|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
94268231|NCT01704287|322778443|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
94268232|NCT01704287|322778444|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
94268233|NCT01704287|322778445|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
94268234|NCT01704287|322778441|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
94268235|NCT01704287|322778442|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
94366779|NCT01039584|323128192|FG000|Overall Study|Protocol Violation|10|||
94366780|NCT01039584|323128193|FG001|Overall Study|Protocol Violation|4|||
94268236|NCT01704287|322778443|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
94366781|NCT01039584|323128194|FG002|Overall Study|Protocol Violation|6|||
94268237|NCT01704287|322778444|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
94268238|NCT01704287|322778445|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
94268239|NCT01704287|322778441|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
94268240|NCT01704287|322778442|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
94268241|NCT01704287|322778443|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
94268242|NCT01704287|322778444|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
94268243|NCT01704287|322778445|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
94268244|NCT01704287|322778441|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
94268245|NCT01704287|322778442|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
94268246|NCT01704287|322778443|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
94268247|NCT01704287|322778444|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
94268248|NCT01704287|322778445|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
94268249|NCT02982239|322778448|FG000|Overall Study|Lost to Follow-up|3|||
94268250|NCT02982239|322778449|FG001|Overall Study|Lost to Follow-up|2|||
94268251|NCT01717287|322778456|FG000|Overall Study|Lost to Follow-up|0|||
94268252|NCT01717287|322778457|FG001|Overall Study|Lost to Follow-up|2|||
94268253|NCT01717287|322778456|FG000|Overall Study|Protocol Violation|0|||
94268254|NCT01717287|322778457|FG001|Overall Study|Protocol Violation|1|||
94268255|NCT02953639|322778460|FG000|Overall Study|Adverse Event|2|||
94268256|NCT02953639|322778461|FG001|Overall Study|Adverse Event|0|||
94268257|NCT02953639|322778462|FG002|Overall Study|Adverse Event|1|||
94268258|NCT02953639|322778460|FG000|Overall Study|Lost to Follow-up|8|||
94268259|NCT02953639|322778461|FG001|Overall Study|Lost to Follow-up|4|||
94268260|NCT02953639|322778462|FG002|Overall Study|Lost to Follow-up|3|||
94268261|NCT02953639|322778460|FG000|Overall Study|Non-Compliance With Study Drug|0|||
94268262|NCT02953639|322778461|FG001|Overall Study|Non-Compliance With Study Drug|2|||
94268263|NCT02953639|322778462|FG002|Overall Study|Non-Compliance With Study Drug|1|||
94268264|NCT02953639|322778460|FG000|Overall Study|Multiple Reasons|1|||
94268265|NCT02953639|322778461|FG001|Overall Study|Multiple Reasons|0|||
94268266|NCT02953639|322778462|FG002|Overall Study|Multiple Reasons|1|||
94268267|NCT02953639|322778460|FG000|Overall Study|Physician Decision|1|||
94268268|NCT02953639|322778461|FG001|Overall Study|Physician Decision|0|||
94268269|NCT02953639|322778462|FG002|Overall Study|Physician Decision|0|||
94268270|NCT02953639|322778460|FG000|Overall Study|Withdrawal by Subject|7|||
94268271|NCT02953639|322778461|FG001|Overall Study|Withdrawal by Subject|8|||
94268272|NCT02953639|322778462|FG002|Overall Study|Withdrawal by Subject|10|||
94268273|NCT02953639|322778460|FG000|Overall Study|Completed or Discontinued information is missing|1|||
94268274|NCT02953639|322778461|FG001|Overall Study|Completed or Discontinued information is missing|0|||
94268275|NCT02953639|322778462|FG002|Overall Study|Completed or Discontinued information is missing|0|||
94268276|NCT04196803|322778463|FG000|Overall Study|Withdrawal by Subject|1|||
94268277|NCT04196803|322778464|FG001|Overall Study|Withdrawal by Subject|3|||
94268278|NCT04196803|322778463|FG000|Overall Study|Adverse Event|4|||
94268279|NCT04196803|322778464|FG001|Overall Study|Adverse Event|2|||
94268280|NCT04196803|322778463|FG000|Overall Study|Lost to Follow-up|0|||
94268281|NCT04196803|322778464|FG001|Overall Study|Lost to Follow-up|1|||
94268282|NCT04490395|322778465|FG000|Overall Study|Lost to Follow-up|0|||
94268283|NCT04490395|322778466|FG001|Overall Study|Lost to Follow-up|1|||
94268284|NCT01667081|322778467|FG000|Overall Study|Death|43|||
94268285|NCT01667081|322778468|FG001|Overall Study|Death|3|||
94268286|NCT01667081|322778467|FG000|Overall Study|Lost to Follow-up|99|||
94268287|NCT01667081|322778468|FG001|Overall Study|Lost to Follow-up|48|||
94268288|NCT01667081|322778467|FG000|Overall Study|Physician Decision|16|||
94268289|NCT01667081|322778468|FG001|Overall Study|Physician Decision|2|||
94268290|NCT01667081|322778467|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
94268291|NCT01667081|322778468|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
94268292|NCT01667081|322778467|FG000|Overall Study|Withdrawal by Subject|90|||
94268293|NCT01667081|322778468|FG001|Overall Study|Withdrawal by Subject|35|||
94268294|NCT00930722|322778469|FG000|Overall Study|Lost to Follow-up|16|||
94268295|NCT00930722|322778469|FG000|Overall Study|No longer willing to participate|9|||
94268296|NCT00930722|322778469|FG000|Overall Study|Study terminated by sponsor|2|||
94268297|NCT03523728|322778470|FG000|Stage 1 (24 Months)|Adverse Event|2|||
94268298|NCT03523728|322778471|FG001|Stage 1 (24 Months)|Adverse Event|2|||
94268299|NCT03523728|322778472|FG002|Stage 1 (24 Months)|Adverse Event|4|||
94268300|NCT03523728|322778473|FG003|Stage 1 (24 Months)|Adverse Event|0|||
94268301|NCT03523728|322778474|FG004|Stage 1 (24 Months)|Adverse Event|0|||
94268302|NCT03523728|322778470|FG000|Stage 1 (24 Months)|Progressive disease|0|||
94268303|NCT03523728|322778471|FG001|Stage 1 (24 Months)|Progressive disease|0|||
94268304|NCT03523728|322778472|FG002|Stage 1 (24 Months)|Progressive disease|1|||
94268305|NCT03523728|322778473|FG003|Stage 1 (24 Months)|Progressive disease|0|||
94268306|NCT03523728|322778474|FG004|Stage 1 (24 Months)|Progressive disease|0|||
94268307|NCT03523728|322778470|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
94268308|NCT03523728|322778471|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
94268309|NCT03523728|322778472|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
94268310|NCT03523728|322778473|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
94366782|NCT01039584|323128192|FG000|Overall Study|Lost to Follow-up|5|||
94366783|NCT01039584|323128193|FG001|Overall Study|Lost to Follow-up|3|||
94366784|NCT01039584|323128194|FG002|Overall Study|Lost to Follow-up|4|||
94710023|NCT02709655|324395824|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
94710024|NCT02709655|324395820|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
94710025|NCT02709655|324395821|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
94710026|NCT02709655|324395822|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
94366785|NCT01039584|323128192|FG000|Overall Study|Negative Baseline culture for Candida|59|||
94268311|NCT03523728|322778474|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
94268312|NCT03523728|322778470|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
94268313|NCT03523728|322778471|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
94268314|NCT03523728|322778472|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
94268315|NCT03523728|322778473|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
94710027|NCT02709655|324395823|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
94710028|NCT02709655|324395824|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
94710029|NCT02709655|324395820|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
94710030|NCT02709655|324395821|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
94268316|NCT03523728|322778474|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
94268317|NCT03523728|322778470|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
94268318|NCT03523728|322778471|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
94268319|NCT03523728|322778472|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
94268320|NCT03523728|322778473|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
94268321|NCT03523728|322778474|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
94710031|NCT02709655|324395822|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
94710032|NCT02709655|324395823|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
94710033|NCT02709655|324395824|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
94710034|NCT02709655|324395820|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
94710035|NCT02709655|324395821|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
94710036|NCT02709655|324395822|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
94710037|NCT02709655|324395823|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
94710038|NCT02709655|324395824|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
94710039|NCT02709655|324395820|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
94710040|NCT02709655|324395821|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
94710041|NCT02709655|324395822|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
94710042|NCT02709655|324395823|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
94710043|NCT02709655|324395824|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
94710044|NCT02709655|324395820|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
94710045|NCT02709655|324395821|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
94710046|NCT02709655|324395822|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
94710047|NCT02709655|324395823|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
94710048|NCT02709655|324395824|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
94710049|NCT02709655|324395820|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
94710050|NCT02709655|324395821|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
94710051|NCT02709655|324395822|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
94710052|NCT02709655|324395823|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
94710053|NCT02709655|324395824|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
94710054|NCT02709655|324395820|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
94710055|NCT02709655|324395821|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
94710056|NCT02709655|324395822|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
94710057|NCT02709655|324395823|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
94710058|NCT02709655|324395824|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
94268322|NCT03523728|322778470|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
94268323|NCT03523728|322778471|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
94268324|NCT03523728|322778472|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
94268325|NCT03523728|322778473|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
94268326|NCT03523728|322778474|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
94268327|NCT03523728|322778470|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
94268328|NCT03523728|322778471|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
94268329|NCT03523728|322778472|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
94268330|NCT03523728|322778473|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
94268331|NCT03523728|322778474|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
94268332|NCT03523728|322778470|FG000|Stage 2 (24 Months)|Adverse Event|0|||
94268333|NCT03523728|322778471|FG001|Stage 2 (24 Months)|Adverse Event|0|||
94268334|NCT03523728|322778472|FG002|Stage 2 (24 Months)|Adverse Event|0|||
94268335|NCT03523728|322778473|FG003|Stage 2 (24 Months)|Adverse Event|1|||
94268336|NCT03523728|322778474|FG004|Stage 2 (24 Months)|Adverse Event|2|||
94268337|NCT03523728|322778470|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
94268338|NCT03523728|322778471|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
94268339|NCT03523728|322778472|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
94268340|NCT03523728|322778473|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
94268341|NCT03523728|322778474|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
94268342|NCT03523728|322778470|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
94710059|NCT02709655|324395820|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
94710060|NCT02709655|324395821|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
94710061|NCT02709655|324395822|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
94710062|NCT02709655|324395823|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
94268343|NCT03523728|322778471|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
94268344|NCT03523728|322778472|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
94710063|NCT02709655|324395824|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
94710064|NCT02709655|324395820|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
94710065|NCT02709655|324395821|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
94710066|NCT02709655|324395822|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
94710067|NCT02709655|324395823|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
94710068|NCT02709655|324395824|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
94710069|NCT02709655|324395820|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
94710070|NCT02709655|324395821|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
94710071|NCT02709655|324395822|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
94710072|NCT02709655|324395823|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
94710073|NCT02709655|324395824|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
94710074|NCT02709655|324395820|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
94710075|NCT02709655|324395821|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
94710076|NCT02709655|324395822|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
94710077|NCT02709655|324395823|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
94710078|NCT02709655|324395824|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
94710079|NCT02709655|324395820|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
94710080|NCT02709655|324395821|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
94710081|NCT02709655|324395822|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
94710082|NCT02709655|324395823|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
94710083|NCT02709655|324395824|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
94710084|NCT02709655|324395820|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
94710085|NCT02709655|324395821|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
94710086|NCT02709655|324395822|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
94710087|NCT02709655|324395823|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
94710088|NCT02709655|324395824|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
94710089|NCT04210180|324395825|FG000|Overall Study|Withdrawal by Subject|2|||
94710090|NCT01179334|324395826|FG000|Treatment Period|Adverse Event|1|||
94710091|NCT01179334|324395827|FG001|Treatment Period|Adverse Event|0|||
94710092|NCT01179334|324395826|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
94710093|NCT01179334|324395827|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
94710094|NCT01179334|324395826|FG000|Long-term Extension (LTE) Period|Death|3|||
94710095|NCT01179334|324395827|FG001|Long-term Extension (LTE) Period|Death|0|||
94710096|NCT01179334|324395826|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
94710097|NCT01179334|324395827|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
94710098|NCT04740164|324395829|FG000|Overall Study|Lack of Efficacy|4|||
94710099|NCT04740164|324395830|FG001|Overall Study|Lack of Efficacy|0|||
94710100|NCT04740164|324395829|FG000|Overall Study|Physician Decision|3|||
94710101|NCT04740164|324395830|FG001|Overall Study|Physician Decision|3|||
94710102|NCT02158091|324395831|FG000|Overall Study|DLT|2|||
94710103|NCT02158091|324395832|FG001|Overall Study|DLT|1|||
94710104|NCT02158091|324395833|FG002|Overall Study|DLT|0|||
94268345|NCT03523728|322778473|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
94268346|NCT03523728|322778474|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
94268347|NCT03523728|322778470|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
94268348|NCT03523728|322778471|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
94268349|NCT03523728|322778472|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
94268350|NCT03523728|322778473|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
94268351|NCT03523728|322778474|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
94268352|NCT03523728|322778470|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
94268353|NCT03523728|322778471|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
94268354|NCT03523728|322778472|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
94268355|NCT03523728|322778473|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
94268356|NCT03523728|322778474|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
94268357|NCT03583450|322778475|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
94268358|NCT03583450|322778476|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
94268359|NCT03593850|322778477|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
94710105|NCT00834834|324395836|FG000|Overall Study|Withdrawal by Subject|4|||
94710106|NCT00834834|324395837|FG001|Overall Study|Withdrawal by Subject|3|||
94710107|NCT00997386|324395842|FG000|Overall Study|Death|7|||
94268360|NCT03593850|322778478|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
94268361|NCT01735279|322778481|FG000|Overall Study|Lost to Follow-up|11|||
94268362|NCT01735279|322778482|FG001|Overall Study|Lost to Follow-up|8|||
94268363|NCT00467779|322778484|FG000|Stage 1|Adverse Event|1|||
94268364|NCT00467779|322778485|FG001|Stage 1|Adverse Event|0|||
94268365|NCT00467779|322778486|FG002|Stage 1|Adverse Event|0|||
94268366|NCT00467779|322778487|FG003|Stage 1|Adverse Event|0|||
94268367|NCT00467779|322778488|FG004|Stage 1|Adverse Event|0|||
94268368|NCT00467779|322778489|FG005|Stage 1|Adverse Event|1|||
94268369|NCT00467779|322778490|FG006|Stage 1|Adverse Event|2|||
94268370|NCT00467779|322778491|FG007|Stage 1|Adverse Event|1|||
94268371|NCT00467779|322778492|FG008|Stage 1|Adverse Event|0|||
94268372|NCT00467779|322778493|FG009|Stage 1|Adverse Event|0|||
94268373|NCT00467779|322778494|FG010|Stage 1|Adverse Event|0|||
94268374|NCT00467779|322778495|FG011|Stage 1|Adverse Event|0|||
94268375|NCT00467779|322778496|FG012|Stage 1|Adverse Event|0|||
94268376|NCT00467779|322778497|FG013|Stage 1|Adverse Event|0|||
94268377|NCT00467779|322778498|FG014|Stage 1|Adverse Event|0|||
94268378|NCT00467779|322778484|FG000|Stage 1|Disease Progression|2|||
94268379|NCT00467779|322778485|FG001|Stage 1|Disease Progression|2|||
94268380|NCT00467779|322778486|FG002|Stage 1|Disease Progression|2|||
94268381|NCT00467779|322778487|FG003|Stage 1|Disease Progression|3|||
94268382|NCT00467779|322778488|FG004|Stage 1|Disease Progression|2|||
94268383|NCT00467779|322778489|FG005|Stage 1|Disease Progression|2|||
94268384|NCT00467779|322778490|FG006|Stage 1|Disease Progression|4|||
94268385|NCT00467779|322778491|FG007|Stage 1|Disease Progression|5|||
94268386|NCT00467779|322778492|FG008|Stage 1|Disease Progression|0|||
94268387|NCT00467779|322778493|FG009|Stage 1|Disease Progression|0|||
94366786|NCT01039584|323128193|FG001|Overall Study|Negative Baseline culture for Candida|59|||
94366787|NCT01039584|323128194|FG002|Overall Study|Negative Baseline culture for Candida|24|||
94710108|NCT01810263|324395849|FG000|Overall Study|Lost to Follow-up|8|||
94710109|NCT01810263|324395850|FG001|Overall Study|Lost to Follow-up|7|||
94710110|NCT01353963|324395855|FG000|Overall Study|Adverse Event|2|||
94710111|NCT01239316|324395861|FG000|Overall Study|Progression/Relapse|11|||
94710112|NCT01239316|324395861|FG000|Overall Study|Adverse Event|1|||
94710113|NCT01616459|324395866|FG000|Overall Study|Adverse Event|1|||
94710114|NCT01616459|324395867|FG001|Overall Study|Adverse Event|1|||
94710115|NCT01616459|324395868|FG002|Overall Study|Adverse Event|2|||
94710116|NCT01616459|324395869|FG003|Overall Study|Adverse Event|0|||
94710117|NCT01616459|324395866|FG000|Overall Study|Lost to Follow-up|1|||
94710118|NCT01616459|324395867|FG001|Overall Study|Lost to Follow-up|11|||
94710119|NCT01616459|324395868|FG002|Overall Study|Lost to Follow-up|3|||
94710120|NCT01616459|324395869|FG003|Overall Study|Lost to Follow-up|2|||
94710121|NCT01616459|324395866|FG000|Overall Study|Protocol Violation|0|||
94710122|NCT01616459|324395867|FG001|Overall Study|Protocol Violation|0|||
94710123|NCT01616459|324395868|FG002|Overall Study|Protocol Violation|0|||
94710124|NCT01616459|324395869|FG003|Overall Study|Protocol Violation|2|||
94710125|NCT01616459|324395866|FG000|Overall Study|Withdrawal by Subject|2|||
94710126|NCT01616459|324395867|FG001|Overall Study|Withdrawal by Subject|4|||
94710127|NCT01616459|324395868|FG002|Overall Study|Withdrawal by Subject|4|||
94710128|NCT01616459|324395869|FG003|Overall Study|Withdrawal by Subject|4|||
94710129|NCT01616459|324395866|FG000|Overall Study|Other reason|0|||
94710130|NCT01616459|324395867|FG001|Overall Study|Other reason|1|||
94710131|NCT01616459|324395868|FG002|Overall Study|Other reason|1|||
94710132|NCT01616459|324395869|FG003|Overall Study|Other reason|0|||
94710133|NCT01420549|324395870|FG000|Overall Study|Adverse Event|1|||
94366788|NCT01039584|323128192|FG000|Overall Study|Lack of Efficacy|7|||
94710134|NCT01420549|324395871|FG001|Overall Study|Adverse Event|1|||
94710135|NCT01420549|324395870|FG000|Overall Study|Lost to Follow-up|2|||
94710136|NCT01420549|324395871|FG001|Overall Study|Lost to Follow-up|2|||
94268388|NCT00467779|322778494|FG010|Stage 1|Disease Progression|0|||
94268389|NCT00467779|322778495|FG011|Stage 1|Disease Progression|0|||
94268390|NCT00467779|322778496|FG012|Stage 1|Disease Progression|0|||
94268391|NCT00467779|322778497|FG013|Stage 1|Disease Progression|0|||
94268392|NCT00467779|322778498|FG014|Stage 1|Disease Progression|0|||
94268393|NCT00467779|322778484|FG000|Stage 1|Unspecified Reason|1|||
94268394|NCT00467779|322778485|FG001|Stage 1|Unspecified Reason|0|||
94268395|NCT00467779|322778486|FG002|Stage 1|Unspecified Reason|1|||
94268396|NCT00467779|322778487|FG003|Stage 1|Unspecified Reason|0|||
94268397|NCT00467779|322778488|FG004|Stage 1|Unspecified Reason|1|||
94268398|NCT00467779|322778489|FG005|Stage 1|Unspecified Reason|2|||
94268399|NCT00467779|322778490|FG006|Stage 1|Unspecified Reason|0|||
94268400|NCT00467779|322778491|FG007|Stage 1|Unspecified Reason|0|||
94268401|NCT00467779|322778492|FG008|Stage 1|Unspecified Reason|0|||
94268402|NCT00467779|322778493|FG009|Stage 1|Unspecified Reason|0|||
94268403|NCT00467779|322778494|FG010|Stage 1|Unspecified Reason|0|||
94268404|NCT00467779|322778495|FG011|Stage 1|Unspecified Reason|0|||
94268405|NCT00467779|322778496|FG012|Stage 1|Unspecified Reason|0|||
94268406|NCT00467779|322778497|FG013|Stage 1|Unspecified Reason|0|||
94268407|NCT00467779|322778498|FG014|Stage 1|Unspecified Reason|0|||
94268408|NCT00467779|322778484|FG000|Stage 1|Physician Decision|0|||
94710137|NCT01420549|324395870|FG000|Overall Study|Protocol Violation|0|||
94710138|NCT01420549|324395871|FG001|Overall Study|Protocol Violation|1|||
94710139|NCT01420549|324395870|FG000|Overall Study|Non-adherence to medication|4|||
94710140|NCT01420549|324395871|FG001|Overall Study|Non-adherence to medication|1|||
94710141|NCT04257058|324397198|FG000|Overall Study|Lost to Follow-up|31|||
94710142|NCT02396316|324397222|FG000|Overall Study|Physician Decision|1|||
94710143|NCT02396316|324397223|FG001|Overall Study|Physician Decision|0|||
94710144|NCT02396316|324397222|FG000|Overall Study|Progressive disease|6|||
94710145|NCT02396316|324397223|FG001|Overall Study|Progressive disease|3|||
94710146|NCT02396316|324397222|FG000|Overall Study|Protocol Violation|0|||
94710147|NCT02396316|324397223|FG001|Overall Study|Protocol Violation|1|||
94710148|NCT02396316|324397222|FG000|Overall Study|Treatment unblinded|0|||
94710149|NCT02396316|324397223|FG001|Overall Study|Treatment unblinded|1|||
94710150|NCT03544515|324397225|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
94710151|NCT03544515|324397226|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
94710152|NCT03544515|324397225|FG000|Overall Study|Lost to Follow-up|2|||
94710153|NCT03544515|324397226|FG001|Overall Study|Lost to Follow-up|0|||
94710154|NCT03175172|324397227|FG000|Overall Study|Death|3|||
94710155|NCT03175172|324397227|FG000|Overall Study|Withdrawal by Subject|3|||
94710156|NCT03175172|324397227|FG000|Overall Study|Lost to Follow-up|1|||
94710157|NCT03175172|324397227|FG000|Overall Study|Study Terminated by Sponsor|3|||
94710158|NCT03169244|324397228|FG000|Overall Study|Lost to Follow-up|1|||
94710159|NCT03169244|324397229|FG001|Overall Study|Lost to Follow-up|2|||
94710160|NCT03169244|324397228|FG000|Overall Study|Adverse Event|1|||
94710161|NCT03169244|324397229|FG001|Overall Study|Adverse Event|0|||
94710162|NCT03169244|324397228|FG000|Overall Study|Withdrawal by Subject|2|||
94710163|NCT03169244|324397229|FG001|Overall Study|Withdrawal by Subject|2|||
94710164|NCT03169244|324397228|FG000|Overall Study|Physician Decision|1|||
94710165|NCT03169244|324397229|FG001|Overall Study|Physician Decision|0|||
94710166|NCT05731700|324397230|FG000|Overall Study|Death|1|||
94710167|NCT02383472|324397231|FG000|Overall Study|Withdrawal by Subject|1|||
94710168|NCT02383472|324397232|FG001|Overall Study|Withdrawal by Subject|1|||
94710169|NCT03262935|324397233|FG000|Overall Study|Withdrawal by Subject|6|||
94710170|NCT03262935|324397234|FG001|Overall Study|Withdrawal by Subject|7|||
94710171|NCT03262935|324397233|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
94710172|NCT03262935|324397234|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
94710173|NCT03262935|324397233|FG000|Overall Study|Death|181|||
94710174|NCT03262935|324397234|FG001|Overall Study|Death|94|||
94710175|NCT03262935|324397233|FG000|Overall Study|Lost to Follow-up|9|||
94710176|NCT03262935|324397234|FG001|Overall Study|Lost to Follow-up|4|||
94710177|NCT03262935|324397233|FG000|Overall Study|Other reason|5|||
94710178|NCT03262935|324397234|FG001|Overall Study|Other reason|0|||
94268409|NCT00467779|322778485|FG001|Stage 1|Physician Decision|1|||
94268410|NCT00467779|322778486|FG002|Stage 1|Physician Decision|0|||
94268411|NCT00467779|322778487|FG003|Stage 1|Physician Decision|0|||
94268412|NCT00467779|322778488|FG004|Stage 1|Physician Decision|0|||
94268413|NCT00467779|322778489|FG005|Stage 1|Physician Decision|0|||
94268414|NCT00467779|322778490|FG006|Stage 1|Physician Decision|0|||
94268415|NCT00467779|322778491|FG007|Stage 1|Physician Decision|0|||
94268416|NCT00467779|322778492|FG008|Stage 1|Physician Decision|0|||
94710179|NCT01811706|324397235|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
94710180|NCT01811706|324397236|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
94710181|NCT02296424|324397237|FG000|Part 1|New therapy for study indication|0|||
94710182|NCT02296424|324397238|FG001|Part 1|New therapy for study indication|1|||
94710183|NCT02296424|324397239|FG002|Part 1|New therapy for study indication|0|||
94710184|NCT02296424|324397240|FG003|Part 1|New therapy for study indication|0|||
94710185|NCT02296424|324397237|FG000|Part 1|Protocol Violation|0|||
94710186|NCT02296424|324397238|FG001|Part 1|Protocol Violation|1|||
94710187|NCT02296424|324397239|FG002|Part 1|Protocol Violation|0|||
94710188|NCT02296424|324397240|FG003|Part 1|Protocol Violation|0|||
94710189|NCT02296424|324397237|FG000|Part 1|Withdrawal by Subject|0|||
94710190|NCT02296424|324397238|FG001|Part 1|Withdrawal by Subject|2|||
94710191|NCT02296424|324397239|FG002|Part 1|Withdrawal by Subject|0|||
94710192|NCT02296424|324397240|FG003|Part 1|Withdrawal by Subject|0|||
94710193|NCT02296424|324397237|FG000|Part 1|Study terminated by sponsor|0|||
94710194|NCT02296424|324397238|FG001|Part 1|Study terminated by sponsor|1|||
94710195|NCT02296424|324397239|FG002|Part 1|Study terminated by sponsor|0|||
94710196|NCT02296424|324397240|FG003|Part 1|Study terminated by sponsor|0|||
94710197|NCT02296424|324397237|FG000|Part 1|Adverse Event|2|||
94710198|NCT02296424|324397238|FG001|Part 1|Adverse Event|11|||
94710199|NCT02296424|324397239|FG002|Part 1|Adverse Event|0|||
94710200|NCT02296424|324397240|FG003|Part 1|Adverse Event|0|||
94710201|NCT02296424|324397237|FG000|Part 1|Lack of Efficacy|5|||
94710202|NCT02296424|324397238|FG001|Part 1|Lack of Efficacy|17|||
94710203|NCT02296424|324397239|FG002|Part 1|Lack of Efficacy|0|||
94710204|NCT02296424|324397240|FG003|Part 1|Lack of Efficacy|0|||
94710205|NCT02296424|324397237|FG000|Part 1|16 directly started part II|16|||
94710206|NCT02296424|324397238|FG001|Part 1|16 directly started part II|0|||
94710207|NCT02296424|324397239|FG002|Part 1|16 directly started part II|0|||
94710208|NCT02296424|324397240|FG003|Part 1|16 directly started part II|0|||
94710209|NCT02296424|324397237|FG000|Part 2|Lack of Efficacy|0|||
94710210|NCT02296424|324397238|FG001|Part 2|Lack of Efficacy|0|||
94710211|NCT02296424|324397239|FG002|Part 2|Lack of Efficacy|1|||
94710212|NCT02296424|324397240|FG003|Part 2|Lack of Efficacy|0|||
94710213|NCT02296424|324397237|FG000|Part 2|Adverse Event|0|||
94710214|NCT02296424|324397238|FG001|Part 2|Adverse Event|0|||
94710215|NCT02296424|324397239|FG002|Part 2|Adverse Event|1|||
94710216|NCT02296424|324397240|FG003|Part 2|Adverse Event|0|||
94710217|NCT02296424|324397237|FG000|Part 2|Lost to Follow-up|0|||
94710218|NCT02296424|324397238|FG001|Part 2|Lost to Follow-up|0|||
94710219|NCT02296424|324397239|FG002|Part 2|Lost to Follow-up|1|||
94710220|NCT02296424|324397240|FG003|Part 2|Lost to Follow-up|0|||
94710221|NCT00807144|324397243|FG000|Overall Study|Lost to Follow-up|0|||
94710222|NCT00807144|324397244|FG001|Overall Study|Lost to Follow-up|1|||
94710223|NCT03287622|324397247|FG000|Overall Study|Withdrawal by Subject|1|||
94710224|NCT03287622|324397248|FG001|Overall Study|Withdrawal by Subject|0|||
94710225|NCT03287622|324397247|FG000|Overall Study|Lost to Follow-up|27|||
94710226|NCT03287622|324397248|FG001|Overall Study|Lost to Follow-up|15|||
94710227|NCT03287622|324397247|FG000|Overall Study|No prescripion after surgery|28|||
94710228|NCT03287622|324397248|FG001|Overall Study|No prescripion after surgery|31|||
94710229|NCT03287622|324397247|FG000|Overall Study|prolonged Length of stay|2|||
94710230|NCT03287622|324397248|FG001|Overall Study|prolonged Length of stay|0|||
94710231|NCT03287622|324397247|FG000|Overall Study|surgery related|0|||
94710232|NCT03287622|324397248|FG001|Overall Study|surgery related|2|||
94710233|NCT05876949|324397252|FG000|Overall Study|Withdrawal by Subject|1|||
94710234|NCT05876949|324397253|FG001|Overall Study|Withdrawal by Subject|3|||
94710235|NCT05876949|324397252|FG000|Overall Study|Physician Decision|0|||
94710236|NCT05876949|324397253|FG001|Overall Study|Physician Decision|2|||
94710237|NCT05876949|324397252|FG000|Overall Study|Death|0|||
94710238|NCT05876949|324397253|FG001|Overall Study|Death|1|||
94710239|NCT00494780|324397254|FG000|Overall Study|Adverse Event|1|||
94710240|NCT00494780|324397255|FG001|Overall Study|Adverse Event|0|||
94710241|NCT00494780|324397254|FG000|Overall Study|Withdrew before Dosed|0|||
94710242|NCT00494780|324397255|FG001|Overall Study|Withdrew before Dosed|1|||
94710243|NCT00494780|324397254|FG000|Overall Study|Progression of Study Disease|7|||
94710244|NCT00494780|324397255|FG001|Overall Study|Progression of Study Disease|8|||
94710245|NCT00494780|324397254|FG000|Overall Study|New Treatment|2|||
94710246|NCT00494780|324397255|FG001|Overall Study|New Treatment|2|||
94710247|NCT00494780|324397254|FG000|Overall Study|Non-compliance|1|||
94710248|NCT00494780|324397255|FG001|Overall Study|Non-compliance|0|||
94710249|NCT00494780|324397254|FG000|Overall Study|Residual Tumour Mass|0|||
94710250|NCT00494780|324397255|FG001|Overall Study|Residual Tumour Mass|1|||
94710251|NCT00494780|324397254|FG000|Overall Study|Insurance Issues|0|||
94710252|NCT00494780|324397255|FG001|Overall Study|Insurance Issues|1|||
94710253|NCT03061474|324397256|FG000|Overall Study|Adverse Event|2|||
94710254|NCT03061474|324397257|FG001|Overall Study|Adverse Event|0|||
94710255|NCT03061474|324397256|FG000|Overall Study|Safety Risk|0|||
94710256|NCT03061474|324397257|FG001|Overall Study|Safety Risk|1|||
94710257|NCT03061474|324397256|FG000|Overall Study|Participant unwilling or unable to participate|0|||
94710258|NCT03061474|324397257|FG001|Overall Study|Participant unwilling or unable to participate|2|||
94710259|NCT03061474|324397256|FG000|Overall Study|Lost to Follow-up|0|||
94710260|NCT03061474|324397257|FG001|Overall Study|Lost to Follow-up|1|||
94710261|NCT01147341|324397258|FG000|Double Blind Period|Lack of Efficacy|1|||
94710262|NCT01147341|324397259|FG001|Double Blind Period|Lack of Efficacy|1|||
94710263|NCT01147341|324397258|FG000|Double Blind Period|Withdrawal by Subject|0|||
94710264|NCT01147341|324397259|FG001|Double Blind Period|Withdrawal by Subject|1|||
94710265|NCT01147341|324397258|FG000|Open Label Period|Lack of Efficacy|3|||
94710266|NCT01147341|324397259|FG001|Open Label Period|Lack of Efficacy|0|||
94710267|NCT01147341|324397258|FG000|Open Label Period|Subject moved|1|||
94710268|NCT01147341|324397259|FG001|Open Label Period|Subject moved|0|||
94710269|NCT02888080|324397260|FG000|Overall Study|Subject / Guardian decision|1|||
94710270|NCT02888080|324397261|FG001|Overall Study|Subject / Guardian decision|3|||
94710271|NCT02888080|324397260|FG000|Overall Study|New Therapy for study indication|1|||
94710272|NCT02888080|324397261|FG001|Overall Study|New Therapy for study indication|0|||
94710273|NCT02888080|324397260|FG000|Overall Study|Lack of Efficacy|0|||
94710274|NCT02888080|324397261|FG001|Overall Study|Lack of Efficacy|1|||
94710275|NCT02888080|324397260|FG000|Overall Study|Adverse Event|0|||
94710276|NCT02888080|324397261|FG001|Overall Study|Adverse Event|1|||
94710277|NCT04439799|324397262|FG000|Overall Study|Lost to Follow-up|6|||
94710278|NCT04439799|324397263|FG001|Overall Study|Lost to Follow-up|6|||
94710279|NCT04439799|324397262|FG000|Overall Study|Withdrawal by Subject|2|||
94710280|NCT04439799|324397263|FG001|Overall Study|Withdrawal by Subject|6|||
94710281|NCT04439799|324397262|FG000|Overall Study|Adverse Event|2|||
94710282|NCT04439799|324397263|FG001|Overall Study|Adverse Event|5|||
94710283|NCT02878330|324397269|FG000|Overall Study|Death|3|||
94710284|NCT02878330|324397270|FG001|Overall Study|Death|2|||
94710285|NCT02878330|324397269|FG000|Overall Study|Lost to Follow-up|11|||
94710286|NCT02878330|324397270|FG001|Overall Study|Lost to Follow-up|26|||
94710287|NCT02878330|324397269|FG000|Overall Study|Withdrawal by Subject|11|||
94710288|NCT02878330|324397270|FG001|Overall Study|Withdrawal by Subject|21|||
94710289|NCT02878330|324397269|FG000|Overall Study|Other|4|||
94710290|NCT02878330|324397270|FG001|Overall Study|Other|7|||
94710291|NCT00189202|324397271|FG000|Overall Study|Physician Decision|5|||
94710292|NCT00665444|324397272|FG000|Overall Study|Physician Decision|1|||
94710293|NCT00665444|324397272|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
94710294|NCT02425111|324397277|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
94710295|NCT02425111|324397277|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
94710296|NCT02425111|324397277|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
94710297|NCT02425111|324397277|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
94710298|NCT02425111|324397277|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
94710299|NCT02425111|324397277|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
94710300|NCT00463788|324397278|FG000|Overall Study|Progressive Disease|86|||
94710301|NCT00463788|324397279|FG001|Overall Study|Progressive Disease|42|||
94710302|NCT00463788|324397278|FG000|Overall Study|Adverse Event|6|||
94710303|NCT00463788|324397279|FG001|Overall Study|Adverse Event|2|||
94710304|NCT00463788|324397278|FG000|Overall Study|Withdrawal by Subject|6|||
94710305|NCT00463788|324397279|FG001|Overall Study|Withdrawal by Subject|2|||
94710306|NCT00463788|324397278|FG000|Overall Study|Death|4|||
94710307|NCT00463788|324397279|FG001|Overall Study|Death|3|||
94710308|NCT00463788|324397278|FG000|Overall Study|Symptomatic Deterioration|2|||
94710309|NCT00463788|324397279|FG001|Overall Study|Symptomatic Deterioration|3|||
94710310|NCT00463788|324397278|FG000|Overall Study|Lost to Follow-up|1|||
94710311|NCT00463788|324397279|FG001|Overall Study|Lost to Follow-up|0|||
94710312|NCT00463788|324397278|FG000|Overall Study|Protocol Violation|0|||
94710313|NCT00463788|324397279|FG001|Overall Study|Protocol Violation|1|||
94710314|NCT00463788|324397278|FG000|Overall Study|Other|3|||
94466257|NCT01358578|323496956|FG005|Maintenance Period|Lost to Follow-up|1|||
94466258|NCT01358578|323496951|FG000|Maintenance Period|Non-compliance with study treatment|3|||
94466259|NCT01358578|323496952|FG001|Maintenance Period|Non-compliance with study treatment|1|||
94466260|NCT01358578|323496953|FG002|Maintenance Period|Non-compliance with study treatment|0|||
94466261|NCT01358578|323496954|FG003|Maintenance Period|Non-compliance with study treatment|2|||
94466262|NCT01358578|323496955|FG004|Maintenance Period|Non-compliance with study treatment|1|||
94466263|NCT01358578|323496956|FG005|Maintenance Period|Non-compliance with study treatment|2|||
94466264|NCT01358578|323496951|FG000|Maintenance Period|Physician Decision|0|||
94466265|NCT01358578|323496952|FG001|Maintenance Period|Physician Decision|1|||
94466266|NCT01358578|323496953|FG002|Maintenance Period|Physician Decision|0|||
94710315|NCT00463788|324397279|FG001|Overall Study|Other|0|||
94710316|NCT00463788|324397278|FG000|Overall Study|Randomized but not treated|1|||
94710317|NCT00463788|324397279|FG001|Overall Study|Randomized but not treated|1|||
94710318|NCT00360698|324397280|FG000|Run-In|Physician Decision|0|||
94710319|NCT00360698|324397281|FG001|Run-In|Physician Decision|1|||
94710320|NCT00360698|324397280|FG000|Run-In|Withdrawal by Subject|0|||
94710321|NCT00360698|324397281|FG001|Run-In|Withdrawal by Subject|2|||
94710322|NCT00360698|324397280|FG000|Run-In|Non compliance with treatment procedure|0|||
94710323|NCT00360698|324397281|FG001|Run-In|Non compliance with treatment procedure|1|||
94710324|NCT00360698|324397280|FG000|Run-In|Sponsor request|0|||
94710325|NCT00360698|324397281|FG001|Run-In|Sponsor request|2|||
94710326|NCT00360698|324397280|FG000|Run-In|Patient did not meet inclusion criteria|0|||
94710327|NCT00360698|324397281|FG001|Run-In|Patient did not meet inclusion criteria|1|||
94710328|NCT00360698|324397280|FG000|Run-In|Patient personal reasons|0|||
94710329|NCT00360698|324397281|FG001|Run-In|Patient personal reasons|2|||
94710330|NCT00360698|324397280|FG000|Run-In|Need of insulin with meals|0|||
94710331|NCT00360698|324397281|FG001|Run-In|Need of insulin with meals|1|||
94710332|NCT00360698|324397280|FG000|Treatment Period|Non compliance with treatment procedure|1|||
94710333|NCT00360698|324397281|FG001|Treatment Period|Non compliance with treatment procedure|0|||
94268417|NCT00467779|322778493|FG009|Stage 1|Physician Decision|0|||
94268418|NCT00467779|322778494|FG010|Stage 1|Physician Decision|0|||
94268419|NCT00467779|322778495|FG011|Stage 1|Physician Decision|0|||
94268420|NCT00467779|322778496|FG012|Stage 1|Physician Decision|0|||
94268421|NCT00467779|322778497|FG013|Stage 1|Physician Decision|0|||
94268422|NCT00467779|322778498|FG014|Stage 1|Physician Decision|0|||
94268423|NCT00467779|322778484|FG000|Stage 1|Withdrawal by Subject|0|||
94268424|NCT00467779|322778485|FG001|Stage 1|Withdrawal by Subject|0|||
94268425|NCT00467779|322778486|FG002|Stage 1|Withdrawal by Subject|0|||
94268426|NCT00467779|322778487|FG003|Stage 1|Withdrawal by Subject|0|||
94268427|NCT00467779|322778488|FG004|Stage 1|Withdrawal by Subject|0|||
94268428|NCT00467779|322778489|FG005|Stage 1|Withdrawal by Subject|0|||
94268429|NCT00467779|322778490|FG006|Stage 1|Withdrawal by Subject|1|||
94268430|NCT00467779|322778491|FG007|Stage 1|Withdrawal by Subject|1|||
94268431|NCT00467779|322778492|FG008|Stage 1|Withdrawal by Subject|0|||
94268432|NCT00467779|322778493|FG009|Stage 1|Withdrawal by Subject|0|||
94268433|NCT00467779|322778494|FG010|Stage 1|Withdrawal by Subject|0|||
94268434|NCT00467779|322778495|FG011|Stage 1|Withdrawal by Subject|0|||
94268435|NCT00467779|322778496|FG012|Stage 1|Withdrawal by Subject|0|||
94268436|NCT00467779|322778497|FG013|Stage 1|Withdrawal by Subject|0|||
94710334|NCT00360698|324397280|FG000|Treatment Period|Early termination by error|0|||
94710335|NCT00360698|324397281|FG001|Treatment Period|Early termination by error|1|||
94710336|NCT01692938|324397284|FG000|Overall Study|Protocol Deviation|1|||
94710337|NCT01692938|324397285|FG001|Overall Study|Protocol Deviation|1|||
94710338|NCT01692938|324397284|FG000|Overall Study|Study completed prior to site completion|3|||
94710339|NCT01692938|324397285|FG001|Overall Study|Study completed prior to site completion|3|||
94710340|NCT05283395|324397286|FG000|Overall Study|Adverse Event|4|||
94710341|NCT05283395|324397287|FG001|Overall Study|Adverse Event|4|||
94710342|NCT05283395|324397288|FG002|Overall Study|Adverse Event|0|||
94710343|NCT05283395|324397286|FG000|Overall Study|Patient Lost to Follow-Up|0|||
94710344|NCT05283395|324397287|FG001|Overall Study|Patient Lost to Follow-Up|0|||
94710345|NCT05283395|324397288|FG002|Overall Study|Patient Lost to Follow-Up|1|||
94710346|NCT05283395|324397286|FG000|Overall Study|Patient Withdrawal|2|||
94710347|NCT05283395|324397287|FG001|Overall Study|Patient Withdrawal|4|||
94710348|NCT05283395|324397288|FG002|Overall Study|Patient Withdrawal|2|||
94710349|NCT05283395|324397286|FG000|Overall Study|Investigator Decision|1|||
94710350|NCT05283395|324397287|FG001|Overall Study|Investigator Decision|0|||
94710351|NCT05283395|324397288|FG002|Overall Study|Investigator Decision|1|||
94710352|NCT05283395|324397286|FG000|Overall Study|Enrolled in error|0|||
94710353|NCT05283395|324397287|FG001|Overall Study|Enrolled in error|0|||
94710354|NCT05283395|324397288|FG002|Overall Study|Enrolled in error|1|||
94710355|NCT03401112|324397289|FG000|Overall Study|Adverse Event|1|||
94710356|NCT03401112|324397290|FG001|Overall Study|Adverse Event|2|||
94710357|NCT03401112|324397291|FG002|Overall Study|Adverse Event|3|||
94710358|NCT03401112|324397292|FG003|Overall Study|Adverse Event|2|||
94710359|NCT03401112|324397293|FG004|Overall Study|Adverse Event|0|||
94710360|NCT03401112|324397289|FG000|Overall Study|Lost to Follow-up|1|||
94710361|NCT03401112|324397290|FG001|Overall Study|Lost to Follow-up|0|||
94710362|NCT03401112|324397291|FG002|Overall Study|Lost to Follow-up|0|||
94710363|NCT03401112|324397292|FG003|Overall Study|Lost to Follow-up|0|||
94710364|NCT03401112|324397293|FG004|Overall Study|Lost to Follow-up|0|||
94710365|NCT03401112|324397289|FG000|Overall Study|Noncompliance|1|||
94710366|NCT03401112|324397290|FG001|Overall Study|Noncompliance|2|||
94710367|NCT03401112|324397291|FG002|Overall Study|Noncompliance|3|||
94710368|NCT03401112|324397292|FG003|Overall Study|Noncompliance|0|||
94710369|NCT03401112|324397293|FG004|Overall Study|Noncompliance|0|||
94710370|NCT03401112|324397289|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
94710371|NCT03401112|324397290|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
94710372|NCT03401112|324397291|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
94710373|NCT03401112|324397292|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
94710374|NCT03401112|324397293|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
94710375|NCT03401112|324397289|FG000|Overall Study|Withdrawal by Subject|0|||
94710376|NCT03401112|324397290|FG001|Overall Study|Withdrawal by Subject|3|||
94710377|NCT03401112|324397291|FG002|Overall Study|Withdrawal by Subject|2|||
94710378|NCT03401112|324397292|FG003|Overall Study|Withdrawal by Subject|1|||
94710379|NCT03401112|324397293|FG004|Overall Study|Withdrawal by Subject|0|||
94268437|NCT00467779|322778498|FG014|Stage 1|Withdrawal by Subject|0|||
94268438|NCT00467779|322778484|FG000|Stage 1A|Adverse Event|0|||
94710380|NCT03401112|324397289|FG000|Overall Study|Physician Decision|0|||
94710381|NCT03401112|324397290|FG001|Overall Study|Physician Decision|0|||
94268439|NCT00467779|322778485|FG001|Stage 1A|Adverse Event|0|||
94268440|NCT00467779|322778486|FG002|Stage 1A|Adverse Event|0|||
94710382|NCT03401112|324397291|FG002|Overall Study|Physician Decision|0|||
94710383|NCT03401112|324397292|FG003|Overall Study|Physician Decision|2|||
94710384|NCT03401112|324397293|FG004|Overall Study|Physician Decision|0|||
94710385|NCT03401112|324397289|FG000|Overall Study|Study was Terminated by Sponsor|0|||
94710386|NCT03401112|324397290|FG001|Overall Study|Study was Terminated by Sponsor|0|||
94710387|NCT03401112|324397291|FG002|Overall Study|Study was Terminated by Sponsor|0|||
94710388|NCT03401112|324397292|FG003|Overall Study|Study was Terminated by Sponsor|1|||
94710389|NCT03401112|324397293|FG004|Overall Study|Study was Terminated by Sponsor|0|||
94710390|NCT03401112|324397289|FG000|Overall Study|Day 1 Assessment not Done|1|||
94710391|NCT03401112|324397290|FG001|Overall Study|Day 1 Assessment not Done|0|||
94710392|NCT03401112|324397291|FG002|Overall Study|Day 1 Assessment not Done|0|||
94710393|NCT03401112|324397292|FG003|Overall Study|Day 1 Assessment not Done|0|||
94710394|NCT03401112|324397293|FG004|Overall Study|Day 1 Assessment not Done|0|||
94710395|NCT03401112|324397289|FG000|Overall Study|Not Dosed|0|||
94710396|NCT03401112|324397290|FG001|Overall Study|Not Dosed|0|||
94710397|NCT03401112|324397291|FG002|Overall Study|Not Dosed|1|||
94710398|NCT03401112|324397292|FG003|Overall Study|Not Dosed|0|||
94710399|NCT03401112|324397293|FG004|Overall Study|Not Dosed|0|||
94710400|NCT03401112|324397289|FG000|Overall Study|Missed Clinical Visit|0|||
94710401|NCT03401112|324397290|FG001|Overall Study|Missed Clinical Visit|0|||
94710402|NCT03401112|324397291|FG002|Overall Study|Missed Clinical Visit|1|||
94710403|NCT03401112|324397292|FG003|Overall Study|Missed Clinical Visit|0|||
94710404|NCT03401112|324397293|FG004|Overall Study|Missed Clinical Visit|0|||
94710405|NCT03401112|324397289|FG000|Overall Study|Missed Doses|0|||
94710406|NCT03401112|324397290|FG001|Overall Study|Missed Doses|0|||
94710407|NCT03401112|324397291|FG002|Overall Study|Missed Doses|1|||
94710408|NCT03401112|324397292|FG003|Overall Study|Missed Doses|0|||
94710409|NCT03401112|324397293|FG004|Overall Study|Missed Doses|0|||
94710410|NCT01202955|324397294|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
94710411|NCT01202955|324397295|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
94710412|NCT00159783|324397296|FG000|Overall Study|Adverse Event|5|||
94710413|NCT00159783|324397297|FG001|Overall Study|Adverse Event|7|||
94710414|NCT00159783|324397298|FG002|Overall Study|Adverse Event|9|||
94710415|NCT00159783|324397296|FG000|Overall Study|Lack of Efficacy|1|||
94710416|NCT00159783|324397297|FG001|Overall Study|Lack of Efficacy|2|||
94710417|NCT00159783|324397298|FG002|Overall Study|Lack of Efficacy|3|||
94710418|NCT00159783|324397296|FG000|Overall Study|Withdrawal by Subject|7|||
94710419|NCT00159783|324397297|FG001|Overall Study|Withdrawal by Subject|11|||
94710420|NCT00159783|324397298|FG002|Overall Study|Withdrawal by Subject|12|||
94710421|NCT00159783|324397296|FG000|Overall Study|Lost to Follow-up|6|||
94710422|NCT00159783|324397297|FG001|Overall Study|Lost to Follow-up|5|||
94710423|NCT00159783|324397298|FG002|Overall Study|Lost to Follow-up|11|||
94710424|NCT00159783|324397296|FG000|Overall Study|Other|0|||
94710425|NCT00159783|324397297|FG001|Overall Study|Other|2|||
94710426|NCT00159783|324397298|FG002|Overall Study|Other|4|||
94710427|NCT02928224|324397299|FG000|Overall Study|Lost to Follow-up|1|||
94710428|NCT02928224|324397300|FG001|Overall Study|Lost to Follow-up|1|||
94710429|NCT02928224|324397301|FG002|Overall Study|Lost to Follow-up|3|||
94710430|NCT02928224|324397302|FG003|Overall Study|Lost to Follow-up|0|||
94710431|NCT02928224|324397299|FG000|Overall Study|Death|30|||
94710432|NCT02928224|324397300|FG001|Overall Study|Death|209|||
94710433|NCT02928224|324397301|FG002|Overall Study|Death|193|||
94710434|NCT02928224|324397302|FG003|Overall Study|Death|198|||
94710435|NCT02928224|324397299|FG000|Overall Study|Withdrawal by Subject|0|||
94710436|NCT02928224|324397300|FG001|Overall Study|Withdrawal by Subject|3|||
94710437|NCT02928224|324397301|FG002|Overall Study|Withdrawal by Subject|7|||
94710438|NCT02928224|324397302|FG003|Overall Study|Withdrawal by Subject|20|||
94710439|NCT02928224|324397299|FG000|Overall Study|Study participation terminated by sponsor|3|||
94710440|NCT02928224|324397300|FG001|Overall Study|Study participation terminated by sponsor|8|||
94710441|NCT02928224|324397301|FG002|Overall Study|Study participation terminated by sponsor|12|||
94710442|NCT02928224|324397302|FG003|Overall Study|Study participation terminated by sponsor|3|||
94710443|NCT02928224|324397299|FG000|Overall Study|Other|3|||
94268441|NCT00467779|322778487|FG003|Stage 1A|Adverse Event|0|||
94268442|NCT00467779|322778488|FG004|Stage 1A|Adverse Event|0|||
94268443|NCT00467779|322778489|FG005|Stage 1A|Adverse Event|0|||
94268444|NCT00467779|322778490|FG006|Stage 1A|Adverse Event|0|||
94710444|NCT02928224|324397300|FG001|Overall Study|Other|3|||
94710445|NCT02928224|324397301|FG002|Overall Study|Other|5|||
94710446|NCT02928224|324397302|FG003|Overall Study|Other|0|||
94710447|NCT00569127|324397304|FG000|Overall Study|Adverse Event|57|||
94710448|NCT00569127|324397305|FG001|Overall Study|Adverse Event|47|||
94710449|NCT00569127|324397304|FG000|Overall Study|Withdrawal by Subject|13|||
94710450|NCT00569127|324397305|FG001|Overall Study|Withdrawal by Subject|27|||
94710451|NCT00569127|324397304|FG000|Overall Study|Progression|99|||
94710452|NCT00569127|324397305|FG001|Overall Study|Progression|100|||
94710453|NCT00569127|324397304|FG000|Overall Study|Death|4|||
94710454|NCT00569127|324397305|FG001|Overall Study|Death|3|||
94710455|NCT00569127|324397304|FG000|Overall Study|Other|20|||
94710456|NCT00569127|324397305|FG001|Overall Study|Other|19|||
94268445|NCT00467779|322778491|FG007|Stage 1A|Adverse Event|0|||
94710457|NCT00569127|324397304|FG000|Overall Study|Lost to Follow-up|0|||
94268446|NCT00467779|322778492|FG008|Stage 1A|Adverse Event|0|||
94268447|NCT00467779|322778493|FG009|Stage 1A|Adverse Event|0|||
94710458|NCT00569127|324397305|FG001|Overall Study|Lost to Follow-up|3|||
94710459|NCT00569127|324397304|FG000|Overall Study|Not Eligible|14|||
94710460|NCT00569127|324397305|FG001|Overall Study|Not Eligible|11|||
94710461|NCT00569127|324397304|FG000|Overall Study|Still on Treatment|7|||
94710462|NCT00569127|324397305|FG001|Overall Study|Still on Treatment|3|||
94710463|NCT00794118|324397309|FG000|Overall Study|Lost to Follow-up|16|||
94710464|NCT00794118|324397309|FG000|Overall Study|Withdrawal by Subject|9|||
94710465|NCT00794118|324397309|FG000|Overall Study|Changed hospital center|2|||
94710466|NCT01170962|324397310|FG000|Treatment Period|Lack of Efficacy|96|||
94710467|NCT01170962|324397311|FG001|Treatment Period|Lack of Efficacy|91|||
94710468|NCT01170962|324397312|FG002|Treatment Period|Lack of Efficacy|7|||
94710469|NCT01170962|324397310|FG000|Treatment Period|Adverse Event|11|||
94710470|NCT01170962|324397311|FG001|Treatment Period|Adverse Event|12|||
94710471|NCT01170962|324397312|FG002|Treatment Period|Adverse Event|3|||
94710472|NCT01170962|324397310|FG000|Treatment Period|Withdrawal by Subject|2|||
94710473|NCT01170962|324397311|FG001|Treatment Period|Withdrawal by Subject|1|||
94710474|NCT01170962|324397312|FG002|Treatment Period|Withdrawal by Subject|0|||
94710475|NCT01170962|324397310|FG000|Treatment Period|Lost to Follow-up|1|||
94710476|NCT01170962|324397311|FG001|Treatment Period|Lost to Follow-up|1|||
94710477|NCT01170962|324397312|FG002|Treatment Period|Lost to Follow-up|1|||
94710478|NCT01170962|324397310|FG000|Treatment Period|Participant no longer meets criteria|0|||
94710479|NCT01170962|324397311|FG001|Treatment Period|Participant no longer meets criteria|1|||
94710480|NCT01170962|324397312|FG002|Treatment Period|Participant no longer meets criteria|0|||
94710481|NCT01170962|324397310|FG000|Treatment Period|Request to discontinue treatment|7|||
94710482|NCT01170962|324397311|FG001|Treatment Period|Request to discontinue treatment|3|||
94710483|NCT01170962|324397312|FG002|Treatment Period|Request to discontinue treatment|1|||
94710484|NCT01170962|324397310|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
94710485|NCT01170962|324397311|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
94710486|NCT01170962|324397312|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
94710487|NCT01170962|324397310|FG000|Follow up Period|Withdrawal by Subject|14|||
94710488|NCT01170962|324397311|FG001|Follow up Period|Withdrawal by Subject|10|||
94710489|NCT01170962|324397312|FG002|Follow up Period|Withdrawal by Subject|2|||
94710490|NCT01170962|324397310|FG000|Follow up Period|Lost to Follow-up|13|||
94710491|NCT01170962|324397311|FG001|Follow up Period|Lost to Follow-up|8|||
94710492|NCT01170962|324397312|FG002|Follow up Period|Lost to Follow-up|1|||
94710493|NCT01170962|324397310|FG000|Follow up Period|Death|2|||
94710494|NCT01170962|324397311|FG001|Follow up Period|Death|2|||
94710495|NCT01170962|324397312|FG002|Follow up Period|Death|0|||
94710496|NCT01170962|324397310|FG000|Follow up Period|Others|10|||
94710497|NCT01170962|324397311|FG001|Follow up Period|Others|7|||
94710498|NCT01170962|324397312|FG002|Follow up Period|Others|3|||
94710499|NCT00688519|324397318|FG000|Overall Study|Adverse Event|2|||
94710500|NCT00688519|324397319|FG001|Overall Study|Adverse Event|3|||
94710501|NCT00688519|324397318|FG000|Overall Study|Lost to Follow-up|3|||
94710502|NCT00688519|324397319|FG001|Overall Study|Lost to Follow-up|3|||
94710503|NCT00688519|324397318|FG000|Overall Study|Lack of Efficacy|3|||
94710504|NCT00688519|324397319|FG001|Overall Study|Lack of Efficacy|1|||
94710505|NCT00688519|324397318|FG000|Overall Study|Withdrawal by Subject|7|||
94710506|NCT00688519|324397319|FG001|Overall Study|Withdrawal by Subject|6|||
94710507|NCT00688519|324397318|FG000|Overall Study|Prohibited medication|1|||
94710508|NCT00688519|324397319|FG001|Overall Study|Prohibited medication|0|||
94710509|NCT00688519|324397318|FG000|Overall Study|Non-compliance|0|||
94710510|NCT00688519|324397319|FG001|Overall Study|Non-compliance|1|||
94710511|NCT00688519|324397318|FG000|Overall Study|Subject moved out of state|1|||
94710512|NCT00688519|324397319|FG001|Overall Study|Subject moved out of state|0|||
94710513|NCT00688519|324397318|FG000|Overall Study|Investigator decision|1|||
94710514|NCT00688519|324397319|FG001|Overall Study|Investigator decision|0|||
94710515|NCT00688519|324397318|FG000|Overall Study|Subject moved out of area|1|||
94710516|NCT00688519|324397319|FG001|Overall Study|Subject moved out of area|0|||
94710517|NCT00688519|324397318|FG000|Overall Study|Pregnancy|0|||
94710518|NCT00688519|324397319|FG001|Overall Study|Pregnancy|1|||
94710519|NCT01199705|324397323|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
94710520|NCT01692730|324397324|FG000|Overall Study|Lost to Follow-up|225|||
94268448|NCT00467779|322778494|FG010|Stage 1A|Adverse Event|0|||
94710521|NCT01692730|324397325|FG001|Overall Study|Lost to Follow-up|227|||
94710522|NCT01415349|324397326|FG000|Treatment Period 1|Adverse Event|0|||
94710523|NCT01415349|324397327|FG001|Treatment Period 1|Adverse Event|1|||
94710524|NCT01415349|324397326|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94710525|NCT01415349|324397327|FG001|Treatment Period 1|Withdrawal by Subject|1|||
94710526|NCT01849055|324397328|FG000|Overall Study|Withdrawal by Subject|0|||
94268449|NCT00467779|322778495|FG011|Stage 1A|Adverse Event|0|||
94268450|NCT00467779|322778496|FG012|Stage 1A|Adverse Event|1|||
94710527|NCT01849055|324397329|FG001|Overall Study|Withdrawal by Subject|0|||
94710528|NCT01849055|324397330|FG002|Overall Study|Withdrawal by Subject|1|||
94268451|NCT00467779|322778497|FG013|Stage 1A|Adverse Event|0|||
94268452|NCT00467779|322778498|FG014|Stage 1A|Adverse Event|0|||
94710529|NCT01849055|324397331|FG003|Overall Study|Withdrawal by Subject|0|||
94710530|NCT01849055|324397332|FG004|Overall Study|Withdrawal by Subject|0|||
94710531|NCT01849055|324397333|FG005|Overall Study|Withdrawal by Subject|0|||
94710532|NCT00203411|324397334|FG000|Follow-up|Progressive Disease|4|||
94710533|NCT01049503|324398696|FG000|Overall Study|Lost to Follow-up|11|||
94268453|NCT00467779|322778484|FG000|Stage 1A|Death|0|||
94652885|NCT00595582|324186240|FG000|Overall Study|Lost to Follow-up|1|||
94652886|NCT00595582|324186240|FG000|Overall Study|Adverse Event|2|||
94652887|NCT00595582|324186240|FG000|Overall Study|Physician Decision|5|||
94652888|NCT01069289|324186241|FG000|Overall Study|Withdrawal by Subject|15|||
94652889|NCT01069289|324186242|FG001|Overall Study|Withdrawal by Subject|26|||
94652890|NCT01069289|324186241|FG000|Overall Study|Adverse Event|21|||
94652891|NCT01069289|324186242|FG001|Overall Study|Adverse Event|28|||
94652892|NCT01069289|324186241|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
94652893|NCT01069289|324186242|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
94652894|NCT01069289|324186241|FG000|Overall Study|Severe non-compliance to protocol|3|||
94652895|NCT01069289|324186242|FG001|Overall Study|Severe non-compliance to protocol|2|||
94652896|NCT01069289|324186241|FG000|Overall Study|Due to deteriorating health condition|1|||
94652897|NCT01069289|324186242|FG001|Overall Study|Due to deteriorating health condition|0|||
94652898|NCT00774995|324186246|FG000|Overall Study|Protocol Violation|0|||
94652899|NCT00774995|324186247|FG001|Overall Study|Protocol Violation|0|||
94652900|NCT00774995|324186248|FG002|Overall Study|Protocol Violation|1|||
94652901|NCT00774995|324186249|FG003|Overall Study|Protocol Violation|0|||
94652902|NCT01310413|324187988|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
94652903|NCT01310413|324187989|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
94652904|NCT01310413|324187990|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
94652905|NCT01310413|324187991|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
94652906|NCT01310413|324187992|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
94652907|NCT01310413|324187993|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
94652908|NCT01310413|324187994|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
94652909|NCT01310413|324187988|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
94652910|NCT01310413|324187989|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
94652911|NCT01310413|324187990|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
94652912|NCT01310413|324187991|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
94652913|NCT01310413|324187992|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
94652914|NCT01310413|324187993|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
94652915|NCT01310413|324187994|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
94652916|NCT01310413|324187988|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
94652917|NCT01310413|324187989|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
94652918|NCT01310413|324187990|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
94652919|NCT01310413|324187991|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
94652920|NCT01310413|324187992|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
94652921|NCT01310413|324187993|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
94652922|NCT01310413|324187994|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
94652923|NCT01310413|324187988|FG000|Day 0 to Day 385|Other|1|||
94652924|NCT01310413|324187989|FG001|Day 0 to Day 385|Other|0|||
94652925|NCT01310413|324187990|FG002|Day 0 to Day 385|Other|3|||
94652926|NCT01310413|324187991|FG003|Day 0 to Day 385|Other|0|||
94652927|NCT01310413|324187992|FG004|Day 0 to Day 385|Other|0|||
94652928|NCT01310413|324187993|FG005|Day 0 to Day 385|Other|0|||
94652929|NCT01310413|324187994|FG006|Day 0 to Day 385|Other|0|||
94652930|NCT01310413|324187988|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
94652931|NCT01310413|324187989|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
94652932|NCT01310413|324187990|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
94652933|NCT01310413|324187991|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
94652934|NCT01310413|324187992|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
94652935|NCT01310413|324187993|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
94652936|NCT01310413|324187994|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
94652937|NCT01310413|324187988|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
94652938|NCT01310413|324187989|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
94652939|NCT01310413|324187990|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
94652940|NCT01310413|324187991|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
94652941|NCT01310413|324187992|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
94652942|NCT01310413|324187993|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
94652943|NCT01310413|324187994|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
94652944|NCT00659646|324187999|FG000|Overall Study|Protocol Violation|12|||
94652945|NCT00659646|324188000|FG001|Overall Study|Protocol Violation|8|||
94710534|NCT01049503|324398697|FG001|Overall Study|Lost to Follow-up|12|||
94710535|NCT01049503|324398698|FG002|Overall Study|Lost to Follow-up|24|||
94710536|NCT01049503|324398699|FG003|Overall Study|Lost to Follow-up|26|||
94710537|NCT01049503|324398700|FG004|Overall Study|Lost to Follow-up|27|||
94710538|NCT01049503|324398701|FG005|Overall Study|Lost to Follow-up|8|||
94710539|NCT00726596|324398702|FG000|Overall Study|Adverse Event|2|||
94710540|NCT00726596|324398703|FG001|Overall Study|Adverse Event|1|||
94710541|NCT00726596|324398702|FG000|Overall Study|Withdrawal by Subject|3|||
94710542|NCT00726596|324398703|FG001|Overall Study|Withdrawal by Subject|3|||
94710543|NCT04424641|324398708|FG000|Overall Study|Death|1|||
94710544|NCT04424641|324398709|FG001|Overall Study|Death|2|||
94710545|NCT04424641|324398710|FG002|Overall Study|Death|3|||
94710546|NCT04424641|324398711|FG003|Overall Study|Death|0|||
94710547|NCT04424641|324398712|FG004|Overall Study|Death|3|||
94710548|NCT04424641|324398713|FG005|Overall Study|Death|0|||
94710549|NCT04424641|324398714|FG006|Overall Study|Death|1|||
94710550|NCT04424641|324398715|FG007|Overall Study|Death|2|||
94710551|NCT04424641|324398708|FG000|Overall Study|Sponsor decision|0|||
94710552|NCT04424641|324398709|FG001|Overall Study|Sponsor decision|2|||
94710553|NCT04424641|324398710|FG002|Overall Study|Sponsor decision|3|||
94710554|NCT04424641|324398711|FG003|Overall Study|Sponsor decision|7|||
94710555|NCT04424641|324398712|FG004|Overall Study|Sponsor decision|2|||
94710556|NCT04424641|324398713|FG005|Overall Study|Sponsor decision|2|||
94710557|NCT04424641|324398714|FG006|Overall Study|Sponsor decision|3|||
94710558|NCT04424641|324398715|FG007|Overall Study|Sponsor decision|4|||
94710559|NCT04424641|324398708|FG000|Overall Study|Withdrawal by Subject|0|||
94710560|NCT04424641|324398709|FG001|Overall Study|Withdrawal by Subject|0|||
94710561|NCT04424641|324398710|FG002|Overall Study|Withdrawal by Subject|0|||
94710562|NCT04424641|324398711|FG003|Overall Study|Withdrawal by Subject|0|||
94710563|NCT04424641|324398712|FG004|Overall Study|Withdrawal by Subject|1|||
94710564|NCT04424641|324398713|FG005|Overall Study|Withdrawal by Subject|0|||
94710565|NCT04424641|324398714|FG006|Overall Study|Withdrawal by Subject|0|||
94710566|NCT04424641|324398715|FG007|Overall Study|Withdrawal by Subject|0|||
94710567|NCT04424641|324398708|FG000|Overall Study|Other|0|||
94710568|NCT04424641|324398709|FG001|Overall Study|Other|0|||
94710569|NCT04424641|324398710|FG002|Overall Study|Other|1|||
94710570|NCT04424641|324398711|FG003|Overall Study|Other|0|||
94710571|NCT04424641|324398712|FG004|Overall Study|Other|0|||
94710572|NCT04424641|324398713|FG005|Overall Study|Other|0|||
94710573|NCT04424641|324398714|FG006|Overall Study|Other|0|||
94710574|NCT04424641|324398715|FG007|Overall Study|Other|0|||
94710575|NCT01426269|324398720|FG000|Period 1: 12 Weeks|Adverse Event|5|||
94710576|NCT01426269|324398721|FG001|Period 1: 12 Weeks|Adverse Event|0|||
94710577|NCT01426269|324398722|FG002|Period 1: 12 Weeks|Adverse Event|0|||
94710578|NCT01426269|324398720|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
94710579|NCT01426269|324398721|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
94710580|NCT01426269|324398722|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
94710581|NCT01426269|324398720|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
94710582|NCT01426269|324398721|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
94268454|NCT00467779|322778485|FG001|Stage 1A|Death|0|||
94268455|NCT00467779|322778486|FG002|Stage 1A|Death|0|||
94268456|NCT00467779|322778487|FG003|Stage 1A|Death|0|||
94268457|NCT00467779|322778488|FG004|Stage 1A|Death|0|||
94710583|NCT01426269|324398722|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
94710584|NCT01426269|324398720|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
94710585|NCT01426269|324398721|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
94710586|NCT01426269|324398722|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
94710587|NCT01426269|324398720|FG000|Period 1: 12 Weeks|Pregnancy|1|||
94710588|NCT01426269|324398721|FG001|Period 1: 12 Weeks|Pregnancy|0|||
94710589|NCT01426269|324398722|FG002|Period 1: 12 Weeks|Pregnancy|0|||
94710590|NCT01426269|324398720|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
94710591|NCT01426269|324398721|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
94710592|NCT01426269|324398722|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
94710593|NCT01426269|324398720|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
94710594|NCT01426269|324398721|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
94710595|NCT01426269|324398722|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
94710596|NCT01426269|324398720|FG000|Period 2: 40 Weeks|Adverse Event|0|||
94710597|NCT01426269|324398721|FG001|Period 2: 40 Weeks|Adverse Event|1|||
94710598|NCT01426269|324398722|FG002|Period 2: 40 Weeks|Adverse Event|2|||
94710599|NCT01426269|324398720|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
94710600|NCT01426269|324398721|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
94710601|NCT01426269|324398722|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
94710602|NCT01426269|324398720|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
94710603|NCT01426269|324398721|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
94710604|NCT01426269|324398722|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
94710605|NCT01426269|324398720|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
94268458|NCT00467779|322778489|FG005|Stage 1A|Death|0|||
94268459|NCT00467779|322778490|FG006|Stage 1A|Death|0|||
94268460|NCT00467779|322778491|FG007|Stage 1A|Death|0|||
94710606|NCT01426269|324398721|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
94268461|NCT00467779|322778492|FG008|Stage 1A|Death|0|||
94268462|NCT00467779|322778493|FG009|Stage 1A|Death|0|||
94268463|NCT00467779|322778494|FG010|Stage 1A|Death|0|||
94268464|NCT00467779|322778495|FG011|Stage 1A|Death|1|||
94268465|NCT00467779|322778496|FG012|Stage 1A|Death|1|||
94268466|NCT00467779|322778497|FG013|Stage 1A|Death|0|||
94268467|NCT00467779|322778498|FG014|Stage 1A|Death|0|||
94268468|NCT00467779|322778484|FG000|Stage 1A|Disease Progression|0|||
94268469|NCT00467779|322778485|FG001|Stage 1A|Disease Progression|0|||
94268470|NCT00467779|322778486|FG002|Stage 1A|Disease Progression|0|||
94268471|NCT00467779|322778487|FG003|Stage 1A|Disease Progression|0|||
94268472|NCT00467779|322778488|FG004|Stage 1A|Disease Progression|0|||
94268473|NCT00467779|322778489|FG005|Stage 1A|Disease Progression|0|||
94268474|NCT00467779|322778490|FG006|Stage 1A|Disease Progression|0|||
94268475|NCT00467779|322778491|FG007|Stage 1A|Disease Progression|0|||
94268476|NCT00467779|322778492|FG008|Stage 1A|Disease Progression|0|||
94268477|NCT00467779|322778493|FG009|Stage 1A|Disease Progression|2|||
94268478|NCT00467779|322778494|FG010|Stage 1A|Disease Progression|2|||
94268479|NCT00467779|322778495|FG011|Stage 1A|Disease Progression|5|||
94268480|NCT00467779|322778496|FG012|Stage 1A|Disease Progression|2|||
94268481|NCT00467779|322778497|FG013|Stage 1A|Disease Progression|0|||
94268482|NCT00467779|322778498|FG014|Stage 1A|Disease Progression|0|||
94268483|NCT00467779|322778484|FG000|Stage 1A|Physician Decision|0|||
94268484|NCT00467779|322778485|FG001|Stage 1A|Physician Decision|0|||
94268485|NCT00467779|322778486|FG002|Stage 1A|Physician Decision|0|||
94268486|NCT00467779|322778487|FG003|Stage 1A|Physician Decision|0|||
94268487|NCT00467779|322778488|FG004|Stage 1A|Physician Decision|0|||
94268488|NCT00467779|322778489|FG005|Stage 1A|Physician Decision|0|||
94268489|NCT00467779|322778490|FG006|Stage 1A|Physician Decision|0|||
94268490|NCT00467779|322778491|FG007|Stage 1A|Physician Decision|0|||
94268491|NCT00467779|322778492|FG008|Stage 1A|Physician Decision|0|||
94268492|NCT00467779|322778493|FG009|Stage 1A|Physician Decision|1|||
94268493|NCT00467779|322778494|FG010|Stage 1A|Physician Decision|0|||
94268494|NCT00467779|322778495|FG011|Stage 1A|Physician Decision|0|||
94268495|NCT00467779|322778496|FG012|Stage 1A|Physician Decision|0|||
94268496|NCT00467779|322778497|FG013|Stage 1A|Physician Decision|0|||
94268497|NCT00467779|322778498|FG014|Stage 1A|Physician Decision|0|||
94268498|NCT00467779|322778484|FG000|Stage 1A|Withdrawal by Subject|0|||
94268499|NCT00467779|322778485|FG001|Stage 1A|Withdrawal by Subject|0|||
94268500|NCT00467779|322778486|FG002|Stage 1A|Withdrawal by Subject|0|||
94268501|NCT00467779|322778487|FG003|Stage 1A|Withdrawal by Subject|0|||
94268502|NCT00467779|322778488|FG004|Stage 1A|Withdrawal by Subject|0|||
94268503|NCT00467779|322778489|FG005|Stage 1A|Withdrawal by Subject|0|||
94268504|NCT00467779|322778490|FG006|Stage 1A|Withdrawal by Subject|0|||
94268505|NCT00467779|322778491|FG007|Stage 1A|Withdrawal by Subject|0|||
94268506|NCT00467779|322778492|FG008|Stage 1A|Withdrawal by Subject|0|||
94268507|NCT00467779|322778493|FG009|Stage 1A|Withdrawal by Subject|0|||
94268508|NCT00467779|322778494|FG010|Stage 1A|Withdrawal by Subject|1|||
94268509|NCT00467779|322778495|FG011|Stage 1A|Withdrawal by Subject|1|||
94268510|NCT00467779|322778496|FG012|Stage 1A|Withdrawal by Subject|1|||
94268511|NCT00467779|322778497|FG013|Stage 1A|Withdrawal by Subject|0|||
94268512|NCT00467779|322778498|FG014|Stage 1A|Withdrawal by Subject|0|||
94268513|NCT00467779|322778484|FG000|Stage 1A|Unspecified Reason|0|||
94268514|NCT00467779|322778485|FG001|Stage 1A|Unspecified Reason|0|||
94268515|NCT00467779|322778486|FG002|Stage 1A|Unspecified Reason|0|||
94268516|NCT00467779|322778487|FG003|Stage 1A|Unspecified Reason|0|||
94268517|NCT00467779|322778488|FG004|Stage 1A|Unspecified Reason|0|||
94268518|NCT00467779|322778489|FG005|Stage 1A|Unspecified Reason|0|||
94268519|NCT00467779|322778490|FG006|Stage 1A|Unspecified Reason|0|||
94268520|NCT00467779|322778491|FG007|Stage 1A|Unspecified Reason|0|||
94268521|NCT00467779|322778492|FG008|Stage 1A|Unspecified Reason|0|||
94268522|NCT00467779|322778493|FG009|Stage 1A|Unspecified Reason|0|||
94268523|NCT00467779|322778494|FG010|Stage 1A|Unspecified Reason|0|||
94268524|NCT00467779|322778495|FG011|Stage 1A|Unspecified Reason|1|||
94268525|NCT00467779|322778496|FG012|Stage 1A|Unspecified Reason|1|||
94268526|NCT00467779|322778497|FG013|Stage 1A|Unspecified Reason|0|||
94268527|NCT00467779|322778498|FG014|Stage 1A|Unspecified Reason|0|||
94268528|NCT00467779|322778484|FG000|Stage 2|Adverse Event|0|||
94268529|NCT00467779|322778485|FG001|Stage 2|Adverse Event|0|||
94268530|NCT00467779|322778486|FG002|Stage 2|Adverse Event|0|||
94268531|NCT00467779|322778487|FG003|Stage 2|Adverse Event|0|||
94268532|NCT00467779|322778488|FG004|Stage 2|Adverse Event|0|||
94268533|NCT00467779|322778489|FG005|Stage 2|Adverse Event|0|||
94268534|NCT00467779|322778490|FG006|Stage 2|Adverse Event|0|||
94268535|NCT00467779|322778491|FG007|Stage 2|Adverse Event|0|||
94268536|NCT00467779|322778492|FG008|Stage 2|Adverse Event|1|||
94268537|NCT00467779|322778493|FG009|Stage 2|Adverse Event|0|||
94268538|NCT00467779|322778494|FG010|Stage 2|Adverse Event|0|||
94268539|NCT00467779|322778495|FG011|Stage 2|Adverse Event|0|||
94268540|NCT00467779|322778496|FG012|Stage 2|Adverse Event|0|||
94268541|NCT00467779|322778497|FG013|Stage 2|Adverse Event|0|||
94268542|NCT00467779|322778498|FG014|Stage 2|Adverse Event|0|||
94268543|NCT00467779|322778484|FG000|Stage 2|Death|0|||
94710607|NCT01426269|324398722|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
94710608|NCT01426269|324398720|FG000|Period 2: 40 Weeks|Site closed|0|||
94710609|NCT01426269|324398721|FG001|Period 2: 40 Weeks|Site closed|6|||
94710610|NCT01426269|324398722|FG002|Period 2: 40 Weeks|Site closed|5|||
94710611|NCT01426269|324398720|FG000|Period 2: 40 Weeks|Relapsed|0|||
94710612|NCT01426269|324398721|FG001|Period 2: 40 Weeks|Relapsed|9|||
94710613|NCT01426269|324398722|FG002|Period 2: 40 Weeks|Relapsed|18|||
94710614|NCT00743444|324398723|FG000|First Intervention|Catheter placement problems|0|||
94710615|NCT00743444|324398724|FG001|First Intervention|Catheter placement problems|1|||
94710616|NCT00743444|324398723|FG000|Washout Period|Adverse Event|0|||
94710617|NCT00743444|324398724|FG001|Washout Period|Adverse Event|1|||
94710618|NCT03593876|324398725|FG000|Overall Study|Withdrawal by Subject|1|||
94710619|NCT03593876|324398725|FG000|Overall Study|Discharged home before intervention completion|2|||
94710620|NCT02034916|324398726|FG000|Overall Study|Death|39|||
94710621|NCT02034916|324398727|FG001|Overall Study|Death|28|||
94710622|NCT02034916|324398726|FG000|Overall Study|Withdrawal by Subject|2|||
94710623|NCT02034916|324398727|FG001|Overall Study|Withdrawal by Subject|1|||
94710624|NCT02034916|324398726|FG000|Overall Study|Lost to Follow-up|4|||
94710625|NCT02034916|324398727|FG001|Overall Study|Lost to Follow-up|1|||
94268544|NCT00467779|322778485|FG001|Stage 2|Death|0|||
94268545|NCT00467779|322778486|FG002|Stage 2|Death|0|||
94268546|NCT00467779|322778487|FG003|Stage 2|Death|0|||
94268547|NCT00467779|322778488|FG004|Stage 2|Death|0|||
94268548|NCT00467779|322778489|FG005|Stage 2|Death|0|||
94268549|NCT00467779|322778490|FG006|Stage 2|Death|0|||
94268550|NCT00467779|322778491|FG007|Stage 2|Death|0|||
94268551|NCT00467779|322778492|FG008|Stage 2|Death|1|||
94268552|NCT00467779|322778493|FG009|Stage 2|Death|0|||
94268553|NCT00467779|322778494|FG010|Stage 2|Death|0|||
94268554|NCT00467779|322778495|FG011|Stage 2|Death|0|||
94268555|NCT00467779|322778496|FG012|Stage 2|Death|0|||
94268556|NCT00467779|322778497|FG013|Stage 2|Death|0|||
94268557|NCT00467779|322778498|FG014|Stage 2|Death|0|||
94268558|NCT00467779|322778484|FG000|Stage 2|Disease Progression|0|||
94268559|NCT00467779|322778485|FG001|Stage 2|Disease Progression|0|||
94268560|NCT00467779|322778486|FG002|Stage 2|Disease Progression|0|||
94268561|NCT00467779|322778487|FG003|Stage 2|Disease Progression|0|||
94268562|NCT00467779|322778488|FG004|Stage 2|Disease Progression|0|||
94268563|NCT00467779|322778489|FG005|Stage 2|Disease Progression|0|||
94268564|NCT00467779|322778490|FG006|Stage 2|Disease Progression|0|||
94268565|NCT00467779|322778491|FG007|Stage 2|Disease Progression|0|||
94268566|NCT00467779|322778492|FG008|Stage 2|Disease Progression|16|||
94268567|NCT00467779|322778493|FG009|Stage 2|Disease Progression|0|||
94268568|NCT00467779|322778494|FG010|Stage 2|Disease Progression|0|||
94268569|NCT00467779|322778495|FG011|Stage 2|Disease Progression|0|||
94268570|NCT00467779|322778496|FG012|Stage 2|Disease Progression|0|||
94268571|NCT00467779|322778497|FG013|Stage 2|Disease Progression|0|||
94268572|NCT00467779|322778498|FG014|Stage 2|Disease Progression|0|||
94268573|NCT00467779|322778484|FG000|Stage 2|Unspecified Reason|0|||
94268574|NCT00467779|322778485|FG001|Stage 2|Unspecified Reason|0|||
94268575|NCT00467779|322778486|FG002|Stage 2|Unspecified Reason|0|||
94268576|NCT00467779|322778487|FG003|Stage 2|Unspecified Reason|0|||
94268577|NCT00467779|322778488|FG004|Stage 2|Unspecified Reason|0|||
94268578|NCT00467779|322778489|FG005|Stage 2|Unspecified Reason|0|||
94268579|NCT00467779|322778490|FG006|Stage 2|Unspecified Reason|0|||
94268580|NCT00467779|322778491|FG007|Stage 2|Unspecified Reason|0|||
94268581|NCT00467779|322778492|FG008|Stage 2|Unspecified Reason|3|||
94268582|NCT00467779|322778493|FG009|Stage 2|Unspecified Reason|0|||
94268583|NCT00467779|322778494|FG010|Stage 2|Unspecified Reason|0|||
94268584|NCT00467779|322778495|FG011|Stage 2|Unspecified Reason|0|||
94268585|NCT00467779|322778496|FG012|Stage 2|Unspecified Reason|0|||
94268586|NCT00467779|322778497|FG013|Stage 2|Unspecified Reason|0|||
94268587|NCT00467779|322778498|FG014|Stage 2|Unspecified Reason|0|||
94268588|NCT00467779|322778484|FG000|Stage 2A|Adverse Event|0|||
94268589|NCT00467779|322778485|FG001|Stage 2A|Adverse Event|0|||
94268590|NCT00467779|322778486|FG002|Stage 2A|Adverse Event|0|||
94710626|NCT02034916|324398726|FG000|Overall Study|Study terminated by sponsor|4|||
94710627|NCT02034916|324398727|FG001|Overall Study|Study terminated by sponsor|5|||
94710628|NCT01708941|324398732|FG000|Overall Study|Adverse Event|4|||
94710629|NCT01708941|324398733|FG001|Overall Study|Adverse Event|6|||
94268591|NCT00467779|322778487|FG003|Stage 2A|Adverse Event|0|||
94268592|NCT00467779|322778488|FG004|Stage 2A|Adverse Event|0|||
94268593|NCT00467779|322778489|FG005|Stage 2A|Adverse Event|0|||
94268594|NCT00467779|322778490|FG006|Stage 2A|Adverse Event|0|||
94710630|NCT01708941|324398734|FG002|Overall Study|Adverse Event|1|||
94710631|NCT01708941|324398735|FG003|Overall Study|Adverse Event|0|||
94710632|NCT01708941|324398732|FG000|Overall Study|Death|1|||
94268595|NCT00467779|322778491|FG007|Stage 2A|Adverse Event|0|||
94268596|NCT00467779|322778492|FG008|Stage 2A|Adverse Event|0|||
94268597|NCT00467779|322778493|FG009|Stage 2A|Adverse Event|0|||
94268598|NCT00467779|322778494|FG010|Stage 2A|Adverse Event|0|||
94268599|NCT00467779|322778495|FG011|Stage 2A|Adverse Event|0|||
94268600|NCT00467779|322778496|FG012|Stage 2A|Adverse Event|0|||
94710633|NCT01708941|324398733|FG001|Overall Study|Death|1|||
94268601|NCT00467779|322778497|FG013|Stage 2A|Adverse Event|2|||
94268602|NCT00467779|322778498|FG014|Stage 2A|Adverse Event|0|||
94268603|NCT00467779|322778484|FG000|Stage 2A|Death|0|||
94268604|NCT00467779|322778485|FG001|Stage 2A|Death|0|||
94268605|NCT00467779|322778486|FG002|Stage 2A|Death|0|||
94268606|NCT00467779|322778487|FG003|Stage 2A|Death|0|||
94268607|NCT00467779|322778488|FG004|Stage 2A|Death|0|||
94268608|NCT00467779|322778489|FG005|Stage 2A|Death|0|||
94268609|NCT00467779|322778490|FG006|Stage 2A|Death|0|||
94710634|NCT01708941|324398734|FG002|Overall Study|Death|2|||
94710635|NCT01708941|324398735|FG003|Overall Study|Death|14|||
94710636|NCT01708941|324398732|FG000|Overall Study|Withdrawal by Subject|1|||
94710637|NCT01708941|324398733|FG001|Overall Study|Withdrawal by Subject|0|||
94710638|NCT01708941|324398734|FG002|Overall Study|Withdrawal by Subject|3|||
94710639|NCT01708941|324398735|FG003|Overall Study|Withdrawal by Subject|4|||
94710640|NCT01708941|324398732|FG000|Overall Study|Disease progression|9|||
94710641|NCT01708941|324398733|FG001|Overall Study|Disease progression|10|||
94710642|NCT01708941|324398734|FG002|Overall Study|Disease progression|8|||
94710643|NCT01708941|324398735|FG003|Overall Study|Disease progression|0|||
94710644|NCT01708941|324398732|FG000|Overall Study|Alternative therapy|0|||
94710645|NCT01708941|324398733|FG001|Overall Study|Alternative therapy|0|||
94710646|NCT01708941|324398734|FG002|Overall Study|Alternative therapy|2|||
94710647|NCT01708941|324398735|FG003|Overall Study|Alternative therapy|0|||
94710648|NCT01708941|324398732|FG000|Overall Study|Ineligible and never started treatment|1|||
94710649|NCT01708941|324398733|FG001|Overall Study|Ineligible and never started treatment|0|||
94710650|NCT01708941|324398734|FG002|Overall Study|Ineligible and never started treatment|1|||
94710651|NCT01708941|324398735|FG003|Overall Study|Ineligible and never started treatment|0|||
94268610|NCT00467779|322778491|FG007|Stage 2A|Death|0|||
94710652|NCT01708941|324398732|FG000|Overall Study|Never started treatment|2|||
94710653|NCT01708941|324398733|FG001|Overall Study|Never started treatment|1|||
94710654|NCT01708941|324398734|FG002|Overall Study|Never started treatment|0|||
94710655|NCT01708941|324398735|FG003|Overall Study|Never started treatment|0|||
94710656|NCT01708941|324398732|FG000|Overall Study|Ineligible|0|||
94710657|NCT01708941|324398733|FG001|Overall Study|Ineligible|0|||
94710658|NCT01708941|324398734|FG002|Overall Study|Ineligible|2|||
94710659|NCT01708941|324398735|FG003|Overall Study|Ineligible|0|||
94710660|NCT00395018|324398736|FG000|On-Treatment|Death|4|||
94710661|NCT00395018|324398736|FG000|On-Treatment|Other Reason|2|||
94710662|NCT00395018|324398736|FG000|On-Treatment|Poor/non-compliance|2|||
94710663|NCT00395018|324398736|FG000|On-Treatment|Subject no longer meets study criteria|2|||
94710664|NCT00395018|324398736|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
94710665|NCT00395018|324398736|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
94710666|NCT00395018|324398736|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
94710667|NCT00101010|324398744|FG000|Overall Study|Physician Decision|1|||
94710668|NCT00346151|324398745|FG000|Overall Study|Withdrawal by Subject|3|||
94710669|NCT03621696|324398752|FG000|Overall Study|Not eligible|0|||
94710670|NCT03621696|324398753|FG001|Overall Study|Not eligible|0|||
94710671|NCT03621696|324398754|FG002|Overall Study|Not eligible|0|||
94710672|NCT03621696|324398755|FG003|Overall Study|Not eligible|5|||
94710673|NCT03621696|324398752|FG000|Overall Study|Withdrawal by Subject|1|||
94710674|NCT03621696|324398753|FG001|Overall Study|Withdrawal by Subject|1|||
94710675|NCT03621696|324398754|FG002|Overall Study|Withdrawal by Subject|1|||
94710676|NCT03621696|324398755|FG003|Overall Study|Withdrawal by Subject|0|||
94710677|NCT03621696|324398752|FG000|Overall Study|Physician Decision|0|||
94710678|NCT03621696|324398753|FG001|Overall Study|Physician Decision|0|||
94710679|NCT03621696|324398754|FG002|Overall Study|Physician Decision|1|||
94268611|NCT00467779|322778492|FG008|Stage 2A|Death|0|||
94268612|NCT00467779|322778493|FG009|Stage 2A|Death|0|||
94268613|NCT00467779|322778494|FG010|Stage 2A|Death|0|||
94268614|NCT00467779|322778495|FG011|Stage 2A|Death|0|||
94268615|NCT00467779|322778496|FG012|Stage 2A|Death|0|||
94268616|NCT00467779|322778497|FG013|Stage 2A|Death|1|||
94710680|NCT03621696|324398755|FG003|Overall Study|Physician Decision|0|||
94710681|NCT02957136|324398757|FG000|Overall Study|Withdrawal by Subject|2|||
94710682|NCT02957136|324398758|FG001|Overall Study|Withdrawal by Subject|1|||
94710683|NCT00439569|324398759|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
94710684|NCT00439569|324398759|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
94710685|NCT00439569|324398759|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
94710686|NCT01444417|324398760|FG000|Overall Study|Ineligibility Determined|0|||
94710687|NCT01444417|324398761|FG001|Overall Study|Ineligibility Determined|1|||
94268617|NCT00467779|322778498|FG014|Stage 2A|Death|0|||
94268618|NCT00467779|322778484|FG000|Stage 2A|Disease Progression|0|||
94268619|NCT00467779|322778485|FG001|Stage 2A|Disease Progression|0|||
94268620|NCT00467779|322778486|FG002|Stage 2A|Disease Progression|0|||
94268621|NCT00467779|322778487|FG003|Stage 2A|Disease Progression|0|||
94710688|NCT01444417|324398760|FG000|Overall Study|Withdrawal by Subject|2|||
94268622|NCT00467779|322778488|FG004|Stage 2A|Disease Progression|0|||
94268623|NCT00467779|322778489|FG005|Stage 2A|Disease Progression|0|||
94268624|NCT00467779|322778490|FG006|Stage 2A|Disease Progression|0|||
94268625|NCT00467779|322778491|FG007|Stage 2A|Disease Progression|0|||
94268626|NCT00467779|322778492|FG008|Stage 2A|Disease Progression|0|||
94268627|NCT00467779|322778493|FG009|Stage 2A|Disease Progression|0|||
94268628|NCT00467779|322778494|FG010|Stage 2A|Disease Progression|0|||
94268629|NCT00467779|322778495|FG011|Stage 2A|Disease Progression|0|||
94268630|NCT00467779|322778496|FG012|Stage 2A|Disease Progression|0|||
94268631|NCT00467779|322778497|FG013|Stage 2A|Disease Progression|10|||
94268632|NCT00467779|322778498|FG014|Stage 2A|Disease Progression|0|||
94268633|NCT00467779|322778484|FG000|Stage 2A|Unspecified Reason|0|||
94268634|NCT00467779|322778485|FG001|Stage 2A|Unspecified Reason|0|||
94710689|NCT01444417|324398761|FG001|Overall Study|Withdrawal by Subject|0|||
94710690|NCT01264679|324398764|FG000|Overall Study|Participation in Another Clinical Trial|1|||
94710691|NCT01264679|324398764|FG000|Overall Study|Physician Decision|1|||
94268635|NCT00467779|322778486|FG002|Stage 2A|Unspecified Reason|0|||
94268636|NCT00467779|322778487|FG003|Stage 2A|Unspecified Reason|0|||
94710692|NCT01264679|324398764|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
94268637|NCT00467779|322778488|FG004|Stage 2A|Unspecified Reason|0|||
94268638|NCT00467779|322778489|FG005|Stage 2A|Unspecified Reason|0|||
94268639|NCT00467779|322778490|FG006|Stage 2A|Unspecified Reason|0|||
94268640|NCT00467779|322778491|FG007|Stage 2A|Unspecified Reason|0|||
94268641|NCT00467779|322778492|FG008|Stage 2A|Unspecified Reason|0|||
94268642|NCT00467779|322778493|FG009|Stage 2A|Unspecified Reason|0|||
94268643|NCT00467779|322778494|FG010|Stage 2A|Unspecified Reason|0|||
94268644|NCT00467779|322778495|FG011|Stage 2A|Unspecified Reason|0|||
94268645|NCT00467779|322778496|FG012|Stage 2A|Unspecified Reason|0|||
94268646|NCT00467779|322778497|FG013|Stage 2A|Unspecified Reason|7|||
94268647|NCT00467779|322778498|FG014|Stage 2A|Unspecified Reason|0|||
94268648|NCT00467779|322778484|FG000|Stage 2A|Withdrawal by Subject|0|||
94268649|NCT00467779|322778485|FG001|Stage 2A|Withdrawal by Subject|0|||
94268650|NCT00467779|322778486|FG002|Stage 2A|Withdrawal by Subject|0|||
94268651|NCT00467779|322778487|FG003|Stage 2A|Withdrawal by Subject|0|||
94268652|NCT00467779|322778488|FG004|Stage 2A|Withdrawal by Subject|0|||
94268653|NCT00467779|322778489|FG005|Stage 2A|Withdrawal by Subject|0|||
94268654|NCT00467779|322778490|FG006|Stage 2A|Withdrawal by Subject|0|||
94268655|NCT00467779|322778491|FG007|Stage 2A|Withdrawal by Subject|0|||
94268656|NCT00467779|322778492|FG008|Stage 2A|Withdrawal by Subject|0|||
94268657|NCT00467779|322778493|FG009|Stage 2A|Withdrawal by Subject|0|||
94268658|NCT00467779|322778494|FG010|Stage 2A|Withdrawal by Subject|0|||
94268659|NCT00467779|322778495|FG011|Stage 2A|Withdrawal by Subject|0|||
94268660|NCT00467779|322778496|FG012|Stage 2A|Withdrawal by Subject|0|||
94268661|NCT00467779|322778497|FG013|Stage 2A|Withdrawal by Subject|1|||
94268662|NCT00467779|322778498|FG014|Stage 2A|Withdrawal by Subject|0|||
94268663|NCT00467779|322778484|FG000|Stage 3|Adverse Event|0|||
94268664|NCT00467779|322778485|FG001|Stage 3|Adverse Event|0|||
94268665|NCT00467779|322778486|FG002|Stage 3|Adverse Event|0|||
94268666|NCT00467779|322778487|FG003|Stage 3|Adverse Event|0|||
94268667|NCT00467779|322778488|FG004|Stage 3|Adverse Event|0|||
94268668|NCT00467779|322778489|FG005|Stage 3|Adverse Event|0|||
94268669|NCT00467779|322778490|FG006|Stage 3|Adverse Event|0|||
94268670|NCT00467779|322778491|FG007|Stage 3|Adverse Event|0|||
94268671|NCT00467779|322778492|FG008|Stage 3|Adverse Event|0|||
94268672|NCT00467779|322778493|FG009|Stage 3|Adverse Event|0|||
94268673|NCT00467779|322778494|FG010|Stage 3|Adverse Event|0|||
94268674|NCT00467779|322778495|FG011|Stage 3|Adverse Event|0|||
94268675|NCT00467779|322778496|FG012|Stage 3|Adverse Event|0|||
94268676|NCT00467779|322778497|FG013|Stage 3|Adverse Event|0|||
94268677|NCT00467779|322778498|FG014|Stage 3|Adverse Event|2|||
94268678|NCT00467779|322778484|FG000|Stage 3|Death|0|||
94268679|NCT00467779|322778485|FG001|Stage 3|Death|0|||
94268680|NCT00467779|322778486|FG002|Stage 3|Death|0|||
94268681|NCT00467779|322778487|FG003|Stage 3|Death|0|||
94268682|NCT00467779|322778488|FG004|Stage 3|Death|0|||
94710693|NCT01264679|324398764|FG000|Overall Study|Withdrawal by Subject|1|||
94710694|NCT00857649|324398769|FG000|Overall Study|Adverse Event|15|||
94268683|NCT00467779|322778489|FG005|Stage 3|Death|0|||
94268684|NCT00467779|322778490|FG006|Stage 3|Death|0|||
94268685|NCT00467779|322778491|FG007|Stage 3|Death|0|||
94268686|NCT00467779|322778492|FG008|Stage 3|Death|0|||
94268687|NCT00467779|322778493|FG009|Stage 3|Death|0|||
94268688|NCT00467779|322778494|FG010|Stage 3|Death|0|||
94466267|NCT01358578|323496954|FG003|Maintenance Period|Physician Decision|1|||
94710695|NCT00857649|324398770|FG001|Overall Study|Adverse Event|10|||
94710696|NCT00857649|324398769|FG000|Overall Study|Non-compliance|1|||
94268689|NCT00467779|322778495|FG011|Stage 3|Death|0|||
94466268|NCT01358578|323496955|FG004|Maintenance Period|Physician Decision|0|||
94268690|NCT00467779|322778496|FG012|Stage 3|Death|0|||
94268691|NCT00467779|322778497|FG013|Stage 3|Death|0|||
94268692|NCT00467779|322778498|FG014|Stage 3|Death|1|||
94268693|NCT00467779|322778484|FG000|Stage 3|Disease Progression|0|||
94268694|NCT00467779|322778485|FG001|Stage 3|Disease Progression|0|||
94268695|NCT00467779|322778486|FG002|Stage 3|Disease Progression|0|||
94268696|NCT00467779|322778487|FG003|Stage 3|Disease Progression|0|||
94268697|NCT00467779|322778488|FG004|Stage 3|Disease Progression|0|||
94268698|NCT00467779|322778489|FG005|Stage 3|Disease Progression|0|||
94268699|NCT00467779|322778490|FG006|Stage 3|Disease Progression|0|||
94710697|NCT00857649|324398770|FG001|Overall Study|Non-compliance|1|||
94710698|NCT00857649|324398769|FG000|Overall Study|Protocol Violation|2|||
94710699|NCT00857649|324398770|FG001|Overall Study|Protocol Violation|2|||
94710700|NCT00857649|324398769|FG000|Overall Study|Withdrawal of Consent|10|||
94710701|NCT00857649|324398770|FG001|Overall Study|Withdrawal of Consent|7|||
94710702|NCT00857649|324398769|FG000|Overall Study|Nursing Home Placement|2|||
94710703|NCT00857649|324398770|FG001|Overall Study|Nursing Home Placement|9|||
94710704|NCT00857649|324398769|FG000|Overall Study|Other Reasons|1|||
94710705|NCT00857649|324398770|FG001|Overall Study|Other Reasons|3|||
94710706|NCT03823911|324398771|FG000|Overall Study|Lost to Follow-up|1|||
94710707|NCT03823911|324398772|FG001|Overall Study|Lost to Follow-up|5|||
94710708|NCT03823911|324398773|FG002|Overall Study|Lost to Follow-up|2|||
94710709|NCT03823911|324398771|FG000|Overall Study|Did not meet eligibility criteria|13|||
94710710|NCT03823911|324398772|FG001|Overall Study|Did not meet eligibility criteria|7|||
94710711|NCT03823911|324398773|FG002|Overall Study|Did not meet eligibility criteria|4|||
94710712|NCT03823911|324398771|FG000|Overall Study|Death|0|||
94710713|NCT03823911|324398772|FG001|Overall Study|Death|1|||
94710714|NCT03823911|324398773|FG002|Overall Study|Death|0|||
94710715|NCT01595321|324398774|FG000|Overall Study|Adverse Event|1|||
94710716|NCT01595321|324398775|FG001|Overall Study|Adverse Event|1|||
94710717|NCT01595321|324398776|FG002|Overall Study|Adverse Event|1|||
94710718|NCT01595321|324398774|FG000|Overall Study|Lack of Efficacy|0|||
94710719|NCT01595321|324398775|FG001|Overall Study|Lack of Efficacy|0|||
94710720|NCT01595321|324398776|FG002|Overall Study|Lack of Efficacy|4|||
94710721|NCT01943799|324398792|FG000|Overall Study|Lost to Follow-up|0|||
94710722|NCT01943799|324398793|FG001|Overall Study|Lost to Follow-up|1|||
94710723|NCT01943799|324398794|FG002|Overall Study|Lost to Follow-up|1|||
94710724|NCT01943799|324398795|FG003|Overall Study|Lost to Follow-up|0|||
94710725|NCT01943799|324398792|FG000|Overall Study|Protocol Violation|1|||
94710726|NCT01943799|324398793|FG001|Overall Study|Protocol Violation|0|||
94710727|NCT01943799|324398794|FG002|Overall Study|Protocol Violation|0|||
94710728|NCT01943799|324398795|FG003|Overall Study|Protocol Violation|0|||
94710729|NCT01943799|324398792|FG000|Overall Study|Withdrawal by Subject|4|||
94710730|NCT01943799|324398793|FG001|Overall Study|Withdrawal by Subject|2|||
94710731|NCT01943799|324398794|FG002|Overall Study|Withdrawal by Subject|1|||
94710732|NCT01943799|324398795|FG003|Overall Study|Withdrawal by Subject|0|||
94710733|NCT04594759|324398796|FG000|Overall Study|Lost to Follow-up|3|||
94710734|NCT00373529|324398799|FG000|Overall Study|Physician Decision|19|||
94710735|NCT00373529|324398799|FG000|Overall Study|Withdrawal by Subject|7|||
94710736|NCT00373529|324398799|FG000|Overall Study|Adverse Event|7|||
94710737|NCT00373529|324398799|FG000|Overall Study|Treatment failure|36|||
94710738|NCT00373529|324398799|FG000|Overall Study|Disease recurrence|10|||
94710739|NCT00373529|324398799|FG000|Overall Study|Death|16|||
94710740|NCT00373529|324398799|FG000|Overall Study|Need for treatment prohibited by study|1|||
94710741|NCT00373529|324398799|FG000|Overall Study|Other|8|||
94710742|NCT00373529|324398799|FG000|Overall Study|Failed independent confirmation of AML|3|||
94710743|NCT00373529|324398799|FG000|Overall Study|Consent violation|1|||
94710744|NCT00442117|324398800|FG000|Overall Study|Adverse Event|3|||
94710745|NCT00442117|324398801|FG001|Overall Study|Adverse Event|2|||
94710746|NCT00442117|324398800|FG000|Overall Study|Lack of Efficacy|2|||
94710747|NCT00442117|324398801|FG001|Overall Study|Lack of Efficacy|6|||
94710748|NCT00442117|324398800|FG000|Overall Study|Lost to Follow-up|1|||
94710749|NCT00442117|324398801|FG001|Overall Study|Lost to Follow-up|2|||
94710750|NCT00442117|324398800|FG000|Overall Study|Withdrawal by Subject|2|||
94710751|NCT00442117|324398801|FG001|Overall Study|Withdrawal by Subject|2|||
94710752|NCT00442117|324398800|FG000|Overall Study|Major Deviation|25|||
94710753|NCT00442117|324398801|FG001|Overall Study|Major Deviation|20|||
94710754|NCT00442117|324398800|FG000|Overall Study|Non compliance with protocol|3|||
94466269|NCT01358578|323496956|FG005|Maintenance Period|Physician Decision|0|||
94710755|NCT00442117|324398801|FG001|Overall Study|Non compliance with protocol|5|||
94710756|NCT00442117|324398800|FG000|Overall Study|Met Withdrawal Criteria|2|||
94710757|NCT00442117|324398801|FG001|Overall Study|Met Withdrawal Criteria|1|||
94710758|NCT03811574|324398807|FG000|Overall Study|Withdrawal by Subject|2|||
94710759|NCT03811574|324398808|FG001|Overall Study|Withdrawal by Subject|4|||
94710760|NCT03811574|324398809|FG002|Overall Study|Withdrawal by Subject|0|||
94710761|NCT04009577|324398810|FG000|Core Study|Adverse Event|1|||
94710762|NCT04009577|324398811|FG001|Core Study|Adverse Event|0|||
94710763|NCT04009577|324398812|FG002|Core Study|Adverse Event|2|||
94710764|NCT04009577|324398813|FG003|Core Study|Adverse Event|4|||
94710765|NCT04009577|324398810|FG000|Core Study|Withdrawal by Subject|0|||
94710766|NCT04009577|324398811|FG001|Core Study|Withdrawal by Subject|0|||
94710767|NCT04009577|324398812|FG002|Core Study|Withdrawal by Subject|2|||
94710768|NCT04009577|324398813|FG003|Core Study|Withdrawal by Subject|0|||
94710769|NCT04009577|324398810|FG000|Core Study|Other|0|||
94710770|NCT04009577|324398811|FG001|Core Study|Other|0|||
94710771|NCT04009577|324398812|FG002|Core Study|Other|0|||
94710772|NCT04009577|324398813|FG003|Core Study|Other|1|||
94710773|NCT04009577|324398810|FG000|Extension Phase|Adverse Event|0|||
94710774|NCT04009577|324398811|FG001|Extension Phase|Adverse Event|0|||
94710775|NCT04009577|324398812|FG002|Extension Phase|Adverse Event|0|||
94466270|NCT01358578|323496951|FG000|Maintenance Period|Pregnancy|1|||
94466271|NCT01358578|323496952|FG001|Maintenance Period|Pregnancy|0|||
94466272|NCT01358578|323496953|FG002|Maintenance Period|Pregnancy|0|||
94268700|NCT00467779|322778491|FG007|Stage 3|Disease Progression|0|||
94466273|NCT01358578|323496954|FG003|Maintenance Period|Pregnancy|0|||
94652946|NCT00659646|324187999|FG000|Overall Study|Adverse Event|1|||
94652947|NCT00659646|324188000|FG001|Overall Study|Adverse Event|0|||
94652948|NCT00659646|324187999|FG000|Overall Study|Lost to Follow-up|1|||
94652949|NCT00659646|324188000|FG001|Overall Study|Lost to Follow-up|0|||
94652950|NCT00659646|324187999|FG000|Overall Study|protocol noncompliance after randomized|1|||
94652951|NCT00659646|324188000|FG001|Overall Study|protocol noncompliance after randomized|0|||
94652952|NCT02391948|324188003|FG000|6-month Assessment|Death|0|||
94652953|NCT02391948|324188004|FG001|6-month Assessment|Death|0|||
94652954|NCT02391948|324188005|FG002|6-month Assessment|Death|0|||
94652955|NCT02391948|324188006|FG003|6-month Assessment|Death|0|||
94652956|NCT02391948|324188007|FG004|6-month Assessment|Death|1|||
94652957|NCT02391948|324188003|FG000|6-month Assessment|Withdrawal by Subject|0|||
94652958|NCT02391948|324188004|FG001|6-month Assessment|Withdrawal by Subject|0|||
94652959|NCT02391948|324188005|FG002|6-month Assessment|Withdrawal by Subject|1|||
94652960|NCT02391948|324188006|FG003|6-month Assessment|Withdrawal by Subject|2|||
94652961|NCT02391948|324188007|FG004|6-month Assessment|Withdrawal by Subject|0|||
94652962|NCT02391948|324188003|FG000|6-month Assessment|Lost to Follow-up|4|||
94652963|NCT02391948|324188004|FG001|6-month Assessment|Lost to Follow-up|5|||
94652964|NCT02391948|324188005|FG002|6-month Assessment|Lost to Follow-up|2|||
94652965|NCT02391948|324188006|FG003|6-month Assessment|Lost to Follow-up|3|||
94652966|NCT02391948|324188007|FG004|6-month Assessment|Lost to Follow-up|1|||
94652967|NCT02391948|324188003|FG000|6-month Assessment|Medical issue/illness|1|||
94652968|NCT02391948|324188004|FG001|6-month Assessment|Medical issue/illness|1|||
94652969|NCT02391948|324188005|FG002|6-month Assessment|Medical issue/illness|0|||
94652970|NCT02391948|324188006|FG003|6-month Assessment|Medical issue/illness|0|||
94652971|NCT02391948|324188007|FG004|6-month Assessment|Medical issue/illness|0|||
94652972|NCT02391948|324188003|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
94652973|NCT02391948|324188004|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
94652974|NCT02391948|324188005|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
94652975|NCT02391948|324188006|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
94652976|NCT02391948|324188007|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
94652977|NCT02391948|324188003|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
94652978|NCT02391948|324188004|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
94652979|NCT02391948|324188005|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
94710776|NCT04009577|324398813|FG003|Extension Phase|Adverse Event|1|||
94710777|NCT04009577|324398810|FG000|Extension Phase|Inadequate therapeutic effect|0|||
94710778|NCT04009577|324398811|FG001|Extension Phase|Inadequate therapeutic effect|0|||
94268701|NCT00467779|322778492|FG008|Stage 3|Disease Progression|0|||
94268702|NCT00467779|322778493|FG009|Stage 3|Disease Progression|0|||
94268703|NCT00467779|322778494|FG010|Stage 3|Disease Progression|0|||
94268704|NCT00467779|322778495|FG011|Stage 3|Disease Progression|0|||
94268705|NCT00467779|322778496|FG012|Stage 3|Disease Progression|0|||
94268706|NCT00467779|322778497|FG013|Stage 3|Disease Progression|0|||
94710779|NCT04009577|324398812|FG002|Extension Phase|Inadequate therapeutic effect|1|||
94710780|NCT04009577|324398813|FG003|Extension Phase|Inadequate therapeutic effect|0|||
94710781|NCT04009577|324398810|FG000|Extension Phase|Withdrawal by Subject|0|||
94710782|NCT04009577|324398811|FG001|Extension Phase|Withdrawal by Subject|0|||
94710783|NCT04009577|324398812|FG002|Extension Phase|Withdrawal by Subject|1|||
94710784|NCT04009577|324398813|FG003|Extension Phase|Withdrawal by Subject|0|||
94710785|NCT04009577|324398810|FG000|Extension Phase|Not Treated|0|||
94710786|NCT04009577|324398811|FG001|Extension Phase|Not Treated|0|||
94710787|NCT04009577|324398812|FG002|Extension Phase|Not Treated|2|||
94710788|NCT04009577|324398813|FG003|Extension Phase|Not Treated|0|||
94710789|NCT02261467|324398817|FG000|Overall Study|Enrolled in Error|1|||
94710790|NCT02261467|324398818|FG001|Overall Study|Enrolled in Error|0|||
94710791|NCT02261467|324398817|FG000|Overall Study|Protocol Violation|0|||
94710792|NCT02261467|324398818|FG001|Overall Study|Protocol Violation|1|||
94710793|NCT02261467|324398817|FG000|Overall Study|Personal Reasons|17|||
94710794|NCT02261467|324398818|FG001|Overall Study|Personal Reasons|22|||
94710795|NCT02261467|324398817|FG000|Overall Study|Lost to Follow-up|2|||
94710796|NCT02261467|324398818|FG001|Overall Study|Lost to Follow-up|13|||
94268707|NCT00467779|322778498|FG014|Stage 3|Disease Progression|9|||
94268708|NCT00467779|322778484|FG000|Stage 3|Unspecified Reason|0|||
94710797|NCT02261467|324398817|FG000|Overall Study|Adverse Event|1|||
94710798|NCT02261467|324398818|FG001|Overall Study|Adverse Event|1|||
94710799|NCT00658996|324398827|FG000|First Intervention|Positive slit lamp finding|1|||
94710800|NCT00658996|324398828|FG001|First Intervention|Positive slit lamp finding|0|||
94710801|NCT00658996|324398827|FG000|First Intervention|Lack of lenses|0|||
94710802|NCT00658996|324398828|FG001|First Intervention|Lack of lenses|1|||
94710803|NCT00658996|324398827|FG000|Crossover Period|Physician Decision|1|||
94710804|NCT00658996|324398828|FG001|Crossover Period|Physician Decision|0|||
94268709|NCT00467779|322778485|FG001|Stage 3|Unspecified Reason|0|||
94268710|NCT00467779|322778486|FG002|Stage 3|Unspecified Reason|0|||
94268711|NCT00467779|322778487|FG003|Stage 3|Unspecified Reason|0|||
94268712|NCT00467779|322778488|FG004|Stage 3|Unspecified Reason|0|||
94710805|NCT00658996|324398827|FG000|Crossover Period|Ineligible|1|||
94710806|NCT00658996|324398828|FG001|Crossover Period|Ineligible|1|||
94710807|NCT00658996|324398827|FG000|Second Intervention|Developed a stye on upper lid|1|||
94710808|NCT00658996|324398828|FG001|Second Intervention|Developed a stye on upper lid|0|||
94710809|NCT00658996|324398827|FG000|Second Intervention|Positive slit lamp finding|0|||
94710810|NCT00658996|324398828|FG001|Second Intervention|Positive slit lamp finding|1|||
94710811|NCT01579916|324398829|FG000|Overall Study|Lost to Follow-up|6|||
94710812|NCT01579916|324398830|FG001|Overall Study|Lost to Follow-up|1|||
94710813|NCT01579916|324398829|FG000|Overall Study|Withdrawal by Subject|1|||
94710814|NCT01579916|324398830|FG001|Overall Study|Withdrawal by Subject|1|||
94710815|NCT01579916|324398829|FG000|Overall Study|Death|1|||
94710816|NCT01579916|324398830|FG001|Overall Study|Death|0|||
94710817|NCT03512756|324398833|FG000|Part 1|Death|23|||
94710818|NCT03512756|324398834|FG001|Part 1|Death|18|||
94710819|NCT03512756|324398835|FG002|Part 1|Death|0|||
94710820|NCT03512756|324398836|FG003|Part 1|Death|0|||
94710821|NCT03512756|324398833|FG000|Part 1|Lost to Follow-up|0|||
94268713|NCT00467779|322778489|FG005|Stage 3|Unspecified Reason|0|||
94268714|NCT00467779|322778490|FG006|Stage 3|Unspecified Reason|0|||
94268715|NCT00467779|322778491|FG007|Stage 3|Unspecified Reason|0|||
94268716|NCT00467779|322778492|FG008|Stage 3|Unspecified Reason|0|||
94268717|NCT00467779|322778493|FG009|Stage 3|Unspecified Reason|0|||
94268718|NCT00467779|322778494|FG010|Stage 3|Unspecified Reason|0|||
94268719|NCT00467779|322778495|FG011|Stage 3|Unspecified Reason|0|||
94268720|NCT00467779|322778496|FG012|Stage 3|Unspecified Reason|0|||
94710822|NCT03512756|324398834|FG001|Part 1|Lost to Follow-up|3|||
94710823|NCT03512756|324398835|FG002|Part 1|Lost to Follow-up|0|||
94710824|NCT03512756|324398836|FG003|Part 1|Lost to Follow-up|0|||
94268721|NCT00467779|322778497|FG013|Stage 3|Unspecified Reason|0|||
94268722|NCT00467779|322778498|FG014|Stage 3|Unspecified Reason|5|||
94710825|NCT03512756|324398833|FG000|Part 1|Physician Decision|0|||
94710826|NCT03512756|324398834|FG001|Part 1|Physician Decision|1|||
94710827|NCT03512756|324398835|FG002|Part 1|Physician Decision|0|||
94710828|NCT03512756|324398836|FG003|Part 1|Physician Decision|0|||
94710829|NCT03512756|324398833|FG000|Part 1|Withdrawal by Subject|2|||
94710830|NCT03512756|324398834|FG001|Part 1|Withdrawal by Subject|2|||
94710831|NCT03512756|324398835|FG002|Part 1|Withdrawal by Subject|0|||
94710832|NCT03512756|324398836|FG003|Part 1|Withdrawal by Subject|0|||
94710833|NCT03512756|324398833|FG000|Part 2|Death|0|||
94710834|NCT03512756|324398834|FG001|Part 2|Death|0|||
94710835|NCT03512756|324398835|FG002|Part 2|Death|32|||
94710836|NCT03512756|324398836|FG003|Part 2|Death|21|||
94710837|NCT03512756|324398833|FG000|Part 2|Lost to Follow-up|0|||
94268723|NCT01519934|322778501|FG000|Overall Study|Lost to Follow-up|3|||
94268724|NCT00922480|322778502|FG000|Main Study|Protocol Violation|3|||
94710838|NCT03512756|324398834|FG001|Part 2|Lost to Follow-up|0|||
94710839|NCT03512756|324398835|FG002|Part 2|Lost to Follow-up|1|||
94268725|NCT00922480|322778503|FG001|Main Study|Protocol Violation|6|||
94268726|NCT00922480|322778502|FG000|Main Study|Adverse Event|6|||
94710840|NCT03512756|324398836|FG003|Part 2|Lost to Follow-up|0|||
94710841|NCT03512756|324398833|FG000|Part 2|Physician Decision|0|||
94710842|NCT03512756|324398834|FG001|Part 2|Physician Decision|0|||
94710843|NCT03512756|324398835|FG002|Part 2|Physician Decision|2|||
94710844|NCT03512756|324398836|FG003|Part 2|Physician Decision|4|||
94710845|NCT03512756|324398833|FG000|Part 2|Study Terminated by Sponsor|0|||
94710846|NCT03512756|324398834|FG001|Part 2|Study Terminated by Sponsor|0|||
94710847|NCT03512756|324398835|FG002|Part 2|Study Terminated by Sponsor|2|||
94710848|NCT03512756|324398836|FG003|Part 2|Study Terminated by Sponsor|6|||
94710849|NCT03512756|324398833|FG000|Part 2|Protocol Violation|0|||
94710850|NCT03512756|324398834|FG001|Part 2|Protocol Violation|0|||
94710851|NCT03512756|324398835|FG002|Part 2|Protocol Violation|1|||
94710852|NCT03512756|324398836|FG003|Part 2|Protocol Violation|0|||
94710853|NCT03512756|324398833|FG000|Part 2|Withdrawal by Subject|0|||
94710854|NCT03512756|324398834|FG001|Part 2|Withdrawal by Subject|0|||
94710855|NCT03512756|324398835|FG002|Part 2|Withdrawal by Subject|3|||
94710856|NCT03512756|324398836|FG003|Part 2|Withdrawal by Subject|9|||
94710857|NCT02079844|324398837|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
94710858|NCT02079844|324398838|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
94710859|NCT02079844|324398839|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
94710860|NCT02079844|324398837|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
94710861|NCT02079844|324398838|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
94710862|NCT02079844|324398839|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
94710863|NCT00589667|324401214|FG000|Overall Study|Adverse Event|2|||
94710864|NCT00589667|324401214|FG000|Overall Study|Withdrawal by Subject|1|||
94710865|NCT01188655|324401215|FG000|Overall Study|Lack of Efficacy|1|||
94710866|NCT01188655|324401215|FG000|Overall Study|Lost to Follow-up|1|||
94710867|NCT01188655|324401215|FG000|Overall Study|Other|11|||
94710868|NCT00493649|324401221|FG000|Overall Study|Adverse Event|44|||
94710869|NCT00493649|324401221|FG000|Overall Study|Patient Request|21|||
94710870|NCT00493649|324401221|FG000|Overall Study|Investigator Request|2|||
94710871|NCT00493649|324401221|FG000|Overall Study|Disease Progression|1|||
94710872|NCT00493649|324401221|FG000|Overall Study|Lost to Follow-up|1|||
94710873|NCT00493649|324401221|FG000|Overall Study|Other|13|||
94710874|NCT05219253|324401222|FG000|Overall Study|Withdrawal by Subject|1|||
94710875|NCT05219253|324401223|FG001|Overall Study|Withdrawal by Subject|2|||
94710876|NCT00683696|324401224|FG000|Overall Study|Withdrawn due to study closure|337|||
94710877|NCT00683696|324401225|FG001|Overall Study|Withdrawn due to study closure|338|||
94710878|NCT00683696|324401224|FG000|Overall Study|Withdrawn prior to study closure|13|||
94710879|NCT00683696|324401225|FG001|Overall Study|Withdrawn prior to study closure|28|||
94710880|NCT00683696|324401224|FG000|Overall Study|Lost to Follow-up|5|||
94710881|NCT00683696|324401225|FG001|Overall Study|Lost to Follow-up|6|||
94710882|NCT00683696|324401224|FG000|Overall Study|Vital status follow-up only|3|||
94710883|NCT00683696|324401225|FG001|Overall Study|Vital status follow-up only|3|||
94710884|NCT00683696|324401224|FG000|Overall Study|Death|46|||
94710885|NCT00683696|324401225|FG001|Overall Study|Death|30|||
94710886|NCT01875848|324401231|FG000|Overall Study|Withdrawal by Subject|2|||
94710887|NCT01875848|324401232|FG001|Overall Study|Withdrawal by Subject|0|||
94710888|NCT00925587|324401235|FG000|Overall Study|Protocol Specified Criteria|6|||
94710889|NCT00925587|324401236|FG001|Overall Study|Protocol Specified Criteria|6|||
94710890|NCT00925587|324401235|FG000|Overall Study|Physician Decision|4|||
94710891|NCT00925587|324401236|FG001|Overall Study|Physician Decision|1|||
94710892|NCT00925587|324401235|FG000|Overall Study|Protocol Violation|6|||
94710893|NCT00925587|324401236|FG001|Overall Study|Protocol Violation|4|||
94710894|NCT00925587|324401235|FG000|Overall Study|Withdrawal by Subject|9|||
94710895|NCT00925587|324401236|FG001|Overall Study|Withdrawal by Subject|6|||
94710896|NCT00925587|324401235|FG000|Overall Study|Death|5|||
94710897|NCT00925587|324401236|FG001|Overall Study|Death|5|||
94710898|NCT00925587|324401235|FG000|Overall Study|Adverse Event|6|||
94710899|NCT00925587|324401236|FG001|Overall Study|Adverse Event|2|||
94710900|NCT00925587|324401235|FG000|Overall Study|Lost to Follow-up|0|||
94710901|NCT00925587|324401236|FG001|Overall Study|Lost to Follow-up|1|||
94710902|NCT04668339|324401237|FG000|Overall Study|Physician Decision|1|||
94710903|NCT04668339|324401238|FG001|Overall Study|Physician Decision|0|||
94710904|NCT04668339|324401239|FG002|Overall Study|Physician Decision|1|||
94710905|NCT04668339|324401240|FG003|Overall Study|Physician Decision|1|||
94710906|NCT04668339|324401237|FG000|Overall Study|Lost to Follow-up|14|||
94710907|NCT04668339|324401238|FG001|Overall Study|Lost to Follow-up|12|||
94710908|NCT04668339|324401239|FG002|Overall Study|Lost to Follow-up|8|||
94710909|NCT04668339|324401240|FG003|Overall Study|Lost to Follow-up|5|||
94710910|NCT04668339|324401237|FG000|Overall Study|Adverse Event|0|||
94710911|NCT04668339|324401238|FG001|Overall Study|Adverse Event|0|||
94710912|NCT04668339|324401239|FG002|Overall Study|Adverse Event|1|||
94710913|NCT04668339|324401240|FG003|Overall Study|Adverse Event|0|||
94710914|NCT04668339|324401237|FG000|Overall Study|Other than specified|3|||
94710915|NCT04668339|324401238|FG001|Overall Study|Other than specified|0|||
94710916|NCT04668339|324401239|FG002|Overall Study|Other than specified|1|||
94710917|NCT04668339|324401240|FG003|Overall Study|Other than specified|0|||
94710918|NCT04668339|324401237|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
94710919|NCT04668339|324401238|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
94710920|NCT04668339|324401239|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
94710921|NCT04668339|324401240|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
94710922|NCT04668339|324401237|FG000|Overall Study|Vaccine not Administered|0|||
94710923|NCT04668339|324401238|FG001|Overall Study|Vaccine not Administered|0|||
94710924|NCT04668339|324401239|FG002|Overall Study|Vaccine not Administered|1|||
94710925|NCT04668339|324401240|FG003|Overall Study|Vaccine not Administered|0|||
94710926|NCT04668339|324401237|FG000|Overall Study|Protocol Violation|18|||
94710927|NCT04668339|324401238|FG001|Overall Study|Protocol Violation|23|||
94710928|NCT04668339|324401239|FG002|Overall Study|Protocol Violation|12|||
94710929|NCT04668339|324401240|FG003|Overall Study|Protocol Violation|20|||
94710930|NCT04668339|324401237|FG000|Overall Study|Withdrawal by Subject|45|||
94710931|NCT04668339|324401238|FG001|Overall Study|Withdrawal by Subject|46|||
94710932|NCT04668339|324401239|FG002|Overall Study|Withdrawal by Subject|46|||
94710933|NCT04668339|324401240|FG003|Overall Study|Withdrawal by Subject|27|||
94710934|NCT04668339|324401237|FG000|Overall Study|Study Terminated by Sponsor|59|||
94710935|NCT04668339|324401238|FG001|Overall Study|Study Terminated by Sponsor|59|||
94710936|NCT04668339|324401239|FG002|Overall Study|Study Terminated by Sponsor|71|||
94710937|NCT04668339|324401240|FG003|Overall Study|Study Terminated by Sponsor|1|||
94710938|NCT02544152|324401241|FG000|Overall Study|Adverse Event|0|||
94710939|NCT02544152|324401242|FG001|Overall Study|Adverse Event|4|||
94710940|NCT02544152|324401241|FG000|Overall Study|Withdrawal by Subject|0|||
94710941|NCT02544152|324401242|FG001|Overall Study|Withdrawal by Subject|3|||
94710942|NCT02544152|324401241|FG000|Overall Study|Other|1|||
94710943|NCT02544152|324401242|FG001|Overall Study|Other|0|||
94710944|NCT00955825|324401245|FG000|Overall Study|Adverse Event|15|||
94710945|NCT00955825|324401246|FG001|Overall Study|Adverse Event|2|||
94710946|NCT00955825|324401245|FG000|Overall Study|Withdrawal by Subject|4|||
94710947|NCT00955825|324401246|FG001|Overall Study|Withdrawal by Subject|6|||
94710948|NCT00955825|324401245|FG000|Overall Study|Any other reason not above-mentioned|7|||
94710949|NCT00955825|324401246|FG001|Overall Study|Any other reason not above-mentioned|9|||
94710950|NCT00516321|324401247|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
94710951|NCT00516321|324401248|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
94710952|NCT00516321|324401249|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
94710953|NCT00516321|324401247|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
94710954|NCT00516321|324401248|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
94710955|NCT00516321|324401249|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
94710956|NCT00516321|324401247|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
94710957|NCT00516321|324401248|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
94710958|NCT00516321|324401249|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
94710959|NCT00516321|324401247|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
94710960|NCT00516321|324401248|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
94710961|NCT00516321|324401249|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
94710962|NCT00516321|324401247|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
94710963|NCT00516321|324401248|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
94710964|NCT00516321|324401249|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
94710965|NCT00516321|324401247|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
94710966|NCT00516321|324401248|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
94710967|NCT00516321|324401249|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
94710968|NCT00516321|324401247|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
94268727|NCT00922480|322778503|FG001|Main Study|Adverse Event|7|||
94268728|NCT00922480|322778502|FG000|Main Study|Lack of Efficacy|3|||
94268729|NCT00922480|322778503|FG001|Main Study|Lack of Efficacy|0|||
94268730|NCT00922480|322778502|FG000|Main Study|Withdrawal by Subject|20|||
94268731|NCT00922480|322778503|FG001|Main Study|Withdrawal by Subject|15|||
94268732|NCT00922480|322778502|FG000|Main Study|Lost to Follow-up|5|||
94268733|NCT00922480|322778503|FG001|Main Study|Lost to Follow-up|0|||
94268734|NCT00922480|322778502|FG000|Main Study|Physician Decision|0|||
94268735|NCT00922480|322778503|FG001|Main Study|Physician Decision|1|||
94268736|NCT00922480|322778502|FG000|Extension Study|Protocol Violation|3|||
94268737|NCT00922480|322778503|FG001|Extension Study|Protocol Violation|0|||
94268738|NCT00922480|322778502|FG000|Extension Study|Adverse Event|1|||
94268739|NCT00922480|322778503|FG001|Extension Study|Adverse Event|1|||
94268740|NCT00922480|322778502|FG000|Extension Study|Withdrawal by Subject|1|||
94268741|NCT00922480|322778503|FG001|Extension Study|Withdrawal by Subject|1|||
94268742|NCT00922480|322778502|FG000|Extension Study|Others|0|||
94268743|NCT00922480|322778503|FG001|Extension Study|Others|1|||
94268744|NCT03083847|322778504|FG000|Main|Physician Decision|0|||
94268745|NCT03083847|322778505|FG001|Main|Physician Decision|0|||
94268746|NCT03083847|322778506|FG002|Main|Physician Decision|0|||
94268747|NCT03083847|322778507|FG003|Main|Physician Decision|0|||
94268748|NCT03083847|322778508|FG004|Main|Physician Decision|0|||
94268749|NCT03083847|322778509|FG005|Main|Physician Decision|1|||
94268750|NCT03083847|322778510|FG006|Main|Physician Decision|0|||
94268751|NCT03083847|322778511|FG007|Main|Physician Decision|0|||
94268752|NCT03083847|322778512|FG008|Main|Physician Decision|0|||
94268753|NCT03083847|322778513|FG009|Main|Physician Decision|0|||
94268754|NCT03083847|322778504|FG000|Main|Pregnancy|0|||
94268755|NCT03083847|322778505|FG001|Main|Pregnancy|0|||
94268756|NCT03083847|322778506|FG002|Main|Pregnancy|0|||
94268757|NCT03083847|322778507|FG003|Main|Pregnancy|0|||
94268758|NCT03083847|322778508|FG004|Main|Pregnancy|0|||
94268759|NCT03083847|322778509|FG005|Main|Pregnancy|0|||
94268760|NCT03083847|322778510|FG006|Main|Pregnancy|0|||
94268761|NCT03083847|322778511|FG007|Main|Pregnancy|1|||
94268762|NCT03083847|322778512|FG008|Main|Pregnancy|0|||
94268763|NCT03083847|322778513|FG009|Main|Pregnancy|0|||
94268764|NCT03083847|322778504|FG000|Main|Adverse Event|0|||
94268765|NCT03083847|322778505|FG001|Main|Adverse Event|0|||
94268766|NCT03083847|322778506|FG002|Main|Adverse Event|0|||
94268767|NCT03083847|322778507|FG003|Main|Adverse Event|0|||
94268768|NCT03083847|322778508|FG004|Main|Adverse Event|0|||
94268769|NCT03083847|322778509|FG005|Main|Adverse Event|0|||
94268770|NCT03083847|322778510|FG006|Main|Adverse Event|0|||
94268771|NCT03083847|322778511|FG007|Main|Adverse Event|2|||
94268772|NCT03083847|322778512|FG008|Main|Adverse Event|0|||
94268773|NCT03083847|322778513|FG009|Main|Adverse Event|0|||
94268774|NCT03083847|322778504|FG000|Main|Withdrawal by Subject|0|||
94268775|NCT03083847|322778505|FG001|Main|Withdrawal by Subject|0|||
94268776|NCT03083847|322778506|FG002|Main|Withdrawal by Subject|0|||
94268777|NCT03083847|322778507|FG003|Main|Withdrawal by Subject|0|||
94268778|NCT03083847|322778508|FG004|Main|Withdrawal by Subject|0|||
94268779|NCT03083847|322778509|FG005|Main|Withdrawal by Subject|0|||
94268780|NCT03083847|322778510|FG006|Main|Withdrawal by Subject|1|||
94268781|NCT03083847|322778511|FG007|Main|Withdrawal by Subject|1|||
94268782|NCT03083847|322778512|FG008|Main|Withdrawal by Subject|0|||
94268783|NCT03083847|322778513|FG009|Main|Withdrawal by Subject|0|||
94268784|NCT00058552|322778514|FG000|Overall Study|Died prior to receiving treatment|4|||
94268785|NCT00058552|322778515|FG001|Overall Study|Died prior to receiving treatment|2|||
94268786|NCT00058552|322778514|FG000|Overall Study|Disease progression|52|||
94268787|NCT00058552|322778515|FG001|Overall Study|Disease progression|44|||
94268788|NCT00058552|322778514|FG000|Overall Study|Adverse Event|4|||
94268789|NCT00058552|322778515|FG001|Overall Study|Adverse Event|2|||
94268790|NCT00058552|322778514|FG000|Overall Study|Withdrawal by Subject|3|||
94268791|NCT00058552|322778515|FG001|Overall Study|Withdrawal by Subject|5|||
94268792|NCT00058552|322778514|FG000|Overall Study|Physician Decision|2|||
94268793|NCT00058552|322778515|FG001|Overall Study|Physician Decision|5|||
94366789|NCT01039584|323128193|FG001|Overall Study|Lack of Efficacy|6|||
94268794|NCT00058552|322778514|FG000|Overall Study|Clinical disease progression|0|||
94268795|NCT00058552|322778515|FG001|Overall Study|Clinical disease progression|4|||
94268796|NCT02066311|322778516|FG000|Overall Study|Adverse Event|4|||
94268797|NCT02066311|322778516|FG000|Overall Study|Withdrawal by Subject|1|||
94268798|NCT01372150|322778517|FG000|Overall Study|Lack of Efficacy|3|||
94268799|NCT01372150|322778518|FG001|Overall Study|Lack of Efficacy|0|||
94268800|NCT01372150|322778519|FG002|Overall Study|Lack of Efficacy|1|||
94268801|NCT01372150|322778517|FG000|Overall Study|Lost to Follow-up|4|||
94268802|NCT01372150|322778518|FG001|Overall Study|Lost to Follow-up|5|||
94268803|NCT01372150|322778519|FG002|Overall Study|Lost to Follow-up|6|||
94268804|NCT01372150|322778517|FG000|Overall Study|Protocol Violation|1|||
94268805|NCT01372150|322778518|FG001|Overall Study|Protocol Violation|0|||
94268806|NCT01372150|322778519|FG002|Overall Study|Protocol Violation|3|||
94268807|NCT01372150|322778517|FG000|Overall Study|Withdrawal by Subject|2|||
94268808|NCT01372150|322778518|FG001|Overall Study|Withdrawal by Subject|7|||
94268809|NCT01372150|322778519|FG002|Overall Study|Withdrawal by Subject|2|||
94268810|NCT01372150|322778517|FG000|Overall Study|Other|1|||
94268811|NCT01372150|322778518|FG001|Overall Study|Other|0|||
94268812|NCT01372150|322778519|FG002|Overall Study|Other|2|||
94268813|NCT01372150|322778517|FG000|Overall Study|Adverse Event|2|||
94268814|NCT01372150|322778518|FG001|Overall Study|Adverse Event|1|||
94268815|NCT01372150|322778519|FG002|Overall Study|Adverse Event|2|||
94268816|NCT01372150|322778517|FG000|Overall Study|Randomized but not treated|0|||
94268817|NCT01372150|322778518|FG001|Overall Study|Randomized but not treated|1|||
94268818|NCT01372150|322778519|FG002|Overall Study|Randomized but not treated|0|||
94268819|NCT03198520|322778520|FG000|Overall Study|Physician Decision|2|||
94268820|NCT03198520|322778520|FG000|Overall Study|Protocol Violation|2|||
94268821|NCT03198520|322778520|FG000|Overall Study|Withdrawal by Subject|1|||
94268822|NCT03198520|322778520|FG000|Overall Study|Study Ended|1|||
94268823|NCT01670539|322778521|FG000|Overall Study|Death|3|||
94268824|NCT01670539|322778522|FG001|Overall Study|Death|5|||
94268825|NCT01670539|322778521|FG000|Overall Study|Withdrawal by Subject|3|||
94268826|NCT01670539|322778522|FG001|Overall Study|Withdrawal by Subject|0|||
94268827|NCT04353596|322778523|FG000|Overall Study|Protocol Violation|4|||
94710969|NCT00516321|324401248|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
94268828|NCT04353596|322778524|FG001|Overall Study|Protocol Violation|4|||
94268829|NCT04353596|322778523|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
94268830|NCT04353596|322778524|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
94268831|NCT02665052|322778527|FG000|Overall Study|Lost to Follow-up|1|||
94268832|NCT02665052|322778528|FG001|Overall Study|Lost to Follow-up|0|||
94268833|NCT02665052|322778529|FG002|Overall Study|Lost to Follow-up|0|||
94268834|NCT02665052|322778530|FG003|Overall Study|Lost to Follow-up|0|||
94268835|NCT02665052|322778527|FG000|Overall Study|Withdrawal by Subject|1|||
94268836|NCT02665052|322778528|FG001|Overall Study|Withdrawal by Subject|1|||
94268837|NCT02665052|322778529|FG002|Overall Study|Withdrawal by Subject|0|||
94268838|NCT02665052|322778530|FG003|Overall Study|Withdrawal by Subject|5|||
94268839|NCT02665052|322778527|FG000|Overall Study|Adverse Event|1|||
94710970|NCT00516321|324401249|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
94710971|NCT00516321|324401247|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
94268840|NCT02665052|322778528|FG001|Overall Study|Adverse Event|1|||
94268841|NCT02665052|322778529|FG002|Overall Study|Adverse Event|0|||
94710972|NCT00516321|324401248|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
94710973|NCT00516321|324401249|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
94710974|NCT00516321|324401247|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
94710975|NCT00516321|324401248|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
94268842|NCT02665052|322778530|FG003|Overall Study|Adverse Event|0|||
94268843|NCT01526551|322778531|FG000|Overall Study|Lack of returned parental consent form|424|||
94268844|NCT00718549|322778532|FG000|Induction Phase|Disease Progression|1|||
94268845|NCT00718549|322778533|FG001|Induction Phase|Disease Progression|0|||
94268846|NCT00718549|322778534|FG002|Induction Phase|Disease Progression|0|||
94268847|NCT00718549|322778532|FG000|Induction Phase|Eligibility Criteria Violation|2|||
94268848|NCT00718549|322778533|FG001|Induction Phase|Eligibility Criteria Violation|0|||
94268849|NCT00718549|322778534|FG002|Induction Phase|Eligibility Criteria Violation|0|||
94268850|NCT00718549|322778532|FG000|Induction Phase|Early Termination - No Additional Info|59|||
94268851|NCT00718549|322778533|FG001|Induction Phase|Early Termination - No Additional Info|0|||
94268852|NCT00718549|322778534|FG002|Induction Phase|Early Termination - No Additional Info|0|||
94268853|NCT00718549|322778532|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
94268854|NCT00718549|322778533|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
94268855|NCT00718549|322778534|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
94268856|NCT00718549|322778532|FG000|Maintenance/ Observation Phase|Death|0|||
94268857|NCT00718549|322778533|FG001|Maintenance/ Observation Phase|Death|1|||
94268858|NCT00718549|322778534|FG002|Maintenance/ Observation Phase|Death|2|||
94268859|NCT00718549|322778532|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
94268860|NCT00718549|322778533|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
94268861|NCT00718549|322778534|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
94268862|NCT00718549|322778532|FG000|Maintenance/ Observation Phase|Progression|0|||
94268863|NCT00718549|322778533|FG001|Maintenance/ Observation Phase|Progression|5|||
94268864|NCT00718549|322778534|FG002|Maintenance/ Observation Phase|Progression|14|||
94268865|NCT00718549|322778532|FG000|Maintenance/ Observation Phase|Relapse|0|||
94268866|NCT00718549|322778533|FG001|Maintenance/ Observation Phase|Relapse|3|||
94268867|NCT00718549|322778534|FG002|Maintenance/ Observation Phase|Relapse|2|||
94268868|NCT01186796|322778536|FG000|Overall Study|Adverse Event|3|||
94268869|NCT01186796|322778537|FG001|Overall Study|Adverse Event|0|||
94268870|NCT01186796|322778536|FG000|Overall Study|Withdrawal by Subject|1|||
94268871|NCT01186796|322778537|FG001|Overall Study|Withdrawal by Subject|1|||
94466274|NCT01358578|323496955|FG004|Maintenance Period|Pregnancy|0|||
94710976|NCT00516321|324401249|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
94268872|NCT01186796|322778536|FG000|Overall Study|Protocol Violation|0|||
94268873|NCT01186796|322778537|FG001|Overall Study|Protocol Violation|1|||
94268874|NCT02613884|322778538|FG000|Overall Study|Death|1|||
94268875|NCT02613884|322778538|FG000|Overall Study|Lost to Follow-up|1|||
94268876|NCT04534491|322778539|FG000|Overall Study|Not completed end-of-study interview|24|||
94268877|NCT04534491|322778539|FG000|Overall Study|Non-users|70|||
94268878|NCT04534491|322778539|FG000|Overall Study|Non-verifiable users|58|||
94268879|NCT00369785|322778545|FG000|Overall Study|Physician Decision|3|||
94268880|NCT00369785|322778546|FG001|Overall Study|Physician Decision|2|||
94268881|NCT00369785|322778545|FG000|Overall Study|Death|1|||
94268882|NCT00369785|322778546|FG001|Overall Study|Death|2|||
94268883|NCT00369785|322778545|FG000|Overall Study|Withdrawal by Subject|7|||
94268884|NCT00369785|322778546|FG001|Overall Study|Withdrawal by Subject|6|||
94268885|NCT00369785|322778545|FG000|Overall Study|Toxicity|6|||
94268886|NCT00369785|322778546|FG001|Overall Study|Toxicity|4|||
94268887|NCT00369785|322778545|FG000|Overall Study|Never started|0|||
94268888|NCT00369785|322778546|FG001|Overall Study|Never started|2|||
94268889|NCT00369785|322778545|FG000|Overall Study|Progression|4|||
94268890|NCT00369785|322778546|FG001|Overall Study|Progression|4|||
94268891|NCT00369785|322778545|FG000|Overall Study|Multiple reasons|6|||
94268892|NCT00369785|322778546|FG001|Overall Study|Multiple reasons|5|||
94268893|NCT00800683|322778547|FG000|Overall Study|Adverse Event|11|||
94268894|NCT00800683|322778548|FG001|Overall Study|Adverse Event|8|||
94268895|NCT00800683|322778547|FG000|Overall Study|Lost to Follow-up|3|||
94268896|NCT00800683|322778548|FG001|Overall Study|Lost to Follow-up|1|||
94268897|NCT00800683|322778547|FG000|Overall Study|Withdrawal by Subject|1|||
94268898|NCT00800683|322778548|FG001|Overall Study|Withdrawal by Subject|7|||
94268899|NCT00800683|322778547|FG000|Overall Study|Lack of Efficacy|1|||
94268900|NCT00800683|322778548|FG001|Overall Study|Lack of Efficacy|1|||
94268901|NCT00800683|322778547|FG000|Overall Study|Other|1|||
94268902|NCT00800683|322778548|FG001|Overall Study|Other|2|||
94268903|NCT01221727|322778549|FG000|Overall Study|Physician Decision|2|||
94268904|NCT01221727|322778550|FG001|Overall Study|Physician Decision|0|||
94268905|NCT01221727|322778549|FG000|Overall Study|Withdrawal by Subject|1|||
94268906|NCT01221727|322778550|FG001|Overall Study|Withdrawal by Subject|1|||
94268907|NCT00199836|322778559|FG000|Overall Study|Progressive Disease|5|||
94268908|NCT00199836|322778559|FG000|Overall Study|Death|1|||
94268909|NCT03986866|322778563|FG000|Overall Study|Withdrawal by Subject|0|||
94268910|NCT03986866|322778564|FG001|Overall Study|Withdrawal by Subject|3|||
94268911|NCT03986866|322778563|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
94268912|NCT03986866|322778564|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
94268913|NCT00430482|322778565|FG000|Completed Treatment|Insufficient Treatment|7|||
94268914|NCT00430482|322778566|FG001|Completed Treatment|Insufficient Treatment|11|||
94268915|NCT00545402|322778567|FG000|Overall Study|Discontinuation of treatment|17|||
94268916|NCT00545402|322778568|FG001|Overall Study|Discontinuation of treatment|9|||
94710977|NCT00516321|324401247|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
94710978|NCT00516321|324401248|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
94710979|NCT00516321|324401249|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
94710980|NCT00516321|324401247|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
94710981|NCT00516321|324401248|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
94710982|NCT00516321|324401249|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
94710983|NCT03557008|324401251|FG000|Overall Study|Withdrawal by Subject|2|||
94710984|NCT03557008|324401252|FG001|Overall Study|Withdrawal by Subject|2|||
94710985|NCT03557008|324401251|FG000|Overall Study|Early termination from study|3|||
94710986|NCT03557008|324401252|FG001|Overall Study|Early termination from study|1|||
94268917|NCT00545402|322778567|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
94268918|NCT00545402|322778568|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
94268919|NCT00545402|322778567|FG000|Overall Study|Death|5|||
94268920|NCT00545402|322778568|FG001|Overall Study|Death|7|||
94268921|NCT00545402|322778567|FG000|Overall Study|Graft loss|2|||
94268922|NCT00545402|322778568|FG001|Overall Study|Graft loss|4|||
94268923|NCT00545402|322778567|FG000|Overall Study|Withdrawal by Subject|0|||
94268924|NCT00545402|322778568|FG001|Overall Study|Withdrawal by Subject|1|||
94268925|NCT00545402|322778567|FG000|Overall Study|Protocol Violation|1|||
94268926|NCT00545402|322778568|FG001|Overall Study|Protocol Violation|0|||
94268927|NCT00545402|322778567|FG000|Overall Study|Reason not specified|1|||
94268928|NCT00545402|322778568|FG001|Overall Study|Reason not specified|1|||
94268929|NCT01817751|322778569|FG000|Overall Study|Physician Decision|1|||
94268930|NCT00397033|322778570|FG000|Overall Study|Adverse Event|7|||
94268931|NCT00397033|322778571|FG001|Overall Study|Adverse Event|10|||
94268932|NCT00397033|322778572|FG002|Overall Study|Adverse Event|4|||
94268933|NCT00397033|322778570|FG000|Overall Study|Lack of Efficacy|22|||
94268934|NCT00397033|322778571|FG001|Overall Study|Lack of Efficacy|12|||
94366790|NCT01039584|323128194|FG002|Overall Study|Lack of Efficacy|10|||
94268935|NCT00397033|322778572|FG002|Overall Study|Lack of Efficacy|9|||
94710987|NCT01307267|324401257|FG000|Overall Study|Death|4|||
94710988|NCT01307267|324401258|FG001|Overall Study|Death|3|||
94710989|NCT01307267|324401259|FG002|Overall Study|Death|5|||
94710990|NCT01307267|324401260|FG003|Overall Study|Death|3|||
94710991|NCT01307267|324401261|FG004|Overall Study|Death|1|||
94710992|NCT01307267|324401262|FG005|Overall Study|Death|26|||
94710993|NCT01307267|324401263|FG006|Overall Study|Death|2|||
94710994|NCT01307267|324401264|FG007|Overall Study|Death|2|||
94710995|NCT01307267|324401265|FG008|Overall Study|Death|21|||
94710996|NCT01307267|324401266|FG009|Overall Study|Death|2|||
94710997|NCT01307267|324401267|FG010|Overall Study|Death|3|||
94268936|NCT00397033|322778570|FG000|Overall Study|Lost to Follow-up|3|||
94710998|NCT01307267|324401268|FG011|Overall Study|Death|9|||
94710999|NCT01307267|324401269|FG012|Overall Study|Death|0|||
94711000|NCT01307267|324401270|FG013|Overall Study|Death|0|||
94711001|NCT01307267|324401271|FG014|Overall Study|Death|0|||
94711002|NCT01307267|324401272|FG015|Overall Study|Death|0|||
94711003|NCT01307267|324401273|FG016|Overall Study|Death|1|||
94711004|NCT01307267|324401274|FG017|Overall Study|Death|1|||
94711005|NCT01307267|324401275|FG018|Overall Study|Death|2|||
94711006|NCT01307267|324401276|FG019|Overall Study|Death|8|||
94711007|NCT01307267|324401277|FG020|Overall Study|Death|1|||
94711008|NCT01307267|324401278|FG021|Overall Study|Death|2|||
94711009|NCT01307267|324401279|FG022|Overall Study|Death|2|||
94711010|NCT01307267|324401257|FG000|Overall Study|Lost to Follow-up|0|||
94711011|NCT01307267|324401258|FG001|Overall Study|Lost to Follow-up|0|||
94711012|NCT01307267|324401259|FG002|Overall Study|Lost to Follow-up|0|||
94711013|NCT01307267|324401260|FG003|Overall Study|Lost to Follow-up|0|||
94711014|NCT01307267|324401261|FG004|Overall Study|Lost to Follow-up|0|||
94711015|NCT01307267|324401262|FG005|Overall Study|Lost to Follow-up|7|||
94711016|NCT01307267|324401263|FG006|Overall Study|Lost to Follow-up|0|||
94711017|NCT01307267|324401264|FG007|Overall Study|Lost to Follow-up|0|||
94711018|NCT01307267|324401265|FG008|Overall Study|Lost to Follow-up|1|||
94711019|NCT01307267|324401266|FG009|Overall Study|Lost to Follow-up|2|||
94268937|NCT00397033|322778571|FG001|Overall Study|Lost to Follow-up|3|||
94268938|NCT00397033|322778572|FG002|Overall Study|Lost to Follow-up|3|||
94268939|NCT00397033|322778570|FG000|Overall Study|Withdrawal by Subject|12|||
94268940|NCT00397033|322778571|FG001|Overall Study|Withdrawal by Subject|7|||
94268941|NCT00397033|322778572|FG002|Overall Study|Withdrawal by Subject|5|||
94268942|NCT00397033|322778570|FG000|Overall Study|Other|0|||
94268943|NCT00397033|322778571|FG001|Overall Study|Other|5|||
94268944|NCT00397033|322778572|FG002|Overall Study|Other|2|||
94268945|NCT03519867|322778573|FG000|Overall Study|Adverse Event|1|||
94268946|NCT03519867|322778574|FG001|Overall Study|Adverse Event|1|||
94268947|NCT03519867|322778575|FG002|Overall Study|Adverse Event|0|||
94268948|NCT03519867|322778576|FG003|Overall Study|Adverse Event|0|||
94268949|NCT03519867|322778577|FG004|Overall Study|Adverse Event|0|||
94268950|NCT03519867|322778578|FG005|Overall Study|Adverse Event|0|||
94268951|NCT03519867|322778579|FG006|Overall Study|Adverse Event|0|||
94268952|NCT03519867|322778580|FG007|Overall Study|Adverse Event|0|||
94268953|NCT03519867|322778581|FG008|Overall Study|Adverse Event|0|||
94268954|NCT03519867|322778582|FG009|Overall Study|Adverse Event|0|||
94711020|NCT01307267|324401267|FG010|Overall Study|Lost to Follow-up|1|||
94711021|NCT01307267|324401268|FG011|Overall Study|Lost to Follow-up|0|||
94711022|NCT01307267|324401269|FG012|Overall Study|Lost to Follow-up|0|||
94711023|NCT01307267|324401270|FG013|Overall Study|Lost to Follow-up|0|||
94268955|NCT03519867|322778573|FG000|Overall Study|Protocol Violation|0|||
94268956|NCT03519867|322778574|FG001|Overall Study|Protocol Violation|0|||
94268957|NCT03519867|322778575|FG002|Overall Study|Protocol Violation|0|||
94268958|NCT03519867|322778576|FG003|Overall Study|Protocol Violation|0|||
94268959|NCT03519867|322778577|FG004|Overall Study|Protocol Violation|0|||
94268960|NCT03519867|322778578|FG005|Overall Study|Protocol Violation|1|||
94268961|NCT03519867|322778579|FG006|Overall Study|Protocol Violation|0|||
94268962|NCT03519867|322778580|FG007|Overall Study|Protocol Violation|0|||
94711024|NCT01307267|324401271|FG014|Overall Study|Lost to Follow-up|0|||
94711025|NCT01307267|324401272|FG015|Overall Study|Lost to Follow-up|0|||
94711026|NCT01307267|324401273|FG016|Overall Study|Lost to Follow-up|0|||
94711027|NCT01307267|324401274|FG017|Overall Study|Lost to Follow-up|0|||
94711028|NCT01307267|324401275|FG018|Overall Study|Lost to Follow-up|0|||
94711029|NCT01307267|324401276|FG019|Overall Study|Lost to Follow-up|2|||
94711030|NCT01307267|324401277|FG020|Overall Study|Lost to Follow-up|0|||
94711031|NCT01307267|324401278|FG021|Overall Study|Lost to Follow-up|0|||
94711032|NCT01307267|324401279|FG022|Overall Study|Lost to Follow-up|0|||
94711033|NCT01307267|324401257|FG000|Overall Study|Withdrawal by Subject|0|||
94711034|NCT01307267|324401258|FG001|Overall Study|Withdrawal by Subject|0|||
94711035|NCT01307267|324401259|FG002|Overall Study|Withdrawal by Subject|0|||
94711036|NCT01307267|324401260|FG003|Overall Study|Withdrawal by Subject|0|||
94711037|NCT01307267|324401261|FG004|Overall Study|Withdrawal by Subject|0|||
94711038|NCT01307267|324401262|FG005|Overall Study|Withdrawal by Subject|1|||
94711039|NCT01307267|324401263|FG006|Overall Study|Withdrawal by Subject|0|||
94711040|NCT01307267|324401264|FG007|Overall Study|Withdrawal by Subject|1|||
94711041|NCT01307267|324401265|FG008|Overall Study|Withdrawal by Subject|5|||
94711042|NCT01307267|324401266|FG009|Overall Study|Withdrawal by Subject|1|||
94268963|NCT03519867|322778581|FG008|Overall Study|Protocol Violation|0|||
94711043|NCT01307267|324401267|FG010|Overall Study|Withdrawal by Subject|1|||
94711044|NCT01307267|324401268|FG011|Overall Study|Withdrawal by Subject|1|||
94711045|NCT01307267|324401269|FG012|Overall Study|Withdrawal by Subject|0|||
94711046|NCT01307267|324401270|FG013|Overall Study|Withdrawal by Subject|0|||
94711047|NCT01307267|324401271|FG014|Overall Study|Withdrawal by Subject|0|||
94711048|NCT01307267|324401272|FG015|Overall Study|Withdrawal by Subject|0|||
94711049|NCT01307267|324401273|FG016|Overall Study|Withdrawal by Subject|0|||
94711050|NCT01307267|324401274|FG017|Overall Study|Withdrawal by Subject|0|||
94711051|NCT01307267|324401275|FG018|Overall Study|Withdrawal by Subject|0|||
94711052|NCT01307267|324401276|FG019|Overall Study|Withdrawal by Subject|3|||
94711053|NCT01307267|324401277|FG020|Overall Study|Withdrawal by Subject|0|||
94711054|NCT01307267|324401278|FG021|Overall Study|Withdrawal by Subject|0|||
94711055|NCT01307267|324401279|FG022|Overall Study|Withdrawal by Subject|0|||
94268964|NCT03519867|322778582|FG009|Overall Study|Protocol Violation|0|||
94268965|NCT03519867|322778573|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
94268966|NCT03519867|322778574|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
94268967|NCT03519867|322778575|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
94268968|NCT03519867|322778576|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
94268969|NCT03519867|322778577|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
94268970|NCT03519867|322778578|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
94711056|NCT01307267|324401257|FG000|Overall Study|Other|0|||
94711057|NCT01307267|324401258|FG001|Overall Study|Other|0|||
94711058|NCT01307267|324401259|FG002|Overall Study|Other|0|||
94711059|NCT01307267|324401260|FG003|Overall Study|Other|0|||
94711060|NCT01307267|324401261|FG004|Overall Study|Other|0|||
94711061|NCT01307267|324401262|FG005|Overall Study|Other|7|||
94711062|NCT01307267|324401263|FG006|Overall Study|Other|0|||
94711063|NCT01307267|324401264|FG007|Overall Study|Other|1|||
94711064|NCT01307267|324401265|FG008|Overall Study|Other|3|||
94711065|NCT01307267|324401266|FG009|Overall Study|Other|0|||
94711066|NCT01307267|324401267|FG010|Overall Study|Other|1|||
94268971|NCT03519867|322778579|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
94268972|NCT03519867|322778580|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
94711067|NCT01307267|324401268|FG011|Overall Study|Other|1|||
94711068|NCT01307267|324401269|FG012|Overall Study|Other|1|||
94268973|NCT03519867|322778581|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
94268974|NCT03519867|322778582|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
94268975|NCT03519867|322778573|FG000|Overall Study|Admin. of other reversal agent|1|||
94268976|NCT03519867|322778574|FG001|Overall Study|Admin. of other reversal agent|1|||
94268977|NCT03519867|322778575|FG002|Overall Study|Admin. of other reversal agent|0|||
94268978|NCT03519867|322778576|FG003|Overall Study|Admin. of other reversal agent|0|||
94268979|NCT03519867|322778577|FG004|Overall Study|Admin. of other reversal agent|0|||
94268980|NCT03519867|322778578|FG005|Overall Study|Admin. of other reversal agent|1|||
94268981|NCT03519867|322778579|FG006|Overall Study|Admin. of other reversal agent|0|||
94268982|NCT03519867|322778580|FG007|Overall Study|Admin. of other reversal agent|0|||
94268983|NCT03519867|322778581|FG008|Overall Study|Admin. of other reversal agent|0|||
94268984|NCT03519867|322778582|FG009|Overall Study|Admin. of other reversal agent|0|||
94268985|NCT03519867|322778573|FG000|Overall Study|Reason not provided|1|||
94268986|NCT03519867|322778574|FG001|Overall Study|Reason not provided|1|||
94268987|NCT03519867|322778575|FG002|Overall Study|Reason not provided|1|||
94268988|NCT03519867|322778576|FG003|Overall Study|Reason not provided|1|||
94268989|NCT03519867|322778577|FG004|Overall Study|Reason not provided|0|||
94268990|NCT03519867|322778578|FG005|Overall Study|Reason not provided|1|||
94268991|NCT03519867|322778579|FG006|Overall Study|Reason not provided|0|||
94268992|NCT03519867|322778580|FG007|Overall Study|Reason not provided|1|||
94268993|NCT03519867|322778581|FG008|Overall Study|Reason not provided|1|||
94268994|NCT03519867|322778582|FG009|Overall Study|Reason not provided|0|||
94268995|NCT01721876|322778583|FG000|Overall Study|Not treated|1|||
94268996|NCT01721876|322778584|FG001|Overall Study|Not treated|4|||
94268997|NCT01721876|322778583|FG000|Overall Study|Disease progression / relapse|123|||
94268998|NCT01721876|322778584|FG001|Overall Study|Disease progression / relapse|156|||
94268999|NCT01721876|322778583|FG000|Overall Study|Death|6|||
94269000|NCT01721876|322778584|FG001|Overall Study|Death|13|||
94269001|NCT01721876|322778583|FG000|Overall Study|Adverse Event|41|||
94269002|NCT01721876|322778584|FG001|Overall Study|Adverse Event|165|||
94269003|NCT01721876|322778583|FG000|Overall Study|Protocol Violation|2|||
94269004|NCT01721876|322778584|FG001|Overall Study|Protocol Violation|1|||
94269005|NCT01721876|322778583|FG000|Overall Study|Withdrawal by Subject|15|||
94269006|NCT01721876|322778584|FG001|Overall Study|Withdrawal by Subject|38|||
94269007|NCT01721876|322778583|FG000|Overall Study|Reason not listed|34|||
94269008|NCT01721876|322778584|FG001|Overall Study|Reason not listed|63|||
94711069|NCT01307267|324401270|FG013|Overall Study|Other|0|||
94711070|NCT01307267|324401271|FG014|Overall Study|Other|2|||
94711071|NCT01307267|324401272|FG015|Overall Study|Other|1|||
94711072|NCT01307267|324401273|FG016|Overall Study|Other|0|||
94711073|NCT01307267|324401274|FG017|Overall Study|Other|0|||
94711074|NCT01307267|324401275|FG018|Overall Study|Other|0|||
94711075|NCT01307267|324401276|FG019|Overall Study|Other|19|||
94711076|NCT01307267|324401277|FG020|Overall Study|Other|2|||
94711077|NCT01307267|324401278|FG021|Overall Study|Other|3|||
94711078|NCT01307267|324401279|FG022|Overall Study|Other|2|||
94711079|NCT05174013|324401280|FG000|Overall Study|Lost to Follow-up|0|||
94711080|NCT05174013|324401281|FG001|Overall Study|Lost to Follow-up|0|||
94711081|NCT05174013|324401282|FG002|Overall Study|Lost to Follow-up|0|||
94711082|NCT05174013|324401283|FG003|Overall Study|Lost to Follow-up|1|||
94711083|NCT05174013|324401284|FG004|Overall Study|Lost to Follow-up|0|||
94711084|NCT05174013|324401285|FG005|Overall Study|Lost to Follow-up|0|||
94711085|NCT05174013|324401280|FG000|Overall Study|Withdrawal by Subject|0|||
94711086|NCT05174013|324401281|FG001|Overall Study|Withdrawal by Subject|0|||
94711087|NCT05174013|324401282|FG002|Overall Study|Withdrawal by Subject|1|||
94711088|NCT05174013|324401283|FG003|Overall Study|Withdrawal by Subject|0|||
94711089|NCT05174013|324401284|FG004|Overall Study|Withdrawal by Subject|0|||
94711090|NCT05174013|324401285|FG005|Overall Study|Withdrawal by Subject|0|||
94711091|NCT01087762|324401289|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
94711092|NCT01087762|324401290|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
94711093|NCT01087762|324401291|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
94711094|NCT01087762|324401292|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
94711095|NCT01087762|324401293|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
94711096|NCT01087762|324401289|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
94711097|NCT01087762|324401290|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
94711098|NCT01087762|324401291|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
94711099|NCT01087762|324401292|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
94711100|NCT01087762|324401293|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
94711101|NCT01087762|324401289|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
94711102|NCT01087762|324401290|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
94711103|NCT01087762|324401291|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
94711104|NCT01087762|324401292|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
94711105|NCT01087762|324401293|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
94711106|NCT01087762|324401289|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
94711107|NCT01087762|324401290|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
94711108|NCT01087762|324401291|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
94711109|NCT01087762|324401292|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
94711110|NCT01087762|324401293|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
94711111|NCT01087762|324401289|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
94711112|NCT01087762|324401290|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
94711113|NCT01087762|324401291|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
94711114|NCT01087762|324401292|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
94711115|NCT01087762|324401293|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
94711116|NCT01087762|324401289|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
94711117|NCT01087762|324401290|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
94711118|NCT01087762|324401291|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
94711119|NCT01087762|324401292|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
94711120|NCT01087762|324401293|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
94711121|NCT01087762|324401289|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
94711122|NCT01087762|324401290|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
94711123|NCT01087762|324401291|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
94711124|NCT01087762|324401292|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
94711125|NCT01087762|324401293|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
94711126|NCT01087762|324401289|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
94711127|NCT01087762|324401290|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
94711128|NCT01087762|324401291|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
94711129|NCT01087762|324401292|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
94711130|NCT01087762|324401293|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
94711131|NCT01087762|324401289|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
94711132|NCT01087762|324401290|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
94269009|NCT01721876|322778583|FG000|Overall Study|Sponsor terminated trial|0|||
94269010|NCT01721876|322778584|FG001|Overall Study|Sponsor terminated trial|4|||
94711133|NCT01087762|324401291|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
94711134|NCT01087762|324401292|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
94711135|NCT01087762|324401293|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
94711136|NCT01087762|324401289|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
94269011|NCT01984164|322778589|FG000|Overall Study|Withdrawal by Subject|4|||
94269012|NCT01984164|322778590|FG001|Overall Study|Withdrawal by Subject|3|||
94269013|NCT01984164|322778589|FG000|Overall Study|Adverse Event|5|||
94269014|NCT01984164|322778590|FG001|Overall Study|Adverse Event|19|||
94269015|NCT01984164|322778589|FG000|Overall Study|Lost to Follow-up|1|||
94269016|NCT01984164|322778590|FG001|Overall Study|Lost to Follow-up|3|||
94269017|NCT02281357|322778591|FG000|Overall Study|Adverse Event|2|||
94269018|NCT02281357|322778592|FG001|Overall Study|Adverse Event|1|||
94269019|NCT02281357|322778591|FG000|Overall Study|Lost to Follow-up|1|||
94269020|NCT02281357|322778592|FG001|Overall Study|Lost to Follow-up|0|||
94711137|NCT01087762|324401290|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
94711138|NCT01087762|324401291|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
94711139|NCT01087762|324401292|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
94711140|NCT01087762|324401293|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
94711141|NCT01087762|324401289|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
94711142|NCT01087762|324401290|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
94711143|NCT01087762|324401291|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
94269021|NCT02281357|322778591|FG000|Overall Study|Withdrawal by Subject|4|||
94269022|NCT02281357|322778592|FG001|Overall Study|Withdrawal by Subject|3|||
94269023|NCT03520959|322778593|FG000|Overall Study|Study terminated by Sponsor|0|||
94269024|NCT03520959|322778594|FG001|Overall Study|Study terminated by Sponsor|1|||
94269025|NCT00268437|322780215|FG000|Overall Study|Ineligible|1|||
94269026|NCT05162027|322780216|FG000|Overall Study|Adverse Event|1|||
94269027|NCT05162027|322780217|FG001|Overall Study|Adverse Event|0|||
94269028|NCT02982590|322780224|FG000|Overall Study|Lost to Follow-up|0|||
94269029|NCT02982590|322780225|FG001|Overall Study|Lost to Follow-up|1|||
94269030|NCT02982590|322780224|FG000|Overall Study|Death|4|||
94269031|NCT02982590|322780225|FG001|Overall Study|Death|0|||
94269032|NCT01628107|322780226|FG000|Overall Study|Withdrawal by Subject|17|||
94269033|NCT01628107|322780226|FG000|Overall Study|Lost to Follow-up|4|||
94269034|NCT01628107|322780226|FG000|Overall Study|Adverse Event|33|||
94269035|NCT01628107|322780226|FG000|Overall Study|Physician Decision|2|||
94269036|NCT01628107|322780226|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
94269037|NCT01628107|322780226|FG000|Overall Study|Non-compliant with Study Procedures|10|||
94269038|NCT01628107|322780226|FG000|Overall Study|Not Treated|8|||
94269039|NCT01628107|322780226|FG000|Overall Study|Sponsor Decision|11|||
94269040|NCT01628107|322780226|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
94269041|NCT01628107|322780226|FG000|Overall Study|Relocated|8|||
94269042|NCT01628107|322780226|FG000|Overall Study|Kidney Transplant|9|||
94269043|NCT01628107|322780226|FG000|Overall Study|Use of Standard of Care|9|||
94366791|NCT01039584|323128192|FG000|Overall Study|other|1|||
94366792|NCT01039584|323128193|FG001|Overall Study|other|3|||
94366793|NCT01039584|323128194|FG002|Overall Study|other|1|||
94366794|NCT01039584|323128192|FG000|Overall Study|Pap smear with significant pathology|10|||
94366795|NCT01039584|323128193|FG001|Overall Study|Pap smear with significant pathology|10|||
94366796|NCT01039584|323128194|FG002|Overall Study|Pap smear with significant pathology|3|||
94366797|NCT01039584|323128192|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
94366798|NCT01039584|323128193|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
94711144|NCT01087762|324401292|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
94711145|NCT01087762|324401293|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
94711146|NCT01087762|324401289|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
94269044|NCT01022996|322780227|FG000|Overall Study|Adverse Event|14|||
94269045|NCT01022996|322780227|FG000|Overall Study|Withdrawal by Subject|3|||
94269046|NCT01022996|322780227|FG000|Overall Study|Lost to Follow-up|1|||
94269047|NCT01022996|322780227|FG000|Overall Study|Administrative problems|6|||
94269048|NCT01022996|322780227|FG000|Overall Study|Disease Progression|32|||
94269049|NCT01022996|322780227|FG000|Overall Study|Protocol Violation|1|||
94269050|NCT01830855|322780228|FG000|Overall Study|Other|7|||
94269051|NCT01830855|322780229|FG001|Overall Study|Other|1|||
94269052|NCT01830855|322780230|FG002|Overall Study|Other|4|||
94269053|NCT01830855|322780231|FG003|Overall Study|Other|4|||
94269054|NCT01830855|322780228|FG000|Overall Study|Medication error without associated AE|1|||
94269055|NCT01830855|322780229|FG001|Overall Study|Medication error without associated AE|0|||
94366799|NCT01039584|323128194|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
94711147|NCT01087762|324401290|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
94711148|NCT01087762|324401291|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
94711149|NCT01087762|324401292|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
94269056|NCT01830855|322780230|FG002|Overall Study|Medication error without associated AE|0|||
94269057|NCT01830855|322780231|FG003|Overall Study|Medication error without associated AE|1|||
94269058|NCT01830855|322780228|FG000|Overall Study|Pregnancy|3|||
94269059|NCT01830855|322780229|FG001|Overall Study|Pregnancy|1|||
94269060|NCT01830855|322780230|FG002|Overall Study|Pregnancy|2|||
94269061|NCT01830855|322780231|FG003|Overall Study|Pregnancy|1|||
94269062|NCT01830855|322780228|FG000|Overall Study|No longer meets eligibility criteria|11|||
94269063|NCT01830855|322780229|FG001|Overall Study|No longer meets eligibility criteria|2|||
94269064|NCT01830855|322780230|FG002|Overall Study|No longer meets eligibility criteria|3|||
94269065|NCT01830855|322780231|FG003|Overall Study|No longer meets eligibility criteria|5|||
94269066|NCT01830855|322780228|FG000|Overall Study|Adverse Event|11|||
94711150|NCT01087762|324401293|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
94711151|NCT01087762|324401289|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
94711152|NCT01087762|324401290|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
94711153|NCT01087762|324401291|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
94711154|NCT01087762|324401292|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
94711155|NCT01087762|324401293|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
94711156|NCT02527148|324401301|FG000|Overall Study|Did not receive study intervention|1|||
94711157|NCT02527148|324401302|FG001|Overall Study|Did not receive study intervention|0|||
94711158|NCT01140048|324401303|FG000|Overall Study|Physician Decision|1|||
94711159|NCT01140048|324401303|FG000|Overall Study|Withdrawal by Subject|13|||
94711160|NCT01140048|324401303|FG000|Overall Study|Lost to Follow-up|31|||
94711161|NCT01190007|324401304|FG000|Overall Study|Withdrawal by Subject|4|||
94269067|NCT01830855|322780229|FG001|Overall Study|Adverse Event|5|||
94269068|NCT01830855|322780230|FG002|Overall Study|Adverse Event|6|||
94269069|NCT01830855|322780231|FG003|Overall Study|Adverse Event|3|||
94269070|NCT01830855|322780228|FG000|Overall Study|Protocol deviation|10|||
94269071|NCT01830855|322780229|FG001|Overall Study|Protocol deviation|5|||
94269072|NCT01830855|322780230|FG002|Overall Study|Protocol deviation|6|||
94269073|NCT01830855|322780231|FG003|Overall Study|Protocol deviation|6|||
94269074|NCT01830855|322780228|FG000|Overall Study|Withdrawal by Subject|33|||
94269075|NCT01830855|322780229|FG001|Overall Study|Withdrawal by Subject|14|||
94269076|NCT01830855|322780230|FG002|Overall Study|Withdrawal by Subject|10|||
94269077|NCT01830855|322780231|FG003|Overall Study|Withdrawal by Subject|12|||
94269078|NCT01830855|322780228|FG000|Overall Study|No longer willing to participate|32|||
94269079|NCT01830855|322780229|FG001|Overall Study|No longer willing to participate|13|||
94269080|NCT01830855|322780230|FG002|Overall Study|No longer willing to participate|12|||
94269081|NCT01830855|322780231|FG003|Overall Study|No longer willing to participate|17|||
94269082|NCT01830855|322780228|FG000|Overall Study|Lost to Follow-up|47|||
94269083|NCT01830855|322780229|FG001|Overall Study|Lost to Follow-up|20|||
94269084|NCT01830855|322780230|FG002|Overall Study|Lost to Follow-up|23|||
94269085|NCT01830855|322780231|FG003|Overall Study|Lost to Follow-up|33|||
94269086|NCT02767323|322780232|FG000|Overall Study|Withdrawal by Subject|17|||
94269087|NCT02767323|322780233|FG001|Overall Study|Withdrawal by Subject|5|||
94269088|NCT02767323|322780234|FG002|Overall Study|Withdrawal by Subject|13|||
94269089|NCT02767323|322780235|FG003|Overall Study|Withdrawal by Subject|0|||
94711162|NCT01190007|324401304|FG000|Overall Study|Adverse Event|8|||
94711163|NCT01190007|324401304|FG000|Overall Study|Difficulty of visit for complications|1|||
94711164|NCT01190007|324401304|FG000|Overall Study|Participant was arrested|1|||
94711165|NCT01254019|324401305|FG000|Overall Study|Adverse Event|0|||
94711166|NCT01254019|324401306|FG001|Overall Study|Adverse Event|2|||
94711167|NCT01254019|324401305|FG000|Overall Study|Protocol Violation|1|||
94269090|NCT02767323|322780232|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
94269091|NCT02767323|322780233|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
94711168|NCT01254019|324401306|FG001|Overall Study|Protocol Violation|0|||
94711169|NCT01254019|324401305|FG000|Overall Study|Withdrawal by Subject|0|||
94711170|NCT01254019|324401306|FG001|Overall Study|Withdrawal by Subject|2|||
94711171|NCT00845832|324401308|FG000|Treatment Period|Adverse Event|0|||
94711172|NCT00845832|324401309|FG001|Treatment Period|Adverse Event|2|||
94711173|NCT00845832|324401310|FG002|Treatment Period|Adverse Event|0|||
94269092|NCT02767323|322780234|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
94269093|NCT02767323|322780235|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
94269094|NCT02319668|322780241|FG000|Overall Study|Other (Not specified)|0|||
94269095|NCT02319668|322780242|FG001|Overall Study|Other (Not specified)|2|||
94269096|NCT01537198|322780246|FG000|Overall Study|RSV infection|2|||
94269097|NCT01537198|322780246|FG000|Overall Study|Adverse Event|4|||
94269098|NCT01537198|322780246|FG000|Overall Study|No Further Visits to the Clinic|37|||
94269099|NCT01537198|322780246|FG000|Overall Study|Other|111|||
94269100|NCT01231659|322780247|FG000|Overall Study|Adverse Event|9|||
94269101|NCT01231659|322780247|FG000|Overall Study|Disease Progression|48|||
94269102|NCT01231659|322780247|FG000|Overall Study|Death|2|||
94269103|NCT01231659|322780247|FG000|Overall Study|Patient refused to complete study visit|1|||
94269104|NCT01231659|322780247|FG000|Overall Study|Other protocol defined criteria|12|||
94269105|NCT00496730|322780254|FG000|Overall Study|Lost to Follow-up|4|||
94269106|NCT00496730|322780255|FG001|Overall Study|Lost to Follow-up|3|||
94269107|NCT00496730|322780254|FG000|Overall Study|Withdrawal by Subject|2|||
94269108|NCT00496730|322780255|FG001|Overall Study|Withdrawal by Subject|2|||
94269109|NCT00766090|322780259|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94269110|NCT00766090|322780260|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94269111|NCT00766090|322780261|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94269112|NCT00766090|322780262|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94269113|NCT00766090|322780263|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94269114|NCT00766090|322780264|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94269115|NCT00766090|322780265|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94269116|NCT00766090|322780266|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94269117|NCT00766090|322780267|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
94711174|NCT00845832|324401308|FG000|Treatment Period|Protocol Violation|1|||
94711175|NCT00845832|324401309|FG001|Treatment Period|Protocol Violation|1|||
94711176|NCT00845832|324401310|FG002|Treatment Period|Protocol Violation|0|||
94711177|NCT00845832|324401308|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
94711178|NCT00845832|324401309|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
94711179|NCT00845832|324401310|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
94711180|NCT00845832|324401308|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
94711181|NCT00845832|324401309|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
94711182|NCT00845832|324401310|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
94711183|NCT03615924|324401311|FG000|Overall Study|Withdrawal by Subject|2|||
94711184|NCT03615924|324401312|FG001|Overall Study|Withdrawal by Subject|5|||
94711185|NCT03615924|324401311|FG000|Overall Study|Death|3|||
94711186|NCT03615924|324401312|FG001|Overall Study|Death|1|||
94711187|NCT03615924|324401311|FG000|Overall Study|Lost to Follow-up|1|||
94269118|NCT00766090|322780268|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94269119|NCT00766090|322780269|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94269120|NCT00766090|322780270|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94711188|NCT03615924|324401312|FG001|Overall Study|Lost to Follow-up|0|||
94711189|NCT03615924|324401311|FG000|Overall Study|Randomized in error|1|||
94711190|NCT03615924|324401312|FG001|Overall Study|Randomized in error|0|||
94711191|NCT03615924|324401311|FG000|Overall Study|Study termination by Sponsor|94|||
94711192|NCT03615924|324401312|FG001|Overall Study|Study termination by Sponsor|86|||
94711193|NCT00980330|324401313|FG000|Overall Study|Adverse Event|0|||
94711194|NCT00980330|324401314|FG001|Overall Study|Adverse Event|0|||
94711195|NCT00980330|324401315|FG002|Overall Study|Adverse Event|0|||
94711196|NCT00980330|324401316|FG003|Overall Study|Adverse Event|1|||
94711197|NCT00980330|324401317|FG004|Overall Study|Adverse Event|0|||
94711198|NCT00980330|324401318|FG005|Overall Study|Adverse Event|0|||
94711199|NCT00980330|324401319|FG006|Overall Study|Adverse Event|0|||
94711200|NCT00980330|324401313|FG000|Overall Study|Lost to Follow-up|1|||
94711201|NCT00980330|324401314|FG001|Overall Study|Lost to Follow-up|1|||
94711202|NCT00980330|324401315|FG002|Overall Study|Lost to Follow-up|4|||
94711203|NCT00980330|324401316|FG003|Overall Study|Lost to Follow-up|2|||
94711204|NCT00980330|324401317|FG004|Overall Study|Lost to Follow-up|1|||
94711205|NCT00980330|324401318|FG005|Overall Study|Lost to Follow-up|1|||
94711206|NCT00980330|324401319|FG006|Overall Study|Lost to Follow-up|2|||
94711207|NCT00980330|324401313|FG000|Overall Study|Withdrawal by Subject|2|||
94711208|NCT00980330|324401314|FG001|Overall Study|Withdrawal by Subject|4|||
94711209|NCT00980330|324401315|FG002|Overall Study|Withdrawal by Subject|4|||
94711210|NCT00980330|324401316|FG003|Overall Study|Withdrawal by Subject|1|||
94711211|NCT00980330|324401317|FG004|Overall Study|Withdrawal by Subject|3|||
94711212|NCT00980330|324401318|FG005|Overall Study|Withdrawal by Subject|2|||
94711213|NCT00980330|324401319|FG006|Overall Study|Withdrawal by Subject|5|||
94711214|NCT00980330|324401313|FG000|Overall Study|(not specified)|2|||
94269121|NCT00766090|322780259|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
94269122|NCT00766090|322780260|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
94269123|NCT00766090|322780261|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
94269124|NCT00766090|322780262|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
94269125|NCT00766090|322780263|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
94269126|NCT00766090|322780264|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
94269127|NCT00766090|322780265|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
94269128|NCT00766090|322780266|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
94711215|NCT00980330|324401314|FG001|Overall Study|(not specified)|0|||
94711216|NCT00980330|324401315|FG002|Overall Study|(not specified)|0|||
94711217|NCT00980330|324401316|FG003|Overall Study|(not specified)|1|||
94711218|NCT00980330|324401317|FG004|Overall Study|(not specified)|1|||
94711219|NCT00980330|324401318|FG005|Overall Study|(not specified)|1|||
94711220|NCT00980330|324401319|FG006|Overall Study|(not specified)|0|||
94711221|NCT01039688|324401320|FG000|Overall Study|Adverse Event|38|||
94711222|NCT01039688|324401321|FG001|Overall Study|Adverse Event|39|||
94711223|NCT01039688|324401322|FG002|Overall Study|Adverse Event|24|||
94711224|NCT01039688|324401320|FG000|Overall Study|Lack of Efficacy|20|||
94711225|NCT01039688|324401321|FG001|Overall Study|Lack of Efficacy|11|||
94711226|NCT01039688|324401322|FG002|Overall Study|Lack of Efficacy|26|||
94711227|NCT01039688|324401320|FG000|Overall Study|Lost to Follow-up|11|||
94711228|NCT01039688|324401321|FG001|Overall Study|Lost to Follow-up|9|||
94711229|NCT01039688|324401322|FG002|Overall Study|Lost to Follow-up|5|||
94711230|NCT01039688|324401320|FG000|Overall Study|Other|13|||
94711231|NCT01039688|324401321|FG001|Overall Study|Other|25|||
94711232|NCT01039688|324401322|FG002|Overall Study|Other|12|||
94711233|NCT01039688|324401320|FG000|Overall Study|Withdrawal by Subject|23|||
94711234|NCT01039688|324401321|FG001|Overall Study|Withdrawal by Subject|27|||
94711235|NCT01039688|324401322|FG002|Overall Study|Withdrawal by Subject|13|||
94711236|NCT01039688|324401320|FG000|Overall Study|Death|2|||
94711237|NCT01039688|324401321|FG001|Overall Study|Death|0|||
94711238|NCT01039688|324401322|FG002|Overall Study|Death|0|||
94711239|NCT00668863|324401323|FG000|Overall Study|Objective Progression or Relapse|42|||
94711240|NCT00668863|324401323|FG000|Overall Study|Adverse Event|13|||
94711241|NCT00668863|324401323|FG000|Overall Study|Study Terminated by Sponsor|8|||
94711242|NCT00668863|324401323|FG000|Overall Study|Global Deterioration of Health Status|4|||
94711243|NCT00668863|324401323|FG000|Overall Study|Withdrawal by Subject|1|||
94711244|NCT00668863|324401323|FG000|Overall Study|Surgery|1|||
94711245|NCT00668863|324401323|FG000|Overall Study|Subject's work scheduling problem|1|||
94711246|NCT00668863|324401323|FG000|Overall Study|Physician Decision|1|||
94711247|NCT02529995|324401324|FG000|Part A|Ongoing Study at Data Cut-off|14|||
94711248|NCT02529995|324401325|FG001|Part A|Ongoing Study at Data Cut-off|16|||
94711249|NCT02529995|324401324|FG000|Part A|Discontinued Study|1|||
94711250|NCT02529995|324401325|FG001|Part A|Discontinued Study|0|||
94711251|NCT02529995|324401324|FG000|Part B|Ongoing Study at Data Cut-off|0|||
94711252|NCT02529995|324401325|FG001|Part B|Ongoing Study at Data Cut-off|7|||
94711253|NCT02529995|324401324|FG000|Part B|Discontinued Study|6|||
94466275|NCT01358578|323496956|FG005|Maintenance Period|Pregnancy|0|||
94466276|NCT01358578|323496951|FG000|Maintenance Period|Protocol deviation|7|||
94466277|NCT01358578|323496952|FG001|Maintenance Period|Protocol deviation|4|||
94466278|NCT01358578|323496953|FG002|Maintenance Period|Protocol deviation|0|||
94711254|NCT02529995|324401325|FG001|Part B|Discontinued Study|5|||
94711255|NCT03844269|324401331|FG000|Overall Study|Withdrawal pre-intervention|1|||
94711256|NCT03844269|324401331|FG000|Overall Study|Did not complete the intervention|2|||
94711257|NCT00638963|324401332|FG000|Overall Study|Withdrawal by Subject|1|||
94711258|NCT00638963|324401333|FG001|Overall Study|Withdrawal by Subject|0|||
94711259|NCT02512965|324401334|FG000|Overall Study|Withdrawal by Subject|0|||
94711260|NCT02512965|324401335|FG001|Overall Study|Withdrawal by Subject|4|||
94711261|NCT01595061|324401337|FG000|Overall Study|Never Treated|3|||
94711262|NCT01595061|324401337|FG000|Overall Study|Inadequate Pathology|1|||
94711263|NCT00630786|324401338|FG000|Overall Study|Physician Decision|0|||
94711264|NCT00630786|324401339|FG001|Overall Study|Physician Decision|0|||
94711265|NCT00630786|324401340|FG002|Overall Study|Physician Decision|1|||
94711266|NCT00630786|324401338|FG000|Overall Study|Withdrawal by Subject|0|||
94711267|NCT00630786|324401339|FG001|Overall Study|Withdrawal by Subject|1|||
94711268|NCT00630786|324401340|FG002|Overall Study|Withdrawal by Subject|1|||
94711269|NCT00630786|324401338|FG000|Overall Study|Lost to Follow-up|0|||
94711270|NCT00630786|324401339|FG001|Overall Study|Lost to Follow-up|1|||
94711271|NCT00630786|324401340|FG002|Overall Study|Lost to Follow-up|0|||
94711272|NCT00630786|324401338|FG000|Overall Study|Other|1|||
94711273|NCT00630786|324401339|FG001|Overall Study|Other|0|||
94711274|NCT00630786|324401340|FG002|Overall Study|Other|0|||
94711275|NCT00433199|324401341|FG000|Double-Blind Period|Adverse Event|0|||
94711276|NCT00433199|324401342|FG001|Double-Blind Period|Adverse Event|25|||
94269129|NCT00766090|322780267|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
94269130|NCT00766090|322780268|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
94269131|NCT00766090|322780269|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
94269132|NCT00766090|322780270|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
94269133|NCT00766090|322780259|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
94269134|NCT00766090|322780260|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94269135|NCT00766090|322780261|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94269136|NCT00766090|322780262|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
94269137|NCT00766090|322780263|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94269138|NCT00766090|322780264|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94269139|NCT00766090|322780265|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94269140|NCT00766090|322780266|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94269141|NCT00766090|322780267|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94269142|NCT00766090|322780268|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94269143|NCT00766090|322780269|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94269144|NCT00766090|322780270|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94269145|NCT00766090|322780259|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
94466279|NCT01358578|323496954|FG003|Maintenance Period|Protocol deviation|2|||
94711277|NCT00433199|324401341|FG000|Double-Blind Period|Lack of Efficacy|0|||
94711278|NCT00433199|324401342|FG001|Double-Blind Period|Lack of Efficacy|2|||
94711279|NCT00433199|324401341|FG000|Double-Blind Period|Lost to Follow-up|2|||
94711280|NCT00433199|324401342|FG001|Double-Blind Period|Lost to Follow-up|5|||
94711281|NCT00433199|324401341|FG000|Double-Blind Period|Withdrawal by Subject|8|||
94711282|NCT00433199|324401342|FG001|Double-Blind Period|Withdrawal by Subject|19|||
94711283|NCT00433199|324401341|FG000|Double-Blind Period|Protocol Violation|1|||
94711284|NCT00433199|324401342|FG001|Double-Blind Period|Protocol Violation|10|||
94711285|NCT00433199|324401341|FG000|Double-Blind Period|Administrative|1|||
94711286|NCT00433199|324401342|FG001|Double-Blind Period|Administrative|5|||
94711287|NCT00433199|324401341|FG000|Open-Label Period|Adverse Event|0|||
94711288|NCT00433199|324401342|FG001|Open-Label Period|Adverse Event|19|||
94711289|NCT00433199|324401341|FG000|Open-Label Period|Lack of Efficacy|0|||
94711290|NCT00433199|324401342|FG001|Open-Label Period|Lack of Efficacy|2|||
94711291|NCT00433199|324401341|FG000|Open-Label Period|Lost to Follow-up|0|||
94711292|NCT00433199|324401342|FG001|Open-Label Period|Lost to Follow-up|3|||
94711293|NCT00433199|324401341|FG000|Open-Label Period|Withdrawal by Subject|0|||
94711294|NCT00433199|324401342|FG001|Open-Label Period|Withdrawal by Subject|7|||
94711295|NCT00433199|324401341|FG000|Open-Label Period|Protocol Violation|0|||
94711296|NCT00433199|324401342|FG001|Open-Label Period|Protocol Violation|2|||
94711297|NCT00433199|324401341|FG000|Open-Label Period|Administrative|0|||
94711298|NCT00433199|324401342|FG001|Open-Label Period|Administrative|1|||
94711299|NCT02674750|324401343|FG000|Overall Study|Death|4|||
94711300|NCT02674750|324401344|FG001|Overall Study|Death|5|||
94711301|NCT02674750|324401345|FG002|Overall Study|Death|8|||
94711302|NCT02674750|324401343|FG000|Overall Study|Lost to Follow-up|0|||
94711303|NCT02674750|324401344|FG001|Overall Study|Lost to Follow-up|8|||
94711304|NCT02674750|324401345|FG002|Overall Study|Lost to Follow-up|0|||
94711305|NCT02674750|324401343|FG000|Overall Study|Lack of Efficacy|1|||
94711306|NCT02674750|324401344|FG001|Overall Study|Lack of Efficacy|17|||
94711307|NCT02674750|324401345|FG002|Overall Study|Lack of Efficacy|3|||
94711308|NCT02674750|324401343|FG000|Overall Study|Withdrawal by Subject|0|||
94711309|NCT02674750|324401344|FG001|Overall Study|Withdrawal by Subject|7|||
94711310|NCT02674750|324401345|FG002|Overall Study|Withdrawal by Subject|1|||
94711311|NCT02674750|324401343|FG000|Overall Study|Other|0|||
94711312|NCT02674750|324401344|FG001|Overall Study|Other|8|||
94711313|NCT02674750|324401345|FG002|Overall Study|Other|0|||
94711314|NCT01685606|324401346|FG000|Overall Study|Withdrawal by Subject|1|||
94711315|NCT01787760|324401347|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
94711316|NCT01787760|324401348|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
94711317|NCT01787760|324401349|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
94711318|NCT01787760|324401347|FG000|Overall Study|Decompensated on left exotropia|0|||
94711319|NCT01787760|324401348|FG001|Overall Study|Decompensated on left exotropia|0|||
94711320|NCT01787760|324401349|FG002|Overall Study|Decompensated on left exotropia|1|||
94711321|NCT01787760|324401347|FG000|Overall Study|Dryness|0|||
94711322|NCT01787760|324401348|FG001|Overall Study|Dryness|1|||
94711323|NCT01787760|324401349|FG002|Overall Study|Dryness|0|||
94711324|NCT01787760|324401347|FG000|Overall Study|Relocation|1|||
94711325|NCT01787760|324401348|FG001|Overall Study|Relocation|1|||
94711326|NCT01787760|324401349|FG002|Overall Study|Relocation|0|||
94711327|NCT01787760|324401347|FG000|Overall Study|Lens discomfort|3|||
94366800|NCT00929864|323128197|FG000|Overall Study|Death|1|||
94366801|NCT00929864|323128198|FG001|Overall Study|Death|1|||
94269146|NCT00766090|322780260|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
94269147|NCT00766090|322780261|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
94269148|NCT00766090|322780262|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
94269149|NCT00766090|322780263|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
94269150|NCT00766090|322780264|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
94269151|NCT00766090|322780265|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
94269152|NCT00766090|322780266|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
94269153|NCT00766090|322780267|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
94269154|NCT00766090|322780268|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
94269155|NCT00766090|322780269|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
94269156|NCT00766090|322780270|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
94269157|NCT00766090|322780259|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94269158|NCT00766090|322780260|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94269159|NCT00766090|322780261|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94269160|NCT00766090|322780262|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94269161|NCT00766090|322780263|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
94269162|NCT00766090|322780264|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94269163|NCT00766090|322780265|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94269164|NCT00766090|322780266|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94269165|NCT00766090|322780267|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94269166|NCT00766090|322780268|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94269167|NCT00766090|322780269|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94269168|NCT00766090|322780270|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94269169|NCT00766090|322780259|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
94269170|NCT00766090|322780260|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
94269171|NCT00766090|322780261|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
94269172|NCT00766090|322780262|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
94269173|NCT00766090|322780263|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
94269174|NCT00766090|322780264|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
94269175|NCT00766090|322780265|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
94269176|NCT00766090|322780266|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
94466280|NCT01358578|323496955|FG004|Maintenance Period|Protocol deviation|2|||
94466281|NCT01358578|323496956|FG005|Maintenance Period|Protocol deviation|2|||
94711328|NCT01787760|324401348|FG001|Overall Study|Lens discomfort|0|||
94711329|NCT01787760|324401349|FG002|Overall Study|Lens discomfort|0|||
94711330|NCT01787760|324401347|FG000|Overall Study|Lens handling difficulty|1|||
94711331|NCT01787760|324401348|FG001|Overall Study|Lens handling difficulty|2|||
94711332|NCT01787760|324401349|FG002|Overall Study|Lens handling difficulty|0|||
94711333|NCT01787760|324401347|FG000|Overall Study|Protocol Violation|6|||
94711334|NCT01787760|324401348|FG001|Overall Study|Protocol Violation|0|||
94711335|NCT01787760|324401349|FG002|Overall Study|Protocol Violation|1|||
94711336|NCT01787760|324401347|FG000|Overall Study|Withdrawal by Subject|5|||
94711337|NCT01787760|324401348|FG001|Overall Study|Withdrawal by Subject|1|||
94711338|NCT01787760|324401349|FG002|Overall Study|Withdrawal by Subject|2|||
94711339|NCT01787760|324401347|FG000|Overall Study|Lost to Follow-up|1|||
94711340|NCT01787760|324401348|FG001|Overall Study|Lost to Follow-up|0|||
94711341|NCT01787760|324401349|FG002|Overall Study|Lost to Follow-up|1|||
94711342|NCT01787760|324401347|FG000|Overall Study|Stroke|1|||
94711343|NCT01787760|324401348|FG001|Overall Study|Stroke|0|||
94711344|NCT01787760|324401349|FG002|Overall Study|Stroke|0|||
94711345|NCT01787760|324401347|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
94711346|NCT01787760|324401348|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
94711347|NCT01787760|324401349|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
94711348|NCT01787760|324401347|FG000|Overall Study|Unsatisfactory physiological response|2|||
94711349|NCT01787760|324401348|FG001|Overall Study|Unsatisfactory physiological response|4|||
94711350|NCT01787760|324401349|FG002|Overall Study|Unsatisfactory physiological response|0|||
94711351|NCT01787760|324401347|FG000|Overall Study|Unsatisfactory visual response|1|||
94711352|NCT01787760|324401348|FG001|Overall Study|Unsatisfactory visual response|1|||
94711353|NCT01787760|324401349|FG002|Overall Study|Unsatisfactory visual response|0|||
94711354|NCT01787760|324401347|FG000|Overall Study|Near vision blur|1|||
94711355|NCT01787760|324401348|FG001|Overall Study|Near vision blur|0|||
94711356|NCT01787760|324401349|FG002|Overall Study|Near vision blur|0|||
94711357|NCT00736853|324401350|FG000|Open-Label Period|Physician Decision|2|||
94711358|NCT00736853|324401351|FG001|Open-Label Period|Physician Decision|0|||
94269177|NCT00766090|322780267|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
94466282|NCT01358578|323496951|FG000|Maintenance Period|Withdrawal by Subject|12|||
94466283|NCT01358578|323496952|FG001|Maintenance Period|Withdrawal by Subject|7|||
94466284|NCT01358578|323496953|FG002|Maintenance Period|Withdrawal by Subject|2|||
94711359|NCT00736853|324401352|FG002|Open-Label Period|Physician Decision|0|||
94711360|NCT00736853|324401350|FG000|Open-Label Period|Adverse Event|31|||
94711361|NCT00736853|324401351|FG001|Open-Label Period|Adverse Event|0|||
94711362|NCT00736853|324401352|FG002|Open-Label Period|Adverse Event|0|||
94711363|NCT00736853|324401350|FG000|Open-Label Period|Withdrawal by Subject|16|||
94269178|NCT00766090|322780268|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
94269179|NCT00766090|322780269|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
94269180|NCT00766090|322780270|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
94269181|NCT00766090|322780259|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
94269182|NCT00766090|322780260|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
94269183|NCT00766090|322780261|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
94269184|NCT00766090|322780262|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
94269185|NCT00766090|322780263|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
94269186|NCT00766090|322780264|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
94269187|NCT00766090|322780265|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
94711364|NCT00736853|324401351|FG001|Open-Label Period|Withdrawal by Subject|0|||
94711365|NCT00736853|324401352|FG002|Open-Label Period|Withdrawal by Subject|0|||
94711366|NCT00736853|324401350|FG000|Open-Label Period|Started but not treated|42|||
94711367|NCT00736853|324401351|FG001|Open-Label Period|Started but not treated|0|||
94711368|NCT00736853|324401352|FG002|Open-Label Period|Started but not treated|0|||
94711369|NCT00736853|324401350|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
94711370|NCT00736853|324401351|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
94711371|NCT00736853|324401352|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
94711372|NCT00736853|324401350|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
94711373|NCT00736853|324401351|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
94711374|NCT00736853|324401352|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
94711375|NCT00736853|324401350|FG000|Double-Blind Period|Lack of Efficacy|0|||
94711376|NCT00736853|324401351|FG001|Double-Blind Period|Lack of Efficacy|19|||
94711377|NCT00736853|324401352|FG002|Double-Blind Period|Lack of Efficacy|42|||
94711378|NCT00736853|324401350|FG000|Double-Blind Period|Adverse Event|0|||
94711379|NCT00736853|324401351|FG001|Double-Blind Period|Adverse Event|3|||
94711380|NCT00736853|324401352|FG002|Double-Blind Period|Adverse Event|2|||
94711381|NCT00736853|324401350|FG000|Double-Blind Period|Withdrawal by Subject|0|||
94711382|NCT00736853|324401351|FG001|Double-Blind Period|Withdrawal by Subject|1|||
94711383|NCT00736853|324401352|FG002|Double-Blind Period|Withdrawal by Subject|4|||
94711384|NCT00736853|324401350|FG000|Double-Blind Period|Ineligible to participate the study|0|||
94711385|NCT00736853|324401351|FG001|Double-Blind Period|Ineligible to participate the study|1|||
94711386|NCT00736853|324401352|FG002|Double-Blind Period|Ineligible to participate the study|0|||
94711387|NCT03473340|324401353|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
94711388|NCT03473340|324401354|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
94711389|NCT03473340|324401353|FG000|Overall Study|Withdrawal by Subject|1|||
94711390|NCT03473340|324401354|FG001|Overall Study|Withdrawal by Subject|0|||
94711391|NCT03473340|324401353|FG000|Overall Study|Lost to Follow-up|1|||
94711392|NCT03473340|324401354|FG001|Overall Study|Lost to Follow-up|2|||
94711393|NCT00801983|324401356|FG000|Period 1|Lost to Follow-up|2|||
94711394|NCT00801983|324401357|FG001|Period 1|Lost to Follow-up|0|||
94711395|NCT00801983|324401356|FG000|Period 1|Withdrawal by Subject|2|||
94711396|NCT00801983|324401357|FG001|Period 1|Withdrawal by Subject|8|||
94711397|NCT00801983|324401356|FG000|Period 2|Withdrawal by Subject|2|||
94711398|NCT00801983|324401357|FG001|Period 2|Withdrawal by Subject|1|||
94711399|NCT00774852|324401358|FG000|Overall Study|Adverse Event|9|||
94711400|NCT00774852|324401359|FG001|Overall Study|Adverse Event|6|||
94711401|NCT00774852|324401358|FG000|Overall Study|Death|2|||
94711402|NCT00774852|324401359|FG001|Overall Study|Death|1|||
94711403|NCT00774852|324401358|FG000|Overall Study|Lack of Efficacy|3|||
94711404|NCT00774852|324401359|FG001|Overall Study|Lack of Efficacy|7|||
94711405|NCT00774852|324401358|FG000|Overall Study|Lost to Follow-up|9|||
94711406|NCT00774852|324401359|FG001|Overall Study|Lost to Follow-up|5|||
94269188|NCT00766090|322780266|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
94269189|NCT00766090|322780267|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
94466285|NCT01358578|323496954|FG003|Maintenance Period|Withdrawal by Subject|15|||
94466286|NCT01358578|323496955|FG004|Maintenance Period|Withdrawal by Subject|6|||
94466287|NCT01358578|323496956|FG005|Maintenance Period|Withdrawal by Subject|3|||
94466288|NCT01358578|323496951|FG000|Follow-up Period|Adverse Event|1|||
94466289|NCT01358578|323496952|FG001|Follow-up Period|Adverse Event|1|||
94466290|NCT01358578|323496953|FG002|Follow-up Period|Adverse Event|0|||
94711407|NCT00774852|324401358|FG000|Overall Study|Physician Decision|2|||
94711408|NCT00774852|324401359|FG001|Overall Study|Physician Decision|6|||
94711409|NCT00774852|324401358|FG000|Overall Study|Pregnancy|1|||
94711410|NCT00774852|324401359|FG001|Overall Study|Pregnancy|2|||
94711411|NCT00774852|324401358|FG000|Overall Study|Withdrawal by Subject|2|||
94711412|NCT00774852|324401359|FG001|Overall Study|Withdrawal by Subject|2|||
94711413|NCT00774852|324401358|FG000|Overall Study|Non-responder|15|||
94711414|NCT00774852|324401359|FG001|Overall Study|Non-responder|11|||
94711415|NCT00774852|324401358|FG000|Overall Study|Subject non-compliance|0|||
94711416|NCT00774852|324401359|FG001|Overall Study|Subject non-compliance|1|||
94466291|NCT01358578|323496954|FG003|Follow-up Period|Adverse Event|0|||
94711417|NCT00774852|324401358|FG000|Overall Study|Protocol Violation|1|||
94711418|NCT00774852|324401359|FG001|Overall Study|Protocol Violation|0|||
94711419|NCT00774852|324401358|FG000|Overall Study|Subject received prohibited medication|1|||
94711420|NCT00774852|324401359|FG001|Overall Study|Subject received prohibited medication|0|||
94711421|NCT03997916|324401363|FG000|Overall Study|Protocol Violation|35|||
94711422|NCT00414544|324402894|FG000|Overall Study|Lost to Follow-up|14|||
94711423|NCT01424397|324402896|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
94711424|NCT01424397|324402897|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
94711425|NCT01424397|324402898|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
94711426|NCT01424397|324402899|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
94711427|NCT01424397|324402900|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
94711428|NCT01424397|324402901|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
94711429|NCT01424397|324402902|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
94711430|NCT01424397|324402903|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
94711431|NCT01424397|324402904|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
94711432|NCT01424397|324402905|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
94711433|NCT01424397|324402906|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
94711434|NCT01424397|324402907|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
94711435|NCT03593213|324402909|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
94711436|NCT03593213|324402910|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
94711437|NCT03593213|324402911|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
94711438|NCT03593213|324402912|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
94711439|NCT03593213|324402909|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
94711440|NCT03593213|324402910|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
94711441|NCT03593213|324402911|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
94711442|NCT03593213|324402912|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
94711443|NCT03593213|324402909|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
94711444|NCT03593213|324402910|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
94711445|NCT03593213|324402911|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
94711446|NCT03593213|324402912|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
94711447|NCT03593213|324402909|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
94711448|NCT03593213|324402910|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
94711449|NCT03593213|324402911|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
94711450|NCT03593213|324402912|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
94711451|NCT03593213|324402909|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
94711452|NCT03593213|324402910|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
94711453|NCT03593213|324402911|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
94711454|NCT03593213|324402912|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
94711455|NCT03593213|324402909|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
94711456|NCT03593213|324402910|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
94711457|NCT03593213|324402911|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
94711458|NCT03593213|324402912|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
94711459|NCT03593213|324402909|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
94711460|NCT03593213|324402910|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
94711461|NCT03593213|324402911|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
94711462|NCT03593213|324402912|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
94711463|NCT03593213|324402909|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
94711464|NCT03593213|324402910|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
94711465|NCT03593213|324402911|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
94711466|NCT03593213|324402912|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
94711467|NCT03593213|324402909|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
94711468|NCT03593213|324402910|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
94711469|NCT03593213|324402911|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
94711470|NCT03593213|324402912|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
94711471|NCT03593213|324402909|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
94711472|NCT03593213|324402910|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
94711473|NCT03593213|324402911|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
94711474|NCT03593213|324402912|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
94711475|NCT03593213|324402909|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
94711476|NCT03593213|324402910|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
94711477|NCT03593213|324402911|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
94711478|NCT03593213|324402912|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
94711479|NCT03593213|324402909|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
94711480|NCT03593213|324402910|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
94711481|NCT03593213|324402911|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
94711482|NCT03593213|324402912|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
94711483|NCT03593213|324402909|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
94269190|NCT00766090|322780268|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
94269191|NCT00766090|322780269|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
94269192|NCT00766090|322780270|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
94269193|NCT00766090|322780259|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
94269194|NCT00766090|322780260|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
94269195|NCT00766090|322780261|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
94269196|NCT00766090|322780262|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
94269197|NCT00766090|322780263|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
94269198|NCT00766090|322780264|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
94269199|NCT00766090|322780265|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
94269200|NCT00766090|322780266|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
94269201|NCT00766090|322780267|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
94269202|NCT00766090|322780268|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
94269203|NCT00766090|322780269|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
94269204|NCT00766090|322780270|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
94269205|NCT00766090|322780259|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
94269206|NCT00766090|322780260|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
94269207|NCT00766090|322780261|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
94269208|NCT00766090|322780262|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
94269209|NCT00766090|322780263|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
94269210|NCT00766090|322780264|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
94269211|NCT00766090|322780265|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
94269212|NCT00766090|322780266|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
94269213|NCT00766090|322780267|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
94269214|NCT00766090|322780268|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
94269215|NCT00766090|322780269|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
94269216|NCT00766090|322780270|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
94269217|NCT00766090|322780259|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
94269218|NCT00766090|322780260|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
94269219|NCT00766090|322780261|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
94269220|NCT00766090|322780262|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
94269221|NCT00766090|322780263|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
94269222|NCT00766090|322780264|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
94269223|NCT00766090|322780265|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
94269224|NCT00766090|322780266|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
94269225|NCT00766090|322780267|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
94269226|NCT00766090|322780268|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
94269227|NCT00766090|322780269|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
94269228|NCT00766090|322780270|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
94269229|NCT02375724|322780273|FG000|Overall Study|Lack of Efficacy|1|||
94269230|NCT02375724|322780274|FG001|Overall Study|Lack of Efficacy|1|||
94269231|NCT02375724|322780273|FG000|Overall Study|Withdrawal by Subject|1|||
94269232|NCT02375724|322780274|FG001|Overall Study|Withdrawal by Subject|1|||
94269233|NCT02375724|322780273|FG000|Overall Study|Lost to Follow-up|1|||
94269234|NCT02375724|322780274|FG001|Overall Study|Lost to Follow-up|0|||
94269235|NCT02375724|322780273|FG000|Overall Study|Protocol Violation|1|||
94269236|NCT02375724|322780274|FG001|Overall Study|Protocol Violation|0|||
94269237|NCT02375724|322780273|FG000|Overall Study|Adverse Event|2|||
94269238|NCT02375724|322780274|FG001|Overall Study|Adverse Event|4|||
94269239|NCT02114268|322780277|FG000|Overall Study|Lost to Follow-up|4|||
94269240|NCT02114268|322780278|FG001|Overall Study|Lost to Follow-up|1|||
94269241|NCT02114268|322780279|FG002|Overall Study|Lost to Follow-up|1|||
94269242|NCT02114268|322780280|FG003|Overall Study|Lost to Follow-up|0|||
94269243|NCT02114268|322780281|FG004|Overall Study|Lost to Follow-up|0|||
94269244|NCT02114268|322780282|FG005|Overall Study|Lost to Follow-up|2|||
94269245|NCT02114268|322780277|FG000|Overall Study|Withdrawal by Subject|1|||
94269246|NCT02114268|322780278|FG001|Overall Study|Withdrawal by Subject|0|||
94269247|NCT02114268|322780279|FG002|Overall Study|Withdrawal by Subject|0|||
94269248|NCT02114268|322780280|FG003|Overall Study|Withdrawal by Subject|0|||
94269249|NCT02114268|322780281|FG004|Overall Study|Withdrawal by Subject|0|||
94269250|NCT02114268|322780282|FG005|Overall Study|Withdrawal by Subject|1|||
94269251|NCT02114268|322780277|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
94269252|NCT02114268|322780278|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
94269253|NCT02114268|322780279|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
94269254|NCT02114268|322780280|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
94269255|NCT02114268|322780281|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
94269256|NCT02114268|322780282|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
94269257|NCT02285777|322780283|FG000|Overall Study|Withdrawal by Subject|1|||
94269258|NCT02285777|322780284|FG001|Overall Study|Withdrawal by Subject|1|||
94269259|NCT02285777|322780283|FG000|Overall Study|Lost to Follow-up|4|||
94269260|NCT02285777|322780284|FG001|Overall Study|Lost to Follow-up|2|||
94269261|NCT00574288|322780285|FG000|Overall Study|Adverse Event|2|||
94269262|NCT00574288|322780286|FG001|Overall Study|Adverse Event|0|||
94269263|NCT00574288|322780287|FG002|Overall Study|Adverse Event|0|||
94269264|NCT00574288|322780288|FG003|Overall Study|Adverse Event|0|||
94269265|NCT00574288|322780289|FG004|Overall Study|Adverse Event|1|||
94269266|NCT00574288|322780290|FG005|Overall Study|Adverse Event|0|||
94269267|NCT00574288|322780291|FG006|Overall Study|Adverse Event|0|||
94269268|NCT00574288|322780285|FG000|Overall Study|Death|0|||
94269269|NCT00574288|322780286|FG001|Overall Study|Death|0|||
94269270|NCT00574288|322780287|FG002|Overall Study|Death|0|||
94269271|NCT00574288|322780288|FG003|Overall Study|Death|0|||
94269272|NCT00574288|322780289|FG004|Overall Study|Death|0|||
94269273|NCT00574288|322780290|FG005|Overall Study|Death|25|||
94711484|NCT03593213|324402910|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
94711485|NCT03593213|324402911|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
94711486|NCT03593213|324402912|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
94711487|NCT03593213|324402909|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
94269274|NCT00574288|322780291|FG006|Overall Study|Death|21|||
94269275|NCT00574288|322780285|FG000|Overall Study|Lost to Follow-up|0|||
94269276|NCT00574288|322780286|FG001|Overall Study|Lost to Follow-up|0|||
94269277|NCT00574288|322780287|FG002|Overall Study|Lost to Follow-up|0|||
94269278|NCT00574288|322780288|FG003|Overall Study|Lost to Follow-up|0|||
94269279|NCT00574288|322780289|FG004|Overall Study|Lost to Follow-up|0|||
94269280|NCT00574288|322780290|FG005|Overall Study|Lost to Follow-up|1|||
94269281|NCT00574288|322780291|FG006|Overall Study|Lost to Follow-up|2|||
94269282|NCT00574288|322780285|FG000|Overall Study|Study Terminated By Sponsor|0|||
94269283|NCT00574288|322780286|FG001|Overall Study|Study Terminated By Sponsor|0|||
94269284|NCT00574288|322780287|FG002|Overall Study|Study Terminated By Sponsor|0|||
94269285|NCT00574288|322780288|FG003|Overall Study|Study Terminated By Sponsor|0|||
94269286|NCT00574288|322780289|FG004|Overall Study|Study Terminated By Sponsor|0|||
94269287|NCT00574288|322780290|FG005|Overall Study|Study Terminated By Sponsor|0|||
94269288|NCT00574288|322780291|FG006|Overall Study|Study Terminated By Sponsor|5|||
94269289|NCT00574288|322780285|FG000|Overall Study|Progressive Disease|17|||
94269290|NCT00574288|322780286|FG001|Overall Study|Progressive Disease|2|||
94269291|NCT00574288|322780287|FG002|Overall Study|Progressive Disease|3|||
94269292|NCT00574288|322780288|FG003|Overall Study|Progressive Disease|2|||
94269293|NCT00574288|322780289|FG004|Overall Study|Progressive Disease|1|||
94269294|NCT00574288|322780290|FG005|Overall Study|Progressive Disease|0|||
94711488|NCT03593213|324402910|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
94711489|NCT03593213|324402911|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
94711490|NCT03593213|324402912|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
94711491|NCT03593213|324402909|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
94711492|NCT03593213|324402910|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
94711493|NCT03593213|324402911|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
94711494|NCT03593213|324402912|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
94711495|NCT03593213|324402909|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
94711496|NCT03593213|324402910|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
94711497|NCT03593213|324402911|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
94711498|NCT03593213|324402912|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
94711499|NCT03593213|324402909|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
94711500|NCT03593213|324402910|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
94711501|NCT03593213|324402911|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
94711502|NCT03593213|324402912|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
94711503|NCT03593213|324402909|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
94269295|NCT00574288|322780291|FG006|Overall Study|Progressive Disease|0|||
94269296|NCT00574288|322780285|FG000|Overall Study|Other|1|||
94269297|NCT00574288|322780286|FG001|Overall Study|Other|1|||
94269298|NCT00574288|322780287|FG002|Overall Study|Other|0|||
94269299|NCT00574288|322780288|FG003|Overall Study|Other|0|||
94269300|NCT00574288|322780289|FG004|Overall Study|Other|0|||
94269301|NCT00574288|322780290|FG005|Overall Study|Other|0|||
94466292|NCT01358578|323496955|FG004|Follow-up Period|Adverse Event|0|||
94466293|NCT01358578|323496956|FG005|Follow-up Period|Adverse Event|0|||
94466294|NCT01358578|323496951|FG000|Follow-up Period|Lack of Efficacy|3|||
94269302|NCT00574288|322780291|FG006|Overall Study|Other|0|||
94269303|NCT02871778|322780292|FG000|Part A: Treatment Period 1|Adverse Event|1|||
94269304|NCT02871778|322780293|FG001|Part A: Treatment Period 1|Adverse Event|1|||
94269305|NCT02871778|322780294|FG002|Part A: Treatment Period 1|Adverse Event|1|||
94269306|NCT02871778|322780295|FG003|Part A: Treatment Period 1|Adverse Event|0|||
94269307|NCT02871778|322780296|FG004|Part A: Treatment Period 1|Adverse Event|0|||
94269308|NCT02871778|322780297|FG005|Part A: Treatment Period 1|Adverse Event|0|||
94269309|NCT02871778|322780298|FG006|Part A: Treatment Period 1|Adverse Event|0|||
94269310|NCT02871778|322780299|FG007|Part A: Treatment Period 1|Adverse Event|0|||
94269311|NCT02871778|322780292|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
94269312|NCT02871778|322780293|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
94269313|NCT02871778|322780294|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
94269314|NCT02871778|322780295|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
94652980|NCT02391948|324188006|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
94269315|NCT02871778|322780296|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
94269316|NCT02871778|322780297|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
94269317|NCT02871778|322780298|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
94269318|NCT02871778|322780299|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
94269319|NCT02871778|322780292|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
94269320|NCT02871778|322780293|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
94269321|NCT02871778|322780294|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
94269322|NCT02871778|322780295|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
94269323|NCT02871778|322780296|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
94269324|NCT02871778|322780297|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
94269325|NCT02871778|322780298|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
94269326|NCT02871778|322780299|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
94366802|NCT00929864|323128197|FG000|Overall Study|Adverse Event|11|||
94366803|NCT00929864|323128198|FG001|Overall Study|Adverse Event|30|||
94366804|NCT00929864|323128197|FG000|Overall Study|Lack of Efficacy|19|||
94366805|NCT00929864|323128198|FG001|Overall Study|Lack of Efficacy|16|||
94366806|NCT00929864|323128197|FG000|Overall Study|Lost to Follow-up|7|||
94366807|NCT00929864|323128198|FG001|Overall Study|Lost to Follow-up|12|||
94366808|NCT00929864|323128197|FG000|Overall Study|Withdrawal by Subject|20|||
94366809|NCT00929864|323128198|FG001|Overall Study|Withdrawal by Subject|9|||
94366810|NCT00929864|323128197|FG000|Overall Study|No longer met criteria|2|||
94366811|NCT00929864|323128198|FG001|Overall Study|No longer met criteria|1|||
94366812|NCT00929864|323128197|FG000|Overall Study|Poor or non-compliance|3|||
94366813|NCT00929864|323128198|FG001|Overall Study|Poor or non-compliance|3|||
94366814|NCT00929864|323128197|FG000|Overall Study|Pregnancy|0|||
94366815|NCT00929864|323128198|FG001|Overall Study|Pregnancy|3|||
94366816|NCT00929864|323128197|FG000|Overall Study|Administrative reason by Sponsor|1|||
94366817|NCT00929864|323128198|FG001|Overall Study|Administrative reason by Sponsor|1|||
94366818|NCT00929864|323128197|FG000|Overall Study|Non-specified|2|||
94366819|NCT00929864|323128198|FG001|Overall Study|Non-specified|7|||
94366820|NCT01494649|323128199|FG000|Overall Study|Lost to Follow-up|0|||
94366821|NCT01494649|323128200|FG001|Overall Study|Lost to Follow-up|1|||
94366822|NCT03454672|323128201|FG000|Overall Study|Adverse Event|1|||
94366823|NCT03454672|323128202|FG001|Overall Study|Adverse Event|1|||
94366824|NCT03454672|323128201|FG000|Overall Study|Lost to Follow-up|1|||
94366825|NCT03454672|323128202|FG001|Overall Study|Lost to Follow-up|3|||
94366826|NCT03454672|323128201|FG000|Overall Study|painful|1|||
94366827|NCT03454672|323128202|FG001|Overall Study|painful|2|||
94366828|NCT03454672|323128201|FG000|Overall Study|Non-compliance|2|||
94366829|NCT03454672|323128202|FG001|Overall Study|Non-compliance|4|||
94366830|NCT03454672|323128201|FG000|Overall Study|personal reasons|3|||
94366831|NCT03454672|323128202|FG001|Overall Study|personal reasons|2|||
94366832|NCT03454672|323128201|FG000|Overall Study|Withdrawal by Subject|1|||
94366833|NCT03454672|323128202|FG001|Overall Study|Withdrawal by Subject|0|||
94366834|NCT05246111|323128203|FG000|Period 01|NOT ELIGIBLE IC5|1|||
94366835|NCT05246111|323128204|FG001|Period 01|NOT ELIGIBLE IC5|0|||
94366836|NCT02587325|323128205|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
94366837|NCT02587325|323128206|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
94366838|NCT02587325|323128207|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
94366839|NCT02587325|323128208|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
94366840|NCT02587325|323128209|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
94366841|NCT02587325|323128205|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
94366842|NCT02587325|323128206|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
94366843|NCT02587325|323128207|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
94269327|NCT02871778|322780292|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
94269328|NCT02871778|322780293|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
94269329|NCT02871778|322780294|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
94269330|NCT02871778|322780295|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
94269331|NCT02871778|322780296|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
94269332|NCT02871778|322780297|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
94269333|NCT02871778|322780298|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
94269334|NCT02871778|322780299|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
94269335|NCT02871778|322780292|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
94269336|NCT02871778|322780293|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
94269337|NCT02871778|322780294|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
94269338|NCT02871778|322780295|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
94269339|NCT02871778|322780296|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
94269340|NCT02871778|322780297|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
94269341|NCT02871778|322780298|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
94269342|NCT02871778|322780299|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
94269343|NCT02871778|322780292|FG000|Part A: Treatment Period 2|Adverse Event|2|||
94269344|NCT02871778|322780293|FG001|Part A: Treatment Period 2|Adverse Event|2|||
94269345|NCT02871778|322780294|FG002|Part A: Treatment Period 2|Adverse Event|0|||
94269346|NCT02871778|322780295|FG003|Part A: Treatment Period 2|Adverse Event|0|||
94269347|NCT02871778|322780296|FG004|Part A: Treatment Period 2|Adverse Event|0|||
94269348|NCT02871778|322780297|FG005|Part A: Treatment Period 2|Adverse Event|0|||
94269349|NCT02871778|322780298|FG006|Part A: Treatment Period 2|Adverse Event|0|||
94269350|NCT02871778|322780299|FG007|Part A: Treatment Period 2|Adverse Event|0|||
94269351|NCT02871778|322780292|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
94269352|NCT02871778|322780293|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
94269353|NCT02871778|322780294|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
94269354|NCT02871778|322780295|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
94269355|NCT02871778|322780296|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
94269356|NCT02871778|322780297|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
94269357|NCT02871778|322780298|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
94269358|NCT02871778|322780299|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
94269359|NCT02871778|322780292|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
94269360|NCT02871778|322780293|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
94269361|NCT02871778|322780294|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
94269362|NCT02871778|322780295|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
94269363|NCT02871778|322780296|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
94269364|NCT02871778|322780297|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
94269365|NCT02871778|322780298|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
94269366|NCT02871778|322780299|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
94269367|NCT02871778|322780292|FG000|Part B: Treatment Period 3|Adverse Event|0|||
94269368|NCT02871778|322780293|FG001|Part B: Treatment Period 3|Adverse Event|0|||
94269369|NCT02871778|322780294|FG002|Part B: Treatment Period 3|Adverse Event|0|||
94269370|NCT02871778|322780295|FG003|Part B: Treatment Period 3|Adverse Event|0|||
94269371|NCT02871778|322780296|FG004|Part B: Treatment Period 3|Adverse Event|1|||
94269372|NCT02871778|322780297|FG005|Part B: Treatment Period 3|Adverse Event|1|||
94269373|NCT02871778|322780298|FG006|Part B: Treatment Period 3|Adverse Event|1|||
94366844|NCT02587325|323128208|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
94366845|NCT02587325|323128209|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
94366846|NCT02587325|323128205|FG000|32-Week Optional Extension Part|Adverse Event|0|||
94366847|NCT02587325|323128206|FG001|32-Week Optional Extension Part|Adverse Event|0|||
94366848|NCT02587325|323128207|FG002|32-Week Optional Extension Part|Adverse Event|1|||
94366849|NCT02587325|323128208|FG003|32-Week Optional Extension Part|Adverse Event|0|||
94366850|NCT02587325|323128209|FG004|32-Week Optional Extension Part|Adverse Event|0|||
94366851|NCT02587325|323128205|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
94466295|NCT01358578|323496952|FG001|Follow-up Period|Lack of Efficacy|0|||
94466296|NCT01358578|323496953|FG002|Follow-up Period|Lack of Efficacy|4|||
94466297|NCT01358578|323496954|FG003|Follow-up Period|Lack of Efficacy|1|||
94466298|NCT01358578|323496955|FG004|Follow-up Period|Lack of Efficacy|0|||
94466299|NCT01358578|323496956|FG005|Follow-up Period|Lack of Efficacy|0|||
94466300|NCT01358578|323496951|FG000|Follow-up Period|Lost to Follow-up|0|||
94466301|NCT01358578|323496952|FG001|Follow-up Period|Lost to Follow-up|1|||
94466302|NCT01358578|323496953|FG002|Follow-up Period|Lost to Follow-up|0|||
94269374|NCT02871778|322780299|FG007|Part B: Treatment Period 3|Adverse Event|0|||
94269375|NCT02170779|322780300|FG000|Overall Study|Withdrawal by Subject|1|||
94466303|NCT01358578|323496954|FG003|Follow-up Period|Lost to Follow-up|4|||
94466304|NCT01358578|323496955|FG004|Follow-up Period|Lost to Follow-up|0|||
94269376|NCT02170779|322780301|FG001|Overall Study|Withdrawal by Subject|0|||
94269377|NCT02170779|322780300|FG000|Overall Study|Lost to Follow-up|0|||
94366852|NCT02587325|323128206|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
94466305|NCT01358578|323496956|FG005|Follow-up Period|Lost to Follow-up|0|||
94269378|NCT02170779|322780301|FG001|Overall Study|Lost to Follow-up|1|||
94269379|NCT03086057|322780302|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
94269380|NCT03086057|322780303|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
94269381|NCT03086057|322780304|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
94269382|NCT03086057|322780305|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
94269383|NCT03086057|322780302|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
94269384|NCT03086057|322780303|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
94269385|NCT03086057|322780304|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
94269386|NCT03086057|322780305|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
94269387|NCT03086057|322780302|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
94269388|NCT03086057|322780303|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
94269389|NCT03086057|322780304|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
94711504|NCT03593213|324402910|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
94711505|NCT03593213|324402911|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
94711506|NCT03593213|324402912|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
94711507|NCT03593213|324402909|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
94711508|NCT03593213|324402910|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
94711509|NCT03593213|324402911|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
94711510|NCT03593213|324402912|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
94711511|NCT01124734|324402916|FG000|Overall Study|Disease progression|13|||
94269390|NCT03086057|322780305|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
94269391|NCT03086057|322780302|FG000|Stage 1: PrEP Uptake|Death|1|||
94269392|NCT03086057|322780303|FG001|Stage 1: PrEP Uptake|Death|0|||
94269393|NCT03086057|322780304|FG002|Stage 1: PrEP Uptake|Death|0|||
94269394|NCT03086057|322780305|FG003|Stage 1: PrEP Uptake|Death|0|||
94269395|NCT03086057|322780302|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
94269396|NCT03086057|322780303|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
94269397|NCT03086057|322780304|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
94269398|NCT03086057|322780305|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
94269399|NCT03086057|322780302|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
94269400|NCT03086057|322780303|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
94269401|NCT03086057|322780304|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
94269402|NCT03086057|322780305|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
94269403|NCT03086057|322780302|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
94269404|NCT03086057|322780303|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
94269405|NCT03086057|322780304|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
94269406|NCT03086057|322780305|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
94269407|NCT03199040|322780308|FG000|Overall Study|Lack of Efficacy|2|||
94269408|NCT03199040|322780309|FG001|Overall Study|Lack of Efficacy|0|||
94269409|NCT03199040|322780308|FG000|Overall Study|Withdrawal by Subject|2|||
94711512|NCT01124734|324402916|FG000|Overall Study|Adverse Event|1|||
94711513|NCT01124734|324402916|FG000|Overall Study|Withdrawal by Subject|1|||
94711514|NCT01124734|324402916|FG000|Overall Study|Elected for alternative treatment|2|||
94711515|NCT02214160|324402917|FG000|Overall Study|Withdrawal by Subject|1|||
94711516|NCT02214160|324402918|FG001|Overall Study|Withdrawal by Subject|0|||
94711517|NCT02214160|324402919|FG002|Overall Study|Withdrawal by Subject|6|||
94711518|NCT02214160|324402917|FG000|Overall Study|Death|2|||
94711519|NCT02214160|324402918|FG001|Overall Study|Death|2|||
94711520|NCT02214160|324402919|FG002|Overall Study|Death|1|||
94711521|NCT02214160|324402917|FG000|Overall Study|Subject Non-Compliance|0|||
94711522|NCT02214160|324402918|FG001|Overall Study|Subject Non-Compliance|3|||
94711523|NCT02214160|324402919|FG002|Overall Study|Subject Non-Compliance|1|||
94269410|NCT03199040|322780309|FG001|Overall Study|Withdrawal by Subject|0|||
94269411|NCT03199040|322780308|FG000|Overall Study|Adverse Event|0|||
94269412|NCT03199040|322780309|FG001|Overall Study|Adverse Event|1|||
94269413|NCT03199040|322780308|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
94269414|NCT03199040|322780309|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
94269415|NCT04607148|322780310|FG000|Overall Study|Withdrawal by Subject|0|||
94711524|NCT02214160|324402917|FG000|Overall Study|Adverse Event|0|||
94711525|NCT02214160|324402918|FG001|Overall Study|Adverse Event|1|||
94711526|NCT02214160|324402919|FG002|Overall Study|Adverse Event|1|||
94711527|NCT02214160|324402917|FG000|Overall Study|Sponsor Decision|0|||
94711528|NCT02214160|324402918|FG001|Overall Study|Sponsor Decision|2|||
94711529|NCT02214160|324402919|FG002|Overall Study|Sponsor Decision|0|||
94269416|NCT04607148|322780311|FG001|Overall Study|Withdrawal by Subject|4|||
94269417|NCT04607148|322780312|FG002|Overall Study|Withdrawal by Subject|2|||
94269418|NCT04607148|322780313|FG003|Overall Study|Withdrawal by Subject|8|||
94269419|NCT04607148|322780310|FG000|Overall Study|Study Terminated by Sponsor|14|||
94711530|NCT02214160|324402917|FG000|Overall Study|Protocol Violation|1|||
94711531|NCT02214160|324402918|FG001|Overall Study|Protocol Violation|0|||
94711532|NCT02214160|324402919|FG002|Overall Study|Protocol Violation|0|||
94711533|NCT02214160|324402917|FG000|Overall Study|Physician Decision|0|||
94711534|NCT02214160|324402918|FG001|Overall Study|Physician Decision|0|||
94269420|NCT04607148|322780311|FG001|Overall Study|Study Terminated by Sponsor|59|||
94269421|NCT04607148|322780312|FG002|Overall Study|Study Terminated by Sponsor|9|||
94269422|NCT04607148|322780313|FG003|Overall Study|Study Terminated by Sponsor|39|||
94269423|NCT04607148|322780310|FG000|Overall Study|Sponsor Decision|0|||
94269424|NCT04607148|322780311|FG001|Overall Study|Sponsor Decision|0|||
94269425|NCT04607148|322780312|FG002|Overall Study|Sponsor Decision|1|||
94269426|NCT04607148|322780313|FG003|Overall Study|Sponsor Decision|0|||
94269427|NCT04607148|322780310|FG000|Overall Study|Non-Compliance With Study Drug|0|||
94269428|NCT04607148|322780311|FG001|Overall Study|Non-Compliance With Study Drug|1|||
94269429|NCT04607148|322780312|FG002|Overall Study|Non-Compliance With Study Drug|0|||
94652981|NCT02391948|324188007|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
94652982|NCT02391948|324188003|FG000|12-month Assessment|Death|0|||
94269430|NCT04607148|322780313|FG003|Overall Study|Non-Compliance With Study Drug|0|||
94269431|NCT04607148|322780310|FG000|Overall Study|Lost to Follow-up|0|||
94269432|NCT04607148|322780311|FG001|Overall Study|Lost to Follow-up|2|||
94269433|NCT04607148|322780312|FG002|Overall Study|Lost to Follow-up|0|||
94269434|NCT04607148|322780313|FG003|Overall Study|Lost to Follow-up|0|||
94269435|NCT04607148|322780310|FG000|Overall Study|Death|0|||
94269436|NCT04607148|322780311|FG001|Overall Study|Death|3|||
94269437|NCT04607148|322780312|FG002|Overall Study|Death|0|||
94269438|NCT04607148|322780313|FG003|Overall Study|Death|1|||
94269439|NCT04607148|322780310|FG000|Overall Study|Adverse Event|0|||
94269440|NCT04607148|322780311|FG001|Overall Study|Adverse Event|1|||
94269441|NCT04607148|322780312|FG002|Overall Study|Adverse Event|0|||
94269442|NCT04607148|322780313|FG003|Overall Study|Adverse Event|0|||
94269443|NCT01793142|322780316|FG000|Overall Study|Randomized not treated|7|||
94269444|NCT01301950|322780317|FG000|Overall Study|Surgery was cancelled by patient|0|||
94269445|NCT01301950|322780318|FG001|Overall Study|Surgery was cancelled by patient|1|||
94269446|NCT00942175|322780319|FG000|Overall Study|Adverse Event|2|||
94269447|NCT00942175|322780320|FG001|Overall Study|Adverse Event|1|||
94269448|NCT00942175|322780321|FG002|Overall Study|Adverse Event|0|||
94269449|NCT00942175|322780322|FG003|Overall Study|Adverse Event|0|||
94269450|NCT00942175|322780319|FG000|Overall Study|Protocol Violation|0|||
94269451|NCT00942175|322780320|FG001|Overall Study|Protocol Violation|1|||
94269452|NCT00942175|322780321|FG002|Overall Study|Protocol Violation|2|||
94269453|NCT00942175|322780322|FG003|Overall Study|Protocol Violation|0|||
94269454|NCT00942175|322780319|FG000|Overall Study|Pregnancy|0|||
94269455|NCT00942175|322780320|FG001|Overall Study|Pregnancy|0|||
94269456|NCT00942175|322780321|FG002|Overall Study|Pregnancy|0|||
94269457|NCT00942175|322780322|FG003|Overall Study|Pregnancy|1|||
94269458|NCT00942175|322780319|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
94269459|NCT00942175|322780320|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
94269460|NCT00942175|322780321|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
94269461|NCT00942175|322780322|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
94269462|NCT00942175|322780319|FG000|Overall Study|Low Platelet Count|0|||
94269463|NCT00942175|322780320|FG001|Overall Study|Low Platelet Count|2|||
94269464|NCT00942175|322780321|FG002|Overall Study|Low Platelet Count|0|||
94269465|NCT00942175|322780322|FG003|Overall Study|Low Platelet Count|0|||
94269466|NCT05093322|322780323|FG000|Overall Study|Death|6|||
94269467|NCT05093322|322780324|FG001|Overall Study|Death|2|||
94269468|NCT05093322|322780323|FG000|Overall Study|Other|4|||
94269469|NCT05093322|322780324|FG001|Overall Study|Other|1|||
94269470|NCT03715153|322780325|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
94269471|NCT03715153|322780326|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
94269472|NCT03715153|322780325|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
94269473|NCT03715153|322780326|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
94269474|NCT03715153|322780325|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
94269475|NCT03715153|322780326|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
94269476|NCT03715153|322780325|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
94269477|NCT03715153|322780326|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
94269478|NCT03715153|322780325|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
94269479|NCT03715153|322780326|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
94269480|NCT03715153|322780325|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
94269481|NCT03715153|322780326|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
94269482|NCT01770912|322780327|FG000|Overall Study|Lost to Follow-up|2|||
94366853|NCT02587325|323128207|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
94366854|NCT02587325|323128208|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
94366855|NCT02587325|323128209|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
94366856|NCT03151226|323128216|FG000|Overall Study|Withdrawal by Subject|2|||
94366857|NCT03151226|323128216|FG000|Overall Study|not wear device correctly|1|||
94366858|NCT02913261|323128217|FG000|Overall Study|Technical problems|0|||
94366859|NCT02913261|323128218|FG001|Overall Study|Technical problems|1|||
94366860|NCT02913261|323128217|FG000|Overall Study|Lack of Efficacy|32|||
94366861|NCT02913261|323128218|FG001|Overall Study|Lack of Efficacy|69|||
94366862|NCT02913261|323128217|FG000|Overall Study|Adverse Event|27|||
94366863|NCT02913261|323128218|FG001|Overall Study|Adverse Event|5|||
94366864|NCT02913261|323128217|FG000|Overall Study|Death|25|||
94366865|NCT02913261|323128218|FG001|Overall Study|Death|22|||
94366866|NCT02913261|323128217|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
94366867|NCT02913261|323128218|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
94366868|NCT02913261|323128217|FG000|Overall Study|Disease relapse|8|||
94366869|NCT02913261|323128218|FG001|Overall Study|Disease relapse|13|||
94366870|NCT02913261|323128217|FG000|Overall Study|Physician Decision|8|||
94366871|NCT02913261|323128218|FG001|Overall Study|Physician Decision|9|||
94366872|NCT02913261|323128217|FG000|Overall Study|Subject/guardian decision|4|||
94366873|NCT02913261|323128218|FG001|Overall Study|Subject/guardian decision|6|||
94366874|NCT02913261|323128217|FG000|Overall Study|Graft loss|2|||
94652983|NCT02391948|324188004|FG001|12-month Assessment|Death|0|||
94269483|NCT01770912|322780328|FG001|Overall Study|Lost to Follow-up|0|||
94366875|NCT02913261|323128218|FG001|Overall Study|Graft loss|0|||
94711535|NCT02214160|324402919|FG002|Overall Study|Physician Decision|1|||
94711536|NCT00457743|324402922|FG000|Overall Study|Adverse Event|0|||
94711537|NCT00457743|324402923|FG001|Overall Study|Adverse Event|4|||
94711538|NCT00457743|324402924|FG002|Overall Study|Adverse Event|0|||
94711539|NCT00457743|324402922|FG000|Overall Study|Lack of Efficacy|3|||
94711540|NCT00457743|324402923|FG001|Overall Study|Lack of Efficacy|23|||
94711541|NCT00457743|324402924|FG002|Overall Study|Lack of Efficacy|3|||
94711542|NCT00566527|324402925|FG000|Overall Study|Reason not provided|3|||
94711543|NCT00566527|324402926|FG001|Overall Study|Reason not provided|11|||
94711544|NCT00566527|324402927|FG002|Overall Study|Reason not provided|10|||
94711545|NCT00566527|324402925|FG000|Overall Study|Adverse Event|2|||
94711546|NCT00566527|324402926|FG001|Overall Study|Adverse Event|0|||
94711547|NCT00566527|324402927|FG002|Overall Study|Adverse Event|1|||
94269484|NCT01536951|322780329|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
94269485|NCT01536951|322780330|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
94366876|NCT00659581|323128219|FG000|Overall Study|Adverse Event|1006|||
94366877|NCT00659581|323128219|FG000|Overall Study|Lack of Efficacy|1183|||
94366878|NCT00659581|323128219|FG000|Overall Study|Other|6393|||
94366879|NCT01831596|323128220|FG000|Overall Study|Other|8|||
94366880|NCT01211613|323129525|FG000|Overall Study|Lost to Follow-up|2|||
94366881|NCT01211613|323129526|FG001|Overall Study|Lost to Follow-up|2|||
94366882|NCT01211613|323129527|FG002|Overall Study|Lost to Follow-up|2|||
94366883|NCT01211613|323129525|FG000|Overall Study|Withdrawal by Subject|1|||
94366884|NCT01211613|323129526|FG001|Overall Study|Withdrawal by Subject|0|||
94366885|NCT01211613|323129527|FG002|Overall Study|Withdrawal by Subject|0|||
94366886|NCT03302299|323129528|FG000|Overall Study|Protocol Violation|1|||
94366887|NCT02038959|323129529|FG000|Overall Study|Withdrawal by Subject|6|||
94366888|NCT02038959|323129530|FG001|Overall Study|Withdrawal by Subject|8|||
94366889|NCT00265239|323129531|FG000|Overall Study|Adverse Event|2|||
94366890|NCT00265239|323129532|FG001|Overall Study|Adverse Event|1|||
94366891|NCT02803138|323129533|FG000|Overall Study|Failure to return|38|||
94366892|NCT02803138|323129533|FG000|Overall Study|Insufficient virological response|2|||
94366893|NCT02803138|323129533|FG000|Overall Study|Withdrawn consent|1|||
94366894|NCT02803138|323129533|FG000|Overall Study|Death|1|||
94366895|NCT02803138|323129533|FG000|Overall Study|Other, not specified|28|||
94366896|NCT04071366|323129534|FG000|Part 1: Open-label (29 Days)|Death|4|||
94366897|NCT04071366|323129535|FG001|Part 1: Open-label (29 Days)|Death|2|||
94366898|NCT04071366|323129536|FG002|Part 1: Open-label (29 Days)|Death|8|||
94366899|NCT04071366|323129537|FG003|Part 1: Open-label (29 Days)|Death|0|||
94366900|NCT04071366|323129538|FG004|Part 1: Open-label (29 Days)|Death|0|||
94366901|NCT04071366|323129534|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
94366902|NCT04071366|323129535|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
94366903|NCT04071366|323129536|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
94366904|NCT04071366|323129537|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
94366905|NCT04071366|323129538|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
94366906|NCT04071366|323129534|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
94366907|NCT04071366|323129535|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
94366908|NCT04071366|323129536|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
94366909|NCT04071366|323129537|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
94366910|NCT04071366|323129538|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
94366911|NCT04071366|323129534|FG000|Part 2: Randomized (29 Days)|Death|0|||
94366912|NCT04071366|323129535|FG001|Part 2: Randomized (29 Days)|Death|0|||
94366913|NCT04071366|323129536|FG002|Part 2: Randomized (29 Days)|Death|0|||
94366914|NCT04071366|323129537|FG003|Part 2: Randomized (29 Days)|Death|2|||
94366915|NCT04071366|323129538|FG004|Part 2: Randomized (29 Days)|Death|2|||
94366916|NCT04071366|323129534|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
94366917|NCT04071366|323129535|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
94366918|NCT04071366|323129536|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
94269486|NCT01536951|322780331|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
94269487|NCT01536951|322780332|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
94269488|NCT01536951|322780333|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
94269489|NCT01536951|322780334|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
94269490|NCT01536951|322780335|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
94269491|NCT01536951|322780336|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
94269492|NCT01536951|322780337|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
94269493|NCT01536951|322780329|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
94366919|NCT04071366|323129537|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
94366920|NCT04071366|323129538|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
94366921|NCT04071366|323129534|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
94711548|NCT00566527|324402925|FG000|Overall Study|Physician Decision|3|||
94711549|NCT00566527|324402926|FG001|Overall Study|Physician Decision|8|||
94711550|NCT00566527|324402927|FG002|Overall Study|Physician Decision|20|||
94711551|NCT00566527|324402925|FG000|Overall Study|Lost to Follow-up|3|||
94711552|NCT00566527|324402926|FG001|Overall Study|Lost to Follow-up|4|||
94269494|NCT01536951|322780330|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
94269495|NCT01536951|322780331|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
94269496|NCT01536951|322780332|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
94269497|NCT01536951|322780333|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
94269498|NCT01536951|322780334|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
94269499|NCT01536951|322780335|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
94269500|NCT01536951|322780336|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
94269501|NCT01536951|322780337|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
94269502|NCT00555477|322780338|FG000|Overall Study|Adverse Event|0|||
94269503|NCT00555477|322780339|FG001|Overall Study|Adverse Event|9|||
94269504|NCT00555477|322780338|FG000|Overall Study|Withdrawal by Subject|1|||
94269505|NCT00555477|322780339|FG001|Overall Study|Withdrawal by Subject|2|||
94269506|NCT00555477|322780338|FG000|Overall Study|Physician Decision|1|||
94269507|NCT00555477|322780339|FG001|Overall Study|Physician Decision|2|||
94269508|NCT00078325|322780340|FG000|Overall Study|Adverse Event|15|||
94269509|NCT00078325|322780341|FG001|Overall Study|Adverse Event|10|||
94269510|NCT00078325|322780342|FG002|Overall Study|Adverse Event|5|||
94269511|NCT00078325|322780340|FG000|Overall Study|Protocol Violation|2|||
94269512|NCT00078325|322780341|FG001|Overall Study|Protocol Violation|2|||
94269513|NCT00078325|322780342|FG002|Overall Study|Protocol Violation|0|||
94269514|NCT00078325|322780340|FG000|Overall Study|Withdrawal by Subject|1|||
94269515|NCT00078325|322780341|FG001|Overall Study|Withdrawal by Subject|5|||
94269516|NCT00078325|322780342|FG002|Overall Study|Withdrawal by Subject|3|||
94269517|NCT00078325|322780340|FG000|Overall Study|Lost to Follow-up|0|||
94269518|NCT00078325|322780341|FG001|Overall Study|Lost to Follow-up|1|||
94269519|NCT00078325|322780342|FG002|Overall Study|Lost to Follow-up|1|||
94269520|NCT00078325|322780340|FG000|Overall Study|Physician Decision|2|||
94269521|NCT00078325|322780341|FG001|Overall Study|Physician Decision|0|||
94269522|NCT00078325|322780342|FG002|Overall Study|Physician Decision|1|||
94269523|NCT00078325|322780340|FG000|Overall Study|Miscellaneous|1|||
94269524|NCT00078325|322780341|FG001|Overall Study|Miscellaneous|1|||
94269525|NCT00078325|322780342|FG002|Overall Study|Miscellaneous|1|||
94269526|NCT01519765|322780343|FG000|Overall Study|Adverse Event|0|||
94269527|NCT01519765|322780344|FG001|Overall Study|Adverse Event|1|||
94269528|NCT01519765|322780343|FG000|Overall Study|Lack of Efficacy|2|||
94269529|NCT01519765|322780344|FG001|Overall Study|Lack of Efficacy|0|||
94269530|NCT01519765|322780343|FG000|Overall Study|Protocol Violation|1|||
94269531|NCT01519765|322780344|FG001|Overall Study|Protocol Violation|0|||
94269532|NCT01519765|322780343|FG000|Overall Study|Withdrawal by Subject|0|||
94269533|NCT01519765|322780344|FG001|Overall Study|Withdrawal by Subject|1|||
94269534|NCT01473563|322780345|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
94269535|NCT01846624|322780346|FG000|Overall Study|Died during induction, no midostaurin|1|||
94269536|NCT01721057|322780347|FG000|Treatment Period|Withdrawal by Subject|11|||
94269537|NCT01721057|322780348|FG001|Treatment Period|Withdrawal by Subject|5|||
94269538|NCT01721057|322780349|FG002|Treatment Period|Withdrawal by Subject|8|||
94269539|NCT01721057|322780350|FG003|Treatment Period|Withdrawal by Subject|0|||
94269540|NCT01721057|322780351|FG004|Treatment Period|Withdrawal by Subject|0|||
94269541|NCT01721057|322780352|FG005|Treatment Period|Withdrawal by Subject|0|||
94269542|NCT01721057|322780353|FG006|Treatment Period|Withdrawal by Subject|0|||
94269543|NCT01721057|322780347|FG000|Treatment Period|Adverse Event|7|||
94269544|NCT01721057|322780348|FG001|Treatment Period|Adverse Event|10|||
94269545|NCT01721057|322780349|FG002|Treatment Period|Adverse Event|12|||
94269546|NCT01721057|322780350|FG003|Treatment Period|Adverse Event|0|||
94269547|NCT01721057|322780351|FG004|Treatment Period|Adverse Event|0|||
94269548|NCT01721057|322780352|FG005|Treatment Period|Adverse Event|0|||
94269549|NCT01721057|322780353|FG006|Treatment Period|Adverse Event|0|||
94269550|NCT01721057|322780347|FG000|Treatment Period|Lack of Efficacy|7|||
94269551|NCT01721057|322780348|FG001|Treatment Period|Lack of Efficacy|3|||
94711553|NCT00566527|324402927|FG002|Overall Study|Lost to Follow-up|4|||
94711554|NCT00566527|324402925|FG000|Overall Study|Withdrawal by Subject|6|||
94269552|NCT01721057|322780349|FG002|Treatment Period|Lack of Efficacy|0|||
94269553|NCT01721057|322780350|FG003|Treatment Period|Lack of Efficacy|0|||
94269554|NCT01721057|322780351|FG004|Treatment Period|Lack of Efficacy|0|||
94269555|NCT01721057|322780352|FG005|Treatment Period|Lack of Efficacy|0|||
94269556|NCT01721057|322780353|FG006|Treatment Period|Lack of Efficacy|0|||
94269557|NCT01721057|322780347|FG000|Treatment Period|Lost to Follow-up|1|||
94269558|NCT01721057|322780348|FG001|Treatment Period|Lost to Follow-up|0|||
94269559|NCT01721057|322780349|FG002|Treatment Period|Lost to Follow-up|0|||
94269560|NCT01721057|322780350|FG003|Treatment Period|Lost to Follow-up|0|||
94269561|NCT01721057|322780351|FG004|Treatment Period|Lost to Follow-up|0|||
94269562|NCT01721057|322780352|FG005|Treatment Period|Lost to Follow-up|0|||
94269563|NCT01721057|322780353|FG006|Treatment Period|Lost to Follow-up|0|||
94269564|NCT01721057|322780347|FG000|Treatment Period|Physician Decision|0|||
94269565|NCT01721057|322780348|FG001|Treatment Period|Physician Decision|1|||
94269566|NCT01721057|322780349|FG002|Treatment Period|Physician Decision|3|||
94269567|NCT01721057|322780350|FG003|Treatment Period|Physician Decision|0|||
94711555|NCT00566527|324402926|FG001|Overall Study|Withdrawal by Subject|43|||
94466306|NCT01358578|323496951|FG000|Follow-up Period|non- compliance with study treatment|1|||
94269568|NCT01721057|322780351|FG004|Treatment Period|Physician Decision|0|||
94269569|NCT01721057|322780352|FG005|Treatment Period|Physician Decision|0|||
94269570|NCT01721057|322780353|FG006|Treatment Period|Physician Decision|0|||
94269571|NCT01721057|322780347|FG000|Treatment Period|Death|2|||
94269572|NCT01721057|322780348|FG001|Treatment Period|Death|0|||
94269573|NCT01721057|322780349|FG002|Treatment Period|Death|0|||
94269574|NCT01721057|322780350|FG003|Treatment Period|Death|0|||
94269575|NCT01721057|322780351|FG004|Treatment Period|Death|0|||
94269576|NCT01721057|322780352|FG005|Treatment Period|Death|0|||
94269577|NCT01721057|322780353|FG006|Treatment Period|Death|0|||
94269578|NCT01721057|322780347|FG000|Rescue Period|Adverse Event|0|||
94269579|NCT01721057|322780348|FG001|Rescue Period|Adverse Event|0|||
94269580|NCT01721057|322780349|FG002|Rescue Period|Adverse Event|0|||
94269581|NCT01721057|322780350|FG003|Rescue Period|Adverse Event|1|||
94269582|NCT01721057|322780351|FG004|Rescue Period|Adverse Event|0|||
94269583|NCT01721057|322780352|FG005|Rescue Period|Adverse Event|0|||
94269584|NCT01721057|322780353|FG006|Rescue Period|Adverse Event|0|||
94269585|NCT01721057|322780347|FG000|Rescue Period|Lack of Efficacy|0|||
94269586|NCT01721057|322780348|FG001|Rescue Period|Lack of Efficacy|0|||
94269587|NCT01721057|322780349|FG002|Rescue Period|Lack of Efficacy|0|||
94269588|NCT01721057|322780350|FG003|Rescue Period|Lack of Efficacy|2|||
94269589|NCT01721057|322780351|FG004|Rescue Period|Lack of Efficacy|0|||
94269590|NCT01721057|322780352|FG005|Rescue Period|Lack of Efficacy|0|||
94269591|NCT01721057|322780353|FG006|Rescue Period|Lack of Efficacy|0|||
94269592|NCT03710486|322780356|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
94269593|NCT03710486|322780357|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
94269594|NCT03710486|322780356|FG000|Overall Study|Missing|0|||
94269595|NCT03710486|322780357|FG001|Overall Study|Missing|2|||
94269596|NCT01987960|322780358|FG000|Period 1|Adverse Event|24|||
94269597|NCT01987960|322780359|FG001|Period 1|Adverse Event|0|||
94269598|NCT01987960|322780360|FG002|Period 1|Adverse Event|0|||
94269599|NCT01987960|322780361|FG003|Period 1|Adverse Event|0|||
94269600|NCT01987960|322780358|FG000|Period 1|Lack of Efficacy|4|||
94466307|NCT01358578|323496952|FG001|Follow-up Period|non- compliance with study treatment|0|||
94466308|NCT01358578|323496953|FG002|Follow-up Period|non- compliance with study treatment|0|||
94652984|NCT02391948|324188005|FG002|12-month Assessment|Death|0|||
94652985|NCT02391948|324188006|FG003|12-month Assessment|Death|1|||
94652986|NCT02391948|324188007|FG004|12-month Assessment|Death|0|||
94652987|NCT02391948|324188003|FG000|12-month Assessment|Withdrawal by Subject|1|||
94652988|NCT02391948|324188004|FG001|12-month Assessment|Withdrawal by Subject|0|||
94652989|NCT02391948|324188005|FG002|12-month Assessment|Withdrawal by Subject|0|||
94652990|NCT02391948|324188006|FG003|12-month Assessment|Withdrawal by Subject|1|||
94652991|NCT02391948|324188007|FG004|12-month Assessment|Withdrawal by Subject|0|||
94652992|NCT02391948|324188003|FG000|12-month Assessment|Lost to Follow-up|5|||
94652993|NCT02391948|324188004|FG001|12-month Assessment|Lost to Follow-up|4|||
94652994|NCT02391948|324188005|FG002|12-month Assessment|Lost to Follow-up|4|||
94652995|NCT02391948|324188006|FG003|12-month Assessment|Lost to Follow-up|4|||
94652996|NCT02391948|324188007|FG004|12-month Assessment|Lost to Follow-up|5|||
94652997|NCT02391948|324188003|FG000|12-month Assessment|Medical issue/illness|0|||
94652998|NCT02391948|324188004|FG001|12-month Assessment|Medical issue/illness|1|||
94652999|NCT02391948|324188005|FG002|12-month Assessment|Medical issue/illness|0|||
94653000|NCT02391948|324188006|FG003|12-month Assessment|Medical issue/illness|1|||
94653001|NCT02391948|324188007|FG004|12-month Assessment|Medical issue/illness|0|||
94653002|NCT02391948|324188003|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
94653003|NCT02391948|324188004|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
94653004|NCT02391948|324188005|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
94653005|NCT02391948|324188006|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
94653006|NCT02391948|324188007|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
94653007|NCT02391948|324188003|FG000|18-month Assessment|Death|0|||
94653008|NCT02391948|324188004|FG001|18-month Assessment|Death|0|||
94653009|NCT02391948|324188005|FG002|18-month Assessment|Death|0|||
94653010|NCT02391948|324188006|FG003|18-month Assessment|Death|1|||
94653011|NCT02391948|324188007|FG004|18-month Assessment|Death|1|||
94653012|NCT02391948|324188003|FG000|18-month Assessment|Withdrawal by Subject|1|||
94653013|NCT02391948|324188004|FG001|18-month Assessment|Withdrawal by Subject|0|||
94653014|NCT02391948|324188005|FG002|18-month Assessment|Withdrawal by Subject|0|||
94653015|NCT02391948|324188006|FG003|18-month Assessment|Withdrawal by Subject|1|||
94653016|NCT02391948|324188007|FG004|18-month Assessment|Withdrawal by Subject|0|||
94653017|NCT02391948|324188003|FG000|18-month Assessment|Lost to Follow-up|2|||
94269601|NCT01987960|322780359|FG001|Period 1|Lack of Efficacy|0|||
94269602|NCT01987960|322780360|FG002|Period 1|Lack of Efficacy|0|||
94269603|NCT01987960|322780361|FG003|Period 1|Lack of Efficacy|0|||
94269604|NCT01987960|322780358|FG000|Period 1|Non-compliance with IMP|6|||
94269605|NCT01987960|322780359|FG001|Period 1|Non-compliance with IMP|0|||
94653018|NCT02391948|324188004|FG001|18-month Assessment|Lost to Follow-up|6|||
94653019|NCT02391948|324188005|FG002|18-month Assessment|Lost to Follow-up|2|||
94653020|NCT02391948|324188006|FG003|18-month Assessment|Lost to Follow-up|2|||
94653021|NCT02391948|324188007|FG004|18-month Assessment|Lost to Follow-up|3|||
94711556|NCT00566527|324402927|FG002|Overall Study|Withdrawal by Subject|43|||
94711557|NCT00356265|324402928|FG000|Overall Study|Withdrawal by Subject|0|||
94711558|NCT00356265|324402929|FG001|Overall Study|Withdrawal by Subject|0|||
94711559|NCT00356265|324402930|FG002|Overall Study|Withdrawal by Subject|1|||
94711560|NCT01837966|324402932|FG000|Overall Study|Withdrawal by Subject|2|||
94711561|NCT01837966|324402933|FG001|Overall Study|Withdrawal by Subject|1|||
94711562|NCT01493778|324402941|FG000|Overall Study|Withdrawal by Subject|8|||
94711563|NCT01278394|324402942|FG000|Overall Study|Lost to Follow-up|1|||
94711564|NCT01792830|324402945|FG000|Overall Study|Withdrawal by Subject|22|||
94711565|NCT01792830|324402946|FG001|Overall Study|Withdrawal by Subject|0|||
94711566|NCT01792830|324402947|FG002|Overall Study|Withdrawal by Subject|0|||
94711567|NCT01792830|324402948|FG003|Overall Study|Withdrawal by Subject|2|||
94711568|NCT01792830|324402949|FG004|Overall Study|Withdrawal by Subject|1|||
94269606|NCT01987960|322780360|FG002|Period 1|Non-compliance with IMP|0|||
94269607|NCT01987960|322780361|FG003|Period 1|Non-compliance with IMP|0|||
94269608|NCT01987960|322780358|FG000|Period 1|Protocol Violation|12|||
94269609|NCT01987960|322780359|FG001|Period 1|Protocol Violation|0|||
94269610|NCT01987960|322780360|FG002|Period 1|Protocol Violation|0|||
94269611|NCT01987960|322780361|FG003|Period 1|Protocol Violation|0|||
94269612|NCT01987960|322780358|FG000|Period 1|Withdrawal by Subject|21|||
94269613|NCT01987960|322780359|FG001|Period 1|Withdrawal by Subject|0|||
94269614|NCT01987960|322780360|FG002|Period 1|Withdrawal by Subject|0|||
94269615|NCT01987960|322780361|FG003|Period 1|Withdrawal by Subject|0|||
94269616|NCT01987960|322780358|FG000|Period 1|Lost to Follow-up|40|||
94269617|NCT01987960|322780359|FG001|Period 1|Lost to Follow-up|0|||
94269618|NCT01987960|322780360|FG002|Period 1|Lost to Follow-up|0|||
94269619|NCT01987960|322780361|FG003|Period 1|Lost to Follow-up|0|||
94269620|NCT01987960|322780358|FG000|Period 1|administrative or other reason|75|||
94269621|NCT01987960|322780359|FG001|Period 1|administrative or other reason|0|||
94269622|NCT01987960|322780360|FG002|Period 1|administrative or other reason|0|||
94269623|NCT01987960|322780361|FG003|Period 1|administrative or other reason|0|||
94269624|NCT01987960|322780358|FG000|Period 1|Withdrawal of consent before treatment|4|||
94269625|NCT01987960|322780359|FG001|Period 1|Withdrawal of consent before treatment|0|||
94269626|NCT01987960|322780360|FG002|Period 1|Withdrawal of consent before treatment|0|||
94269627|NCT01987960|322780361|FG003|Period 1|Withdrawal of consent before treatment|0|||
94269628|NCT01987960|322780358|FG000|Period 2|Adverse Event|0|||
94269629|NCT01987960|322780359|FG001|Period 2|Adverse Event|0|||
94269630|NCT01987960|322780360|FG002|Period 2|Adverse Event|1|||
94269631|NCT01987960|322780361|FG003|Period 2|Adverse Event|0|||
94269632|NCT01987960|322780358|FG000|Period 2|Withdrawal by Subject|0|||
94269633|NCT01987960|322780359|FG001|Period 2|Withdrawal by Subject|0|||
94269634|NCT01987960|322780360|FG002|Period 2|Withdrawal by Subject|1|||
94711569|NCT01792830|324402950|FG005|Overall Study|Withdrawal by Subject|1|||
94269635|NCT01987960|322780361|FG003|Period 2|Withdrawal by Subject|0|||
94269636|NCT01987960|322780358|FG000|Period 2|Administrative or other reason|0|||
94269637|NCT01987960|322780359|FG001|Period 2|Administrative or other reason|5|||
94269638|NCT01987960|322780360|FG002|Period 2|Administrative or other reason|7|||
94269639|NCT01987960|322780361|FG003|Period 2|Administrative or other reason|0|||
94269640|NCT01987960|322780358|FG000|Period 3|Adverse Event|0|||
94711570|NCT01792830|324402951|FG006|Overall Study|Withdrawal by Subject|1|||
94711571|NCT01792830|324402952|FG007|Overall Study|Withdrawal by Subject|1|||
94366922|NCT04071366|323129535|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
94366923|NCT04071366|323129536|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
94366924|NCT04071366|323129537|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
94366925|NCT04071366|323129538|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
94366926|NCT04071366|323129534|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
94366927|NCT04071366|323129535|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
94366928|NCT04071366|323129536|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
94366929|NCT04071366|323129537|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
94366930|NCT04071366|323129538|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
94366931|NCT04071366|323129534|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
94366932|NCT04071366|323129535|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
94366933|NCT04071366|323129536|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
94366934|NCT04071366|323129537|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
94711572|NCT01792830|324402953|FG008|Overall Study|Withdrawal by Subject|7|||
94711573|NCT01792830|324402954|FG009|Overall Study|Withdrawal by Subject|0|||
94366935|NCT04071366|323129538|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
94366936|NCT04071366|323129534|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
94366937|NCT04071366|323129535|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
94366938|NCT04071366|323129536|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
94366939|NCT04071366|323129537|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
94653022|NCT02391948|324188003|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
94653023|NCT02391948|324188004|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
94711574|NCT01792830|324402955|FG010|Overall Study|Withdrawal by Subject|2|||
94711575|NCT01792830|324402945|FG000|Overall Study|Death|3|||
94711576|NCT01792830|324402946|FG001|Overall Study|Death|0|||
94711577|NCT01792830|324402947|FG002|Overall Study|Death|0|||
94711578|NCT01792830|324402948|FG003|Overall Study|Death|1|||
94711579|NCT01792830|324402949|FG004|Overall Study|Death|0|||
94711580|NCT01792830|324402950|FG005|Overall Study|Death|0|||
94711581|NCT01792830|324402951|FG006|Overall Study|Death|1|||
94711582|NCT01792830|324402952|FG007|Overall Study|Death|0|||
94711583|NCT01792830|324402953|FG008|Overall Study|Death|1|||
94711584|NCT01792830|324402954|FG009|Overall Study|Death|0|||
94711585|NCT01792830|324402955|FG010|Overall Study|Death|1|||
94711586|NCT01792830|324402945|FG000|Overall Study|Adverse Event|0|||
94711587|NCT01792830|324402946|FG001|Overall Study|Adverse Event|0|||
94711588|NCT01792830|324402947|FG002|Overall Study|Adverse Event|0|||
94711589|NCT01792830|324402948|FG003|Overall Study|Adverse Event|0|||
94711590|NCT01792830|324402949|FG004|Overall Study|Adverse Event|0|||
94711591|NCT01792830|324402950|FG005|Overall Study|Adverse Event|0|||
94711592|NCT01792830|324402951|FG006|Overall Study|Adverse Event|0|||
94653024|NCT02391948|324188005|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
94653025|NCT02391948|324188006|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
94653026|NCT02391948|324188007|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
94653027|NCT02391948|324188003|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
94653028|NCT02391948|324188004|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
94653029|NCT02391948|324188005|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
94653030|NCT02391948|324188006|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
94711593|NCT01792830|324402952|FG007|Overall Study|Adverse Event|0|||
94366940|NCT04071366|323129538|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
94711594|NCT01792830|324402953|FG008|Overall Study|Adverse Event|1|||
94711595|NCT01792830|324402954|FG009|Overall Study|Adverse Event|0|||
94711596|NCT01792830|324402955|FG010|Overall Study|Adverse Event|0|||
94711597|NCT04504916|324402956|FG000|Overall Study|Study terminated|7|||
94711598|NCT04504916|324402957|FG001|Overall Study|Study terminated|8|||
94711599|NCT04504916|324402956|FG000|Overall Study|Death|54|||
94711600|NCT04504916|324402957|FG001|Overall Study|Death|18|||
94711601|NCT04504916|324402956|FG000|Overall Study|Lost to Follow-up|1|||
94711602|NCT04504916|324402957|FG001|Overall Study|Lost to Follow-up|1|||
94711603|NCT04504916|324402956|FG000|Overall Study|Withdrawal by Subject|8|||
94711604|NCT04504916|324402957|FG001|Overall Study|Withdrawal by Subject|4|||
94711605|NCT04504916|324402956|FG000|Overall Study|Did not agree to follow-up|0|||
94711606|NCT04504916|324402957|FG001|Overall Study|Did not agree to follow-up|1|||
94711607|NCT01832480|324402958|FG000|Overall Study|Lost to Follow-up|33|||
94711608|NCT01832480|324402959|FG001|Overall Study|Lost to Follow-up|30|||
94711609|NCT01832480|324402958|FG000|Overall Study|Withdrawal by Subject|0|||
94711610|NCT01832480|324402959|FG001|Overall Study|Withdrawal by Subject|2|||
94711611|NCT01832480|324402958|FG000|Overall Study|post randomization ineligible|8|||
94711612|NCT01832480|324402959|FG001|Overall Study|post randomization ineligible|10|||
94711613|NCT00958633|324402961|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
94711614|NCT00958633|324402962|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
94711615|NCT00958633|324402963|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
94711616|NCT00958633|324402961|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
94711617|NCT00958633|324402962|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
94711618|NCT00958633|324402963|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
94711619|NCT00958633|324402961|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
94711620|NCT00958633|324402962|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
94711621|NCT00958633|324402963|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
94711622|NCT00958633|324402961|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
94711623|NCT00958633|324402962|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
94711624|NCT00958633|324402963|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
94711625|NCT00958633|324402961|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
94711626|NCT00958633|324402962|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
94711627|NCT00958633|324402963|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
94711628|NCT00958633|324402961|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
94711629|NCT00958633|324402962|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
94711630|NCT00958633|324402963|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
94711631|NCT00958633|324402961|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
94711632|NCT00958633|324402962|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
94711633|NCT00958633|324402963|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
94711634|NCT05510245|324402964|FG000|Overall Study|Withdrawal by Subject|1|||
94711635|NCT05510245|324402965|FG001|Overall Study|Withdrawal by Subject|0|||
94711636|NCT05510245|324402966|FG002|Overall Study|Withdrawal by Subject|0|||
94711637|NCT01373346|324402972|FG000|Overall Study|Death|1|||
94711638|NCT01198028|324402973|FG000|Overall Study|Adverse Event|5|||
94711639|NCT01198028|324402973|FG000|Overall Study|Death|3|||
94711640|NCT01198028|324402973|FG000|Overall Study|Physician Decision|2|||
94711641|NCT01395758|324402974|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
94711642|NCT01395758|324402975|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
94711643|NCT01395758|324402976|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
94711644|NCT04305405|324402979|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94711645|NCT04305405|324402980|FG001|Overall Study|Withdrawal by parent/guardian|1|||
94711646|NCT02528188|324402981|FG000|Overall Study|Adverse Event|23|||
94711647|NCT02528188|324402982|FG001|Overall Study|Adverse Event|22|||
94711648|NCT02528188|324402983|FG002|Overall Study|Adverse Event|8|||
94711649|NCT02528188|324402981|FG000|Overall Study|Protocol Violation|4|||
94711650|NCT02528188|324402982|FG001|Overall Study|Protocol Violation|6|||
94711651|NCT02528188|324402983|FG002|Overall Study|Protocol Violation|4|||
94711652|NCT02528188|324402981|FG000|Overall Study|Lack of Efficacy|19|||
94711653|NCT02528188|324402982|FG001|Overall Study|Lack of Efficacy|21|||
94711654|NCT02528188|324402983|FG002|Overall Study|Lack of Efficacy|22|||
94711655|NCT02528188|324402981|FG000|Overall Study|Withdrawal by Subject|97|||
94711656|NCT02528188|324402982|FG001|Overall Study|Withdrawal by Subject|104|||
94711657|NCT02528188|324402983|FG002|Overall Study|Withdrawal by Subject|100|||
94711658|NCT02528188|324402981|FG000|Overall Study|Lost to Follow-up|25|||
94711659|NCT02528188|324402982|FG001|Overall Study|Lost to Follow-up|21|||
94711660|NCT02528188|324402983|FG002|Overall Study|Lost to Follow-up|31|||
94711661|NCT02528188|324402981|FG000|Overall Study|Death|4|||
94711662|NCT02528188|324402982|FG001|Overall Study|Death|4|||
94711663|NCT02528188|324402983|FG002|Overall Study|Death|0|||
94711664|NCT02528188|324402981|FG000|Overall Study|Other|89|||
94711665|NCT02528188|324402982|FG001|Overall Study|Other|91|||
94711666|NCT02528188|324402983|FG002|Overall Study|Other|74|||
94711667|NCT02528188|324402981|FG000|Overall Study|Randomized but not treated|6|||
94711668|NCT02528188|324402982|FG001|Overall Study|Randomized but not treated|7|||
94711669|NCT02528188|324402983|FG002|Overall Study|Randomized but not treated|12|||
94711670|NCT00206375|324402984|FG000|Overall Study|Lost to Follow-up|1|||
94711671|NCT00206375|324402985|FG001|Overall Study|Lost to Follow-up|0|||
94269641|NCT01987960|322780359|FG001|Period 3|Adverse Event|0|||
94269642|NCT01987960|322780360|FG002|Period 3|Adverse Event|0|||
94269643|NCT01987960|322780361|FG003|Period 3|Adverse Event|7|||
94269644|NCT01987960|322780358|FG000|Period 3|Non-compliance with IMP|0|||
94269645|NCT01987960|322780359|FG001|Period 3|Non-compliance with IMP|0|||
94269646|NCT01987960|322780360|FG002|Period 3|Non-compliance with IMP|0|||
94269647|NCT01987960|322780361|FG003|Period 3|Non-compliance with IMP|1|||
94269648|NCT01987960|322780358|FG000|Period 3|Protocol Violation|0|||
94269649|NCT01987960|322780359|FG001|Period 3|Protocol Violation|0|||
94269650|NCT01987960|322780360|FG002|Period 3|Protocol Violation|0|||
94269651|NCT01987960|322780361|FG003|Period 3|Protocol Violation|6|||
94269652|NCT01987960|322780358|FG000|Period 3|Withdrawal by Subject|0|||
94269653|NCT01987960|322780359|FG001|Period 3|Withdrawal by Subject|0|||
94269654|NCT01987960|322780360|FG002|Period 3|Withdrawal by Subject|0|||
94269655|NCT01987960|322780361|FG003|Period 3|Withdrawal by Subject|9|||
94269656|NCT01987960|322780358|FG000|Period 3|Lost to Follow-up|0|||
94269657|NCT01987960|322780359|FG001|Period 3|Lost to Follow-up|0|||
94269658|NCT01987960|322780360|FG002|Period 3|Lost to Follow-up|0|||
94269659|NCT01987960|322780361|FG003|Period 3|Lost to Follow-up|5|||
94269660|NCT01987960|322780358|FG000|Period 3|Administrative or other reason|0|||
94269661|NCT01987960|322780359|FG001|Period 3|Administrative or other reason|0|||
94269662|NCT01987960|322780360|FG002|Period 3|Administrative or other reason|0|||
94269663|NCT01987960|322780361|FG003|Period 3|Administrative or other reason|43|||
94269664|NCT02811549|322780362|FG000|Overall Study|Lost to Follow-up|1|||
94269665|NCT02811549|322780362|FG000|Overall Study|Withdrawal by Subject|3|||
94269666|NCT02811549|322780362|FG000|Overall Study|Subject screen failed|4|||
94269667|NCT02811549|322780362|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
94269668|NCT00789880|322780364|FG000|Overall Study|Adverse Event|0|||
94269669|NCT00789880|322780365|FG001|Overall Study|Adverse Event|0|||
94269670|NCT00789880|322780366|FG002|Overall Study|Adverse Event|0|||
94269671|NCT00789880|322780367|FG003|Overall Study|Adverse Event|0|||
94269672|NCT00789880|322780368|FG004|Overall Study|Adverse Event|1|||
94269673|NCT00789880|322780369|FG005|Overall Study|Adverse Event|0|||
94269674|NCT00789880|322780364|FG000|Overall Study|Protocol Violation|0|||
94269675|NCT00789880|322780365|FG001|Overall Study|Protocol Violation|1|||
94269676|NCT00789880|322780366|FG002|Overall Study|Protocol Violation|0|||
94269677|NCT00789880|322780367|FG003|Overall Study|Protocol Violation|1|||
94269678|NCT00789880|322780368|FG004|Overall Study|Protocol Violation|0|||
94269679|NCT00789880|322780369|FG005|Overall Study|Protocol Violation|0|||
94269680|NCT00789880|322780364|FG000|Overall Study|Withdrawal by Subject|1|||
94269681|NCT00789880|322780365|FG001|Overall Study|Withdrawal by Subject|0|||
94269682|NCT00789880|322780366|FG002|Overall Study|Withdrawal by Subject|0|||
94269683|NCT00789880|322780367|FG003|Overall Study|Withdrawal by Subject|0|||
94269684|NCT00789880|322780368|FG004|Overall Study|Withdrawal by Subject|2|||
94269685|NCT00789880|322780369|FG005|Overall Study|Withdrawal by Subject|0|||
94269686|NCT03472924|322780375|FG000|Overall Study|Adverse Event|1|||
94269687|NCT03472924|322780376|FG001|Overall Study|Adverse Event|0|||
94269688|NCT05082376|322780381|FG000|Overall Study|Lost to Follow-up|2|||
94269689|NCT01045798|322780382|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
94269690|NCT01045798|322780383|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
94269691|NCT01045798|322780382|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
94269692|NCT01045798|322780383|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
94269693|NCT01045798|322780382|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
94269694|NCT01045798|322780383|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
94269695|NCT01045798|322780382|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
94711672|NCT00206375|324402986|FG002|Overall Study|Lost to Follow-up|0|||
94711673|NCT00206375|324402984|FG000|Overall Study|Withdrawal by Subject|2|||
94711674|NCT00206375|324402985|FG001|Overall Study|Withdrawal by Subject|1|||
94711675|NCT00206375|324402986|FG002|Overall Study|Withdrawal by Subject|3|||
94711676|NCT00206375|324402984|FG000|Overall Study|Study terminated due to lack of funds|0|||
94269696|NCT01045798|322780383|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
94269697|NCT01876251|322782017|FG000|Overall Study|Clinical progression|1|||
94269698|NCT01876251|322782018|FG001|Overall Study|Clinical progression|0|||
94269699|NCT01876251|322782019|FG002|Overall Study|Clinical progression|0|||
94269700|NCT01876251|322782017|FG000|Overall Study|Death|2|||
94269701|NCT01876251|322782018|FG001|Overall Study|Death|0|||
94269702|NCT01876251|322782019|FG002|Overall Study|Death|1|||
94269703|NCT01876251|322782017|FG000|Overall Study|Participant started new treatment|1|||
94269704|NCT01876251|322782018|FG001|Overall Study|Participant started new treatment|0|||
94269705|NCT01876251|322782019|FG002|Overall Study|Participant started new treatment|1|||
94269706|NCT01876251|322782017|FG000|Overall Study|Participant refused further follow-up|0|||
94269707|NCT01876251|322782018|FG001|Overall Study|Participant refused further follow-up|0|||
94269708|NCT01876251|322782019|FG002|Overall Study|Participant refused further follow-up|1|||
94269709|NCT01876251|322782017|FG000|Overall Study|Study terminated|1|||
94269710|NCT01876251|322782018|FG001|Overall Study|Study terminated|0|||
94269711|NCT01876251|322782019|FG002|Overall Study|Study terminated|0|||
94269712|NCT01876251|322782017|FG000|Overall Study|Objective progression or relapse|10|||
94269713|NCT01876251|322782018|FG001|Overall Study|Objective progression or relapse|3|||
94269714|NCT01876251|322782019|FG002|Overall Study|Objective progression or relapse|8|||
94269715|NCT02285920|322782026|FG000|Overall Study|Kidney transplantation|2|||
94269716|NCT02285920|322782027|FG001|Overall Study|Kidney transplantation|2|||
94269717|NCT02285920|322782028|FG002|Overall Study|Kidney transplantation|2|||
94269718|NCT02285920|322782029|FG003|Overall Study|Kidney transplantation|0|||
94269719|NCT02285920|322782026|FG000|Overall Study|Change to peritoneal dialysis|0|||
94269720|NCT02285920|322782027|FG001|Overall Study|Change to peritoneal dialysis|0|||
94269721|NCT02285920|322782028|FG002|Overall Study|Change to peritoneal dialysis|1|||
94269722|NCT02285920|322782029|FG003|Overall Study|Change to peritoneal dialysis|0|||
94269723|NCT02285920|322782026|FG000|Overall Study|Transfer to non-participating unit|0|||
94269724|NCT02285920|322782027|FG001|Overall Study|Transfer to non-participating unit|1|||
94269725|NCT02285920|322782028|FG002|Overall Study|Transfer to non-participating unit|0|||
94653031|NCT02391948|324188007|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
94653032|NCT02391948|324188003|FG000|24-month Assessment|Death|0|||
94653033|NCT02391948|324188004|FG001|24-month Assessment|Death|0|||
94653034|NCT02391948|324188005|FG002|24-month Assessment|Death|0|||
94653035|NCT02391948|324188006|FG003|24-month Assessment|Death|0|||
94653036|NCT02391948|324188007|FG004|24-month Assessment|Death|1|||
94653037|NCT02391948|324188003|FG000|24-month Assessment|Withdrawal by Subject|1|||
94653038|NCT02391948|324188004|FG001|24-month Assessment|Withdrawal by Subject|1|||
94653039|NCT02391948|324188005|FG002|24-month Assessment|Withdrawal by Subject|0|||
94653040|NCT02391948|324188006|FG003|24-month Assessment|Withdrawal by Subject|0|||
94269726|NCT02285920|322782029|FG003|Overall Study|Transfer to non-participating unit|0|||
94269727|NCT02285920|322782026|FG000|Overall Study|Dialysis discontinuation|0|||
94653041|NCT02391948|324188007|FG004|24-month Assessment|Withdrawal by Subject|1|||
94653042|NCT02391948|324188003|FG000|24-month Assessment|Lost to Follow-up|5|||
94269728|NCT02285920|322782027|FG001|Overall Study|Dialysis discontinuation|1|||
94269729|NCT02285920|322782028|FG002|Overall Study|Dialysis discontinuation|0|||
94269730|NCT02285920|322782029|FG003|Overall Study|Dialysis discontinuation|0|||
94269731|NCT02285920|322782026|FG000|Overall Study|Death|2|||
94269732|NCT02285920|322782027|FG001|Overall Study|Death|0|||
94269733|NCT02285920|322782028|FG002|Overall Study|Death|2|||
94269734|NCT02285920|322782029|FG003|Overall Study|Death|1|||
94269735|NCT01444742|322782031|FG000|Overall Study|Death|1|||
94269736|NCT02713542|322782032|FG000|Overall Study|Use of prohibited medication|14|||
94269737|NCT02713542|322782033|FG001|Overall Study|Use of prohibited medication|5|||
94269738|NCT02713542|322782032|FG000|Overall Study|Withdrawal by Subject|4|||
94269739|NCT02713542|322782033|FG001|Overall Study|Withdrawal by Subject|1|||
94269740|NCT00478933|322782037|FG000|Overall Study|Protocol Violation|22|||
94269741|NCT00478933|322782037|FG000|Overall Study|Informed consent not verified|3|||
94269742|NCT00478933|322782037|FG000|Overall Study|Inadequate data available|53|||
94269743|NCT02716675|322782038|FG000|Overall Study|Death|2|||
94269744|NCT02716675|322782039|FG001|Overall Study|Death|3|||
94269745|NCT02716675|322782040|FG002|Overall Study|Death|0|||
94269746|NCT02716675|322782038|FG000|Overall Study|Physician Decision|2|||
94269747|NCT02716675|322782039|FG001|Overall Study|Physician Decision|1|||
94269748|NCT02716675|322782040|FG002|Overall Study|Physician Decision|1|||
94269749|NCT02716675|322782038|FG000|Overall Study|Lost to Follow-up|100|||
94269750|NCT02716675|322782039|FG001|Overall Study|Lost to Follow-up|87|||
94269751|NCT02716675|322782040|FG002|Overall Study|Lost to Follow-up|99|||
94269752|NCT02716675|322782038|FG000|Overall Study|Withdrawal by Subject|22|||
94269753|NCT02716675|322782039|FG001|Overall Study|Withdrawal by Subject|25|||
94269754|NCT02716675|322782040|FG002|Overall Study|Withdrawal by Subject|20|||
94269755|NCT02716675|322782038|FG000|Overall Study|Protocol Violation|0|||
94269756|NCT02716675|322782039|FG001|Overall Study|Protocol Violation|3|||
94269757|NCT02716675|322782040|FG002|Overall Study|Protocol Violation|1|||
94269758|NCT02716675|322782038|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
94711677|NCT00206375|324402985|FG001|Overall Study|Study terminated due to lack of funds|1|||
94711678|NCT00206375|324402986|FG002|Overall Study|Study terminated due to lack of funds|1|||
94711679|NCT03062358|324402987|FG000|Overall Study|Death|220|||
94711680|NCT03062358|324402988|FG001|Overall Study|Death|127|||
94711681|NCT03062358|324402987|FG000|Overall Study|Withdrawal by Subject|2|||
94711682|NCT03062358|324402988|FG001|Overall Study|Withdrawal by Subject|1|||
94711683|NCT03062358|324402987|FG000|Overall Study|Ongoing in Trial|78|||
94711684|NCT03062358|324402988|FG001|Overall Study|Ongoing in Trial|25|||
94711685|NCT03887650|324402990|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
94711686|NCT03887650|324402991|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
94711687|NCT03887650|324402990|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
94711688|NCT03887650|324402991|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
94711689|NCT03887650|324402990|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
94711690|NCT03887650|324402991|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
94711691|NCT03942042|324402994|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
94711692|NCT03942042|324402995|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
94711693|NCT03942042|324402994|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
94711694|NCT03942042|324402995|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
94711695|NCT01597258|324402998|FG000|Overall Study|No Drug Administration|1|||
94711696|NCT00933400|324402999|FG000|Overall Study|Withdrawal by Subject|21|||
94711697|NCT00933400|324403000|FG001|Overall Study|Withdrawal by Subject|1|||
94711698|NCT00223795|324403001|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
94711699|NCT00223795|324403002|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
94711700|NCT00223795|324403001|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
94711701|NCT00223795|324403002|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
94711702|NCT02139943|324403007|FG000|Overall Study|Adverse Event|0|||
94711703|NCT02139943|324403008|FG001|Overall Study|Adverse Event|1|||
94711704|NCT02139943|324403009|FG002|Overall Study|Adverse Event|2|||
94711705|NCT02139943|324403007|FG000|Overall Study|Lost to Follow-up|3|||
94711706|NCT02139943|324403008|FG001|Overall Study|Lost to Follow-up|2|||
94711707|NCT02139943|324403009|FG002|Overall Study|Lost to Follow-up|2|||
94711708|NCT02139943|324403007|FG000|Overall Study|Withdrawal by Subject|4|||
94711709|NCT02139943|324403008|FG001|Overall Study|Withdrawal by Subject|3|||
94269759|NCT02716675|322782039|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
94269760|NCT02716675|322782040|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
94269761|NCT02716675|322782038|FG000|Overall Study|Other|38|||
94269762|NCT02716675|322782039|FG001|Overall Study|Other|47|||
94269763|NCT02716675|322782040|FG002|Overall Study|Other|48|||
94269764|NCT01211535|322782043|FG000|Overall Study|Adverse Event|0|||
94269765|NCT01211535|322782044|FG001|Overall Study|Adverse Event|1|||
94711710|NCT02139943|324403009|FG002|Overall Study|Withdrawal by Subject|0|||
94711711|NCT02139943|324403007|FG000|Overall Study|Other|0|||
94711712|NCT02139943|324403008|FG001|Overall Study|Other|0|||
94269766|NCT00549939|322782050|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
94711713|NCT02139943|324403009|FG002|Overall Study|Other|1|||
94269767|NCT00549939|322782051|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
94269768|NCT00549939|322782052|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
94269769|NCT00549939|322782050|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
94269770|NCT00549939|322782051|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
94269771|NCT00549939|322782052|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
94269772|NCT00549939|322782050|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
94269773|NCT00549939|322782051|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
94269774|NCT00549939|322782052|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
94269775|NCT00549939|322782050|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
94269776|NCT00549939|322782051|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
94269777|NCT00549939|322782052|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
94269778|NCT00549939|322782050|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
94269779|NCT00549939|322782051|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
94269780|NCT00549939|322782052|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
94269781|NCT00549939|322782050|FG000|40-week Open Label Treatment Period|Other|0|||
94269782|NCT00549939|322782051|FG001|40-week Open Label Treatment Period|Other|1|||
94269783|NCT00549939|322782052|FG002|40-week Open Label Treatment Period|Other|4|||
94269784|NCT03677596|322782053|FG000|Overall Study|Adverse Event|0|||
94269785|NCT03677596|322782054|FG001|Overall Study|Adverse Event|1|||
94269786|NCT03677596|322782053|FG000|Overall Study|Death|10|||
94269787|NCT03677596|322782054|FG001|Overall Study|Death|6|||
94269788|NCT03677596|322782053|FG000|Overall Study|Lost to Follow-up|0|||
94269789|NCT03677596|322782054|FG001|Overall Study|Lost to Follow-up|1|||
94269790|NCT03677596|322782053|FG000|Overall Study|Progressive Disease|8|||
94269791|NCT03677596|322782054|FG001|Overall Study|Progressive Disease|8|||
94269792|NCT03677596|322782053|FG000|Overall Study|Withdrawal by Subject|3|||
94711714|NCT02139943|324403007|FG000|Overall Study|Participant wishes to discontinue|2|||
94711715|NCT02139943|324403008|FG001|Overall Study|Participant wishes to discontinue|0|||
94711716|NCT02139943|324403009|FG002|Overall Study|Participant wishes to discontinue|0|||
94711717|NCT02139943|324403007|FG000|Overall Study|Participant in Poor Compliance|1|||
94711718|NCT02139943|324403008|FG001|Overall Study|Participant in Poor Compliance|0|||
94269793|NCT03677596|322782054|FG001|Overall Study|Withdrawal by Subject|0|||
94269794|NCT03677596|322782053|FG000|Overall Study|Disease Relapse|2|||
94269795|NCT03677596|322782054|FG001|Overall Study|Disease Relapse|2|||
94269796|NCT03677596|322782053|FG000|Overall Study|Other|0|||
94269797|NCT03677596|322782054|FG001|Overall Study|Other|1|||
94269798|NCT00806195|322782059|FG000|Overall Study|Death|6|||
94269799|NCT00806195|322782060|FG001|Overall Study|Death|0|||
94269800|NCT00806195|322782061|FG002|Overall Study|Death|1|||
94269801|NCT00806195|322782062|FG003|Overall Study|Death|0|||
94269802|NCT00806195|322782059|FG000|Overall Study|Adverse Event|25|||
94269803|NCT00806195|322782060|FG001|Overall Study|Adverse Event|5|||
94269804|NCT00806195|322782061|FG002|Overall Study|Adverse Event|11|||
94269805|NCT00806195|322782062|FG003|Overall Study|Adverse Event|2|||
94269806|NCT00806195|322782059|FG000|Overall Study|Withdrawal by Subject|119|||
94269807|NCT00806195|322782060|FG001|Overall Study|Withdrawal by Subject|31|||
94269808|NCT00806195|322782061|FG002|Overall Study|Withdrawal by Subject|76|||
94269809|NCT00806195|322782062|FG003|Overall Study|Withdrawal by Subject|35|||
94269810|NCT00806195|322782059|FG000|Overall Study|Lost to Follow-up|217|||
94269811|NCT00806195|322782060|FG001|Overall Study|Lost to Follow-up|66|||
94269812|NCT00806195|322782061|FG002|Overall Study|Lost to Follow-up|90|||
94269813|NCT00806195|322782062|FG003|Overall Study|Lost to Follow-up|34|||
94269814|NCT00806195|322782059|FG000|Overall Study|Inappropriate Enrollment|0|||
94269815|NCT00806195|322782060|FG001|Overall Study|Inappropriate Enrollment|1|||
94269816|NCT00806195|322782061|FG002|Overall Study|Inappropriate Enrollment|0|||
94269817|NCT00806195|322782062|FG003|Overall Study|Inappropriate Enrollment|0|||
94269818|NCT00806195|322782059|FG000|Overall Study|Administrative Reason|113|||
94269819|NCT00806195|322782060|FG001|Overall Study|Administrative Reason|35|||
94269820|NCT00806195|322782061|FG002|Overall Study|Administrative Reason|66|||
94711719|NCT02139943|324403009|FG002|Overall Study|Participant in Poor Compliance|1|||
94711720|NCT02139943|324403007|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
94711721|NCT02139943|324403008|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
94269821|NCT00806195|322782062|FG003|Overall Study|Administrative Reason|26|||
94269822|NCT00806195|322782059|FG000|Overall Study|Protocol Violation|34|||
94269823|NCT00806195|322782060|FG001|Overall Study|Protocol Violation|24|||
94269824|NCT00806195|322782061|FG002|Overall Study|Protocol Violation|26|||
94269825|NCT00806195|322782062|FG003|Overall Study|Protocol Violation|9|||
94269826|NCT01994382|322782063|FG000|Overall Study|Informed consent withdrawn|0|||
94269827|NCT01994382|322782064|FG001|Overall Study|Informed consent withdrawn|0|||
94269828|NCT01994382|322782065|FG002|Overall Study|Informed consent withdrawn|0|||
94269829|NCT01994382|322782066|FG003|Overall Study|Informed consent withdrawn|0|||
94269830|NCT01994382|322782067|FG004|Overall Study|Informed consent withdrawn|0|||
94269831|NCT01994382|322782068|FG005|Overall Study|Informed consent withdrawn|0|||
94269832|NCT01994382|322782069|FG006|Overall Study|Informed consent withdrawn|1|||
94711722|NCT02139943|324403009|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
94269833|NCT01994382|322782070|FG007|Overall Study|Informed consent withdrawn|0|||
94269834|NCT01994382|322782071|FG008|Overall Study|Informed consent withdrawn|0|||
94269835|NCT01994382|322782072|FG009|Overall Study|Informed consent withdrawn|0|||
94269836|NCT01994382|322782073|FG010|Overall Study|Informed consent withdrawn|0|||
94269837|NCT01994382|322782074|FG011|Overall Study|Informed consent withdrawn|0|||
94269838|NCT01994382|322782075|FG012|Overall Study|Informed consent withdrawn|0|||
94269839|NCT01994382|322782076|FG013|Overall Study|Informed consent withdrawn|0|||
94269840|NCT01994382|322782077|FG014|Overall Study|Informed consent withdrawn|0|||
94269841|NCT01994382|322782078|FG015|Overall Study|Informed consent withdrawn|0|||
94269842|NCT01994382|322782079|FG016|Overall Study|Informed consent withdrawn|0|||
94269843|NCT01994382|322782063|FG000|Overall Study|Progressive disease|3|||
94269844|NCT01994382|322782064|FG001|Overall Study|Progressive disease|4|||
94269845|NCT01994382|322782065|FG002|Overall Study|Progressive disease|4|||
94269846|NCT01994382|322782066|FG003|Overall Study|Progressive disease|3|||
94269847|NCT01994382|322782067|FG004|Overall Study|Progressive disease|2|||
94269848|NCT01994382|322782068|FG005|Overall Study|Progressive disease|3|||
94269849|NCT01994382|322782069|FG006|Overall Study|Progressive disease|3|||
94269850|NCT01994382|322782070|FG007|Overall Study|Progressive disease|6|||
94269851|NCT01994382|322782071|FG008|Overall Study|Progressive disease|2|||
94269852|NCT01994382|322782072|FG009|Overall Study|Progressive disease|2|||
94269853|NCT01994382|322782073|FG010|Overall Study|Progressive disease|13|||
94269854|NCT01994382|322782074|FG011|Overall Study|Progressive disease|8|||
94269855|NCT01994382|322782075|FG012|Overall Study|Progressive disease|7|||
94269856|NCT01994382|322782076|FG013|Overall Study|Progressive disease|3|||
94269857|NCT01994382|322782077|FG014|Overall Study|Progressive disease|6|||
94653043|NCT02391948|324188004|FG001|24-month Assessment|Lost to Follow-up|4|||
94269858|NCT01994382|322782078|FG015|Overall Study|Progressive disease|44|||
94269859|NCT01994382|322782079|FG016|Overall Study|Progressive disease|28|||
94466309|NCT01358578|323496954|FG003|Follow-up Period|non- compliance with study treatment|0|||
94653044|NCT02391948|324188005|FG002|24-month Assessment|Lost to Follow-up|0|||
94653045|NCT02391948|324188006|FG003|24-month Assessment|Lost to Follow-up|0|||
94269860|NCT01994382|322782063|FG000|Overall Study|Physician Decision|0|||
94269861|NCT01994382|322782064|FG001|Overall Study|Physician Decision|1|||
94269862|NCT01994382|322782065|FG002|Overall Study|Physician Decision|0|||
94269863|NCT01994382|322782066|FG003|Overall Study|Physician Decision|0|||
94269864|NCT01994382|322782067|FG004|Overall Study|Physician Decision|0|||
94269865|NCT01994382|322782068|FG005|Overall Study|Physician Decision|0|||
94269866|NCT01994382|322782069|FG006|Overall Study|Physician Decision|0|||
94269867|NCT01994382|322782070|FG007|Overall Study|Physician Decision|0|||
94269868|NCT01994382|322782071|FG008|Overall Study|Physician Decision|0|||
94269869|NCT01994382|322782072|FG009|Overall Study|Physician Decision|0|||
94269870|NCT01994382|322782073|FG010|Overall Study|Physician Decision|3|||
94269871|NCT01994382|322782074|FG011|Overall Study|Physician Decision|1|||
94269872|NCT01994382|322782075|FG012|Overall Study|Physician Decision|1|||
94269873|NCT01994382|322782076|FG013|Overall Study|Physician Decision|0|||
94269874|NCT01994382|322782077|FG014|Overall Study|Physician Decision|1|||
94269875|NCT01994382|322782078|FG015|Overall Study|Physician Decision|4|||
94269876|NCT01994382|322782079|FG016|Overall Study|Physician Decision|2|||
94269877|NCT01994382|322782063|FG000|Overall Study|Death|0|||
94269878|NCT01994382|322782064|FG001|Overall Study|Death|0|||
94269879|NCT01994382|322782065|FG002|Overall Study|Death|0|||
94466310|NCT01358578|323496955|FG004|Follow-up Period|non- compliance with study treatment|0|||
94653046|NCT02391948|324188007|FG004|24-month Assessment|Lost to Follow-up|0|||
94653047|NCT02391948|324188003|FG000|24-month Assessment|Medical issue/illness|0|||
94269880|NCT01994382|322782066|FG003|Overall Study|Death|0|||
94269881|NCT01994382|322782067|FG004|Overall Study|Death|1|||
94269882|NCT01994382|322782068|FG005|Overall Study|Death|0|||
94269883|NCT01994382|322782069|FG006|Overall Study|Death|0|||
94269884|NCT01994382|322782070|FG007|Overall Study|Death|0|||
94653048|NCT02391948|324188004|FG001|24-month Assessment|Medical issue/illness|0|||
94653049|NCT02391948|324188005|FG002|24-month Assessment|Medical issue/illness|1|||
94653050|NCT02391948|324188006|FG003|24-month Assessment|Medical issue/illness|0|||
94653051|NCT02391948|324188007|FG004|24-month Assessment|Medical issue/illness|0|||
94653052|NCT02391948|324188003|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
94653053|NCT02391948|324188004|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
94653054|NCT02391948|324188005|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
94653055|NCT02391948|324188006|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
94653056|NCT02391948|324188007|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
94653057|NCT00577122|324188008|FG000|Overall Study|Adverse Event|0|||
94653058|NCT00577122|324188009|FG001|Overall Study|Adverse Event|2|||
94653059|NCT00577122|324188008|FG000|Overall Study|Progression, relapse during active trt|6|||
94653060|NCT00577122|324188009|FG001|Overall Study|Progression, relapse during active trt|8|||
94653061|NCT00577122|324188008|FG000|Overall Study|Prog, refract disease during active trt|8|||
94653062|NCT00577122|324188009|FG001|Overall Study|Prog, refract disease during active trt|5|||
94653063|NCT00577122|324188008|FG000|Overall Study|Alternative Therapy|0|||
94653064|NCT00577122|324188009|FG001|Overall Study|Alternative Therapy|1|||
94653065|NCT02167035|324188010|FG000|Overall Study|Adverse Event|2|||
94653066|NCT02167035|324188011|FG001|Overall Study|Adverse Event|2|||
94653067|NCT02167035|324188010|FG000|Overall Study|Lost to Follow-up|3|||
94653068|NCT02167035|324188011|FG001|Overall Study|Lost to Follow-up|3|||
94653069|NCT02167035|324188010|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
94653070|NCT02167035|324188011|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
94653071|NCT01565993|324188012|FG000|Overall Study|Physician Decision|0|||
94653072|NCT01565993|324188013|FG001|Overall Study|Physician Decision|3|||
94653073|NCT02840877|324188014|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
94653074|NCT02840877|324188014|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
94653075|NCT02840877|324188014|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
94653076|NCT02840877|324188014|FG000|Baseline to 12 Weeks|Death|1|||
94653077|NCT02840877|324188014|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
94653078|NCT02840877|324188014|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
94653079|NCT02840877|324188014|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
94653080|NCT02840877|324188014|FG000|12 Weeks to 6 Months|Treatment failure|1|||
94653081|NCT02840877|324188014|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
94653082|NCT02840877|324188014|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
94653083|NCT02840877|324188014|FG000|12 Weeks to 6 Months|Death|1|||
94653084|NCT02840877|324188014|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
94653085|NCT02840877|324188014|FG000|6 Months to 18 Months|Treatment failure|7|||
94653086|NCT02840877|324188014|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
94653087|NCT02840877|324188014|FG000|6 Months to 18 Months|Moved/transferred out|6|||
94653088|NCT02840877|324188014|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
94653089|NCT02840877|324188014|FG000|6 Months to 18 Months|Death|4|||
94653090|NCT02840877|324188014|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
94269885|NCT01994382|322782071|FG008|Overall Study|Death|1|||
94269886|NCT01994382|322782072|FG009|Overall Study|Death|1|||
94269887|NCT01994382|322782073|FG010|Overall Study|Death|0|||
94269888|NCT01994382|322782074|FG011|Overall Study|Death|0|||
94269889|NCT01994382|322782075|FG012|Overall Study|Death|0|||
94269890|NCT01994382|322782076|FG013|Overall Study|Death|0|||
94269891|NCT01994382|322782077|FG014|Overall Study|Death|0|||
94269892|NCT01994382|322782078|FG015|Overall Study|Death|1|||
94269893|NCT01994382|322782079|FG016|Overall Study|Death|0|||
94269894|NCT01994382|322782063|FG000|Overall Study|Adverse Event|0|||
94269895|NCT01994382|322782064|FG001|Overall Study|Adverse Event|1|||
94269896|NCT01994382|322782065|FG002|Overall Study|Adverse Event|2|||
94269897|NCT01994382|322782066|FG003|Overall Study|Adverse Event|0|||
94269898|NCT01994382|322782067|FG004|Overall Study|Adverse Event|0|||
94269899|NCT01994382|322782068|FG005|Overall Study|Adverse Event|0|||
94269900|NCT01994382|322782069|FG006|Overall Study|Adverse Event|0|||
94269901|NCT01994382|322782070|FG007|Overall Study|Adverse Event|0|||
94269902|NCT01994382|322782071|FG008|Overall Study|Adverse Event|0|||
94269903|NCT01994382|322782072|FG009|Overall Study|Adverse Event|0|||
94269904|NCT01994382|322782073|FG010|Overall Study|Adverse Event|15|||
94269905|NCT01994382|322782074|FG011|Overall Study|Adverse Event|2|||
94269906|NCT01994382|322782075|FG012|Overall Study|Adverse Event|7|||
94269907|NCT01994382|322782076|FG013|Overall Study|Adverse Event|3|||
94269908|NCT01994382|322782077|FG014|Overall Study|Adverse Event|17|||
94711723|NCT01041417|324403012|FG000|Overall Study|Adverse Event|5|||
94711724|NCT01041417|324403013|FG001|Overall Study|Adverse Event|2|||
94711725|NCT01041417|324403012|FG000|Overall Study|Lost to Follow-up|1|||
94711726|NCT01041417|324403013|FG001|Overall Study|Lost to Follow-up|1|||
94711727|NCT01041417|324403012|FG000|Overall Study|Death|1|||
94711728|NCT01041417|324403013|FG001|Overall Study|Death|0|||
94711729|NCT02299375|324403014|FG000|Overall Study|Adverse Event, serious fatal|1|||
94711730|NCT02299375|324403015|FG001|Overall Study|Adverse Event, serious fatal|3|||
94711731|NCT02299375|324403014|FG000|Overall Study|Adverse Event, non-fatal|8|||
94269909|NCT01994382|322782078|FG015|Overall Study|Adverse Event|6|||
94711732|NCT02299375|324403015|FG001|Overall Study|Adverse Event, non-fatal|9|||
94711733|NCT02299375|324403014|FG000|Overall Study|Lack of Efficacy|1|||
94269910|NCT01994382|322782079|FG016|Overall Study|Adverse Event|3|||
94269911|NCT01994382|322782063|FG000|Overall Study|Other than specified|0|||
94269912|NCT01994382|322782064|FG001|Overall Study|Other than specified|0|||
94269913|NCT01994382|322782065|FG002|Overall Study|Other than specified|0|||
94269914|NCT01994382|322782066|FG003|Overall Study|Other than specified|0|||
94269915|NCT01994382|322782067|FG004|Overall Study|Other than specified|0|||
94269916|NCT01994382|322782068|FG005|Overall Study|Other than specified|0|||
94269917|NCT01994382|322782069|FG006|Overall Study|Other than specified|0|||
94269918|NCT01994382|322782070|FG007|Overall Study|Other than specified|0|||
94269919|NCT01994382|322782071|FG008|Overall Study|Other than specified|0|||
94366941|NCT04071366|323129534|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
94366942|NCT04071366|323129535|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
94711734|NCT02299375|324403015|FG001|Overall Study|Lack of Efficacy|3|||
94711735|NCT02299375|324403014|FG000|Overall Study|Protocol Violation|1|||
94711736|NCT02299375|324403015|FG001|Overall Study|Protocol Violation|3|||
94711737|NCT02299375|324403014|FG000|Overall Study|Other: Met stopping criteria|1|||
94366943|NCT04071366|323129536|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
94711738|NCT02299375|324403015|FG001|Overall Study|Other: Met stopping criteria|0|||
94711739|NCT02299375|324403014|FG000|Overall Study|Other: Study closed/terminated|66|||
94711740|NCT02299375|324403015|FG001|Overall Study|Other: Study closed/terminated|55|||
94711741|NCT02299375|324403014|FG000|Overall Study|Lost to Follow-up|0|||
94711742|NCT02299375|324403015|FG001|Overall Study|Lost to Follow-up|2|||
94269920|NCT01994382|322782072|FG009|Overall Study|Other than specified|0|||
94269921|NCT01994382|322782073|FG010|Overall Study|Other than specified|2|||
94269922|NCT01994382|322782074|FG011|Overall Study|Other than specified|0|||
94711743|NCT02299375|324403014|FG000|Overall Study|Physician Decision|1|||
94711744|NCT02299375|324403015|FG001|Overall Study|Physician Decision|1|||
94711745|NCT02299375|324403014|FG000|Overall Study|Withdrawal by Subject|1|||
94711746|NCT02299375|324403015|FG001|Overall Study|Withdrawal by Subject|4|||
94269923|NCT01994382|322782075|FG012|Overall Study|Other than specified|2|||
94711747|NCT00704184|324403017|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
94711748|NCT00704184|324403018|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
94711749|NCT00704184|324403019|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
94711750|NCT00704184|324403020|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
94711751|NCT00704184|324403021|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
94711752|NCT00704184|324403017|FG000|Open-Label Treatment|Adverse Event|0|||
94711753|NCT00704184|324403018|FG001|Open-Label Treatment|Adverse Event|0|||
94711754|NCT00704184|324403019|FG002|Open-Label Treatment|Adverse Event|2|||
94711755|NCT00704184|324403020|FG003|Open-Label Treatment|Adverse Event|0|||
94711756|NCT00704184|324403021|FG004|Open-Label Treatment|Adverse Event|1|||
94711757|NCT00704184|324403017|FG000|Open-Label Treatment|Lack of Efficacy|0|||
94711758|NCT00704184|324403018|FG001|Open-Label Treatment|Lack of Efficacy|2|||
94711759|NCT00704184|324403019|FG002|Open-Label Treatment|Lack of Efficacy|2|||
94711760|NCT00704184|324403020|FG003|Open-Label Treatment|Lack of Efficacy|2|||
94711761|NCT00704184|324403021|FG004|Open-Label Treatment|Lack of Efficacy|1|||
94711762|NCT00704184|324403017|FG000|Open-Label Treatment|Physician Decision|0|||
94711763|NCT00704184|324403018|FG001|Open-Label Treatment|Physician Decision|0|||
94711764|NCT00704184|324403019|FG002|Open-Label Treatment|Physician Decision|0|||
94711765|NCT00704184|324403020|FG003|Open-Label Treatment|Physician Decision|0|||
94711766|NCT00704184|324403021|FG004|Open-Label Treatment|Physician Decision|1|||
94711767|NCT00704184|324403017|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
94711768|NCT00704184|324403018|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
94711769|NCT00704184|324403019|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
94711770|NCT00704184|324403020|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
94711771|NCT00704184|324403021|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
94711772|NCT01764464|324403024|FG000|First Intervention|Withdrawal by Subject|1|||
94711773|NCT01764464|324403025|FG001|First Intervention|Withdrawal by Subject|0|||
94711774|NCT01764464|324403024|FG000|First Intervention|Lost to Follow-up|1|||
94711775|NCT01764464|324403025|FG001|First Intervention|Lost to Follow-up|0|||
94711776|NCT01764464|324403024|FG000|First Intervention|Adverse Event|0|||
94711777|NCT01764464|324403025|FG001|First Intervention|Adverse Event|2|||
94711778|NCT01764464|324403024|FG000|First Intervention|did not receive study drug|0|||
94711779|NCT01764464|324403025|FG001|First Intervention|did not receive study drug|1|||
94711780|NCT01764464|324403024|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
94711781|NCT01764464|324403025|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
94711782|NCT01803555|324403026|FG000|Overall Study|Adverse Event|3|||
94711783|NCT01803555|324403027|FG001|Overall Study|Adverse Event|2|||
94711784|NCT01803555|324403026|FG000|Overall Study|Withdrawal by Subject|3|||
94711785|NCT01803555|324403027|FG001|Overall Study|Withdrawal by Subject|3|||
94711786|NCT01803555|324403026|FG000|Overall Study|Non-compliance|1|||
94711787|NCT01803555|324403027|FG001|Overall Study|Non-compliance|1|||
94711788|NCT01803555|324403026|FG000|Overall Study|Protocol Violation|3|||
94711789|NCT01803555|324403027|FG001|Overall Study|Protocol Violation|5|||
94711790|NCT01803555|324403026|FG000|Overall Study|Lost to Follow-up|0|||
94711791|NCT01803555|324403027|FG001|Overall Study|Lost to Follow-up|2|||
94711792|NCT01803555|324403026|FG000|Overall Study|Other than specified|3|||
94711793|NCT01803555|324403027|FG001|Overall Study|Other than specified|5|||
94711794|NCT01551355|324403030|FG000|Overall Study|Lost to Follow-up|51|||
94711795|NCT01551355|324403031|FG001|Overall Study|Lost to Follow-up|49|||
94711796|NCT01551355|324403032|FG002|Overall Study|Lost to Follow-up|34|||
94711797|NCT01551355|324403033|FG003|Overall Study|Lost to Follow-up|24|||
94711798|NCT01551355|324403034|FG004|Overall Study|Lost to Follow-up|9|||
94711799|NCT01551355|324403035|FG005|Overall Study|Lost to Follow-up|6|||
94711800|NCT02918071|324403036|FG000|Overall Study|Withdrawal by Subject|2|||
94711801|NCT02918071|324403036|FG000|Overall Study|Lost to Follow-up|1|||
94711802|NCT02595879|324404011|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
94711803|NCT02595879|324404012|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
94711804|NCT03762668|324404013|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
94711805|NCT03762668|324404014|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
94711806|NCT04425629|324404015|FG000|Overall Study|Adverse Event|0|||
94711807|NCT04425629|324404016|FG001|Overall Study|Adverse Event|0|||
94711808|NCT04425629|324404017|FG002|Overall Study|Adverse Event|0|||
94711809|NCT04425629|324404018|FG003|Overall Study|Adverse Event|0|||
94711810|NCT04425629|324404019|FG004|Overall Study|Adverse Event|1|||
94711811|NCT04425629|324404020|FG005|Overall Study|Adverse Event|0|||
94711812|NCT04425629|324404021|FG006|Overall Study|Adverse Event|0|||
94711813|NCT04425629|324404022|FG007|Overall Study|Adverse Event|0|||
94711814|NCT04425629|324404023|FG008|Overall Study|Adverse Event|0|||
94711815|NCT04425629|324404024|FG009|Overall Study|Adverse Event|3|||
94711816|NCT04425629|324404025|FG010|Overall Study|Adverse Event|2|||
94711817|NCT04425629|324404026|FG011|Overall Study|Adverse Event|1|||
94711818|NCT04425629|324404027|FG012|Overall Study|Adverse Event|1|||
94711819|NCT04425629|324404028|FG013|Overall Study|Adverse Event|0|||
94711820|NCT04425629|324404029|FG014|Overall Study|Adverse Event|0|||
94711821|NCT04425629|324404030|FG015|Overall Study|Adverse Event|0|||
94711822|NCT04425629|324404031|FG016|Overall Study|Adverse Event|0|||
94269924|NCT01994382|322782076|FG013|Overall Study|Other than specified|0|||
94269925|NCT01994382|322782077|FG014|Overall Study|Other than specified|0|||
94269926|NCT01994382|322782078|FG015|Overall Study|Other than specified|4|||
94269927|NCT01994382|322782079|FG016|Overall Study|Other than specified|4|||
94269928|NCT01994382|322782063|FG000|Overall Study|Withdrawal by Subject|0|||
94269929|NCT01994382|322782064|FG001|Overall Study|Withdrawal by Subject|0|||
94269930|NCT01994382|322782065|FG002|Overall Study|Withdrawal by Subject|0|||
94269931|NCT01994382|322782066|FG003|Overall Study|Withdrawal by Subject|0|||
94269932|NCT01994382|322782067|FG004|Overall Study|Withdrawal by Subject|0|||
94269933|NCT01994382|322782068|FG005|Overall Study|Withdrawal by Subject|0|||
94269934|NCT01994382|322782069|FG006|Overall Study|Withdrawal by Subject|0|||
94269935|NCT01994382|322782070|FG007|Overall Study|Withdrawal by Subject|0|||
94269936|NCT01994382|322782071|FG008|Overall Study|Withdrawal by Subject|0|||
94269937|NCT01994382|322782072|FG009|Overall Study|Withdrawal by Subject|0|||
94269938|NCT01994382|322782073|FG010|Overall Study|Withdrawal by Subject|6|||
94269939|NCT01994382|322782074|FG011|Overall Study|Withdrawal by Subject|0|||
94269940|NCT01994382|322782075|FG012|Overall Study|Withdrawal by Subject|2|||
94269941|NCT01994382|322782076|FG013|Overall Study|Withdrawal by Subject|0|||
94269942|NCT01994382|322782077|FG014|Overall Study|Withdrawal by Subject|4|||
94269943|NCT01994382|322782078|FG015|Overall Study|Withdrawal by Subject|3|||
94269944|NCT01994382|322782079|FG016|Overall Study|Withdrawal by Subject|0|||
94269945|NCT01994382|322782063|FG000|Overall Study|Lost to Follow-up|0|||
94269946|NCT01994382|322782064|FG001|Overall Study|Lost to Follow-up|0|||
94269947|NCT01994382|322782065|FG002|Overall Study|Lost to Follow-up|0|||
94269948|NCT01994382|322782066|FG003|Overall Study|Lost to Follow-up|0|||
94269949|NCT01994382|322782067|FG004|Overall Study|Lost to Follow-up|0|||
94269950|NCT01994382|322782068|FG005|Overall Study|Lost to Follow-up|0|||
94269951|NCT01994382|322782069|FG006|Overall Study|Lost to Follow-up|0|||
94269952|NCT01994382|322782070|FG007|Overall Study|Lost to Follow-up|0|||
94269953|NCT01994382|322782071|FG008|Overall Study|Lost to Follow-up|0|||
94269954|NCT01994382|322782072|FG009|Overall Study|Lost to Follow-up|0|||
94269955|NCT01994382|322782073|FG010|Overall Study|Lost to Follow-up|1|||
94269956|NCT01994382|322782074|FG011|Overall Study|Lost to Follow-up|0|||
94269957|NCT01994382|322782075|FG012|Overall Study|Lost to Follow-up|0|||
94269958|NCT01994382|322782076|FG013|Overall Study|Lost to Follow-up|0|||
94269959|NCT01994382|322782077|FG014|Overall Study|Lost to Follow-up|0|||
94269960|NCT01994382|322782078|FG015|Overall Study|Lost to Follow-up|0|||
94269961|NCT01994382|322782079|FG016|Overall Study|Lost to Follow-up|0|||
94269962|NCT01994382|322782063|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
94269963|NCT01994382|322782064|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
94269964|NCT01994382|322782065|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
94269965|NCT01994382|322782066|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
94269966|NCT01994382|322782067|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
94269967|NCT01994382|322782068|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
94269968|NCT01994382|322782069|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
94269969|NCT01994382|322782070|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
94269970|NCT01994382|322782071|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
94269971|NCT01994382|322782072|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
94269972|NCT01994382|322782073|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
94269973|NCT01994382|322782074|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
94269974|NCT01994382|322782075|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
94269975|NCT01994382|322782076|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
94269976|NCT01994382|322782077|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
94269977|NCT01994382|322782078|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
94269978|NCT01994382|322782079|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
94269979|NCT01994382|322782063|FG000|Overall Study|Protocol violation/noncompliance|0|||
94269980|NCT01994382|322782064|FG001|Overall Study|Protocol violation/noncompliance|0|||
94269981|NCT01994382|322782065|FG002|Overall Study|Protocol violation/noncompliance|0|||
94269982|NCT01994382|322782066|FG003|Overall Study|Protocol violation/noncompliance|0|||
94269983|NCT01994382|322782067|FG004|Overall Study|Protocol violation/noncompliance|0|||
94269984|NCT01994382|322782068|FG005|Overall Study|Protocol violation/noncompliance|0|||
94269985|NCT01994382|322782069|FG006|Overall Study|Protocol violation/noncompliance|0|||
94269986|NCT01994382|322782070|FG007|Overall Study|Protocol violation/noncompliance|0|||
94269987|NCT01994382|322782071|FG008|Overall Study|Protocol violation/noncompliance|0|||
94269988|NCT01994382|322782072|FG009|Overall Study|Protocol violation/noncompliance|0|||
94269989|NCT01994382|322782073|FG010|Overall Study|Protocol violation/noncompliance|0|||
94269990|NCT01994382|322782074|FG011|Overall Study|Protocol violation/noncompliance|1|||
94269991|NCT01994382|322782075|FG012|Overall Study|Protocol violation/noncompliance|0|||
94711823|NCT04425629|324404032|FG017|Overall Study|Adverse Event|0|||
94711824|NCT04425629|324404033|FG018|Overall Study|Adverse Event|0|||
94711825|NCT04425629|324404015|FG000|Overall Study|Lost to Follow-up|1|||
94711826|NCT04425629|324404016|FG001|Overall Study|Lost to Follow-up|3|||
94711827|NCT04425629|324404017|FG002|Overall Study|Lost to Follow-up|1|||
94711828|NCT04425629|324404018|FG003|Overall Study|Lost to Follow-up|7|||
94711829|NCT04425629|324404019|FG004|Overall Study|Lost to Follow-up|1|||
94711830|NCT04425629|324404020|FG005|Overall Study|Lost to Follow-up|2|||
94711831|NCT04425629|324404021|FG006|Overall Study|Lost to Follow-up|1|||
94711832|NCT04425629|324404022|FG007|Overall Study|Lost to Follow-up|0|||
94711833|NCT04425629|324404023|FG008|Overall Study|Lost to Follow-up|1|||
94711834|NCT04425629|324404024|FG009|Overall Study|Lost to Follow-up|64|||
94711835|NCT04425629|324404025|FG010|Overall Study|Lost to Follow-up|70|||
94711836|NCT04425629|324404026|FG011|Overall Study|Lost to Follow-up|98|||
94711837|NCT04425629|324404027|FG012|Overall Study|Lost to Follow-up|30|||
94711838|NCT04425629|324404028|FG013|Overall Study|Lost to Follow-up|0|||
94711839|NCT04425629|324404029|FG014|Overall Study|Lost to Follow-up|5|||
94711840|NCT04425629|324404030|FG015|Overall Study|Lost to Follow-up|4|||
94711841|NCT04425629|324404031|FG016|Overall Study|Lost to Follow-up|0|||
94711842|NCT04425629|324404032|FG017|Overall Study|Lost to Follow-up|3|||
94711843|NCT04425629|324404033|FG018|Overall Study|Lost to Follow-up|1|||
94711844|NCT04425629|324404015|FG000|Overall Study|Subject Decision|0|||
94711845|NCT04425629|324404016|FG001|Overall Study|Subject Decision|2|||
94711846|NCT04425629|324404017|FG002|Overall Study|Subject Decision|1|||
94711847|NCT04425629|324404018|FG003|Overall Study|Subject Decision|3|||
94711848|NCT04425629|324404019|FG004|Overall Study|Subject Decision|6|||
94711849|NCT04425629|324404020|FG005|Overall Study|Subject Decision|6|||
94711850|NCT04425629|324404021|FG006|Overall Study|Subject Decision|3|||
94711851|NCT04425629|324404022|FG007|Overall Study|Subject Decision|3|||
94711852|NCT04425629|324404023|FG008|Overall Study|Subject Decision|1|||
94711853|NCT04425629|324404024|FG009|Overall Study|Subject Decision|70|||
94711854|NCT04425629|324404025|FG010|Overall Study|Subject Decision|95|||
94711855|NCT04425629|324404026|FG011|Overall Study|Subject Decision|124|||
94711856|NCT04425629|324404027|FG012|Overall Study|Subject Decision|25|||
94711857|NCT04425629|324404028|FG013|Overall Study|Subject Decision|0|||
94711858|NCT04425629|324404029|FG014|Overall Study|Subject Decision|1|||
94711859|NCT04425629|324404030|FG015|Overall Study|Subject Decision|4|||
94711860|NCT04425629|324404031|FG016|Overall Study|Subject Decision|1|||
94711861|NCT04425629|324404032|FG017|Overall Study|Subject Decision|0|||
94711862|NCT04425629|324404033|FG018|Overall Study|Subject Decision|2|||
94711863|NCT04425629|324404015|FG000|Overall Study|Death|0|||
94711864|NCT04425629|324404016|FG001|Overall Study|Death|0|||
94711865|NCT04425629|324404017|FG002|Overall Study|Death|0|||
94711866|NCT04425629|324404018|FG003|Overall Study|Death|0|||
94711867|NCT04425629|324404019|FG004|Overall Study|Death|0|||
94711868|NCT04425629|324404020|FG005|Overall Study|Death|0|||
94711869|NCT04425629|324404021|FG006|Overall Study|Death|0|||
94711870|NCT04425629|324404022|FG007|Overall Study|Death|0|||
94711871|NCT04425629|324404023|FG008|Overall Study|Death|0|||
94711872|NCT04425629|324404024|FG009|Overall Study|Death|11|||
94711873|NCT04425629|324404025|FG010|Overall Study|Death|2|||
94711874|NCT04425629|324404026|FG011|Overall Study|Death|4|||
94711875|NCT04425629|324404027|FG012|Overall Study|Death|0|||
94711876|NCT04425629|324404028|FG013|Overall Study|Death|0|||
94711877|NCT04425629|324404029|FG014|Overall Study|Death|0|||
94711878|NCT04425629|324404030|FG015|Overall Study|Death|0|||
94711879|NCT04425629|324404031|FG016|Overall Study|Death|0|||
94711880|NCT04425629|324404032|FG017|Overall Study|Death|0|||
94711881|NCT04425629|324404033|FG018|Overall Study|Death|0|||
94711882|NCT04425629|324404015|FG000|Overall Study|Sponsor Request|0|||
94711883|NCT04425629|324404016|FG001|Overall Study|Sponsor Request|0|||
94711884|NCT04425629|324404017|FG002|Overall Study|Sponsor Request|0|||
94711885|NCT04425629|324404018|FG003|Overall Study|Sponsor Request|2|||
94711886|NCT04425629|324404019|FG004|Overall Study|Sponsor Request|2|||
94711887|NCT04425629|324404020|FG005|Overall Study|Sponsor Request|2|||
94711888|NCT04425629|324404021|FG006|Overall Study|Sponsor Request|1|||
94711889|NCT04425629|324404022|FG007|Overall Study|Sponsor Request|0|||
94711890|NCT04425629|324404023|FG008|Overall Study|Sponsor Request|0|||
94711891|NCT04425629|324404024|FG009|Overall Study|Sponsor Request|9|||
94711892|NCT04425629|324404025|FG010|Overall Study|Sponsor Request|9|||
94711893|NCT04425629|324404026|FG011|Overall Study|Sponsor Request|10|||
94711894|NCT04425629|324404027|FG012|Overall Study|Sponsor Request|8|||
94711895|NCT04425629|324404028|FG013|Overall Study|Sponsor Request|0|||
94711896|NCT04425629|324404029|FG014|Overall Study|Sponsor Request|0|||
94711897|NCT04425629|324404030|FG015|Overall Study|Sponsor Request|1|||
94711898|NCT04425629|324404031|FG016|Overall Study|Sponsor Request|0|||
94466311|NCT01358578|323496956|FG005|Follow-up Period|non- compliance with study treatment|0|||
94711899|NCT04425629|324404032|FG017|Overall Study|Sponsor Request|0|||
94711900|NCT04425629|324404033|FG018|Overall Study|Sponsor Request|0|||
94711901|NCT04425629|324404015|FG000|Overall Study|Physician Decision|0|||
94466312|NCT01358578|323496951|FG000|Follow-up Period|Pregnancy|1|||
94466313|NCT01358578|323496952|FG001|Follow-up Period|Pregnancy|0|||
94466314|NCT01358578|323496953|FG002|Follow-up Period|Pregnancy|0|||
94466315|NCT01358578|323496954|FG003|Follow-up Period|Pregnancy|0|||
94466316|NCT01358578|323496955|FG004|Follow-up Period|Pregnancy|0|||
94466317|NCT01358578|323496956|FG005|Follow-up Period|Pregnancy|0|||
94466318|NCT01358578|323496951|FG000|Follow-up Period|Withdrawal by Subject|3|||
94466319|NCT01358578|323496952|FG001|Follow-up Period|Withdrawal by Subject|3|||
94466320|NCT01358578|323496953|FG002|Follow-up Period|Withdrawal by Subject|1|||
94466321|NCT01358578|323496954|FG003|Follow-up Period|Withdrawal by Subject|12|||
94466322|NCT01358578|323496955|FG004|Follow-up Period|Withdrawal by Subject|0|||
94466323|NCT01358578|323496956|FG005|Follow-up Period|Withdrawal by Subject|0|||
94466324|NCT01358578|323496951|FG000|Follow-up Period|Physician Decision|1|||
94466325|NCT01358578|323496952|FG001|Follow-up Period|Physician Decision|1|||
94466326|NCT01358578|323496953|FG002|Follow-up Period|Physician Decision|0|||
94466327|NCT01358578|323496954|FG003|Follow-up Period|Physician Decision|2|||
94466328|NCT01358578|323496955|FG004|Follow-up Period|Physician Decision|0|||
94466329|NCT01358578|323496956|FG005|Follow-up Period|Physician Decision|0|||
94466330|NCT03605849|323496959|FG000|Overall Study|Adverse Event|20|||
94466331|NCT03605849|323496960|FG001|Overall Study|Adverse Event|21|||
94466332|NCT03605849|323496961|FG002|Overall Study|Adverse Event|29|||
94466333|NCT03605849|323496962|FG003|Overall Study|Adverse Event|11|||
94466334|NCT03605849|323496959|FG000|Overall Study|Lack of Efficacy|4|||
94466335|NCT03605849|323496960|FG001|Overall Study|Lack of Efficacy|7|||
94466336|NCT03605849|323496961|FG002|Overall Study|Lack of Efficacy|9|||
94466337|NCT03605849|323496962|FG003|Overall Study|Lack of Efficacy|2|||
94711902|NCT04425629|324404016|FG001|Overall Study|Physician Decision|0|||
94711903|NCT04425629|324404017|FG002|Overall Study|Physician Decision|0|||
94711904|NCT04425629|324404018|FG003|Overall Study|Physician Decision|0|||
94711905|NCT04425629|324404019|FG004|Overall Study|Physician Decision|0|||
94711906|NCT04425629|324404020|FG005|Overall Study|Physician Decision|0|||
94711907|NCT04425629|324404021|FG006|Overall Study|Physician Decision|0|||
94711908|NCT04425629|324404022|FG007|Overall Study|Physician Decision|0|||
94711909|NCT04425629|324404023|FG008|Overall Study|Physician Decision|0|||
94711910|NCT04425629|324404024|FG009|Overall Study|Physician Decision|4|||
94711911|NCT04425629|324404025|FG010|Overall Study|Physician Decision|3|||
94711912|NCT04425629|324404026|FG011|Overall Study|Physician Decision|5|||
94711913|NCT04425629|324404027|FG012|Overall Study|Physician Decision|1|||
94711914|NCT04425629|324404028|FG013|Overall Study|Physician Decision|0|||
94711915|NCT04425629|324404029|FG014|Overall Study|Physician Decision|0|||
94711916|NCT04425629|324404030|FG015|Overall Study|Physician Decision|1|||
94711917|NCT04425629|324404031|FG016|Overall Study|Physician Decision|0|||
94711918|NCT04425629|324404032|FG017|Overall Study|Physician Decision|0|||
94711919|NCT04425629|324404033|FG018|Overall Study|Physician Decision|0|||
94711920|NCT04425629|324404015|FG000|Overall Study|Lack of Efficacy|0|||
94711921|NCT04425629|324404016|FG001|Overall Study|Lack of Efficacy|0|||
94711922|NCT04425629|324404017|FG002|Overall Study|Lack of Efficacy|0|||
94269992|NCT01994382|322782076|FG013|Overall Study|Protocol violation/noncompliance|0|||
94466338|NCT03605849|323496959|FG000|Overall Study|Lost to Follow-up|8|||
94466339|NCT03605849|323496960|FG001|Overall Study|Lost to Follow-up|8|||
94466340|NCT03605849|323496961|FG002|Overall Study|Lost to Follow-up|14|||
94466341|NCT03605849|323496962|FG003|Overall Study|Lost to Follow-up|11|||
94711923|NCT04425629|324404018|FG003|Overall Study|Lack of Efficacy|0|||
94711924|NCT04425629|324404019|FG004|Overall Study|Lack of Efficacy|0|||
94711925|NCT04425629|324404020|FG005|Overall Study|Lack of Efficacy|0|||
94711926|NCT04425629|324404021|FG006|Overall Study|Lack of Efficacy|0|||
94711927|NCT04425629|324404022|FG007|Overall Study|Lack of Efficacy|0|||
94269993|NCT01994382|322782077|FG014|Overall Study|Protocol violation/noncompliance|0|||
94269994|NCT01994382|322782078|FG015|Overall Study|Protocol violation/noncompliance|0|||
94269995|NCT01994382|322782079|FG016|Overall Study|Protocol violation/noncompliance|2|||
94269996|NCT01994382|322782063|FG000|Overall Study|Rolled over to Phase 2a|0|||
94269997|NCT01994382|322782064|FG001|Overall Study|Rolled over to Phase 2a|0|||
94269998|NCT01994382|322782065|FG002|Overall Study|Rolled over to Phase 2a|1|||
94269999|NCT01994382|322782066|FG003|Overall Study|Rolled over to Phase 2a|0|||
94270000|NCT01994382|322782067|FG004|Overall Study|Rolled over to Phase 2a|0|||
94270001|NCT01994382|322782068|FG005|Overall Study|Rolled over to Phase 2a|0|||
94270002|NCT01994382|322782069|FG006|Overall Study|Rolled over to Phase 2a|0|||
94270003|NCT01994382|322782070|FG007|Overall Study|Rolled over to Phase 2a|0|||
94270004|NCT01994382|322782071|FG008|Overall Study|Rolled over to Phase 2a|0|||
94270005|NCT01994382|322782072|FG009|Overall Study|Rolled over to Phase 2a|2|||
94270006|NCT01994382|322782073|FG010|Overall Study|Rolled over to Phase 2a|0|||
94270007|NCT01994382|322782074|FG011|Overall Study|Rolled over to Phase 2a|0|||
94270008|NCT01994382|322782075|FG012|Overall Study|Rolled over to Phase 2a|0|||
94270009|NCT01994382|322782076|FG013|Overall Study|Rolled over to Phase 2a|0|||
94270010|NCT01994382|322782077|FG014|Overall Study|Rolled over to Phase 2a|0|||
94270011|NCT01994382|322782078|FG015|Overall Study|Rolled over to Phase 2a|0|||
94270012|NCT01994382|322782079|FG016|Overall Study|Rolled over to Phase 2a|0|||
94270013|NCT04667377|322782080|FG000|Dose Escalation Period|Other not specified below|3|||
94466342|NCT03605849|323496959|FG000|Overall Study|Non-compliance With IMP|6|||
94466343|NCT03605849|323496960|FG001|Overall Study|Non-compliance With IMP|5|||
94466344|NCT03605849|323496961|FG002|Overall Study|Non-compliance With IMP|2|||
94466345|NCT03605849|323496962|FG003|Overall Study|Non-compliance With IMP|1|||
94466346|NCT03605849|323496959|FG000|Overall Study|Protocol Deviation|1|||
94466347|NCT03605849|323496960|FG001|Overall Study|Protocol Deviation|2|||
94466348|NCT03605849|323496961|FG002|Overall Study|Protocol Deviation|1|||
94711928|NCT04425629|324404023|FG008|Overall Study|Lack of Efficacy|0|||
94711929|NCT04425629|324404024|FG009|Overall Study|Lack of Efficacy|0|||
94711930|NCT04425629|324404025|FG010|Overall Study|Lack of Efficacy|1|||
94711931|NCT04425629|324404026|FG011|Overall Study|Lack of Efficacy|0|||
94466349|NCT03605849|323496962|FG003|Overall Study|Protocol Deviation|3|||
94466350|NCT03605849|323496959|FG000|Overall Study|Withdrawal by Subject|33|||
94466351|NCT03605849|323496960|FG001|Overall Study|Withdrawal by Subject|28|||
94466352|NCT03605849|323496961|FG002|Overall Study|Withdrawal by Subject|30|||
94466353|NCT03605849|323496962|FG003|Overall Study|Withdrawal by Subject|28|||
94466354|NCT03605849|323496959|FG000|Overall Study|Site Terminated by Sponsor|0|||
94466355|NCT03605849|323496960|FG001|Overall Study|Site Terminated by Sponsor|0|||
94466356|NCT03605849|323496961|FG002|Overall Study|Site Terminated by Sponsor|0|||
94466357|NCT03605849|323496962|FG003|Overall Study|Site Terminated by Sponsor|1|||
94466358|NCT03605849|323496959|FG000|Overall Study|Physician Decision|2|||
94466359|NCT03605849|323496960|FG001|Overall Study|Physician Decision|1|||
94466360|NCT03605849|323496961|FG002|Overall Study|Physician Decision|2|||
94711932|NCT04425629|324404027|FG012|Overall Study|Lack of Efficacy|0|||
94466361|NCT03605849|323496962|FG003|Overall Study|Physician Decision|1|||
94711933|NCT04425629|324404028|FG013|Overall Study|Lack of Efficacy|0|||
94711934|NCT04425629|324404029|FG014|Overall Study|Lack of Efficacy|0|||
94711935|NCT04425629|324404030|FG015|Overall Study|Lack of Efficacy|0|||
94711936|NCT04425629|324404031|FG016|Overall Study|Lack of Efficacy|0|||
94711937|NCT04425629|324404032|FG017|Overall Study|Lack of Efficacy|0|||
94270014|NCT04667377|322782081|FG001|Dose Escalation Period|Other not specified below|3|||
94270015|NCT04667377|322782082|FG002|Dose Escalation Period|Other not specified below|2|||
94270016|NCT04667377|322782083|FG003|Dose Escalation Period|Other not specified below|1|||
94366944|NCT04071366|323129537|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
94366945|NCT04071366|323129538|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
94366946|NCT04318535|323129539|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
94366947|NCT04318535|323129540|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
94366948|NCT04318535|323129541|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
94366949|NCT01678924|323129542|FG000|Overall Study|Adverse Event|1|||
94366950|NCT01678924|323129543|FG001|Overall Study|Adverse Event|1|||
94366951|NCT01678924|323129544|FG002|Overall Study|Adverse Event|0|||
94366952|NCT01678924|323129545|FG003|Overall Study|Adverse Event|1|||
94366953|NCT01678924|323129542|FG000|Overall Study|Lack of Efficacy|7|||
94366954|NCT01678924|323129543|FG001|Overall Study|Lack of Efficacy|2|||
94366955|NCT01678924|323129544|FG002|Overall Study|Lack of Efficacy|0|||
94366956|NCT01678924|323129545|FG003|Overall Study|Lack of Efficacy|5|||
94366957|NCT01678924|323129542|FG000|Overall Study|Lost to Follow-up|0|||
94366958|NCT01678924|323129543|FG001|Overall Study|Lost to Follow-up|4|||
94366959|NCT01678924|323129544|FG002|Overall Study|Lost to Follow-up|0|||
94366960|NCT01678924|323129545|FG003|Overall Study|Lost to Follow-up|2|||
94366961|NCT01678924|323129542|FG000|Overall Study|Personal Reasons|2|||
94366962|NCT01678924|323129543|FG001|Overall Study|Personal Reasons|2|||
94711938|NCT04425629|324404033|FG018|Overall Study|Lack of Efficacy|0|||
94711939|NCT00002842|324404034|FG000|Overall Study|ineligible for surgical resection|27|||
94711940|NCT00818454|324404035|FG000|Treatment Period 1|Adverse Event|0|||
94466362|NCT03605849|323496959|FG000|Overall Study|Enrolled, but not Treated|2|||
94466363|NCT03605849|323496960|FG001|Overall Study|Enrolled, but not Treated|2|||
94466364|NCT03605849|323496961|FG002|Overall Study|Enrolled, but not Treated|3|||
94466365|NCT03605849|323496962|FG003|Overall Study|Enrolled, but not Treated|2|||
94466366|NCT03605849|323496959|FG000|Overall Study|Other (COVID-19 Related)|0|||
94466367|NCT03605849|323496960|FG001|Overall Study|Other (COVID-19 Related)|1|||
94466368|NCT03605849|323496961|FG002|Overall Study|Other (COVID-19 Related)|1|||
94711941|NCT00818454|324404036|FG001|Treatment Period 1|Adverse Event|1|||
94711942|NCT00818454|324404037|FG002|Treatment Period 1|Adverse Event|0|||
94711943|NCT00818454|324404038|FG003|Treatment Period 1|Adverse Event|0|||
94711944|NCT00818454|324404035|FG000|Treatment Period 1|Other|3|||
94711945|NCT00818454|324404036|FG001|Treatment Period 1|Other|0|||
94711946|NCT00818454|324404037|FG002|Treatment Period 1|Other|0|||
94711947|NCT00818454|324404038|FG003|Treatment Period 1|Other|0|||
94711948|NCT00818454|324404035|FG000|Washout Period of 1 Week|Adverse Event|1|||
94711949|NCT00818454|324404036|FG001|Washout Period of 1 Week|Adverse Event|1|||
94711950|NCT00818454|324404037|FG002|Washout Period of 1 Week|Adverse Event|0|||
94711951|NCT00818454|324404038|FG003|Washout Period of 1 Week|Adverse Event|0|||
94711952|NCT00818454|324404035|FG000|Washout Period of 1 Week|Protocol Violation|2|||
94711953|NCT00818454|324404036|FG001|Washout Period of 1 Week|Protocol Violation|0|||
94711954|NCT00818454|324404037|FG002|Washout Period of 1 Week|Protocol Violation|0|||
94711955|NCT00818454|324404038|FG003|Washout Period of 1 Week|Protocol Violation|0|||
94711956|NCT00818454|324404035|FG000|Washout Period of 1 Week|Other|1|||
94711957|NCT00818454|324404036|FG001|Washout Period of 1 Week|Other|2|||
94711958|NCT00818454|324404037|FG002|Washout Period of 1 Week|Other|0|||
94711959|NCT00818454|324404038|FG003|Washout Period of 1 Week|Other|0|||
94711960|NCT00818454|324404035|FG000|Treatment Period 2|Other|2|||
94711961|NCT00818454|324404036|FG001|Treatment Period 2|Other|1|||
94711962|NCT00818454|324404037|FG002|Treatment Period 2|Other|0|||
94711963|NCT00818454|324404038|FG003|Treatment Period 2|Other|0|||
94711964|NCT00818454|324404035|FG000|Treatment Period 3|Adverse Event|0|||
94711965|NCT00818454|324404036|FG001|Treatment Period 3|Adverse Event|0|||
94711966|NCT00818454|324404037|FG002|Treatment Period 3|Adverse Event|0|||
94711967|NCT00818454|324404038|FG003|Treatment Period 3|Adverse Event|1|||
94711968|NCT01765543|324404043|FG000|Overall Study|Death|1|||
94711969|NCT01765543|324404043|FG000|Overall Study|Withdrawal by Subject|2|||
94711970|NCT00585533|324404046|FG000|Overall Study|objective or symptomatic progression|9|||
94711971|NCT01254188|324404047|FG000|Overall Study|Disease Progression|6|||
94711972|NCT01254188|324404047|FG000|Overall Study|Protocol Violation|6|||
94711973|NCT01254188|324404047|FG000|Overall Study|Pregnancy|2|||
94711974|NCT01254188|324404047|FG000|Overall Study|Death|4|||
94711975|NCT01254188|324404047|FG000|Overall Study|Lost to Follow-up|5|||
94711976|NCT01254188|324404047|FG000|Overall Study|Withdrawal by Subject|7|||
94711977|NCT01254188|324404047|FG000|Overall Study|Adverse Event|43|||
94711978|NCT01254188|324404047|FG000|Overall Study|per investigator discretion|20|||
94466369|NCT03605849|323496962|FG003|Overall Study|Other (COVID-19 Related)|0|||
94466370|NCT03605849|323496959|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
94466371|NCT03605849|323496960|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
94466372|NCT03605849|323496961|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
94466373|NCT03605849|323496962|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
94466374|NCT00328094|323496965|FG000|Overall Study|Physician Decision|3|||
94466375|NCT00328094|323496966|FG001|Overall Study|Physician Decision|3|||
94466376|NCT02667626|323496967|FG000|Overall Study|Withdrawal by Subject|0|||
94466377|NCT02667626|323496968|FG001|Overall Study|Withdrawal by Subject|1|||
94466378|NCT00427999|323496969|FG000|Overall Study|Adverse Event|6|||
94466379|NCT00427999|323496969|FG000|Overall Study|Abnormal laboratory values|1|||
94466380|NCT00427999|323496969|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
94466381|NCT00427999|323496969|FG000|Overall Study|Protocol Violation|2|||
94466382|NCT00427999|323496969|FG000|Overall Study|Withdrawal by Subject|9|||
94466383|NCT00427999|323496969|FG000|Overall Study|Death|1|||
94466384|NCT00766467|323496971|FG000|Overall Study|Withdrawal by Subject|7|||
94466385|NCT00766467|323496972|FG001|Overall Study|Withdrawal by Subject|2|||
94466386|NCT00766467|323496971|FG000|Overall Study|Adverse Event|1|||
94466387|NCT00766467|323496972|FG001|Overall Study|Adverse Event|1|||
94466388|NCT00766467|323496971|FG000|Overall Study|Protocol Violation|2|||
94466389|NCT00766467|323496972|FG001|Overall Study|Protocol Violation|4|||
94466390|NCT00766467|323496971|FG000|Overall Study|Tumor Progression on Study|0|||
94466391|NCT00766467|323496972|FG001|Overall Study|Tumor Progression on Study|1|||
94466392|NCT00766467|323496971|FG000|Overall Study|Physician Decision|1|||
94466393|NCT00766467|323496972|FG001|Overall Study|Physician Decision|0|||
94466394|NCT03956615|323496973|FG000|Overall Study|No multiple myeloma confirmed|2|||
94711979|NCT03740009|324404049|FG000|Overall Study|Physician Decision|9|||
94711980|NCT03740009|324404049|FG000|Overall Study|Lost to Follow-up|1|||
94711981|NCT02202499|324404052|FG000|Overall Study|Cancer diagnosis|0|||
94711982|NCT02202499|324404053|FG001|Overall Study|Cancer diagnosis|0|||
94711983|NCT02202499|324404054|FG002|Overall Study|Cancer diagnosis|1|||
94711984|NCT02202499|324404052|FG000|Overall Study|Moved from area|0|||
94711985|NCT02202499|324404053|FG001|Overall Study|Moved from area|0|||
94466395|NCT03956615|323496973|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
94466396|NCT03956615|323496973|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
94466397|NCT03956615|323496973|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
94466398|NCT02604550|323496974|FG000|Overall Study|Lost to Follow-up|7|||
94466399|NCT02604550|323496975|FG001|Overall Study|Lost to Follow-up|6|||
94466400|NCT02604550|323496974|FG000|Overall Study|Withdrawal by Subject|0|||
94466401|NCT02604550|323496975|FG001|Overall Study|Withdrawal by Subject|1|||
94466402|NCT02604550|323496974|FG000|Overall Study|Incomplete data using paper journal|18|||
94466403|NCT02604550|323496975|FG001|Overall Study|Incomplete data using paper journal|19|||
94466404|NCT01777295|323496976|FG000|Overall Study|Withdrawal by Subject|2|||
94466405|NCT01777295|323496977|FG001|Overall Study|Withdrawal by Subject|2|||
94466406|NCT01777295|323496976|FG000|Overall Study|Pregnancy|0|||
94466407|NCT01777295|323496977|FG001|Overall Study|Pregnancy|1|||
94466408|NCT01777295|323496976|FG000|Overall Study|Personal problem|1|||
94466409|NCT01777295|323496977|FG001|Overall Study|Personal problem|0|||
94466410|NCT01777295|323496976|FG000|Overall Study|Investigator call for AEs check|1|||
94466411|NCT01777295|323496977|FG001|Overall Study|Investigator call for AEs check|0|||
94466412|NCT01199822|323496978|FG000|Overall Study|Investigator discontinued therapy|0|||
94466413|NCT01199822|323496979|FG001|Overall Study|Investigator discontinued therapy|1|||
94466414|NCT01199822|323496980|FG002|Overall Study|Investigator discontinued therapy|0|||
94466415|NCT00908076|323496981|FG000|Overall Study|Lack of Efficacy|1|||
94466416|NCT00908076|323496982|FG001|Overall Study|Lack of Efficacy|1|||
94466417|NCT04526574|323496987|FG000|Overall Study|Protocol Violation|3|||
94466418|NCT04526574|323496988|FG001|Overall Study|Protocol Violation|1|||
94466419|NCT04526574|323496987|FG000|Overall Study|Withdrawal by Subject|12|||
94466420|NCT04526574|323496988|FG001|Overall Study|Withdrawal by Subject|9|||
94466421|NCT04526574|323496987|FG000|Overall Study|Other|1|||
94466422|NCT04526574|323496988|FG001|Overall Study|Other|2|||
94466423|NCT04526574|323496987|FG000|Overall Study|Adverse Event|1|||
94466424|NCT04526574|323496988|FG001|Overall Study|Adverse Event|1|||
94466425|NCT04526574|323496987|FG000|Overall Study|Death|2|||
94466426|NCT04526574|323496988|FG001|Overall Study|Death|3|||
94466427|NCT04526574|323496987|FG000|Overall Study|Lost to Follow-up|9|||
94466428|NCT04526574|323496988|FG001|Overall Study|Lost to Follow-up|9|||
94466429|NCT04526574|323496987|FG000|Overall Study|No longer meets eligibility criteria|8|||
94466430|NCT04526574|323496988|FG001|Overall Study|No longer meets eligibility criteria|8|||
94466431|NCT03747302|323496989|FG000|Overall Study|Withdrawal by Subject|1|||
94466432|NCT03747302|323496990|FG001|Overall Study|Withdrawal by Subject|2|||
94466433|NCT02772276|323496991|FG000|Overall Study|Lost to Follow-up|0|||
94466434|NCT02772276|323496992|FG001|Overall Study|Lost to Follow-up|0|||
94466435|NCT02772276|323496993|FG002|Overall Study|Lost to Follow-up|0|||
94466436|NCT02772276|323496994|FG003|Overall Study|Lost to Follow-up|0|||
94466437|NCT02772276|323496995|FG004|Overall Study|Lost to Follow-up|0|||
94466438|NCT02772276|323496996|FG005|Overall Study|Lost to Follow-up|0|||
94466439|NCT02772276|323496997|FG006|Overall Study|Lost to Follow-up|1|||
94466440|NCT02772276|323496998|FG007|Overall Study|Lost to Follow-up|0|||
94466441|NCT02772276|323496999|FG008|Overall Study|Lost to Follow-up|0|||
94466442|NCT02772276|323497000|FG009|Overall Study|Lost to Follow-up|0|||
94466443|NCT02772276|323497001|FG010|Overall Study|Lost to Follow-up|0|||
94466444|NCT02772276|323497002|FG011|Overall Study|Lost to Follow-up|0|||
94466445|NCT02772276|323497003|FG012|Overall Study|Lost to Follow-up|0|||
94466446|NCT02772276|323496991|FG000|Overall Study|Withdrew consent|0|||
94466447|NCT02772276|323496992|FG001|Overall Study|Withdrew consent|0|||
94466448|NCT02772276|323496993|FG002|Overall Study|Withdrew consent|0|||
94466449|NCT02772276|323496994|FG003|Overall Study|Withdrew consent|0|||
94466450|NCT02772276|323496995|FG004|Overall Study|Withdrew consent|0|||
94466451|NCT02772276|323496996|FG005|Overall Study|Withdrew consent|0|||
94466452|NCT02772276|323496997|FG006|Overall Study|Withdrew consent|0|||
94466453|NCT02772276|323496998|FG007|Overall Study|Withdrew consent|1|||
94466454|NCT02772276|323496999|FG008|Overall Study|Withdrew consent|0|||
94466455|NCT02772276|323497000|FG009|Overall Study|Withdrew consent|0|||
94466456|NCT02772276|323497001|FG010|Overall Study|Withdrew consent|0|||
94466457|NCT02772276|323497002|FG011|Overall Study|Withdrew consent|0|||
94466458|NCT02772276|323497003|FG012|Overall Study|Withdrew consent|0|||
94466459|NCT02554318|323497004|FG000|Overall Study|Withdrawal by Subject|10|||
94466460|NCT02554318|323497005|FG001|Overall Study|Withdrawal by Subject|8|||
94466461|NCT00033657|323497006|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
94466462|NCT00033657|323497007|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
94466463|NCT00033657|323497006|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
94466464|NCT00033657|323497007|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
94466465|NCT00033657|323497006|FG000|Neoadjuvant Chemotherapy|Death|1|||
94466466|NCT00033657|323497007|FG001|Neoadjuvant Chemotherapy|Death|1|||
94466467|NCT00033657|323497006|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
94466468|NCT00033657|323497007|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
94466469|NCT00033657|323497006|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
94466470|NCT00033657|323497007|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
94711986|NCT02202499|324404054|FG002|Overall Study|Moved from area|1|||
94466471|NCT00033657|323497006|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
94466472|NCT00033657|323497007|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
94466473|NCT00033657|323497006|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
94466474|NCT00033657|323497007|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
94466475|NCT00033657|323497006|FG000|Surgical Resection|not complete resection|0|||
94466476|NCT00033657|323497007|FG001|Surgical Resection|not complete resection|3|||
94466477|NCT00033657|323497006|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
94466478|NCT00033657|323497007|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
94466479|NCT00033657|323497006|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
94466480|NCT00033657|323497007|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
94466481|NCT00033657|323497006|FG000|Adjuvant Chemotherapy|Death|2|||
94466482|NCT00033657|323497007|FG001|Adjuvant Chemotherapy|Death|1|||
94466483|NCT00033657|323497006|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
94466484|NCT00033657|323497007|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
94466485|NCT00033657|323497006|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
94466486|NCT00033657|323497007|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
94466487|NCT00033657|323497006|FG000|Adjuvant Chemotherapy|Other|0|||
94466488|NCT00033657|323497007|FG001|Adjuvant Chemotherapy|Other|2|||
94466489|NCT01179737|323497009|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
94466490|NCT01179737|323497010|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
94466491|NCT01179737|323497011|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
94466492|NCT01179737|323497012|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
94466493|NCT01179737|323497009|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
94466494|NCT01179737|323497010|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
94466495|NCT01179737|323497011|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
94466496|NCT01179737|323497012|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
94466497|NCT01179737|323497009|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
94466498|NCT01179737|323497010|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
94466499|NCT01179737|323497011|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
94466500|NCT01179737|323497012|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
94466501|NCT01179737|323497009|FG000|Cohort 1 & Cohort 2|Death|0|||
94466502|NCT01179737|323497010|FG001|Cohort 1 & Cohort 2|Death|0|||
94466503|NCT01179737|323497011|FG002|Cohort 1 & Cohort 2|Death|1|||
94466504|NCT01179737|323497012|FG003|Cohort 1 & Cohort 2|Death|0|||
94466505|NCT01179737|323497009|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
94466506|NCT01179737|323497010|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
94466507|NCT01179737|323497011|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
94466508|NCT01179737|323497012|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
94466509|NCT01179737|323497009|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
94466510|NCT01179737|323497010|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
94466511|NCT01179737|323497011|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
94466512|NCT01179737|323497012|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
94466513|NCT01179737|323497009|FG000|Extension|The study was terminated|3|||
94466514|NCT01179737|323497010|FG001|Extension|The study was terminated|0|||
94466515|NCT01179737|323497011|FG002|Extension|The study was terminated|0|||
94466516|NCT01179737|323497012|FG003|Extension|The study was terminated|0|||
94466517|NCT00717275|323497013|FG000|Overall Study|Premature study termination.|3|||
94466518|NCT01955109|323497018|FG000|Overall Study|Adverse Event|2|||
94466519|NCT01955109|323497019|FG001|Overall Study|Adverse Event|0|||
94466520|NCT01955109|323497018|FG000|Overall Study|Participant unwilling to continue|35|||
94466521|NCT01955109|323497019|FG001|Overall Study|Participant unwilling to continue|7|||
94466522|NCT01955109|323497018|FG000|Overall Study|Physician Decision|2|||
94466523|NCT01955109|323497019|FG001|Overall Study|Physician Decision|0|||
94466524|NCT01955109|323497018|FG000|Overall Study|Lost to Follow-up|3|||
94466525|NCT01955109|323497019|FG001|Overall Study|Lost to Follow-up|1|||
94466526|NCT01955109|323497018|FG000|Overall Study|Non-compliance|3|||
94466527|NCT01955109|323497019|FG001|Overall Study|Non-compliance|1|||
94466528|NCT03769194|323497020|FG000|Overall Study|Withdrawal by Subject|0|||
94466529|NCT03769194|323497021|FG001|Overall Study|Withdrawal by Subject|7|||
94466530|NCT03769194|323497022|FG002|Overall Study|Withdrawal by Subject|4|||
94466531|NCT03769194|323497023|FG003|Overall Study|Withdrawal by Subject|1|||
94466532|NCT03769194|323497020|FG000|Overall Study|moved from study area|0|||
94466533|NCT03769194|323497021|FG001|Overall Study|moved from study area|2|||
94466534|NCT03769194|323497022|FG002|Overall Study|moved from study area|1|||
94466535|NCT03769194|323497023|FG003|Overall Study|moved from study area|1|||
94466536|NCT03769194|323497020|FG000|Overall Study|Lost to Follow-up|3|||
94466537|NCT03769194|323497021|FG001|Overall Study|Lost to Follow-up|6|||
94466538|NCT03769194|323497022|FG002|Overall Study|Lost to Follow-up|3|||
94466539|NCT03769194|323497023|FG003|Overall Study|Lost to Follow-up|6|||
94466540|NCT03769194|323497020|FG000|Overall Study|other|1|||
94466541|NCT03769194|323497021|FG001|Overall Study|other|3|||
94466542|NCT03769194|323497022|FG002|Overall Study|other|0|||
94466543|NCT03769194|323497023|FG003|Overall Study|other|1|||
94466544|NCT03000530|323497024|FG000|Overall Study|Adverse Event|0|||
94466545|NCT03000530|323497025|FG001|Overall Study|Adverse Event|0|||
94466546|NCT03000530|323497026|FG002|Overall Study|Adverse Event|2|||
94466547|NCT03000530|323497024|FG000|Overall Study|Lost to Follow-up|0|||
94270017|NCT04667377|322782084|FG004|Dose Escalation Period|Other not specified below|3|||
94270018|NCT04667377|322782080|FG000|Dose Escalation Period|Protocol Violation|2|||
94270019|NCT04667377|322782081|FG001|Dose Escalation Period|Protocol Violation|2|||
94270020|NCT04667377|322782082|FG002|Dose Escalation Period|Protocol Violation|0|||
94270021|NCT04667377|322782083|FG003|Dose Escalation Period|Protocol Violation|2|||
94270022|NCT04667377|322782084|FG004|Dose Escalation Period|Protocol Violation|1|||
94270023|NCT04667377|322782080|FG000|Dose Escalation Period|Burden of study procedures|2|||
94270024|NCT04667377|322782081|FG001|Dose Escalation Period|Burden of study procedures|1|||
94270025|NCT04667377|322782082|FG002|Dose Escalation Period|Burden of study procedures|1|||
94270026|NCT04667377|322782083|FG003|Dose Escalation Period|Burden of study procedures|1|||
94270027|NCT04667377|322782084|FG004|Dose Escalation Period|Burden of study procedures|5|||
94270028|NCT04667377|322782080|FG000|Dose Escalation Period|Change of residence|0|||
94270029|NCT04667377|322782081|FG001|Dose Escalation Period|Change of residence|0|||
94270030|NCT04667377|322782082|FG002|Dose Escalation Period|Change of residence|1|||
94270031|NCT04667377|322782083|FG003|Dose Escalation Period|Change of residence|0|||
94270032|NCT04667377|322782084|FG004|Dose Escalation Period|Change of residence|0|||
94270033|NCT04667377|322782080|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
94270034|NCT04667377|322782081|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
94270035|NCT04667377|322782082|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
94270036|NCT04667377|322782083|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
94270037|NCT04667377|322782084|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
94270038|NCT04667377|322782080|FG000|Dose Escalation Period|Adverse Event|9|||
94270039|NCT04667377|322782081|FG001|Dose Escalation Period|Adverse Event|10|||
94270040|NCT04667377|322782082|FG002|Dose Escalation Period|Adverse Event|12|||
94270041|NCT04667377|322782083|FG003|Dose Escalation Period|Adverse Event|17|||
94270042|NCT04667377|322782084|FG004|Dose Escalation Period|Adverse Event|3|||
94270043|NCT04667377|322782080|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
94270044|NCT04667377|322782081|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
94270045|NCT04667377|322782082|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
94270046|NCT04667377|322782083|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
94270047|NCT04667377|322782084|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
94270048|NCT04667377|322782080|FG000|Dose Escalation Period|Not treated|1|||
94366963|NCT01678924|323129544|FG002|Overall Study|Personal Reasons|2|||
94366964|NCT01678924|323129545|FG003|Overall Study|Personal Reasons|7|||
94366965|NCT01678924|323129542|FG000|Overall Study|Withdrawal by Subject|0|||
94366966|NCT01678924|323129543|FG001|Overall Study|Withdrawal by Subject|3|||
94366967|NCT01678924|323129544|FG002|Overall Study|Withdrawal by Subject|0|||
94366968|NCT01678924|323129545|FG003|Overall Study|Withdrawal by Subject|2|||
94366969|NCT01678924|323129542|FG000|Overall Study|Unable to attend scheduled visits|0|||
94366970|NCT01678924|323129543|FG001|Overall Study|Unable to attend scheduled visits|0|||
94366971|NCT01678924|323129544|FG002|Overall Study|Unable to attend scheduled visits|0|||
94366972|NCT01678924|323129545|FG003|Overall Study|Unable to attend scheduled visits|1|||
94366973|NCT02675426|323129550|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
94366974|NCT02675426|323129551|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
94366975|NCT02675426|323129552|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
94366976|NCT02675426|323129553|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
94366977|NCT02675426|323129550|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
94366978|NCT02675426|323129551|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
94366979|NCT02675426|323129552|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
94366980|NCT02675426|323129553|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
94366981|NCT02675426|323129550|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
94366982|NCT02675426|323129551|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
94366983|NCT02675426|323129552|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
94366984|NCT02675426|323129553|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
94366985|NCT02675426|323129550|FG000|Period 1: Week 1 to Week 12|Other|2|||
94366986|NCT02675426|323129551|FG001|Period 1: Week 1 to Week 12|Other|1|||
94366987|NCT02675426|323129552|FG002|Period 1: Week 1 to Week 12|Other|0|||
94366988|NCT02675426|323129553|FG003|Period 1: Week 1 to Week 12|Other|2|||
94366989|NCT02675426|323129550|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
94366990|NCT02675426|323129551|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
94366991|NCT02675426|323129552|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
94366992|NCT02675426|323129553|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
94366993|NCT02675426|323129550|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
94366994|NCT02675426|323129551|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
94366995|NCT02675426|323129552|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
94366996|NCT02675426|323129553|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
94366997|NCT02675426|323129550|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
94366998|NCT02675426|323129551|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
94366999|NCT02675426|323129552|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
94367000|NCT02675426|323129553|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
94367001|NCT02675426|323129550|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
94466548|NCT03000530|323497025|FG001|Overall Study|Lost to Follow-up|3|||
94466549|NCT03000530|323497026|FG002|Overall Study|Lost to Follow-up|1|||
94466550|NCT03000530|323497024|FG000|Overall Study|Withdrawal by Subject|0|||
94466551|NCT03000530|323497025|FG001|Overall Study|Withdrawal by Subject|2|||
94466552|NCT03000530|323497026|FG002|Overall Study|Withdrawal by Subject|1|||
94466553|NCT05385224|323497027|FG000|Overall Study|Unable to swallow capsule|2|||
94466554|NCT05385224|323497027|FG000|Overall Study|Withdrawal by Subject|2|||
94466555|NCT05385224|323497027|FG000|Overall Study|Did not meet study criteria|1|||
94466556|NCT02614131|323497035|FG000|Overall Study|Withdrawal by Subject|1|||
94466557|NCT02614131|323497036|FG001|Overall Study|Withdrawal by Subject|0|||
94466558|NCT02614131|323497037|FG002|Overall Study|Withdrawal by Subject|0|||
94466559|NCT02614131|323497038|FG003|Overall Study|Withdrawal by Subject|0|||
94466560|NCT02614131|323497039|FG004|Overall Study|Withdrawal by Subject|0|||
94466561|NCT02614131|323497040|FG005|Overall Study|Withdrawal by Subject|0|||
94466562|NCT02614131|323497041|FG006|Overall Study|Withdrawal by Subject|0|||
94466563|NCT02614131|323497035|FG000|Overall Study|Adverse Event|0|||
94466564|NCT02614131|323497036|FG001|Overall Study|Adverse Event|0|||
94466565|NCT02614131|323497037|FG002|Overall Study|Adverse Event|0|||
94466566|NCT02614131|323497038|FG003|Overall Study|Adverse Event|0|||
94466567|NCT02614131|323497039|FG004|Overall Study|Adverse Event|0|||
94466568|NCT02614131|323497040|FG005|Overall Study|Adverse Event|0|||
94466569|NCT02614131|323497041|FG006|Overall Study|Adverse Event|1|||
94466570|NCT01832818|323497042|FG000|Overall Study|Lost to Follow-up|6|||
94466571|NCT01935700|323497047|FG000|Overall Study|Withdrawal by Subject|1|||
94466572|NCT01935700|323497048|FG001|Overall Study|Withdrawal by Subject|0|||
94466573|NCT01935700|323497047|FG000|Overall Study|Physician Decision|4|||
94653091|NCT02840877|324188014|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
94466574|NCT01935700|323497048|FG001|Overall Study|Physician Decision|0|||
94466575|NCT02854605|323497050|FG000|Overall Study|Adverse Event|1|||
94466576|NCT02854605|323497051|FG001|Overall Study|Adverse Event|5|||
94466577|NCT02854605|323497052|FG002|Overall Study|Adverse Event|2|||
94653092|NCT02840877|324188014|FG000|6 Months to 18 Months|Still in study.|14|||
94653093|NCT03348904|324188017|FG000|Overall Study|Administrative reason by the sponsor|0|||
94653094|NCT03348904|324188018|FG001|Overall Study|Administrative reason by the sponsor|1|||
94653095|NCT03348904|324188019|FG002|Overall Study|Administrative reason by the sponsor|0|||
94653096|NCT00844545|324188020|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
94653097|NCT00844545|324188020|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
94653098|NCT00844545|324188020|FG000|Extension Treatment Period|Adverse Event|2|||
94270049|NCT04667377|322782081|FG001|Dose Escalation Period|Not treated|0|||
94270050|NCT04667377|322782082|FG002|Dose Escalation Period|Not treated|0|||
94270051|NCT04667377|322782083|FG003|Dose Escalation Period|Not treated|0|||
94270052|NCT04667377|322782084|FG004|Dose Escalation Period|Not treated|0|||
94270053|NCT04667377|322782080|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
94466578|NCT02854605|323497050|FG000|Overall Study|Lost to Follow-up|0|||
94466579|NCT02854605|323497051|FG001|Overall Study|Lost to Follow-up|2|||
94466580|NCT02854605|323497052|FG002|Overall Study|Lost to Follow-up|0|||
94466581|NCT02854605|323497050|FG000|Overall Study|Withdrew Consent|1|||
94466582|NCT02854605|323497051|FG001|Overall Study|Withdrew Consent|0|||
94466583|NCT02854605|323497052|FG002|Overall Study|Withdrew Consent|1|||
94466584|NCT02854605|323497050|FG000|Overall Study|Investigator's Discretion|1|||
94466585|NCT02854605|323497051|FG001|Overall Study|Investigator's Discretion|0|||
94466586|NCT02854605|323497052|FG002|Overall Study|Investigator's Discretion|0|||
94466587|NCT02854605|323497050|FG000|Overall Study|Protocol Violation|0|||
94466588|NCT02854605|323497051|FG001|Overall Study|Protocol Violation|0|||
94466589|NCT02854605|323497052|FG002|Overall Study|Protocol Violation|1|||
94711987|NCT02202499|324404052|FG000|Overall Study|Declined before randomization|1|||
94711988|NCT02202499|324404053|FG001|Overall Study|Declined before randomization|0|||
94711989|NCT02202499|324404054|FG002|Overall Study|Declined before randomization|0|||
94711990|NCT02202499|324404052|FG000|Overall Study|Auto accident|1|||
94466590|NCT01273155|323497053|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
94466591|NCT01273155|323497054|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
94466592|NCT01273155|323497055|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
94466593|NCT01273155|323497056|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
94466594|NCT01273155|323497057|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
94466595|NCT01273155|323497058|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
94466596|NCT01273155|323497059|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
94466597|NCT01273155|323497053|FG000|Overall Study|Change in liver function/no longer eval.|0|||
94466598|NCT01273155|323497054|FG001|Overall Study|Change in liver function/no longer eval.|1|||
94466599|NCT01273155|323497055|FG002|Overall Study|Change in liver function/no longer eval.|0|||
94466600|NCT01273155|323497056|FG003|Overall Study|Change in liver function/no longer eval.|0|||
94466601|NCT01273155|323497057|FG004|Overall Study|Change in liver function/no longer eval.|1|||
94466602|NCT01273155|323497058|FG005|Overall Study|Change in liver function/no longer eval.|0|||
94466603|NCT01273155|323497059|FG006|Overall Study|Change in liver function/no longer eval.|0|||
94466604|NCT01273155|323497053|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
94466605|NCT01273155|323497054|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
94466606|NCT01273155|323497055|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
94466607|NCT01273155|323497056|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
94466608|NCT01273155|323497057|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
94466609|NCT01273155|323497058|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
94466610|NCT01273155|323497059|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
94466611|NCT01273155|323497053|FG000|Overall Study|Died during Cycle 1|0|||
94466612|NCT01273155|323497054|FG001|Overall Study|Died during Cycle 1|0|||
94711991|NCT02202499|324404053|FG001|Overall Study|Auto accident|0|||
94711992|NCT02202499|324404054|FG002|Overall Study|Auto accident|0|||
94711993|NCT02423798|324404055|FG000|Overall Study|Withdrawal by Subject|3|||
94711994|NCT01236560|324404056|FG000|Overall Study|Adverse Event|0|||
94711995|NCT01236560|324404057|FG001|Overall Study|Adverse Event|2|||
94711996|NCT01236560|324404058|FG002|Overall Study|Adverse Event|1|||
94711997|NCT01236560|324404059|FG003|Overall Study|Adverse Event|3|||
94711998|NCT01236560|324404060|FG004|Overall Study|Adverse Event|0|||
94711999|NCT01236560|324404061|FG005|Overall Study|Adverse Event|0|||
94270054|NCT04667377|322782081|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
94270055|NCT04667377|322782082|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
94712000|NCT01236560|324404056|FG000|Overall Study|Death|0|||
94712001|NCT01236560|324404057|FG001|Overall Study|Death|1|||
94712002|NCT01236560|324404058|FG002|Overall Study|Death|0|||
94712003|NCT01236560|324404059|FG003|Overall Study|Death|1|||
94712004|NCT01236560|324404060|FG004|Overall Study|Death|0|||
94712005|NCT01236560|324404061|FG005|Overall Study|Death|0|||
94712006|NCT01236560|324404056|FG000|Overall Study|Lost to Follow-up|0|||
94712007|NCT01236560|324404057|FG001|Overall Study|Lost to Follow-up|1|||
94712008|NCT01236560|324404058|FG002|Overall Study|Lost to Follow-up|1|||
94270056|NCT04667377|322782083|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
94270057|NCT04667377|322782084|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
94270058|NCT04667377|322782080|FG000|Dose Escalation Period|Lost to Follow-up|0|||
94466613|NCT01273155|323497055|FG002|Overall Study|Died during Cycle 1|1|||
94466614|NCT01273155|323497056|FG003|Overall Study|Died during Cycle 1|1|||
94466615|NCT01273155|323497057|FG004|Overall Study|Died during Cycle 1|0|||
94466616|NCT01273155|323497058|FG005|Overall Study|Died during Cycle 1|2|||
94466617|NCT01273155|323497059|FG006|Overall Study|Died during Cycle 1|2|||
94466618|NCT01273155|323497053|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
94712009|NCT01236560|324404059|FG003|Overall Study|Lost to Follow-up|0|||
94270059|NCT04667377|322782081|FG001|Dose Escalation Period|Lost to Follow-up|1|||
94270060|NCT04667377|322782082|FG002|Dose Escalation Period|Lost to Follow-up|0|||
94712010|NCT01236560|324404060|FG004|Overall Study|Lost to Follow-up|0|||
94712011|NCT01236560|324404061|FG005|Overall Study|Lost to Follow-up|0|||
94712012|NCT01236560|324404056|FG000|Overall Study|Physician Decision|0|||
94712013|NCT01236560|324404057|FG001|Overall Study|Physician Decision|1|||
94712014|NCT01236560|324404058|FG002|Overall Study|Physician Decision|8|||
94712015|NCT01236560|324404059|FG003|Overall Study|Physician Decision|0|||
94270061|NCT04667377|322782083|FG003|Dose Escalation Period|Lost to Follow-up|0|||
94270062|NCT04667377|322782084|FG004|Dose Escalation Period|Lost to Follow-up|0|||
94712016|NCT01236560|324404060|FG004|Overall Study|Physician Decision|0|||
94712017|NCT01236560|324404061|FG005|Overall Study|Physician Decision|0|||
94712018|NCT01236560|324404056|FG000|Overall Study|Withdrawal by Subject|0|||
94712019|NCT01236560|324404057|FG001|Overall Study|Withdrawal by Subject|0|||
94712020|NCT01236560|324404058|FG002|Overall Study|Withdrawal by Subject|1|||
94712021|NCT01236560|324404059|FG003|Overall Study|Withdrawal by Subject|2|||
94712022|NCT01236560|324404060|FG004|Overall Study|Withdrawal by Subject|0|||
94712023|NCT01236560|324404061|FG005|Overall Study|Withdrawal by Subject|0|||
94712024|NCT01236560|324404056|FG000|Overall Study|Progressive disease|5|||
94712025|NCT01236560|324404057|FG001|Overall Study|Progressive disease|19|||
94712026|NCT01236560|324404058|FG002|Overall Study|Progressive disease|9|||
94712027|NCT01236560|324404059|FG003|Overall Study|Progressive disease|16|||
94712028|NCT01236560|324404060|FG004|Overall Study|Progressive disease|0|||
94712029|NCT01236560|324404061|FG005|Overall Study|Progressive disease|0|||
94712030|NCT02115139|324404062|FG000|Overall Study|Protocol Violation|1|||
94712031|NCT02115139|324404062|FG000|Overall Study|treatment discontinuation|6|||
94712032|NCT00468910|324404063|FG000|Overall Study|Lost to Follow-up|2|||
94712033|NCT00468910|324404064|FG001|Overall Study|Lost to Follow-up|1|||
94712034|NCT00468910|324404063|FG000|Overall Study|Withdrawal by Subject|2|||
94712035|NCT00468910|324404064|FG001|Overall Study|Withdrawal by Subject|1|||
94712036|NCT00468910|324404063|FG000|Overall Study|Medical Contraindication|0|||
94270063|NCT04667377|322782080|FG000|Maintenance Period|Perceived lack of efficacy|0|||
94270064|NCT04667377|322782081|FG001|Maintenance Period|Perceived lack of efficacy|2|||
94270065|NCT04667377|322782082|FG002|Maintenance Period|Perceived lack of efficacy|1|||
94270066|NCT04667377|322782083|FG003|Maintenance Period|Perceived lack of efficacy|0|||
94270067|NCT04667377|322782084|FG004|Maintenance Period|Perceived lack of efficacy|1|||
94270068|NCT04667377|322782080|FG000|Maintenance Period|Adverse Event|2|||
94270069|NCT04667377|322782081|FG001|Maintenance Period|Adverse Event|8|||
94270070|NCT04667377|322782082|FG002|Maintenance Period|Adverse Event|5|||
94712037|NCT00468910|324404064|FG001|Overall Study|Medical Contraindication|1|||
94712038|NCT01576484|324404069|FG000|Overall Study|Adverse Event|1|||
94712039|NCT01576484|324404070|FG001|Overall Study|Adverse Event|1|||
94712040|NCT01576484|324404069|FG000|Overall Study|Protocol Violation|0|||
94712041|NCT01576484|324404070|FG001|Overall Study|Protocol Violation|2|||
94712042|NCT01576484|324404069|FG000|Overall Study|Sponsor Decision|2|||
94712043|NCT01576484|324404070|FG001|Overall Study|Sponsor Decision|8|||
94712044|NCT01576484|324404069|FG000|Overall Study|Withdrawal by Subject|0|||
94712045|NCT01576484|324404070|FG001|Overall Study|Withdrawal by Subject|3|||
94712046|NCT01576484|324404069|FG000|Overall Study|Other|2|||
94712047|NCT01576484|324404070|FG001|Overall Study|Other|5|||
94712048|NCT05274217|324404076|FG000|Overall Study|Study terminated.|11|||
94712049|NCT05274217|324404077|FG001|Overall Study|Study terminated.|0|||
94712050|NCT01212991|324404085|FG000|Double-blind|Lost to Follow-up|8|||
94712051|NCT01212991|324404086|FG001|Double-blind|Lost to Follow-up|4|||
94712052|NCT01212991|324404087|FG002|Double-blind|Lost to Follow-up|0|||
94712053|NCT01212991|324404085|FG000|Double-blind|Death|699|||
94712054|NCT01212991|324404086|FG001|Double-blind|Death|550|||
94712055|NCT01212991|324404087|FG002|Double-blind|Death|0|||
94712056|NCT01212991|324404085|FG000|Double-blind|Withdrawal by Subject|16|||
94712057|NCT01212991|324404086|FG001|Double-blind|Withdrawal by Subject|19|||
94270071|NCT04667377|322782083|FG003|Maintenance Period|Adverse Event|4|||
94270072|NCT04667377|322782084|FG004|Maintenance Period|Adverse Event|1|||
94270073|NCT04667377|322782080|FG000|Maintenance Period|Adverse event: COVID infection|0|||
94367002|NCT02675426|323129551|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
94367003|NCT02675426|323129552|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
94367004|NCT02675426|323129553|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
94367005|NCT02675426|323129550|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
94367006|NCT02675426|323129551|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
94367007|NCT02675426|323129552|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
94367008|NCT02675426|323129553|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
94367009|NCT02675426|323129550|FG000|Period 2: Week 12 to Week 260|Other|8|||
94367010|NCT02675426|323129551|FG001|Period 2: Week 12 to Week 260|Other|12|||
94367011|NCT02675426|323129552|FG002|Period 2: Week 12 to Week 260|Other|23|||
94367012|NCT02675426|323129553|FG003|Period 2: Week 12 to Week 260|Other|15|||
94712058|NCT01212991|324404087|FG002|Double-blind|Withdrawal by Subject|0|||
94712059|NCT01212991|324404085|FG000|Double-blind|Other|7|||
94466619|NCT01273155|323497054|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
94466620|NCT01273155|323497055|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
94466621|NCT01273155|323497056|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
94466622|NCT01273155|323497057|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
94466623|NCT01273155|323497058|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
94466624|NCT01273155|323497059|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
94466625|NCT00568334|323497060|FG000|Overall Study|Withdrawal by Subject|0|||
94466626|NCT00568334|323497061|FG001|Overall Study|Withdrawal by Subject|1|||
94466627|NCT00568334|323497060|FG000|Overall Study|Lost to Follow-up|1|||
94466628|NCT00568334|323497061|FG001|Overall Study|Lost to Follow-up|0|||
94466629|NCT01256385|323497062|FG000|Overall Study|Physician Decision|1|||
94466630|NCT01256385|323497063|FG001|Overall Study|Physician Decision|1|||
94466631|NCT01256385|323497062|FG000|Overall Study|Withdrawal by Subject|2|||
94466632|NCT01256385|323497063|FG001|Overall Study|Withdrawal by Subject|2|||
94466633|NCT01797094|323497064|FG000|Overall Study|Adverse Event|1|||
94466634|NCT01797094|323497065|FG001|Overall Study|Adverse Event|1|||
94466635|NCT01797094|323497064|FG000|Overall Study|Personal Reasons|4|||
94466636|NCT01797094|323497065|FG001|Overall Study|Personal Reasons|0|||
94466637|NCT01797094|323497064|FG000|Overall Study|Protocol Violation|0|||
94466638|NCT01797094|323497065|FG001|Overall Study|Protocol Violation|1|||
94466639|NCT01797094|323497064|FG000|Overall Study|Other Miscellaneous Reasons|1|||
94466640|NCT01797094|323497065|FG001|Overall Study|Other Miscellaneous Reasons|0|||
94466641|NCT00401960|323497066|FG000|Overall Study|Lost to Follow-up|3|||
94466642|NCT00401960|323497067|FG001|Overall Study|Lost to Follow-up|0|||
94466643|NCT00401960|323497066|FG000|Overall Study|Death|2|||
94466644|NCT00401960|323497067|FG001|Overall Study|Death|0|||
94466645|NCT02649426|323497068|FG000|Overall Study|Follow-up on going|1|||
94466646|NCT02649426|323497069|FG001|Overall Study|Follow-up on going|26|||
94466647|NCT02649426|323497070|FG002|Overall Study|Follow-up on going|28|||
94466648|NCT02649426|323497071|FG003|Overall Study|Follow-up on going|31|||
94466649|NCT01606202|323497072|FG000|Overall Study|Adverse Event|5|||
94466650|NCT01606202|323497073|FG001|Overall Study|Adverse Event|0|||
94466651|NCT01606202|323497072|FG000|Overall Study|Withdrawal by Subject|2|||
94466652|NCT01606202|323497073|FG001|Overall Study|Withdrawal by Subject|1|||
94466653|NCT01606202|323497072|FG000|Overall Study|Personal problems|0|||
94466654|NCT01606202|323497073|FG001|Overall Study|Personal problems|1|||
94466655|NCT01606202|323497072|FG000|Overall Study|Problems with administration|0|||
94466656|NCT01606202|323497073|FG001|Overall Study|Problems with administration|1|||
94466657|NCT00422422|323497082|FG000|Overall Study|Lack of Efficacy|1|||
94466658|NCT00422422|323497082|FG000|Overall Study|Protocol Violation|1|||
94270074|NCT04667377|322782081|FG001|Maintenance Period|Adverse event: COVID infection|1|||
94270075|NCT04667377|322782082|FG002|Maintenance Period|Adverse event: COVID infection|0|||
94270076|NCT04667377|322782083|FG003|Maintenance Period|Adverse event: COVID infection|0|||
94270077|NCT04667377|322782084|FG004|Maintenance Period|Adverse event: COVID infection|0|||
94270078|NCT04667377|322782080|FG000|Maintenance Period|COVID-related|0|||
94270079|NCT04667377|322782081|FG001|Maintenance Period|COVID-related|0|||
94270080|NCT04667377|322782082|FG002|Maintenance Period|COVID-related|1|||
94270081|NCT04667377|322782083|FG003|Maintenance Period|COVID-related|1|||
94270082|NCT04667377|322782084|FG004|Maintenance Period|COVID-related|0|||
94270083|NCT04667377|322782080|FG000|Maintenance Period|Protocol Violation|1|||
94270084|NCT04667377|322782081|FG001|Maintenance Period|Protocol Violation|0|||
94270085|NCT04667377|322782082|FG002|Maintenance Period|Protocol Violation|0|||
94270086|NCT04667377|322782083|FG003|Maintenance Period|Protocol Violation|0|||
94270087|NCT04667377|322782084|FG004|Maintenance Period|Protocol Violation|1|||
94270088|NCT04667377|322782080|FG000|Maintenance Period|Burden of study procedures|1|||
94270089|NCT04667377|322782081|FG001|Maintenance Period|Burden of study procedures|2|||
94270090|NCT04667377|322782082|FG002|Maintenance Period|Burden of study procedures|0|||
94466659|NCT00422422|323497082|FG000|Overall Study|Withdrawal by Subject|2|||
94466660|NCT00422422|323497082|FG000|Overall Study|SAE, non-fatal|1|||
94466661|NCT00422422|323497082|FG000|Overall Study|AE, non-serious non-fatal|5|||
94466662|NCT00270231|323497091|FG000|First Intervention|Lost to Follow-up|1|||
94466663|NCT00270231|323497092|FG001|First Intervention|Lost to Follow-up|1|||
94466664|NCT00270231|323497091|FG000|Washout Period|Lost to Follow-up|1|||
94270091|NCT04667377|322782083|FG003|Maintenance Period|Burden of study procedures|1|||
94270092|NCT04667377|322782084|FG004|Maintenance Period|Burden of study procedures|0|||
94270093|NCT04667377|322782080|FG000|Maintenance Period|Change of residence|0|||
94466665|NCT00270231|323497092|FG001|Washout Period|Lost to Follow-up|0|||
94466666|NCT00270231|323497091|FG000|Second Intervention|Lost to Follow-up|0|||
94466667|NCT00270231|323497092|FG001|Second Intervention|Lost to Follow-up|1|||
94466668|NCT00483704|323497093|FG000|Randomization|Withdrawal by Subject|19|||
94466669|NCT00483704|323497094|FG001|Randomization|Withdrawal by Subject|28|||
94466670|NCT00483704|323497095|FG002|Randomization|Withdrawal by Subject|18|||
94466671|NCT00483704|323497093|FG000|Randomization|Protocol Violation|14|||
94466672|NCT00483704|323497094|FG001|Randomization|Protocol Violation|25|||
94466673|NCT00483704|323497095|FG002|Randomization|Protocol Violation|22|||
94712060|NCT01212991|324404086|FG001|Double-blind|Other|0|||
94466674|NCT00483704|323497093|FG000|Randomization|Lost to Follow-up|14|||
94466675|NCT00483704|323497094|FG001|Randomization|Lost to Follow-up|14|||
94466676|NCT00483704|323497095|FG002|Randomization|Lost to Follow-up|19|||
94466677|NCT00483704|323497093|FG000|Randomization|Pregnancy|1|||
94466678|NCT00483704|323497094|FG001|Randomization|Pregnancy|0|||
94466679|NCT00483704|323497095|FG002|Randomization|Pregnancy|0|||
94466680|NCT00483704|323497093|FG000|Randomization|Physician Decision|2|||
94466681|NCT00483704|323497094|FG001|Randomization|Physician Decision|4|||
94712061|NCT01212991|324404087|FG002|Double-blind|Other|0|||
94712062|NCT01212991|324404085|FG000|Double-blind|Sponsor decision|142|||
94712063|NCT01212991|324404086|FG001|Double-blind|Sponsor decision|38|||
94712064|NCT01212991|324404087|FG002|Double-blind|Sponsor decision|0|||
94712065|NCT01212991|324404085|FG000|Open-label|Death|0|||
94712066|NCT01212991|324404086|FG001|Open-label|Death|0|||
94712067|NCT01212991|324404087|FG002|Open-label|Death|166|||
94712068|NCT01212991|324404085|FG000|Open-label|Lost to Follow-up|0|||
94712069|NCT01212991|324404086|FG001|Open-label|Lost to Follow-up|0|||
94712070|NCT01212991|324404087|FG002|Open-label|Lost to Follow-up|5|||
94712071|NCT01212991|324404085|FG000|Open-label|Withdrawal by Subject|0|||
94712072|NCT01212991|324404086|FG001|Open-label|Withdrawal by Subject|0|||
94712073|NCT01212991|324404087|FG002|Open-label|Withdrawal by Subject|7|||
94712074|NCT01212991|324404085|FG000|Open-label|Sponsor decision|0|||
94712075|NCT01212991|324404086|FG001|Open-label|Sponsor decision|0|||
94367013|NCT04292171|323129554|FG000|Overall Study|Pharmacy error|2|||
94367014|NCT04292171|323129555|FG001|Overall Study|Pharmacy error|0|||
94367015|NCT04292171|323129554|FG000|Overall Study|Delivered prior to procedure|0|||
94367016|NCT04292171|323129555|FG001|Overall Study|Delivered prior to procedure|1|||
94367017|NCT01777191|323129556|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
94367018|NCT01777191|323129557|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
94367019|NCT01777191|323129556|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
94367020|NCT01777191|323129557|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
94367021|NCT01777191|323129556|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
94367022|NCT01777191|323129557|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
94367023|NCT01777191|323129556|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
94367024|NCT01777191|323129557|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
94367025|NCT01777191|323129556|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
94367026|NCT01777191|323129557|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
94367027|NCT01777191|323129556|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
94367028|NCT01777191|323129557|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
94367029|NCT01777191|323129556|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
94367030|NCT01777191|323129557|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
94367031|NCT01777191|323129556|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
94367032|NCT01777191|323129557|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
94367033|NCT01777191|323129556|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
94367034|NCT01777191|323129557|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
94367035|NCT01777191|323129556|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
94367036|NCT01777191|323129557|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
94367037|NCT01777191|323129556|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
94367038|NCT01777191|323129557|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
94367039|NCT04723173|323129558|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
94367040|NCT02996448|323129559|FG000|Overall Study|Study terminated due to adverse effects|3|||
94367041|NCT02703454|323129563|FG000|Overall Study|Not treated|1|||
94367042|NCT02703454|323129564|FG001|Overall Study|Not treated|3|||
94367043|NCT02703454|323129563|FG000|Overall Study|Withdrawal by Subject|4|||
94367044|NCT02703454|323129564|FG001|Overall Study|Withdrawal by Subject|3|||
94367045|NCT02703454|323129563|FG000|Overall Study|Lost to Follow-up|1|||
94367046|NCT02703454|323129564|FG001|Overall Study|Lost to Follow-up|2|||
94367047|NCT02703454|323129563|FG000|Overall Study|Study discontinuation|5|||
94367048|NCT02703454|323129564|FG001|Overall Study|Study discontinuation|8|||
94367049|NCT00791154|323129569|FG000|Overall Study|Noncompliance|0|||
94367050|NCT00791154|323129570|FG001|Overall Study|Noncompliance|1|||
94367051|NCT00791154|323129571|FG002|Overall Study|Noncompliance|0|||
94367052|NCT00791154|323129572|FG003|Overall Study|Noncompliance|0|||
94367053|NCT00791154|323129573|FG004|Overall Study|Noncompliance|1|||
94367054|NCT00791154|323129574|FG005|Overall Study|Noncompliance|1|||
94367055|NCT00791154|323129575|FG006|Overall Study|Noncompliance|1|||
94367056|NCT00791154|323129569|FG000|Overall Study|Adverse Event|0|||
94367057|NCT00791154|323129570|FG001|Overall Study|Adverse Event|0|||
94367058|NCT00791154|323129571|FG002|Overall Study|Adverse Event|0|||
94367059|NCT00791154|323129572|FG003|Overall Study|Adverse Event|0|||
94367060|NCT00791154|323129573|FG004|Overall Study|Adverse Event|2|||
94367061|NCT00791154|323129574|FG005|Overall Study|Adverse Event|0|||
94367062|NCT00791154|323129575|FG006|Overall Study|Adverse Event|1|||
94466682|NCT00483704|323497095|FG002|Randomization|Physician Decision|0|||
94712076|NCT01212991|324404087|FG002|Open-label|Sponsor decision|53|||
94712077|NCT01212991|324404085|FG000|Open-label|Other|0|||
94712078|NCT01212991|324404086|FG001|Open-label|Other|0|||
94712079|NCT01212991|324404087|FG002|Open-label|Other|3|||
94712080|NCT03807778|324404094|FG000|Overall Study|Adverse Event|0|||
94712081|NCT03807778|324404095|FG001|Overall Study|Adverse Event|0|||
94712082|NCT03807778|324404096|FG002|Overall Study|Adverse Event|3|||
94712083|NCT03807778|324404097|FG003|Overall Study|Adverse Event|5|||
94712084|NCT03807778|324404094|FG000|Overall Study|Progressive Disease|4|||
94712085|NCT03807778|324404095|FG001|Overall Study|Progressive Disease|2|||
94466683|NCT00483704|323497093|FG000|Randomization|Progressive disease|0|||
94466684|NCT00483704|323497094|FG001|Randomization|Progressive disease|0|||
94466685|NCT00483704|323497095|FG002|Randomization|Progressive disease|1|||
94466686|NCT00483704|323497093|FG000|Randomization|Lack of qualifying migraines|21|||
94466687|NCT00483704|323497094|FG001|Randomization|Lack of qualifying migraines|25|||
94466688|NCT00483704|323497095|FG002|Randomization|Lack of qualifying migraines|31|||
94466689|NCT00483704|323497093|FG000|Treatment|Lack of qualifying migraines|101|||
94466690|NCT00483704|323497094|FG001|Treatment|Lack of qualifying migraines|99|||
94466691|NCT00483704|323497095|FG002|Treatment|Lack of qualifying migraines|116|||
94466692|NCT00483704|323497093|FG000|Treatment|Adverse Event|3|||
94466693|NCT00483704|323497094|FG001|Treatment|Adverse Event|5|||
94466694|NCT00483704|323497095|FG002|Treatment|Adverse Event|4|||
94466695|NCT00483704|323497093|FG000|Treatment|Withdrawal by Subject|16|||
94466696|NCT00483704|323497094|FG001|Treatment|Withdrawal by Subject|12|||
94466697|NCT00483704|323497095|FG002|Treatment|Withdrawal by Subject|21|||
94466698|NCT00483704|323497093|FG000|Treatment|Protocol Violation|6|||
94466699|NCT00483704|323497094|FG001|Treatment|Protocol Violation|3|||
94466700|NCT00483704|323497095|FG002|Treatment|Protocol Violation|5|||
94466701|NCT00483704|323497093|FG000|Treatment|Lost to Follow-up|2|||
94466702|NCT00483704|323497094|FG001|Treatment|Lost to Follow-up|7|||
94466703|NCT00483704|323497095|FG002|Treatment|Lost to Follow-up|5|||
94466704|NCT00483704|323497093|FG000|Treatment|Lack of Efficacy|1|||
94466705|NCT00483704|323497094|FG001|Treatment|Lack of Efficacy|1|||
94466706|NCT00483704|323497095|FG002|Treatment|Lack of Efficacy|1|||
94466707|NCT00483704|323497093|FG000|Treatment|Pregnancy|0|||
94466708|NCT00483704|323497094|FG001|Treatment|Pregnancy|1|||
94466709|NCT00483704|323497095|FG002|Treatment|Pregnancy|0|||
94466710|NCT00483704|323497093|FG000|Treatment|Physician Decision|0|||
94466711|NCT00483704|323497094|FG001|Treatment|Physician Decision|1|||
94466712|NCT00483704|323497095|FG002|Treatment|Physician Decision|4|||
94466713|NCT01534208|323497096|FG000|Overall Study|Lost to Follow-up|19|||
94466714|NCT01534208|323497097|FG001|Overall Study|Lost to Follow-up|14|||
94466715|NCT01534208|323497096|FG000|Overall Study|Withdrawal by Subject|6|||
94466716|NCT01534208|323497097|FG001|Overall Study|Withdrawal by Subject|20|||
94466717|NCT01534208|323497096|FG000|Overall Study|Adverse Event|15|||
94466718|NCT01534208|323497097|FG001|Overall Study|Adverse Event|8|||
94466719|NCT01534208|323497096|FG000|Overall Study|Physician Decision|2|||
94466720|NCT01534208|323497097|FG001|Overall Study|Physician Decision|0|||
94466721|NCT01534208|323497096|FG000|Overall Study|Lack of Efficacy|0|||
94466722|NCT01534208|323497097|FG001|Overall Study|Lack of Efficacy|3|||
94466723|NCT01534208|323497096|FG000|Overall Study|Protocol Violation|2|||
94466724|NCT01534208|323497097|FG001|Overall Study|Protocol Violation|2|||
94466725|NCT01534208|323497096|FG000|Overall Study|Sponsor decision|4|||
94466726|NCT01534208|323497097|FG001|Overall Study|Sponsor decision|1|||
94466727|NCT01534208|323497096|FG000|Overall Study|Subject relocation|2|||
94466728|NCT01534208|323497097|FG001|Overall Study|Subject relocation|0|||
94466729|NCT01534208|323497096|FG000|Overall Study|Lab assessment|2|||
94466730|NCT01534208|323497097|FG001|Overall Study|Lab assessment|1|||
94712086|NCT03807778|324404096|FG002|Overall Study|Progressive Disease|8|||
94712087|NCT03807778|324404097|FG003|Overall Study|Progressive Disease|15|||
94712088|NCT03807778|324404094|FG000|Overall Study|Symptomatic Deterioration|0|||
94712089|NCT03807778|324404095|FG001|Overall Study|Symptomatic Deterioration|1|||
94466731|NCT01534208|323497096|FG000|Overall Study|Eligibility error|3|||
94466732|NCT01534208|323497097|FG001|Overall Study|Eligibility error|0|||
94466733|NCT01534208|323497096|FG000|Overall Study|PCP decision|1|||
94466734|NCT01534208|323497097|FG001|Overall Study|PCP decision|0|||
94466735|NCT01534208|323497096|FG000|Overall Study|Needed prohibited meds|1|||
94466736|NCT01534208|323497097|FG001|Overall Study|Needed prohibited meds|0|||
94466737|NCT01904903|323497099|FG000|Overall Study|Withdrawal by Subject|1|||
94466738|NCT01706575|323497102|FG000|Overall Study|Participant Withdrew Consent|4|||
94466739|NCT01706575|323497102|FG000|Overall Study|Lost to Follow-up|2|||
94466740|NCT01706575|323497102|FG000|Overall Study|Started but not Treated|6|||
94466741|NCT00634049|323497103|FG000|Overall Study|Never received study drug|1|||
94466742|NCT00634049|323497103|FG000|Overall Study|Died prior to receiving study drug|1|||
94466743|NCT00634049|323497103|FG000|Overall Study|Screening failure|1|||
94466744|NCT02536781|323497104|FG000|Overall Study|Lost to Follow-up|2|||
94712090|NCT03807778|324404096|FG002|Overall Study|Symptomatic Deterioration|0|||
94712091|NCT03807778|324404097|FG003|Overall Study|Symptomatic Deterioration|1|||
94466745|NCT02536781|323497105|FG001|Overall Study|Lost to Follow-up|0|||
94466746|NCT02921750|323498521|FG000|Overall Study|Adverse Event|1|||
94466747|NCT02921750|323498522|FG001|Overall Study|Adverse Event|2|||
94466748|NCT02921750|323498521|FG000|Overall Study|Withdrawal by Subject|1|||
94466749|NCT02921750|323498522|FG001|Overall Study|Withdrawal by Subject|1|||
94466750|NCT02921750|323498521|FG000|Overall Study|Lost to Follow-up|3|||
94466751|NCT02921750|323498522|FG001|Overall Study|Lost to Follow-up|3|||
94466752|NCT02921750|323498521|FG000|Overall Study|Wound healed|3|||
94466753|NCT02921750|323498522|FG001|Overall Study|Wound healed|3|||
94466754|NCT02921750|323498521|FG000|Overall Study|Serious Adverse Event|1|||
94466755|NCT02921750|323498522|FG001|Overall Study|Serious Adverse Event|2|||
94466756|NCT02638129|323498524|FG000|Overall Study|Study terminated|28|||
94466757|NCT02638129|323498525|FG001|Overall Study|Study terminated|30|||
94466758|NCT02304380|323498526|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
94466759|NCT02304380|323498527|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
94466760|NCT02304380|323498528|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
94466761|NCT02304380|323498529|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
94466762|NCT02304380|323498530|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
94466763|NCT02304380|323498531|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
94466764|NCT02607280|323498532|FG000|Overall Study|Adverse Event|4|||
94466765|NCT02607280|323498533|FG001|Overall Study|Adverse Event|0|||
94466766|NCT02607280|323498532|FG000|Overall Study|Decrease in CrCl <15|0|||
94466767|NCT02607280|323498533|FG001|Overall Study|Decrease in CrCl <15|1|||
94466768|NCT02696434|323498534|FG000|Overall Study|Adverse Event|3|||
94466769|NCT02696434|323498535|FG001|Overall Study|Adverse Event|1|||
94466770|NCT02696434|323498534|FG000|Overall Study|Lost to Follow-up|5|||
94466771|NCT02696434|323498535|FG001|Overall Study|Lost to Follow-up|4|||
94466772|NCT02696434|323498534|FG000|Overall Study|Withdrawal by Subject|14|||
94466773|NCT02696434|323498535|FG001|Overall Study|Withdrawal by Subject|12|||
94466774|NCT02696434|323498534|FG000|Overall Study|Physician Decision|0|||
94466775|NCT02696434|323498535|FG001|Overall Study|Physician Decision|1|||
94466776|NCT00590538|323498536|FG000|Overall Study|Study terminated before completed|2|||
94466777|NCT02380859|323498537|FG000|Overall Study|Withdrawal by Subject|2|||
94466778|NCT02380859|323498538|FG001|Overall Study|Withdrawal by Subject|0|||
94466779|NCT02971800|323498539|FG000|Overall Study|Protocol Violation|1|||
94466780|NCT02971800|323498539|FG000|Overall Study|Withdrawal by Subject|1|||
94466781|NCT02971800|323498539|FG000|Overall Study|Exclusion criteria prior intervention|1|||
94466782|NCT02971800|323498539|FG000|Overall Study|Number evaluable participant already reached|4|||
94466783|NCT05323994|323498540|FG000|Overall Study|Protocol Violation|1|||
94466784|NCT01420679|323498543|FG000|Overall Study|Disease Progression|3|||
94466785|NCT01420679|323498544|FG001|Overall Study|Disease Progression|2|||
94466786|NCT01420679|323498543|FG000|Overall Study|Adverse Event|4|||
94466787|NCT01420679|323498544|FG001|Overall Study|Adverse Event|0|||
94466788|NCT01420679|323498543|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
94466789|NCT01420679|323498544|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
94466790|NCT01420679|323498543|FG000|Overall Study|Patient Decision|1|||
94466791|NCT01420679|323498544|FG001|Overall Study|Patient Decision|0|||
94466792|NCT01420679|323498543|FG000|Overall Study|Investigator Decision|1|||
94466793|NCT01420679|323498544|FG001|Overall Study|Investigator Decision|2|||
94466794|NCT01420679|323498543|FG000|Overall Study|Sponsor Decision|3|||
94466795|NCT01420679|323498544|FG001|Overall Study|Sponsor Decision|3|||
94466796|NCT01420679|323498543|FG000|Overall Study|Other|1|||
94466797|NCT01420679|323498544|FG001|Overall Study|Other|0|||
94466798|NCT00480493|323498545|FG000|Overall Study|moved|2|||
94466799|NCT00480493|323498546|FG001|Overall Study|moved|7|||
94466800|NCT04027075|323498547|FG000|Overall Study|Lost to Follow-up|41|||
94466801|NCT04027075|323498548|FG001|Overall Study|Lost to Follow-up|22|||
94466802|NCT03769675|323498549|FG000|Overall Study|Lost to Follow-up|1|||
94466803|NCT01032070|323498550|FG000|Overall Study|Disease progression|13|||
94466804|NCT01032070|323498551|FG001|Overall Study|Disease progression|8|||
94270094|NCT04667377|322782081|FG001|Maintenance Period|Change of residence|1|||
94270095|NCT04667377|322782082|FG002|Maintenance Period|Change of residence|0|||
94270096|NCT04667377|322782083|FG003|Maintenance Period|Change of residence|0|||
94270097|NCT04667377|322782084|FG004|Maintenance Period|Change of residence|1|||
94270098|NCT04667377|322782080|FG000|Maintenance Period|Missing|1|||
94270099|NCT04667377|322782081|FG001|Maintenance Period|Missing|0|||
94270100|NCT04667377|322782082|FG002|Maintenance Period|Missing|0|||
94466805|NCT01032070|323498550|FG000|Overall Study|Medical or ethical reasons|0|||
94466806|NCT01032070|323498551|FG001|Overall Study|Medical or ethical reasons|2|||
94466807|NCT01032070|323498550|FG000|Overall Study|Withdrawal by Subject|0|||
94270101|NCT04667377|322782083|FG003|Maintenance Period|Missing|0|||
94466808|NCT01032070|323498551|FG001|Overall Study|Withdrawal by Subject|2|||
94466809|NCT00329641|323498554|FG000|Overall Study|Did not start treatment|1|||
94466810|NCT00329641|323498554|FG000|Overall Study|Not eligible|1|||
94466811|NCT00329641|323498554|FG000|Overall Study|Adverse Event|3|||
94466812|NCT00329641|323498554|FG000|Overall Study|Other reason, not protocol specified|1|||
94466813|NCT00396877|323498558|FG000|Overall Study|Lost to Follow-up|2|||
94466814|NCT00396877|323498559|FG001|Overall Study|Lost to Follow-up|1|||
94466815|NCT00396877|323498558|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
94466816|NCT00396877|323498559|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
94466817|NCT03422159|323498560|FG000|Overall Study|Exclusion due to terminal disease|2|||
94466818|NCT03422159|323498561|FG001|Overall Study|Exclusion due to terminal disease|1|||
94466819|NCT02631070|323498562|FG000|Overall Study|Withdrawal by Subject|35|||
94466820|NCT02631070|323498563|FG001|Overall Study|Withdrawal by Subject|13|||
94466821|NCT02631070|323498562|FG000|Overall Study|Death|45|||
94466822|NCT02631070|323498563|FG001|Overall Study|Death|24|||
94270102|NCT04667377|322782084|FG004|Maintenance Period|Missing|0|||
94466823|NCT02631070|323498562|FG000|Overall Study|Lost to Follow-up|5|||
94466824|NCT02631070|323498563|FG001|Overall Study|Lost to Follow-up|1|||
94466825|NCT02631070|323498562|FG000|Overall Study|Transition to rollover protocol|52|||
94466826|NCT02631070|323498563|FG001|Overall Study|Transition to rollover protocol|21|||
94466827|NCT02631070|323498562|FG000|Overall Study|Other reasons|12|||
94466828|NCT02631070|323498563|FG001|Overall Study|Other reasons|5|||
94466829|NCT03515629|323498564|FG000|Overall Study|Death|0|||
94466830|NCT03515629|323498565|FG001|Overall Study|Death|1|||
94466831|NCT03515629|323498566|FG002|Overall Study|Death|1|||
94466832|NCT03515629|323498564|FG000|Overall Study|Progressive disease|0|||
94466833|NCT03515629|323498565|FG001|Overall Study|Progressive disease|1|||
94466834|NCT03515629|323498566|FG002|Overall Study|Progressive disease|0|||
94466835|NCT00980018|323498571|FG000|Overall Study|Adverse Event|8|||
94466836|NCT00980018|323498571|FG000|Overall Study|Patient withdrew consent|3|||
94466837|NCT00980018|323498571|FG000|Overall Study|Lost to Follow-up|1|||
94466838|NCT00987402|323498572|FG000|Overall Study|Insufficient data entry|86|||
94466839|NCT00987402|323498573|FG001|Overall Study|Insufficient data entry|98|||
94466840|NCT03597022|323498575|FG000|Overall Study|Premature termination of the study|7|||
94466841|NCT03597022|323498576|FG001|Overall Study|Premature termination of the study|7|||
94466842|NCT03597022|323498577|FG002|Overall Study|Premature termination of the study|8|||
94466843|NCT03597022|323498575|FG000|Overall Study|Serious adverse event|1|||
94466844|NCT03597022|323498576|FG001|Overall Study|Serious adverse event|1|||
94466845|NCT03597022|323498577|FG002|Overall Study|Serious adverse event|0|||
94466846|NCT00106639|323498578|FG000|Overall Study|Adverse Event|3|||
94466847|NCT00106639|323498579|FG001|Overall Study|Adverse Event|4|||
94466848|NCT00106639|323498580|FG002|Overall Study|Adverse Event|1|||
94466849|NCT00106639|323498578|FG000|Overall Study|Protocol Violation|0|||
94712092|NCT03807778|324404094|FG000|Overall Study|Withdrawal by Subject|0|||
94712093|NCT03807778|324404095|FG001|Overall Study|Withdrawal by Subject|1|||
94712094|NCT03807778|324404096|FG002|Overall Study|Withdrawal by Subject|0|||
94712095|NCT03807778|324404097|FG003|Overall Study|Withdrawal by Subject|1|||
94712096|NCT03807778|324404094|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
94712097|NCT03807778|324404095|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
94712098|NCT03807778|324404096|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
94712099|NCT03807778|324404097|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
94712100|NCT05135000|324404098|FG000|Overall Study|Adverse Event|2|||
94712101|NCT05135000|324404099|FG001|Overall Study|Adverse Event|0|||
94712102|NCT05135000|324404098|FG000|Overall Study|Lost to Follow-up|1|||
94712103|NCT05135000|324404099|FG001|Overall Study|Lost to Follow-up|0|||
94712104|NCT05135000|324404098|FG000|Overall Study|Study Terminated by Sponsor|6|||
94712105|NCT05135000|324404099|FG001|Overall Study|Study Terminated by Sponsor|3|||
94270103|NCT04667377|322782080|FG000|Maintenance Period|Other than listed above|2|||
94466850|NCT00106639|323498579|FG001|Overall Study|Protocol Violation|1|||
94466851|NCT00106639|323498580|FG002|Overall Study|Protocol Violation|0|||
94466852|NCT00106639|323498578|FG000|Overall Study|Withdrawal by Subject|0|||
94466853|NCT00106639|323498579|FG001|Overall Study|Withdrawal by Subject|1|||
94466854|NCT00106639|323498580|FG002|Overall Study|Withdrawal by Subject|0|||
94466855|NCT00106639|323498578|FG000|Overall Study|Participant defaulted|0|||
94712106|NCT00089544|324405256|FG000|Overall Study|Ineligible|1|||
94712107|NCT00089544|324405257|FG001|Overall Study|Ineligible|0|||
94712108|NCT03648762|324405259|FG000|Overall Study|Lost to Follow-up|1|||
94712109|NCT03648762|324405260|FG001|Overall Study|Lost to Follow-up|2|||
94712110|NCT03648762|324405261|FG002|Overall Study|Lost to Follow-up|0|||
94712111|NCT03648762|324405259|FG000|Overall Study|Withdrawal by Subject|5|||
94712112|NCT03648762|324405260|FG001|Overall Study|Withdrawal by Subject|2|||
94712113|NCT03648762|324405261|FG002|Overall Study|Withdrawal by Subject|1|||
94712114|NCT02189252|324405262|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
94712115|NCT02189252|324405263|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
94712116|NCT02189252|324405264|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
94712117|NCT02189252|324405265|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
94712118|NCT02189252|324405262|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
94712119|NCT02189252|324405263|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
94712120|NCT02189252|324405264|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
94712121|NCT02189252|324405265|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
94712122|NCT00840177|324405266|FG000|Overall Study|Adverse Event|5|||
94712123|NCT00840177|324405267|FG001|Overall Study|Adverse Event|1|||
94712124|NCT00840177|324405268|FG002|Overall Study|Adverse Event|1|||
94712125|NCT00840177|324405266|FG000|Overall Study|Refusal unrelated to adverse events|1|||
94712126|NCT00840177|324405267|FG001|Overall Study|Refusal unrelated to adverse events|0|||
94712127|NCT00840177|324405268|FG002|Overall Study|Refusal unrelated to adverse events|1|||
94712128|NCT00840177|324405266|FG000|Overall Study|Progression/relapse|2|||
94712129|NCT00840177|324405267|FG001|Overall Study|Progression/relapse|0|||
94712130|NCT00840177|324405268|FG002|Overall Study|Progression/relapse|0|||
94712131|NCT00840177|324405266|FG000|Overall Study|Death|4|||
94712132|NCT00840177|324405267|FG001|Overall Study|Death|5|||
94712133|NCT00840177|324405268|FG002|Overall Study|Death|5|||
94712134|NCT00840177|324405266|FG000|Overall Study|not protocol specified|6|||
94712135|NCT00840177|324405267|FG001|Overall Study|not protocol specified|3|||
94712136|NCT00840177|324405268|FG002|Overall Study|not protocol specified|0|||
94712137|NCT00840177|324405266|FG000|Overall Study|Ineligible|0|||
94712138|NCT00840177|324405267|FG001|Overall Study|Ineligible|0|||
94712139|NCT00840177|324405268|FG002|Overall Study|Ineligible|3|||
94712140|NCT00840177|324405266|FG000|Overall Study|Did not start treatment|0|||
94712141|NCT00840177|324405267|FG001|Overall Study|Did not start treatment|0|||
94712142|NCT00840177|324405268|FG002|Overall Study|Did not start treatment|1|||
94712143|NCT04603924|324405269|FG000|Overall Study|Not Dosed|2|||
94712144|NCT04603924|324405270|FG001|Overall Study|Not Dosed|1|||
94712145|NCT04603924|324405269|FG000|Overall Study|Withdrawal by Subject|6|||
94712146|NCT04603924|324405270|FG001|Overall Study|Withdrawal by Subject|6|||
94712147|NCT04603924|324405269|FG000|Overall Study|Adverse Event|2|||
94712148|NCT04603924|324405270|FG001|Overall Study|Adverse Event|2|||
94712149|NCT03454529|324405286|FG000|Overall Study|Did not receive treatment|6|||
94712150|NCT03454529|324405286|FG000|Overall Study|Received < 80% doses|1|||
94712151|NCT02567656|324405287|FG000|Overall Study|Premature discontinuation due to PD|1|||
94712152|NCT02567656|324405288|FG001|Overall Study|Premature discontinuation due to PD|1|||
94712153|NCT02567656|324405289|FG002|Overall Study|Premature discontinuation due to PD|2|||
94712154|NCT02567656|324405290|FG003|Overall Study|Premature discontinuation due to PD|0|||
94712155|NCT02567656|324405291|FG004|Overall Study|Premature discontinuation due to PD|0|||
94712156|NCT02567656|324405292|FG005|Overall Study|Premature discontinuation due to PD|0|||
94712157|NCT04532528|324405296|FG000|Overall Study|Adverse Event|12|||
94712158|NCT04532528|324405297|FG001|Overall Study|Adverse Event|17|||
94712159|NCT04532528|324405296|FG000|Overall Study|Withdrawal of consent|16|||
94712160|NCT04532528|324405297|FG001|Overall Study|Withdrawal of consent|17|||
94712161|NCT04532528|324405296|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
94367063|NCT00791154|323129569|FG000|Overall Study|Full Consent withdrawn|1|||
94367064|NCT00791154|323129570|FG001|Overall Study|Full Consent withdrawn|3|||
94367065|NCT00791154|323129571|FG002|Overall Study|Full Consent withdrawn|0|||
94367066|NCT00791154|323129572|FG003|Overall Study|Full Consent withdrawn|0|||
94367067|NCT00791154|323129573|FG004|Overall Study|Full Consent withdrawn|1|||
94367068|NCT00791154|323129574|FG005|Overall Study|Full Consent withdrawn|3|||
94367069|NCT00791154|323129575|FG006|Overall Study|Full Consent withdrawn|1|||
94367070|NCT00791154|323129569|FG000|Overall Study|Lost to Follow-up|0|||
94712162|NCT04532528|324405297|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
94712163|NCT04532528|324405296|FG000|Overall Study|Lost to Follow-up|69|||
94712164|NCT04532528|324405297|FG001|Overall Study|Lost to Follow-up|68|||
94712165|NCT04532528|324405296|FG000|Overall Study|Administrative problems|12|||
94712166|NCT04532528|324405297|FG001|Overall Study|Administrative problems|14|||
94712167|NCT04532528|324405296|FG000|Overall Study|Death|3|||
94712168|NCT04532528|324405297|FG001|Overall Study|Death|3|||
94712169|NCT04532528|324405296|FG000|Overall Study|Other|38|||
94712170|NCT04532528|324405297|FG001|Overall Study|Other|46|||
94712171|NCT01460290|324405300|FG000|Overall Study|Adverse Event|3|||
94712172|NCT01460290|324405300|FG000|Overall Study|Elevated liver function|1|||
94712173|NCT02918279|324405301|FG000|Overall Study|Lost to Follow-up|3|||
94367071|NCT00791154|323129570|FG001|Overall Study|Lost to Follow-up|0|||
94712174|NCT02918279|324405302|FG001|Overall Study|Lost to Follow-up|6|||
94712175|NCT02918279|324405301|FG000|Overall Study|Withdrawal by Subject|5|||
94712176|NCT02918279|324405302|FG001|Overall Study|Withdrawal by Subject|15|||
94712177|NCT02918279|324405301|FG000|Overall Study|Withdrawal by parent/guardian|2|||
94712178|NCT02918279|324405302|FG001|Overall Study|Withdrawal by parent/guardian|1|||
94712179|NCT02918279|324405301|FG000|Overall Study|Other|3|||
94712180|NCT02918279|324405302|FG001|Overall Study|Other|1|||
94712181|NCT00309907|324405307|FG000|Overall Study|Death|4|||
94712182|NCT00309907|324405307|FG000|Overall Study|Physician Decision|1|||
94712183|NCT00309907|324405307|FG000|Overall Study|Ineligible|11|||
94712184|NCT00309907|324405307|FG000|Overall Study|Major infectious event|4|||
94712185|NCT01641198|324405308|FG000|After 12 Months of Function|Lost to Follow-up|3|||
94712186|NCT01641198|324405309|FG001|After 12 Months of Function|Lost to Follow-up|2|||
94712187|NCT01641198|324405310|FG002|After 12 Months of Function|Lost to Follow-up|2|||
94712188|NCT01641198|324405308|FG000|After 12 Months of Function|Protocol Violation|1|||
94712189|NCT01641198|324405309|FG001|After 12 Months of Function|Protocol Violation|0|||
94712190|NCT01641198|324405310|FG002|After 12 Months of Function|Protocol Violation|0|||
94712191|NCT01641198|324405308|FG000|After 12 Months of Function|Adverse Event|0|||
94712192|NCT01641198|324405309|FG001|After 12 Months of Function|Adverse Event|1|||
94712193|NCT01641198|324405310|FG002|After 12 Months of Function|Adverse Event|0|||
94712194|NCT01641198|324405308|FG000|After 24 Months of Function|Lost to Follow-up|4|||
94367072|NCT00791154|323129571|FG002|Overall Study|Lost to Follow-up|0|||
94367073|NCT00791154|323129572|FG003|Overall Study|Lost to Follow-up|1|||
94367074|NCT00791154|323129573|FG004|Overall Study|Lost to Follow-up|2|||
94466856|NCT00106639|323498579|FG001|Overall Study|Participant defaulted|1|||
94466857|NCT00106639|323498580|FG002|Overall Study|Participant defaulted|1|||
94466858|NCT01430624|323498583|FG000|Overall Study|Lost to Follow-up|23|||
94466859|NCT01430624|323498584|FG001|Overall Study|Lost to Follow-up|29|||
94466860|NCT01430624|323498585|FG002|Overall Study|Lost to Follow-up|27|||
94466861|NCT01430624|323498583|FG000|Overall Study|technical or eligibility|5|||
94466862|NCT01430624|323498584|FG001|Overall Study|technical or eligibility|5|||
94466863|NCT01430624|323498585|FG002|Overall Study|technical or eligibility|2|||
94466864|NCT00087126|323498586|FG000|Overall Study|Ineligible - second primary|1|||
94466865|NCT00087126|323498586|FG000|Overall Study|Never treated|1|||
94466866|NCT03217968|323498594|FG000|Overall Study|Withdrawal by Subject|4|||
94466867|NCT03217968|323498594|FG000|Overall Study|Lost to Follow-up|1|||
94466868|NCT03217968|323498594|FG000|Overall Study|Protocol Violation|6|||
94466869|NCT01438814|323498596|FG000|Overall Study|Adverse Event|3|||
94466870|NCT01438814|323498597|FG001|Overall Study|Adverse Event|3|||
94466871|NCT01438814|323498596|FG000|Overall Study|Protocol Violation|1|||
94466872|NCT01438814|323498597|FG001|Overall Study|Protocol Violation|2|||
94466873|NCT01438814|323498596|FG000|Overall Study|Lost to Follow-up|4|||
94466874|NCT01438814|323498597|FG001|Overall Study|Lost to Follow-up|3|||
94466875|NCT01438814|323498596|FG000|Overall Study|Withdrawal by Subject|4|||
94466876|NCT01438814|323498597|FG001|Overall Study|Withdrawal by Subject|2|||
94367075|NCT00791154|323129574|FG005|Overall Study|Lost to Follow-up|0|||
94367076|NCT00791154|323129575|FG006|Overall Study|Lost to Follow-up|4|||
94367077|NCT00791154|323129569|FG000|Overall Study|Death|5|||
94367078|NCT00791154|323129570|FG001|Overall Study|Death|4|||
94466877|NCT01438814|323498596|FG000|Overall Study|Other|2|||
94466878|NCT01438814|323498597|FG001|Overall Study|Other|4|||
94466879|NCT05268016|323498598|FG000|Overall Study|Unacceptable toxicity or AE|2|||
94466880|NCT05268016|323498599|FG001|Overall Study|Unacceptable toxicity or AE|2|||
94466881|NCT05268016|323498600|FG002|Overall Study|Unacceptable toxicity or AE|4|||
94466882|NCT05268016|323498601|FG003|Overall Study|Unacceptable toxicity or AE|3|||
94466883|NCT05268016|323498602|FG004|Overall Study|Unacceptable toxicity or AE|1|||
94466884|NCT05268016|323498598|FG000|Overall Study|Withdrawal by Subject|1|||
94466885|NCT05268016|323498599|FG001|Overall Study|Withdrawal by Subject|3|||
94466886|NCT05268016|323498600|FG002|Overall Study|Withdrawal by Subject|2|||
94466887|NCT05268016|323498601|FG003|Overall Study|Withdrawal by Subject|2|||
94466888|NCT05268016|323498602|FG004|Overall Study|Withdrawal by Subject|1|||
94466889|NCT05268016|323498598|FG000|Overall Study|Lost to Follow-up|4|||
94466890|NCT05268016|323498599|FG001|Overall Study|Lost to Follow-up|7|||
94466891|NCT05268016|323498600|FG002|Overall Study|Lost to Follow-up|1|||
94466892|NCT05268016|323498601|FG003|Overall Study|Lost to Follow-up|3|||
94466893|NCT05268016|323498602|FG004|Overall Study|Lost to Follow-up|5|||
94466894|NCT05268016|323498598|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
94466895|NCT05268016|323498599|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
94466896|NCT05268016|323498600|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
94466897|NCT05268016|323498601|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
94712195|NCT01641198|324405309|FG001|After 24 Months of Function|Lost to Follow-up|9|||
94712196|NCT01641198|324405310|FG002|After 24 Months of Function|Lost to Follow-up|6|||
94367079|NCT00791154|323129571|FG002|Overall Study|Death|4|||
94367080|NCT00791154|323129572|FG003|Overall Study|Death|7|||
94466898|NCT05268016|323498602|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
94270104|NCT04667377|322782081|FG001|Maintenance Period|Other than listed above|0|||
94270105|NCT04667377|322782082|FG002|Maintenance Period|Other than listed above|3|||
94270106|NCT04667377|322782083|FG003|Maintenance Period|Other than listed above|2|||
94270107|NCT04667377|322782084|FG004|Maintenance Period|Other than listed above|6|||
94270108|NCT04667377|322782080|FG000|Maintenance Period|Withdrawal by Subject|0|||
94270109|NCT04667377|322782081|FG001|Maintenance Period|Withdrawal by Subject|1|||
94270110|NCT04667377|322782082|FG002|Maintenance Period|Withdrawal by Subject|0|||
94270111|NCT04667377|322782083|FG003|Maintenance Period|Withdrawal by Subject|0|||
94270112|NCT04667377|322782084|FG004|Maintenance Period|Withdrawal by Subject|0|||
94270113|NCT04667377|322782080|FG000|Maintenance Period|Lost to Follow-up|1|||
94270114|NCT04667377|322782081|FG001|Maintenance Period|Lost to Follow-up|0|||
94270115|NCT04667377|322782082|FG002|Maintenance Period|Lost to Follow-up|1|||
94270116|NCT04667377|322782083|FG003|Maintenance Period|Lost to Follow-up|0|||
94270117|NCT04667377|322782084|FG004|Maintenance Period|Lost to Follow-up|1|||
94270118|NCT02819635|322782085|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
94270119|NCT02819635|322782086|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
94270120|NCT02819635|322782087|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
94270121|NCT02819635|322782088|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
94270122|NCT02819635|322782089|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
94270123|NCT02819635|322782090|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
94270124|NCT02819635|322782091|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
94270125|NCT02819635|322782092|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
94270126|NCT02819635|322782093|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
94270127|NCT02819635|322782094|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
94270128|NCT02819635|322782095|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
94653099|NCT00844545|324188020|FG000|Post Treatment Period|Withdrawal by Subject|1|||
94653100|NCT01743092|324188021|FG000|Overall Study|Lost to Follow-up|14|||
94653101|NCT01743092|324188022|FG001|Overall Study|Lost to Follow-up|15|||
94653102|NCT00563797|324188026|FG000|Overall Study|Lost to Follow-up|7|||
94653103|NCT00563797|324188027|FG001|Overall Study|Lost to Follow-up|2|||
94653104|NCT01794949|324188030|FG000|Overall Study|Lost to Follow-up|1|||
94653105|NCT01794949|324188031|FG001|Overall Study|Lost to Follow-up|0|||
94653106|NCT02984995|324188032|FG000|Overall Study|Required stem cell transplant|13|||
94653107|NCT02984995|324188033|FG001|Overall Study|Required stem cell transplant|2|||
94653108|NCT02984995|324188032|FG000|Overall Study|Progressive disease|11|||
94653109|NCT02984995|324188033|FG001|Overall Study|Progressive disease|1|||
94653110|NCT02984995|324188032|FG000|Overall Study|Adverse Event|1|||
94653111|NCT02984995|324188033|FG001|Overall Study|Adverse Event|0|||
94653112|NCT04574362|324188038|FG000|Overall Study|Other|0|||
94653113|NCT04574362|324188039|FG001|Overall Study|Other|5|||
94653114|NCT04574362|324188038|FG000|Overall Study|COVID-19|0|||
94653115|NCT04574362|324188039|FG001|Overall Study|COVID-19|1|||
94653116|NCT04574362|324188038|FG000|Overall Study|Adverse Event|1|||
94653117|NCT04574362|324188039|FG001|Overall Study|Adverse Event|1|||
94653118|NCT04574362|324188038|FG000|Overall Study|Withdrawal by Subject|2|||
94653119|NCT04574362|324188039|FG001|Overall Study|Withdrawal by Subject|4|||
94653120|NCT04574362|324188038|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
94653121|NCT04574362|324188039|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
94653122|NCT04574362|324188038|FG000|Overall Study|Participant refused to come to the hospital|1|||
94653123|NCT04574362|324188039|FG001|Overall Study|Participant refused to come to the hospital|0|||
94653124|NCT04574362|324188038|FG000|Overall Study|Participant refused the visit|1|||
94653125|NCT04574362|324188039|FG001|Overall Study|Participant refused the visit|0|||
94653126|NCT04574362|324188038|FG000|Overall Study|Participant quit early because of business trip|1|||
94653127|NCT04574362|324188039|FG001|Overall Study|Participant quit early because of business trip|0|||
94653128|NCT01332305|324188040|FG000|Overall Study|Adverse Event|1|||
94653129|NCT01332305|324188041|FG001|Overall Study|Adverse Event|4|||
94653130|NCT01332305|324188042|FG002|Overall Study|Adverse Event|6|||
94653131|NCT01332305|324188043|FG003|Overall Study|Adverse Event|3|||
94653132|NCT01332305|324188044|FG004|Overall Study|Adverse Event|5|||
94653133|NCT01332305|324188040|FG000|Overall Study|Withdrawal by Subject|6|||
94653134|NCT01332305|324188041|FG001|Overall Study|Withdrawal by Subject|5|||
94653135|NCT01332305|324188042|FG002|Overall Study|Withdrawal by Subject|4|||
94653136|NCT01332305|324188043|FG003|Overall Study|Withdrawal by Subject|1|||
94653137|NCT01332305|324188044|FG004|Overall Study|Withdrawal by Subject|0|||
94653138|NCT01332305|324188040|FG000|Overall Study|Lost to Follow-up|0|||
94270129|NCT02819635|322782096|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
94270130|NCT02819635|322782085|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
94653139|NCT01332305|324188041|FG001|Overall Study|Lost to Follow-up|2|||
94653140|NCT01332305|324188042|FG002|Overall Study|Lost to Follow-up|3|||
94653141|NCT01332305|324188043|FG003|Overall Study|Lost to Follow-up|2|||
94653142|NCT01332305|324188044|FG004|Overall Study|Lost to Follow-up|3|||
94653143|NCT01332305|324188040|FG000|Overall Study|Protocol Violation|1|||
94653144|NCT01332305|324188041|FG001|Overall Study|Protocol Violation|2|||
94653145|NCT01332305|324188042|FG002|Overall Study|Protocol Violation|1|||
94466899|NCT05268016|323498598|FG000|Overall Study|Lack of Efficacy|0|||
94466900|NCT05268016|323498599|FG001|Overall Study|Lack of Efficacy|0|||
94466901|NCT05268016|323498600|FG002|Overall Study|Lack of Efficacy|0|||
94466902|NCT05268016|323498601|FG003|Overall Study|Lack of Efficacy|0|||
94466903|NCT05268016|323498602|FG004|Overall Study|Lack of Efficacy|4|||
94466904|NCT05268016|323498598|FG000|Overall Study|Physician Decision|0|||
94466905|NCT05268016|323498599|FG001|Overall Study|Physician Decision|0|||
94466906|NCT05268016|323498600|FG002|Overall Study|Physician Decision|0|||
94466907|NCT05268016|323498601|FG003|Overall Study|Physician Decision|1|||
94466908|NCT05268016|323498602|FG004|Overall Study|Physician Decision|0|||
94466909|NCT05268016|323498598|FG000|Overall Study|Other|1|||
94466910|NCT05268016|323498599|FG001|Overall Study|Other|0|||
94466911|NCT05268016|323498600|FG002|Overall Study|Other|1|||
94466912|NCT05268016|323498601|FG003|Overall Study|Other|2|||
94466913|NCT05268016|323498602|FG004|Overall Study|Other|0|||
94466914|NCT00513357|323498605|FG000|Overall Study|did not receive allocated placebo|2|||
94466915|NCT00513357|323498606|FG001|Overall Study|did not receive allocated placebo|3|||
94466916|NCT00513357|323498605|FG000|Overall Study|Adverse Event|4|||
94466917|NCT00513357|323498606|FG001|Overall Study|Adverse Event|2|||
94466918|NCT00513357|323498605|FG000|Overall Study|Death|2|||
94466919|NCT00513357|323498606|FG001|Overall Study|Death|0|||
94466920|NCT00513357|323498605|FG000|Overall Study|Withdrawal by Subject|5|||
94466921|NCT00513357|323498606|FG001|Overall Study|Withdrawal by Subject|4|||
94466922|NCT00513357|323498605|FG000|Overall Study|Disease Progression|2|||
94466923|NCT00513357|323498606|FG001|Overall Study|Disease Progression|1|||
94466924|NCT03913104|323498607|FG000|Overall Study|Lost to Follow-up|20|||
94466925|NCT03913104|323498607|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
94466926|NCT03913104|323498607|FG000|Overall Study|Withdrawal by Subject|2|||
94466927|NCT01389258|323498608|FG000|Overall Study|Lost to Follow-up|5|||
94466928|NCT00089635|323498609|FG000|Overall Study|Adverse Event|2|||
94466929|NCT00089635|323498609|FG000|Overall Study|Death|17|||
94466930|NCT00089635|323498609|FG000|Overall Study|Disease Progression|12|||
94466931|NCT00089635|323498609|FG000|Overall Study|Lost to Follow-up|3|||
94466932|NCT00089635|323498609|FG000|Overall Study|Withdrawal by Subject|6|||
94466933|NCT00089635|323498609|FG000|Overall Study|Ineligibility determined|1|||
94466934|NCT00089635|323498609|FG000|Overall Study|Other|2|||
94466935|NCT03564795|323498619|FG000|Overall Study|Withdrawal by Subject|3|||
94466936|NCT03564795|323498619|FG000|Overall Study|Lost to Follow-up|6|||
94466937|NCT03564795|323498619|FG000|Overall Study|Physician Decision|2|||
94466938|NCT02906033|323498620|FG000|Baseline|Protocol Violation|37|||
94466939|NCT02906033|323498621|FG001|Baseline|Protocol Violation|33|||
94466940|NCT02906033|323498620|FG000|Follow-up|Lost to Follow-up|46|||
94466941|NCT02906033|323498621|FG001|Follow-up|Lost to Follow-up|62|||
94466942|NCT02920177|323498626|FG000|Overall Study|Withdrawal by Subject|1|||
94466943|NCT02920177|323498627|FG001|Overall Study|Withdrawal by Subject|1|||
94466944|NCT02920177|323498626|FG000|Overall Study|Physician Decision|1|||
94466945|NCT02920177|323498627|FG001|Overall Study|Physician Decision|0|||
94466946|NCT02920177|323498626|FG000|Overall Study|Lost to Follow-up|0|||
94466947|NCT02920177|323498627|FG001|Overall Study|Lost to Follow-up|1|||
94466948|NCT01625689|323498628|FG000|Overall Study|Migration|2|||
94466949|NCT01625689|323498629|FG001|Overall Study|Migration|1|||
94466950|NCT01333956|323498633|FG000|Overall Study|Lost to Follow-up|1|||
94466951|NCT01333956|323498634|FG001|Overall Study|Lost to Follow-up|2|||
94466952|NCT01333956|323498635|FG002|Overall Study|Lost to Follow-up|0|||
94466953|NCT01333956|323498636|FG003|Overall Study|Lost to Follow-up|1|||
94466954|NCT01333956|323498633|FG000|Overall Study|Unable to complete study procedure|1|||
94466955|NCT01333956|323498634|FG001|Overall Study|Unable to complete study procedure|0|||
94466956|NCT01333956|323498635|FG002|Overall Study|Unable to complete study procedure|0|||
94466957|NCT01333956|323498636|FG003|Overall Study|Unable to complete study procedure|1|||
94466958|NCT01333956|323498633|FG000|Overall Study|Withdrawal by Subject|0|||
94466959|NCT01333956|323498634|FG001|Overall Study|Withdrawal by Subject|2|||
94466960|NCT01333956|323498635|FG002|Overall Study|Withdrawal by Subject|1|||
94466961|NCT01333956|323498636|FG003|Overall Study|Withdrawal by Subject|0|||
94466962|NCT02134353|323498638|FG000|Overall Study|Adverse Event|10|||
94466963|NCT02134353|323498639|FG001|Overall Study|Adverse Event|6|||
94466964|NCT02134353|323498638|FG000|Overall Study|Lost to Follow-up|1|||
94653146|NCT01332305|324188043|FG003|Overall Study|Protocol Violation|0|||
94653147|NCT01332305|324188044|FG004|Overall Study|Protocol Violation|3|||
94653148|NCT01332305|324188040|FG000|Overall Study|Withdrawal by Sponsor|1|||
94653149|NCT01332305|324188041|FG001|Overall Study|Withdrawal by Sponsor|0|||
94653150|NCT01332305|324188042|FG002|Overall Study|Withdrawal by Sponsor|0|||
94653151|NCT01332305|324188043|FG003|Overall Study|Withdrawal by Sponsor|1|||
94653152|NCT01332305|324188044|FG004|Overall Study|Withdrawal by Sponsor|1|||
94653153|NCT01332305|324188040|FG000|Overall Study|Treatment Failure|1|||
94653154|NCT01332305|324188041|FG001|Overall Study|Treatment Failure|1|||
94653155|NCT01332305|324188042|FG002|Overall Study|Treatment Failure|0|||
94653156|NCT01332305|324188043|FG003|Overall Study|Treatment Failure|0|||
94653157|NCT01332305|324188044|FG004|Overall Study|Treatment Failure|0|||
94653158|NCT01332305|324188040|FG000|Overall Study|Physician Decision|0|||
94653159|NCT01332305|324188041|FG001|Overall Study|Physician Decision|0|||
94270131|NCT02819635|322782086|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
94270132|NCT02819635|322782087|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
94270133|NCT02819635|322782088|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
94270134|NCT02819635|322782089|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
94270135|NCT02819635|322782090|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
94270136|NCT02819635|322782091|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
94270137|NCT02819635|322782092|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
94270138|NCT02819635|322782093|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
94270139|NCT02819635|322782094|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
94270140|NCT02819635|322782095|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
94270141|NCT02819635|322782096|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
94270142|NCT02819635|322782085|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
94270143|NCT02819635|322782086|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
94270144|NCT02819635|322782087|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
94270145|NCT02819635|322782088|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
94270146|NCT02819635|322782089|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
94270147|NCT02819635|322782090|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
94270148|NCT02819635|322782091|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
94270149|NCT02819635|322782092|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
94270150|NCT02819635|322782093|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
94270151|NCT02819635|322782094|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
94270152|NCT02819635|322782095|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
94270153|NCT02819635|322782096|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
94270154|NCT02819635|322782085|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
94270155|NCT02819635|322782086|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
94270156|NCT02819635|322782087|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
94270157|NCT02819635|322782088|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
94466965|NCT02134353|323498639|FG001|Overall Study|Lost to Follow-up|1|||
94466966|NCT02134353|323498638|FG000|Overall Study|Lack of Efficacy|2|||
94466967|NCT02134353|323498639|FG001|Overall Study|Lack of Efficacy|1|||
94466968|NCT02134353|323498638|FG000|Overall Study|Withdrawal by Subject|12|||
94466969|NCT02134353|323498639|FG001|Overall Study|Withdrawal by Subject|13|||
94466970|NCT02134353|323498638|FG000|Overall Study|Death|0|||
94712197|NCT01641198|324405308|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
94712198|NCT01641198|324405309|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
94712199|NCT01641198|324405310|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
94270158|NCT02819635|322782089|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
94270159|NCT02819635|322782090|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
94270160|NCT02819635|322782091|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
94367081|NCT00791154|323129573|FG004|Overall Study|Death|54|||
94367082|NCT00791154|323129574|FG005|Overall Study|Death|54|||
94367083|NCT00791154|323129575|FG006|Overall Study|Death|52|||
94367084|NCT00791154|323129569|FG000|Overall Study|Other event|0|||
94367085|NCT00791154|323129570|FG001|Overall Study|Other event|0|||
94367086|NCT00791154|323129571|FG002|Overall Study|Other event|2|||
94367087|NCT00791154|323129572|FG003|Overall Study|Other event|0|||
94367088|NCT00791154|323129573|FG004|Overall Study|Other event|2|||
94367089|NCT00791154|323129574|FG005|Overall Study|Other event|4|||
94367090|NCT00791154|323129575|FG006|Overall Study|Other event|2|||
94367091|NCT01652573|323129576|FG000|Overall Study|Adverse Event|0|||
94367092|NCT01652573|323129577|FG001|Overall Study|Adverse Event|1|||
94367093|NCT00740480|323129578|FG000|Overall Study|Adverse Event|1|||
94367094|NCT00740480|323129578|FG000|Overall Study|Physician Decision|1|||
94367095|NCT00817778|323129589|FG000|Overall Study|Adverse Event|1|||
94367096|NCT00817778|323129590|FG001|Overall Study|Adverse Event|0|||
94367097|NCT00817778|323129589|FG000|Overall Study|Withdrawal by Subject|1|||
94367098|NCT00817778|323129590|FG001|Overall Study|Withdrawal by Subject|1|||
94367099|NCT00817778|323129589|FG000|Overall Study|Protocol Violation|0|||
94367100|NCT00817778|323129590|FG001|Overall Study|Protocol Violation|1|||
94367101|NCT00817778|323129589|FG000|Overall Study|Study-specific discontinuation criteria|0|||
94367102|NCT00817778|323129590|FG001|Overall Study|Study-specific discontinuation criteria|1|||
94367103|NCT00817778|323129589|FG000|Overall Study|Poor venous access|1|||
94367104|NCT00817778|323129590|FG001|Overall Study|Poor venous access|0|||
94367105|NCT03343054|323129591|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
94367106|NCT03343054|323129592|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
94367107|NCT03343054|323129593|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
94367108|NCT03343054|323129591|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
94367109|NCT03343054|323129592|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
94367110|NCT03343054|323129593|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
94712200|NCT01641198|324405308|FG000|At 15-20 Years of Function|Death|1|||
94712201|NCT01641198|324405309|FG001|At 15-20 Years of Function|Death|0|||
94712202|NCT01641198|324405310|FG002|At 15-20 Years of Function|Death|1|||
94712203|NCT02594735|324405311|FG000|Overall Study|Adverse Event|1|||
94712204|NCT02969863|324405312|FG000|Overall Study|Physician Decision|1|||
94712205|NCT02969863|324405313|FG001|Overall Study|Physician Decision|0|||
94712206|NCT02969863|324405314|FG002|Overall Study|Physician Decision|0|||
94712207|NCT02969863|324405315|FG003|Overall Study|Physician Decision|0|||
94712208|NCT02969863|324405316|FG004|Overall Study|Physician Decision|0|||
94712209|NCT02969863|324405317|FG005|Overall Study|Physician Decision|0|||
94712210|NCT00835770|324405318|FG000|Overall Study|MS Relapse|17|||
94712211|NCT00835770|324405319|FG001|Overall Study|MS Relapse|23|||
94712212|NCT00835770|324405318|FG000|Overall Study|MS Progression|14|||
94712213|NCT00835770|324405319|FG001|Overall Study|MS Progression|9|||
94712214|NCT00835770|324405318|FG000|Overall Study|Adverse Event|113|||
94712215|NCT00835770|324405319|FG001|Overall Study|Adverse Event|124|||
94712216|NCT00835770|324405318|FG000|Overall Study|Lost to Follow-up|22|||
94712217|NCT00835770|324405319|FG001|Overall Study|Lost to Follow-up|19|||
94712218|NCT00835770|324405318|FG000|Overall Study|Consent Withdrawn|144|||
94712219|NCT00835770|324405319|FG001|Overall Study|Consent Withdrawn|156|||
94712220|NCT00835770|324405318|FG000|Overall Study|Investigator Decision|42|||
94712221|NCT00835770|324405319|FG001|Overall Study|Investigator Decision|42|||
94712222|NCT00835770|324405318|FG000|Overall Study|Participant Non-Compliance|11|||
94712223|NCT00835770|324405319|FG001|Overall Study|Participant Non-Compliance|9|||
94712224|NCT00835770|324405318|FG000|Overall Study|Death|4|||
94712225|NCT00835770|324405319|FG001|Overall Study|Death|6|||
94712226|NCT00835770|324405318|FG000|Overall Study|Other|115|||
94712227|NCT00835770|324405319|FG001|Overall Study|Other|104|||
94712228|NCT00835770|324405318|FG000|Overall Study|Other|2|||
94712229|NCT00835770|324405319|FG001|Overall Study|Other|1|||
94712230|NCT02507752|324405321|FG000|Overall Study|Adverse Event|1|||
94712231|NCT02507752|324405321|FG000|Overall Study|Protocol Violation|6|||
94712232|NCT02507752|324405321|FG000|Overall Study|Lost to Follow-up|7|||
94712233|NCT02507752|324405321|FG000|Overall Study|Infusion reaction at first infusion|1|||
94712234|NCT02507752|324405321|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
94712235|NCT02507752|324405321|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
94466971|NCT02134353|323498639|FG001|Overall Study|Death|1|||
94466972|NCT02134353|323498638|FG000|Overall Study|Pregnancy|0|||
94466973|NCT02134353|323498639|FG001|Overall Study|Pregnancy|1|||
94466974|NCT02134353|323498638|FG000|Overall Study|Relocation|1|||
94466975|NCT02134353|323498639|FG001|Overall Study|Relocation|0|||
94466976|NCT02134353|323498638|FG000|Overall Study|Other - Patient's Choice|0|||
94466977|NCT02134353|323498639|FG001|Overall Study|Other - Patient's Choice|1|||
94466978|NCT01712334|323498640|FG000|Treatment Period 1|Randomized in Error|0|||
94466979|NCT01712334|323498641|FG001|Treatment Period 1|Randomized in Error|2|||
94466980|NCT00358956|323498642|FG000|Overall Study|Adverse Event|3|||
94466981|NCT00358956|323498642|FG000|Overall Study|condition under investigation worsened|4|||
94466982|NCT00358956|323498642|FG000|Overall Study|Withdrawal by Subject|1|||
94466983|NCT05249127|323498643|FG000|Overall Study|Protocol Violation|13|||
94466984|NCT05249127|323498643|FG000|Overall Study|Physician Decision|4|||
94466985|NCT05249127|323498643|FG000|Overall Study|Withdrawal by Subject|2|||
94466986|NCT05249127|323498643|FG000|Overall Study|Participant Non-compliance|1|||
94466987|NCT02908074|323498644|FG000|Overall Study|sponsor/ICON decision|0|||
94466988|NCT02908074|323498645|FG001|Overall Study|sponsor/ICON decision|0|||
94270161|NCT02819635|322782092|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
94466989|NCT02908074|323498646|FG002|Overall Study|sponsor/ICON decision|1|||
94712236|NCT00444600|324405322|FG000|Overall Study|Death|7|||
94466990|NCT02908074|323498647|FG003|Overall Study|sponsor/ICON decision|0|||
94712237|NCT00444600|324405323|FG001|Overall Study|Death|5|||
94712238|NCT00444600|324405324|FG002|Overall Study|Death|3|||
94712239|NCT00444600|324405325|FG003|Overall Study|Death|2|||
94712240|NCT00444600|324405322|FG000|Overall Study|Dropped|11|||
94466991|NCT02908074|323498648|FG004|Overall Study|sponsor/ICON decision|0|||
94466992|NCT02908074|323498649|FG005|Overall Study|sponsor/ICON decision|0|||
94466993|NCT02908074|323498644|FG000|Overall Study|Protocol Violation|0|||
94466994|NCT02908074|323498645|FG001|Overall Study|Protocol Violation|1|||
94466995|NCT02908074|323498646|FG002|Overall Study|Protocol Violation|0|||
94466996|NCT02908074|323498647|FG003|Overall Study|Protocol Violation|0|||
94466997|NCT02908074|323498648|FG004|Overall Study|Protocol Violation|0|||
94466998|NCT02908074|323498649|FG005|Overall Study|Protocol Violation|0|||
94466999|NCT02908074|323498644|FG000|Overall Study|Adverse Event|5|||
94467000|NCT02908074|323498645|FG001|Overall Study|Adverse Event|2|||
94467001|NCT02908074|323498646|FG002|Overall Study|Adverse Event|0|||
94467002|NCT02908074|323498647|FG003|Overall Study|Adverse Event|0|||
94467003|NCT02908074|323498648|FG004|Overall Study|Adverse Event|1|||
94467004|NCT02908074|323498649|FG005|Overall Study|Adverse Event|0|||
94467005|NCT02908074|323498644|FG000|Overall Study|AESI|1|||
94467006|NCT02908074|323498645|FG001|Overall Study|AESI|0|||
94467007|NCT02908074|323498646|FG002|Overall Study|AESI|1|||
94467008|NCT02908074|323498647|FG003|Overall Study|AESI|0|||
94467009|NCT02908074|323498648|FG004|Overall Study|AESI|1|||
94467010|NCT02908074|323498649|FG005|Overall Study|AESI|0|||
94467011|NCT02908074|323498644|FG000|Overall Study|Discontinuation criteria per protocol|0|||
94467012|NCT02908074|323498645|FG001|Overall Study|Discontinuation criteria per protocol|0|||
94467013|NCT02908074|323498646|FG002|Overall Study|Discontinuation criteria per protocol|1|||
94467014|NCT02908074|323498647|FG003|Overall Study|Discontinuation criteria per protocol|0|||
94467015|NCT02908074|323498648|FG004|Overall Study|Discontinuation criteria per protocol|0|||
94467016|NCT02908074|323498649|FG005|Overall Study|Discontinuation criteria per protocol|1|||
94467017|NCT02908074|323498644|FG000|Overall Study|Withdrawal by Subject|3|||
94467018|NCT02908074|323498645|FG001|Overall Study|Withdrawal by Subject|2|||
94467019|NCT02908074|323498646|FG002|Overall Study|Withdrawal by Subject|2|||
94467020|NCT02908074|323498647|FG003|Overall Study|Withdrawal by Subject|2|||
94467021|NCT02908074|323498648|FG004|Overall Study|Withdrawal by Subject|2|||
94467022|NCT02908074|323498649|FG005|Overall Study|Withdrawal by Subject|2|||
94467023|NCT02908074|323498644|FG000|Overall Study|Lost to Follow-up|0|||
94467024|NCT02908074|323498645|FG001|Overall Study|Lost to Follow-up|1|||
94467025|NCT02908074|323498646|FG002|Overall Study|Lost to Follow-up|1|||
94467026|NCT02908074|323498647|FG003|Overall Study|Lost to Follow-up|1|||
94467027|NCT02908074|323498648|FG004|Overall Study|Lost to Follow-up|0|||
94467028|NCT02908074|323498649|FG005|Overall Study|Lost to Follow-up|1|||
94467029|NCT02669082|323498650|FG000|Overall Study|Adverse Event|1|||
94467030|NCT01777139|323500432|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
94467031|NCT01777139|323500433|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
94467032|NCT01777139|323500432|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
94467033|NCT01777139|323500433|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
94467034|NCT01777139|323500432|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
94467035|NCT01777139|323500433|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
94467036|NCT01777139|323500432|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
94467037|NCT01777139|323500433|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
94467038|NCT01777139|323500432|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
94467039|NCT01777139|323500433|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
94712241|NCT00444600|324405323|FG001|Overall Study|Dropped|11|||
94712242|NCT00444600|324405324|FG002|Overall Study|Dropped|7|||
94712243|NCT00444600|324405325|FG003|Overall Study|Dropped|7|||
94467040|NCT01777139|323500432|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
94467041|NCT01777139|323500433|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
94467042|NCT01777139|323500432|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
94467043|NCT01777139|323500433|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
94467044|NCT01777139|323500432|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
94467045|NCT01777139|323500433|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
94467046|NCT02907619|323500434|FG000|Overall Study|Study terminated by sponsor|18|||
94467047|NCT02907619|323500435|FG001|Overall Study|Study terminated by sponsor|18|||
94467048|NCT02907619|323500436|FG002|Overall Study|Study terminated by sponsor|19|||
94467049|NCT02907619|323500434|FG000|Overall Study|Death|0|||
94467050|NCT02907619|323500435|FG001|Overall Study|Death|0|||
94467051|NCT02907619|323500436|FG002|Overall Study|Death|1|||
94467052|NCT02907619|323500434|FG000|Overall Study|Withdrawal by Subject|1|||
94467053|NCT02907619|323500435|FG001|Overall Study|Withdrawal by Subject|1|||
94712244|NCT00444600|324405322|FG000|Overall Study|Missed visit|1|||
94712245|NCT00444600|324405323|FG001|Overall Study|Missed visit|0|||
94467054|NCT02907619|323500436|FG002|Overall Study|Withdrawal by Subject|0|||
94467055|NCT02907619|323500434|FG000|Overall Study|Other|0|||
94467056|NCT02907619|323500435|FG001|Overall Study|Other|1|||
94467057|NCT02907619|323500436|FG002|Overall Study|Other|0|||
94467058|NCT00593606|323500439|FG000|Overall Study|Adverse Event|13|||
94467059|NCT00593606|323500439|FG000|Overall Study|Withdrawal by Subject|1|||
94467060|NCT00593606|323500439|FG000|Overall Study|Protocol Violation|3|||
94467061|NCT00593606|323500439|FG000|Overall Study|Lost to Follow-up|2|||
94467062|NCT00593606|323500439|FG000|Overall Study|Run-In Failure|5|||
94467063|NCT00593606|323500439|FG000|Overall Study|Screen Failure|3|||
94467064|NCT02223819|323500442|FG000|Overall Study|Lost to Follow-up|2|||
94467065|NCT00424021|323500443|FG000|NCT00046319 Study Period|Adverse Event|1|||
94467066|NCT00424021|323500444|FG001|NCT00046319 Study Period|Adverse Event|0|||
94467067|NCT00424021|323500445|FG002|NCT00046319 Study Period|Adverse Event|1|||
94467068|NCT00424021|323500446|FG003|NCT00046319 Study Period|Adverse Event|1|||
94467069|NCT00424021|323500443|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
94467070|NCT00424021|323500444|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
94467071|NCT00424021|323500445|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
94467072|NCT00424021|323500446|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
94467073|NCT00424021|323500443|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
94467074|NCT00424021|323500444|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
94467075|NCT00424021|323500445|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
94467076|NCT00424021|323500446|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
94467077|NCT00424021|323500443|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
94467078|NCT00424021|323500444|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
94467079|NCT00424021|323500445|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
94467080|NCT00424021|323500446|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
94467081|NCT00424021|323500443|FG000|AMB-220-E Study Period|Adverse Event|1|||
94467082|NCT00424021|323500444|FG001|AMB-220-E Study Period|Adverse Event|1|||
94467083|NCT00424021|323500445|FG002|AMB-220-E Study Period|Adverse Event|3|||
94467084|NCT00424021|323500446|FG003|AMB-220-E Study Period|Adverse Event|7|||
94467085|NCT00424021|323500443|FG000|AMB-220-E Study Period|Death|0|||
94467086|NCT00424021|323500444|FG001|AMB-220-E Study Period|Death|0|||
94467087|NCT00424021|323500445|FG002|AMB-220-E Study Period|Death|1|||
94467088|NCT00424021|323500446|FG003|AMB-220-E Study Period|Death|1|||
94467089|NCT00424021|323500443|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
94467090|NCT00424021|323500444|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
94467091|NCT00424021|323500445|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
94467092|NCT00424021|323500446|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
94467093|NCT00424021|323500443|FG000|AMB-220-E Study Period|Physician Decision|0|||
94467094|NCT00424021|323500444|FG001|AMB-220-E Study Period|Physician Decision|0|||
94467095|NCT00424021|323500445|FG002|AMB-220-E Study Period|Physician Decision|0|||
94467096|NCT00424021|323500446|FG003|AMB-220-E Study Period|Physician Decision|1|||
94467097|NCT00904839|323500447|FG000|Overall Study|Adverse Event|0|||
94467098|NCT00904839|323500448|FG001|Overall Study|Adverse Event|5|||
94467099|NCT00904839|323500449|FG002|Overall Study|Adverse Event|4|||
94467100|NCT00904839|323500447|FG000|Overall Study|Protocol Violation|0|||
94467101|NCT00904839|323500448|FG001|Overall Study|Protocol Violation|1|||
94467102|NCT00904839|323500449|FG002|Overall Study|Protocol Violation|1|||
94467103|NCT00904839|323500447|FG000|Overall Study|Lost to Follow-up|0|||
94467104|NCT00904839|323500448|FG001|Overall Study|Lost to Follow-up|1|||
94467105|NCT00904839|323500449|FG002|Overall Study|Lost to Follow-up|2|||
94467106|NCT00904839|323500447|FG000|Overall Study|Withdrawal by Subject|0|||
94467107|NCT00904839|323500448|FG001|Overall Study|Withdrawal by Subject|2|||
94467108|NCT00904839|323500449|FG002|Overall Study|Withdrawal by Subject|0|||
94467109|NCT00904839|323500447|FG000|Overall Study|Not treated|1|||
94467110|NCT00904839|323500448|FG001|Overall Study|Not treated|0|||
94467111|NCT00904839|323500449|FG002|Overall Study|Not treated|1|||
94467112|NCT00904839|323500447|FG000|Overall Study|Other than above|0|||
94467113|NCT00904839|323500448|FG001|Overall Study|Other than above|9|||
94270162|NCT02819635|322782093|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
94270163|NCT02819635|322782094|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
94467114|NCT00904839|323500449|FG002|Overall Study|Other than above|7|||
94467115|NCT01167634|323500454|FG000|Overall Study|Lost to Follow-up|1|||
94467116|NCT01167634|323500455|FG001|Overall Study|Lost to Follow-up|3|||
94467117|NCT01167634|323500456|FG002|Overall Study|Lost to Follow-up|3|||
94467118|NCT01167634|323500457|FG003|Overall Study|Lost to Follow-up|4|||
94467119|NCT01167634|323500454|FG000|Overall Study|Withdrawal by Subject|1|||
94467120|NCT01167634|323500455|FG001|Overall Study|Withdrawal by Subject|1|||
94467121|NCT01167634|323500456|FG002|Overall Study|Withdrawal by Subject|0|||
94467122|NCT01167634|323500457|FG003|Overall Study|Withdrawal by Subject|0|||
94467123|NCT01362517|323500458|FG000|Overall Study|Protocol Violation|1|||
94467124|NCT01362517|323500458|FG000|Overall Study|Lost to Follow-up|1|||
94467125|NCT03209518|323500459|FG000|Overall Study|Case Report Forms Uncollected|1|||
94467126|NCT03209518|323500459|FG000|Overall Study|Protocol Deviation|1|||
94467127|NCT00236899|323500460|FG000|Overall Study|Adverse Event (Study Related)|1|||
94653160|NCT01332305|324188042|FG002|Overall Study|Physician Decision|0|||
94367111|NCT03343054|323129591|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
94367112|NCT03343054|323129592|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
94367113|NCT03343054|323129593|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
94367114|NCT03343054|323129591|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
94367115|NCT03343054|323129592|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
94367116|NCT03343054|323129593|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
94367117|NCT02239601|323129594|FG000|Overall Study|Withdrawal by Subject|3|||
94367118|NCT02239601|323129595|FG001|Overall Study|Withdrawal by Subject|4|||
94367119|NCT02239601|323129594|FG000|Overall Study|Protocol Violation|4|||
94367120|NCT02239601|323129595|FG001|Overall Study|Protocol Violation|2|||
94367121|NCT01890109|323129596|FG000|Overall Study|Withdrawal by Subject|0|||
94367122|NCT01890109|323129597|FG001|Overall Study|Withdrawal by Subject|3|||
94367123|NCT01890109|323129596|FG000|Overall Study|Lost to Follow-up|1|||
94367124|NCT01890109|323129597|FG001|Overall Study|Lost to Follow-up|2|||
94367125|NCT01383954|323129598|FG000|Overall Study|Lack of Efficacy|2|||
94367126|NCT01383954|323129598|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
94367127|NCT01383954|323129598|FG000|Overall Study|Adverse Event|1|||
94367128|NCT01383954|323129598|FG000|Overall Study|Reason Not Specified|9|||
94367129|NCT00763269|323129601|FG000|Overall Study|Lost to Follow-up|12|||
94367130|NCT00763269|323129602|FG001|Overall Study|Lost to Follow-up|13|||
94367131|NCT00589693|323129608|FG000|Overall Study|randomized in error|12|||
94367132|NCT00589693|323129609|FG001|Overall Study|randomized in error|6|||
94367133|NCT00589693|323129608|FG000|Overall Study|Adverse Event|4|||
94367134|NCT00589693|323129609|FG001|Overall Study|Adverse Event|4|||
94367135|NCT00589693|323129608|FG000|Overall Study|Death|26|||
94367136|NCT00589693|323129609|FG001|Overall Study|Death|16|||
94367137|NCT00589693|323129608|FG000|Overall Study|Lack of Efficacy|0|||
94367138|NCT00589693|323129609|FG001|Overall Study|Lack of Efficacy|1|||
94367139|NCT00589693|323129608|FG000|Overall Study|Lost to Follow-up|1|||
94367140|NCT00589693|323129609|FG001|Overall Study|Lost to Follow-up|0|||
94367141|NCT00589693|323129608|FG000|Overall Study|Physician Decision|0|||
94367142|NCT00589693|323129609|FG001|Overall Study|Physician Decision|1|||
94367143|NCT00589693|323129608|FG000|Overall Study|Protocol Violation|1|||
94367144|NCT00589693|323129609|FG001|Overall Study|Protocol Violation|1|||
94367145|NCT03231709|323129610|FG000|Treatment Period 1|Reason not Specified|0|||
94367146|NCT03231709|323129611|FG001|Treatment Period 1|Reason not Specified|1|||
94367147|NCT03231709|323129610|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
94367148|NCT03231709|323129611|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
94367149|NCT03451331|323129612|FG000|Overall Study|Withdrawal by Subject|1|||
94467128|NCT00236899|323500461|FG001|Overall Study|Adverse Event (Study Related)|1|||
94467129|NCT00236899|323500462|FG002|Overall Study|Adverse Event (Study Related)|2|||
94467130|NCT00236899|323500463|FG003|Overall Study|Adverse Event (Study Related)|1|||
94467131|NCT00236899|323500460|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
94467132|NCT00236899|323500461|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
94467133|NCT00236899|323500462|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
94467134|NCT00236899|323500463|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
94467135|NCT00236899|323500460|FG000|Overall Study|Death (Study Disease)|1|||
94467136|NCT00236899|323500461|FG001|Overall Study|Death (Study Disease)|4|||
94467137|NCT00236899|323500462|FG002|Overall Study|Death (Study Disease)|0|||
94467138|NCT00236899|323500463|FG003|Overall Study|Death (Study Disease)|0|||
94467139|NCT00236899|323500460|FG000|Overall Study|Death (Not Study Related)|2|||
94467140|NCT00236899|323500461|FG001|Overall Study|Death (Not Study Related)|0|||
94467141|NCT00236899|323500462|FG002|Overall Study|Death (Not Study Related)|0|||
94270164|NCT02819635|322782095|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
94467142|NCT00236899|323500463|FG003|Overall Study|Death (Not Study Related)|0|||
94467143|NCT00236899|323500460|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
94467144|NCT00236899|323500461|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
94467145|NCT00236899|323500462|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
94270165|NCT02819635|322782096|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
94270166|NCT02819635|322782085|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
94270167|NCT02819635|322782086|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
94270168|NCT02819635|322782087|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
94270169|NCT02819635|322782088|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
94270170|NCT02819635|322782089|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
94467146|NCT00236899|323500463|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
94270171|NCT02819635|322782090|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
94270172|NCT02819635|322782091|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
94467147|NCT00236899|323500460|FG000|Overall Study|Lost to Follow-up|0|||
94467148|NCT00236899|323500461|FG001|Overall Study|Lost to Follow-up|1|||
94467149|NCT00236899|323500462|FG002|Overall Study|Lost to Follow-up|0|||
94270173|NCT02819635|322782092|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
94270174|NCT02819635|322782093|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
94270175|NCT02819635|322782094|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
94270176|NCT02819635|322782095|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
94270177|NCT02819635|322782096|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
94270178|NCT02819635|322782085|FG000|Substudy 2, Part 2|Adverse Event|0|||
94270179|NCT02819635|322782086|FG001|Substudy 2, Part 2|Adverse Event|0|||
94270180|NCT02819635|322782087|FG002|Substudy 2, Part 2|Adverse Event|0|||
94270181|NCT02819635|322782088|FG003|Substudy 2, Part 2|Adverse Event|0|||
94270182|NCT02819635|322782089|FG004|Substudy 2, Part 2|Adverse Event|0|||
94367150|NCT03451331|323129613|FG001|Overall Study|Withdrawal by Subject|0|||
94367151|NCT03451331|323129612|FG000|Overall Study|Unable to start treatment.|1|||
94367152|NCT03451331|323129613|FG001|Overall Study|Unable to start treatment.|1|||
94467150|NCT00236899|323500463|FG003|Overall Study|Lost to Follow-up|0|||
94467151|NCT00236899|323500460|FG000|Overall Study|Entry Criteria Exclusion|0|||
94467152|NCT00236899|323500461|FG001|Overall Study|Entry Criteria Exclusion|1|||
94467153|NCT00236899|323500462|FG002|Overall Study|Entry Criteria Exclusion|1|||
94467154|NCT00236899|323500463|FG003|Overall Study|Entry Criteria Exclusion|0|||
94467155|NCT00236899|323500460|FG000|Overall Study|Protocol Violation|1|||
94467156|NCT00236899|323500461|FG001|Overall Study|Protocol Violation|0|||
94467157|NCT00236899|323500462|FG002|Overall Study|Protocol Violation|0|||
94467158|NCT00236899|323500463|FG003|Overall Study|Protocol Violation|0|||
94467159|NCT00236899|323500460|FG000|Overall Study|Withdrawal by Subject|6|||
94467160|NCT00236899|323500461|FG001|Overall Study|Withdrawal by Subject|4|||
94467161|NCT00236899|323500462|FG002|Overall Study|Withdrawal by Subject|5|||
94467162|NCT00236899|323500463|FG003|Overall Study|Withdrawal by Subject|2|||
94467163|NCT00236899|323500460|FG000|Overall Study|Physician Decision|7|||
94467164|NCT00236899|323500461|FG001|Overall Study|Physician Decision|8|||
94467165|NCT00236899|323500462|FG002|Overall Study|Physician Decision|7|||
94712246|NCT00444600|324405324|FG002|Overall Study|Missed visit|0|||
94712247|NCT00444600|324405325|FG003|Overall Study|Missed visit|1|||
94467166|NCT00236899|323500463|FG003|Overall Study|Physician Decision|6|||
94467167|NCT00236899|323500460|FG000|Overall Study|Satisfactory Response|2|||
94467168|NCT00236899|323500461|FG001|Overall Study|Satisfactory Response|0|||
94467169|NCT00236899|323500462|FG002|Overall Study|Satisfactory Response|0|||
94467170|NCT00236899|323500463|FG003|Overall Study|Satisfactory Response|1|||
94467171|NCT00236899|323500460|FG000|Overall Study|Lack of Efficacy|18|||
94467172|NCT00236899|323500461|FG001|Overall Study|Lack of Efficacy|18|||
94467173|NCT00236899|323500462|FG002|Overall Study|Lack of Efficacy|25|||
94270183|NCT02819635|322782090|FG005|Substudy 2, Part 2|Adverse Event|4|||
94270184|NCT02819635|322782091|FG006|Substudy 2, Part 2|Adverse Event|0|||
94367153|NCT04991311|323129614|FG000|Overall Study|Adverse Event|1|||
94367154|NCT04330482|323129617|FG000|Overall Study|Lost to Follow-up|2|||
94367155|NCT04330482|323129618|FG001|Overall Study|Lost to Follow-up|1|||
94367156|NCT04330482|323129617|FG000|Overall Study|Withdrawal by Subject|0|||
94367157|NCT04330482|323129618|FG001|Overall Study|Withdrawal by Subject|3|||
94367158|NCT05473247|323129621|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
94367159|NCT00402779|323129622|FG000|Overall Study|Screen Failure|77|||
94367160|NCT00402779|323129623|FG001|Overall Study|Screen Failure|76|||
94367161|NCT00944125|323129624|FG000|3 to 6 Months|Withdrawal by Subject|0|||
94367162|NCT00944125|323129625|FG001|3 to 6 Months|Withdrawal by Subject|2|||
94367163|NCT00944125|323129624|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
94367164|NCT00944125|323129625|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
94367165|NCT02956005|323129629|FG000|Overall Study|Not eligible|1|||
94367166|NCT02956005|323129629|FG000|Overall Study|Withdrawal by Subject|3|||
94367167|NCT02956005|323129629|FG000|Overall Study|Physician Decision|12|||
94367168|NCT05458895|323129633|FG000|Overall Study|Withdrawal by Subject|8|||
94367169|NCT05458895|323129633|FG000|Overall Study|Lost to Follow-up|17|||
94367170|NCT05458895|323129633|FG000|Overall Study|Pregnancy|2|||
94467174|NCT00236899|323500463|FG003|Overall Study|Lack of Efficacy|23|||
94467175|NCT02565706|323500468|FG000|Overall Study|Withdrawal by Subject|5|||
94467176|NCT02565706|323500469|FG001|Overall Study|Withdrawal by Subject|7|||
94467177|NCT02565706|323500470|FG002|Overall Study|Withdrawal by Subject|7|||
94467178|NCT02565706|323500471|FG003|Overall Study|Withdrawal by Subject|11|||
94712248|NCT05132478|324405326|FG000|Overall Study|did not complete survey after consent|1|||
94467179|NCT02565706|323500468|FG000|Overall Study|Lost to Follow-up|72|||
94467180|NCT02565706|323500469|FG001|Overall Study|Lost to Follow-up|75|||
94467181|NCT02565706|323500470|FG002|Overall Study|Lost to Follow-up|82|||
94467182|NCT02565706|323500471|FG003|Overall Study|Lost to Follow-up|74|||
94467183|NCT00934856|323500472|FG000|Feasibility Part|Progressive disease|4|||
94467184|NCT00934856|323500473|FG001|Feasibility Part|Progressive disease|4|||
94467185|NCT00934856|323500474|FG002|Feasibility Part|Progressive disease|2|||
94467186|NCT00934856|323500475|FG003|Feasibility Part|Progressive disease|3|||
94467187|NCT00934856|323500476|FG004|Feasibility Part|Progressive disease|0|||
94467188|NCT00934856|323500477|FG005|Feasibility Part|Progressive disease|0|||
94467189|NCT00934856|323500472|FG000|Feasibility Part|Physician Decision|0|||
94467190|NCT00934856|323500473|FG001|Feasibility Part|Physician Decision|0|||
94467191|NCT00934856|323500474|FG002|Feasibility Part|Physician Decision|1|||
94467192|NCT00934856|323500475|FG003|Feasibility Part|Physician Decision|0|||
94467193|NCT00934856|323500476|FG004|Feasibility Part|Physician Decision|0|||
94467194|NCT00934856|323500477|FG005|Feasibility Part|Physician Decision|0|||
94467195|NCT00934856|323500472|FG000|Feasibility Part|Adverse Event|1|||
94467196|NCT00934856|323500473|FG001|Feasibility Part|Adverse Event|1|||
94467197|NCT00934856|323500474|FG002|Feasibility Part|Adverse Event|0|||
94467198|NCT00934856|323500475|FG003|Feasibility Part|Adverse Event|1|||
94467199|NCT00934856|323500476|FG004|Feasibility Part|Adverse Event|0|||
94467200|NCT00934856|323500477|FG005|Feasibility Part|Adverse Event|2|||
94467201|NCT00934856|323500472|FG000|Feasibility Part|Withdrawal by Subject|0|||
94467202|NCT00934856|323500473|FG001|Feasibility Part|Withdrawal by Subject|0|||
94467203|NCT00934856|323500474|FG002|Feasibility Part|Withdrawal by Subject|0|||
94467204|NCT00934856|323500475|FG003|Feasibility Part|Withdrawal by Subject|1|||
94712249|NCT05132478|324405327|FG001|Overall Study|did not complete survey after consent|1|||
94712250|NCT05132478|324405326|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
94712251|NCT05132478|324405327|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
94712252|NCT02755116|324405331|FG000|Overall Study|surgery converted to open, pt admitted|3|||
94712253|NCT02755116|324405332|FG001|Overall Study|surgery converted to open, pt admitted|1|||
94712254|NCT03950622|324405333|FG000|Overall Study|Withdrawal by Subject|1|||
94712255|NCT03950622|324405334|FG001|Overall Study|Withdrawal by Subject|0|||
94712256|NCT03950622|324405333|FG000|Overall Study|Protocol Deviation|0|||
94712257|NCT03950622|324405334|FG001|Overall Study|Protocol Deviation|1|||
94467205|NCT00934856|323500476|FG004|Feasibility Part|Withdrawal by Subject|0|||
94467206|NCT00934856|323500477|FG005|Feasibility Part|Withdrawal by Subject|1|||
94467207|NCT00934856|323500472|FG000|Extension Part|Adverse Event|0|||
94467208|NCT00934856|323500473|FG001|Extension Part|Adverse Event|0|||
94467209|NCT00934856|323500474|FG002|Extension Part|Adverse Event|0|||
94467210|NCT00934856|323500475|FG003|Extension Part|Adverse Event|1|||
94712258|NCT03950622|324405333|FG000|Overall Study|Physician Decision|1|||
94712259|NCT03950622|324405334|FG001|Overall Study|Physician Decision|0|||
94712260|NCT03950622|324405333|FG000|Overall Study|Lost to Follow-up|5|||
94712261|NCT03950622|324405334|FG001|Overall Study|Lost to Follow-up|5|||
94712262|NCT03950622|324405333|FG000|Overall Study|Death|1|||
94712263|NCT03950622|324405334|FG001|Overall Study|Death|1|||
94712264|NCT00424645|324405345|FG000|Overall Study|Death|1|||
94712265|NCT00424645|324405346|FG001|Overall Study|Death|0|||
94712266|NCT03074331|324405347|FG000|Overall Study|Enrolled but Not Treated|1|||
94712267|NCT03074331|324405347|FG000|Overall Study|Lost to Follow-up|5|||
94712268|NCT03074331|324405347|FG000|Overall Study|Withdrew Consent|1|||
94712269|NCT02555215|324405349|FG000|Overall Study|Other|1|||
94712270|NCT02555215|324405349|FG000|Overall Study|Investigator Decision|2|||
94712271|NCT00468052|324405350|FG000|Overall Study|Protocol Violation|7|||
94712272|NCT00468052|324405351|FG001|Overall Study|Protocol Violation|8|||
94712273|NCT00529789|324405352|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
94712274|NCT00529789|324405352|FG000|Study Period II/III|Adverse Event|3|||
94712275|NCT00529789|324405352|FG000|Study Period II/III|Lack of Efficacy|2|||
94712276|NCT00529789|324405352|FG000|Study Period II/III|Withdrawal by Subject|1|||
94712277|NCT00529789|324405352|FG000|Study Period II/III|Protocol Violation|3|||
94712278|NCT00529789|324405352|FG000|Study Period II/III|Physician Decision|3|||
94712279|NCT00529789|324405352|FG000|Study Period II/III|Lost to Follow-up|3|||
94712280|NCT00529789|324405352|FG000|Study Period IV|Parent/Caregiver Decision|1|||
94712281|NCT00529789|324405352|FG000|Study Period IV|Adverse Event|1|||
94712282|NCT00529789|324405352|FG000|Study Period IV|Lack of Efficacy|1|||
94467211|NCT00934856|323500476|FG004|Extension Part|Adverse Event|4|||
94467212|NCT00934856|323500477|FG005|Extension Part|Adverse Event|4|||
94467213|NCT00934856|323500472|FG000|Extension Part|Progressive disease|0|||
94467214|NCT00934856|323500473|FG001|Extension Part|Progressive disease|0|||
94712283|NCT00529789|324405352|FG000|Study Period IV|Lost to Follow-up|3|||
94712284|NCT02204982|324405355|FG000|Overall Study|Patient ineligible-medical monitor|1|||
94712285|NCT02204982|324405356|FG001|Overall Study|Patient ineligible-medical monitor|0|||
94712286|NCT02204982|324405355|FG000|Overall Study|Withdrawal by Subject|1|||
94270185|NCT02819635|322782092|FG007|Substudy 2, Part 2|Adverse Event|0|||
94270186|NCT02819635|322782093|FG008|Substudy 2, Part 2|Adverse Event|0|||
94270187|NCT02819635|322782094|FG009|Substudy 2, Part 2|Adverse Event|0|||
94270188|NCT02819635|322782095|FG010|Substudy 2, Part 2|Adverse Event|0|||
94270189|NCT02819635|322782096|FG011|Substudy 2, Part 2|Adverse Event|0|||
94270190|NCT02819635|322782085|FG000|Substudy 2, Part 2|Withdrew consent|0|||
94270191|NCT02819635|322782086|FG001|Substudy 2, Part 2|Withdrew consent|0|||
94270192|NCT02819635|322782087|FG002|Substudy 2, Part 2|Withdrew consent|0|||
94270193|NCT02819635|322782088|FG003|Substudy 2, Part 2|Withdrew consent|0|||
94270194|NCT02819635|322782089|FG004|Substudy 2, Part 2|Withdrew consent|0|||
94270195|NCT02819635|322782090|FG005|Substudy 2, Part 2|Withdrew consent|3|||
94270196|NCT02819635|322782091|FG006|Substudy 2, Part 2|Withdrew consent|1|||
94270197|NCT02819635|322782092|FG007|Substudy 2, Part 2|Withdrew consent|0|||
94270198|NCT02819635|322782093|FG008|Substudy 2, Part 2|Withdrew consent|0|||
94270199|NCT02819635|322782094|FG009|Substudy 2, Part 2|Withdrew consent|0|||
94270200|NCT02819635|322782095|FG010|Substudy 2, Part 2|Withdrew consent|0|||
94270201|NCT02819635|322782096|FG011|Substudy 2, Part 2|Withdrew consent|0|||
94270202|NCT02819635|322782085|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
94270203|NCT02819635|322782086|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
94270204|NCT02819635|322782087|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
94270205|NCT02819635|322782088|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
94270206|NCT02819635|322782089|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
94270207|NCT02819635|322782090|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
94270208|NCT02819635|322782091|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
94270209|NCT02819635|322782092|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
94270210|NCT02819635|322782093|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
94270211|NCT02819635|322782094|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
94270212|NCT02819635|322782095|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
94270213|NCT02819635|322782096|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
94270214|NCT02819635|322782085|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
94270215|NCT02819635|322782086|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
94270216|NCT02819635|322782087|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
94270217|NCT02819635|322782088|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
94270218|NCT02819635|322782089|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
94270219|NCT02819635|322782090|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
94270220|NCT02819635|322782091|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
94270221|NCT02819635|322782092|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
94270222|NCT02819635|322782093|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
94270223|NCT02819635|322782094|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
94270224|NCT02819635|322782095|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
94270225|NCT02819635|322782096|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
94270226|NCT02819635|322782085|FG000|Substudy 2, Part 2|Other, not specified|0|||
94270227|NCT02819635|322782086|FG001|Substudy 2, Part 2|Other, not specified|0|||
94270228|NCT02819635|322782087|FG002|Substudy 2, Part 2|Other, not specified|0|||
94270229|NCT02819635|322782088|FG003|Substudy 2, Part 2|Other, not specified|0|||
94270230|NCT02819635|322782089|FG004|Substudy 2, Part 2|Other, not specified|0|||
94270231|NCT02819635|322782090|FG005|Substudy 2, Part 2|Other, not specified|4|||
94270232|NCT02819635|322782091|FG006|Substudy 2, Part 2|Other, not specified|8|||
94270233|NCT02819635|322782092|FG007|Substudy 2, Part 2|Other, not specified|0|||
94270234|NCT02819635|322782093|FG008|Substudy 2, Part 2|Other, not specified|0|||
94270235|NCT02819635|322782094|FG009|Substudy 2, Part 2|Other, not specified|0|||
94270236|NCT02819635|322782095|FG010|Substudy 2, Part 2|Other, not specified|0|||
94270237|NCT02819635|322782096|FG011|Substudy 2, Part 2|Other, not specified|0|||
94270238|NCT02819635|322782085|FG000|Substudy 3|Adverse Event|0|||
94270239|NCT02819635|322782086|FG001|Substudy 3|Adverse Event|0|||
94270240|NCT02819635|322782087|FG002|Substudy 3|Adverse Event|0|||
94270241|NCT02819635|322782088|FG003|Substudy 3|Adverse Event|0|||
94270242|NCT02819635|322782089|FG004|Substudy 3|Adverse Event|0|||
94270243|NCT02819635|322782090|FG005|Substudy 3|Adverse Event|0|||
94270244|NCT02819635|322782091|FG006|Substudy 3|Adverse Event|0|||
94270245|NCT02819635|322782092|FG007|Substudy 3|Adverse Event|0|||
94270246|NCT02819635|322782093|FG008|Substudy 3|Adverse Event|32|||
94712287|NCT02204982|324405356|FG001|Overall Study|Withdrawal by Subject|0|||
94712288|NCT02204982|324405355|FG000|Overall Study|Adverse Event|1|||
94270247|NCT02819635|322782094|FG009|Substudy 3|Adverse Event|3|||
94270248|NCT02819635|322782095|FG010|Substudy 3|Adverse Event|12|||
94270249|NCT02819635|322782096|FG011|Substudy 3|Adverse Event|18|||
94270250|NCT02819635|322782085|FG000|Substudy 3|Withdrew consent|0|||
94270251|NCT02819635|322782086|FG001|Substudy 3|Withdrew consent|0|||
94270252|NCT02819635|322782087|FG002|Substudy 3|Withdrew consent|0|||
94270253|NCT02819635|322782088|FG003|Substudy 3|Withdrew consent|0|||
94712289|NCT02204982|324405356|FG001|Overall Study|Adverse Event|0|||
94712290|NCT02204982|324405355|FG000|Overall Study|Adverse Event and Investigator decision|1|||
94270254|NCT02819635|322782089|FG004|Substudy 3|Withdrew consent|0|||
94270255|NCT02819635|322782090|FG005|Substudy 3|Withdrew consent|0|||
94467215|NCT00934856|323500474|FG002|Extension Part|Progressive disease|0|||
94270256|NCT02819635|322782091|FG006|Substudy 3|Withdrew consent|0|||
94270257|NCT02819635|322782092|FG007|Substudy 3|Withdrew consent|0|||
94270258|NCT02819635|322782093|FG008|Substudy 3|Withdrew consent|11|||
94270259|NCT02819635|322782094|FG009|Substudy 3|Withdrew consent|1|||
94270260|NCT02819635|322782095|FG010|Substudy 3|Withdrew consent|4|||
94270261|NCT02819635|322782096|FG011|Substudy 3|Withdrew consent|9|||
94712291|NCT02204982|324405356|FG001|Overall Study|Adverse Event and Investigator decision|0|||
94467216|NCT00934856|323500475|FG003|Extension Part|Progressive disease|1|||
94270262|NCT02819635|322782085|FG000|Substudy 3|Lost to Follow-up|0|||
94270263|NCT02819635|322782086|FG001|Substudy 3|Lost to Follow-up|0|||
94270264|NCT02819635|322782087|FG002|Substudy 3|Lost to Follow-up|0|||
94270265|NCT02819635|322782088|FG003|Substudy 3|Lost to Follow-up|0|||
94270266|NCT02819635|322782089|FG004|Substudy 3|Lost to Follow-up|0|||
94270267|NCT02819635|322782090|FG005|Substudy 3|Lost to Follow-up|0|||
94270268|NCT02819635|322782091|FG006|Substudy 3|Lost to Follow-up|0|||
94270269|NCT02819635|322782092|FG007|Substudy 3|Lost to Follow-up|0|||
94270270|NCT02819635|322782093|FG008|Substudy 3|Lost to Follow-up|1|||
94270271|NCT02819635|322782094|FG009|Substudy 3|Lost to Follow-up|0|||
94270272|NCT02819635|322782095|FG010|Substudy 3|Lost to Follow-up|1|||
94270273|NCT02819635|322782096|FG011|Substudy 3|Lost to Follow-up|1|||
94270274|NCT02819635|322782085|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
94270275|NCT02819635|322782086|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
94270276|NCT02819635|322782087|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
94270277|NCT02819635|322782088|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
94270278|NCT02819635|322782089|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
94270279|NCT02819635|322782090|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
94467217|NCT00934856|323500476|FG004|Extension Part|Progressive disease|0|||
94467218|NCT00934856|323500477|FG005|Extension Part|Progressive disease|0|||
94467219|NCT00934856|323500472|FG000|Extension Part|Non-compliance with drug|0|||
94467220|NCT00934856|323500473|FG001|Extension Part|Non-compliance with drug|0|||
94467221|NCT00934856|323500474|FG002|Extension Part|Non-compliance with drug|0|||
94467222|NCT00934856|323500475|FG003|Extension Part|Non-compliance with drug|0|||
94467223|NCT00934856|323500476|FG004|Extension Part|Non-compliance with drug|0|||
94467224|NCT00934856|323500477|FG005|Extension Part|Non-compliance with drug|1|||
94712292|NCT02204982|324405355|FG000|Overall Study|Physician Decision|0|||
94712293|NCT02204982|324405356|FG001|Overall Study|Physician Decision|2|||
94712294|NCT02204982|324405355|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
94712295|NCT02204982|324405356|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
94712296|NCT02204982|324405355|FG000|Overall Study|Termination of Study bySponsor|0|||
94712297|NCT02204982|324405356|FG001|Overall Study|Termination of Study bySponsor|1|||
94712298|NCT00960141|324405357|FG000|Overall Study|Adverse Event|4|||
94712299|NCT00960141|324405358|FG001|Overall Study|Adverse Event|8|||
94712300|NCT00960141|324405359|FG002|Overall Study|Adverse Event|2|||
94712301|NCT00960141|324405357|FG000|Overall Study|Lack of Efficacy|3|||
94712302|NCT00960141|324405358|FG001|Overall Study|Lack of Efficacy|4|||
94712303|NCT00960141|324405359|FG002|Overall Study|Lack of Efficacy|2|||
94712304|NCT00960141|324405357|FG000|Overall Study|Lost to Follow-up|1|||
94712305|NCT00960141|324405358|FG001|Overall Study|Lost to Follow-up|0|||
94712306|NCT00960141|324405359|FG002|Overall Study|Lost to Follow-up|0|||
94712307|NCT00960141|324405357|FG000|Overall Study|Protocol Violation|1|||
94712308|NCT00960141|324405358|FG001|Overall Study|Protocol Violation|3|||
94712309|NCT00960141|324405359|FG002|Overall Study|Protocol Violation|2|||
94712310|NCT00960141|324405357|FG000|Overall Study|Withdrawal by Subject|1|||
94712311|NCT00960141|324405358|FG001|Overall Study|Withdrawal by Subject|2|||
94712312|NCT00960141|324405359|FG002|Overall Study|Withdrawal by Subject|1|||
94712313|NCT04590963|324405362|FG000|Overall Study|Death|118|||
94712314|NCT04590963|324405363|FG001|Overall Study|Death|59|||
94712315|NCT04590963|324405362|FG000|Overall Study|Lost to Follow-up|1|||
94270280|NCT02819635|322782091|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
94270281|NCT02819635|322782092|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
94270282|NCT02819635|322782093|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
94270283|NCT02819635|322782094|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
94712316|NCT04590963|324405363|FG001|Overall Study|Lost to Follow-up|1|||
94712317|NCT04590963|324405362|FG000|Overall Study|Progressive disease|0|||
94712318|NCT04590963|324405363|FG001|Overall Study|Progressive disease|1|||
94712319|NCT04590963|324405362|FG000|Overall Study|Study terminated by sponsor|103|||
94712320|NCT04590963|324405363|FG001|Overall Study|Study terminated by sponsor|50|||
94270284|NCT02819635|322782095|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
94270285|NCT02819635|322782096|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
94270286|NCT02819635|322782085|FG000|Substudy 3|Other, not specified|0|||
94270287|NCT02819635|322782086|FG001|Substudy 3|Other, not specified|0|||
94270288|NCT02819635|322782087|FG002|Substudy 3|Other, not specified|0|||
94270289|NCT02819635|322782088|FG003|Substudy 3|Other, not specified|0|||
94467225|NCT01672294|323500479|FG000|Overall Study|Withdrawal by Subject|4|||
94467226|NCT01672294|323500480|FG001|Overall Study|Withdrawal by Subject|4|||
94712321|NCT04590963|324405362|FG000|Overall Study|Withdrawal by Subject|15|||
94712322|NCT04590963|324405363|FG001|Overall Study|Withdrawal by Subject|8|||
94712323|NCT04590963|324405362|FG000|Overall Study|Ongoing at data cut-off|9|||
94712324|NCT04590963|324405363|FG001|Overall Study|Ongoing at data cut-off|4|||
94712325|NCT04590963|324405362|FG000|Overall Study|Screen failure|1|||
94712326|NCT04590963|324405363|FG001|Overall Study|Screen failure|0|||
94712327|NCT05609032|324405365|FG000|Overall Study|Lost to Follow-up|3|||
94712328|NCT05609032|324405366|FG001|Overall Study|Lost to Follow-up|1|||
94712329|NCT05609032|324405365|FG000|Overall Study|Withdrawal by Subject|1|||
94712330|NCT05609032|324405366|FG001|Overall Study|Withdrawal by Subject|0|||
94712331|NCT01759771|324405372|FG000|Overall Study|Withdrawal by Subject|1|||
94712332|NCT01759771|324405373|FG001|Overall Study|Withdrawal by Subject|1|||
94712333|NCT00357097|324405374|FG000|Overall Study|Did not meet inclusion criteria|5|||
94712334|NCT00357097|324405375|FG001|Overall Study|Did not meet inclusion criteria|3|||
94712335|NCT00357097|324405374|FG000|Overall Study|Adverse Event|34|||
94712336|NCT00357097|324405375|FG001|Overall Study|Adverse Event|6|||
94712337|NCT00357097|324405374|FG000|Overall Study|Withdrawal by Subject|8|||
94712338|NCT00357097|324405375|FG001|Overall Study|Withdrawal by Subject|7|||
94712339|NCT00357097|324405374|FG000|Overall Study|Non-compliance|1|||
94712340|NCT00357097|324405375|FG001|Overall Study|Non-compliance|2|||
94712341|NCT00357097|324405374|FG000|Overall Study|Lack of Efficacy|2|||
94712342|NCT00357097|324405375|FG001|Overall Study|Lack of Efficacy|8|||
94712343|NCT00357097|324405374|FG000|Overall Study|Met Exclusion Criteria|3|||
94712344|NCT00357097|324405375|FG001|Overall Study|Met Exclusion Criteria|1|||
94712345|NCT00357097|324405374|FG000|Overall Study|Other|1|||
94712346|NCT00357097|324405375|FG001|Overall Study|Other|1|||
94712347|NCT00357097|324405374|FG000|Overall Study|Increase of RLS Symptoms|0|||
94712348|NCT00357097|324405375|FG001|Overall Study|Increase of RLS Symptoms|1|||
94712349|NCT00529659|324405376|FG000|Overall Study|Adverse Event|8|||
94712350|NCT00529659|324405377|FG001|Overall Study|Adverse Event|7|||
94712351|NCT00529659|324405376|FG000|Overall Study|Lost to Follow-up|0|||
94712352|NCT00529659|324405377|FG001|Overall Study|Lost to Follow-up|2|||
94712353|NCT00529659|324405376|FG000|Overall Study|Physician Decision|0|||
94712354|NCT00529659|324405377|FG001|Overall Study|Physician Decision|2|||
94712355|NCT00529659|324405376|FG000|Overall Study|Protocol Violation|2|||
94712356|NCT00529659|324405377|FG001|Overall Study|Protocol Violation|6|||
94712357|NCT00529659|324405376|FG000|Overall Study|Withdrawal by Subject|1|||
94712358|NCT00529659|324405377|FG001|Overall Study|Withdrawal by Subject|6|||
94712359|NCT01251354|324405378|FG000|Overall Study|Adverse Event|1|||
94712360|NCT01251354|324405378|FG000|Overall Study|Investigator's Decision|1|||
94712361|NCT01251354|324405378|FG000|Overall Study|Disease Progression|4|||
94712362|NCT02731755|324406583|FG000|First Intervention|Withdrawal by Subject|0|||
94712363|NCT02731755|324406584|FG001|First Intervention|Withdrawal by Subject|2|||
94712364|NCT04218110|324406585|FG000|Overall Study|Withdrawal by Subject|0|||
94712365|NCT04218110|324406586|FG001|Overall Study|Withdrawal by Subject|0|||
94712366|NCT04218110|324406587|FG002|Overall Study|Withdrawal by Subject|0|||
94712367|NCT04218110|324406588|FG003|Overall Study|Withdrawal by Subject|1|||
94712368|NCT01613716|324406589|FG000|Overall Study|screen failures|3|||
94712369|NCT01613716|324406589|FG000|Overall Study|Lost to Follow-up|4|||
94712370|NCT00799396|324406590|FG000|Clopidogrel Treatment|Adverse Event|6|||
94712371|NCT00799396|324406590|FG000|Clopidogrel Treatment|Physician Decision|5|||
94712372|NCT00799396|324406590|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
94712373|NCT00799396|324406590|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
94712374|NCT00799396|324406590|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
94712375|NCT01599104|324406591|FG000|Overall Study|Withdrawal by Subject|1|||
94712376|NCT01599104|324406592|FG001|Overall Study|Withdrawal by Subject|1|||
94712377|NCT01599104|324406593|FG002|Overall Study|Withdrawal by Subject|2|||
94712378|NCT01599104|324406591|FG000|Overall Study|Technical Problems|1|||
94712379|NCT01599104|324406592|FG001|Overall Study|Technical Problems|0|||
94712380|NCT01599104|324406593|FG002|Overall Study|Technical Problems|0|||
94712381|NCT01599104|324406591|FG000|Overall Study|Physician Decision|3|||
94712382|NCT01599104|324406592|FG001|Overall Study|Physician Decision|2|||
94712383|NCT01599104|324406593|FG002|Overall Study|Physician Decision|2|||
94712384|NCT01599104|324406591|FG000|Overall Study|Non-compliance with study treatment|0|||
94712385|NCT01599104|324406592|FG001|Overall Study|Non-compliance with study treatment|1|||
94712386|NCT01599104|324406593|FG002|Overall Study|Non-compliance with study treatment|0|||
94712387|NCT01599104|324406591|FG000|Overall Study|Lack of Efficacy|4|||
94712388|NCT01599104|324406592|FG001|Overall Study|Lack of Efficacy|4|||
94712389|NCT01599104|324406593|FG002|Overall Study|Lack of Efficacy|10|||
94712390|NCT01599104|324406591|FG000|Overall Study|Adverse Event|7|||
94712391|NCT01599104|324406592|FG001|Overall Study|Adverse Event|6|||
94712392|NCT01599104|324406593|FG002|Overall Study|Adverse Event|12|||
94712393|NCT01582100|324406599|FG000|Overall Study|Adverse Event|1|||
94712394|NCT01582100|324406599|FG000|Overall Study|Withdrawal by Subject|1|||
94712395|NCT01951170|324406601|FG000|Overall Study|Investigator decision|1|||
94712396|NCT00446459|324406608|FG000|8 Months|Protocol Violation|12|||
94367171|NCT05458895|323129633|FG000|Overall Study|Withdrawal by Study Team|1|||
94712397|NCT00446459|324406608|FG000|12 Months|Protocol Violation|4|||
94712398|NCT00446459|324406608|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
94712399|NCT02242487|324406609|FG000|Overall Study|Adverse Event|13|||
94712400|NCT02242487|324406610|FG001|Overall Study|Adverse Event|15|||
94712401|NCT02242487|324406609|FG000|Overall Study|Lack of Efficacy|4|||
94712402|NCT02242487|324406610|FG001|Overall Study|Lack of Efficacy|6|||
94712403|NCT02242487|324406609|FG000|Overall Study|Protocol Violation|2|||
94712404|NCT02242487|324406610|FG001|Overall Study|Protocol Violation|0|||
94712405|NCT02242487|324406609|FG000|Overall Study|Lost to Follow-up|2|||
94712406|NCT02242487|324406610|FG001|Overall Study|Lost to Follow-up|1|||
94712407|NCT02242487|324406609|FG000|Overall Study|Other - Miscellaneous|4|||
94712408|NCT02242487|324406610|FG001|Overall Study|Other - Miscellaneous|6|||
94712409|NCT02242487|324406609|FG000|Overall Study|Withdrawal by Subject|37|||
94712410|NCT02242487|324406610|FG001|Overall Study|Withdrawal by Subject|19|||
94712411|NCT03644849|324406613|FG000|Overall Study|Lost to Follow-up|1|||
94712412|NCT03644849|324406614|FG001|Overall Study|Lost to Follow-up|3|||
94712413|NCT02564744|324406615|FG000|Overall Study|Investigator decision|0|||
94712414|NCT02564744|324406616|FG001|Overall Study|Investigator decision|0|||
94712415|NCT02564744|324406617|FG002|Overall Study|Investigator decision|0|||
94712416|NCT02564744|324406618|FG003|Overall Study|Investigator decision|0|||
94712417|NCT02564744|324406619|FG004|Overall Study|Investigator decision|1|||
94712418|NCT02564744|324406615|FG000|Overall Study|Death|10|||
94712419|NCT02564744|324406616|FG001|Overall Study|Death|5|||
94712420|NCT02564744|324406617|FG002|Overall Study|Death|4|||
94712421|NCT02564744|324406618|FG003|Overall Study|Death|16|||
94712422|NCT02564744|324406619|FG004|Overall Study|Death|16|||
94712423|NCT02564744|324406615|FG000|Overall Study|End of study Page Missing|0|||
94712424|NCT02564744|324406616|FG001|Overall Study|End of study Page Missing|0|||
94712425|NCT02564744|324406617|FG002|Overall Study|End of study Page Missing|3|||
94712426|NCT02564744|324406618|FG003|Overall Study|End of study Page Missing|3|||
94712427|NCT02564744|324406619|FG004|Overall Study|End of study Page Missing|0|||
94712428|NCT02564744|324406615|FG000|Overall Study|Subject Withdrew Consent|1|||
94712429|NCT02564744|324406616|FG001|Overall Study|Subject Withdrew Consent|1|||
94712430|NCT02564744|324406617|FG002|Overall Study|Subject Withdrew Consent|1|||
94712431|NCT02564744|324406618|FG003|Overall Study|Subject Withdrew Consent|0|||
94712432|NCT02564744|324406619|FG004|Overall Study|Subject Withdrew Consent|2|||
94712433|NCT02564744|324406615|FG000|Overall Study|Lost to Follow-up|0|||
94712434|NCT02564744|324406616|FG001|Overall Study|Lost to Follow-up|1|||
94712435|NCT02564744|324406617|FG002|Overall Study|Lost to Follow-up|0|||
94712436|NCT02564744|324406618|FG003|Overall Study|Lost to Follow-up|0|||
94712437|NCT02564744|324406619|FG004|Overall Study|Lost to Follow-up|1|||
94712438|NCT02564744|324406615|FG000|Overall Study|Reason not specified|1|||
94712439|NCT02564744|324406616|FG001|Overall Study|Reason not specified|0|||
94712440|NCT02564744|324406617|FG002|Overall Study|Reason not specified|0|||
94712441|NCT02564744|324406618|FG003|Overall Study|Reason not specified|0|||
94712442|NCT02564744|324406619|FG004|Overall Study|Reason not specified|0|||
94712443|NCT00508924|324406623|FG000|Overall Study|Protocol Violation|0|||
94712444|NCT00508924|324406624|FG001|Overall Study|Protocol Violation|0|||
94712445|NCT00508924|324406625|FG002|Overall Study|Protocol Violation|1|||
94712446|NCT00508924|324406626|FG003|Overall Study|Protocol Violation|1|||
94712447|NCT00071799|324406631|FG000|Overall Study|Adverse Event|19|||
94712448|NCT00071799|324406632|FG001|Overall Study|Adverse Event|10|||
94712449|NCT00071799|324406631|FG000|Overall Study|Protocol Violation|1|||
94712450|NCT00071799|324406632|FG001|Overall Study|Protocol Violation|7|||
94712451|NCT00071799|324406631|FG000|Overall Study|Lost to Follow-up|1|||
94712452|NCT00071799|324406632|FG001|Overall Study|Lost to Follow-up|1|||
94712453|NCT00071799|324406631|FG000|Overall Study|Withdrawal by Subject|15|||
94712454|NCT00071799|324406632|FG001|Overall Study|Withdrawal by Subject|37|||
94712455|NCT00071799|324406631|FG000|Overall Study|Physician Decision|0|||
94270290|NCT02819635|322782089|FG004|Substudy 3|Other, not specified|0|||
94270291|NCT02819635|322782090|FG005|Substudy 3|Other, not specified|0|||
94712456|NCT00071799|324406632|FG001|Overall Study|Physician Decision|2|||
94712457|NCT00071799|324406631|FG000|Overall Study|Lack of Efficacy|11|||
94712458|NCT00071799|324406632|FG001|Overall Study|Lack of Efficacy|18|||
94712459|NCT00071799|324406631|FG000|Overall Study|Disease Progression|23|||
94712460|NCT00071799|324406632|FG001|Overall Study|Disease Progression|20|||
94712461|NCT00071799|324406631|FG000|Overall Study|Different Central+Local Pathology Review|0|||
94712462|NCT00071799|324406632|FG001|Overall Study|Different Central+Local Pathology Review|1|||
94712463|NCT00071799|324406631|FG000|Overall Study|Not Documented|0|||
94712464|NCT00071799|324406632|FG001|Overall Study|Not Documented|2|||
94712465|NCT03737240|324406633|FG000|Overall Study|Lost to Follow-up|16|||
94712466|NCT03737240|324406634|FG001|Overall Study|Lost to Follow-up|15|||
94712467|NCT01185782|324406635|FG000|Overall Study|Adverse Event|0|||
94270292|NCT02819635|322782091|FG006|Substudy 3|Other, not specified|0|||
94712468|NCT01185782|324406636|FG001|Overall Study|Adverse Event|1|||
94712469|NCT01185782|324406635|FG000|Overall Study|Protocol Violation|1|||
94712470|NCT01185782|324406636|FG001|Overall Study|Protocol Violation|0|||
94712471|NCT01185782|324406635|FG000|Overall Study|Poor Response to Treatment|3|||
94712472|NCT01185782|324406636|FG001|Overall Study|Poor Response to Treatment|1|||
94712473|NCT01185782|324406635|FG000|Overall Study|Other|2|||
94712474|NCT01185782|324406636|FG001|Overall Study|Other|5|||
94712475|NCT01185782|324406635|FG000|Overall Study|Randomized but not treated|0|||
94712476|NCT01185782|324406636|FG001|Overall Study|Randomized but not treated|4|||
94712477|NCT00535145|324406639|FG000|Phase I|Adverse Event|3|||
94712478|NCT00535145|324406639|FG000|Phase I|Lost to Follow-up|7|||
94712479|NCT00535145|324406639|FG000|Phase I|Withdrawal by Subject|6|||
94270293|NCT02819635|322782092|FG007|Substudy 3|Other, not specified|0|||
94270294|NCT02819635|322782093|FG008|Substudy 3|Other, not specified|202|||
94270295|NCT02819635|322782094|FG009|Substudy 3|Other, not specified|5|||
94270296|NCT02819635|322782095|FG010|Substudy 3|Other, not specified|89|||
94270297|NCT02819635|322782096|FG011|Substudy 3|Other, not specified|39|||
94270298|NCT01011439|322782097|FG000|Overall Study|Death|37|||
94270299|NCT01011439|322782097|FG000|Overall Study|Lost to Follow-up|4|||
94270300|NCT01011439|322782097|FG000|Overall Study|Withdrawal by Subject|1|||
94270301|NCT01011439|322782097|FG000|Overall Study|Sponsor's decision|15|||
94270302|NCT02428855|322782098|FG000|Overall Study|Withdrawal by Subject|2|||
94270303|NCT00359021|322782099|FG000|Overall Study|Adverse Event|26|||
94270304|NCT00359021|322782100|FG001|Overall Study|Adverse Event|8|||
94270305|NCT00359021|322782099|FG000|Overall Study|Subject Non-Compliant|1|||
94270306|NCT00359021|322782100|FG001|Overall Study|Subject Non-Compliant|2|||
94712480|NCT00535145|324406639|FG000|Phase I|(eligibility)|8|||
94712481|NCT00535145|324406639|FG000|Phase I|(protocol violation)|1|||
94712482|NCT00535145|324406639|FG000|Phase I|(PI decision)|1|||
94712483|NCT00535145|324406639|FG000|Phase I|(diagnosis)|3|||
94712484|NCT00535145|324406639|FG000|Phase II|Adverse Event|2|||
94712485|NCT00535145|324406639|FG000|Phase II|Lack of Efficacy|1|||
94712486|NCT00535145|324406639|FG000|Phase II|Lost to Follow-up|5|||
94712487|NCT00535145|324406639|FG000|Phase II|Withdrawal by Subject|5|||
94712488|NCT00535145|324406639|FG000|Phase II|Subject non-compliance|2|||
94712489|NCT01236001|324406640|FG000|Overall Study|Adverse Event|5|||
94712490|NCT01236001|324406641|FG001|Overall Study|Adverse Event|14|||
94712491|NCT01236001|324406640|FG000|Overall Study|Lack of Efficacy|6|||
94712492|NCT01236001|324406641|FG001|Overall Study|Lack of Efficacy|6|||
94712493|NCT01236001|324406640|FG000|Overall Study|Lost to Follow-up|6|||
94712494|NCT01236001|324406641|FG001|Overall Study|Lost to Follow-up|1|||
94712495|NCT01236001|324406640|FG000|Overall Study|Incompliance|1|||
94712496|NCT01236001|324406641|FG001|Overall Study|Incompliance|0|||
94712497|NCT01236001|324406640|FG000|Overall Study|Planned Visit After End of Study|0|||
94712498|NCT01236001|324406641|FG001|Overall Study|Planned Visit After End of Study|1|||
94712499|NCT01063972|324406647|FG000|Overall Study|Death|12|||
94712500|NCT01063972|324406648|FG001|Overall Study|Death|11|||
94712501|NCT01063972|324406647|FG000|Overall Study|Incarcerated|2|||
94712502|NCT01063972|324406648|FG001|Overall Study|Incarcerated|1|||
94712503|NCT01546753|324406651|FG000|Overall Study|anxiety|1|||
94712504|NCT01546753|324406652|FG001|Overall Study|anxiety|1|||
94712505|NCT01546753|324406651|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
94712506|NCT01546753|324406652|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
94712507|NCT03036813|324406653|FG000|Overall Study|Adverse Event|6|||
94712508|NCT03036813|324406654|FG001|Overall Study|Adverse Event|11|||
94712509|NCT03036813|324406655|FG002|Overall Study|Adverse Event|6|||
94712510|NCT03036813|324406653|FG000|Overall Study|Withdrawal by Subject|12|||
94712511|NCT03036813|324406654|FG001|Overall Study|Withdrawal by Subject|6|||
94712512|NCT03036813|324406655|FG002|Overall Study|Withdrawal by Subject|10|||
94712513|NCT03036813|324406653|FG000|Overall Study|Lost to Follow-up|1|||
94712514|NCT03036813|324406654|FG001|Overall Study|Lost to Follow-up|1|||
94712515|NCT03036813|324406655|FG002|Overall Study|Lost to Follow-up|0|||
94712516|NCT03036813|324406653|FG000|Overall Study|Physician Decision|2|||
94712517|NCT03036813|324406654|FG001|Overall Study|Physician Decision|1|||
94712518|NCT03036813|324406655|FG002|Overall Study|Physician Decision|1|||
94270307|NCT00359021|322782099|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
94270308|NCT00359021|322782100|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
94270309|NCT00359021|322782099|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
94270310|NCT00359021|322782100|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
94270311|NCT00359021|322782099|FG000|Overall Study|Withdrawal by Subject|2|||
94270312|NCT00359021|322782100|FG001|Overall Study|Withdrawal by Subject|9|||
94270313|NCT00359021|322782099|FG000|Overall Study|Lost to Follow-up|1|||
94270314|NCT00359021|322782100|FG001|Overall Study|Lost to Follow-up|0|||
94270315|NCT00359021|322782099|FG000|Overall Study|Other|4|||
94467227|NCT01672294|323500481|FG002|Overall Study|Withdrawal by Subject|4|||
94712519|NCT03036813|324406653|FG000|Overall Study|Non-Compliance|1|||
94712520|NCT03036813|324406654|FG001|Overall Study|Non-Compliance|5|||
94712521|NCT03036813|324406655|FG002|Overall Study|Non-Compliance|3|||
94712522|NCT03036813|324406653|FG000|Overall Study|Pregnancy|0|||
94712523|NCT03036813|324406654|FG001|Overall Study|Pregnancy|0|||
94712524|NCT03036813|324406655|FG002|Overall Study|Pregnancy|1|||
94712525|NCT03036813|324406653|FG000|Overall Study|Other|0|||
94712526|NCT03036813|324406654|FG001|Overall Study|Other|3|||
94712527|NCT03036813|324406655|FG002|Overall Study|Other|5|||
94712528|NCT00174382|324406656|FG000|Overall Study|Death|2|||
94712529|NCT00174382|324406656|FG000|Overall Study|Adverse Event|19|||
94712530|NCT00174382|324406656|FG000|Overall Study|Withdrawal by Subject|6|||
94270316|NCT00359021|322782100|FG001|Overall Study|Other|1|||
94270317|NCT00359021|322782099|FG000|Overall Study|Pregnancy|1|||
94270318|NCT00359021|322782100|FG001|Overall Study|Pregnancy|0|||
94712531|NCT00174382|324406656|FG000|Overall Study|Protocol Violation|3|||
94712532|NCT00174382|324406656|FG000|Overall Study|Arrived early for last visit in error|1|||
94712533|NCT00174382|324406656|FG000|Overall Study|Subject felt pill not effective enough|1|||
94712534|NCT00174382|324406656|FG000|Overall Study|Lost to Follow-up|1|||
94712535|NCT03830866|324406657|FG000|Overall Study|Death|90|||
94712536|NCT03830866|324406658|FG001|Overall Study|Death|111|||
94712537|NCT03830866|324406657|FG000|Overall Study|Lost to Follow-up|7|||
94712538|NCT03830866|324406658|FG001|Overall Study|Lost to Follow-up|7|||
94712539|NCT03830866|324406657|FG000|Overall Study|Withdrawal by Subject|19|||
94712540|NCT03830866|324406658|FG001|Overall Study|Withdrawal by Subject|16|||
94712541|NCT03830866|324406657|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
94712542|NCT03830866|324406658|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
94712543|NCT03830866|324406657|FG000|Overall Study|Other|1|||
94712544|NCT03830866|324406658|FG001|Overall Study|Other|1|||
94712545|NCT00510887|324406659|FG000|Overall Study|Lost to Follow-up|1|||
94712546|NCT00393484|324406665|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
94712547|NCT00393484|324406666|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
94712548|NCT00393484|324406665|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
94712549|NCT00393484|324406666|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
94712550|NCT00393484|324406665|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
94712551|NCT00393484|324406666|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
94712552|NCT00393484|324406665|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
94712553|NCT00393484|324406666|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
94712554|NCT00393484|324406665|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
94712555|NCT00393484|324406666|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
94712556|NCT00393484|324406665|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
94712557|NCT00393484|324406666|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
94712558|NCT00393484|324406665|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
94712559|NCT00393484|324406666|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
94712560|NCT00393484|324406665|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
94712561|NCT00393484|324406666|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
94712562|NCT00393484|324406665|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
94712563|NCT00393484|324406666|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
94712564|NCT00393484|324406665|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
94712565|NCT00393484|324406666|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
94712566|NCT00411216|324406680|FG000|Overall Study|Ten participants were entered into the c|0|||
94712567|NCT00411216|324406681|FG001|Overall Study|Ten participants were entered into the c|2|||
94712568|NCT02531113|324406688|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
94712569|NCT02531113|324406688|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
94712570|NCT02531113|324406688|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
94712571|NCT02531113|324406688|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
94270319|NCT02316340|322782111|FG000|First Progression|Clinical progression|2|||
94270320|NCT02316340|322782112|FG001|First Progression|Clinical progression|1|||
94270321|NCT02316340|322782111|FG000|First Progression|Withdrawal by Subject|1|||
94270322|NCT02316340|322782112|FG001|First Progression|Withdrawal by Subject|0|||
94270323|NCT01835015|322782113|FG000|Overall Study|Adverse Event|0|||
94270324|NCT01835015|322782114|FG001|Overall Study|Adverse Event|0|||
94270325|NCT01835015|322782115|FG002|Overall Study|Adverse Event|1|||
94270326|NCT01835015|322782116|FG003|Overall Study|Adverse Event|0|||
94270327|NCT01835015|322782117|FG004|Overall Study|Adverse Event|0|||
94270328|NCT00424749|322782118|FG000|Overall Study|Withdrawal by Subject|1|||
94270329|NCT01555151|322782124|FG000|Overall Study|Withdrawal by Subject|6|||
94270330|NCT01555151|322782125|FG001|Overall Study|Withdrawal by Subject|2|||
94270331|NCT01555151|322782126|FG002|Overall Study|Withdrawal by Subject|0|||
94270332|NCT01555151|322782127|FG003|Overall Study|Withdrawal by Subject|2|||
94270333|NCT01555151|322782124|FG000|Overall Study|Administrative|3|||
94270334|NCT01555151|322782125|FG001|Overall Study|Administrative|1|||
94270335|NCT01555151|322782126|FG002|Overall Study|Administrative|2|||
94270336|NCT01555151|322782127|FG003|Overall Study|Administrative|0|||
94270337|NCT01555151|322782124|FG000|Overall Study|Protocol Violation|3|||
94270338|NCT01555151|322782125|FG001|Overall Study|Protocol Violation|3|||
94270339|NCT01555151|322782126|FG002|Overall Study|Protocol Violation|3|||
94270340|NCT01555151|322782127|FG003|Overall Study|Protocol Violation|5|||
94712572|NCT02531113|324406688|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
94712573|NCT02531113|324406688|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
94712574|NCT02531113|324406688|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
94712575|NCT02531113|324406688|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
94712576|NCT03351075|324408381|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
94712577|NCT03351075|324408382|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
94270341|NCT01555151|322782124|FG000|Overall Study|Adverse Event|1|||
94270342|NCT01555151|322782125|FG001|Overall Study|Adverse Event|2|||
94270343|NCT01555151|322782126|FG002|Overall Study|Adverse Event|1|||
94270344|NCT01555151|322782127|FG003|Overall Study|Adverse Event|2|||
94270345|NCT01555151|322782124|FG000|Overall Study|Lost to Follow-up|0|||
94712578|NCT03351075|324408381|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
94712579|NCT03351075|324408382|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
94712580|NCT03351075|324408381|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
94712581|NCT03351075|324408382|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
94712582|NCT03351075|324408381|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
94712583|NCT03351075|324408382|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
94712584|NCT03086369|324408383|FG000|Overall Study|Lost to Follow-up|1|||
94712585|NCT03086369|324408384|FG001|Overall Study|Lost to Follow-up|0|||
94712586|NCT03086369|324408385|FG002|Overall Study|Lost to Follow-up|0|||
94712587|NCT03086369|324408386|FG003|Overall Study|Lost to Follow-up|2|||
94712588|NCT03086369|324408387|FG004|Overall Study|Lost to Follow-up|1|||
94712589|NCT03086369|324408383|FG000|Overall Study|Physician Decision|0|||
94712590|NCT03086369|324408384|FG001|Overall Study|Physician Decision|0|||
94712591|NCT03086369|324408385|FG002|Overall Study|Physician Decision|0|||
94712592|NCT03086369|324408386|FG003|Overall Study|Physician Decision|1|||
94712593|NCT03086369|324408387|FG004|Overall Study|Physician Decision|2|||
94367172|NCT04639310|323129634|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
94367173|NCT04639310|323129635|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
94367174|NCT03853213|323131475|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
94367175|NCT03853213|323131476|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
94367176|NCT03853213|323131475|FG000|Overall Study|Other (e.g., too busy)|0|||
94367177|NCT03853213|323131476|FG001|Overall Study|Other (e.g., too busy)|2|||
94367178|NCT01964898|323131483|FG000|Overall Study|ineligible post-randomization|1|||
94367179|NCT01964898|323131484|FG001|Overall Study|ineligible post-randomization|1|||
94367180|NCT01964898|323131483|FG000|Overall Study|did not receive the allocated interventi|2|||
94367181|NCT01964898|323131484|FG001|Overall Study|did not receive the allocated interventi|1|||
94367182|NCT01964898|323131483|FG000|Overall Study|Lost to Follow-up|3|||
94367183|NCT01964898|323131484|FG001|Overall Study|Lost to Follow-up|5|||
94712594|NCT03086369|324408383|FG000|Overall Study|Withdrawal by Subject|0|||
94712595|NCT03086369|324408384|FG001|Overall Study|Withdrawal by Subject|0|||
94712596|NCT03086369|324408385|FG002|Overall Study|Withdrawal by Subject|0|||
94712597|NCT03086369|324408386|FG003|Overall Study|Withdrawal by Subject|5|||
94712598|NCT03086369|324408387|FG004|Overall Study|Withdrawal by Subject|3|||
94712599|NCT03086369|324408383|FG000|Overall Study|Progressive Disease|0|||
94712600|NCT03086369|324408384|FG001|Overall Study|Progressive Disease|0|||
94712601|NCT03086369|324408385|FG002|Overall Study|Progressive Disease|0|||
94712602|NCT03086369|324408386|FG003|Overall Study|Progressive Disease|1|||
94712603|NCT03086369|324408387|FG004|Overall Study|Progressive Disease|1|||
94712604|NCT00566735|324408390|FG000|Overall Study|Withdrawal by Subject|0|||
94712605|NCT00566735|324408391|FG001|Overall Study|Withdrawal by Subject|1|||
94712606|NCT00566735|324408390|FG000|Overall Study|Refused neuropsychological testing|2|||
94712607|NCT00566735|324408391|FG001|Overall Study|Refused neuropsychological testing|5|||
94712608|NCT00566735|324408390|FG000|Overall Study|Switched into a manic episode|0|||
94712609|NCT00566735|324408391|FG001|Overall Study|Switched into a manic episode|1|||
94712610|NCT00686855|324408399|FG000|Overall Study|Lost to Follow-up|1|||
94712611|NCT00686855|324408400|FG001|Overall Study|Lost to Follow-up|0|||
94712612|NCT00686855|324408399|FG000|Overall Study|Progressive GVHD|0|||
94712613|NCT00686855|324408400|FG001|Overall Study|Progressive GVHD|1|||
94712614|NCT01318382|324408402|FG000|Overall Study|Physician Decision|2|||
94712615|NCT01318382|324408402|FG000|Overall Study|Device Malfunction|10|||
94712616|NCT01318382|324408402|FG000|Overall Study|Protocol Violation|1|||
94712617|NCT01867216|324408403|FG000|Overall Study|Withdrawal by Subject|2|||
94712618|NCT01867216|324408404|FG001|Overall Study|Withdrawal by Subject|0|||
94712619|NCT01867216|324408405|FG002|Overall Study|Withdrawal by Subject|0|||
94712620|NCT01867216|324408406|FG003|Overall Study|Withdrawal by Subject|0|||
94712621|NCT01867216|324408407|FG004|Overall Study|Withdrawal by Subject|1|||
94712622|NCT01867216|324408408|FG005|Overall Study|Withdrawal by Subject|0|||
94712623|NCT01867216|324408409|FG006|Overall Study|Withdrawal by Subject|1|||
94712624|NCT01867216|324408403|FG000|Overall Study|Physician Decision|1|||
94712625|NCT01867216|324408404|FG001|Overall Study|Physician Decision|0|||
94712626|NCT01867216|324408405|FG002|Overall Study|Physician Decision|0|||
94712627|NCT01867216|324408406|FG003|Overall Study|Physician Decision|0|||
94712628|NCT01867216|324408407|FG004|Overall Study|Physician Decision|0|||
94712629|NCT01867216|324408408|FG005|Overall Study|Physician Decision|0|||
94712630|NCT01867216|324408409|FG006|Overall Study|Physician Decision|0|||
94712631|NCT01867216|324408403|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
94712632|NCT01867216|324408404|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
94712633|NCT01867216|324408405|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
94712634|NCT01867216|324408406|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
94712635|NCT01867216|324408407|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
94712636|NCT01867216|324408408|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
94712637|NCT01867216|324408409|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
94712638|NCT00714714|324408412|FG000|Overall Study|Adverse Event|1|||
94712639|NCT01571596|324408413|FG000|Overall Study|Adverse Event|2|||
94712640|NCT01571596|324408414|FG001|Overall Study|Adverse Event|0|||
94712641|NCT01571596|324408415|FG002|Overall Study|Adverse Event|0|||
94712642|NCT01571596|324408413|FG000|Overall Study|Study Terminated by the Sponsor|0|||
94712643|NCT01571596|324408414|FG001|Overall Study|Study Terminated by the Sponsor|1|||
94712644|NCT01571596|324408415|FG002|Overall Study|Study Terminated by the Sponsor|1|||
94712645|NCT00802464|324408416|FG000|Month 0 - Month 8|Adverse Event|0|||
94712646|NCT00802464|324408417|FG001|Month 0 - Month 8|Adverse Event|1|||
94712647|NCT00802464|324408418|FG002|Month 0 - Month 8|Adverse Event|1|||
94712648|NCT00802464|324408419|FG003|Month 0 - Month 8|Adverse Event|2|||
94712649|NCT00802464|324408416|FG000|Month 0 - Month 8|Protocol Violation|0|||
94712650|NCT00802464|324408417|FG001|Month 0 - Month 8|Protocol Violation|0|||
94712651|NCT00802464|324408418|FG002|Month 0 - Month 8|Protocol Violation|1|||
94712652|NCT00802464|324408419|FG003|Month 0 - Month 8|Protocol Violation|0|||
94712653|NCT00802464|324408416|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
94712654|NCT00802464|324408417|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
94712655|NCT00802464|324408418|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
94712656|NCT00802464|324408419|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
94712657|NCT00802464|324408416|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
94712658|NCT00802464|324408417|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
94712659|NCT00802464|324408418|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
94712660|NCT00802464|324408419|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
94712661|NCT00802464|324408416|FG000|Month 0 - Month 8|Other|0|||
94712662|NCT00802464|324408417|FG001|Month 0 - Month 8|Other|0|||
94712663|NCT00802464|324408418|FG002|Month 0 - Month 8|Other|1|||
94712664|NCT00802464|324408419|FG003|Month 0 - Month 8|Other|0|||
94712665|NCT00802464|324408416|FG000|Month 8 - Month 14|Adverse Event|0|||
94712666|NCT00802464|324408417|FG001|Month 8 - Month 14|Adverse Event|1|||
94712667|NCT00802464|324408418|FG002|Month 8 - Month 14|Adverse Event|0|||
94712668|NCT00802464|324408419|FG003|Month 8 - Month 14|Adverse Event|0|||
94712669|NCT00802464|324408416|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
94712670|NCT00802464|324408417|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
94270346|NCT01555151|322782125|FG001|Overall Study|Lost to Follow-up|0|||
94270347|NCT01555151|322782126|FG002|Overall Study|Lost to Follow-up|0|||
94270348|NCT01555151|322782127|FG003|Overall Study|Lost to Follow-up|1|||
94270349|NCT01576172|322782128|FG000|Overall Study|Ineligible|2|||
94270350|NCT01576172|322782129|FG001|Overall Study|Ineligible|1|||
94270351|NCT01576172|322782128|FG000|Overall Study|Withdrawal by Subject|2|||
94270352|NCT01576172|322782129|FG001|Overall Study|Withdrawal by Subject|0|||
94270353|NCT01576172|322782128|FG000|Overall Study|Insurance issue|1|||
94270354|NCT01576172|322782129|FG001|Overall Study|Insurance issue|0|||
94712671|NCT00802464|324408418|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
94712672|NCT00802464|324408419|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
94712673|NCT00802464|324408416|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
94712674|NCT00802464|324408417|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
94712675|NCT00802464|324408418|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
94712676|NCT00802464|324408419|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
94712677|NCT01113931|324408420|FG000|Overall Study|Adverse Event|2|||
94712678|NCT01113931|324408421|FG001|Overall Study|Adverse Event|2|||
94712679|NCT01113931|324408420|FG000|Overall Study|Physician Decision|0|||
94712680|NCT01113931|324408421|FG001|Overall Study|Physician Decision|2|||
94712681|NCT01113931|324408420|FG000|Overall Study|Lost to Follow-up|12|||
94712682|NCT01113931|324408421|FG001|Overall Study|Lost to Follow-up|9|||
94712683|NCT01113931|324408420|FG000|Overall Study|Various|2|||
94712684|NCT01113931|324408421|FG001|Overall Study|Various|4|||
94712685|NCT01113931|324408420|FG000|Overall Study|Withdrawal by Subject|3|||
94712686|NCT01113931|324408421|FG001|Overall Study|Withdrawal by Subject|0|||
94712687|NCT01149369|324408422|FG000|Overall Study|Adverse Event|6|||
94712688|NCT01149369|324408423|FG001|Overall Study|Adverse Event|3|||
94712689|NCT02767765|324408424|FG000|Overall Study|Adverse Event|4|||
94712690|NCT02767765|324408424|FG000|Overall Study|Death|1|||
94712691|NCT02767765|324408424|FG000|Overall Study|Insufficient response|1|||
94712692|NCT02767765|324408424|FG000|Overall Study|Lost to Follow-up|2|||
94712693|NCT02767765|324408424|FG000|Overall Study|Investigator decision|1|||
94712694|NCT02767765|324408424|FG000|Overall Study|Non-Compliance|1|||
94712695|NCT02767765|324408424|FG000|Overall Study|Withdrawal by Subject|1|||
94712696|NCT01040689|324408429|FG000|Overall Study|Adverse Event|0|||
94712697|NCT01040689|324408430|FG001|Overall Study|Adverse Event|0|||
94712698|NCT01040689|324408431|FG002|Overall Study|Adverse Event|2|||
94712699|NCT01040689|324408432|FG003|Overall Study|Adverse Event|4|||
94712700|NCT01040689|324408429|FG000|Overall Study|Lack of Efficacy|0|||
94712701|NCT01040689|324408430|FG001|Overall Study|Lack of Efficacy|0|||
94712702|NCT01040689|324408431|FG002|Overall Study|Lack of Efficacy|1|||
94712703|NCT01040689|324408432|FG003|Overall Study|Lack of Efficacy|0|||
94712704|NCT01040689|324408429|FG000|Overall Study|Lost to Follow-up|1|||
94712705|NCT01040689|324408430|FG001|Overall Study|Lost to Follow-up|0|||
94712706|NCT01040689|324408431|FG002|Overall Study|Lost to Follow-up|0|||
94712707|NCT01040689|324408432|FG003|Overall Study|Lost to Follow-up|0|||
94712708|NCT01040689|324408429|FG000|Overall Study|Withdrawal by Subject|2|||
94712709|NCT01040689|324408430|FG001|Overall Study|Withdrawal by Subject|1|||
94712710|NCT01040689|324408431|FG002|Overall Study|Withdrawal by Subject|1|||
94712711|NCT01040689|324408432|FG003|Overall Study|Withdrawal by Subject|0|||
94712712|NCT01040689|324408429|FG000|Overall Study|Other reasons not listed above|0|||
94712713|NCT01040689|324408430|FG001|Overall Study|Other reasons not listed above|1|||
94712714|NCT01040689|324408431|FG002|Overall Study|Other reasons not listed above|0|||
94712715|NCT01040689|324408432|FG003|Overall Study|Other reasons not listed above|0|||
94712716|NCT01185561|324408435|FG000|Overall Study|Lost to Follow-up|0|||
94712717|NCT01185561|324408436|FG001|Overall Study|Lost to Follow-up|4|||
94712718|NCT01185561|324408435|FG000|Overall Study|Withdrawal by Subject|2|||
94712719|NCT01185561|324408436|FG001|Overall Study|Withdrawal by Subject|8|||
94712720|NCT01078116|324408437|FG000|Overall Study|Lost to Follow-up|17|||
94712721|NCT01078116|324408437|FG000|Overall Study|Adverse Event|5|||
94712722|NCT01078116|324408437|FG000|Overall Study|Withdrawal by Subject|8|||
94712723|NCT01078116|324408437|FG000|Overall Study|Lack of effectiveness|15|||
94712724|NCT01078116|324408437|FG000|Overall Study|Case report form not completed|3|||
94712725|NCT00774397|324408438|FG000|Overall Study|Adverse Event|1|||
94712726|NCT00774397|324408439|FG001|Overall Study|Adverse Event|3|||
94270355|NCT01265615|322782130|FG000|Overall Study|Protocol Violation|2|||
94270356|NCT01265615|322782131|FG001|Overall Study|Protocol Violation|2|||
94712727|NCT00774397|324408440|FG002|Overall Study|Adverse Event|16|||
94712728|NCT00774397|324408441|FG003|Overall Study|Adverse Event|8|||
94712729|NCT00774397|324408442|FG004|Overall Study|Adverse Event|8|||
94270357|NCT01265615|322782132|FG002|Overall Study|Protocol Violation|4|||
94712730|NCT00774397|324408443|FG005|Overall Study|Adverse Event|3|||
94712731|NCT00774397|324408444|FG006|Overall Study|Adverse Event|16|||
94712732|NCT00774397|324408438|FG000|Overall Study|Lack of Efficacy|11|||
94712733|NCT00774397|324408439|FG001|Overall Study|Lack of Efficacy|4|||
94712734|NCT00774397|324408440|FG002|Overall Study|Lack of Efficacy|5|||
94270358|NCT01265615|322782133|FG003|Overall Study|Protocol Violation|3|||
94712735|NCT00774397|324408441|FG003|Overall Study|Lack of Efficacy|3|||
94712736|NCT00774397|324408442|FG004|Overall Study|Lack of Efficacy|27|||
94712737|NCT00774397|324408443|FG005|Overall Study|Lack of Efficacy|15|||
94712738|NCT00774397|324408444|FG006|Overall Study|Lack of Efficacy|9|||
94712739|NCT00774397|324408438|FG000|Overall Study|Protocol Violation|0|||
94270359|NCT01961349|322782134|FG000|Overall Study|Withdrawal by Subject|1|||
94270360|NCT01961349|322782135|FG001|Overall Study|Withdrawal by Subject|4|||
94270361|NCT01961349|322782136|FG002|Overall Study|Withdrawal by Subject|0|||
94270362|NCT01961349|322782134|FG000|Overall Study|Adverse Event|0|||
94270363|NCT01961349|322782135|FG001|Overall Study|Adverse Event|0|||
94270364|NCT01961349|322782136|FG002|Overall Study|Adverse Event|1|||
94270365|NCT01961349|322782134|FG000|Overall Study|registration error, personal reason etc|2|||
94270366|NCT01961349|322782135|FG001|Overall Study|registration error, personal reason etc|2|||
94653161|NCT01332305|324188043|FG003|Overall Study|Physician Decision|1|||
94653162|NCT01332305|324188044|FG004|Overall Study|Physician Decision|0|||
94653163|NCT00111228|324188048|FG000|Overall Study|Withdrawal by Subject|5|||
94653164|NCT00111228|324188049|FG001|Overall Study|Withdrawal by Subject|1|||
94653165|NCT00111228|324188050|FG002|Overall Study|Withdrawal by Subject|0|||
94653166|NCT00779766|324188057|FG000|Month 24|Serious Adverse Event|2|||
94653167|NCT00779766|324188058|FG001|Month 24|Serious Adverse Event|3|||
94653168|NCT00779766|324188057|FG000|Month 24|Adverse Event|3|||
94653169|NCT00779766|324188058|FG001|Month 24|Adverse Event|3|||
94653170|NCT00779766|324188057|FG000|Month 24|Protocol Violation|3|||
94653171|NCT00779766|324188058|FG001|Month 24|Protocol Violation|1|||
94653172|NCT00779766|324188057|FG000|Month 24|Withdrawal by Subject|159|||
94653173|NCT00779766|324188058|FG001|Month 24|Withdrawal by Subject|127|||
94653174|NCT00779766|324188057|FG000|Month 24|Migrated/moved from study area|138|||
94653175|NCT00779766|324188058|FG001|Month 24|Migrated/moved from study area|162|||
94653176|NCT00779766|324188057|FG000|Month 24|Lost to Follow-up|9|||
94653177|NCT00779766|324188058|FG001|Month 24|Lost to Follow-up|9|||
94653178|NCT00779766|324188057|FG000|Month 24|Other|18|||
94653179|NCT00779766|324188058|FG001|Month 24|Other|27|||
94653180|NCT00779766|324188057|FG000|Month 48|Withdrawal by Subject|68|||
94653181|NCT00779766|324188058|FG001|Month 48|Withdrawal by Subject|63|||
94653182|NCT00779766|324188057|FG000|Month 48|Migrated/moved from study area|76|||
94653183|NCT00779766|324188058|FG001|Month 48|Migrated/moved from study area|75|||
94653184|NCT00779766|324188057|FG000|Month 48|Lost to Follow-up|29|||
94653185|NCT00779766|324188058|FG001|Month 48|Lost to Follow-up|30|||
94653186|NCT00779766|324188057|FG000|Month 48|Other|1|||
94653187|NCT00779766|324188058|FG001|Month 48|Other|0|||
94653188|NCT00779766|324188057|FG000|Month 72|Withdrawal by Subject|55|||
94653189|NCT00779766|324188058|FG001|Month 72|Withdrawal by Subject|71|||
94653190|NCT00779766|324188057|FG000|Month 72|Migrated/moved from study area|124|||
94653191|NCT00779766|324188058|FG001|Month 72|Migrated/moved from study area|109|||
94653192|NCT00779766|324188057|FG000|Month 72|Lost to Follow-up|6|||
94653193|NCT00779766|324188058|FG001|Month 72|Lost to Follow-up|8|||
94653194|NCT00779766|324188057|FG000|Month 72|Other|0|||
94653195|NCT00779766|324188058|FG001|Month 72|Other|1|||
94653196|NCT02443298|324188059|FG000|Overall Study|Adverse Event|3|||
94653197|NCT02443298|324188060|FG001|Overall Study|Adverse Event|3|||
94653198|NCT02443298|324188059|FG000|Overall Study|Withdrawal by Subject|1|||
94653199|NCT02443298|324188060|FG001|Overall Study|Withdrawal by Subject|2|||
94653200|NCT02664038|324188061|FG000|13 Week|Lost to Follow-up|7|||
94653201|NCT02664038|324188062|FG001|13 Week|Lost to Follow-up|14|||
94653202|NCT02664038|324188061|FG000|13 Week|Withdrawal by Subject|1|||
94653203|NCT02664038|324188062|FG001|13 Week|Withdrawal by Subject|0|||
94653204|NCT02664038|324188061|FG000|26 Week|Lost to Follow-up|5|||
94653205|NCT02664038|324188062|FG001|26 Week|Lost to Follow-up|4|||
94653206|NCT02606136|324188067|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
94653207|NCT02606136|324188067|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
94653208|NCT02606136|324188067|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
94653209|NCT02606136|324188067|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
94653210|NCT03698773|324188071|FG000|Overall Study|Lost to Follow-up|2|||
94653211|NCT03698773|324188072|FG001|Overall Study|Lost to Follow-up|1|||
94653212|NCT05074433|324188073|FG000|Overall Study|Adverse Event|0|||
94653213|NCT05074433|324188074|FG001|Overall Study|Adverse Event|2|||
94653214|NCT05074433|324188075|FG002|Overall Study|Adverse Event|0|||
94653215|NCT05074433|324188076|FG003|Overall Study|Adverse Event|1|||
94653216|NCT05074433|324188073|FG000|Overall Study|Sponsor Request|0|||
94653217|NCT05074433|324188074|FG001|Overall Study|Sponsor Request|1|||
94653218|NCT05074433|324188075|FG002|Overall Study|Sponsor Request|1|||
94653219|NCT05074433|324188076|FG003|Overall Study|Sponsor Request|0|||
94653220|NCT05074433|324188073|FG000|Overall Study|Death|1|||
94653221|NCT05074433|324188074|FG001|Overall Study|Death|0|||
94653222|NCT05074433|324188075|FG002|Overall Study|Death|0|||
94653223|NCT05074433|324188076|FG003|Overall Study|Death|0|||
94653224|NCT05074433|324188073|FG000|Overall Study|Lost to Follow-up|0|||
94653225|NCT05074433|324188074|FG001|Overall Study|Lost to Follow-up|0|||
94653226|NCT05074433|324188075|FG002|Overall Study|Lost to Follow-up|2|||
94653227|NCT05074433|324188076|FG003|Overall Study|Lost to Follow-up|0|||
94712740|NCT00774397|324408439|FG001|Overall Study|Protocol Violation|1|||
94712741|NCT00774397|324408440|FG002|Overall Study|Protocol Violation|3|||
94712742|NCT00774397|324408441|FG003|Overall Study|Protocol Violation|1|||
94712743|NCT00774397|324408442|FG004|Overall Study|Protocol Violation|2|||
94712744|NCT00774397|324408443|FG005|Overall Study|Protocol Violation|1|||
94712745|NCT00774397|324408444|FG006|Overall Study|Protocol Violation|0|||
94712746|NCT00774397|324408438|FG000|Overall Study|Lost to Follow-up|0|||
94712747|NCT00774397|324408439|FG001|Overall Study|Lost to Follow-up|1|||
94712748|NCT00774397|324408440|FG002|Overall Study|Lost to Follow-up|1|||
94712749|NCT00774397|324408441|FG003|Overall Study|Lost to Follow-up|1|||
94712750|NCT00774397|324408442|FG004|Overall Study|Lost to Follow-up|0|||
94712751|NCT00774397|324408443|FG005|Overall Study|Lost to Follow-up|1|||
94712752|NCT00774397|324408444|FG006|Overall Study|Lost to Follow-up|0|||
94712753|NCT00774397|324408438|FG000|Overall Study|Refused to continue trial medication|1|||
94712754|NCT00774397|324408439|FG001|Overall Study|Refused to continue trial medication|3|||
94712755|NCT00774397|324408440|FG002|Overall Study|Refused to continue trial medication|2|||
94712756|NCT00774397|324408441|FG003|Overall Study|Refused to continue trial medication|2|||
94712757|NCT00774397|324408442|FG004|Overall Study|Refused to continue trial medication|6|||
94712758|NCT00774397|324408443|FG005|Overall Study|Refused to continue trial medication|2|||
94712759|NCT00774397|324408444|FG006|Overall Study|Refused to continue trial medication|3|||
94712760|NCT00774397|324408438|FG000|Overall Study|Not treated|0|||
94712761|NCT00774397|324408439|FG001|Overall Study|Not treated|0|||
94712762|NCT00774397|324408440|FG002|Overall Study|Not treated|0|||
94712763|NCT00774397|324408441|FG003|Overall Study|Not treated|0|||
94712764|NCT00774397|324408442|FG004|Overall Study|Not treated|1|||
94712765|NCT00774397|324408443|FG005|Overall Study|Not treated|0|||
94712766|NCT00774397|324408444|FG006|Overall Study|Not treated|1|||
94712767|NCT00774397|324408438|FG000|Overall Study|Other than those stated above|1|||
94712768|NCT00774397|324408439|FG001|Overall Study|Other than those stated above|1|||
94712769|NCT00774397|324408440|FG002|Overall Study|Other than those stated above|3|||
94712770|NCT00774397|324408441|FG003|Overall Study|Other than those stated above|2|||
94712771|NCT00774397|324408442|FG004|Overall Study|Other than those stated above|2|||
94712772|NCT00774397|324408443|FG005|Overall Study|Other than those stated above|0|||
94712773|NCT00774397|324408444|FG006|Overall Study|Other than those stated above|1|||
94712774|NCT02616900|324408449|FG000|Overall Study|Lack of Efficacy|7|||
94712775|NCT02616900|324408449|FG000|Overall Study|Lost to Follow-up|2|||
94712776|NCT02616900|324408449|FG000|Overall Study|Protocol Violation|5|||
94712777|NCT02616900|324408449|FG000|Overall Study|Withdrawal by Subject|3|||
94712778|NCT02616900|324408449|FG000|Overall Study|Incomplete data|6|||
94712779|NCT02499159|324408450|FG000|Randomization|Protocol Violation|1|||
94712780|NCT02499159|324408451|FG001|Randomization|Protocol Violation|1|||
94712781|NCT02499159|324408450|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
94712782|NCT02499159|324408451|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
94712783|NCT02499159|324408450|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
94712784|NCT02499159|324408451|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
94712785|NCT02499159|324408450|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
94712786|NCT02499159|324408451|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
94712787|NCT02499159|324408450|FG000|30-Day Follow-Up Phone Call|Other|1|||
94712788|NCT02499159|324408451|FG001|30-Day Follow-Up Phone Call|Other|0|||
94712789|NCT02601820|324408453|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
94712790|NCT02601820|324408453|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
94712791|NCT02601820|324408453|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
94712792|NCT02601820|324408453|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
94712793|NCT01854385|324408456|FG000|Pre-Treatment|Withdrawal by Subject|4|||
94712794|NCT01854385|324408456|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
94712795|NCT01854385|324408456|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
94712796|NCT01854385|324408456|FG000|Pre-Treatment|Unable to come for study visits|1|||
94712797|NCT01854385|324408456|FG000|Treatment|Lost to Follow-up|1|||
94712798|NCT01972724|324408458|FG000|Double-Blind|Rescue Criteria Met|1|||
94712799|NCT01972724|324408459|FG001|Double-Blind|Rescue Criteria Met|0|||
94712800|NCT01972724|324408460|FG002|Double-Blind|Rescue Criteria Met|0|||
94712801|NCT01972724|324408458|FG000|Double-Blind|Adverse Event|1|||
94712802|NCT01972724|324408459|FG001|Double-Blind|Adverse Event|0|||
94712803|NCT01972724|324408460|FG002|Double-Blind|Adverse Event|0|||
94712804|NCT01972724|324408458|FG000|Double-Blind|Withdrawal of Consent|2|||
94712805|NCT01972724|324408459|FG001|Double-Blind|Withdrawal of Consent|1|||
94712806|NCT01972724|324408460|FG002|Double-Blind|Withdrawal of Consent|0|||
94712807|NCT01972724|324408458|FG000|Double-Blind|Significant Protocol Deviation|5|||
94712808|NCT01972724|324408459|FG001|Double-Blind|Significant Protocol Deviation|8|||
94712809|NCT01972724|324408460|FG002|Double-Blind|Significant Protocol Deviation|0|||
94712810|NCT01972724|324408458|FG000|Open-Label|Withdrew Consent|0|||
94712811|NCT01972724|324408459|FG001|Open-Label|Withdrew Consent|0|||
94712812|NCT01972724|324408460|FG002|Open-Label|Withdrew Consent|3|||
94712813|NCT01972724|324408458|FG000|Open-Label|Significant Protocol Deviation|0|||
94712814|NCT01972724|324408459|FG001|Open-Label|Significant Protocol Deviation|0|||
94712815|NCT01972724|324408460|FG002|Open-Label|Significant Protocol Deviation|2|||
94712816|NCT00636207|324408468|FG000|Overall Study|Adverse Event|1|||
94712817|NCT00636207|324408469|FG001|Overall Study|Adverse Event|0|||
94712818|NCT00636207|324408470|FG002|Overall Study|Adverse Event|0|||
94712819|NCT00636207|324408471|FG003|Overall Study|Adverse Event|0|||
94712820|NCT00636207|324408472|FG004|Overall Study|Adverse Event|0|||
94712821|NCT00636207|324408473|FG005|Overall Study|Adverse Event|0|||
94712822|NCT00636207|324408474|FG006|Overall Study|Adverse Event|0|||
94712823|NCT00636207|324408468|FG000|Overall Study|Withdrawal by Subject|0|||
94712824|NCT00636207|324408469|FG001|Overall Study|Withdrawal by Subject|1|||
94712825|NCT00636207|324408470|FG002|Overall Study|Withdrawal by Subject|0|||
94712826|NCT00636207|324408471|FG003|Overall Study|Withdrawal by Subject|0|||
94712827|NCT00636207|324408472|FG004|Overall Study|Withdrawal by Subject|1|||
94712828|NCT00636207|324408473|FG005|Overall Study|Withdrawal by Subject|0|||
94712829|NCT00636207|324408474|FG006|Overall Study|Withdrawal by Subject|0|||
94712830|NCT01075217|324408475|FG000|Overall Study|Adverse Event|1|||
94712831|NCT01075217|324408476|FG001|Overall Study|Adverse Event|1|||
94712832|NCT01075217|324408475|FG000|Overall Study|Physician Decision|1|||
94712833|NCT01075217|324408476|FG001|Overall Study|Physician Decision|0|||
94712834|NCT01266122|324408479|FG000|Overall Study|Lost to Follow-up|6|||
94712835|NCT01266122|324408480|FG001|Overall Study|Lost to Follow-up|6|||
94712836|NCT03752151|324408481|FG000|Overall Study|Withdrawal by Subject|1|||
94712837|NCT03752151|324408481|FG000|Overall Study|Protocol Violation|1|||
94712838|NCT03482011|324408484|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
94712839|NCT03482011|324408485|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
94712840|NCT03482011|324408486|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
94712841|NCT03482011|324408487|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
94712842|NCT03482011|324408488|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
94712843|NCT03482011|324408489|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
94712844|NCT03482011|324408490|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
94712845|NCT03482011|324408491|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
94712846|NCT03482011|324408484|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
94712847|NCT03482011|324408485|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
94712848|NCT03482011|324408486|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94712849|NCT03482011|324408487|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94712850|NCT03482011|324408488|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94712851|NCT03482011|324408489|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94712852|NCT03482011|324408490|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94712853|NCT03482011|324408491|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94712854|NCT03482011|324408484|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
94712855|NCT03482011|324408485|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
94712856|NCT03482011|324408486|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
94712857|NCT03482011|324408487|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
94712858|NCT03482011|324408488|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
94712859|NCT03482011|324408489|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
94712860|NCT03482011|324408490|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
94712861|NCT03482011|324408491|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
94712862|NCT03482011|324408484|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
94712863|NCT03482011|324408485|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
94712864|NCT03482011|324408486|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
94712865|NCT03482011|324408487|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
94712866|NCT03482011|324408488|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
94712867|NCT03482011|324408489|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
94712868|NCT03482011|324408490|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
94712869|NCT03482011|324408491|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
94712870|NCT03482011|324408484|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
94712871|NCT03482011|324408485|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
94712872|NCT03482011|324408486|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94712873|NCT03482011|324408487|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94712874|NCT03482011|324408488|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94712875|NCT03482011|324408489|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94712876|NCT03482011|324408490|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94712877|NCT03482011|324408491|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94712878|NCT03482011|324408484|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
94712879|NCT03482011|324408485|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
94712880|NCT03482011|324408486|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
94712881|NCT03482011|324408487|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
94712882|NCT03482011|324408488|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
94712883|NCT03482011|324408489|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
94712884|NCT03482011|324408490|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
94712885|NCT03482011|324408491|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
94712886|NCT03482011|324408484|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
94712887|NCT03482011|324408485|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
94712888|NCT03482011|324408486|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
94712889|NCT03482011|324408487|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
94712890|NCT03482011|324408488|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
94712891|NCT03482011|324408489|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
94712892|NCT03482011|324408490|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
94712893|NCT03482011|324408491|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
94712894|NCT03482011|324408484|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94712895|NCT03482011|324408485|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94712896|NCT03482011|324408486|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94712897|NCT03482011|324408487|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94712898|NCT03482011|324408488|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
94712899|NCT03482011|324408489|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94712900|NCT03482011|324408490|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94712901|NCT03482011|324408491|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
94712902|NCT03482011|324408484|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
94712903|NCT03482011|324408485|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
94712904|NCT03482011|324408486|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
94712905|NCT03482011|324408487|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
94712906|NCT03482011|324408488|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
94712907|NCT03482011|324408489|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
94712908|NCT03482011|324408490|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
94712909|NCT03482011|324408491|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
94712910|NCT03482011|324408484|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94712911|NCT03482011|324408485|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94712912|NCT03482011|324408486|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94712913|NCT03482011|324408487|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
94712914|NCT03482011|324408488|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
94712915|NCT03482011|324408489|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
94712916|NCT03482011|324408490|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
94712917|NCT03482011|324408491|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
94712918|NCT03482011|324408484|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
94712919|NCT03482011|324408485|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
94712920|NCT03482011|324408486|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
94712921|NCT03482011|324408487|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
94712922|NCT03482011|324408488|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
94712923|NCT03482011|324408489|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
94712924|NCT03482011|324408490|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
94712925|NCT03482011|324408491|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
94712926|NCT03482011|324408484|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
94712927|NCT03482011|324408485|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
94712928|NCT03482011|324408486|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
94712929|NCT03482011|324408487|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
94712930|NCT03482011|324408488|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
94712931|NCT03482011|324408489|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
94712932|NCT03482011|324408490|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
94712933|NCT03482011|324408491|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
94712934|NCT03482011|324408484|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
94712935|NCT03482011|324408485|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
94712936|NCT03482011|324408486|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
94712937|NCT03482011|324408487|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
94712938|NCT03482011|324408488|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
94712939|NCT03482011|324408489|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
94712940|NCT03482011|324408490|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
94712941|NCT03482011|324408491|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
94712942|NCT03482011|324408484|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
94712943|NCT03482011|324408485|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
94712944|NCT03482011|324408486|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
94712945|NCT03482011|324408487|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
94712946|NCT03482011|324408488|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
94712947|NCT03482011|324408489|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
94712948|NCT03482011|324408490|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
94712949|NCT03482011|324408491|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
94712950|NCT03482011|324408484|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
94712951|NCT03482011|324408485|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
94712952|NCT03482011|324408486|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
94712953|NCT03482011|324408487|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
94712954|NCT03482011|324408488|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
94712955|NCT03482011|324408489|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
94712956|NCT03482011|324408490|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
94712957|NCT03482011|324408491|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
94712958|NCT01000480|324408498|FG000|Induction Phase|Adverse Event|2|||
94712959|NCT01000480|324408498|FG000|Induction Phase|Lost to Follow-up|1|||
94712960|NCT01000480|324408498|FG000|Induction Phase|Physician Decision|1|||
94712961|NCT01000480|324408498|FG000|Induction Phase|Entry Criteria Not Met|3|||
94712962|NCT01000480|324408498|FG000|Concurrent Therapy Phase|Adverse Event|4|||
94712963|NCT01000480|324408498|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
94712964|NCT01000480|324408498|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
94712965|NCT01000480|324408498|FG000|Concurrent Therapy Phase|Physician Decision|1|||
94712966|NCT00939510|324408499|FG000|Overall Study|Withdrawal by Subject|1|||
94712967|NCT00520546|324408500|FG000|Overall Study|Withdrawal by Subject|1|||
94712968|NCT00520546|324408500|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
94712969|NCT03903822|324408508|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
94712970|NCT03903822|324408509|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
94712971|NCT03903822|324408510|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
94712972|NCT03903822|324408511|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
94712973|NCT03903822|324408512|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
94712974|NCT03903822|324408513|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
94712975|NCT03903822|324408514|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
94712976|NCT03903822|324408515|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
94712977|NCT03903822|324408508|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
94270367|NCT01961349|322782136|FG002|Overall Study|registration error, personal reason etc|1|||
94712978|NCT03903822|324408509|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
94712979|NCT03903822|324408510|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
94712980|NCT03903822|324408511|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
94712981|NCT03903822|324408512|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
94712982|NCT03903822|324408513|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
94712983|NCT03903822|324408514|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
94712984|NCT03903822|324408515|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
94712985|NCT03903822|324408508|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
94712986|NCT03903822|324408509|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
94712987|NCT03903822|324408510|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
94712988|NCT03903822|324408511|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
94712989|NCT03903822|324408512|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
94712990|NCT03903822|324408513|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
94712991|NCT03903822|324408514|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
94712992|NCT03903822|324408515|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
94712993|NCT03903822|324408508|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
94712994|NCT03903822|324408509|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
94712995|NCT03903822|324408510|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
94712996|NCT03903822|324408511|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
94712997|NCT03903822|324408512|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
94712998|NCT03903822|324408513|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
94712999|NCT03903822|324408514|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
94713000|NCT03903822|324408515|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
94713001|NCT03903822|324408508|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
94713002|NCT03903822|324408509|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
94713003|NCT03903822|324408510|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
94713004|NCT03903822|324408511|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
94713005|NCT03903822|324408512|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
94713006|NCT03903822|324408513|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
94713007|NCT03903822|324408514|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
94713008|NCT03903822|324408515|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
94713009|NCT03903822|324408508|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
94270368|NCT00433914|322782142|FG000|Overall Study|Withdrawal by Subject|0|||
94270369|NCT00433914|322782143|FG001|Overall Study|Withdrawal by Subject|2|||
94270370|NCT00433914|322782142|FG000|Overall Study|Lost to Follow-up|0|||
94270371|NCT00433914|322782143|FG001|Overall Study|Lost to Follow-up|1|||
94270372|NCT02844920|322782146|FG000|Overall Study|Lost to Follow-up|2|||
94270373|NCT02486653|322782149|FG000|Overall Study|Withdrawal by Subject|1|||
94270374|NCT02486653|322782150|FG001|Overall Study|Withdrawal by Subject|3|||
94270375|NCT02486653|322782149|FG000|Overall Study|Protocol Violation|1|||
94270376|NCT02486653|322782150|FG001|Overall Study|Protocol Violation|0|||
94270377|NCT02486653|322782149|FG000|Overall Study|surgery cancelled|4|||
94270378|NCT02486653|322782150|FG001|Overall Study|surgery cancelled|1|||
94270379|NCT03000179|322782151|FG000|Overall Study|Lost to Follow-up|2|||
94270380|NCT01299376|322782152|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
94270381|NCT01299376|322782153|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
94270382|NCT01299376|322782152|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
94270383|NCT01299376|322782153|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
94270384|NCT01299376|322782152|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
94270385|NCT01299376|322782153|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
94270386|NCT01299376|322782152|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
94270387|NCT01299376|322782153|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
94270388|NCT01299376|322782152|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
94270389|NCT01299376|322782153|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
94270390|NCT01299376|322782152|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
94270391|NCT01299376|322782153|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
94270392|NCT01299376|322782152|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
94270393|NCT01299376|322782153|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
94270394|NCT01299376|322782152|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
94270395|NCT01299376|322782153|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
94713010|NCT03903822|324408509|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
94713011|NCT03903822|324408510|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
94713012|NCT03903822|324408511|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
94713013|NCT03903822|324408512|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
94270396|NCT01299376|322782152|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
94270397|NCT01299376|322782153|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
94270398|NCT01299376|322782152|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
94270399|NCT01299376|322782153|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
94270400|NCT01299376|322782152|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
94270401|NCT01299376|322782153|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
94467228|NCT01672294|323500482|FG003|Overall Study|Withdrawal by Subject|4|||
94467229|NCT01672294|323500479|FG000|Overall Study|Excluded by study|1|||
94467230|NCT01672294|323500480|FG001|Overall Study|Excluded by study|1|||
94467231|NCT01672294|323500481|FG002|Overall Study|Excluded by study|0|||
94653228|NCT05074433|324188073|FG000|Overall Study|Subject Decision|8|||
94653229|NCT05074433|324188074|FG001|Overall Study|Subject Decision|6|||
94653230|NCT05074433|324188075|FG002|Overall Study|Subject Decision|4|||
94653231|NCT05074433|324188076|FG003|Overall Study|Subject Decision|5|||
94653232|NCT02357576|324188079|FG000|Treatment Period|Withdrawal by Subject|0|||
94653233|NCT02357576|324188080|FG001|Treatment Period|Withdrawal by Subject|1|||
94653234|NCT02357576|324188079|FG000|Treatment Period|Physician Decision|0|||
94653235|NCT02357576|324188080|FG001|Treatment Period|Physician Decision|1|||
94653236|NCT02357576|324188079|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
94653237|NCT02357576|324188080|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
94653238|NCT02357576|324188079|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
94653239|NCT02357576|324188080|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
94653240|NCT02357576|324188079|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
94653241|NCT02357576|324188080|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
94653242|NCT02357576|324188079|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
94653243|NCT02357576|324188080|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
94653244|NCT03795922|324188082|FG000|Overall Study|Adverse Event|2|||
94653245|NCT03795922|324188083|FG001|Overall Study|Adverse Event|1|||
94653246|NCT03795922|324188082|FG000|Overall Study|Withdrawal by Subject|5|||
94653247|NCT03795922|324188083|FG001|Overall Study|Withdrawal by Subject|13|||
94653248|NCT03795922|324188082|FG000|Overall Study|Lost to Follow-up|2|||
94653249|NCT03795922|324188083|FG001|Overall Study|Lost to Follow-up|3|||
94653250|NCT03795922|324188082|FG000|Overall Study|Pregnancy|0|||
94653251|NCT03795922|324188083|FG001|Overall Study|Pregnancy|1|||
94653252|NCT03795922|324188082|FG000|Overall Study|Physician Decision|1|||
94653253|NCT03795922|324188083|FG001|Overall Study|Physician Decision|2|||
94653254|NCT03795922|324188082|FG000|Overall Study|Protocol Violation|0|||
94653255|NCT03795922|324188083|FG001|Overall Study|Protocol Violation|1|||
94653256|NCT03795922|324188082|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
94653257|NCT03795922|324188083|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
94713014|NCT03903822|324408513|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
94713015|NCT03903822|324408514|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
94713016|NCT03903822|324408515|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
94467232|NCT01672294|323500482|FG003|Overall Study|Excluded by study|0|||
94467233|NCT01672294|323500479|FG000|Overall Study|Lost to Follow-up|1|||
94713017|NCT03903822|324408508|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
94713018|NCT03903822|324408509|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
94713019|NCT03903822|324408510|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
94713020|NCT03903822|324408511|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
94713021|NCT03903822|324408512|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
94713022|NCT03903822|324408513|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
94713023|NCT03903822|324408514|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
94713024|NCT03903822|324408515|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
94713025|NCT03903822|324408508|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
94713026|NCT03903822|324408509|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
94713027|NCT03903822|324408510|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
94713028|NCT03903822|324408511|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
94713029|NCT03903822|324408512|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
94713030|NCT03903822|324408513|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
94713031|NCT03903822|324408514|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
94713032|NCT03903822|324408515|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
94713033|NCT03903822|324408508|FG000|Treatment Phase (6 Weeks)|Other|2|||
94713034|NCT03903822|324408509|FG001|Treatment Phase (6 Weeks)|Other|1|||
94713035|NCT03903822|324408510|FG002|Treatment Phase (6 Weeks)|Other|0|||
94713036|NCT03903822|324408511|FG003|Treatment Phase (6 Weeks)|Other|0|||
94713037|NCT03903822|324408512|FG004|Treatment Phase (6 Weeks)|Other|1|||
94713038|NCT03903822|324408513|FG005|Treatment Phase (6 Weeks)|Other|1|||
94713039|NCT03903822|324408514|FG006|Treatment Phase (6 Weeks)|Other|0|||
94713040|NCT03903822|324408515|FG007|Treatment Phase (6 Weeks)|Other|0|||
94713041|NCT03903822|324408508|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
94713042|NCT03903822|324408509|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
94713043|NCT03903822|324408510|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
94713044|NCT03903822|324408511|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
94713045|NCT03903822|324408512|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
94713046|NCT03903822|324408513|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
94713047|NCT03903822|324408514|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
94713048|NCT03903822|324408515|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
94713049|NCT03903822|324408508|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
94713050|NCT03903822|324408509|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
94713051|NCT03903822|324408510|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
94713052|NCT03903822|324408511|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
94713053|NCT03903822|324408512|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
94713054|NCT03903822|324408513|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
94713055|NCT03903822|324408514|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
94713056|NCT03903822|324408515|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
94713057|NCT03903822|324408508|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
94713058|NCT03903822|324408509|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
94713059|NCT03903822|324408510|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
94713060|NCT03903822|324408511|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
94713061|NCT03903822|324408512|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
94713062|NCT03903822|324408513|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
94713063|NCT03903822|324408514|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
94713064|NCT03903822|324408515|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
94713065|NCT03903822|324408508|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
94713066|NCT03903822|324408509|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
94713067|NCT03903822|324408510|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
94713068|NCT03903822|324408511|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
94713069|NCT03903822|324408512|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
94713070|NCT03903822|324408513|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
94713071|NCT03903822|324408514|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
94713072|NCT03903822|324408515|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
94713073|NCT03903822|324408508|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
94713074|NCT03903822|324408509|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
94713075|NCT03903822|324408510|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
94713076|NCT03903822|324408511|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
94713077|NCT03903822|324408512|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
94713078|NCT03903822|324408513|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
94270402|NCT01977820|322782154|FG000|Overall Study|Sponsor terminated the study|1|||
94270403|NCT01977820|322782155|FG001|Overall Study|Sponsor terminated the study|1|||
94270404|NCT00698997|322782157|FG000|Overall Study|Lost to Follow-up|3|||
94270405|NCT00698997|322782158|FG001|Overall Study|Lost to Follow-up|0|||
94270406|NCT00698997|322782157|FG000|Overall Study|Withdrawal by Subject|7|||
94270407|NCT00698997|322782158|FG001|Overall Study|Withdrawal by Subject|27|||
94270408|NCT02625233|322782159|FG000|Overall Study|Adverse Event|2|||
94270409|NCT02625233|322782160|FG001|Overall Study|Adverse Event|0|||
94270410|NCT04425720|322782168|FG000|Overall Study|Withdrawal by Subject|0|||
94270411|NCT04425720|322782169|FG001|Overall Study|Withdrawal by Subject|20|||
94270412|NCT00445224|322782172|FG000|Specific Exercises|Withdrawal by Subject|3|||
94270413|NCT00445224|322782173|FG001|Specific Exercises|Withdrawal by Subject|3|||
94270414|NCT00445224|322782172|FG000|Specific Exercises|Withdrawal by Subject|1|||
94270415|NCT00445224|322782173|FG001|Specific Exercises|Withdrawal by Subject|0|||
94270416|NCT00609986|322782179|FG000|Overall Study|Did not receive transplant or treatment|8|||
94270417|NCT00609986|322782180|FG001|Overall Study|Did not receive transplant or treatment|3|||
94270418|NCT01889238|322782181|FG000|Overall Study|Death|1|||
94270419|NCT01889238|322782181|FG000|Overall Study|Withdrawal by Subject|1|||
94270420|NCT01889238|322782181|FG000|Overall Study|Adverse Event|6|||
94270421|NCT01889238|322782181|FG000|Overall Study|Disease Progression|104|||
94270422|NCT01889238|322782181|FG000|Overall Study|Other|6|||
94270423|NCT02046096|322782186|FG000|Overall Study|Death|28|||
94270424|NCT02046096|322782187|FG001|Overall Study|Death|45|||
94270425|NCT02046096|322782186|FG000|Overall Study|Lost to Follow-up|9|||
94270426|NCT02046096|322782187|FG001|Overall Study|Lost to Follow-up|20|||
94270427|NCT02046096|322782186|FG000|Overall Study|Withdrawal by Subject|5|||
94270428|NCT02046096|322782187|FG001|Overall Study|Withdrawal by Subject|17|||
94270429|NCT02046096|322782186|FG000|Overall Study|Other endpoint|2|||
94270430|NCT02046096|322782187|FG001|Overall Study|Other endpoint|19|||
94270431|NCT05419128|322782189|FG000|Overall Study|Withdrawal by Subject|1|||
94270432|NCT05419128|322782190|FG001|Overall Study|Withdrawal by Subject|1|||
94270433|NCT05419128|322782191|FG002|Overall Study|Withdrawal by Subject|0|||
94270434|NCT05419128|322782192|FG003|Overall Study|Withdrawal by Subject|1|||
94270435|NCT05419128|322782193|FG004|Overall Study|Withdrawal by Subject|1|||
94270436|NCT05419128|322782194|FG005|Overall Study|Withdrawal by Subject|0|||
94270437|NCT05419128|322782189|FG000|Overall Study|Lost to Follow-up|0|||
94270438|NCT05419128|322782190|FG001|Overall Study|Lost to Follow-up|0|||
94270439|NCT05419128|322782191|FG002|Overall Study|Lost to Follow-up|1|||
94270440|NCT05419128|322782192|FG003|Overall Study|Lost to Follow-up|0|||
94270441|NCT05419128|322782193|FG004|Overall Study|Lost to Follow-up|0|||
94270442|NCT05419128|322782194|FG005|Overall Study|Lost to Follow-up|1|||
94270443|NCT04869345|322782195|FG000|Overall Study|Lost to Follow-up|8|||
94270444|NCT04869345|322782196|FG001|Overall Study|Lost to Follow-up|3|||
94270445|NCT01380379|322782202|FG000|Overall Study|Pregnancy|1|||
94270446|NCT02246582|322783700|FG000|Overall Study|Withdrawal by Subject|3|||
94270447|NCT02246582|322783701|FG001|Overall Study|Withdrawal by Subject|4|||
94270448|NCT00761306|322783704|FG000|Overall Study|Adverse Event|5|||
94270449|NCT00761306|322783704|FG000|Overall Study|Lack of Efficacy|4|||
94270450|NCT00761306|322783704|FG000|Overall Study|Protocol Violation|2|||
94270451|NCT00761306|322783704|FG000|Overall Study|Withdrawal of Consent|3|||
94270452|NCT00761306|322783704|FG000|Overall Study|Lost to Follow-up|1|||
94713079|NCT03903822|324408514|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
94713080|NCT03903822|324408515|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
94713081|NCT03903822|324408508|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
94713082|NCT03903822|324408509|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
94713083|NCT03903822|324408510|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
94713084|NCT03903822|324408511|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
94713085|NCT03903822|324408512|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
94713086|NCT03903822|324408513|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
94270453|NCT00761306|322783704|FG000|Overall Study|Administrative or Other Reasons|5|||
94270454|NCT03335163|322783705|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
94270455|NCT03335163|322783705|FG000|Overall Study|Withdrawal by Subject|18|||
94270456|NCT00938717|322783710|FG000|Overall Study|Adverse Event|10|||
94467234|NCT01672294|323500480|FG001|Overall Study|Lost to Follow-up|16|||
94713087|NCT03903822|324408514|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
94713088|NCT03903822|324408515|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
94270457|NCT00938717|322783711|FG001|Overall Study|Adverse Event|41|||
94270458|NCT00938717|322783710|FG000|Overall Study|Protocol Violation|11|||
94270459|NCT00938717|322783711|FG001|Overall Study|Protocol Violation|8|||
94270460|NCT00938717|322783710|FG000|Overall Study|Withdrawal by Subject|26|||
94270461|NCT00938717|322783711|FG001|Overall Study|Withdrawal by Subject|24|||
94270462|NCT00938717|322783710|FG000|Overall Study|Lost to Follow-up|13|||
94270463|NCT00938717|322783711|FG001|Overall Study|Lost to Follow-up|18|||
94270464|NCT00938717|322783710|FG000|Overall Study|Lack of Efficacy|33|||
94270465|NCT00938717|322783711|FG001|Overall Study|Lack of Efficacy|15|||
94270466|NCT00938717|322783710|FG000|Overall Study|Other reason|5|||
94713089|NCT03903822|324408508|FG000|Follow up Phase (4 Weeks)|Other|1|||
94713090|NCT03903822|324408509|FG001|Follow up Phase (4 Weeks)|Other|1|||
94713091|NCT03903822|324408510|FG002|Follow up Phase (4 Weeks)|Other|0|||
94713092|NCT03903822|324408511|FG003|Follow up Phase (4 Weeks)|Other|0|||
94713093|NCT03903822|324408512|FG004|Follow up Phase (4 Weeks)|Other|0|||
94713094|NCT03903822|324408513|FG005|Follow up Phase (4 Weeks)|Other|0|||
94713095|NCT03903822|324408514|FG006|Follow up Phase (4 Weeks)|Other|0|||
94713096|NCT03903822|324408515|FG007|Follow up Phase (4 Weeks)|Other|0|||
94713097|NCT03733119|324408524|FG000|Overall Study|Physician Decision|2|||
94713098|NCT03733119|324408525|FG001|Overall Study|Physician Decision|1|||
94713099|NCT03733119|324408524|FG000|Overall Study|ineligible to treat per protocol|0|||
94713100|NCT03733119|324408525|FG001|Overall Study|ineligible to treat per protocol|1|||
94713101|NCT01943916|324408526|FG000|Overall Study|Technically invalid images|10|||
94713102|NCT01943916|324408526|FG000|Overall Study|Enrollment Failure|23|||
94713103|NCT01943916|324408526|FG000|Overall Study|Pilot Phase exclusion|100|||
94713104|NCT01943916|324408526|FG000|Overall Study|Quality Assurance Reader Fail|130|||
94713105|NCT01943916|324408526|FG000|Overall Study|Technical Failure|39|||
94713106|NCT01943916|324408526|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
94713107|NCT01943916|324408526|FG000|Overall Study|No Truth Panel Review|38|||
94713108|NCT01943916|324408526|FG000|Overall Study|Protocol Deviation|1|||
94713109|NCT05782231|324408528|FG000|Overall Study|Withdrawal by Subject|1|||
94713110|NCT00304031|324410616|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
94713111|NCT00304031|324410617|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
94713112|NCT00304031|324410618|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
94713113|NCT00304031|324410616|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
94713114|NCT00304031|324410617|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
94713115|NCT00304031|324410618|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
94713116|NCT00304031|324410616|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
94713117|NCT00304031|324410617|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
94713118|NCT00304031|324410618|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
94713119|NCT00304031|324410616|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
94713120|NCT00304031|324410617|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
94713121|NCT00304031|324410618|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
94713122|NCT00304031|324410616|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
94713123|NCT00304031|324410617|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
94713124|NCT00304031|324410618|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
94713125|NCT00304031|324410616|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
94713126|NCT00304031|324410617|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
94713127|NCT00304031|324410618|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
94713128|NCT00304031|324410616|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
94713129|NCT00304031|324410617|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
94713130|NCT00304031|324410618|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
94713131|NCT00304031|324410616|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
94713132|NCT00304031|324410617|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
94713133|NCT00304031|324410618|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
94713134|NCT00304031|324410616|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
94713135|NCT00304031|324410617|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
94713136|NCT00304031|324410618|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
94713137|NCT01391832|324410619|FG000|Overall Study|Withdrawal by Subject|21|||
94713138|NCT01391832|324410620|FG001|Overall Study|Withdrawal by Subject|22|||
94713139|NCT01391832|324410619|FG000|Overall Study|Lost to Follow-up|0|||
94713140|NCT01391832|324410620|FG001|Overall Study|Lost to Follow-up|1|||
94713141|NCT03452189|324410621|FG000|First Intervention (3 Months)|Adverse Event|1|||
94713142|NCT03452189|324410622|FG001|First Intervention (3 Months)|Adverse Event|0|||
94713143|NCT03452189|324410621|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
94713144|NCT03452189|324410622|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
94713145|NCT01308567|324410623|FG000|Overall Study|Lost to Follow-up|2|||
94713146|NCT01308567|324410624|FG001|Overall Study|Lost to Follow-up|4|||
94713147|NCT01308567|324410625|FG002|Overall Study|Lost to Follow-up|4|||
94713148|NCT00542789|324410626|FG000|Overall Study|Adverse Event|18|||
94713149|NCT00542789|324410627|FG001|Overall Study|Adverse Event|17|||
94713150|NCT00542789|324410626|FG000|Overall Study|Withdrawal by Subject|7|||
94713151|NCT00542789|324410627|FG001|Overall Study|Withdrawal by Subject|3|||
94713152|NCT00542789|324410626|FG000|Overall Study|Protocol Violation|8|||
94713153|NCT00542789|324410627|FG001|Overall Study|Protocol Violation|1|||
94713154|NCT00542789|324410626|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
94713155|NCT00542789|324410627|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
94270467|NCT00938717|322783711|FG001|Overall Study|Other reason|2|||
94713156|NCT01808339|324410634|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
94713157|NCT01808339|324410635|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
94713158|NCT01808339|324410636|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
94713159|NCT01808339|324410637|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
94713160|NCT01808339|324410638|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
94713161|NCT01808339|324410639|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
94713162|NCT01808339|324410634|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
94713163|NCT01808339|324410635|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
94713164|NCT01808339|324410636|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
94713165|NCT01808339|324410637|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
94713166|NCT01808339|324410638|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
94713167|NCT01808339|324410639|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
94713168|NCT01808339|324410634|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
94713169|NCT01808339|324410635|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
94713170|NCT01808339|324410636|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
94713171|NCT01808339|324410637|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
94713172|NCT01808339|324410638|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
94713173|NCT01808339|324410639|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
94713174|NCT00858117|324410642|FG000|Treatment on Study|Adverse Event|2|||
94713175|NCT00858117|324410642|FG000|Follow up for 5 Years|Death|4|||
94713176|NCT00858117|324410642|FG000|Follow up for 5 Years|No further data collected for study|9|||
94713177|NCT01599793|324410643|FG000|Overall Study|Adverse Event|2|||
94713178|NCT02755805|324410647|FG000|Overall Study|Lost to Follow-up|1|||
94713179|NCT02755805|324410648|FG001|Overall Study|Lost to Follow-up|2|||
94713180|NCT02755805|324410647|FG000|Overall Study|Refused assessments|1|||
94713181|NCT02755805|324410648|FG001|Overall Study|Refused assessments|0|||
94713182|NCT02755805|324410647|FG000|Overall Study|Withdrawal by Subject|0|||
94713183|NCT02755805|324410648|FG001|Overall Study|Withdrawal by Subject|2|||
94713184|NCT02765100|324410649|FG000|Overall Study|subject found ineligible after baseline|1|||
94713185|NCT02765100|324410650|FG001|Overall Study|subject found ineligible after baseline|1|||
94713186|NCT02765100|324410649|FG000|Overall Study|Lost to Follow-up|0|||
94713187|NCT02765100|324410650|FG001|Overall Study|Lost to Follow-up|1|||
94713188|NCT02252042|324410652|FG000|Overall Study|Adverse Event|9|||
94713189|NCT02252042|324410653|FG001|Overall Study|Adverse Event|6|||
94713190|NCT02252042|324410652|FG000|Overall Study|Death|209|||
94713191|NCT02252042|324410653|FG001|Overall Study|Death|217|||
94713192|NCT02252042|324410652|FG000|Overall Study|Physician Decision|0|||
94713193|NCT02252042|324410653|FG001|Overall Study|Physician Decision|2|||
94713194|NCT02252042|324410652|FG000|Overall Study|Transferred to Extension Study|7|||
94713195|NCT02252042|324410653|FG001|Overall Study|Transferred to Extension Study|1|||
94713196|NCT02252042|324410652|FG000|Overall Study|Did Not Continue on Extension Study|7|||
94713197|NCT02252042|324410653|FG001|Overall Study|Did Not Continue on Extension Study|2|||
94713198|NCT02252042|324410652|FG000|Overall Study|Withdrawal by Subject|15|||
94713199|NCT02252042|324410653|FG001|Overall Study|Withdrawal by Subject|20|||
94713200|NCT02593149|324410656|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
94713201|NCT02593149|324410657|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
94713202|NCT02593149|324410656|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
94713203|NCT02593149|324410657|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
94713204|NCT00391898|324410659|FG000|Overall Study|Adverse Event|3|||
94713205|NCT00391898|324410660|FG001|Overall Study|Adverse Event|0|||
94713206|NCT00391898|324410659|FG000|Overall Study|Other|8|||
94713207|NCT00391898|324410660|FG001|Overall Study|Other|10|||
94713208|NCT00979992|324410661|FG000|Overall Study|Ineligible - inadequate pathology|1|||
94713209|NCT00979992|324410661|FG000|Overall Study|Ineligible - wrong cell type|2|||
94270468|NCT02163187|322783716|FG000|Overall Study|Device removed|1|||
94270469|NCT02163187|322783717|FG001|Overall Study|Device removed|0|||
94270470|NCT02163187|322783716|FG000|Overall Study|Progressive disease|1|||
94270471|NCT02163187|322783717|FG001|Overall Study|Progressive disease|0|||
94270472|NCT03104075|322783718|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
94270473|NCT03104075|322783719|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
94270474|NCT03349775|322783720|FG000|Overall Study|Side Effects|1|||
94270475|NCT03349775|322783721|FG001|Overall Study|Side Effects|2|||
94270476|NCT03349775|322783720|FG000|Overall Study|Withdrawal by Subject|1|||
94270477|NCT03349775|322783721|FG001|Overall Study|Withdrawal by Subject|1|||
94270478|NCT03349775|322783720|FG000|Overall Study|No primary outcome measurements|0|||
94270479|NCT03349775|322783721|FG001|Overall Study|No primary outcome measurements|1|||
94270480|NCT02573870|322783722|FG000|Overall Study|Adverse Event|0|||
94467235|NCT01672294|323500481|FG002|Overall Study|Lost to Follow-up|7|||
94713210|NCT00979992|324410661|FG000|Overall Study|Refused - Never Treated|2|||
94713211|NCT01636687|324410664|FG000|Induction Period|Withdrawal by Subject|1|||
94713212|NCT01636687|324410665|FG001|Induction Period|Withdrawal by Subject|0|||
94713213|NCT01636687|324410666|FG002|Induction Period|Withdrawal by Subject|0|||
94713214|NCT01636687|324410667|FG003|Induction Period|Withdrawal by Subject|0|||
94467236|NCT01672294|323500482|FG003|Overall Study|Lost to Follow-up|9|||
94653258|NCT00705575|324188084|FG000|Overall Study|Abnormal laboratory value(s)|0|||
94653259|NCT00705575|324188085|FG001|Overall Study|Abnormal laboratory value(s)|3|||
94653260|NCT00705575|324188084|FG000|Overall Study|Abnormal test procedure result(s)|2|||
94653261|NCT00705575|324188085|FG001|Overall Study|Abnormal test procedure result(s)|12|||
94653262|NCT00705575|324188084|FG000|Overall Study|Adverse Event|11|||
94653263|NCT00705575|324188085|FG001|Overall Study|Adverse Event|15|||
94653264|NCT00705575|324188084|FG000|Overall Study|Lost to Follow-up|3|||
94653265|NCT00705575|324188085|FG001|Overall Study|Lost to Follow-up|4|||
94653266|NCT00705575|324188084|FG000|Overall Study|Protocol Violation|2|||
94653267|NCT00705575|324188085|FG001|Overall Study|Protocol Violation|2|||
94653268|NCT00705575|324188084|FG000|Overall Study|Withdrawal by Subject|5|||
94653269|NCT00705575|324188085|FG001|Overall Study|Withdrawal by Subject|10|||
94653270|NCT02822794|324188087|FG000|Overall Study|Withdrew Consent|1|||
94653271|NCT02822794|324188088|FG001|Overall Study|Withdrew Consent|0|||
94653272|NCT00414050|324188091|FG000|Overall Study|Adverse Event|1|||
94653273|NCT00414050|324188092|FG001|Overall Study|Adverse Event|1|||
94653274|NCT00414050|324188093|FG002|Overall Study|Adverse Event|1|||
94653275|NCT00414050|324188094|FG003|Overall Study|Adverse Event|1|||
94653276|NCT00414050|324188091|FG000|Overall Study|Lost to Follow-up|2|||
94653277|NCT00414050|324188092|FG001|Overall Study|Lost to Follow-up|2|||
94653278|NCT00414050|324188093|FG002|Overall Study|Lost to Follow-up|1|||
94653279|NCT00414050|324188094|FG003|Overall Study|Lost to Follow-up|1|||
94653280|NCT00414050|324188091|FG000|Overall Study|Withdrawal by Subject|5|||
94653281|NCT00414050|324188092|FG001|Overall Study|Withdrawal by Subject|3|||
94653282|NCT00414050|324188093|FG002|Overall Study|Withdrawal by Subject|2|||
94653283|NCT00414050|324188094|FG003|Overall Study|Withdrawal by Subject|4|||
94653284|NCT00414050|324188091|FG000|Overall Study|Subject discontinued for other reason|1|||
94653285|NCT00414050|324188092|FG001|Overall Study|Subject discontinued for other reason|2|||
94653286|NCT00414050|324188093|FG002|Overall Study|Subject discontinued for other reason|2|||
94653287|NCT00414050|324188094|FG003|Overall Study|Subject discontinued for other reason|1|||
94653288|NCT00414050|324188091|FG000|Overall Study|Subject Moved|0|||
94653289|NCT00414050|324188092|FG001|Overall Study|Subject Moved|0|||
94653290|NCT00414050|324188093|FG002|Overall Study|Subject Moved|0|||
94653291|NCT00414050|324188094|FG003|Overall Study|Subject Moved|1|||
94653292|NCT01959581|324188095|FG000|Overall Study|Lost to Follow-up|5|||
94653293|NCT00720876|324188096|FG000|Overall Study|found to be ineligible after starting tx|2|||
94653294|NCT03323099|324188102|FG000|Overall Study|Withdrawal by Subject|6|||
94653295|NCT03323099|324188103|FG001|Overall Study|Withdrawal by Subject|12|||
94653296|NCT03323099|324188102|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
94653297|NCT03323099|324188103|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
94653298|NCT00079274|324188104|FG000|Overall Study|Withdrawal by Subject|111|||
94653299|NCT00079274|324188105|FG001|Overall Study|Withdrawal by Subject|10|||
94653300|NCT00079274|324188106|FG002|Overall Study|Withdrawal by Subject|12|||
94653301|NCT00079274|324188107|FG003|Overall Study|Withdrawal by Subject|163|||
94653302|NCT00079274|324188108|FG004|Overall Study|Withdrawal by Subject|7|||
94653303|NCT00079274|324188109|FG005|Overall Study|Withdrawal by Subject|8|||
94653304|NCT00079274|324188110|FG006|Overall Study|Withdrawal by Subject|0|||
94653305|NCT00079274|324188104|FG000|Overall Study|Adverse Event|130|||
94653306|NCT00079274|324188105|FG001|Overall Study|Adverse Event|8|||
94653307|NCT00079274|324188106|FG002|Overall Study|Adverse Event|8|||
94653308|NCT00079274|324188107|FG003|Overall Study|Adverse Event|184|||
94653309|NCT00079274|324188108|FG004|Overall Study|Adverse Event|7|||
94653310|NCT00079274|324188109|FG005|Overall Study|Adverse Event|8|||
94653311|NCT00079274|324188110|FG006|Overall Study|Adverse Event|0|||
94653312|NCT00079274|324188104|FG000|Overall Study|Recurrence|21|||
94653313|NCT00079274|324188105|FG001|Overall Study|Recurrence|0|||
94653314|NCT00079274|324188106|FG002|Overall Study|Recurrence|1|||
94653315|NCT00079274|324188107|FG003|Overall Study|Recurrence|15|||
94653316|NCT00079274|324188108|FG004|Overall Study|Recurrence|0|||
94653317|NCT00079274|324188109|FG005|Overall Study|Recurrence|2|||
94653318|NCT00079274|324188110|FG006|Overall Study|Recurrence|0|||
94653319|NCT00079274|324188104|FG000|Overall Study|Alternate Treatment|6|||
94653320|NCT00079274|324188105|FG001|Overall Study|Alternate Treatment|1|||
94653321|NCT00079274|324188106|FG002|Overall Study|Alternate Treatment|0|||
94653322|NCT00079274|324188107|FG003|Overall Study|Alternate Treatment|3|||
94653323|NCT00079274|324188108|FG004|Overall Study|Alternate Treatment|0|||
94653324|NCT00079274|324188109|FG005|Overall Study|Alternate Treatment|0|||
94653325|NCT00079274|324188110|FG006|Overall Study|Alternate Treatment|0|||
94653326|NCT00079274|324188104|FG000|Overall Study|Other Medical Problems|6|||
94653327|NCT00079274|324188105|FG001|Overall Study|Other Medical Problems|1|||
94653328|NCT00079274|324188106|FG002|Overall Study|Other Medical Problems|0|||
94653329|NCT00079274|324188107|FG003|Overall Study|Other Medical Problems|7|||
94653330|NCT00079274|324188108|FG004|Overall Study|Other Medical Problems|0|||
94653331|NCT00079274|324188109|FG005|Overall Study|Other Medical Problems|0|||
94653332|NCT00079274|324188110|FG006|Overall Study|Other Medical Problems|0|||
94653333|NCT00079274|324188104|FG000|Overall Study|Death|4|||
94653334|NCT00079274|324188105|FG001|Overall Study|Death|0|||
94713215|NCT01636687|324410668|FG004|Induction Period|Withdrawal by Subject|0|||
94713216|NCT01636687|324410664|FG000|Induction Period|Adverse Event|1|||
94713217|NCT01636687|324410665|FG001|Induction Period|Adverse Event|0|||
94713218|NCT01636687|324410666|FG002|Induction Period|Adverse Event|0|||
94713219|NCT01636687|324410667|FG003|Induction Period|Adverse Event|0|||
94713220|NCT01636687|324410668|FG004|Induction Period|Adverse Event|1|||
94713221|NCT01636687|324410664|FG000|Induction Period|Lack of Efficacy|0|||
94713222|NCT01636687|324410665|FG001|Induction Period|Lack of Efficacy|0|||
94713223|NCT01636687|324410666|FG002|Induction Period|Lack of Efficacy|0|||
94713224|NCT01636687|324410667|FG003|Induction Period|Lack of Efficacy|0|||
94713225|NCT01636687|324410668|FG004|Induction Period|Lack of Efficacy|1|||
94713226|NCT01636687|324410664|FG000|Induction Period|Physician Decision|1|||
94713227|NCT01636687|324410665|FG001|Induction Period|Physician Decision|0|||
94713228|NCT01636687|324410666|FG002|Induction Period|Physician Decision|0|||
94713229|NCT01636687|324410667|FG003|Induction Period|Physician Decision|0|||
94713230|NCT01636687|324410668|FG004|Induction Period|Physician Decision|0|||
94713231|NCT01636687|324410664|FG000|Maintenance Period|Withdrawal by Subject|2|||
94713232|NCT01636687|324410665|FG001|Maintenance Period|Withdrawal by Subject|0|||
94713233|NCT01636687|324410666|FG002|Maintenance Period|Withdrawal by Subject|2|||
94713234|NCT01636687|324410667|FG003|Maintenance Period|Withdrawal by Subject|0|||
94713235|NCT01636687|324410668|FG004|Maintenance Period|Withdrawal by Subject|0|||
94713236|NCT01636687|324410664|FG000|Maintenance Period|Adverse Event|1|||
94713237|NCT01636687|324410665|FG001|Maintenance Period|Adverse Event|0|||
94713238|NCT01636687|324410666|FG002|Maintenance Period|Adverse Event|0|||
94713239|NCT01636687|324410667|FG003|Maintenance Period|Adverse Event|0|||
94713240|NCT01636687|324410668|FG004|Maintenance Period|Adverse Event|0|||
94713241|NCT01636687|324410664|FG000|Maintenance Period|Lack of Efficacy|4|||
94713242|NCT01636687|324410665|FG001|Maintenance Period|Lack of Efficacy|1|||
94713243|NCT01636687|324410666|FG002|Maintenance Period|Lack of Efficacy|0|||
94713244|NCT01636687|324410667|FG003|Maintenance Period|Lack of Efficacy|0|||
94713245|NCT01636687|324410668|FG004|Maintenance Period|Lack of Efficacy|0|||
94713246|NCT01636687|324410664|FG000|Maintenance Period|Lost to Follow-up|1|||
94713247|NCT01636687|324410665|FG001|Maintenance Period|Lost to Follow-up|1|||
94713248|NCT01636687|324410666|FG002|Maintenance Period|Lost to Follow-up|0|||
94713249|NCT01636687|324410667|FG003|Maintenance Period|Lost to Follow-up|0|||
94713250|NCT01636687|324410668|FG004|Maintenance Period|Lost to Follow-up|1|||
94270481|NCT02573870|322783723|FG001|Overall Study|Adverse Event|2|||
94270482|NCT02573870|322783722|FG000|Overall Study|Lack of Efficacy|0|||
94270483|NCT02573870|322783723|FG001|Overall Study|Lack of Efficacy|1|||
94270484|NCT02573870|322783722|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
94270485|NCT02573870|322783723|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
94270486|NCT02573870|322783722|FG000|Overall Study|Lost to Follow-up|0|||
94270487|NCT02573870|322783723|FG001|Overall Study|Lost to Follow-up|1|||
94270488|NCT02573870|322783722|FG000|Overall Study|Other: Fail to Meet Visit|0|||
94270489|NCT02573870|322783723|FG001|Overall Study|Other: Fail to Meet Visit|2|||
94270490|NCT01858532|322783724|FG000|Overall Study|Adverse Event|58|||
94270491|NCT01858532|322783725|FG001|Overall Study|Adverse Event|50|||
94270492|NCT01858532|322783726|FG002|Overall Study|Adverse Event|23|||
94270493|NCT01858532|322783727|FG003|Overall Study|Adverse Event|28|||
94270494|NCT01858532|322783724|FG000|Overall Study|Withdrew consent|71|||
94270495|NCT01858532|322783725|FG001|Overall Study|Withdrew consent|93|||
94270496|NCT01858532|322783726|FG002|Overall Study|Withdrew consent|46|||
94270497|NCT01858532|322783727|FG003|Overall Study|Withdrew consent|27|||
94270498|NCT01858532|322783724|FG000|Overall Study|Lost to Follow-up|17|||
94270499|NCT01858532|322783725|FG001|Overall Study|Lost to Follow-up|26|||
94270500|NCT01858532|322783726|FG002|Overall Study|Lost to Follow-up|11|||
94270501|NCT01858532|322783727|FG003|Overall Study|Lost to Follow-up|14|||
94270502|NCT01858532|322783724|FG000|Overall Study|Deterioration of medical status|3|||
94270503|NCT01858532|322783725|FG001|Overall Study|Deterioration of medical status|4|||
94270504|NCT01858532|322783726|FG002|Overall Study|Deterioration of medical status|3|||
94270505|NCT01858532|322783727|FG003|Overall Study|Deterioration of medical status|7|||
94270506|NCT01858532|322783724|FG000|Overall Study|Investigator request|3|||
94270507|NCT01858532|322783725|FG001|Overall Study|Investigator request|4|||
94270508|NCT01858532|322783726|FG002|Overall Study|Investigator request|2|||
94270509|NCT01858532|322783727|FG003|Overall Study|Investigator request|6|||
94270510|NCT01858532|322783724|FG000|Overall Study|Other, not specified|29|||
94270511|NCT01858532|322783725|FG001|Overall Study|Other, not specified|15|||
94270512|NCT01858532|322783726|FG002|Overall Study|Other, not specified|13|||
94270513|NCT01858532|322783727|FG003|Overall Study|Other, not specified|11|||
94270514|NCT00434421|322783728|FG000|Overall Study|Withdrawal by Subject|1|||
94270515|NCT00434421|322783728|FG000|Overall Study|Non-compliance with study treatment|1|||
94270516|NCT01380730|322783729|FG000|Overall Study|Death|0|||
94270517|NCT01380730|322783730|FG001|Overall Study|Death|0|||
94270518|NCT01380730|322783731|FG002|Overall Study|Death|0|||
94713251|NCT01636687|324410664|FG000|Maintenance Period|Physician Decision|0|||
94713252|NCT01636687|324410665|FG001|Maintenance Period|Physician Decision|0|||
94713253|NCT01636687|324410666|FG002|Maintenance Period|Physician Decision|0|||
94713254|NCT01636687|324410667|FG003|Maintenance Period|Physician Decision|0|||
94713255|NCT01636687|324410668|FG004|Maintenance Period|Physician Decision|1|||
94713256|NCT01636687|324410664|FG000|Extension Period|technical problems|0|||
94713257|NCT01636687|324410665|FG001|Extension Period|technical problems|1|||
94713258|NCT01636687|324410666|FG002|Extension Period|technical problems|2|||
94713259|NCT01636687|324410667|FG003|Extension Period|technical problems|1|||
94713260|NCT01636687|324410668|FG004|Extension Period|technical problems|0|||
94713261|NCT01636687|324410664|FG000|Extension Period|Adverse Event|4|||
94713262|NCT01636687|324410665|FG001|Extension Period|Adverse Event|3|||
94713263|NCT01636687|324410666|FG002|Extension Period|Adverse Event|2|||
94713264|NCT01636687|324410667|FG003|Extension Period|Adverse Event|1|||
94713265|NCT01636687|324410668|FG004|Extension Period|Adverse Event|0|||
94713266|NCT01636687|324410664|FG000|Extension Period|Lack of Efficacy|7|||
94713267|NCT01636687|324410665|FG001|Extension Period|Lack of Efficacy|0|||
94713268|NCT01636687|324410666|FG002|Extension Period|Lack of Efficacy|2|||
94713269|NCT01636687|324410667|FG003|Extension Period|Lack of Efficacy|1|||
94713270|NCT01636687|324410668|FG004|Extension Period|Lack of Efficacy|0|||
94713271|NCT01636687|324410664|FG000|Extension Period|Lost to Follow-up|1|||
94713272|NCT01636687|324410665|FG001|Extension Period|Lost to Follow-up|0|||
94713273|NCT01636687|324410666|FG002|Extension Period|Lost to Follow-up|1|||
94713274|NCT01636687|324410667|FG003|Extension Period|Lost to Follow-up|0|||
94713275|NCT01636687|324410668|FG004|Extension Period|Lost to Follow-up|0|||
94713276|NCT01636687|324410664|FG000|Extension Period|Physician Decision|1|||
94713277|NCT01636687|324410665|FG001|Extension Period|Physician Decision|0|||
94713278|NCT01636687|324410666|FG002|Extension Period|Physician Decision|0|||
94713279|NCT01636687|324410667|FG003|Extension Period|Physician Decision|1|||
94713280|NCT01636687|324410668|FG004|Extension Period|Physician Decision|0|||
94713281|NCT01636687|324410664|FG000|Extension Period|study terminated by sponsor|33|||
94713282|NCT01636687|324410665|FG001|Extension Period|study terminated by sponsor|50|||
94713283|NCT01636687|324410666|FG002|Extension Period|study terminated by sponsor|17|||
94713284|NCT01636687|324410667|FG003|Extension Period|study terminated by sponsor|23|||
94713285|NCT01636687|324410668|FG004|Extension Period|study terminated by sponsor|0|||
94713286|NCT01636687|324410664|FG000|Extension Period|Withdrawal by Subject|1|||
94713287|NCT01636687|324410665|FG001|Extension Period|Withdrawal by Subject|0|||
94713288|NCT01636687|324410666|FG002|Extension Period|Withdrawal by Subject|1|||
94713289|NCT01636687|324410667|FG003|Extension Period|Withdrawal by Subject|1|||
94713290|NCT01636687|324410668|FG004|Extension Period|Withdrawal by Subject|0|||
94713291|NCT01636687|324410664|FG000|Follow-up Period|Withdrawal by Subject|1|||
94713292|NCT01636687|324410665|FG001|Follow-up Period|Withdrawal by Subject|0|||
94270519|NCT01380730|322783732|FG003|Overall Study|Death|0|||
94713293|NCT01636687|324410666|FG002|Follow-up Period|Withdrawal by Subject|0|||
94713294|NCT01636687|324410667|FG003|Follow-up Period|Withdrawal by Subject|0|||
94713295|NCT01636687|324410668|FG004|Follow-up Period|Withdrawal by Subject|1|||
94713296|NCT00244855|324410673|FG000|Overall Study|Withdrawal by Subject|0|||
94713297|NCT00244855|324410674|FG001|Overall Study|Withdrawal by Subject|1|||
94713298|NCT01135511|324410680|FG000|Overall Study|Adverse Event|0|||
94713299|NCT01135511|324410681|FG001|Overall Study|Adverse Event|1|||
94270520|NCT01380730|322783733|FG004|Overall Study|Death|1|||
94270521|NCT01380730|322783734|FG005|Overall Study|Death|0|||
94270522|NCT01380730|322783735|FG006|Overall Study|Death|0|||
94713300|NCT01135511|324410682|FG002|Overall Study|Adverse Event|2|||
94713301|NCT01135511|324410683|FG003|Overall Study|Adverse Event|0|||
94713302|NCT01135511|324410684|FG004|Overall Study|Adverse Event|0|||
94713303|NCT01135511|324410685|FG005|Overall Study|Adverse Event|1|||
94713304|NCT01135511|324410686|FG006|Overall Study|Adverse Event|0|||
94713305|NCT01135511|324410687|FG007|Overall Study|Adverse Event|1|||
94713306|NCT01135511|324410688|FG008|Overall Study|Adverse Event|0|||
94713307|NCT01135511|324410680|FG000|Overall Study|Lack of Efficacy|0|||
94713308|NCT01135511|324410681|FG001|Overall Study|Lack of Efficacy|1|||
94713309|NCT01135511|324410682|FG002|Overall Study|Lack of Efficacy|1|||
94270523|NCT01380730|322783736|FG007|Overall Study|Death|0|||
94713310|NCT01135511|324410683|FG003|Overall Study|Lack of Efficacy|2|||
94713311|NCT01135511|324410684|FG004|Overall Study|Lack of Efficacy|0|||
94713312|NCT01135511|324410685|FG005|Overall Study|Lack of Efficacy|0|||
94713313|NCT01135511|324410686|FG006|Overall Study|Lack of Efficacy|0|||
94713314|NCT01135511|324410687|FG007|Overall Study|Lack of Efficacy|0|||
94713315|NCT01135511|324410688|FG008|Overall Study|Lack of Efficacy|0|||
94713316|NCT01135511|324410680|FG000|Overall Study|Protocol Violation|0|||
94713317|NCT01135511|324410681|FG001|Overall Study|Protocol Violation|0|||
94713318|NCT01135511|324410682|FG002|Overall Study|Protocol Violation|3|||
94713319|NCT01135511|324410683|FG003|Overall Study|Protocol Violation|0|||
94713320|NCT01135511|324410684|FG004|Overall Study|Protocol Violation|0|||
94713321|NCT01135511|324410685|FG005|Overall Study|Protocol Violation|0|||
94713322|NCT01135511|324410686|FG006|Overall Study|Protocol Violation|0|||
94713323|NCT01135511|324410687|FG007|Overall Study|Protocol Violation|0|||
94713324|NCT01135511|324410688|FG008|Overall Study|Protocol Violation|0|||
94713325|NCT01135511|324410680|FG000|Overall Study|Pregnancy|0|||
94713326|NCT01135511|324410681|FG001|Overall Study|Pregnancy|0|||
94713327|NCT01135511|324410682|FG002|Overall Study|Pregnancy|0|||
94713328|NCT01135511|324410683|FG003|Overall Study|Pregnancy|1|||
94713329|NCT01135511|324410684|FG004|Overall Study|Pregnancy|0|||
94713330|NCT01135511|324410685|FG005|Overall Study|Pregnancy|0|||
94713331|NCT01135511|324410686|FG006|Overall Study|Pregnancy|0|||
94713332|NCT01135511|324410687|FG007|Overall Study|Pregnancy|0|||
94713333|NCT01135511|324410688|FG008|Overall Study|Pregnancy|0|||
94713334|NCT01135511|324410680|FG000|Overall Study|could not visit the clinic|0|||
94713335|NCT01135511|324410681|FG001|Overall Study|could not visit the clinic|1|||
94713336|NCT01135511|324410682|FG002|Overall Study|could not visit the clinic|2|||
94713337|NCT01135511|324410683|FG003|Overall Study|could not visit the clinic|0|||
94713338|NCT01135511|324410684|FG004|Overall Study|could not visit the clinic|0|||
94713339|NCT01135511|324410685|FG005|Overall Study|could not visit the clinic|0|||
94713340|NCT01135511|324410686|FG006|Overall Study|could not visit the clinic|0|||
94713341|NCT01135511|324410687|FG007|Overall Study|could not visit the clinic|0|||
94713342|NCT01135511|324410688|FG008|Overall Study|could not visit the clinic|0|||
94713343|NCT01135511|324410680|FG000|Overall Study|noncompliance with study drug taken|0|||
94713344|NCT01135511|324410681|FG001|Overall Study|noncompliance with study drug taken|0|||
94713345|NCT01135511|324410682|FG002|Overall Study|noncompliance with study drug taken|0|||
94713346|NCT01135511|324410683|FG003|Overall Study|noncompliance with study drug taken|0|||
94270524|NCT02490475|322783737|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
94270525|NCT02490475|322783738|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
94270526|NCT02490475|322783739|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
94270527|NCT02490475|322783740|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
94270528|NCT02490475|322783737|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
94270529|NCT02490475|322783738|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
94270530|NCT02490475|322783739|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
94270531|NCT02490475|322783740|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
94270532|NCT02490475|322783737|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
94270533|NCT02490475|322783738|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
94270534|NCT02490475|322783739|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
94270535|NCT02490475|322783740|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
94270536|NCT02490475|322783737|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
94270537|NCT02490475|322783738|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
94270538|NCT02490475|322783739|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
94270539|NCT02490475|322783740|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
94270540|NCT02490475|322783737|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
94270541|NCT02490475|322783738|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
94270542|NCT02490475|322783739|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
94270543|NCT02490475|322783740|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
94270544|NCT02490475|322783737|FG000|Period 2: Extension Phase|Refused Treatment|0|||
94270545|NCT02490475|322783738|FG001|Period 2: Extension Phase|Refused Treatment|0|||
94270546|NCT02490475|322783739|FG002|Period 2: Extension Phase|Refused Treatment|0|||
94270547|NCT02490475|322783740|FG003|Period 2: Extension Phase|Refused Treatment|1|||
94270548|NCT02490475|322783737|FG000|Period 2: Extension Phase|Adverse Event|0|||
94270549|NCT02490475|322783738|FG001|Period 2: Extension Phase|Adverse Event|0|||
94270550|NCT02490475|322783739|FG002|Period 2: Extension Phase|Adverse Event|1|||
94270551|NCT02490475|322783740|FG003|Period 2: Extension Phase|Adverse Event|0|||
94270552|NCT00139776|322783741|FG000|Period I|Did not enter Period II|575|||
94270553|NCT00139776|322783742|FG001|Period I|Did not enter Period II|0|||
94270554|NCT00139776|322783743|FG002|Period I|Did not enter Period II|0|||
94270555|NCT00139776|322783744|FG003|Period I|Did not enter Period II|0|||
94270556|NCT00139776|322783741|FG000|Period II|Not Randomized into Period III|0|||
94270557|NCT00139776|322783742|FG001|Period II|Not Randomized into Period III|322|||
94713347|NCT01135511|324410684|FG004|Overall Study|noncompliance with study drug taken|1|||
94713348|NCT01135511|324410685|FG005|Overall Study|noncompliance with study drug taken|0|||
94713349|NCT01135511|324410686|FG006|Overall Study|noncompliance with study drug taken|0|||
94713350|NCT01135511|324410687|FG007|Overall Study|noncompliance with study drug taken|0|||
94713351|NCT01135511|324410688|FG008|Overall Study|noncompliance with study drug taken|0|||
94713352|NCT01135511|324410680|FG000|Overall Study|Withdrawal by Subject|0|||
94713353|NCT01135511|324410681|FG001|Overall Study|Withdrawal by Subject|0|||
94713354|NCT01135511|324410682|FG002|Overall Study|Withdrawal by Subject|0|||
94713355|NCT01135511|324410683|FG003|Overall Study|Withdrawal by Subject|0|||
94713356|NCT01135511|324410684|FG004|Overall Study|Withdrawal by Subject|0|||
94713357|NCT01135511|324410685|FG005|Overall Study|Withdrawal by Subject|0|||
94713358|NCT01135511|324410686|FG006|Overall Study|Withdrawal by Subject|1|||
94713359|NCT01135511|324410687|FG007|Overall Study|Withdrawal by Subject|0|||
94713360|NCT01135511|324410688|FG008|Overall Study|Withdrawal by Subject|1|||
94713361|NCT01068743|324410691|FG000|Period 3|Adverse Event|0|||
94713362|NCT01068743|324410692|FG001|Period 3|Adverse Event|1|||
94713363|NCT01068743|324410693|FG002|Period 3|Adverse Event|0|||
94713364|NCT01068743|324410694|FG003|Period 3|Adverse Event|0|||
94713365|NCT00364013|324410695|FG000|Overall Study|Ineligibility determined|4|||
94713366|NCT00364013|324410696|FG001|Overall Study|Ineligibility determined|2|||
94713367|NCT00364013|324410695|FG000|Overall Study|Adverse Event|4|||
94713368|NCT00364013|324410696|FG001|Overall Study|Adverse Event|3|||
94713369|NCT00364013|324410695|FG000|Overall Study|Withdrawal by Subject|13|||
94713370|NCT00364013|324410696|FG001|Overall Study|Withdrawal by Subject|18|||
94713371|NCT00364013|324410695|FG000|Overall Study|Physician Decision|3|||
94713372|NCT00364013|324410696|FG001|Overall Study|Physician Decision|3|||
94713373|NCT00364013|324410695|FG000|Overall Study|Lost to Follow-up|10|||
94270558|NCT00139776|322783743|FG002|Period II|Not Randomized into Period III|0|||
94270559|NCT00139776|322783744|FG003|Period II|Not Randomized into Period III|0|||
94270560|NCT00139776|322783741|FG000|Period III|Adverse Event|0|||
94270561|NCT00139776|322783742|FG001|Period III|Adverse Event|0|||
94270562|NCT00139776|322783743|FG002|Period III|Adverse Event|22|||
94270563|NCT00139776|322783744|FG003|Period III|Adverse Event|23|||
94270564|NCT00139776|322783741|FG000|Period III|Other|0|||
94270565|NCT00139776|322783742|FG001|Period III|Other|0|||
94270566|NCT00139776|322783743|FG002|Period III|Other|23|||
94270567|NCT00139776|322783744|FG003|Period III|Other|34|||
94270568|NCT00139776|322783741|FG000|Period III|Lack of Efficacy|0|||
94270569|NCT00139776|322783742|FG001|Period III|Lack of Efficacy|0|||
94270570|NCT00139776|322783743|FG002|Period III|Lack of Efficacy|10|||
94270571|NCT00139776|322783744|FG003|Period III|Lack of Efficacy|24|||
94270572|NCT00139776|322783741|FG000|Period III|Lost to Follow-up|0|||
94270573|NCT00139776|322783742|FG001|Period III|Lost to Follow-up|0|||
94270574|NCT00139776|322783743|FG002|Period III|Lost to Follow-up|5|||
94270575|NCT00139776|322783744|FG003|Period III|Lost to Follow-up|4|||
94270576|NCT00139776|322783741|FG000|Period III|Withdrawal by Subject|0|||
94270577|NCT00139776|322783742|FG001|Period III|Withdrawal by Subject|0|||
94270578|NCT00139776|322783743|FG002|Period III|Withdrawal by Subject|16|||
94270579|NCT00139776|322783744|FG003|Period III|Withdrawal by Subject|21|||
94270580|NCT01360554|322783745|FG000|Overall Study|Death|359|||
94270581|NCT01360554|322783746|FG001|Overall Study|Death|371|||
94270582|NCT01360554|322783745|FG000|Overall Study|Lost to Follow-up|4|||
94270583|NCT01360554|322783746|FG001|Overall Study|Lost to Follow-up|4|||
94270584|NCT01360554|322783745|FG000|Overall Study|Withdrawal by Subject|23|||
94270585|NCT01360554|322783746|FG001|Overall Study|Withdrawal by Subject|24|||
94270586|NCT01360554|322783745|FG000|Overall Study|Study terminated by sponsor|49|||
94270587|NCT01360554|322783746|FG001|Overall Study|Study terminated by sponsor|37|||
94270588|NCT01360554|322783745|FG000|Overall Study|Other, not specified|1|||
94713374|NCT00364013|324410696|FG001|Overall Study|Lost to Follow-up|3|||
94270589|NCT01360554|322783746|FG001|Overall Study|Other, not specified|0|||
94713375|NCT00364013|324410695|FG000|Overall Study|Protocol-specified criteria|6|||
94713376|NCT00364013|324410696|FG001|Overall Study|Protocol-specified criteria|6|||
94270590|NCT01360554|322783745|FG000|Overall Study|Randomized but not treated.|3|||
94713377|NCT00364013|324410695|FG000|Overall Study|Other|41|||
94713378|NCT00364013|324410696|FG001|Overall Study|Other|47|||
94713379|NCT00364013|324410695|FG000|Overall Study|Ongoing|20|||
94713380|NCT00364013|324410696|FG001|Overall Study|Ongoing|13|||
94713381|NCT00293293|324410697|FG000|Overall Study|Withdrawal by Subject|1|||
94713382|NCT00293293|324410698|FG001|Overall Study|Withdrawal by Subject|1|||
94713383|NCT00293293|324410697|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
94713384|NCT00293293|324410698|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
94713385|NCT00293293|324410697|FG000|Overall Study|Patient discontinued chemotherapy|0|||
94713386|NCT00293293|324410698|FG001|Overall Study|Patient discontinued chemotherapy|1|||
94713387|NCT01061151|324410699|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
94713388|NCT01061151|324410700|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
94713389|NCT01061151|324410701|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
94713390|NCT01061151|324410702|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
94713391|NCT01061151|324410699|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
94713392|NCT01061151|324410700|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
94713393|NCT01061151|324410701|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
94713394|NCT01061151|324410702|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
94713395|NCT01061151|324410699|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
94713396|NCT01061151|324410700|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
94713397|NCT01061151|324410701|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
94713398|NCT01061151|324410702|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
94713399|NCT01061151|324410699|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
94713400|NCT01061151|324410700|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
94713401|NCT01061151|324410701|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
94713402|NCT01061151|324410702|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
94713403|NCT01061151|324410699|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
94713404|NCT01061151|324410700|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
94713405|NCT01061151|324410701|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
94713406|NCT01061151|324410702|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
94713407|NCT01061151|324410699|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
94713408|NCT01061151|324410700|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
94270591|NCT01360554|322783746|FG001|Overall Study|Randomized but not treated.|3|||
94270592|NCT00187096|322783747|FG000|Overall Study|unacceptable toxicity|0|||
94713409|NCT01061151|324410701|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
94713410|NCT01061151|324410702|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
94713411|NCT01061151|324410699|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
94713412|NCT01061151|324410700|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
94713413|NCT01061151|324410701|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
94713414|NCT01061151|324410702|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
94713415|NCT01061151|324410699|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
94713416|NCT01061151|324410700|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
94713417|NCT01061151|324410701|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
94713418|NCT01061151|324410702|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
94713419|NCT01061151|324410699|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
94713420|NCT01061151|324410700|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
94713421|NCT01061151|324410701|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
94713422|NCT01061151|324410702|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
94713423|NCT01061151|324410699|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
94713424|NCT01061151|324410700|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
94713425|NCT01061151|324410701|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
94713426|NCT01061151|324410702|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
94713427|NCT01061151|324410699|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
94713428|NCT01061151|324410700|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
94713429|NCT01061151|324410701|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
94713430|NCT01061151|324410702|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
94713431|NCT01061151|324410699|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
94713432|NCT01061151|324410700|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
94713433|NCT01061151|324410701|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
94713434|NCT01061151|324410702|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
94713435|NCT01061151|324410699|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
94713436|NCT01061151|324410700|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
94713437|NCT01061151|324410701|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
94713438|NCT01061151|324410702|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
94713439|NCT01061151|324410699|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
94713440|NCT01061151|324410700|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
94713441|NCT01061151|324410701|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
94713442|NCT01061151|324410702|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
94713443|NCT01061151|324410699|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
94713444|NCT01061151|324410700|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
94713445|NCT01061151|324410701|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
94713446|NCT01061151|324410702|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
94713447|NCT01369498|324410703|FG000|Overall Study|Lack of Efficacy|9|||
94713448|NCT01369498|324410704|FG001|Overall Study|Lack of Efficacy|9|||
94713449|NCT01369498|324410705|FG002|Overall Study|Lack of Efficacy|1|||
94713450|NCT01369498|324410706|FG003|Overall Study|Lack of Efficacy|3|||
94713451|NCT01369498|324410703|FG000|Overall Study|Adverse Event|1|||
94713452|NCT01369498|324410704|FG001|Overall Study|Adverse Event|2|||
94713453|NCT01369498|324410705|FG002|Overall Study|Adverse Event|0|||
94713454|NCT01369498|324410706|FG003|Overall Study|Adverse Event|1|||
94713455|NCT01369498|324410703|FG000|Overall Study|Withdrawal of Consent|0|||
94713456|NCT01369498|324410704|FG001|Overall Study|Withdrawal of Consent|1|||
94713457|NCT01369498|324410705|FG002|Overall Study|Withdrawal of Consent|1|||
94713458|NCT01369498|324410706|FG003|Overall Study|Withdrawal of Consent|1|||
94713459|NCT01369498|324410703|FG000|Overall Study|Death|0|||
94713460|NCT01369498|324410704|FG001|Overall Study|Death|0|||
94713461|NCT01369498|324410705|FG002|Overall Study|Death|1|||
94713462|NCT01369498|324410706|FG003|Overall Study|Death|0|||
94713463|NCT01369498|324410703|FG000|Overall Study|Investigator's Discretion|1|||
94713464|NCT01369498|324410704|FG001|Overall Study|Investigator's Discretion|0|||
94713465|NCT01369498|324410705|FG002|Overall Study|Investigator's Discretion|1|||
94713466|NCT01369498|324410706|FG003|Overall Study|Investigator's Discretion|3|||
94713467|NCT01369498|324410703|FG000|Overall Study|Unknown Reason|1|||
94713468|NCT01369498|324410704|FG001|Overall Study|Unknown Reason|0|||
94713469|NCT01369498|324410705|FG002|Overall Study|Unknown Reason|11|||
94713470|NCT01369498|324410706|FG003|Overall Study|Unknown Reason|6|||
94713471|NCT01369498|324410703|FG000|Overall Study|Disease Progression|0|||
94713472|NCT01369498|324410704|FG001|Overall Study|Disease Progression|0|||
94713473|NCT01369498|324410705|FG002|Overall Study|Disease Progression|0|||
94713474|NCT01369498|324410706|FG003|Overall Study|Disease Progression|1|||
94713475|NCT03260140|324410707|FG000|Overall Study|Death|4|||
94713476|NCT03260140|324410708|FG001|Overall Study|Death|1|||
94713477|NCT03260140|324410707|FG000|Overall Study|Withdrawal by Subject|1|||
94713478|NCT03260140|324410708|FG001|Overall Study|Withdrawal by Subject|4|||
94713479|NCT02988817|324410711|FG000|Overall Study|Withdrawal by Subject|1|||
94713480|NCT02988817|324410712|FG001|Overall Study|Withdrawal by Subject|0|||
94713481|NCT02988817|324410713|FG002|Overall Study|Withdrawal by Subject|0|||
94713482|NCT02988817|324410714|FG003|Overall Study|Withdrawal by Subject|1|||
94713483|NCT02988817|324410715|FG004|Overall Study|Withdrawal by Subject|3|||
94713484|NCT02988817|324410716|FG005|Overall Study|Withdrawal by Subject|1|||
94713485|NCT02988817|324410717|FG006|Overall Study|Withdrawal by Subject|2|||
94713486|NCT02988817|324410718|FG007|Overall Study|Withdrawal by Subject|1|||
94713487|NCT02988817|324410719|FG008|Overall Study|Withdrawal by Subject|1|||
94713488|NCT02988817|324410720|FG009|Overall Study|Withdrawal by Subject|1|||
94713489|NCT02988817|324410721|FG010|Overall Study|Withdrawal by Subject|1|||
94713490|NCT02988817|324410722|FG011|Overall Study|Withdrawal by Subject|12|||
94713491|NCT02988817|324410723|FG012|Overall Study|Withdrawal by Subject|6|||
94713492|NCT02988817|324410724|FG013|Overall Study|Withdrawal by Subject|6|||
94713493|NCT02988817|324410725|FG014|Overall Study|Withdrawal by Subject|4|||
94713494|NCT02988817|324410726|FG015|Overall Study|Withdrawal by Subject|5|||
94713495|NCT02988817|324410727|FG016|Overall Study|Withdrawal by Subject|4|||
94713496|NCT02988817|324410728|FG017|Overall Study|Withdrawal by Subject|11|||
94713497|NCT02988817|324410729|FG018|Overall Study|Withdrawal by Subject|4|||
94713498|NCT02988817|324410730|FG019|Overall Study|Withdrawal by Subject|2|||
94713499|NCT02988817|324410711|FG000|Overall Study|Death|0|||
94713500|NCT02988817|324410712|FG001|Overall Study|Death|1|||
94713501|NCT02988817|324410713|FG002|Overall Study|Death|3|||
94713502|NCT02988817|324410714|FG003|Overall Study|Death|1|||
94713503|NCT02988817|324410715|FG004|Overall Study|Death|6|||
94713504|NCT02988817|324410716|FG005|Overall Study|Death|10|||
94713505|NCT02988817|324410717|FG006|Overall Study|Death|1|||
94713506|NCT02988817|324410718|FG007|Overall Study|Death|2|||
94713507|NCT02988817|324410719|FG008|Overall Study|Death|1|||
94713508|NCT02988817|324410720|FG009|Overall Study|Death|5|||
94713509|NCT02988817|324410721|FG010|Overall Study|Death|1|||
94713510|NCT02988817|324410722|FG011|Overall Study|Death|8|||
94713511|NCT02988817|324410723|FG012|Overall Study|Death|9|||
94713512|NCT02988817|324410724|FG013|Overall Study|Death|17|||
94713513|NCT02988817|324410725|FG014|Overall Study|Death|18|||
94713514|NCT02988817|324410726|FG015|Overall Study|Death|30|||
94367184|NCT01964898|323131483|FG000|Overall Study|Withdrawal by Subject|1|||
94367185|NCT01964898|323131484|FG001|Overall Study|Withdrawal by Subject|0|||
94367186|NCT00391092|323131485|FG000|Overall Study|Death|78|||
94367187|NCT00391092|323131486|FG001|Overall Study|Death|81|||
94367188|NCT00391092|323131485|FG000|Overall Study|Lost to Follow-up|13|||
94713515|NCT02988817|324410727|FG016|Overall Study|Death|17|||
94713516|NCT02988817|324410728|FG017|Overall Study|Death|38|||
94713517|NCT02988817|324410729|FG018|Overall Study|Death|14|||
94713518|NCT02988817|324410730|FG019|Overall Study|Death|16|||
94713519|NCT02988817|324410711|FG000|Overall Study|Other|0|||
94713520|NCT02988817|324410712|FG001|Overall Study|Other|0|||
94713521|NCT02988817|324410713|FG002|Overall Study|Other|0|||
94713522|NCT02988817|324410714|FG003|Overall Study|Other|1|||
94713523|NCT02988817|324410715|FG004|Overall Study|Other|1|||
94713524|NCT02988817|324410716|FG005|Overall Study|Other|0|||
94713525|NCT02988817|324410717|FG006|Overall Study|Other|0|||
94713526|NCT02988817|324410718|FG007|Overall Study|Other|0|||
94713527|NCT02988817|324410719|FG008|Overall Study|Other|0|||
94713528|NCT02988817|324410720|FG009|Overall Study|Other|0|||
94713529|NCT02988817|324410721|FG010|Overall Study|Other|0|||
94713530|NCT02988817|324410722|FG011|Overall Study|Other|0|||
94713531|NCT02988817|324410723|FG012|Overall Study|Other|0|||
94713532|NCT02988817|324410724|FG013|Overall Study|Other|0|||
94713533|NCT02988817|324410725|FG014|Overall Study|Other|0|||
94713534|NCT02988817|324410726|FG015|Overall Study|Other|1|||
94713535|NCT02988817|324410727|FG016|Overall Study|Other|0|||
94713536|NCT02988817|324410728|FG017|Overall Study|Other|0|||
94713537|NCT02988817|324410729|FG018|Overall Study|Other|0|||
94713538|NCT02988817|324410730|FG019|Overall Study|Other|0|||
94713539|NCT02988817|324410711|FG000|Overall Study|Lost to Follow-up|0|||
94713540|NCT02988817|324410712|FG001|Overall Study|Lost to Follow-up|0|||
94713541|NCT02988817|324410713|FG002|Overall Study|Lost to Follow-up|0|||
94713542|NCT02988817|324410714|FG003|Overall Study|Lost to Follow-up|0|||
94713543|NCT02988817|324410715|FG004|Overall Study|Lost to Follow-up|0|||
94713544|NCT02988817|324410716|FG005|Overall Study|Lost to Follow-up|0|||
94713545|NCT02988817|324410717|FG006|Overall Study|Lost to Follow-up|0|||
94713546|NCT02988817|324410718|FG007|Overall Study|Lost to Follow-up|0|||
94713547|NCT02988817|324410719|FG008|Overall Study|Lost to Follow-up|1|||
94713548|NCT02988817|324410720|FG009|Overall Study|Lost to Follow-up|0|||
94713549|NCT02988817|324410721|FG010|Overall Study|Lost to Follow-up|1|||
94713550|NCT02988817|324410722|FG011|Overall Study|Lost to Follow-up|1|||
94713551|NCT02988817|324410723|FG012|Overall Study|Lost to Follow-up|0|||
94713552|NCT02988817|324410724|FG013|Overall Study|Lost to Follow-up|0|||
94713553|NCT02988817|324410725|FG014|Overall Study|Lost to Follow-up|1|||
94713554|NCT02988817|324410726|FG015|Overall Study|Lost to Follow-up|1|||
94713555|NCT02988817|324410727|FG016|Overall Study|Lost to Follow-up|2|||
94713556|NCT02988817|324410728|FG017|Overall Study|Lost to Follow-up|3|||
94713557|NCT02988817|324410729|FG018|Overall Study|Lost to Follow-up|0|||
94713558|NCT02988817|324410730|FG019|Overall Study|Lost to Follow-up|0|||
94713559|NCT02988817|324410711|FG000|Overall Study|Sponsor decision|0|||
94713560|NCT02988817|324410712|FG001|Overall Study|Sponsor decision|0|||
94367189|NCT00391092|323131486|FG001|Overall Study|Lost to Follow-up|18|||
94713561|NCT02988817|324410713|FG002|Overall Study|Sponsor decision|0|||
94713562|NCT02988817|324410714|FG003|Overall Study|Sponsor decision|0|||
94713563|NCT02988817|324410715|FG004|Overall Study|Sponsor decision|0|||
94713564|NCT02988817|324410716|FG005|Overall Study|Sponsor decision|0|||
94713565|NCT02988817|324410717|FG006|Overall Study|Sponsor decision|0|||
94713566|NCT02988817|324410718|FG007|Overall Study|Sponsor decision|0|||
94713567|NCT02988817|324410719|FG008|Overall Study|Sponsor decision|0|||
94713568|NCT02988817|324410720|FG009|Overall Study|Sponsor decision|0|||
94467237|NCT01285492|323500483|FG000|Overall Study|Adverse Event|11|||
94467238|NCT01285492|323500484|FG001|Overall Study|Adverse Event|0|||
94713569|NCT02988817|324410721|FG010|Overall Study|Sponsor decision|0|||
94713570|NCT02988817|324410722|FG011|Overall Study|Sponsor decision|1|||
94713571|NCT02988817|324410723|FG012|Overall Study|Sponsor decision|1|||
94713572|NCT02988817|324410724|FG013|Overall Study|Sponsor decision|2|||
94713573|NCT02988817|324410725|FG014|Overall Study|Sponsor decision|2|||
94713574|NCT02988817|324410726|FG015|Overall Study|Sponsor decision|6|||
94713575|NCT02988817|324410727|FG016|Overall Study|Sponsor decision|2|||
94713576|NCT02988817|324410728|FG017|Overall Study|Sponsor decision|3|||
94713577|NCT02988817|324410729|FG018|Overall Study|Sponsor decision|2|||
94713578|NCT02988817|324410730|FG019|Overall Study|Sponsor decision|7|||
94713579|NCT02988817|324410711|FG000|Overall Study|Physician Decision|0|||
94713580|NCT02988817|324410712|FG001|Overall Study|Physician Decision|0|||
94713581|NCT02988817|324410713|FG002|Overall Study|Physician Decision|0|||
94713582|NCT02988817|324410714|FG003|Overall Study|Physician Decision|0|||
94713583|NCT02988817|324410715|FG004|Overall Study|Physician Decision|0|||
94713584|NCT02988817|324410716|FG005|Overall Study|Physician Decision|0|||
94713585|NCT02988817|324410717|FG006|Overall Study|Physician Decision|0|||
94713586|NCT02988817|324410718|FG007|Overall Study|Physician Decision|0|||
94713587|NCT02988817|324410719|FG008|Overall Study|Physician Decision|0|||
94713588|NCT02988817|324410720|FG009|Overall Study|Physician Decision|0|||
94713589|NCT02988817|324410721|FG010|Overall Study|Physician Decision|0|||
94713590|NCT02988817|324410722|FG011|Overall Study|Physician Decision|0|||
94713591|NCT02988817|324410723|FG012|Overall Study|Physician Decision|0|||
94713592|NCT02988817|324410724|FG013|Overall Study|Physician Decision|0|||
94713593|NCT02988817|324410725|FG014|Overall Study|Physician Decision|0|||
94713594|NCT02988817|324410726|FG015|Overall Study|Physician Decision|1|||
94713595|NCT02988817|324410727|FG016|Overall Study|Physician Decision|0|||
94713596|NCT02988817|324410728|FG017|Overall Study|Physician Decision|0|||
94713597|NCT02988817|324410729|FG018|Overall Study|Physician Decision|1|||
94713598|NCT02988817|324410730|FG019|Overall Study|Physician Decision|1|||
94713599|NCT00421889|324410739|FG000|Overall Study|Adverse Event|1|||
94713600|NCT00421889|324410740|FG001|Overall Study|Adverse Event|0|||
94713601|NCT00421889|324410741|FG002|Overall Study|Adverse Event|1|||
94713602|NCT00421889|324410742|FG003|Overall Study|Adverse Event|1|||
94713603|NCT00421889|324410743|FG004|Overall Study|Adverse Event|1|||
94713604|NCT00421889|324410744|FG005|Overall Study|Adverse Event|4|||
94713605|NCT00421889|324410745|FG006|Overall Study|Adverse Event|1|||
94713606|NCT00421889|324410746|FG007|Overall Study|Adverse Event|0|||
94713607|NCT00421889|324410747|FG008|Overall Study|Adverse Event|2|||
94270593|NCT00187096|322783748|FG001|Overall Study|unacceptable toxicity|0|||
94270594|NCT00187096|322783749|FG002|Overall Study|unacceptable toxicity|1|||
94270595|NCT05111041|322783754|FG000|Overall Study|Lost to Follow-up|6|||
94270596|NCT05111041|322783755|FG001|Overall Study|Lost to Follow-up|7|||
94270597|NCT05111041|322783754|FG000|Overall Study|Withdrawal by Subject|1|||
94270598|NCT05111041|322783755|FG001|Overall Study|Withdrawal by Subject|0|||
94270599|NCT04912245|322783756|FG000|Overall Study|Withdrawal by Subject|21|||
94270600|NCT04912245|322783757|FG001|Overall Study|Withdrawal by Subject|4|||
94270601|NCT04912245|322783756|FG000|Overall Study|Lost to Follow-up|5|||
94270602|NCT04912245|322783757|FG001|Overall Study|Lost to Follow-up|11|||
94270603|NCT03680911|322783765|FG000|At Home Treatment|Study Termination|3|||
94270604|NCT03680911|322783766|FG001|At Home Treatment|Study Termination|0|||
94270605|NCT03680911|322783765|FG000|At Home Treatment|Lost to Follow-up|0|||
94270606|NCT03680911|322783766|FG001|At Home Treatment|Lost to Follow-up|1|||
94270607|NCT03680911|322783765|FG000|At Home Treatment|Withdrawal by Subject|0|||
94270608|NCT03680911|322783766|FG001|At Home Treatment|Withdrawal by Subject|2|||
94270609|NCT03680911|322783765|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
94270610|NCT03680911|322783766|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
94270611|NCT01075412|322783769|FG000|Overall Study|Withdrawal by Subject|0|||
94270612|NCT01075412|322783770|FG001|Overall Study|Withdrawal by Subject|1|||
94270613|NCT00131469|322783771|FG000|Overall Study|Withdrawal by Subject|3|||
94270614|NCT00131469|322783772|FG001|Overall Study|Withdrawal by Subject|4|||
94270615|NCT00131469|322783771|FG000|Overall Study|Protocol Violation|3|||
94270616|NCT00131469|322783772|FG001|Overall Study|Protocol Violation|1|||
94270617|NCT00131469|322783771|FG000|Overall Study|Death|0|||
94270618|NCT00131469|322783772|FG001|Overall Study|Death|1|||
94270619|NCT00131469|322783771|FG000|Overall Study|Lost to Follow-up|0|||
94270620|NCT00131469|322783772|FG001|Overall Study|Lost to Follow-up|1|||
94270621|NCT00131469|322783771|FG000|Overall Study|scan not analyzable|3|||
94713608|NCT00421889|324410739|FG000|Overall Study|Withdrawal by Subject|1|||
94270622|NCT00131469|322783772|FG001|Overall Study|scan not analyzable|6|||
94270623|NCT02247960|322783773|FG000|Patient Consent and Randomization|Physician Decision|2|||
94270624|NCT02247960|322783774|FG001|Patient Consent and Randomization|Physician Decision|2|||
94270625|NCT02247960|322783773|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
94270626|NCT02247960|322783774|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
94713609|NCT00421889|324410740|FG001|Overall Study|Withdrawal by Subject|3|||
94713610|NCT00421889|324410741|FG002|Overall Study|Withdrawal by Subject|0|||
94713611|NCT00421889|324410742|FG003|Overall Study|Withdrawal by Subject|0|||
94713612|NCT00421889|324410743|FG004|Overall Study|Withdrawal by Subject|2|||
94713613|NCT00421889|324410744|FG005|Overall Study|Withdrawal by Subject|0|||
94713614|NCT00421889|324410745|FG006|Overall Study|Withdrawal by Subject|0|||
94713615|NCT00421889|324410746|FG007|Overall Study|Withdrawal by Subject|0|||
94713616|NCT00421889|324410747|FG008|Overall Study|Withdrawal by Subject|0|||
94713617|NCT00421889|324410739|FG000|Overall Study|Death|0|||
94713618|NCT00421889|324410740|FG001|Overall Study|Death|0|||
94713619|NCT00421889|324410741|FG002|Overall Study|Death|0|||
94713620|NCT00421889|324410742|FG003|Overall Study|Death|0|||
94713621|NCT00421889|324410743|FG004|Overall Study|Death|1|||
94713622|NCT00421889|324410744|FG005|Overall Study|Death|1|||
94713623|NCT00421889|324410745|FG006|Overall Study|Death|0|||
94713624|NCT00421889|324410746|FG007|Overall Study|Death|0|||
94713625|NCT00421889|324410747|FG008|Overall Study|Death|0|||
94713626|NCT00421889|324410739|FG000|Overall Study|Progressive disease|3|||
94713627|NCT00421889|324410740|FG001|Overall Study|Progressive disease|2|||
94270627|NCT02247960|322783773|FG000|Catheter Removed|Lost to Follow-up|7|||
94270628|NCT02247960|322783774|FG001|Catheter Removed|Lost to Follow-up|10|||
94270629|NCT00356889|322783775|FG000|Overall Study|Protocol Violation|2|||
94270630|NCT00356889|322783775|FG000|Overall Study|Adverse Event|1|||
94270631|NCT00865904|322783780|FG000|Overall Study|Randomized but not Treated|2|||
94270632|NCT00865904|322783781|FG001|Overall Study|Randomized but not Treated|0|||
94270633|NCT00865904|322783782|FG002|Overall Study|Randomized but not Treated|0|||
94270634|NCT00865904|322783783|FG003|Overall Study|Randomized but not Treated|1|||
94270635|NCT00865904|322783784|FG004|Overall Study|Randomized but not Treated|1|||
94270636|NCT00590044|322783785|FG000|Overall Study|Withdrawal by Subject|2|||
94270637|NCT00590044|322783786|FG001|Overall Study|Withdrawal by Subject|2|||
94270638|NCT00590044|322783785|FG000|Overall Study|wrong insulin arm assigned|1|||
94270639|NCT00590044|322783786|FG001|Overall Study|wrong insulin arm assigned|0|||
94270640|NCT00590044|322783785|FG000|Overall Study|Protocol Violation|1|||
94270641|NCT00590044|322783786|FG001|Overall Study|Protocol Violation|0|||
94270642|NCT01431274|322783787|FG000|Overall Study|Adverse Event|51|||
94270643|NCT01431274|322783788|FG001|Overall Study|Adverse Event|37|||
94270644|NCT01431274|322783789|FG002|Overall Study|Adverse Event|43|||
94270645|NCT01431274|322783790|FG003|Overall Study|Adverse Event|30|||
94270646|NCT01431274|322783791|FG004|Overall Study|Adverse Event|37|||
94270647|NCT01431274|322783787|FG000|Overall Study|Consent withdrawn not due to AE|29|||
94270648|NCT01431274|322783788|FG001|Overall Study|Consent withdrawn not due to AE|20|||
94270649|NCT01431274|322783789|FG002|Overall Study|Consent withdrawn not due to AE|17|||
94270650|NCT01431274|322783790|FG003|Overall Study|Consent withdrawn not due to AE|20|||
94270651|NCT01431274|322783791|FG004|Overall Study|Consent withdrawn not due to AE|11|||
94653335|NCT00079274|324188106|FG002|Overall Study|Death|1|||
94653336|NCT00079274|324188107|FG003|Overall Study|Death|15|||
94653337|NCT00079274|324188108|FG004|Overall Study|Death|0|||
94653338|NCT00079274|324188109|FG005|Overall Study|Death|0|||
94653339|NCT00079274|324188110|FG006|Overall Study|Death|0|||
94653340|NCT00079274|324188104|FG000|Overall Study|Cytogenetic resistance|0|||
94653341|NCT00079274|324188105|FG001|Overall Study|Cytogenetic resistance|0|||
94653342|NCT00079274|324188106|FG002|Overall Study|Cytogenetic resistance|0|||
94653343|NCT00079274|324188107|FG003|Overall Study|Cytogenetic resistance|2|||
94653344|NCT00079274|324188108|FG004|Overall Study|Cytogenetic resistance|0|||
94653345|NCT00079274|324188109|FG005|Overall Study|Cytogenetic resistance|0|||
94653346|NCT00079274|324188110|FG006|Overall Study|Cytogenetic resistance|0|||
94653347|NCT00079274|324188104|FG000|Overall Study|Other|43|||
94653348|NCT00079274|324188105|FG001|Overall Study|Other|7|||
94653349|NCT00079274|324188106|FG002|Overall Study|Other|5|||
94653350|NCT00079274|324188107|FG003|Overall Study|Other|55|||
94653351|NCT00079274|324188108|FG004|Overall Study|Other|1|||
94653352|NCT00079274|324188109|FG005|Overall Study|Other|2|||
94653353|NCT00079274|324188110|FG006|Overall Study|Other|0|||
94653354|NCT03495908|324188113|FG000|Overall Study|Withdrawal by Subject|3|||
94653355|NCT03495908|324188114|FG001|Overall Study|Withdrawal by Subject|1|||
94653356|NCT03495908|324188113|FG000|Overall Study|Lost to Follow-up|1|||
94653357|NCT03495908|324188114|FG001|Overall Study|Lost to Follow-up|4|||
94653358|NCT03495908|324188113|FG000|Overall Study|Adverse Event|0|||
94653359|NCT03495908|324188114|FG001|Overall Study|Adverse Event|2|||
94713628|NCT00421889|324410741|FG002|Overall Study|Progressive disease|2|||
94270652|NCT01431274|322783787|FG000|Overall Study|Non compliant with protocol|5|||
94653360|NCT03495908|324188113|FG000|Overall Study|Death|1|||
94653361|NCT03495908|324188114|FG001|Overall Study|Death|0|||
94270653|NCT01431274|322783788|FG001|Overall Study|Non compliant with protocol|8|||
94270654|NCT01431274|322783789|FG002|Overall Study|Non compliant with protocol|4|||
94270655|NCT01431274|322783790|FG003|Overall Study|Non compliant with protocol|4|||
94270656|NCT01431274|322783791|FG004|Overall Study|Non compliant with protocol|4|||
94653362|NCT03495908|324188113|FG000|Overall Study|Physician Decision|5|||
94653363|NCT03495908|324188114|FG001|Overall Study|Physician Decision|4|||
94653364|NCT03495908|324188113|FG000|Overall Study|No documented reason|0|||
94653365|NCT03495908|324188114|FG001|Overall Study|No documented reason|2|||
94713629|NCT00421889|324410742|FG003|Overall Study|Progressive disease|3|||
94713630|NCT00421889|324410743|FG004|Overall Study|Progressive disease|2|||
94713631|NCT00421889|324410744|FG005|Overall Study|Progressive disease|21|||
94713632|NCT00421889|324410745|FG006|Overall Study|Progressive disease|3|||
94713633|NCT00421889|324410746|FG007|Overall Study|Progressive disease|1|||
94713634|NCT00421889|324410747|FG008|Overall Study|Progressive disease|5|||
94713635|NCT00421889|324410739|FG000|Overall Study|Patient/Investigator request|0|||
94713636|NCT00421889|324410740|FG001|Overall Study|Patient/Investigator request|0|||
94713637|NCT00421889|324410741|FG002|Overall Study|Patient/Investigator request|0|||
94713638|NCT00421889|324410742|FG003|Overall Study|Patient/Investigator request|0|||
94713639|NCT00421889|324410743|FG004|Overall Study|Patient/Investigator request|0|||
94713640|NCT00421889|324410744|FG005|Overall Study|Patient/Investigator request|9|||
94713641|NCT00421889|324410745|FG006|Overall Study|Patient/Investigator request|0|||
94713642|NCT00421889|324410746|FG007|Overall Study|Patient/Investigator request|1|||
94713643|NCT00421889|324410747|FG008|Overall Study|Patient/Investigator request|3|||
94713644|NCT00421889|324410739|FG000|Overall Study|Lost to Follow-up|0|||
94713645|NCT00421889|324410740|FG001|Overall Study|Lost to Follow-up|0|||
94713646|NCT00421889|324410741|FG002|Overall Study|Lost to Follow-up|0|||
94713647|NCT00421889|324410742|FG003|Overall Study|Lost to Follow-up|0|||
94713648|NCT00421889|324410743|FG004|Overall Study|Lost to Follow-up|0|||
94713649|NCT00421889|324410744|FG005|Overall Study|Lost to Follow-up|0|||
94713650|NCT00421889|324410745|FG006|Overall Study|Lost to Follow-up|0|||
94713651|NCT00421889|324410746|FG007|Overall Study|Lost to Follow-up|0|||
94713652|NCT00421889|324410747|FG008|Overall Study|Lost to Follow-up|1|||
94713653|NCT01839331|324410748|FG000|Overall Study|Early Termination|3|||
94713654|NCT01839331|324410749|FG001|Overall Study|Early Termination|0|||
94713655|NCT01839331|324410750|FG002|Overall Study|Early Termination|1|||
94713656|NCT01839331|324410751|FG003|Overall Study|Early Termination|2|||
94713657|NCT01839331|324410748|FG000|Overall Study|Protocol Violation|1|||
94713658|NCT01839331|324410749|FG001|Overall Study|Protocol Violation|6|||
94713659|NCT01839331|324410750|FG002|Overall Study|Protocol Violation|4|||
94713660|NCT01839331|324410751|FG003|Overall Study|Protocol Violation|3|||
94713661|NCT04149002|324410758|FG000|Overall Study|Lost to Follow-up|1|||
94713662|NCT04149002|324410759|FG001|Overall Study|Lost to Follow-up|0|||
94713663|NCT04149002|324410758|FG000|Overall Study|Withdrawal by Subject|1|||
94713664|NCT04149002|324410759|FG001|Overall Study|Withdrawal by Subject|0|||
94713665|NCT00807937|324410760|FG000|Overall Study|Adverse Event|12|||
94713666|NCT00807937|324410761|FG001|Overall Study|Adverse Event|12|||
94713667|NCT00807937|324410762|FG002|Overall Study|Adverse Event|5|||
94367190|NCT00391092|323131485|FG000|Overall Study|Alive on treatment|29|||
94367191|NCT00391092|323131486|FG001|Overall Study|Alive on treatment|33|||
94367192|NCT00391092|323131485|FG000|Overall Study|Alive in follow-up|88|||
94367193|NCT00391092|323131486|FG001|Overall Study|Alive in follow-up|84|||
94367194|NCT00953927|323131496|FG000|Overall Study|Lost to Follow-up|61|||
94367195|NCT00953927|323131497|FG001|Overall Study|Lost to Follow-up|65|||
94367196|NCT00953927|323131496|FG000|Overall Study|Withdrawal by Subject|36|||
94367197|NCT00953927|323131497|FG001|Overall Study|Withdrawal by Subject|25|||
94367198|NCT00953927|323131496|FG000|Overall Study|Death|7|||
94367199|NCT00953927|323131497|FG001|Overall Study|Death|4|||
94367200|NCT00953927|323131496|FG000|Overall Study|Other study discontinuation|1|||
94367201|NCT00953927|323131497|FG001|Overall Study|Other study discontinuation|1|||
94367202|NCT03284424|323131498|FG000|Overall Study|Death|70|||
94367203|NCT03284424|323131499|FG001|Overall Study|Death|24|||
94367204|NCT03284424|323131498|FG000|Overall Study|Lost to Follow-up|3|||
94367205|NCT03284424|323131499|FG001|Overall Study|Lost to Follow-up|1|||
94367206|NCT03284424|323131498|FG000|Overall Study|Physician Decision|1|||
94367207|NCT03284424|323131499|FG001|Overall Study|Physician Decision|2|||
94367208|NCT03284424|323131498|FG000|Overall Study|Withdrawal by Subject|4|||
94367209|NCT03284424|323131499|FG001|Overall Study|Withdrawal by Subject|5|||
94367210|NCT03284424|323131498|FG000|Overall Study|Sponsor's decision|27|||
94367211|NCT03284424|323131499|FG001|Overall Study|Sponsor's decision|22|||
94367212|NCT01508325|323131507|FG000|Overall Study|Withdrawal by Subject|8|||
94713668|NCT00807937|324410763|FG003|Overall Study|Adverse Event|4|||
94713669|NCT00807937|324410760|FG000|Overall Study|Protocol Violation|4|||
94713670|NCT00807937|324410761|FG001|Overall Study|Protocol Violation|5|||
94713671|NCT00807937|324410762|FG002|Overall Study|Protocol Violation|3|||
94713672|NCT00807937|324410763|FG003|Overall Study|Protocol Violation|3|||
94713673|NCT00807937|324410760|FG000|Overall Study|Withdrawal by Subject|5|||
94713674|NCT00807937|324410761|FG001|Overall Study|Withdrawal by Subject|4|||
94713675|NCT00807937|324410762|FG002|Overall Study|Withdrawal by Subject|1|||
94713676|NCT00807937|324410763|FG003|Overall Study|Withdrawal by Subject|4|||
94367213|NCT01508325|323131508|FG001|Overall Study|Withdrawal by Subject|9|||
94367214|NCT01508325|323131507|FG000|Overall Study|Protocol Violation|0|||
94367215|NCT01508325|323131508|FG001|Overall Study|Protocol Violation|3|||
94367216|NCT01508325|323131507|FG000|Overall Study|Physician Decision|2|||
94367217|NCT01508325|323131508|FG001|Overall Study|Physician Decision|1|||
94713677|NCT00807937|324410760|FG000|Overall Study|Lost to Follow-up|4|||
94713678|NCT00807937|324410761|FG001|Overall Study|Lost to Follow-up|0|||
94713679|NCT00807937|324410762|FG002|Overall Study|Lost to Follow-up|2|||
94367218|NCT01508325|323131507|FG000|Overall Study|Adverse Event|1|||
94367219|NCT01508325|323131508|FG001|Overall Study|Adverse Event|0|||
94367220|NCT01508325|323131507|FG000|Overall Study|Lost to Follow-up|5|||
94367221|NCT01508325|323131508|FG001|Overall Study|Lost to Follow-up|6|||
94367222|NCT01508325|323131507|FG000|Overall Study|Other|2|||
94367223|NCT01508325|323131508|FG001|Overall Study|Other|2|||
94367224|NCT04682639|323131509|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
94367225|NCT04682639|323131510|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
94367226|NCT04682639|323131511|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
94367227|NCT04682639|323131512|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
94367228|NCT04682639|323131513|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
94367229|NCT04682639|323131509|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
94367230|NCT04682639|323131510|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
94367231|NCT04682639|323131511|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
94367232|NCT04682639|323131512|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94367233|NCT04682639|323131513|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94367234|NCT04682639|323131509|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
94367235|NCT04682639|323131510|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
94367236|NCT04682639|323131511|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94367237|NCT04682639|323131512|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94367238|NCT04682639|323131513|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94367239|NCT04682639|323131509|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
94367240|NCT04682639|323131510|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
94367241|NCT04682639|323131511|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
94367242|NCT04682639|323131512|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
94367243|NCT04682639|323131513|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
94367244|NCT04682639|323131509|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
94367245|NCT04682639|323131510|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
94367246|NCT04682639|323131511|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
94367247|NCT04682639|323131512|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
94367248|NCT04682639|323131513|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
94367249|NCT04682639|323131509|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
94367250|NCT04682639|323131510|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
94367251|NCT04682639|323131511|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
94367252|NCT04682639|323131512|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
94367253|NCT04682639|323131513|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
94367254|NCT04682639|323131509|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
94367255|NCT04682639|323131510|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
94367256|NCT04682639|323131511|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
94367257|NCT04682639|323131512|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
94367258|NCT04682639|323131513|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
94367259|NCT04682639|323131509|FG000|OLE Period (28 Weeks)|Other|1|||
94713680|NCT00807937|324410763|FG003|Overall Study|Lost to Follow-up|1|||
94713681|NCT00807937|324410760|FG000|Overall Study|Lack of Efficacy|0|||
94367260|NCT04682639|323131510|FG001|OLE Period (28 Weeks)|Other|2|||
94367261|NCT04682639|323131511|FG002|OLE Period (28 Weeks)|Other|0|||
94367262|NCT04682639|323131512|FG003|OLE Period (28 Weeks)|Other|0|||
94367263|NCT04682639|323131513|FG004|OLE Period (28 Weeks)|Other|1|||
94367264|NCT04682639|323131509|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
94367265|NCT04682639|323131510|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
94367266|NCT04682639|323131511|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
94367267|NCT04682639|323131512|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
94713682|NCT00807937|324410761|FG001|Overall Study|Lack of Efficacy|0|||
94713683|NCT00807937|324410762|FG002|Overall Study|Lack of Efficacy|1|||
94713684|NCT00807937|324410763|FG003|Overall Study|Lack of Efficacy|2|||
94713685|NCT00807937|324410760|FG000|Overall Study|Intake of prohibited medicine|0|||
94713686|NCT00807937|324410761|FG001|Overall Study|Intake of prohibited medicine|0|||
94713687|NCT00807937|324410762|FG002|Overall Study|Intake of prohibited medicine|2|||
94713688|NCT00807937|324410763|FG003|Overall Study|Intake of prohibited medicine|0|||
94713689|NCT00807937|324410760|FG000|Overall Study|All other reasons (not provided)|2|||
94713690|NCT00807937|324410761|FG001|Overall Study|All other reasons (not provided)|4|||
94713691|NCT00807937|324410762|FG002|Overall Study|All other reasons (not provided)|0|||
94713692|NCT00807937|324410763|FG003|Overall Study|All other reasons (not provided)|1|||
94713693|NCT00311363|324410766|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
94713694|NCT00311363|324410767|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
94713695|NCT00311363|324410768|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
94367268|NCT04682639|323131513|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
94713696|NCT00311363|324410766|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
94713697|NCT00311363|324410767|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
94367269|NCT04682639|323131509|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
94367270|NCT04682639|323131510|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
94713698|NCT00311363|324410768|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
94713699|NCT00311363|324410766|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
94367271|NCT04682639|323131511|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
94367272|NCT04682639|323131512|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
94367273|NCT04682639|323131513|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
94713700|NCT00311363|324410767|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
94713701|NCT00311363|324410768|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
94713702|NCT00311363|324410766|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
94713703|NCT00311363|324410767|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
94713704|NCT00311363|324410768|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
94713705|NCT00311363|324410766|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
94713706|NCT00311363|324410767|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
94713707|NCT00311363|324410768|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
94713708|NCT00311363|324410766|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
94713709|NCT00311363|324410767|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
94713710|NCT00311363|324410768|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
94713711|NCT00311363|324410766|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
94713712|NCT00311363|324410767|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
94713713|NCT00311363|324410768|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
94713714|NCT00311363|324410766|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
94713715|NCT00311363|324410767|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
94713716|NCT00311363|324410768|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
94713717|NCT00311363|324410766|FG000|24-Week Single-Blind Treatment Period|Death|1|||
94713718|NCT00311363|324410767|FG001|24-Week Single-Blind Treatment Period|Death|0|||
94713719|NCT00311363|324410768|FG002|24-Week Single-Blind Treatment Period|Death|0|||
94713720|NCT00311363|324410766|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
94713721|NCT00311363|324410767|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
94713722|NCT00311363|324410768|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
94713723|NCT00311363|324410766|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
94367274|NCT04682639|323131509|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
94367275|NCT04682639|323131510|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
94367276|NCT04682639|323131511|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
94367277|NCT04682639|323131512|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
94367278|NCT04682639|323131513|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
94367279|NCT04682639|323131509|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
94653366|NCT00617240|324188116|FG000|Overall Study|Lack of Efficacy|1|||
94653367|NCT00617240|324188117|FG001|Overall Study|Lack of Efficacy|0|||
94653368|NCT01611259|324188118|FG000|Overall Study|Physician Decision|1|||
94653369|NCT01611259|324188118|FG000|Overall Study|Lack of Efficacy|2|||
94653370|NCT01611259|324188118|FG000|Overall Study|Adverse Event|4|||
94653371|NCT01611259|324188118|FG000|Overall Study|Withdrawal by Subject|7|||
94653372|NCT00684424|324188119|FG000|Overall Study|Adverse Event|1|||
94653373|NCT00684424|324188119|FG000|Overall Study|Lost to Follow-up|2|||
94653374|NCT00684424|324188119|FG000|Overall Study|Other|2|||
94653375|NCT03056690|324188120|FG000|Overall Study|Adverse Event|3|||
94653376|NCT03056690|324188121|FG001|Overall Study|Adverse Event|2|||
94653377|NCT03056690|324188120|FG000|Overall Study|Lack of Efficacy|1|||
94653378|NCT03056690|324188121|FG001|Overall Study|Lack of Efficacy|2|||
94653379|NCT03056690|324188120|FG000|Overall Study|Lost to Follow-up|3|||
94653380|NCT03056690|324188121|FG001|Overall Study|Lost to Follow-up|2|||
94653381|NCT03056690|324188120|FG000|Overall Study|Protocol Violation|2|||
94653382|NCT03056690|324188121|FG001|Overall Study|Protocol Violation|2|||
94653383|NCT03056690|324188120|FG000|Overall Study|Withdrawal by Subject|3|||
94653384|NCT03056690|324188121|FG001|Overall Study|Withdrawal by Subject|6|||
94653385|NCT03056690|324188120|FG000|Overall Study|Non-compliance with Study Drug|1|||
94653386|NCT03056690|324188121|FG001|Overall Study|Non-compliance with Study Drug|0|||
94653387|NCT03056690|324188120|FG000|Overall Study|Miscellaneous|1|||
94653388|NCT03056690|324188121|FG001|Overall Study|Miscellaneous|2|||
94653389|NCT02052739|324188122|FG000|Overall Study|Withdrew due to Adverse Event|3|||
94653390|NCT02052739|324188123|FG001|Overall Study|Withdrew due to Adverse Event|0|||
94653391|NCT02052739|324188122|FG000|Overall Study|Participant Died|2|||
94653392|NCT02052739|324188123|FG001|Overall Study|Participant Died|1|||
94653393|NCT02985736|324188130|FG000|Overall Study|Lost to Follow-up|3|||
94653394|NCT00382733|324188131|FG000|Overall Study|Withdrawal by Subject|0|||
94653395|NCT00382733|324188132|FG001|Overall Study|Withdrawal by Subject|1|||
94653396|NCT00382733|324188133|FG002|Overall Study|Withdrawal by Subject|0|||
94653397|NCT00382733|324188134|FG003|Overall Study|Withdrawal by Subject|0|||
94653398|NCT00382733|324188135|FG004|Overall Study|Withdrawal by Subject|0|||
94653399|NCT03049813|324188136|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
94653400|NCT03049813|324188137|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
94367280|NCT04682639|323131510|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
94367281|NCT04682639|323131511|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
94367282|NCT04682639|323131512|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
94367283|NCT04682639|323131513|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
94713724|NCT00311363|324410767|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
94713725|NCT00311363|324410768|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
94713726|NCT00311363|324410766|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
94713727|NCT00311363|324410767|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
94713728|NCT00311363|324410768|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
94713729|NCT00311363|324410766|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
94713730|NCT00311363|324410767|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
94713731|NCT00311363|324410768|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
94713732|NCT00311363|324410766|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
94713733|NCT00311363|324410767|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
94713734|NCT00311363|324410768|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
94713735|NCT00311363|324410766|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
94713736|NCT00311363|324410767|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
94713737|NCT00311363|324410768|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
94713738|NCT01697969|324410771|FG000|Overall Study|Did not meet inc/exc criteria|3|||
94713739|NCT01561989|324410772|FG000|Overall Study|accural target not met.|5|||
94713740|NCT01561989|324410773|FG001|Overall Study|accural target not met.|6|||
94713741|NCT03764475|324410776|FG000|Overall Study|Adverse Event|11|||
94713742|NCT03764475|324410777|FG001|Overall Study|Adverse Event|2|||
94713743|NCT03764475|324410776|FG000|Overall Study|Lost to Follow-up|24|||
94713744|NCT03764475|324410777|FG001|Overall Study|Lost to Follow-up|10|||
94713745|NCT03764475|324410776|FG000|Overall Study|Withdrawal by Subject|26|||
94713746|NCT03764475|324410777|FG001|Overall Study|Withdrawal by Subject|10|||
94713747|NCT03764475|324410776|FG000|Overall Study|Lack of Efficacy|3|||
94713748|NCT03764475|324410777|FG001|Overall Study|Lack of Efficacy|0|||
94713749|NCT03764475|324410776|FG000|Overall Study|COVID-19 Disruption|2|||
94713750|NCT03764475|324410777|FG001|Overall Study|COVID-19 Disruption|0|||
94713751|NCT00970359|324410778|FG000|Overall Study|Not Treated|4|||
94713752|NCT01565148|324410779|FG000|Overall Study|Withdrawal by Subject|1|||
94713753|NCT01565148|324410780|FG001|Overall Study|Withdrawal by Subject|1|||
94713754|NCT01565148|324410781|FG002|Overall Study|Withdrawal by Subject|1|||
94713755|NCT01565148|324410782|FG003|Overall Study|Withdrawal by Subject|2|||
94713756|NCT01565148|324410779|FG000|Overall Study|Lost to Follow-up|4|||
94713757|NCT01565148|324410780|FG001|Overall Study|Lost to Follow-up|4|||
94713758|NCT01565148|324410781|FG002|Overall Study|Lost to Follow-up|0|||
94713759|NCT01565148|324410782|FG003|Overall Study|Lost to Follow-up|3|||
94713760|NCT01565148|324410779|FG000|Overall Study|Rescue Therapy|8|||
94713761|NCT01565148|324410780|FG001|Overall Study|Rescue Therapy|5|||
94713762|NCT01565148|324410781|FG002|Overall Study|Rescue Therapy|5|||
94713763|NCT01565148|324410782|FG003|Overall Study|Rescue Therapy|8|||
94713764|NCT01565148|324410779|FG000|Overall Study|Death|0|||
94713765|NCT01565148|324410780|FG001|Overall Study|Death|0|||
94713766|NCT01565148|324410781|FG002|Overall Study|Death|1|||
94713767|NCT01565148|324410782|FG003|Overall Study|Death|0|||
94713768|NCT01565148|324410779|FG000|Overall Study|Physician Decision|2|||
94713769|NCT01565148|324410780|FG001|Overall Study|Physician Decision|5|||
94713770|NCT01565148|324410781|FG002|Overall Study|Physician Decision|0|||
94713771|NCT01565148|324410782|FG003|Overall Study|Physician Decision|0|||
94713772|NCT00539734|324410783|FG000|Overall Study|Protocol Violation|1|||
94713773|NCT00068601|324410784|FG000|Overall Study|Ineligible|11|||
94713774|NCT00068601|324410785|FG001|Overall Study|Ineligible|13|||
94713775|NCT00068601|324410784|FG000|Overall Study|Not evaluable: withdrew consent|5|||
94713776|NCT00068601|324410785|FG001|Overall Study|Not evaluable: withdrew consent|4|||
94713777|NCT00068601|324410784|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
94713778|NCT00068601|324410785|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
94713779|NCT00068601|324410784|FG000|Overall Study|Death|11|||
94713780|NCT00068601|324410785|FG001|Overall Study|Death|3|||
94713781|NCT00068601|324410784|FG000|Overall Study|Lost to Follow-up|3|||
94713782|NCT00068601|324410785|FG001|Overall Study|Lost to Follow-up|2|||
94713783|NCT00068601|324410784|FG000|Overall Study|Missing primary outcome data|30|||
94713784|NCT00068601|324410785|FG001|Overall Study|Missing primary outcome data|34|||
94713785|NCT01061671|324410786|FG000|Overall Study|Withdrawal by Subject|16|||
94713786|NCT01061671|324410787|FG001|Overall Study|Withdrawal by Subject|20|||
94367284|NCT01392170|323131516|FG000|Overall Study|Withdrawal by Subject|1|||
94713787|NCT01061671|324410786|FG000|Overall Study|Lost to Follow-up|3|||
94713788|NCT01061671|324410787|FG001|Overall Study|Lost to Follow-up|5|||
94713789|NCT01061671|324410786|FG000|Overall Study|Death|28|||
94713790|NCT01061671|324410787|FG001|Overall Study|Death|30|||
94713791|NCT01070069|324410790|FG000|Overall Study|Death|1|||
94713792|NCT01070069|324410791|FG001|Overall Study|Death|0|||
94713793|NCT01070069|324410792|FG002|Overall Study|Death|2|||
94713794|NCT01070069|324410793|FG003|Overall Study|Death|0|||
94713795|NCT01070069|324410794|FG004|Overall Study|Death|1|||
94713796|NCT01070069|324410790|FG000|Overall Study|Withdrawal by Subject|1|||
94713797|NCT01070069|324410791|FG001|Overall Study|Withdrawal by Subject|1|||
94713798|NCT01070069|324410792|FG002|Overall Study|Withdrawal by Subject|4|||
94713799|NCT01070069|324410793|FG003|Overall Study|Withdrawal by Subject|0|||
94713800|NCT01070069|324410794|FG004|Overall Study|Withdrawal by Subject|0|||
94713801|NCT01070069|324410790|FG000|Overall Study|Lost to Follow-up|4|||
94713802|NCT01070069|324410791|FG001|Overall Study|Lost to Follow-up|1|||
94713803|NCT01070069|324410792|FG002|Overall Study|Lost to Follow-up|0|||
94713804|NCT01070069|324410793|FG003|Overall Study|Lost to Follow-up|0|||
94713805|NCT01070069|324410794|FG004|Overall Study|Lost to Follow-up|3|||
94713806|NCT04623008|324412336|FG000|Baseline to T2|Withdrawal by Subject|4|||
94713807|NCT04623008|324412337|FG001|Baseline to T2|Withdrawal by Subject|2|||
94713808|NCT04623008|324412336|FG000|Baseline to T3|Withdrawal by Subject|4|||
94713809|NCT04623008|324412337|FG001|Baseline to T3|Withdrawal by Subject|2|||
94713810|NCT03422276|324412338|FG000|Overall Study|Withdrawal by Subject|21|||
94713811|NCT03422276|324412339|FG001|Overall Study|Withdrawal by Subject|25|||
94713812|NCT03422276|324412340|FG002|Overall Study|Withdrawal by Subject|14|||
94713813|NCT03422276|324412341|FG003|Overall Study|Withdrawal by Subject|16|||
94713814|NCT03422276|324412338|FG000|Overall Study|Death|14|||
94713815|NCT03422276|324412339|FG001|Overall Study|Death|21|||
94713816|NCT03422276|324412340|FG002|Overall Study|Death|3|||
94713817|NCT03422276|324412341|FG003|Overall Study|Death|1|||
94713818|NCT03422276|324412338|FG000|Overall Study|Discontinued, ineligible|4|||
94713819|NCT03422276|324412339|FG001|Overall Study|Discontinued, ineligible|3|||
94713820|NCT03422276|324412340|FG002|Overall Study|Discontinued, ineligible|0|||
94713821|NCT03422276|324412341|FG003|Overall Study|Discontinued, ineligible|0|||
94713822|NCT03422276|324412338|FG000|Overall Study|Lost to Follow-up|15|||
94713823|NCT03422276|324412339|FG001|Overall Study|Lost to Follow-up|8|||
94713824|NCT03422276|324412340|FG002|Overall Study|Lost to Follow-up|13|||
94713825|NCT03422276|324412341|FG003|Overall Study|Lost to Follow-up|4|||
94713826|NCT03422276|324412338|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
94713827|NCT03422276|324412339|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
94713828|NCT03422276|324412340|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
94713829|NCT03422276|324412341|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
94713830|NCT03422276|324412338|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
94713831|NCT03422276|324412339|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
94713832|NCT03422276|324412340|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
94713833|NCT03422276|324412341|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
94713834|NCT03422276|324412338|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
94713835|NCT03422276|324412339|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
94713836|NCT03422276|324412340|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
94713837|NCT03422276|324412341|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
94713838|NCT03422276|324412338|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
94713839|NCT03422276|324412339|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
94713840|NCT03422276|324412340|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
94713841|NCT03422276|324412341|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
94713842|NCT03422276|324412338|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
94713843|NCT03422276|324412339|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
94713844|NCT03422276|324412340|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
94713845|NCT03422276|324412341|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
94713846|NCT01460446|324412346|FG000|Overall Study|Non-compliance|2|||
94713847|NCT01460446|324412347|FG001|Overall Study|Non-compliance|9|||
94713848|NCT01460446|324412346|FG000|Overall Study|Consent Withdrawn|0|||
94713849|NCT01460446|324412347|FG001|Overall Study|Consent Withdrawn|4|||
94713850|NCT01460446|324412346|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
94713851|NCT01460446|324412347|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
94713852|NCT01460446|324412346|FG000|Overall Study|Surgery/Illness|1|||
94713853|NCT01460446|324412347|FG001|Overall Study|Surgery/Illness|1|||
94713854|NCT01460446|324412346|FG000|Overall Study|Pregnancy|1|||
94713855|NCT01460446|324412347|FG001|Overall Study|Pregnancy|0|||
94713856|NCT01460446|324412346|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
94713857|NCT01460446|324412347|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
94713858|NCT04252586|324412349|FG000|Overall Study|Withdrawal by parent/guardian|3|||
94713859|NCT04252586|324412349|FG000|Overall Study|Adverse Event|1|||
94713860|NCT04252586|324412349|FG000|Overall Study|Death|2|||
94713861|NCT04252586|324412349|FG000|Overall Study|Study terminated by sponsor|4|||
94713862|NCT04252586|324412349|FG000|Overall Study|Sponsor request|10|||
94713863|NCT04252586|324412349|FG000|Overall Study|Did not complete treatment period|1|||
94713864|NCT00232180|324412350|FG000|Double-blind (DB) Phase|Death|186|||
94713865|NCT00232180|324412351|FG001|Double-blind (DB) Phase|Death|222|||
94713866|NCT00232180|324412352|FG002|Double-blind (DB) Phase|Death|0|||
94713867|NCT00232180|324412350|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
94713868|NCT00232180|324412351|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
94713869|NCT00232180|324412352|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
94713870|NCT00232180|324412350|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
94713871|NCT00232180|324412351|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
94713872|NCT00232180|324412352|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
94713873|NCT00232180|324412350|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
94713874|NCT00232180|324412351|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
94713875|NCT00232180|324412352|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
94713876|NCT00232180|324412350|FG000|Double-blind (DB) Phase|Adverse Event|83|||
94713877|NCT00232180|324412351|FG001|Double-blind (DB) Phase|Adverse Event|100|||
94713878|NCT00232180|324412352|FG002|Double-blind (DB) Phase|Adverse Event|0|||
94713879|NCT00232180|324412350|FG000|Double-blind (DB) Phase|Other|70|||
94713880|NCT00232180|324412351|FG001|Double-blind (DB) Phase|Other|75|||
94713881|NCT00232180|324412352|FG002|Double-blind (DB) Phase|Other|0|||
94713882|NCT00232180|324412350|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
94713883|NCT00232180|324412351|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
94713884|NCT00232180|324412352|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
94713885|NCT00232180|324412350|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
94713886|NCT00232180|324412351|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
94713887|NCT00232180|324412352|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
94713888|NCT00232180|324412350|FG000|Open Label Phase|Death|0|||
94713889|NCT00232180|324412351|FG001|Open Label Phase|Death|0|||
94713890|NCT00232180|324412352|FG002|Open Label Phase|Death|48|||
94713891|NCT00232180|324412350|FG000|Open Label Phase|Lost to Follow-up|0|||
94713892|NCT00232180|324412351|FG001|Open Label Phase|Lost to Follow-up|0|||
94713893|NCT00232180|324412352|FG002|Open Label Phase|Lost to Follow-up|5|||
94713894|NCT00232180|324412350|FG000|Open Label Phase|Protocol Violation|0|||
94713895|NCT00232180|324412351|FG001|Open Label Phase|Protocol Violation|0|||
94713896|NCT00232180|324412352|FG002|Open Label Phase|Protocol Violation|3|||
94713897|NCT00232180|324412350|FG000|Open Label Phase|Study terminated by sponsor|0|||
94713898|NCT00232180|324412351|FG001|Open Label Phase|Study terminated by sponsor|0|||
94713899|NCT00232180|324412352|FG002|Open Label Phase|Study terminated by sponsor|3|||
94713900|NCT00232180|324412350|FG000|Open Label Phase|Withdrawal by Subject|0|||
94713901|NCT00232180|324412351|FG001|Open Label Phase|Withdrawal by Subject|0|||
94713902|NCT00232180|324412352|FG002|Open Label Phase|Withdrawal by Subject|37|||
94713903|NCT00232180|324412350|FG000|Open Label Phase|Other|0|||
94713904|NCT00232180|324412351|FG001|Open Label Phase|Other|0|||
94713905|NCT00232180|324412352|FG002|Open Label Phase|Other|16|||
94713906|NCT00232180|324412350|FG000|Open Label Phase|Adverse Event|0|||
94713907|NCT00232180|324412351|FG001|Open Label Phase|Adverse Event|0|||
94713908|NCT00232180|324412352|FG002|Open Label Phase|Adverse Event|25|||
94713909|NCT00232180|324412350|FG000|Open Label Phase|Laboratory abnormality|0|||
94713910|NCT00232180|324412351|FG001|Open Label Phase|Laboratory abnormality|0|||
94713911|NCT00232180|324412352|FG002|Open Label Phase|Laboratory abnormality|10|||
94713912|NCT00232180|324412350|FG000|Open Label Phase|Randomized but not treated|0|||
94713913|NCT00232180|324412351|FG001|Open Label Phase|Randomized but not treated|0|||
94713914|NCT00232180|324412352|FG002|Open Label Phase|Randomized but not treated|1|||
94713915|NCT01534494|324412353|FG000|Overall Study|Withdrawal by Subject|1|||
94713916|NCT00434304|324412359|FG000|Overall Study|Adverse Event|14|||
94713917|NCT00434304|324412359|FG000|Overall Study|Lack of Efficacy|2|||
94713918|NCT00434304|324412359|FG000|Overall Study|Withdrawal by Subject|4|||
94713919|NCT02652442|324412370|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
94713920|NCT00869258|324412371|FG000|Overall Study|Physician Decision|1|||
94713921|NCT02706717|324412374|FG000|Overall Study|Withdrawal by Subject|1|||
94713922|NCT02706717|324412375|FG001|Overall Study|Withdrawal by Subject|8|||
94713923|NCT02706717|324412374|FG000|Overall Study|Lost to Follow-up|0|||
94713924|NCT02706717|324412375|FG001|Overall Study|Lost to Follow-up|1|||
94713925|NCT02706717|324412374|FG000|Overall Study|Physician Decision|0|||
94713926|NCT02706717|324412375|FG001|Overall Study|Physician Decision|1|||
94713927|NCT02706717|324412374|FG000|Overall Study|Death|0|||
94713928|NCT02706717|324412375|FG001|Overall Study|Death|1|||
94713929|NCT02549170|324412379|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
94713930|NCT02549170|324412380|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
94713931|NCT02549170|324412381|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
94713932|NCT02549170|324412382|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
94713933|NCT02549170|324412383|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
94713934|NCT02549170|324412379|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
94713935|NCT02549170|324412380|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
94713936|NCT02549170|324412381|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
94713937|NCT02549170|324412382|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
94713938|NCT02549170|324412383|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
94713939|NCT02549170|324412379|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
94713940|NCT02549170|324412380|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
94713941|NCT02549170|324412381|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
94713942|NCT02549170|324412382|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
94713943|NCT02549170|324412383|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
94713944|NCT04530747|324412384|FG000|Overall Study|Withdrawal by Subject|1|||
94713945|NCT04530747|324412385|FG001|Overall Study|Withdrawal by Subject|0|||
94713946|NCT02379819|324412386|FG000|Overall Study|Withdrawal by Subject|10|||
94713947|NCT02379819|324412386|FG000|Overall Study|Death|2|||
94713948|NCT02379819|324412386|FG000|Overall Study|Lack of Efficacy|1|||
94713949|NCT02379819|324412386|FG000|Overall Study|Lost to Follow-up|1|||
94713950|NCT01510717|324412387|FG000|Overall Study|Adverse Event|1|||
94713951|NCT01510717|324412388|FG001|Overall Study|Adverse Event|2|||
94713952|NCT01510717|324412387|FG000|Overall Study|Death|1|||
94713953|NCT01510717|324412388|FG001|Overall Study|Death|0|||
94713954|NCT01510717|324412387|FG000|Overall Study|Lost to Follow-up|0|||
94713955|NCT01510717|324412388|FG001|Overall Study|Lost to Follow-up|1|||
94713956|NCT01510717|324412387|FG000|Overall Study|Withdrawal by Subject|0|||
94713957|NCT01510717|324412388|FG001|Overall Study|Withdrawal by Subject|2|||
94713958|NCT00785512|324412390|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
94713959|NCT00785512|324412391|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
94713960|NCT00785512|324412390|FG000|Overall Study|Adverse Event|0|||
94713961|NCT00785512|324412391|FG001|Overall Study|Adverse Event|0|||
94713962|NCT00785512|324412390|FG000|Overall Study|Lack of Efficacy|0|||
94713963|NCT00785512|324412391|FG001|Overall Study|Lack of Efficacy|2|||
94713964|NCT00785512|324412390|FG000|Overall Study|Withdrawal by Subject|0|||
94713965|NCT00785512|324412391|FG001|Overall Study|Withdrawal by Subject|1|||
94713966|NCT00785512|324412390|FG000|Overall Study|Lost to Follow-up|3|||
94713967|NCT00785512|324412391|FG001|Overall Study|Lost to Follow-up|0|||
94713968|NCT00785512|324412390|FG000|Overall Study|Precedure Refused|0|||
94713969|NCT00785512|324412391|FG001|Overall Study|Precedure Refused|0|||
94713970|NCT00785512|324412390|FG000|Overall Study|IVRS Programing Error|0|||
94713971|NCT00785512|324412391|FG001|Overall Study|IVRS Programing Error|0|||
94713972|NCT00785512|324412390|FG000|Overall Study|Physician Decision|0|||
94713973|NCT00785512|324412391|FG001|Overall Study|Physician Decision|0|||
94713974|NCT00785512|324412390|FG000|Overall Study|Lack of compliance|0|||
94713975|NCT00785512|324412391|FG001|Overall Study|Lack of compliance|1|||
94713976|NCT00546754|324412392|FG000|Overall Study|Serious Adverse Event|1|||
94713977|NCT00546754|324412393|FG001|Overall Study|Serious Adverse Event|1|||
94713978|NCT00546754|324412392|FG000|Overall Study|Adverse Event|11|||
94713979|NCT00546754|324412393|FG001|Overall Study|Adverse Event|16|||
94713980|NCT00546754|324412392|FG000|Overall Study|Lack of Efficacy|1|||
94713981|NCT00546754|324412393|FG001|Overall Study|Lack of Efficacy|1|||
94713982|NCT00546754|324412392|FG000|Overall Study|Lost to Follow-up|9|||
94713983|NCT00546754|324412393|FG001|Overall Study|Lost to Follow-up|15|||
94713984|NCT00546754|324412392|FG000|Overall Study|Protocol Violation|3|||
94713985|NCT00546754|324412393|FG001|Overall Study|Protocol Violation|0|||
94713986|NCT00546754|324412392|FG000|Overall Study|Withdrawal by Subject|6|||
94713987|NCT00546754|324412393|FG001|Overall Study|Withdrawal by Subject|7|||
94713988|NCT00546754|324412392|FG000|Overall Study|Dyspnea|1|||
94713989|NCT00546754|324412393|FG001|Overall Study|Dyspnea|0|||
94713990|NCT00546754|324412392|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
94713991|NCT00546754|324412393|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
94713992|NCT00546754|324412392|FG000|Overall Study|Hip Replacement|1|||
94713993|NCT00546754|324412393|FG001|Overall Study|Hip Replacement|0|||
94713994|NCT00546754|324412392|FG000|Overall Study|Suicide|1|||
94713995|NCT00546754|324412393|FG001|Overall Study|Suicide|0|||
94713996|NCT00546754|324412392|FG000|Overall Study|Missing Cooperation|1|||
94713997|NCT00546754|324412393|FG001|Overall Study|Missing Cooperation|0|||
94713998|NCT00546754|324412392|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
94713999|NCT00546754|324412393|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
94714000|NCT00546754|324412392|FG000|Overall Study|Patient's Decision|0|||
94714001|NCT00546754|324412393|FG001|Overall Study|Patient's Decision|1|||
94714002|NCT00546754|324412392|FG000|Overall Study|Missing|14|||
94714003|NCT00546754|324412393|FG001|Overall Study|Missing|7|||
94714004|NCT02374307|324412396|FG000|3-months Follow-up|Lost to Follow-up|1|||
94714005|NCT02374307|324412397|FG001|3-months Follow-up|Lost to Follow-up|2|||
94714006|NCT02374307|324412396|FG000|3-months Follow-up|Withdrawal by Subject|1|||
94714007|NCT02374307|324412397|FG001|3-months Follow-up|Withdrawal by Subject|4|||
94714008|NCT02374307|324412396|FG000|3-months Follow-up|Death|1|||
94714009|NCT02374307|324412397|FG001|3-months Follow-up|Death|2|||
94714010|NCT02374307|324412396|FG000|3-months Follow-up|Missed first follow-up|5|||
94714011|NCT02374307|324412397|FG001|3-months Follow-up|Missed first follow-up|1|||
94714012|NCT02374307|324412396|FG000|6-months Follow-up|Lost to Follow-up|1|||
94714013|NCT02374307|324412397|FG001|6-months Follow-up|Lost to Follow-up|2|||
94714014|NCT02374307|324412396|FG000|6-months Follow-up|Death|2|||
94714015|NCT02374307|324412397|FG001|6-months Follow-up|Death|1|||
94714016|NCT02374307|324412396|FG000|6-months Follow-up|Withdrawal by Subject|0|||
94714017|NCT02374307|324412397|FG001|6-months Follow-up|Withdrawal by Subject|3|||
94714018|NCT00529100|324412398|FG000|Overall Study|Adverse Event|0|||
94714019|NCT00529100|324412399|FG001|Overall Study|Adverse Event|5|||
94714020|NCT00529100|324412398|FG000|Overall Study|Protocol Violation|0|||
94714021|NCT00529100|324412399|FG001|Overall Study|Protocol Violation|1|||
94714022|NCT00529100|324412398|FG000|Overall Study|Progressive Disease|0|||
94714023|NCT00529100|324412399|FG001|Overall Study|Progressive Disease|1|||
94714024|NCT00529100|324412398|FG000|Overall Study|Withdrawal by Subject|0|||
94714025|NCT00529100|324412399|FG001|Overall Study|Withdrawal by Subject|1|||
94714026|NCT00529100|324412398|FG000|Overall Study|Participant Ineligibility|0|||
94714027|NCT00529100|324412399|FG001|Overall Study|Participant Ineligibility|1|||
94714028|NCT05368831|324412405|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
94714029|NCT03565315|324412411|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
94714030|NCT03565315|324412412|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
94714031|NCT03565315|324412413|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
94714032|NCT03565315|324412414|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
94714033|NCT01771731|324412422|FG000|Overall Study|Physician Decision|1|||
94714034|NCT01771731|324412423|FG001|Overall Study|Physician Decision|0|||
94714035|NCT01771731|324412422|FG000|Overall Study|Protocol Violation|0|||
94714036|NCT01771731|324412423|FG001|Overall Study|Protocol Violation|1|||
94714037|NCT01771731|324412422|FG000|Overall Study|Adverse event: Pain Crisis|1|||
94714038|NCT01771731|324412423|FG001|Overall Study|Adverse event: Pain Crisis|1|||
94714039|NCT00419341|324412427|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
94714040|NCT00419341|324412427|FG000|Wash in/Wash Out Period|Adverse Event|2|||
94714041|NCT00419341|324412427|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
94714042|NCT00419341|324412427|FG000|Efficacy Period|Withdrawal by Subject|6|||
94714043|NCT00419341|324412427|FG000|Efficacy Period|Protocol Violation|1|||
94714044|NCT00419341|324412427|FG000|Efficacy Period|Lost to Follow-up|1|||
94714045|NCT00419341|324412427|FG000|Efficacy Period|Non-compliance|1|||
94714046|NCT00419341|324412427|FG000|Efficacy Period|Termination of study site|1|||
94714047|NCT04200365|324412428|FG000|Overall Study|Adverse Event|2|||
94714048|NCT04200365|324412428|FG000|Overall Study|Progressive Disease|4|||
94714049|NCT04200365|324412428|FG000|Overall Study|Lack of Efficacy|1|||
94714050|NCT04200365|324412428|FG000|Overall Study|Study Closure|4|||
94714051|NCT04128319|324412430|FG000|Overall Study|Death|3|||
94714052|NCT02692417|324412431|FG000|Overall Study|Withdrawal by Subject|5|||
94714053|NCT02692417|324412432|FG001|Overall Study|Withdrawal by Subject|1|||
94714054|NCT02692417|324412431|FG000|Overall Study|Adverse Event|1|||
94714055|NCT02692417|324412432|FG001|Overall Study|Adverse Event|0|||
94714056|NCT01199575|324412437|FG000|Overall Study|Withdrawal by Subject|5|||
94714057|NCT04732338|324412441|FG000|Overall Study|Lost to Follow-up|3|||
94714058|NCT04732338|324412442|FG001|Overall Study|Lost to Follow-up|3|||
94714059|NCT03432858|324412447|FG000|Overall Study|Protocol Violation|2|||
94714060|NCT03432858|324412448|FG001|Overall Study|Protocol Violation|1|||
94714061|NCT03432858|324412449|FG002|Overall Study|Protocol Violation|9|||
94714062|NCT03432858|324412447|FG000|Overall Study|Withdrawal by Subject|0|||
94714063|NCT03432858|324412448|FG001|Overall Study|Withdrawal by Subject|1|||
94714064|NCT03432858|324412449|FG002|Overall Study|Withdrawal by Subject|1|||
94714065|NCT03432858|324412447|FG000|Overall Study|Procedure canceled/rescheduled|0|||
94714066|NCT03432858|324412448|FG001|Overall Study|Procedure canceled/rescheduled|9|||
94714067|NCT03432858|324412449|FG002|Overall Study|Procedure canceled/rescheduled|6|||
94714068|NCT03432858|324412447|FG000|Overall Study|Required postop mobilization with splinting|0|||
94714069|NCT03432858|324412448|FG001|Overall Study|Required postop mobilization with splinting|0|||
94714070|NCT03432858|324412449|FG002|Overall Study|Required postop mobilization with splinting|1|||
94714071|NCT00088413|324412450|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
94714072|NCT00088413|324412451|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
94714073|NCT00088413|324412452|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
94714074|NCT00088413|324412453|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
94714075|NCT00088413|324412450|FG000|Overall Study|Adverse Events/Side Effects|0|||
94714076|NCT00088413|324412451|FG001|Overall Study|Adverse Events/Side Effects|1|||
94714077|NCT00088413|324412452|FG002|Overall Study|Adverse Events/Side Effects|1|||
94714078|NCT00088413|324412453|FG003|Overall Study|Adverse Events/Side Effects|0|||
94714079|NCT00088413|324412450|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
94714080|NCT00088413|324412451|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
94714081|NCT00088413|324412452|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
94714082|NCT00088413|324412453|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
94714083|NCT00088413|324412450|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
94714084|NCT00088413|324412451|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
94714085|NCT00088413|324412452|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
94714086|NCT00088413|324412453|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
94714087|NCT00088413|324412450|FG000|Overall Study|Death|0|||
94714088|NCT00088413|324412451|FG001|Overall Study|Death|1|||
94714089|NCT00088413|324412452|FG002|Overall Study|Death|0|||
94714090|NCT00088413|324412453|FG003|Overall Study|Death|0|||
94714091|NCT00088413|324412450|FG000|Overall Study|Progressive disease|9|||
94714092|NCT00088413|324412451|FG001|Overall Study|Progressive disease|11|||
94714093|NCT00088413|324412452|FG002|Overall Study|Progressive disease|8|||
94714094|NCT00088413|324412453|FG003|Overall Study|Progressive disease|14|||
94714095|NCT00088413|324412450|FG000|Overall Study|Other|0|||
94714096|NCT00088413|324412451|FG001|Overall Study|Other|1|||
94714097|NCT00088413|324412452|FG002|Overall Study|Other|0|||
94714098|NCT00088413|324412453|FG003|Overall Study|Other|0|||
94714099|NCT00088413|324412450|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
94714100|NCT00088413|324412451|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
94714101|NCT00088413|324412452|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
94714102|NCT00088413|324412453|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
94714103|NCT01044303|324412454|FG000|Overall Study|Lost to Follow-up|2|||
94714104|NCT02539225|324412455|FG000|Part A|Adverse Event|13|||
94714105|NCT02539225|324412456|FG001|Part A|Adverse Event|4|||
94714106|NCT02539225|324412455|FG000|Part A|Withdrawal by Subject|2|||
94714107|NCT02539225|324412456|FG001|Part A|Withdrawal by Subject|4|||
94714108|NCT02539225|324412455|FG000|Part A|Physician Decision|4|||
94714109|NCT02539225|324412456|FG001|Part A|Physician Decision|7|||
94714110|NCT02539225|324412455|FG000|Part A|Did Not Receive study Drug|1|||
94714111|NCT02539225|324412456|FG001|Part A|Did Not Receive study Drug|1|||
94714112|NCT02539225|324412455|FG000|Pre Treatment for Part B|Progressive disease|1|||
94714113|NCT02539225|324412456|FG001|Pre Treatment for Part B|Progressive disease|1|||
94714114|NCT02539225|324412455|FG000|Pre Treatment for Part B|Adverse Event|1|||
94714115|NCT02539225|324412456|FG001|Pre Treatment for Part B|Adverse Event|1|||
94714116|NCT02539225|324412455|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
94270657|NCT01431274|322783787|FG000|Overall Study|Lost to Follow-up|6|||
94714117|NCT02539225|324412456|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
94714118|NCT02539225|324412455|FG000|Pre Treatment for Part B|Physician Decision|2|||
94714119|NCT02539225|324412456|FG001|Pre Treatment for Part B|Physician Decision|0|||
94714120|NCT02539225|324412455|FG000|Part B|Adverse Event|4|||
94714121|NCT02539225|324412456|FG001|Part B|Adverse Event|4|||
94714122|NCT02539225|324412455|FG000|Part B|Withdrawal by Subject|0|||
94714123|NCT02539225|324412456|FG001|Part B|Withdrawal by Subject|3|||
94714124|NCT02539225|324412455|FG000|Part B|Physician Decision|0|||
94714125|NCT02539225|324412456|FG001|Part B|Physician Decision|9|||
94714126|NCT03101371|324412457|FG000|Overall Study|Physician Decision|0|||
94714127|NCT03101371|324412458|FG001|Overall Study|Physician Decision|1|||
94714128|NCT03101371|324412457|FG000|Overall Study|Lost to Follow-up|1|||
94714129|NCT03101371|324412458|FG001|Overall Study|Lost to Follow-up|4|||
94270658|NCT01431274|322783788|FG001|Overall Study|Lost to Follow-up|7|||
94270659|NCT01431274|322783789|FG002|Overall Study|Lost to Follow-up|1|||
94270660|NCT01431274|322783790|FG003|Overall Study|Lost to Follow-up|4|||
94714130|NCT03101371|324412457|FG000|Overall Study|Did not meet eligibility criteria|2|||
94714131|NCT03101371|324412458|FG001|Overall Study|Did not meet eligibility criteria|1|||
94714132|NCT02556138|324412459|FG000|Overall Study|Withdrawal by Subject|1|||
94714133|NCT01255670|324412463|FG000|Overall Study|Adverse Event|10|||
94714134|NCT01255670|324412464|FG001|Overall Study|Adverse Event|10|||
94714135|NCT01255670|324412463|FG000|Overall Study|Lost to Follow-up|16|||
94714136|NCT01255670|324412464|FG001|Overall Study|Lost to Follow-up|10|||
94270661|NCT01431274|322783791|FG004|Overall Study|Lost to Follow-up|0|||
94270662|NCT01431274|322783787|FG000|Overall Study|Other reason not stated above|6|||
94714137|NCT03394885|324412468|FG000|Overall Study|Adverse Event|4|||
94714138|NCT03394885|324412468|FG000|Overall Study|Lack of Efficacy|1|||
94714139|NCT03394885|324412468|FG000|Overall Study|Physician Decision|1|||
94714140|NCT03394885|324412468|FG000|Overall Study|Withdrawal by Subject|8|||
94714141|NCT03394885|324412468|FG000|Overall Study|Alternative Therapy|1|||
94714142|NCT00632424|324412472|FG000|Overall Study|Disease Progression|17|||
94714143|NCT00632424|324412472|FG000|Overall Study|Study Drug Toxicity|1|||
94714144|NCT03482635|324412473|FG000|Overall Study|Lack of Efficacy|0|||
94270663|NCT01431274|322783788|FG001|Overall Study|Other reason not stated above|5|||
94270664|NCT01431274|322783789|FG002|Overall Study|Other reason not stated above|7|||
94653401|NCT03049813|324188138|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
94653402|NCT03049813|324188139|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
94653403|NCT03049813|324188136|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
94653404|NCT03049813|324188137|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
94653405|NCT03049813|324188138|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
94653406|NCT03049813|324188139|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
94653407|NCT03049813|324188136|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
94653408|NCT03049813|324188137|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
94653409|NCT03049813|324188138|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
94653410|NCT03049813|324188139|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
94653411|NCT03049813|324188136|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
94653412|NCT03049813|324188137|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
94653413|NCT03049813|324188138|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
94653414|NCT03049813|324188139|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
94653415|NCT00281840|324188145|FG000|Overall Study|Adverse Event|12|||
94653416|NCT00281840|324188145|FG000|Overall Study|Physician Decision|6|||
94653417|NCT00281840|324188145|FG000|Overall Study|Withdrawal by Subject|3|||
94653418|NCT00281840|324188145|FG000|Overall Study|Disease Progression|2|||
94653419|NCT00281840|324188145|FG000|Overall Study|exceed maximum delay in treatment|1|||
94653420|NCT00281840|324188145|FG000|Overall Study|Complicating Disease|1|||
94653421|NCT01114516|324188154|FG000|Overall Study|Lost to Follow-up|2|||
94653422|NCT01114516|324188155|FG001|Overall Study|Lost to Follow-up|1|||
94653423|NCT02556710|324190331|FG000|Overall Study|Surgical treatment|3|||
94653424|NCT02556710|324190332|FG001|Overall Study|Surgical treatment|0|||
94653425|NCT02556710|324190331|FG000|Overall Study|Required proscribed pain medication|2|||
94653426|NCT02556710|324190332|FG001|Overall Study|Required proscribed pain medication|1|||
94653427|NCT02556710|324190331|FG000|Overall Study|Lack of Efficacy|1|||
94653428|NCT02556710|324190332|FG001|Overall Study|Lack of Efficacy|0|||
94653429|NCT02556710|324190331|FG000|Overall Study|Worsening osteoarthritis|1|||
94653430|NCT02556710|324190332|FG001|Overall Study|Worsening osteoarthritis|0|||
94653431|NCT02556710|324190331|FG000|Overall Study|Moved out of state|1|||
94653432|NCT02556710|324190332|FG001|Overall Study|Moved out of state|0|||
94653433|NCT02556710|324190331|FG000|Overall Study|Missing reason|3|||
94653434|NCT02556710|324190332|FG001|Overall Study|Missing reason|1|||
94653435|NCT02556710|324190331|FG000|Overall Study|Pain as lack of efficacy|0|||
94653436|NCT02556710|324190332|FG001|Overall Study|Pain as lack of efficacy|4|||
94653437|NCT02742103|324190333|FG000|Overall Study|Protocol Violation|1|||
94653438|NCT02742103|324190334|FG001|Overall Study|Protocol Violation|0|||
94653439|NCT02742103|324190333|FG000|Overall Study|Death|2|||
94653440|NCT02742103|324190334|FG001|Overall Study|Death|2|||
94653441|NCT02742103|324190333|FG000|Overall Study|Adverse Event|1|||
94653442|NCT02742103|324190334|FG001|Overall Study|Adverse Event|0|||
94653443|NCT02742103|324190333|FG000|Overall Study|Moved to another town|0|||
94653444|NCT02742103|324190334|FG001|Overall Study|Moved to another town|1|||
94653445|NCT02742103|324190333|FG000|Overall Study|Withdrawal by Subject|5|||
94653446|NCT02742103|324190334|FG001|Overall Study|Withdrawal by Subject|2|||
94653447|NCT01709318|324190335|FG000|Overall Study|Adverse Event|3|||
94653448|NCT01709318|324190336|FG001|Overall Study|Adverse Event|4|||
94653449|NCT01709318|324190337|FG002|Overall Study|Adverse Event|2|||
94653450|NCT01709318|324190338|FG003|Overall Study|Adverse Event|2|||
94653451|NCT01709318|324190339|FG004|Overall Study|Adverse Event|0|||
94367285|NCT01392170|323131516|FG000|Overall Study|Ineligible|1|||
94653452|NCT01709318|324190340|FG005|Overall Study|Adverse Event|1|||
94653453|NCT01709318|324190341|FG006|Overall Study|Adverse Event|2|||
94653454|NCT01709318|324190335|FG000|Overall Study|Lost to Follow-up|2|||
94653455|NCT01709318|324190336|FG001|Overall Study|Lost to Follow-up|0|||
94653456|NCT01709318|324190337|FG002|Overall Study|Lost to Follow-up|0|||
94653457|NCT01709318|324190338|FG003|Overall Study|Lost to Follow-up|0|||
94653458|NCT01709318|324190339|FG004|Overall Study|Lost to Follow-up|1|||
94653459|NCT01709318|324190340|FG005|Overall Study|Lost to Follow-up|1|||
94653460|NCT01709318|324190341|FG006|Overall Study|Lost to Follow-up|1|||
94653461|NCT01709318|324190335|FG000|Overall Study|Non-compliance with Study Drug|0|||
94653462|NCT01709318|324190336|FG001|Overall Study|Non-compliance with Study Drug|2|||
94653463|NCT01709318|324190337|FG002|Overall Study|Non-compliance with Study Drug|1|||
94653464|NCT01709318|324190338|FG003|Overall Study|Non-compliance with Study Drug|1|||
94714145|NCT03482635|324412474|FG001|Overall Study|Lack of Efficacy|0|||
94714146|NCT03482635|324412475|FG002|Overall Study|Lack of Efficacy|1|||
94714147|NCT03482635|324412476|FG003|Overall Study|Lack of Efficacy|3|||
94714148|NCT03482635|324412473|FG000|Overall Study|Adverse Event|2|||
94714149|NCT03482635|324412474|FG001|Overall Study|Adverse Event|2|||
94714150|NCT03482635|324412475|FG002|Overall Study|Adverse Event|0|||
94714151|NCT03482635|324412476|FG003|Overall Study|Adverse Event|3|||
94714152|NCT03482635|324412473|FG000|Overall Study|Withdrawal by Subject|2|||
94714153|NCT03482635|324412474|FG001|Overall Study|Withdrawal by Subject|1|||
94714154|NCT03482635|324412475|FG002|Overall Study|Withdrawal by Subject|0|||
94714155|NCT03482635|324412476|FG003|Overall Study|Withdrawal by Subject|1|||
94714156|NCT03482635|324412473|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
94714157|NCT03482635|324412474|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
94714158|NCT03482635|324412475|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
94714159|NCT03482635|324412476|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
94714160|NCT03482635|324412473|FG000|Overall Study|Not treated|0|||
94714161|NCT03482635|324412474|FG001|Overall Study|Not treated|0|||
94714162|NCT03482635|324412475|FG002|Overall Study|Not treated|0|||
94714163|NCT03482635|324412476|FG003|Overall Study|Not treated|1|||
94714164|NCT02769858|324412477|FG000|Overall Study|Withdrawal by Subject|2|||
94714165|NCT02411084|324413782|FG000|Overall Study|Lack of Efficacy|6|||
94714166|NCT02411084|324413783|FG001|Overall Study|Lack of Efficacy|3|||
94714167|NCT02411084|324413782|FG000|Overall Study|Death|5|||
94714168|NCT02411084|324413783|FG001|Overall Study|Death|4|||
94714169|NCT02411084|324413782|FG000|Overall Study|Adverse Event|2|||
94714170|NCT02411084|324413783|FG001|Overall Study|Adverse Event|1|||
94714171|NCT02411084|324413782|FG000|Overall Study|Other reasons|0|||
94714172|NCT02411084|324413783|FG001|Overall Study|Other reasons|5|||
94714173|NCT02407249|324413784|FG000|Overall Study|Did not complete 12-month follow-up|13|||
94714174|NCT02407249|324413784|FG000|Overall Study|Not treated|13|||
94714175|NCT03345901|324413787|FG000|Overall Study|The study was terminated|18|||
94714176|NCT03050814|324413794|FG000|Overall Study|Screen failures|0|||
94714177|NCT03050814|324413795|FG001|Overall Study|Screen failures|0|||
94714178|NCT03050814|324413796|FG002|Overall Study|Screen failures|4|||
94714179|NCT02271854|324413800|FG000|Overall Study|Withdrawal by Subject|2|||
94714180|NCT02271854|324413800|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
94714181|NCT02271854|324413800|FG000|Overall Study|Lost to Follow-up|1|||
94714182|NCT02584829|324413801|FG000|Overall Study|Physician Decision|1|||
94714183|NCT02584829|324413802|FG001|Overall Study|Physician Decision|0|||
94714184|NCT02584829|324413801|FG000|Overall Study|Withdrawal by Subject|0|||
94714185|NCT02584829|324413802|FG001|Overall Study|Withdrawal by Subject|1|||
94714186|NCT02584829|324413801|FG000|Overall Study|Progressive Disease|0|||
94714187|NCT02584829|324413802|FG001|Overall Study|Progressive Disease|3|||
94714188|NCT02724956|324413803|FG000|Overall Study|Physician Decision|1|||
94714189|NCT02724956|324413804|FG001|Overall Study|Physician Decision|0|||
94714190|NCT02724956|324413803|FG000|Overall Study|Lack of Efficacy|0|||
94714191|NCT02724956|324413804|FG001|Overall Study|Lack of Efficacy|1|||
94714192|NCT02724956|324413803|FG000|Overall Study|Withdrawal by Subject|0|||
94714193|NCT02724956|324413804|FG001|Overall Study|Withdrawal by Subject|1|||
94714194|NCT05262738|324413807|FG000|Overall Study|Withdrawal by Subject|1|||
94714195|NCT05262738|324413808|FG001|Overall Study|Withdrawal by Subject|0|||
94714196|NCT02622568|324413810|FG000|Overall Study|Lost to Follow-up|5|||
94714197|NCT02622568|324413811|FG001|Overall Study|Lost to Follow-up|5|||
94714198|NCT04512482|324413812|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
94714199|NCT04512482|324413813|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
94714200|NCT04723394|324413816|FG000|Overall Study|Adverse Event|0|||
94714201|NCT04723394|324413817|FG001|Overall Study|Adverse Event|3|||
94714202|NCT04723394|324413816|FG000|Overall Study|Death|8|||
94714203|NCT04723394|324413817|FG001|Overall Study|Death|8|||
94714204|NCT04723394|324413816|FG000|Overall Study|Lost to Follow-up|20|||
94714205|NCT04723394|324413817|FG001|Overall Study|Lost to Follow-up|17|||
94714206|NCT04723394|324413816|FG000|Overall Study|Physician Decision|1|||
94714207|NCT04723394|324413817|FG001|Overall Study|Physician Decision|0|||
94714208|NCT04723394|324413816|FG000|Overall Study|Withdrawal by Subject|20|||
94714209|NCT04723394|324413817|FG001|Overall Study|Withdrawal by Subject|34|||
94714210|NCT04723394|324413816|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
94714211|NCT04723394|324413817|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
94714212|NCT00371787|324413818|FG000|Overall Study|Withdrawal by Subject|3|||
94714213|NCT00371787|324413819|FG001|Overall Study|Withdrawal by Subject|1|||
94714214|NCT00077675|324413820|FG000|Overall Study|Adverse Event|1|||
94714215|NCT00077675|324413821|FG001|Overall Study|Adverse Event|2|||
94714216|NCT00077675|324413820|FG000|Overall Study|Lost to Follow-up|6|||
94714217|NCT00077675|324413821|FG001|Overall Study|Lost to Follow-up|3|||
94714218|NCT00077675|324413820|FG000|Overall Study|Withdrawal by Subject|1|||
94714219|NCT00077675|324413821|FG001|Overall Study|Withdrawal by Subject|0|||
94714220|NCT00077675|324413820|FG000|Overall Study|Other|0|||
94714221|NCT00077675|324413821|FG001|Overall Study|Other|1|||
94714222|NCT00077675|324413820|FG000|Overall Study|Never received study treatment|3|||
94714223|NCT00077675|324413821|FG001|Overall Study|Never received study treatment|3|||
94714224|NCT04425863|324413822|FG000|Overall Study|Death|0|||
94714225|NCT04425863|324413823|FG001|Overall Study|Death|0|||
94714226|NCT04425863|324413824|FG002|Overall Study|Death|1|||
94714227|NCT02932579|324413825|FG000|Overall Study|Withdrawal by Subject|4|||
94714228|NCT02932579|324413826|FG001|Overall Study|Withdrawal by Subject|1|||
94367286|NCT01286207|323131517|FG000|Overall Study|Adverse Event|27|||
94367287|NCT01286207|323131518|FG001|Overall Study|Adverse Event|41|||
94367288|NCT01286207|323131519|FG002|Overall Study|Adverse Event|8|||
94367289|NCT01286207|323131517|FG000|Overall Study|Lost to Follow-up|49|||
94714229|NCT00277355|324413830|FG000|Overall Study|Withdrawal by Subject|3|||
94714230|NCT00277355|324413831|FG001|Overall Study|Withdrawal by Subject|3|||
94714231|NCT00277355|324413830|FG000|Overall Study|Lost to Follow-up|2|||
94714232|NCT00277355|324413831|FG001|Overall Study|Lost to Follow-up|2|||
94714233|NCT00277355|324413830|FG000|Overall Study|Adverse Event|5|||
94367290|NCT01286207|323131518|FG001|Overall Study|Lost to Follow-up|43|||
94367291|NCT01286207|323131519|FG002|Overall Study|Lost to Follow-up|20|||
94367292|NCT01286207|323131517|FG000|Overall Study|Withdrawal by Subject|93|||
94367293|NCT01286207|323131518|FG001|Overall Study|Withdrawal by Subject|79|||
94367294|NCT01286207|323131519|FG002|Overall Study|Withdrawal by Subject|41|||
94367295|NCT01286207|323131517|FG000|Overall Study|Lack of Response|92|||
94367296|NCT01286207|323131518|FG001|Overall Study|Lack of Response|38|||
94714234|NCT00277355|324413831|FG001|Overall Study|Adverse Event|0|||
94714235|NCT00277355|324413830|FG000|Overall Study|Death|3|||
94714236|NCT00277355|324413831|FG001|Overall Study|Death|0|||
94714237|NCT00277355|324413830|FG000|Overall Study|Physician Decision|1|||
94714238|NCT00277355|324413831|FG001|Overall Study|Physician Decision|0|||
94714239|NCT02675244|324413836|FG000|Overall Study|Death|9|||
94714240|NCT02675244|324413837|FG001|Overall Study|Death|6|||
94714241|NCT02675244|324413836|FG000|Overall Study|Withdrawal by Subject|3|||
94714242|NCT02675244|324413837|FG001|Overall Study|Withdrawal by Subject|6|||
94714243|NCT02675244|324413836|FG000|Overall Study|Lost to Follow-up|1|||
94714244|NCT02675244|324413837|FG001|Overall Study|Lost to Follow-up|1|||
94714245|NCT02675244|324413836|FG000|Overall Study|Ongoing at 2 Years|190|||
94714246|NCT02675244|324413837|FG001|Overall Study|Ongoing at 2 Years|185|||
94714247|NCT00642850|324413838|FG000|Overall Study|Death|7|||
94714248|NCT00642850|324413838|FG000|Overall Study|Adverse Event|2|||
94714249|NCT00642850|324413838|FG000|Overall Study|Lack of Efficacy|1|||
94714250|NCT00642850|324413838|FG000|Overall Study|Protocol Violation|2|||
94714251|NCT00642850|324413838|FG000|Overall Study|Kidney transplantation|8|||
94714252|NCT00642850|324413838|FG000|Overall Study|Blood transfusion|6|||
94714253|NCT00642850|324413838|FG000|Overall Study|Other reasons|7|||
94714254|NCT01177670|324413839|FG000|Overall Study|Study Terminated|115|||
94714255|NCT01177670|324413839|FG000|Overall Study|Physician Decision|50|||
94714256|NCT01177670|324413839|FG000|Overall Study|Withdrawal by Subject|4|||
94714257|NCT00106080|324413843|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
94714258|NCT00106080|324413844|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
94714259|NCT03051165|324413845|FG000|Overall Study|Withdrawal by Subject|1|||
94714260|NCT03051165|324413845|FG000|Overall Study|Early termination of study|12|||
94714261|NCT00761605|324413846|FG000|Overall Study|Adverse Event|26|||
94714262|NCT00761605|324413846|FG000|Overall Study|Death|2|||
94714263|NCT00761605|324413846|FG000|Overall Study|Lack of Efficacy|26|||
94714264|NCT00761605|324413846|FG000|Overall Study|Lost to Follow-up|29|||
94714265|NCT00761605|324413846|FG000|Overall Study|Withdrawal by Subject|37|||
94714266|NCT00761605|324413846|FG000|Overall Study|Other|21|||
94714267|NCT00350792|324413847|FG000|Overall Study|Adverse Event|11|||
94714268|NCT00350792|324413847|FG000|Overall Study|Death from Study Disease|1|||
94714269|NCT00350792|324413847|FG000|Overall Study|Death from Study Drug Toxicity|1|||
94714270|NCT00350792|324413847|FG000|Overall Study|Death Not Study Drug Related|2|||
94714271|NCT00350792|324413847|FG000|Overall Study|Protocol Violation|1|||
94714272|NCT00350792|324413847|FG000|Overall Study|Withdrawal by Subject|4|||
94714273|NCT00350792|324413847|FG000|Overall Study|Physician Decision|2|||
94367297|NCT01286207|323131519|FG002|Overall Study|Lack of Response|8|||
94714274|NCT00350792|324413847|FG000|Overall Study|Lack of Efficacy|11|||
94714275|NCT00243503|324413849|FG000|Overall Study|Adverse Event|11|||
94714276|NCT00243503|324413849|FG000|Overall Study|Withdrawal by Subject|1|||
94714277|NCT00243503|324413849|FG000|Overall Study|Lack of Efficacy|44|||
94714278|NCT00243503|324413849|FG000|Overall Study|Death|1|||
94714279|NCT00243503|324413849|FG000|Overall Study|Other|1|||
94714280|NCT00914589|324413850|FG000|Overall Study|Adverse Event|1|||
94714281|NCT00914589|324413851|FG001|Overall Study|Adverse Event|0|||
94714282|NCT00914589|324413852|FG002|Overall Study|Adverse Event|1|||
94714283|NCT00914589|324413850|FG000|Overall Study|Protocol Violation|8|||
94367298|NCT01286207|323131517|FG000|Overall Study|Other|37|||
94714284|NCT00914589|324413851|FG001|Overall Study|Protocol Violation|6|||
94714285|NCT00914589|324413852|FG002|Overall Study|Protocol Violation|3|||
94714286|NCT00914589|324413850|FG000|Overall Study|unclassified|16|||
94714287|NCT00914589|324413851|FG001|Overall Study|unclassified|9|||
94714288|NCT00914589|324413852|FG002|Overall Study|unclassified|7|||
94714289|NCT00914589|324413850|FG000|Overall Study|Death|0|||
94714290|NCT00914589|324413851|FG001|Overall Study|Death|1|||
94714291|NCT00914589|324413852|FG002|Overall Study|Death|1|||
94714292|NCT01102231|324413853|FG000|Overall Study|Protocol Violation|3|||
94714293|NCT01102231|324413853|FG000|Overall Study|Lack of Efficacy|2|||
94714294|NCT01102231|324413853|FG000|Overall Study|Death|2|||
94367299|NCT01286207|323131518|FG001|Overall Study|Other|47|||
94367300|NCT01286207|323131519|FG002|Overall Study|Other|13|||
94367301|NCT00981409|323131522|FG000|Overall Study|Adverse Event|4|||
94367302|NCT00981409|323131523|FG001|Overall Study|Adverse Event|0|||
94367303|NCT00981409|323131522|FG000|Overall Study|Protocol Violation|0|||
94367304|NCT00981409|323131523|FG001|Overall Study|Protocol Violation|1|||
94367305|NCT00981409|323131522|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
94367306|NCT00981409|323131523|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
94367307|NCT02923115|323131530|FG000|Overall Study|Lost to Follow-up|0|||
94367308|NCT02923115|323131531|FG001|Overall Study|Lost to Follow-up|0|||
94714295|NCT01102231|324413853|FG000|Overall Study|Adverse Event|3|||
94714296|NCT01102231|324413853|FG000|Overall Study|Withdrawal by Subject|1|||
94714297|NCT01102231|324413853|FG000|Overall Study|Did not received the treatment|4|||
94714298|NCT02538107|324413854|FG000|Overall Study|Did not receive any Mircera dose|11|||
94714299|NCT02538107|324413854|FG000|Overall Study|Missing|5|||
94714300|NCT02538107|324413854|FG000|Overall Study|Necessity of dialysis|20|||
94714301|NCT02538107|324413854|FG000|Overall Study|Administration of other ESA|11|||
94714302|NCT02538107|324413854|FG000|Overall Study|No further treatment necessary|18|||
94714303|NCT02538107|324413854|FG000|Overall Study|Withdrawal by Subject|17|||
94714304|NCT02538107|324413854|FG000|Overall Study|Death|4|||
94714305|NCT02538107|324413854|FG000|Overall Study|Administrative reason|5|||
94714306|NCT02538107|324413854|FG000|Overall Study|Adverse Event|4|||
94714307|NCT02538107|324413854|FG000|Overall Study|Surgery|1|||
94714308|NCT02538107|324413854|FG000|Overall Study|Other|7|||
94714309|NCT02538107|324413854|FG000|Overall Study|Not recorded|7|||
94714310|NCT02554786|324413860|FG000|Overall Study|Subject/guardian decision|29|||
94714311|NCT02554786|324413861|FG001|Overall Study|Subject/guardian decision|17|||
94714312|NCT02554786|324413862|FG002|Overall Study|Subject/guardian decision|18|||
94714313|NCT02554786|324413863|FG003|Overall Study|Subject/guardian decision|30|||
94714314|NCT02554786|324413864|FG004|Overall Study|Subject/guardian decision|20|||
94714315|NCT02554786|324413860|FG000|Overall Study|Lost to Follow-up|4|||
94714316|NCT02554786|324413861|FG001|Overall Study|Lost to Follow-up|3|||
94714317|NCT02554786|324413862|FG002|Overall Study|Lost to Follow-up|4|||
94714318|NCT02554786|324413863|FG003|Overall Study|Lost to Follow-up|2|||
94714319|NCT02554786|324413864|FG004|Overall Study|Lost to Follow-up|2|||
94714320|NCT02554786|324413860|FG000|Overall Study|Protocol deviation|1|||
94714321|NCT02554786|324413861|FG001|Overall Study|Protocol deviation|3|||
94714322|NCT02554786|324413862|FG002|Overall Study|Protocol deviation|3|||
94714323|NCT02554786|324413863|FG003|Overall Study|Protocol deviation|4|||
94714324|NCT02554786|324413864|FG004|Overall Study|Protocol deviation|2|||
94714325|NCT02554786|324413860|FG000|Overall Study|Technical problems|1|||
94714326|NCT02554786|324413861|FG001|Overall Study|Technical problems|1|||
94714327|NCT02554786|324413862|FG002|Overall Study|Technical problems|0|||
94714328|NCT02554786|324413863|FG003|Overall Study|Technical problems|2|||
94714329|NCT02554786|324413864|FG004|Overall Study|Technical problems|1|||
94714330|NCT02554786|324413860|FG000|Overall Study|Adverse Event|0|||
94714331|NCT02554786|324413861|FG001|Overall Study|Adverse Event|0|||
94367309|NCT02923115|323131532|FG002|Overall Study|Lost to Follow-up|0|||
94367310|NCT02923115|323131533|FG003|Overall Study|Lost to Follow-up|1|||
94367311|NCT02923115|323131534|FG004|Overall Study|Lost to Follow-up|0|||
94367312|NCT02923115|323131535|FG005|Overall Study|Lost to Follow-up|0|||
94367313|NCT02923115|323131530|FG000|Overall Study|Withdrawal by Subject|0|||
94367314|NCT02923115|323131531|FG001|Overall Study|Withdrawal by Subject|1|||
94367315|NCT02923115|323131532|FG002|Overall Study|Withdrawal by Subject|0|||
94367316|NCT02923115|323131533|FG003|Overall Study|Withdrawal by Subject|0|||
94714332|NCT02554786|324413862|FG002|Overall Study|Adverse Event|0|||
94714333|NCT02554786|324413863|FG003|Overall Study|Adverse Event|0|||
94714334|NCT02554786|324413864|FG004|Overall Study|Adverse Event|2|||
94714335|NCT02554786|324413860|FG000|Overall Study|Death|0|||
94714336|NCT02554786|324413861|FG001|Overall Study|Death|0|||
94714337|NCT02554786|324413862|FG002|Overall Study|Death|0|||
94714338|NCT02554786|324413863|FG003|Overall Study|Death|1|||
94714339|NCT02554786|324413864|FG004|Overall Study|Death|0|||
94714340|NCT02554786|324413860|FG000|Overall Study|Non-compliance with study treatment|0|||
94714341|NCT02554786|324413861|FG001|Overall Study|Non-compliance with study treatment|1|||
94714342|NCT02554786|324413862|FG002|Overall Study|Non-compliance with study treatment|1|||
94714343|NCT02554786|324413863|FG003|Overall Study|Non-compliance with study treatment|0|||
94714344|NCT02554786|324413864|FG004|Overall Study|Non-compliance with study treatment|1|||
94714345|NCT02554786|324413860|FG000|Overall Study|Physician Decision|0|||
94714346|NCT02554786|324413861|FG001|Overall Study|Physician Decision|1|||
94714347|NCT02554786|324413862|FG002|Overall Study|Physician Decision|4|||
94714348|NCT02554786|324413863|FG003|Overall Study|Physician Decision|1|||
94714349|NCT02554786|324413864|FG004|Overall Study|Physician Decision|1|||
94714350|NCT02554786|324413860|FG000|Overall Study|Pregnancy|0|||
94714351|NCT02554786|324413861|FG001|Overall Study|Pregnancy|0|||
94714352|NCT02554786|324413862|FG002|Overall Study|Pregnancy|0|||
94714353|NCT02554786|324413863|FG003|Overall Study|Pregnancy|1|||
94714354|NCT02554786|324413864|FG004|Overall Study|Pregnancy|1|||
94714355|NCT03684044|324413865|FG000|Overall Study|Adverse Event|3|||
94714356|NCT03684044|324413866|FG001|Overall Study|Adverse Event|0|||
94714357|NCT03684044|324413865|FG000|Overall Study|Death|4|||
94714358|NCT03684044|324413866|FG001|Overall Study|Death|7|||
94714359|NCT03684044|324413865|FG000|Overall Study|Lost to Follow-up|3|||
94714360|NCT03684044|324413866|FG001|Overall Study|Lost to Follow-up|2|||
94714361|NCT03684044|324413865|FG000|Overall Study|Patient Not Available|0|||
94714362|NCT03684044|324413866|FG001|Overall Study|Patient Not Available|2|||
94714363|NCT03684044|324413865|FG000|Overall Study|Physician Decision|1|||
94714364|NCT03684044|324413866|FG001|Overall Study|Physician Decision|0|||
94714365|NCT03684044|324413865|FG000|Overall Study|Withdrawal by Subject|11|||
94714366|NCT03684044|324413866|FG001|Overall Study|Withdrawal by Subject|9|||
94714367|NCT02708108|324413867|FG000|Overall Study|Death|1|||
94714368|NCT02708108|324413868|FG001|Overall Study|Death|2|||
94714369|NCT02708108|324413867|FG000|Overall Study|Regimen change|1|||
94714370|NCT02708108|324413868|FG001|Overall Study|Regimen change|0|||
94714371|NCT02708108|324413867|FG000|Overall Study|No MRD and no imaging available|0|||
94714372|NCT02708108|324413868|FG001|Overall Study|No MRD and no imaging available|1|||
94714373|NCT01127373|324413871|FG000|Overall Study|Not Treated|3|||
94714374|NCT01127373|324413871|FG000|Overall Study|Lost to Follow-up|7|||
94714375|NCT01127373|324413871|FG000|Overall Study|Withdrawal by Subject|1|||
94714376|NCT01127373|324413871|FG000|Overall Study|Disease progression|1|||
94714377|NCT01736215|324413883|FG000|Overall Study|Early termination of erythropoietin use|1|||
94714378|NCT01736215|324413883|FG000|Overall Study|Adverse Event|4|||
94714379|NCT01736215|324413883|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
94714380|NCT01736215|324413883|FG000|Overall Study|Insufficient data to perform analysis|8|||
94714381|NCT03447249|324413894|FG000|Overall Study|Adverse Event|1|||
94714382|NCT03447249|324413895|FG001|Overall Study|Adverse Event|0|||
94714383|NCT03447249|324413894|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
94714384|NCT03447249|324413895|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
94714385|NCT03447249|324413894|FG000|Overall Study|Other|3|||
94714386|NCT03447249|324413895|FG001|Overall Study|Other|0|||
94714387|NCT00988858|324413896|FG000|Overall Study|Adverse Event|7|||
94270665|NCT01431274|322783790|FG003|Overall Study|Other reason not stated above|2|||
94270666|NCT01431274|322783791|FG004|Overall Study|Other reason not stated above|4|||
94270667|NCT01543828|322783792|FG000|Treatment 2|Lost to Follow-up|1|||
94367317|NCT02923115|323131534|FG004|Overall Study|Withdrawal by Subject|0|||
94714388|NCT00988858|324413896|FG000|Overall Study|Death|1|||
94270668|NCT01543828|322783793|FG001|Treatment 2|Lost to Follow-up|0|||
94270669|NCT01069172|322783794|FG000|Overall Study|Withdrawal by Subject|1|||
94714389|NCT00988858|324413896|FG000|Overall Study|Physician Decision|1|||
94714390|NCT00988858|324413896|FG000|Overall Study|Sponsor Decision|1|||
94714391|NCT00440011|324413899|FG000|Overall Study|Adverse Event|2|||
94270670|NCT01069172|322783795|FG001|Overall Study|Withdrawal by Subject|0|||
94270671|NCT00711425|322783798|FG000|Overall Study|Protocol Violation|1|||
94270672|NCT00711425|322783798|FG000|Overall Study|Death|2|||
94270673|NCT00711425|322783798|FG000|Overall Study|Lost to Follow-up|1|||
94714392|NCT00440011|324413900|FG001|Overall Study|Adverse Event|0|||
94714393|NCT00440011|324413899|FG000|Overall Study|Lost to Follow-up|0|||
94714394|NCT00440011|324413900|FG001|Overall Study|Lost to Follow-up|2|||
94714395|NCT00440011|324413899|FG000|Overall Study|Protocol Violation|1|||
94714396|NCT00440011|324413900|FG001|Overall Study|Protocol Violation|1|||
94714397|NCT00440011|324413899|FG000|Overall Study|Withdrawal by Subject|1|||
94270674|NCT01786603|322783799|FG000|Overall Study|Death|5|||
94270675|NCT01786603|322783800|FG001|Overall Study|Death|1|||
94270676|NCT01786603|322783799|FG000|Overall Study|Adverse Event|6|||
94714398|NCT00440011|324413900|FG001|Overall Study|Withdrawal by Subject|0|||
94714399|NCT00331136|324413901|FG000|Overall Study|Adverse Event|3|||
94714400|NCT00331136|324413902|FG001|Overall Study|Adverse Event|5|||
94714401|NCT00331136|324413903|FG002|Overall Study|Adverse Event|0|||
94714402|NCT00331136|324413904|FG003|Overall Study|Adverse Event|1|||
94714403|NCT00331136|324413901|FG000|Overall Study|Withdrawal by Subject|0|||
94714404|NCT00331136|324413902|FG001|Overall Study|Withdrawal by Subject|1|||
94714405|NCT00331136|324413903|FG002|Overall Study|Withdrawal by Subject|0|||
94270677|NCT01786603|322783800|FG001|Overall Study|Adverse Event|2|||
94270678|NCT01786603|322783799|FG000|Overall Study|Physician decision to withdraw|6|||
94270679|NCT01786603|322783800|FG001|Overall Study|Physician decision to withdraw|7|||
94270680|NCT01786603|322783799|FG000|Overall Study|Lost to Follow-up|1|||
94270681|NCT01786603|322783800|FG001|Overall Study|Lost to Follow-up|2|||
94714406|NCT00331136|324413904|FG003|Overall Study|Withdrawal by Subject|0|||
94714407|NCT00331136|324413901|FG000|Overall Study|Lost to Follow-up|0|||
94714408|NCT00331136|324413902|FG001|Overall Study|Lost to Follow-up|1|||
94714409|NCT00331136|324413903|FG002|Overall Study|Lost to Follow-up|0|||
94714410|NCT00331136|324413904|FG003|Overall Study|Lost to Follow-up|0|||
94714411|NCT00331136|324413901|FG000|Overall Study|Protocol Violation|1|||
94714412|NCT00331136|324413902|FG001|Overall Study|Protocol Violation|0|||
94714413|NCT00331136|324413903|FG002|Overall Study|Protocol Violation|0|||
94714414|NCT00331136|324413904|FG003|Overall Study|Protocol Violation|0|||
94714415|NCT00331136|324413901|FG000|Overall Study|Not treated|1|||
94714416|NCT00331136|324413902|FG001|Overall Study|Not treated|0|||
94714417|NCT00331136|324413903|FG002|Overall Study|Not treated|0|||
94714418|NCT00331136|324413904|FG003|Overall Study|Not treated|0|||
94270682|NCT03700320|322783801|FG000|Overall Study|Adverse Event|5|||
94270683|NCT03700320|322783802|FG001|Overall Study|Adverse Event|31|||
94270684|NCT03700320|322783801|FG000|Overall Study|Lack of Efficacy|2|||
94270685|NCT03700320|322783802|FG001|Overall Study|Lack of Efficacy|5|||
94270686|NCT03700320|322783801|FG000|Overall Study|Withdrawal by Subject|29|||
94270687|NCT03700320|322783802|FG001|Overall Study|Withdrawal by Subject|75|||
94714419|NCT01499199|324413905|FG000|Overall Study|Adverse Event|1|||
94714420|NCT01499199|324413905|FG000|Overall Study|Lack of Efficacy|1|||
94714421|NCT02372253|324413906|FG000|Overall Study|Non Compliance|2|||
94714422|NCT02372253|324413907|FG001|Overall Study|Non Compliance|0|||
94714423|NCT01538719|324413908|FG000|Overall Study|Lost to Follow-up|2|||
94714424|NCT01538719|324413909|FG001|Overall Study|Lost to Follow-up|0|||
94714425|NCT01205048|324413910|FG000|Overall Study|Withdrawal by Subject|14|||
94714426|NCT01205048|324413910|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
94714427|NCT01205048|324413910|FG000|Overall Study|Lost to Follow-up|4|||
94714428|NCT01205048|324413910|FG000|Overall Study|Other|2|||
94714429|NCT02730871|324413911|FG000|Overall Study|Adverse Event|6|||
94714430|NCT02730871|324413912|FG001|Overall Study|Adverse Event|0|||
94714431|NCT04019444|324413913|FG000|Overall Study|Withdrawal by Subject|0|||
94714432|NCT04019444|324413914|FG001|Overall Study|Withdrawal by Subject|1|||
94714433|NCT04019444|324413915|FG002|Overall Study|Withdrawal by Subject|0|||
94714434|NCT04019444|324413916|FG003|Overall Study|Withdrawal by Subject|1|||
94714435|NCT04019444|324413913|FG000|Overall Study|Solicited Event|0|||
94714436|NCT04019444|324413914|FG001|Overall Study|Solicited Event|0|||
94714437|NCT04019444|324413915|FG002|Overall Study|Solicited Event|2|||
94714438|NCT04019444|324413916|FG003|Overall Study|Solicited Event|0|||
94714439|NCT01609218|324413917|FG000|Period 1|Adverse Event|3|||
94714440|NCT01609218|324413918|FG001|Period 1|Adverse Event|5|||
94714441|NCT01609218|324413917|FG000|Period 1|Sponsor Decision|0|||
94714442|NCT01609218|324413918|FG001|Period 1|Sponsor Decision|1|||
94714443|NCT01609218|324413917|FG000|Period 2|Adverse Event|1|||
94714444|NCT01609218|324413918|FG001|Period 2|Adverse Event|0|||
94714445|NCT01170026|324415118|FG000|Overall Study|Lost to Follow-up|4|||
94714446|NCT01170026|324415119|FG001|Overall Study|Lost to Follow-up|2|||
94714447|NCT03783026|324415120|FG000|Treatment Phase|Adverse Event|15|||
94714448|NCT03783026|324415120|FG000|Treatment Phase|Lack of Efficacy|11|||
94714449|NCT03783026|324415120|FG000|Treatment Phase|Withdrawal by Subject|6|||
94714450|NCT03783026|324415120|FG000|Treatment Phase|Lost to Follow-up|2|||
94714451|NCT03783026|324415120|FG000|Treatment Phase|Protocol Deviation|8|||
94714452|NCT03783026|324415120|FG000|Treatment Phase|Did Not Receive Treatment|1|||
94714453|NCT03783026|324415120|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
94714454|NCT03889925|324415125|FG000|Overall Study|Lost to Follow-up|11|||
94714455|NCT03889925|324415126|FG001|Overall Study|Lost to Follow-up|10|||
94714456|NCT04188379|324415130|FG000|Overall Study|Withdrawal by Subject|10|||
94714457|NCT04188379|324415131|FG001|Overall Study|Withdrawal by Subject|3|||
94714458|NCT04188379|324415130|FG000|Overall Study|Physician Decision|0|||
94714459|NCT04188379|324415131|FG001|Overall Study|Physician Decision|1|||
94714460|NCT04188379|324415130|FG000|Overall Study|Adverse Event|3|||
94714461|NCT04188379|324415131|FG001|Overall Study|Adverse Event|1|||
94714462|NCT04188379|324415130|FG000|Overall Study|Pregnancy|1|||
94714463|NCT04188379|324415131|FG001|Overall Study|Pregnancy|0|||
94714464|NCT04188379|324415130|FG000|Overall Study|Lack of Efficacy|8|||
94714465|NCT04188379|324415131|FG001|Overall Study|Lack of Efficacy|5|||
94714466|NCT04188379|324415130|FG000|Overall Study|Other|0|||
94714467|NCT04188379|324415131|FG001|Overall Study|Other|3|||
94714468|NCT01823536|324415133|FG000|Overall Study|Lost to Follow-up|1|||
94714469|NCT01823536|324415134|FG001|Overall Study|Lost to Follow-up|0|||
94714470|NCT01823536|324415135|FG002|Overall Study|Lost to Follow-up|0|||
94714471|NCT01823536|324415136|FG003|Overall Study|Lost to Follow-up|1|||
94714472|NCT01823536|324415137|FG004|Overall Study|Lost to Follow-up|1|||
94714473|NCT01823536|324415138|FG005|Overall Study|Lost to Follow-up|0|||
94714474|NCT01823536|324415133|FG000|Overall Study|Protocol Violation|0|||
94714475|NCT01823536|324415134|FG001|Overall Study|Protocol Violation|1|||
94714476|NCT01823536|324415135|FG002|Overall Study|Protocol Violation|0|||
94714477|NCT01823536|324415136|FG003|Overall Study|Protocol Violation|0|||
94714478|NCT01823536|324415137|FG004|Overall Study|Protocol Violation|0|||
94714479|NCT01823536|324415138|FG005|Overall Study|Protocol Violation|0|||
94714480|NCT01823536|324415133|FG000|Overall Study|Withdrawal by Subject|1|||
94714481|NCT01823536|324415134|FG001|Overall Study|Withdrawal by Subject|1|||
94714482|NCT01823536|324415135|FG002|Overall Study|Withdrawal by Subject|0|||
94714483|NCT01823536|324415136|FG003|Overall Study|Withdrawal by Subject|0|||
94714484|NCT01823536|324415137|FG004|Overall Study|Withdrawal by Subject|0|||
94714485|NCT01823536|324415138|FG005|Overall Study|Withdrawal by Subject|0|||
94714486|NCT01823536|324415133|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
94714487|NCT01823536|324415134|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
94714488|NCT01823536|324415135|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
94714489|NCT01823536|324415136|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
94714490|NCT01823536|324415137|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
94714491|NCT01823536|324415138|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
94714492|NCT01823536|324415133|FG000|Overall Study|Met exclusion criterion No 6|0|||
94714493|NCT01823536|324415134|FG001|Overall Study|Met exclusion criterion No 6|0|||
94714494|NCT01823536|324415135|FG002|Overall Study|Met exclusion criterion No 6|0|||
94714495|NCT01823536|324415136|FG003|Overall Study|Met exclusion criterion No 6|1|||
94714496|NCT01823536|324415137|FG004|Overall Study|Met exclusion criterion No 6|0|||
94714497|NCT01823536|324415138|FG005|Overall Study|Met exclusion criterion No 6|0|||
94714498|NCT01823536|324415133|FG000|Overall Study|Subject moved out of the state|0|||
94714499|NCT01823536|324415134|FG001|Overall Study|Subject moved out of the state|0|||
94714500|NCT01823536|324415135|FG002|Overall Study|Subject moved out of the state|0|||
94714501|NCT01823536|324415136|FG003|Overall Study|Subject moved out of the state|0|||
94714502|NCT01823536|324415137|FG004|Overall Study|Subject moved out of the state|1|||
94714503|NCT01823536|324415138|FG005|Overall Study|Subject moved out of the state|0|||
94714504|NCT01622868|324415142|FG000|Overall Study|Protocol Violation|7|||
94714505|NCT01622868|324415143|FG001|Overall Study|Protocol Violation|0|||
94714506|NCT03990649|324415144|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
94714507|NCT03990649|324415145|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
94714508|NCT03990649|324415146|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
94714509|NCT03990649|324415144|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
94714510|NCT03990649|324415145|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
94270688|NCT03700320|322783801|FG000|Overall Study|Lost to Follow-up|16|||
94270689|NCT03700320|322783802|FG001|Overall Study|Lost to Follow-up|23|||
94270690|NCT03700320|322783801|FG000|Overall Study|Pregnancy|2|||
94270691|NCT03700320|322783802|FG001|Overall Study|Pregnancy|4|||
94714511|NCT03990649|324415146|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
94714512|NCT03990649|324415144|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
94270692|NCT03700320|322783801|FG000|Overall Study|Protocol Deviation|7|||
94270693|NCT03700320|322783802|FG001|Overall Study|Protocol Deviation|31|||
94714513|NCT03990649|324415145|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
94714514|NCT03990649|324415146|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
94270694|NCT03700320|322783801|FG000|Overall Study|Non-compliance with Study Drug|1|||
94270695|NCT03700320|322783802|FG001|Overall Study|Non-compliance with Study Drug|3|||
94270696|NCT03700320|322783801|FG000|Overall Study|Reason not Specified|0|||
94270697|NCT03700320|322783802|FG001|Overall Study|Reason not Specified|1|||
94270698|NCT00916149|322783808|FG000|Overall Study|Lost to Follow-up|3|||
94270699|NCT00916149|322783809|FG001|Overall Study|Lost to Follow-up|2|||
94270700|NCT00916149|322783810|FG002|Overall Study|Lost to Follow-up|0|||
94270701|NCT00916149|322783808|FG000|Overall Study|Unable to place scalp EEG leads|1|||
94270702|NCT00916149|322783809|FG001|Overall Study|Unable to place scalp EEG leads|0|||
94714515|NCT03990649|324415144|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
94270703|NCT00916149|322783810|FG002|Overall Study|Unable to place scalp EEG leads|0|||
94270704|NCT04305275|322783815|FG000|Overall Study|Adverse Event|4|||
94270705|NCT04305275|322783816|FG001|Overall Study|Adverse Event|0|||
94270706|NCT04305275|322783815|FG000|Overall Study|Lost to Follow-up|1|||
94270707|NCT04305275|322783816|FG001|Overall Study|Lost to Follow-up|1|||
94714516|NCT03990649|324415145|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
94714517|NCT03990649|324415146|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
94714518|NCT03990649|324415144|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
94714519|NCT03990649|324415145|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
94714520|NCT03990649|324415146|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
94714521|NCT03990649|324415144|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
94714522|NCT03990649|324415145|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
94714523|NCT03990649|324415146|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
94714524|NCT03990649|324415144|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
94714525|NCT03990649|324415145|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
94714526|NCT03990649|324415146|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
94714527|NCT00610649|324415147|FG000|Overall Study|Adverse Event|1|||
94714528|NCT00610649|324415148|FG001|Overall Study|Adverse Event|0|||
94714529|NCT00610649|324415149|FG002|Overall Study|Adverse Event|0|||
94714530|NCT00610649|324415150|FG003|Overall Study|Adverse Event|0|||
94270708|NCT04305275|322783815|FG000|Overall Study|Withdrawal by Participant|8|||
94270709|NCT04305275|322783816|FG001|Overall Study|Withdrawal by Participant|1|||
94270710|NCT01553188|322783820|FG000|Overall Study|Patient choice|1|||
94270711|NCT01553188|322783821|FG001|Overall Study|Patient choice|0|||
94270712|NCT01553188|322783822|FG002|Overall Study|Patient choice|0|||
94270713|NCT01553188|322783823|FG003|Overall Study|Patient choice|0|||
94270714|NCT01553188|322783820|FG000|Overall Study|Intercurrent illness and adverse event|0|||
94270715|NCT01553188|322783821|FG001|Overall Study|Intercurrent illness and adverse event|1|||
94270716|NCT01553188|322783822|FG002|Overall Study|Intercurrent illness and adverse event|2|||
94270717|NCT01553188|322783823|FG003|Overall Study|Intercurrent illness and adverse event|0|||
94270718|NCT01066585|322783824|FG000|Overall Study|Protocol Violation|1|||
94270719|NCT01066585|322783825|FG001|Overall Study|Protocol Violation|0|||
94270720|NCT01066585|322783824|FG000|Overall Study|Withdrawal by Subject|0|||
94270721|NCT01066585|322783825|FG001|Overall Study|Withdrawal by Subject|3|||
94270722|NCT01358760|322783828|FG000|Overall Study|Adverse Event|3|||
94270723|NCT01358760|322783829|FG001|Overall Study|Adverse Event|4|||
94270724|NCT01358760|322783830|FG002|Overall Study|Adverse Event|3|||
94270725|NCT01358760|322783828|FG000|Overall Study|Lost to Follow-up|1|||
94270726|NCT01358760|322783829|FG001|Overall Study|Lost to Follow-up|1|||
94270727|NCT01358760|322783830|FG002|Overall Study|Lost to Follow-up|3|||
94270728|NCT01358760|322783828|FG000|Overall Study|Withdrawal by Subject|5|||
94270729|NCT01358760|322783829|FG001|Overall Study|Withdrawal by Subject|3|||
94270730|NCT01358760|322783830|FG002|Overall Study|Withdrawal by Subject|2|||
94714531|NCT00610649|324415151|FG004|Overall Study|Adverse Event|0|||
94714532|NCT00610649|324415152|FG005|Overall Study|Adverse Event|0|||
94714533|NCT00610649|324415153|FG006|Overall Study|Adverse Event|0|||
94714534|NCT00610649|324415154|FG007|Overall Study|Adverse Event|0|||
94714535|NCT00610649|324415155|FG008|Overall Study|Adverse Event|0|||
94714536|NCT00610649|324415156|FG009|Overall Study|Adverse Event|0|||
94714537|NCT00610649|324415157|FG010|Overall Study|Adverse Event|1|||
94714538|NCT00610649|324415147|FG000|Overall Study|Family Emergency|0|||
94714539|NCT00610649|324415148|FG001|Overall Study|Family Emergency|1|||
94270731|NCT01358760|322783828|FG000|Overall Study|Physician Decision|1|||
94714540|NCT00610649|324415149|FG002|Overall Study|Family Emergency|0|||
94714541|NCT00610649|324415150|FG003|Overall Study|Family Emergency|0|||
94714542|NCT00610649|324415151|FG004|Overall Study|Family Emergency|0|||
94714543|NCT00610649|324415152|FG005|Overall Study|Family Emergency|0|||
94270732|NCT01358760|322783829|FG001|Overall Study|Physician Decision|0|||
94714544|NCT00610649|324415153|FG006|Overall Study|Family Emergency|0|||
94714545|NCT00610649|324415154|FG007|Overall Study|Family Emergency|0|||
94714546|NCT00610649|324415155|FG008|Overall Study|Family Emergency|0|||
94270733|NCT01358760|322783830|FG002|Overall Study|Physician Decision|1|||
94270734|NCT01358760|322783828|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
94270735|NCT01358760|322783829|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
94270736|NCT01358760|322783830|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
94270737|NCT00450723|322783831|FG000|Overall Study|Physician Decision|5|||
94270738|NCT05003622|322783834|FG000|Overall Study|Progressive disease|2|||
94270739|NCT05003622|322783834|FG000|Overall Study|Withdrawal by Subject|1|||
94270740|NCT03184077|322783837|FG000|Overall Study|Lost to Follow-up|21|||
94714547|NCT00610649|324415156|FG009|Overall Study|Family Emergency|0|||
94714548|NCT00610649|324415157|FG010|Overall Study|Family Emergency|0|||
94714549|NCT00610649|324415147|FG000|Overall Study|Withdrawal by Subject|0|||
94714550|NCT00610649|324415148|FG001|Overall Study|Withdrawal by Subject|0|||
94714551|NCT00610649|324415149|FG002|Overall Study|Withdrawal by Subject|0|||
94714552|NCT00610649|324415150|FG003|Overall Study|Withdrawal by Subject|0|||
94714553|NCT00610649|324415151|FG004|Overall Study|Withdrawal by Subject|0|||
94714554|NCT00610649|324415152|FG005|Overall Study|Withdrawal by Subject|0|||
94714555|NCT00610649|324415153|FG006|Overall Study|Withdrawal by Subject|0|||
94714556|NCT00610649|324415154|FG007|Overall Study|Withdrawal by Subject|0|||
94714557|NCT00610649|324415155|FG008|Overall Study|Withdrawal by Subject|0|||
94714558|NCT00610649|324415156|FG009|Overall Study|Withdrawal by Subject|1|||
94714559|NCT00610649|324415157|FG010|Overall Study|Withdrawal by Subject|0|||
94714560|NCT02748317|324415158|FG000|Overall Study|Withdrawal by Subject|14|||
94714561|NCT02748317|324415158|FG000|Overall Study|Lost to Follow-up|8|||
94714562|NCT02748317|324415158|FG000|Overall Study|Death|1|||
94714563|NCT00505934|324415159|FG000|Overall Study|Adverse Event|1|||
94714564|NCT00505934|324415159|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
94714565|NCT00505934|324415159|FG000|Overall Study|Other: IV dose needed to be changed|1|||
94714566|NCT01303445|324415166|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
94714567|NCT01303445|324415167|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
94714568|NCT01303445|324415166|FG000|Second Intervention (7 Days)|Adverse Event|0|||
94714569|NCT01303445|324415167|FG001|Second Intervention (7 Days)|Adverse Event|2|||
94714570|NCT01303445|324415166|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
94714571|NCT01303445|324415167|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
94714572|NCT01303445|324415166|FG000|Washout (14 Days)|Protocol Violation|1|||
94714573|NCT01303445|324415167|FG001|Washout (14 Days)|Protocol Violation|0|||
94714574|NCT01303445|324415166|FG000|Washout (14 Days)|Lost to Follow-up|0|||
94714575|NCT01303445|324415167|FG001|Washout (14 Days)|Lost to Follow-up|2|||
94714576|NCT01303445|324415166|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
94714577|NCT01303445|324415167|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
94714578|NCT01303445|324415166|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
94714579|NCT01303445|324415167|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
94714580|NCT01443845|324415168|FG000|Overall Study|Protocol Violation|43|||
94714581|NCT01443845|324415169|FG001|Overall Study|Protocol Violation|45|||
94714582|NCT01443845|324415168|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
94714583|NCT01443845|324415169|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
94714584|NCT01443845|324415168|FG000|Overall Study|Deterioration in pulmonary function|1|||
94714585|NCT01443845|324415169|FG001|Overall Study|Deterioration in pulmonary function|4|||
94714586|NCT01443845|324415168|FG000|Overall Study|Lack of Efficacy|10|||
94714587|NCT01443845|324415169|FG001|Overall Study|Lack of Efficacy|5|||
94714588|NCT01443845|324415168|FG000|Overall Study|Adverse Event|64|||
94714589|NCT01443845|324415169|FG001|Overall Study|Adverse Event|138|||
94714590|NCT01443845|324415168|FG000|Overall Study|Withdrawal by Subject|63|||
94714591|NCT01443845|324415169|FG001|Overall Study|Withdrawal by Subject|67|||
94714592|NCT01443845|324415168|FG000|Overall Study|Military Conflict - Site Terminated|20|||
94714593|NCT01443845|324415169|FG001|Overall Study|Military Conflict - Site Terminated|21|||
94714594|NCT01443845|324415168|FG000|Overall Study|Lost to Follow-up|9|||
94714595|NCT01443845|324415169|FG001|Overall Study|Lost to Follow-up|13|||
94714596|NCT00332241|324415176|FG000|Overall Study|Lack of Efficacy|6|||
94714597|NCT00332241|324415177|FG001|Overall Study|Lack of Efficacy|1|||
94714598|NCT00332241|324415176|FG000|Overall Study|Adverse Event|3|||
94714599|NCT00332241|324415177|FG001|Overall Study|Adverse Event|5|||
94714600|NCT00332241|324415176|FG000|Overall Study|Withdrawal by Subject|2|||
94714601|NCT00332241|324415177|FG001|Overall Study|Withdrawal by Subject|1|||
94714602|NCT00332241|324415176|FG000|Overall Study|Lost to Follow-up|4|||
94714603|NCT00332241|324415177|FG001|Overall Study|Lost to Follow-up|1|||
94714604|NCT02724592|324415179|FG000|Overall Study|Lost to Follow-up|4|||
94714605|NCT02724592|324415180|FG001|Overall Study|Lost to Follow-up|1|||
94714606|NCT00402246|324415181|FG000|Overall Study|Death|62|||
94714607|NCT00402246|324415182|FG001|Overall Study|Death|58|||
94714608|NCT00402246|324415181|FG000|Overall Study|Lost to Follow-up|20|||
94714609|NCT00402246|324415182|FG001|Overall Study|Lost to Follow-up|28|||
94714610|NCT00402246|324415181|FG000|Overall Study|Withdrawal by Subject|72|||
94714611|NCT00402246|324415182|FG001|Overall Study|Withdrawal by Subject|87|||
94714612|NCT00402246|324415181|FG000|Overall Study|Physician Decision|24|||
94714613|NCT00402246|324415182|FG001|Overall Study|Physician Decision|26|||
94714614|NCT00402246|324415181|FG000|Overall Study|Protocol Violation|25|||
94714615|NCT00402246|324415182|FG001|Overall Study|Protocol Violation|24|||
94714616|NCT00402246|324415181|FG000|Overall Study|Missed Final Visit|1|||
94714617|NCT00402246|324415182|FG001|Overall Study|Missed Final Visit|2|||
94714618|NCT00402246|324415181|FG000|Overall Study|Insurance Issues|2|||
94714619|NCT00402246|324415182|FG001|Overall Study|Insurance Issues|1|||
94714620|NCT00402246|324415181|FG000|Overall Study|Heart Transplant|0|||
94270741|NCT03184077|322783838|FG001|Overall Study|Lost to Follow-up|21|||
94270742|NCT00262522|322783839|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
94270743|NCT00262522|322783840|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
94270744|NCT00262522|322783841|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
94270745|NCT00262522|322783842|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
94270746|NCT00262522|322783839|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
94270747|NCT00262522|322783840|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
94270748|NCT00262522|322783841|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
94270749|NCT00262522|322783842|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
94270750|NCT00262522|322783839|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
94270751|NCT00262522|322783840|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
94270752|NCT00262522|322783841|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
94270753|NCT00262522|322783842|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
94270754|NCT00262522|322783839|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
94270755|NCT00262522|322783840|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
94270756|NCT00262522|322783841|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
94270757|NCT00262522|322783842|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
94270758|NCT00262522|322783839|FG000|Study Start Through 8 Weeks|Death|1|||
94270759|NCT00262522|322783840|FG001|Study Start Through 8 Weeks|Death|0|||
94270760|NCT00262522|322783841|FG002|Study Start Through 8 Weeks|Death|0|||
94270761|NCT00262522|322783842|FG003|Study Start Through 8 Weeks|Death|0|||
94270762|NCT00262522|322783839|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
94270763|NCT00262522|322783840|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
94270764|NCT00262522|322783841|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
94714621|NCT00402246|324415182|FG001|Overall Study|Heart Transplant|1|||
94714622|NCT00402246|324415181|FG000|Overall Study|Patient's device explanted|6|||
94714623|NCT00402246|324415182|FG001|Overall Study|Patient's device explanted|2|||
94714624|NCT00402246|324415181|FG000|Overall Study|Center Closure|5|||
94714625|NCT00402246|324415182|FG001|Overall Study|Center Closure|3|||
94714626|NCT00402246|324415181|FG000|Overall Study|Deterioriating Condition|3|||
94714627|NCT00402246|324415182|FG001|Overall Study|Deterioriating Condition|2|||
94714628|NCT02374463|324415185|FG000|Overall Study|Withdrawal by Subject|3|||
94714629|NCT02374463|324415186|FG001|Overall Study|Withdrawal by Subject|3|||
94714630|NCT01414738|324415187|FG000|Overall Study|Death|26|||
94714631|NCT01414738|324415187|FG000|Overall Study|Refused testing|5|||
94714632|NCT01414738|324415187|FG000|Overall Study|Lost to Follow-up|2|||
94714633|NCT01414738|324415187|FG000|Overall Study|Refused, disease progression|8|||
94714634|NCT01414738|324415187|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
94714635|NCT03292913|324415188|FG000|Overall Study|Death|9|||
94714636|NCT03292913|324415189|FG001|Overall Study|Death|3|||
94714637|NCT03292913|324415188|FG000|Overall Study|Lost to Follow-up|49|||
94714638|NCT03292913|324415189|FG001|Overall Study|Lost to Follow-up|49|||
94714639|NCT03292913|324415188|FG000|Overall Study|Withdrawal by Subject|2|||
94714640|NCT03292913|324415189|FG001|Overall Study|Withdrawal by Subject|0|||
94714641|NCT03292913|324415188|FG000|Overall Study|Clinic closed due to COVID|22|||
94714642|NCT03292913|324415189|FG001|Overall Study|Clinic closed due to COVID|36|||
94714643|NCT01610297|324415190|FG000|Overall Study|Lost to Follow-up|1|||
94714644|NCT02092116|324415192|FG000|Overall Study|Withdrawal by Subject|0|||
94714645|NCT02092116|324415193|FG001|Overall Study|Withdrawal by Subject|3|||
94714646|NCT02092116|324415192|FG000|Overall Study|Adverse Event|0|||
94714647|NCT02092116|324415193|FG001|Overall Study|Adverse Event|1|||
94714648|NCT03451721|324415194|FG000|Overall Study|Death|1|||
94714649|NCT03403413|324415195|FG000|Overall Study|Lack of Efficacy|2|||
94714650|NCT03655262|324415196|FG000|Overall Study|Withdrawal by Subject|0|||
94714651|NCT03655262|324415197|FG001|Overall Study|Withdrawal by Subject|0|||
94714652|NCT03655262|324415198|FG002|Overall Study|Withdrawal by Subject|1|||
94714653|NCT01989455|324415199|FG000|Overall Study|Adverse Event|0|||
94714654|NCT01989455|324415200|FG001|Overall Study|Adverse Event|1|||
94714655|NCT01989455|324415201|FG002|Overall Study|Adverse Event|0|||
94714656|NCT01989455|324415202|FG003|Overall Study|Adverse Event|0|||
94714657|NCT01989455|324415203|FG004|Overall Study|Adverse Event|0|||
94714658|NCT01989455|324415199|FG000|Overall Study|Withdrawal by Subject|0|||
94714659|NCT01989455|324415200|FG001|Overall Study|Withdrawal by Subject|1|||
94714660|NCT01989455|324415201|FG002|Overall Study|Withdrawal by Subject|0|||
94714661|NCT01989455|324415202|FG003|Overall Study|Withdrawal by Subject|0|||
94714662|NCT01989455|324415203|FG004|Overall Study|Withdrawal by Subject|0|||
94714663|NCT01989455|324415199|FG000|Overall Study|Technical problems with infusion|0|||
94714664|NCT01989455|324415200|FG001|Overall Study|Technical problems with infusion|0|||
94714665|NCT01989455|324415201|FG002|Overall Study|Technical problems with infusion|1|||
94714666|NCT01989455|324415202|FG003|Overall Study|Technical problems with infusion|0|||
94714667|NCT01989455|324415203|FG004|Overall Study|Technical problems with infusion|1|||
94714668|NCT00999167|324415204|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
94714669|NCT00999167|324415205|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
94714670|NCT00999167|324415206|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
94714671|NCT00999167|324415204|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
94714672|NCT00999167|324415205|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
94714673|NCT00999167|324415206|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
94714674|NCT00999167|324415204|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
94714675|NCT00999167|324415205|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
94714676|NCT00999167|324415206|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
94714677|NCT00999167|324415204|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
94714678|NCT00999167|324415205|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
94714679|NCT00999167|324415206|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
94714680|NCT00999167|324415204|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
94714681|NCT00999167|324415205|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
94714682|NCT00999167|324415206|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
94714683|NCT00999167|324415204|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
94714684|NCT00999167|324415205|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
94714685|NCT00999167|324415206|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
94714686|NCT00999167|324415204|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
94714687|NCT00999167|324415205|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
94714688|NCT00999167|324415206|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
94714689|NCT00999167|324415204|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
94714690|NCT00999167|324415205|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
94714691|NCT00999167|324415206|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
94714692|NCT03703336|324415207|FG000|Overall Study|Parent withdrew consent|29|||
94714693|NCT03703336|324415208|FG001|Overall Study|Parent withdrew consent|8|||
94714694|NCT03703336|324415207|FG000|Overall Study|Migration|3|||
94714695|NCT03703336|324415208|FG001|Overall Study|Migration|3|||
94714696|NCT03703336|324415207|FG000|Overall Study|Protocol Violation|3|||
94714697|NCT03703336|324415208|FG001|Overall Study|Protocol Violation|1|||
94714698|NCT03703336|324415207|FG000|Overall Study|Physician Decision|2|||
94714699|NCT03703336|324415208|FG001|Overall Study|Physician Decision|0|||
94714700|NCT03703336|324415207|FG000|Overall Study|Adverse Event|0|||
94714701|NCT03703336|324415208|FG001|Overall Study|Adverse Event|2|||
94714702|NCT03703336|324415207|FG000|Overall Study|Lost to Follow-up|1|||
94714703|NCT03703336|324415208|FG001|Overall Study|Lost to Follow-up|0|||
94270765|NCT00262522|322783842|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
94270766|NCT00262522|322783839|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
94270767|NCT00262522|322783840|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
94270768|NCT00262522|322783841|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
94270769|NCT00262522|322783842|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
94270770|NCT00262522|322783839|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
94270771|NCT00262522|322783840|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
94270772|NCT00262522|322783841|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
94270773|NCT00262522|322783842|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
94270774|NCT00262522|322783839|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
94270775|NCT00262522|322783840|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
94270776|NCT00262522|322783841|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
94367318|NCT02923115|323131535|FG005|Overall Study|Withdrawal by Subject|0|||
94714704|NCT03380390|324415209|FG000|Overall Study|Adverse Event|3|||
94714705|NCT01248936|324415210|FG000|Overall Study|Sponsor Decision|259|||
94714706|NCT01248936|324415210|FG000|Overall Study|Progression of Disease|50|||
94714707|NCT01248936|324415210|FG000|Overall Study|Death|26|||
94714708|NCT01248936|324415210|FG000|Overall Study|Withdrawal of Consent|20|||
94714709|NCT01248936|324415210|FG000|Overall Study|Adverse Event|8|||
94714710|NCT01248936|324415210|FG000|Overall Study|Lost to Follow-up|7|||
94714711|NCT01248936|324415210|FG000|Overall Study|Refused Treatment|1|||
94714712|NCT01248936|324415210|FG000|Overall Study|Other reason|3|||
94714713|NCT00609336|324415211|FG000|Overall Study|Protocol Violation|3|||
94714714|NCT00609336|324415211|FG000|Overall Study|Death|1|||
94714715|NCT00609336|324415211|FG000|Overall Study|LA or Met at Surgery|9|||
94714716|NCT02574455|324415212|FG000|Overall Study|Death|197|||
94714717|NCT02574455|324415213|FG001|Overall Study|Death|210|||
94714718|NCT02574455|324415212|FG000|Overall Study|Withdrawal of Consent|11|||
94714719|NCT02574455|324415213|FG001|Overall Study|Withdrawal of Consent|28|||
94270777|NCT00262522|322783842|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
94270778|NCT00262522|322783839|FG000|Study Start Through 48 Weeks|Death|2|||
94270779|NCT00262522|322783840|FG001|Study Start Through 48 Weeks|Death|0|||
94270780|NCT00262522|322783841|FG002|Study Start Through 48 Weeks|Death|1|||
94270781|NCT00262522|322783842|FG003|Study Start Through 48 Weeks|Death|0|||
94270782|NCT00262522|322783839|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
94270783|NCT00262522|322783840|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
94270784|NCT00262522|322783841|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
94270785|NCT00262522|322783842|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
94270786|NCT00262522|322783839|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
94270787|NCT00262522|322783840|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
94270788|NCT00262522|322783841|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
94270789|NCT00262522|322783842|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
94270790|NCT00262522|322783839|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
94270791|NCT00262522|322783840|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
94270792|NCT00262522|322783841|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
94270793|NCT00262522|322783842|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
94270794|NCT00262522|322783839|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
94270795|NCT00262522|322783840|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
94270796|NCT00262522|322783841|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
94270797|NCT00262522|322783842|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
94270798|NCT00262522|322783839|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
94270799|NCT00262522|322783840|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
94270800|NCT00262522|322783841|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
94270801|NCT00262522|322783842|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
94270802|NCT00262522|322783839|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
94270803|NCT00262522|322783840|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
94270804|NCT00262522|322783841|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
94270805|NCT00262522|322783842|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
94270806|NCT00262522|322783839|FG000|Study Start Through 96 Weeks|Death|2|||
94270807|NCT00262522|322783840|FG001|Study Start Through 96 Weeks|Death|0|||
94270808|NCT00262522|322783841|FG002|Study Start Through 96 Weeks|Death|2|||
94270809|NCT00262522|322783842|FG003|Study Start Through 96 Weeks|Death|0|||
94270810|NCT00262522|322783839|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
94270811|NCT00262522|322783840|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
94270812|NCT00262522|322783841|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
94270813|NCT00262522|322783842|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
94270814|NCT00262522|322783839|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
94270815|NCT00262522|322783840|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
94270816|NCT00262522|322783841|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
94714720|NCT02574455|324415212|FG000|Overall Study|Lost to Follow-up|4|||
94270817|NCT00262522|322783842|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
94270818|NCT00517751|322783844|FG000|Overall Study|Death|3|||
94270819|NCT00517751|322783844|FG000|Overall Study|Withdrawal by Subject|37|||
94270820|NCT00517751|322783844|FG000|Overall Study|Lost to Follow-up|4|||
94270821|NCT00517751|322783844|FG000|Overall Study|patient not over due|6|||
94270822|NCT00517751|322783844|FG000|Overall Study|Patient not due for visit|76|||
94270823|NCT00517751|322783844|FG000|Overall Study|Missing|3|||
94270824|NCT02321930|322783851|FG000|Overall Study|Lost to Follow-up|1|||
94270825|NCT01293968|322783854|FG000|Overall Study|non-cooperation|3|||
94270826|NCT01293968|322783855|FG001|Overall Study|non-cooperation|3|||
94270827|NCT01210690|322783856|FG000|Overall Study|Adverse Event|7|||
94270828|NCT01210690|322783856|FG000|Overall Study|Lack of Efficacy|12|||
94714721|NCT02574455|324415213|FG001|Overall Study|Lost to Follow-up|4|||
94714722|NCT02574455|324415212|FG000|Overall Study|Sponsor's Decision|55|||
94714723|NCT02574455|324415213|FG001|Overall Study|Sponsor's Decision|20|||
94714724|NCT00390299|324415219|FG000|Overall Study|Cancellation|1|||
94714725|NCT00390299|324415220|FG001|Overall Study|Cancellation|0|||
94714726|NCT00390299|324415221|FG002|Overall Study|Cancellation|0|||
94714727|NCT00390299|324415222|FG003|Overall Study|Cancellation|0|||
94714728|NCT00390299|324415223|FG004|Overall Study|Cancellation|0|||
94714729|NCT01388361|324415226|FG000|Overall Study|Adverse Event|0|||
94714730|NCT01388361|324415227|FG001|Overall Study|Adverse Event|5|||
94714731|NCT01388361|324415228|FG002|Overall Study|Adverse Event|1|||
94270829|NCT01210690|322783856|FG000|Overall Study|Lost to Follow-up|3|||
94270830|NCT01210690|322783856|FG000|Overall Study|Disease Remission|1|||
94270831|NCT01210690|322783856|FG000|Overall Study|Withdrawal by Subject|1|||
94270832|NCT01210690|322783856|FG000|Overall Study|Patient refused to swallow|1|||
94270833|NCT01210690|322783856|FG000|Overall Study|Patient could not take glucose|1|||
94270834|NCT01484977|322783857|FG000|Overall Study|Adverse Event|8|||
94270835|NCT01484977|322783857|FG000|Overall Study|Lack of Efficacy|4|||
94270836|NCT01484977|322783857|FG000|Overall Study|Protocol Violation|6|||
94270837|NCT01484977|322783857|FG000|Overall Study|Lost to Follow-up|1|||
94270838|NCT01484977|322783857|FG000|Overall Study|Withdrawal by Subject|4|||
94270839|NCT01484977|322783857|FG000|Overall Study|Subject Protocol Non-compliant|1|||
94270840|NCT01484977|322783857|FG000|Overall Study|Moving Overseas|1|||
94270841|NCT01484977|322783857|FG000|Overall Study|Low White Blood Cell Count|1|||
94270842|NCT01484977|322783857|FG000|Overall Study|Lack of Compliance|1|||
94270843|NCT00853749|322783858|FG000|Overall Study|Lost to Follow-up|0|||
94270844|NCT00853749|322783859|FG001|Overall Study|Lost to Follow-up|1|||
94270845|NCT04857996|322783862|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
94270846|NCT04857996|322783863|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
94714732|NCT01388361|324415226|FG000|Overall Study|Protocol Violation|0|||
94714733|NCT01388361|324415227|FG001|Overall Study|Protocol Violation|0|||
94714734|NCT01388361|324415228|FG002|Overall Study|Protocol Violation|2|||
94714735|NCT01388361|324415226|FG000|Overall Study|Withdrawal criteria|12|||
94714736|NCT01388361|324415227|FG001|Overall Study|Withdrawal criteria|7|||
94714737|NCT01388361|324415228|FG002|Overall Study|Withdrawal criteria|10|||
94714738|NCT01388361|324415226|FG000|Overall Study|Unclassified|0|||
94714739|NCT01388361|324415227|FG001|Overall Study|Unclassified|0|||
94714740|NCT01388361|324415228|FG002|Overall Study|Unclassified|1|||
94714741|NCT01017146|324415229|FG000|Overall Study|Adverse Event|11|||
94714742|NCT01017146|324415230|FG001|Overall Study|Adverse Event|1|||
94714743|NCT01017146|324415229|FG000|Overall Study|Lost to Follow-up|14|||
94714744|NCT01017146|324415230|FG001|Overall Study|Lost to Follow-up|14|||
94714745|NCT01017146|324415229|FG000|Overall Study|Noncompliance with Study Product|1|||
94714746|NCT01017146|324415230|FG001|Overall Study|Noncompliance with Study Product|1|||
94714747|NCT01017146|324415229|FG000|Overall Study|Withdrawal by Subject|32|||
94714748|NCT01017146|324415230|FG001|Overall Study|Withdrawal by Subject|16|||
94270847|NCT04857996|322783862|FG000|Overall Study|Lost to Follow-up|1|||
94714749|NCT01017146|324415229|FG000|Overall Study|Relocation|0|||
94714750|NCT01017146|324415230|FG001|Overall Study|Relocation|4|||
94714751|NCT01017146|324415229|FG000|Overall Study|Pregnancy|2|||
94270848|NCT04857996|322783863|FG001|Overall Study|Lost to Follow-up|3|||
94714752|NCT01017146|324415230|FG001|Overall Study|Pregnancy|1|||
94714753|NCT01017146|324415229|FG000|Overall Study|Protocol Violation|2|||
94714754|NCT01017146|324415230|FG001|Overall Study|Protocol Violation|0|||
94714755|NCT01017146|324415229|FG000|Overall Study|Took Excluded Medication|2|||
94714756|NCT01017146|324415230|FG001|Overall Study|Took Excluded Medication|0|||
94270849|NCT04857996|322783862|FG000|Overall Study|Site Closure|1|||
94270850|NCT04857996|322783863|FG001|Overall Study|Site Closure|0|||
94270851|NCT04857996|322783862|FG000|Overall Study|Withdrawal by Subject|1|||
94270852|NCT04857996|322783863|FG001|Overall Study|Withdrawal by Subject|0|||
94714757|NCT01017146|324415229|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
94714758|NCT01017146|324415230|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
94467239|NCT01285492|323500483|FG000|Overall Study|Protocol Violation|3|||
94714759|NCT01017146|324415229|FG000|Overall Study|Change in Work Situation|1|||
94714760|NCT01017146|324415230|FG001|Overall Study|Change in Work Situation|0|||
94270853|NCT00798135|322783864|FG000|Overall Study|Disease progression, relapse|11|||
94270854|NCT00798135|322783864|FG000|Overall Study|Disease progression, refractory|1|||
94270855|NCT00798135|322783864|FG000|Overall Study|Physician Decision|1|||
94270856|NCT01401842|322783865|FG000|Overall Study|Withdrawal by Subject|3|||
94270857|NCT01401842|322783866|FG001|Overall Study|Withdrawal by Subject|2|||
94270858|NCT01401842|322783865|FG000|Overall Study|academic reason|4|||
94270859|NCT01401842|322783866|FG001|Overall Study|academic reason|1|||
94714761|NCT02538341|324415231|FG000|Overall Study|Lost to Follow-up|51|||
94714762|NCT02538341|324415232|FG001|Overall Study|Lost to Follow-up|46|||
94714763|NCT02538341|324415231|FG000|Overall Study|Withdrawal by Subject|3|||
94714764|NCT02538341|324415232|FG001|Overall Study|Withdrawal by Subject|1|||
94714765|NCT02538341|324415231|FG000|Overall Study|Death|2|||
94714766|NCT02538341|324415232|FG001|Overall Study|Death|0|||
94714767|NCT00976937|324415233|FG000|Overall Study|Adverse Event|4|||
94714768|NCT00976937|324415234|FG001|Overall Study|Adverse Event|5|||
94714769|NCT00976937|324415233|FG000|Overall Study|Lost to Follow-up|2|||
94714770|NCT00976937|324415234|FG001|Overall Study|Lost to Follow-up|1|||
94270860|NCT01401842|322783865|FG000|Overall Study|changed companies|20|||
94270861|NCT01401842|322783866|FG001|Overall Study|changed companies|34|||
94270862|NCT01401842|322783865|FG000|Overall Study|discharged from US Army|3|||
94270863|NCT01401842|322783866|FG001|Overall Study|discharged from US Army|4|||
94270864|NCT01401842|322783865|FG000|Overall Study|invalid follow-up strength data|1|||
94270865|NCT01401842|322783866|FG001|Overall Study|invalid follow-up strength data|4|||
94270866|NCT01401842|322783865|FG000|Overall Study|on profile|9|||
94270867|NCT01401842|322783866|FG001|Overall Study|on profile|5|||
94270868|NCT01401842|322783865|FG000|Overall Study|other/unknown|28|||
94270869|NCT01401842|322783866|FG001|Overall Study|other/unknown|17|||
94270870|NCT00282295|322783867|FG000|Overall Study|Adverse Event|0|||
94270871|NCT00282295|322783868|FG001|Overall Study|Adverse Event|1|||
94270872|NCT00282295|322783869|FG002|Overall Study|Adverse Event|0|||
94270873|NCT00282295|322783867|FG000|Overall Study|Serious Adverse Events|0|||
94270874|NCT00282295|322783868|FG001|Overall Study|Serious Adverse Events|0|||
94270875|NCT00282295|322783869|FG002|Overall Study|Serious Adverse Events|1|||
94270876|NCT00282295|322783867|FG000|Overall Study|Protocol Violation|0|||
94270877|NCT00282295|322783868|FG001|Overall Study|Protocol Violation|2|||
94270878|NCT00282295|322783869|FG002|Overall Study|Protocol Violation|1|||
94270879|NCT00282295|322783867|FG000|Overall Study|Withdrawal by Subject|2|||
94270880|NCT00282295|322783868|FG001|Overall Study|Withdrawal by Subject|6|||
94270881|NCT00282295|322783869|FG002|Overall Study|Withdrawal by Subject|4|||
94270882|NCT00282295|322783867|FG000|Overall Study|Lost to Follow-up|1|||
94270883|NCT00282295|322783868|FG001|Overall Study|Lost to Follow-up|7|||
94367319|NCT02923115|323131530|FG000|Overall Study|Randomized, but not dosed|0|||
94367320|NCT02923115|323131531|FG001|Overall Study|Randomized, but not dosed|0|||
94714771|NCT00976937|324415233|FG000|Overall Study|Withdrawal by Subject|5|||
94714772|NCT00976937|324415234|FG001|Overall Study|Withdrawal by Subject|3|||
94714773|NCT00976937|324415233|FG000|Overall Study|Poor compliance to protocol|3|||
94714774|NCT00976937|324415234|FG001|Overall Study|Poor compliance to protocol|0|||
94270884|NCT00282295|322783869|FG002|Overall Study|Lost to Follow-up|2|||
94270885|NCT00282295|322783867|FG000|Overall Study|Other|0|||
94270886|NCT00282295|322783868|FG001|Overall Study|Other|1|||
94270887|NCT00282295|322783869|FG002|Overall Study|Other|0|||
94714775|NCT00976937|324415233|FG000|Overall Study|Personal and Familial Reason|2|||
94714776|NCT00976937|324415234|FG001|Overall Study|Personal and Familial Reason|2|||
94270888|NCT03337542|322783870|FG000|Overall Study|Withdrew Consent|17|||
94270889|NCT03337542|322783870|FG000|Overall Study|Allergic Adverse Event|1|||
94367321|NCT02923115|323131532|FG002|Overall Study|Randomized, but not dosed|3|||
94714777|NCT00716859|324415237|FG000|Overall Study|Adverse Event|4|||
94714778|NCT00716859|324415238|FG001|Overall Study|Adverse Event|1|||
94714779|NCT00716859|324415237|FG000|Overall Study|Lack of Efficacy|3|||
94467240|NCT01285492|323500484|FG001|Overall Study|Protocol Violation|0|||
94467241|NCT01285492|323500483|FG000|Overall Study|Withdrawal by Subject|2|||
94467242|NCT01285492|323500484|FG001|Overall Study|Withdrawal by Subject|1|||
94467243|NCT01285492|323500483|FG000|Overall Study|Death|1|||
94467244|NCT01285492|323500484|FG001|Overall Study|Death|0|||
94367322|NCT02923115|323131533|FG003|Overall Study|Randomized, but not dosed|1|||
94367323|NCT02923115|323131534|FG004|Overall Study|Randomized, but not dosed|5|||
94367324|NCT02923115|323131535|FG005|Overall Study|Randomized, but not dosed|0|||
94270890|NCT03337542|322783870|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
94270891|NCT03337542|322783870|FG000|Overall Study|Lost to Follow-up|1|||
94270892|NCT03337542|322783870|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
94270893|NCT00257166|322785080|FG000|Overall Study|Adverse Event|18|||
94270894|NCT00257166|322785081|FG001|Overall Study|Adverse Event|13|||
94270895|NCT00257166|322785080|FG000|Overall Study|Laboratory abnormality|1|||
94270896|NCT00257166|322785081|FG001|Overall Study|Laboratory abnormality|0|||
94270897|NCT00257166|322785080|FG000|Overall Study|Lost to Follow-up|8|||
94270898|NCT00257166|322785081|FG001|Overall Study|Lost to Follow-up|1|||
94270899|NCT00257166|322785080|FG000|Overall Study|Withdrawal by Subject|9|||
94270900|NCT00257166|322785081|FG001|Overall Study|Withdrawal by Subject|2|||
94270901|NCT00257166|322785080|FG000|Overall Study|Other|16|||
94270902|NCT00257166|322785081|FG001|Overall Study|Other|21|||
94270903|NCT00257166|322785080|FG000|Overall Study|Randomized, but not treated|1|||
94270904|NCT00257166|322785081|FG001|Overall Study|Randomized, but not treated|0|||
94270905|NCT00404820|322785084|FG000|Overall Study|Adverse Event|4|||
94270906|NCT00404820|322785085|FG001|Overall Study|Adverse Event|16|||
94270907|NCT00404820|322785084|FG000|Overall Study|Withdrawal by Subject|5|||
94270908|NCT00404820|322785085|FG001|Overall Study|Withdrawal by Subject|3|||
94270909|NCT00404820|322785084|FG000|Overall Study|Lost to Follow-up|7|||
94270910|NCT00404820|322785085|FG001|Overall Study|Lost to Follow-up|3|||
94270911|NCT00404820|322785084|FG000|Overall Study|Administrative problems|2|||
94270912|NCT00404820|322785085|FG001|Overall Study|Administrative problems|0|||
94270913|NCT00404820|322785084|FG000|Overall Study|Death|1|||
94270914|NCT00404820|322785085|FG001|Overall Study|Death|0|||
94270915|NCT00404820|322785084|FG000|Overall Study|Other|0|||
94270916|NCT00404820|322785085|FG001|Overall Study|Other|2|||
94270917|NCT01462435|322785086|FG000|Overall Study|Lack of Efficacy|1|||
94270918|NCT01462435|322785087|FG001|Overall Study|Lack of Efficacy|0|||
94270919|NCT01462435|322785088|FG002|Overall Study|Lack of Efficacy|0|||
94270920|NCT01462435|322785089|FG003|Overall Study|Lack of Efficacy|3|||
94270921|NCT01462435|322785086|FG000|Overall Study|Physician Decision|0|||
94270922|NCT01462435|322785087|FG001|Overall Study|Physician Decision|0|||
94270923|NCT01462435|322785088|FG002|Overall Study|Physician Decision|1|||
94270924|NCT01462435|322785089|FG003|Overall Study|Physician Decision|0|||
94270925|NCT01462435|322785086|FG000|Overall Study|Withdrawal by Subject|0|||
94270926|NCT01462435|322785087|FG001|Overall Study|Withdrawal by Subject|0|||
94270927|NCT01462435|322785088|FG002|Overall Study|Withdrawal by Subject|0|||
94270928|NCT01462435|322785089|FG003|Overall Study|Withdrawal by Subject|1|||
94270929|NCT01462435|322785086|FG000|Overall Study|Lost to Follow-up|0|||
94270930|NCT01462435|322785087|FG001|Overall Study|Lost to Follow-up|0|||
94270931|NCT01462435|322785088|FG002|Overall Study|Lost to Follow-up|0|||
94270932|NCT01462435|322785089|FG003|Overall Study|Lost to Follow-up|1|||
94270933|NCT00516048|322785090|FG000|Overall Study|Death|0|||
94270934|NCT00516048|322785091|FG001|Overall Study|Death|0|||
94270935|NCT00516048|322785092|FG002|Overall Study|Death|1|||
94270936|NCT00516048|322785090|FG000|Overall Study|Subject Decision|0|||
94270937|NCT00516048|322785091|FG001|Overall Study|Subject Decision|2|||
94270938|NCT00516048|322785092|FG002|Overall Study|Subject Decision|0|||
94270939|NCT00054704|322785097|FG000|Overall Study|Lack of Efficacy|2|||
94270940|NCT00054704|322785098|FG001|Overall Study|Lack of Efficacy|3|||
94270941|NCT00054704|322785097|FG000|Overall Study|Adverse Event|3|||
94270942|NCT00054704|322785098|FG001|Overall Study|Adverse Event|1|||
94270943|NCT00054704|322785097|FG000|Overall Study|Lost to Follow-up|0|||
94270944|NCT00054704|322785098|FG001|Overall Study|Lost to Follow-up|1|||
94270945|NCT00362414|322785099|FG000|Overall Study|Death|2|||
94270946|NCT00362414|322785099|FG000|Overall Study|Adverse Event|1|||
94270947|NCT01848288|322785102|FG000|Overall Study|Death|1|||
94270948|NCT01848288|322785102|FG000|Overall Study|Protocol Violation|1|||
94270949|NCT01848288|322785102|FG000|Overall Study|Withdrawal by Subject|1|||
94270950|NCT01101438|322785105|FG000|Overall Study|Withdrawal by Subject|8|||
94270951|NCT01101438|322785106|FG001|Overall Study|Withdrawal by Subject|9|||
94270952|NCT02865018|322785109|FG000|Overall Study|Withdrawal by Subject|1|||
94270953|NCT03861936|322785110|FG000|Overall Study|Withdrawal by Subject|4|||
94270954|NCT03861936|322785111|FG001|Overall Study|Withdrawal by Subject|1|||
94270955|NCT03861936|322785112|FG002|Overall Study|Withdrawal by Subject|3|||
94270956|NCT03861936|322785110|FG000|Overall Study|Lost to Follow-up|5|||
94270957|NCT03861936|322785111|FG001|Overall Study|Lost to Follow-up|3|||
94270958|NCT03861936|322785112|FG002|Overall Study|Lost to Follow-up|3|||
94270959|NCT03861936|322785110|FG000|Overall Study|Physician Decision|0|||
94270960|NCT03861936|322785111|FG001|Overall Study|Physician Decision|1|||
94270961|NCT03861936|322785112|FG002|Overall Study|Physician Decision|0|||
94270962|NCT03861936|322785110|FG000|Overall Study|Protocol Deviation|0|||
94270963|NCT03861936|322785111|FG001|Overall Study|Protocol Deviation|0|||
94270964|NCT03861936|322785112|FG002|Overall Study|Protocol Deviation|1|||
94270965|NCT03861936|322785110|FG000|Overall Study|Reason not Specified|5|||
94270966|NCT03861936|322785111|FG001|Overall Study|Reason not Specified|5|||
94270967|NCT03861936|322785112|FG002|Overall Study|Reason not Specified|3|||
94270968|NCT02969187|322785113|FG000|Overall Study|Physician Decision|12|||
94270969|NCT02969187|322785114|FG001|Overall Study|Physician Decision|13|||
94714780|NCT00716859|324415238|FG001|Overall Study|Lack of Efficacy|0|||
94714781|NCT00716859|324415237|FG000|Overall Study|Withdrawal by Subject|1|||
94714782|NCT00716859|324415238|FG001|Overall Study|Withdrawal by Subject|3|||
94714783|NCT00716859|324415237|FG000|Overall Study|Not treated|1|||
94714784|NCT00716859|324415238|FG001|Overall Study|Not treated|1|||
94714785|NCT00065260|324415239|FG000|Overall Study|Death|0|||
94714786|NCT00065260|324415240|FG001|Overall Study|Death|1|||
94714787|NCT00001277|324415241|FG000|Overall Study|Adverse Event|0|||
94714788|NCT00001277|324415242|FG001|Overall Study|Adverse Event|0|||
94714789|NCT00001277|324415243|FG002|Overall Study|Adverse Event|1|||
94714790|NCT00001277|324415241|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
94714791|NCT00001277|324415242|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
94714792|NCT00001277|324415243|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
94714793|NCT04048382|324415252|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
94714794|NCT04048382|324415253|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
94714795|NCT04048382|324415252|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
94714796|NCT04048382|324415253|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
94714797|NCT04048382|324415252|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
94714798|NCT04048382|324415253|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
94714799|NCT03779048|324416800|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
94714800|NCT03779048|324416801|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
94714801|NCT03779048|324416802|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
94714802|NCT03779048|324416800|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
94714803|NCT03779048|324416801|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
94714804|NCT03779048|324416802|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
94714805|NCT03779048|324416800|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
94714806|NCT03779048|324416801|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
94714807|NCT03779048|324416802|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
94714808|NCT05985044|324416803|FG000|Overall Study|Death|6|||
94714809|NCT05985044|324416803|FG000|Overall Study|Lost to Follow-up|4|||
94270970|NCT02161575|322785116|FG000|Overall Study|Protocol Violation|8|||
94270971|NCT02161575|322785116|FG000|Overall Study|Lack of Efficacy|1|||
94270972|NCT02161575|322785116|FG000|Overall Study|Adverse Event|2|||
94270973|NCT01376778|322785120|FG000|Overall Study|Lost to Follow-up|3|||
94270974|NCT01376778|322785121|FG001|Overall Study|Lost to Follow-up|2|||
94270975|NCT00596947|322785123|FG000|Overall Study|study halted due to low enrollment|5|||
94270976|NCT00596947|322785124|FG001|Overall Study|study halted due to low enrollment|3|||
94270977|NCT00596947|322785123|FG000|Overall Study|Lost to Follow-up|1|||
94270978|NCT00596947|322785124|FG001|Overall Study|Lost to Follow-up|0|||
94270979|NCT00800436|322785125|FG000|Overall Study|Withdrawal by Subject|0|||
94270980|NCT00800436|322785126|FG001|Overall Study|Withdrawal by Subject|0|||
94270981|NCT00800436|322785127|FG002|Overall Study|Withdrawal by Subject|1|||
94270982|NCT00800436|322785128|FG003|Overall Study|Withdrawal by Subject|1|||
94270983|NCT00800436|322785129|FG004|Overall Study|Withdrawal by Subject|0|||
94270984|NCT00800436|322785130|FG005|Overall Study|Withdrawal by Subject|0|||
94270985|NCT00800436|322785131|FG006|Overall Study|Withdrawal by Subject|0|||
94270986|NCT00113074|322785132|FG000|Overall Study|Lost to Follow-up|10|||
94270987|NCT00113074|322785133|FG001|Overall Study|Lost to Follow-up|10|||
94270988|NCT00113074|322785134|FG002|Overall Study|Lost to Follow-up|14|||
94367325|NCT02419469|323131536|FG000|Overall Study|Withdrawal by Subject|1|||
94367326|NCT02487979|323131544|FG000|Overall Study|Physician Decision|2|||
94367327|NCT02487979|323131544|FG000|Overall Study|Withdrawal by Subject|2|||
94714810|NCT05985044|324416803|FG000|Overall Study|Incapacitation|3|||
94714811|NCT05985044|324416803|FG000|Overall Study|Withdrawal by Subject|2|||
94714812|NCT05938413|324416805|FG000|Overall Study|Lost to Follow-up|1|||
94714813|NCT05938413|324416806|FG001|Overall Study|Lost to Follow-up|7|||
94714814|NCT05938413|324416805|FG000|Overall Study|Withdrawal by Subject|1|||
94714815|NCT05938413|324416806|FG001|Overall Study|Withdrawal by Subject|1|||
94714816|NCT03073941|324416807|FG000|Overall Study|Received non-study device intraoperatively|0|||
94714817|NCT03073941|324416808|FG001|Overall Study|Received non-study device intraoperatively|2|||
94714818|NCT03073941|324416807|FG000|Overall Study|Death|1|||
94270989|NCT03625687|322785135|FG000|Overall Study|Death|1|||
94270990|NCT00843518|322785136|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
94270991|NCT00843518|322785137|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
94270992|NCT00843518|322785136|FG000|Period 2 (Double-blind Treatment)|Death|0|||
94270993|NCT00843518|322785137|FG001|Period 2 (Double-blind Treatment)|Death|1|||
94270994|NCT00843518|322785136|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
94367328|NCT02487979|323131544|FG000|Overall Study|Progressive Disease|17|||
94714819|NCT03073941|324416808|FG001|Overall Study|Death|0|||
94714820|NCT03073941|324416807|FG000|Overall Study|Withdrawal by Subject|1|||
94714821|NCT03073941|324416808|FG001|Overall Study|Withdrawal by Subject|3|||
94714822|NCT03073941|324416807|FG000|Overall Study|Lost to Follow-up|5|||
94714823|NCT03073941|324416808|FG001|Overall Study|Lost to Follow-up|4|||
94714824|NCT03073941|324416807|FG000|Overall Study|Adverse Event|4|||
94714825|NCT03073941|324416808|FG001|Overall Study|Adverse Event|2|||
94714826|NCT03073941|324416807|FG000|Overall Study|Met an exclusion criterion|0|||
94714827|NCT03073941|324416808|FG001|Overall Study|Met an exclusion criterion|1|||
94714828|NCT01939899|324416811|FG000|Lead-in Dose Finding Phase|Death|0|||
94714829|NCT01939899|324416812|FG001|Lead-in Dose Finding Phase|Death|3|||
94714830|NCT01939899|324416813|FG002|Lead-in Dose Finding Phase|Death|1|||
94714831|NCT01939899|324416814|FG003|Lead-in Dose Finding Phase|Death|0|||
94714832|NCT01939899|324416815|FG004|Lead-in Dose Finding Phase|Death|0|||
94714833|NCT01939899|324416811|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
94714834|NCT01939899|324416812|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
94714835|NCT01939899|324416813|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
94714836|NCT01939899|324416814|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
94714837|NCT01939899|324416815|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
94714838|NCT01939899|324416811|FG000|Lead-in Dose Finding Phase|Other|0|||
94714839|NCT01939899|324416812|FG001|Lead-in Dose Finding Phase|Other|0|||
94714840|NCT01939899|324416813|FG002|Lead-in Dose Finding Phase|Other|1|||
94714841|NCT01939899|324416814|FG003|Lead-in Dose Finding Phase|Other|0|||
94714842|NCT01939899|324416815|FG004|Lead-in Dose Finding Phase|Other|0|||
94714843|NCT01939899|324416811|FG000|Phase 2|Withdrawal by Subject|0|||
94714844|NCT01939899|324416812|FG001|Phase 2|Withdrawal by Subject|0|||
94714845|NCT01939899|324416813|FG002|Phase 2|Withdrawal by Subject|0|||
94714846|NCT01939899|324416814|FG003|Phase 2|Withdrawal by Subject|2|||
94714847|NCT01939899|324416815|FG004|Phase 2|Withdrawal by Subject|0|||
94714848|NCT01939899|324416811|FG000|Phase 2|Disease Progression|0|||
94714849|NCT01939899|324416812|FG001|Phase 2|Disease Progression|0|||
94714850|NCT01939899|324416813|FG002|Phase 2|Disease Progression|0|||
94714851|NCT01939899|324416814|FG003|Phase 2|Disease Progression|9|||
94714852|NCT01939899|324416815|FG004|Phase 2|Disease Progression|1|||
94367329|NCT00627458|323131545|FG000|Overall Study|Migrated from study area|1|||
94367330|NCT00627458|323131546|FG001|Overall Study|Migrated from study area|0|||
94714853|NCT02597920|324416816|FG000|Overall Study|Worsening of other pre-existing disease|0|||
94367331|NCT00627458|323131547|FG002|Overall Study|Migrated from study area|1|||
94714854|NCT02597920|324416817|FG001|Overall Study|Worsening of other pre-existing disease|1|||
94714855|NCT02597920|324416818|FG002|Overall Study|Worsening of other pre-existing disease|0|||
94714856|NCT02597920|324416816|FG000|Overall Study|Other adverse event|20|||
94714857|NCT02597920|324416817|FG001|Overall Study|Other adverse event|30|||
94714858|NCT02597920|324416818|FG002|Overall Study|Other adverse event|0|||
94714859|NCT02597920|324416816|FG000|Overall Study|Lost to Follow-up|7|||
94714860|NCT02597920|324416817|FG001|Overall Study|Lost to Follow-up|9|||
94714861|NCT02597920|324416818|FG002|Overall Study|Lost to Follow-up|0|||
94270995|NCT00843518|322785137|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
94270996|NCT00843518|322785136|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
94270997|NCT00843518|322785137|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
94270998|NCT00843518|322785136|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
94270999|NCT00843518|322785137|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
94271000|NCT00843518|322785136|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
94271001|NCT00843518|322785137|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
94271002|NCT00843518|322785136|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
94271003|NCT00843518|322785137|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
94271004|NCT01226459|322785138|FG000|Overall Study|Adverse Event|2|||
94271005|NCT01226459|322785139|FG001|Overall Study|Adverse Event|8|||
94271006|NCT01226459|322785138|FG000|Overall Study|Protocol Violation|4|||
94271007|NCT01226459|322785139|FG001|Overall Study|Protocol Violation|3|||
94271008|NCT01226459|322785138|FG000|Overall Study|Withdrawal by Subject|10|||
94714862|NCT02597920|324416816|FG000|Overall Study|Refuse to continue in the study|3|||
94714863|NCT02597920|324416817|FG001|Overall Study|Refuse to continue in the study|13|||
94714864|NCT02597920|324416818|FG002|Overall Study|Refuse to continue in the study|1|||
94714865|NCT02597920|324416816|FG000|Overall Study|Other than specified|10|||
94714866|NCT02597920|324416817|FG001|Overall Study|Other than specified|31|||
94714867|NCT02597920|324416818|FG002|Overall Study|Other than specified|5|||
94714868|NCT02597920|324416816|FG000|Overall Study|Other|1|||
94714869|NCT02597920|324416817|FG001|Overall Study|Other|0|||
94714870|NCT02597920|324416818|FG002|Overall Study|Other|0|||
94714871|NCT00529516|324416819|FG000|Overall Study|Adverse Event|2|||
94714872|NCT00529516|324416820|FG001|Overall Study|Adverse Event|1|||
94714873|NCT00529516|324416821|FG002|Overall Study|Adverse Event|0|||
94714874|NCT00529516|324416819|FG000|Overall Study|Withdrawal by Subject|1|||
94714875|NCT00529516|324416820|FG001|Overall Study|Withdrawal by Subject|1|||
94714876|NCT00529516|324416821|FG002|Overall Study|Withdrawal by Subject|0|||
94714877|NCT00529516|324416819|FG000|Overall Study|Lost to Follow-up|0|||
94714878|NCT00529516|324416820|FG001|Overall Study|Lost to Follow-up|0|||
94714879|NCT00529516|324416821|FG002|Overall Study|Lost to Follow-up|1|||
94714880|NCT03531840|324416824|FG000|Overall Study|Death on study|3|||
94714881|NCT03531840|324416825|FG001|Overall Study|Death on study|2|||
94714882|NCT03531840|324416826|FG002|Overall Study|Death on study|1|||
94714883|NCT03531840|324416827|FG003|Overall Study|Death on study|2|||
94714884|NCT03531840|324416824|FG000|Overall Study|Death during follow up|2|||
94714885|NCT03531840|324416825|FG001|Overall Study|Death during follow up|3|||
94714886|NCT03531840|324416826|FG002|Overall Study|Death during follow up|4|||
94714887|NCT03531840|324416827|FG003|Overall Study|Death during follow up|1|||
94714888|NCT02462759|324416828|FG000|Part 1: Double Blind|Death|1|||
94714889|NCT02462759|324416829|FG001|Part 1: Double Blind|Death|0|||
94714890|NCT02462759|324416830|FG002|Part 1: Double Blind|Death|0|||
94714891|NCT01985334|324416831|FG000|Overall Study|Administrative problems|1|||
94714892|NCT01985334|324416832|FG001|Overall Study|Administrative problems|1|||
94714893|NCT01985334|324416833|FG002|Overall Study|Administrative problems|0|||
94714894|NCT01985334|324416834|FG003|Overall Study|Administrative problems|2|||
94714895|NCT01985334|324416835|FG004|Overall Study|Administrative problems|0|||
94714896|NCT01985334|324416836|FG005|Overall Study|Administrative problems|1|||
94714897|NCT01985334|324416837|FG006|Overall Study|Administrative problems|1|||
94714898|NCT01985334|324416838|FG007|Overall Study|Administrative problems|3|||
94714899|NCT01985334|324416831|FG000|Overall Study|Death|1|||
94714900|NCT01985334|324416832|FG001|Overall Study|Death|0|||
94714901|NCT01985334|324416833|FG002|Overall Study|Death|0|||
94714902|NCT01985334|324416834|FG003|Overall Study|Death|3|||
94714903|NCT01985334|324416835|FG004|Overall Study|Death|0|||
94714904|NCT01985334|324416836|FG005|Overall Study|Death|0|||
94714905|NCT01985334|324416837|FG006|Overall Study|Death|1|||
94714906|NCT01985334|324416838|FG007|Overall Study|Death|2|||
94714907|NCT01985334|324416831|FG000|Overall Study|Worsening of disease|0|||
94714908|NCT01985334|324416832|FG001|Overall Study|Worsening of disease|0|||
94714909|NCT01985334|324416833|FG002|Overall Study|Worsening of disease|0|||
94271009|NCT01226459|322785139|FG001|Overall Study|Withdrawal by Subject|13|||
94271010|NCT01226459|322785138|FG000|Overall Study|Lost to Follow-up|4|||
94714910|NCT01985334|324416834|FG003|Overall Study|Worsening of disease|1|||
94714911|NCT01985334|324416835|FG004|Overall Study|Worsening of disease|0|||
94714912|NCT01985334|324416836|FG005|Overall Study|Worsening of disease|3|||
94714913|NCT01985334|324416837|FG006|Overall Study|Worsening of disease|0|||
94714914|NCT01985334|324416838|FG007|Overall Study|Worsening of disease|1|||
94714915|NCT01985334|324416831|FG000|Overall Study|Other|2|||
94714916|NCT01985334|324416832|FG001|Overall Study|Other|9|||
94714917|NCT01985334|324416833|FG002|Overall Study|Other|7|||
94714918|NCT01985334|324416834|FG003|Overall Study|Other|17|||
94714919|NCT01985334|324416835|FG004|Overall Study|Other|4|||
94714920|NCT01985334|324416836|FG005|Overall Study|Other|8|||
94714921|NCT01985334|324416837|FG006|Overall Study|Other|4|||
94714922|NCT01985334|324416838|FG007|Overall Study|Other|7|||
94714923|NCT01985334|324416831|FG000|Overall Study|Protocol deviation|6|||
94271011|NCT01226459|322785139|FG001|Overall Study|Lost to Follow-up|8|||
94714924|NCT01985334|324416832|FG001|Overall Study|Protocol deviation|31|||
94714925|NCT01985334|324416833|FG002|Overall Study|Protocol deviation|25|||
94714926|NCT01985334|324416834|FG003|Overall Study|Protocol deviation|84|||
94714927|NCT01985334|324416835|FG004|Overall Study|Protocol deviation|17|||
94714928|NCT01985334|324416836|FG005|Overall Study|Protocol deviation|47|||
94714929|NCT01985334|324416837|FG006|Overall Study|Protocol deviation|15|||
94714930|NCT01985334|324416838|FG007|Overall Study|Protocol deviation|42|||
94714931|NCT01985334|324416831|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
94714932|NCT01985334|324416832|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
94714933|NCT01985334|324416833|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
94714934|NCT01985334|324416834|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
94714935|NCT01985334|324416835|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
94714936|NCT01985334|324416836|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
94714937|NCT01985334|324416837|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
94714938|NCT01985334|324416838|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
94714939|NCT01985334|324416831|FG000|Overall Study|Subject withdrawal of consent|3|||
94714940|NCT01985334|324416832|FG001|Overall Study|Subject withdrawal of consent|6|||
94714941|NCT01985334|324416833|FG002|Overall Study|Subject withdrawal of consent|2|||
94714942|NCT01985334|324416834|FG003|Overall Study|Subject withdrawal of consent|28|||
94714943|NCT01985334|324416835|FG004|Overall Study|Subject withdrawal of consent|4|||
94714944|NCT01985334|324416836|FG005|Overall Study|Subject withdrawal of consent|19|||
94714945|NCT01985334|324416837|FG006|Overall Study|Subject withdrawal of consent|0|||
94714946|NCT01985334|324416838|FG007|Overall Study|Subject withdrawal of consent|20|||
94714947|NCT01985334|324416831|FG000|Overall Study|Adverse Event|0|||
94714948|NCT01985334|324416832|FG001|Overall Study|Adverse Event|8|||
94714949|NCT01985334|324416833|FG002|Overall Study|Adverse Event|2|||
94714950|NCT01985334|324416834|FG003|Overall Study|Adverse Event|26|||
94714951|NCT01985334|324416835|FG004|Overall Study|Adverse Event|3|||
94714952|NCT01985334|324416836|FG005|Overall Study|Adverse Event|18|||
94714953|NCT01985334|324416837|FG006|Overall Study|Adverse Event|3|||
94714954|NCT01985334|324416838|FG007|Overall Study|Adverse Event|15|||
94714955|NCT01985334|324416831|FG000|Overall Study|Other|4|||
94714956|NCT01985334|324416832|FG001|Overall Study|Other|2|||
94714957|NCT01985334|324416833|FG002|Overall Study|Other|3|||
94714958|NCT01985334|324416834|FG003|Overall Study|Other|10|||
94714959|NCT01985334|324416835|FG004|Overall Study|Other|1|||
94714960|NCT01985334|324416836|FG005|Overall Study|Other|6|||
94714961|NCT01985334|324416837|FG006|Overall Study|Other|2|||
94714962|NCT01985334|324416838|FG007|Overall Study|Other|2|||
94714963|NCT01985334|324416831|FG000|Overall Study|Medication non-compliance|0|||
94714964|NCT01985334|324416832|FG001|Overall Study|Medication non-compliance|4|||
94714965|NCT01985334|324416833|FG002|Overall Study|Medication non-compliance|1|||
94714966|NCT01985334|324416834|FG003|Overall Study|Medication non-compliance|6|||
94714967|NCT01985334|324416835|FG004|Overall Study|Medication non-compliance|2|||
94714968|NCT01985334|324416836|FG005|Overall Study|Medication non-compliance|3|||
94714969|NCT01985334|324416837|FG006|Overall Study|Medication non-compliance|1|||
94714970|NCT01985334|324416838|FG007|Overall Study|Medication non-compliance|3|||
94714971|NCT01985334|324416831|FG000|Overall Study|Use of prohibited treatment|1|||
94714972|NCT01985334|324416832|FG001|Overall Study|Use of prohibited treatment|4|||
94714973|NCT01985334|324416833|FG002|Overall Study|Use of prohibited treatment|1|||
94714974|NCT01985334|324416834|FG003|Overall Study|Use of prohibited treatment|2|||
94714975|NCT01985334|324416835|FG004|Overall Study|Use of prohibited treatment|1|||
94714976|NCT01985334|324416836|FG005|Overall Study|Use of prohibited treatment|6|||
94714977|NCT01985334|324416837|FG006|Overall Study|Use of prohibited treatment|2|||
94714978|NCT01985334|324416838|FG007|Overall Study|Use of prohibited treatment|0|||
94714979|NCT01985334|324416831|FG000|Overall Study|Investigator decision|0|||
94714980|NCT01985334|324416832|FG001|Overall Study|Investigator decision|3|||
94714981|NCT01985334|324416833|FG002|Overall Study|Investigator decision|0|||
94714982|NCT01985334|324416834|FG003|Overall Study|Investigator decision|7|||
94714983|NCT01985334|324416835|FG004|Overall Study|Investigator decision|1|||
94714984|NCT01985334|324416836|FG005|Overall Study|Investigator decision|1|||
94714985|NCT01985334|324416837|FG006|Overall Study|Investigator decision|0|||
94714986|NCT01985334|324416838|FG007|Overall Study|Investigator decision|4|||
94714987|NCT01985334|324416831|FG000|Overall Study|Lost to Follow-up|0|||
94714988|NCT01985334|324416832|FG001|Overall Study|Lost to Follow-up|2|||
94714989|NCT01985334|324416833|FG002|Overall Study|Lost to Follow-up|0|||
94467245|NCT03379792|323500485|FG000|Overall Study|Physician Decision|0|||
94467246|NCT03379792|323500486|FG001|Overall Study|Physician Decision|0|||
94467247|NCT03379792|323500487|FG002|Overall Study|Physician Decision|0|||
94714990|NCT01985334|324416834|FG003|Overall Study|Lost to Follow-up|3|||
94714991|NCT01985334|324416835|FG004|Overall Study|Lost to Follow-up|1|||
94714992|NCT01985334|324416836|FG005|Overall Study|Lost to Follow-up|4|||
94714993|NCT01985334|324416837|FG006|Overall Study|Lost to Follow-up|0|||
94714994|NCT01985334|324416838|FG007|Overall Study|Lost to Follow-up|3|||
94714995|NCT02740231|324416839|FG000|Overall Study|Withdrawal by Subject|1|||
94714996|NCT02740231|324416840|FG001|Overall Study|Withdrawal by Subject|1|||
94714997|NCT02740231|324416841|FG002|Overall Study|Withdrawal by Subject|1|||
94714998|NCT02740231|324416842|FG003|Overall Study|Withdrawal by Subject|0|||
94714999|NCT02740231|324416839|FG000|Overall Study|Lack of Efficacy|0|||
94715000|NCT02740231|324416840|FG001|Overall Study|Lack of Efficacy|1|||
94715001|NCT02740231|324416841|FG002|Overall Study|Lack of Efficacy|0|||
94715002|NCT02740231|324416842|FG003|Overall Study|Lack of Efficacy|4|||
94715003|NCT02740231|324416839|FG000|Overall Study|Lost to Follow-up|1|||
94715004|NCT02740231|324416840|FG001|Overall Study|Lost to Follow-up|3|||
94715005|NCT02740231|324416841|FG002|Overall Study|Lost to Follow-up|0|||
94715006|NCT02740231|324416842|FG003|Overall Study|Lost to Follow-up|3|||
94715007|NCT02740231|324416839|FG000|Overall Study|Adverse Event|0|||
94715008|NCT02740231|324416840|FG001|Overall Study|Adverse Event|1|||
94715009|NCT02740231|324416841|FG002|Overall Study|Adverse Event|0|||
94715010|NCT02740231|324416842|FG003|Overall Study|Adverse Event|1|||
94715011|NCT01290341|324416845|FG000|Overall Study|Protocol Violation|7|||
94715012|NCT01290341|324416846|FG001|Overall Study|Protocol Violation|3|||
94715013|NCT01290341|324416845|FG000|Overall Study|Adverse Event|1|||
94715014|NCT01290341|324416846|FG001|Overall Study|Adverse Event|0|||
94715015|NCT01290341|324416845|FG000|Overall Study|Lost to Follow-up|21|||
94715016|NCT01290341|324416846|FG001|Overall Study|Lost to Follow-up|10|||
94715017|NCT01290341|324416845|FG000|Overall Study|Withdrawal by Subject|19|||
94715018|NCT01290341|324416846|FG001|Overall Study|Withdrawal by Subject|5|||
94715019|NCT01290341|324416845|FG000|Overall Study|Negative baseline culture and others|44|||
94715020|NCT01290341|324416846|FG001|Overall Study|Negative baseline culture and others|11|||
94715021|NCT00093015|324416848|FG000|Overall Study|Withdrawal by Subject|194|||
94715022|NCT00093015|324416849|FG001|Overall Study|Withdrawal by Subject|171|||
94715023|NCT00093015|324416848|FG000|Overall Study|Lost to Follow-up|96|||
94715024|NCT00093015|324416849|FG001|Overall Study|Lost to Follow-up|108|||
94715025|NCT00093015|324416848|FG000|Overall Study|Death|375|||
94715026|NCT00093015|324416849|FG001|Overall Study|Death|385|||
94715027|NCT02874534|324416852|FG000|Overall Study|Withdrawal by Subject|5|||
94715028|NCT02874534|324416853|FG001|Overall Study|Withdrawal by Subject|8|||
94715029|NCT02874534|324416852|FG000|Overall Study|Lost to Follow-up|2|||
94715030|NCT02874534|324416853|FG001|Overall Study|Lost to Follow-up|2|||
94715031|NCT02874534|324416852|FG000|Overall Study|Ongoing in study|1|||
94715032|NCT02874534|324416853|FG001|Overall Study|Ongoing in study|1|||
94715033|NCT03988023|324416855|FG000|Overall Study|Non-compliance|3|||
94715034|NCT03988023|324416856|FG001|Overall Study|Non-compliance|0|||
94715035|NCT03988023|324416855|FG000|Overall Study|Withdrawal by Subject|39|||
94715036|NCT03988023|324416856|FG001|Overall Study|Withdrawal by Subject|37|||
94715037|NCT03988023|324416855|FG000|Overall Study|Adverse Event|0|||
94715038|NCT03988023|324416856|FG001|Overall Study|Adverse Event|2|||
94715039|NCT03988023|324416855|FG000|Overall Study|Physician Decision|0|||
94715040|NCT03988023|324416856|FG001|Overall Study|Physician Decision|1|||
94715041|NCT03988023|324416855|FG000|Overall Study|Lost to Follow-up|5|||
94715042|NCT03988023|324416856|FG001|Overall Study|Lost to Follow-up|8|||
94715043|NCT03988023|324416855|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
94715044|NCT03988023|324416856|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
94715045|NCT03988023|324416855|FG000|Overall Study|Lack of Efficacy|3|||
94715046|NCT03988023|324416856|FG001|Overall Study|Lack of Efficacy|1|||
94715047|NCT03988023|324416855|FG000|Overall Study|COVID-19 pandemic|225|||
94715048|NCT03988023|324416856|FG001|Overall Study|COVID-19 pandemic|227|||
94715049|NCT00480077|324416857|FG000|Overall Study|Death|19|||
94715050|NCT00480077|324416858|FG001|Overall Study|Death|15|||
94715051|NCT00480077|324416857|FG000|Overall Study|early exit|12|||
94715052|NCT00480077|324416858|FG001|Overall Study|early exit|11|||
94715053|NCT02101281|324416859|FG000|Overall Study|Adverse Event|0|||
94715054|NCT02101281|324416860|FG001|Overall Study|Adverse Event|1|||
94715055|NCT04452318|324416861|FG000|Overall Study|Physician Decision|1|||
94715056|NCT04452318|324416862|FG001|Overall Study|Physician Decision|2|||
94715057|NCT04452318|324416863|FG002|Overall Study|Physician Decision|0|||
94715058|NCT04452318|324416864|FG003|Overall Study|Physician Decision|2|||
94715059|NCT04452318|324416865|FG004|Overall Study|Physician Decision|0|||
94715060|NCT04452318|324416866|FG005|Overall Study|Physician Decision|2|||
94715061|NCT04452318|324416867|FG006|Overall Study|Physician Decision|5|||
94715062|NCT04452318|324416861|FG000|Overall Study|Death|2|||
94715063|NCT04452318|324416862|FG001|Overall Study|Death|3|||
94715064|NCT04452318|324416863|FG002|Overall Study|Death|0|||
94715065|NCT04452318|324416864|FG003|Overall Study|Death|0|||
94715066|NCT04452318|324416865|FG004|Overall Study|Death|0|||
94715067|NCT04452318|324416866|FG005|Overall Study|Death|0|||
94715068|NCT04452318|324416867|FG006|Overall Study|Death|0|||
94271012|NCT01226459|322785138|FG000|Overall Study|Pregnancy|1|||
94271013|NCT01226459|322785139|FG001|Overall Study|Pregnancy|0|||
94271014|NCT00474708|322785140|FG000|Overall Study|Lack of Efficacy|11|||
94715069|NCT04452318|324416861|FG000|Overall Study|Lost to Follow-up|38|||
94715070|NCT04452318|324416862|FG001|Overall Study|Lost to Follow-up|28|||
94715071|NCT04452318|324416863|FG002|Overall Study|Lost to Follow-up|0|||
94715072|NCT04452318|324416864|FG003|Overall Study|Lost to Follow-up|3|||
94271015|NCT00474708|322785141|FG001|Overall Study|Lack of Efficacy|5|||
94715073|NCT04452318|324416865|FG004|Overall Study|Lost to Follow-up|3|||
94715074|NCT04452318|324416866|FG005|Overall Study|Lost to Follow-up|2|||
94715075|NCT04452318|324416867|FG006|Overall Study|Lost to Follow-up|1|||
94467248|NCT03379792|323500488|FG003|Overall Study|Physician Decision|1|||
94715076|NCT04452318|324416861|FG000|Overall Study|Withdrawal by Subject|46|||
94715077|NCT04452318|324416862|FG001|Overall Study|Withdrawal by Subject|40|||
94715078|NCT04452318|324416863|FG002|Overall Study|Withdrawal by Subject|0|||
94715079|NCT04452318|324416864|FG003|Overall Study|Withdrawal by Subject|18|||
94715080|NCT04452318|324416865|FG004|Overall Study|Withdrawal by Subject|6|||
94715081|NCT04452318|324416866|FG005|Overall Study|Withdrawal by Subject|8|||
94715082|NCT04452318|324416867|FG006|Overall Study|Withdrawal by Subject|6|||
94715083|NCT03951805|324416870|FG000|Overall Study|Adverse Event|1|||
94715084|NCT03951805|324416871|FG001|Overall Study|Adverse Event|0|||
94715085|NCT03951805|324416872|FG002|Overall Study|Adverse Event|0|||
94715086|NCT03951805|324416873|FG003|Overall Study|Adverse Event|0|||
94715087|NCT00604669|324416874|FG000|Overall Study|lack of information in chart|7|||
94715088|NCT01695954|324416875|FG000|Overall Study|Withdrawal by Subject|4|||
94715089|NCT01695954|324416876|FG001|Overall Study|Withdrawal by Subject|0|||
94715090|NCT01695954|324416875|FG000|Overall Study|Adverse Event|0|||
94715091|NCT01695954|324416876|FG001|Overall Study|Adverse Event|2|||
94715092|NCT02789020|324416877|FG000|Overall Study|Withdrawal by Subject|6|||
94715093|NCT02789020|324416878|FG001|Overall Study|Withdrawal by Subject|5|||
94715094|NCT03233633|324416893|FG000|Overall Study|Adverse Event|2|||
94715095|NCT03233633|324416893|FG000|Overall Study|Less Than 3 Days of Data|6|||
94715096|NCT01198145|324416899|FG000|Overall Study|Withdrawal by Subject|1|||
94715097|NCT01198145|324416900|FG001|Overall Study|Withdrawal by Subject|1|||
94715098|NCT00396084|324416901|FG000|Overall Study|Adverse Event|0|||
94715099|NCT00396084|324416902|FG001|Overall Study|Adverse Event|0|||
94715100|NCT00396084|324416903|FG002|Overall Study|Adverse Event|0|||
94715101|NCT00396084|324416904|FG003|Overall Study|Adverse Event|0|||
94715102|NCT00396084|324416905|FG004|Overall Study|Adverse Event|1|||
94715103|NCT00396084|324416906|FG005|Overall Study|Adverse Event|2|||
94715104|NCT00396084|324416901|FG000|Overall Study|Withdrawal by Subject|0|||
94715105|NCT00396084|324416902|FG001|Overall Study|Withdrawal by Subject|0|||
94715106|NCT00396084|324416903|FG002|Overall Study|Withdrawal by Subject|0|||
94715107|NCT00396084|324416904|FG003|Overall Study|Withdrawal by Subject|1|||
94715108|NCT00396084|324416905|FG004|Overall Study|Withdrawal by Subject|0|||
94715109|NCT00396084|324416906|FG005|Overall Study|Withdrawal by Subject|0|||
94715110|NCT02886286|324416907|FG000|Overall Study|pump motor stall|0|||
94715111|NCT02886286|324416908|FG001|Overall Study|pump motor stall|1|||
94715112|NCT02568683|324416909|FG000|Overall Study|Death|0|||
94715113|NCT02568683|324416910|FG001|Overall Study|Death|2|||
94715114|NCT02568683|324416909|FG000|Overall Study|Withdrew Consent|1|||
94715115|NCT02568683|324416910|FG001|Overall Study|Withdrew Consent|0|||
94715116|NCT02568683|324416909|FG000|Overall Study|Study Terminated By Sponsor|5|||
94715117|NCT02568683|324416910|FG001|Overall Study|Study Terminated By Sponsor|2|||
94715118|NCT00522951|324416911|FG000|Period 1|body motion|0|||
94715119|NCT00522951|324416912|FG001|Period 1|body motion|1|||
94715120|NCT00522951|324416911|FG000|Washout Period|Adverse Event|0|||
94715121|NCT00522951|324416912|FG001|Washout Period|Adverse Event|1|||
94715122|NCT00522951|324416911|FG000|Washout Period|Death|0|||
94715123|NCT00522951|324416912|FG001|Washout Period|Death|1|||
94715124|NCT00522951|324416911|FG000|Period 2|Withdrawal by Subject|1|||
94715125|NCT00522951|324416912|FG001|Period 2|Withdrawal by Subject|0|||
94715126|NCT00522951|324416911|FG000|Period 2|residual contrast medium|1|||
94715127|NCT00522951|324416912|FG001|Period 2|residual contrast medium|1|||
94715128|NCT03485950|324416916|FG000|Overall Study|Adverse Event|1|||
94271016|NCT00474708|322785140|FG000|Overall Study|Suicide ideation/behavior|0|||
94271017|NCT00474708|322785141|FG001|Overall Study|Suicide ideation/behavior|1|||
94271018|NCT00474708|322785140|FG000|Overall Study|Withdrawal by Subject|7|||
94271019|NCT00474708|322785141|FG001|Overall Study|Withdrawal by Subject|0|||
94271020|NCT00474708|322785140|FG000|Overall Study|Lack of compliance|12|||
94271021|NCT00474708|322785141|FG001|Overall Study|Lack of compliance|4|||
94271022|NCT00474708|322785140|FG000|Overall Study|Lost to Follow-up|18|||
94271023|NCT00474708|322785141|FG001|Overall Study|Lost to Follow-up|9|||
94271024|NCT00474708|322785140|FG000|Overall Study|Physician Decision|9|||
94715129|NCT03485950|324416917|FG001|Overall Study|Adverse Event|0|||
94715130|NCT03485950|324416916|FG000|Overall Study|Death|3|||
94715131|NCT03485950|324416917|FG001|Overall Study|Death|2|||
94715132|NCT03485950|324416916|FG000|Overall Study|Withdrawal by Subject|3|||
94715133|NCT03485950|324416917|FG001|Overall Study|Withdrawal by Subject|0|||
94715134|NCT00580866|324416918|FG000|Overall Study|Lost to Follow-up|2|||
94715135|NCT00580866|324416919|FG001|Overall Study|Lost to Follow-up|2|||
94715136|NCT02238483|324416923|FG000|Overall Study|Withdrawal by Subject|2|||
94271025|NCT00474708|322785141|FG001|Overall Study|Physician Decision|6|||
94271026|NCT01087775|322785144|FG000|Overall Study|failed inclusion criteria|2|||
94715137|NCT02238483|324416924|FG001|Overall Study|Withdrawal by Subject|7|||
94715138|NCT02238483|324416923|FG000|Overall Study|Lost to Follow-up|1|||
94715139|NCT02238483|324416924|FG001|Overall Study|Lost to Follow-up|1|||
94271027|NCT00808236|322785146|FG000|Overall Study|Was not resuscitated|50|||
94271028|NCT00808236|322785147|FG001|Overall Study|Was not resuscitated|56|||
94715140|NCT02238483|324416923|FG000|Overall Study|Protocol Violation|1|||
94715141|NCT02238483|324416924|FG001|Overall Study|Protocol Violation|2|||
94367332|NCT00627458|323131545|FG000|Overall Study|Withdrawal by Subject|2|||
94367333|NCT00627458|323131546|FG001|Overall Study|Withdrawal by Subject|6|||
94367334|NCT00627458|323131547|FG002|Overall Study|Withdrawal by Subject|5|||
94367335|NCT00627458|323131545|FG000|Overall Study|Lost to Follow-up|1|||
94367336|NCT00627458|323131546|FG001|Overall Study|Lost to Follow-up|1|||
94367337|NCT00627458|323131547|FG002|Overall Study|Lost to Follow-up|0|||
94367338|NCT01466673|323131551|FG000|Overall Study|Non-compliance with study treatment|2|||
94367339|NCT01466673|323131552|FG001|Overall Study|Non-compliance with study treatment|0|||
94367340|NCT01466673|323131551|FG000|Overall Study|Lost to Follow-up|3|||
94367341|NCT01466673|323131552|FG001|Overall Study|Lost to Follow-up|5|||
94367342|NCT01466673|323131551|FG000|Overall Study|Adverse Event|2|||
94367343|NCT01466673|323131552|FG001|Overall Study|Adverse Event|1|||
94367344|NCT02426125|323131558|FG000|Overall Study|Lost to Follow-up|14|||
94367345|NCT02426125|323131559|FG001|Overall Study|Lost to Follow-up|12|||
94367346|NCT02426125|323131558|FG000|Overall Study|Withdrawal by Subject|13|||
94367347|NCT02426125|323131559|FG001|Overall Study|Withdrawal by Subject|14|||
94367348|NCT02426125|323131558|FG000|Overall Study|Death|185|||
94367349|NCT02426125|323131559|FG001|Overall Study|Death|200|||
94367350|NCT02426125|323131558|FG000|Overall Study|Randomized, But Never Treated|5|||
94367351|NCT02426125|323131559|FG001|Overall Study|Randomized, But Never Treated|2|||
94367352|NCT00963599|323131560|FG000|Overall Study|Adverse Event|2|||
94367353|NCT00963599|323131561|FG001|Overall Study|Adverse Event|0|||
94367354|NCT00963599|323131562|FG002|Overall Study|Adverse Event|1|||
94367355|NCT00963599|323131563|FG003|Overall Study|Adverse Event|2|||
94367356|NCT00963599|323131560|FG000|Overall Study|Lack of Efficacy|0|||
94367357|NCT00963599|323131561|FG001|Overall Study|Lack of Efficacy|2|||
94367358|NCT00963599|323131562|FG002|Overall Study|Lack of Efficacy|1|||
94367359|NCT00963599|323131563|FG003|Overall Study|Lack of Efficacy|4|||
94367360|NCT00963599|323131560|FG000|Overall Study|Lost to Follow-up|0|||
94367361|NCT00963599|323131561|FG001|Overall Study|Lost to Follow-up|1|||
94367362|NCT00963599|323131562|FG002|Overall Study|Lost to Follow-up|1|||
94367363|NCT00963599|323131563|FG003|Overall Study|Lost to Follow-up|1|||
94715142|NCT02238483|324416923|FG000|Overall Study|Death|1|||
94715143|NCT02238483|324416924|FG001|Overall Study|Death|0|||
94715144|NCT02238483|324416923|FG000|Overall Study|Adverse Event|7|||
94715145|NCT02238483|324416924|FG001|Overall Study|Adverse Event|3|||
94715146|NCT02238483|324416923|FG000|Overall Study|Withdrawn due to physician decision|1|||
94715147|NCT02238483|324416924|FG001|Overall Study|Withdrawn due to physician decision|0|||
94715148|NCT02238483|324416923|FG000|Overall Study|Completion status not recorded|1|||
94715149|NCT02238483|324416924|FG001|Overall Study|Completion status not recorded|1|||
94715150|NCT02238483|324416923|FG000|Overall Study|Illness in family member|1|||
94715151|NCT02238483|324416924|FG001|Overall Study|Illness in family member|0|||
94715152|NCT03101930|324416925|FG000|Overall Study|Withdrawal by Subject|2|||
94715153|NCT03101930|324416926|FG001|Overall Study|Withdrawal by Subject|1|||
94271029|NCT00808236|322785146|FG000|Overall Study|Pre-defined exclusion|13|||
94271030|NCT00808236|322785147|FG001|Overall Study|Pre-defined exclusion|3|||
94271031|NCT00808236|322785146|FG000|Overall Study|Lost to Follow-up|1|||
94271032|NCT00808236|322785147|FG001|Overall Study|Lost to Follow-up|1|||
94271033|NCT00808236|322785146|FG000|Overall Study|Physician Decision|0|||
94271034|NCT00808236|322785147|FG001|Overall Study|Physician Decision|1|||
94271035|NCT00808236|322785146|FG000|Overall Study|Death|18|||
94271036|NCT00808236|322785147|FG001|Overall Study|Death|30|||
94271037|NCT04247061|322785151|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
94271038|NCT04247061|322785151|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
94271039|NCT04247061|322785151|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
94271040|NCT01136655|322785152|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
94271041|NCT01136655|322785152|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
94271042|NCT01136655|322785152|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
94271043|NCT01136655|322785152|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
94271044|NCT01177683|322785155|FG000|Study Treatment|Disease Progressions during treatment|2|||
94271045|NCT01177683|322785156|FG001|Study Treatment|Disease Progressions during treatment|0|||
94271046|NCT01177683|322785157|FG002|Study Treatment|Disease Progressions during treatment|3|||
94271047|NCT01177683|322785155|FG000|Study Treatment|Adverse Event|0|||
94271048|NCT01177683|322785156|FG001|Study Treatment|Adverse Event|1|||
94271049|NCT01177683|322785157|FG002|Study Treatment|Adverse Event|12|||
94271050|NCT01177683|322785155|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
94271051|NCT01177683|322785156|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
94271052|NCT01177683|322785157|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
94271053|NCT01177683|322785155|FG000|Study Treatment|Alternative therapy|0|||
94271054|NCT01177683|322785156|FG001|Study Treatment|Alternative therapy|0|||
94367364|NCT00963599|323131560|FG000|Overall Study|Protocol Violation|2|||
94367365|NCT00963599|323131561|FG001|Overall Study|Protocol Violation|2|||
94367366|NCT00963599|323131562|FG002|Overall Study|Protocol Violation|3|||
94367367|NCT00963599|323131563|FG003|Overall Study|Protocol Violation|4|||
94715154|NCT03101930|324416927|FG002|Overall Study|Withdrawal by Subject|2|||
94715155|NCT00262301|324416928|FG000|Double-blind Phase|Lost to Follow-up|1|||
94715156|NCT00262301|324416929|FG001|Double-blind Phase|Lost to Follow-up|0|||
94715157|NCT00262301|324416930|FG002|Double-blind Phase|Lost to Follow-up|0|||
94715158|NCT00262301|324416928|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
94715159|NCT00262301|324416929|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
94715160|NCT00262301|324416930|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
94715161|NCT01747486|324416934|FG000|Stage 1|Physician Decision|3|||
94715162|NCT01747486|324416935|FG001|Stage 1|Physician Decision|0|||
94715163|NCT01747486|324416934|FG000|Stage 1|Withdrawal by Subject|4|||
94715164|NCT01747486|324416935|FG001|Stage 1|Withdrawal by Subject|3|||
94715165|NCT01747486|324416934|FG000|Stage 1|Disease progression|4|||
94715166|NCT01747486|324416935|FG001|Stage 1|Disease progression|9|||
94715167|NCT01747486|324416934|FG000|Stage 1|Death|1|||
94715168|NCT01747486|324416935|FG001|Stage 1|Death|1|||
94715169|NCT01747486|324416934|FG000|Stage 2|Physician Decision|2|||
94715170|NCT01747486|324416935|FG001|Stage 2|Physician Decision|0|||
94715171|NCT01747486|324416934|FG000|Stage 2|Withdrawal by Subject|1|||
94715172|NCT01747486|324416935|FG001|Stage 2|Withdrawal by Subject|0|||
94715173|NCT01747486|324416934|FG000|Stage 2|New Cancer Therapy|3|||
94715174|NCT01747486|324416935|FG001|Stage 2|New Cancer Therapy|0|||
94715175|NCT01747486|324416934|FG000|Stage 2|Disease Progression|3|||
94715176|NCT01747486|324416935|FG001|Stage 2|Disease Progression|0|||
94715177|NCT03201562|324416936|FG000|Overall Study|Physician Decision|0|||
94715178|NCT03201562|324416937|FG001|Overall Study|Physician Decision|0|||
94715179|NCT03201562|324416938|FG002|Overall Study|Physician Decision|1|||
94715180|NCT03201562|324416936|FG000|Overall Study|Adverse Event|0|||
94715181|NCT03201562|324416937|FG001|Overall Study|Adverse Event|0|||
94715182|NCT03201562|324416938|FG002|Overall Study|Adverse Event|1|||
94715183|NCT03201562|324416936|FG000|Overall Study|Lost to Follow-up|0|||
94715184|NCT03201562|324416937|FG001|Overall Study|Lost to Follow-up|1|||
94715185|NCT03201562|324416938|FG002|Overall Study|Lost to Follow-up|2|||
94715186|NCT01227265|324416945|FG000|Overall Study|Did Not Receive Treatment|1|||
94715187|NCT01227265|324416946|FG001|Overall Study|Did Not Receive Treatment|2|||
94715188|NCT01227265|324416947|FG002|Overall Study|Did Not Receive Treatment|0|||
94715189|NCT01227265|324416945|FG000|Overall Study|Administrative|1|||
94715190|NCT01227265|324416946|FG001|Overall Study|Administrative|0|||
94715191|NCT01227265|324416947|FG002|Overall Study|Administrative|2|||
94715192|NCT01227265|324416945|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
94715193|NCT01227265|324416946|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
94715194|NCT01227265|324416947|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
94715195|NCT01227265|324416945|FG000|Overall Study|Protocol Violation|2|||
94715196|NCT01227265|324416946|FG001|Overall Study|Protocol Violation|1|||
94715197|NCT01227265|324416947|FG002|Overall Study|Protocol Violation|0|||
94715198|NCT01227265|324416945|FG000|Overall Study|Withdrawal by Subject|7|||
94715199|NCT01227265|324416946|FG001|Overall Study|Withdrawal by Subject|7|||
94715200|NCT01227265|324416947|FG002|Overall Study|Withdrawal by Subject|3|||
94715201|NCT01227265|324416945|FG000|Overall Study|Lost to Follow-up|2|||
94715202|NCT01227265|324416946|FG001|Overall Study|Lost to Follow-up|0|||
94715203|NCT01227265|324416947|FG002|Overall Study|Lost to Follow-up|3|||
94715204|NCT01227265|324416945|FG000|Overall Study|Adverse Event|6|||
94715205|NCT01227265|324416946|FG001|Overall Study|Adverse Event|10|||
94715206|NCT01227265|324416947|FG002|Overall Study|Adverse Event|5|||
94715207|NCT01037985|324416948|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
94715208|NCT01037985|324416949|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
94715209|NCT01037985|324416948|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
94715210|NCT01037985|324416949|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
94715211|NCT01037985|324416948|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
94715212|NCT01037985|324416949|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
94715213|NCT01037985|324416948|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
94715214|NCT01037985|324416949|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
94715215|NCT02269475|324416950|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
94715216|NCT02269475|324416951|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
94715217|NCT02269475|324416950|FG000|Overall Study|Withdrawal by Subject|0|||
94715218|NCT02269475|324416951|FG001|Overall Study|Withdrawal by Subject|1|||
94715219|NCT03664960|324416952|FG000|Overall Study|Adverse Event|0|||
94715220|NCT03664960|324416953|FG001|Overall Study|Adverse Event|3|||
94715221|NCT03664960|324416952|FG000|Overall Study|Lost to Follow-up|3|||
94715222|NCT03664960|324416953|FG001|Overall Study|Lost to Follow-up|2|||
94715223|NCT03664960|324416952|FG000|Overall Study|Physician Decision|1|||
94715224|NCT03664960|324416953|FG001|Overall Study|Physician Decision|0|||
94715225|NCT03664960|324416952|FG000|Overall Study|Withdrawal by Subject|3|||
94715226|NCT03664960|324416953|FG001|Overall Study|Withdrawal by Subject|14|||
94715227|NCT03664960|324416952|FG000|Overall Study|Sponsor Decision|1|||
94367368|NCT00963599|323131560|FG000|Overall Study|Withdrawal by Subject|2|||
94715228|NCT03664960|324416953|FG001|Overall Study|Sponsor Decision|1|||
94715229|NCT03664960|324416952|FG000|Overall Study|Other|1|||
94715230|NCT03664960|324416953|FG001|Overall Study|Other|2|||
94715231|NCT00823472|324416954|FG000|Overall Study|Physician Decision|24|||
94271055|NCT01177683|322785157|FG002|Study Treatment|Alternative therapy|4|||
94271056|NCT01177683|322785155|FG000|Study Treatment|Physician Decision|1|||
94271057|NCT01177683|322785156|FG001|Study Treatment|Physician Decision|0|||
94271058|NCT01177683|322785157|FG002|Study Treatment|Physician Decision|1|||
94715232|NCT00823472|324416955|FG001|Overall Study|Physician Decision|28|||
94271059|NCT01177683|322785155|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
94271060|NCT01177683|322785156|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
94271061|NCT01177683|322785157|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
94271062|NCT01177683|322785155|FG000|Study Treatment|Symptomatic Deterioration|0|||
94271063|NCT01177683|322785156|FG001|Study Treatment|Symptomatic Deterioration|0|||
94271064|NCT01177683|322785157|FG002|Study Treatment|Symptomatic Deterioration|1|||
94271065|NCT01177683|322785155|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
94271066|NCT01177683|322785156|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
94715233|NCT04411056|324418849|FG000|Overall Study|surgery cancelled|1|||
94715234|NCT04411056|324418850|FG001|Overall Study|surgery cancelled|0|||
94715235|NCT04411056|324418849|FG000|Overall Study|Equipment problem during intubation|0|||
94715236|NCT04411056|324418850|FG001|Overall Study|Equipment problem during intubation|1|||
94715237|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
94715238|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
94715239|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
94715240|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
94715241|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
94715242|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
94715243|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
94715244|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
94715245|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
94715246|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
94715247|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
94715248|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
94715249|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
94715250|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
94715251|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
94715252|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
94715253|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
94715254|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
94715255|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
94715256|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
94715257|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
94271067|NCT01177683|322785157|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
94271068|NCT01177683|322785155|FG000|Follow up|Patient lost to follow up|0|||
94271069|NCT01177683|322785156|FG001|Follow up|Patient lost to follow up|0|||
94271070|NCT01177683|322785157|FG002|Follow up|Patient lost to follow up|2|||
94271071|NCT01177683|322785155|FG000|Follow up|Death|2|||
94271072|NCT01177683|322785156|FG001|Follow up|Death|1|||
94367369|NCT00963599|323131561|FG001|Overall Study|Withdrawal by Subject|1|||
94367370|NCT00963599|323131562|FG002|Overall Study|Withdrawal by Subject|3|||
94367371|NCT00963599|323131563|FG003|Overall Study|Withdrawal by Subject|3|||
94367372|NCT04529096|323131569|FG000|Overall Study|Adverse Event|6|||
94715258|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
94715259|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
94715260|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
94715261|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
94715262|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
94715263|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
94715264|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
94715265|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
94715266|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
94715267|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
94715268|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
94715269|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
94271073|NCT01177683|322785157|FG002|Follow up|Death|7|||
94271074|NCT01177683|322785155|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
94271075|NCT01177683|322785156|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
94271076|NCT01177683|322785157|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
94271077|NCT02437864|322785162|FG000|Overall Study|Protocol Violation|4|||
94367373|NCT04529096|323131570|FG001|Overall Study|Adverse Event|1|||
94715270|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
94715271|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
94715272|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
94271078|NCT02437864|322785163|FG001|Overall Study|Protocol Violation|0|||
94271079|NCT01924182|322785164|FG000|Overall Study|Withdrawal by Subject|1|||
94271080|NCT01924182|322785165|FG001|Overall Study|Withdrawal by Subject|0|||
94271081|NCT00219284|322785167|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
94271082|NCT00219284|322785168|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
94271083|NCT00219284|322785167|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
94271084|NCT00219284|322785168|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
94271085|NCT00219284|322785167|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
94271086|NCT00219284|322785168|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
94715273|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
94715274|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
94715275|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
94715276|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
94715277|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
94715278|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
94715279|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
94715280|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
94715281|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
94715282|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
94715283|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
94715284|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
94715285|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
94715286|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
94715287|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
94715288|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
94715289|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
94715290|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
94715291|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
94715292|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
94715293|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
94715294|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
94715295|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
94715296|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
94715297|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
94715298|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
94715299|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
94715300|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
94715301|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
94715302|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
94715303|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
94715304|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
94715305|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
94715306|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
94715307|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
94715308|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
94715309|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
94715310|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
94715311|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
94715312|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
94715313|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
94715314|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
94715315|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
94715316|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
94715317|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
94715318|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
94715319|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
94715320|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
94715321|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
94715322|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
94715323|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
94715324|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
94271087|NCT00219284|322785167|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
94271088|NCT00219284|322785168|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
94271089|NCT00219284|322785167|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
94271090|NCT00219284|322785168|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
94271091|NCT00219284|322785167|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
94715325|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
94715326|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
94715327|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
94715328|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
94715329|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
94715330|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
94715331|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
94715332|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
94715333|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
94715334|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
94715335|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
94715336|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
94715337|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
94715338|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
94715339|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
94715340|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
94715341|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
94715342|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
94715343|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
94715344|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
94715345|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
94715346|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
94715347|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
94715348|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
94715349|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
94715350|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
94715351|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
94715352|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
94715353|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
94715354|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
94715355|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
94715356|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
94715357|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
94715358|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
94715359|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
94715360|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
94715361|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
94715362|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
94715363|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
94715364|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
94715365|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
94715366|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
94715367|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
94715368|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
94715369|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
94715370|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
94715371|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
94715372|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
94715373|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
94715374|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
94715375|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
94715376|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
94715377|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
94715378|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
94715379|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
94715380|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
94715381|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
94715382|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
94715383|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
94715384|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
94715385|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
94715386|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
94715387|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
94715388|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
94715389|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
94715390|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
94715391|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
94715392|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
94715393|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
94715394|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
94715395|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
94715396|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
94715397|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
94715398|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
94715399|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
94715400|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
94715401|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
94715402|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
94715403|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
94715404|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
94715405|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
94715406|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
94715407|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
94715408|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
94715409|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
94271092|NCT00219284|322785168|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
94271093|NCT00219284|322785167|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
94271094|NCT00219284|322785168|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
94271095|NCT00219284|322785167|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
94271096|NCT00219284|322785168|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
94271097|NCT00219284|322785167|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
94271098|NCT00219284|322785168|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
94271099|NCT02090413|322785170|FG000|Overall Study|Adverse Event|11|||
94271100|NCT02090413|322785171|FG001|Overall Study|Adverse Event|15|||
94271101|NCT02090413|322785172|FG002|Overall Study|Adverse Event|20|||
94271102|NCT02090413|322785170|FG000|Overall Study|Flushing event|2|||
94271103|NCT02090413|322785171|FG001|Overall Study|Flushing event|0|||
94271104|NCT02090413|322785172|FG002|Overall Study|Flushing event|1|||
94715410|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
94715411|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
94715412|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
94715413|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
94715414|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
94715415|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
94715416|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
94715417|NCT03598790|324418858|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
94715418|NCT03598790|324418859|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
94715419|NCT03598790|324418860|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
94715420|NCT03598790|324418861|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
94715421|NCT03598790|324418862|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
94715422|NCT03598790|324418863|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
94715423|NCT03598790|324418864|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
94715424|NCT03598790|324418865|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
94715425|NCT03598790|324418866|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
94715426|NCT03598790|324418858|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
94715427|NCT03598790|324418859|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
94715428|NCT03598790|324418860|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
94715429|NCT03598790|324418861|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
94715430|NCT03598790|324418862|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
94715431|NCT03598790|324418863|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
94715432|NCT03598790|324418864|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
94715433|NCT03598790|324418865|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
94715434|NCT03598790|324418866|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
94715435|NCT03598790|324418858|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
94715436|NCT03598790|324418859|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
94715437|NCT03598790|324418860|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
94715438|NCT03598790|324418861|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
94715439|NCT03598790|324418862|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
94715440|NCT03598790|324418863|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
94715441|NCT03598790|324418864|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
94715442|NCT03598790|324418865|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
94715443|NCT03598790|324418866|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
94715444|NCT03598790|324418858|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
94715445|NCT03598790|324418859|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
94715446|NCT03598790|324418860|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
94715447|NCT03598790|324418861|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
94715448|NCT03598790|324418862|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
94715449|NCT03598790|324418863|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
94715450|NCT03598790|324418864|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
94715451|NCT03598790|324418865|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
94715452|NCT03598790|324418866|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
94715453|NCT03598790|324418858|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
94715454|NCT03598790|324418859|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
94715455|NCT03598790|324418860|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
94715456|NCT03598790|324418861|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
94715457|NCT03598790|324418862|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
94715458|NCT03598790|324418863|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
94715459|NCT03598790|324418864|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
94271105|NCT02090413|322785170|FG000|Overall Study|Withdrawal by Subject|2|||
94271106|NCT02090413|322785171|FG001|Overall Study|Withdrawal by Subject|2|||
94271107|NCT02090413|322785172|FG002|Overall Study|Withdrawal by Subject|2|||
94271108|NCT02090413|322785170|FG000|Overall Study|Investigator Decision|1|||
94271109|NCT02090413|322785171|FG001|Overall Study|Investigator Decision|1|||
94271110|NCT02090413|322785172|FG002|Overall Study|Investigator Decision|0|||
94271111|NCT02090413|322785170|FG000|Overall Study|Other|2|||
94271112|NCT02090413|322785171|FG001|Overall Study|Other|1|||
94271113|NCT02090413|322785172|FG002|Overall Study|Other|0|||
94271114|NCT02090413|322785170|FG000|Overall Study|Lost to Follow-up|1|||
94271115|NCT02090413|322785171|FG001|Overall Study|Lost to Follow-up|1|||
94271116|NCT02090413|322785172|FG002|Overall Study|Lost to Follow-up|0|||
94271117|NCT05264740|322785177|FG000|Baseline|Withdrawal by Subject|0|||
94467249|NCT03379792|323500489|FG004|Overall Study|Physician Decision|0|||
94271118|NCT05264740|322785178|FG001|Baseline|Withdrawal by Subject|1|||
94271119|NCT05264740|322785177|FG000|Follow Up 1|Lost to Follow-up|1|||
94271120|NCT05264740|322785178|FG001|Follow Up 1|Lost to Follow-up|1|||
94271121|NCT05264740|322785177|FG000|Follow Up 1|Withdrawal by Subject|0|||
94715460|NCT03598790|324418865|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
94715461|NCT03598790|324418866|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
94715462|NCT03598790|324418858|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
94715463|NCT03598790|324418859|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
94715464|NCT03598790|324418860|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
94715465|NCT03598790|324418861|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
94715466|NCT03598790|324418862|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
94715467|NCT03598790|324418863|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
94715468|NCT03598790|324418864|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
94715469|NCT03598790|324418865|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
94715470|NCT03598790|324418866|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
94715471|NCT03215927|324418867|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
94715472|NCT03215927|324418868|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
94715473|NCT03215927|324418867|FG000|Open Label Extension|Adverse Event|1|||
94715474|NCT03215927|324418868|FG001|Open Label Extension|Adverse Event|0|||
94715475|NCT03215927|324418867|FG000|Open Label Extension|Lack of Efficacy|1|||
94715476|NCT03215927|324418868|FG001|Open Label Extension|Lack of Efficacy|0|||
94715477|NCT03215927|324418867|FG000|Open Label Extension|Death|0|||
94715478|NCT03215927|324418868|FG001|Open Label Extension|Death|1|||
94715479|NCT03122886|324418869|FG000|Overall Study|Withdrawal by Subject|1|||
94715480|NCT03122886|324418870|FG001|Overall Study|Withdrawal by Subject|2|||
94715481|NCT03785782|324418873|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
94715482|NCT03785782|324418874|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
94715483|NCT03785782|324418873|FG000|Overall Study|Withdrawal by Subject|1|||
94715484|NCT03785782|324418874|FG001|Overall Study|Withdrawal by Subject|1|||
94715485|NCT03785782|324418873|FG000|Overall Study|insufficient image quality.|3|||
94715486|NCT03785782|324418874|FG001|Overall Study|insufficient image quality.|0|||
94715487|NCT05568615|324418875|FG000|Overall Study|Death|1|||
94715488|NCT05568615|324418875|FG000|Overall Study|Physician Decision|1|||
94715489|NCT02279095|324418880|FG000|Overall Study|Non-Compliance|1|||
94715490|NCT02279095|324418880|FG000|Overall Study|Withdrawal by Subject|8|||
94715491|NCT02279095|324418880|FG000|Overall Study|Adverse Event|2|||
94715492|NCT02279095|324418880|FG000|Overall Study|Other|7|||
94715493|NCT02279095|324418880|FG000|Overall Study|Lost to Follow-up|1|||
94715494|NCT05777785|324418881|FG000|Overall Study|Withdrawal by Subject|5|||
94715495|NCT05777785|324418881|FG000|Overall Study|Lost to Follow-up|1|||
94715496|NCT04817670|324418882|FG000|Overall Study|Withdrawal by Subject|1|||
94715497|NCT04817670|324418883|FG001|Overall Study|Withdrawal by Subject|0|||
94715498|NCT04817670|324418884|FG002|Overall Study|Withdrawal by Subject|0|||
94715499|NCT04817670|324418885|FG003|Overall Study|Withdrawal by Subject|0|||
94715500|NCT04817670|324418886|FG004|Overall Study|Withdrawal by Subject|0|||
94715501|NCT04817670|324418882|FG000|Overall Study|Lost to Follow-up|0|||
94715502|NCT04817670|324418883|FG001|Overall Study|Lost to Follow-up|0|||
94271122|NCT05264740|322785178|FG001|Follow Up 1|Withdrawal by Subject|1|||
94271123|NCT05264740|322785177|FG000|Follow Up 2|Lost to Follow-up|1|||
94271124|NCT05264740|322785178|FG001|Follow Up 2|Lost to Follow-up|4|||
94271125|NCT05264740|322785177|FG000|Follow Up 3|Lost to Follow-up|7|||
94271126|NCT05264740|322785178|FG001|Follow Up 3|Lost to Follow-up|4|||
94271127|NCT00102960|322785179|FG000|Overall Study|Death|23|||
94271128|NCT00102960|322785180|FG001|Overall Study|Death|11|||
94271129|NCT00102960|322785181|FG002|Overall Study|Death|11|||
94271130|NCT00102960|322785179|FG000|Overall Study|Lost to Follow-up|6|||
94271131|NCT00102960|322785180|FG001|Overall Study|Lost to Follow-up|12|||
94271132|NCT00102960|322785181|FG002|Overall Study|Lost to Follow-up|16|||
94271133|NCT00102960|322785179|FG000|Overall Study|Withdrawal by Subject|1|||
94271134|NCT00102960|322785180|FG001|Overall Study|Withdrawal by Subject|0|||
94271135|NCT00102960|322785181|FG002|Overall Study|Withdrawal by Subject|1|||
94271136|NCT01423851|322785182|FG000|Whole Study|Disease progression|2|||
94271137|NCT01423851|322785183|FG001|Whole Study|Disease progression|1|||
94271138|NCT01423851|322785184|FG002|Whole Study|Disease progression|1|||
94271139|NCT01423851|322785185|FG003|Whole Study|Disease progression|4|||
94467250|NCT03379792|323500490|FG005|Overall Study|Physician Decision|0|||
94271140|NCT01423851|322785186|FG004|Whole Study|Disease progression|1|||
94271141|NCT01423851|322785187|FG005|Whole Study|Disease progression|3|||
94271142|NCT01423851|322785188|FG006|Whole Study|Disease progression|1|||
94271143|NCT01423851|322785189|FG007|Whole Study|Disease progression|4|||
94271144|NCT01423851|322785190|FG008|Whole Study|Disease progression|0|||
94271145|NCT01423851|322785191|FG009|Whole Study|Disease progression|2|||
94467251|NCT03379792|323500485|FG000|Overall Study|Withdrawal by Subject|0|||
94715503|NCT04817670|324418884|FG002|Overall Study|Lost to Follow-up|1|||
94715504|NCT04817670|324418885|FG003|Overall Study|Lost to Follow-up|0|||
94715505|NCT04817670|324418886|FG004|Overall Study|Lost to Follow-up|0|||
94715506|NCT03312907|324418887|FG000|Overall Study|Adverse Event|1|||
94715507|NCT03312907|324418888|FG001|Overall Study|Adverse Event|6|||
94715508|NCT03312907|324418889|FG002|Overall Study|Adverse Event|1|||
94715509|NCT03312907|324418887|FG000|Overall Study|Protocol Violation|2|||
94715510|NCT03312907|324418888|FG001|Overall Study|Protocol Violation|3|||
94715511|NCT03312907|324418889|FG002|Overall Study|Protocol Violation|4|||
94715512|NCT03312907|324418887|FG000|Overall Study|Lost to Follow-up|2|||
94271146|NCT01423851|322785192|FG010|Whole Study|Disease progression|10|||
94271147|NCT01423851|322785182|FG000|Whole Study|Physician Decision|0|||
94271148|NCT01423851|322785183|FG001|Whole Study|Physician Decision|1|||
94271149|NCT01423851|322785184|FG002|Whole Study|Physician Decision|2|||
94271150|NCT01423851|322785185|FG003|Whole Study|Physician Decision|0|||
94271151|NCT01423851|322785186|FG004|Whole Study|Physician Decision|2|||
94271152|NCT01423851|322785187|FG005|Whole Study|Physician Decision|0|||
94271153|NCT01423851|322785188|FG006|Whole Study|Physician Decision|2|||
94271154|NCT01423851|322785189|FG007|Whole Study|Physician Decision|1|||
94271155|NCT01423851|322785190|FG008|Whole Study|Physician Decision|3|||
94271156|NCT01423851|322785191|FG009|Whole Study|Physician Decision|4|||
94271157|NCT01423851|322785192|FG010|Whole Study|Physician Decision|12|||
94271158|NCT01423851|322785182|FG000|Whole Study|Withdrawal by Subject|1|||
94271159|NCT01423851|322785183|FG001|Whole Study|Withdrawal by Subject|1|||
94271160|NCT01423851|322785184|FG002|Whole Study|Withdrawal by Subject|0|||
94271161|NCT01423851|322785185|FG003|Whole Study|Withdrawal by Subject|0|||
94271162|NCT01423851|322785186|FG004|Whole Study|Withdrawal by Subject|0|||
94271163|NCT01423851|322785187|FG005|Whole Study|Withdrawal by Subject|0|||
94271164|NCT01423851|322785188|FG006|Whole Study|Withdrawal by Subject|0|||
94271165|NCT01423851|322785189|FG007|Whole Study|Withdrawal by Subject|0|||
94271166|NCT01423851|322785190|FG008|Whole Study|Withdrawal by Subject|2|||
94271167|NCT01423851|322785191|FG009|Whole Study|Withdrawal by Subject|0|||
94271168|NCT01423851|322785192|FG010|Whole Study|Withdrawal by Subject|4|||
94271169|NCT01423851|322785182|FG000|Whole Study|Adverse Event|0|||
94271170|NCT01423851|322785183|FG001|Whole Study|Adverse Event|0|||
94271171|NCT01423851|322785184|FG002|Whole Study|Adverse Event|0|||
94271172|NCT01423851|322785185|FG003|Whole Study|Adverse Event|2|||
94271173|NCT01423851|322785186|FG004|Whole Study|Adverse Event|0|||
94271174|NCT01423851|322785187|FG005|Whole Study|Adverse Event|0|||
94271175|NCT01423851|322785188|FG006|Whole Study|Adverse Event|0|||
94271176|NCT01423851|322785189|FG007|Whole Study|Adverse Event|3|||
94271177|NCT01423851|322785190|FG008|Whole Study|Adverse Event|3|||
94271178|NCT01423851|322785191|FG009|Whole Study|Adverse Event|2|||
94271179|NCT01423851|322785192|FG010|Whole Study|Adverse Event|3|||
94271180|NCT02229539|322787074|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
94271181|NCT02229539|322787075|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
94271182|NCT02229539|322787076|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
94271183|NCT02229539|322787074|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
94271184|NCT02229539|322787075|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
94271185|NCT02229539|322787076|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
94271186|NCT02229539|322787074|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
94271187|NCT02229539|322787075|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
94271188|NCT02229539|322787076|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
94271189|NCT02229539|322787074|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
94271190|NCT02229539|322787075|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
94271191|NCT02229539|322787076|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
94271192|NCT02229539|322787074|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
94271193|NCT02229539|322787075|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
94271194|NCT02229539|322787076|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
94271195|NCT02229539|322787074|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
94271196|NCT02229539|322787075|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
94467252|NCT03379792|323500486|FG001|Overall Study|Withdrawal by Subject|0|||
94467253|NCT03379792|323500487|FG002|Overall Study|Withdrawal by Subject|0|||
94715513|NCT03312907|324418888|FG001|Overall Study|Lost to Follow-up|3|||
94715514|NCT03312907|324418889|FG002|Overall Study|Lost to Follow-up|2|||
94715515|NCT03312907|324418887|FG000|Overall Study|Physician Decision|3|||
94271197|NCT02229539|322787076|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
94271198|NCT03227471|322787079|FG000|Overall Study|Withdrawal by Subject|0|||
94271199|NCT03227471|322787080|FG001|Overall Study|Withdrawal by Subject|0|||
94271200|NCT03227471|322787081|FG002|Overall Study|Withdrawal by Subject|0|||
94271201|NCT03227471|322787082|FG003|Overall Study|Withdrawal by Subject|0|||
94271202|NCT03227471|322787083|FG004|Overall Study|Withdrawal by Subject|1|||
94271203|NCT03227471|322787084|FG005|Overall Study|Withdrawal by Subject|0|||
94271204|NCT03227471|322787085|FG006|Overall Study|Withdrawal by Subject|0|||
94271205|NCT03227471|322787086|FG007|Overall Study|Withdrawal by Subject|0|||
94715516|NCT03312907|324418888|FG001|Overall Study|Physician Decision|4|||
94715517|NCT03312907|324418889|FG002|Overall Study|Physician Decision|2|||
94367374|NCT04529096|323131569|FG000|Overall Study|Lack of Efficacy|1|||
94367375|NCT04529096|323131570|FG001|Overall Study|Lack of Efficacy|0|||
94367376|NCT04529096|323131569|FG000|Overall Study|Lost to Follow-up|1|||
94367377|NCT04529096|323131570|FG001|Overall Study|Lost to Follow-up|1|||
94367378|NCT04529096|323131569|FG000|Overall Study|Non-Compliance With Study Drug|0|||
94367379|NCT04529096|323131570|FG001|Overall Study|Non-Compliance With Study Drug|1|||
94367380|NCT04529096|323131569|FG000|Overall Study|Physician Decision|1|||
94367381|NCT04529096|323131570|FG001|Overall Study|Physician Decision|3|||
94367382|NCT04529096|323131569|FG000|Overall Study|Withdrawal by Subject|5|||
94367383|NCT04529096|323131570|FG001|Overall Study|Withdrawal by Subject|0|||
94367384|NCT01656967|323131571|FG000|Overall Study|faulty monitor|1|||
94367385|NCT01656967|323131572|FG001|Overall Study|faulty monitor|0|||
94367386|NCT01656967|323131571|FG000|Overall Study|unsuccessful ETT insertion|3|||
94367387|NCT01656967|323131572|FG001|Overall Study|unsuccessful ETT insertion|2|||
94367388|NCT01220128|323131573|FG000|Overall Study|Progressive disease|0|||
94367389|NCT01220128|323131574|FG001|Overall Study|Progressive disease|0|||
94367390|NCT01220128|323131575|FG002|Overall Study|Progressive disease|2|||
94367391|NCT01220128|323131576|FG003|Overall Study|Progressive disease|0|||
94367392|NCT01220128|323131577|FG004|Overall Study|Progressive disease|0|||
94367393|NCT01220128|323131578|FG005|Overall Study|Progressive disease|0|||
94367394|NCT01220128|323131579|FG006|Overall Study|Progressive disease|0|||
94367395|NCT01220128|323131573|FG000|Overall Study|Sponsor study termination|0|||
94367396|NCT01220128|323131574|FG001|Overall Study|Sponsor study termination|1|||
94367397|NCT01220128|323131575|FG002|Overall Study|Sponsor study termination|0|||
94367398|NCT01220128|323131576|FG003|Overall Study|Sponsor study termination|0|||
94367399|NCT01220128|323131577|FG004|Overall Study|Sponsor study termination|0|||
94367400|NCT01220128|323131578|FG005|Overall Study|Sponsor study termination|0|||
94367401|NCT01220128|323131579|FG006|Overall Study|Sponsor study termination|1|||
94367402|NCT01220128|323131573|FG000|Overall Study|Adverse event, serious fatal|2|||
94367403|NCT01220128|323131574|FG001|Overall Study|Adverse event, serious fatal|0|||
94367404|NCT01220128|323131575|FG002|Overall Study|Adverse event, serious fatal|0|||
94367405|NCT01220128|323131576|FG003|Overall Study|Adverse event, serious fatal|0|||
94367406|NCT01220128|323131577|FG004|Overall Study|Adverse event, serious fatal|0|||
94367407|NCT01220128|323131578|FG005|Overall Study|Adverse event, serious fatal|0|||
94367408|NCT01220128|323131579|FG006|Overall Study|Adverse event, serious fatal|1|||
94367409|NCT01220128|323131573|FG000|Overall Study|Adverse event, non-fatal|1|||
94367410|NCT01220128|323131574|FG001|Overall Study|Adverse event, non-fatal|0|||
94367411|NCT01220128|323131575|FG002|Overall Study|Adverse event, non-fatal|0|||
94367412|NCT01220128|323131576|FG003|Overall Study|Adverse event, non-fatal|0|||
94367413|NCT01220128|323131577|FG004|Overall Study|Adverse event, non-fatal|0|||
94367414|NCT01220128|323131578|FG005|Overall Study|Adverse event, non-fatal|0|||
94367415|NCT01220128|323131579|FG006|Overall Study|Adverse event, non-fatal|3|||
94367416|NCT01220128|323131573|FG000|Overall Study|Other|0|||
94367417|NCT01220128|323131574|FG001|Overall Study|Other|0|||
94367418|NCT01220128|323131575|FG002|Overall Study|Other|1|||
94367419|NCT01220128|323131576|FG003|Overall Study|Other|0|||
94367420|NCT01220128|323131577|FG004|Overall Study|Other|0|||
94367421|NCT01220128|323131578|FG005|Overall Study|Other|0|||
94367422|NCT01220128|323131579|FG006|Overall Study|Other|0|||
94367423|NCT01220128|323131573|FG000|Overall Study|Consent withdrawn by subject|1|||
94367424|NCT01220128|323131574|FG001|Overall Study|Consent withdrawn by subject|0|||
94367425|NCT01220128|323131575|FG002|Overall Study|Consent withdrawn by subject|0|||
94367426|NCT01220128|323131576|FG003|Overall Study|Consent withdrawn by subject|0|||
94367427|NCT01220128|323131577|FG004|Overall Study|Consent withdrawn by subject|0|||
94367428|NCT01220128|323131578|FG005|Overall Study|Consent withdrawn by subject|0|||
94367429|NCT01220128|323131579|FG006|Overall Study|Consent withdrawn by subject|0|||
94467254|NCT03379792|323500488|FG003|Overall Study|Withdrawal by Subject|0|||
94467255|NCT03379792|323500489|FG004|Overall Study|Withdrawal by Subject|1|||
94367430|NCT00000135|323131580|FG000|Overall Study|Death|27|||
94367431|NCT00000135|323131581|FG001|Overall Study|Death|14|||
94367432|NCT02340078|323131583|FG000|Overall Study|Protocol Violation|1|||
94367433|NCT00446134|323131586|FG000|Overall Study|Adverse Event|7|||
94367434|NCT00446134|323131587|FG001|Overall Study|Adverse Event|17|||
94367435|NCT00446134|323131588|FG002|Overall Study|Adverse Event|13|||
94367436|NCT00446134|323131589|FG003|Overall Study|Adverse Event|18|||
94367437|NCT00446134|323131586|FG000|Overall Study|Lack of Efficacy|19|||
94367438|NCT00446134|323131587|FG001|Overall Study|Lack of Efficacy|19|||
94367439|NCT00446134|323131588|FG002|Overall Study|Lack of Efficacy|24|||
94367440|NCT00446134|323131589|FG003|Overall Study|Lack of Efficacy|19|||
94367441|NCT00446134|323131586|FG000|Overall Study|Protocol Violation|0|||
94367442|NCT00446134|323131587|FG001|Overall Study|Protocol Violation|2|||
94367443|NCT00446134|323131588|FG002|Overall Study|Protocol Violation|1|||
94367444|NCT00446134|323131589|FG003|Overall Study|Protocol Violation|0|||
94367445|NCT00446134|323131586|FG000|Overall Study|Lost to Follow-up|1|||
94367446|NCT00446134|323131587|FG001|Overall Study|Lost to Follow-up|3|||
94367447|NCT00446134|323131588|FG002|Overall Study|Lost to Follow-up|1|||
94367448|NCT00446134|323131589|FG003|Overall Study|Lost to Follow-up|1|||
94367449|NCT00446134|323131586|FG000|Overall Study|Withdrawal by Subject|3|||
94715518|NCT03312907|324418887|FG000|Overall Study|Withdrawal by Subject|9|||
94715519|NCT03312907|324418888|FG001|Overall Study|Withdrawal by Subject|14|||
94715520|NCT03312907|324418889|FG002|Overall Study|Withdrawal by Subject|10|||
94715521|NCT01843374|324418890|FG000|Overall Study|Death|155|||
94715522|NCT01843374|324418891|FG001|Overall Study|Death|313|||
94715523|NCT01843374|324418890|FG000|Overall Study|Withdrawal by Subject|14|||
94715524|NCT01843374|324418891|FG001|Overall Study|Withdrawal by Subject|20|||
94715525|NCT01843374|324418890|FG000|Overall Study|Withdrawing due to Other reason|20|||
94715526|NCT01843374|324418891|FG001|Overall Study|Withdrawing due to Other reason|46|||
94715527|NCT01353313|324418892|FG000|Overall Study|Lost to Follow-up|22|||
94271206|NCT03227471|322787087|FG008|Overall Study|Withdrawal by Subject|0|||
94271207|NCT03227471|322787088|FG009|Overall Study|Withdrawal by Subject|0|||
94271208|NCT03227471|322787089|FG010|Overall Study|Withdrawal by Subject|0|||
94271209|NCT03227471|322787090|FG011|Overall Study|Withdrawal by Subject|0|||
94271210|NCT03227471|322787091|FG012|Overall Study|Withdrawal by Subject|1|||
94271211|NCT03227471|322787092|FG013|Overall Study|Withdrawal by Subject|0|||
94271212|NCT03227471|322787093|FG014|Overall Study|Withdrawal by Subject|0|||
94271213|NCT03227471|322787079|FG000|Overall Study|Randomized, Never Dosed|0|||
94271214|NCT03227471|322787080|FG001|Overall Study|Randomized, Never Dosed|0|||
94271215|NCT03227471|322787081|FG002|Overall Study|Randomized, Never Dosed|0|||
94271216|NCT03227471|322787082|FG003|Overall Study|Randomized, Never Dosed|0|||
94271217|NCT03227471|322787083|FG004|Overall Study|Randomized, Never Dosed|0|||
94715528|NCT01353313|324418893|FG001|Overall Study|Lost to Follow-up|23|||
94715529|NCT01353313|324418892|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
94715530|NCT01353313|324418893|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
94715531|NCT04755660|324418894|FG000|Overall Study|Lost to Follow-up|1|||
94271218|NCT03227471|322787084|FG005|Overall Study|Randomized, Never Dosed|0|||
94271219|NCT03227471|322787085|FG006|Overall Study|Randomized, Never Dosed|0|||
94271220|NCT03227471|322787086|FG007|Overall Study|Randomized, Never Dosed|0|||
94367450|NCT00446134|323131587|FG001|Overall Study|Withdrawal by Subject|3|||
94715532|NCT04755660|324418895|FG001|Overall Study|Lost to Follow-up|1|||
94715533|NCT04755660|324418896|FG002|Overall Study|Lost to Follow-up|0|||
94715534|NCT04755660|324418894|FG000|Overall Study|Withdrawal by Subject|0|||
94715535|NCT04755660|324418895|FG001|Overall Study|Withdrawal by Subject|1|||
94715536|NCT04755660|324418896|FG002|Overall Study|Withdrawal by Subject|1|||
94715537|NCT04755660|324418894|FG000|Overall Study|Physician Decision|0|||
94367451|NCT00446134|323131588|FG002|Overall Study|Withdrawal by Subject|1|||
94367452|NCT00446134|323131589|FG003|Overall Study|Withdrawal by Subject|3|||
94367453|NCT00446134|323131586|FG000|Overall Study|Physician Decision|0|||
94367454|NCT00446134|323131587|FG001|Overall Study|Physician Decision|0|||
94367455|NCT00446134|323131588|FG002|Overall Study|Physician Decision|0|||
94367456|NCT00446134|323131589|FG003|Overall Study|Physician Decision|2|||
94367457|NCT00446134|323131586|FG000|Overall Study|Adverse Event-Diarrhea|1|||
94367458|NCT00446134|323131587|FG001|Overall Study|Adverse Event-Diarrhea|1|||
94367459|NCT00446134|323131588|FG002|Overall Study|Adverse Event-Diarrhea|2|||
94367460|NCT00446134|323131589|FG003|Overall Study|Adverse Event-Diarrhea|0|||
94367461|NCT00446134|323131586|FG000|Overall Study|Reason Not Completed|3|||
94367462|NCT00446134|323131587|FG001|Overall Study|Reason Not Completed|0|||
94367463|NCT00446134|323131588|FG002|Overall Study|Reason Not Completed|1|||
94367464|NCT00446134|323131589|FG003|Overall Study|Reason Not Completed|2|||
94367465|NCT03909971|323131592|FG000|Overall Study|Other Reasons Not Specified|0|||
94367466|NCT03909971|323131593|FG001|Overall Study|Other Reasons Not Specified|1|||
94367467|NCT03909971|323131592|FG000|Overall Study|Global Deterioration of Health Status|2|||
94367468|NCT03909971|323131593|FG001|Overall Study|Global Deterioration of Health Status|1|||
94367469|NCT03909971|323131592|FG000|Overall Study|Progressive Disease|6|||
94367470|NCT03909971|323131593|FG001|Overall Study|Progressive Disease|14|||
94367471|NCT03909971|323131592|FG000|Overall Study|Death|2|||
94367472|NCT03909971|323131593|FG001|Overall Study|Death|6|||
94367473|NCT04816877|323131594|FG000|Overall Study|Withdrawal by Subject|1|||
94367474|NCT04816877|323131595|FG001|Overall Study|Withdrawal by Subject|0|||
94367475|NCT02524665|323131596|FG000|Overall Study|Lost to Follow-up|1|||
94367476|NCT00295620|323131597|FG000|Overall Study|Lost to Follow-up|9|||
94367477|NCT00295620|323131598|FG001|Overall Study|Lost to Follow-up|5|||
94367478|NCT00295620|323131597|FG000|Overall Study|Withdrawal by Subject|37|||
94367479|NCT00295620|323131598|FG001|Overall Study|Withdrawal by Subject|50|||
94367480|NCT00295620|323131597|FG000|Overall Study|Death|206|||
94367481|NCT00295620|323131598|FG001|Overall Study|Death|207|||
94367482|NCT00295620|323131597|FG000|Overall Study|Other reasons|10|||
94367483|NCT00295620|323131598|FG001|Overall Study|Other reasons|9|||
94367484|NCT00295620|323131597|FG000|Overall Study|Discontinuation by sponsor|580|||
94367485|NCT00295620|323131598|FG001|Overall Study|Discontinuation by sponsor|593|||
94367486|NCT00295620|323131597|FG000|Overall Study|Protocol Violation|30|||
94367487|NCT00295620|323131598|FG001|Overall Study|Protocol Violation|32|||
94367488|NCT02989610|323131599|FG000|Overall Study|Withdrawal by Subject|20|||
94367489|NCT02989610|323131599|FG000|Overall Study|Departure of PI from Site|8|||
94367490|NCT02989610|323131599|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
94367491|NCT02989610|323131599|FG000|Overall Study|Lost to Follow-up|3|||
94367492|NCT02989610|323131599|FG000|Overall Study|Death|3|||
94367493|NCT02989610|323131599|FG000|Overall Study|System Explant|3|||
94367494|NCT02989610|323131599|FG000|Overall Study|Subject Non-Compliance|2|||
94715538|NCT04755660|324418895|FG001|Overall Study|Physician Decision|0|||
94715539|NCT04755660|324418896|FG002|Overall Study|Physician Decision|1|||
94715540|NCT03613740|324418904|FG000|Overall Study|Lost to Follow-up|1|||
94715541|NCT03613740|324418905|FG001|Overall Study|Lost to Follow-up|1|||
94271221|NCT03227471|322787087|FG008|Overall Study|Randomized, Never Dosed|0|||
94271222|NCT03227471|322787088|FG009|Overall Study|Randomized, Never Dosed|0|||
94271223|NCT03227471|322787089|FG010|Overall Study|Randomized, Never Dosed|0|||
94271224|NCT03227471|322787090|FG011|Overall Study|Randomized, Never Dosed|0|||
94271225|NCT03227471|322787091|FG012|Overall Study|Randomized, Never Dosed|0|||
94271226|NCT03227471|322787092|FG013|Overall Study|Randomized, Never Dosed|0|||
94271227|NCT03227471|322787093|FG014|Overall Study|Randomized, Never Dosed|1|||
94271228|NCT00766038|322787098|FG000|Overall Study|Lost to Follow-up|15|||
94271229|NCT00766038|322787099|FG001|Overall Study|Lost to Follow-up|14|||
94271230|NCT00449670|322787105|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
94271231|NCT00449670|322787106|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
94271232|NCT00449670|322787105|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
94271233|NCT00449670|322787106|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
94271234|NCT00449670|322787105|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
94367495|NCT02989610|323131599|FG000|Overall Study|System Revision|2|||
94367496|NCT02989610|323131599|FG000|Overall Study|PI Left, Study Closing|1|||
94367497|NCT02989610|323131599|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
94367498|NCT02989610|323131599|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
94367499|NCT02602080|323131600|FG000|Overall Study|Protocol Violation|6|||
94367500|NCT02602080|323131601|FG001|Overall Study|Protocol Violation|1|||
94367501|NCT02602080|323131602|FG002|Overall Study|Protocol Violation|3|||
94367502|NCT00808015|323131608|FG000|Overall Study|Death|1|||
94367503|NCT00808015|323131608|FG000|Overall Study|Lack of Efficacy|58|||
94367504|NCT00808015|323131608|FG000|Overall Study|Lost to Follow-up|76|||
94367505|NCT00808015|323131608|FG000|Overall Study|Participants not willing to participate|158|||
94367506|NCT00808015|323131608|FG000|Overall Study|Adverse Event|22|||
94367507|NCT00808015|323131608|FG000|Overall Study|Other|25|||
94367508|NCT00808015|323131608|FG000|Overall Study|Enrolled but not treated|4|||
94367509|NCT04508621|323131612|FG000|Overall Study|Adverse Event|39|||
94715542|NCT04279574|324418906|FG000|Overall Study|Death|1|||
94715543|NCT04279574|324418907|FG001|Overall Study|Death|0|||
94715544|NCT04279574|324418906|FG000|Overall Study|lost restoration, tooth fracture|1|||
94715545|NCT04279574|324418907|FG001|Overall Study|lost restoration, tooth fracture|0|||
94715546|NCT04279574|324418906|FG000|Overall Study|Lost to Follow-up|0|||
94715547|NCT04279574|324418907|FG001|Overall Study|Lost to Follow-up|1|||
94715548|NCT01693120|324418909|FG000|Enrollment|Lost to Follow-up|1|||
94715549|NCT01693120|324418909|FG000|Enrollment|Withdrawal by Subject|10|||
94715550|NCT01693120|324418909|FG000|Enrollment|Protocol Violation|46|||
94715551|NCT01693120|324418909|FG000|Enrollment|Physician Decision|3|||
94715552|NCT01693120|324418909|FG000|Enrollment|Adverse Event|1|||
94715553|NCT01693120|324418909|FG000|Enrollment|Study closed|8|||
94715554|NCT01693120|324418909|FG000|Enrollment|Other|1|||
94715555|NCT01693120|324418909|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
94715556|NCT01693120|324418909|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
94715557|NCT01693120|324418909|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
94715558|NCT01693120|324418909|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
94715559|NCT01693120|324418909|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
94715560|NCT03936660|324418910|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
94715561|NCT03936660|324418911|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
94715562|NCT00670046|324418918|FG000|Overall Study|Lost to Follow-up|1|||
94715563|NCT00670046|324418919|FG001|Overall Study|Lost to Follow-up|1|||
94715564|NCT00670046|324418918|FG000|Overall Study|Withdrawal by Subject|0|||
94715565|NCT00670046|324418919|FG001|Overall Study|Withdrawal by Subject|1|||
94715566|NCT02566902|324418920|FG000|Overall Study|Protocol Violation|2|||
94715567|NCT02566902|324418921|FG001|Overall Study|Protocol Violation|1|||
94715568|NCT00722046|324418922|FG000|Overall Study|Adverse Event|0|||
94715569|NCT00722046|324418923|FG001|Overall Study|Adverse Event|1|||
94715570|NCT00722046|324418924|FG002|Overall Study|Adverse Event|2|||
94715571|NCT00722046|324418925|FG003|Overall Study|Adverse Event|1|||
94715572|NCT00722046|324418926|FG004|Overall Study|Adverse Event|2|||
94715573|NCT00722046|324418927|FG005|Overall Study|Adverse Event|1|||
94715574|NCT00722046|324418928|FG006|Overall Study|Adverse Event|0|||
94715575|NCT00722046|324418922|FG000|Overall Study|Death|0|||
94715576|NCT00722046|324418923|FG001|Overall Study|Death|1|||
94715577|NCT00722046|324418924|FG002|Overall Study|Death|0|||
94715578|NCT00722046|324418925|FG003|Overall Study|Death|0|||
94715579|NCT00722046|324418926|FG004|Overall Study|Death|0|||
94715580|NCT00722046|324418927|FG005|Overall Study|Death|0|||
94715581|NCT00722046|324418928|FG006|Overall Study|Death|2|||
94715582|NCT00722046|324418922|FG000|Overall Study|Protocol Violation|1|||
94715583|NCT00722046|324418923|FG001|Overall Study|Protocol Violation|0|||
94715584|NCT00722046|324418924|FG002|Overall Study|Protocol Violation|0|||
94715585|NCT00722046|324418925|FG003|Overall Study|Protocol Violation|0|||
94715586|NCT00722046|324418926|FG004|Overall Study|Protocol Violation|0|||
94715587|NCT00722046|324418927|FG005|Overall Study|Protocol Violation|1|||
94715588|NCT00722046|324418928|FG006|Overall Study|Protocol Violation|0|||
94715589|NCT00722046|324418922|FG000|Overall Study|Withdrawal by Subject|3|||
94715590|NCT00722046|324418923|FG001|Overall Study|Withdrawal by Subject|3|||
94715591|NCT00722046|324418924|FG002|Overall Study|Withdrawal by Subject|4|||
94715592|NCT00722046|324418925|FG003|Overall Study|Withdrawal by Subject|4|||
94715593|NCT00722046|324418926|FG004|Overall Study|Withdrawal by Subject|4|||
94715594|NCT00722046|324418927|FG005|Overall Study|Withdrawal by Subject|7|||
94715595|NCT00722046|324418928|FG006|Overall Study|Withdrawal by Subject|3|||
94715596|NCT00722046|324418922|FG000|Overall Study|Randomized, but not treated|1|||
94715597|NCT00722046|324418923|FG001|Overall Study|Randomized, but not treated|1|||
94367510|NCT04508621|323131613|FG001|Overall Study|Adverse Event|16|||
94367511|NCT04508621|323131612|FG000|Overall Study|Lack of Efficacy|2|||
94715598|NCT00722046|324418924|FG002|Overall Study|Randomized, but not treated|0|||
94715599|NCT00722046|324418925|FG003|Overall Study|Randomized, but not treated|2|||
94367512|NCT04508621|323131613|FG001|Overall Study|Lack of Efficacy|8|||
94715600|NCT00722046|324418926|FG004|Overall Study|Randomized, but not treated|0|||
94715601|NCT00722046|324418927|FG005|Overall Study|Randomized, but not treated|0|||
94715602|NCT00722046|324418928|FG006|Overall Study|Randomized, but not treated|0|||
94715603|NCT00722046|324418922|FG000|Overall Study|Other|0|||
94715604|NCT00722046|324418923|FG001|Overall Study|Other|0|||
94715605|NCT00722046|324418924|FG002|Overall Study|Other|1|||
94271235|NCT00449670|322787106|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
94271236|NCT00449670|322787105|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
94271237|NCT00449670|322787106|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
94271238|NCT00449670|322787105|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
94271239|NCT00449670|322787106|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
94271240|NCT00449670|322787105|FG000|Booster Phase (Study no.109873)|Other|0|||
94271241|NCT00449670|322787106|FG001|Booster Phase (Study no.109873)|Other|2|||
94271242|NCT00847145|322787107|FG000|Overall Study|AE or Death|0|||
94271243|NCT00847145|322787108|FG001|Overall Study|AE or Death|1|||
94271244|NCT00847145|322787109|FG002|Overall Study|AE or Death|1|||
94271245|NCT00847145|322787110|FG003|Overall Study|AE or Death|0|||
94271246|NCT00847145|322787111|FG004|Overall Study|AE or Death|0|||
94271247|NCT00847145|322787112|FG005|Overall Study|AE or Death|0|||
94271248|NCT00847145|322787113|FG006|Overall Study|AE or Death|0|||
94271249|NCT00847145|322787114|FG007|Overall Study|AE or Death|0|||
94271250|NCT00847145|322787107|FG000|Overall Study|Withdrawal by Subject|3|||
94271251|NCT00847145|322787108|FG001|Overall Study|Withdrawal by Subject|4|||
94271252|NCT00847145|322787109|FG002|Overall Study|Withdrawal by Subject|6|||
94271253|NCT00847145|322787110|FG003|Overall Study|Withdrawal by Subject|1|||
94271254|NCT00847145|322787111|FG004|Overall Study|Withdrawal by Subject|0|||
94271255|NCT00847145|322787112|FG005|Overall Study|Withdrawal by Subject|0|||
94271256|NCT00847145|322787113|FG006|Overall Study|Withdrawal by Subject|1|||
94271257|NCT00847145|322787114|FG007|Overall Study|Withdrawal by Subject|1|||
94271258|NCT00847145|322787107|FG000|Overall Study|Lost to Follow-up|3|||
94271259|NCT00847145|322787108|FG001|Overall Study|Lost to Follow-up|1|||
94271260|NCT00847145|322787109|FG002|Overall Study|Lost to Follow-up|1|||
94271261|NCT00847145|322787110|FG003|Overall Study|Lost to Follow-up|0|||
94271262|NCT00847145|322787111|FG004|Overall Study|Lost to Follow-up|4|||
94271263|NCT00847145|322787112|FG005|Overall Study|Lost to Follow-up|4|||
94271264|NCT00847145|322787113|FG006|Overall Study|Lost to Follow-up|8|||
94271265|NCT00847145|322787114|FG007|Overall Study|Lost to Follow-up|2|||
94271266|NCT00847145|322787107|FG000|Overall Study|Inappropriate enrollment|0|||
94271267|NCT00847145|322787108|FG001|Overall Study|Inappropriate enrollment|0|||
94271268|NCT00847145|322787109|FG002|Overall Study|Inappropriate enrollment|0|||
94271269|NCT00847145|322787110|FG003|Overall Study|Inappropriate enrollment|0|||
94271270|NCT00847145|322787111|FG004|Overall Study|Inappropriate enrollment|1|||
94271271|NCT00847145|322787112|FG005|Overall Study|Inappropriate enrollment|0|||
94271272|NCT00847145|322787113|FG006|Overall Study|Inappropriate enrollment|0|||
94271273|NCT00847145|322787114|FG007|Overall Study|Inappropriate enrollment|0|||
94271274|NCT00847145|322787107|FG000|Overall Study|Protocol Violation|0|||
94271275|NCT00847145|322787108|FG001|Overall Study|Protocol Violation|0|||
94271276|NCT00847145|322787109|FG002|Overall Study|Protocol Violation|3|||
94271277|NCT00847145|322787110|FG003|Overall Study|Protocol Violation|0|||
94271278|NCT00847145|322787111|FG004|Overall Study|Protocol Violation|1|||
94271279|NCT00847145|322787112|FG005|Overall Study|Protocol Violation|0|||
94271280|NCT00847145|322787113|FG006|Overall Study|Protocol Violation|0|||
94271281|NCT00847145|322787114|FG007|Overall Study|Protocol Violation|1|||
94271282|NCT04419610|322787116|FG000|Overall Study|Withdrawal by Subject|3|||
94271283|NCT04419610|322787117|FG001|Overall Study|Withdrawal by Subject|1|||
94271284|NCT04419610|322787116|FG000|Overall Study|Adverse Event|1|||
94271285|NCT04419610|322787117|FG001|Overall Study|Adverse Event|0|||
94271286|NCT04419610|322787116|FG000|Overall Study|discharged early|1|||
94271287|NCT04419610|322787117|FG001|Overall Study|discharged early|1|||
94271288|NCT01524198|322787118|FG000|Overall Study|Protocol Violation|8|||
94271289|NCT01524198|322787119|FG001|Overall Study|Protocol Violation|6|||
94271290|NCT01524198|322787118|FG000|Overall Study|Withdrawal by Subject|15|||
94271291|NCT01524198|322787119|FG001|Overall Study|Withdrawal by Subject|10|||
94271292|NCT02142738|322787120|FG000|Overall Study|Adverse Event|13|||
94271293|NCT02142738|322787121|FG001|Overall Study|Adverse Event|9|||
94715606|NCT00722046|324418925|FG003|Overall Study|Other|1|||
94715607|NCT00722046|324418926|FG004|Overall Study|Other|3|||
94715608|NCT00722046|324418927|FG005|Overall Study|Other|2|||
94715609|NCT00722046|324418928|FG006|Overall Study|Other|1|||
94715610|NCT00431834|324418934|FG000|Overall Study|Withdrawal by Subject|7|||
94715611|NCT00431834|324418934|FG000|Overall Study|Death|3|||
94715612|NCT00431834|324418934|FG000|Overall Study|Missed Endpoint Visit|2|||
94715613|NCT00431834|324418934|FG000|Overall Study|Lost to Follow-up|1|||
94715614|NCT02461628|324418938|FG000|Overall Study|Refused to complete survey|4|||
94715615|NCT02461628|324418939|FG001|Overall Study|Refused to complete survey|7|||
94715616|NCT00585052|324418940|FG000|Overall Study|Withdrawal by Subject|1|||
94715617|NCT00411151|324418943|FG000|Overall Study|Death|38|||
94715618|NCT00411151|324418943|FG000|Overall Study|Withdrawal by Subject|2|||
94715619|NCT00411151|324418943|FG000|Overall Study|Lost to Follow-up|2|||
94715620|NCT00411151|324418943|FG000|Overall Study|Protocol Violation|1|||
94715621|NCT00411151|324418943|FG000|Overall Study|Trial prematurely closed|4|||
94715622|NCT00111813|324418944|FG000|Overall Study|Adverse Event|1|||
94715623|NCT00111813|324418945|FG001|Overall Study|Adverse Event|2|||
94715624|NCT00111813|324418946|FG002|Overall Study|Adverse Event|4|||
94715625|NCT00111813|324418947|FG003|Overall Study|Adverse Event|2|||
94715626|NCT00111813|324418948|FG004|Overall Study|Adverse Event|2|||
94715627|NCT00111813|324418949|FG005|Overall Study|Adverse Event|2|||
94715628|NCT00111813|324418944|FG000|Overall Study|Progressive disease|2|||
94715629|NCT00111813|324418945|FG001|Overall Study|Progressive disease|1|||
94715630|NCT00111813|324418946|FG002|Overall Study|Progressive disease|5|||
94715631|NCT00111813|324418947|FG003|Overall Study|Progressive disease|3|||
94715632|NCT00111813|324418948|FG004|Overall Study|Progressive disease|4|||
94715633|NCT00111813|324418949|FG005|Overall Study|Progressive disease|3|||
94715634|NCT00111813|324418944|FG000|Overall Study|Lack of Efficacy|0|||
94715635|NCT00111813|324418945|FG001|Overall Study|Lack of Efficacy|0|||
94715636|NCT00111813|324418946|FG002|Overall Study|Lack of Efficacy|0|||
94715637|NCT00111813|324418947|FG003|Overall Study|Lack of Efficacy|0|||
94715638|NCT00111813|324418948|FG004|Overall Study|Lack of Efficacy|0|||
94715639|NCT00111813|324418949|FG005|Overall Study|Lack of Efficacy|1|||
94715640|NCT00111813|324418944|FG000|Overall Study|Other|0|||
94715641|NCT00111813|324418945|FG001|Overall Study|Other|0|||
94715642|NCT00111813|324418946|FG002|Overall Study|Other|1|||
94715643|NCT00111813|324418947|FG003|Overall Study|Other|0|||
94271294|NCT02142738|322787120|FG000|Overall Study|Death|92|||
94271295|NCT02142738|322787121|FG001|Overall Study|Death|112|||
94271296|NCT02142738|322787120|FG000|Overall Study|Lost to Follow-up|0|||
94271297|NCT02142738|322787121|FG001|Overall Study|Lost to Follow-up|3|||
94271298|NCT02142738|322787120|FG000|Overall Study|Withdrawal by Subject|6|||
94271299|NCT02142738|322787121|FG001|Overall Study|Withdrawal by Subject|7|||
94271300|NCT02142738|322787120|FG000|Overall Study|Follow up ended by sponsor|43|||
94271301|NCT02142738|322787121|FG001|Overall Study|Follow up ended by sponsor|20|||
94271302|NCT03688880|322787126|FG000|Overall Study|Withdrawal by Subject|0|||
94271303|NCT03688880|322787127|FG001|Overall Study|Withdrawal by Subject|2|||
94271304|NCT03688880|322787126|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
94271305|NCT03688880|322787127|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
94271306|NCT03688880|322787126|FG000|Overall Study|Lost to Follow-up|4|||
94271307|NCT03688880|322787127|FG001|Overall Study|Lost to Follow-up|7|||
94271308|NCT03688880|322787126|FG000|Overall Study|Adverse Event|0|||
94271309|NCT03688880|322787127|FG001|Overall Study|Adverse Event|2|||
94271310|NCT03688880|322787126|FG000|Overall Study|Device deficiencies|0|||
94271311|NCT03688880|322787127|FG001|Overall Study|Device deficiencies|2|||
94271312|NCT03688880|322787126|FG000|Overall Study|Other|10|||
94271313|NCT03688880|322787127|FG001|Overall Study|Other|16|||
94271314|NCT02553265|322787128|FG000|Enrollment|Death|0|||
94271315|NCT02553265|322787129|FG001|Enrollment|Death|0|||
94271316|NCT02553265|322787130|FG002|Enrollment|Death|1|||
94271317|NCT02553265|322787128|FG000|First Intervention (28 Days)|Adverse Event|1|||
94271318|NCT02553265|322787129|FG001|First Intervention (28 Days)|Adverse Event|0|||
94271319|NCT02553265|322787130|FG002|First Intervention (28 Days)|Adverse Event|0|||
94271320|NCT02553265|322787128|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
94271321|NCT02553265|322787129|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
94271322|NCT02553265|322787130|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
94271323|NCT02553265|322787128|FG000|Second Intervention (28 Days)|Adverse Event|1|||
94271324|NCT02553265|322787129|FG001|Second Intervention (28 Days)|Adverse Event|0|||
94271325|NCT02553265|322787130|FG002|Second Intervention (28 Days)|Adverse Event|0|||
94271326|NCT02553265|322787128|FG000|Third Intervention (28 Days)|Adverse Event|1|||
94271327|NCT02553265|322787129|FG001|Third Intervention (28 Days)|Adverse Event|0|||
94271328|NCT02553265|322787130|FG002|Third Intervention (28 Days)|Adverse Event|0|||
94271329|NCT02553265|322787128|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
94271330|NCT02553265|322787129|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
94271331|NCT02553265|322787130|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
94271332|NCT01168973|322787131|FG000|Overall Study|Progressive Disease|341|||
94271333|NCT01168973|322787132|FG001|Overall Study|Progressive Disease|429|||
94715644|NCT00111813|324418948|FG004|Overall Study|Other|0|||
94367513|NCT04508621|323131612|FG000|Overall Study|Physician Decision|0|||
94367514|NCT04508621|323131613|FG001|Overall Study|Physician Decision|1|||
94367515|NCT04508621|323131612|FG000|Overall Study|Withdrawal by Subject|10|||
94367516|NCT04508621|323131613|FG001|Overall Study|Withdrawal by Subject|14|||
94367517|NCT04508621|323131612|FG000|Overall Study|Lost to Follow-up|12|||
94367518|NCT04508621|323131613|FG001|Overall Study|Lost to Follow-up|9|||
94367519|NCT04508621|323131612|FG000|Overall Study|COVID-19 related crisis|3|||
94367520|NCT04508621|323131613|FG001|Overall Study|COVID-19 related crisis|0|||
94367521|NCT04508621|323131612|FG000|Overall Study|Subject non-compliance|1|||
94367522|NCT04508621|323131613|FG001|Overall Study|Subject non-compliance|0|||
94367523|NCT01066039|323131614|FG000|Overall Study|Adverse Event|6|||
94367524|NCT01066039|323131614|FG000|Overall Study|Withdrawal by Subject|17|||
94367525|NCT01066039|323131614|FG000|Overall Study|Protocol Violation|2|||
94715645|NCT00111813|324418949|FG005|Overall Study|Other|0|||
94715646|NCT04056624|324418950|FG000|Overall Study|Withdrawal by Subject|0|||
94715647|NCT04056624|324418951|FG001|Overall Study|Withdrawal by Subject|0|||
94715648|NCT04056624|324418952|FG002|Overall Study|Withdrawal by Subject|1|||
94715649|NCT04056624|324418950|FG000|Overall Study|Protocol Violation|1|||
94715650|NCT04056624|324418951|FG001|Overall Study|Protocol Violation|2|||
94715651|NCT04056624|324418952|FG002|Overall Study|Protocol Violation|0|||
94715652|NCT00703820|324418953|FG000|Overall Study|Adverse Event|12|||
94715653|NCT00703820|324418954|FG001|Overall Study|Adverse Event|17|||
94715654|NCT00703820|324418953|FG000|Overall Study|Death|5|||
94715655|NCT00703820|324418954|FG001|Overall Study|Death|0|||
94715656|NCT00703820|324418953|FG000|Overall Study|Lack of Efficacy|11|||
94715657|NCT00703820|324418954|FG001|Overall Study|Lack of Efficacy|11|||
94715658|NCT00703820|324418953|FG000|Overall Study|Received non-protocol therapy|1|||
94715659|NCT00703820|324418954|FG001|Overall Study|Received non-protocol therapy|0|||
94715660|NCT00703820|324418953|FG000|Overall Study|Physician Decision|4|||
94715661|NCT00703820|324418954|FG001|Overall Study|Physician Decision|5|||
94715662|NCT00703820|324418953|FG000|Overall Study|Withdrawal by Subject|2|||
94715663|NCT00703820|324418954|FG001|Overall Study|Withdrawal by Subject|1|||
94715664|NCT02121002|324418955|FG000|Overall Study|Physician Decision|2|||
94715665|NCT02121002|324418956|FG001|Overall Study|Physician Decision|0|||
94715666|NCT02121002|324418957|FG002|Overall Study|Physician Decision|0|||
94715667|NCT02121002|324418955|FG000|Overall Study|Withdrawal by Subject|3|||
94715668|NCT02121002|324418956|FG001|Overall Study|Withdrawal by Subject|1|||
94715669|NCT02121002|324418957|FG002|Overall Study|Withdrawal by Subject|4|||
94715670|NCT02121002|324418955|FG000|Overall Study|Protocol Violation|1|||
94715671|NCT02121002|324418956|FG001|Overall Study|Protocol Violation|2|||
94715672|NCT02121002|324418957|FG002|Overall Study|Protocol Violation|4|||
94715673|NCT02121002|324418955|FG000|Overall Study|Concomitant therapy|0|||
94715674|NCT02121002|324418956|FG001|Overall Study|Concomitant therapy|1|||
94715675|NCT02121002|324418957|FG002|Overall Study|Concomitant therapy|1|||
94715676|NCT02121002|324418955|FG000|Overall Study|Others|1|||
94715677|NCT02121002|324418956|FG001|Overall Study|Others|0|||
94715678|NCT02121002|324418957|FG002|Overall Study|Others|1|||
94715679|NCT02590432|324418958|FG000|Open-label Treatment Period|Adverse Event|97|||
94715680|NCT02590432|324418959|FG001|Open-label Treatment Period|Adverse Event|79|||
94715681|NCT02590432|324418960|FG002|Open-label Treatment Period|Adverse Event|0|||
94715682|NCT02590432|324418961|FG003|Open-label Treatment Period|Adverse Event|0|||
94715683|NCT02590432|324418962|FG004|Open-label Treatment Period|Adverse Event|0|||
94715684|NCT02590432|324418963|FG005|Open-label Treatment Period|Adverse Event|0|||
94715685|NCT02590432|324418964|FG006|Open-label Treatment Period|Adverse Event|0|||
94715686|NCT02590432|324418965|FG007|Open-label Treatment Period|Adverse Event|0|||
94715687|NCT02590432|324418966|FG008|Open-label Treatment Period|Adverse Event|0|||
94715688|NCT02590432|324418958|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
94715689|NCT02590432|324418959|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
94367526|NCT01066039|323131614|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
94715690|NCT02590432|324418960|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
94715691|NCT02590432|324418961|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
94715692|NCT02590432|324418962|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
94715693|NCT02590432|324418963|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
94715694|NCT02590432|324418964|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
94715695|NCT02590432|324418965|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
94715696|NCT02590432|324418966|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
94367527|NCT01066039|323131614|FG000|Overall Study|Investigator's Request|1|||
94367528|NCT01066039|323131614|FG000|Overall Study|Dropout due to Insulin Administration|1|||
94367529|NCT01066039|323131614|FG000|Overall Study|Additional Antihypertensive Required|4|||
94367530|NCT01066039|323131614|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
94367531|NCT01066039|323131614|FG000|Overall Study|Failure to Control Blood Pressure|1|||
94715697|NCT02590432|324418958|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
94715698|NCT02590432|324418959|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
94715699|NCT02590432|324418960|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
94715700|NCT02590432|324418961|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
94715701|NCT02590432|324418962|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
94715702|NCT02590432|324418963|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
94715703|NCT02590432|324418964|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
94715704|NCT02590432|324418965|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
94715705|NCT02590432|324418966|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
94715706|NCT02590432|324418958|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
94715707|NCT02590432|324418959|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
94715708|NCT02590432|324418960|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
94715709|NCT02590432|324418961|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
94715710|NCT02590432|324418962|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
94715711|NCT02590432|324418963|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
94715712|NCT02590432|324418964|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
94715713|NCT02590432|324418965|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
94715714|NCT02590432|324418966|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
94715715|NCT02590432|324418958|FG000|Open-label Treatment Period|Protocol Violation|10|||
94715716|NCT02590432|324418959|FG001|Open-label Treatment Period|Protocol Violation|4|||
94715717|NCT02590432|324418960|FG002|Open-label Treatment Period|Protocol Violation|0|||
94715718|NCT02590432|324418961|FG003|Open-label Treatment Period|Protocol Violation|0|||
94715719|NCT02590432|324418962|FG004|Open-label Treatment Period|Protocol Violation|0|||
94715720|NCT02590432|324418963|FG005|Open-label Treatment Period|Protocol Violation|0|||
94715721|NCT02590432|324418964|FG006|Open-label Treatment Period|Protocol Violation|0|||
94715722|NCT02590432|324418965|FG007|Open-label Treatment Period|Protocol Violation|0|||
94715723|NCT02590432|324418966|FG008|Open-label Treatment Period|Protocol Violation|0|||
94715724|NCT02590432|324418958|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
94715725|NCT02590432|324418959|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
94715726|NCT02590432|324418960|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
94715727|NCT02590432|324418961|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
94715728|NCT02590432|324418962|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
94715729|NCT02590432|324418963|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
94715730|NCT02590432|324418964|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
94715731|NCT02590432|324418965|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
94715732|NCT02590432|324418966|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
94715733|NCT02590432|324418958|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
94715734|NCT02590432|324418959|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
94715735|NCT02590432|324418960|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
94715736|NCT02590432|324418961|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
94715737|NCT02590432|324418962|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
94715738|NCT02590432|324418963|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
94715739|NCT02590432|324418964|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
94715740|NCT02590432|324418965|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
94715741|NCT02590432|324418966|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
94715742|NCT02590432|324418958|FG000|Double-blind Treatment Period|Adverse Event|0|||
94715743|NCT02590432|324418959|FG001|Double-blind Treatment Period|Adverse Event|0|||
94715744|NCT02590432|324418960|FG002|Double-blind Treatment Period|Adverse Event|14|||
94715745|NCT02590432|324418961|FG003|Double-blind Treatment Period|Adverse Event|12|||
94715746|NCT02590432|324418962|FG004|Double-blind Treatment Period|Adverse Event|6|||
94715747|NCT02590432|324418963|FG005|Double-blind Treatment Period|Adverse Event|22|||
94715748|NCT02590432|324418964|FG006|Double-blind Treatment Period|Adverse Event|20|||
94715749|NCT02590432|324418965|FG007|Double-blind Treatment Period|Adverse Event|0|||
94715750|NCT02590432|324418966|FG008|Double-blind Treatment Period|Adverse Event|0|||
94715751|NCT02590432|324418958|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
94715752|NCT02590432|324418959|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
94715753|NCT02590432|324418960|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
94715754|NCT02590432|324418961|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
94715755|NCT02590432|324418962|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
94715756|NCT02590432|324418963|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
94715757|NCT02590432|324418964|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
94715758|NCT02590432|324418965|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
94715759|NCT02590432|324418966|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
94715760|NCT02590432|324418958|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
94467256|NCT03379792|323500490|FG005|Overall Study|Withdrawal by Subject|1|||
94467257|NCT01121536|323500492|FG000|Overall Study|Adverse Event|63|||
94715761|NCT02590432|324418959|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
94715762|NCT02590432|324418960|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
94467258|NCT01121536|323500492|FG000|Overall Study|Lack of Efficacy|35|||
94715763|NCT02590432|324418961|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
94467259|NCT01121536|323500492|FG000|Overall Study|Withdrawal by Subject|65|||
94467260|NCT01121536|323500492|FG000|Overall Study|Protocol Violation|20|||
94367532|NCT01066039|323131614|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
94367533|NCT00928135|323131626|FG000|Overall Study|Withdrawal by Subject|1|||
94367534|NCT00928135|323131627|FG001|Overall Study|Withdrawal by Subject|0|||
94367535|NCT03338673|323131630|FG000|Overall Study|Lost to Follow-up|1|||
94367536|NCT03338673|323131631|FG001|Overall Study|Lost to Follow-up|1|||
94367537|NCT02200614|323131632|FG000|Double Blind Treatment|Adverse Event|86|||
94367538|NCT02200614|323131633|FG001|Double Blind Treatment|Adverse Event|48|||
94367539|NCT02200614|323131632|FG000|Double Blind Treatment|Confirmed metastasis|120|||
94367540|NCT02200614|323131633|FG001|Double Blind Treatment|Confirmed metastasis|140|||
94367541|NCT02200614|323131632|FG000|Double Blind Treatment|Judgment of the investigator|59|||
94367542|NCT02200614|323131633|FG001|Double Blind Treatment|Judgment of the investigator|99|||
94367543|NCT02200614|323131632|FG000|Double Blind Treatment|Metastasis by local reading|1|||
94367544|NCT02200614|323131633|FG001|Double Blind Treatment|Metastasis by local reading|3|||
94367545|NCT02200614|323131632|FG000|Double Blind Treatment|Other reason|6|||
94367546|NCT02200614|323131633|FG001|Double Blind Treatment|Other reason|2|||
94367547|NCT02200614|323131632|FG000|Double Blind Treatment|Personal reason|77|||
94367548|NCT02200614|323131633|FG001|Double Blind Treatment|Personal reason|85|||
94367549|NCT02200614|323131632|FG000|Double Blind Treatment|Protocol deviation|14|||
94367550|NCT02200614|323131633|FG001|Double Blind Treatment|Protocol deviation|7|||
94367551|NCT02200614|323131632|FG000|Double Blind Treatment|Not treated|1|||
94367552|NCT02200614|323131633|FG001|Double Blind Treatment|Not treated|0|||
94367553|NCT02200614|323131632|FG000|Open Label|Adverse Event|41|||
94367554|NCT02200614|323131633|FG001|Open Label|Adverse Event|11|||
94367555|NCT02200614|323131632|FG000|Open Label|Confirmed metastasis|1|||
94367556|NCT02200614|323131633|FG001|Open Label|Confirmed metastasis|0|||
94367557|NCT02200614|323131632|FG000|Open Label|Judgment of the investigator|29|||
94367558|NCT02200614|323131633|FG001|Open Label|Judgment of the investigator|2|||
94367559|NCT02200614|323131632|FG000|Open Label|Metastasis by local reading|138|||
94367560|NCT02200614|323131633|FG001|Open Label|Metastasis by local reading|27|||
94367561|NCT02200614|323131632|FG000|Open Label|Other reason|22|||
94367562|NCT02200614|323131633|FG001|Open Label|Other reason|4|||
94367563|NCT02200614|323131632|FG000|Open Label|Personal reason|60|||
94367564|NCT02200614|323131633|FG001|Open Label|Personal reason|8|||
94367565|NCT02200614|323131632|FG000|Open Label|Protocol deviation|3|||
94367566|NCT02200614|323131633|FG001|Open Label|Protocol deviation|2|||
94367567|NCT02200614|323131632|FG000|Open Label|Missing|2|||
94367568|NCT02200614|323131633|FG001|Open Label|Missing|2|||
94367569|NCT00434148|323131636|FG000|Overall Study|Adverse Event|18|||
94367570|NCT00434148|323131637|FG001|Overall Study|Adverse Event|18|||
94367571|NCT00434148|323131636|FG000|Overall Study|Lack of Efficacy|25|||
94367572|NCT00434148|323131637|FG001|Overall Study|Lack of Efficacy|28|||
94367573|NCT00434148|323131636|FG000|Overall Study|Withdrawal by Subject|15|||
94715764|NCT02590432|324418962|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
94715765|NCT02590432|324418963|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
94715766|NCT02590432|324418964|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
94715767|NCT02590432|324418965|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
94715768|NCT02590432|324418966|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
94715769|NCT02590432|324418958|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
94715770|NCT02590432|324418959|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
94715771|NCT02590432|324418960|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
94715772|NCT02590432|324418961|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
94367574|NCT00434148|323131637|FG001|Overall Study|Withdrawal by Subject|15|||
94367575|NCT00434148|323131636|FG000|Overall Study|Protocol Violation|4|||
94367576|NCT00434148|323131637|FG001|Overall Study|Protocol Violation|0|||
94367577|NCT00434148|323131636|FG000|Overall Study|Administrative problems|6|||
94367578|NCT00434148|323131637|FG001|Overall Study|Administrative problems|10|||
94367579|NCT00434148|323131636|FG000|Overall Study|Lost to Follow-up|0|||
94367580|NCT00434148|323131637|FG001|Overall Study|Lost to Follow-up|1|||
94367581|NCT00434148|323131636|FG000|Overall Study|Condition no longer requires study drug|1|||
94367582|NCT00434148|323131637|FG001|Overall Study|Condition no longer requires study drug|0|||
94367583|NCT00434148|323131636|FG000|Overall Study|Abnormal test procedure result|0|||
94367584|NCT00434148|323131637|FG001|Overall Study|Abnormal test procedure result|1|||
94367585|NCT02428231|323132963|FG000|Overall Study|Other|10|||
94367586|NCT02428231|323132964|FG001|Overall Study|Other|16|||
94367587|NCT02428231|323132963|FG000|Overall Study|Required Symptomatic Therapy|0|||
94367588|NCT02428231|323132964|FG001|Overall Study|Required Symptomatic Therapy|1|||
94367589|NCT02428231|323132963|FG000|Overall Study|Adverse Event|3|||
94715773|NCT02590432|324418962|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
94715774|NCT02590432|324418963|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
94367590|NCT02428231|323132964|FG001|Overall Study|Adverse Event|0|||
94367591|NCT01784419|323132965|FG000|Overall Study|Adverse Event|3|||
94367592|NCT02237118|323132966|FG000|Overall Study|Protocol Violation|0|||
94367593|NCT02237118|323132967|FG001|Overall Study|Protocol Violation|1|||
94367594|NCT02237118|323132966|FG000|Overall Study|consent withdrawn|1|||
94367595|NCT02237118|323132967|FG001|Overall Study|consent withdrawn|0|||
94715775|NCT02590432|324418964|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
94715776|NCT02590432|324418965|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
94715777|NCT02590432|324418966|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
94715778|NCT02590432|324418958|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
94715779|NCT02590432|324418959|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
94715780|NCT02590432|324418960|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
94715781|NCT02590432|324418961|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
94715782|NCT02590432|324418962|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
94715783|NCT02590432|324418963|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
94715784|NCT02590432|324418964|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
94715785|NCT02590432|324418965|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
94715786|NCT02590432|324418966|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
94715787|NCT02590432|324418958|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
94715788|NCT02590432|324418959|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
94367596|NCT00366678|323132968|FG000|Infant Series|Withdrawal by Subject|8|||
94367597|NCT00366678|323132969|FG001|Infant Series|Withdrawal by Subject|6|||
94367598|NCT00366678|323132970|FG002|Infant Series|Withdrawal by Subject|0|||
94367599|NCT00366678|323132968|FG000|Infant Series|Protocol Violation|4|||
94367600|NCT00366678|323132969|FG001|Infant Series|Protocol Violation|3|||
94367601|NCT00366678|323132970|FG002|Infant Series|Protocol Violation|0|||
94367602|NCT00366678|323132968|FG000|Infant Series|Failed to return|1|||
94367603|NCT00366678|323132969|FG001|Infant Series|Failed to return|1|||
94367604|NCT00366678|323132970|FG002|Infant Series|Failed to return|0|||
94367605|NCT00366678|323132968|FG000|Infant Series|Adverse Event|1|||
94367606|NCT00366678|323132969|FG001|Infant Series|Adverse Event|0|||
94367607|NCT00366678|323132970|FG002|Infant Series|Adverse Event|0|||
94367608|NCT00366678|323132968|FG000|After Infant|Withdrawal by Subject|8|||
94367609|NCT00366678|323132969|FG001|After Infant|Withdrawal by Subject|4|||
94367610|NCT00366678|323132970|FG002|After Infant|Withdrawal by Subject|0|||
94367611|NCT00366678|323132968|FG000|After Infant|Lost to Follow-up|2|||
94367612|NCT00366678|323132969|FG001|After Infant|Lost to Follow-up|1|||
94367613|NCT00366678|323132970|FG002|After Infant|Lost to Follow-up|0|||
94367614|NCT00366678|323132968|FG000|After Infant|Failed to return|5|||
94367615|NCT00366678|323132969|FG001|After Infant|Failed to return|5|||
94367616|NCT00366678|323132970|FG002|After Infant|Failed to return|0|||
94367617|NCT00366678|323132968|FG000|After Infant|Adverse Event|1|||
94367618|NCT00366678|323132969|FG001|After Infant|Adverse Event|0|||
94367619|NCT00366678|323132970|FG002|After Infant|Adverse Event|0|||
94367620|NCT00366678|323132968|FG000|After Infant|Protocol Violation|1|||
94367621|NCT00366678|323132969|FG001|After Infant|Protocol Violation|0|||
94367622|NCT00366678|323132970|FG002|After Infant|Protocol Violation|0|||
94367623|NCT00366678|323132968|FG000|Toddler Dose|Protocol Violation|2|||
94367624|NCT00366678|323132969|FG001|Toddler Dose|Protocol Violation|1|||
94367625|NCT00366678|323132970|FG002|Toddler Dose|Protocol Violation|0|||
94367626|NCT00366678|323132968|FG000|Toddler Dose|Failed to return|1|||
94367627|NCT00366678|323132969|FG001|Toddler Dose|Failed to return|0|||
94367628|NCT00366678|323132970|FG002|Toddler Dose|Failed to return|0|||
94367629|NCT00366678|323132968|FG000|Toddler Dose|Withdrawal by Subject|1|||
94367630|NCT00366678|323132969|FG001|Toddler Dose|Withdrawal by Subject|0|||
94367631|NCT00366678|323132970|FG002|Toddler Dose|Withdrawal by Subject|0|||
94367632|NCT00366678|323132968|FG000|Toddler Dose|protocol deviation|1|||
94367633|NCT00366678|323132969|FG001|Toddler Dose|protocol deviation|0|||
94367634|NCT00366678|323132970|FG002|Toddler Dose|protocol deviation|0|||
94367635|NCT02253654|323132971|FG000|Overall Study|Withdrawal by Subject|12|||
94367636|NCT02253654|323132972|FG001|Overall Study|Withdrawal by Subject|4|||
94367637|NCT02253654|323132971|FG000|Overall Study|Decision by Sponsor|1|||
94367638|NCT02253654|323132972|FG001|Overall Study|Decision by Sponsor|1|||
94367639|NCT02253654|323132971|FG000|Overall Study|Lost to Follow-up|2|||
94367640|NCT02253654|323132972|FG001|Overall Study|Lost to Follow-up|5|||
94367641|NCT02253654|323132971|FG000|Overall Study|Death|4|||
94367642|NCT02253654|323132972|FG001|Overall Study|Death|7|||
94367643|NCT02253654|323132971|FG000|Overall Study|Did Not Receive Study Treatment|4|||
94367644|NCT02253654|323132972|FG001|Overall Study|Did Not Receive Study Treatment|1|||
94367645|NCT02328547|323132973|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
94367646|NCT02328547|323132974|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
94367647|NCT02328547|323132973|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
94367648|NCT02328547|323132974|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
94367649|NCT02576054|323132978|FG000|Overall Study|Withdrawal by Subject|1|||
94367650|NCT02284373|323132980|FG000|Overall Study|Withdrawal by Subject|0|||
94367651|NCT02284373|323132981|FG001|Overall Study|Withdrawal by Subject|1|||
94367652|NCT02284373|323132982|FG002|Overall Study|Withdrawal by Subject|0|||
94367653|NCT02284373|323132980|FG000|Overall Study|Other|0|||
94367654|NCT02284373|323132981|FG001|Overall Study|Other|1|||
94367655|NCT02284373|323132982|FG002|Overall Study|Other|0|||
94367656|NCT02284373|323132980|FG000|Overall Study|Lost to Follow-up|0|||
94367657|NCT02284373|323132981|FG001|Overall Study|Lost to Follow-up|1|||
94715789|NCT02590432|324418960|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
94715790|NCT02590432|324418961|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
94715791|NCT02590432|324418962|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
94715792|NCT02590432|324418963|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
94715793|NCT02590432|324418964|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
94715794|NCT02590432|324418965|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
94367658|NCT02284373|323132982|FG002|Overall Study|Lost to Follow-up|0|||
94271334|NCT01168973|322787131|FG000|Overall Study|Adverse Event|94|||
94271335|NCT01168973|322787132|FG001|Overall Study|Adverse Event|55|||
94271336|NCT01168973|322787131|FG000|Overall Study|Withdrawal by Subject|90|||
94271337|NCT01168973|322787132|FG001|Overall Study|Withdrawal by Subject|53|||
94271338|NCT01168973|322787131|FG000|Overall Study|Death|42|||
94271339|NCT01168973|322787132|FG001|Overall Study|Death|45|||
94271340|NCT01168973|322787131|FG000|Overall Study|Physician Decision|37|||
94271341|NCT01168973|322787132|FG001|Overall Study|Physician Decision|19|||
94271342|NCT01168973|322787131|FG000|Overall Study|Sponsor Decision|2|||
94271343|NCT01168973|322787132|FG001|Overall Study|Sponsor Decision|1|||
94367659|NCT00468312|323132986|FG000|Overall Study|Adverse Event|2|||
94367660|NCT00468312|323132987|FG001|Overall Study|Adverse Event|1|||
94271344|NCT01168973|322787131|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
94367661|NCT00468312|323132986|FG000|Overall Study|Lack of Efficacy|0|||
94715795|NCT02590432|324418966|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
94715796|NCT02590432|324418958|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
94715797|NCT02590432|324418959|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
94715798|NCT02590432|324418960|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
94715799|NCT02590432|324418961|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
94715800|NCT02590432|324418962|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
94715801|NCT02590432|324418963|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
94715802|NCT02590432|324418964|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
94715803|NCT02590432|324418965|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
94715804|NCT02590432|324418966|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
94715805|NCT02590432|324418958|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
94715806|NCT02590432|324418959|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
94715807|NCT02590432|324418960|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
94715808|NCT02590432|324418961|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
94715809|NCT02590432|324418962|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
94715810|NCT02590432|324418963|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
94715811|NCT02590432|324418964|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
94715812|NCT02590432|324418965|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
94715813|NCT02590432|324418966|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
94715814|NCT02590432|324418958|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
94715815|NCT02590432|324418959|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
94715816|NCT02590432|324418960|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
94715817|NCT02590432|324418961|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
94715818|NCT02590432|324418962|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
94715819|NCT02590432|324418963|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
94715820|NCT02590432|324418964|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
94715821|NCT02590432|324418965|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
94715822|NCT02590432|324418966|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
94715823|NCT02590432|324418958|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
94715824|NCT02590432|324418959|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
94715825|NCT02590432|324418960|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
94715826|NCT02590432|324418961|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
94715827|NCT02590432|324418962|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
94715828|NCT02590432|324418963|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
94715829|NCT02590432|324418964|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
94715830|NCT02590432|324418965|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
94715831|NCT02590432|324418966|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
94715832|NCT02590432|324418958|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
94715833|NCT02590432|324418959|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
94715834|NCT02590432|324418960|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
94715835|NCT02590432|324418961|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
94715836|NCT02590432|324418962|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
94715837|NCT02590432|324418963|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
94715838|NCT02590432|324418964|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
94715839|NCT02590432|324418965|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
94715840|NCT02590432|324418966|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
94715841|NCT02590432|324418958|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
94715842|NCT02590432|324418959|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
94715843|NCT02590432|324418960|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
94715844|NCT02590432|324418961|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
94715845|NCT02590432|324418962|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
94715846|NCT02590432|324418963|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
94467261|NCT01121536|323500492|FG000|Overall Study|Noncompliance with study medication|12|||
94467262|NCT01121536|323500492|FG000|Overall Study|Noncompliance with study procedures|9|||
94467263|NCT01121536|323500492|FG000|Overall Study|Lost to Follow-up|39|||
94467264|NCT01121536|323500492|FG000|Overall Study|Other|118|||
94467265|NCT01935128|323500493|FG000|Overall Study|Death|1|||
94467266|NCT01935128|323500493|FG000|Overall Study|Adverse Event|6|||
94367662|NCT00468312|323132987|FG001|Overall Study|Lack of Efficacy|1|||
94367663|NCT00468312|323132986|FG000|Overall Study|Withdrawal by Subject|0|||
94367664|NCT00468312|323132987|FG001|Overall Study|Withdrawal by Subject|1|||
94367665|NCT00468312|323132986|FG000|Overall Study|Protocol Violation|2|||
94367666|NCT00468312|323132987|FG001|Overall Study|Protocol Violation|1|||
94367667|NCT00468312|323132986|FG000|Overall Study|Did not meet protocol eligibility|0|||
94367668|NCT00468312|323132987|FG001|Overall Study|Did not meet protocol eligibility|1|||
94367669|NCT02016755|323132988|FG000|Overall Study|Major amputation of index limb|2|||
94367670|NCT02016755|323132988|FG000|Overall Study|Adverse Event|2|||
94367671|NCT02016755|323132988|FG000|Overall Study|Physician Decision|1|||
94367672|NCT02016755|323132988|FG000|Overall Study|Death|2|||
94367673|NCT03591107|323132989|FG000|Overall Study|Same patient in both arms|1|||
94367674|NCT03591107|323132990|FG001|Overall Study|Same patient in both arms|1|||
94367675|NCT03591107|323132989|FG000|Overall Study|Sought care at other clinics|0|||
94367676|NCT03591107|323132990|FG001|Overall Study|Sought care at other clinics|2|||
94367677|NCT03591107|323132989|FG000|Overall Study|Discharged from clinic|0|||
94367678|NCT03591107|323132990|FG001|Overall Study|Discharged from clinic|1|||
94715847|NCT02590432|324418964|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
94715848|NCT02590432|324418965|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
94715849|NCT02590432|324418966|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
94715850|NCT02794480|324418969|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
94715851|NCT02794480|324418970|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
94715852|NCT02794480|324418971|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
94715853|NCT02794480|324418972|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
94715854|NCT02794480|324418969|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
94715855|NCT02794480|324418970|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
94715856|NCT02794480|324418971|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
94715857|NCT02794480|324418972|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
94715858|NCT02794480|324418969|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94715859|NCT02794480|324418970|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94715860|NCT02794480|324418971|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94715861|NCT02794480|324418972|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
94715862|NCT02794480|324418969|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94715863|NCT02794480|324418970|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
94715864|NCT02794480|324418971|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94715865|NCT02794480|324418972|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
94715866|NCT02794480|324418969|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
94715867|NCT02794480|324418970|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94715868|NCT02794480|324418971|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94715869|NCT02794480|324418972|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
94715870|NCT01084707|324418973|FG000|Overall Study|Withdrawal by Subject|6|||
94715871|NCT00976495|324418974|FG000|Overall Study|Withdrawal by Subject|0|||
94715872|NCT00976495|324418975|FG001|Overall Study|Withdrawal by Subject|1|||
94715873|NCT00976495|324418976|FG002|Overall Study|Withdrawal by Subject|0|||
94715874|NCT01136876|324418977|FG000|Overall Study|Lost to Follow-up|0|||
94715875|NCT01136876|324418978|FG001|Overall Study|Lost to Follow-up|1|||
94715876|NCT01136876|324418977|FG000|Overall Study|Physician Decision|3|||
94715877|NCT01136876|324418978|FG001|Overall Study|Physician Decision|5|||
94715878|NCT01136876|324418977|FG000|Overall Study|Missing NGAL measurement|2|||
94715879|NCT01136876|324418978|FG001|Overall Study|Missing NGAL measurement|5|||
94715880|NCT04484935|324418983|FG000|Overall Study|Other|0|||
94715881|NCT04484935|324418984|FG001|Overall Study|Other|1|||
94715882|NCT04484935|324418983|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94715883|NCT04484935|324418984|FG001|Overall Study|Withdrawal by parent/guardian|1|||
94715884|NCT04484935|324418983|FG000|Overall Study|Lost to Follow-up|1|||
94715885|NCT04484935|324418984|FG001|Overall Study|Lost to Follow-up|0|||
94715886|NCT04484935|324418983|FG000|Overall Study|Death|2|||
94715887|NCT04484935|324418984|FG001|Overall Study|Death|1|||
94715888|NCT01109524|324418989|FG000|Overall Study|Disease Progression|29|||
94715889|NCT01109524|324418989|FG000|Overall Study|Study Drug toxicity|6|||
94715890|NCT01109524|324418989|FG000|Overall Study|Adverse Event|4|||
94715891|NCT01109524|324418989|FG000|Overall Study|Withdrawal by Subject|2|||
94715892|NCT01109524|324418989|FG000|Overall Study|Maximum clinical benefit|3|||
94715893|NCT01109524|324418989|FG000|Overall Study|Death|2|||
94715894|NCT01109524|324418989|FG000|Overall Study|No longer meets criteria|2|||
94715895|NCT01109524|324418989|FG000|Overall Study|Participant requested to end treatment|4|||
94715896|NCT01109524|324418989|FG000|Overall Study|Other|5|||
94715897|NCT02409667|324418998|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
94715898|NCT02409667|324418999|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
94715899|NCT02409667|324419000|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
94715900|NCT02409667|324419001|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
94715901|NCT02409667|324419002|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
94715902|NCT02409667|324418998|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
94715903|NCT02409667|324418999|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
94715904|NCT02409667|324419000|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
94715905|NCT02409667|324419001|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
94715906|NCT02409667|324419002|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
94715907|NCT02409667|324418998|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
94715908|NCT02409667|324418999|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
94715909|NCT02409667|324419000|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
94715910|NCT02409667|324419001|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
94715911|NCT02409667|324419002|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
94715912|NCT02409667|324418998|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
94715913|NCT02409667|324418999|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
94715914|NCT02409667|324419000|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
94715915|NCT02409667|324419001|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
94715916|NCT02409667|324419002|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
94715917|NCT02409667|324418998|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
94715918|NCT02409667|324418999|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
94715919|NCT02409667|324419000|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
94715920|NCT02409667|324419001|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
94715921|NCT02409667|324419002|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
94715922|NCT02409667|324418998|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
94715923|NCT02409667|324418999|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
94715924|NCT02409667|324419000|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
94715925|NCT02409667|324419001|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
94715926|NCT02409667|324419002|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
94715927|NCT02409667|324418998|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
94715928|NCT02409667|324418999|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
94715929|NCT02409667|324419000|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
94715930|NCT02409667|324419001|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
94715931|NCT02409667|324419002|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
94715932|NCT02409667|324418998|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
94715933|NCT02409667|324418999|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
94715934|NCT02409667|324419000|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
94715935|NCT02409667|324419001|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
94715936|NCT02409667|324419002|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
94715937|NCT02409667|324418998|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
94715938|NCT02409667|324418999|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
94715939|NCT02409667|324419000|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
94715940|NCT02409667|324419001|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
94715941|NCT02409667|324419002|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
94715942|NCT02409667|324418998|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
94715943|NCT02409667|324418999|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
94715944|NCT02409667|324419000|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
94715945|NCT02409667|324419001|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
94715946|NCT02409667|324419002|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
94715947|NCT02409667|324418998|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
94715948|NCT02409667|324418999|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
94715949|NCT02409667|324419000|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
94715950|NCT02409667|324419001|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
94715951|NCT02409667|324419002|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
94715952|NCT02409667|324418998|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
94715953|NCT02409667|324418999|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
94715954|NCT02409667|324419000|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
94715955|NCT02409667|324419001|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
94715956|NCT02409667|324419002|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
94715957|NCT02409667|324418998|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
94715958|NCT02409667|324418999|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
94715959|NCT02409667|324419000|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
94715960|NCT02409667|324419001|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
94715961|NCT02409667|324419002|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
94715962|NCT02409667|324418998|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
94715963|NCT02409667|324418999|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
94715964|NCT02409667|324419000|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
94715965|NCT02409667|324419001|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
94715966|NCT02409667|324419002|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
94715967|NCT02409667|324418998|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
94715968|NCT02409667|324418999|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
94715969|NCT02409667|324419000|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
94715970|NCT02409667|324419001|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
94715971|NCT02409667|324419002|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
94715972|NCT02409667|324418998|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
94715973|NCT02409667|324418999|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
94715974|NCT02409667|324419000|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
94715975|NCT02409667|324419001|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
94715976|NCT02409667|324419002|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
94715977|NCT02318134|324419003|FG000|Overall Study|Withdrawal by Subject|2|||
94715978|NCT02318134|324419004|FG001|Overall Study|Withdrawal by Subject|1|||
94715979|NCT01925339|324419005|FG000|Overall Study|Adverse Event|2|||
94715980|NCT01925339|324419006|FG001|Overall Study|Adverse Event|0|||
94715981|NCT00031694|324419011|FG000|Overall Study|Adverse Event|12|||
94715982|NCT00031694|324419011|FG000|Overall Study|Death|2|||
94715983|NCT00031694|324419011|FG000|Overall Study|Withdrawal by Subject|5|||
94715984|NCT04766034|324419012|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
94715985|NCT04766034|324419013|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
94715986|NCT04766034|324419014|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
94715987|NCT04766034|324419015|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
94715988|NCT04766034|324419016|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
94715989|NCT04766034|324419012|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
94715990|NCT04766034|324419013|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
94715991|NCT04766034|324419014|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
94715992|NCT04766034|324419015|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
94715993|NCT04766034|324419016|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
94715994|NCT04766034|324419012|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
94715995|NCT04766034|324419013|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
94271345|NCT01168973|322787132|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
94271346|NCT02230254|322787135|FG000|Overall Study|Lost to Follow-up|3|||
94271347|NCT02023242|322787136|FG000|Overall Study|Lost to Follow-up|3|||
94271348|NCT02023242|322787137|FG001|Overall Study|Lost to Follow-up|1|||
94271349|NCT02023242|322787136|FG000|Overall Study|Death|0|||
94271350|NCT02023242|322787137|FG001|Overall Study|Death|1|||
94271351|NCT05092919|322787138|FG000|Overall Study|Lost to Follow-up|7|||
94271352|NCT05092919|322787138|FG000|Overall Study|Withdrawal by Subject|2|||
94271353|NCT04854434|322787141|FG000|Overall Study|Death|1|||
94271354|NCT04854434|322787142|FG001|Overall Study|Death|3|||
94271355|NCT04854434|322787143|FG002|Overall Study|Death|4|||
94271356|NCT04854434|322787141|FG000|Overall Study|Study Terminated by Sponsor|2|||
94271357|NCT04854434|322787142|FG001|Overall Study|Study Terminated by Sponsor|0|||
94271358|NCT04854434|322787143|FG002|Overall Study|Study Terminated by Sponsor|0|||
94271359|NCT04854434|322787141|FG000|Overall Study|Other|1|||
94271360|NCT04854434|322787142|FG001|Overall Study|Other|1|||
94271361|NCT04854434|322787143|FG002|Overall Study|Other|0|||
94271362|NCT01469182|322787146|FG000|Overall Study|Adverse Event|21|||
94271363|NCT01469182|322787147|FG001|Overall Study|Adverse Event|3|||
94271364|NCT01469182|322787146|FG000|Overall Study|Lost to Follow-up|3|||
94271365|NCT01469182|322787147|FG001|Overall Study|Lost to Follow-up|0|||
94271366|NCT01469182|322787146|FG000|Overall Study|Withdrawal by Subject|4|||
94271367|NCT01469182|322787147|FG001|Overall Study|Withdrawal by Subject|1|||
94271368|NCT01469182|322787146|FG000|Overall Study|Protocol Violation|4|||
94271369|NCT01469182|322787147|FG001|Overall Study|Protocol Violation|2|||
94271370|NCT01469182|322787146|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
94271371|NCT01469182|322787147|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
94271372|NCT01516970|322787148|FG000|Overall Study|Lost to Follow-up|7|||
94271373|NCT01516970|322787149|FG001|Overall Study|Lost to Follow-up|8|||
94271374|NCT01516970|322787148|FG000|Overall Study|Adverse Event|1|||
94271375|NCT01516970|322787149|FG001|Overall Study|Adverse Event|5|||
94271376|NCT01516970|322787148|FG000|Overall Study|Withdrawal by Subject|1|||
94271377|NCT01516970|322787149|FG001|Overall Study|Withdrawal by Subject|1|||
94715996|NCT04766034|324419014|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
94715997|NCT04766034|324419015|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
94715998|NCT04766034|324419016|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
94715999|NCT04766034|324419012|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
94716000|NCT04766034|324419013|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
94716001|NCT04766034|324419014|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
94716002|NCT04766034|324419015|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
94716003|NCT04766034|324419016|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
94716004|NCT03892564|324419019|FG000|Overall Study|Withdrawal by Subject|2|||
94716005|NCT03481816|324419020|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
94716006|NCT03481816|324419021|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
94716007|NCT03481816|324419020|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
94716008|NCT03481816|324419021|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
94716009|NCT03481816|324419020|FG000|Dose Expansion|Withdrawal by Subject|0|||
94716010|NCT03481816|324419021|FG001|Dose Expansion|Withdrawal by Subject|2|||
94716011|NCT03481816|324419020|FG000|Dose Expansion|Physician Decision|0|||
94716012|NCT03481816|324419021|FG001|Dose Expansion|Physician Decision|5|||
94716013|NCT01721291|324419022|FG000|Overall Study|Withdrawal by Subject|1|||
94716014|NCT01721291|324419023|FG001|Overall Study|Withdrawal by Subject|0|||
94716015|NCT01721291|324419022|FG000|Overall Study|did not like the treatment|1|||
94716016|NCT01721291|324419023|FG001|Overall Study|did not like the treatment|0|||
94716017|NCT01091168|324419025|FG000|Overall Study|Progressive disease|250|||
94716018|NCT01091168|324419026|FG001|Overall Study|Progressive disease|234|||
94271378|NCT01516970|322787148|FG000|Overall Study|Other|9|||
94271379|NCT01516970|322787149|FG001|Overall Study|Other|7|||
94271380|NCT02053168|322787150|FG000|Overall Study|Withdrawal by Subject|1|||
94271381|NCT02053168|322787150|FG000|Overall Study|Physician Decision|1|||
94271382|NCT02053168|322787150|FG000|Overall Study|Lost to Follow-up|1|||
94271383|NCT02687542|322787151|FG000|Overall Study|Medication error without associated AEs|0|||
94271384|NCT02687542|322787152|FG001|Overall Study|Medication error without associated AEs|0|||
94271385|NCT02687542|322787153|FG002|Overall Study|Medication error without associated AEs|0|||
94271386|NCT02687542|322787154|FG003|Overall Study|Medication error without associated AEs|0|||
94271387|NCT02687542|322787155|FG004|Overall Study|Medication error without associated AEs|1|||
94271388|NCT02687542|322787151|FG000|Overall Study|Lost to Follow-up|0|||
94271389|NCT02687542|322787152|FG001|Overall Study|Lost to Follow-up|0|||
94271390|NCT02687542|322787153|FG002|Overall Study|Lost to Follow-up|0|||
94271391|NCT02687542|322787154|FG003|Overall Study|Lost to Follow-up|0|||
94271392|NCT02687542|322787155|FG004|Overall Study|Lost to Follow-up|1|||
94271393|NCT02687542|322787151|FG000|Overall Study|Protocol Violation|0|||
94271394|NCT02687542|322787152|FG001|Overall Study|Protocol Violation|1|||
94271395|NCT02687542|322787153|FG002|Overall Study|Protocol Violation|0|||
94271396|NCT02687542|322787154|FG003|Overall Study|Protocol Violation|0|||
94271397|NCT02687542|322787155|FG004|Overall Study|Protocol Violation|0|||
94271398|NCT02687542|322787151|FG000|Overall Study|Other|5|||
94271399|NCT02687542|322787152|FG001|Overall Study|Other|9|||
94716019|NCT01091168|324419025|FG000|Overall Study|Adverse Event|21|||
94716020|NCT01091168|324419026|FG001|Overall Study|Adverse Event|24|||
94716021|NCT01091168|324419025|FG000|Overall Study|Lost to Follow-up|0|||
94716022|NCT01091168|324419026|FG001|Overall Study|Lost to Follow-up|1|||
94716023|NCT01091168|324419025|FG000|Overall Study|Physician, patient's decision, other|27|||
94716024|NCT01091168|324419026|FG001|Overall Study|Physician, patient's decision, other|37|||
94716025|NCT04688450|324421144|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
94716026|NCT04688450|324421144|FG000|Overall Study|Withdrawal by Subject|1|||
94716027|NCT01643070|324421145|FG000|Overall Study|Withdrawal by Subject|3|||
94716028|NCT01643070|324421146|FG001|Overall Study|Withdrawal by Subject|1|||
94716029|NCT01643070|324421145|FG000|Overall Study|Death|1|||
94716030|NCT01643070|324421146|FG001|Overall Study|Death|0|||
94716031|NCT01643070|324421145|FG000|Overall Study|Pregressive disease|0|||
94716032|NCT01643070|324421146|FG001|Overall Study|Pregressive disease|2|||
94716033|NCT01259401|324421147|FG000|4-month Follow-up|Death|0|||
94716034|NCT01259401|324421148|FG001|4-month Follow-up|Death|1|||
94716035|NCT01259401|324421147|FG000|4-month Follow-up|Lost to Follow-up|0|||
94716036|NCT01259401|324421148|FG001|4-month Follow-up|Lost to Follow-up|1|||
94716037|NCT05644002|324421149|FG000|Overall Study|Lost to Follow-up|1|||
94716038|NCT05644002|324421150|FG001|Overall Study|Lost to Follow-up|2|||
94716039|NCT05644002|324421149|FG000|Overall Study|Withdrawal by Subject|0|||
94716040|NCT05644002|324421150|FG001|Overall Study|Withdrawal by Subject|1|||
94716041|NCT02652260|324421151|FG000|Base Study|Pregnancy|0|||
94716042|NCT02652260|324421152|FG001|Base Study|Pregnancy|1|||
94716043|NCT02652260|324421151|FG000|Base Study|Withdrawal by Subject|0|||
94716044|NCT02652260|324421152|FG001|Base Study|Withdrawal by Subject|1|||
94716045|NCT02652260|324421151|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
94716046|NCT02652260|324421152|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
94716047|NCT02652260|324421151|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
94716048|NCT02652260|324421152|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
94716049|NCT02652260|324421151|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
94716050|NCT02652260|324421152|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
94716051|NCT02652260|324421151|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
94716052|NCT02652260|324421152|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
94716053|NCT02652260|324421151|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
94716054|NCT02652260|324421152|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
94716055|NCT02652260|324421151|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
94716056|NCT02652260|324421152|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
94716057|NCT02652260|324421151|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
94716058|NCT02652260|324421152|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
94716059|NCT02652260|324421151|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
94716060|NCT02652260|324421152|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
94716061|NCT02652260|324421151|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
94716062|NCT02652260|324421152|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
94716063|NCT02652260|324421151|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
94716064|NCT02652260|324421152|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
94716065|NCT02652260|324421151|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
94716066|NCT02652260|324421152|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
94716067|NCT02652260|324421151|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
94716068|NCT02652260|324421152|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
94716069|NCT02723955|324421153|FG000|Escalation Phase|Death|1|||
94716070|NCT02723955|324421154|FG001|Escalation Phase|Death|1|||
94716071|NCT02723955|324421155|FG002|Escalation Phase|Death|2|||
94716072|NCT02723955|324421156|FG003|Escalation Phase|Death|7|||
94716073|NCT02723955|324421157|FG004|Escalation Phase|Death|18|||
94716074|NCT02723955|324421158|FG005|Escalation Phase|Death|17|||
94716075|NCT02723955|324421159|FG006|Escalation Phase|Death|11|||
94716076|NCT02723955|324421160|FG007|Escalation Phase|Death|21|||
94716077|NCT02723955|324421161|FG008|Escalation Phase|Death|3|||
94716078|NCT02723955|324421162|FG009|Escalation Phase|Death|0|||
94716079|NCT02723955|324421163|FG010|Escalation Phase|Death|0|||
94716080|NCT02723955|324421164|FG011|Escalation Phase|Death|0|||
94716081|NCT02723955|324421165|FG012|Escalation Phase|Death|2|||
94716082|NCT02723955|324421166|FG013|Escalation Phase|Death|4|||
94716083|NCT02723955|324421167|FG014|Escalation Phase|Death|5|||
94716084|NCT02723955|324421168|FG015|Escalation Phase|Death|6|||
94716085|NCT02723955|324421169|FG016|Escalation Phase|Death|6|||
94716086|NCT02723955|324421170|FG017|Escalation Phase|Death|7|||
94716087|NCT02723955|324421171|FG018|Escalation Phase|Death|1|||
94716088|NCT02723955|324421172|FG019|Escalation Phase|Death|3|||
94716089|NCT02723955|324421173|FG020|Escalation Phase|Death|13|||
94716090|NCT02723955|324421174|FG021|Escalation Phase|Death|3|||
94271400|NCT02687542|322787153|FG002|Overall Study|Other|10|||
94716091|NCT02723955|324421175|FG022|Escalation Phase|Death|2|||
94716092|NCT02723955|324421176|FG023|Escalation Phase|Death|4|||
94716093|NCT02723955|324421177|FG024|Escalation Phase|Death|31|||
94716094|NCT02723955|324421178|FG025|Escalation Phase|Death|7|||
94716095|NCT02723955|324421179|FG026|Escalation Phase|Death|13|||
94716096|NCT02723955|324421180|FG027|Escalation Phase|Death|0|||
94716097|NCT02723955|324421181|FG028|Escalation Phase|Death|1|||
94716098|NCT02723955|324421182|FG029|Escalation Phase|Death|0|||
94716099|NCT02723955|324421183|FG030|Escalation Phase|Death|0|||
94716100|NCT02723955|324421184|FG031|Escalation Phase|Death|0|||
94716101|NCT02723955|324421185|FG032|Escalation Phase|Death|0|||
94716102|NCT02723955|324421186|FG033|Escalation Phase|Death|0|||
94716103|NCT02723955|324421187|FG034|Escalation Phase|Death|0|||
94716104|NCT02723955|324421188|FG035|Escalation Phase|Death|0|||
94716105|NCT02723955|324421189|FG036|Escalation Phase|Death|0|||
94716106|NCT02723955|324421190|FG037|Escalation Phase|Death|0|||
94716107|NCT02723955|324421191|FG038|Escalation Phase|Death|0|||
94716108|NCT02723955|324421192|FG039|Escalation Phase|Death|0|||
94716109|NCT02723955|324421193|FG040|Escalation Phase|Death|0|||
94716110|NCT02723955|324421194|FG041|Escalation Phase|Death|0|||
94716111|NCT02723955|324421195|FG042|Escalation Phase|Death|0|||
94716112|NCT02723955|324421153|FG000|Escalation Phase|Lost to Follow-up|0|||
94716113|NCT02723955|324421154|FG001|Escalation Phase|Lost to Follow-up|0|||
94716114|NCT02723955|324421155|FG002|Escalation Phase|Lost to Follow-up|0|||
94716115|NCT02723955|324421156|FG003|Escalation Phase|Lost to Follow-up|0|||
94716116|NCT02723955|324421157|FG004|Escalation Phase|Lost to Follow-up|0|||
94271401|NCT02687542|322787154|FG003|Overall Study|Other|6|||
94271402|NCT02687542|322787155|FG004|Overall Study|Other|5|||
94271403|NCT02687542|322787151|FG000|Overall Study|Adverse Event|3|||
94271404|NCT02687542|322787152|FG001|Overall Study|Adverse Event|1|||
94271405|NCT02687542|322787153|FG002|Overall Study|Adverse Event|3|||
94271406|NCT02687542|322787154|FG003|Overall Study|Adverse Event|2|||
94271407|NCT02687542|322787155|FG004|Overall Study|Adverse Event|9|||
94271408|NCT02687542|322787151|FG000|Overall Study|Withdrawal by Subject|0|||
94271409|NCT02687542|322787152|FG001|Overall Study|Withdrawal by Subject|1|||
94271410|NCT02687542|322787153|FG002|Overall Study|Withdrawal by Subject|1|||
94271411|NCT02687542|322787154|FG003|Overall Study|Withdrawal by Subject|2|||
94271412|NCT02687542|322787155|FG004|Overall Study|Withdrawal by Subject|4|||
94271413|NCT01838616|322787156|FG000|Titration Period|Adverse Event|18|||
94716117|NCT02723955|324421158|FG005|Escalation Phase|Lost to Follow-up|2|||
94716118|NCT02723955|324421159|FG006|Escalation Phase|Lost to Follow-up|1|||
94271414|NCT01838616|322787157|FG001|Titration Period|Adverse Event|48|||
94271415|NCT01838616|322787156|FG000|Titration Period|Lack of Efficacy|5|||
94271416|NCT01838616|322787157|FG001|Titration Period|Lack of Efficacy|12|||
94271417|NCT01838616|322787156|FG000|Titration Period|Withdrawal by Subject|5|||
94271418|NCT01838616|322787157|FG001|Titration Period|Withdrawal by Subject|5|||
94271419|NCT01838616|322787156|FG000|Titration Period|Technical problems|1|||
94271420|NCT01838616|322787157|FG001|Titration Period|Technical problems|0|||
94271421|NCT01838616|322787156|FG000|Titration Period|Other|1|||
94271422|NCT01838616|322787157|FG001|Titration Period|Other|0|||
94271423|NCT01838616|322787156|FG000|Titration Period|Protocol Violation|0|||
94271424|NCT01838616|322787157|FG001|Titration Period|Protocol Violation|1|||
94271425|NCT01838616|322787156|FG000|Continuation Period|Lack of Efficacy|3|||
94271426|NCT01838616|322787157|FG001|Continuation Period|Lack of Efficacy|5|||
94271427|NCT01838616|322787156|FG000|Continuation Period|Adverse Event|8|||
94271428|NCT01838616|322787157|FG001|Continuation Period|Adverse Event|4|||
94271429|NCT01838616|322787156|FG000|Continuation Period|Protocol Violation|2|||
94271430|NCT01838616|322787157|FG001|Continuation Period|Protocol Violation|0|||
94271431|NCT01838616|322787156|FG000|Continuation Period|Lost to Follow-up|1|||
94271432|NCT01838616|322787157|FG001|Continuation Period|Lost to Follow-up|0|||
94716119|NCT02723955|324421160|FG007|Escalation Phase|Lost to Follow-up|1|||
94716120|NCT02723955|324421161|FG008|Escalation Phase|Lost to Follow-up|1|||
94716121|NCT02723955|324421162|FG009|Escalation Phase|Lost to Follow-up|0|||
94716122|NCT02723955|324421163|FG010|Escalation Phase|Lost to Follow-up|0|||
94716123|NCT02723955|324421164|FG011|Escalation Phase|Lost to Follow-up|0|||
94271433|NCT01838616|322787156|FG000|Continuation Period|Withdrawal by Subject|0|||
94271434|NCT01838616|322787157|FG001|Continuation Period|Withdrawal by Subject|4|||
94271435|NCT01838616|322787156|FG000|Continuation Period|Technical problems|0|||
94271436|NCT01838616|322787157|FG001|Continuation Period|Technical problems|1|||
94271437|NCT01838616|322787156|FG000|Pick-up Arm|Lack of Efficacy|4|||
94271438|NCT01838616|322787157|FG001|Pick-up Arm|Lack of Efficacy|0|||
94271439|NCT01838616|322787156|FG000|Pick-up Arm|Adverse Event|9|||
94716124|NCT02723955|324421165|FG012|Escalation Phase|Lost to Follow-up|1|||
94716125|NCT02723955|324421166|FG013|Escalation Phase|Lost to Follow-up|0|||
94716126|NCT02723955|324421167|FG014|Escalation Phase|Lost to Follow-up|0|||
94716127|NCT02723955|324421168|FG015|Escalation Phase|Lost to Follow-up|0|||
94716128|NCT02723955|324421169|FG016|Escalation Phase|Lost to Follow-up|1|||
94716129|NCT02723955|324421170|FG017|Escalation Phase|Lost to Follow-up|2|||
94716130|NCT02723955|324421171|FG018|Escalation Phase|Lost to Follow-up|0|||
94716131|NCT02723955|324421172|FG019|Escalation Phase|Lost to Follow-up|1|||
94716132|NCT02723955|324421173|FG020|Escalation Phase|Lost to Follow-up|2|||
94716133|NCT02723955|324421174|FG021|Escalation Phase|Lost to Follow-up|1|||
94716134|NCT02723955|324421175|FG022|Escalation Phase|Lost to Follow-up|0|||
94716135|NCT02723955|324421176|FG023|Escalation Phase|Lost to Follow-up|0|||
94716136|NCT02723955|324421177|FG024|Escalation Phase|Lost to Follow-up|1|||
94716137|NCT02723955|324421178|FG025|Escalation Phase|Lost to Follow-up|1|||
94716138|NCT02723955|324421179|FG026|Escalation Phase|Lost to Follow-up|3|||
94716139|NCT02723955|324421180|FG027|Escalation Phase|Lost to Follow-up|0|||
94716140|NCT02723955|324421181|FG028|Escalation Phase|Lost to Follow-up|1|||
94716141|NCT02723955|324421182|FG029|Escalation Phase|Lost to Follow-up|0|||
94716142|NCT02723955|324421183|FG030|Escalation Phase|Lost to Follow-up|0|||
94716143|NCT02723955|324421184|FG031|Escalation Phase|Lost to Follow-up|0|||
94716144|NCT02723955|324421185|FG032|Escalation Phase|Lost to Follow-up|0|||
94716145|NCT02723955|324421186|FG033|Escalation Phase|Lost to Follow-up|0|||
94716146|NCT02723955|324421187|FG034|Escalation Phase|Lost to Follow-up|0|||
94716147|NCT02723955|324421188|FG035|Escalation Phase|Lost to Follow-up|0|||
94716148|NCT02723955|324421189|FG036|Escalation Phase|Lost to Follow-up|0|||
94716149|NCT02723955|324421190|FG037|Escalation Phase|Lost to Follow-up|0|||
94716150|NCT02723955|324421191|FG038|Escalation Phase|Lost to Follow-up|0|||
94716151|NCT02723955|324421192|FG039|Escalation Phase|Lost to Follow-up|0|||
94716152|NCT02723955|324421193|FG040|Escalation Phase|Lost to Follow-up|0|||
94716153|NCT02723955|324421194|FG041|Escalation Phase|Lost to Follow-up|0|||
94716154|NCT02723955|324421195|FG042|Escalation Phase|Lost to Follow-up|0|||
94716155|NCT02723955|324421153|FG000|Escalation Phase|Physician Decision|0|||
94716156|NCT02723955|324421154|FG001|Escalation Phase|Physician Decision|0|||
94716157|NCT02723955|324421155|FG002|Escalation Phase|Physician Decision|0|||
94716158|NCT02723955|324421156|FG003|Escalation Phase|Physician Decision|0|||
94716159|NCT02723955|324421157|FG004|Escalation Phase|Physician Decision|0|||
94716160|NCT02723955|324421158|FG005|Escalation Phase|Physician Decision|2|||
94716161|NCT02723955|324421159|FG006|Escalation Phase|Physician Decision|0|||
94716162|NCT02723955|324421160|FG007|Escalation Phase|Physician Decision|0|||
94716163|NCT02723955|324421161|FG008|Escalation Phase|Physician Decision|0|||
94716164|NCT02723955|324421162|FG009|Escalation Phase|Physician Decision|0|||
94716165|NCT02723955|324421163|FG010|Escalation Phase|Physician Decision|0|||
94716166|NCT02723955|324421164|FG011|Escalation Phase|Physician Decision|0|||
94716167|NCT02723955|324421165|FG012|Escalation Phase|Physician Decision|0|||
94716168|NCT02723955|324421166|FG013|Escalation Phase|Physician Decision|0|||
94716169|NCT02723955|324421167|FG014|Escalation Phase|Physician Decision|0|||
94716170|NCT02723955|324421168|FG015|Escalation Phase|Physician Decision|0|||
94716171|NCT02723955|324421169|FG016|Escalation Phase|Physician Decision|0|||
94716172|NCT02723955|324421170|FG017|Escalation Phase|Physician Decision|0|||
94716173|NCT02723955|324421171|FG018|Escalation Phase|Physician Decision|0|||
94716174|NCT02723955|324421172|FG019|Escalation Phase|Physician Decision|0|||
94716175|NCT02723955|324421173|FG020|Escalation Phase|Physician Decision|0|||
94716176|NCT02723955|324421174|FG021|Escalation Phase|Physician Decision|0|||
94716177|NCT02723955|324421175|FG022|Escalation Phase|Physician Decision|0|||
94716178|NCT02723955|324421176|FG023|Escalation Phase|Physician Decision|0|||
94716179|NCT02723955|324421177|FG024|Escalation Phase|Physician Decision|0|||
94716180|NCT02723955|324421178|FG025|Escalation Phase|Physician Decision|0|||
94716181|NCT02723955|324421179|FG026|Escalation Phase|Physician Decision|2|||
94716182|NCT02723955|324421180|FG027|Escalation Phase|Physician Decision|0|||
94716183|NCT02723955|324421181|FG028|Escalation Phase|Physician Decision|0|||
94716184|NCT02723955|324421182|FG029|Escalation Phase|Physician Decision|0|||
94716185|NCT02723955|324421183|FG030|Escalation Phase|Physician Decision|0|||
94716186|NCT02723955|324421184|FG031|Escalation Phase|Physician Decision|0|||
94716187|NCT02723955|324421185|FG032|Escalation Phase|Physician Decision|0|||
94716188|NCT02723955|324421186|FG033|Escalation Phase|Physician Decision|0|||
94716189|NCT02723955|324421187|FG034|Escalation Phase|Physician Decision|0|||
94716190|NCT02723955|324421188|FG035|Escalation Phase|Physician Decision|0|||
94716191|NCT02723955|324421189|FG036|Escalation Phase|Physician Decision|0|||
94716192|NCT02723955|324421190|FG037|Escalation Phase|Physician Decision|0|||
94716193|NCT02723955|324421191|FG038|Escalation Phase|Physician Decision|0|||
94716194|NCT02723955|324421192|FG039|Escalation Phase|Physician Decision|0|||
94716195|NCT02723955|324421193|FG040|Escalation Phase|Physician Decision|0|||
94467267|NCT01897571|323500496|FG000|Overall Study|Lost to Follow-up|3|||
94716196|NCT02723955|324421194|FG041|Escalation Phase|Physician Decision|0|||
94716197|NCT02723955|324421195|FG042|Escalation Phase|Physician Decision|0|||
94716198|NCT02723955|324421153|FG000|Escalation Phase|Withdrawal by Subject|0|||
94716199|NCT02723955|324421154|FG001|Escalation Phase|Withdrawal by Subject|0|||
94716200|NCT02723955|324421155|FG002|Escalation Phase|Withdrawal by Subject|0|||
94716201|NCT02723955|324421156|FG003|Escalation Phase|Withdrawal by Subject|0|||
94716202|NCT02723955|324421157|FG004|Escalation Phase|Withdrawal by Subject|1|||
94716203|NCT02723955|324421158|FG005|Escalation Phase|Withdrawal by Subject|1|||
94716204|NCT02723955|324421159|FG006|Escalation Phase|Withdrawal by Subject|1|||
94716205|NCT02723955|324421160|FG007|Escalation Phase|Withdrawal by Subject|1|||
94716206|NCT02723955|324421161|FG008|Escalation Phase|Withdrawal by Subject|0|||
94716207|NCT02723955|324421162|FG009|Escalation Phase|Withdrawal by Subject|0|||
94716208|NCT02723955|324421163|FG010|Escalation Phase|Withdrawal by Subject|0|||
94716209|NCT02723955|324421164|FG011|Escalation Phase|Withdrawal by Subject|0|||
94716210|NCT02723955|324421165|FG012|Escalation Phase|Withdrawal by Subject|1|||
94716211|NCT02723955|324421166|FG013|Escalation Phase|Withdrawal by Subject|0|||
94716212|NCT02723955|324421167|FG014|Escalation Phase|Withdrawal by Subject|0|||
94716213|NCT02723955|324421168|FG015|Escalation Phase|Withdrawal by Subject|0|||
94716214|NCT02723955|324421169|FG016|Escalation Phase|Withdrawal by Subject|1|||
94716215|NCT02723955|324421170|FG017|Escalation Phase|Withdrawal by Subject|0|||
94716216|NCT02723955|324421171|FG018|Escalation Phase|Withdrawal by Subject|0|||
94716217|NCT02723955|324421172|FG019|Escalation Phase|Withdrawal by Subject|0|||
94716218|NCT02723955|324421173|FG020|Escalation Phase|Withdrawal by Subject|0|||
94716219|NCT02723955|324421174|FG021|Escalation Phase|Withdrawal by Subject|0|||
94716220|NCT02723955|324421175|FG022|Escalation Phase|Withdrawal by Subject|0|||
94716221|NCT02723955|324421176|FG023|Escalation Phase|Withdrawal by Subject|2|||
94716222|NCT02723955|324421177|FG024|Escalation Phase|Withdrawal by Subject|0|||
94716223|NCT02723955|324421178|FG025|Escalation Phase|Withdrawal by Subject|1|||
94716224|NCT02723955|324421179|FG026|Escalation Phase|Withdrawal by Subject|0|||
94716225|NCT02723955|324421180|FG027|Escalation Phase|Withdrawal by Subject|0|||
94716226|NCT02723955|324421181|FG028|Escalation Phase|Withdrawal by Subject|1|||
94716227|NCT02723955|324421182|FG029|Escalation Phase|Withdrawal by Subject|0|||
94716228|NCT02723955|324421183|FG030|Escalation Phase|Withdrawal by Subject|0|||
94716229|NCT02723955|324421184|FG031|Escalation Phase|Withdrawal by Subject|0|||
94716230|NCT02723955|324421185|FG032|Escalation Phase|Withdrawal by Subject|0|||
94716231|NCT02723955|324421186|FG033|Escalation Phase|Withdrawal by Subject|0|||
94716232|NCT02723955|324421187|FG034|Escalation Phase|Withdrawal by Subject|0|||
94716233|NCT02723955|324421188|FG035|Escalation Phase|Withdrawal by Subject|0|||
94716234|NCT02723955|324421189|FG036|Escalation Phase|Withdrawal by Subject|0|||
94716235|NCT02723955|324421190|FG037|Escalation Phase|Withdrawal by Subject|0|||
94716236|NCT02723955|324421191|FG038|Escalation Phase|Withdrawal by Subject|0|||
94716237|NCT02723955|324421192|FG039|Escalation Phase|Withdrawal by Subject|0|||
94716238|NCT02723955|324421193|FG040|Escalation Phase|Withdrawal by Subject|0|||
94716239|NCT02723955|324421194|FG041|Escalation Phase|Withdrawal by Subject|0|||
94716240|NCT02723955|324421195|FG042|Escalation Phase|Withdrawal by Subject|0|||
94716241|NCT02723955|324421153|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716242|NCT02723955|324421154|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716243|NCT02723955|324421155|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716244|NCT02723955|324421156|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716245|NCT02723955|324421157|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
94716246|NCT02723955|324421158|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
94716247|NCT02723955|324421159|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
94716248|NCT02723955|324421160|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
94716249|NCT02723955|324421161|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
94716250|NCT02723955|324421162|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716251|NCT02723955|324421163|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716252|NCT02723955|324421164|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716253|NCT02723955|324421165|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716254|NCT02723955|324421166|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716255|NCT02723955|324421167|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716256|NCT02723955|324421168|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716257|NCT02723955|324421169|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716258|NCT02723955|324421170|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716259|NCT02723955|324421171|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94271440|NCT01838616|322787157|FG001|Pick-up Arm|Adverse Event|0|||
94271441|NCT01838616|322787156|FG000|Pick-up Arm|Withdrawal by Subject|1|||
94271442|NCT01838616|322787157|FG001|Pick-up Arm|Withdrawal by Subject|0|||
94271443|NCT01838616|322787156|FG000|Pick-up Arm|Technical problems|1|||
94271444|NCT01838616|322787157|FG001|Pick-up Arm|Technical problems|0|||
94271445|NCT00514514|322787158|FG000|Pre-phase|Death|10|||
94716260|NCT02723955|324421172|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716261|NCT02723955|324421173|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94271446|NCT00514514|322787159|FG001|Pre-phase|Death|0|||
94271447|NCT00514514|322787160|FG002|Pre-phase|Death|0|||
94716262|NCT02723955|324421174|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716263|NCT02723955|324421175|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716264|NCT02723955|324421176|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716265|NCT02723955|324421177|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716266|NCT02723955|324421178|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716267|NCT02723955|324421179|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716268|NCT02723955|324421180|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716269|NCT02723955|324421181|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716270|NCT02723955|324421182|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716271|NCT02723955|324421183|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716272|NCT02723955|324421184|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716273|NCT02723955|324421185|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716274|NCT02723955|324421186|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716275|NCT02723955|324421187|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716276|NCT02723955|324421188|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716277|NCT02723955|324421189|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716278|NCT02723955|324421190|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716279|NCT02723955|324421191|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716280|NCT02723955|324421192|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716281|NCT02723955|324421193|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716282|NCT02723955|324421194|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716283|NCT02723955|324421195|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
94716284|NCT02723955|324421153|FG000|Escalation Phase|Site Closed|0|||
94716285|NCT02723955|324421154|FG001|Escalation Phase|Site Closed|0|||
94716286|NCT02723955|324421155|FG002|Escalation Phase|Site Closed|0|||
94716287|NCT02723955|324421156|FG003|Escalation Phase|Site Closed|0|||
94716288|NCT02723955|324421157|FG004|Escalation Phase|Site Closed|0|||
94716289|NCT02723955|324421158|FG005|Escalation Phase|Site Closed|0|||
94716290|NCT02723955|324421159|FG006|Escalation Phase|Site Closed|0|||
94716291|NCT02723955|324421160|FG007|Escalation Phase|Site Closed|0|||
94716292|NCT02723955|324421161|FG008|Escalation Phase|Site Closed|0|||
94716293|NCT02723955|324421162|FG009|Escalation Phase|Site Closed|0|||
94716294|NCT02723955|324421163|FG010|Escalation Phase|Site Closed|0|||
94716295|NCT02723955|324421164|FG011|Escalation Phase|Site Closed|0|||
94716296|NCT02723955|324421165|FG012|Escalation Phase|Site Closed|0|||
94716297|NCT02723955|324421166|FG013|Escalation Phase|Site Closed|0|||
94716298|NCT02723955|324421167|FG014|Escalation Phase|Site Closed|0|||
94716299|NCT02723955|324421168|FG015|Escalation Phase|Site Closed|1|||
94716300|NCT02723955|324421169|FG016|Escalation Phase|Site Closed|0|||
94716301|NCT02723955|324421170|FG017|Escalation Phase|Site Closed|2|||
94716302|NCT02723955|324421171|FG018|Escalation Phase|Site Closed|0|||
94716303|NCT02723955|324421172|FG019|Escalation Phase|Site Closed|0|||
94716304|NCT02723955|324421173|FG020|Escalation Phase|Site Closed|1|||
94716305|NCT02723955|324421174|FG021|Escalation Phase|Site Closed|0|||
94716306|NCT02723955|324421175|FG022|Escalation Phase|Site Closed|0|||
94716307|NCT02723955|324421176|FG023|Escalation Phase|Site Closed|0|||
94716308|NCT02723955|324421177|FG024|Escalation Phase|Site Closed|3|||
94716309|NCT02723955|324421178|FG025|Escalation Phase|Site Closed|1|||
94716310|NCT02723955|324421179|FG026|Escalation Phase|Site Closed|3|||
94716311|NCT02723955|324421180|FG027|Escalation Phase|Site Closed|1|||
94716312|NCT02723955|324421181|FG028|Escalation Phase|Site Closed|1|||
94716313|NCT02723955|324421182|FG029|Escalation Phase|Site Closed|0|||
94716314|NCT02723955|324421183|FG030|Escalation Phase|Site Closed|0|||
94716315|NCT02723955|324421184|FG031|Escalation Phase|Site Closed|0|||
94716316|NCT02723955|324421185|FG032|Escalation Phase|Site Closed|0|||
94716317|NCT02723955|324421186|FG033|Escalation Phase|Site Closed|0|||
94716318|NCT02723955|324421187|FG034|Escalation Phase|Site Closed|0|||
94716319|NCT02723955|324421188|FG035|Escalation Phase|Site Closed|0|||
94716320|NCT02723955|324421189|FG036|Escalation Phase|Site Closed|0|||
94716321|NCT02723955|324421190|FG037|Escalation Phase|Site Closed|0|||
94716322|NCT02723955|324421191|FG038|Escalation Phase|Site Closed|0|||
94716323|NCT02723955|324421192|FG039|Escalation Phase|Site Closed|0|||
94716324|NCT02723955|324421193|FG040|Escalation Phase|Site Closed|0|||
94716325|NCT02723955|324421194|FG041|Escalation Phase|Site Closed|0|||
94716326|NCT02723955|324421195|FG042|Escalation Phase|Site Closed|0|||
94367679|NCT03591107|323132989|FG000|Overall Study|Withdrawal by Subject|0|||
94367680|NCT03591107|323132990|FG001|Overall Study|Withdrawal by Subject|1|||
94367681|NCT02626182|323132991|FG000|Overall Study|Adverse Event|2|||
94367682|NCT02626182|323132992|FG001|Overall Study|Adverse Event|0|||
94367683|NCT01222715|323132993|FG000|Overall Study|Adverse Event|0|||
94367684|NCT01222715|323132994|FG001|Overall Study|Adverse Event|4|||
94367685|NCT01222715|323132993|FG000|Overall Study|Death|0|||
94716327|NCT02723955|324421153|FG000|Expansion Phase|Death|0|||
94716328|NCT02723955|324421154|FG001|Expansion Phase|Death|0|||
94716329|NCT02723955|324421155|FG002|Expansion Phase|Death|0|||
94716330|NCT02723955|324421156|FG003|Expansion Phase|Death|0|||
94716331|NCT02723955|324421157|FG004|Expansion Phase|Death|0|||
94716332|NCT02723955|324421158|FG005|Expansion Phase|Death|0|||
94716333|NCT02723955|324421159|FG006|Expansion Phase|Death|0|||
94716334|NCT02723955|324421160|FG007|Expansion Phase|Death|0|||
94716335|NCT02723955|324421161|FG008|Expansion Phase|Death|0|||
94716336|NCT02723955|324421162|FG009|Expansion Phase|Death|25|||
94716337|NCT02723955|324421163|FG010|Expansion Phase|Death|69|||
94716338|NCT02723955|324421164|FG011|Expansion Phase|Death|48|||
94716339|NCT02723955|324421165|FG012|Expansion Phase|Death|0|||
94716340|NCT02723955|324421166|FG013|Expansion Phase|Death|0|||
94716341|NCT02723955|324421167|FG014|Expansion Phase|Death|0|||
94716342|NCT02723955|324421168|FG015|Expansion Phase|Death|0|||
94716343|NCT02723955|324421169|FG016|Expansion Phase|Death|0|||
94716344|NCT02723955|324421170|FG017|Expansion Phase|Death|0|||
94716345|NCT02723955|324421171|FG018|Expansion Phase|Death|0|||
94716346|NCT02723955|324421172|FG019|Expansion Phase|Death|0|||
94716347|NCT02723955|324421173|FG020|Expansion Phase|Death|0|||
94716348|NCT02723955|324421174|FG021|Expansion Phase|Death|0|||
94716349|NCT02723955|324421175|FG022|Expansion Phase|Death|0|||
94716350|NCT02723955|324421176|FG023|Expansion Phase|Death|0|||
94716351|NCT02723955|324421177|FG024|Expansion Phase|Death|0|||
94716352|NCT02723955|324421178|FG025|Expansion Phase|Death|0|||
94716353|NCT02723955|324421179|FG026|Expansion Phase|Death|0|||
94716354|NCT02723955|324421180|FG027|Expansion Phase|Death|0|||
94716355|NCT02723955|324421181|FG028|Expansion Phase|Death|0|||
94716356|NCT02723955|324421182|FG029|Expansion Phase|Death|12|||
94716357|NCT02723955|324421183|FG030|Expansion Phase|Death|202|||
94716358|NCT02723955|324421184|FG031|Expansion Phase|Death|31|||
94716359|NCT02723955|324421185|FG032|Expansion Phase|Death|17|||
94716360|NCT02723955|324421186|FG033|Expansion Phase|Death|2|||
94716361|NCT02723955|324421187|FG034|Expansion Phase|Death|3|||
94716362|NCT02723955|324421188|FG035|Expansion Phase|Death|3|||
94716363|NCT02723955|324421189|FG036|Expansion Phase|Death|1|||
94367686|NCT01222715|323132994|FG001|Overall Study|Death|1|||
94367687|NCT01222715|323132993|FG000|Overall Study|Lack of Efficacy|22|||
94367688|NCT01222715|323132994|FG001|Overall Study|Lack of Efficacy|14|||
94367689|NCT01222715|323132993|FG000|Overall Study|Physician Decision|12|||
94367690|NCT01222715|323132994|FG001|Overall Study|Physician Decision|2|||
94367691|NCT01222715|323132993|FG000|Overall Study|Refusal of further protocol therapy|0|||
94367692|NCT01222715|323132994|FG001|Overall Study|Refusal of further protocol therapy|4|||
94367693|NCT01222715|323132993|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
94367694|NCT01222715|323132994|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
94367695|NCT01222715|323132993|FG000|Overall Study|Ineligible|0|||
94367696|NCT01222715|323132994|FG001|Overall Study|Ineligible|1|||
94367697|NCT01222715|323132993|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
94367698|NCT01222715|323132994|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
94367699|NCT03372369|323132995|FG000|Qualification Period|Withdrawal by Subject|16|||
94367700|NCT03372369|323132996|FG001|Qualification Period|Withdrawal by Subject|13|||
94367701|NCT03372369|323132995|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
94367702|NCT03372369|323132996|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
94716364|NCT02723955|324421190|FG037|Expansion Phase|Death|0|||
94716365|NCT02723955|324421191|FG038|Expansion Phase|Death|0|||
94716366|NCT02723955|324421192|FG039|Expansion Phase|Death|0|||
94716367|NCT02723955|324421193|FG040|Expansion Phase|Death|0|||
94716368|NCT02723955|324421194|FG041|Expansion Phase|Death|0|||
94367703|NCT03372369|323132995|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
94716369|NCT02723955|324421195|FG042|Expansion Phase|Death|0|||
94716370|NCT02723955|324421153|FG000|Expansion Phase|Lost to Follow-up|0|||
94716371|NCT02723955|324421154|FG001|Expansion Phase|Lost to Follow-up|0|||
94716372|NCT02723955|324421155|FG002|Expansion Phase|Lost to Follow-up|0|||
94367704|NCT03372369|323132996|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
94716373|NCT02723955|324421156|FG003|Expansion Phase|Lost to Follow-up|0|||
94716374|NCT02723955|324421157|FG004|Expansion Phase|Lost to Follow-up|0|||
94716375|NCT02723955|324421158|FG005|Expansion Phase|Lost to Follow-up|0|||
94716376|NCT02723955|324421159|FG006|Expansion Phase|Lost to Follow-up|0|||
94716377|NCT02723955|324421160|FG007|Expansion Phase|Lost to Follow-up|0|||
94716378|NCT02723955|324421161|FG008|Expansion Phase|Lost to Follow-up|0|||
94716379|NCT02723955|324421162|FG009|Expansion Phase|Lost to Follow-up|0|||
94716380|NCT02723955|324421163|FG010|Expansion Phase|Lost to Follow-up|4|||
94716381|NCT02723955|324421164|FG011|Expansion Phase|Lost to Follow-up|1|||
94716382|NCT02723955|324421165|FG012|Expansion Phase|Lost to Follow-up|0|||
94367705|NCT04056299|323132997|FG000|Overall Study|Sponsor discontinued study|3|||
94367706|NCT04056299|323132998|FG001|Overall Study|Sponsor discontinued study|3|||
94367707|NCT01227954|323132999|FG000|Overall Study|Protocol Violation|6|||
94367708|NCT01227954|323132999|FG000|Overall Study|No protocol treatment|7|||
94367709|NCT01791127|323133000|FG000|Overall Study|Death|356|||
94367710|NCT01791127|323133000|FG000|Overall Study|Patient has withdrawn from study|293|||
94367711|NCT01791127|323133000|FG000|Overall Study|Lost to Follow-up|42|||
94367712|NCT01791127|323133000|FG000|Overall Study|All Siello leads are explanted|31|||
94367713|NCT01791127|323133000|FG000|Overall Study|Completion of 30 day safety registry|1|||
94367714|NCT01791127|323133000|FG000|Overall Study|Study terminated for EP Passion|749|||
94367715|NCT03333382|323133001|FG000|Overall Study|Lost to Follow-up|1|||
94367716|NCT03333382|323133002|FG001|Overall Study|Lost to Follow-up|0|||
94367717|NCT03273712|323133004|FG000|Overall Study|Death|5|||
94367718|NCT03273712|323133004|FG000|Overall Study|Adverse Event|1|||
94367719|NCT03273712|323133004|FG000|Overall Study|Disease Progression|1|||
94367720|NCT04333199|323133011|FG000|Evaluated Patients|Lost to Follow-up|0|||
94367721|NCT04333199|323133012|FG001|Evaluated Patients|Lost to Follow-up|1|||
94367722|NCT04333199|323133013|FG002|Evaluated Patients|Lost to Follow-up|2|||
94367723|NCT00447694|323133014|FG000|Overall Study|Adverse Event|2|||
94367724|NCT00447694|323133014|FG000|Overall Study|Abnormal laboratory value|1|||
94367725|NCT00447694|323133014|FG000|Overall Study|Abnormal test procedure result|1|||
94367726|NCT00447694|323133014|FG000|Overall Study|Withdrawal by Subject|2|||
94367727|NCT00709735|323133015|FG000|Overall Study|Lost to Follow-up|1|||
94716383|NCT02723955|324421166|FG013|Expansion Phase|Lost to Follow-up|0|||
94716384|NCT02723955|324421167|FG014|Expansion Phase|Lost to Follow-up|0|||
94716385|NCT02723955|324421168|FG015|Expansion Phase|Lost to Follow-up|0|||
94716386|NCT02723955|324421169|FG016|Expansion Phase|Lost to Follow-up|0|||
94716387|NCT02723955|324421170|FG017|Expansion Phase|Lost to Follow-up|0|||
94716388|NCT02723955|324421171|FG018|Expansion Phase|Lost to Follow-up|0|||
94716389|NCT02723955|324421172|FG019|Expansion Phase|Lost to Follow-up|0|||
94716390|NCT02723955|324421173|FG020|Expansion Phase|Lost to Follow-up|0|||
94716391|NCT02723955|324421174|FG021|Expansion Phase|Lost to Follow-up|0|||
94716392|NCT02723955|324421175|FG022|Expansion Phase|Lost to Follow-up|0|||
94716393|NCT02723955|324421176|FG023|Expansion Phase|Lost to Follow-up|0|||
94716394|NCT02723955|324421177|FG024|Expansion Phase|Lost to Follow-up|0|||
94716395|NCT02723955|324421178|FG025|Expansion Phase|Lost to Follow-up|0|||
94367728|NCT00709735|323133016|FG001|Overall Study|Lost to Follow-up|1|||
94367729|NCT00709735|323133015|FG000|Overall Study|Relapse into Opioid Abuse|0|||
94367730|NCT00709735|323133016|FG001|Overall Study|Relapse into Opioid Abuse|1|||
94367731|NCT00709735|323133015|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
94367732|NCT00709735|323133016|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
94367733|NCT01333475|323133017|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
94716396|NCT02723955|324421179|FG026|Expansion Phase|Lost to Follow-up|0|||
94716397|NCT02723955|324421180|FG027|Expansion Phase|Lost to Follow-up|0|||
94716398|NCT02723955|324421181|FG028|Expansion Phase|Lost to Follow-up|0|||
94716399|NCT02723955|324421182|FG029|Expansion Phase|Lost to Follow-up|1|||
94716400|NCT02723955|324421183|FG030|Expansion Phase|Lost to Follow-up|19|||
94716401|NCT02723955|324421184|FG031|Expansion Phase|Lost to Follow-up|2|||
94716402|NCT02723955|324421185|FG032|Expansion Phase|Lost to Follow-up|1|||
94716403|NCT02723955|324421186|FG033|Expansion Phase|Lost to Follow-up|0|||
94716404|NCT02723955|324421187|FG034|Expansion Phase|Lost to Follow-up|0|||
94716405|NCT02723955|324421188|FG035|Expansion Phase|Lost to Follow-up|0|||
94716406|NCT02723955|324421189|FG036|Expansion Phase|Lost to Follow-up|0|||
94716407|NCT02723955|324421190|FG037|Expansion Phase|Lost to Follow-up|0|||
94716408|NCT02723955|324421191|FG038|Expansion Phase|Lost to Follow-up|0|||
94716409|NCT02723955|324421192|FG039|Expansion Phase|Lost to Follow-up|0|||
94716410|NCT02723955|324421193|FG040|Expansion Phase|Lost to Follow-up|0|||
94716411|NCT02723955|324421194|FG041|Expansion Phase|Lost to Follow-up|0|||
94716412|NCT02723955|324421195|FG042|Expansion Phase|Lost to Follow-up|0|||
94716413|NCT02723955|324421153|FG000|Expansion Phase|Physician Decision|0|||
94716414|NCT02723955|324421154|FG001|Expansion Phase|Physician Decision|0|||
94716415|NCT02723955|324421155|FG002|Expansion Phase|Physician Decision|0|||
94716416|NCT02723955|324421156|FG003|Expansion Phase|Physician Decision|0|||
94716417|NCT02723955|324421157|FG004|Expansion Phase|Physician Decision|0|||
94716418|NCT02723955|324421158|FG005|Expansion Phase|Physician Decision|0|||
94716419|NCT02723955|324421159|FG006|Expansion Phase|Physician Decision|0|||
94716420|NCT02723955|324421160|FG007|Expansion Phase|Physician Decision|0|||
94716421|NCT02723955|324421161|FG008|Expansion Phase|Physician Decision|0|||
94716422|NCT02723955|324421162|FG009|Expansion Phase|Physician Decision|0|||
94716423|NCT02723955|324421163|FG010|Expansion Phase|Physician Decision|0|||
94716424|NCT02723955|324421164|FG011|Expansion Phase|Physician Decision|0|||
94716425|NCT02723955|324421165|FG012|Expansion Phase|Physician Decision|0|||
94716426|NCT02723955|324421166|FG013|Expansion Phase|Physician Decision|0|||
94716427|NCT02723955|324421167|FG014|Expansion Phase|Physician Decision|0|||
94716428|NCT02723955|324421168|FG015|Expansion Phase|Physician Decision|0|||
94716429|NCT02723955|324421169|FG016|Expansion Phase|Physician Decision|0|||
94716430|NCT02723955|324421170|FG017|Expansion Phase|Physician Decision|0|||
94716431|NCT02723955|324421171|FG018|Expansion Phase|Physician Decision|0|||
94716432|NCT02723955|324421172|FG019|Expansion Phase|Physician Decision|0|||
94716433|NCT02723955|324421173|FG020|Expansion Phase|Physician Decision|0|||
94716434|NCT02723955|324421174|FG021|Expansion Phase|Physician Decision|0|||
94716435|NCT02723955|324421175|FG022|Expansion Phase|Physician Decision|0|||
94716436|NCT02723955|324421176|FG023|Expansion Phase|Physician Decision|0|||
94716437|NCT02723955|324421177|FG024|Expansion Phase|Physician Decision|0|||
94716438|NCT02723955|324421178|FG025|Expansion Phase|Physician Decision|0|||
94716439|NCT02723955|324421179|FG026|Expansion Phase|Physician Decision|0|||
94716440|NCT02723955|324421180|FG027|Expansion Phase|Physician Decision|0|||
94716441|NCT02723955|324421181|FG028|Expansion Phase|Physician Decision|0|||
94716442|NCT02723955|324421182|FG029|Expansion Phase|Physician Decision|0|||
94467268|NCT01897571|323500497|FG001|Overall Study|Lost to Follow-up|0|||
94467269|NCT01897571|323500498|FG002|Overall Study|Lost to Follow-up|0|||
94716443|NCT02723955|324421183|FG030|Expansion Phase|Physician Decision|1|||
94716444|NCT02723955|324421184|FG031|Expansion Phase|Physician Decision|1|||
94716445|NCT02723955|324421185|FG032|Expansion Phase|Physician Decision|0|||
94716446|NCT02723955|324421186|FG033|Expansion Phase|Physician Decision|0|||
94716447|NCT02723955|324421187|FG034|Expansion Phase|Physician Decision|0|||
94716448|NCT02723955|324421188|FG035|Expansion Phase|Physician Decision|0|||
94716449|NCT02723955|324421189|FG036|Expansion Phase|Physician Decision|0|||
94716450|NCT02723955|324421190|FG037|Expansion Phase|Physician Decision|0|||
94716451|NCT02723955|324421191|FG038|Expansion Phase|Physician Decision|0|||
94716452|NCT02723955|324421192|FG039|Expansion Phase|Physician Decision|0|||
94271448|NCT00514514|322787158|FG000|Pre-phase|administrative problems|2|||
94716453|NCT02723955|324421193|FG040|Expansion Phase|Physician Decision|0|||
94716454|NCT02723955|324421194|FG041|Expansion Phase|Physician Decision|0|||
94716455|NCT02723955|324421195|FG042|Expansion Phase|Physician Decision|0|||
94716456|NCT02723955|324421153|FG000|Expansion Phase|Withdrawal by Subject|0|||
94716457|NCT02723955|324421154|FG001|Expansion Phase|Withdrawal by Subject|0|||
94716458|NCT02723955|324421155|FG002|Expansion Phase|Withdrawal by Subject|0|||
94716459|NCT02723955|324421156|FG003|Expansion Phase|Withdrawal by Subject|0|||
94716460|NCT02723955|324421157|FG004|Expansion Phase|Withdrawal by Subject|0|||
94716461|NCT02723955|324421158|FG005|Expansion Phase|Withdrawal by Subject|0|||
94716462|NCT02723955|324421159|FG006|Expansion Phase|Withdrawal by Subject|0|||
94716463|NCT02723955|324421160|FG007|Expansion Phase|Withdrawal by Subject|0|||
94716464|NCT02723955|324421161|FG008|Expansion Phase|Withdrawal by Subject|0|||
94716465|NCT02723955|324421162|FG009|Expansion Phase|Withdrawal by Subject|2|||
94716466|NCT02723955|324421163|FG010|Expansion Phase|Withdrawal by Subject|1|||
94716467|NCT02723955|324421164|FG011|Expansion Phase|Withdrawal by Subject|0|||
94716468|NCT02723955|324421165|FG012|Expansion Phase|Withdrawal by Subject|0|||
94716469|NCT02723955|324421166|FG013|Expansion Phase|Withdrawal by Subject|0|||
94716470|NCT02723955|324421167|FG014|Expansion Phase|Withdrawal by Subject|0|||
94716471|NCT02723955|324421168|FG015|Expansion Phase|Withdrawal by Subject|0|||
94716472|NCT02723955|324421169|FG016|Expansion Phase|Withdrawal by Subject|0|||
94716473|NCT02723955|324421170|FG017|Expansion Phase|Withdrawal by Subject|0|||
94716474|NCT02723955|324421171|FG018|Expansion Phase|Withdrawal by Subject|0|||
94716475|NCT02723955|324421172|FG019|Expansion Phase|Withdrawal by Subject|0|||
94716476|NCT02723955|324421173|FG020|Expansion Phase|Withdrawal by Subject|0|||
94716477|NCT02723955|324421174|FG021|Expansion Phase|Withdrawal by Subject|0|||
94716478|NCT02723955|324421175|FG022|Expansion Phase|Withdrawal by Subject|0|||
94716479|NCT02723955|324421176|FG023|Expansion Phase|Withdrawal by Subject|0|||
94716480|NCT02723955|324421177|FG024|Expansion Phase|Withdrawal by Subject|0|||
94716481|NCT02723955|324421178|FG025|Expansion Phase|Withdrawal by Subject|0|||
94716482|NCT02723955|324421179|FG026|Expansion Phase|Withdrawal by Subject|0|||
94716483|NCT02723955|324421180|FG027|Expansion Phase|Withdrawal by Subject|0|||
94716484|NCT02723955|324421181|FG028|Expansion Phase|Withdrawal by Subject|0|||
94716485|NCT02723955|324421182|FG029|Expansion Phase|Withdrawal by Subject|0|||
94716486|NCT02723955|324421183|FG030|Expansion Phase|Withdrawal by Subject|8|||
94716487|NCT02723955|324421184|FG031|Expansion Phase|Withdrawal by Subject|4|||
94716488|NCT02723955|324421185|FG032|Expansion Phase|Withdrawal by Subject|0|||
94716489|NCT02723955|324421186|FG033|Expansion Phase|Withdrawal by Subject|0|||
94716490|NCT02723955|324421187|FG034|Expansion Phase|Withdrawal by Subject|0|||
94271449|NCT00514514|322787159|FG001|Pre-phase|administrative problems|0|||
94271450|NCT00514514|322787160|FG002|Pre-phase|administrative problems|0|||
94271451|NCT00514514|322787158|FG000|Pre-phase|Protocol Violation|6|||
94716491|NCT02723955|324421188|FG035|Expansion Phase|Withdrawal by Subject|1|||
94716492|NCT02723955|324421189|FG036|Expansion Phase|Withdrawal by Subject|0|||
94716493|NCT02723955|324421190|FG037|Expansion Phase|Withdrawal by Subject|0|||
94716494|NCT02723955|324421191|FG038|Expansion Phase|Withdrawal by Subject|0|||
94716495|NCT02723955|324421192|FG039|Expansion Phase|Withdrawal by Subject|0|||
94716496|NCT02723955|324421193|FG040|Expansion Phase|Withdrawal by Subject|0|||
94716497|NCT02723955|324421194|FG041|Expansion Phase|Withdrawal by Subject|0|||
94716498|NCT02723955|324421195|FG042|Expansion Phase|Withdrawal by Subject|0|||
94716499|NCT02723955|324421153|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716500|NCT02723955|324421154|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716501|NCT02723955|324421155|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716502|NCT02723955|324421156|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716503|NCT02723955|324421157|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94467270|NCT01897571|323500499|FG003|Overall Study|Lost to Follow-up|0|||
94467271|NCT01897571|323500500|FG004|Overall Study|Lost to Follow-up|2|||
94467272|NCT01897571|323500501|FG005|Overall Study|Lost to Follow-up|0|||
94467273|NCT01897571|323500502|FG006|Overall Study|Lost to Follow-up|0|||
94467274|NCT01897571|323500503|FG007|Overall Study|Lost to Follow-up|0|||
94467275|NCT01897571|323500504|FG008|Overall Study|Lost to Follow-up|1|||
94467276|NCT01897571|323500505|FG009|Overall Study|Lost to Follow-up|2|||
94467277|NCT01897571|323500506|FG010|Overall Study|Lost to Follow-up|4|||
94467278|NCT01897571|323500496|FG000|Overall Study|Withdrawal by Subject|0|||
94467279|NCT01897571|323500497|FG001|Overall Study|Withdrawal by Subject|0|||
94467280|NCT01897571|323500498|FG002|Overall Study|Withdrawal by Subject|0|||
94467281|NCT01897571|323500499|FG003|Overall Study|Withdrawal by Subject|0|||
94467282|NCT01897571|323500500|FG004|Overall Study|Withdrawal by Subject|0|||
94467283|NCT01897571|323500501|FG005|Overall Study|Withdrawal by Subject|0|||
94467284|NCT01897571|323500502|FG006|Overall Study|Withdrawal by Subject|0|||
94716504|NCT02723955|324421158|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716505|NCT02723955|324421159|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716506|NCT02723955|324421160|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716507|NCT02723955|324421161|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716508|NCT02723955|324421162|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
94716509|NCT02723955|324421163|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
94716510|NCT02723955|324421164|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
94716511|NCT02723955|324421165|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716512|NCT02723955|324421166|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716513|NCT02723955|324421167|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716514|NCT02723955|324421168|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716515|NCT02723955|324421169|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716516|NCT02723955|324421170|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716517|NCT02723955|324421171|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716518|NCT02723955|324421172|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716519|NCT02723955|324421173|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716520|NCT02723955|324421174|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716521|NCT02723955|324421175|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716522|NCT02723955|324421176|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716523|NCT02723955|324421177|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716524|NCT02723955|324421178|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716525|NCT02723955|324421179|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716526|NCT02723955|324421180|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716527|NCT02723955|324421181|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716528|NCT02723955|324421182|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716529|NCT02723955|324421183|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
94716530|NCT02723955|324421184|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716531|NCT02723955|324421185|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716532|NCT02723955|324421186|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716533|NCT02723955|324421187|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716534|NCT02723955|324421188|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716535|NCT02723955|324421189|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716536|NCT02723955|324421190|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716537|NCT02723955|324421191|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716538|NCT02723955|324421192|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716539|NCT02723955|324421193|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716540|NCT02723955|324421194|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716541|NCT02723955|324421195|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
94716542|NCT02723955|324421153|FG000|Expansion Phase|Site Closed|0|||
94716543|NCT02723955|324421154|FG001|Expansion Phase|Site Closed|0|||
94716544|NCT02723955|324421155|FG002|Expansion Phase|Site Closed|0|||
94716545|NCT02723955|324421156|FG003|Expansion Phase|Site Closed|0|||
94716546|NCT02723955|324421157|FG004|Expansion Phase|Site Closed|0|||
94716547|NCT02723955|324421158|FG005|Expansion Phase|Site Closed|0|||
94716548|NCT02723955|324421159|FG006|Expansion Phase|Site Closed|0|||
94716549|NCT02723955|324421160|FG007|Expansion Phase|Site Closed|0|||
94716550|NCT02723955|324421161|FG008|Expansion Phase|Site Closed|0|||
94716551|NCT02723955|324421162|FG009|Expansion Phase|Site Closed|1|||
94716552|NCT02723955|324421163|FG010|Expansion Phase|Site Closed|2|||
94716553|NCT02723955|324421164|FG011|Expansion Phase|Site Closed|6|||
94716554|NCT02723955|324421165|FG012|Expansion Phase|Site Closed|0|||
94716555|NCT02723955|324421166|FG013|Expansion Phase|Site Closed|0|||
94716556|NCT02723955|324421167|FG014|Expansion Phase|Site Closed|0|||
94716557|NCT02723955|324421168|FG015|Expansion Phase|Site Closed|0|||
94716558|NCT02723955|324421169|FG016|Expansion Phase|Site Closed|0|||
94716559|NCT02723955|324421170|FG017|Expansion Phase|Site Closed|0|||
94716560|NCT02723955|324421171|FG018|Expansion Phase|Site Closed|0|||
94716561|NCT02723955|324421172|FG019|Expansion Phase|Site Closed|0|||
94716562|NCT02723955|324421173|FG020|Expansion Phase|Site Closed|0|||
94716563|NCT02723955|324421174|FG021|Expansion Phase|Site Closed|0|||
94716564|NCT02723955|324421175|FG022|Expansion Phase|Site Closed|0|||
94716565|NCT02723955|324421176|FG023|Expansion Phase|Site Closed|0|||
94716566|NCT02723955|324421177|FG024|Expansion Phase|Site Closed|0|||
94716567|NCT02723955|324421178|FG025|Expansion Phase|Site Closed|0|||
94716568|NCT02723955|324421179|FG026|Expansion Phase|Site Closed|0|||
94716569|NCT02723955|324421180|FG027|Expansion Phase|Site Closed|0|||
94716570|NCT02723955|324421181|FG028|Expansion Phase|Site Closed|0|||
94716571|NCT02723955|324421182|FG029|Expansion Phase|Site Closed|0|||
94716572|NCT02723955|324421183|FG030|Expansion Phase|Site Closed|8|||
94716573|NCT02723955|324421184|FG031|Expansion Phase|Site Closed|4|||
94716574|NCT02723955|324421185|FG032|Expansion Phase|Site Closed|2|||
94716575|NCT02723955|324421186|FG033|Expansion Phase|Site Closed|2|||
94716576|NCT02723955|324421187|FG034|Expansion Phase|Site Closed|0|||
94716577|NCT02723955|324421188|FG035|Expansion Phase|Site Closed|0|||
94716578|NCT02723955|324421189|FG036|Expansion Phase|Site Closed|0|||
94716579|NCT02723955|324421190|FG037|Expansion Phase|Site Closed|0|||
94716580|NCT02723955|324421191|FG038|Expansion Phase|Site Closed|0|||
94716581|NCT02723955|324421192|FG039|Expansion Phase|Site Closed|0|||
94716582|NCT02723955|324421193|FG040|Expansion Phase|Site Closed|0|||
94716583|NCT02723955|324421194|FG041|Expansion Phase|Site Closed|0|||
94716584|NCT02723955|324421195|FG042|Expansion Phase|Site Closed|0|||
94716585|NCT02723955|324421153|FG000|Crossover/ Re-treatment Phase|Death|0|||
94716586|NCT02723955|324421154|FG001|Crossover/ Re-treatment Phase|Death|0|||
94716587|NCT02723955|324421155|FG002|Crossover/ Re-treatment Phase|Death|0|||
94716588|NCT02723955|324421156|FG003|Crossover/ Re-treatment Phase|Death|0|||
94716589|NCT02723955|324421157|FG004|Crossover/ Re-treatment Phase|Death|0|||
94716590|NCT02723955|324421158|FG005|Crossover/ Re-treatment Phase|Death|0|||
94716591|NCT02723955|324421159|FG006|Crossover/ Re-treatment Phase|Death|0|||
94716592|NCT02723955|324421160|FG007|Crossover/ Re-treatment Phase|Death|0|||
94716593|NCT02723955|324421161|FG008|Crossover/ Re-treatment Phase|Death|0|||
94716594|NCT02723955|324421162|FG009|Crossover/ Re-treatment Phase|Death|0|||
94716595|NCT02723955|324421163|FG010|Crossover/ Re-treatment Phase|Death|0|||
94716596|NCT02723955|324421164|FG011|Crossover/ Re-treatment Phase|Death|0|||
94716597|NCT02723955|324421165|FG012|Crossover/ Re-treatment Phase|Death|0|||
94716598|NCT02723955|324421166|FG013|Crossover/ Re-treatment Phase|Death|0|||
94716599|NCT02723955|324421167|FG014|Crossover/ Re-treatment Phase|Death|0|||
94716600|NCT02723955|324421168|FG015|Crossover/ Re-treatment Phase|Death|0|||
94716601|NCT02723955|324421169|FG016|Crossover/ Re-treatment Phase|Death|0|||
94716602|NCT02723955|324421170|FG017|Crossover/ Re-treatment Phase|Death|0|||
94716603|NCT02723955|324421171|FG018|Crossover/ Re-treatment Phase|Death|0|||
94716604|NCT02723955|324421172|FG019|Crossover/ Re-treatment Phase|Death|0|||
94716605|NCT02723955|324421173|FG020|Crossover/ Re-treatment Phase|Death|0|||
94716606|NCT02723955|324421174|FG021|Crossover/ Re-treatment Phase|Death|0|||
94716607|NCT02723955|324421175|FG022|Crossover/ Re-treatment Phase|Death|0|||
94716608|NCT02723955|324421176|FG023|Crossover/ Re-treatment Phase|Death|0|||
94716609|NCT02723955|324421177|FG024|Crossover/ Re-treatment Phase|Death|0|||
94716610|NCT02723955|324421178|FG025|Crossover/ Re-treatment Phase|Death|0|||
94716611|NCT02723955|324421179|FG026|Crossover/ Re-treatment Phase|Death|0|||
94716612|NCT02723955|324421180|FG027|Crossover/ Re-treatment Phase|Death|0|||
94716613|NCT02723955|324421181|FG028|Crossover/ Re-treatment Phase|Death|0|||
94716614|NCT02723955|324421182|FG029|Crossover/ Re-treatment Phase|Death|0|||
94716615|NCT02723955|324421183|FG030|Crossover/ Re-treatment Phase|Death|0|||
94716616|NCT02723955|324421184|FG031|Crossover/ Re-treatment Phase|Death|0|||
94716617|NCT02723955|324421185|FG032|Crossover/ Re-treatment Phase|Death|0|||
94716618|NCT02723955|324421186|FG033|Crossover/ Re-treatment Phase|Death|0|||
94716619|NCT02723955|324421187|FG034|Crossover/ Re-treatment Phase|Death|0|||
94716620|NCT02723955|324421188|FG035|Crossover/ Re-treatment Phase|Death|0|||
94716621|NCT02723955|324421189|FG036|Crossover/ Re-treatment Phase|Death|0|||
94716622|NCT02723955|324421190|FG037|Crossover/ Re-treatment Phase|Death|1|||
94716623|NCT02723955|324421191|FG038|Crossover/ Re-treatment Phase|Death|14|||
94716624|NCT02723955|324421192|FG039|Crossover/ Re-treatment Phase|Death|32|||
94716625|NCT02723955|324421193|FG040|Crossover/ Re-treatment Phase|Death|2|||
94716626|NCT02723955|324421194|FG041|Crossover/ Re-treatment Phase|Death|1|||
94716627|NCT02723955|324421195|FG042|Crossover/ Re-treatment Phase|Death|0|||
94716628|NCT02723955|324421153|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716629|NCT02723955|324421154|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716630|NCT02723955|324421155|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716631|NCT02723955|324421156|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716632|NCT02723955|324421157|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716633|NCT02723955|324421158|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716634|NCT02723955|324421159|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716635|NCT02723955|324421160|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716636|NCT02723955|324421161|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716637|NCT02723955|324421162|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94271452|NCT00514514|322787159|FG001|Pre-phase|Protocol Violation|0|||
94271453|NCT00514514|322787160|FG002|Pre-phase|Protocol Violation|0|||
94271454|NCT00514514|322787158|FG000|Pre-phase|condition no longer requires study drug|7|||
94271455|NCT00514514|322787159|FG001|Pre-phase|condition no longer requires study drug|0|||
94716638|NCT02723955|324421163|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716639|NCT02723955|324421164|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716640|NCT02723955|324421165|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716641|NCT02723955|324421166|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716642|NCT02723955|324421167|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716643|NCT02723955|324421168|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716644|NCT02723955|324421169|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716645|NCT02723955|324421170|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716646|NCT02723955|324421171|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716647|NCT02723955|324421172|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716648|NCT02723955|324421173|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716649|NCT02723955|324421174|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716650|NCT02723955|324421175|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716651|NCT02723955|324421176|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716652|NCT02723955|324421177|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716653|NCT02723955|324421178|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716654|NCT02723955|324421179|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716655|NCT02723955|324421180|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716656|NCT02723955|324421181|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716657|NCT02723955|324421182|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716658|NCT02723955|324421183|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716659|NCT02723955|324421184|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716660|NCT02723955|324421185|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716661|NCT02723955|324421186|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716662|NCT02723955|324421187|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716663|NCT02723955|324421188|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716664|NCT02723955|324421189|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716665|NCT02723955|324421190|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716666|NCT02723955|324421191|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716667|NCT02723955|324421192|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
94716668|NCT02723955|324421193|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716669|NCT02723955|324421194|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716670|NCT02723955|324421195|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
94716671|NCT02723955|324421153|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716672|NCT02723955|324421154|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716673|NCT02723955|324421155|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716674|NCT02723955|324421156|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716675|NCT02723955|324421157|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
94271456|NCT00514514|322787160|FG002|Pre-phase|condition no longer requires study drug|0|||
94271457|NCT00514514|322787158|FG000|Pre-phase|abnormal test procedure results|15|||
94271458|NCT00514514|322787159|FG001|Pre-phase|abnormal test procedure results|0|||
94271459|NCT00514514|322787160|FG002|Pre-phase|abnormal test procedure results|0|||
94716676|NCT02723955|324421158|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
94271460|NCT00514514|322787158|FG000|Pre-phase|Lost to Follow-up|2|||
94271461|NCT00514514|322787159|FG001|Pre-phase|Lost to Follow-up|0|||
94271462|NCT00514514|322787160|FG002|Pre-phase|Lost to Follow-up|0|||
94271463|NCT00514514|322787158|FG000|Pre-phase|abnormal lab values|23|||
94716677|NCT02723955|324421159|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716678|NCT02723955|324421160|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716679|NCT02723955|324421161|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716680|NCT02723955|324421162|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
94271464|NCT00514514|322787159|FG001|Pre-phase|abnormal lab values|0|||
94716681|NCT02723955|324421163|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716682|NCT02723955|324421164|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716683|NCT02723955|324421165|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716684|NCT02723955|324421166|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716685|NCT02723955|324421167|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716686|NCT02723955|324421168|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716687|NCT02723955|324421169|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716688|NCT02723955|324421170|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
94271465|NCT00514514|322787160|FG002|Pre-phase|abnormal lab values|0|||
94271466|NCT00514514|322787158|FG000|Pre-phase|Lack of Efficacy|35|||
94716689|NCT02723955|324421171|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716690|NCT02723955|324421172|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716691|NCT02723955|324421173|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716692|NCT02723955|324421174|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716693|NCT02723955|324421175|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716694|NCT02723955|324421176|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716695|NCT02723955|324421177|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716696|NCT02723955|324421178|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716697|NCT02723955|324421179|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716698|NCT02723955|324421180|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716699|NCT02723955|324421181|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716700|NCT02723955|324421182|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716701|NCT02723955|324421183|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716702|NCT02723955|324421184|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716703|NCT02723955|324421185|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716704|NCT02723955|324421186|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
94271467|NCT00514514|322787159|FG001|Pre-phase|Lack of Efficacy|0|||
94271468|NCT00514514|322787160|FG002|Pre-phase|Lack of Efficacy|0|||
94716705|NCT02723955|324421187|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716706|NCT02723955|324421188|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716707|NCT02723955|324421189|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716708|NCT02723955|324421190|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716709|NCT02723955|324421191|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
94716710|NCT02723955|324421192|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
94716711|NCT02723955|324421193|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
94271469|NCT00514514|322787158|FG000|Pre-phase|Adverse Event|137|||
94271470|NCT00514514|322787159|FG001|Pre-phase|Adverse Event|0|||
94716712|NCT02723955|324421194|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
94716713|NCT02723955|324421195|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
94271471|NCT00514514|322787160|FG002|Pre-phase|Adverse Event|0|||
94271472|NCT00514514|322787158|FG000|Pre-phase|Withdrawal by Subject|66|||
94271473|NCT00514514|322787159|FG001|Pre-phase|Withdrawal by Subject|0|||
94271474|NCT00514514|322787160|FG002|Pre-phase|Withdrawal by Subject|0|||
94271475|NCT00514514|322787158|FG000|Randomized - 9 Month|Death|3|||
94271476|NCT00514514|322787159|FG001|Randomized - 9 Month|Death|2|||
94271477|NCT00514514|322787160|FG002|Randomized - 9 Month|Death|2|||
94271478|NCT00514514|322787158|FG000|Randomized - 9 Month|Administrative problems|1|||
94271479|NCT00514514|322787159|FG001|Randomized - 9 Month|Administrative problems|1|||
94271480|NCT00514514|322787160|FG002|Randomized - 9 Month|Administrative problems|2|||
94271481|NCT00514514|322787158|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
94271482|NCT00514514|322787159|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
94271483|NCT00514514|322787160|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
94271484|NCT00514514|322787158|FG000|Randomized - 9 Month|Protocol Violation|1|||
94271485|NCT00514514|322787159|FG001|Randomized - 9 Month|Protocol Violation|1|||
94271486|NCT00514514|322787160|FG002|Randomized - 9 Month|Protocol Violation|0|||
94271487|NCT00514514|322787158|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
94271488|NCT00514514|322787159|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
94271489|NCT00514514|322787160|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
94271490|NCT00514514|322787158|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
94716714|NCT02723955|324421153|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
94271491|NCT00514514|322787159|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
94271492|NCT00514514|322787160|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
94271493|NCT00514514|322787158|FG000|Randomized - 9 Month|Adverse Event|25|||
94271494|NCT00514514|322787159|FG001|Randomized - 9 Month|Adverse Event|44|||
94716715|NCT02723955|324421154|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
94716716|NCT02723955|324421155|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
94716717|NCT02723955|324421156|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
94716718|NCT02723955|324421157|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
94716719|NCT02723955|324421158|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
94716720|NCT02723955|324421159|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
94716721|NCT02723955|324421160|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
94716722|NCT02723955|324421161|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
94716723|NCT02723955|324421162|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
94716724|NCT02723955|324421163|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
94716725|NCT02723955|324421164|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
94716726|NCT02723955|324421165|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
94716727|NCT02723955|324421166|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
94716728|NCT02723955|324421167|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
94716729|NCT02723955|324421168|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
94716730|NCT02723955|324421169|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
94271495|NCT00514514|322787160|FG002|Randomized - 9 Month|Adverse Event|27|||
94271496|NCT00514514|322787158|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
94271497|NCT00514514|322787159|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
94271498|NCT00514514|322787160|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
94271499|NCT00514514|322787158|FG000|Extension - 4 Years|Lost to Follow-up|12|||
94271500|NCT00514514|322787159|FG001|Extension - 4 Years|Lost to Follow-up|10|||
94271501|NCT00514514|322787160|FG002|Extension - 4 Years|Lost to Follow-up|9|||
94271502|NCT00514514|322787158|FG000|Extension - 4 Years|Administrative problems|3|||
94271503|NCT00514514|322787159|FG001|Extension - 4 Years|Administrative problems|1|||
94271504|NCT00514514|322787160|FG002|Extension - 4 Years|Administrative problems|1|||
94271505|NCT00514514|322787158|FG000|Extension - 4 Years|Death|8|||
94271506|NCT00514514|322787159|FG001|Extension - 4 Years|Death|3|||
94271507|NCT00514514|322787160|FG002|Extension - 4 Years|Death|6|||
94271508|NCT00514514|322787158|FG000|Extension - 4 Years|Adverse Event|9|||
94271509|NCT00514514|322787159|FG001|Extension - 4 Years|Adverse Event|6|||
94271510|NCT00514514|322787160|FG002|Extension - 4 Years|Adverse Event|3|||
94271511|NCT03785925|322787166|FG000|Overall Study|Withdrawal by Subject|15|||
94271512|NCT03785925|322787166|FG000|Overall Study|Lost to Follow-up|1|||
94271513|NCT02667275|322787171|FG000|Overall Study|Protocol Violation|11|||
94271514|NCT02667275|322787172|FG001|Overall Study|Protocol Violation|7|||
94271515|NCT02667275|322787171|FG000|Overall Study|Lost to Follow-up|0|||
94271516|NCT02667275|322787172|FG001|Overall Study|Lost to Follow-up|2|||
94271517|NCT02667275|322787171|FG000|Overall Study|Withdrawal by Subject|0|||
94271518|NCT02667275|322787172|FG001|Overall Study|Withdrawal by Subject|5|||
94271519|NCT02667275|322787171|FG000|Overall Study|Discontinued early without completing|0|||
94271520|NCT02667275|322787172|FG001|Overall Study|Discontinued early without completing|1|||
94271521|NCT01274715|322787173|FG000|Overall Study|Lost to Follow-up|1|||
94271522|NCT01274715|322787173|FG000|Overall Study|After consent, met exclusion criteria.|1|||
94271523|NCT01274715|322787173|FG000|Overall Study|After consent, met exclusion criteria.|1|||
94271524|NCT01274715|322787173|FG000|Overall Study|After consent, met exclusion criteria.|1|||
94271525|NCT04479436|322787174|FG000|Overall Study|Progressive disease|26|||
94271526|NCT04479436|322787175|FG001|Overall Study|Progressive disease|1|||
94271527|NCT04479436|322787174|FG000|Overall Study|Adverse Event|6|||
94716731|NCT02723955|324421170|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
94716732|NCT02723955|324421171|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
94716733|NCT02723955|324421172|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
94716734|NCT02723955|324421173|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
94271528|NCT04479436|322787175|FG001|Overall Study|Adverse Event|0|||
94271529|NCT04479436|322787174|FG000|Overall Study|Withdrawal by Subject|5|||
94716735|NCT02723955|324421174|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
94716736|NCT02723955|324421175|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
94716737|NCT02723955|324421176|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
94716738|NCT02723955|324421177|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
94716739|NCT02723955|324421178|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
94716740|NCT02723955|324421179|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
94716741|NCT02723955|324421180|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
94716742|NCT02723955|324421181|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
94716743|NCT02723955|324421182|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
94716744|NCT02723955|324421183|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
94716745|NCT02723955|324421184|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
94716746|NCT02723955|324421185|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
94716747|NCT02723955|324421186|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
94716748|NCT02723955|324421187|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
94716749|NCT02723955|324421188|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
94716750|NCT02723955|324421189|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
94716751|NCT02723955|324421190|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
94716752|NCT02723955|324421191|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
94271530|NCT04479436|322787175|FG001|Overall Study|Withdrawal by Subject|0|||
94271531|NCT04479436|322787174|FG000|Overall Study|Clinical progression|1|||
94271532|NCT04479436|322787175|FG001|Overall Study|Clinical progression|0|||
94271533|NCT04479436|322787174|FG000|Overall Study|Physician Decision|1|||
94271534|NCT04479436|322787175|FG001|Overall Study|Physician Decision|0|||
94271535|NCT02318667|322787176|FG000|Overall Study|Adverse Event|1|||
94271536|NCT02318667|322787176|FG000|Overall Study|Lack of Efficacy|6|||
94271537|NCT02318667|322787176|FG000|Overall Study|Protocol Violation|2|||
94367734|NCT01333475|323133018|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
94367735|NCT01333475|323133017|FG000|Overall Study|Toxicity|1|||
94716753|NCT02723955|324421192|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
94367736|NCT01333475|323133018|FG001|Overall Study|Toxicity|3|||
94367737|NCT00854607|323133019|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
94716754|NCT02723955|324421193|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
94716755|NCT02723955|324421194|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
94716756|NCT02723955|324421195|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
94716757|NCT04300647|324421196|FG000|Pre-Crossover|Death|19|||
94716758|NCT04300647|324421197|FG001|Pre-Crossover|Death|58|||
94716759|NCT04300647|324421198|FG002|Pre-Crossover|Death|0|||
94716760|NCT04300647|324421196|FG000|Pre-Crossover|Lost to Follow-up|0|||
94716761|NCT04300647|324421197|FG001|Pre-Crossover|Lost to Follow-up|3|||
94716762|NCT04300647|324421198|FG002|Pre-Crossover|Lost to Follow-up|0|||
94716763|NCT04300647|324421196|FG000|Pre-Crossover|Withdrawal by Subject|2|||
94716764|NCT04300647|324421197|FG001|Pre-Crossover|Withdrawal by Subject|4|||
94716765|NCT04300647|324421198|FG002|Pre-Crossover|Withdrawal by Subject|0|||
94716766|NCT04300647|324421196|FG000|Pre-Crossover|On-going in Study|24|||
94716767|NCT04300647|324421197|FG001|Pre-Crossover|On-going in Study|61|||
94716768|NCT04300647|324421198|FG002|Pre-Crossover|On-going in Study|0|||
94367738|NCT02725671|323133027|FG000|Overall Study|Lost to Follow-up|1|||
94716769|NCT04300647|324421196|FG000|Post-Crossover|Death|0|||
94716770|NCT04300647|324421197|FG001|Post-Crossover|Death|0|||
94716771|NCT04300647|324421198|FG002|Post-Crossover|Death|3|||
94716772|NCT04300647|324421196|FG000|Post-Crossover|Lost to Follow-up|0|||
94716773|NCT04300647|324421197|FG001|Post-Crossover|Lost to Follow-up|0|||
94716774|NCT04300647|324421198|FG002|Post-Crossover|Lost to Follow-up|1|||
94716775|NCT04300647|324421196|FG000|Post-Crossover|Withdrawal by Subject|0|||
94716776|NCT04300647|324421197|FG001|Post-Crossover|Withdrawal by Subject|0|||
94716777|NCT04300647|324421198|FG002|Post-Crossover|Withdrawal by Subject|1|||
94716778|NCT04300647|324421196|FG000|Post-Crossover|On-going in Study|0|||
94716779|NCT04300647|324421197|FG001|Post-Crossover|On-going in Study|0|||
94716780|NCT04300647|324421198|FG002|Post-Crossover|On-going in Study|8|||
94716781|NCT01471691|324421201|FG000|Overall Study|Lack of Efficacy|0|||
94716782|NCT01471691|324421202|FG001|Overall Study|Lack of Efficacy|1|||
94716783|NCT00894543|324421203|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
94716784|NCT00894543|324421204|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
94716785|NCT00894543|324421203|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
94716786|NCT00894543|324421204|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
94716787|NCT04048681|324421205|FG000|Overall Study|family emergency|0|||
94716788|NCT04048681|324421206|FG001|Overall Study|family emergency|0|||
94716789|NCT04048681|324421207|FG002|Overall Study|family emergency|0|||
94716790|NCT04048681|324421208|FG003|Overall Study|family emergency|1|||
94716791|NCT04048681|324421209|FG004|Overall Study|family emergency|0|||
94716792|NCT02647905|324421214|FG000|Overall Study|Lost to Follow-up|1|||
94716793|NCT02647905|324421214|FG000|Overall Study|Withdrawal by Subject|2|||
94716794|NCT02015520|324421215|FG000|Overall Study|Lack of Efficacy|1|||
94716795|NCT02015520|324421216|FG001|Overall Study|Lack of Efficacy|0|||
94716796|NCT02015520|324421217|FG002|Overall Study|Lack of Efficacy|3|||
94716797|NCT02015520|324421218|FG003|Overall Study|Lack of Efficacy|2|||
94716798|NCT02015520|324421215|FG000|Overall Study|Adverse Event|0|||
94716799|NCT02015520|324421216|FG001|Overall Study|Adverse Event|0|||
94716800|NCT02015520|324421217|FG002|Overall Study|Adverse Event|0|||
94716801|NCT02015520|324421218|FG003|Overall Study|Adverse Event|1|||
94716802|NCT02015520|324421215|FG000|Overall Study|Withdrawal by Subject|2|||
94716803|NCT02015520|324421216|FG001|Overall Study|Withdrawal by Subject|2|||
94716804|NCT02015520|324421217|FG002|Overall Study|Withdrawal by Subject|1|||
94716805|NCT02015520|324421218|FG003|Overall Study|Withdrawal by Subject|0|||
94716806|NCT02015520|324421215|FG000|Overall Study|Death|1|||
94716807|NCT02015520|324421216|FG001|Overall Study|Death|0|||
94716808|NCT02015520|324421217|FG002|Overall Study|Death|0|||
94716809|NCT02015520|324421218|FG003|Overall Study|Death|0|||
94716810|NCT02015520|324421215|FG000|Overall Study|Lost to Follow-up|0|||
94716811|NCT02015520|324421216|FG001|Overall Study|Lost to Follow-up|0|||
94716812|NCT02015520|324421217|FG002|Overall Study|Lost to Follow-up|1|||
94716813|NCT02015520|324421218|FG003|Overall Study|Lost to Follow-up|0|||
94716814|NCT02015520|324421215|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
94716815|NCT02015520|324421216|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
94716816|NCT02015520|324421217|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
94716817|NCT02015520|324421218|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
94716818|NCT02015520|324421215|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
94716819|NCT02015520|324421216|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
94716820|NCT02015520|324421217|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
94716821|NCT02015520|324421218|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
94716822|NCT01532388|324421219|FG000|3-month Follow-up|Lost to Follow-up|68|||
94716823|NCT01532388|324421220|FG001|3-month Follow-up|Lost to Follow-up|68|||
94716824|NCT01532388|324421219|FG000|6-month Follow-up|Lost to Follow-up|74|||
94716825|NCT01532388|324421220|FG001|6-month Follow-up|Lost to Follow-up|66|||
94716826|NCT01532388|324421219|FG000|12-month Follow-up|Lost to Follow-up|69|||
94716827|NCT01532388|324421220|FG001|12-month Follow-up|Lost to Follow-up|67|||
94716828|NCT00792636|324421221|FG000|Overall Study|Protocol Violation|17|||
94716829|NCT00792636|324421222|FG001|Overall Study|Protocol Violation|23|||
94716830|NCT00792636|324421223|FG002|Overall Study|Protocol Violation|20|||
94716831|NCT00792636|324421221|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
94716832|NCT00792636|324421222|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
94716833|NCT00792636|324421223|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
94716834|NCT00792636|324421221|FG000|Overall Study|Lost to Follow-up|13|||
94716835|NCT00792636|324421222|FG001|Overall Study|Lost to Follow-up|19|||
94716836|NCT00792636|324421223|FG002|Overall Study|Lost to Follow-up|14|||
94716837|NCT00792636|324421221|FG000|Overall Study|Withdrew Consent|10|||
94716838|NCT00792636|324421222|FG001|Overall Study|Withdrew Consent|13|||
94716839|NCT00792636|324421223|FG002|Overall Study|Withdrew Consent|9|||
94716840|NCT00792636|324421221|FG000|Overall Study|Lack of Efficacy|3|||
94716841|NCT00792636|324421222|FG001|Overall Study|Lack of Efficacy|4|||
94716842|NCT00792636|324421223|FG002|Overall Study|Lack of Efficacy|13|||
94716843|NCT00792636|324421221|FG000|Overall Study|Adverse Event|4|||
94716844|NCT00792636|324421222|FG001|Overall Study|Adverse Event|2|||
94716845|NCT00792636|324421223|FG002|Overall Study|Adverse Event|3|||
94716846|NCT00792636|324421221|FG000|Overall Study|Investigator Discretion|2|||
94716847|NCT00792636|324421222|FG001|Overall Study|Investigator Discretion|0|||
94716848|NCT00792636|324421223|FG002|Overall Study|Investigator Discretion|2|||
94716849|NCT01046136|324421224|FG000|Overall Study|Withdrawal by Subject|0|||
94716850|NCT01046136|324421225|FG001|Overall Study|Withdrawal by Subject|4|||
94716851|NCT01046136|324421224|FG000|Overall Study|Physician Decision|1|||
94716852|NCT01046136|324421225|FG001|Overall Study|Physician Decision|1|||
94716853|NCT01046136|324421224|FG000|Overall Study|Lost to Follow-up|3|||
94716854|NCT01046136|324421225|FG001|Overall Study|Lost to Follow-up|3|||
94716855|NCT00727909|324421226|FG000|Overall Study|Withdrawal by Subject|5|||
94716856|NCT00727909|324421227|FG001|Overall Study|Withdrawal by Subject|11|||
94716857|NCT00727909|324421228|FG002|Overall Study|Withdrawal by Subject|8|||
94716858|NCT00727909|324421229|FG003|Overall Study|Withdrawal by Subject|5|||
94716859|NCT00727909|324421226|FG000|Overall Study|Death|0|||
94716860|NCT00727909|324421227|FG001|Overall Study|Death|0|||
94716861|NCT00727909|324421228|FG002|Overall Study|Death|1|||
94716862|NCT00727909|324421229|FG003|Overall Study|Death|0|||
94716863|NCT03756571|324421232|FG000|Overall Study|Lost to Follow-up|1|||
94716864|NCT03756571|324421233|FG001|Overall Study|Lost to Follow-up|1|||
94716865|NCT00978042|324421234|FG000|Initial Treatment Period|Treated in Error|0|||
94716866|NCT00978042|324421235|FG001|Initial Treatment Period|Treated in Error|3|||
94716867|NCT00978042|324421234|FG000|Initial Treatment Period|Ineligibility|1|||
94716868|NCT00978042|324421235|FG001|Initial Treatment Period|Ineligibility|0|||
94716869|NCT00978042|324421234|FG000|Initial Treatment Period|Lost to Follow-up|21|||
94716870|NCT00978042|324421235|FG001|Initial Treatment Period|Lost to Follow-up|3|||
94716871|NCT00978042|324421234|FG000|Initial Treatment Period|Adverse Event|2|||
94716872|NCT00978042|324421235|FG001|Initial Treatment Period|Adverse Event|0|||
94716873|NCT00978042|324421234|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
94716874|NCT00978042|324421235|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
94716875|NCT00978042|324421234|FG000|Initial Treatment Period|Consent withdrawn|22|||
94716876|NCT00978042|324421235|FG001|Initial Treatment Period|Consent withdrawn|9|||
94716877|NCT00978042|324421234|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
94716878|NCT00978042|324421235|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
94716879|NCT01121991|324421237|FG000|Overall Study|Lack of Ovarian Response|2|||
94716880|NCT01121991|324421237|FG000|Overall Study|No Oocytes Retrieved|3|||
94716881|NCT01121991|324421237|FG000|Overall Study|No Fertilization|1|||
94716882|NCT02267824|324421238|FG000|Overall Study|Pregnancy|1|||
94716883|NCT02267824|324421239|FG001|Overall Study|Pregnancy|1|||
94716884|NCT02267824|324421238|FG000|Overall Study|Lost to Follow-up|4|||
94716885|NCT02267824|324421239|FG001|Overall Study|Lost to Follow-up|0|||
94716886|NCT02267824|324421238|FG000|Overall Study|Protocol Violation|3|||
94716887|NCT02267824|324421239|FG001|Overall Study|Protocol Violation|0|||
94716888|NCT02267824|324421238|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
94716889|NCT02267824|324421239|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
94716890|NCT02538900|324421240|FG000|Overall Study|Death|2|||
94716891|NCT02538900|324421241|FG001|Overall Study|Death|2|||
94716892|NCT02538900|324421242|FG002|Overall Study|Death|2|||
94716893|NCT02538900|324421240|FG000|Overall Study|Withdrawal by Subject|18|||
94716894|NCT02538900|324421241|FG001|Overall Study|Withdrawal by Subject|16|||
94716895|NCT02538900|324421242|FG002|Overall Study|Withdrawal by Subject|15|||
94716896|NCT00296036|324421243|FG000|Overall Study|Withdrawal by Subject|1|||
94716897|NCT00296036|324421244|FG001|Overall Study|Withdrawal by Subject|0|||
94716898|NCT00296036|324421245|FG002|Overall Study|Withdrawal by Subject|2|||
94716899|NCT00296036|324421246|FG003|Overall Study|Withdrawal by Subject|1|||
94716900|NCT00296036|324421247|FG004|Overall Study|Withdrawal by Subject|2|||
94271538|NCT01007032|322787178|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
94271539|NCT01007032|322787179|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
94271540|NCT01007032|322787180|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
94271541|NCT01007032|322787181|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
94271542|NCT01007032|322787178|FG000|Overall Study|Withdrawal by Subject|0|||
94271543|NCT01007032|322787179|FG001|Overall Study|Withdrawal by Subject|0|||
94271544|NCT01007032|322787180|FG002|Overall Study|Withdrawal by Subject|0|||
94271545|NCT01007032|322787181|FG003|Overall Study|Withdrawal by Subject|1|||
94271546|NCT00677820|322787182|FG000|Overall Study|Lost to Follow-up|1|||
94271547|NCT00677820|322787183|FG001|Overall Study|Lost to Follow-up|0|||
94271548|NCT00290290|322787184|FG000|Overall Study|Death|3|||
94271549|NCT00290290|322787185|FG001|Overall Study|Death|4|||
94271550|NCT00290290|322787184|FG000|Overall Study|Withdrawal by Subject|2|||
94271551|NCT00290290|322787185|FG001|Overall Study|Withdrawal by Subject|2|||
94271552|NCT00290290|322787184|FG000|Overall Study|Underwent clean surgical procedure|13|||
94271553|NCT00290290|322787185|FG001|Overall Study|Underwent clean surgical procedure|12|||
94367739|NCT00965263|323133028|FG000|Overall Study|Physician Decision|2|||
94716901|NCT00296036|324421248|FG005|Overall Study|Withdrawal by Subject|1|||
94716902|NCT00296036|324421243|FG000|Overall Study|Protocol Violation|0|||
94716903|NCT00296036|324421244|FG001|Overall Study|Protocol Violation|0|||
94716904|NCT00296036|324421245|FG002|Overall Study|Protocol Violation|0|||
94716905|NCT00296036|324421246|FG003|Overall Study|Protocol Violation|0|||
94367740|NCT00965263|323133029|FG001|Overall Study|Physician Decision|0|||
94367741|NCT00965263|323133028|FG000|Overall Study|Family emergency|0|||
94367742|NCT00965263|323133029|FG001|Overall Study|Family emergency|1|||
94367743|NCT00965263|323133028|FG000|Overall Study|Protocol Violation|0|||
94367744|NCT00965263|323133029|FG001|Overall Study|Protocol Violation|2|||
94367745|NCT00666718|323133030|FG000|Overall Study|Adverse Event|0|||
94367746|NCT00666718|323133031|FG001|Overall Study|Adverse Event|1|||
94367747|NCT00666718|323133030|FG000|Overall Study|Death|1|||
94367748|NCT00666718|323133031|FG001|Overall Study|Death|0|||
94367749|NCT00666718|323133030|FG000|Overall Study|Lost to Follow-up|1|||
94367750|NCT00666718|323133031|FG001|Overall Study|Lost to Follow-up|0|||
94367751|NCT00666718|323133030|FG000|Overall Study|Entry Criteria Not Met|2|||
94367752|NCT00666718|323133031|FG001|Overall Study|Entry Criteria Not Met|0|||
94367753|NCT00666718|323133030|FG000|Overall Study|Protocol Violation|1|||
94367754|NCT00666718|323133031|FG001|Overall Study|Protocol Violation|3|||
94367755|NCT00666718|323133030|FG000|Overall Study|Withdrawal by Subject|7|||
94467285|NCT01897571|323500503|FG007|Overall Study|Withdrawal by Subject|1|||
94467286|NCT01897571|323500504|FG008|Overall Study|Withdrawal by Subject|4|||
94716906|NCT00296036|324421247|FG004|Overall Study|Protocol Violation|0|||
94716907|NCT00296036|324421248|FG005|Overall Study|Protocol Violation|3|||
94716908|NCT00595413|324421250|FG000|Overall Study|Adverse Event|0|||
94716909|NCT00595413|324421251|FG001|Overall Study|Adverse Event|2|||
94716910|NCT00595413|324421252|FG002|Overall Study|Adverse Event|1|||
94716911|NCT00595413|324421253|FG003|Overall Study|Adverse Event|1|||
94716912|NCT00595413|324421250|FG000|Overall Study|Lost to Follow-up|2|||
94716913|NCT00595413|324421251|FG001|Overall Study|Lost to Follow-up|2|||
94716914|NCT00595413|324421252|FG002|Overall Study|Lost to Follow-up|1|||
94716915|NCT00595413|324421253|FG003|Overall Study|Lost to Follow-up|3|||
94716916|NCT00595413|324421250|FG000|Overall Study|Death|0|||
94716917|NCT00595413|324421251|FG001|Overall Study|Death|0|||
94716918|NCT00595413|324421252|FG002|Overall Study|Death|1|||
94716919|NCT00595413|324421253|FG003|Overall Study|Death|0|||
94716920|NCT00595413|324421250|FG000|Overall Study|Other|5|||
94716921|NCT00595413|324421251|FG001|Overall Study|Other|1|||
94716922|NCT00595413|324421252|FG002|Overall Study|Other|5|||
94716923|NCT00595413|324421253|FG003|Overall Study|Other|0|||
94716924|NCT02477605|324421254|FG000|Overall Study|Discontinued prior to treatment|1|||
94716925|NCT02477605|324421255|FG001|Overall Study|Discontinued prior to treatment|0|||
94716926|NCT02477605|324421254|FG000|Overall Study|Lost to Follow-up|0|||
94716927|NCT02477605|324421255|FG001|Overall Study|Lost to Follow-up|2|||
94367756|NCT00666718|323133031|FG001|Overall Study|Withdrawal by Subject|12|||
94367757|NCT00666718|323133030|FG000|Overall Study|Physician Decision|0|||
94367758|NCT00666718|323133031|FG001|Overall Study|Physician Decision|2|||
94716928|NCT02477605|324421254|FG000|Overall Study|Withdrawal by Subject|0|||
94367759|NCT00190684|323133036|FG000|Overall Study|Adverse Event|86|||
94467287|NCT01897571|323500505|FG009|Overall Study|Withdrawal by Subject|3|||
94716929|NCT02477605|324421255|FG001|Overall Study|Withdrawal by Subject|1|||
94367760|NCT00190684|323133036|FG000|Overall Study|Satisfactory response|80|||
94367761|NCT00190684|323133036|FG000|Overall Study|Lack of efficacy|204|||
94367762|NCT00190684|323133036|FG000|Overall Study|Lost to Follow-up|232|||
94716930|NCT02477605|324421254|FG000|Overall Study|Administered gas during surgery|0|||
94716931|NCT02477605|324421255|FG001|Overall Study|Administered gas during surgery|1|||
94716932|NCT00901901|324421256|FG000|Treatment Period|Adverse Event|120|||
94716933|NCT00901901|324421257|FG001|Treatment Period|Adverse Event|128|||
94716934|NCT00901901|324421256|FG000|Treatment Period|Withdrawal by Subject|26|||
94716935|NCT00901901|324421257|FG001|Treatment Period|Withdrawal by Subject|24|||
94716936|NCT00901901|324421256|FG000|Treatment Period|Physician Decision|2|||
94716937|NCT00901901|324421257|FG001|Treatment Period|Physician Decision|2|||
94716938|NCT00901901|324421256|FG000|Treatment Period|Lost to Follow-up|3|||
94716939|NCT00901901|324421257|FG001|Treatment Period|Lost to Follow-up|5|||
94716940|NCT00901901|324421256|FG000|Treatment Period|Noncompliance with study medication|4|||
94716941|NCT00901901|324421257|FG001|Treatment Period|Noncompliance with study medication|1|||
94716942|NCT00901901|324421256|FG000|Treatment Period|Missing|1|||
94716943|NCT00901901|324421257|FG001|Treatment Period|Missing|0|||
94716944|NCT00901901|324421256|FG000|Treatment Period|Never treated|0|||
94716945|NCT00901901|324421257|FG001|Treatment Period|Never treated|3|||
94716946|NCT00901901|324421256|FG000|Treatment Period|Protocol driven decision point|0|||
94716947|NCT00901901|324421257|FG001|Treatment Period|Protocol driven decision point|2|||
94716948|NCT00901901|324421256|FG000|Treatment Period|Study terminated by sponsor|2|||
94716949|NCT00901901|324421257|FG001|Treatment Period|Study terminated by sponsor|0|||
94716950|NCT00901901|324421256|FG000|Treatment Period|Protocol Violation|5|||
94716951|NCT00901901|324421257|FG001|Treatment Period|Protocol Violation|9|||
94716952|NCT00901901|324421256|FG000|Treatment Period|Switch to commercial drug|1|||
94716953|NCT00901901|324421257|FG001|Treatment Period|Switch to commercial drug|1|||
94716954|NCT00901901|324421256|FG000|Treatment Period|Transfer to treatment continuation study|5|||
94716955|NCT00901901|324421257|FG001|Treatment Period|Transfer to treatment continuation study|2|||
94716956|NCT00901901|324421256|FG000|Follow-up Period|Death|181|||
94716957|NCT00901901|324421257|FG001|Follow-up Period|Death|208|||
94716958|NCT00901901|324421256|FG000|Follow-up Period|Protocol driven decision point|47|||
94716959|NCT00901901|324421257|FG001|Follow-up Period|Protocol driven decision point|36|||
94716960|NCT00901901|324421256|FG000|Follow-up Period|Withdrawal by Subject|6|||
94716961|NCT00901901|324421257|FG001|Follow-up Period|Withdrawal by Subject|9|||
94716962|NCT00901901|324421256|FG000|Follow-up Period|Lost to Follow-up|12|||
94716963|NCT00901901|324421257|FG001|Follow-up Period|Lost to Follow-up|8|||
94716964|NCT00901901|324421256|FG000|Follow-up Period|Missing|94|||
94716965|NCT00901901|324421257|FG001|Follow-up Period|Missing|80|||
94716966|NCT00087139|324421258|FG000|Overall Study|Adverse Event|18|||
94716967|NCT00087139|324421259|FG001|Overall Study|Adverse Event|17|||
94716968|NCT00087139|324421260|FG002|Overall Study|Adverse Event|13|||
94716969|NCT00087139|324421258|FG000|Overall Study|Death|2|||
94716970|NCT00087139|324421259|FG001|Overall Study|Death|1|||
94716971|NCT00087139|324421260|FG002|Overall Study|Death|0|||
94716972|NCT00087139|324421258|FG000|Overall Study|Withdrawal by Subject|3|||
94716973|NCT00087139|324421259|FG001|Overall Study|Withdrawal by Subject|2|||
94716974|NCT00087139|324421260|FG002|Overall Study|Withdrawal by Subject|2|||
94716975|NCT00087139|324421258|FG000|Overall Study|Physician Decision|1|||
94716976|NCT00087139|324421259|FG001|Overall Study|Physician Decision|1|||
94716977|NCT00087139|324421260|FG002|Overall Study|Physician Decision|1|||
94716978|NCT00087139|324421258|FG000|Overall Study|Disease progression|9|||
94716979|NCT00087139|324421259|FG001|Overall Study|Disease progression|19|||
94716980|NCT00087139|324421260|FG002|Overall Study|Disease progression|12|||
94716981|NCT00087139|324421258|FG000|Overall Study|Ineligible|4|||
94716982|NCT00087139|324421259|FG001|Overall Study|Ineligible|7|||
94716983|NCT00087139|324421260|FG002|Overall Study|Ineligible|4|||
94716984|NCT00087139|324421258|FG000|Overall Study|Symptomatic deterioration|1|||
94716985|NCT00087139|324421259|FG001|Overall Study|Symptomatic deterioration|1|||
94716986|NCT00087139|324421260|FG002|Overall Study|Symptomatic deterioration|3|||
94716987|NCT00087139|324421258|FG000|Overall Study|Use of coumadin|1|||
94716988|NCT00087139|324421259|FG001|Overall Study|Use of coumadin|0|||
94716989|NCT00087139|324421260|FG002|Overall Study|Use of coumadin|0|||
94716990|NCT00087139|324421258|FG000|Overall Study|Response achieved|0|||
94367763|NCT00190684|323133036|FG000|Overall Study|Patient moved|60|||
94716991|NCT00087139|324421259|FG001|Overall Study|Response achieved|1|||
94367764|NCT00190684|323133036|FG000|Overall Study|Patient Decision|432|||
94716992|NCT00087139|324421260|FG002|Overall Study|Response achieved|0|||
94716993|NCT00087139|324421258|FG000|Overall Study|Extradural disease|0|||
94716994|NCT00087139|324421259|FG001|Overall Study|Extradural disease|0|||
94716995|NCT00087139|324421260|FG002|Overall Study|Extradural disease|1|||
94716996|NCT02272816|324421263|FG000|Overall Study|Adverse Event|1|||
94716997|NCT05171777|324421264|FG000|Treatment Crossover Period|Adverse Event|9|||
94716998|NCT05171777|324421265|FG001|Treatment Crossover Period|Adverse Event|6|||
94716999|NCT05171777|324421266|FG002|Treatment Crossover Period|Adverse Event|0|||
94717000|NCT05171777|324421267|FG003|Treatment Crossover Period|Adverse Event|0|||
94717001|NCT05171777|324421264|FG000|Treatment Crossover Period|Death|5|||
94367765|NCT00190684|323133036|FG000|Overall Study|Clinical relapse|67|||
94367766|NCT00190684|323133036|FG000|Overall Study|Sponsor's decision|17|||
94367767|NCT00190684|323133036|FG000|Overall Study|Physician Decision|84|||
94367768|NCT00190684|323133036|FG000|Overall Study|Protocol Violation|123|||
94367769|NCT00190684|323133036|FG000|Overall Study|Study Period III Completed|103|||
94367770|NCT00190684|323133036|FG000|Overall Study|Study Period V Completed|1|||
94367771|NCT03496207|323133037|FG000|Base Study|Adverse Event|0|||
94717002|NCT05171777|324421265|FG001|Treatment Crossover Period|Death|5|||
94717003|NCT05171777|324421266|FG002|Treatment Crossover Period|Death|0|||
94717004|NCT05171777|324421267|FG003|Treatment Crossover Period|Death|0|||
94717005|NCT05171777|324421264|FG000|Treatment Crossover Period|Disease Relapse|0|||
94717006|NCT05171777|324421265|FG001|Treatment Crossover Period|Disease Relapse|1|||
94717007|NCT05171777|324421266|FG002|Treatment Crossover Period|Disease Relapse|0|||
94717008|NCT05171777|324421267|FG003|Treatment Crossover Period|Disease Relapse|0|||
94717009|NCT05171777|324421264|FG000|Treatment Crossover Period|Reason not Specified|2|||
94717010|NCT05171777|324421265|FG001|Treatment Crossover Period|Reason not Specified|1|||
94717011|NCT05171777|324421266|FG002|Treatment Crossover Period|Reason not Specified|0|||
94717012|NCT05171777|324421267|FG003|Treatment Crossover Period|Reason not Specified|0|||
94717013|NCT05171777|324421264|FG000|Treatment Crossover Period|Physician Decision|0|||
94717014|NCT05171777|324421265|FG001|Treatment Crossover Period|Physician Decision|1|||
94717015|NCT05171777|324421266|FG002|Treatment Crossover Period|Physician Decision|0|||
94717016|NCT05171777|324421267|FG003|Treatment Crossover Period|Physician Decision|0|||
94717017|NCT05171777|324421264|FG000|Treatment Crossover Period|Progressive Disease|13|||
94717018|NCT05171777|324421265|FG001|Treatment Crossover Period|Progressive Disease|9|||
94717019|NCT05171777|324421266|FG002|Treatment Crossover Period|Progressive Disease|0|||
94717020|NCT05171777|324421267|FG003|Treatment Crossover Period|Progressive Disease|0|||
94717021|NCT05171777|324421264|FG000|Treatment Crossover Period|Protocol Violation|0|||
94717022|NCT05171777|324421265|FG001|Treatment Crossover Period|Protocol Violation|2|||
94717023|NCT05171777|324421266|FG002|Treatment Crossover Period|Protocol Violation|0|||
94717024|NCT05171777|324421267|FG003|Treatment Crossover Period|Protocol Violation|0|||
94717025|NCT05171777|324421264|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
94717026|NCT05171777|324421265|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
94717027|NCT05171777|324421266|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
94717028|NCT05171777|324421267|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
94717029|NCT05171777|324421264|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
94717030|NCT05171777|324421265|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
94717031|NCT05171777|324421266|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
94717032|NCT05171777|324421267|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
94717033|NCT05171777|324421264|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
94717034|NCT05171777|324421265|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
94717035|NCT05171777|324421266|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
94717036|NCT05171777|324421267|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
94717037|NCT05171777|324421264|FG000|Treatment Continuation Period|Death|0|||
94717038|NCT05171777|324421265|FG001|Treatment Continuation Period|Death|0|||
94717039|NCT05171777|324421266|FG002|Treatment Continuation Period|Death|1|||
94717040|NCT05171777|324421267|FG003|Treatment Continuation Period|Death|6|||
94717041|NCT05171777|324421264|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
94717042|NCT05171777|324421265|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
94717043|NCT05171777|324421266|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
94717044|NCT05171777|324421267|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
94717045|NCT01083316|324421268|FG000|Overall Study|Adverse Event|2|||
94717046|NCT01083316|324421268|FG000|Overall Study|Withdrawal by Subject|1|||
94717047|NCT04154384|324421273|FG000|Overall Study|Lost to Follow-up|24|||
94717048|NCT04154384|324421274|FG001|Overall Study|Lost to Follow-up|33|||
94717049|NCT04154384|324421275|FG002|Overall Study|Lost to Follow-up|0|||
94717050|NCT04154384|324421273|FG000|Overall Study|Withdrawal by Subject|7|||
94717051|NCT04154384|324421274|FG001|Overall Study|Withdrawal by Subject|18|||
94717052|NCT04154384|324421275|FG002|Overall Study|Withdrawal by Subject|0|||
94367772|NCT03496207|323133038|FG001|Base Study|Adverse Event|0|||
94367773|NCT03496207|323133039|FG002|Base Study|Adverse Event|1|||
94717053|NCT04154384|324421273|FG000|Overall Study|Missing outcome data|1|||
94717054|NCT04154384|324421274|FG001|Overall Study|Missing outcome data|0|||
94717055|NCT04154384|324421275|FG002|Overall Study|Missing outcome data|0|||
94717056|NCT05048186|324421276|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
94717057|NCT05048186|324421277|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
94717058|NCT05048186|324421276|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
94717059|NCT05048186|324421277|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
94717060|NCT02412748|324421280|FG000|Overall Study|Lost to Follow-up|38|||
94717061|NCT02412748|324421281|FG001|Overall Study|Lost to Follow-up|39|||
94367774|NCT03496207|323133040|FG003|Base Study|Adverse Event|1|||
94367775|NCT03496207|323133041|FG004|Base Study|Adverse Event|4|||
94367776|NCT03496207|323133037|FG000|Base Study|Death|0|||
94717062|NCT03750968|324421284|FG000|Overall Study|Adverse Event|2|||
94717063|NCT03750968|324421285|FG001|Overall Study|Adverse Event|0|||
94717064|NCT03750968|324421284|FG000|Overall Study|Lost to Follow-up|1|||
94717065|NCT03750968|324421285|FG001|Overall Study|Lost to Follow-up|3|||
94717066|NCT02742519|324421286|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
94717067|NCT02742519|324421287|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
94717068|NCT02742519|324421288|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
94717069|NCT02742519|324421286|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
94717070|NCT02742519|324421287|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
94717071|NCT02742519|324421288|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
94717072|NCT02742519|324421286|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
94717073|NCT02742519|324421287|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
94717074|NCT02742519|324421288|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
94717075|NCT02178098|324421289|FG000|Overall Study|Withdrawal by Subject|0|||
94717076|NCT02178098|324421290|FG001|Overall Study|Withdrawal by Subject|6|||
94717077|NCT02178098|324421289|FG000|Overall Study|Adverse Event|1|||
94717078|NCT02178098|324421290|FG001|Overall Study|Adverse Event|2|||
94717079|NCT02178098|324421289|FG000|Overall Study|Protocol Violation|1|||
94717080|NCT02178098|324421290|FG001|Overall Study|Protocol Violation|1|||
94717081|NCT02178098|324421289|FG000|Overall Study|Lost to Follow-up|0|||
94717082|NCT02178098|324421290|FG001|Overall Study|Lost to Follow-up|1|||
94717083|NCT02178098|324421289|FG000|Overall Study|Sponsor Request|1|||
94717084|NCT02178098|324421290|FG001|Overall Study|Sponsor Request|0|||
94717085|NCT02178098|324421289|FG000|Overall Study|Other|2|||
94717086|NCT02178098|324421290|FG001|Overall Study|Other|2|||
94717087|NCT04820686|324421293|FG000|Overall Study|Withdrawal by Subject|5|||
94717088|NCT04820686|324421294|FG001|Overall Study|Withdrawal by Subject|2|||
94717089|NCT04820686|324421295|FG002|Overall Study|Withdrawal by Subject|3|||
94717090|NCT04820686|324421293|FG000|Overall Study|Study Termination|25|||
94717091|NCT04820686|324421294|FG001|Overall Study|Study Termination|13|||
94717092|NCT04820686|324421295|FG002|Overall Study|Study Termination|14|||
94717093|NCT04820686|324421293|FG000|Overall Study|Adverse Event|0|||
94717094|NCT04820686|324421294|FG001|Overall Study|Adverse Event|1|||
94717095|NCT04820686|324421295|FG002|Overall Study|Adverse Event|0|||
94717096|NCT01094184|324421296|FG000|Overall Study|Death|35|||
94717097|NCT01094184|324421297|FG001|Overall Study|Death|11|||
94717098|NCT03988842|324421298|FG000|Overall Study|Death|1|||
94717099|NCT02544074|324423292|FG000|Overall Study|Withdrawal by Subject|0|||
94717100|NCT02544074|324423293|FG001|Overall Study|Withdrawal by Subject|1|||
94717101|NCT02544074|324423294|FG002|Overall Study|Withdrawal by Subject|0|||
94717102|NCT02544074|324423295|FG003|Overall Study|Withdrawal by Subject|0|||
94717103|NCT02544074|324423296|FG004|Overall Study|Withdrawal by Subject|0|||
94717104|NCT02544074|324423297|FG005|Overall Study|Withdrawal by Subject|0|||
94717105|NCT02544074|324423298|FG006|Overall Study|Withdrawal by Subject|0|||
94717106|NCT02544074|324423299|FG007|Overall Study|Withdrawal by Subject|0|||
94717107|NCT02544074|324423300|FG008|Overall Study|Withdrawal by Subject|0|||
94717108|NCT02544074|324423301|FG009|Overall Study|Withdrawal by Subject|0|||
94717109|NCT02544074|324423302|FG010|Overall Study|Withdrawal by Subject|0|||
94717110|NCT02544074|324423303|FG011|Overall Study|Withdrawal by Subject|0|||
94717111|NCT02544074|324423304|FG012|Overall Study|Withdrawal by Subject|0|||
94717112|NCT02544074|324423305|FG013|Overall Study|Withdrawal by Subject|0|||
94717113|NCT02544074|324423306|FG014|Overall Study|Withdrawal by Subject|0|||
94717114|NCT02544074|324423307|FG015|Overall Study|Withdrawal by Subject|0|||
94717115|NCT02544074|324423308|FG016|Overall Study|Withdrawal by Subject|0|||
94717116|NCT02544074|324423309|FG017|Overall Study|Withdrawal by Subject|0|||
94717117|NCT02544074|324423310|FG018|Overall Study|Withdrawal by Subject|0|||
94717118|NCT02544074|324423311|FG019|Overall Study|Withdrawal by Subject|0|||
94717119|NCT02544074|324423312|FG020|Overall Study|Withdrawal by Subject|0|||
94717120|NCT02544074|324423292|FG000|Overall Study|Tablet error|0|||
94717121|NCT02544074|324423293|FG001|Overall Study|Tablet error|0|||
94717122|NCT02544074|324423294|FG002|Overall Study|Tablet error|0|||
94717123|NCT02544074|324423295|FG003|Overall Study|Tablet error|0|||
94717124|NCT02544074|324423296|FG004|Overall Study|Tablet error|0|||
94717125|NCT02544074|324423297|FG005|Overall Study|Tablet error|1|||
94717126|NCT02544074|324423298|FG006|Overall Study|Tablet error|0|||
94717127|NCT02544074|324423299|FG007|Overall Study|Tablet error|0|||
94717128|NCT02544074|324423300|FG008|Overall Study|Tablet error|0|||
94717129|NCT02544074|324423301|FG009|Overall Study|Tablet error|1|||
94717130|NCT02544074|324423302|FG010|Overall Study|Tablet error|0|||
94717131|NCT02544074|324423303|FG011|Overall Study|Tablet error|0|||
94717132|NCT02544074|324423304|FG012|Overall Study|Tablet error|0|||
94717133|NCT02544074|324423305|FG013|Overall Study|Tablet error|0|||
94717134|NCT02544074|324423306|FG014|Overall Study|Tablet error|0|||
94717135|NCT02544074|324423307|FG015|Overall Study|Tablet error|0|||
94717136|NCT02544074|324423308|FG016|Overall Study|Tablet error|0|||
94367777|NCT03496207|323133038|FG001|Base Study|Death|0|||
94717137|NCT02544074|324423309|FG017|Overall Study|Tablet error|0|||
94717138|NCT02544074|324423310|FG018|Overall Study|Tablet error|0|||
94271554|NCT01236573|322787188|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
94271555|NCT01236573|322787189|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
94271556|NCT01236573|322787190|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
94717139|NCT02544074|324423311|FG019|Overall Study|Tablet error|0|||
94717140|NCT02544074|324423312|FG020|Overall Study|Tablet error|0|||
94717141|NCT03725722|324423318|FG000|Overall Study|Lack of Efficacy|2|||
94717142|NCT03725722|324423319|FG001|Overall Study|Lack of Efficacy|1|||
94717143|NCT03725722|324423320|FG002|Overall Study|Lack of Efficacy|2|||
94717144|NCT03725722|324423321|FG003|Overall Study|Lack of Efficacy|0|||
94717145|NCT03725722|324423322|FG004|Overall Study|Lack of Efficacy|2|||
94717146|NCT03725722|324423318|FG000|Overall Study|Adverse Event|2|||
94717147|NCT03725722|324423319|FG001|Overall Study|Adverse Event|2|||
94717148|NCT03725722|324423320|FG002|Overall Study|Adverse Event|1|||
94717149|NCT03725722|324423321|FG003|Overall Study|Adverse Event|0|||
94717150|NCT03725722|324423322|FG004|Overall Study|Adverse Event|6|||
94717151|NCT03725722|324423318|FG000|Overall Study|Withdrawal by Subject|4|||
94717152|NCT03725722|324423319|FG001|Overall Study|Withdrawal by Subject|1|||
94717153|NCT03725722|324423320|FG002|Overall Study|Withdrawal by Subject|0|||
94717154|NCT03725722|324423321|FG003|Overall Study|Withdrawal by Subject|4|||
94717155|NCT03725722|324423322|FG004|Overall Study|Withdrawal by Subject|4|||
94717156|NCT03725722|324423318|FG000|Overall Study|Lost to Follow-up|3|||
94717157|NCT03725722|324423319|FG001|Overall Study|Lost to Follow-up|1|||
94717158|NCT03725722|324423320|FG002|Overall Study|Lost to Follow-up|2|||
94717159|NCT03725722|324423321|FG003|Overall Study|Lost to Follow-up|2|||
94717160|NCT03725722|324423322|FG004|Overall Study|Lost to Follow-up|1|||
94717161|NCT03725722|324423318|FG000|Overall Study|Personal reasons|0|||
94717162|NCT03725722|324423319|FG001|Overall Study|Personal reasons|0|||
94717163|NCT03725722|324423320|FG002|Overall Study|Personal reasons|1|||
94717164|NCT03725722|324423321|FG003|Overall Study|Personal reasons|0|||
94717165|NCT03725722|324423322|FG004|Overall Study|Personal reasons|1|||
94717166|NCT03725722|324423318|FG000|Overall Study|COVID-19 situation|0|||
94717167|NCT03725722|324423319|FG001|Overall Study|COVID-19 situation|1|||
94717168|NCT03725722|324423320|FG002|Overall Study|COVID-19 situation|0|||
94717169|NCT03725722|324423321|FG003|Overall Study|COVID-19 situation|0|||
94717170|NCT03725722|324423322|FG004|Overall Study|COVID-19 situation|0|||
94717171|NCT05505045|324423323|FG000|Overall Study|Withdrawal by Subject|2|||
94717172|NCT05505045|324423324|FG001|Overall Study|Withdrawal by Subject|1|||
94717173|NCT00368641|324423333|FG000|Overall Study|Adverse Event|2|||
94717174|NCT00368641|324423334|FG001|Overall Study|Adverse Event|1|||
94717175|NCT00368641|324423333|FG000|Overall Study|Death|1|||
94717176|NCT00368641|324423334|FG001|Overall Study|Death|0|||
94717177|NCT00368641|324423333|FG000|Overall Study|Withdrawal by Subject|1|||
94717178|NCT00368641|324423334|FG001|Overall Study|Withdrawal by Subject|0|||
94717179|NCT00368641|324423333|FG000|Overall Study|Sponsor decision to terminate study|2|||
94717180|NCT00368641|324423334|FG001|Overall Study|Sponsor decision to terminate study|5|||
94717181|NCT03398200|324423339|FG000|Overall Study|Withdrawal by Subject|0|||
94717182|NCT03398200|324423340|FG001|Overall Study|Withdrawal by Subject|1|||
94717183|NCT04038957|324423344|FG000|Overall Study|Withdrawal by Subject|1|||
94717184|NCT04038957|324423344|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
94717185|NCT03189524|324423345|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
94717186|NCT03189524|324423346|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
94717187|NCT03189524|324423347|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
94717188|NCT03189524|324423345|FG000|Overall Study|Death|2|||
94717189|NCT03189524|324423346|FG001|Overall Study|Death|2|||
94717190|NCT03189524|324423347|FG002|Overall Study|Death|1|||
94717191|NCT03189524|324423345|FG000|Overall Study|Lost to Follow-up|1|||
94271557|NCT01236573|322787191|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
94271558|NCT01236573|322787192|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
94271559|NCT01236573|322787193|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
94271560|NCT01236573|322787194|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
94467288|NCT01897571|323500506|FG010|Overall Study|Withdrawal by Subject|1|||
94717192|NCT03189524|324423346|FG001|Overall Study|Lost to Follow-up|0|||
94717193|NCT03189524|324423347|FG002|Overall Study|Lost to Follow-up|8|||
94717194|NCT03189524|324423345|FG000|Overall Study|Withdrawal by Subject|1|||
94717195|NCT03189524|324423346|FG001|Overall Study|Withdrawal by Subject|1|||
94717196|NCT03189524|324423347|FG002|Overall Study|Withdrawal by Subject|3|||
94717197|NCT03189524|324423345|FG000|Overall Study|Progressive Disease|0|||
94717198|NCT03189524|324423346|FG001|Overall Study|Progressive Disease|2|||
94717199|NCT03189524|324423347|FG002|Overall Study|Progressive Disease|0|||
94717200|NCT03821844|324423348|FG000|Overall Study|Death|37|||
94717201|NCT03821844|324423349|FG001|Overall Study|Death|31|||
94717202|NCT03821844|324423348|FG000|Overall Study|Discharged|10|||
94717203|NCT03821844|324423349|FG001|Overall Study|Discharged|14|||
94717204|NCT03821844|324423348|FG000|Overall Study|Not present in facility at followup|2|||
94717205|NCT03821844|324423349|FG001|Overall Study|Not present in facility at followup|3|||
94717206|NCT02980276|324423350|FG000|Overall Study|Withdrawal by Subject|4|||
94717207|NCT02980276|324423351|FG001|Overall Study|Withdrawal by Subject|4|||
94717208|NCT02980276|324423350|FG000|Overall Study|Physician Decision|0|||
94717209|NCT02980276|324423351|FG001|Overall Study|Physician Decision|1|||
94717210|NCT02980276|324423350|FG000|Overall Study|Lost to Follow-up|18|||
94717211|NCT02980276|324423351|FG001|Overall Study|Lost to Follow-up|18|||
94717212|NCT02980276|324423350|FG000|Overall Study|Death|1|||
94717213|NCT02980276|324423351|FG001|Overall Study|Death|0|||
94717214|NCT02980276|324423350|FG000|Overall Study|Miscellaneous other|10|||
94717215|NCT02980276|324423351|FG001|Overall Study|Miscellaneous other|4|||
94717216|NCT04065048|324423356|FG000|Overall Study|Withdrawal by Subject|1|||
94717217|NCT04065048|324423357|FG001|Overall Study|Withdrawal by Subject|2|||
94717218|NCT04065048|324423358|FG002|Overall Study|Withdrawal by Subject|1|||
94717219|NCT04065048|324423359|FG003|Overall Study|Withdrawal by Subject|1|||
94717220|NCT04065048|324423356|FG000|Overall Study|Adverse Event|1|||
94717221|NCT04065048|324423357|FG001|Overall Study|Adverse Event|0|||
94717222|NCT04065048|324423358|FG002|Overall Study|Adverse Event|1|||
94717223|NCT04065048|324423359|FG003|Overall Study|Adverse Event|0|||
94717224|NCT01780298|324423360|FG000|Overall Study|Physician Decision|1|||
94717225|NCT01780298|324423361|FG001|Overall Study|Physician Decision|5|||
94717226|NCT01780298|324423362|FG002|Overall Study|Physician Decision|1|||
94717227|NCT01780298|324423363|FG003|Overall Study|Physician Decision|1|||
94717228|NCT01780298|324423360|FG000|Overall Study|Subject not matched|1|||
94717229|NCT01780298|324423361|FG001|Overall Study|Subject not matched|0|||
94717230|NCT01780298|324423362|FG002|Overall Study|Subject not matched|1|||
94717231|NCT01780298|324423363|FG003|Overall Study|Subject not matched|0|||
94717232|NCT01780298|324423360|FG000|Overall Study|Adverse Event|0|||
94717233|NCT01780298|324423361|FG001|Overall Study|Adverse Event|0|||
94717234|NCT01780298|324423362|FG002|Overall Study|Adverse Event|2|||
94717235|NCT01780298|324423363|FG003|Overall Study|Adverse Event|0|||
94717236|NCT04139668|324423364|FG000|Overall Study|Withdrawal by Subject|1|||
94717237|NCT03554265|324423365|FG000|Overall Study|Withdrawal by Subject|2|||
94717238|NCT03554265|324423366|FG001|Overall Study|Withdrawal by Subject|2|||
94717239|NCT03554265|324423367|FG002|Overall Study|Withdrawal by Subject|3|||
94717240|NCT03554265|324423365|FG000|Overall Study|Physician Decision|0|||
94717241|NCT03554265|324423366|FG001|Overall Study|Physician Decision|0|||
94717242|NCT03554265|324423367|FG002|Overall Study|Physician Decision|1|||
94717243|NCT04999085|324423370|FG000|Overall Study|Death|1|||
94717244|NCT05057897|324423371|FG000|Overall Study|Site closure|2|||
94717245|NCT05057897|324423372|FG001|Overall Study|Site closure|2|||
94717246|NCT05057897|324423371|FG000|Overall Study|Death|1|||
94717247|NCT05057897|324423372|FG001|Overall Study|Death|0|||
94717248|NCT05656911|324423373|FG000|Treatment Phase|Physician Decision|2|||
94717249|NCT05656911|324423374|FG001|Treatment Phase|Physician Decision|0|||
94717250|NCT05656911|324423373|FG000|Treatment Phase|Lack of Efficacy|6|||
94717251|NCT05656911|324423374|FG001|Treatment Phase|Lack of Efficacy|3|||
94717252|NCT05656911|324423373|FG000|Treatment Phase|Subject Decision|4|||
94717253|NCT05656911|324423374|FG001|Treatment Phase|Subject Decision|2|||
94717254|NCT05656911|324423373|FG000|Treatment Phase|Other Reasons|1|||
94717255|NCT05656911|324423374|FG001|Treatment Phase|Other Reasons|0|||
94717256|NCT05656911|324423373|FG000|Treatment Phase|Adverse Event|3|||
94717257|NCT05656911|324423374|FG001|Treatment Phase|Adverse Event|1|||
94717258|NCT05656911|324423373|FG000|Follow-up Phase|Subject Decision|0|||
94717259|NCT05656911|324423374|FG001|Follow-up Phase|Subject Decision|1|||
94717260|NCT05656911|324423373|FG000|Follow-up Phase|Missing|1|||
94717261|NCT05656911|324423374|FG001|Follow-up Phase|Missing|0|||
94717262|NCT02824029|324423375|FG000|Overall Study|Didn't receive treatment|2|||
94717263|NCT02824029|324423375|FG000|Overall Study|Patient decision to discontinue treatment|3|||
94717264|NCT02824029|324423375|FG000|Overall Study|Non-compliant|5|||
94367778|NCT03496207|323133039|FG002|Base Study|Death|0|||
94717265|NCT02824029|324423375|FG000|Overall Study|Progression of disease|15|||
94717266|NCT02824029|324423375|FG000|Overall Study|Inadequate response to therapy|2|||
94717267|NCT02824029|324423375|FG000|Overall Study|Possible progression per treating physician|1|||
94717268|NCT05672667|324423377|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
94717269|NCT02837510|324423378|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
94717270|NCT02837510|324423379|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
94717271|NCT02837510|324423378|FG000|Washout (2 Weeks)|Adverse Event|0|||
94717272|NCT02837510|324423379|FG001|Washout (2 Weeks)|Adverse Event|1|||
94717273|NCT02837510|324423378|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
94717274|NCT02837510|324423379|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
94717275|NCT02837510|324423378|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
94717276|NCT02837510|324423379|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
94717277|NCT02837510|324423378|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
94717278|NCT02837510|324423379|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
94717279|NCT02837510|324423378|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
94717280|NCT02837510|324423379|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
94717281|NCT03873779|324423380|FG000|Overall Study|Withdrawal by Subject|1|||
94717282|NCT04250883|324423381|FG000|Overall Study|Lost to Follow-up|1|||
94717283|NCT04250883|324423382|FG001|Overall Study|Lost to Follow-up|0|||
94717284|NCT04588259|324423383|FG000|Run-in Period|Run-in failure|0|||
94717285|NCT04588259|324423384|FG001|Run-in Period|Run-in failure|23|||
94717286|NCT04588259|324423383|FG000|Run-in Period|Withdrawn before randomisation|0|||
94717287|NCT04588259|324423384|FG001|Run-in Period|Withdrawn before randomisation|8|||
94717288|NCT04588259|324423383|FG000|Treatment Period|Withdrawal by Subject|6|||
94717289|NCT04588259|324423384|FG001|Treatment Period|Withdrawal by Subject|6|||
94717290|NCT02058108|324423391|FG000|Overall Study|Abnormal Laboratory Values|0|||
94717291|NCT02058108|324423392|FG001|Overall Study|Abnormal Laboratory Values|1|||
94717292|NCT02058108|324423391|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
94717293|NCT02058108|324423392|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
94717294|NCT02058108|324423391|FG000|Overall Study|No longer requires study drug|0|||
94717295|NCT02058108|324423392|FG001|Overall Study|No longer requires study drug|1|||
94717296|NCT02058108|324423391|FG000|Overall Study|Withdrawal by Subject|1|||
94717297|NCT02058108|324423392|FG001|Overall Study|Withdrawal by Subject|0|||
94717298|NCT02058108|324423391|FG000|Overall Study|Administrative problems|3|||
94717299|NCT02058108|324423392|FG001|Overall Study|Administrative problems|3|||
94717300|NCT02058108|324423391|FG000|Overall Study|Protocol Violation|0|||
94717301|NCT02058108|324423392|FG001|Overall Study|Protocol Violation|1|||
94717302|NCT04759833|324423393|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
94717303|NCT04759833|324423394|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
94717304|NCT04759833|324423395|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
94717305|NCT04759833|324423396|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
94717306|NCT04759833|324423397|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
94717307|NCT04759833|324423393|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
94271561|NCT01236573|322787195|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
94271562|NCT01236573|322787196|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
94271563|NCT01236573|322787197|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
94271564|NCT01236573|322787198|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
94271565|NCT01236573|322787188|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
94271566|NCT01236573|322787189|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
94271567|NCT01236573|322787190|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
94271568|NCT01236573|322787191|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
94271569|NCT01236573|322787192|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
94271570|NCT01236573|322787193|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
94271571|NCT01236573|322787194|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
94271572|NCT01236573|322787195|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
94271573|NCT01236573|322787196|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
94271574|NCT01236573|322787197|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
94271575|NCT01236573|322787198|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
94271576|NCT01236573|322787188|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
94271577|NCT01236573|322787189|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
94271578|NCT01236573|322787190|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
94271579|NCT01236573|322787191|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
94271580|NCT01236573|322787192|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
94271581|NCT01236573|322787193|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
94271582|NCT01236573|322787194|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
94271583|NCT01236573|322787195|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
94717308|NCT04759833|324423394|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
94717309|NCT04759833|324423395|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
94717310|NCT04759833|324423396|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
94717311|NCT04759833|324423397|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
94717312|NCT04759833|324423393|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
94717313|NCT04759833|324423394|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
94717314|NCT04759833|324423395|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
94717315|NCT04759833|324423396|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
94717316|NCT04759833|324423397|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
94717317|NCT04759833|324423393|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
94717318|NCT04759833|324423394|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
94717319|NCT04759833|324423395|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
94717320|NCT04759833|324423396|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
94717321|NCT04759833|324423397|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
94717322|NCT04759833|324423393|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
94717323|NCT04759833|324423394|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
94717324|NCT04759833|324423395|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
94717325|NCT04759833|324423396|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
94717326|NCT04759833|324423397|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
94271584|NCT01236573|322787196|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
94367779|NCT03496207|323133040|FG003|Base Study|Death|0|||
94717327|NCT04759833|324423393|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
94717328|NCT04759833|324423394|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
94717329|NCT04759833|324423395|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
94717330|NCT04759833|324423396|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
94717331|NCT04759833|324423397|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
94717332|NCT04759833|324423393|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
94717333|NCT04759833|324423394|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
94717334|NCT04759833|324423395|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
94717335|NCT04759833|324423396|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
94367780|NCT03496207|323133041|FG004|Base Study|Death|1|||
94271585|NCT01236573|322787197|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
94271586|NCT01236573|322787198|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
94271587|NCT04206605|322787205|FG000|Overall Study|Adverse Event|0|||
94271588|NCT04206605|322787206|FG001|Overall Study|Adverse Event|1|||
94271589|NCT04206605|322787205|FG000|Overall Study|Withdrawal by Subject|1|||
94271590|NCT04206605|322787206|FG001|Overall Study|Withdrawal by Subject|0|||
94271591|NCT04688775|322787210|FG000|Placebo-controlled Period|Randomized, not treated|1|||
94271592|NCT04688775|322787211|FG001|Placebo-controlled Period|Randomized, not treated|1|||
94271593|NCT04688775|322787212|FG002|Placebo-controlled Period|Randomized, not treated|0|||
94271594|NCT04688775|322787213|FG003|Placebo-controlled Period|Randomized, not treated|0|||
94271595|NCT04688775|322787210|FG000|Placebo-controlled Period|Adverse Event|2|||
94271596|NCT04688775|322787211|FG001|Placebo-controlled Period|Adverse Event|0|||
94271597|NCT04688775|322787212|FG002|Placebo-controlled Period|Adverse Event|0|||
94271598|NCT04688775|322787213|FG003|Placebo-controlled Period|Adverse Event|0|||
94271599|NCT04688775|322787210|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
94271600|NCT04688775|322787211|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
94271601|NCT04688775|322787212|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
94271602|NCT04688775|322787213|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
94271603|NCT04688775|322787210|FG000|Placebo-controlled Period|Protocol Violation|0|||
94271604|NCT04688775|322787211|FG001|Placebo-controlled Period|Protocol Violation|1|||
94271605|NCT04688775|322787212|FG002|Placebo-controlled Period|Protocol Violation|0|||
94271606|NCT04688775|322787213|FG003|Placebo-controlled Period|Protocol Violation|0|||
94717336|NCT04759833|324423397|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
94717337|NCT04759833|324423393|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
94717338|NCT04759833|324423394|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
94717339|NCT04759833|324423395|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
94717340|NCT04759833|324423396|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
94717341|NCT04759833|324423397|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
94717342|NCT04759833|324423393|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
94717343|NCT04759833|324423394|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
94717344|NCT04759833|324423395|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
94717345|NCT04759833|324423396|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
94717346|NCT04759833|324423397|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
94717347|NCT04759833|324423393|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
94717348|NCT04759833|324423394|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
94717349|NCT04759833|324423395|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
94717350|NCT04759833|324423396|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
94717351|NCT04759833|324423397|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
94717352|NCT04759833|324423393|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
94717353|NCT04759833|324423394|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
94717354|NCT04759833|324423395|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
94717355|NCT04759833|324423396|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
94717356|NCT04759833|324423397|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
94717357|NCT04759833|324423393|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
94717358|NCT04759833|324423394|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
94717359|NCT04759833|324423395|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
94717360|NCT04759833|324423396|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
94717361|NCT04759833|324423397|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
94717362|NCT04759833|324423393|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
94717363|NCT04759833|324423394|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
94717364|NCT04759833|324423395|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
94717365|NCT04759833|324423396|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
94717366|NCT04759833|324423397|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
94717367|NCT02006758|324423403|FG000|Overall Study|Protocol Violation|1|||
94717368|NCT02006758|324423403|FG000|Overall Study|Death|1|||
94717369|NCT02006758|324423403|FG000|Overall Study|Lost to Follow-up|4|||
94717370|NCT02006758|324423403|FG000|Overall Study|Withdrawal by Subject|4|||
94717371|NCT02006758|324423403|FG000|Overall Study|Procedurally excluded|1|||
94271607|NCT04688775|322787210|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
94271608|NCT04688775|322787211|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
94271609|NCT04688775|322787212|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
94271610|NCT04688775|322787213|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
94271611|NCT04688775|322787210|FG000|Placebo-controlled Period|Other reasons|0|||
94271612|NCT04688775|322787211|FG001|Placebo-controlled Period|Other reasons|1|||
94271613|NCT04688775|322787212|FG002|Placebo-controlled Period|Other reasons|0|||
94271614|NCT04688775|322787213|FG003|Placebo-controlled Period|Other reasons|0|||
94271615|NCT04688775|322787210|FG000|Delayed Start Period|Adverse Event|0|||
94271616|NCT04688775|322787211|FG001|Delayed Start Period|Adverse Event|0|||
94271617|NCT04688775|322787212|FG002|Delayed Start Period|Adverse Event|1|||
94271618|NCT04688775|322787213|FG003|Delayed Start Period|Adverse Event|0|||
94271619|NCT04688775|322787210|FG000|Delayed Start Period|Lack of Efficacy|0|||
94271620|NCT04688775|322787211|FG001|Delayed Start Period|Lack of Efficacy|0|||
94271621|NCT04688775|322787212|FG002|Delayed Start Period|Lack of Efficacy|0|||
94271622|NCT04688775|322787213|FG003|Delayed Start Period|Lack of Efficacy|3|||
94271623|NCT04688775|322787210|FG000|Delayed Start Period|Withdrawal by Subject|0|||
94271624|NCT04688775|322787211|FG001|Delayed Start Period|Withdrawal by Subject|0|||
94271625|NCT04688775|322787212|FG002|Delayed Start Period|Withdrawal by Subject|2|||
94271626|NCT04688775|322787213|FG003|Delayed Start Period|Withdrawal by Subject|4|||
94271627|NCT04688775|322787210|FG000|Delayed Start Period|Lost to Follow-up|0|||
94271628|NCT04688775|322787211|FG001|Delayed Start Period|Lost to Follow-up|0|||
94271629|NCT04688775|322787212|FG002|Delayed Start Period|Lost to Follow-up|2|||
94271630|NCT04688775|322787213|FG003|Delayed Start Period|Lost to Follow-up|1|||
94271631|NCT04688775|322787210|FG000|Delayed Start Period|other reasons|0|||
94271632|NCT04688775|322787211|FG001|Delayed Start Period|other reasons|0|||
94271633|NCT04688775|322787212|FG002|Delayed Start Period|other reasons|1|||
94271634|NCT04688775|322787213|FG003|Delayed Start Period|other reasons|0|||
94271635|NCT03574753|322787214|FG000|Overall Study|Adverse Event|3|||
94271636|NCT03574753|322787214|FG000|Overall Study|Progression/relapse|19|||
94271637|NCT03574753|322787214|FG000|Overall Study|Death|1|||
94271638|NCT00932360|322787215|FG000|Washout (One Week)|Withdrawal by Subject|0|||
94367781|NCT03496207|323133037|FG000|Base Study|Withdrawal by Subject|0|||
94367782|NCT03496207|323133038|FG001|Base Study|Withdrawal by Subject|0|||
94367783|NCT03496207|323133039|FG002|Base Study|Withdrawal by Subject|1|||
94367784|NCT03496207|323133040|FG003|Base Study|Withdrawal by Subject|0|||
94367785|NCT03496207|323133041|FG004|Base Study|Withdrawal by Subject|1|||
94367786|NCT03496207|323133037|FG000|Extension Period|Adverse Event|0|||
94367787|NCT03496207|323133038|FG001|Extension Period|Adverse Event|0|||
94367788|NCT03496207|323133039|FG002|Extension Period|Adverse Event|0|||
94367789|NCT03496207|323133040|FG003|Extension Period|Adverse Event|1|||
94367790|NCT03496207|323133041|FG004|Extension Period|Adverse Event|1|||
94653465|NCT01709318|324190339|FG004|Overall Study|Non-compliance with Study Drug|0|||
94717372|NCT02006758|324423403|FG000|Overall Study|Other|2|||
94717373|NCT01250769|324423409|FG000|Overall Study|Withdrawal by Subject|0|||
94653466|NCT01709318|324190340|FG005|Overall Study|Non-compliance with Study Drug|0|||
94653467|NCT01709318|324190341|FG006|Overall Study|Non-compliance with Study Drug|2|||
94653468|NCT01709318|324190335|FG000|Overall Study|Physician Decision|0|||
94653469|NCT01709318|324190336|FG001|Overall Study|Physician Decision|0|||
94653470|NCT01709318|324190337|FG002|Overall Study|Physician Decision|0|||
94653471|NCT01709318|324190338|FG003|Overall Study|Physician Decision|0|||
94653472|NCT01709318|324190339|FG004|Overall Study|Physician Decision|0|||
94653473|NCT01709318|324190340|FG005|Overall Study|Physician Decision|0|||
94717374|NCT01250769|324423410|FG001|Overall Study|Withdrawal by Subject|1|||
94717375|NCT01250769|324423411|FG002|Overall Study|Withdrawal by Subject|1|||
94717376|NCT01250769|324423412|FG003|Overall Study|Withdrawal by Subject|0|||
94717377|NCT01250769|324423409|FG000|Overall Study|Adverse Event|0|||
94717378|NCT01250769|324423410|FG001|Overall Study|Adverse Event|0|||
94717379|NCT01250769|324423411|FG002|Overall Study|Adverse Event|1|||
94717380|NCT01250769|324423412|FG003|Overall Study|Adverse Event|0|||
94717381|NCT03283371|324423413|FG000|Placebo-controlled|Adverse Event|1|||
94717382|NCT03283371|324423414|FG001|Placebo-controlled|Adverse Event|1|||
94717383|NCT03283371|324423415|FG002|Placebo-controlled|Adverse Event|0|||
94717384|NCT03283371|324423416|FG003|Placebo-controlled|Adverse Event|0|||
94717385|NCT03283371|324423413|FG000|Placebo-controlled|Lack of Efficacy|1|||
94717386|NCT03283371|324423414|FG001|Placebo-controlled|Lack of Efficacy|0|||
94717387|NCT03283371|324423415|FG002|Placebo-controlled|Lack of Efficacy|0|||
94717388|NCT03283371|324423416|FG003|Placebo-controlled|Lack of Efficacy|0|||
94717389|NCT03283371|324423413|FG000|Placebo-controlled|Withdrawal by Subject|1|||
94717390|NCT03283371|324423414|FG001|Placebo-controlled|Withdrawal by Subject|1|||
94717391|NCT03283371|324423415|FG002|Placebo-controlled|Withdrawal by Subject|0|||
94717392|NCT03283371|324423416|FG003|Placebo-controlled|Withdrawal by Subject|0|||
94717393|NCT03283371|324423413|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
94717394|NCT03283371|324423414|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
94717395|NCT03283371|324423415|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
94717396|NCT03283371|324423416|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
94717397|NCT03283371|324423413|FG000|Open-label Phase|Adverse Event|0|||
94653474|NCT01709318|324190341|FG006|Overall Study|Physician Decision|1|||
94653475|NCT01709318|324190335|FG000|Overall Study|Pregnancy|0|||
94653476|NCT01709318|324190336|FG001|Overall Study|Pregnancy|0|||
94653477|NCT01709318|324190337|FG002|Overall Study|Pregnancy|0|||
94653478|NCT01709318|324190338|FG003|Overall Study|Pregnancy|0|||
94717398|NCT03283371|324423414|FG001|Open-label Phase|Adverse Event|0|||
94717399|NCT03283371|324423415|FG002|Open-label Phase|Adverse Event|2|||
94717400|NCT03283371|324423416|FG003|Open-label Phase|Adverse Event|0|||
94367791|NCT03496207|323133037|FG000|Extension Period|Death|1|||
94653479|NCT01709318|324190339|FG004|Overall Study|Pregnancy|1|||
94653480|NCT01709318|324190340|FG005|Overall Study|Pregnancy|0|||
94653481|NCT01709318|324190341|FG006|Overall Study|Pregnancy|0|||
94653482|NCT01709318|324190335|FG000|Overall Study|Protocol Violation|0|||
94653483|NCT01709318|324190336|FG001|Overall Study|Protocol Violation|0|||
94653484|NCT01709318|324190337|FG002|Overall Study|Protocol Violation|0|||
94653485|NCT01709318|324190338|FG003|Overall Study|Protocol Violation|0|||
94653486|NCT01709318|324190339|FG004|Overall Study|Protocol Violation|2|||
94717401|NCT03283371|324423413|FG000|Open-label Phase|Withdrawal by Subject|0|||
94717402|NCT03283371|324423414|FG001|Open-label Phase|Withdrawal by Subject|0|||
94367792|NCT03496207|323133038|FG001|Extension Period|Death|0|||
94367793|NCT03496207|323133039|FG002|Extension Period|Death|0|||
94653487|NCT01709318|324190340|FG005|Overall Study|Protocol Violation|0|||
94653488|NCT01709318|324190341|FG006|Overall Study|Protocol Violation|1|||
94653489|NCT01709318|324190335|FG000|Overall Study|Technical Problems|1|||
94717403|NCT03283371|324423415|FG002|Open-label Phase|Withdrawal by Subject|1|||
94717404|NCT03283371|324423416|FG003|Open-label Phase|Withdrawal by Subject|0|||
94717405|NCT03283371|324423413|FG000|Open-label Phase|Other|0|||
94717406|NCT03283371|324423414|FG001|Open-label Phase|Other|0|||
94367794|NCT03496207|323133040|FG003|Extension Period|Death|1|||
94367795|NCT03496207|323133041|FG004|Extension Period|Death|2|||
94653490|NCT01709318|324190336|FG001|Overall Study|Technical Problems|0|||
94653491|NCT01709318|324190337|FG002|Overall Study|Technical Problems|0|||
94653492|NCT01709318|324190338|FG003|Overall Study|Technical Problems|0|||
94653493|NCT01709318|324190339|FG004|Overall Study|Technical Problems|0|||
94653494|NCT01709318|324190340|FG005|Overall Study|Technical Problems|0|||
94271639|NCT00932360|322787216|FG001|Washout (One Week)|Withdrawal by Subject|0|||
94271640|NCT00932360|322787217|FG002|Washout (One Week)|Withdrawal by Subject|0|||
94271641|NCT00932360|322787218|FG003|Washout (One Week)|Withdrawal by Subject|0|||
94271642|NCT00932360|322787219|FG004|Washout (One Week)|Withdrawal by Subject|2|||
94271643|NCT00932360|322787220|FG005|Washout (One Week)|Withdrawal by Subject|0|||
94271644|NCT02536313|322787221|FG000|Overall Study|Lack of Efficacy|0|||
94271645|NCT02536313|322787222|FG001|Overall Study|Lack of Efficacy|1|||
94271646|NCT00495820|322787226|FG000|Overall Study|Adverse Event|1|||
94653495|NCT01709318|324190341|FG006|Overall Study|Technical Problems|0|||
94653496|NCT01709318|324190335|FG000|Overall Study|Withdrawal by Subject|3|||
94653497|NCT01709318|324190336|FG001|Overall Study|Withdrawal by Subject|0|||
94653498|NCT01709318|324190337|FG002|Overall Study|Withdrawal by Subject|3|||
94653499|NCT01709318|324190338|FG003|Overall Study|Withdrawal by Subject|3|||
94653500|NCT01709318|324190339|FG004|Overall Study|Withdrawal by Subject|0|||
94653501|NCT01709318|324190340|FG005|Overall Study|Withdrawal by Subject|2|||
94653502|NCT01709318|324190341|FG006|Overall Study|Withdrawal by Subject|4|||
94653503|NCT01709318|324190335|FG000|Overall Study|Other Protocol Specified Criteria|0|||
94653504|NCT01709318|324190336|FG001|Overall Study|Other Protocol Specified Criteria|1|||
94653505|NCT01709318|324190337|FG002|Overall Study|Other Protocol Specified Criteria|0|||
94653506|NCT01709318|324190338|FG003|Overall Study|Other Protocol Specified Criteria|0|||
94653507|NCT01709318|324190339|FG004|Overall Study|Other Protocol Specified Criteria|0|||
94653508|NCT01709318|324190340|FG005|Overall Study|Other Protocol Specified Criteria|0|||
94653509|NCT01709318|324190341|FG006|Overall Study|Other Protocol Specified Criteria|0|||
94653510|NCT04258839|324190344|FG000|Overall Study|Adverse Event|2|||
94653511|NCT04258839|324190345|FG001|Overall Study|Adverse Event|4|||
94653512|NCT04258839|324190344|FG000|Overall Study|Lack of Efficacy|0|||
94653513|NCT04258839|324190345|FG001|Overall Study|Lack of Efficacy|2|||
94653514|NCT04258839|324190344|FG000|Overall Study|Lost to Follow-up|2|||
94653515|NCT04258839|324190345|FG001|Overall Study|Lost to Follow-up|0|||
94653516|NCT04258839|324190344|FG000|Overall Study|Withdrawal by Subject|1|||
94653517|NCT04258839|324190345|FG001|Overall Study|Withdrawal by Subject|2|||
94653518|NCT04258839|324190344|FG000|Overall Study|Withdrawal by Caregiver|5|||
94653519|NCT04258839|324190345|FG001|Overall Study|Withdrawal by Caregiver|6|||
94653520|NCT04258839|324190344|FG000|Overall Study|Reason not Specified|0|||
94653521|NCT04258839|324190345|FG001|Overall Study|Reason not Specified|1|||
94653522|NCT00827372|324190346|FG000|Overall Study|Adverse Event|5|||
94653523|NCT00827372|324190346|FG000|Overall Study|Lack of Efficacy|3|||
94653524|NCT01105533|324190347|FG000|Overall Study|Death|0|||
94653525|NCT01105533|324190348|FG001|Overall Study|Death|0|||
94653526|NCT01105533|324190349|FG002|Overall Study|Death|0|||
94653527|NCT01105533|324190350|FG003|Overall Study|Death|0|||
94653528|NCT01105533|324190351|FG004|Overall Study|Death|1|||
94653529|NCT01105533|324190352|FG005|Overall Study|Death|0|||
94653530|NCT01105533|324190353|FG006|Overall Study|Death|0|||
94653531|NCT01105533|324190354|FG007|Overall Study|Death|0|||
94653532|NCT01105533|324190355|FG008|Overall Study|Death|0|||
94653533|NCT01105533|324190347|FG000|Overall Study|Lack of Efficacy|1|||
94653534|NCT01105533|324190348|FG001|Overall Study|Lack of Efficacy|1|||
94653535|NCT01105533|324190349|FG002|Overall Study|Lack of Efficacy|3|||
94653536|NCT01105533|324190350|FG003|Overall Study|Lack of Efficacy|3|||
94653537|NCT01105533|324190351|FG004|Overall Study|Lack of Efficacy|4|||
94653538|NCT01105533|324190352|FG005|Overall Study|Lack of Efficacy|5|||
94653539|NCT01105533|324190353|FG006|Overall Study|Lack of Efficacy|3|||
94653540|NCT01105533|324190354|FG007|Overall Study|Lack of Efficacy|2|||
94653541|NCT01105533|324190355|FG008|Overall Study|Lack of Efficacy|9|||
94653542|NCT01105533|324190347|FG000|Overall Study|Adverse Event|0|||
94653543|NCT01105533|324190348|FG001|Overall Study|Adverse Event|0|||
94271647|NCT00495820|322787227|FG001|Overall Study|Adverse Event|1|||
94271648|NCT00470054|322787228|FG000|Overall Study|Ineligible|1|||
94653544|NCT01105533|324190349|FG002|Overall Study|Adverse Event|0|||
94653545|NCT01105533|324190350|FG003|Overall Study|Adverse Event|0|||
94653546|NCT01105533|324190351|FG004|Overall Study|Adverse Event|1|||
94653547|NCT01105533|324190352|FG005|Overall Study|Adverse Event|2|||
94653548|NCT01105533|324190353|FG006|Overall Study|Adverse Event|2|||
94653549|NCT01105533|324190354|FG007|Overall Study|Adverse Event|0|||
94653550|NCT01105533|324190355|FG008|Overall Study|Adverse Event|1|||
94653551|NCT01105533|324190347|FG000|Overall Study|Other|0|||
94653552|NCT01105533|324190348|FG001|Overall Study|Other|0|||
94653553|NCT01105533|324190349|FG002|Overall Study|Other|0|||
94653554|NCT01105533|324190350|FG003|Overall Study|Other|0|||
94653555|NCT01105533|324190351|FG004|Overall Study|Other|1|||
94653556|NCT01105533|324190352|FG005|Overall Study|Other|0|||
94653557|NCT01105533|324190353|FG006|Overall Study|Other|3|||
94653558|NCT01105533|324190354|FG007|Overall Study|Other|1|||
94653559|NCT01105533|324190355|FG008|Overall Study|Other|2|||
94271649|NCT02269787|322787229|FG000|Overall Study|Lost to Follow-up|20|||
94653560|NCT01105533|324190347|FG000|Overall Study|Physician Decision|0|||
94653561|NCT01105533|324190348|FG001|Overall Study|Physician Decision|0|||
94653562|NCT01105533|324190349|FG002|Overall Study|Physician Decision|0|||
94653563|NCT01105533|324190350|FG003|Overall Study|Physician Decision|0|||
94717407|NCT03283371|324423415|FG002|Open-label Phase|Other|1|||
94717408|NCT03283371|324423416|FG003|Open-label Phase|Other|1|||
94653564|NCT01105533|324190351|FG004|Overall Study|Physician Decision|0|||
94653565|NCT01105533|324190352|FG005|Overall Study|Physician Decision|0|||
94653566|NCT01105533|324190353|FG006|Overall Study|Physician Decision|0|||
94653567|NCT01105533|324190354|FG007|Overall Study|Physician Decision|1|||
94653568|NCT01105533|324190355|FG008|Overall Study|Physician Decision|0|||
94653569|NCT02096835|324190357|FG000|Overall Study|Withdrawal by Subject|1|||
94653570|NCT02096835|324190358|FG001|Overall Study|Withdrawal by Subject|0|||
94653571|NCT02096835|324190359|FG002|Overall Study|Withdrawal by Subject|0|||
94653572|NCT02096835|324190357|FG000|Overall Study|converted to open procedures|1|||
94653573|NCT02096835|324190358|FG001|Overall Study|converted to open procedures|0|||
94653574|NCT02096835|324190359|FG002|Overall Study|converted to open procedures|0|||
94653575|NCT02096835|324190357|FG000|Overall Study|Lost to Follow-up|1|||
94653576|NCT02096835|324190358|FG001|Overall Study|Lost to Follow-up|0|||
94653577|NCT02096835|324190359|FG002|Overall Study|Lost to Follow-up|1|||
94653578|NCT01677195|324190360|FG000|Overall Study|Lost to Follow-up|14|||
94653579|NCT01677195|324190361|FG001|Overall Study|Lost to Follow-up|22|||
94653580|NCT01677195|324190362|FG002|Overall Study|Lost to Follow-up|22|||
94653581|NCT01677195|324190360|FG000|Overall Study|Withdrawal by Subject|1|||
94653582|NCT01677195|324190361|FG001|Overall Study|Withdrawal by Subject|0|||
94653583|NCT01677195|324190362|FG002|Overall Study|Withdrawal by Subject|1|||
94653584|NCT01677195|324190360|FG000|Overall Study|Adverse Event|6|||
94653585|NCT01677195|324190361|FG001|Overall Study|Adverse Event|4|||
94653586|NCT01677195|324190362|FG002|Overall Study|Adverse Event|1|||
94653587|NCT01677195|324190360|FG000|Overall Study|Physician Decision|1|||
94653588|NCT01677195|324190361|FG001|Overall Study|Physician Decision|2|||
94653589|NCT01677195|324190362|FG002|Overall Study|Physician Decision|2|||
94653590|NCT01677195|324190360|FG000|Overall Study|Pregnancy|0|||
94653591|NCT01677195|324190361|FG001|Overall Study|Pregnancy|1|||
94653592|NCT01677195|324190362|FG002|Overall Study|Pregnancy|0|||
94653593|NCT01677195|324190360|FG000|Overall Study|Protocol Violation|7|||
94653594|NCT01677195|324190361|FG001|Overall Study|Protocol Violation|3|||
94653595|NCT01677195|324190362|FG002|Overall Study|Protocol Violation|4|||
94653596|NCT03455855|324190363|FG000|Overall Study|Lost to Follow-up|4|||
94653597|NCT03455855|324190364|FG001|Overall Study|Lost to Follow-up|2|||
94653598|NCT01257204|324190367|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
94653599|NCT01257204|324190368|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
94653600|NCT01257204|324190369|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
94653601|NCT01257204|324190367|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
94653602|NCT01257204|324190368|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
94717409|NCT04110054|324423417|FG000|Overall Study|COVID-19 reason other than AE|0|||
94717410|NCT04110054|324423418|FG001|Overall Study|COVID-19 reason other than AE|0|||
94717411|NCT04110054|324423419|FG002|Overall Study|COVID-19 reason other than AE|2|||
94717412|NCT04110054|324423420|FG003|Overall Study|COVID-19 reason other than AE|0|||
94717413|NCT04110054|324423417|FG000|Overall Study|Withdrawal by Subject|0|||
94717414|NCT04110054|324423418|FG001|Overall Study|Withdrawal by Subject|3|||
94271650|NCT02269787|322787230|FG001|Overall Study|Lost to Follow-up|6|||
94271651|NCT02269787|322787229|FG000|Overall Study|Death|2|||
94271652|NCT02269787|322787230|FG001|Overall Study|Death|3|||
94271653|NCT02269787|322787229|FG000|Overall Study|Incapacitated|0|||
94271654|NCT02269787|322787230|FG001|Overall Study|Incapacitated|1|||
94271655|NCT04202679|322787232|FG000|Overall Study|Adverse Event|2|||
94271656|NCT04202679|322787233|FG001|Overall Study|Adverse Event|0|||
94271657|NCT04202679|322787232|FG000|Overall Study|Poor compliance to protocol|1|||
94271658|NCT04202679|322787233|FG001|Overall Study|Poor compliance to protocol|0|||
94271659|NCT04202679|322787232|FG000|Overall Study|Withdrawal by Subject|23|||
94271660|NCT04202679|322787233|FG001|Overall Study|Withdrawal by Subject|6|||
94467289|NCT01897571|323500496|FG000|Overall Study|Other|1|||
94653603|NCT01257204|324190369|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
94653604|NCT01257204|324190367|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
94653605|NCT01257204|324190368|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
94653606|NCT01257204|324190369|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
94653607|NCT01257204|324190367|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
94653608|NCT01257204|324190368|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
94653609|NCT01257204|324190369|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
94653610|NCT01257204|324190367|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
94653611|NCT01257204|324190368|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
94653612|NCT01257204|324190369|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
94653613|NCT01257204|324190367|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
94653614|NCT01257204|324190368|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
94653615|NCT01257204|324190369|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
94717415|NCT04110054|324423419|FG002|Overall Study|Withdrawal by Subject|2|||
94717416|NCT04110054|324423420|FG003|Overall Study|Withdrawal by Subject|0|||
94271661|NCT00687440|322787236|FG000|Overall Study|Adverse Event|3|||
94653616|NCT01257204|324190367|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
94653617|NCT01257204|324190368|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
94653618|NCT01257204|324190369|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
94653619|NCT01257204|324190367|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
94653620|NCT01257204|324190368|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
94717417|NCT04110054|324423417|FG000|Overall Study|Adverse Event|1|||
94717418|NCT04110054|324423418|FG001|Overall Study|Adverse Event|1|||
94717419|NCT04110054|324423419|FG002|Overall Study|Adverse Event|4|||
94717420|NCT04110054|324423420|FG003|Overall Study|Adverse Event|3|||
94717421|NCT04600752|324423421|FG000|Overall Study|Physician Decision|0|||
94717422|NCT04600752|324423422|FG001|Overall Study|Physician Decision|0|||
94653621|NCT01257204|324190369|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
94653622|NCT01257204|324190367|FG000|Follow-up Period (up to Week 48)|Other|0|||
94653623|NCT01257204|324190368|FG001|Follow-up Period (up to Week 48)|Other|0|||
94653624|NCT01257204|324190369|FG002|Follow-up Period (up to Week 48)|Other|5|||
94653625|NCT00120042|324190374|FG000|Overall Study|all completed protocl|0|||
94653626|NCT00120042|324190375|FG001|Overall Study|all completed protocl|0|||
94653627|NCT00120042|324190376|FG002|Overall Study|all completed protocl|0|||
94653628|NCT02252081|324190377|FG000|Overall Study|Withdrawal by Subject|2|||
94653629|NCT02252081|324190378|FG001|Overall Study|Withdrawal by Subject|1|||
94653630|NCT02252081|324190377|FG000|Overall Study|Adverse Event|4|||
94653631|NCT02252081|324190378|FG001|Overall Study|Adverse Event|1|||
94653632|NCT02252081|324190377|FG000|Overall Study|non compliance & others|0|||
94653633|NCT02252081|324190378|FG001|Overall Study|non compliance & others|2|||
94653634|NCT01274637|324190381|FG000|Overall Study|Withdrawal by Subject|0|||
94653635|NCT01274637|324190382|FG001|Overall Study|Withdrawal by Subject|1|||
94653636|NCT01274637|324190381|FG000|Overall Study|Lost to Follow-up|0|||
94653637|NCT01274637|324190382|FG001|Overall Study|Lost to Follow-up|1|||
94653638|NCT01490060|324190383|FG000|Cycle 1|Change of Treatment|0|||
94653639|NCT01490060|324190384|FG001|Cycle 1|Change of Treatment|1|||
94653640|NCT01490060|324190385|FG002|Cycle 1|Change of Treatment|1|||
94653641|NCT01490060|324190386|FG003|Cycle 1|Change of Treatment|1|||
94653642|NCT01490060|324190383|FG000|Cycle 1|Insurance Denied|0|||
94653643|NCT01490060|324190384|FG001|Cycle 1|Insurance Denied|0|||
94653644|NCT01490060|324190385|FG002|Cycle 1|Insurance Denied|2|||
94653645|NCT01490060|324190386|FG003|Cycle 1|Insurance Denied|0|||
94653646|NCT01490060|324190383|FG000|Cycle 1|Withdrawal by Subject|0|||
94653647|NCT01490060|324190384|FG001|Cycle 1|Withdrawal by Subject|0|||
94653648|NCT01490060|324190385|FG002|Cycle 1|Withdrawal by Subject|0|||
94653649|NCT01490060|324190386|FG003|Cycle 1|Withdrawal by Subject|1|||
94653650|NCT01490060|324190383|FG000|Cycle 1|Treatment at Another Facility|0|||
94653651|NCT01490060|324190384|FG001|Cycle 1|Treatment at Another Facility|0|||
94653652|NCT01490060|324190385|FG002|Cycle 1|Treatment at Another Facility|0|||
94653653|NCT01490060|324190386|FG003|Cycle 1|Treatment at Another Facility|1|||
94653654|NCT01490060|324190383|FG000|Cycle 2|Change of Treatment|1|||
94653655|NCT01490060|324190384|FG001|Cycle 2|Change of Treatment|1|||
94653656|NCT01490060|324190385|FG002|Cycle 2|Change of Treatment|0|||
94653657|NCT01490060|324190386|FG003|Cycle 2|Change of Treatment|0|||
94653658|NCT01490060|324190383|FG000|Cycle 2|Non-Compliance|0|||
94653659|NCT01490060|324190384|FG001|Cycle 2|Non-Compliance|0|||
94653660|NCT01490060|324190385|FG002|Cycle 2|Non-Compliance|1|||
94653661|NCT01490060|324190386|FG003|Cycle 2|Non-Compliance|0|||
94717423|NCT04600752|324423423|FG002|Overall Study|Physician Decision|1|||
94717424|NCT04600752|324423421|FG000|Overall Study|Adverse Event|0|||
94653662|NCT01490060|324190383|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
94653663|NCT01490060|324190384|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
94653664|NCT01490060|324190385|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
94653665|NCT01490060|324190386|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
94653666|NCT04304001|324190387|FG000|Overall Study|Lost to Follow-up|13|||
94653667|NCT04304001|324190388|FG001|Overall Study|Lost to Follow-up|9|||
94653668|NCT00908960|324190392|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
94653669|NCT00908960|324190393|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
94653670|NCT00908960|324190394|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
94653671|NCT03235024|324190395|FG000|Overall Study|Adverse Event|2|||
94653672|NCT03235024|324190396|FG001|Overall Study|Adverse Event|2|||
94653673|NCT03235024|324190395|FG000|Overall Study|Death|1|||
94653674|NCT03235024|324190396|FG001|Overall Study|Death|0|||
94653675|NCT03235024|324190395|FG000|Overall Study|Lost to Follow-up|2|||
94653676|NCT03235024|324190396|FG001|Overall Study|Lost to Follow-up|5|||
94653677|NCT03235024|324190395|FG000|Overall Study|Protocol Violation|1|||
94653678|NCT03235024|324190396|FG001|Overall Study|Protocol Violation|0|||
94653679|NCT03235024|324190395|FG000|Overall Study|Withdrawal by Subject|0|||
94717425|NCT04600752|324423422|FG001|Overall Study|Adverse Event|1|||
94717426|NCT04600752|324423423|FG002|Overall Study|Adverse Event|0|||
94717427|NCT04600752|324423421|FG000|Overall Study|Withdrawal by Subject|2|||
94717428|NCT04600752|324423422|FG001|Overall Study|Withdrawal by Subject|1|||
94717429|NCT04600752|324423423|FG002|Overall Study|Withdrawal by Subject|0|||
94717430|NCT04600752|324423421|FG000|Overall Study|Lack of Efficacy|1|||
94367796|NCT03496207|323133037|FG000|Extension Period|Withdrawal by Subject|1|||
94367797|NCT03496207|323133038|FG001|Extension Period|Withdrawal by Subject|0|||
94367798|NCT03496207|323133039|FG002|Extension Period|Withdrawal by Subject|0|||
94367799|NCT03496207|323133040|FG003|Extension Period|Withdrawal by Subject|1|||
94367800|NCT03496207|323133041|FG004|Extension Period|Withdrawal by Subject|1|||
94653680|NCT03235024|324190396|FG001|Overall Study|Withdrawal by Subject|3|||
94653681|NCT01599650|324190398|FG000|Overall Study|Administrative issue|1|||
94653682|NCT01599650|324190399|FG001|Overall Study|Administrative issue|0|||
94653683|NCT01599650|324190400|FG002|Overall Study|Administrative issue|1|||
94653684|NCT01599650|324190398|FG000|Overall Study|Physician Decision|2|||
94653685|NCT01599650|324190399|FG001|Overall Study|Physician Decision|0|||
94653686|NCT01599650|324190400|FG002|Overall Study|Physician Decision|7|||
94653687|NCT01599650|324190398|FG000|Overall Study|Protocol Violation|0|||
94653688|NCT01599650|324190399|FG001|Overall Study|Protocol Violation|3|||
94653689|NCT01599650|324190400|FG002|Overall Study|Protocol Violation|0|||
94653690|NCT01599650|324190398|FG000|Overall Study|Death|2|||
94653691|NCT01599650|324190399|FG001|Overall Study|Death|1|||
94653692|NCT01599650|324190400|FG002|Overall Study|Death|2|||
94653693|NCT01599650|324190398|FG000|Overall Study|Lost to Follow-up|3|||
94653694|NCT01599650|324190399|FG001|Overall Study|Lost to Follow-up|3|||
94653695|NCT01599650|324190400|FG002|Overall Study|Lost to Follow-up|3|||
94653696|NCT01599650|324190398|FG000|Overall Study|Withdrawal by Subject|11|||
94653697|NCT01599650|324190399|FG001|Overall Study|Withdrawal by Subject|11|||
94653698|NCT01599650|324190400|FG002|Overall Study|Withdrawal by Subject|10|||
94653699|NCT01599650|324190398|FG000|Overall Study|Adverse Event|3|||
94653700|NCT01599650|324190399|FG001|Overall Study|Adverse Event|8|||
94653701|NCT01599650|324190400|FG002|Overall Study|Adverse Event|4|||
94653702|NCT04632940|324190401|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
94653703|NCT04632940|324190402|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
94653704|NCT04632940|324190401|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
94653705|NCT04632940|324190402|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
94653706|NCT04632940|324190401|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
94653707|NCT04632940|324190402|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
94653708|NCT04632940|324190401|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
94653709|NCT04632940|324190402|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
94653710|NCT04632940|324190401|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
94653711|NCT04632940|324190402|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
94653712|NCT04632940|324190401|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
94653713|NCT04632940|324190402|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
94653714|NCT04632940|324190401|FG000|OLE Period (52 Weeks)|Other than specified|0|||
94653715|NCT04632940|324190402|FG001|OLE Period (52 Weeks)|Other than specified|1|||
94653716|NCT04632940|324190401|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
94653717|NCT04632940|324190402|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
94653718|NCT03251924|324190414|FG000|Overall Study|Disease Progression|6|||
94653719|NCT03251924|324190415|FG001|Overall Study|Disease Progression|6|||
94653720|NCT03251924|324190416|FG002|Overall Study|Disease Progression|7|||
94653721|NCT03251924|324190417|FG003|Overall Study|Disease Progression|8|||
94653722|NCT03251924|324190418|FG004|Overall Study|Disease Progression|8|||
94653723|NCT03251924|324190419|FG005|Overall Study|Disease Progression|7|||
94653724|NCT03251924|324190420|FG006|Overall Study|Disease Progression|6|||
94653725|NCT03251924|324190421|FG007|Overall Study|Disease Progression|10|||
94653726|NCT03251924|324190422|FG008|Overall Study|Disease Progression|6|||
94653727|NCT03251924|324190414|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
94653728|NCT03251924|324190415|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
94653729|NCT03251924|324190416|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
94653730|NCT03251924|324190417|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
94653731|NCT03251924|324190418|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
94653732|NCT03251924|324190419|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
94653733|NCT03251924|324190420|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
94653734|NCT03251924|324190421|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
94653735|NCT03251924|324190422|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
94653736|NCT03251924|324190414|FG000|Overall Study|Death|0|||
94653737|NCT03251924|324190415|FG001|Overall Study|Death|1|||
94653738|NCT03251924|324190416|FG002|Overall Study|Death|0|||
94653739|NCT03251924|324190417|FG003|Overall Study|Death|1|||
94653740|NCT03251924|324190418|FG004|Overall Study|Death|1|||
94367801|NCT03496207|323133037|FG000|Extension Period|Elevated hemoglobin levels|0|||
94653741|NCT03251924|324190419|FG005|Overall Study|Death|1|||
94653742|NCT03251924|324190420|FG006|Overall Study|Death|0|||
94653743|NCT03251924|324190421|FG007|Overall Study|Death|0|||
94653744|NCT03251924|324190422|FG008|Overall Study|Death|0|||
94653745|NCT03251924|324190414|FG000|Overall Study|Study Drug Toxicity|0|||
94653746|NCT03251924|324190415|FG001|Overall Study|Study Drug Toxicity|0|||
94653747|NCT03251924|324190416|FG002|Overall Study|Study Drug Toxicity|0|||
94653748|NCT03251924|324190417|FG003|Overall Study|Study Drug Toxicity|1|||
94653749|NCT03251924|324190418|FG004|Overall Study|Study Drug Toxicity|0|||
94653750|NCT03251924|324190419|FG005|Overall Study|Study Drug Toxicity|0|||
94653751|NCT03251924|324190420|FG006|Overall Study|Study Drug Toxicity|0|||
94653752|NCT03251924|324190421|FG007|Overall Study|Study Drug Toxicity|0|||
94653753|NCT03251924|324190422|FG008|Overall Study|Study Drug Toxicity|1|||
94653754|NCT03251924|324190414|FG000|Overall Study|Other Reasons|0|||
94653755|NCT03251924|324190415|FG001|Overall Study|Other Reasons|0|||
94653756|NCT03251924|324190416|FG002|Overall Study|Other Reasons|0|||
94653757|NCT03251924|324190417|FG003|Overall Study|Other Reasons|0|||
94653758|NCT03251924|324190418|FG004|Overall Study|Other Reasons|0|||
94653759|NCT03251924|324190419|FG005|Overall Study|Other Reasons|0|||
94653760|NCT03251924|324190420|FG006|Overall Study|Other Reasons|0|||
94653761|NCT03251924|324190421|FG007|Overall Study|Other Reasons|0|||
94653762|NCT03251924|324190422|FG008|Overall Study|Other Reasons|1|||
94653763|NCT03251924|324190414|FG000|Overall Study|Participant request to discontinue study treatment|0|||
94653764|NCT03251924|324190415|FG001|Overall Study|Participant request to discontinue study treatment|0|||
94653765|NCT03251924|324190416|FG002|Overall Study|Participant request to discontinue study treatment|0|||
94653766|NCT03251924|324190417|FG003|Overall Study|Participant request to discontinue study treatment|0|||
94653767|NCT03251924|324190418|FG004|Overall Study|Participant request to discontinue study treatment|0|||
94653768|NCT03251924|324190419|FG005|Overall Study|Participant request to discontinue study treatment|0|||
94653769|NCT03251924|324190420|FG006|Overall Study|Participant request to discontinue study treatment|0|||
94653770|NCT03251924|324190421|FG007|Overall Study|Participant request to discontinue study treatment|1|||
94653771|NCT03251924|324190422|FG008|Overall Study|Participant request to discontinue study treatment|0|||
94653772|NCT02486406|324190423|FG000|Overall Study|Withdrew consent|1|||
94653773|NCT02486406|324190424|FG001|Overall Study|Withdrew consent|0|||
94653774|NCT02486406|324190425|FG002|Overall Study|Withdrew consent|0|||
94653775|NCT02486406|324190426|FG003|Overall Study|Withdrew consent|1|||
94653776|NCT02486406|324190423|FG000|Overall Study|Lost to Follow-up|1|||
94653777|NCT02486406|324190424|FG001|Overall Study|Lost to Follow-up|3|||
94653778|NCT02486406|324190425|FG002|Overall Study|Lost to Follow-up|1|||
94653779|NCT02486406|324190426|FG003|Overall Study|Lost to Follow-up|3|||
94653780|NCT02486406|324190423|FG000|Overall Study|Other, not specified|0|||
94653781|NCT02486406|324190424|FG001|Overall Study|Other, not specified|0|||
94653782|NCT02486406|324190425|FG002|Overall Study|Other, not specified|1|||
94653783|NCT02486406|324190426|FG003|Overall Study|Other, not specified|0|||
94653784|NCT03509948|324190430|FG000|Overall Study|Protocol Violation|0|||
94653785|NCT03509948|324190431|FG001|Overall Study|Protocol Violation|1|||
94653786|NCT03221257|324190432|FG000|Overall Study|Lost to Follow-up|0|||
94653787|NCT03221257|324190433|FG001|Overall Study|Lost to Follow-up|1|||
94653788|NCT03221257|324190432|FG000|Overall Study|Withdrawal by Subject|1|||
94653789|NCT03221257|324190433|FG001|Overall Study|Withdrawal by Subject|1|||
94653790|NCT00799617|324190440|FG000|Main Testosterone Trial|Randomized in error|1|||
94653791|NCT00799617|324190441|FG001|Main Testosterone Trial|Randomized in error|1|||
94653792|NCT00799617|324190440|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
94653793|NCT00799617|324190441|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
94653794|NCT00799617|324190440|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
94653795|NCT00799617|324190441|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
94653796|NCT00799617|324190440|FG000|Sexual Funtion Trial|No Baseline Data|4|||
94653797|NCT00799617|324190441|FG001|Sexual Funtion Trial|No Baseline Data|7|||
94653798|NCT00799617|324190440|FG000|Physical Function Trial|Lost to Follow-up|6|||
94653799|NCT00799617|324190441|FG001|Physical Function Trial|Lost to Follow-up|11|||
94653800|NCT00799617|324190440|FG000|Vitality Trial|Lost to Follow-up|7|||
94653801|NCT00799617|324190441|FG001|Vitality Trial|Lost to Follow-up|22|||
94653802|NCT00799617|324190440|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
94653803|NCT00799617|324190441|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
94653804|NCT00799617|324190440|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
94653805|NCT00799617|324190441|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
94653806|NCT00799617|324190440|FG000|Bone Trial|Month 12 scan not available|6|||
94653807|NCT00799617|324190441|FG001|Bone Trial|Month 12 scan not available|16|||
94653808|NCT00799617|324190440|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
94653809|NCT00799617|324190441|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
94653810|NCT00799617|324190440|FG000|Anemia Trial|Withdrawal by Subject|3|||
94653811|NCT00799617|324190441|FG001|Anemia Trial|Withdrawal by Subject|3|||
94653812|NCT01712984|324190445|FG000|Overall Study|Adverse Event|0|||
94653813|NCT01712984|324190446|FG001|Overall Study|Adverse Event|0|||
94653814|NCT01712984|324190447|FG002|Overall Study|Adverse Event|1|||
94653815|NCT01712984|324190445|FG000|Overall Study|Protocol Violation|2|||
94653816|NCT01712984|324190446|FG001|Overall Study|Protocol Violation|0|||
94653817|NCT01712984|324190447|FG002|Overall Study|Protocol Violation|1|||
94653818|NCT01712984|324190445|FG000|Overall Study|Lost to Follow-up|8|||
94653819|NCT01712984|324190446|FG001|Overall Study|Lost to Follow-up|10|||
94653820|NCT01712984|324190447|FG002|Overall Study|Lost to Follow-up|1|||
94653821|NCT01712984|324190445|FG000|Overall Study|Withdrawal by Subject|6|||
94653822|NCT01712984|324190446|FG001|Overall Study|Withdrawal by Subject|6|||
94653823|NCT01712984|324190447|FG002|Overall Study|Withdrawal by Subject|7|||
94653824|NCT01652716|324190448|FG000|Overall Study|Loss of glucose control|1|||
94653825|NCT01652716|324190449|FG001|Overall Study|Loss of glucose control|0|||
94271662|NCT00687440|322787236|FG000|Overall Study|Lost to Follow-up|3|||
94271663|NCT00687440|322787236|FG000|Overall Study|Lack of Efficacy|2|||
94271664|NCT00687440|322787236|FG000|Overall Study|Death|2|||
94271665|NCT00687440|322787236|FG000|Overall Study|Other|1|||
94271666|NCT00687440|322787236|FG000|Overall Study|Missing|1|||
94271667|NCT02228720|322787237|FG000|Open Label - Day 30|Lost to Follow-up|1|||
94271668|NCT02663453|322787241|FG000|Overall Study|Death|4|||
94271669|NCT02663453|322787242|FG001|Overall Study|Death|4|||
94271670|NCT02663453|322787241|FG000|Overall Study|Withdrawal by Subject|1|||
94271671|NCT02663453|322787242|FG001|Overall Study|Withdrawal by Subject|0|||
94271672|NCT04050670|322788500|FG000|Period 3|Physician Decision|0|||
94271673|NCT04050670|322788501|FG001|Period 3|Physician Decision|1|||
94271674|NCT04050670|322788502|FG002|Period 3|Physician Decision|0|||
94271675|NCT00525044|322788503|FG000|Overall Study|Lost to Follow-up|0|||
94271676|NCT00525044|322788504|FG001|Overall Study|Lost to Follow-up|1|||
94271677|NCT04183790|322788505|FG000|Overall Study|Participants did not rollover to Part B|12|||
94271678|NCT04183790|322788506|FG001|Overall Study|Participants did not rollover to Part B|0|||
94271679|NCT04183790|322788505|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
94271680|NCT04183790|322788506|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
94271681|NCT04183790|322788505|FG000|Overall Study|Commercial drug is available for participant|6|||
94271682|NCT04183790|322788506|FG001|Overall Study|Commercial drug is available for participant|0|||
94271683|NCT04183790|322788505|FG000|Overall Study|Adverse Event|1|||
94271684|NCT04183790|322788506|FG001|Overall Study|Adverse Event|0|||
94271685|NCT04183790|322788505|FG000|Overall Study|Not enrolled in 107 study|0|||
94271686|NCT04183790|322788506|FG001|Overall Study|Not enrolled in 107 study|2|||
94271687|NCT01251653|322788507|FG000|Overall Study|Progressive Disease|1|||
94271688|NCT01251653|322788508|FG001|Overall Study|Progressive Disease|7|||
94271689|NCT01251653|322788509|FG002|Overall Study|Progressive Disease|16|||
94271690|NCT01251653|322788510|FG003|Overall Study|Progressive Disease|4|||
94271691|NCT01251653|322788511|FG004|Overall Study|Progressive Disease|0|||
94271692|NCT01251653|322788512|FG005|Overall Study|Progressive Disease|17|||
94271693|NCT01251653|322788513|FG006|Overall Study|Progressive Disease|14|||
94271694|NCT01251653|322788514|FG007|Overall Study|Progressive Disease|7|||
94271695|NCT01251653|322788515|FG008|Overall Study|Progressive Disease|5|||
94271696|NCT01251653|322788507|FG000|Overall Study|Dose-limiting toxicity|0|||
94271697|NCT01251653|322788508|FG001|Overall Study|Dose-limiting toxicity|1|||
94271698|NCT01251653|322788509|FG002|Overall Study|Dose-limiting toxicity|1|||
94271699|NCT01251653|322788510|FG003|Overall Study|Dose-limiting toxicity|1|||
94271700|NCT01251653|322788511|FG004|Overall Study|Dose-limiting toxicity|0|||
94271701|NCT01251653|322788512|FG005|Overall Study|Dose-limiting toxicity|0|||
94271702|NCT01251653|322788513|FG006|Overall Study|Dose-limiting toxicity|2|||
94271703|NCT01251653|322788514|FG007|Overall Study|Dose-limiting toxicity|0|||
94271704|NCT01251653|322788515|FG008|Overall Study|Dose-limiting toxicity|0|||
94271705|NCT01251653|322788507|FG000|Overall Study|Adverse Event|1|||
94271706|NCT01251653|322788508|FG001|Overall Study|Adverse Event|0|||
94271707|NCT01251653|322788509|FG002|Overall Study|Adverse Event|2|||
94271708|NCT01251653|322788510|FG003|Overall Study|Adverse Event|1|||
94271709|NCT01251653|322788511|FG004|Overall Study|Adverse Event|1|||
94271710|NCT01251653|322788512|FG005|Overall Study|Adverse Event|0|||
94271711|NCT01251653|322788513|FG006|Overall Study|Adverse Event|2|||
94271712|NCT01251653|322788514|FG007|Overall Study|Adverse Event|2|||
94271713|NCT01251653|322788515|FG008|Overall Study|Adverse Event|1|||
94271714|NCT01251653|322788507|FG000|Overall Study|Withdrawal by Subject|1|||
94271715|NCT01251653|322788508|FG001|Overall Study|Withdrawal by Subject|0|||
94271716|NCT01251653|322788509|FG002|Overall Study|Withdrawal by Subject|1|||
94271717|NCT01251653|322788510|FG003|Overall Study|Withdrawal by Subject|0|||
94271718|NCT01251653|322788511|FG004|Overall Study|Withdrawal by Subject|1|||
94271719|NCT01251653|322788512|FG005|Overall Study|Withdrawal by Subject|1|||
94271720|NCT01251653|322788513|FG006|Overall Study|Withdrawal by Subject|0|||
94271721|NCT01251653|322788514|FG007|Overall Study|Withdrawal by Subject|1|||
94271722|NCT01251653|322788515|FG008|Overall Study|Withdrawal by Subject|0|||
94271723|NCT01251653|322788507|FG000|Overall Study|Other reason not mentioned above|0|||
94271724|NCT01251653|322788508|FG001|Overall Study|Other reason not mentioned above|0|||
94271725|NCT01251653|322788509|FG002|Overall Study|Other reason not mentioned above|0|||
94271726|NCT01251653|322788510|FG003|Overall Study|Other reason not mentioned above|0|||
94271727|NCT01251653|322788511|FG004|Overall Study|Other reason not mentioned above|0|||
94271728|NCT01251653|322788512|FG005|Overall Study|Other reason not mentioned above|0|||
94271729|NCT01251653|322788513|FG006|Overall Study|Other reason not mentioned above|0|||
94271730|NCT01251653|322788514|FG007|Overall Study|Other reason not mentioned above|2|||
94271731|NCT01251653|322788515|FG008|Overall Study|Other reason not mentioned above|0|||
94271732|NCT02807480|322788516|FG000|Overall Study|Withdrawal by Subject|14|||
94271733|NCT02807480|322788517|FG001|Overall Study|Withdrawal by Subject|10|||
94271734|NCT02369848|322788518|FG000|Overall Study|Death|1|||
94717431|NCT04600752|324423422|FG001|Overall Study|Lack of Efficacy|0|||
94271735|NCT02369848|322788518|FG000|Overall Study|Withdrawal by Subject|2|||
94271736|NCT02369848|322788518|FG000|Overall Study|Lost to Follow-up|1|||
94271737|NCT01756040|322788519|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
94271738|NCT01756040|322788519|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
94271739|NCT01756040|322788519|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
94271740|NCT00909181|322788526|FG000|Overall Study|Lost to Follow-up|39|||
94271741|NCT00909181|322788527|FG001|Overall Study|Lost to Follow-up|18|||
94271742|NCT00909181|322788528|FG002|Overall Study|Lost to Follow-up|33|||
94271743|NCT02138617|322788529|FG000|Overall Study|Death|1|||
94271744|NCT02138617|322788530|FG001|Overall Study|Death|2|||
94271745|NCT02138617|322788531|FG002|Overall Study|Death|2|||
94271746|NCT02138617|322788529|FG000|Overall Study|Adverse Event|8|||
94367802|NCT03496207|323133038|FG001|Extension Period|Elevated hemoglobin levels|0|||
94367803|NCT03496207|323133039|FG002|Extension Period|Elevated hemoglobin levels|0|||
94367804|NCT03496207|323133040|FG003|Extension Period|Elevated hemoglobin levels|0|||
94367805|NCT03496207|323133041|FG004|Extension Period|Elevated hemoglobin levels|1|||
94367806|NCT01169987|323133042|FG000|Overall Study|Withdrawal by Subject|3|||
94367807|NCT01169987|323133042|FG000|Overall Study|Lost to Follow-up|24|||
94367808|NCT01169987|323133042|FG000|Overall Study|Other|4|||
94367809|NCT00943384|323133043|FG000|Overall Study|Dispositioned prior to treatment|23|||
94367810|NCT00943384|323133043|FG000|Overall Study|Treated off protocol-protocol violation|5|||
94367811|NCT00943384|323133043|FG000|Overall Study|Lost to Follow-up|16|||
94367812|NCT00943384|323133043|FG000|Overall Study|Withdrawal by Subject|5|||
94367813|NCT01155284|323133044|FG000|Overall Study|Withdrawal by Subject|4|||
94367814|NCT01155284|323133045|FG001|Overall Study|Withdrawal by Subject|3|||
94367815|NCT01155284|323133044|FG000|Overall Study|Lost to Follow-up|1|||
94367816|NCT01155284|323133045|FG001|Overall Study|Lost to Follow-up|2|||
94367817|NCT01155284|323133044|FG000|Overall Study|Physician Decision|1|||
94367818|NCT01155284|323133045|FG001|Overall Study|Physician Decision|0|||
94367819|NCT01155284|323133044|FG000|Overall Study|Adverse Event|1|||
94367820|NCT01155284|323133045|FG001|Overall Study|Adverse Event|0|||
94367821|NCT00051636|323133046|FG000|Period 1 - Core|Adverse Event|2|||
94367822|NCT00051636|323133047|FG001|Period 1 - Core|Adverse Event|2|||
94367823|NCT00051636|323133046|FG000|Period 1 - Core|Protocol Violation|1|||
94367824|NCT00051636|323133047|FG001|Period 1 - Core|Protocol Violation|0|||
94367825|NCT00051636|323133046|FG000|Period 1 - Core|Withdrawal by Subject|1|||
94367826|NCT00051636|323133047|FG001|Period 1 - Core|Withdrawal by Subject|2|||
94367827|NCT00051636|323133046|FG000|Period 1 - Core|Lost to Follow-up|0|||
94367828|NCT00051636|323133047|FG001|Period 1 - Core|Lost to Follow-up|2|||
94367829|NCT00051636|323133046|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
94367830|NCT00051636|323133047|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
94367831|NCT00051636|323133046|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
94367832|NCT00051636|323133047|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
94367833|NCT00051636|323133046|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
94367834|NCT00051636|323133047|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
94367835|NCT00051636|323133046|FG000|Period 2- Extended Observation Period|Death|4|||
94367836|NCT00051636|323133047|FG001|Period 2- Extended Observation Period|Death|5|||
94367837|NCT00051636|323133046|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
94367838|NCT00051636|323133047|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
94367839|NCT00975884|323133048|FG000|Overall Study|Adverse Event|1|||
94367840|NCT00975884|323133049|FG001|Overall Study|Adverse Event|0|||
94367841|NCT00975884|323133048|FG000|Overall Study|Lost to Follow-up|5|||
94367842|NCT00975884|323133049|FG001|Overall Study|Lost to Follow-up|3|||
94367843|NCT00975884|323133048|FG000|Overall Study|Withdrawal by Subject|9|||
94367844|NCT00975884|323133049|FG001|Overall Study|Withdrawal by Subject|9|||
94367845|NCT00975884|323133048|FG000|Overall Study|Other|1|||
94367846|NCT00975884|323133049|FG001|Overall Study|Other|3|||
94367847|NCT04969263|323133052|FG000|Overall Study|Death|1|||
94367848|NCT04969263|323133052|FG000|Overall Study|Lost to Follow-up|2|||
94367849|NCT04969263|323133052|FG000|Overall Study|Withdrawal by Subject|5|||
94367850|NCT04969263|323133052|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
94367851|NCT02176642|323133053|FG000|Overall Study|Withdrawal by Subject|0|||
94367852|NCT02176642|323133054|FG001|Overall Study|Withdrawal by Subject|1|||
94653826|NCT01652716|324190448|FG000|Overall Study|Administrative|0|||
94653827|NCT01652716|324190449|FG001|Overall Study|Administrative|2|||
94653828|NCT01652716|324190448|FG000|Overall Study|Investigator decision|1|||
94653829|NCT01652716|324190449|FG001|Overall Study|Investigator decision|4|||
94653830|NCT01652716|324190448|FG000|Overall Study|Lost to Follow-up|12|||
94653831|NCT01652716|324190449|FG001|Overall Study|Lost to Follow-up|11|||
94653832|NCT01652716|324190448|FG000|Overall Study|Protocol Violation|2|||
94653833|NCT01652716|324190449|FG001|Overall Study|Protocol Violation|1|||
94653834|NCT01652716|324190448|FG000|Overall Study|Adverse Event|7|||
94653835|NCT01652716|324190449|FG001|Overall Study|Adverse Event|10|||
94653836|NCT01652716|324190448|FG000|Overall Study|Withdrawal by Subject|33|||
94653837|NCT01652716|324190449|FG001|Overall Study|Withdrawal by Subject|18|||
94653838|NCT01337297|324190454|FG000|Overall Study|They entered to single anodal tDCS|4|||
94653839|NCT01337297|324190455|FG001|Overall Study|They entered to single anodal tDCS|3|||
94653840|NCT01337297|324190454|FG000|Overall Study|Lost to Follow-up|1|||
94367853|NCT01999322|323133058|FG000|Overall Study|Adverse Event|1|||
94367854|NCT01999322|323133059|FG001|Overall Study|Adverse Event|0|||
94367855|NCT01185639|323133060|FG000|Overall Study|Progressed and didn't receive therapy|2|||
94367856|NCT00759759|323133061|FG000|Overall Study|didn't return for period 2|1|||
94653841|NCT01337297|324190455|FG001|Overall Study|Lost to Follow-up|3|||
94653842|NCT02316717|324190456|FG000|Overall Study|Adverse Event|2|||
94653843|NCT02316717|324190457|FG001|Overall Study|Adverse Event|2|||
94653844|NCT02316717|324190458|FG002|Overall Study|Adverse Event|0|||
94653845|NCT02316717|324190456|FG000|Overall Study|Lost to Follow-up|1|||
94653846|NCT02316717|324190457|FG001|Overall Study|Lost to Follow-up|2|||
94653847|NCT02316717|324190458|FG002|Overall Study|Lost to Follow-up|1|||
94653848|NCT02316717|324190456|FG000|Overall Study|Non compliance|3|||
94653849|NCT02316717|324190457|FG001|Overall Study|Non compliance|1|||
94653850|NCT02316717|324190458|FG002|Overall Study|Non compliance|0|||
94653851|NCT02316717|324190456|FG000|Overall Study|Protocol Violation|2|||
94653852|NCT02316717|324190457|FG001|Overall Study|Protocol Violation|0|||
94653853|NCT02316717|324190458|FG002|Overall Study|Protocol Violation|0|||
94653854|NCT02316717|324190456|FG000|Overall Study|Withdrawal by Subject|2|||
94653855|NCT02316717|324190457|FG001|Overall Study|Withdrawal by Subject|1|||
94653856|NCT02316717|324190458|FG002|Overall Study|Withdrawal by Subject|1|||
94653857|NCT02316717|324190456|FG000|Overall Study|Death|0|||
94653858|NCT02316717|324190457|FG001|Overall Study|Death|0|||
94653859|NCT02316717|324190458|FG002|Overall Study|Death|1|||
94653860|NCT02316717|324190456|FG000|Overall Study|Physician Decision|0|||
94653861|NCT02316717|324190457|FG001|Overall Study|Physician Decision|1|||
94653862|NCT02316717|324190458|FG002|Overall Study|Physician Decision|0|||
94653863|NCT02316717|324190456|FG000|Overall Study|TBC|1|||
94653864|NCT02316717|324190457|FG001|Overall Study|TBC|0|||
94653865|NCT02316717|324190458|FG002|Overall Study|TBC|0|||
94653866|NCT02442830|324190459|FG000|Overall Study|Technical Failure|0|||
94653867|NCT02442830|324190460|FG001|Overall Study|Technical Failure|1|||
94653868|NCT00298831|324190461|FG000|Overall Study|Adverse Event|1|||
94653869|NCT00298831|324190461|FG000|Overall Study|Lost to Follow-up|3|||
94653870|NCT00298831|324190461|FG000|Overall Study|Withdrawal by Subject|1|||
94653871|NCT00298831|324190461|FG000|Overall Study|Participants did not receive treatment|27|||
94653872|NCT04122443|324190462|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
94653873|NCT04122443|324190463|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
94653874|NCT04122443|324190464|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
94653875|NCT04122443|324190462|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
94653876|NCT04122443|324190463|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
94653877|NCT04122443|324190464|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
94653878|NCT01072201|324190465|FG000|Overall Study|Lost to Follow-up|0|||
94653879|NCT01072201|324190466|FG001|Overall Study|Lost to Follow-up|1|||
94653880|NCT00678561|324190467|FG000|Overall Study|Adverse Event|0|||
94653881|NCT00678561|324190468|FG001|Overall Study|Adverse Event|1|||
94653882|NCT00678561|324190469|FG002|Overall Study|Adverse Event|1|||
94653883|NCT00678561|324190470|FG003|Overall Study|Adverse Event|0|||
94653884|NCT00678561|324190471|FG004|Overall Study|Adverse Event|1|||
94653885|NCT00678561|324190472|FG005|Overall Study|Adverse Event|0|||
94653886|NCT00678561|324190473|FG006|Overall Study|Adverse Event|0|||
94653887|NCT00678561|324190474|FG007|Overall Study|Adverse Event|0|||
94653888|NCT00678561|324190467|FG000|Overall Study|Protocol Violation|0|||
94653889|NCT00678561|324190468|FG001|Overall Study|Protocol Violation|0|||
94653890|NCT00678561|324190469|FG002|Overall Study|Protocol Violation|0|||
94653891|NCT00678561|324190470|FG003|Overall Study|Protocol Violation|0|||
94653892|NCT00678561|324190471|FG004|Overall Study|Protocol Violation|1|||
94653893|NCT00678561|324190472|FG005|Overall Study|Protocol Violation|1|||
94653894|NCT00678561|324190473|FG006|Overall Study|Protocol Violation|0|||
94653895|NCT00678561|324190474|FG007|Overall Study|Protocol Violation|0|||
94653896|NCT00678561|324190467|FG000|Overall Study|Withdrawal by Subject|0|||
94653897|NCT00678561|324190468|FG001|Overall Study|Withdrawal by Subject|0|||
94653898|NCT00678561|324190469|FG002|Overall Study|Withdrawal by Subject|0|||
94653899|NCT00678561|324190470|FG003|Overall Study|Withdrawal by Subject|0|||
94653900|NCT00678561|324190471|FG004|Overall Study|Withdrawal by Subject|0|||
94653901|NCT00678561|324190472|FG005|Overall Study|Withdrawal by Subject|0|||
94653902|NCT00678561|324190473|FG006|Overall Study|Withdrawal by Subject|0|||
94653903|NCT00678561|324190474|FG007|Overall Study|Withdrawal by Subject|1|||
94653904|NCT00700011|324190475|FG000|Overall Study|Death|0|||
94653905|NCT00700011|324190476|FG001|Overall Study|Death|1|||
94653906|NCT00853658|324190479|FG000|Overall Study|Death|713|||
94653907|NCT00853658|324190480|FG001|Overall Study|Death|768|||
94653908|NCT00853658|324190481|FG002|Overall Study|Death|753|||
94653909|NCT00853658|324190479|FG000|Overall Study|Lost to Follow-up|11|||
94653910|NCT00853658|324190480|FG001|Overall Study|Lost to Follow-up|6|||
94653911|NCT00853658|324190481|FG002|Overall Study|Lost to Follow-up|11|||
94653912|NCT00853658|324190479|FG000|Overall Study|H.A. Request|26|||
94653913|NCT00853658|324190480|FG001|Overall Study|H.A. Request|23|||
94653914|NCT00853658|324190481|FG002|Overall Study|H.A. Request|19|||
94653915|NCT00853658|324190479|FG000|Overall Study|IRB request|0|||
94653916|NCT00853658|324190480|FG001|Overall Study|IRB request|0|||
94653917|NCT00853658|324190481|FG002|Overall Study|IRB request|2|||
94653918|NCT00853658|324190479|FG000|Overall Study|Vital Status known (alive) at study end|2|||
94653919|NCT00853658|324190480|FG001|Overall Study|Vital Status known (alive) at study end|3|||
94653920|NCT00853658|324190481|FG002|Overall Study|Vital Status known (alive) at study end|3|||
94653921|NCT00853658|324190479|FG000|Overall Study|Vital Status unknown at study end|1|||
94653922|NCT00853658|324190480|FG001|Overall Study|Vital Status unknown at study end|1|||
94653923|NCT00853658|324190481|FG002|Overall Study|Vital Status unknown at study end|0|||
94653924|NCT00853658|324190479|FG000|Overall Study|Vital Status at study end N/A|8|||
94653925|NCT00853658|324190480|FG001|Overall Study|Vital Status at study end N/A|10|||
94653926|NCT00853658|324190481|FG002|Overall Study|Vital Status at study end N/A|10|||
94653927|NCT00853658|324190479|FG000|Overall Study|Patient's request|21|||
94653928|NCT00853658|324190480|FG001|Overall Study|Patient's request|17|||
94653929|NCT00853658|324190481|FG002|Overall Study|Patient's request|11|||
94653930|NCT00853658|324190479|FG000|Overall Study|Missing study completion information|5|||
94653931|NCT00853658|324190480|FG001|Overall Study|Missing study completion information|4|||
94653932|NCT00853658|324190481|FG002|Overall Study|Missing study completion information|6|||
94653933|NCT02797262|324190482|FG000|Overall Study|Withdrawal by Subject|5|||
94653934|NCT02797262|324190483|FG001|Overall Study|Withdrawal by Subject|1|||
94653935|NCT02797262|324190482|FG000|Overall Study|Lost to Follow-up|10|||
94653936|NCT02797262|324190483|FG001|Overall Study|Lost to Follow-up|7|||
94653937|NCT02797262|324190482|FG000|Overall Study|Death|1|||
94653938|NCT02797262|324190483|FG001|Overall Study|Death|2|||
94653939|NCT02797262|324190482|FG000|Overall Study|Adverse Event|1|||
94653940|NCT02797262|324190483|FG001|Overall Study|Adverse Event|0|||
94653941|NCT02797262|324190482|FG000|Overall Study|COVID-19|2|||
94653942|NCT02797262|324190483|FG001|Overall Study|COVID-19|1|||
94653943|NCT02797262|324190482|FG000|Overall Study|Out-of-country|1|||
94653944|NCT02797262|324190483|FG001|Overall Study|Out-of-country|0|||
94653945|NCT01916304|324190484|FG000|Overall Study|Screening failure|17|||
94653946|NCT01600586|324190485|FG000|Overall Study|Physician Decision|3|||
94653947|NCT01600586|324190486|FG001|Overall Study|Physician Decision|3|||
94653948|NCT01978184|324190487|FG000|Overall Study|Progressive disease|5|||
94653949|NCT01978184|324190488|FG001|Overall Study|Progressive disease|5|||
94717432|NCT04600752|324423423|FG002|Overall Study|Lack of Efficacy|0|||
94717433|NCT01095796|324423424|FG000|Overall Study|Randomized but Not Treated|5|||
94717434|NCT01095796|324423425|FG001|Overall Study|Randomized but Not Treated|2|||
94717435|NCT01095796|324423424|FG000|Overall Study|Adverse Event|9|||
94717436|NCT01095796|324423425|FG001|Overall Study|Adverse Event|19|||
94717437|NCT01095796|324423424|FG000|Overall Study|Death|3|||
94717438|NCT01095796|324423425|FG001|Overall Study|Death|2|||
94717439|NCT01095796|324423424|FG000|Overall Study|Pregnancy|2|||
94717440|NCT01095796|324423425|FG001|Overall Study|Pregnancy|0|||
94717441|NCT01095796|324423424|FG000|Overall Study|Lack of Efficacy|5|||
94717442|NCT01095796|324423425|FG001|Overall Study|Lack of Efficacy|3|||
94717443|NCT01095796|324423424|FG000|Overall Study|Investigator's Discretion|7|||
94717444|NCT01095796|324423425|FG001|Overall Study|Investigator's Discretion|2|||
94717445|NCT01095796|324423424|FG000|Overall Study|Withdrew Consent|16|||
94717446|NCT01095796|324423425|FG001|Overall Study|Withdrew Consent|22|||
94717447|NCT01095796|324423424|FG000|Overall Study|Lost to Follow-up|27|||
94717448|NCT01095796|324423425|FG001|Overall Study|Lost to Follow-up|29|||
94717449|NCT01095796|324423424|FG000|Overall Study|Participant Noncompliance|5|||
94271747|NCT02138617|322788530|FG001|Overall Study|Adverse Event|5|||
94271748|NCT02138617|322788531|FG002|Overall Study|Adverse Event|2|||
94271749|NCT02138617|322788529|FG000|Overall Study|Disease Progression|20|||
94271750|NCT02138617|322788530|FG001|Overall Study|Disease Progression|13|||
94271751|NCT02138617|322788531|FG002|Overall Study|Disease Progression|4|||
94271752|NCT02138617|322788529|FG000|Overall Study|Withdrawal by Subject|7|||
94271753|NCT02138617|322788530|FG001|Overall Study|Withdrawal by Subject|10|||
94271754|NCT02138617|322788531|FG002|Overall Study|Withdrawal by Subject|2|||
94271755|NCT02138617|322788529|FG000|Overall Study|other complicating disease|0|||
94271756|NCT02138617|322788530|FG001|Overall Study|other complicating disease|2|||
94271757|NCT02138617|322788531|FG002|Overall Study|other complicating disease|0|||
94271758|NCT02138617|322788529|FG000|Overall Study|Protocol Violation|1|||
94271759|NCT02138617|322788530|FG001|Overall Study|Protocol Violation|0|||
94271760|NCT02138617|322788531|FG002|Overall Study|Protocol Violation|0|||
94271761|NCT02138617|322788529|FG000|Overall Study|Physician Decision|7|||
94271762|NCT02138617|322788530|FG001|Overall Study|Physician Decision|6|||
94271763|NCT02138617|322788531|FG002|Overall Study|Physician Decision|0|||
94271764|NCT02138617|322788529|FG000|Overall Study|financial reason|0|||
94653950|NCT01978184|324190487|FG000|Overall Study|Other than PDA|2|||
94653951|NCT01978184|324190488|FG001|Overall Study|Other than PDA|2|||
94653952|NCT01978184|324190487|FG000|Overall Study|Physician Decision|0|||
94653953|NCT01978184|324190488|FG001|Overall Study|Physician Decision|3|||
94653954|NCT01978184|324190487|FG000|Overall Study|Noncompliance|1|||
94717450|NCT01095796|324423425|FG001|Overall Study|Participant Noncompliance|10|||
94717451|NCT01095796|324423424|FG000|Overall Study|Protocol Violation|1|||
94717452|NCT01095796|324423425|FG001|Overall Study|Protocol Violation|0|||
94717453|NCT01095796|324423424|FG000|Overall Study|Participant Transferred to Another Study|215|||
94717454|NCT01095796|324423425|FG001|Overall Study|Participant Transferred to Another Study|200|||
94717455|NCT00448669|324423437|FG000|Overall Study|Lost to Follow-up|52|||
94717456|NCT00448669|324423438|FG001|Overall Study|Lost to Follow-up|63|||
94717457|NCT00448669|324423437|FG000|Overall Study|Withdrawal by Subject|90|||
94717458|NCT00448669|324423438|FG001|Overall Study|Withdrawal by Subject|74|||
94717459|NCT00448669|324423437|FG000|Overall Study|Relocated|49|||
94717460|NCT00448669|324423438|FG001|Overall Study|Relocated|36|||
94717461|NCT00448669|324423437|FG000|Overall Study|Were withdrawn by investigator|10|||
94271765|NCT02138617|322788530|FG001|Overall Study|financial reason|1|||
94271766|NCT02138617|322788531|FG002|Overall Study|financial reason|0|||
94271767|NCT02138617|322788529|FG000|Overall Study|other therapy|3|||
94271768|NCT02138617|322788530|FG001|Overall Study|other therapy|4|||
94653955|NCT01978184|324190488|FG001|Overall Study|Noncompliance|2|||
94653956|NCT01978184|324190487|FG000|Overall Study|Death|1|||
94653957|NCT01978184|324190488|FG001|Overall Study|Death|0|||
94653958|NCT01978184|324190487|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
94653959|NCT01978184|324190488|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
94653960|NCT01898793|324190490|FG000|Overall Study|Death|2|||
94653961|NCT01898793|324190491|FG001|Overall Study|Death|1|||
94653962|NCT01898793|324190492|FG002|Overall Study|Death|4|||
94653963|NCT01898793|324190493|FG003|Overall Study|Death|0|||
94653964|NCT01898793|324190494|FG004|Overall Study|Death|0|||
94653965|NCT01898793|324190495|FG005|Overall Study|Death|0|||
94653966|NCT01898793|324190496|FG006|Overall Study|Death|0|||
94653967|NCT03146650|324190497|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
94653968|NCT03146650|324190497|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
94653969|NCT03146650|324190497|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
94653970|NCT03146650|324190497|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
94653971|NCT03146650|324190497|FG000|2 Year Follow-up|Death|11|||
94653972|NCT03146650|324190497|FG000|2 Year Follow-up|Still in follow-up|7|||
94653973|NCT03146650|324190497|FG000|2 Year Follow-up|Lost to Follow-up|1|||
94653974|NCT00931307|324190502|FG000|Overall Study|Lack of Efficacy|12|||
94653975|NCT00931307|324190502|FG000|Overall Study|Biomicroscopy|1|||
94653976|NCT01306617|324190508|FG000|Overall Study|Adverse Event|1|||
94653977|NCT01306617|324190509|FG001|Overall Study|Adverse Event|0|||
94653978|NCT01306617|324190510|FG002|Overall Study|Adverse Event|0|||
94653979|NCT01306617|324190508|FG000|Overall Study|Virologic Failure|0|||
94653980|NCT01306617|324190509|FG001|Overall Study|Virologic Failure|0|||
94653981|NCT01306617|324190510|FG002|Overall Study|Virologic Failure|5|||
94653982|NCT01306617|324190508|FG000|Overall Study|Non-compliance|0|||
94653983|NCT01306617|324190509|FG001|Overall Study|Non-compliance|1|||
94653984|NCT01306617|324190510|FG002|Overall Study|Non-compliance|0|||
94653985|NCT00983814|324190511|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
94653986|NCT00983814|324190512|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
94653987|NCT00983814|324190513|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
94653988|NCT00983814|324190511|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
94653989|NCT00983814|324190512|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
94653990|NCT00983814|324190513|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
94653991|NCT00983814|324190511|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
94653992|NCT00983814|324190512|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
94653993|NCT00983814|324190513|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
94271769|NCT02138617|322788531|FG002|Overall Study|other therapy|0|||
94653994|NCT00983814|324190511|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
94653995|NCT00983814|324190512|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
94653996|NCT00983814|324190513|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
94653997|NCT00983814|324190511|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
94653998|NCT00983814|324190512|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
94653999|NCT00983814|324190513|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
94654000|NCT00773097|324190514|FG000|Overall Study|Withdrawal by Subject|1|||
94654001|NCT00773097|324190514|FG000|Overall Study|Physician Decision|6|||
94654002|NCT01994395|324190519|FG000|Overall Study|Withdrawal by Subject|1|||
94654003|NCT01994395|324190520|FG001|Overall Study|Withdrawal by Subject|2|||
94654004|NCT01818336|324192147|FG000|Overall Study|Declined retest visit|0|||
94654005|NCT01818336|324192148|FG001|Overall Study|Declined retest visit|11|||
94654006|NCT01818336|324192147|FG000|Overall Study|Lost to Follow-up|0|||
94654007|NCT01818336|324192148|FG001|Overall Study|Lost to Follow-up|1|||
94654008|NCT02139644|324192149|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
94654009|NCT02139644|324192150|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
94654010|NCT02139644|324192151|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
94654011|NCT02139644|324192152|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
94654012|NCT02139644|324192153|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
94654013|NCT02139644|324192154|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
94654014|NCT02139644|324192149|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
94654015|NCT02139644|324192150|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
94654016|NCT02139644|324192151|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
94654017|NCT02139644|324192152|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
94654018|NCT02139644|324192153|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
94654019|NCT02139644|324192154|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
94654020|NCT02139644|324192149|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
94654021|NCT02139644|324192150|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
94654022|NCT02139644|324192151|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
94654023|NCT02139644|324192152|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
94654024|NCT02139644|324192153|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
94654025|NCT02139644|324192154|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
94654026|NCT02139644|324192149|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
94654027|NCT02139644|324192150|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
94654028|NCT02139644|324192151|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
94654029|NCT02139644|324192152|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
94654030|NCT02139644|324192153|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
94654031|NCT02139644|324192154|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
94654032|NCT02139644|324192149|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
94654033|NCT02139644|324192150|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
94654034|NCT02139644|324192151|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
94654035|NCT02139644|324192152|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
94654036|NCT02139644|324192153|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
94654037|NCT02139644|324192154|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
94654038|NCT02139644|324192149|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
94654039|NCT02139644|324192150|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
94654040|NCT02139644|324192151|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
94654041|NCT02139644|324192152|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
94654042|NCT02139644|324192153|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
94654043|NCT02139644|324192154|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
94654044|NCT02139644|324192149|FG000|Run-In Period (Pre-assignment)|Other|6|||
94654045|NCT02139644|324192150|FG001|Run-In Period (Pre-assignment)|Other|0|||
94654046|NCT02139644|324192151|FG002|Run-In Period (Pre-assignment)|Other|0|||
94654047|NCT02139644|324192152|FG003|Run-In Period (Pre-assignment)|Other|0|||
94654048|NCT02139644|324192153|FG004|Run-In Period (Pre-assignment)|Other|0|||
94654049|NCT02139644|324192154|FG005|Run-In Period (Pre-assignment)|Other|0|||
94654050|NCT02139644|324192149|FG000|Treatment Period|Adverse Event|0|||
94654051|NCT02139644|324192150|FG001|Treatment Period|Adverse Event|0|||
94654052|NCT02139644|324192151|FG002|Treatment Period|Adverse Event|3|||
94654053|NCT02139644|324192152|FG003|Treatment Period|Adverse Event|2|||
94654054|NCT02139644|324192153|FG004|Treatment Period|Adverse Event|1|||
94654055|NCT02139644|324192154|FG005|Treatment Period|Adverse Event|6|||
94654056|NCT02139644|324192149|FG000|Treatment Period|Withdrawal by Subject|0|||
94654057|NCT02139644|324192150|FG001|Treatment Period|Withdrawal by Subject|0|||
94654058|NCT02139644|324192151|FG002|Treatment Period|Withdrawal by Subject|2|||
94654059|NCT02139644|324192152|FG003|Treatment Period|Withdrawal by Subject|2|||
94654060|NCT02139644|324192153|FG004|Treatment Period|Withdrawal by Subject|3|||
94654061|NCT02139644|324192154|FG005|Treatment Period|Withdrawal by Subject|2|||
94654062|NCT02139644|324192149|FG000|Treatment Period|Non-compliance|0|||
94654063|NCT02139644|324192150|FG001|Treatment Period|Non-compliance|0|||
94654064|NCT02139644|324192151|FG002|Treatment Period|Non-compliance|0|||
94654065|NCT02139644|324192152|FG003|Treatment Period|Non-compliance|1|||
94654066|NCT02139644|324192153|FG004|Treatment Period|Non-compliance|0|||
94654067|NCT02139644|324192154|FG005|Treatment Period|Non-compliance|0|||
94654068|NCT02139644|324192149|FG000|Treatment Period|Protocol Violation|0|||
94654069|NCT02139644|324192150|FG001|Treatment Period|Protocol Violation|0|||
94654070|NCT02139644|324192151|FG002|Treatment Period|Protocol Violation|0|||
94654071|NCT02139644|324192152|FG003|Treatment Period|Protocol Violation|1|||
94654072|NCT02139644|324192153|FG004|Treatment Period|Protocol Violation|1|||
94654073|NCT02139644|324192154|FG005|Treatment Period|Protocol Violation|1|||
94654074|NCT02139644|324192149|FG000|Treatment Period|Disease progression|0|||
94654075|NCT02139644|324192150|FG001|Treatment Period|Disease progression|0|||
94654076|NCT02139644|324192151|FG002|Treatment Period|Disease progression|0|||
94654077|NCT02139644|324192152|FG003|Treatment Period|Disease progression|1|||
94654078|NCT02139644|324192153|FG004|Treatment Period|Disease progression|1|||
94654079|NCT02139644|324192154|FG005|Treatment Period|Disease progression|2|||
94654080|NCT02139644|324192149|FG000|Treatment Period|Lost to Follow-up|0|||
94717462|NCT00448669|324423438|FG001|Overall Study|Were withdrawn by investigator|6|||
94717463|NCT00448669|324423437|FG000|Overall Study|Death|2|||
94717464|NCT00448669|324423438|FG001|Overall Study|Death|4|||
94654081|NCT02139644|324192150|FG001|Treatment Period|Lost to Follow-up|0|||
94654082|NCT02139644|324192151|FG002|Treatment Period|Lost to Follow-up|1|||
94654083|NCT02139644|324192152|FG003|Treatment Period|Lost to Follow-up|1|||
94654084|NCT02139644|324192153|FG004|Treatment Period|Lost to Follow-up|1|||
94654085|NCT02139644|324192154|FG005|Treatment Period|Lost to Follow-up|1|||
94654086|NCT02139644|324192149|FG000|Treatment Period|Lack of Efficacy|0|||
94654087|NCT02139644|324192150|FG001|Treatment Period|Lack of Efficacy|0|||
94654088|NCT02139644|324192151|FG002|Treatment Period|Lack of Efficacy|1|||
94654089|NCT02139644|324192152|FG003|Treatment Period|Lack of Efficacy|0|||
94654090|NCT02139644|324192153|FG004|Treatment Period|Lack of Efficacy|1|||
94654091|NCT02139644|324192154|FG005|Treatment Period|Lack of Efficacy|4|||
94717465|NCT00448669|324423437|FG000|Overall Study|Had other reasons|5|||
94717466|NCT00448669|324423438|FG001|Overall Study|Had other reasons|6|||
94717467|NCT00448669|324423437|FG000|Overall Study|HIV-infected at enrollment|1|||
94654092|NCT02139644|324192149|FG000|Treatment Period|Other|0|||
94654093|NCT02139644|324192150|FG001|Treatment Period|Other|3|||
94654094|NCT02139644|324192151|FG002|Treatment Period|Other|1|||
94654095|NCT02139644|324192152|FG003|Treatment Period|Other|1|||
94654096|NCT02139644|324192153|FG004|Treatment Period|Other|0|||
94654097|NCT02139644|324192154|FG005|Treatment Period|Other|1|||
94654098|NCT00612066|324192155|FG000|Overall Study|Adverse Event|1|||
94654099|NCT02944578|324192165|FG000|Overall Study|Physician Decision|1|||
94654100|NCT02944578|324192166|FG001|Overall Study|Physician Decision|0|||
94654101|NCT00456092|324192169|FG000|Extension Phase|Grade 2 or Greater AE|2|||
94654102|NCT00456092|324192170|FG001|Extension Phase|Grade 2 or Greater AE|2|||
94654103|NCT00456092|324192171|FG002|Extension Phase|Grade 2 or Greater AE|0|||
94654104|NCT00456092|324192172|FG003|Extension Phase|Grade 2 or Greater AE|0|||
94654105|NCT00456092|324192173|FG004|Extension Phase|Grade 2 or Greater AE|2|||
94654106|NCT00456092|324192169|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
94654107|NCT00456092|324192170|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
94654108|NCT00456092|324192171|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
94654109|NCT00456092|324192172|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
94654110|NCT00456092|324192173|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
94654111|NCT00456092|324192169|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
94654112|NCT00456092|324192170|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
94654113|NCT00456092|324192171|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
94654114|NCT00456092|324192172|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
94654115|NCT00456092|324192173|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
94654116|NCT00456092|324192169|FG000|Extension Phase|Withdrew Consent|2|||
94654117|NCT00456092|324192170|FG001|Extension Phase|Withdrew Consent|0|||
94654118|NCT00456092|324192171|FG002|Extension Phase|Withdrew Consent|0|||
94654119|NCT00456092|324192172|FG003|Extension Phase|Withdrew Consent|0|||
94654120|NCT00456092|324192173|FG004|Extension Phase|Withdrew Consent|0|||
94654121|NCT00456092|324192169|FG000|Extension Phase|Lost to Follow-up|1|||
94654122|NCT00456092|324192170|FG001|Extension Phase|Lost to Follow-up|1|||
94654123|NCT00456092|324192171|FG002|Extension Phase|Lost to Follow-up|0|||
94654124|NCT00456092|324192172|FG003|Extension Phase|Lost to Follow-up|0|||
94654125|NCT00456092|324192173|FG004|Extension Phase|Lost to Follow-up|1|||
94654126|NCT00456092|324192169|FG000|Extension Phase|Other|2|||
94654127|NCT00456092|324192170|FG001|Extension Phase|Other|0|||
94654128|NCT00456092|324192171|FG002|Extension Phase|Other|0|||
94654129|NCT00456092|324192172|FG003|Extension Phase|Other|1|||
94654130|NCT00456092|324192173|FG004|Extension Phase|Other|1|||
94654131|NCT00456092|324192169|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
94654132|NCT00456092|324192170|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
94654133|NCT00456092|324192171|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
94654134|NCT00456092|324192172|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
94654135|NCT00456092|324192173|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
94654136|NCT00456092|324192169|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
94654137|NCT00456092|324192170|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
94654138|NCT00456092|324192171|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
94654139|NCT00456092|324192172|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
94654140|NCT00456092|324192173|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
94654141|NCT00456092|324192169|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
94654142|NCT00456092|324192170|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
94654143|NCT00456092|324192171|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
94654144|NCT00456092|324192172|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
94654145|NCT00456092|324192173|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
94654146|NCT00456092|324192169|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
94654147|NCT00456092|324192170|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
94654148|NCT00456092|324192171|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
94654149|NCT00456092|324192172|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
94654150|NCT00456092|324192173|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
94654151|NCT00456092|324192169|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
94654152|NCT00456092|324192170|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
94654153|NCT00456092|324192171|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
94654154|NCT00456092|324192172|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
94654155|NCT00456092|324192173|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
94654156|NCT00456092|324192169|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
94654157|NCT00456092|324192170|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
94654158|NCT00456092|324192171|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
94654159|NCT00456092|324192172|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
94654160|NCT00456092|324192173|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
94654161|NCT00456092|324192169|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
94654162|NCT00456092|324192170|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
94271770|NCT05291689|322788532|FG000|Overall Study|Adverse Event|3|||
94271771|NCT05291689|322788532|FG000|Overall Study|Lack of Efficacy|10|||
94654163|NCT00456092|324192171|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
94654164|NCT00456092|324192172|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
94654165|NCT00456092|324192173|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
94654166|NCT00456092|324192169|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
94654167|NCT00456092|324192170|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
94654168|NCT00456092|324192171|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
94654169|NCT00456092|324192172|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
94654170|NCT00456092|324192173|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
94654171|NCT00456092|324192169|FG000|Treatment Phase (12 Weeks)|Other|1|||
94654172|NCT00456092|324192170|FG001|Treatment Phase (12 Weeks)|Other|0|||
94654173|NCT00456092|324192171|FG002|Treatment Phase (12 Weeks)|Other|1|||
94654174|NCT00456092|324192172|FG003|Treatment Phase (12 Weeks)|Other|0|||
94654175|NCT00456092|324192173|FG004|Treatment Phase (12 Weeks)|Other|0|||
94654176|NCT00723801|324192174|FG000|Overall Study|Lost to Follow-up|1|||
94717468|NCT00448669|324423438|FG001|Overall Study|HIV-infected at enrollment|2|||
94717469|NCT00448669|324423437|FG000|Overall Study|Never started drug|9|||
94717470|NCT00448669|324423438|FG001|Overall Study|Never started drug|7|||
94717471|NCT01340066|324423439|FG000|Placebo Run in Period|Screen Failures|27|||
94717472|NCT01340066|324423440|FG001|Placebo Run in Period|Screen Failures|0|||
94717473|NCT01340066|324423441|FG002|Placebo Run in Period|Screen Failures|0|||
94717474|NCT01340066|324423439|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
94717475|NCT01340066|324423440|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
94717476|NCT01340066|324423441|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
94717477|NCT01340066|324423439|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
94717478|NCT01340066|324423440|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
94717479|NCT01340066|324423441|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
94717480|NCT01340066|324423439|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
94717481|NCT01340066|324423440|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
94717482|NCT01340066|324423441|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
94717483|NCT03771352|324423443|FG000|Overall Study|Screen failure|2|||
94717484|NCT03771352|324423443|FG000|Overall Study|Withdrawal by Subject|2|||
94717485|NCT03338816|324423444|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
94717486|NCT03338816|324423445|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
94717487|NCT03338816|324423446|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
94717488|NCT03338816|324423447|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
94717489|NCT03338816|324423444|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
94717490|NCT03338816|324423445|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
94717491|NCT03338816|324423446|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
94717492|NCT03338816|324423447|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
94717493|NCT03338816|324423444|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
94717494|NCT03338816|324423445|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
94717495|NCT03338816|324423446|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
94717496|NCT03338816|324423447|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
94717497|NCT03338816|324423444|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
94717498|NCT03338816|324423445|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
94717499|NCT03338816|324423446|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
94717500|NCT03338816|324423447|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
94717501|NCT03338816|324423444|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
94717502|NCT03338816|324423445|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
94717503|NCT03338816|324423446|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
94717504|NCT03338816|324423447|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
94717505|NCT03338816|324423444|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
94654177|NCT00723801|324192175|FG001|Overall Study|Lost to Follow-up|2|||
94654178|NCT00723801|324192174|FG000|Overall Study|Protocol Violation|2|||
94717506|NCT03338816|324423445|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
94717507|NCT03338816|324423446|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
94717508|NCT03338816|324423447|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
94717509|NCT03338816|324423444|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
94717510|NCT03338816|324423445|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
94717511|NCT03338816|324423446|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
94717512|NCT03338816|324423447|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
94717513|NCT00632749|324423454|FG000|Overall Study|Progressive disease|3|||
94717514|NCT00632749|324423455|FG001|Overall Study|Progressive disease|2|||
94717515|NCT00632749|324423456|FG002|Overall Study|Progressive disease|2|||
94717516|NCT00632749|324423457|FG003|Overall Study|Progressive disease|2|||
94717517|NCT00632749|324423458|FG004|Overall Study|Progressive disease|4|||
94654179|NCT00723801|324192175|FG001|Overall Study|Protocol Violation|1|||
94654180|NCT01863446|324192178|FG000|Overall Study|Withdrawal by Subject|1|||
94654181|NCT01863446|324192179|FG001|Overall Study|Withdrawal by Subject|0|||
94654182|NCT01863446|324192180|FG002|Overall Study|Withdrawal by Subject|1|||
94654183|NCT01863446|324192181|FG003|Overall Study|Withdrawal by Subject|2|||
94654184|NCT01863446|324192178|FG000|Overall Study|Physician Decision|0|||
94654185|NCT01863446|324192179|FG001|Overall Study|Physician Decision|0|||
94654186|NCT01863446|324192180|FG002|Overall Study|Physician Decision|1|||
94654187|NCT01863446|324192181|FG003|Overall Study|Physician Decision|0|||
94654188|NCT00633984|324192182|FG000|Overall Study|Lost to Follow-up|0|||
94654189|NCT00633984|324192183|FG001|Overall Study|Lost to Follow-up|6|||
94654190|NCT00633984|324192182|FG000|Overall Study|Withdrawal by Subject|8|||
94654191|NCT00633984|324192183|FG001|Overall Study|Withdrawal by Subject|7|||
94654192|NCT00633984|324192182|FG000|Overall Study|Hospitalized|1|||
94654193|NCT00633984|324192183|FG001|Overall Study|Hospitalized|0|||
94654194|NCT04532112|324192184|FG000|Overall Study|Adverse Event|3|||
94654195|NCT04532112|324192185|FG001|Overall Study|Adverse Event|0|||
94654196|NCT01824303|324192186|FG000|Randomized Study|Withdrawal by Subject|1|||
94654197|NCT01824303|324192187|FG001|Randomized Study|Withdrawal by Subject|1|||
94654198|NCT01824303|324192186|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
94654199|NCT01824303|324192187|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
94654200|NCT04086472|324192188|FG000|Overall Study|Lost to Follow-up|1|||
94654201|NCT04086472|324192189|FG001|Overall Study|Lost to Follow-up|0|||
94654202|NCT04086472|324192190|FG002|Overall Study|Lost to Follow-up|0|||
94654203|NCT04086472|324192191|FG003|Overall Study|Lost to Follow-up|0|||
94654204|NCT04086472|324192192|FG004|Overall Study|Lost to Follow-up|1|||
94654205|NCT04086472|324192188|FG000|Overall Study|Physician Decision|0|||
94654206|NCT04086472|324192189|FG001|Overall Study|Physician Decision|1|||
94654207|NCT04086472|324192190|FG002|Overall Study|Physician Decision|1|||
94654208|NCT04086472|324192191|FG003|Overall Study|Physician Decision|0|||
94654209|NCT04086472|324192192|FG004|Overall Study|Physician Decision|0|||
94654210|NCT04086472|324192188|FG000|Overall Study|Withdrawal by Subject|1|||
94654211|NCT04086472|324192189|FG001|Overall Study|Withdrawal by Subject|1|||
94654212|NCT04086472|324192190|FG002|Overall Study|Withdrawal by Subject|1|||
94654213|NCT04086472|324192191|FG003|Overall Study|Withdrawal by Subject|0|||
94654214|NCT04086472|324192192|FG004|Overall Study|Withdrawal by Subject|0|||
94654215|NCT04086472|324192188|FG000|Overall Study|Various reasons|2|||
94654216|NCT04086472|324192189|FG001|Overall Study|Various reasons|0|||
94654217|NCT04086472|324192190|FG002|Overall Study|Various reasons|0|||
94271772|NCT05291689|322788532|FG000|Overall Study|Withdrawal by Subject|4|||
94654218|NCT04086472|324192191|FG003|Overall Study|Various reasons|3|||
94654219|NCT04086472|324192192|FG004|Overall Study|Various reasons|1|||
94654220|NCT00048724|324192198|FG000|Overall Study|Adverse Event|53|||
94654221|NCT00048724|324192199|FG001|Overall Study|Adverse Event|12|||
94654222|NCT00048724|324192198|FG000|Overall Study|Withdrawal by Subject|34|||
94654223|NCT00048724|324192199|FG001|Overall Study|Withdrawal by Subject|54|||
94654224|NCT00048724|324192198|FG000|Overall Study|Lost to Follow-up|5|||
94654225|NCT00048724|324192199|FG001|Overall Study|Lost to Follow-up|5|||
94654226|NCT00048724|324192198|FG000|Overall Study|Protocol-defined Clinical Event|17|||
94654227|NCT00048724|324192199|FG001|Overall Study|Protocol-defined Clinical Event|32|||
94654228|NCT00048724|324192198|FG000|Overall Study|Noncompliance With Protocol|4|||
94654229|NCT00048724|324192199|FG001|Overall Study|Noncompliance With Protocol|12|||
94271773|NCT05500274|322788533|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
94654230|NCT00048724|324192198|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
94271774|NCT05500274|322788534|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
94467290|NCT01897571|323500497|FG001|Overall Study|Other|0|||
94271775|NCT05500274|322788533|FG000|Overall Study|Lost to Follow-up|76|||
94271776|NCT05500274|322788534|FG001|Overall Study|Lost to Follow-up|51|||
94271777|NCT01390272|322788535|FG000|Overall Study|Death|3|||
94271778|NCT01390272|322788536|FG001|Overall Study|Death|2|||
94271779|NCT01390272|322788535|FG000|Overall Study|Withdrawal by Subject|9|||
94271780|NCT01390272|322788536|FG001|Overall Study|Withdrawal by Subject|5|||
94271781|NCT01390272|322788535|FG000|Overall Study|Patient moved, no longer eligible|5|||
94271782|NCT01390272|322788536|FG001|Overall Study|Patient moved, no longer eligible|8|||
94271783|NCT04315181|322788537|FG000|Overall Study|Non-responsive to drug conditions.|1|||
94271784|NCT00618410|322788538|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
94271785|NCT00618410|322788539|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
94271786|NCT05879107|322788542|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
94271787|NCT05879107|322788543|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
94271788|NCT05879107|322788542|FG000|Overall Study|Migrated / moved from the study area|1|||
94271789|NCT05879107|322788543|FG001|Overall Study|Migrated / moved from the study area|1|||
94271790|NCT05879107|322788542|FG000|Overall Study|Lost to Follow-up|8|||
94271791|NCT05879107|322788543|FG001|Overall Study|Lost to Follow-up|13|||
94271792|NCT05879107|322788542|FG000|Overall Study|Death|0|||
94271793|NCT05879107|322788543|FG001|Overall Study|Death|2|||
94271794|NCT05879107|322788542|FG000|Overall Study|Other|0|||
94271795|NCT05879107|322788543|FG001|Overall Study|Other|3|||
94271796|NCT01056510|322788544|FG000|Overall Study|Dropout Before Start of Treatment|1|||
94271797|NCT01056510|322788545|FG001|Overall Study|Dropout Before Start of Treatment|1|||
94271798|NCT01056510|322788544|FG000|Overall Study|Withdrawal by Subject|4|||
94467291|NCT01897571|323500498|FG002|Overall Study|Other|0|||
94271799|NCT01056510|322788545|FG001|Overall Study|Withdrawal by Subject|2|||
94271800|NCT01056510|322788544|FG000|Overall Study|Death|29|||
94271801|NCT01056510|322788545|FG001|Overall Study|Death|34|||
94717518|NCT00632749|324423459|FG005|Overall Study|Progressive disease|4|||
94271802|NCT01056510|322788544|FG000|Overall Study|Noncompliance|1|||
94271803|NCT01056510|322788545|FG001|Overall Study|Noncompliance|3|||
94271804|NCT01056510|322788544|FG000|Overall Study|Physician Decision|4|||
94271805|NCT01056510|322788545|FG001|Overall Study|Physician Decision|5|||
94271806|NCT01056510|322788544|FG000|Overall Study|Lost to Follow-up|5|||
94271807|NCT01056510|322788545|FG001|Overall Study|Lost to Follow-up|6|||
94271808|NCT01056510|322788544|FG000|Overall Study|Other|10|||
94271809|NCT01056510|322788545|FG001|Overall Study|Other|12|||
94271810|NCT01056510|322788544|FG000|Overall Study|Missing|0|||
94654231|NCT00048724|324192199|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
94654232|NCT00048724|324192198|FG000|Overall Study|Administrative|1|||
94654233|NCT00048724|324192199|FG001|Overall Study|Administrative|1|||
94654234|NCT01168999|324192200|FG000|Overall Study|Lost to Follow-up|2|||
94654235|NCT01168999|324192201|FG001|Overall Study|Lost to Follow-up|1|||
94654236|NCT01168999|324192202|FG002|Overall Study|Lost to Follow-up|0|||
94654237|NCT01168999|324192203|FG003|Overall Study|Lost to Follow-up|0|||
94654238|NCT02039427|324192204|FG000|Overall Study|Duration of surgery > 3h|1|||
94654239|NCT02039427|324192205|FG001|Overall Study|Duration of surgery > 3h|1|||
94654240|NCT02039427|324192206|FG002|Overall Study|Duration of surgery > 3h|0|||
94654241|NCT02039427|324192207|FG003|Overall Study|Duration of surgery > 3h|0|||
94654242|NCT02039427|324192204|FG000|Overall Study|Withdrawal on concent|0|||
94654243|NCT02039427|324192205|FG001|Overall Study|Withdrawal on concent|0|||
94654244|NCT02039427|324192206|FG002|Overall Study|Withdrawal on concent|0|||
94654245|NCT02039427|324192207|FG003|Overall Study|Withdrawal on concent|1|||
94654246|NCT02039427|324192204|FG000|Overall Study|Cancellation of surgery|0|||
94654247|NCT02039427|324192205|FG001|Overall Study|Cancellation of surgery|0|||
94654248|NCT02039427|324192206|FG002|Overall Study|Cancellation of surgery|1|||
94654249|NCT02039427|324192207|FG003|Overall Study|Cancellation of surgery|0|||
94654250|NCT02039427|324192204|FG000|Overall Study|Loss of follow - up|1|||
94654251|NCT02039427|324192205|FG001|Overall Study|Loss of follow - up|0|||
94654252|NCT02039427|324192206|FG002|Overall Study|Loss of follow - up|2|||
94654253|NCT02039427|324192207|FG003|Overall Study|Loss of follow - up|4|||
94654254|NCT02039427|324192204|FG000|Overall Study|Steroid Use|1|||
94654255|NCT02039427|324192205|FG001|Overall Study|Steroid Use|0|||
94654256|NCT02039427|324192206|FG002|Overall Study|Steroid Use|0|||
94654257|NCT02039427|324192207|FG003|Overall Study|Steroid Use|0|||
94654258|NCT04317586|324192208|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
94271811|NCT01056510|322788545|FG001|Overall Study|Missing|1|||
94271812|NCT00589420|322788546|FG000|Overall Study|screen failure|1|||
94271813|NCT00243386|322788547|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
94271814|NCT00243386|322788548|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
94271815|NCT00243386|322788549|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
94271816|NCT00243386|322788547|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
94271817|NCT00243386|322788548|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
94271818|NCT00243386|322788549|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
94271819|NCT00243386|322788547|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
94271820|NCT00243386|322788548|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
94271821|NCT00243386|322788549|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
94271822|NCT00243386|322788547|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
94271823|NCT00243386|322788548|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
94271824|NCT00243386|322788549|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
94271825|NCT00243386|322788547|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
94271826|NCT00243386|322788548|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
94271827|NCT00243386|322788549|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
94271828|NCT00243386|322788547|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
94271829|NCT00243386|322788548|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
94271830|NCT00243386|322788549|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
94654259|NCT04317586|324192208|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
94654260|NCT01276327|324192209|FG000|Overall Study|Adverse Event|1|||
94654261|NCT01276327|324192210|FG001|Overall Study|Adverse Event|3|||
94654262|NCT01276327|324192209|FG000|Overall Study|Withdrawal by Subject|1|||
94654263|NCT01276327|324192210|FG001|Overall Study|Withdrawal by Subject|0|||
94271831|NCT00243386|322788547|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
94271832|NCT00243386|322788548|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
94271833|NCT00243386|322788549|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
94271834|NCT00243386|322788547|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
94271835|NCT00243386|322788548|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
94271836|NCT00243386|322788549|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
94271837|NCT00912028|322788550|FG000|Overall Study|Lost to Follow-up|2|||
94271838|NCT00912028|322788551|FG001|Overall Study|Lost to Follow-up|3|||
94271839|NCT00912028|322788552|FG002|Overall Study|Lost to Follow-up|0|||
94271840|NCT00912028|322788553|FG003|Overall Study|Lost to Follow-up|1|||
94271841|NCT00912028|322788554|FG004|Overall Study|Lost to Follow-up|3|||
94271842|NCT00912028|322788550|FG000|Overall Study|Withdrawal by Subject|3|||
94271843|NCT00912028|322788551|FG001|Overall Study|Withdrawal by Subject|0|||
94271844|NCT00912028|322788552|FG002|Overall Study|Withdrawal by Subject|0|||
94271845|NCT00912028|322788553|FG003|Overall Study|Withdrawal by Subject|0|||
94271846|NCT00912028|322788554|FG004|Overall Study|Withdrawal by Subject|0|||
94271847|NCT02285998|322788555|FG000|Overall Study|Adverse Event|9|||
94271848|NCT02285998|322788556|FG001|Overall Study|Adverse Event|8|||
94271849|NCT02285998|322788555|FG000|Overall Study|Physician Decision|1|||
94271850|NCT02285998|322788556|FG001|Overall Study|Physician Decision|2|||
94271851|NCT02285998|322788555|FG000|Overall Study|Lost to Follow-up|176|||
94271852|NCT02285998|322788556|FG001|Overall Study|Lost to Follow-up|172|||
94271853|NCT02285998|322788555|FG000|Overall Study|Withdrawal by Subject|53|||
94271854|NCT02285998|322788556|FG001|Overall Study|Withdrawal by Subject|61|||
94271855|NCT02285998|322788555|FG000|Overall Study|Other Reasons|7|||
94271856|NCT02285998|322788556|FG001|Overall Study|Other Reasons|10|||
94271857|NCT03451084|322788559|FG000|Overall Study|Withdrawal by Subject|2|||
94271858|NCT03451084|322788560|FG001|Overall Study|Withdrawal by Subject|1|||
94271859|NCT03451084|322788561|FG002|Overall Study|Withdrawal by Subject|2|||
94271860|NCT03451084|322788562|FG003|Overall Study|Withdrawal by Subject|1|||
94271861|NCT03451084|322788559|FG000|Overall Study|Disease recurrence|0|||
94271862|NCT03451084|322788560|FG001|Overall Study|Disease recurrence|2|||
94271863|NCT03451084|322788561|FG002|Overall Study|Disease recurrence|0|||
94271864|NCT03451084|322788562|FG003|Overall Study|Disease recurrence|0|||
94271865|NCT03451084|322788559|FG000|Overall Study|Lack of Efficacy|0|||
94271866|NCT03451084|322788560|FG001|Overall Study|Lack of Efficacy|3|||
94271867|NCT03451084|322788561|FG002|Overall Study|Lack of Efficacy|0|||
94271868|NCT03451084|322788562|FG003|Overall Study|Lack of Efficacy|1|||
94271869|NCT03451084|322788559|FG000|Overall Study|Death|1|||
94271870|NCT03451084|322788560|FG001|Overall Study|Death|0|||
94271871|NCT03451084|322788561|FG002|Overall Study|Death|2|||
94271872|NCT03451084|322788562|FG003|Overall Study|Death|0|||
94271873|NCT03451084|322788559|FG000|Overall Study|Physician Decision|0|||
94271874|NCT03451084|322788560|FG001|Overall Study|Physician Decision|0|||
94271875|NCT03451084|322788561|FG002|Overall Study|Physician Decision|2|||
94271876|NCT03451084|322788562|FG003|Overall Study|Physician Decision|2|||
94271877|NCT03451084|322788559|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
94717519|NCT00632749|324423460|FG006|Overall Study|Progressive disease|3|||
94717520|NCT00632749|324423461|FG007|Overall Study|Progressive disease|2|||
94717521|NCT00632749|324423462|FG008|Overall Study|Progressive disease|3|||
94717522|NCT00632749|324423463|FG009|Overall Study|Progressive disease|2|||
94717523|NCT00632749|324423464|FG010|Overall Study|Progressive disease|4|||
94717524|NCT00632749|324423465|FG011|Overall Study|Progressive disease|3|||
94717525|NCT00632749|324423466|FG012|Overall Study|Progressive disease|2|||
94717526|NCT00632749|324423467|FG013|Overall Study|Progressive disease|4|||
94717527|NCT00632749|324423454|FG000|Overall Study|Other Adverse event|1|||
94717528|NCT00632749|324423455|FG001|Overall Study|Other Adverse event|1|||
94717529|NCT00632749|324423456|FG002|Overall Study|Other Adverse event|1|||
94717530|NCT00632749|324423457|FG003|Overall Study|Other Adverse event|1|||
94717531|NCT00632749|324423458|FG004|Overall Study|Other Adverse event|2|||
94717532|NCT00632749|324423459|FG005|Overall Study|Other Adverse event|4|||
94717533|NCT00632749|324423460|FG006|Overall Study|Other Adverse event|1|||
94717534|NCT00632749|324423461|FG007|Overall Study|Other Adverse event|2|||
94717535|NCT00632749|324423462|FG008|Overall Study|Other Adverse event|2|||
94271878|NCT03451084|322788560|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
94271879|NCT03451084|322788561|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
94271880|NCT03451084|322788562|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
94271881|NCT03418129|322788563|FG000|Overall Study|Lost to Follow-up|11|||
94271882|NCT03418129|322788564|FG001|Overall Study|Lost to Follow-up|20|||
94271883|NCT03418129|322788565|FG002|Overall Study|Lost to Follow-up|15|||
94271884|NCT03418129|322788563|FG000|Overall Study|Withdrawal by Subject|3|||
94717536|NCT00632749|324423463|FG009|Overall Study|Other Adverse event|0|||
94717537|NCT00632749|324423464|FG010|Overall Study|Other Adverse event|1|||
94271885|NCT03418129|322788564|FG001|Overall Study|Withdrawal by Subject|6|||
94271886|NCT03418129|322788565|FG002|Overall Study|Withdrawal by Subject|4|||
94717538|NCT00632749|324423465|FG011|Overall Study|Other Adverse event|0|||
94717539|NCT00632749|324423466|FG012|Overall Study|Other Adverse event|1|||
94717540|NCT00632749|324423467|FG013|Overall Study|Other Adverse event|0|||
94717541|NCT00632749|324423454|FG000|Overall Study|Refuse to continue medication|0|||
94717542|NCT00632749|324423455|FG001|Overall Study|Refuse to continue medication|0|||
94717543|NCT00632749|324423456|FG002|Overall Study|Refuse to continue medication|0|||
94717544|NCT00632749|324423457|FG003|Overall Study|Refuse to continue medication|1|||
94717545|NCT00632749|324423458|FG004|Overall Study|Refuse to continue medication|0|||
94717546|NCT00632749|324423459|FG005|Overall Study|Refuse to continue medication|0|||
94717547|NCT00632749|324423460|FG006|Overall Study|Refuse to continue medication|0|||
94717548|NCT00632749|324423461|FG007|Overall Study|Refuse to continue medication|0|||
94717549|NCT00632749|324423462|FG008|Overall Study|Refuse to continue medication|0|||
94717550|NCT00632749|324423463|FG009|Overall Study|Refuse to continue medication|1|||
94717551|NCT00632749|324423464|FG010|Overall Study|Refuse to continue medication|0|||
94717552|NCT00632749|324423465|FG011|Overall Study|Refuse to continue medication|0|||
94717553|NCT00632749|324423466|FG012|Overall Study|Refuse to continue medication|0|||
94717554|NCT00632749|324423467|FG013|Overall Study|Refuse to continue medication|0|||
94717555|NCT00632749|324423454|FG000|Overall Study|Reason other than those specified above|0|||
94717556|NCT00632749|324423455|FG001|Overall Study|Reason other than those specified above|2|||
94717557|NCT00632749|324423456|FG002|Overall Study|Reason other than those specified above|0|||
94717558|NCT00632749|324423457|FG003|Overall Study|Reason other than those specified above|0|||
94717559|NCT00632749|324423458|FG004|Overall Study|Reason other than those specified above|1|||
94717560|NCT00632749|324423459|FG005|Overall Study|Reason other than those specified above|0|||
94717561|NCT00632749|324423460|FG006|Overall Study|Reason other than those specified above|1|||
94717562|NCT00632749|324423461|FG007|Overall Study|Reason other than those specified above|0|||
94717563|NCT00632749|324423462|FG008|Overall Study|Reason other than those specified above|0|||
94717564|NCT00632749|324423463|FG009|Overall Study|Reason other than those specified above|0|||
94717565|NCT00632749|324423464|FG010|Overall Study|Reason other than those specified above|2|||
94717566|NCT00632749|324423465|FG011|Overall Study|Reason other than those specified above|1|||
94717567|NCT00632749|324423466|FG012|Overall Study|Reason other than those specified above|0|||
94717568|NCT00632749|324423467|FG013|Overall Study|Reason other than those specified above|2|||
94717569|NCT00761189|324423471|FG000|Overall Study|Adverse Event|42|||
94717570|NCT00761189|324423471|FG000|Overall Study|Lack of Efficacy|45|||
94717571|NCT00761189|324423471|FG000|Overall Study|Lost to Follow-up|36|||
94717572|NCT00761189|324423471|FG000|Overall Study|Withdrawal by Subject|49|||
94717573|NCT00761189|324423471|FG000|Overall Study|Other|13|||
94717574|NCT01976312|324423472|FG000|Overall Study|Pregnancy|0|||
94717575|NCT01976312|324423473|FG001|Overall Study|Pregnancy|1|||
94717576|NCT01976312|324423472|FG000|Overall Study|Lost to Follow-up|2|||
94717577|NCT01976312|324423473|FG001|Overall Study|Lost to Follow-up|0|||
94717578|NCT01976312|324423472|FG000|Overall Study|Withdrawal by Subject|7|||
94717579|NCT01976312|324423473|FG001|Overall Study|Withdrawal by Subject|2|||
94717580|NCT01976312|324423472|FG000|Overall Study|Adverse Event|6|||
94717581|NCT01976312|324423473|FG001|Overall Study|Adverse Event|6|||
94717582|NCT01976312|324423472|FG000|Overall Study|Protocol Violation|2|||
94717583|NCT01976312|324423473|FG001|Overall Study|Protocol Violation|0|||
94717584|NCT03939312|324423474|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
94717585|NCT03939312|324423474|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
94717586|NCT03939312|324423474|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
94717587|NCT03939312|324423474|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
94717588|NCT03939312|324423474|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
94717589|NCT03939312|324423474|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
94717590|NCT03939312|324423474|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
94717591|NCT03939312|324423474|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
94717592|NCT03939312|324423474|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
94717593|NCT03939312|324423474|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
94717594|NCT03939312|324423474|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
94717595|NCT03939312|324423474|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
94717596|NCT04814186|324425024|FG000|Treatment Phase|Adverse Event|1|||
94717597|NCT04814186|324425024|FG000|Treatment Phase|Death|6|||
94717598|NCT04814186|324425024|FG000|Treatment Phase|Withdrawal by Subject|2|||
94717599|NCT04814186|324425024|FG000|Treatment Phase|Other|1|||
94367857|NCT00759759|323133062|FG001|Overall Study|didn't return for period 2|0|||
94367858|NCT00759759|323133061|FG000|Overall Study|Didn't receive drug in period 2|1|||
94367859|NCT00759759|323133062|FG001|Overall Study|Didn't receive drug in period 2|0|||
94717600|NCT04814186|324425024|FG000|Follow-Up Phase|Adverse Event|1|||
94717601|NCT04814186|324425024|FG000|Follow-Up Phase|Death|6|||
94717602|NCT04814186|324425024|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
94717603|NCT04814186|324425024|FG000|Follow-Up Phase|Other|1|||
94717604|NCT01853748|324425030|FG000|Allocation|Withdrawal by Subject|1|||
94717605|NCT01853748|324425031|FG001|Allocation|Withdrawal by Subject|13|||
94717606|NCT01853748|324425030|FG000|Allocation|not sufficient to receive intervention|0|||
94717607|NCT01853748|324425031|FG001|Allocation|not sufficient to receive intervention|1|||
94717608|NCT01853748|324425030|FG000|Follow-Up|Withdrawal by Subject|7|||
94367860|NCT00759759|323133061|FG000|Overall Study|Withdrawal by Subject|2|||
94367861|NCT00759759|323133062|FG001|Overall Study|Withdrawal by Subject|1|||
94367862|NCT04556838|323133064|FG000|Overall Study|Withdrawal by Subject|3|||
94367863|NCT04556838|323133065|FG001|Overall Study|Withdrawal by Subject|1|||
94367864|NCT04556838|323133066|FG002|Overall Study|Withdrawal by Subject|2|||
94367865|NCT04556838|323133064|FG000|Overall Study|Adverse Event|0|||
94367866|NCT04556838|323133065|FG001|Overall Study|Adverse Event|1|||
94367867|NCT04556838|323133066|FG002|Overall Study|Adverse Event|1|||
94654264|NCT04116229|324192211|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
94654265|NCT04116229|324192212|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
94654266|NCT04116229|324192211|FG000|Overall Study|Scheduling not possible.|0|||
94654267|NCT04116229|324192212|FG001|Overall Study|Scheduling not possible.|1|||
94654268|NCT00403455|324192213|FG000|Overall Study|Withdrawal by Subject|1|||
94654269|NCT02992899|324192216|FG000|Overall Study|Withdrawal by Subject|1|||
94654270|NCT02992899|324192217|FG001|Overall Study|Withdrawal by Subject|0|||
94654271|NCT02992899|324192216|FG000|Overall Study|Lost to Follow-up|1|||
94654272|NCT02992899|324192217|FG001|Overall Study|Lost to Follow-up|3|||
94367868|NCT04556838|323133064|FG000|Overall Study|Lost to Follow-up|0|||
94367869|NCT04556838|323133065|FG001|Overall Study|Lost to Follow-up|0|||
94367870|NCT04556838|323133066|FG002|Overall Study|Lost to Follow-up|2|||
94367871|NCT04556838|323133064|FG000|Overall Study|Subject travel|0|||
94367872|NCT04556838|323133065|FG001|Overall Study|Subject travel|1|||
94367873|NCT04556838|323133066|FG002|Overall Study|Subject travel|0|||
94367874|NCT04556838|323133064|FG000|Overall Study|Physician Decision|1|||
94367875|NCT04556838|323133065|FG001|Overall Study|Physician Decision|0|||
94367876|NCT04556838|323133066|FG002|Overall Study|Physician Decision|0|||
94367877|NCT00995930|323133067|FG000|Overall Study|Protocol deviation|2|||
94367878|NCT00995930|323133068|FG001|Overall Study|Protocol deviation|5|||
94367879|NCT00995930|323133067|FG000|Overall Study|Death|0|||
94367880|NCT00995930|323133068|FG001|Overall Study|Death|1|||
94367881|NCT00995930|323133067|FG000|Overall Study|Administrative problems|4|||
94654273|NCT01993719|324192218|FG000|First Drug Administration|Not treated|1|||
94654274|NCT01993719|324192219|FG001|First Drug Administration|Not treated|0|||
94654275|NCT01993719|324192220|FG002|First Drug Administration|Not treated|0|||
94654276|NCT01993719|324192221|FG003|First Drug Administration|Not treated|0|||
94654277|NCT01993719|324192222|FG004|First Drug Administration|Not treated|0|||
94717609|NCT01853748|324425031|FG001|Follow-Up|Withdrawal by Subject|6|||
94717610|NCT01853748|324425030|FG000|Follow-Up|Adverse Event|67|||
94717611|NCT01853748|324425031|FG001|Follow-Up|Adverse Event|7|||
94717612|NCT01853748|324425030|FG000|Follow-Up|not available for data collection|16|||
94717613|NCT01853748|324425031|FG001|Follow-Up|not available for data collection|4|||
94717614|NCT03960463|324425047|FG000|Overall Study|Withdrawal by Subject|2|||
94717615|NCT03960463|324425048|FG001|Overall Study|Withdrawal by Subject|0|||
94717616|NCT05194917|324425049|FG000|Overall Study|Lost to Follow-up|7|||
94717617|NCT05194917|324425050|FG001|Overall Study|Lost to Follow-up|5|||
94717618|NCT05194917|324425051|FG002|Overall Study|Lost to Follow-up|6|||
94717619|NCT05194917|324425052|FG003|Overall Study|Lost to Follow-up|5|||
94717620|NCT04922021|324425053|FG000|Overall Study|Withdrawal by Subject|4|||
94717621|NCT04922021|324425054|FG001|Overall Study|Withdrawal by Subject|10|||
94717622|NCT04922021|324425053|FG000|Overall Study|Adverse Event|2|||
94717623|NCT04922021|324425054|FG001|Overall Study|Adverse Event|2|||
94717624|NCT04922021|324425053|FG000|Overall Study|Lack of Efficacy|0|||
94717625|NCT04922021|324425054|FG001|Overall Study|Lack of Efficacy|1|||
94717626|NCT04922021|324425053|FG000|Overall Study|Multiple reasons|1|||
94717627|NCT04922021|324425054|FG001|Overall Study|Multiple reasons|0|||
94717628|NCT05644444|324425059|FG000|Tolerance Phase|Adverse Event|0|||
94717629|NCT05644444|324425060|FG001|Tolerance Phase|Adverse Event|2|||
94717630|NCT05644444|324425059|FG000|Treatment Phase|Adverse Event|0|||
94717631|NCT05644444|324425060|FG001|Treatment Phase|Adverse Event|2|||
94717632|NCT02576509|324425066|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
94717633|NCT02576509|324425067|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
94717634|NCT02576509|324425066|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
94717635|NCT02576509|324425067|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
94717636|NCT02576509|324425066|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
94717637|NCT02576509|324425067|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
94367882|NCT00995930|323133068|FG001|Overall Study|Administrative problems|2|||
94367883|NCT00995930|323133067|FG000|Overall Study|Lost to Follow-up|1|||
94367884|NCT00995930|323133068|FG001|Overall Study|Lost to Follow-up|2|||
94367885|NCT00995930|323133067|FG000|Overall Study|Withdrawal by Subject|3|||
94717638|NCT02576509|324425066|FG000|Treatment Period|Disease progression|263|||
94717639|NCT02576509|324425067|FG001|Treatment Period|Disease progression|244|||
94717640|NCT02576509|324425066|FG000|Treatment Period|Study drug toxicity|37|||
94717641|NCT02576509|324425067|FG001|Treatment Period|Study drug toxicity|41|||
94717642|NCT02576509|324425066|FG000|Treatment Period|Death|1|||
94717643|NCT02576509|324425067|FG001|Treatment Period|Death|1|||
94367886|NCT00995930|323133068|FG001|Overall Study|Withdrawal by Subject|4|||
94367887|NCT00995930|323133067|FG000|Overall Study|Adverse Event|11|||
94654278|NCT02461589|324192228|FG000|Overall Study|Withdrawal by Subject|5|||
94654279|NCT02461589|324192229|FG001|Overall Study|Withdrawal by Subject|1|||
94654280|NCT02461589|324192230|FG002|Overall Study|Withdrawal by Subject|3|||
94654281|NCT02461589|324192231|FG003|Overall Study|Withdrawal by Subject|2|||
94654282|NCT02461589|324192232|FG004|Overall Study|Withdrawal by Subject|1|||
94654283|NCT02461589|324192233|FG005|Overall Study|Withdrawal by Subject|2|||
94654284|NCT02461589|324192234|FG006|Overall Study|Withdrawal by Subject|1|||
94654285|NCT02461589|324192235|FG007|Overall Study|Withdrawal by Subject|3|||
94654286|NCT02461589|324192236|FG008|Overall Study|Withdrawal by Subject|3|||
94654287|NCT02461589|324192237|FG009|Overall Study|Withdrawal by Subject|1|||
94654288|NCT02461589|324192228|FG000|Overall Study|Lost to Follow-up|0|||
94654289|NCT02461589|324192229|FG001|Overall Study|Lost to Follow-up|0|||
94654290|NCT02461589|324192230|FG002|Overall Study|Lost to Follow-up|2|||
94367888|NCT00995930|323133068|FG001|Overall Study|Adverse Event|14|||
94367889|NCT02367781|323133069|FG000|Overall Study|Withdrawal by Subject|20|||
94654291|NCT02461589|324192231|FG003|Overall Study|Lost to Follow-up|3|||
94654292|NCT02461589|324192232|FG004|Overall Study|Lost to Follow-up|1|||
94654293|NCT02461589|324192233|FG005|Overall Study|Lost to Follow-up|1|||
94654294|NCT02461589|324192234|FG006|Overall Study|Lost to Follow-up|3|||
94654295|NCT02461589|324192235|FG007|Overall Study|Lost to Follow-up|1|||
94654296|NCT02461589|324192236|FG008|Overall Study|Lost to Follow-up|3|||
94654297|NCT02461589|324192237|FG009|Overall Study|Lost to Follow-up|1|||
94654298|NCT02461589|324192228|FG000|Overall Study|Death|0|||
94654299|NCT02461589|324192229|FG001|Overall Study|Death|0|||
94654300|NCT02461589|324192230|FG002|Overall Study|Death|0|||
94654301|NCT02461589|324192231|FG003|Overall Study|Death|0|||
94654302|NCT02461589|324192232|FG004|Overall Study|Death|0|||
94654303|NCT02461589|324192233|FG005|Overall Study|Death|0|||
94654304|NCT02461589|324192234|FG006|Overall Study|Death|0|||
94654305|NCT02461589|324192235|FG007|Overall Study|Death|1|||
94654306|NCT02461589|324192236|FG008|Overall Study|Death|0|||
94654307|NCT02461589|324192237|FG009|Overall Study|Death|0|||
94654308|NCT02461589|324192228|FG000|Overall Study|Unclassified|0|||
94654309|NCT02461589|324192229|FG001|Overall Study|Unclassified|0|||
94654310|NCT02461589|324192230|FG002|Overall Study|Unclassified|0|||
94654311|NCT02461589|324192231|FG003|Overall Study|Unclassified|0|||
94654312|NCT02461589|324192232|FG004|Overall Study|Unclassified|0|||
94654313|NCT02461589|324192233|FG005|Overall Study|Unclassified|0|||
94654314|NCT02461589|324192234|FG006|Overall Study|Unclassified|1|||
94654315|NCT02461589|324192235|FG007|Overall Study|Unclassified|0|||
94654316|NCT02461589|324192236|FG008|Overall Study|Unclassified|0|||
94654317|NCT02461589|324192237|FG009|Overall Study|Unclassified|2|||
94654318|NCT02461589|324192228|FG000|Overall Study|Missing follow-up information|1|||
94654319|NCT02461589|324192229|FG001|Overall Study|Missing follow-up information|1|||
94654320|NCT02461589|324192230|FG002|Overall Study|Missing follow-up information|0|||
94654321|NCT02461589|324192231|FG003|Overall Study|Missing follow-up information|0|||
94654322|NCT02461589|324192232|FG004|Overall Study|Missing follow-up information|0|||
94654323|NCT02461589|324192233|FG005|Overall Study|Missing follow-up information|0|||
94654324|NCT02461589|324192234|FG006|Overall Study|Missing follow-up information|1|||
94654325|NCT02461589|324192235|FG007|Overall Study|Missing follow-up information|0|||
94654326|NCT02461589|324192236|FG008|Overall Study|Missing follow-up information|0|||
94654327|NCT02461589|324192237|FG009|Overall Study|Missing follow-up information|0|||
94654328|NCT02461589|324192228|FG000|Overall Study|Withdrawal from trial before exposure|0|||
94654329|NCT02461589|324192229|FG001|Overall Study|Withdrawal from trial before exposure|0|||
94654330|NCT02461589|324192230|FG002|Overall Study|Withdrawal from trial before exposure|0|||
94654331|NCT02461589|324192231|FG003|Overall Study|Withdrawal from trial before exposure|0|||
94654332|NCT02461589|324192232|FG004|Overall Study|Withdrawal from trial before exposure|0|||
94654333|NCT02461589|324192233|FG005|Overall Study|Withdrawal from trial before exposure|0|||
94654334|NCT02461589|324192234|FG006|Overall Study|Withdrawal from trial before exposure|0|||
94654335|NCT02461589|324192235|FG007|Overall Study|Withdrawal from trial before exposure|0|||
94654336|NCT02461589|324192236|FG008|Overall Study|Withdrawal from trial before exposure|0|||
94654337|NCT02461589|324192237|FG009|Overall Study|Withdrawal from trial before exposure|1|||
94654338|NCT01557946|324192242|FG000|Overall Study|Adverse Event|3|||
94654339|NCT01557946|324192243|FG001|Overall Study|Adverse Event|0|||
94654340|NCT04067141|324192244|FG000|First Intervention|Withdrawal by Subject|0|||
94654341|NCT04067141|324192245|FG001|First Intervention|Withdrawal by Subject|1|||
94654342|NCT04067141|324192244|FG000|Second Intervention|Adverse Event|0|||
94654343|NCT04067141|324192245|FG001|Second Intervention|Adverse Event|2|||
94654344|NCT01038921|324192246|FG000|Overall Study|Withdrawal by Subject|1|||
94654345|NCT01038921|324192247|FG001|Overall Study|Withdrawal by Subject|0|||
94654346|NCT01038921|324192246|FG000|Overall Study|Physician Decision|1|||
94654347|NCT01038921|324192247|FG001|Overall Study|Physician Decision|0|||
94654348|NCT01978119|324192248|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
94654349|NCT01978119|324192249|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
94654350|NCT01978119|324192248|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
94654351|NCT01978119|324192249|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
94654352|NCT01978119|324192248|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
94654353|NCT01978119|324192249|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
94654354|NCT03669081|324192250|FG000|Overall Study|Data could not be validated|1|||
94654355|NCT03669081|324192251|FG001|Overall Study|Data could not be validated|1|||
94654356|NCT00812812|324192252|FG000|Overall Study|Adverse Event|2|||
94654357|NCT00812812|324192253|FG001|Overall Study|Adverse Event|1|||
94654358|NCT00812812|324192252|FG000|Overall Study|Lack of Efficacy|1|||
94654359|NCT00812812|324192253|FG001|Overall Study|Lack of Efficacy|0|||
94654360|NCT00812812|324192252|FG000|Overall Study|Lost to Follow-up|0|||
94654361|NCT00812812|324192253|FG001|Overall Study|Lost to Follow-up|1|||
94654362|NCT00812812|324192252|FG000|Overall Study|Withdrawal by Subject|0|||
94654363|NCT00812812|324192253|FG001|Overall Study|Withdrawal by Subject|2|||
94654364|NCT02223390|324192254|FG000|Overall Study|Lost to Follow-up|9|||
94654365|NCT02223390|324192255|FG001|Overall Study|Lost to Follow-up|4|||
94654366|NCT00572572|324192256|FG000|Overall Study|Withdrawal by Subject|3|||
94654367|NCT00572572|324192257|FG001|Overall Study|Withdrawal by Subject|6|||
94654368|NCT01831089|324192258|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
94654369|NCT01831089|324192259|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
94654370|NCT01831089|324192260|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
94654371|NCT01831089|324192261|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
94654372|NCT01831089|324192262|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
94654373|NCT01831089|324192263|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
94654374|NCT01831089|324192258|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
94654375|NCT01831089|324192259|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
94654376|NCT01831089|324192260|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
94654377|NCT01831089|324192261|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
94654378|NCT01831089|324192262|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
94654379|NCT01831089|324192263|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
94654380|NCT01831089|324192258|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
94654381|NCT01831089|324192259|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
94654382|NCT01831089|324192260|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
94654383|NCT01831089|324192261|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
94654384|NCT01831089|324192262|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
94654385|NCT01831089|324192263|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
94654386|NCT01831089|324192258|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
94654387|NCT01831089|324192259|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
94654388|NCT01831089|324192260|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
94654389|NCT01831089|324192261|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
94654390|NCT01831089|324192262|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
94654391|NCT01831089|324192263|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
94654392|NCT01831089|324192258|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
94654393|NCT01831089|324192259|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
94654394|NCT01831089|324192260|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
94654395|NCT01831089|324192261|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
94654396|NCT01831089|324192262|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
94654397|NCT01831089|324192263|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
94654398|NCT01831089|324192258|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
94654399|NCT01831089|324192259|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
94654400|NCT01831089|324192260|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
94654401|NCT01831089|324192261|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
94654402|NCT01831089|324192262|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
94654403|NCT01831089|324192263|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
94654404|NCT01831089|324192258|FG000|Cohort III: Dose Level 3|Global end of study|0|||
94654405|NCT01831089|324192259|FG001|Cohort III: Dose Level 3|Global end of study|0|||
94654406|NCT01831089|324192260|FG002|Cohort III: Dose Level 3|Global end of study|1|||
94654407|NCT01831089|324192261|FG003|Cohort III: Dose Level 3|Global end of study|0|||
94654408|NCT01831089|324192262|FG004|Cohort III: Dose Level 3|Global end of study|0|||
94654409|NCT01831089|324192263|FG005|Cohort III: Dose Level 3|Global end of study|0|||
94654410|NCT01831089|324192258|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
94654411|NCT01831089|324192259|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
94654412|NCT01831089|324192260|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
94654413|NCT01831089|324192261|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
94654414|NCT01831089|324192262|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
94654415|NCT01831089|324192263|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
94654416|NCT01831089|324192258|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
94654417|NCT01831089|324192259|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
94654418|NCT01831089|324192260|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
94654419|NCT01831089|324192261|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
94654420|NCT01831089|324192262|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
94654421|NCT01831089|324192263|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
94654422|NCT01831089|324192258|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
94654423|NCT01831089|324192259|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
94271887|NCT02664272|322788574|FG000|Overall Study|Fluoroscopic images not made available|2|||
94271888|NCT01940471|322788579|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
94271889|NCT01940471|322788580|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
94271890|NCT01940471|322788581|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
94271891|NCT01940471|322788582|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
94271892|NCT01940471|322788579|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
94271893|NCT01940471|322788580|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
94271894|NCT01940471|322788581|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
94271895|NCT01940471|322788582|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
94271896|NCT01940471|322788579|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
94271897|NCT01940471|322788580|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
94271898|NCT01940471|322788581|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
94271899|NCT01940471|322788582|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
94271900|NCT01940471|322788579|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
94271901|NCT01940471|322788580|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
94271902|NCT01940471|322788581|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
94271903|NCT01940471|322788582|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
94271904|NCT01940471|322788579|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
94271905|NCT01940471|322788580|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
94271906|NCT01940471|322788581|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
94271907|NCT01940471|322788582|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
94271908|NCT01940471|322788579|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
94271909|NCT01940471|322788580|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
94271910|NCT01940471|322788581|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
94271911|NCT01940471|322788582|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
94271912|NCT01940471|322788579|FG000|Period 1: Double-blind Phase|Death|2|||
94271913|NCT01940471|322788580|FG001|Period 1: Double-blind Phase|Death|1|||
94271914|NCT01940471|322788581|FG002|Period 1: Double-blind Phase|Death|0|||
94271915|NCT01940471|322788582|FG003|Period 1: Double-blind Phase|Death|0|||
94271916|NCT01940471|322788579|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
94271917|NCT01940471|322788580|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
94271918|NCT01940471|322788581|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
94271919|NCT01940471|322788582|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
94271920|NCT01940471|322788579|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
94271921|NCT01940471|322788580|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
94271922|NCT01940471|322788581|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
94271923|NCT01940471|322788582|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
94271924|NCT01940471|322788579|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
94271925|NCT01940471|322788580|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
94271926|NCT01940471|322788581|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
94271927|NCT01940471|322788582|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
94271928|NCT01940471|322788579|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
94271929|NCT01940471|322788580|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
94271930|NCT01940471|322788581|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
94271931|NCT01940471|322788582|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
94271932|NCT01940471|322788579|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
94271933|NCT01940471|322788580|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
94271934|NCT01940471|322788581|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
94271935|NCT01940471|322788582|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
94467292|NCT01897571|323500499|FG003|Overall Study|Other|3|||
94654424|NCT01831089|324192260|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
94654425|NCT01831089|324192261|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
94654426|NCT01831089|324192262|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
94654427|NCT01831089|324192263|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
94654428|NCT01831089|324192258|FG000|Cohort V: Dose Level 5|Death|0|||
94654429|NCT01831089|324192259|FG001|Cohort V: Dose Level 5|Death|0|||
94654430|NCT01831089|324192260|FG002|Cohort V: Dose Level 5|Death|0|||
94654431|NCT01831089|324192261|FG003|Cohort V: Dose Level 5|Death|0|||
94654432|NCT01831089|324192262|FG004|Cohort V: Dose Level 5|Death|1|||
94654433|NCT01831089|324192263|FG005|Cohort V: Dose Level 5|Death|0|||
94654434|NCT01831089|324192258|FG000|Cohort V: Dose Level 5|Global end of study|0|||
94654435|NCT01831089|324192259|FG001|Cohort V: Dose Level 5|Global end of study|0|||
94654436|NCT01831089|324192260|FG002|Cohort V: Dose Level 5|Global end of study|0|||
94654437|NCT01831089|324192261|FG003|Cohort V: Dose Level 5|Global end of study|0|||
94654438|NCT01831089|324192262|FG004|Cohort V: Dose Level 5|Global end of study|2|||
94654439|NCT01831089|324192263|FG005|Cohort V: Dose Level 5|Global end of study|0|||
94654440|NCT01831089|324192258|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
94654441|NCT01831089|324192259|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
94654442|NCT01831089|324192260|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
94654443|NCT01831089|324192261|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
94654444|NCT01831089|324192262|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
94654445|NCT01831089|324192263|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
94654446|NCT01831089|324192258|FG000|Cohort B: Arm B|Progressive disease|0|||
94654447|NCT01831089|324192259|FG001|Cohort B: Arm B|Progressive disease|0|||
94654448|NCT01831089|324192260|FG002|Cohort B: Arm B|Progressive disease|0|||
94654449|NCT01831089|324192261|FG003|Cohort B: Arm B|Progressive disease|0|||
94654450|NCT01831089|324192262|FG004|Cohort B: Arm B|Progressive disease|0|||
94654451|NCT01831089|324192263|FG005|Cohort B: Arm B|Progressive disease|8|||
94654452|NCT01831089|324192258|FG000|Cohort B: Arm B|Physician Decision|0|||
94654453|NCT01831089|324192259|FG001|Cohort B: Arm B|Physician Decision|0|||
94654454|NCT01831089|324192260|FG002|Cohort B: Arm B|Physician Decision|0|||
94654455|NCT01831089|324192261|FG003|Cohort B: Arm B|Physician Decision|0|||
94654456|NCT01831089|324192262|FG004|Cohort B: Arm B|Physician Decision|0|||
94654457|NCT01831089|324192263|FG005|Cohort B: Arm B|Physician Decision|2|||
94654458|NCT01831089|324192258|FG000|Cohort B: Arm B|Never treated|0|||
94654459|NCT01831089|324192259|FG001|Cohort B: Arm B|Never treated|0|||
94654460|NCT01831089|324192260|FG002|Cohort B: Arm B|Never treated|0|||
94654461|NCT01831089|324192261|FG003|Cohort B: Arm B|Never treated|0|||
94654462|NCT01831089|324192262|FG004|Cohort B: Arm B|Never treated|0|||
94654463|NCT01831089|324192263|FG005|Cohort B: Arm B|Never treated|2|||
94654464|NCT01831089|324192258|FG000|Cohort B: Arm B|Adverse Event|0|||
94654465|NCT01831089|324192259|FG001|Cohort B: Arm B|Adverse Event|0|||
94654466|NCT01831089|324192260|FG002|Cohort B: Arm B|Adverse Event|0|||
94654467|NCT01831089|324192261|FG003|Cohort B: Arm B|Adverse Event|0|||
94654468|NCT01831089|324192262|FG004|Cohort B: Arm B|Adverse Event|0|||
94654469|NCT01831089|324192263|FG005|Cohort B: Arm B|Adverse Event|1|||
94654470|NCT01831089|324192258|FG000|Cohort B: Arm B|Global end of study|0|||
94654471|NCT01831089|324192259|FG001|Cohort B: Arm B|Global end of study|0|||
94654472|NCT01831089|324192260|FG002|Cohort B: Arm B|Global end of study|0|||
94654473|NCT01831089|324192261|FG003|Cohort B: Arm B|Global end of study|0|||
94654474|NCT01831089|324192262|FG004|Cohort B: Arm B|Global end of study|0|||
94654475|NCT01831089|324192263|FG005|Cohort B: Arm B|Global end of study|1|||
94654476|NCT03755765|324192264|FG000|Overall Study|Withdrawal by Subject|2|||
94654477|NCT03755765|324192265|FG001|Overall Study|Withdrawal by Subject|4|||
94654478|NCT03755765|324192266|FG002|Overall Study|Withdrawal by Subject|4|||
94654479|NCT00659269|324192269|FG000|Overall Study|Physician Decision|1|||
94654480|NCT00659269|324192270|FG001|Overall Study|Physician Decision|1|||
94654481|NCT01158222|324192271|FG000|Overall Study|Not eligible for intermediate phase|17|||
94654482|NCT00678691|324192272|FG000|Overall Study|Adverse Event|6|||
94654483|NCT00678691|324192273|FG001|Overall Study|Adverse Event|4|||
94654492|NCT00833924|324192276|FG000|Overall Study|Death|21|||
94717644|NCT02576509|324425066|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
94654493|NCT00833924|324192276|FG000|Overall Study|Conversion|2|||
94654494|NCT00833924|324192276|FG000|Overall Study|Lost to Follow-up|2|||
94654495|NCT00833924|324192276|FG000|Overall Study|Withdrawal by Subject|13|||
94654496|NCT00833924|324192276|FG000|Overall Study|In study follow-up|71|||
94654497|NCT01416805|324192277|FG000|Overall Study|Lost to Follow-up|4|||
94654498|NCT01416805|324192278|FG001|Overall Study|Lost to Follow-up|4|||
94654499|NCT02610140|324192283|FG000|Randomization and Treatment Period|Radiological progression|23|||
94271936|NCT01940471|322788579|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
94271937|NCT01940471|322788580|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
94271938|NCT01940471|322788581|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
94654500|NCT02610140|324192284|FG001|Randomization and Treatment Period|Radiological progression|15|||
94654501|NCT02610140|324192283|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
94654502|NCT02610140|324192284|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
94654503|NCT02610140|324192283|FG000|Randomization and Treatment Period|Protocol Violation|1|||
94654504|NCT02610140|324192284|FG001|Randomization and Treatment Period|Protocol Violation|0|||
94654505|NCT02610140|324192283|FG000|Randomization and Treatment Period|Physician Decision|0|||
94654506|NCT02610140|324192284|FG001|Randomization and Treatment Period|Physician Decision|1|||
94654507|NCT02610140|324192283|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
94654508|NCT02610140|324192284|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
94654509|NCT02610140|324192283|FG000|Randomization and Treatment Period|Death|7|||
94654510|NCT02610140|324192284|FG001|Randomization and Treatment Period|Death|1|||
94654511|NCT02610140|324192283|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
94654512|NCT02610140|324192284|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
94654513|NCT02610140|324192283|FG000|Randomization and Treatment Period|Adverse Event|44|||
94654514|NCT02610140|324192284|FG001|Randomization and Treatment Period|Adverse Event|13|||
94654515|NCT02610140|324192283|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
94654516|NCT02610140|324192284|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
94654517|NCT02610140|324192283|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
94654518|NCT02610140|324192284|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
94654519|NCT02610140|324192283|FG000|Randomization and Treatment Period|Not treated|3|||
94654520|NCT02610140|324192284|FG001|Randomization and Treatment Period|Not treated|10|||
94654521|NCT02610140|324192283|FG000|Safety Follow-up|Other|0|||
94654522|NCT02610140|324192284|FG001|Safety Follow-up|Other|2|||
94654523|NCT02610140|324192283|FG000|Safety Follow-up|Lost to Follow-up|1|||
94654524|NCT02610140|324192284|FG001|Safety Follow-up|Lost to Follow-up|0|||
94654525|NCT02610140|324192283|FG000|Safety Follow-up|No follow-up|5|||
94654526|NCT02610140|324192284|FG001|Safety Follow-up|No follow-up|3|||
94654527|NCT02610140|324192283|FG000|Safety Follow-up|Death|12|||
94654528|NCT02610140|324192284|FG001|Safety Follow-up|Death|2|||
94654529|NCT02610140|324192283|FG000|Safety Follow-up|Deterioration of general conditions|15|||
94654530|NCT02610140|324192284|FG001|Safety Follow-up|Deterioration of general conditions|5|||
94654531|NCT02610140|324192283|FG000|Safety Follow-up|Withdrawal by Subject|12|||
94654532|NCT02610140|324192284|FG001|Safety Follow-up|Withdrawal by Subject|12|||
94654533|NCT02610140|324192283|FG000|Active Follow-up|Progressive disease - radiological|30|||
94654534|NCT02610140|324192284|FG001|Active Follow-up|Progressive disease - radiological|22|||
94654535|NCT02610140|324192283|FG000|Active Follow-up|Death|8|||
94654536|NCT02610140|324192284|FG001|Active Follow-up|Death|1|||
94654537|NCT02610140|324192283|FG000|Active Follow-up|Withdrawal by Subject|4|||
94654538|NCT02610140|324192284|FG001|Active Follow-up|Withdrawal by Subject|0|||
94654539|NCT02610140|324192283|FG000|Active Follow-up|Progressive disease - clinical|1|||
94654540|NCT02610140|324192284|FG001|Active Follow-up|Progressive disease - clinical|2|||
94654541|NCT02610140|324192283|FG000|Active Follow-up|Deterioration of general conditions|1|||
94654542|NCT02610140|324192284|FG001|Active Follow-up|Deterioration of general conditions|0|||
94654543|NCT02610140|324192283|FG000|Active Follow-up|Ongoing but not completed|4|||
94654544|NCT02610140|324192284|FG001|Active Follow-up|Ongoing but not completed|1|||
94654545|NCT02610140|324192283|FG000|Long-term Follow-up|Death|86|||
94654546|NCT02610140|324192284|FG001|Long-term Follow-up|Death|44|||
94654547|NCT02610140|324192283|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
94654548|NCT02610140|324192284|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
94654549|NCT02610140|324192283|FG000|Long-term Follow-up|Lost to Follow-up|1|||
94654550|NCT02610140|324192284|FG001|Long-term Follow-up|Lost to Follow-up|2|||
94654551|NCT02610140|324192283|FG000|Long-term Follow-up|Ongoing but not completed|30|||
94654552|NCT02610140|324192284|FG001|Long-term Follow-up|Ongoing but not completed|17|||
94654553|NCT00179647|324192287|FG000|Overall Study|Adverse Event|294|||
94654554|NCT00179647|324192287|FG000|Overall Study|Lack of Efficacy|478|||
94654555|NCT00179647|324192287|FG000|Overall Study|Withdrawal by Subject|83|||
94654556|NCT00179647|324192287|FG000|Overall Study|Lost to Follow-up|4|||
94654557|NCT00179647|324192287|FG000|Overall Study|Death|94|||
94654558|NCT00179647|324192287|FG000|Overall Study|Other|960|||
94654559|NCT01826825|324192295|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
94654560|NCT01826825|324192296|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
94654561|NCT01312961|324192297|FG000|Overall Study|Adverse Event|3|||
94654562|NCT01312961|324192298|FG001|Overall Study|Adverse Event|3|||
94654563|NCT01312961|324192297|FG000|Overall Study|Lack of Efficacy|11|||
94654564|NCT01312961|324192298|FG001|Overall Study|Lack of Efficacy|1|||
94654565|NCT01312961|324192297|FG000|Overall Study|Poor compliance to protocol|1|||
94654566|NCT01312961|324192298|FG001|Overall Study|Poor compliance to protocol|0|||
94717645|NCT02576509|324425067|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
94654567|NCT01312961|324192297|FG000|Overall Study|Other than specified above|2|||
94654568|NCT01312961|324192298|FG001|Overall Study|Other than specified above|3|||
94654569|NCT01848990|324192299|FG000|Overall Study|Adverse Event|6|||
94654570|NCT01848990|324192300|FG001|Overall Study|Adverse Event|2|||
94654571|NCT01848990|324192301|FG002|Overall Study|Adverse Event|0|||
94654572|NCT01848990|324192299|FG000|Overall Study|Lost to Follow-up|6|||
94271939|NCT01940471|322788582|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
94271940|NCT01940471|322788579|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
94271941|NCT01940471|322788580|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
94654573|NCT01848990|324192300|FG001|Overall Study|Lost to Follow-up|2|||
94654574|NCT01848990|324192301|FG002|Overall Study|Lost to Follow-up|2|||
94654575|NCT01848990|324192299|FG000|Overall Study|Protocol Violation|1|||
94654576|NCT01848990|324192300|FG001|Overall Study|Protocol Violation|1|||
94654577|NCT01848990|324192301|FG002|Overall Study|Protocol Violation|0|||
94654578|NCT01848990|324192299|FG000|Overall Study|Withdrawal by Subject|29|||
94654579|NCT01848990|324192300|FG001|Overall Study|Withdrawal by Subject|10|||
94654580|NCT01848990|324192301|FG002|Overall Study|Withdrawal by Subject|11|||
94654581|NCT01848990|324192299|FG000|Overall Study|Physician Decision|1|||
94367890|NCT02367781|323133070|FG001|Overall Study|Withdrawal by Subject|13|||
94654582|NCT01848990|324192300|FG001|Overall Study|Physician Decision|1|||
94367891|NCT02367781|323133069|FG000|Overall Study|Protocol Violation|0|||
94654583|NCT01848990|324192301|FG002|Overall Study|Physician Decision|0|||
94654584|NCT01848990|324192299|FG000|Overall Study|Non Compliance|1|||
94654585|NCT01848990|324192300|FG001|Overall Study|Non Compliance|0|||
94654586|NCT01848990|324192301|FG002|Overall Study|Non Compliance|0|||
94654587|NCT01848990|324192299|FG000|Overall Study|Death|1|||
94654588|NCT01848990|324192300|FG001|Overall Study|Death|0|||
94654589|NCT01848990|324192301|FG002|Overall Study|Death|1|||
94654590|NCT01848990|324192299|FG000|Overall Study|Other|1|||
94654591|NCT01848990|324192300|FG001|Overall Study|Other|4|||
94654592|NCT01848990|324192301|FG002|Overall Study|Other|2|||
94654593|NCT00298038|324192303|FG000|Overall Study|Lost to Follow-up|0|||
94654594|NCT00298038|324192304|FG001|Overall Study|Lost to Follow-up|1|||
94654595|NCT00298038|324192303|FG000|Overall Study|Liver Transplant|0|||
94654596|NCT00298038|324192304|FG001|Overall Study|Liver Transplant|1|||
94654597|NCT00298038|324192303|FG000|Overall Study|Protocol Violation|1|||
94654598|NCT00298038|324192304|FG001|Overall Study|Protocol Violation|3|||
94654599|NCT00298038|324192303|FG000|Overall Study|Death|6|||
94654600|NCT00298038|324192304|FG001|Overall Study|Death|3|||
94654601|NCT00298038|324192303|FG000|Overall Study|Withdrawal by Subject|6|||
94654602|NCT00298038|324192304|FG001|Overall Study|Withdrawal by Subject|9|||
94654603|NCT00298038|324192303|FG000|Overall Study|Adverse Event|8|||
94654604|NCT00298038|324192304|FG001|Overall Study|Adverse Event|7|||
94654605|NCT00298038|324192303|FG000|Overall Study|Breakthrough overt HE episode|28|||
94654606|NCT00298038|324192304|FG001|Overall Study|Breakthrough overt HE episode|69|||
94654607|NCT00298038|324192303|FG000|Overall Study|Noncompliance|1|||
94654608|NCT00298038|324192304|FG001|Overall Study|Noncompliance|0|||
94654609|NCT00298038|324192303|FG000|Overall Study|Cocaine Abuse|1|||
94654610|NCT00298038|324192304|FG001|Overall Study|Cocaine Abuse|0|||
94654611|NCT00298038|324192303|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
94654612|NCT00298038|324192304|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
94654613|NCT03149328|324192305|FG000|Overall Study|Withdrawal by Subject|30|||
94654614|NCT03149328|324192306|FG001|Overall Study|Withdrawal by Subject|26|||
94654615|NCT03149328|324192305|FG000|Overall Study|Changed Dialysis Modality|18|||
94654616|NCT03149328|324192306|FG001|Overall Study|Changed Dialysis Modality|1|||
94654617|NCT03149328|324192305|FG000|Overall Study|Transplant|9|||
94654618|NCT03149328|324192306|FG001|Overall Study|Transplant|1|||
94654619|NCT03149328|324192305|FG000|Overall Study|Lost to Follow-up|25|||
94654620|NCT03149328|324192306|FG001|Overall Study|Lost to Follow-up|16|||
94654621|NCT03149328|324192305|FG000|Overall Study|Left Study Site|1|||
94654622|NCT03149328|324192306|FG001|Overall Study|Left Study Site|2|||
94654623|NCT03149328|324192305|FG000|Overall Study|Language Barrier|1|||
94717646|NCT02576509|324425066|FG000|Treatment Period|Participant request to stop treatment|8|||
94271942|NCT01940471|322788581|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
94271943|NCT01940471|322788582|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
94271944|NCT01940471|322788579|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
94271945|NCT01940471|322788580|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
94271946|NCT01940471|322788581|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
94271947|NCT01940471|322788582|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
94271948|NCT01940471|322788579|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
94271949|NCT01940471|322788580|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
94271950|NCT01940471|322788581|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
94271951|NCT01940471|322788582|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
94271952|NCT01940471|322788579|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
94271953|NCT01940471|322788580|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
94271954|NCT01940471|322788581|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
94271955|NCT01940471|322788582|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
94271956|NCT01940471|322788579|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
94271957|NCT01940471|322788580|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
94271958|NCT01940471|322788581|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
94271959|NCT01940471|322788582|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
94271960|NCT01940471|322788579|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
94271961|NCT01940471|322788580|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
94271962|NCT01940471|322788581|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
94271963|NCT01940471|322788582|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
94271964|NCT01940471|322788579|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
94271965|NCT01940471|322788580|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
94654624|NCT03149328|324192306|FG001|Overall Study|Language Barrier|0|||
94654625|NCT02447991|324192307|FG000|Overall Study|Withdrawn by subject - no data|0|||
94654626|NCT02447991|324192308|FG001|Overall Study|Withdrawn by subject - no data|2|||
94654627|NCT02447991|324192307|FG000|Overall Study|Withdrawn by Subject - with data|4|||
94654628|NCT02447991|324192308|FG001|Overall Study|Withdrawn by Subject - with data|4|||
94654629|NCT02447991|324192307|FG000|Overall Study|Lost to Follow-up - no data|3|||
94654630|NCT02447991|324192308|FG001|Overall Study|Lost to Follow-up - no data|6|||
94654631|NCT02447991|324192307|FG000|Overall Study|Lost to follow-up - with data|0|||
94654632|NCT02447991|324192308|FG001|Overall Study|Lost to follow-up - with data|3|||
94654633|NCT02447991|324192307|FG000|Overall Study|End of study - no treatment results|3|||
94654634|NCT02447991|324192308|FG001|Overall Study|End of study - no treatment results|6|||
94654635|NCT02447991|324192307|FG000|Overall Study|End of study - partial treatment results|0|||
94654636|NCT02447991|324192308|FG001|Overall Study|End of study - partial treatment results|9|||
94654637|NCT00162136|324192309|FG000|Overall Study|Adverse Event|1|||
94367892|NCT02367781|323133070|FG001|Overall Study|Protocol Violation|1|||
94367893|NCT02367781|323133069|FG000|Overall Study|Physician Decision|7|||
94654638|NCT00162136|324192309|FG000|Overall Study|Death|1|||
94654639|NCT00162136|324192309|FG000|Overall Study|Disease Progression/Relapse|23|||
94654640|NCT00162136|324192309|FG000|Overall Study|Investigator Request|5|||
94654641|NCT00162136|324192309|FG000|Overall Study|Study Drug Toxicity|4|||
94654642|NCT00162136|324192309|FG000|Overall Study|Withdrawal by Subject|1|||
94654643|NCT02788175|324192310|FG000|Overall Study|Protocol Violation|3|||
94654644|NCT02788175|324192310|FG000|Overall Study|Withdrawal by Subject|4|||
94654645|NCT02788175|324192310|FG000|Overall Study|Ineligible prior to study agent|6|||
94654646|NCT00612313|324192312|FG000|Overall Study|Withdrawal by Subject|6|||
94654647|NCT00612313|324192313|FG001|Overall Study|Withdrawal by Subject|9|||
94654648|NCT00612313|324192312|FG000|Overall Study|Lost to Follow-up|11|||
94654649|NCT00612313|324192313|FG001|Overall Study|Lost to Follow-up|4|||
94654650|NCT00441337|324192317|FG000|Overall Study|Disease Progression|6|||
94654651|NCT00441337|324192318|FG001|Overall Study|Disease Progression|6|||
94654652|NCT00441337|324192319|FG002|Overall Study|Disease Progression|4|||
94654653|NCT00441337|324192320|FG003|Overall Study|Disease Progression|18|||
94654654|NCT00441337|324192317|FG000|Overall Study|Lost to Follow-up|0|||
94654655|NCT00441337|324192318|FG001|Overall Study|Lost to Follow-up|0|||
94654656|NCT00441337|324192319|FG002|Overall Study|Lost to Follow-up|0|||
94654657|NCT00441337|324192320|FG003|Overall Study|Lost to Follow-up|1|||
94654658|NCT00441337|324192317|FG000|Overall Study|Sponsor Decision|0|||
94654659|NCT00441337|324192318|FG001|Overall Study|Sponsor Decision|0|||
94654660|NCT00441337|324192319|FG002|Overall Study|Sponsor Decision|1|||
94654661|NCT00441337|324192320|FG003|Overall Study|Sponsor Decision|2|||
94654662|NCT00441337|324192317|FG000|Overall Study|Did not meet inclusion criteria|0|||
94654663|NCT00441337|324192318|FG001|Overall Study|Did not meet inclusion criteria|0|||
94654664|NCT00441337|324192319|FG002|Overall Study|Did not meet inclusion criteria|1|||
94654665|NCT00441337|324192320|FG003|Overall Study|Did not meet inclusion criteria|0|||
94654666|NCT00428610|324192323|FG000|Overall Study|Death Due to Adverse Event|3|||
94654667|NCT00428610|324192324|FG001|Overall Study|Death Due to Adverse Event|0|||
94654668|NCT00428610|324192325|FG002|Overall Study|Death Due to Adverse Event|5|||
94654669|NCT00428610|324192323|FG000|Overall Study|Death Due to Progressive Disease|0|||
94654670|NCT00428610|324192324|FG001|Overall Study|Death Due to Progressive Disease|0|||
94654671|NCT00428610|324192325|FG002|Overall Study|Death Due to Progressive Disease|2|||
94654672|NCT00428610|324192323|FG000|Overall Study|Adverse Event|2|||
94654673|NCT00428610|324192324|FG001|Overall Study|Adverse Event|3|||
94654674|NCT00428610|324192325|FG002|Overall Study|Adverse Event|2|||
94654675|NCT00428610|324192323|FG000|Overall Study|Investigator Decision|2|||
94654676|NCT00428610|324192324|FG001|Overall Study|Investigator Decision|1|||
94654677|NCT00428610|324192325|FG002|Overall Study|Investigator Decision|1|||
94654678|NCT00428610|324192323|FG000|Overall Study|Progressive Disease|42|||
94654679|NCT00428610|324192324|FG001|Overall Study|Progressive Disease|14|||
94654680|NCT00428610|324192325|FG002|Overall Study|Progressive Disease|22|||
94654681|NCT00428610|324192323|FG000|Overall Study|Withdrawal by Subject|4|||
94654682|NCT00428610|324192324|FG001|Overall Study|Withdrawal by Subject|0|||
94654683|NCT00428610|324192325|FG002|Overall Study|Withdrawal by Subject|0|||
94654684|NCT02293005|324194099|FG000|Overall Study|Adverse Event|2|||
94654685|NCT02293005|324194099|FG000|Overall Study|Death|4|||
94654686|NCT02293005|324194099|FG000|Overall Study|Lost to Follow-up|1|||
94654687|NCT02293005|324194099|FG000|Overall Study|Withdrawal by Subject|2|||
94654688|NCT02293005|324194099|FG000|Overall Study|Progression|17|||
94654689|NCT03143829|324194107|FG000|Overall Study|Withdrawal by Subject|2|||
94654690|NCT03143829|324194108|FG001|Overall Study|Withdrawal by Subject|5|||
94654691|NCT03143829|324194107|FG000|Overall Study|Lost to Follow-up|0|||
94654692|NCT03143829|324194108|FG001|Overall Study|Lost to Follow-up|2|||
94654693|NCT03143829|324194107|FG000|Overall Study|Death|1|||
94654694|NCT03143829|324194108|FG001|Overall Study|Death|1|||
94654695|NCT03143829|324194107|FG000|Overall Study|changed treatment, no longer eligible|2|||
94654696|NCT03143829|324194108|FG001|Overall Study|changed treatment, no longer eligible|2|||
94654697|NCT00023673|324194109|FG000|Overall Study|Ineligible / no protocol treatment|0|||
94654698|NCT00023673|324194110|FG001|Overall Study|Ineligible / no protocol treatment|0|||
94367894|NCT02367781|323133070|FG001|Overall Study|Physician Decision|0|||
94654699|NCT00023673|324194111|FG002|Overall Study|Ineligible / no protocol treatment|0|||
94654700|NCT00023673|324194112|FG003|Overall Study|Ineligible / no protocol treatment|1|||
94717647|NCT02576509|324425067|FG001|Treatment Period|Participant request to stop treatment|18|||
94717648|NCT02576509|324425066|FG000|Treatment Period|Participant withdrew consent|3|||
94717649|NCT02576509|324425067|FG001|Treatment Period|Participant withdrew consent|7|||
94717650|NCT02576509|324425066|FG000|Treatment Period|Lost to Follow-up|0|||
94717651|NCT02576509|324425067|FG001|Treatment Period|Lost to Follow-up|1|||
94717652|NCT02576509|324425066|FG000|Treatment Period|Maximum clinical benefit|1|||
94717653|NCT02576509|324425067|FG001|Treatment Period|Maximum clinical benefit|0|||
94717654|NCT02576509|324425066|FG000|Treatment Period|Poor/non-compliance|1|||
94717655|NCT02576509|324425067|FG001|Treatment Period|Poor/non-compliance|1|||
94717656|NCT02576509|324425066|FG000|Treatment Period|Participant no longer meets criteria|1|||
94717657|NCT02576509|324425067|FG001|Treatment Period|Participant no longer meets criteria|0|||
94717658|NCT02576509|324425066|FG000|Treatment Period|Other reason|12|||
94717659|NCT02576509|324425067|FG001|Treatment Period|Other reason|8|||
94717660|NCT02576509|324425066|FG000|Treatment Period|NOT REPORTED|1|||
94717661|NCT02576509|324425067|FG001|Treatment Period|NOT REPORTED|0|||
94717662|NCT02576509|324425066|FG000|Treatment Period|Administrative reason by sponsor|0|||
94717663|NCT02576509|324425067|FG001|Treatment Period|Administrative reason by sponsor|1|||
94717664|NCT01216176|324425075|FG000|Overall Study|Adverse Event|0|||
94717665|NCT01216176|324425076|FG001|Overall Study|Adverse Event|8|||
94717666|NCT01216176|324425077|FG002|Overall Study|Adverse Event|0|||
94717667|NCT01216176|324425075|FG000|Overall Study|Physician Decision|0|||
94717668|NCT01216176|324425076|FG001|Overall Study|Physician Decision|0|||
94717669|NCT01216176|324425077|FG002|Overall Study|Physician Decision|1|||
94717670|NCT04923347|324425078|FG000|Overall Study|Withdrawal by Subject|14|||
94717671|NCT03481660|324425079|FG000|Overall Study|Adverse Event|5|||
94717672|NCT03481660|324425080|FG001|Overall Study|Adverse Event|4|||
94717673|NCT03481660|324425079|FG000|Overall Study|Death|13|||
94717674|NCT03481660|324425080|FG001|Overall Study|Death|9|||
94717675|NCT03481660|324425079|FG000|Overall Study|Lost to Follow-up|2|||
94717676|NCT03481660|324425080|FG001|Overall Study|Lost to Follow-up|2|||
94717677|NCT03481660|324425079|FG000|Overall Study|Physician Decision|2|||
94717678|NCT03481660|324425080|FG001|Overall Study|Physician Decision|3|||
94717679|NCT03481660|324425079|FG000|Overall Study|Withdrawal by Subject|14|||
94717680|NCT03481660|324425080|FG001|Overall Study|Withdrawal by Subject|7|||
94717681|NCT03398148|324425081|FG000|Substudy 1 Period 1|Adverse Event|5|||
94717682|NCT03398148|324425082|FG001|Substudy 1 Period 1|Adverse Event|2|||
94717683|NCT03398148|324425083|FG002|Substudy 1 Period 1|Adverse Event|2|||
94717684|NCT03398148|324425084|FG003|Substudy 1 Period 1|Adverse Event|0|||
94717685|NCT03398148|324425085|FG004|Substudy 1 Period 1|Adverse Event|8|||
94717686|NCT03398148|324425086|FG005|Substudy 1 Period 1|Adverse Event|0|||
94717687|NCT03398148|324425087|FG006|Substudy 1 Period 1|Adverse Event|0|||
94717688|NCT03398148|324425088|FG007|Substudy 1 Period 1|Adverse Event|0|||
94717689|NCT03398148|324425089|FG008|Substudy 1 Period 1|Adverse Event|0|||
94717690|NCT03398148|324425090|FG009|Substudy 1 Period 1|Adverse Event|0|||
94717691|NCT03398148|324425091|FG010|Substudy 1 Period 1|Adverse Event|0|||
94717692|NCT03398148|324425092|FG011|Substudy 1 Period 1|Adverse Event|0|||
94717693|NCT03398148|324425093|FG012|Substudy 1 Period 1|Adverse Event|0|||
94717694|NCT03398148|324425094|FG013|Substudy 1 Period 1|Adverse Event|0|||
94717695|NCT03398148|324425095|FG014|Substudy 1 Period 1|Adverse Event|0|||
94717696|NCT03398148|324425081|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
94717697|NCT03398148|324425082|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
94717698|NCT03398148|324425083|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
94717699|NCT03398148|324425084|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
94717700|NCT03398148|324425085|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
94717701|NCT03398148|324425086|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
94717702|NCT03398148|324425087|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
94717703|NCT03398148|324425088|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
94717704|NCT03398148|324425089|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
94367895|NCT02367781|323133069|FG000|Overall Study|Randomized in Error|5|||
94717705|NCT03398148|324425090|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
94717706|NCT03398148|324425091|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
94717707|NCT03398148|324425092|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
94717708|NCT03398148|324425093|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
94717709|NCT03398148|324425094|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
94717710|NCT03398148|324425095|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
94717711|NCT03398148|324425081|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
94717712|NCT03398148|324425082|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
94717713|NCT03398148|324425083|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
94717714|NCT03398148|324425084|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
94717715|NCT03398148|324425085|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
94717716|NCT03398148|324425086|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
94367896|NCT02367781|323133070|FG001|Overall Study|Randomized in Error|4|||
94367897|NCT02367781|323133069|FG000|Overall Study|Non-Compliance|1|||
94654701|NCT00023673|324194109|FG000|Overall Study|Patient withdrew consent|0|||
94654702|NCT00023673|324194110|FG001|Overall Study|Patient withdrew consent|0|||
94654703|NCT00023673|324194111|FG002|Overall Study|Patient withdrew consent|0|||
94654704|NCT00023673|324194112|FG003|Overall Study|Patient withdrew consent|1|||
94654705|NCT02453594|324194118|FG000|Overall Study|Protocol Violation|0|||
94654706|NCT02453594|324194119|FG001|Overall Study|Protocol Violation|0|||
94654707|NCT02453594|324194120|FG002|Overall Study|Protocol Violation|1|||
94654708|NCT02453594|324194118|FG000|Overall Study|Cohort Was Closed|17|||
94654709|NCT02453594|324194119|FG001|Overall Study|Cohort Was Closed|21|||
94654710|NCT02453594|324194120|FG002|Overall Study|Cohort Was Closed|14|||
94654711|NCT02453594|324194118|FG000|Overall Study|Death|20|||
94654712|NCT02453594|324194119|FG001|Overall Study|Death|24|||
94654713|NCT02453594|324194120|FG002|Overall Study|Death|16|||
94654714|NCT02453594|324194118|FG000|Overall Study|Lost to Follow-up|6|||
94654715|NCT02453594|324194119|FG001|Overall Study|Lost to Follow-up|14|||
94654716|NCT02453594|324194120|FG002|Overall Study|Lost to Follow-up|2|||
94654717|NCT02453594|324194118|FG000|Overall Study|Physician Decision|2|||
94654718|NCT02453594|324194119|FG001|Overall Study|Physician Decision|4|||
94654719|NCT02453594|324194120|FG002|Overall Study|Physician Decision|0|||
94654720|NCT02453594|324194118|FG000|Overall Study|Site Terminated by Sponsor|1|||
94654721|NCT02453594|324194119|FG001|Overall Study|Site Terminated by Sponsor|0|||
94654722|NCT02453594|324194120|FG002|Overall Study|Site Terminated by Sponsor|1|||
94654723|NCT02453594|324194118|FG000|Overall Study|Transitioned to Extension Study|16|||
94654724|NCT02453594|324194119|FG001|Overall Study|Transitioned to Extension Study|9|||
94654725|NCT02453594|324194120|FG002|Overall Study|Transitioned to Extension Study|16|||
94654726|NCT02453594|324194118|FG000|Overall Study|Withdrawal by Subject|7|||
94654727|NCT02453594|324194119|FG001|Overall Study|Withdrawal by Subject|9|||
94654728|NCT02453594|324194120|FG002|Overall Study|Withdrawal by Subject|11|||
94654729|NCT01529645|324194125|FG000|Overall Study|Lost to Follow-up|0|||
94654730|NCT01529645|324194126|FG001|Overall Study|Lost to Follow-up|1|||
94654731|NCT01529645|324194127|FG002|Overall Study|Lost to Follow-up|1|||
94654732|NCT01529645|324194128|FG003|Overall Study|Lost to Follow-up|1|||
94654733|NCT01529645|324194129|FG004|Overall Study|Lost to Follow-up|1|||
94654734|NCT01529645|324194130|FG005|Overall Study|Lost to Follow-up|0|||
94654735|NCT01529645|324194131|FG006|Overall Study|Lost to Follow-up|2|||
94654736|NCT01529645|324194132|FG007|Overall Study|Lost to Follow-up|0|||
94654737|NCT01529645|324194133|FG008|Overall Study|Lost to Follow-up|1|||
94654738|NCT01529645|324194134|FG009|Overall Study|Lost to Follow-up|0|||
94654739|NCT01529645|324194125|FG000|Overall Study|SAE - Premature contractions|0|||
94654740|NCT01529645|324194126|FG001|Overall Study|SAE - Premature contractions|0|||
94654741|NCT01529645|324194127|FG002|Overall Study|SAE - Premature contractions|1|||
94654742|NCT01529645|324194128|FG003|Overall Study|SAE - Premature contractions|0|||
94654743|NCT01529645|324194129|FG004|Overall Study|SAE - Premature contractions|0|||
94654744|NCT01529645|324194130|FG005|Overall Study|SAE - Premature contractions|0|||
94654745|NCT01529645|324194131|FG006|Overall Study|SAE - Premature contractions|0|||
94654746|NCT01529645|324194132|FG007|Overall Study|SAE - Premature contractions|0|||
94654747|NCT01529645|324194133|FG008|Overall Study|SAE - Premature contractions|0|||
94654748|NCT01529645|324194134|FG009|Overall Study|SAE - Premature contractions|0|||
94654749|NCT01529645|324194125|FG000|Overall Study|Withdrawal by Subject|2|||
94654750|NCT01529645|324194126|FG001|Overall Study|Withdrawal by Subject|0|||
94654751|NCT01529645|324194127|FG002|Overall Study|Withdrawal by Subject|0|||
94654752|NCT01529645|324194128|FG003|Overall Study|Withdrawal by Subject|1|||
94654753|NCT01529645|324194129|FG004|Overall Study|Withdrawal by Subject|1|||
94654754|NCT01529645|324194130|FG005|Overall Study|Withdrawal by Subject|1|||
94654755|NCT01529645|324194131|FG006|Overall Study|Withdrawal by Subject|0|||
94654756|NCT01529645|324194132|FG007|Overall Study|Withdrawal by Subject|0|||
94654757|NCT01529645|324194133|FG008|Overall Study|Withdrawal by Subject|0|||
94654758|NCT01529645|324194134|FG009|Overall Study|Withdrawal by Subject|0|||
94654759|NCT02212730|324194137|FG000|Overall Study|Tumor not of the required cell histology|1|||
94654760|NCT02212730|324194138|FG001|Overall Study|Tumor not of the required cell histology|0|||
94654761|NCT02212730|324194137|FG000|Overall Study|Withdrawal by Subject|1|||
94654762|NCT02212730|324194138|FG001|Overall Study|Withdrawal by Subject|0|||
94654763|NCT02212730|324194137|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
94654764|NCT02212730|324194138|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
94654765|NCT00587587|324194139|FG000|Overall Study|Lost to Follow-up|6|||
94654766|NCT00587587|324194140|FG001|Overall Study|Lost to Follow-up|1|||
94654767|NCT02880371|324194143|FG000|Phase 1b|Lost to Follow-up|1|||
94654768|NCT02880371|324194144|FG001|Phase 1b|Lost to Follow-up|0|||
94654769|NCT02880371|324194145|FG002|Phase 1b|Lost to Follow-up|0|||
94654770|NCT02880371|324194146|FG003|Phase 1b|Lost to Follow-up|0|||
94654771|NCT02880371|324194147|FG004|Phase 1b|Lost to Follow-up|0|||
94654772|NCT02880371|324194148|FG005|Phase 1b|Lost to Follow-up|0|||
94654773|NCT02880371|324194149|FG006|Phase 1b|Lost to Follow-up|0|||
94654774|NCT02880371|324194150|FG007|Phase 1b|Lost to Follow-up|0|||
94654775|NCT02880371|324194143|FG000|Phase 1b|Participants terminated by Sponsor|1|||
94654776|NCT02880371|324194144|FG001|Phase 1b|Participants terminated by Sponsor|0|||
94654777|NCT02880371|324194145|FG002|Phase 1b|Participants terminated by Sponsor|0|||
94654778|NCT02880371|324194146|FG003|Phase 1b|Participants terminated by Sponsor|0|||
94654779|NCT02880371|324194147|FG004|Phase 1b|Participants terminated by Sponsor|0|||
94654780|NCT02880371|324194148|FG005|Phase 1b|Participants terminated by Sponsor|0|||
94654781|NCT02880371|324194149|FG006|Phase 1b|Participants terminated by Sponsor|0|||
94654782|NCT02880371|324194150|FG007|Phase 1b|Participants terminated by Sponsor|0|||
94654783|NCT02880371|324194143|FG000|Phase 1b|Withdrawal by Subject|0|||
94654784|NCT02880371|324194144|FG001|Phase 1b|Withdrawal by Subject|0|||
94654785|NCT02880371|324194145|FG002|Phase 1b|Withdrawal by Subject|1|||
94654786|NCT02880371|324194146|FG003|Phase 1b|Withdrawal by Subject|0|||
94654787|NCT02880371|324194147|FG004|Phase 1b|Withdrawal by Subject|0|||
94654788|NCT02880371|324194148|FG005|Phase 1b|Withdrawal by Subject|0|||
94654789|NCT02880371|324194149|FG006|Phase 1b|Withdrawal by Subject|0|||
94654790|NCT02880371|324194150|FG007|Phase 1b|Withdrawal by Subject|0|||
94654791|NCT02880371|324194143|FG000|Phase 1b|Death|4|||
94654792|NCT02880371|324194144|FG001|Phase 1b|Death|6|||
94654793|NCT02880371|324194145|FG002|Phase 1b|Death|5|||
94654794|NCT02880371|324194146|FG003|Phase 1b|Death|1|||
94654795|NCT02880371|324194147|FG004|Phase 1b|Death|0|||
94654796|NCT02880371|324194148|FG005|Phase 1b|Death|0|||
94654797|NCT02880371|324194149|FG006|Phase 1b|Death|0|||
94654798|NCT02880371|324194150|FG007|Phase 1b|Death|0|||
94654799|NCT02880371|324194143|FG000|Phase 1b|Enrolled but not Treated|0|||
94654800|NCT02880371|324194144|FG001|Phase 1b|Enrolled but not Treated|1|||
94654801|NCT02880371|324194145|FG002|Phase 1b|Enrolled but not Treated|0|||
94654802|NCT02880371|324194146|FG003|Phase 1b|Enrolled but not Treated|0|||
94654803|NCT02880371|324194147|FG004|Phase 1b|Enrolled but not Treated|0|||
94654804|NCT02880371|324194148|FG005|Phase 1b|Enrolled but not Treated|0|||
94654805|NCT02880371|324194149|FG006|Phase 1b|Enrolled but not Treated|0|||
94654806|NCT02880371|324194150|FG007|Phase 1b|Enrolled but not Treated|0|||
94654807|NCT02880371|324194143|FG000|Phase 2|Enrolled but not Treated|0|||
94654808|NCT02880371|324194144|FG001|Phase 2|Enrolled but not Treated|0|||
94654809|NCT02880371|324194145|FG002|Phase 2|Enrolled but not Treated|0|||
94654810|NCT02880371|324194146|FG003|Phase 2|Enrolled but not Treated|0|||
94654811|NCT02880371|324194147|FG004|Phase 2|Enrolled but not Treated|0|||
94654812|NCT02880371|324194148|FG005|Phase 2|Enrolled but not Treated|1|||
94654813|NCT02880371|324194149|FG006|Phase 2|Enrolled but not Treated|1|||
94654814|NCT02880371|324194150|FG007|Phase 2|Enrolled but not Treated|0|||
94654815|NCT02880371|324194143|FG000|Phase 2|Other|0|||
94654816|NCT02880371|324194144|FG001|Phase 2|Other|0|||
94654817|NCT02880371|324194145|FG002|Phase 2|Other|0|||
94654818|NCT02880371|324194146|FG003|Phase 2|Other|0|||
94654819|NCT02880371|324194147|FG004|Phase 2|Other|0|||
94654820|NCT02880371|324194148|FG005|Phase 2|Other|1|||
94654821|NCT02880371|324194149|FG006|Phase 2|Other|2|||
94654822|NCT02880371|324194150|FG007|Phase 2|Other|1|||
94654823|NCT02880371|324194143|FG000|Phase 2|Participants terminated by Sponsor|0|||
94717717|NCT03398148|324425087|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
94654824|NCT02880371|324194144|FG001|Phase 2|Participants terminated by Sponsor|0|||
94654825|NCT02880371|324194145|FG002|Phase 2|Participants terminated by Sponsor|0|||
94654826|NCT02880371|324194146|FG003|Phase 2|Participants terminated by Sponsor|0|||
94654827|NCT02880371|324194147|FG004|Phase 2|Participants terminated by Sponsor|1|||
94654828|NCT02880371|324194148|FG005|Phase 2|Participants terminated by Sponsor|6|||
94654829|NCT02880371|324194149|FG006|Phase 2|Participants terminated by Sponsor|1|||
94654830|NCT02880371|324194150|FG007|Phase 2|Participants terminated by Sponsor|5|||
94654831|NCT02880371|324194143|FG000|Phase 2|Death|0|||
94654832|NCT02880371|324194144|FG001|Phase 2|Death|0|||
94654833|NCT02880371|324194145|FG002|Phase 2|Death|0|||
94654834|NCT02880371|324194146|FG003|Phase 2|Death|0|||
94654835|NCT02880371|324194147|FG004|Phase 2|Death|1|||
94654836|NCT02880371|324194148|FG005|Phase 2|Death|10|||
94654837|NCT02880371|324194149|FG006|Phase 2|Death|20|||
94654838|NCT02880371|324194150|FG007|Phase 2|Death|5|||
94654839|NCT02880371|324194143|FG000|Phase 2|Lost to Follow-up|0|||
94654840|NCT02880371|324194144|FG001|Phase 2|Lost to Follow-up|0|||
94654841|NCT02880371|324194145|FG002|Phase 2|Lost to Follow-up|0|||
94654842|NCT02880371|324194146|FG003|Phase 2|Lost to Follow-up|0|||
94654843|NCT02880371|324194147|FG004|Phase 2|Lost to Follow-up|0|||
94654844|NCT02880371|324194148|FG005|Phase 2|Lost to Follow-up|0|||
94654845|NCT02880371|324194149|FG006|Phase 2|Lost to Follow-up|3|||
94654846|NCT02880371|324194150|FG007|Phase 2|Lost to Follow-up|0|||
94654847|NCT02880371|324194143|FG000|Phase 2|Withdrawal by Subject|0|||
94654848|NCT02880371|324194144|FG001|Phase 2|Withdrawal by Subject|0|||
94654849|NCT02880371|324194145|FG002|Phase 2|Withdrawal by Subject|0|||
94654850|NCT02880371|324194146|FG003|Phase 2|Withdrawal by Subject|0|||
94654851|NCT02880371|324194147|FG004|Phase 2|Withdrawal by Subject|0|||
94654852|NCT02880371|324194148|FG005|Phase 2|Withdrawal by Subject|1|||
94654853|NCT02880371|324194149|FG006|Phase 2|Withdrawal by Subject|1|||
94654854|NCT02880371|324194150|FG007|Phase 2|Withdrawal by Subject|0|||
94654855|NCT02880371|324194143|FG000|Phase 2|End of Study page not completed by error|0|||
94654856|NCT02880371|324194144|FG001|Phase 2|End of Study page not completed by error|0|||
94654857|NCT02880371|324194145|FG002|Phase 2|End of Study page not completed by error|0|||
94654858|NCT02880371|324194146|FG003|Phase 2|End of Study page not completed by error|0|||
94654859|NCT02880371|324194147|FG004|Phase 2|End of Study page not completed by error|0|||
94654860|NCT02880371|324194148|FG005|Phase 2|End of Study page not completed by error|1|||
94654861|NCT02880371|324194149|FG006|Phase 2|End of Study page not completed by error|0|||
94654862|NCT02880371|324194150|FG007|Phase 2|End of Study page not completed by error|0|||
94654863|NCT01777997|324194155|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
94654864|NCT01777997|324194155|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
94654865|NCT01777997|324194155|FG000|Weeks 48 to 72/96 on ART|Death|1|||
94654866|NCT01777997|324194155|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
94654867|NCT02660359|324194156|FG000|Overall Study|Protocol Deviation|0|||
94654868|NCT02660359|324194157|FG001|Overall Study|Protocol Deviation|0|||
94654869|NCT02660359|324194158|FG002|Overall Study|Protocol Deviation|1|||
94654870|NCT02660359|324194156|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
94654871|NCT02660359|324194157|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
94654872|NCT02660359|324194158|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
94654873|NCT02660359|324194156|FG000|Overall Study|Lack of Efficacy|1|||
94654874|NCT02660359|324194157|FG001|Overall Study|Lack of Efficacy|1|||
94654875|NCT02660359|324194158|FG002|Overall Study|Lack of Efficacy|1|||
94654876|NCT02660359|324194156|FG000|Overall Study|Adverse Event|0|||
94654877|NCT02660359|324194157|FG001|Overall Study|Adverse Event|1|||
94654878|NCT02660359|324194158|FG002|Overall Study|Adverse Event|0|||
94654879|NCT02660359|324194156|FG000|Overall Study|Other|2|||
94654880|NCT02660359|324194157|FG001|Overall Study|Other|1|||
94654881|NCT02660359|324194158|FG002|Overall Study|Other|3|||
94654882|NCT02660359|324194156|FG000|Overall Study|Withdrawal by Subject|7|||
94654883|NCT02660359|324194157|FG001|Overall Study|Withdrawal by Subject|5|||
94654884|NCT02660359|324194158|FG002|Overall Study|Withdrawal by Subject|8|||
94654885|NCT02660359|324194156|FG000|Overall Study|Lost to Follow-up|3|||
94654886|NCT02660359|324194157|FG001|Overall Study|Lost to Follow-up|3|||
94654887|NCT02660359|324194158|FG002|Overall Study|Lost to Follow-up|0|||
94654888|NCT01694706|324194159|FG000|Overall Study|Adverse Event|0|||
94654889|NCT01694706|324194160|FG001|Overall Study|Adverse Event|1|||
94654890|NCT01694706|324194161|FG002|Overall Study|Adverse Event|0|||
94654891|NCT01694706|324194159|FG000|Overall Study|other reason not defined above|1|||
94654892|NCT01694706|324194160|FG001|Overall Study|other reason not defined above|0|||
94654893|NCT01694706|324194161|FG002|Overall Study|other reason not defined above|0|||
94654894|NCT00961259|324194166|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
94654895|NCT00961259|324194167|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
94654896|NCT00961259|324194168|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
94654897|NCT02691455|324194172|FG000|Overall Study|Withdrawal by Subject|1|||
94654898|NCT02691455|324194173|FG001|Overall Study|Withdrawal by Subject|2|||
94654899|NCT02691455|324194172|FG000|Overall Study|Lost to Follow-up|15|||
94654900|NCT02691455|324194173|FG001|Overall Study|Lost to Follow-up|15|||
94654901|NCT01375049|324194174|FG000|Overall Study|Adverse Event|2|||
94654902|NCT01375049|324194174|FG000|Overall Study|Lost to Follow-up|1|||
94654903|NCT01375049|324194174|FG000|Overall Study|Withdrawal by Subject|2|||
94654904|NCT01375049|324194174|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
94654905|NCT02057757|324194179|FG000|Overall Study|Withdrawal by Subject|3|||
94654906|NCT02057757|324194180|FG001|Overall Study|Withdrawal by Subject|5|||
94654907|NCT02057757|324194179|FG000|Overall Study|Death|2|||
94654908|NCT02057757|324194180|FG001|Overall Study|Death|0|||
94654909|NCT02057757|324194179|FG000|Overall Study|Lost to Follow-up|8|||
94654910|NCT02057757|324194180|FG001|Overall Study|Lost to Follow-up|3|||
94654911|NCT02057757|324194179|FG000|Overall Study|Non-compliance|1|||
94654912|NCT02057757|324194180|FG001|Overall Study|Non-compliance|0|||
94654913|NCT03614793|324194181|FG000|Overall Study|Lost to Follow-up|1|||
94654914|NCT03614793|324194182|FG001|Overall Study|Lost to Follow-up|2|||
94654915|NCT03614793|324194181|FG000|Overall Study|Lack of Efficacy|0|||
94654916|NCT03614793|324194182|FG001|Overall Study|Lack of Efficacy|5|||
94654917|NCT03614793|324194181|FG000|Overall Study|Withdrawal by Subject|0|||
94654918|NCT03614793|324194182|FG001|Overall Study|Withdrawal by Subject|1|||
94654919|NCT03614793|324194181|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
94654920|NCT03614793|324194182|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
94654921|NCT02082522|324194183|FG000|Overall Study|Sponsor termination|5|||
94654922|NCT02082522|324194184|FG001|Overall Study|Sponsor termination|3|||
94654923|NCT02082522|324194183|FG000|Overall Study|Withdrawal by Subject|2|||
94654924|NCT02082522|324194184|FG001|Overall Study|Withdrawal by Subject|4|||
94654925|NCT02082522|324194183|FG000|Overall Study|Death|1|||
94654926|NCT02082522|324194184|FG001|Overall Study|Death|0|||
94654927|NCT02082522|324194183|FG000|Overall Study|Lost to Follow-up|1|||
94654928|NCT02082522|324194184|FG001|Overall Study|Lost to Follow-up|0|||
94654929|NCT02082522|324194183|FG000|Overall Study|Physician Decision|3|||
94717718|NCT03398148|324425088|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
94367898|NCT02367781|323133070|FG001|Overall Study|Non-Compliance|0|||
94367899|NCT02367781|323133069|FG000|Overall Study|Lost to Follow-up|1|||
94367900|NCT02367781|323133070|FG001|Overall Study|Lost to Follow-up|2|||
94717719|NCT03398148|324425089|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
94717720|NCT03398148|324425090|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
94717721|NCT03398148|324425091|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
94717722|NCT03398148|324425092|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
94717723|NCT03398148|324425093|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
94717724|NCT03398148|324425094|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
94717725|NCT03398148|324425095|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
94717726|NCT03398148|324425081|FG000|Substudy 1 Period 1|Other|0|||
94717727|NCT03398148|324425082|FG001|Substudy 1 Period 1|Other|1|||
94717728|NCT03398148|324425083|FG002|Substudy 1 Period 1|Other|0|||
94717729|NCT03398148|324425084|FG003|Substudy 1 Period 1|Other|0|||
94717730|NCT03398148|324425085|FG004|Substudy 1 Period 1|Other|3|||
94717731|NCT03398148|324425086|FG005|Substudy 1 Period 1|Other|0|||
94717732|NCT03398148|324425087|FG006|Substudy 1 Period 1|Other|0|||
94717733|NCT03398148|324425088|FG007|Substudy 1 Period 1|Other|0|||
94717734|NCT03398148|324425089|FG008|Substudy 1 Period 1|Other|0|||
94717735|NCT03398148|324425090|FG009|Substudy 1 Period 1|Other|0|||
94717736|NCT03398148|324425091|FG010|Substudy 1 Period 1|Other|0|||
94717737|NCT03398148|324425092|FG011|Substudy 1 Period 1|Other|0|||
94717738|NCT03398148|324425093|FG012|Substudy 1 Period 1|Other|0|||
94717739|NCT03398148|324425094|FG013|Substudy 1 Period 1|Other|0|||
94717740|NCT03398148|324425095|FG014|Substudy 1 Period 1|Other|0|||
94367901|NCT02367781|323133069|FG000|Overall Study|Death|330|||
94367902|NCT02367781|323133070|FG001|Overall Study|Death|176|||
94367903|NCT02367781|323133069|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
94367904|NCT02367781|323133070|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
94717741|NCT03398148|324425081|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
94717742|NCT03398148|324425082|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
94717743|NCT03398148|324425083|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
94717744|NCT03398148|324425084|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
94717745|NCT03398148|324425085|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
94717746|NCT03398148|324425086|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
94717747|NCT03398148|324425087|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
94717748|NCT03398148|324425088|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
94717749|NCT03398148|324425089|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
94717750|NCT03398148|324425090|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
94717751|NCT03398148|324425091|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
94717752|NCT03398148|324425092|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
94717753|NCT03398148|324425093|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
94717754|NCT03398148|324425094|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
94717755|NCT03398148|324425095|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
94717756|NCT03398148|324425081|FG000|Substudy 1 Period 2|Adverse Event|0|||
94717757|NCT03398148|324425082|FG001|Substudy 1 Period 2|Adverse Event|0|||
94717758|NCT03398148|324425083|FG002|Substudy 1 Period 2|Adverse Event|0|||
94717759|NCT03398148|324425084|FG003|Substudy 1 Period 2|Adverse Event|0|||
94717760|NCT03398148|324425085|FG004|Substudy 1 Period 2|Adverse Event|0|||
94717761|NCT03398148|324425086|FG005|Substudy 1 Period 2|Adverse Event|2|||
94717762|NCT03398148|324425087|FG006|Substudy 1 Period 2|Adverse Event|4|||
94717763|NCT03398148|324425088|FG007|Substudy 1 Period 2|Adverse Event|0|||
94717764|NCT03398148|324425089|FG008|Substudy 1 Period 2|Adverse Event|0|||
94717765|NCT03398148|324425090|FG009|Substudy 1 Period 2|Adverse Event|0|||
94717766|NCT03398148|324425091|FG010|Substudy 1 Period 2|Adverse Event|0|||
94717767|NCT03398148|324425092|FG011|Substudy 1 Period 2|Adverse Event|0|||
94717768|NCT03398148|324425093|FG012|Substudy 1 Period 2|Adverse Event|0|||
94717769|NCT03398148|324425094|FG013|Substudy 1 Period 2|Adverse Event|0|||
94717770|NCT03398148|324425095|FG014|Substudy 1 Period 2|Adverse Event|0|||
94717771|NCT03398148|324425081|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
94717772|NCT03398148|324425082|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
94717773|NCT03398148|324425083|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
94717774|NCT03398148|324425084|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
94717775|NCT03398148|324425085|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
94367905|NCT02367781|323133069|FG000|Overall Study|Prolonged Hospitalization|1|||
94717776|NCT03398148|324425086|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
94717777|NCT03398148|324425087|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
94717778|NCT03398148|324425088|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
94717779|NCT03398148|324425089|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
94717780|NCT03398148|324425090|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
94717781|NCT03398148|324425091|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
94717782|NCT03398148|324425092|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
94717783|NCT03398148|324425093|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
94717784|NCT03398148|324425094|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
94717785|NCT03398148|324425095|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
94717786|NCT03398148|324425081|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
94717787|NCT03398148|324425082|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
94717788|NCT03398148|324425083|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
94654930|NCT02082522|324194184|FG001|Overall Study|Physician Decision|1|||
94654931|NCT02082522|324194183|FG000|Overall Study|Disease progression|2|||
94271966|NCT01940471|322788581|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
94271967|NCT01940471|322788582|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
94271968|NCT01940471|322788579|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
94654932|NCT02082522|324194184|FG001|Overall Study|Disease progression|2|||
94654933|NCT02082522|324194183|FG000|Overall Study|Chemotherapy change|1|||
94654934|NCT02082522|324194184|FG001|Overall Study|Chemotherapy change|3|||
94654935|NCT00440271|324194187|FG000|Overall Study|Protocol Violation|1|||
94654936|NCT00440271|324194188|FG001|Overall Study|Protocol Violation|1|||
94654937|NCT00440271|324194187|FG000|Overall Study|Adverse Event|0|||
94654938|NCT00440271|324194188|FG001|Overall Study|Adverse Event|1|||
94654939|NCT00440271|324194187|FG000|Overall Study|Lost to Follow-up|1|||
94654940|NCT00440271|324194188|FG001|Overall Study|Lost to Follow-up|0|||
94654941|NCT00440271|324194187|FG000|Overall Study|Withdrawal by Subject|0|||
94654942|NCT00440271|324194188|FG001|Overall Study|Withdrawal by Subject|2|||
94654943|NCT00440271|324194187|FG000|Overall Study|Lack of Efficacy|0|||
94654944|NCT00440271|324194188|FG001|Overall Study|Lack of Efficacy|1|||
94654945|NCT00440271|324194187|FG000|Overall Study|Due to closure of trial|8|||
94654946|NCT00440271|324194188|FG001|Overall Study|Due to closure of trial|10|||
94654947|NCT00440271|324194187|FG000|Overall Study|Other|2|||
94654948|NCT00440271|324194188|FG001|Overall Study|Other|0|||
94654949|NCT02370888|324194189|FG000|Overall Study|disease progression|2|||
94654950|NCT02370888|324194189|FG000|Overall Study|did not meet chimerism criteria|6|||
94654951|NCT02956629|324194190|FG000|Overall Study|Adverse Event|0|||
94654952|NCT02956629|324194191|FG001|Overall Study|Adverse Event|0|||
94654953|NCT02956629|324194192|FG002|Overall Study|Adverse Event|1|||
94654954|NCT02956629|324194193|FG003|Overall Study|Adverse Event|0|||
94654955|NCT02956629|324194194|FG004|Overall Study|Adverse Event|0|||
94654956|NCT02956629|324194195|FG005|Overall Study|Adverse Event|0|||
94654957|NCT02956629|324194190|FG000|Overall Study|Lost to Follow-up|2|||
94654958|NCT02956629|324194191|FG001|Overall Study|Lost to Follow-up|5|||
94654959|NCT02956629|324194192|FG002|Overall Study|Lost to Follow-up|3|||
94654960|NCT02956629|324194193|FG003|Overall Study|Lost to Follow-up|1|||
94654961|NCT02956629|324194194|FG004|Overall Study|Lost to Follow-up|0|||
94654962|NCT02956629|324194195|FG005|Overall Study|Lost to Follow-up|1|||
94654963|NCT02956629|324194190|FG000|Overall Study|Withdrawal by Subject|3|||
94654964|NCT02956629|324194191|FG001|Overall Study|Withdrawal by Subject|1|||
94654965|NCT02956629|324194192|FG002|Overall Study|Withdrawal by Subject|0|||
94654966|NCT02956629|324194193|FG003|Overall Study|Withdrawal by Subject|0|||
94654967|NCT02956629|324194194|FG004|Overall Study|Withdrawal by Subject|0|||
94654968|NCT02956629|324194195|FG005|Overall Study|Withdrawal by Subject|0|||
94654969|NCT01709227|324194196|FG000|Overall Study|Physician Decision|1|||
94654970|NCT01709227|324194197|FG001|Overall Study|Physician Decision|0|||
94654971|NCT01709227|324194196|FG000|Overall Study|Pleural Peritoneal communication|0|||
94654972|NCT01709227|324194197|FG001|Overall Study|Pleural Peritoneal communication|9|||
94654973|NCT02352493|324194198|FG000|Overall Study|Pregnancy|0|||
94654974|NCT02352493|324194199|FG001|Overall Study|Pregnancy|0|||
94654975|NCT02352493|324194200|FG002|Overall Study|Pregnancy|0|||
94654976|NCT02352493|324194201|FG003|Overall Study|Pregnancy|0|||
94654977|NCT02352493|324194202|FG004|Overall Study|Pregnancy|0|||
94654978|NCT02352493|324194203|FG005|Overall Study|Pregnancy|0|||
94654979|NCT02352493|324194204|FG006|Overall Study|Pregnancy|1|||
94654980|NCT02352493|324194205|FG007|Overall Study|Pregnancy|0|||
94654981|NCT02352493|324194206|FG008|Overall Study|Pregnancy|1|||
94654982|NCT02352493|324194207|FG009|Overall Study|Pregnancy|0|||
94654983|NCT02352493|324194208|FG010|Overall Study|Pregnancy|0|||
94654984|NCT02352493|324194209|FG011|Overall Study|Pregnancy|0|||
94654985|NCT02352493|324194210|FG012|Overall Study|Pregnancy|0|||
94654986|NCT02352493|324194211|FG013|Overall Study|Pregnancy|0|||
94654987|NCT02352493|324194212|FG014|Overall Study|Pregnancy|0|||
94654988|NCT02352493|324194213|FG015|Overall Study|Pregnancy|0|||
94654989|NCT02352493|324194214|FG016|Overall Study|Pregnancy|0|||
94654990|NCT02352493|324194215|FG017|Overall Study|Pregnancy|0|||
94654991|NCT02352493|324194198|FG000|Overall Study|Withdrawal by Subject|0|||
94654992|NCT02352493|324194199|FG001|Overall Study|Withdrawal by Subject|0|||
94654993|NCT02352493|324194200|FG002|Overall Study|Withdrawal by Subject|0|||
94654994|NCT02352493|324194201|FG003|Overall Study|Withdrawal by Subject|0|||
94654995|NCT02352493|324194202|FG004|Overall Study|Withdrawal by Subject|0|||
94654996|NCT02352493|324194203|FG005|Overall Study|Withdrawal by Subject|0|||
94654997|NCT02352493|324194204|FG006|Overall Study|Withdrawal by Subject|0|||
94654998|NCT02352493|324194205|FG007|Overall Study|Withdrawal by Subject|0|||
94654999|NCT02352493|324194206|FG008|Overall Study|Withdrawal by Subject|1|||
94655000|NCT02352493|324194207|FG009|Overall Study|Withdrawal by Subject|0|||
94655001|NCT02352493|324194208|FG010|Overall Study|Withdrawal by Subject|0|||
94655002|NCT02352493|324194209|FG011|Overall Study|Withdrawal by Subject|0|||
94655003|NCT02352493|324194210|FG012|Overall Study|Withdrawal by Subject|0|||
94655004|NCT02352493|324194211|FG013|Overall Study|Withdrawal by Subject|0|||
94655005|NCT02352493|324194212|FG014|Overall Study|Withdrawal by Subject|1|||
94271969|NCT01940471|322788580|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
94271970|NCT01940471|322788581|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
94271971|NCT01940471|322788582|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
94271972|NCT00258674|322788583|FG000|Overall Study|Death|32|||
94271973|NCT00258674|322788584|FG001|Overall Study|Death|53|||
94271974|NCT00258674|322788585|FG002|Overall Study|Death|34|||
94271975|NCT02973087|322788588|FG000|Overall Study|Withdrawal by Subject|2|||
94271976|NCT02973087|322788589|FG001|Overall Study|Withdrawal by Subject|1|||
94271977|NCT02973087|322788588|FG000|Overall Study|Adverse Event|1|||
94271978|NCT02973087|322788589|FG001|Overall Study|Adverse Event|0|||
94271979|NCT02973087|322788588|FG000|Overall Study|other|1|||
94655006|NCT02352493|324194213|FG015|Overall Study|Withdrawal by Subject|0|||
94655007|NCT02352493|324194214|FG016|Overall Study|Withdrawal by Subject|0|||
94655008|NCT02352493|324194215|FG017|Overall Study|Withdrawal by Subject|0|||
94655009|NCT02352493|324194198|FG000|Overall Study|Lost to Follow-up|0|||
94655010|NCT02352493|324194199|FG001|Overall Study|Lost to Follow-up|0|||
94655011|NCT02352493|324194200|FG002|Overall Study|Lost to Follow-up|0|||
94655012|NCT02352493|324194201|FG003|Overall Study|Lost to Follow-up|0|||
94655013|NCT02352493|324194202|FG004|Overall Study|Lost to Follow-up|0|||
94655014|NCT02352493|324194203|FG005|Overall Study|Lost to Follow-up|0|||
94655015|NCT02352493|324194204|FG006|Overall Study|Lost to Follow-up|0|||
94655016|NCT02352493|324194205|FG007|Overall Study|Lost to Follow-up|0|||
94655017|NCT02352493|324194206|FG008|Overall Study|Lost to Follow-up|0|||
94655018|NCT02352493|324194207|FG009|Overall Study|Lost to Follow-up|1|||
94655019|NCT02352493|324194208|FG010|Overall Study|Lost to Follow-up|0|||
94655020|NCT02352493|324194209|FG011|Overall Study|Lost to Follow-up|0|||
94655021|NCT02352493|324194210|FG012|Overall Study|Lost to Follow-up|1|||
94655022|NCT02352493|324194211|FG013|Overall Study|Lost to Follow-up|2|||
94655023|NCT02352493|324194212|FG014|Overall Study|Lost to Follow-up|0|||
94655024|NCT02352493|324194213|FG015|Overall Study|Lost to Follow-up|0|||
94655025|NCT02352493|324194214|FG016|Overall Study|Lost to Follow-up|0|||
94655026|NCT02352493|324194215|FG017|Overall Study|Lost to Follow-up|0|||
94655027|NCT03295201|324194217|FG000|Overall Study|Lost to Follow-up|1|||
94717789|NCT03398148|324425084|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
94717790|NCT03398148|324425085|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
94717791|NCT03398148|324425086|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
94717792|NCT03398148|324425087|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
94717793|NCT03398148|324425088|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
94717794|NCT03398148|324425089|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
94717795|NCT03398148|324425090|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
94717796|NCT03398148|324425091|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
94717797|NCT03398148|324425092|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
94717798|NCT03398148|324425093|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
94717799|NCT03398148|324425094|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
94717800|NCT03398148|324425095|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
94717801|NCT03398148|324425081|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717802|NCT03398148|324425082|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717803|NCT03398148|324425083|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717804|NCT03398148|324425084|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717805|NCT03398148|324425085|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717806|NCT03398148|324425086|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717807|NCT03398148|324425087|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
94717808|NCT03398148|324425088|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717809|NCT03398148|324425089|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717810|NCT03398148|324425090|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717811|NCT03398148|324425091|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717812|NCT03398148|324425092|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717813|NCT03398148|324425093|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717814|NCT03398148|324425094|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717815|NCT03398148|324425095|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717816|NCT03398148|324425081|FG000|Substudy 1 Period 2|Other|0|||
94717817|NCT03398148|324425082|FG001|Substudy 1 Period 2|Other|0|||
94717818|NCT03398148|324425083|FG002|Substudy 1 Period 2|Other|0|||
94717819|NCT03398148|324425084|FG003|Substudy 1 Period 2|Other|0|||
94717820|NCT03398148|324425085|FG004|Substudy 1 Period 2|Other|0|||
94717821|NCT03398148|324425086|FG005|Substudy 1 Period 2|Other|0|||
94717822|NCT03398148|324425087|FG006|Substudy 1 Period 2|Other|1|||
94717823|NCT03398148|324425088|FG007|Substudy 1 Period 2|Other|0|||
94717824|NCT03398148|324425089|FG008|Substudy 1 Period 2|Other|0|||
94717825|NCT03398148|324425090|FG009|Substudy 1 Period 2|Other|0|||
94717826|NCT03398148|324425091|FG010|Substudy 1 Period 2|Other|0|||
94717827|NCT03398148|324425092|FG011|Substudy 1 Period 2|Other|0|||
94717828|NCT03398148|324425093|FG012|Substudy 1 Period 2|Other|0|||
94717829|NCT03398148|324425094|FG013|Substudy 1 Period 2|Other|0|||
94717830|NCT03398148|324425095|FG014|Substudy 1 Period 2|Other|0|||
94717831|NCT03398148|324425081|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
94717832|NCT03398148|324425082|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
94717833|NCT03398148|324425083|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
94717834|NCT03398148|324425084|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
94717835|NCT03398148|324425085|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
94717836|NCT03398148|324425086|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
94717837|NCT03398148|324425087|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
94717838|NCT03398148|324425088|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
94717839|NCT03398148|324425089|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
94717840|NCT03398148|324425090|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
94717841|NCT03398148|324425091|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
94717842|NCT03398148|324425092|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
94717843|NCT03398148|324425093|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
94717844|NCT03398148|324425094|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
94717845|NCT03398148|324425095|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
94717846|NCT03398148|324425081|FG000|Substudy 2 Period 1|Adverse Event|0|||
94717847|NCT03398148|324425082|FG001|Substudy 2 Period 1|Adverse Event|0|||
94717848|NCT03398148|324425083|FG002|Substudy 2 Period 1|Adverse Event|0|||
94717849|NCT03398148|324425084|FG003|Substudy 2 Period 1|Adverse Event|0|||
94717850|NCT03398148|324425085|FG004|Substudy 2 Period 1|Adverse Event|0|||
94717851|NCT03398148|324425086|FG005|Substudy 2 Period 1|Adverse Event|0|||
94717852|NCT03398148|324425087|FG006|Substudy 2 Period 1|Adverse Event|0|||
94717853|NCT03398148|324425088|FG007|Substudy 2 Period 1|Adverse Event|0|||
94717854|NCT03398148|324425089|FG008|Substudy 2 Period 1|Adverse Event|0|||
94717855|NCT03398148|324425090|FG009|Substudy 2 Period 1|Adverse Event|12|||
94717856|NCT03398148|324425091|FG010|Substudy 2 Period 1|Adverse Event|2|||
94717857|NCT03398148|324425092|FG011|Substudy 2 Period 1|Adverse Event|0|||
94717858|NCT03398148|324425093|FG012|Substudy 2 Period 1|Adverse Event|0|||
94717859|NCT03398148|324425094|FG013|Substudy 2 Period 1|Adverse Event|0|||
94717860|NCT03398148|324425095|FG014|Substudy 2 Period 1|Adverse Event|0|||
94717861|NCT03398148|324425081|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
94717862|NCT03398148|324425082|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
94717863|NCT03398148|324425083|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
94717864|NCT03398148|324425084|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
94717865|NCT03398148|324425085|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
94717866|NCT03398148|324425086|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
94717867|NCT03398148|324425087|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
94717868|NCT03398148|324425088|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
94717869|NCT03398148|324425089|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
94717870|NCT03398148|324425090|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
94717871|NCT03398148|324425091|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
94717872|NCT03398148|324425092|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
94717873|NCT03398148|324425093|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
94717874|NCT03398148|324425094|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
94717875|NCT03398148|324425095|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
94717876|NCT03398148|324425081|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
94717877|NCT03398148|324425082|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
94717878|NCT03398148|324425083|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
94717879|NCT03398148|324425084|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
94717880|NCT03398148|324425085|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
94717881|NCT03398148|324425086|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
94717882|NCT03398148|324425087|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
94717883|NCT03398148|324425088|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
94717884|NCT03398148|324425089|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
94717885|NCT03398148|324425090|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
94717886|NCT03398148|324425091|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
94717887|NCT03398148|324425092|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
94717888|NCT03398148|324425093|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
94717889|NCT03398148|324425094|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
94717890|NCT03398148|324425095|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
94717891|NCT03398148|324425081|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
94717892|NCT03398148|324425082|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
94717893|NCT03398148|324425083|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
94717894|NCT03398148|324425084|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
94717895|NCT03398148|324425085|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
94717896|NCT03398148|324425086|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
94717897|NCT03398148|324425087|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
94717898|NCT03398148|324425088|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
94717899|NCT03398148|324425089|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
94717900|NCT03398148|324425090|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
94467293|NCT01897571|323500500|FG004|Overall Study|Other|3|||
94467294|NCT01897571|323500501|FG005|Overall Study|Other|4|||
94467295|NCT01897571|323500502|FG006|Overall Study|Other|7|||
94467296|NCT01897571|323500503|FG007|Overall Study|Other|0|||
94467297|NCT01897571|323500504|FG008|Overall Study|Other|0|||
94717901|NCT03398148|324425091|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
94271980|NCT02973087|322788589|FG001|Overall Study|other|1|||
94717902|NCT03398148|324425092|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
94717903|NCT03398148|324425093|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
94717904|NCT03398148|324425094|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
94717905|NCT03398148|324425095|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
94717906|NCT03398148|324425081|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94467298|NCT01897571|323500505|FG009|Overall Study|Other|0|||
94467299|NCT01897571|323500506|FG010|Overall Study|Other|0|||
94717907|NCT03398148|324425082|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717908|NCT03398148|324425083|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717909|NCT03398148|324425084|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717910|NCT03398148|324425085|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717911|NCT03398148|324425086|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717912|NCT03398148|324425087|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717913|NCT03398148|324425088|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717914|NCT03398148|324425089|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717915|NCT03398148|324425090|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717916|NCT03398148|324425091|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
94717917|NCT03398148|324425092|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717918|NCT03398148|324425093|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717919|NCT03398148|324425094|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717920|NCT03398148|324425095|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
94717921|NCT03398148|324425081|FG000|Substudy 2 Period 1|Other|0|||
94717922|NCT03398148|324425082|FG001|Substudy 2 Period 1|Other|0|||
94717923|NCT03398148|324425083|FG002|Substudy 2 Period 1|Other|0|||
94717924|NCT03398148|324425084|FG003|Substudy 2 Period 1|Other|0|||
94717925|NCT03398148|324425085|FG004|Substudy 2 Period 1|Other|0|||
94717926|NCT03398148|324425086|FG005|Substudy 2 Period 1|Other|0|||
94717927|NCT03398148|324425087|FG006|Substudy 2 Period 1|Other|0|||
94717928|NCT03398148|324425088|FG007|Substudy 2 Period 1|Other|0|||
94717929|NCT03398148|324425089|FG008|Substudy 2 Period 1|Other|0|||
94717930|NCT03398148|324425090|FG009|Substudy 2 Period 1|Other|4|||
94717931|NCT03398148|324425091|FG010|Substudy 2 Period 1|Other|4|||
94717932|NCT03398148|324425092|FG011|Substudy 2 Period 1|Other|0|||
94717933|NCT03398148|324425093|FG012|Substudy 2 Period 1|Other|0|||
94717934|NCT03398148|324425094|FG013|Substudy 2 Period 1|Other|0|||
94717935|NCT03398148|324425095|FG014|Substudy 2 Period 1|Other|0|||
94717936|NCT03398148|324425081|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
94717937|NCT03398148|324425082|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
94717938|NCT03398148|324425083|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
94717939|NCT03398148|324425084|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
94717940|NCT03398148|324425085|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
94717941|NCT03398148|324425086|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
94717942|NCT03398148|324425087|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
94717943|NCT03398148|324425088|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
94717944|NCT03398148|324425089|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
94717945|NCT03398148|324425090|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
94717946|NCT03398148|324425091|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
94717947|NCT03398148|324425092|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
94717948|NCT03398148|324425093|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
94717949|NCT03398148|324425094|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
94717950|NCT03398148|324425095|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
94717951|NCT03398148|324425081|FG000|Substudy 2 Period 2|Adverse Event|0|||
94717952|NCT03398148|324425082|FG001|Substudy 2 Period 2|Adverse Event|0|||
94717953|NCT03398148|324425083|FG002|Substudy 2 Period 2|Adverse Event|0|||
94717954|NCT03398148|324425084|FG003|Substudy 2 Period 2|Adverse Event|0|||
94717955|NCT03398148|324425085|FG004|Substudy 2 Period 2|Adverse Event|0|||
94717956|NCT03398148|324425086|FG005|Substudy 2 Period 2|Adverse Event|0|||
94717957|NCT03398148|324425087|FG006|Substudy 2 Period 2|Adverse Event|0|||
94717958|NCT03398148|324425088|FG007|Substudy 2 Period 2|Adverse Event|0|||
94717959|NCT03398148|324425089|FG008|Substudy 2 Period 2|Adverse Event|0|||
94717960|NCT03398148|324425090|FG009|Substudy 2 Period 2|Adverse Event|0|||
94717961|NCT03398148|324425091|FG010|Substudy 2 Period 2|Adverse Event|0|||
94717962|NCT03398148|324425092|FG011|Substudy 2 Period 2|Adverse Event|0|||
94717963|NCT03398148|324425093|FG012|Substudy 2 Period 2|Adverse Event|0|||
94717964|NCT03398148|324425094|FG013|Substudy 2 Period 2|Adverse Event|1|||
94717965|NCT03398148|324425095|FG014|Substudy 2 Period 2|Adverse Event|3|||
94717966|NCT03398148|324425081|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
94717967|NCT03398148|324425082|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
94717968|NCT03398148|324425083|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
94717969|NCT03398148|324425084|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
94717970|NCT03398148|324425085|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
94717971|NCT03398148|324425086|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
94717972|NCT03398148|324425087|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
94717973|NCT03398148|324425088|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
94717974|NCT03398148|324425089|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
94717975|NCT03398148|324425090|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
94717976|NCT03398148|324425091|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
94717977|NCT03398148|324425092|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
94717978|NCT03398148|324425093|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
94717979|NCT03398148|324425094|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
94717980|NCT03398148|324425095|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
94717981|NCT03398148|324425081|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
94717982|NCT03398148|324425082|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
94717983|NCT03398148|324425083|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
94717984|NCT03398148|324425084|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
94717985|NCT03398148|324425085|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
94717986|NCT03398148|324425086|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
94717987|NCT03398148|324425087|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
94717988|NCT03398148|324425088|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
94717989|NCT03398148|324425089|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
94717990|NCT03398148|324425090|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
94717991|NCT03398148|324425091|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
94717992|NCT03398148|324425092|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
94717993|NCT03398148|324425093|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
94717994|NCT03398148|324425094|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
94717995|NCT03398148|324425095|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
94717996|NCT03398148|324425081|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
94655028|NCT03295201|324194218|FG001|Overall Study|Lost to Follow-up|1|||
94655029|NCT03295201|324194217|FG000|Overall Study|Hospital admission|0|||
94655030|NCT03295201|324194218|FG001|Overall Study|Hospital admission|1|||
94655031|NCT01465334|324194219|FG000|Overall Study|Disease Progression|1|||
94655032|NCT01465334|324194220|FG001|Overall Study|Disease Progression|0|||
94655033|NCT01465334|324194219|FG000|Overall Study|Adverse Event|1|||
94655034|NCT01465334|324194220|FG001|Overall Study|Adverse Event|0|||
94655035|NCT01465334|324194219|FG000|Overall Study|Richter's transformation|0|||
94655036|NCT01465334|324194220|FG001|Overall Study|Richter's transformation|3|||
94655037|NCT01465334|324194219|FG000|Overall Study|Refractory Disease|0|||
94655038|NCT01465334|324194220|FG001|Overall Study|Refractory Disease|3|||
94655039|NCT03525834|324194221|FG000|Overall Study|Progressive disease|1|||
94655040|NCT00840970|324194222|FG000|Overall Study|Adverse Event|0|||
94655041|NCT00840970|324194223|FG001|Overall Study|Adverse Event|0|||
94655042|NCT00840970|324194224|FG002|Overall Study|Adverse Event|1|||
94655043|NCT04096560|324194225|FG000|Overall Study|Reason not Specified|1|||
94655044|NCT04096560|324194226|FG001|Overall Study|Reason not Specified|0|||
94655045|NCT04096560|324194227|FG002|Overall Study|Reason not Specified|0|||
94655046|NCT04096560|324194228|FG003|Overall Study|Reason not Specified|0|||
94271981|NCT01506960|322788594|FG000|Overall Study|Did not meet angiographic criteria|47|||
94271982|NCT00578136|322788598|FG000|Overall Study|Not given intervention|1|||
94271983|NCT00578136|322788599|FG001|Overall Study|Not given intervention|1|||
94271984|NCT01279850|322788602|FG000|Overall Study|Protocol Violation|50|||
94271985|NCT01279850|322788602|FG000|Overall Study|No Drug Administration Information|7|||
94271986|NCT01279850|322788602|FG000|Overall Study|No Visit After Treatment|34|||
94271987|NCT00427349|322788604|FG000|Overall Study|Lack of Efficacy|23|||
94271988|NCT00427349|322788604|FG000|Overall Study|Adverse Event|14|||
94271989|NCT00427349|322788604|FG000|Overall Study|Death|1|||
94271990|NCT00427349|322788604|FG000|Overall Study|Withdrawal by Subject|3|||
94271991|NCT00427349|322788604|FG000|Overall Study|Alternative therapy|1|||
94271992|NCT00427349|322788604|FG000|Overall Study|Other|2|||
94271993|NCT00427349|322788604|FG000|Overall Study|Ineligible|1|||
94271994|NCT00427349|322788604|FG000|Overall Study|Never started therapy|1|||
94271995|NCT01892163|322788613|FG000|Overall Study|Death|1|||
94271996|NCT01892163|322788614|FG001|Overall Study|Death|1|||
94271997|NCT01892163|322788613|FG000|Overall Study|Lost to Follow-up|1|||
94271998|NCT01892163|322788614|FG001|Overall Study|Lost to Follow-up|0|||
94271999|NCT03302975|322788615|FG000|Overall Study|Lost to Follow-up|4|||
94272000|NCT01357655|322788616|FG000|Overall Study|Administrative Reason by Sponsor|45|||
94272001|NCT01357655|322788617|FG001|Overall Study|Administrative Reason by Sponsor|0|||
94272002|NCT01357655|322788616|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
94272003|NCT01357655|322788617|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
94272004|NCT01357655|322788616|FG000|Overall Study|Disease Progression|1|||
94272005|NCT01357655|322788617|FG001|Overall Study|Disease Progression|0|||
94272006|NCT01357655|322788616|FG000|Overall Study|Lost to Follow-up|2|||
94272007|NCT01357655|322788617|FG001|Overall Study|Lost to Follow-up|0|||
94272008|NCT01357655|322788616|FG000|Overall Study|Maximum Clinical Benefit|2|||
94272009|NCT01357655|322788617|FG001|Overall Study|Maximum Clinical Benefit|0|||
94272010|NCT01357655|322788616|FG000|Overall Study|Reason Unspecified|1|||
94272011|NCT01357655|322788617|FG001|Overall Study|Reason Unspecified|0|||
94272012|NCT01357655|322788616|FG000|Overall Study|Study Drug Toxicity|11|||
94272013|NCT01357655|322788617|FG001|Overall Study|Study Drug Toxicity|0|||
94272014|NCT01357655|322788616|FG000|Overall Study|Subject Withdrew Consent|1|||
94272015|NCT01357655|322788617|FG001|Overall Study|Subject Withdrew Consent|0|||
94272016|NCT04013529|322788618|FG000|Overall Study|Withdrawal by Subject|1|||
94272017|NCT04013529|322788619|FG001|Overall Study|Withdrawal by Subject|1|||
94655047|NCT04096560|324194229|FG004|Overall Study|Reason not Specified|1|||
94655048|NCT04096560|324194230|FG005|Overall Study|Reason not Specified|1|||
94655049|NCT04096560|324194231|FG006|Overall Study|Reason not Specified|1|||
94655050|NCT04096560|324194232|FG007|Overall Study|Reason not Specified|0|||
94655051|NCT04096560|324194225|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
94655052|NCT04096560|324194226|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
94655053|NCT04096560|324194227|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
94655054|NCT04096560|324194228|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
94655055|NCT04096560|324194229|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
94655056|NCT04096560|324194230|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
94655057|NCT04096560|324194231|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
94655058|NCT04096560|324194232|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
94655059|NCT04096560|324194225|FG000|Overall Study|Study Terminated by Sponsor|0|||
94655060|NCT04096560|324194226|FG001|Overall Study|Study Terminated by Sponsor|0|||
94655061|NCT04096560|324194227|FG002|Overall Study|Study Terminated by Sponsor|0|||
94655062|NCT04096560|324194228|FG003|Overall Study|Study Terminated by Sponsor|5|||
94655063|NCT04096560|324194229|FG004|Overall Study|Study Terminated by Sponsor|6|||
94655064|NCT04096560|324194230|FG005|Overall Study|Study Terminated by Sponsor|4|||
94655065|NCT04096560|324194231|FG006|Overall Study|Study Terminated by Sponsor|6|||
94655066|NCT04096560|324194232|FG007|Overall Study|Study Terminated by Sponsor|1|||
94655067|NCT04096560|324194225|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
94655068|NCT04096560|324194226|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
94655069|NCT04096560|324194227|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
94655070|NCT04096560|324194228|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
94655071|NCT04096560|324194229|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
94655072|NCT04096560|324194230|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
94655073|NCT04096560|324194231|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
94655074|NCT04096560|324194232|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
94655075|NCT02399085|324194233|FG000|Overall Study|Adverse Event|16|||
94655076|NCT02399085|324194233|FG000|Overall Study|Death|2|||
94655077|NCT02399085|324194233|FG000|Overall Study|Withdrawal by Subject|8|||
94655078|NCT02399085|324194233|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
94272018|NCT00098475|322788622|FG000|Step 1|Progressive disease|33|||
94272019|NCT00098475|322788623|FG001|Step 1|Progressive disease|35|||
94272020|NCT00098475|322788624|FG002|Step 1|Progressive disease|2|||
94717997|NCT03398148|324425082|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
94717998|NCT03398148|324425083|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
94717999|NCT03398148|324425084|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
94718000|NCT03398148|324425085|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
94718001|NCT03398148|324425086|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
94718002|NCT03398148|324425087|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
94718003|NCT03398148|324425088|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
94718004|NCT03398148|324425089|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
94718005|NCT03398148|324425090|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
94718006|NCT03398148|324425091|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
94718007|NCT03398148|324425092|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
94718008|NCT03398148|324425093|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
94718009|NCT03398148|324425094|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
94718010|NCT03398148|324425095|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
94718011|NCT03398148|324425081|FG000|Substudy 2 Period 2|Other|0|||
94718012|NCT03398148|324425082|FG001|Substudy 2 Period 2|Other|0|||
94718013|NCT03398148|324425083|FG002|Substudy 2 Period 2|Other|0|||
94718014|NCT03398148|324425084|FG003|Substudy 2 Period 2|Other|0|||
94718015|NCT03398148|324425085|FG004|Substudy 2 Period 2|Other|0|||
94718016|NCT03398148|324425086|FG005|Substudy 2 Period 2|Other|0|||
94718017|NCT03398148|324425087|FG006|Substudy 2 Period 2|Other|0|||
94718018|NCT03398148|324425088|FG007|Substudy 2 Period 2|Other|0|||
94718019|NCT03398148|324425089|FG008|Substudy 2 Period 2|Other|0|||
94718020|NCT03398148|324425090|FG009|Substudy 2 Period 2|Other|0|||
94718021|NCT03398148|324425091|FG010|Substudy 2 Period 2|Other|0|||
94718022|NCT03398148|324425092|FG011|Substudy 2 Period 2|Other|0|||
94718023|NCT03398148|324425093|FG012|Substudy 2 Period 2|Other|0|||
94718024|NCT03398148|324425094|FG013|Substudy 2 Period 2|Other|1|||
94718025|NCT03398148|324425095|FG014|Substudy 2 Period 2|Other|1|||
94718026|NCT03398148|324425081|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
94718027|NCT03398148|324425082|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
94718028|NCT03398148|324425083|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
94718029|NCT03398148|324425084|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
94718030|NCT03398148|324425085|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
94718031|NCT03398148|324425086|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
94718032|NCT03398148|324425087|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
94718033|NCT03398148|324425088|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
94718034|NCT03398148|324425089|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
94718035|NCT03398148|324425090|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
94718036|NCT03398148|324425091|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
94718037|NCT03398148|324425092|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
94718038|NCT03398148|324425093|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
94718039|NCT03398148|324425094|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
94718040|NCT03398148|324425095|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
94718041|NCT00212355|324425096|FG000|Overall Study|Adverse Event|1|||
94718042|NCT00212355|324425096|FG000|Overall Study|Withdrawal by Subject|1|||
94718043|NCT00212355|324425096|FG000|Overall Study|A change of address|1|||
94718044|NCT04486716|324425097|FG000|Overall Study|Subject decision|6|||
94718045|NCT04486716|324425097|FG000|Overall Study|Adverse Event|5|||
94718046|NCT04486716|324425097|FG000|Overall Study|Lost to Follow-up|1|||
94718047|NCT04486716|324425097|FG000|Overall Study|Physician Decision|1|||
94718048|NCT04486716|324425097|FG000|Overall Study|Enrolled subjects not treated|9|||
94718049|NCT00092534|324425098|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
94718050|NCT00092534|324425099|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
94718051|NCT00092534|324425100|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
94718052|NCT00092534|324425101|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
94718053|NCT00092534|324425102|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
94718054|NCT00092534|324425098|FG000|Base Study Vaccination Period|Adverse Event|3|||
94718055|NCT00092534|324425099|FG001|Base Study Vaccination Period|Adverse Event|1|||
94718056|NCT00092534|324425100|FG002|Base Study Vaccination Period|Adverse Event|0|||
94718057|NCT00092534|324425101|FG003|Base Study Vaccination Period|Adverse Event|0|||
94718058|NCT00092534|324425102|FG004|Base Study Vaccination Period|Adverse Event|0|||
94718059|NCT00092534|324425098|FG000|Base Study Vaccination Period|Death|5|||
94718060|NCT00092534|324425099|FG001|Base Study Vaccination Period|Death|4|||
94367906|NCT02367781|323133070|FG001|Overall Study|Prolonged Hospitalization|0|||
94718061|NCT00092534|324425100|FG002|Base Study Vaccination Period|Death|0|||
94718062|NCT00092534|324425101|FG003|Base Study Vaccination Period|Death|0|||
94718063|NCT00092534|324425102|FG004|Base Study Vaccination Period|Death|0|||
94718064|NCT00092534|324425098|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
94718065|NCT00092534|324425099|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
94367907|NCT02367781|323133069|FG000|Overall Study|Death Prior First Dose|1|||
94367908|NCT02367781|323133070|FG001|Overall Study|Death Prior First Dose|0|||
94718066|NCT00092534|324425100|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
94718067|NCT00092534|324425101|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
94718068|NCT00092534|324425102|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
94718069|NCT00092534|324425098|FG000|Base Study Vaccination Period|Physician Decision|1|||
94718070|NCT00092534|324425099|FG001|Base Study Vaccination Period|Physician Decision|0|||
94718071|NCT00092534|324425100|FG002|Base Study Vaccination Period|Physician Decision|0|||
94718072|NCT00092534|324425101|FG003|Base Study Vaccination Period|Physician Decision|0|||
94718073|NCT00092534|324425102|FG004|Base Study Vaccination Period|Physician Decision|0|||
94718074|NCT00092534|324425098|FG000|Base Study Vaccination Period|Pregnancy|9|||
94718075|NCT00092534|324425099|FG001|Base Study Vaccination Period|Pregnancy|7|||
94718076|NCT00092534|324425100|FG002|Base Study Vaccination Period|Pregnancy|0|||
94718077|NCT00092534|324425101|FG003|Base Study Vaccination Period|Pregnancy|0|||
94718078|NCT00092534|324425102|FG004|Base Study Vaccination Period|Pregnancy|0|||
94718079|NCT00092534|324425098|FG000|Base Study Vaccination Period|Protocol Violation|2|||
94718080|NCT00092534|324425099|FG001|Base Study Vaccination Period|Protocol Violation|1|||
94718081|NCT00092534|324425100|FG002|Base Study Vaccination Period|Protocol Violation|0|||
94718082|NCT00092534|324425101|FG003|Base Study Vaccination Period|Protocol Violation|0|||
94718083|NCT00092534|324425102|FG004|Base Study Vaccination Period|Protocol Violation|0|||
94718084|NCT00092534|324425098|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
94718085|NCT00092534|324425099|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
94718086|NCT00092534|324425100|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
94718087|NCT00092534|324425101|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
94718088|NCT00092534|324425102|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
94718089|NCT00092534|324425098|FG000|Base Study Vaccination Period|Moved|14|||
94718090|NCT00092534|324425099|FG001|Base Study Vaccination Period|Moved|12|||
94718091|NCT00092534|324425100|FG002|Base Study Vaccination Period|Moved|0|||
94718092|NCT00092534|324425101|FG003|Base Study Vaccination Period|Moved|0|||
94718093|NCT00092534|324425102|FG004|Base Study Vaccination Period|Moved|0|||
94718094|NCT00092534|324425098|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
94718095|NCT00092534|324425099|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
94272021|NCT00098475|322788625|FG003|Step 1|Progressive disease|1|||
94718096|NCT00092534|324425100|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
94718097|NCT00092534|324425101|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
94718098|NCT00092534|324425102|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
94718099|NCT00092534|324425098|FG000|Base Study Vaccination Period|Travel|1|||
94718100|NCT00092534|324425099|FG001|Base Study Vaccination Period|Travel|0|||
94367909|NCT02367781|323133069|FG000|Overall Study|Administrative-Change Facility|1|||
94367910|NCT02367781|323133070|FG001|Overall Study|Administrative-Change Facility|0|||
94718101|NCT00092534|324425100|FG002|Base Study Vaccination Period|Travel|0|||
94718102|NCT00092534|324425101|FG003|Base Study Vaccination Period|Travel|0|||
94718103|NCT00092534|324425102|FG004|Base Study Vaccination Period|Travel|0|||
94718104|NCT00092534|324425098|FG000|Base Study Vaccination Period|Site Closed|0|||
94718105|NCT00092534|324425099|FG001|Base Study Vaccination Period|Site Closed|1|||
94718106|NCT00092534|324425100|FG002|Base Study Vaccination Period|Site Closed|0|||
94718107|NCT00092534|324425101|FG003|Base Study Vaccination Period|Site Closed|0|||
94718108|NCT00092534|324425102|FG004|Base Study Vaccination Period|Site Closed|0|||
94718109|NCT00092534|324425098|FG000|Base Study Follow-Up Period|Adverse Event|2|||
94718110|NCT00092534|324425099|FG001|Base Study Follow-Up Period|Adverse Event|4|||
94718111|NCT00092534|324425100|FG002|Base Study Follow-Up Period|Adverse Event|0|||
94718112|NCT00092534|324425101|FG003|Base Study Follow-Up Period|Adverse Event|0|||
94718113|NCT00092534|324425102|FG004|Base Study Follow-Up Period|Adverse Event|0|||
94718114|NCT00092534|324425098|FG000|Base Study Follow-Up Period|Death|2|||
94718115|NCT00092534|324425099|FG001|Base Study Follow-Up Period|Death|1|||
94718116|NCT00092534|324425100|FG002|Base Study Follow-Up Period|Death|0|||
94718117|NCT00092534|324425101|FG003|Base Study Follow-Up Period|Death|0|||
94718118|NCT00092534|324425102|FG004|Base Study Follow-Up Period|Death|0|||
94718119|NCT00092534|324425098|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
94718120|NCT00092534|324425099|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
94718121|NCT00092534|324425100|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
94718122|NCT00092534|324425101|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
94718123|NCT00092534|324425102|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
94718124|NCT00092534|324425098|FG000|Base Study Follow-Up Period|Pregnancy|6|||
94718125|NCT00092534|324425099|FG001|Base Study Follow-Up Period|Pregnancy|10|||
94718126|NCT00092534|324425100|FG002|Base Study Follow-Up Period|Pregnancy|0|||
94718127|NCT00092534|324425101|FG003|Base Study Follow-Up Period|Pregnancy|0|||
94718128|NCT00092534|324425102|FG004|Base Study Follow-Up Period|Pregnancy|0|||
94718129|NCT00092534|324425098|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
94718130|NCT00092534|324425099|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
94718131|NCT00092534|324425100|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
94718132|NCT00092534|324425101|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
94718133|NCT00092534|324425102|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
94718134|NCT00092534|324425098|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
94718135|NCT00092534|324425099|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
94718136|NCT00092534|324425100|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
94718137|NCT00092534|324425101|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
94718138|NCT00092534|324425102|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
94718139|NCT00092534|324425098|FG000|Base Study Follow-Up Period|Moved|62|||
94367911|NCT02367781|323133069|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
94367912|NCT02367781|323133070|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
94367913|NCT02367781|323133069|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
94367914|NCT02367781|323133070|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
94367915|NCT02367781|323133069|FG000|Overall Study|Study Terminated by Sponsor|3|||
94367916|NCT02367781|323133070|FG001|Overall Study|Study Terminated by Sponsor|1|||
94367917|NCT02367781|323133069|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
94367918|NCT02367781|323133070|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
94367919|NCT02367781|323133069|FG000|Overall Study|Sponsor Decision|2|||
94367920|NCT02367781|323133070|FG001|Overall Study|Sponsor Decision|0|||
94467300|NCT01897571|323500496|FG000|Overall Study|Enrolled in rollover study|0|||
94718140|NCT00092534|324425099|FG001|Base Study Follow-Up Period|Moved|58|||
94718141|NCT00092534|324425100|FG002|Base Study Follow-Up Period|Moved|0|||
94718142|NCT00092534|324425101|FG003|Base Study Follow-Up Period|Moved|0|||
94718143|NCT00092534|324425102|FG004|Base Study Follow-Up Period|Moved|0|||
94718144|NCT00092534|324425098|FG000|Base Study Follow-Up Period|Travel|10|||
94718145|NCT00092534|324425099|FG001|Base Study Follow-Up Period|Travel|7|||
94718146|NCT00092534|324425100|FG002|Base Study Follow-Up Period|Travel|0|||
94718147|NCT00092534|324425101|FG003|Base Study Follow-Up Period|Travel|0|||
94718148|NCT00092534|324425102|FG004|Base Study Follow-Up Period|Travel|0|||
94718149|NCT00092534|324425098|FG000|Base Study Follow-Up Period|Site Closed|0|||
94718150|NCT00092534|324425099|FG001|Base Study Follow-Up Period|Site Closed|2|||
94718151|NCT00092534|324425100|FG002|Base Study Follow-Up Period|Site Closed|0|||
94718152|NCT00092534|324425101|FG003|Base Study Follow-Up Period|Site Closed|0|||
94718153|NCT00092534|324425102|FG004|Base Study Follow-Up Period|Site Closed|0|||
94718154|NCT00092534|324425098|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
94718155|NCT00092534|324425099|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
94718156|NCT00092534|324425100|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
94718157|NCT00092534|324425101|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
94718158|NCT00092534|324425102|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
94718159|NCT00092534|324425098|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
94718160|NCT00092534|324425099|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
94718161|NCT00092534|324425100|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
94718162|NCT00092534|324425101|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
94718163|NCT00092534|324425102|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
94718164|NCT00092534|324425098|FG000|Base Study EXT|Lost to Follow-up|0|||
94718165|NCT00092534|324425099|FG001|Base Study EXT|Lost to Follow-up|0|||
94718166|NCT00092534|324425100|FG002|Base Study EXT|Lost to Follow-up|41|||
94718167|NCT00092534|324425101|FG003|Base Study EXT|Lost to Follow-up|0|||
94718168|NCT00092534|324425102|FG004|Base Study EXT|Lost to Follow-up|0|||
94718169|NCT00092534|324425098|FG000|Base Study EXT|Physician Decision|0|||
94718170|NCT00092534|324425099|FG001|Base Study EXT|Physician Decision|0|||
94718171|NCT00092534|324425100|FG002|Base Study EXT|Physician Decision|1|||
94718172|NCT00092534|324425101|FG003|Base Study EXT|Physician Decision|0|||
94718173|NCT00092534|324425102|FG004|Base Study EXT|Physician Decision|0|||
94718174|NCT00092534|324425098|FG000|Base Study EXT|Pregnancy|0|||
94718175|NCT00092534|324425099|FG001|Base Study EXT|Pregnancy|0|||
94718176|NCT00092534|324425100|FG002|Base Study EXT|Pregnancy|12|||
94718177|NCT00092534|324425101|FG003|Base Study EXT|Pregnancy|0|||
94718178|NCT00092534|324425102|FG004|Base Study EXT|Pregnancy|0|||
94718179|NCT00092534|324425098|FG000|Base Study EXT|Withdrawal by Subject|0|||
94718180|NCT00092534|324425099|FG001|Base Study EXT|Withdrawal by Subject|0|||
94718181|NCT00092534|324425100|FG002|Base Study EXT|Withdrawal by Subject|18|||
94718182|NCT00092534|324425101|FG003|Base Study EXT|Withdrawal by Subject|0|||
94718183|NCT00092534|324425102|FG004|Base Study EXT|Withdrawal by Subject|0|||
94718184|NCT00092534|324425098|FG000|Base Study EXT|Participant moved|0|||
94718185|NCT00092534|324425099|FG001|Base Study EXT|Participant moved|0|||
94718186|NCT00092534|324425100|FG002|Base Study EXT|Participant moved|6|||
94718187|NCT00092534|324425101|FG003|Base Study EXT|Participant moved|0|||
94272022|NCT00098475|322788622|FG000|Step 1|Adverse Event|56|||
94718188|NCT00092534|324425102|FG004|Base Study EXT|Participant moved|0|||
94718189|NCT00092534|324425098|FG000|Base Study EXT|Travel|0|||
94718190|NCT00092534|324425099|FG001|Base Study EXT|Travel|0|||
94718191|NCT00092534|324425100|FG002|Base Study EXT|Travel|2|||
94718192|NCT00092534|324425101|FG003|Base Study EXT|Travel|0|||
94718193|NCT00092534|324425102|FG004|Base Study EXT|Travel|0|||
94718194|NCT00092534|324425098|FG000|Base Study EXT|Site closed|0|||
94272023|NCT00098475|322788623|FG001|Step 1|Adverse Event|37|||
94272024|NCT00098475|322788624|FG002|Step 1|Adverse Event|0|||
94272025|NCT00098475|322788625|FG003|Step 1|Adverse Event|1|||
94272026|NCT00098475|322788622|FG000|Step 1|Death|8|||
94272027|NCT00098475|322788623|FG001|Step 1|Death|5|||
94272028|NCT00098475|322788624|FG002|Step 1|Death|0|||
94272029|NCT00098475|322788625|FG003|Step 1|Death|1|||
94272030|NCT00098475|322788622|FG000|Step 1|Withdrawal by Subject|14|||
94272031|NCT00098475|322788623|FG001|Step 1|Withdrawal by Subject|11|||
94272032|NCT00098475|322788624|FG002|Step 1|Withdrawal by Subject|0|||
94272033|NCT00098475|322788625|FG003|Step 1|Withdrawal by Subject|0|||
94272034|NCT00098475|322788622|FG000|Step 1|Physician Decision|5|||
94272035|NCT00098475|322788623|FG001|Step 1|Physician Decision|2|||
94272036|NCT00098475|322788624|FG002|Step 1|Physician Decision|0|||
94272037|NCT00098475|322788625|FG003|Step 1|Physician Decision|0|||
94272038|NCT00098475|322788622|FG000|Step 1|Alternative therapy|31|||
94655079|NCT02399085|324194233|FG000|Overall Study|Physician Decision|5|||
94655080|NCT00724451|324194234|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
94718195|NCT00092534|324425099|FG001|Base Study EXT|Site closed|0|||
94718196|NCT00092534|324425100|FG002|Base Study EXT|Site closed|21|||
94718197|NCT00092534|324425101|FG003|Base Study EXT|Site closed|0|||
94718198|NCT00092534|324425102|FG004|Base Study EXT|Site closed|0|||
94718199|NCT00092534|324425098|FG000|Base Study EXT|Study ended|0|||
94718200|NCT00092534|324425099|FG001|Base Study EXT|Study ended|0|||
94718201|NCT00092534|324425100|FG002|Base Study EXT|Study ended|29|||
94718202|NCT00092534|324425101|FG003|Base Study EXT|Study ended|0|||
94718203|NCT00092534|324425102|FG004|Base Study EXT|Study ended|0|||
94718204|NCT00092534|324425098|FG000|Base Study EXT|Protocol Violation|0|||
94718205|NCT00092534|324425099|FG001|Base Study EXT|Protocol Violation|0|||
94718206|NCT00092534|324425100|FG002|Base Study EXT|Protocol Violation|15|||
94718207|NCT00092534|324425101|FG003|Base Study EXT|Protocol Violation|0|||
94718208|NCT00092534|324425102|FG004|Base Study EXT|Protocol Violation|0|||
94718209|NCT00092534|324425098|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
94718210|NCT00092534|324425099|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
94718211|NCT00092534|324425100|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
94718212|NCT00092534|324425101|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
94467301|NCT01897571|323500497|FG001|Overall Study|Enrolled in rollover study|0|||
94718213|NCT00092534|324425102|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
94718214|NCT01998984|324425103|FG000|Overall Study|Adverse Event|0|||
94718215|NCT01998984|324425104|FG001|Overall Study|Adverse Event|0|||
94718216|NCT01998984|324425105|FG002|Overall Study|Adverse Event|0|||
94718217|NCT01998984|324425106|FG003|Overall Study|Adverse Event|1|||
94718218|NCT01998984|324425103|FG000|Overall Study|Lost to Follow-up|0|||
94718219|NCT01998984|324425104|FG001|Overall Study|Lost to Follow-up|1|||
94718220|NCT01998984|324425105|FG002|Overall Study|Lost to Follow-up|0|||
94718221|NCT01998984|324425106|FG003|Overall Study|Lost to Follow-up|1|||
94718222|NCT01998984|324425103|FG000|Overall Study|Withdrawal by Subject|0|||
94718223|NCT01998984|324425104|FG001|Overall Study|Withdrawal by Subject|0|||
94718224|NCT01998984|324425105|FG002|Overall Study|Withdrawal by Subject|1|||
94718225|NCT01998984|324425106|FG003|Overall Study|Withdrawal by Subject|0|||
94718226|NCT01998984|324425103|FG000|Overall Study|Other|0|||
94718227|NCT01998984|324425104|FG001|Overall Study|Other|0|||
94718228|NCT01998984|324425105|FG002|Overall Study|Other|0|||
94718229|NCT01998984|324425106|FG003|Overall Study|Other|1|||
94718230|NCT03025789|324425109|FG000|Overall Study|Lack of Efficacy|6|||
94718231|NCT03025789|324425110|FG001|Overall Study|Lack of Efficacy|1|||
94718232|NCT03025789|324425109|FG000|Overall Study|Death|1|||
94718233|NCT03025789|324425110|FG001|Overall Study|Death|0|||
94718234|NCT03025789|324425109|FG000|Overall Study|Withdrawal by Subject|0|||
94718235|NCT03025789|324425110|FG001|Overall Study|Withdrawal by Subject|2|||
94718236|NCT05104697|324425111|FG000|Overall Study|Withdrawal by Subject|0|||
94718237|NCT05104697|324425112|FG001|Overall Study|Withdrawal by Subject|1|||
94718238|NCT04714320|324425114|FG000|Overall Study|Voluntary Withdrawal|4|||
94718239|NCT04714320|324425115|FG001|Overall Study|Voluntary Withdrawal|1|||
94718240|NCT04714320|324425116|FG002|Overall Study|Voluntary Withdrawal|2|||
94718241|NCT04714320|324425114|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
94718242|NCT04714320|324425115|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
94718243|NCT04714320|324425116|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
94718244|NCT04714320|324425114|FG000|Overall Study|Reason Not Specified|1|||
94718245|NCT04714320|324425115|FG001|Overall Study|Reason Not Specified|3|||
94718246|NCT04714320|324425116|FG002|Overall Study|Reason Not Specified|3|||
94718247|NCT03088813|324425119|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
94718248|NCT03088813|324425120|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
94718249|NCT03088813|324425121|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
94718250|NCT03088813|324425122|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
94718251|NCT03088813|324425119|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
94718252|NCT03088813|324425120|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
94718253|NCT03088813|324425121|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
94718254|NCT03088813|324425122|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
94718255|NCT03088813|324425119|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
94718256|NCT03088813|324425120|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
94718257|NCT03088813|324425121|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
94718258|NCT03088813|324425122|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
94718259|NCT03088813|324425119|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
94718260|NCT03088813|324425120|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
94718261|NCT03088813|324425121|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
94718262|NCT03088813|324425122|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
94718263|NCT03088813|324425119|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
94718264|NCT03088813|324425120|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
94367921|NCT02367781|323133069|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
94367922|NCT02367781|323133070|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
94367923|NCT00529802|323134797|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
94367924|NCT00529802|323134797|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
94367925|NCT00529802|323134797|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
94367926|NCT00529802|323134797|FG000|Evaluable for Primary Endpoint|Death|1|||
94367927|NCT00529802|323134797|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
94367928|NCT00529802|323134797|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
94367929|NCT00529802|323134797|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
94367930|NCT02209454|323134798|FG000|Second Period|Adverse Event|1|||
94367931|NCT02209454|323134799|FG001|Second Period|Adverse Event|0|||
94367932|NCT00021229|323134800|FG000|Overall Study|Adverse Event|10|||
94367933|NCT00021229|323134801|FG001|Overall Study|Adverse Event|5|||
94367934|NCT00021229|323134802|FG002|Overall Study|Adverse Event|2|||
94367935|NCT00021229|323134800|FG000|Overall Study|Death|0|||
94367936|NCT00021229|323134801|FG001|Overall Study|Death|1|||
94367937|NCT00021229|323134802|FG002|Overall Study|Death|0|||
94367938|NCT00021229|323134800|FG000|Overall Study|Withdrawal by Subject|7|||
94367939|NCT00021229|323134801|FG001|Overall Study|Withdrawal by Subject|7|||
94367940|NCT00021229|323134802|FG002|Overall Study|Withdrawal by Subject|1|||
94655081|NCT00724451|324194234|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
94718265|NCT03088813|324425121|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
94718266|NCT03088813|324425122|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
94718267|NCT03088813|324425119|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
94718268|NCT03088813|324425120|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
94718269|NCT03088813|324425121|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
94718270|NCT03088813|324425122|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
94718271|NCT03088813|324425119|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
94718272|NCT03088813|324425120|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
94718273|NCT03088813|324425121|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
94718274|NCT03088813|324425122|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
94718275|NCT05307783|324425131|FG000|Overall Study|Death|7|||
94718276|NCT05307783|324425131|FG000|Overall Study|Lost to Follow-up|4|||
94718277|NCT01903811|324425132|FG000|Overall Study|No measurable disease|1|||
94718278|NCT01903811|324425133|FG001|Overall Study|No measurable disease|1|||
94718279|NCT01903811|324425132|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
94718280|NCT01903811|324425133|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
94718281|NCT01903811|324425132|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
94718282|NCT01903811|324425133|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
94718283|NCT01903811|324425132|FG000|Overall Study|Withdrawal by Subject|0|||
94718284|NCT01903811|324425133|FG001|Overall Study|Withdrawal by Subject|1|||
94718285|NCT06194214|324425134|FG000|Overall Study|Adverse Event|1|||
94718286|NCT00979576|324425135|FG000|Combination Treatment Phase|Progressive disease|3|||
94718287|NCT00979576|324425136|FG001|Combination Treatment Phase|Progressive disease|1|||
94718288|NCT00979576|324425137|FG002|Combination Treatment Phase|Progressive disease|5|||
94718289|NCT00979576|324425135|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
94718290|NCT00979576|324425136|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
94718291|NCT00979576|324425137|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
94718292|NCT00979576|324425135|FG000|Combination Treatment Phase|Adverse Event|0|||
94718293|NCT00979576|324425136|FG001|Combination Treatment Phase|Adverse Event|2|||
94718294|NCT00979576|324425137|FG002|Combination Treatment Phase|Adverse Event|2|||
94718295|NCT00979576|324425135|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
94718296|NCT00979576|324425136|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
94718297|NCT00979576|324425137|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
94718298|NCT04540913|324425138|FG000|Overall Study|Withdrawal by Subject|14|||
94718299|NCT04540913|324425139|FG001|Overall Study|Withdrawal by Subject|3|||
94718300|NCT00567398|324425142|FG000|Overall Study|Adverse Event|6|||
94718301|NCT00567398|324425143|FG001|Overall Study|Adverse Event|14|||
94718302|NCT00567398|324425142|FG000|Overall Study|Physician Decision|0|||
94718303|NCT00567398|324425143|FG001|Overall Study|Physician Decision|4|||
94718304|NCT00567398|324425142|FG000|Overall Study|Withdrawal by Subject|0|||
94718305|NCT00567398|324425143|FG001|Overall Study|Withdrawal by Subject|2|||
94718306|NCT00567398|324425142|FG000|Overall Study|Renal Transplantation|0|||
94718307|NCT00567398|324425143|FG001|Overall Study|Renal Transplantation|3|||
94718308|NCT00567398|324425142|FG000|Overall Study|Other|1|||
94718309|NCT00567398|324425143|FG001|Overall Study|Other|0|||
94718310|NCT03517553|324425144|FG000|Overall Study|Withdrawal by Subject|2|||
94718311|NCT03103321|324425145|FG000|Overall Study|Protocol Violation|1|||
94718312|NCT03103321|324425146|FG001|Overall Study|Protocol Violation|1|||
94718313|NCT03103321|324425147|FG002|Overall Study|Protocol Violation|1|||
94718314|NCT03103321|324425148|FG003|Overall Study|Protocol Violation|0|||
94718315|NCT04247542|324425149|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
94718316|NCT04247542|324425150|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
94718317|NCT04247542|324425151|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
94718318|NCT04247542|324425149|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
94718319|NCT04247542|324425150|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
94718320|NCT04247542|324425151|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
94718321|NCT02201108|324425152|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
94718322|NCT02201108|324425153|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
94718323|NCT02201108|324425154|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
94718324|NCT02201108|324425152|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
94718325|NCT02201108|324425153|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
94718326|NCT02201108|324425154|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
94718327|NCT02201108|324425152|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
94718328|NCT02201108|324425153|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
94718329|NCT02201108|324425154|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
94718330|NCT02201108|324425152|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
94718331|NCT02201108|324425153|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
94718332|NCT02201108|324425154|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
94718333|NCT02201108|324425152|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
94655082|NCT00724451|324194234|FG000|Overall Study|Not Eligible for Treatment|431|||
94655083|NCT00724451|324194234|FG000|Overall Study|Participant Refused Treatment|89|||
94655084|NCT00724451|324194234|FG000|Overall Study|Never Started Treatment|89|||
94655085|NCT00724451|324194234|FG000|Overall Study|Unknown; No Data Sources Available|9|||
94655086|NCT00724451|324194234|FG000|Overall Study|Physician Decision|116|||
94655087|NCT00724451|324194234|FG000|Overall Study|Withdrawal by Subject|45|||
94655088|NCT00724451|324194234|FG000|Overall Study|Investigator + Participant Decision|13|||
94655089|NCT01632800|324194235|FG000|Overall Study|Subject did not fit in apparatus|1|||
94655090|NCT02266381|324194236|FG000|Overall Study|Physician Decision|3|||
94655091|NCT02266381|324194237|FG001|Overall Study|Physician Decision|5|||
94655092|NCT02266381|324194238|FG002|Overall Study|Physician Decision|4|||
94655093|NCT03732248|324194239|FG000|Overall Study|Withdrawal by Subject|1|||
94655094|NCT03732248|324194240|FG001|Overall Study|Withdrawal by Subject|0|||
94655095|NCT04796610|324194241|FG000|Overall Study|Withdrawal by Subject|1|||
94272039|NCT00098475|322788623|FG001|Step 1|Alternative therapy|43|||
94272040|NCT00098475|322788624|FG002|Step 1|Alternative therapy|1|||
94272041|NCT00098475|322788625|FG003|Step 1|Alternative therapy|0|||
94272042|NCT00098475|322788622|FG000|Step 1|Other disease|2|||
94272043|NCT00098475|322788623|FG001|Step 1|Other disease|1|||
94272044|NCT00098475|322788624|FG002|Step 1|Other disease|1|||
94272045|NCT00098475|322788625|FG003|Step 1|Other disease|0|||
94272046|NCT00098475|322788622|FG000|Step 1|Never started treatment|0|||
94272047|NCT00098475|322788623|FG001|Step 1|Never started treatment|2|||
94272048|NCT00098475|322788624|FG002|Step 1|Never started treatment|0|||
94272049|NCT00098475|322788625|FG003|Step 1|Never started treatment|0|||
94272050|NCT00098475|322788622|FG000|Step 1|Still on treatment as of this analysis|14|||
94272051|NCT00098475|322788623|FG001|Step 1|Still on treatment as of this analysis|27|||
94272052|NCT00098475|322788624|FG002|Step 1|Still on treatment as of this analysis|0|||
94272053|NCT00098475|322788625|FG003|Step 1|Still on treatment as of this analysis|0|||
94272054|NCT00098475|322788622|FG000|Step 1|Knee surgery|1|||
94272055|NCT00098475|322788623|FG001|Step 1|Knee surgery|0|||
94272056|NCT00098475|322788624|FG002|Step 1|Knee surgery|0|||
94272057|NCT00098475|322788625|FG003|Step 1|Knee surgery|0|||
94272058|NCT00098475|322788622|FG000|Step 1|Complications|1|||
94272059|NCT00098475|322788623|FG001|Step 1|Complications|0|||
94272060|NCT00098475|322788624|FG002|Step 1|Complications|0|||
94655096|NCT04796610|324194242|FG001|Overall Study|Withdrawal by Subject|0|||
94655097|NCT04796610|324194243|FG002|Overall Study|Withdrawal by Subject|0|||
94655098|NCT04796610|324194244|FG003|Overall Study|Withdrawal by Subject|0|||
94272061|NCT00098475|322788625|FG003|Step 1|Complications|0|||
94272062|NCT00098475|322788622|FG000|Step 1|Cannot comply due to other tx|0|||
94272063|NCT00098475|322788623|FG001|Step 1|Cannot comply due to other tx|1|||
94272064|NCT00098475|322788624|FG002|Step 1|Cannot comply due to other tx|0|||
94718334|NCT02201108|324425153|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
94718335|NCT02201108|324425154|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
94367941|NCT00021229|323134800|FG000|Overall Study|Progressive Disease|15|||
94718336|NCT02201108|324425152|FG000|Open Label Period (up to Week 192)|Other reason|4|||
94718337|NCT02201108|324425153|FG001|Open Label Period (up to Week 192)|Other reason|7|||
94718338|NCT02201108|324425154|FG002|Open Label Period (up to Week 192)|Other reason|0|||
94718339|NCT02201108|324425152|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
94718340|NCT02201108|324425153|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
94718341|NCT02201108|324425154|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
94718342|NCT02201108|324425152|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
94718343|NCT02201108|324425153|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
94718344|NCT02201108|324425154|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
94718345|NCT02201108|324425152|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
94718346|NCT02201108|324425153|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
94718347|NCT02201108|324425154|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
94718348|NCT04934722|324425155|FG000|Overall Study|Death|4|||
94718349|NCT04934722|324425156|FG001|Overall Study|Death|3|||
94718350|NCT04934722|324425155|FG000|Overall Study|Participants Ongoing|88|||
94718351|NCT04934722|324425156|FG001|Overall Study|Participants Ongoing|91|||
94718352|NCT00603954|324425157|FG000|Overall Study|Protocol Violation|1|||
94718353|NCT00603954|324425158|FG001|Overall Study|Protocol Violation|2|||
94718354|NCT01426412|324425161|FG000|Overall Study|Withdrawal by Subject|1|||
94718355|NCT01426412|324425162|FG001|Overall Study|Withdrawal by Subject|0|||
94718356|NCT01426412|324425163|FG002|Overall Study|Withdrawal by Subject|0|||
94718357|NCT01426412|324425164|FG003|Overall Study|Withdrawal by Subject|0|||
94718358|NCT01426412|324425165|FG004|Overall Study|Withdrawal by Subject|1|||
94718359|NCT01426412|324425166|FG005|Overall Study|Withdrawal by Subject|0|||
94718360|NCT01426412|324425167|FG006|Overall Study|Withdrawal by Subject|0|||
94718361|NCT01426412|324425168|FG007|Overall Study|Withdrawal by Subject|3|||
94718362|NCT01426412|324425169|FG008|Overall Study|Withdrawal by Subject|1|||
94718363|NCT01011946|324425170|FG000|Overall Study|Transferred to another hospital|2|||
94718364|NCT01011946|324425170|FG000|Overall Study|No pathological lab value|1|||
94718365|NCT01872078|324425171|FG000|Overall Study|Adverse Event|0|||
94718366|NCT01872078|324425172|FG001|Overall Study|Adverse Event|0|||
94718367|NCT01872078|324425173|FG002|Overall Study|Adverse Event|1|||
94718368|NCT01872078|324425174|FG003|Overall Study|Adverse Event|0|||
94718369|NCT01872078|324425171|FG000|Overall Study|Dose administration non-compliance|0|||
94718370|NCT01872078|324425172|FG001|Overall Study|Dose administration non-compliance|0|||
94718371|NCT01872078|324425173|FG002|Overall Study|Dose administration non-compliance|0|||
94718372|NCT01872078|324425174|FG003|Overall Study|Dose administration non-compliance|1|||
94718373|NCT01872078|324425171|FG000|Overall Study|Protocol Violation|0|||
94718374|NCT01872078|324425172|FG001|Overall Study|Protocol Violation|0|||
94718375|NCT01872078|324425173|FG002|Overall Study|Protocol Violation|1|||
94718376|NCT01872078|324425174|FG003|Overall Study|Protocol Violation|0|||
94718377|NCT01872078|324425171|FG000|Overall Study|Withdrawal by Subject|0|||
94718378|NCT01872078|324425172|FG001|Overall Study|Withdrawal by Subject|0|||
94718379|NCT01872078|324425173|FG002|Overall Study|Withdrawal by Subject|1|||
94718380|NCT01872078|324425174|FG003|Overall Study|Withdrawal by Subject|0|||
94718381|NCT01872078|324425171|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
94718382|NCT01872078|324425172|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
94367942|NCT00021229|323134801|FG001|Overall Study|Progressive Disease|19|||
94718383|NCT01872078|324425173|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
94718384|NCT01872078|324425174|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
94718385|NCT02759016|324425175|FG000|Overall Study|Not treated with BI 836826|1|||
94718386|NCT02759016|324425176|FG001|Overall Study|Not treated with BI 836826|0|||
94718387|NCT02759016|324425175|FG000|Overall Study|Progressive disease|1|||
94718388|NCT02759016|324425176|FG001|Overall Study|Progressive disease|0|||
94718389|NCT02759016|324425175|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
94718390|NCT02759016|324425176|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
94718391|NCT02759016|324425175|FG000|Overall Study|Other not defined above|2|||
94718392|NCT02759016|324425176|FG001|Overall Study|Other not defined above|1|||
94718393|NCT04377308|324425177|FG000|Overall Study|Withdrawal by Subject|0|||
94718394|NCT04377308|324425178|FG001|Overall Study|Withdrawal by Subject|1|||
94718395|NCT01494922|324425179|FG000|Overall Study|Adverse Event|1|||
94718396|NCT03580369|324425180|FG000|Overall Study|No treatment due to mis-randomization|1|||
94718397|NCT03580369|324425181|FG001|Overall Study|No treatment due to mis-randomization|0|||
94367943|NCT00021229|323134802|FG002|Overall Study|Progressive Disease|12|||
94367944|NCT00021229|323134800|FG000|Overall Study|Protocol Violation|1|||
94718398|NCT03580369|324425182|FG002|Overall Study|No treatment due to mis-randomization|0|||
94718399|NCT03580369|324425183|FG003|Overall Study|No treatment due to mis-randomization|0|||
94367945|NCT00021229|323134801|FG001|Overall Study|Protocol Violation|1|||
94367946|NCT00021229|323134802|FG002|Overall Study|Protocol Violation|0|||
94718400|NCT03580369|324425184|FG004|Overall Study|No treatment due to mis-randomization|3|||
94718401|NCT03580369|324425185|FG005|Overall Study|No treatment due to mis-randomization|0|||
94718402|NCT03580369|324425186|FG006|Overall Study|No treatment due to mis-randomization|0|||
94718403|NCT03580369|324425187|FG007|Overall Study|No treatment due to mis-randomization|0|||
94718404|NCT03580369|324425180|FG000|Overall Study|Reason unknown|0|||
94718405|NCT03580369|324425181|FG001|Overall Study|Reason unknown|0|||
94718406|NCT03580369|324425182|FG002|Overall Study|Reason unknown|1|||
94718407|NCT03580369|324425183|FG003|Overall Study|Reason unknown|0|||
94718408|NCT03580369|324425184|FG004|Overall Study|Reason unknown|0|||
94718409|NCT03580369|324425185|FG005|Overall Study|Reason unknown|0|||
94718410|NCT03580369|324425186|FG006|Overall Study|Reason unknown|0|||
94718411|NCT03580369|324425187|FG007|Overall Study|Reason unknown|0|||
94718412|NCT03580369|324425180|FG000|Overall Study|Technical problems|0|||
94718413|NCT03580369|324425181|FG001|Overall Study|Technical problems|0|||
94718414|NCT03580369|324425182|FG002|Overall Study|Technical problems|0|||
94718415|NCT03580369|324425183|FG003|Overall Study|Technical problems|0|||
94718416|NCT03580369|324425184|FG004|Overall Study|Technical problems|1|||
94718417|NCT03580369|324425185|FG005|Overall Study|Technical problems|0|||
94718418|NCT03580369|324425186|FG006|Overall Study|Technical problems|2|||
94718419|NCT03580369|324425187|FG007|Overall Study|Technical problems|0|||
94718420|NCT03580369|324425180|FG000|Overall Study|Pregnancy|2|||
94718421|NCT03580369|324425181|FG001|Overall Study|Pregnancy|0|||
94718422|NCT03580369|324425182|FG002|Overall Study|Pregnancy|3|||
94718423|NCT03580369|324425183|FG003|Overall Study|Pregnancy|0|||
94718424|NCT03580369|324425184|FG004|Overall Study|Pregnancy|2|||
94718425|NCT03580369|324425185|FG005|Overall Study|Pregnancy|0|||
94718426|NCT03580369|324425186|FG006|Overall Study|Pregnancy|0|||
94718427|NCT03580369|324425187|FG007|Overall Study|Pregnancy|0|||
94718428|NCT03580369|324425180|FG000|Overall Study|Lost to Follow-up|2|||
94718429|NCT03580369|324425181|FG001|Overall Study|Lost to Follow-up|0|||
94718430|NCT03580369|324425182|FG002|Overall Study|Lost to Follow-up|2|||
94718431|NCT03580369|324425183|FG003|Overall Study|Lost to Follow-up|0|||
94718432|NCT03580369|324425184|FG004|Overall Study|Lost to Follow-up|3|||
94718433|NCT03580369|324425185|FG005|Overall Study|Lost to Follow-up|0|||
94718434|NCT03580369|324425186|FG006|Overall Study|Lost to Follow-up|1|||
94718435|NCT03580369|324425187|FG007|Overall Study|Lost to Follow-up|0|||
94718436|NCT03580369|324425180|FG000|Overall Study|Physician Decision|4|||
94718437|NCT03580369|324425181|FG001|Overall Study|Physician Decision|0|||
94718438|NCT03580369|324425182|FG002|Overall Study|Physician Decision|4|||
94718439|NCT03580369|324425183|FG003|Overall Study|Physician Decision|1|||
94718440|NCT03580369|324425184|FG004|Overall Study|Physician Decision|1|||
94718441|NCT03580369|324425185|FG005|Overall Study|Physician Decision|0|||
94718442|NCT03580369|324425186|FG006|Overall Study|Physician Decision|0|||
94718443|NCT03580369|324425187|FG007|Overall Study|Physician Decision|0|||
94718444|NCT03580369|324425180|FG000|Overall Study|Lack of Efficacy|3|||
94718445|NCT03580369|324425181|FG001|Overall Study|Lack of Efficacy|0|||
94718446|NCT03580369|324425182|FG002|Overall Study|Lack of Efficacy|7|||
94718447|NCT03580369|324425183|FG003|Overall Study|Lack of Efficacy|0|||
94718448|NCT03580369|324425184|FG004|Overall Study|Lack of Efficacy|2|||
94718449|NCT03580369|324425185|FG005|Overall Study|Lack of Efficacy|0|||
94718450|NCT03580369|324425186|FG006|Overall Study|Lack of Efficacy|3|||
94718451|NCT03580369|324425187|FG007|Overall Study|Lack of Efficacy|0|||
94718452|NCT03580369|324425180|FG000|Overall Study|Protocol Violation|6|||
94718453|NCT03580369|324425181|FG001|Overall Study|Protocol Violation|0|||
94718454|NCT03580369|324425182|FG002|Overall Study|Protocol Violation|6|||
94718455|NCT03580369|324425183|FG003|Overall Study|Protocol Violation|1|||
94718456|NCT03580369|324425184|FG004|Overall Study|Protocol Violation|8|||
94718457|NCT03580369|324425185|FG005|Overall Study|Protocol Violation|2|||
94718458|NCT03580369|324425186|FG006|Overall Study|Protocol Violation|1|||
94718459|NCT03580369|324425187|FG007|Overall Study|Protocol Violation|0|||
94718460|NCT03580369|324425180|FG000|Overall Study|Adverse Event|7|||
94718461|NCT03580369|324425181|FG001|Overall Study|Adverse Event|0|||
94718462|NCT03580369|324425182|FG002|Overall Study|Adverse Event|14|||
94718463|NCT03580369|324425183|FG003|Overall Study|Adverse Event|1|||
94718464|NCT03580369|324425184|FG004|Overall Study|Adverse Event|6|||
94718465|NCT03580369|324425185|FG005|Overall Study|Adverse Event|0|||
94718466|NCT03580369|324425186|FG006|Overall Study|Adverse Event|1|||
94718467|NCT03580369|324425187|FG007|Overall Study|Adverse Event|0|||
94718468|NCT03580369|324425180|FG000|Overall Study|Withdrawal by Subject|19|||
94718469|NCT03580369|324425181|FG001|Overall Study|Withdrawal by Subject|0|||
94718470|NCT03580369|324425182|FG002|Overall Study|Withdrawal by Subject|17|||
94718471|NCT03580369|324425183|FG003|Overall Study|Withdrawal by Subject|0|||
94718472|NCT03580369|324425184|FG004|Overall Study|Withdrawal by Subject|16|||
94718473|NCT03580369|324425185|FG005|Overall Study|Withdrawal by Subject|1|||
94718474|NCT03580369|324425186|FG006|Overall Study|Withdrawal by Subject|7|||
94718475|NCT03580369|324425187|FG007|Overall Study|Withdrawal by Subject|0|||
94718476|NCT03527160|324425188|FG000|Overall Study|No urine collected|13|||
94718477|NCT03527160|324425188|FG000|Overall Study|No clinical serum creatinine collected|6|||
94718478|NCT03527160|324425188|FG000|Overall Study|Did not meet inclusion|2|||
94655099|NCT04796610|324194241|FG000|Overall Study|Lost to Follow-up|2|||
94655100|NCT04796610|324194242|FG001|Overall Study|Lost to Follow-up|0|||
94655101|NCT04796610|324194243|FG002|Overall Study|Lost to Follow-up|1|||
94655102|NCT04796610|324194244|FG003|Overall Study|Lost to Follow-up|1|||
94655103|NCT01459796|324194245|FG000|Overall Study|Non compliance with protocol|2|||
94655104|NCT01459796|324194246|FG001|Overall Study|Non compliance with protocol|4|||
94655105|NCT01459796|324194245|FG000|Overall Study|Adverse Event|5|||
94655106|NCT01459796|324194246|FG001|Overall Study|Adverse Event|5|||
94655107|NCT01459796|324194245|FG000|Overall Study|Withdrawal by Subject|6|||
94655108|NCT01459796|324194246|FG001|Overall Study|Withdrawal by Subject|3|||
94655109|NCT01459796|324194245|FG000|Overall Study|Lost to Follow-up|5|||
94655110|NCT01459796|324194246|FG001|Overall Study|Lost to Follow-up|4|||
94655111|NCT01459796|324194245|FG000|Overall Study|Reason unspecified|1|||
94655112|NCT01459796|324194246|FG001|Overall Study|Reason unspecified|2|||
94655113|NCT01459796|324194245|FG000|Overall Study|Decision by the sponsor|75|||
94655114|NCT01459796|324194246|FG001|Overall Study|Decision by the sponsor|108|||
94655115|NCT00733824|324194247|FG000|Phase I|Withdrawal by Subject|1|||
94655116|NCT00733824|324194248|FG001|Phase I|Withdrawal by Subject|0|||
94655117|NCT00733824|324194249|FG002|Phase I|Withdrawal by Subject|0|||
94655118|NCT00733824|324194250|FG003|Phase I|Withdrawal by Subject|0|||
94655119|NCT00733824|324194251|FG004|Phase I|Withdrawal by Subject|0|||
94655120|NCT01748994|324194257|FG000|Overall Study|Lost to Follow-up|8|||
94655121|NCT01748994|324194258|FG001|Overall Study|Lost to Follow-up|6|||
94655122|NCT02520531|324194260|FG000|Overall Study|Revision of study device components|2|||
94655123|NCT02520531|324194261|FG001|Overall Study|Revision of study device components|2|||
94655124|NCT02520531|324194260|FG000|Overall Study|Death|1|||
94655125|NCT02520531|324194261|FG001|Overall Study|Death|2|||
94655126|NCT02520531|324194260|FG000|Overall Study|Lost to Follow-up|1|||
94655127|NCT02520531|324194261|FG001|Overall Study|Lost to Follow-up|1|||
94655128|NCT02520531|324194260|FG000|Overall Study|Meet exclusion criterion|0|||
94655129|NCT02520531|324194261|FG001|Overall Study|Meet exclusion criterion|1|||
94655130|NCT02520531|324194260|FG000|Overall Study|Withdrawal by Subject|1|||
94655131|NCT02520531|324194261|FG001|Overall Study|Withdrawal by Subject|0|||
94655132|NCT02520531|324194260|FG000|Overall Study|Not study device|1|||
94655133|NCT02520531|324194261|FG001|Overall Study|Not study device|0|||
94718479|NCT02891915|324425189|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
94718480|NCT02891915|324425190|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
94718481|NCT02891915|324425189|FG000|Overall Study|Withdrawal by Subject|3|||
94655134|NCT02158039|324194264|FG000|Overall Study|Withdrawal by Subject|1|||
94718482|NCT02891915|324425190|FG001|Overall Study|Withdrawal by Subject|3|||
94467302|NCT01897571|323500498|FG002|Overall Study|Enrolled in rollover study|0|||
94467303|NCT01897571|323500499|FG003|Overall Study|Enrolled in rollover study|0|||
94467304|NCT01897571|323500500|FG004|Overall Study|Enrolled in rollover study|0|||
94467305|NCT01897571|323500501|FG005|Overall Study|Enrolled in rollover study|0|||
94467306|NCT01897571|323500502|FG006|Overall Study|Enrolled in rollover study|0|||
94655135|NCT02158039|324194264|FG000|Overall Study|Screen Failure|9|||
94655136|NCT00958880|324194266|FG000|Overall Study|Lost to Follow-up|2|||
94655137|NCT00958880|324194267|FG001|Overall Study|Lost to Follow-up|2|||
94655138|NCT01971346|324194268|FG000|Overall Study|Protocol Violation|3|||
94655139|NCT01971346|324194268|FG000|Overall Study|Lost to Follow-up|2|||
94655140|NCT01971346|324194268|FG000|Overall Study|Withdrawal by Subject|2|||
94655141|NCT01971346|324194268|FG000|Overall Study|Physician Decision|1|||
94655142|NCT01687166|324194269|FG000|Overall Study|Attempt subject|2|||
94655143|NCT01687166|324194270|FG001|Overall Study|Attempt subject|3|||
94655144|NCT01687166|324194271|FG002|Overall Study|Attempt subject|2|||
94655145|NCT01687166|324194272|FG003|Overall Study|Attempt subject|0|||
94655146|NCT01687166|324194269|FG000|Overall Study|Did not meet eligibility criteria|4|||
94655147|NCT01687166|324194270|FG001|Overall Study|Did not meet eligibility criteria|6|||
94655148|NCT01687166|324194271|FG002|Overall Study|Did not meet eligibility criteria|1|||
94655149|NCT01687166|324194272|FG003|Overall Study|Did not meet eligibility criteria|1|||
94655150|NCT01687166|324194269|FG000|Overall Study|Adverse Event|2|||
94655151|NCT01687166|324194270|FG001|Overall Study|Adverse Event|1|||
94655152|NCT01687166|324194271|FG002|Overall Study|Adverse Event|0|||
94655153|NCT01687166|324194272|FG003|Overall Study|Adverse Event|0|||
94655154|NCT01687166|324194269|FG000|Overall Study|Physician Decision|3|||
94655155|NCT01687166|324194270|FG001|Overall Study|Physician Decision|2|||
94655156|NCT01687166|324194271|FG002|Overall Study|Physician Decision|1|||
94655157|NCT01687166|324194272|FG003|Overall Study|Physician Decision|0|||
94655158|NCT01687166|324194269|FG000|Overall Study|Withdrawal by Subject|11|||
94655159|NCT01687166|324194270|FG001|Overall Study|Withdrawal by Subject|4|||
94655160|NCT01687166|324194271|FG002|Overall Study|Withdrawal by Subject|3|||
94655161|NCT01687166|324194272|FG003|Overall Study|Withdrawal by Subject|0|||
94655162|NCT01687166|324194269|FG000|Overall Study|Lost to Follow-up|2|||
94655163|NCT01687166|324194270|FG001|Overall Study|Lost to Follow-up|5|||
94655164|NCT01687166|324194271|FG002|Overall Study|Lost to Follow-up|1|||
94655165|NCT01687166|324194272|FG003|Overall Study|Lost to Follow-up|0|||
94655166|NCT01687166|324194269|FG000|Overall Study|Equipment/Device Availability|0|||
94655167|NCT01687166|324194270|FG001|Overall Study|Equipment/Device Availability|1|||
94655168|NCT01687166|324194271|FG002|Overall Study|Equipment/Device Availability|0|||
94655169|NCT01687166|324194272|FG003|Overall Study|Equipment/Device Availability|0|||
94655170|NCT01687166|324194269|FG000|Overall Study|Death|1|||
94655171|NCT01687166|324194270|FG001|Overall Study|Death|1|||
94655172|NCT01687166|324194271|FG002|Overall Study|Death|0|||
94655173|NCT01687166|324194272|FG003|Overall Study|Death|0|||
94655174|NCT01687166|324194269|FG000|Overall Study|Protocol Violation|1|||
94655175|NCT01687166|324194270|FG001|Overall Study|Protocol Violation|1|||
94655176|NCT01687166|324194271|FG002|Overall Study|Protocol Violation|1|||
94655177|NCT01687166|324194272|FG003|Overall Study|Protocol Violation|0|||
94655178|NCT01687166|324194269|FG000|Overall Study|Subject moved out of state|0|||
94655179|NCT01687166|324194270|FG001|Overall Study|Subject moved out of state|1|||
94655180|NCT01687166|324194271|FG002|Overall Study|Subject moved out of state|0|||
94655181|NCT01687166|324194272|FG003|Overall Study|Subject moved out of state|0|||
94655182|NCT01687166|324194269|FG000|Overall Study|Patient unable to be compliant|1|||
94655183|NCT01687166|324194270|FG001|Overall Study|Patient unable to be compliant|0|||
94655184|NCT01687166|324194271|FG002|Overall Study|Patient unable to be compliant|0|||
94655185|NCT01687166|324194272|FG003|Overall Study|Patient unable to be compliant|0|||
94655186|NCT01687166|324194269|FG000|Overall Study|Physician choice to use different device|1|||
94655187|NCT01687166|324194270|FG001|Overall Study|Physician choice to use different device|2|||
94655188|NCT01687166|324194271|FG002|Overall Study|Physician choice to use different device|4|||
94655189|NCT01687166|324194272|FG003|Overall Study|Physician choice to use different device|0|||
94655190|NCT01687166|324194269|FG000|Overall Study|Insurance|0|||
94655191|NCT01687166|324194270|FG001|Overall Study|Insurance|0|||
94655192|NCT01687166|324194271|FG002|Overall Study|Insurance|1|||
94655193|NCT01687166|324194272|FG003|Overall Study|Insurance|1|||
94655194|NCT01800903|324194273|FG000|Second Test Period|unable to catheterise|1|||
94655195|NCT01800903|324194274|FG001|Second Test Period|unable to catheterise|0|||
94655196|NCT01800903|324194275|FG002|Second Test Period|unable to catheterise|0|||
94655197|NCT01800903|324194276|FG003|Second Test Period|unable to catheterise|0|||
94655198|NCT01800903|324194277|FG004|Second Test Period|unable to catheterise|0|||
94655199|NCT01800903|324194278|FG005|Second Test Period|unable to catheterise|0|||
94655200|NCT02778204|324194279|FG000|Overall Study|Adverse Event|1|||
94655201|NCT02778204|324194280|FG001|Overall Study|Adverse Event|0|||
94655202|NCT02778204|324194281|FG002|Overall Study|Adverse Event|0|||
94718483|NCT02891915|324425189|FG000|Overall Study|Became Ineligible After Enrollment|2|||
94272065|NCT00098475|322788625|FG003|Step 1|Cannot comply due to other tx|0|||
94272066|NCT00098475|322788622|FG000|Step 1|Both patient and physician's decision|2|||
94272067|NCT00098475|322788623|FG001|Step 1|Both patient and physician's decision|1|||
94718484|NCT02891915|324425190|FG001|Overall Study|Became Ineligible After Enrollment|1|||
94718485|NCT02891915|324425189|FG000|Overall Study|Lost to Follow-up|1|||
94718486|NCT02891915|324425190|FG001|Overall Study|Lost to Follow-up|4|||
94272068|NCT00098475|322788624|FG002|Step 1|Both patient and physician's decision|0|||
94272069|NCT00098475|322788625|FG003|Step 1|Both patient and physician's decision|0|||
94272070|NCT00098475|322788622|FG000|Step 1|Incorrect disease assessment|2|||
94272071|NCT00098475|322788623|FG001|Step 1|Incorrect disease assessment|0|||
94718487|NCT02891915|324425189|FG000|Overall Study|Physician Decision|1|||
94718488|NCT02891915|324425190|FG001|Overall Study|Physician Decision|0|||
94718489|NCT02910713|324425193|FG000|Overall Study|Protocol Violation|2|||
94718490|NCT02910713|324425193|FG000|Overall Study|Subject Choice|4|||
94718491|NCT02910713|324425193|FG000|Overall Study|Received One Application|10|||
94718492|NCT02910713|324425193|FG000|Overall Study|Received Neither Application|18|||
94718493|NCT02910713|324425193|FG000|Overall Study|Enrollment cap|7|||
94718494|NCT02910713|324425193|FG000|Overall Study|Investigator Discretion|1|||
94718495|NCT04043455|324426731|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
94718496|NCT04043455|324426732|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
94718497|NCT04043455|324426733|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
94718498|NCT04043455|324426734|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
94718499|NCT04043455|324426735|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
94718500|NCT04043455|324426736|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
94718501|NCT04043455|324426731|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
94718502|NCT04043455|324426732|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
94718503|NCT04043455|324426733|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
94718504|NCT04043455|324426734|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
94718505|NCT04043455|324426735|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
94718506|NCT04043455|324426736|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
94272072|NCT00098475|322788624|FG002|Step 1|Incorrect disease assessment|0|||
94272073|NCT00098475|322788625|FG003|Step 1|Incorrect disease assessment|0|||
94272074|NCT00098475|322788622|FG000|Step 1|Off treatment for > specified timeframe|1|||
94718507|NCT04043455|324426731|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
94718508|NCT04043455|324426732|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
94718509|NCT04043455|324426733|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
94718510|NCT04043455|324426734|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
94718511|NCT04043455|324426735|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
94718512|NCT04043455|324426736|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
94718513|NCT04043455|324426731|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
94718514|NCT04043455|324426732|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
94718515|NCT04043455|324426733|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
94718516|NCT04043455|324426734|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
94718517|NCT04043455|324426735|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
94718518|NCT04043455|324426736|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
94718519|NCT04043455|324426731|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
94718520|NCT04043455|324426732|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
94718521|NCT04043455|324426733|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
94718522|NCT04043455|324426734|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
94718523|NCT04043455|324426735|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
94718524|NCT04043455|324426736|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
94718525|NCT04043455|324426731|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
94718526|NCT04043455|324426732|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
94718527|NCT04043455|324426733|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
94718528|NCT04043455|324426734|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
94718529|NCT04043455|324426735|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
94718530|NCT04043455|324426736|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
94718531|NCT04043455|324426731|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
94718532|NCT04043455|324426732|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
94718533|NCT04043455|324426733|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
94718534|NCT04043455|324426734|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
94718535|NCT04043455|324426735|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
94718536|NCT04043455|324426736|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
94718537|NCT04043455|324426731|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
94718538|NCT04043455|324426732|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
94718539|NCT04043455|324426733|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
94718540|NCT04043455|324426734|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
94718541|NCT04043455|324426735|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
94718542|NCT04043455|324426736|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
94718543|NCT04043455|324426731|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
94718544|NCT04043455|324426732|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
94718545|NCT04043455|324426733|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
94718546|NCT04043455|324426734|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
94718547|NCT04043455|324426735|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
94718548|NCT04043455|324426736|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
94718549|NCT04043455|324426731|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
94718550|NCT04043455|324426732|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
94718551|NCT04043455|324426733|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
94718552|NCT04043455|324426734|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
94718553|NCT04043455|324426735|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
94718554|NCT04043455|324426736|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
94718555|NCT04043455|324426731|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
94718556|NCT04043455|324426732|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
94718557|NCT04043455|324426733|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
94718558|NCT04043455|324426734|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
94718559|NCT04043455|324426735|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
94718560|NCT04043455|324426736|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
94718561|NCT03237481|324426739|FG000|Overall Study|Lost to Follow-up|1|||
94718562|NCT03237481|324426740|FG001|Overall Study|Lost to Follow-up|0|||
94718563|NCT03237481|324426741|FG002|Overall Study|Lost to Follow-up|0|||
94718564|NCT03237481|324426739|FG000|Overall Study|Protocol Violation|1|||
94718565|NCT03237481|324426740|FG001|Overall Study|Protocol Violation|0|||
94718566|NCT03237481|324426741|FG002|Overall Study|Protocol Violation|0|||
94272075|NCT00098475|322788623|FG001|Step 1|Off treatment for > specified timeframe|1|||
94718567|NCT03237481|324426739|FG000|Overall Study|Withdrawal by Subject|3|||
94718568|NCT03237481|324426740|FG001|Overall Study|Withdrawal by Subject|2|||
94718569|NCT03237481|324426741|FG002|Overall Study|Withdrawal by Subject|1|||
94718570|NCT02605837|324426746|FG000|Overall Study|Adverse Event|3|||
94718571|NCT02605837|324426747|FG001|Overall Study|Adverse Event|1|||
94718572|NCT02605837|324426746|FG000|Overall Study|Non-Compliance with Study Drug|0|||
94467307|NCT01897571|323500503|FG007|Overall Study|Enrolled in rollover study|9|||
94467308|NCT01897571|323500504|FG008|Overall Study|Enrolled in rollover study|7|||
94655203|NCT02778204|324194282|FG003|Overall Study|Adverse Event|0|||
94655204|NCT02778204|324194279|FG000|Overall Study|Withdrawal by Subject|0|||
94655205|NCT02778204|324194280|FG001|Overall Study|Withdrawal by Subject|0|||
94655206|NCT02778204|324194281|FG002|Overall Study|Withdrawal by Subject|1|||
94655207|NCT02778204|324194282|FG003|Overall Study|Withdrawal by Subject|2|||
94655208|NCT02778204|324194279|FG000|Overall Study|Lost to Follow-up|1|||
94655209|NCT02778204|324194280|FG001|Overall Study|Lost to Follow-up|0|||
94655210|NCT02778204|324194281|FG002|Overall Study|Lost to Follow-up|2|||
94655211|NCT02778204|324194282|FG003|Overall Study|Lost to Follow-up|1|||
94655212|NCT02778204|324194279|FG000|Overall Study|Protocol Violation|0|||
94655213|NCT02778204|324194280|FG001|Overall Study|Protocol Violation|0|||
94655214|NCT02778204|324194281|FG002|Overall Study|Protocol Violation|1|||
94655215|NCT02778204|324194282|FG003|Overall Study|Protocol Violation|0|||
94655216|NCT02778204|324194279|FG000|Overall Study|Eligibility Violation|0|||
94655217|NCT02778204|324194280|FG001|Overall Study|Eligibility Violation|0|||
94655218|NCT02778204|324194281|FG002|Overall Study|Eligibility Violation|0|||
94655219|NCT02778204|324194282|FG003|Overall Study|Eligibility Violation|1|||
94655220|NCT03779841|324194285|FG000|Randomized Population|Did Not Receive Treatment|3|||
94655221|NCT03779841|324194286|FG001|Randomized Population|Did Not Receive Treatment|1|||
94655222|NCT03779841|324194287|FG002|Randomized Population|Did Not Receive Treatment|0|||
94655223|NCT03779841|324194285|FG000|Treated (Safety) Population|Adverse Event|1|||
94655224|NCT03779841|324194286|FG001|Treated (Safety) Population|Adverse Event|1|||
94655225|NCT03779841|324194287|FG002|Treated (Safety) Population|Adverse Event|0|||
94655226|NCT03779841|324194285|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
94655227|NCT03779841|324194286|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
94655228|NCT03779841|324194287|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
94655229|NCT03779841|324194285|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
94655230|NCT03779841|324194286|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
94655231|NCT03779841|324194287|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
94655232|NCT03779841|324194285|FG000|Treated (Safety) Population|Death|1|||
94655233|NCT03779841|324194286|FG001|Treated (Safety) Population|Death|0|||
94655234|NCT03779841|324194287|FG002|Treated (Safety) Population|Death|2|||
94655235|NCT02019719|324195914|FG000|Overall Study|Adverse Event|1|||
94655236|NCT02019719|324195915|FG001|Overall Study|Adverse Event|0|||
94655237|NCT02019719|324195916|FG002|Overall Study|Adverse Event|0|||
94655238|NCT02019719|324195917|FG003|Overall Study|Adverse Event|1|||
94655239|NCT02019719|324195918|FG004|Overall Study|Adverse Event|1|||
94655240|NCT02019719|324195914|FG000|Overall Study|Protocol Violation|1|||
94655241|NCT02019719|324195915|FG001|Overall Study|Protocol Violation|1|||
94655242|NCT02019719|324195916|FG002|Overall Study|Protocol Violation|0|||
94655243|NCT02019719|324195917|FG003|Overall Study|Protocol Violation|0|||
94655244|NCT02019719|324195918|FG004|Overall Study|Protocol Violation|0|||
94655245|NCT02019719|324195914|FG000|Overall Study|Protocol defined stopping criteria|2|||
94655246|NCT02019719|324195915|FG001|Overall Study|Protocol defined stopping criteria|0|||
94655247|NCT02019719|324195916|FG002|Overall Study|Protocol defined stopping criteria|0|||
94655248|NCT02019719|324195917|FG003|Overall Study|Protocol defined stopping criteria|1|||
94655249|NCT02019719|324195918|FG004|Overall Study|Protocol defined stopping criteria|1|||
94655250|NCT02019719|324195914|FG000|Overall Study|Physician Decision|2|||
94655251|NCT02019719|324195915|FG001|Overall Study|Physician Decision|0|||
94655252|NCT02019719|324195916|FG002|Overall Study|Physician Decision|0|||
94655253|NCT02019719|324195917|FG003|Overall Study|Physician Decision|0|||
94655254|NCT02019719|324195918|FG004|Overall Study|Physician Decision|0|||
94655255|NCT00009737|324195923|FG000|Overall Study|Adverse Event|112|||
94655256|NCT00009737|324195924|FG001|Overall Study|Adverse Event|75|||
94655257|NCT00009737|324195923|FG000|Overall Study|Death|4|||
94655258|NCT00009737|324195924|FG001|Overall Study|Death|6|||
94655259|NCT00009737|324195923|FG000|Overall Study|Lack of Efficacy|17|||
94655260|NCT00009737|324195924|FG001|Overall Study|Lack of Efficacy|15|||
94655261|NCT00009737|324195923|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
94655262|NCT00009737|324195924|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
94655263|NCT00009737|324195923|FG000|Overall Study|Other Protocol Violation|1|||
94655264|NCT00009737|324195924|FG001|Overall Study|Other Protocol Violation|0|||
94655265|NCT00009737|324195923|FG000|Overall Study|Refused Treatment|15|||
94655266|NCT00009737|324195924|FG001|Overall Study|Refused Treatment|16|||
94655267|NCT00009737|324195923|FG000|Overall Study|Lost to Follow-up|1|||
94655268|NCT00009737|324195924|FG001|Overall Study|Lost to Follow-up|1|||
94655269|NCT00009737|324195923|FG000|Overall Study|Administrative/Other Reasons|7|||
94655270|NCT00009737|324195924|FG001|Overall Study|Administrative/Other Reasons|1|||
94655271|NCT04808609|324195925|FG000|Overall Study|Lost to Follow-up|0|||
94655272|NCT04808609|324195926|FG001|Overall Study|Lost to Follow-up|2|||
94655273|NCT04808609|324195925|FG000|Overall Study|Administrative Withdrawal|0|||
94655274|NCT04808609|324195926|FG001|Overall Study|Administrative Withdrawal|1|||
94467309|NCT01897571|323500505|FG009|Overall Study|Enrolled in rollover study|9|||
94655275|NCT01158924|324195937|FG000|Overall Study|Withdrawal by Subject|1|||
94718573|NCT02605837|324426747|FG001|Overall Study|Non-Compliance with Study Drug|1|||
94718574|NCT02605837|324426746|FG000|Overall Study|Withdrawal by Subject|8|||
94718575|NCT02605837|324426747|FG001|Overall Study|Withdrawal by Subject|8|||
94718576|NCT02605837|324426746|FG000|Overall Study|Physician Decision|0|||
94718577|NCT02605837|324426747|FG001|Overall Study|Physician Decision|1|||
94718578|NCT00410761|324426748|FG000|Overall Study|Adverse Event|29|||
94718579|NCT00410761|324426749|FG001|Overall Study|Adverse Event|3|||
94718580|NCT00410761|324426748|FG000|Overall Study|objective disease progression|71|||
94718581|NCT00410761|324426749|FG001|Overall Study|objective disease progression|55|||
94718582|NCT00410761|324426748|FG000|Overall Study|Withdrawal by Subject|8|||
94718583|NCT00410761|324426749|FG001|Overall Study|Withdrawal by Subject|4|||
94718584|NCT00410761|324426748|FG000|Overall Study|Other|12|||
94718585|NCT00410761|324426749|FG001|Overall Study|Other|9|||
94718586|NCT00410761|324426748|FG000|Overall Study|Never received randomised treatment|0|||
94718587|NCT00410761|324426749|FG001|Overall Study|Never received randomised treatment|1|||
94718588|NCT03845465|324426750|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
94718589|NCT03845465|324426751|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
94718590|NCT03845465|324426750|FG000|6-month Data Collection|Withdrawal by Subject|0|||
94718591|NCT03845465|324426751|FG001|6-month Data Collection|Withdrawal by Subject|2|||
94718592|NCT03845465|324426750|FG000|12-month Data Collection|Withdrawal by Subject|0|||
94718593|NCT03845465|324426751|FG001|12-month Data Collection|Withdrawal by Subject|2|||
94718594|NCT02180724|324426752|FG000|Overall Study|Death|26|||
94718595|NCT02180724|324426753|FG001|Overall Study|Death|1|||
94718596|NCT02180724|324426752|FG000|Overall Study|Lost to Follow-up|3|||
94718597|NCT02180724|324426753|FG001|Overall Study|Lost to Follow-up|1|||
94718598|NCT02180724|324426752|FG000|Overall Study|Withdrawal by Subject|4|||
94718599|NCT02180724|324426753|FG001|Overall Study|Withdrawal by Subject|2|||
94718600|NCT02180724|324426752|FG000|Overall Study|PI Decision|5|||
94718601|NCT02180724|324426753|FG001|Overall Study|PI Decision|2|||
94718602|NCT02180724|324426752|FG000|Overall Study|Study terminated by sponsor|54|||
94718603|NCT02180724|324426753|FG001|Overall Study|Study terminated by sponsor|8|||
94718604|NCT03299049|324426759|FG000|Overall Study|On-going|486|||
94718605|NCT03299049|324426760|FG001|Overall Study|On-going|481|||
94718606|NCT03299049|324426759|FG000|Overall Study|Withdrawal by Subject|6|||
94718607|NCT03299049|324426760|FG001|Overall Study|Withdrawal by Subject|21|||
94718608|NCT03299049|324426759|FG000|Overall Study|Physician Decision|5|||
94718609|NCT03299049|324426760|FG001|Overall Study|Physician Decision|1|||
94718610|NCT03299049|324426759|FG000|Overall Study|Lost to Follow-up|2|||
94718611|NCT03299049|324426760|FG001|Overall Study|Lost to Follow-up|0|||
94718612|NCT03299049|324426759|FG000|Overall Study|Pregnancy|1|||
94718613|NCT03299049|324426760|FG001|Overall Study|Pregnancy|3|||
94718614|NCT03299049|324426759|FG000|Overall Study|Protocol Violation|1|||
94718615|NCT03299049|324426760|FG001|Overall Study|Protocol Violation|1|||
94718616|NCT03299049|324426759|FG000|Overall Study|Lack of Efficacy|9|||
94718617|NCT03299049|324426760|FG001|Overall Study|Lack of Efficacy|3|||
94718618|NCT03299049|324426759|FG000|Overall Study|Adverse Event|12|||
94718619|NCT03299049|324426760|FG001|Overall Study|Adverse Event|13|||
94718620|NCT04524390|324426761|FG000|Double Blind|Consent Withdrawal by subject|2|||
94718621|NCT04524390|324426762|FG001|Double Blind|Consent Withdrawal by subject|1|||
94718622|NCT04524390|324426763|FG002|Double Blind|Consent Withdrawal by subject|0|||
94718623|NCT04524390|324426761|FG000|Double Blind|Adverse Event|5|||
94718624|NCT04524390|324426762|FG001|Double Blind|Adverse Event|3|||
94718625|NCT04524390|324426763|FG002|Double Blind|Adverse Event|0|||
94718626|NCT04524390|324426761|FG000|Double Blind|Liver Transplant|5|||
94718627|NCT04524390|324426762|FG001|Double Blind|Liver Transplant|6|||
94718628|NCT04524390|324426763|FG002|Double Blind|Liver Transplant|0|||
94718629|NCT04524390|324426761|FG000|Double Blind|Disease Progression|0|||
94718630|NCT04524390|324426762|FG001|Double Blind|Disease Progression|1|||
94718631|NCT04524390|324426763|FG002|Double Blind|Disease Progression|0|||
94718632|NCT04524390|324426761|FG000|Open-Label|Drug interruption criteria|0|||
94718633|NCT04524390|324426762|FG001|Open-Label|Drug interruption criteria|0|||
94718634|NCT04524390|324426763|FG002|Open-Label|Drug interruption criteria|1|||
94718635|NCT04524390|324426761|FG000|Open-Label|Liver Transplant|0|||
94718636|NCT04524390|324426762|FG001|Open-Label|Liver Transplant|0|||
94718637|NCT04524390|324426763|FG002|Open-Label|Liver Transplant|1|||
94718638|NCT04524390|324426761|FG000|Open-Label|Disease Progression|0|||
94718639|NCT04524390|324426762|FG001|Open-Label|Disease Progression|0|||
94718640|NCT04524390|324426763|FG002|Open-Label|Disease Progression|1|||
94718641|NCT04524390|324426761|FG000|Open-Label|Adverse Event|0|||
94718642|NCT04524390|324426762|FG001|Open-Label|Adverse Event|0|||
94718643|NCT04524390|324426763|FG002|Open-Label|Adverse Event|3|||
94718644|NCT04524390|324426761|FG000|Open-Label|Study Termination by sponsor|0|||
94718645|NCT04524390|324426762|FG001|Open-Label|Study Termination by sponsor|0|||
94718646|NCT04524390|324426763|FG002|Open-Label|Study Termination by sponsor|45|||
94718647|NCT02581215|324426764|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
94718648|NCT02581215|324426765|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
94718649|NCT02581215|324426764|FG000|Overall Study|Eligibility Criteria Not Met|0|||
94718650|NCT02581215|324426765|FG001|Overall Study|Eligibility Criteria Not Met|1|||
94718651|NCT02780388|324426768|FG000|Overall Study|Lost to Follow-up|0|||
94718652|NCT02780388|324426769|FG001|Overall Study|Lost to Follow-up|1|||
94718653|NCT02780388|324426770|FG002|Overall Study|Lost to Follow-up|0|||
94718654|NCT02780388|324426771|FG003|Overall Study|Lost to Follow-up|0|||
94718655|NCT02780388|324426772|FG004|Overall Study|Lost to Follow-up|0|||
94718656|NCT02780388|324426768|FG000|Overall Study|Withdrawal by Subject|1|||
94718657|NCT02780388|324426769|FG001|Overall Study|Withdrawal by Subject|1|||
94718658|NCT02780388|324426770|FG002|Overall Study|Withdrawal by Subject|0|||
94718659|NCT02780388|324426771|FG003|Overall Study|Withdrawal by Subject|0|||
94718660|NCT02780388|324426772|FG004|Overall Study|Withdrawal by Subject|0|||
94718661|NCT04527146|324426773|FG000|Overall Study|Withdrawal by Subject|12|||
94718662|NCT04527146|324426774|FG001|Overall Study|Withdrawal by Subject|15|||
94718663|NCT04527146|324426775|FG002|Overall Study|Withdrawal by Subject|7|||
94718664|NCT04527146|324426776|FG003|Overall Study|Withdrawal by Subject|16|||
94718665|NCT04527146|324426773|FG000|Overall Study|Lost to Follow-up|13|||
94718666|NCT04527146|324426774|FG001|Overall Study|Lost to Follow-up|9|||
94718667|NCT04527146|324426775|FG002|Overall Study|Lost to Follow-up|16|||
94718668|NCT04527146|324426776|FG003|Overall Study|Lost to Follow-up|13|||
94718669|NCT04527146|324426773|FG000|Overall Study|Death|0|||
94718670|NCT04527146|324426774|FG001|Overall Study|Death|1|||
94718671|NCT04527146|324426775|FG002|Overall Study|Death|1|||
94718672|NCT04527146|324426776|FG003|Overall Study|Death|0|||
94718673|NCT04527146|324426773|FG000|Overall Study|Adverse Event|0|||
94718674|NCT04527146|324426774|FG001|Overall Study|Adverse Event|0|||
94718675|NCT04527146|324426775|FG002|Overall Study|Adverse Event|1|||
94718676|NCT04527146|324426776|FG003|Overall Study|Adverse Event|0|||
94718677|NCT04527146|324426773|FG000|Overall Study|Ineligible after randomization|2|||
94718678|NCT04527146|324426774|FG001|Overall Study|Ineligible after randomization|0|||
94718679|NCT04527146|324426775|FG002|Overall Study|Ineligible after randomization|2|||
94718680|NCT04527146|324426776|FG003|Overall Study|Ineligible after randomization|2|||
94718681|NCT04527146|324426773|FG000|Overall Study|Moved to a different group|6|||
94718682|NCT04527146|324426774|FG001|Overall Study|Moved to a different group|3|||
94718683|NCT04527146|324426775|FG002|Overall Study|Moved to a different group|0|||
94718684|NCT04527146|324426776|FG003|Overall Study|Moved to a different group|2|||
94718685|NCT05107401|324426777|FG000|Overall Study|Lost to Follow-up|13|||
94718686|NCT05107401|324426778|FG001|Overall Study|Lost to Follow-up|12|||
94718687|NCT04878354|324426779|FG000|Overall Study|Adverse Event|4|||
94718688|NCT04878354|324426780|FG001|Overall Study|Adverse Event|13|||
94718689|NCT04878354|324426779|FG000|Overall Study|Withdrawal by Subject|14|||
94718690|NCT04878354|324426780|FG001|Overall Study|Withdrawal by Subject|12|||
94718691|NCT04878354|324426779|FG000|Overall Study|Lost to Follow-up|4|||
94718692|NCT04878354|324426780|FG001|Overall Study|Lost to Follow-up|1|||
94718693|NCT04878354|324426779|FG000|Overall Study|Lack of Efficacy|1|||
94718694|NCT04878354|324426780|FG001|Overall Study|Lack of Efficacy|0|||
94718695|NCT04878354|324426779|FG000|Overall Study|Protocol Violation|0|||
94718696|NCT04878354|324426780|FG001|Overall Study|Protocol Violation|1|||
94718697|NCT04878354|324426779|FG000|Overall Study|"Reason stated as other in CRF"|2|||
94718698|NCT04878354|324426780|FG001|Overall Study|"Reason stated as other in CRF"|3|||
94718699|NCT04468776|324426783|FG000|Overall Study|Lost to Follow-up|4|||
94718700|NCT04468776|324426784|FG001|Overall Study|Lost to Follow-up|3|||
94718701|NCT04468776|324426785|FG002|Overall Study|Lost to Follow-up|4|||
94718702|NCT04468776|324426783|FG000|Overall Study|Withdrawal by Subject|1|||
94718703|NCT04468776|324426784|FG001|Overall Study|Withdrawal by Subject|10|||
94718704|NCT04468776|324426785|FG002|Overall Study|Withdrawal by Subject|4|||
94718705|NCT04468776|324426783|FG000|Overall Study|Physician Decision|0|||
94718706|NCT04468776|324426784|FG001|Overall Study|Physician Decision|1|||
94718707|NCT04468776|324426785|FG002|Overall Study|Physician Decision|1|||
94718708|NCT04608045|324426786|FG000|Overall Study|Physician Decision|1|||
94718709|NCT03656562|324426792|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
94718710|NCT03656562|324426793|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
94718711|NCT03656562|324426794|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
94718712|NCT03656562|324426795|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
94718713|NCT03656562|324426792|FG000|Overall Study|Physician Decision|1|||
94718714|NCT03656562|324426793|FG001|Overall Study|Physician Decision|2|||
94272076|NCT00098475|322788624|FG002|Step 1|Off treatment for > specified timeframe|0|||
94272077|NCT00098475|322788625|FG003|Step 1|Off treatment for > specified timeframe|0|||
94272078|NCT00098475|322788622|FG000|Step 1|Declining performance status|0|||
94718715|NCT03656562|324426794|FG002|Overall Study|Physician Decision|0|||
94718716|NCT03656562|324426795|FG003|Overall Study|Physician Decision|0|||
94718717|NCT03656562|324426792|FG000|Overall Study|Subject Decision|3|||
94718718|NCT03656562|324426793|FG001|Overall Study|Subject Decision|5|||
94718719|NCT03656562|324426794|FG002|Overall Study|Subject Decision|0|||
94718720|NCT03656562|324426795|FG003|Overall Study|Subject Decision|2|||
94718721|NCT00753090|324426796|FG000|Overall Study|Withdrawal by Subject|10|||
94272079|NCT00098475|322788623|FG001|Step 1|Declining performance status|1|||
94272080|NCT00098475|322788624|FG002|Step 1|Declining performance status|0|||
94272081|NCT00098475|322788625|FG003|Step 1|Declining performance status|0|||
94272082|NCT00098475|322788622|FG000|Step 1|Insurance issue|0|||
94718722|NCT00753090|324426797|FG001|Overall Study|Withdrawal by Subject|10|||
94718723|NCT00753090|324426796|FG000|Overall Study|Death|17|||
94718724|NCT00753090|324426797|FG001|Overall Study|Death|6|||
94718725|NCT00753090|324426796|FG000|Overall Study|Study Prosthesis Removed|12|||
94718726|NCT00753090|324426797|FG001|Overall Study|Study Prosthesis Removed|3|||
94718727|NCT00753090|324426796|FG000|Overall Study|Lost to Follow-up|2|||
94718728|NCT00753090|324426797|FG001|Overall Study|Lost to Follow-up|2|||
94718729|NCT00753090|324426796|FG000|Overall Study|Other|127|||
94718730|NCT00753090|324426797|FG001|Overall Study|Other|75|||
94718731|NCT04847999|324426808|FG000|Overall Study|Lost to Follow-up|0|||
94718732|NCT04847999|324426809|FG001|Overall Study|Lost to Follow-up|1|||
94718733|NCT02879448|324426810|FG000|Overall Study|Death|251|||
94718734|NCT02879448|324426811|FG001|Overall Study|Death|263|||
94718735|NCT02879448|324426810|FG000|Overall Study|Lost to Follow-up|23|||
94718736|NCT02879448|324426811|FG001|Overall Study|Lost to Follow-up|28|||
94718737|NCT02879448|324426810|FG000|Overall Study|Withdrawal by Subject|42|||
94718738|NCT02879448|324426811|FG001|Overall Study|Withdrawal by Subject|79|||
94718739|NCT02879448|324426810|FG000|Overall Study|Other Reasons|8|||
94718740|NCT02879448|324426811|FG001|Overall Study|Other Reasons|12|||
94718741|NCT02991807|324426812|FG000|Overall Study|Withdrawal by Subject|2|||
94718742|NCT02991807|324426813|FG001|Overall Study|Withdrawal by Subject|1|||
94718743|NCT02991807|324426812|FG000|Overall Study|Physician Decision|0|||
94718744|NCT02991807|324426813|FG001|Overall Study|Physician Decision|1|||
94718745|NCT02991807|324426812|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
94718746|NCT02991807|324426813|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
94718747|NCT03739996|324426814|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
94718748|NCT03739996|324426814|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
94718749|NCT03739996|324426814|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
94718750|NCT03739996|324426814|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
94718751|NCT03739996|324426814|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
94718752|NCT03739996|324426814|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
94718753|NCT03739996|324426814|FG000|Step 3 (SOC ART)|Death|1|||
94718754|NCT03739996|324426814|FG000|Step 3 (SOC ART)|Participant moved|1|||
94718755|NCT05387447|324426815|FG000|Overall Study|Participants changed their minds about study participation.|3|||
94718756|NCT05387447|324426816|FG001|Overall Study|Participants changed their minds about study participation.|5|||
94718757|NCT00150813|324426819|FG000|Overall Study|Adverse Event|1|||
94718758|NCT00150813|324426819|FG000|Overall Study|Lack of Efficacy|1|||
94718759|NCT00150813|324426819|FG000|Overall Study|Lost to Follow-up|5|||
94718760|NCT00150813|324426819|FG000|Overall Study|Withdrawal by Subject|5|||
94718761|NCT00150813|324426819|FG000|Overall Study|Remission|3|||
94718762|NCT00150813|324426819|FG000|Overall Study|Planned pregancy|1|||
94718763|NCT00150813|324426819|FG000|Overall Study|Switch to commercially available LEV|2|||
94718764|NCT03624972|324426820|FG000|Overall Study|Lost to Follow-up|2|||
94718765|NCT03624972|324426821|FG001|Overall Study|Lost to Follow-up|0|||
94718766|NCT03624972|324426822|FG002|Overall Study|Lost to Follow-up|0|||
94718767|NCT03624972|324426820|FG000|Overall Study|Withdrawal by Subject|0|||
94718768|NCT03624972|324426821|FG001|Overall Study|Withdrawal by Subject|2|||
94718769|NCT03624972|324426822|FG002|Overall Study|Withdrawal by Subject|0|||
94718770|NCT00650104|324426832|FG000|Overall Study|Adverse Event|17|||
94718771|NCT00650104|324426832|FG000|Overall Study|Death|2|||
94718772|NCT00650104|324426832|FG000|Overall Study|Withdrawal by Subject|11|||
94718773|NCT00650104|324426832|FG000|Overall Study|Physician Decision|7|||
94718774|NCT00650104|324426832|FG000|Overall Study|Lost to Follow-up|1|||
94718775|NCT00650104|324426832|FG000|Overall Study|Non-compliance|2|||
94718776|NCT00650104|324426832|FG000|Overall Study|Sponsor Terminated Dosing|1|||
94718777|NCT04579250|324426833|FG000|Overall Study|Withdrawal by Subject|1|||
94718778|NCT04579250|324426834|FG001|Overall Study|Withdrawal by Subject|1|||
94718779|NCT04579250|324426835|FG002|Overall Study|Withdrawal by Subject|0|||
94718780|NCT04579250|324426833|FG000|Overall Study|Lost to Follow-up|1|||
94718781|NCT04579250|324426834|FG001|Overall Study|Lost to Follow-up|1|||
94272083|NCT00098475|322788623|FG001|Step 1|Insurance issue|1|||
94718782|NCT04579250|324426835|FG002|Overall Study|Lost to Follow-up|0|||
94718783|NCT04579250|324426833|FG000|Overall Study|Moved from area|0|||
94718784|NCT04579250|324426834|FG001|Overall Study|Moved from area|1|||
94718785|NCT04579250|324426835|FG002|Overall Study|Moved from area|2|||
94718786|NCT00998881|324426841|FG000|Overall Study|Adverse Event|2|||
94718787|NCT00998881|324426842|FG001|Overall Study|Adverse Event|2|||
94718788|NCT00998881|324426841|FG000|Overall Study|Lack of Efficacy|1|||
94718789|NCT00998881|324426842|FG001|Overall Study|Lack of Efficacy|0|||
94718790|NCT00998881|324426841|FG000|Overall Study|Physician Decision|3|||
94718791|NCT00998881|324426842|FG001|Overall Study|Physician Decision|0|||
94272084|NCT00098475|322788624|FG002|Step 1|Insurance issue|0|||
94718792|NCT00998881|324426841|FG000|Overall Study|Withdrawal by Subject|1|||
94718793|NCT00998881|324426842|FG001|Overall Study|Withdrawal by Subject|0|||
94718794|NCT00998881|324426841|FG000|Overall Study|Personal matter|1|||
94718795|NCT00998881|324426842|FG001|Overall Study|Personal matter|0|||
94718796|NCT00818246|324426843|FG000|Overall Study|Impossible to match pictures|5|||
94718797|NCT01007396|324426847|FG000|Overall Study|Lost to Follow-up|47|||
94718798|NCT00409838|324426848|FG000|Short-term Period|Adverse Event|0|||
94718799|NCT00409838|324426849|FG001|Short-term Period|Adverse Event|1|||
94718800|NCT00409838|324426848|FG000|Short-term Period|Lost to Follow-up|0|||
94718801|NCT00409838|324426849|FG001|Short-term Period|Lost to Follow-up|1|||
94718802|NCT00409838|324426848|FG000|Short-term Period|Withdrawal by Subject|2|||
94718803|NCT00409838|324426849|FG001|Short-term Period|Withdrawal by Subject|3|||
94718804|NCT00409838|324426848|FG000|Short-term Period|Never Treated|1|||
94718805|NCT00409838|324426849|FG001|Short-term Period|Never Treated|0|||
94718806|NCT00409838|324426848|FG000|Long-term Extension Period|Adverse Event|10|||
94718807|NCT00409838|324426849|FG001|Long-term Extension Period|Adverse Event|0|||
94718808|NCT00409838|324426848|FG000|Long-term Extension Period|Death|1|||
94718809|NCT00409838|324426849|FG001|Long-term Extension Period|Death|0|||
94718810|NCT00409838|324426848|FG000|Long-term Extension Period|Lack of Efficacy|2|||
94718811|NCT00409838|324426849|FG001|Long-term Extension Period|Lack of Efficacy|0|||
94718812|NCT00409838|324426848|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
94718813|NCT00409838|324426849|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
94718814|NCT00409838|324426848|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
94718815|NCT00409838|324426849|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
94718816|NCT00409838|324426848|FG000|Long-term Extension Period|Pregnancy|1|||
94718817|NCT00409838|324426849|FG001|Long-term Extension Period|Pregnancy|0|||
94718818|NCT01619410|324426850|FG000|Overall Study|Lost to Follow-up|7|||
94718819|NCT01619410|324426851|FG001|Overall Study|Lost to Follow-up|4|||
94718820|NCT04788641|324426852|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
94718821|NCT04788641|324426853|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
94718822|NCT04788641|324426854|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
94718823|NCT04788641|324426855|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
94718824|NCT04788641|324426852|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
94718825|NCT04788641|324426853|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
94718826|NCT04788641|324426854|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
94718827|NCT04788641|324426855|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
94718828|NCT04788641|324426852|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
94718829|NCT04788641|324426853|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
94718830|NCT04788641|324426854|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
94718831|NCT04788641|324426855|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
94718832|NCT00632203|324426856|FG000|Overall Study|Did not start study treatment|1|||
94718833|NCT00632203|324426857|FG001|Overall Study|Did not start study treatment|0|||
94718834|NCT02638337|324426858|FG000|Overall Study|Adverse Event|6|||
94718835|NCT02638337|324426859|FG001|Overall Study|Adverse Event|10|||
94718836|NCT02638337|324426858|FG000|Overall Study|Protocol Violation|3|||
94718837|NCT02638337|324426859|FG001|Overall Study|Protocol Violation|0|||
94718838|NCT02638337|324426858|FG000|Overall Study|Withdrawal by Subject|13|||
94718839|NCT02638337|324426859|FG001|Overall Study|Withdrawal by Subject|16|||
94718840|NCT02638337|324426858|FG000|Overall Study|Lost to Follow-up|7|||
94718841|NCT02638337|324426859|FG001|Overall Study|Lost to Follow-up|7|||
94718842|NCT02638337|324426858|FG000|Overall Study|Other - Miscellaneous|4|||
94718843|NCT02638337|324426859|FG001|Overall Study|Other - Miscellaneous|3|||
94718844|NCT04238247|324426860|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
94718845|NCT04238247|324426861|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
94718846|NCT04238247|324426862|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
94718847|NCT04238247|324426863|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
94718848|NCT04238247|324426860|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
94718849|NCT04238247|324426861|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
94718850|NCT04238247|324426862|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
94718851|NCT04238247|324426863|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
94718852|NCT04238247|324426860|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
94718853|NCT04238247|324426861|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
94718854|NCT04238247|324426862|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
94718855|NCT04238247|324426863|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
94718856|NCT04238247|324426860|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
94718857|NCT04238247|324426861|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
94718858|NCT04238247|324426862|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
94718859|NCT04238247|324426863|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
94718860|NCT01948661|324426864|FG000|Overall Study|Withdrawal by Subject|2|||
94718861|NCT01948661|324426865|FG001|Overall Study|Withdrawal by Subject|4|||
94718862|NCT02119650|324426866|FG000|Overall Study|Adverse Event|3|||
94718863|NCT02119650|324426867|FG001|Overall Study|Adverse Event|4|||
94467310|NCT01897571|323500506|FG010|Overall Study|Enrolled in rollover study|1|||
94467311|NCT01897571|323500496|FG000|Overall Study|Death|2|||
94718864|NCT02119650|324426866|FG000|Overall Study|Subject decision|2|||
94718865|NCT02119650|324426867|FG001|Overall Study|Subject decision|3|||
94718866|NCT02119650|324426866|FG000|Overall Study|Disease progression|11|||
94718867|NCT02119650|324426867|FG001|Overall Study|Disease progression|14|||
94718868|NCT02119650|324426866|FG000|Overall Study|Death|5|||
94718869|NCT02119650|324426867|FG001|Overall Study|Death|1|||
94718870|NCT02119650|324426866|FG000|Overall Study|Noncompliance with study treatment|1|||
94718871|NCT02119650|324426867|FG001|Overall Study|Noncompliance with study treatment|1|||
94718872|NCT02119650|324426866|FG000|Overall Study|Study terminated by the sponsor|1|||
94718873|NCT02119650|324426867|FG001|Overall Study|Study terminated by the sponsor|0|||
94718874|NCT02119650|324426866|FG000|Overall Study|Physician Decision|0|||
94718875|NCT02119650|324426867|FG001|Overall Study|Physician Decision|2|||
94718876|NCT02119650|324426866|FG000|Overall Study|Multiple reasons for termination|2|||
94718877|NCT02119650|324426867|FG001|Overall Study|Multiple reasons for termination|1|||
94718878|NCT03582722|324426868|FG000|Overall Study|Lost to Follow-up|1|||
94718879|NCT03582722|324426869|FG001|Overall Study|Lost to Follow-up|4|||
94718880|NCT03582722|324426868|FG000|Overall Study|Withdrawal by Subject|3|||
94718881|NCT03582722|324426869|FG001|Overall Study|Withdrawal by Subject|3|||
94718882|NCT05134337|324428767|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
94718883|NCT05134337|324428768|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
94718884|NCT03246347|324428778|FG000|Overall Study|On Study|23|||
94718885|NCT04310735|324428783|FG000|Overall Study|Withdrawal by Subject|1|||
94718886|NCT04310735|324428784|FG001|Overall Study|Withdrawal by Subject|3|||
94718887|NCT04310735|324428785|FG002|Overall Study|Withdrawal by Subject|8|||
94718888|NCT04310735|324428783|FG000|Overall Study|Equipment malfunction|0|||
94718889|NCT04310735|324428784|FG001|Overall Study|Equipment malfunction|1|||
94718890|NCT04310735|324428785|FG002|Overall Study|Equipment malfunction|0|||
94718891|NCT05696080|324428786|FG000|Overall Study|Lost to Follow-up|2|||
94718892|NCT05696080|324428787|FG001|Overall Study|Lost to Follow-up|1|||
94718893|NCT05696080|324428786|FG000|Overall Study|Physician Decision|1|||
94718894|NCT05696080|324428787|FG001|Overall Study|Physician Decision|0|||
94718895|NCT05696080|324428786|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94718896|NCT05696080|324428787|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
94718897|NCT05696080|324428786|FG000|Overall Study|Withdrawal by Subject|12|||
94718898|NCT05696080|324428787|FG001|Overall Study|Withdrawal by Subject|0|||
94718899|NCT03769168|324428788|FG000|Overall Study|Adverse Event|0|||
94718900|NCT03769168|324428789|FG001|Overall Study|Adverse Event|1|||
94718901|NCT03769168|324428788|FG000|Overall Study|Lack of Efficacy|2|||
94718902|NCT03769168|324428789|FG001|Overall Study|Lack of Efficacy|4|||
94718903|NCT03769168|324428788|FG000|Overall Study|Post study access to treatment|3|||
94718904|NCT03769168|324428789|FG001|Overall Study|Post study access to treatment|11|||
94718905|NCT03769168|324428788|FG000|Overall Study|Physician Decision|1|||
94718906|NCT03769168|324428789|FG001|Overall Study|Physician Decision|4|||
94718907|NCT03769168|324428788|FG000|Overall Study|Subject Decision|2|||
94718908|NCT03769168|324428789|FG001|Overall Study|Subject Decision|4|||
94718909|NCT03769168|324428788|FG000|Overall Study|Guardian decision|1|||
94718910|NCT03769168|324428789|FG001|Overall Study|Guardian decision|0|||
94718911|NCT03954184|324428792|FG000|Overall Study|Lost to Follow-up|500|||
94718912|NCT03954184|324428793|FG001|Overall Study|Lost to Follow-up|0|||
94718913|NCT01649271|324428794|FG000|Overall Study|Progressive disease|4|||
94718914|NCT01649271|324428795|FG001|Overall Study|Progressive disease|5|||
94718915|NCT01649271|324428794|FG000|Overall Study|Other Adverse Event|0|||
94718916|NCT01649271|324428795|FG001|Overall Study|Other Adverse Event|2|||
94718917|NCT01649271|324428794|FG000|Overall Study|Withdrawal by Subject|1|||
94718918|NCT01649271|324428795|FG001|Overall Study|Withdrawal by Subject|0|||
94718919|NCT01649271|324428794|FG000|Overall Study|Other than stated above|1|||
94718920|NCT01649271|324428795|FG001|Overall Study|Other than stated above|0|||
94467312|NCT01897571|323500497|FG001|Overall Study|Death|2|||
94272085|NCT00098475|322788625|FG003|Step 1|Insurance issue|0|||
94272086|NCT00098475|322788622|FG000|Step 1|Rising paraprotein|0|||
94272087|NCT00098475|322788623|FG001|Step 1|Rising paraprotein|1|||
94718921|NCT04842500|324428800|FG000|Overall Study|Withdrawal by Subject|4|||
94718922|NCT04842500|324428801|FG001|Overall Study|Withdrawal by Subject|1|||
94718923|NCT04842500|324428802|FG002|Overall Study|Withdrawal by Subject|2|||
94718924|NCT04842500|324428803|FG003|Overall Study|Withdrawal by Subject|3|||
94718925|NCT04842500|324428800|FG000|Overall Study|Protocol Violation|1|||
94718926|NCT04842500|324428801|FG001|Overall Study|Protocol Violation|0|||
94718927|NCT04842500|324428802|FG002|Overall Study|Protocol Violation|0|||
94718928|NCT04842500|324428803|FG003|Overall Study|Protocol Violation|1|||
94718929|NCT05756075|324428806|FG000|Overall Study|Withdrawal by Subject|16|||
94272088|NCT00098475|322788624|FG002|Step 1|Rising paraprotein|0|||
94467313|NCT01897571|323500498|FG002|Overall Study|Death|3|||
94718930|NCT05756075|324428807|FG001|Overall Study|Withdrawal by Subject|9|||
94718931|NCT03397108|324428812|FG000|Overall Study|Lost to Follow-up|15|||
94718932|NCT03397108|324428813|FG001|Overall Study|Lost to Follow-up|0|||
94272089|NCT00098475|322788625|FG003|Step 1|Rising paraprotein|0|||
94718933|NCT03397108|324428812|FG000|Overall Study|Insufficient milk production|3|||
94718934|NCT03397108|324428813|FG001|Overall Study|Insufficient milk production|2|||
94718935|NCT03397108|324428812|FG000|Overall Study|Withdrawal by Subject|2|||
94718936|NCT03397108|324428813|FG001|Overall Study|Withdrawal by Subject|0|||
94718937|NCT05056246|324428816|FG000|Overall Study|Adverse Event|0|||
94718938|NCT05056246|324428817|FG001|Overall Study|Adverse Event|0|||
94718939|NCT05056246|324428818|FG002|Overall Study|Adverse Event|0|||
94718940|NCT05056246|324428819|FG003|Overall Study|Adverse Event|0|||
94718941|NCT05056246|324428820|FG004|Overall Study|Adverse Event|1|||
94718942|NCT05056246|324428816|FG000|Overall Study|Lost to Follow-up|0|||
94718943|NCT05056246|324428817|FG001|Overall Study|Lost to Follow-up|0|||
94718944|NCT05056246|324428818|FG002|Overall Study|Lost to Follow-up|0|||
94718945|NCT05056246|324428819|FG003|Overall Study|Lost to Follow-up|2|||
94718946|NCT05056246|324428820|FG004|Overall Study|Lost to Follow-up|0|||
94718947|NCT05056246|324428816|FG000|Overall Study|Withdrawal by Subject|0|||
94718948|NCT05056246|324428817|FG001|Overall Study|Withdrawal by Subject|1|||
94718949|NCT05056246|324428818|FG002|Overall Study|Withdrawal by Subject|0|||
94718950|NCT05056246|324428819|FG003|Overall Study|Withdrawal by Subject|0|||
94718951|NCT05056246|324428820|FG004|Overall Study|Withdrawal by Subject|0|||
94718952|NCT04907474|324428821|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
94718953|NCT04907474|324428822|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
94718954|NCT03899961|324428823|FG000|Overall Study|-delivery prior to|2|||
94718955|NCT03899961|324428824|FG001|Overall Study|-delivery prior to|7|||
94718956|NCT03899961|324428823|FG000|Overall Study|req general anesth|1|||
94718957|NCT03899961|324428824|FG001|Overall Study|req general anesth|2|||
94718958|NCT03899961|324428823|FG000|Overall Study|capacity|5|||
94718959|NCT03899961|324428824|FG001|Overall Study|capacity|6|||
94718960|NCT03899961|324428823|FG000|Overall Study|Withdrawal by Subject|1|||
94718961|NCT03899961|324428824|FG001|Overall Study|Withdrawal by Subject|1|||
94718962|NCT03324984|324428831|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
94718963|NCT03324984|324428832|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
94718964|NCT04023526|324428839|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
94718965|NCT04023526|324428840|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
94718966|NCT04023526|324428839|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
94718967|NCT04023526|324428840|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
94718968|NCT05613205|324428853|FG000|Overall Study|Lost to Follow-up|0|||
94718969|NCT05613205|324428854|FG001|Overall Study|Lost to Follow-up|0|||
94718970|NCT05613205|324428855|FG002|Overall Study|Lost to Follow-up|1|||
94718971|NCT05613205|324428856|FG003|Overall Study|Lost to Follow-up|1|||
94718972|NCT05613205|324428857|FG004|Overall Study|Lost to Follow-up|0|||
94718973|NCT05613205|324428853|FG000|Overall Study|Withdrawal by Subject|0|||
94718974|NCT05613205|324428854|FG001|Overall Study|Withdrawal by Subject|0|||
94718975|NCT05613205|324428855|FG002|Overall Study|Withdrawal by Subject|1|||
94718976|NCT05613205|324428856|FG003|Overall Study|Withdrawal by Subject|1|||
94718977|NCT05613205|324428857|FG004|Overall Study|Withdrawal by Subject|0|||
94718978|NCT05338086|324428860|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
94718979|NCT05338086|324428861|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
94718980|NCT05338086|324428862|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
94718981|NCT05338086|324428863|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
94718982|NCT05338086|324428864|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
94718983|NCT05338086|324428860|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
94718984|NCT05338086|324428861|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
94718985|NCT05338086|324428862|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
94718986|NCT05338086|324428863|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
94718987|NCT05338086|324428864|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
94718988|NCT05338086|324428860|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
94718989|NCT05338086|324428861|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
94718990|NCT05338086|324428862|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
94718991|NCT05338086|324428863|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
94718992|NCT05338086|324428864|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
94718993|NCT05338086|324428860|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
94272090|NCT00098475|322788622|FG000|Step 1|Referred to other physicians|0|||
94467314|NCT01897571|323500499|FG003|Overall Study|Death|6|||
94718994|NCT05338086|324428861|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
94718995|NCT05338086|324428862|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
94718996|NCT05338086|324428863|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
94467315|NCT01897571|323500500|FG004|Overall Study|Death|7|||
94272091|NCT00098475|322788623|FG001|Step 1|Referred to other physicians|1|||
94272092|NCT00098475|322788624|FG002|Step 1|Referred to other physicians|0|||
94467316|NCT01897571|323500501|FG005|Overall Study|Death|9|||
94272093|NCT00098475|322788625|FG003|Step 1|Referred to other physicians|0|||
94272094|NCT00098475|322788622|FG000|Step 1|Criteria to continue treatment not met|0|||
94272095|NCT00098475|322788623|FG001|Step 1|Criteria to continue treatment not met|1|||
94467317|NCT01897571|323500502|FG006|Overall Study|Death|5|||
94718997|NCT05338086|324428864|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
94718998|NCT05338086|324428860|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
94718999|NCT05338086|324428861|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
94719000|NCT05338086|324428862|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
94719001|NCT05338086|324428863|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
94719002|NCT05338086|324428864|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
94719003|NCT05338086|324428860|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
94719004|NCT05338086|324428861|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
94719005|NCT05338086|324428862|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
94719006|NCT05338086|324428863|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
94719007|NCT05338086|324428864|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
94719008|NCT05338086|324428860|FG000|Transition Period (M12 to M18)|Death|0|||
94367947|NCT00021229|323134800|FG000|Overall Study|Physician Decision|0|||
94367948|NCT00021229|323134801|FG001|Overall Study|Physician Decision|0|||
94367949|NCT00021229|323134802|FG002|Overall Study|Physician Decision|1|||
94367950|NCT00021229|323134800|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
94367951|NCT00021229|323134801|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
94367952|NCT00021229|323134802|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
94367953|NCT01901146|323134803|FG000|Neoadjuvant Phase|Death|1|||
94367954|NCT01901146|323134804|FG001|Neoadjuvant Phase|Death|2|||
94367955|NCT01901146|323134805|FG002|Neoadjuvant Phase|Death|0|||
94367956|NCT01901146|323134806|FG003|Neoadjuvant Phase|Death|0|||
94367957|NCT01901146|323134807|FG004|Neoadjuvant Phase|Death|0|||
94367958|NCT01901146|323134803|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
94719009|NCT05338086|324428861|FG001|Transition Period (M12 to M18)|Death|0|||
94719010|NCT05338086|324428862|FG002|Transition Period (M12 to M18)|Death|1|||
94719011|NCT05338086|324428863|FG003|Transition Period (M12 to M18)|Death|0|||
94719012|NCT05338086|324428864|FG004|Transition Period (M12 to M18)|Death|0|||
94719013|NCT05338086|324428860|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
94719014|NCT05338086|324428861|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
94719015|NCT05338086|324428862|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
94719016|NCT05338086|324428863|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
94719017|NCT05338086|324428864|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
94719018|NCT05338086|324428860|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
94719019|NCT05338086|324428861|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
94719020|NCT05338086|324428862|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
94719021|NCT05338086|324428863|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
94719022|NCT05338086|324428864|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
94719023|NCT05338086|324428860|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
94719024|NCT05338086|324428861|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
94719025|NCT05338086|324428862|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
94719026|NCT05338086|324428863|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
94719027|NCT05338086|324428864|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
94719028|NCT04840199|324428865|FG000|Overall Study|Study Terminated by Sponsor|8|||
94719029|NCT04840199|324428866|FG001|Overall Study|Study Terminated by Sponsor|9|||
94719030|NCT04840199|324428865|FG000|Overall Study|Lost to Follow-up|0|||
94719031|NCT04840199|324428866|FG001|Overall Study|Lost to Follow-up|2|||
94719032|NCT04840199|324428865|FG000|Overall Study|Withdrawal by Subject|2|||
94719033|NCT04840199|324428866|FG001|Overall Study|Withdrawal by Subject|0|||
94719034|NCT04840199|324428865|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
94719035|NCT04840199|324428866|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
94719036|NCT04440176|324428867|FG000|Overall Study|Withdrawal by Subject|5|||
94719037|NCT04440176|324428868|FG001|Overall Study|Withdrawal by Subject|3|||
94719038|NCT04440176|324428867|FG000|Overall Study|Withdrawal by parent/guardian|4|||
94719039|NCT04440176|324428868|FG001|Overall Study|Withdrawal by parent/guardian|5|||
94719040|NCT04440176|324428867|FG000|Overall Study|Adverse Event|2|||
94719041|NCT04440176|324428868|FG001|Overall Study|Adverse Event|6|||
94719042|NCT04440176|324428867|FG000|Overall Study|Lost to Follow-up|22|||
94719043|NCT04440176|324428868|FG001|Overall Study|Lost to Follow-up|23|||
94719044|NCT04440176|324428867|FG000|Overall Study|Medication error without associated adverse event|0|||
94719045|NCT04440176|324428868|FG001|Overall Study|Medication error without associated adverse event|1|||
94719046|NCT04440176|324428867|FG000|Overall Study|No longer met eligibility criteria|7|||
94719047|NCT04440176|324428868|FG001|Overall Study|No longer met eligibility criteria|1|||
94719048|NCT04440176|324428867|FG000|Overall Study|Other|1|||
94719049|NCT04440176|324428868|FG001|Overall Study|Other|2|||
94719050|NCT04440176|324428867|FG000|Overall Study|Protocol deviation|6|||
94719051|NCT04440176|324428868|FG001|Overall Study|Protocol deviation|8|||
94719052|NCT04440176|324428867|FG000|Overall Study|Randomized but not vaccinated|6|||
94719053|NCT04440176|324428868|FG001|Overall Study|Randomized but not vaccinated|3|||
94719054|NCT04112316|324428876|FG000|First Period (8 Weeks)|Protocol Violation|1|||
94719055|NCT04112316|324428877|FG001|First Period (8 Weeks)|Protocol Violation|0|||
94367959|NCT01901146|323134804|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
94367960|NCT01901146|323134805|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
94367961|NCT01901146|323134806|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
94367962|NCT01901146|323134807|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
94367963|NCT01901146|323134803|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
94719056|NCT04112316|324428876|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
94719057|NCT04112316|324428877|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
94719058|NCT03575052|324428878|FG000|Overall Study|Adverse Event|6|||
94719059|NCT03575052|324428879|FG001|Overall Study|Adverse Event|10|||
94719060|NCT03575052|324428878|FG000|Overall Study|Not further specified|5|||
94719061|NCT03575052|324428879|FG001|Overall Study|Not further specified|7|||
94719062|NCT03575052|324428878|FG000|Overall Study|Withdrawal by Subject|5|||
94719063|NCT03575052|324428879|FG001|Overall Study|Withdrawal by Subject|6|||
94719064|NCT03575052|324428878|FG000|Overall Study|Lost to Follow-up|3|||
94719065|NCT03575052|324428879|FG001|Overall Study|Lost to Follow-up|0|||
94719066|NCT03575052|324428878|FG000|Overall Study|Death|2|||
94719067|NCT03575052|324428879|FG001|Overall Study|Death|1|||
94719068|NCT03575052|324428878|FG000|Overall Study|Lack of Efficacy|2|||
94719069|NCT03575052|324428879|FG001|Overall Study|Lack of Efficacy|1|||
94719070|NCT03575052|324428878|FG000|Overall Study|Study drug noncompliance|1|||
94719071|NCT03575052|324428879|FG001|Overall Study|Study drug noncompliance|2|||
94719072|NCT03575052|324428878|FG000|Overall Study|Protocol Violation|0|||
94719073|NCT03575052|324428879|FG001|Overall Study|Protocol Violation|2|||
94719074|NCT03575052|324428878|FG000|Overall Study|Physician Decision|1|||
94719075|NCT03575052|324428879|FG001|Overall Study|Physician Decision|0|||
94719076|NCT04093362|324428880|FG000|Overall Study|Study Termination|1|||
94719077|NCT04093362|324428881|FG001|Overall Study|Study Termination|1|||
94719078|NCT04093362|324428880|FG000|Overall Study|Withdrawal of Consent|1|||
94719079|NCT04093362|324428881|FG001|Overall Study|Withdrawal of Consent|0|||
94719080|NCT04093362|324428880|FG000|Overall Study|Death|1|||
94719081|NCT04093362|324428881|FG001|Overall Study|Death|3|||
94719082|NCT04093362|324428880|FG000|Overall Study|Reason not Specified|1|||
94719083|NCT04093362|324428881|FG001|Overall Study|Reason not Specified|2|||
94467318|NCT01897571|323500503|FG007|Overall Study|Death|22|||
94467319|NCT01897571|323500504|FG008|Overall Study|Death|23|||
94467320|NCT01897571|323500505|FG009|Overall Study|Death|129|||
94719084|NCT03433339|324428884|FG000|Overall Study|Lost to Follow-up|2|||
94719085|NCT03433339|324428885|FG001|Overall Study|Lost to Follow-up|0|||
94719086|NCT03433339|324428884|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
94719087|NCT03433339|324428885|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
94467321|NCT01897571|323500506|FG010|Overall Study|Death|59|||
94467322|NCT00306787|323500507|FG000|Overall Study|Discontinued without taking study drug|208|||
94719088|NCT03433339|324428884|FG000|Overall Study|Withdrawal by Subject|0|||
94719089|NCT03433339|324428885|FG001|Overall Study|Withdrawal by Subject|2|||
94719090|NCT05608005|324428887|FG000|Overall Study|Adverse Event|2|||
94719091|NCT05608005|324428888|FG001|Overall Study|Adverse Event|1|||
94719092|NCT05608005|324428889|FG002|Overall Study|Adverse Event|3|||
94719093|NCT05608005|324428887|FG000|Overall Study|Protocol Violation|2|||
94719094|NCT05608005|324428888|FG001|Overall Study|Protocol Violation|3|||
94719095|NCT05608005|324428889|FG002|Overall Study|Protocol Violation|0|||
94719096|NCT05608005|324428887|FG000|Overall Study|Withdrawal by Subject|10|||
94719097|NCT05608005|324428888|FG001|Overall Study|Withdrawal by Subject|12|||
94719098|NCT05608005|324428889|FG002|Overall Study|Withdrawal by Subject|4|||
94719099|NCT05608005|324428887|FG000|Overall Study|Lost to Follow-up|25|||
94719100|NCT05608005|324428888|FG001|Overall Study|Lost to Follow-up|27|||
94719101|NCT05608005|324428889|FG002|Overall Study|Lost to Follow-up|15|||
94719102|NCT05608005|324428887|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
94719103|NCT05608005|324428888|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
94719104|NCT05608005|324428889|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
94719105|NCT02140645|324428891|FG000|Overall Study|Not linked|5489|||
94719106|NCT02140645|324428892|FG001|Overall Study|Not linked|61654|||
94719107|NCT02140645|324428893|FG002|Overall Study|Not linked|4236|||
94719108|NCT02140645|324428894|FG003|Overall Study|Not linked|13833|||
94719109|NCT02140645|324428895|FG004|Overall Study|Not linked|3286|||
94719110|NCT02140645|324428896|FG005|Overall Study|Not linked|70896|||
94719111|NCT03014453|324428898|FG000|Overall Study|Lost to Follow-up|12|||
94719112|NCT03014453|324428898|FG000|Overall Study|Discontinued GER|3|||
94719113|NCT03014453|324428898|FG000|Overall Study|Excluded|19|||
94719114|NCT03014453|324428898|FG000|Overall Study|Refused to take part in|37|||
94719115|NCT02965846|324428900|FG000|Overall Study|Lost to Follow-up|1|||
94719116|NCT02965846|324428901|FG001|Overall Study|Lost to Follow-up|0|||
94719117|NCT02965846|324428902|FG002|Overall Study|Lost to Follow-up|0|||
94719118|NCT02965846|324428900|FG000|Overall Study|Withdrawal by Subject|0|||
94719119|NCT02965846|324428901|FG001|Overall Study|Withdrawal by Subject|1|||
94719120|NCT02965846|324428902|FG002|Overall Study|Withdrawal by Subject|0|||
94719121|NCT02965846|324428900|FG000|Overall Study|Study Terminated By Sponsor|4|||
94719122|NCT02965846|324428901|FG001|Overall Study|Study Terminated By Sponsor|4|||
94719123|NCT02965846|324428902|FG002|Overall Study|Study Terminated By Sponsor|0|||
94719124|NCT02965846|324428900|FG000|Overall Study|Participants not randomized|0|||
94719125|NCT02965846|324428901|FG001|Overall Study|Participants not randomized|0|||
94719126|NCT02965846|324428902|FG002|Overall Study|Participants not randomized|33|||
94719127|NCT00593489|324428903|FG000|Allocation|did not attend workshop; allocation not|2|||
94719128|NCT00593489|324428904|FG001|Allocation|did not attend workshop; allocation not|1|||
94719129|NCT00611559|324428905|FG000|Overall Study|Lost to Follow-up|0|||
94719130|NCT00611559|324428906|FG001|Overall Study|Lost to Follow-up|1|||
94719131|NCT00611559|324428907|FG002|Overall Study|Lost to Follow-up|0|||
94719132|NCT00611559|324428905|FG000|Overall Study|Protocol Violation|1|||
94719133|NCT00611559|324428906|FG001|Overall Study|Protocol Violation|0|||
94719134|NCT00611559|324428907|FG002|Overall Study|Protocol Violation|1|||
94719135|NCT00879333|324428908|FG000|Overall Study|Adverse Event|94|||
94719136|NCT00879333|324428909|FG001|Overall Study|Adverse Event|34|||
94719137|NCT00879333|324428908|FG000|Overall Study|Abnormal Laboratory Value|1|||
94719138|NCT00879333|324428909|FG001|Overall Study|Abnormal Laboratory Value|0|||
94719139|NCT00879333|324428908|FG000|Overall Study|Withdrawal by Subject|20|||
94719140|NCT00879333|324428909|FG001|Overall Study|Withdrawal by Subject|7|||
94719141|NCT00879333|324428908|FG000|Overall Study|Lost to Follow-up|2|||
94719142|NCT00879333|324428909|FG001|Overall Study|Lost to Follow-up|1|||
94719143|NCT00879333|324428908|FG000|Overall Study|Administrative Problems|2|||
94719144|NCT00879333|324428909|FG001|Overall Study|Administrative Problems|0|||
94719145|NCT00879333|324428908|FG000|Overall Study|Death|16|||
94719146|NCT00879333|324428909|FG001|Overall Study|Death|5|||
94719147|NCT00879333|324428908|FG000|Overall Study|Disease Progression|292|||
94719148|NCT00879333|324428909|FG001|Overall Study|Disease Progression|169|||
94719149|NCT00879333|324428908|FG000|Overall Study|Protocol Violation|1|||
94719150|NCT00879333|324428909|FG001|Overall Study|Protocol Violation|1|||
94719151|NCT00951379|324428910|FG000|Overall Study|Adverse Event|4|||
94719152|NCT00951379|324428911|FG001|Overall Study|Adverse Event|1|||
94719153|NCT00951379|324428910|FG000|Overall Study|Withdrawal by Subject|1|||
94719154|NCT00951379|324428911|FG001|Overall Study|Withdrawal by Subject|0|||
94719155|NCT00951379|324428910|FG000|Overall Study|Noncompliance|1|||
94719156|NCT00951379|324428911|FG001|Overall Study|Noncompliance|0|||
94719157|NCT00951379|324428910|FG000|Overall Study|Disease Progression|0|||
94719158|NCT00951379|324428911|FG001|Overall Study|Disease Progression|1|||
94719159|NCT03069313|324428912|FG000|Overall Study|Adverse Event|5|||
94719160|NCT04218266|324428913|FG000|Overall Study|Death|1|||
94719161|NCT04218266|324428914|FG001|Overall Study|Death|2|||
94719162|NCT04218266|324428915|FG002|Overall Study|Death|3|||
94719163|NCT04218266|324428913|FG000|Overall Study|Adverse Event|13|||
94719164|NCT04218266|324428914|FG001|Overall Study|Adverse Event|14|||
94719165|NCT04218266|324428915|FG002|Overall Study|Adverse Event|11|||
94272096|NCT00098475|322788624|FG002|Step 1|Criteria to continue treatment not met|0|||
94272097|NCT00098475|322788625|FG003|Step 1|Criteria to continue treatment not met|0|||
94272098|NCT00098475|322788622|FG000|Step 1|Misinterpretation of lab data|0|||
94272099|NCT00098475|322788623|FG001|Step 1|Misinterpretation of lab data|1|||
94272100|NCT00098475|322788624|FG002|Step 1|Misinterpretation of lab data|0|||
94272101|NCT00098475|322788625|FG003|Step 1|Misinterpretation of lab data|0|||
94272102|NCT00098475|322788622|FG000|Step 1|Patient fell with fracture|1|||
94272103|NCT00098475|322788623|FG001|Step 1|Patient fell with fracture|0|||
94272104|NCT00098475|322788624|FG002|Step 1|Patient fell with fracture|0|||
94272105|NCT00098475|322788625|FG003|Step 1|Patient fell with fracture|0|||
94272106|NCT00098475|322788622|FG000|Step 1|Not documented|0|||
94272107|NCT00098475|322788623|FG001|Step 1|Not documented|1|||
94272108|NCT00098475|322788624|FG002|Step 1|Not documented|0|||
94272109|NCT00098475|322788625|FG003|Step 1|Not documented|0|||
94272110|NCT00098475|322788622|FG000|Step 2|Disease progression|1|||
94272111|NCT00098475|322788623|FG001|Step 2|Disease progression|4|||
94272112|NCT00098475|322788624|FG002|Step 2|Disease progression|0|||
94272113|NCT00098475|322788625|FG003|Step 2|Disease progression|0|||
94272114|NCT00098475|322788622|FG000|Step 2|Adverse Event|2|||
94272115|NCT00098475|322788623|FG001|Step 2|Adverse Event|0|||
94272116|NCT00098475|322788624|FG002|Step 2|Adverse Event|0|||
94272117|NCT00098475|322788625|FG003|Step 2|Adverse Event|0|||
94272118|NCT00098475|322788622|FG000|Step 2|Withdrawal by Subject|0|||
94272119|NCT00098475|322788623|FG001|Step 2|Withdrawal by Subject|2|||
94272120|NCT00098475|322788624|FG002|Step 2|Withdrawal by Subject|0|||
94272121|NCT00098475|322788625|FG003|Step 2|Withdrawal by Subject|0|||
94272122|NCT00098475|322788622|FG000|Step 2|Physician Decision|0|||
94272123|NCT00098475|322788623|FG001|Step 2|Physician Decision|1|||
94272124|NCT00098475|322788624|FG002|Step 2|Physician Decision|0|||
94272125|NCT00098475|322788625|FG003|Step 2|Physician Decision|0|||
94272126|NCT00098475|322788622|FG000|Step 2|Alternative therapy|1|||
94272127|NCT00098475|322788623|FG001|Step 2|Alternative therapy|2|||
94272128|NCT00098475|322788624|FG002|Step 2|Alternative therapy|0|||
94272129|NCT00098475|322788625|FG003|Step 2|Alternative therapy|0|||
94272130|NCT00098475|322788622|FG000|Step 2|Never started treatment|1|||
94272131|NCT00098475|322788623|FG001|Step 2|Never started treatment|1|||
94272132|NCT00098475|322788624|FG002|Step 2|Never started treatment|0|||
94272133|NCT00098475|322788625|FG003|Step 2|Never started treatment|0|||
94272134|NCT04722042|322788626|FG000|Overall Study|Withdrawal by Subject|2|||
94272135|NCT04722042|322788627|FG001|Overall Study|Withdrawal by Subject|1|||
94272136|NCT04722042|322788628|FG002|Overall Study|Withdrawal by Subject|0|||
94272137|NCT03496012|322790317|FG000|Overall Study|Withdrawal by Subject|2|||
94367964|NCT01901146|323134804|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
94367965|NCT01901146|323134805|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
94367966|NCT01901146|323134806|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
94367967|NCT01901146|323134807|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
94367968|NCT01901146|323134803|FG000|Neoadjuvant Phase|Physician Decision|1|||
94367969|NCT01901146|323134804|FG001|Neoadjuvant Phase|Physician Decision|2|||
94367970|NCT01901146|323134805|FG002|Neoadjuvant Phase|Physician Decision|0|||
94367971|NCT01901146|323134806|FG003|Neoadjuvant Phase|Physician Decision|0|||
94367972|NCT01901146|323134807|FG004|Neoadjuvant Phase|Physician Decision|0|||
94367973|NCT01901146|323134803|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
94719166|NCT04218266|324428913|FG000|Overall Study|Other|7|||
94719167|NCT04218266|324428914|FG001|Overall Study|Other|5|||
94719168|NCT04218266|324428915|FG002|Overall Study|Other|14|||
94719169|NCT04218266|324428913|FG000|Overall Study|Physician Decision|1|||
94719170|NCT04218266|324428914|FG001|Overall Study|Physician Decision|3|||
94719171|NCT04218266|324428915|FG002|Overall Study|Physician Decision|2|||
94719172|NCT04218266|324428913|FG000|Overall Study|Non-compliance with study drug|0|||
94719173|NCT04218266|324428914|FG001|Overall Study|Non-compliance with study drug|0|||
94719174|NCT04218266|324428915|FG002|Overall Study|Non-compliance with study drug|1|||
94719175|NCT04218266|324428913|FG000|Overall Study|Withdrawal by Subject|1|||
94719176|NCT04218266|324428914|FG001|Overall Study|Withdrawal by Subject|3|||
94719177|NCT04218266|324428915|FG002|Overall Study|Withdrawal by Subject|1|||
94719178|NCT04218266|324428913|FG000|Overall Study|Study drug never administered|2|||
94719179|NCT04218266|324428914|FG001|Overall Study|Study drug never administered|0|||
94719180|NCT04218266|324428915|FG002|Overall Study|Study drug never administered|0|||
94719181|NCT01424670|324428919|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
94467323|NCT00306787|323500508|FG001|Overall Study|Discontinued without taking study drug|215|||
94719182|NCT01424670|324428920|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
94719183|NCT01424670|324428919|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
94719184|NCT01424670|324428920|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
94719185|NCT01424670|324428919|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
94719186|NCT01424670|324428920|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
94719187|NCT01424670|324428919|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
94719188|NCT01424670|324428920|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
94719189|NCT01424670|324428919|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
94719190|NCT01424670|324428920|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
94719191|NCT01424670|324428919|FG000|Continuation Period|Adverse Event|13|||
94719192|NCT01424670|324428920|FG001|Continuation Period|Adverse Event|5|||
94719193|NCT01424670|324428919|FG000|Continuation Period|Lost to Follow-up|2|||
94719194|NCT01424670|324428920|FG001|Continuation Period|Lost to Follow-up|0|||
94719195|NCT01424670|324428919|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
94719196|NCT01424670|324428920|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
94719197|NCT01424670|324428919|FG000|Continuation Period|Physician Decision|5|||
94719198|NCT01424670|324428920|FG001|Continuation Period|Physician Decision|4|||
94719199|NCT01424670|324428919|FG000|Continuation Period|Withdrawal by Subject|13|||
94719200|NCT01424670|324428920|FG001|Continuation Period|Withdrawal by Subject|4|||
94719201|NCT03912831|324428921|FG000|Overall Study|Death|1|||
94719202|NCT03912831|324428922|FG001|Overall Study|Death|1|||
94719203|NCT03912831|324428923|FG002|Overall Study|Death|1|||
94719204|NCT03912831|324428924|FG003|Overall Study|Death|1|||
94719205|NCT03912831|324428925|FG004|Overall Study|Death|1|||
94719206|NCT03912831|324428926|FG005|Overall Study|Death|1|||
94719207|NCT03912831|324428921|FG000|Overall Study|Reason not Specified|0|||
94719208|NCT03912831|324428922|FG001|Overall Study|Reason not Specified|0|||
94719209|NCT03912831|324428923|FG002|Overall Study|Reason not Specified|0|||
94719210|NCT03912831|324428924|FG003|Overall Study|Reason not Specified|0|||
94719211|NCT03912831|324428925|FG004|Overall Study|Reason not Specified|1|||
94719212|NCT03912831|324428926|FG005|Overall Study|Reason not Specified|0|||
94719213|NCT03912831|324428921|FG000|Overall Study|Withdrawal by Participant|0|||
94719214|NCT03912831|324428922|FG001|Overall Study|Withdrawal by Participant|0|||
94719215|NCT03912831|324428923|FG002|Overall Study|Withdrawal by Participant|0|||
94719216|NCT03912831|324428924|FG003|Overall Study|Withdrawal by Participant|0|||
94719217|NCT03912831|324428925|FG004|Overall Study|Withdrawal by Participant|1|||
94719218|NCT03912831|324428926|FG005|Overall Study|Withdrawal by Participant|0|||
94719219|NCT00709098|324428927|FG000|Double-blind Period|Withdrawal of consent|3|||
94719220|NCT00709098|324428928|FG001|Double-blind Period|Withdrawal of consent|3|||
94719221|NCT00709098|324428929|FG002|Double-blind Period|Withdrawal of consent|0|||
94719222|NCT00709098|324428927|FG000|Double-blind Period|Administrative reason|1|||
94367974|NCT01901146|323134804|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
94719223|NCT00709098|324428928|FG001|Double-blind Period|Administrative reason|3|||
94719224|NCT00709098|324428929|FG002|Double-blind Period|Administrative reason|0|||
94719225|NCT00709098|324428927|FG000|Double-blind Period|Death|1|||
94719226|NCT00709098|324428928|FG001|Double-blind Period|Death|1|||
94719227|NCT00709098|324428929|FG002|Double-blind Period|Death|0|||
94719228|NCT00709098|324428927|FG000|Double-blind Period|Lost to Follow-up|1|||
94719229|NCT00709098|324428928|FG001|Double-blind Period|Lost to Follow-up|1|||
94719230|NCT00709098|324428929|FG002|Double-blind Period|Lost to Follow-up|0|||
94719231|NCT00709098|324428927|FG000|Open-label Period|Withdrawal of consent|0|||
94719232|NCT00709098|324428928|FG001|Open-label Period|Withdrawal of consent|0|||
94719233|NCT00709098|324428929|FG002|Open-label Period|Withdrawal of consent|7|||
94719234|NCT00709098|324428927|FG000|Open-label Period|Administrative reason|0|||
94719235|NCT00709098|324428928|FG001|Open-label Period|Administrative reason|0|||
94719236|NCT00709098|324428929|FG002|Open-label Period|Administrative reason|5|||
94719237|NCT00709098|324428927|FG000|Open-label Period|Death|0|||
94719238|NCT00709098|324428928|FG001|Open-label Period|Death|0|||
94719239|NCT00709098|324428929|FG002|Open-label Period|Death|1|||
94719240|NCT00709098|324428927|FG000|Open-label Period|Lost to Follow-up|0|||
94719241|NCT00709098|324428928|FG001|Open-label Period|Lost to Follow-up|0|||
94719242|NCT00709098|324428929|FG002|Open-label Period|Lost to Follow-up|1|||
94719243|NCT01012817|324430489|FG000|Overall Study|Withdrawal by Subject|0|||
94719244|NCT01012817|324430490|FG001|Overall Study|Withdrawal by Subject|0|||
94719245|NCT01012817|324430491|FG002|Overall Study|Withdrawal by Subject|0|||
94719246|NCT01012817|324430492|FG003|Overall Study|Withdrawal by Subject|1|||
94719247|NCT01012817|324430493|FG004|Overall Study|Withdrawal by Subject|0|||
94719248|NCT01012817|324430494|FG005|Overall Study|Withdrawal by Subject|0|||
94719249|NCT01012817|324430495|FG006|Overall Study|Withdrawal by Subject|0|||
94719250|NCT01012817|324430496|FG007|Overall Study|Withdrawal by Subject|1|||
94719251|NCT01012817|324430497|FG008|Overall Study|Withdrawal by Subject|0|||
94367975|NCT01901146|323134805|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
94367976|NCT01901146|323134806|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
94367977|NCT01901146|323134807|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
94367978|NCT01901146|323134803|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
94367979|NCT01901146|323134804|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
94367980|NCT01901146|323134805|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
94367981|NCT01901146|323134806|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
94367982|NCT01901146|323134807|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
94367983|NCT01901146|323134803|FG000|Adjuvant Phase|Other|0|||
94367984|NCT01901146|323134804|FG001|Adjuvant Phase|Other|0|||
94367985|NCT01901146|323134805|FG002|Adjuvant Phase|Other|1|||
94367986|NCT01901146|323134806|FG003|Adjuvant Phase|Other|0|||
94367987|NCT01901146|323134807|FG004|Adjuvant Phase|Other|0|||
94367988|NCT01901146|323134803|FG000|Adjuvant Phase|Death|0|||
94367989|NCT01901146|323134804|FG001|Adjuvant Phase|Death|0|||
94367990|NCT01901146|323134805|FG002|Adjuvant Phase|Death|0|||
94367991|NCT01901146|323134806|FG003|Adjuvant Phase|Death|0|||
94367992|NCT01901146|323134807|FG004|Adjuvant Phase|Death|3|||
94367993|NCT01901146|323134803|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
94367994|NCT01901146|323134804|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
94367995|NCT01901146|323134805|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
94367996|NCT01901146|323134806|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
94367997|NCT01901146|323134807|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
94367998|NCT01901146|323134803|FG000|Adjuvant Phase|Physician Decision|0|||
94367999|NCT01901146|323134804|FG001|Adjuvant Phase|Physician Decision|0|||
94368000|NCT01901146|323134805|FG002|Adjuvant Phase|Physician Decision|9|||
94368001|NCT01901146|323134806|FG003|Adjuvant Phase|Physician Decision|2|||
94368002|NCT01901146|323134807|FG004|Adjuvant Phase|Physician Decision|4|||
94368003|NCT01901146|323134803|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
94368004|NCT01901146|323134804|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
94368005|NCT01901146|323134805|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
94368006|NCT01901146|323134806|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
94368007|NCT01901146|323134807|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
94368008|NCT00297492|323134808|FG000|Set Quit Date|Lost to Follow-up|7|||
94368009|NCT00297492|323134809|FG001|Set Quit Date|Lost to Follow-up|13|||
94368010|NCT00297492|323134810|FG002|Set Quit Date|Lost to Follow-up|5|||
94368011|NCT00297492|323134808|FG000|6 Month Follow-up|Lost to Follow-up|63|||
94368012|NCT00297492|323134809|FG001|6 Month Follow-up|Lost to Follow-up|49|||
94368013|NCT00297492|323134810|FG002|6 Month Follow-up|Lost to Follow-up|27|||
94368014|NCT03044431|323134811|FG000|Overall Study|Lost to Follow-up|59|||
94368015|NCT04470622|323134812|FG000|Overall Study|Withdrawal by Subject|0|||
94368016|NCT04470622|323134813|FG001|Overall Study|Withdrawal by Subject|1|||
94368017|NCT04470622|323134812|FG000|Overall Study|Screen Failure|0|||
94467324|NCT00306787|323500507|FG000|Overall Study|Adverse Event|1|||
94719252|NCT01012817|324430498|FG009|Overall Study|Withdrawal by Subject|0|||
94719253|NCT01012817|324430499|FG010|Overall Study|Withdrawal by Subject|1|||
94719254|NCT01012817|324430500|FG011|Overall Study|Withdrawal by Subject|1|||
94719255|NCT01012817|324430501|FG012|Overall Study|Withdrawal by Subject|0|||
94719256|NCT01012817|324430502|FG013|Overall Study|Withdrawal by Subject|1|||
94719257|NCT01012817|324430489|FG000|Overall Study|Adverse Event|0|||
94719258|NCT01012817|324430490|FG001|Overall Study|Adverse Event|0|||
94719259|NCT01012817|324430491|FG002|Overall Study|Adverse Event|0|||
94719260|NCT01012817|324430492|FG003|Overall Study|Adverse Event|0|||
94719261|NCT01012817|324430493|FG004|Overall Study|Adverse Event|0|||
94719262|NCT01012817|324430494|FG005|Overall Study|Adverse Event|1|||
94719263|NCT01012817|324430495|FG006|Overall Study|Adverse Event|0|||
94719264|NCT01012817|324430496|FG007|Overall Study|Adverse Event|0|||
94719265|NCT01012817|324430497|FG008|Overall Study|Adverse Event|0|||
94719266|NCT01012817|324430498|FG009|Overall Study|Adverse Event|0|||
94719267|NCT01012817|324430499|FG010|Overall Study|Adverse Event|1|||
94719268|NCT01012817|324430500|FG011|Overall Study|Adverse Event|0|||
94368018|NCT04470622|323134813|FG001|Overall Study|Screen Failure|1|||
94368019|NCT04470622|323134812|FG000|Overall Study|Death|0|||
94368020|NCT04470622|323134813|FG001|Overall Study|Death|1|||
94368021|NCT02437890|323134814|FG000|Overall Study|Non-compliance to study drug|0|||
94368022|NCT02437890|323134815|FG001|Overall Study|Non-compliance to study drug|1|||
94368023|NCT02437890|323134816|FG002|Overall Study|Non-compliance to study drug|0|||
94467325|NCT00306787|323500508|FG001|Overall Study|Adverse Event|1|||
94719269|NCT01012817|324430501|FG012|Overall Study|Adverse Event|0|||
94719270|NCT01012817|324430502|FG013|Overall Study|Adverse Event|1|||
94368024|NCT02437890|323134817|FG003|Overall Study|Non-compliance to study drug|0|||
94719271|NCT02791230|324430507|FG000|Overall Study|Adverse Event|10|||
94719272|NCT02791230|324430508|FG001|Overall Study|Adverse Event|9|||
94719273|NCT02791230|324430509|FG002|Overall Study|Adverse Event|66|||
94719274|NCT02791230|324430507|FG000|Overall Study|Death|38|||
94368025|NCT02437890|323134818|FG004|Overall Study|Non-compliance to study drug|1|||
94368026|NCT02437890|323134814|FG000|Overall Study|Sponsor's decision|1|||
94368027|NCT02437890|323134815|FG001|Overall Study|Sponsor's decision|1|||
94272138|NCT03496012|322790318|FG001|Overall Study|Withdrawal by Subject|0|||
94272139|NCT03496012|322790319|FG002|Overall Study|Withdrawal by Subject|2|||
94272140|NCT03496012|322790317|FG000|Overall Study|Adverse Event|0|||
94272141|NCT03496012|322790318|FG001|Overall Study|Adverse Event|0|||
94272142|NCT03496012|322790319|FG002|Overall Study|Adverse Event|1|||
94272143|NCT03496012|322790317|FG000|Overall Study|Reason Not Specified|2|||
94272144|NCT03496012|322790318|FG001|Overall Study|Reason Not Specified|0|||
94272145|NCT03496012|322790319|FG002|Overall Study|Reason Not Specified|1|||
94272146|NCT01502709|322790321|FG000|Overall Study|Lost to Follow-up|4|||
94272147|NCT01502709|322790322|FG001|Overall Study|Lost to Follow-up|0|||
94272148|NCT02289742|322790323|FG000|First Wear Period|Adverse event prior to treatment|0|||
94272149|NCT02289742|322790324|FG001|First Wear Period|Adverse event prior to treatment|1|||
94272150|NCT02289742|322790325|FG002|First Wear Period|Adverse event prior to treatment|0|||
94272151|NCT02289742|322790326|FG003|First Wear Period|Adverse event prior to treatment|0|||
94272152|NCT02289742|322790323|FG000|First Wear Period|Adverse Event|0|||
94272153|NCT02289742|322790324|FG001|First Wear Period|Adverse Event|0|||
94272154|NCT02289742|322790325|FG002|First Wear Period|Adverse Event|1|||
94272155|NCT02289742|322790326|FG003|First Wear Period|Adverse Event|0|||
94272156|NCT02289742|322790323|FG000|First Wear Period|Other prior to treatment|0|||
94272157|NCT02289742|322790324|FG001|First Wear Period|Other prior to treatment|0|||
94272158|NCT02289742|322790325|FG002|First Wear Period|Other prior to treatment|0|||
94272159|NCT02289742|322790326|FG003|First Wear Period|Other prior to treatment|1|||
94719275|NCT02791230|324430508|FG001|Overall Study|Death|25|||
94719276|NCT02791230|324430509|FG002|Overall Study|Death|184|||
94719277|NCT02791230|324430507|FG000|Overall Study|Lack of Efficacy|1|||
94719278|NCT02791230|324430508|FG001|Overall Study|Lack of Efficacy|0|||
94719279|NCT02791230|324430509|FG002|Overall Study|Lack of Efficacy|3|||
94719280|NCT02791230|324430507|FG000|Overall Study|Lost to Follow-up|0|||
94719281|NCT02791230|324430508|FG001|Overall Study|Lost to Follow-up|0|||
94719282|NCT02791230|324430509|FG002|Overall Study|Lost to Follow-up|10|||
94719283|NCT02791230|324430507|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
94719284|NCT02791230|324430508|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
94719285|NCT02791230|324430509|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
94719286|NCT02791230|324430507|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
94719287|NCT02791230|324430508|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
94719288|NCT02791230|324430509|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
94719289|NCT02791230|324430507|FG000|Overall Study|Study sites terminated by sponsor|1|||
94719290|NCT02791230|324430508|FG001|Overall Study|Study sites terminated by sponsor|0|||
94719291|NCT02791230|324430509|FG002|Overall Study|Study sites terminated by sponsor|5|||
94719292|NCT02791230|324430507|FG000|Overall Study|Other|9|||
94719293|NCT02791230|324430508|FG001|Overall Study|Other|1|||
94719294|NCT02791230|324430509|FG002|Overall Study|Other|28|||
94719295|NCT02791230|324430507|FG000|Overall Study|Protocol Violation|0|||
94719296|NCT02791230|324430508|FG001|Overall Study|Protocol Violation|0|||
94719297|NCT02791230|324430509|FG002|Overall Study|Protocol Violation|4|||
94719298|NCT02791230|324430507|FG000|Overall Study|Withdrawal by Subject|24|||
94272160|NCT02289742|322790323|FG000|Third Wear Period|Adverse Event|0|||
94272161|NCT02289742|322790324|FG001|Third Wear Period|Adverse Event|1|||
94272162|NCT02289742|322790325|FG002|Third Wear Period|Adverse Event|0|||
94272163|NCT02289742|322790326|FG003|Third Wear Period|Adverse Event|0|||
94272164|NCT02289742|322790323|FG000|Third Wear Period|Reason not given|0|||
94272165|NCT02289742|322790324|FG001|Third Wear Period|Reason not given|0|||
94272166|NCT02289742|322790325|FG002|Third Wear Period|Reason not given|0|||
94719299|NCT02791230|324430508|FG001|Overall Study|Withdrawal by Subject|13|||
94719300|NCT02791230|324430509|FG002|Overall Study|Withdrawal by Subject|172|||
94719301|NCT02791230|324430507|FG000|Overall Study|Enrolled but not treated|0|||
94272167|NCT02289742|322790326|FG003|Third Wear Period|Reason not given|1|||
94719302|NCT02791230|324430508|FG001|Overall Study|Enrolled but not treated|0|||
94719303|NCT02791230|324430509|FG002|Overall Study|Enrolled but not treated|5|||
94719304|NCT04201834|324430510|FG000|Overall Study|Screen fail|1|||
94719305|NCT05478525|324430511|FG000|Overall Study|Withdrawal by Subject|0|||
94719306|NCT05478525|324430512|FG001|Overall Study|Withdrawal by Subject|1|||
94719307|NCT05478525|324430513|FG002|Overall Study|Withdrawal by Subject|2|||
94719308|NCT05478525|324430514|FG003|Overall Study|Withdrawal by Subject|0|||
94719309|NCT05478525|324430511|FG000|Overall Study|COVID-19 Infection|2|||
94719310|NCT05478525|324430512|FG001|Overall Study|COVID-19 Infection|0|||
94719311|NCT05478525|324430513|FG002|Overall Study|COVID-19 Infection|1|||
94719312|NCT05478525|324430514|FG003|Overall Study|COVID-19 Infection|1|||
94719313|NCT05369208|324430515|FG000|Core Phase|Prohibited Medication Required|2|||
94719314|NCT05369208|324430515|FG000|Core Phase|Adverse Event|1|||
94719315|NCT05369208|324430515|FG000|Core Phase|Lack of Efficacy|1|||
94719316|NCT03416023|324430517|FG000|Overall Study|Exclusion criteria failure|1|||
94719317|NCT03416023|324430517|FG000|Overall Study|Withdrawal by Subject|6|||
94719318|NCT03416023|324430517|FG000|Overall Study|Explanted|7|||
94719319|NCT03416023|324430517|FG000|Overall Study|Physician Decision|1|||
94719320|NCT03416023|324430517|FG000|Overall Study|Lost to Follow-up|1|||
94719321|NCT03416023|324430517|FG000|Overall Study|Death|1|||
94719322|NCT03358875|324430518|FG000|Overall Study|Death|409|||
94719323|NCT03358875|324430519|FG001|Overall Study|Death|223|||
94719324|NCT03358875|324430518|FG000|Overall Study|Study Closed by Sponsor|66|||
94719325|NCT03358875|324430519|FG001|Overall Study|Study Closed by Sponsor|29|||
94719326|NCT03358875|324430518|FG000|Overall Study|Withdrawal by Subject|13|||
94719327|NCT03358875|324430519|FG001|Overall Study|Withdrawal by Subject|16|||
94719328|NCT03358875|324430518|FG000|Overall Study|Lost to Follow-up|13|||
94719329|NCT03358875|324430519|FG001|Overall Study|Lost to Follow-up|2|||
94719330|NCT03358875|324430518|FG000|Overall Study|Miscellaneous|33|||
94719331|NCT03358875|324430519|FG001|Overall Study|Miscellaneous|0|||
94719332|NCT03358875|324430518|FG000|Overall Study|Remained on Study|1|||
94719333|NCT03358875|324430519|FG001|Overall Study|Remained on Study|0|||
94719334|NCT03021486|324430526|FG000|Overall Study|Withdrawal by Subject|1|||
94719335|NCT03021486|324430527|FG001|Overall Study|Withdrawal by Subject|1|||
94719336|NCT03021486|324430528|FG002|Overall Study|Withdrawal by Subject|3|||
94719337|NCT03021486|324430526|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
94719338|NCT03021486|324430527|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
94719339|NCT03021486|324430528|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
94719340|NCT01631214|324430529|FG000|Overall Study|Withdrawal by Subject|276|||
94719341|NCT01631214|324430530|FG001|Overall Study|Withdrawal by Subject|290|||
94719342|NCT01631214|324430529|FG000|Overall Study|Death|113|||
94719343|NCT01631214|324430530|FG001|Overall Study|Death|106|||
94719344|NCT01631214|324430529|FG000|Overall Study|Lost to Follow-up|54|||
94719345|NCT01631214|324430530|FG001|Overall Study|Lost to Follow-up|40|||
94719346|NCT01631214|324430529|FG000|Overall Study|Adverse Event|45|||
94719347|NCT01631214|324430530|FG001|Overall Study|Adverse Event|45|||
94719348|NCT01631214|324430529|FG000|Overall Study|Other|22|||
94719349|NCT01631214|324430530|FG001|Overall Study|Other|19|||
94719350|NCT01631214|324430529|FG000|Overall Study|Noncompliance|16|||
94719351|NCT01631214|324430530|FG001|Overall Study|Noncompliance|15|||
94719352|NCT01631214|324430529|FG000|Overall Study|Requirement for Alternative Therapy|8|||
94719353|NCT01631214|324430530|FG001|Overall Study|Requirement for Alternative Therapy|3|||
94719354|NCT01631214|324430529|FG000|Overall Study|Protocol Deviation|4|||
94719355|NCT01631214|324430530|FG001|Overall Study|Protocol Deviation|3|||
94719356|NCT01631214|324430529|FG000|Overall Study|Ineligibility determined|5|||
94719357|NCT01631214|324430530|FG001|Overall Study|Ineligibility determined|2|||
94719358|NCT01631214|324430529|FG000|Overall Study|Administrative Decision|1|||
94719359|NCT01631214|324430530|FG001|Overall Study|Administrative Decision|0|||
94719360|NCT04118452|324430531|FG000|Overall Study|Lost to Follow-up|5|||
94719361|NCT04118452|324430532|FG001|Overall Study|Lost to Follow-up|5|||
94719362|NCT04118452|324430531|FG000|Overall Study|Withdrawal by Subject|17|||
94719363|NCT04118452|324430532|FG001|Overall Study|Withdrawal by Subject|17|||
94719364|NCT03438188|324430533|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
94719365|NCT03438188|324430534|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
94467326|NCT00306787|323500507|FG000|Overall Study|Lack of Efficacy|1|||
94719366|NCT03438188|324430535|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
94719367|NCT03438188|324430533|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
94719368|NCT03438188|324430534|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
94719369|NCT03438188|324430535|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
94719370|NCT03438188|324430533|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
94719371|NCT03438188|324430534|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
94719372|NCT03438188|324430535|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
94719373|NCT03438188|324430533|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
94719374|NCT03438188|324430534|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
94719375|NCT03438188|324430535|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
94719376|NCT03438188|324430533|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
94719377|NCT03438188|324430534|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
94719378|NCT03438188|324430535|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
94719379|NCT05215847|324430536|FG000|Overall Study|Lost to Follow-up|1|||
94719380|NCT05952076|324430537|FG000|Overall Study|Death|1|||
94719381|NCT05952076|324430538|FG001|Overall Study|Death|1|||
94719382|NCT05952076|324430537|FG000|Overall Study|Lost to Follow-up|0|||
94719383|NCT05952076|324430538|FG001|Overall Study|Lost to Follow-up|1|||
94719384|NCT06066541|324430545|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
94719385|NCT06066541|324430546|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
94719386|NCT06066541|324430547|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
94719387|NCT06066541|324430548|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
94719388|NCT06066541|324430549|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
94719389|NCT06066541|324430550|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
94719390|NCT06066541|324430551|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
94719391|NCT06066541|324430545|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
94719392|NCT06066541|324430546|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
94719393|NCT06066541|324430547|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
94719394|NCT06066541|324430548|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
94719395|NCT06066541|324430549|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
94719396|NCT06066541|324430550|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
94719397|NCT06066541|324430551|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
94719398|NCT03602014|324430552|FG000|Overall Study|Lost to Follow-up|2|||
94719399|NCT03602014|324430553|FG001|Overall Study|Lost to Follow-up|0|||
94719400|NCT03602014|324430554|FG002|Overall Study|Lost to Follow-up|0|||
94719401|NCT03289039|324430555|FG000|Overall Study|Withdrawal by Subject|0|||
94719402|NCT03289039|324430556|FG001|Overall Study|Withdrawal by Subject|1|||
94719403|NCT03289039|324430555|FG000|Overall Study|Became ineligible prior to treatment start|0|||
94719404|NCT03289039|324430556|FG001|Overall Study|Became ineligible prior to treatment start|1|||
94719405|NCT03289039|324430555|FG000|Overall Study|progressed before treatment start|1|||
94719406|NCT03289039|324430556|FG001|Overall Study|progressed before treatment start|0|||
94719407|NCT05086744|324430559|FG000|Part A|Adverse Event|0|||
94719408|NCT05086744|324430560|FG001|Part A|Adverse Event|1|||
94719409|NCT05086744|324430559|FG000|Part A|Lack of Efficacy|3|||
94719410|NCT05086744|324430560|FG001|Part A|Lack of Efficacy|0|||
94719411|NCT05086744|324430559|FG000|Part A|Protocol deviation|1|||
94719412|NCT05086744|324430560|FG001|Part A|Protocol deviation|0|||
94719413|NCT05086744|324430559|FG000|Part A|Subject decision|1|||
94719414|NCT05086744|324430560|FG001|Part A|Subject decision|0|||
94719415|NCT05086744|324430559|FG000|Part B|Adverse Event|0|||
94719416|NCT05086744|324430560|FG001|Part B|Adverse Event|1|||
94719417|NCT05086744|324430559|FG000|Part B|Lack of Efficacy|0|||
94719418|NCT05086744|324430560|FG001|Part B|Lack of Efficacy|1|||
94719419|NCT05086744|324430559|FG000|Part B|Study terminated by sponsor|1|||
94719420|NCT05086744|324430560|FG001|Part B|Study terminated by sponsor|6|||
94719421|NCT03948763|324430564|FG000|Overall Study|Sponsor's decision|0|||
94719422|NCT03948763|324430565|FG001|Overall Study|Sponsor's decision|2|||
94719423|NCT03948763|324430566|FG002|Overall Study|Sponsor's decision|6|||
94719424|NCT03948763|324430567|FG003|Overall Study|Sponsor's decision|4|||
94719425|NCT03948763|324430568|FG004|Overall Study|Sponsor's decision|0|||
94719426|NCT03948763|324430564|FG000|Overall Study|Physician Decision|0|||
94719427|NCT03948763|324430565|FG001|Overall Study|Physician Decision|0|||
94719428|NCT03948763|324430566|FG002|Overall Study|Physician Decision|1|||
94719429|NCT03948763|324430567|FG003|Overall Study|Physician Decision|0|||
94719430|NCT03948763|324430568|FG004|Overall Study|Physician Decision|0|||
94719431|NCT03948763|324430564|FG000|Overall Study|Lost to Follow-up|0|||
94719432|NCT03948763|324430565|FG001|Overall Study|Lost to Follow-up|0|||
94719433|NCT03948763|324430566|FG002|Overall Study|Lost to Follow-up|0|||
94719434|NCT03948763|324430567|FG003|Overall Study|Lost to Follow-up|0|||
94719435|NCT03948763|324430568|FG004|Overall Study|Lost to Follow-up|1|||
94719436|NCT03948763|324430564|FG000|Overall Study|Death|2|||
94719437|NCT03948763|324430565|FG001|Overall Study|Death|12|||
94719438|NCT03948763|324430566|FG002|Overall Study|Death|13|||
94719439|NCT03948763|324430567|FG003|Overall Study|Death|10|||
94719440|NCT03948763|324430568|FG004|Overall Study|Death|11|||
94719441|NCT03948763|324430564|FG000|Overall Study|Withdrawal by Subject|1|||
94719442|NCT03948763|324430565|FG001|Overall Study|Withdrawal by Subject|1|||
94719443|NCT03948763|324430566|FG002|Overall Study|Withdrawal by Subject|0|||
94719444|NCT03948763|324430567|FG003|Overall Study|Withdrawal by Subject|2|||
94719445|NCT03948763|324430568|FG004|Overall Study|Withdrawal by Subject|4|||
94719446|NCT05415436|324430569|FG000|Overall Study|Surgeon cancelled procedure|1|||
94719447|NCT05415436|324430570|FG001|Overall Study|Surgeon cancelled procedure|0|||
94719448|NCT05415436|324430569|FG000|Overall Study|Death|1|||
94719449|NCT05415436|324430570|FG001|Overall Study|Death|0|||
94719450|NCT05386355|324430571|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
94719451|NCT05386355|324430572|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
94719452|NCT05386355|324430573|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
94719453|NCT05386355|324430574|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
94719454|NCT01704079|324430580|FG000|Overall Study|Withdrawal by Subject|5|||
94719455|NCT01704079|324430581|FG001|Overall Study|Withdrawal by Subject|7|||
94719456|NCT01704079|324430580|FG000|Overall Study|Lost to Follow-up|2|||
94719457|NCT01704079|324430581|FG001|Overall Study|Lost to Follow-up|5|||
94719458|NCT01704079|324430580|FG000|Overall Study|Adverse Event|4|||
94719459|NCT01704079|324430581|FG001|Overall Study|Adverse Event|7|||
94719460|NCT01704079|324430580|FG000|Overall Study|Protocol Violation|1|||
94719461|NCT01704079|324430581|FG001|Overall Study|Protocol Violation|0|||
94467327|NCT00306787|323500508|FG001|Overall Study|Lack of Efficacy|0|||
94467328|NCT00306787|323500507|FG000|Overall Study|Protocol Violation|8|||
94719462|NCT01704079|324430580|FG000|Overall Study|Subject noncompliance|2|||
94719463|NCT01704079|324430581|FG001|Overall Study|Subject noncompliance|3|||
94719464|NCT01704079|324430580|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
94719465|NCT01704079|324430581|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
94719466|NCT04300231|324430582|FG000|Overall Study|Protocol Violation|4|||
94719467|NCT04300231|324430583|FG001|Overall Study|Protocol Violation|3|||
94719468|NCT04300231|324430584|FG002|Overall Study|Protocol Violation|0|||
94719469|NCT04300231|324430585|FG003|Overall Study|Protocol Violation|2|||
94719470|NCT05986565|324430588|FG000|Overall Study|Lost to Follow-up|8|||
94719471|NCT05986565|324430589|FG001|Overall Study|Lost to Follow-up|3|||
94719472|NCT05986565|324430588|FG000|Overall Study|Withdrawal by Subject|0|||
94719473|NCT05986565|324430589|FG001|Overall Study|Withdrawal by Subject|1|||
94719474|NCT03775109|324430590|FG000|Overall Study|Adverse Event|1|||
94719475|NCT03775109|324430591|FG001|Overall Study|Adverse Event|0|||
94719476|NCT03775109|324430590|FG000|Overall Study|COVID-19 outbreak|2|||
94719477|NCT03775109|324430591|FG001|Overall Study|COVID-19 outbreak|0|||
94719478|NCT03775109|324430590|FG000|Overall Study|Lost to Follow-up|0|||
94719479|NCT03775109|324430591|FG001|Overall Study|Lost to Follow-up|2|||
94719480|NCT03775109|324430590|FG000|Overall Study|Withdrawal by Subject|1|||
94719481|NCT03775109|324430591|FG001|Overall Study|Withdrawal by Subject|1|||
94719482|NCT03775109|324430590|FG000|Overall Study|Death|0|||
94719483|NCT03775109|324430591|FG001|Overall Study|Death|1|||
94719484|NCT03775109|324430590|FG000|Overall Study|Lack of Efficacy|1|||
94719485|NCT03775109|324430591|FG001|Overall Study|Lack of Efficacy|0|||
94719486|NCT04823611|324430592|FG000|Overall Study|Adverse Event|2|||
94719487|NCT04823611|324430593|FG001|Overall Study|Adverse Event|0|||
94719488|NCT04823611|324430594|FG002|Overall Study|Adverse Event|1|||
94719489|NCT04823611|324430595|FG003|Overall Study|Adverse Event|0|||
94719490|NCT04823611|324430596|FG004|Overall Study|Adverse Event|0|||
94719491|NCT04823611|324430597|FG005|Overall Study|Adverse Event|0|||
94368028|NCT02437890|323134816|FG002|Overall Study|Sponsor's decision|4|||
94368029|NCT02437890|323134817|FG003|Overall Study|Sponsor's decision|0|||
94368030|NCT02437890|323134818|FG004|Overall Study|Sponsor's decision|2|||
94368031|NCT02437890|323134814|FG000|Overall Study|Physician Decision|0|||
94368032|NCT02437890|323134815|FG001|Overall Study|Physician Decision|0|||
94368033|NCT02437890|323134816|FG002|Overall Study|Physician Decision|0|||
94368034|NCT02437890|323134817|FG003|Overall Study|Physician Decision|1|||
94368035|NCT02437890|323134818|FG004|Overall Study|Physician Decision|0|||
94368036|NCT02437890|323134814|FG000|Overall Study|Unable to attend visit(s)|1|||
94368037|NCT02437890|323134815|FG001|Overall Study|Unable to attend visit(s)|0|||
94719492|NCT04823611|324430598|FG006|Overall Study|Adverse Event|0|||
94719493|NCT01673984|324430599|FG000|Overall Study|Adverse Event|1|||
94719494|NCT01673984|324430600|FG001|Overall Study|Adverse Event|0|||
94719495|NCT01673984|324430599|FG000|Overall Study|Study termination|9|||
94719496|NCT01673984|324430600|FG001|Overall Study|Study termination|6|||
94719497|NCT04774237|324430605|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
94719498|NCT04774237|324430606|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
94719499|NCT04774237|324430607|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
94719500|NCT04774237|324430608|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
94719501|NCT04774237|324430609|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
94719502|NCT04774237|324430610|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
94719503|NCT00931710|324430611|FG000|Overall Study|Adverse Event|16|||
94719504|NCT00931710|324430612|FG001|Overall Study|Adverse Event|10|||
94719505|NCT00931710|324430611|FG000|Overall Study|Abnormal test procedure results|2|||
94368038|NCT02437890|323134816|FG002|Overall Study|Unable to attend visit(s)|0|||
94368039|NCT02437890|323134817|FG003|Overall Study|Unable to attend visit(s)|0|||
94368040|NCT02437890|323134818|FG004|Overall Study|Unable to attend visit(s)|0|||
94368041|NCT02437890|323134814|FG000|Overall Study|Lack of Efficacy|1|||
94719506|NCT00931710|324430612|FG001|Overall Study|Abnormal test procedure results|0|||
94368042|NCT02437890|323134815|FG001|Overall Study|Lack of Efficacy|3|||
94719507|NCT00931710|324430611|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
94368043|NCT02437890|323134816|FG002|Overall Study|Lack of Efficacy|0|||
94368044|NCT02437890|323134817|FG003|Overall Study|Lack of Efficacy|3|||
94719508|NCT00931710|324430612|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
94719509|NCT00931710|324430611|FG000|Overall Study|Patient withdrew consent|4|||
94719510|NCT00931710|324430612|FG001|Overall Study|Patient withdrew consent|9|||
94719511|NCT00931710|324430611|FG000|Overall Study|Lost to Follow-up|6|||
94719512|NCT00931710|324430612|FG001|Overall Study|Lost to Follow-up|5|||
94719513|NCT00931710|324430611|FG000|Overall Study|Protocol deviation|1|||
94719514|NCT00931710|324430612|FG001|Overall Study|Protocol deviation|2|||
94719515|NCT02919449|324430613|FG000|Overall Study|Withdrawal by Subject|1|||
94719516|NCT02919449|324430613|FG000|Overall Study|Investigator decision|1|||
94719517|NCT01376700|324430614|FG000|Overall Study|Sponsor terminated study early|8|||
94719518|NCT01376700|324430614|FG000|Overall Study|Low or high titer inhibitor|8|||
94719519|NCT05623345|324430625|FG000|Overall Study|Withdrawal by Subject|14|||
94719520|NCT05623345|324430626|FG001|Overall Study|Withdrawal by Subject|0|||
94719521|NCT05623345|324430627|FG002|Overall Study|Withdrawal by Subject|9|||
94719522|NCT05623345|324430628|FG003|Overall Study|Withdrawal by Subject|20|||
94719523|NCT05623345|324430625|FG000|Overall Study|Lost to Follow-up|3|||
94719524|NCT05623345|324430626|FG001|Overall Study|Lost to Follow-up|0|||
94719525|NCT05623345|324430627|FG002|Overall Study|Lost to Follow-up|7|||
94719526|NCT05623345|324430628|FG003|Overall Study|Lost to Follow-up|2|||
94719527|NCT05623345|324430625|FG000|Overall Study|Termination of Study By Sponsor|37|||
94719528|NCT05623345|324430626|FG001|Overall Study|Termination of Study By Sponsor|4|||
94719529|NCT05623345|324430627|FG002|Overall Study|Termination of Study By Sponsor|40|||
94719530|NCT05623345|324430628|FG003|Overall Study|Termination of Study By Sponsor|38|||
94719531|NCT01385176|324430629|FG000|Randomization Phase|Death|1|||
94719532|NCT01385176|324430630|FG001|Randomization Phase|Death|2|||
94719533|NCT01385176|324430629|FG000|6-18 Month All VNS Active|Death|1|||
94719534|NCT01385176|324430630|FG001|6-18 Month All VNS Active|Death|2|||
94719535|NCT01385176|324430629|FG000|6-18 Month All VNS Active|Physician Decision|0|||
94719536|NCT01385176|324430630|FG001|6-18 Month All VNS Active|Physician Decision|1|||
94719537|NCT01385176|324430629|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
94719538|NCT01385176|324430630|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
94719539|NCT01385176|324430629|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
94719540|NCT01385176|324430630|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
94719541|NCT05384730|324430633|FG000|Overall Study|Adverse Event|1|||
94719542|NCT05384730|324430634|FG001|Overall Study|Adverse Event|0|||
94719543|NCT05384730|324430633|FG000|Overall Study|Lack of social support|2|||
94719544|NCT05384730|324430634|FG001|Overall Study|Lack of social support|0|||
94719545|NCT05384730|324430633|FG000|Overall Study|Hospital readmission|2|||
94719546|NCT05384730|324430634|FG001|Overall Study|Hospital readmission|0|||
94719547|NCT05384730|324430633|FG000|Overall Study|Disease progression|5|||
94719548|NCT05384730|324430634|FG001|Overall Study|Disease progression|0|||
94719549|NCT05384730|324430633|FG000|Overall Study|Overwhelmed with College commitments|0|||
94719550|NCT05384730|324430634|FG001|Overall Study|Overwhelmed with College commitments|2|||
94719551|NCT04711135|324430636|FG000|Overall Study|Physician Decision|0|||
94272168|NCT04640272|322790327|FG000|Overall Study|Subject moved out of area|1|||
94272169|NCT02181816|322790328|FG000|Overall Study|Case Report Forms Uncollected|38|||
94272170|NCT02181816|322790328|FG000|Overall Study|Protocol Deviation|21|||
94272171|NCT04773106|322790329|FG000|Overall Study|Withdrawal by Subject|3|||
94272172|NCT04773106|322790329|FG000|Overall Study|Death|1|||
94272173|NCT00383084|322790339|FG000|Overall Study|Withdrawal by Subject|12|||
94272174|NCT00383084|322790340|FG001|Overall Study|Withdrawal by Subject|10|||
94272175|NCT05418673|322790341|FG000|Overall Study|Study Terminated by Sponsor|2|||
94272176|NCT05418673|322790342|FG001|Overall Study|Study Terminated by Sponsor|4|||
94272177|NCT05418673|322790341|FG000|Overall Study|Lost to Follow-up|1|||
94272178|NCT05418673|322790342|FG001|Overall Study|Lost to Follow-up|0|||
94272179|NCT01648790|322790345|FG000|Treatment 3|Withdrawal by Subject|0|||
94272180|NCT01648790|322790346|FG001|Treatment 3|Withdrawal by Subject|0|||
94272181|NCT01648790|322790347|FG002|Treatment 3|Withdrawal by Subject|0|||
94272182|NCT01648790|322790348|FG003|Treatment 3|Withdrawal by Subject|1|||
94272183|NCT01648790|322790349|FG004|Treatment 3|Withdrawal by Subject|0|||
94272184|NCT02164929|322790352|FG000|Overall Study|Converted to open procedure|1|||
94272185|NCT02164929|322790353|FG001|Overall Study|Converted to open procedure|0|||
94719552|NCT04711135|324430637|FG001|Overall Study|Physician Decision|1|||
94719553|NCT04711135|324430636|FG000|Overall Study|Ongoing treatment|0|||
94719554|NCT04711135|324430637|FG001|Overall Study|Ongoing treatment|1|||
94719555|NCT03092726|324430643|FG000|Overall Study|Adverse Event|3|||
94719556|NCT03092726|324430644|FG001|Overall Study|Adverse Event|10|||
94719557|NCT03092726|324430643|FG000|Overall Study|Lack of Efficacy|0|||
94719558|NCT03092726|324430644|FG001|Overall Study|Lack of Efficacy|1|||
94719559|NCT03092726|324430643|FG000|Overall Study|Lost to Follow-up|1|||
94719560|NCT03092726|324430644|FG001|Overall Study|Lost to Follow-up|0|||
94719561|NCT03092726|324430643|FG000|Overall Study|Withdrawal by Subject|5|||
94719562|NCT03092726|324430644|FG001|Overall Study|Withdrawal by Subject|3|||
94719563|NCT05512962|324430645|FG000|Overall Study|Withdrawal by Subject|1|||
94272186|NCT02164929|322790354|FG002|Overall Study|Converted to open procedure|0|||
94368045|NCT02437890|323134818|FG004|Overall Study|Lack of Efficacy|1|||
94368046|NCT02437890|323134814|FG000|Overall Study|Adverse Event|4|||
94368047|NCT02437890|323134815|FG001|Overall Study|Adverse Event|9|||
94368048|NCT02437890|323134816|FG002|Overall Study|Adverse Event|5|||
94368049|NCT02437890|323134817|FG003|Overall Study|Adverse Event|11|||
94368050|NCT02437890|323134818|FG004|Overall Study|Adverse Event|7|||
94719564|NCT05512962|324430646|FG001|Overall Study|Withdrawal by Subject|0|||
94272187|NCT02164929|322790355|FG003|Overall Study|Converted to open procedure|2|||
94467329|NCT00306787|323500508|FG001|Overall Study|Protocol Violation|10|||
94467330|NCT00306787|323500507|FG000|Overall Study|Withdrawal by Subject|2|||
94719565|NCT03152786|324432232|FG000|Overall Study|Withdrawal by Subject|2|||
94719566|NCT03152786|324432233|FG001|Overall Study|Withdrawal by Subject|1|||
94719567|NCT04104321|324432234|FG000|Overall Study|didn't take the study drug|3|||
94719568|NCT03012841|324432235|FG000|Overall Study|Protocol Violation|0|||
94719569|NCT03012841|324432236|FG001|Overall Study|Protocol Violation|10|||
94719570|NCT03012841|324432235|FG000|Overall Study|Lost to Follow-up|6|||
94719571|NCT03012841|324432236|FG001|Overall Study|Lost to Follow-up|1|||
94719572|NCT03012841|324432235|FG000|Overall Study|Withdrawal by Subject|6|||
94719573|NCT03012841|324432236|FG001|Overall Study|Withdrawal by Subject|0|||
94719574|NCT03012841|324432235|FG000|Overall Study|Unable to complete 12 month visit|6|||
94719575|NCT03012841|324432236|FG001|Overall Study|Unable to complete 12 month visit|0|||
94719576|NCT03012841|324432235|FG000|Overall Study|Subject relocation|1|||
94655276|NCT01158924|324195938|FG001|Overall Study|Withdrawal by Subject|2|||
94719577|NCT03012841|324432236|FG001|Overall Study|Subject relocation|0|||
94719578|NCT03012841|324432235|FG000|Overall Study|Seasonal winter travel|1|||
94719579|NCT03012841|324432236|FG001|Overall Study|Seasonal winter travel|0|||
94719580|NCT03012841|324432235|FG000|Overall Study|Physician Decision|0|||
94719581|NCT03012841|324432236|FG001|Overall Study|Physician Decision|2|||
94719582|NCT03012841|324432235|FG000|Overall Study|No ablation performed|0|||
94719583|NCT03012841|324432236|FG001|Overall Study|No ablation performed|2|||
94655277|NCT01158924|324195937|FG000|Overall Study|Lost to Follow-up|0|||
94655278|NCT01158924|324195938|FG001|Overall Study|Lost to Follow-up|1|||
94655279|NCT00699699|324195939|FG000|Overall Study|Adverse Event|36|||
94655280|NCT00699699|324195939|FG000|Overall Study|Individual different reasons|21|||
94655281|NCT01260922|324195943|FG000|First Intervention|Withdrawal by Subject|0|||
94655282|NCT01260922|324195944|FG001|First Intervention|Withdrawal by Subject|1|||
94655283|NCT01260922|324195943|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
94655284|NCT01260922|324195944|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
94655285|NCT01260922|324195943|FG000|Second Intervention|Emesis|0|||
94655286|NCT01260922|324195944|FG001|Second Intervention|Emesis|2|||
94655287|NCT00096941|324195949|FG000|Overall Study|disease progression|3|||
94655288|NCT02170727|324195950|FG000|Overall Study|Lost to Follow-up|1|||
94655289|NCT02170727|324195951|FG001|Overall Study|Lost to Follow-up|0|||
94655290|NCT02170727|324195950|FG000|Overall Study|Withdrawal by Subject|2|||
94655291|NCT02170727|324195951|FG001|Overall Study|Withdrawal by Subject|0|||
94655292|NCT01243944|324195952|FG000|Overall Study|Adverse Event|15|||
94655293|NCT01243944|324195953|FG001|Overall Study|Adverse Event|13|||
94655294|NCT01243944|324195952|FG000|Overall Study|Lost to Follow-up|2|||
94655295|NCT01243944|324195953|FG001|Overall Study|Lost to Follow-up|1|||
94655296|NCT01243944|324195952|FG000|Overall Study|Physician Decision|2|||
94655297|NCT01243944|324195953|FG001|Overall Study|Physician Decision|7|||
94655298|NCT01243944|324195952|FG000|Overall Study|Disease progression|12|||
94655299|NCT01243944|324195953|FG001|Overall Study|Disease progression|11|||
94655300|NCT01243944|324195952|FG000|Overall Study|Protocol deviation|1|||
94655301|NCT01243944|324195953|FG001|Overall Study|Protocol deviation|1|||
94655302|NCT01243944|324195952|FG000|Overall Study|Participant decision|10|||
94655303|NCT01243944|324195953|FG001|Overall Study|Participant decision|15|||
94655304|NCT01243944|324195952|FG000|Overall Study|Death|2|||
94655305|NCT01243944|324195953|FG001|Overall Study|Death|3|||
94655306|NCT01243944|324195952|FG000|Overall Study|Non-compliance with study treatment|1|||
94655307|NCT01243944|324195953|FG001|Overall Study|Non-compliance with study treatment|0|||
94655308|NCT02480621|324195966|FG000|Randomization|Withdrawal by Subject|1|||
94655309|NCT02480621|324195967|FG001|Randomization|Withdrawal by Subject|0|||
94655310|NCT02480621|324195966|FG000|Randomization|Surgeon did not give intervention|0|||
94655311|NCT02480621|324195967|FG001|Randomization|Surgeon did not give intervention|1|||
94655312|NCT02480621|324195966|FG000|Follow Up|Lost to Follow-up|4|||
94655313|NCT02480621|324195967|FG001|Follow Up|Lost to Follow-up|2|||
94655314|NCT00022516|324195968|FG000|Overall Study|Adverse Event|0|||
94655315|NCT00022516|324195969|FG001|Overall Study|Adverse Event|59|||
94655316|NCT00022516|324195968|FG000|Overall Study|Lack of Efficacy|0|||
94655317|NCT00022516|324195969|FG001|Overall Study|Lack of Efficacy|27|||
94655318|NCT00022516|324195968|FG000|Overall Study|Physician Decision|0|||
94655319|NCT00022516|324195969|FG001|Overall Study|Physician Decision|1|||
94655320|NCT00022516|324195968|FG000|Overall Study|Protocol Violation|1|||
94655321|NCT00022516|324195969|FG001|Overall Study|Protocol Violation|3|||
94272188|NCT02164929|322790352|FG000|Overall Study|Failed regional block|0|||
94272189|NCT02164929|322790353|FG001|Overall Study|Failed regional block|0|||
94719584|NCT03012841|324432235|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
94719585|NCT03012841|324432236|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
94719586|NCT03012841|324432235|FG000|Overall Study|Insurance change|0|||
94719587|NCT03012841|324432236|FG001|Overall Study|Insurance change|1|||
94719588|NCT03683069|324432237|FG000|Overall Study|see limitations|12|||
94719589|NCT03683069|324432238|FG001|Overall Study|see limitations|13|||
94719590|NCT04941287|324432239|FG000|Overall Study|Rapid decline before starting treatment|3|||
94719591|NCT04941287|324432240|FG001|Overall Study|Rapid decline before starting treatment|1|||
94719592|NCT05075408|324432242|FG000|Overall Study|Withdrawal by Subject|5|||
94719593|NCT05075408|324432243|FG001|Overall Study|Withdrawal by Subject|3|||
94719594|NCT05075408|324432244|FG002|Overall Study|Withdrawal by Subject|4|||
94719595|NCT05075408|324432242|FG000|Overall Study|Adverse Event|5|||
94719596|NCT05075408|324432243|FG001|Overall Study|Adverse Event|7|||
94719597|NCT05075408|324432244|FG002|Overall Study|Adverse Event|8|||
94719598|NCT05075408|324432242|FG000|Overall Study|Protocol Violation|0|||
94719599|NCT05075408|324432243|FG001|Overall Study|Protocol Violation|1|||
94719600|NCT05075408|324432244|FG002|Overall Study|Protocol Violation|0|||
94719601|NCT05075408|324432242|FG000|Overall Study|Lost to Follow-up|2|||
94719602|NCT05075408|324432243|FG001|Overall Study|Lost to Follow-up|1|||
94719603|NCT05075408|324432244|FG002|Overall Study|Lost to Follow-up|1|||
94719604|NCT05075408|324432242|FG000|Overall Study|Physician Decision|1|||
94719605|NCT05075408|324432243|FG001|Overall Study|Physician Decision|0|||
94719606|NCT05075408|324432244|FG002|Overall Study|Physician Decision|0|||
94719607|NCT05075408|324432242|FG000|Overall Study|Other-unspecified|3|||
94719608|NCT05075408|324432243|FG001|Overall Study|Other-unspecified|2|||
94719609|NCT05075408|324432244|FG002|Overall Study|Other-unspecified|0|||
94719610|NCT05419505|324432245|FG000|Overall Study|Adverse Event|0|||
94719611|NCT05419505|324432246|FG001|Overall Study|Adverse Event|0|||
94719612|NCT05419505|324432247|FG002|Overall Study|Adverse Event|0|||
94719613|NCT05419505|324432248|FG003|Overall Study|Adverse Event|1|||
94719614|NCT05419505|324432249|FG004|Overall Study|Adverse Event|0|||
94719615|NCT05419505|324432250|FG005|Overall Study|Adverse Event|0|||
94719616|NCT05419505|324432251|FG006|Overall Study|Adverse Event|0|||
94719617|NCT05419505|324432252|FG007|Overall Study|Adverse Event|0|||
94719618|NCT05419505|324432245|FG000|Overall Study|Withdrawal by Subject|1|||
94719619|NCT05419505|324432246|FG001|Overall Study|Withdrawal by Subject|2|||
94719620|NCT05419505|324432247|FG002|Overall Study|Withdrawal by Subject|0|||
94719621|NCT05419505|324432248|FG003|Overall Study|Withdrawal by Subject|0|||
94719622|NCT05419505|324432249|FG004|Overall Study|Withdrawal by Subject|0|||
94719623|NCT05419505|324432250|FG005|Overall Study|Withdrawal by Subject|0|||
94719624|NCT05419505|324432251|FG006|Overall Study|Withdrawal by Subject|1|||
94719625|NCT05419505|324432252|FG007|Overall Study|Withdrawal by Subject|0|||
94719626|NCT05419505|324432245|FG000|Overall Study|Lost to Follow-up|2|||
94719627|NCT05419505|324432246|FG001|Overall Study|Lost to Follow-up|1|||
94719628|NCT05419505|324432247|FG002|Overall Study|Lost to Follow-up|0|||
94719629|NCT05419505|324432248|FG003|Overall Study|Lost to Follow-up|0|||
94719630|NCT05419505|324432249|FG004|Overall Study|Lost to Follow-up|1|||
94719631|NCT05419505|324432250|FG005|Overall Study|Lost to Follow-up|2|||
94719632|NCT05419505|324432251|FG006|Overall Study|Lost to Follow-up|0|||
94719633|NCT05419505|324432252|FG007|Overall Study|Lost to Follow-up|1|||
94719634|NCT02152137|324432253|FG000|Overall Study|Withdrawal by Subject|1|||
94719635|NCT02152137|324432253|FG000|Overall Study|Originally assigned to Arm B|3|||
94719636|NCT05510232|324432254|FG000|Overall Study|Withdrawal by Subject|2|||
94719637|NCT05510232|324432255|FG001|Overall Study|Withdrawal by Subject|7|||
94719638|NCT05510232|324432256|FG002|Overall Study|Withdrawal by Subject|6|||
94719639|NCT01064440|324432263|FG000|Overall Study|Lost to Follow-up|1|||
94719640|NCT01064440|324432264|FG001|Overall Study|Lost to Follow-up|1|||
94719641|NCT01064440|324432265|FG002|Overall Study|Lost to Follow-up|1|||
94719642|NCT01064440|324432263|FG000|Overall Study|Non-compliance|0|||
94719643|NCT01064440|324432264|FG001|Overall Study|Non-compliance|1|||
94719644|NCT01064440|324432265|FG002|Overall Study|Non-compliance|0|||
94719645|NCT01064440|324432263|FG000|Overall Study|Death|1|||
94719646|NCT01064440|324432264|FG001|Overall Study|Death|0|||
94719647|NCT01064440|324432265|FG002|Overall Study|Death|1|||
94272190|NCT02164929|322790354|FG002|Overall Study|Failed regional block|1|||
94719648|NCT01064440|324432263|FG000|Overall Study|Withdrawal by Subject|0|||
94719649|NCT01064440|324432264|FG001|Overall Study|Withdrawal by Subject|1|||
94719650|NCT01064440|324432265|FG002|Overall Study|Withdrawal by Subject|1|||
94719651|NCT01064440|324432263|FG000|Overall Study|Other: amputation|1|||
94719652|NCT01064440|324432264|FG001|Overall Study|Other: amputation|0|||
94719653|NCT01064440|324432265|FG002|Overall Study|Other: amputation|0|||
94719654|NCT04337372|324432266|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
94719655|NCT04337372|324432267|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
94719656|NCT04337372|324432268|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
94719657|NCT04337372|324432269|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
94719658|NCT04337372|324432266|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
94719659|NCT04337372|324432267|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
94719660|NCT04337372|324432268|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
94719661|NCT04337372|324432269|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
94719662|NCT04337372|324432266|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
94719663|NCT04337372|324432267|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
94719664|NCT04337372|324432268|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
94719665|NCT04337372|324432269|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
94719666|NCT04337372|324432266|FG000|Day 2: EEG Measures|Protocol Violation|6|||
94719667|NCT04337372|324432267|FG001|Day 2: EEG Measures|Protocol Violation|6|||
94719668|NCT04337372|324432268|FG002|Day 2: EEG Measures|Protocol Violation|5|||
94719669|NCT04337372|324432269|FG003|Day 2: EEG Measures|Protocol Violation|17|||
94719670|NCT05687903|324432270|FG000|Overall Study|Protocol Deviation|1|||
94719671|NCT05687903|324432271|FG001|Overall Study|Protocol Deviation|1|||
94719672|NCT05687903|324432272|FG002|Overall Study|Protocol Deviation|0|||
94719673|NCT05687903|324432273|FG003|Overall Study|Protocol Deviation|1|||
94719674|NCT05687903|324432274|FG004|Overall Study|Protocol Deviation|0|||
94719675|NCT04855760|324432275|FG000|Overall Study|Adverse Event|21|||
94719676|NCT04855760|324432275|FG000|Overall Study|Withdrawal by Subject|116|||
94719677|NCT04855760|324432275|FG000|Overall Study|Lack of Efficacy|21|||
94719678|NCT04855760|324432275|FG000|Overall Study|Lost to Follow-up|49|||
94719679|NCT04855760|324432275|FG000|Overall Study|Protocol Violation|2|||
94719680|NCT04855760|324432275|FG000|Overall Study|Physician Decision|5|||
94719681|NCT04855760|324432275|FG000|Overall Study|Pregnancy|1|||
94719682|NCT04855760|324432275|FG000|Overall Study|Non-Compliance with Study Drug|11|||
94719683|NCT04855760|324432275|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
94719684|NCT04855760|324432275|FG000|Overall Study|Study Completed by Sponsor|202|||
94719685|NCT04855760|324432275|FG000|Overall Study|Other|13|||
94719686|NCT04533022|324432289|FG000|Overall Study|Withdrawal by Subject|15|||
94719687|NCT04533022|324432289|FG000|Overall Study|Adverse Event|6|||
94719688|NCT04533022|324432289|FG000|Overall Study|Death|1|||
94719689|NCT04533022|324432289|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
94719690|NCT04533022|324432289|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
94719691|NCT02819843|324432290|FG000|Overall Study|Disease progression before RT|0|||
94719692|NCT02819843|324432291|FG001|Overall Study|Disease progression before RT|1|||
94719693|NCT04732494|324432292|FG000|Overall Study|Death|39|||
94719694|NCT04732494|324432293|FG001|Overall Study|Death|36|||
94719695|NCT04732494|324432292|FG000|Overall Study|Study Closed by Sponsor|20|||
94719696|NCT04732494|324432293|FG001|Overall Study|Study Closed by Sponsor|15|||
94719697|NCT04732494|324432292|FG000|Overall Study|Withdrawal by Subject|2|||
94719698|NCT04732494|324432293|FG001|Overall Study|Withdrawal by Subject|7|||
94719699|NCT04732494|324432292|FG000|Overall Study|Lost to Follow-up|1|||
94719700|NCT04732494|324432293|FG001|Overall Study|Lost to Follow-up|5|||
94719701|NCT03055858|324432294|FG000|Overall Study|Death|9|||
94719702|NCT03055858|324432294|FG000|Overall Study|Withdrawal by Subject|11|||
94719703|NCT03055858|324432294|FG000|Overall Study|Lost to Follow-up|6|||
94719704|NCT03055858|324432294|FG000|Overall Study|Missed Follow-Up Visits|18|||
94719705|NCT05288283|324432295|FG000|Overall Study|Study Terminated Early|1|||
94719706|NCT05288283|324432296|FG001|Overall Study|Study Terminated Early|1|||
94719707|NCT02728557|324432297|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
94719708|NCT02728557|324432298|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
94719709|NCT02728557|324432297|FG000|Overall Study|Dissatisfaction with research tasks|0|||
94719710|NCT02728557|324432298|FG001|Overall Study|Dissatisfaction with research tasks|1|||
94719711|NCT02728557|324432297|FG000|Overall Study|Scheduling or change in availability|1|||
94719712|NCT02728557|324432298|FG001|Overall Study|Scheduling or change in availability|1|||
94719713|NCT06422377|324432310|FG000|Overall Study|Study Terminated by Sponsor|1|||
94719714|NCT03089398|324432311|FG000|Overall Study|Death|4|||
94719715|NCT03089398|324432312|FG001|Overall Study|Death|9|||
94719716|NCT03089398|324432311|FG000|Overall Study|Lost to Follow-up|21|||
94719717|NCT03089398|324432312|FG001|Overall Study|Lost to Follow-up|30|||
94719718|NCT03089398|324432311|FG000|Overall Study|Withdrawal by Subject|2|||
94719719|NCT03089398|324432312|FG001|Overall Study|Withdrawal by Subject|2|||
94719720|NCT05062265|324432313|FG000|Overall Study|Withdrawal by Subject|1|||
94719721|NCT05062265|324432314|FG001|Overall Study|Withdrawal by Subject|0|||
94719722|NCT02300298|324432315|FG000|Disposition for Nintedanib|Progressive disease|10|||
94719723|NCT02300298|324432316|FG001|Disposition for Nintedanib|Progressive disease|0|||
94719724|NCT02300298|324432315|FG000|Disposition for Docetaxel|Progressive disease|0|||
94719725|NCT02300298|324432316|FG001|Disposition for Docetaxel|Progressive disease|6|||
94719726|NCT02300298|324432315|FG000|Disposition for Docetaxel|other adverse event|0|||
94719727|NCT02300298|324432316|FG001|Disposition for Docetaxel|other adverse event|4|||
94719728|NCT05444192|324432317|FG000|Overall Study|Lost to Follow-up|1|||
94719729|NCT05444192|324432318|FG001|Overall Study|Lost to Follow-up|0|||
94719730|NCT05054374|324432319|FG000|Overall Study|Withdrawal by Subject|1|||
94719731|NCT05054374|324432320|FG001|Overall Study|Withdrawal by Subject|0|||
94719732|NCT05054374|324432321|FG002|Overall Study|Withdrawal by Subject|0|||
94719733|NCT05054374|324432322|FG003|Overall Study|Withdrawal by Subject|0|||
94719734|NCT05054374|324432319|FG000|Overall Study|Progressive Disease|5|||
94719735|NCT05054374|324432320|FG001|Overall Study|Progressive Disease|0|||
94719736|NCT05054374|324432321|FG002|Overall Study|Progressive Disease|0|||
94719737|NCT05054374|324432322|FG003|Overall Study|Progressive Disease|0|||
94719738|NCT03594110|324432323|FG000|Overall Study|Participant concerned about study treatment|23|||
94719739|NCT03594110|324432324|FG001|Overall Study|Participant concerned about study treatment|28|||
94719740|NCT03594110|324432323|FG000|Overall Study|Doctor advice|38|||
94719741|NCT03594110|324432324|FG001|Overall Study|Doctor advice|40|||
94719742|NCT03594110|324432323|FG000|Overall Study|Participants' wish|89|||
94719743|NCT03594110|324432324|FG001|Overall Study|Participants' wish|68|||
94719744|NCT03594110|324432323|FG000|Overall Study|Adverse event-non-fatal events|119|||
94719745|NCT03594110|324432324|FG001|Overall Study|Adverse event-non-fatal events|116|||
94719746|NCT03594110|324432323|FG000|Overall Study|Study drug stopped, reason missing|336|||
94719747|NCT03594110|324432324|FG001|Overall Study|Study drug stopped, reason missing|294|||
94719748|NCT03594110|324432323|FG000|Overall Study|Cannot attend clinic because of personal problems|8|||
94719749|NCT03594110|324432324|FG001|Overall Study|Cannot attend clinic because of personal problems|16|||
94719750|NCT03594110|324432323|FG000|Overall Study|Cannot attend clinic because moving out of the area|15|||
94719751|NCT03594110|324432324|FG001|Overall Study|Cannot attend clinic because moving out of the area|9|||
94719752|NCT03594110|324432323|FG000|Overall Study|Contraindicated drug started|32|||
94719753|NCT03594110|324432324|FG001|Overall Study|Contraindicated drug started|18|||
94719754|NCT03594110|324432323|FG000|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|58|||
94719755|NCT03594110|324432324|FG001|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|45|||
94719756|NCT03594110|324432323|FG000|Overall Study|Adverse event-Serious fatal events|130|||
94719757|NCT03594110|324432324|FG001|Overall Study|Adverse event-Serious fatal events|121|||
94719758|NCT00601900|324432327|FG000|Overall Study|Withdrawal by Subject|0|||
94719759|NCT00601900|324432328|FG001|Overall Study|Withdrawal by Subject|3|||
94719760|NCT04450342|324432329|FG000|Overall Study|Adverse Event|1|||
94719761|NCT04450342|324432330|FG001|Overall Study|Adverse Event|1|||
94719762|NCT04450342|324432331|FG002|Overall Study|Adverse Event|0|||
94719763|NCT04450342|324432329|FG000|Overall Study|Device not used|1|||
94719764|NCT04450342|324432330|FG001|Overall Study|Device not used|0|||
94719765|NCT04450342|324432331|FG002|Overall Study|Device not used|0|||
94719766|NCT04450342|324432329|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
94719767|NCT04450342|324432330|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
94719768|NCT04450342|324432331|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
94719769|NCT04450342|324432329|FG000|Overall Study|Physician Decision|1|||
94719770|NCT04450342|324432330|FG001|Overall Study|Physician Decision|0|||
94719771|NCT04450342|324432331|FG002|Overall Study|Physician Decision|1|||
94719772|NCT04450342|324432329|FG000|Overall Study|Protocol Deviation|0|||
94719773|NCT04450342|324432330|FG001|Overall Study|Protocol Deviation|1|||
94719774|NCT04450342|324432331|FG002|Overall Study|Protocol Deviation|0|||
94719775|NCT04450342|324432329|FG000|Overall Study|Reoperation|1|||
94719776|NCT04450342|324432330|FG001|Overall Study|Reoperation|1|||
94719777|NCT04450342|324432331|FG002|Overall Study|Reoperation|0|||
94719778|NCT04450342|324432329|FG000|Overall Study|Screen Failures|0|||
94719779|NCT04450342|324432330|FG001|Overall Study|Screen Failures|0|||
94719780|NCT04450342|324432331|FG002|Overall Study|Screen Failures|2|||
94719781|NCT04450342|324432329|FG000|Overall Study|Site Terminated by Sponsor|1|||
94719782|NCT04450342|324432330|FG001|Overall Study|Site Terminated by Sponsor|1|||
94719783|NCT04450342|324432331|FG002|Overall Study|Site Terminated by Sponsor|1|||
94719784|NCT04450342|324432329|FG000|Overall Study|Study Terminated by Sponsor|31|||
94719785|NCT04450342|324432330|FG001|Overall Study|Study Terminated by Sponsor|29|||
94719786|NCT04450342|324432331|FG002|Overall Study|Study Terminated by Sponsor|6|||
94719787|NCT04450342|324432329|FG000|Overall Study|Withdrawal by Subject|0|||
94719788|NCT04450342|324432330|FG001|Overall Study|Withdrawal by Subject|1|||
94719789|NCT04450342|324432331|FG002|Overall Study|Withdrawal by Subject|2|||
94719790|NCT04033445|324432332|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
94719791|NCT04033445|324432333|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
94719792|NCT04033445|324432334|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
94719793|NCT04033445|324432335|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
94719794|NCT04033445|324432336|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
94719795|NCT04033445|324432337|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
94719796|NCT04033445|324432338|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
94719797|NCT04033445|324432339|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
94719798|NCT04033445|324432340|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
94719799|NCT04033445|324432341|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
94719800|NCT04033445|324432342|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
94368051|NCT02437890|323134814|FG000|Overall Study|Withdrawal by Subject|1|||
94719801|NCT04033445|324432343|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
94719802|NCT04033445|324432344|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
94719803|NCT04033445|324432345|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
94719804|NCT04033445|324432332|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
94719805|NCT04033445|324432333|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
94719806|NCT04033445|324432334|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
94719807|NCT04033445|324432335|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
94719808|NCT04033445|324432336|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
94719809|NCT04033445|324432337|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
94719810|NCT04033445|324432338|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
94719811|NCT04033445|324432339|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
94719812|NCT04033445|324432340|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
94719813|NCT04033445|324432341|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
94719814|NCT04033445|324432342|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
94719815|NCT04033445|324432343|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
94719816|NCT04033445|324432344|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
94719817|NCT04033445|324432345|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
94719818|NCT04033445|324432332|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
94719819|NCT04033445|324432333|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
94719820|NCT04033445|324432334|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
94719821|NCT04033445|324432335|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
94719822|NCT04033445|324432336|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
94719823|NCT04033445|324432337|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
94719824|NCT04033445|324432338|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
94719825|NCT04033445|324432339|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
94719826|NCT04033445|324432340|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
94719827|NCT04033445|324432341|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
94719828|NCT04033445|324432342|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
94719829|NCT04033445|324432343|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
94719830|NCT04033445|324432344|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
94719831|NCT04033445|324432345|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
94719832|NCT04033445|324432332|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
94719833|NCT04033445|324432333|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
94719834|NCT04033445|324432334|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
94719835|NCT04033445|324432335|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
94719836|NCT04033445|324432336|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
94719837|NCT04033445|324432337|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
94719838|NCT04033445|324432338|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
94719839|NCT04033445|324432339|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
94719840|NCT04033445|324432340|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
94719841|NCT04033445|324432341|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
94719842|NCT04033445|324432342|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
94719843|NCT04033445|324432343|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
94719844|NCT04033445|324432344|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
94719845|NCT04033445|324432345|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
94719846|NCT04033445|324432332|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
94719847|NCT04033445|324432333|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
94719848|NCT04033445|324432334|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
94719849|NCT04033445|324432335|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
94719850|NCT04033445|324432336|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
94719851|NCT04033445|324432337|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
94719852|NCT04033445|324432338|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
94719853|NCT04033445|324432339|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
94719854|NCT04033445|324432340|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
94719855|NCT04033445|324432341|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
94719856|NCT04033445|324432342|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
94719857|NCT04033445|324432343|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
94719858|NCT04033445|324432344|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
94719859|NCT04033445|324432345|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
94719860|NCT04033445|324432332|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
94719861|NCT04033445|324432333|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
94719862|NCT04033445|324432334|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
94719863|NCT04033445|324432335|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
94719864|NCT04033445|324432336|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
94719865|NCT04033445|324432337|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
94719866|NCT04033445|324432338|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
94368052|NCT02437890|323134815|FG001|Overall Study|Withdrawal by Subject|2|||
94368053|NCT02437890|323134816|FG002|Overall Study|Withdrawal by Subject|6|||
94719867|NCT04033445|324432339|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
94719868|NCT04033445|324432340|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
94719869|NCT04033445|324432341|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
94719870|NCT04033445|324432342|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
94719871|NCT04033445|324432343|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
94719872|NCT04033445|324432344|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
94719873|NCT04033445|324432345|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
94719874|NCT04033445|324432332|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
94719875|NCT04033445|324432333|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
94719876|NCT04033445|324432334|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
94719877|NCT04033445|324432335|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
94719878|NCT04033445|324432336|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
94719879|NCT04033445|324432337|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
94719880|NCT04033445|324432338|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
94719881|NCT04033445|324432339|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
94719882|NCT04033445|324432340|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
94719883|NCT04033445|324432341|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
94719884|NCT04033445|324432342|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
94719885|NCT04033445|324432343|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
94719886|NCT04033445|324432344|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
94719887|NCT04033445|324432345|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
94719888|NCT04033445|324432332|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
94719889|NCT04033445|324432333|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
94719890|NCT04033445|324432334|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
94719891|NCT04033445|324432335|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
94719892|NCT04033445|324432336|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
94719893|NCT04033445|324432337|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
94719894|NCT04033445|324432338|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
94719895|NCT04033445|324432339|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
94719896|NCT04033445|324432340|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
94719897|NCT04033445|324432341|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
94719898|NCT04033445|324432342|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
94719899|NCT04033445|324432343|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
94719900|NCT04033445|324432344|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
94719901|NCT04033445|324432345|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
94719902|NCT04033445|324432332|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
94719903|NCT04033445|324432333|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
94719904|NCT04033445|324432334|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
94719905|NCT04033445|324432335|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
94719906|NCT04033445|324432336|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
94719907|NCT04033445|324432337|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
94719908|NCT04033445|324432338|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
94719909|NCT04033445|324432339|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
94719910|NCT04033445|324432340|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
94719911|NCT04033445|324432341|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
94719912|NCT04033445|324432342|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
94719913|NCT04033445|324432343|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
94719914|NCT04033445|324432344|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
94719915|NCT04033445|324432345|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
94719916|NCT04033445|324432332|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
94719917|NCT04033445|324432333|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
94719918|NCT04033445|324432334|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
94719919|NCT04033445|324432335|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
94719920|NCT04033445|324432336|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
94719921|NCT04033445|324432337|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
94719922|NCT04033445|324432338|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
94719923|NCT04033445|324432339|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
94719924|NCT04033445|324432340|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
94719925|NCT04033445|324432341|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
94719926|NCT04033445|324432342|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
94719927|NCT04033445|324432343|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
94719928|NCT04033445|324432344|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
94719929|NCT04033445|324432345|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
94719930|NCT04033445|324432332|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
94719931|NCT04033445|324432333|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
94719932|NCT04033445|324432334|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
94719933|NCT04033445|324432335|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
94719934|NCT04033445|324432336|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
94719935|NCT04033445|324432337|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
94719936|NCT04033445|324432338|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
94719937|NCT04033445|324432339|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
94719938|NCT04033445|324432340|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
94719939|NCT04033445|324432341|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
94719940|NCT04033445|324432342|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
94719941|NCT04033445|324432343|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
94719942|NCT04033445|324432344|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
94719943|NCT04033445|324432345|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
94719944|NCT04033445|324432332|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
94719945|NCT04033445|324432333|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
94719946|NCT04033445|324432334|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
94719947|NCT04033445|324432335|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
94719948|NCT04033445|324432336|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
94719949|NCT04033445|324432337|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
94719950|NCT04033445|324432338|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
94719951|NCT04033445|324432339|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
94719952|NCT04033445|324432340|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
94719953|NCT04033445|324432341|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
94719954|NCT04033445|324432342|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
94719955|NCT04033445|324432343|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
94719956|NCT04033445|324432344|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
94719957|NCT04033445|324432345|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
94719958|NCT04033445|324432332|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
94719959|NCT04033445|324432333|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
94719960|NCT04033445|324432334|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
94719961|NCT04033445|324432335|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
94719962|NCT04033445|324432336|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
94719963|NCT04033445|324432337|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
94719964|NCT04033445|324432338|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
94719965|NCT04033445|324432339|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
94719966|NCT04033445|324432340|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
94719967|NCT04033445|324432341|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
94719968|NCT04033445|324432342|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
94719969|NCT04033445|324432343|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
94719970|NCT04033445|324432344|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
94719971|NCT04033445|324432345|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
94719972|NCT04033445|324432332|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
94719973|NCT04033445|324432333|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
94719974|NCT04033445|324432334|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
94719975|NCT04033445|324432335|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
94719976|NCT04033445|324432336|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
94719977|NCT04033445|324432337|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
94719978|NCT04033445|324432338|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
94719979|NCT04033445|324432339|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
94719980|NCT04033445|324432340|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
94719981|NCT04033445|324432341|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
94719982|NCT04033445|324432342|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
94719983|NCT04033445|324432343|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
94719984|NCT04033445|324432344|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
94719985|NCT04033445|324432345|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
94719986|NCT04033445|324432332|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
94719987|NCT04033445|324432333|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
94719988|NCT04033445|324432334|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
94719989|NCT04033445|324432335|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
94719990|NCT04033445|324432336|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
94719991|NCT04033445|324432337|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
94719992|NCT04033445|324432338|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
94719993|NCT04033445|324432339|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
94719994|NCT04033445|324432340|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
94719995|NCT04033445|324432341|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
94719996|NCT04033445|324432342|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
94719997|NCT04033445|324432343|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
94719998|NCT04033445|324432344|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
94719999|NCT04033445|324432345|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
94720000|NCT04033445|324432332|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
94720001|NCT04033445|324432333|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
94720002|NCT04033445|324432334|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
94720003|NCT04033445|324432335|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
94720004|NCT04033445|324432336|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
94720005|NCT04033445|324432337|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
94720006|NCT04033445|324432338|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
94720007|NCT04033445|324432339|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
94720008|NCT04033445|324432340|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
94720009|NCT04033445|324432341|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
94720010|NCT04033445|324432342|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
94720011|NCT04033445|324432343|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
94720012|NCT04033445|324432344|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
94720013|NCT04033445|324432345|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
94720014|NCT04033445|324432332|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
94720015|NCT04033445|324432333|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
94720016|NCT04033445|324432334|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
94368054|NCT02437890|323134817|FG003|Overall Study|Withdrawal by Subject|5|||
94368055|NCT02437890|323134818|FG004|Overall Study|Withdrawal by Subject|5|||
94368056|NCT02437890|323134814|FG000|Overall Study|Death|0|||
94368057|NCT02437890|323134815|FG001|Overall Study|Death|0|||
94368058|NCT02437890|323134816|FG002|Overall Study|Death|0|||
94368059|NCT02437890|323134817|FG003|Overall Study|Death|2|||
94720017|NCT04033445|324432335|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
94720018|NCT04033445|324432336|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
94720019|NCT04033445|324432337|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
94720020|NCT04033445|324432338|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
94720021|NCT04033445|324432339|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
94720022|NCT04033445|324432340|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
94720023|NCT04033445|324432341|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
94720024|NCT04033445|324432342|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
94368060|NCT02437890|323134818|FG004|Overall Study|Death|0|||
94720025|NCT04033445|324432343|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
94720026|NCT04033445|324432344|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
94368061|NCT00344305|323134819|FG000|Overall Study|Lost to Follow-up|2|||
94720027|NCT04033445|324432345|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
94720028|NCT04033445|324432332|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
94720029|NCT04033445|324432333|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
94720030|NCT04033445|324432334|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
94720031|NCT04033445|324432335|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
94720032|NCT04033445|324432336|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
94720033|NCT04033445|324432337|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
94720034|NCT04033445|324432338|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
94720035|NCT04033445|324432339|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
94720036|NCT04033445|324432340|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
94720037|NCT04033445|324432341|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
94720038|NCT04033445|324432342|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
94720039|NCT04033445|324432343|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
94720040|NCT04033445|324432344|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
94720041|NCT04033445|324432345|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
94720042|NCT04033445|324432332|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
94720043|NCT04033445|324432333|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
94720044|NCT04033445|324432334|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
94720045|NCT04033445|324432335|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
94272191|NCT02164929|322790355|FG003|Overall Study|Failed regional block|0|||
94272192|NCT00971178|322790359|FG000|Overall Study|Lost to Follow-up|2|||
94272193|NCT00971178|322790360|FG001|Overall Study|Lost to Follow-up|2|||
94272194|NCT00971178|322790361|FG002|Overall Study|Lost to Follow-up|2|||
94272195|NCT01486927|322790362|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
94272196|NCT01486927|322790362|FG000|Overall Study|Physician Decision|1|||
94272197|NCT01486927|322790362|FG000|Overall Study|50 Exposure days not reached|2|||
94272198|NCT01486927|322790362|FG000|Overall Study|Withdrawal by Subject|8|||
94272199|NCT01486927|322790362|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
94272200|NCT00365456|322790363|FG000|Trial Period I (12 Months)|Adverse Event|84|||
94272201|NCT00365456|322790364|FG001|Trial Period I (12 Months)|Adverse Event|0|||
94272202|NCT00365456|322790363|FG000|Trial Period I (12 Months)|Non-compliance|3|||
94272203|NCT00365456|322790364|FG001|Trial Period I (12 Months)|Non-compliance|0|||
94272204|NCT00365456|322790363|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
94272205|NCT00365456|322790364|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
94272206|NCT00365456|322790363|FG000|Trial Period I (12 Months)|Other|11|||
94272207|NCT00365456|322790364|FG001|Trial Period I (12 Months)|Other|0|||
94272208|NCT00365456|322790363|FG000|Trial Period II (12 Months)|Adverse Event|0|||
94272209|NCT00365456|322790364|FG001|Trial Period II (12 Months)|Adverse Event|6|||
94272210|NCT00365456|322790363|FG000|Trial Period II (12 Months)|Non-compliance|0|||
94272211|NCT00365456|322790364|FG001|Trial Period II (12 Months)|Non-compliance|2|||
94272212|NCT00365456|322790363|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
94272213|NCT00365456|322790364|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
94272214|NCT00365456|322790363|FG000|Trial Period II (12 Months)|Other|0|||
94272215|NCT00365456|322790364|FG001|Trial Period II (12 Months)|Other|1|||
94272216|NCT00365456|322790363|FG000|Trial Period III (12 Months)|Adverse Event|13|||
94272217|NCT00365456|322790364|FG001|Trial Period III (12 Months)|Adverse Event|3|||
94272218|NCT00365456|322790363|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
94272219|NCT00365456|322790364|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
94272220|NCT00365456|322790363|FG000|Trial Period III (12 Months)|Other|1|||
94272221|NCT00365456|322790364|FG001|Trial Period III (12 Months)|Other|1|||
94272222|NCT03668600|322790365|FG000|Overall Study|Study Terminated by the Sponsor|157|||
94272223|NCT03668600|322790365|FG000|Overall Study|Protocol Violation|1|||
94272224|NCT03668600|322790365|FG000|Overall Study|Pregnancy|1|||
94272225|NCT03668600|322790365|FG000|Overall Study|Lost to Follow-up|7|||
94272226|NCT03668600|322790365|FG000|Overall Study|Withdrawal by Subject|56|||
94272227|NCT03668600|322790365|FG000|Overall Study|Lack of Efficacy|7|||
94272228|NCT03668600|322790365|FG000|Overall Study|Adverse Event|1|||
94272229|NCT01438489|322790366|FG000|Overall Study|Lost to Follow-up|4|||
94272230|NCT01438489|322790367|FG001|Overall Study|Lost to Follow-up|2|||
94272231|NCT01438489|322790368|FG002|Overall Study|Lost to Follow-up|2|||
94272232|NCT01438489|322790366|FG000|Overall Study|Withdrawal by Subject|11|||
94272233|NCT01438489|322790367|FG001|Overall Study|Withdrawal by Subject|3|||
94272234|NCT01438489|322790368|FG002|Overall Study|Withdrawal by Subject|8|||
94272235|NCT01438489|322790366|FG000|Overall Study|Death|0|||
94272236|NCT01438489|322790367|FG001|Overall Study|Death|0|||
94272237|NCT01438489|322790368|FG002|Overall Study|Death|1|||
94272238|NCT01438489|322790366|FG000|Overall Study|Sponsor decision|4|||
94272239|NCT01438489|322790367|FG001|Overall Study|Sponsor decision|1|||
94272240|NCT01438489|322790368|FG002|Overall Study|Sponsor decision|4|||
94272241|NCT01438489|322790366|FG000|Overall Study|Subject choice/Subject moved|2|||
94272242|NCT01438489|322790367|FG001|Overall Study|Subject choice/Subject moved|1|||
94272243|NCT01438489|322790368|FG002|Overall Study|Subject choice/Subject moved|1|||
94368062|NCT00344305|323134820|FG001|Overall Study|Lost to Follow-up|0|||
94272244|NCT01438489|322790366|FG000|Overall Study|Investigator decision|0|||
94368063|NCT00344305|323134819|FG000|Overall Study|Participant was not contacted in window|0|||
94720046|NCT04033445|324432336|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
94720047|NCT04033445|324432337|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
94720048|NCT04033445|324432338|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
94720049|NCT04033445|324432339|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
94720050|NCT04033445|324432340|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
94720051|NCT04033445|324432341|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
94720052|NCT04033445|324432342|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
94720053|NCT04033445|324432343|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
94720054|NCT04033445|324432344|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
94720055|NCT04033445|324432345|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
94720056|NCT04033445|324432332|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
94720057|NCT04033445|324432333|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
94720058|NCT04033445|324432334|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
94720059|NCT04033445|324432335|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
94720060|NCT04033445|324432336|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
94720061|NCT04033445|324432337|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
94720062|NCT04033445|324432338|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
94720063|NCT04033445|324432339|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
94720064|NCT04033445|324432340|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
94720065|NCT04033445|324432341|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
94720066|NCT04033445|324432342|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
94720067|NCT04033445|324432343|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
94720068|NCT04033445|324432344|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
94720069|NCT04033445|324432345|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
94720070|NCT04033445|324432332|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
94720071|NCT04033445|324432333|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
94720072|NCT04033445|324432334|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
94720073|NCT04033445|324432335|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
94720074|NCT04033445|324432336|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
94720075|NCT04033445|324432337|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
94720076|NCT04033445|324432338|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
94720077|NCT04033445|324432339|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
94720078|NCT04033445|324432340|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
94720079|NCT04033445|324432341|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
94720080|NCT04033445|324432342|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
94720081|NCT04033445|324432343|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
94720082|NCT04033445|324432344|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
94720083|NCT04033445|324432345|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
94720084|NCT04033445|324432332|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
94720085|NCT04033445|324432333|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
94720086|NCT04033445|324432334|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
94720087|NCT04033445|324432335|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
94720088|NCT04033445|324432336|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
94720089|NCT04033445|324432337|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
94720090|NCT04033445|324432338|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
94720091|NCT04033445|324432339|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
94720092|NCT04033445|324432340|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
94720093|NCT04033445|324432341|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
94720094|NCT04033445|324432342|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
94720095|NCT04033445|324432343|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
94720096|NCT04033445|324432344|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
94720097|NCT04033445|324432345|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
94720098|NCT04033445|324432332|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
94720099|NCT04033445|324432333|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
94720100|NCT04033445|324432334|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
94720101|NCT04033445|324432335|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
94720102|NCT04033445|324432336|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
94720103|NCT04033445|324432337|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
94720104|NCT04033445|324432338|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
94720105|NCT04033445|324432339|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
94720106|NCT04033445|324432340|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
94720107|NCT04033445|324432341|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
94467331|NCT00306787|323500508|FG001|Overall Study|Withdrawal by Subject|9|||
94467332|NCT00306787|323500507|FG000|Overall Study|Lost to Follow-up|9|||
94720108|NCT04033445|324432342|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
94720109|NCT04033445|324432343|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
94720110|NCT04033445|324432344|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
94720111|NCT04033445|324432345|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
94720112|NCT05633407|324432346|FG000|Overall Study|Physician Decision|2|||
94720113|NCT05633407|324432347|FG001|Overall Study|Physician Decision|0|||
94720114|NCT05633407|324432346|FG000|Overall Study|Adverse Event|1|||
94720115|NCT05633407|324432347|FG001|Overall Study|Adverse Event|0|||
94720116|NCT05633407|324432346|FG000|Overall Study|Withdrawal by Subject|1|||
94720117|NCT05633407|324432347|FG001|Overall Study|Withdrawal by Subject|0|||
94720118|NCT05633407|324432346|FG000|Overall Study|Other|1|||
94720119|NCT05633407|324432347|FG001|Overall Study|Other|1|||
94720120|NCT02500758|324432350|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
94720121|NCT02500758|324432351|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
94720122|NCT02500758|324432350|FG000|Washout (1 Week)|Lost to Follow-up|2|||
94720123|NCT02500758|324432351|FG001|Washout (1 Week)|Lost to Follow-up|2|||
94720124|NCT02500758|324432350|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
94720125|NCT02500758|324432351|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
94720126|NCT02500758|324432350|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
94720127|NCT02500758|324432351|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
94720128|NCT02500758|324432350|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
94720129|NCT02500758|324432351|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
94720130|NCT00220740|324432352|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
94720131|NCT00220740|324432353|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
94720132|NCT00220740|324432352|FG000|Efficacy Period|Adverse Event|1|||
94720133|NCT00220740|324432353|FG001|Efficacy Period|Adverse Event|1|||
94720134|NCT00220740|324432352|FG000|Efficacy Period|Withdrawal by Subject|1|||
94720135|NCT00220740|324432353|FG001|Efficacy Period|Withdrawal by Subject|0|||
94720136|NCT00220740|324432352|FG000|Efficacy Period|Protocol Violation|1|||
94720137|NCT00220740|324432353|FG001|Efficacy Period|Protocol Violation|0|||
94272245|NCT01438489|322790367|FG001|Overall Study|Investigator decision|1|||
94720138|NCT00220740|324432352|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
94720139|NCT00220740|324432353|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
94720140|NCT01057433|324432354|FG000|Overall Study|Adverse Event|1|||
94720141|NCT03578536|324432355|FG000|Overall Study|Lost to Follow-up|1|||
94720142|NCT04287985|324432357|FG000|Overall Study|Adverse Event|1|||
94720143|NCT04287985|324432358|FG001|Overall Study|Adverse Event|0|||
94720144|NCT04287985|324432359|FG002|Overall Study|Adverse Event|0|||
94720145|NCT04287985|324432360|FG003|Overall Study|Adverse Event|0|||
94720146|NCT04287985|324432357|FG000|Overall Study|Protocol Violation|0|||
94720147|NCT04287985|324432358|FG001|Overall Study|Protocol Violation|1|||
94720148|NCT04287985|324432359|FG002|Overall Study|Protocol Violation|0|||
94720149|NCT04287985|324432360|FG003|Overall Study|Protocol Violation|0|||
94720150|NCT04287985|324432357|FG000|Overall Study|Physician Decision|0|||
94720151|NCT04287985|324432358|FG001|Overall Study|Physician Decision|0|||
94720152|NCT04287985|324432359|FG002|Overall Study|Physician Decision|0|||
94720153|NCT04287985|324432360|FG003|Overall Study|Physician Decision|1|||
94720154|NCT04287985|324432357|FG000|Overall Study|Withdrawal by Subject|2|||
94720155|NCT04287985|324432358|FG001|Overall Study|Withdrawal by Subject|1|||
94720156|NCT04287985|324432359|FG002|Overall Study|Withdrawal by Subject|1|||
94720157|NCT04287985|324432360|FG003|Overall Study|Withdrawal by Subject|2|||
94720158|NCT00274469|324432365|FG000|Overall Study|Death|63|||
94720159|NCT00274469|324432366|FG001|Overall Study|Death|74|||
94720160|NCT00274469|324432365|FG000|Overall Study|Did not consent to OS follow-up|16|||
94720161|NCT00274469|324432366|FG001|Overall Study|Did not consent to OS follow-up|19|||
94720162|NCT02376790|324432369|FG000|Overall Study|Withdrawal by Subject|43|||
94720163|NCT02376790|324432370|FG001|Overall Study|Withdrawal by Subject|36|||
94720164|NCT02376790|324432371|FG002|Overall Study|Withdrawal by Subject|37|||
94720165|NCT02376790|324432369|FG000|Overall Study|Decision by Sponsor|2|||
94720166|NCT02376790|324432370|FG001|Overall Study|Decision by Sponsor|1|||
94720167|NCT02376790|324432371|FG002|Overall Study|Decision by Sponsor|4|||
94720168|NCT02376790|324432369|FG000|Overall Study|Lost to Follow-up|15|||
94720169|NCT02376790|324432370|FG001|Overall Study|Lost to Follow-up|10|||
94720170|NCT02376790|324432371|FG002|Overall Study|Lost to Follow-up|12|||
94720171|NCT02814838|324432376|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
94720172|NCT02814838|324432377|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
94720173|NCT02814838|324432376|FG000|Overall Study|Consent withdrawal|1|||
94720174|NCT02814838|324432377|FG001|Overall Study|Consent withdrawal|1|||
94720175|NCT00073749|324432378|FG000|Overall Study|Disease Progression|2|||
94720176|NCT00073749|324432379|FG001|Overall Study|Disease Progression|0|||
94368064|NCT00344305|323134820|FG001|Overall Study|Participant was not contacted in window|1|||
94720177|NCT00073749|324432380|FG002|Overall Study|Disease Progression|3|||
94720178|NCT00073749|324432381|FG003|Overall Study|Disease Progression|2|||
94720179|NCT00073749|324432382|FG004|Overall Study|Disease Progression|3|||
94720180|NCT00073749|324432383|FG005|Overall Study|Disease Progression|1|||
94720181|NCT00073749|324432384|FG006|Overall Study|Disease Progression|3|||
94720182|NCT00073749|324432378|FG000|Overall Study|Death|0|||
94720183|NCT00073749|324432379|FG001|Overall Study|Death|1|||
94720184|NCT00073749|324432380|FG002|Overall Study|Death|1|||
94720185|NCT00073749|324432381|FG003|Overall Study|Death|0|||
94720186|NCT00073749|324432382|FG004|Overall Study|Death|0|||
94720187|NCT00073749|324432383|FG005|Overall Study|Death|0|||
94720188|NCT00073749|324432384|FG006|Overall Study|Death|29|||
94720189|NCT00073749|324432378|FG000|Overall Study|Adverse Event|0|||
94720190|NCT00073749|324432379|FG001|Overall Study|Adverse Event|3|||
94720191|NCT00073749|324432380|FG002|Overall Study|Adverse Event|6|||
94720192|NCT00073749|324432381|FG003|Overall Study|Adverse Event|4|||
94720193|NCT00073749|324432382|FG004|Overall Study|Adverse Event|2|||
94720194|NCT00073749|324432383|FG005|Overall Study|Adverse Event|1|||
94720195|NCT00073749|324432384|FG006|Overall Study|Adverse Event|0|||
94720196|NCT00073749|324432378|FG000|Overall Study|Physician Decision|0|||
94720197|NCT00073749|324432379|FG001|Overall Study|Physician Decision|0|||
94720198|NCT00073749|324432380|FG002|Overall Study|Physician Decision|1|||
94720199|NCT00073749|324432381|FG003|Overall Study|Physician Decision|0|||
94720200|NCT00073749|324432382|FG004|Overall Study|Physician Decision|0|||
94720201|NCT00073749|324432383|FG005|Overall Study|Physician Decision|2|||
94720202|NCT00073749|324432384|FG006|Overall Study|Physician Decision|0|||
94720203|NCT00073749|324432378|FG000|Overall Study|Withdrawal by Subject|0|||
94720204|NCT00073749|324432379|FG001|Overall Study|Withdrawal by Subject|1|||
94720205|NCT00073749|324432380|FG002|Overall Study|Withdrawal by Subject|0|||
94720206|NCT00073749|324432381|FG003|Overall Study|Withdrawal by Subject|0|||
94720207|NCT00073749|324432382|FG004|Overall Study|Withdrawal by Subject|1|||
94720208|NCT00073749|324432383|FG005|Overall Study|Withdrawal by Subject|0|||
94720209|NCT00073749|324432384|FG006|Overall Study|Withdrawal by Subject|2|||
94720210|NCT00073749|324432378|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
94720211|NCT00073749|324432379|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
94720212|NCT00073749|324432380|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
94720213|NCT00073749|324432381|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
94720214|NCT00073749|324432382|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
94720215|NCT00073749|324432383|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
94368065|NCT02162511|323134822|FG000|Overall Study|Lack of Efficacy|0|||
94368066|NCT02162511|323134823|FG001|Overall Study|Lack of Efficacy|0|||
94368067|NCT02162511|323134824|FG002|Overall Study|Lack of Efficacy|2|||
94368068|NCT01160198|323134825|FG000|Overall Study|Withdrawal by Subject|2|||
94368069|NCT01160198|323134826|FG001|Overall Study|Withdrawal by Subject|1|||
94368070|NCT01160198|323134827|FG002|Overall Study|Withdrawal by Subject|0|||
94368071|NCT01160198|323134825|FG000|Overall Study|Adverse Event|0|||
94368072|NCT01160198|323134826|FG001|Overall Study|Adverse Event|1|||
94368073|NCT01160198|323134827|FG002|Overall Study|Adverse Event|0|||
94720216|NCT00073749|324432384|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
94720217|NCT00073749|324432378|FG000|Overall Study|Lost to Follow-up|0|||
94720218|NCT00073749|324432379|FG001|Overall Study|Lost to Follow-up|0|||
94720219|NCT00073749|324432380|FG002|Overall Study|Lost to Follow-up|0|||
94720220|NCT00073749|324432381|FG003|Overall Study|Lost to Follow-up|0|||
94720221|NCT00073749|324432382|FG004|Overall Study|Lost to Follow-up|0|||
94720222|NCT00073749|324432383|FG005|Overall Study|Lost to Follow-up|0|||
94720223|NCT00073749|324432384|FG006|Overall Study|Lost to Follow-up|2|||
94720224|NCT00073749|324432378|FG000|Overall Study|Other|0|||
94720225|NCT00073749|324432379|FG001|Overall Study|Other|0|||
94720226|NCT00073749|324432380|FG002|Overall Study|Other|0|||
94720227|NCT00073749|324432381|FG003|Overall Study|Other|0|||
94720228|NCT00073749|324432382|FG004|Overall Study|Other|0|||
94720229|NCT00073749|324432383|FG005|Overall Study|Other|2|||
94720230|NCT00073749|324432384|FG006|Overall Study|Other|0|||
94720231|NCT03396588|324432385|FG000|Overall Study|Physician Decision|2|||
94720232|NCT03396588|324432386|FG001|Overall Study|Physician Decision|3|||
94720233|NCT05179395|324432387|FG000|Overall Study|Lack of Efficacy|1|||
94720234|NCT00812461|324432390|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
94368074|NCT01160198|323134825|FG000|Overall Study|Lost to Follow-up|0|||
94368075|NCT01160198|323134826|FG001|Overall Study|Lost to Follow-up|1|||
94720235|NCT00812461|324432391|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
94720236|NCT00812461|324432390|FG000|All Treated Patients|Adverse Event|8|||
94720237|NCT00812461|324432391|FG001|All Treated Patients|Adverse Event|15|||
94720238|NCT00812461|324432390|FG000|All Treated Patients|Lack of Efficacy|13|||
94720239|NCT00812461|324432391|FG001|All Treated Patients|Lack of Efficacy|7|||
94368076|NCT01160198|323134827|FG002|Overall Study|Lost to Follow-up|0|||
94467333|NCT00306787|323500508|FG001|Overall Study|Lost to Follow-up|6|||
94720240|NCT00812461|324432390|FG000|All Treated Patients|Non-compliance|6|||
94720241|NCT00812461|324432391|FG001|All Treated Patients|Non-compliance|9|||
94720242|NCT00812461|324432390|FG000|All Treated Patients|Protocol Violation|36|||
94720243|NCT00812461|324432391|FG001|All Treated Patients|Protocol Violation|27|||
94720244|NCT00812461|324432390|FG000|All Treated Patients|Withdrawal by Subject|45|||
94720245|NCT00812461|324432391|FG001|All Treated Patients|Withdrawal by Subject|54|||
94720246|NCT00812461|324432390|FG000|All Treated Patients|Lost to Follow-up|11|||
94720247|NCT00812461|324432391|FG001|All Treated Patients|Lost to Follow-up|14|||
94720248|NCT00812461|324432390|FG000|All Treated Patients|Other Reason|13|||
94720249|NCT00812461|324432391|FG001|All Treated Patients|Other Reason|21|||
94720250|NCT01600014|324433896|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
94720251|NCT01600014|324433897|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
94720252|NCT01600014|324433896|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
94720253|NCT01600014|324433897|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
94720254|NCT01600014|324433896|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
94720255|NCT01600014|324433897|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
94720256|NCT01600014|324433896|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
94720257|NCT01600014|324433897|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
94720258|NCT01600014|324433896|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
94720259|NCT01600014|324433897|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
94720260|NCT01600014|324433896|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
94720261|NCT01600014|324433897|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
94720262|NCT01600014|324433896|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
94720263|NCT01600014|324433897|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
94720264|NCT01600014|324433896|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
94720265|NCT01600014|324433897|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
94720266|NCT01600014|324433896|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
94720267|NCT01600014|324433897|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
94720268|NCT01600014|324433896|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
94720269|NCT01600014|324433897|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
94720270|NCT01600014|324433896|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
94720271|NCT01600014|324433897|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
94720272|NCT01600014|324433896|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
94720273|NCT01600014|324433897|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
94720274|NCT01600014|324433896|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
94720275|NCT01600014|324433897|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
94720276|NCT01600014|324433896|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
94720277|NCT01600014|324433897|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
94720278|NCT01600014|324433896|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
94720279|NCT01600014|324433897|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
94720280|NCT01600014|324433896|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
94720281|NCT01600014|324433897|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
94720282|NCT01600014|324433896|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
94720283|NCT01600014|324433897|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
94720284|NCT00788671|324433898|FG000|Overall Study|Death|2|||
94720285|NCT00788671|324433898|FG000|Overall Study|Unable to biopsy|1|||
94720286|NCT00788671|324433898|FG000|Overall Study|Withdrawal by Subject|4|||
94720287|NCT00788671|324433898|FG000|Overall Study|IUD expulsed|1|||
94720288|NCT00788671|324433898|FG000|Overall Study|Lost to follow up|2|||
94720289|NCT02392429|324433900|FG000|Screening|Screen failure|15|||
94720290|NCT02392429|324433900|FG000|Enrolled Participants|Ineligible due to disease|3|||
94720291|NCT02392429|324433900|FG000|Enrolled Participants|Withdrawal by Subject|4|||
94720292|NCT02392429|324433900|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
94720293|NCT02392429|324433900|FG000|Evaluable|Death|5|||
94720294|NCT02392429|324433900|FG000|Evaluable|Withdrawal by Subject|1|||
94720295|NCT02392429|324433900|FG000|Evaluable|Adverse Event|1|||
94720296|NCT02392429|324433900|FG000|Evaluable|remission bone marrow biopsy|3|||
94720297|NCT05386238|324433908|FG000|Overall Study|Lost to Follow-up|3|||
94720298|NCT05386238|324433909|FG001|Overall Study|Lost to Follow-up|2|||
94720299|NCT05386238|324433908|FG000|Overall Study|Withdrawal by Subject|0|||
94720300|NCT05386238|324433909|FG001|Overall Study|Withdrawal by Subject|1|||
94720301|NCT05307978|324433910|FG000|Overall Study|Lost to Follow-up|0|||
94720302|NCT05307978|324433911|FG001|Overall Study|Lost to Follow-up|1|||
94720303|NCT05307978|324433912|FG002|Overall Study|Lost to Follow-up|0|||
94720304|NCT05307978|324433913|FG003|Overall Study|Lost to Follow-up|4|||
94720305|NCT05307978|324433914|FG004|Overall Study|Lost to Follow-up|0|||
94720306|NCT05307978|324433915|FG005|Overall Study|Lost to Follow-up|0|||
94720307|NCT05307978|324433916|FG006|Overall Study|Lost to Follow-up|1|||
94720308|NCT03547908|324433917|FG000|Blinded Phase|Lost to Follow-up|3|||
94720309|NCT03547908|324433918|FG001|Blinded Phase|Lost to Follow-up|3|||
94368077|NCT01160198|323134825|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
94720310|NCT03547908|324433919|FG002|Blinded Phase|Lost to Follow-up|0|||
94720311|NCT03547908|324433920|FG003|Blinded Phase|Lost to Follow-up|0|||
94720312|NCT03547908|324433917|FG000|Blinded Phase|Withdrew Consent|2|||
94720313|NCT03547908|324433918|FG001|Blinded Phase|Withdrew Consent|3|||
94720314|NCT03547908|324433919|FG002|Blinded Phase|Withdrew Consent|0|||
94720315|NCT03547908|324433920|FG003|Blinded Phase|Withdrew Consent|0|||
94720316|NCT03547908|324433917|FG000|Blinded Phase|Investigator's Discretion|2|||
94720317|NCT03547908|324433918|FG001|Blinded Phase|Investigator's Discretion|1|||
94720318|NCT03547908|324433919|FG002|Blinded Phase|Investigator's Discretion|0|||
94720319|NCT03547908|324433920|FG003|Blinded Phase|Investigator's Discretion|0|||
94720320|NCT03547908|324433917|FG000|Blinded Phase|Death|2|||
94720321|NCT03547908|324433918|FG001|Blinded Phase|Death|0|||
94720322|NCT03547908|324433919|FG002|Blinded Phase|Death|0|||
94720323|NCT03547908|324433920|FG003|Blinded Phase|Death|0|||
94720324|NCT03547908|324433917|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
94720325|NCT03547908|324433918|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
94720326|NCT03547908|324433919|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
94720327|NCT03547908|324433920|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
94720328|NCT03547908|324433917|FG000|Blinded Phase|Adverse Event|1|||
94720329|NCT03547908|324433918|FG001|Blinded Phase|Adverse Event|0|||
94720330|NCT03547908|324433919|FG002|Blinded Phase|Adverse Event|0|||
94720331|NCT03547908|324433920|FG003|Blinded Phase|Adverse Event|0|||
94720332|NCT03547908|324433917|FG000|Blinded Phase|Randomized But Never Treated|1|||
94720333|NCT03547908|324433918|FG001|Blinded Phase|Randomized But Never Treated|0|||
94720334|NCT03547908|324433919|FG002|Blinded Phase|Randomized But Never Treated|0|||
94720335|NCT03547908|324433920|FG003|Blinded Phase|Randomized But Never Treated|0|||
94720336|NCT03547908|324433917|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
94720337|NCT03547908|324433918|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
94720338|NCT03547908|324433919|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
94720339|NCT03547908|324433920|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
94720340|NCT03547908|324433917|FG000|Open-label Extension Phase|Death|0|||
94720341|NCT03547908|324433918|FG001|Open-label Extension Phase|Death|0|||
94720342|NCT03547908|324433919|FG002|Open-label Extension Phase|Death|1|||
94720343|NCT03547908|324433920|FG003|Open-label Extension Phase|Death|0|||
94720344|NCT04607044|324433921|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
94720345|NCT04607044|324433921|FG000|Overall Study|Adverse Event|1|||
94720346|NCT04607044|324433921|FG000|Overall Study|Did not receive study device|3|||
94720347|NCT04607044|324433921|FG000|Overall Study|Death|1|||
94720348|NCT04883645|324433922|FG000|Overall Study|Death|1|||
94720349|NCT02473250|324433923|FG000|Overall Study|Lost to Follow-up|10|||
94720350|NCT02473250|324433923|FG000|Overall Study|Physician Decision|5|||
94720351|NCT02473250|324433923|FG000|Overall Study|Did not tolerate medication washout|3|||
94720352|NCT02473250|324433923|FG000|Overall Study|Antidepressant effect of divalproex|2|||
94720353|NCT05113966|324433924|FG000|Overall Study|Death|21|||
94720354|NCT05113966|324433924|FG000|Overall Study|Study Terminated by Sponsor|9|||
94720355|NCT03833245|324433927|FG000|Overall Study|Death|0|||
94720356|NCT03833245|324433928|FG001|Overall Study|Death|1|||
94720357|NCT05439603|324433930|FG000|Overall Study|met withdrawal criteria|2|||
94720358|NCT05418296|324433931|FG000|Overall Study|Withdrawal by Subject|4|||
94720359|NCT05418296|324433932|FG001|Overall Study|Withdrawal by Subject|1|||
94720360|NCT05382936|324433933|FG000|Overall Study|Progressive Disease|3|||
94720361|NCT05382936|324433934|FG001|Overall Study|Progressive Disease|5|||
94720362|NCT05382936|324433935|FG002|Overall Study|Progressive Disease|2|||
94720363|NCT05382936|324433936|FG003|Overall Study|Progressive Disease|5|||
94720364|NCT05382936|324433933|FG000|Overall Study|Adverse Event|0|||
94720365|NCT05382936|324433934|FG001|Overall Study|Adverse Event|1|||
94720366|NCT05382936|324433935|FG002|Overall Study|Adverse Event|1|||
94720367|NCT05382936|324433936|FG003|Overall Study|Adverse Event|0|||
94720368|NCT05382936|324433933|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
94720369|NCT05382936|324433934|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
94720370|NCT05382936|324433935|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
94720371|NCT05382936|324433936|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
94720372|NCT05382936|324433933|FG000|Overall Study|Withdrawal by Subject|0|||
94720373|NCT05382936|324433934|FG001|Overall Study|Withdrawal by Subject|0|||
94720374|NCT05382936|324433935|FG002|Overall Study|Withdrawal by Subject|1|||
94720375|NCT05382936|324433936|FG003|Overall Study|Withdrawal by Subject|1|||
94720376|NCT05268302|324433937|FG000|Overall Study|Death|0|||
94720377|NCT05268302|324433938|FG001|Overall Study|Death|1|||
94720378|NCT02063724|324433939|FG000|Overall Study|Disease progression|1|||
94720379|NCT04436107|324433940|FG000|Overall Study|Sponsor Ended Study|2|||
94720380|NCT04436107|324433941|FG001|Overall Study|Sponsor Ended Study|4|||
94720381|NCT04436107|324433942|FG002|Overall Study|Sponsor Ended Study|8|||
94720382|NCT04436107|324433943|FG003|Overall Study|Sponsor Ended Study|20|||
94720383|NCT04436107|324433940|FG000|Overall Study|Death|3|||
94720384|NCT04436107|324433941|FG001|Overall Study|Death|5|||
94720385|NCT04436107|324433942|FG002|Overall Study|Death|3|||
94720386|NCT04436107|324433943|FG003|Overall Study|Death|18|||
94720387|NCT04436107|324433940|FG000|Overall Study|Withdrawal by Subject|1|||
94368078|NCT01160198|323134826|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
94720388|NCT04436107|324433941|FG001|Overall Study|Withdrawal by Subject|1|||
94720389|NCT04436107|324433942|FG002|Overall Study|Withdrawal by Subject|0|||
94720390|NCT04436107|324433943|FG003|Overall Study|Withdrawal by Subject|1|||
94720391|NCT04116736|324433944|FG000|Overall Study|Withdrew consent during study|3|||
94720392|NCT04116736|324433945|FG001|Overall Study|Withdrew consent during study|1|||
94720393|NCT04116736|324433944|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
94720394|NCT04116736|324433945|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
94720395|NCT04116736|324433944|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
94720396|NCT04116736|324433945|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
94720397|NCT04116736|324433944|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
94720398|NCT04116736|324433945|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
94720399|NCT04116736|324433944|FG000|Overall Study|Subject was enrolled in error|2|||
94720400|NCT04116736|324433945|FG001|Overall Study|Subject was enrolled in error|0|||
94720401|NCT04116736|324433944|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
94720402|NCT04116736|324433945|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
94720403|NCT04116736|324433944|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
94720404|NCT04116736|324433945|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
94720405|NCT04116736|324433944|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
94720406|NCT04116736|324433945|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
94720407|NCT03473743|324433950|FG000|Overall Study|Withdrawal by Subject|0|||
94720408|NCT03473743|324433951|FG001|Overall Study|Withdrawal by Subject|0|||
94720409|NCT03473743|324433952|FG002|Overall Study|Withdrawal by Subject|0|||
94720410|NCT03473743|324433953|FG003|Overall Study|Withdrawal by Subject|0|||
94720411|NCT03473743|324433954|FG004|Overall Study|Withdrawal by Subject|0|||
94720412|NCT03473743|324433955|FG005|Overall Study|Withdrawal by Subject|0|||
94720413|NCT03473743|324433956|FG006|Overall Study|Withdrawal by Subject|0|||
94720414|NCT03473743|324433957|FG007|Overall Study|Withdrawal by Subject|3|||
94720415|NCT03473743|324433950|FG000|Overall Study|Other|0|||
94720416|NCT03473743|324433951|FG001|Overall Study|Other|0|||
94720417|NCT03473743|324433952|FG002|Overall Study|Other|0|||
94720418|NCT03473743|324433953|FG003|Overall Study|Other|1|||
94720419|NCT03473743|324433954|FG004|Overall Study|Other|0|||
94720420|NCT03473743|324433955|FG005|Overall Study|Other|0|||
94720421|NCT03473743|324433956|FG006|Overall Study|Other|0|||
94720422|NCT03473743|324433957|FG007|Overall Study|Other|0|||
94720423|NCT03473743|324433950|FG000|Overall Study|Ongoing|0|||
94720424|NCT03473743|324433951|FG001|Overall Study|Ongoing|0|||
94720425|NCT03473743|324433952|FG002|Overall Study|Ongoing|6|||
94720426|NCT03473743|324433953|FG003|Overall Study|Ongoing|8|||
94720427|NCT03473743|324433954|FG004|Overall Study|Ongoing|1|||
94720428|NCT03473743|324433955|FG005|Overall Study|Ongoing|1|||
94720429|NCT03473743|324433956|FG006|Overall Study|Ongoing|22|||
94720430|NCT03473743|324433957|FG007|Overall Study|Ongoing|24|||
94720431|NCT03473743|324433950|FG000|Overall Study|Randomized but not treated|0|||
94720432|NCT03473743|324433951|FG001|Overall Study|Randomized but not treated|0|||
94720433|NCT03473743|324433952|FG002|Overall Study|Randomized but not treated|0|||
94720434|NCT03473743|324433953|FG003|Overall Study|Randomized but not treated|0|||
94720435|NCT03473743|324433954|FG004|Overall Study|Randomized but not treated|0|||
94720436|NCT03473743|324433955|FG005|Overall Study|Randomized but not treated|0|||
94720437|NCT03473743|324433956|FG006|Overall Study|Randomized but not treated|1|||
94720438|NCT03473743|324433957|FG007|Overall Study|Randomized but not treated|1|||
94720439|NCT02811679|324433958|FG000|Overall Study|Adverse Event|1|||
94720440|NCT02811679|324433958|FG000|Overall Study|Lack of Efficacy|6|||
94720441|NCT02811679|324433958|FG000|Overall Study|Early study closure due to slow accrual|3|||
94720442|NCT04472429|324433963|FG000|Randomized Period|Ongoing|90|||
94720443|NCT04472429|324433964|FG001|Randomized Period|Ongoing|40|||
94720444|NCT04472429|324433965|FG002|Randomized Period|Ongoing|0|||
94368079|NCT01160198|323134827|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
94368080|NCT01408576|323134828|FG000|Overall Study|Lack of Efficacy|17|||
94368081|NCT01408576|323134829|FG001|Overall Study|Lack of Efficacy|30|||
94368082|NCT01408576|323134830|FG002|Overall Study|Lack of Efficacy|48|||
94368083|NCT01408576|323134828|FG000|Overall Study|Protocol Violation|1|||
94720445|NCT04472429|324433963|FG000|Randomized Period|Death|52|||
94720446|NCT04472429|324433964|FG001|Randomized Period|Death|37|||
94720447|NCT04472429|324433965|FG002|Randomized Period|Death|0|||
94368084|NCT01408576|323134829|FG001|Overall Study|Protocol Violation|2|||
94720448|NCT04472429|324433963|FG000|Randomized Period|Lost to Follow-up|4|||
94720449|NCT04472429|324433964|FG001|Randomized Period|Lost to Follow-up|0|||
94720450|NCT04472429|324433965|FG002|Randomized Period|Lost to Follow-up|0|||
94720451|NCT04472429|324433963|FG000|Randomized Period|Physician Decision|1|||
94720452|NCT04472429|324433964|FG001|Randomized Period|Physician Decision|2|||
94720453|NCT04472429|324433965|FG002|Randomized Period|Physician Decision|0|||
94720454|NCT04472429|324433963|FG000|Randomized Period|Withdrawal by Subject|6|||
94720455|NCT04472429|324433964|FG001|Randomized Period|Withdrawal by Subject|5|||
94720456|NCT04472429|324433965|FG002|Randomized Period|Withdrawal by Subject|0|||
94720457|NCT04472429|324433963|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
94720458|NCT04472429|324433964|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
94720459|NCT04472429|324433965|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
94720460|NCT04472429|324433963|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
94720461|NCT04472429|324433964|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
94720462|NCT04472429|324433965|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
94720463|NCT04472429|324433963|FG000|Open-label Monotherapy Period|Ongoing|0|||
94720464|NCT04472429|324433964|FG001|Open-label Monotherapy Period|Ongoing|0|||
94720465|NCT04472429|324433965|FG002|Open-label Monotherapy Period|Ongoing|32|||
94720466|NCT04472429|324433963|FG000|Open-label Monotherapy Period|Death|0|||
94720467|NCT04472429|324433964|FG001|Open-label Monotherapy Period|Death|0|||
94720468|NCT04472429|324433965|FG002|Open-label Monotherapy Period|Death|35|||
94720469|NCT04472429|324433963|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
94720470|NCT04472429|324433964|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
94720471|NCT04472429|324433965|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
94720472|NCT04251533|324433966|FG000|Overall Study|Progressive disease|33|||
94720473|NCT04251533|324433967|FG001|Overall Study|Progressive disease|29|||
94720474|NCT04251533|324433968|FG002|Overall Study|Progressive disease|22|||
94720475|NCT04251533|324433966|FG000|Overall Study|Death|5|||
94720476|NCT04251533|324433967|FG001|Overall Study|Death|1|||
94720477|NCT04251533|324433968|FG002|Overall Study|Death|3|||
94720478|NCT04251533|324433966|FG000|Overall Study|Physician Decision|3|||
94720479|NCT04251533|324433967|FG001|Overall Study|Physician Decision|2|||
94720480|NCT04251533|324433968|FG002|Overall Study|Physician Decision|4|||
94720481|NCT04251533|324433966|FG000|Overall Study|Participant decision|1|||
94720482|NCT04251533|324433967|FG001|Overall Study|Participant decision|3|||
94720483|NCT04251533|324433968|FG002|Overall Study|Participant decision|1|||
94720484|NCT04251533|324433966|FG000|Overall Study|Adverse Event|2|||
94720485|NCT04251533|324433967|FG001|Overall Study|Adverse Event|1|||
94720486|NCT04251533|324433968|FG002|Overall Study|Adverse Event|1|||
94720487|NCT03462719|324433969|FG000|Overall Study|Withdrawal by Subject|4|||
94720488|NCT03462719|324433970|FG001|Overall Study|Withdrawal by Subject|3|||
94720489|NCT03462719|324433969|FG000|Overall Study|Ongoing|87|||
94720490|NCT03462719|324433970|FG001|Overall Study|Ongoing|72|||
94720491|NCT04314895|324433971|FG000|Overall Study|Lost to Follow-up|1|||
94720492|NCT04314895|324433971|FG000|Overall Study|Death|10|||
94720493|NCT04314895|324433971|FG000|Overall Study|Physician Decision|2|||
94720494|NCT03941860|324433972|FG000|Overall Study|Withdrawal by Subject|0|||
94720495|NCT03941860|324433973|FG001|Overall Study|Withdrawal by Subject|1|||
94720496|NCT03361748|324433977|FG000|Overall Study|Death|77|||
94720497|NCT03361748|324433977|FG000|Overall Study|Lost to Follow-up|4|||
94720498|NCT03361748|324433977|FG000|Overall Study|Withdrawal by Subject|20|||
94720499|NCT02516241|324433978|FG000|Overall Study|Death|255|||
94720500|NCT02516241|324433979|FG001|Overall Study|Death|262|||
94720501|NCT02516241|324433980|FG002|Overall Study|Death|270|||
94720502|NCT02516241|324433978|FG000|Overall Study|Lost to Follow-up|1|||
94720503|NCT02516241|324433979|FG001|Overall Study|Lost to Follow-up|1|||
94720504|NCT02516241|324433980|FG002|Overall Study|Lost to Follow-up|3|||
94720505|NCT02516241|324433978|FG000|Overall Study|Withdrawal by Subject|2|||
94720506|NCT02516241|324433979|FG001|Overall Study|Withdrawal by Subject|7|||
94720507|NCT02516241|324433980|FG002|Overall Study|Withdrawal by Subject|12|||
94720508|NCT02516241|324433978|FG000|Overall Study|participants ongoing at data cut-off|84|||
94720509|NCT02516241|324433979|FG001|Overall Study|participants ongoing at data cut-off|76|||
94720510|NCT02516241|324433980|FG002|Overall Study|participants ongoing at data cut-off|59|||
94720511|NCT04093752|324433981|FG000|Overall Study|Adverse Event|7|||
94720512|NCT04093752|324433982|FG001|Overall Study|Adverse Event|19|||
94720513|NCT04093752|324433983|FG002|Overall Study|Adverse Event|18|||
94720514|NCT04093752|324433984|FG003|Overall Study|Adverse Event|4|||
94720515|NCT04093752|324433981|FG000|Overall Study|Withdrawal by Subject|6|||
94720516|NCT04093752|324433982|FG001|Overall Study|Withdrawal by Subject|6|||
94720517|NCT04093752|324433983|FG002|Overall Study|Withdrawal by Subject|8|||
94720518|NCT04093752|324433984|FG003|Overall Study|Withdrawal by Subject|20|||
94720519|NCT04093752|324433981|FG000|Overall Study|Lost to Follow-up|2|||
94720520|NCT04093752|324433982|FG001|Overall Study|Lost to Follow-up|1|||
94720521|NCT04093752|324433983|FG002|Overall Study|Lost to Follow-up|1|||
94720522|NCT04093752|324433984|FG003|Overall Study|Lost to Follow-up|1|||
94720523|NCT04093752|324433981|FG000|Overall Study|Death|0|||
94720524|NCT04093752|324433982|FG001|Overall Study|Death|0|||
94720525|NCT04093752|324433983|FG002|Overall Study|Death|1|||
94720526|NCT04093752|324433984|FG003|Overall Study|Death|2|||
94720527|NCT04093752|324433981|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
94720528|NCT04093752|324433982|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
94720529|NCT04093752|324433983|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
94720530|NCT04093752|324433984|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
94720531|NCT04093752|324433981|FG000|Overall Study|Covid 19|0|||
94720532|NCT04093752|324433982|FG001|Overall Study|Covid 19|0|||
94720533|NCT04093752|324433983|FG002|Overall Study|Covid 19|0|||
94720534|NCT04093752|324433984|FG003|Overall Study|Covid 19|1|||
94720535|NCT04093752|324433981|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
94720536|NCT04093752|324433982|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
94720537|NCT04093752|324433983|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
94720538|NCT04093752|324433984|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
94720539|NCT04093752|324433981|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
94720540|NCT04093752|324433982|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
94720541|NCT04093752|324433983|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
94720542|NCT04093752|324433984|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
94720543|NCT04093752|324433981|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
94720544|NCT04093752|324433982|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
94720545|NCT04093752|324433983|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
94720546|NCT04093752|324433984|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
94720547|NCT01101451|324433985|FG000|Overall Study|Eligible and never treated|0|||
94720548|NCT01101451|324433986|FG001|Overall Study|Eligible and never treated|5|||
94720549|NCT01101451|324433985|FG000|Overall Study|Ineligible and treated|12|||
94720550|NCT01101451|324433986|FG001|Overall Study|Ineligible and treated|8|||
94720551|NCT01101451|324433985|FG000|Overall Study|Ineligible and never treated|2|||
94720552|NCT01101451|324433986|FG001|Overall Study|Ineligible and never treated|2|||
94720553|NCT04854096|324433987|FG000|Overall Study|Adverse Event|1|||
94720554|NCT04854096|324433988|FG001|Overall Study|Adverse Event|0|||
94720555|NCT04854096|324433987|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
94720556|NCT04854096|324433988|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
94720557|NCT04854096|324433987|FG000|Overall Study|Withdrawal by Subject|1|||
94720558|NCT04854096|324433988|FG001|Overall Study|Withdrawal by Subject|0|||
94720559|NCT04854096|324433987|FG000|Overall Study|Other reasons|1|||
94720560|NCT04854096|324433988|FG001|Overall Study|Other reasons|0|||
94720561|NCT02829918|324433989|FG000|Overall Study|Death|2|||
94720562|NCT02829918|324433989|FG000|Overall Study|Withdrawal by Subject|4|||
94720563|NCT02829918|324433989|FG000|Overall Study|Adverse Event|1|||
94720564|NCT02829918|324433989|FG000|Overall Study|Progression|1|||
94720565|NCT01361711|324433992|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
94720566|NCT01361711|324433992|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
94720567|NCT01361711|324433992|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
94720568|NCT01361711|324433992|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
94720569|NCT01361711|324433992|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
94720570|NCT01361711|324433992|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
94720571|NCT01361711|324433992|FG000|Completed Week 18 of Treatment|Other|9|||
94720572|NCT01361711|324433992|FG000|10 Year Follow-up|Still in follow-up|22|||
94720573|NCT01361711|324433992|FG000|10 Year Follow-up|Death|7|||
94720574|NCT01361711|324433992|FG000|10 Year Follow-up|Developed new cancer|1|||
94720575|NCT01361711|324433992|FG000|10 Year Follow-up|Lost to Follow-up|2|||
94720576|NCT01361711|324433992|FG000|10 Year Follow-up|New treatment started|6|||
94720577|NCT01361711|324433992|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
94720578|NCT01361711|324433992|FG000|10 Year Follow-up|Progressive Disease|1|||
94720579|NCT02596126|324433993|FG000|Overall Study|Lost to Follow-up|12|||
94720580|NCT02596126|324433994|FG001|Overall Study|Lost to Follow-up|21|||
94720581|NCT02596126|324433993|FG000|Overall Study|Protocol Violation|7|||
94720582|NCT02596126|324433994|FG001|Overall Study|Protocol Violation|9|||
94720583|NCT03492177|324433995|FG000|Overall Study|Adverse Event|1|||
94720584|NCT03492177|324433996|FG001|Overall Study|Adverse Event|0|||
94720585|NCT03492177|324433997|FG002|Overall Study|Adverse Event|0|||
94720586|NCT03492177|324433995|FG000|Overall Study|Death|3|||
94720587|NCT03492177|324433996|FG001|Overall Study|Death|0|||
94720588|NCT03492177|324433997|FG002|Overall Study|Death|3|||
94368085|NCT01408576|323134830|FG002|Overall Study|Protocol Violation|2|||
94368086|NCT01408576|323134828|FG000|Overall Study|Lost to Follow-up|10|||
94720589|NCT03492177|324433995|FG000|Overall Study|Lack of Efficacy|1|||
94720590|NCT03492177|324433996|FG001|Overall Study|Lack of Efficacy|2|||
94720591|NCT03492177|324433997|FG002|Overall Study|Lack of Efficacy|0|||
94720592|NCT03492177|324433995|FG000|Overall Study|Other|1|||
94720593|NCT03492177|324433996|FG001|Overall Study|Other|0|||
94720594|NCT03492177|324433997|FG002|Overall Study|Other|0|||
94720595|NCT03492177|324433995|FG000|Overall Study|Ongoing|16|||
94368087|NCT01408576|323134829|FG001|Overall Study|Lost to Follow-up|9|||
94368088|NCT01408576|323134830|FG002|Overall Study|Lost to Follow-up|17|||
94720596|NCT03492177|324433996|FG001|Overall Study|Ongoing|19|||
94720597|NCT03492177|324433997|FG002|Overall Study|Ongoing|17|||
94720598|NCT04442126|324434001|FG000|Overall Study|Withdrawal by Subject|0|||
94720599|NCT04442126|324434002|FG001|Overall Study|Withdrawal by Subject|0|||
94368089|NCT01408576|323134828|FG000|Overall Study|Withdrawal by Subject|34|||
94720600|NCT04442126|324434003|FG002|Overall Study|Withdrawal by Subject|0|||
94720601|NCT04442126|324434004|FG003|Overall Study|Withdrawal by Subject|2|||
94720602|NCT04442126|324434005|FG004|Overall Study|Withdrawal by Subject|1|||
94655322|NCT00022516|324195968|FG000|Overall Study|Withdrawal by Subject|2|||
94655323|NCT00022516|324195969|FG001|Overall Study|Withdrawal by Subject|113|||
94655324|NCT00022516|324195968|FG000|Overall Study|Incomplete documentation|0|||
94655325|NCT00022516|324195969|FG001|Overall Study|Incomplete documentation|27|||
94655326|NCT02410811|324195970|FG000|Overall Study|Withdrawal by Subject|0|||
94655327|NCT02410811|324195971|FG001|Overall Study|Withdrawal by Subject|0|||
94655328|NCT02410811|324195972|FG002|Overall Study|Withdrawal by Subject|1|||
94655329|NCT02410811|324195973|FG003|Overall Study|Withdrawal by Subject|0|||
94655330|NCT02799082|324195976|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
94655331|NCT02799082|324195977|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
94655332|NCT02799082|324195976|FG000|Overall Study|Protocol Violation|0|||
94655333|NCT02799082|324195977|FG001|Overall Study|Protocol Violation|1|||
94655334|NCT03783923|324195978|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
94655335|NCT03783923|324195979|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
94655336|NCT03783923|324195978|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
94655337|NCT03783923|324195979|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
94655338|NCT03783923|324195978|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
94655339|NCT03783923|324195979|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
94655340|NCT03783923|324195978|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
94655341|NCT03783923|324195979|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
94655342|NCT03783923|324195978|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
94655343|NCT03783923|324195979|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
94655344|NCT01592708|324195980|FG000|Overall Study|Protocol Violation|3|||
94655345|NCT01592708|324195981|FG001|Overall Study|Protocol Violation|0|||
94655346|NCT03433456|324195984|FG000|Overall Study|Death|1|||
94655347|NCT03433456|324195985|FG001|Overall Study|Death|1|||
94655348|NCT03433456|324195984|FG000|Overall Study|Lost to Follow-up|14|||
94655349|NCT03433456|324195985|FG001|Overall Study|Lost to Follow-up|11|||
94655350|NCT03433456|324195984|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
94655351|NCT03433456|324195985|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
94655352|NCT01785602|324195991|FG000|Overall Study|Withdrawal by Subject|2|||
94655353|NCT01785602|324195992|FG001|Overall Study|Withdrawal by Subject|0|||
94655354|NCT01785602|324195991|FG000|Overall Study|Lost to Follow-up|1|||
94655355|NCT01785602|324195992|FG001|Overall Study|Lost to Follow-up|1|||
94655356|NCT01785602|324195991|FG000|Overall Study|Adverse Event|3|||
94655357|NCT01785602|324195992|FG001|Overall Study|Adverse Event|5|||
94655358|NCT01785602|324195991|FG000|Overall Study|Administrative problems|7|||
94655359|NCT01785602|324195992|FG001|Overall Study|Administrative problems|3|||
94655360|NCT02041429|324195993|FG000|Overall Study|Progressive Disease|2|||
94655361|NCT02041429|324195994|FG001|Overall Study|Progressive Disease|2|||
94655362|NCT02041429|324195995|FG002|Overall Study|Progressive Disease|3|||
94655363|NCT02041429|324195996|FG003|Overall Study|Progressive Disease|2|||
94655364|NCT02041429|324195993|FG000|Overall Study|Toxicity|0|||
94655365|NCT02041429|324195994|FG001|Overall Study|Toxicity|1|||
94655366|NCT02041429|324195995|FG002|Overall Study|Toxicity|4|||
94655367|NCT02041429|324195996|FG003|Overall Study|Toxicity|2|||
94655368|NCT02041429|324195993|FG000|Overall Study|Withdrawal by Subject|0|||
94655369|NCT02041429|324195994|FG001|Overall Study|Withdrawal by Subject|1|||
94655370|NCT02041429|324195995|FG002|Overall Study|Withdrawal by Subject|0|||
94655371|NCT02041429|324195996|FG003|Overall Study|Withdrawal by Subject|0|||
94655372|NCT02041429|324195993|FG000|Overall Study|On Maintenance Therapy|1|||
94655373|NCT02041429|324195994|FG001|Overall Study|On Maintenance Therapy|0|||
94655374|NCT02041429|324195995|FG002|Overall Study|On Maintenance Therapy|0|||
94655375|NCT02041429|324195996|FG003|Overall Study|On Maintenance Therapy|2|||
94655376|NCT01669343|324196007|FG000|Part A: All Patients|Withdrawal by Subject|7|||
94655377|NCT01669343|324196007|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
94655378|NCT01669343|324196007|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
94655379|NCT01669343|324196007|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
94655380|NCT01669343|324196007|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
94655381|NCT01591681|324196010|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
94655382|NCT01591681|324196010|FG000|Overall Study|Failed to use system during run-in|1|||
94655383|NCT00835406|324196011|FG000|Period: First Intervention|Adverse Event|0|||
94655384|NCT00835406|324196012|FG001|Period: First Intervention|Adverse Event|1|||
94655385|NCT00835406|324196011|FG000|Period: First Intervention|Withdrawal by Subject|2|||
94655386|NCT00835406|324196012|FG001|Period: First Intervention|Withdrawal by Subject|0|||
94655387|NCT00835406|324196011|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
94655388|NCT00835406|324196012|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
94655389|NCT01866709|324196015|FG000|Overall Study|Adverse Event|1|||
94655390|NCT01866709|324196016|FG001|Overall Study|Adverse Event|0|||
94720603|NCT04442126|324434006|FG005|Overall Study|Withdrawal by Subject|0|||
94720604|NCT04442126|324434007|FG006|Overall Study|Withdrawal by Subject|1|||
94720605|NCT04442126|324434008|FG007|Overall Study|Withdrawal by Subject|1|||
94720606|NCT04442126|324434009|FG008|Overall Study|Withdrawal by Subject|3|||
94720607|NCT04442126|324434001|FG000|Overall Study|Death|1|||
94720608|NCT04442126|324434002|FG001|Overall Study|Death|0|||
94720609|NCT04442126|324434003|FG002|Overall Study|Death|0|||
94720610|NCT04442126|324434004|FG003|Overall Study|Death|1|||
94720611|NCT04442126|324434005|FG004|Overall Study|Death|2|||
94720612|NCT04442126|324434006|FG005|Overall Study|Death|2|||
94720613|NCT04442126|324434007|FG006|Overall Study|Death|4|||
94720614|NCT04442126|324434008|FG007|Overall Study|Death|1|||
94720615|NCT04442126|324434009|FG008|Overall Study|Death|5|||
94720616|NCT04442126|324434001|FG000|Overall Study|Study Terminated by Sponsor|0|||
94720617|NCT04442126|324434002|FG001|Overall Study|Study Terminated by Sponsor|0|||
94720618|NCT04442126|324434003|FG002|Overall Study|Study Terminated by Sponsor|0|||
94720619|NCT04442126|324434004|FG003|Overall Study|Study Terminated by Sponsor|0|||
94720620|NCT04442126|324434005|FG004|Overall Study|Study Terminated by Sponsor|0|||
94720621|NCT04442126|324434006|FG005|Overall Study|Study Terminated by Sponsor|1|||
94720622|NCT04442126|324434007|FG006|Overall Study|Study Terminated by Sponsor|4|||
94720623|NCT04442126|324434008|FG007|Overall Study|Study Terminated by Sponsor|2|||
94720624|NCT04442126|324434009|FG008|Overall Study|Study Terminated by Sponsor|10|||
94720625|NCT04442126|324434001|FG000|Overall Study|Lost to Follow-up|0|||
94720626|NCT04442126|324434002|FG001|Overall Study|Lost to Follow-up|0|||
94720627|NCT04442126|324434003|FG002|Overall Study|Lost to Follow-up|0|||
94720628|NCT04442126|324434004|FG003|Overall Study|Lost to Follow-up|0|||
94720629|NCT04442126|324434005|FG004|Overall Study|Lost to Follow-up|0|||
94720630|NCT04442126|324434006|FG005|Overall Study|Lost to Follow-up|0|||
94720631|NCT04442126|324434007|FG006|Overall Study|Lost to Follow-up|0|||
94720632|NCT04442126|324434008|FG007|Overall Study|Lost to Follow-up|1|||
94720633|NCT04442126|324434009|FG008|Overall Study|Lost to Follow-up|2|||
94720634|NCT04442126|324434001|FG000|Overall Study|Progressive Disease|0|||
94720635|NCT04442126|324434002|FG001|Overall Study|Progressive Disease|1|||
94720636|NCT04442126|324434003|FG002|Overall Study|Progressive Disease|3|||
94720637|NCT04442126|324434004|FG003|Overall Study|Progressive Disease|0|||
94720638|NCT04442126|324434005|FG004|Overall Study|Progressive Disease|3|||
94720639|NCT04442126|324434006|FG005|Overall Study|Progressive Disease|0|||
94720640|NCT04442126|324434007|FG006|Overall Study|Progressive Disease|0|||
94720641|NCT04442126|324434008|FG007|Overall Study|Progressive Disease|0|||
94720642|NCT04442126|324434009|FG008|Overall Study|Progressive Disease|0|||
94720643|NCT04442126|324434001|FG000|Overall Study|Other|0|||
94720644|NCT04442126|324434002|FG001|Overall Study|Other|0|||
94720645|NCT04442126|324434003|FG002|Overall Study|Other|0|||
94720646|NCT04442126|324434004|FG003|Overall Study|Other|0|||
94720647|NCT04442126|324434005|FG004|Overall Study|Other|0|||
94720648|NCT04442126|324434006|FG005|Overall Study|Other|0|||
94720649|NCT04442126|324434007|FG006|Overall Study|Other|0|||
94720650|NCT04442126|324434008|FG007|Overall Study|Other|0|||
94720651|NCT04442126|324434009|FG008|Overall Study|Other|1|||
94720652|NCT03744312|324434705|FG000|Overall Study|Withdrawal by Subject|0|||
94720653|NCT03744312|324434706|FG001|Overall Study|Withdrawal by Subject|1|||
94720654|NCT03744312|324434705|FG000|Overall Study|Screen fail|0|||
94720655|NCT03744312|324434706|FG001|Overall Study|Screen fail|1|||
94720656|NCT00186992|324434707|FG000|Overall Study|Withdrawal by Subject|5|||
94720657|NCT00186992|324434707|FG000|Overall Study|Physician's discretion|13|||
94720658|NCT00186992|324434707|FG000|Overall Study|PI Discretion|4|||
94720659|NCT00186992|324434707|FG000|Overall Study|Ineligible|2|||
94720660|NCT00186992|324434707|FG000|Overall Study|Lost to Follow-up|2|||
94720661|NCT00186992|324434707|FG000|Overall Study|Still on Study|9|||
94720662|NCT04924062|324434708|FG000|Overall Study|Death|49|||
94467334|NCT00306787|323500507|FG000|Overall Study|Administrative problems|4|||
94720663|NCT04924062|324434709|FG001|Overall Study|Death|63|||
94720664|NCT04924062|324434708|FG000|Overall Study|Participant On-going|26|||
94720665|NCT04924062|324434709|FG001|Overall Study|Participant On-going|20|||
94720666|NCT03346538|324434710|FG000|Overall Study|Physician Decision|0|||
94720667|NCT03346538|324434711|FG001|Overall Study|Physician Decision|1|||
94720668|NCT03346538|324434712|FG002|Overall Study|Physician Decision|0|||
94720669|NCT03346538|324434710|FG000|Overall Study|Withdrawal by Subject|3|||
94720670|NCT03346538|324434711|FG001|Overall Study|Withdrawal by Subject|2|||
94720671|NCT03346538|324434712|FG002|Overall Study|Withdrawal by Subject|0|||
94720672|NCT03346538|324434710|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
94720673|NCT03346538|324434711|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
94720674|NCT03346538|324434712|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
94720675|NCT04396366|324434713|FG000|Overall Study|Adverse Event|1|||
94720676|NCT04396366|324434714|FG001|Overall Study|Adverse Event|0|||
94720677|NCT04059354|324434717|FG000|Overall Study|COVID-19 pandemic|3|||
94720678|NCT05403801|324434718|FG000|Overall Study|Withdrawal by Subject|2|||
94720679|NCT02349412|324434721|FG000|Overall Study|Withdrawal by Subject|7|||
94720680|NCT02349412|324434722|FG001|Overall Study|Withdrawal by Subject|7|||
94720681|NCT03460236|324434723|FG000|Overall Study|failed radiographic screening|16|||
94720682|NCT03460236|324434723|FG000|Overall Study|Withdrawal by Subject|11|||
94720683|NCT04869982|324434727|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
94720684|NCT04869982|324434728|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
94720685|NCT04869982|324434727|FG000|Overall Study|Migrated / moved from the study area|1|||
94720686|NCT04869982|324434728|FG001|Overall Study|Migrated / moved from the study area|1|||
94720687|NCT04869982|324434727|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
94720688|NCT04869982|324434728|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
94720689|NCT04869982|324434727|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
94720690|NCT04869982|324434728|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
94720691|NCT04869982|324434727|FG000|Overall Study|Solicited adverse event|2|||
94720692|NCT04869982|324434728|FG001|Overall Study|Solicited adverse event|1|||
94720693|NCT03271151|324434731|FG000|Overall Study|Lost to Follow-up|1|||
94720694|NCT03271151|324434732|FG001|Overall Study|Lost to Follow-up|3|||
94720695|NCT03271151|324434731|FG000|Overall Study|Withdrawal by Subject|1|||
94720696|NCT03271151|324434732|FG001|Overall Study|Withdrawal by Subject|0|||
94720697|NCT03055377|324434733|FG000|Treatment Phase|Lost to Follow-up|28|||
94720698|NCT03055377|324434734|FG001|Treatment Phase|Lost to Follow-up|24|||
94720699|NCT03055377|324434733|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
94720700|NCT03055377|324434734|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
94720701|NCT01718743|324434736|FG000|Overall Study|Physician Decision|7|||
94720702|NCT01718743|324434736|FG000|Overall Study|Withdrawal by Subject|14|||
94720703|NCT01718743|324434736|FG000|Overall Study|Progressive Disease|22|||
94720704|NCT01718743|324434736|FG000|Overall Study|Toxicity|1|||
94720705|NCT01718743|324434736|FG000|Overall Study|Malignancy|1|||
94720706|NCT03416010|324434737|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
94720707|NCT03416010|324434738|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
94720708|NCT03416010|324434737|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
94720709|NCT03416010|324434738|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
94720710|NCT03416010|324434737|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
94720711|NCT03416010|324434738|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
94720712|NCT03416010|324434737|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
94720713|NCT03416010|324434738|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
94720714|NCT03416010|324434737|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
94720715|NCT03416010|324434738|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
94720716|NCT03416010|324434737|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
94720717|NCT03416010|324434738|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
94720718|NCT03416010|324434737|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
94720719|NCT03416010|324434738|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
94720720|NCT03747484|324434740|FG000|Overall Study|Lack of Efficacy|0|||
94720721|NCT03747484|324434741|FG001|Overall Study|Lack of Efficacy|1|||
94720722|NCT03747484|324434742|FG002|Overall Study|Lack of Efficacy|1|||
94720723|NCT03747484|324434743|FG003|Overall Study|Lack of Efficacy|2|||
94720724|NCT03747484|324434744|FG004|Overall Study|Lack of Efficacy|2|||
94720725|NCT04868110|324434747|FG000|Overall Study|Withdrawal by Subject|3|||
94720726|NCT04868110|324434748|FG001|Overall Study|Withdrawal by Subject|4|||
94720727|NCT03263026|324434749|FG000|Overall Study|Withdrawal by Subject|1|||
94720728|NCT03263026|324434750|FG001|Overall Study|Withdrawal by Subject|0|||
94368090|NCT01408576|323134829|FG001|Overall Study|Withdrawal by Subject|60|||
94720729|NCT03263026|324434749|FG000|Overall Study|Death|1|||
94720730|NCT03263026|324434750|FG001|Overall Study|Death|0|||
94720731|NCT03263026|324434749|FG000|Overall Study|Other/ Various|41|||
94720732|NCT03263026|324434750|FG001|Overall Study|Other/ Various|29|||
94720733|NCT02546986|324434751|FG000|Treatment Period|Progressive Disease|20|||
94720734|NCT02546986|324434752|FG001|Treatment Period|Progressive Disease|22|||
94720735|NCT02546986|324434751|FG000|Treatment Period|Adverse Event|14|||
94720736|NCT02546986|324434752|FG001|Treatment Period|Adverse Event|6|||
94720737|NCT02546986|324434751|FG000|Treatment Period|Symptomatic Deterioration|4|||
94720738|NCT02546986|324434752|FG001|Treatment Period|Symptomatic Deterioration|3|||
94720739|NCT02546986|324434751|FG000|Treatment Period|Death|3|||
94720740|NCT02546986|324434752|FG001|Treatment Period|Death|4|||
94720741|NCT02546986|324434751|FG000|Treatment Period|Physician Decision|1|||
94720742|NCT02546986|324434752|FG001|Treatment Period|Physician Decision|2|||
94720743|NCT02546986|324434751|FG000|Treatment Period|Protocol Violation|1|||
94720744|NCT02546986|324434752|FG001|Treatment Period|Protocol Violation|0|||
94368091|NCT01408576|323134830|FG002|Overall Study|Withdrawal by Subject|66|||
94720745|NCT02546986|324434751|FG000|Treatment Period|Withdrawal by Subject|1|||
94720746|NCT02546986|324434752|FG001|Treatment Period|Withdrawal by Subject|1|||
94720747|NCT02546986|324434751|FG000|Treatment Period|Non-compliance with Study Drug|0|||
94720748|NCT02546986|324434752|FG001|Treatment Period|Non-compliance with Study Drug|1|||
94368092|NCT01408576|323134828|FG000|Overall Study|Sponsor terminated study|89|||
94720749|NCT02546986|324434751|FG000|Treatment Period|Study Terminated by Sponsor|0|||
94720750|NCT02546986|324434752|FG001|Treatment Period|Study Terminated by Sponsor|1|||
94720751|NCT02546986|324434751|FG000|Treatment Period|Miscellaneous|7|||
94720752|NCT02546986|324434752|FG001|Treatment Period|Miscellaneous|9|||
94720753|NCT02546986|324434751|FG000|Survival Follow-Up Phase|Missing Status|3|||
94720754|NCT02546986|324434752|FG001|Survival Follow-Up Phase|Missing Status|5|||
94720755|NCT02546986|324434751|FG000|Survival Follow-Up Phase|Death|18|||
94720756|NCT02546986|324434752|FG001|Survival Follow-Up Phase|Death|12|||
94720757|NCT02546986|324434751|FG000|Survival Follow-Up Phase|Alive|13|||
94720758|NCT02546986|324434752|FG001|Survival Follow-Up Phase|Alive|16|||
94720759|NCT02546986|324434751|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
94720760|NCT02546986|324434752|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
94720761|NCT03347383|324434753|FG000|Overall Study|Death|39|||
94720762|NCT03347383|324434753|FG000|Overall Study|Withdrawal by Subject|3|||
94720763|NCT03347383|324434753|FG000|Overall Study|Lost to Follow-up|9|||
94720764|NCT04703322|324434758|FG000|Overall Study|Ongoing|8|||
94720765|NCT04703322|324434758|FG000|Overall Study|Withdrawal by Subject|1|||
94720766|NCT03285763|324434759|FG000|Overall Study|Death|470|||
94720767|NCT03285763|324434759|FG000|Overall Study|Lost to Follow-up|18|||
94720768|NCT03285763|324434759|FG000|Overall Study|Physician Decision|2|||
94720769|NCT03285763|324434759|FG000|Overall Study|Study Terminated By Sponsor|79|||
94720770|NCT03285763|324434759|FG000|Overall Study|Withdrawal by Subject|33|||
94720771|NCT05792423|324434772|FG000|Overall Study|Withdrawal by Subject|2|||
94720772|NCT03451851|324434773|FG000|PCP: Week 0 -16|Adverse Event|1|||
94720773|NCT03451851|324434774|FG001|PCP: Week 0 -16|Adverse Event|0|||
94720774|NCT03451851|324434775|FG002|PCP: Week 0 -16|Adverse Event|0|||
94720775|NCT03451851|324434776|FG003|PCP: Week 0 -16|Adverse Event|0|||
94720776|NCT03451851|324434777|FG004|PCP: Week 0 -16|Adverse Event|0|||
94720777|NCT03451851|324434778|FG005|PCP: Week 0 -16|Adverse Event|0|||
94720778|NCT03451851|324434779|FG006|PCP: Week 0 -16|Adverse Event|1|||
94720779|NCT03451851|324434780|FG007|PCP: Week 0 -16|Adverse Event|0|||
94720780|NCT03451851|324434773|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
94720781|NCT03451851|324434774|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
94720782|NCT03451851|324434775|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
94720783|NCT03451851|324434776|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
94720784|NCT03451851|324434777|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
94720785|NCT03451851|324434778|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
94720786|NCT03451851|324434779|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
94720787|NCT03451851|324434780|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
94720788|NCT03451851|324434773|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
94720789|NCT03451851|324434774|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
94720790|NCT03451851|324434775|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
94720791|NCT03451851|324434776|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
94368093|NCT01408576|323134829|FG001|Overall Study|Sponsor terminated study|333|||
94720792|NCT03451851|324434777|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
94720793|NCT03451851|324434778|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
94720794|NCT03451851|324434779|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
94720795|NCT03451851|324434780|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
94720796|NCT03451851|324434773|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
94720797|NCT03451851|324434774|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
94720798|NCT03451851|324434775|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
94720799|NCT03451851|324434776|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
94720800|NCT03451851|324434777|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
94720801|NCT03451851|324434778|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
94720802|NCT03451851|324434779|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
94720803|NCT03451851|324434780|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
94720804|NCT03451851|324434773|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
94720805|NCT03451851|324434774|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
94720806|NCT03451851|324434775|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
94720807|NCT03451851|324434776|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
94720808|NCT03451851|324434777|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
94720809|NCT03451851|324434778|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
94720810|NCT03451851|324434779|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
94720811|NCT03451851|324434780|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
94720812|NCT03451851|324434773|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
94720813|NCT03451851|324434774|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
94720814|NCT03451851|324434775|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
94720815|NCT03451851|324434776|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
94720816|NCT03451851|324434777|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
94720817|NCT03451851|324434778|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
94720818|NCT03451851|324434779|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
94720819|NCT03451851|324434780|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
94720820|NCT03481777|324435738|FG000|Overall Study|Withdrawal by Subject|36|||
94720821|NCT03481777|324435739|FG001|Overall Study|Withdrawal by Subject|31|||
94720822|NCT03481777|324435738|FG000|Overall Study|Non stroke = non target population|277|||
94720823|NCT03481777|324435739|FG001|Overall Study|Non stroke = non target population|254|||
94720824|NCT02525692|324435747|FG000|Overall Study|Withdrawal by Subject|1|||
94720825|NCT02525692|324435748|FG001|Overall Study|Withdrawal by Subject|1|||
94720826|NCT02525692|324435749|FG002|Overall Study|Withdrawal by Subject|0|||
94720827|NCT02525692|324435750|FG003|Overall Study|Withdrawal by Subject|5|||
94720828|NCT02525692|324435751|FG004|Overall Study|Withdrawal by Subject|0|||
94720829|NCT02525692|324435752|FG005|Overall Study|Withdrawal by Subject|1|||
94720830|NCT02525692|324435747|FG000|Overall Study|Death|16|||
94720831|NCT02525692|324435748|FG001|Overall Study|Death|18|||
94720832|NCT02525692|324435749|FG002|Overall Study|Death|7|||
94720833|NCT02525692|324435750|FG003|Overall Study|Death|20|||
94720834|NCT02525692|324435751|FG004|Overall Study|Death|3|||
94720835|NCT02525692|324435752|FG005|Overall Study|Death|6|||
94720836|NCT02525692|324435747|FG000|Overall Study|Lost to Follow-up|0|||
94720837|NCT02525692|324435748|FG001|Overall Study|Lost to Follow-up|0|||
94720838|NCT02525692|324435749|FG002|Overall Study|Lost to Follow-up|1|||
94720839|NCT02525692|324435750|FG003|Overall Study|Lost to Follow-up|5|||
94720840|NCT02525692|324435751|FG004|Overall Study|Lost to Follow-up|0|||
94720841|NCT02525692|324435752|FG005|Overall Study|Lost to Follow-up|0|||
94720842|NCT02396199|324435754|FG000|Overall Study|Lost to Follow-up|1|||
94720843|NCT02396199|324435754|FG000|Overall Study|Death|4|||
94720844|NCT03424811|324435756|FG000|Overall Study|Lost to Follow-up|9|||
94720845|NCT03424811|324435757|FG001|Overall Study|Lost to Follow-up|0|||
94720846|NCT03857620|324435758|FG000|Overall Study|Death|4|||
94720847|NCT03857620|324435759|FG001|Overall Study|Death|5|||
94720848|NCT03857620|324435760|FG002|Overall Study|Death|7|||
94720849|NCT03857620|324435758|FG000|Overall Study|Lost to Follow-up|2|||
94720850|NCT03857620|324435759|FG001|Overall Study|Lost to Follow-up|5|||
94720851|NCT03857620|324435760|FG002|Overall Study|Lost to Follow-up|3|||
94720852|NCT03857620|324435758|FG000|Overall Study|Disease progression or relapse after study registration|1|||
94720853|NCT03857620|324435759|FG001|Overall Study|Disease progression or relapse after study registration|5|||
94720854|NCT03857620|324435760|FG002|Overall Study|Disease progression or relapse after study registration|1|||
94720855|NCT03857620|324435758|FG000|Overall Study|Ineligible|5|||
94720856|NCT03857620|324435759|FG001|Overall Study|Ineligible|0|||
94720857|NCT03857620|324435760|FG002|Overall Study|Ineligible|2|||
94272246|NCT01438489|322790368|FG002|Overall Study|Investigator decision|0|||
94720858|NCT03857620|324435758|FG000|Overall Study|No malignancy|1|||
94720859|NCT03857620|324435759|FG001|Overall Study|No malignancy|0|||
94720860|NCT03857620|324435760|FG002|Overall Study|No malignancy|1|||
94720861|NCT03857620|324435758|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
94720862|NCT03857620|324435759|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
94720863|NCT03857620|324435760|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
94720864|NCT03857620|324435758|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
94720865|NCT03857620|324435759|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
94720866|NCT03857620|324435760|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
94720867|NCT03857620|324435758|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
94720868|NCT03857620|324435759|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
94720869|NCT03857620|324435760|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
94720870|NCT03857620|324435758|FG000|Overall Study|Surgery not performed, patient decision|0|||
94720871|NCT03857620|324435759|FG001|Overall Study|Surgery not performed, patient decision|3|||
94720872|NCT03857620|324435760|FG002|Overall Study|Surgery not performed, patient decision|1|||
94720873|NCT03857620|324435758|FG000|Overall Study|Surgery not performed, other reason|3|||
94720874|NCT03857620|324435759|FG001|Overall Study|Surgery not performed, other reason|1|||
94720875|NCT03857620|324435760|FG002|Overall Study|Surgery not performed, other reason|4|||
94720876|NCT03857620|324435758|FG000|Overall Study|Worsening performance status after surgery performed|0|||
94720877|NCT03857620|324435759|FG001|Overall Study|Worsening performance status after surgery performed|1|||
94720878|NCT03857620|324435760|FG002|Overall Study|Worsening performance status after surgery performed|1|||
94720879|NCT04143061|324435763|FG000|Overall Study|Protocol Deviation|0|||
94720880|NCT04143061|324435764|FG001|Overall Study|Protocol Deviation|0|||
94720881|NCT04143061|324435765|FG002|Overall Study|Protocol Deviation|0|||
94720882|NCT04143061|324435766|FG003|Overall Study|Protocol Deviation|0|||
94720883|NCT04143061|324435767|FG004|Overall Study|Protocol Deviation|0|||
94720884|NCT04143061|324435768|FG005|Overall Study|Protocol Deviation|0|||
94720885|NCT04143061|324435769|FG006|Overall Study|Protocol Deviation|5|||
94720886|NCT04143061|324435770|FG007|Overall Study|Protocol Deviation|5|||
94720887|NCT04143061|324435763|FG000|Overall Study|Withdrawal by Subject|2|||
94720888|NCT04143061|324435764|FG001|Overall Study|Withdrawal by Subject|0|||
94720889|NCT04143061|324435765|FG002|Overall Study|Withdrawal by Subject|0|||
94720890|NCT04143061|324435766|FG003|Overall Study|Withdrawal by Subject|0|||
94720891|NCT04143061|324435767|FG004|Overall Study|Withdrawal by Subject|0|||
94720892|NCT04143061|324435768|FG005|Overall Study|Withdrawal by Subject|1|||
94720893|NCT04143061|324435769|FG006|Overall Study|Withdrawal by Subject|0|||
94720894|NCT04143061|324435770|FG007|Overall Study|Withdrawal by Subject|0|||
94720895|NCT04143061|324435763|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94720896|NCT04143061|324435764|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94720897|NCT04143061|324435765|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
94720898|NCT04143061|324435766|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
94720899|NCT04143061|324435767|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
94720900|NCT04143061|324435768|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
94720901|NCT04143061|324435769|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
94272247|NCT01438489|322790366|FG000|Overall Study|AE/SAEs|2|||
94272248|NCT01438489|322790367|FG001|Overall Study|AE/SAEs|1|||
94272249|NCT01438489|322790368|FG002|Overall Study|AE/SAEs|1|||
94272250|NCT01438489|322790366|FG000|Overall Study|Received prohibited medication|1|||
94655391|NCT02207829|324196017|FG000|Overall Study|Adverse Event|10|||
94655392|NCT02207829|324196018|FG001|Overall Study|Adverse Event|9|||
94655393|NCT02207829|324196017|FG000|Overall Study|Lack of Efficacy|7|||
94655394|NCT02207829|324196018|FG001|Overall Study|Lack of Efficacy|5|||
94655395|NCT02207829|324196017|FG000|Overall Study|Lost to Follow-up|2|||
94655396|NCT02207829|324196018|FG001|Overall Study|Lost to Follow-up|2|||
94655397|NCT02207829|324196017|FG000|Overall Study|Protocol deviation|5|||
94655398|NCT02207829|324196018|FG001|Overall Study|Protocol deviation|4|||
94655399|NCT02207829|324196017|FG000|Overall Study|Withdrew consent|18|||
94655400|NCT02207829|324196018|FG001|Overall Study|Withdrew consent|14|||
94655401|NCT02755831|324196021|FG000|Overall Study|Lost to Follow-up|3|||
94655402|NCT02755831|324196022|FG001|Overall Study|Lost to Follow-up|3|||
94655403|NCT01516879|324196023|FG000|Overall Study|Withdrawal by Subject|9|||
94655404|NCT01516879|324196024|FG001|Overall Study|Withdrawal by Subject|11|||
94655405|NCT01516879|324196023|FG000|Overall Study|Death|0|||
94655406|NCT01516879|324196024|FG001|Overall Study|Death|2|||
94655407|NCT01516879|324196023|FG000|Overall Study|Lost to Follow-up|2|||
94655408|NCT01516879|324196024|FG001|Overall Study|Lost to Follow-up|11|||
94655409|NCT01516879|324196023|FG000|Overall Study|Other|5|||
94655410|NCT01516879|324196024|FG001|Overall Study|Other|10|||
94655411|NCT00965848|324196027|FG000|Overall Study|Protocol Violation|3|||
94655412|NCT00965848|324196028|FG001|Overall Study|Protocol Violation|0|||
94655413|NCT00965848|324196029|FG002|Overall Study|Protocol Violation|1|||
94655414|NCT00965848|324196027|FG000|Overall Study|Death|11|||
94655415|NCT00965848|324196028|FG001|Overall Study|Death|1|||
94720902|NCT04143061|324435770|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
94720903|NCT01898494|324435771|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
94720904|NCT01898494|324435772|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
94720905|NCT01898494|324435773|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
94720906|NCT01898494|324435774|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
94720907|NCT01898494|324435775|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
94720908|NCT01898494|324435771|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
94720909|NCT01898494|324435772|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
94720910|NCT01898494|324435773|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
94720911|NCT01898494|324435774|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
94720912|NCT01898494|324435775|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
94720913|NCT01898494|324435771|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
94720914|NCT01898494|324435772|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
94720915|NCT01898494|324435773|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
94720916|NCT01898494|324435774|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
94720917|NCT01898494|324435775|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
94720918|NCT01898494|324435771|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
94720919|NCT01898494|324435772|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
94720920|NCT01898494|324435773|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
94720921|NCT01898494|324435774|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
94720922|NCT01898494|324435775|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
94720923|NCT01898494|324435771|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
94720924|NCT01898494|324435772|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
94720925|NCT01898494|324435773|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
94720926|NCT01898494|324435774|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
94720927|NCT01898494|324435775|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
94720928|NCT01898494|324435771|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
94720929|NCT01898494|324435772|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
94720930|NCT01898494|324435773|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
94720931|NCT01898494|324435774|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
94720932|NCT01898494|324435775|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
94720933|NCT01898494|324435771|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
94720934|NCT01898494|324435772|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
94720935|NCT01898494|324435773|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
94720936|NCT01898494|324435774|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
94720937|NCT01898494|324435775|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
94720938|NCT01898494|324435771|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
94720939|NCT01898494|324435772|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
94720940|NCT01898494|324435773|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
94720941|NCT01898494|324435774|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
94720942|NCT01898494|324435775|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
94720943|NCT01898494|324435771|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
94720944|NCT01898494|324435772|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
94720945|NCT01898494|324435773|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
94467335|NCT00306787|323500508|FG001|Overall Study|Administrative problems|0|||
94467336|NCT00306787|323500507|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94720946|NCT01898494|324435774|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
94720947|NCT01898494|324435775|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
94720948|NCT01898494|324435771|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
94720949|NCT01898494|324435772|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
94720950|NCT01898494|324435773|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
94720951|NCT01898494|324435774|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
94720952|NCT01898494|324435775|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
94720953|NCT01898494|324435771|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
94720954|NCT01898494|324435772|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
94720955|NCT01898494|324435773|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
94720956|NCT01898494|324435774|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
94720957|NCT01898494|324435775|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
94272251|NCT01438489|322790367|FG001|Overall Study|Received prohibited medication|0|||
94720958|NCT01898494|324435771|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
94720959|NCT01898494|324435772|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
94720960|NCT01898494|324435773|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
94720961|NCT01898494|324435774|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
94720962|NCT01898494|324435775|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
94720963|NCT01898494|324435771|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
94720964|NCT01898494|324435772|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
94720965|NCT01898494|324435773|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
94720966|NCT01898494|324435774|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
94720967|NCT01898494|324435775|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
94720968|NCT01898494|324435771|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
94720969|NCT01898494|324435772|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
94720970|NCT01898494|324435773|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
94720971|NCT01898494|324435774|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
94720972|NCT01898494|324435775|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
94720973|NCT02163447|324435776|FG000|Overall Study|Withdrawal by Subject|2|||
94720974|NCT02163447|324435777|FG001|Overall Study|Withdrawal by Subject|0|||
94720975|NCT02163447|324435778|FG002|Overall Study|Withdrawal by Subject|1|||
94720976|NCT02163447|324435776|FG000|Overall Study|Lost to Follow-up|1|||
94720977|NCT02163447|324435777|FG001|Overall Study|Lost to Follow-up|3|||
94720978|NCT02163447|324435778|FG002|Overall Study|Lost to Follow-up|0|||
94720979|NCT02163447|324435776|FG000|Overall Study|Moved out of study area|2|||
94720980|NCT02163447|324435777|FG001|Overall Study|Moved out of study area|3|||
94720981|NCT02163447|324435778|FG002|Overall Study|Moved out of study area|2|||
94720982|NCT02163447|324435776|FG000|Overall Study|Became HIV infected at time of delivery|1|||
94720983|NCT02163447|324435777|FG001|Overall Study|Became HIV infected at time of delivery|0|||
94720984|NCT02163447|324435778|FG002|Overall Study|Became HIV infected at time of delivery|0|||
94720985|NCT03897686|324435784|FG000|Overall Study|Protocol Violation|1|||
94720986|NCT03897686|324435785|FG001|Overall Study|Protocol Violation|1|||
94720987|NCT03897686|324435784|FG000|Overall Study|Withdrawal by Subject|1|||
94720988|NCT03897686|324435785|FG001|Overall Study|Withdrawal by Subject|1|||
94720989|NCT05058391|324435788|FG000|Overall Study|Adverse Event|1|||
94720990|NCT03538041|324435797|FG000|12-Week Treatment Period|Adverse Event|1|||
94720991|NCT03538041|324435798|FG001|12-Week Treatment Period|Adverse Event|1|||
94720992|NCT03538041|324435797|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
94720993|NCT03538041|324435798|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
94720994|NCT03538041|324435797|FG000|Treatment Extension Period|Adverse Event|4|||
94720995|NCT03538041|324435798|FG001|Treatment Extension Period|Adverse Event|1|||
94720996|NCT03538041|324435797|FG000|Treatment Extension Period|Physician Decision|1|||
94720997|NCT03538041|324435798|FG001|Treatment Extension Period|Physician Decision|1|||
94720998|NCT03538041|324435797|FG000|Treatment Extension Period|Lack of Efficacy|1|||
94720999|NCT03538041|324435798|FG001|Treatment Extension Period|Lack of Efficacy|4|||
94721000|NCT03538041|324435797|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
94721001|NCT03538041|324435798|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
94721002|NCT03538041|324435797|FG000|Treatment Extension Period|Death|0|||
94721003|NCT03538041|324435798|FG001|Treatment Extension Period|Death|1|||
94721004|NCT03655132|324435805|FG000|Overall Study|Lost to Follow-up|2|||
94721005|NCT03655132|324435806|FG001|Overall Study|Lost to Follow-up|1|||
94721006|NCT03655132|324435805|FG000|Overall Study|Withdrawal by Subject|0|||
94721007|NCT03655132|324435806|FG001|Overall Study|Withdrawal by Subject|1|||
94721008|NCT03655132|324435805|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
94721009|NCT03655132|324435806|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
94721010|NCT02682316|324435814|FG000|Overall Study|Benign Final Pathology|27|||
94721011|NCT02682316|324435815|FG001|Overall Study|Benign Final Pathology|26|||
94721012|NCT02682316|324435814|FG000|Overall Study|Reoperation before 30 days|7|||
94721013|NCT02682316|324435815|FG001|Overall Study|Reoperation before 30 days|6|||
94721014|NCT02682316|324435814|FG000|Overall Study|Ineligible|1|||
94721015|NCT02682316|324435815|FG001|Overall Study|Ineligible|0|||
94721016|NCT02682316|324435814|FG000|Overall Study|Death|1|||
94721017|NCT02682316|324435815|FG001|Overall Study|Death|0|||
94721018|NCT02682316|324435814|FG000|Overall Study|Lost to Follow-up|7|||
94721019|NCT02682316|324435815|FG001|Overall Study|Lost to Follow-up|3|||
94721020|NCT05927753|324435817|FG000|Overall Study|Withdrawal by Subject|0|||
94721021|NCT05927753|324435818|FG001|Overall Study|Withdrawal by Subject|2|||
94721022|NCT05927753|324435817|FG000|Overall Study|Physician Decision|0|||
94721023|NCT05927753|324435818|FG001|Overall Study|Physician Decision|1|||
94721024|NCT03978871|324435821|FG000|Overall Study|Lost to Follow-up|11|||
94721025|NCT03978871|324435822|FG001|Overall Study|Lost to Follow-up|12|||
94721026|NCT05575076|324435823|FG000|Overall Study|Adverse Event|24|||
94721027|NCT05575076|324435823|FG000|Overall Study|Death|7|||
94721028|NCT05575076|324435823|FG000|Overall Study|Lost to Follow-up|16|||
94721029|NCT05575076|324435823|FG000|Overall Study|Non-Compliance|3|||
94721030|NCT05575076|324435823|FG000|Overall Study|Physician Decision|6|||
94721031|NCT05575076|324435823|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
94721032|NCT05575076|324435823|FG000|Overall Study|Withdrawal by Subject|71|||
94721033|NCT05575076|324435823|FG000|Overall Study|Study Terminated by Sponsor|630|||
94721034|NCT05575076|324435823|FG000|Overall Study|Other|17|||
94721035|NCT05089734|324435826|FG000|Overall Study|Still on study|122|||
94721036|NCT05089734|324435827|FG001|Overall Study|Still on study|101|||
94721037|NCT05089734|324435826|FG000|Overall Study|Death|161|||
94721038|NCT05089734|324435827|FG001|Overall Study|Death|179|||
94721039|NCT05089734|324435826|FG000|Overall Study|Withdrew consent|11|||
94721040|NCT05089734|324435827|FG001|Overall Study|Withdrew consent|24|||
94721041|NCT05089734|324435826|FG000|Overall Study|Lost to Follow-up|5|||
94721042|NCT05089734|324435827|FG001|Overall Study|Lost to Follow-up|0|||
94721043|NCT04999592|324435829|FG000|Overall Study|Withdrawal by Subject|1|||
94721044|NCT04999592|324435830|FG001|Overall Study|Withdrawal by Subject|0|||
94721045|NCT04095104|324435831|FG000|Overall Study|Withdrawal by Subject|0|||
94721046|NCT04095104|324435832|FG001|Overall Study|Withdrawal by Subject|1|||
94721047|NCT03767517|324435833|FG000|Overall Study|Lost to Follow-up|16|||
94721048|NCT03767517|324435834|FG001|Overall Study|Lost to Follow-up|10|||
94721049|NCT03767517|324435833|FG000|Overall Study|Death|2|||
94721050|NCT03767517|324435834|FG001|Overall Study|Death|3|||
94721051|NCT03651895|324436857|FG000|First Drug Assignment|Adverse Event|4|||
94721052|NCT03651895|324436858|FG001|First Drug Assignment|Adverse Event|5|||
94721053|NCT03651895|324436857|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
94721054|NCT03651895|324436858|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
94721055|NCT04586920|324436859|FG000|Overall Study|Lost to Follow-up|0|||
94721056|NCT04586920|324436860|FG001|Overall Study|Lost to Follow-up|0|||
94721057|NCT04586920|324436861|FG002|Overall Study|Lost to Follow-up|0|||
94721058|NCT04586920|324436862|FG003|Overall Study|Lost to Follow-up|0|||
94721059|NCT04586920|324436863|FG004|Overall Study|Lost to Follow-up|0|||
94721060|NCT04586920|324436864|FG005|Overall Study|Lost to Follow-up|0|||
94721061|NCT04586920|324436865|FG006|Overall Study|Lost to Follow-up|1|||
94721062|NCT04586920|324436866|FG007|Overall Study|Lost to Follow-up|1|||
94721063|NCT04586920|324436867|FG008|Overall Study|Lost to Follow-up|0|||
94721064|NCT04586920|324436868|FG009|Overall Study|Lost to Follow-up|1|||
94721065|NCT04586920|324436869|FG010|Overall Study|Lost to Follow-up|0|||
94721066|NCT04586920|324436870|FG011|Overall Study|Lost to Follow-up|0|||
94721067|NCT04586920|324436871|FG012|Overall Study|Lost to Follow-up|0|||
94721068|NCT04586920|324436872|FG013|Overall Study|Lost to Follow-up|1|||
94721069|NCT04586920|324436873|FG014|Overall Study|Lost to Follow-up|0|||
94721070|NCT04586920|324436874|FG015|Overall Study|Lost to Follow-up|0|||
94721071|NCT04586920|324436875|FG016|Overall Study|Lost to Follow-up|0|||
94721072|NCT04586920|324436876|FG017|Overall Study|Lost to Follow-up|0|||
94721073|NCT04586920|324436859|FG000|Overall Study|Withdrawal by Subject|0|||
94721074|NCT04586920|324436860|FG001|Overall Study|Withdrawal by Subject|0|||
94721075|NCT04586920|324436861|FG002|Overall Study|Withdrawal by Subject|0|||
94721076|NCT04586920|324436862|FG003|Overall Study|Withdrawal by Subject|0|||
94721077|NCT04586920|324436863|FG004|Overall Study|Withdrawal by Subject|0|||
94721078|NCT04586920|324436864|FG005|Overall Study|Withdrawal by Subject|0|||
94721079|NCT04586920|324436865|FG006|Overall Study|Withdrawal by Subject|0|||
94721080|NCT04586920|324436866|FG007|Overall Study|Withdrawal by Subject|1|||
94721081|NCT04586920|324436867|FG008|Overall Study|Withdrawal by Subject|0|||
94721082|NCT04586920|324436868|FG009|Overall Study|Withdrawal by Subject|1|||
94721083|NCT04586920|324436869|FG010|Overall Study|Withdrawal by Subject|0|||
94721084|NCT04586920|324436870|FG011|Overall Study|Withdrawal by Subject|1|||
94721085|NCT04586920|324436871|FG012|Overall Study|Withdrawal by Subject|0|||
94721086|NCT04586920|324436872|FG013|Overall Study|Withdrawal by Subject|0|||
94721087|NCT04586920|324436873|FG014|Overall Study|Withdrawal by Subject|0|||
94721088|NCT04586920|324436874|FG015|Overall Study|Withdrawal by Subject|0|||
94721089|NCT04586920|324436875|FG016|Overall Study|Withdrawal by Subject|0|||
94721090|NCT04586920|324436876|FG017|Overall Study|Withdrawal by Subject|0|||
94721091|NCT03819686|324436880|FG000|Overall Study|Lost to Follow-up|2|||
94721092|NCT03819686|324436881|FG001|Overall Study|Lost to Follow-up|3|||
94721093|NCT06143670|324436882|FG000|Overall Study|Lost to Follow-up|0|||
94721094|NCT06143670|324436883|FG001|Overall Study|Lost to Follow-up|1|||
94721095|NCT06143670|324436882|FG000|Overall Study|Withdrawal by Subject|3|||
94721096|NCT06143670|324436883|FG001|Overall Study|Withdrawal by Subject|0|||
94721097|NCT04905407|324436888|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
94721098|NCT04905407|324436889|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
94721099|NCT04905407|324436890|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
94721100|NCT04905407|324436891|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
94721101|NCT04905407|324436888|FG000|Part 1 and Part 2|Death|7|||
94721102|NCT04905407|324436889|FG001|Part 1 and Part 2|Death|7|||
94721103|NCT04905407|324436890|FG002|Part 1 and Part 2|Death|7|||
94721104|NCT04905407|324436891|FG003|Part 1 and Part 2|Death|0|||
94721105|NCT04905407|324436888|FG000|Part 1 and Part 2|Other than specified|0|||
94721106|NCT04905407|324436889|FG001|Part 1 and Part 2|Other than specified|0|||
94721107|NCT04905407|324436890|FG002|Part 1 and Part 2|Other than specified|1|||
94721108|NCT04905407|324436891|FG003|Part 1 and Part 2|Other than specified|0|||
94721109|NCT04905407|324436888|FG000|Part 3|Death|0|||
94721110|NCT04905407|324436889|FG001|Part 3|Death|0|||
94721111|NCT04905407|324436890|FG002|Part 3|Death|0|||
94721112|NCT04905407|324436891|FG003|Part 3|Death|2|||
94721113|NCT06023082|324436897|FG000|Overall Study|Withdrawal by Subject|2|||
94721114|NCT06023082|324436897|FG000|Overall Study|Lost to Follow-up|15|||
94721115|NCT06023082|324436897|FG000|Overall Study|Side effects|5|||
94721116|NCT05136404|324436903|FG000|Period 1|Adverse Event|0|||
94721117|NCT05136404|324436904|FG001|Period 1|Adverse Event|1|||
94721118|NCT05136404|324436905|FG002|Period 1|Adverse Event|1|||
94721119|NCT05136404|324436903|FG000|Period 2|Inappropriate Behavior|0|||
94721120|NCT05136404|324436904|FG001|Period 2|Inappropriate Behavior|0|||
94721121|NCT05136404|324436905|FG002|Period 2|Inappropriate Behavior|1|||
94721122|NCT05136404|324436903|FG000|Period 3|Adverse Event|0|||
94721123|NCT05136404|324436904|FG001|Period 3|Adverse Event|0|||
94721124|NCT05136404|324436905|FG002|Period 3|Adverse Event|1|||
94721125|NCT03584516|324436906|FG000|Part 1|Death|2|||
94721126|NCT03584516|324436907|FG001|Part 1|Death|3|||
94721127|NCT03584516|324436908|FG002|Part 1|Death|0|||
94721128|NCT03584516|324436909|FG003|Part 1|Death|0|||
94721129|NCT03584516|324436910|FG004|Part 1|Death|0|||
94721130|NCT03584516|324436911|FG005|Part 1|Death|0|||
94721131|NCT03584516|324436906|FG000|Part 1|Withdrawal by Subject|2|||
94721132|NCT03584516|324436907|FG001|Part 1|Withdrawal by Subject|0|||
94721133|NCT03584516|324436908|FG002|Part 1|Withdrawal by Subject|0|||
94721134|NCT03584516|324436909|FG003|Part 1|Withdrawal by Subject|0|||
94721135|NCT03584516|324436910|FG004|Part 1|Withdrawal by Subject|0|||
94721136|NCT03584516|324436911|FG005|Part 1|Withdrawal by Subject|0|||
94721137|NCT03584516|324436906|FG000|Part 1|Lost to Follow-up|1|||
94721138|NCT03584516|324436907|FG001|Part 1|Lost to Follow-up|0|||
94721139|NCT03584516|324436908|FG002|Part 1|Lost to Follow-up|0|||
94721140|NCT03584516|324436909|FG003|Part 1|Lost to Follow-up|0|||
94721141|NCT03584516|324436910|FG004|Part 1|Lost to Follow-up|0|||
94721142|NCT03584516|324436911|FG005|Part 1|Lost to Follow-up|0|||
94721143|NCT03584516|324436906|FG000|Part 1|Study Terminated by Sponsor|0|||
94721144|NCT03584516|324436907|FG001|Part 1|Study Terminated by Sponsor|2|||
94721145|NCT03584516|324436908|FG002|Part 1|Study Terminated by Sponsor|0|||
94721146|NCT03584516|324436909|FG003|Part 1|Study Terminated by Sponsor|0|||
94721147|NCT03584516|324436910|FG004|Part 1|Study Terminated by Sponsor|0|||
94721148|NCT03584516|324436911|FG005|Part 1|Study Terminated by Sponsor|0|||
94721149|NCT03584516|324436906|FG000|Part 1 Expansion|Death|0|||
94721150|NCT03584516|324436907|FG001|Part 1 Expansion|Death|0|||
94721151|NCT03584516|324436908|FG002|Part 1 Expansion|Death|9|||
94721152|NCT03584516|324436909|FG003|Part 1 Expansion|Death|8|||
94721153|NCT03584516|324436910|FG004|Part 1 Expansion|Death|4|||
94721154|NCT03584516|324436911|FG005|Part 1 Expansion|Death|5|||
94721155|NCT03584516|324436906|FG000|Part 1 Expansion|Lost to Follow-up|0|||
94721156|NCT03584516|324436907|FG001|Part 1 Expansion|Lost to Follow-up|0|||
94721157|NCT03584516|324436908|FG002|Part 1 Expansion|Lost to Follow-up|0|||
94721158|NCT03584516|324436909|FG003|Part 1 Expansion|Lost to Follow-up|1|||
94721159|NCT03584516|324436910|FG004|Part 1 Expansion|Lost to Follow-up|0|||
94721160|NCT03584516|324436911|FG005|Part 1 Expansion|Lost to Follow-up|0|||
94721161|NCT03584516|324436906|FG000|Part 1 Expansion|Physician Decision|0|||
94721162|NCT03584516|324436907|FG001|Part 1 Expansion|Physician Decision|0|||
94721163|NCT03584516|324436908|FG002|Part 1 Expansion|Physician Decision|4|||
94721164|NCT03584516|324436909|FG003|Part 1 Expansion|Physician Decision|3|||
94721165|NCT03584516|324436910|FG004|Part 1 Expansion|Physician Decision|2|||
94721166|NCT03584516|324436911|FG005|Part 1 Expansion|Physician Decision|3|||
94721167|NCT03584516|324436906|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
94721168|NCT03584516|324436907|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
94721169|NCT03584516|324436908|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
94721170|NCT03584516|324436909|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
94721171|NCT03584516|324436910|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
94721172|NCT03584516|324436911|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
94721173|NCT03584516|324436906|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
94721174|NCT03584516|324436907|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
94721175|NCT03584516|324436908|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
94721176|NCT03584516|324436909|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
94368094|NCT01408576|323134830|FG002|Overall Study|Sponsor terminated study|330|||
94721177|NCT03584516|324436910|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
94721178|NCT03584516|324436911|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
94721179|NCT03584516|324436906|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
94721180|NCT03584516|324436907|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
94721181|NCT03584516|324436908|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
94721182|NCT03584516|324436909|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
94721183|NCT03584516|324436910|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
94721184|NCT03584516|324436911|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
94721185|NCT03584516|324436906|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
94721186|NCT03584516|324436907|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
94721187|NCT03584516|324436908|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
94721188|NCT03584516|324436909|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
94721189|NCT03584516|324436910|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
94721190|NCT03584516|324436911|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
94721191|NCT05691452|324436916|FG000|Overall Study|Withdrawal by Subject|1|||
94721192|NCT05691452|324436917|FG001|Overall Study|Withdrawal by Subject|1|||
94721193|NCT05691452|324436918|FG002|Overall Study|Withdrawal by Subject|0|||
94721194|NCT05691452|324436916|FG000|Overall Study|Physician Decision|1|||
94721195|NCT05691452|324436917|FG001|Overall Study|Physician Decision|0|||
94721196|NCT05691452|324436918|FG002|Overall Study|Physician Decision|0|||
94721197|NCT05691452|324436916|FG000|Overall Study|Lost to Follow-up|0|||
94721198|NCT05691452|324436917|FG001|Overall Study|Lost to Follow-up|0|||
94721199|NCT05691452|324436918|FG002|Overall Study|Lost to Follow-up|1|||
94721200|NCT05691452|324436916|FG000|Overall Study|Adverse Event|0|||
94721201|NCT05691452|324436917|FG001|Overall Study|Adverse Event|0|||
94721202|NCT05691452|324436918|FG002|Overall Study|Adverse Event|1|||
94721203|NCT05320432|324436919|FG000|Overall Study|Withdrawal by Subject|0|||
94721204|NCT05320432|324436920|FG001|Overall Study|Withdrawal by Subject|2|||
94721205|NCT03484702|324436921|FG000|Treatment Period|Death|3|||
94721206|NCT03484702|324436922|FG001|Treatment Period|Death|1|||
94721207|NCT03484702|324436923|FG002|Treatment Period|Death|0|||
94721208|NCT03484702|324436924|FG003|Treatment Period|Death|0|||
94721209|NCT03484702|324436925|FG004|Treatment Period|Death|0|||
94721210|NCT03484702|324436926|FG005|Treatment Period|Death|0|||
94721211|NCT03484702|324436921|FG000|Treatment Period|Adverse Event|1|||
94721212|NCT03484702|324436922|FG001|Treatment Period|Adverse Event|0|||
94721213|NCT03484702|324436923|FG002|Treatment Period|Adverse Event|0|||
94721214|NCT03484702|324436924|FG003|Treatment Period|Adverse Event|0|||
94721215|NCT03484702|324436925|FG004|Treatment Period|Adverse Event|0|||
94721216|NCT03484702|324436926|FG005|Treatment Period|Adverse Event|0|||
94721217|NCT03484702|324436921|FG000|Treatment Period|Participant Withdrew from Study|0|||
94721218|NCT03484702|324436922|FG001|Treatment Period|Participant Withdrew from Study|1|||
94721219|NCT03484702|324436923|FG002|Treatment Period|Participant Withdrew from Study|0|||
94721220|NCT03484702|324436924|FG003|Treatment Period|Participant Withdrew from Study|0|||
94721221|NCT03484702|324436925|FG004|Treatment Period|Participant Withdrew from Study|0|||
94721222|NCT03484702|324436926|FG005|Treatment Period|Participant Withdrew from Study|0|||
94721223|NCT03484702|324436921|FG000|Treatment Period|Physician Decision|0|||
94721224|NCT03484702|324436922|FG001|Treatment Period|Physician Decision|1|||
94721225|NCT03484702|324436923|FG002|Treatment Period|Physician Decision|0|||
94721226|NCT03484702|324436924|FG003|Treatment Period|Physician Decision|0|||
94721227|NCT03484702|324436925|FG004|Treatment Period|Physician Decision|0|||
94721228|NCT03484702|324436926|FG005|Treatment Period|Physician Decision|1|||
94721229|NCT00739648|324436931|FG000|Overall Study|Adverse Event|3|||
94721230|NCT00739648|324436932|FG001|Overall Study|Adverse Event|15|||
94721231|NCT00739648|324436931|FG000|Overall Study|Withdrawal by Subject|13|||
94721232|NCT00739648|324436932|FG001|Overall Study|Withdrawal by Subject|25|||
94721233|NCT00739648|324436931|FG000|Overall Study|Lost to Follow-up|4|||
94721234|NCT00739648|324436932|FG001|Overall Study|Lost to Follow-up|7|||
94721235|NCT00739648|324436931|FG000|Overall Study|Death|2|||
94721236|NCT00739648|324436932|FG001|Overall Study|Death|0|||
94721237|NCT00739648|324436931|FG000|Overall Study|Do not know|4|||
94721238|NCT00739648|324436932|FG001|Overall Study|Do not know|6|||
94721239|NCT05110495|324436933|FG000|Overall Study|Lost to Follow-up|1|||
94721240|NCT05110495|324436933|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
94368095|NCT01408576|323134828|FG000|Overall Study|AE, serious fatal|4|||
94368096|NCT01408576|323134829|FG001|Overall Study|AE, serious fatal|4|||
94721241|NCT04920084|324436935|FG000|Overall Study|Adverse Event|1|||
94721242|NCT04920084|324436935|FG000|Overall Study|Lost to Follow-up|2|||
94721243|NCT04920084|324436935|FG000|Overall Study|Withdrawal by Subject|2|||
94721244|NCT01757665|324436936|FG000|Overall Study|Still on Study - Visit Completed|240|||
94721245|NCT01757665|324436937|FG001|Overall Study|Still on Study - Visit Completed|30|||
94721246|NCT01757665|324436936|FG000|Overall Study|Still on Study - Visit Pending|398|||
94721247|NCT01757665|324436937|FG001|Overall Study|Still on Study - Visit Pending|40|||
94721248|NCT01757665|324436936|FG000|Overall Study|Still on Study - Missed Visit|14|||
94721249|NCT01757665|324436937|FG001|Overall Study|Still on Study - Missed Visit|1|||
94721250|NCT01757665|324436936|FG000|Overall Study|Death|25|||
94721251|NCT01757665|324436937|FG001|Overall Study|Death|8|||
94721252|NCT01757665|324436936|FG000|Overall Study|Explant|1|||
94721253|NCT01757665|324436937|FG001|Overall Study|Explant|2|||
94721254|NCT01757665|324436936|FG000|Overall Study|Withdrawal by Subject|10|||
94721255|NCT01757665|324436937|FG001|Overall Study|Withdrawal by Subject|0|||
94721256|NCT01757665|324436936|FG000|Overall Study|Lost to Follow-up|1|||
94721257|NCT01757665|324436937|FG001|Overall Study|Lost to Follow-up|1|||
94721258|NCT01757665|324436936|FG000|Overall Study|Not Implanted with Device|5|||
94721259|NCT01757665|324436937|FG001|Overall Study|Not Implanted with Device|1|||
94721260|NCT04850807|324436938|FG000|Overall Study|Death|50|||
94721261|NCT04850807|324436939|FG001|Overall Study|Death|55|||
94721262|NCT04850807|324436938|FG000|Overall Study|Discharged|17|||
94721263|NCT04850807|324436939|FG001|Overall Study|Discharged|13|||
94721264|NCT04850807|324436938|FG000|Overall Study|Incomplete baseline data|3|||
94721265|NCT04850807|324436939|FG001|Overall Study|Incomplete baseline data|2|||
94721266|NCT02630823|324436941|FG000|Overall Study|Withdrawal by Subject|1|||
94721267|NCT02630823|324436941|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
94721268|NCT04419168|324436944|FG000|Overall Study|Protocol Violation|1|||
94721269|NCT04419168|324436945|FG001|Overall Study|Protocol Violation|1|||
94721270|NCT04419168|324436944|FG000|Overall Study|Lost to Follow-up|7|||
94721271|NCT04419168|324436945|FG001|Overall Study|Lost to Follow-up|7|||
94721272|NCT04419168|324436944|FG000|Overall Study|Missed 6-month Visit|48|||
94721273|NCT04419168|324436945|FG001|Overall Study|Missed 6-month Visit|45|||
94721274|NCT03113500|324436948|FG000|Overall Study|Withdrawal by Subject|1|||
94721275|NCT06311084|324436950|FG000|Overall Study|Lost to Follow-up|14|||
94721276|NCT03940703|324437870|FG000|Overall Study|Still under treatment|31|||
94721277|NCT03940703|324437871|FG001|Overall Study|Still under treatment|0|||
94721278|NCT03157167|324437872|FG000|Overall Study|Withdrawal by Subject|1|||
94721279|NCT03157167|324437873|FG001|Overall Study|Withdrawal by Subject|0|||
94721280|NCT03157167|324437874|FG002|Overall Study|Withdrawal by Subject|0|||
94721281|NCT02597946|324437876|FG000|Overall Study|Withdrawal by Subject|1|||
94721282|NCT02597946|324437876|FG000|Overall Study|Progressive disease|16|||
94721283|NCT02597946|324437876|FG000|Overall Study|Other than above|1|||
94721284|NCT04521478|324437879|FG000|Overall Study|Protocol Violation|2|||
94721285|NCT04521478|324437880|FG001|Overall Study|Protocol Violation|0|||
94721286|NCT04521478|324437881|FG002|Overall Study|Protocol Violation|1|||
94721287|NCT04521478|324437882|FG003|Overall Study|Protocol Violation|0|||
94721288|NCT04521478|324437883|FG004|Overall Study|Protocol Violation|0|||
94721289|NCT04521478|324437884|FG005|Overall Study|Protocol Violation|0|||
94721290|NCT04521478|324437879|FG000|Overall Study|Technical Problems|0|||
94721291|NCT04521478|324437880|FG001|Overall Study|Technical Problems|0|||
94721292|NCT04521478|324437881|FG002|Overall Study|Technical Problems|0|||
94721293|NCT04521478|324437882|FG003|Overall Study|Technical Problems|1|||
94721294|NCT04521478|324437883|FG004|Overall Study|Technical Problems|0|||
94721295|NCT04521478|324437884|FG005|Overall Study|Technical Problems|0|||
94721296|NCT04521478|324437879|FG000|Overall Study|Burden of Study Procedures|1|||
94721297|NCT04521478|324437880|FG001|Overall Study|Burden of Study Procedures|0|||
94721298|NCT04521478|324437881|FG002|Overall Study|Burden of Study Procedures|0|||
94721299|NCT04521478|324437882|FG003|Overall Study|Burden of Study Procedures|1|||
94721300|NCT04521478|324437883|FG004|Overall Study|Burden of Study Procedures|0|||
94721301|NCT04521478|324437884|FG005|Overall Study|Burden of Study Procedures|1|||
94721302|NCT04521478|324437879|FG000|Overall Study|Lack of Efficacy|0|||
94721303|NCT04521478|324437880|FG001|Overall Study|Lack of Efficacy|0|||
94721304|NCT04521478|324437881|FG002|Overall Study|Lack of Efficacy|0|||
94721305|NCT04521478|324437882|FG003|Overall Study|Lack of Efficacy|0|||
94721306|NCT04521478|324437883|FG004|Overall Study|Lack of Efficacy|1|||
94721307|NCT04521478|324437884|FG005|Overall Study|Lack of Efficacy|1|||
94721308|NCT04521478|324437879|FG000|Overall Study|Adverse Event|7|||
94721309|NCT04521478|324437880|FG001|Overall Study|Adverse Event|0|||
94721310|NCT04521478|324437881|FG002|Overall Study|Adverse Event|2|||
94721311|NCT04521478|324437882|FG003|Overall Study|Adverse Event|1|||
94721312|NCT04521478|324437883|FG004|Overall Study|Adverse Event|2|||
94721313|NCT04521478|324437884|FG005|Overall Study|Adverse Event|7|||
94721314|NCT04521478|324437879|FG000|Overall Study|No Reason Available|0|||
94721315|NCT04521478|324437880|FG001|Overall Study|No Reason Available|2|||
94721316|NCT04521478|324437881|FG002|Overall Study|No Reason Available|0|||
94368097|NCT01408576|323134830|FG002|Overall Study|AE, serious fatal|1|||
94721317|NCT04521478|324437882|FG003|Overall Study|No Reason Available|0|||
94721318|NCT04521478|324437883|FG004|Overall Study|No Reason Available|1|||
94721319|NCT04521478|324437884|FG005|Overall Study|No Reason Available|0|||
94721320|NCT04521478|324437879|FG000|Overall Study|Other than listed|3|||
94721321|NCT04521478|324437880|FG001|Overall Study|Other than listed|3|||
94721322|NCT04521478|324437881|FG002|Overall Study|Other than listed|3|||
94368098|NCT01408576|323134828|FG000|Overall Study|SAE, non-fatal|11|||
94368099|NCT01408576|323134829|FG001|Overall Study|SAE, non-fatal|23|||
94368100|NCT01408576|323134830|FG002|Overall Study|SAE, non-fatal|14|||
94368101|NCT01408576|323134828|FG000|Overall Study|AE, non-serious non-fatal|12|||
94368102|NCT01408576|323134829|FG001|Overall Study|AE, non-serious non-fatal|19|||
94368103|NCT01408576|323134830|FG002|Overall Study|AE, non-serious non-fatal|11|||
94368104|NCT01408576|323134828|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
94368105|NCT01408576|323134829|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
94368106|NCT01408576|323134830|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
94368107|NCT01408576|323134828|FG000|Overall Study|AE, unknown type|0|||
94368108|NCT01408576|323134829|FG001|Overall Study|AE, unknown type|1|||
94368109|NCT01408576|323134830|FG002|Overall Study|AE, unknown type|0|||
94368110|NCT01408576|323134828|FG000|Overall Study|Other|10|||
94368111|NCT01408576|323134829|FG001|Overall Study|Other|16|||
94721323|NCT04521478|324437882|FG003|Overall Study|Other than listed|2|||
94721324|NCT04521478|324437883|FG004|Overall Study|Other than listed|3|||
94721325|NCT04521478|324437884|FG005|Overall Study|Other than listed|3|||
94721326|NCT04521478|324437879|FG000|Overall Study|Not treated|0|||
94721327|NCT04521478|324437880|FG001|Overall Study|Not treated|0|||
94721328|NCT04521478|324437881|FG002|Overall Study|Not treated|0|||
94721329|NCT04521478|324437882|FG003|Overall Study|Not treated|0|||
94721330|NCT04521478|324437883|FG004|Overall Study|Not treated|0|||
94721331|NCT04521478|324437884|FG005|Overall Study|Not treated|1|||
94721332|NCT03625882|324437885|FG000|Overall Study|Protocol Violation|3|||
94721333|NCT05141903|324437894|FG000|Overall Study|Withdrawal by Subject|0|||
94721334|NCT05141903|324437895|FG001|Overall Study|Withdrawal by Subject|1|||
94721335|NCT05141903|324437896|FG002|Overall Study|Withdrawal by Subject|1|||
94721336|NCT05141903|324437897|FG003|Overall Study|Withdrawal by Subject|0|||
94721337|NCT05141903|324437898|FG004|Overall Study|Withdrawal by Subject|0|||
94721338|NCT05141903|324437894|FG000|Overall Study|Other|1|||
94721339|NCT05141903|324437895|FG001|Overall Study|Other|1|||
94721340|NCT05141903|324437896|FG002|Overall Study|Other|0|||
94721341|NCT05141903|324437897|FG003|Overall Study|Other|0|||
94721342|NCT05141903|324437898|FG004|Overall Study|Other|0|||
94721343|NCT04716634|324437899|FG000|Overall Study|Death|24|||
94721344|NCT04716634|324437900|FG001|Overall Study|Death|24|||
94721345|NCT04716634|324437901|FG002|Overall Study|Death|8|||
94721346|NCT04716634|324437899|FG000|Overall Study|Closed by Sponsor|4|||
94721347|NCT04716634|324437900|FG001|Overall Study|Closed by Sponsor|4|||
94721348|NCT04716634|324437901|FG002|Overall Study|Closed by Sponsor|5|||
94721349|NCT04716634|324437899|FG000|Overall Study|Lost to Follow-up|1|||
94721350|NCT04716634|324437900|FG001|Overall Study|Lost to Follow-up|0|||
94721351|NCT04716634|324437901|FG002|Overall Study|Lost to Follow-up|1|||
94721352|NCT04716634|324437899|FG000|Overall Study|Withdrawal by Subject|0|||
94721353|NCT04716634|324437900|FG001|Overall Study|Withdrawal by Subject|0|||
94721354|NCT04716634|324437901|FG002|Overall Study|Withdrawal by Subject|1|||
94721355|NCT02287311|324437915|FG000|Cohort 1: Dose Level 1|Death|2|||
94721356|NCT02287311|324437916|FG001|Cohort 1: Dose Level 1|Death|0|||
94721357|NCT02287311|324437917|FG002|Cohort 1: Dose Level 1|Death|0|||
94721358|NCT02287311|324437918|FG003|Cohort 1: Dose Level 1|Death|3|||
94721359|NCT02287311|324437919|FG004|Cohort 1: Dose Level 1|Death|0|||
94721360|NCT02287311|324437920|FG005|Cohort 1: Dose Level 1|Death|0|||
94721361|NCT02287311|324437921|FG006|Cohort 1: Dose Level 1|Death|1|||
94721362|NCT02287311|324437922|FG007|Cohort 1: Dose Level 1|Death|0|||
94721363|NCT02287311|324437923|FG008|Cohort 1: Dose Level 1|Death|0|||
94721364|NCT02287311|324437915|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
94721365|NCT02287311|324437916|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
94721366|NCT02287311|324437917|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
94721367|NCT02287311|324437918|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
94368112|NCT01408576|323134830|FG002|Overall Study|Other|18|||
94721368|NCT02287311|324437919|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
94721369|NCT02287311|324437920|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
94721370|NCT02287311|324437921|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
94721371|NCT02287311|324437922|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
94721372|NCT02287311|324437923|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
94721373|NCT02287311|324437915|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
94721374|NCT02287311|324437916|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
94721375|NCT02287311|324437917|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
94721376|NCT02287311|324437918|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
94721377|NCT02287311|324437919|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
94721378|NCT02287311|324437920|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
94721379|NCT02287311|324437921|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
94721380|NCT02287311|324437922|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
94368113|NCT03349437|323134835|FG000|Screening|Screen Fail|4|||
94368114|NCT03349437|323134836|FG001|Screening|Screen Fail|0|||
94368115|NCT03349437|323134837|FG002|Screening|Screen Fail|0|||
94368116|NCT03349437|323134835|FG000|Screening|Withdrawn|1|||
94721381|NCT02287311|324437923|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
94721382|NCT02287311|324437915|FG000|Cohort 2: Dose Level 2|Death|0|||
94721383|NCT02287311|324437916|FG001|Cohort 2: Dose Level 2|Death|2|||
94721384|NCT02287311|324437917|FG002|Cohort 2: Dose Level 2|Death|0|||
94721385|NCT02287311|324437918|FG003|Cohort 2: Dose Level 2|Death|0|||
94721386|NCT02287311|324437919|FG004|Cohort 2: Dose Level 2|Death|2|||
94721387|NCT02287311|324437920|FG005|Cohort 2: Dose Level 2|Death|0|||
94721388|NCT02287311|324437921|FG006|Cohort 2: Dose Level 2|Death|0|||
94721389|NCT02287311|324437922|FG007|Cohort 2: Dose Level 2|Death|2|||
94721390|NCT02287311|324437923|FG008|Cohort 2: Dose Level 2|Death|0|||
94721391|NCT02287311|324437915|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
94721392|NCT02287311|324437916|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
94721393|NCT02287311|324437917|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
94721394|NCT02287311|324437918|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
94721395|NCT02287311|324437919|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
94721396|NCT02287311|324437920|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
94721397|NCT02287311|324437921|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
94272252|NCT01438489|322790368|FG002|Overall Study|Received prohibited medication|0|||
94272253|NCT01438489|322790366|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
94272254|NCT01438489|322790367|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
94272255|NCT01438489|322790368|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
94272256|NCT01438489|322790366|FG000|Overall Study|Inadequate venous access|0|||
94272257|NCT01438489|322790367|FG001|Overall Study|Inadequate venous access|2|||
94272258|NCT01438489|322790368|FG002|Overall Study|Inadequate venous access|0|||
94272259|NCT02234284|322790369|FG000|Overall Study|Death|4|||
94272260|NCT02234284|322790370|FG001|Overall Study|Death|2|||
94272261|NCT02234284|322790369|FG000|Overall Study|Withdrawal by Subject|1|||
94272262|NCT02234284|322790370|FG001|Overall Study|Withdrawal by Subject|0|||
94272263|NCT02234284|322790369|FG000|Overall Study|Lost to Follow-up|20|||
94272264|NCT02234284|322790370|FG001|Overall Study|Lost to Follow-up|7|||
94272265|NCT01476475|322790372|FG000|Overall Study|Adverse Event|6|||
94272266|NCT01476475|322790373|FG001|Overall Study|Adverse Event|0|||
94272267|NCT01476475|322790372|FG000|Overall Study|Poor compliance to protocol|1|||
94272268|NCT01476475|322790373|FG001|Overall Study|Poor compliance to protocol|1|||
94272269|NCT01476475|322790372|FG000|Overall Study|Other reasons|4|||
94272270|NCT01476475|322790373|FG001|Overall Study|Other reasons|2|||
94272271|NCT00326209|322790374|FG000|Overall Study|Adverse Event|28|||
94721398|NCT02287311|324437922|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
94272272|NCT00326209|322790374|FG000|Overall Study|Withdrawal by Subject|22|||
94721399|NCT02287311|324437923|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
94721400|NCT02287311|324437915|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
94368117|NCT03349437|323134836|FG001|Screening|Withdrawn|0|||
94368118|NCT03349437|323134837|FG002|Screening|Withdrawn|0|||
94368119|NCT01461369|323134838|FG000|Overall Study|Lack of Efficacy|2|||
94368120|NCT01461369|323134839|FG001|Overall Study|Lack of Efficacy|0|||
94368121|NCT01461369|323134840|FG002|Overall Study|Lack of Efficacy|6|||
94368122|NCT01461369|323134838|FG000|Overall Study|Lost to Follow-up|0|||
94368123|NCT01461369|323134839|FG001|Overall Study|Lost to Follow-up|0|||
94368124|NCT01461369|323134840|FG002|Overall Study|Lost to Follow-up|3|||
94368125|NCT01461369|323134838|FG000|Overall Study|Adverse Event|9|||
94368126|NCT01461369|323134839|FG001|Overall Study|Adverse Event|12|||
94368127|NCT01461369|323134840|FG002|Overall Study|Adverse Event|4|||
94368128|NCT01461369|323134838|FG000|Overall Study|Protocol Violation|1|||
94368129|NCT01461369|323134839|FG001|Overall Study|Protocol Violation|2|||
94368130|NCT01461369|323134840|FG002|Overall Study|Protocol Violation|2|||
94368131|NCT01461369|323134838|FG000|Overall Study|Withdrawal by Subject|1|||
94368132|NCT01461369|323134839|FG001|Overall Study|Withdrawal by Subject|3|||
94368133|NCT01461369|323134840|FG002|Overall Study|Withdrawal by Subject|2|||
94368134|NCT00765999|323134841|FG000|Overall Study|Adverse Event|203|||
94368135|NCT00765999|323134841|FG000|Overall Study|Insufficient Therapeutic Response|100|||
94368136|NCT00765999|323134841|FG000|Overall Study|Protocol Violation|95|||
94368137|NCT00765999|323134841|FG000|Overall Study|Consent Withdrawn|202|||
94368138|NCT00765999|323134841|FG000|Overall Study|Lost to Follow-up|131|||
94368139|NCT00765999|323134841|FG000|Overall Study|Study Terminated by Sponsor|2|||
94721401|NCT02287311|324437916|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
94721402|NCT02287311|324437917|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
94721403|NCT02287311|324437918|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
94721404|NCT02287311|324437919|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
94721405|NCT02287311|324437920|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
94721406|NCT02287311|324437921|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
94721407|NCT02287311|324437922|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
94721408|NCT02287311|324437923|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
94721409|NCT02287311|324437915|FG000|Cohort 3: Dose Level 3|Death|0|||
94721410|NCT02287311|324437916|FG001|Cohort 3: Dose Level 3|Death|0|||
94721411|NCT02287311|324437917|FG002|Cohort 3: Dose Level 3|Death|4|||
94721412|NCT02287311|324437918|FG003|Cohort 3: Dose Level 3|Death|0|||
94721413|NCT02287311|324437919|FG004|Cohort 3: Dose Level 3|Death|0|||
94721414|NCT02287311|324437920|FG005|Cohort 3: Dose Level 3|Death|4|||
94721415|NCT02287311|324437921|FG006|Cohort 3: Dose Level 3|Death|0|||
94721416|NCT02287311|324437922|FG007|Cohort 3: Dose Level 3|Death|0|||
94721417|NCT02287311|324437923|FG008|Cohort 3: Dose Level 3|Death|2|||
94721418|NCT02287311|324437915|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
94721419|NCT02287311|324437916|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
94721420|NCT02287311|324437917|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
94721421|NCT02287311|324437918|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
94721422|NCT02287311|324437919|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
94721423|NCT02287311|324437920|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
94721424|NCT02287311|324437921|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
94721425|NCT02287311|324437922|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
94721426|NCT02287311|324437923|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
94721427|NCT02287311|324437915|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
94721428|NCT02287311|324437916|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
94721429|NCT02287311|324437917|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
94721430|NCT02287311|324437918|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
94721431|NCT02287311|324437919|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
94721432|NCT02287311|324437920|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
94721433|NCT02287311|324437921|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
94721434|NCT02287311|324437922|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
94721435|NCT02287311|324437923|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
94721436|NCT03896516|324437924|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
94721437|NCT03896516|324437925|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
94721438|NCT03896516|324437924|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
94721439|NCT03896516|324437925|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
94721440|NCT03896516|324437924|FG000|Washout Period|Physician Decision|3|||
94721441|NCT03896516|324437925|FG001|Washout Period|Physician Decision|1|||
94721442|NCT03896516|324437924|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
94721443|NCT03896516|324437925|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
94368140|NCT00765999|323134841|FG000|Overall Study|Other Miscellaneous Reasons|51|||
94368141|NCT01399125|323134842|FG000|Overall Study|Adverse Event|32|||
94368142|NCT01399125|323134843|FG001|Overall Study|Adverse Event|30|||
94368143|NCT01399125|323134842|FG000|Overall Study|Abnormal Lab values|0|||
94368144|NCT01399125|323134843|FG001|Overall Study|Abnormal Lab values|1|||
94368145|NCT01399125|323134842|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
94368146|NCT01399125|323134843|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
94721444|NCT03648840|324437928|FG000|First IV Infusion Session|Adverse Event|0|||
94721445|NCT03648840|324437929|FG001|First IV Infusion Session|Adverse Event|2|||
94721446|NCT03648840|324437928|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
94721447|NCT03648840|324437929|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
94721448|NCT03648840|324437928|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
94721449|NCT03648840|324437929|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
94721450|NCT03648840|324437928|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
94721451|NCT03648840|324437929|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
94721452|NCT05063994|324437933|FG000|Cortef Run-In|Withdrawal of Consent|1|||
94721453|NCT05063994|324437934|FG001|Cortef Run-In|Withdrawal of Consent|0|||
94721454|NCT05063994|324437935|FG002|Cortef Run-In|Withdrawal of Consent|0|||
94721455|NCT05063994|324437933|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
94721456|NCT05063994|324437934|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
94721457|NCT05063994|324437935|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
94721458|NCT05063994|324437933|FG000|Treatment|Physician Decision|0|||
94721459|NCT05063994|324437934|FG001|Treatment|Physician Decision|0|||
94721460|NCT05063994|324437935|FG002|Treatment|Physician Decision|1|||
94721461|NCT05063994|324437933|FG000|Treatment|Withdrawal by Subject|0|||
94721462|NCT05063994|324437934|FG001|Treatment|Withdrawal by Subject|0|||
94721463|NCT05063994|324437935|FG002|Treatment|Withdrawal by Subject|1|||
94721464|NCT05063994|324437933|FG000|Treatment|Withdrawal of Consent|0|||
94721465|NCT05063994|324437934|FG001|Treatment|Withdrawal of Consent|0|||
94721466|NCT05063994|324437935|FG002|Treatment|Withdrawal of Consent|1|||
94721467|NCT03101904|324437938|FG000|Wash Out (10 Days)|Adverse Event|1|||
94721468|NCT03101904|324437939|FG001|Wash Out (10 Days)|Adverse Event|0|||
94721469|NCT03101904|324437938|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
94721470|NCT03101904|324437939|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
94721471|NCT04820855|324437955|FG000|Overall Study|Lost to Follow-up|6|||
94721472|NCT04820855|324437956|FG001|Overall Study|Lost to Follow-up|9|||
94721473|NCT02592330|324437957|FG000|Overall Study|Withdrawal by Subject|1|||
94721474|NCT02592330|324437958|FG001|Overall Study|Withdrawal by Subject|0|||
94721475|NCT02592330|324437957|FG000|Overall Study|Failed Biopsy|1|||
94721476|NCT02592330|324437958|FG001|Overall Study|Failed Biopsy|0|||
94721477|NCT03514017|324437960|FG000|Overall Study|Death|1|||
94721478|NCT03514017|324437960|FG000|Overall Study|Adverse Event|1|||
94721479|NCT02471638|324437961|FG000|Overall Study|Early Term Withdrawal|10|||
94721480|NCT04052516|324439073|FG000|Overall Study|Withdrawal by Subject|4|||
94721481|NCT04052516|324439074|FG001|Overall Study|Withdrawal by Subject|5|||
94721482|NCT04052516|324439075|FG002|Overall Study|Withdrawal by Subject|6|||
94721483|NCT04052516|324439073|FG000|Overall Study|Adverse Event|3|||
94721484|NCT04052516|324439074|FG001|Overall Study|Adverse Event|2|||
94721485|NCT04052516|324439075|FG002|Overall Study|Adverse Event|8|||
94721486|NCT04052516|324439073|FG000|Overall Study|Lost to Follow-up|2|||
94721487|NCT04052516|324439074|FG001|Overall Study|Lost to Follow-up|5|||
94721488|NCT04052516|324439075|FG002|Overall Study|Lost to Follow-up|3|||
94721489|NCT04052516|324439073|FG000|Overall Study|Protocol Violation|1|||
94721490|NCT04052516|324439074|FG001|Overall Study|Protocol Violation|1|||
94721491|NCT04052516|324439075|FG002|Overall Study|Protocol Violation|0|||
94721492|NCT04052516|324439073|FG000|Overall Study|Death|1|||
94467337|NCT00306787|323500508|FG001|Overall Study|Abnormal laboratory value(s)|0|||
94721493|NCT04052516|324439074|FG001|Overall Study|Death|0|||
94721494|NCT04052516|324439075|FG002|Overall Study|Death|0|||
94721495|NCT04052516|324439073|FG000|Overall Study|Physician Decision|0|||
94721496|NCT04052516|324439074|FG001|Overall Study|Physician Decision|1|||
94721497|NCT04052516|324439075|FG002|Overall Study|Physician Decision|0|||
94721498|NCT04052516|324439073|FG000|Overall Study|Pregnancy|1|||
94721499|NCT04052516|324439074|FG001|Overall Study|Pregnancy|0|||
94721500|NCT04052516|324439075|FG002|Overall Study|Pregnancy|0|||
94721501|NCT04052516|324439073|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
94721502|NCT04052516|324439074|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
94721503|NCT04052516|324439075|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
94721504|NCT04052516|324439073|FG000|Overall Study|Reason not recorded|0|||
94721505|NCT04052516|324439074|FG001|Overall Study|Reason not recorded|1|||
94721506|NCT04052516|324439075|FG002|Overall Study|Reason not recorded|0|||
94721507|NCT01938547|324439077|FG000|Overall Study|Physician Decision|1|||
94721508|NCT01894061|324439082|FG000|Overall Study|Screen failure|1|||
94721509|NCT01894061|324439082|FG000|Overall Study|Withdrawal by Subject|1|||
94721510|NCT02840474|324439086|FG000|Overall Study|Lost to Follow-up|1|||
94721511|NCT02840474|324439087|FG001|Overall Study|Lost to Follow-up|0|||
94721512|NCT04402489|324439088|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
94721513|NCT04402489|324439089|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
94721514|NCT04402489|324439090|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
94721515|NCT04402489|324439091|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
94721516|NCT04402489|324439092|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
94721517|NCT04402489|324439088|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
94721518|NCT04402489|324439089|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
94721519|NCT04402489|324439090|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
94721520|NCT04402489|324439091|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
94721521|NCT04402489|324439092|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
94721522|NCT04402489|324439088|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
94721523|NCT04402489|324439089|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
94721524|NCT04402489|324439090|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
94721525|NCT04402489|324439091|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
94721526|NCT04402489|324439092|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
94721527|NCT04402489|324439088|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
94721528|NCT04402489|324439089|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
94721529|NCT04402489|324439090|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
94721530|NCT04402489|324439091|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
94272273|NCT00326209|322790374|FG000|Overall Study|Lack of Efficacy|31|||
94272274|NCT00326209|322790374|FG000|Overall Study|Lost to Follow-up|18|||
94272275|NCT00326209|322790374|FG000|Overall Study|Participant non-compliant|6|||
94272276|NCT00326209|322790374|FG000|Overall Study|Sponsor closed study|173|||
94272277|NCT00326209|322790374|FG000|Overall Study|Prohibited medication use|1|||
94272278|NCT00326209|322790374|FG000|Overall Study|Violation of entry criteria|1|||
94272279|NCT00326209|322790374|FG000|Overall Study|Withdrawn in error|1|||
94272280|NCT00326209|322790374|FG000|Overall Study|Pregnancy|1|||
94272281|NCT01278745|322790379|FG000|Overall Study|Death|2|||
94272282|NCT01278745|322790380|FG001|Overall Study|Death|5|||
94272283|NCT01278745|322790381|FG002|Overall Study|Death|7|||
94272284|NCT01278745|322790382|FG003|Overall Study|Death|0|||
94272285|NCT01278745|322790379|FG000|Overall Study|Physician Decision|1|||
94272286|NCT01278745|322790380|FG001|Overall Study|Physician Decision|0|||
94272287|NCT01278745|322790381|FG002|Overall Study|Physician Decision|0|||
94272288|NCT01278745|322790382|FG003|Overall Study|Physician Decision|9|||
94272289|NCT01278745|322790379|FG000|Overall Study|Withdrawal by Subject|1|||
94272290|NCT01278745|322790380|FG001|Overall Study|Withdrawal by Subject|1|||
94272291|NCT01278745|322790381|FG002|Overall Study|Withdrawal by Subject|5|||
94272292|NCT01278745|322790382|FG003|Overall Study|Withdrawal by Subject|1|||
94272293|NCT01278745|322790379|FG000|Overall Study|Sponsor Decision|1|||
94272294|NCT01278745|322790380|FG001|Overall Study|Sponsor Decision|0|||
94272295|NCT01278745|322790381|FG002|Overall Study|Sponsor Decision|62|||
94272296|NCT01278745|322790382|FG003|Overall Study|Sponsor Decision|6|||
94272297|NCT01278745|322790379|FG000|Overall Study|Ineligible|0|||
94272298|NCT01278745|322790380|FG001|Overall Study|Ineligible|0|||
94272299|NCT01278745|322790381|FG002|Overall Study|Ineligible|42|||
94272300|NCT01278745|322790382|FG003|Overall Study|Ineligible|61|||
94272301|NCT01278745|322790379|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
94272302|NCT01278745|322790380|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
94272303|NCT01278745|322790381|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
94272304|NCT01278745|322790382|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
94272305|NCT02577406|322790383|FG000|Randomized Period|Death|1|||
94721531|NCT04402489|324439092|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
94272306|NCT02577406|322790384|FG001|Randomized Period|Death|0|||
94272307|NCT02577406|322790383|FG000|Randomized Period|Other reasons|0|||
94272308|NCT02577406|322790384|FG001|Randomized Period|Other reasons|20|||
94272309|NCT02577406|322790383|FG000|Treatment Period|Death|38|||
94272310|NCT02577406|322790384|FG001|Treatment Period|Death|23|||
94272311|NCT02577406|322790383|FG000|Treatment Period|Adverse Event|17|||
94272312|NCT02577406|322790384|FG001|Treatment Period|Adverse Event|12|||
94272313|NCT02577406|322790383|FG000|Treatment Period|Progressive Disease|53|||
94272314|NCT02577406|322790384|FG001|Treatment Period|Progressive Disease|37|||
94272315|NCT02577406|322790383|FG000|Treatment Period|Withdrawal by Subject|10|||
94272316|NCT02577406|322790384|FG001|Treatment Period|Withdrawal by Subject|24|||
94272317|NCT02577406|322790383|FG000|Treatment Period|Lost to Follow-up|0|||
94272318|NCT02577406|322790384|FG001|Treatment Period|Lost to Follow-up|1|||
94272319|NCT02577406|322790383|FG000|Treatment Period|Transition to commercially available treatment|1|||
94272320|NCT02577406|322790384|FG001|Treatment Period|Transition to commercially available treatment|1|||
94272321|NCT02577406|322790383|FG000|Treatment Period|Physician Decision|1|||
94272322|NCT02577406|322790384|FG001|Treatment Period|Physician Decision|0|||
94272323|NCT02577406|322790383|FG000|Treatment Period|Disease Relapse|28|||
94272324|NCT02577406|322790384|FG001|Treatment Period|Disease Relapse|1|||
94272325|NCT02577406|322790383|FG000|Treatment Period|Protocol Violation|0|||
94272326|NCT02577406|322790384|FG001|Treatment Period|Protocol Violation|1|||
94272327|NCT02577406|322790383|FG000|Treatment Period|Other Reasons|3|||
94272328|NCT02577406|322790384|FG001|Treatment Period|Other Reasons|39|||
94272329|NCT02577406|322790383|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
94272330|NCT02577406|322790384|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
94272331|NCT01671111|322790390|FG000|Overall Study|Adverse Event|2|||
94272332|NCT01671111|322790390|FG000|Overall Study|Lack of Efficacy|1|||
94272333|NCT01671111|322790390|FG000|Overall Study|Withdrawal by Subject|2|||
94272334|NCT01671111|322790390|FG000|Overall Study|Physician Decision|1|||
94272335|NCT01671111|322790390|FG000|Overall Study|Other|24|||
94272336|NCT02953340|322790391|FG000|Overall Study|Death|0|||
94272337|NCT02953340|322790392|FG001|Overall Study|Death|1|||
94368147|NCT01399125|323134842|FG000|Overall Study|Withdrawal by Subject|5|||
94272338|NCT02953340|322790391|FG000|Overall Study|Investigator Decision|3|||
94272339|NCT02953340|322790392|FG001|Overall Study|Investigator Decision|3|||
94721532|NCT04402489|324439088|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
94721533|NCT04402489|324439089|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
94721534|NCT04402489|324439090|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
94721535|NCT04402489|324439091|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
94721536|NCT04402489|324439092|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
94721537|NCT04402489|324439088|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
94721538|NCT04402489|324439089|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
94721539|NCT04402489|324439090|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
94721540|NCT04402489|324439091|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
94721541|NCT04402489|324439092|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
94721542|NCT03192891|324439093|FG000|Overall Study|Lost to Follow-up|55|||
94721543|NCT04630262|324439096|FG000|Overall Study|Intraoperative Screen Failure|5|||
94721544|NCT04630262|324439096|FG000|Overall Study|Study terminated prematurely|71|||
94272340|NCT02953340|322790391|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
94272341|NCT02953340|322790392|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
94272342|NCT02953340|322790391|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
94272343|NCT02953340|322790392|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
94272344|NCT02953340|322790391|FG000|Overall Study|Withdrawal by Subject|9|||
94272345|NCT02953340|322790392|FG001|Overall Study|Withdrawal by Subject|9|||
94272346|NCT02953340|322790391|FG000|Overall Study|Sponsor decision|0|||
94368148|NCT01399125|323134843|FG001|Overall Study|Withdrawal by Subject|8|||
94368149|NCT01399125|323134842|FG000|Overall Study|Lost to Follow-up|2|||
94721545|NCT04630262|324439096|FG000|Overall Study|Withdrawal by Subject|2|||
94721546|NCT04630262|324439096|FG000|Overall Study|Physician Decision|2|||
94721547|NCT01195831|324439097|FG000|Overall Study|Lost to Follow-up|2|||
94721548|NCT01195831|324439098|FG001|Overall Study|Lost to Follow-up|4|||
94721549|NCT01195831|324439097|FG000|Overall Study|Withdrawal by Subject|2|||
94721550|NCT01195831|324439098|FG001|Overall Study|Withdrawal by Subject|2|||
94721551|NCT01195831|324439097|FG000|Overall Study|Adverse Event|4|||
94721552|NCT01195831|324439098|FG001|Overall Study|Adverse Event|2|||
94721553|NCT01195831|324439097|FG000|Overall Study|Protocol Violation|0|||
94721554|NCT01195831|324439098|FG001|Overall Study|Protocol Violation|2|||
94721555|NCT01857934|324439099|FG000|Overall Study|Relapse or progression|2|||
94721556|NCT01857934|324439099|FG000|Overall Study|Unacceptable toxicity|3|||
94721557|NCT01857934|324439099|FG000|Overall Study|Unwillingness or inability to comply|2|||
94721558|NCT01857934|324439099|FG000|Overall Study|Physician Decision|3|||
94721559|NCT04638998|324439101|FG000|Overall Study|Withdrawal by Subject|1|||
94721560|NCT04638998|324439102|FG001|Overall Study|Withdrawal by Subject|3|||
94721561|NCT03692676|324439103|FG000|Overall Study|exclude patients with prior use|4424|||
94721562|NCT03692676|324439104|FG001|Overall Study|exclude patients with prior use|24726|||
94721563|NCT03692676|324439105|FG002|Overall Study|exclude patients with prior use|0|||
94721564|NCT03692676|324439106|FG003|Overall Study|exclude patients with prior use|0|||
94272347|NCT02953340|322790392|FG001|Overall Study|Sponsor decision|2|||
94272348|NCT02953340|322790391|FG000|Overall Study|Lost to Follow-up|3|||
94272349|NCT02953340|322790392|FG001|Overall Study|Lost to Follow-up|2|||
94272350|NCT02953340|322790391|FG000|Overall Study|Reason not specified|2|||
94272351|NCT02953340|322790392|FG001|Overall Study|Reason not specified|2|||
94368150|NCT01399125|323134843|FG001|Overall Study|Lost to Follow-up|3|||
94721565|NCT03692676|324439103|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
94721566|NCT03692676|324439104|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
94721567|NCT03692676|324439105|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
94721568|NCT03692676|324439106|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
94721569|NCT03692676|324439103|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
94721570|NCT03692676|324439104|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
94721571|NCT03692676|324439105|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
94721572|NCT03692676|324439106|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
94721573|NCT03692676|324439103|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
94721574|NCT03692676|324439104|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
94721575|NCT03692676|324439105|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
94721576|NCT03692676|324439106|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
94721577|NCT03692676|324439103|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
94721578|NCT03692676|324439104|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
94721579|NCT03692676|324439105|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
94721580|NCT03692676|324439106|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
94721581|NCT03692676|324439103|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
94721582|NCT03692676|324439104|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
94721583|NCT03692676|324439105|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
94721584|NCT03692676|324439106|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
94721585|NCT03692676|324439103|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
94721586|NCT03692676|324439104|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
94721587|NCT03692676|324439105|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
94721588|NCT03692676|324439106|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
94721589|NCT03692676|324439103|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
94721590|NCT03692676|324439104|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
94721591|NCT03692676|324439105|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
94721592|NCT03692676|324439106|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
94721593|NCT03692676|324439103|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
94721594|NCT03692676|324439104|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
94721595|NCT03692676|324439105|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
94721596|NCT03692676|324439106|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
94721597|NCT03692676|324439103|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
94721598|NCT03692676|324439104|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
94721599|NCT03692676|324439105|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
94721600|NCT03692676|324439106|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
94721601|NCT03692676|324439103|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
94721602|NCT03692676|324439104|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
94721603|NCT03692676|324439105|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
94721604|NCT03692676|324439106|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
94721605|NCT03692676|324439103|FG000|Overall Study|Other|0|||
94721606|NCT03692676|324439104|FG001|Overall Study|Other|805|||
94721607|NCT03692676|324439105|FG002|Overall Study|Other|758|||
94721608|NCT03692676|324439106|FG003|Overall Study|Other|277|||
94721609|NCT03692676|324439103|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
94721610|NCT03692676|324439104|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
94721611|NCT03692676|324439105|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
94721612|NCT03692676|324439106|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
94721613|NCT04549168|324439107|FG000|Randomization Phase|Adverse Event|0|||
94721614|NCT04549168|324439108|FG001|Randomization Phase|Adverse Event|0|||
94721615|NCT04549168|324439109|FG002|Randomization Phase|Adverse Event|1|||
94721616|NCT04549168|324439107|FG000|Randomization Phase|Other|0|||
94721617|NCT04549168|324439108|FG001|Randomization Phase|Other|2|||
94721618|NCT04549168|324439109|FG002|Randomization Phase|Other|0|||
94721619|NCT04549168|324439107|FG000|Randomization Phase|Withdrawal by Subject|0|||
94721620|NCT04549168|324439108|FG001|Randomization Phase|Withdrawal by Subject|2|||
94721621|NCT04549168|324439109|FG002|Randomization Phase|Withdrawal by Subject|1|||
94721622|NCT01180634|324439110|FG000|Overall Study|Adverse Event|4|||
94721623|NCT01180634|324439111|FG001|Overall Study|Adverse Event|1|||
94721624|NCT01180634|324439110|FG000|Overall Study|Miscellaneous|2|||
94721625|NCT01180634|324439111|FG001|Overall Study|Miscellaneous|0|||
94721626|NCT01180634|324439110|FG000|Overall Study|Withdrawal by Subject|4|||
94721627|NCT01180634|324439111|FG001|Overall Study|Withdrawal by Subject|0|||
94721628|NCT04725240|324439118|FG000|Overall Study|Adverse Event|2|||
94721629|NCT03147287|324439122|FG000|Overall Study|Randomized Not Treated|2|||
94721630|NCT03147287|324439123|FG001|Overall Study|Randomized Not Treated|1|||
94721631|NCT03147287|324439124|FG002|Overall Study|Randomized Not Treated|1|||
94721632|NCT03147287|324439122|FG000|Overall Study|Progressive Disease RECIST|31|||
94721633|NCT03147287|324439123|FG001|Overall Study|Progressive Disease RECIST|72|||
94721634|NCT03147287|324439124|FG002|Overall Study|Progressive Disease RECIST|32|||
94721635|NCT03147287|324439122|FG000|Overall Study|Progressive Disease not RECIST|13|||
94721636|NCT03147287|324439123|FG001|Overall Study|Progressive Disease not RECIST|21|||
94721637|NCT03147287|324439124|FG002|Overall Study|Progressive Disease not RECIST|13|||
94721638|NCT03147287|324439122|FG000|Overall Study|Physician Decision|1|||
94721639|NCT03147287|324439123|FG001|Overall Study|Physician Decision|2|||
94721640|NCT03147287|324439124|FG002|Overall Study|Physician Decision|1|||
94721641|NCT03147287|324439122|FG000|Overall Study|Intercurrent illness|0|||
94721642|NCT03147287|324439123|FG001|Overall Study|Intercurrent illness|1|||
94721643|NCT03147287|324439124|FG002|Overall Study|Intercurrent illness|0|||
94721644|NCT03147287|324439122|FG000|Overall Study|Withdrawal by Subject|2|||
94721645|NCT03147287|324439123|FG001|Overall Study|Withdrawal by Subject|3|||
94721646|NCT03147287|324439124|FG002|Overall Study|Withdrawal by Subject|2|||
94721647|NCT03147287|324439122|FG000|Overall Study|Patient Non-Compliance|0|||
94721648|NCT03147287|324439123|FG001|Overall Study|Patient Non-Compliance|2|||
94721649|NCT03147287|324439124|FG002|Overall Study|Patient Non-Compliance|0|||
94721650|NCT03147287|324439122|FG000|Overall Study|Patient moved|0|||
94721651|NCT03147287|324439123|FG001|Overall Study|Patient moved|1|||
94721652|NCT03147287|324439124|FG002|Overall Study|Patient moved|0|||
94721653|NCT03147287|324439122|FG000|Overall Study|Arm A crossover without PD|1|||
94721654|NCT03147287|324439123|FG001|Overall Study|Arm A crossover without PD|0|||
94721655|NCT03147287|324439124|FG002|Overall Study|Arm A crossover without PD|0|||
94721656|NCT03147287|324439122|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
94721657|NCT03147287|324439123|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
94721658|NCT03147287|324439124|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
94721659|NCT03090152|324439127|FG000|Overall Study|Withdrawal by Subject|0|||
94721660|NCT03090152|324439128|FG001|Overall Study|Withdrawal by Subject|2|||
94721661|NCT03090152|324439129|FG002|Overall Study|Withdrawal by Subject|1|||
94721662|NCT03090152|324439127|FG000|Overall Study|Surgery Canceled|1|||
94721663|NCT03090152|324439128|FG001|Overall Study|Surgery Canceled|0|||
94721664|NCT03090152|324439129|FG002|Overall Study|Surgery Canceled|0|||
94721665|NCT03090152|324439127|FG000|Overall Study|Epidural catheter could not be placed|0|||
94721666|NCT03090152|324439128|FG001|Overall Study|Epidural catheter could not be placed|2|||
94721667|NCT03090152|324439129|FG002|Overall Study|Epidural catheter could not be placed|0|||
94721668|NCT01566695|324439141|FG000|Overall Study|Lack of Efficacy|1|||
94721669|NCT01566695|324439142|FG001|Overall Study|Lack of Efficacy|0|||
94721670|NCT01566695|324439141|FG000|Overall Study|Adverse Event|3|||
94721671|NCT01566695|324439142|FG001|Overall Study|Adverse Event|0|||
94721672|NCT01566695|324439141|FG000|Overall Study|Death|79|||
94721673|NCT01566695|324439142|FG001|Overall Study|Death|86|||
94721674|NCT01566695|324439141|FG000|Overall Study|Withdrawal by Subject|13|||
94721675|NCT01566695|324439142|FG001|Overall Study|Withdrawal by Subject|12|||
94721676|NCT01566695|324439141|FG000|Overall Study|Lost to Follow-up|0|||
94721677|NCT01566695|324439142|FG001|Overall Study|Lost to Follow-up|3|||
94721678|NCT01566695|324439141|FG000|Overall Study|Other reasons|11|||
94721679|NCT01566695|324439142|FG001|Overall Study|Other reasons|8|||
94721680|NCT01809691|324439143|FG000|Overall Study|Currently on Treatment|192|||
94721681|NCT01809691|324439144|FG001|Overall Study|Currently on Treatment|100|||
94721682|NCT01809691|324439143|FG000|Overall Study|No Protocol Treatment|10|||
94721683|NCT01809691|324439144|FG001|Overall Study|No Protocol Treatment|11|||
94721684|NCT01809691|324439143|FG000|Overall Study|Adverse Event|80|||
94721685|NCT01809691|324439144|FG001|Overall Study|Adverse Event|21|||
94721686|NCT01809691|324439143|FG000|Overall Study|Disease Progression|226|||
94721687|NCT01809691|324439144|FG001|Overall Study|Disease Progression|372|||
94721688|NCT01809691|324439143|FG000|Overall Study|Death|26|||
94721689|NCT01809691|324439144|FG001|Overall Study|Death|13|||
94721690|NCT01809691|324439143|FG000|Overall Study|Participant Refusal|70|||
94721691|NCT01809691|324439144|FG001|Overall Study|Participant Refusal|72|||
94721692|NCT01809691|324439143|FG000|Overall Study|Other, Not Specified|34|||
94721693|NCT01809691|324439144|FG001|Overall Study|Other, Not Specified|52|||
94721694|NCT04401800|324439145|FG000|Overall Study|Death|17|||
94721695|NCT04401800|324439145|FG000|Overall Study|Lost to Follow-up|5|||
94721696|NCT04401800|324439145|FG000|Overall Study|Withdrawal by Subject|4|||
94721697|NCT04285567|324439147|FG000|Overall Study|Death|3|||
94368151|NCT01399125|323134842|FG000|Overall Study|Administrative Problems|7|||
94368152|NCT01399125|323134843|FG001|Overall Study|Administrative Problems|11|||
94368153|NCT01399125|323134842|FG000|Overall Study|Death|0|||
94368154|NCT01399125|323134843|FG001|Overall Study|Death|1|||
94368155|NCT01399125|323134842|FG000|Overall Study|Protocol Deviation|5|||
94368156|NCT01399125|323134843|FG001|Overall Study|Protocol Deviation|2|||
94368157|NCT00337129|323134844|FG000|Overall Study|Adverse Event|4|||
94368158|NCT00337129|323134844|FG000|Overall Study|Withdrawal by Subject|1|||
94368159|NCT00337129|323134844|FG000|Overall Study|Lack of Efficacy|32|||
94368160|NCT00337129|323134844|FG000|Overall Study|Death|2|||
94368161|NCT00337129|323134844|FG000|Overall Study|not protocol specified|1|||
94368162|NCT04440163|323134860|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
94368163|NCT04440163|323134861|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
94368164|NCT04440163|323134862|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
94368165|NCT04440163|323134863|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
94368166|NCT04440163|323134864|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
94368167|NCT04440163|323134865|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
94368168|NCT04440163|323134866|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
94368169|NCT04440163|323134867|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
94368170|NCT04440163|323134860|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
94721698|NCT04285567|324439148|FG001|Overall Study|Death|3|||
94721699|NCT04285567|324439147|FG000|Overall Study|Lost to Follow-up|1|||
94721700|NCT04285567|324439148|FG001|Overall Study|Lost to Follow-up|1|||
94721701|NCT04285567|324439147|FG000|Overall Study|Reason Not Specified|1|||
94721702|NCT04285567|324439148|FG001|Overall Study|Reason Not Specified|1|||
94721703|NCT04285567|324439147|FG000|Overall Study|Physician Decision|2|||
94721704|NCT04285567|324439148|FG001|Overall Study|Physician Decision|1|||
94721705|NCT04285567|324439147|FG000|Overall Study|Withdrawal by Subject|2|||
94721706|NCT04285567|324439148|FG001|Overall Study|Withdrawal by Subject|6|||
94721707|NCT04285567|324439147|FG000|Overall Study|Adverse Event|1|||
94721708|NCT04285567|324439148|FG001|Overall Study|Adverse Event|0|||
94721709|NCT04285567|324439147|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
94721710|NCT04285567|324439148|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
94721711|NCT05319860|324439150|FG000|Overall Study|Death|1|||
94721712|NCT05319860|324439151|FG001|Overall Study|Death|1|||
94721713|NCT05319860|324439150|FG000|Overall Study|Lost to Follow-up|3|||
94721714|NCT05319860|324439151|FG001|Overall Study|Lost to Follow-up|1|||
94721715|NCT05319860|324439150|FG000|Overall Study|Withdrawal by Subject|1|||
94721716|NCT05319860|324439151|FG001|Overall Study|Withdrawal by Subject|7|||
94721717|NCT03043872|324439159|FG000|Overall Study|Withdrawal by Subject|6|||
94721718|NCT03043872|324439160|FG001|Overall Study|Withdrawal by Subject|6|||
94721719|NCT03043872|324439161|FG002|Overall Study|Withdrawal by Subject|15|||
94721720|NCT03043872|324439159|FG000|Overall Study|Lost to Follow-up|2|||
94721721|NCT03043872|324439160|FG001|Overall Study|Lost to Follow-up|1|||
94721722|NCT03043872|324439161|FG002|Overall Study|Lost to Follow-up|1|||
94721723|NCT03043872|324439159|FG000|Overall Study|Death|270|||
94721724|NCT03043872|324439160|FG001|Overall Study|Death|269|||
94368171|NCT04440163|323134861|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
94368172|NCT04440163|323134862|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
94467338|NCT01490697|323500513|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
94467339|NCT01490697|323500514|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
94467340|NCT00574795|323500522|FG000|Infant Series|Withdrawal by Subject|2|||
94721725|NCT03043872|324439161|FG002|Overall Study|Death|296|||
94721726|NCT04842643|324440483|FG000|Overall Study|Physician Decision|1|||
94721727|NCT04842643|324440483|FG000|Overall Study|Other|1|||
94721728|NCT04511702|324440486|FG000|Overall Study|Lost to Follow-up|3|||
94721729|NCT04511702|324440487|FG001|Overall Study|Lost to Follow-up|0|||
94721730|NCT04511702|324440488|FG002|Overall Study|Lost to Follow-up|4|||
94721731|NCT04511702|324440486|FG000|Overall Study|Withdrawal by Subject|17|||
94721732|NCT04511702|324440487|FG001|Overall Study|Withdrawal by Subject|1|||
94721733|NCT04511702|324440488|FG002|Overall Study|Withdrawal by Subject|8|||
94721734|NCT02187003|324440491|FG000|Overall Study|Adverse Event|2|||
94721735|NCT02187003|324440492|FG001|Overall Study|Adverse Event|0|||
94721736|NCT02187003|324440491|FG000|Overall Study|Lost to Follow-up|14|||
94721737|NCT02187003|324440492|FG001|Overall Study|Lost to Follow-up|10|||
94721738|NCT02187003|324440491|FG000|Overall Study|Withdrawal by Subject|3|||
94721739|NCT02187003|324440492|FG001|Overall Study|Withdrawal by Subject|7|||
94721740|NCT02187003|324440491|FG000|Overall Study|Protocol Violation|2|||
94721741|NCT02187003|324440492|FG001|Overall Study|Protocol Violation|4|||
94721742|NCT02187003|324440491|FG000|Overall Study|Other|5|||
94721743|NCT02187003|324440492|FG001|Overall Study|Other|5|||
94721744|NCT02187003|324440491|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
94721745|NCT02187003|324440492|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
94721746|NCT05816551|324440495|FG000|Overall Study|Withdrawal by Subject|0|||
94721747|NCT05816551|324440496|FG001|Overall Study|Withdrawal by Subject|1|||
94721748|NCT05816551|324440495|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
94721749|NCT05816551|324440496|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
94721750|NCT04593472|324440501|FG000|Overall Study|Death|31|||
94721751|NCT04593472|324440502|FG001|Overall Study|Death|27|||
94721752|NCT04593472|324440501|FG000|Overall Study|Withdrawal by Subject|12|||
94721753|NCT04593472|324440502|FG001|Overall Study|Withdrawal by Subject|12|||
94721754|NCT04593472|324440501|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
94721755|NCT04593472|324440502|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
94721756|NCT04593472|324440501|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
94721757|NCT04593472|324440502|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
94721758|NCT04593472|324440501|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
94721759|NCT04593472|324440502|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
94721760|NCT04593472|324440501|FG000|Overall Study|Lost to Follow-up|0|||
94721761|NCT04593472|324440502|FG001|Overall Study|Lost to Follow-up|2|||
94721762|NCT04593472|324440501|FG000|Overall Study|Still collecting 24-month assessment|17|||
94721763|NCT04593472|324440502|FG001|Overall Study|Still collecting 24-month assessment|10|||
94721764|NCT04538417|324440508|FG000|Overall Study|Withdrawal by Subject|2|||
94721765|NCT03161379|324440519|FG000|Overall Study|Withdrawal by Subject|4|||
94721766|NCT03161379|324440519|FG000|Overall Study|disease progression during chemotherapy|5|||
94721767|NCT03161379|324440519|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
94721768|NCT03161379|324440519|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
94721769|NCT02549339|324440520|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
94721770|NCT02549339|324440521|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
94721771|NCT02549339|324440520|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
94721772|NCT02549339|324440521|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
94721773|NCT02549339|324440520|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
94721774|NCT02549339|324440521|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
94721775|NCT02549339|324440520|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
94721776|NCT02549339|324440521|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
94721777|NCT02549339|324440520|FG000|12-month Follow-up|Lack of Efficacy|0|||
94721778|NCT02549339|324440521|FG001|12-month Follow-up|Lack of Efficacy|2|||
94721779|NCT02549339|324440520|FG000|12-month Follow-up|Withdrawal by Subject|8|||
94721780|NCT02549339|324440521|FG001|12-month Follow-up|Withdrawal by Subject|3|||
94721781|NCT02549339|324440520|FG000|12-month Follow-up|Lost to Follow-up|1|||
94721782|NCT02549339|324440521|FG001|12-month Follow-up|Lost to Follow-up|3|||
94721783|NCT02549339|324440520|FG000|12-month Follow-up|Other|0|||
94721784|NCT02549339|324440521|FG001|12-month Follow-up|Other|3|||
94721785|NCT02312960|324440522|FG000|Overall Study|Death|24|||
94721786|NCT02312960|324440523|FG001|Overall Study|Death|32|||
94721787|NCT02312960|324440524|FG002|Overall Study|Death|25|||
94721788|NCT02312960|324440525|FG003|Overall Study|Death|11|||
94721789|NCT02312960|324440526|FG004|Overall Study|Death|5|||
94721790|NCT02312960|324440527|FG005|Overall Study|Death|5|||
94721791|NCT02312960|324440528|FG006|Overall Study|Death|8|||
94721792|NCT02312960|324440529|FG007|Overall Study|Death|5|||
94721793|NCT02312960|324440530|FG008|Overall Study|Death|7|||
94721794|NCT02312960|324440531|FG009|Overall Study|Death|3|||
94721795|NCT02312960|324440532|FG010|Overall Study|Death|3|||
94721796|NCT02312960|324440533|FG011|Overall Study|Death|1|||
94721797|NCT02312960|324440534|FG012|Overall Study|Death|25|||
94721798|NCT02312960|324440535|FG013|Overall Study|Death|19|||
94721799|NCT02312960|324440522|FG000|Overall Study|Missing|0|||
94721800|NCT02312960|324440523|FG001|Overall Study|Missing|0|||
94721801|NCT02312960|324440524|FG002|Overall Study|Missing|2|||
94721802|NCT02312960|324440525|FG003|Overall Study|Missing|0|||
94721803|NCT02312960|324440526|FG004|Overall Study|Missing|0|||
94721804|NCT02312960|324440527|FG005|Overall Study|Missing|0|||
94721805|NCT02312960|324440528|FG006|Overall Study|Missing|0|||
94721806|NCT02312960|324440529|FG007|Overall Study|Missing|0|||
94721807|NCT02312960|324440530|FG008|Overall Study|Missing|0|||
94721808|NCT02312960|324440531|FG009|Overall Study|Missing|0|||
94721809|NCT02312960|324440532|FG010|Overall Study|Missing|0|||
94721810|NCT02312960|324440533|FG011|Overall Study|Missing|0|||
94721811|NCT02312960|324440534|FG012|Overall Study|Missing|0|||
94721812|NCT02312960|324440535|FG013|Overall Study|Missing|0|||
94721813|NCT02312960|324440522|FG000|Overall Study|Lost to Follow-up|0|||
94721814|NCT02312960|324440523|FG001|Overall Study|Lost to Follow-up|0|||
94721815|NCT02312960|324440524|FG002|Overall Study|Lost to Follow-up|1|||
94721816|NCT02312960|324440525|FG003|Overall Study|Lost to Follow-up|0|||
94721817|NCT02312960|324440526|FG004|Overall Study|Lost to Follow-up|0|||
94721818|NCT02312960|324440527|FG005|Overall Study|Lost to Follow-up|0|||
94721819|NCT02312960|324440528|FG006|Overall Study|Lost to Follow-up|1|||
94721820|NCT02312960|324440529|FG007|Overall Study|Lost to Follow-up|1|||
94721821|NCT02312960|324440530|FG008|Overall Study|Lost to Follow-up|0|||
94721822|NCT02312960|324440531|FG009|Overall Study|Lost to Follow-up|1|||
94721823|NCT02312960|324440532|FG010|Overall Study|Lost to Follow-up|0|||
94721824|NCT02312960|324440533|FG011|Overall Study|Lost to Follow-up|0|||
94721825|NCT02312960|324440534|FG012|Overall Study|Lost to Follow-up|1|||
94721826|NCT02312960|324440535|FG013|Overall Study|Lost to Follow-up|0|||
94721827|NCT02312960|324440522|FG000|Overall Study|Withdrawal by Subject|1|||
94721828|NCT02312960|324440523|FG001|Overall Study|Withdrawal by Subject|2|||
94721829|NCT02312960|324440524|FG002|Overall Study|Withdrawal by Subject|0|||
94721830|NCT02312960|324440525|FG003|Overall Study|Withdrawal by Subject|0|||
94721831|NCT02312960|324440526|FG004|Overall Study|Withdrawal by Subject|1|||
94721832|NCT02312960|324440527|FG005|Overall Study|Withdrawal by Subject|0|||
94721833|NCT02312960|324440528|FG006|Overall Study|Withdrawal by Subject|1|||
94721834|NCT02312960|324440529|FG007|Overall Study|Withdrawal by Subject|2|||
94721835|NCT02312960|324440530|FG008|Overall Study|Withdrawal by Subject|2|||
94721836|NCT02312960|324440531|FG009|Overall Study|Withdrawal by Subject|3|||
94721837|NCT02312960|324440532|FG010|Overall Study|Withdrawal by Subject|0|||
94721838|NCT02312960|324440533|FG011|Overall Study|Withdrawal by Subject|0|||
94721839|NCT02312960|324440534|FG012|Overall Study|Withdrawal by Subject|2|||
94721840|NCT02312960|324440535|FG013|Overall Study|Withdrawal by Subject|0|||
94721841|NCT02728076|324440537|FG000|Overall Study|Physician Decision|4|||
94721842|NCT04060355|324440538|FG000|Overall Study|Lost to Follow-up|41|||
94721843|NCT01707030|324440541|FG000|Overall Study|Death|1|||
94721844|NCT01707030|324440542|FG001|Overall Study|Death|1|||
94721845|NCT01707030|324440541|FG000|Overall Study|Withdrawal by Subject|2|||
94721846|NCT01707030|324440542|FG001|Overall Study|Withdrawal by Subject|3|||
94721847|NCT01707030|324440541|FG000|Overall Study|Lost to Follow-up|8|||
94721848|NCT01707030|324440542|FG001|Overall Study|Lost to Follow-up|13|||
94721849|NCT04263311|324440545|FG000|Overall Study|Lost to Follow-up|1|||
94721850|NCT04263311|324440546|FG001|Overall Study|Lost to Follow-up|2|||
94721851|NCT04263311|324440547|FG002|Overall Study|Lost to Follow-up|0|||
94721852|NCT04263311|324440545|FG000|Overall Study|Health Issues|1|||
94721853|NCT04263311|324440546|FG001|Overall Study|Health Issues|0|||
94721854|NCT04263311|324440547|FG002|Overall Study|Health Issues|0|||
94721855|NCT04263311|324440545|FG000|Overall Study|Left the country|1|||
94721856|NCT04263311|324440546|FG001|Overall Study|Left the country|0|||
94721857|NCT04263311|324440547|FG002|Overall Study|Left the country|0|||
94721858|NCT04263311|324440545|FG000|Overall Study|Unable to maintain time commitment|1|||
94721859|NCT04263311|324440546|FG001|Overall Study|Unable to maintain time commitment|0|||
94721860|NCT04263311|324440547|FG002|Overall Study|Unable to maintain time commitment|0|||
94721861|NCT04263311|324440545|FG000|Overall Study|No longer interested|1|||
94721862|NCT04263311|324440546|FG001|Overall Study|No longer interested|0|||
94721863|NCT04263311|324440547|FG002|Overall Study|No longer interested|0|||
94721864|NCT04263311|324440545|FG000|Overall Study|Ineligible post consent|0|||
94721865|NCT04263311|324440546|FG001|Overall Study|Ineligible post consent|0|||
94721866|NCT04263311|324440547|FG002|Overall Study|Ineligible post consent|5|||
94721867|NCT04088630|324440548|FG000|Overall Study|Lost to Follow-up|3|||
94721868|NCT04088630|324440549|FG001|Overall Study|Lost to Follow-up|2|||
94721869|NCT04088630|324440550|FG002|Overall Study|Lost to Follow-up|6|||
94721870|NCT04088630|324440548|FG000|Overall Study|Death|3|||
94721871|NCT04088630|324440549|FG001|Overall Study|Death|1|||
94721872|NCT04088630|324440550|FG002|Overall Study|Death|1|||
94721873|NCT04088630|324440548|FG000|Overall Study|Physician Decision|0|||
94721874|NCT04088630|324440549|FG001|Overall Study|Physician Decision|1|||
94721875|NCT04088630|324440550|FG002|Overall Study|Physician Decision|1|||
94721876|NCT03047928|324440551|FG000|Overall Study|Adverse Event|0|||
94721877|NCT03047928|324440552|FG001|Overall Study|Adverse Event|2|||
94721878|NCT03047928|324440553|FG002|Overall Study|Adverse Event|0|||
94721879|NCT03047928|324440551|FG000|Overall Study|Protocol Violation|0|||
94721880|NCT03047928|324440552|FG001|Overall Study|Protocol Violation|1|||
94721881|NCT03047928|324440553|FG002|Overall Study|Protocol Violation|0|||
94721882|NCT03047928|324440551|FG000|Overall Study|included in another protocol|0|||
94721883|NCT03047928|324440552|FG001|Overall Study|included in another protocol|1|||
94721884|NCT03047928|324440553|FG002|Overall Study|included in another protocol|0|||
94721885|NCT02437318|324440554|FG000|Overall Study|Progressive disease|207|||
94721886|NCT02437318|324440555|FG001|Overall Study|Progressive disease|240|||
94721887|NCT02437318|324440554|FG000|Overall Study|Subject/guardian decision|24|||
94721888|NCT02437318|324440555|FG001|Overall Study|Subject/guardian decision|11|||
94721889|NCT02437318|324440554|FG000|Overall Study|Physician Decision|29|||
94721890|NCT02437318|324440555|FG001|Overall Study|Physician Decision|22|||
94721891|NCT02437318|324440554|FG000|Overall Study|Adverse Event|14|||
94721892|NCT02437318|324440555|FG001|Overall Study|Adverse Event|4|||
94721893|NCT02437318|324440554|FG000|Overall Study|Death|4|||
94721894|NCT02437318|324440555|FG001|Overall Study|Death|4|||
94721895|NCT02437318|324440554|FG000|Overall Study|Protocol deviation|5|||
94721896|NCT02437318|324440555|FG001|Overall Study|Protocol deviation|7|||
94368173|NCT04440163|323134863|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
94721897|NCT02437318|324440554|FG000|Overall Study|Sponsor decision|1|||
94721898|NCT02437318|324440555|FG001|Overall Study|Sponsor decision|0|||
94721899|NCT00920621|324440556|FG000|Overall Study|Lost to Follow-up|16|||
94721900|NCT00920621|324440557|FG001|Overall Study|Lost to Follow-up|17|||
94721901|NCT00920621|324440558|FG002|Overall Study|Lost to Follow-up|19|||
94721902|NCT00920621|324440559|FG003|Overall Study|Lost to Follow-up|21|||
94721903|NCT00920621|324440556|FG000|Overall Study|Fetal/neonatal deaths|16|||
94721904|NCT00920621|324440557|FG001|Overall Study|Fetal/neonatal deaths|14|||
94368174|NCT04440163|323134864|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
94721905|NCT00920621|324440558|FG002|Overall Study|Fetal/neonatal deaths|16|||
94721906|NCT00920621|324440559|FG003|Overall Study|Fetal/neonatal deaths|14|||
94721907|NCT00920621|324440556|FG000|Overall Study|Blood sample not collected|22|||
94721908|NCT00920621|324440557|FG001|Overall Study|Blood sample not collected|14|||
94721909|NCT00920621|324440558|FG002|Overall Study|Blood sample not collected|0|||
94721910|NCT00920621|324440559|FG003|Overall Study|Blood sample not collected|0|||
94272352|NCT02700412|322790394|FG000|Overall Study|Adverse Event|6|||
94272353|NCT02700412|322790394|FG000|Overall Study|Death|1|||
94272354|NCT02700412|322790394|FG000|Overall Study|Lack of Efficacy|19|||
94272355|NCT02700412|322790394|FG000|Overall Study|Protocol Violation|5|||
94721911|NCT03526861|324440565|FG000|Initial Treatment Period|Not dosed|1|||
94721912|NCT03526861|324440566|FG001|Initial Treatment Period|Not dosed|1|||
94721913|NCT03526861|324440567|FG002|Initial Treatment Period|Not dosed|1|||
94721914|NCT03526861|324440568|FG003|Initial Treatment Period|Not dosed|0|||
94721915|NCT03526861|324440569|FG004|Initial Treatment Period|Not dosed|0|||
94721916|NCT03526861|324440570|FG005|Initial Treatment Period|Not dosed|0|||
94721917|NCT03526861|324440571|FG006|Initial Treatment Period|Not dosed|0|||
94721918|NCT03526861|324440572|FG007|Initial Treatment Period|Not dosed|0|||
94721919|NCT03526861|324440573|FG008|Initial Treatment Period|Not dosed|0|||
94721920|NCT03526861|324440565|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
94721921|NCT03526861|324440566|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
94721922|NCT03526861|324440567|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
94721923|NCT03526861|324440568|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721924|NCT03526861|324440569|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721925|NCT03526861|324440570|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721926|NCT03526861|324440571|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721927|NCT03526861|324440572|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721928|NCT03526861|324440573|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721929|NCT03526861|324440565|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
94721930|NCT03526861|324440566|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
94721931|NCT03526861|324440567|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
94721932|NCT03526861|324440568|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
94721933|NCT03526861|324440569|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
94721934|NCT03526861|324440570|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
94721935|NCT03526861|324440571|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
94721936|NCT03526861|324440572|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
94721937|NCT03526861|324440573|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
94721938|NCT03526861|324440565|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
94721939|NCT03526861|324440566|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
94721940|NCT03526861|324440567|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
94721941|NCT03526861|324440568|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
94721942|NCT03526861|324440569|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
94721943|NCT03526861|324440570|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
94721944|NCT03526861|324440571|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
94721945|NCT03526861|324440572|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
94721946|NCT03526861|324440573|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
94721947|NCT03526861|324440565|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
94721948|NCT03526861|324440566|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
94721949|NCT03526861|324440567|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
94721950|NCT03526861|324440568|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
94721951|NCT03526861|324440569|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
94721952|NCT03526861|324440570|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
94721953|NCT03526861|324440571|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
94721954|NCT03526861|324440572|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
94721955|NCT03526861|324440573|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
94721956|NCT03526861|324440565|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721957|NCT03526861|324440566|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721958|NCT03526861|324440567|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721959|NCT03526861|324440568|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
94272356|NCT02700412|322790394|FG000|Overall Study|Withdrawal by Subject|2|||
94272357|NCT00928889|322790395|FG000|Overall Study|Lost to Follow-up|3|||
94272358|NCT00928889|322790396|FG001|Overall Study|Lost to Follow-up|1|||
94272359|NCT00928889|322790395|FG000|Overall Study|Protocol Violation|0|||
94272360|NCT00928889|322790396|FG001|Overall Study|Protocol Violation|1|||
94272361|NCT00928889|322790395|FG000|Overall Study|Adverse Event|1|||
94272362|NCT00928889|322790396|FG001|Overall Study|Adverse Event|0|||
94272363|NCT00928889|322790395|FG000|Overall Study|Other|1|||
94272364|NCT00928889|322790396|FG001|Overall Study|Other|0|||
94721960|NCT03526861|324440569|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721961|NCT03526861|324440570|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721962|NCT03526861|324440571|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721963|NCT03526861|324440572|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721964|NCT03526861|324440573|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721965|NCT03526861|324440565|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
94721966|NCT03526861|324440566|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
94721967|NCT03526861|324440567|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
94721968|NCT03526861|324440568|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
94721969|NCT03526861|324440569|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
94721970|NCT03526861|324440570|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
94721971|NCT03526861|324440571|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
94721972|NCT03526861|324440572|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
94721973|NCT03526861|324440573|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
94721974|NCT03526861|324440565|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
94721975|NCT03526861|324440566|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
94721976|NCT03526861|324440567|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
94721977|NCT03526861|324440568|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
94721978|NCT03526861|324440569|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
94721979|NCT03526861|324440570|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
94721980|NCT03526861|324440571|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
94721981|NCT03526861|324440572|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
94721982|NCT03526861|324440573|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
94721983|NCT03526861|324440565|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721984|NCT03526861|324440566|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721985|NCT03526861|324440567|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721986|NCT03526861|324440568|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721987|NCT03526861|324440569|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721988|NCT03526861|324440570|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721989|NCT03526861|324440571|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721990|NCT03526861|324440572|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
94721991|NCT03526861|324440573|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
94721992|NCT03281291|324440574|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
94721993|NCT03281291|324440575|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
94721994|NCT03281291|324440576|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
94721995|NCT03281291|324440577|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
94721996|NCT03281291|324440578|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
94721997|NCT03281291|324440574|FG000|Overall Study|Protocol Deviation|2|||
94721998|NCT03281291|324440575|FG001|Overall Study|Protocol Deviation|0|||
94721999|NCT03281291|324440576|FG002|Overall Study|Protocol Deviation|1|||
94722000|NCT03281291|324440577|FG003|Overall Study|Protocol Deviation|2|||
94722001|NCT03281291|324440578|FG004|Overall Study|Protocol Deviation|1|||
94722002|NCT03281291|324440574|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
94722003|NCT03281291|324440575|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
94722004|NCT03281291|324440576|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
94368175|NCT04440163|323134865|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
94368176|NCT04440163|323134866|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
94368177|NCT04440163|323134867|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
94722005|NCT03281291|324440577|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
94722006|NCT03281291|324440578|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
94722007|NCT03281291|324440574|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
94722008|NCT03281291|324440575|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
94722009|NCT03281291|324440576|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
94722010|NCT03281291|324440577|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
94722011|NCT03281291|324440578|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
94722012|NCT03281291|324440574|FG000|Overall Study|Lost to Follow-up|10|||
94722013|NCT03281291|324440575|FG001|Overall Study|Lost to Follow-up|10|||
94722014|NCT03281291|324440576|FG002|Overall Study|Lost to Follow-up|4|||
94722015|NCT03281291|324440577|FG003|Overall Study|Lost to Follow-up|6|||
94722016|NCT03281291|324440578|FG004|Overall Study|Lost to Follow-up|10|||
94722017|NCT03281291|324440574|FG000|Overall Study|Other|0|||
94722018|NCT03281291|324440575|FG001|Overall Study|Other|2|||
94722019|NCT03281291|324440576|FG002|Overall Study|Other|0|||
94722020|NCT03281291|324440577|FG003|Overall Study|Other|2|||
94722021|NCT03281291|324440578|FG004|Overall Study|Other|1|||
94722022|NCT05524233|324440579|FG000|Overall Study|Lost to Follow-up|2|||
94722023|NCT05524233|324440579|FG000|Overall Study|Adverse Event|2|||
94722024|NCT05524233|324440579|FG000|Overall Study|Withdrawal by Subject|1|||
94722025|NCT04710576|324440580|FG000|Overall Study|Participants still in the study|73|||
94722026|NCT04710576|324440581|FG001|Overall Study|Participants still in the study|70|||
94722027|NCT04710576|324440582|FG002|Overall Study|Participants still in the study|60|||
94722028|NCT04710576|324440580|FG000|Overall Study|Death|2|||
94722029|NCT04710576|324440581|FG001|Overall Study|Death|7|||
94722030|NCT04710576|324440582|FG002|Overall Study|Death|12|||
94722031|NCT04710576|324440580|FG000|Overall Study|Withdrawal by Subject|4|||
94722032|NCT04710576|324440581|FG001|Overall Study|Withdrawal by Subject|3|||
94722033|NCT04710576|324440582|FG002|Overall Study|Withdrawal by Subject|7|||
94722034|NCT04710576|324440580|FG000|Overall Study|Sponsor decision|1|||
94722035|NCT04710576|324440581|FG001|Overall Study|Sponsor decision|0|||
94722036|NCT04710576|324440582|FG002|Overall Study|Sponsor decision|0|||
94722037|NCT02543281|324440583|FG000|Overall Study|Lost to Follow-up|0|||
94722038|NCT02543281|324440584|FG001|Overall Study|Lost to Follow-up|0|||
94722039|NCT02543281|324440585|FG002|Overall Study|Lost to Follow-up|1|||
94722040|NCT03385629|324440607|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
94722041|NCT03385629|324440608|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
94722042|NCT03385629|324440607|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
94722043|NCT03385629|324440608|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
94722044|NCT03385629|324440607|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
94722045|NCT03385629|324440608|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
94722046|NCT04049643|324440611|FG000|Overall Study|Lack of Efficacy|1|||
94722047|NCT04049643|324440612|FG001|Overall Study|Lack of Efficacy|1|||
94722048|NCT04049643|324440613|FG002|Overall Study|Lack of Efficacy|0|||
94722049|NCT04049643|324440611|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
94722050|NCT04049643|324440612|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
94722051|NCT04049643|324440613|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
94722052|NCT05351554|324440616|FG000|Overall Study|Study terminated by sponsor|1|||
94722053|NCT05093829|324440617|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
94722054|NCT05093829|324440618|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
94722055|NCT05093829|324440619|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
94722056|NCT05093829|324440620|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
94722057|NCT05093829|324440621|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
94722058|NCT02651324|324441820|FG000|Overall Study|drug not administered, due dispensing issue|1|||
94722059|NCT02651324|324441821|FG001|Overall Study|drug not administered, due dispensing issue|0|||
94722060|NCT03692611|324441826|FG000|Overall Study|Found to be ineligible postrandomization|3|||
94722061|NCT03692611|324441827|FG001|Overall Study|Found to be ineligible postrandomization|0|||
94722062|NCT04490915|324441828|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
94722063|NCT04490915|324441829|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
94722064|NCT04490915|324441828|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
94722065|NCT04490915|324441829|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
94467341|NCT00574795|323500522|FG000|Infant Series|Protocol Violation|2|||
94722066|NCT04490915|324441828|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
94722067|NCT04490915|324441829|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
94722068|NCT04490915|324441828|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
94722069|NCT04490915|324441829|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
94722070|NCT04490915|324441828|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
94722071|NCT04490915|324441829|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
94722072|NCT04490915|324441828|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
94722073|NCT04490915|324441829|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
94722074|NCT04490915|324441828|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
94722075|NCT04490915|324441829|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
94722076|NCT05009251|324441830|FG000|Overall Study|Protocol Violation|100|||
94722077|NCT05009251|324441831|FG001|Overall Study|Protocol Violation|105|||
94722078|NCT05009251|324441832|FG002|Overall Study|Protocol Violation|119|||
94722079|NCT05009251|324441833|FG003|Overall Study|Protocol Violation|120|||
94722080|NCT05009251|324441834|FG004|Overall Study|Protocol Violation|119|||
94722081|NCT05009251|324441830|FG000|Overall Study|Death|25|||
94722082|NCT05009251|324441831|FG001|Overall Study|Death|22|||
94722083|NCT05009251|324441832|FG002|Overall Study|Death|24|||
94722084|NCT05009251|324441833|FG003|Overall Study|Death|19|||
94722085|NCT05009251|324441834|FG004|Overall Study|Death|15|||
94722086|NCT03052608|324441835|FG000|Treatment Phase|Adverse Event|10|||
94722087|NCT03052608|324441836|FG001|Treatment Phase|Adverse Event|12|||
94722088|NCT03052608|324441835|FG000|Treatment Phase|Death|6|||
94722089|NCT03052608|324441836|FG001|Treatment Phase|Death|4|||
94722090|NCT03052608|324441835|FG000|Treatment Phase|Withdrawal by Subject|4|||
94722091|NCT03052608|324441836|FG001|Treatment Phase|Withdrawal by Subject|12|||
94722092|NCT03052608|324441835|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
94722093|NCT03052608|324441836|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
94722094|NCT03052608|324441835|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
94722095|NCT03052608|324441836|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
94722096|NCT03052608|324441835|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
94722097|NCT03052608|324441836|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
94722098|NCT03052608|324441835|FG000|Treatment Phase|Ongoing|103|||
94722099|NCT03052608|324441836|FG001|Treatment Phase|Ongoing|31|||
94722100|NCT03052608|324441835|FG000|Long-Term Follow-up Phase|Death|23|||
94722101|NCT03052608|324441836|FG001|Long-Term Follow-up Phase|Death|28|||
94722102|NCT03052608|324441835|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
94722103|NCT03052608|324441836|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
94722104|NCT03052608|324441835|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
94722105|NCT03052608|324441836|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
94722106|NCT03052608|324441835|FG000|Long-Term Follow-up Phase|Ongoing|122|||
94722107|NCT03052608|324441836|FG001|Long-Term Follow-up Phase|Ongoing|99|||
94722108|NCT02662062|324441837|FG000|Overall Study|Withdrawal by Subject|1|||
94722109|NCT05406921|324441840|FG000|Overall Study|Withdrawal by Subject|25|||
94722110|NCT05406921|324441841|FG001|Overall Study|Withdrawal by Subject|0|||
94722111|NCT05406921|324441842|FG002|Overall Study|Withdrawal by Subject|25|||
94722112|NCT05406921|324441840|FG000|Overall Study|Protocol Violation|0|||
94722113|NCT05406921|324441841|FG001|Overall Study|Protocol Violation|12|||
94722114|NCT05406921|324441842|FG002|Overall Study|Protocol Violation|0|||
94722115|NCT00676715|324441846|FG000|Treatment Period (TP)|Adverse Event|0|||
94722116|NCT00676715|324441847|FG001|Treatment Period (TP)|Adverse Event|3|||
94722117|NCT00676715|324441848|FG002|Treatment Period (TP)|Adverse Event|2|||
94722118|NCT00676715|324441849|FG003|Treatment Period (TP)|Adverse Event|2|||
94722119|NCT00676715|324441846|FG000|Treatment Period (TP)|Death|0|||
94722120|NCT00676715|324441847|FG001|Treatment Period (TP)|Death|0|||
94722121|NCT00676715|324441848|FG002|Treatment Period (TP)|Death|1|||
94722122|NCT00676715|324441849|FG003|Treatment Period (TP)|Death|0|||
94722123|NCT00676715|324441846|FG000|Treatment Period (TP)|Failure to return|1|||
94722124|NCT00676715|324441847|FG001|Treatment Period (TP)|Failure to return|0|||
94722125|NCT00676715|324441848|FG002|Treatment Period (TP)|Failure to return|0|||
94722126|NCT00676715|324441849|FG003|Treatment Period (TP)|Failure to return|0|||
94722127|NCT00676715|324441846|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
94722128|NCT00676715|324441847|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
94722129|NCT00676715|324441848|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
94722130|NCT00676715|324441849|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
94722131|NCT00676715|324441846|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
94722132|NCT00676715|324441847|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
94722133|NCT00676715|324441848|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
94722134|NCT00676715|324441849|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
94722135|NCT00676715|324441846|FG000|Treatment Period (TP)|Withdrew consent|3|||
94467342|NCT00574795|323500522|FG000|Infant Series|Adverse Event|1|||
94722136|NCT00676715|324441847|FG001|Treatment Period (TP)|Withdrew consent|3|||
94722137|NCT00676715|324441848|FG002|Treatment Period (TP)|Withdrew consent|3|||
94722138|NCT00676715|324441849|FG003|Treatment Period (TP)|Withdrew consent|3|||
94722139|NCT00676715|324441846|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
94722140|NCT00676715|324441847|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
94722141|NCT00676715|324441848|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
94722142|NCT00676715|324441849|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
94722143|NCT00676715|324441846|FG000|Treatment Period (TP)|Administrative|0|||
94722144|NCT00676715|324441847|FG001|Treatment Period (TP)|Administrative|0|||
94722145|NCT00676715|324441848|FG002|Treatment Period (TP)|Administrative|0|||
94722146|NCT00676715|324441849|FG003|Treatment Period (TP)|Administrative|1|||
94722147|NCT00676715|324441846|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
94722148|NCT00676715|324441847|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
94722149|NCT00676715|324441848|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
94722150|NCT00676715|324441849|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
94722151|NCT00676715|324441846|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
94722152|NCT00676715|324441847|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
94722153|NCT00676715|324441848|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
94722154|NCT00676715|324441849|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
94722155|NCT00676715|324441846|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
94722156|NCT00676715|324441847|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
94722157|NCT00676715|324441848|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
94722158|NCT00676715|324441849|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
94722159|NCT00676715|324441846|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
94722160|NCT00676715|324441847|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
94722161|NCT00676715|324441848|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
94722162|NCT00676715|324441849|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
94722163|NCT00676715|324441846|FG000|Treatment-free Period (TFP)|Death|1|||
94722164|NCT00676715|324441847|FG001|Treatment-free Period (TFP)|Death|1|||
94722165|NCT00676715|324441848|FG002|Treatment-free Period (TFP)|Death|1|||
94722166|NCT00676715|324441849|FG003|Treatment-free Period (TFP)|Death|0|||
94722167|NCT00676715|324441846|FG000|Open Label Extension (OLE)|Reason not provided|3|||
94722168|NCT00676715|324441847|FG001|Open Label Extension (OLE)|Reason not provided|4|||
94722169|NCT00676715|324441848|FG002|Open Label Extension (OLE)|Reason not provided|1|||
94722170|NCT00676715|324441849|FG003|Open Label Extension (OLE)|Reason not provided|4|||
94722171|NCT00676715|324441846|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
94722172|NCT00676715|324441847|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
94722173|NCT00676715|324441848|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
94722174|NCT00676715|324441849|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
94722175|NCT00676715|324441846|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
94722176|NCT00676715|324441847|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
94722177|NCT00676715|324441848|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
94722178|NCT00676715|324441849|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
94722179|NCT00676715|324441846|FG000|Open Label Extension (OLE)|Adverse Event|0|||
94722180|NCT00676715|324441847|FG001|Open Label Extension (OLE)|Adverse Event|3|||
94722181|NCT00676715|324441848|FG002|Open Label Extension (OLE)|Adverse Event|1|||
94722182|NCT00676715|324441849|FG003|Open Label Extension (OLE)|Adverse Event|0|||
94722183|NCT00676715|324441846|FG000|Open Label Extension (OLE)|Death|2|||
94722184|NCT00676715|324441847|FG001|Open Label Extension (OLE)|Death|0|||
94722185|NCT00676715|324441848|FG002|Open Label Extension (OLE)|Death|2|||
94722186|NCT00676715|324441849|FG003|Open Label Extension (OLE)|Death|2|||
94722187|NCT00616967|324441850|FG000|Overall Study|Withdrawal by Subject|0|||
94722188|NCT00616967|324441851|FG001|Overall Study|Withdrawal by Subject|0|||
94722189|NCT00616967|324441852|FG002|Overall Study|Withdrawal by Subject|1|||
94722190|NCT02910583|324441853|FG000|Overall Study|Death|7|||
94722191|NCT02910583|324441854|FG001|Overall Study|Death|3|||
94722192|NCT02910583|324441853|FG000|Overall Study|Lost to Follow-up|1|||
94722193|NCT02910583|324441854|FG001|Overall Study|Lost to Follow-up|0|||
94722194|NCT02910583|324441853|FG000|Overall Study|Withdrawal by Subject|12|||
94722195|NCT02910583|324441854|FG001|Overall Study|Withdrawal by Subject|8|||
94722196|NCT02910583|324441853|FG000|Overall Study|Other, Not Specified|6|||
94722197|NCT02910583|324441854|FG001|Overall Study|Other, Not Specified|3|||
94722198|NCT02249949|324441855|FG000|Overall Study|Cancelled prior to treatment|2|||
94722199|NCT02097420|324441858|FG000|Overall Study|Death|6|||
94722200|NCT02097420|324441858|FG000|Overall Study|Valve explanted|13|||
94722201|NCT02097420|324441858|FG000|Overall Study|Other Reason|1|||
94722202|NCT01331005|324441859|FG000|Overall Study|Lost to Follow-up|2|||
94722203|NCT01331005|324441860|FG001|Overall Study|Lost to Follow-up|1|||
94722204|NCT01331005|324441859|FG000|Overall Study|Withdrawal by Subject|2|||
94722205|NCT01331005|324441860|FG001|Overall Study|Withdrawal by Subject|3|||
94722206|NCT05059262|324441861|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
94722207|NCT05059262|324441862|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
94722208|NCT05059262|324441861|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
94722209|NCT05059262|324441862|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
94722210|NCT05059262|324441861|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
94722211|NCT05059262|324441862|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
94722212|NCT05059262|324441861|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
94722213|NCT05059262|324441862|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
94722214|NCT05059262|324441861|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
94722215|NCT05059262|324441862|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
94722216|NCT05059262|324441861|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
94722217|NCT05059262|324441862|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
94722218|NCT05059262|324441861|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
94722219|NCT05059262|324441862|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
94722220|NCT05059262|324441861|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
94722221|NCT05059262|324441862|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
94722222|NCT05059262|324441861|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
94722223|NCT05059262|324441862|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
94722224|NCT02867384|324441863|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
94722225|NCT02867384|324441864|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
94722226|NCT02867384|324441865|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
94722227|NCT02867384|324441863|FG000|Overall Study|Progression/ Relapse|15|||
94722228|NCT02867384|324441864|FG001|Overall Study|Progression/ Relapse|19|||
94722229|NCT02867384|324441865|FG002|Overall Study|Progression/ Relapse|0|||
94722230|NCT02867384|324441863|FG000|Overall Study|Adverse Event|13|||
94722231|NCT02867384|324441864|FG001|Overall Study|Adverse Event|1|||
94722232|NCT02867384|324441865|FG002|Overall Study|Adverse Event|0|||
94722233|NCT02867384|324441863|FG000|Overall Study|Withdrawal by Subject|6|||
94722234|NCT02867384|324441864|FG001|Overall Study|Withdrawal by Subject|5|||
94722235|NCT02867384|324441865|FG002|Overall Study|Withdrawal by Subject|0|||
94722236|NCT02867384|324441863|FG000|Overall Study|Physician Decision|1|||
94722237|NCT02867384|324441864|FG001|Overall Study|Physician Decision|2|||
94722238|NCT02867384|324441865|FG002|Overall Study|Physician Decision|0|||
94722239|NCT02867384|324441863|FG000|Overall Study|Patient compliance|1|||
94722240|NCT02867384|324441864|FG001|Overall Study|Patient compliance|0|||
94722241|NCT02867384|324441865|FG002|Overall Study|Patient compliance|0|||
94722242|NCT02867384|324441863|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
94722243|NCT02867384|324441864|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
94722244|NCT02867384|324441865|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
94722245|NCT02867384|324441863|FG000|Overall Study|Never start treatment|0|||
94722246|NCT02867384|324441864|FG001|Overall Study|Never start treatment|0|||
94722247|NCT02867384|324441865|FG002|Overall Study|Never start treatment|3|||
94722248|NCT05633953|324441880|FG000|Overall Study|Adverse Event|7|||
94722249|NCT05633953|324441880|FG000|Overall Study|Death|30|||
94722250|NCT05633953|324441880|FG000|Overall Study|Lost to Follow-up|1|||
94722251|NCT05633953|324441880|FG000|Overall Study|Osilodrostat discontinued|4|||
94722252|NCT05633953|324441880|FG000|Overall Study|Physician Decision|1|||
94722253|NCT05633953|324441880|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
94722254|NCT05633953|324441880|FG000|Overall Study|Progressive disease|2|||
94722255|NCT02729311|324441881|FG000|Overall Study|Withdrawal by Subject|8|||
94722256|NCT02729311|324441882|FG001|Overall Study|Withdrawal by Subject|2|||
94722257|NCT05324124|324441883|FG000|Period 1|Withdrawal by Subject|1|||
94722258|NCT05324124|324441884|FG001|Period 1|Withdrawal by Subject|0|||
94722259|NCT05324124|324441883|FG000|Period 1|Physician Decision|0|||
94722260|NCT05324124|324441884|FG001|Period 1|Physician Decision|1|||
94722261|NCT02287610|324441885|FG000|Overall Study|Lost to Follow-up|3|||
94722262|NCT02287610|324441885|FG000|Overall Study|Withdrawal by Subject|8|||
94722263|NCT02287610|324441885|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
94722264|NCT04950660|324441886|FG000|Overall Study|Protocol Violation|4|||
94722265|NCT04950660|324441887|FG001|Overall Study|Protocol Violation|2|||
94722266|NCT04950660|324441886|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
94722267|NCT04950660|324441887|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
94722268|NCT04950660|324441886|FG000|Overall Study|Withdrawal by Subject|0|||
94722269|NCT04950660|324441887|FG001|Overall Study|Withdrawal by Subject|1|||
94722270|NCT04950660|324441886|FG000|Overall Study|Hypotension|1|||
94722271|NCT04950660|324441887|FG001|Overall Study|Hypotension|0|||
94722272|NCT03056755|324441907|FG000|Treatment- Core Phase|Progressive disease|89|||
94722273|NCT03056755|324441908|FG001|Treatment- Core Phase|Progressive disease|88|||
94722274|NCT03056755|324441909|FG002|Treatment- Core Phase|Progressive disease|90|||
94722275|NCT03056755|324441907|FG000|Treatment- Core Phase|Adverse Event|20|||
94722276|NCT03056755|324441908|FG001|Treatment- Core Phase|Adverse Event|14|||
94722277|NCT03056755|324441909|FG002|Treatment- Core Phase|Adverse Event|13|||
94722278|NCT03056755|324441907|FG000|Treatment- Core Phase|Physician Decision|7|||
94722279|NCT03056755|324441908|FG001|Treatment- Core Phase|Physician Decision|13|||
94722280|NCT03056755|324441909|FG002|Treatment- Core Phase|Physician Decision|5|||
94722281|NCT03056755|324441907|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
94722282|NCT03056755|324441908|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
94722283|NCT03056755|324441909|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
94722284|NCT03056755|324441907|FG000|Treatment- Core Phase|Death|3|||
94722285|NCT03056755|324441908|FG001|Treatment- Core Phase|Death|2|||
94722286|NCT03056755|324441909|FG002|Treatment- Core Phase|Death|4|||
94722287|NCT03056755|324441907|FG000|Treatment- Core Phase|Protocol deviation|1|||
94722288|NCT03056755|324441908|FG001|Treatment- Core Phase|Protocol deviation|1|||
94722289|NCT03056755|324441909|FG002|Treatment- Core Phase|Protocol deviation|0|||
94722290|NCT03056755|324441907|FG000|Treatment- Core Phase|Technical problems|1|||
94722291|NCT03056755|324441908|FG001|Treatment- Core Phase|Technical problems|0|||
94722292|NCT03056755|324441909|FG002|Treatment- Core Phase|Technical problems|0|||
94722293|NCT03056755|324441907|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
94722294|NCT03056755|324441908|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
94722295|NCT03056755|324441909|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
94722296|NCT03056755|324441907|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
94722297|NCT03056755|324441908|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
94722298|NCT03056755|324441909|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
94722299|NCT03056755|324441907|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
94722300|NCT03056755|324441908|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
94722301|NCT03056755|324441909|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
94272365|NCT00829179|322790397|FG000|Overall Study|Withdrawal by Subject|1|||
94722302|NCT03056755|324441907|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
94722303|NCT03056755|324441908|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
94722304|NCT03056755|324441909|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
94722305|NCT06074523|324441910|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
94722306|NCT06074523|324441910|FG000|Overall Study|Withdrawal by Subject|1|||
94722307|NCT04245501|324441911|FG000|Overall Study|Adverse Event|2|||
94722308|NCT04245501|324441912|FG001|Overall Study|Adverse Event|0|||
94722309|NCT04245501|324441911|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
94722310|NCT04245501|324441912|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
94722311|NCT01426425|324441913|FG000|Overall Study|Exited prior to EP study|22|||
94722312|NCT01426425|324441913|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
94722313|NCT01426425|324441913|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
94722314|NCT05337748|324441914|FG000|Overall Study|Withdrawal by Subject|1|||
94722315|NCT05337748|324441915|FG001|Overall Study|Withdrawal by Subject|0|||
94722316|NCT05337748|324441914|FG000|Overall Study|Death|1|||
94722317|NCT05337748|324441915|FG001|Overall Study|Death|0|||
94722318|NCT03453619|324441916|FG000|Core Study (Part A)|Physician Decision|0|||
94722319|NCT03453619|324441917|FG001|Core Study (Part A)|Physician Decision|0|||
94722320|NCT03453619|324441918|FG002|Core Study (Part A)|Physician Decision|2|||
94722321|NCT03453619|324441919|FG003|Core Study (Part A)|Physician Decision|0|||
94722322|NCT03453619|324441916|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
94722323|NCT03453619|324441917|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
94722324|NCT03453619|324441918|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
94722325|NCT03453619|324441919|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
94722326|NCT03453619|324441916|FG000|Core Study (Part A)|Other|0|||
94722327|NCT03453619|324441917|FG001|Core Study (Part A)|Other|1|||
94722328|NCT03453619|324441918|FG002|Core Study (Part A)|Other|0|||
94722329|NCT03453619|324441919|FG003|Core Study (Part A)|Other|0|||
94722330|NCT03453619|324441916|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
94722331|NCT03453619|324441917|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
94722332|NCT03453619|324441918|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
94722333|NCT03453619|324441919|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
94722334|NCT03453619|324441916|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
94722335|NCT03453619|324441917|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
94722336|NCT03453619|324441918|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
94722337|NCT03453619|324441919|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
94722338|NCT03453619|324441916|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
94722339|NCT03453619|324441917|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
94722340|NCT03453619|324441918|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
94722341|NCT03453619|324441919|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
94272366|NCT04206020|322790398|FG000|Overall Study|Adverse Event|1|||
94272367|NCT04206020|322790399|FG001|Overall Study|Adverse Event|4|||
94272368|NCT04206020|322790398|FG000|Overall Study|Protocol Violation|2|||
94722342|NCT03453619|324441916|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
94722343|NCT03453619|324441917|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
94467343|NCT00574795|323500522|FG000|After Infant Series|Withdrawal by Subject|1|||
94467344|NCT00574795|323500522|FG000|After Infant Series|Adverse Event|2|||
94722344|NCT03453619|324441918|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
94722345|NCT03453619|324441919|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
94722346|NCT02900924|324441920|FG000|Overall Study|Death|52|||
94722347|NCT02900924|324441920|FG000|Overall Study|Lost to Follow-up|4|||
94722348|NCT02900924|324441920|FG000|Overall Study|Withdrawal by Subject|20|||
94722349|NCT02900924|324441920|FG000|Overall Study|Missed Visit|33|||
94722350|NCT03763708|324441924|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
94722351|NCT03763708|324441925|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
94722352|NCT03763708|324441926|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
94722353|NCT03763708|324441927|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
94722354|NCT03763708|324441928|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
94722355|NCT03763708|324441929|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
94722356|NCT03763708|324441930|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
94272369|NCT04206020|322790399|FG001|Overall Study|Protocol Violation|0|||
94722357|NCT03763708|324441931|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
94272370|NCT04206020|322790398|FG000|Overall Study|Withdrawal by Subject|2|||
94272371|NCT04206020|322790399|FG001|Overall Study|Withdrawal by Subject|0|||
94272372|NCT04206020|322790398|FG000|Overall Study|Lost to Follow-up|2|||
94272373|NCT04206020|322790399|FG001|Overall Study|Lost to Follow-up|0|||
94272374|NCT04206020|322790398|FG000|Overall Study|Pregnancy|0|||
94272375|NCT04206020|322790399|FG001|Overall Study|Pregnancy|1|||
94272376|NCT04206020|322790398|FG000|Overall Study|Unable to attend visits|1|||
94272377|NCT04206020|322790399|FG001|Overall Study|Unable to attend visits|2|||
94272378|NCT01517893|322790408|FG000|Overall Study|Withdrawal by Subject|3|||
94272379|NCT01517893|322790409|FG001|Overall Study|Withdrawal by Subject|0|||
94272380|NCT03200366|322790410|FG000|Patient Navigation Intervention Given|Death|0|||
94272381|NCT03200366|322790411|FG001|Patient Navigation Intervention Given|Death|2|||
94272382|NCT03200366|322790412|FG002|Patient Navigation Intervention Given|Death|0|||
94272383|NCT03200366|322790410|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
94272384|NCT03200366|322790411|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
94272385|NCT03200366|322790412|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
94722358|NCT03763708|324441932|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
94722359|NCT03763708|324441924|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
94722360|NCT03763708|324441925|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
94722361|NCT03763708|324441926|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
94722362|NCT03763708|324441927|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
94722363|NCT03763708|324441928|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
94722364|NCT03763708|324441929|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
94722365|NCT03763708|324441930|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
94722366|NCT03763708|324441931|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
94722367|NCT03763708|324441932|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
94722368|NCT03763708|324441924|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
94722369|NCT03763708|324441925|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
94722370|NCT03763708|324441926|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
94722371|NCT03763708|324441927|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
94722372|NCT03763708|324441928|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
94722373|NCT03763708|324441929|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
94722374|NCT03763708|324441930|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
94722375|NCT03763708|324441931|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
94722376|NCT03763708|324441932|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
94722377|NCT03763708|324441924|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
94722378|NCT03763708|324441925|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
94722379|NCT03763708|324441926|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
94722380|NCT03763708|324441927|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
94722381|NCT03763708|324441928|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
94722382|NCT03763708|324441929|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
94722383|NCT03763708|324441930|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
94722384|NCT03763708|324441931|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
94722385|NCT03763708|324441932|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
94722386|NCT03763708|324441924|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
94722387|NCT03763708|324441925|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
94722388|NCT03763708|324441926|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
94722389|NCT03763708|324441927|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
94722390|NCT03763708|324441928|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
94722391|NCT03763708|324441929|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
94722392|NCT03763708|324441930|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
94722393|NCT03763708|324441931|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
94722394|NCT03763708|324441932|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
94722395|NCT03763708|324441924|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
94722396|NCT03763708|324441925|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
94722397|NCT03763708|324441926|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
94722398|NCT03763708|324441927|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
94722399|NCT03763708|324441928|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
94722400|NCT03763708|324441929|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
94722401|NCT03763708|324441930|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
94722402|NCT03763708|324441931|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
94722403|NCT03763708|324441932|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
94722404|NCT03763708|324441924|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
94722405|NCT03763708|324441925|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
94722406|NCT03763708|324441926|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
94722407|NCT03763708|324441927|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
94722408|NCT03763708|324441928|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
94722409|NCT03763708|324441929|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
94272386|NCT03200366|322790410|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
94722410|NCT03763708|324441930|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
94722411|NCT03763708|324441931|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
94722412|NCT03763708|324441932|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
94722413|NCT03763708|324441924|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
94722414|NCT03763708|324441925|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
94722415|NCT03763708|324441926|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
94722416|NCT03763708|324441927|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
94722417|NCT03763708|324441928|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
94722418|NCT03763708|324441929|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
94722419|NCT03763708|324441930|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
94722420|NCT03763708|324441931|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
94722421|NCT03763708|324441932|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
94722422|NCT03763708|324441924|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
94722423|NCT03763708|324441925|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
94722424|NCT03763708|324441926|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
94722425|NCT03763708|324441927|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
94722426|NCT03763708|324441928|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
94722427|NCT03763708|324441929|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
94722428|NCT03763708|324441930|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
94722429|NCT03763708|324441931|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
94722430|NCT03763708|324441932|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
94722431|NCT03930342|324441938|FG000|Overall Study|Lost to Follow-up|70|||
94722432|NCT03930342|324441939|FG001|Overall Study|Lost to Follow-up|77|||
94722433|NCT03861273|324441940|FG000|Screening Phase (3 Weeks)|Other|1|||
94722434|NCT03861273|324441940|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
94722435|NCT03861273|324441940|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
94722436|NCT03861273|324441940|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
94722437|NCT03861273|324441940|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
94722438|NCT03774082|324441943|FG000|Overall Study|Death|6|||
94722439|NCT03774082|324441944|FG001|Overall Study|Death|3|||
94722440|NCT03774082|324441945|FG002|Overall Study|Death|2|||
94722441|NCT03774082|324441943|FG000|Overall Study|Subject decision|0|||
94722442|NCT03774082|324441944|FG001|Overall Study|Subject decision|3|||
94722443|NCT03774082|324441945|FG002|Overall Study|Subject decision|0|||
94722444|NCT03774082|324441943|FG000|Overall Study|Lost to Follow-up|2|||
94722445|NCT03774082|324441944|FG001|Overall Study|Lost to Follow-up|0|||
94722446|NCT03774082|324441945|FG002|Overall Study|Lost to Follow-up|0|||
94722447|NCT03774082|324441943|FG000|Overall Study|Guardian decision|0|||
94722448|NCT03774082|324441944|FG001|Overall Study|Guardian decision|0|||
94722449|NCT03774082|324441945|FG002|Overall Study|Guardian decision|1|||
94722450|NCT03774082|324441943|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
94722451|NCT03774082|324441944|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
94722452|NCT03774082|324441945|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
94722453|NCT05302596|324441946|FG000|Overall Study|Withdrawal by Subject|1|||
94722454|NCT05302596|324441947|FG001|Overall Study|Withdrawal by Subject|1|||
94722455|NCT05038566|324443024|FG000|Overall Study|Technical Difficulties with the Device|0|||
94722456|NCT05038566|324443025|FG001|Overall Study|Technical Difficulties with the Device|1|||
94722457|NCT04178733|324443036|FG000|Overall Study|Investigator Decision|0|||
94722458|NCT04178733|324443037|FG001|Overall Study|Investigator Decision|0|||
94722459|NCT04178733|324443038|FG002|Overall Study|Investigator Decision|0|||
94722460|NCT04178733|324443039|FG003|Overall Study|Investigator Decision|1|||
94722461|NCT04178733|324443040|FG004|Overall Study|Investigator Decision|2|||
94722462|NCT03391466|324443042|FG000|Overall Study|Death|82|||
94722463|NCT03391466|324443043|FG001|Overall Study|Death|85|||
94722464|NCT03391466|324443042|FG000|Overall Study|Still on study|93|||
94722465|NCT03391466|324443043|FG001|Overall Study|Still on study|74|||
94722466|NCT03391466|324443042|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
94722467|NCT03391466|324443043|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
94722468|NCT03391466|324443042|FG000|Overall Study|Lost to Follow-up|5|||
94722469|NCT03391466|324443043|FG001|Overall Study|Lost to Follow-up|5|||
94722470|NCT03391466|324443042|FG000|Overall Study|Investigator decision|0|||
94722471|NCT03391466|324443043|FG001|Overall Study|Investigator decision|1|||
94722472|NCT03391466|324443042|FG000|Overall Study|Other|0|||
94722473|NCT03391466|324443043|FG001|Overall Study|Other|1|||
94722474|NCT05461131|324443046|FG000|Overall Study|Lost to Follow-up|0|||
94722475|NCT05461131|324443047|FG001|Overall Study|Lost to Follow-up|2|||
94722476|NCT03713086|324443050|FG000|Overall Study|Withdrawal by Subject|0|||
94722477|NCT03713086|324443051|FG001|Overall Study|Withdrawal by Subject|2|||
94722478|NCT03713086|324443052|FG002|Overall Study|Withdrawal by Subject|1|||
94722479|NCT03713086|324443053|FG003|Overall Study|Withdrawal by Subject|0|||
94722480|NCT03713086|324443050|FG000|Overall Study|Lost to Follow-up|0|||
94722481|NCT03713086|324443051|FG001|Overall Study|Lost to Follow-up|1|||
94722482|NCT03713086|324443052|FG002|Overall Study|Lost to Follow-up|0|||
94722483|NCT03713086|324443053|FG003|Overall Study|Lost to Follow-up|1|||
94722484|NCT03988634|324443054|FG000|Double-Blind|Adverse Event|4|||
94722485|NCT03988634|324443055|FG001|Double-Blind|Adverse Event|0|||
94722486|NCT03988634|324443056|FG002|Double-Blind|Adverse Event|0|||
94722487|NCT03988634|324443054|FG000|Double-Blind|Death|18|||
94722488|NCT03988634|324443055|FG001|Double-Blind|Death|26|||
94722489|NCT03988634|324443056|FG002|Double-Blind|Death|0|||
94722490|NCT03988634|324443054|FG000|Double-Blind|Lost to Follow-up|6|||
94722491|NCT03988634|324443055|FG001|Double-Blind|Lost to Follow-up|7|||
94722492|NCT03988634|324443056|FG002|Double-Blind|Lost to Follow-up|0|||
94722493|NCT03988634|324443054|FG000|Double-Blind|Physician Decision|9|||
94722494|NCT03988634|324443055|FG001|Double-Blind|Physician Decision|5|||
94722495|NCT03988634|324443056|FG002|Double-Blind|Physician Decision|0|||
94272387|NCT03200366|322790411|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
94272388|NCT03200366|322790412|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
94272389|NCT03200366|322790410|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
94272390|NCT03200366|322790411|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
94272391|NCT03200366|322790412|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
94272392|NCT03200366|322790410|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
94272393|NCT03200366|322790411|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
94272394|NCT03200366|322790412|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
94272395|NCT03200366|322790410|FG000|6 Month Post-Baseline Interview|Death|1|||
94272396|NCT03200366|322790411|FG001|6 Month Post-Baseline Interview|Death|1|||
94272397|NCT03200366|322790412|FG002|6 Month Post-Baseline Interview|Death|1|||
94722496|NCT03988634|324443054|FG000|Double-Blind|Subject decision|24|||
94722497|NCT03988634|324443055|FG001|Double-Blind|Subject decision|13|||
94722498|NCT03988634|324443056|FG002|Double-Blind|Subject decision|0|||
94722499|NCT03988634|324443054|FG000|Open-Label|Adverse Event|0|||
94722500|NCT03988634|324443055|FG001|Open-Label|Adverse Event|0|||
94722501|NCT03988634|324443056|FG002|Open-Label|Adverse Event|7|||
94722502|NCT03988634|324443054|FG000|Open-Label|Physician Decision|0|||
94722503|NCT03988634|324443055|FG001|Open-Label|Physician Decision|0|||
94722504|NCT03988634|324443056|FG002|Open-Label|Physician Decision|1|||
94722505|NCT03988634|324443054|FG000|Open-Label|Technical problems|0|||
94722506|NCT03988634|324443055|FG001|Open-Label|Technical problems|0|||
94722507|NCT03988634|324443056|FG002|Open-Label|Technical problems|1|||
94722508|NCT01820260|324443064|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
94722509|NCT01820260|324443065|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
94722510|NCT01820260|324443066|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
94722511|NCT01820260|324443067|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
94722512|NCT01820260|324443068|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
94722513|NCT01820260|324443069|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
94722514|NCT01820260|324443070|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
94722515|NCT01820260|324443071|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
94272398|NCT03200366|322790410|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
94272399|NCT03200366|322790411|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
94272400|NCT03200366|322790412|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
94272401|NCT03200366|322790410|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
94272402|NCT03200366|322790411|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
94272403|NCT03200366|322790412|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
94272404|NCT03200366|322790410|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
94272405|NCT03200366|322790411|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
94272406|NCT03200366|322790412|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
94272407|NCT03200366|322790410|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
94272408|NCT03200366|322790411|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
94272409|NCT03200366|322790412|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
94272410|NCT03200366|322790410|FG000|9 Month Post-Baseline Interview|Death|1|||
94272411|NCT03200366|322790411|FG001|9 Month Post-Baseline Interview|Death|1|||
94272412|NCT03200366|322790412|FG002|9 Month Post-Baseline Interview|Death|1|||
94272413|NCT03200366|322790410|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
94272414|NCT03200366|322790411|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
94272415|NCT03200366|322790412|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
94272416|NCT03200366|322790410|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
94272417|NCT03200366|322790411|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
94272418|NCT03200366|322790412|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
94272419|NCT03200366|322790410|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
94272420|NCT03200366|322790411|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
94272421|NCT03200366|322790412|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
94272422|NCT03024970|322790413|FG000|First Intervention|Adverse Event|1|||
94272423|NCT03024970|322790414|FG001|First Intervention|Adverse Event|0|||
94272424|NCT03024970|322790413|FG000|Second Intervention|Lost to Follow-up|1|||
94272425|NCT03024970|322790414|FG001|Second Intervention|Lost to Follow-up|0|||
94272426|NCT03901079|322790416|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
94272427|NCT04544475|322790417|FG000|Overall Study|Withdrawal by Subject|1|||
94272428|NCT04544475|322790418|FG001|Overall Study|Withdrawal by Subject|3|||
94272429|NCT01147744|322790420|FG000|Overall Study|Protocol Violation|1|||
94272430|NCT01147744|322790421|FG001|Overall Study|Protocol Violation|0|||
94272431|NCT01147744|322790422|FG002|Overall Study|Protocol Violation|1|||
94272432|NCT01147744|322790423|FG003|Overall Study|Protocol Violation|0|||
94272433|NCT01147744|322790424|FG004|Overall Study|Protocol Violation|1|||
94272434|NCT01147744|322790425|FG005|Overall Study|Protocol Violation|3|||
94272435|NCT01147744|322790426|FG006|Overall Study|Protocol Violation|1|||
94272436|NCT01147744|322790420|FG000|Overall Study|Physician Decision|0|||
94722516|NCT01820260|324443072|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
94722517|NCT01820260|324443073|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
94722518|NCT01820260|324443074|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
94722519|NCT01820260|324443075|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
94722520|NCT01820260|324443076|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
94722521|NCT01820260|324443077|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
94722522|NCT01820260|324443064|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
94722523|NCT01820260|324443065|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
94722524|NCT01820260|324443066|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
94722525|NCT01820260|324443067|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
94722526|NCT01820260|324443068|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
94722527|NCT01820260|324443069|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
94722528|NCT01820260|324443070|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
94722529|NCT01820260|324443071|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
94722530|NCT01820260|324443072|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
94722531|NCT01820260|324443073|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
94722532|NCT01820260|324443074|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
94722533|NCT01820260|324443075|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
94722534|NCT01820260|324443076|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
94722535|NCT01820260|324443077|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
94722536|NCT04831281|324443078|FG000|Overall Study|Adverse Event|1|||
94722537|NCT04831281|324443079|FG001|Overall Study|Adverse Event|0|||
94722538|NCT04831281|324443080|FG002|Overall Study|Adverse Event|3|||
94722539|NCT04831281|324443078|FG000|Overall Study|Withdrawal by Subject|0|||
94722540|NCT04831281|324443079|FG001|Overall Study|Withdrawal by Subject|1|||
94722541|NCT04831281|324443080|FG002|Overall Study|Withdrawal by Subject|2|||
94722542|NCT04831281|324443078|FG000|Overall Study|Undetermined|1|||
94722543|NCT04831281|324443079|FG001|Overall Study|Undetermined|1|||
94722544|NCT04831281|324443080|FG002|Overall Study|Undetermined|0|||
94722545|NCT05249439|324443081|FG000|Overall Study|Withdrawal by Subject|2|||
94722546|NCT05249439|324443082|FG001|Overall Study|Withdrawal by Subject|5|||
94722547|NCT05249439|324443081|FG000|Overall Study|Physician Decision|3|||
94722548|NCT05249439|324443082|FG001|Overall Study|Physician Decision|1|||
94722549|NCT03786783|324443083|FG000|Overall Study|Death|1|||
94722550|NCT03786783|324443083|FG000|Overall Study|Physician Decision|6|||
94722551|NCT03786783|324443083|FG000|Overall Study|Withdrawal by Subject|2|||
94722552|NCT03786783|324443083|FG000|Overall Study|Disease Progression|7|||
94722553|NCT03786783|324443083|FG000|Overall Study|Patient/Parent Refusal|4|||
94722554|NCT05691309|324443104|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
94722555|NCT05691309|324443104|FG000|Overall Study|vancomycin levels not evaluable|2|||
94722556|NCT02724878|324443105|FG000|Overall Study|Still on Active Therapy|15|||
94722557|NCT02724878|324443105|FG000|Overall Study|Disease Progression|31|||
94722558|NCT02724878|324443105|FG000|Overall Study|Toxicity|5|||
94722559|NCT02724878|324443105|FG000|Overall Study|Death|1|||
94722560|NCT02724878|324443105|FG000|Overall Study|Withdrawal by Subject|4|||
94722561|NCT02724878|324443105|FG000|Overall Study|Lost to Follow-up|2|||
94722562|NCT02724878|324443105|FG000|Overall Study|Protocol Violation|1|||
94722563|NCT02724878|324443105|FG000|Overall Study|Ineligible for Study Drug|5|||
94722564|NCT02724878|324443105|FG000|Overall Study|not started|1|||
94722565|NCT04258709|324443107|FG000|Overall Study|Lost to Follow-up|10|||
94722566|NCT04258709|324443108|FG001|Overall Study|Lost to Follow-up|4|||
94722567|NCT04258709|324443107|FG000|Overall Study|Withdrawal by Subject|1|||
94722568|NCT04258709|324443108|FG001|Overall Study|Withdrawal by Subject|0|||
94272437|NCT01147744|322790421|FG001|Overall Study|Physician Decision|1|||
94272438|NCT01147744|322790422|FG002|Overall Study|Physician Decision|1|||
94272439|NCT01147744|322790423|FG003|Overall Study|Physician Decision|0|||
94272440|NCT01147744|322790424|FG004|Overall Study|Physician Decision|0|||
94272441|NCT01147744|322790425|FG005|Overall Study|Physician Decision|0|||
94272442|NCT01147744|322790426|FG006|Overall Study|Physician Decision|1|||
94272443|NCT01147744|322790420|FG000|Overall Study|Lack of Efficacy|11|||
94272444|NCT01147744|322790421|FG001|Overall Study|Lack of Efficacy|11|||
94272445|NCT01147744|322790422|FG002|Overall Study|Lack of Efficacy|9|||
94272446|NCT01147744|322790423|FG003|Overall Study|Lack of Efficacy|11|||
94272447|NCT01147744|322790424|FG004|Overall Study|Lack of Efficacy|13|||
94272448|NCT01147744|322790425|FG005|Overall Study|Lack of Efficacy|8|||
94272449|NCT01147744|322790426|FG006|Overall Study|Lack of Efficacy|7|||
94272450|NCT01147744|322790420|FG000|Overall Study|Adverse Event|1|||
94272451|NCT01147744|322790421|FG001|Overall Study|Adverse Event|2|||
94368178|NCT04440163|323134860|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
94722569|NCT04258709|324443107|FG000|Overall Study|Fetal demise|0|||
94722570|NCT04258709|324443108|FG001|Overall Study|Fetal demise|1|||
94722571|NCT04258709|324443107|FG000|Overall Study|Protocol Violation|1|||
94272452|NCT01147744|322790422|FG002|Overall Study|Adverse Event|3|||
94272453|NCT01147744|322790423|FG003|Overall Study|Adverse Event|0|||
94272454|NCT01147744|322790424|FG004|Overall Study|Adverse Event|2|||
94272455|NCT01147744|322790425|FG005|Overall Study|Adverse Event|1|||
94272456|NCT01147744|322790426|FG006|Overall Study|Adverse Event|2|||
94722572|NCT04258709|324443108|FG001|Overall Study|Protocol Violation|1|||
94722573|NCT04838262|324443109|FG000|Overall Study|Withdrawal by Subject|9|||
94722574|NCT04838262|324443110|FG001|Overall Study|Withdrawal by Subject|4|||
94722575|NCT04541706|324443115|FG000|Overall Study|Withdrawal by Subject|3|||
94722576|NCT04541706|324443115|FG000|Overall Study|Progressive disease|33|||
94722577|NCT04541706|324443115|FG000|Overall Study|Physician Decision|1|||
94722578|NCT04541706|324443115|FG000|Overall Study|Lost to Follow-up|2|||
94722579|NCT04541706|324443115|FG000|Overall Study|Death|5|||
94722580|NCT04541706|324443115|FG000|Overall Study|Adverse Event|1|||
94722581|NCT04918147|324443116|FG000|Overall Study|Disease flare as defined in protocol|0|||
94722582|NCT04918147|324443117|FG001|Overall Study|Disease flare as defined in protocol|2|||
94722583|NCT02365766|324443118|FG000|Overall Study|Withdrawal by Subject|0|||
94722584|NCT02365766|324443119|FG001|Overall Study|Withdrawal by Subject|0|||
94722585|NCT02365766|324443120|FG002|Overall Study|Withdrawal by Subject|1|||
94722586|NCT02365766|324443118|FG000|Overall Study|Eligibility Criteria Not Met|0|||
94722587|NCT02365766|324443119|FG001|Overall Study|Eligibility Criteria Not Met|0|||
94722588|NCT02365766|324443120|FG002|Overall Study|Eligibility Criteria Not Met|1|||
94722589|NCT03138512|324443122|FG000|Randomization|Participants withdrew consent|0|||
94722590|NCT03138512|324443123|FG001|Randomization|Participants withdrew consent|1|||
94722591|NCT03138512|324443124|FG002|Randomization|Participants withdrew consent|1|||
94722592|NCT03138512|324443125|FG003|Randomization|Participants withdrew consent|0|||
94722593|NCT03138512|324443126|FG004|Randomization|Participants withdrew consent|0|||
94722594|NCT03138512|324443122|FG000|Randomization|Participant no longer meets study criteria|0|||
94722595|NCT03138512|324443123|FG001|Randomization|Participant no longer meets study criteria|3|||
94722596|NCT03138512|324443124|FG002|Randomization|Participant no longer meets study criteria|1|||
94722597|NCT03138512|324443125|FG003|Randomization|Participant no longer meets study criteria|1|||
94722598|NCT03138512|324443126|FG004|Randomization|Participant no longer meets study criteria|3|||
94722599|NCT03138512|324443122|FG000|Randomization|Other reasons|1|||
94722600|NCT03138512|324443123|FG001|Randomization|Other reasons|0|||
94722601|NCT03138512|324443124|FG002|Randomization|Other reasons|0|||
94722602|NCT03138512|324443125|FG003|Randomization|Other reasons|0|||
94722603|NCT03138512|324443126|FG004|Randomization|Other reasons|0|||
94722604|NCT03138512|324443122|FG000|Treatment Part A|Disease recurrence|10|||
94722605|NCT03138512|324443123|FG001|Treatment Part A|Disease recurrence|20|||
94722606|NCT03138512|324443124|FG002|Treatment Part A|Disease recurrence|0|||
94722607|NCT03138512|324443125|FG003|Treatment Part A|Disease recurrence|0|||
94722608|NCT03138512|324443126|FG004|Treatment Part A|Disease recurrence|0|||
94722609|NCT03138512|324443122|FG000|Treatment Part A|Study Drug Toxicity|132|||
94722610|NCT03138512|324443123|FG001|Treatment Part A|Study Drug Toxicity|5|||
94722611|NCT03138512|324443124|FG002|Treatment Part A|Study Drug Toxicity|0|||
94722612|NCT03138512|324443125|FG003|Treatment Part A|Study Drug Toxicity|0|||
94722613|NCT03138512|324443126|FG004|Treatment Part A|Study Drug Toxicity|0|||
94722614|NCT03138512|324443122|FG000|Treatment Part A|Death|1|||
94722615|NCT03138512|324443123|FG001|Treatment Part A|Death|0|||
94272457|NCT01147744|322790420|FG000|Overall Study|Withdrawal by Subject|8|||
94272458|NCT01147744|322790421|FG001|Overall Study|Withdrawal by Subject|4|||
94722616|NCT03138512|324443124|FG002|Treatment Part A|Death|0|||
94272459|NCT01147744|322790422|FG002|Overall Study|Withdrawal by Subject|2|||
94722617|NCT03138512|324443125|FG003|Treatment Part A|Death|0|||
94722618|NCT03138512|324443126|FG004|Treatment Part A|Death|0|||
94722619|NCT03138512|324443122|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
94722620|NCT03138512|324443123|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
94722621|NCT03138512|324443124|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
94722622|NCT03138512|324443125|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
94722623|NCT03138512|324443126|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
94722624|NCT03138512|324443122|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
94722625|NCT03138512|324443123|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
94722626|NCT03138512|324443124|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
94722627|NCT03138512|324443125|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
94722628|NCT03138512|324443126|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
94722629|NCT03138512|324443122|FG000|Treatment Part A|Participant withdrew consent|2|||
94722630|NCT03138512|324443123|FG001|Treatment Part A|Participant withdrew consent|4|||
94722631|NCT03138512|324443124|FG002|Treatment Part A|Participant withdrew consent|0|||
94722632|NCT03138512|324443125|FG003|Treatment Part A|Participant withdrew consent|0|||
94368179|NCT04440163|323134861|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
94368180|NCT04440163|323134862|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
94368181|NCT04440163|323134863|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
94368182|NCT04440163|323134864|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
94368183|NCT04440163|323134865|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
94368184|NCT04440163|323134866|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
94368185|NCT04440163|323134867|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
94368186|NCT04440163|323134860|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
94368187|NCT04440163|323134861|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
94368188|NCT04440163|323134862|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
94368189|NCT04440163|323134863|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
94368190|NCT04440163|323134864|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
94368191|NCT04440163|323134865|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
94368192|NCT04440163|323134866|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
94368193|NCT04440163|323134867|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
94368194|NCT04440163|323134860|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
94368195|NCT04440163|323134861|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
94368196|NCT04440163|323134862|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
94368197|NCT04440163|323134863|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
94368198|NCT04440163|323134864|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
94368199|NCT04440163|323134865|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
94722633|NCT03138512|324443126|FG004|Treatment Part A|Participant withdrew consent|0|||
94722634|NCT03138512|324443122|FG000|Treatment Part A|Lost to Follow-up|0|||
94722635|NCT03138512|324443123|FG001|Treatment Part A|Lost to Follow-up|1|||
94722636|NCT03138512|324443124|FG002|Treatment Part A|Lost to Follow-up|0|||
94722637|NCT03138512|324443125|FG003|Treatment Part A|Lost to Follow-up|0|||
94722638|NCT03138512|324443126|FG004|Treatment Part A|Lost to Follow-up|0|||
94722639|NCT03138512|324443122|FG000|Treatment Part A|Poor/non-compliance|1|||
94722640|NCT03138512|324443123|FG001|Treatment Part A|Poor/non-compliance|0|||
94722641|NCT03138512|324443124|FG002|Treatment Part A|Poor/non-compliance|0|||
94722642|NCT03138512|324443125|FG003|Treatment Part A|Poor/non-compliance|0|||
94722643|NCT03138512|324443126|FG004|Treatment Part A|Poor/non-compliance|0|||
94722644|NCT03138512|324443122|FG000|Treatment Part A|Pregnancy|0|||
94722645|NCT03138512|324443123|FG001|Treatment Part A|Pregnancy|1|||
94722646|NCT03138512|324443124|FG002|Treatment Part A|Pregnancy|0|||
94722647|NCT03138512|324443125|FG003|Treatment Part A|Pregnancy|0|||
94722648|NCT03138512|324443126|FG004|Treatment Part A|Pregnancy|0|||
94722649|NCT03138512|324443122|FG000|Treatment Part A|Other reasons|11|||
94722650|NCT03138512|324443123|FG001|Treatment Part A|Other reasons|8|||
94722651|NCT03138512|324443124|FG002|Treatment Part A|Other reasons|0|||
94722652|NCT03138512|324443125|FG003|Treatment Part A|Other reasons|0|||
94722653|NCT03138512|324443126|FG004|Treatment Part A|Other reasons|0|||
94722654|NCT03138512|324443122|FG000|Treatment Part B|Disease recurrence|0|||
94722655|NCT03138512|324443123|FG001|Treatment Part B|Disease recurrence|0|||
94722656|NCT03138512|324443124|FG002|Treatment Part B|Disease recurrence|6|||
94722657|NCT03138512|324443125|FG003|Treatment Part B|Disease recurrence|12|||
94722658|NCT03138512|324443126|FG004|Treatment Part B|Disease recurrence|10|||
94722659|NCT03138512|324443122|FG000|Treatment Part B|Study drug toxicity|0|||
94722660|NCT03138512|324443123|FG001|Treatment Part B|Study drug toxicity|0|||
94722661|NCT03138512|324443124|FG002|Treatment Part B|Study drug toxicity|63|||
94722662|NCT03138512|324443125|FG003|Treatment Part B|Study drug toxicity|3|||
94722663|NCT03138512|324443126|FG004|Treatment Part B|Study drug toxicity|45|||
94722664|NCT03138512|324443122|FG000|Treatment Part B|Death|0|||
94722665|NCT03138512|324443123|FG001|Treatment Part B|Death|0|||
94722666|NCT03138512|324443124|FG002|Treatment Part B|Death|1|||
94722667|NCT03138512|324443125|FG003|Treatment Part B|Death|0|||
94722668|NCT03138512|324443126|FG004|Treatment Part B|Death|0|||
94722669|NCT03138512|324443122|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
94722670|NCT03138512|324443123|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
94722671|NCT03138512|324443124|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
94722672|NCT03138512|324443125|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
94722673|NCT03138512|324443126|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
94722674|NCT03138512|324443122|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
94722675|NCT03138512|324443123|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
94722676|NCT03138512|324443124|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
94722677|NCT03138512|324443125|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
94722678|NCT03138512|324443126|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
94722679|NCT03138512|324443122|FG000|Treatment Part B|Participant withdrew consent|0|||
94722680|NCT03138512|324443123|FG001|Treatment Part B|Participant withdrew consent|0|||
94722681|NCT03138512|324443124|FG002|Treatment Part B|Participant withdrew consent|1|||
94722682|NCT03138512|324443125|FG003|Treatment Part B|Participant withdrew consent|1|||
94722683|NCT03138512|324443126|FG004|Treatment Part B|Participant withdrew consent|2|||
94722684|NCT03138512|324443122|FG000|Treatment Part B|Lost to Follow-up|0|||
94722685|NCT03138512|324443123|FG001|Treatment Part B|Lost to Follow-up|0|||
94722686|NCT03138512|324443124|FG002|Treatment Part B|Lost to Follow-up|0|||
94722687|NCT03138512|324443125|FG003|Treatment Part B|Lost to Follow-up|1|||
94722688|NCT03138512|324443126|FG004|Treatment Part B|Lost to Follow-up|0|||
94722689|NCT03138512|324443122|FG000|Treatment Part B|Poor/non-compliance|0|||
94722690|NCT03138512|324443123|FG001|Treatment Part B|Poor/non-compliance|0|||
94722691|NCT03138512|324443124|FG002|Treatment Part B|Poor/non-compliance|1|||
94722692|NCT03138512|324443125|FG003|Treatment Part B|Poor/non-compliance|1|||
94722693|NCT03138512|324443126|FG004|Treatment Part B|Poor/non-compliance|1|||
94722694|NCT03138512|324443122|FG000|Treatment Part B|Other reasons|0|||
94722695|NCT03138512|324443123|FG001|Treatment Part B|Other reasons|0|||
94722696|NCT03138512|324443124|FG002|Treatment Part B|Other reasons|3|||
94722697|NCT03138512|324443125|FG003|Treatment Part B|Other reasons|1|||
94722698|NCT03138512|324443126|FG004|Treatment Part B|Other reasons|5|||
94722699|NCT03317405|324443127|FG000|Overall Study|Withdrawal by Subject|1|||
94722700|NCT03317405|324443128|FG001|Overall Study|Withdrawal by Subject|0|||
94722701|NCT03317405|324443129|FG002|Overall Study|Withdrawal by Subject|0|||
94722702|NCT03317405|324443127|FG000|Overall Study|Physician Decision|0|||
94722703|NCT03317405|324443128|FG001|Overall Study|Physician Decision|0|||
94722704|NCT03317405|324443129|FG002|Overall Study|Physician Decision|1|||
94722705|NCT03317405|324443127|FG000|Overall Study|Surgery Rescheduled|0|||
94722706|NCT03317405|324443128|FG001|Overall Study|Surgery Rescheduled|1|||
94722707|NCT03317405|324443129|FG002|Overall Study|Surgery Rescheduled|0|||
94722708|NCT04382404|324443130|FG000|Overall Study|Adverse Event|1|||
94722709|NCT04382404|324443130|FG000|Overall Study|Lost to Follow-up|2|||
94722710|NCT02960893|324443132|FG000|Randomization Phase (8-week)|Adverse Event|5|||
94722711|NCT02960893|324443133|FG001|Randomization Phase (8-week)|Adverse Event|0|||
94722712|NCT02960893|324443132|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
94368200|NCT04440163|323134866|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
94368201|NCT04440163|323134867|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
94368202|NCT04440163|323134860|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
94368203|NCT04440163|323134861|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
94368204|NCT04440163|323134862|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
94368205|NCT04440163|323134863|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
94368206|NCT04440163|323134864|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
94722713|NCT02960893|324443133|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
94722714|NCT02960893|324443132|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
94722715|NCT02960893|324443133|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
94722716|NCT02960893|324443132|FG000|Extension Phase (48-week)|Adverse Event|2|||
94722717|NCT02960893|324443133|FG001|Extension Phase (48-week)|Adverse Event|3|||
94722718|NCT02960893|324443132|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
94722719|NCT02960893|324443133|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
94722720|NCT02960893|324443132|FG000|Extension Phase (48-week)|Other Reason|2|||
94722721|NCT02960893|324443133|FG001|Extension Phase (48-week)|Other Reason|1|||
94722722|NCT02960893|324443132|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
94722723|NCT02960893|324443133|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
94722724|NCT02960893|324443132|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
94722725|NCT02960893|324443133|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
94722726|NCT03738228|324443135|FG000|Overall Study|Never received study treatment|2|||
94722727|NCT03738228|324443136|FG001|Overall Study|Never received study treatment|2|||
94722728|NCT04936035|324443137|FG000|Overall Study|Adverse Event|0|||
94722729|NCT04936035|324443138|FG001|Overall Study|Adverse Event|1|||
94722730|NCT04936035|324443139|FG002|Overall Study|Adverse Event|0|||
94722731|NCT04936035|324443140|FG003|Overall Study|Adverse Event|0|||
94722732|NCT04936035|324443141|FG004|Overall Study|Adverse Event|0|||
94722733|NCT04936035|324443137|FG000|Overall Study|Death|0|||
94722734|NCT04936035|324443138|FG001|Overall Study|Death|0|||
94722735|NCT04936035|324443139|FG002|Overall Study|Death|0|||
94722736|NCT04936035|324443140|FG003|Overall Study|Death|1|||
94722737|NCT04936035|324443141|FG004|Overall Study|Death|0|||
94722738|NCT04936035|324443137|FG000|Overall Study|Lost to Follow-up|0|||
94722739|NCT04936035|324443138|FG001|Overall Study|Lost to Follow-up|1|||
94722740|NCT04936035|324443139|FG002|Overall Study|Lost to Follow-up|1|||
94722741|NCT04936035|324443140|FG003|Overall Study|Lost to Follow-up|2|||
94722742|NCT04936035|324443141|FG004|Overall Study|Lost to Follow-up|1|||
94722743|NCT04936035|324443137|FG000|Overall Study|Physician Decision|0|||
94722744|NCT04936035|324443138|FG001|Overall Study|Physician Decision|1|||
94722745|NCT04936035|324443139|FG002|Overall Study|Physician Decision|0|||
94722746|NCT04936035|324443140|FG003|Overall Study|Physician Decision|0|||
94722747|NCT04936035|324443141|FG004|Overall Study|Physician Decision|0|||
94722748|NCT04936035|324443137|FG000|Overall Study|Protocol Deviation|0|||
94722749|NCT04936035|324443138|FG001|Overall Study|Protocol Deviation|0|||
94722750|NCT04936035|324443139|FG002|Overall Study|Protocol Deviation|1|||
94722751|NCT04936035|324443140|FG003|Overall Study|Protocol Deviation|0|||
94722752|NCT04936035|324443141|FG004|Overall Study|Protocol Deviation|0|||
94722753|NCT04936035|324443137|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
94722754|NCT04936035|324443138|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
94722755|NCT04936035|324443139|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
94722756|NCT04936035|324443140|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
94722757|NCT04936035|324443141|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
94722758|NCT04936035|324443137|FG000|Overall Study|Reason Unknown|0|||
94722759|NCT04936035|324443138|FG001|Overall Study|Reason Unknown|0|||
94722760|NCT04936035|324443139|FG002|Overall Study|Reason Unknown|0|||
94368207|NCT04440163|323134865|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
94368208|NCT04440163|323134866|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
94722761|NCT04936035|324443140|FG003|Overall Study|Reason Unknown|0|||
94722762|NCT04936035|324443141|FG004|Overall Study|Reason Unknown|1|||
94722763|NCT04936035|324443137|FG000|Overall Study|Withdrawal by Subject|1|||
94722764|NCT04936035|324443138|FG001|Overall Study|Withdrawal by Subject|0|||
94722765|NCT04936035|324443139|FG002|Overall Study|Withdrawal by Subject|0|||
94722766|NCT04936035|324443140|FG003|Overall Study|Withdrawal by Subject|0|||
94722767|NCT04936035|324443141|FG004|Overall Study|Withdrawal by Subject|0|||
94722768|NCT04936035|324443137|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
94722769|NCT04936035|324443138|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
94722770|NCT04936035|324443139|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
94722771|NCT04936035|324443140|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
94722772|NCT04936035|324443141|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
94722773|NCT04936035|324443137|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
94722774|NCT04936035|324443138|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
94722775|NCT04936035|324443139|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
94722776|NCT04936035|324443140|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
94722777|NCT04936035|324443141|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
94722778|NCT04936035|324443137|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
94722779|NCT04936035|324443138|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
94722780|NCT04936035|324443139|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
94722781|NCT04936035|324443140|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
94722782|NCT04936035|324443141|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
94722783|NCT04060654|324443142|FG000|Overall Study|Withdrawal by Subject|1|||
94722784|NCT04060654|324443142|FG000|Overall Study|Lost to Follow-up|5|||
94722785|NCT04533347|324443143|FG000|Overall Study|Adverse Event|1|||
94722786|NCT04533347|324443144|FG001|Overall Study|Adverse Event|2|||
94722787|NCT04533347|324443143|FG000|Overall Study|Lost to Follow-up|2|||
94722788|NCT04533347|324443144|FG001|Overall Study|Lost to Follow-up|0|||
94722789|NCT04533347|324443143|FG000|Overall Study|Withdrawal by Subject|1|||
94722790|NCT04533347|324443144|FG001|Overall Study|Withdrawal by Subject|0|||
94722791|NCT05609760|324443145|FG000|Overall Study|Lost to Follow-up|0|||
94722792|NCT05609760|324443146|FG001|Overall Study|Lost to Follow-up|1|||
94722793|NCT05609760|324443145|FG000|Overall Study|Withdrawal by Subject|1|||
94722794|NCT05609760|324443146|FG001|Overall Study|Withdrawal by Subject|0|||
94722795|NCT04173663|324444674|FG000|Overall Study|Withdrawal by Subject|1|||
94722796|NCT04173663|324444675|FG001|Overall Study|Withdrawal by Subject|6|||
94722797|NCT04173663|324444674|FG000|Overall Study|Lost to Follow-up|17|||
94722798|NCT04173663|324444675|FG001|Overall Study|Lost to Follow-up|24|||
94722799|NCT05919082|324444678|FG000|Overall Study|Adverse Event|3|||
94722800|NCT05919082|324444679|FG001|Overall Study|Adverse Event|0|||
94722801|NCT05919082|324444678|FG000|Overall Study|Lost to Follow-up|0|||
94722802|NCT05919082|324444679|FG001|Overall Study|Lost to Follow-up|1|||
94722803|NCT05919082|324444678|FG000|Overall Study|Withdrawal by Subject|8|||
94722804|NCT05919082|324444679|FG001|Overall Study|Withdrawal by Subject|9|||
94722805|NCT05919082|324444678|FG000|Overall Study|Lack of Efficacy|0|||
94722806|NCT05919082|324444679|FG001|Overall Study|Lack of Efficacy|1|||
94722807|NCT05919082|324444678|FG000|Overall Study|Investigator Decision|1|||
94722808|NCT05919082|324444679|FG001|Overall Study|Investigator Decision|0|||
94722809|NCT04833777|324444681|FG000|Overall Study|Lost to Follow-up|1|||
94722810|NCT04833777|324444682|FG001|Overall Study|Lost to Follow-up|0|||
94722811|NCT05021640|324444685|FG000|Overall Study|Lost to Follow-up|0|||
94722812|NCT05021640|324444686|FG001|Overall Study|Lost to Follow-up|0|||
94722813|NCT05021640|324444687|FG002|Overall Study|Lost to Follow-up|0|||
94722814|NCT05021640|324444688|FG003|Overall Study|Lost to Follow-up|0|||
94722815|NCT05021640|324444689|FG004|Overall Study|Lost to Follow-up|1|||
94722816|NCT04737772|324444690|FG000|Phase 2 Study|Lost to Follow-up|15|||
94722817|NCT04737772|324444691|FG001|Phase 2 Study|Lost to Follow-up|15|||
94722818|NCT04737772|324444690|FG000|Phase 2 Study|Withdrawal by Subject|0|||
94722819|NCT04737772|324444691|FG001|Phase 2 Study|Withdrawal by Subject|1|||
94722820|NCT04737772|324444690|FG000|Phase 2 Study|Did not take any coaching calls|4|||
94722821|NCT04737772|324444691|FG001|Phase 2 Study|Did not take any coaching calls|0|||
94722822|NCT04737772|324444690|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
94722823|NCT04737772|324444691|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
94722824|NCT04737772|324444690|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
94722825|NCT04737772|324444691|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
94722826|NCT04083235|324444694|FG000|Overall Study|Death|252|||
94722827|NCT04083235|324444695|FG001|Overall Study|Death|277|||
94722828|NCT04083235|324444694|FG000|Overall Study|Withdrawal by Subject|13|||
94722829|NCT04083235|324444695|FG001|Overall Study|Withdrawal by Subject|17|||
94722830|NCT04083235|324444694|FG000|Overall Study|Lost to Follow-up|1|||
94722831|NCT04083235|324444695|FG001|Overall Study|Lost to Follow-up|1|||
94722832|NCT04083235|324444694|FG000|Overall Study|Does not meet entry criteria|1|||
94722833|NCT04083235|324444695|FG001|Overall Study|Does not meet entry criteria|0|||
94722834|NCT04083235|324444694|FG000|Overall Study|Did not receive treatment|13|||
94722835|NCT04083235|324444695|FG001|Overall Study|Did not receive treatment|8|||
94722836|NCT04083235|324444694|FG000|Overall Study|Ongoing at the time of DCO|44|||
94722837|NCT04083235|324444695|FG001|Overall Study|Ongoing at the time of DCO|7|||
94722838|NCT00667251|324444696|FG000|Overall Study|Disease progression|232|||
94722839|NCT00667251|324444697|FG001|Overall Study|Disease progression|203|||
94722840|NCT00667251|324444696|FG000|Overall Study|Toxicity|44|||
94722841|NCT00667251|324444697|FG001|Overall Study|Toxicity|23|||
94722842|NCT00667251|324444696|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
94722843|NCT00667251|324444697|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
94722844|NCT00667251|324444696|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
94722845|NCT00667251|324444697|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
94722846|NCT00667251|324444696|FG000|Overall Study|Symptomatic progression|8|||
94722847|NCT00667251|324444697|FG001|Overall Study|Symptomatic progression|4|||
94722848|NCT00667251|324444696|FG000|Overall Study|Death|6|||
94722849|NCT00667251|324444697|FG001|Overall Study|Death|11|||
94722850|NCT00667251|324444696|FG000|Overall Study|Intercurrent illness|5|||
94722851|NCT00667251|324444697|FG001|Overall Study|Intercurrent illness|6|||
94722852|NCT00667251|324444696|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
94722853|NCT00667251|324444697|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
94722854|NCT00667251|324444696|FG000|Overall Study|Randomized not Treated|4|||
94722855|NCT00667251|324444697|FG001|Overall Study|Randomized not Treated|1|||
94722856|NCT05458011|324444698|FG000|DB Period (12 Weeks)|Adverse Event|2|||
94722857|NCT05458011|324444699|FG001|DB Period (12 Weeks)|Adverse Event|1|||
94722858|NCT05458011|324444700|FG002|DB Period (12 Weeks)|Adverse Event|1|||
94722859|NCT05458011|324444698|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
94722860|NCT05458011|324444699|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
94722861|NCT05458011|324444700|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
94722862|NCT05458011|324444698|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
94722863|NCT05458011|324444699|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
94722864|NCT05458011|324444700|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
94722865|NCT05458011|324444698|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
94722866|NCT05458011|324444699|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
94722867|NCT05458011|324444700|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
94722868|NCT05458011|324444698|FG000|OL Period (12 Weeks)|Adverse Event|1|||
94722869|NCT05458011|324444699|FG001|OL Period (12 Weeks)|Adverse Event|2|||
94722870|NCT05458011|324444700|FG002|OL Period (12 Weeks)|Adverse Event|1|||
94722871|NCT05458011|324444698|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
94722872|NCT05458011|324444699|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
94722873|NCT05458011|324444700|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
94722874|NCT03376321|324444701|FG000|Overall Study|Other|5|||
94722875|NCT03376321|324444702|FG001|Overall Study|Other|1|||
94722876|NCT03376321|324444701|FG000|Overall Study|Withdrawal by Subject|8|||
94722877|NCT03376321|324444702|FG001|Overall Study|Withdrawal by Subject|14|||
94722878|NCT03376321|324444701|FG000|Overall Study|Lost to Follow-up|1|||
94722879|NCT03376321|324444702|FG001|Overall Study|Lost to Follow-up|7|||
94722880|NCT03376321|324444701|FG000|Overall Study|Death|4|||
94722881|NCT03376321|324444702|FG001|Overall Study|Death|0|||
94722882|NCT03376321|324444701|FG000|Overall Study|Randomized, not treated|5|||
94722883|NCT03376321|324444702|FG001|Overall Study|Randomized, not treated|3|||
94722884|NCT02671903|324444703|FG000|Period 0 (Run-In)|Death|0|||
94722885|NCT02671903|324444704|FG001|Period 0 (Run-In)|Death|0|||
94722886|NCT02671903|324444705|FG002|Period 0 (Run-In)|Death|3|||
94722887|NCT02671903|324444703|FG000|Period 0 (Run-In)|Physician Decision|0|||
94722888|NCT02671903|324444704|FG001|Period 0 (Run-In)|Physician Decision|0|||
94722889|NCT02671903|324444705|FG002|Period 0 (Run-In)|Physician Decision|4|||
94722890|NCT02671903|324444703|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
94722891|NCT02671903|324444704|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
94722892|NCT02671903|324444705|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
94722893|NCT02671903|324444703|FG000|Period 0 (Run-In)|Protocol Violation|0|||
94272460|NCT01147744|322790423|FG003|Overall Study|Withdrawal by Subject|2|||
94272461|NCT01147744|322790424|FG004|Overall Study|Withdrawal by Subject|2|||
94272462|NCT01147744|322790425|FG005|Overall Study|Withdrawal by Subject|5|||
94272463|NCT01147744|322790426|FG006|Overall Study|Withdrawal by Subject|2|||
94272464|NCT01147744|322790420|FG000|Overall Study|Lost to Follow-up|0|||
94272465|NCT01147744|322790421|FG001|Overall Study|Lost to Follow-up|1|||
94272466|NCT01147744|322790422|FG002|Overall Study|Lost to Follow-up|0|||
94272467|NCT01147744|322790423|FG003|Overall Study|Lost to Follow-up|0|||
94272468|NCT01147744|322790424|FG004|Overall Study|Lost to Follow-up|0|||
94272469|NCT01147744|322790425|FG005|Overall Study|Lost to Follow-up|0|||
94272470|NCT01147744|322790426|FG006|Overall Study|Lost to Follow-up|0|||
94272471|NCT01147744|322790420|FG000|Overall Study|Sponsor decision to amend protocol|7|||
94272472|NCT01147744|322790421|FG001|Overall Study|Sponsor decision to amend protocol|4|||
94272473|NCT01147744|322790422|FG002|Overall Study|Sponsor decision to amend protocol|2|||
94272474|NCT01147744|322790423|FG003|Overall Study|Sponsor decision to amend protocol|5|||
94272475|NCT01147744|322790424|FG004|Overall Study|Sponsor decision to amend protocol|7|||
94272476|NCT01147744|322790425|FG005|Overall Study|Sponsor decision to amend protocol|2|||
94272477|NCT01147744|322790426|FG006|Overall Study|Sponsor decision to amend protocol|6|||
94722894|NCT02671903|324444704|FG001|Period 0 (Run-In)|Protocol Violation|0|||
94722895|NCT02671903|324444705|FG002|Period 0 (Run-In)|Protocol Violation|1|||
94722896|NCT02671903|324444703|FG000|Period 0 (Run-In)|Adverse Event|0|||
94722897|NCT02671903|324444704|FG001|Period 0 (Run-In)|Adverse Event|0|||
94722898|NCT02671903|324444705|FG002|Period 0 (Run-In)|Adverse Event|1|||
94722899|NCT02671903|324444703|FG000|Period 0 (Run-In)|Implantation Failure|0|||
94722900|NCT02671903|324444704|FG001|Period 0 (Run-In)|Implantation Failure|0|||
94722901|NCT02671903|324444705|FG002|Period 0 (Run-In)|Implantation Failure|2|||
94272478|NCT01147744|322790420|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
94722902|NCT02671903|324444703|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
94722903|NCT02671903|324444704|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
94722904|NCT02671903|324444705|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
94722905|NCT02992925|324444706|FG000|Cohort 2|Physician Decision|0|||
94722906|NCT02992925|324444707|FG001|Cohort 2|Physician Decision|0|||
94722907|NCT02992925|324444708|FG002|Cohort 2|Physician Decision|1|||
94722908|NCT02992925|324444709|FG003|Cohort 2|Physician Decision|0|||
94722909|NCT02992925|324444706|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
94722910|NCT02992925|324444707|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
94722911|NCT02992925|324444708|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
94722912|NCT02992925|324444709|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
94722913|NCT01804816|324444710|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
94722914|NCT01804816|324444710|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
94722915|NCT04421378|324444711|FG000|Overall Study|Adverse Event|2|||
94722916|NCT04421378|324444712|FG001|Overall Study|Adverse Event|7|||
94722917|NCT04421378|324444713|FG002|Overall Study|Adverse Event|0|||
94722918|NCT04421378|324444714|FG003|Overall Study|Adverse Event|1|||
94722919|NCT04421378|324444715|FG004|Overall Study|Adverse Event|0|||
94722920|NCT04421378|324444711|FG000|Overall Study|Physician Decision|1|||
94722921|NCT04421378|324444712|FG001|Overall Study|Physician Decision|2|||
94722922|NCT04421378|324444713|FG002|Overall Study|Physician Decision|0|||
94722923|NCT04421378|324444714|FG003|Overall Study|Physician Decision|0|||
94722924|NCT04421378|324444715|FG004|Overall Study|Physician Decision|0|||
94722925|NCT04421378|324444711|FG000|Overall Study|Progressive Disease|16|||
94722926|NCT04421378|324444712|FG001|Overall Study|Progressive Disease|4|||
94722927|NCT04421378|324444713|FG002|Overall Study|Progressive Disease|18|||
94722928|NCT04421378|324444714|FG003|Overall Study|Progressive Disease|11|||
94722929|NCT04421378|324444715|FG004|Overall Study|Progressive Disease|3|||
94722930|NCT04421378|324444711|FG000|Overall Study|Study Terminated by Sponsor|0|||
94722931|NCT04421378|324444712|FG001|Overall Study|Study Terminated by Sponsor|1|||
94722932|NCT04421378|324444713|FG002|Overall Study|Study Terminated by Sponsor|1|||
94722933|NCT04421378|324444714|FG003|Overall Study|Study Terminated by Sponsor|0|||
94722934|NCT04421378|324444715|FG004|Overall Study|Study Terminated by Sponsor|0|||
94722935|NCT04421378|324444711|FG000|Overall Study|Withdrawal by Subject|3|||
94722936|NCT04421378|324444712|FG001|Overall Study|Withdrawal by Subject|1|||
94722937|NCT04421378|324444713|FG002|Overall Study|Withdrawal by Subject|0|||
94722938|NCT04421378|324444714|FG003|Overall Study|Withdrawal by Subject|2|||
94722939|NCT04421378|324444715|FG004|Overall Study|Withdrawal by Subject|0|||
94722940|NCT04421378|324444711|FG000|Overall Study|Other|1|||
94722941|NCT04421378|324444712|FG001|Overall Study|Other|0|||
94722942|NCT04421378|324444713|FG002|Overall Study|Other|0|||
94722943|NCT04421378|324444714|FG003|Overall Study|Other|0|||
94722944|NCT04421378|324444715|FG004|Overall Study|Other|0|||
94722945|NCT04150718|324444716|FG000|Overall Study|Withdrawal by Subject|2|||
94722946|NCT04150718|324444717|FG001|Overall Study|Withdrawal by Subject|7|||
94722947|NCT04150718|324444718|FG002|Overall Study|Withdrawal by Subject|1|||
94722948|NCT04150718|324444716|FG000|Overall Study|Lost to Follow-up|1|||
94722949|NCT04150718|324444717|FG001|Overall Study|Lost to Follow-up|2|||
94722950|NCT04150718|324444718|FG002|Overall Study|Lost to Follow-up|0|||
94722951|NCT04150718|324444716|FG000|Overall Study|Ineligible|1|||
94722952|NCT04150718|324444717|FG001|Overall Study|Ineligible|0|||
94722953|NCT04150718|324444718|FG002|Overall Study|Ineligible|10|||
94722954|NCT04673929|324444719|FG000|Overall Study|Death|73|||
94722955|NCT04673929|324444719|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
94722956|NCT00512070|324444724|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
94722957|NCT00512070|324444725|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
94722958|NCT00512070|324444726|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
94722959|NCT00512070|324444724|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
94722960|NCT00512070|324444725|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
94722961|NCT00512070|324444726|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
94722962|NCT00961571|324444727|FG000|Overall Study|Physician Decision|39|||
94722963|NCT04089371|324444730|FG000|Overall Study|Withdrawal by Subject|0|||
94722964|NCT04089371|324444731|FG001|Overall Study|Withdrawal by Subject|1|||
94722965|NCT04089371|324444730|FG000|Overall Study|Study terminated early|0|||
94722966|NCT04089371|324444731|FG001|Overall Study|Study terminated early|9|||
94722967|NCT04382898|324444732|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
94722968|NCT04382898|324444733|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
94722969|NCT04382898|324444734|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
94722970|NCT04382898|324444735|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
94722971|NCT04382898|324444736|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
94722972|NCT04382898|324444732|FG000|Part 1: Dose Titration|Death|6|||
94722973|NCT04382898|324444733|FG001|Part 1: Dose Titration|Death|0|||
94722974|NCT04382898|324444734|FG002|Part 1: Dose Titration|Death|0|||
94722975|NCT04382898|324444735|FG003|Part 1: Dose Titration|Death|0|||
94722976|NCT04382898|324444736|FG004|Part 1: Dose Titration|Death|0|||
94722977|NCT04382898|324444732|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
94722978|NCT04382898|324444733|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
94655416|NCT00965848|324196029|FG002|Overall Study|Death|5|||
94655417|NCT00965848|324196027|FG000|Overall Study|Lost to Follow-up|0|||
94655418|NCT00965848|324196028|FG001|Overall Study|Lost to Follow-up|0|||
94655419|NCT00965848|324196029|FG002|Overall Study|Lost to Follow-up|1|||
94655420|NCT00965848|324196027|FG000|Overall Study|Withdrawal by Subject|1|||
94655421|NCT00965848|324196028|FG001|Overall Study|Withdrawal by Subject|0|||
94655422|NCT00965848|324196029|FG002|Overall Study|Withdrawal by Subject|0|||
94655423|NCT00965848|324196027|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
94655424|NCT00965848|324196028|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
94655425|NCT00965848|324196029|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
94655426|NCT00965848|324196027|FG000|Overall Study|Not Clinically Evaluable|7|||
94655427|NCT00965848|324196028|FG001|Overall Study|Not Clinically Evaluable|1|||
94655428|NCT00965848|324196029|FG002|Overall Study|Not Clinically Evaluable|1|||
94655429|NCT00965848|324196027|FG000|Overall Study|Other|5|||
94655430|NCT00965848|324196028|FG001|Overall Study|Other|0|||
94655431|NCT00965848|324196029|FG002|Overall Study|Other|1|||
94655432|NCT03191903|324196031|FG000|Overall Study|Withdrawal by Subject|6|||
94655433|NCT03191903|324196032|FG001|Overall Study|Withdrawal by Subject|5|||
94655434|NCT03191903|324196033|FG002|Overall Study|Withdrawal by Subject|4|||
94655435|NCT03191903|324196031|FG000|Overall Study|Adverse Event|1|||
94655436|NCT03191903|324196032|FG001|Overall Study|Adverse Event|0|||
94655437|NCT03191903|324196033|FG002|Overall Study|Adverse Event|0|||
94655438|NCT01328002|324196034|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
94368209|NCT04440163|323134867|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
94368210|NCT04440163|323134860|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
94722979|NCT04382898|324444734|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
94722980|NCT04382898|324444735|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
94722981|NCT04382898|324444736|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
94722982|NCT04382898|324444732|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
94722983|NCT04382898|324444733|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
94722984|NCT04382898|324444734|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
94722985|NCT04382898|324444735|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
94722986|NCT04382898|324444736|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
94722987|NCT04382898|324444732|FG000|Part 2: Dose Expansion|Death|0|||
94722988|NCT04382898|324444733|FG001|Part 2: Dose Expansion|Death|17|||
94722989|NCT04382898|324444734|FG002|Part 2: Dose Expansion|Death|13|||
94722990|NCT04382898|324444735|FG003|Part 2: Dose Expansion|Death|1|||
94722991|NCT04382898|324444736|FG004|Part 2: Dose Expansion|Death|0|||
94722992|NCT04382898|324444732|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
94722993|NCT04382898|324444733|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
94722994|NCT04382898|324444734|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
94722995|NCT04382898|324444735|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
94722996|NCT04382898|324444736|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
94722997|NCT04382898|324444732|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
94722998|NCT04382898|324444733|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
94722999|NCT04382898|324444734|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
94723000|NCT04382898|324444735|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
94723001|NCT04382898|324444736|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
94723002|NCT04382898|324444732|FG000|Part 2: Dose Expansion|Other|0|||
94723003|NCT04382898|324444733|FG001|Part 2: Dose Expansion|Other|0|||
94723004|NCT04382898|324444734|FG002|Part 2: Dose Expansion|Other|1|||
94723005|NCT04382898|324444735|FG003|Part 2: Dose Expansion|Other|0|||
94723006|NCT04382898|324444736|FG004|Part 2: Dose Expansion|Other|0|||
94723007|NCT03932682|324444739|FG000|Overall Study|Death|1|||
94723008|NCT03932682|324444740|FG001|Overall Study|Death|2|||
94723009|NCT03932682|324444739|FG000|Overall Study|Withdrawal by Subject|37|||
94723010|NCT03932682|324444740|FG001|Overall Study|Withdrawal by Subject|45|||
94723011|NCT03932682|324444739|FG000|Overall Study|Lost to Follow-up|19|||
94723012|NCT03932682|324444740|FG001|Overall Study|Lost to Follow-up|25|||
94723013|NCT03932682|324444739|FG000|Overall Study|Protocol Violation|0|||
94723014|NCT03932682|324444740|FG001|Overall Study|Protocol Violation|2|||
94723015|NCT03932682|324444739|FG000|Overall Study|Other|9|||
94723016|NCT03932682|324444740|FG001|Overall Study|Other|23|||
94723017|NCT04321031|324444741|FG000|Overall Study|Adverse Event|0|||
94723018|NCT04321031|324444742|FG001|Overall Study|Adverse Event|2|||
94723019|NCT04321031|324444743|FG002|Overall Study|Adverse Event|2|||
94723020|NCT04321031|324444744|FG003|Overall Study|Adverse Event|2|||
94723021|NCT04321031|324444745|FG004|Overall Study|Adverse Event|2|||
94723022|NCT04321031|324444746|FG005|Overall Study|Adverse Event|2|||
94723023|NCT04321031|324444747|FG006|Overall Study|Adverse Event|0|||
94723024|NCT04321031|324444741|FG000|Overall Study|Lost to Follow-up|0|||
94723025|NCT04321031|324444742|FG001|Overall Study|Lost to Follow-up|0|||
94723026|NCT04321031|324444743|FG002|Overall Study|Lost to Follow-up|0|||
94723027|NCT04321031|324444744|FG003|Overall Study|Lost to Follow-up|1|||
94723028|NCT04321031|324444745|FG004|Overall Study|Lost to Follow-up|0|||
94723029|NCT04321031|324444746|FG005|Overall Study|Lost to Follow-up|2|||
94723030|NCT04321031|324444747|FG006|Overall Study|Lost to Follow-up|1|||
94723031|NCT04321031|324444741|FG000|Overall Study|Withdrawal by Subject|2|||
94723032|NCT04321031|324444742|FG001|Overall Study|Withdrawal by Subject|2|||
94723033|NCT04321031|324444743|FG002|Overall Study|Withdrawal by Subject|1|||
94723034|NCT04321031|324444744|FG003|Overall Study|Withdrawal by Subject|3|||
94723035|NCT04321031|324444745|FG004|Overall Study|Withdrawal by Subject|1|||
94723036|NCT04321031|324444746|FG005|Overall Study|Withdrawal by Subject|0|||
94723037|NCT04321031|324444747|FG006|Overall Study|Withdrawal by Subject|1|||
94723038|NCT04321031|324444741|FG000|Overall Study|Non-compliance with study drug|0|||
94723039|NCT04321031|324444742|FG001|Overall Study|Non-compliance with study drug|0|||
94723040|NCT04321031|324444743|FG002|Overall Study|Non-compliance with study drug|0|||
94723041|NCT04321031|324444744|FG003|Overall Study|Non-compliance with study drug|0|||
94723042|NCT04321031|324444745|FG004|Overall Study|Non-compliance with study drug|0|||
94723043|NCT04321031|324444746|FG005|Overall Study|Non-compliance with study drug|1|||
94723044|NCT04321031|324444747|FG006|Overall Study|Non-compliance with study drug|0|||
94272479|NCT01147744|322790421|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
94272480|NCT01147744|322790422|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
94272481|NCT01147744|322790423|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
94272482|NCT01147744|322790424|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
94272483|NCT01147744|322790425|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
94723045|NCT04321031|324444741|FG000|Overall Study|Other|0|||
94723046|NCT04321031|324444742|FG001|Overall Study|Other|0|||
94723047|NCT04321031|324444743|FG002|Overall Study|Other|0|||
94723048|NCT04321031|324444744|FG003|Overall Study|Other|1|||
94723049|NCT04321031|324444745|FG004|Overall Study|Other|0|||
94723050|NCT04321031|324444746|FG005|Overall Study|Other|0|||
94723051|NCT04321031|324444747|FG006|Overall Study|Other|0|||
94723052|NCT03126019|324444756|FG000|Overall Study|Death|5|||
94723053|NCT03126019|324444757|FG001|Overall Study|Death|27|||
94723054|NCT03126019|324444756|FG000|Overall Study|Lost to Follow-up|2|||
94723055|NCT03126019|324444757|FG001|Overall Study|Lost to Follow-up|4|||
94723056|NCT03126019|324444756|FG000|Overall Study|Withdrawal by Subject|1|||
94723057|NCT03126019|324444757|FG001|Overall Study|Withdrawal by Subject|9|||
94723058|NCT03126019|324444756|FG000|Overall Study|Physician Decision|1|||
94723059|NCT03126019|324444757|FG001|Overall Study|Physician Decision|0|||
94723060|NCT03126019|324444756|FG000|Overall Study|Transitioned to Rollover Study|0|||
94723061|NCT03126019|324444757|FG001|Overall Study|Transitioned to Rollover Study|11|||
94723062|NCT03126019|324444756|FG000|Overall Study|Did Not Return to Site for Care|0|||
94723063|NCT03126019|324444757|FG001|Overall Study|Did Not Return to Site for Care|1|||
94723064|NCT03126019|324444756|FG000|Overall Study|Site Closed|0|||
94723065|NCT03126019|324444757|FG001|Overall Study|Site Closed|1|||
94723068|NCT00170573|324444764|FG000|Overall Study|Violation of inclusion criteria|13|||
94723069|NCT05536440|324444765|FG000|Overall Study|Adverse Event|0|||
94723070|NCT05536440|324444766|FG001|Overall Study|Adverse Event|0|||
94723071|NCT05536440|324444767|FG002|Overall Study|Adverse Event|0|||
94723072|NCT05536440|324444768|FG003|Overall Study|Adverse Event|0|||
94723073|NCT05536440|324444769|FG004|Overall Study|Adverse Event|0|||
94723074|NCT05536440|324444770|FG005|Overall Study|Adverse Event|0|||
94723075|NCT05536440|324444771|FG006|Overall Study|Adverse Event|0|||
94723076|NCT05536440|324444772|FG007|Overall Study|Adverse Event|0|||
94723077|NCT05536440|324444773|FG008|Overall Study|Adverse Event|1|||
94723078|NCT06283173|324444774|FG000|Overall Study|Did not show for first visit|10|||
94723079|NCT06283173|324444774|FG000|Overall Study|Lost to Follow-up|12|||
94723080|NCT06283173|324444774|FG000|Overall Study|Physician Decision|7|||
94723081|NCT05563246|324444782|FG000|Overall Study|Withdrawal by Subject|1|||
94723082|NCT05563246|324444783|FG001|Overall Study|Withdrawal by Subject|2|||
94723083|NCT05563246|324444784|FG002|Overall Study|Withdrawal by Subject|0|||
94723084|NCT05563246|324444785|FG003|Overall Study|Withdrawal by Subject|0|||
94723085|NCT05563246|324444782|FG000|Overall Study|Protocol Deviation|0|||
94723086|NCT05563246|324444783|FG001|Overall Study|Protocol Deviation|1|||
94723087|NCT05563246|324444784|FG002|Overall Study|Protocol Deviation|0|||
94723088|NCT05563246|324444785|FG003|Overall Study|Protocol Deviation|0|||
94723089|NCT05563246|324444782|FG000|Overall Study|Physician Decision|0|||
94723090|NCT05563246|324444783|FG001|Overall Study|Physician Decision|1|||
94723091|NCT05563246|324444784|FG002|Overall Study|Physician Decision|0|||
94723092|NCT05563246|324444785|FG003|Overall Study|Physician Decision|0|||
94723093|NCT05563246|324444782|FG000|Overall Study|Adverse Event|0|||
94723094|NCT05563246|324444783|FG001|Overall Study|Adverse Event|0|||
94723095|NCT05563246|324444784|FG002|Overall Study|Adverse Event|2|||
94723096|NCT05563246|324444785|FG003|Overall Study|Adverse Event|0|||
94723097|NCT05563246|324444782|FG000|Overall Study|Lost to Follow-up|0|||
94723098|NCT05563246|324444783|FG001|Overall Study|Lost to Follow-up|0|||
94723099|NCT05563246|324444784|FG002|Overall Study|Lost to Follow-up|1|||
94723100|NCT05563246|324444785|FG003|Overall Study|Lost to Follow-up|0|||
94723101|NCT04784559|324444786|FG000|Overall Study|Withdrawal by Subject|3|||
94723102|NCT04784559|324444787|FG001|Overall Study|Withdrawal by Subject|2|||
94723103|NCT04784559|324444788|FG002|Overall Study|Withdrawal by Subject|1|||
94723104|NCT04784559|324444786|FG000|Overall Study|Death|2|||
94723105|NCT04784559|324444787|FG001|Overall Study|Death|1|||
94723106|NCT04784559|324444788|FG002|Overall Study|Death|2|||
94723107|NCT04784559|324444786|FG000|Overall Study|Lost to Follow-up|0|||
94723108|NCT04784559|324444787|FG001|Overall Study|Lost to Follow-up|0|||
94723109|NCT04784559|324444788|FG002|Overall Study|Lost to Follow-up|2|||
94723110|NCT04784559|324444786|FG000|Overall Study|Participant worsened, PI decision|1|||
94723111|NCT04784559|324444787|FG001|Overall Study|Participant worsened, PI decision|0|||
94723112|NCT04784559|324444788|FG002|Overall Study|Participant worsened, PI decision|0|||
94723113|NCT04784559|324444786|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
94723114|NCT04784559|324444787|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
94723115|NCT04784559|324444788|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
94723116|NCT04784559|324444786|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
94723117|NCT04784559|324444787|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
94723118|NCT04784559|324444788|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
94723119|NCT04784559|324444786|FG000|Overall Study|Did not meet all inclusion criteria|0|||
94723120|NCT04784559|324444787|FG001|Overall Study|Did not meet all inclusion criteria|1|||
94723121|NCT04784559|324444788|FG002|Overall Study|Did not meet all inclusion criteria|0|||
94723122|NCT04784559|324444786|FG000|Overall Study|The participant was transferred to IRCU|0|||
94723123|NCT04784559|324444787|FG001|Overall Study|The participant was transferred to IRCU|1|||
94723124|NCT04784559|324444788|FG002|Overall Study|The participant was transferred to IRCU|0|||
94723125|NCT04784559|324444786|FG000|Overall Study|SAE|0|||
94723126|NCT04784559|324444787|FG001|Overall Study|SAE|1|||
94723127|NCT04784559|324444788|FG002|Overall Study|SAE|0|||
94723128|NCT04784559|324444786|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
94723129|NCT04784559|324444787|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
94723130|NCT04784559|324444788|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
94723131|NCT04179500|324444789|FG000|Treatment|Withdrawal by Subject|1|||
94723132|NCT04179500|324444789|FG000|Treatment|Adverse Event|2|||
94723133|NCT04179500|324444789|FG000|Treatment|pyrazinamide resistance|1|||
94723134|NCT04831216|324444794|FG000|Overall Study|Lost to Follow-up|32|||
94723135|NCT04925986|324444795|FG000|Overall Study|Death|0|||
94723136|NCT04925986|324444796|FG001|Overall Study|Death|0|||
94723137|NCT04925986|324444797|FG002|Overall Study|Death|2|||
94723138|NCT04925986|324444798|FG003|Overall Study|Death|0|||
94723139|NCT04925986|324444795|FG000|Overall Study|Lack of Efficacy|1|||
94723140|NCT04925986|324444796|FG001|Overall Study|Lack of Efficacy|2|||
94723141|NCT04925986|324444797|FG002|Overall Study|Lack of Efficacy|0|||
94723142|NCT04925986|324444798|FG003|Overall Study|Lack of Efficacy|1|||
94723143|NCT04925986|324444795|FG000|Overall Study|Withdrawal by Subject|0|||
94723144|NCT04925986|324444796|FG001|Overall Study|Withdrawal by Subject|0|||
94723145|NCT04925986|324444797|FG002|Overall Study|Withdrawal by Subject|1|||
94723146|NCT04925986|324444798|FG003|Overall Study|Withdrawal by Subject|2|||
94272484|NCT01147744|322790426|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
94272485|NCT00993265|322790427|FG000|Overall Study|Adverse Event|1|||
94272486|NCT00993265|322790428|FG001|Overall Study|Adverse Event|0|||
94272487|NCT00993265|322790427|FG000|Overall Study|Changed dose of concomitant drug|2|||
94272488|NCT00993265|322790428|FG001|Overall Study|Changed dose of concomitant drug|0|||
94723147|NCT05030233|324444800|FG000|Overall Study|withdrawn for transfer|1|||
94723148|NCT05030233|324444801|FG001|Overall Study|withdrawn for transfer|0|||
94723149|NCT03365882|324444802|FG000|Randomization|Still Receiving Protocol Treatment|2|||
94723150|NCT03365882|324444803|FG001|Randomization|Still Receiving Protocol Treatment|0|||
94723151|NCT03365882|324444802|FG000|Randomization|Adverse Event|1|||
94723152|NCT03365882|324444803|FG001|Randomization|Adverse Event|2|||
94723153|NCT03365882|324444802|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
94723154|NCT03365882|324444803|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
94723155|NCT03365882|324444802|FG000|Randomization|Progression/Relapse|21|||
94723156|NCT03365882|324444803|FG001|Randomization|Progression/Relapse|3|||
94723157|NCT03365882|324444802|FG000|Randomization|Death|1|||
94723158|NCT03365882|324444803|FG001|Randomization|Death|0|||
94723159|NCT03365882|324444802|FG000|Randomization|Other - Not Protocol Specified|1|||
94723160|NCT03365882|324444803|FG001|Randomization|Other - Not Protocol Specified|1|||
94723161|NCT03365882|324444802|FG000|Randomization|Major Protocol Deviation|0|||
94723162|NCT03365882|324444803|FG001|Randomization|Major Protocol Deviation|1|||
94723163|NCT03365882|324444802|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
94723164|NCT03365882|324444803|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
94723165|NCT03365882|324444802|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
94723166|NCT03365882|324444803|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
94723167|NCT03365882|324444802|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
94723168|NCT03365882|324444803|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
94723169|NCT03365882|324444802|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
94723170|NCT03365882|324444803|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
94723171|NCT04437615|324444804|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
94723172|NCT02029443|324446599|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
94723173|NCT02029443|324446600|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
94723174|NCT02029443|324446601|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
94723175|NCT02029443|324446602|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
94723176|NCT02029443|324446603|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
94723177|NCT02029443|324446599|FG000|Overall Study|Death|13|||
94723178|NCT02029443|324446600|FG001|Overall Study|Death|2|||
94723179|NCT02029443|324446601|FG002|Overall Study|Death|2|||
94723180|NCT02029443|324446602|FG003|Overall Study|Death|11|||
94723181|NCT02029443|324446603|FG004|Overall Study|Death|2|||
94723182|NCT02029443|324446599|FG000|Overall Study|Lost to Follow-up|1|||
94723183|NCT02029443|324446600|FG001|Overall Study|Lost to Follow-up|0|||
94723184|NCT02029443|324446601|FG002|Overall Study|Lost to Follow-up|1|||
94723185|NCT02029443|324446602|FG003|Overall Study|Lost to Follow-up|1|||
94723186|NCT02029443|324446603|FG004|Overall Study|Lost to Follow-up|0|||
94723187|NCT02029443|324446599|FG000|Overall Study|Started other anti-cancer therapy|17|||
94723188|NCT02029443|324446600|FG001|Overall Study|Started other anti-cancer therapy|4|||
94723189|NCT02029443|324446601|FG002|Overall Study|Started other anti-cancer therapy|7|||
94723190|NCT02029443|324446602|FG003|Overall Study|Started other anti-cancer therapy|9|||
94723191|NCT02029443|324446603|FG004|Overall Study|Started other anti-cancer therapy|3|||
94723192|NCT02029443|324446599|FG000|Overall Study|Withdrawal by Subject|3|||
94723193|NCT02029443|324446600|FG001|Overall Study|Withdrawal by Subject|1|||
94723194|NCT02029443|324446601|FG002|Overall Study|Withdrawal by Subject|1|||
94723195|NCT02029443|324446602|FG003|Overall Study|Withdrawal by Subject|1|||
94723196|NCT02029443|324446603|FG004|Overall Study|Withdrawal by Subject|0|||
94723197|NCT02029443|324446599|FG000|Overall Study|Other|6|||
94723198|NCT02029443|324446600|FG001|Overall Study|Other|6|||
94368211|NCT04440163|323134861|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
94368212|NCT04440163|323134862|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
94723199|NCT02029443|324446601|FG002|Overall Study|Other|4|||
94723200|NCT02029443|324446602|FG003|Overall Study|Other|2|||
94723201|NCT02029443|324446603|FG004|Overall Study|Other|0|||
94723202|NCT03016169|324446606|FG000|Overall Study|Lost to Follow-up|4|||
94723203|NCT03016169|324446606|FG000|Overall Study|Death|54|||
94723204|NCT03016169|324446606|FG000|Overall Study|Device Explant|11|||
94723205|NCT03016169|324446606|FG000|Overall Study|Withdrawal by Subject|19|||
94723206|NCT03016169|324446606|FG000|Overall Study|Other Reasons|1|||
94723207|NCT02727699|324446607|FG000|Overall Study|Adverse Event|2|||
94723208|NCT02727699|324446608|FG001|Overall Study|Adverse Event|0|||
94723209|NCT02727699|324446607|FG000|Overall Study|Withdrawal by Subject|5|||
94723210|NCT02727699|324446608|FG001|Overall Study|Withdrawal by Subject|3|||
94723211|NCT02727699|324446607|FG000|Overall Study|Protocol Violation|0|||
94723212|NCT02727699|324446608|FG001|Overall Study|Protocol Violation|1|||
94723213|NCT02727699|324446607|FG000|Overall Study|Physician Decision|0|||
94723214|NCT02727699|324446608|FG001|Overall Study|Physician Decision|1|||
94723215|NCT02727699|324446607|FG000|Overall Study|Lost to Follow-up|1|||
94723216|NCT02727699|324446608|FG001|Overall Study|Lost to Follow-up|0|||
94723217|NCT02727699|324446607|FG000|Overall Study|Sponsor Decision|1|||
94723218|NCT02727699|324446608|FG001|Overall Study|Sponsor Decision|0|||
94723219|NCT01140880|324446611|FG000|Overall Study|Death|0|||
94723220|NCT01140880|324446612|FG001|Overall Study|Death|1|||
94723221|NCT01140880|324446611|FG000|Overall Study|Withdrawal by Subject|6|||
94723222|NCT01140880|324446612|FG001|Overall Study|Withdrawal by Subject|3|||
94723223|NCT01140880|324446611|FG000|Overall Study|Lost to Follow-up|8|||
94723224|NCT01140880|324446612|FG001|Overall Study|Lost to Follow-up|10|||
94723225|NCT01140880|324446611|FG000|Overall Study|Protocol Violation|0|||
94723226|NCT01140880|324446612|FG001|Overall Study|Protocol Violation|30|||
94723227|NCT03779204|324446613|FG000|Overall Study|Lost to Follow-up|2|||
94723228|NCT03779204|324446614|FG001|Overall Study|Lost to Follow-up|0|||
94723229|NCT02807636|324446615|FG000|Overall Study|Lost to Follow-up|10|||
94723230|NCT02807636|324446616|FG001|Overall Study|Lost to Follow-up|13|||
94723231|NCT02807636|324446617|FG002|Overall Study|Lost to Follow-up|6|||
94723232|NCT02807636|324446615|FG000|Overall Study|Protocol Deviation|1|||
94723233|NCT02807636|324446616|FG001|Overall Study|Protocol Deviation|0|||
94723234|NCT02807636|324446617|FG002|Overall Study|Protocol Deviation|0|||
94723235|NCT02807636|324446615|FG000|Overall Study|Symptomatic Deterioration|0|||
94723236|NCT02807636|324446616|FG001|Overall Study|Symptomatic Deterioration|1|||
94723237|NCT02807636|324446617|FG002|Overall Study|Symptomatic Deterioration|0|||
94723238|NCT02807636|324446615|FG000|Overall Study|Withdrawal by Subject|39|||
94723239|NCT02807636|324446616|FG001|Overall Study|Withdrawal by Subject|28|||
94723240|NCT02807636|324446617|FG002|Overall Study|Withdrawal by Subject|24|||
94723241|NCT02807636|324446615|FG000|Overall Study|Death|303|||
94723242|NCT02807636|324446616|FG001|Overall Study|Death|332|||
94723243|NCT02807636|324446617|FG002|Overall Study|Death|272|||
94723244|NCT02807636|324446615|FG000|Overall Study|Study Terminated By Sponsor|47|||
94723245|NCT02807636|324446616|FG001|Overall Study|Study Terminated By Sponsor|76|||
94723246|NCT02807636|324446617|FG002|Overall Study|Study Terminated By Sponsor|60|||
94723247|NCT02807636|324446615|FG000|Overall Study|Physician Decision|0|||
94723248|NCT02807636|324446616|FG001|Overall Study|Physician Decision|1|||
94723249|NCT02807636|324446617|FG002|Overall Study|Physician Decision|0|||
94723250|NCT03175029|324446618|FG000|Overall Study|Withdrawal by Subject|2|||
94723251|NCT03175029|324446619|FG001|Overall Study|Withdrawal by Subject|1|||
94723252|NCT03175029|324446618|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
94723253|NCT03175029|324446619|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
94723254|NCT04024813|324446620|FG000|Overall Study|Study terminated by Sponsor|1|||
94723255|NCT04034251|324446621|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
94723256|NCT04034251|324446622|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
94723257|NCT04034251|324446623|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
94723258|NCT05034952|324446624|FG000|Overall Study|Adverse Event|1|||
94723259|NCT05034952|324446625|FG001|Overall Study|Adverse Event|0|||
94723260|NCT05034952|324446626|FG002|Overall Study|Adverse Event|0|||
94723261|NCT05034952|324446627|FG003|Overall Study|Adverse Event|0|||
94723262|NCT05034952|324446624|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
94723263|NCT05034952|324446625|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
94723264|NCT05034952|324446626|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
94723265|NCT05034952|324446627|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
94723266|NCT05034952|324446624|FG000|Overall Study|Lost to Follow-up|1|||
94368213|NCT04440163|323134863|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
94723267|NCT05034952|324446625|FG001|Overall Study|Lost to Follow-up|4|||
94723268|NCT05034952|324446626|FG002|Overall Study|Lost to Follow-up|3|||
94723269|NCT05034952|324446627|FG003|Overall Study|Lost to Follow-up|3|||
94723270|NCT05034952|324446624|FG000|Overall Study|Other|0|||
94723271|NCT05034952|324446625|FG001|Overall Study|Other|0|||
94723272|NCT05034952|324446626|FG002|Overall Study|Other|0|||
94723273|NCT05034952|324446627|FG003|Overall Study|Other|1|||
94723274|NCT04783935|324446629|FG000|Overall Study|Withdrawal by Subject|6|||
94723275|NCT04783935|324446629|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
94723276|NCT04783935|324446629|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
94723277|NCT04783935|324446629|FG000|Overall Study|Lost to Follow-up|3|||
94723278|NCT04783935|324446629|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
94723285|NCT05470400|324446635|FG000|Overall Study|Lost to Follow-up|0|||
94723286|NCT05470400|324446636|FG001|Overall Study|Lost to Follow-up|0|||
94723287|NCT05470400|324446637|FG002|Overall Study|Lost to Follow-up|0|||
94723288|NCT05470400|324446638|FG003|Overall Study|Lost to Follow-up|0|||
94723289|NCT05470400|324446639|FG004|Overall Study|Lost to Follow-up|0|||
94723290|NCT05470400|324446640|FG005|Overall Study|Lost to Follow-up|0|||
94723291|NCT05470400|324446641|FG006|Overall Study|Lost to Follow-up|0|||
94723292|NCT05470400|324446642|FG007|Overall Study|Lost to Follow-up|1|||
94723293|NCT05470400|324446635|FG000|Overall Study|Withdrawal by Subject|1|||
94723294|NCT05470400|324446636|FG001|Overall Study|Withdrawal by Subject|0|||
94723295|NCT05470400|324446637|FG002|Overall Study|Withdrawal by Subject|0|||
94723296|NCT05470400|324446638|FG003|Overall Study|Withdrawal by Subject|0|||
94723297|NCT05470400|324446639|FG004|Overall Study|Withdrawal by Subject|0|||
94723298|NCT05470400|324446640|FG005|Overall Study|Withdrawal by Subject|1|||
94723299|NCT05470400|324446641|FG006|Overall Study|Withdrawal by Subject|0|||
94723300|NCT05470400|324446642|FG007|Overall Study|Withdrawal by Subject|2|||
94723301|NCT05215314|324446643|FG000|Overall Study|Lost to Follow-up|2|||
94723302|NCT05215314|324446644|FG001|Overall Study|Lost to Follow-up|2|||
94723303|NCT05215314|324446643|FG000|Overall Study|Withdrawal by Subject|2|||
94723304|NCT05215314|324446644|FG001|Overall Study|Withdrawal by Subject|0|||
94723305|NCT05215314|324446643|FG000|Overall Study|Physician Decision|1|||
94723306|NCT05215314|324446644|FG001|Overall Study|Physician Decision|0|||
94723307|NCT05323084|324446648|FG000|Period 2 - Washout|Lost to Follow-up|0|||
94723308|NCT05323084|324446649|FG001|Period 2 - Washout|Lost to Follow-up|1|||
94723309|NCT02307565|324446650|FG000|Overall Study|Adverse Event|3|||
94723310|NCT02307565|324446651|FG001|Overall Study|Adverse Event|2|||
94723311|NCT02307565|324446650|FG000|Overall Study|Withdrawal by Subject|2|||
94723312|NCT02307565|324446651|FG001|Overall Study|Withdrawal by Subject|2|||
94723313|NCT05687916|324446653|FG000|Overall Study|Adverse Event|1|||
94723314|NCT05687916|324446654|FG001|Overall Study|Adverse Event|2|||
94723315|NCT05687916|324446655|FG002|Overall Study|Adverse Event|0|||
94723316|NCT05687916|324446653|FG000|Overall Study|Withdrawal by Subject|1|||
94723317|NCT05687916|324446654|FG001|Overall Study|Withdrawal by Subject|0|||
94723318|NCT05687916|324446655|FG002|Overall Study|Withdrawal by Subject|1|||
94723319|NCT05687916|324446653|FG000|Overall Study|Protocol Violation|0|||
94723320|NCT05687916|324446654|FG001|Overall Study|Protocol Violation|2|||
94723321|NCT05687916|324446655|FG002|Overall Study|Protocol Violation|1|||
94723322|NCT05687916|324446653|FG000|Overall Study|Reason not Specified|1|||
94723323|NCT05687916|324446654|FG001|Overall Study|Reason not Specified|0|||
94723324|NCT05687916|324446655|FG002|Overall Study|Reason not Specified|0|||
94723325|NCT04294225|324446658|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
94723326|NCT04294225|324446658|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
94723327|NCT04294225|324446658|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
94723328|NCT04294225|324446658|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
94723329|NCT04294225|324446658|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
94723330|NCT04485039|324446671|FG000|TPOXX Only|Adverse Event|2|||
94723331|NCT04485039|324446671|FG000|TPOXX Only|Physician Decision|1|||
94723332|NCT04485039|324446671|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
94723333|NCT04485039|324446671|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
94723334|NCT04021602|324446672|FG000|Overall Study|Lost to Follow-up|3|||
94723335|NCT04021602|324446673|FG001|Overall Study|Lost to Follow-up|3|||
94723336|NCT04021602|324446674|FG002|Overall Study|Lost to Follow-up|1|||
94723337|NCT04021602|324446672|FG000|Overall Study|Adverse Event|1|||
94723338|NCT04021602|324446673|FG001|Overall Study|Adverse Event|0|||
94723339|NCT04021602|324446674|FG002|Overall Study|Adverse Event|1|||
94723340|NCT04649359|324446675|FG000|Overall Study|Withdrawal by Subject|7|||
94723341|NCT04649359|324446676|FG001|Overall Study|Withdrawal by Subject|7|||
94723342|NCT04649359|324446675|FG000|Overall Study|Death|41|||
94723343|NCT04649359|324446676|FG001|Overall Study|Death|26|||
94723344|NCT04649359|324446675|FG000|Overall Study|Ongoing in the study|75|||
94723345|NCT04649359|324446676|FG001|Overall Study|Ongoing in the study|31|||
94272489|NCT00993265|322790427|FG000|Overall Study|Non-compliant with study medication|1|||
94723346|NCT04241068|324446677|FG000|Core Treatment Period|Adverse Event|91|||
94723347|NCT04241068|324446677|FG000|Core Treatment Period|Change of Treatment|4|||
94723348|NCT04241068|324446677|FG000|Core Treatment Period|Consent Withdrawn|143|||
94723349|NCT04241068|324446677|FG000|Core Treatment Period|Death|26|||
94723350|NCT04241068|324446677|FG000|Core Treatment Period|Disease Progression|67|||
94723351|NCT04241068|324446677|FG000|Core Treatment Period|Investigator Decision|40|||
94723352|NCT04241068|324446677|FG000|Core Treatment Period|Loss of Capacity|9|||
94723353|NCT04241068|324446677|FG000|Core Treatment Period|Lost to Follow-up|11|||
94723354|NCT04241068|324446677|FG000|Core Treatment Period|Relocation|4|||
94723355|NCT04241068|324446677|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
94723356|NCT04241068|324446677|FG000|Core Treatment Period|Study Visit Burden|40|||
94723357|NCT04241068|324446677|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
94723358|NCT04241068|324446677|FG000|Core Treatment Period|Missing|2|||
94723359|NCT04241068|324446677|FG000|Core Treatment Period|Reason Not Specified|41|||
94723360|NCT04241068|324446677|FG000|LTE Period|Adverse Event|19|||
94723361|NCT04241068|324446677|FG000|LTE Period|Change of Treatment|1|||
94723362|NCT04241068|324446677|FG000|LTE Period|Consent Withdrawn|71|||
94723363|NCT04241068|324446677|FG000|LTE Period|Death|8|||
94723364|NCT04241068|324446677|FG000|LTE Period|Disease Progression|11|||
94723365|NCT04241068|324446677|FG000|LTE Period|Investigator Decision|12|||
94723366|NCT04241068|324446677|FG000|LTE Period|Loss of Capacity|2|||
94723367|NCT04241068|324446677|FG000|LTE Period|Lost to Follow-up|7|||
94723368|NCT04241068|324446677|FG000|LTE Period|Relocation|6|||
94723369|NCT04241068|324446677|FG000|LTE Period|Site Terminated by Sponsor|26|||
94723370|NCT04241068|324446677|FG000|LTE Period|Study Terminated by Sponsor|276|||
94723371|NCT04241068|324446677|FG000|LTE Period|Study Visit Burden|10|||
94723372|NCT04241068|324446677|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
94723373|NCT04241068|324446677|FG000|LTE Period|Reason Not Specified|65|||
94723374|NCT01785719|324446681|FG000|4-week Baseline Evaluation|Physician Decision|1|||
94723375|NCT01785719|324446682|FG001|4-week Baseline Evaluation|Physician Decision|0|||
94723376|NCT01785719|324446681|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
94723377|NCT01785719|324446682|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
94723378|NCT01785719|324446681|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
94723379|NCT01785719|324446682|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
94723380|NCT01785719|324446681|FG000|4-week Baseline Evaluation|Pregnancy|0|||
94723381|NCT01785719|324446682|FG001|4-week Baseline Evaluation|Pregnancy|2|||
94723382|NCT01785719|324446681|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
94723383|NCT01785719|324446682|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
94723384|NCT01785719|324446681|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
94723385|NCT01785719|324446682|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
94723386|NCT01785719|324446681|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
94723387|NCT01785719|324446682|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
94723388|NCT01785719|324446681|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
94723389|NCT01785719|324446682|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
94723390|NCT01785719|324446681|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
94723391|NCT01785719|324446682|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
94723392|NCT01785719|324446681|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
94723393|NCT01785719|324446682|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
94723394|NCT01785719|324446681|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
94723395|NCT01785719|324446682|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
94723396|NCT01785719|324446681|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
94723397|NCT01785719|324446682|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
94723398|NCT01785719|324446681|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
94723399|NCT01785719|324446682|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
94723400|NCT01785719|324446681|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
94723401|NCT01785719|324446682|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
94723402|NCT01785719|324446681|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
94723403|NCT01785719|324446682|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
94723404|NCT04492007|324446685|FG000|Overall Study|Lost to Follow-up|1|||
94723405|NCT04492007|324446686|FG001|Overall Study|Lost to Follow-up|1|||
94272490|NCT00993265|322790428|FG001|Overall Study|Non-compliant with study medication|0|||
94272491|NCT00807742|322790429|FG000|Overall Study|Death|9|||
94723406|NCT04492007|324446687|FG002|Overall Study|Lost to Follow-up|2|||
94723407|NCT04492007|324446688|FG003|Overall Study|Lost to Follow-up|2|||
94272492|NCT00807742|322790430|FG001|Overall Study|Death|2|||
94723408|NCT04492007|324446685|FG000|Overall Study|Protocol Violation|1|||
94723409|NCT04492007|324446686|FG001|Overall Study|Protocol Violation|1|||
94723410|NCT04492007|324446687|FG002|Overall Study|Protocol Violation|1|||
94272493|NCT00807742|322790429|FG000|Overall Study|Withdrawal by Subject|2|||
94272494|NCT00807742|322790430|FG001|Overall Study|Withdrawal by Subject|1|||
94723411|NCT04492007|324446688|FG003|Overall Study|Protocol Violation|1|||
94723412|NCT04492007|324446685|FG000|Overall Study|Withdrawal by Subject|0|||
94723413|NCT04492007|324446686|FG001|Overall Study|Withdrawal by Subject|0|||
94723414|NCT04492007|324446687|FG002|Overall Study|Withdrawal by Subject|1|||
94723415|NCT04492007|324446688|FG003|Overall Study|Withdrawal by Subject|1|||
94723416|NCT04169373|324446689|FG000|Week 1 to Week 14|Adverse Event|1|||
94723417|NCT04169373|324446690|FG001|Week 1 to Week 14|Adverse Event|0|||
94723418|NCT04169373|324446691|FG002|Week 1 to Week 14|Adverse Event|1|||
94723419|NCT04169373|324446692|FG003|Week 1 to Week 14|Adverse Event|2|||
94723420|NCT04169373|324446689|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
94723421|NCT04169373|324446690|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
94723422|NCT04169373|324446691|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
94723423|NCT04169373|324446692|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
94723424|NCT04169373|324446689|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
94723425|NCT04169373|324446690|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
94723426|NCT04169373|324446691|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
94723427|NCT04169373|324446692|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
94723428|NCT04169373|324446689|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
94723429|NCT04169373|324446690|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
94723430|NCT04169373|324446691|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
94723431|NCT04169373|324446692|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
94723432|NCT04169373|324446689|FG000|Week 1 to Week 14|Other|1|||
94723433|NCT04169373|324446690|FG001|Week 1 to Week 14|Other|3|||
94723434|NCT04169373|324446691|FG002|Week 1 to Week 14|Other|3|||
94723435|NCT04169373|324446692|FG003|Week 1 to Week 14|Other|5|||
94723436|NCT04169373|324446689|FG000|Week 14 to Week 52|Adverse Event|1|||
94723437|NCT04169373|324446690|FG001|Week 14 to Week 52|Adverse Event|0|||
94723438|NCT04169373|324446691|FG002|Week 14 to Week 52|Adverse Event|0|||
94723439|NCT04169373|324446692|FG003|Week 14 to Week 52|Adverse Event|1|||
94723440|NCT04169373|324446689|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
94723441|NCT04169373|324446690|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
94723442|NCT04169373|324446691|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
94723443|NCT04169373|324446692|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
94723444|NCT04169373|324446689|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
94723445|NCT04169373|324446690|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
94723446|NCT04169373|324446691|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
94723447|NCT04169373|324446692|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
94723448|NCT04169373|324446689|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
94723449|NCT04169373|324446690|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
94723450|NCT04169373|324446691|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
94723451|NCT04169373|324446692|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
94723452|NCT04169373|324446689|FG000|Week 14 to Week 52|Other|4|||
94723453|NCT04169373|324446690|FG001|Week 14 to Week 52|Other|5|||
94723454|NCT04169373|324446691|FG002|Week 14 to Week 52|Other|4|||
94723455|NCT04169373|324446692|FG003|Week 14 to Week 52|Other|5|||
94723456|NCT04169373|324446689|FG000|Week 14 to Week 52|Ongoing|0|||
94723457|NCT04169373|324446690|FG001|Week 14 to Week 52|Ongoing|1|||
94723458|NCT04169373|324446691|FG002|Week 14 to Week 52|Ongoing|0|||
94723459|NCT04169373|324446692|FG003|Week 14 to Week 52|Ongoing|0|||
94723463|NCT04610892|324446696|FG000|Overall Study|Adverse Event|1|||
94723464|NCT04610892|324446697|FG001|Overall Study|Adverse Event|0|||
94723465|NCT04610892|324446698|FG002|Overall Study|Adverse Event|0|||
94723466|NCT04610892|324446699|FG003|Overall Study|Adverse Event|1|||
94723467|NCT04610892|324446700|FG004|Overall Study|Adverse Event|3|||
94723468|NCT04610892|324446696|FG000|Overall Study|Death|0|||
94723469|NCT04610892|324446697|FG001|Overall Study|Death|1|||
94723470|NCT04610892|324446698|FG002|Overall Study|Death|0|||
94723471|NCT04610892|324446699|FG003|Overall Study|Death|1|||
94272495|NCT00807742|322790429|FG000|Overall Study|Lost to Follow-up|35|||
94723472|NCT04610892|324446700|FG004|Overall Study|Death|0|||
94723473|NCT04610892|324446696|FG000|Overall Study|Withdrawal by Subject|3|||
94723474|NCT04610892|324446697|FG001|Overall Study|Withdrawal by Subject|2|||
94723475|NCT04610892|324446698|FG002|Overall Study|Withdrawal by Subject|0|||
94723476|NCT04610892|324446699|FG003|Overall Study|Withdrawal by Subject|6|||
94723477|NCT04610892|324446700|FG004|Overall Study|Withdrawal by Subject|6|||
94723478|NCT04610892|324446696|FG000|Overall Study|Subjects who did not receive treatment|1|||
94723479|NCT04610892|324446697|FG001|Overall Study|Subjects who did not receive treatment|0|||
94723480|NCT04610892|324446698|FG002|Overall Study|Subjects who did not receive treatment|0|||
94723481|NCT04610892|324446699|FG003|Overall Study|Subjects who did not receive treatment|0|||
94723482|NCT04610892|324446700|FG004|Overall Study|Subjects who did not receive treatment|2|||
94723483|NCT05520190|324446701|FG000|Overall Study|Lost to Follow-up|7|||
94272496|NCT00807742|322790430|FG001|Overall Study|Lost to Follow-up|51|||
94272497|NCT03159091|322790433|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
94723484|NCT05520190|324446701|FG000|Overall Study|Withdrawal by Subject|2|||
94723485|NCT03683719|324446702|FG000|Overall Study|Lack of Efficacy|1|||
94723486|NCT03683719|324446703|FG001|Overall Study|Lack of Efficacy|3|||
94723487|NCT03683719|324446704|FG002|Overall Study|Lack of Efficacy|4|||
94723488|NCT03683719|324446705|FG003|Overall Study|Lack of Efficacy|0|||
94723489|NCT03683719|324446706|FG004|Overall Study|Lack of Efficacy|4|||
94723490|NCT03683719|324446702|FG000|Overall Study|Adverse Event|6|||
94723491|NCT03683719|324446703|FG001|Overall Study|Adverse Event|6|||
94723492|NCT03683719|324446704|FG002|Overall Study|Adverse Event|0|||
94723493|NCT03683719|324446705|FG003|Overall Study|Adverse Event|1|||
94723494|NCT03683719|324446706|FG004|Overall Study|Adverse Event|3|||
94723495|NCT03683719|324446702|FG000|Overall Study|Withdrawal by Subject|4|||
94723496|NCT03683719|324446703|FG001|Overall Study|Withdrawal by Subject|4|||
94723497|NCT03683719|324446704|FG002|Overall Study|Withdrawal by Subject|3|||
94723498|NCT03683719|324446705|FG003|Overall Study|Withdrawal by Subject|5|||
94723499|NCT03683719|324446706|FG004|Overall Study|Withdrawal by Subject|5|||
94723500|NCT03683719|324446702|FG000|Overall Study|Lost to Follow-up|1|||
94723501|NCT03683719|324446703|FG001|Overall Study|Lost to Follow-up|0|||
94723502|NCT03683719|324446704|FG002|Overall Study|Lost to Follow-up|0|||
94723503|NCT03683719|324446705|FG003|Overall Study|Lost to Follow-up|1|||
94723504|NCT03683719|324446706|FG004|Overall Study|Lost to Follow-up|1|||
94723505|NCT03683719|324446702|FG000|Overall Study|Other personal reasons|0|||
94723506|NCT03683719|324446703|FG001|Overall Study|Other personal reasons|0|||
94723507|NCT03683719|324446704|FG002|Overall Study|Other personal reasons|1|||
94723508|NCT03683719|324446705|FG003|Overall Study|Other personal reasons|0|||
94723509|NCT03683719|324446706|FG004|Overall Study|Other personal reasons|1|||
94723510|NCT03476187|324446710|FG000|Overall Study|Protocol Violation|7|||
94723511|NCT03476187|324446710|FG000|Overall Study|Physician Decision|5|||
94723512|NCT03135548|324446711|FG000|Overall Study|Lost to Follow-up|3|||
94723513|NCT03135548|324446712|FG001|Overall Study|Lost to Follow-up|0|||
94723514|NCT03135548|324446713|FG002|Overall Study|Lost to Follow-up|0|||
94723515|NCT03135548|324446711|FG000|Overall Study|Withdrawal by Subject|2|||
94723516|NCT03135548|324446712|FG001|Overall Study|Withdrawal by Subject|2|||
94723517|NCT03135548|324446713|FG002|Overall Study|Withdrawal by Subject|1|||
94723518|NCT03135548|324446711|FG000|Overall Study|Other than listed|0|||
94723519|NCT03135548|324446712|FG001|Overall Study|Other than listed|2|||
94723520|NCT03135548|324446713|FG002|Overall Study|Other than listed|2|||
94723521|NCT03699709|324446719|FG000|Overall Study|Death|1|||
94723522|NCT03699709|324446720|FG001|Overall Study|Death|2|||
94723523|NCT03699709|324446719|FG000|Overall Study|Lost to Follow-up|10|||
94723524|NCT03699709|324446720|FG001|Overall Study|Lost to Follow-up|3|||
94723525|NCT03699709|324446719|FG000|Overall Study|Withdrawal by Subject|5|||
94723526|NCT03699709|324446720|FG001|Overall Study|Withdrawal by Subject|0|||
94723527|NCT03699709|324446719|FG000|Overall Study|incarcerated|1|||
94723528|NCT03699709|324446720|FG001|Overall Study|incarcerated|0|||
94723529|NCT03699709|324446719|FG000|Overall Study|scheduled, but no show|0|||
94723530|NCT03699709|324446720|FG001|Overall Study|scheduled, but no show|1|||
94723531|NCT02907099|324446721|FG000|Overall Study|Adverse Event|1|||
94723532|NCT02907099|324446721|FG000|Overall Study|Withdrawal by Subject|2|||
94723533|NCT02907099|324446721|FG000|Overall Study|Screen Fail|2|||
94723534|NCT03056040|324446722|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
94723535|NCT03056040|324446723|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
94723536|NCT03056040|324446722|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
94723537|NCT03056040|324446723|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
94723538|NCT03056040|324446722|FG000|Primary Evaluation Period|Pregnancy|0|||
94723539|NCT03056040|324446723|FG001|Primary Evaluation Period|Pregnancy|1|||
94723540|NCT03056040|324446722|FG000|Primary Evaluation Period|Randomized, not treated|1|||
94723541|NCT03056040|324446723|FG001|Primary Evaluation Period|Randomized, not treated|1|||
94723542|NCT03056040|324446722|FG000|Extension Period|Physician Decision|3|||
94723543|NCT03056040|324446723|FG001|Extension Period|Physician Decision|3|||
94723544|NCT03056040|324446722|FG000|Extension Period|Lost to Follow-up|0|||
94723545|NCT03056040|324446723|FG001|Extension Period|Lost to Follow-up|1|||
94723546|NCT03056040|324446722|FG000|Extension Period|Death|0|||
94723547|NCT03056040|324446723|FG001|Extension Period|Death|3|||
94723548|NCT03056040|324446722|FG000|Extension Period|Withdrawal by Subject|1|||
94723549|NCT03056040|324446723|FG001|Extension Period|Withdrawal by Subject|0|||
94723550|NCT03232138|324446728|FG000|Overall Study|Physician Decision|1|||
94723551|NCT03232138|324446729|FG001|Overall Study|Physician Decision|0|||
94723552|NCT03232138|324446728|FG000|Overall Study|Adverse Event|2|||
94723553|NCT03232138|324446729|FG001|Overall Study|Adverse Event|0|||
94723554|NCT03232138|324446728|FG000|Overall Study|Withdrawal by Subject|1|||
94723555|NCT03232138|324446729|FG001|Overall Study|Withdrawal by Subject|2|||
94723556|NCT02323321|324446732|FG000|Overall Study|Re-Transplant|1|||
94723557|NCT02323321|324446732|FG000|Overall Study|Death|12|||
94723558|NCT00446225|324446733|FG000|Overall Study|Protocol Violation|1|||
94723559|NCT00446225|324446734|FG001|Overall Study|Protocol Violation|0|||
94723560|NCT03150810|324446735|FG000|Overall Study|Death|4|||
94723561|NCT03150810|324446736|FG001|Overall Study|Death|8|||
94723562|NCT03150810|324446737|FG002|Overall Study|Death|7|||
94723563|NCT03150810|324446738|FG003|Overall Study|Death|2|||
94723564|NCT03150810|324446739|FG004|Overall Study|Death|2|||
94723565|NCT03150810|324446740|FG005|Overall Study|Death|10|||
94272498|NCT03159091|322790434|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
94272499|NCT03159091|322790433|FG000|Overall Study|Patient has taken no dose of study drug|0|||
94272500|NCT03159091|322790434|FG001|Overall Study|Patient has taken no dose of study drug|1|||
94272501|NCT02258451|322790435|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
94272502|NCT02258451|322790436|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
94272503|NCT02258451|322790435|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
94272504|NCT02258451|322790436|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
94272505|NCT02258451|322790435|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
94272506|NCT02258451|322790436|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
94272507|NCT02258451|322790435|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
94272508|NCT02258451|322790436|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
94272509|NCT02258451|322790435|FG000|Overall Study|Discontinuation all treatment due to death|4|||
94272510|NCT02258451|322790436|FG001|Overall Study|Discontinuation all treatment due to death|3|||
94272511|NCT02258451|322790435|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
94272512|NCT02258451|322790436|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
94272513|NCT02258451|322790435|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
94272514|NCT02258451|322790436|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
94272515|NCT02258451|322790435|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
94272516|NCT02258451|322790436|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
94272517|NCT02258451|322790435|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
94272518|NCT02258451|322790436|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
94272519|NCT02258451|322790435|FG000|Overall Study|Other reason|1|||
94272520|NCT02258451|322790436|FG001|Overall Study|Other reason|1|||
94272521|NCT02258451|322790435|FG000|Overall Study|Never treated|2|||
94272522|NCT02258451|322790436|FG001|Overall Study|Never treated|3|||
94272523|NCT03834519|322790449|FG000|Overall Study|Lost to Follow-up|2|||
94272524|NCT03834519|322790450|FG001|Overall Study|Lost to Follow-up|1|||
94723566|NCT03150810|324446741|FG006|Overall Study|Death|8|||
94723567|NCT03150810|324446742|FG007|Overall Study|Death|6|||
94723568|NCT03150810|324446743|FG008|Overall Study|Death|18|||
94723569|NCT03150810|324446744|FG009|Overall Study|Death|3|||
94723570|NCT03150810|324446745|FG010|Overall Study|Death|19|||
94723571|NCT03150810|324446746|FG011|Overall Study|Death|1|||
94723572|NCT03150810|324446747|FG012|Overall Study|Death|19|||
94723573|NCT03150810|324446735|FG000|Overall Study|Withdrawal by Subject|0|||
94723574|NCT03150810|324446736|FG001|Overall Study|Withdrawal by Subject|1|||
94723575|NCT03150810|324446737|FG002|Overall Study|Withdrawal by Subject|1|||
94723576|NCT03150810|324446738|FG003|Overall Study|Withdrawal by Subject|1|||
94723577|NCT03150810|324446739|FG004|Overall Study|Withdrawal by Subject|0|||
94723578|NCT03150810|324446740|FG005|Overall Study|Withdrawal by Subject|0|||
94723579|NCT03150810|324446741|FG006|Overall Study|Withdrawal by Subject|2|||
94723580|NCT03150810|324446742|FG007|Overall Study|Withdrawal by Subject|0|||
94723581|NCT03150810|324446743|FG008|Overall Study|Withdrawal by Subject|2|||
94723582|NCT03150810|324446744|FG009|Overall Study|Withdrawal by Subject|0|||
94723583|NCT03150810|324446745|FG010|Overall Study|Withdrawal by Subject|1|||
94723584|NCT03150810|324446746|FG011|Overall Study|Withdrawal by Subject|0|||
94723585|NCT03150810|324446747|FG012|Overall Study|Withdrawal by Subject|1|||
94723586|NCT03150810|324446735|FG000|Overall Study|Sponsor Decision|0|||
94723587|NCT03150810|324446736|FG001|Overall Study|Sponsor Decision|2|||
94723588|NCT03150810|324446737|FG002|Overall Study|Sponsor Decision|0|||
94723589|NCT03150810|324446738|FG003|Overall Study|Sponsor Decision|0|||
94723590|NCT03150810|324446739|FG004|Overall Study|Sponsor Decision|1|||
94723591|NCT03150810|324446740|FG005|Overall Study|Sponsor Decision|1|||
94723592|NCT03150810|324446741|FG006|Overall Study|Sponsor Decision|0|||
94723593|NCT03150810|324446742|FG007|Overall Study|Sponsor Decision|0|||
94723594|NCT03150810|324446743|FG008|Overall Study|Sponsor Decision|1|||
94723595|NCT03150810|324446744|FG009|Overall Study|Sponsor Decision|0|||
94723596|NCT03150810|324446745|FG010|Overall Study|Sponsor Decision|0|||
94723597|NCT03150810|324446746|FG011|Overall Study|Sponsor Decision|0|||
94723598|NCT03150810|324446747|FG012|Overall Study|Sponsor Decision|5|||
94723599|NCT03150810|324446735|FG000|Overall Study|Lost to Follow-up|0|||
94723600|NCT03150810|324446736|FG001|Overall Study|Lost to Follow-up|1|||
94723601|NCT03150810|324446737|FG002|Overall Study|Lost to Follow-up|1|||
94723602|NCT03150810|324446738|FG003|Overall Study|Lost to Follow-up|0|||
94723603|NCT03150810|324446739|FG004|Overall Study|Lost to Follow-up|0|||
94723604|NCT03150810|324446740|FG005|Overall Study|Lost to Follow-up|0|||
94723605|NCT03150810|324446741|FG006|Overall Study|Lost to Follow-up|1|||
94723606|NCT03150810|324446742|FG007|Overall Study|Lost to Follow-up|0|||
94723607|NCT03150810|324446743|FG008|Overall Study|Lost to Follow-up|0|||
94723608|NCT03150810|324446744|FG009|Overall Study|Lost to Follow-up|0|||
94723609|NCT03150810|324446745|FG010|Overall Study|Lost to Follow-up|1|||
94723610|NCT03150810|324446746|FG011|Overall Study|Lost to Follow-up|0|||
94723611|NCT03150810|324446747|FG012|Overall Study|Lost to Follow-up|0|||
94723612|NCT03150810|324446735|FG000|Overall Study|Physician Decision|0|||
94723613|NCT03150810|324446736|FG001|Overall Study|Physician Decision|0|||
94723614|NCT03150810|324446737|FG002|Overall Study|Physician Decision|0|||
94723615|NCT03150810|324446738|FG003|Overall Study|Physician Decision|0|||
94723616|NCT03150810|324446739|FG004|Overall Study|Physician Decision|0|||
94723617|NCT03150810|324446740|FG005|Overall Study|Physician Decision|1|||
94655439|NCT01328002|324196035|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
94655440|NCT01328002|324196034|FG000|Open-Label Period|Adverse Event|8|||
94655441|NCT01328002|324196035|FG001|Open-Label Period|Adverse Event|0|||
94655442|NCT01328002|324196034|FG000|Open-Label Period|Lack of Efficacy|3|||
94655443|NCT01328002|324196035|FG001|Open-Label Period|Lack of Efficacy|0|||
94655444|NCT01328002|324196034|FG000|Open-Label Period|Protocol Violation|2|||
94655445|NCT01328002|324196035|FG001|Open-Label Period|Protocol Violation|0|||
94655446|NCT01328002|324196034|FG000|Open-Label Period|Withdrawal by Subject|9|||
94655447|NCT01328002|324196035|FG001|Open-Label Period|Withdrawal by Subject|0|||
94655448|NCT01328002|324196034|FG000|Open-Label Period|Lost to Follow-up|6|||
94655449|NCT01328002|324196035|FG001|Open-Label Period|Lost to Follow-up|0|||
94655450|NCT01328002|324196034|FG000|Open-Label Period|Other Reason|2|||
94655451|NCT01328002|324196035|FG001|Open-Label Period|Other Reason|0|||
94655452|NCT01328002|324196034|FG000|Double-Blind Period|Adverse Event|1|||
94655453|NCT01328002|324196035|FG001|Double-Blind Period|Adverse Event|0|||
94655454|NCT01328002|324196034|FG000|Double-Blind Period|Lack of Efficacy|1|||
94655455|NCT01328002|324196035|FG001|Double-Blind Period|Lack of Efficacy|0|||
94655456|NCT00813761|324196036|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
94655457|NCT00813761|324196037|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
94655458|NCT00813761|324196038|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
94655459|NCT00813761|324196039|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
94655460|NCT00813761|324196036|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
94655461|NCT00813761|324196037|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
94655462|NCT00813761|324196038|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
94655463|NCT00813761|324196039|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
94655464|NCT00813761|324196036|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
94655465|NCT00813761|324196037|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
94655466|NCT00813761|324196038|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
94655467|NCT00813761|324196039|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
94655468|NCT00813761|324196036|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
94655469|NCT00813761|324196037|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
94655470|NCT00813761|324196038|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
94655471|NCT00813761|324196039|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
94655472|NCT00813761|324196036|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
94655473|NCT00813761|324196037|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
94655474|NCT00813761|324196038|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
94655475|NCT00813761|324196039|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
94655476|NCT00813761|324196036|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
94655477|NCT00813761|324196037|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
94655478|NCT00813761|324196038|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
94655479|NCT00813761|324196039|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
94655480|NCT00813761|324196036|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
94655481|NCT00813761|324196037|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
94655482|NCT00813761|324196038|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
94655483|NCT00813761|324196039|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
94655484|NCT00813761|324196036|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
94655485|NCT00813761|324196037|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
94655486|NCT00813761|324196038|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
94655487|NCT00813761|324196039|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
94655488|NCT00813761|324196036|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
94655489|NCT00813761|324196037|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
94655490|NCT00813761|324196038|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
94655491|NCT00813761|324196039|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
94655492|NCT00813761|324196036|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
94655493|NCT00813761|324196037|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
94655494|NCT00813761|324196038|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
94655495|NCT00813761|324196039|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
94655496|NCT00813761|324196036|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
94723618|NCT03150810|324446741|FG006|Overall Study|Physician Decision|1|||
94723619|NCT03150810|324446742|FG007|Overall Study|Physician Decision|0|||
94723620|NCT03150810|324446743|FG008|Overall Study|Physician Decision|0|||
94723621|NCT03150810|324446744|FG009|Overall Study|Physician Decision|0|||
94723622|NCT03150810|324446745|FG010|Overall Study|Physician Decision|0|||
94723623|NCT03150810|324446746|FG011|Overall Study|Physician Decision|0|||
94723624|NCT03150810|324446747|FG012|Overall Study|Physician Decision|0|||
94723625|NCT03150810|324446735|FG000|Overall Study|Site withdrawal from study|0|||
94723626|NCT03150810|324446736|FG001|Overall Study|Site withdrawal from study|1|||
94723627|NCT03150810|324446737|FG002|Overall Study|Site withdrawal from study|0|||
94723628|NCT03150810|324446738|FG003|Overall Study|Site withdrawal from study|0|||
94723629|NCT03150810|324446739|FG004|Overall Study|Site withdrawal from study|0|||
94723630|NCT03150810|324446740|FG005|Overall Study|Site withdrawal from study|0|||
94723631|NCT03150810|324446741|FG006|Overall Study|Site withdrawal from study|0|||
94723632|NCT03150810|324446742|FG007|Overall Study|Site withdrawal from study|0|||
94723633|NCT03150810|324446743|FG008|Overall Study|Site withdrawal from study|0|||
94272525|NCT03834519|322790449|FG000|Overall Study|Withdrawal by Subject|5|||
94272526|NCT03834519|322790450|FG001|Overall Study|Withdrawal by Subject|8|||
94272527|NCT03834519|322790449|FG000|Overall Study|Death|368|||
94272528|NCT03834519|322790450|FG001|Overall Study|Death|174|||
94272529|NCT03834519|322790449|FG000|Overall Study|Physician Decision|5|||
94272530|NCT03834519|322790450|FG001|Overall Study|Physician Decision|1|||
94272531|NCT03834519|322790449|FG000|Overall Study|Sponsor decision|149|||
94272532|NCT03834519|322790450|FG001|Overall Study|Sponsor decision|80|||
94272533|NCT05248295|322790451|FG000|Overall Study|found ineligible|4|||
94272534|NCT05248295|322790452|FG001|Overall Study|found ineligible|1|||
94272535|NCT05248295|322790451|FG000|Overall Study|Withdrawal by Subject|0|||
94272536|NCT05248295|322790452|FG001|Overall Study|Withdrawal by Subject|1|||
94272537|NCT05248295|322790451|FG000|Overall Study|Data loss: audio recording error|1|||
94272538|NCT05248295|322790452|FG001|Overall Study|Data loss: audio recording error|1|||
94272539|NCT04066491|322790453|FG000|Overall Study|Randomized, not treated|0|||
94272540|NCT04066491|322790454|FG001|Overall Study|Randomized, not treated|0|||
94272541|NCT04066491|322790455|FG002|Overall Study|Randomized, not treated|2|||
94272542|NCT04506086|322790456|FG000|Overall Study|Withdrawal by Subject|2|||
94467345|NCT00574795|323500522|FG000|Toddler Dose|Withdrawal by Subject|1|||
94723634|NCT03150810|324446744|FG009|Overall Study|Site withdrawal from study|1|||
94723635|NCT03150810|324446745|FG010|Overall Study|Site withdrawal from study|1|||
94723636|NCT03150810|324446746|FG011|Overall Study|Site withdrawal from study|0|||
94272543|NCT03021499|322790457|FG000|Overall Study|Adverse Event|1|||
94272544|NCT03021499|322790458|FG001|Overall Study|Adverse Event|0|||
94272545|NCT03021499|322790457|FG000|Overall Study|Death|1|||
94272546|NCT03021499|322790458|FG001|Overall Study|Death|5|||
94272547|NCT03021499|322790457|FG000|Overall Study|Lack of Efficacy|0|||
94723637|NCT03150810|324446747|FG012|Overall Study|Site withdrawal from study|0|||
94723638|NCT03150810|324446735|FG000|Overall Study|Hospice|0|||
94723639|NCT03150810|324446736|FG001|Overall Study|Hospice|0|||
94723640|NCT03150810|324446737|FG002|Overall Study|Hospice|0|||
94723641|NCT03150810|324446738|FG003|Overall Study|Hospice|0|||
94723642|NCT03150810|324446739|FG004|Overall Study|Hospice|0|||
94723643|NCT03150810|324446740|FG005|Overall Study|Hospice|1|||
94723644|NCT03150810|324446741|FG006|Overall Study|Hospice|0|||
94723645|NCT03150810|324446742|FG007|Overall Study|Hospice|0|||
94723646|NCT03150810|324446743|FG008|Overall Study|Hospice|0|||
94723647|NCT03150810|324446744|FG009|Overall Study|Hospice|0|||
94723648|NCT03150810|324446745|FG010|Overall Study|Hospice|0|||
94723649|NCT03150810|324446746|FG011|Overall Study|Hospice|0|||
94723650|NCT03150810|324446747|FG012|Overall Study|Hospice|0|||
94723651|NCT03150810|324446735|FG000|Overall Study|Participant relocated abroad.|0|||
94723652|NCT03150810|324446736|FG001|Overall Study|Participant relocated abroad.|0|||
94723653|NCT03150810|324446737|FG002|Overall Study|Participant relocated abroad.|0|||
94723654|NCT03150810|324446738|FG003|Overall Study|Participant relocated abroad.|0|||
94723655|NCT03150810|324446739|FG004|Overall Study|Participant relocated abroad.|0|||
94723656|NCT03150810|324446740|FG005|Overall Study|Participant relocated abroad.|1|||
94723657|NCT03150810|324446741|FG006|Overall Study|Participant relocated abroad.|0|||
94723658|NCT03150810|324446742|FG007|Overall Study|Participant relocated abroad.|0|||
94723659|NCT03150810|324446743|FG008|Overall Study|Participant relocated abroad.|0|||
94723660|NCT03150810|324446744|FG009|Overall Study|Participant relocated abroad.|0|||
94723661|NCT03150810|324446745|FG010|Overall Study|Participant relocated abroad.|0|||
94723662|NCT03150810|324446746|FG011|Overall Study|Participant relocated abroad.|0|||
94723663|NCT03150810|324446747|FG012|Overall Study|Participant relocated abroad.|0|||
94723664|NCT03150810|324446735|FG000|Overall Study|Transferred care to oncologist|0|||
94723665|NCT03150810|324446736|FG001|Overall Study|Transferred care to oncologist|0|||
94723666|NCT03150810|324446737|FG002|Overall Study|Transferred care to oncologist|0|||
94723667|NCT03150810|324446738|FG003|Overall Study|Transferred care to oncologist|0|||
94723668|NCT03150810|324446739|FG004|Overall Study|Transferred care to oncologist|0|||
94723669|NCT03150810|324446740|FG005|Overall Study|Transferred care to oncologist|0|||
94723670|NCT03150810|324446741|FG006|Overall Study|Transferred care to oncologist|2|||
94723671|NCT03150810|324446742|FG007|Overall Study|Transferred care to oncologist|0|||
94723672|NCT03150810|324446743|FG008|Overall Study|Transferred care to oncologist|0|||
94723673|NCT03150810|324446744|FG009|Overall Study|Transferred care to oncologist|0|||
94723674|NCT03150810|324446745|FG010|Overall Study|Transferred care to oncologist|0|||
94723675|NCT03150810|324446746|FG011|Overall Study|Transferred care to oncologist|0|||
94723676|NCT03150810|324446747|FG012|Overall Study|Transferred care to oncologist|0|||
94723677|NCT04209465|324446748|FG000|Overall Study|Adverse Event|0|||
94723678|NCT04209465|324446749|FG001|Overall Study|Adverse Event|0|||
94723679|NCT04209465|324446750|FG002|Overall Study|Adverse Event|0|||
94723680|NCT04209465|324446751|FG003|Overall Study|Adverse Event|0|||
94723681|NCT04209465|324446752|FG004|Overall Study|Adverse Event|0|||
94723682|NCT04209465|324446753|FG005|Overall Study|Adverse Event|1|||
94723683|NCT04209465|324446754|FG006|Overall Study|Adverse Event|0|||
94723684|NCT04209465|324446755|FG007|Overall Study|Adverse Event|0|||
94723685|NCT04209465|324446756|FG008|Overall Study|Adverse Event|1|||
94723686|NCT04209465|324446757|FG009|Overall Study|Adverse Event|0|||
94723687|NCT04209465|324446758|FG010|Overall Study|Adverse Event|2|||
94723688|NCT04209465|324446759|FG011|Overall Study|Adverse Event|1|||
94723689|NCT04209465|324446760|FG012|Overall Study|Adverse Event|1|||
94723690|NCT04209465|324446748|FG000|Overall Study|Death|1|||
94723691|NCT04209465|324446749|FG001|Overall Study|Death|0|||
94723692|NCT04209465|324446750|FG002|Overall Study|Death|0|||
94723693|NCT04209465|324446751|FG003|Overall Study|Death|0|||
94723694|NCT04209465|324446752|FG004|Overall Study|Death|2|||
94723695|NCT04209465|324446753|FG005|Overall Study|Death|7|||
94723696|NCT04209465|324446754|FG006|Overall Study|Death|2|||
94368214|NCT04440163|323134864|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
94368215|NCT04440163|323134865|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
94368216|NCT04440163|323134866|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
94368217|NCT04440163|323134867|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
94368218|NCT04440163|323134860|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
94368219|NCT04440163|323134861|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
94368220|NCT04440163|323134862|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
94723697|NCT04209465|324446755|FG007|Overall Study|Death|2|||
94723698|NCT04209465|324446756|FG008|Overall Study|Death|1|||
94723699|NCT04209465|324446757|FG009|Overall Study|Death|1|||
94723700|NCT04209465|324446758|FG010|Overall Study|Death|1|||
94723701|NCT04209465|324446759|FG011|Overall Study|Death|0|||
94723702|NCT04209465|324446760|FG012|Overall Study|Death|10|||
94723703|NCT04209465|324446748|FG000|Overall Study|Physician Decision|0|||
94723704|NCT04209465|324446749|FG001|Overall Study|Physician Decision|1|||
94723705|NCT04209465|324446750|FG002|Overall Study|Physician Decision|0|||
94723706|NCT04209465|324446751|FG003|Overall Study|Physician Decision|0|||
94723707|NCT04209465|324446752|FG004|Overall Study|Physician Decision|0|||
94723708|NCT04209465|324446753|FG005|Overall Study|Physician Decision|0|||
94723709|NCT04209465|324446754|FG006|Overall Study|Physician Decision|0|||
94723710|NCT04209465|324446755|FG007|Overall Study|Physician Decision|0|||
94723711|NCT04209465|324446756|FG008|Overall Study|Physician Decision|0|||
94723712|NCT04209465|324446757|FG009|Overall Study|Physician Decision|0|||
94723713|NCT04209465|324446758|FG010|Overall Study|Physician Decision|0|||
94723714|NCT04209465|324446759|FG011|Overall Study|Physician Decision|0|||
94723715|NCT04209465|324446760|FG012|Overall Study|Physician Decision|0|||
94723716|NCT04209465|324446748|FG000|Overall Study|Progressive Disease|0|||
94723717|NCT04209465|324446749|FG001|Overall Study|Progressive Disease|0|||
94723718|NCT04209465|324446750|FG002|Overall Study|Progressive Disease|1|||
94723719|NCT04209465|324446751|FG003|Overall Study|Progressive Disease|2|||
94723720|NCT04209465|324446752|FG004|Overall Study|Progressive Disease|8|||
94723721|NCT04209465|324446753|FG005|Overall Study|Progressive Disease|5|||
94723722|NCT04209465|324446754|FG006|Overall Study|Progressive Disease|3|||
94723723|NCT04209465|324446755|FG007|Overall Study|Progressive Disease|4|||
94723724|NCT04209465|324446756|FG008|Overall Study|Progressive Disease|1|||
94723725|NCT04209465|324446757|FG009|Overall Study|Progressive Disease|3|||
94723726|NCT04209465|324446758|FG010|Overall Study|Progressive Disease|2|||
94723727|NCT04209465|324446759|FG011|Overall Study|Progressive Disease|1|||
94723728|NCT04209465|324446760|FG012|Overall Study|Progressive Disease|0|||
94723729|NCT04209465|324446748|FG000|Overall Study|Withdrawal by Subject|0|||
94723730|NCT04209465|324446749|FG001|Overall Study|Withdrawal by Subject|0|||
94723731|NCT04209465|324446750|FG002|Overall Study|Withdrawal by Subject|0|||
94723732|NCT04209465|324446751|FG003|Overall Study|Withdrawal by Subject|0|||
94723733|NCT04209465|324446752|FG004|Overall Study|Withdrawal by Subject|0|||
94723734|NCT04209465|324446753|FG005|Overall Study|Withdrawal by Subject|1|||
94723735|NCT04209465|324446754|FG006|Overall Study|Withdrawal by Subject|2|||
94723736|NCT04209465|324446755|FG007|Overall Study|Withdrawal by Subject|0|||
94723737|NCT04209465|324446756|FG008|Overall Study|Withdrawal by Subject|1|||
94723738|NCT04209465|324446757|FG009|Overall Study|Withdrawal by Subject|0|||
94723739|NCT04209465|324446758|FG010|Overall Study|Withdrawal by Subject|0|||
94723740|NCT04209465|324446759|FG011|Overall Study|Withdrawal by Subject|2|||
94723741|NCT04209465|324446760|FG012|Overall Study|Withdrawal by Subject|2|||
94723742|NCT04209465|324446748|FG000|Overall Study|Lost to Follow-up|0|||
94723743|NCT04209465|324446749|FG001|Overall Study|Lost to Follow-up|0|||
94723744|NCT04209465|324446750|FG002|Overall Study|Lost to Follow-up|0|||
94723745|NCT04209465|324446751|FG003|Overall Study|Lost to Follow-up|0|||
94723746|NCT04209465|324446752|FG004|Overall Study|Lost to Follow-up|0|||
94723747|NCT04209465|324446753|FG005|Overall Study|Lost to Follow-up|1|||
94723748|NCT04209465|324446754|FG006|Overall Study|Lost to Follow-up|0|||
94723749|NCT04209465|324446755|FG007|Overall Study|Lost to Follow-up|0|||
94723750|NCT04209465|324446756|FG008|Overall Study|Lost to Follow-up|1|||
94723751|NCT04209465|324446757|FG009|Overall Study|Lost to Follow-up|0|||
94723752|NCT04209465|324446758|FG010|Overall Study|Lost to Follow-up|0|||
94723753|NCT04209465|324446759|FG011|Overall Study|Lost to Follow-up|1|||
94723754|NCT04209465|324446760|FG012|Overall Study|Lost to Follow-up|0|||
94723755|NCT04209465|324446748|FG000|Overall Study|Started new therapy|0|||
94723756|NCT04209465|324446749|FG001|Overall Study|Started new therapy|0|||
94723757|NCT04209465|324446750|FG002|Overall Study|Started new therapy|0|||
94723758|NCT04209465|324446751|FG003|Overall Study|Started new therapy|0|||
94723759|NCT04209465|324446752|FG004|Overall Study|Started new therapy|0|||
94723760|NCT04209465|324446753|FG005|Overall Study|Started new therapy|1|||
94272548|NCT03021499|322790458|FG001|Overall Study|Lack of Efficacy|1|||
94272549|NCT03021499|322790457|FG000|Overall Study|Lost to Follow-up|1|||
94272550|NCT03021499|322790458|FG001|Overall Study|Lost to Follow-up|3|||
94272551|NCT03021499|322790457|FG000|Overall Study|Physician Decision|2|||
94272552|NCT03021499|322790458|FG001|Overall Study|Physician Decision|3|||
94272553|NCT03021499|322790457|FG000|Overall Study|Pregnancy|1|||
94272554|NCT03021499|322790458|FG001|Overall Study|Pregnancy|0|||
94467346|NCT04299048|323500523|FG000|Overall Study|Death|1|||
94723761|NCT04209465|324446754|FG006|Overall Study|Started new therapy|0|||
94723762|NCT04209465|324446755|FG007|Overall Study|Started new therapy|0|||
94723763|NCT04209465|324446756|FG008|Overall Study|Started new therapy|0|||
94723764|NCT04209465|324446757|FG009|Overall Study|Started new therapy|0|||
94723765|NCT04209465|324446758|FG010|Overall Study|Started new therapy|0|||
94723766|NCT04209465|324446759|FG011|Overall Study|Started new therapy|0|||
94723767|NCT04209465|324446760|FG012|Overall Study|Started new therapy|0|||
94723768|NCT04209465|324446748|FG000|Overall Study|Study terminated early by sponsor|0|||
94723769|NCT04209465|324446749|FG001|Overall Study|Study terminated early by sponsor|0|||
94723770|NCT04209465|324446750|FG002|Overall Study|Study terminated early by sponsor|0|||
94723771|NCT04209465|324446751|FG003|Overall Study|Study terminated early by sponsor|0|||
94723772|NCT04209465|324446752|FG004|Overall Study|Study terminated early by sponsor|0|||
94272555|NCT03021499|322790457|FG000|Overall Study|Withdrawal by Subject|7|||
94272556|NCT03021499|322790458|FG001|Overall Study|Withdrawal by Subject|14|||
94723773|NCT04209465|324446753|FG005|Overall Study|Study terminated early by sponsor|0|||
94723774|NCT04209465|324446754|FG006|Overall Study|Study terminated early by sponsor|3|||
94723775|NCT04209465|324446755|FG007|Overall Study|Study terminated early by sponsor|0|||
94723776|NCT04209465|324446756|FG008|Overall Study|Study terminated early by sponsor|0|||
94723777|NCT04209465|324446757|FG009|Overall Study|Study terminated early by sponsor|0|||
94723778|NCT04209465|324446758|FG010|Overall Study|Study terminated early by sponsor|0|||
94723779|NCT04209465|324446759|FG011|Overall Study|Study terminated early by sponsor|0|||
94723780|NCT04209465|324446760|FG012|Overall Study|Study terminated early by sponsor|3|||
94723781|NCT04209465|324446748|FG000|Overall Study|Other|0|||
94723782|NCT04209465|324446749|FG001|Overall Study|Other|0|||
94723783|NCT04209465|324446750|FG002|Overall Study|Other|0|||
94723784|NCT04209465|324446751|FG003|Overall Study|Other|0|||
94723785|NCT04209465|324446752|FG004|Overall Study|Other|0|||
94723786|NCT04209465|324446753|FG005|Overall Study|Other|0|||
94723787|NCT04209465|324446754|FG006|Overall Study|Other|0|||
94272557|NCT03021499|322790457|FG000|Overall Study|Prohibited medication required|1|||
94272558|NCT03021499|322790458|FG001|Overall Study|Prohibited medication required|0|||
94272559|NCT03021499|322790457|FG000|Overall Study|Protocol non-compliance|1|||
94272560|NCT03021499|322790458|FG001|Overall Study|Protocol non-compliance|1|||
94723788|NCT04209465|324446755|FG007|Overall Study|Other|0|||
94723789|NCT04209465|324446756|FG008|Overall Study|Other|1|||
94723790|NCT04209465|324446757|FG009|Overall Study|Other|0|||
94272561|NCT03021499|322790457|FG000|Overall Study|None of the above|0|||
94272562|NCT03021499|322790458|FG001|Overall Study|None of the above|4|||
94272563|NCT03021499|322790457|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
94272564|NCT03021499|322790458|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
94272565|NCT00528021|322790465|FG000|Overall Study|Lack of Efficacy|17|||
94272566|NCT00528021|322790466|FG001|Overall Study|Lack of Efficacy|13|||
94272567|NCT00528021|322790467|FG002|Overall Study|Lack of Efficacy|7|||
94272568|NCT00528021|322790468|FG003|Overall Study|Lack of Efficacy|9|||
94272569|NCT05054114|322790472|FG000|Overall Study|Protocol Violation|13|||
94272570|NCT05054114|322790473|FG001|Overall Study|Protocol Violation|1|||
94272571|NCT05054114|322790472|FG000|Overall Study|Pregnancy|0|||
94272572|NCT05054114|322790473|FG001|Overall Study|Pregnancy|1|||
94272573|NCT02186847|322790476|FG000|Overall Study|Protocol Violation|3|||
94272574|NCT02186847|322790477|FG001|Overall Study|Protocol Violation|0|||
94272575|NCT00885703|322791640|FG000|Overall Study|Death|9|||
94272576|NCT00885703|322791641|FG001|Overall Study|Death|7|||
94272577|NCT00885703|322791642|FG002|Overall Study|Death|8|||
94272578|NCT00885703|322791643|FG003|Overall Study|Death|7|||
94272579|NCT00885703|322791644|FG004|Overall Study|Death|7|||
94272580|NCT00885703|322791645|FG005|Overall Study|Death|8|||
94272581|NCT00885703|322791646|FG006|Overall Study|Death|4|||
94272582|NCT00885703|322791640|FG000|Overall Study|Lost to Follow-up|0|||
94272583|NCT00885703|322791641|FG001|Overall Study|Lost to Follow-up|0|||
94272584|NCT00885703|322791642|FG002|Overall Study|Lost to Follow-up|1|||
94368221|NCT04440163|323134863|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
94368222|NCT04440163|323134864|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
94723791|NCT04209465|324446758|FG010|Overall Study|Other|0|||
94723792|NCT04209465|324446759|FG011|Overall Study|Other|0|||
94723793|NCT04209465|324446760|FG012|Overall Study|Other|0|||
94723794|NCT02927769|324448635|FG000|Induction Phase|Study drug toxicity|1|||
94723795|NCT02927769|324448636|FG001|Induction Phase|Study drug toxicity|1|||
94723796|NCT02927769|324448635|FG000|Induction Phase|Disease progression|0|||
94723797|NCT02927769|324448636|FG001|Induction Phase|Disease progression|1|||
94723798|NCT02927769|324448635|FG000|Intensification Phase|Study drug toxicity|1|||
94723799|NCT02927769|324448636|FG001|Intensification Phase|Study drug toxicity|0|||
94723800|NCT05082909|324448637|FG000|Overall Study|Protocol Violation|0|||
94723801|NCT05082909|324448638|FG001|Overall Study|Protocol Violation|0|||
94723802|NCT05082909|324448639|FG002|Overall Study|Protocol Violation|1|||
94723803|NCT05082909|324448640|FG003|Overall Study|Protocol Violation|0|||
94723804|NCT05082909|324448641|FG004|Overall Study|Protocol Violation|0|||
94723805|NCT05082909|324448642|FG005|Overall Study|Protocol Violation|0|||
94723806|NCT02954341|324448645|FG000|Overall Study|Attempted Implant unsuccessful|5|||
94723807|NCT02954341|324448645|FG000|Overall Study|Death|90|||
94723808|NCT02954341|324448645|FG000|Overall Study|Withdrawal by Subject|4|||
94723809|NCT02954341|324448645|FG000|Overall Study|Physician Decision|13|||
94723810|NCT02954341|324448645|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
94723811|NCT02954341|324448645|FG000|Overall Study|Not implanted due to physician's decision|1|||
94723812|NCT02954341|324448645|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
94723813|NCT05273749|324448650|FG000|Overall Study|Adverse Event|14|||
94723814|NCT05273749|324448651|FG001|Overall Study|Adverse Event|8|||
94723815|NCT05273749|324448650|FG000|Overall Study|Lack of Efficacy|2|||
94723816|NCT05273749|324448651|FG001|Overall Study|Lack of Efficacy|8|||
94723817|NCT05273749|324448650|FG000|Overall Study|Physician Decision|0|||
94272585|NCT00885703|322791643|FG003|Overall Study|Lost to Follow-up|0|||
94272586|NCT00885703|322791644|FG004|Overall Study|Lost to Follow-up|0|||
94272587|NCT00885703|322791645|FG005|Overall Study|Lost to Follow-up|1|||
94723818|NCT05273749|324448651|FG001|Overall Study|Physician Decision|2|||
94723819|NCT05273749|324448650|FG000|Overall Study|Withdrawal by Subject|14|||
94723820|NCT05273749|324448651|FG001|Overall Study|Withdrawal by Subject|16|||
94272588|NCT00885703|322791646|FG006|Overall Study|Lost to Follow-up|0|||
94272589|NCT00885703|322791640|FG000|Overall Study|Withdrawal by Subject|0|||
94272590|NCT00885703|322791641|FG001|Overall Study|Withdrawal by Subject|0|||
94723821|NCT05273749|324448650|FG000|Overall Study|Lost to Follow-up|10|||
94368223|NCT04440163|323134865|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
94368224|NCT04440163|323134866|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
94368225|NCT04440163|323134867|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
94723822|NCT05273749|324448651|FG001|Overall Study|Lost to Follow-up|10|||
94723823|NCT05273749|324448650|FG000|Overall Study|Pregnancy|1|||
94723824|NCT05273749|324448651|FG001|Overall Study|Pregnancy|0|||
94723825|NCT05273749|324448650|FG000|Overall Study|Non-Compliance|3|||
94723826|NCT05273749|324448651|FG001|Overall Study|Non-Compliance|2|||
94723827|NCT05273749|324448650|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
94723828|NCT05273749|324448651|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
94723829|NCT02312557|324448656|FG000|Overall Study|Survival follow-up|4|||
94723830|NCT04237298|324448657|FG000|Overall Study|Lost to Follow-up|4|||
94723831|NCT04237298|324448658|FG001|Overall Study|Lost to Follow-up|5|||
94723832|NCT04318548|324448659|FG000|Overall Study|Adverse Event|0|||
94723833|NCT04318548|324448660|FG001|Overall Study|Adverse Event|0|||
94723834|NCT04318548|324448661|FG002|Overall Study|Adverse Event|1|||
94368226|NCT04440163|323134860|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
94368227|NCT04440163|323134861|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
94723835|NCT04318548|324448659|FG000|Overall Study|Lost to Follow-up|6|||
94723836|NCT04318548|324448660|FG001|Overall Study|Lost to Follow-up|13|||
94723837|NCT04318548|324448661|FG002|Overall Study|Lost to Follow-up|9|||
94723838|NCT04318548|324448659|FG000|Overall Study|Protocol Violation|1|||
94723839|NCT04318548|324448660|FG001|Overall Study|Protocol Violation|0|||
94723840|NCT04318548|324448661|FG002|Overall Study|Protocol Violation|2|||
94723841|NCT04318548|324448659|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
94723842|NCT04318548|324448660|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
94723843|NCT04318548|324448661|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
94723844|NCT04318548|324448659|FG000|Overall Study|Migrated / moved from the study area|0|||
94723845|NCT04318548|324448660|FG001|Overall Study|Migrated / moved from the study area|0|||
94723846|NCT04318548|324448661|FG002|Overall Study|Migrated / moved from the study area|1|||
94723847|NCT04318548|324448659|FG000|Overall Study|Other|1|||
94723848|NCT04318548|324448660|FG001|Overall Study|Other|2|||
94723849|NCT04318548|324448661|FG002|Overall Study|Other|3|||
94723850|NCT05247489|324448662|FG000|Overall Study|Lost to Follow-up|5|||
94723851|NCT05247489|324448663|FG001|Overall Study|Lost to Follow-up|1|||
94723852|NCT05247489|324448662|FG000|Overall Study|Withdrawal by Subject|6|||
94723853|NCT05247489|324448663|FG001|Overall Study|Withdrawal by Subject|7|||
94723854|NCT05247489|324448662|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
94723855|NCT05247489|324448663|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
94723856|NCT05247489|324448662|FG000|Overall Study|Left Country|1|||
94723857|NCT05247489|324448663|FG001|Overall Study|Left Country|0|||
94723858|NCT05247489|324448662|FG000|Overall Study|Noncompliance with Investigational Product|1|||
94723859|NCT05247489|324448663|FG001|Overall Study|Noncompliance with Investigational Product|0|||
94723860|NCT05247489|324448662|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
94723861|NCT05247489|324448663|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
94723862|NCT03771898|324448664|FG000|Overall Study|Adverse Event|1|||
94723863|NCT03771898|324448665|FG001|Overall Study|Adverse Event|0|||
94723864|NCT03771898|324448666|FG002|Overall Study|Adverse Event|0|||
94723865|NCT03771898|324448667|FG003|Overall Study|Adverse Event|0|||
94723866|NCT03771898|324448668|FG004|Overall Study|Adverse Event|0|||
94723867|NCT03771898|324448664|FG000|Overall Study|Lost to Follow-up|1|||
94723868|NCT03771898|324448665|FG001|Overall Study|Lost to Follow-up|1|||
94723869|NCT03771898|324448666|FG002|Overall Study|Lost to Follow-up|1|||
94723870|NCT03771898|324448667|FG003|Overall Study|Lost to Follow-up|0|||
94723871|NCT03771898|324448668|FG004|Overall Study|Lost to Follow-up|0|||
94723872|NCT03771898|324448664|FG000|Overall Study|Withdrawal by parent/guardian|1|||
94723873|NCT03771898|324448665|FG001|Overall Study|Withdrawal by parent/guardian|1|||
94723874|NCT03771898|324448666|FG002|Overall Study|Withdrawal by parent/guardian|0|||
94723875|NCT03771898|324448667|FG003|Overall Study|Withdrawal by parent/guardian|0|||
94723876|NCT03771898|324448668|FG004|Overall Study|Withdrawal by parent/guardian|0|||
94723877|NCT03771898|324448664|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
94723878|NCT03771898|324448665|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
94723879|NCT03771898|324448666|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
94723880|NCT03771898|324448667|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
94723881|NCT03771898|324448668|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
94723882|NCT04390048|324448669|FG000|Overall Study|Withdrawal by Subject|1|||
94723883|NCT04390048|324448670|FG001|Overall Study|Withdrawal by Subject|3|||
94723884|NCT01415154|324448671|FG000|Overall Study|Lack of Efficacy|4|||
94723885|NCT01415154|324448672|FG001|Overall Study|Lack of Efficacy|5|||
94723886|NCT01415154|324448671|FG000|Overall Study|Withdrawal by Subject|7|||
94723887|NCT01415154|324448672|FG001|Overall Study|Withdrawal by Subject|8|||
94723888|NCT01415154|324448671|FG000|Overall Study|Lost to Follow-up|1|||
94723889|NCT01415154|324448672|FG001|Overall Study|Lost to Follow-up|4|||
94723890|NCT01415154|324448671|FG000|Overall Study|Protocol Violation|0|||
94723891|NCT01415154|324448672|FG001|Overall Study|Protocol Violation|1|||
94723892|NCT01415154|324448671|FG000|Overall Study|Satisfactory Response|0|||
94723893|NCT01415154|324448672|FG001|Overall Study|Satisfactory Response|1|||
94723894|NCT01415154|324448671|FG000|Overall Study|Adverse Event|1|||
94723895|NCT01415154|324448672|FG001|Overall Study|Adverse Event|1|||
94723896|NCT05956002|324448676|FG000|Treatment Period 3|Adverse Event|0|||
94723897|NCT05956002|324448677|FG001|Treatment Period 3|Adverse Event|0|||
94723898|NCT05956002|324448678|FG002|Treatment Period 3|Adverse Event|1|||
94723899|NCT05956002|324448679|FG003|Treatment Period 3|Adverse Event|0|||
94723900|NCT01261312|324448680|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
94723901|NCT01261312|324448681|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
94723902|NCT01261312|324448682|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
94723903|NCT01261312|324448683|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
94723904|NCT01261312|324448684|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
94723905|NCT01261312|324448685|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
94723906|NCT01261312|324448686|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
94723907|NCT01261312|324448687|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
94723908|NCT01261312|324448688|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
94723909|NCT01261312|324448689|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
94723910|NCT01261312|324448690|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
94723911|NCT01261312|324448691|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
94723912|NCT01261312|324448692|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
94723913|NCT01261312|324448680|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
94723914|NCT01261312|324448681|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
94723915|NCT01261312|324448682|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
94723916|NCT01261312|324448683|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
94723917|NCT01261312|324448684|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
94723918|NCT01261312|324448685|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
94723919|NCT01261312|324448686|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
94723920|NCT01261312|324448687|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
94723921|NCT01261312|324448688|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
94723922|NCT01261312|324448689|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
94723923|NCT01261312|324448690|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
94723924|NCT01261312|324448691|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
94723925|NCT01261312|324448692|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
94723926|NCT01261312|324448680|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
94723927|NCT01261312|324448681|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
94723928|NCT01261312|324448682|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
94723929|NCT01261312|324448683|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
94723930|NCT01261312|324448684|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
94723931|NCT01261312|324448685|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
94723932|NCT01261312|324448686|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
94723933|NCT01261312|324448687|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
94723934|NCT01261312|324448688|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
94723935|NCT01261312|324448689|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
94723936|NCT01261312|324448690|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
94723937|NCT01261312|324448691|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
94723938|NCT01261312|324448692|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
94723939|NCT01261312|324448680|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
94723940|NCT01261312|324448681|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
94723941|NCT01261312|324448682|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
94723942|NCT01261312|324448683|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
94723943|NCT01261312|324448684|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
94723944|NCT01261312|324448685|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
94723945|NCT01261312|324448686|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
94723946|NCT01261312|324448687|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
94723947|NCT01261312|324448688|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
94723948|NCT01261312|324448689|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
94723949|NCT01261312|324448690|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
94723950|NCT01261312|324448691|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
94723951|NCT01261312|324448692|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
94723952|NCT01261312|324448680|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
94723953|NCT01261312|324448681|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
94723954|NCT01261312|324448682|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
94723955|NCT01261312|324448683|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
94723956|NCT01261312|324448684|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
94723957|NCT01261312|324448685|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
94723958|NCT01261312|324448686|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
94723959|NCT01261312|324448687|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
94723960|NCT01261312|324448688|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
94723961|NCT01261312|324448689|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
94723962|NCT01261312|324448690|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
94723963|NCT01261312|324448691|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
94723964|NCT01261312|324448692|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
94723965|NCT01261312|324448680|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
94723966|NCT01261312|324448681|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
94723967|NCT01261312|324448682|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
94723968|NCT01261312|324448683|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
94723969|NCT01261312|324448684|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
94723970|NCT01261312|324448685|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
94723971|NCT01261312|324448686|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
94723972|NCT01261312|324448687|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
94723973|NCT01261312|324448688|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
94723974|NCT01261312|324448689|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
94723975|NCT01261312|324448690|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
94723976|NCT01261312|324448691|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
94723977|NCT01261312|324448692|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
94723978|NCT01261312|324448680|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
94723979|NCT01261312|324448681|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
94723980|NCT01261312|324448682|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
94723981|NCT01261312|324448683|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
94723982|NCT01261312|324448684|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
94723983|NCT01261312|324448685|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
94723984|NCT01261312|324448686|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
94723985|NCT01261312|324448687|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
94723986|NCT01261312|324448688|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
94723987|NCT01261312|324448689|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
94723988|NCT01261312|324448690|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
94723989|NCT01261312|324448691|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
94723990|NCT01261312|324448692|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
94723991|NCT01261312|324448680|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
94723992|NCT01261312|324448681|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
94723993|NCT01261312|324448682|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
94723994|NCT01261312|324448683|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
94723995|NCT01261312|324448684|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
94723996|NCT01261312|324448685|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
94723997|NCT01261312|324448686|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
94723998|NCT01261312|324448687|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
94723999|NCT01261312|324448688|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
94724000|NCT01261312|324448689|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
94724001|NCT01261312|324448690|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
94724002|NCT01261312|324448691|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
94724003|NCT01261312|324448692|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
94724004|NCT01261312|324448680|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
94724005|NCT01261312|324448681|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
94724006|NCT01261312|324448682|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
94368228|NCT04440163|323134862|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
94724007|NCT01261312|324448683|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
94724008|NCT01261312|324448684|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
94724009|NCT01261312|324448685|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
94724010|NCT01261312|324448686|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
94724011|NCT01261312|324448687|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
94724012|NCT01261312|324448688|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
94724013|NCT01261312|324448689|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
94724014|NCT01261312|324448690|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
94724015|NCT01261312|324448691|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
94724016|NCT01261312|324448692|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
94724017|NCT01261312|324448680|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
94724018|NCT01261312|324448681|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
94724019|NCT01261312|324448682|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
94724020|NCT01261312|324448683|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
94724021|NCT01261312|324448684|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
94724022|NCT01261312|324448685|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
94724023|NCT01261312|324448686|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
94724024|NCT01261312|324448687|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
94724025|NCT01261312|324448688|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
94724026|NCT01261312|324448689|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
94724027|NCT01261312|324448690|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
94724028|NCT01261312|324448691|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
94724029|NCT01261312|324448692|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
94724030|NCT01261312|324448680|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
94724031|NCT01261312|324448681|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
94724032|NCT01261312|324448682|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
94724033|NCT01261312|324448683|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
94724034|NCT01261312|324448684|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
94724035|NCT01261312|324448685|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
94724036|NCT01261312|324448686|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
94724037|NCT01261312|324448687|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
94724038|NCT01261312|324448688|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
94724039|NCT01261312|324448689|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
94724040|NCT01261312|324448690|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
94724041|NCT01261312|324448691|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
94724042|NCT01261312|324448692|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
94724043|NCT01261312|324448680|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
94724044|NCT01261312|324448681|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
94724045|NCT01261312|324448682|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
94724046|NCT01261312|324448683|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
94724047|NCT01261312|324448684|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
94724048|NCT01261312|324448685|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
94724049|NCT01261312|324448686|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
94724050|NCT01261312|324448687|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
94724051|NCT01261312|324448688|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
94724052|NCT01261312|324448689|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
94724053|NCT01261312|324448690|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
94724054|NCT01261312|324448691|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
94724055|NCT01261312|324448692|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
94724056|NCT01261312|324448680|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
94724057|NCT01261312|324448681|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
94724058|NCT01261312|324448682|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
94724059|NCT01261312|324448683|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
94724060|NCT01261312|324448684|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
94724061|NCT01261312|324448685|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
94724062|NCT01261312|324448686|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
94724063|NCT01261312|324448687|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
94724064|NCT01261312|324448688|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
94724065|NCT01261312|324448689|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
94724066|NCT01261312|324448690|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
94724067|NCT01261312|324448691|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
94724068|NCT01261312|324448692|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
94272591|NCT00885703|322791642|FG002|Overall Study|Withdrawal by Subject|0|||
94272592|NCT00885703|322791643|FG003|Overall Study|Withdrawal by Subject|1|||
94272593|NCT00885703|322791644|FG004|Overall Study|Withdrawal by Subject|3|||
94272594|NCT00885703|322791645|FG005|Overall Study|Withdrawal by Subject|1|||
94272595|NCT00885703|322791646|FG006|Overall Study|Withdrawal by Subject|1|||
94272596|NCT00885703|322791640|FG000|Overall Study|Ineligible (no CM)|1|||
94272597|NCT00885703|322791641|FG001|Overall Study|Ineligible (no CM)|3|||
94724069|NCT01261312|324448680|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
94272598|NCT00885703|322791642|FG002|Overall Study|Ineligible (no CM)|2|||
94272599|NCT00885703|322791643|FG003|Overall Study|Ineligible (no CM)|1|||
94724070|NCT01261312|324448681|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
94724071|NCT01261312|324448682|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
94724072|NCT01261312|324448683|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
94724073|NCT01261312|324448684|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
94724074|NCT01261312|324448685|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
94724075|NCT01261312|324448686|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
94724076|NCT01261312|324448687|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
94724077|NCT01261312|324448688|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
94724078|NCT01261312|324448689|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
94724079|NCT01261312|324448690|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
94724080|NCT01261312|324448691|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
94724081|NCT01261312|324448692|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
94724082|NCT01261312|324448680|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
94724083|NCT01261312|324448681|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
94724084|NCT01261312|324448682|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
94724085|NCT01261312|324448683|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
94724086|NCT01261312|324448684|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
94724087|NCT01261312|324448685|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
94724088|NCT01261312|324448686|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
94724089|NCT01261312|324448687|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
94724090|NCT01261312|324448688|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
94724091|NCT01261312|324448689|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
94724092|NCT01261312|324448690|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
94724093|NCT01261312|324448691|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
94724094|NCT01261312|324448692|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
94724095|NCT01261312|324448680|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
94724096|NCT01261312|324448681|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
94724097|NCT01261312|324448682|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
94724098|NCT01261312|324448683|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
94724099|NCT01261312|324448684|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
94724100|NCT01261312|324448685|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
94724101|NCT01261312|324448686|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
94724102|NCT01261312|324448687|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
94724103|NCT01261312|324448688|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
94724104|NCT01261312|324448689|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
94272600|NCT00885703|322791644|FG004|Overall Study|Ineligible (no CM)|2|||
94272601|NCT00885703|322791645|FG005|Overall Study|Ineligible (no CM)|3|||
94272602|NCT00885703|322791646|FG006|Overall Study|Ineligible (no CM)|1|||
94272603|NCT00307151|322791648|FG000|Overall Study|Death|4|||
94272604|NCT00307151|322791649|FG001|Overall Study|Death|3|||
94272605|NCT00307151|322791650|FG002|Overall Study|Death|10|||
94272606|NCT00307151|322791651|FG003|Overall Study|Death|3|||
94272607|NCT00307151|322791648|FG000|Overall Study|Severe debilitation, unable to continue|1|||
94272608|NCT00307151|322791649|FG001|Overall Study|Severe debilitation, unable to continue|0|||
94272609|NCT00307151|322791650|FG002|Overall Study|Severe debilitation, unable to continue|0|||
94724105|NCT01261312|324448690|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
94724106|NCT01261312|324448691|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
94724107|NCT01261312|324448692|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
94724108|NCT01261312|324448680|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
94272610|NCT00307151|322791651|FG003|Overall Study|Severe debilitation, unable to continue|0|||
94724109|NCT01261312|324448681|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
94724110|NCT01261312|324448682|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
94724111|NCT01261312|324448683|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
94724112|NCT01261312|324448684|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
94724113|NCT01261312|324448685|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
94724114|NCT01261312|324448686|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
94724115|NCT01261312|324448687|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
94724116|NCT01261312|324448688|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
94724117|NCT01261312|324448689|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
94724118|NCT01261312|324448690|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
94724119|NCT01261312|324448691|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
94724120|NCT01261312|324448692|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
94724121|NCT01261312|324448680|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
94724122|NCT01261312|324448681|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
94724123|NCT01261312|324448682|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
94724124|NCT01261312|324448683|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
94724125|NCT01261312|324448684|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
94724126|NCT01261312|324448685|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
94724127|NCT01261312|324448686|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
94724128|NCT01261312|324448687|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
94724129|NCT01261312|324448688|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
94724130|NCT01261312|324448689|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
94724131|NCT01261312|324448690|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
94724132|NCT01261312|324448691|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
94724133|NCT01261312|324448692|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
94724134|NCT01261312|324448680|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
94724135|NCT01261312|324448681|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
94724136|NCT01261312|324448682|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
94724137|NCT01261312|324448683|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
94724138|NCT01261312|324448684|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
94724139|NCT01261312|324448685|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
94724140|NCT01261312|324448686|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
94724141|NCT01261312|324448687|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
94724142|NCT01261312|324448688|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
94724143|NCT01261312|324448689|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
94724144|NCT01261312|324448690|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
94724145|NCT01261312|324448691|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
94724146|NCT01261312|324448692|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
94724147|NCT01261312|324448680|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
94724148|NCT01261312|324448681|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
94724149|NCT01261312|324448682|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
94724150|NCT01261312|324448683|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
94724151|NCT01261312|324448684|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
94724152|NCT01261312|324448685|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
94724153|NCT01261312|324448686|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
94724154|NCT01261312|324448687|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
94724155|NCT01261312|324448688|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
94724156|NCT01261312|324448689|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
94724157|NCT01261312|324448690|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
94724158|NCT01261312|324448691|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
94724159|NCT01261312|324448692|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
94724160|NCT01261312|324448680|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
94724161|NCT01261312|324448681|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
94724162|NCT01261312|324448682|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
94724163|NCT01261312|324448683|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
94724164|NCT01261312|324448684|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
94724165|NCT01261312|324448685|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
94724166|NCT01261312|324448686|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
94724167|NCT01261312|324448687|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
94724168|NCT01261312|324448688|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
94724169|NCT01261312|324448689|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
94724170|NCT01261312|324448690|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
94724171|NCT01261312|324448691|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
94724172|NCT01261312|324448692|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
94724173|NCT01261312|324448680|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
94724174|NCT01261312|324448681|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
94724175|NCT01261312|324448682|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
94724176|NCT01261312|324448683|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
94724177|NCT01261312|324448684|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
94724178|NCT01261312|324448685|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
94724179|NCT01261312|324448686|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
94724180|NCT01261312|324448687|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
94724181|NCT01261312|324448688|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
94724182|NCT01261312|324448689|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
94724183|NCT01261312|324448690|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
94724184|NCT01261312|324448691|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
94724185|NCT01261312|324448692|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
94724186|NCT01261312|324448680|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
94724187|NCT01261312|324448681|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
94724188|NCT01261312|324448682|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
94724189|NCT01261312|324448683|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
94724190|NCT01261312|324448684|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
94724191|NCT01261312|324448685|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
94724192|NCT01261312|324448686|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
94724193|NCT01261312|324448687|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
94724194|NCT01261312|324448688|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
94724195|NCT01261312|324448689|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
94724196|NCT01261312|324448690|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
94724197|NCT01261312|324448691|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
94724198|NCT01261312|324448692|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
94724199|NCT01261312|324448680|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
94724200|NCT01261312|324448681|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
94724201|NCT01261312|324448682|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
94724202|NCT01261312|324448683|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
94724203|NCT01261312|324448684|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
94724204|NCT01261312|324448685|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
94724205|NCT01261312|324448686|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
94724206|NCT01261312|324448687|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
94724207|NCT01261312|324448688|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
94724208|NCT01261312|324448689|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
94724209|NCT01261312|324448690|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
94724210|NCT01261312|324448691|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
94724211|NCT01261312|324448692|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
94724212|NCT01261312|324448680|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
94724213|NCT01261312|324448681|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
94724214|NCT01261312|324448682|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
94724215|NCT01261312|324448683|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
94724216|NCT01261312|324448684|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
94724217|NCT01261312|324448685|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
94724218|NCT01261312|324448686|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
94724219|NCT01261312|324448687|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
94724220|NCT01261312|324448688|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
94724221|NCT01261312|324448689|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
94724222|NCT01261312|324448690|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
94724223|NCT01261312|324448691|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
94724224|NCT01261312|324448692|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
94724225|NCT01261312|324448680|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
94724226|NCT01261312|324448681|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
94724227|NCT01261312|324448682|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
94724228|NCT01261312|324448683|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
94724229|NCT01261312|324448684|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
94724230|NCT01261312|324448685|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
94724231|NCT01261312|324448686|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
94724232|NCT01261312|324448687|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
94724233|NCT01261312|324448688|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
94724234|NCT01261312|324448689|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
94724235|NCT01261312|324448690|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
94724236|NCT01261312|324448691|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
94724237|NCT01261312|324448692|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
94724238|NCT01261312|324448680|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
94724239|NCT01261312|324448681|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
94724240|NCT01261312|324448682|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
94724241|NCT01261312|324448683|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
94724242|NCT01261312|324448684|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
94724243|NCT01261312|324448685|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
94724244|NCT01261312|324448686|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
94724245|NCT01261312|324448687|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
94724246|NCT01261312|324448688|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
94724247|NCT01261312|324448689|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
94724248|NCT01261312|324448690|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
94724249|NCT01261312|324448691|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
94724250|NCT01261312|324448692|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
94724251|NCT01261312|324448680|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
94724252|NCT01261312|324448681|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
94724253|NCT01261312|324448682|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
94724254|NCT01261312|324448683|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
94724255|NCT01261312|324448684|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
94724256|NCT01261312|324448685|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
94724257|NCT01261312|324448686|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
94724258|NCT01261312|324448687|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
94724259|NCT01261312|324448688|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
94724260|NCT01261312|324448689|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
94724261|NCT01261312|324448690|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
94724262|NCT01261312|324448691|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
94724263|NCT01261312|324448692|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
94724264|NCT04812535|324448693|FG000|Overall Study|Withdrawal by Subject|0|||
94724265|NCT04812535|324448694|FG001|Overall Study|Withdrawal by Subject|0|||
94724266|NCT04812535|324448695|FG002|Overall Study|Withdrawal by Subject|0|||
94724267|NCT04812535|324448696|FG003|Overall Study|Withdrawal by Subject|1|||
94724268|NCT04812535|324448693|FG000|Overall Study|Death|7|||
94724269|NCT04812535|324448694|FG001|Overall Study|Death|2|||
94724270|NCT04812535|324448695|FG002|Overall Study|Death|4|||
94724271|NCT04812535|324448696|FG003|Overall Study|Death|1|||
94724272|NCT04812535|324448693|FG000|Overall Study|Due to premature study termination by sponsor|2|||
94724273|NCT04812535|324448694|FG001|Overall Study|Due to premature study termination by sponsor|0|||
94724274|NCT04812535|324448695|FG002|Overall Study|Due to premature study termination by sponsor|1|||
94724275|NCT04812535|324448696|FG003|Overall Study|Due to premature study termination by sponsor|3|||
94724276|NCT04606771|324448701|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
94724277|NCT04606771|324448702|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
94724278|NCT04606771|324448701|FG000|Overall Study|Death|5|||
94724279|NCT04606771|324448702|FG001|Overall Study|Death|6|||
94724280|NCT04606771|324448701|FG000|Overall Study|Wrong randomisation|0|||
94724281|NCT04606771|324448702|FG001|Overall Study|Wrong randomisation|1|||
94724282|NCT03406871|324448704|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
94724283|NCT03406871|324448705|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
94724284|NCT03406871|324448706|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
94724285|NCT03406871|324448704|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
94724286|NCT03406871|324448705|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
94724287|NCT03406871|324448706|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
94724288|NCT03406871|324448704|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
94724289|NCT03406871|324448705|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
94724290|NCT03406871|324448706|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
94724291|NCT03406871|324448704|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
94724292|NCT03406871|324448705|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
94724293|NCT03406871|324448706|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
94724294|NCT03406871|324448704|FG000|Expansion Cohort(Final Analysis)|Death|0|||
94724295|NCT03406871|324448705|FG001|Expansion Cohort(Final Analysis)|Death|1|||
94724296|NCT03406871|324448706|FG002|Expansion Cohort(Final Analysis)|Death|0|||
94724297|NCT03406871|324448704|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
94724298|NCT03406871|324448705|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
94724299|NCT03406871|324448706|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
94724300|NCT03366649|324448711|FG000|Overall Study|Failed preoperative screening|4|||
94724301|NCT03366649|324448712|FG001|Overall Study|Failed preoperative screening|0|||
94724302|NCT03366649|324448713|FG002|Overall Study|Failed preoperative screening|0|||
94724303|NCT03366649|324448711|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
94724304|NCT03366649|324448712|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
94724305|NCT03366649|324448713|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
94724306|NCT04588298|324448723|FG000|Overall Study|Adverse Event|0|||
94724307|NCT04588298|324448724|FG001|Overall Study|Adverse Event|0|||
94724308|NCT04588298|324448725|FG002|Overall Study|Adverse Event|1|||
94724309|NCT04588298|324448726|FG003|Overall Study|Adverse Event|0|||
94724310|NCT04588298|324448727|FG004|Overall Study|Adverse Event|2|||
94724311|NCT04588298|324448723|FG000|Overall Study|Withdrawal by Subject|1|||
94724312|NCT04588298|324448724|FG001|Overall Study|Withdrawal by Subject|0|||
94724313|NCT04588298|324448725|FG002|Overall Study|Withdrawal by Subject|0|||
94724314|NCT04588298|324448726|FG003|Overall Study|Withdrawal by Subject|1|||
94724315|NCT04588298|324448727|FG004|Overall Study|Withdrawal by Subject|0|||
94724316|NCT03673111|324448729|FG000|Overall Study|Protocol Violation|0|||
94724317|NCT03673111|324448730|FG001|Overall Study|Protocol Violation|0|||
94724318|NCT03673111|324448731|FG002|Overall Study|Protocol Violation|0|||
94724319|NCT03673111|324448732|FG003|Overall Study|Protocol Violation|0|||
94724320|NCT03673111|324448733|FG004|Overall Study|Protocol Violation|0|||
94724321|NCT03673111|324448734|FG005|Overall Study|Protocol Violation|0|||
94724322|NCT03673111|324448735|FG006|Overall Study|Protocol Violation|0|||
94724323|NCT03673111|324448736|FG007|Overall Study|Protocol Violation|0|||
94724324|NCT03673111|324448737|FG008|Overall Study|Protocol Violation|0|||
94724325|NCT03673111|324448738|FG009|Overall Study|Protocol Violation|0|||
94724326|NCT03673111|324448739|FG010|Overall Study|Protocol Violation|1|||
94724327|NCT03673111|324448740|FG011|Overall Study|Protocol Violation|0|||
94724328|NCT03673111|324448741|FG012|Overall Study|Protocol Violation|0|||
94724329|NCT03673111|324448742|FG013|Overall Study|Protocol Violation|0|||
94724330|NCT03673111|324448729|FG000|Overall Study|Adverse Event|1|||
94724331|NCT03673111|324448730|FG001|Overall Study|Adverse Event|0|||
94724332|NCT03673111|324448731|FG002|Overall Study|Adverse Event|0|||
94724333|NCT03673111|324448732|FG003|Overall Study|Adverse Event|0|||
94724334|NCT03673111|324448733|FG004|Overall Study|Adverse Event|0|||
94724335|NCT03673111|324448734|FG005|Overall Study|Adverse Event|0|||
94724336|NCT03673111|324448735|FG006|Overall Study|Adverse Event|0|||
94724337|NCT03673111|324448736|FG007|Overall Study|Adverse Event|0|||
94724338|NCT03673111|324448737|FG008|Overall Study|Adverse Event|0|||
94724339|NCT03673111|324448738|FG009|Overall Study|Adverse Event|0|||
94724340|NCT03673111|324448739|FG010|Overall Study|Adverse Event|0|||
94724341|NCT03673111|324448740|FG011|Overall Study|Adverse Event|0|||
94724342|NCT03673111|324448741|FG012|Overall Study|Adverse Event|0|||
94724343|NCT03673111|324448742|FG013|Overall Study|Adverse Event|0|||
94724344|NCT03846505|324448743|FG000|Treatment Phase|Withdrawal by Subject|9|||
94724345|NCT03846505|324448744|FG001|Treatment Phase|Withdrawal by Subject|11|||
94724346|NCT03846505|324448743|FG000|Treatment Phase|Lost to Follow-up|6|||
94724347|NCT03846505|324448744|FG001|Treatment Phase|Lost to Follow-up|2|||
94724348|NCT03846505|324448743|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
94724349|NCT03846505|324448744|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
94724350|NCT03846505|324448743|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
94724351|NCT03846505|324448744|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
94724352|NCT03834493|324448745|FG000|Overall Study|Participants Ongoing|311|||
94724353|NCT03834493|324448746|FG001|Overall Study|Participants Ongoing|324|||
94724354|NCT03834493|324448745|FG000|Overall Study|Withdrawal by Subject|20|||
94724355|NCT03834493|324448746|FG001|Overall Study|Withdrawal by Subject|17|||
94724356|NCT03834493|324448745|FG000|Overall Study|Physician Decision|1|||
94724357|NCT03834493|324448746|FG001|Overall Study|Physician Decision|0|||
94724358|NCT03834493|324448745|FG000|Overall Study|Death|289|||
94724359|NCT03834493|324448746|FG001|Overall Study|Death|282|||
94724360|NCT02281955|324448750|FG000|Overall Study|Death|1|||
94724361|NCT03792555|324448751|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
94724362|NCT03792555|324448752|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
94724363|NCT03792555|324448753|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
94724364|NCT03792555|324448751|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
94724365|NCT03792555|324448752|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
94724366|NCT03792555|324448753|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
94724367|NCT03792555|324448751|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
94724368|NCT03792555|324448752|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
94724369|NCT03792555|324448753|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
94724370|NCT04005716|324448757|FG000|Overall Study|Death|175|||
94724371|NCT04005716|324448758|FG001|Overall Study|Death|196|||
94724372|NCT04005716|324448757|FG000|Overall Study|Withdrawal by Subject|1|||
94724373|NCT04005716|324448758|FG001|Overall Study|Withdrawal by Subject|6|||
94724374|NCT04005716|324448757|FG000|Overall Study|Lost to Follow-up|2|||
94724375|NCT04005716|324448758|FG001|Overall Study|Lost to Follow-up|2|||
94724376|NCT01744782|324448759|FG000|Overall Study|Death|1|||
94724377|NCT03892616|324448760|FG000|Washout Period 2|Met discontinuation criterion|0|||
94724378|NCT03892616|324448761|FG001|Washout Period 2|Met discontinuation criterion|0|||
94724379|NCT03892616|324448762|FG002|Washout Period 2|Met discontinuation criterion|0|||
94724380|NCT03892616|324448763|FG003|Washout Period 2|Met discontinuation criterion|0|||
94724381|NCT03892616|324448764|FG004|Washout Period 2|Met discontinuation criterion|0|||
94724382|NCT03892616|324448765|FG005|Washout Period 2|Met discontinuation criterion|0|||
94724383|NCT03892616|324448766|FG006|Washout Period 2|Met discontinuation criterion|0|||
94724384|NCT03892616|324448767|FG007|Washout Period 2|Met discontinuation criterion|0|||
94724385|NCT03892616|324448768|FG008|Washout Period 2|Met discontinuation criterion|1|||
94724386|NCT03892616|324448769|FG009|Washout Period 2|Met discontinuation criterion|0|||
94724387|NCT03892616|324448770|FG010|Washout Period 2|Met discontinuation criterion|0|||
94724388|NCT03892616|324448771|FG011|Washout Period 2|Met discontinuation criterion|0|||
94724389|NCT02243709|324448775|FG000|Phase 1|Lost to Follow-up|0|||
94724390|NCT02243709|324448776|FG001|Phase 1|Lost to Follow-up|1|||
94724391|NCT02243709|324448775|FG000|Phase 1|Withdrawal by Subject|1|||
94724392|NCT02243709|324448776|FG001|Phase 1|Withdrawal by Subject|0|||
94724393|NCT02243709|324448775|FG000|Phase 1|Protocol Violation|0|||
94724394|NCT02243709|324448776|FG001|Phase 1|Protocol Violation|1|||
94724395|NCT02243709|324448775|FG000|Phase 1|Adverse Event|0|||
94724396|NCT02243709|324448776|FG001|Phase 1|Adverse Event|1|||
94724397|NCT03443323|324448779|FG000|Overall Study|Lost to Follow-up|2|||
94724398|NCT03443323|324448780|FG001|Overall Study|Lost to Follow-up|2|||
94724399|NCT03443323|324448779|FG000|Overall Study|PI withdrawal|1|||
94724400|NCT03443323|324448780|FG001|Overall Study|PI withdrawal|0|||
94724401|NCT02455557|324448787|FG000|Overall Study|Withdrawal by Subject|2|||
94724402|NCT03707951|324448788|FG000|Overall Study|Lost to Follow-up|8|||
94724403|NCT03707951|324448789|FG001|Overall Study|Lost to Follow-up|17|||
94724404|NCT03707951|324448788|FG000|Overall Study|Withdrawal by Subject|6|||
94724405|NCT03707951|324448789|FG001|Overall Study|Withdrawal by Subject|6|||
94724406|NCT04347161|324448790|FG000|Overall Study|Death|0|||
94724407|NCT04347161|324448791|FG001|Overall Study|Death|2|||
94724408|NCT04347161|324448790|FG000|Overall Study|Withdrawal by Subject|1|||
94724409|NCT04347161|324448791|FG001|Overall Study|Withdrawal by Subject|0|||
94724410|NCT04347161|324448790|FG000|Overall Study|Lost to Follow-up|0|||
94724411|NCT04347161|324448791|FG001|Overall Study|Lost to Follow-up|1|||
94724412|NCT04347161|324448790|FG000|Overall Study|No longer on study medication|1|||
94724413|NCT04347161|324448791|FG001|Overall Study|No longer on study medication|1|||
94724414|NCT01772472|324448798|FG000|Overall Study|Death|56|||
94724415|NCT01772472|324448799|FG001|Overall Study|Death|42|||
94724416|NCT01772472|324448798|FG000|Overall Study|Physician Decision|1|||
94724417|NCT01772472|324448799|FG001|Overall Study|Physician Decision|3|||
94724418|NCT01772472|324448798|FG000|Overall Study|Other|5|||
94724419|NCT01772472|324448799|FG001|Overall Study|Other|5|||
94724420|NCT01772472|324448798|FG000|Overall Study|Lost to Follow-up|12|||
94724421|NCT01772472|324448799|FG001|Overall Study|Lost to Follow-up|8|||
94724422|NCT01772472|324448798|FG000|Overall Study|Withdrawal by Subject|72|||
94724423|NCT01772472|324448799|FG001|Overall Study|Withdrawal by Subject|50|||
94724424|NCT01772472|324448798|FG000|Overall Study|Ongoing|597|||
94724425|NCT01772472|324448799|FG001|Overall Study|Ongoing|635|||
94724426|NCT03611621|324448800|FG000|Overall Study|Graft loss|3|||
94724427|NCT03611621|324448800|FG000|Overall Study|Death|3|||
94724428|NCT03611621|324448800|FG000|Overall Study|Lost to Follow-up|1|||
94724429|NCT02689284|324448802|FG000|Overall Study|Adverse Event|1|||
94724430|NCT02689284|324448803|FG001|Overall Study|Adverse Event|8|||
94724431|NCT02689284|324448802|FG000|Overall Study|Death|0|||
94724432|NCT02689284|324448803|FG001|Overall Study|Death|1|||
94724433|NCT02689284|324448802|FG000|Overall Study|Physician Decision|1|||
94724434|NCT02689284|324448803|FG001|Overall Study|Physician Decision|2|||
94724435|NCT02689284|324448802|FG000|Overall Study|Withdrawal by Subject|0|||
94724436|NCT02689284|324448803|FG001|Overall Study|Withdrawal by Subject|1|||
94724437|NCT02689284|324448802|FG000|Overall Study|progression of cancer|1|||
94724438|NCT02689284|324448803|FG001|Overall Study|progression of cancer|72|||
94724439|NCT02689284|324448802|FG000|Overall Study|decreased heart function|0|||
94724440|NCT02689284|324448803|FG001|Overall Study|decreased heart function|1|||
94724441|NCT02689284|324448802|FG000|Overall Study|concern for anemia|0|||
94724442|NCT02689284|324448803|FG001|Overall Study|concern for anemia|1|||
94724443|NCT02689284|324448802|FG000|Overall Study|no measurable cancer for evaluation|0|||
94724444|NCT02689284|324448803|FG001|Overall Study|no measurable cancer for evaluation|1|||
94724445|NCT02913872|324448806|FG000|Overall Study|Withdrawal by Subject|1|||
94724446|NCT03110315|324448811|FG000|Overall Study|Withdrawal by Subject|1|||
94724447|NCT03110315|324448812|FG001|Overall Study|Withdrawal by Subject|0|||
94724448|NCT05374837|324450447|FG000|Overall Study|Lost to Follow-up|17|||
94724449|NCT05374837|324450448|FG001|Overall Study|Lost to Follow-up|18|||
94724450|NCT03470922|324450450|FG000|Overall Study|Death|107|||
94724451|NCT03470922|324450451|FG001|Overall Study|Death|118|||
94724452|NCT03470922|324450450|FG000|Overall Study|Lost to Follow-up|5|||
94724453|NCT03470922|324450451|FG001|Overall Study|Lost to Follow-up|5|||
94724454|NCT03470922|324450450|FG000|Overall Study|Participant Withdrew Consent|4|||
94724455|NCT03470922|324450451|FG001|Overall Study|Participant Withdrew Consent|9|||
94724456|NCT03470922|324450450|FG000|Overall Study|Other reasons|1|||
94724457|NCT03470922|324450451|FG001|Overall Study|Other reasons|0|||
94724458|NCT03470922|324450450|FG000|Overall Study|Not reported|1|||
94272611|NCT00307151|322791648|FG000|Overall Study|Subject unable to get to clinic|1|||
94272612|NCT00307151|322791649|FG001|Overall Study|Subject unable to get to clinic|0|||
94272613|NCT00307151|322791650|FG002|Overall Study|Subject unable to get to clinic|6|||
94272614|NCT00307151|322791651|FG003|Overall Study|Subject unable to get to clinic|2|||
94724459|NCT03470922|324450451|FG001|Overall Study|Not reported|0|||
94272615|NCT00307151|322791648|FG000|Overall Study|Withdrew consent|0|||
94272616|NCT00307151|322791649|FG001|Overall Study|Withdrew consent|1|||
94272617|NCT00307151|322791650|FG002|Overall Study|Withdrew consent|1|||
94724460|NCT03393975|324450452|FG000|Urgent Treatment Period|Physician Decision|0|||
94724461|NCT03393975|324450453|FG001|Urgent Treatment Period|Physician Decision|0|||
94724462|NCT03393975|324450454|FG002|Urgent Treatment Period|Physician Decision|0|||
94724463|NCT03393975|324450455|FG003|Urgent Treatment Period|Physician Decision|1|||
94724464|NCT03393975|324450452|FG000|Prophylaxis Period 1|Reason not Specified|0|||
94724465|NCT03393975|324450453|FG001|Prophylaxis Period 1|Reason not Specified|1|||
94724466|NCT03393975|324450454|FG002|Prophylaxis Period 1|Reason not Specified|0|||
94724467|NCT03393975|324450455|FG003|Prophylaxis Period 1|Reason not Specified|0|||
94724468|NCT03393975|324450452|FG000|Prophylaxis Period 2|Reason not Specified|0|||
94724469|NCT03393975|324450453|FG001|Prophylaxis Period 2|Reason not Specified|1|||
94724470|NCT03393975|324450454|FG002|Prophylaxis Period 2|Reason not Specified|0|||
94368229|NCT04440163|323134863|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
94368230|NCT04440163|323134864|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
94724471|NCT03393975|324450455|FG003|Prophylaxis Period 2|Reason not Specified|0|||
94724472|NCT04353661|324450456|FG000|Overall Study|Protocol Violation|0|||
94724473|NCT04353661|324450457|FG001|Overall Study|Protocol Violation|0|||
94724474|NCT04353661|324450458|FG002|Overall Study|Protocol Violation|1|||
94724475|NCT04353661|324450456|FG000|Overall Study|Study termination by the Sponsor|1|||
94724476|NCT04353661|324450457|FG001|Overall Study|Study termination by the Sponsor|1|||
94724477|NCT04353661|324450458|FG002|Overall Study|Study termination by the Sponsor|1|||
94724478|NCT03131648|324450459|FG000|Initial Treatment Period|Not dosed|2|||
94724479|NCT03131648|324450460|FG001|Initial Treatment Period|Not dosed|2|||
94724480|NCT03131648|324450461|FG002|Initial Treatment Period|Not dosed|0|||
94724481|NCT03131648|324450462|FG003|Initial Treatment Period|Not dosed|0|||
94724482|NCT03131648|324450463|FG004|Initial Treatment Period|Not dosed|0|||
94724483|NCT03131648|324450464|FG005|Initial Treatment Period|Not dosed|0|||
94724484|NCT03131648|324450465|FG006|Initial Treatment Period|Not dosed|0|||
94724485|NCT03131648|324450466|FG007|Initial Treatment Period|Not dosed|0|||
94724486|NCT03131648|324450459|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
94724487|NCT03131648|324450460|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
94724488|NCT03131648|324450461|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
94724489|NCT03131648|324450462|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
94724490|NCT03131648|324450463|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
94724491|NCT03131648|324450464|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
94724492|NCT03131648|324450465|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
94724493|NCT03131648|324450466|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
94724494|NCT03131648|324450459|FG000|Open-label Treatment|Discontinued IMP|0|||
94724495|NCT03131648|324450460|FG001|Open-label Treatment|Discontinued IMP|0|||
94724496|NCT03131648|324450461|FG002|Open-label Treatment|Discontinued IMP|0|||
94724497|NCT03131648|324450462|FG003|Open-label Treatment|Discontinued IMP|0|||
94724498|NCT03131648|324450463|FG004|Open-label Treatment|Discontinued IMP|0|||
94724499|NCT03131648|324450464|FG005|Open-label Treatment|Discontinued IMP|0|||
94724500|NCT03131648|324450465|FG006|Open-label Treatment|Discontinued IMP|112|||
94272618|NCT00307151|322791651|FG003|Overall Study|Withdrew consent|3|||
94272619|NCT00307151|322791648|FG000|Overall Study|Not willing to adhere to study reqs|2|||
94272620|NCT00307151|322791649|FG001|Overall Study|Not willing to adhere to study reqs|0|||
94272621|NCT00307151|322791650|FG002|Overall Study|Not willing to adhere to study reqs|2|||
94272622|NCT00307151|322791651|FG003|Overall Study|Not willing to adhere to study reqs|2|||
94272623|NCT00307151|322791648|FG000|Overall Study|Clinic unable to contact subject|3|||
94272624|NCT00307151|322791649|FG001|Overall Study|Clinic unable to contact subject|3|||
94272625|NCT00307151|322791650|FG002|Overall Study|Clinic unable to contact subject|1|||
94272626|NCT00307151|322791651|FG003|Overall Study|Clinic unable to contact subject|1|||
94272627|NCT00003535|322791652|FG000|Overall Study|Not evaluable|5|||
94272628|NCT02535715|322791659|FG000|Overall Study|Withdrawal by Subject|0|||
94272629|NCT02535715|322791660|FG001|Overall Study|Withdrawal by Subject|0|||
94272630|NCT02535715|322791661|FG002|Overall Study|Withdrawal by Subject|1|||
94272631|NCT01365039|322791662|FG000|Overall Study|Study related symptoms and complaints|1|||
94272632|NCT01365039|322791663|FG001|Overall Study|Study related symptoms and complaints|0|||
94272633|NCT04353284|322791664|FG000|Overall Study|Adverse Event|1|||
94272634|NCT04353284|322791665|FG001|Overall Study|Adverse Event|1|||
94272635|NCT04353284|322791664|FG000|Overall Study|Lost to Follow-up|1|||
94272636|NCT04353284|322791665|FG001|Overall Study|Lost to Follow-up|0|||
94272637|NCT03807349|322791666|FG000|Overall Study|Early Study Termination|9|||
94272638|NCT00003895|322791667|FG000|Overall Study|Adverse Event|4|||
94272639|NCT00003895|322791668|FG001|Overall Study|Adverse Event|0|||
94272640|NCT00003895|322791667|FG000|Overall Study|Lack of Efficacy|1|||
94368231|NCT04440163|323134865|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
94368232|NCT04440163|323134866|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
94724501|NCT03131648|324450466|FG007|Open-label Treatment|Discontinued IMP|0|||
94724502|NCT03131648|324450459|FG000|Open-label Treatment|Completed Week 50|0|||
94724503|NCT03131648|324450460|FG001|Open-label Treatment|Completed Week 50|0|||
94272641|NCT00003895|322791668|FG001|Overall Study|Lack of Efficacy|1|||
94272642|NCT00003895|322791667|FG000|Overall Study|Patient Vacation|2|||
94724504|NCT03131648|324450461|FG002|Open-label Treatment|Completed Week 50|0|||
94724505|NCT03131648|324450462|FG003|Open-label Treatment|Completed Week 50|0|||
94724506|NCT03131648|324450463|FG004|Open-label Treatment|Completed Week 50|0|||
94724507|NCT03131648|324450464|FG005|Open-label Treatment|Completed Week 50|0|||
94724508|NCT03131648|324450465|FG006|Open-label Treatment|Completed Week 50|6|||
94724509|NCT03131648|324450466|FG007|Open-label Treatment|Completed Week 50|0|||
94724510|NCT03131648|324450459|FG000|Maintenance Treatment Period|Not dosed|0|||
94368233|NCT04440163|323134867|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
94368234|NCT04440163|323134860|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
94368235|NCT04440163|323134861|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
94368236|NCT04440163|323134862|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
94368237|NCT04440163|323134863|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
94368238|NCT04440163|323134864|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
94368239|NCT04440163|323134865|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
94368240|NCT04440163|323134866|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
94368241|NCT04440163|323134867|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
94368242|NCT04440163|323134860|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
94368243|NCT04440163|323134861|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
94368244|NCT04440163|323134862|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
94368245|NCT04440163|323134863|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
94724511|NCT03131648|324450460|FG001|Maintenance Treatment Period|Not dosed|0|||
94724512|NCT03131648|324450461|FG002|Maintenance Treatment Period|Not dosed|3|||
94272643|NCT00003895|322791668|FG001|Overall Study|Patient Vacation|0|||
94272644|NCT00003895|322791667|FG000|Overall Study|Withdrawal by Subject|0|||
94272645|NCT00003895|322791668|FG001|Overall Study|Withdrawal by Subject|3|||
94272646|NCT01375114|322791670|FG000|Overall Study|Lost to Follow-up|1|||
94272647|NCT01375114|322791671|FG001|Overall Study|Lost to Follow-up|0|||
94272648|NCT01375114|322791672|FG002|Overall Study|Lost to Follow-up|1|||
94272649|NCT01375114|322791670|FG000|Overall Study|Disease Progression|3|||
94272650|NCT01375114|322791671|FG001|Overall Study|Disease Progression|2|||
94272651|NCT01375114|322791672|FG002|Overall Study|Disease Progression|2|||
94272652|NCT01375114|322791670|FG000|Overall Study|Patient Changed Mind|0|||
94272653|NCT01375114|322791671|FG001|Overall Study|Patient Changed Mind|0|||
94272654|NCT01375114|322791672|FG002|Overall Study|Patient Changed Mind|2|||
94272655|NCT01375114|322791670|FG000|Overall Study|Pruritus|0|||
94272656|NCT01375114|322791671|FG001|Overall Study|Pruritus|0|||
94272657|NCT01375114|322791672|FG002|Overall Study|Pruritus|1|||
94272658|NCT01375114|322791670|FG000|Overall Study|Restlessness|0|||
94272659|NCT01375114|322791671|FG001|Overall Study|Restlessness|0|||
94272660|NCT01375114|322791672|FG002|Overall Study|Restlessness|1|||
94272661|NCT01375114|322791670|FG000|Overall Study|Diarrhea|0|||
94272662|NCT01375114|322791671|FG001|Overall Study|Diarrhea|0|||
94272663|NCT01375114|322791672|FG002|Overall Study|Diarrhea|1|||
94272664|NCT01375114|322791670|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
94272665|NCT01375114|322791671|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
94272666|NCT01375114|322791672|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
94272667|NCT01375114|322791670|FG000|Overall Study|Nausea|0|||
94272668|NCT01375114|322791671|FG001|Overall Study|Nausea|1|||
94272669|NCT01375114|322791672|FG002|Overall Study|Nausea|0|||
94272670|NCT01375114|322791670|FG000|Overall Study|Increased AST/ALT|0|||
94272671|NCT01375114|322791671|FG001|Overall Study|Increased AST/ALT|1|||
94272672|NCT01375114|322791672|FG002|Overall Study|Increased AST/ALT|0|||
94272673|NCT01375114|322791670|FG000|Overall Study|Vaginal Hemorrhage|0|||
94272674|NCT01375114|322791671|FG001|Overall Study|Vaginal Hemorrhage|1|||
94272675|NCT01375114|322791672|FG002|Overall Study|Vaginal Hemorrhage|0|||
94272676|NCT01375114|322791670|FG000|Overall Study|Family problem|0|||
94272677|NCT01375114|322791671|FG001|Overall Study|Family problem|1|||
94272678|NCT01375114|322791672|FG002|Overall Study|Family problem|0|||
94272679|NCT01375114|322791670|FG000|Overall Study|Protocol Violation|2|||
94272680|NCT01375114|322791671|FG001|Overall Study|Protocol Violation|0|||
94272681|NCT01375114|322791672|FG002|Overall Study|Protocol Violation|0|||
94272682|NCT02349048|322791673|FG000|Overall Study|Withdrawal by Subject|4|||
94272683|NCT02349048|322791674|FG001|Overall Study|Withdrawal by Subject|0|||
94272684|NCT02349048|322791673|FG000|Overall Study|Lost to Follow-up|1|||
94272685|NCT02349048|322791674|FG001|Overall Study|Lost to Follow-up|0|||
94272686|NCT01161043|322791675|FG000|Overall Study|Withdrawal by Subject|3|||
94272687|NCT02113436|322791676|FG000|Period 1: 8 Weeks|Adverse Event|1|||
94272688|NCT02113436|322791677|FG001|Period 1: 8 Weeks|Adverse Event|0|||
94272689|NCT02113436|322791678|FG002|Period 1: 8 Weeks|Adverse Event|0|||
94272690|NCT02113436|322791679|FG003|Period 1: 8 Weeks|Adverse Event|0|||
94272691|NCT02113436|322791676|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
94272692|NCT02113436|322791677|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
94272693|NCT02113436|322791678|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
94272694|NCT02113436|322791679|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
94272695|NCT02113436|322791676|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
94368246|NCT04440163|323134864|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
94368247|NCT04440163|323134865|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
94368248|NCT04440163|323134866|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
94368249|NCT04440163|323134867|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
94368250|NCT04440163|323134860|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
94368251|NCT04440163|323134861|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
94368252|NCT04440163|323134862|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
94368253|NCT04440163|323134863|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
94368254|NCT04440163|323134864|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
94368255|NCT04440163|323134865|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
94368256|NCT04440163|323134866|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
94368257|NCT04440163|323134867|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
94368258|NCT02748616|323134868|FG000|Overall Study|Lost to Follow-up|1|||
94467347|NCT04299048|323500523|FG000|Overall Study|Global deterioration of health status|2|||
94467348|NCT04299048|323500523|FG000|Overall Study|Enrolled and not treated|1|||
94467349|NCT03578146|323500524|FG000|Overall Study|Did Not Receive Treatment|1|||
94467350|NCT03578146|323500525|FG001|Overall Study|Did Not Receive Treatment|0|||
94467351|NCT03578146|323500526|FG002|Overall Study|Did Not Receive Treatment|0|||
94467352|NCT03578146|323500527|FG003|Overall Study|Did Not Receive Treatment|0|||
94467353|NCT03578146|323500528|FG004|Overall Study|Did Not Receive Treatment|0|||
94467354|NCT03578146|323500529|FG005|Overall Study|Did Not Receive Treatment|2|||
94467355|NCT03578146|323500524|FG000|Overall Study|Lost to Follow-up|0|||
94467356|NCT03578146|323500525|FG001|Overall Study|Lost to Follow-up|1|||
94467357|NCT03578146|323500526|FG002|Overall Study|Lost to Follow-up|1|||
94467358|NCT03578146|323500527|FG003|Overall Study|Lost to Follow-up|0|||
94467359|NCT03578146|323500528|FG004|Overall Study|Lost to Follow-up|0|||
94467360|NCT03578146|323500529|FG005|Overall Study|Lost to Follow-up|1|||
94467361|NCT00314132|323500532|FG000|Overall Study|Lost to Follow-up|3|||
94467362|NCT00314132|323500533|FG001|Overall Study|Lost to Follow-up|13|||
94467363|NCT00314132|323500532|FG000|Overall Study|Withdrawal by Subject|3|||
94724513|NCT03131648|324450462|FG003|Maintenance Treatment Period|Not dosed|2|||
94724514|NCT03131648|324450463|FG004|Maintenance Treatment Period|Not dosed|1|||
94724515|NCT03131648|324450464|FG005|Maintenance Treatment Period|Not dosed|0|||
94724516|NCT03131648|324450465|FG006|Maintenance Treatment Period|Not dosed|0|||
94724517|NCT03131648|324450466|FG007|Maintenance Treatment Period|Not dosed|0|||
94724518|NCT03131648|324450459|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
94724519|NCT03131648|324450460|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
94724520|NCT03131648|324450461|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
94724521|NCT03131648|324450462|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
94724522|NCT03131648|324450463|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
94724523|NCT03131648|324450464|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
94724524|NCT03131648|324450465|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
94724525|NCT03131648|324450466|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
94724526|NCT03131648|324450459|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
94724527|NCT03131648|324450460|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
94724528|NCT03131648|324450461|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
94724529|NCT03131648|324450462|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
94724530|NCT03131648|324450463|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
94724531|NCT03131648|324450464|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
94724532|NCT03131648|324450465|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
94724533|NCT03131648|324450466|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
94724534|NCT03131648|324450459|FG000|Maintenance Treatment Period|Completed Week 50|0|||
94724535|NCT03131648|324450460|FG001|Maintenance Treatment Period|Completed Week 50|0|||
94724536|NCT03131648|324450461|FG002|Maintenance Treatment Period|Completed Week 50|0|||
94724537|NCT03131648|324450462|FG003|Maintenance Treatment Period|Completed Week 50|0|||
94724538|NCT03131648|324450463|FG004|Maintenance Treatment Period|Completed Week 50|1|||
94724539|NCT03131648|324450464|FG005|Maintenance Treatment Period|Completed Week 50|0|||
94724540|NCT03131648|324450465|FG006|Maintenance Treatment Period|Completed Week 50|0|||
94724541|NCT03131648|324450466|FG007|Maintenance Treatment Period|Completed Week 50|0|||
94724542|NCT03131648|324450459|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
94724543|NCT03131648|324450460|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
94724544|NCT03131648|324450461|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
94724545|NCT03131648|324450462|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
94724546|NCT03131648|324450463|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
94724547|NCT03131648|324450464|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
94724548|NCT03131648|324450465|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
94467364|NCT00314132|323500533|FG001|Overall Study|Withdrawal by Subject|5|||
94724549|NCT03131648|324450466|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
94724550|NCT04401267|324450467|FG000|Overall Study|Death|0|||
94724551|NCT04401267|324450468|FG001|Overall Study|Death|1|||
94724552|NCT04401267|324450467|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
94724553|NCT04401267|324450468|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
94724554|NCT04401267|324450467|FG000|Overall Study|Found to be Ineligible|1|||
94724555|NCT04401267|324450468|FG001|Overall Study|Found to be Ineligible|0|||
94724556|NCT02995434|324450478|FG000|Overall Study|Adverse Event|1|||
94724557|NCT02995434|324450479|FG001|Overall Study|Adverse Event|0|||
94724558|NCT02995434|324450478|FG000|Overall Study|Withdrawal by Subject|6|||
94724559|NCT02995434|324450479|FG001|Overall Study|Withdrawal by Subject|3|||
94724560|NCT05227209|324450484|FG000|Overall Study|Adverse Event|11|||
94724561|NCT05227209|324450484|FG000|Overall Study|Lost to Follow-up|1|||
94724562|NCT05227209|324450484|FG000|Overall Study|Withdrawal by Subject|7|||
94724563|NCT05227209|324450484|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
94724564|NCT04233879|324450486|FG000|Overall Study|Death|2|||
94724565|NCT04233879|324450487|FG001|Overall Study|Death|0|||
94724566|NCT04233879|324450486|FG000|Overall Study|Lost to Follow-up|3|||
94724567|NCT04233879|324450487|FG001|Overall Study|Lost to Follow-up|8|||
94724568|NCT04233879|324450486|FG000|Overall Study|Physician Decision|4|||
94724569|NCT04233879|324450487|FG001|Overall Study|Physician Decision|4|||
94724570|NCT04233879|324450486|FG000|Overall Study|Withdrawal by Subject|7|||
94724571|NCT04233879|324450487|FG001|Overall Study|Withdrawal by Subject|10|||
94724572|NCT04233879|324450486|FG000|Overall Study|Other|281|||
94272696|NCT02113436|322791677|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
94272697|NCT02113436|322791678|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
94272698|NCT02113436|322791679|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
94272699|NCT02113436|322791676|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
94272700|NCT02113436|322791677|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
94272701|NCT02113436|322791678|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
94272702|NCT02113436|322791679|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
94272703|NCT02113436|322791676|FG000|Period 2: 16 Weeks|Adverse Event|0|||
94272704|NCT02113436|322791677|FG001|Period 2: 16 Weeks|Adverse Event|0|||
94272705|NCT02113436|322791678|FG002|Period 2: 16 Weeks|Adverse Event|4|||
94368259|NCT02748616|323134868|FG000|Overall Study|Withdrawal by Subject|2|||
94368260|NCT02748616|323134868|FG000|Overall Study|Physician Decision|2|||
94368261|NCT02748616|323134868|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
94368262|NCT00068406|323134869|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
94368263|NCT00068406|323134869|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
94368264|NCT00289731|323134870|FG000|Overall Study|Adverse Event|1|||
94368265|NCT00289731|323134871|FG001|Overall Study|Adverse Event|2|||
94368266|NCT00289731|323134872|FG002|Overall Study|Adverse Event|2|||
94368267|NCT00289731|323134870|FG000|Overall Study|Other|1|||
94368268|NCT00289731|323134871|FG001|Overall Study|Other|0|||
94724573|NCT04233879|324450487|FG001|Overall Study|Other|279|||
94724574|NCT02506959|324450491|FG000|Overall Study|Physician Decision|2|||
94724575|NCT02506959|324450492|FG001|Overall Study|Physician Decision|1|||
94724576|NCT05862870|324450498|FG000|Overall Study|Lost to Follow-up|3|||
94368269|NCT00289731|323134872|FG002|Overall Study|Other|0|||
94724577|NCT04556656|324450500|FG000|Overall Study|Withdrawal by Subject|14|||
94724578|NCT04556656|324450501|FG001|Overall Study|Withdrawal by Subject|12|||
94724579|NCT04556656|324450500|FG000|Overall Study|Physician Decision|1|||
94724580|NCT04556656|324450501|FG001|Overall Study|Physician Decision|0|||
94724581|NCT04556656|324450500|FG000|Overall Study|Adverse Event|4|||
94724582|NCT04556656|324450501|FG001|Overall Study|Adverse Event|7|||
94724583|NCT04556656|324450500|FG000|Overall Study|Death|4|||
94724584|NCT04556656|324450501|FG001|Overall Study|Death|0|||
94724585|NCT04556656|324450500|FG000|Overall Study|Lost to Follow-up|3|||
94724586|NCT04556656|324450501|FG001|Overall Study|Lost to Follow-up|2|||
94724587|NCT04556656|324450500|FG000|Overall Study|Not further specified|2|||
94724588|NCT04556656|324450501|FG001|Overall Study|Not further specified|1|||
94724589|NCT03332017|324450505|FG000|Overall Study|Lost to Follow-up|1|||
94724590|NCT03332017|324450506|FG001|Overall Study|Lost to Follow-up|2|||
94724591|NCT03332017|324450505|FG000|Overall Study|Death|17|||
94724592|NCT03332017|324450506|FG001|Overall Study|Death|16|||
94724593|NCT03332017|324450505|FG000|Overall Study|Withdrawal by Subject|6|||
94724594|NCT03332017|324450506|FG001|Overall Study|Withdrawal by Subject|14|||
94724595|NCT03332017|324450505|FG000|Overall Study|Other|1|||
94724596|NCT03332017|324450506|FG001|Overall Study|Other|3|||
94724597|NCT03332017|324450505|FG000|Overall Study|Remained in Study (Ongoing)|47|||
94724598|NCT03332017|324450506|FG001|Overall Study|Remained in Study (Ongoing)|110|||
94724599|NCT01580488|324450511|FG000|Overall Study|Withdrawal by Subject|1|||
94724600|NCT04927065|324450517|FG000|First Booster|Adverse Event|1|||
94724601|NCT04927065|324450518|FG001|First Booster|Adverse Event|0|||
94724602|NCT04927065|324450519|FG002|First Booster|Adverse Event|0|||
94724603|NCT04927065|324450520|FG003|First Booster|Adverse Event|0|||
94724604|NCT04927065|324450521|FG004|First Booster|Adverse Event|0|||
94724605|NCT04927065|324450522|FG005|First Booster|Adverse Event|0|||
94724606|NCT04927065|324450523|FG006|First Booster|Adverse Event|0|||
94724607|NCT04927065|324450524|FG007|First Booster|Adverse Event|1|||
94724608|NCT04927065|324450525|FG008|First Booster|Adverse Event|0|||
94724609|NCT04927065|324450526|FG009|First Booster|Adverse Event|0|||
94724610|NCT04927065|324450527|FG010|First Booster|Adverse Event|0|||
94724611|NCT04927065|324450528|FG011|First Booster|Adverse Event|0|||
94724612|NCT04927065|324450529|FG012|First Booster|Adverse Event|0|||
94724613|NCT04927065|324450530|FG013|First Booster|Adverse Event|0|||
94724614|NCT04927065|324450531|FG014|First Booster|Adverse Event|0|||
94724615|NCT04927065|324450532|FG015|First Booster|Adverse Event|0|||
94724616|NCT04927065|324450517|FG000|First Booster|Death|1|||
94724617|NCT04927065|324450518|FG001|First Booster|Death|0|||
94724618|NCT04927065|324450519|FG002|First Booster|Death|0|||
94724619|NCT04927065|324450520|FG003|First Booster|Death|1|||
94724620|NCT04927065|324450521|FG004|First Booster|Death|0|||
94724621|NCT04927065|324450522|FG005|First Booster|Death|1|||
94724622|NCT04927065|324450523|FG006|First Booster|Death|0|||
94724623|NCT04927065|324450524|FG007|First Booster|Death|0|||
94724624|NCT04927065|324450525|FG008|First Booster|Death|0|||
94724625|NCT04927065|324450526|FG009|First Booster|Death|0|||
94724626|NCT04927065|324450527|FG010|First Booster|Death|0|||
94724627|NCT04927065|324450528|FG011|First Booster|Death|0|||
94724628|NCT04927065|324450529|FG012|First Booster|Death|0|||
94724629|NCT04927065|324450530|FG013|First Booster|Death|0|||
94724630|NCT04927065|324450531|FG014|First Booster|Death|0|||
94724631|NCT04927065|324450532|FG015|First Booster|Death|0|||
94724632|NCT04927065|324450517|FG000|First Booster|Lost to Follow-up|8|||
94724633|NCT04927065|324450518|FG001|First Booster|Lost to Follow-up|20|||
94724634|NCT04927065|324450519|FG002|First Booster|Lost to Follow-up|0|||
94724635|NCT04927065|324450520|FG003|First Booster|Lost to Follow-up|11|||
94724636|NCT04927065|324450521|FG004|First Booster|Lost to Follow-up|43|||
94724637|NCT04927065|324450522|FG005|First Booster|Lost to Follow-up|30|||
94724638|NCT04927065|324450523|FG006|First Booster|Lost to Follow-up|28|||
94724639|NCT04927065|324450524|FG007|First Booster|Lost to Follow-up|23|||
94724640|NCT04927065|324450525|FG008|First Booster|Lost to Follow-up|4|||
94724641|NCT04927065|324450526|FG009|First Booster|Lost to Follow-up|15|||
94724642|NCT04927065|324450527|FG010|First Booster|Lost to Follow-up|0|||
94724643|NCT04927065|324450528|FG011|First Booster|Lost to Follow-up|0|||
94724644|NCT04927065|324450529|FG012|First Booster|Lost to Follow-up|0|||
94724645|NCT04927065|324450530|FG013|First Booster|Lost to Follow-up|0|||
94724646|NCT04927065|324450531|FG014|First Booster|Lost to Follow-up|0|||
94724647|NCT04927065|324450532|FG015|First Booster|Lost to Follow-up|0|||
94724648|NCT04927065|324450517|FG000|First Booster|Physician Decision|1|||
94724649|NCT04927065|324450518|FG001|First Booster|Physician Decision|0|||
94724650|NCT04927065|324450519|FG002|First Booster|Physician Decision|0|||
94724651|NCT04927065|324450520|FG003|First Booster|Physician Decision|3|||
94724652|NCT04927065|324450521|FG004|First Booster|Physician Decision|1|||
94724653|NCT04927065|324450522|FG005|First Booster|Physician Decision|1|||
94724654|NCT04927065|324450523|FG006|First Booster|Physician Decision|0|||
94724655|NCT04927065|324450524|FG007|First Booster|Physician Decision|3|||
94724656|NCT04927065|324450525|FG008|First Booster|Physician Decision|0|||
94724657|NCT04927065|324450526|FG009|First Booster|Physician Decision|0|||
94724658|NCT04927065|324450527|FG010|First Booster|Physician Decision|0|||
94724659|NCT04927065|324450528|FG011|First Booster|Physician Decision|0|||
94724660|NCT04927065|324450529|FG012|First Booster|Physician Decision|0|||
94724661|NCT04927065|324450530|FG013|First Booster|Physician Decision|0|||
94724662|NCT04927065|324450531|FG014|First Booster|Physician Decision|0|||
94724663|NCT04927065|324450532|FG015|First Booster|Physician Decision|0|||
94724664|NCT04927065|324450517|FG000|First Booster|Protocol Violation|4|||
94724665|NCT04927065|324450518|FG001|First Booster|Protocol Violation|4|||
94724666|NCT04927065|324450519|FG002|First Booster|Protocol Violation|0|||
94724667|NCT04927065|324450520|FG003|First Booster|Protocol Violation|3|||
94724668|NCT04927065|324450521|FG004|First Booster|Protocol Violation|0|||
94724669|NCT04927065|324450522|FG005|First Booster|Protocol Violation|0|||
94724670|NCT04927065|324450523|FG006|First Booster|Protocol Violation|0|||
94724671|NCT04927065|324450524|FG007|First Booster|Protocol Violation|2|||
94724672|NCT04927065|324450525|FG008|First Booster|Protocol Violation|0|||
94724673|NCT04927065|324450526|FG009|First Booster|Protocol Violation|0|||
94724674|NCT04927065|324450527|FG010|First Booster|Protocol Violation|0|||
94724675|NCT04927065|324450528|FG011|First Booster|Protocol Violation|0|||
94724676|NCT04927065|324450529|FG012|First Booster|Protocol Violation|0|||
94724677|NCT04927065|324450530|FG013|First Booster|Protocol Violation|0|||
94724678|NCT04927065|324450531|FG014|First Booster|Protocol Violation|0|||
94724679|NCT04927065|324450532|FG015|First Booster|Protocol Violation|0|||
94724680|NCT04927065|324450517|FG000|First Booster|Withdrawal by Subject|8|||
94724681|NCT04927065|324450518|FG001|First Booster|Withdrawal by Subject|23|||
94724682|NCT04927065|324450519|FG002|First Booster|Withdrawal by Subject|0|||
94724683|NCT04927065|324450520|FG003|First Booster|Withdrawal by Subject|19|||
94724684|NCT04927065|324450521|FG004|First Booster|Withdrawal by Subject|20|||
94724685|NCT04927065|324450522|FG005|First Booster|Withdrawal by Subject|15|||
94724686|NCT04927065|324450523|FG006|First Booster|Withdrawal by Subject|6|||
94724687|NCT04927065|324450524|FG007|First Booster|Withdrawal by Subject|24|||
94724688|NCT04927065|324450525|FG008|First Booster|Withdrawal by Subject|0|||
94724689|NCT04927065|324450526|FG009|First Booster|Withdrawal by Subject|4|||
94724690|NCT04927065|324450527|FG010|First Booster|Withdrawal by Subject|0|||
94724691|NCT04927065|324450528|FG011|First Booster|Withdrawal by Subject|0|||
94724692|NCT04927065|324450529|FG012|First Booster|Withdrawal by Subject|0|||
94724693|NCT04927065|324450530|FG013|First Booster|Withdrawal by Subject|0|||
94724694|NCT04927065|324450531|FG014|First Booster|Withdrawal by Subject|0|||
94724695|NCT04927065|324450532|FG015|First Booster|Withdrawal by Subject|0|||
94724696|NCT04927065|324450517|FG000|First Booster|Other Than Specified|1|||
94724697|NCT04927065|324450518|FG001|First Booster|Other Than Specified|1|||
94724698|NCT04927065|324450519|FG002|First Booster|Other Than Specified|0|||
94724699|NCT04927065|324450520|FG003|First Booster|Other Than Specified|1|||
94724700|NCT04927065|324450521|FG004|First Booster|Other Than Specified|2|||
94724701|NCT04927065|324450522|FG005|First Booster|Other Than Specified|3|||
94724702|NCT04927065|324450523|FG006|First Booster|Other Than Specified|2|||
94724703|NCT04927065|324450524|FG007|First Booster|Other Than Specified|6|||
94724704|NCT04927065|324450525|FG008|First Booster|Other Than Specified|0|||
94724705|NCT04927065|324450526|FG009|First Booster|Other Than Specified|4|||
94724706|NCT04927065|324450527|FG010|First Booster|Other Than Specified|0|||
94724707|NCT04927065|324450528|FG011|First Booster|Other Than Specified|0|||
94724708|NCT04927065|324450529|FG012|First Booster|Other Than Specified|0|||
94724709|NCT04927065|324450530|FG013|First Booster|Other Than Specified|0|||
94724710|NCT04927065|324450531|FG014|First Booster|Other Than Specified|0|||
94724711|NCT04927065|324450532|FG015|First Booster|Other Than Specified|0|||
94724712|NCT04927065|324450517|FG000|Second Booster|Death|0|||
94724713|NCT04927065|324450518|FG001|Second Booster|Death|0|||
94724714|NCT04927065|324450519|FG002|Second Booster|Death|0|||
94724715|NCT04927065|324450520|FG003|Second Booster|Death|0|||
94724716|NCT04927065|324450521|FG004|Second Booster|Death|0|||
94724717|NCT04927065|324450522|FG005|Second Booster|Death|0|||
94724718|NCT04927065|324450523|FG006|Second Booster|Death|0|||
94724719|NCT04927065|324450524|FG007|Second Booster|Death|0|||
94724720|NCT04927065|324450525|FG008|Second Booster|Death|0|||
94724721|NCT04927065|324450526|FG009|Second Booster|Death|0|||
94724722|NCT04927065|324450527|FG010|Second Booster|Death|2|||
94724723|NCT04927065|324450528|FG011|Second Booster|Death|0|||
94724724|NCT04927065|324450529|FG012|Second Booster|Death|2|||
94724725|NCT04927065|324450530|FG013|Second Booster|Death|2|||
94724726|NCT04927065|324450531|FG014|Second Booster|Death|0|||
94724727|NCT04927065|324450532|FG015|Second Booster|Death|0|||
94724728|NCT04927065|324450517|FG000|Second Booster|Lost to Follow-up|0|||
94724729|NCT04927065|324450518|FG001|Second Booster|Lost to Follow-up|0|||
94724730|NCT04927065|324450519|FG002|Second Booster|Lost to Follow-up|3|||
94724731|NCT04927065|324450520|FG003|Second Booster|Lost to Follow-up|0|||
94724732|NCT04927065|324450521|FG004|Second Booster|Lost to Follow-up|0|||
94724733|NCT04927065|324450522|FG005|Second Booster|Lost to Follow-up|0|||
94724734|NCT04927065|324450523|FG006|Second Booster|Lost to Follow-up|0|||
94724735|NCT04927065|324450524|FG007|Second Booster|Lost to Follow-up|0|||
94724736|NCT04927065|324450525|FG008|Second Booster|Lost to Follow-up|0|||
94724737|NCT04927065|324450526|FG009|Second Booster|Lost to Follow-up|0|||
94724738|NCT04927065|324450527|FG010|Second Booster|Lost to Follow-up|14|||
94724739|NCT04927065|324450528|FG011|Second Booster|Lost to Follow-up|10|||
94724740|NCT04927065|324450529|FG012|Second Booster|Lost to Follow-up|13|||
94724741|NCT04927065|324450530|FG013|Second Booster|Lost to Follow-up|16|||
94724742|NCT04927065|324450531|FG014|Second Booster|Lost to Follow-up|0|||
94724743|NCT04927065|324450532|FG015|Second Booster|Lost to Follow-up|0|||
94724744|NCT04927065|324450517|FG000|Second Booster|Physician Decision|0|||
94724745|NCT04927065|324450518|FG001|Second Booster|Physician Decision|0|||
94724746|NCT04927065|324450519|FG002|Second Booster|Physician Decision|0|||
94724747|NCT04927065|324450520|FG003|Second Booster|Physician Decision|0|||
94724748|NCT04927065|324450521|FG004|Second Booster|Physician Decision|0|||
94724749|NCT04927065|324450522|FG005|Second Booster|Physician Decision|0|||
94724750|NCT04927065|324450523|FG006|Second Booster|Physician Decision|0|||
94724751|NCT04927065|324450524|FG007|Second Booster|Physician Decision|0|||
94724752|NCT04927065|324450525|FG008|Second Booster|Physician Decision|0|||
94724753|NCT04927065|324450526|FG009|Second Booster|Physician Decision|0|||
94724754|NCT04927065|324450527|FG010|Second Booster|Physician Decision|0|||
94724755|NCT04927065|324450528|FG011|Second Booster|Physician Decision|3|||
94724756|NCT04927065|324450529|FG012|Second Booster|Physician Decision|0|||
94724757|NCT04927065|324450530|FG013|Second Booster|Physician Decision|1|||
94724758|NCT04927065|324450531|FG014|Second Booster|Physician Decision|0|||
94724759|NCT04927065|324450532|FG015|Second Booster|Physician Decision|0|||
94724760|NCT04927065|324450517|FG000|Second Booster|Withdrawal by Subject|0|||
94724761|NCT04927065|324450518|FG001|Second Booster|Withdrawal by Subject|0|||
94724762|NCT04927065|324450519|FG002|Second Booster|Withdrawal by Subject|4|||
94724763|NCT04927065|324450520|FG003|Second Booster|Withdrawal by Subject|0|||
94724764|NCT04927065|324450521|FG004|Second Booster|Withdrawal by Subject|0|||
94724765|NCT04927065|324450522|FG005|Second Booster|Withdrawal by Subject|0|||
94724766|NCT04927065|324450523|FG006|Second Booster|Withdrawal by Subject|0|||
94724767|NCT04927065|324450524|FG007|Second Booster|Withdrawal by Subject|0|||
94724768|NCT04927065|324450525|FG008|Second Booster|Withdrawal by Subject|0|||
94724769|NCT04927065|324450526|FG009|Second Booster|Withdrawal by Subject|0|||
94724770|NCT04927065|324450527|FG010|Second Booster|Withdrawal by Subject|3|||
94724771|NCT04927065|324450528|FG011|Second Booster|Withdrawal by Subject|16|||
94724772|NCT04927065|324450529|FG012|Second Booster|Withdrawal by Subject|13|||
94724773|NCT04927065|324450530|FG013|Second Booster|Withdrawal by Subject|9|||
94724774|NCT04927065|324450531|FG014|Second Booster|Withdrawal by Subject|0|||
94724775|NCT04927065|324450532|FG015|Second Booster|Withdrawal by Subject|0|||
94724776|NCT04927065|324450517|FG000|Second Booster|Other Than Specified|0|||
94724777|NCT04927065|324450518|FG001|Second Booster|Other Than Specified|0|||
94724778|NCT04927065|324450519|FG002|Second Booster|Other Than Specified|0|||
94724779|NCT04927065|324450520|FG003|Second Booster|Other Than Specified|0|||
94724780|NCT04927065|324450521|FG004|Second Booster|Other Than Specified|0|||
94724781|NCT04927065|324450522|FG005|Second Booster|Other Than Specified|0|||
94724782|NCT04927065|324450523|FG006|Second Booster|Other Than Specified|0|||
94724783|NCT04927065|324450524|FG007|Second Booster|Other Than Specified|0|||
94724784|NCT04927065|324450525|FG008|Second Booster|Other Than Specified|0|||
94724785|NCT04927065|324450526|FG009|Second Booster|Other Than Specified|0|||
94724786|NCT04927065|324450527|FG010|Second Booster|Other Than Specified|1|||
94724787|NCT04927065|324450528|FG011|Second Booster|Other Than Specified|1|||
94724788|NCT04927065|324450529|FG012|Second Booster|Other Than Specified|4|||
94724789|NCT04927065|324450530|FG013|Second Booster|Other Than Specified|0|||
94724790|NCT04927065|324450531|FG014|Second Booster|Other Than Specified|0|||
94724791|NCT04927065|324450532|FG015|Second Booster|Other Than Specified|0|||
94724792|NCT04927065|324450517|FG000|Third Booster|Lost to Follow-up|0|||
94724793|NCT04927065|324450518|FG001|Third Booster|Lost to Follow-up|0|||
94724794|NCT04927065|324450519|FG002|Third Booster|Lost to Follow-up|0|||
94724795|NCT04927065|324450520|FG003|Third Booster|Lost to Follow-up|0|||
94724796|NCT04927065|324450521|FG004|Third Booster|Lost to Follow-up|0|||
94724797|NCT04927065|324450522|FG005|Third Booster|Lost to Follow-up|0|||
94724798|NCT04927065|324450523|FG006|Third Booster|Lost to Follow-up|0|||
94724799|NCT04927065|324450524|FG007|Third Booster|Lost to Follow-up|0|||
94724800|NCT04927065|324450525|FG008|Third Booster|Lost to Follow-up|0|||
94724801|NCT04927065|324450526|FG009|Third Booster|Lost to Follow-up|0|||
94724802|NCT04927065|324450527|FG010|Third Booster|Lost to Follow-up|0|||
94724803|NCT04927065|324450528|FG011|Third Booster|Lost to Follow-up|0|||
94724804|NCT04927065|324450529|FG012|Third Booster|Lost to Follow-up|0|||
94724805|NCT04927065|324450530|FG013|Third Booster|Lost to Follow-up|0|||
94724806|NCT04927065|324450531|FG014|Third Booster|Lost to Follow-up|0|||
94724807|NCT04927065|324450532|FG015|Third Booster|Lost to Follow-up|1|||
94724808|NCT04927065|324450517|FG000|Third Booster|Withdrawal by Subject|0|||
94724809|NCT04927065|324450518|FG001|Third Booster|Withdrawal by Subject|0|||
94724810|NCT04927065|324450519|FG002|Third Booster|Withdrawal by Subject|0|||
94724811|NCT04927065|324450520|FG003|Third Booster|Withdrawal by Subject|0|||
94724812|NCT04927065|324450521|FG004|Third Booster|Withdrawal by Subject|0|||
94724813|NCT04927065|324450522|FG005|Third Booster|Withdrawal by Subject|0|||
94724814|NCT04927065|324450523|FG006|Third Booster|Withdrawal by Subject|0|||
94724815|NCT04927065|324450524|FG007|Third Booster|Withdrawal by Subject|0|||
94724816|NCT04927065|324450525|FG008|Third Booster|Withdrawal by Subject|0|||
94724817|NCT04927065|324450526|FG009|Third Booster|Withdrawal by Subject|0|||
94724818|NCT04927065|324450527|FG010|Third Booster|Withdrawal by Subject|0|||
94368270|NCT03547531|323134873|FG000|Overall Study|not coming in data collection : sick|2|||
94724819|NCT04927065|324450528|FG011|Third Booster|Withdrawal by Subject|0|||
94724820|NCT04927065|324450529|FG012|Third Booster|Withdrawal by Subject|0|||
94724821|NCT04927065|324450530|FG013|Third Booster|Withdrawal by Subject|0|||
94724822|NCT04927065|324450531|FG014|Third Booster|Withdrawal by Subject|0|||
94724823|NCT04927065|324450532|FG015|Third Booster|Withdrawal by Subject|1|||
94724824|NCT03338790|324450533|FG000|Overall Study|Disease Progression|65|||
94724825|NCT03338790|324450534|FG001|Overall Study|Disease Progression|43|||
94724826|NCT03338790|324450535|FG002|Overall Study|Disease Progression|50|||
94724827|NCT03338790|324450536|FG003|Overall Study|Disease Progression|37|||
94724828|NCT03338790|324450533|FG000|Overall Study|Study Drug Toxicity|9|||
94368271|NCT03547531|323134874|FG001|Overall Study|not coming in data collection : sick|2|||
94368272|NCT03547531|323134873|FG000|Overall Study|having family occasion|0|||
94368273|NCT03547531|323134874|FG001|Overall Study|having family occasion|2|||
94368274|NCT03959137|323134881|FG000|Overall Study|Protocol Violation|6|||
94724829|NCT03338790|324450534|FG001|Overall Study|Study Drug Toxicity|8|||
94724830|NCT03338790|324450535|FG002|Overall Study|Study Drug Toxicity|15|||
94724831|NCT03338790|324450536|FG003|Overall Study|Study Drug Toxicity|0|||
94724832|NCT03338790|324450533|FG000|Overall Study|Death|1|||
94724833|NCT03338790|324450534|FG001|Overall Study|Death|1|||
94724834|NCT03338790|324450535|FG002|Overall Study|Death|1|||
94724835|NCT03338790|324450536|FG003|Overall Study|Death|0|||
94724836|NCT03338790|324450533|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
94724837|NCT03338790|324450534|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
94724838|NCT03338790|324450535|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
94724839|NCT03338790|324450536|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
94724840|NCT03338790|324450533|FG000|Overall Study|Participant request to discontinue study treatment|3|||
94724841|NCT03338790|324450534|FG001|Overall Study|Participant request to discontinue study treatment|3|||
94724842|NCT03338790|324450535|FG002|Overall Study|Participant request to discontinue study treatment|2|||
94724843|NCT03338790|324450536|FG003|Overall Study|Participant request to discontinue study treatment|1|||
94724844|NCT03338790|324450533|FG000|Overall Study|Poor/non-compliance|0|||
94724845|NCT03338790|324450534|FG001|Overall Study|Poor/non-compliance|1|||
94724846|NCT03338790|324450535|FG002|Overall Study|Poor/non-compliance|0|||
94724847|NCT03338790|324450536|FG003|Overall Study|Poor/non-compliance|0|||
94724848|NCT03338790|324450533|FG000|Overall Study|Participant withdrew consent|1|||
94724849|NCT03338790|324450534|FG001|Overall Study|Participant withdrew consent|0|||
94724850|NCT03338790|324450535|FG002|Overall Study|Participant withdrew consent|1|||
94724851|NCT03338790|324450536|FG003|Overall Study|Participant withdrew consent|1|||
94724852|NCT03338790|324450533|FG000|Overall Study|Other reasons|0|||
94724853|NCT03338790|324450534|FG001|Overall Study|Other reasons|5|||
94724854|NCT03338790|324450535|FG002|Overall Study|Other reasons|0|||
94724855|NCT03338790|324450536|FG003|Overall Study|Other reasons|2|||
94724856|NCT03338790|324450533|FG000|Overall Study|Not reported|0|||
94724857|NCT03338790|324450534|FG001|Overall Study|Not reported|0|||
94724858|NCT03338790|324450535|FG002|Overall Study|Not reported|1|||
94724859|NCT03338790|324450536|FG003|Overall Study|Not reported|0|||
94724860|NCT03338790|324450533|FG000|Overall Study|Completed treatment period|1|||
94724861|NCT03338790|324450534|FG001|Overall Study|Completed treatment period|2|||
94724862|NCT03338790|324450535|FG002|Overall Study|Completed treatment period|0|||
94724863|NCT03338790|324450536|FG003|Overall Study|Completed treatment period|0|||
94724864|NCT04229992|324450539|FG000|Overall Study|Withdrawal by Subject|0|||
94724865|NCT04229992|324450540|FG001|Overall Study|Withdrawal by Subject|2|||
94724866|NCT04229992|324450541|FG002|Overall Study|Withdrawal by Subject|1|||
94724867|NCT04229992|324450542|FG003|Overall Study|Withdrawal by Subject|1|||
94724868|NCT04229992|324450539|FG000|Overall Study|Adverse Event|1|||
94724869|NCT04229992|324450540|FG001|Overall Study|Adverse Event|1|||
94724870|NCT04229992|324450541|FG002|Overall Study|Adverse Event|3|||
94724871|NCT04229992|324450542|FG003|Overall Study|Adverse Event|1|||
94724872|NCT04229992|324450539|FG000|Overall Study|Lost to Follow-up|0|||
94724873|NCT04229992|324450540|FG001|Overall Study|Lost to Follow-up|0|||
94724874|NCT04229992|324450541|FG002|Overall Study|Lost to Follow-up|0|||
94724875|NCT04229992|324450542|FG003|Overall Study|Lost to Follow-up|1|||
94724876|NCT03907397|324450543|FG000|Overall Study|Lost to Follow-up|0|||
94724877|NCT03907397|324450544|FG001|Overall Study|Lost to Follow-up|1|||
94467365|NCT00314132|323500532|FG000|Overall Study|Adverse Event|1|||
94724878|NCT03907397|324450543|FG000|Overall Study|Physician Decision|2|||
94724879|NCT03907397|324450544|FG001|Overall Study|Physician Decision|1|||
94724880|NCT03907397|324450543|FG000|Overall Study|Withdrawal by Subject|5|||
94724881|NCT03907397|324450544|FG001|Overall Study|Withdrawal by Subject|4|||
94724882|NCT03907397|324450543|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
94724883|NCT03907397|324450544|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
94724884|NCT03924986|324450547|FG000|Overall Study|Death|57|||
94724885|NCT03924986|324450548|FG001|Overall Study|Death|66|||
94724886|NCT03924986|324450547|FG000|Overall Study|Study Concluded by Sponsor|51|||
94724887|NCT03924986|324450548|FG001|Overall Study|Study Concluded by Sponsor|41|||
94724888|NCT03924986|324450547|FG000|Overall Study|Withdrawal by Subject|15|||
94724889|NCT03924986|324450548|FG001|Overall Study|Withdrawal by Subject|20|||
94724890|NCT03924986|324450547|FG000|Overall Study|Lost to Follow-up|7|||
94724891|NCT03924986|324450548|FG001|Overall Study|Lost to Follow-up|5|||
94724892|NCT03924986|324450547|FG000|Overall Study|Miscellaneous|1|||
94724893|NCT03924986|324450548|FG001|Overall Study|Miscellaneous|0|||
94724894|NCT05948670|324450550|FG000|Overall Study|Protocol Violation|6|||
94724895|NCT05948670|324450551|FG001|Overall Study|Protocol Violation|8|||
94724896|NCT05948670|324450550|FG000|Overall Study|Withdrawal by Subject|0|||
94724897|NCT05948670|324450551|FG001|Overall Study|Withdrawal by Subject|1|||
94724898|NCT03039023|324450565|FG000|Overall Study|Withdrawal by Subject|1|||
94724899|NCT03039023|324450566|FG001|Overall Study|Withdrawal by Subject|0|||
94724900|NCT03039023|324450567|FG002|Overall Study|Withdrawal by Subject|1|||
94724901|NCT03039023|324450568|FG003|Overall Study|Withdrawal by Subject|1|||
94724902|NCT03039023|324450569|FG004|Overall Study|Withdrawal by Subject|0|||
94724903|NCT03039023|324450565|FG000|Overall Study|Physician Decision|0|||
94724904|NCT03039023|324450566|FG001|Overall Study|Physician Decision|0|||
94724905|NCT03039023|324450567|FG002|Overall Study|Physician Decision|0|||
94724906|NCT03039023|324450568|FG003|Overall Study|Physician Decision|1|||
94724907|NCT03039023|324450569|FG004|Overall Study|Physician Decision|0|||
94724908|NCT05569252|324450570|FG000|Overall Study|Adverse event (central vision loss)|1|||
94724909|NCT05569252|324450571|FG001|Overall Study|Adverse event (central vision loss)|0|||
94724910|NCT05569252|324450572|FG002|Overall Study|Adverse event (central vision loss)|0|||
94724911|NCT05569252|324450573|FG003|Overall Study|Adverse event (central vision loss)|0|||
94724912|NCT04176965|324450579|FG000|Overall Study|Death|1|||
94724913|NCT04176965|324450580|FG001|Overall Study|Death|2|||
94724914|NCT04176965|324450579|FG000|Overall Study|Lost to Follow-up|10|||
94724915|NCT04176965|324450580|FG001|Overall Study|Lost to Follow-up|2|||
94724916|NCT04176965|324450579|FG000|Overall Study|Withdrawal by Subject|6|||
94724917|NCT04176965|324450580|FG001|Overall Study|Withdrawal by Subject|1|||
94724918|NCT05051124|324450581|FG000|Overall Study|Lost to Follow-up|2|||
94724919|NCT05051124|324450581|FG000|Overall Study|Withdrawal by Subject|1|||
94724920|NCT05051124|324450581|FG000|Overall Study|Residential relocation|2|||
94724921|NCT05051124|324450581|FG000|Overall Study|Death|1|||
94724922|NCT04924660|324450582|FG000|United States|Death|29|||
94724923|NCT04924660|324450583|FG001|United States|Death|32|||
94724924|NCT04924660|324450584|FG002|United States|Death|34|||
94724925|NCT04924660|324450585|FG003|United States|Death|25|||
94724926|NCT04924660|324450586|FG004|United States|Death|26|||
94724927|NCT04924660|324450587|FG005|United States|Death|23|||
94724928|NCT04924660|324450582|FG000|United States|Lost to Follow-up|15|||
94724929|NCT04924660|324450583|FG001|United States|Lost to Follow-up|10|||
94724930|NCT04924660|324450584|FG002|United States|Lost to Follow-up|13|||
94724931|NCT04924660|324450585|FG003|United States|Lost to Follow-up|5|||
94724932|NCT04924660|324450586|FG004|United States|Lost to Follow-up|19|||
94724933|NCT04924660|324450587|FG005|United States|Lost to Follow-up|20|||
94724934|NCT04924660|324450582|FG000|United States|Withdrawal by Subject|8|||
94724935|NCT04924660|324450583|FG001|United States|Withdrawal by Subject|3|||
94724936|NCT04924660|324450584|FG002|United States|Withdrawal by Subject|3|||
94724937|NCT04924660|324450585|FG003|United States|Withdrawal by Subject|3|||
94724938|NCT04924660|324450586|FG004|United States|Withdrawal by Subject|8|||
94724939|NCT04924660|324450587|FG005|United States|Withdrawal by Subject|4|||
94724940|NCT04924660|324450582|FG000|Spain|Death|0|||
94724941|NCT04924660|324450583|FG001|Spain|Death|0|||
94724942|NCT04924660|324450584|FG002|Spain|Death|0|||
94724943|NCT04924660|324450585|FG003|Spain|Death|0|||
94724944|NCT04924660|324450586|FG004|Spain|Death|0|||
94724945|NCT04924660|324450587|FG005|Spain|Death|2|||
94724946|NCT04924660|324450582|FG000|Spain|Lost to Follow-up|0|||
94724947|NCT04924660|324450583|FG001|Spain|Lost to Follow-up|0|||
94724948|NCT04924660|324450584|FG002|Spain|Lost to Follow-up|0|||
94724949|NCT04924660|324450585|FG003|Spain|Lost to Follow-up|0|||
94724950|NCT04924660|324450586|FG004|Spain|Lost to Follow-up|1|||
94724951|NCT04924660|324450587|FG005|Spain|Lost to Follow-up|0|||
94467366|NCT00314132|323500533|FG001|Overall Study|Adverse Event|0|||
94467367|NCT00314132|323500532|FG000|Overall Study|Physician Decision|1|||
94724952|NCT04924660|324450582|FG000|Brazil|Death|0|||
94724953|NCT04924660|324450583|FG001|Brazil|Death|0|||
94724954|NCT04924660|324450584|FG002|Brazil|Death|0|||
94724955|NCT04924660|324450585|FG003|Brazil|Death|0|||
94467368|NCT00314132|323500533|FG001|Overall Study|Physician Decision|0|||
94724956|NCT04924660|324450586|FG004|Brazil|Death|1|||
94724957|NCT04924660|324450587|FG005|Brazil|Death|0|||
94724958|NCT04924660|324450582|FG000|Italy|Lost to Follow-up|0|||
94724959|NCT04924660|324450583|FG001|Italy|Lost to Follow-up|0|||
94724960|NCT04924660|324450584|FG002|Italy|Lost to Follow-up|0|||
94724961|NCT04924660|324450585|FG003|Italy|Lost to Follow-up|0|||
94724962|NCT04924660|324450586|FG004|Italy|Lost to Follow-up|0|||
94724963|NCT04924660|324450587|FG005|Italy|Lost to Follow-up|1|||
94724964|NCT04924660|324450582|FG000|South Africa|Death|0|||
94724965|NCT04924660|324450583|FG001|South Africa|Death|0|||
94724966|NCT04924660|324450584|FG002|South Africa|Death|0|||
94724967|NCT04924660|324450585|FG003|South Africa|Death|0|||
94724968|NCT04924660|324450586|FG004|South Africa|Death|0|||
94724969|NCT04924660|324450587|FG005|South Africa|Death|1|||
94724970|NCT04924660|324450582|FG000|South Africa|Lost to Follow-up|0|||
94724971|NCT04924660|324450583|FG001|South Africa|Lost to Follow-up|0|||
94724972|NCT04924660|324450584|FG002|South Africa|Lost to Follow-up|0|||
94724973|NCT04924660|324450585|FG003|South Africa|Lost to Follow-up|0|||
94724974|NCT04924660|324450586|FG004|South Africa|Lost to Follow-up|0|||
94724975|NCT04924660|324450587|FG005|South Africa|Lost to Follow-up|1|||
94724976|NCT05478499|324450590|FG000|Overall Study|Adverse Event|4|||
94724977|NCT05478499|324450591|FG001|Overall Study|Adverse Event|2|||
94724978|NCT05478499|324450590|FG000|Overall Study|Withdrawal by Subject|3|||
94724979|NCT05478499|324450591|FG001|Overall Study|Withdrawal by Subject|2|||
94724980|NCT05478499|324450590|FG000|Overall Study|Lack of Efficacy|1|||
94724981|NCT05478499|324450591|FG001|Overall Study|Lack of Efficacy|0|||
94724982|NCT05478499|324450590|FG000|Overall Study|Lost to Follow-up|1|||
94724983|NCT05478499|324450591|FG001|Overall Study|Lost to Follow-up|0|||
94724984|NCT05478499|324450590|FG000|Overall Study|Other reasons|0|||
94724985|NCT05478499|324450591|FG001|Overall Study|Other reasons|1|||
94724986|NCT02962895|324450592|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
94724987|NCT02962895|324450593|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
94724988|NCT02962895|324450594|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
94724989|NCT02962895|324450595|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
94724990|NCT02962895|324450596|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
94724991|NCT02962895|324450597|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
94724992|NCT02962895|324450598|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
94724993|NCT02962895|324450592|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
94724994|NCT02962895|324450593|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
94724995|NCT02962895|324450594|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
94467369|NCT03677934|323500534|FG000|Overall Study|Adverse Event|1|||
94272706|NCT02113436|322791679|FG003|Period 2: 16 Weeks|Adverse Event|5|||
94272707|NCT02113436|322791676|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
94272708|NCT02113436|322791677|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
94272709|NCT02113436|322791678|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
94272710|NCT02113436|322791679|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
94272711|NCT02113436|322791676|FG000|Period 2: 16 Weeks|Physician Decision|0|||
94272712|NCT02113436|322791677|FG001|Period 2: 16 Weeks|Physician Decision|0|||
94272713|NCT02113436|322791678|FG002|Period 2: 16 Weeks|Physician Decision|2|||
94272714|NCT02113436|322791679|FG003|Period 2: 16 Weeks|Physician Decision|0|||
94272715|NCT02113436|322791676|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
94272716|NCT02113436|322791677|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
94272717|NCT02113436|322791678|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
94272718|NCT02113436|322791679|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
94272719|NCT02159729|322791682|FG000|Overall Study|Adverse Event|0|||
94272720|NCT02159729|322791683|FG001|Overall Study|Adverse Event|1|||
94272721|NCT02159729|322791682|FG000|Overall Study|Subject's Request|13|||
94272722|NCT02159729|322791683|FG001|Overall Study|Subject's Request|10|||
94272723|NCT02159729|322791682|FG000|Overall Study|Lost to Follow-up|24|||
94272724|NCT02159729|322791683|FG001|Overall Study|Lost to Follow-up|9|||
94272725|NCT02159729|322791682|FG000|Overall Study|Non compliance|2|||
94272726|NCT02159729|322791683|FG001|Overall Study|Non compliance|0|||
94272727|NCT02159729|322791682|FG000|Overall Study|Other Unspecified|3|||
94272728|NCT02159729|322791683|FG001|Overall Study|Other Unspecified|1|||
94272729|NCT02636582|322791684|FG000|Overall Study|Surgical Pathology|1|||
94272730|NCT02636582|322791685|FG001|Overall Study|Surgical Pathology|0|||
94272731|NCT01263483|322791686|FG000|Overall Study|Adverse Event|4|||
94272732|NCT01263483|322791687|FG001|Overall Study|Adverse Event|0|||
94272733|NCT01263483|322791688|FG002|Overall Study|Adverse Event|3|||
94272734|NCT01263483|322791686|FG000|Overall Study|Withdrawal by Subject|1|||
94272735|NCT01263483|322791687|FG001|Overall Study|Withdrawal by Subject|0|||
94272736|NCT01263483|322791688|FG002|Overall Study|Withdrawal by Subject|0|||
94272737|NCT01263483|322791686|FG000|Overall Study|Lack of Efficacy|2|||
94272738|NCT01263483|322791687|FG001|Overall Study|Lack of Efficacy|0|||
94272739|NCT01263483|322791688|FG002|Overall Study|Lack of Efficacy|0|||
94272740|NCT01263483|322791686|FG000|Overall Study|Protocol Violation|0|||
94272741|NCT01263483|322791687|FG001|Overall Study|Protocol Violation|1|||
94272742|NCT01263483|322791688|FG002|Overall Study|Protocol Violation|1|||
94272743|NCT01263483|322791686|FG000|Overall Study|Participant Unavailability|0|||
94272744|NCT01263483|322791687|FG001|Overall Study|Participant Unavailability|1|||
94272745|NCT01263483|322791688|FG002|Overall Study|Participant Unavailability|1|||
94272746|NCT00441974|322791692|FG000|Overall Study|Adverse Event|6|||
94272747|NCT00441974|322791692|FG000|Overall Study|Consent Withdrawn|35|||
94272748|NCT00441974|322791692|FG000|Overall Study|Lost to Follow-up|80|||
94272749|NCT00441974|322791692|FG000|Overall Study|Protocol Violation|7|||
94272750|NCT02576444|322791693|FG000|Overall Study|Death|1|||
94272751|NCT02576444|322791694|FG001|Overall Study|Death|1|||
94272752|NCT02576444|322791695|FG002|Overall Study|Death|0|||
94272753|NCT02576444|322791696|FG003|Overall Study|Death|0|||
94272754|NCT02576444|322791693|FG000|Overall Study|Withdrawal by Subject|0|||
94272755|NCT02576444|322791694|FG001|Overall Study|Withdrawal by Subject|0|||
94272756|NCT02576444|322791695|FG002|Overall Study|Withdrawal by Subject|2|||
94272757|NCT02576444|322791696|FG003|Overall Study|Withdrawal by Subject|0|||
94272758|NCT02576444|322791693|FG000|Overall Study|Adverse Event|0|||
94272759|NCT02576444|322791694|FG001|Overall Study|Adverse Event|0|||
94272760|NCT02576444|322791695|FG002|Overall Study|Adverse Event|1|||
94272761|NCT02576444|322791696|FG003|Overall Study|Adverse Event|0|||
94272762|NCT02576444|322791693|FG000|Overall Study|Physician Decision|0|||
94272763|NCT02576444|322791694|FG001|Overall Study|Physician Decision|0|||
94272764|NCT02576444|322791695|FG002|Overall Study|Physician Decision|1|||
94272765|NCT02576444|322791696|FG003|Overall Study|Physician Decision|0|||
94272766|NCT00454857|322791697|FG000|Overall Study|Withdrawal by Subject|15|||
94272767|NCT00454857|322791697|FG000|Overall Study|Lost to Follow-up|16|||
94272768|NCT00454857|322791697|FG000|Overall Study|Noncompliance|6|||
94272769|NCT00454857|322791697|FG000|Overall Study|Death|5|||
94272770|NCT00454857|322791697|FG000|Overall Study|Other|11|||
94272771|NCT00454857|322791697|FG000|Overall Study|Reason unknown|1|||
94272772|NCT04416555|322791698|FG000|Overall Study|Withdrawal by Subject|0|||
94272773|NCT04416555|322791699|FG001|Overall Study|Withdrawal by Subject|3|||
94272774|NCT01617070|322791708|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
94272775|NCT00117598|322791709|FG000|Prior to Treatment Cross Over|Death|40|||
94272776|NCT00117598|322791710|FG001|Prior to Treatment Cross Over|Death|41|||
94272777|NCT00117598|322791711|FG002|Prior to Treatment Cross Over|Death|37|||
94272778|NCT00117598|322791712|FG003|Prior to Treatment Cross Over|Death|0|||
94272779|NCT00117598|322791713|FG004|Prior to Treatment Cross Over|Death|0|||
94272780|NCT00117598|322791709|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
94272781|NCT00117598|322791710|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
94272782|NCT00117598|322791711|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
94272783|NCT00117598|322791712|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
94272784|NCT00117598|322791713|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
94272785|NCT00117598|322791709|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
94272786|NCT00117598|322791710|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
94272787|NCT00117598|322791711|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
94272788|NCT00117598|322791712|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
94272789|NCT00117598|322791713|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
94272790|NCT00117598|322791709|FG000|Prior to Treatment Cross Over|Other|15|||
94724996|NCT02962895|324450595|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
94724997|NCT02962895|324450596|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
94724998|NCT02962895|324450597|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
94724999|NCT02962895|324450598|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
94725000|NCT02962895|324450592|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
94725001|NCT02962895|324450593|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
94725002|NCT02962895|324450594|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
94725003|NCT02962895|324450595|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
94725004|NCT02962895|324450596|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
94725005|NCT02962895|324450597|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
94725006|NCT02962895|324450598|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
94725007|NCT02962895|324450592|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
94725008|NCT02962895|324450593|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
94725009|NCT02962895|324450594|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
94725010|NCT02962895|324450595|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
94725011|NCT02962895|324450596|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
94725012|NCT02962895|324450597|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
94725013|NCT02962895|324450598|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
94725014|NCT02962895|324450592|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
94725015|NCT02962895|324450593|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
94725016|NCT02962895|324450594|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
94725017|NCT02962895|324450595|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
94725018|NCT02962895|324450596|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
94725019|NCT02962895|324450597|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
94725020|NCT02962895|324450598|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
94725021|NCT02962895|324450592|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
94725022|NCT02962895|324450593|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
94725023|NCT02962895|324450594|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
94725024|NCT02962895|324450595|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
94725025|NCT02962895|324450596|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
94725026|NCT02962895|324450597|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
94725027|NCT02962895|324450598|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
94725028|NCT02962895|324450592|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
94725029|NCT02962895|324450593|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
94725030|NCT02962895|324450594|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
94725031|NCT02962895|324450595|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
94725032|NCT02962895|324450596|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
94725033|NCT02962895|324450597|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
94725034|NCT02962895|324450598|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
94725035|NCT02962895|324450592|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
94725036|NCT02962895|324450593|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
94725037|NCT02962895|324450594|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
94725038|NCT02962895|324450595|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
94725039|NCT02962895|324450596|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
94725040|NCT02962895|324450597|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
94725041|NCT02962895|324450598|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
94725042|NCT02962895|324450592|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
94725043|NCT02962895|324450593|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
94725044|NCT02962895|324450594|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
94272791|NCT00117598|322791710|FG001|Prior to Treatment Cross Over|Other|9|||
94272792|NCT00117598|322791711|FG002|Prior to Treatment Cross Over|Other|9|||
94272793|NCT00117598|322791712|FG003|Prior to Treatment Cross Over|Other|0|||
94272794|NCT00117598|322791713|FG004|Prior to Treatment Cross Over|Other|0|||
94272795|NCT00117598|322791709|FG000|After Treament Cross Over|Death|0|||
94368275|NCT00386100|323134882|FG000|Overall Study|Did not receive study medication|6|||
94368276|NCT00386100|323134883|FG001|Overall Study|Did not receive study medication|4|||
94725045|NCT02962895|324450595|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
94725046|NCT02962895|324450596|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
94725047|NCT02962895|324450597|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
94725048|NCT02962895|324450598|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
94725049|NCT02962895|324450592|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
94725050|NCT02962895|324450593|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
94725051|NCT02962895|324450594|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
94725052|NCT02962895|324450595|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
94725053|NCT02962895|324450596|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
94725054|NCT02962895|324450597|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
94725055|NCT02962895|324450598|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
94725056|NCT02962895|324450592|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
94725057|NCT02962895|324450593|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
94725058|NCT02962895|324450594|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
94725059|NCT02962895|324450595|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
94725060|NCT02962895|324450596|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
94725061|NCT02962895|324450597|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
94725062|NCT02962895|324450598|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
94725063|NCT02962895|324450592|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
94725064|NCT02962895|324450593|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
94725065|NCT02962895|324450594|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
94725066|NCT02962895|324450595|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
94725067|NCT02962895|324450596|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
94725068|NCT02962895|324450597|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
94725069|NCT02962895|324450598|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
94725070|NCT02962895|324450592|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
94725071|NCT02962895|324450593|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
94725072|NCT02962895|324450594|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
94725073|NCT02962895|324450595|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
94725074|NCT02962895|324450596|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
94725075|NCT02962895|324450597|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
94725076|NCT02962895|324450598|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
94725077|NCT02962895|324450592|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
94725078|NCT02962895|324450593|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
94725079|NCT02962895|324450594|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
94725080|NCT02962895|324450595|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
94725081|NCT02962895|324450596|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
94725082|NCT02962895|324450597|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
94725083|NCT02962895|324450598|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
94725084|NCT02979522|324450599|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
94725085|NCT02979522|324450600|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
94725086|NCT02979522|324450599|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
94725087|NCT02979522|324450600|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
94725088|NCT05282173|324450601|FG000|Overall Study|Missed|3|||
94725089|NCT05282173|324450602|FG001|Overall Study|Missed|2|||
94725090|NCT05282173|324450603|FG002|Overall Study|Missed|4|||
94725091|NCT03958955|324452196|FG000|Overall Study|Adverse Event|1|||
94725092|NCT05229120|324452202|FG000|Overall Study|Withdrawal by Subject|8|||
94725093|NCT04806594|324452203|FG000|Overall Study|Withdrawal by Subject|2|||
94725094|NCT04806594|324452203|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
94725095|NCT03615326|324452215|FG000|Overall Study|Death|266|||
94725096|NCT03615326|324452216|FG001|Overall Study|Death|286|||
94725097|NCT03615326|324452217|FG002|Overall Study|Death|14|||
94725098|NCT03615326|324452218|FG003|Overall Study|Death|17|||
94725099|NCT03615326|324452215|FG000|Overall Study|Lost to Follow-up|0|||
94725100|NCT03615326|324452216|FG001|Overall Study|Lost to Follow-up|1|||
94725101|NCT03615326|324452217|FG002|Overall Study|Lost to Follow-up|0|||
94725102|NCT03615326|324452218|FG003|Overall Study|Lost to Follow-up|0|||
94725103|NCT03615326|324452215|FG000|Overall Study|Withdrawal by Subject|1|||
94725104|NCT03615326|324452216|FG001|Overall Study|Withdrawal by Subject|3|||
94725105|NCT03615326|324452217|FG002|Overall Study|Withdrawal by Subject|0|||
94725106|NCT03615326|324452218|FG003|Overall Study|Withdrawal by Subject|0|||
94725107|NCT03615326|324452215|FG000|Overall Study|Participants Ongoing|83|||
94725108|NCT03615326|324452216|FG001|Overall Study|Participants Ongoing|58|||
94725109|NCT03615326|324452217|FG002|Overall Study|Participants Ongoing|6|||
94725110|NCT03615326|324452218|FG003|Overall Study|Participants Ongoing|3|||
94725111|NCT01416831|324452219|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
94725112|NCT01416831|324452220|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
94725113|NCT03436745|324452222|FG000|Overall Study|Ineligible|0|||
94272796|NCT00117598|322791710|FG001|After Treament Cross Over|Death|0|||
94272797|NCT00117598|322791711|FG002|After Treament Cross Over|Death|0|||
94272798|NCT00117598|322791712|FG003|After Treament Cross Over|Death|1|||
94272799|NCT00117598|322791713|FG004|After Treament Cross Over|Death|2|||
94272800|NCT00117598|322791709|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
94272801|NCT00117598|322791710|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
94272802|NCT00117598|322791711|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
94272803|NCT00117598|322791712|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
94368277|NCT00386100|323134882|FG000|Overall Study|Adverse Event|15|||
94368278|NCT00386100|323134883|FG001|Overall Study|Adverse Event|25|||
94368279|NCT00386100|323134882|FG000|Overall Study|Death|0|||
94368280|NCT00386100|323134883|FG001|Overall Study|Death|1|||
94725114|NCT03436745|324452223|FG001|Overall Study|Ineligible|0|||
94725115|NCT03436745|324452224|FG002|Overall Study|Ineligible|1|||
94725116|NCT02783300|324452226|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725117|NCT02783300|324452227|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725118|NCT02783300|324452228|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725119|NCT02783300|324452229|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725120|NCT02783300|324452230|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725121|NCT02783300|324452231|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725122|NCT02783300|324452232|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
94725123|NCT02783300|324452233|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725124|NCT02783300|324452234|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725125|NCT02783300|324452235|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725126|NCT02783300|324452236|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725127|NCT02783300|324452237|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725128|NCT02783300|324452238|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725129|NCT02783300|324452239|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725130|NCT02783300|324452240|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725131|NCT02783300|324452241|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725132|NCT02783300|324452242|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725133|NCT02783300|324452243|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725134|NCT02783300|324452244|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94272804|NCT00117598|322791713|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
94272805|NCT00117598|322791709|FG000|After Treament Cross Over|Other|0|||
94272806|NCT00117598|322791710|FG001|After Treament Cross Over|Other|0|||
94272807|NCT00117598|322791711|FG002|After Treament Cross Over|Other|0|||
94272808|NCT00117598|322791712|FG003|After Treament Cross Over|Other|1|||
94272809|NCT00117598|322791713|FG004|After Treament Cross Over|Other|2|||
94272810|NCT02230384|322791715|FG000|Phase 1|Lost to Follow-up|1|||
94272811|NCT02230384|322791716|FG001|Phase 1|Lost to Follow-up|0|||
94272812|NCT02230384|322791715|FG000|Phase 1|Physician Decision|0|||
94272813|NCT02230384|322791716|FG001|Phase 1|Physician Decision|1|||
94272814|NCT02230384|322791715|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
94272815|NCT02230384|322791716|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
94272816|NCT02230384|322791715|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
94272817|NCT02230384|322791716|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
94272818|NCT02230384|322791715|FG000|Phase 2 - Switch|Adverse Event|2|||
94272819|NCT02230384|322791716|FG001|Phase 2 - Switch|Adverse Event|0|||
94272820|NCT05376215|322791717|FG000|Overall Study|Withdrawal by Subject|2|||
94272821|NCT05376215|322791718|FG001|Overall Study|Withdrawal by Subject|1|||
94272822|NCT05376215|322791717|FG000|Overall Study|Lost to Follow-up|0|||
94272823|NCT05376215|322791718|FG001|Overall Study|Lost to Follow-up|1|||
94272824|NCT01378858|322791720|FG000|Overall Study|Withdrawal by Subject|4|||
94272825|NCT01378858|322791721|FG001|Overall Study|Withdrawal by Subject|4|||
94272826|NCT00545064|322791732|FG000|Overall Study|Lost to Follow-up|3|||
94272827|NCT00545064|322791732|FG000|Overall Study|Withdrawal by Subject|2|||
94272828|NCT00545064|322791732|FG000|Overall Study|did not complete course of treatment|1|||
94272829|NCT00545064|322791732|FG000|Overall Study|cancel all appointments, no rebooking|1|||
94725135|NCT02783300|324452245|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725136|NCT02783300|324452246|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725137|NCT02783300|324452247|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725138|NCT02783300|324452248|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94368281|NCT00386100|323134882|FG000|Overall Study|Insufficient therapeutic effect|30|||
94725139|NCT02783300|324452249|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725140|NCT02783300|324452250|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725141|NCT02783300|324452251|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94272830|NCT00545064|322791732|FG000|Overall Study|inclement weather|1|||
94368282|NCT00386100|323134883|FG001|Overall Study|Insufficient therapeutic effect|6|||
94272831|NCT00501007|322791733|FG000|Overall Study|Inclusion criteria not met.|29|||
94368283|NCT00386100|323134882|FG000|Overall Study|Lost to Follow-up|29|||
94272832|NCT00501007|322791734|FG001|Overall Study|Inclusion criteria not met.|25|||
94368284|NCT00386100|323134883|FG001|Overall Study|Lost to Follow-up|29|||
94272833|NCT02255409|322791735|FG000|Overall Study|Administrative Reason|3|||
94272834|NCT02255409|322791736|FG001|Overall Study|Administrative Reason|7|||
94272835|NCT02255409|322791735|FG000|Overall Study|Withdrawal by Subject|1|||
94272836|NCT02255409|322791736|FG001|Overall Study|Withdrawal by Subject|5|||
94272837|NCT02255409|322791735|FG000|Overall Study|Lost to Follow-up|10|||
94272838|NCT02255409|322791736|FG001|Overall Study|Lost to Follow-up|19|||
94272839|NCT02016820|322791737|FG000|Overall Study|Lost to Follow-up|2|||
94272840|NCT02016820|322791738|FG001|Overall Study|Lost to Follow-up|4|||
94272841|NCT01378104|322791739|FG000|Overall Study|Adverse Event|8|||
94272842|NCT01378104|322791740|FG001|Overall Study|Adverse Event|8|||
94272843|NCT01378104|322791739|FG000|Overall Study|Lack of Efficacy|7|||
94272844|NCT01378104|322791740|FG001|Overall Study|Lack of Efficacy|5|||
94272845|NCT01378104|322791739|FG000|Overall Study|Withdrawal by Subject|12|||
94272846|NCT01378104|322791740|FG001|Overall Study|Withdrawal by Subject|13|||
94272847|NCT03610724|322791741|FG000|Overall Study|Death|17|||
94368285|NCT00386100|323134882|FG000|Overall Study|Non-compliance|18|||
94368286|NCT00386100|323134883|FG001|Overall Study|Non-compliance|19|||
94368287|NCT00386100|323134882|FG000|Overall Study|Protocol Violation|5|||
94368288|NCT00386100|323134883|FG001|Overall Study|Protocol Violation|3|||
94368289|NCT00386100|323134882|FG000|Overall Study|Withdrawal by Subject|32|||
94368290|NCT00386100|323134883|FG001|Overall Study|Withdrawal by Subject|31|||
94368291|NCT00386100|323134882|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
94368292|NCT00386100|323134883|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
94368293|NCT00386100|323134882|FG000|Overall Study|BMD <2.5|1|||
94368294|NCT00386100|323134883|FG001|Overall Study|BMD <2.5|0|||
94368295|NCT00386100|323134882|FG000|Overall Study|Consecutive elevated Hba1C|1|||
94368296|NCT00386100|323134883|FG001|Overall Study|Consecutive elevated Hba1C|0|||
94368297|NCT00386100|323134882|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
94368298|NCT00386100|323134883|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
94368299|NCT00386100|323134882|FG000|Overall Study|Laboratory findings|1|||
94368300|NCT00386100|323134883|FG001|Overall Study|Laboratory findings|0|||
94368301|NCT00386100|323134882|FG000|Overall Study|Participant's concern due to CPK levels|1|||
94368302|NCT00386100|323134883|FG001|Overall Study|Participant's concern due to CPK levels|0|||
94368303|NCT00386100|323134882|FG000|Overall Study|Participant moving out of state|2|||
94368304|NCT00386100|323134883|FG001|Overall Study|Participant moving out of state|0|||
94368305|NCT00386100|323134882|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
94368306|NCT00386100|323134883|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
94368307|NCT00386100|323134882|FG000|Overall Study|Didn't meet entry criteria|1|||
94368308|NCT00386100|323134883|FG001|Overall Study|Didn't meet entry criteria|1|||
94368309|NCT00386100|323134882|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
94368310|NCT00386100|323134883|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
94368311|NCT00386100|323134882|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
94368312|NCT00386100|323134883|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
94368313|NCT00386100|323134882|FG000|Overall Study|Bad metabolic control & patient security|1|||
94368314|NCT00386100|323134883|FG001|Overall Study|Bad metabolic control & patient security|0|||
94368315|NCT00386100|323134882|FG000|Overall Study|Bone loss by DXA bone scan|1|||
94368316|NCT00386100|323134883|FG001|Overall Study|Bone loss by DXA bone scan|0|||
94368317|NCT00386100|323134882|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
94368318|NCT00386100|323134883|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
94368319|NCT00386100|323134882|FG000|Overall Study|7.6% bone loss|1|||
94368320|NCT00386100|323134883|FG001|Overall Study|7.6% bone loss|0|||
94368321|NCT00386100|323134882|FG000|Overall Study|Osteoporosis|0|||
94368322|NCT00386100|323134883|FG001|Overall Study|Osteoporosis|1|||
94368323|NCT00386100|323134882|FG000|Overall Study|Positive pregnancy test|1|||
94368324|NCT00386100|323134883|FG001|Overall Study|Positive pregnancy test|3|||
94368325|NCT00386100|323134882|FG000|Overall Study|Out of country for 5 months|1|||
94368326|NCT00386100|323134883|FG001|Overall Study|Out of country for 5 months|0|||
94368327|NCT00386100|323134882|FG000|Overall Study|Hb1Ac >8%|0|||
94368328|NCT00386100|323134883|FG001|Overall Study|Hb1Ac >8%|1|||
94368329|NCT00386100|323134882|FG000|Overall Study|Participant randomized in error|1|||
94368330|NCT00386100|323134883|FG001|Overall Study|Participant randomized in error|0|||
94368331|NCT00810615|323134884|FG000|Overall Study|Withdrawal by Subject|1|||
94368332|NCT00810615|323134885|FG001|Overall Study|Withdrawal by Subject|1|||
94368333|NCT02525562|323134886|FG000|Overall Study|Death|9|||
94368334|NCT02525562|323134887|FG001|Overall Study|Death|0|||
94467370|NCT03677934|323500535|FG001|Overall Study|Adverse Event|1|||
94467371|NCT03677934|323500534|FG000|Overall Study|Death|8|||
94725142|NCT02783300|324452252|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
94725143|NCT02783300|324452226|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725144|NCT02783300|324452227|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725145|NCT02783300|324452228|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725146|NCT02783300|324452229|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
94725147|NCT02783300|324452230|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725148|NCT02783300|324452231|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725149|NCT02783300|324452232|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725150|NCT02783300|324452233|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725151|NCT02783300|324452234|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725152|NCT02783300|324452235|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725153|NCT02783300|324452236|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94368335|NCT02525562|323134888|FG002|Overall Study|Death|0|||
94368336|NCT02525562|323134886|FG000|Overall Study|Lost to Follow-up|19|||
94368337|NCT02525562|323134887|FG001|Overall Study|Lost to Follow-up|0|||
94368338|NCT02525562|323134888|FG002|Overall Study|Lost to Follow-up|0|||
94368339|NCT02525562|323134886|FG000|Overall Study|Withdrawal by Subject|37|||
94368340|NCT02525562|323134887|FG001|Overall Study|Withdrawal by Subject|0|||
94368341|NCT02525562|323134888|FG002|Overall Study|Withdrawal by Subject|0|||
94368342|NCT02525562|323134886|FG000|Overall Study|Revision/Removal of Study Device|4|||
94368343|NCT02525562|323134887|FG001|Overall Study|Revision/Removal of Study Device|0|||
94467372|NCT03677934|323500535|FG001|Overall Study|Death|4|||
94725154|NCT02783300|324452237|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725155|NCT02783300|324452238|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725156|NCT02783300|324452239|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725157|NCT02783300|324452240|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725158|NCT02783300|324452241|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725159|NCT02783300|324452242|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725160|NCT02783300|324452243|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725161|NCT02783300|324452244|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725162|NCT02783300|324452245|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725163|NCT02783300|324452246|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725164|NCT02783300|324452247|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725165|NCT02783300|324452248|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725166|NCT02783300|324452249|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725167|NCT02783300|324452250|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725168|NCT02783300|324452251|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725169|NCT02783300|324452252|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
94725170|NCT02783300|324452226|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
94725171|NCT02783300|324452227|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
94725172|NCT02783300|324452228|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
94725173|NCT02783300|324452229|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
94725174|NCT02783300|324452230|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
94725175|NCT02783300|324452231|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
94725176|NCT02783300|324452232|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
94725177|NCT02783300|324452233|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
94725178|NCT02783300|324452234|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
94725179|NCT02783300|324452235|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
94725180|NCT02783300|324452236|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
94725181|NCT02783300|324452237|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
94725182|NCT02783300|324452238|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
94725183|NCT02783300|324452239|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
94725184|NCT02783300|324452240|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
94725185|NCT02783300|324452241|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
94725186|NCT02783300|324452242|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
94725187|NCT02783300|324452243|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
94725188|NCT02783300|324452244|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
94725189|NCT02783300|324452245|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
94725190|NCT02783300|324452246|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
94725191|NCT02783300|324452247|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
94725192|NCT02783300|324452248|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
94725193|NCT02783300|324452249|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
94725194|NCT02783300|324452250|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
94725195|NCT02783300|324452251|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
94725196|NCT02783300|324452252|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
94725197|NCT02783300|324452226|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725198|NCT02783300|324452227|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725199|NCT02783300|324452228|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725200|NCT02783300|324452229|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725201|NCT02783300|324452230|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725202|NCT02783300|324452231|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725203|NCT02783300|324452232|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
94725204|NCT02783300|324452233|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725205|NCT02783300|324452234|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725206|NCT02783300|324452235|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725207|NCT02783300|324452236|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725208|NCT02783300|324452237|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725209|NCT02783300|324452238|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
94725210|NCT02783300|324452239|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725211|NCT02783300|324452240|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725212|NCT02783300|324452241|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725213|NCT02783300|324452242|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725214|NCT02783300|324452243|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725215|NCT02783300|324452244|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725216|NCT02783300|324452245|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725217|NCT02783300|324452246|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725218|NCT02783300|324452247|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725219|NCT02783300|324452248|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725220|NCT02783300|324452249|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725221|NCT02783300|324452250|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725222|NCT02783300|324452251|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725223|NCT02783300|324452252|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
94725224|NCT02783300|324452226|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725225|NCT02783300|324452227|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725226|NCT02783300|324452228|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725227|NCT02783300|324452229|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725228|NCT02783300|324452230|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
94725229|NCT02783300|324452231|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725230|NCT02783300|324452232|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
94725231|NCT02783300|324452233|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725232|NCT02783300|324452234|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725233|NCT02783300|324452235|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
94725234|NCT02783300|324452236|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725235|NCT02783300|324452237|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94368344|NCT02525562|323134888|FG002|Overall Study|Revision/Removal of Study Device|0|||
94368345|NCT02525562|323134886|FG000|Overall Study|Study Closed by Sponsor|154|||
94368346|NCT02525562|323134887|FG001|Overall Study|Study Closed by Sponsor|0|||
94272848|NCT03610724|322791741|FG000|Overall Study|Lost to Follow-up|1|||
94272849|NCT03610724|322791741|FG000|Overall Study|Physician Decision|1|||
94272850|NCT03610724|322791741|FG000|Overall Study|Died prior to infusion|1|||
94272851|NCT04126083|322791745|FG000|Overall Study|Withdrawal by Subject|1|||
94272852|NCT00786565|322791746|FG000|Enrollment Prior to Surgery|Site Closed|3|||
94272853|NCT00786565|322791746|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
94272854|NCT00786565|322791746|FG000|Post Surgery|Abnormal macular pucker|1|||
94272855|NCT00786565|322791746|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
94272856|NCT02047253|322791747|FG000|Overall Study|Lost to Follow-up|8|||
94272857|NCT01131520|322791748|FG000|Overall Study|Computer problem|1|||
94272858|NCT01131520|322791749|FG001|Overall Study|Computer problem|0|||
94272859|NCT01131520|322791748|FG000|Overall Study|Counselor not available|0|||
94272860|NCT01131520|322791749|FG001|Overall Study|Counselor not available|3|||
94272861|NCT01131520|322791748|FG000|Overall Study|Subject changed history after enrollment|0|||
94272862|NCT01131520|322791749|FG001|Overall Study|Subject changed history after enrollment|1|||
94272863|NCT01449461|322791750|FG000|Overall Study|Adverse Event|0|||
94272864|NCT01449461|322791751|FG001|Overall Study|Adverse Event|3|||
94272865|NCT01449461|322791752|FG002|Overall Study|Adverse Event|2|||
94272866|NCT01449461|322791753|FG003|Overall Study|Adverse Event|3|||
94272867|NCT01449461|322791754|FG004|Overall Study|Adverse Event|4|||
94272868|NCT01449461|322791755|FG005|Overall Study|Adverse Event|4|||
94272869|NCT01449461|322791750|FG000|Overall Study|Death|0|||
94272870|NCT01449461|322791751|FG001|Overall Study|Death|2|||
94272871|NCT01449461|322791752|FG002|Overall Study|Death|0|||
94272872|NCT01449461|322791753|FG003|Overall Study|Death|0|||
94272873|NCT01449461|322791754|FG004|Overall Study|Death|7|||
94272874|NCT01449461|322791755|FG005|Overall Study|Death|1|||
94272875|NCT01449461|322791750|FG000|Overall Study|Physician Decision|0|||
94272876|NCT01449461|322791751|FG001|Overall Study|Physician Decision|1|||
94272877|NCT01449461|322791752|FG002|Overall Study|Physician Decision|0|||
94272878|NCT01449461|322791753|FG003|Overall Study|Physician Decision|4|||
94272879|NCT01449461|322791754|FG004|Overall Study|Physician Decision|1|||
94272880|NCT01449461|322791755|FG005|Overall Study|Physician Decision|0|||
94272881|NCT01449461|322791750|FG000|Overall Study|Documented Progressive Disease|4|||
94272882|NCT01449461|322791751|FG001|Overall Study|Documented Progressive Disease|7|||
94272883|NCT01449461|322791752|FG002|Overall Study|Documented Progressive Disease|14|||
94272884|NCT01449461|322791753|FG003|Overall Study|Documented Progressive Disease|15|||
94272885|NCT01449461|322791754|FG004|Overall Study|Documented Progressive Disease|24|||
94272886|NCT01449461|322791755|FG005|Overall Study|Documented Progressive Disease|5|||
94272887|NCT01449461|322791750|FG000|Overall Study|Clinical Progressive Disease|2|||
94272888|NCT01449461|322791751|FG001|Overall Study|Clinical Progressive Disease|2|||
94272889|NCT01449461|322791752|FG002|Overall Study|Clinical Progressive Disease|0|||
94272890|NCT01449461|322791753|FG003|Overall Study|Clinical Progressive Disease|3|||
94272891|NCT01449461|322791754|FG004|Overall Study|Clinical Progressive Disease|4|||
94272892|NCT01449461|322791755|FG005|Overall Study|Clinical Progressive Disease|2|||
94272893|NCT01449461|322791750|FG000|Overall Study|Protocol Violation|0|||
94272894|NCT01449461|322791751|FG001|Overall Study|Protocol Violation|0|||
94272895|NCT01449461|322791752|FG002|Overall Study|Protocol Violation|0|||
94272896|NCT01449461|322791753|FG003|Overall Study|Protocol Violation|1|||
94272897|NCT01449461|322791754|FG004|Overall Study|Protocol Violation|0|||
94272898|NCT01449461|322791755|FG005|Overall Study|Protocol Violation|0|||
94272899|NCT01449461|322791750|FG000|Overall Study|Site Terminated by Sponsor|0|||
94272900|NCT01449461|322791751|FG001|Overall Study|Site Terminated by Sponsor|1|||
94272901|NCT01449461|322791752|FG002|Overall Study|Site Terminated by Sponsor|2|||
94272902|NCT01449461|322791753|FG003|Overall Study|Site Terminated by Sponsor|3|||
94272903|NCT01449461|322791754|FG004|Overall Study|Site Terminated by Sponsor|4|||
94272904|NCT01449461|322791755|FG005|Overall Study|Site Terminated by Sponsor|1|||
94272905|NCT01449461|322791750|FG000|Overall Study|Withdrawal by Subject|0|||
94272906|NCT01449461|322791751|FG001|Overall Study|Withdrawal by Subject|1|||
94272907|NCT01449461|322791752|FG002|Overall Study|Withdrawal by Subject|0|||
94272908|NCT01449461|322791753|FG003|Overall Study|Withdrawal by Subject|0|||
94272909|NCT01449461|322791754|FG004|Overall Study|Withdrawal by Subject|2|||
94272910|NCT01449461|322791755|FG005|Overall Study|Withdrawal by Subject|1|||
94272911|NCT01449461|322791750|FG000|Overall Study|Reason not Specified|0|||
94272912|NCT01449461|322791751|FG001|Overall Study|Reason not Specified|1|||
94272913|NCT01449461|322791752|FG002|Overall Study|Reason not Specified|0|||
94272914|NCT01449461|322791753|FG003|Overall Study|Reason not Specified|3|||
94272915|NCT01449461|322791754|FG004|Overall Study|Reason not Specified|2|||
94272916|NCT01449461|322791755|FG005|Overall Study|Reason not Specified|1|||
94368347|NCT02525562|323134888|FG002|Overall Study|Study Closed by Sponsor|0|||
94368348|NCT00886782|323134891|FG000|Overall Study|Disease progression|3|||
94272917|NCT01392677|322791758|FG000|Overall Study|Adverse Event|3|||
94272918|NCT01392677|322791759|FG001|Overall Study|Adverse Event|1|||
94272919|NCT01392677|322791758|FG000|Overall Study|Withdrawal by Subject|0|||
94272920|NCT01392677|322791759|FG001|Overall Study|Withdrawal by Subject|2|||
94272921|NCT01392677|322791758|FG000|Overall Study|Incorrect enrollment|2|||
94272922|NCT01392677|322791759|FG001|Overall Study|Incorrect enrollment|3|||
94725236|NCT02783300|324452238|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
94725237|NCT02783300|324452239|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725238|NCT02783300|324452240|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725239|NCT02783300|324452241|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725240|NCT02783300|324452242|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725241|NCT02783300|324452243|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725242|NCT02783300|324452244|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725243|NCT02783300|324452245|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725244|NCT02783300|324452246|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725245|NCT02783300|324452247|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725246|NCT02783300|324452248|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725247|NCT02783300|324452249|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725248|NCT02783300|324452250|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725249|NCT02783300|324452251|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725250|NCT02783300|324452252|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
94725251|NCT02783300|324452226|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725252|NCT02783300|324452227|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725253|NCT02783300|324452228|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725254|NCT02783300|324452229|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725255|NCT02783300|324452230|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725256|NCT02783300|324452231|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725257|NCT02783300|324452232|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725258|NCT02783300|324452233|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725259|NCT02783300|324452234|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725260|NCT02783300|324452235|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725261|NCT02783300|324452236|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725262|NCT02783300|324452237|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725263|NCT02783300|324452238|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725264|NCT02783300|324452239|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725265|NCT02783300|324452240|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725266|NCT02783300|324452241|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
94467373|NCT03677934|323500534|FG000|Overall Study|Lost to Follow-up|3|||
94725267|NCT02783300|324452242|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725268|NCT02783300|324452243|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
94725269|NCT02783300|324452244|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
94272923|NCT01392677|322791758|FG000|Overall Study|Other reason|3|||
94272924|NCT01392677|322791759|FG001|Overall Study|Other reason|2|||
94272925|NCT04294901|322791763|FG000|Overall Study|Death|86|||
94272926|NCT04294901|322791764|FG001|Overall Study|Death|110|||
94272927|NCT04294901|322791763|FG000|Overall Study|Provider did not have historical control patients|581|||
94272928|NCT04294901|322791764|FG001|Overall Study|Provider did not have historical control patients|0|||
94272929|NCT04294901|322791763|FG000|Overall Study|Provider did not have intervention patients|0|||
94272930|NCT04294901|322791764|FG001|Overall Study|Provider did not have intervention patients|98|||
94272931|NCT01538628|322791765|FG000|Overall Study|Withdrawal by Subject|1|||
94272932|NCT01538628|322791766|FG001|Overall Study|Withdrawal by Subject|1|||
94272933|NCT01538628|322791765|FG000|Overall Study|Lost to Follow-up|0|||
94272934|NCT01538628|322791766|FG001|Overall Study|Lost to Follow-up|1|||
94272935|NCT00733954|322791767|FG000|Overall Study|Lost to Follow-up|5|||
94272936|NCT00733954|322791768|FG001|Overall Study|Lost to Follow-up|2|||
94272937|NCT00733954|322791767|FG000|Overall Study|Protocol Violation|1|||
94272938|NCT00733954|322791768|FG001|Overall Study|Protocol Violation|0|||
94272939|NCT00733954|322791767|FG000|Overall Study|Withdrawal by Subject|2|||
94272940|NCT00733954|322791768|FG001|Overall Study|Withdrawal by Subject|0|||
94272941|NCT03697720|322793612|FG000|Overall Study|Lost to Follow-up|7|||
94272942|NCT03581786|322793623|FG000|Overall Study|Death|17|||
94272943|NCT03581786|322793624|FG001|Overall Study|Death|12|||
94272944|NCT03581786|322793623|FG000|Overall Study|Withdrawal by Subject|2|||
94272945|NCT03581786|322793624|FG001|Overall Study|Withdrawal by Subject|4|||
94272946|NCT03581786|322793623|FG000|Overall Study|Lost to Follow-up|1|||
94272947|NCT03581786|322793624|FG001|Overall Study|Lost to Follow-up|0|||
94272948|NCT03581786|322793623|FG000|Overall Study|reason other than specified above|0|||
94272949|NCT03581786|322793624|FG001|Overall Study|reason other than specified above|1|||
94272950|NCT03581786|322793623|FG000|Overall Study|Ongoing in the study|123|||
94272951|NCT03581786|322793624|FG001|Overall Study|Ongoing in the study|129|||
94467374|NCT03677934|323500535|FG001|Overall Study|Lost to Follow-up|0|||
94467375|NCT03677934|323500534|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94272952|NCT00388973|322793625|FG000|Overall Study|Adverse Event|16|||
94272953|NCT00388973|322793626|FG001|Overall Study|Adverse Event|6|||
94272954|NCT00388973|322793625|FG000|Overall Study|Lack of Efficacy|1|||
94272955|NCT00388973|322793626|FG001|Overall Study|Lack of Efficacy|12|||
94272956|NCT00388973|322793625|FG000|Overall Study|Protocol Violation|3|||
94272957|NCT00388973|322793626|FG001|Overall Study|Protocol Violation|0|||
94272958|NCT00388973|322793625|FG000|Overall Study|Withdrawal by Subject|14|||
94272959|NCT00388973|322793626|FG001|Overall Study|Withdrawal by Subject|17|||
94725270|NCT02783300|324452245|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
94725271|NCT02783300|324452246|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725272|NCT02783300|324452247|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725273|NCT02783300|324452248|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725274|NCT02783300|324452249|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725275|NCT02783300|324452250|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
94725276|NCT02783300|324452251|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725277|NCT02783300|324452252|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
94725278|NCT02783300|324452226|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725279|NCT02783300|324452227|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725280|NCT02783300|324452228|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725281|NCT02783300|324452229|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725282|NCT02783300|324452230|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725283|NCT02783300|324452231|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725284|NCT02783300|324452232|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725285|NCT02783300|324452233|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725286|NCT02783300|324452234|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725287|NCT02783300|324452235|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725288|NCT02783300|324452236|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725289|NCT02783300|324452237|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725290|NCT02783300|324452238|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725291|NCT02783300|324452239|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725292|NCT02783300|324452240|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725293|NCT02783300|324452241|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725294|NCT02783300|324452242|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
94725295|NCT02783300|324452243|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725296|NCT02783300|324452244|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
94725297|NCT02783300|324452245|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
94725298|NCT02783300|324452246|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725299|NCT02783300|324452247|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725300|NCT02783300|324452248|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725301|NCT02783300|324452249|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725302|NCT02783300|324452250|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725303|NCT02783300|324452251|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725304|NCT02783300|324452252|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
94725305|NCT02783300|324452226|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725306|NCT02783300|324452227|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725307|NCT02783300|324452228|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725308|NCT02783300|324452229|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725309|NCT02783300|324452230|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725310|NCT02783300|324452231|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725311|NCT02783300|324452232|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725312|NCT02783300|324452233|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725313|NCT02783300|324452234|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725314|NCT02783300|324452235|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725315|NCT02783300|324452236|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725316|NCT02783300|324452237|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725317|NCT02783300|324452238|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725318|NCT02783300|324452239|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725319|NCT02783300|324452240|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725320|NCT02783300|324452241|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725321|NCT02783300|324452242|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
94725322|NCT02783300|324452243|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725323|NCT02783300|324452244|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
94725324|NCT02783300|324452245|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
94725325|NCT02783300|324452246|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
94725326|NCT02783300|324452247|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725327|NCT02783300|324452248|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725328|NCT02783300|324452249|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725329|NCT02783300|324452250|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94368349|NCT00886782|323134892|FG001|Overall Study|Disease progression|3|||
94368350|NCT00886782|323134893|FG002|Overall Study|Disease progression|3|||
94368351|NCT00886782|323134891|FG000|Overall Study|Study drug toxicity|0|||
94368352|NCT00886782|323134892|FG001|Overall Study|Study drug toxicity|0|||
94368353|NCT00886782|323134893|FG002|Overall Study|Study drug toxicity|1|||
94368354|NCT00886782|323134891|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
94368355|NCT00886782|323134892|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
94368356|NCT00886782|323134893|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
94368357|NCT03674827|323134894|FG000|Treatment Phase|Adverse Event|0|||
94368358|NCT03674827|323134895|FG001|Treatment Phase|Adverse Event|0|||
94368359|NCT03674827|323134896|FG002|Treatment Phase|Adverse Event|0|||
94368360|NCT03674827|323134897|FG003|Treatment Phase|Adverse Event|0|||
94368361|NCT03674827|323134898|FG004|Treatment Phase|Adverse Event|0|||
94368362|NCT03674827|323134899|FG005|Treatment Phase|Adverse Event|2|||
94368363|NCT03674827|323134894|FG000|Treatment Phase|Death|2|||
94368364|NCT03674827|323134895|FG001|Treatment Phase|Death|0|||
94368365|NCT03674827|323134896|FG002|Treatment Phase|Death|0|||
94368366|NCT03674827|323134897|FG003|Treatment Phase|Death|0|||
94368367|NCT03674827|323134898|FG004|Treatment Phase|Death|1|||
94368368|NCT03674827|323134899|FG005|Treatment Phase|Death|0|||
94368369|NCT03674827|323134894|FG000|Treatment Phase|Progressive Disease|0|||
94368370|NCT03674827|323134895|FG001|Treatment Phase|Progressive Disease|4|||
94368371|NCT03674827|323134896|FG002|Treatment Phase|Progressive Disease|3|||
94368372|NCT03674827|323134897|FG003|Treatment Phase|Progressive Disease|4|||
94368373|NCT03674827|323134898|FG004|Treatment Phase|Progressive Disease|4|||
94368374|NCT03674827|323134899|FG005|Treatment Phase|Progressive Disease|9|||
94272960|NCT00388973|322793625|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
94272961|NCT00388973|322793626|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
94272962|NCT00388973|322793625|FG000|Overall Study|Did not complete 61 days of treatment|5|||
94272963|NCT00388973|322793626|FG001|Overall Study|Did not complete 61 days of treatment|4|||
94272964|NCT00388973|322793625|FG000|Overall Study|Left region|0|||
94272965|NCT00388973|322793626|FG001|Overall Study|Left region|1|||
94368375|NCT03674827|323134894|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
94368376|NCT03674827|323134895|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
94368377|NCT03674827|323134896|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
94725330|NCT02783300|324452251|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725331|NCT02783300|324452252|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
94725332|NCT02783300|324452226|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725333|NCT02783300|324452227|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725334|NCT02783300|324452228|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94272966|NCT00388973|322793625|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
94272967|NCT00388973|322793626|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
94272968|NCT02833974|322793628|FG000|Overall Study|Lost to Follow-up|1|||
94272969|NCT02833974|322793629|FG001|Overall Study|Lost to Follow-up|0|||
94272970|NCT02833974|322793628|FG000|Overall Study|Adverse Event|0|||
94272971|NCT02833974|322793629|FG001|Overall Study|Adverse Event|3|||
94272972|NCT03703882|322793640|FG000|Overall Study|Adverse Event|1|||
94272973|NCT03703882|322793641|FG001|Overall Study|Adverse Event|0|||
94272974|NCT03703882|322793640|FG000|Overall Study|Lost to Follow-up|0|||
94272975|NCT03703882|322793641|FG001|Overall Study|Lost to Follow-up|2|||
94272976|NCT03703882|322793640|FG000|Overall Study|Non-compliance with study drug|0|||
94272977|NCT03703882|322793641|FG001|Overall Study|Non-compliance with study drug|1|||
94272978|NCT03703882|322793640|FG000|Overall Study|Physician Decision|0|||
94272979|NCT03703882|322793641|FG001|Overall Study|Physician Decision|1|||
94272980|NCT03703882|322793640|FG000|Overall Study|Progressive disease|1|||
94272981|NCT03703882|322793641|FG001|Overall Study|Progressive disease|0|||
94272982|NCT03703882|322793640|FG000|Overall Study|Withdrawal by parent/guardian|1|||
94272983|NCT03703882|322793641|FG001|Overall Study|Withdrawal by parent/guardian|0|||
94368378|NCT03674827|323134897|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
94368379|NCT03674827|323134898|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
94368380|NCT03674827|323134899|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
94368381|NCT03674827|323134894|FG000|Treatment Phase|Withdrawal by Subject|0|||
94368382|NCT03674827|323134895|FG001|Treatment Phase|Withdrawal by Subject|0|||
94725335|NCT02783300|324452229|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725336|NCT02783300|324452230|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725337|NCT02783300|324452231|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725338|NCT02783300|324452232|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725339|NCT02783300|324452233|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94368383|NCT03674827|323134896|FG002|Treatment Phase|Withdrawal by Subject|0|||
94272984|NCT03703882|322793640|FG000|Overall Study|Starting another treatment|0|||
94272985|NCT03703882|322793641|FG001|Overall Study|Starting another treatment|1|||
94272986|NCT03703882|322793640|FG000|Overall Study|noncompliance with study procedures|0|||
94272987|NCT03703882|322793641|FG001|Overall Study|noncompliance with study procedures|1|||
94368384|NCT03674827|323134897|FG003|Treatment Phase|Withdrawal by Subject|0|||
94368385|NCT03674827|323134898|FG004|Treatment Phase|Withdrawal by Subject|0|||
94725340|NCT02783300|324452234|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725341|NCT02783300|324452235|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725342|NCT02783300|324452236|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725343|NCT02783300|324452237|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725344|NCT02783300|324452238|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725345|NCT02783300|324452239|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725346|NCT02783300|324452240|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725347|NCT02783300|324452241|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
94725348|NCT02783300|324452242|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725349|NCT02783300|324452243|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725350|NCT02783300|324452244|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725351|NCT02783300|324452245|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725352|NCT02783300|324452246|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725353|NCT02783300|324452247|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725354|NCT02783300|324452248|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
94725355|NCT02783300|324452249|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725356|NCT02783300|324452250|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725357|NCT02783300|324452251|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725358|NCT02783300|324452252|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
94725359|NCT02783300|324452226|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725360|NCT02783300|324452227|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725361|NCT02783300|324452228|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725362|NCT02783300|324452229|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725363|NCT02783300|324452230|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725364|NCT02783300|324452231|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725365|NCT02783300|324452232|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725366|NCT02783300|324452233|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725367|NCT02783300|324452234|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725368|NCT02783300|324452235|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725369|NCT02783300|324452236|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725370|NCT02783300|324452237|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725371|NCT02783300|324452238|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725372|NCT02783300|324452239|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
94725373|NCT02783300|324452240|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
94725374|NCT02783300|324452241|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
94725375|NCT02783300|324452242|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
94725376|NCT02783300|324452243|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725377|NCT02783300|324452244|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
94725378|NCT02783300|324452245|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
94725379|NCT02783300|324452246|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725380|NCT02783300|324452247|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725381|NCT02783300|324452248|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725382|NCT02783300|324452249|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725383|NCT02783300|324452250|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725384|NCT02783300|324452251|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725385|NCT02783300|324452252|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
94725386|NCT02783300|324452226|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
94725387|NCT02783300|324452227|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
94725388|NCT02783300|324452228|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
94725389|NCT02783300|324452229|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
94725390|NCT02783300|324452230|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
94725391|NCT02783300|324452231|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
94725392|NCT02783300|324452232|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
94725393|NCT02783300|324452233|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
94725394|NCT02783300|324452234|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
94725395|NCT02783300|324452235|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
94725396|NCT02783300|324452236|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
94725397|NCT02783300|324452237|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
94725398|NCT02783300|324452238|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
94725399|NCT02783300|324452239|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
94725400|NCT02783300|324452240|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
94725401|NCT02783300|324452241|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
94725402|NCT02783300|324452242|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
94725403|NCT02783300|324452243|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
94725404|NCT02783300|324452244|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
94725405|NCT02783300|324452245|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
94725406|NCT02783300|324452246|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
94725407|NCT02783300|324452247|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
94725408|NCT02783300|324452248|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
94725409|NCT02783300|324452249|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
94725410|NCT02783300|324452250|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
94725411|NCT02783300|324452251|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
94725412|NCT02783300|324452252|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
94725413|NCT02783300|324452226|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725414|NCT02783300|324452227|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725415|NCT02783300|324452228|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725416|NCT02783300|324452229|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725417|NCT02783300|324452230|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725418|NCT02783300|324452231|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725419|NCT02783300|324452232|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725420|NCT02783300|324452233|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725421|NCT02783300|324452234|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725422|NCT02783300|324452235|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725423|NCT02783300|324452236|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725424|NCT02783300|324452237|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725425|NCT02783300|324452238|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725426|NCT02783300|324452239|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725427|NCT02783300|324452240|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725428|NCT02783300|324452241|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725429|NCT02783300|324452242|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725430|NCT02783300|324452243|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725431|NCT02783300|324452244|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725432|NCT02783300|324452245|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725433|NCT02783300|324452246|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725434|NCT02783300|324452247|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725435|NCT02783300|324452248|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725436|NCT02783300|324452249|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725437|NCT02783300|324452250|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725438|NCT02783300|324452251|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
94725439|NCT02783300|324452252|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
94725440|NCT02783300|324452226|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725441|NCT02783300|324452227|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725442|NCT02783300|324452228|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
94272988|NCT02966509|322793642|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
94272989|NCT02966509|322793643|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
94272990|NCT02966509|322793642|FG000|Baseline Satisfaction Survey|Death|0|||
94272991|NCT02966509|322793643|FG001|Baseline Satisfaction Survey|Death|1|||
94272992|NCT02966509|322793642|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
94272993|NCT02966509|322793643|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
94272994|NCT02966509|322793642|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
94272995|NCT02966509|322793643|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
94272996|NCT02966509|322793642|FG000|6 Month Satisfaction Decision Survey|Death|22|||
94272997|NCT02966509|322793643|FG001|6 Month Satisfaction Decision Survey|Death|25|||
94272998|NCT02966509|322793642|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
94272999|NCT02966509|322793643|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
94368386|NCT03674827|323134899|FG005|Treatment Phase|Withdrawal by Subject|1|||
94368387|NCT03674827|323134894|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
94368388|NCT03674827|323134895|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
94368389|NCT03674827|323134896|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
94368390|NCT03674827|323134897|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
94725443|NCT02783300|324452229|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725444|NCT02783300|324452230|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725445|NCT02783300|324452231|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725446|NCT02783300|324452232|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725447|NCT02783300|324452233|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
94273000|NCT02966509|322793642|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
94725448|NCT02783300|324452234|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725449|NCT02783300|324452235|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725450|NCT02783300|324452236|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725451|NCT02783300|324452237|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725452|NCT02783300|324452238|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725453|NCT02783300|324452239|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725454|NCT02783300|324452240|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725455|NCT02783300|324452241|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725456|NCT02783300|324452242|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725457|NCT02783300|324452243|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725458|NCT02783300|324452244|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725459|NCT02783300|324452245|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725460|NCT02783300|324452246|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725461|NCT02783300|324452247|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725462|NCT02783300|324452248|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725463|NCT02783300|324452249|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725464|NCT02783300|324452250|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725465|NCT02783300|324452251|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
94725466|NCT02783300|324452252|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
94725467|NCT03535272|324452253|FG000|Overall Study|Lost to Follow-up|71|||
94725468|NCT03535272|324452254|FG001|Overall Study|Lost to Follow-up|73|||
94725469|NCT00378105|324452257|FG000|Overall Study|Adverse Event|3|||
94725470|NCT00378105|324452258|FG001|Overall Study|Adverse Event|1|||
94725471|NCT00378105|324452257|FG000|Overall Study|Withdrawal by Subject|3|||
94725472|NCT00378105|324452258|FG001|Overall Study|Withdrawal by Subject|3|||
94725473|NCT00378105|324452257|FG000|Overall Study|Death|1|||
94725474|NCT00378105|324452258|FG001|Overall Study|Death|0|||
94725475|NCT00378105|324452257|FG000|Overall Study|Going to transplant|7|||
94725476|NCT00378105|324452258|FG001|Overall Study|Going to transplant|8|||
94725477|NCT00378105|324452257|FG000|Overall Study|Progressive disease|3|||
94725478|NCT00378105|324452258|FG001|Overall Study|Progressive disease|3|||
94725479|NCT00378105|324452257|FG000|Overall Study|remain on study|3|||
94725480|NCT00378105|324452258|FG001|Overall Study|remain on study|11|||
94725481|NCT00378105|324452257|FG000|Overall Study|Physician Decision|0|||
94725482|NCT00378105|324452258|FG001|Overall Study|Physician Decision|2|||
94725483|NCT00378105|324452257|FG000|Overall Study|Going non-protocol therapy|0|||
94725484|NCT00378105|324452258|FG001|Overall Study|Going non-protocol therapy|1|||
94725485|NCT00378105|324452257|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
94725486|NCT00378105|324452258|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
94725487|NCT02120456|324452259|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
94725488|NCT02120456|324452260|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
94725489|NCT02120456|324452261|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
94725490|NCT02120456|324452262|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
94725491|NCT02120456|324452263|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
94725492|NCT02120456|324452264|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
94725493|NCT02120456|324452265|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
94725494|NCT02120456|324452266|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
94725495|NCT02120456|324452267|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
94725496|NCT02120456|324452259|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
94725497|NCT02120456|324452260|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
94725498|NCT02120456|324452261|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
94725499|NCT02120456|324452262|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
94725500|NCT02120456|324452263|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
94725501|NCT02120456|324452264|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
94725502|NCT02120456|324452265|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
94725503|NCT02120456|324452266|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
94725504|NCT02120456|324452267|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
94725505|NCT02120456|324452259|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
94725506|NCT02120456|324452260|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
94725507|NCT02120456|324452261|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
94725508|NCT02120456|324452262|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
94725509|NCT02120456|324452263|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
94725510|NCT02120456|324452264|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
94725511|NCT02120456|324452265|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
94725512|NCT02120456|324452266|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
94725513|NCT02120456|324452267|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
94725514|NCT03457142|324452268|FG000|Overall Study|Death|1|||
94725515|NCT01748448|324452274|FG000|Treatment Period|Consent withdrawn by subject|1|||
94725516|NCT01748448|324452275|FG001|Treatment Period|Consent withdrawn by subject|0|||
94725517|NCT01748448|324452274|FG000|Treatment Period|Adverse Event|1|||
94725518|NCT01748448|324452275|FG001|Treatment Period|Adverse Event|0|||
94725519|NCT01748448|324452274|FG000|Treatment Period|Personal|0|||
94725520|NCT01748448|324452275|FG001|Treatment Period|Personal|1|||
94725521|NCT04034927|324452276|FG000|Overall Study|Adverse Event|4|||
94725522|NCT04034927|324452277|FG001|Overall Study|Adverse Event|9|||
94725523|NCT04034927|324452276|FG000|Overall Study|Death|0|||
94725524|NCT04034927|324452277|FG001|Overall Study|Death|1|||
94725525|NCT04034927|324452276|FG000|Overall Study|Withdrawal by Subject|0|||
94725526|NCT04034927|324452277|FG001|Overall Study|Withdrawal by Subject|3|||
94725527|NCT04034927|324452276|FG000|Overall Study|Still on Treatment|2|||
94725528|NCT04034927|324452277|FG001|Overall Study|Still on Treatment|1|||
94725529|NCT04034927|324452276|FG000|Overall Study|Other|1|||
94725530|NCT04034927|324452277|FG001|Overall Study|Other|1|||
94725531|NCT03675282|324452283|FG000|Overall Study|Lost to Follow-up|4|||
94725532|NCT03675282|324452284|FG001|Overall Study|Lost to Follow-up|8|||
94725533|NCT03675282|324452285|FG002|Overall Study|Lost to Follow-up|1|||
94725534|NCT03675282|324452286|FG003|Overall Study|Lost to Follow-up|0|||
94725535|NCT03675282|324452287|FG004|Overall Study|Lost to Follow-up|2|||
94725536|NCT03675282|324452288|FG005|Overall Study|Lost to Follow-up|7|||
94725537|NCT03675282|324452283|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
94725538|NCT03675282|324452284|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
94725539|NCT03675282|324452285|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
94725540|NCT03675282|324452286|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
94725541|NCT03675282|324452287|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
94725542|NCT03675282|324452288|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
94725543|NCT03675282|324452283|FG000|Overall Study|Physician Decision|1|||
94725544|NCT03675282|324452284|FG001|Overall Study|Physician Decision|0|||
94725545|NCT03675282|324452285|FG002|Overall Study|Physician Decision|0|||
94725546|NCT03675282|324452286|FG003|Overall Study|Physician Decision|0|||
94725547|NCT03675282|324452287|FG004|Overall Study|Physician Decision|0|||
94725548|NCT03675282|324452288|FG005|Overall Study|Physician Decision|0|||
94725549|NCT05784662|324452292|FG000|Overall Study|Lost to Follow-up|21|||
94725550|NCT05784662|324452293|FG001|Overall Study|Lost to Follow-up|17|||
94725551|NCT03425331|324452301|FG000|Overall Study|Withdrawal by Subject|1|||
94725552|NCT03425331|324452301|FG000|Overall Study|Death|1|||
94725553|NCT03425331|324452301|FG000|Overall Study|Adverse Event|1|||
94725554|NCT03425331|324452301|FG000|Overall Study|Disease Progression|2|||
94725555|NCT02677298|324452304|FG000|Double Blind Phase|Adverse Event|2|||
94725556|NCT02677298|324452305|FG001|Double Blind Phase|Adverse Event|1|||
94725557|NCT02677298|324452306|FG002|Double Blind Phase|Adverse Event|0|||
94725558|NCT02677298|324452304|FG000|Double Blind Phase|Physician Decision|5|||
94725559|NCT02677298|324452305|FG001|Double Blind Phase|Physician Decision|0|||
94725560|NCT02677298|324452306|FG002|Double Blind Phase|Physician Decision|0|||
94725561|NCT02677298|324452304|FG000|Double Blind Phase|Lost to Follow-up|11|||
94725562|NCT02677298|324452305|FG001|Double Blind Phase|Lost to Follow-up|7|||
94725563|NCT02677298|324452306|FG002|Double Blind Phase|Lost to Follow-up|0|||
94725564|NCT02677298|324452304|FG000|Double Blind Phase|Withdrawal by Subject|11|||
94725565|NCT02677298|324452305|FG001|Double Blind Phase|Withdrawal by Subject|8|||
94725566|NCT02677298|324452306|FG002|Double Blind Phase|Withdrawal by Subject|0|||
94725567|NCT02677298|324452304|FG000|Double Blind Phase|No study drug available at site|0|||
94725568|NCT02677298|324452305|FG001|Double Blind Phase|No study drug available at site|1|||
94725569|NCT02677298|324452306|FG002|Double Blind Phase|No study drug available at site|0|||
94725570|NCT02677298|324452304|FG000|Open Label Phase|Adverse Event|0|||
94725571|NCT02677298|324452305|FG001|Open Label Phase|Adverse Event|0|||
94725572|NCT02677298|324452306|FG002|Open Label Phase|Adverse Event|4|||
94725573|NCT02677298|324452304|FG000|Open Label Phase|Physician Decision|0|||
94725574|NCT02677298|324452305|FG001|Open Label Phase|Physician Decision|0|||
94725575|NCT02677298|324452306|FG002|Open Label Phase|Physician Decision|1|||
94725576|NCT02677298|324452304|FG000|Open Label Phase|Lost to Follow-up|0|||
94725577|NCT02677298|324452305|FG001|Open Label Phase|Lost to Follow-up|0|||
94725578|NCT02677298|324452306|FG002|Open Label Phase|Lost to Follow-up|17|||
94725579|NCT02677298|324452304|FG000|Open Label Phase|Withdrawal by Subject|0|||
94725580|NCT02677298|324452305|FG001|Open Label Phase|Withdrawal by Subject|0|||
94725581|NCT02677298|324452306|FG002|Open Label Phase|Withdrawal by Subject|38|||
94725582|NCT03988608|324452307|FG000|Overall Study|Adverse Event|1|||
94725583|NCT03988608|324452307|FG000|Overall Study|Lost to Follow-up|1|||
94725584|NCT03988608|324452307|FG000|Overall Study|Withdrawal by Subject|3|||
94725585|NCT03988608|324452307|FG000|Overall Study|Death|1|||
94725586|NCT05592418|324452309|FG000|Overall Study|Adverse Event|1|||
94725587|NCT05592418|324452310|FG001|Overall Study|Adverse Event|0|||
94725588|NCT05592418|324452309|FG000|Overall Study|Lost to Follow-up|1|||
94725589|NCT05592418|324452310|FG001|Overall Study|Lost to Follow-up|3|||
94725590|NCT05592418|324452309|FG000|Overall Study|Withdrawal by Subject|2|||
94725591|NCT05592418|324452310|FG001|Overall Study|Withdrawal by Subject|7|||
94725592|NCT04557124|324452314|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
94725593|NCT04557124|324452315|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
94368391|NCT03674827|323134898|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
94368392|NCT03674827|323134899|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
94368393|NCT03674827|323134894|FG000|Treatment Phase|Other|0|||
94368394|NCT03674827|323134895|FG001|Treatment Phase|Other|1|||
94368395|NCT03674827|323134896|FG002|Treatment Phase|Other|0|||
94368396|NCT03674827|323134897|FG003|Treatment Phase|Other|0|||
94368397|NCT03674827|323134898|FG004|Treatment Phase|Other|0|||
94368398|NCT03674827|323134899|FG005|Treatment Phase|Other|1|||
94368399|NCT03674827|323134894|FG000|Long-Term Follow-up Phase|Death|2|||
94368400|NCT03674827|323134895|FG001|Long-Term Follow-up Phase|Death|4|||
94368401|NCT03674827|323134896|FG002|Long-Term Follow-up Phase|Death|2|||
94368402|NCT03674827|323134897|FG003|Long-Term Follow-up Phase|Death|3|||
94368403|NCT03674827|323134898|FG004|Long-Term Follow-up Phase|Death|2|||
94368404|NCT03674827|323134899|FG005|Long-Term Follow-up Phase|Death|6|||
94368405|NCT03674827|323134894|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
94368406|NCT03674827|323134895|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
94368407|NCT03674827|323134896|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
94368408|NCT03674827|323134897|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
94368409|NCT03674827|323134898|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
94368410|NCT03674827|323134899|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
94368411|NCT03674827|323134894|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
94368412|NCT03674827|323134895|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
94368413|NCT03674827|323134896|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
94368414|NCT03674827|323134897|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
94368415|NCT03674827|323134898|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
94368416|NCT03674827|323134899|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
94368417|NCT02441179|323134901|FG000|Overall Study|Withdrawal by Subject|1|||
94368418|NCT02441179|323134902|FG001|Overall Study|Withdrawal by Subject|1|||
94368419|NCT01358708|323134903|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
94725594|NCT04557124|324452314|FG000|Mid-point (1 Month)|Missed testing|5|||
94725595|NCT04557124|324452315|FG001|Mid-point (1 Month)|Missed testing|4|||
94725596|NCT04557124|324452314|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
94725597|NCT04557124|324452315|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
94725598|NCT04557124|324452314|FG000|Post-testing (2 Months)|Missed testing|1|||
94725599|NCT04557124|324452315|FG001|Post-testing (2 Months)|Missed testing|5|||
94725600|NCT04557124|324452314|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
94725601|NCT04557124|324452315|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
94725602|NCT04557124|324452314|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
94725603|NCT04557124|324452315|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
94725604|NCT04739956|324452316|FG000|Overall Study|Withdrawal by Subject|1|||
94725605|NCT04739956|324452317|FG001|Overall Study|Withdrawal by Subject|1|||
94725606|NCT03920111|324452318|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
94725607|NCT03920111|324452319|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
94725608|NCT03920111|324452320|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
94725609|NCT05516147|324452321|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
94725610|NCT01084876|324452326|FG000|Main Study Treatment Period|Adverse Event|12|||
94725611|NCT01084876|324452327|FG001|Main Study Treatment Period|Adverse Event|7|||
94725612|NCT01084876|324452326|FG000|Main Study Treatment Period|Disease Progression|41|||
94725613|NCT01084876|324452327|FG001|Main Study Treatment Period|Disease Progression|24|||
94273001|NCT02966509|322793643|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
94273002|NCT02966509|322793642|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
94273003|NCT02966509|322793643|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
94273004|NCT02966509|322793642|FG000|6 Month Satisfaction Survey|Death|36|||
94273005|NCT02966509|322793643|FG001|6 Month Satisfaction Survey|Death|33|||
94273006|NCT02966509|322793642|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
94273007|NCT02966509|322793643|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
94273008|NCT02966509|322793642|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
94273009|NCT02966509|322793643|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
94273010|NCT02966509|322793642|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
94273011|NCT02966509|322793643|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
94273012|NCT02966509|322793642|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
94273013|NCT02966509|322793643|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
94273014|NCT02966509|322793642|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
94273015|NCT02966509|322793643|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
94273016|NCT00402649|322793644|FG000|Overall Study|Lost to Follow-up|1|||
94273017|NCT00402649|322793644|FG000|Overall Study|Withdrawal by Subject|1|||
94273018|NCT03281668|322793645|FG000|Overall Study|Physician Decision|1|||
94368420|NCT01358708|323134904|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
94725614|NCT01084876|324452326|FG000|Main Study Treatment Period|Physician Decision|2|||
94725615|NCT01084876|324452327|FG001|Main Study Treatment Period|Physician Decision|0|||
94368421|NCT01358708|323134903|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
94368422|NCT01358708|323134904|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
94725616|NCT01084876|324452326|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
94725617|NCT01084876|324452327|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
94273019|NCT03281668|322793645|FG000|Overall Study|scheduling conflict, family circumstance|2|||
94273020|NCT03281668|322793645|FG000|Overall Study|Withdrawal by Subject|4|||
94273021|NCT03281668|322793645|FG000|Overall Study|Lost to Follow-up|1|||
94273022|NCT01199042|322793646|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
94273023|NCT01199042|322793646|FG000|At Home (3 Months)|Lost to Follow-up|1|||
94273024|NCT01543152|322793647|FG000|Overall Study|Withdrawal by Subject|0|||
94273025|NCT01543152|322793648|FG001|Overall Study|Withdrawal by Subject|2|||
94273026|NCT01543152|322793649|FG002|Overall Study|Withdrawal by Subject|0|||
94273027|NCT01543152|322793650|FG003|Overall Study|Withdrawal by Subject|0|||
94273028|NCT01543152|322793651|FG004|Overall Study|Withdrawal by Subject|0|||
94273029|NCT00096785|322793656|FG000|Overall Study|Lost to Follow-up|1|||
94273030|NCT00096785|322793657|FG001|Overall Study|Lost to Follow-up|0|||
94273031|NCT00096785|322793656|FG000|Overall Study|Withdrawal by Subject|0|||
94273032|NCT00096785|322793657|FG001|Overall Study|Withdrawal by Subject|1|||
94273033|NCT00096785|322793656|FG000|Overall Study|Relocated|1|||
94273034|NCT00096785|322793657|FG001|Overall Study|Relocated|0|||
94273035|NCT01227187|322793658|FG000|Overall Study|Physician Decision|0|||
94273036|NCT01227187|322793659|FG001|Overall Study|Physician Decision|0|||
94273037|NCT01227187|322793660|FG002|Overall Study|Physician Decision|0|||
94273038|NCT01227187|322793661|FG003|Overall Study|Physician Decision|1|||
94273039|NCT02554019|322793663|FG000|Overall Study|Withdrawal by Subject|1|||
94273040|NCT02554019|322793664|FG001|Overall Study|Withdrawal by Subject|0|||
94273041|NCT02554019|322793665|FG002|Overall Study|Withdrawal by Subject|2|||
94273042|NCT02554019|322793663|FG000|Overall Study|Adverse Event|1|||
94273043|NCT02554019|322793664|FG001|Overall Study|Adverse Event|0|||
94273044|NCT02554019|322793665|FG002|Overall Study|Adverse Event|0|||
94273045|NCT00833053|322793666|FG000|Overall Study|Adverse Event|4|||
94273046|NCT00833053|322793667|FG001|Overall Study|Adverse Event|0|||
94273047|NCT00833053|322793666|FG000|Overall Study|Treatment Failure|3|||
94273048|NCT00833053|322793667|FG001|Overall Study|Treatment Failure|1|||
94273049|NCT00833053|322793666|FG000|Overall Study|Withdrawal by Subject|0|||
94273050|NCT00833053|322793667|FG001|Overall Study|Withdrawal by Subject|1|||
94273051|NCT00833053|322793666|FG000|Overall Study|Protocol Violation|2|||
94273052|NCT00833053|322793667|FG001|Overall Study|Protocol Violation|1|||
94273053|NCT02236520|322793669|FG000|Overall Study|Physician Decision|0|||
94273054|NCT02236520|322793670|FG001|Overall Study|Physician Decision|5|||
94273055|NCT02236520|322793671|FG002|Overall Study|Physician Decision|0|||
94273056|NCT02236520|322793672|FG003|Overall Study|Physician Decision|0|||
94273057|NCT02236520|322793669|FG000|Overall Study|Withdrawal by Subject|1|||
94273058|NCT02236520|322793670|FG001|Overall Study|Withdrawal by Subject|0|||
94273059|NCT02236520|322793671|FG002|Overall Study|Withdrawal by Subject|0|||
94273060|NCT02236520|322793672|FG003|Overall Study|Withdrawal by Subject|1|||
94273061|NCT02236520|322793669|FG000|Overall Study|Pregnancy|1|||
94273062|NCT02236520|322793670|FG001|Overall Study|Pregnancy|0|||
94273063|NCT02236520|322793671|FG002|Overall Study|Pregnancy|0|||
94273064|NCT02236520|322793672|FG003|Overall Study|Pregnancy|0|||
94273065|NCT02234479|322793680|FG000|Overall Study|Withdrawal by Subject|1|||
94273066|NCT02234479|322793681|FG001|Overall Study|Withdrawal by Subject|3|||
94273067|NCT00880399|322793682|FG000|Overall Study|Adverse Event|4|||
94273068|NCT00880399|322793683|FG001|Overall Study|Adverse Event|6|||
94273069|NCT00880399|322793684|FG002|Overall Study|Adverse Event|5|||
94273070|NCT00880399|322793682|FG000|Overall Study|Lack of Efficacy|1|||
94273071|NCT00880399|322793683|FG001|Overall Study|Lack of Efficacy|4|||
94273072|NCT00880399|322793684|FG002|Overall Study|Lack of Efficacy|2|||
94273073|NCT00880399|322793682|FG000|Overall Study|Protocol Violation|4|||
94273074|NCT00880399|322793683|FG001|Overall Study|Protocol Violation|4|||
94273075|NCT00880399|322793684|FG002|Overall Study|Protocol Violation|6|||
94273076|NCT00880399|322793682|FG000|Overall Study|Study closed/terminated|3|||
94273077|NCT00880399|322793683|FG001|Overall Study|Study closed/terminated|7|||
94273078|NCT00880399|322793684|FG002|Overall Study|Study closed/terminated|4|||
94273079|NCT00880399|322793682|FG000|Overall Study|Lost to Follow-up|8|||
94273080|NCT00880399|322793683|FG001|Overall Study|Lost to Follow-up|5|||
94273081|NCT00880399|322793684|FG002|Overall Study|Lost to Follow-up|3|||
94273082|NCT00880399|322793682|FG000|Overall Study|Physician Decision|5|||
94725618|NCT01084876|324452326|FG000|Main Study Treatment Period|Other Reason|0|||
94725619|NCT01084876|324452327|FG001|Main Study Treatment Period|Other Reason|1|||
94725620|NCT01084876|324452326|FG000|Main Study Treatment Period|Other|0|||
94273083|NCT00880399|322793683|FG001|Overall Study|Physician Decision|0|||
94273084|NCT00880399|322793684|FG002|Overall Study|Physician Decision|3|||
94273085|NCT00880399|322793682|FG000|Overall Study|Withdrawal by Subject|6|||
94273086|NCT00880399|322793683|FG001|Overall Study|Withdrawal by Subject|3|||
94273087|NCT00880399|322793684|FG002|Overall Study|Withdrawal by Subject|3|||
94273088|NCT00111800|322793687|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
94273089|NCT00111800|322793688|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
94273090|NCT00111800|322793689|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
94273091|NCT00111800|322793690|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
94368423|NCT00479765|323134905|FG000|Overall Study|study terminated|4|||
94368424|NCT00725725|323134932|FG000|Overall Study|Adverse Event|1|||
94368425|NCT00725725|323134933|FG001|Overall Study|Adverse Event|3|||
94368426|NCT00725725|323134934|FG002|Overall Study|Adverse Event|2|||
94368427|NCT00725725|323134932|FG000|Overall Study|Lost to Follow-up|2|||
94368428|NCT00725725|323134933|FG001|Overall Study|Lost to Follow-up|0|||
94368429|NCT00725725|323134934|FG002|Overall Study|Lost to Follow-up|2|||
94368430|NCT00725725|323134932|FG000|Overall Study|Withdrawal by Subject|1|||
94368431|NCT00725725|323134933|FG001|Overall Study|Withdrawal by Subject|0|||
94368432|NCT00725725|323134934|FG002|Overall Study|Withdrawal by Subject|1|||
94368433|NCT00725725|323134932|FG000|Overall Study|Protocol Violation|0|||
94368434|NCT00725725|323134933|FG001|Overall Study|Protocol Violation|1|||
94725621|NCT01084876|324452327|FG001|Main Study Treatment Period|Other|1|||
94725622|NCT01084876|324452326|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
94725623|NCT01084876|324452327|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
94725624|NCT01084876|324452326|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
94725625|NCT01084876|324452327|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
94725626|NCT01084876|324452326|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
94368435|NCT00725725|323134934|FG002|Overall Study|Protocol Violation|0|||
94368436|NCT03125915|323134935|FG000|1 Month Follow up|Lost to Follow-up|3|||
94368437|NCT03125915|323134936|FG001|1 Month Follow up|Lost to Follow-up|3|||
94725627|NCT01084876|324452327|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
94725628|NCT01084876|324452326|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
94725629|NCT01084876|324452327|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
94725630|NCT01084876|324452326|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
94725631|NCT01084876|324452327|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
94725632|NCT01084876|324452326|FG000|Treatment Period Beyond Cycle 8|Other|6|||
94725633|NCT01084876|324452327|FG001|Treatment Period Beyond Cycle 8|Other|9|||
94725634|NCT05028634|324452328|FG000|Overall Study|Withdrawal by Subject|0|||
94725635|NCT05028634|324452329|FG001|Overall Study|Withdrawal by Subject|1|||
94725636|NCT05256706|324452331|FG000|Overall Study|Lost to Follow-up|9|||
94725637|NCT05256706|324452332|FG001|Overall Study|Lost to Follow-up|3|||
94725638|NCT05256706|324452331|FG000|Overall Study|Withdrawal by Subject|7|||
94725639|NCT05256706|324452332|FG001|Overall Study|Withdrawal by Subject|11|||
94725640|NCT05256706|324452331|FG000|Overall Study|Screen Failures|3|||
94725641|NCT05256706|324452332|FG001|Overall Study|Screen Failures|0|||
94725642|NCT03850678|324452335|FG000|Overall Study|Withdrawal by Subject|3|||
94725643|NCT03850678|324452336|FG001|Overall Study|Withdrawal by Subject|0|||
94725644|NCT03850678|324452335|FG000|Overall Study|Experimenter Error|1|||
94725645|NCT03850678|324452336|FG001|Overall Study|Experimenter Error|1|||
94725646|NCT03850678|324452335|FG000|Overall Study|Did Not Condition To Experiment|7|||
94725647|NCT03850678|324452336|FG001|Overall Study|Did Not Condition To Experiment|2|||
94725648|NCT03720795|324452337|FG000|Phase 1|Lost to Follow-up|4|||
94725649|NCT03720795|324452337|FG000|Phase 1|Withdrawal by Subject|6|||
94725650|NCT03720795|324452337|FG000|Phase 1|Protocol Violation|1|||
94725651|NCT03720795|324452337|FG000|Phase 1|Other|1|||
94725652|NCT03720795|324452337|FG000|Phase 2|Lost to Follow-up|5|||
94725653|NCT03720795|324452337|FG000|Phase 2|Withdrawal by Subject|10|||
94725654|NCT03720795|324452337|FG000|Phase 2|Protocol Violation|2|||
94725655|NCT03720795|324452337|FG000|3 Month Follow Up|Lost to Follow-up|2|||
94725656|NCT03746015|324452338|FG000|Overall Study|Withdrawal of Consent|1|||
94725657|NCT03746015|324452339|FG001|Overall Study|Withdrawal of Consent|0|||
94725658|NCT03746015|324452340|FG002|Overall Study|Withdrawal of Consent|0|||
94725659|NCT03891667|324452341|FG000|Overall Study|Physician Decision|1|||
94725660|NCT03891667|324452342|FG001|Overall Study|Physician Decision|1|||
94725661|NCT03891667|324452341|FG000|Overall Study|COVID related pause|1|||
94725662|NCT03891667|324452342|FG001|Overall Study|COVID related pause|0|||
94725663|NCT03891667|324452341|FG000|Overall Study|Withdrawal by Subject|0|||
94725664|NCT03891667|324452342|FG001|Overall Study|Withdrawal by Subject|1|||
94725665|NCT03891667|324452341|FG000|Overall Study|Adverse Event|0|||
94725666|NCT03891667|324452342|FG001|Overall Study|Adverse Event|1|||
94725667|NCT05134233|324452343|FG000|Overall Study|Pregnancy|1|||
94725668|NCT05134233|324452343|FG000|Overall Study|MEP value too low|2|||
94725669|NCT05134233|324452343|FG000|Overall Study|Lost to Follow-up|1|||
94725670|NCT03706690|324452344|FG000|Overall Study|Withdrawal by Subject|8|||
94368438|NCT03125915|323134937|FG002|1 Month Follow up|Lost to Follow-up|2|||
94368439|NCT03125915|323134938|FG003|1 Month Follow up|Lost to Follow-up|3|||
94725671|NCT03706690|324452345|FG001|Overall Study|Withdrawal by Subject|8|||
94725672|NCT03706690|324452344|FG000|Overall Study|Death|143|||
94725673|NCT03706690|324452345|FG001|Overall Study|Death|75|||
94725674|NCT03706690|324452344|FG000|Overall Study|Ongoing at DCO|121|||
94725675|NCT03706690|324452345|FG001|Overall Study|Ongoing at DCO|52|||
94725676|NCT03315754|324453945|FG000|Overall Study|COVID-19 complications leading to death|1|||
94725677|NCT03315754|324453945|FG000|Overall Study|insurance coverage issue|1|||
94725678|NCT04956861|324453950|FG000|Overall Study|Withdrawal by Subject|4|||
94725679|NCT04956861|324453951|FG001|Overall Study|Withdrawal by Subject|4|||
94368440|NCT03125915|323134935|FG000|3 Month Follow-up|Lost to Follow-up|6|||
94725680|NCT04956861|324453952|FG002|Overall Study|Withdrawal by Subject|2|||
94725681|NCT04956861|324453950|FG000|Overall Study|Physician Decision|4|||
94725682|NCT04956861|324453951|FG001|Overall Study|Physician Decision|5|||
94725683|NCT04956861|324453952|FG002|Overall Study|Physician Decision|1|||
94725684|NCT03143153|324453954|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
94725685|NCT03143153|324453955|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
94725686|NCT03143153|324453956|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
94725687|NCT03143153|324453954|FG000|Pre-Treatment|Participant withdrew consent|0|||
94725688|NCT03143153|324453955|FG001|Pre-Treatment|Participant withdrew consent|1|||
94725689|NCT03143153|324453956|FG002|Pre-Treatment|Participant withdrew consent|12|||
94725690|NCT03143153|324453954|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
94273092|NCT00111800|322793691|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
94273093|NCT00111800|322793692|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
94273094|NCT00111800|322793687|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
94273095|NCT00111800|322793688|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
94273096|NCT00111800|322793689|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
94273097|NCT00111800|322793690|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
94273098|NCT00111800|322793691|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
94273099|NCT00111800|322793692|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
94273100|NCT00111800|322793687|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
94273101|NCT00111800|322793688|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
94273102|NCT00111800|322793689|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
94273103|NCT00111800|322793690|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
94273104|NCT00111800|322793691|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
94273105|NCT00111800|322793692|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
94273106|NCT00111800|322793687|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
94273107|NCT00111800|322793688|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
94273108|NCT00111800|322793689|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
94273109|NCT00111800|322793690|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
94273110|NCT00111800|322793691|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
94273111|NCT00111800|322793692|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
94273112|NCT00111800|322793687|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
94273113|NCT00111800|322793688|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
94273114|NCT00111800|322793689|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
94273115|NCT00111800|322793690|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
94273116|NCT00111800|322793691|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
94273117|NCT00111800|322793692|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
94273118|NCT00111800|322793687|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
94273119|NCT00111800|322793688|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
94273120|NCT00111800|322793689|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
94273121|NCT00111800|322793690|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
94273122|NCT00111800|322793691|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
94273123|NCT00111800|322793692|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
94273124|NCT00111800|322793687|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
94273125|NCT00111800|322793688|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
94273126|NCT00111800|322793689|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
94273127|NCT00111800|322793690|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
94273128|NCT00111800|322793691|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
94273129|NCT00111800|322793692|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
94273130|NCT00111800|322793687|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
94273131|NCT00111800|322793688|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
94273132|NCT00111800|322793689|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
94725691|NCT03143153|324453955|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
94725692|NCT03143153|324453956|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
94725693|NCT03143153|324453954|FG000|Pre-Treatment|Other Reasons|1|||
94725694|NCT03143153|324453955|FG001|Pre-Treatment|Other Reasons|2|||
94725695|NCT03143153|324453956|FG002|Pre-Treatment|Other Reasons|1|||
94725696|NCT03143153|324453954|FG000|Pre-Treatment|Disease Progression|1|||
94725697|NCT03143153|324453955|FG001|Pre-Treatment|Disease Progression|1|||
94725698|NCT03143153|324453956|FG002|Pre-Treatment|Disease Progression|2|||
94725699|NCT03143153|324453954|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
94725700|NCT03143153|324453955|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
94725701|NCT03143153|324453956|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
94725702|NCT03143153|324453954|FG000|Treatment|Disease progression|174|||
94725703|NCT03143153|324453955|FG001|Treatment|Disease progression|184|||
94725704|NCT03143153|324453956|FG002|Treatment|Disease progression|193|||
94725705|NCT03143153|324453954|FG000|Treatment|Study drug toxicity|59|||
94725706|NCT03143153|324453955|FG001|Treatment|Study drug toxicity|33|||
94725707|NCT03143153|324453956|FG002|Treatment|Study drug toxicity|40|||
94725708|NCT03143153|324453954|FG000|Treatment|Death|5|||
94725709|NCT03143153|324453955|FG001|Treatment|Death|3|||
94725710|NCT03143153|324453956|FG002|Treatment|Death|4|||
94725711|NCT03143153|324453954|FG000|Treatment|Adverse event unrelated to study drug|19|||
94725712|NCT03143153|324453955|FG001|Treatment|Adverse event unrelated to study drug|28|||
94725713|NCT03143153|324453956|FG002|Treatment|Adverse event unrelated to study drug|12|||
94725714|NCT03143153|324453954|FG000|Treatment|Participant request to discontinue study treatment|13|||
94725715|NCT03143153|324453955|FG001|Treatment|Participant request to discontinue study treatment|15|||
94725716|NCT03143153|324453956|FG002|Treatment|Participant request to discontinue study treatment|20|||
94725717|NCT03143153|324453954|FG000|Treatment|Participant withdrew consent|3|||
94725718|NCT03143153|324453955|FG001|Treatment|Participant withdrew consent|4|||
94725719|NCT03143153|324453956|FG002|Treatment|Participant withdrew consent|12|||
94725720|NCT03143153|324453954|FG000|Treatment|Pregnancy|1|||
94725721|NCT03143153|324453955|FG001|Treatment|Pregnancy|0|||
94725722|NCT03143153|324453956|FG002|Treatment|Pregnancy|0|||
94725723|NCT03143153|324453954|FG000|Treatment|Maximum clinical benefit|1|||
94725724|NCT03143153|324453955|FG001|Treatment|Maximum clinical benefit|3|||
94725725|NCT03143153|324453956|FG002|Treatment|Maximum clinical benefit|4|||
94725726|NCT03143153|324453954|FG000|Treatment|Completed treatment as per Protocol|13|||
94725727|NCT03143153|324453955|FG001|Treatment|Completed treatment as per Protocol|8|||
94725728|NCT03143153|324453956|FG002|Treatment|Completed treatment as per Protocol|0|||
94725729|NCT03143153|324453954|FG000|Treatment|Other reasons|12|||
94725730|NCT03143153|324453955|FG001|Treatment|Other reasons|7|||
94725731|NCT03143153|324453956|FG002|Treatment|Other reasons|15|||
94725732|NCT03143153|324453954|FG000|Treatment|Not reported|1|||
94725733|NCT03143153|324453955|FG001|Treatment|Not reported|0|||
94725734|NCT03143153|324453956|FG002|Treatment|Not reported|0|||
94725735|NCT02530671|324453957|FG000|Overall Study|Lost to Follow-up|2|||
94725736|NCT02530671|324453958|FG001|Overall Study|Lost to Follow-up|0|||
94725737|NCT02530671|324453957|FG000|Overall Study|Withdrawal by Subject|1|||
94725738|NCT02530671|324453958|FG001|Overall Study|Withdrawal by Subject|0|||
94368441|NCT03125915|323134936|FG001|3 Month Follow-up|Lost to Follow-up|4|||
94368442|NCT03125915|323134937|FG002|3 Month Follow-up|Lost to Follow-up|4|||
94725739|NCT02736409|324453959|FG000|Overall Study|Withdrawal by Subject|4|||
94725740|NCT02736409|324453960|FG001|Overall Study|Withdrawal by Subject|2|||
94725741|NCT02736409|324453961|FG002|Overall Study|Withdrawal by Subject|17|||
94725742|NCT02736409|324453962|FG003|Overall Study|Withdrawal by Subject|3|||
94725743|NCT02736409|324453959|FG000|Overall Study|Non-Compliance with Study Drug|0|||
94725744|NCT02736409|324453960|FG001|Overall Study|Non-Compliance with Study Drug|0|||
94725745|NCT02736409|324453961|FG002|Overall Study|Non-Compliance with Study Drug|0|||
94725746|NCT02736409|324453962|FG003|Overall Study|Non-Compliance with Study Drug|1|||
94725747|NCT02736409|324453959|FG000|Overall Study|Adverse Event|0|||
94725748|NCT02736409|324453960|FG001|Overall Study|Adverse Event|1|||
94725749|NCT02736409|324453961|FG002|Overall Study|Adverse Event|5|||
94725750|NCT02736409|324453962|FG003|Overall Study|Adverse Event|4|||
94725751|NCT02736409|324453959|FG000|Overall Study|Other|0|||
94725752|NCT02736409|324453960|FG001|Overall Study|Other|0|||
94725753|NCT02736409|324453961|FG002|Overall Study|Other|1|||
94725754|NCT02736409|324453962|FG003|Overall Study|Other|1|||
94725755|NCT02736409|324453959|FG000|Overall Study|Pregnancy|0|||
94725756|NCT02736409|324453960|FG001|Overall Study|Pregnancy|0|||
94725757|NCT02736409|324453961|FG002|Overall Study|Pregnancy|1|||
94725758|NCT02736409|324453962|FG003|Overall Study|Pregnancy|0|||
94725759|NCT02736409|324453959|FG000|Overall Study|Lost to Follow-up|0|||
94725760|NCT02736409|324453960|FG001|Overall Study|Lost to Follow-up|0|||
94725761|NCT02736409|324453961|FG002|Overall Study|Lost to Follow-up|2|||
94725762|NCT02736409|324453962|FG003|Overall Study|Lost to Follow-up|1|||
94725763|NCT02736409|324453959|FG000|Overall Study|Physician Decision|0|||
94725764|NCT02736409|324453960|FG001|Overall Study|Physician Decision|0|||
94725765|NCT02736409|324453961|FG002|Overall Study|Physician Decision|0|||
94467376|NCT03677934|323500535|FG001|Overall Study|Non-Compliance With Study Drug|0|||
94467377|NCT03677934|323500534|FG000|Overall Study|Physician Decision|0|||
94467378|NCT03677934|323500535|FG001|Overall Study|Physician Decision|1|||
94725766|NCT02736409|324453962|FG003|Overall Study|Physician Decision|2|||
94725767|NCT03336333|324453963|FG000|Overall Study|Remained on study at time of data cut-off|202|||
94725768|NCT03336333|324453964|FG001|Overall Study|Remained on study at time of data cut-off|219|||
94725769|NCT03336333|324453965|FG002|Overall Study|Remained on study at time of data cut-off|102|||
94725770|NCT03336333|324453963|FG000|Overall Study|Death|14|||
94725771|NCT03336333|324453964|FG001|Overall Study|Death|16|||
94725772|NCT03336333|324453965|FG002|Overall Study|Death|8|||
94725773|NCT03336333|324453963|FG000|Overall Study|Withdrawal by Subject|16|||
94725774|NCT03336333|324453964|FG001|Overall Study|Withdrawal by Subject|5|||
94725775|NCT03336333|324453965|FG002|Overall Study|Withdrawal by Subject|1|||
94725776|NCT03336333|324453963|FG000|Overall Study|Physician Decision|5|||
94725777|NCT03336333|324453964|FG001|Overall Study|Physician Decision|1|||
94725778|NCT03336333|324453965|FG002|Overall Study|Physician Decision|0|||
94725779|NCT03336333|324453963|FG000|Overall Study|Lost to Follow-up|1|||
94725780|NCT03336333|324453964|FG001|Overall Study|Lost to Follow-up|0|||
94725781|NCT03336333|324453965|FG002|Overall Study|Lost to Follow-up|0|||
94725782|NCT05192200|324453970|FG000|Treatment Period|Other|1|||
94725783|NCT05192200|324453970|FG000|Treatment Period|Lack of Efficacy|1|||
94725784|NCT05192200|324453970|FG000|Treatment Period|Withdrawal by Subject|1|||
94725785|NCT05192200|324453970|FG000|Follow-up|Withdrawal by Subject|1|||
94725786|NCT03623321|324453971|FG000|Overall Study|Adverse Event|32|||
94725787|NCT03623321|324453971|FG000|Overall Study|Death|9|||
94725788|NCT03623321|324453971|FG000|Overall Study|Lack of Efficacy|9|||
94725789|NCT03623321|324453971|FG000|Overall Study|Lost to Follow-up|6|||
94725790|NCT03623321|324453971|FG000|Overall Study|Noncompliance with study drug|6|||
94725791|NCT03623321|324453971|FG000|Overall Study|Use of prohibited medication|3|||
94725792|NCT03623321|324453971|FG000|Overall Study|Physician Decision|5|||
94725793|NCT03623321|324453971|FG000|Overall Study|Protocol Violation|1|||
94725794|NCT03623321|324453971|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
94725795|NCT03623321|324453971|FG000|Overall Study|Not further specified|43|||
94725796|NCT04177823|324453972|FG000|Overall Study|Physician Decision|1|||
94725797|NCT04177823|324453972|FG000|Overall Study|Withdrawal by Subject|1|||
94725798|NCT05178316|324453973|FG000|Overall Study|Adverse Event|5|||
94725799|NCT05178316|324453974|FG001|Overall Study|Adverse Event|4|||
94725800|NCT05178316|324453975|FG002|Overall Study|Adverse Event|9|||
94725801|NCT05178316|324453973|FG000|Overall Study|Enrolled in Error|1|||
94725802|NCT05178316|324453974|FG001|Overall Study|Enrolled in Error|2|||
94725803|NCT05178316|324453975|FG002|Overall Study|Enrolled in Error|1|||
94725804|NCT05178316|324453973|FG000|Overall Study|Lost to Follow-up|3|||
94725805|NCT05178316|324453974|FG001|Overall Study|Lost to Follow-up|15|||
94725806|NCT05178316|324453975|FG002|Overall Study|Lost to Follow-up|11|||
94725807|NCT05178316|324453973|FG000|Overall Study|Noncompliance|1|||
94725808|NCT05178316|324453974|FG001|Overall Study|Noncompliance|3|||
94725809|NCT05178316|324453975|FG002|Overall Study|Noncompliance|1|||
94725810|NCT05178316|324453973|FG000|Overall Study|Other|0|||
94725811|NCT05178316|324453974|FG001|Overall Study|Other|1|||
94725812|NCT05178316|324453975|FG002|Overall Study|Other|0|||
94725813|NCT05178316|324453973|FG000|Overall Study|Physician Decision|0|||
94725814|NCT05178316|324453974|FG001|Overall Study|Physician Decision|3|||
94368443|NCT03125915|323134938|FG003|3 Month Follow-up|Lost to Follow-up|2|||
94368444|NCT03125915|323134935|FG000|6 Month Follow-up|Lost to Follow-up|7|||
94368445|NCT03125915|323134936|FG001|6 Month Follow-up|Lost to Follow-up|3|||
94368446|NCT03125915|323134937|FG002|6 Month Follow-up|Lost to Follow-up|6|||
94368447|NCT03125915|323134938|FG003|6 Month Follow-up|Lost to Follow-up|3|||
94368448|NCT00828516|323134943|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
94368449|NCT00990093|323134944|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
94368450|NCT00990093|323134945|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
94368451|NCT00990093|323134944|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
94368452|NCT00990093|323134945|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
94368453|NCT00990093|323134944|FG000|Test Period 1 (1-14 Days)|Other|1|||
94725815|NCT05178316|324453975|FG002|Overall Study|Physician Decision|2|||
94725816|NCT05178316|324453973|FG000|Overall Study|Protocol deviation|1|||
94725817|NCT05178316|324453974|FG001|Overall Study|Protocol deviation|0|||
94725818|NCT05178316|324453975|FG002|Overall Study|Protocol deviation|1|||
94725819|NCT05178316|324453973|FG000|Overall Study|Sponsor decision|1|||
94725820|NCT05178316|324453974|FG001|Overall Study|Sponsor decision|0|||
94725821|NCT05178316|324453975|FG002|Overall Study|Sponsor decision|1|||
94725822|NCT05178316|324453973|FG000|Overall Study|Withdrawal by Subject|5|||
94725823|NCT05178316|324453974|FG001|Overall Study|Withdrawal by Subject|11|||
94725824|NCT05178316|324453975|FG002|Overall Study|Withdrawal by Subject|5|||
94725825|NCT05369403|324453977|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
94725826|NCT05369403|324453978|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
94725827|NCT05369403|324453979|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
94725828|NCT05369403|324453977|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
94725829|NCT05369403|324453978|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
94725830|NCT05369403|324453979|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
94725831|NCT05369403|324453977|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
94725832|NCT05369403|324453978|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
94725833|NCT05369403|324453979|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
94725834|NCT05369403|324453977|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
94725835|NCT05369403|324453978|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
94725836|NCT05369403|324453979|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
94725837|NCT05369403|324453977|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
94725838|NCT05369403|324453978|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
94725839|NCT05369403|324453979|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
94725840|NCT05369403|324453977|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
94725841|NCT05369403|324453978|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
94725842|NCT05369403|324453979|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
94725843|NCT05369403|324453977|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
94725844|NCT05369403|324453978|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
94725845|NCT05369403|324453979|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
94725846|NCT05369403|324453977|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
94725847|NCT05369403|324453978|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
94725848|NCT05369403|324453979|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
94725849|NCT05369403|324453977|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
94725850|NCT05369403|324453978|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
94725851|NCT05369403|324453979|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
94725852|NCT05369403|324453977|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
94725853|NCT05369403|324453978|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
94725854|NCT05369403|324453979|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
94725855|NCT05369403|324453977|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
94725856|NCT05369403|324453978|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
94725857|NCT05369403|324453979|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
94273133|NCT00111800|322793690|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
94273134|NCT00111800|322793691|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
94273135|NCT00111800|322793692|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
94273136|NCT00111800|322793687|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
94273137|NCT00111800|322793688|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
94273138|NCT00111800|322793689|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
94273139|NCT00111800|322793690|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
94273140|NCT00111800|322793691|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
94273141|NCT00111800|322793692|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
94273142|NCT00111800|322793687|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
94273143|NCT00111800|322793688|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
94273144|NCT00111800|322793689|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
94273145|NCT00111800|322793690|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
94368454|NCT00990093|323134945|FG001|Test Period 1 (1-14 Days)|Other|0|||
94725858|NCT03792256|324453984|FG000|Overall Study|Death|0|||
94725859|NCT03792256|324453985|FG001|Overall Study|Death|1|||
94725860|NCT03792256|324453984|FG000|Overall Study|Lack of Efficacy|0|||
94725861|NCT03792256|324453985|FG001|Overall Study|Lack of Efficacy|1|||
94725862|NCT03792256|324453984|FG000|Overall Study|Withdrawal by Subject|0|||
94725863|NCT03792256|324453985|FG001|Overall Study|Withdrawal by Subject|1|||
94725864|NCT04896476|324453986|FG000|Overall Study|Withdrawal by Subject|1|||
94725865|NCT04896476|324453986|FG000|Overall Study|Lost to Follow-up|2|||
94725866|NCT04977947|324453987|FG000|Overall Study|Lost to Follow-up|1|||
94725867|NCT04977947|324453988|FG001|Overall Study|Lost to Follow-up|1|||
94725868|NCT05875142|324453989|FG000|Overall Study|Lost to Follow-up|0|||
94725869|NCT05875142|324453990|FG001|Overall Study|Lost to Follow-up|1|||
94725870|NCT05875142|324453991|FG002|Overall Study|Lost to Follow-up|1|||
94725871|NCT03665597|324453992|FG000|Period 1|Adverse Event|1|||
94725872|NCT03665597|324453993|FG001|Period 1|Adverse Event|0|||
94725873|NCT03665597|324453994|FG002|Period 1|Adverse Event|0|||
94725874|NCT03665597|324453995|FG003|Period 1|Adverse Event|1|||
94725875|NCT03665597|324453996|FG004|Period 1|Adverse Event|0|||
94725876|NCT03665597|324453997|FG005|Period 1|Adverse Event|0|||
94725877|NCT03665597|324453998|FG006|Period 1|Adverse Event|0|||
94725878|NCT03665597|324453992|FG000|Period 1|Screen Failure|0|||
94725879|NCT03665597|324453993|FG001|Period 1|Screen Failure|0|||
94725880|NCT03665597|324453994|FG002|Period 1|Screen Failure|0|||
94725881|NCT03665597|324453995|FG003|Period 1|Screen Failure|1|||
94725882|NCT03665597|324453996|FG004|Period 1|Screen Failure|0|||
94725883|NCT03665597|324453997|FG005|Period 1|Screen Failure|0|||
94725884|NCT03665597|324453998|FG006|Period 1|Screen Failure|0|||
94725885|NCT03665597|324453992|FG000|Period 1|Death|0|||
94725886|NCT03665597|324453993|FG001|Period 1|Death|0|||
94725887|NCT03665597|324453994|FG002|Period 1|Death|0|||
94725888|NCT03665597|324453995|FG003|Period 1|Death|0|||
94725889|NCT03665597|324453996|FG004|Period 1|Death|0|||
94725890|NCT03665597|324453997|FG005|Period 1|Death|0|||
94725891|NCT03665597|324453998|FG006|Period 1|Death|45|||
94725892|NCT03665597|324453992|FG000|Period 1|Withdrawal by Subject|0|||
94725893|NCT03665597|324453993|FG001|Period 1|Withdrawal by Subject|0|||
94725894|NCT03665597|324453994|FG002|Period 1|Withdrawal by Subject|0|||
94725895|NCT03665597|324453995|FG003|Period 1|Withdrawal by Subject|0|||
94725896|NCT03665597|324453996|FG004|Period 1|Withdrawal by Subject|0|||
94725897|NCT03665597|324453997|FG005|Period 1|Withdrawal by Subject|0|||
94725898|NCT03665597|324453998|FG006|Period 1|Withdrawal by Subject|5|||
94725899|NCT03665597|324453992|FG000|Period 2|Adverse Event|0|||
94725900|NCT03665597|324453993|FG001|Period 2|Adverse Event|0|||
94725901|NCT03665597|324453994|FG002|Period 2|Adverse Event|0|||
94725902|NCT03665597|324453995|FG003|Period 2|Adverse Event|0|||
94725903|NCT03665597|324453996|FG004|Period 2|Adverse Event|0|||
94725904|NCT03665597|324453997|FG005|Period 2|Adverse Event|1|||
94725905|NCT03665597|324453998|FG006|Period 2|Adverse Event|0|||
94725906|NCT03665597|324453992|FG000|Period 3|Adverse Event|0|||
94725907|NCT03665597|324453993|FG001|Period 3|Adverse Event|1|||
94725908|NCT03665597|324453994|FG002|Period 3|Adverse Event|0|||
94725909|NCT03665597|324453995|FG003|Period 3|Adverse Event|0|||
94725910|NCT03665597|324453996|FG004|Period 3|Adverse Event|0|||
94725911|NCT03665597|324453997|FG005|Period 3|Adverse Event|0|||
94725912|NCT03665597|324453998|FG006|Period 3|Adverse Event|0|||
94725913|NCT03665597|324453992|FG000|Period 3|Death|0|||
94725914|NCT03665597|324453993|FG001|Period 3|Death|0|||
94725915|NCT03665597|324453994|FG002|Period 3|Death|0|||
94273146|NCT00111800|322793691|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
94273147|NCT00111800|322793692|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
94273148|NCT00111800|322793687|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
94273149|NCT00111800|322793688|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
94725916|NCT03665597|324453995|FG003|Period 3|Death|0|||
94725917|NCT03665597|324453996|FG004|Period 3|Death|1|||
94725918|NCT03665597|324453997|FG005|Period 3|Death|0|||
94725919|NCT03665597|324453998|FG006|Period 3|Death|0|||
94273150|NCT00111800|322793689|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
94725920|NCT03665597|324453992|FG000|Period 4|Adverse Event|2|||
94725921|NCT03665597|324453993|FG001|Period 4|Adverse Event|2|||
94725922|NCT03665597|324453994|FG002|Period 4|Adverse Event|2|||
94725923|NCT03665597|324453995|FG003|Period 4|Adverse Event|2|||
94725924|NCT03665597|324453996|FG004|Period 4|Adverse Event|1|||
94725925|NCT03665597|324453997|FG005|Period 4|Adverse Event|0|||
94725926|NCT03665597|324453998|FG006|Period 4|Adverse Event|0|||
94725927|NCT03665597|324453992|FG000|Period 4|Death|0|||
94725928|NCT03665597|324453993|FG001|Period 4|Death|0|||
94725929|NCT03665597|324453994|FG002|Period 4|Death|2|||
94725930|NCT03665597|324453995|FG003|Period 4|Death|0|||
94725931|NCT03665597|324453996|FG004|Period 4|Death|0|||
94725932|NCT03665597|324453997|FG005|Period 4|Death|0|||
94725933|NCT03665597|324453998|FG006|Period 4|Death|0|||
94725934|NCT03665597|324453992|FG000|Period 4|Physician Decision|1|||
94725935|NCT03665597|324453993|FG001|Period 4|Physician Decision|2|||
94725936|NCT03665597|324453994|FG002|Period 4|Physician Decision|0|||
94725937|NCT03665597|324453995|FG003|Period 4|Physician Decision|0|||
94725938|NCT03665597|324453996|FG004|Period 4|Physician Decision|0|||
94725939|NCT03665597|324453997|FG005|Period 4|Physician Decision|0|||
94725940|NCT03665597|324453998|FG006|Period 4|Physician Decision|0|||
94725941|NCT05177848|324454001|FG000|Overall Study|Lost to Follow-up|1|||
94725942|NCT05177848|324454002|FG001|Overall Study|Lost to Follow-up|4|||
94725943|NCT05177848|324454001|FG000|Overall Study|Discontinued|2|||
94725944|NCT05177848|324454002|FG001|Overall Study|Discontinued|1|||
94725945|NCT04256941|324454012|FG000|Overall Study|Withdrawal by Subject|0|||
94725946|NCT04256941|324454013|FG001|Overall Study|Withdrawal by Subject|1|||
94725947|NCT04256941|324454012|FG000|Overall Study|Death|1|||
94725948|NCT04256941|324454013|FG001|Overall Study|Death|0|||
94725949|NCT04256941|324454012|FG000|Overall Study|Disease Progession|0|||
94725950|NCT04256941|324454013|FG001|Overall Study|Disease Progession|2|||
94725951|NCT01573442|324454018|FG000|Overall Study|Cancels|9|||
94725952|NCT01573442|324454019|FG001|Overall Study|Cancels|10|||
94725953|NCT04072822|324454026|FG000|Treatment|Adverse Event|9|||
94725954|NCT04072822|324454027|FG001|Treatment|Adverse Event|5|||
94725955|NCT04072822|324454026|FG000|Treatment|Met Stopping Criteria|13|||
94725956|NCT04072822|324454027|FG001|Treatment|Met Stopping Criteria|24|||
94725957|NCT04072822|324454026|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
94725958|NCT04072822|324454027|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
94725959|NCT04072822|324454026|FG000|Treatment|Withdrawal by Subject|0|||
94725960|NCT04072822|324454027|FG001|Treatment|Withdrawal by Subject|2|||
94725961|NCT04072822|324454026|FG000|Treatment|Death|0|||
94725962|NCT04072822|324454027|FG001|Treatment|Death|2|||
94725963|NCT04072822|324454026|FG000|Treatment|Lost to Follow-up|11|||
94725964|NCT04072822|324454027|FG001|Treatment|Lost to Follow-up|3|||
94725965|NCT04072822|324454026|FG000|Treatment|Physician Decision|1|||
94725966|NCT04072822|324454027|FG001|Treatment|Physician Decision|0|||
94725967|NCT04072822|324454026|FG000|Treatment|Other|7|||
94725968|NCT04072822|324454027|FG001|Treatment|Other|9|||
94725969|NCT04072822|324454026|FG000|Follow-up|Withdrawal by Subject|1|||
94725970|NCT04072822|324454027|FG001|Follow-up|Withdrawal by Subject|0|||
94725971|NCT04072822|324454026|FG000|Follow-up|Lost to Follow-up|5|||
94725972|NCT04072822|324454027|FG001|Follow-up|Lost to Follow-up|4|||
94725973|NCT05076708|324454028|FG000|Overall Study|Withdrawal by Subject|4|||
94725974|NCT05076708|324454028|FG000|Overall Study|Lost to study during switch phase|8|||
94725975|NCT04391894|324454032|FG000|Overall Study|Adverse Event|1|||
94725976|NCT04391894|324454033|FG001|Overall Study|Adverse Event|1|||
94725977|NCT04391894|324454034|FG002|Overall Study|Adverse Event|1|||
94725978|NCT04391894|324454035|FG003|Overall Study|Adverse Event|1|||
94725979|NCT04391894|324454036|FG004|Overall Study|Adverse Event|1|||
94725980|NCT04391894|324454032|FG000|Overall Study|Lost to Follow-up|1|||
94725981|NCT04391894|324454033|FG001|Overall Study|Lost to Follow-up|0|||
94725982|NCT04391894|324454034|FG002|Overall Study|Lost to Follow-up|0|||
94467379|NCT03677934|323500534|FG000|Overall Study|Withdrawal by Subject|1|||
94467380|NCT03677934|323500535|FG001|Overall Study|Withdrawal by Subject|7|||
94725983|NCT04391894|324454035|FG003|Overall Study|Lost to Follow-up|0|||
94725984|NCT04391894|324454036|FG004|Overall Study|Lost to Follow-up|0|||
94725985|NCT04391894|324454032|FG000|Overall Study|Protocol Violation|0|||
94725986|NCT04391894|324454033|FG001|Overall Study|Protocol Violation|0|||
94725987|NCT04391894|324454034|FG002|Overall Study|Protocol Violation|0|||
94725988|NCT04391894|324454035|FG003|Overall Study|Protocol Violation|1|||
94725989|NCT04391894|324454036|FG004|Overall Study|Protocol Violation|0|||
94725990|NCT04391894|324454032|FG000|Overall Study|Withdrawal by Subject|2|||
94725991|NCT04391894|324454033|FG001|Overall Study|Withdrawal by Subject|0|||
94725992|NCT04391894|324454034|FG002|Overall Study|Withdrawal by Subject|3|||
94725993|NCT04391894|324454035|FG003|Overall Study|Withdrawal by Subject|0|||
94725994|NCT04391894|324454036|FG004|Overall Study|Withdrawal by Subject|1|||
94725995|NCT04391894|324454032|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
94725996|NCT04391894|324454033|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
94725997|NCT04391894|324454034|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
94725998|NCT04391894|324454035|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
94725999|NCT04391894|324454036|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
94726000|NCT04971395|324454043|FG000|Overall Study|Withdrawal by Subject|0|||
94726001|NCT04971395|324454044|FG001|Overall Study|Withdrawal by Subject|1|||
94726002|NCT04971395|324454045|FG002|Overall Study|Withdrawal by Subject|0|||
94726003|NCT03269136|324454046|FG000|Part 1: Dose Escalation|Other|0|||
94726004|NCT03269136|324454047|FG001|Part 1: Dose Escalation|Other|0|||
94726005|NCT03269136|324454048|FG002|Part 1: Dose Escalation|Other|0|||
94726006|NCT03269136|324454049|FG003|Part 1: Dose Escalation|Other|0|||
94726007|NCT03269136|324454050|FG004|Part 1: Dose Escalation|Other|0|||
94726008|NCT03269136|324454051|FG005|Part 1: Dose Escalation|Other|0|||
94726009|NCT03269136|324454052|FG006|Part 1: Dose Escalation|Other|0|||
94726010|NCT03269136|324454053|FG007|Part 1: Dose Escalation|Other|0|||
94726011|NCT03269136|324454054|FG008|Part 1: Dose Escalation|Other|0|||
94726012|NCT03269136|324454055|FG009|Part 1: Dose Escalation|Other|0|||
94726013|NCT03269136|324454056|FG010|Part 1: Dose Escalation|Other|1|||
94726014|NCT03269136|324454057|FG011|Part 1: Dose Escalation|Other|1|||
94726015|NCT03269136|324454058|FG012|Part 1: Dose Escalation|Other|1|||
94726016|NCT03269136|324454059|FG013|Part 1: Dose Escalation|Other|0|||
94726017|NCT03269136|324454060|FG014|Part 1: Dose Escalation|Other|3|||
94726018|NCT03269136|324454061|FG015|Part 1: Dose Escalation|Other|1|||
94726019|NCT03269136|324454062|FG016|Part 1: Dose Escalation|Other|1|||
94726020|NCT03269136|324454063|FG017|Part 1: Dose Escalation|Other|0|||
94726021|NCT03269136|324454046|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
94726022|NCT03269136|324454047|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
94726023|NCT03269136|324454048|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
94726024|NCT03269136|324454049|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
94726025|NCT03269136|324454050|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
94726026|NCT03269136|324454051|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
94726027|NCT03269136|324454052|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
94726028|NCT03269136|324454053|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
94726029|NCT03269136|324454054|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
94726030|NCT03269136|324454055|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
94726031|NCT03269136|324454056|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
94726032|NCT03269136|324454057|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
94726033|NCT03269136|324454058|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
94726034|NCT03269136|324454059|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
94726035|NCT03269136|324454060|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
94726036|NCT03269136|324454061|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
94726037|NCT03269136|324454062|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
94726038|NCT03269136|324454063|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
94726039|NCT03269136|324454046|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
94726040|NCT03269136|324454047|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
94726041|NCT03269136|324454048|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
94726042|NCT03269136|324454049|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
94726043|NCT03269136|324454050|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
94726044|NCT03269136|324454051|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
94726045|NCT03269136|324454052|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
94726046|NCT03269136|324454053|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
94726047|NCT03269136|324454054|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
94726048|NCT03269136|324454055|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
94726049|NCT03269136|324454056|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
94726050|NCT03269136|324454057|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
94726051|NCT03269136|324454058|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
94726052|NCT03269136|324454059|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
94726053|NCT03269136|324454060|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
94726054|NCT03269136|324454061|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
94726055|NCT03269136|324454062|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
94726056|NCT03269136|324454063|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
94726057|NCT03269136|324454046|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
94726058|NCT03269136|324454047|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
94726059|NCT03269136|324454048|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
94726060|NCT03269136|324454049|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
94726061|NCT03269136|324454050|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
94726062|NCT03269136|324454051|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
94726063|NCT03269136|324454052|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
94726064|NCT03269136|324454053|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
94726065|NCT03269136|324454054|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
94726066|NCT03269136|324454055|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
94726067|NCT03269136|324454056|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
94726068|NCT03269136|324454057|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
94726069|NCT03269136|324454058|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
94726070|NCT03269136|324454059|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
94726071|NCT03269136|324454060|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
94726072|NCT03269136|324454061|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
94726073|NCT03269136|324454062|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
94726074|NCT03269136|324454063|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
94726075|NCT03269136|324454046|FG000|Part 1: Dose Escalation|Death|0|||
94726076|NCT03269136|324454047|FG001|Part 1: Dose Escalation|Death|0|||
94726077|NCT03269136|324454048|FG002|Part 1: Dose Escalation|Death|0|||
94726078|NCT03269136|324454049|FG003|Part 1: Dose Escalation|Death|0|||
94726079|NCT03269136|324454050|FG004|Part 1: Dose Escalation|Death|0|||
94726080|NCT03269136|324454051|FG005|Part 1: Dose Escalation|Death|0|||
94726081|NCT03269136|324454052|FG006|Part 1: Dose Escalation|Death|0|||
94726082|NCT03269136|324454053|FG007|Part 1: Dose Escalation|Death|0|||
94726083|NCT03269136|324454054|FG008|Part 1: Dose Escalation|Death|0|||
94726084|NCT03269136|324454055|FG009|Part 1: Dose Escalation|Death|1|||
94726085|NCT03269136|324454056|FG010|Part 1: Dose Escalation|Death|0|||
94726086|NCT03269136|324454057|FG011|Part 1: Dose Escalation|Death|1|||
94726087|NCT03269136|324454058|FG012|Part 1: Dose Escalation|Death|0|||
94726088|NCT03269136|324454059|FG013|Part 1: Dose Escalation|Death|1|||
94726089|NCT03269136|324454060|FG014|Part 1: Dose Escalation|Death|0|||
94726090|NCT03269136|324454061|FG015|Part 1: Dose Escalation|Death|0|||
94726091|NCT03269136|324454062|FG016|Part 1: Dose Escalation|Death|2|||
94726092|NCT03269136|324454063|FG017|Part 1: Dose Escalation|Death|0|||
94726093|NCT03269136|324454046|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
94726094|NCT03269136|324454047|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
94726095|NCT03269136|324454048|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
94726096|NCT03269136|324454049|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
94726097|NCT03269136|324454050|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
94726098|NCT03269136|324454051|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
94726099|NCT03269136|324454052|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
94726100|NCT03269136|324454053|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
94726101|NCT03269136|324454054|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
94726102|NCT03269136|324454055|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
94726103|NCT03269136|324454056|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
94726104|NCT03269136|324454057|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
94726105|NCT03269136|324454058|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
94726106|NCT03269136|324454059|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
94726107|NCT03269136|324454060|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
94726108|NCT03269136|324454061|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
94726109|NCT03269136|324454062|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
94726110|NCT03269136|324454063|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
94726111|NCT03269136|324454046|FG000|Part 1: Dose Escalation|Adverse Event|0|||
94726112|NCT03269136|324454047|FG001|Part 1: Dose Escalation|Adverse Event|0|||
94726113|NCT03269136|324454048|FG002|Part 1: Dose Escalation|Adverse Event|0|||
94726114|NCT03269136|324454049|FG003|Part 1: Dose Escalation|Adverse Event|0|||
94726115|NCT03269136|324454050|FG004|Part 1: Dose Escalation|Adverse Event|0|||
94726116|NCT03269136|324454051|FG005|Part 1: Dose Escalation|Adverse Event|0|||
94726117|NCT03269136|324454052|FG006|Part 1: Dose Escalation|Adverse Event|2|||
94726118|NCT03269136|324454053|FG007|Part 1: Dose Escalation|Adverse Event|0|||
94726119|NCT03269136|324454054|FG008|Part 1: Dose Escalation|Adverse Event|0|||
94726120|NCT03269136|324454055|FG009|Part 1: Dose Escalation|Adverse Event|0|||
94726121|NCT03269136|324454056|FG010|Part 1: Dose Escalation|Adverse Event|1|||
94726122|NCT03269136|324454057|FG011|Part 1: Dose Escalation|Adverse Event|2|||
94726123|NCT03269136|324454058|FG012|Part 1: Dose Escalation|Adverse Event|0|||
94726124|NCT03269136|324454059|FG013|Part 1: Dose Escalation|Adverse Event|1|||
94726125|NCT03269136|324454060|FG014|Part 1: Dose Escalation|Adverse Event|0|||
94726126|NCT03269136|324454061|FG015|Part 1: Dose Escalation|Adverse Event|0|||
94726127|NCT03269136|324454062|FG016|Part 1: Dose Escalation|Adverse Event|1|||
94726128|NCT03269136|324454063|FG017|Part 1: Dose Escalation|Adverse Event|0|||
94726129|NCT03269136|324454046|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
94726130|NCT03269136|324454047|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
94726131|NCT03269136|324454048|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
94726132|NCT03269136|324454049|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
94726133|NCT03269136|324454050|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
94726134|NCT03269136|324454051|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
94726135|NCT03269136|324454052|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
94726136|NCT03269136|324454053|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
94726137|NCT03269136|324454054|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
94726138|NCT03269136|324454055|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
94368455|NCT00990093|323134944|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
94368456|NCT00990093|323134945|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
94368457|NCT00990093|323134944|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
94368458|NCT00990093|323134945|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
94368459|NCT00990093|323134944|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
94368460|NCT00990093|323134945|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
94368461|NCT00990093|323134944|FG000|Test Period 2 (15-28 Days)|Other|0|||
94368462|NCT00990093|323134945|FG001|Test Period 2 (15-28 Days)|Other|1|||
94726139|NCT03269136|324454056|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
94726140|NCT03269136|324454057|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
94726141|NCT03269136|324454058|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
94726142|NCT03269136|324454059|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
94726143|NCT03269136|324454060|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
94726144|NCT03269136|324454061|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
94726145|NCT03269136|324454062|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
94726146|NCT03269136|324454063|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
94726147|NCT03269136|324454046|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94726148|NCT03269136|324454047|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94726149|NCT03269136|324454048|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94726150|NCT03269136|324454049|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94726151|NCT03269136|324454050|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94726152|NCT03269136|324454051|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94726153|NCT03269136|324454052|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94726154|NCT03269136|324454053|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94726155|NCT03269136|324454054|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94726156|NCT03269136|324454055|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94726157|NCT03269136|324454056|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94368463|NCT02623426|323134949|FG000|Overall Study|Lost to Follow-up|0|||
94726158|NCT03269136|324454057|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94368464|NCT02623426|323134950|FG001|Overall Study|Lost to Follow-up|0|||
94368465|NCT02623426|323134951|FG002|Overall Study|Lost to Follow-up|1|||
94368466|NCT02623426|323134949|FG000|Overall Study|Withdrawal by Subject|1|||
94368467|NCT02623426|323134950|FG001|Overall Study|Withdrawal by Subject|2|||
94368468|NCT02623426|323134951|FG002|Overall Study|Withdrawal by Subject|2|||
94368469|NCT00378482|323134952|FG000|Overall Study|Lost to Follow-up|1|||
94368470|NCT00378482|323134952|FG000|Overall Study|Lack of Efficacy|8|||
94368471|NCT00378482|323134952|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
94368472|NCT00378482|323134952|FG000|Overall Study|Withdrawal by Subject|4|||
94368473|NCT00378482|323134952|FG000|Overall Study|Adverse Event|9|||
94368474|NCT03751124|323134953|FG000|Overall Study|Adverse Event|4|||
94368475|NCT03751124|323134954|FG001|Overall Study|Adverse Event|3|||
94368476|NCT03751124|323134953|FG000|Overall Study|Protocol Deviation|0|||
94368477|NCT03751124|323134954|FG001|Overall Study|Protocol Deviation|1|||
94368478|NCT03751124|323134953|FG000|Overall Study|Lost to Follow-up|6|||
94368479|NCT03751124|323134954|FG001|Overall Study|Lost to Follow-up|4|||
94368480|NCT03751124|323134953|FG000|Overall Study|Withdrawal by Subject|6|||
94368481|NCT03751124|323134954|FG001|Overall Study|Withdrawal by Subject|8|||
94368482|NCT03751124|323134953|FG000|Overall Study|Lack of Efficacy|1|||
94368483|NCT03751124|323134954|FG001|Overall Study|Lack of Efficacy|1|||
94368484|NCT03751124|323134953|FG000|Overall Study|Pregnancy|0|||
94368485|NCT03751124|323134954|FG001|Overall Study|Pregnancy|1|||
94368486|NCT03751124|323134953|FG000|Overall Study|Other|9|||
94368487|NCT03751124|323134954|FG001|Overall Study|Other|9|||
94726159|NCT03269136|324454058|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
94368488|NCT03751124|323134953|FG000|Overall Study|Participants who did not receive any study drug|0|||
94368489|NCT03751124|323134954|FG001|Overall Study|Participants who did not receive any study drug|1|||
94368490|NCT00858234|323136454|FG000|Overall Study|Adverse Event|6|||
94368491|NCT00858234|323136454|FG000|Overall Study|Progressive disease|2|||
94368492|NCT00858234|323136454|FG000|Overall Study|Status unknown|1|||
94368493|NCT01336608|323136455|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
94368494|NCT01336608|323136456|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
94467381|NCT01634659|323500552|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
94726160|NCT03269136|324454059|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
94726161|NCT03269136|324454060|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
94726162|NCT03269136|324454061|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94726163|NCT03269136|324454062|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
94726164|NCT03269136|324454063|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94726165|NCT03269136|324454046|FG000|Part 2A: Dose Expansion|Other|0|||
94726166|NCT03269136|324454047|FG001|Part 2A: Dose Expansion|Other|0|||
94726167|NCT03269136|324454048|FG002|Part 2A: Dose Expansion|Other|0|||
94726168|NCT03269136|324454049|FG003|Part 2A: Dose Expansion|Other|0|||
94726169|NCT03269136|324454050|FG004|Part 2A: Dose Expansion|Other|0|||
94726170|NCT03269136|324454051|FG005|Part 2A: Dose Expansion|Other|0|||
94726171|NCT03269136|324454052|FG006|Part 2A: Dose Expansion|Other|0|||
94726172|NCT03269136|324454053|FG007|Part 2A: Dose Expansion|Other|0|||
94726173|NCT03269136|324454054|FG008|Part 2A: Dose Expansion|Other|0|||
94726174|NCT03269136|324454055|FG009|Part 2A: Dose Expansion|Other|0|||
94726175|NCT03269136|324454056|FG010|Part 2A: Dose Expansion|Other|0|||
94726176|NCT03269136|324454057|FG011|Part 2A: Dose Expansion|Other|0|||
94726177|NCT03269136|324454058|FG012|Part 2A: Dose Expansion|Other|0|||
94726178|NCT03269136|324454059|FG013|Part 2A: Dose Expansion|Other|0|||
94726179|NCT03269136|324454060|FG014|Part 2A: Dose Expansion|Other|0|||
94726180|NCT03269136|324454061|FG015|Part 2A: Dose Expansion|Other|0|||
94726181|NCT03269136|324454062|FG016|Part 2A: Dose Expansion|Other|0|||
94726182|NCT03269136|324454063|FG017|Part 2A: Dose Expansion|Other|1|||
94726183|NCT03269136|324454046|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
94726184|NCT03269136|324454047|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
94726185|NCT03269136|324454048|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
94726186|NCT03269136|324454049|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
94726187|NCT03269136|324454050|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
94726188|NCT03269136|324454051|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
94726189|NCT03269136|324454052|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
94726190|NCT03269136|324454053|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
94726191|NCT03269136|324454054|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
94726192|NCT03269136|324454055|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
94726193|NCT03269136|324454056|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
94726194|NCT03269136|324454057|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
94726195|NCT03269136|324454058|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
94726196|NCT03269136|324454059|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
94726197|NCT03269136|324454060|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
94726198|NCT03269136|324454061|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
94726199|NCT03269136|324454062|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
94726200|NCT03269136|324454063|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
94726201|NCT03269136|324454046|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
94726202|NCT03269136|324454047|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
94726203|NCT03269136|324454048|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
94726204|NCT03269136|324454049|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
94726205|NCT03269136|324454050|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
94726206|NCT03269136|324454051|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
94726207|NCT03269136|324454052|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
94726208|NCT03269136|324454053|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
94726209|NCT03269136|324454054|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
94726210|NCT03269136|324454055|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
94726211|NCT03269136|324454056|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
94726212|NCT03269136|324454057|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
94726213|NCT03269136|324454058|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
94726214|NCT03269136|324454059|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
94726215|NCT03269136|324454060|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
94726216|NCT03269136|324454061|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
94726217|NCT03269136|324454062|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
94726218|NCT03269136|324454063|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
94726219|NCT03269136|324454046|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
94726220|NCT03269136|324454047|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
94726221|NCT03269136|324454048|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
94726222|NCT03269136|324454049|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
94726223|NCT03269136|324454050|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
94726224|NCT03269136|324454051|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
94726225|NCT03269136|324454052|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
94726226|NCT03269136|324454053|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
94726227|NCT03269136|324454054|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
94726228|NCT03269136|324454055|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
94726229|NCT03269136|324454056|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
94726230|NCT03269136|324454057|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
94467382|NCT01634659|323500553|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
94467383|NCT01634659|323500552|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
94726231|NCT03269136|324454058|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
94726232|NCT03269136|324454059|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
94726233|NCT03269136|324454060|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
94726234|NCT03269136|324454061|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
94726235|NCT03269136|324454062|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
94726236|NCT03269136|324454063|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
94726237|NCT03269136|324454046|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
94726238|NCT03269136|324454047|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
94726239|NCT03269136|324454048|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
94726240|NCT03269136|324454049|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
94726241|NCT03269136|324454050|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
94726242|NCT03269136|324454051|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
94726243|NCT03269136|324454052|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
94726244|NCT03269136|324454053|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
94726245|NCT03269136|324454054|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
94726246|NCT03269136|324454055|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
94726247|NCT03269136|324454056|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
94726248|NCT03269136|324454057|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
94726249|NCT03269136|324454058|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
94726250|NCT03269136|324454059|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
94726251|NCT03269136|324454060|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
94726252|NCT03269136|324454061|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
94726253|NCT03269136|324454062|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
94726254|NCT03269136|324454063|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
94726255|NCT04717492|324454065|FG000|Overall Study|Withdrawal by Subject|2|||
94726256|NCT04717492|324454066|FG001|Overall Study|Withdrawal by Subject|13|||
94726257|NCT04717492|324454065|FG000|Overall Study|Lost to Follow-up|2|||
94726258|NCT04717492|324454066|FG001|Overall Study|Lost to Follow-up|9|||
94726259|NCT03771417|324454067|FG000|Overall Study|Withdrawal by Subject|1|||
94726260|NCT03771417|324454068|FG001|Overall Study|Withdrawal by Subject|0|||
94726261|NCT03771417|324454069|FG002|Overall Study|Withdrawal by Subject|0|||
94726262|NCT03771417|324454067|FG000|Overall Study|Covid-19 Shutdown|0|||
94726263|NCT03771417|324454068|FG001|Overall Study|Covid-19 Shutdown|1|||
94726264|NCT03771417|324454069|FG002|Overall Study|Covid-19 Shutdown|0|||
94726265|NCT03766009|324454070|FG000|Usual Care|Death|0|||
94726266|NCT03766009|324454071|FG001|Usual Care|Death|0|||
94726267|NCT03766009|324454072|FG002|Usual Care|Death|0|||
94726268|NCT03766009|324454073|FG003|Usual Care|Death|1|||
94726269|NCT03766009|324454074|FG004|Usual Care|Death|0|||
94726270|NCT03766009|324454075|FG005|Usual Care|Death|0|||
94726271|NCT03766009|324454070|FG000|Usual Care|Lost to Follow-up|0|||
94726272|NCT03766009|324454071|FG001|Usual Care|Lost to Follow-up|0|||
94726273|NCT03766009|324454072|FG002|Usual Care|Lost to Follow-up|0|||
94726274|NCT03766009|324454073|FG003|Usual Care|Lost to Follow-up|1|||
94726275|NCT03766009|324454074|FG004|Usual Care|Lost to Follow-up|0|||
94726276|NCT03766009|324454075|FG005|Usual Care|Lost to Follow-up|0|||
94726277|NCT03766009|324454070|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
94726278|NCT03766009|324454071|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
94726279|NCT03766009|324454072|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
94726280|NCT03766009|324454073|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
94726281|NCT03766009|324454074|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
94726282|NCT03766009|324454075|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
94726283|NCT03766009|324454070|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
94726284|NCT03766009|324454071|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
94726285|NCT03766009|324454072|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
94726286|NCT03766009|324454073|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
94467384|NCT01634659|323500553|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
94467385|NCT02267135|323500554|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
94726287|NCT03766009|324454074|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
94726288|NCT03766009|324454075|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
94726289|NCT03766009|324454070|FG000|Usual Care|No treatment or declined surgery|0|||
94726290|NCT03766009|324454071|FG001|Usual Care|No treatment or declined surgery|0|||
94726291|NCT03766009|324454072|FG002|Usual Care|No treatment or declined surgery|0|||
94726292|NCT03766009|324454073|FG003|Usual Care|No treatment or declined surgery|2|||
94726293|NCT03766009|324454074|FG004|Usual Care|No treatment or declined surgery|0|||
94726294|NCT03766009|324454075|FG005|Usual Care|No treatment or declined surgery|0|||
94726295|NCT03766009|324454070|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
94726296|NCT03766009|324454071|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
94467386|NCT02267135|323500555|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
94726297|NCT03766009|324454072|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
94726298|NCT03766009|324454073|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
94726299|NCT03766009|324454074|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
94726300|NCT03766009|324454075|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
94726301|NCT03766009|324454070|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
94726302|NCT03766009|324454071|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
94726303|NCT03766009|324454072|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
94726304|NCT03766009|324454073|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
94726305|NCT03766009|324454074|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
94726306|NCT03766009|324454075|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
94726307|NCT03766009|324454070|FG000|Usual Care|Ineligible|0|||
94726308|NCT03766009|324454071|FG001|Usual Care|Ineligible|1|||
94726309|NCT03766009|324454072|FG002|Usual Care|Ineligible|0|||
94726310|NCT03766009|324454073|FG003|Usual Care|Ineligible|0|||
94726311|NCT03766009|324454074|FG004|Usual Care|Ineligible|0|||
94726312|NCT03766009|324454075|FG005|Usual Care|Ineligible|0|||
94726313|NCT03766009|324454070|FG000|Usual Care|Other: Staff turnover|0|||
94726314|NCT03766009|324454071|FG001|Usual Care|Other: Staff turnover|0|||
94726315|NCT03766009|324454072|FG002|Usual Care|Other: Staff turnover|0|||
94726316|NCT03766009|324454073|FG003|Usual Care|Other: Staff turnover|0|||
94726317|NCT03766009|324454074|FG004|Usual Care|Other: Staff turnover|0|||
94726318|NCT03766009|324454075|FG005|Usual Care|Other: Staff turnover|2|||
94726319|NCT04055090|324454082|FG000|Overall Study|screen failure|1|||
94726320|NCT04055090|324454083|FG001|Overall Study|screen failure|0|||
94726321|NCT04055090|324454082|FG000|Overall Study|Withdrawal by Subject|1|||
94726322|NCT04055090|324454083|FG001|Overall Study|Withdrawal by Subject|0|||
94726323|NCT02515773|324454084|FG000|Overall Study|Withdrawal by Subject|12|||
94726324|NCT02515773|324454085|FG001|Overall Study|Withdrawal by Subject|2|||
94726325|NCT02515773|324454084|FG000|Overall Study|Lost to Follow-up|119|||
94726326|NCT02515773|324454085|FG001|Overall Study|Lost to Follow-up|126|||
94726327|NCT02515773|324454084|FG000|Overall Study|Discharged from Clinic Services|53|||
94726328|NCT02515773|324454085|FG001|Overall Study|Discharged from Clinic Services|84|||
94726329|NCT02515773|324454084|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
94726330|NCT02515773|324454085|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
94726331|NCT02515773|324454084|FG000|Overall Study|Follow-up at non-study site|8|||
94726332|NCT02515773|324454085|FG001|Overall Study|Follow-up at non-study site|16|||
94726333|NCT02515773|324454084|FG000|Overall Study|Moved from area|9|||
94726334|NCT02515773|324454085|FG001|Overall Study|Moved from area|14|||
94726335|NCT05835336|324454086|FG000|Overall Study|Withdrawal by Subject|5|||
94726336|NCT05835336|324454086|FG000|Overall Study|Did not complete the personalization process|3|||
94726337|NCT03770273|324455535|FG000|Overall Study|Adverse Event|2|||
94726338|NCT03770273|324455536|FG001|Overall Study|Adverse Event|0|||
94726339|NCT03770273|324455535|FG000|Overall Study|Lost to Follow-up|1|||
94726340|NCT03770273|324455536|FG001|Overall Study|Lost to Follow-up|1|||
94726341|NCT00418886|324455537|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
94726342|NCT00418886|324455538|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
94726343|NCT00418886|324455537|FG000|Randomized Period|Death|122|||
94726344|NCT00418886|324455538|FG001|Randomized Period|Death|147|||
94726345|NCT00418886|324455537|FG000|Randomized Period|Withdrawal by Subject|9|||
94726346|NCT00418886|324455538|FG001|Randomized Period|Withdrawal by Subject|10|||
94726347|NCT00418886|324455537|FG000|Randomized Period|Lost to Follow-up|4|||
94726348|NCT00418886|324455538|FG001|Randomized Period|Lost to Follow-up|6|||
94726349|NCT00418886|324455537|FG000|Randomized Period|withdrawn due to other reason|1|||
94726350|NCT00418886|324455538|FG001|Randomized Period|withdrawn due to other reason|0|||
94726351|NCT00418886|324455537|FG000|Randomized Period|randomised but no treatment received|0|||
94726352|NCT00418886|324455538|FG001|Randomized Period|randomised but no treatment received|1|||
94726353|NCT04887129|324455539|FG000|Overall Study|Lost to Follow-up|0|||
94726354|NCT04887129|324455540|FG001|Overall Study|Lost to Follow-up|24|||
94726355|NCT04887129|324455539|FG000|Overall Study|Withdrawal by Subject|9|||
94726356|NCT04887129|324455540|FG001|Overall Study|Withdrawal by Subject|57|||
94726357|NCT04887129|324455539|FG000|Overall Study|Other|2|||
94726358|NCT04887129|324455540|FG001|Overall Study|Other|9|||
94726359|NCT01999075|324455541|FG000|Overall Study|Lost to Follow-up|0|||
94726360|NCT01999075|324455542|FG001|Overall Study|Lost to Follow-up|2|||
94726361|NCT01999075|324455541|FG000|Overall Study|Withdrawal by Subject|2|||
94726362|NCT01999075|324455542|FG001|Overall Study|Withdrawal by Subject|7|||
94273151|NCT00111800|322793690|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
94273152|NCT00111800|322793691|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
94726363|NCT01999075|324455541|FG000|Overall Study|Enrolled in drug trial|3|||
94726364|NCT01999075|324455542|FG001|Overall Study|Enrolled in drug trial|1|||
94726365|NCT01999075|324455541|FG000|Overall Study|Became ineligible|0|||
94273153|NCT00111800|322793692|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
94368495|NCT01336608|323136457|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
94368496|NCT01336608|323136458|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
94368497|NCT01336608|323136455|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
94368498|NCT01336608|323136456|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
94726366|NCT01999075|324455542|FG001|Overall Study|Became ineligible|2|||
94726367|NCT01413100|324455543|FG000|Overall Study|Withdrawal by Subject|1|||
94726368|NCT04760678|324455544|FG000|Overall Study|Death|13|||
94726369|NCT04760678|324455544|FG000|Overall Study|Lost to Follow-up|48|||
94726370|NCT04760678|324455544|FG000|Overall Study|Withdrawal by Subject|1|||
94726371|NCT04562649|324455545|FG000|Overall Study|Withdrawal by Subject|11|||
94726372|NCT04562649|324455546|FG001|Overall Study|Withdrawal by Subject|8|||
94726373|NCT04562649|324455545|FG000|Overall Study|Lost to Follow-up|26|||
94726374|NCT04562649|324455546|FG001|Overall Study|Lost to Follow-up|20|||
94726375|NCT04029688|324455547|FG000|Overall Study|Death|8|||
94726376|NCT04029688|324455548|FG001|Overall Study|Death|3|||
94726377|NCT04029688|324455549|FG002|Overall Study|Death|6|||
94726378|NCT04029688|324455550|FG003|Overall Study|Death|2|||
94726379|NCT04029688|324455551|FG004|Overall Study|Death|5|||
94726380|NCT04029688|324455552|FG005|Overall Study|Death|0|||
94726381|NCT04029688|324455553|FG006|Overall Study|Death|2|||
94726382|NCT04029688|324455554|FG007|Overall Study|Death|3|||
94726383|NCT04029688|324455547|FG000|Overall Study|Study Terminated by Sponsor|0|||
94726384|NCT04029688|324455548|FG001|Overall Study|Study Terminated by Sponsor|0|||
94726385|NCT04029688|324455549|FG002|Overall Study|Study Terminated by Sponsor|0|||
94726386|NCT04029688|324455550|FG003|Overall Study|Study Terminated by Sponsor|0|||
94726387|NCT04029688|324455551|FG004|Overall Study|Study Terminated by Sponsor|1|||
94726388|NCT04029688|324455552|FG005|Overall Study|Study Terminated by Sponsor|3|||
94726389|NCT04029688|324455553|FG006|Overall Study|Study Terminated by Sponsor|1|||
94726390|NCT04029688|324455554|FG007|Overall Study|Study Terminated by Sponsor|3|||
94726391|NCT04029688|324455547|FG000|Overall Study|Withdrawal by Subject|0|||
94726392|NCT04029688|324455548|FG001|Overall Study|Withdrawal by Subject|0|||
94726393|NCT04029688|324455549|FG002|Overall Study|Withdrawal by Subject|0|||
94726394|NCT04029688|324455550|FG003|Overall Study|Withdrawal by Subject|1|||
94726395|NCT04029688|324455551|FG004|Overall Study|Withdrawal by Subject|0|||
94726396|NCT04029688|324455552|FG005|Overall Study|Withdrawal by Subject|0|||
94726397|NCT04029688|324455553|FG006|Overall Study|Withdrawal by Subject|0|||
94726398|NCT04029688|324455554|FG007|Overall Study|Withdrawal by Subject|0|||
94726399|NCT05048238|324455559|FG000|Overall Study|Withdrawal by Subject|1|||
94726400|NCT00450658|324455560|FG000|Overall Study|Adverse Event|24|||
94726401|NCT00450658|324455561|FG001|Overall Study|Adverse Event|15|||
94726402|NCT00450658|324455560|FG000|Overall Study|Withdrawal by Subject|43|||
94726403|NCT00450658|324455561|FG001|Overall Study|Withdrawal by Subject|26|||
94726404|NCT00450658|324455560|FG000|Overall Study|Lost to Follow-up|22|||
94726405|NCT00450658|324455561|FG001|Overall Study|Lost to Follow-up|5|||
94726406|NCT00450658|324455560|FG000|Overall Study|UGI ulcer|33|||
94726407|NCT00450658|324455561|FG001|Overall Study|UGI ulcer|34|||
94726408|NCT00450658|324455560|FG000|Overall Study|misc|21|||
94726409|NCT00450658|324455561|FG001|Overall Study|misc|10|||
94726410|NCT02975934|324455562|FG000|Treatment Phase|Ongoing at data-analysis|33|||
94726411|NCT02975934|324455563|FG001|Treatment Phase|Ongoing at data-analysis|5|||
94726412|NCT02975934|324455562|FG000|Treatment Phase|Discontinued prior to study drug|0|||
94726413|NCT02975934|324455563|FG001|Treatment Phase|Discontinued prior to study drug|5|||
94726414|NCT02975934|324455562|FG000|Cross-Over Phase|Ongoing at data-analysis|0|||
94726415|NCT02975934|324455563|FG001|Cross-Over Phase|Ongoing at data-analysis|7|||
94273154|NCT00111800|322793687|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
94273155|NCT00111800|322793688|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
94273156|NCT00111800|322793689|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
94726416|NCT04764448|324455564|FG000|Overall Study|Study terminated by sponsor|2|||
94726417|NCT04764448|324455565|FG001|Overall Study|Study terminated by sponsor|2|||
94273157|NCT00111800|322793690|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
94273158|NCT00111800|322793691|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
94726418|NCT04764448|324455566|FG002|Overall Study|Study terminated by sponsor|5|||
94726419|NCT04764448|324455564|FG000|Overall Study|Withdrawal by Subject|3|||
94273159|NCT00111800|322793692|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
94726420|NCT04764448|324455565|FG001|Overall Study|Withdrawal by Subject|3|||
94726421|NCT04764448|324455566|FG002|Overall Study|Withdrawal by Subject|1|||
94726422|NCT04727554|324455569|FG000|Overall Study|Lost to Follow-up|0|||
94726423|NCT04727554|324455570|FG001|Overall Study|Lost to Follow-up|1|||
94726424|NCT04727554|324455569|FG000|Overall Study|Death|2|||
94726425|NCT04727554|324455570|FG001|Overall Study|Death|6|||
94726426|NCT04727554|324455569|FG000|Overall Study|Withdrawal by Subject|1|||
94726427|NCT04727554|324455570|FG001|Overall Study|Withdrawal by Subject|0|||
94726428|NCT04515576|324455571|FG000|Overall Study|Withdrawal by Subject|0|||
94726429|NCT04515576|324455572|FG001|Overall Study|Withdrawal by Subject|0|||
94726430|NCT04515576|324455573|FG002|Overall Study|Withdrawal by Subject|0|||
94726431|NCT04515576|324455574|FG003|Overall Study|Withdrawal by Subject|0|||
94726432|NCT04515576|324455575|FG004|Overall Study|Withdrawal by Subject|0|||
94726433|NCT04515576|324455576|FG005|Overall Study|Withdrawal by Subject|1|||
94726434|NCT05763823|324455577|FG000|Overall Study|Death|6|||
94726435|NCT05763823|324455577|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
94726436|NCT05763823|324455577|FG000|Overall Study|Withdrawal by Subject|6|||
94726437|NCT00999804|324455580|FG000|Overall Study|Lack of Efficacy|9|||
94726438|NCT00999804|324455581|FG001|Overall Study|Lack of Efficacy|2|||
94726439|NCT00999804|324455580|FG000|Overall Study|Adverse Event|4|||
94726440|NCT00999804|324455581|FG001|Overall Study|Adverse Event|3|||
94726441|NCT00999804|324455580|FG000|Overall Study|Withdrawal by Subject|4|||
94726442|NCT00999804|324455581|FG001|Overall Study|Withdrawal by Subject|0|||
94726443|NCT00999804|324455580|FG000|Overall Study|Death|1|||
94726444|NCT00999804|324455581|FG001|Overall Study|Death|0|||
94726445|NCT00999804|324455580|FG000|Overall Study|Ineligible|3|||
94726446|NCT00999804|324455581|FG001|Overall Study|Ineligible|0|||
94726447|NCT03812679|324455584|FG000|Overall Study|Adverse Event|2|||
94726448|NCT03812679|324455584|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
94726449|NCT03812679|324455584|FG000|Overall Study|Renal transplant|1|||
94726450|NCT03812679|324455584|FG000|Overall Study|Withdrawal by Subject|1|||
94726451|NCT03812679|324455584|FG000|Overall Study|Termination of study|2|||
94726452|NCT03812679|324455584|FG000|Overall Study|Water device replacement|1|||
94726453|NCT01997840|324455587|FG000|Overall Study|Lost to Follow-up|0|||
94726454|NCT01997840|324455588|FG001|Overall Study|Lost to Follow-up|0|||
94726455|NCT01997840|324455589|FG002|Overall Study|Lost to Follow-up|1|||
94726456|NCT01997840|324455590|FG003|Overall Study|Lost to Follow-up|0|||
94726457|NCT01997840|324455587|FG000|Overall Study|Withdrawal by participant|0|||
94726458|NCT01997840|324455588|FG001|Overall Study|Withdrawal by participant|0|||
94726459|NCT01997840|324455589|FG002|Overall Study|Withdrawal by participant|8|||
94726460|NCT01997840|324455590|FG003|Overall Study|Withdrawal by participant|1|||
94726461|NCT01997840|324455587|FG000|Overall Study|Physician Decision|0|||
94726462|NCT01997840|324455588|FG001|Overall Study|Physician Decision|0|||
94726463|NCT01997840|324455589|FG002|Overall Study|Physician Decision|3|||
94726464|NCT01997840|324455590|FG003|Overall Study|Physician Decision|0|||
94726465|NCT01997840|324455587|FG000|Overall Study|Progressive disease|3|||
94726466|NCT01997840|324455588|FG001|Overall Study|Progressive disease|4|||
94726467|NCT01997840|324455589|FG002|Overall Study|Progressive disease|57|||
94726468|NCT01997840|324455590|FG003|Overall Study|Progressive disease|8|||
94726469|NCT01997840|324455587|FG000|Overall Study|Other reasons|0|||
94726470|NCT01997840|324455588|FG001|Overall Study|Other reasons|0|||
94726471|NCT01997840|324455589|FG002|Overall Study|Other reasons|1|||
94726472|NCT01997840|324455590|FG003|Overall Study|Other reasons|0|||
94726473|NCT01997840|324455587|FG000|Overall Study|Adverse Event|0|||
94726474|NCT01997840|324455588|FG001|Overall Study|Adverse Event|0|||
94726475|NCT01997840|324455589|FG002|Overall Study|Adverse Event|15|||
94726476|NCT01997840|324455590|FG003|Overall Study|Adverse Event|2|||
94726477|NCT02724631|324455598|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
94726478|NCT04166773|324455599|FG000|Overall Study|Adverse Event|2|||
94726479|NCT04166773|324455600|FG001|Overall Study|Adverse Event|0|||
94726480|NCT04166773|324455601|FG002|Overall Study|Adverse Event|2|||
94726481|NCT04166773|324455602|FG003|Overall Study|Adverse Event|1|||
94726482|NCT04166773|324455599|FG000|Overall Study|Lost to Follow-up|4|||
94726483|NCT04166773|324455600|FG001|Overall Study|Lost to Follow-up|2|||
94726484|NCT04166773|324455601|FG002|Overall Study|Lost to Follow-up|1|||
94726485|NCT04166773|324455602|FG003|Overall Study|Lost to Follow-up|3|||
94726486|NCT04166773|324455599|FG000|Overall Study|Physician Decision|0|||
94726487|NCT04166773|324455600|FG001|Overall Study|Physician Decision|0|||
94726488|NCT04166773|324455601|FG002|Overall Study|Physician Decision|0|||
94726489|NCT04166773|324455602|FG003|Overall Study|Physician Decision|1|||
94726490|NCT04166773|324455599|FG000|Overall Study|Withdrawal by Subject|1|||
94726491|NCT04166773|324455600|FG001|Overall Study|Withdrawal by Subject|1|||
94726492|NCT04166773|324455601|FG002|Overall Study|Withdrawal by Subject|2|||
94726493|NCT04166773|324455602|FG003|Overall Study|Withdrawal by Subject|5|||
94726494|NCT04763265|324455603|FG000|Overall Study|Adverse Event|1|||
94726495|NCT04763265|324455604|FG001|Overall Study|Adverse Event|0|||
94726496|NCT04763265|324455603|FG000|Overall Study|Lost to Follow-up|2|||
94726497|NCT04763265|324455604|FG001|Overall Study|Lost to Follow-up|4|||
94726498|NCT04763265|324455603|FG000|Overall Study|Withdrawal by Subject|0|||
94726499|NCT04763265|324455604|FG001|Overall Study|Withdrawal by Subject|1|||
94726500|NCT04728347|324455609|FG000|Overall Study|Sponsor decision|0|||
94726501|NCT04728347|324455610|FG001|Overall Study|Sponsor decision|0|||
94726502|NCT04728347|324455611|FG002|Overall Study|Sponsor decision|1|||
94726503|NCT04728347|324455612|FG003|Overall Study|Sponsor decision|0|||
94726504|NCT04221490|324455615|FG000|At 30 Days Follow-up|Death|7|||
94726505|NCT04221490|324455615|FG000|At 30 Days Follow-up|Missed Visit|4|||
94726506|NCT04221490|324455615|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
94726507|NCT04221490|324455615|FG000|At 6 Months Follow-up|Death|9|||
94726508|NCT04221490|324455615|FG000|At 6 Months Follow-up|Physician Decision|1|||
94726509|NCT04221490|324455615|FG000|At 6 Months Follow-up|Missed Visit|8|||
94726510|NCT04221490|324455615|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
94726511|NCT04011722|324455616|FG000|30 Days|Death|5|||
94726512|NCT04011722|324455617|FG001|30 Days|Death|1|||
94726513|NCT04011722|324455616|FG000|1 Year|Death|13|||
94726514|NCT04011722|324455617|FG001|1 Year|Death|5|||
94726515|NCT04011722|324455616|FG000|1 Year|Withdrawal by Subject|8|||
94726516|NCT04011722|324455617|FG001|1 Year|Withdrawal by Subject|2|||
94726517|NCT04011722|324455616|FG000|1 Year|Missed Visit|6|||
94726518|NCT04011722|324455617|FG001|1 Year|Missed Visit|1|||
94726519|NCT04011722|324455616|FG000|1 Year|Pending Visit|0|||
94726520|NCT04011722|324455617|FG001|1 Year|Pending Visit|11|||
94726521|NCT04011722|324455616|FG000|1 Year|Not Yet Due|0|||
94726522|NCT04011722|324455617|FG001|1 Year|Not Yet Due|9|||
94726523|NCT04011722|324455616|FG000|2 Year|Death|16|||
94726524|NCT04011722|324455617|FG001|2 Year|Death|1|||
94726525|NCT04011722|324455616|FG000|2 Year|Withdrawal by Subject|10|||
94726526|NCT04011722|324455617|FG001|2 Year|Withdrawal by Subject|1|||
94726527|NCT04011722|324455616|FG000|2 Year|Missed Visit|9|||
94726528|NCT04011722|324455617|FG001|2 Year|Missed Visit|0|||
94726529|NCT04011722|324455616|FG000|2 Year|Visit Pending|1|||
94726530|NCT04011722|324455617|FG001|2 Year|Visit Pending|3|||
94726531|NCT04011722|324455616|FG000|2 Year|Not Yet Due|43|||
94726532|NCT04011722|324455617|FG001|2 Year|Not Yet Due|54|||
94726533|NCT04011722|324455616|FG000|3 Year|Death|10|||
94726534|NCT04011722|324455617|FG001|3 Year|Death|0|||
94726535|NCT04011722|324455616|FG000|3 Year|Withdrawal by Subject|2|||
94726536|NCT04011722|324455617|FG001|3 Year|Withdrawal by Subject|0|||
94726537|NCT04011722|324455616|FG000|3 Year|Missed Visit|2|||
94726538|NCT04011722|324455617|FG001|3 Year|Missed Visit|0|||
94726539|NCT04011722|324455616|FG000|3 Year|Pending Visit|34|||
94726540|NCT04011722|324455617|FG001|3 Year|Pending Visit|0|||
94726541|NCT04011722|324455616|FG000|3 Year|Not Yet Due|99|||
94726542|NCT04011722|324455617|FG001|3 Year|Not Yet Due|0|||
94726543|NCT04456517|324455620|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
94726544|NCT04456517|324455621|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
94726545|NCT02924272|324455622|FG000|Overall Study|Site Terminated by Sponsor|4|||
94726546|NCT02924272|324455623|FG001|Overall Study|Site Terminated by Sponsor|1|||
94726547|NCT02924272|324455622|FG000|Overall Study|Withdrawal by Subject|2|||
94726548|NCT02924272|324455623|FG001|Overall Study|Withdrawal by Subject|0|||
94726549|NCT02924272|324455622|FG000|Overall Study|Adverse Event|3|||
94467387|NCT02267135|323500554|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
94726550|NCT02924272|324455623|FG001|Overall Study|Adverse Event|0|||
94726551|NCT02924272|324455622|FG000|Overall Study|Progressive Disease|11|||
94726552|NCT02924272|324455623|FG001|Overall Study|Progressive Disease|8|||
94726553|NCT02924272|324455622|FG000|Overall Study|Clinical Deterioration|1|||
94726554|NCT02924272|324455623|FG001|Overall Study|Clinical Deterioration|0|||
94726555|NCT02924272|324455622|FG000|Overall Study|Death|1|||
94726556|NCT02924272|324455623|FG001|Overall Study|Death|0|||
94726557|NCT02924272|324455622|FG000|Overall Study|Reason Not Specified|1|||
94726558|NCT02924272|324455623|FG001|Overall Study|Reason Not Specified|0|||
94726559|NCT02100813|324455628|FG000|Overall Study|Adverse Event|0|||
94726560|NCT02100813|324455629|FG001|Overall Study|Adverse Event|0|||
94726561|NCT02100813|324455630|FG002|Overall Study|Adverse Event|0|||
94726562|NCT02100813|324455631|FG003|Overall Study|Adverse Event|0|||
94726563|NCT02100813|324455632|FG004|Overall Study|Adverse Event|0|||
94726564|NCT02100813|324455633|FG005|Overall Study|Adverse Event|0|||
94726565|NCT02100813|324455634|FG006|Overall Study|Adverse Event|0|||
94726566|NCT02100813|324455635|FG007|Overall Study|Adverse Event|1|||
94726567|NCT05071807|324455636|FG000|Overall Study|Withdrawal by Subject|4|||
94726568|NCT05071807|324455637|FG001|Overall Study|Withdrawal by Subject|0|||
94726569|NCT05071807|324455636|FG000|Overall Study|Unrelated medical issues|3|||
94726570|NCT05071807|324455637|FG001|Overall Study|Unrelated medical issues|0|||
94726571|NCT05071807|324455636|FG000|Overall Study|Relocated|0|||
94726572|NCT05071807|324455637|FG001|Overall Study|Relocated|1|||
94726573|NCT03575897|324455639|FG000|Overall Study|Lost to Follow-up|12|||
94726574|NCT03575897|324455640|FG001|Overall Study|Lost to Follow-up|13|||
94726575|NCT00506519|324455641|FG000|Overall Study|Death|4|||
94726576|NCT00506519|324455642|FG001|Overall Study|Death|6|||
94726577|NCT00506519|324455643|FG002|Overall Study|Death|0|||
94726578|NCT00506519|324455641|FG000|Overall Study|Adverse Event|1|||
94726579|NCT00506519|324455642|FG001|Overall Study|Adverse Event|0|||
94726580|NCT00506519|324455643|FG002|Overall Study|Adverse Event|0|||
94726581|NCT01219959|324455644|FG000|Overall Study|Adverse Event|6|||
94726582|NCT01219959|324455645|FG001|Overall Study|Adverse Event|14|||
94726583|NCT01219959|324455644|FG000|Overall Study|Physician Decision|0|||
94726584|NCT01219959|324455645|FG001|Overall Study|Physician Decision|4|||
94726585|NCT01219959|324455644|FG000|Overall Study|Withdrawal by Subject|0|||
94726586|NCT01219959|324455645|FG001|Overall Study|Withdrawal by Subject|2|||
94726587|NCT01219959|324455644|FG000|Overall Study|Renal Transplantation|0|||
94726588|NCT01219959|324455645|FG001|Overall Study|Renal Transplantation|3|||
94726589|NCT01219959|324455644|FG000|Overall Study|Other|1|||
94726590|NCT01219959|324455645|FG001|Overall Study|Other|0|||
94726591|NCT01186367|324455646|FG000|Overall Study|Lost to Follow-up|7|||
94726592|NCT01186367|324455647|FG001|Overall Study|Lost to Follow-up|4|||
94726593|NCT01186367|324455648|FG002|Overall Study|Lost to Follow-up|7|||
94726594|NCT01186367|324455646|FG000|Overall Study|Did not receive study treatment|0|||
94726595|NCT01186367|324455647|FG001|Overall Study|Did not receive study treatment|1|||
94726596|NCT01186367|324455648|FG002|Overall Study|Did not receive study treatment|0|||
94726597|NCT04359108|324455649|FG000|Overall Study|Withdrawal by Subject|1|||
94726598|NCT04359108|324455650|FG001|Overall Study|Withdrawal by Subject|0|||
94726599|NCT04359108|324455649|FG000|Overall Study|Unable or too feeble to walk independently|0|||
94726600|NCT04359108|324455650|FG001|Overall Study|Unable or too feeble to walk independently|2|||
94726601|NCT04359108|324455649|FG000|Overall Study|Argus II system stopped functioning|0|||
94726602|NCT04359108|324455650|FG001|Overall Study|Argus II system stopped functioning|1|||
94726603|NCT04359108|324455649|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
94726604|NCT04359108|324455650|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
94726605|NCT01160211|324455652|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
94726606|NCT01160211|324455653|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
94726607|NCT01160211|324455654|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
94726608|NCT01160211|324455652|FG000|Overall Study|Lost to Follow-up|4|||
94726609|NCT01160211|324455653|FG001|Overall Study|Lost to Follow-up|8|||
94726610|NCT01160211|324455654|FG002|Overall Study|Lost to Follow-up|4|||
94467388|NCT02267135|323500555|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
94726611|NCT01160211|324455652|FG000|Overall Study|Physician Decision|1|||
94726612|NCT01160211|324455653|FG001|Overall Study|Physician Decision|0|||
94726613|NCT01160211|324455654|FG002|Overall Study|Physician Decision|0|||
94726614|NCT01160211|324455652|FG000|Overall Study|Withdrawal by Subject|4|||
94726615|NCT01160211|324455653|FG001|Overall Study|Withdrawal by Subject|2|||
94726616|NCT01160211|324455654|FG002|Overall Study|Withdrawal by Subject|2|||
94726617|NCT01160211|324455652|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
94726618|NCT01160211|324455653|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
94726619|NCT01160211|324455654|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
94726620|NCT03829410|324455655|FG000|Overall Study|Adverse Event|1|||
94726621|NCT03829410|324455656|FG001|Overall Study|Adverse Event|0|||
94726622|NCT03829410|324455657|FG002|Overall Study|Adverse Event|1|||
94726623|NCT03829410|324455658|FG003|Overall Study|Adverse Event|4|||
94726624|NCT03829410|324455655|FG000|Overall Study|Physician Decision|0|||
94726625|NCT03829410|324455656|FG001|Overall Study|Physician Decision|0|||
94726626|NCT03829410|324455657|FG002|Overall Study|Physician Decision|0|||
94726627|NCT03829410|324455658|FG003|Overall Study|Physician Decision|2|||
94726628|NCT03829410|324455655|FG000|Overall Study|Disease Progressing|3|||
94726629|NCT03829410|324455656|FG001|Overall Study|Disease Progressing|4|||
94726630|NCT03829410|324455657|FG002|Overall Study|Disease Progressing|2|||
94726631|NCT03829410|324455658|FG003|Overall Study|Disease Progressing|31|||
94726632|NCT03829410|324455655|FG000|Overall Study|Miscellaneous|2|||
94726633|NCT03829410|324455656|FG001|Overall Study|Miscellaneous|4|||
94726634|NCT03829410|324455657|FG002|Overall Study|Miscellaneous|3|||
94726635|NCT03829410|324455658|FG003|Overall Study|Miscellaneous|10|||
94726636|NCT03033576|324455659|FG000|Overall Study|Ineligible|1|||
94726637|NCT03033576|324455660|FG001|Overall Study|Ineligible|1|||
94726638|NCT03033576|324455659|FG000|Overall Study|Adverse Event|4|||
94726639|NCT03033576|324455660|FG001|Overall Study|Adverse Event|20|||
94726640|NCT03033576|324455659|FG000|Overall Study|Progression/relapse|9|||
94726641|NCT03033576|324455660|FG001|Overall Study|Progression/relapse|36|||
94726642|NCT03033576|324455659|FG000|Overall Study|Death|1|||
94726643|NCT03033576|324455660|FG001|Overall Study|Death|1|||
94726644|NCT03033576|324455659|FG000|Overall Study|Patient refusal|1|||
94726645|NCT03033576|324455660|FG001|Overall Study|Patient refusal|6|||
94726646|NCT03033576|324455659|FG000|Overall Study|Other, unspecified reasons|0|||
94726647|NCT03033576|324455660|FG001|Overall Study|Other, unspecified reasons|4|||
94726648|NCT03033576|324455659|FG000|Overall Study|Currently on protocol therapy|0|||
94726649|NCT03033576|324455660|FG001|Overall Study|Currently on protocol therapy|2|||
94726650|NCT05179837|324455661|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
94726651|NCT05179837|324455661|FG000|Overall Study|Device malfunctioned|1|||
94726652|NCT05179837|324455661|FG000|Overall Study|Image quality too low|2|||
94726653|NCT02076113|324457110|FG000|Overall Study|Lost to Follow-up|4|||
94726654|NCT02076113|324457111|FG001|Overall Study|Lost to Follow-up|1|||
94726655|NCT02076113|324457110|FG000|Overall Study|Withdrawal by Subject|2|||
94726656|NCT02076113|324457111|FG001|Overall Study|Withdrawal by Subject|3|||
94726657|NCT02076113|324457110|FG000|Overall Study|Death|1|||
94726658|NCT02076113|324457111|FG001|Overall Study|Death|3|||
94726659|NCT05368103|324457114|FG000|Overall Study|Withdrawal by Subject|4|||
94726660|NCT05368103|324457114|FG000|Overall Study|Lost to Follow-up|1|||
94726661|NCT05368103|324457114|FG000|Overall Study|Lack of Efficacy|3|||
94726662|NCT03445988|324457120|FG000|Overall Study|Lost to Follow-up|14|||
94726663|NCT03445988|324457121|FG001|Overall Study|Lost to Follow-up|26|||
94726664|NCT03445988|324457122|FG002|Overall Study|Lost to Follow-up|27|||
94726665|NCT03445988|324457123|FG003|Overall Study|Lost to Follow-up|66|||
94726666|NCT03445988|324457120|FG000|Overall Study|Withdrawal by Subject|7|||
94726667|NCT03445988|324457121|FG001|Overall Study|Withdrawal by Subject|4|||
94726668|NCT03445988|324457122|FG002|Overall Study|Withdrawal by Subject|3|||
94726669|NCT03445988|324457123|FG003|Overall Study|Withdrawal by Subject|5|||
94726670|NCT03445988|324457120|FG000|Overall Study|Death (unrelated to study)|5|||
94726671|NCT03445988|324457121|FG001|Overall Study|Death (unrelated to study)|1|||
94726672|NCT03445988|324457122|FG002|Overall Study|Death (unrelated to study)|2|||
94726673|NCT03445988|324457123|FG003|Overall Study|Death (unrelated to study)|4|||
94726674|NCT03436290|324457124|FG000|Overall Study|Post-randomization Exclusion|1|||
94726675|NCT03436290|324457125|FG001|Overall Study|Post-randomization Exclusion|0|||
94726676|NCT03436290|324457124|FG000|Overall Study|Death|6|||
94726677|NCT03436290|324457125|FG001|Overall Study|Death|0|||
94726678|NCT03436290|324457124|FG000|Overall Study|Withdrawal by Subject|4|||
94726679|NCT03436290|324457125|FG001|Overall Study|Withdrawal by Subject|0|||
94726680|NCT03436290|324457124|FG000|Overall Study|Protocol Violation|30|||
94726681|NCT03436290|324457125|FG001|Overall Study|Protocol Violation|0|||
94726682|NCT04274764|324457129|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
94726683|NCT04274764|324457130|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
94726684|NCT04130438|324457133|FG000|Overall Study|Lost to Follow-up|0|||
94726685|NCT04130438|324457134|FG001|Overall Study|Lost to Follow-up|0|||
94726686|NCT04130438|324457135|FG002|Overall Study|Lost to Follow-up|1|||
94726687|NCT04142788|324457140|FG000|Overall Study|Trial terminated prematurely|2|||
94726688|NCT04142788|324457141|FG001|Overall Study|Trial terminated prematurely|2|||
94726689|NCT02035787|324457144|FG000|Overall Study- 12 Months|Adverse Event|3|||
94726690|NCT02035787|324457145|FG001|Overall Study- 12 Months|Adverse Event|0|||
94726691|NCT02035787|324457144|FG000|Overall Study- 12 Months|Complete response|4|||
94726692|NCT02035787|324457145|FG001|Overall Study- 12 Months|Complete response|1|||
94726693|NCT02035787|324457144|FG000|Overall Study- 12 Months|Protocol Violation|1|||
94726694|NCT02035787|324457145|FG001|Overall Study- 12 Months|Protocol Violation|1|||
94726695|NCT06414213|324457146|FG000|Overall Study|Lost to Follow-up|1|||
94726696|NCT06414213|324457147|FG001|Overall Study|Lost to Follow-up|1|||
94726697|NCT06414213|324457148|FG002|Overall Study|Lost to Follow-up|3|||
94726698|NCT04410042|324457149|FG000|Overall Study|Not Eligible|1|||
94726699|NCT04410042|324457150|FG001|Overall Study|Not Eligible|1|||
94726700|NCT05311384|324457151|FG000|Overall Study|Uncontrolled health conditions|2|||
94726701|NCT05311384|324457151|FG000|Overall Study|Withdrawal by Subject|1|||
94726702|NCT03018288|324457152|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
94726703|NCT03018288|324457153|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
94273160|NCT00111800|322793687|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
94273161|NCT00111800|322793688|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
94273162|NCT00111800|322793689|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
94273163|NCT00111800|322793690|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
94273164|NCT00111800|322793691|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
94273165|NCT00111800|322793692|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
94273166|NCT00111800|322793687|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
94273167|NCT00111800|322793688|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
94273168|NCT00111800|322793689|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
94273169|NCT00111800|322793690|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
94273170|NCT00111800|322793691|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
94273171|NCT00111800|322793692|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
94273172|NCT00111800|322793687|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
94726704|NCT03018288|324457154|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
94726705|NCT03018288|324457155|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
94726706|NCT03018288|324457152|FG000|Overall Study|Participant withdrew consent.|0|||
94726707|NCT03018288|324457153|FG001|Overall Study|Participant withdrew consent.|0|||
94726708|NCT03018288|324457154|FG002|Overall Study|Participant withdrew consent.|1|||
94726709|NCT03018288|324457155|FG003|Overall Study|Participant withdrew consent.|0|||
94726710|NCT03018288|324457152|FG000|Overall Study|Switched to alternative treatment.|0|||
94726711|NCT03018288|324457153|FG001|Overall Study|Switched to alternative treatment.|0|||
94726712|NCT03018288|324457154|FG002|Overall Study|Switched to alternative treatment.|1|||
94726713|NCT03018288|324457155|FG003|Overall Study|Switched to alternative treatment.|0|||
94726714|NCT03018288|324457152|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
94726715|NCT03018288|324457153|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
94726716|NCT03018288|324457154|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
94726717|NCT03018288|324457155|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
94726718|NCT03018288|324457152|FG000|Overall Study|Screen failures|0|||
94726719|NCT03018288|324457153|FG001|Overall Study|Screen failures|0|||
94726720|NCT03018288|324457154|FG002|Overall Study|Screen failures|0|||
94726721|NCT03018288|324457155|FG003|Overall Study|Screen failures|51|||
94726722|NCT03018288|324457152|FG000|Overall Study|Chose treatment outside of UNC|0|||
94726723|NCT03018288|324457153|FG001|Overall Study|Chose treatment outside of UNC|0|||
94726724|NCT03018288|324457154|FG002|Overall Study|Chose treatment outside of UNC|0|||
94726725|NCT03018288|324457155|FG003|Overall Study|Chose treatment outside of UNC|1|||
94726726|NCT03018288|324457152|FG000|Overall Study|Unable to comply with protocol requirements|1|||
94726727|NCT03018288|324457153|FG001|Overall Study|Unable to comply with protocol requirements|1|||
94726728|NCT03018288|324457154|FG002|Overall Study|Unable to comply with protocol requirements|0|||
94726729|NCT03018288|324457155|FG003|Overall Study|Unable to comply with protocol requirements|1|||
94368499|NCT01336608|323136457|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
94368500|NCT01336608|323136458|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
94368501|NCT01336608|323136455|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
94368502|NCT01336608|323136456|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
94368503|NCT01336608|323136457|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
94368504|NCT01336608|323136458|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
94368505|NCT01336608|323136455|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
94368506|NCT01336608|323136456|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
94467389|NCT02267135|323500554|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
94726730|NCT03018288|324457152|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
94273173|NCT00111800|322793688|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
94273174|NCT00111800|322793689|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
94273175|NCT00111800|322793690|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
94273176|NCT00111800|322793691|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
94273177|NCT00111800|322793692|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
94273178|NCT00111800|322793687|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
94273179|NCT00111800|322793688|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
94273180|NCT00111800|322793689|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
94273181|NCT00111800|322793690|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
94273182|NCT00111800|322793691|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
94273183|NCT00111800|322793692|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
94273184|NCT00111800|322793687|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
94273185|NCT00111800|322793688|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
94273186|NCT00111800|322793689|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
94273187|NCT00111800|322793690|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
94273188|NCT00111800|322793691|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
94273189|NCT00111800|322793692|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
94368507|NCT01336608|323136457|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
94467390|NCT02267135|323500555|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
94726731|NCT03018288|324457153|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
94726732|NCT03018288|324457154|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
94726733|NCT03018288|324457155|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
94726734|NCT03018288|324457152|FG000|Overall Study|Physician Decision|0|||
94726735|NCT03018288|324457153|FG001|Overall Study|Physician Decision|0|||
94726736|NCT03018288|324457154|FG002|Overall Study|Physician Decision|0|||
94726737|NCT03018288|324457155|FG003|Overall Study|Physician Decision|1|||
94726738|NCT05710107|324457159|FG000|Overall Study|Withdrawal by Subject|1|||
94726739|NCT05710107|324457160|FG001|Overall Study|Withdrawal by Subject|1|||
94726740|NCT05710107|324457159|FG000|Overall Study|Lost to Follow-up|8|||
94726741|NCT05710107|324457160|FG001|Overall Study|Lost to Follow-up|9|||
94726742|NCT05710107|324457159|FG000|Overall Study|Unable to place assigned block|2|||
94726743|NCT05710107|324457160|FG001|Overall Study|Unable to place assigned block|0|||
94726744|NCT05710107|324457159|FG000|Overall Study|Withdrawn by study team|0|||
94726745|NCT05710107|324457160|FG001|Overall Study|Withdrawn by study team|1|||
94726746|NCT05308004|324457161|FG000|Overall Study|Not seen by Palliative Care NP|0|||
94726747|NCT05308004|324457162|FG001|Overall Study|Not seen by Palliative Care NP|1|||
94726748|NCT04552223|324457170|FG000|Overall Study|Withdrawal by Subject|1|||
94726749|NCT03869866|324457171|FG000|Overall Study|Protocol Violation|1|||
94726750|NCT03869866|324457171|FG000|Overall Study|Withdrawal by Subject|3|||
94726751|NCT05116787|324457173|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
94726752|NCT05116787|324457174|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
94726753|NCT05116787|324457173|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
94726754|NCT05116787|324457174|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
94726755|NCT05116787|324457173|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
94726756|NCT05116787|324457174|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
94726757|NCT05116787|324457173|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
94726758|NCT05116787|324457174|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
94726759|NCT02737436|324457175|FG000|Washout Period|Lost to Follow-up|5|||
94726760|NCT02737436|324457176|FG001|Washout Period|Lost to Follow-up|11|||
94726761|NCT02737436|324457175|FG000|Data Analysis|Scanning data problems|5|||
94726762|NCT02737436|324457176|FG001|Data Analysis|Scanning data problems|8|||
94726763|NCT05551637|324457179|FG000|Overall Study|Lack of Efficacy|0|||
94726764|NCT05551637|324457180|FG001|Overall Study|Lack of Efficacy|6|||
94726765|NCT05551637|324457179|FG000|Overall Study|Lost to Follow-up|1|||
94726766|NCT05551637|324457180|FG001|Overall Study|Lost to Follow-up|1|||
94726767|NCT02734290|324457183|FG000|Overall Study|Adverse Event|1|||
94726768|NCT02734290|324457184|FG001|Overall Study|Adverse Event|0|||
94726769|NCT02734290|324457183|FG000|Overall Study|Death|1|||
94726770|NCT02734290|324457184|FG001|Overall Study|Death|0|||
94726771|NCT03468218|324457185|FG000|Overall Study|Adverse Event|5|||
94726772|NCT03468218|324457185|FG000|Overall Study|Progressive Disease|16|||
94726773|NCT03468218|324457185|FG000|Overall Study|Death|1|||
94726774|NCT03468218|324457185|FG000|Overall Study|Alternate therapy|1|||
94726775|NCT03468218|324457185|FG000|Overall Study|Withdrawal by Subject|2|||
94726776|NCT03719443|324457186|FG000|Overall Study|Lost to Follow-up|0|||
94726777|NCT03719443|324457187|FG001|Overall Study|Lost to Follow-up|0|||
94726778|NCT03719443|324457188|FG002|Overall Study|Lost to Follow-up|1|||
94726779|NCT03719443|324457189|FG003|Overall Study|Lost to Follow-up|0|||
94726780|NCT03719443|324457190|FG004|Overall Study|Lost to Follow-up|1|||
94726781|NCT03719443|324457191|FG005|Overall Study|Lost to Follow-up|0|||
94726782|NCT03719443|324457192|FG006|Overall Study|Lost to Follow-up|1|||
94726783|NCT03719443|324457186|FG000|Overall Study|Withdrawal by Subject|0|||
94726784|NCT03719443|324457187|FG001|Overall Study|Withdrawal by Subject|0|||
94726785|NCT03719443|324457188|FG002|Overall Study|Withdrawal by Subject|1|||
94726786|NCT03719443|324457189|FG003|Overall Study|Withdrawal by Subject|0|||
94726787|NCT03719443|324457190|FG004|Overall Study|Withdrawal by Subject|0|||
94726788|NCT03719443|324457191|FG005|Overall Study|Withdrawal by Subject|0|||
94726789|NCT03719443|324457192|FG006|Overall Study|Withdrawal by Subject|0|||
94726790|NCT04782973|324457193|FG000|Overall Study|Withdrawal by Subject|5|||
94726791|NCT04782973|324457193|FG000|Overall Study|Protocol Violation|6|||
94726792|NCT04782973|324457193|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
94726793|NCT03557697|324457194|FG000|Overall Study|Withdrawal by Subject|2|||
94726794|NCT03557697|324457195|FG001|Overall Study|Withdrawal by Subject|4|||
94726795|NCT06491433|324457196|FG000|Overall Study|Protocol Violation|51|||
94726796|NCT06491433|324457196|FG000|Overall Study|consent withdrawal|2|||
94726797|NCT06491433|324457196|FG000|Overall Study|screen failure|1|||
94726798|NCT04516967|324457197|FG000|Core Phase|Adverse Event|2|||
94726799|NCT04516967|324457198|FG001|Core Phase|Adverse Event|1|||
94726800|NCT04516967|324457199|FG002|Core Phase|Adverse Event|0|||
94726801|NCT04516967|324457197|FG000|Core Phase|Physician Decision|1|||
94726802|NCT04516967|324457198|FG001|Core Phase|Physician Decision|1|||
94726803|NCT04516967|324457199|FG002|Core Phase|Physician Decision|0|||
94726804|NCT04516967|324457197|FG000|Core Phase|Lack of Efficacy|7|||
94726805|NCT04516967|324457198|FG001|Core Phase|Lack of Efficacy|18|||
94726806|NCT04516967|324457199|FG002|Core Phase|Lack of Efficacy|0|||
94726807|NCT03611491|324457200|FG000|Overall Study|Lost to Follow-up|1|||
94726808|NCT04342494|324457201|FG000|Overall Study|Questionnaire partially completed|1|||
94726809|NCT04342494|324457202|FG001|Overall Study|Questionnaire partially completed|0|||
94726810|NCT04342494|324457203|FG002|Overall Study|Questionnaire partially completed|2|||
94726811|NCT04342494|324457204|FG003|Overall Study|Questionnaire partially completed|0|||
94726812|NCT04342494|324457205|FG004|Overall Study|Questionnaire partially completed|1|||
94726813|NCT04342494|324457201|FG000|Overall Study|Lost to Follow-up|49|||
94726814|NCT04342494|324457202|FG001|Overall Study|Lost to Follow-up|38|||
94726815|NCT04342494|324457203|FG002|Overall Study|Lost to Follow-up|34|||
94726816|NCT04342494|324457204|FG003|Overall Study|Lost to Follow-up|34|||
94726817|NCT04342494|324457205|FG004|Overall Study|Lost to Follow-up|35|||
94726818|NCT04676022|324457206|FG000|Overall Study|Screen Failure/|1|||
94726819|NCT04676022|324457207|FG001|Overall Study|Screen Failure/|1|||
94726820|NCT04676022|324457208|FG002|Overall Study|Screen Failure/|85|||
94726821|NCT04676022|324457206|FG000|Overall Study|Lost to Follow-up|1|||
94726822|NCT04676022|324457207|FG001|Overall Study|Lost to Follow-up|1|||
94726823|NCT04676022|324457208|FG002|Overall Study|Lost to Follow-up|0|||
94726824|NCT04676022|324457206|FG000|Overall Study|Adverse Event|2|||
94726825|NCT04676022|324457207|FG001|Overall Study|Adverse Event|0|||
94726826|NCT04676022|324457208|FG002|Overall Study|Adverse Event|1|||
94726827|NCT04676022|324457206|FG000|Overall Study|Physician Decision|2|||
94726828|NCT04676022|324457207|FG001|Overall Study|Physician Decision|0|||
94726829|NCT04676022|324457208|FG002|Overall Study|Physician Decision|1|||
94726830|NCT04676022|324457206|FG000|Overall Study|Withdrawal by Subject|3|||
94726831|NCT04676022|324457207|FG001|Overall Study|Withdrawal by Subject|1|||
94726832|NCT04676022|324457208|FG002|Overall Study|Withdrawal by Subject|6|||
94726833|NCT04676022|324457206|FG000|Overall Study|Will not move forward with permanent implant|6|||
94726834|NCT04676022|324457207|FG001|Overall Study|Will not move forward with permanent implant|0|||
94368508|NCT01336608|323136458|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
94368509|NCT01336608|323136455|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
94368510|NCT01336608|323136456|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
94368511|NCT01336608|323136457|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
94726835|NCT04676022|324457208|FG002|Overall Study|Will not move forward with permanent implant|0|||
94726836|NCT04676022|324457206|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
94726837|NCT04676022|324457207|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
94726838|NCT04676022|324457208|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
94726839|NCT05409183|324457224|FG000|Complete Study|Adverse Event|1|||
94726840|NCT05409183|324457225|FG001|Complete Study|Adverse Event|2|||
94726841|NCT05409183|324457224|FG000|Complete Study|Withdrawal by Subject|3|||
94726842|NCT05409183|324457225|FG001|Complete Study|Withdrawal by Subject|0|||
94726843|NCT03194217|324457226|FG000|Overall Study|Adverse Event|0|||
94726844|NCT03194217|324457227|FG001|Overall Study|Adverse Event|2|||
94726845|NCT03194217|324457228|FG002|Overall Study|Adverse Event|3|||
94726846|NCT03194217|324457229|FG003|Overall Study|Adverse Event|3|||
94726847|NCT03194217|324457226|FG000|Overall Study|Failure to meet randomisation criteria|0|||
94726848|NCT03194217|324457227|FG001|Overall Study|Failure to meet randomisation criteria|0|||
94726849|NCT03194217|324457228|FG002|Overall Study|Failure to meet randomisation criteria|0|||
94726850|NCT03194217|324457229|FG003|Overall Study|Failure to meet randomisation criteria|1|||
94726851|NCT03194217|324457226|FG000|Overall Study|Other|0|||
94726852|NCT03194217|324457227|FG001|Overall Study|Other|1|||
94726853|NCT03194217|324457228|FG002|Overall Study|Other|1|||
94726854|NCT03194217|324457229|FG003|Overall Study|Other|0|||
94726855|NCT02936752|324457230|FG000|Overall Study|Death|2|||
94726856|NCT02936752|324457231|FG001|Overall Study|Death|1|||
94726857|NCT02936752|324457230|FG000|Overall Study|Physician Decision|4|||
94726858|NCT02936752|324457231|FG001|Overall Study|Physician Decision|0|||
94726859|NCT02936752|324457230|FG000|Overall Study|Withdrawal by Subject|0|||
94726860|NCT02936752|324457231|FG001|Overall Study|Withdrawal by Subject|2|||
94726861|NCT05292365|324457239|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
94726862|NCT05292365|324457240|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
94726863|NCT05292365|324457241|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
94726864|NCT05292365|324457242|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
94726865|NCT03896789|324457248|FG000|Baseline|Lost to Follow-up|1|||
94726866|NCT03896789|324457249|FG001|Baseline|Lost to Follow-up|2|||
94726867|NCT03896789|324457248|FG000|Baseline|Death|3|||
94726868|NCT03896789|324457249|FG001|Baseline|Death|6|||
94726869|NCT03896789|324457248|FG000|Post-Randomization|Lost to Follow-up|12|||
94726870|NCT03896789|324457249|FG001|Post-Randomization|Lost to Follow-up|11|||
94726871|NCT03896789|324457248|FG000|Post-Randomization|Death|12|||
94726872|NCT03896789|324457249|FG001|Post-Randomization|Death|13|||
94726873|NCT03732820|324457250|FG000|Overall Study|Death|168|||
94726874|NCT03732820|324457251|FG001|Overall Study|Death|203|||
94726875|NCT03732820|324457250|FG000|Overall Study|Other|2|||
94726876|NCT03732820|324457251|FG001|Overall Study|Other|2|||
94726877|NCT03732820|324457250|FG000|Overall Study|Failure to meet randomisation criteria|1|||
94726878|NCT03732820|324457251|FG001|Overall Study|Failure to meet randomisation criteria|1|||
94726879|NCT03732820|324457250|FG000|Overall Study|Patient decision|14|||
94726880|NCT03732820|324457251|FG001|Overall Study|Patient decision|10|||
94726881|NCT03732820|324457250|FG000|Overall Study|Screen failure|0|||
94726882|NCT03732820|324457251|FG001|Overall Study|Screen failure|1|||
94726883|NCT03732820|324457250|FG000|Overall Study|Patients ongoing study at data cut off|210|||
94368512|NCT01336608|323136458|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
94368513|NCT01336608|323136455|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
94368514|NCT01336608|323136456|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
94368515|NCT01336608|323136457|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
94726884|NCT03732820|324457251|FG001|Overall Study|Patients ongoing study at data cut off|178|||
94368516|NCT01336608|323136458|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
94726885|NCT03732820|324457250|FG000|Overall Study|Lost to Follow-up|4|||
94368517|NCT01336608|323136455|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
94368518|NCT01336608|323136456|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
94726886|NCT03732820|324457251|FG001|Overall Study|Lost to Follow-up|2|||
94726887|NCT04650269|324457252|FG000|Overall Study|Death|3|||
94726888|NCT04650269|324457252|FG000|Overall Study|Lost to Follow-up|6|||
94726889|NCT02975882|324458728|FG000|Overall Study|Adverse Event|1|||
94726890|NCT02975882|324458729|FG001|Overall Study|Adverse Event|2|||
94726891|NCT02975882|324458730|FG002|Overall Study|Adverse Event|1|||
94726892|NCT02975882|324458731|FG003|Overall Study|Adverse Event|1|||
94726893|NCT02975882|324458728|FG000|Overall Study|Death|0|||
94726894|NCT02975882|324458729|FG001|Overall Study|Death|1|||
94726895|NCT02975882|324458730|FG002|Overall Study|Death|0|||
94726896|NCT02975882|324458731|FG003|Overall Study|Death|0|||
94726897|NCT02975882|324458728|FG000|Overall Study|Lack of Efficacy|3|||
94726898|NCT02975882|324458729|FG001|Overall Study|Lack of Efficacy|7|||
94726899|NCT02975882|324458730|FG002|Overall Study|Lack of Efficacy|4|||
94726900|NCT02975882|324458731|FG003|Overall Study|Lack of Efficacy|3|||
94726901|NCT02975882|324458728|FG000|Overall Study|Physician Decision|0|||
94726902|NCT02975882|324458729|FG001|Overall Study|Physician Decision|2|||
94726903|NCT02975882|324458730|FG002|Overall Study|Physician Decision|4|||
94726904|NCT02975882|324458731|FG003|Overall Study|Physician Decision|2|||
94273190|NCT00111800|322793687|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
94273191|NCT00111800|322793688|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
94273192|NCT00111800|322793689|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
94273193|NCT00111800|322793690|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
94273194|NCT00111800|322793691|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
94273195|NCT00111800|322793692|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
94273196|NCT00111800|322793687|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
94273197|NCT00111800|322793688|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
94273198|NCT00111800|322793689|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
94273199|NCT00111800|322793690|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
94273200|NCT00111800|322793691|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
94273201|NCT00111800|322793692|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
94273202|NCT00111800|322793687|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
94273203|NCT00111800|322793688|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
94273204|NCT00111800|322793689|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
94273205|NCT00111800|322793690|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
94273206|NCT00111800|322793691|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
94273207|NCT00111800|322793692|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
94273208|NCT00111800|322793687|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
94273209|NCT00111800|322793688|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
94273210|NCT00111800|322793689|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
94273211|NCT00111800|322793690|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
94273212|NCT00111800|322793691|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
94273213|NCT00111800|322793692|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
94273214|NCT00111800|322793687|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
94273215|NCT00111800|322793688|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
94273216|NCT00111800|322793689|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
94273217|NCT00111800|322793690|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
94273218|NCT00111800|322793691|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
94273219|NCT00111800|322793692|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
94273220|NCT00111800|322793687|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
94273221|NCT00111800|322793688|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
94273222|NCT00111800|322793689|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
94273223|NCT00111800|322793690|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
94273224|NCT00111800|322793691|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
94273225|NCT00111800|322793692|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
94273226|NCT00111800|322793687|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
94273227|NCT00111800|322793688|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
94273228|NCT00111800|322793689|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
94726905|NCT02975882|324458728|FG000|Overall Study|Ineligible|0|||
94726906|NCT02975882|324458729|FG001|Overall Study|Ineligible|1|||
94726907|NCT02975882|324458730|FG002|Overall Study|Ineligible|0|||
94726908|NCT02975882|324458731|FG003|Overall Study|Ineligible|0|||
94726909|NCT02919683|324458732|FG000|Post-Surgery Follow-Up|Death|2|||
94726910|NCT02919683|324458733|FG001|Post-Surgery Follow-Up|Death|2|||
94726911|NCT02919683|324458732|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
94726912|NCT02919683|324458733|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
94726913|NCT03701399|324458734|FG000|Overall Study|Adverse Event|3|||
94726914|NCT03701399|324458735|FG001|Overall Study|Adverse Event|5|||
94726915|NCT03701399|324458734|FG000|Overall Study|Withdrawal by Subject|6|||
94726916|NCT03701399|324458735|FG001|Overall Study|Withdrawal by Subject|3|||
94726917|NCT03701399|324458734|FG000|Overall Study|Investigators decision|1|||
94726918|NCT03701399|324458735|FG001|Overall Study|Investigators decision|2|||
94726919|NCT03701399|324458734|FG000|Overall Study|Lost to Follow-up|1|||
94726920|NCT03701399|324458735|FG001|Overall Study|Lost to Follow-up|2|||
94726921|NCT03701399|324458734|FG000|Overall Study|Death|1|||
94726922|NCT03701399|324458735|FG001|Overall Study|Death|1|||
94726923|NCT03701399|324458734|FG000|Overall Study|Randomized but not treated|1|||
94726924|NCT03701399|324458735|FG001|Overall Study|Randomized but not treated|0|||
94726925|NCT04225039|324458737|FG000|Overall Study|Withdrawal by Subject|1|||
94726926|NCT04225039|324458738|FG001|Overall Study|Withdrawal by Subject|0|||
94726927|NCT04225039|324458739|FG002|Overall Study|Withdrawal by Subject|0|||
94726928|NCT04225039|324458740|FG003|Overall Study|Withdrawal by Subject|1|||
94726929|NCT04225039|324458737|FG000|Overall Study|Currently active on study treatment|0|||
94726930|NCT04225039|324458738|FG001|Overall Study|Currently active on study treatment|1|||
94726931|NCT04225039|324458739|FG002|Overall Study|Currently active on study treatment|0|||
94726932|NCT04225039|324458740|FG003|Overall Study|Currently active on study treatment|0|||
94726933|NCT04225039|324458737|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
94726934|NCT04225039|324458738|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
94726935|NCT04225039|324458739|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
94726936|NCT04225039|324458740|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
94726937|NCT04225039|324458737|FG000|Overall Study|Ineligible for treatment|0|||
94726938|NCT04225039|324458738|FG001|Overall Study|Ineligible for treatment|0|||
94726939|NCT04225039|324458739|FG002|Overall Study|Ineligible for treatment|0|||
94726940|NCT04225039|324458740|FG003|Overall Study|Ineligible for treatment|4|||
94726941|NCT04749615|324458741|FG000|Overall Study|Lost to Follow-up|6|||
94726942|NCT04749615|324458742|FG001|Overall Study|Lost to Follow-up|10|||
94726943|NCT04806451|324458748|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
94726944|NCT04806451|324458749|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
94726945|NCT04806451|324458748|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
94726946|NCT04806451|324458749|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
94726947|NCT04806451|324458748|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
94726948|NCT04806451|324458749|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
94726949|NCT04489771|324458750|FG000|Overall Study|Death|27|||
94273229|NCT00111800|322793690|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
94273230|NCT00111800|322793691|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
94273231|NCT00111800|322793692|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
94273232|NCT00111800|322793687|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
94273233|NCT00111800|322793688|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
94273234|NCT00111800|322793689|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
94273235|NCT00111800|322793690|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
94273236|NCT00111800|322793691|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
94273237|NCT00111800|322793692|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
94273238|NCT00111800|322793687|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
94273239|NCT00111800|322793688|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
94273240|NCT00111800|322793689|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
94273241|NCT00111800|322793690|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
94273242|NCT00111800|322793691|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
94273243|NCT00111800|322793692|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
94273244|NCT00914927|322793694|FG000|Overall Study|Adverse Event|0|||
94273245|NCT00914927|322793695|FG001|Overall Study|Adverse Event|0|||
94273246|NCT00914927|322793696|FG002|Overall Study|Adverse Event|0|||
94273247|NCT00914927|322793697|FG003|Overall Study|Adverse Event|0|||
94273248|NCT00914927|322793698|FG004|Overall Study|Adverse Event|1|||
94273249|NCT00914927|322793699|FG005|Overall Study|Adverse Event|0|||
94273250|NCT00914927|322793700|FG006|Overall Study|Adverse Event|0|||
94273251|NCT00914927|322793694|FG000|Overall Study|Withdrawal by Subject|0|||
94273252|NCT00914927|322793695|FG001|Overall Study|Withdrawal by Subject|1|||
94273253|NCT00914927|322793696|FG002|Overall Study|Withdrawal by Subject|0|||
94273254|NCT00914927|322793697|FG003|Overall Study|Withdrawal by Subject|1|||
94273255|NCT00914927|322793698|FG004|Overall Study|Withdrawal by Subject|0|||
94273256|NCT00914927|322793699|FG005|Overall Study|Withdrawal by Subject|0|||
94273257|NCT00914927|322793700|FG006|Overall Study|Withdrawal by Subject|0|||
94273258|NCT00914927|322793694|FG000|Overall Study|Lost to Follow-up|0|||
94273259|NCT00914927|322793695|FG001|Overall Study|Lost to Follow-up|0|||
94273260|NCT00914927|322793696|FG002|Overall Study|Lost to Follow-up|0|||
94273261|NCT00914927|322793697|FG003|Overall Study|Lost to Follow-up|1|||
94273262|NCT00914927|322793698|FG004|Overall Study|Lost to Follow-up|0|||
94273263|NCT00914927|322793699|FG005|Overall Study|Lost to Follow-up|0|||
94273264|NCT00914927|322793700|FG006|Overall Study|Lost to Follow-up|0|||
94273265|NCT00914927|322793694|FG000|Overall Study|Administrative/Other|2|||
94726950|NCT04489771|324458751|FG001|Overall Study|Death|25|||
94726951|NCT04489771|324458750|FG000|Overall Study|Withdrawal by Subject|1|||
94273266|NCT00914927|322793695|FG001|Overall Study|Administrative/Other|1|||
94273267|NCT00914927|322793696|FG002|Overall Study|Administrative/Other|0|||
94726952|NCT04489771|324458751|FG001|Overall Study|Withdrawal by Subject|0|||
94726953|NCT04489771|324458750|FG000|Overall Study|Participants Ongoing in Study|50|||
94726954|NCT04489771|324458751|FG001|Overall Study|Participants Ongoing in Study|51|||
94726955|NCT05894577|324458752|FG000|Overall Study|No receipt of study drug|14|||
94726956|NCT05894577|324458753|FG001|Overall Study|No receipt of study drug|13|||
94726957|NCT05894577|324458752|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
94726958|NCT05894577|324458753|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
94726959|NCT05894577|324458752|FG000|Overall Study|Screen Fail|2|||
94726960|NCT05894577|324458753|FG001|Overall Study|Screen Fail|0|||
94726961|NCT05894577|324458752|FG000|Overall Study|Study drug recall|86|||
94726962|NCT05894577|324458753|FG001|Overall Study|Study drug recall|63|||
94726963|NCT04509674|324458756|FG000|Overall Study|Not treated|33|||
94726964|NCT04509674|324458757|FG001|Overall Study|Not treated|26|||
94726965|NCT04509674|324458756|FG000|Overall Study|Protocol Violation|9|||
94726966|NCT04509674|324458757|FG001|Overall Study|Protocol Violation|10|||
94726967|NCT04509674|324458756|FG000|Overall Study|Lost to Follow-up|31|||
94726968|NCT04509674|324458757|FG001|Overall Study|Lost to Follow-up|39|||
94726969|NCT04509674|324458756|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
94726970|NCT04509674|324458757|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
94726971|NCT04509674|324458756|FG000|Overall Study|Adverse event, serious fatal event|11|||
94726972|NCT04509674|324458757|FG001|Overall Study|Adverse event, serious fatal event|4|||
94726973|NCT04509674|324458756|FG000|Overall Study|Adverse event, non-fatal event|107|||
94726974|NCT04509674|324458757|FG001|Overall Study|Adverse event, non-fatal event|118|||
94726975|NCT04509674|324458756|FG000|Overall Study|Other reason than listed|106|||
94726976|NCT04509674|324458757|FG001|Overall Study|Other reason than listed|95|||
94726977|NCT05579899|324458764|FG000|Overall Study|Lost to Follow-up|3|||
94726978|NCT05579899|324458765|FG001|Overall Study|Lost to Follow-up|1|||
94726979|NCT05579899|324458764|FG000|Overall Study|Adverse Event|0|||
94726980|NCT05579899|324458765|FG001|Overall Study|Adverse Event|3|||
94726981|NCT05579899|324458764|FG000|Overall Study|Pregnancy|0|||
94726982|NCT05579899|324458765|FG001|Overall Study|Pregnancy|1|||
94726983|NCT05579899|324458764|FG000|Overall Study|Withdrawal by Subject|0|||
94726984|NCT05579899|324458765|FG001|Overall Study|Withdrawal by Subject|3|||
94726985|NCT04059484|324458766|FG000|Overall Study|Adverse Event|2|||
94726986|NCT04059484|324458767|FG001|Overall Study|Adverse Event|5|||
94726987|NCT04059484|324458766|FG000|Overall Study|Withdrawal by Subject|5|||
94726988|NCT04059484|324458767|FG001|Overall Study|Withdrawal by Subject|3|||
94726989|NCT04059484|324458766|FG000|Overall Study|Progressive disease|112|||
94726990|NCT04059484|324458767|FG001|Overall Study|Progressive disease|112|||
94726991|NCT04059484|324458766|FG000|Overall Study|Other|8|||
94726992|NCT04059484|324458767|FG001|Overall Study|Other|3|||
94726993|NCT04059484|324458766|FG000|Overall Study|Ongoing|20|||
94726994|NCT04059484|324458767|FG001|Overall Study|Ongoing|20|||
94726995|NCT01000961|324458768|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
94726996|NCT01000961|324458769|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
94726997|NCT01000961|324458768|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
94726998|NCT01000961|324458769|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
94726999|NCT03199469|324458772|FG000|Overall Study|Randomized, not treated|0|||
94727000|NCT03199469|324458773|FG001|Overall Study|Randomized, not treated|3|||
94727001|NCT03199469|324458772|FG000|Overall Study|Withdrawal by Subject|1|||
94727002|NCT03199469|324458773|FG001|Overall Study|Withdrawal by Subject|0|||
94727003|NCT03199469|324458772|FG000|Overall Study|Death|1|||
94727004|NCT03199469|324458773|FG001|Overall Study|Death|3|||
94727005|NCT03199469|324458772|FG000|Overall Study|Ongoing|5|||
94727006|NCT03199469|324458773|FG001|Overall Study|Ongoing|14|||
94727007|NCT04292223|324458777|FG000|Overall Study|Adverse Event|1|||
94727008|NCT04292223|324458777|FG000|Overall Study|Lost to Follow-up|1|||
94727009|NCT04292223|324458777|FG000|Overall Study|Noncompliance with study drug|2|||
94727010|NCT04292223|324458777|FG000|Overall Study|Patient moved out of the state|1|||
94727011|NCT02023866|324458780|FG000|Overall Study|Non-compliance|2|||
94727012|NCT02023866|324458780|FG000|Overall Study|Adverse Event|3|||
94727013|NCT02023866|324458780|FG000|Overall Study|Withdrawal by Subject|1|||
94727014|NCT02485938|324458781|FG000|Overall Study|Withdrawal of consent|2|||
94727015|NCT02485938|324458782|FG001|Overall Study|Withdrawal of consent|0|||
94727016|NCT04633122|324458783|FG000|Overall Study|Remained on treatment|19|||
94467391|NCT02267135|323500554|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
94727017|NCT04633122|324458784|FG001|Overall Study|Remained on treatment|14|||
94727018|NCT04633122|324458783|FG000|Overall Study|Survival follow-up stopped|22|||
94727019|NCT04633122|324458784|FG001|Overall Study|Survival follow-up stopped|25|||
94727020|NCT03307343|324458785|FG000|Overall Study|Withdrawal by Subject|1|||
94727021|NCT03307343|324458786|FG001|Overall Study|Withdrawal by Subject|2|||
94727022|NCT03307343|324458785|FG000|Overall Study|Pregnancy|0|||
94727023|NCT03307343|324458786|FG001|Overall Study|Pregnancy|2|||
94727024|NCT03307343|324458785|FG000|Overall Study|Physician Decision|1|||
94727025|NCT03307343|324458786|FG001|Overall Study|Physician Decision|0|||
94727026|NCT03307343|324458785|FG000|Overall Study|Lost to Follow-up|0|||
94727027|NCT03307343|324458786|FG001|Overall Study|Lost to Follow-up|2|||
94727028|NCT04799899|324458793|FG000|Overall Study|Lost to Follow-up|2|||
94727029|NCT04799899|324458794|FG001|Overall Study|Lost to Follow-up|4|||
94727030|NCT04185298|324458796|FG000|Overall Study|Lost to Follow-up|1|||
94727031|NCT04185298|324458797|FG001|Overall Study|Lost to Follow-up|3|||
94727032|NCT04185298|324458796|FG000|Overall Study|Withdrawal by Subject|0|||
94727033|NCT04185298|324458797|FG001|Overall Study|Withdrawal by Subject|3|||
94727034|NCT03447470|324458798|FG000|Overall Study|Death|0|||
94727035|NCT03447470|324458799|FG001|Overall Study|Death|1|||
94727036|NCT03447470|324458800|FG002|Overall Study|Death|3|||
94727037|NCT03447470|324458801|FG003|Overall Study|Death|0|||
94727038|NCT03447470|324458802|FG004|Overall Study|Death|1|||
94727039|NCT03447470|324458803|FG005|Overall Study|Death|0|||
94727040|NCT03447470|324458804|FG006|Overall Study|Death|3|||
94727041|NCT03447470|324458805|FG007|Overall Study|Death|3|||
94727042|NCT03447470|324458806|FG008|Overall Study|Death|1|||
94727043|NCT03447470|324458798|FG000|Overall Study|Withdrawal by Subject|1|||
94727044|NCT03447470|324458799|FG001|Overall Study|Withdrawal by Subject|0|||
94727045|NCT03447470|324458800|FG002|Overall Study|Withdrawal by Subject|0|||
94727046|NCT03447470|324458801|FG003|Overall Study|Withdrawal by Subject|0|||
94727047|NCT03447470|324458802|FG004|Overall Study|Withdrawal by Subject|1|||
94727048|NCT03447470|324458803|FG005|Overall Study|Withdrawal by Subject|0|||
94727049|NCT03447470|324458804|FG006|Overall Study|Withdrawal by Subject|1|||
94727050|NCT03447470|324458805|FG007|Overall Study|Withdrawal by Subject|1|||
94727051|NCT03447470|324458806|FG008|Overall Study|Withdrawal by Subject|3|||
94727052|NCT03447470|324458798|FG000|Overall Study|Treatment discontinued|3|||
94727053|NCT03447470|324458799|FG001|Overall Study|Treatment discontinued|2|||
94727054|NCT03447470|324458800|FG002|Overall Study|Treatment discontinued|4|||
94727055|NCT03447470|324458801|FG003|Overall Study|Treatment discontinued|6|||
94727056|NCT03447470|324458802|FG004|Overall Study|Treatment discontinued|2|||
94727057|NCT03447470|324458803|FG005|Overall Study|Treatment discontinued|1|||
94727058|NCT03447470|324458804|FG006|Overall Study|Treatment discontinued|2|||
94727059|NCT03447470|324458805|FG007|Overall Study|Treatment discontinued|4|||
94727060|NCT03447470|324458806|FG008|Overall Study|Treatment discontinued|3|||
94727061|NCT01606215|324458807|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
94727062|NCT01606215|324458808|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
94727063|NCT05184192|324458810|FG000|Overall Study|Lost to Follow-up|4|||
94727064|NCT05184192|324458811|FG001|Overall Study|Lost to Follow-up|7|||
94727065|NCT05184192|324458810|FG000|Overall Study|Adverse Event|1|||
94727066|NCT05184192|324458811|FG001|Overall Study|Adverse Event|4|||
94727067|NCT05184192|324458810|FG000|Overall Study|PI withdrawal|1|||
94727068|NCT05184192|324458811|FG001|Overall Study|PI withdrawal|2|||
94727069|NCT05184192|324458810|FG000|Overall Study|Withdrew due to adverse effect|1|||
94727070|NCT05184192|324458811|FG001|Overall Study|Withdrew due to adverse effect|0|||
94727071|NCT05184192|324458810|FG000|Overall Study|Medication schedule|1|||
94727072|NCT05184192|324458811|FG001|Overall Study|Medication schedule|0|||
94727073|NCT05184192|324458810|FG000|Overall Study|Concern for adverse effects|0|||
94727074|NCT05184192|324458811|FG001|Overall Study|Concern for adverse effects|4|||
94727075|NCT03945292|324458812|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
94727076|NCT03945292|324458813|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
94727077|NCT03945292|324458814|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
94727078|NCT03945292|324458815|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
94727079|NCT03945292|324458816|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
94727080|NCT03945292|324458817|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
94727081|NCT03945292|324458818|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
94727082|NCT03945292|324458819|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
94727083|NCT03945292|324458812|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
94727084|NCT03945292|324458813|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
94727085|NCT03945292|324458814|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
94727086|NCT03945292|324458815|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
94727087|NCT03945292|324458816|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
94727088|NCT03945292|324458817|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
94727089|NCT03945292|324458818|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
94727090|NCT03945292|324458819|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
94727091|NCT03945292|324458812|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
94727092|NCT03945292|324458813|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
94727093|NCT03945292|324458814|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
94727094|NCT03945292|324458815|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
94727095|NCT03945292|324458816|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
94727096|NCT03945292|324458817|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
94727097|NCT03945292|324458818|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
94727098|NCT03945292|324458819|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
94727099|NCT03524118|324458826|FG000|Overall Study|Lost to Follow-up|0|||
94727100|NCT03524118|324458827|FG001|Overall Study|Lost to Follow-up|0|||
94727101|NCT03524118|324458828|FG002|Overall Study|Lost to Follow-up|0|||
94727102|NCT03524118|324458829|FG003|Overall Study|Lost to Follow-up|0|||
94727103|NCT03524118|324458830|FG004|Overall Study|Lost to Follow-up|1|||
94727104|NCT03524118|324458831|FG005|Overall Study|Lost to Follow-up|0|||
94727105|NCT03524118|324458826|FG000|Overall Study|Other|0|||
94727106|NCT03524118|324458827|FG001|Overall Study|Other|1|||
94727107|NCT03524118|324458828|FG002|Overall Study|Other|0|||
94727108|NCT03524118|324458829|FG003|Overall Study|Other|0|||
94727109|NCT03524118|324458830|FG004|Overall Study|Other|1|||
94727110|NCT03524118|324458831|FG005|Overall Study|Other|1|||
94727111|NCT03524118|324458826|FG000|Overall Study|Physician Decision|0|||
94727112|NCT03524118|324458827|FG001|Overall Study|Physician Decision|0|||
94727113|NCT03524118|324458828|FG002|Overall Study|Physician Decision|0|||
94727114|NCT03524118|324458829|FG003|Overall Study|Physician Decision|0|||
94727115|NCT03524118|324458830|FG004|Overall Study|Physician Decision|1|||
94727116|NCT03524118|324458831|FG005|Overall Study|Physician Decision|0|||
94727117|NCT03524118|324458826|FG000|Overall Study|Protocol Violation|0|||
94727118|NCT03524118|324458827|FG001|Overall Study|Protocol Violation|0|||
94727119|NCT03524118|324458828|FG002|Overall Study|Protocol Violation|1|||
94727120|NCT03524118|324458829|FG003|Overall Study|Protocol Violation|0|||
94727121|NCT03524118|324458830|FG004|Overall Study|Protocol Violation|1|||
94727122|NCT03524118|324458831|FG005|Overall Study|Protocol Violation|0|||
94727123|NCT03524118|324458826|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94727124|NCT03524118|324458827|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
94727125|NCT03524118|324458828|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
94727126|NCT03524118|324458829|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
94727127|NCT03524118|324458830|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
94727128|NCT03524118|324458831|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
94727129|NCT04927364|324458832|FG000|Overall Study|Withdrawal by Subject|3|||
94727130|NCT04927364|324458832|FG000|Overall Study|Unable to complete preassessment MRI|1|||
94727131|NCT04624633|324458840|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
94727132|NCT04624633|324458841|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
94727133|NCT04624633|324458840|FG000|Overall Study|Death|1|||
94727134|NCT04624633|324458841|FG001|Overall Study|Death|0|||
94727135|NCT04316871|324458842|FG000|Overall Study|Protocol Violation|2|||
94727136|NCT04316871|324458843|FG001|Overall Study|Protocol Violation|2|||
94727137|NCT04316871|324458844|FG002|Overall Study|Protocol Violation|2|||
94727138|NCT04316871|324458845|FG003|Overall Study|Protocol Violation|2|||
94727139|NCT01437709|324458846|FG000|Overall Study|Adverse Event|0|||
94727140|NCT01437709|324458847|FG001|Overall Study|Adverse Event|1|||
94727141|NCT01437709|324458848|FG002|Overall Study|Adverse Event|0|||
94727142|NCT01437709|324458846|FG000|Overall Study|Pt trasnferred care|0|||
94727143|NCT01437709|324458847|FG001|Overall Study|Pt trasnferred care|1|||
94727144|NCT01437709|324458848|FG002|Overall Study|Pt trasnferred care|0|||
94727145|NCT04987320|324458849|FG000|Overall Study|Withdrawal by Subject|0|||
94727146|NCT04987320|324458850|FG001|Overall Study|Withdrawal by Subject|1|||
94727147|NCT04473222|324458851|FG000|Overall Study|Lost to Follow-up|13|||
94727148|NCT04473222|324458852|FG001|Overall Study|Lost to Follow-up|13|||
94727149|NCT04473222|324458851|FG000|Overall Study|Withdrawal by Subject|0|||
94727150|NCT04473222|324458852|FG001|Overall Study|Withdrawal by Subject|1|||
94727151|NCT04473222|324458851|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
94727152|NCT04473222|324458852|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
94727153|NCT04625283|324458853|FG000|Overall Study|post randomization exclusion|28|||
94727154|NCT04625283|324458854|FG001|Overall Study|post randomization exclusion|20|||
94727155|NCT04025554|324458855|FG000|Overall Study|Adverse Event|3|||
94727156|NCT02489903|324458856|FG000|Screening|Screen Failure|24|||
94727157|NCT02489903|324458857|FG001|Screening|Screen Failure|0|||
94368519|NCT01336608|323136457|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
94368520|NCT01336608|323136458|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
94727158|NCT02489903|324458858|FG002|Screening|Screen Failure|0|||
94727159|NCT02489903|324458859|FG003|Screening|Screen Failure|8|||
94727160|NCT02489903|324458856|FG000|Randomized and Received Treatment|Protocol Violation|0|||
94727161|NCT02489903|324458857|FG001|Randomized and Received Treatment|Protocol Violation|1|||
94727162|NCT02489903|324458858|FG002|Randomized and Received Treatment|Protocol Violation|0|||
94727163|NCT02489903|324458859|FG003|Randomized and Received Treatment|Protocol Violation|0|||
94727164|NCT02489903|324458856|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
94368521|NCT01336608|323136455|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
94368522|NCT01336608|323136456|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
94467392|NCT02267135|323500555|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
94727165|NCT02489903|324458857|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
94727166|NCT02489903|324458858|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
94727167|NCT02489903|324458859|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
94727168|NCT02489903|324458856|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
94727169|NCT02489903|324458857|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
94727170|NCT02489903|324458858|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
94727171|NCT02489903|324458859|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
94727172|NCT02489903|324458856|FG000|Randomized and Received Treatment|Death|10|||
94727173|NCT02489903|324458857|FG001|Randomized and Received Treatment|Death|1|||
94727174|NCT02489903|324458858|FG002|Randomized and Received Treatment|Death|0|||
94727175|NCT02489903|324458859|FG003|Randomized and Received Treatment|Death|0|||
94727176|NCT02921230|324460255|FG000|Overall Study|Withdrawal by Subject|20|||
94727177|NCT02921230|324460256|FG001|Overall Study|Withdrawal by Subject|8|||
94727178|NCT02921230|324460255|FG000|Overall Study|Death|12|||
94727179|NCT02921230|324460256|FG001|Overall Study|Death|3|||
94727180|NCT02921230|324460255|FG000|Overall Study|Protocol Violation|17|||
94727181|NCT02921230|324460256|FG001|Overall Study|Protocol Violation|6|||
94727182|NCT02921230|324460255|FG000|Overall Study|Early completion|5|||
94273268|NCT00914927|322793697|FG003|Overall Study|Administrative/Other|0|||
94273269|NCT00914927|322793698|FG004|Overall Study|Administrative/Other|1|||
94273270|NCT00914927|322793699|FG005|Overall Study|Administrative/Other|0|||
94273271|NCT00914927|322793700|FG006|Overall Study|Administrative/Other|0|||
94273272|NCT01911442|322793701|FG000|Overall Study|Adverse Event|2|||
94273273|NCT01911442|322793702|FG001|Overall Study|Adverse Event|2|||
94727183|NCT02921230|324460256|FG001|Overall Study|Early completion|1|||
94727184|NCT02921230|324460255|FG000|Overall Study|Pending data entry|1|||
94727185|NCT02921230|324460256|FG001|Overall Study|Pending data entry|0|||
94727186|NCT03519581|324460257|FG000|Overall Study|Lost to Follow-up|3|||
94727187|NCT03519581|324460258|FG001|Overall Study|Lost to Follow-up|2|||
94727188|NCT03519581|324460257|FG000|Overall Study|Adverse Event|5|||
94727189|NCT03519581|324460258|FG001|Overall Study|Adverse Event|2|||
94727190|NCT03519581|324460257|FG000|Overall Study|Withdrawal by Subject|2|||
94727191|NCT03519581|324460258|FG001|Overall Study|Withdrawal by Subject|0|||
94727192|NCT03519581|324460257|FG000|Overall Study|Change to insurance|2|||
94727193|NCT03519581|324460258|FG001|Overall Study|Change to insurance|1|||
94727194|NCT03519581|324460257|FG000|Overall Study|Other|2|||
94727195|NCT03519581|324460258|FG001|Overall Study|Other|4|||
94727196|NCT05268393|324460259|FG000|Overall Study|Withdrawal by Subject|2|||
94727197|NCT05268393|324460260|FG001|Overall Study|Withdrawal by Subject|1|||
94727198|NCT03396926|324460261|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
94727199|NCT03396926|324460262|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
94727200|NCT03338933|324460263|FG000|Screening Visit|Lost to Follow-up|1|||
94727201|NCT03338933|324460264|FG001|Screening Visit|Lost to Follow-up|3|||
94727202|NCT03338933|324460265|FG002|Screening Visit|Lost to Follow-up|1|||
94727203|NCT03338933|324460266|FG003|Screening Visit|Lost to Follow-up|4|||
94727204|NCT03338933|324460263|FG000|Screening Visit|Screen fail after consent|2|||
94727205|NCT03338933|324460264|FG001|Screening Visit|Screen fail after consent|7|||
94727206|NCT03338933|324460265|FG002|Screening Visit|Screen fail after consent|1|||
94727207|NCT03338933|324460266|FG003|Screening Visit|Screen fail after consent|4|||
94727208|NCT03338933|324460263|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
94727209|NCT03338933|324460264|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
94727210|NCT03338933|324460265|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
94727211|NCT03338933|324460266|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
94273274|NCT01911442|322793703|FG002|Overall Study|Adverse Event|4|||
94273275|NCT01911442|322793701|FG000|Overall Study|Lack of Efficacy|1|||
94273276|NCT01911442|322793702|FG001|Overall Study|Lack of Efficacy|1|||
94273277|NCT01911442|322793703|FG002|Overall Study|Lack of Efficacy|1|||
94727212|NCT03338933|324460263|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
94727213|NCT03338933|324460264|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
94727214|NCT03338933|324460265|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
94727215|NCT03338933|324460266|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
94727216|NCT03338933|324460263|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
94273278|NCT01911442|322793701|FG000|Overall Study|Lost to Follow-up|2|||
94273279|NCT01911442|322793702|FG001|Overall Study|Lost to Follow-up|0|||
94273280|NCT01911442|322793703|FG002|Overall Study|Lost to Follow-up|1|||
94727217|NCT03338933|324460264|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
94727218|NCT03338933|324460265|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
94727219|NCT03338933|324460266|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
94727220|NCT03853746|324460268|FG000|Overall Study|Withdrawal by Subject|1|||
94727221|NCT05371652|324460269|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
94727222|NCT05371652|324460269|FG000|Overall Study|Withdrawal by Subject|12|||
94727223|NCT05371652|324460269|FG000|Overall Study|Adverse Event|1|||
94727224|NCT05371652|324460269|FG000|Overall Study|Other|11|||
94727225|NCT01081951|324460272|FG000|Overall Study|Death|54|||
94727226|NCT01081951|324460273|FG001|Overall Study|Death|47|||
94727227|NCT01081951|324460272|FG000|Overall Study|Withdrawal by Subject|2|||
94727228|NCT01081951|324460273|FG001|Overall Study|Withdrawal by Subject|6|||
94727229|NCT01081951|324460272|FG000|Overall Study|Allocated treatment but did not take it|0|||
94727230|NCT01081951|324460273|FG001|Overall Study|Allocated treatment but did not take it|1|||
94727231|NCT01081951|324460272|FG000|Overall Study|Lost to Follow-up|0|||
94727232|NCT01081951|324460273|FG001|Overall Study|Lost to Follow-up|1|||
94727233|NCT01494662|324460274|FG000|Overall Study|Withdrawal by Subject|0|||
94727234|NCT01494662|324460275|FG001|Overall Study|Withdrawal by Subject|0|||
94727235|NCT01494662|324460276|FG002|Overall Study|Withdrawal by Subject|1|||
94727236|NCT01494662|324460277|FG003|Overall Study|Withdrawal by Subject|0|||
94727237|NCT01494662|324460278|FG004|Overall Study|Withdrawal by Subject|0|||
94727238|NCT01494662|324460279|FG005|Overall Study|Withdrawal by Subject|0|||
94727239|NCT01494662|324460280|FG006|Overall Study|Withdrawal by Subject|0|||
94727240|NCT01494662|324460274|FG000|Overall Study|Physician Decision|0|||
94727241|NCT01494662|324460275|FG001|Overall Study|Physician Decision|0|||
94727242|NCT01494662|324460276|FG002|Overall Study|Physician Decision|1|||
94727243|NCT01494662|324460277|FG003|Overall Study|Physician Decision|0|||
94727244|NCT01494662|324460278|FG004|Overall Study|Physician Decision|0|||
94727245|NCT01494662|324460279|FG005|Overall Study|Physician Decision|0|||
94727246|NCT01494662|324460280|FG006|Overall Study|Physician Decision|0|||
94727247|NCT04322643|324460281|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
94727248|NCT03302494|324460289|FG000|Overall Study|Other|7|||
94727249|NCT03302494|324460290|FG001|Overall Study|Other|4|||
94727250|NCT03302494|324460291|FG002|Overall Study|Other|6|||
94727251|NCT03302494|324460289|FG000|Overall Study|Withdrawal by Subject|10|||
94727252|NCT03302494|324460290|FG001|Overall Study|Withdrawal by Subject|2|||
94727253|NCT03302494|324460291|FG002|Overall Study|Withdrawal by Subject|9|||
94727254|NCT03302494|324460289|FG000|Overall Study|Study Terminated by Sponsor|32|||
94727255|NCT03302494|324460290|FG001|Overall Study|Study Terminated by Sponsor|29|||
94727256|NCT03302494|324460291|FG002|Overall Study|Study Terminated by Sponsor|30|||
94727257|NCT03302494|324460289|FG000|Overall Study|Physician Decision|1|||
94727258|NCT03302494|324460290|FG001|Overall Study|Physician Decision|0|||
94727259|NCT03302494|324460291|FG002|Overall Study|Physician Decision|1|||
94727260|NCT03302494|324460289|FG000|Overall Study|Lost to Follow-up|1|||
94727261|NCT03302494|324460290|FG001|Overall Study|Lost to Follow-up|3|||
94727262|NCT03302494|324460291|FG002|Overall Study|Lost to Follow-up|3|||
94727263|NCT03302494|324460289|FG000|Overall Study|Death|13|||
94727264|NCT03302494|324460290|FG001|Overall Study|Death|11|||
94727265|NCT03302494|324460291|FG002|Overall Study|Death|4|||
94727266|NCT03302494|324460289|FG000|Overall Study|Adverse Event|1|||
94727267|NCT03302494|324460290|FG001|Overall Study|Adverse Event|2|||
94727268|NCT03302494|324460291|FG002|Overall Study|Adverse Event|0|||
94727269|NCT03302494|324460289|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
94727270|NCT03302494|324460290|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
94727271|NCT03302494|324460291|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
94727272|NCT02908477|324460292|FG000|Overall Study|Withdrawal by Subject|8|||
94727273|NCT02908477|324460293|FG001|Overall Study|Withdrawal by Subject|28|||
94727274|NCT02140554|324460294|FG000|Overall Study|Withdrawal of consent|1|||
94727275|NCT02140554|324460295|FG001|Overall Study|Withdrawal of consent|0|||
94727276|NCT02140554|324460296|FG002|Overall Study|Withdrawal of consent|4|||
94727277|NCT02140554|324460294|FG000|Overall Study|Physician Decision|1|||
94368523|NCT01336608|323136457|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
94368524|NCT01336608|323136458|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
94727278|NCT02140554|324460295|FG001|Overall Study|Physician Decision|0|||
94727279|NCT02140554|324460296|FG002|Overall Study|Physician Decision|2|||
94727280|NCT02140554|324460294|FG000|Overall Study|Death|0|||
94727281|NCT02140554|324460295|FG001|Overall Study|Death|0|||
94727282|NCT02140554|324460296|FG002|Overall Study|Death|1|||
94727283|NCT02140554|324460294|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
94727284|NCT02140554|324460295|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
94727285|NCT02140554|324460296|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
94727286|NCT05590403|324460297|FG000|Overall Study|Lost to Follow-up|13|||
94727287|NCT05590403|324460298|FG001|Overall Study|Lost to Follow-up|1|||
94727288|NCT05590403|324460299|FG002|Overall Study|Lost to Follow-up|7|||
94727289|NCT05590403|324460300|FG003|Overall Study|Lost to Follow-up|3|||
94727290|NCT05590403|324460301|FG004|Overall Study|Lost to Follow-up|4|||
94727291|NCT05590403|324460297|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
94727292|NCT05590403|324460298|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
94727293|NCT05590403|324460299|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
94727294|NCT05590403|324460300|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
94727295|NCT05590403|324460301|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
94727296|NCT05590403|324460297|FG000|Overall Study|Other|2|||
94727297|NCT05590403|324460298|FG001|Overall Study|Other|0|||
94727298|NCT05590403|324460299|FG002|Overall Study|Other|2|||
94727299|NCT05590403|324460300|FG003|Overall Study|Other|2|||
94727300|NCT05590403|324460301|FG004|Overall Study|Other|0|||
94727301|NCT05590403|324460297|FG000|Overall Study|Migrated / moved from the study area|1|||
94727302|NCT05590403|324460298|FG001|Overall Study|Migrated / moved from the study area|1|||
94727303|NCT05590403|324460299|FG002|Overall Study|Migrated / moved from the study area|0|||
94727304|NCT05590403|324460300|FG003|Overall Study|Migrated / moved from the study area|3|||
94727305|NCT05590403|324460301|FG004|Overall Study|Migrated / moved from the study area|1|||
94727306|NCT05590403|324460297|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
94727307|NCT05590403|324460298|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
94727308|NCT05590403|324460299|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
94727309|NCT05590403|324460300|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
94727310|NCT05590403|324460301|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
94727311|NCT05659537|324460302|FG000|Overall Study|Adverse Event|5|||
94727312|NCT05659537|324460302|FG000|Overall Study|Lost to Follow-up|4|||
94727313|NCT05659537|324460302|FG000|Overall Study|Withdrawal by Subject|13|||
94727314|NCT05659537|324460302|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
94727315|NCT05659537|324460302|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
94727316|NCT05659537|324460302|FG000|Overall Study|Participant was suffering from anaemia|1|||
94727317|NCT03953508|324460303|FG000|Baseline|Lost to Follow-up|3|||
94727318|NCT03953508|324460304|FG001|Baseline|Lost to Follow-up|2|||
94727319|NCT03953508|324460303|FG000|6-month Follow-up|Lost to Follow-up|62|||
94727320|NCT03953508|324460304|FG001|6-month Follow-up|Lost to Follow-up|70|||
94727321|NCT04952909|324460305|FG000|Overall Study|Death|3|||
94727322|NCT00881621|324460308|FG000|Overall Study|Physician Decision|34|||
94727323|NCT03936322|324460313|FG000|Overall Study|Lost to Follow-up|1|||
94727324|NCT03936322|324460313|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
94727325|NCT06393088|324460315|FG000|Overall Study|Withdrawal by Subject|0|||
94727326|NCT06393088|324460316|FG001|Overall Study|Withdrawal by Subject|2|||
94727327|NCT05434078|324460318|FG000|Overall Study|Lost to Follow-up|2|||
94727328|NCT05434078|324460319|FG001|Overall Study|Lost to Follow-up|1|||
94727329|NCT05434078|324460318|FG000|Overall Study|Withdrawal by Subject|1|||
94727330|NCT05434078|324460319|FG001|Overall Study|Withdrawal by Subject|0|||
94727331|NCT04072380|324460320|FG000|Overall Study|Adverse Event|4|||
94727332|NCT04072380|324460321|FG001|Overall Study|Adverse Event|6|||
94727333|NCT04072380|324460322|FG002|Overall Study|Adverse Event|0|||
94727334|NCT04072380|324460320|FG000|Overall Study|Withdrawal by Subject|3|||
94727335|NCT04072380|324460321|FG001|Overall Study|Withdrawal by Subject|1|||
94727336|NCT04072380|324460322|FG002|Overall Study|Withdrawal by Subject|1|||
94727337|NCT04072380|324460320|FG000|Overall Study|Physician Decision|2|||
94727338|NCT04072380|324460321|FG001|Overall Study|Physician Decision|0|||
94727339|NCT04072380|324460322|FG002|Overall Study|Physician Decision|0|||
94727340|NCT04072380|324460320|FG000|Overall Study|Protocol Violation|0|||
94727341|NCT04072380|324460321|FG001|Overall Study|Protocol Violation|2|||
94727342|NCT04072380|324460322|FG002|Overall Study|Protocol Violation|3|||
94727343|NCT04072380|324460320|FG000|Overall Study|Intercurrent Illness and Others|3|||
94727344|NCT04072380|324460321|FG001|Overall Study|Intercurrent Illness and Others|5|||
94727345|NCT04072380|324460322|FG002|Overall Study|Intercurrent Illness and Others|6|||
94727346|NCT03652688|324460323|FG000|Baseline|Withdrawal by Subject|0|||
94727347|NCT03652688|324460324|FG001|Baseline|Withdrawal by Subject|3|||
94727348|NCT03652688|324460323|FG000|Follow-up|Lost to Follow-up|56|||
94727349|NCT03652688|324460324|FG001|Follow-up|Lost to Follow-up|54|||
94727350|NCT02105766|324460328|FG000|Overall Study|Physician Decision|1|||
94727351|NCT02105766|324460329|FG001|Overall Study|Physician Decision|1|||
94727352|NCT02105766|324460330|FG002|Overall Study|Physician Decision|0|||
94727353|NCT02105766|324460328|FG000|Overall Study|Lost to Follow-up|2|||
94727354|NCT02105766|324460329|FG001|Overall Study|Lost to Follow-up|0|||
94727355|NCT02105766|324460330|FG002|Overall Study|Lost to Follow-up|0|||
94727356|NCT02105766|324460328|FG000|Overall Study|Death|1|||
94727357|NCT02105766|324460329|FG001|Overall Study|Death|1|||
94727358|NCT02105766|324460330|FG002|Overall Study|Death|0|||
94727359|NCT03867500|324460331|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
94727360|NCT06205407|324460332|FG000|Period 2|Withdrawal by Subject|0|||
94727361|NCT06205407|324460333|FG001|Period 2|Withdrawal by Subject|1|||
94727362|NCT06205407|324460332|FG000|Period 2|Adverse Event|2|||
94273281|NCT01911442|322793701|FG000|Overall Study|Withdrawal by Subject|1|||
94727363|NCT06205407|324460333|FG001|Period 2|Adverse Event|1|||
94727364|NCT02985957|324460334|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94727365|NCT02985957|324460335|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94727366|NCT02985957|324460336|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94727367|NCT02985957|324460337|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94727368|NCT02985957|324460338|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
94727369|NCT02985957|324460339|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94727370|NCT02985957|324460340|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94727371|NCT02985957|324460334|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
94727372|NCT02985957|324460335|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
94727373|NCT02985957|324460336|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
94727374|NCT02985957|324460337|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
94727375|NCT02985957|324460338|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
94727376|NCT02985957|324460339|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
94727377|NCT02985957|324460340|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
94727378|NCT02985957|324460334|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
94727379|NCT02985957|324460335|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
94727380|NCT02985957|324460336|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
94727381|NCT02985957|324460337|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
94727382|NCT02985957|324460338|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
94727383|NCT02985957|324460339|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
94727384|NCT02985957|324460340|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
94727385|NCT02985957|324460334|FG000|Treatment Period|Death|0|||
94727386|NCT02985957|324460335|FG001|Treatment Period|Death|0|||
94727387|NCT02985957|324460336|FG002|Treatment Period|Death|0|||
94727388|NCT02985957|324460337|FG003|Treatment Period|Death|0|||
94727389|NCT02985957|324460338|FG004|Treatment Period|Death|1|||
94727390|NCT02985957|324460339|FG005|Treatment Period|Death|0|||
94727391|NCT02985957|324460340|FG006|Treatment Period|Death|0|||
94727392|NCT02985957|324460334|FG000|Treatment Period|Participant withdrew consent|0|||
94727393|NCT02985957|324460335|FG001|Treatment Period|Participant withdrew consent|0|||
94727394|NCT02985957|324460336|FG002|Treatment Period|Participant withdrew consent|0|||
94727395|NCT02985957|324460337|FG003|Treatment Period|Participant withdrew consent|1|||
94727396|NCT02985957|324460338|FG004|Treatment Period|Participant withdrew consent|3|||
94727397|NCT02985957|324460339|FG005|Treatment Period|Participant withdrew consent|0|||
94727398|NCT02985957|324460340|FG006|Treatment Period|Participant withdrew consent|1|||
94727399|NCT02985957|324460334|FG000|Treatment Period|Lost to Follow-up|0|||
94727400|NCT02985957|324460335|FG001|Treatment Period|Lost to Follow-up|0|||
94727401|NCT02985957|324460336|FG002|Treatment Period|Lost to Follow-up|0|||
94727402|NCT02985957|324460337|FG003|Treatment Period|Lost to Follow-up|0|||
94727403|NCT02985957|324460338|FG004|Treatment Period|Lost to Follow-up|1|||
94727404|NCT02985957|324460339|FG005|Treatment Period|Lost to Follow-up|0|||
94727405|NCT02985957|324460340|FG006|Treatment Period|Lost to Follow-up|0|||
94727406|NCT02985957|324460334|FG000|Treatment Period|Other reasons|0|||
94727407|NCT02985957|324460335|FG001|Treatment Period|Other reasons|0|||
94727408|NCT02985957|324460336|FG002|Treatment Period|Other reasons|1|||
94727409|NCT02985957|324460337|FG003|Treatment Period|Other reasons|3|||
94727410|NCT02985957|324460338|FG004|Treatment Period|Other reasons|6|||
94727411|NCT02985957|324460339|FG005|Treatment Period|Other reasons|0|||
94727412|NCT02985957|324460340|FG006|Treatment Period|Other reasons|1|||
94727413|NCT02985957|324460334|FG000|Treatment Period|Not reported|0|||
94727414|NCT02985957|324460335|FG001|Treatment Period|Not reported|1|||
94727415|NCT02985957|324460336|FG002|Treatment Period|Not reported|2|||
94727416|NCT02985957|324460337|FG003|Treatment Period|Not reported|5|||
94727417|NCT02985957|324460338|FG004|Treatment Period|Not reported|0|||
94727418|NCT02985957|324460339|FG005|Treatment Period|Not reported|0|||
94727419|NCT02985957|324460340|FG006|Treatment Period|Not reported|0|||
94727420|NCT02985957|324460334|FG000|Treatment Period|Maximum clinical benefit|0|||
94727421|NCT02985957|324460335|FG001|Treatment Period|Maximum clinical benefit|0|||
94727422|NCT02985957|324460336|FG002|Treatment Period|Maximum clinical benefit|1|||
94727423|NCT02985957|324460337|FG003|Treatment Period|Maximum clinical benefit|1|||
94727424|NCT02985957|324460338|FG004|Treatment Period|Maximum clinical benefit|0|||
94727425|NCT02985957|324460339|FG005|Treatment Period|Maximum clinical benefit|0|||
94727426|NCT02985957|324460340|FG006|Treatment Period|Maximum clinical benefit|2|||
94727427|NCT02985957|324460334|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
94727428|NCT02985957|324460335|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
94727429|NCT02985957|324460336|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
94727430|NCT02985957|324460337|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
94727431|NCT02985957|324460338|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
94727432|NCT02985957|324460339|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
94727433|NCT02985957|324460340|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
94727434|NCT02985957|324460334|FG000|Treatment Period|Study drug toxicity|1|||
94727435|NCT02985957|324460335|FG001|Treatment Period|Study drug toxicity|23|||
94727436|NCT02985957|324460336|FG002|Treatment Period|Study drug toxicity|20|||
94727437|NCT02985957|324460337|FG003|Treatment Period|Study drug toxicity|11|||
94727438|NCT02985957|324460338|FG004|Treatment Period|Study drug toxicity|19|||
94727439|NCT02985957|324460339|FG005|Treatment Period|Study drug toxicity|3|||
94727440|NCT02985957|324460340|FG006|Treatment Period|Study drug toxicity|5|||
94727441|NCT02985957|324460334|FG000|Treatment Period|Disease progression|0|||
94727442|NCT02985957|324460335|FG001|Treatment Period|Disease progression|16|||
94727443|NCT02985957|324460336|FG002|Treatment Period|Disease progression|20|||
94727444|NCT02985957|324460337|FG003|Treatment Period|Disease progression|39|||
94727445|NCT02985957|324460338|FG004|Treatment Period|Disease progression|29|||
94727446|NCT02985957|324460339|FG005|Treatment Period|Disease progression|11|||
94727447|NCT02985957|324460340|FG006|Treatment Period|Disease progression|28|||
94727448|NCT02985957|324460334|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
94727449|NCT02985957|324460335|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
94727450|NCT02985957|324460336|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
94727451|NCT02985957|324460337|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
94727452|NCT02985957|324460338|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
94727453|NCT02985957|324460339|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
94727454|NCT02985957|324460340|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
94727455|NCT02985957|324460334|FG000|Treatment Period|Poor/Non-Compliance|0|||
94727456|NCT02985957|324460335|FG001|Treatment Period|Poor/Non-Compliance|0|||
94727457|NCT02985957|324460336|FG002|Treatment Period|Poor/Non-Compliance|0|||
94727458|NCT02985957|324460337|FG003|Treatment Period|Poor/Non-Compliance|0|||
94727459|NCT02985957|324460338|FG004|Treatment Period|Poor/Non-Compliance|1|||
94727460|NCT02985957|324460339|FG005|Treatment Period|Poor/Non-Compliance|1|||
94727461|NCT02985957|324460340|FG006|Treatment Period|Poor/Non-Compliance|0|||
94727462|NCT02985957|324460334|FG000|Treatment Period|Continuing in Treatment Period|0|||
94727463|NCT02985957|324460335|FG001|Treatment Period|Continuing in Treatment Period|1|||
94727464|NCT02985957|324460336|FG002|Treatment Period|Continuing in Treatment Period|0|||
94727465|NCT02985957|324460337|FG003|Treatment Period|Continuing in Treatment Period|4|||
94727466|NCT02985957|324460338|FG004|Treatment Period|Continuing in Treatment Period|4|||
94727467|NCT02985957|324460339|FG005|Treatment Period|Continuing in Treatment Period|0|||
94727468|NCT02985957|324460340|FG006|Treatment Period|Continuing in Treatment Period|0|||
94727469|NCT02577835|324460341|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
94727470|NCT05119023|324460342|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
94727471|NCT05119023|324460342|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
94727472|NCT05119023|324460342|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
94727473|NCT02274662|324460343|FG000|Overall Study|Death|1|||
94727474|NCT02274662|324460343|FG000|Overall Study|Lost to Follow-up|3|||
94727475|NCT02949362|324460352|FG000|Retrospective Period|Inform consent not signed by participant|4|||
94727476|NCT02949362|324460353|FG001|Retrospective Period|Inform consent not signed by participant|1|||
94727477|NCT02949362|324460354|FG002|Retrospective Period|Inform consent not signed by participant|0|||
94727478|NCT02949362|324460355|FG003|Retrospective Period|Inform consent not signed by participant|0|||
94727479|NCT02949362|324460352|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
94727480|NCT02949362|324460353|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
94727481|NCT02949362|324460354|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
94727482|NCT02949362|324460355|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
94727483|NCT02949362|324460352|FG000|Prospective Period|Other|0|||
94727484|NCT02949362|324460353|FG001|Prospective Period|Other|0|||
94727485|NCT02949362|324460354|FG002|Prospective Period|Other|0|||
94727486|NCT02949362|324460355|FG003|Prospective Period|Other|4|||
94727487|NCT05453773|324460359|FG000|Overall Study|Withdrawal by Subject|3|||
94727488|NCT05453773|324460359|FG000|Overall Study|Lost to Follow-up|3|||
94727489|NCT05453773|324460359|FG000|Overall Study|Difficult Blood Draw|3|||
94467393|NCT02267135|323500554|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
94467394|NCT02267135|323500555|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
94467395|NCT04608344|323500556|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
94727490|NCT01798498|324460360|FG000|Overall Study|Lost to Follow-up|1|||
94727491|NCT04091750|324460362|FG000|Overall Study|Adverse Event|4|||
94727492|NCT04091750|324460362|FG000|Overall Study|Withdrawal by Subject|1|||
94727493|NCT06424236|324460363|FG000|Overall Study|Adverse Event|0|||
94727494|NCT06424236|324460364|FG001|Overall Study|Adverse Event|1|||
94727495|NCT06424236|324460365|FG002|Overall Study|Adverse Event|0|||
94727496|NCT06424236|324460363|FG000|Overall Study|Withdrawal by Subject|3|||
94727497|NCT06424236|324460364|FG001|Overall Study|Withdrawal by Subject|1|||
94727498|NCT06424236|324460365|FG002|Overall Study|Withdrawal by Subject|2|||
94727499|NCT06424236|324460363|FG000|Overall Study|Physician Decision|0|||
94727500|NCT06424236|324460364|FG001|Overall Study|Physician Decision|1|||
94727501|NCT06424236|324460365|FG002|Overall Study|Physician Decision|0|||
94727502|NCT06424236|324460363|FG000|Overall Study|Study Terminated by Sponsor|11|||
94727503|NCT06424236|324460364|FG001|Overall Study|Study Terminated by Sponsor|20|||
94727504|NCT06424236|324460365|FG002|Overall Study|Study Terminated by Sponsor|16|||
94727505|NCT06424236|324460363|FG000|Overall Study|Lost to Follow-up|0|||
94727506|NCT06424236|324460364|FG001|Overall Study|Lost to Follow-up|1|||
94727507|NCT06424236|324460365|FG002|Overall Study|Lost to Follow-up|0|||
94727508|NCT06424236|324460363|FG000|Overall Study|Disease Progression|0|||
94727509|NCT06424236|324460364|FG001|Overall Study|Disease Progression|1|||
94727510|NCT06424236|324460365|FG002|Overall Study|Disease Progression|2|||
94727511|NCT06424236|324460363|FG000|Overall Study|Other|0|||
94727512|NCT06424236|324460364|FG001|Overall Study|Other|0|||
94727513|NCT06424236|324460365|FG002|Overall Study|Other|1|||
94727514|NCT01824394|324460368|FG000|Overall Study|Early Termination|1|||
94467396|NCT04608344|323500557|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
94727515|NCT01824394|324460369|FG001|Overall Study|Early Termination|1|||
94727516|NCT01824394|324460370|FG002|Overall Study|Early Termination|3|||
94727517|NCT01824394|324460368|FG000|Overall Study|Withdrawn due to Study Termination|91|||
94727518|NCT01824394|324460369|FG001|Overall Study|Withdrawn due to Study Termination|83|||
94727519|NCT01824394|324460370|FG002|Overall Study|Withdrawn due to Study Termination|41|||
94727520|NCT01824394|324460368|FG000|Overall Study|Lost to Follow-up|0|||
94727521|NCT01824394|324460369|FG001|Overall Study|Lost to Follow-up|9|||
94727522|NCT01824394|324460370|FG002|Overall Study|Lost to Follow-up|3|||
94727523|NCT01824394|324460368|FG000|Overall Study|Death|3|||
94727524|NCT01824394|324460369|FG001|Overall Study|Death|2|||
94727525|NCT01824394|324460370|FG002|Overall Study|Death|4|||
94727526|NCT01824394|324460368|FG000|Overall Study|Discontinued Subjects|1|||
94727527|NCT01824394|324460369|FG001|Overall Study|Discontinued Subjects|1|||
94727528|NCT01824394|324460370|FG002|Overall Study|Discontinued Subjects|2|||
94727529|NCT01824394|324460368|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
94727530|NCT01824394|324460369|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
94727531|NCT01824394|324460370|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
94727532|NCT00227344|324460371|FG000|Overall Study|study terminated early|12|||
94727533|NCT00227344|324460372|FG001|Overall Study|study terminated early|5|||
94727534|NCT01987895|324460373|FG000|Overall Study|Withdrawal by Subject|12|||
94727535|NCT01987895|324460374|FG001|Overall Study|Withdrawal by Subject|7|||
94727536|NCT01987895|324460373|FG000|Overall Study|Physician Decision|8|||
94273282|NCT01911442|322793702|FG001|Overall Study|Withdrawal by Subject|0|||
94273283|NCT01911442|322793703|FG002|Overall Study|Withdrawal by Subject|6|||
94273284|NCT01911442|322793701|FG000|Overall Study|Mother's Work Schedule|0|||
94273285|NCT01911442|322793702|FG001|Overall Study|Mother's Work Schedule|1|||
94273286|NCT01911442|322793703|FG002|Overall Study|Mother's Work Schedule|0|||
94273287|NCT00122681|322793704|FG000|Overall Study|Adverse Event|20|||
94273288|NCT00122681|322793705|FG001|Overall Study|Adverse Event|16|||
94273289|NCT00122681|322793704|FG000|Overall Study|Lost to Follow-up|1080|||
94273290|NCT00122681|322793705|FG001|Overall Study|Lost to Follow-up|1097|||
94273291|NCT00122681|322793704|FG000|Overall Study|Protocol Violation|7|||
94273292|NCT00122681|322793705|FG001|Overall Study|Protocol Violation|10|||
94273293|NCT00122681|322793704|FG000|Overall Study|Withdrawal by Subject|257|||
94273294|NCT00122681|322793705|FG001|Overall Study|Withdrawal by Subject|251|||
94273295|NCT00122681|322793704|FG000|Overall Study|Personal reasons|150|||
94273296|NCT00122681|322793705|FG001|Overall Study|Personal reasons|147|||
94273297|NCT00714285|322793707|FG000|Overall Study|Lost to Follow-up|0|||
94273298|NCT00714285|322793708|FG001|Overall Study|Lost to Follow-up|2|||
94273299|NCT00714285|322793709|FG002|Overall Study|Lost to Follow-up|0|||
94467397|NCT04608344|323500556|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
94727537|NCT01987895|324460374|FG001|Overall Study|Physician Decision|10|||
94727538|NCT01987895|324460373|FG000|Overall Study|Death|7|||
94727539|NCT01987895|324460374|FG001|Overall Study|Death|7|||
94727540|NCT01987895|324460373|FG000|Overall Study|Lost to Follow-up|3|||
94727541|NCT01987895|324460374|FG001|Overall Study|Lost to Follow-up|5|||
94727542|NCT01987895|324460373|FG000|Overall Study|randomized before giving IC|0|||
94727543|NCT01987895|324460374|FG001|Overall Study|randomized before giving IC|1|||
94727544|NCT02359890|324460375|FG000|Overall Study|Not meeting eligibility|4|||
94727545|NCT02359890|324460375|FG000|Overall Study|Never treated with study catheter|6|||
94727546|NCT04810650|324460376|FG000|Overall Study|Disenrolled in error|0|||
94727547|NCT04810650|324460377|FG001|Overall Study|Disenrolled in error|0|||
94727548|NCT04810650|324460378|FG002|Overall Study|Disenrolled in error|0|||
94727549|NCT04810650|324460379|FG003|Overall Study|Disenrolled in error|0|||
94727550|NCT04810650|324460380|FG004|Overall Study|Disenrolled in error|0|||
94727551|NCT04810650|324460381|FG005|Overall Study|Disenrolled in error|0|||
94273300|NCT00714285|322793710|FG003|Overall Study|Lost to Follow-up|1|||
94273301|NCT00714285|322793707|FG000|Overall Study|Migrated/moved from study area|0|||
94273302|NCT00714285|322793708|FG001|Overall Study|Migrated/moved from study area|1|||
94273303|NCT00714285|322793709|FG002|Overall Study|Migrated/moved from study area|0|||
94273304|NCT00714285|322793710|FG003|Overall Study|Migrated/moved from study area|0|||
94273305|NCT02037295|322793711|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
94273306|NCT02037295|322793712|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
94273307|NCT02037295|322793713|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
94273308|NCT02037295|322793714|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
94273309|NCT01372384|322793715|FG000|Overall Study|Progression of disease|3|||
94273310|NCT01131676|322793716|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
94273311|NCT01131676|322793717|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
94273312|NCT01131676|322793718|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
94273313|NCT01131676|322793716|FG000|Discontinuation From Treatment|Not treated|4|||
94273314|NCT01131676|322793717|FG001|Discontinuation From Treatment|Not treated|2|||
94273315|NCT01131676|322793718|FG002|Discontinuation From Treatment|Not treated|2|||
94273316|NCT01131676|322793716|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
94273317|NCT01131676|322793717|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
94273318|NCT01131676|322793718|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
94273319|NCT01131676|322793716|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
94273320|NCT01131676|322793717|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
94273321|NCT01131676|322793718|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
94273322|NCT01131676|322793716|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
94273323|NCT01131676|322793717|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
94273324|NCT01131676|322793718|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
94273325|NCT01131676|322793716|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
94273326|NCT01131676|322793717|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
94273327|NCT01131676|322793718|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
94273328|NCT01131676|322793716|FG000|Discontinuation From Treatment|Other than those specified|162|||
94273329|NCT01131676|322793717|FG001|Discontinuation From Treatment|Other than those specified|142|||
94273330|NCT01131676|322793718|FG002|Discontinuation From Treatment|Other than those specified|125|||
94273331|NCT01131676|322793716|FG000|Discontinuation From Treatment|Adverse Event|303|||
94273332|NCT01131676|322793717|FG001|Discontinuation From Treatment|Adverse Event|267|||
94273333|NCT01131676|322793718|FG002|Discontinuation From Treatment|Adverse Event|273|||
94273334|NCT01131676|322793716|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
94273335|NCT01131676|322793717|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
94273336|NCT01131676|322793718|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
94273337|NCT01131676|322793716|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
94273338|NCT01131676|322793717|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
94273339|NCT01131676|322793718|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
94273340|NCT01131676|322793716|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
94273341|NCT01131676|322793717|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
94273342|NCT01131676|322793718|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
94273343|NCT01131676|322793716|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
94273344|NCT01131676|322793717|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
94273345|NCT01131676|322793718|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
94273346|NCT01131676|322793716|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
94273347|NCT01131676|322793717|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
94273348|NCT01131676|322793718|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
94273349|NCT01131676|322793716|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
94273350|NCT01131676|322793717|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
94273351|NCT01131676|322793718|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
94273352|NCT00960661|322793722|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
94273353|NCT00960661|322793723|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
94273354|NCT00960661|322793724|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
94273355|NCT00960661|322793722|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
94273356|NCT00960661|322793723|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
94368525|NCT01336608|323136455|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
94368526|NCT01336608|323136456|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
94368527|NCT01336608|323136457|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
94368528|NCT01336608|323136458|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
94368529|NCT01336608|323136455|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
94368530|NCT01336608|323136456|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
94368531|NCT01336608|323136457|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
94368532|NCT01336608|323136458|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
94368533|NCT01336608|323136455|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
94368534|NCT01336608|323136456|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
94368535|NCT01336608|323136457|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
94368536|NCT01336608|323136458|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
94368537|NCT01336608|323136455|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
94368538|NCT01336608|323136456|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
94368539|NCT01336608|323136457|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
94368540|NCT01336608|323136458|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
94368541|NCT01336608|323136455|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
94368542|NCT01336608|323136456|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
94368543|NCT01336608|323136457|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
94368544|NCT01336608|323136458|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
94368545|NCT03456726|323136459|FG000|Overall Study|Disease Progression|6|||
94368546|NCT03456726|323136460|FG001|Overall Study|Disease Progression|1|||
94368547|NCT03456726|323136459|FG000|Overall Study|Adverse Event|4|||
94368548|NCT03456726|323136460|FG001|Overall Study|Adverse Event|2|||
94368549|NCT03456726|323136459|FG000|Overall Study|Withdrawal by Subject|1|||
94368550|NCT03456726|323136460|FG001|Overall Study|Withdrawal by Subject|0|||
94727552|NCT04810650|324460382|FG006|Overall Study|Disenrolled in error|0|||
94727553|NCT04810650|324460383|FG007|Overall Study|Disenrolled in error|0|||
94727554|NCT04810650|324460384|FG008|Overall Study|Disenrolled in error|1|||
94727555|NCT04810650|324460385|FG009|Overall Study|Disenrolled in error|0|||
94727556|NCT04810650|324460386|FG010|Overall Study|Disenrolled in error|0|||
94368551|NCT03456726|323136459|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
94727557|NCT04810650|324460387|FG011|Overall Study|Disenrolled in error|0|||
94727558|NCT04810650|324460388|FG012|Overall Study|Disenrolled in error|0|||
94727559|NCT04810650|324460389|FG013|Overall Study|Disenrolled in error|0|||
94727560|NCT04810650|324460376|FG000|Overall Study|Death|0|||
94727561|NCT04810650|324460377|FG001|Overall Study|Death|0|||
94727562|NCT04810650|324460378|FG002|Overall Study|Death|0|||
94727563|NCT04810650|324460379|FG003|Overall Study|Death|0|||
94727564|NCT04810650|324460380|FG004|Overall Study|Death|0|||
94727565|NCT04810650|324460381|FG005|Overall Study|Death|0|||
94727566|NCT04810650|324460382|FG006|Overall Study|Death|2|||
94727567|NCT04810650|324460383|FG007|Overall Study|Death|2|||
94727568|NCT04810650|324460384|FG008|Overall Study|Death|0|||
94727569|NCT04810650|324460385|FG009|Overall Study|Death|1|||
94727570|NCT04810650|324460386|FG010|Overall Study|Death|0|||
94727571|NCT04810650|324460387|FG011|Overall Study|Death|0|||
94727572|NCT04810650|324460388|FG012|Overall Study|Death|2|||
94727573|NCT04810650|324460389|FG013|Overall Study|Death|1|||
94727574|NCT04810650|324460376|FG000|Overall Study|Moved/transferred care|0|||
94727575|NCT04810650|324460377|FG001|Overall Study|Moved/transferred care|0|||
94727576|NCT04810650|324460378|FG002|Overall Study|Moved/transferred care|0|||
94727577|NCT04810650|324460379|FG003|Overall Study|Moved/transferred care|0|||
94727578|NCT04810650|324460380|FG004|Overall Study|Moved/transferred care|0|||
94727579|NCT04810650|324460381|FG005|Overall Study|Moved/transferred care|0|||
94727580|NCT04810650|324460382|FG006|Overall Study|Moved/transferred care|0|||
94727581|NCT04810650|324460383|FG007|Overall Study|Moved/transferred care|1|||
94727582|NCT04810650|324460384|FG008|Overall Study|Moved/transferred care|12|||
94727583|NCT04810650|324460385|FG009|Overall Study|Moved/transferred care|10|||
94727584|NCT04810650|324460386|FG010|Overall Study|Moved/transferred care|0|||
94727585|NCT04810650|324460387|FG011|Overall Study|Moved/transferred care|0|||
94727586|NCT04810650|324460388|FG012|Overall Study|Moved/transferred care|0|||
94727587|NCT04810650|324460389|FG013|Overall Study|Moved/transferred care|0|||
94727588|NCT04810650|324460376|FG000|Overall Study|Lost to Follow-up|15|||
94727589|NCT04810650|324460377|FG001|Overall Study|Lost to Follow-up|12|||
94727590|NCT04810650|324460378|FG002|Overall Study|Lost to Follow-up|7|||
94368552|NCT03456726|323136460|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
94727591|NCT04810650|324460379|FG003|Overall Study|Lost to Follow-up|9|||
94727592|NCT04810650|324460380|FG004|Overall Study|Lost to Follow-up|10|||
94727593|NCT04810650|324460381|FG005|Overall Study|Lost to Follow-up|6|||
94727594|NCT04810650|324460382|FG006|Overall Study|Lost to Follow-up|0|||
94727595|NCT04810650|324460383|FG007|Overall Study|Lost to Follow-up|0|||
94727596|NCT04810650|324460384|FG008|Overall Study|Lost to Follow-up|0|||
94727597|NCT04810650|324460385|FG009|Overall Study|Lost to Follow-up|0|||
94727598|NCT04810650|324460386|FG010|Overall Study|Lost to Follow-up|1|||
94727599|NCT04810650|324460387|FG011|Overall Study|Lost to Follow-up|0|||
94727600|NCT04810650|324460388|FG012|Overall Study|Lost to Follow-up|3|||
94727601|NCT04810650|324460389|FG013|Overall Study|Lost to Follow-up|9|||
94727602|NCT04810650|324460376|FG000|Overall Study|Participant declined|0|||
94727603|NCT04810650|324460377|FG001|Overall Study|Participant declined|0|||
94727604|NCT04810650|324460378|FG002|Overall Study|Participant declined|0|||
94727605|NCT04810650|324460379|FG003|Overall Study|Participant declined|0|||
94727606|NCT04810650|324460380|FG004|Overall Study|Participant declined|0|||
94727607|NCT04810650|324460381|FG005|Overall Study|Participant declined|0|||
94727608|NCT04810650|324460382|FG006|Overall Study|Participant declined|0|||
94727609|NCT04810650|324460383|FG007|Overall Study|Participant declined|0|||
94727610|NCT04810650|324460384|FG008|Overall Study|Participant declined|0|||
94727611|NCT04810650|324460385|FG009|Overall Study|Participant declined|0|||
94727612|NCT04810650|324460386|FG010|Overall Study|Participant declined|2|||
94727613|NCT04810650|324460387|FG011|Overall Study|Participant declined|0|||
94727614|NCT04810650|324460388|FG012|Overall Study|Participant declined|0|||
94727615|NCT04810650|324460389|FG013|Overall Study|Participant declined|0|||
94727616|NCT03903146|324462587|FG000|Overall Study|Lost to Follow-up|6|||
94727617|NCT03903146|324462588|FG001|Overall Study|Lost to Follow-up|4|||
94727618|NCT03903146|324462587|FG000|Overall Study|Withdrawal by Subject|0|||
94727619|NCT03903146|324462588|FG001|Overall Study|Withdrawal by Subject|1|||
94727620|NCT03158129|324462589|FG000|Overall Study|Adverse Event|0|||
94727621|NCT03158129|324462590|FG001|Overall Study|Adverse Event|1|||
94727622|NCT03158129|324462591|FG002|Overall Study|Adverse Event|0|||
94727623|NCT03158129|324462592|FG003|Overall Study|Adverse Event|0|||
94727624|NCT03158129|324462589|FG000|Overall Study|Death|0|||
94727625|NCT03158129|324462590|FG001|Overall Study|Death|0|||
94727626|NCT03158129|324462591|FG002|Overall Study|Death|0|||
94727627|NCT03158129|324462592|FG003|Overall Study|Death|1|||
94727628|NCT03158129|324462589|FG000|Overall Study|High surgical risk|1|||
94727629|NCT03158129|324462590|FG001|Overall Study|High surgical risk|1|||
94727630|NCT03158129|324462591|FG002|Overall Study|High surgical risk|0|||
94727631|NCT03158129|324462592|FG003|Overall Study|High surgical risk|0|||
94727632|NCT03158129|324462589|FG000|Overall Study|Progression|1|||
94727633|NCT03158129|324462590|FG001|Overall Study|Progression|1|||
94727634|NCT03158129|324462591|FG002|Overall Study|Progression|0|||
94727635|NCT03158129|324462592|FG003|Overall Study|Progression|0|||
94727636|NCT03158129|324462589|FG000|Overall Study|Lack of resectability|0|||
94727637|NCT03158129|324462590|FG001|Overall Study|Lack of resectability|1|||
94727638|NCT03158129|324462591|FG002|Overall Study|Lack of resectability|0|||
94727639|NCT03158129|324462592|FG003|Overall Study|Lack of resectability|0|||
94727640|NCT03158129|324462589|FG000|Overall Study|Declined surgery|0|||
94727641|NCT03158129|324462590|FG001|Overall Study|Declined surgery|1|||
94727642|NCT03158129|324462591|FG002|Overall Study|Declined surgery|0|||
94727643|NCT03158129|324462592|FG003|Overall Study|Declined surgery|0|||
94727644|NCT03158129|324462589|FG000|Overall Study|No longer surgical candidate|0|||
94727645|NCT03158129|324462590|FG001|Overall Study|No longer surgical candidate|0|||
94727646|NCT03158129|324462591|FG002|Overall Study|No longer surgical candidate|0|||
94727647|NCT03158129|324462592|FG003|Overall Study|No longer surgical candidate|1|||
94273357|NCT00960661|322793724|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
94273358|NCT00960661|322793722|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
94273359|NCT00960661|322793723|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
94273360|NCT00960661|322793724|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
94273361|NCT00960661|322793722|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
94273362|NCT00960661|322793723|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
94273363|NCT00960661|322793724|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
94273364|NCT00960661|322793722|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
94273365|NCT00960661|322793723|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
94273366|NCT00960661|322793724|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
94273367|NCT00960661|322793722|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
94273368|NCT00960661|322793723|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
94273369|NCT00960661|322793724|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
94273370|NCT00960661|322793722|FG000|Interventional Phase|Adverse Event|0|||
94273371|NCT00960661|322793723|FG001|Interventional Phase|Adverse Event|17|||
94368553|NCT02414854|323136463|FG000|Overall Study|Adverse Event|9|||
94727648|NCT03197662|324462599|FG000|Overall Study|Withdrawn by family|0|||
94727649|NCT03197662|324462600|FG001|Overall Study|Withdrawn by family|2|||
94727650|NCT01214616|324462605|FG000|Overall Study|Progressive disease|2|||
94727651|NCT01214616|324462606|FG001|Overall Study|Progressive disease|2|||
94727652|NCT01214616|324462607|FG002|Overall Study|Progressive disease|2|||
94727653|NCT01214616|324462608|FG003|Overall Study|Progressive disease|4|||
94727654|NCT01214616|324462605|FG000|Overall Study|Dose limiting toxicity|0|||
94727655|NCT01214616|324462606|FG001|Overall Study|Dose limiting toxicity|2|||
94727656|NCT01214616|324462607|FG002|Overall Study|Dose limiting toxicity|0|||
94727657|NCT01214616|324462608|FG003|Overall Study|Dose limiting toxicity|0|||
94727658|NCT01214616|324462605|FG000|Overall Study|Other adverse events|0|||
94727659|NCT01214616|324462606|FG001|Overall Study|Other adverse events|1|||
94727660|NCT01214616|324462607|FG002|Overall Study|Other adverse events|1|||
94727661|NCT01214616|324462608|FG003|Overall Study|Other adverse events|1|||
94727662|NCT01214616|324462605|FG000|Overall Study|Withdrawal by Subject|1|||
94727663|NCT01214616|324462606|FG001|Overall Study|Withdrawal by Subject|0|||
94727664|NCT01214616|324462607|FG002|Overall Study|Withdrawal by Subject|0|||
94727665|NCT01214616|324462608|FG003|Overall Study|Withdrawal by Subject|1|||
94727666|NCT06516705|324462610|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
94727667|NCT06516705|324462611|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
94727668|NCT06516705|324462610|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
94727669|NCT06516705|324462611|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
94727670|NCT06516705|324462610|FG000|T3 ( 3 Month After Education)|covid-19|1|||
94727671|NCT06516705|324462611|FG001|T3 ( 3 Month After Education)|covid-19|2|||
94727672|NCT06516705|324462610|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
94727673|NCT06516705|324462611|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
94727674|NCT06516705|324462610|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
94727675|NCT06516705|324462611|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
94727676|NCT06516705|324462610|FG000|T4 ( 6 Month After Education)|covid-19|3|||
94727677|NCT06516705|324462611|FG001|T4 ( 6 Month After Education)|covid-19|2|||
94727678|NCT06516705|324462610|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
94727679|NCT06516705|324462611|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
94727680|NCT04064164|324462612|FG000|Overall Study|Withdrawal by Subject|8|||
94727681|NCT04064164|324462613|FG001|Overall Study|Withdrawal by Subject|8|||
94727682|NCT04719390|324462614|FG000|Overall Study|Withdrawal by Subject|1|||
94727683|NCT03257410|324462615|FG000|Overall Study|Adverse Event|2|||
94727684|NCT03257410|324462616|FG001|Overall Study|Adverse Event|3|||
94727685|NCT03257410|324462615|FG000|Overall Study|Protocol Violation|1|||
94727686|NCT03257410|324462616|FG001|Overall Study|Protocol Violation|2|||
94727687|NCT03257410|324462615|FG000|Overall Study|Lost to Follow-up|1|||
94727688|NCT03257410|324462616|FG001|Overall Study|Lost to Follow-up|0|||
94727689|NCT03257410|324462615|FG000|Overall Study|Withdrawal by Subject|1|||
94727690|NCT03257410|324462616|FG001|Overall Study|Withdrawal by Subject|2|||
94727691|NCT03257410|324462615|FG000|Overall Study|Physician Decision|1|||
94727692|NCT03257410|324462616|FG001|Overall Study|Physician Decision|1|||
94727693|NCT03257410|324462615|FG000|Overall Study|Renal transplantation|2|||
94727694|NCT03257410|324462616|FG001|Overall Study|Renal transplantation|0|||
94727695|NCT03257410|324462615|FG000|Overall Study|Switch to peritoneal dialysis|1|||
94727696|NCT03257410|324462616|FG001|Overall Study|Switch to peritoneal dialysis|0|||
94727697|NCT03257410|324462615|FG000|Overall Study|Death|3|||
94727698|NCT03257410|324462616|FG001|Overall Study|Death|2|||
94727699|NCT03257410|324462615|FG000|Overall Study|Change to another dialysis center|2|||
94727700|NCT03257410|324462616|FG001|Overall Study|Change to another dialysis center|2|||
94727701|NCT03257410|324462615|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
94727702|NCT03257410|324462616|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
94727703|NCT03257410|324462615|FG000|Overall Study|Miscellaneous|2|||
94727704|NCT03257410|324462616|FG001|Overall Study|Miscellaneous|2|||
94273372|NCT00960661|322793724|FG002|Interventional Phase|Adverse Event|8|||
94273373|NCT00960661|322793722|FG000|Interventional Phase|Death|0|||
94273374|NCT00960661|322793723|FG001|Interventional Phase|Death|1|||
94273375|NCT00960661|322793724|FG002|Interventional Phase|Death|0|||
94273376|NCT00960661|322793722|FG000|Interventional Phase|Lost to Follow-up|0|||
94273377|NCT00960661|322793723|FG001|Interventional Phase|Lost to Follow-up|0|||
94273378|NCT00960661|322793724|FG002|Interventional Phase|Lost to Follow-up|2|||
94273379|NCT00960661|322793722|FG000|Interventional Phase|entry criteria not met|0|||
94273380|NCT00960661|322793723|FG001|Interventional Phase|entry criteria not met|3|||
94273381|NCT00960661|322793724|FG002|Interventional Phase|entry criteria not met|0|||
94273382|NCT00960661|322793722|FG000|Interventional Phase|Protocol Violation|0|||
94273383|NCT00960661|322793723|FG001|Interventional Phase|Protocol Violation|7|||
94273384|NCT00960661|322793724|FG002|Interventional Phase|Protocol Violation|2|||
94273385|NCT00960661|322793722|FG000|Interventional Phase|Withdrawal by Subject|0|||
94273386|NCT00960661|322793723|FG001|Interventional Phase|Withdrawal by Subject|18|||
94273387|NCT00960661|322793724|FG002|Interventional Phase|Withdrawal by Subject|29|||
94273388|NCT00960661|322793722|FG000|Interventional Phase|Physician Decision|0|||
94273389|NCT00960661|322793723|FG001|Interventional Phase|Physician Decision|3|||
94273390|NCT00960661|322793724|FG002|Interventional Phase|Physician Decision|5|||
94273391|NCT00960661|322793722|FG000|Interventional Phase|sponsor decision|0|||
94273392|NCT00960661|322793723|FG001|Interventional Phase|sponsor decision|1|||
94273393|NCT00960661|322793724|FG002|Interventional Phase|sponsor decision|0|||
94273394|NCT00960661|322793722|FG000|Interventional Phase|Lack of Efficacy|0|||
94273395|NCT00960661|322793723|FG001|Interventional Phase|Lack of Efficacy|2|||
94273396|NCT00960661|322793724|FG002|Interventional Phase|Lack of Efficacy|0|||
94273397|NCT02699892|322793725|FG000|Overall Study|Other|36|||
94273398|NCT00393887|322793729|FG000|Overall Study|Physician Decision|5|||
94727705|NCT03257410|324462615|FG000|Overall Study|Other|0|||
94273399|NCT00393887|322793730|FG001|Overall Study|Physician Decision|0|||
94273400|NCT00393887|322793729|FG000|Overall Study|Lost to Follow-up|11|||
94273401|NCT00393887|322793730|FG001|Overall Study|Lost to Follow-up|9|||
94273402|NCT01816061|322793733|FG000|Overall Study|Lost to Follow-up|13|||
94273403|NCT01816061|322793734|FG001|Overall Study|Lost to Follow-up|24|||
94273404|NCT01843842|322793735|FG000|Overall Study|Do not meet inclusion criteria|1|||
94368554|NCT02414854|323136464|FG001|Overall Study|Adverse Event|7|||
94368555|NCT02414854|323136465|FG002|Overall Study|Adverse Event|1|||
94368556|NCT02414854|323136466|FG003|Overall Study|Adverse Event|12|||
94368557|NCT02414854|323136463|FG000|Overall Study|Poor compliance to protocol|1|||
94368558|NCT02414854|323136464|FG001|Overall Study|Poor compliance to protocol|1|||
94368559|NCT02414854|323136465|FG002|Overall Study|Poor compliance to protocol|2|||
94368560|NCT02414854|323136466|FG003|Overall Study|Poor compliance to protocol|2|||
94368561|NCT02414854|323136463|FG000|Overall Study|Other than specified above|12|||
94368562|NCT02414854|323136464|FG001|Overall Study|Other than specified above|37|||
94368563|NCT02414854|323136465|FG002|Overall Study|Other than specified above|17|||
94368564|NCT02414854|323136466|FG003|Overall Study|Other than specified above|37|||
94368565|NCT01190098|323136467|FG000|Overall Study|Adverse Event|2|||
94368566|NCT01190098|323136468|FG001|Overall Study|Adverse Event|0|||
94368567|NCT01190098|323136467|FG000|Overall Study|Patient coomorbidity|0|||
94368568|NCT01190098|323136468|FG001|Overall Study|Patient coomorbidity|1|||
94368569|NCT01190098|323136467|FG000|Overall Study|Lack of transportation|1|||
94368570|NCT01190098|323136468|FG001|Overall Study|Lack of transportation|0|||
94368571|NCT01190098|323136467|FG000|Overall Study|Other|0|||
94368572|NCT01190098|323136468|FG001|Overall Study|Other|1|||
94368573|NCT02957682|323136469|FG000|Overall Study|Adverse Event|64|||
94368574|NCT02957682|323136470|FG001|Overall Study|Adverse Event|67|||
94368575|NCT02957682|323136469|FG000|Overall Study|Poor Compliance to Protocol|30|||
94368576|NCT02957682|323136470|FG001|Overall Study|Poor Compliance to Protocol|26|||
94368577|NCT02957682|323136469|FG000|Overall Study|Physician Decision|4|||
94368578|NCT02957682|323136470|FG001|Overall Study|Physician Decision|4|||
94368579|NCT02957682|323136469|FG000|Overall Study|Study Terminated by Sponsor|4|||
94368580|NCT02957682|323136470|FG001|Overall Study|Study Terminated by Sponsor|3|||
94368581|NCT02957682|323136469|FG000|Overall Study|Subject Moved|10|||
94368582|NCT02957682|323136470|FG001|Overall Study|Subject Moved|16|||
94368583|NCT02957682|323136469|FG000|Overall Study|Withdrawal by Subject|64|||
94368584|NCT02957682|323136470|FG001|Overall Study|Withdrawal by Subject|33|||
94368585|NCT02957682|323136469|FG000|Overall Study|Related to IMP Administration|3|||
94368586|NCT02957682|323136470|FG001|Overall Study|Related to IMP Administration|6|||
94368587|NCT02957682|323136469|FG000|Overall Study|Non-disclosed|16|||
94368588|NCT02957682|323136470|FG001|Overall Study|Non-disclosed|12|||
94368589|NCT02957682|323136469|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
94368590|NCT02957682|323136470|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
94368591|NCT00303316|323136471|FG000|Overall Study|Protocol Violation|1|||
94368592|NCT00303316|323136472|FG001|Overall Study|Protocol Violation|0|||
94368593|NCT00303316|323136471|FG000|Overall Study|Lost to Follow-up|0|||
94368594|NCT00303316|323136472|FG001|Overall Study|Lost to Follow-up|1|||
94368595|NCT00303316|323136471|FG000|Overall Study|Withdrawal by Subject|1|||
94727706|NCT03257410|324462616|FG001|Overall Study|Other|1|||
94727707|NCT03241745|324462617|FG000|Overall Study|Adverse Event|7|||
94727708|NCT03241745|324462617|FG000|Overall Study|Death|1|||
94727709|NCT03241745|324462617|FG000|Overall Study|Withdrawal by Subject|5|||
94727710|NCT03241745|324462617|FG000|Overall Study|Treatment delay >28 days|2|||
94273405|NCT01843842|322793736|FG001|Overall Study|Do not meet inclusion criteria|1|||
94273406|NCT03370120|322793737|FG000|Overall Study|Adverse event, non-fatal|24|||
94273407|NCT03370120|322793737|FG000|Overall Study|Withdrawal by Subject|6|||
94273408|NCT03370120|322793737|FG000|Overall Study|Lost to Follow-up|1|||
94273409|NCT03370120|322793737|FG000|Overall Study|Lack of Efficacy|37|||
94273410|NCT03370120|322793737|FG000|Overall Study|Per sponsor's instructions|1|||
94273411|NCT03370120|322793737|FG000|Overall Study|Study was terminated by parent company UCB|2|||
94727711|NCT03241745|324462617|FG000|Overall Study|Lack of Efficacy|14|||
94727712|NCT00470704|324462618|FG000|Overall Study|Withdrawal by Subject|4|||
94273412|NCT03370120|322793737|FG000|Overall Study|The study was ended by the promoter|3|||
94273413|NCT03370120|322793737|FG000|Overall Study|Discontinuation of drug development|3|||
94273414|NCT03370120|322793737|FG000|Overall Study|End of project|2|||
94273415|NCT03370120|322793737|FG000|Overall Study|Premature study closure|2|||
94273416|NCT03370120|322793737|FG000|Overall Study|Premature program termination|1|||
94273417|NCT03370120|322793737|FG000|Overall Study|Premature study termination|7|||
94273418|NCT03370120|322793737|FG000|Overall Study|Trial terminated by sponsor|2|||
94273419|NCT03370120|322793737|FG000|Overall Study|Trial discontinued by sponsor|2|||
94273420|NCT03370120|322793737|FG000|Overall Study|Study ended|15|||
94368596|NCT00303316|323136472|FG001|Overall Study|Withdrawal by Subject|2|||
94727713|NCT00470704|324462619|FG001|Overall Study|Withdrawal by Subject|3|||
94727714|NCT00470704|324462618|FG000|Overall Study|Relapse/Progression|37|||
94273421|NCT03370120|322793737|FG000|Overall Study|Clinical trial has been cancelled|1|||
94368597|NCT00304954|323136474|FG000|Overall Study|Withdrawal by Subject|0|||
94368598|NCT00304954|323136475|FG001|Overall Study|Withdrawal by Subject|0|||
94727715|NCT00470704|324462619|FG001|Overall Study|Relapse/Progression|42|||
94273422|NCT03370120|322793737|FG000|Overall Study|End of study per sponsor decision|2|||
94368599|NCT00304954|323136476|FG002|Overall Study|Withdrawal by Subject|1|||
94727716|NCT00470704|324462618|FG000|Overall Study|toxicity|0|||
94727717|NCT00470704|324462619|FG001|Overall Study|toxicity|1|||
94273423|NCT03370120|322793737|FG000|Overall Study|Promoter's decision|2|||
94273424|NCT03370120|322793737|FG000|Overall Study|The trial has been suspended|3|||
94273425|NCT03370120|322793737|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
94273426|NCT03370120|322793737|FG000|Overall Study|Early termination by order of sponsor|2|||
94273427|NCT03370120|322793737|FG000|Overall Study|Discontinuation of the study|5|||
94273428|NCT03370120|322793737|FG000|Overall Study|End of clinical trial discontinuation|1|||
94273429|NCT03370120|322793737|FG000|Overall Study|Because the clinical trial ended halfway|4|||
94273430|NCT03370120|322793737|FG000|Overall Study|Development discontinued|5|||
94273431|NCT03370120|322793737|FG000|Overall Study|Padsenovil program closed|3|||
94273432|NCT03370120|322793737|FG000|Overall Study|End of project|2|||
94273433|NCT03370120|322793737|FG000|Overall Study|Termination of project|1|||
94273434|NCT03370120|322793737|FG000|Overall Study|The study was interrupted by sponsor|4|||
94273435|NCT03370120|322793737|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
94273436|NCT03370120|322793737|FG000|Overall Study|End of sponsor decision|1|||
94273437|NCT03370120|322793737|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
94273438|NCT03370120|322793737|FG000|Overall Study|Early termination of studies|5|||
94273439|NCT03370120|322793737|FG000|Overall Study|This study is ended early|1|||
94273440|NCT03370120|322793737|FG000|Overall Study|End of padsevonil program|2|||
94273441|NCT03370120|322793737|FG000|Overall Study|Decision of sponsor|6|||
94273442|NCT03370120|322793737|FG000|Overall Study|Asked by the sponsor|3|||
94273443|NCT03370120|322793737|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
94273444|NCT03370120|322793737|FG000|Overall Study|PI decision poor compliance from participant|1|||
94273445|NCT03370120|322793737|FG000|Overall Study|Promoter ended the study|3|||
94273446|NCT03370120|322793737|FG000|Overall Study|Premature study close by sponsor's decision|4|||
94273447|NCT03370120|322793737|FG000|Overall Study|Study terminated by sponsor|33|||
94273448|NCT03370120|322793737|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
94273449|NCT03370120|322793737|FG000|Overall Study|Sponsor decision to terminate study|63|||
94273450|NCT03370120|322793737|FG000|Overall Study|Program closure|3|||
94273451|NCT03370120|322793737|FG000|Overall Study|Study ended prematurely|1|||
94273452|NCT03370120|322793737|FG000|Overall Study|Study stopped by sponsor|2|||
94273453|NCT03370120|322793737|FG000|Overall Study|Program termination|55|||
94273454|NCT03370120|322793737|FG000|Overall Study|Sponsor decision|62|||
94273455|NCT03370120|322793737|FG000|Overall Study|Sponsor study closure|10|||
94273456|NCT02004262|322793740|FG000|Overall Study|Death|67|||
94273457|NCT02004262|322793741|FG001|Overall Study|Death|64|||
94273458|NCT02004262|322793742|FG002|Overall Study|Death|66|||
94273459|NCT02004262|322793743|FG003|Overall Study|Death|28|||
94273460|NCT02004262|322793744|FG004|Overall Study|Death|29|||
94273461|NCT02004262|322793745|FG005|Overall Study|Death|22|||
94273462|NCT02004262|322793740|FG000|Overall Study|Withdrawal by Subject|1|||
94273463|NCT02004262|322793741|FG001|Overall Study|Withdrawal by Subject|0|||
94273464|NCT02004262|322793742|FG002|Overall Study|Withdrawal by Subject|4|||
94273465|NCT02004262|322793743|FG003|Overall Study|Withdrawal by Subject|0|||
94273466|NCT02004262|322793744|FG004|Overall Study|Withdrawal by Subject|1|||
94273467|NCT02004262|322793745|FG005|Overall Study|Withdrawal by Subject|3|||
94273468|NCT02004262|322793740|FG000|Overall Study|Lost to Follow-up|1|||
94273469|NCT02004262|322793741|FG001|Overall Study|Lost to Follow-up|1|||
94273470|NCT02004262|322793742|FG002|Overall Study|Lost to Follow-up|0|||
94273471|NCT02004262|322793743|FG003|Overall Study|Lost to Follow-up|0|||
94273472|NCT02004262|322793744|FG004|Overall Study|Lost to Follow-up|0|||
94273473|NCT02004262|322793745|FG005|Overall Study|Lost to Follow-up|0|||
94727718|NCT04019873|324462620|FG000|Overall Study|Discontinued from the treatment|1|||
94727719|NCT04019873|324462621|FG001|Overall Study|Discontinued from the treatment|39|||
94727720|NCT04019873|324462622|FG002|Overall Study|Discontinued from the treatment|2|||
94727721|NCT04683744|324462623|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
94727722|NCT04683744|324462624|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
94727723|NCT04683744|324462625|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
94727724|NCT02561247|324462626|FG000|Overall Study|Protocol Violation|1|||
94727725|NCT02561247|324462626|FG000|Overall Study|Withdrawal by Subject|1|||
94727726|NCT02561247|324462626|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
94727727|NCT02923180|324462627|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
94727728|NCT02923180|324462627|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
94727729|NCT02619838|324462633|FG000|Overall Study|Lost to Follow-up|9|||
94273474|NCT02004262|322793740|FG000|Overall Study|Study Terminated by Sponsor|4|||
94273475|NCT02004262|322793741|FG001|Overall Study|Study Terminated by Sponsor|3|||
94273476|NCT02004262|322793742|FG002|Overall Study|Study Terminated by Sponsor|2|||
94273477|NCT02004262|322793743|FG003|Overall Study|Study Terminated by Sponsor|1|||
94273478|NCT02004262|322793744|FG004|Overall Study|Study Terminated by Sponsor|1|||
94273479|NCT02004262|322793745|FG005|Overall Study|Study Terminated by Sponsor|5|||
94727730|NCT02619838|324462633|FG000|Overall Study|Withdrawal by Subject|15|||
94727731|NCT05364671|324462634|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
94727732|NCT05364671|324462635|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
94727733|NCT05364671|324462634|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
94727734|NCT05364671|324462635|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
94727735|NCT05364671|324462634|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
94727736|NCT05364671|324462635|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
94727737|NCT05364671|324462634|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
94273480|NCT01820364|322793747|FG000|Part I: LGX818|Death|1|||
94727738|NCT05364671|324462635|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
94727739|NCT05364671|324462634|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
94727740|NCT05364671|324462635|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
94727741|NCT01073566|324462636|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
94727742|NCT01073566|324462637|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
94727743|NCT05780437|324462642|FG000|Overall Study|Withdrawal by Subject|22|||
94727744|NCT05780437|324462643|FG001|Overall Study|Withdrawal by Subject|16|||
94727745|NCT04015167|324462644|FG000|Overall Study|Lost to Follow-up|40|||
94727746|NCT04015167|324462644|FG000|Overall Study|Adverse Event|5|||
94727747|NCT04015167|324462644|FG000|Overall Study|Withdrawal by Subject|2|||
94727748|NCT04015167|324462644|FG000|Overall Study|Subject went to jail|1|||
94727749|NCT03640312|324462645|FG000|Overall Study|Lost to Follow-up|3|||
94727750|NCT03640312|324462646|FG001|Overall Study|Lost to Follow-up|6|||
94727751|NCT03382652|324462647|FG000|Overall Study|Lost to Follow-up|6|||
94727752|NCT03382652|324462647|FG000|Overall Study|Death|4|||
94727753|NCT03382652|324462647|FG000|Overall Study|Revision|5|||
94273481|NCT01820364|322793748|FG001|Part I: LGX818|Death|0|||
94273482|NCT01820364|322793747|FG000|Part I: LGX818|Administrative Problems|3|||
94727754|NCT03382652|324462647|FG000|Overall Study|Patient withdrew|3|||
94727755|NCT03382652|324462647|FG000|Overall Study|Other reasons|21|||
94727756|NCT05057247|324462653|FG000|Overall Study|Death|4|||
94727757|NCT05057247|324462653|FG000|Overall Study|Physician Decision|3|||
94727758|NCT05057247|324462653|FG000|Overall Study|Progressive Disease|7|||
94727759|NCT05057247|324462653|FG000|Overall Study|Withdrawal by Subject|3|||
94727760|NCT05057247|324462653|FG000|Overall Study|Adverse Event|6|||
94727761|NCT05057247|324462653|FG000|Overall Study|Subject Non-Compliance|1|||
94727762|NCT05057247|324462653|FG000|Overall Study|On treatment|2|||
94727763|NCT05071053|324462667|FG000|Overall Study|Ongoing study treatment at the time of primary analysis completion|2|||
94727764|NCT05071053|324462667|FG000|Overall Study|Progressive disease|28|||
94727765|NCT05071053|324462667|FG000|Overall Study|Adverse Event|5|||
94727766|NCT04376502|324462668|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
94727767|NCT04350463|324462669|FG000|Overall Study|Other reason|0|||
94727768|NCT04350463|324462670|FG001|Overall Study|Other reason|0|||
94727769|NCT04350463|324462671|FG002|Overall Study|Other reason|0|||
94727770|NCT04350463|324462672|FG003|Overall Study|Other reason|1|||
94727771|NCT04350463|324462669|FG000|Overall Study|Lost to Follow-up|0|||
94727772|NCT04350463|324462670|FG001|Overall Study|Lost to Follow-up|0|||
94727773|NCT04350463|324462671|FG002|Overall Study|Lost to Follow-up|0|||
94727774|NCT04350463|324462672|FG003|Overall Study|Lost to Follow-up|2|||
94727775|NCT04350463|324462669|FG000|Overall Study|Withdrawal by Subject|4|||
94727776|NCT04350463|324462670|FG001|Overall Study|Withdrawal by Subject|0|||
94727777|NCT04350463|324462671|FG002|Overall Study|Withdrawal by Subject|1|||
94727778|NCT04350463|324462672|FG003|Overall Study|Withdrawal by Subject|4|||
94727779|NCT04350463|324462669|FG000|Overall Study|Adverse Event|0|||
94727780|NCT04350463|324462670|FG001|Overall Study|Adverse Event|0|||
94727781|NCT04350463|324462671|FG002|Overall Study|Adverse Event|0|||
94727782|NCT04350463|324462672|FG003|Overall Study|Adverse Event|2|||
94727783|NCT04350463|324462669|FG000|Overall Study|Death|27|||
94727784|NCT04350463|324462670|FG001|Overall Study|Death|2|||
94727785|NCT04350463|324462671|FG002|Overall Study|Death|13|||
94727786|NCT04350463|324462672|FG003|Overall Study|Death|26|||
94727787|NCT04111536|324462673|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
94727788|NCT04111536|324462674|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
94727789|NCT04111536|324462673|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
94727790|NCT04111536|324462674|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
94727791|NCT04111536|324462673|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
94273483|NCT01820364|322793748|FG001|Part I: LGX818|Administrative Problems|0|||
94727792|NCT04111536|324462674|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
94727793|NCT04111536|324462673|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
94727794|NCT04111536|324462674|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
94368600|NCT00304954|323136477|FG003|Overall Study|Withdrawal by Subject|0|||
94368601|NCT00304954|323136474|FG000|Overall Study|Adverse Event|1|||
94368602|NCT00304954|323136475|FG001|Overall Study|Adverse Event|0|||
94727795|NCT04652700|324462675|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
94727796|NCT04652700|324462676|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
94273484|NCT01820364|322793747|FG000|Part I: LGX818|Adverse Event|6|||
94727797|NCT04652700|324462675|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
94727798|NCT04652700|324462676|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
94727799|NCT04652700|324462675|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
94727800|NCT04652700|324462676|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
94727801|NCT04652700|324462675|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
94727802|NCT04652700|324462676|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
94727803|NCT04652700|324462675|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
94727804|NCT04652700|324462676|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
94727805|NCT04652700|324462675|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
94727806|NCT04652700|324462676|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
94273485|NCT01820364|322793748|FG001|Part I: LGX818|Adverse Event|0|||
94273486|NCT01820364|322793747|FG000|Part I: LGX818|Disease Progression|4|||
94273487|NCT01820364|322793748|FG001|Part I: LGX818|Disease Progression|0|||
94273488|NCT01820364|322793747|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
94273489|NCT01820364|322793748|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
94273490|NCT04995055|322793749|FG000|Period 1|COVID-19 Related|1|||
94273491|NCT04995055|322793750|FG001|Period 1|COVID-19 Related|0|||
94273492|NCT04995055|322793749|FG000|Period 1|Withdrawal by Subject|0|||
94273493|NCT04995055|322793750|FG001|Period 1|Withdrawal by Subject|1|||
94273494|NCT04995055|322793749|FG000|Period 1|Subject discontinued due to timing|4|||
94368603|NCT00304954|323136476|FG002|Overall Study|Adverse Event|0|||
94368604|NCT00304954|323136477|FG003|Overall Study|Adverse Event|0|||
94368605|NCT01440647|323136478|FG000|Overall Study|Death|2|||
94368606|NCT01440647|323136479|FG001|Overall Study|Death|3|||
94727807|NCT04652700|324462675|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
94727808|NCT04652700|324462676|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
94727809|NCT04652700|324462675|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
94727810|NCT04652700|324462676|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
94727811|NCT04652700|324462675|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
94727812|NCT04652700|324462676|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
94727813|NCT04187833|324462677|FG000|Overall Study|Withdrawal by Subject|1|||
94727814|NCT04277442|324462679|FG000|Overall Study|Death|1|||
94727815|NCT03596866|324462680|FG000|Overall Study|Ongoing at Data Cut-off|91|||
94727816|NCT03596866|324462681|FG001|Overall Study|Ongoing at Data Cut-off|101|||
94727817|NCT03596866|324462680|FG000|Overall Study|Randomized but Never Received Drug|0|||
94727818|NCT03596866|324462681|FG001|Overall Study|Randomized but Never Received Drug|1|||
94727819|NCT03596866|324462680|FG000|Overall Study|Death|27|||
94727820|NCT03596866|324462681|FG001|Overall Study|Death|14|||
94727821|NCT03596866|324462680|FG000|Overall Study|Withdrawal by Subject|6|||
94727822|NCT03596866|324462681|FG001|Overall Study|Withdrawal by Subject|5|||
94727823|NCT03596866|324462680|FG000|Overall Study|Lost to Follow-up|1|||
94727824|NCT03596866|324462681|FG001|Overall Study|Lost to Follow-up|1|||
94727825|NCT03596866|324462680|FG000|Overall Study|Reason Not Specified|0|||
94727826|NCT03596866|324462681|FG001|Overall Study|Reason Not Specified|1|||
94727827|NCT05949788|324462683|FG000|Overall Study|severe birth deformity|2|||
94727828|NCT05949788|324462684|FG001|Overall Study|severe birth deformity|7|||
94727829|NCT05949788|324462683|FG000|Overall Study|twin-twin transfusion syndrome|2|||
94727830|NCT05949788|324462684|FG001|Overall Study|twin-twin transfusion syndrome|7|||
94727831|NCT05949788|324462683|FG000|Overall Study|neonatal hemolytic disease|3|||
94727832|NCT05949788|324462684|FG001|Overall Study|neonatal hemolytic disease|8|||
94727833|NCT05949788|324462683|FG000|Overall Study|death within 14 days after birth|2|||
94727834|NCT05949788|324462684|FG001|Overall Study|death within 14 days after birth|6|||
94273495|NCT04995055|322793750|FG001|Period 1|Subject discontinued due to timing|4|||
94727835|NCT05949788|324462683|FG000|Overall Study|transfer to another hospital|2|||
94273496|NCT00825162|322793753|FG000|Overall Study|Withdrawal by Subject|11|||
94368607|NCT03578276|323136480|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
94727836|NCT05949788|324462684|FG001|Overall Study|transfer to another hospital|6|||
94727837|NCT05213390|324462685|FG000|Overall Study|Withdrawal by Subject|2|||
94727838|NCT05213390|324462685|FG000|Overall Study|Lost to Follow-up|12|||
94727839|NCT05213390|324462685|FG000|Overall Study|Protocol Violation|9|||
94727840|NCT02146378|324462686|FG000|Overall Study|No information of administration|2|||
94273497|NCT00825162|322793754|FG001|Overall Study|Withdrawal by Subject|13|||
94368608|NCT03578276|323136481|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
94273498|NCT00825162|322793755|FG002|Overall Study|Withdrawal by Subject|3|||
94368609|NCT03174925|323136482|FG000|Overall Study|Elastographic images not retrievable|2|||
94727841|NCT03808818|324462687|FG000|Overall Study|Death|6|||
94727842|NCT03808818|324462688|FG001|Overall Study|Death|6|||
94727843|NCT03808818|324462687|FG000|Overall Study|Withdrawal by Subject|7|||
94727844|NCT03808818|324462688|FG001|Overall Study|Withdrawal by Subject|18|||
94727845|NCT03808818|324462687|FG000|Overall Study|Lost to Follow-up|31|||
94727846|NCT03808818|324462688|FG001|Overall Study|Lost to Follow-up|33|||
94727847|NCT03858634|324462689|FG000|Overall Study|Withdrawal by Subject|1|||
94727848|NCT03858634|324462690|FG001|Overall Study|Withdrawal by Subject|0|||
94727849|NCT03858634|324462689|FG000|Overall Study|Adverse Event|1|||
94727850|NCT03858634|324462690|FG001|Overall Study|Adverse Event|0|||
94727851|NCT03858634|324462689|FG000|Overall Study|Lost to Follow-up|0|||
94727852|NCT03858634|324462690|FG001|Overall Study|Lost to Follow-up|1|||
94727853|NCT03858634|324462689|FG000|Overall Study|Other, Not Specified|1|||
94727854|NCT03858634|324462690|FG001|Overall Study|Other, Not Specified|1|||
94727855|NCT06181760|324462691|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
94727856|NCT06181760|324462692|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
94727857|NCT06181760|324462693|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
94727858|NCT06181760|324462694|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
94727859|NCT04629716|324462695|FG000|Overall Study|Lost to Follow-up|7|||
94727860|NCT04629716|324462696|FG001|Overall Study|Lost to Follow-up|3|||
94727861|NCT04537715|324462697|FG000|Overall Study|Death|3|||
94727862|NCT04537715|324462698|FG001|Overall Study|Death|1|||
94727863|NCT04537715|324462697|FG000|Overall Study|Withdrawal by Subject|3|||
94727864|NCT04537715|324462698|FG001|Overall Study|Withdrawal by Subject|1|||
94727865|NCT04537715|324462697|FG000|Overall Study|Other|4|||
94727866|NCT04537715|324462698|FG001|Overall Study|Other|3|||
94727867|NCT04537715|324462697|FG000|Overall Study|Progressive disease|1|||
94727868|NCT04537715|324462698|FG001|Overall Study|Progressive disease|0|||
94727869|NCT03448107|324462700|FG000|Overall Study|Lost to Follow-up|229|||
94727870|NCT03448107|324462701|FG001|Overall Study|Lost to Follow-up|258|||
94727871|NCT03115476|324462702|FG000|LP0084-1369|Death|1|||
94727872|NCT03115476|324462703|FG001|LP0084-1369|Death|0|||
94727873|NCT03115476|324462704|FG002|LP0084-1369|Death|2|||
94727874|NCT03115476|324462702|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
94727875|NCT03115476|324462703|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
94727876|NCT03115476|324462704|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
94727877|NCT04663737|324462705|FG000|Overall Study|Withdrawal by Subject|2|||
94727878|NCT04663737|324462706|FG001|Overall Study|Withdrawal by Subject|0|||
94727879|NCT02310646|324462710|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
94727880|NCT02310646|324462711|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
94727881|NCT02310646|324462710|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
94727882|NCT02310646|324462711|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
94727883|NCT03976362|324462714|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
94727884|NCT03976362|324462715|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
94727885|NCT03976362|324462716|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
94727886|NCT03976362|324462714|FG000|Induction Phase|Death|62|||
94727887|NCT03976362|324462715|FG001|Induction Phase|Death|0|||
94727888|NCT03976362|324462716|FG002|Induction Phase|Death|0|||
94727889|NCT03976362|324462714|FG000|Maintenance Phase|Participants Ongoing|0|||
94727890|NCT03976362|324462715|FG001|Maintenance Phase|Participants Ongoing|106|||
94727891|NCT03976362|324462716|FG002|Maintenance Phase|Participants Ongoing|103|||
94727892|NCT03976362|324462714|FG000|Maintenance Phase|Withdrawal by Subject|0|||
94727893|NCT03976362|324462715|FG001|Maintenance Phase|Withdrawal by Subject|4|||
94727894|NCT03976362|324462716|FG002|Maintenance Phase|Withdrawal by Subject|4|||
94727895|NCT03976362|324462714|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
94727896|NCT03976362|324462715|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
94727897|NCT03976362|324462716|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
94727898|NCT03976362|324462714|FG000|Maintenance Phase|Death|0|||
94727899|NCT03976362|324462715|FG001|Maintenance Phase|Death|186|||
94727900|NCT03976362|324462716|FG002|Maintenance Phase|Death|187|||
94727901|NCT00613106|324462723|FG000|Overall Study|Adverse Event|3|||
94727902|NCT00613106|324462724|FG001|Overall Study|Adverse Event|1|||
94727903|NCT00613106|324462723|FG000|Overall Study|Withdrawal by Subject|6|||
94727904|NCT00613106|324462724|FG001|Overall Study|Withdrawal by Subject|3|||
94727905|NCT00613106|324462723|FG000|Overall Study|Lost to Follow-up|7|||
94727906|NCT00613106|324462724|FG001|Overall Study|Lost to Follow-up|2|||
94727907|NCT00613106|324462723|FG000|Overall Study|misc|4|||
94727908|NCT00613106|324462724|FG001|Overall Study|misc|3|||
94727909|NCT04568603|324462725|FG000|Overall Study|Physician Decision|1|||
94273499|NCT00825162|322793753|FG000|Overall Study|Lost to Follow-up|9|||
94273500|NCT00825162|322793754|FG001|Overall Study|Lost to Follow-up|6|||
94273501|NCT00825162|322793755|FG002|Overall Study|Lost to Follow-up|3|||
94273502|NCT00825162|322793753|FG000|Overall Study|Physician Decision|2|||
94273503|NCT00825162|322793754|FG001|Overall Study|Physician Decision|0|||
94273504|NCT00825162|322793755|FG002|Overall Study|Physician Decision|0|||
94273505|NCT00825162|322793753|FG000|Overall Study|Move away from the study area|1|||
94273506|NCT00825162|322793754|FG001|Overall Study|Move away from the study area|0|||
94273507|NCT00825162|322793755|FG002|Overall Study|Move away from the study area|0|||
94273508|NCT00825162|322793753|FG000|Overall Study|Unable to attend the study visit|5|||
94273509|NCT00825162|322793754|FG001|Overall Study|Unable to attend the study visit|2|||
94273510|NCT00825162|322793755|FG002|Overall Study|Unable to attend the study visit|0|||
94273511|NCT00781911|322793756|FG000|Overall Study|Adverse Event|4|||
94727922|NCT05939388|324462736|FG000|Overall Study|Lost to Follow-up|1|||
94727923|NCT05084508|324462737|FG000|Overall Study|Lost to Follow-up|6|||
94727924|NCT05084508|324462738|FG001|Overall Study|Lost to Follow-up|3|||
94727925|NCT05084508|324462739|FG002|Overall Study|Lost to Follow-up|7|||
94727926|NCT05084508|324462740|FG003|Overall Study|Lost to Follow-up|3|||
94727927|NCT05084508|324462737|FG000|Overall Study|Withdrawal by Subject|0|||
94727928|NCT05084508|324462738|FG001|Overall Study|Withdrawal by Subject|2|||
94727929|NCT05084508|324462739|FG002|Overall Study|Withdrawal by Subject|3|||
94727930|NCT05084508|324462740|FG003|Overall Study|Withdrawal by Subject|1|||
94727931|NCT05084508|324462737|FG000|Overall Study|Other|0|||
94727932|NCT05084508|324462738|FG001|Overall Study|Other|0|||
94727933|NCT05084508|324462739|FG002|Overall Study|Other|0|||
94727934|NCT05084508|324462740|FG003|Overall Study|Other|1|||
94727935|NCT01420237|324462743|FG000|Overall Study|Death|13|||
94727936|NCT01420237|324462743|FG000|Overall Study|Withdrawal by Subject|41|||
94727937|NCT01420237|324462743|FG000|Overall Study|Lost to Follow-up|32|||
94727938|NCT01420237|324462743|FG000|Overall Study|Adverse Event|10|||
94727939|NCT01420237|324462743|FG000|Overall Study|Investigative Site Termination|43|||
94727940|NCT01420237|324462743|FG000|Overall Study|Censored because study device not implanted|21|||
94727941|NCT01420237|324462743|FG000|Overall Study|Censored because surgery not performed|2|||
94727942|NCT01420237|324462743|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
94727943|NCT01420237|324462743|FG000|Overall Study|Sponsor terminated study early|127|||
94727944|NCT05269667|324462744|FG000|Overall Study|Study Terminated by Sponsor|4|||
94727945|NCT04856163|324464573|FG000|Overall Study|Lost to Follow-up|97|||
94727946|NCT04856163|324464574|FG001|Overall Study|Lost to Follow-up|100|||
94727947|NCT04526704|324464575|FG000|Overall Study|Adverse Event|1|||
94727948|NCT04526704|324464576|FG001|Overall Study|Adverse Event|0|||
94727949|NCT04526704|324464575|FG000|Overall Study|Physician Decision|1|||
94727950|NCT04526704|324464576|FG001|Overall Study|Physician Decision|0|||
94727951|NCT04526704|324464575|FG000|Overall Study|Withdrawal by Subject|2|||
94727952|NCT04526704|324464576|FG001|Overall Study|Withdrawal by Subject|0|||
94727953|NCT03897465|324464581|FG000|Overall Study|Lost to Follow-up|2|||
94727954|NCT03897465|324464582|FG001|Overall Study|Lost to Follow-up|1|||
94727955|NCT03897465|324464581|FG000|Overall Study|Adverse Event|2|||
94727956|NCT03897465|324464582|FG001|Overall Study|Adverse Event|0|||
94727957|NCT03897465|324464581|FG000|Overall Study|complete healing by V2|1|||
94727958|NCT03897465|324464582|FG001|Overall Study|complete healing by V2|0|||
94727959|NCT03897465|324464581|FG000|Overall Study|occurence of exclusion criterion|1|||
94727960|NCT03897465|324464582|FG001|Overall Study|occurence of exclusion criterion|1|||
94727961|NCT03897465|324464581|FG000|Overall Study|Other|1|||
94727962|NCT03897465|324464582|FG001|Overall Study|Other|0|||
94727963|NCT05481320|324464583|FG000|Overall Study|Withdrawal by Subject|1|||
94727964|NCT05481320|324464584|FG001|Overall Study|Withdrawal by Subject|1|||
94727965|NCT05481320|324464583|FG000|Overall Study|Care recipent passed away|0|||
94727966|NCT05481320|324464584|FG001|Overall Study|Care recipent passed away|1|||
94273512|NCT00781911|322793757|FG001|Overall Study|Adverse Event|4|||
94727967|NCT05481320|324464583|FG000|Overall Study|Out-of-window assessment|0|||
94273513|NCT00781911|322793756|FG000|Overall Study|Withdrawal by Subject|1|||
94273514|NCT00781911|322793757|FG001|Overall Study|Withdrawal by Subject|2|||
94727968|NCT05481320|324464584|FG001|Overall Study|Out-of-window assessment|1|||
94727969|NCT05481320|324464583|FG000|Overall Study|No longer a primary caregiver|3|||
94727970|NCT05481320|324464584|FG001|Overall Study|No longer a primary caregiver|0|||
94727971|NCT05481320|324464583|FG000|Overall Study|Unable to contact|1|||
94727972|NCT05481320|324464584|FG001|Overall Study|Unable to contact|0|||
94273515|NCT00781911|322793756|FG000|Overall Study|Physician Decision|0|||
94727973|NCT03839940|324464588|FG000|Overall Study|Withdrawal by Subject|3|||
94727974|NCT03839940|324464589|FG001|Overall Study|Withdrawal by Subject|0|||
94467398|NCT04608344|323500557|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
94727975|NCT03839940|324464588|FG000|Overall Study|Protocol Violation|0|||
94273516|NCT00781911|322793757|FG001|Overall Study|Physician Decision|2|||
94727976|NCT03839940|324464589|FG001|Overall Study|Protocol Violation|1|||
94273517|NCT00781911|322793756|FG000|Overall Study|Sponsor Decision|1|||
94273518|NCT00781911|322793757|FG001|Overall Study|Sponsor Decision|0|||
94273519|NCT00939783|322793758|FG000|Overall Study|Death|6|||
94273520|NCT00939783|322793758|FG000|Overall Study|Adverse Event|39|||
94273521|NCT00939783|322793758|FG000|Overall Study|Study Terminated by Sponsor|498|||
94727977|NCT03839940|324464588|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
94727978|NCT03839940|324464589|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
94727979|NCT03023410|324464590|FG000|Overall Study|study termination|0|||
94727980|NCT03023410|324464591|FG001|Overall Study|study termination|1|||
94727981|NCT04592549|324464602|FG000|Overall Study|Withdrawal by Subject|0|||
94727982|NCT04592549|324464603|FG001|Overall Study|Withdrawal by Subject|1|||
94727983|NCT04592549|324464604|FG002|Overall Study|Withdrawal by Subject|0|||
94727984|NCT04592549|324464605|FG003|Overall Study|Withdrawal by Subject|1|||
94727985|NCT04592549|324464606|FG004|Overall Study|Withdrawal by Subject|1|||
94727986|NCT04592549|324464607|FG005|Overall Study|Withdrawal by Subject|0|||
94727987|NCT04592549|324464602|FG000|Overall Study|Lost to Follow-up|2|||
94727988|NCT04592549|324464603|FG001|Overall Study|Lost to Follow-up|0|||
94727989|NCT04592549|324464604|FG002|Overall Study|Lost to Follow-up|0|||
94727990|NCT04592549|324464605|FG003|Overall Study|Lost to Follow-up|1|||
94727991|NCT04592549|324464606|FG004|Overall Study|Lost to Follow-up|1|||
94727992|NCT04592549|324464607|FG005|Overall Study|Lost to Follow-up|1|||
94727993|NCT02362503|324464610|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
94727994|NCT02362503|324464611|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
94727995|NCT02362503|324464612|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
94727996|NCT02362503|324464610|FG000|Double-blind Period-Up to 8 Days|Death|1|||
94727997|NCT02362503|324464611|FG001|Double-blind Period-Up to 8 Days|Death|0|||
94727998|NCT02362503|324464612|FG002|Double-blind Period-Up to 8 Days|Death|0|||
94727999|NCT02362503|324464610|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
94728000|NCT02362503|324464611|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
94728001|NCT02362503|324464612|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
94728002|NCT02362503|324464610|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
94728003|NCT02362503|324464611|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
94728004|NCT02362503|324464612|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
94728005|NCT02362503|324464610|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
94728006|NCT02362503|324464611|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
94728007|NCT02362503|324464612|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
94728008|NCT02362503|324464610|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
94728009|NCT02362503|324464611|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
94728010|NCT02362503|324464612|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
94728011|NCT02362503|324464610|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
94728012|NCT02362503|324464611|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
94728013|NCT02362503|324464612|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
94728014|NCT02362503|324464610|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
94728015|NCT02362503|324464611|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
94728016|NCT02362503|324464612|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
94728017|NCT02362503|324464610|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
94728018|NCT02362503|324464611|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
94728019|NCT02362503|324464612|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
94728020|NCT02362503|324464610|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
94728021|NCT02362503|324464611|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
94728022|NCT02362503|324464612|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
94728023|NCT02362503|324464610|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
94728024|NCT02362503|324464611|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
94728025|NCT02362503|324464612|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
94728026|NCT02362503|324464610|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
94728027|NCT02362503|324464611|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
94728028|NCT02362503|324464612|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
94728029|NCT02362503|324464610|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
94728030|NCT02362503|324464611|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
94728031|NCT02362503|324464612|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
94728032|NCT02362503|324464610|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
94728033|NCT02362503|324464611|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
94728034|NCT02362503|324464612|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
94728035|NCT05087992|324464613|FG000|Overall Study|Adverse Event|0|||
94728036|NCT05087992|324464614|FG001|Overall Study|Adverse Event|1|||
94728037|NCT05087992|324464615|FG002|Overall Study|Adverse Event|0|||
94728038|NCT05087992|324464613|FG000|Overall Study|Withdrawal by Subject|2|||
94467399|NCT00415597|323500560|FG000|Enrollment|Withdrawal by Subject|1|||
94728039|NCT05087992|324464614|FG001|Overall Study|Withdrawal by Subject|0|||
94273522|NCT00939783|322793758|FG000|Overall Study|Withdrawal by Subject|78|||
94273523|NCT00939783|322793758|FG000|Overall Study|Other|16|||
94728040|NCT05087992|324464615|FG002|Overall Study|Withdrawal by Subject|0|||
94728041|NCT05087992|324464613|FG000|Overall Study|clinical disease progression|3|||
94728042|NCT05087992|324464614|FG001|Overall Study|clinical disease progression|1|||
94728043|NCT05087992|324464615|FG002|Overall Study|clinical disease progression|0|||
94728044|NCT05087992|324464613|FG000|Overall Study|objective disease progression|4|||
94728045|NCT05087992|324464614|FG001|Overall Study|objective disease progression|1|||
94728046|NCT05087992|324464615|FG002|Overall Study|objective disease progression|0|||
94728047|NCT00085735|324464616|FG000|Overall Study|Adverse Event|1|||
94728048|NCT00085735|324464617|FG001|Overall Study|Adverse Event|0|||
94728049|NCT00085735|324464618|FG002|Overall Study|Adverse Event|0|||
94728050|NCT00085735|324464619|FG003|Overall Study|Adverse Event|0|||
94728051|NCT00085735|324464620|FG004|Overall Study|Adverse Event|0|||
94728052|NCT00085735|324464621|FG005|Overall Study|Adverse Event|0|||
94728053|NCT00085735|324464616|FG000|Overall Study|Lack of Efficacy|2|||
94728054|NCT00085735|324464617|FG001|Overall Study|Lack of Efficacy|4|||
94728055|NCT00085735|324464618|FG002|Overall Study|Lack of Efficacy|6|||
94728056|NCT00085735|324464619|FG003|Overall Study|Lack of Efficacy|3|||
94728057|NCT00085735|324464620|FG004|Overall Study|Lack of Efficacy|4|||
94728058|NCT00085735|324464621|FG005|Overall Study|Lack of Efficacy|3|||
94728059|NCT00085735|324464616|FG000|Overall Study|Lost to Follow-up|0|||
94728060|NCT00085735|324464617|FG001|Overall Study|Lost to Follow-up|1|||
94728061|NCT00085735|324464618|FG002|Overall Study|Lost to Follow-up|0|||
94728062|NCT00085735|324464619|FG003|Overall Study|Lost to Follow-up|0|||
94728063|NCT00085735|324464620|FG004|Overall Study|Lost to Follow-up|1|||
94728064|NCT00085735|324464621|FG005|Overall Study|Lost to Follow-up|0|||
94728065|NCT00085735|324464616|FG000|Overall Study|Physician Decision|2|||
94728066|NCT00085735|324464617|FG001|Overall Study|Physician Decision|3|||
94728067|NCT00085735|324464618|FG002|Overall Study|Physician Decision|2|||
94728068|NCT00085735|324464619|FG003|Overall Study|Physician Decision|3|||
94728069|NCT00085735|324464620|FG004|Overall Study|Physician Decision|11|||
94728070|NCT00085735|324464621|FG005|Overall Study|Physician Decision|8|||
94728071|NCT00085735|324464616|FG000|Overall Study|Protocol Violation|1|||
94728072|NCT00085735|324464617|FG001|Overall Study|Protocol Violation|0|||
94728073|NCT00085735|324464618|FG002|Overall Study|Protocol Violation|0|||
94728074|NCT00085735|324464619|FG003|Overall Study|Protocol Violation|0|||
94728075|NCT00085735|324464620|FG004|Overall Study|Protocol Violation|0|||
94728076|NCT00085735|324464621|FG005|Overall Study|Protocol Violation|0|||
94728077|NCT00085735|324464616|FG000|Overall Study|Withdrawal by Subject|1|||
94728078|NCT00085735|324464617|FG001|Overall Study|Withdrawal by Subject|0|||
94728079|NCT00085735|324464618|FG002|Overall Study|Withdrawal by Subject|4|||
94728080|NCT00085735|324464619|FG003|Overall Study|Withdrawal by Subject|5|||
94728081|NCT00085735|324464620|FG004|Overall Study|Withdrawal by Subject|7|||
94728082|NCT00085735|324464621|FG005|Overall Study|Withdrawal by Subject|8|||
94728083|NCT00085735|324464616|FG000|Overall Study|Patient ineligible|1|||
94728084|NCT00085735|324464617|FG001|Overall Study|Patient ineligible|0|||
94728085|NCT00085735|324464618|FG002|Overall Study|Patient ineligible|3|||
94728086|NCT00085735|324464619|FG003|Overall Study|Patient ineligible|7|||
94728087|NCT00085735|324464620|FG004|Overall Study|Patient ineligible|17|||
94728088|NCT00085735|324464621|FG005|Overall Study|Patient ineligible|8|||
94728089|NCT00085735|324464616|FG000|Overall Study|Excess residual disease|2|||
94728090|NCT00085735|324464617|FG001|Overall Study|Excess residual disease|2|||
94728091|NCT00085735|324464618|FG002|Overall Study|Excess residual disease|1|||
94728092|NCT00085735|324464619|FG003|Overall Study|Excess residual disease|1|||
94728093|NCT00085735|324464620|FG004|Overall Study|Excess residual disease|1|||
94728094|NCT00085735|324464621|FG005|Overall Study|Excess residual disease|4|||
94728095|NCT00085735|324464616|FG000|Overall Study|Reason not documented|1|||
94728096|NCT00085735|324464617|FG001|Overall Study|Reason not documented|0|||
94728097|NCT00085735|324464618|FG002|Overall Study|Reason not documented|1|||
94728098|NCT00085735|324464619|FG003|Overall Study|Reason not documented|0|||
94728099|NCT00085735|324464620|FG004|Overall Study|Reason not documented|1|||
94728100|NCT00085735|324464621|FG005|Overall Study|Reason not documented|0|||
94368610|NCT03174925|323136482|FG000|Overall Study|Elastography image not interpretable|1|||
94728101|NCT00085735|324464616|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
94728102|NCT00085735|324464617|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
94728103|NCT00085735|324464618|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
94728104|NCT00085735|324464619|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
94728105|NCT00085735|324464620|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
94368611|NCT04388527|323136483|FG000|Overall Study|Death|14|||
94368612|NCT04388527|323136483|FG000|Overall Study|Withdrawal by Subject|2|||
94728106|NCT00085735|324464621|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
94728107|NCT02919306|324464624|FG000|Overall Study|Withdrawal by Subject|1|||
94728108|NCT02919306|324464625|FG001|Overall Study|Withdrawal by Subject|0|||
94728109|NCT02919306|324464624|FG000|Overall Study|Protocol Violation|1|||
94728110|NCT02919306|324464625|FG001|Overall Study|Protocol Violation|0|||
94728111|NCT04293055|324464626|FG000|Overall Study|Lost to Follow-up|1|||
94728112|NCT04293055|324464627|FG001|Overall Study|Lost to Follow-up|1|||
94728113|NCT04293055|324464626|FG000|Overall Study|Did not trigger randomization|6|||
94728114|NCT04293055|324464627|FG001|Overall Study|Did not trigger randomization|5|||
94728115|NCT03560609|324464628|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
94728116|NCT03560609|324464629|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
94728117|NCT02319759|324464640|FG000|Week 0 - 16|Lack of Efficacy|1|||
94728118|NCT02319759|324464641|FG001|Week 0 - 16|Lack of Efficacy|0|||
94728119|NCT02319759|324464642|FG002|Week 0 - 16|Lack of Efficacy|0|||
94728120|NCT02319759|324464643|FG003|Week 0 - 16|Lack of Efficacy|0|||
94728121|NCT02319759|324464644|FG004|Week 0 - 16|Lack of Efficacy|0|||
94728122|NCT02319759|324464640|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
94728123|NCT02319759|324464641|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
94728124|NCT02319759|324464642|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
94728125|NCT02319759|324464643|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
94728126|NCT02319759|324464644|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
94728127|NCT02319759|324464640|FG000|Week 16 - 24|Lack of Efficacy|1|||
94728128|NCT02319759|324464641|FG001|Week 16 - 24|Lack of Efficacy|0|||
94728129|NCT02319759|324464642|FG002|Week 16 - 24|Lack of Efficacy|1|||
94728130|NCT02319759|324464643|FG003|Week 16 - 24|Lack of Efficacy|0|||
94728131|NCT02319759|324464644|FG004|Week 16 - 24|Lack of Efficacy|0|||
94728132|NCT02319759|324464640|FG000|Week 16 - 24|Lost to Follow-up|1|||
94728133|NCT02319759|324464641|FG001|Week 16 - 24|Lost to Follow-up|0|||
94728134|NCT02319759|324464642|FG002|Week 16 - 24|Lost to Follow-up|0|||
94728135|NCT02319759|324464643|FG003|Week 16 - 24|Lost to Follow-up|0|||
94728136|NCT02319759|324464644|FG004|Week 16 - 24|Lost to Follow-up|0|||
94728137|NCT02319759|324464640|FG000|Week 16 - 24|Withdrawal by Subject|0|||
94728138|NCT02319759|324464641|FG001|Week 16 - 24|Withdrawal by Subject|0|||
94728139|NCT02319759|324464642|FG002|Week 16 - 24|Withdrawal by Subject|2|||
94728140|NCT02319759|324464643|FG003|Week 16 - 24|Withdrawal by Subject|0|||
94728141|NCT02319759|324464644|FG004|Week 16 - 24|Withdrawal by Subject|0|||
94728142|NCT02319759|324464640|FG000|Week 24 - 56|Adverse Event|0|||
94728143|NCT02319759|324464641|FG001|Week 24 - 56|Adverse Event|0|||
94728144|NCT02319759|324464642|FG002|Week 24 - 56|Adverse Event|2|||
94728145|NCT02319759|324464643|FG003|Week 24 - 56|Adverse Event|0|||
94728146|NCT02319759|324464644|FG004|Week 24 - 56|Adverse Event|0|||
94728147|NCT02319759|324464640|FG000|Week 24 - 56|Lack of Efficacy|0|||
94728148|NCT02319759|324464641|FG001|Week 24 - 56|Lack of Efficacy|0|||
94728149|NCT02319759|324464642|FG002|Week 24 - 56|Lack of Efficacy|0|||
94728150|NCT02319759|324464643|FG003|Week 24 - 56|Lack of Efficacy|2|||
94728151|NCT02319759|324464644|FG004|Week 24 - 56|Lack of Efficacy|1|||
94728152|NCT02319759|324464640|FG000|Week 24 - 56|Withdrawal by Subject|0|||
94728153|NCT02319759|324464641|FG001|Week 24 - 56|Withdrawal by Subject|1|||
94728154|NCT02319759|324464642|FG002|Week 24 - 56|Withdrawal by Subject|0|||
94728155|NCT02319759|324464643|FG003|Week 24 - 56|Withdrawal by Subject|0|||
94728156|NCT02319759|324464644|FG004|Week 24 - 56|Withdrawal by Subject|0|||
94728157|NCT02319759|324464640|FG000|Week 24 - 56|Lost to Follow-up|0|||
94728158|NCT02319759|324464641|FG001|Week 24 - 56|Lost to Follow-up|0|||
94728159|NCT02319759|324464642|FG002|Week 24 - 56|Lost to Follow-up|0|||
94728160|NCT02319759|324464643|FG003|Week 24 - 56|Lost to Follow-up|0|||
94728161|NCT02319759|324464644|FG004|Week 24 - 56|Lost to Follow-up|1|||
94728162|NCT02262728|324464645|FG000|Follow-up Phase (3 Years)|Death|0|||
94728163|NCT02262728|324464646|FG001|Follow-up Phase (3 Years)|Death|1|||
94728164|NCT02262728|324464645|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
94728165|NCT02262728|324464646|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
94728166|NCT02262728|324464645|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
94728167|NCT02262728|324464646|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
94728168|NCT05540665|324464647|FG000|Overall Study|Study terminated by sponsor|6|||
94728169|NCT05540665|324464648|FG001|Overall Study|Study terminated by sponsor|6|||
94728170|NCT05540665|324464649|FG002|Overall Study|Study terminated by sponsor|7|||
94728171|NCT01358877|324464652|FG000|Overall Study|Death|80|||
94728172|NCT01358877|324464653|FG001|Overall Study|Death|89|||
94728173|NCT01358877|324464652|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
94728174|NCT01358877|324464653|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
94728175|NCT01358877|324464652|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
94728176|NCT01358877|324464653|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
94728177|NCT01358877|324464652|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
94728178|NCT01358877|324464653|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
94728179|NCT01358877|324464652|FG000|Overall Study|Other|142|||
94728180|NCT01358877|324464653|FG001|Overall Study|Other|129|||
94728181|NCT02598388|324464654|FG000|Overall Study|Lost to Follow-up|1|||
94728182|NCT02598388|324464655|FG001|Overall Study|Lost to Follow-up|0|||
94728183|NCT02598388|324464656|FG002|Overall Study|Lost to Follow-up|1|||
94728184|NCT02598388|324464657|FG003|Overall Study|Lost to Follow-up|0|||
94728185|NCT02598388|324464658|FG004|Overall Study|Lost to Follow-up|5|||
94728186|NCT02598388|324464659|FG005|Overall Study|Lost to Follow-up|1|||
94728187|NCT02598388|324464660|FG006|Overall Study|Lost to Follow-up|2|||
94728188|NCT02598388|324464661|FG007|Overall Study|Lost to Follow-up|1|||
94728189|NCT02598388|324464662|FG008|Overall Study|Lost to Follow-up|0|||
94728190|NCT02598388|324464663|FG009|Overall Study|Lost to Follow-up|0|||
94728191|NCT02598388|324464664|FG010|Overall Study|Lost to Follow-up|1|||
94728192|NCT02598388|324464665|FG011|Overall Study|Lost to Follow-up|0|||
94728193|NCT02598388|324464654|FG000|Overall Study|Withdrawal by Subject|0|||
94728194|NCT02598388|324464655|FG001|Overall Study|Withdrawal by Subject|0|||
94728195|NCT02598388|324464656|FG002|Overall Study|Withdrawal by Subject|0|||
94728196|NCT02598388|324464657|FG003|Overall Study|Withdrawal by Subject|0|||
94728197|NCT02598388|324464658|FG004|Overall Study|Withdrawal by Subject|2|||
94728198|NCT02598388|324464659|FG005|Overall Study|Withdrawal by Subject|0|||
94728199|NCT02598388|324464660|FG006|Overall Study|Withdrawal by Subject|2|||
94728200|NCT02598388|324464661|FG007|Overall Study|Withdrawal by Subject|0|||
94728201|NCT02598388|324464662|FG008|Overall Study|Withdrawal by Subject|0|||
94728202|NCT02598388|324464663|FG009|Overall Study|Withdrawal by Subject|1|||
94728203|NCT02598388|324464664|FG010|Overall Study|Withdrawal by Subject|0|||
94728204|NCT02598388|324464665|FG011|Overall Study|Withdrawal by Subject|0|||
94728205|NCT02598388|324464654|FG000|Overall Study|Other|0|||
94728206|NCT02598388|324464655|FG001|Overall Study|Other|0|||
94728207|NCT02598388|324464656|FG002|Overall Study|Other|1|||
94728208|NCT02598388|324464657|FG003|Overall Study|Other|0|||
94728209|NCT02598388|324464658|FG004|Overall Study|Other|3|||
94728210|NCT02598388|324464659|FG005|Overall Study|Other|0|||
94728211|NCT02598388|324464660|FG006|Overall Study|Other|1|||
94728212|NCT02598388|324464661|FG007|Overall Study|Other|0|||
94728213|NCT02598388|324464662|FG008|Overall Study|Other|0|||
94728214|NCT02598388|324464663|FG009|Overall Study|Other|0|||
94728215|NCT02598388|324464664|FG010|Overall Study|Other|0|||
94728216|NCT02598388|324464665|FG011|Overall Study|Other|0|||
94728217|NCT05256017|324464666|FG000|Treatment Period|Withdrawal by Subject|1|||
94728218|NCT05256017|324464667|FG001|Treatment Period|Withdrawal by Subject|1|||
94728219|NCT05256017|324464666|FG000|Follow-up|Lost to Follow-up|7|||
94728220|NCT05256017|324464667|FG001|Follow-up|Lost to Follow-up|1|||
94728221|NCT05256017|324464666|FG000|Follow-up|Withdrawal by Subject|1|||
94728222|NCT05256017|324464667|FG001|Follow-up|Withdrawal by Subject|0|||
94728223|NCT05256017|324464666|FG000|Follow-up|Death|0|||
94728224|NCT05256017|324464667|FG001|Follow-up|Death|1|||
94728225|NCT04066244|324464668|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
94728226|NCT04066244|324464669|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
94728227|NCT04066244|324464670|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
94728228|NCT04066244|324464671|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
94728229|NCT04066244|324464672|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
94728230|NCT04066244|324464673|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
94728231|NCT04066244|324464668|FG000|Part 2 (Cohort 5)|Death|0|||
94728232|NCT04066244|324464669|FG001|Part 2 (Cohort 5)|Death|0|||
94728233|NCT04066244|324464670|FG002|Part 2 (Cohort 5)|Death|0|||
94728234|NCT04066244|324464671|FG003|Part 2 (Cohort 5)|Death|0|||
94728235|NCT04066244|324464672|FG004|Part 2 (Cohort 5)|Death|0|||
94728236|NCT04066244|324464673|FG005|Part 2 (Cohort 5)|Death|2|||
94728237|NCT04066244|324464668|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
94728238|NCT04066244|324464669|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
94728239|NCT04066244|324464670|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
94728240|NCT04066244|324464671|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
94728241|NCT04066244|324464672|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
94728242|NCT04066244|324464673|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
94728243|NCT04066244|324464668|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
94728244|NCT04066244|324464669|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
94728245|NCT04066244|324464670|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
94728246|NCT04066244|324464671|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
94728247|NCT04066244|324464672|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
94728248|NCT04066244|324464673|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
94728249|NCT04788511|324464675|FG000|Overall Study|Withdrawal by Subject|2|||
94728250|NCT04788511|324464676|FG001|Overall Study|Withdrawal by Subject|1|||
94728251|NCT04788511|324464675|FG000|Overall Study|Lost to Follow-up|2|||
94728252|NCT04788511|324464676|FG001|Overall Study|Lost to Follow-up|7|||
94728253|NCT04788511|324464675|FG000|Overall Study|Death|3|||
94728254|NCT04788511|324464676|FG001|Overall Study|Death|4|||
94728255|NCT04332926|324464677|FG000|Overall Study|Withdrawal by Subject|6|||
94728256|NCT04332926|324464677|FG000|Overall Study|Physician Decision|6|||
94467400|NCT00415597|323500560|FG000|Enrollment|Protocol Violation|1|||
94728257|NCT05052996|324464678|FG000|Overall Study|Still on study|0|||
94728258|NCT05052996|324464679|FG001|Overall Study|Still on study|0|||
94728259|NCT05052996|324464680|FG002|Overall Study|Still on study|47|||
94728260|NCT05052996|324464681|FG003|Overall Study|Still on study|44|||
94728261|NCT05052996|324464678|FG000|Overall Study|Cohort terminated by sponsor|21|||
94728262|NCT05052996|324464679|FG001|Overall Study|Cohort terminated by sponsor|12|||
94728263|NCT05052996|324464680|FG002|Overall Study|Cohort terminated by sponsor|0|||
94728264|NCT05052996|324464681|FG003|Overall Study|Cohort terminated by sponsor|0|||
94728265|NCT05052996|324464678|FG000|Overall Study|Withdrew consent|1|||
94728266|NCT05052996|324464679|FG001|Overall Study|Withdrew consent|0|||
94728267|NCT05052996|324464680|FG002|Overall Study|Withdrew consent|1|||
94728268|NCT05052996|324464681|FG003|Overall Study|Withdrew consent|2|||
94728269|NCT05052996|324464678|FG000|Overall Study|Lost to Follow-up|1|||
94728270|NCT05052996|324464679|FG001|Overall Study|Lost to Follow-up|0|||
94728271|NCT05052996|324464680|FG002|Overall Study|Lost to Follow-up|0|||
94728272|NCT05052996|324464681|FG003|Overall Study|Lost to Follow-up|2|||
94728273|NCT05052996|324464678|FG000|Overall Study|Adverse Event|0|||
94728274|NCT05052996|324464679|FG001|Overall Study|Adverse Event|0|||
94728275|NCT05052996|324464680|FG002|Overall Study|Adverse Event|2|||
94728276|NCT05052996|324464681|FG003|Overall Study|Adverse Event|0|||
94728277|NCT05052996|324464678|FG000|Overall Study|Randomized but never treated|0|||
94728278|NCT05052996|324464679|FG001|Overall Study|Randomized but never treated|0|||
94728279|NCT05052996|324464680|FG002|Overall Study|Randomized but never treated|1|||
94728280|NCT05052996|324464681|FG003|Overall Study|Randomized but never treated|1|||
94728281|NCT05052996|324464678|FG000|Overall Study|Protocol Violation|1|||
94728282|NCT05052996|324464679|FG001|Overall Study|Protocol Violation|0|||
94728283|NCT05052996|324464680|FG002|Overall Study|Protocol Violation|0|||
94728284|NCT05052996|324464681|FG003|Overall Study|Protocol Violation|0|||
94728285|NCT05714761|324464682|FG000|Overall Study|Lost to Follow-up|3|||
94728286|NCT05714761|324464682|FG000|Overall Study|Withdrawal by Subject|3|||
94728287|NCT05714761|324464682|FG000|Overall Study|unblinding of sensor data|1|||
94728288|NCT05714761|324464682|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
94728289|NCT05714761|324464682|FG000|Overall Study|did not return second CGM sensor|4|||
94728290|NCT05603143|324464685|FG000|Overall Study|Withdrew consent|6|||
94728291|NCT05603143|324464686|FG001|Overall Study|Withdrew consent|2|||
94728292|NCT05603143|324464685|FG000|Overall Study|Randomized but never treated|0|||
94728293|NCT05603143|324464686|FG001|Overall Study|Randomized but never treated|3|||
94728294|NCT05603143|324464685|FG000|Overall Study|Adverse Event|2|||
94728295|NCT05603143|324464686|FG001|Overall Study|Adverse Event|0|||
94728296|NCT05603143|324464685|FG000|Overall Study|Death|0|||
94728297|NCT05603143|324464686|FG001|Overall Study|Death|1|||
94728298|NCT05603143|324464685|FG000|Overall Study|Investigator's discretion|1|||
94728299|NCT05603143|324464686|FG001|Overall Study|Investigator's discretion|0|||
94728300|NCT05603143|324464685|FG000|Overall Study|Lost to Follow-up|0|||
94728301|NCT05603143|324464686|FG001|Overall Study|Lost to Follow-up|1|||
94728302|NCT05603143|324464685|FG000|Overall Study|Protocol Violation|0|||
94728303|NCT05603143|324464686|FG001|Overall Study|Protocol Violation|1|||
94728304|NCT04876118|324464687|FG000|Overall Study|Pregnancy|1|||
94728305|NCT04876118|324464687|FG000|Overall Study|Withdrawal by Subject|14|||
94728306|NCT06019559|324464688|FG000|Overall Study|Withdrawal by Subject|7|||
94728307|NCT06019559|324464689|FG001|Overall Study|Withdrawal by Subject|6|||
94728308|NCT06019559|324464690|FG002|Overall Study|Withdrawal by Subject|5|||
94728309|NCT06019559|324464688|FG000|Overall Study|Lost to Follow-up|2|||
94728310|NCT06019559|324464689|FG001|Overall Study|Lost to Follow-up|0|||
94728311|NCT06019559|324464690|FG002|Overall Study|Lost to Follow-up|3|||
94728312|NCT04096040|324464704|FG000|Overall Study|Protocol Violation|12|||
94728313|NCT04096040|324464704|FG000|Overall Study|Non-compliant site|4|||
94728314|NCT04439357|324464705|FG000|Overall Study|Disease Progression|4|||
94728315|NCT02721732|324464706|FG000|Overall Study|Adverse Event|2|||
94728316|NCT02721732|324464707|FG001|Overall Study|Adverse Event|0|||
94728317|NCT02721732|324464708|FG002|Overall Study|Adverse Event|2|||
94728318|NCT02721732|324464709|FG003|Overall Study|Adverse Event|0|||
94728319|NCT02721732|324464710|FG004|Overall Study|Adverse Event|1|||
94728320|NCT02721732|324464711|FG005|Overall Study|Adverse Event|0|||
94728321|NCT02721732|324464712|FG006|Overall Study|Adverse Event|1|||
94728322|NCT02721732|324464713|FG007|Overall Study|Adverse Event|0|||
94728323|NCT02721732|324464714|FG008|Overall Study|Adverse Event|1|||
94728324|NCT02721732|324464715|FG009|Overall Study|Adverse Event|1|||
94728325|NCT02721732|324464706|FG000|Overall Study|Death|0|||
94728326|NCT02721732|324464707|FG001|Overall Study|Death|0|||
94728327|NCT02721732|324464708|FG002|Overall Study|Death|0|||
94728328|NCT02721732|324464709|FG003|Overall Study|Death|0|||
94728329|NCT02721732|324464710|FG004|Overall Study|Death|1|||
94728330|NCT02721732|324464711|FG005|Overall Study|Death|0|||
94728331|NCT02721732|324464712|FG006|Overall Study|Death|1|||
94728332|NCT02721732|324464713|FG007|Overall Study|Death|0|||
94728333|NCT02721732|324464714|FG008|Overall Study|Death|0|||
94728334|NCT02721732|324464715|FG009|Overall Study|Death|1|||
94728335|NCT02721732|324464706|FG000|Overall Study|Lack of Efficacy|12|||
94728336|NCT02721732|324464707|FG001|Overall Study|Lack of Efficacy|11|||
94728337|NCT02721732|324464708|FG002|Overall Study|Lack of Efficacy|18|||
94728338|NCT02721732|324464709|FG003|Overall Study|Lack of Efficacy|5|||
94728339|NCT02721732|324464710|FG004|Overall Study|Lack of Efficacy|21|||
94728340|NCT02721732|324464711|FG005|Overall Study|Lack of Efficacy|2|||
94728341|NCT02721732|324464712|FG006|Overall Study|Lack of Efficacy|8|||
94728342|NCT02721732|324464713|FG007|Overall Study|Lack of Efficacy|11|||
94728343|NCT02721732|324464714|FG008|Overall Study|Lack of Efficacy|10|||
94728344|NCT02721732|324464715|FG009|Overall Study|Lack of Efficacy|20|||
94728345|NCT02721732|324464706|FG000|Overall Study|Physician Decision|0|||
94728346|NCT02721732|324464707|FG001|Overall Study|Physician Decision|0|||
94728347|NCT02721732|324464708|FG002|Overall Study|Physician Decision|1|||
94728348|NCT02721732|324464709|FG003|Overall Study|Physician Decision|0|||
94728349|NCT02721732|324464710|FG004|Overall Study|Physician Decision|0|||
94728350|NCT02721732|324464711|FG005|Overall Study|Physician Decision|0|||
94728351|NCT02721732|324464712|FG006|Overall Study|Physician Decision|0|||
94728352|NCT02721732|324464713|FG007|Overall Study|Physician Decision|0|||
94728353|NCT02721732|324464714|FG008|Overall Study|Physician Decision|0|||
94728354|NCT02721732|324464715|FG009|Overall Study|Physician Decision|0|||
94728355|NCT02721732|324464706|FG000|Overall Study|Withdrawal by Subject|1|||
94728356|NCT02721732|324464707|FG001|Overall Study|Withdrawal by Subject|0|||
94728357|NCT02721732|324464708|FG002|Overall Study|Withdrawal by Subject|0|||
94728358|NCT02721732|324464709|FG003|Overall Study|Withdrawal by Subject|0|||
94728359|NCT02721732|324464710|FG004|Overall Study|Withdrawal by Subject|3|||
94728360|NCT02721732|324464711|FG005|Overall Study|Withdrawal by Subject|0|||
94728361|NCT02721732|324464712|FG006|Overall Study|Withdrawal by Subject|1|||
94728362|NCT02721732|324464713|FG007|Overall Study|Withdrawal by Subject|1|||
94728363|NCT02721732|324464714|FG008|Overall Study|Withdrawal by Subject|0|||
94728364|NCT02721732|324464715|FG009|Overall Study|Withdrawal by Subject|1|||
94728365|NCT02721732|324464706|FG000|Overall Study|Participant Choice|1|||
94728366|NCT02721732|324464707|FG001|Overall Study|Participant Choice|0|||
94728367|NCT02721732|324464708|FG002|Overall Study|Participant Choice|0|||
94728368|NCT02721732|324464709|FG003|Overall Study|Participant Choice|0|||
94728369|NCT02721732|324464710|FG004|Overall Study|Participant Choice|0|||
94728370|NCT02721732|324464711|FG005|Overall Study|Participant Choice|0|||
94728371|NCT02721732|324464712|FG006|Overall Study|Participant Choice|0|||
94728372|NCT02721732|324464713|FG007|Overall Study|Participant Choice|0|||
94728373|NCT02721732|324464714|FG008|Overall Study|Participant Choice|0|||
94728374|NCT02721732|324464715|FG009|Overall Study|Participant Choice|1|||
94728375|NCT02721732|324464706|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
94728376|NCT02721732|324464707|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
94728377|NCT02721732|324464708|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
94728378|NCT02721732|324464709|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
94728379|NCT02721732|324464710|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
94728380|NCT02721732|324464711|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
94467401|NCT00415597|323500560|FG000|Treatment|Adverse Event|110|||
94728381|NCT02721732|324464712|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
94728382|NCT02721732|324464713|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
94728383|NCT02721732|324464714|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
94728384|NCT02721732|324464715|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
94728385|NCT02721732|324464706|FG000|Overall Study|Progression and withdrew consent|1|||
94728386|NCT02721732|324464707|FG001|Overall Study|Progression and withdrew consent|1|||
94273524|NCT00939783|322793758|FG000|Overall Study|Lost to Follow-up|8|||
94273525|NCT00939783|322793758|FG000|Overall Study|Protocol Violation|3|||
94273526|NCT00939783|322793758|FG000|Overall Study|Enrolled but not treated|1|||
94273527|NCT03073980|322793759|FG000|Overall Study|Lost to Follow-up|10|||
94273528|NCT03073980|322793760|FG001|Overall Study|Lost to Follow-up|2|||
94273529|NCT03073980|322793761|FG002|Overall Study|Lost to Follow-up|9|||
94273530|NCT03073980|322793759|FG000|Overall Study|No post-procedure data|0|||
94273531|NCT03073980|322793760|FG001|Overall Study|No post-procedure data|0|||
94273532|NCT03073980|322793761|FG002|Overall Study|No post-procedure data|2|||
94273533|NCT02937818|322793764|FG000|Overall Study|Participants decision|2|||
94273534|NCT02937818|322793765|FG001|Overall Study|Participants decision|1|||
94273535|NCT02937818|322793766|FG002|Overall Study|Participants decision|1|||
94273536|NCT02937818|322793767|FG003|Overall Study|Participants decision|1|||
94273537|NCT02937818|322793764|FG000|Overall Study|Adverse Event|2|||
94273538|NCT02937818|322793765|FG001|Overall Study|Adverse Event|4|||
94273539|NCT02937818|322793766|FG002|Overall Study|Adverse Event|1|||
94273540|NCT02937818|322793767|FG003|Overall Study|Adverse Event|1|||
94273541|NCT02937818|322793764|FG000|Overall Study|Disease progression|17|||
94273542|NCT02937818|322793765|FG001|Overall Study|Disease progression|15|||
94273543|NCT02937818|322793766|FG002|Overall Study|Disease progression|7|||
94273544|NCT02937818|322793767|FG003|Overall Study|Disease progression|19|||
94273545|NCT02937818|322793764|FG000|Overall Study|Condition under investigation worsened|0|||
94273546|NCT02937818|322793765|FG001|Overall Study|Condition under investigation worsened|0|||
94728387|NCT02721732|324464708|FG002|Overall Study|Progression and withdrew consent|0|||
94728388|NCT02721732|324464709|FG003|Overall Study|Progression and withdrew consent|0|||
94728389|NCT02721732|324464710|FG004|Overall Study|Progression and withdrew consent|0|||
94728390|NCT02721732|324464711|FG005|Overall Study|Progression and withdrew consent|0|||
94728391|NCT02721732|324464712|FG006|Overall Study|Progression and withdrew consent|0|||
94728392|NCT02721732|324464713|FG007|Overall Study|Progression and withdrew consent|0|||
94728393|NCT02721732|324464714|FG008|Overall Study|Progression and withdrew consent|0|||
94728394|NCT02721732|324464715|FG009|Overall Study|Progression and withdrew consent|1|||
94728395|NCT02721732|324464706|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
94728396|NCT02721732|324464707|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
94728397|NCT02721732|324464708|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
94728398|NCT02721732|324464709|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
94728399|NCT02721732|324464710|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
94728400|NCT02721732|324464711|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
94728401|NCT02721732|324464712|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
94728402|NCT02721732|324464713|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
94728403|NCT02721732|324464714|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
94728404|NCT02721732|324464715|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
94728405|NCT04542317|324464717|FG000|Overall Study|Care recipients passed away|18|||
94728406|NCT04542317|324464718|FG001|Overall Study|Care recipients passed away|13|||
94728407|NCT04542317|324464717|FG000|Overall Study|No longer a primary caregiver|5|||
94728408|NCT04542317|324464718|FG001|Overall Study|No longer a primary caregiver|1|||
94273547|NCT02937818|322793766|FG002|Overall Study|Condition under investigation worsened|1|||
94273548|NCT02937818|322793767|FG003|Overall Study|Condition under investigation worsened|0|||
94273549|NCT00432042|322793769|FG000|Overall Study|Protocol Violation|2|||
94273550|NCT00432042|322793770|FG001|Overall Study|Protocol Violation|0|||
94273551|NCT00432042|322793771|FG002|Overall Study|Protocol Violation|0|||
94273552|NCT00432042|322793769|FG000|Overall Study|Withdrawal by Subject|0|||
94273553|NCT00432042|322793770|FG001|Overall Study|Withdrawal by Subject|0|||
94728409|NCT04542317|324464717|FG000|Overall Study|Withdrawal by Subject|4|||
94368613|NCT04388527|323136483|FG000|Overall Study|Lost to Follow-up|1|||
94368614|NCT00520494|323136486|FG000|Overall Study|Withdrawal by Subject|1|||
94368615|NCT04247594|323136487|FG000|Overall Study|Withdrawal by Subject|4|||
94368616|NCT00331773|323136497|FG000|Overall Study|Withdrawal by Subject|6|||
94368617|NCT00331773|323136498|FG001|Overall Study|Withdrawal by Subject|4|||
94368618|NCT00331773|323136497|FG000|Overall Study|Protocol Violation|10|||
94728410|NCT04542317|324464718|FG001|Overall Study|Withdrawal by Subject|2|||
94728411|NCT04542317|324464717|FG000|Overall Study|Caregivers passed away|0|||
94728412|NCT04542317|324464718|FG001|Overall Study|Caregivers passed away|2|||
94728413|NCT05126433|324464721|FG000|Overall Study|Withdrawal by Subject|3|||
94728414|NCT05126433|324464722|FG001|Overall Study|Withdrawal by Subject|0|||
94728415|NCT05126433|324464723|FG002|Overall Study|Withdrawal by Subject|4|||
94728416|NCT05126433|324464721|FG000|Overall Study|Death|9|||
94728417|NCT05126433|324464722|FG001|Overall Study|Death|3|||
94728418|NCT05126433|324464723|FG002|Overall Study|Death|5|||
94728419|NCT05126433|324464721|FG000|Overall Study|Study Terminated by sponsor|0|||
94728420|NCT05126433|324464722|FG001|Overall Study|Study Terminated by sponsor|1|||
94728421|NCT05126433|324464723|FG002|Overall Study|Study Terminated by sponsor|2|||
94728422|NCT05126433|324464721|FG000|Overall Study|Progressive Disease|1|||
94728423|NCT05126433|324464722|FG001|Overall Study|Progressive Disease|4|||
94728424|NCT05126433|324464723|FG002|Overall Study|Progressive Disease|3|||
94728425|NCT05126433|324464721|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
94728426|NCT05126433|324464722|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
94728427|NCT05126433|324464723|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
94728428|NCT03907878|324464724|FG000|Treatment Period|Withdrawal by Subject|5|||
94728429|NCT03907878|324464724|FG000|Treatment Period|Adverse Event|4|||
94728430|NCT03907878|324464724|FG000|Treatment Period|Lack of Efficacy|1|||
94728431|NCT03907878|324464724|FG000|Treatment Period|Protocol Violation|1|||
94728432|NCT03907878|324464724|FG000|Follow-up Period|Adverse Event|3|||
94728433|NCT03907878|324464724|FG000|Follow-up Period|Withdrawal by Subject|3|||
94728434|NCT05144009|324464725|FG000|Overall Study|Lost to Follow-up|0|||
94728435|NCT05144009|324464726|FG001|Overall Study|Lost to Follow-up|1|||
94728436|NCT05144009|324464725|FG000|Overall Study|Study Termination by the Sponsor|11|||
94728437|NCT05144009|324464726|FG001|Overall Study|Study Termination by the Sponsor|11|||
94728438|NCT05144009|324464725|FG000|Overall Study|Disease Progression|1|||
94728439|NCT05144009|324464726|FG001|Overall Study|Disease Progression|0|||
94728440|NCT05144009|324464725|FG000|Overall Study|Participant Decision|0|||
94728441|NCT05144009|324464726|FG001|Overall Study|Participant Decision|2|||
94728442|NCT05144009|324464725|FG000|Overall Study|Death|5|||
94728443|NCT05144009|324464726|FG001|Overall Study|Death|10|||
94728444|NCT03020199|324464730|FG000|Treatment Period|Adverse Event|0|||
94728445|NCT03020199|324464731|FG001|Treatment Period|Adverse Event|2|||
94728446|NCT03020199|324464730|FG000|Treatment Period|Lack of Efficacy|1|||
94728447|NCT03020199|324464731|FG001|Treatment Period|Lack of Efficacy|6|||
94728448|NCT03020199|324464730|FG000|Treatment Period|Lost to Follow-up|1|||
94728449|NCT03020199|324464731|FG001|Treatment Period|Lost to Follow-up|6|||
94728450|NCT03020199|324464730|FG000|Treatment Period|Physician Decision|0|||
94728451|NCT03020199|324464731|FG001|Treatment Period|Physician Decision|1|||
94728452|NCT03020199|324464730|FG000|Treatment Period|Subject/guardian decision|8|||
94728453|NCT03020199|324464731|FG001|Treatment Period|Subject/guardian decision|15|||
94728454|NCT03020199|324464730|FG000|Treatment Period|Subjects not treated|3|||
94728455|NCT03020199|324464731|FG001|Treatment Period|Subjects not treated|4|||
94728456|NCT03020199|324464730|FG000|Follow-up Period|Disease relapse|32|||
94728457|NCT03020199|324464731|FG001|Follow-up Period|Disease relapse|7|||
94728458|NCT03020199|324464730|FG000|Follow-up Period|Lack of Efficacy|1|||
94728459|NCT03020199|324464731|FG001|Follow-up Period|Lack of Efficacy|2|||
94728460|NCT03020199|324464730|FG000|Follow-up Period|Lost to Follow-up|4|||
94728461|NCT03020199|324464731|FG001|Follow-up Period|Lost to Follow-up|6|||
94728462|NCT03020199|324464730|FG000|Follow-up Period|Physician Decision|2|||
94728463|NCT03020199|324464731|FG001|Follow-up Period|Physician Decision|2|||
94728464|NCT03020199|324464730|FG000|Follow-up Period|Protocol Violation|1|||
94728465|NCT03020199|324464731|FG001|Follow-up Period|Protocol Violation|2|||
94728466|NCT03020199|324464730|FG000|Follow-up Period|Study terminated by Sponsor|6|||
94728467|NCT03020199|324464731|FG001|Follow-up Period|Study terminated by Sponsor|3|||
94728468|NCT03020199|324464730|FG000|Follow-up Period|Subject/guardian decision|14|||
94728469|NCT03020199|324464731|FG001|Follow-up Period|Subject/guardian decision|9|||
94728470|NCT04042233|324464732|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
94728471|NCT04042233|324464733|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
94368619|NCT00331773|323136498|FG001|Overall Study|Protocol Violation|3|||
94368620|NCT01954082|323136499|FG000|Overall Study|Study Suspension|42|||
94728472|NCT04042233|324464732|FG000|Overall Study|Protocol Violation|0|||
94728473|NCT04042233|324464733|FG001|Overall Study|Protocol Violation|2|||
94728474|NCT03852472|324464734|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
94728475|NCT03852472|324464735|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
94728476|NCT03852472|324464736|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
94728477|NCT03852472|324464737|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
94728478|NCT03852472|324464738|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
94728479|NCT03852472|324464734|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
94728480|NCT03852472|324464735|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
94728481|NCT03852472|324464736|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
94728482|NCT03852472|324464737|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
94728483|NCT03852472|324464738|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
94728484|NCT03852472|324464734|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
94728485|NCT03852472|324464735|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
94728486|NCT03852472|324464736|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
94728487|NCT03852472|324464737|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
94728488|NCT03852472|324464738|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
94728489|NCT03852472|324464734|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
94728490|NCT03852472|324464735|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
94728491|NCT03852472|324464736|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
94728492|NCT03852472|324464737|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
94728493|NCT03852472|324464738|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
94728494|NCT03852472|324464734|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
94728495|NCT03852472|324464735|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
94728496|NCT03852472|324464736|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
94728497|NCT03852472|324464737|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
94728498|NCT03852472|324464738|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
94728499|NCT03852472|324464734|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
94728500|NCT03852472|324464735|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
94728501|NCT03852472|324464736|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
94728502|NCT03852472|324464737|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
94728503|NCT03852472|324464738|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
94728504|NCT03852472|324464734|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
94728505|NCT03852472|324464735|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
94728506|NCT03852472|324464736|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
94728507|NCT03852472|324464737|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
94728508|NCT03852472|324464738|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
94728509|NCT03852472|324464734|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
94728510|NCT03852472|324464735|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
94728511|NCT03852472|324464736|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
94728512|NCT03852472|324464737|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
94728513|NCT03852472|324464738|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
94728514|NCT03852472|324464734|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
94728515|NCT03852472|324464735|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
94728516|NCT03852472|324464736|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
94728517|NCT03852472|324464737|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
94728518|NCT03852472|324464738|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
94728519|NCT03852472|324464734|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
94728520|NCT03852472|324464735|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
94728521|NCT03852472|324464736|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
94728522|NCT03852472|324464737|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
94728523|NCT03852472|324464738|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
94728524|NCT03852472|324464734|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
94728525|NCT03852472|324464735|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
94728526|NCT03852472|324464736|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
94728527|NCT03852472|324464737|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
94728528|NCT03852472|324464738|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
94728529|NCT03852472|324464734|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
94728530|NCT03852472|324464735|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
94728531|NCT03852472|324464736|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
94728532|NCT03852472|324464737|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
94728533|NCT03852472|324464738|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
94728534|NCT03852472|324464734|FG000|Period 2 - Week 44|Adverse Event|0|||
94728535|NCT03852472|324464735|FG001|Period 2 - Week 44|Adverse Event|3|||
94728536|NCT03852472|324464736|FG002|Period 2 - Week 44|Adverse Event|1|||
94728537|NCT03852472|324464737|FG003|Period 2 - Week 44|Adverse Event|2|||
94728538|NCT03852472|324464738|FG004|Period 2 - Week 44|Adverse Event|2|||
94728539|NCT03852472|324464734|FG000|Period 2 - Week 44|COVID-19 Related|0|||
94728540|NCT03852472|324464735|FG001|Period 2 - Week 44|COVID-19 Related|0|||
94728541|NCT03852472|324464736|FG002|Period 2 - Week 44|COVID-19 Related|0|||
94728542|NCT03852472|324464737|FG003|Period 2 - Week 44|COVID-19 Related|1|||
94728543|NCT03852472|324464738|FG004|Period 2 - Week 44|COVID-19 Related|0|||
94728544|NCT03852472|324464734|FG000|Period 2 - Week 44|Reason not stated|0|||
94728545|NCT03852472|324464735|FG001|Period 2 - Week 44|Reason not stated|0|||
94728546|NCT03852472|324464736|FG002|Period 2 - Week 44|Reason not stated|0|||
94728547|NCT03852472|324464737|FG003|Period 2 - Week 44|Reason not stated|0|||
94728548|NCT03852472|324464738|FG004|Period 2 - Week 44|Reason not stated|1|||
94728549|NCT01396278|324466073|FG000|Overall Study|Adverse Event|0|||
94728550|NCT01396278|324466074|FG001|Overall Study|Adverse Event|0|||
94728551|NCT01396278|324466075|FG002|Overall Study|Adverse Event|0|||
94728552|NCT01396278|324466076|FG003|Overall Study|Adverse Event|2|||
94728553|NCT01396278|324466077|FG004|Overall Study|Adverse Event|0|||
94728554|NCT01396278|324466073|FG000|Overall Study|Withdraw due to trial termination|2|||
94728555|NCT01396278|324466074|FG001|Overall Study|Withdraw due to trial termination|1|||
94728556|NCT01396278|324466075|FG002|Overall Study|Withdraw due to trial termination|1|||
94728557|NCT01396278|324466076|FG003|Overall Study|Withdraw due to trial termination|0|||
94728558|NCT01396278|324466077|FG004|Overall Study|Withdraw due to trial termination|2|||
94728559|NCT05653427|324466080|FG000|Overall Study|Study Terminated by Sponsor|13|||
94728560|NCT01415882|324466081|FG000|Overall Study|Ineligible|1|||
94728561|NCT01415882|324466082|FG001|Overall Study|Ineligible|0|||
94728562|NCT01415882|324466083|FG002|Overall Study|Ineligible|0|||
94728563|NCT01415882|324466084|FG003|Overall Study|Ineligible|3|||
94728564|NCT01415882|324466085|FG004|Overall Study|Ineligible|0|||
94728565|NCT01415882|324466081|FG000|Overall Study|Withdrawal by Subject|0|||
94728566|NCT01415882|324466082|FG001|Overall Study|Withdrawal by Subject|1|||
94728567|NCT01415882|324466083|FG002|Overall Study|Withdrawal by Subject|0|||
94728568|NCT01415882|324466084|FG003|Overall Study|Withdrawal by Subject|1|||
94728569|NCT01415882|324466085|FG004|Overall Study|Withdrawal by Subject|0|||
94728570|NCT00554788|324466089|FG000|Overall Study|Adverse Event|0|||
94728571|NCT00554788|324466090|FG001|Overall Study|Adverse Event|1|||
94728572|NCT00554788|324466091|FG002|Overall Study|Adverse Event|2|||
94728573|NCT00554788|324466089|FG000|Overall Study|Lost to Follow-up|4|||
94728574|NCT00554788|324466090|FG001|Overall Study|Lost to Follow-up|3|||
94728575|NCT00554788|324466091|FG002|Overall Study|Lost to Follow-up|3|||
94728576|NCT00554788|324466089|FG000|Overall Study|Physician Decision|1|||
94728577|NCT00554788|324466090|FG001|Overall Study|Physician Decision|1|||
94728578|NCT00554788|324466091|FG002|Overall Study|Physician Decision|3|||
94728579|NCT00554788|324466089|FG000|Overall Study|Withdrawal by Subject|0|||
94728580|NCT00554788|324466090|FG001|Overall Study|Withdrawal by Subject|0|||
94728581|NCT00554788|324466091|FG002|Overall Study|Withdrawal by Subject|1|||
94728582|NCT00554788|324466089|FG000|Overall Study|Refusal of further protocol therapy|0|||
94728583|NCT00554788|324466090|FG001|Overall Study|Refusal of further protocol therapy|1|||
94728584|NCT00554788|324466091|FG002|Overall Study|Refusal of further protocol therapy|1|||
94728585|NCT00554788|324466089|FG000|Overall Study|Progressive disease|0|||
94728586|NCT00554788|324466090|FG001|Overall Study|Progressive disease|0|||
94728587|NCT00554788|324466091|FG002|Overall Study|Progressive disease|3|||
94728588|NCT00554788|324466089|FG000|Overall Study|Ineligible|2|||
94728589|NCT00554788|324466090|FG001|Overall Study|Ineligible|0|||
94728590|NCT00554788|324466091|FG002|Overall Study|Ineligible|1|||
94728591|NCT03721952|324466097|FG000|Overall Study|Lost to Follow-up|0|||
94728592|NCT03721952|324466098|FG001|Overall Study|Lost to Follow-up|0|||
94728593|NCT03721952|324466099|FG002|Overall Study|Lost to Follow-up|2|||
94728594|NCT03721952|324466100|FG003|Overall Study|Lost to Follow-up|0|||
94728595|NCT03721952|324466101|FG004|Overall Study|Lost to Follow-up|0|||
94728596|NCT03721952|324466097|FG000|Overall Study|Protocol Violation|0|||
94728597|NCT03721952|324466098|FG001|Overall Study|Protocol Violation|1|||
94728598|NCT03721952|324466099|FG002|Overall Study|Protocol Violation|0|||
94728599|NCT03721952|324466100|FG003|Overall Study|Protocol Violation|0|||
94728600|NCT03721952|324466101|FG004|Overall Study|Protocol Violation|0|||
94728601|NCT03721952|324466097|FG000|Overall Study|Withdrawal by Subject|1|||
94368621|NCT01954082|323136500|FG001|Overall Study|Study Suspension|36|||
94368622|NCT01954082|323136499|FG000|Overall Study|Adverse Event|10|||
94728602|NCT03721952|324466098|FG001|Overall Study|Withdrawal by Subject|0|||
94728603|NCT03721952|324466099|FG002|Overall Study|Withdrawal by Subject|40|||
94728604|NCT03721952|324466100|FG003|Overall Study|Withdrawal by Subject|28|||
94728605|NCT03721952|324466101|FG004|Overall Study|Withdrawal by Subject|0|||
94728606|NCT03476460|324466104|FG000|Overall Study|Withdrawal by Subject|3|||
94728607|NCT03476460|324466105|FG001|Overall Study|Withdrawal by Subject|2|||
94728608|NCT03476460|324466104|FG000|Overall Study|Non-compliance with treatment|3|||
94728609|NCT03476460|324466105|FG001|Overall Study|Non-compliance with treatment|0|||
94728610|NCT03476460|324466104|FG000|Overall Study|Missing laboratory tests|5|||
94368623|NCT01954082|323136500|FG001|Overall Study|Adverse Event|4|||
94728611|NCT03476460|324466105|FG001|Overall Study|Missing laboratory tests|5|||
94728612|NCT03476460|324466104|FG000|Overall Study|Adverse Event|0|||
94728613|NCT03476460|324466105|FG001|Overall Study|Adverse Event|1|||
94728614|NCT05746455|324466106|FG000|Overall Study|Discharged from Clinical Service|1|||
94728615|NCT05746455|324466106|FG000|Overall Study|Lost to Follow-up|1|||
94728616|NCT04195698|324466107|FG000|Overall Study|Adverse Event|4|||
94728617|NCT04195698|324466108|FG001|Overall Study|Adverse Event|11|||
94728618|NCT04195698|324466107|FG000|Overall Study|Withdrawal by Subject|9|||
94728619|NCT04195698|324466108|FG001|Overall Study|Withdrawal by Subject|10|||
94728620|NCT04195698|324466107|FG000|Overall Study|Lost to Follow-up|5|||
94728621|NCT04195698|324466108|FG001|Overall Study|Lost to Follow-up|4|||
94728622|NCT04195698|324466107|FG000|Overall Study|Lack of Efficacy|2|||
94728623|NCT04195698|324466108|FG001|Overall Study|Lack of Efficacy|10|||
94728624|NCT04195698|324466107|FG000|Overall Study|Other|5|||
94728625|NCT04195698|324466108|FG001|Overall Study|Other|4|||
94728626|NCT00433329|324466109|FG000|Overall Study|Adverse Event|9|||
94728627|NCT00433329|324466109|FG000|Overall Study|Death|4|||
94728628|NCT00433329|324466109|FG000|Overall Study|Withdrew consent|3|||
94728629|NCT00433329|324466109|FG000|Overall Study|Discontinued sildenafil|2|||
94728630|NCT00433329|324466109|FG000|Overall Study|Moved out of state|1|||
94728631|NCT00433329|324466109|FG000|Overall Study|Lost to Follow-up|1|||
94728632|NCT00433329|324466109|FG000|Overall Study|Physician Decision|1|||
94728633|NCT01098812|324466110|FG000|Overall Study|Death|2|||
94728634|NCT01098812|324466111|FG001|Overall Study|Death|0|||
94728635|NCT01098812|324466112|FG002|Overall Study|Death|1|||
94728636|NCT01098812|324466110|FG000|Overall Study|Lost to Follow-up|0|||
94728637|NCT01098812|324466111|FG001|Overall Study|Lost to Follow-up|1|||
94728638|NCT01098812|324466112|FG002|Overall Study|Lost to Follow-up|0|||
94728639|NCT04908722|324466113|FG000|Overall Study|Protocol deviation|1|||
94728640|NCT04908722|324466114|FG001|Overall Study|Protocol deviation|0|||
94728641|NCT04908722|324466115|FG002|Overall Study|Protocol deviation|0|||
94728642|NCT04908722|324466116|FG003|Overall Study|Protocol deviation|0|||
94728643|NCT04908722|324466117|FG004|Overall Study|Protocol deviation|0|||
94728644|NCT04908722|324466118|FG005|Overall Study|Protocol deviation|1|||
94728645|NCT04908722|324466113|FG000|Overall Study|Lost to Follow-up|33|||
94728646|NCT04908722|324466114|FG001|Overall Study|Lost to Follow-up|33|||
94728647|NCT04908722|324466115|FG002|Overall Study|Lost to Follow-up|36|||
94728648|NCT04908722|324466116|FG003|Overall Study|Lost to Follow-up|30|||
94728649|NCT04908722|324466117|FG004|Overall Study|Lost to Follow-up|32|||
94728650|NCT04908722|324466118|FG005|Overall Study|Lost to Follow-up|34|||
94728651|NCT04908722|324466113|FG000|Overall Study|Physician Decision|1|||
94728652|NCT04908722|324466114|FG001|Overall Study|Physician Decision|1|||
94728653|NCT04908722|324466115|FG002|Overall Study|Physician Decision|1|||
94728654|NCT04908722|324466116|FG003|Overall Study|Physician Decision|2|||
94728655|NCT04908722|324466117|FG004|Overall Study|Physician Decision|0|||
94728656|NCT04908722|324466118|FG005|Overall Study|Physician Decision|0|||
94728657|NCT04908722|324466113|FG000|Overall Study|Death|1|||
94728658|NCT04908722|324466114|FG001|Overall Study|Death|0|||
94728659|NCT04908722|324466115|FG002|Overall Study|Death|0|||
94728660|NCT04908722|324466116|FG003|Overall Study|Death|0|||
94728661|NCT04908722|324466117|FG004|Overall Study|Death|0|||
94728662|NCT04908722|324466118|FG005|Overall Study|Death|1|||
94728663|NCT04908722|324466113|FG000|Overall Study|Withdrawal by Subject|12|||
94728664|NCT04908722|324466114|FG001|Overall Study|Withdrawal by Subject|8|||
94728665|NCT04908722|324466115|FG002|Overall Study|Withdrawal by Subject|7|||
94728666|NCT04908722|324466116|FG003|Overall Study|Withdrawal by Subject|6|||
94728667|NCT04908722|324466117|FG004|Overall Study|Withdrawal by Subject|12|||
94728668|NCT04908722|324466118|FG005|Overall Study|Withdrawal by Subject|14|||
94728669|NCT04908722|324466113|FG000|Overall Study|Other|3|||
94728670|NCT04908722|324466114|FG001|Overall Study|Other|1|||
94728671|NCT04908722|324466115|FG002|Overall Study|Other|3|||
94728672|NCT04908722|324466116|FG003|Overall Study|Other|2|||
94728673|NCT04908722|324466117|FG004|Overall Study|Other|4|||
94728674|NCT04908722|324466118|FG005|Overall Study|Other|1|||
94728675|NCT04908722|324466113|FG000|Overall Study|Initiated prohibited medication|0|||
94728676|NCT04908722|324466114|FG001|Overall Study|Initiated prohibited medication|0|||
94728677|NCT04908722|324466115|FG002|Overall Study|Initiated prohibited medication|0|||
94728678|NCT04908722|324466116|FG003|Overall Study|Initiated prohibited medication|1|||
94728679|NCT04908722|324466117|FG004|Overall Study|Initiated prohibited medication|0|||
94728680|NCT04908722|324466118|FG005|Overall Study|Initiated prohibited medication|1|||
94728681|NCT04908722|324466113|FG000|Overall Study|Randomized but not vaccinated|3|||
94728682|NCT04908722|324466114|FG001|Overall Study|Randomized but not vaccinated|1|||
94728683|NCT04908722|324466115|FG002|Overall Study|Randomized but not vaccinated|2|||
94728684|NCT04908722|324466116|FG003|Overall Study|Randomized but not vaccinated|2|||
94728685|NCT04908722|324466117|FG004|Overall Study|Randomized but not vaccinated|3|||
94728686|NCT04908722|324466118|FG005|Overall Study|Randomized but not vaccinated|4|||
94368624|NCT01954082|323136499|FG000|Overall Study|Intolerance|0|||
94728687|NCT01369355|324466123|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
94728688|NCT01369355|324466124|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
94728689|NCT01369355|324466125|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
94728690|NCT01369355|324466126|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
94368625|NCT01954082|323136500|FG001|Overall Study|Intolerance|1|||
94728691|NCT01369355|324466127|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
94728692|NCT01369355|324466128|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
94728693|NCT01369355|324466129|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
94728694|NCT01369355|324466130|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
94728695|NCT01369355|324466131|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
94728696|NCT01369355|324466123|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
94728697|NCT01369355|324466124|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
94728698|NCT01369355|324466125|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
94728699|NCT01369355|324466126|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
94728700|NCT01369355|324466127|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
94728701|NCT01369355|324466128|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
94728702|NCT01369355|324466129|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
94728703|NCT01369355|324466130|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
94728704|NCT01369355|324466131|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
94728705|NCT01369355|324466123|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
94728706|NCT01369355|324466124|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
94728707|NCT01369355|324466125|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
94728708|NCT01369355|324466126|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
94728709|NCT01369355|324466127|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
94728710|NCT01369355|324466128|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
94728711|NCT01369355|324466129|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
94728712|NCT01369355|324466130|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
94728713|NCT01369355|324466131|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
94728714|NCT01369355|324466123|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
94728715|NCT01369355|324466124|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
94728716|NCT01369355|324466125|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
94728717|NCT01369355|324466126|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
94728718|NCT01369355|324466127|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
94728719|NCT01369355|324466128|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
94728720|NCT01369355|324466129|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
94728721|NCT01369355|324466130|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
94728722|NCT01369355|324466131|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
94728723|NCT01369355|324466123|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
94728724|NCT01369355|324466124|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
94728725|NCT01369355|324466125|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
94728726|NCT01369355|324466126|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
94728727|NCT01369355|324466127|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
94728728|NCT01369355|324466128|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
94728729|NCT01369355|324466129|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
94728730|NCT01369355|324466130|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
94728731|NCT01369355|324466131|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
94728732|NCT01369355|324466123|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
94728733|NCT01369355|324466124|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
94728734|NCT01369355|324466125|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
94728735|NCT01369355|324466126|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
94728736|NCT01369355|324466127|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
94728737|NCT01369355|324466128|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
94728738|NCT01369355|324466129|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
94728739|NCT01369355|324466130|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
94728740|NCT01369355|324466131|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
94728741|NCT01369355|324466123|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
94728742|NCT01369355|324466124|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
94728743|NCT01369355|324466125|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
94728744|NCT01369355|324466126|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
94728745|NCT01369355|324466127|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
94728746|NCT01369355|324466128|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
94728747|NCT01369355|324466129|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
94728748|NCT01369355|324466130|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
94728749|NCT01369355|324466131|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
94368626|NCT01954082|323136499|FG000|Overall Study|Non-compliance|6|||
94368627|NCT01954082|323136500|FG001|Overall Study|Non-compliance|4|||
94273554|NCT00432042|322793771|FG002|Overall Study|Withdrawal by Subject|2|||
94273555|NCT00432042|322793769|FG000|Overall Study|Lost to Follow-up|5|||
94273556|NCT00432042|322793770|FG001|Overall Study|Lost to Follow-up|1|||
94728750|NCT01369355|324466123|FG000|Long-term Extension (Week 44-272)|Death|0|||
94728751|NCT01369355|324466124|FG001|Long-term Extension (Week 44-272)|Death|0|||
94728752|NCT01369355|324466125|FG002|Long-term Extension (Week 44-272)|Death|0|||
94728753|NCT01369355|324466126|FG003|Long-term Extension (Week 44-272)|Death|0|||
94728754|NCT01369355|324466127|FG004|Long-term Extension (Week 44-272)|Death|0|||
94273557|NCT00432042|322793771|FG002|Overall Study|Lost to Follow-up|0|||
94467402|NCT00415597|323500560|FG000|Treatment|Lack of Efficacy|39|||
94467403|NCT00415597|323500560|FG000|Treatment|Protocol Violation|67|||
94728755|NCT01369355|324466128|FG005|Long-term Extension (Week 44-272)|Death|0|||
94728756|NCT01369355|324466129|FG006|Long-term Extension (Week 44-272)|Death|0|||
94728757|NCT01369355|324466130|FG007|Long-term Extension (Week 44-272)|Death|1|||
94728758|NCT01369355|324466131|FG008|Long-term Extension (Week 44-272)|Death|3|||
94728759|NCT01369355|324466123|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
94728760|NCT01369355|324466124|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
94728761|NCT01369355|324466125|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
94728762|NCT01369355|324466126|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
94728763|NCT01369355|324466127|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
94728764|NCT01369355|324466128|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
94728765|NCT01369355|324466129|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
94728766|NCT01369355|324466130|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
94728767|NCT01369355|324466131|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
94728768|NCT01369355|324466123|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
94728769|NCT01369355|324466124|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
94728770|NCT01369355|324466125|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
94728771|NCT01369355|324466126|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
94728772|NCT01369355|324466127|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
94728773|NCT01369355|324466128|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
94728774|NCT01369355|324466129|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
94728775|NCT01369355|324466130|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
94728776|NCT01369355|324466131|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
94728777|NCT01369355|324466123|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
94728778|NCT01369355|324466124|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
94728779|NCT01369355|324466125|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
94728780|NCT01369355|324466126|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
94728781|NCT01369355|324466127|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
94728782|NCT01369355|324466128|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
94728783|NCT01369355|324466129|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
94728784|NCT01369355|324466130|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
94728785|NCT01369355|324466131|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
94728786|NCT01369355|324466123|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
94728787|NCT01369355|324466124|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
94728788|NCT01369355|324466125|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
94728789|NCT01369355|324466126|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
94728790|NCT01369355|324466127|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
94728791|NCT01369355|324466128|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
94728792|NCT01369355|324466129|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
94728793|NCT01369355|324466130|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
94728794|NCT01369355|324466131|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
94728795|NCT01369355|324466123|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
94728796|NCT01369355|324466124|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
94728797|NCT01369355|324466125|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
94728798|NCT01369355|324466126|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
94728799|NCT01369355|324466127|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
94728800|NCT01369355|324466128|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
94728801|NCT01369355|324466129|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
94728802|NCT01369355|324466130|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
94728803|NCT01369355|324466131|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
94728804|NCT01369355|324466123|FG000|Long-term Extension (Week 44-272)|Other|0|||
94728805|NCT01369355|324466124|FG001|Long-term Extension (Week 44-272)|Other|0|||
94728806|NCT01369355|324466125|FG002|Long-term Extension (Week 44-272)|Other|0|||
94728807|NCT01369355|324466126|FG003|Long-term Extension (Week 44-272)|Other|0|||
94728808|NCT01369355|324466127|FG004|Long-term Extension (Week 44-272)|Other|0|||
94728809|NCT01369355|324466128|FG005|Long-term Extension (Week 44-272)|Other|0|||
94728810|NCT01369355|324466129|FG006|Long-term Extension (Week 44-272)|Other|110|||
94273558|NCT04143009|322793772|FG000|Pilot Trial|Lost to Follow-up|0|||
94467404|NCT00415597|323500560|FG000|Treatment|Physician Decision|3|||
94273559|NCT04143009|322793773|FG001|Pilot Trial|Lost to Follow-up|1|||
94273560|NCT04143009|322793774|FG002|Pilot Trial|Lost to Follow-up|1|||
94273561|NCT00492752|322793779|FG000|Double Blind Treatment|Death|13|||
94273562|NCT00492752|322793780|FG001|Double Blind Treatment|Death|0|||
94273563|NCT00492752|322793781|FG002|Double Blind Treatment|Death|2|||
94273564|NCT00492752|322793782|FG003|Double Blind Treatment|Death|0|||
94273565|NCT00492752|322793779|FG000|Double Blind Treatment|Adverse Event|1|||
94728811|NCT01369355|324466130|FG007|Long-term Extension (Week 44-272)|Other|9|||
94728812|NCT01369355|324466131|FG008|Long-term Extension (Week 44-272)|Other|17|||
94728813|NCT03339713|324466135|FG000|Overall Study|Lost to Follow-up|2|||
94728814|NCT03339713|324466136|FG001|Overall Study|Lost to Follow-up|1|||
94728815|NCT03339713|324466135|FG000|Overall Study|Protocol Violation|1|||
94728816|NCT03339713|324466136|FG001|Overall Study|Protocol Violation|0|||
94728817|NCT03339713|324466135|FG000|Overall Study|Withdrawal by Subject|1|||
94728818|NCT03339713|324466136|FG001|Overall Study|Withdrawal by Subject|1|||
94728819|NCT01959425|324466137|FG000|Overall Study|Withdrawal by Subject|5|||
94728820|NCT01959425|324466138|FG001|Overall Study|Withdrawal by Subject|4|||
94728821|NCT01959425|324466137|FG000|Overall Study|Lost to Follow-up|1|||
94728822|NCT01959425|324466138|FG001|Overall Study|Lost to Follow-up|0|||
94728823|NCT01959425|324466137|FG000|Overall Study|Discontinued Subjects|6|||
94728824|NCT01959425|324466138|FG001|Overall Study|Discontinued Subjects|4|||
94728825|NCT01902173|324466149|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
94728826|NCT01902173|324466150|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
94728827|NCT01902173|324466151|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
94728828|NCT01902173|324466152|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
94728829|NCT01902173|324466153|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
94728830|NCT01902173|324466154|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
94728831|NCT01902173|324466149|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
94728832|NCT01902173|324466150|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
94728833|NCT01902173|324466151|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
94728834|NCT01902173|324466152|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
94728835|NCT01902173|324466153|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
94728836|NCT01902173|324466154|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
94728837|NCT01902173|324466149|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
94728838|NCT01902173|324466150|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
94728839|NCT01902173|324466151|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
94728840|NCT01902173|324466152|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
94728841|NCT01902173|324466153|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
94728842|NCT01902173|324466154|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
94728843|NCT01902173|324466149|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
94728844|NCT01902173|324466150|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
94728845|NCT01902173|324466151|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
94728846|NCT01902173|324466152|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
94728847|NCT01902173|324466153|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
94728848|NCT01902173|324466154|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
94728849|NCT01902173|324466149|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
94728850|NCT01902173|324466150|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
94728851|NCT01902173|324466151|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
94728852|NCT01902173|324466152|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
94728853|NCT01902173|324466153|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
94728854|NCT01902173|324466154|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
94728855|NCT01902173|324466149|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
94728856|NCT01902173|324466150|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
94728857|NCT01902173|324466151|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
94728858|NCT01902173|324466152|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
94728859|NCT01902173|324466153|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
94728860|NCT01902173|324466154|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
94728861|NCT01902173|324466149|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
94728862|NCT01902173|324466150|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
94728863|NCT01902173|324466151|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
94728864|NCT01902173|324466152|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
94728865|NCT01902173|324466153|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
94728866|NCT01902173|324466154|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
94728867|NCT01902173|324466149|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
94728868|NCT01902173|324466150|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
94728869|NCT01902173|324466151|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
94728870|NCT01902173|324466152|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
94728871|NCT01902173|324466153|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
94273566|NCT00492752|322793780|FG001|Double Blind Treatment|Adverse Event|0|||
94273567|NCT00492752|322793781|FG002|Double Blind Treatment|Adverse Event|0|||
94728872|NCT01902173|324466154|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
94728873|NCT01902173|324466149|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
94728874|NCT01902173|324466150|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
94728875|NCT01902173|324466151|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
94728876|NCT01902173|324466152|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
94728877|NCT01902173|324466153|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
94728878|NCT01902173|324466154|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
94728879|NCT01902173|324466149|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
94728880|NCT01902173|324466150|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
94728881|NCT01902173|324466151|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
94728882|NCT01902173|324466152|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
94728883|NCT01902173|324466153|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
94728884|NCT01902173|324466154|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
94728885|NCT01902173|324466149|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
94728886|NCT01902173|324466150|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
94728887|NCT01902173|324466151|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
94728888|NCT01902173|324466152|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
94728889|NCT01902173|324466153|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
94728890|NCT01902173|324466154|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
94728891|NCT01902173|324466149|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
94728892|NCT01902173|324466150|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
94728893|NCT01902173|324466151|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
94728894|NCT01902173|324466152|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
94728895|NCT01902173|324466153|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
94728896|NCT01902173|324466154|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
94728897|NCT01902173|324466149|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
94728898|NCT01902173|324466150|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
94728899|NCT01902173|324466151|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
94728900|NCT01902173|324466152|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
94728901|NCT01902173|324466153|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
94728902|NCT01902173|324466154|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
94728903|NCT01902173|324466149|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
94728904|NCT01902173|324466150|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
94728905|NCT01902173|324466151|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
94728906|NCT01902173|324466152|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
94728907|NCT01902173|324466153|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
94728908|NCT01902173|324466154|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
94728909|NCT02883049|324466156|FG000|Induction|Adverse Event|52|||
94728910|NCT02883049|324466157|FG001|Induction|Adverse Event|2|||
94728911|NCT02883049|324466158|FG002|Induction|Adverse Event|0|||
94728912|NCT02883049|324466159|FG003|Induction|Adverse Event|0|||
94728913|NCT02883049|324466160|FG004|Induction|Adverse Event|0|||
94728914|NCT02883049|324466161|FG005|Induction|Adverse Event|0|||
94728915|NCT02883049|324466162|FG006|Induction|Adverse Event|0|||
94728916|NCT02883049|324466163|FG007|Induction|Adverse Event|0|||
94728917|NCT02883049|324466164|FG008|Induction|Adverse Event|0|||
94728918|NCT02883049|324466165|FG009|Induction|Adverse Event|0|||
94728919|NCT02883049|324466166|FG010|Induction|Adverse Event|0|||
94728920|NCT02883049|324466167|FG011|Induction|Adverse Event|0|||
94728921|NCT02883049|324466168|FG012|Induction|Adverse Event|0|||
94728922|NCT02883049|324466169|FG013|Induction|Adverse Event|0|||
94728923|NCT02883049|324466170|FG014|Induction|Adverse Event|0|||
94728924|NCT02883049|324466171|FG015|Induction|Adverse Event|0|||
94728925|NCT02883049|324466156|FG000|Induction|Death|76|||
94728926|NCT02883049|324466157|FG001|Induction|Death|8|||
94728927|NCT02883049|324466158|FG002|Induction|Death|0|||
94728928|NCT02883049|324466159|FG003|Induction|Death|0|||
94728929|NCT02883049|324466160|FG004|Induction|Death|0|||
94728930|NCT02883049|324466161|FG005|Induction|Death|0|||
94728931|NCT02883049|324466162|FG006|Induction|Death|0|||
94728932|NCT02883049|324466163|FG007|Induction|Death|0|||
94728933|NCT02883049|324466164|FG008|Induction|Death|0|||
94728934|NCT02883049|324466165|FG009|Induction|Death|0|||
94728935|NCT02883049|324466166|FG010|Induction|Death|0|||
94728936|NCT02883049|324466167|FG011|Induction|Death|0|||
94728937|NCT02883049|324466168|FG012|Induction|Death|0|||
94728938|NCT02883049|324466169|FG013|Induction|Death|0|||
94728939|NCT02883049|324466170|FG014|Induction|Death|0|||
94728940|NCT02883049|324466171|FG015|Induction|Death|0|||
94728941|NCT02883049|324466156|FG000|Induction|Lost to Follow-up|2|||
94728942|NCT02883049|324466157|FG001|Induction|Lost to Follow-up|0|||
94728943|NCT02883049|324466158|FG002|Induction|Lost to Follow-up|0|||
94728944|NCT02883049|324466159|FG003|Induction|Lost to Follow-up|0|||
94728945|NCT02883049|324466160|FG004|Induction|Lost to Follow-up|0|||
94728946|NCT02883049|324466161|FG005|Induction|Lost to Follow-up|0|||
94728947|NCT02883049|324466162|FG006|Induction|Lost to Follow-up|0|||
94728948|NCT02883049|324466163|FG007|Induction|Lost to Follow-up|0|||
94728949|NCT02883049|324466164|FG008|Induction|Lost to Follow-up|0|||
94728950|NCT02883049|324466165|FG009|Induction|Lost to Follow-up|0|||
94728951|NCT02883049|324466166|FG010|Induction|Lost to Follow-up|0|||
94728952|NCT02883049|324466167|FG011|Induction|Lost to Follow-up|0|||
94728953|NCT02883049|324466168|FG012|Induction|Lost to Follow-up|0|||
94728954|NCT02883049|324466169|FG013|Induction|Lost to Follow-up|0|||
94728955|NCT02883049|324466170|FG014|Induction|Lost to Follow-up|0|||
94728956|NCT02883049|324466171|FG015|Induction|Lost to Follow-up|0|||
94728957|NCT02883049|324466156|FG000|Induction|Physician Decision|1407|||
94728958|NCT02883049|324466157|FG001|Induction|Physician Decision|8|||
94728959|NCT02883049|324466158|FG002|Induction|Physician Decision|0|||
94728960|NCT02883049|324466159|FG003|Induction|Physician Decision|0|||
94728961|NCT02883049|324466160|FG004|Induction|Physician Decision|0|||
94728962|NCT02883049|324466161|FG005|Induction|Physician Decision|0|||
94728963|NCT02883049|324466162|FG006|Induction|Physician Decision|0|||
94728964|NCT02883049|324466163|FG007|Induction|Physician Decision|0|||
94728965|NCT02883049|324466164|FG008|Induction|Physician Decision|0|||
94728966|NCT02883049|324466165|FG009|Induction|Physician Decision|0|||
94728967|NCT02883049|324466166|FG010|Induction|Physician Decision|0|||
94728968|NCT02883049|324466167|FG011|Induction|Physician Decision|0|||
94728969|NCT02883049|324466168|FG012|Induction|Physician Decision|0|||
94728970|NCT02883049|324466169|FG013|Induction|Physician Decision|0|||
94728971|NCT02883049|324466170|FG014|Induction|Physician Decision|0|||
94728972|NCT02883049|324466171|FG015|Induction|Physician Decision|0|||
94728973|NCT02883049|324466156|FG000|Induction|Protocol Violation|6|||
94728974|NCT02883049|324466157|FG001|Induction|Protocol Violation|0|||
94728975|NCT02883049|324466158|FG002|Induction|Protocol Violation|0|||
94728976|NCT02883049|324466159|FG003|Induction|Protocol Violation|0|||
94728977|NCT02883049|324466160|FG004|Induction|Protocol Violation|0|||
94728978|NCT02883049|324466161|FG005|Induction|Protocol Violation|0|||
94728979|NCT02883049|324466162|FG006|Induction|Protocol Violation|0|||
94728980|NCT02883049|324466163|FG007|Induction|Protocol Violation|0|||
94728981|NCT02883049|324466164|FG008|Induction|Protocol Violation|0|||
94728982|NCT02883049|324466165|FG009|Induction|Protocol Violation|0|||
94728983|NCT02883049|324466166|FG010|Induction|Protocol Violation|0|||
94728984|NCT02883049|324466167|FG011|Induction|Protocol Violation|0|||
94728985|NCT02883049|324466168|FG012|Induction|Protocol Violation|0|||
94728986|NCT02883049|324466169|FG013|Induction|Protocol Violation|0|||
94728987|NCT02883049|324466170|FG014|Induction|Protocol Violation|0|||
94728988|NCT02883049|324466171|FG015|Induction|Protocol Violation|0|||
94728989|NCT02883049|324466156|FG000|Induction|Withdrawal by Subject|6|||
94728990|NCT02883049|324466157|FG001|Induction|Withdrawal by Subject|0|||
94728991|NCT02883049|324466158|FG002|Induction|Withdrawal by Subject|0|||
94728992|NCT02883049|324466159|FG003|Induction|Withdrawal by Subject|0|||
94728993|NCT02883049|324466160|FG004|Induction|Withdrawal by Subject|0|||
94728994|NCT02883049|324466161|FG005|Induction|Withdrawal by Subject|0|||
94728995|NCT02883049|324466162|FG006|Induction|Withdrawal by Subject|0|||
94728996|NCT02883049|324466163|FG007|Induction|Withdrawal by Subject|0|||
94728997|NCT02883049|324466164|FG008|Induction|Withdrawal by Subject|0|||
94728998|NCT02883049|324466165|FG009|Induction|Withdrawal by Subject|0|||
94728999|NCT02883049|324466166|FG010|Induction|Withdrawal by Subject|0|||
94729000|NCT02883049|324466167|FG011|Induction|Withdrawal by Subject|0|||
94729001|NCT02883049|324466168|FG012|Induction|Withdrawal by Subject|0|||
94729002|NCT02883049|324466169|FG013|Induction|Withdrawal by Subject|0|||
94729003|NCT02883049|324466170|FG014|Induction|Withdrawal by Subject|0|||
94729004|NCT02883049|324466171|FG015|Induction|Withdrawal by Subject|0|||
94729005|NCT02883049|324466156|FG000|Induction|Ineligible|35|||
94729006|NCT02883049|324466157|FG001|Induction|Ineligible|1|||
94729007|NCT02883049|324466158|FG002|Induction|Ineligible|0|||
94729008|NCT02883049|324466159|FG003|Induction|Ineligible|0|||
94729009|NCT02883049|324466160|FG004|Induction|Ineligible|0|||
94729010|NCT02883049|324466161|FG005|Induction|Ineligible|0|||
94273568|NCT00492752|322793782|FG003|Double Blind Treatment|Adverse Event|0|||
94273569|NCT00492752|322793779|FG000|Double Blind Treatment|Protocol Violation|0|||
94273570|NCT00492752|322793780|FG001|Double Blind Treatment|Protocol Violation|0|||
94729011|NCT02883049|324466162|FG006|Induction|Ineligible|0|||
94729012|NCT02883049|324466163|FG007|Induction|Ineligible|0|||
94729013|NCT02883049|324466164|FG008|Induction|Ineligible|0|||
94729014|NCT02883049|324466165|FG009|Induction|Ineligible|0|||
94729015|NCT02883049|324466166|FG010|Induction|Ineligible|0|||
94729016|NCT02883049|324466167|FG011|Induction|Ineligible|0|||
94729017|NCT02883049|324466168|FG012|Induction|Ineligible|0|||
94729018|NCT02883049|324466169|FG013|Induction|Ineligible|0|||
94273571|NCT00492752|322793781|FG002|Double Blind Treatment|Protocol Violation|1|||
94729019|NCT02883049|324466170|FG014|Induction|Ineligible|0|||
94729020|NCT02883049|324466171|FG015|Induction|Ineligible|0|||
94729021|NCT02883049|324466156|FG000|Induction|Refusal of further protocol therapy|466|||
94729022|NCT02883049|324466157|FG001|Induction|Refusal of further protocol therapy|2|||
94729023|NCT02883049|324466158|FG002|Induction|Refusal of further protocol therapy|0|||
94729024|NCT02883049|324466159|FG003|Induction|Refusal of further protocol therapy|0|||
94729025|NCT02883049|324466160|FG004|Induction|Refusal of further protocol therapy|0|||
94729026|NCT02883049|324466161|FG005|Induction|Refusal of further protocol therapy|0|||
94729027|NCT02883049|324466162|FG006|Induction|Refusal of further protocol therapy|0|||
94729028|NCT02883049|324466163|FG007|Induction|Refusal of further protocol therapy|0|||
94729029|NCT02883049|324466164|FG008|Induction|Refusal of further protocol therapy|0|||
94729030|NCT02883049|324466165|FG009|Induction|Refusal of further protocol therapy|0|||
94729031|NCT02883049|324466166|FG010|Induction|Refusal of further protocol therapy|0|||
94729032|NCT02883049|324466167|FG011|Induction|Refusal of further protocol therapy|0|||
94729033|NCT02883049|324466168|FG012|Induction|Refusal of further protocol therapy|0|||
94729034|NCT02883049|324466169|FG013|Induction|Refusal of further protocol therapy|0|||
94729035|NCT02883049|324466170|FG014|Induction|Refusal of further protocol therapy|0|||
94729036|NCT02883049|324466171|FG015|Induction|Refusal of further protocol therapy|0|||
94729037|NCT02883049|324466156|FG000|Induction|Identified as Ph+ patients|279|||
94729038|NCT02883049|324466157|FG001|Induction|Identified as Ph+ patients|1|||
94729039|NCT02883049|324466158|FG002|Induction|Identified as Ph+ patients|0|||
94729040|NCT02883049|324466159|FG003|Induction|Identified as Ph+ patients|0|||
94729041|NCT02883049|324466160|FG004|Induction|Identified as Ph+ patients|0|||
94729042|NCT02883049|324466161|FG005|Induction|Identified as Ph+ patients|0|||
94729043|NCT02883049|324466162|FG006|Induction|Identified as Ph+ patients|0|||
94729044|NCT02883049|324466163|FG007|Induction|Identified as Ph+ patients|0|||
94729045|NCT02883049|324466164|FG008|Induction|Identified as Ph+ patients|0|||
94729046|NCT02883049|324466165|FG009|Induction|Identified as Ph+ patients|0|||
94729047|NCT02883049|324466166|FG010|Induction|Identified as Ph+ patients|0|||
94729048|NCT02883049|324466167|FG011|Induction|Identified as Ph+ patients|0|||
94729049|NCT02883049|324466168|FG012|Induction|Identified as Ph+ patients|0|||
94729050|NCT02883049|324466169|FG013|Induction|Identified as Ph+ patients|0|||
94729051|NCT02883049|324466170|FG014|Induction|Identified as Ph+ patients|0|||
94729052|NCT02883049|324466171|FG015|Induction|Identified as Ph+ patients|0|||
94729053|NCT02883049|324466156|FG000|Induction|M3 Marrow at Day29|8|||
94729054|NCT02883049|324466157|FG001|Induction|M3 Marrow at Day29|1|||
94729055|NCT02883049|324466158|FG002|Induction|M3 Marrow at Day29|0|||
94729056|NCT02883049|324466159|FG003|Induction|M3 Marrow at Day29|0|||
94729057|NCT02883049|324466160|FG004|Induction|M3 Marrow at Day29|0|||
94729058|NCT02883049|324466161|FG005|Induction|M3 Marrow at Day29|0|||
94729059|NCT02883049|324466162|FG006|Induction|M3 Marrow at Day29|0|||
94729060|NCT02883049|324466163|FG007|Induction|M3 Marrow at Day29|0|||
94729061|NCT02883049|324466164|FG008|Induction|M3 Marrow at Day29|0|||
94729062|NCT02883049|324466165|FG009|Induction|M3 Marrow at Day29|0|||
94729063|NCT02883049|324466166|FG010|Induction|M3 Marrow at Day29|0|||
94729064|NCT02883049|324466167|FG011|Induction|M3 Marrow at Day29|0|||
94729065|NCT02883049|324466168|FG012|Induction|M3 Marrow at Day29|0|||
94729066|NCT02883049|324466169|FG013|Induction|M3 Marrow at Day29|0|||
94729067|NCT02883049|324466170|FG014|Induction|M3 Marrow at Day29|0|||
94729068|NCT02883049|324466171|FG015|Induction|M3 Marrow at Day29|0|||
94729069|NCT02883049|324466156|FG000|Induction|Inevaluable|33|||
94729070|NCT02883049|324466157|FG001|Induction|Inevaluable|1|||
94729071|NCT02883049|324466158|FG002|Induction|Inevaluable|0|||
94729072|NCT02883049|324466159|FG003|Induction|Inevaluable|0|||
94729073|NCT02883049|324466160|FG004|Induction|Inevaluable|0|||
94729074|NCT02883049|324466161|FG005|Induction|Inevaluable|0|||
94729075|NCT02883049|324466162|FG006|Induction|Inevaluable|0|||
94729076|NCT02883049|324466163|FG007|Induction|Inevaluable|0|||
94729077|NCT02883049|324466164|FG008|Induction|Inevaluable|0|||
94729078|NCT02883049|324466165|FG009|Induction|Inevaluable|0|||
94729079|NCT02883049|324466166|FG010|Induction|Inevaluable|0|||
94729080|NCT02883049|324466167|FG011|Induction|Inevaluable|0|||
94729081|NCT02883049|324466168|FG012|Induction|Inevaluable|0|||
94729082|NCT02883049|324466169|FG013|Induction|Inevaluable|0|||
94729083|NCT02883049|324466170|FG014|Induction|Inevaluable|0|||
94729084|NCT02883049|324466171|FG015|Induction|Inevaluable|0|||
94729085|NCT02883049|324466156|FG000|Induction|Identified as VHR at end of Induction|244|||
94729086|NCT02883049|324466157|FG001|Induction|Identified as VHR at end of Induction|0|||
94729087|NCT02883049|324466158|FG002|Induction|Identified as VHR at end of Induction|0|||
94729088|NCT02883049|324466159|FG003|Induction|Identified as VHR at end of Induction|0|||
94729089|NCT02883049|324466160|FG004|Induction|Identified as VHR at end of Induction|0|||
94729090|NCT02883049|324466161|FG005|Induction|Identified as VHR at end of Induction|0|||
94273572|NCT00492752|322793782|FG003|Double Blind Treatment|Protocol Violation|0|||
94273573|NCT00492752|322793779|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
94273574|NCT00492752|322793780|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
94273575|NCT00492752|322793781|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
94273576|NCT00492752|322793782|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
94273577|NCT00492752|322793779|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
94729091|NCT02883049|324466162|FG006|Induction|Identified as VHR at end of Induction|0|||
94729092|NCT02883049|324466163|FG007|Induction|Identified as VHR at end of Induction|0|||
94729093|NCT02883049|324466164|FG008|Induction|Identified as VHR at end of Induction|0|||
94729094|NCT02883049|324466165|FG009|Induction|Identified as VHR at end of Induction|0|||
94729095|NCT02883049|324466166|FG010|Induction|Identified as VHR at end of Induction|0|||
94729096|NCT02883049|324466167|FG011|Induction|Identified as VHR at end of Induction|0|||
94729097|NCT02883049|324466168|FG012|Induction|Identified as VHR at end of Induction|0|||
94273578|NCT00492752|322793780|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
94273579|NCT00492752|322793781|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
94273580|NCT00492752|322793782|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
94273581|NCT00492752|322793779|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
94273582|NCT00492752|322793780|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
94273583|NCT00492752|322793781|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
94273584|NCT00492752|322793782|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
94273585|NCT00492752|322793779|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
94273586|NCT00492752|322793780|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
94273587|NCT00492752|322793781|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
94273588|NCT00492752|322793782|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
94273589|NCT00492752|322793779|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
94273590|NCT00492752|322793780|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
94273591|NCT00492752|322793781|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
94273592|NCT00492752|322793782|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
94273593|NCT00492752|322793779|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
94273594|NCT00492752|322793780|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
94273595|NCT00492752|322793781|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
94273596|NCT00492752|322793782|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
94273597|NCT00492752|322793779|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
94273598|NCT00492752|322793780|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
94273599|NCT00492752|322793781|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
94273600|NCT00492752|322793782|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
94273601|NCT00492752|322793779|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
94273602|NCT00492752|322793780|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
94273603|NCT00492752|322793781|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
94273604|NCT00492752|322793782|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
94273605|NCT03803059|322793783|FG000|Overall Study|Protocol Violation|2|||
94273606|NCT03803059|322793783|FG000|Overall Study|Lost to Follow-up|1|||
94273607|NCT01033825|322793784|FG000|Overall Study|Withdrawal by Subject|2|||
94273608|NCT01033825|322793785|FG001|Overall Study|Withdrawal by Subject|3|||
94273609|NCT01033825|322793786|FG002|Overall Study|Withdrawal by Subject|2|||
94273610|NCT01033825|322793787|FG003|Overall Study|Withdrawal by Subject|1|||
94273611|NCT01033825|322793788|FG004|Overall Study|Withdrawal by Subject|1|||
94273612|NCT01033825|322793789|FG005|Overall Study|Withdrawal by Subject|0|||
94273613|NCT01033825|322793790|FG006|Overall Study|Withdrawal by Subject|0|||
94273614|NCT01033825|322793784|FG000|Overall Study|Adverse Event|0|||
94273615|NCT01033825|322793785|FG001|Overall Study|Adverse Event|0|||
94273616|NCT01033825|322793786|FG002|Overall Study|Adverse Event|0|||
94273617|NCT01033825|322793787|FG003|Overall Study|Adverse Event|1|||
94273618|NCT01033825|322793788|FG004|Overall Study|Adverse Event|0|||
94273619|NCT01033825|322793789|FG005|Overall Study|Adverse Event|0|||
94273620|NCT01033825|322793790|FG006|Overall Study|Adverse Event|0|||
94729098|NCT02883049|324466169|FG013|Induction|Identified as VHR at end of Induction|0|||
94729099|NCT02883049|324466170|FG014|Induction|Identified as VHR at end of Induction|0|||
94729100|NCT02883049|324466171|FG015|Induction|Identified as VHR at end of Induction|0|||
94729101|NCT02883049|324466156|FG000|Induction|Moved to another non-COG institution|3|||
94729102|NCT02883049|324466157|FG001|Induction|Moved to another non-COG institution|0|||
94729103|NCT02883049|324466158|FG002|Induction|Moved to another non-COG institution|0|||
94729104|NCT02883049|324466159|FG003|Induction|Moved to another non-COG institution|0|||
94729105|NCT02883049|324466160|FG004|Induction|Moved to another non-COG institution|0|||
94729106|NCT02883049|324466161|FG005|Induction|Moved to another non-COG institution|0|||
94729107|NCT02883049|324466162|FG006|Induction|Moved to another non-COG institution|0|||
94729108|NCT02883049|324466163|FG007|Induction|Moved to another non-COG institution|0|||
94729109|NCT02883049|324466164|FG008|Induction|Moved to another non-COG institution|0|||
94729110|NCT02883049|324466165|FG009|Induction|Moved to another non-COG institution|0|||
94729111|NCT02883049|324466166|FG010|Induction|Moved to another non-COG institution|0|||
94729112|NCT02883049|324466167|FG011|Induction|Moved to another non-COG institution|0|||
94729113|NCT02883049|324466168|FG012|Induction|Moved to another non-COG institution|0|||
94729114|NCT02883049|324466169|FG013|Induction|Moved to another non-COG institution|0|||
94729115|NCT02883049|324466170|FG014|Induction|Moved to another non-COG institution|0|||
94729116|NCT02883049|324466171|FG015|Induction|Moved to another non-COG institution|0|||
94729117|NCT02883049|324466156|FG000|Induction|Randomization closed|41|||
94729118|NCT02883049|324466157|FG001|Induction|Randomization closed|0|||
94729119|NCT02883049|324466158|FG002|Induction|Randomization closed|0|||
94729120|NCT02883049|324466159|FG003|Induction|Randomization closed|0|||
94729121|NCT02883049|324466160|FG004|Induction|Randomization closed|0|||
94729122|NCT02883049|324466161|FG005|Induction|Randomization closed|0|||
94729123|NCT02883049|324466162|FG006|Induction|Randomization closed|0|||
94729124|NCT02883049|324466163|FG007|Induction|Randomization closed|0|||
94273621|NCT01033825|322793784|FG000|Overall Study|Protocol Violation|1|||
94273622|NCT01033825|322793785|FG001|Overall Study|Protocol Violation|0|||
94273623|NCT01033825|322793786|FG002|Overall Study|Protocol Violation|0|||
94273624|NCT01033825|322793787|FG003|Overall Study|Protocol Violation|0|||
94273625|NCT01033825|322793788|FG004|Overall Study|Protocol Violation|0|||
94273626|NCT01033825|322793789|FG005|Overall Study|Protocol Violation|0|||
94273627|NCT01033825|322793790|FG006|Overall Study|Protocol Violation|0|||
94273628|NCT01033825|322793784|FG000|Overall Study|Other|0|||
94729125|NCT02883049|324466164|FG008|Induction|Randomization closed|0|||
94729126|NCT02883049|324466165|FG009|Induction|Randomization closed|0|||
94729127|NCT02883049|324466166|FG010|Induction|Randomization closed|0|||
94729128|NCT02883049|324466167|FG011|Induction|Randomization closed|0|||
94729129|NCT02883049|324466168|FG012|Induction|Randomization closed|0|||
94273629|NCT01033825|322793785|FG001|Overall Study|Other|0|||
94273630|NCT01033825|322793786|FG002|Overall Study|Other|0|||
94273631|NCT01033825|322793787|FG003|Overall Study|Other|0|||
94273632|NCT01033825|322793788|FG004|Overall Study|Other|1|||
94273633|NCT01033825|322793789|FG005|Overall Study|Other|0|||
94273634|NCT01033825|322793790|FG006|Overall Study|Other|0|||
94273635|NCT03116698|322793791|FG000|Overall Study|Adverse Event|1|||
94273636|NCT03116698|322793792|FG001|Overall Study|Adverse Event|1|||
94273637|NCT03116698|322793793|FG002|Overall Study|Adverse Event|1|||
94729130|NCT02883049|324466169|FG013|Induction|Randomization closed|0|||
94729131|NCT02883049|324466170|FG014|Induction|Randomization closed|0|||
94729132|NCT02883049|324466171|FG015|Induction|Randomization closed|0|||
94729133|NCT02883049|324466156|FG000|Induction|MRD negative|36|||
94729134|NCT02883049|324466157|FG001|Induction|MRD negative|0|||
94729135|NCT02883049|324466158|FG002|Induction|MRD negative|0|||
94729136|NCT02883049|324466159|FG003|Induction|MRD negative|0|||
94729137|NCT02883049|324466160|FG004|Induction|MRD negative|0|||
94729138|NCT02883049|324466161|FG005|Induction|MRD negative|0|||
94729139|NCT02883049|324466162|FG006|Induction|MRD negative|0|||
94729140|NCT02883049|324466163|FG007|Induction|MRD negative|0|||
94729141|NCT02883049|324466164|FG008|Induction|MRD negative|0|||
94729142|NCT02883049|324466165|FG009|Induction|MRD negative|0|||
94729143|NCT02883049|324466166|FG010|Induction|MRD negative|0|||
94729144|NCT02883049|324466167|FG011|Induction|MRD negative|0|||
94729145|NCT02883049|324466168|FG012|Induction|MRD negative|0|||
94729146|NCT02883049|324466169|FG013|Induction|MRD negative|0|||
94729147|NCT02883049|324466170|FG014|Induction|MRD negative|0|||
94729148|NCT02883049|324466171|FG015|Induction|MRD negative|0|||
94729149|NCT02883049|324466156|FG000|Induction|Identified as HR patients|165|||
94729150|NCT02883049|324466157|FG001|Induction|Identified as HR patients|0|||
94729151|NCT02883049|324466158|FG002|Induction|Identified as HR patients|0|||
94729152|NCT02883049|324466159|FG003|Induction|Identified as HR patients|0|||
94729153|NCT02883049|324466160|FG004|Induction|Identified as HR patients|0|||
94729154|NCT02883049|324466161|FG005|Induction|Identified as HR patients|0|||
94729155|NCT02883049|324466162|FG006|Induction|Identified as HR patients|0|||
94729156|NCT02883049|324466163|FG007|Induction|Identified as HR patients|0|||
94729157|NCT02883049|324466164|FG008|Induction|Identified as HR patients|0|||
94729158|NCT02883049|324466165|FG009|Induction|Identified as HR patients|0|||
94729159|NCT02883049|324466166|FG010|Induction|Identified as HR patients|0|||
94729160|NCT02883049|324466167|FG011|Induction|Identified as HR patients|0|||
94729161|NCT02883049|324466168|FG012|Induction|Identified as HR patients|0|||
94273638|NCT03116698|322793794|FG003|Overall Study|Adverse Event|0|||
94273639|NCT03116698|322793791|FG000|Overall Study|Withdrawal by Subject|1|||
94273640|NCT03116698|322793792|FG001|Overall Study|Withdrawal by Subject|4|||
94729162|NCT02883049|324466169|FG013|Induction|Identified as HR patients|0|||
94729163|NCT02883049|324466170|FG014|Induction|Identified as HR patients|0|||
94729164|NCT02883049|324466171|FG015|Induction|Identified as HR patients|0|||
94273641|NCT03116698|322793793|FG002|Overall Study|Withdrawal by Subject|5|||
94273642|NCT03116698|322793794|FG003|Overall Study|Withdrawal by Subject|2|||
94273643|NCT03116698|322793791|FG000|Overall Study|Lost to Follow-up|2|||
94273644|NCT03116698|322793792|FG001|Overall Study|Lost to Follow-up|0|||
94368628|NCT01954082|323136499|FG000|Overall Study|Physician Decision|2|||
94368629|NCT01954082|323136500|FG001|Overall Study|Physician Decision|0|||
94368630|NCT01954082|323136499|FG000|Overall Study|Parent Decision|1|||
94368631|NCT01954082|323136500|FG001|Overall Study|Parent Decision|0|||
94368632|NCT01954082|323136499|FG000|Overall Study|Withdrawal by Subject|0|||
94368633|NCT01954082|323136500|FG001|Overall Study|Withdrawal by Subject|1|||
94368634|NCT01954082|323136499|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
94368635|NCT01954082|323136500|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
94368636|NCT01954082|323136499|FG000|Overall Study|Redirection of Care|0|||
94368637|NCT01954082|323136500|FG001|Overall Study|Redirection of Care|2|||
94368638|NCT01954082|323136499|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
94368639|NCT01954082|323136500|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
94368640|NCT01954082|323136499|FG000|Overall Study|Comfort Care|0|||
94368641|NCT01954082|323136500|FG001|Overall Study|Comfort Care|1|||
94368642|NCT01954082|323136499|FG000|Overall Study|Infant Moved|0|||
94368643|NCT01954082|323136500|FG001|Overall Study|Infant Moved|1|||
94729165|NCT02883049|324466156|FG000|Induction|Developed SMN|0|||
94729166|NCT02883049|324466157|FG001|Induction|Developed SMN|1|||
94729167|NCT02883049|324466158|FG002|Induction|Developed SMN|0|||
94729168|NCT02883049|324466159|FG003|Induction|Developed SMN|0|||
94729169|NCT02883049|324466160|FG004|Induction|Developed SMN|0|||
94729170|NCT02883049|324466161|FG005|Induction|Developed SMN|0|||
94273645|NCT03116698|322793793|FG002|Overall Study|Lost to Follow-up|0|||
94273646|NCT03116698|322793794|FG003|Overall Study|Lost to Follow-up|0|||
94273647|NCT03116698|322793791|FG000|Overall Study|Physician Decision|1|||
94273648|NCT03116698|322793792|FG001|Overall Study|Physician Decision|1|||
94273649|NCT03116698|322793793|FG002|Overall Study|Physician Decision|0|||
94273650|NCT03116698|322793794|FG003|Overall Study|Physician Decision|0|||
94273651|NCT03116698|322793791|FG000|Overall Study|Protocol Violation|1|||
94273652|NCT03116698|322793792|FG001|Overall Study|Protocol Violation|0|||
94273653|NCT03116698|322793793|FG002|Overall Study|Protocol Violation|0|||
94273654|NCT03116698|322793794|FG003|Overall Study|Protocol Violation|0|||
94273655|NCT03116698|322793791|FG000|Overall Study|Death|0|||
94273656|NCT03116698|322793792|FG001|Overall Study|Death|0|||
94273657|NCT03116698|322793793|FG002|Overall Study|Death|2|||
94273658|NCT03116698|322793794|FG003|Overall Study|Death|0|||
94273659|NCT00820950|322793796|FG000|Overall Study|Scheduling Conflict|0|||
94273660|NCT00820950|322793797|FG001|Overall Study|Scheduling Conflict|0|||
94273661|NCT00820950|322793798|FG002|Overall Study|Scheduling Conflict|0|||
94273662|NCT00820950|322793799|FG003|Overall Study|Scheduling Conflict|0|||
94273663|NCT00820950|322793800|FG004|Overall Study|Scheduling Conflict|0|||
94273664|NCT00820950|322793801|FG005|Overall Study|Scheduling Conflict|0|||
94273665|NCT00820950|322793802|FG006|Overall Study|Scheduling Conflict|1|||
94273666|NCT00820950|322793803|FG007|Overall Study|Scheduling Conflict|1|||
94273667|NCT00820950|322793804|FG008|Overall Study|Scheduling Conflict|0|||
94273668|NCT00820950|322793805|FG009|Overall Study|Scheduling Conflict|0|||
94273669|NCT00820950|322793796|FG000|Overall Study|Protocol Violation|1|||
94729171|NCT02883049|324466162|FG006|Induction|Developed SMN|0|||
94729172|NCT02883049|324466163|FG007|Induction|Developed SMN|0|||
94729173|NCT02883049|324466164|FG008|Induction|Developed SMN|0|||
94729174|NCT02883049|324466165|FG009|Induction|Developed SMN|0|||
94729175|NCT02883049|324466166|FG010|Induction|Developed SMN|0|||
94729176|NCT02883049|324466167|FG011|Induction|Developed SMN|0|||
94729177|NCT02883049|324466168|FG012|Induction|Developed SMN|0|||
94729178|NCT02883049|324466169|FG013|Induction|Developed SMN|0|||
94729179|NCT02883049|324466170|FG014|Induction|Developed SMN|0|||
94729180|NCT02883049|324466171|FG015|Induction|Developed SMN|0|||
94273670|NCT00820950|322793797|FG001|Overall Study|Protocol Violation|1|||
94729181|NCT02883049|324466156|FG000|Induction|Enrolled onto another COG study|72|||
94729182|NCT02883049|324466157|FG001|Induction|Enrolled onto another COG study|0|||
94729183|NCT02883049|324466158|FG002|Induction|Enrolled onto another COG study|0|||
94273671|NCT00820950|322793798|FG002|Overall Study|Protocol Violation|0|||
94273672|NCT00820950|322793799|FG003|Overall Study|Protocol Violation|0|||
94273673|NCT00820950|322793800|FG004|Overall Study|Protocol Violation|0|||
94273674|NCT00820950|322793801|FG005|Overall Study|Protocol Violation|0|||
94368644|NCT01954082|323136499|FG000|Overall Study|Randomized not Treated|4|||
94368645|NCT01954082|323136500|FG001|Overall Study|Randomized not Treated|2|||
94368646|NCT01682512|323136501|FG000|Overall Study|Adverse Event|6|||
94273675|NCT00820950|322793802|FG006|Overall Study|Protocol Violation|0|||
94273676|NCT00820950|322793803|FG007|Overall Study|Protocol Violation|0|||
94273677|NCT00820950|322793804|FG008|Overall Study|Protocol Violation|0|||
94273678|NCT00820950|322793805|FG009|Overall Study|Protocol Violation|0|||
94368647|NCT01682512|323136502|FG001|Overall Study|Adverse Event|5|||
94368648|NCT01682512|323136503|FG002|Overall Study|Adverse Event|2|||
94368649|NCT01682512|323136501|FG000|Overall Study|Withdrawal by Subject|2|||
94729184|NCT02883049|324466159|FG003|Induction|Enrolled onto another COG study|0|||
94729185|NCT02883049|324466160|FG004|Induction|Enrolled onto another COG study|0|||
94729186|NCT02883049|324466161|FG005|Induction|Enrolled onto another COG study|0|||
94729187|NCT02883049|324466162|FG006|Induction|Enrolled onto another COG study|0|||
94729188|NCT02883049|324466163|FG007|Induction|Enrolled onto another COG study|0|||
94729189|NCT02883049|324466164|FG008|Induction|Enrolled onto another COG study|0|||
94729190|NCT02883049|324466165|FG009|Induction|Enrolled onto another COG study|0|||
94729191|NCT02883049|324466166|FG010|Induction|Enrolled onto another COG study|0|||
94729192|NCT02883049|324466167|FG011|Induction|Enrolled onto another COG study|0|||
94729193|NCT02883049|324466168|FG012|Induction|Enrolled onto another COG study|0|||
94729194|NCT02883049|324466169|FG013|Induction|Enrolled onto another COG study|0|||
94729195|NCT02883049|324466170|FG014|Induction|Enrolled onto another COG study|0|||
94729196|NCT02883049|324466171|FG015|Induction|Enrolled onto another COG study|0|||
94729197|NCT02883049|324466156|FG000|Induction|Incomplete induction data|17|||
94729198|NCT02883049|324466157|FG001|Induction|Incomplete induction data|0|||
94729199|NCT02883049|324466158|FG002|Induction|Incomplete induction data|0|||
94729200|NCT02883049|324466159|FG003|Induction|Incomplete induction data|0|||
94729201|NCT02883049|324466160|FG004|Induction|Incomplete induction data|0|||
94729202|NCT02883049|324466161|FG005|Induction|Incomplete induction data|0|||
94729203|NCT02883049|324466162|FG006|Induction|Incomplete induction data|0|||
94729204|NCT02883049|324466163|FG007|Induction|Incomplete induction data|0|||
94729205|NCT02883049|324466164|FG008|Induction|Incomplete induction data|0|||
94729206|NCT02883049|324466165|FG009|Induction|Incomplete induction data|0|||
94729207|NCT02883049|324466166|FG010|Induction|Incomplete induction data|0|||
94729208|NCT02883049|324466167|FG011|Induction|Incomplete induction data|0|||
94729209|NCT02883049|324466168|FG012|Induction|Incomplete induction data|0|||
94729210|NCT02883049|324466169|FG013|Induction|Incomplete induction data|0|||
94729211|NCT02883049|324466170|FG014|Induction|Incomplete induction data|0|||
94729212|NCT02883049|324466171|FG015|Induction|Incomplete induction data|0|||
94729213|NCT02883049|324466156|FG000|Post Induction|Adverse Event|0|||
94729214|NCT02883049|324466157|FG001|Post Induction|Adverse Event|0|||
94729215|NCT02883049|324466158|FG002|Post Induction|Adverse Event|0|||
94729216|NCT02883049|324466159|FG003|Post Induction|Adverse Event|7|||
94729217|NCT02883049|324466160|FG004|Post Induction|Adverse Event|8|||
94729218|NCT02883049|324466161|FG005|Post Induction|Adverse Event|3|||
94729219|NCT02883049|324466162|FG006|Post Induction|Adverse Event|4|||
94729220|NCT02883049|324466163|FG007|Post Induction|Adverse Event|5|||
94729221|NCT02883049|324466164|FG008|Post Induction|Adverse Event|6|||
94729222|NCT02883049|324466165|FG009|Post Induction|Adverse Event|7|||
94729223|NCT02883049|324466166|FG010|Post Induction|Adverse Event|2|||
94729224|NCT02883049|324466167|FG011|Post Induction|Adverse Event|2|||
94729225|NCT02883049|324466168|FG012|Post Induction|Adverse Event|0|||
94729226|NCT02883049|324466169|FG013|Post Induction|Adverse Event|0|||
94729227|NCT02883049|324466170|FG014|Post Induction|Adverse Event|5|||
94729228|NCT02883049|324466171|FG015|Post Induction|Adverse Event|2|||
94729229|NCT02883049|324466156|FG000|Post Induction|Death|0|||
94729230|NCT02883049|324466157|FG001|Post Induction|Death|0|||
94729231|NCT02883049|324466158|FG002|Post Induction|Death|0|||
94729232|NCT02883049|324466159|FG003|Post Induction|Death|9|||
94729233|NCT02883049|324466160|FG004|Post Induction|Death|9|||
94729234|NCT02883049|324466161|FG005|Post Induction|Death|0|||
94729235|NCT02883049|324466162|FG006|Post Induction|Death|1|||
94729236|NCT02883049|324466163|FG007|Post Induction|Death|6|||
94729237|NCT02883049|324466164|FG008|Post Induction|Death|5|||
94729238|NCT02883049|324466165|FG009|Post Induction|Death|3|||
94729239|NCT02883049|324466166|FG010|Post Induction|Death|1|||
94729240|NCT02883049|324466167|FG011|Post Induction|Death|0|||
94729241|NCT02883049|324466168|FG012|Post Induction|Death|1|||
94729242|NCT02883049|324466169|FG013|Post Induction|Death|1|||
94729243|NCT02883049|324466170|FG014|Post Induction|Death|10|||
94729244|NCT02883049|324466171|FG015|Post Induction|Death|2|||
94729245|NCT02883049|324466156|FG000|Post Induction|Lost to Follow-up|0|||
94729246|NCT02883049|324466157|FG001|Post Induction|Lost to Follow-up|0|||
94729247|NCT02883049|324466158|FG002|Post Induction|Lost to Follow-up|0|||
94729248|NCT02883049|324466159|FG003|Post Induction|Lost to Follow-up|0|||
94729249|NCT02883049|324466160|FG004|Post Induction|Lost to Follow-up|1|||
94729250|NCT02883049|324466161|FG005|Post Induction|Lost to Follow-up|1|||
94729251|NCT02883049|324466162|FG006|Post Induction|Lost to Follow-up|0|||
94729252|NCT02883049|324466163|FG007|Post Induction|Lost to Follow-up|0|||
94729253|NCT02883049|324466164|FG008|Post Induction|Lost to Follow-up|3|||
94729254|NCT02883049|324466165|FG009|Post Induction|Lost to Follow-up|0|||
94729255|NCT02883049|324466166|FG010|Post Induction|Lost to Follow-up|1|||
94729256|NCT02883049|324466167|FG011|Post Induction|Lost to Follow-up|0|||
94729257|NCT02883049|324466168|FG012|Post Induction|Lost to Follow-up|0|||
94729258|NCT02883049|324466169|FG013|Post Induction|Lost to Follow-up|0|||
94729259|NCT02883049|324466170|FG014|Post Induction|Lost to Follow-up|0|||
94729260|NCT02883049|324466171|FG015|Post Induction|Lost to Follow-up|0|||
94729261|NCT02883049|324466156|FG000|Post Induction|Physician Decision|0|||
94729262|NCT02883049|324466157|FG001|Post Induction|Physician Decision|0|||
94729263|NCT02883049|324466158|FG002|Post Induction|Physician Decision|0|||
94729264|NCT02883049|324466159|FG003|Post Induction|Physician Decision|27|||
94729265|NCT02883049|324466160|FG004|Post Induction|Physician Decision|27|||
94729266|NCT02883049|324466161|FG005|Post Induction|Physician Decision|23|||
94729267|NCT02883049|324466162|FG006|Post Induction|Physician Decision|30|||
94729268|NCT02883049|324466163|FG007|Post Induction|Physician Decision|56|||
94729269|NCT02883049|324466164|FG008|Post Induction|Physician Decision|85|||
94729270|NCT02883049|324466165|FG009|Post Induction|Physician Decision|12|||
94729271|NCT02883049|324466166|FG010|Post Induction|Physician Decision|5|||
94729272|NCT02883049|324466167|FG011|Post Induction|Physician Decision|14|||
94729273|NCT02883049|324466168|FG012|Post Induction|Physician Decision|1|||
94729274|NCT02883049|324466169|FG013|Post Induction|Physician Decision|11|||
94729275|NCT02883049|324466170|FG014|Post Induction|Physician Decision|19|||
94729276|NCT02883049|324466171|FG015|Post Induction|Physician Decision|5|||
94729277|NCT02883049|324466156|FG000|Post Induction|Protocol Violation|0|||
94729278|NCT02883049|324466157|FG001|Post Induction|Protocol Violation|0|||
94729279|NCT02883049|324466158|FG002|Post Induction|Protocol Violation|0|||
94729280|NCT02883049|324466159|FG003|Post Induction|Protocol Violation|0|||
94729281|NCT02883049|324466160|FG004|Post Induction|Protocol Violation|0|||
94729282|NCT02883049|324466161|FG005|Post Induction|Protocol Violation|0|||
94729283|NCT02883049|324466162|FG006|Post Induction|Protocol Violation|0|||
94729284|NCT02883049|324466163|FG007|Post Induction|Protocol Violation|1|||
94729285|NCT02883049|324466164|FG008|Post Induction|Protocol Violation|0|||
94729286|NCT02883049|324466165|FG009|Post Induction|Protocol Violation|0|||
94729287|NCT02883049|324466166|FG010|Post Induction|Protocol Violation|0|||
94729288|NCT02883049|324466167|FG011|Post Induction|Protocol Violation|0|||
94729289|NCT02883049|324466168|FG012|Post Induction|Protocol Violation|0|||
94729290|NCT02883049|324466169|FG013|Post Induction|Protocol Violation|0|||
94729291|NCT02883049|324466170|FG014|Post Induction|Protocol Violation|0|||
94729292|NCT02883049|324466171|FG015|Post Induction|Protocol Violation|0|||
94729293|NCT02883049|324466156|FG000|Post Induction|Withdrawal by Subject|0|||
94729294|NCT02883049|324466157|FG001|Post Induction|Withdrawal by Subject|0|||
94729295|NCT02883049|324466158|FG002|Post Induction|Withdrawal by Subject|0|||
94729296|NCT02883049|324466159|FG003|Post Induction|Withdrawal by Subject|5|||
94729297|NCT02883049|324466160|FG004|Post Induction|Withdrawal by Subject|2|||
94729298|NCT02883049|324466161|FG005|Post Induction|Withdrawal by Subject|1|||
94729299|NCT02883049|324466162|FG006|Post Induction|Withdrawal by Subject|0|||
94729300|NCT02883049|324466163|FG007|Post Induction|Withdrawal by Subject|0|||
94729301|NCT02883049|324466164|FG008|Post Induction|Withdrawal by Subject|2|||
94729302|NCT02883049|324466165|FG009|Post Induction|Withdrawal by Subject|0|||
94729303|NCT02883049|324466166|FG010|Post Induction|Withdrawal by Subject|1|||
94729304|NCT02883049|324466167|FG011|Post Induction|Withdrawal by Subject|1|||
94729305|NCT02883049|324466168|FG012|Post Induction|Withdrawal by Subject|0|||
94729306|NCT02883049|324466169|FG013|Post Induction|Withdrawal by Subject|0|||
94273679|NCT03996876|322793809|FG000|Overall Study|Incomplete Data|2|||
94273680|NCT03996876|322793810|FG001|Overall Study|Incomplete Data|4|||
94729307|NCT02883049|324466170|FG014|Post Induction|Withdrawal by Subject|1|||
94729308|NCT02883049|324466171|FG015|Post Induction|Withdrawal by Subject|0|||
94729309|NCT02883049|324466156|FG000|Post Induction|Ineligible|0|||
94729310|NCT02883049|324466157|FG001|Post Induction|Ineligible|0|||
94729311|NCT02883049|324466158|FG002|Post Induction|Ineligible|2|||
94729312|NCT02883049|324466159|FG003|Post Induction|Ineligible|0|||
94729313|NCT02883049|324466160|FG004|Post Induction|Ineligible|0|||
94729314|NCT02883049|324466161|FG005|Post Induction|Ineligible|0|||
94729315|NCT02883049|324466162|FG006|Post Induction|Ineligible|1|||
94729316|NCT02883049|324466163|FG007|Post Induction|Ineligible|0|||
94729317|NCT02883049|324466164|FG008|Post Induction|Ineligible|0|||
94729318|NCT02883049|324466165|FG009|Post Induction|Ineligible|0|||
94729319|NCT02883049|324466166|FG010|Post Induction|Ineligible|1|||
94729320|NCT02883049|324466167|FG011|Post Induction|Ineligible|0|||
94729321|NCT02883049|324466168|FG012|Post Induction|Ineligible|0|||
94729322|NCT02883049|324466169|FG013|Post Induction|Ineligible|0|||
94729323|NCT02883049|324466170|FG014|Post Induction|Ineligible|0|||
94729324|NCT02883049|324466171|FG015|Post Induction|Ineligible|1|||
94729325|NCT02883049|324466156|FG000|Post Induction|Refusal of further protocol therapy|0|||
94729326|NCT02883049|324466157|FG001|Post Induction|Refusal of further protocol therapy|0|||
94729327|NCT02883049|324466158|FG002|Post Induction|Refusal of further protocol therapy|0|||
94729328|NCT02883049|324466159|FG003|Post Induction|Refusal of further protocol therapy|11|||
94729329|NCT02883049|324466160|FG004|Post Induction|Refusal of further protocol therapy|15|||
94729330|NCT02883049|324466161|FG005|Post Induction|Refusal of further protocol therapy|9|||
94729331|NCT02883049|324466162|FG006|Post Induction|Refusal of further protocol therapy|13|||
94729332|NCT02883049|324466163|FG007|Post Induction|Refusal of further protocol therapy|5|||
94729333|NCT02883049|324466164|FG008|Post Induction|Refusal of further protocol therapy|21|||
94729334|NCT02883049|324466165|FG009|Post Induction|Refusal of further protocol therapy|7|||
94729335|NCT02883049|324466166|FG010|Post Induction|Refusal of further protocol therapy|0|||
94729336|NCT02883049|324466167|FG011|Post Induction|Refusal of further protocol therapy|7|||
94729337|NCT02883049|324466168|FG012|Post Induction|Refusal of further protocol therapy|3|||
94729338|NCT02883049|324466169|FG013|Post Induction|Refusal of further protocol therapy|0|||
94729339|NCT02883049|324466170|FG014|Post Induction|Refusal of further protocol therapy|4|||
94729340|NCT02883049|324466171|FG015|Post Induction|Refusal of further protocol therapy|1|||
94729341|NCT02883049|324466156|FG000|Post Induction|Inevaluable|0|||
94729342|NCT02883049|324466157|FG001|Post Induction|Inevaluable|0|||
94729343|NCT02883049|324466158|FG002|Post Induction|Inevaluable|0|||
94729344|NCT02883049|324466159|FG003|Post Induction|Inevaluable|1|||
94729345|NCT02883049|324466160|FG004|Post Induction|Inevaluable|1|||
94729346|NCT02883049|324466161|FG005|Post Induction|Inevaluable|2|||
94729347|NCT02883049|324466162|FG006|Post Induction|Inevaluable|7|||
94729348|NCT02883049|324466163|FG007|Post Induction|Inevaluable|6|||
94729349|NCT02883049|324466164|FG008|Post Induction|Inevaluable|4|||
94729350|NCT02883049|324466165|FG009|Post Induction|Inevaluable|4|||
94729351|NCT02883049|324466166|FG010|Post Induction|Inevaluable|1|||
94729352|NCT02883049|324466167|FG011|Post Induction|Inevaluable|1|||
94729353|NCT02883049|324466168|FG012|Post Induction|Inevaluable|2|||
94729354|NCT02883049|324466169|FG013|Post Induction|Inevaluable|0|||
94729355|NCT02883049|324466170|FG014|Post Induction|Inevaluable|0|||
94729356|NCT02883049|324466171|FG015|Post Induction|Inevaluable|1|||
94729357|NCT02883049|324466156|FG000|Post Induction|Moved to another non-COG institution|0|||
94729358|NCT02883049|324466157|FG001|Post Induction|Moved to another non-COG institution|0|||
94729359|NCT02883049|324466158|FG002|Post Induction|Moved to another non-COG institution|0|||
94729360|NCT02883049|324466159|FG003|Post Induction|Moved to another non-COG institution|0|||
94729361|NCT02883049|324466160|FG004|Post Induction|Moved to another non-COG institution|0|||
94729362|NCT02883049|324466161|FG005|Post Induction|Moved to another non-COG institution|0|||
94729363|NCT02883049|324466162|FG006|Post Induction|Moved to another non-COG institution|0|||
94729364|NCT02883049|324466163|FG007|Post Induction|Moved to another non-COG institution|2|||
94729365|NCT02883049|324466164|FG008|Post Induction|Moved to another non-COG institution|2|||
94729366|NCT02883049|324466165|FG009|Post Induction|Moved to another non-COG institution|0|||
94729367|NCT02883049|324466166|FG010|Post Induction|Moved to another non-COG institution|0|||
94729368|NCT02883049|324466167|FG011|Post Induction|Moved to another non-COG institution|1|||
94729369|NCT02883049|324466168|FG012|Post Induction|Moved to another non-COG institution|0|||
94729370|NCT02883049|324466169|FG013|Post Induction|Moved to another non-COG institution|0|||
94729371|NCT02883049|324466170|FG014|Post Induction|Moved to another non-COG institution|0|||
94729372|NCT02883049|324466171|FG015|Post Induction|Moved to another non-COG institution|0|||
94729373|NCT02883049|324466156|FG000|Post Induction|Randomization closed|0|||
94729374|NCT02883049|324466157|FG001|Post Induction|Randomization closed|0|||
94729375|NCT02883049|324466158|FG002|Post Induction|Randomization closed|0|||
94729376|NCT02883049|324466159|FG003|Post Induction|Randomization closed|0|||
94729377|NCT02883049|324466160|FG004|Post Induction|Randomization closed|0|||
94729378|NCT02883049|324466161|FG005|Post Induction|Randomization closed|0|||
94729379|NCT02883049|324466162|FG006|Post Induction|Randomization closed|0|||
94729380|NCT02883049|324466163|FG007|Post Induction|Randomization closed|20|||
94729381|NCT02883049|324466164|FG008|Post Induction|Randomization closed|0|||
94729382|NCT02883049|324466165|FG009|Post Induction|Randomization closed|0|||
94729383|NCT02883049|324466166|FG010|Post Induction|Randomization closed|0|||
94729384|NCT02883049|324466167|FG011|Post Induction|Randomization closed|0|||
94729385|NCT02883049|324466168|FG012|Post Induction|Randomization closed|0|||
94729386|NCT02883049|324466169|FG013|Post Induction|Randomization closed|0|||
94729387|NCT02883049|324466170|FG014|Post Induction|Randomization closed|0|||
94729388|NCT02883049|324466171|FG015|Post Induction|Randomization closed|0|||
94729389|NCT02883049|324466156|FG000|Post Induction|MRD negative|0|||
94729390|NCT02883049|324466157|FG001|Post Induction|MRD negative|0|||
94729391|NCT02883049|324466158|FG002|Post Induction|MRD negative|0|||
94729392|NCT02883049|324466159|FG003|Post Induction|MRD negative|0|||
94729393|NCT02883049|324466160|FG004|Post Induction|MRD negative|0|||
94729394|NCT02883049|324466161|FG005|Post Induction|MRD negative|0|||
94729395|NCT02883049|324466162|FG006|Post Induction|MRD negative|0|||
94729396|NCT02883049|324466163|FG007|Post Induction|MRD negative|11|||
94729397|NCT02883049|324466164|FG008|Post Induction|MRD negative|0|||
94729398|NCT02883049|324466165|FG009|Post Induction|MRD negative|0|||
94729399|NCT02883049|324466166|FG010|Post Induction|MRD negative|0|||
94729400|NCT02883049|324466167|FG011|Post Induction|MRD negative|0|||
94729401|NCT02883049|324466168|FG012|Post Induction|MRD negative|0|||
94729402|NCT02883049|324466169|FG013|Post Induction|MRD negative|0|||
94729403|NCT02883049|324466170|FG014|Post Induction|MRD negative|0|||
94729404|NCT02883049|324466171|FG015|Post Induction|MRD negative|0|||
94729405|NCT02883049|324466156|FG000|Post Induction|Developed SMN|0|||
94729406|NCT02883049|324466157|FG001|Post Induction|Developed SMN|0|||
94729407|NCT02883049|324466158|FG002|Post Induction|Developed SMN|0|||
94729408|NCT02883049|324466159|FG003|Post Induction|Developed SMN|0|||
94729409|NCT02883049|324466160|FG004|Post Induction|Developed SMN|1|||
94729410|NCT02883049|324466161|FG005|Post Induction|Developed SMN|0|||
94729411|NCT02883049|324466162|FG006|Post Induction|Developed SMN|1|||
94729412|NCT02883049|324466163|FG007|Post Induction|Developed SMN|0|||
94729413|NCT02883049|324466164|FG008|Post Induction|Developed SMN|0|||
94729414|NCT02883049|324466165|FG009|Post Induction|Developed SMN|0|||
94729415|NCT02883049|324466166|FG010|Post Induction|Developed SMN|1|||
94729416|NCT02883049|324466167|FG011|Post Induction|Developed SMN|1|||
94729417|NCT02883049|324466168|FG012|Post Induction|Developed SMN|0|||
94729418|NCT02883049|324466169|FG013|Post Induction|Developed SMN|0|||
94729419|NCT02883049|324466170|FG014|Post Induction|Developed SMN|1|||
94729420|NCT02883049|324466171|FG015|Post Induction|Developed SMN|0|||
94729421|NCT02883049|324466156|FG000|Post Induction|Enrolled onto another COG study|0|||
94729422|NCT02883049|324466157|FG001|Post Induction|Enrolled onto another COG study|0|||
94729423|NCT02883049|324466158|FG002|Post Induction|Enrolled onto another COG study|0|||
94729424|NCT02883049|324466159|FG003|Post Induction|Enrolled onto another COG study|1|||
94729425|NCT02883049|324466160|FG004|Post Induction|Enrolled onto another COG study|1|||
94729426|NCT02883049|324466161|FG005|Post Induction|Enrolled onto another COG study|0|||
94729427|NCT02883049|324466162|FG006|Post Induction|Enrolled onto another COG study|0|||
94729428|NCT02883049|324466163|FG007|Post Induction|Enrolled onto another COG study|4|||
94729429|NCT02883049|324466164|FG008|Post Induction|Enrolled onto another COG study|0|||
94729430|NCT02883049|324466165|FG009|Post Induction|Enrolled onto another COG study|0|||
94729431|NCT02883049|324466166|FG010|Post Induction|Enrolled onto another COG study|0|||
94729432|NCT02883049|324466167|FG011|Post Induction|Enrolled onto another COG study|2|||
94729433|NCT02883049|324466168|FG012|Post Induction|Enrolled onto another COG study|0|||
94729434|NCT02883049|324466169|FG013|Post Induction|Enrolled onto another COG study|1|||
94729435|NCT02883049|324466170|FG014|Post Induction|Enrolled onto another COG study|0|||
94729436|NCT02883049|324466171|FG015|Post Induction|Enrolled onto another COG study|0|||
94729437|NCT02883049|324466156|FG000|Post Induction|Recurrent leukemia|0|||
94729438|NCT02883049|324466157|FG001|Post Induction|Recurrent leukemia|0|||
94729439|NCT02883049|324466158|FG002|Post Induction|Recurrent leukemia|0|||
94729440|NCT02883049|324466159|FG003|Post Induction|Recurrent leukemia|17|||
94729441|NCT02883049|324466160|FG004|Post Induction|Recurrent leukemia|12|||
94729442|NCT02883049|324466161|FG005|Post Induction|Recurrent leukemia|4|||
94729443|NCT02883049|324466162|FG006|Post Induction|Recurrent leukemia|1|||
94729444|NCT02883049|324466163|FG007|Post Induction|Recurrent leukemia|13|||
94729445|NCT02883049|324466164|FG008|Post Induction|Recurrent leukemia|27|||
94729446|NCT02883049|324466165|FG009|Post Induction|Recurrent leukemia|5|||
94729447|NCT02883049|324466166|FG010|Post Induction|Recurrent leukemia|3|||
94729448|NCT02883049|324466167|FG011|Post Induction|Recurrent leukemia|12|||
94729449|NCT02883049|324466168|FG012|Post Induction|Recurrent leukemia|1|||
94729450|NCT02883049|324466169|FG013|Post Induction|Recurrent leukemia|1|||
94729451|NCT02883049|324466170|FG014|Post Induction|Recurrent leukemia|9|||
94729452|NCT02883049|324466171|FG015|Post Induction|Recurrent leukemia|3|||
94729453|NCT02883049|324466156|FG000|Post Induction|Induction Failure|0|||
94729454|NCT02883049|324466157|FG001|Post Induction|Induction Failure|0|||
94729455|NCT02883049|324466158|FG002|Post Induction|Induction Failure|0|||
94729456|NCT02883049|324466159|FG003|Post Induction|Induction Failure|0|||
94729457|NCT02883049|324466160|FG004|Post Induction|Induction Failure|0|||
94729458|NCT02883049|324466161|FG005|Post Induction|Induction Failure|0|||
94729459|NCT02883049|324466162|FG006|Post Induction|Induction Failure|0|||
94729460|NCT02883049|324466163|FG007|Post Induction|Induction Failure|2|||
94729461|NCT02883049|324466164|FG008|Post Induction|Induction Failure|2|||
94729462|NCT02883049|324466165|FG009|Post Induction|Induction Failure|0|||
94729463|NCT02883049|324466166|FG010|Post Induction|Induction Failure|0|||
94729464|NCT02883049|324466167|FG011|Post Induction|Induction Failure|0|||
94729465|NCT02883049|324466168|FG012|Post Induction|Induction Failure|0|||
94729466|NCT02883049|324466169|FG013|Post Induction|Induction Failure|2|||
94729467|NCT02883049|324466170|FG014|Post Induction|Induction Failure|0|||
94729468|NCT02883049|324466171|FG015|Post Induction|Induction Failure|0|||
94729469|NCT04858321|324466186|FG000|Overall Study|Withdrawal by Subject|3|||
94729470|NCT01539083|324466187|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
94729471|NCT01539083|324466188|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
94729472|NCT01539083|324466189|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
94729473|NCT01539083|324466187|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
94729474|NCT01539083|324466188|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
94729475|NCT01539083|324466189|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
94729476|NCT01539083|324466187|FG000|Before Randomization (VCD Induction)|Death|6|||
94729477|NCT01539083|324466188|FG001|Before Randomization (VCD Induction)|Death|0|||
94729478|NCT01539083|324466189|FG002|Before Randomization (VCD Induction)|Death|0|||
94729479|NCT01539083|324466187|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
94729480|NCT01539083|324466188|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
94729481|NCT01539083|324466189|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
94729482|NCT01539083|324466187|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
94729483|NCT01539083|324466188|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
94729484|NCT01539083|324466189|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
94729485|NCT01539083|324466187|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
94729486|NCT01539083|324466188|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
94729487|NCT01539083|324466189|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
94729488|NCT01539083|324466187|FG000|Before Randomization (VCD Induction)|Other|5|||
94729489|NCT01539083|324466188|FG001|Before Randomization (VCD Induction)|Other|0|||
94729490|NCT01539083|324466189|FG002|Before Randomization (VCD Induction)|Other|0|||
94729491|NCT01539083|324466187|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
94729492|NCT01539083|324466188|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
94729493|NCT01539083|324466189|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
94729494|NCT01539083|324466187|FG000|After Randomization (TP and VTP)|Other|0|||
94729495|NCT01539083|324466188|FG001|After Randomization (TP and VTP)|Other|1|||
94729496|NCT01539083|324466189|FG002|After Randomization (TP and VTP)|Other|1|||
94729497|NCT01539083|324466187|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
94729498|NCT01539083|324466188|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
94729499|NCT01539083|324466189|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
94729500|NCT01539083|324466187|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
94729501|NCT01539083|324466188|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
94729502|NCT01539083|324466189|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
94729503|NCT01539083|324466187|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
94729504|NCT01539083|324466188|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
94729505|NCT01539083|324466189|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
94729506|NCT01539083|324466187|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
94729507|NCT01539083|324466188|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
94729508|NCT01539083|324466189|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
94729509|NCT01539083|324466187|FG000|After Randomization (TP and VTP)|Death|0|||
94729510|NCT01539083|324466188|FG001|After Randomization (TP and VTP)|Death|6|||
94729511|NCT01539083|324466189|FG002|After Randomization (TP and VTP)|Death|11|||
94729512|NCT05794243|324466190|FG000|Overall Study|Withdrawal by Subject|1|||
94729513|NCT05794243|324466191|FG001|Overall Study|Withdrawal by Subject|0|||
94729514|NCT05794243|324466192|FG002|Overall Study|Withdrawal by Subject|1|||
94729515|NCT05794243|324466190|FG000|Overall Study|Physician Decision|0|||
94729516|NCT05794243|324466191|FG001|Overall Study|Physician Decision|3|||
94729517|NCT05794243|324466192|FG002|Overall Study|Physician Decision|1|||
94729518|NCT05006872|324466196|FG000|Overall Study|Lost to Follow-up|37|||
94729519|NCT05006872|324466197|FG001|Overall Study|Lost to Follow-up|31|||
94729520|NCT02268253|324466208|FG000|Stage 1|Withdrawal by Subject|1|||
94729521|NCT02268253|324466209|FG001|Stage 1|Withdrawal by Subject|0|||
94729522|NCT02268253|324466210|FG002|Stage 1|Withdrawal by Subject|0|||
94729523|NCT02268253|324466211|FG003|Stage 1|Withdrawal by Subject|0|||
94729524|NCT02268253|324466212|FG004|Stage 1|Withdrawal by Subject|0|||
94729525|NCT02268253|324466213|FG005|Stage 1|Withdrawal by Subject|0|||
94729526|NCT02268253|324466214|FG006|Stage 1|Withdrawal by Subject|0|||
94729527|NCT02268253|324466208|FG000|Stage 1|Death|0|||
94729528|NCT02268253|324466209|FG001|Stage 1|Death|2|||
94729529|NCT02268253|324466210|FG002|Stage 1|Death|2|||
94729530|NCT02268253|324466211|FG003|Stage 1|Death|2|||
94729531|NCT02268253|324466212|FG004|Stage 1|Death|1|||
94729532|NCT02268253|324466213|FG005|Stage 1|Death|1|||
94729533|NCT02268253|324466214|FG006|Stage 1|Death|0|||
94729534|NCT02268253|324466208|FG000|Stage 2|Disease Recurrence/ Progression|0|||
94729535|NCT02268253|324466209|FG001|Stage 2|Disease Recurrence/ Progression|0|||
94729536|NCT02268253|324466210|FG002|Stage 2|Disease Recurrence/ Progression|1|||
94729537|NCT02268253|324466211|FG003|Stage 2|Disease Recurrence/ Progression|0|||
94729538|NCT02268253|324466212|FG004|Stage 2|Disease Recurrence/ Progression|0|||
94729539|NCT02268253|324466213|FG005|Stage 2|Disease Recurrence/ Progression|0|||
94729540|NCT02268253|324466214|FG006|Stage 2|Disease Recurrence/ Progression|0|||
94729541|NCT02268253|324466208|FG000|Stage 2|Withdrawal by Subject|0|||
94729542|NCT02268253|324466209|FG001|Stage 2|Withdrawal by Subject|0|||
94729543|NCT02268253|324466210|FG002|Stage 2|Withdrawal by Subject|2|||
94729544|NCT02268253|324466211|FG003|Stage 2|Withdrawal by Subject|0|||
94729545|NCT02268253|324466212|FG004|Stage 2|Withdrawal by Subject|0|||
94729546|NCT02268253|324466213|FG005|Stage 2|Withdrawal by Subject|2|||
94729547|NCT02268253|324466214|FG006|Stage 2|Withdrawal by Subject|0|||
94729548|NCT02268253|324466208|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
94729549|NCT02268253|324466209|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
94729550|NCT02268253|324466210|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
94729551|NCT02268253|324466211|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
94729552|NCT02268253|324466212|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
94729553|NCT02268253|324466213|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
94729554|NCT02268253|324466214|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
94729555|NCT02268253|324466208|FG000|Stage 2|Death|0|||
94729556|NCT02268253|324466209|FG001|Stage 2|Death|0|||
94729557|NCT02268253|324466210|FG002|Stage 2|Death|19|||
94729558|NCT02268253|324466211|FG003|Stage 2|Death|0|||
94729559|NCT02268253|324466212|FG004|Stage 2|Death|0|||
94729560|NCT02268253|324466213|FG005|Stage 2|Death|20|||
94729561|NCT02268253|324466214|FG006|Stage 2|Death|1|||
94729562|NCT02268253|324466208|FG000|Stage 2|Lost to Follow-up|0|||
94729563|NCT02268253|324466209|FG001|Stage 2|Lost to Follow-up|0|||
94729564|NCT02268253|324466210|FG002|Stage 2|Lost to Follow-up|0|||
94729565|NCT02268253|324466211|FG003|Stage 2|Lost to Follow-up|0|||
94729566|NCT02268253|324466212|FG004|Stage 2|Lost to Follow-up|0|||
94729567|NCT02268253|324466213|FG005|Stage 2|Lost to Follow-up|4|||
94729568|NCT02268253|324466214|FG006|Stage 2|Lost to Follow-up|0|||
94729569|NCT02268253|324466208|FG000|Stage 2|Transferred to Hospice|0|||
94729570|NCT02268253|324466209|FG001|Stage 2|Transferred to Hospice|0|||
94729571|NCT02268253|324466210|FG002|Stage 2|Transferred to Hospice|0|||
94729572|NCT02268253|324466211|FG003|Stage 2|Transferred to Hospice|0|||
94729573|NCT02268253|324466212|FG004|Stage 2|Transferred to Hospice|0|||
94729574|NCT02268253|324466213|FG005|Stage 2|Transferred to Hospice|2|||
94729575|NCT02268253|324466214|FG006|Stage 2|Transferred to Hospice|0|||
94729576|NCT02268253|324466208|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
94729577|NCT02268253|324466209|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
94729578|NCT02268253|324466210|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
94729579|NCT02268253|324466211|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
94729580|NCT02268253|324466212|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
94729581|NCT02268253|324466213|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
94729582|NCT02268253|324466214|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
94729583|NCT02268253|324466208|FG000|Stage 3A|Withdrawal by Subject|0|||
94729584|NCT02268253|324466209|FG001|Stage 3A|Withdrawal by Subject|0|||
94729585|NCT02268253|324466210|FG002|Stage 3A|Withdrawal by Subject|2|||
94729586|NCT02268253|324466211|FG003|Stage 3A|Withdrawal by Subject|0|||
94729587|NCT02268253|324466212|FG004|Stage 3A|Withdrawal by Subject|0|||
94729588|NCT02268253|324466213|FG005|Stage 3A|Withdrawal by Subject|0|||
94729589|NCT02268253|324466214|FG006|Stage 3A|Withdrawal by Subject|0|||
94729590|NCT02268253|324466208|FG000|Stage 3A|Physician Decision|0|||
94729591|NCT02268253|324466209|FG001|Stage 3A|Physician Decision|0|||
94729592|NCT02268253|324466210|FG002|Stage 3A|Physician Decision|2|||
94729593|NCT02268253|324466211|FG003|Stage 3A|Physician Decision|0|||
94729594|NCT02268253|324466212|FG004|Stage 3A|Physician Decision|0|||
94729595|NCT02268253|324466213|FG005|Stage 3A|Physician Decision|0|||
94729596|NCT02268253|324466214|FG006|Stage 3A|Physician Decision|0|||
94729597|NCT02268253|324466208|FG000|Stage 3A|Study Terminated by Sponsor|0|||
94729598|NCT02268253|324466209|FG001|Stage 3A|Study Terminated by Sponsor|0|||
94729599|NCT02268253|324466210|FG002|Stage 3A|Study Terminated by Sponsor|2|||
94729600|NCT02268253|324466211|FG003|Stage 3A|Study Terminated by Sponsor|0|||
94729601|NCT02268253|324466212|FG004|Stage 3A|Study Terminated by Sponsor|0|||
94729602|NCT02268253|324466213|FG005|Stage 3A|Study Terminated by Sponsor|0|||
94729603|NCT02268253|324466214|FG006|Stage 3A|Study Terminated by Sponsor|0|||
94729604|NCT02268253|324466208|FG000|Stage 3A|Lost to Follow-up|0|||
94729605|NCT02268253|324466209|FG001|Stage 3A|Lost to Follow-up|0|||
94729606|NCT02268253|324466210|FG002|Stage 3A|Lost to Follow-up|1|||
94729607|NCT02268253|324466211|FG003|Stage 3A|Lost to Follow-up|0|||
94729608|NCT02268253|324466212|FG004|Stage 3A|Lost to Follow-up|0|||
94729609|NCT02268253|324466213|FG005|Stage 3A|Lost to Follow-up|0|||
94729610|NCT02268253|324466214|FG006|Stage 3A|Lost to Follow-up|0|||
94729611|NCT02268253|324466208|FG000|Stage 3A|Death|0|||
94729612|NCT02268253|324466209|FG001|Stage 3A|Death|0|||
94729613|NCT02268253|324466210|FG002|Stage 3A|Death|5|||
94729614|NCT02268253|324466211|FG003|Stage 3A|Death|0|||
94729615|NCT02268253|324466212|FG004|Stage 3A|Death|0|||
94729616|NCT02268253|324466213|FG005|Stage 3A|Death|0|||
94729617|NCT02268253|324466214|FG006|Stage 3A|Death|0|||
94729618|NCT03524612|324466217|FG000|Overall Study|Lack of Efficacy|10|||
94729619|NCT03524612|324466217|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
94729620|NCT03524612|324466217|FG000|Overall Study|Adverse Event|10|||
94729621|NCT03524612|324466217|FG000|Overall Study|Withdrawal by Subject|7|||
94729622|NCT03524612|324466217|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
94729623|NCT03524612|324466217|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
94729624|NCT03524612|324466217|FG000|Overall Study|New therapy for study indication|6|||
94729625|NCT03524612|324466217|FG000|Overall Study|Death|3|||
94729626|NCT03524612|324466217|FG000|Overall Study|Lost to Follow-up|2|||
94729627|NCT03524612|324466217|FG000|Overall Study|Protocol Violation|1|||
94729628|NCT04770532|324466223|FG000|Overall Study|Withdrawal by Subject|0|||
94729629|NCT04770532|324466224|FG001|Overall Study|Withdrawal by Subject|3|||
94729630|NCT04770532|324466223|FG000|Overall Study|Physician Decision|1|||
94729631|NCT04770532|324466224|FG001|Overall Study|Physician Decision|0|||
94729632|NCT04770532|324466223|FG000|Overall Study|Death|2|||
94729633|NCT04770532|324466224|FG001|Overall Study|Death|2|||
94729634|NCT05457647|324466225|FG000|Overall Study|Lost to Follow-up|3|||
94729635|NCT02683447|324466227|FG000|Overall Study|Lost to Follow-up|2|||
94729636|NCT04623671|324466228|FG000|Overall Study|Adverse Event|0|||
94729637|NCT04623671|324466229|FG001|Overall Study|Adverse Event|1|||
94729638|NCT04623671|324466228|FG000|Overall Study|Lost to Follow-up|2|||
94729639|NCT04623671|324466229|FG001|Overall Study|Lost to Follow-up|1|||
94729640|NCT04623671|324466228|FG000|Overall Study|Death|5|||
94729641|NCT04623671|324466229|FG001|Overall Study|Death|5|||
94729642|NCT02998268|324466230|FG000|Overall Study|Adverse Event|0|||
94729643|NCT02998268|324466231|FG001|Overall Study|Adverse Event|2|||
94729644|NCT02998268|324466230|FG000|Overall Study|Withdrawal by Subject|0|||
94729645|NCT02998268|324466231|FG001|Overall Study|Withdrawal by Subject|1|||
94729646|NCT03652389|324466233|FG000|Overall Study|Lost to Follow-up|1|||
94729647|NCT03652389|324466234|FG001|Overall Study|Lost to Follow-up|5|||
94729648|NCT03652389|324466233|FG000|Overall Study|Withdrawal by Subject|5|||
94729649|NCT03652389|324466234|FG001|Overall Study|Withdrawal by Subject|1|||
94729650|NCT03652389|324466233|FG000|Overall Study|New diagnosis|2|||
94729651|NCT03652389|324466234|FG001|Overall Study|New diagnosis|0|||
94729652|NCT03364647|324467781|FG000|Overall Study|Withdrawal by Subject|3|||
94729653|NCT03364647|324467782|FG001|Overall Study|Withdrawal by Subject|1|||
94729654|NCT00753545|324467783|FG000|Overall Study|Death|98|||
94729655|NCT00753545|324467784|FG001|Overall Study|Death|112|||
94729656|NCT00753545|324467783|FG000|Overall Study|Lost to Follow-up|2|||
94729657|NCT00753545|324467784|FG001|Overall Study|Lost to Follow-up|3|||
94729658|NCT00753545|324467783|FG000|Overall Study|Protocol Violation|1|||
94729659|NCT00753545|324467784|FG001|Overall Study|Protocol Violation|0|||
94729660|NCT00753545|324467783|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
94729661|NCT00753545|324467784|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
94729662|NCT06190691|324467785|FG000|Overall Study|Adverse Event|2|||
94729663|NCT06190691|324467786|FG001|Overall Study|Adverse Event|0|||
94729664|NCT06190691|324467787|FG002|Overall Study|Adverse Event|0|||
94729665|NCT06190691|324467788|FG003|Overall Study|Adverse Event|0|||
94729666|NCT03016754|324467790|FG000|Overall Study|Death|5|||
94729667|NCT03016754|324467791|FG001|Overall Study|Death|4|||
94729668|NCT03016754|324467792|FG002|Overall Study|Death|5|||
94729669|NCT03016754|324467793|FG003|Overall Study|Death|1|||
94729670|NCT03016754|324467790|FG000|Overall Study|Lost to Follow-up|23|||
94729671|NCT03016754|324467791|FG001|Overall Study|Lost to Follow-up|17|||
94729672|NCT03016754|324467792|FG002|Overall Study|Lost to Follow-up|4|||
94729673|NCT03016754|324467793|FG003|Overall Study|Lost to Follow-up|2|||
94729674|NCT03016754|324467790|FG000|Overall Study|Withdrawal by Subject|6|||
94729675|NCT03016754|324467791|FG001|Overall Study|Withdrawal by Subject|6|||
94729676|NCT03016754|324467792|FG002|Overall Study|Withdrawal by Subject|2|||
94729677|NCT03016754|324467793|FG003|Overall Study|Withdrawal by Subject|2|||
94729678|NCT03016754|324467790|FG000|Overall Study|Other/Unknown|2|||
94729679|NCT03016754|324467791|FG001|Overall Study|Other/Unknown|4|||
94729680|NCT03016754|324467792|FG002|Overall Study|Other/Unknown|2|||
94729681|NCT03016754|324467793|FG003|Overall Study|Other/Unknown|1|||
94729682|NCT03016754|324467790|FG000|Overall Study|Protocol Violation|0|||
94729683|NCT03016754|324467791|FG001|Overall Study|Protocol Violation|0|||
94729684|NCT03016754|324467792|FG002|Overall Study|Protocol Violation|0|||
94729685|NCT03016754|324467793|FG003|Overall Study|Protocol Violation|4|||
94729686|NCT05459688|324467802|FG000|Overall Study|Lost to Follow-up|6|||
94273681|NCT02116777|322793813|FG000|Overall Study|Adverse Event|0|||
94729687|NCT05459688|324467802|FG000|Overall Study|Physician Decision|1|||
94729688|NCT05459688|324467802|FG000|Overall Study|Withdrawal by Subject|19|||
94273682|NCT02116777|322793814|FG001|Overall Study|Adverse Event|0|||
94273683|NCT02116777|322793815|FG002|Overall Study|Adverse Event|0|||
94273684|NCT02116777|322793816|FG003|Overall Study|Adverse Event|0|||
94273685|NCT02116777|322793817|FG004|Overall Study|Adverse Event|2|||
94273686|NCT02116777|322793818|FG005|Overall Study|Adverse Event|2|||
94273687|NCT02116777|322793819|FG006|Overall Study|Adverse Event|0|||
94273688|NCT02116777|322793813|FG000|Overall Study|Death|0|||
94273689|NCT02116777|322793814|FG001|Overall Study|Death|0|||
94273690|NCT02116777|322793815|FG002|Overall Study|Death|0|||
94729689|NCT05459688|324467802|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
94729690|NCT04477486|324467803|FG000|Overall Study|Death|2|||
94729691|NCT04477486|324467803|FG000|Overall Study|Ongoing at Time of Analysis|11|||
94729692|NCT02817776|324467804|FG000|Overall Study|Excluded|33|||
94729693|NCT02817776|324467804|FG000|Overall Study|Lost to Follow-up|20|||
94729694|NCT02817776|324467804|FG000|Overall Study|Withdrawal by Subject|33|||
94729695|NCT02817776|324467804|FG000|Overall Study|Death|2|||
94729696|NCT03462030|324467805|FG000|Overall Study|Withdrawal by Subject|1|||
94729697|NCT03462030|324467806|FG001|Overall Study|Withdrawal by Subject|1|||
94729698|NCT02879695|324467807|FG000|Overall Study|Did not start study treatment|2|||
94729699|NCT02879695|324467808|FG001|Overall Study|Did not start study treatment|0|||
94729700|NCT02879695|324467809|FG002|Overall Study|Did not start study treatment|3|||
94729701|NCT02879695|324467810|FG003|Overall Study|Did not start study treatment|0|||
94729702|NCT03381196|324467811|FG000|Overall Study|Withdrawal by Subject|7|||
94729703|NCT03381196|324467812|FG001|Overall Study|Withdrawal by Subject|7|||
94729704|NCT03381196|324467811|FG000|Overall Study|Other|0|||
94729705|NCT03381196|324467812|FG001|Overall Study|Other|1|||
94729706|NCT03381196|324467811|FG000|Overall Study|Lost to Follow-up|5|||
94729707|NCT03381196|324467812|FG001|Overall Study|Lost to Follow-up|4|||
94729708|NCT03381196|324467811|FG000|Overall Study|Death|0|||
94729709|NCT03381196|324467812|FG001|Overall Study|Death|1|||
94729710|NCT03381196|324467811|FG000|Overall Study|Adverse Event|1|||
94729711|NCT03381196|324467812|FG001|Overall Study|Adverse Event|0|||
94729712|NCT03381196|324467811|FG000|Overall Study|Randomized, not treated|3|||
94729713|NCT03381196|324467812|FG001|Overall Study|Randomized, not treated|6|||
94273691|NCT02116777|322793816|FG003|Overall Study|Death|1|||
94273692|NCT02116777|322793817|FG004|Overall Study|Death|0|||
94273693|NCT02116777|322793818|FG005|Overall Study|Death|0|||
94729714|NCT01715285|324467813|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
94729715|NCT01715285|324467814|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
94729716|NCT01715285|324467815|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
94729717|NCT01715285|324467813|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
94729718|NCT01715285|324467814|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
94273694|NCT02116777|322793819|FG006|Overall Study|Death|0|||
94273695|NCT02116777|322793813|FG000|Overall Study|Lack of Efficacy|3|||
94273696|NCT02116777|322793814|FG001|Overall Study|Lack of Efficacy|3|||
94273697|NCT02116777|322793815|FG002|Overall Study|Lack of Efficacy|3|||
94273698|NCT02116777|322793816|FG003|Overall Study|Lack of Efficacy|8|||
94273699|NCT02116777|322793817|FG004|Overall Study|Lack of Efficacy|4|||
94273700|NCT02116777|322793818|FG005|Overall Study|Lack of Efficacy|1|||
94273701|NCT02116777|322793819|FG006|Overall Study|Lack of Efficacy|9|||
94273702|NCT02116777|322793813|FG000|Overall Study|Physician Decision|0|||
94273703|NCT02116777|322793814|FG001|Overall Study|Physician Decision|0|||
94273704|NCT02116777|322793815|FG002|Overall Study|Physician Decision|0|||
94273705|NCT02116777|322793816|FG003|Overall Study|Physician Decision|2|||
94273706|NCT02116777|322793817|FG004|Overall Study|Physician Decision|0|||
94273707|NCT02116777|322793818|FG005|Overall Study|Physician Decision|0|||
94729719|NCT01715285|324467815|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
94729720|NCT01715285|324467813|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
94729721|NCT01715285|324467814|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
94729722|NCT01715285|324467815|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
94729723|NCT01715285|324467813|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
94729724|NCT01715285|324467814|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
94729725|NCT01715285|324467815|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
94729726|NCT01715285|324467813|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
94729727|NCT01715285|324467814|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
94729728|NCT01715285|324467815|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
94729729|NCT01715285|324467813|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
94729730|NCT01715285|324467814|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
94729731|NCT01715285|324467815|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
94729732|NCT01715285|324467813|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
94729733|NCT01715285|324467814|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
94729734|NCT01715285|324467815|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
94729735|NCT01715285|324467813|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
94729736|NCT01715285|324467814|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
94729737|NCT01715285|324467815|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
94729738|NCT01715285|324467813|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
94729739|NCT01715285|324467814|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
94729740|NCT01715285|324467815|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
94729741|NCT01715285|324467813|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
94729742|NCT01715285|324467814|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
94729743|NCT01715285|324467815|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
94729744|NCT01715285|324467813|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
94729745|NCT01715285|324467814|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
94729746|NCT01715285|324467815|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
94729747|NCT01715285|324467813|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
94729748|NCT01715285|324467814|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
94729749|NCT01715285|324467815|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
94729750|NCT01715285|324467813|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
94729751|NCT01715285|324467814|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
94729752|NCT01715285|324467815|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
94729753|NCT01715285|324467813|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
94729754|NCT01715285|324467814|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
94729755|NCT01715285|324467815|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
94729756|NCT02675751|324467816|FG000|Overall Study|Lost to Follow-up|16|||
94729757|NCT03371381|324467817|FG000|Overall Study|Death|5|||
94729758|NCT03371381|324467817|FG000|Overall Study|Study terminated by sponsor|3|||
94729759|NCT03371381|324467817|FG000|Overall Study|Other|4|||
94729760|NCT02979327|324467818|FG000|First Intervention|Protocol Violation|1|||
94729761|NCT02979327|324467819|FG001|First Intervention|Protocol Violation|0|||
94729762|NCT05020249|324467820|FG000|Overall Study|Protocol Violation|1|||
94729763|NCT05020249|324467821|FG001|Overall Study|Protocol Violation|0|||
94729764|NCT03628924|324467824|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
94729765|NCT03628924|324467825|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
94729766|NCT03628924|324467826|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
94729767|NCT03628924|324467827|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
94729768|NCT03628924|324467828|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
94729769|NCT03628924|324467829|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
94729770|NCT03628924|324467830|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
94729771|NCT03628924|324467824|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
94729772|NCT03628924|324467825|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
94729773|NCT03628924|324467826|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
94729774|NCT03628924|324467827|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
94729775|NCT03628924|324467828|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
94729776|NCT03628924|324467829|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
94729777|NCT03628924|324467830|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
94729778|NCT03628924|324467824|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
94729779|NCT03628924|324467825|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
94729780|NCT03628924|324467826|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
94729781|NCT03628924|324467827|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
94729782|NCT03628924|324467828|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
94729783|NCT03628924|324467829|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
94729784|NCT03628924|324467830|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
94467405|NCT00415597|323500560|FG000|Treatment|Withdrawal by Subject|51|||
94467406|NCT00415597|323500560|FG000|Treatment|Lost to Follow-up|28|||
94729785|NCT03628924|324467824|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
94729786|NCT03628924|324467825|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
94729787|NCT03628924|324467826|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
94729788|NCT03628924|324467827|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
94729789|NCT03628924|324467828|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
94467407|NCT00415597|323500560|FG000|Treatment|Drug Screen|2|||
94467408|NCT00415597|323500560|FG000|Treatment|Administrative|3|||
94729790|NCT03628924|324467829|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
94729791|NCT03628924|324467830|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
94729792|NCT03628924|324467824|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
94729793|NCT03628924|324467825|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
94729794|NCT03628924|324467826|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
94729795|NCT03628924|324467827|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
94729796|NCT03628924|324467828|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
94729797|NCT03628924|324467829|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
94729798|NCT03628924|324467830|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
94729799|NCT03628924|324467824|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
94729800|NCT03628924|324467825|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
94729801|NCT03628924|324467826|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
94729802|NCT03628924|324467827|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
94729803|NCT03628924|324467828|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
94729804|NCT03628924|324467829|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
94729805|NCT03628924|324467830|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
94729806|NCT03628924|324467824|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
94729807|NCT03628924|324467825|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
94729808|NCT03628924|324467826|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
94729809|NCT03628924|324467827|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
94729810|NCT03628924|324467828|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
94729811|NCT03628924|324467829|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
94729812|NCT03628924|324467830|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
94729813|NCT03628924|324467824|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
94729814|NCT03628924|324467825|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
94729815|NCT03628924|324467826|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
94729816|NCT03628924|324467827|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
94729817|NCT03628924|324467828|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
94729818|NCT03628924|324467829|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
94729819|NCT03628924|324467830|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
94729820|NCT03628924|324467824|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
94729821|NCT03628924|324467825|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
94729822|NCT03628924|324467826|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
94729823|NCT03628924|324467827|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
94729824|NCT03628924|324467828|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
94729825|NCT03628924|324467829|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
94729826|NCT03628924|324467830|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
94729827|NCT03628924|324467824|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
94729828|NCT03628924|324467825|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
94729829|NCT03628924|324467826|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
94729830|NCT03628924|324467827|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
94729831|NCT03628924|324467828|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
94729832|NCT03628924|324467829|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
94729833|NCT03628924|324467830|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
94729834|NCT03452579|324467834|FG000|Overall Study|Death|0|||
94729835|NCT03452579|324467835|FG001|Overall Study|Death|1|||
94729836|NCT03452579|324467834|FG000|Overall Study|Withdrawal by Subject|2|||
94729837|NCT03452579|324467835|FG001|Overall Study|Withdrawal by Subject|0|||
94729838|NCT03452579|324467834|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
94729839|NCT03452579|324467835|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
94729840|NCT03452579|324467834|FG000|Overall Study|Physician Decision|1|||
94729841|NCT03452579|324467835|FG001|Overall Study|Physician Decision|1|||
94729842|NCT03452579|324467834|FG000|Overall Study|Adverse Event|1|||
94729843|NCT03452579|324467835|FG001|Overall Study|Adverse Event|4|||
94729844|NCT03474679|324467836|FG000|Overall Study|Death|7|||
94729845|NCT03474679|324467836|FG000|Overall Study|Withdrawal by Subject|1|||
94729846|NCT02438722|324467839|FG000|Overall Study|Adverse Event|12|||
94729847|NCT02438722|324467840|FG001|Overall Study|Adverse Event|9|||
94729848|NCT02438722|324467839|FG000|Overall Study|Refusal unrelated to AE|2|||
94729849|NCT02438722|324467840|FG001|Overall Study|Refusal unrelated to AE|5|||
94729850|NCT02438722|324467839|FG000|Overall Study|Disease progression/relapse|46|||
94729851|NCT02438722|324467840|FG001|Overall Study|Disease progression/relapse|51|||
94467409|NCT00415597|323500560|FG000|Treatment|Sponsor Decision|1|||
94467410|NCT00415597|323500560|FG000|Treatment|Multiple Reasons|1|||
94729852|NCT02438722|324467839|FG000|Overall Study|Death|0|||
94729853|NCT02438722|324467840|FG001|Overall Study|Death|3|||
94729854|NCT02438722|324467839|FG000|Overall Study|Physician Decision|2|||
94729855|NCT02438722|324467840|FG001|Overall Study|Physician Decision|2|||
94273708|NCT02116777|322793819|FG006|Overall Study|Physician Decision|0|||
94273709|NCT02116777|322793813|FG000|Overall Study|Protocol Violation|0|||
94273710|NCT02116777|322793814|FG001|Overall Study|Protocol Violation|0|||
94273711|NCT02116777|322793815|FG002|Overall Study|Protocol Violation|0|||
94729856|NCT02438722|324467839|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
94729857|NCT02438722|324467840|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
94729858|NCT02438722|324467839|FG000|Overall Study|Withdrawal by Subject|0|||
94729859|NCT02438722|324467840|FG001|Overall Study|Withdrawal by Subject|1|||
94729860|NCT02438722|324467839|FG000|Overall Study|On protocol treatment|15|||
94729861|NCT02438722|324467840|FG001|Overall Study|On protocol treatment|14|||
94729862|NCT02438722|324467839|FG000|Overall Study|Did not receive protocol treatment|5|||
94729863|NCT02438722|324467840|FG001|Overall Study|Did not receive protocol treatment|0|||
94729864|NCT02761057|324467842|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
94729865|NCT02761057|324467843|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
94729866|NCT02761057|324467844|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
94729867|NCT02761057|324467845|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
94729868|NCT02761057|324467842|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
94729869|NCT02761057|324467843|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
94729870|NCT02761057|324467844|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
94729871|NCT02761057|324467845|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
94729872|NCT02761057|324467842|FG000|Overall Study|Currently On Study Treatment|0|||
94729873|NCT02761057|324467843|FG001|Overall Study|Currently On Study Treatment|3|||
94729874|NCT02761057|324467844|FG002|Overall Study|Currently On Study Treatment|0|||
94729875|NCT02761057|324467845|FG003|Overall Study|Currently On Study Treatment|0|||
94729876|NCT02761057|324467842|FG000|Overall Study|Adverse Event|11|||
94729877|NCT02761057|324467843|FG001|Overall Study|Adverse Event|9|||
94729878|NCT02761057|324467844|FG002|Overall Study|Adverse Event|5|||
94729879|NCT02761057|324467845|FG003|Overall Study|Adverse Event|3|||
94729880|NCT02761057|324467842|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
94729881|NCT02761057|324467843|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
94729882|NCT02761057|324467844|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
94729883|NCT02761057|324467845|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
94729884|NCT02761057|324467842|FG000|Overall Study|Progression/Relapse|29|||
94729885|NCT02761057|324467843|FG001|Overall Study|Progression/Relapse|27|||
94729886|NCT02761057|324467844|FG002|Overall Study|Progression/Relapse|20|||
94729887|NCT02761057|324467845|FG003|Overall Study|Progression/Relapse|23|||
94729888|NCT02761057|324467842|FG000|Overall Study|Death|2|||
94729889|NCT02761057|324467843|FG001|Overall Study|Death|2|||
94729890|NCT02761057|324467844|FG002|Overall Study|Death|1|||
94729891|NCT02761057|324467845|FG003|Overall Study|Death|1|||
94729892|NCT02761057|324467842|FG000|Overall Study|Other - Not Protocol Specified|2|||
94729893|NCT02761057|324467843|FG001|Overall Study|Other - Not Protocol Specified|1|||
94729894|NCT02761057|324467844|FG002|Overall Study|Other - Not Protocol Specified|2|||
94729895|NCT02761057|324467845|FG003|Overall Study|Other - Not Protocol Specified|0|||
94729896|NCT04632992|324467853|FG000|Overall Study|Adverse Event|0|||
94729897|NCT04632992|324467854|FG001|Overall Study|Adverse Event|0|||
94729898|NCT04632992|324467855|FG002|Overall Study|Adverse Event|0|||
94729899|NCT04632992|324467856|FG003|Overall Study|Adverse Event|0|||
94729900|NCT04632992|324467857|FG004|Overall Study|Adverse Event|0|||
94729901|NCT04632992|324467858|FG005|Overall Study|Adverse Event|0|||
94729902|NCT04632992|324467859|FG006|Overall Study|Adverse Event|0|||
94729903|NCT04632992|324467860|FG007|Overall Study|Adverse Event|0|||
94729904|NCT04632992|324467861|FG008|Overall Study|Adverse Event|0|||
94729905|NCT04632992|324467862|FG009|Overall Study|Adverse Event|0|||
94729906|NCT04632992|324467863|FG010|Overall Study|Adverse Event|0|||
94729907|NCT04632992|324467864|FG011|Overall Study|Adverse Event|0|||
94729908|NCT04632992|324467865|FG012|Overall Study|Adverse Event|1|||
94729909|NCT04632992|324467866|FG013|Overall Study|Adverse Event|0|||
94729910|NCT04632992|324467853|FG000|Overall Study|Death|17|||
94729911|NCT04632992|324467854|FG001|Overall Study|Death|1|||
94729912|NCT04632992|324467855|FG002|Overall Study|Death|14|||
94729913|NCT04632992|324467856|FG003|Overall Study|Death|14|||
94729914|NCT04632992|324467857|FG004|Overall Study|Death|13|||
94729915|NCT04632992|324467858|FG005|Overall Study|Death|6|||
94273712|NCT02116777|322793816|FG003|Overall Study|Protocol Violation|1|||
94729916|NCT04632992|324467859|FG006|Overall Study|Death|7|||
94729917|NCT04632992|324467860|FG007|Overall Study|Death|12|||
94729918|NCT04632992|324467861|FG008|Overall Study|Death|15|||
94729919|NCT04632992|324467862|FG009|Overall Study|Death|20|||
94729920|NCT04632992|324467863|FG010|Overall Study|Death|8|||
94729921|NCT04632992|324467864|FG011|Overall Study|Death|2|||
94729922|NCT04632992|324467865|FG012|Overall Study|Death|10|||
94729923|NCT04632992|324467866|FG013|Overall Study|Death|1|||
94729924|NCT04632992|324467853|FG000|Overall Study|Lost to Follow-up|1|||
94729925|NCT04632992|324467854|FG001|Overall Study|Lost to Follow-up|0|||
94729926|NCT04632992|324467855|FG002|Overall Study|Lost to Follow-up|1|||
94729927|NCT04632992|324467856|FG003|Overall Study|Lost to Follow-up|0|||
94273713|NCT02116777|322793817|FG004|Overall Study|Protocol Violation|0|||
94273714|NCT02116777|322793818|FG005|Overall Study|Protocol Violation|0|||
94273715|NCT02116777|322793819|FG006|Overall Study|Protocol Violation|0|||
94273716|NCT02116777|322793813|FG000|Overall Study|Withdrawal by Subject|0|||
94273717|NCT02116777|322793814|FG001|Overall Study|Withdrawal by Subject|0|||
94273718|NCT02116777|322793815|FG002|Overall Study|Withdrawal by Subject|0|||
94273719|NCT02116777|322793816|FG003|Overall Study|Withdrawal by Subject|1|||
94467411|NCT04015518|323500561|FG000|Overall Study|Adverse Event|6|||
94273720|NCT02116777|322793817|FG004|Overall Study|Withdrawal by Subject|0|||
94273721|NCT02116777|322793818|FG005|Overall Study|Withdrawal by Subject|0|||
94273722|NCT02116777|322793819|FG006|Overall Study|Withdrawal by Subject|0|||
94273723|NCT03080883|322793822|FG000|Overall Study|Withdrawal by Subject|11|||
94273724|NCT03080883|322793823|FG001|Overall Study|Withdrawal by Subject|15|||
94273725|NCT03080883|322793822|FG000|Overall Study|Adverse Event|22|||
94273726|NCT03080883|322793823|FG001|Overall Study|Adverse Event|22|||
94273727|NCT03080883|322793822|FG000|Overall Study|Alternative Therapy|0|||
94273728|NCT03080883|322793823|FG001|Overall Study|Alternative Therapy|3|||
94273729|NCT03080883|322793822|FG000|Overall Study|Other Complicating Disease|9|||
94273730|NCT03080883|322793823|FG001|Overall Study|Other Complicating Disease|5|||
94273731|NCT03080883|322793822|FG000|Overall Study|Death|21|||
94273732|NCT03080883|322793823|FG001|Overall Study|Death|16|||
94273733|NCT03080883|322793822|FG000|Overall Study|Physician Decision|2|||
94273734|NCT03080883|322793823|FG001|Overall Study|Physician Decision|2|||
94273735|NCT03080883|322793822|FG000|Overall Study|Disease Progression|2|||
94273736|NCT03080883|322793823|FG001|Overall Study|Disease Progression|8|||
94273737|NCT03080883|322793822|FG000|Overall Study|Lost to Follow-up|1|||
94273738|NCT03080883|322793823|FG001|Overall Study|Lost to Follow-up|1|||
94273739|NCT00457015|322795632|FG000|Overall Study|Left study site against medical advice|0|||
94273740|NCT00457015|322795633|FG001|Overall Study|Left study site against medical advice|1|||
94273741|NCT01490450|322795634|FG000|Period 1|Lack of Efficacy|2|||
94273742|NCT01490450|322795635|FG001|Period 1|Lack of Efficacy|0|||
94273743|NCT01490450|322795636|FG002|Period 1|Lack of Efficacy|3|||
94273744|NCT01490450|322795637|FG003|Period 1|Lack of Efficacy|0|||
94273745|NCT01490450|322795634|FG000|Period 1|Adverse Event|0|||
94273746|NCT01490450|322795635|FG001|Period 1|Adverse Event|0|||
94729928|NCT04632992|324467857|FG004|Overall Study|Lost to Follow-up|2|||
94729929|NCT04632992|324467858|FG005|Overall Study|Lost to Follow-up|0|||
94729930|NCT04632992|324467859|FG006|Overall Study|Lost to Follow-up|1|||
94273747|NCT01490450|322795636|FG002|Period 1|Adverse Event|0|||
94273748|NCT01490450|322795637|FG003|Period 1|Adverse Event|5|||
94273749|NCT01490450|322795634|FG000|Period 1|Request to discontinue treatment|1|||
94273750|NCT01490450|322795635|FG001|Period 1|Request to discontinue treatment|0|||
94273751|NCT01490450|322795636|FG002|Period 1|Request to discontinue treatment|0|||
94273752|NCT01490450|322795637|FG003|Period 1|Request to discontinue treatment|0|||
94273753|NCT01490450|322795634|FG000|Period 1|Withdrawal by Subject|0|||
94273754|NCT01490450|322795635|FG001|Period 1|Withdrawal by Subject|0|||
94273755|NCT01490450|322795636|FG002|Period 1|Withdrawal by Subject|0|||
94273756|NCT01490450|322795637|FG003|Period 1|Withdrawal by Subject|3|||
94273757|NCT01490450|322795634|FG000|Period 1|No longer met study criteria|0|||
94273758|NCT01490450|322795635|FG001|Period 1|No longer met study criteria|1|||
94273759|NCT01490450|322795636|FG002|Period 1|No longer met study criteria|1|||
94273760|NCT01490450|322795637|FG003|Period 1|No longer met study criteria|0|||
94273761|NCT01490450|322795634|FG000|Period 2|Lack of Efficacy|0|||
94273762|NCT01490450|322795635|FG001|Period 2|Lack of Efficacy|0|||
94729931|NCT04632992|324467860|FG007|Overall Study|Lost to Follow-up|1|||
94729932|NCT04632992|324467861|FG008|Overall Study|Lost to Follow-up|1|||
94729933|NCT04632992|324467862|FG009|Overall Study|Lost to Follow-up|1|||
94729934|NCT04632992|324467863|FG010|Overall Study|Lost to Follow-up|2|||
94729935|NCT04632992|324467864|FG011|Overall Study|Lost to Follow-up|0|||
94729936|NCT04632992|324467865|FG012|Overall Study|Lost to Follow-up|0|||
94729937|NCT04632992|324467866|FG013|Overall Study|Lost to Follow-up|0|||
94729938|NCT04632992|324467853|FG000|Overall Study|Reason not Specified|2|||
94729939|NCT04632992|324467854|FG001|Overall Study|Reason not Specified|0|||
94729940|NCT04632992|324467855|FG002|Overall Study|Reason not Specified|1|||
94729941|NCT04632992|324467856|FG003|Overall Study|Reason not Specified|1|||
94729942|NCT04632992|324467857|FG004|Overall Study|Reason not Specified|0|||
94729943|NCT04632992|324467858|FG005|Overall Study|Reason not Specified|0|||
94729944|NCT04632992|324467859|FG006|Overall Study|Reason not Specified|0|||
94729945|NCT04632992|324467860|FG007|Overall Study|Reason not Specified|0|||
94729946|NCT04632992|324467861|FG008|Overall Study|Reason not Specified|0|||
94729947|NCT04632992|324467862|FG009|Overall Study|Reason not Specified|0|||
94729948|NCT04632992|324467863|FG010|Overall Study|Reason not Specified|1|||
94729949|NCT04632992|324467864|FG011|Overall Study|Reason not Specified|0|||
94729950|NCT04632992|324467865|FG012|Overall Study|Reason not Specified|0|||
94729951|NCT04632992|324467866|FG013|Overall Study|Reason not Specified|0|||
94729952|NCT04632992|324467853|FG000|Overall Study|Physician Decision|0|||
94729953|NCT04632992|324467854|FG001|Overall Study|Physician Decision|0|||
94729954|NCT04632992|324467855|FG002|Overall Study|Physician Decision|0|||
94729955|NCT04632992|324467856|FG003|Overall Study|Physician Decision|2|||
94729956|NCT04632992|324467857|FG004|Overall Study|Physician Decision|1|||
94729957|NCT04632992|324467858|FG005|Overall Study|Physician Decision|0|||
94729958|NCT04632992|324467859|FG006|Overall Study|Physician Decision|0|||
94729959|NCT04632992|324467860|FG007|Overall Study|Physician Decision|0|||
94729960|NCT04632992|324467861|FG008|Overall Study|Physician Decision|0|||
94729961|NCT04632992|324467862|FG009|Overall Study|Physician Decision|0|||
94729962|NCT04632992|324467863|FG010|Overall Study|Physician Decision|0|||
94729963|NCT04632992|324467864|FG011|Overall Study|Physician Decision|0|||
94729964|NCT04632992|324467865|FG012|Overall Study|Physician Decision|3|||
94729965|NCT04632992|324467866|FG013|Overall Study|Physician Decision|0|||
94729966|NCT04632992|324467853|FG000|Overall Study|Progressive Disease|0|||
94729967|NCT04632992|324467854|FG001|Overall Study|Progressive Disease|0|||
94729968|NCT04632992|324467855|FG002|Overall Study|Progressive Disease|0|||
94729969|NCT04632992|324467856|FG003|Overall Study|Progressive Disease|0|||
94729970|NCT04632992|324467857|FG004|Overall Study|Progressive Disease|1|||
94273763|NCT01490450|322795636|FG002|Period 2|Lack of Efficacy|0|||
94273764|NCT01490450|322795637|FG003|Period 2|Lack of Efficacy|1|||
94273765|NCT01490450|322795634|FG000|Period 2|Adverse Event|1|||
94273766|NCT01490450|322795635|FG001|Period 2|Adverse Event|1|||
94273767|NCT01490450|322795636|FG002|Period 2|Adverse Event|0|||
94273768|NCT01490450|322795637|FG003|Period 2|Adverse Event|1|||
94273769|NCT01490450|322795634|FG000|Period 2|Withdrawal by Subject|1|||
94273770|NCT01490450|322795635|FG001|Period 2|Withdrawal by Subject|0|||
94273771|NCT01490450|322795636|FG002|Period 2|Withdrawal by Subject|0|||
94273772|NCT01490450|322795637|FG003|Period 2|Withdrawal by Subject|0|||
94273773|NCT01490450|322795634|FG000|Period 2|Lost to Follow-up|0|||
94729971|NCT04632992|324467858|FG005|Overall Study|Progressive Disease|0|||
94729972|NCT04632992|324467859|FG006|Overall Study|Progressive Disease|0|||
94729973|NCT04632992|324467860|FG007|Overall Study|Progressive Disease|0|||
94729974|NCT04632992|324467861|FG008|Overall Study|Progressive Disease|0|||
94729975|NCT04632992|324467862|FG009|Overall Study|Progressive Disease|1|||
94729976|NCT04632992|324467863|FG010|Overall Study|Progressive Disease|1|||
94729977|NCT04632992|324467864|FG011|Overall Study|Progressive Disease|0|||
94729978|NCT04632992|324467865|FG012|Overall Study|Progressive Disease|2|||
94729979|NCT04632992|324467866|FG013|Overall Study|Progressive Disease|0|||
94729980|NCT04632992|324467853|FG000|Overall Study|Withdrawal by Subject|4|||
94729981|NCT04632992|324467854|FG001|Overall Study|Withdrawal by Subject|1|||
94729982|NCT04632992|324467855|FG002|Overall Study|Withdrawal by Subject|5|||
94729983|NCT04632992|324467856|FG003|Overall Study|Withdrawal by Subject|4|||
94729984|NCT04632992|324467857|FG004|Overall Study|Withdrawal by Subject|3|||
94729985|NCT04632992|324467858|FG005|Overall Study|Withdrawal by Subject|3|||
94729986|NCT04632992|324467859|FG006|Overall Study|Withdrawal by Subject|0|||
94729987|NCT04632992|324467860|FG007|Overall Study|Withdrawal by Subject|5|||
94729988|NCT04632992|324467861|FG008|Overall Study|Withdrawal by Subject|0|||
94729989|NCT04632992|324467862|FG009|Overall Study|Withdrawal by Subject|2|||
94729990|NCT04632992|324467863|FG010|Overall Study|Withdrawal by Subject|8|||
94729991|NCT04632992|324467864|FG011|Overall Study|Withdrawal by Subject|0|||
94729992|NCT04632992|324467865|FG012|Overall Study|Withdrawal by Subject|1|||
94729993|NCT04632992|324467866|FG013|Overall Study|Withdrawal by Subject|1|||
94729994|NCT02677805|324467867|FG000|Double Blind Phase|Lost to Follow-up|8|||
94729995|NCT02677805|324467868|FG001|Double Blind Phase|Lost to Follow-up|3|||
94729996|NCT02677805|324467869|FG002|Double Blind Phase|Lost to Follow-up|0|||
94729997|NCT02677805|324467867|FG000|Double Blind Phase|Withdrawal by Subject|5|||
94729998|NCT02677805|324467868|FG001|Double Blind Phase|Withdrawal by Subject|2|||
94729999|NCT02677805|324467869|FG002|Double Blind Phase|Withdrawal by Subject|0|||
94730000|NCT02677805|324467867|FG000|Open Label Phase|Lost to Follow-up|0|||
94730001|NCT02677805|324467868|FG001|Open Label Phase|Lost to Follow-up|0|||
94730002|NCT02677805|324467869|FG002|Open Label Phase|Lost to Follow-up|10|||
94730003|NCT02677805|324467867|FG000|Open Label Phase|Withdrawal by Subject|0|||
94730004|NCT02677805|324467868|FG001|Open Label Phase|Withdrawal by Subject|0|||
94730005|NCT02677805|324467869|FG002|Open Label Phase|Withdrawal by Subject|6|||
94730006|NCT06037369|324467870|FG000|Overall Study|Lost to Follow-up|0|||
94730007|NCT06037369|324467871|FG001|Overall Study|Lost to Follow-up|1|||
94730008|NCT03097549|324467872|FG000|Overall Study|Withdrawal by Subject|1|||
94730009|NCT03097549|324467873|FG001|Overall Study|Withdrawal by Subject|0|||
94730010|NCT03097549|324467872|FG000|Overall Study|Lost to Follow-up|1|||
94273774|NCT01490450|322795635|FG001|Period 2|Lost to Follow-up|0|||
94273775|NCT01490450|322795636|FG002|Period 2|Lost to Follow-up|0|||
94273776|NCT01490450|322795637|FG003|Period 2|Lost to Follow-up|2|||
94273777|NCT00747643|322795638|FG000|Overall Study|Withdrawal by Subject|36|||
94730011|NCT03097549|324467873|FG001|Overall Study|Lost to Follow-up|0|||
94730012|NCT05783102|324467874|FG000|Overall Study|Lost to Follow-up|1|||
94730013|NCT05783102|324467874|FG000|Overall Study|Withdrawal by Subject|2|||
94730014|NCT05647304|324467875|FG000|Overall Study|Withdrawal by Subject|1|||
94730015|NCT05647304|324467876|FG001|Overall Study|Withdrawal by Subject|0|||
94730016|NCT05008835|324467877|FG000|Overall Study|Adverse Event|5|||
94730017|NCT05008835|324467878|FG001|Overall Study|Adverse Event|2|||
94730018|NCT05008835|324467879|FG002|Overall Study|Adverse Event|1|||
94730019|NCT05008835|324467877|FG000|Overall Study|Lack of Efficacy|0|||
94730020|NCT05008835|324467878|FG001|Overall Study|Lack of Efficacy|0|||
94730021|NCT05008835|324467879|FG002|Overall Study|Lack of Efficacy|1|||
94730022|NCT05008835|324467877|FG000|Overall Study|Study terminated by sponsor|0|||
94730023|NCT05008835|324467878|FG001|Overall Study|Study terminated by sponsor|0|||
94730024|NCT05008835|324467879|FG002|Overall Study|Study terminated by sponsor|1|||
94730025|NCT05008835|324467877|FG000|Overall Study|Not further specified|3|||
94730026|NCT05008835|324467878|FG001|Overall Study|Not further specified|2|||
94730027|NCT05008835|324467879|FG002|Overall Study|Not further specified|1|||
94730028|NCT04171999|324467880|FG000|Overall Study|deemed ineligible after randomization|2|||
94730029|NCT04171999|324467881|FG001|Overall Study|deemed ineligible after randomization|1|||
94730030|NCT02547233|324467882|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
94730031|NCT02547233|324467883|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
94730032|NCT02547233|324467882|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
94730033|NCT02547233|324467883|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
94730034|NCT02547233|324467882|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
94730035|NCT02547233|324467883|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
94730036|NCT02547233|324467882|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
94730037|NCT02547233|324467883|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
94730038|NCT02547233|324467882|FG000|12-month Follow-up|Withdrawal by Subject|10|||
94730039|NCT02547233|324467883|FG001|12-month Follow-up|Withdrawal by Subject|10|||
94730040|NCT02547233|324467882|FG000|12-month Follow-up|Lost to Follow-up|3|||
94730041|NCT02547233|324467883|FG001|12-month Follow-up|Lost to Follow-up|3|||
94730042|NCT02547233|324467882|FG000|12-month Follow-up|Lack of Efficacy|1|||
94730043|NCT02547233|324467883|FG001|12-month Follow-up|Lack of Efficacy|2|||
94730044|NCT02547233|324467882|FG000|12-month Follow-up|Protocol Violation|0|||
94730045|NCT02547233|324467883|FG001|12-month Follow-up|Protocol Violation|1|||
94730046|NCT02547233|324467882|FG000|12-month Follow-up|Other|0|||
94730047|NCT02547233|324467883|FG001|12-month Follow-up|Other|1|||
94730048|NCT03092518|324467884|FG000|Overall Study|Ineligible|2|||
94730049|NCT02043678|324467889|FG000|Overall Study|Never treated|11|||
94730050|NCT02043678|324467890|FG001|Overall Study|Never treated|9|||
94730051|NCT02043678|324467889|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
94730052|NCT02043678|324467890|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
94730053|NCT02043678|324467889|FG000|Overall Study|AE without clinical PD|54|||
94730054|NCT02043678|324467890|FG001|Overall Study|AE without clinical PD|36|||
94730055|NCT02043678|324467889|FG000|Overall Study|Lost to Follow-up|1|||
94730056|NCT02043678|324467890|FG001|Overall Study|Lost to Follow-up|1|||
94730057|NCT02043678|324467889|FG000|Overall Study|Other|10|||
94730058|NCT02043678|324467890|FG001|Overall Study|Other|14|||
94730059|NCT02043678|324467889|FG000|Overall Study|Clinical PD|114|||
94730060|NCT02043678|324467890|FG001|Overall Study|Clinical PD|148|||
94730061|NCT02043678|324467889|FG000|Overall Study|Radiological PD|100|||
94730062|NCT02043678|324467890|FG001|Overall Study|Radiological PD|90|||
94730063|NCT02043678|324467889|FG000|Overall Study|Protocol-driven decision point|59|||
94730064|NCT02043678|324467890|FG001|Overall Study|Protocol-driven decision point|58|||
94730065|NCT02043678|324467889|FG000|Overall Study|Withdrawal by Subject|16|||
94730066|NCT02043678|324467890|FG001|Overall Study|Withdrawal by Subject|20|||
94730067|NCT02043678|324467889|FG000|Overall Study|Protocol Violation|1|||
94730068|NCT02043678|324467890|FG001|Overall Study|Protocol Violation|0|||
94730069|NCT02043678|324467889|FG000|Overall Study|Deterioration of general conditions|1|||
94730070|NCT02043678|324467890|FG001|Overall Study|Deterioration of general conditions|1|||
94730071|NCT02043678|324467889|FG000|Overall Study|Logistical difficulties|2|||
94730072|NCT02043678|324467890|FG001|Overall Study|Logistical difficulties|0|||
94730073|NCT02043678|324467889|FG000|Overall Study|Non-compliance with study drug|3|||
94730074|NCT02043678|324467890|FG001|Overall Study|Non-compliance with study drug|1|||
94730075|NCT02043678|324467889|FG000|Overall Study|Physician Decision|4|||
94730076|NCT02043678|324467890|FG001|Overall Study|Physician Decision|3|||
94730077|NCT02043678|324467889|FG000|Overall Study|Subject decision|0|||
94730078|NCT02043678|324467890|FG001|Overall Study|Subject decision|1|||
94730079|NCT02043678|324467889|FG000|Overall Study|Switching to other therapy|3|||
94730080|NCT02043678|324467890|FG001|Overall Study|Switching to other therapy|2|||
94730081|NCT02043678|324467889|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
94730082|NCT02043678|324467890|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
94730083|NCT02043678|324467889|FG000|Overall Study|Missing|1|||
94730084|NCT02043678|324467890|FG001|Overall Study|Missing|0|||
94730085|NCT02043678|324467889|FG000|Overall Study|Adverse Event|0|||
94730086|NCT02043678|324467890|FG001|Overall Study|Adverse Event|1|||
94730087|NCT04137367|324467893|FG000|Overall Study|Lost to Follow-up|8|||
94730088|NCT04137367|324467894|FG001|Overall Study|Lost to Follow-up|6|||
94730089|NCT04137367|324467895|FG002|Overall Study|Lost to Follow-up|4|||
94730090|NCT05533632|324467896|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
94730091|NCT05533632|324467896|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
94730092|NCT05533632|324467896|FG000|Overall Study|Lost to Follow-up|1|||
94730093|NCT05533632|324467896|FG000|Overall Study|Withdrawal by Subject|4|||
94730094|NCT05533632|324467896|FG000|Overall Study|Adverse Event|4|||
94730095|NCT05296525|324467897|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
94730096|NCT05296525|324467898|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
94730097|NCT05296525|324467899|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
94730098|NCT05296525|324467900|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
94730099|NCT04948697|324467903|FG000|Overall Study|Progressive disease|27|||
94730100|NCT04948697|324467904|FG001|Overall Study|Progressive disease|18|||
94730101|NCT04948697|324467903|FG000|Overall Study|Adverse Event|14|||
94730102|NCT04948697|324467904|FG001|Overall Study|Adverse Event|4|||
94730103|NCT04948697|324467903|FG000|Overall Study|Participant moved to long term extension study|7|||
94730104|NCT04948697|324467904|FG001|Overall Study|Participant moved to long term extension study|4|||
94730105|NCT04948697|324467903|FG000|Overall Study|Withdrawal by Subject|10|||
94730106|NCT04948697|324467904|FG001|Overall Study|Withdrawal by Subject|0|||
94730107|NCT04948697|324467903|FG000|Overall Study|Closed by Sponsor|3|||
94730108|NCT04948697|324467904|FG001|Overall Study|Closed by Sponsor|2|||
94730109|NCT04948697|324467903|FG000|Overall Study|Physician Decision|0|||
94730110|NCT04948697|324467904|FG001|Overall Study|Physician Decision|2|||
94730111|NCT04948697|324467903|FG000|Overall Study|Lost to Follow-up|0|||
94730112|NCT04948697|324467904|FG001|Overall Study|Lost to Follow-up|1|||
94730113|NCT04948697|324467903|FG000|Overall Study|Other-Miscellaneous|1|||
94730114|NCT04948697|324467904|FG001|Overall Study|Other-Miscellaneous|0|||
94730115|NCT04948697|324467903|FG000|Overall Study|Randomized but not treated|0|||
94730116|NCT04948697|324467904|FG001|Overall Study|Randomized but not treated|1|||
94730117|NCT04338061|324467906|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
94730118|NCT04338061|324467907|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
94730119|NCT04338061|324467906|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
94730120|NCT04338061|324467907|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
94730121|NCT04338061|324467906|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
94730122|NCT04338061|324467907|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
94730123|NCT04338061|324467906|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
94730124|NCT04338061|324467907|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
94730125|NCT04338061|324467906|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
94730126|NCT04338061|324467907|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
94730127|NCT04338061|324467906|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
94730128|NCT04338061|324467907|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
94730129|NCT04338061|324467906|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
94730130|NCT04338061|324467907|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
94730131|NCT04338061|324467906|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
94730132|NCT04338061|324467907|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
94730133|NCT04338061|324467906|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
94730134|NCT04338061|324467907|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
94730135|NCT04338061|324467906|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
94730136|NCT04338061|324467907|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
94730137|NCT04338061|324467906|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
94730138|NCT04338061|324467907|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
94730139|NCT04338061|324467906|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
94730140|NCT04338061|324467907|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
94730141|NCT04599062|324467908|FG000|Overall Study|Physician Decision|1|||
94730142|NCT04599062|324467909|FG001|Overall Study|Physician Decision|0|||
94730143|NCT03631784|324467910|FG000|Overall Study|Participants Ongoing|1|||
94730144|NCT03631784|324467911|FG001|Overall Study|Participants Ongoing|0|||
94730145|NCT03631784|324467910|FG000|Overall Study|Withdrawal by Subject|3|||
94730146|NCT03631784|324467911|FG001|Overall Study|Withdrawal by Subject|3|||
94730147|NCT03631784|324467910|FG000|Overall Study|Sponsor's Decision|36|||
94730148|NCT03631784|324467911|FG001|Overall Study|Sponsor's Decision|52|||
94730149|NCT03631784|324467910|FG000|Overall Study|Lost to Follow-up|1|||
94730150|NCT03631784|324467911|FG001|Overall Study|Lost to Follow-up|0|||
94730151|NCT03631784|324467910|FG000|Overall Study|Death|71|||
94730152|NCT03631784|324467911|FG001|Overall Study|Death|49|||
94730153|NCT04907851|324467914|FG000|Overall Study|Consent withdrawn|1|||
94730154|NCT04907851|324467915|FG001|Overall Study|Consent withdrawn|2|||
94730155|NCT04907851|324467916|FG002|Overall Study|Consent withdrawn|0|||
94730156|NCT04907851|324467914|FG000|Overall Study|Death|5|||
94730157|NCT04907851|324467915|FG001|Overall Study|Death|15|||
94730158|NCT04907851|324467916|FG002|Overall Study|Death|10|||
94467412|NCT04015518|323500562|FG001|Overall Study|Adverse Event|1|||
94730159|NCT06232590|324467918|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
94730160|NCT06232590|324467919|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
94730161|NCT03134196|324469990|FG000|Overall Study|Death|2|||
94730162|NCT03134196|324469991|FG001|Overall Study|Death|1|||
94730163|NCT03134196|324469990|FG000|Overall Study|Lost to Follow-up|13|||
94730164|NCT03134196|324469991|FG001|Overall Study|Lost to Follow-up|15|||
94730165|NCT03134196|324469990|FG000|Overall Study|Physician Decision|0|||
94730166|NCT03134196|324469991|FG001|Overall Study|Physician Decision|1|||
94730167|NCT03134196|324469990|FG000|Overall Study|Withdrawal by Subject|19|||
94730168|NCT03134196|324469991|FG001|Overall Study|Withdrawal by Subject|12|||
94730169|NCT03134196|324469990|FG000|Overall Study|Site Unable to Contact Participant|2|||
94730170|NCT03134196|324469991|FG001|Overall Study|Site Unable to Contact Participant|0|||
94730171|NCT03134196|324469990|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
94730172|NCT03134196|324469991|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
94730173|NCT03134196|324469990|FG000|Overall Study|Scheduling Conflict|1|||
94730174|NCT03134196|324469991|FG001|Overall Study|Scheduling Conflict|0|||
94730175|NCT04495894|324469993|FG000|Overall Study|Withdrawal by Subject|2|||
94730176|NCT04495894|324469994|FG001|Overall Study|Withdrawal by Subject|0|||
94730177|NCT04495894|324469995|FG002|Overall Study|Withdrawal by Subject|2|||
94730178|NCT04495894|324469996|FG003|Overall Study|Withdrawal by Subject|3|||
94730179|NCT04495894|324469993|FG000|Overall Study|Early termination|0|||
94730180|NCT04495894|324469994|FG001|Overall Study|Early termination|0|||
94730181|NCT04495894|324469995|FG002|Overall Study|Early termination|3|||
94730182|NCT04495894|324469996|FG003|Overall Study|Early termination|0|||
94730183|NCT03694418|324469997|FG000|Overall Study|Lost to Follow-up|115|||
94730184|NCT03694418|324469998|FG001|Overall Study|Lost to Follow-up|23|||
94730185|NCT03694418|324469999|FG002|Overall Study|Lost to Follow-up|12|||
94730186|NCT03694418|324470000|FG003|Overall Study|Lost to Follow-up|12|||
94730187|NCT03694418|324470001|FG004|Overall Study|Lost to Follow-up|13|||
94730188|NCT04963270|324470002|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
94730189|NCT04963270|324470003|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
94730190|NCT04963270|324470004|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
94730191|NCT04963270|324470005|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
94730192|NCT04963270|324470002|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
94730193|NCT04963270|324470003|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
94730194|NCT04963270|324470004|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
94730195|NCT04963270|324470005|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
94730196|NCT04963270|324470002|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
94730197|NCT04963270|324470003|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
94730198|NCT04963270|324470004|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
94730199|NCT04963270|324470005|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
94730200|NCT04963270|324470002|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
94730201|NCT04963270|324470003|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
94730202|NCT04963270|324470004|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
94730203|NCT04963270|324470005|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
94730204|NCT04963270|324470002|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
94730205|NCT04963270|324470003|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
94273778|NCT00747643|322795639|FG001|Overall Study|Withdrawal by Subject|27|||
94273779|NCT01999465|322795644|FG000|Overall Study|Lost to Follow-up|0|||
94273780|NCT01999465|322795645|FG001|Overall Study|Lost to Follow-up|2|||
94273781|NCT01999465|322795644|FG000|Overall Study|Protocol Violation|0|||
94730206|NCT04963270|324470004|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
94730207|NCT04963270|324470005|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
94730208|NCT04963270|324470002|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
94730209|NCT04963270|324470003|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
94730210|NCT04963270|324470004|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
94730211|NCT04963270|324470005|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
94730212|NCT04963270|324470002|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
94730213|NCT04963270|324470003|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
94730214|NCT04963270|324470004|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
94730215|NCT04963270|324470005|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
94730216|NCT04963270|324470002|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
94730217|NCT04963270|324470003|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
94730218|NCT04963270|324470004|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
94730219|NCT04963270|324470005|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
94730220|NCT04963270|324470002|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
94730221|NCT04963270|324470003|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
94730222|NCT04963270|324470004|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
94730223|NCT04963270|324470005|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
94273782|NCT01999465|322795645|FG001|Overall Study|Protocol Violation|1|||
94273783|NCT00636675|322795646|FG000|Overall Study|Lost to Follow-up|121|||
94730224|NCT04963270|324470002|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
94730225|NCT04963270|324470003|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
94730226|NCT04963270|324470004|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
94730227|NCT04963270|324470005|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
94730228|NCT04963270|324470002|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
94730229|NCT04963270|324470003|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
94730230|NCT04963270|324470004|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
94730231|NCT04963270|324470005|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
94730232|NCT04963270|324470002|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
94730233|NCT04963270|324470003|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
94730234|NCT04963270|324470004|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
94730235|NCT04963270|324470005|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
94730236|NCT04963270|324470002|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
94730237|NCT04963270|324470003|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
94730238|NCT04963270|324470004|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
94730239|NCT04963270|324470005|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
94730240|NCT04963270|324470002|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
94730241|NCT04963270|324470003|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
94730242|NCT04963270|324470004|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
94730243|NCT04963270|324470005|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
94730244|NCT04802967|324470006|FG000|Part B|Withdrawal by Subject|0|||
94730245|NCT04802967|324470007|FG001|Part B|Withdrawal by Subject|0|||
94730246|NCT04802967|324470008|FG002|Part B|Withdrawal by Subject|0|||
94730247|NCT04802967|324470009|FG003|Part B|Withdrawal by Subject|0|||
94730248|NCT04802967|324470010|FG004|Part B|Withdrawal by Subject|0|||
94730249|NCT04802967|324470011|FG005|Part B|Withdrawal by Subject|1|||
94730250|NCT04802967|324470012|FG006|Part B|Withdrawal by Subject|0|||
94730251|NCT04802967|324470013|FG007|Part B|Withdrawal by Subject|0|||
94730252|NCT04802967|324470014|FG008|Part B|Withdrawal by Subject|0|||
94730253|NCT04802967|324470015|FG009|Part B|Withdrawal by Subject|0|||
94730254|NCT04295798|324470016|FG000|Overall Study|Lost to Follow-up|1|||
94730255|NCT01824875|324470018|FG000|Overall Study|Disease progression|22|||
94730256|NCT01824875|324470019|FG001|Overall Study|Disease progression|15|||
94730257|NCT01824875|324470018|FG000|Overall Study|Withdrawal by Subject|5|||
94730258|NCT01824875|324470019|FG001|Overall Study|Withdrawal by Subject|4|||
94730259|NCT01824875|324470018|FG000|Overall Study|Adverse Event|4|||
94730260|NCT01824875|324470019|FG001|Overall Study|Adverse Event|10|||
94730261|NCT01824875|324470018|FG000|Overall Study|Alternative therapy|3|||
94730262|NCT01824875|324470019|FG001|Overall Study|Alternative therapy|0|||
94730263|NCT01824875|324470018|FG000|Overall Study|Complicating disease|1|||
94730264|NCT01824875|324470019|FG001|Overall Study|Complicating disease|0|||
94730265|NCT01824875|324470018|FG000|Overall Study|Physician Decision|0|||
94730266|NCT01824875|324470019|FG001|Overall Study|Physician Decision|1|||
94730267|NCT01824875|324470018|FG000|Overall Study|Non-compliance|1|||
94730268|NCT01824875|324470019|FG001|Overall Study|Non-compliance|1|||
94730269|NCT01824875|324470018|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
94730270|NCT01824875|324470019|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
94730271|NCT01824875|324470018|FG000|Overall Study|Administrative issues|0|||
94730272|NCT01824875|324470019|FG001|Overall Study|Administrative issues|2|||
94730273|NCT01824875|324470018|FG000|Overall Study|Ineligible or never started treatment|9|||
94730274|NCT01824875|324470019|FG001|Overall Study|Ineligible or never started treatment|5|||
94730275|NCT01824875|324470018|FG000|Overall Study|Other|0|||
94730276|NCT01824875|324470019|FG001|Overall Study|Other|2|||
94730277|NCT01842542|324470020|FG000|Overall Study|Withdrawal by Subject|2|||
94730278|NCT01842542|324470020|FG000|Overall Study|Lack of Efficacy|1|||
94730279|NCT01842542|324470020|FG000|Overall Study|Protocol Non-compliance|2|||
94730280|NCT01842542|324470020|FG000|Overall Study|Lost to Follow-up|1|||
94730281|NCT02573493|324470035|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
94730282|NCT02573493|324470036|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
94730283|NCT02573493|324470037|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
94730284|NCT02573493|324470038|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
94730285|NCT04971681|324470039|FG000|Followup|Lost to Follow-up|1|||
94730286|NCT04971681|324470040|FG001|Followup|Lost to Follow-up|0|||
94730287|NCT00686335|324470041|FG000|Run-in Period|Adverse Event|1|||
94730288|NCT00686335|324470041|FG000|Run-in Period|asthma exacerbation|1|||
94730289|NCT00686335|324470041|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
94730290|NCT04149704|324470045|FG000|Three Month Follow-up|Death|2|||
94730291|NCT04149704|324470046|FG001|Three Month Follow-up|Death|0|||
94730292|NCT04149704|324470047|FG002|Three Month Follow-up|Death|0|||
94730293|NCT04149704|324470048|FG003|Three Month Follow-up|Death|0|||
94730294|NCT04149704|324470045|FG000|Three Month Follow-up|Lost to Follow-up|1|||
94730295|NCT04149704|324470046|FG001|Three Month Follow-up|Lost to Follow-up|4|||
94730296|NCT04149704|324470047|FG002|Three Month Follow-up|Lost to Follow-up|5|||
94730297|NCT04149704|324470048|FG003|Three Month Follow-up|Lost to Follow-up|5|||
94730298|NCT04149704|324470045|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
94730299|NCT04149704|324470046|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
94730300|NCT04149704|324470047|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
94730301|NCT04149704|324470048|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
94730302|NCT04149704|324470045|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
94730303|NCT04149704|324470046|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
94730304|NCT04149704|324470047|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
94730305|NCT04149704|324470048|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
94730306|NCT06132282|324470049|FG000|Overall Study|Lost to Follow-up|31|||
94730307|NCT03544281|324470055|FG000|Main Study Phase|Death|3|||
94730308|NCT03544281|324470056|FG001|Main Study Phase|Death|2|||
94730309|NCT03544281|324470057|FG002|Main Study Phase|Death|6|||
94730310|NCT03544281|324470058|FG003|Main Study Phase|Death|8|||
94730311|NCT03544281|324470059|FG004|Main Study Phase|Death|4|||
94730312|NCT03544281|324470060|FG005|Main Study Phase|Death|2|||
94730313|NCT03544281|324470061|FG006|Main Study Phase|Death|4|||
94730314|NCT03544281|324470062|FG007|Main Study Phase|Death|5|||
94730315|NCT03544281|324470063|FG008|Main Study Phase|Death|5|||
94730316|NCT03544281|324470064|FG009|Main Study Phase|Death|8|||
94730317|NCT03544281|324470065|FG010|Main Study Phase|Death|6|||
94730318|NCT03544281|324470066|FG011|Main Study Phase|Death|4|||
94730319|NCT03544281|324470067|FG012|Main Study Phase|Death|0|||
94730320|NCT03544281|324470068|FG013|Main Study Phase|Death|0|||
94730321|NCT03544281|324470069|FG014|Main Study Phase|Death|0|||
94730322|NCT03544281|324470070|FG015|Main Study Phase|Death|0|||
94730323|NCT03544281|324470071|FG016|Main Study Phase|Death|0|||
94730324|NCT03544281|324470072|FG017|Main Study Phase|Death|0|||
94730325|NCT03544281|324470073|FG018|Main Study Phase|Death|0|||
94730326|NCT03544281|324470074|FG019|Main Study Phase|Death|0|||
94730327|NCT03544281|324470075|FG020|Main Study Phase|Death|0|||
94730328|NCT03544281|324470076|FG021|Main Study Phase|Death|0|||
94730329|NCT03544281|324470055|FG000|Main Study Phase|Lost to Follow-up|0|||
94730330|NCT03544281|324470056|FG001|Main Study Phase|Lost to Follow-up|0|||
94730331|NCT03544281|324470057|FG002|Main Study Phase|Lost to Follow-up|0|||
94730332|NCT03544281|324470058|FG003|Main Study Phase|Lost to Follow-up|0|||
94730333|NCT03544281|324470059|FG004|Main Study Phase|Lost to Follow-up|0|||
94730334|NCT03544281|324470060|FG005|Main Study Phase|Lost to Follow-up|0|||
94730335|NCT03544281|324470061|FG006|Main Study Phase|Lost to Follow-up|0|||
94730336|NCT03544281|324470062|FG007|Main Study Phase|Lost to Follow-up|0|||
94730337|NCT03544281|324470063|FG008|Main Study Phase|Lost to Follow-up|0|||
94730338|NCT03544281|324470064|FG009|Main Study Phase|Lost to Follow-up|0|||
94730339|NCT03544281|324470065|FG010|Main Study Phase|Lost to Follow-up|1|||
94730340|NCT03544281|324470066|FG011|Main Study Phase|Lost to Follow-up|0|||
94730341|NCT03544281|324470067|FG012|Main Study Phase|Lost to Follow-up|0|||
94730342|NCT03544281|324470068|FG013|Main Study Phase|Lost to Follow-up|0|||
94730343|NCT03544281|324470069|FG014|Main Study Phase|Lost to Follow-up|0|||
94730344|NCT03544281|324470070|FG015|Main Study Phase|Lost to Follow-up|0|||
94730345|NCT03544281|324470071|FG016|Main Study Phase|Lost to Follow-up|0|||
94730346|NCT03544281|324470072|FG017|Main Study Phase|Lost to Follow-up|0|||
94730347|NCT03544281|324470073|FG018|Main Study Phase|Lost to Follow-up|0|||
94730348|NCT03544281|324470074|FG019|Main Study Phase|Lost to Follow-up|0|||
94730349|NCT03544281|324470075|FG020|Main Study Phase|Lost to Follow-up|0|||
94730350|NCT03544281|324470076|FG021|Main Study Phase|Lost to Follow-up|0|||
94730351|NCT03544281|324470055|FG000|Main Study Phase|Physician Decision|0|||
94730352|NCT03544281|324470056|FG001|Main Study Phase|Physician Decision|0|||
94730353|NCT03544281|324470057|FG002|Main Study Phase|Physician Decision|0|||
94730354|NCT03544281|324470058|FG003|Main Study Phase|Physician Decision|0|||
94730355|NCT03544281|324470059|FG004|Main Study Phase|Physician Decision|0|||
94730356|NCT03544281|324470060|FG005|Main Study Phase|Physician Decision|0|||
94730357|NCT03544281|324470061|FG006|Main Study Phase|Physician Decision|0|||
94730358|NCT03544281|324470062|FG007|Main Study Phase|Physician Decision|1|||
94730359|NCT03544281|324470063|FG008|Main Study Phase|Physician Decision|0|||
94730360|NCT03544281|324470064|FG009|Main Study Phase|Physician Decision|0|||
94730361|NCT03544281|324470065|FG010|Main Study Phase|Physician Decision|0|||
94730362|NCT03544281|324470066|FG011|Main Study Phase|Physician Decision|0|||
94730363|NCT03544281|324470067|FG012|Main Study Phase|Physician Decision|0|||
94730364|NCT03544281|324470068|FG013|Main Study Phase|Physician Decision|0|||
94730365|NCT03544281|324470069|FG014|Main Study Phase|Physician Decision|0|||
94730366|NCT03544281|324470070|FG015|Main Study Phase|Physician Decision|0|||
94730367|NCT03544281|324470071|FG016|Main Study Phase|Physician Decision|0|||
94730368|NCT03544281|324470072|FG017|Main Study Phase|Physician Decision|0|||
94730369|NCT03544281|324470073|FG018|Main Study Phase|Physician Decision|0|||
94730370|NCT03544281|324470074|FG019|Main Study Phase|Physician Decision|0|||
94730371|NCT03544281|324470075|FG020|Main Study Phase|Physician Decision|0|||
94730372|NCT03544281|324470076|FG021|Main Study Phase|Physician Decision|0|||
94730373|NCT03544281|324470055|FG000|Main Study Phase|Withdrawal by Subject|2|||
94730374|NCT03544281|324470056|FG001|Main Study Phase|Withdrawal by Subject|0|||
94730375|NCT03544281|324470057|FG002|Main Study Phase|Withdrawal by Subject|1|||
94730376|NCT03544281|324470058|FG003|Main Study Phase|Withdrawal by Subject|2|||
94730377|NCT03544281|324470059|FG004|Main Study Phase|Withdrawal by Subject|0|||
94730378|NCT03544281|324470060|FG005|Main Study Phase|Withdrawal by Subject|0|||
94730379|NCT03544281|324470061|FG006|Main Study Phase|Withdrawal by Subject|0|||
94730380|NCT03544281|324470062|FG007|Main Study Phase|Withdrawal by Subject|0|||
94730381|NCT03544281|324470063|FG008|Main Study Phase|Withdrawal by Subject|2|||
94730382|NCT03544281|324470064|FG009|Main Study Phase|Withdrawal by Subject|3|||
94730383|NCT03544281|324470065|FG010|Main Study Phase|Withdrawal by Subject|0|||
94273784|NCT00636675|322795647|FG001|Overall Study|Lost to Follow-up|31|||
94273785|NCT00636675|322795646|FG000|Overall Study|Withdrawal by Subject|19|||
94273786|NCT00636675|322795647|FG001|Overall Study|Withdrawal by Subject|10|||
94273787|NCT04053868|322795648|FG000|Overall Study|Withdrawal by Subject|1|||
94273788|NCT04053868|322795649|FG001|Overall Study|Withdrawal by Subject|0|||
94273789|NCT00257725|322795651|FG000|Overall Study|Adverse Event|3|||
94273790|NCT00840086|322795654|FG000|Overall Study|Adverse Event|1|||
94730384|NCT03544281|324470066|FG011|Main Study Phase|Withdrawal by Subject|4|||
94730385|NCT03544281|324470067|FG012|Main Study Phase|Withdrawal by Subject|0|||
94730386|NCT03544281|324470068|FG013|Main Study Phase|Withdrawal by Subject|0|||
94730387|NCT03544281|324470069|FG014|Main Study Phase|Withdrawal by Subject|0|||
94730388|NCT03544281|324470070|FG015|Main Study Phase|Withdrawal by Subject|0|||
94730389|NCT03544281|324470071|FG016|Main Study Phase|Withdrawal by Subject|0|||
94730390|NCT03544281|324470072|FG017|Main Study Phase|Withdrawal by Subject|0|||
94730391|NCT03544281|324470073|FG018|Main Study Phase|Withdrawal by Subject|0|||
94730392|NCT03544281|324470074|FG019|Main Study Phase|Withdrawal by Subject|0|||
94273791|NCT00840086|322795654|FG000|Overall Study|Protocol Violation|2|||
94273792|NCT00840086|322795654|FG000|Overall Study|Lost to Follow-up|1|||
94273793|NCT01471015|322795655|FG000|Overall Study|Death|0|||
94273794|NCT01471015|322795656|FG001|Overall Study|Death|1|||
94273795|NCT01471015|322795657|FG002|Overall Study|Death|1|||
94273796|NCT01732796|322795658|FG000|Overall Study|Adverse Event|16|||
94273797|NCT01732796|322795659|FG001|Overall Study|Adverse Event|16|||
94273798|NCT01732796|322795660|FG002|Overall Study|Adverse Event|4|||
94273799|NCT01732796|322795658|FG000|Overall Study|Lack of Efficacy|21|||
94273800|NCT01732796|322795659|FG001|Overall Study|Lack of Efficacy|18|||
94273801|NCT01732796|322795660|FG002|Overall Study|Lack of Efficacy|5|||
94273802|NCT01732796|322795658|FG000|Overall Study|Lost to Follow-up|2|||
94273803|NCT01732796|322795659|FG001|Overall Study|Lost to Follow-up|0|||
94273804|NCT01732796|322795660|FG002|Overall Study|Lost to Follow-up|0|||
94273805|NCT01732796|322795658|FG000|Overall Study|Withdrawal by Subject|6|||
94273806|NCT01732796|322795659|FG001|Overall Study|Withdrawal by Subject|8|||
94273807|NCT01732796|322795660|FG002|Overall Study|Withdrawal by Subject|2|||
94273808|NCT01732796|322795658|FG000|Overall Study|Other reason not defined above|1|||
94273809|NCT01732796|322795659|FG001|Overall Study|Other reason not defined above|0|||
94273810|NCT01732796|322795660|FG002|Overall Study|Other reason not defined above|2|||
94273811|NCT02343159|322795663|FG000|Overall Study|Early Study Termination|16|||
94273812|NCT02343159|322795664|FG001|Overall Study|Early Study Termination|19|||
94273813|NCT02343159|322795665|FG002|Overall Study|Early Study Termination|23|||
94273814|NCT02343159|322795663|FG000|Overall Study|Physician Decision|2|||
94273815|NCT02343159|322795664|FG001|Overall Study|Physician Decision|0|||
94273816|NCT02343159|322795665|FG002|Overall Study|Physician Decision|1|||
94273817|NCT02343159|322795663|FG000|Overall Study|Withdrawal by Subject|3|||
94273818|NCT02343159|322795664|FG001|Overall Study|Withdrawal by Subject|0|||
94273819|NCT02343159|322795665|FG002|Overall Study|Withdrawal by Subject|2|||
94273820|NCT02343159|322795663|FG000|Overall Study|Lost to Follow-up|0|||
94273821|NCT02343159|322795664|FG001|Overall Study|Lost to Follow-up|2|||
94273822|NCT02343159|322795665|FG002|Overall Study|Lost to Follow-up|2|||
94273823|NCT02343159|322795663|FG000|Overall Study|Adverse Event|4|||
94273824|NCT02343159|322795664|FG001|Overall Study|Adverse Event|4|||
94273825|NCT02343159|322795665|FG002|Overall Study|Adverse Event|2|||
94273826|NCT02343159|322795663|FG000|Overall Study|Sponsor Decision|0|||
94273827|NCT02343159|322795664|FG001|Overall Study|Sponsor Decision|1|||
94273828|NCT02343159|322795665|FG002|Overall Study|Sponsor Decision|0|||
94273829|NCT02343159|322795663|FG000|Overall Study|Enrollment Error|1|||
94273830|NCT02343159|322795664|FG001|Overall Study|Enrollment Error|0|||
94273831|NCT02343159|322795665|FG002|Overall Study|Enrollment Error|0|||
94273832|NCT01923285|322795666|FG000|Overall Study|Withdrawal by Subject|7|||
94273833|NCT01923285|322795667|FG001|Overall Study|Withdrawal by Subject|6|||
94273834|NCT03374189|322795669|FG000|Overall Study|Lost to Follow-up|1|||
94273835|NCT03374189|322795670|FG001|Overall Study|Lost to Follow-up|0|||
94273836|NCT00631020|322795674|FG000|Overall Study|Lost to Follow-up|7|||
94273837|NCT00631020|322795674|FG000|Overall Study|Incarcerated|1|||
94273838|NCT00271596|322795676|FG000|Overall Study|Protocol Violation|1|||
94730393|NCT03544281|324470075|FG020|Main Study Phase|Withdrawal by Subject|0|||
94730394|NCT03544281|324470076|FG021|Main Study Phase|Withdrawal by Subject|0|||
94730395|NCT03544281|324470055|FG000|Main Study Phase|Ongoing|3|||
94730396|NCT03544281|324470056|FG001|Main Study Phase|Ongoing|1|||
94730397|NCT03544281|324470057|FG002|Main Study Phase|Ongoing|2|||
94730398|NCT03544281|324470058|FG003|Main Study Phase|Ongoing|4|||
94730399|NCT03544281|324470059|FG004|Main Study Phase|Ongoing|2|||
94730400|NCT03544281|324470060|FG005|Main Study Phase|Ongoing|4|||
94730401|NCT03544281|324470061|FG006|Main Study Phase|Ongoing|4|||
94730402|NCT03544281|324470062|FG007|Main Study Phase|Ongoing|0|||
94730403|NCT03544281|324470063|FG008|Main Study Phase|Ongoing|2|||
94730404|NCT03544281|324470064|FG009|Main Study Phase|Ongoing|2|||
94730405|NCT03544281|324470065|FG010|Main Study Phase|Ongoing|1|||
94730406|NCT03544281|324470066|FG011|Main Study Phase|Ongoing|0|||
94730407|NCT03544281|324470067|FG012|Main Study Phase|Ongoing|0|||
94730408|NCT03544281|324470068|FG013|Main Study Phase|Ongoing|0|||
94730409|NCT03544281|324470069|FG014|Main Study Phase|Ongoing|0|||
94730410|NCT03544281|324470070|FG015|Main Study Phase|Ongoing|0|||
94730411|NCT03544281|324470071|FG016|Main Study Phase|Ongoing|0|||
94730412|NCT03544281|324470072|FG017|Main Study Phase|Ongoing|0|||
94730413|NCT03544281|324470073|FG018|Main Study Phase|Ongoing|0|||
94730414|NCT03544281|324470074|FG019|Main Study Phase|Ongoing|0|||
94730415|NCT03544281|324470075|FG020|Main Study Phase|Ongoing|0|||
94730416|NCT03544281|324470076|FG021|Main Study Phase|Ongoing|0|||
94730417|NCT03544281|324470055|FG000|Main Study Phase|Investigator Site Closed|0|||
94730418|NCT03544281|324470056|FG001|Main Study Phase|Investigator Site Closed|0|||
94730419|NCT03544281|324470057|FG002|Main Study Phase|Investigator Site Closed|0|||
94730420|NCT03544281|324470058|FG003|Main Study Phase|Investigator Site Closed|0|||
94730421|NCT03544281|324470059|FG004|Main Study Phase|Investigator Site Closed|0|||
94730422|NCT03544281|324470060|FG005|Main Study Phase|Investigator Site Closed|0|||
94730423|NCT03544281|324470061|FG006|Main Study Phase|Investigator Site Closed|0|||
94730424|NCT03544281|324470062|FG007|Main Study Phase|Investigator Site Closed|0|||
94730425|NCT03544281|324470063|FG008|Main Study Phase|Investigator Site Closed|0|||
94730426|NCT03544281|324470064|FG009|Main Study Phase|Investigator Site Closed|1|||
94730427|NCT03544281|324470065|FG010|Main Study Phase|Investigator Site Closed|0|||
94730428|NCT03544281|324470066|FG011|Main Study Phase|Investigator Site Closed|0|||
94730429|NCT03544281|324470067|FG012|Main Study Phase|Investigator Site Closed|0|||
94730430|NCT03544281|324470068|FG013|Main Study Phase|Investigator Site Closed|0|||
94730431|NCT03544281|324470069|FG014|Main Study Phase|Investigator Site Closed|0|||
94730432|NCT03544281|324470070|FG015|Main Study Phase|Investigator Site Closed|0|||
94730433|NCT03544281|324470071|FG016|Main Study Phase|Investigator Site Closed|0|||
94730434|NCT03544281|324470072|FG017|Main Study Phase|Investigator Site Closed|0|||
94730435|NCT03544281|324470073|FG018|Main Study Phase|Investigator Site Closed|0|||
94730436|NCT03544281|324470074|FG019|Main Study Phase|Investigator Site Closed|0|||
94730437|NCT03544281|324470075|FG020|Main Study Phase|Investigator Site Closed|0|||
94730438|NCT03544281|324470076|FG021|Main Study Phase|Investigator Site Closed|0|||
94730439|NCT03544281|324470055|FG000|Main Study Phase|Did not receive study treatment|0|||
94730440|NCT03544281|324470056|FG001|Main Study Phase|Did not receive study treatment|0|||
94730441|NCT03544281|324470057|FG002|Main Study Phase|Did not receive study treatment|0|||
94730442|NCT03544281|324470058|FG003|Main Study Phase|Did not receive study treatment|0|||
94730443|NCT03544281|324470059|FG004|Main Study Phase|Did not receive study treatment|0|||
94730444|NCT03544281|324470060|FG005|Main Study Phase|Did not receive study treatment|0|||
94730445|NCT03544281|324470061|FG006|Main Study Phase|Did not receive study treatment|1|||
94730446|NCT03544281|324470062|FG007|Main Study Phase|Did not receive study treatment|0|||
94730447|NCT03544281|324470063|FG008|Main Study Phase|Did not receive study treatment|0|||
94730448|NCT03544281|324470064|FG009|Main Study Phase|Did not receive study treatment|0|||
94730449|NCT03544281|324470065|FG010|Main Study Phase|Did not receive study treatment|0|||
94730450|NCT03544281|324470066|FG011|Main Study Phase|Did not receive study treatment|0|||
94730451|NCT03544281|324470067|FG012|Main Study Phase|Did not receive study treatment|0|||
94730452|NCT03544281|324470068|FG013|Main Study Phase|Did not receive study treatment|0|||
94730453|NCT03544281|324470069|FG014|Main Study Phase|Did not receive study treatment|0|||
94730454|NCT03544281|324470070|FG015|Main Study Phase|Did not receive study treatment|0|||
94730455|NCT03544281|324470071|FG016|Main Study Phase|Did not receive study treatment|0|||
94730456|NCT03544281|324470072|FG017|Main Study Phase|Did not receive study treatment|0|||
94730457|NCT03544281|324470073|FG018|Main Study Phase|Did not receive study treatment|0|||
94730458|NCT03544281|324470074|FG019|Main Study Phase|Did not receive study treatment|0|||
94730459|NCT03544281|324470075|FG020|Main Study Phase|Did not receive study treatment|0|||
94730460|NCT03544281|324470076|FG021|Main Study Phase|Did not receive study treatment|0|||
94730461|NCT03544281|324470055|FG000|PACT Phase|Adverse Event|0|||
94730462|NCT03544281|324470056|FG001|PACT Phase|Adverse Event|0|||
94730463|NCT03544281|324470057|FG002|PACT Phase|Adverse Event|0|||
94730464|NCT03544281|324470058|FG003|PACT Phase|Adverse Event|0|||
94730465|NCT03544281|324470059|FG004|PACT Phase|Adverse Event|0|||
94730466|NCT03544281|324470060|FG005|PACT Phase|Adverse Event|0|||
94730467|NCT03544281|324470061|FG006|PACT Phase|Adverse Event|0|||
94730468|NCT03544281|324470062|FG007|PACT Phase|Adverse Event|0|||
94730469|NCT03544281|324470063|FG008|PACT Phase|Adverse Event|0|||
94730470|NCT03544281|324470064|FG009|PACT Phase|Adverse Event|0|||
94273839|NCT00271596|322795677|FG001|Overall Study|Protocol Violation|0|||
94273840|NCT00271596|322795676|FG000|Overall Study|Withdrawal by Subject|0|||
94273841|NCT00271596|322795677|FG001|Overall Study|Withdrawal by Subject|1|||
94273842|NCT00732303|322795678|FG000|Overall Study|Study Terminated|2|||
94273843|NCT04707157|322795679|FG000|Overall Study|Adverse Event|12|||
94273844|NCT04707157|322795680|FG001|Overall Study|Adverse Event|3|||
94273845|NCT04707157|322795679|FG000|Overall Study|Lost to Follow-up|2|||
94273846|NCT04707157|322795680|FG001|Overall Study|Lost to Follow-up|0|||
94273847|NCT04707157|322795679|FG000|Overall Study|Sponsor's decision|1|||
94273848|NCT04707157|322795680|FG001|Overall Study|Sponsor's decision|0|||
94273849|NCT04707157|322795679|FG000|Overall Study|Physician Decision|8|||
94273850|NCT04707157|322795680|FG001|Overall Study|Physician Decision|5|||
94273851|NCT04707157|322795679|FG000|Overall Study|Protocol Deviation|1|||
94368650|NCT01682512|323136502|FG001|Overall Study|Withdrawal by Subject|6|||
94368651|NCT01682512|323136503|FG002|Overall Study|Withdrawal by Subject|3|||
94368652|NCT01682512|323136501|FG000|Overall Study|Physician Decision|0|||
94368653|NCT01682512|323136502|FG001|Overall Study|Physician Decision|2|||
94730471|NCT03544281|324470065|FG010|PACT Phase|Adverse Event|0|||
94730472|NCT03544281|324470066|FG011|PACT Phase|Adverse Event|0|||
94730473|NCT03544281|324470067|FG012|PACT Phase|Adverse Event|1|||
94730474|NCT03544281|324470068|FG013|PACT Phase|Adverse Event|0|||
94730475|NCT03544281|324470069|FG014|PACT Phase|Adverse Event|0|||
94730476|NCT03544281|324470070|FG015|PACT Phase|Adverse Event|0|||
94730477|NCT03544281|324470071|FG016|PACT Phase|Adverse Event|0|||
94730478|NCT03544281|324470072|FG017|PACT Phase|Adverse Event|1|||
94730479|NCT03544281|324470073|FG018|PACT Phase|Adverse Event|1|||
94730480|NCT03544281|324470074|FG019|PACT Phase|Adverse Event|0|||
94730481|NCT03544281|324470075|FG020|PACT Phase|Adverse Event|0|||
94730482|NCT03544281|324470076|FG021|PACT Phase|Adverse Event|0|||
94730483|NCT04282148|324470077|FG000|Overall Study|Death|7|||
94730484|NCT04282148|324470077|FG000|Overall Study|Withdrawal by Subject|1|||
94730485|NCT04282148|324470077|FG000|Overall Study|Physician Decision|1|||
94730486|NCT04676763|324470078|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
94730487|NCT04676763|324470079|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
94730488|NCT04676763|324470080|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
94730489|NCT04676763|324470078|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
94730490|NCT04676763|324470079|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
94730491|NCT04676763|324470080|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
94730492|NCT04676763|324470078|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
94730493|NCT04676763|324470079|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
94730494|NCT04676763|324470080|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
94730495|NCT03150173|324470081|FG000|Overall Study|Lost to Follow-up|13|||
94730496|NCT03150173|324470082|FG001|Overall Study|Lost to Follow-up|5|||
94730497|NCT05415722|324470084|FG000|Overall Study|Lost to Follow-up|0|||
94730498|NCT05415722|324470085|FG001|Overall Study|Lost to Follow-up|2|||
94730499|NCT05415722|324470086|FG002|Overall Study|Lost to Follow-up|0|||
94730500|NCT05415722|324470087|FG003|Overall Study|Lost to Follow-up|1|||
94730501|NCT05415722|324470088|FG004|Overall Study|Lost to Follow-up|0|||
94730502|NCT05415722|324470089|FG005|Overall Study|Lost to Follow-up|0|||
94730503|NCT05415722|324470090|FG006|Overall Study|Lost to Follow-up|1|||
94730504|NCT05415722|324470084|FG000|Overall Study|Physician Decision|0|||
94730505|NCT05415722|324470085|FG001|Overall Study|Physician Decision|0|||
94730506|NCT05415722|324470086|FG002|Overall Study|Physician Decision|0|||
94730507|NCT05415722|324470087|FG003|Overall Study|Physician Decision|1|||
94730508|NCT05415722|324470088|FG004|Overall Study|Physician Decision|0|||
94730509|NCT05415722|324470089|FG005|Overall Study|Physician Decision|0|||
94730510|NCT05415722|324470090|FG006|Overall Study|Physician Decision|1|||
94730511|NCT05415722|324470084|FG000|Overall Study|Protocol Violation|0|||
94730512|NCT05415722|324470085|FG001|Overall Study|Protocol Violation|0|||
94730513|NCT05415722|324470086|FG002|Overall Study|Protocol Violation|0|||
94730514|NCT05415722|324470087|FG003|Overall Study|Protocol Violation|1|||
94730515|NCT05415722|324470088|FG004|Overall Study|Protocol Violation|0|||
94730516|NCT05415722|324470089|FG005|Overall Study|Protocol Violation|0|||
94730517|NCT05415722|324470090|FG006|Overall Study|Protocol Violation|0|||
94730518|NCT05415722|324470084|FG000|Overall Study|Sponsor Discretion|0|||
94730519|NCT05415722|324470085|FG001|Overall Study|Sponsor Discretion|0|||
94273852|NCT04707157|322795680|FG001|Overall Study|Protocol Deviation|0|||
94273853|NCT04707157|322795679|FG000|Overall Study|Withdrawal by Subject|1|||
94273854|NCT04707157|322795680|FG001|Overall Study|Withdrawal by Subject|1|||
94368654|NCT01682512|323136503|FG002|Overall Study|Physician Decision|0|||
94467413|NCT04015518|323500563|FG002|Overall Study|Adverse Event|1|||
94730520|NCT05415722|324470086|FG002|Overall Study|Sponsor Discretion|0|||
94730521|NCT05415722|324470087|FG003|Overall Study|Sponsor Discretion|0|||
94730522|NCT05415722|324470088|FG004|Overall Study|Sponsor Discretion|1|||
94730523|NCT05415722|324470089|FG005|Overall Study|Sponsor Discretion|1|||
94730524|NCT05415722|324470090|FG006|Overall Study|Sponsor Discretion|0|||
94273855|NCT02919436|322795681|FG000|Overall Study|Did not undergo surgery|16|||
94273856|NCT02919436|322795682|FG001|Overall Study|Did not undergo surgery|20|||
94273857|NCT02919436|322795681|FG000|Overall Study|Enrolled before trial registration|44|||
94730525|NCT05415722|324470084|FG000|Overall Study|Withdrawal by Subject|0|||
94730526|NCT05415722|324470085|FG001|Overall Study|Withdrawal by Subject|1|||
94730527|NCT05415722|324470086|FG002|Overall Study|Withdrawal by Subject|0|||
94730528|NCT05415722|324470087|FG003|Overall Study|Withdrawal by Subject|1|||
94730529|NCT05415722|324470088|FG004|Overall Study|Withdrawal by Subject|1|||
94730530|NCT05415722|324470089|FG005|Overall Study|Withdrawal by Subject|0|||
94730531|NCT05415722|324470090|FG006|Overall Study|Withdrawal by Subject|1|||
94730532|NCT03031470|324470096|FG000|Overall Study|Adverse Event|3|||
94730533|NCT03031470|324470097|FG001|Overall Study|Adverse Event|0|||
94730534|NCT03031470|324470096|FG000|Overall Study|Death|3|||
94730535|NCT03031470|324470097|FG001|Overall Study|Death|1|||
94730536|NCT03031470|324470096|FG000|Overall Study|Lost to Follow-up|1|||
94730537|NCT03031470|324470097|FG001|Overall Study|Lost to Follow-up|1|||
94730538|NCT03031470|324470096|FG000|Overall Study|Withdrawal by Subject|1|||
94730539|NCT03031470|324470097|FG001|Overall Study|Withdrawal by Subject|0|||
94730540|NCT03031470|324470096|FG000|Overall Study|Protocol entry criteria not met|0|||
94730541|NCT03031470|324470097|FG001|Overall Study|Protocol entry criteria not met|1|||
94730542|NCT03031470|324470096|FG000|Overall Study|Cancel the operation|0|||
94730543|NCT03031470|324470097|FG001|Overall Study|Cancel the operation|1|||
94730544|NCT03461276|324470098|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
94730545|NCT03461276|324470099|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
94730546|NCT03461276|324470098|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
94730547|NCT03461276|324470099|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
94730548|NCT03461276|324470098|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
94730549|NCT03461276|324470099|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
94730550|NCT03461276|324470098|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
94730551|NCT03461276|324470099|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
94730552|NCT03461276|324470098|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
94730553|NCT03461276|324470099|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
94730554|NCT03461276|324470098|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
94730555|NCT03461276|324470099|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
94730556|NCT03461276|324470098|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
94730557|NCT03461276|324470099|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
94730558|NCT03461276|324470098|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
94730559|NCT03461276|324470099|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
94730560|NCT03461276|324470098|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
94730561|NCT03461276|324470099|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
94730562|NCT03461276|324470098|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
94730563|NCT03461276|324470099|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
94730564|NCT03496168|324470102|FG000|Overall Study|Other Reasons|1|||
94730565|NCT03496168|324470102|FG000|Overall Study|Adverse Event|1|||
94730566|NCT04858451|324470103|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
94730567|NCT04858451|324470104|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
94730568|NCT04858451|324470105|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
94730569|NCT04858451|324470106|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
94730570|NCT04858451|324470107|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
94730571|NCT04858451|324470108|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
94730572|NCT04858451|324470109|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
94730573|NCT04858451|324470110|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
94730574|NCT04858451|324470111|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
94730575|NCT04858451|324470103|FG000|Part 2|Discontinued|0|||
94730576|NCT04858451|324470104|FG001|Part 2|Discontinued|0|||
94730577|NCT04858451|324470105|FG002|Part 2|Discontinued|0|||
94730578|NCT04858451|324470106|FG003|Part 2|Discontinued|0|||
94730579|NCT04858451|324470107|FG004|Part 2|Discontinued|0|||
94273858|NCT02919436|322795682|FG001|Overall Study|Enrolled before trial registration|33|||
94273859|NCT03259074|322795688|FG000|Overall Study|Adverse Event|9|||
94730580|NCT04858451|324470108|FG005|Part 2|Discontinued|0|||
94730581|NCT04858451|324470109|FG006|Part 2|Discontinued|0|||
94730582|NCT04858451|324470110|FG007|Part 2|Discontinued|0|||
94730583|NCT04858451|324470111|FG008|Part 2|Discontinued|63|||
94730584|NCT03314454|324470114|FG000|Overall Study|Protocol Violation|1|||
94730585|NCT04499924|324470115|FG000|Overall Study|Study termination by sponsor|4|||
94730586|NCT04499924|324470116|FG001|Overall Study|Study termination by sponsor|6|||
94730587|NCT04499924|324470115|FG000|Overall Study|Withdrawal by Subject|1|||
94730588|NCT04499924|324470116|FG001|Overall Study|Withdrawal by Subject|3|||
94730589|NCT05808257|324470128|FG000|Overall Study|Lost to Follow-up|8|||
94730590|NCT05808257|324470129|FG001|Overall Study|Lost to Follow-up|8|||
94730591|NCT04568486|324470130|FG000|Overall Study|Withdrawal by Subject|26|||
94730592|NCT04568486|324470130|FG000|Overall Study|Lost to Follow-up|7|||
94730593|NCT00777036|324470131|FG000|On Treatment|Reason Not Specified|4|||
94730594|NCT00777036|324470132|FG001|On Treatment|Reason Not Specified|7|||
94730595|NCT00777036|324470133|FG002|On Treatment|Reason Not Specified|12|||
94730596|NCT00777036|324470131|FG000|On Treatment|Failure to Meet Study Criteria|0|||
94730597|NCT00777036|324470132|FG001|On Treatment|Failure to Meet Study Criteria|1|||
94730598|NCT00777036|324470133|FG002|On Treatment|Failure to Meet Study Criteria|0|||
94730599|NCT00777036|324470131|FG000|On Treatment|Non-compliance with Study Drug|1|||
94730600|NCT00777036|324470132|FG001|On Treatment|Non-compliance with Study Drug|0|||
94730601|NCT00777036|324470133|FG002|On Treatment|Non-compliance with Study Drug|0|||
94730602|NCT00777036|324470131|FG000|On Treatment|Maximum Clinical Benefit|2|||
94730603|NCT00777036|324470132|FG001|On Treatment|Maximum Clinical Benefit|0|||
94730604|NCT00777036|324470133|FG002|On Treatment|Maximum Clinical Benefit|1|||
94730605|NCT00777036|324470131|FG000|On Treatment|Withdrawal by Subject|3|||
94730606|NCT00777036|324470132|FG001|On Treatment|Withdrawal by Subject|2|||
94730607|NCT00777036|324470133|FG002|On Treatment|Withdrawal by Subject|3|||
94730608|NCT00777036|324470131|FG000|On Treatment|Death|0|||
94730609|NCT00777036|324470132|FG001|On Treatment|Death|2|||
94730610|NCT00777036|324470133|FG002|On Treatment|Death|0|||
94730611|NCT00777036|324470131|FG000|On Treatment|Study Drug Toxicity|0|||
94730612|NCT00777036|324470132|FG001|On Treatment|Study Drug Toxicity|0|||
94730613|NCT00777036|324470133|FG002|On Treatment|Study Drug Toxicity|1|||
94730614|NCT00777036|324470131|FG000|On Treatment|Progressive Disease|5|||
94730615|NCT00777036|324470132|FG001|On Treatment|Progressive Disease|4|||
94730616|NCT00777036|324470133|FG002|On Treatment|Progressive Disease|6|||
94730617|NCT00777036|324470131|FG000|Follow-Up|Lost to Follow-up|1|||
94730618|NCT00777036|324470132|FG001|Follow-Up|Lost to Follow-up|0|||
94730619|NCT00777036|324470133|FG002|Follow-Up|Lost to Follow-up|0|||
94730620|NCT00777036|324470131|FG000|Follow-Up|Reason Not Specified|2|||
94730621|NCT00777036|324470132|FG001|Follow-Up|Reason Not Specified|0|||
94730622|NCT00777036|324470133|FG002|Follow-Up|Reason Not Specified|0|||
94730623|NCT00777036|324470131|FG000|Follow-Up|Withdrawal by Subject|1|||
94730624|NCT00777036|324470132|FG001|Follow-Up|Withdrawal by Subject|0|||
94730625|NCT00777036|324470133|FG002|Follow-Up|Withdrawal by Subject|4|||
94730626|NCT00777036|324470131|FG000|Follow-Up|Death|1|||
94730627|NCT00777036|324470132|FG001|Follow-Up|Death|8|||
94730628|NCT00777036|324470133|FG002|Follow-Up|Death|0|||
94730629|NCT00324805|324470134|FG000|Overall Study|Adverse Event|62|||
94730630|NCT00324805|324470135|FG001|Overall Study|Adverse Event|203|||
94730631|NCT00324805|324470134|FG000|Overall Study|Progression|7|||
94730632|NCT00324805|324470135|FG001|Overall Study|Progression|35|||
94730633|NCT00324805|324470134|FG000|Overall Study|Withdrawal by Subject|51|||
94730634|NCT00324805|324470135|FG001|Overall Study|Withdrawal by Subject|174|||
94730635|NCT00324805|324470134|FG000|Overall Study|Death|6|||
94730636|NCT00324805|324470135|FG001|Overall Study|Death|9|||
94730637|NCT00324805|324470134|FG000|Overall Study|Alternative therapy|4|||
94730638|NCT00324805|324470135|FG001|Overall Study|Alternative therapy|8|||
94730639|NCT00324805|324470134|FG000|Overall Study|Other complicating disease|1|||
94730640|NCT00324805|324470135|FG001|Overall Study|Other complicating disease|9|||
94730641|NCT00324805|324470134|FG000|Overall Study|Other reasons|7|||
94730642|NCT00324805|324470135|FG001|Overall Study|Other reasons|26|||
94730643|NCT00324805|324470134|FG000|Overall Study|Other|0|||
94730644|NCT00324805|324470135|FG001|Overall Study|Other|2|||
94730645|NCT00324805|324470134|FG000|Overall Study|Did not start therapy|12|||
94730646|NCT00324805|324470135|FG001|Overall Study|Did not start therapy|17|||
94730647|NCT04898673|324470138|FG000|Overall Study|Screenfail|1|||
94730648|NCT04898673|324470139|FG001|Overall Study|Screenfail|0|||
94467414|NCT04015518|323500564|FG003|Overall Study|Adverse Event|3|||
94467415|NCT04015518|323500565|FG004|Overall Study|Adverse Event|3|||
94467416|NCT04015518|323500561|FG000|Overall Study|Lack of Efficacy|1|||
94730649|NCT03536754|324471736|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
94730650|NCT03536754|324471737|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
94730651|NCT03536754|324471738|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
94730652|NCT03536754|324471739|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
94730653|NCT03536754|324471740|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
94730654|NCT03536754|324471736|FG000|Open Label Extension|Other|0|||
94730655|NCT03536754|324471737|FG001|Open Label Extension|Other|0|||
94730656|NCT03536754|324471738|FG002|Open Label Extension|Other|0|||
94730657|NCT03536754|324471739|FG003|Open Label Extension|Other|0|||
94730658|NCT03536754|324471740|FG004|Open Label Extension|Other|1|||
94730659|NCT03854227|324471747|FG000|Overall Study|Adverse Event|0|||
94730660|NCT03854227|324471748|FG001|Overall Study|Adverse Event|0|||
94730661|NCT03854227|324471749|FG002|Overall Study|Adverse Event|0|||
94730662|NCT03854227|324471750|FG003|Overall Study|Adverse Event|1|||
94730663|NCT03854227|324471751|FG004|Overall Study|Adverse Event|0|||
94730664|NCT03854227|324471752|FG005|Overall Study|Adverse Event|0|||
94730665|NCT03854227|324471753|FG006|Overall Study|Adverse Event|1|||
94730666|NCT03854227|324471754|FG007|Overall Study|Adverse Event|0|||
94730667|NCT03854227|324471755|FG008|Overall Study|Adverse Event|0|||
94730668|NCT03854227|324471756|FG009|Overall Study|Adverse Event|3|||
94730669|NCT03854227|324471757|FG010|Overall Study|Adverse Event|0|||
94730670|NCT03854227|324471758|FG011|Overall Study|Adverse Event|1|||
94730671|NCT03854227|324471747|FG000|Overall Study|Death|0|||
94730672|NCT03854227|324471748|FG001|Overall Study|Death|0|||
94730673|NCT03854227|324471749|FG002|Overall Study|Death|0|||
94730674|NCT03854227|324471750|FG003|Overall Study|Death|0|||
94730675|NCT03854227|324471751|FG004|Overall Study|Death|0|||
94730676|NCT03854227|324471752|FG005|Overall Study|Death|1|||
94730677|NCT03854227|324471753|FG006|Overall Study|Death|0|||
94730678|NCT03854227|324471754|FG007|Overall Study|Death|0|||
94730679|NCT03854227|324471755|FG008|Overall Study|Death|0|||
94730680|NCT03854227|324471756|FG009|Overall Study|Death|1|||
94730681|NCT03854227|324471757|FG010|Overall Study|Death|0|||
94730682|NCT03854227|324471758|FG011|Overall Study|Death|1|||
94730683|NCT03854227|324471747|FG000|Overall Study|Physician Decision|0|||
94730684|NCT03854227|324471748|FG001|Overall Study|Physician Decision|0|||
94730685|NCT03854227|324471749|FG002|Overall Study|Physician Decision|0|||
94730686|NCT03854227|324471750|FG003|Overall Study|Physician Decision|0|||
94730687|NCT03854227|324471751|FG004|Overall Study|Physician Decision|0|||
94730688|NCT03854227|324471752|FG005|Overall Study|Physician Decision|1|||
94730689|NCT03854227|324471753|FG006|Overall Study|Physician Decision|0|||
94730690|NCT03854227|324471754|FG007|Overall Study|Physician Decision|0|||
94730691|NCT03854227|324471755|FG008|Overall Study|Physician Decision|1|||
94730692|NCT03854227|324471756|FG009|Overall Study|Physician Decision|1|||
94730693|NCT03854227|324471757|FG010|Overall Study|Physician Decision|0|||
94730694|NCT03854227|324471758|FG011|Overall Study|Physician Decision|1|||
94730695|NCT03854227|324471747|FG000|Overall Study|Progressive disease|1|||
94730696|NCT03854227|324471748|FG001|Overall Study|Progressive disease|1|||
94730697|NCT03854227|324471749|FG002|Overall Study|Progressive disease|1|||
94730698|NCT03854227|324471750|FG003|Overall Study|Progressive disease|2|||
94730699|NCT03854227|324471751|FG004|Overall Study|Progressive disease|3|||
94730700|NCT03854227|324471752|FG005|Overall Study|Progressive disease|1|||
94730701|NCT03854227|324471753|FG006|Overall Study|Progressive disease|2|||
94730702|NCT03854227|324471754|FG007|Overall Study|Progressive disease|5|||
94730703|NCT03854227|324471755|FG008|Overall Study|Progressive disease|2|||
94730704|NCT03854227|324471756|FG009|Overall Study|Progressive disease|5|||
94730705|NCT03854227|324471757|FG010|Overall Study|Progressive disease|1|||
94730706|NCT03854227|324471758|FG011|Overall Study|Progressive disease|6|||
94730707|NCT03854227|324471747|FG000|Overall Study|Study terminated by sponsor|0|||
94730708|NCT03854227|324471748|FG001|Overall Study|Study terminated by sponsor|0|||
94730709|NCT03854227|324471749|FG002|Overall Study|Study terminated by sponsor|0|||
94730710|NCT03854227|324471750|FG003|Overall Study|Study terminated by sponsor|0|||
94730711|NCT03854227|324471751|FG004|Overall Study|Study terminated by sponsor|0|||
94730712|NCT03854227|324471752|FG005|Overall Study|Study terminated by sponsor|0|||
94730713|NCT03854227|324471753|FG006|Overall Study|Study terminated by sponsor|0|||
94730714|NCT03854227|324471754|FG007|Overall Study|Study terminated by sponsor|0|||
94730715|NCT03854227|324471755|FG008|Overall Study|Study terminated by sponsor|0|||
94730716|NCT03854227|324471756|FG009|Overall Study|Study terminated by sponsor|1|||
94730717|NCT03854227|324471757|FG010|Overall Study|Study terminated by sponsor|0|||
94730718|NCT03854227|324471758|FG011|Overall Study|Study terminated by sponsor|0|||
94730719|NCT03854227|324471747|FG000|Overall Study|Withdrawal by Subject|0|||
94730720|NCT03854227|324471748|FG001|Overall Study|Withdrawal by Subject|0|||
94730721|NCT03854227|324471749|FG002|Overall Study|Withdrawal by Subject|1|||
94730722|NCT03854227|324471750|FG003|Overall Study|Withdrawal by Subject|0|||
94730723|NCT03854227|324471751|FG004|Overall Study|Withdrawal by Subject|0|||
94730724|NCT03854227|324471752|FG005|Overall Study|Withdrawal by Subject|0|||
94467417|NCT04015518|323500562|FG001|Overall Study|Lack of Efficacy|0|||
94730725|NCT03854227|324471753|FG006|Overall Study|Withdrawal by Subject|0|||
94730726|NCT03854227|324471754|FG007|Overall Study|Withdrawal by Subject|0|||
94730727|NCT03854227|324471755|FG008|Overall Study|Withdrawal by Subject|0|||
94730728|NCT03854227|324471756|FG009|Overall Study|Withdrawal by Subject|1|||
94730729|NCT03854227|324471757|FG010|Overall Study|Withdrawal by Subject|1|||
94730730|NCT03854227|324471758|FG011|Overall Study|Withdrawal by Subject|0|||
94730731|NCT03854227|324471747|FG000|Overall Study|Disease relapse|0|||
94730732|NCT03854227|324471748|FG001|Overall Study|Disease relapse|0|||
94730733|NCT03854227|324471749|FG002|Overall Study|Disease relapse|0|||
94730734|NCT03854227|324471750|FG003|Overall Study|Disease relapse|0|||
94730735|NCT03854227|324471751|FG004|Overall Study|Disease relapse|0|||
94730736|NCT03854227|324471752|FG005|Overall Study|Disease relapse|0|||
94730737|NCT03854227|324471753|FG006|Overall Study|Disease relapse|0|||
94730738|NCT03854227|324471754|FG007|Overall Study|Disease relapse|0|||
94730739|NCT03854227|324471755|FG008|Overall Study|Disease relapse|1|||
94730740|NCT03854227|324471756|FG009|Overall Study|Disease relapse|0|||
94730741|NCT03854227|324471757|FG010|Overall Study|Disease relapse|0|||
94730742|NCT03854227|324471758|FG011|Overall Study|Disease relapse|0|||
94368655|NCT01682512|323136501|FG000|Overall Study|Study terminated by sponsor|46|||
94368656|NCT01682512|323136502|FG001|Overall Study|Study terminated by sponsor|43|||
94368657|NCT01682512|323136503|FG002|Overall Study|Study terminated by sponsor|0|||
94368658|NCT01682512|323136501|FG000|Overall Study|Lost to Follow-up|3|||
94368659|NCT01682512|323136502|FG001|Overall Study|Lost to Follow-up|0|||
94730743|NCT03854227|324471747|FG000|Overall Study|Global deterioration of health status|0|||
94730744|NCT03854227|324471748|FG001|Overall Study|Global deterioration of health status|0|||
94730745|NCT03854227|324471749|FG002|Overall Study|Global deterioration of health status|0|||
94730746|NCT03854227|324471750|FG003|Overall Study|Global deterioration of health status|0|||
94730747|NCT03854227|324471751|FG004|Overall Study|Global deterioration of health status|0|||
94730748|NCT03854227|324471752|FG005|Overall Study|Global deterioration of health status|1|||
94730749|NCT03854227|324471753|FG006|Overall Study|Global deterioration of health status|0|||
94730750|NCT03854227|324471754|FG007|Overall Study|Global deterioration of health status|1|||
94730751|NCT03854227|324471755|FG008|Overall Study|Global deterioration of health status|0|||
94730752|NCT03854227|324471756|FG009|Overall Study|Global deterioration of health status|0|||
94730753|NCT03854227|324471757|FG010|Overall Study|Global deterioration of health status|0|||
94730754|NCT03854227|324471758|FG011|Overall Study|Global deterioration of health status|0|||
94730755|NCT03854227|324471747|FG000|Overall Study|Refused further treatment|0|||
94730756|NCT03854227|324471748|FG001|Overall Study|Refused further treatment|0|||
94730757|NCT03854227|324471749|FG002|Overall Study|Refused further treatment|0|||
94730758|NCT03854227|324471750|FG003|Overall Study|Refused further treatment|0|||
94730759|NCT03854227|324471751|FG004|Overall Study|Refused further treatment|0|||
94730760|NCT03854227|324471752|FG005|Overall Study|Refused further treatment|0|||
94730761|NCT03854227|324471753|FG006|Overall Study|Refused further treatment|0|||
94730762|NCT03854227|324471754|FG007|Overall Study|Refused further treatment|0|||
94730763|NCT03854227|324471755|FG008|Overall Study|Refused further treatment|0|||
94730764|NCT03854227|324471756|FG009|Overall Study|Refused further treatment|1|||
94730765|NCT03854227|324471757|FG010|Overall Study|Refused further treatment|0|||
94730766|NCT03854227|324471758|FG011|Overall Study|Refused further treatment|1|||
94730767|NCT03854227|324471747|FG000|Overall Study|Other|0|||
94730768|NCT03854227|324471748|FG001|Overall Study|Other|0|||
94730769|NCT03854227|324471749|FG002|Overall Study|Other|0|||
94730770|NCT03854227|324471750|FG003|Overall Study|Other|0|||
94730771|NCT03854227|324471751|FG004|Overall Study|Other|0|||
94730772|NCT03854227|324471752|FG005|Overall Study|Other|0|||
94730773|NCT03854227|324471753|FG006|Overall Study|Other|0|||
94730774|NCT03854227|324471754|FG007|Overall Study|Other|0|||
94730775|NCT03854227|324471755|FG008|Overall Study|Other|1|||
94730776|NCT03854227|324471756|FG009|Overall Study|Other|1|||
94730777|NCT03854227|324471757|FG010|Overall Study|Other|0|||
94730778|NCT03854227|324471758|FG011|Overall Study|Other|0|||
94730779|NCT03668236|324471759|FG000|90-day Follow-up|Withdrawal by Subject|3|||
94730780|NCT03668236|324471760|FG001|90-day Follow-up|Withdrawal by Subject|2|||
94730781|NCT03668236|324471759|FG000|90-day Follow-up|Lost to Follow-up|3|||
94730782|NCT03668236|324471760|FG001|90-day Follow-up|Lost to Follow-up|1|||
94730783|NCT03668236|324471759|FG000|Baseline Characteristics|Lost to Follow-up|9|||
94730784|NCT03668236|324471760|FG001|Baseline Characteristics|Lost to Follow-up|5|||
94730785|NCT03668236|324471759|FG000|1-year Follow-up|Withdrawal by Subject|17|||
94730786|NCT03668236|324471760|FG001|1-year Follow-up|Withdrawal by Subject|15|||
94730787|NCT02276885|324471765|FG000|Overall Study|Withdrawal by Subject|2|||
94730788|NCT02276885|324471766|FG001|Overall Study|Withdrawal by Subject|0|||
94730789|NCT02276885|324471765|FG000|Overall Study|Lost to Follow-up|5|||
94730790|NCT02276885|324471766|FG001|Overall Study|Lost to Follow-up|2|||
94730791|NCT04505904|324471774|FG000|Overall Study|Withdrawal by Subject|1|||
94730792|NCT04505904|324471775|FG001|Overall Study|Withdrawal by Subject|2|||
94730793|NCT04505904|324471776|FG002|Overall Study|Withdrawal by Subject|0|||
94730794|NCT04505904|324471777|FG003|Overall Study|Withdrawal by Subject|0|||
94730795|NCT04505904|324471774|FG000|Overall Study|Physician Decision|1|||
94730796|NCT04505904|324471775|FG001|Overall Study|Physician Decision|0|||
94730797|NCT04505904|324471776|FG002|Overall Study|Physician Decision|0|||
94730798|NCT04505904|324471777|FG003|Overall Study|Physician Decision|0|||
94730799|NCT04505904|324471774|FG000|Overall Study|Adverse Event|0|||
94730800|NCT04505904|324471775|FG001|Overall Study|Adverse Event|1|||
94730801|NCT04505904|324471776|FG002|Overall Study|Adverse Event|0|||
94730802|NCT04505904|324471777|FG003|Overall Study|Adverse Event|0|||
94730803|NCT01824537|324471778|FG000|Overall Study|Lost to Follow-up|78|||
94730804|NCT01824537|324471779|FG001|Overall Study|Lost to Follow-up|87|||
94730805|NCT02547987|324471780|FG000|Overall Study|Withdrawal by Subject|1|||
94730806|NCT02547987|324471780|FG000|Overall Study|Adverse Event|2|||
94368660|NCT01682512|323136503|FG002|Overall Study|Lost to Follow-up|2|||
94730807|NCT05362487|324471781|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
94730808|NCT03113487|324471782|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
94730809|NCT06215521|324471784|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
94368661|NCT01682512|323136501|FG000|Overall Study|Protocol Violation|2|||
94368662|NCT01682512|323136502|FG001|Overall Study|Protocol Violation|3|||
94368663|NCT01682512|323136503|FG002|Overall Study|Protocol Violation|2|||
94368664|NCT01682512|323136501|FG000|Overall Study|Primary lack of efficacy|10|||
94368665|NCT01682512|323136502|FG001|Overall Study|Primary lack of efficacy|7|||
94368666|NCT01682512|323136503|FG002|Overall Study|Primary lack of efficacy|7|||
94273860|NCT03259074|322795689|FG001|Overall Study|Adverse Event|12|||
94273861|NCT03259074|322795690|FG002|Overall Study|Adverse Event|8|||
94273862|NCT03259074|322795688|FG000|Overall Study|Death|1|||
94273863|NCT03259074|322795689|FG001|Overall Study|Death|1|||
94273864|NCT03259074|322795690|FG002|Overall Study|Death|3|||
94273865|NCT03259074|322795688|FG000|Overall Study|Lost to Follow-up|2|||
94273866|NCT03259074|322795689|FG001|Overall Study|Lost to Follow-up|4|||
94273867|NCT03259074|322795690|FG002|Overall Study|Lost to Follow-up|3|||
94273868|NCT03259074|322795688|FG000|Overall Study|New Therapy For Study Indication|1|||
94273869|NCT03259074|322795689|FG001|Overall Study|New Therapy For Study Indication|2|||
94273870|NCT03259074|322795690|FG002|Overall Study|New Therapy For Study Indication|2|||
94273871|NCT03259074|322795688|FG000|Overall Study|Physician Decision|4|||
94273872|NCT03259074|322795689|FG001|Overall Study|Physician Decision|12|||
94273873|NCT03259074|322795690|FG002|Overall Study|Physician Decision|10|||
94273874|NCT03259074|322795688|FG000|Overall Study|Pregnancy|1|||
94273875|NCT03259074|322795689|FG001|Overall Study|Pregnancy|1|||
94273876|NCT03259074|322795690|FG002|Overall Study|Pregnancy|0|||
94273877|NCT03259074|322795688|FG000|Overall Study|Progressive Disease|1|||
94273878|NCT03259074|322795689|FG001|Overall Study|Progressive Disease|0|||
94273879|NCT03259074|322795690|FG002|Overall Study|Progressive Disease|0|||
94273880|NCT03259074|322795688|FG000|Overall Study|Protocol Deviation|1|||
94273881|NCT03259074|322795689|FG001|Overall Study|Protocol Deviation|1|||
94273882|NCT03259074|322795690|FG002|Overall Study|Protocol Deviation|3|||
94273883|NCT03259074|322795688|FG000|Overall Study|Subject/Guardian Decision|13|||
94273884|NCT03259074|322795689|FG001|Overall Study|Subject/Guardian Decision|16|||
94273885|NCT03259074|322795690|FG002|Overall Study|Subject/Guardian Decision|14|||
94273886|NCT04191382|322795703|FG000|Overall Study|Withdrawal by Subject|1|||
94368667|NCT01682512|323136501|FG000|Overall Study|Secondary lack of efficacy|1|||
94368668|NCT01682512|323136502|FG001|Overall Study|Secondary lack of efficacy|1|||
94273887|NCT04191382|322795704|FG001|Overall Study|Withdrawal by Subject|0|||
94273888|NCT04191382|322795705|FG002|Overall Study|Withdrawal by Subject|0|||
94273889|NCT02409290|322795706|FG000|Overall Study|Protocol Violation|3|||
94273890|NCT02409290|322795707|FG001|Overall Study|Protocol Violation|6|||
94273891|NCT02409290|322795708|FG002|Overall Study|Protocol Violation|9|||
94273892|NCT02409290|322795709|FG003|Overall Study|Protocol Violation|4|||
94273893|NCT02409290|322795706|FG000|Overall Study|No positive culture/no baseline sample|3|||
94273894|NCT02409290|322795707|FG001|Overall Study|No positive culture/no baseline sample|9|||
94730810|NCT06215521|324471785|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
94730811|NCT06215521|324471786|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
94730812|NCT06215521|324471787|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
94730813|NCT06215521|324471788|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
94730814|NCT06215521|324471789|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
94730815|NCT03603600|324471790|FG000|Overall Study|Withdrawal by Subject|5|||
94730816|NCT03603600|324471791|FG001|Overall Study|Withdrawal by Subject|7|||
94730817|NCT03603600|324471790|FG000|Overall Study|Lost to Follow-up|2|||
94730818|NCT03603600|324471791|FG001|Overall Study|Lost to Follow-up|3|||
94730819|NCT03603600|324471790|FG000|Overall Study|Death|3|||
94730820|NCT03603600|324471791|FG001|Overall Study|Death|1|||
94730821|NCT03603600|324471790|FG000|Overall Study|Physician Decision|2|||
94730822|NCT03603600|324471791|FG001|Overall Study|Physician Decision|1|||
94730823|NCT03603600|324471790|FG000|Overall Study|Other reason|1|||
94730824|NCT03603600|324471791|FG001|Overall Study|Other reason|0|||
94730825|NCT04973254|324471792|FG000|Overall Study|Not adherent|0|||
94730826|NCT04973254|324471793|FG001|Overall Study|Not adherent|1|||
94730827|NCT04973254|324471794|FG002|Overall Study|Not adherent|0|||
94730828|NCT04044768|324471795|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
94730829|NCT04044768|324471796|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
94730830|NCT05089019|324471801|FG000|Period 1|Withdrawal by Subject|0|||
94730831|NCT05089019|324471802|FG001|Period 1|Withdrawal by Subject|1|||
94730832|NCT05089019|324471801|FG000|Washout Period|Adverse Event|3|||
94730833|NCT05089019|324471802|FG001|Washout Period|Adverse Event|4|||
94730834|NCT05089019|324471801|FG000|Washout Period|Lost to Follow-up|1|||
94730835|NCT05089019|324471802|FG001|Washout Period|Lost to Follow-up|0|||
94730836|NCT05089019|324471801|FG000|Washout Period|Physician Decision|2|||
94730837|NCT05089019|324471802|FG001|Washout Period|Physician Decision|0|||
94730838|NCT05089019|324471801|FG000|Washout Period|Withdrawal by Subject|6|||
94730839|NCT05089019|324471802|FG001|Washout Period|Withdrawal by Subject|3|||
94730840|NCT05089019|324471801|FG000|Period 2|Adverse Event|4|||
94730841|NCT05089019|324471802|FG001|Period 2|Adverse Event|2|||
94730842|NCT05089019|324471801|FG000|Period 2|Lost to Follow-up|1|||
94730843|NCT05089019|324471802|FG001|Period 2|Lost to Follow-up|0|||
94730844|NCT05089019|324471801|FG000|Period 2|Withdrawal by Subject|0|||
94730845|NCT05089019|324471802|FG001|Period 2|Withdrawal by Subject|1|||
94730846|NCT05170009|324471803|FG000|Overall Study|Physician Decision|0|||
94730847|NCT05170009|324471804|FG001|Overall Study|Physician Decision|1|||
94730848|NCT05543629|324471811|FG000|Overall Study|Death|1|||
94730849|NCT05543629|324471812|FG001|Overall Study|Death|0|||
94730850|NCT05543629|324471813|FG002|Overall Study|Death|1|||
94730851|NCT05543629|324471814|FG003|Overall Study|Death|0|||
94730852|NCT05543629|324471815|FG004|Overall Study|Death|0|||
94730853|NCT05543629|324471816|FG005|Overall Study|Death|1|||
94730854|NCT05543629|324471817|FG006|Overall Study|Death|2|||
94730855|NCT05543629|324471818|FG007|Overall Study|Death|2|||
94730856|NCT05543629|324471811|FG000|Overall Study|Other Reasons|0|||
94730857|NCT05543629|324471812|FG001|Overall Study|Other Reasons|0|||
94730858|NCT05543629|324471813|FG002|Overall Study|Other Reasons|0|||
94730859|NCT05543629|324471814|FG003|Overall Study|Other Reasons|0|||
94730860|NCT05543629|324471815|FG004|Overall Study|Other Reasons|1|||
94273895|NCT02409290|322795708|FG002|Overall Study|No positive culture/no baseline sample|6|||
94730861|NCT05543629|324471816|FG005|Overall Study|Other Reasons|0|||
94730862|NCT05543629|324471817|FG006|Overall Study|Other Reasons|0|||
94730863|NCT05543629|324471818|FG007|Overall Study|Other Reasons|0|||
94730864|NCT05543629|324471811|FG000|Overall Study|Physician Decision|0|||
94730865|NCT05543629|324471812|FG001|Overall Study|Physician Decision|0|||
94730866|NCT05543629|324471813|FG002|Overall Study|Physician Decision|3|||
94730867|NCT05543629|324471814|FG003|Overall Study|Physician Decision|0|||
94730868|NCT05543629|324471815|FG004|Overall Study|Physician Decision|0|||
94730869|NCT05543629|324471816|FG005|Overall Study|Physician Decision|0|||
94730870|NCT05543629|324471817|FG006|Overall Study|Physician Decision|1|||
94730871|NCT05543629|324471818|FG007|Overall Study|Physician Decision|0|||
94730872|NCT05543629|324471811|FG000|Overall Study|Study terminated by Sponsor|1|||
94730873|NCT05543629|324471812|FG001|Overall Study|Study terminated by Sponsor|0|||
94730874|NCT05543629|324471813|FG002|Overall Study|Study terminated by Sponsor|0|||
94730875|NCT05543629|324471814|FG003|Overall Study|Study terminated by Sponsor|1|||
94730876|NCT05543629|324471815|FG004|Overall Study|Study terminated by Sponsor|0|||
94730877|NCT05543629|324471816|FG005|Overall Study|Study terminated by Sponsor|4|||
94730878|NCT05543629|324471817|FG006|Overall Study|Study terminated by Sponsor|1|||
94730879|NCT05543629|324471818|FG007|Overall Study|Study terminated by Sponsor|0|||
94730880|NCT05543629|324471811|FG000|Overall Study|Withdrawal by Subject|1|||
94730881|NCT05543629|324471812|FG001|Overall Study|Withdrawal by Subject|1|||
94730882|NCT05543629|324471813|FG002|Overall Study|Withdrawal by Subject|0|||
94730883|NCT05543629|324471814|FG003|Overall Study|Withdrawal by Subject|2|||
94730884|NCT05543629|324471815|FG004|Overall Study|Withdrawal by Subject|1|||
94730885|NCT05543629|324471816|FG005|Overall Study|Withdrawal by Subject|1|||
94730886|NCT05543629|324471817|FG006|Overall Study|Withdrawal by Subject|1|||
94730887|NCT05543629|324471818|FG007|Overall Study|Withdrawal by Subject|1|||
94730888|NCT05543629|324471811|FG000|Overall Study|Not Reported|2|||
94730889|NCT05543629|324471812|FG001|Overall Study|Not Reported|2|||
94730890|NCT05543629|324471813|FG002|Overall Study|Not Reported|0|||
94730891|NCT05543629|324471814|FG003|Overall Study|Not Reported|0|||
94730892|NCT05543629|324471815|FG004|Overall Study|Not Reported|1|||
94730893|NCT05543629|324471816|FG005|Overall Study|Not Reported|1|||
94730894|NCT05543629|324471817|FG006|Overall Study|Not Reported|3|||
94730895|NCT05543629|324471818|FG007|Overall Study|Not Reported|0|||
94730896|NCT04564742|324471819|FG000|Overall Study|Lost to Follow-up|1|||
94730897|NCT04564742|324471820|FG001|Overall Study|Lost to Follow-up|0|||
94730898|NCT04564742|324471819|FG000|Overall Study|Consent Withdrawal|4|||
94730899|NCT04564742|324471820|FG001|Overall Study|Consent Withdrawal|4|||
94730900|NCT03313076|324471824|FG000|Overall Study|Withdrawal by Subject|2|||
94730901|NCT03313076|324471825|FG001|Overall Study|Withdrawal by Subject|0|||
94730902|NCT03313076|324471826|FG002|Overall Study|Withdrawal by Subject|0|||
94730903|NCT03313076|324471827|FG003|Overall Study|Withdrawal by Subject|0|||
94730904|NCT03313076|324471824|FG000|Overall Study|Lost to Follow-up|0|||
94730905|NCT03313076|324471825|FG001|Overall Study|Lost to Follow-up|2|||
94730906|NCT03313076|324471826|FG002|Overall Study|Lost to Follow-up|2|||
94730907|NCT03313076|324471827|FG003|Overall Study|Lost to Follow-up|2|||
94730908|NCT04119843|324471828|FG000|Overall Study|Adverse Event|3|||
94730909|NCT04119843|324471828|FG000|Overall Study|Death|1|||
94730910|NCT05869383|324471829|FG000|Overall Study|Withdrawal by Subject|2|||
94730911|NCT05869383|324471830|FG001|Overall Study|Withdrawal by Subject|0|||
94730912|NCT04662931|324471833|FG000|Overall Study|Withdrawal by Subject|17|||
94730913|NCT04662931|324471833|FG000|Overall Study|Death|3|||
94730914|NCT04662931|324471833|FG000|Overall Study|Lost to Follow-up|3|||
94730915|NCT04662931|324471833|FG000|Overall Study|Guardian Decision|1|||
94730916|NCT01648023|324471834|FG000|Overall Study|Screen Fail Post Randomization|1|||
94730917|NCT01648023|324471835|FG001|Overall Study|Screen Fail Post Randomization|2|||
94730918|NCT05201079|324471849|FG000|Overall Study|Adverse Event|7|||
94730919|NCT05201079|324471850|FG001|Overall Study|Adverse Event|11|||
94730920|NCT05201079|324471849|FG000|Overall Study|Death|1|||
94730921|NCT05201079|324471850|FG001|Overall Study|Death|1|||
94730922|NCT05201079|324471849|FG000|Overall Study|Lack of Efficacy|0|||
94730923|NCT05201079|324471850|FG001|Overall Study|Lack of Efficacy|2|||
94730924|NCT05201079|324471849|FG000|Overall Study|Lost to Follow-up|0|||
94730925|NCT05201079|324471850|FG001|Overall Study|Lost to Follow-up|1|||
94730926|NCT05201079|324471849|FG000|Overall Study|Physician Decision|1|||
94730927|NCT05201079|324471850|FG001|Overall Study|Physician Decision|1|||
94730928|NCT05201079|324471849|FG000|Overall Study|Protocol Violation|1|||
94730929|NCT05201079|324471850|FG001|Overall Study|Protocol Violation|0|||
94730930|NCT05201079|324471849|FG000|Overall Study|Withdrawal by Subject|1|||
94730931|NCT05201079|324471850|FG001|Overall Study|Withdrawal by Subject|0|||
94730932|NCT05201079|324471849|FG000|Overall Study|Forbidden medication|9|||
94730933|NCT05201079|324471850|FG001|Overall Study|Forbidden medication|5|||
94730934|NCT05201079|324471849|FG000|Overall Study|Transfer to another hospital|0|||
94730935|NCT05201079|324471850|FG001|Overall Study|Transfer to another hospital|1|||
94730936|NCT05201079|324471849|FG000|Overall Study|Clinical condition|1|||
94730937|NCT05201079|324471850|FG001|Overall Study|Clinical condition|0|||
94730938|NCT05201079|324471849|FG000|Overall Study|SAE and sepsis|1|||
94730939|NCT05201079|324471850|FG001|Overall Study|SAE and sepsis|0|||
94730940|NCT04145440|324471851|FG000|Overall Study|Physician Decision|3|||
94730941|NCT04145440|324471852|FG001|Overall Study|Physician Decision|0|||
94730942|NCT04145440|324471851|FG000|Overall Study|Use of prohibited therapy|2|||
94730943|NCT04145440|324471852|FG001|Overall Study|Use of prohibited therapy|3|||
94730944|NCT05281562|324471861|FG000|Overall Study|Ineligible patient|1|||
94730945|NCT05281562|324471862|FG001|Overall Study|Ineligible patient|0|||
94730946|NCT03931174|324471867|FG000|Providers|Staff left organization|26|||
94730947|NCT03931174|324471868|FG001|Providers|Staff left organization|25|||
94730948|NCT03931174|324471867|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
94730949|NCT03931174|324471868|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
94730950|NCT03931174|324471867|FG000|Providers|Lost to Follow-up|4|||
94730951|NCT03931174|324471868|FG001|Providers|Lost to Follow-up|4|||
94730952|NCT03931174|324471867|FG000|Patients|Post-consent screening failure|1|||
94730953|NCT03931174|324471868|FG001|Patients|Post-consent screening failure|1|||
94730954|NCT03931174|324471867|FG000|Patients|Death|1|||
94730955|NCT03931174|324471868|FG001|Patients|Death|1|||
94730956|NCT03931174|324471867|FG000|Patients|Lost to Follow-up|60|||
94730957|NCT03931174|324471868|FG001|Patients|Lost to Follow-up|89|||
94730958|NCT03322267|324471869|FG000|Overall Study|Lack of Efficacy|11|||
94730959|NCT03322267|324471869|FG000|Overall Study|Adverse Event|1|||
94730960|NCT03322267|324471869|FG000|Overall Study|Withdrawal by Subject|2|||
94730961|NCT01919554|324471871|FG000|Overall Study|Withdrawal by Subject|0|||
94730962|NCT01919554|324471872|FG001|Overall Study|Withdrawal by Subject|0|||
94730963|NCT01919554|324471873|FG002|Overall Study|Withdrawal by Subject|1|||
94730964|NCT01919554|324471874|FG003|Overall Study|Withdrawal by Subject|1|||
94730965|NCT04880863|324471877|FG000|Overall Study|Adverse Event|1|||
94730966|NCT04880863|324471877|FG000|Overall Study|Patient decision|2|||
94730967|NCT04880863|324471877|FG000|Overall Study|Confirmed Disease Progression|15|||
94730968|NCT04880863|324471877|FG000|Overall Study|Death|3|||
94730969|NCT04880863|324471877|FG000|Overall Study|Physician Decision|4|||
94730970|NCT04880863|324471877|FG000|Overall Study|Unconfirmed Disease Progression|4|||
94730971|NCT04880863|324471877|FG000|Overall Study|Withdrawal by Subject|2|||
94730972|NCT04880863|324471877|FG000|Overall Study|Study discontinuation by the sponsor|4|||
94730973|NCT04880863|324471877|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
94730974|NCT04880863|324471877|FG000|Overall Study|Not received study drug NAP|2|||
94730975|NCT01467427|324471878|FG000|Overall Study|Withdrawal by Subject|1|||
94730976|NCT01467427|324471879|FG001|Overall Study|Withdrawal by Subject|0|||
94730977|NCT01467427|324471878|FG000|Overall Study|Not continuing in extension phase|0|||
94730978|NCT01467427|324471879|FG001|Overall Study|Not continuing in extension phase|2|||
94730979|NCT01467427|324471878|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
94730980|NCT01467427|324471879|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
94730981|NCT01467427|324471878|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
94730982|NCT01467427|324471879|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
94730983|NCT01467427|324471878|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
94730984|NCT01467427|324471879|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
94730985|NCT01467427|324471878|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
94730986|NCT01467427|324471879|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
94730987|NCT03190915|324471887|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
94730988|NCT03190915|324471887|FG000|Overall Study|Progressive Disease|3|||
94730989|NCT02364557|324471888|FG000|Overall Study|Protocol Violation|3|||
94730990|NCT02364557|324471889|FG001|Overall Study|Protocol Violation|1|||
94730991|NCT03748953|324473936|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
94730992|NCT03748953|324473937|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
94730993|NCT03748953|324473936|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
94730994|NCT03748953|324473937|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
94730995|NCT03748953|324473936|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
94730996|NCT03748953|324473937|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
94730997|NCT03748953|324473936|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
94730998|NCT03748953|324473937|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
94730999|NCT03748953|324473936|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
94731000|NCT03748953|324473937|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
94731001|NCT05672069|324473938|FG000|Overall Study|Implant removal|1|||
94731002|NCT05672069|324473938|FG000|Overall Study|Lost to Follow-up|2|||
94731003|NCT02191618|324473939|FG000|Overall Study|Withdrawal by Subject|3|||
94731004|NCT02191618|324473939|FG000|Overall Study|Missed Visit|4|||
94731005|NCT01593917|324473943|FG000|Overall Study|Death|67|||
94731006|NCT01593917|324473943|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
94731007|NCT01593917|324473943|FG000|Overall Study|Withdrawal by Subject|23|||
94731008|NCT01593917|324473943|FG000|Overall Study|Lost to Follow-up|12|||
94731009|NCT01593917|324473943|FG000|Overall Study|Protocol Violation|5|||
94731010|NCT01593917|324473943|FG000|Overall Study|Physician Decision|3|||
94731011|NCT04938492|324473944|FG000|Overall Study|Lost to Follow-up|17|||
94731012|NCT04938492|324473945|FG001|Overall Study|Lost to Follow-up|18|||
94731013|NCT04171141|324473948|FG000|Overall Study|Adverse Event|0|||
94731014|NCT04171141|324473949|FG001|Overall Study|Adverse Event|0|||
94731015|NCT04171141|324473950|FG002|Overall Study|Adverse Event|2|||
94273896|NCT02409290|322795709|FG003|Overall Study|No positive culture/no baseline sample|5|||
94273897|NCT02409290|322795706|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
94273898|NCT02409290|322795707|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
94731016|NCT04171141|324473951|FG003|Overall Study|Adverse Event|0|||
94731017|NCT04171141|324473952|FG004|Overall Study|Adverse Event|0|||
94731018|NCT04171141|324473953|FG005|Overall Study|Adverse Event|0|||
94731019|NCT04171141|324473954|FG006|Overall Study|Adverse Event|0|||
94731020|NCT04171141|324473955|FG007|Overall Study|Adverse Event|0|||
94731021|NCT04171141|324473956|FG008|Overall Study|Adverse Event|0|||
94731022|NCT04171141|324473957|FG009|Overall Study|Adverse Event|0|||
94731023|NCT04171141|324473958|FG010|Overall Study|Adverse Event|0|||
94731024|NCT04171141|324473959|FG011|Overall Study|Adverse Event|0|||
94731025|NCT04171141|324473960|FG012|Overall Study|Adverse Event|0|||
94731026|NCT04171141|324473961|FG013|Overall Study|Adverse Event|2|||
94731027|NCT04171141|324473962|FG014|Overall Study|Adverse Event|0|||
94731028|NCT04171141|324473963|FG015|Overall Study|Adverse Event|0|||
94731029|NCT04171141|324473948|FG000|Overall Study|Physician Decision|0|||
94731030|NCT04171141|324473949|FG001|Overall Study|Physician Decision|0|||
94731031|NCT04171141|324473950|FG002|Overall Study|Physician Decision|0|||
94731032|NCT04171141|324473951|FG003|Overall Study|Physician Decision|0|||
94731033|NCT04171141|324473952|FG004|Overall Study|Physician Decision|1|||
94731034|NCT04171141|324473953|FG005|Overall Study|Physician Decision|0|||
94731035|NCT04171141|324473954|FG006|Overall Study|Physician Decision|0|||
94731036|NCT04171141|324473955|FG007|Overall Study|Physician Decision|0|||
94731037|NCT04171141|324473956|FG008|Overall Study|Physician Decision|0|||
94731038|NCT04171141|324473957|FG009|Overall Study|Physician Decision|0|||
94731039|NCT04171141|324473958|FG010|Overall Study|Physician Decision|0|||
94731040|NCT04171141|324473959|FG011|Overall Study|Physician Decision|0|||
94731041|NCT04171141|324473960|FG012|Overall Study|Physician Decision|0|||
94731042|NCT04171141|324473961|FG013|Overall Study|Physician Decision|0|||
94731043|NCT04171141|324473962|FG014|Overall Study|Physician Decision|0|||
94731044|NCT04171141|324473963|FG015|Overall Study|Physician Decision|1|||
94731045|NCT04171141|324473948|FG000|Overall Study|Progressive disease|2|||
94731046|NCT04171141|324473949|FG001|Overall Study|Progressive disease|3|||
94731047|NCT04171141|324473950|FG002|Overall Study|Progressive disease|4|||
94731048|NCT04171141|324473951|FG003|Overall Study|Progressive disease|7|||
94731049|NCT04171141|324473952|FG004|Overall Study|Progressive disease|1|||
94731050|NCT04171141|324473953|FG005|Overall Study|Progressive disease|8|||
94731051|NCT04171141|324473954|FG006|Overall Study|Progressive disease|4|||
94731052|NCT04171141|324473955|FG007|Overall Study|Progressive disease|6|||
94731053|NCT04171141|324473956|FG008|Overall Study|Progressive disease|7|||
94731054|NCT04171141|324473957|FG009|Overall Study|Progressive disease|3|||
94731055|NCT04171141|324473958|FG010|Overall Study|Progressive disease|4|||
94731056|NCT04171141|324473959|FG011|Overall Study|Progressive disease|3|||
94731057|NCT04171141|324473960|FG012|Overall Study|Progressive disease|4|||
94731058|NCT04171141|324473961|FG013|Overall Study|Progressive disease|2|||
94731059|NCT04171141|324473962|FG014|Overall Study|Progressive disease|4|||
94731060|NCT04171141|324473963|FG015|Overall Study|Progressive disease|1|||
94731061|NCT04171141|324473948|FG000|Overall Study|Withdrawal by Subject|0|||
94731062|NCT04171141|324473949|FG001|Overall Study|Withdrawal by Subject|0|||
94731063|NCT04171141|324473950|FG002|Overall Study|Withdrawal by Subject|0|||
94731064|NCT04171141|324473951|FG003|Overall Study|Withdrawal by Subject|1|||
94731065|NCT04171141|324473952|FG004|Overall Study|Withdrawal by Subject|0|||
94731066|NCT04171141|324473953|FG005|Overall Study|Withdrawal by Subject|0|||
94731067|NCT04171141|324473954|FG006|Overall Study|Withdrawal by Subject|1|||
94731068|NCT04171141|324473955|FG007|Overall Study|Withdrawal by Subject|0|||
94731069|NCT04171141|324473956|FG008|Overall Study|Withdrawal by Subject|0|||
94731070|NCT04171141|324473957|FG009|Overall Study|Withdrawal by Subject|1|||
94731071|NCT04171141|324473958|FG010|Overall Study|Withdrawal by Subject|0|||
94731072|NCT04171141|324473959|FG011|Overall Study|Withdrawal by Subject|0|||
94731073|NCT04171141|324473960|FG012|Overall Study|Withdrawal by Subject|0|||
94731074|NCT04171141|324473961|FG013|Overall Study|Withdrawal by Subject|0|||
94731075|NCT04171141|324473962|FG014|Overall Study|Withdrawal by Subject|0|||
94731076|NCT04171141|324473963|FG015|Overall Study|Withdrawal by Subject|0|||
94273899|NCT02409290|322795708|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
94273900|NCT02409290|322795709|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
94731077|NCT04171141|324473948|FG000|Overall Study|Global deterioration of health status|0|||
94731078|NCT04171141|324473949|FG001|Overall Study|Global deterioration of health status|0|||
94731079|NCT04171141|324473950|FG002|Overall Study|Global deterioration of health status|0|||
94731080|NCT04171141|324473951|FG003|Overall Study|Global deterioration of health status|1|||
94731081|NCT04171141|324473952|FG004|Overall Study|Global deterioration of health status|0|||
94731082|NCT04171141|324473953|FG005|Overall Study|Global deterioration of health status|2|||
94731083|NCT04171141|324473954|FG006|Overall Study|Global deterioration of health status|1|||
94731084|NCT04171141|324473955|FG007|Overall Study|Global deterioration of health status|0|||
94731085|NCT04171141|324473956|FG008|Overall Study|Global deterioration of health status|1|||
94731086|NCT04171141|324473957|FG009|Overall Study|Global deterioration of health status|0|||
94731087|NCT04171141|324473958|FG010|Overall Study|Global deterioration of health status|0|||
94731088|NCT04171141|324473959|FG011|Overall Study|Global deterioration of health status|0|||
94731089|NCT04171141|324473960|FG012|Overall Study|Global deterioration of health status|0|||
94731090|NCT04171141|324473961|FG013|Overall Study|Global deterioration of health status|0|||
94731091|NCT04171141|324473962|FG014|Overall Study|Global deterioration of health status|1|||
94731092|NCT04171141|324473963|FG015|Overall Study|Global deterioration of health status|1|||
94731093|NCT04016662|324473964|FG000|Run-In Phase|Death|1|||
94731094|NCT04016662|324473964|FG000|Run-In Phase|Withdrawal by Subject|11|||
94731095|NCT04016662|324473964|FG000|Run-In Phase|Not meeting screening eligibility|9|||
94731096|NCT04016662|324473964|FG000|Run-In Phase|Physician Decision|3|||
94731097|NCT04016662|324473964|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
94731098|NCT04016662|324473964|FG000|PLGS (12 Weeks)|Death|1|||
94731099|NCT04016662|324473964|FG000|SAP (12 Weeks)|Death|1|||
94731100|NCT01802788|324473965|FG000|Overall Study|Withdrawal by Subject|102|||
94731101|NCT01802788|324473966|FG001|Overall Study|Withdrawal by Subject|5|||
94731102|NCT01802788|324473965|FG000|Overall Study|Death|382|||
94731103|NCT01802788|324473966|FG001|Overall Study|Death|18|||
94731104|NCT01802788|324473965|FG000|Overall Study|Lost to Follow-up|31|||
94731105|NCT01802788|324473966|FG001|Overall Study|Lost to Follow-up|2|||
94731106|NCT01802788|324473965|FG000|Overall Study|Physician Decision|3|||
94731107|NCT01802788|324473966|FG001|Overall Study|Physician Decision|0|||
94731108|NCT01802788|324473965|FG000|Overall Study|Patient Non-Compliance|1|||
94731109|NCT01802788|324473966|FG001|Overall Study|Patient Non-Compliance|0|||
94731110|NCT01802788|324473965|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
94731111|NCT01802788|324473966|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
94731112|NCT01802788|324473965|FG000|Overall Study|Other Reasons|19|||
94731113|NCT01802788|324473966|FG001|Overall Study|Other Reasons|0|||
94731114|NCT03021096|324473967|FG000|Overall Study|Lost to Follow-up|4|||
94731115|NCT03021096|324473967|FG000|Overall Study|Protocol Violation|2|||
94731116|NCT03848065|324473968|FG000|Overall Study|Death|0|||
94731117|NCT03848065|324473969|FG001|Overall Study|Death|1|||
94731118|NCT03848065|324473970|FG002|Overall Study|Death|0|||
94731119|NCT03848065|324473968|FG000|Overall Study|Lost to Follow-up|0|||
94731120|NCT03848065|324473969|FG001|Overall Study|Lost to Follow-up|0|||
94731121|NCT03848065|324473970|FG002|Overall Study|Lost to Follow-up|1|||
94273901|NCT02184195|322795713|FG000|Overall Study|Patient decision|5|||
94273902|NCT02184195|322795714|FG001|Overall Study|Patient decision|2|||
94273903|NCT02184195|322795713|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
94731122|NCT03848065|324473968|FG000|Overall Study|Physician Decision|0|||
94731123|NCT03848065|324473969|FG001|Overall Study|Physician Decision|0|||
94731124|NCT03848065|324473970|FG002|Overall Study|Physician Decision|1|||
94731125|NCT03865498|324473971|FG000|Overall Study|Lack of Efficacy|12|||
94731126|NCT03865498|324473972|FG001|Overall Study|Lack of Efficacy|11|||
94731127|NCT03865498|324473971|FG000|Overall Study|Lost to Follow-up|125|||
94731128|NCT03865498|324473972|FG001|Overall Study|Lost to Follow-up|133|||
94731129|NCT03865498|324473971|FG000|Overall Study|Withdrawal by Subject|2|||
94273904|NCT02184195|322795714|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
94273905|NCT02184195|322795713|FG000|Overall Study|Death|67|||
94273906|NCT02184195|322795714|FG001|Overall Study|Death|44|||
94273907|NCT02184195|322795713|FG000|Overall Study|Lost to Follow-up|1|||
94273908|NCT02184195|322795714|FG001|Overall Study|Lost to Follow-up|5|||
94273909|NCT02184195|322795713|FG000|Overall Study|Other|0|||
94273910|NCT02184195|322795714|FG001|Overall Study|Other|3|||
94273911|NCT00804570|322795715|FG000|Overall Study|Adverse Event|14|||
94731130|NCT03865498|324473972|FG001|Overall Study|Withdrawal by Subject|4|||
94731131|NCT03270501|324473977|FG000|Overall Study|Screen failure|6|||
94731132|NCT03270501|324473977|FG000|Overall Study|Lost to Follow-up|2|||
94731133|NCT03270501|324473977|FG000|Overall Study|Adverse Event|1|||
94731134|NCT00764751|324473982|FG000|Overall Study|Adverse Event|1|||
94731135|NCT00764751|324473983|FG001|Overall Study|Adverse Event|1|||
94731136|NCT00764751|324473982|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
94731137|NCT00764751|324473983|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
94731138|NCT02841579|324473984|FG000|Overall Study|Death|1|||
94731139|NCT02841579|324473984|FG000|Overall Study|Adverse Event|1|||
94731140|NCT02841579|324473984|FG000|Overall Study|Lack of Efficacy|9|||
94731141|NCT03011333|324473998|FG000|Overall Study|Lost to Follow-up|0|||
94731142|NCT03011333|324473999|FG001|Overall Study|Lost to Follow-up|1|||
94731143|NCT03011333|324474000|FG002|Overall Study|Lost to Follow-up|0|||
94731144|NCT03011333|324474001|FG003|Overall Study|Lost to Follow-up|1|||
94731145|NCT03011333|324474002|FG004|Overall Study|Lost to Follow-up|4|||
94731146|NCT03011333|324474003|FG005|Overall Study|Lost to Follow-up|4|||
94731147|NCT03011333|324474004|FG006|Overall Study|Lost to Follow-up|5|||
94731148|NCT04233216|324474005|FG000|Overall Study|Lost to Follow-up|1|||
94731149|NCT04233216|324474006|FG001|Overall Study|Lost to Follow-up|0|||
94731150|NCT04233216|324474007|FG002|Overall Study|Lost to Follow-up|2|||
94731151|NCT04233216|324474008|FG003|Overall Study|Lost to Follow-up|0|||
94731152|NCT04233216|324474005|FG000|Overall Study|Physician Decision|0|||
94731153|NCT04233216|324474006|FG001|Overall Study|Physician Decision|3|||
94731154|NCT04233216|324474007|FG002|Overall Study|Physician Decision|0|||
94731155|NCT04233216|324474008|FG003|Overall Study|Physician Decision|2|||
94731156|NCT04233216|324474005|FG000|Overall Study|Withdrawal by Subject|0|||
94731157|NCT04233216|324474006|FG001|Overall Study|Withdrawal by Subject|2|||
94731158|NCT04233216|324474007|FG002|Overall Study|Withdrawal by Subject|1|||
94731159|NCT04233216|324474008|FG003|Overall Study|Withdrawal by Subject|0|||
94731160|NCT04137289|324474009|FG000|Overall Study|Death|0|||
94731161|NCT04137289|324474010|FG001|Overall Study|Death|0|||
94731162|NCT04137289|324474011|FG002|Overall Study|Death|0|||
94731163|NCT04137289|324474012|FG003|Overall Study|Death|0|||
94731164|NCT04137289|324474013|FG004|Overall Study|Death|0|||
94731165|NCT04137289|324474014|FG005|Overall Study|Death|0|||
94731166|NCT04137289|324474015|FG006|Overall Study|Death|1|||
94731167|NCT04137289|324474016|FG007|Overall Study|Death|0|||
94731168|NCT04137289|324474017|FG008|Overall Study|Death|0|||
94731169|NCT04137289|324474009|FG000|Overall Study|Clinical disease progression|0|||
94731170|NCT04137289|324474010|FG001|Overall Study|Clinical disease progression|0|||
94731171|NCT04137289|324474011|FG002|Overall Study|Clinical disease progression|0|||
94731172|NCT04137289|324474012|FG003|Overall Study|Clinical disease progression|4|||
94731173|NCT04137289|324474013|FG004|Overall Study|Clinical disease progression|4|||
94731174|NCT04137289|324474014|FG005|Overall Study|Clinical disease progression|2|||
94731175|NCT04137289|324474015|FG006|Overall Study|Clinical disease progression|5|||
94731176|NCT04137289|324474016|FG007|Overall Study|Clinical disease progression|1|||
94731177|NCT04137289|324474017|FG008|Overall Study|Clinical disease progression|0|||
94731178|NCT04137289|324474009|FG000|Overall Study|Lost to Follow-up|0|||
94731179|NCT04137289|324474010|FG001|Overall Study|Lost to Follow-up|0|||
94731180|NCT04137289|324474011|FG002|Overall Study|Lost to Follow-up|0|||
94731181|NCT04137289|324474012|FG003|Overall Study|Lost to Follow-up|1|||
94731182|NCT04137289|324474013|FG004|Overall Study|Lost to Follow-up|0|||
94731183|NCT04137289|324474014|FG005|Overall Study|Lost to Follow-up|0|||
94731184|NCT04137289|324474015|FG006|Overall Study|Lost to Follow-up|0|||
94731185|NCT04137289|324474016|FG007|Overall Study|Lost to Follow-up|0|||
94731186|NCT04137289|324474017|FG008|Overall Study|Lost to Follow-up|0|||
94731187|NCT04137289|324474009|FG000|Overall Study|Adverse Event|0|||
94731188|NCT04137289|324474010|FG001|Overall Study|Adverse Event|0|||
94731189|NCT04137289|324474011|FG002|Overall Study|Adverse Event|1|||
94731190|NCT04137289|324474012|FG003|Overall Study|Adverse Event|0|||
94731191|NCT04137289|324474013|FG004|Overall Study|Adverse Event|0|||
94731192|NCT04137289|324474014|FG005|Overall Study|Adverse Event|1|||
94731193|NCT04137289|324474015|FG006|Overall Study|Adverse Event|0|||
94731194|NCT04137289|324474016|FG007|Overall Study|Adverse Event|0|||
94731195|NCT04137289|324474017|FG008|Overall Study|Adverse Event|0|||
94731196|NCT04137289|324474009|FG000|Overall Study|Lack of clinical benefit|0|||
94731197|NCT04137289|324474010|FG001|Overall Study|Lack of clinical benefit|0|||
94731198|NCT04137289|324474011|FG002|Overall Study|Lack of clinical benefit|0|||
94731199|NCT04137289|324474012|FG003|Overall Study|Lack of clinical benefit|0|||
94273912|NCT00804570|322795716|FG001|Overall Study|Adverse Event|7|||
94273913|NCT00804570|322795715|FG000|Overall Study|Lack of Efficacy|0|||
94273914|NCT00804570|322795716|FG001|Overall Study|Lack of Efficacy|1|||
94731200|NCT04137289|324474013|FG004|Overall Study|Lack of clinical benefit|0|||
94731201|NCT04137289|324474014|FG005|Overall Study|Lack of clinical benefit|0|||
94731202|NCT04137289|324474015|FG006|Overall Study|Lack of clinical benefit|0|||
94731203|NCT04137289|324474016|FG007|Overall Study|Lack of clinical benefit|0|||
94731204|NCT04137289|324474017|FG008|Overall Study|Lack of clinical benefit|1|||
94467418|NCT04015518|323500563|FG002|Overall Study|Lack of Efficacy|1|||
94731205|NCT04137289|324474009|FG000|Overall Study|Objective disease progression|1|||
94731206|NCT04137289|324474010|FG001|Overall Study|Objective disease progression|1|||
94731207|NCT04137289|324474011|FG002|Overall Study|Objective disease progression|6|||
94731208|NCT04137289|324474012|FG003|Overall Study|Objective disease progression|18|||
94731209|NCT04137289|324474013|FG004|Overall Study|Objective disease progression|12|||
94731210|NCT04137289|324474014|FG005|Overall Study|Objective disease progression|20|||
94731211|NCT04137289|324474015|FG006|Overall Study|Objective disease progression|18|||
94731212|NCT04137289|324474016|FG007|Overall Study|Objective disease progression|7|||
94273915|NCT00804570|322795715|FG000|Overall Study|Lost to Follow-up|18|||
94731213|NCT04137289|324474017|FG008|Overall Study|Objective disease progression|6|||
94731214|NCT04307355|324474018|FG000|Overall Study|Non-Compliance|3|||
94731215|NCT04307355|324474019|FG001|Overall Study|Non-Compliance|3|||
94731216|NCT04307355|324474020|FG002|Overall Study|Non-Compliance|0|||
94731217|NCT04065841|324474021|FG000|Overall Study|Adverse Event|4|||
94731218|NCT04065841|324474022|FG001|Overall Study|Adverse Event|2|||
94731219|NCT04065841|324474023|FG002|Overall Study|Adverse Event|10|||
94731220|NCT04065841|324474024|FG003|Overall Study|Adverse Event|1|||
94731221|NCT04065841|324474021|FG000|Overall Study|Lost to Follow-up|1|||
94731222|NCT04065841|324474022|FG001|Overall Study|Lost to Follow-up|2|||
94731223|NCT04065841|324474023|FG002|Overall Study|Lost to Follow-up|2|||
94731224|NCT04065841|324474024|FG003|Overall Study|Lost to Follow-up|2|||
94731225|NCT04065841|324474021|FG000|Overall Study|Physician Decision|1|||
94731226|NCT04065841|324474022|FG001|Overall Study|Physician Decision|0|||
94731227|NCT04065841|324474023|FG002|Overall Study|Physician Decision|0|||
94731228|NCT04065841|324474024|FG003|Overall Study|Physician Decision|0|||
94731229|NCT04065841|324474021|FG000|Overall Study|Protocol Violation|0|||
94731230|NCT04065841|324474022|FG001|Overall Study|Protocol Violation|1|||
94731231|NCT04065841|324474023|FG002|Overall Study|Protocol Violation|0|||
94731232|NCT04065841|324474024|FG003|Overall Study|Protocol Violation|0|||
94731233|NCT04065841|324474021|FG000|Overall Study|Study terminated by Sponsor|22|||
94731234|NCT04065841|324474022|FG001|Overall Study|Study terminated by Sponsor|16|||
94731235|NCT04065841|324474023|FG002|Overall Study|Study terminated by Sponsor|28|||
94731236|NCT04065841|324474024|FG003|Overall Study|Study terminated by Sponsor|17|||
94731237|NCT04065841|324474021|FG000|Overall Study|Withdrawal by Subject|1|||
94731238|NCT04065841|324474022|FG001|Overall Study|Withdrawal by Subject|1|||
94731239|NCT04065841|324474023|FG002|Overall Study|Withdrawal by Subject|2|||
94731240|NCT04065841|324474024|FG003|Overall Study|Withdrawal by Subject|0|||
94731241|NCT04032704|324474027|FG000|Part A|Withdrawal by Subject|0|||
94731242|NCT04032704|324474028|FG001|Part A|Withdrawal by Subject|0|||
94731243|NCT04032704|324474029|FG002|Part A|Withdrawal by Subject|3|||
94731244|NCT04032704|324474030|FG003|Part A|Withdrawal by Subject|0|||
94731245|NCT04032704|324474031|FG004|Part A|Withdrawal by Subject|1|||
94731246|NCT04032704|324474032|FG005|Part A|Withdrawal by Subject|7|||
94731247|NCT04032704|324474033|FG006|Part A|Withdrawal by Subject|0|||
94731248|NCT04032704|324474034|FG007|Part A|Withdrawal by Subject|0|||
94731249|NCT04032704|324474035|FG008|Part A|Withdrawal by Subject|0|||
94731250|NCT04032704|324474036|FG009|Part A|Withdrawal by Subject|0|||
94731251|NCT04032704|324474037|FG010|Part A|Withdrawal by Subject|0|||
94731252|NCT04032704|324474038|FG011|Part A|Withdrawal by Subject|0|||
94731253|NCT04032704|324474039|FG012|Part A|Withdrawal by Subject|0|||
94731254|NCT04032704|324474040|FG013|Part A|Withdrawal by Subject|0|||
94731255|NCT04032704|324474041|FG014|Part A|Withdrawal by Subject|0|||
94731256|NCT04032704|324474042|FG015|Part A|Withdrawal by Subject|0|||
94731257|NCT04032704|324474043|FG016|Part A|Withdrawal by Subject|0|||
94731258|NCT04032704|324474044|FG017|Part A|Withdrawal by Subject|0|||
94731259|NCT04032704|324474027|FG000|Part A|Lost to Follow-up|1|||
94731260|NCT04032704|324474028|FG001|Part A|Lost to Follow-up|0|||
94731261|NCT04032704|324474029|FG002|Part A|Lost to Follow-up|0|||
94731262|NCT04032704|324474030|FG003|Part A|Lost to Follow-up|0|||
94731263|NCT04032704|324474031|FG004|Part A|Lost to Follow-up|0|||
94731264|NCT04032704|324474032|FG005|Part A|Lost to Follow-up|0|||
94731265|NCT04032704|324474033|FG006|Part A|Lost to Follow-up|0|||
94731266|NCT04032704|324474034|FG007|Part A|Lost to Follow-up|0|||
94731267|NCT04032704|324474035|FG008|Part A|Lost to Follow-up|0|||
94731268|NCT04032704|324474036|FG009|Part A|Lost to Follow-up|0|||
94731269|NCT04032704|324474037|FG010|Part A|Lost to Follow-up|0|||
94731270|NCT04032704|324474038|FG011|Part A|Lost to Follow-up|0|||
94731271|NCT04032704|324474039|FG012|Part A|Lost to Follow-up|0|||
94731272|NCT04032704|324474040|FG013|Part A|Lost to Follow-up|0|||
94273916|NCT00804570|322795716|FG001|Overall Study|Lost to Follow-up|21|||
94731273|NCT04032704|324474041|FG014|Part A|Lost to Follow-up|0|||
94731274|NCT04032704|324474042|FG015|Part A|Lost to Follow-up|0|||
94731275|NCT04032704|324474043|FG016|Part A|Lost to Follow-up|0|||
94731276|NCT04032704|324474044|FG017|Part A|Lost to Follow-up|0|||
94731277|NCT04032704|324474027|FG000|Part A|Death|9|||
94731278|NCT04032704|324474028|FG001|Part A|Death|2|||
94731279|NCT04032704|324474029|FG002|Part A|Death|10|||
94731280|NCT04032704|324474030|FG003|Part A|Death|7|||
94731281|NCT04032704|324474031|FG004|Part A|Death|4|||
94731282|NCT04032704|324474032|FG005|Part A|Death|5|||
94731283|NCT04032704|324474033|FG006|Part A|Death|0|||
94731284|NCT04032704|324474034|FG007|Part A|Death|0|||
94731285|NCT04032704|324474035|FG008|Part A|Death|0|||
94731286|NCT04032704|324474036|FG009|Part A|Death|0|||
94731287|NCT04032704|324474037|FG010|Part A|Death|0|||
94731288|NCT04032704|324474038|FG011|Part A|Death|0|||
94731289|NCT04032704|324474039|FG012|Part A|Death|0|||
94731290|NCT04032704|324474040|FG013|Part A|Death|0|||
94731291|NCT04032704|324474041|FG014|Part A|Death|0|||
94731292|NCT04032704|324474042|FG015|Part A|Death|0|||
94731293|NCT04032704|324474043|FG016|Part A|Death|0|||
94731294|NCT04032704|324474044|FG017|Part A|Death|0|||
94731295|NCT04032704|324474027|FG000|Part B|Other|0|||
94731296|NCT04032704|324474028|FG001|Part B|Other|0|||
94731297|NCT04032704|324474029|FG002|Part B|Other|0|||
94731298|NCT04032704|324474030|FG003|Part B|Other|0|||
94731299|NCT04032704|324474031|FG004|Part B|Other|0|||
94731300|NCT04032704|324474032|FG005|Part B|Other|0|||
94731301|NCT04032704|324474033|FG006|Part B|Other|0|||
94731302|NCT04032704|324474034|FG007|Part B|Other|1|||
94731303|NCT04032704|324474035|FG008|Part B|Other|2|||
94731304|NCT04032704|324474036|FG009|Part B|Other|1|||
94731305|NCT04032704|324474037|FG010|Part B|Other|1|||
94731306|NCT04032704|324474038|FG011|Part B|Other|1|||
94731307|NCT04032704|324474039|FG012|Part B|Other|5|||
94731308|NCT04032704|324474040|FG013|Part B|Other|13|||
94731309|NCT04032704|324474041|FG014|Part B|Other|0|||
94731310|NCT04032704|324474042|FG015|Part B|Other|0|||
94731311|NCT04032704|324474043|FG016|Part B|Other|0|||
94731312|NCT04032704|324474044|FG017|Part B|Other|0|||
94731313|NCT04032704|324474027|FG000|Part B|Study termination by Sponsor|0|||
94731314|NCT04032704|324474028|FG001|Part B|Study termination by Sponsor|0|||
94731315|NCT04032704|324474029|FG002|Part B|Study termination by Sponsor|0|||
94731316|NCT04032704|324474030|FG003|Part B|Study termination by Sponsor|0|||
94731317|NCT04032704|324474031|FG004|Part B|Study termination by Sponsor|0|||
94731318|NCT04032704|324474032|FG005|Part B|Study termination by Sponsor|0|||
94731319|NCT04032704|324474033|FG006|Part B|Study termination by Sponsor|0|||
94731320|NCT04032704|324474034|FG007|Part B|Study termination by Sponsor|0|||
94731321|NCT04032704|324474035|FG008|Part B|Study termination by Sponsor|1|||
94731322|NCT04032704|324474036|FG009|Part B|Study termination by Sponsor|0|||
94731323|NCT04032704|324474037|FG010|Part B|Study termination by Sponsor|0|||
94731324|NCT04032704|324474038|FG011|Part B|Study termination by Sponsor|0|||
94731325|NCT04032704|324474039|FG012|Part B|Study termination by Sponsor|0|||
94731326|NCT04032704|324474040|FG013|Part B|Study termination by Sponsor|0|||
94731327|NCT04032704|324474041|FG014|Part B|Study termination by Sponsor|0|||
94731328|NCT04032704|324474042|FG015|Part B|Study termination by Sponsor|0|||
94731329|NCT04032704|324474043|FG016|Part B|Study termination by Sponsor|0|||
94731330|NCT04032704|324474044|FG017|Part B|Study termination by Sponsor|0|||
94731331|NCT04032704|324474027|FG000|Part B|Withdrawal by Subject|0|||
94731332|NCT04032704|324474028|FG001|Part B|Withdrawal by Subject|0|||
94731333|NCT04032704|324474029|FG002|Part B|Withdrawal by Subject|0|||
94731334|NCT04032704|324474030|FG003|Part B|Withdrawal by Subject|0|||
94731335|NCT04032704|324474031|FG004|Part B|Withdrawal by Subject|0|||
94731336|NCT04032704|324474032|FG005|Part B|Withdrawal by Subject|0|||
94731337|NCT04032704|324474033|FG006|Part B|Withdrawal by Subject|3|||
94731338|NCT04032704|324474034|FG007|Part B|Withdrawal by Subject|2|||
94467419|NCT04015518|323500564|FG003|Overall Study|Lack of Efficacy|0|||
94731339|NCT04032704|324474035|FG008|Part B|Withdrawal by Subject|2|||
94731340|NCT04032704|324474036|FG009|Part B|Withdrawal by Subject|1|||
94731341|NCT04032704|324474037|FG010|Part B|Withdrawal by Subject|4|||
94731342|NCT04032704|324474038|FG011|Part B|Withdrawal by Subject|6|||
94731343|NCT04032704|324474039|FG012|Part B|Withdrawal by Subject|2|||
94731344|NCT04032704|324474040|FG013|Part B|Withdrawal by Subject|1|||
94731345|NCT04032704|324474041|FG014|Part B|Withdrawal by Subject|0|||
94731346|NCT04032704|324474042|FG015|Part B|Withdrawal by Subject|1|||
94731347|NCT04032704|324474043|FG016|Part B|Withdrawal by Subject|0|||
94731348|NCT04032704|324474044|FG017|Part B|Withdrawal by Subject|0|||
94731349|NCT04032704|324474027|FG000|Part B|Lost to Follow-up|0|||
94731350|NCT04032704|324474028|FG001|Part B|Lost to Follow-up|0|||
94731351|NCT04032704|324474029|FG002|Part B|Lost to Follow-up|0|||
94731352|NCT04032704|324474030|FG003|Part B|Lost to Follow-up|0|||
94731353|NCT04032704|324474031|FG004|Part B|Lost to Follow-up|0|||
94731354|NCT04032704|324474032|FG005|Part B|Lost to Follow-up|0|||
94731355|NCT04032704|324474033|FG006|Part B|Lost to Follow-up|0|||
94731356|NCT04032704|324474034|FG007|Part B|Lost to Follow-up|0|||
94731357|NCT04032704|324474035|FG008|Part B|Lost to Follow-up|0|||
94731358|NCT04032704|324474036|FG009|Part B|Lost to Follow-up|0|||
94731359|NCT04032704|324474037|FG010|Part B|Lost to Follow-up|0|||
94731360|NCT04032704|324474038|FG011|Part B|Lost to Follow-up|1|||
94731361|NCT04032704|324474039|FG012|Part B|Lost to Follow-up|0|||
94731362|NCT04032704|324474040|FG013|Part B|Lost to Follow-up|0|||
94731363|NCT04032704|324474041|FG014|Part B|Lost to Follow-up|0|||
94368669|NCT01682512|323136503|FG002|Overall Study|Secondary lack of efficacy|0|||
94368670|NCT01682512|323136501|FG000|Overall Study|Other than stated above|2|||
94368671|NCT01682512|323136502|FG001|Overall Study|Other than stated above|4|||
94368672|NCT01682512|323136503|FG002|Overall Study|Other than stated above|2|||
94368673|NCT03876873|323136504|FG000|Overall Study|Physician Decision|0|||
94368674|NCT03876873|323136505|FG001|Overall Study|Physician Decision|1|||
94368675|NCT02261974|323136506|FG000|Overall Study|Withdrawal by Subject|3|||
94368676|NCT02261974|323136507|FG001|Overall Study|Withdrawal by Subject|2|||
94368677|NCT02261974|323136506|FG000|Overall Study|Pregnancy|0|||
94368678|NCT02261974|323136507|FG001|Overall Study|Pregnancy|1|||
94731364|NCT04032704|324474042|FG015|Part B|Lost to Follow-up|0|||
94731365|NCT04032704|324474043|FG016|Part B|Lost to Follow-up|0|||
94731366|NCT04032704|324474044|FG017|Part B|Lost to Follow-up|0|||
94731367|NCT04032704|324474027|FG000|Part B|Death|0|||
94731368|NCT04032704|324474028|FG001|Part B|Death|0|||
94731369|NCT04032704|324474029|FG002|Part B|Death|0|||
94731370|NCT04032704|324474030|FG003|Part B|Death|0|||
94731371|NCT04032704|324474031|FG004|Part B|Death|0|||
94731372|NCT04032704|324474032|FG005|Part B|Death|0|||
94368679|NCT02261974|323136506|FG000|Overall Study|Missed treatment cut-off date|6|||
94731373|NCT04032704|324474033|FG006|Part B|Death|13|||
94731374|NCT04032704|324474034|FG007|Part B|Death|13|||
94731375|NCT04032704|324474035|FG008|Part B|Death|14|||
94731376|NCT04032704|324474036|FG009|Part B|Death|12|||
94731377|NCT04032704|324474037|FG010|Part B|Death|12|||
94731378|NCT04032704|324474038|FG011|Part B|Death|13|||
94731379|NCT04032704|324474039|FG012|Part B|Death|7|||
94731380|NCT04032704|324474040|FG013|Part B|Death|17|||
94731381|NCT04032704|324474041|FG014|Part B|Death|2|||
94731382|NCT04032704|324474042|FG015|Part B|Death|1|||
94731383|NCT04032704|324474043|FG016|Part B|Death|2|||
94731384|NCT04032704|324474044|FG017|Part B|Death|2|||
94731385|NCT02519348|324474045|FG000|Overall Study|Death|31|||
94731386|NCT02519348|324474046|FG001|Overall Study|Death|74|||
94731387|NCT02519348|324474047|FG002|Overall Study|Death|47|||
94731388|NCT02519348|324474048|FG003|Overall Study|Death|54|||
94731389|NCT02519348|324474049|FG004|Overall Study|Death|63|||
94731390|NCT02519348|324474050|FG005|Overall Study|Death|18|||
94731391|NCT02519348|324474051|FG006|Overall Study|Death|2|||
94731392|NCT02519348|324474052|FG007|Overall Study|Death|5|||
94731393|NCT02519348|324474053|FG008|Overall Study|Death|5|||
94731394|NCT02519348|324474045|FG000|Overall Study|Withdrawal by Subject|4|||
94731395|NCT02519348|324474046|FG001|Overall Study|Withdrawal by Subject|7|||
94731396|NCT02519348|324474047|FG002|Overall Study|Withdrawal by Subject|4|||
94731397|NCT02519348|324474048|FG003|Overall Study|Withdrawal by Subject|3|||
94731398|NCT02519348|324474049|FG004|Overall Study|Withdrawal by Subject|3|||
94731399|NCT02519348|324474050|FG005|Overall Study|Withdrawal by Subject|2|||
94731400|NCT02519348|324474051|FG006|Overall Study|Withdrawal by Subject|0|||
94731401|NCT02519348|324474052|FG007|Overall Study|Withdrawal by Subject|0|||
94731402|NCT02519348|324474053|FG008|Overall Study|Withdrawal by Subject|1|||
94731403|NCT02519348|324474045|FG000|Overall Study|Lost to Follow-up|0|||
94731404|NCT02519348|324474046|FG001|Overall Study|Lost to Follow-up|0|||
94731405|NCT02519348|324474047|FG002|Overall Study|Lost to Follow-up|1|||
94731406|NCT02519348|324474048|FG003|Overall Study|Lost to Follow-up|0|||
94368680|NCT02261974|323136507|FG001|Overall Study|Missed treatment cut-off date|3|||
94368681|NCT02261974|323136506|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
94731407|NCT02519348|324474049|FG004|Overall Study|Lost to Follow-up|2|||
94731408|NCT02519348|324474050|FG005|Overall Study|Lost to Follow-up|1|||
94731409|NCT02519348|324474051|FG006|Overall Study|Lost to Follow-up|1|||
94731410|NCT02519348|324474052|FG007|Overall Study|Lost to Follow-up|0|||
94731411|NCT02519348|324474053|FG008|Overall Study|Lost to Follow-up|0|||
94731412|NCT02519348|324474045|FG000|Overall Study|Other|0|||
94731413|NCT02519348|324474046|FG001|Overall Study|Other|3|||
94731414|NCT02519348|324474047|FG002|Overall Study|Other|0|||
94731415|NCT02519348|324474048|FG003|Overall Study|Other|0|||
94731416|NCT02519348|324474049|FG004|Overall Study|Other|1|||
94731417|NCT02519348|324474050|FG005|Overall Study|Other|0|||
94731418|NCT02519348|324474051|FG006|Overall Study|Other|0|||
94731419|NCT02519348|324474052|FG007|Overall Study|Other|0|||
94731420|NCT02519348|324474053|FG008|Overall Study|Other|0|||
94731421|NCT02519348|324474045|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
94731422|NCT02519348|324474046|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
94731423|NCT02519348|324474047|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
94731424|NCT02519348|324474048|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
94731425|NCT02519348|324474049|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
94731426|NCT02519348|324474050|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
94731427|NCT02519348|324474051|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
94731428|NCT02519348|324474052|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
94731429|NCT02519348|324474053|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
94731430|NCT02465268|324474057|FG000|Overall Study|Withdrawal by Subject|4|||
94731431|NCT02465268|324474058|FG001|Overall Study|Withdrawal by Subject|3|||
94731432|NCT02465268|324474059|FG002|Overall Study|Withdrawal by Subject|1|||
94731433|NCT02465268|324474057|FG000|Overall Study|Not evaluable per protocol criteria|3|||
94731434|NCT02465268|324474058|FG001|Overall Study|Not evaluable per protocol criteria|2|||
94731435|NCT02465268|324474059|FG002|Overall Study|Not evaluable per protocol criteria|1|||
94731436|NCT02465268|324474057|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
94731437|NCT02465268|324474058|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
94731438|NCT02465268|324474059|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
94731439|NCT02465268|324474057|FG000|Overall Study|Study drug did not pass QA/QC|1|||
94731440|NCT02465268|324474058|FG001|Overall Study|Study drug did not pass QA/QC|0|||
94731441|NCT02465268|324474059|FG002|Overall Study|Study drug did not pass QA/QC|0|||
94731442|NCT02465268|324474057|FG000|Overall Study|Adverse Event|0|||
94731443|NCT02465268|324474058|FG001|Overall Study|Adverse Event|1|||
94731444|NCT02465268|324474059|FG002|Overall Study|Adverse Event|0|||
94731445|NCT02465268|324474057|FG000|Overall Study|Physician Decision|0|||
94731446|NCT02465268|324474058|FG001|Overall Study|Physician Decision|1|||
94731447|NCT02465268|324474059|FG002|Overall Study|Physician Decision|0|||
94731448|NCT02365467|324474061|FG000|Overall Study|Death|3|||
94731449|NCT04231149|324474062|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
94731450|NCT04231149|324474063|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
94731451|NCT04231149|324474064|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
94731452|NCT04231149|324474065|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
94731453|NCT04231149|324474066|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
94731454|NCT03252847|324474067|FG000|Overall Study|Withdrawal by Subject|0|||
94731455|NCT03252847|324474068|FG001|Overall Study|Withdrawal by Subject|0|||
94731456|NCT03252847|324474069|FG002|Overall Study|Withdrawal by Subject|1|||
94731457|NCT03252847|324474070|FG003|Overall Study|Withdrawal by Subject|0|||
94731458|NCT03252847|324474071|FG004|Overall Study|Withdrawal by Subject|0|||
94731459|NCT03252847|324474072|FG005|Overall Study|Withdrawal by Subject|0|||
94731460|NCT03252847|324474073|FG006|Overall Study|Withdrawal by Subject|0|||
94731461|NCT03252847|324474067|FG000|Overall Study|Other: Patient decision|0|||
94731462|NCT03252847|324474068|FG001|Overall Study|Other: Patient decision|0|||
94731463|NCT03252847|324474069|FG002|Overall Study|Other: Patient decision|0|||
94731464|NCT03252847|324474070|FG003|Overall Study|Other: Patient decision|0|||
94731465|NCT03252847|324474071|FG004|Overall Study|Other: Patient decision|1|||
94731466|NCT03252847|324474072|FG005|Overall Study|Other: Patient decision|0|||
94731467|NCT03252847|324474073|FG006|Overall Study|Other: Patient decision|0|||
94731468|NCT03133546|324474078|FG000|Overall Study|Death|46|||
94731469|NCT03133546|324474079|FG001|Overall Study|Death|43|||
94731470|NCT03133546|324474078|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
94731471|NCT03133546|324474079|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
94273917|NCT00804570|322795715|FG000|Overall Study|Entry criteria not met|5|||
94273918|NCT00804570|322795716|FG001|Overall Study|Entry criteria not met|5|||
94273919|NCT00804570|322795715|FG000|Overall Study|Protocol Violation|12|||
94273920|NCT00804570|322795716|FG001|Overall Study|Protocol Violation|16|||
94273921|NCT00804570|322795715|FG000|Overall Study|Physician Decision|1|||
94273922|NCT00804570|322795716|FG001|Overall Study|Physician Decision|2|||
94273923|NCT00804570|322795715|FG000|Overall Study|Sponsor decision|1|||
94273924|NCT00804570|322795716|FG001|Overall Study|Sponsor decision|4|||
94273925|NCT00804570|322795715|FG000|Overall Study|Withdrawal by Subject|21|||
94273926|NCT00804570|322795716|FG001|Overall Study|Withdrawal by Subject|38|||
94273927|NCT00545298|322795719|FG000|Overall Study|Issues with Standard of Care|2|||
94273928|NCT00545298|322795720|FG001|Overall Study|Issues with Standard of Care|0|||
94273929|NCT00545298|322795721|FG002|Overall Study|Issues with Standard of Care|1|||
94273930|NCT05289570|322795732|FG000|Overall Study|Physician Decision|1|||
94273931|NCT00964743|322795737|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
94731472|NCT01501955|324474083|FG000|Overall Study|Withdrawal by Subject|1|||
94731473|NCT01501955|324474084|FG001|Overall Study|Withdrawal by Subject|0|||
94731474|NCT01501955|324474083|FG000|Overall Study|Adverse Event|1|||
94731475|NCT01501955|324474084|FG001|Overall Study|Adverse Event|3|||
94731476|NCT04298983|324474088|FG000|Overall Study|Adverse Event|4|||
94273932|NCT02739620|322795746|FG000|Overall Study|Lost to Follow-up|3|||
94273933|NCT02739620|322795747|FG001|Overall Study|Lost to Follow-up|1|||
94273934|NCT02739620|322795746|FG000|Overall Study|Adverse Event|0|||
94273935|NCT02739620|322795747|FG001|Overall Study|Adverse Event|1|||
94273936|NCT02873936|322795748|FG000|Overall Study|Withdrew Consent|4|||
94273937|NCT02873936|322795749|FG001|Overall Study|Withdrew Consent|11|||
94273938|NCT02873936|322795750|FG002|Overall Study|Withdrew Consent|20|||
94273939|NCT02873936|322795748|FG000|Overall Study|Investigator's Discretion|3|||
94731477|NCT04298983|324474088|FG000|Overall Study|Lack of Efficacy|3|||
94731478|NCT04005794|324474091|FG000|Overall Study|Lost to Follow-up|0|||
94731479|NCT04005794|324474092|FG001|Overall Study|Lost to Follow-up|4|||
94731480|NCT04005794|324474093|FG002|Overall Study|Lost to Follow-up|0|||
94731481|NCT05792085|324474096|FG000|Overall Study|Death|0|||
94731482|NCT05792085|324474097|FG001|Overall Study|Death|0|||
94731483|NCT05792085|324474098|FG002|Overall Study|Death|0|||
94731484|NCT05792085|324474099|FG003|Overall Study|Death|0|||
94731485|NCT05792085|324474100|FG004|Overall Study|Death|1|||
94731486|NCT05386030|324474102|FG000|Overall Study|Death|1|||
94731487|NCT05386030|324474103|FG001|Overall Study|Death|0|||
94731488|NCT05386030|324474102|FG000|Overall Study|Physician Decision|2|||
94731489|NCT05386030|324474103|FG001|Overall Study|Physician Decision|1|||
94731490|NCT05386030|324474102|FG000|Overall Study|Lost to Follow-up|19|||
94731491|NCT05386030|324474103|FG001|Overall Study|Lost to Follow-up|7|||
94731492|NCT05386030|324474102|FG000|Overall Study|Withdrawal by Subject|20|||
94731493|NCT05386030|324474103|FG001|Overall Study|Withdrawal by Subject|10|||
94731494|NCT05386030|324474102|FG000|Overall Study|Eligibility criteria violation|1|||
94731495|NCT05386030|324474103|FG001|Overall Study|Eligibility criteria violation|1|||
94731496|NCT05386030|324474102|FG000|Overall Study|Personal Reasons|1|||
94731497|NCT05386030|324474103|FG001|Overall Study|Personal Reasons|0|||
94731498|NCT03161028|324474106|FG000|Overall Study|Withdrawal by Subject|6|||
94731499|NCT03161028|324474107|FG001|Overall Study|Withdrawal by Subject|4|||
94731500|NCT03161028|324474106|FG000|Overall Study|Adverse Event|5|||
94731501|NCT03161028|324474107|FG001|Overall Study|Adverse Event|1|||
94731502|NCT03161028|324474106|FG000|Overall Study|Study drug side effects|2|||
94731503|NCT03161028|324474107|FG001|Overall Study|Study drug side effects|2|||
94731504|NCT03161028|324474106|FG000|Overall Study|Administrative PD/UP|4|||
94731505|NCT03161028|324474107|FG001|Overall Study|Administrative PD/UP|2|||
94731506|NCT03161028|324474106|FG000|Overall Study|Lost to Follow-up|2|||
94731507|NCT03161028|324474107|FG001|Overall Study|Lost to Follow-up|0|||
94731508|NCT03161028|324474106|FG000|Overall Study|Unable to comply with procedures|1|||
94731509|NCT03161028|324474107|FG001|Overall Study|Unable to comply with procedures|1|||
94731510|NCT06182033|324474109|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
94731511|NCT06182033|324474110|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
94731512|NCT06182033|324474109|FG000|Overall Study|Target child relocation|1|||
94731513|NCT06182033|324474110|FG001|Overall Study|Target child relocation|1|||
94731514|NCT06182033|324474109|FG000|Overall Study|Withdrawal by Subject|1|||
94731515|NCT06182033|324474110|FG001|Overall Study|Withdrawal by Subject|0|||
94731516|NCT04517253|324474115|FG000|Overall Study|Adverse Event|1|||
94731517|NCT04517253|324474116|FG001|Overall Study|Adverse Event|0|||
94731518|NCT04517253|324474117|FG002|Overall Study|Adverse Event|0|||
94731519|NCT04517253|324474115|FG000|Overall Study|Death|0|||
94731520|NCT04517253|324474116|FG001|Overall Study|Death|1|||
94731521|NCT04517253|324474117|FG002|Overall Study|Death|0|||
94731522|NCT04909801|324474119|FG000|Overall Study|Lack of Efficacy|2|||
94731523|NCT04909801|324474120|FG001|Overall Study|Lack of Efficacy|1|||
94731524|NCT04909801|324474119|FG000|Overall Study|Adverse Event|1|||
94731525|NCT04909801|324474120|FG001|Overall Study|Adverse Event|2|||
94731526|NCT04909801|324474119|FG000|Overall Study|Participant request to discontinue study treatment|1|||
94731527|NCT04909801|324474120|FG001|Overall Study|Participant request to discontinue study treatment|2|||
94731528|NCT04909801|324474119|FG000|Overall Study|Withdrawal by Subject|2|||
94731529|NCT04909801|324474120|FG001|Overall Study|Withdrawal by Subject|1|||
94731530|NCT04909801|324474119|FG000|Overall Study|other reasons|1|||
94731531|NCT04909801|324474120|FG001|Overall Study|other reasons|1|||
94731532|NCT01129102|324475694|FG000|Overall Study|No study drug treatment|2|||
94731533|NCT01129102|324475695|FG001|Overall Study|No study drug treatment|3|||
94731534|NCT01129102|324475696|FG002|Overall Study|No study drug treatment|1|||
94731535|NCT01129102|324475694|FG000|Overall Study|Withdrawal by Subject|2|||
94731536|NCT01129102|324475695|FG001|Overall Study|Withdrawal by Subject|0|||
94731537|NCT01129102|324475696|FG002|Overall Study|Withdrawal by Subject|3|||
94731538|NCT01129102|324475694|FG000|Overall Study|Protocol Violation|0|||
94731539|NCT01129102|324475695|FG001|Overall Study|Protocol Violation|1|||
94731540|NCT01129102|324475696|FG002|Overall Study|Protocol Violation|1|||
94731541|NCT01129102|324475694|FG000|Overall Study|Pregnancy|0|||
94731542|NCT01129102|324475695|FG001|Overall Study|Pregnancy|0|||
94731543|NCT01129102|324475696|FG002|Overall Study|Pregnancy|1|||
94731544|NCT01129102|324475694|FG000|Overall Study|Adverse Event|2|||
94731545|NCT01129102|324475695|FG001|Overall Study|Adverse Event|2|||
94731546|NCT01129102|324475696|FG002|Overall Study|Adverse Event|1|||
94273940|NCT02873936|322795749|FG001|Overall Study|Investigator's Discretion|5|||
94273941|NCT02873936|322795750|FG002|Overall Study|Investigator's Discretion|4|||
94731547|NCT01129102|324475694|FG000|Overall Study|Lost to Follow-up|2|||
94731548|NCT01129102|324475695|FG001|Overall Study|Lost to Follow-up|0|||
94731549|NCT01129102|324475696|FG002|Overall Study|Lost to Follow-up|0|||
94731550|NCT03379675|324475699|FG000|Overall Study|Lost to Follow-up|0|||
94731551|NCT03379675|324475700|FG001|Overall Study|Lost to Follow-up|1|||
94731552|NCT03379675|324475701|FG002|Overall Study|Lost to Follow-up|0|||
94731553|NCT03379675|324475699|FG000|Overall Study|Adverse Event|2|||
94731554|NCT03379675|324475700|FG001|Overall Study|Adverse Event|0|||
94731555|NCT03379675|324475701|FG002|Overall Study|Adverse Event|0|||
94731556|NCT03379675|324475699|FG000|Overall Study|Withdrawal by Subject|2|||
94731557|NCT03379675|324475700|FG001|Overall Study|Withdrawal by Subject|1|||
94731558|NCT03379675|324475701|FG002|Overall Study|Withdrawal by Subject|2|||
94731559|NCT05499377|324475710|FG000|Overall Study|Withdrawal by Subject|2|||
94731560|NCT05499377|324475711|FG001|Overall Study|Withdrawal by Subject|0|||
94731561|NCT05499377|324475710|FG000|Overall Study|Physician Decision|1|||
94731562|NCT05499377|324475711|FG001|Overall Study|Physician Decision|0|||
94731563|NCT01574274|324475712|FG000|Overall Study|Ineligible|0|||
94731564|NCT01574274|324475713|FG001|Overall Study|Ineligible|1|||
94731565|NCT01574274|324475712|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
94731566|NCT01574274|324475713|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
94731567|NCT01574274|324475712|FG000|Overall Study|Ph+ B-ALL|3|||
94731568|NCT01574274|324475713|FG001|Overall Study|Ph+ B-ALL|4|||
94731569|NCT01574274|324475712|FG000|Overall Study|Induction Death|2|||
94731570|NCT01574274|324475713|FG001|Overall Study|Induction Death|0|||
94731571|NCT01574274|324475712|FG000|Overall Study|Induction Failure|4|||
94731572|NCT01574274|324475713|FG001|Overall Study|Induction Failure|1|||
94731573|NCT01574274|324475712|FG000|Overall Study|Adverse Event|16|||
94731574|NCT01574274|324475713|FG001|Overall Study|Adverse Event|13|||
94731575|NCT01574274|324475712|FG000|Overall Study|Remission Death|1|||
94731576|NCT01574274|324475713|FG001|Overall Study|Remission Death|0|||
94731577|NCT01574274|324475712|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
94731578|NCT01574274|324475713|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
94731579|NCT01574274|324475712|FG000|Overall Study|Other, unknown|3|||
94731580|NCT01574274|324475713|FG001|Overall Study|Other, unknown|2|||
94731581|NCT04908397|324475715|FG000|Overall Study|Withdrawal by Subject|2|||
94731582|NCT05257486|324475716|FG000|Overall Study|Protocol Violation|3|||
94731583|NCT04700163|324475717|FG000|Overall Study|Lost to Follow-up|0|||
94731584|NCT04700163|324475718|FG001|Overall Study|Lost to Follow-up|0|||
94731585|NCT04700163|324475719|FG002|Overall Study|Lost to Follow-up|0|||
94731586|NCT04700163|324475720|FG003|Overall Study|Lost to Follow-up|0|||
94731587|NCT04700163|324475721|FG004|Overall Study|Lost to Follow-up|0|||
94731588|NCT04700163|324475722|FG005|Overall Study|Lost to Follow-up|1|||
94731589|NCT03904147|324475724|FG000|Overall Study|Death|15|||
94731590|NCT03904147|324475725|FG001|Overall Study|Death|13|||
94731591|NCT03904147|324475726|FG002|Overall Study|Death|15|||
94731592|NCT03904147|324475724|FG000|Overall Study|Withdrawal by Subject|7|||
94731593|NCT03904147|324475725|FG001|Overall Study|Withdrawal by Subject|12|||
94731594|NCT03904147|324475726|FG002|Overall Study|Withdrawal by Subject|1|||
94731595|NCT03904147|324475724|FG000|Overall Study|1Y visit completed after 365 days|1|||
94731596|NCT03904147|324475725|FG001|Overall Study|1Y visit completed after 365 days|1|||
94731597|NCT03904147|324475726|FG002|Overall Study|1Y visit completed after 365 days|0|||
94731598|NCT04225273|324475730|FG000|Overall Study|Lost to Follow-up|3|||
94731599|NCT04413708|324475731|FG000|Overall Study|Lost to Follow-up|1|||
94731600|NCT04413708|324475732|FG001|Overall Study|Lost to Follow-up|2|||
94731601|NCT05270408|324475734|FG000|Started Treatment|Withdrawal by Subject|0|||
94731602|NCT05270408|324475735|FG001|Started Treatment|Withdrawal by Subject|0|||
94731603|NCT05270408|324475736|FG002|Started Treatment|Withdrawal by Subject|3|||
94731604|NCT05270408|324475734|FG000|Started Treatment|Adverse Event|0|||
94731605|NCT05270408|324475735|FG001|Started Treatment|Adverse Event|0|||
94731606|NCT05270408|324475736|FG002|Started Treatment|Adverse Event|1|||
94731607|NCT05270408|324475734|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
94731608|NCT05270408|324475735|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
94731609|NCT05270408|324475736|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
94731610|NCT03768505|324475737|FG000|Overall Study|sponsor decision|76|||
94731611|NCT03768505|324475737|FG000|Overall Study|Death|35|||
94731612|NCT03768505|324475737|FG000|Overall Study|Other -Various|30|||
94731613|NCT03768505|324475737|FG000|Overall Study|Withdrawal by Subject|22|||
94731614|NCT03768505|324475737|FG000|Overall Study|Lost to Follow-up|6|||
94731615|NCT02815566|324475741|FG000|Overall Study|Adverse Event|1|||
94731616|NCT02815566|324475742|FG001|Overall Study|Adverse Event|1|||
94731617|NCT02815566|324475741|FG000|Overall Study|Withdrawal by Subject|1|||
94731618|NCT02815566|324475742|FG001|Overall Study|Withdrawal by Subject|0|||
94731619|NCT02815566|324475741|FG000|Overall Study|Lost to Follow-up|0|||
94731620|NCT02815566|324475742|FG001|Overall Study|Lost to Follow-up|1|||
94731621|NCT04492722|324475743|FG000|Overall Study|Adverse Event|7|||
94731622|NCT04492722|324475744|FG001|Overall Study|Adverse Event|2|||
94731623|NCT04492722|324475745|FG002|Overall Study|Adverse Event|3|||
94731624|NCT04492722|324475746|FG003|Overall Study|Adverse Event|0|||
94731625|NCT04492722|324475743|FG000|Overall Study|Death|0|||
94731626|NCT04492722|324475744|FG001|Overall Study|Death|0|||
94731627|NCT04492722|324475745|FG002|Overall Study|Death|0|||
94731628|NCT04492722|324475746|FG003|Overall Study|Death|1|||
94731629|NCT04492722|324475743|FG000|Overall Study|Lost to Follow-up|0|||
94731630|NCT04492722|324475744|FG001|Overall Study|Lost to Follow-up|1|||
94731631|NCT04492722|324475745|FG002|Overall Study|Lost to Follow-up|0|||
94731632|NCT04492722|324475746|FG003|Overall Study|Lost to Follow-up|1|||
94731633|NCT04492722|324475743|FG000|Overall Study|Physician Decision|0|||
94731634|NCT04492722|324475744|FG001|Overall Study|Physician Decision|3|||
94731635|NCT04492722|324475745|FG002|Overall Study|Physician Decision|1|||
94731636|NCT04492722|324475746|FG003|Overall Study|Physician Decision|1|||
94731637|NCT04492722|324475743|FG000|Overall Study|Withdrawal by Subject|6|||
94731638|NCT04492722|324475744|FG001|Overall Study|Withdrawal by Subject|6|||
94731639|NCT04492722|324475745|FG002|Overall Study|Withdrawal by Subject|0|||
94731640|NCT04492722|324475746|FG003|Overall Study|Withdrawal by Subject|3|||
94731641|NCT04492722|324475743|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
94731642|NCT04492722|324475744|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
94731643|NCT04492722|324475745|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
94731644|NCT04492722|324475746|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
94731645|NCT04492722|324475743|FG000|Overall Study|Due to Covid-19 pandemic|7|||
94731646|NCT04492722|324475744|FG001|Overall Study|Due to Covid-19 pandemic|3|||
94731647|NCT04492722|324475745|FG002|Overall Study|Due to Covid-19 pandemic|7|||
94731648|NCT04492722|324475746|FG003|Overall Study|Due to Covid-19 pandemic|6|||
94731649|NCT04492722|324475743|FG000|Overall Study|Failure to meet randomisation criteria|2|||
94731650|NCT04492722|324475744|FG001|Overall Study|Failure to meet randomisation criteria|3|||
94731651|NCT04492722|324475745|FG002|Overall Study|Failure to meet randomisation criteria|4|||
94731652|NCT04492722|324475746|FG003|Overall Study|Failure to meet randomisation criteria|2|||
94731653|NCT04492722|324475743|FG000|Overall Study|Early termination from the study|54|||
94731654|NCT04492722|324475744|FG001|Overall Study|Early termination from the study|51|||
94731655|NCT04492722|324475745|FG002|Overall Study|Early termination from the study|50|||
94731656|NCT04492722|324475746|FG003|Overall Study|Early termination from the study|50|||
94731657|NCT04492722|324475743|FG000|Overall Study|Missing|3|||
94731658|NCT04492722|324475744|FG001|Overall Study|Missing|0|||
94731659|NCT04492722|324475745|FG002|Overall Study|Missing|0|||
94368682|NCT02261974|323136507|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
94368683|NCT02261974|323136506|FG000|Overall Study|Lost to Follow-up|2|||
94368684|NCT02261974|323136507|FG001|Overall Study|Lost to Follow-up|0|||
94368685|NCT02261974|323136506|FG000|Overall Study|Adverse Event|1|||
94368686|NCT02261974|323136507|FG001|Overall Study|Adverse Event|0|||
94731660|NCT04492722|324475746|FG003|Overall Study|Missing|5|||
94731661|NCT04492722|324475743|FG000|Overall Study|Participants who did not receive treatment|0|||
94731662|NCT04492722|324475744|FG001|Overall Study|Participants who did not receive treatment|1|||
94731663|NCT04492722|324475745|FG002|Overall Study|Participants who did not receive treatment|4|||
94731664|NCT04492722|324475746|FG003|Overall Study|Participants who did not receive treatment|0|||
94731665|NCT04074759|324475749|FG000|Overall Study|Withdrawal by Subject|0|||
94731666|NCT04074759|324475750|FG001|Overall Study|Withdrawal by Subject|0|||
94731667|NCT04074759|324475751|FG002|Overall Study|Withdrawal by Subject|0|||
94731668|NCT04074759|324475752|FG003|Overall Study|Withdrawal by Subject|0|||
94731669|NCT04074759|324475753|FG004|Overall Study|Withdrawal by Subject|0|||
94731670|NCT04074759|324475754|FG005|Overall Study|Withdrawal by Subject|2|||
94731671|NCT04074759|324475755|FG006|Overall Study|Withdrawal by Subject|0|||
94731672|NCT04074759|324475756|FG007|Overall Study|Withdrawal by Subject|2|||
94731673|NCT04074759|324475757|FG008|Overall Study|Withdrawal by Subject|1|||
94731674|NCT04074759|324475758|FG009|Overall Study|Withdrawal by Subject|2|||
94731675|NCT04074759|324475759|FG010|Overall Study|Withdrawal by Subject|9|||
94731676|NCT04074759|324475760|FG011|Overall Study|Withdrawal by Subject|2|||
94731677|NCT04074759|324475761|FG012|Overall Study|Withdrawal by Subject|1|||
94731678|NCT04074759|324475762|FG013|Overall Study|Withdrawal by Subject|3|||
94731679|NCT04074759|324475763|FG014|Overall Study|Withdrawal by Subject|2|||
94731680|NCT04074759|324475764|FG015|Overall Study|Withdrawal by Subject|0|||
94731681|NCT04074759|324475765|FG016|Overall Study|Withdrawal by Subject|0|||
94731682|NCT04074759|324475766|FG017|Overall Study|Withdrawal by Subject|3|||
94731683|NCT04074759|324475767|FG018|Overall Study|Withdrawal by Subject|1|||
94731684|NCT04074759|324475749|FG000|Overall Study|Death|1|||
94731685|NCT04074759|324475750|FG001|Overall Study|Death|0|||
94731686|NCT04074759|324475751|FG002|Overall Study|Death|1|||
94731687|NCT04074759|324475752|FG003|Overall Study|Death|1|||
94731688|NCT04074759|324475753|FG004|Overall Study|Death|2|||
94731689|NCT04074759|324475754|FG005|Overall Study|Death|0|||
94731690|NCT04074759|324475755|FG006|Overall Study|Death|1|||
94731691|NCT04074759|324475756|FG007|Overall Study|Death|0|||
94731692|NCT04074759|324475757|FG008|Overall Study|Death|3|||
94731693|NCT04074759|324475758|FG009|Overall Study|Death|2|||
94731694|NCT04074759|324475759|FG010|Overall Study|Death|4|||
94731695|NCT04074759|324475760|FG011|Overall Study|Death|1|||
94731696|NCT04074759|324475761|FG012|Overall Study|Death|0|||
94731697|NCT04074759|324475762|FG013|Overall Study|Death|2|||
94731698|NCT04074759|324475763|FG014|Overall Study|Death|1|||
94731699|NCT04074759|324475764|FG015|Overall Study|Death|0|||
94731700|NCT04074759|324475765|FG016|Overall Study|Death|1|||
94731701|NCT04074759|324475766|FG017|Overall Study|Death|0|||
94731702|NCT04074759|324475767|FG018|Overall Study|Death|1|||
94368687|NCT04440007|323136515|FG000|Overall Study|Adverse Event|0|||
94731703|NCT04074759|324475749|FG000|Overall Study|Lost to Follow-up|0|||
94731704|NCT04074759|324475750|FG001|Overall Study|Lost to Follow-up|0|||
94731705|NCT04074759|324475751|FG002|Overall Study|Lost to Follow-up|0|||
94368688|NCT04440007|323136516|FG001|Overall Study|Adverse Event|1|||
94731706|NCT04074759|324475752|FG003|Overall Study|Lost to Follow-up|0|||
94731707|NCT04074759|324475753|FG004|Overall Study|Lost to Follow-up|0|||
94731708|NCT04074759|324475754|FG005|Overall Study|Lost to Follow-up|0|||
94731709|NCT04074759|324475755|FG006|Overall Study|Lost to Follow-up|0|||
94731710|NCT04074759|324475756|FG007|Overall Study|Lost to Follow-up|0|||
94731711|NCT04074759|324475757|FG008|Overall Study|Lost to Follow-up|0|||
94273942|NCT02873936|322795748|FG000|Overall Study|Adverse Event|3|||
94273943|NCT02873936|322795749|FG001|Overall Study|Adverse Event|5|||
94273944|NCT02873936|322795750|FG002|Overall Study|Adverse Event|3|||
94731712|NCT04074759|324475758|FG009|Overall Study|Lost to Follow-up|0|||
94731713|NCT04074759|324475759|FG010|Overall Study|Lost to Follow-up|1|||
94731714|NCT04074759|324475760|FG011|Overall Study|Lost to Follow-up|0|||
94731715|NCT04074759|324475761|FG012|Overall Study|Lost to Follow-up|0|||
94731716|NCT04074759|324475762|FG013|Overall Study|Lost to Follow-up|0|||
94731717|NCT04074759|324475763|FG014|Overall Study|Lost to Follow-up|0|||
94731718|NCT04074759|324475764|FG015|Overall Study|Lost to Follow-up|0|||
94731719|NCT04074759|324475765|FG016|Overall Study|Lost to Follow-up|1|||
94731720|NCT04074759|324475766|FG017|Overall Study|Lost to Follow-up|0|||
94731721|NCT04074759|324475767|FG018|Overall Study|Lost to Follow-up|1|||
94731722|NCT04074759|324475749|FG000|Overall Study|Other|0|||
94731723|NCT04074759|324475750|FG001|Overall Study|Other|1|||
94731724|NCT04074759|324475751|FG002|Overall Study|Other|1|||
94731725|NCT04074759|324475752|FG003|Overall Study|Other|0|||
94731726|NCT04074759|324475753|FG004|Overall Study|Other|2|||
94731727|NCT04074759|324475754|FG005|Overall Study|Other|1|||
94731728|NCT04074759|324475755|FG006|Overall Study|Other|2|||
94731729|NCT04074759|324475756|FG007|Overall Study|Other|1|||
94731730|NCT04074759|324475757|FG008|Overall Study|Other|1|||
94731731|NCT04074759|324475758|FG009|Overall Study|Other|4|||
94731732|NCT04074759|324475759|FG010|Overall Study|Other|4|||
94731733|NCT04074759|324475760|FG011|Overall Study|Other|2|||
94731734|NCT04074759|324475761|FG012|Overall Study|Other|0|||
94731735|NCT04074759|324475762|FG013|Overall Study|Other|0|||
94731736|NCT04074759|324475763|FG014|Overall Study|Other|0|||
94731737|NCT04074759|324475764|FG015|Overall Study|Other|1|||
94731738|NCT04074759|324475765|FG016|Overall Study|Other|0|||
94731739|NCT04074759|324475766|FG017|Overall Study|Other|0|||
94731740|NCT04074759|324475767|FG018|Overall Study|Other|0|||
94731741|NCT04074759|324475749|FG000|Overall Study|Missing end of study status|0|||
94731742|NCT04074759|324475750|FG001|Overall Study|Missing end of study status|0|||
94731743|NCT04074759|324475751|FG002|Overall Study|Missing end of study status|0|||
94731744|NCT04074759|324475752|FG003|Overall Study|Missing end of study status|0|||
94731745|NCT04074759|324475753|FG004|Overall Study|Missing end of study status|0|||
94731746|NCT04074759|324475754|FG005|Overall Study|Missing end of study status|0|||
94731747|NCT04074759|324475755|FG006|Overall Study|Missing end of study status|0|||
94731748|NCT04074759|324475756|FG007|Overall Study|Missing end of study status|0|||
94731749|NCT04074759|324475757|FG008|Overall Study|Missing end of study status|0|||
94731750|NCT04074759|324475758|FG009|Overall Study|Missing end of study status|0|||
94731751|NCT04074759|324475759|FG010|Overall Study|Missing end of study status|2|||
94731752|NCT04074759|324475760|FG011|Overall Study|Missing end of study status|0|||
94731753|NCT04074759|324475761|FG012|Overall Study|Missing end of study status|0|||
94731754|NCT04074759|324475762|FG013|Overall Study|Missing end of study status|0|||
94731755|NCT04074759|324475763|FG014|Overall Study|Missing end of study status|0|||
94731756|NCT04074759|324475764|FG015|Overall Study|Missing end of study status|0|||
94731757|NCT04074759|324475765|FG016|Overall Study|Missing end of study status|1|||
94273945|NCT02873936|322795748|FG000|Overall Study|Protocol Violation|0|||
94731758|NCT04074759|324475766|FG017|Overall Study|Missing end of study status|0|||
94731759|NCT04074759|324475767|FG018|Overall Study|Missing end of study status|0|||
94731760|NCT05329220|324475770|FG000|Active Trial Period|Adverse Event|0|||
94731761|NCT05329220|324475771|FG001|Active Trial Period|Adverse Event|0|||
94731762|NCT05329220|324475772|FG002|Active Trial Period|Adverse Event|0|||
94731763|NCT05329220|324475773|FG003|Active Trial Period|Adverse Event|0|||
94731764|NCT05329220|324475774|FG004|Active Trial Period|Adverse Event|1|||
94731765|NCT05329220|324475775|FG005|Active Trial Period|Adverse Event|0|||
94731766|NCT05329220|324475770|FG000|Active Trial Period|Lost to Follow-up|0|||
94731767|NCT05329220|324475771|FG001|Active Trial Period|Lost to Follow-up|0|||
94731768|NCT05329220|324475772|FG002|Active Trial Period|Lost to Follow-up|0|||
94731769|NCT05329220|324475773|FG003|Active Trial Period|Lost to Follow-up|0|||
94731770|NCT05329220|324475774|FG004|Active Trial Period|Lost to Follow-up|32|||
94731771|NCT05329220|324475775|FG005|Active Trial Period|Lost to Follow-up|28|||
94731772|NCT05329220|324475770|FG000|Active Trial Period|Physician Decision|0|||
94731773|NCT05329220|324475771|FG001|Active Trial Period|Physician Decision|0|||
94731774|NCT05329220|324475772|FG002|Active Trial Period|Physician Decision|0|||
94731775|NCT05329220|324475773|FG003|Active Trial Period|Physician Decision|0|||
94731776|NCT05329220|324475774|FG004|Active Trial Period|Physician Decision|2|||
94731777|NCT05329220|324475775|FG005|Active Trial Period|Physician Decision|0|||
94273946|NCT02873936|322795749|FG001|Overall Study|Protocol Violation|1|||
94273947|NCT02873936|322795750|FG002|Overall Study|Protocol Violation|3|||
94273948|NCT02873936|322795748|FG000|Overall Study|Lost to Follow-up|1|||
94273949|NCT02873936|322795749|FG001|Overall Study|Lost to Follow-up|1|||
94273950|NCT02873936|322795750|FG002|Overall Study|Lost to Follow-up|1|||
94273951|NCT02873936|322795748|FG000|Overall Study|Non-compliance With Study Drug|1|||
94273952|NCT02873936|322795749|FG001|Overall Study|Non-compliance With Study Drug|0|||
94273953|NCT02873936|322795750|FG002|Overall Study|Non-compliance With Study Drug|1|||
94273954|NCT02873936|322795748|FG000|Overall Study|Randomized but not Dosed|1|||
94273955|NCT02873936|322795749|FG001|Overall Study|Randomized but not Dosed|0|||
94273956|NCT02873936|322795750|FG002|Overall Study|Randomized but not Dosed|0|||
94273957|NCT05513625|322795751|FG000|Overall Study|Withdrawal by Subject|1|||
94731778|NCT05329220|324475770|FG000|Active Trial Period|Protocol Violation|0|||
94731779|NCT05329220|324475771|FG001|Active Trial Period|Protocol Violation|0|||
94731780|NCT05329220|324475772|FG002|Active Trial Period|Protocol Violation|0|||
94731781|NCT05329220|324475773|FG003|Active Trial Period|Protocol Violation|0|||
94731782|NCT05329220|324475774|FG004|Active Trial Period|Protocol Violation|1|||
94731783|NCT05329220|324475775|FG005|Active Trial Period|Protocol Violation|3|||
94731784|NCT05329220|324475770|FG000|Active Trial Period|Withdrawal by Subject|0|||
94731785|NCT05329220|324475771|FG001|Active Trial Period|Withdrawal by Subject|0|||
94731786|NCT05329220|324475772|FG002|Active Trial Period|Withdrawal by Subject|0|||
94731787|NCT05329220|324475773|FG003|Active Trial Period|Withdrawal by Subject|1|||
94731788|NCT05329220|324475774|FG004|Active Trial Period|Withdrawal by Subject|12|||
94731789|NCT05329220|324475775|FG005|Active Trial Period|Withdrawal by Subject|13|||
94731790|NCT05329220|324475770|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
94731791|NCT05329220|324475771|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
94731792|NCT05329220|324475772|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
94731793|NCT05329220|324475773|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
94731794|NCT05329220|324475774|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
94731795|NCT05329220|324475775|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
94731796|NCT05329220|324475770|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
94731797|NCT05329220|324475771|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
94731798|NCT05329220|324475772|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
94731799|NCT05329220|324475773|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
94731800|NCT05329220|324475774|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
94731801|NCT05329220|324475775|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
94731802|NCT05329220|324475770|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
94731803|NCT05329220|324475771|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
94731804|NCT05329220|324475772|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
94731805|NCT05329220|324475773|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
94731806|NCT05329220|324475774|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
94731807|NCT05329220|324475775|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
94731808|NCT05329220|324475770|FG000|Follow-up Period|Adverse Event|0|||
94731809|NCT05329220|324475771|FG001|Follow-up Period|Adverse Event|0|||
94731810|NCT05329220|324475772|FG002|Follow-up Period|Adverse Event|0|||
94731811|NCT05329220|324475773|FG003|Follow-up Period|Adverse Event|0|||
94731812|NCT05329220|324475774|FG004|Follow-up Period|Adverse Event|2|||
94731813|NCT05329220|324475775|FG005|Follow-up Period|Adverse Event|1|||
94731814|NCT05329220|324475770|FG000|Follow-up Period|Death|0|||
94731815|NCT05329220|324475771|FG001|Follow-up Period|Death|0|||
94273958|NCT01015768|322795752|FG000|Overall Study|Some subject data unuseable|4|||
94467420|NCT04015518|323500565|FG004|Overall Study|Lack of Efficacy|4|||
94273959|NCT01015768|322795753|FG001|Overall Study|Some subject data unuseable|4|||
94467421|NCT04015518|323500561|FG000|Overall Study|Lost to Follow-up|0|||
94731816|NCT05329220|324475772|FG002|Follow-up Period|Death|1|||
94731817|NCT05329220|324475773|FG003|Follow-up Period|Death|1|||
94731818|NCT05329220|324475774|FG004|Follow-up Period|Death|0|||
94731819|NCT05329220|324475775|FG005|Follow-up Period|Death|1|||
94731820|NCT05329220|324475770|FG000|Follow-up Period|Lost to Follow-up|0|||
94731821|NCT05329220|324475771|FG001|Follow-up Period|Lost to Follow-up|1|||
94731822|NCT05329220|324475772|FG002|Follow-up Period|Lost to Follow-up|2|||
94731823|NCT05329220|324475773|FG003|Follow-up Period|Lost to Follow-up|2|||
94731824|NCT05329220|324475774|FG004|Follow-up Period|Lost to Follow-up|113|||
94731825|NCT05329220|324475775|FG005|Follow-up Period|Lost to Follow-up|89|||
94731826|NCT05329220|324475770|FG000|Follow-up Period|Physician Decision|0|||
94731827|NCT05329220|324475771|FG001|Follow-up Period|Physician Decision|0|||
94731828|NCT05329220|324475772|FG002|Follow-up Period|Physician Decision|0|||
94731829|NCT05329220|324475773|FG003|Follow-up Period|Physician Decision|0|||
94731830|NCT05329220|324475774|FG004|Follow-up Period|Physician Decision|2|||
94731831|NCT05329220|324475775|FG005|Follow-up Period|Physician Decision|2|||
94731832|NCT05329220|324475770|FG000|Follow-up Period|Protocol Violation|0|||
94731833|NCT05329220|324475771|FG001|Follow-up Period|Protocol Violation|0|||
94731834|NCT05329220|324475772|FG002|Follow-up Period|Protocol Violation|0|||
94731835|NCT05329220|324475773|FG003|Follow-up Period|Protocol Violation|0|||
94731836|NCT05329220|324475774|FG004|Follow-up Period|Protocol Violation|0|||
94731837|NCT05329220|324475775|FG005|Follow-up Period|Protocol Violation|1|||
94731838|NCT05329220|324475770|FG000|Follow-up Period|Withdrawal by Subject|0|||
94731839|NCT05329220|324475771|FG001|Follow-up Period|Withdrawal by Subject|0|||
94731840|NCT05329220|324475772|FG002|Follow-up Period|Withdrawal by Subject|1|||
94731841|NCT05329220|324475773|FG003|Follow-up Period|Withdrawal by Subject|1|||
94731842|NCT05329220|324475774|FG004|Follow-up Period|Withdrawal by Subject|34|||
94731843|NCT05329220|324475775|FG005|Follow-up Period|Withdrawal by Subject|35|||
94731844|NCT05329220|324475770|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
94731845|NCT05329220|324475771|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
94731846|NCT05329220|324475772|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
94731847|NCT05329220|324475773|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
94731848|NCT05329220|324475774|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
94731849|NCT05329220|324475775|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
94731850|NCT05329220|324475770|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
94731851|NCT05329220|324475771|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
94731852|NCT05329220|324475772|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
94731853|NCT05329220|324475773|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
94731854|NCT05329220|324475774|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
94731855|NCT05329220|324475775|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
94731856|NCT05329220|324475770|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
94731857|NCT05329220|324475771|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
94731858|NCT05329220|324475772|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
94731859|NCT05329220|324475773|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
94731860|NCT05329220|324475774|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
94731861|NCT05329220|324475775|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
94731862|NCT05329220|324475770|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
94731863|NCT05329220|324475771|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
94731864|NCT05329220|324475772|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
94731865|NCT05329220|324475773|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
94731866|NCT05329220|324475774|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
94731867|NCT05329220|324475775|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
94731868|NCT05329220|324475770|FG000|Follow-up Period|EARLY TERMINATION|0|||
94731869|NCT05329220|324475771|FG001|Follow-up Period|EARLY TERMINATION|0|||
94731870|NCT05329220|324475772|FG002|Follow-up Period|EARLY TERMINATION|0|||
94731871|NCT05329220|324475773|FG003|Follow-up Period|EARLY TERMINATION|0|||
94731872|NCT05329220|324475774|FG004|Follow-up Period|EARLY TERMINATION|0|||
94731873|NCT05329220|324475775|FG005|Follow-up Period|EARLY TERMINATION|1|||
94731874|NCT05329220|324475770|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
94731875|NCT05329220|324475771|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
94731876|NCT05329220|324475772|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
94731877|NCT05329220|324475773|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
94731878|NCT05329220|324475774|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
94731879|NCT05329220|324475775|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
94731880|NCT05329220|324475770|FG000|Follow-up Period|DROPPED|0|||
94731881|NCT05329220|324475771|FG001|Follow-up Period|DROPPED|0|||
94731882|NCT05329220|324475772|FG002|Follow-up Period|DROPPED|0|||
94731883|NCT05329220|324475773|FG003|Follow-up Period|DROPPED|0|||
94731884|NCT05329220|324475774|FG004|Follow-up Period|DROPPED|0|||
94731885|NCT05329220|324475775|FG005|Follow-up Period|DROPPED|1|||
94731886|NCT05329220|324475770|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
94731887|NCT05329220|324475771|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
94731888|NCT05329220|324475772|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
94731889|NCT05329220|324475773|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
94731890|NCT05329220|324475774|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
94731891|NCT05329220|324475775|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
94731892|NCT02993159|324475780|FG000|Overall Study|Withdrawal by Subject|1|||
94731893|NCT02993159|324475781|FG001|Overall Study|Withdrawal by Subject|3|||
94731894|NCT02993159|324475780|FG000|Overall Study|Protocol Violation|1|||
94731895|NCT02993159|324475781|FG001|Overall Study|Protocol Violation|0|||
94731896|NCT02993159|324475780|FG000|Overall Study|Opted out of surgery|2|||
94731897|NCT02993159|324475781|FG001|Overall Study|Opted out of surgery|0|||
94731898|NCT02993159|324475780|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
94731899|NCT02993159|324475781|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
94731900|NCT02993159|324475780|FG000|Overall Study|Physician Decision|0|||
94731901|NCT02993159|324475781|FG001|Overall Study|Physician Decision|1|||
94731902|NCT06103188|324475787|FG000|Overall Study|Lost to Follow-up|1|||
94731903|NCT06103188|324475788|FG001|Overall Study|Lost to Follow-up|6|||
94731904|NCT06103188|324475789|FG002|Overall Study|Lost to Follow-up|4|||
94731905|NCT02969707|324475794|FG000|Overall Study|Withdrawal by Subject|6|||
94731906|NCT02969707|324475795|FG001|Overall Study|Withdrawal by Subject|5|||
94731907|NCT02969707|324475794|FG000|Overall Study|Severe anxiety|0|||
94731908|NCT02969707|324475795|FG001|Overall Study|Severe anxiety|1|||
94731909|NCT02969707|324475794|FG000|Overall Study|Positive toxicology screen|0|||
94731910|NCT02969707|324475795|FG001|Overall Study|Positive toxicology screen|2|||
94731911|NCT02969707|324475794|FG000|Overall Study|Claustrophobia|2|||
94731912|NCT02969707|324475795|FG001|Overall Study|Claustrophobia|2|||
94731913|NCT02969707|324475794|FG000|Overall Study|Non-compliance|1|||
94731914|NCT02969707|324475795|FG001|Overall Study|Non-compliance|2|||
94731915|NCT01175356|324475796|FG000|Overall Study|Death|1|||
94731916|NCT01175356|324475796|FG000|Overall Study|Lack of Efficacy|12|||
94731917|NCT01175356|324475796|FG000|Overall Study|Lost to Follow-up|1|||
94731918|NCT01175356|324475796|FG000|Overall Study|Physician Decision|23|||
94731919|NCT01175356|324475796|FG000|Overall Study|Ineligible|1|||
94731920|NCT01175356|324475796|FG000|Overall Study|Treatment Slot Not Available|18|||
94731921|NCT01175356|324475796|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
94731922|NCT01175356|324475796|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
94731923|NCT01175356|324475796|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
94731924|NCT01175356|324475796|FG000|Overall Study|Inadequate stem cell for transplant|1|||
94731925|NCT01175356|324475796|FG000|Overall Study|Initiation other tx prior to completion|9|||
94731926|NCT05583578|324475799|FG000|Overall Study|Withdrawal by Subject|2|||
94731927|NCT05583578|324475800|FG001|Overall Study|Withdrawal by Subject|0|||
94731928|NCT02714257|324475801|FG000|Overall Study|Withdrawal by Subject|6|||
94731929|NCT02714257|324475802|FG001|Overall Study|Withdrawal by Subject|11|||
94731930|NCT02714257|324475801|FG000|Overall Study|Death|3|||
94731931|NCT02714257|324475802|FG001|Overall Study|Death|4|||
94731932|NCT02714257|324475801|FG000|Overall Study|Lost to Follow-up|1|||
94731933|NCT02714257|324475802|FG001|Overall Study|Lost to Follow-up|6|||
94731934|NCT04248725|324475812|FG000|Post-Treatment|Lost to Follow-up|6|||
94731935|NCT04248725|324475813|FG001|Post-Treatment|Lost to Follow-up|5|||
94731936|NCT04248725|324475812|FG000|6-Month Follow Up|Lost to Follow-up|9|||
94731937|NCT04248725|324475813|FG001|6-Month Follow Up|Lost to Follow-up|8|||
94731938|NCT05622812|324475814|FG000|Overall Study|Withdrawal by Subject|1|||
94731939|NCT05622812|324475815|FG001|Overall Study|Withdrawal by Subject|4|||
94731940|NCT05622812|324475814|FG000|Overall Study|Lost to Follow-up|2|||
94731941|NCT05622812|324475815|FG001|Overall Study|Lost to Follow-up|1|||
94731942|NCT01210807|324475820|FG000|Overall Study|Lost to Follow-up|1|||
94731943|NCT01210807|324475821|FG001|Overall Study|Lost to Follow-up|2|||
94731944|NCT01210807|324475820|FG000|Overall Study|Not implanted bilaterally|2|||
94731945|NCT01210807|324475821|FG001|Overall Study|Not implanted bilaterally|1|||
94731946|NCT05977530|324475822|FG000|Overall Study|Withdrawal by Subject|1|||
94731947|NCT05977530|324475822|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
94731948|NCT04719832|324475823|FG000|Overall Study|Adverse Event|2|||
94731949|NCT04719832|324475824|FG001|Overall Study|Adverse Event|0|||
94731950|NCT04719832|324475823|FG000|Overall Study|Lack of Efficacy|2|||
94731951|NCT04719832|324475824|FG001|Overall Study|Lack of Efficacy|4|||
94731952|NCT04719832|324475823|FG000|Overall Study|Lost to Follow-up|0|||
94731953|NCT04719832|324475824|FG001|Overall Study|Lost to Follow-up|2|||
94731954|NCT04719832|324475823|FG000|Overall Study|Physician Decision|0|||
94731955|NCT04719832|324475824|FG001|Overall Study|Physician Decision|1|||
94731956|NCT04719832|324475823|FG000|Overall Study|Pregnancy|1|||
94731957|NCT04719832|324475824|FG001|Overall Study|Pregnancy|1|||
94731958|NCT04719832|324475823|FG000|Overall Study|Withdrawal by Subject|5|||
94731959|NCT04719832|324475824|FG001|Overall Study|Withdrawal by Subject|5|||
94731960|NCT04719832|324475823|FG000|Overall Study|Randomized, not treated|0|||
94731961|NCT04719832|324475824|FG001|Overall Study|Randomized, not treated|2|||
94731962|NCT04719832|324475823|FG000|Overall Study|GCP violations|4|||
94731963|NCT04719832|324475824|FG001|Overall Study|GCP violations|7|||
94731964|NCT00736723|324475825|FG000|Overall Study|Withdrawal by Subject|4|||
94731965|NCT00736723|324475826|FG001|Overall Study|Withdrawal by Subject|3|||
94731966|NCT03492216|324475827|FG000|Overall Study|Death|1|||
94731967|NCT03492216|324475828|FG001|Overall Study|Death|0|||
94731968|NCT03492216|324475829|FG002|Overall Study|Death|4|||
94731969|NCT03492216|324475830|FG003|Overall Study|Death|0|||
94731970|NCT03492216|324475827|FG000|Overall Study|Withdrawal by Subject|5|||
94731971|NCT03492216|324475828|FG001|Overall Study|Withdrawal by Subject|3|||
94731972|NCT03492216|324475829|FG002|Overall Study|Withdrawal by Subject|1|||
94731973|NCT03492216|324475830|FG003|Overall Study|Withdrawal by Subject|1|||
94731974|NCT03492216|324475827|FG000|Overall Study|Lost to Follow-up|9|||
94731975|NCT03492216|324475828|FG001|Overall Study|Lost to Follow-up|2|||
94731976|NCT03492216|324475829|FG002|Overall Study|Lost to Follow-up|7|||
94731977|NCT03492216|324475830|FG003|Overall Study|Lost to Follow-up|8|||
94731978|NCT03492216|324475827|FG000|Overall Study|Moved|5|||
94731979|NCT03492216|324475828|FG001|Overall Study|Moved|3|||
94731980|NCT03492216|324475829|FG002|Overall Study|Moved|3|||
94731981|NCT03492216|324475830|FG003|Overall Study|Moved|5|||
94731982|NCT03492216|324475827|FG000|Overall Study|Too ill|0|||
94731983|NCT03492216|324475828|FG001|Overall Study|Too ill|1|||
94731984|NCT03492216|324475829|FG002|Overall Study|Too ill|0|||
94731985|NCT03492216|324475830|FG003|Overall Study|Too ill|0|||
94731986|NCT03492216|324475827|FG000|Overall Study|Incarcerated|0|||
94731987|NCT03492216|324475828|FG001|Overall Study|Incarcerated|0|||
94731988|NCT03492216|324475829|FG002|Overall Study|Incarcerated|2|||
94731989|NCT03492216|324475830|FG003|Overall Study|Incarcerated|0|||
94731990|NCT01197378|324475831|FG000|Overall Study|Adverse Event|3|||
94731991|NCT01197378|324475831|FG000|Overall Study|Withdrawal by Subject|1|||
94731992|NCT01197378|324475831|FG000|Overall Study|Physician Decision|1|||
94273960|NCT01225731|322795757|FG000|Part 1|Did not meet eligibility criteria|1|||
94273961|NCT01225731|322795758|FG001|Part 1|Did not meet eligibility criteria|0|||
94273962|NCT01225731|322795759|FG002|Part 1|Did not meet eligibility criteria|0|||
94273963|NCT01225731|322795760|FG003|Part 1|Did not meet eligibility criteria|0|||
94273964|NCT01225731|322795761|FG004|Part 1|Did not meet eligibility criteria|1|||
94273965|NCT01225731|322795762|FG005|Part 1|Did not meet eligibility criteria|0|||
94273966|NCT01225731|322795763|FG006|Part 1|Did not meet eligibility criteria|0|||
94273967|NCT01225731|322795764|FG007|Part 1|Did not meet eligibility criteria|0|||
94273968|NCT01225731|322795765|FG008|Part 1|Did not meet eligibility criteria|0|||
94273969|NCT01225731|322795766|FG009|Part 1|Did not meet eligibility criteria|0|||
94273970|NCT01225731|322795767|FG010|Part 1|Did not meet eligibility criteria|0|||
94273971|NCT01225731|322795768|FG011|Part 1|Did not meet eligibility criteria|0|||
94273972|NCT01225731|322795769|FG012|Part 1|Did not meet eligibility criteria|0|||
94273973|NCT01225731|322795757|FG000|Part 1|Adverse Event|1|||
94731993|NCT01197378|324475831|FG000|Overall Study|Other|2|||
94731994|NCT01544114|324475832|FG000|Overall Study|Withdrawal by Subject|0|||
94731995|NCT01544114|324475833|FG001|Overall Study|Withdrawal by Subject|0|||
94731996|NCT01544114|324475834|FG002|Overall Study|Withdrawal by Subject|3|||
94731997|NCT01544114|324475832|FG000|Overall Study|Lost to Follow-up|0|||
94731998|NCT01544114|324475833|FG001|Overall Study|Lost to Follow-up|2|||
94731999|NCT01544114|324475834|FG002|Overall Study|Lost to Follow-up|0|||
94732000|NCT01544114|324475832|FG000|Overall Study|Adverse Event|1|||
94732001|NCT01544114|324475833|FG001|Overall Study|Adverse Event|1|||
94732002|NCT01544114|324475834|FG002|Overall Study|Adverse Event|2|||
94732003|NCT01544114|324475832|FG000|Overall Study|Protocol Violation|0|||
94732004|NCT01544114|324475833|FG001|Overall Study|Protocol Violation|1|||
94732005|NCT01544114|324475834|FG002|Overall Study|Protocol Violation|0|||
94732006|NCT05239455|324475836|FG000|Overall Study|Adverse Event|1|||
94732007|NCT05239455|324475836|FG000|Overall Study|Sponsor Decision|5|||
94732008|NCT05239455|324475836|FG000|Overall Study|Incomplete Blood Collection|1|||
94732009|NCT02589522|324475837|FG000|Overall Study|Physician Decision|1|||
94732010|NCT02589522|324475838|FG001|Overall Study|Physician Decision|2|||
94732011|NCT02589522|324475839|FG002|Overall Study|Physician Decision|0|||
94732012|NCT02589522|324475837|FG000|Overall Study|Did not start treatment|1|||
94732013|NCT02589522|324475838|FG001|Overall Study|Did not start treatment|0|||
94732014|NCT02589522|324475839|FG002|Overall Study|Did not start treatment|0|||
94732015|NCT02319837|324475840|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
94732016|NCT02319837|324475841|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
94732017|NCT02319837|324475842|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
94732018|NCT02319837|324475840|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
94732019|NCT02319837|324475841|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
94732020|NCT02319837|324475842|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
94732021|NCT02319837|324475840|FG000|Study Treatment Phase|Adverse Event|73|||
94732022|NCT02319837|324475841|FG001|Study Treatment Phase|Adverse Event|36|||
94732023|NCT02319837|324475842|FG002|Study Treatment Phase|Adverse Event|63|||
94732024|NCT02319837|324475840|FG000|Study Treatment Phase|Development of castration resistance|0|||
94732025|NCT02319837|324475841|FG001|Study Treatment Phase|Development of castration resistance|2|||
94732026|NCT02319837|324475842|FG002|Study Treatment Phase|Development of castration resistance|0|||
94732027|NCT02319837|324475840|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
94732028|NCT02319837|324475841|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
94732029|NCT02319837|324475842|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
94732030|NCT02319837|324475840|FG000|Study Treatment Phase|Protocol Violation|2|||
94732031|NCT02319837|324475841|FG001|Study Treatment Phase|Protocol Violation|2|||
94732032|NCT02319837|324475842|FG002|Study Treatment Phase|Protocol Violation|1|||
94732033|NCT02319837|324475840|FG000|Study Treatment Phase|Lost to Follow-up|0|||
94732034|NCT02319837|324475841|FG001|Study Treatment Phase|Lost to Follow-up|1|||
94732035|NCT02319837|324475842|FG002|Study Treatment Phase|Lost to Follow-up|0|||
94732036|NCT02319837|324475840|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
94732037|NCT02319837|324475841|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
94732038|NCT02319837|324475842|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
94732039|NCT02319837|324475840|FG000|Study Treatment Phase|Other|0|||
94732040|NCT02319837|324475841|FG001|Study Treatment Phase|Other|1|||
94732041|NCT02319837|324475842|FG002|Study Treatment Phase|Other|0|||
94732042|NCT02319837|324475840|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
94732043|NCT02319837|324475841|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
94732044|NCT02319837|324475842|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
94732045|NCT02319837|324475840|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
94732046|NCT02319837|324475841|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
94732047|NCT02319837|324475842|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
94732048|NCT02319837|324475840|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
94732049|NCT02319837|324475841|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
94732050|NCT02319837|324475842|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
94732051|NCT02319837|324475840|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
94732052|NCT02319837|324475841|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
94732053|NCT02319837|324475842|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
94732054|NCT02319837|324475840|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
94368689|NCT04440007|323136515|FG000|Overall Study|Lost to Follow-up|1|||
94732055|NCT02319837|324475841|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
94732056|NCT02319837|324475842|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
94273974|NCT01225731|322795758|FG001|Part 1|Adverse Event|2|||
94273975|NCT01225731|322795759|FG002|Part 1|Adverse Event|1|||
94273976|NCT01225731|322795760|FG003|Part 1|Adverse Event|1|||
94273977|NCT01225731|322795761|FG004|Part 1|Adverse Event|1|||
94273978|NCT01225731|322795762|FG005|Part 1|Adverse Event|0|||
94273979|NCT01225731|322795763|FG006|Part 1|Adverse Event|0|||
94273980|NCT01225731|322795764|FG007|Part 1|Adverse Event|0|||
94273981|NCT01225731|322795765|FG008|Part 1|Adverse Event|0|||
94273982|NCT01225731|322795766|FG009|Part 1|Adverse Event|0|||
94273983|NCT01225731|322795767|FG010|Part 1|Adverse Event|0|||
94273984|NCT01225731|322795768|FG011|Part 1|Adverse Event|0|||
94273985|NCT01225731|322795769|FG012|Part 1|Adverse Event|0|||
94273986|NCT01225731|322795757|FG000|Part 1|Withdrawal by Subject|0|||
94273987|NCT01225731|322795758|FG001|Part 1|Withdrawal by Subject|3|||
94273988|NCT01225731|322795759|FG002|Part 1|Withdrawal by Subject|0|||
94273989|NCT01225731|322795760|FG003|Part 1|Withdrawal by Subject|0|||
94273990|NCT01225731|322795761|FG004|Part 1|Withdrawal by Subject|4|||
94273991|NCT01225731|322795762|FG005|Part 1|Withdrawal by Subject|0|||
94273992|NCT01225731|322795763|FG006|Part 1|Withdrawal by Subject|0|||
94273993|NCT01225731|322795764|FG007|Part 1|Withdrawal by Subject|0|||
94273994|NCT01225731|322795765|FG008|Part 1|Withdrawal by Subject|0|||
94273995|NCT01225731|322795766|FG009|Part 1|Withdrawal by Subject|0|||
94273996|NCT01225731|322795767|FG010|Part 1|Withdrawal by Subject|0|||
94273997|NCT01225731|322795768|FG011|Part 1|Withdrawal by Subject|0|||
94273998|NCT01225731|322795769|FG012|Part 1|Withdrawal by Subject|0|||
94273999|NCT01225731|322795757|FG000|Part 1|Protocol Violation|0|||
94274000|NCT01225731|322795758|FG001|Part 1|Protocol Violation|0|||
94274001|NCT01225731|322795759|FG002|Part 1|Protocol Violation|0|||
94274002|NCT01225731|322795760|FG003|Part 1|Protocol Violation|1|||
94274003|NCT01225731|322795761|FG004|Part 1|Protocol Violation|0|||
94274004|NCT01225731|322795762|FG005|Part 1|Protocol Violation|0|||
94274005|NCT01225731|322795763|FG006|Part 1|Protocol Violation|0|||
94274006|NCT01225731|322795764|FG007|Part 1|Protocol Violation|0|||
94274007|NCT01225731|322795765|FG008|Part 1|Protocol Violation|0|||
94274008|NCT01225731|322795766|FG009|Part 1|Protocol Violation|0|||
94274009|NCT01225731|322795767|FG010|Part 1|Protocol Violation|0|||
94274010|NCT01225731|322795768|FG011|Part 1|Protocol Violation|0|||
94274011|NCT01225731|322795769|FG012|Part 1|Protocol Violation|0|||
94274012|NCT01225731|322795757|FG000|Part 2|Protocol Violation|0|||
94274013|NCT01225731|322795758|FG001|Part 2|Protocol Violation|0|||
94274014|NCT01225731|322795759|FG002|Part 2|Protocol Violation|0|||
94274015|NCT01225731|322795760|FG003|Part 2|Protocol Violation|0|||
94274016|NCT01225731|322795761|FG004|Part 2|Protocol Violation|0|||
94274017|NCT01225731|322795762|FG005|Part 2|Protocol Violation|1|||
94274018|NCT01225731|322795763|FG006|Part 2|Protocol Violation|0|||
94274019|NCT01225731|322795764|FG007|Part 2|Protocol Violation|0|||
94274020|NCT01225731|322795765|FG008|Part 2|Protocol Violation|1|||
94274021|NCT01225731|322795766|FG009|Part 2|Protocol Violation|0|||
94274022|NCT01225731|322795767|FG010|Part 2|Protocol Violation|0|||
94274023|NCT01225731|322795768|FG011|Part 2|Protocol Violation|0|||
94274024|NCT01225731|322795769|FG012|Part 2|Protocol Violation|0|||
94274025|NCT01225731|322795757|FG000|Part 2|Adverse Event|0|||
94274026|NCT01225731|322795758|FG001|Part 2|Adverse Event|0|||
94274027|NCT01225731|322795759|FG002|Part 2|Adverse Event|0|||
94274028|NCT01225731|322795760|FG003|Part 2|Adverse Event|0|||
94274029|NCT01225731|322795761|FG004|Part 2|Adverse Event|0|||
94274030|NCT01225731|322795762|FG005|Part 2|Adverse Event|0|||
94274031|NCT01225731|322795763|FG006|Part 2|Adverse Event|4|||
94274032|NCT01225731|322795764|FG007|Part 2|Adverse Event|4|||
94274033|NCT01225731|322795765|FG008|Part 2|Adverse Event|2|||
94274034|NCT01225731|322795766|FG009|Part 2|Adverse Event|0|||
94274035|NCT01225731|322795767|FG010|Part 2|Adverse Event|0|||
94274036|NCT01225731|322795768|FG011|Part 2|Adverse Event|0|||
94274037|NCT01225731|322795769|FG012|Part 2|Adverse Event|0|||
94274038|NCT01225731|322795757|FG000|Part 2|Lack of Efficacy|0|||
94274039|NCT01225731|322795758|FG001|Part 2|Lack of Efficacy|0|||
94274040|NCT01225731|322795759|FG002|Part 2|Lack of Efficacy|0|||
94274041|NCT01225731|322795760|FG003|Part 2|Lack of Efficacy|0|||
94274042|NCT01225731|322795761|FG004|Part 2|Lack of Efficacy|0|||
94274043|NCT01225731|322795762|FG005|Part 2|Lack of Efficacy|1|||
94274044|NCT01225731|322795763|FG006|Part 2|Lack of Efficacy|0|||
94274045|NCT01225731|322795764|FG007|Part 2|Lack of Efficacy|12|||
94274046|NCT01225731|322795765|FG008|Part 2|Lack of Efficacy|3|||
94274047|NCT01225731|322795766|FG009|Part 2|Lack of Efficacy|0|||
94274048|NCT01225731|322795767|FG010|Part 2|Lack of Efficacy|0|||
94732057|NCT02319837|324475840|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
94732058|NCT02319837|324475841|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
94732059|NCT02319837|324475842|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
94732060|NCT02319837|324475840|FG000|Long-Term Follow-Up Phase|Death|33|||
94732061|NCT02319837|324475841|FG001|Long-Term Follow-Up Phase|Death|54|||
94732062|NCT02319837|324475842|FG002|Long-Term Follow-Up Phase|Death|42|||
94732063|NCT04159415|324475843|FG000|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
94732064|NCT04159415|324475844|FG001|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
94732065|NCT04159415|324475845|FG002|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
94732066|NCT04159415|324475846|FG003|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
94732067|NCT04159415|324475847|FG004|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
94732068|NCT04159415|324475848|FG005|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
94732069|NCT04159415|324475849|FG006|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
94732070|NCT04159415|324475850|FG007|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
94732071|NCT01570868|324475851|FG000|Overall Study|Adverse Event|8|||
94732072|NCT01570868|324475852|FG001|Overall Study|Adverse Event|1|||
94732073|NCT01570868|324475851|FG000|Overall Study|FDA Recommendation|23|||
94732074|NCT01570868|324475852|FG001|Overall Study|FDA Recommendation|3|||
94732075|NCT01570868|324475851|FG000|Overall Study|Physician Decision|10|||
94732076|NCT01570868|324475852|FG001|Overall Study|Physician Decision|4|||
94732077|NCT01570868|324475851|FG000|Overall Study|Lost to Follow-up|1|||
94732078|NCT01570868|324475852|FG001|Overall Study|Lost to Follow-up|0|||
94732079|NCT01570868|324475851|FG000|Overall Study|Withdrawal by Subject|1|||
94732080|NCT01570868|324475852|FG001|Overall Study|Withdrawal by Subject|0|||
94732081|NCT05704543|324475853|FG000|Overall Study|Withdrawal by Subject|1|||
94732082|NCT05704543|324475854|FG001|Overall Study|Withdrawal by Subject|1|||
94732083|NCT05704543|324475855|FG002|Overall Study|Withdrawal by Subject|0|||
94732084|NCT05704543|324475856|FG003|Overall Study|Withdrawal by Subject|2|||
94732085|NCT05704543|324475853|FG000|Overall Study|Lost to Follow-up|1|||
94732086|NCT05704543|324475854|FG001|Overall Study|Lost to Follow-up|2|||
94732087|NCT05704543|324475855|FG002|Overall Study|Lost to Follow-up|0|||
94732088|NCT05704543|324475856|FG003|Overall Study|Lost to Follow-up|0|||
94732089|NCT03785964|324475859|FG000|Overall Study|Adverse Event|14|||
94732090|NCT03785964|324475860|FG001|Overall Study|Adverse Event|1|||
94732091|NCT03785964|324475859|FG000|Overall Study|Unqualified Clinical Progression|1|||
94732092|NCT03785964|324475860|FG001|Overall Study|Unqualified Clinical Progression|1|||
94732093|NCT03785964|324475859|FG000|Overall Study|Participant non-compliance|1|||
94732094|NCT03785964|324475860|FG001|Overall Study|Participant non-compliance|1|||
94732095|NCT03785964|324475859|FG000|Overall Study|Not treated|1|||
94732096|NCT03785964|324475860|FG001|Overall Study|Not treated|0|||
94732097|NCT03785964|324475859|FG000|Overall Study|Other reason|5|||
94732098|NCT03785964|324475860|FG001|Overall Study|Other reason|11|||
94732099|NCT03785964|324475859|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
94732100|NCT03785964|324475860|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
94732101|NCT03599661|324475868|FG000|Overall Study|Lost to Follow-up|9|||
94732102|NCT01943409|324477885|FG000|Overall Study|resumed oral/entral|24|||
94732103|NCT01943409|324477886|FG001|Overall Study|resumed oral/entral|20|||
94732104|NCT01943409|324477885|FG000|Overall Study|Protocol Violation|14|||
94732105|NCT01943409|324477886|FG001|Overall Study|Protocol Violation|24|||
94732106|NCT01943409|324477885|FG000|Overall Study|Death|3|||
94732107|NCT01943409|324477886|FG001|Overall Study|Death|1|||
94732108|NCT01943409|324477885|FG000|Overall Study|Withdrawal by Subject|4|||
94732109|NCT01943409|324477886|FG001|Overall Study|Withdrawal by Subject|3|||
94732110|NCT03663569|324477889|FG000|Overall Study|Discontinuation of study|11|||
94732111|NCT03663569|324477889|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
94732112|NCT03663569|324477889|FG000|Overall Study|Deceased patient|6|||
94732113|NCT03663569|324477889|FG000|Overall Study|Lost to Follow-up|18|||
94732114|NCT03663569|324477889|FG000|Overall Study|Withdrawal of consent|5|||
94732115|NCT03663569|324477889|FG000|Overall Study|Patient's request|11|||
94732116|NCT03663569|324477889|FG000|Overall Study|Adverse Event|4|||
94732117|NCT03663569|324477889|FG000|Overall Study|Not come to second visit|3|||
94732118|NCT03663569|324477889|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
94732119|NCT03663569|324477889|FG000|Overall Study|Serious adverse event|1|||
94732120|NCT02861300|324477895|FG000|Overall Study|Death|0|||
94732121|NCT02861300|324477896|FG001|Overall Study|Death|0|||
94732122|NCT02861300|324477897|FG002|Overall Study|Death|0|||
94732123|NCT02861300|324477898|FG003|Overall Study|Death|0|||
94732124|NCT02861300|324477899|FG004|Overall Study|Death|0|||
94732125|NCT02861300|324477900|FG005|Overall Study|Death|0|||
94732126|NCT02861300|324477901|FG006|Overall Study|Death|24|||
94732127|NCT02861300|324477895|FG000|Overall Study|Delay in treatment|0|||
94732128|NCT02861300|324477896|FG001|Overall Study|Delay in treatment|0|||
94732129|NCT02861300|324477897|FG002|Overall Study|Delay in treatment|0|||
94732130|NCT02861300|324477898|FG003|Overall Study|Delay in treatment|0|||
94274049|NCT01225731|322795768|FG011|Part 2|Lack of Efficacy|0|||
94274050|NCT01225731|322795769|FG012|Part 2|Lack of Efficacy|0|||
94274051|NCT01225731|322795757|FG000|Part 2|Pregnancy|0|||
94274052|NCT01225731|322795758|FG001|Part 2|Pregnancy|0|||
94274053|NCT01225731|322795759|FG002|Part 2|Pregnancy|0|||
94274054|NCT01225731|322795760|FG003|Part 2|Pregnancy|0|||
94274055|NCT01225731|322795761|FG004|Part 2|Pregnancy|0|||
94467422|NCT04015518|323500562|FG001|Overall Study|Lost to Follow-up|0|||
94274056|NCT01225731|322795762|FG005|Part 2|Pregnancy|0|||
94274057|NCT01225731|322795763|FG006|Part 2|Pregnancy|1|||
94274058|NCT01225731|322795764|FG007|Part 2|Pregnancy|0|||
94274059|NCT01225731|322795765|FG008|Part 2|Pregnancy|1|||
94274060|NCT01225731|322795766|FG009|Part 2|Pregnancy|0|||
94274061|NCT01225731|322795767|FG010|Part 2|Pregnancy|0|||
94274062|NCT01225731|322795768|FG011|Part 2|Pregnancy|0|||
94274063|NCT01225731|322795769|FG012|Part 2|Pregnancy|0|||
94274064|NCT01225731|322795757|FG000|Part 2|Lost to Follow-up|0|||
94274065|NCT01225731|322795758|FG001|Part 2|Lost to Follow-up|0|||
94274066|NCT01225731|322795759|FG002|Part 2|Lost to Follow-up|0|||
94274067|NCT01225731|322795760|FG003|Part 2|Lost to Follow-up|0|||
94274068|NCT01225731|322795761|FG004|Part 2|Lost to Follow-up|0|||
94274069|NCT01225731|322795762|FG005|Part 2|Lost to Follow-up|0|||
94274070|NCT01225731|322795763|FG006|Part 2|Lost to Follow-up|0|||
94274071|NCT01225731|322795764|FG007|Part 2|Lost to Follow-up|3|||
94274072|NCT01225731|322795765|FG008|Part 2|Lost to Follow-up|1|||
94274073|NCT01225731|322795766|FG009|Part 2|Lost to Follow-up|0|||
94274074|NCT01225731|322795767|FG010|Part 2|Lost to Follow-up|0|||
94274075|NCT01225731|322795768|FG011|Part 2|Lost to Follow-up|0|||
94467423|NCT04015518|323500563|FG002|Overall Study|Lost to Follow-up|0|||
94467424|NCT04015518|323500564|FG003|Overall Study|Lost to Follow-up|0|||
94732131|NCT02861300|324477899|FG004|Overall Study|Delay in treatment|0|||
94732132|NCT02861300|324477900|FG005|Overall Study|Delay in treatment|1|||
94732133|NCT02861300|324477901|FG006|Overall Study|Delay in treatment|0|||
94732134|NCT02861300|324477895|FG000|Overall Study|Disease Progression|0|||
94732135|NCT02861300|324477896|FG001|Overall Study|Disease Progression|1|||
94732136|NCT02861300|324477897|FG002|Overall Study|Disease Progression|0|||
94732137|NCT02861300|324477898|FG003|Overall Study|Disease Progression|0|||
94732138|NCT02861300|324477899|FG004|Overall Study|Disease Progression|0|||
94732139|NCT02861300|324477900|FG005|Overall Study|Disease Progression|0|||
94732140|NCT02861300|324477901|FG006|Overall Study|Disease Progression|2|||
94732141|NCT02861300|324477895|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
94732142|NCT02861300|324477896|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
94732143|NCT02861300|324477897|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
94732144|NCT02861300|324477898|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
94732145|NCT02861300|324477899|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
94732146|NCT02861300|324477900|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
94732147|NCT02861300|324477901|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
94732148|NCT02861300|324477895|FG000|Overall Study|Clinical Complications|0|||
94732149|NCT02861300|324477896|FG001|Overall Study|Clinical Complications|0|||
94732150|NCT02861300|324477897|FG002|Overall Study|Clinical Complications|0|||
94732151|NCT02861300|324477898|FG003|Overall Study|Clinical Complications|0|||
94732152|NCT02861300|324477899|FG004|Overall Study|Clinical Complications|0|||
94732153|NCT02861300|324477900|FG005|Overall Study|Clinical Complications|0|||
94732154|NCT02861300|324477901|FG006|Overall Study|Clinical Complications|1|||
94732155|NCT05034328|324477902|FG000|Overall Study|Protocol Violation|1|||
94732156|NCT05034328|324477903|FG001|Overall Study|Protocol Violation|0|||
94732157|NCT05034328|324477902|FG000|Overall Study|Lost to Follow-up|0|||
94732158|NCT05034328|324477903|FG001|Overall Study|Lost to Follow-up|10|||
94732159|NCT05399459|324477904|FG000|Overall Study|Randomized but not treated|29|||
94732160|NCT05399459|324477905|FG001|Overall Study|Randomized but not treated|30|||
94732161|NCT05399459|324477906|FG002|Overall Study|Randomized but not treated|38|||
94732162|NCT05399459|324477904|FG000|Overall Study|Lost to Follow-up|1|||
94732163|NCT05399459|324477905|FG001|Overall Study|Lost to Follow-up|0|||
94732164|NCT05399459|324477906|FG002|Overall Study|Lost to Follow-up|0|||
94732165|NCT04992520|324477907|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
94274076|NCT01225731|322795769|FG012|Part 2|Lost to Follow-up|0|||
94274077|NCT01225731|322795757|FG000|Part 2|Physician Decision|0|||
94274078|NCT01225731|322795758|FG001|Part 2|Physician Decision|0|||
94274079|NCT01225731|322795759|FG002|Part 2|Physician Decision|0|||
94274080|NCT01225731|322795760|FG003|Part 2|Physician Decision|0|||
94274081|NCT01225731|322795761|FG004|Part 2|Physician Decision|0|||
94274082|NCT01225731|322795762|FG005|Part 2|Physician Decision|0|||
94274083|NCT01225731|322795763|FG006|Part 2|Physician Decision|0|||
94274084|NCT01225731|322795764|FG007|Part 2|Physician Decision|2|||
94274085|NCT01225731|322795765|FG008|Part 2|Physician Decision|2|||
94274086|NCT01225731|322795766|FG009|Part 2|Physician Decision|0|||
94732166|NCT04992520|324477908|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
94732167|NCT04992520|324477909|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
94732168|NCT04992520|324477910|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
94732169|NCT04992520|324477911|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
94732170|NCT04992520|324477912|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
94732171|NCT04992520|324477907|FG000|Part A: First Challenge|Non-compliance|0|||
94274087|NCT01225731|322795767|FG010|Part 2|Physician Decision|0|||
94274088|NCT01225731|322795768|FG011|Part 2|Physician Decision|0|||
94274089|NCT01225731|322795769|FG012|Part 2|Physician Decision|0|||
94274090|NCT01225731|322795757|FG000|Part 2|Withdrawal by Subject|0|||
94274091|NCT01225731|322795758|FG001|Part 2|Withdrawal by Subject|0|||
94274092|NCT01225731|322795759|FG002|Part 2|Withdrawal by Subject|0|||
94274093|NCT01225731|322795760|FG003|Part 2|Withdrawal by Subject|0|||
94274094|NCT01225731|322795761|FG004|Part 2|Withdrawal by Subject|0|||
94274095|NCT01225731|322795762|FG005|Part 2|Withdrawal by Subject|1|||
94274096|NCT01225731|322795763|FG006|Part 2|Withdrawal by Subject|3|||
94274097|NCT01225731|322795764|FG007|Part 2|Withdrawal by Subject|4|||
94274098|NCT01225731|322795765|FG008|Part 2|Withdrawal by Subject|1|||
94274099|NCT01225731|322795766|FG009|Part 2|Withdrawal by Subject|0|||
94274100|NCT01225731|322795767|FG010|Part 2|Withdrawal by Subject|0|||
94274101|NCT01225731|322795768|FG011|Part 2|Withdrawal by Subject|0|||
94274102|NCT01225731|322795769|FG012|Part 2|Withdrawal by Subject|0|||
94274103|NCT01225731|322795757|FG000|Part 3|Adverse Event|0|||
94274104|NCT01225731|322795758|FG001|Part 3|Adverse Event|0|||
94274105|NCT01225731|322795759|FG002|Part 3|Adverse Event|0|||
94274106|NCT01225731|322795760|FG003|Part 3|Adverse Event|0|||
94274107|NCT01225731|322795761|FG004|Part 3|Adverse Event|0|||
94274108|NCT01225731|322795762|FG005|Part 3|Adverse Event|0|||
94274109|NCT01225731|322795763|FG006|Part 3|Adverse Event|0|||
94274110|NCT01225731|322795764|FG007|Part 3|Adverse Event|0|||
94274111|NCT01225731|322795765|FG008|Part 3|Adverse Event|0|||
94274112|NCT01225731|322795766|FG009|Part 3|Adverse Event|0|||
94274113|NCT01225731|322795767|FG010|Part 3|Adverse Event|1|||
94274114|NCT01225731|322795768|FG011|Part 3|Adverse Event|1|||
94274115|NCT01225731|322795769|FG012|Part 3|Adverse Event|0|||
94274116|NCT01225731|322795757|FG000|Part 3|Lost to Follow-up|0|||
94274117|NCT01225731|322795758|FG001|Part 3|Lost to Follow-up|0|||
94274118|NCT01225731|322795759|FG002|Part 3|Lost to Follow-up|0|||
94274119|NCT01225731|322795760|FG003|Part 3|Lost to Follow-up|0|||
94274120|NCT01225731|322795761|FG004|Part 3|Lost to Follow-up|0|||
94274121|NCT01225731|322795762|FG005|Part 3|Lost to Follow-up|0|||
94274122|NCT01225731|322795763|FG006|Part 3|Lost to Follow-up|0|||
94274123|NCT01225731|322795764|FG007|Part 3|Lost to Follow-up|0|||
94274124|NCT01225731|322795765|FG008|Part 3|Lost to Follow-up|0|||
94274125|NCT01225731|322795766|FG009|Part 3|Lost to Follow-up|0|||
94274126|NCT01225731|322795767|FG010|Part 3|Lost to Follow-up|1|||
94274127|NCT01225731|322795768|FG011|Part 3|Lost to Follow-up|2|||
94274128|NCT01225731|322795769|FG012|Part 3|Lost to Follow-up|1|||
94274129|NCT01225731|322795757|FG000|Part 3|Physician Decision|0|||
94274130|NCT01225731|322795758|FG001|Part 3|Physician Decision|0|||
94274131|NCT01225731|322795759|FG002|Part 3|Physician Decision|0|||
94274132|NCT01225731|322795760|FG003|Part 3|Physician Decision|0|||
94274133|NCT01225731|322795761|FG004|Part 3|Physician Decision|0|||
94274134|NCT01225731|322795762|FG005|Part 3|Physician Decision|0|||
94274135|NCT01225731|322795763|FG006|Part 3|Physician Decision|0|||
94274136|NCT01225731|322795764|FG007|Part 3|Physician Decision|0|||
94274137|NCT01225731|322795765|FG008|Part 3|Physician Decision|0|||
94274138|NCT01225731|322795766|FG009|Part 3|Physician Decision|0|||
94274139|NCT01225731|322795767|FG010|Part 3|Physician Decision|0|||
94274140|NCT01225731|322795768|FG011|Part 3|Physician Decision|1|||
94274141|NCT01225731|322795769|FG012|Part 3|Physician Decision|2|||
94274142|NCT01225731|322795757|FG000|Part 3|Withdrawal by Subject|0|||
94274143|NCT01225731|322795758|FG001|Part 3|Withdrawal by Subject|0|||
94274144|NCT01225731|322795759|FG002|Part 3|Withdrawal by Subject|0|||
94274145|NCT01225731|322795760|FG003|Part 3|Withdrawal by Subject|0|||
94274146|NCT01225731|322795761|FG004|Part 3|Withdrawal by Subject|0|||
94274147|NCT01225731|322795762|FG005|Part 3|Withdrawal by Subject|0|||
94274148|NCT01225731|322795763|FG006|Part 3|Withdrawal by Subject|0|||
94274149|NCT01225731|322795764|FG007|Part 3|Withdrawal by Subject|0|||
94274150|NCT01225731|322795765|FG008|Part 3|Withdrawal by Subject|0|||
94274151|NCT01225731|322795766|FG009|Part 3|Withdrawal by Subject|0|||
94274152|NCT01225731|322795767|FG010|Part 3|Withdrawal by Subject|4|||
94274153|NCT01225731|322795768|FG011|Part 3|Withdrawal by Subject|6|||
94274154|NCT01225731|322795769|FG012|Part 3|Withdrawal by Subject|4|||
94274155|NCT01073267|322795770|FG000|Overall Study|Disease Progression|3|||
94274156|NCT01342484|322795773|FG000|Overall Study|Other Reasons|1|||
94274157|NCT01342484|322795774|FG001|Overall Study|Other Reasons|0|||
94274158|NCT01342484|322795775|FG002|Overall Study|Other Reasons|0|||
94274159|NCT01342484|322795773|FG000|Overall Study|Protocol Violation|0|||
94274160|NCT01342484|322795774|FG001|Overall Study|Protocol Violation|0|||
94368690|NCT04440007|323136516|FG001|Overall Study|Lost to Follow-up|3|||
94368691|NCT04440007|323136515|FG000|Overall Study|Death|7|||
94368692|NCT04440007|323136516|FG001|Overall Study|Death|2|||
94368693|NCT04440007|323136515|FG000|Overall Study|Physician Decision|1|||
94274161|NCT01342484|322795775|FG002|Overall Study|Protocol Violation|1|||
94274162|NCT01342484|322795773|FG000|Overall Study|Withdrawal by Subject|1|||
94274163|NCT01342484|322795774|FG001|Overall Study|Withdrawal by Subject|0|||
94274164|NCT01342484|322795775|FG002|Overall Study|Withdrawal by Subject|0|||
94274165|NCT01840579|322795778|FG000|Overall Study|Status not recorded|0|||
94274166|NCT01840579|322795779|FG001|Overall Study|Status not recorded|0|||
94368694|NCT04440007|323136516|FG001|Overall Study|Physician Decision|1|||
94732172|NCT04992520|324477908|FG001|Part A: First Challenge|Non-compliance|0|||
94732173|NCT04992520|324477909|FG002|Part A: First Challenge|Non-compliance|0|||
94732174|NCT04992520|324477910|FG003|Part A: First Challenge|Non-compliance|1|||
94732175|NCT04992520|324477911|FG004|Part A: First Challenge|Non-compliance|0|||
94732176|NCT04992520|324477912|FG005|Part A: First Challenge|Non-compliance|0|||
94732177|NCT04992520|324477907|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
94732178|NCT04992520|324477908|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
94732179|NCT04992520|324477909|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
94732180|NCT04992520|324477910|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
94732181|NCT04992520|324477911|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
94732182|NCT04992520|324477912|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
94732183|NCT04992520|324477907|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
94732184|NCT04992520|324477908|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
94732185|NCT04992520|324477909|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
94732186|NCT04992520|324477910|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
94732187|NCT04992520|324477911|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
94732188|NCT04992520|324477912|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
94732189|NCT04979442|324477917|FG000|Overall Study|Death|43|||
94732190|NCT04979442|324477918|FG001|Overall Study|Death|30|||
94732191|NCT04979442|324477917|FG000|Overall Study|Withdrawal by Subject|8|||
94732192|NCT04979442|324477918|FG001|Overall Study|Withdrawal by Subject|13|||
94732193|NCT04979442|324477917|FG000|Overall Study|Physician Decision|1|||
94732194|NCT04979442|324477918|FG001|Overall Study|Physician Decision|1|||
94732195|NCT04979442|324477917|FG000|Overall Study|Lost to Follow-up|0|||
94732196|NCT04979442|324477918|FG001|Overall Study|Lost to Follow-up|2|||
94732197|NCT04979442|324477917|FG000|Overall Study|do not want to continue|0|||
94732198|NCT04979442|324477918|FG001|Overall Study|do not want to continue|1|||
94732199|NCT04313972|324477921|FG000|Overall Study|Withdrawal by Subject|0|||
94732200|NCT04313972|324477922|FG001|Overall Study|Withdrawal by Subject|1|||
94732201|NCT05877976|324477923|FG000|Overall Study|Lost to Follow-up|31|||
94732202|NCT04314713|324477924|FG000|Overall Study|Lost to Follow-up|0|||
94732203|NCT04314713|324477925|FG001|Overall Study|Lost to Follow-up|0|||
94732204|NCT04314713|324477926|FG002|Overall Study|Lost to Follow-up|0|||
94732205|NCT04314713|324477927|FG003|Overall Study|Lost to Follow-up|1|||
94732206|NCT04314713|324477928|FG004|Overall Study|Lost to Follow-up|0|||
94732207|NCT04314713|324477929|FG005|Overall Study|Lost to Follow-up|0|||
94732208|NCT02427464|324477934|FG000|Overall Study|Adverse Event|6|||
94732209|NCT02427464|324477935|FG001|Overall Study|Adverse Event|1|||
94732210|NCT02427464|324477934|FG000|Overall Study|Lost to Follow-up|16|||
94732211|NCT02427464|324477935|FG001|Overall Study|Lost to Follow-up|5|||
94732212|NCT02427464|324477934|FG000|Overall Study|Physician Decision|2|||
94732213|NCT02427464|324477935|FG001|Overall Study|Physician Decision|0|||
94732214|NCT02427464|324477934|FG000|Overall Study|Withdrawal by Subject|10|||
94732215|NCT02427464|324477935|FG001|Overall Study|Withdrawal by Subject|8|||
94732216|NCT02427464|324477934|FG000|Overall Study|Noncompliance|16|||
94732217|NCT02427464|324477935|FG001|Overall Study|Noncompliance|10|||
94732218|NCT02547363|324477936|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
94732219|NCT02547363|324477937|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
94732220|NCT02547363|324477936|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
94732221|NCT02547363|324477937|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
94732222|NCT02547363|324477936|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
94732223|NCT02547363|324477937|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
94732224|NCT02547363|324477936|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
94732225|NCT02547363|324477937|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
94732226|NCT02547363|324477936|FG000|12-month Follow-up|Withdrawal by Subject|4|||
94732227|NCT02547363|324477937|FG001|12-month Follow-up|Withdrawal by Subject|3|||
94732228|NCT02547363|324477936|FG000|12-month Follow-up|Lost to Follow-up|4|||
94732229|NCT02547363|324477937|FG001|12-month Follow-up|Lost to Follow-up|1|||
94732230|NCT02547363|324477936|FG000|12-month Follow-up|Lack of Efficacy|1|||
94732231|NCT02547363|324477937|FG001|12-month Follow-up|Lack of Efficacy|1|||
94732232|NCT02547363|324477936|FG000|12-month Follow-up|Other|1|||
94467425|NCT04015518|323500565|FG004|Overall Study|Lost to Follow-up|1|||
94732233|NCT02547363|324477937|FG001|12-month Follow-up|Other|0|||
94732234|NCT00248287|324477938|FG000|Overall Study|Adverse Event|11|||
94732235|NCT00248287|324477939|FG001|Overall Study|Adverse Event|10|||
94732236|NCT00248287|324477938|FG000|Overall Study|Death|1|||
94732237|NCT00248287|324477939|FG001|Overall Study|Death|0|||
94732238|NCT00248287|324477938|FG000|Overall Study|Lost to Follow-up|0|||
94732239|NCT00248287|324477939|FG001|Overall Study|Lost to Follow-up|1|||
94732240|NCT00248287|324477938|FG000|Overall Study|Investigator Request|4|||
94732241|NCT00248287|324477939|FG001|Overall Study|Investigator Request|3|||
94732242|NCT00248287|324477938|FG000|Overall Study|Patient Request|5|||
94732243|NCT00248287|324477939|FG001|Overall Study|Patient Request|3|||
94732244|NCT00248287|324477938|FG000|Overall Study|Other|3|||
94732245|NCT00248287|324477939|FG001|Overall Study|Other|2|||
94732246|NCT04103580|324477942|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
94732247|NCT04103580|324477943|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
94732248|NCT04103580|324477942|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
94732249|NCT04103580|324477943|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
94732250|NCT04103580|324477942|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
94732251|NCT04103580|324477943|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
94732252|NCT04103580|324477942|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
94732253|NCT04103580|324477943|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
94732254|NCT04103580|324477942|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
94732255|NCT04103580|324477943|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
94732256|NCT04103580|324477942|FG000|Phase 1 Active Caregiving|Other|3|||
94732257|NCT04103580|324477943|FG001|Phase 1 Active Caregiving|Other|3|||
94732258|NCT04103580|324477942|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
94732259|NCT04103580|324477943|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
94732260|NCT04103580|324477942|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
94732261|NCT04103580|324477943|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
94732262|NCT04103580|324477942|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
94732263|NCT04103580|324477943|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
94732264|NCT04103580|324477942|FG000|Phase 2 Bereavement|Other|8|||
94732265|NCT04103580|324477943|FG001|Phase 2 Bereavement|Other|6|||
94732266|NCT00104676|324477946|FG000|Overall Study|Death|3|||
94732267|NCT00104676|324477947|FG001|Overall Study|Death|2|||
94732268|NCT00104676|324477946|FG000|Overall Study|Withdrawal by Subject|0|||
94732269|NCT00104676|324477947|FG001|Overall Study|Withdrawal by Subject|2|||
94732270|NCT00104676|324477946|FG000|Overall Study|treatment interruption|4|||
94732271|NCT00104676|324477947|FG001|Overall Study|treatment interruption|10|||
94732272|NCT02425904|324477956|FG000|Overall Study|Lost to Follow-up|1|||
94732273|NCT02425904|324477957|FG001|Overall Study|Lost to Follow-up|0|||
94732274|NCT02425904|324477956|FG000|Overall Study|Withdrawal by Subject|2|||
94732275|NCT02425904|324477957|FG001|Overall Study|Withdrawal by Subject|0|||
94732276|NCT02425904|324477956|FG000|Overall Study|Death|0|||
94732277|NCT02425904|324477957|FG001|Overall Study|Death|3|||
94732278|NCT02927236|324477960|FG000|Characterization Phase|Physician Decision|0|||
94732279|NCT02927236|324477961|FG001|Characterization Phase|Physician Decision|3|||
94732280|NCT02927236|324477962|FG002|Characterization Phase|Physician Decision|0|||
94732281|NCT02927236|324477963|FG003|Characterization Phase|Physician Decision|2|||
94732282|NCT02927236|324477960|FG000|Characterization Phase|Lost to Follow-up|0|||
94732283|NCT02927236|324477961|FG001|Characterization Phase|Lost to Follow-up|0|||
94732284|NCT02927236|324477962|FG002|Characterization Phase|Lost to Follow-up|0|||
94732285|NCT02927236|324477963|FG003|Characterization Phase|Lost to Follow-up|3|||
94732286|NCT02927236|324477960|FG000|Characterization Phase|Withdrawal by Subject|1|||
94732287|NCT02927236|324477961|FG001|Characterization Phase|Withdrawal by Subject|0|||
94732288|NCT02927236|324477962|FG002|Characterization Phase|Withdrawal by Subject|0|||
94732289|NCT02927236|324477963|FG003|Characterization Phase|Withdrawal by Subject|1|||
94732290|NCT02927236|324477960|FG000|Treatment Phase|Adverse Event|1|||
94732291|NCT02927236|324477961|FG001|Treatment Phase|Adverse Event|0|||
94732292|NCT02927236|324477962|FG002|Treatment Phase|Adverse Event|1|||
94732293|NCT02927236|324477963|FG003|Treatment Phase|Adverse Event|1|||
94732294|NCT02927236|324477960|FG000|Treatment Phase|Protocol Violation|3|||
94732295|NCT02927236|324477961|FG001|Treatment Phase|Protocol Violation|0|||
94732296|NCT02927236|324477962|FG002|Treatment Phase|Protocol Violation|0|||
94732297|NCT02927236|324477963|FG003|Treatment Phase|Protocol Violation|1|||
94732298|NCT02927236|324477960|FG000|Treatment Phase|Lost to Follow-up|1|||
94732299|NCT02927236|324477961|FG001|Treatment Phase|Lost to Follow-up|0|||
94732300|NCT02927236|324477962|FG002|Treatment Phase|Lost to Follow-up|0|||
94732301|NCT02927236|324477963|FG003|Treatment Phase|Lost to Follow-up|0|||
94732302|NCT02927236|324477960|FG000|Follow-up Phase|Lost to Follow-up|1|||
94732303|NCT02927236|324477961|FG001|Follow-up Phase|Lost to Follow-up|0|||
94732304|NCT02927236|324477962|FG002|Follow-up Phase|Lost to Follow-up|1|||
94732305|NCT02927236|324477963|FG003|Follow-up Phase|Lost to Follow-up|0|||
94732306|NCT04436276|324477964|FG000|Overall Study|Adverse Event|0|||
94732307|NCT04436276|324477965|FG001|Overall Study|Adverse Event|0|||
94732308|NCT04436276|324477966|FG002|Overall Study|Adverse Event|0|||
94274167|NCT01840579|322795780|FG002|Overall Study|Status not recorded|2|||
94274168|NCT01840579|322795781|FG003|Overall Study|Status not recorded|3|||
94274169|NCT01840579|322795782|FG004|Overall Study|Status not recorded|4|||
94274170|NCT01840579|322795783|FG005|Overall Study|Status not recorded|3|||
94732309|NCT04436276|324477967|FG003|Overall Study|Adverse Event|0|||
94732310|NCT04436276|324477968|FG004|Overall Study|Adverse Event|0|||
94732311|NCT04436276|324477969|FG005|Overall Study|Adverse Event|0|||
94732312|NCT04436276|324477970|FG006|Overall Study|Adverse Event|0|||
94732313|NCT04436276|324477971|FG007|Overall Study|Adverse Event|0|||
94732314|NCT04436276|324477972|FG008|Overall Study|Adverse Event|0|||
94732315|NCT04436276|324477973|FG009|Overall Study|Adverse Event|0|||
94732316|NCT04436276|324477974|FG010|Overall Study|Adverse Event|0|||
94732317|NCT04436276|324477975|FG011|Overall Study|Adverse Event|0|||
94732318|NCT04436276|324477976|FG012|Overall Study|Adverse Event|0|||
94732319|NCT04436276|324477977|FG013|Overall Study|Adverse Event|0|||
94732320|NCT04436276|324477978|FG014|Overall Study|Adverse Event|0|||
94732321|NCT04436276|324477979|FG015|Overall Study|Adverse Event|0|||
94732322|NCT04436276|324477980|FG016|Overall Study|Adverse Event|1|||
94732323|NCT04436276|324477981|FG017|Overall Study|Adverse Event|0|||
94732324|NCT04436276|324477982|FG018|Overall Study|Adverse Event|0|||
94732325|NCT04436276|324477983|FG019|Overall Study|Adverse Event|0|||
94732326|NCT04436276|324477984|FG020|Overall Study|Adverse Event|0|||
94732327|NCT04436276|324477985|FG021|Overall Study|Adverse Event|0|||
94732328|NCT04436276|324477986|FG022|Overall Study|Adverse Event|0|||
94732329|NCT04436276|324477964|FG000|Overall Study|Death|0|||
94732330|NCT04436276|324477965|FG001|Overall Study|Death|0|||
94732331|NCT04436276|324477966|FG002|Overall Study|Death|0|||
94732332|NCT04436276|324477967|FG003|Overall Study|Death|0|||
94732333|NCT04436276|324477968|FG004|Overall Study|Death|0|||
94732334|NCT04436276|324477969|FG005|Overall Study|Death|0|||
94732335|NCT04436276|324477970|FG006|Overall Study|Death|0|||
94732336|NCT04436276|324477971|FG007|Overall Study|Death|0|||
94732337|NCT04436276|324477972|FG008|Overall Study|Death|0|||
94732338|NCT04436276|324477973|FG009|Overall Study|Death|0|||
94732339|NCT04436276|324477974|FG010|Overall Study|Death|0|||
94732340|NCT04436276|324477975|FG011|Overall Study|Death|0|||
94732341|NCT04436276|324477976|FG012|Overall Study|Death|1|||
94732342|NCT04436276|324477977|FG013|Overall Study|Death|0|||
94732343|NCT04436276|324477978|FG014|Overall Study|Death|1|||
94732344|NCT04436276|324477979|FG015|Overall Study|Death|0|||
94732345|NCT04436276|324477980|FG016|Overall Study|Death|0|||
94732346|NCT04436276|324477981|FG017|Overall Study|Death|0|||
94732347|NCT04436276|324477982|FG018|Overall Study|Death|0|||
94732348|NCT04436276|324477983|FG019|Overall Study|Death|2|||
94732349|NCT04436276|324477984|FG020|Overall Study|Death|0|||
94732350|NCT04436276|324477985|FG021|Overall Study|Death|1|||
94732351|NCT04436276|324477986|FG022|Overall Study|Death|0|||
94732352|NCT04436276|324477964|FG000|Overall Study|Lost to Follow-up|0|||
94732353|NCT04436276|324477965|FG001|Overall Study|Lost to Follow-up|2|||
94732354|NCT04436276|324477966|FG002|Overall Study|Lost to Follow-up|2|||
94732355|NCT04436276|324477967|FG003|Overall Study|Lost to Follow-up|1|||
94732356|NCT04436276|324477968|FG004|Overall Study|Lost to Follow-up|4|||
94732357|NCT04436276|324477969|FG005|Overall Study|Lost to Follow-up|1|||
94732358|NCT04436276|324477970|FG006|Overall Study|Lost to Follow-up|0|||
94732359|NCT04436276|324477971|FG007|Overall Study|Lost to Follow-up|0|||
94732360|NCT04436276|324477972|FG008|Overall Study|Lost to Follow-up|1|||
94732361|NCT04436276|324477973|FG009|Overall Study|Lost to Follow-up|0|||
94732362|NCT04436276|324477974|FG010|Overall Study|Lost to Follow-up|5|||
94732363|NCT04436276|324477975|FG011|Overall Study|Lost to Follow-up|5|||
94732364|NCT04436276|324477976|FG012|Overall Study|Lost to Follow-up|4|||
94732365|NCT04436276|324477977|FG013|Overall Study|Lost to Follow-up|1|||
94732366|NCT04436276|324477978|FG014|Overall Study|Lost to Follow-up|7|||
94732367|NCT04436276|324477979|FG015|Overall Study|Lost to Follow-up|7|||
94732368|NCT04436276|324477980|FG016|Overall Study|Lost to Follow-up|1|||
94732369|NCT04436276|324477981|FG017|Overall Study|Lost to Follow-up|0|||
94732370|NCT04436276|324477982|FG018|Overall Study|Lost to Follow-up|1|||
94732371|NCT04436276|324477983|FG019|Overall Study|Lost to Follow-up|1|||
94732372|NCT04436276|324477984|FG020|Overall Study|Lost to Follow-up|2|||
94732373|NCT04436276|324477985|FG021|Overall Study|Lost to Follow-up|1|||
94732374|NCT04436276|324477986|FG022|Overall Study|Lost to Follow-up|1|||
94732375|NCT04436276|324477964|FG000|Overall Study|Physician Decision|1|||
94732376|NCT04436276|324477965|FG001|Overall Study|Physician Decision|0|||
94732377|NCT04436276|324477966|FG002|Overall Study|Physician Decision|2|||
94732378|NCT04436276|324477967|FG003|Overall Study|Physician Decision|1|||
94732379|NCT04436276|324477968|FG004|Overall Study|Physician Decision|0|||
94732380|NCT04436276|324477969|FG005|Overall Study|Physician Decision|0|||
94732381|NCT04436276|324477970|FG006|Overall Study|Physician Decision|0|||
94732382|NCT04436276|324477971|FG007|Overall Study|Physician Decision|0|||
94732383|NCT04436276|324477972|FG008|Overall Study|Physician Decision|0|||
94732384|NCT04436276|324477973|FG009|Overall Study|Physician Decision|0|||
94732385|NCT04436276|324477974|FG010|Overall Study|Physician Decision|0|||
94732386|NCT04436276|324477975|FG011|Overall Study|Physician Decision|1|||
94732387|NCT04436276|324477976|FG012|Overall Study|Physician Decision|2|||
94274171|NCT01840579|322795784|FG006|Overall Study|Status not recorded|0|||
94732388|NCT04436276|324477977|FG013|Overall Study|Physician Decision|0|||
94732389|NCT04436276|324477978|FG014|Overall Study|Physician Decision|0|||
94732390|NCT04436276|324477979|FG015|Overall Study|Physician Decision|0|||
94732391|NCT04436276|324477980|FG016|Overall Study|Physician Decision|0|||
94732392|NCT04436276|324477981|FG017|Overall Study|Physician Decision|0|||
94732393|NCT04436276|324477982|FG018|Overall Study|Physician Decision|0|||
94732394|NCT04436276|324477983|FG019|Overall Study|Physician Decision|0|||
94732395|NCT04436276|324477984|FG020|Overall Study|Physician Decision|1|||
94732396|NCT04436276|324477985|FG021|Overall Study|Physician Decision|2|||
94732397|NCT04436276|324477986|FG022|Overall Study|Physician Decision|0|||
94732398|NCT04436276|324477964|FG000|Overall Study|Protocol Violation|0|||
94732399|NCT04436276|324477965|FG001|Overall Study|Protocol Violation|0|||
94732400|NCT04436276|324477966|FG002|Overall Study|Protocol Violation|0|||
94732401|NCT04436276|324477967|FG003|Overall Study|Protocol Violation|0|||
94732402|NCT04436276|324477968|FG004|Overall Study|Protocol Violation|0|||
94732403|NCT04436276|324477969|FG005|Overall Study|Protocol Violation|0|||
94732404|NCT04436276|324477970|FG006|Overall Study|Protocol Violation|0|||
94732405|NCT04436276|324477971|FG007|Overall Study|Protocol Violation|0|||
94732406|NCT04436276|324477972|FG008|Overall Study|Protocol Violation|0|||
94732407|NCT04436276|324477973|FG009|Overall Study|Protocol Violation|0|||
94732408|NCT04436276|324477974|FG010|Overall Study|Protocol Violation|0|||
94732409|NCT04436276|324477975|FG011|Overall Study|Protocol Violation|0|||
94732410|NCT04436276|324477976|FG012|Overall Study|Protocol Violation|0|||
94732411|NCT04436276|324477977|FG013|Overall Study|Protocol Violation|1|||
94732412|NCT04436276|324477978|FG014|Overall Study|Protocol Violation|0|||
94732413|NCT04436276|324477979|FG015|Overall Study|Protocol Violation|1|||
94732414|NCT04436276|324477980|FG016|Overall Study|Protocol Violation|0|||
94732415|NCT04436276|324477981|FG017|Overall Study|Protocol Violation|0|||
94732416|NCT04436276|324477982|FG018|Overall Study|Protocol Violation|0|||
94732417|NCT04436276|324477983|FG019|Overall Study|Protocol Violation|0|||
94732418|NCT04436276|324477984|FG020|Overall Study|Protocol Violation|0|||
94732419|NCT04436276|324477985|FG021|Overall Study|Protocol Violation|0|||
94732420|NCT04436276|324477986|FG022|Overall Study|Protocol Violation|0|||
94732421|NCT04436276|324477964|FG000|Overall Study|Withdrawal by Subject|25|||
94732422|NCT04436276|324477965|FG001|Overall Study|Withdrawal by Subject|22|||
94732423|NCT04436276|324477966|FG002|Overall Study|Withdrawal by Subject|24|||
94732424|NCT04436276|324477967|FG003|Overall Study|Withdrawal by Subject|23|||
94732425|NCT04436276|324477968|FG004|Overall Study|Withdrawal by Subject|14|||
94732426|NCT04436276|324477969|FG005|Overall Study|Withdrawal by Subject|0|||
94732427|NCT04436276|324477970|FG006|Overall Study|Withdrawal by Subject|0|||
94732428|NCT04436276|324477971|FG007|Overall Study|Withdrawal by Subject|1|||
94732429|NCT04436276|324477972|FG008|Overall Study|Withdrawal by Subject|0|||
94732430|NCT04436276|324477973|FG009|Overall Study|Withdrawal by Subject|1|||
94732431|NCT04436276|324477974|FG010|Overall Study|Withdrawal by Subject|17|||
94732432|NCT04436276|324477975|FG011|Overall Study|Withdrawal by Subject|7|||
94732433|NCT04436276|324477976|FG012|Overall Study|Withdrawal by Subject|10|||
94732434|NCT04436276|324477977|FG013|Overall Study|Withdrawal by Subject|6|||
94732435|NCT04436276|324477978|FG014|Overall Study|Withdrawal by Subject|20|||
94732436|NCT04436276|324477979|FG015|Overall Study|Withdrawal by Subject|6|||
94732437|NCT04436276|324477980|FG016|Overall Study|Withdrawal by Subject|11|||
94732438|NCT04436276|324477981|FG017|Overall Study|Withdrawal by Subject|4|||
94732439|NCT04436276|324477982|FG018|Overall Study|Withdrawal by Subject|14|||
94732440|NCT04436276|324477983|FG019|Overall Study|Withdrawal by Subject|24|||
94732441|NCT04436276|324477984|FG020|Overall Study|Withdrawal by Subject|24|||
94732442|NCT04436276|324477985|FG021|Overall Study|Withdrawal by Subject|16|||
94732443|NCT04436276|324477986|FG022|Overall Study|Withdrawal by Subject|14|||
94732444|NCT04436276|324477964|FG000|Overall Study|Other|3|||
94732445|NCT04436276|324477965|FG001|Overall Study|Other|2|||
94732446|NCT04436276|324477966|FG002|Overall Study|Other|5|||
94732447|NCT04436276|324477967|FG003|Overall Study|Other|9|||
94732448|NCT04436276|324477968|FG004|Overall Study|Other|23|||
94732449|NCT04436276|324477969|FG005|Overall Study|Other|1|||
94732450|NCT04436276|324477970|FG006|Overall Study|Other|0|||
94732451|NCT04436276|324477971|FG007|Overall Study|Other|0|||
94732452|NCT04436276|324477972|FG008|Overall Study|Other|0|||
94732453|NCT04436276|324477973|FG009|Overall Study|Other|0|||
94732454|NCT04436276|324477974|FG010|Overall Study|Other|3|||
94732455|NCT04436276|324477975|FG011|Overall Study|Other|1|||
94732456|NCT04436276|324477976|FG012|Overall Study|Other|1|||
94274172|NCT01840579|322795785|FG007|Overall Study|Status not recorded|3|||
94732457|NCT04436276|324477977|FG013|Overall Study|Other|2|||
94732458|NCT04436276|324477978|FG014|Overall Study|Other|3|||
94732459|NCT04436276|324477979|FG015|Overall Study|Other|0|||
94732460|NCT04436276|324477980|FG016|Overall Study|Other|0|||
94732461|NCT04436276|324477981|FG017|Overall Study|Other|6|||
94732462|NCT04436276|324477982|FG018|Overall Study|Other|1|||
94732463|NCT04436276|324477983|FG019|Overall Study|Other|0|||
94732464|NCT04436276|324477984|FG020|Overall Study|Other|2|||
94732465|NCT04436276|324477985|FG021|Overall Study|Other|2|||
94732466|NCT04436276|324477986|FG022|Overall Study|Other|60|||
94467426|NCT04015518|323500561|FG000|Overall Study|Withdrawal by Subject|0|||
94467427|NCT04015518|323500562|FG001|Overall Study|Withdrawal by Subject|1|||
94732467|NCT03656510|324477989|FG000|Overall Study|Lost to Follow-up|1|||
94732468|NCT03656510|324477990|FG001|Overall Study|Lost to Follow-up|0|||
94732469|NCT03656510|324477991|FG002|Overall Study|Lost to Follow-up|0|||
94732470|NCT03656510|324477992|FG003|Overall Study|Lost to Follow-up|0|||
94732471|NCT03656510|324477993|FG004|Overall Study|Lost to Follow-up|0|||
94732472|NCT03656510|324477994|FG005|Overall Study|Lost to Follow-up|0|||
94732473|NCT03656510|324477989|FG000|Overall Study|Withdrawal by Subject|1|||
94732474|NCT03656510|324477990|FG001|Overall Study|Withdrawal by Subject|1|||
94732475|NCT03656510|324477991|FG002|Overall Study|Withdrawal by Subject|0|||
94732476|NCT03656510|324477992|FG003|Overall Study|Withdrawal by Subject|1|||
94732477|NCT03656510|324477993|FG004|Overall Study|Withdrawal by Subject|0|||
94732478|NCT03656510|324477994|FG005|Overall Study|Withdrawal by Subject|0|||
94732479|NCT05477186|324477995|FG000|Overall Study|Vaccine not administered|0|||
94732480|NCT05477186|324477996|FG001|Overall Study|Vaccine not administered|2|||
94732481|NCT05477186|324477997|FG002|Overall Study|Vaccine not administered|1|||
94732482|NCT05477186|324477998|FG003|Overall Study|Vaccine not administered|0|||
94732483|NCT05477186|324477999|FG004|Overall Study|Vaccine not administered|1|||
94732484|NCT05477186|324478000|FG005|Overall Study|Vaccine not administered|0|||
94732485|NCT05477186|324478001|FG006|Overall Study|Vaccine not administered|0|||
94732486|NCT05477186|324477995|FG000|Overall Study|Withdrawal by Subject|1|||
94732487|NCT05477186|324477996|FG001|Overall Study|Withdrawal by Subject|0|||
94732488|NCT05477186|324477997|FG002|Overall Study|Withdrawal by Subject|0|||
94732489|NCT05477186|324477998|FG003|Overall Study|Withdrawal by Subject|0|||
94732490|NCT05477186|324477999|FG004|Overall Study|Withdrawal by Subject|0|||
94732491|NCT05477186|324478000|FG005|Overall Study|Withdrawal by Subject|1|||
94732492|NCT05477186|324478001|FG006|Overall Study|Withdrawal by Subject|0|||
94732493|NCT05477186|324477995|FG000|Overall Study|Lost to Follow-up|1|||
94732494|NCT05477186|324477996|FG001|Overall Study|Lost to Follow-up|0|||
94732495|NCT05477186|324477997|FG002|Overall Study|Lost to Follow-up|2|||
94732496|NCT05477186|324477998|FG003|Overall Study|Lost to Follow-up|1|||
94732497|NCT05477186|324477999|FG004|Overall Study|Lost to Follow-up|1|||
94732498|NCT05477186|324478000|FG005|Overall Study|Lost to Follow-up|0|||
94732499|NCT05477186|324478001|FG006|Overall Study|Lost to Follow-up|2|||
94732500|NCT02844465|324478006|FG000|Overall Study|Screen Failure|36|||
94732501|NCT02844465|324478006|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
94732502|NCT02844465|324478006|FG000|Overall Study|Withdrawal by Subject|5|||
94732503|NCT02844465|324478006|FG000|Overall Study|Lost to Follow-up|1|||
94732504|NCT02844465|324478006|FG000|Overall Study|Retreatment|1|||
94732505|NCT05297565|324478007|FG000|Overall Study|Other Reasons|0|||
94732506|NCT05297565|324478008|FG001|Overall Study|Other Reasons|1|||
94732507|NCT05297565|324478007|FG000|Overall Study|Physician Decision|0|||
94732508|NCT05297565|324478008|FG001|Overall Study|Physician Decision|1|||
94732509|NCT05297565|324478007|FG000|Overall Study|Disease recurrence|1|||
94732510|NCT05297565|324478008|FG001|Overall Study|Disease recurrence|0|||
94732511|NCT04797897|324478011|FG000|Overall Study|Study Termination by Sponsor|1|||
94732512|NCT04797897|324478012|FG001|Overall Study|Study Termination by Sponsor|1|||
94732513|NCT05670587|324478013|FG000|Overall Study|Withdrawal by Subject|3|||
94732514|NCT02305888|324478019|FG000|Overall Study|Lost to Follow-up|0|||
94732515|NCT02305888|324478020|FG001|Overall Study|Lost to Follow-up|0|||
94732516|NCT02305888|324478021|FG002|Overall Study|Lost to Follow-up|1|||
94732517|NCT02305888|324478019|FG000|Overall Study|Adverse Event|0|||
94732518|NCT02305888|324478020|FG001|Overall Study|Adverse Event|1|||
94732519|NCT02305888|324478021|FG002|Overall Study|Adverse Event|0|||
94732520|NCT05139810|324478022|FG000|Overall Study|Voluntary Withdrawal|2|||
94732521|NCT05139810|324478023|FG001|Overall Study|Voluntary Withdrawal|1|||
94732522|NCT05139810|324478024|FG002|Overall Study|Voluntary Withdrawal|0|||
94732523|NCT05139810|324478022|FG000|Overall Study|Pregnancy|1|||
94467428|NCT04015518|323500563|FG002|Overall Study|Withdrawal by Subject|0|||
94732524|NCT05139810|324478023|FG001|Overall Study|Pregnancy|0|||
94732525|NCT05139810|324478024|FG002|Overall Study|Pregnancy|0|||
94732526|NCT05139810|324478022|FG000|Overall Study|Roll Over to CS7|19|||
94732527|NCT05139810|324478023|FG001|Overall Study|Roll Over to CS7|44|||
94732528|NCT05139810|324478024|FG002|Overall Study|Roll Over to CS7|20|||
94732529|NCT05940194|324478026|FG000|Overall Study|Adverse Event|0|||
94732530|NCT05940194|324478027|FG001|Overall Study|Adverse Event|1|||
94732531|NCT05940194|324478028|FG002|Overall Study|Adverse Event|0|||
94732532|NCT05940194|324478026|FG000|Overall Study|Migrated/Moved from the study area|2|||
94732533|NCT05940194|324478027|FG001|Overall Study|Migrated/Moved from the study area|2|||
94732534|NCT05940194|324478028|FG002|Overall Study|Migrated/Moved from the study area|4|||
94732535|NCT03800654|324478029|FG000|Overall Study|Time constraints|3|||
94368695|NCT04440007|323136515|FG000|Overall Study|Withdrawal by Subject|2|||
94732536|NCT03800654|324478030|FG001|Overall Study|Time constraints|3|||
94732537|NCT03800654|324478031|FG002|Overall Study|Time constraints|3|||
94274173|NCT01840579|322795786|FG008|Overall Study|Status not recorded|3|||
94274174|NCT01840579|322795787|FG009|Overall Study|Status not recorded|3|||
94274175|NCT01840579|322795778|FG000|Overall Study|Progressive disease|3|||
94274176|NCT01840579|322795779|FG001|Overall Study|Progressive disease|5|||
94274177|NCT01840579|322795780|FG002|Overall Study|Progressive disease|0|||
94274178|NCT01840579|322795781|FG003|Overall Study|Progressive disease|0|||
94274179|NCT01840579|322795782|FG004|Overall Study|Progressive disease|0|||
94274180|NCT01840579|322795783|FG005|Overall Study|Progressive disease|0|||
94274181|NCT01840579|322795784|FG006|Overall Study|Progressive disease|0|||
94274182|NCT01840579|322795785|FG007|Overall Study|Progressive disease|0|||
94274183|NCT01840579|322795786|FG008|Overall Study|Progressive disease|0|||
94274184|NCT01840579|322795787|FG009|Overall Study|Progressive disease|0|||
94368696|NCT04440007|323136516|FG001|Overall Study|Withdrawal by Subject|1|||
94368697|NCT04440007|323136515|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
94732538|NCT03800654|324478029|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
94732539|NCT03800654|324478030|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
94732540|NCT03800654|324478031|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
94732541|NCT03800654|324478029|FG000|Overall Study|Lost to Follow-up|2|||
94732542|NCT03800654|324478030|FG001|Overall Study|Lost to Follow-up|1|||
94732543|NCT03800654|324478031|FG002|Overall Study|Lost to Follow-up|6|||
94732544|NCT03800654|324478029|FG000|Overall Study|Medical Health Issue|0|||
94732545|NCT03800654|324478030|FG001|Overall Study|Medical Health Issue|0|||
94732546|NCT03800654|324478031|FG002|Overall Study|Medical Health Issue|1|||
94732547|NCT03800654|324478029|FG000|Overall Study|Personal Issues|0|||
94732548|NCT03800654|324478030|FG001|Overall Study|Personal Issues|2|||
94732549|NCT03800654|324478031|FG002|Overall Study|Personal Issues|0|||
94732550|NCT03800654|324478029|FG000|Overall Study|Protocol Violation|0|||
94732551|NCT03800654|324478030|FG001|Overall Study|Protocol Violation|1|||
94732552|NCT03800654|324478031|FG002|Overall Study|Protocol Violation|0|||
94732553|NCT03459729|324478032|FG000|Overall Study|Physician Decision|2|||
94732554|NCT04447755|324478033|FG000|Overall Study|Death|8|||
94732555|NCT04447755|324478034|FG001|Overall Study|Death|14|||
94732556|NCT04447755|324478035|FG002|Overall Study|Death|8|||
94732557|NCT04447755|324478036|FG003|Overall Study|Death|9|||
94732558|NCT04447755|324478037|FG004|Overall Study|Death|7|||
94732559|NCT04447755|324478038|FG005|Overall Study|Death|7|||
94732560|NCT04447755|324478039|FG006|Overall Study|Death|40|||
94732561|NCT04447755|324478033|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94732562|NCT04447755|324478034|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
94732563|NCT04447755|324478035|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
94732564|NCT04447755|324478036|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
94732565|NCT04447755|324478037|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
94732566|NCT04447755|324478038|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
94732567|NCT04447755|324478039|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
94732568|NCT04447755|324478033|FG000|Overall Study|Ongoing in Study|1|||
94732569|NCT04447755|324478034|FG001|Overall Study|Ongoing in Study|2|||
94732570|NCT04447755|324478035|FG002|Overall Study|Ongoing in Study|0|||
94732571|NCT04447755|324478036|FG003|Overall Study|Ongoing in Study|0|||
94732572|NCT04447755|324478037|FG004|Overall Study|Ongoing in Study|2|||
94732573|NCT04447755|324478038|FG005|Overall Study|Ongoing in Study|2|||
94732574|NCT04447755|324478039|FG006|Overall Study|Ongoing in Study|26|||
94732575|NCT05436262|324478041|FG000|Pre-Randomization|Withdrawal by Subject|1|||
94732576|NCT05436262|324478042|FG001|Pre-Randomization|Withdrawal by Subject|0|||
94732577|NCT05436262|324478043|FG002|Pre-Randomization|Withdrawal by Subject|0|||
94732578|NCT05436262|324478041|FG000|Randomization|Withdrawal by Subject|0|||
94732579|NCT05436262|324478042|FG001|Randomization|Withdrawal by Subject|1|||
94732580|NCT05436262|324478043|FG002|Randomization|Withdrawal by Subject|0|||
94732581|NCT04830800|324478044|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
94732582|NCT04830800|324478045|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
94732583|NCT04830800|324478046|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
94467429|NCT04015518|323500564|FG003|Overall Study|Withdrawal by Subject|1|||
94732584|NCT04830800|324478047|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
94732585|NCT04830800|324478048|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
94732586|NCT03216057|324479078|FG000|Overall Study|Lost to Follow-up|2|||
94732587|NCT03216057|324479079|FG001|Overall Study|Lost to Follow-up|2|||
94274185|NCT01840579|322795778|FG000|Overall Study|Ongoing in study|0|||
94274186|NCT01840579|322795779|FG001|Overall Study|Ongoing in study|1|||
94274187|NCT01840579|322795780|FG002|Overall Study|Ongoing in study|0|||
94732588|NCT03625167|324479081|FG000|Overall Study|Protocol Violation|5|||
94732589|NCT02231164|324479082|FG000|Overall Study|Adverse Event|1|||
94732590|NCT02231164|324479083|FG001|Overall Study|Adverse Event|1|||
94732591|NCT02231164|324479082|FG000|Overall Study|Lack of Efficacy|4|||
94732592|NCT02231164|324479083|FG001|Overall Study|Lack of Efficacy|3|||
94732593|NCT02231164|324479082|FG000|Overall Study|Withdrawal by Subject|1|||
94732594|NCT02231164|324479083|FG001|Overall Study|Withdrawal by Subject|2|||
94732595|NCT03916185|324479084|FG000|Overall Study|Lost to Follow-up|0|||
94732596|NCT03916185|324479085|FG001|Overall Study|Lost to Follow-up|1|||
94732597|NCT03916185|324479086|FG002|Overall Study|Lost to Follow-up|0|||
94732598|NCT03916185|324479087|FG003|Overall Study|Lost to Follow-up|0|||
94732599|NCT03916185|324479084|FG000|Overall Study|Moved|1|||
94732600|NCT03916185|324479085|FG001|Overall Study|Moved|0|||
94732601|NCT03916185|324479086|FG002|Overall Study|Moved|0|||
94732602|NCT03916185|324479087|FG003|Overall Study|Moved|1|||
94732603|NCT03916185|324479084|FG000|Overall Study|Not Able to Get to Clinic|1|||
94732604|NCT03916185|324479085|FG001|Overall Study|Not Able to Get to Clinic|0|||
94732605|NCT03916185|324479086|FG002|Overall Study|Not Able to Get to Clinic|0|||
94732606|NCT03916185|324479087|FG003|Overall Study|Not Able to Get to Clinic|0|||
94732607|NCT04564027|324479088|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
94732608|NCT04564027|324479089|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
94732609|NCT04564027|324479090|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
94732610|NCT04564027|324479091|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
94732611|NCT02116530|324479092|FG000|Overall Study|Withdrawal by Subject|1|||
94732612|NCT02116530|324479093|FG001|Overall Study|Withdrawal by Subject|2|||
94732613|NCT02116530|324479092|FG000|Overall Study|Adverse Event|4|||
94732614|NCT02116530|324479093|FG001|Overall Study|Adverse Event|0|||
94732615|NCT02116530|324479092|FG000|Overall Study|Physician Decision|1|||
94732616|NCT02116530|324479093|FG001|Overall Study|Physician Decision|0|||
94732617|NCT02116530|324479092|FG000|Overall Study|Lost to Follow-up|1|||
94732618|NCT02116530|324479093|FG001|Overall Study|Lost to Follow-up|0|||
94732619|NCT02116530|324479092|FG000|Overall Study|Other Medical Problems|2|||
94732620|NCT02116530|324479093|FG001|Overall Study|Other Medical Problems|2|||
94732621|NCT06457802|324479102|FG000|Overall Study|Early termination of study prior to participant completion|2|||
94732622|NCT06457802|324479103|FG001|Overall Study|Early termination of study prior to participant completion|2|||
94732623|NCT05496231|324479104|FG000|Overall Study|Adverse Event|1|||
94732624|NCT05496231|324479105|FG001|Overall Study|Adverse Event|1|||
94732625|NCT05496231|324479106|FG002|Overall Study|Adverse Event|0|||
94732626|NCT05496231|324479107|FG003|Overall Study|Adverse Event|4|||
94732627|NCT05496231|324479104|FG000|Overall Study|Withdrawal by Subject|5|||
94732628|NCT05496231|324479105|FG001|Overall Study|Withdrawal by Subject|5|||
94732629|NCT05496231|324479106|FG002|Overall Study|Withdrawal by Subject|4|||
94732630|NCT05496231|324479107|FG003|Overall Study|Withdrawal by Subject|11|||
94732631|NCT05496231|324479104|FG000|Overall Study|Migrated/moved from the study area|3|||
94732632|NCT05496231|324479105|FG001|Overall Study|Migrated/moved from the study area|5|||
94732633|NCT05496231|324479106|FG002|Overall Study|Migrated/moved from the study area|3|||
94732634|NCT05496231|324479107|FG003|Overall Study|Migrated/moved from the study area|3|||
94732635|NCT05496231|324479104|FG000|Overall Study|Lost to Follow-up|13|||
94732636|NCT05496231|324479105|FG001|Overall Study|Lost to Follow-up|6|||
94732637|NCT05496231|324479106|FG002|Overall Study|Lost to Follow-up|11|||
94732638|NCT05496231|324479107|FG003|Overall Study|Lost to Follow-up|6|||
94732639|NCT05496231|324479104|FG000|Overall Study|Other|9|||
94732640|NCT05496231|324479105|FG001|Overall Study|Other|7|||
94732641|NCT05496231|324479106|FG002|Overall Study|Other|7|||
94732642|NCT05496231|324479107|FG003|Overall Study|Other|8|||
94732643|NCT04524442|324479110|FG000|Overall Study|Subject Decision|1|||
94732644|NCT01267955|324479111|FG000|Stage 1 (6 Months)|Death|3|||
94732645|NCT01267955|324479111|FG000|Stage 2 (6 Months)|Death|5|||
94732646|NCT01267955|324479111|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
94732647|NCT05228457|324479119|FG000|Overall Study|Withdrawal by Subject|1|||
94732648|NCT05228457|324479120|FG001|Overall Study|Withdrawal by Subject|1|||
94732649|NCT04914676|324479137|FG000|Overall Study|Study termination|3|||
94732650|NCT04914676|324479138|FG001|Overall Study|Study termination|0|||
94732651|NCT03085810|324479139|FG000|Main Study|Withdrawal by Subject|77|||
94732652|NCT03085810|324479140|FG001|Main Study|Withdrawal by Subject|0|||
94274188|NCT01840579|322795781|FG003|Overall Study|Ongoing in study|0|||
94467430|NCT04015518|323500565|FG004|Overall Study|Withdrawal by Subject|1|||
94732653|NCT03085810|324479141|FG002|Main Study|Withdrawal by Subject|0|||
94732654|NCT03085810|324479139|FG000|Main Study|Terminated By Sponsor|14|||
94732655|NCT03085810|324479140|FG001|Main Study|Terminated By Sponsor|0|||
94732656|NCT03085810|324479141|FG002|Main Study|Terminated By Sponsor|0|||
94732657|NCT03085810|324479139|FG000|Main Study|Protocol Violation|15|||
94467431|NCT04015518|323500561|FG000|Overall Study|Patient did not come for consecutive visits|0|||
94732658|NCT03085810|324479140|FG001|Main Study|Protocol Violation|0|||
94732659|NCT03085810|324479141|FG002|Main Study|Protocol Violation|0|||
94732660|NCT03085810|324479139|FG000|Main Study|Physician Decision|13|||
94732661|NCT03085810|324479140|FG001|Main Study|Physician Decision|0|||
94732662|NCT03085810|324479141|FG002|Main Study|Physician Decision|0|||
94732663|NCT03085810|324479139|FG000|Main Study|Lost to Follow-up|17|||
94732664|NCT03085810|324479140|FG001|Main Study|Lost to Follow-up|0|||
94732665|NCT03085810|324479141|FG002|Main Study|Lost to Follow-up|0|||
94732666|NCT03085810|324479139|FG000|Main Study|Adverse Event|25|||
94732667|NCT03085810|324479140|FG001|Main Study|Adverse Event|0|||
94732668|NCT03085810|324479141|FG002|Main Study|Adverse Event|0|||
94732669|NCT03085810|324479139|FG000|Main Study|Pregnancy|7|||
94732670|NCT03085810|324479140|FG001|Main Study|Pregnancy|0|||
94732671|NCT03085810|324479141|FG002|Main Study|Pregnancy|0|||
94732672|NCT03085810|324479139|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
94732673|NCT03085810|324479140|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
94732674|NCT03085810|324479141|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
94732675|NCT03085810|324479139|FG000|Main Study|Lack of Efficacy|10|||
94732676|NCT03085810|324479140|FG001|Main Study|Lack of Efficacy|0|||
94732677|NCT03085810|324479141|FG002|Main Study|Lack of Efficacy|0|||
94732678|NCT03085810|324479139|FG000|Main Study|Death|12|||
94732679|NCT03085810|324479140|FG001|Main Study|Death|0|||
94732680|NCT03085810|324479141|FG002|Main Study|Death|0|||
94732681|NCT03085810|324479139|FG000|Main Study|Disease progression|1|||
94732682|NCT03085810|324479140|FG001|Main Study|Disease progression|0|||
94732683|NCT03085810|324479141|FG002|Main Study|Disease progression|0|||
94732684|NCT03085810|324479139|FG000|Main Study|Site Closure|3|||
94732685|NCT03085810|324479140|FG001|Main Study|Site Closure|0|||
94732686|NCT03085810|324479141|FG002|Main Study|Site Closure|0|||
94732687|NCT03085810|324479139|FG000|Main Study|Planned pregnancy|17|||
94732688|NCT03085810|324479140|FG001|Main Study|Planned pregnancy|0|||
94732689|NCT03085810|324479141|FG002|Main Study|Planned pregnancy|0|||
94732690|NCT03085810|324479139|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
94732691|NCT03085810|324479140|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
94732692|NCT03085810|324479141|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
94732693|NCT03085810|324479139|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
94732694|NCT03085810|324479140|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
94732695|NCT03085810|324479141|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
94732696|NCT03085810|324479139|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
94732697|NCT03085810|324479140|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
94732698|NCT03085810|324479141|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
94732699|NCT03085810|324479139|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
94732700|NCT03085810|324479140|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
94732701|NCT03085810|324479141|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
94732702|NCT03024437|324479142|FG000|Overall Study|Adverse Event|0|||
94732703|NCT03024437|324479143|FG001|Overall Study|Adverse Event|1|||
94732704|NCT03024437|324479144|FG002|Overall Study|Adverse Event|3|||
94732705|NCT03024437|324479145|FG003|Overall Study|Adverse Event|5|||
94732706|NCT03024437|324479146|FG004|Overall Study|Adverse Event|0|||
94732707|NCT03024437|324479142|FG000|Overall Study|Physician Decision|1|||
94732708|NCT03024437|324479143|FG001|Overall Study|Physician Decision|0|||
94732709|NCT03024437|324479144|FG002|Overall Study|Physician Decision|0|||
94732710|NCT03024437|324479145|FG003|Overall Study|Physician Decision|1|||
94732711|NCT03024437|324479146|FG004|Overall Study|Physician Decision|0|||
94732712|NCT03024437|324479142|FG000|Overall Study|Disease progression, relapse|1|||
94732713|NCT03024437|324479143|FG001|Overall Study|Disease progression, relapse|0|||
94732714|NCT03024437|324479144|FG002|Overall Study|Disease progression, relapse|0|||
94732715|NCT03024437|324479145|FG003|Overall Study|Disease progression, relapse|3|||
94732716|NCT03024437|324479146|FG004|Overall Study|Disease progression, relapse|0|||
94732717|NCT03024437|324479142|FG000|Overall Study|Disease progression, refractory disease|4|||
94732718|NCT03024437|324479143|FG001|Overall Study|Disease progression, refractory disease|4|||
94732719|NCT03024437|324479144|FG002|Overall Study|Disease progression, refractory disease|2|||
94732720|NCT03024437|324479145|FG003|Overall Study|Disease progression, refractory disease|2|||
94732721|NCT03024437|324479146|FG004|Overall Study|Disease progression, refractory disease|1|||
94732722|NCT03024437|324479142|FG000|Overall Study|Newly diagnosed cancer|0|||
94732723|NCT03024437|324479143|FG001|Overall Study|Newly diagnosed cancer|0|||
94732724|NCT03024437|324479144|FG002|Overall Study|Newly diagnosed cancer|0|||
94732725|NCT03024437|324479145|FG003|Overall Study|Newly diagnosed cancer|1|||
94732726|NCT03024437|324479146|FG004|Overall Study|Newly diagnosed cancer|0|||
94732727|NCT03024437|324479142|FG000|Overall Study|Moved out of state|0|||
94732728|NCT03024437|324479143|FG001|Overall Study|Moved out of state|1|||
94732729|NCT03024437|324479144|FG002|Overall Study|Moved out of state|0|||
94732730|NCT03024437|324479145|FG003|Overall Study|Moved out of state|0|||
94732731|NCT03024437|324479146|FG004|Overall Study|Moved out of state|0|||
94732732|NCT03024437|324479142|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
94732733|NCT03024437|324479143|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
94732734|NCT03024437|324479144|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
94732735|NCT03024437|324479145|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
94732736|NCT03024437|324479146|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
94732737|NCT05200403|324479149|FG000|Overall Study|Withdrawal by Subject|4|||
94732738|NCT05200403|324479150|FG001|Overall Study|Withdrawal by Subject|2|||
94732739|NCT05200403|324479151|FG002|Overall Study|Withdrawal by Subject|6|||
94732740|NCT02606422|324479152|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
94732741|NCT02606422|324479153|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
94732742|NCT02606422|324479152|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
94732743|NCT02606422|324479153|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
94732744|NCT02606422|324479152|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
94732745|NCT02606422|324479153|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
94732746|NCT02606422|324479152|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
94732747|NCT02606422|324479153|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
94732748|NCT02601313|324479154|FG000|Overall Study|Death|2|||
94732749|NCT02601313|324479155|FG001|Overall Study|Death|41|||
94732750|NCT02601313|324479156|FG002|Overall Study|Death|6|||
94732751|NCT02601313|324479154|FG000|Overall Study|Enrolled but never treated|0|||
94732752|NCT02601313|324479155|FG001|Overall Study|Enrolled but never treated|6|||
94732753|NCT02601313|324479156|FG002|Overall Study|Enrolled but never treated|3|||
94732754|NCT02601313|324479154|FG000|Overall Study|Enrolled, did not initiate AC|4|||
94732755|NCT02601313|324479155|FG001|Overall Study|Enrolled, did not initiate AC|0|||
94732756|NCT02601313|324479156|FG002|Overall Study|Enrolled, did not initiate AC|0|||
94732757|NCT02601313|324479154|FG000|Overall Study|Full consent withdrawal|0|||
94732758|NCT02601313|324479155|FG001|Overall Study|Full consent withdrawal|3|||
94732759|NCT02601313|324479156|FG002|Overall Study|Full consent withdrawal|2|||
94732760|NCT02601313|324479154|FG000|Overall Study|Lost to Follow-up|0|||
94732761|NCT02601313|324479155|FG001|Overall Study|Lost to Follow-up|1|||
94732762|NCT02601313|324479156|FG002|Overall Study|Lost to Follow-up|1|||
94732763|NCT04501614|324479159|FG000|Overall Study|Study Terminated by Sponsor|6|||
94732764|NCT04501614|324479160|FG001|Overall Study|Study Terminated by Sponsor|3|||
94732765|NCT04501614|324479159|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
94732766|NCT04501614|324479160|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
94732767|NCT05566639|324479161|FG000|Overall Study|Adverse Event|1|||
94732768|NCT05566639|324479162|FG001|Overall Study|Adverse Event|1|||
94732769|NCT05566639|324479161|FG000|Overall Study|Serious Adverse Event|1|||
94732770|NCT05566639|324479162|FG001|Overall Study|Serious Adverse Event|3|||
94732771|NCT05566639|324479161|FG000|Overall Study|Death|44|||
94732772|NCT05566639|324479162|FG001|Overall Study|Death|45|||
94732773|NCT05566639|324479161|FG000|Overall Study|Lost to Follow-up|467|||
94732774|NCT05566639|324479162|FG001|Overall Study|Lost to Follow-up|461|||
94732775|NCT05566639|324479161|FG000|Overall Study|Physician Decision|45|||
94732776|NCT05566639|324479162|FG001|Overall Study|Physician Decision|44|||
94732777|NCT05566639|324479161|FG000|Overall Study|Protocol Deviation|4|||
94732778|NCT05566639|324479162|FG001|Overall Study|Protocol Deviation|4|||
94732779|NCT05566639|324479161|FG000|Overall Study|Withdrawal by Subject|277|||
94732780|NCT05566639|324479162|FG001|Overall Study|Withdrawal by Subject|271|||
94732781|NCT05566639|324479161|FG000|Overall Study|Other Than Specified|52|||
94732782|NCT05566639|324479162|FG001|Overall Study|Other Than Specified|64|||
94732783|NCT04054193|324479164|FG000|Cycle 1|Physician Decision|1|||
94732784|NCT04054193|324479164|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
94732785|NCT04054193|324479164|FG000|Cycle 1|Allocated but not treated|3|||
94732786|NCT04054193|324479164|FG000|Cycles 2-3|Physician Decision|2|||
94732787|NCT04054193|324479164|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
94732788|NCT04054193|324479164|FG000|Cycles 2-3|Various reasons|17|||
94732789|NCT01799265|324479165|FG000|Overall Study|Lost to Follow-up|1|||
94732790|NCT01799265|324479166|FG001|Overall Study|Lost to Follow-up|0|||
94732791|NCT01799265|324479165|FG000|Overall Study|Protocol Violation|2|||
94732792|NCT01799265|324479166|FG001|Overall Study|Protocol Violation|1|||
94732793|NCT01799265|324479165|FG000|Overall Study|inadequate sleep study|0|||
94732794|NCT01799265|324479166|FG001|Overall Study|inadequate sleep study|2|||
94274189|NCT01840579|322795782|FG004|Overall Study|Ongoing in study|0|||
94274190|NCT01840579|322795783|FG005|Overall Study|Ongoing in study|0|||
94274191|NCT01840579|322795784|FG006|Overall Study|Ongoing in study|0|||
94274192|NCT01840579|322795785|FG007|Overall Study|Ongoing in study|0|||
94274193|NCT01840579|322795786|FG008|Overall Study|Ongoing in study|0|||
94274194|NCT01840579|322795787|FG009|Overall Study|Ongoing in study|0|||
94274195|NCT01840579|322795778|FG000|Overall Study|Death|0|||
94274196|NCT01840579|322795779|FG001|Overall Study|Death|0|||
94274197|NCT01840579|322795780|FG002|Overall Study|Death|0|||
94274198|NCT01840579|322795781|FG003|Overall Study|Death|0|||
94274199|NCT01840579|322795782|FG004|Overall Study|Death|0|||
94274200|NCT01840579|322795783|FG005|Overall Study|Death|1|||
94274201|NCT01840579|322795784|FG006|Overall Study|Death|0|||
94274202|NCT01840579|322795785|FG007|Overall Study|Death|0|||
94274203|NCT01840579|322795786|FG008|Overall Study|Death|0|||
94274204|NCT01840579|322795787|FG009|Overall Study|Death|0|||
94274205|NCT01840579|322795778|FG000|Overall Study|Adverse Event|0|||
94274206|NCT01840579|322795779|FG001|Overall Study|Adverse Event|1|||
94274207|NCT01840579|322795780|FG002|Overall Study|Adverse Event|0|||
94274208|NCT01840579|322795781|FG003|Overall Study|Adverse Event|0|||
94274209|NCT01840579|322795782|FG004|Overall Study|Adverse Event|0|||
94274210|NCT01840579|322795783|FG005|Overall Study|Adverse Event|0|||
94274211|NCT01840579|322795784|FG006|Overall Study|Adverse Event|0|||
94274212|NCT01840579|322795785|FG007|Overall Study|Adverse Event|0|||
94274213|NCT01840579|322795786|FG008|Overall Study|Adverse Event|0|||
94274214|NCT01840579|322795787|FG009|Overall Study|Adverse Event|0|||
94274215|NCT01840579|322795778|FG000|Overall Study|Follow-up ended by Sponsor|0|||
94274216|NCT01840579|322795779|FG001|Overall Study|Follow-up ended by Sponsor|0|||
94274217|NCT01840579|322795780|FG002|Overall Study|Follow-up ended by Sponsor|0|||
94274218|NCT01840579|322795781|FG003|Overall Study|Follow-up ended by Sponsor|0|||
94274219|NCT01840579|322795782|FG004|Overall Study|Follow-up ended by Sponsor|0|||
94274220|NCT01840579|322795783|FG005|Overall Study|Follow-up ended by Sponsor|0|||
94274221|NCT01840579|322795784|FG006|Overall Study|Follow-up ended by Sponsor|2|||
94274222|NCT01840579|322795785|FG007|Overall Study|Follow-up ended by Sponsor|0|||
94274223|NCT01840579|322795786|FG008|Overall Study|Follow-up ended by Sponsor|0|||
94274224|NCT01840579|322795787|FG009|Overall Study|Follow-up ended by Sponsor|0|||
94274225|NCT01744665|322795789|FG000|Monitoring Phase|Adverse Event|4|||
94274226|NCT01744665|322795789|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
94274227|NCT01744665|322795789|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
94274228|NCT01744665|322795789|FG000|Monitoring Phase|Withdrawal by Subject|5|||
94274229|NCT01744665|322795789|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
94274230|NCT01744665|322795789|FG000|Consolidation Phase|Adverse Event|2|||
94274231|NCT01744665|322795789|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
94274232|NCT01744665|322795789|FG000|Consolidation Phase|Withdrawal by Subject|4|||
94274233|NCT01744665|322795789|FG000|Consolidation Phase|Administrative problems|9|||
94274234|NCT01744665|322795789|FG000|Re-initiation Phase|Administrative problems|10|||
94274235|NCT01744665|322795789|FG000|Re-initiation Phase|Adverse Event|1|||
94274236|NCT01744665|322795789|FG000|Re-initiation Phase|No longer required treatment|1|||
94274237|NCT01744665|322795789|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
94274238|NCT02577146|322795790|FG000|Overall Study|Lost to Follow-up|8|||
94274239|NCT02577146|322795790|FG000|Overall Study|Physician Decision|3|||
94274240|NCT02577146|322795790|FG000|Overall Study|Screen Failure|17|||
94274241|NCT03765138|322795791|FG000|Overall Study|Lost to Follow-up|1|||
94274242|NCT01624662|322795792|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
94368698|NCT04440007|323136516|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
94368699|NCT04440007|323136515|FG000|Overall Study|Discontinued prior to dosing|0|||
94368700|NCT04440007|323136516|FG001|Overall Study|Discontinued prior to dosing|2|||
94368701|NCT00829439|323136524|FG000|Overall Study|Adverse Event|0|||
94368702|NCT00829439|323136525|FG001|Overall Study|Adverse Event|0|||
94368703|NCT00829439|323136526|FG002|Overall Study|Adverse Event|1|||
94368704|NCT00829439|323136527|FG003|Overall Study|Adverse Event|0|||
94732795|NCT03084536|324479167|FG000|Overall Study|Determined to be ineligible|0|||
94732796|NCT03084536|324479168|FG001|Overall Study|Determined to be ineligible|0|||
94274243|NCT01624662|322795793|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
94274244|NCT01624662|322795794|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
94274245|NCT01624662|322795795|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
94274246|NCT01624662|322795792|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
94274247|NCT01624662|322795793|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
94274248|NCT01624662|322795794|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
94274249|NCT01624662|322795795|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
94274250|NCT01624662|322795792|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
94274251|NCT01624662|322795793|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
94274252|NCT01624662|322795794|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
94274253|NCT01624662|322795795|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
94274254|NCT01624662|322795792|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
94274255|NCT01624662|322795793|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
94274256|NCT01624662|322795794|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
94274257|NCT01624662|322795795|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
94274258|NCT01624662|322795792|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
94274259|NCT01624662|322795793|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
94274260|NCT01624662|322795794|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
94274261|NCT01624662|322795795|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
94274262|NCT01624662|322795792|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
94274263|NCT01624662|322795793|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
94274264|NCT01624662|322795794|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
94274265|NCT01624662|322795795|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
94274266|NCT01624662|322795792|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
94274267|NCT01624662|322795793|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
94274268|NCT01624662|322795794|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
94274269|NCT01624662|322795795|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
94274270|NCT00081159|322795796|FG000|Overall Study|Withdrawal by Subject|0|||
94274271|NCT00081159|322795797|FG001|Overall Study|Withdrawal by Subject|3|||
94274272|NCT00081159|322795796|FG000|Overall Study|Myelosuppression prior to treatment|0|||
94274273|NCT00081159|322795797|FG001|Overall Study|Myelosuppression prior to treatment|1|||
94274274|NCT00081159|322795796|FG000|Overall Study|Lost to Follow-up|2|||
94274275|NCT00081159|322795797|FG001|Overall Study|Lost to Follow-up|1|||
94368705|NCT00837577|323136528|FG000|Double-blind Period|Clinical Adverse Event|1|||
94368706|NCT00837577|323136529|FG001|Double-blind Period|Clinical Adverse Event|0|||
94732797|NCT03084536|324479169|FG002|Overall Study|Determined to be ineligible|16|||
94732798|NCT03084536|324479167|FG000|Overall Study|Withdrawal by Subject|0|||
94732799|NCT03084536|324479168|FG001|Overall Study|Withdrawal by Subject|0|||
94732800|NCT03084536|324479169|FG002|Overall Study|Withdrawal by Subject|4|||
94732801|NCT03084536|324479167|FG000|Overall Study|Physician Decision|0|||
94732802|NCT03084536|324479168|FG001|Overall Study|Physician Decision|0|||
94732803|NCT03084536|324479169|FG002|Overall Study|Physician Decision|3|||
94732804|NCT03084536|324479167|FG000|Overall Study|Death|0|||
94732805|NCT03084536|324479168|FG001|Overall Study|Death|0|||
94732806|NCT03084536|324479169|FG002|Overall Study|Death|1|||
94732807|NCT03084536|324479167|FG000|Overall Study|Lost to Follow-up|0|||
94274276|NCT01979536|322795798|FG000|Overall Study|Physician Decision|2|||
94274277|NCT01979536|322795799|FG001|Overall Study|Physician Decision|3|||
94732808|NCT03084536|324479168|FG001|Overall Study|Lost to Follow-up|0|||
94732809|NCT03084536|324479169|FG002|Overall Study|Lost to Follow-up|1|||
94732810|NCT03084536|324479167|FG000|Overall Study|Protocol Violation|0|||
94732811|NCT03084536|324479168|FG001|Overall Study|Protocol Violation|0|||
94732812|NCT03084536|324479169|FG002|Overall Study|Protocol Violation|1|||
94732813|NCT03084536|324479167|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
94732814|NCT03084536|324479168|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
94732815|NCT03084536|324479169|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
94732816|NCT05073458|324479173|FG000|24-week Double-blind Period|Adverse Event|1|||
94732817|NCT05073458|324479174|FG001|24-week Double-blind Period|Adverse Event|0|||
94732818|NCT05073458|324479173|FG000|24-week Double-blind Period|Physician Decision|1|||
94732819|NCT05073458|324479174|FG001|24-week Double-blind Period|Physician Decision|0|||
94732820|NCT05073458|324479173|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
94732821|NCT05073458|324479174|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
94732822|NCT05073458|324479173|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
94732823|NCT05073458|324479174|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
94732824|NCT05073458|324479173|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
94732825|NCT05073458|324479174|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
94732826|NCT05073458|324479173|FG000|24-week Open-label Period|Adverse Event|1|||
94732827|NCT05073458|324479174|FG001|24-week Open-label Period|Adverse Event|2|||
94732828|NCT03976375|324479182|FG000|Overall Study|Death|147|||
94732829|NCT03976375|324479183|FG001|Overall Study|Death|150|||
94732830|NCT03976375|324479184|FG002|Overall Study|Death|38|||
94732831|NCT03976375|324479182|FG000|Overall Study|Lost to Follow-up|1|||
94732832|NCT03976375|324479183|FG001|Overall Study|Lost to Follow-up|1|||
94732833|NCT03976375|324479184|FG002|Overall Study|Lost to Follow-up|1|||
94732834|NCT03976375|324479182|FG000|Overall Study|Withdrawal by Subject|4|||
94274278|NCT01979536|322795798|FG000|Overall Study|Withdrawal by Subject|0|||
94732835|NCT03976375|324479183|FG001|Overall Study|Withdrawal by Subject|9|||
94274279|NCT01979536|322795799|FG001|Overall Study|Withdrawal by Subject|1|||
94274280|NCT01979536|322795798|FG000|Overall Study|Refusal|0|||
94274281|NCT01979536|322795799|FG001|Overall Study|Refusal|1|||
94274282|NCT01979536|322795798|FG000|Overall Study|Relapse|0|||
94732836|NCT03976375|324479184|FG002|Overall Study|Withdrawal by Subject|4|||
94732837|NCT03976375|324479182|FG000|Overall Study|Ongoing|33|||
94732838|NCT03976375|324479183|FG001|Overall Study|Ongoing|29|||
94732839|NCT03976375|324479184|FG002|Overall Study|Ongoing|5|||
94732840|NCT05029622|324481187|FG000|Overall Study|Lost to Follow-up|1|||
94732841|NCT03829319|324481188|FG000|Overall Study|Ongoing|4|||
94732842|NCT03829319|324481189|FG001|Overall Study|Ongoing|125|||
94732843|NCT03829319|324481190|FG002|Overall Study|Ongoing|130|||
94732844|NCT03829319|324481188|FG000|Overall Study|Withdrawal by Subject|1|||
94732845|NCT03829319|324481189|FG001|Overall Study|Withdrawal by Subject|6|||
94732846|NCT03829319|324481190|FG002|Overall Study|Withdrawal by Subject|8|||
94732847|NCT03829319|324481188|FG000|Overall Study|Physician Decision|0|||
94732848|NCT03829319|324481189|FG001|Overall Study|Physician Decision|1|||
94732849|NCT03829319|324481190|FG002|Overall Study|Physician Decision|0|||
94732850|NCT03829319|324481188|FG000|Overall Study|Lost to Follow-up|0|||
94732851|NCT03829319|324481189|FG001|Overall Study|Lost to Follow-up|0|||
94732852|NCT03829319|324481190|FG002|Overall Study|Lost to Follow-up|1|||
94732853|NCT03829319|324481188|FG000|Overall Study|Death|8|||
94732854|NCT03829319|324481189|FG001|Overall Study|Death|243|||
94732855|NCT03829319|324481190|FG002|Overall Study|Death|234|||
94732856|NCT05671653|324481191|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
94732857|NCT05671653|324481192|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
94732858|NCT05671653|324481193|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
94732859|NCT05671653|324481194|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
94732860|NCT05671653|324481195|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
94732861|NCT05671653|324481196|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
94732862|NCT05671653|324481197|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
94732863|NCT05671653|324481198|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
94732864|NCT05671653|324481199|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
94732865|NCT05671653|324481200|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
94732866|NCT05671653|324481201|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
94732867|NCT05671653|324481202|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
94732868|NCT05671653|324481203|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
94732869|NCT05671653|324481191|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
94732870|NCT05671653|324481192|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
94732871|NCT05671653|324481193|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
94732872|NCT05671653|324481194|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
94732873|NCT05671653|324481195|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
94732874|NCT05671653|324481196|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
94732875|NCT05671653|324481197|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
94732876|NCT05671653|324481198|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
94732877|NCT05671653|324481199|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
94732878|NCT05671653|324481200|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
94732879|NCT05671653|324481201|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
94732880|NCT05671653|324481202|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
94732881|NCT05671653|324481203|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
94732882|NCT05671653|324481191|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
94732883|NCT05671653|324481192|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
94732884|NCT05671653|324481193|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
94732885|NCT05671653|324481194|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
94732886|NCT05671653|324481195|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
94732887|NCT05671653|324481196|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
94732888|NCT05671653|324481197|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
94732889|NCT05671653|324481198|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
94732890|NCT05671653|324481199|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
94732891|NCT05671653|324481200|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
94732892|NCT05671653|324481201|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
94732893|NCT05671653|324481202|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
94732894|NCT05671653|324481203|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
94732895|NCT05671653|324481191|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
94732896|NCT05671653|324481192|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
94732897|NCT05671653|324481193|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
94732898|NCT05671653|324481194|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
94732899|NCT05671653|324481195|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
94732900|NCT05671653|324481196|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
94732901|NCT05671653|324481197|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
94732902|NCT05671653|324481198|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
94274283|NCT01979536|322795799|FG001|Overall Study|Relapse|1|||
94274284|NCT01979536|322795798|FG000|Overall Study|Study terminated by Sponsor|0|||
94274285|NCT01979536|322795799|FG001|Overall Study|Study terminated by Sponsor|1|||
94732903|NCT05671653|324481199|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
94732904|NCT05671653|324481200|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
94732905|NCT05671653|324481201|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
94732906|NCT05671653|324481202|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
94732907|NCT05671653|324481203|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
94732908|NCT05671653|324481191|FG000|Cohort 2 Period 2|Adverse Event|0|||
94732909|NCT05671653|324481192|FG001|Cohort 2 Period 2|Adverse Event|0|||
94732910|NCT05671653|324481193|FG002|Cohort 2 Period 2|Adverse Event|0|||
94732911|NCT05671653|324481194|FG003|Cohort 2 Period 2|Adverse Event|0|||
94732912|NCT05671653|324481195|FG004|Cohort 2 Period 2|Adverse Event|0|||
94732913|NCT05671653|324481196|FG005|Cohort 2 Period 2|Adverse Event|0|||
94732914|NCT05671653|324481197|FG006|Cohort 2 Period 2|Adverse Event|0|||
94732915|NCT05671653|324481198|FG007|Cohort 2 Period 2|Adverse Event|0|||
94732916|NCT05671653|324481199|FG008|Cohort 2 Period 2|Adverse Event|0|||
94732917|NCT05671653|324481200|FG009|Cohort 2 Period 2|Adverse Event|0|||
94732918|NCT05671653|324481201|FG010|Cohort 2 Period 2|Adverse Event|1|||
94732919|NCT05671653|324481202|FG011|Cohort 2 Period 2|Adverse Event|0|||
94732920|NCT05671653|324481203|FG012|Cohort 2 Period 2|Adverse Event|0|||
94732921|NCT05671653|324481191|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
94732922|NCT05671653|324481192|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
94732923|NCT05671653|324481193|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
94732924|NCT05671653|324481194|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
94732925|NCT05671653|324481195|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
94732926|NCT05671653|324481196|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
94732927|NCT05671653|324481197|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
94732928|NCT05671653|324481198|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
94732929|NCT05671653|324481199|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
94732930|NCT05671653|324481200|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
94732931|NCT05671653|324481201|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
94732932|NCT05671653|324481202|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
94732933|NCT05671653|324481203|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
94732934|NCT05671653|324481191|FG000|Cohort 2 Period 2|Pregnancy|0|||
94732935|NCT05671653|324481192|FG001|Cohort 2 Period 2|Pregnancy|0|||
94732936|NCT05671653|324481193|FG002|Cohort 2 Period 2|Pregnancy|0|||
94732937|NCT05671653|324481194|FG003|Cohort 2 Period 2|Pregnancy|0|||
94732938|NCT05671653|324481195|FG004|Cohort 2 Period 2|Pregnancy|0|||
94732939|NCT05671653|324481196|FG005|Cohort 2 Period 2|Pregnancy|0|||
94732940|NCT05671653|324481197|FG006|Cohort 2 Period 2|Pregnancy|0|||
94732941|NCT05671653|324481198|FG007|Cohort 2 Period 2|Pregnancy|0|||
94732942|NCT05671653|324481199|FG008|Cohort 2 Period 2|Pregnancy|0|||
94732943|NCT05671653|324481200|FG009|Cohort 2 Period 2|Pregnancy|0|||
94732944|NCT05671653|324481201|FG010|Cohort 2 Period 2|Pregnancy|1|||
94732945|NCT05671653|324481202|FG011|Cohort 2 Period 2|Pregnancy|0|||
94732946|NCT05671653|324481203|FG012|Cohort 2 Period 2|Pregnancy|0|||
94732947|NCT05671653|324481191|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
94732948|NCT05671653|324481192|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
94732949|NCT05671653|324481193|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
94732950|NCT05671653|324481194|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
94732951|NCT05671653|324481195|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
94732952|NCT05671653|324481196|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
94368707|NCT00837577|323136528|FG000|Double-blind Period|Withdrawal by Subject|1|||
94732953|NCT05671653|324481197|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
94732954|NCT05671653|324481198|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
94732955|NCT05671653|324481199|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
94732956|NCT05671653|324481200|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
94732957|NCT05671653|324481201|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
94732958|NCT05671653|324481202|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
94732959|NCT05671653|324481203|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
94732960|NCT05671653|324481191|FG000|Cohort 2 Period 2|Other|0|||
94732961|NCT05671653|324481192|FG001|Cohort 2 Period 2|Other|0|||
94732962|NCT05671653|324481193|FG002|Cohort 2 Period 2|Other|0|||
94732963|NCT05671653|324481194|FG003|Cohort 2 Period 2|Other|0|||
94732964|NCT05671653|324481195|FG004|Cohort 2 Period 2|Other|0|||
94732965|NCT05671653|324481196|FG005|Cohort 2 Period 2|Other|0|||
94732966|NCT05671653|324481197|FG006|Cohort 2 Period 2|Other|0|||
94732967|NCT05671653|324481198|FG007|Cohort 2 Period 2|Other|0|||
94732968|NCT05671653|324481199|FG008|Cohort 2 Period 2|Other|0|||
94732969|NCT05671653|324481200|FG009|Cohort 2 Period 2|Other|0|||
94732970|NCT05671653|324481201|FG010|Cohort 2 Period 2|Other|1|||
94732971|NCT05671653|324481202|FG011|Cohort 2 Period 2|Other|0|||
94732972|NCT05671653|324481203|FG012|Cohort 2 Period 2|Other|0|||
94732973|NCT05671653|324481191|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
94732974|NCT05671653|324481192|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
94732975|NCT05671653|324481193|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
94732976|NCT05671653|324481194|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
94732977|NCT05671653|324481195|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
94732978|NCT05671653|324481196|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
94732979|NCT05671653|324481197|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
94732980|NCT05671653|324481198|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
94732981|NCT05671653|324481199|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
94732982|NCT05671653|324481200|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
94732983|NCT05671653|324481201|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
94732984|NCT05671653|324481202|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
94732985|NCT05671653|324481203|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
94732986|NCT03974178|324481205|FG000|Overall Study|Death|0|||
94732987|NCT03974178|324481206|FG001|Overall Study|Death|1|||
94732988|NCT03899259|324481210|FG000|Overall Study|Adverse Event|5|||
94732989|NCT03899259|324481211|FG001|Overall Study|Adverse Event|4|||
94732990|NCT03899259|324481212|FG002|Overall Study|Adverse Event|6|||
94732991|NCT03899259|324481210|FG000|Overall Study|Lack of Efficacy|5|||
94732992|NCT03899259|324481211|FG001|Overall Study|Lack of Efficacy|0|||
94732993|NCT03899259|324481212|FG002|Overall Study|Lack of Efficacy|2|||
94732994|NCT03899259|324481210|FG000|Overall Study|Pregnancy|3|||
94732995|NCT03899259|324481211|FG001|Overall Study|Pregnancy|0|||
94732996|NCT03899259|324481212|FG002|Overall Study|Pregnancy|1|||
94732997|NCT03899259|324481210|FG000|Overall Study|Physician Decision|0|||
94732998|NCT03899259|324481211|FG001|Overall Study|Physician Decision|1|||
94732999|NCT03899259|324481212|FG002|Overall Study|Physician Decision|0|||
94733000|NCT03899259|324481210|FG000|Overall Study|Protocol Deviation|1|||
94733001|NCT03899259|324481211|FG001|Overall Study|Protocol Deviation|1|||
94733002|NCT03899259|324481212|FG002|Overall Study|Protocol Deviation|1|||
94733003|NCT03899259|324481210|FG000|Overall Study|Withdrawal by Subject|8|||
94733004|NCT03899259|324481211|FG001|Overall Study|Withdrawal by Subject|10|||
94733005|NCT03899259|324481212|FG002|Overall Study|Withdrawal by Subject|12|||
94733006|NCT03899259|324481210|FG000|Overall Study|Lost to Follow-up|5|||
94733007|NCT03899259|324481211|FG001|Overall Study|Lost to Follow-up|6|||
94733008|NCT03899259|324481212|FG002|Overall Study|Lost to Follow-up|2|||
94733009|NCT03899259|324481210|FG000|Overall Study|Lack of Adherence|1|||
94733010|NCT03899259|324481211|FG001|Overall Study|Lack of Adherence|0|||
94733011|NCT03899259|324481212|FG002|Overall Study|Lack of Adherence|0|||
94733012|NCT03899259|324481210|FG000|Overall Study|Screen Failure|1|||
94733013|NCT03899259|324481211|FG001|Overall Study|Screen Failure|0|||
94733014|NCT03899259|324481212|FG002|Overall Study|Screen Failure|0|||
94733015|NCT03899259|324481210|FG000|Overall Study|Ongoing Study Participation|127|||
94733016|NCT03899259|324481211|FG001|Overall Study|Ongoing Study Participation|134|||
94733017|NCT03899259|324481212|FG002|Overall Study|Ongoing Study Participation|210|||
94733018|NCT01152450|324481215|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
94733019|NCT01152450|324481216|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
94733020|NCT01152450|324481217|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
94733021|NCT01152450|324481218|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
94733022|NCT01152450|324481219|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
94733023|NCT01152450|324481220|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
94733024|NCT01152450|324481215|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
94733025|NCT01152450|324481216|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
94733026|NCT01152450|324481217|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
94733027|NCT01152450|324481218|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
94733028|NCT01152450|324481219|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
94733029|NCT01152450|324481220|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
94733030|NCT01152450|324481215|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
94733031|NCT01152450|324481216|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
94733032|NCT01152450|324481217|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
94733033|NCT01152450|324481218|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
94733034|NCT01152450|324481219|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
94733035|NCT01152450|324481220|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
94733036|NCT04508309|324481226|FG000|Overall Study|Death|0|||
94733037|NCT04508309|324481227|FG001|Overall Study|Death|0|||
94733038|NCT04508309|324481228|FG002|Overall Study|Death|0|||
94733039|NCT04508309|324481229|FG003|Overall Study|Death|0|||
94733040|NCT04508309|324481230|FG004|Overall Study|Death|1|||
94368708|NCT00837577|323136529|FG001|Double-blind Period|Withdrawal by Subject|0|||
94368709|NCT00837577|323136528|FG000|Open-label Period|Clinical Adverse Event|2|||
94733041|NCT04508309|324481226|FG000|Overall Study|Lost to Follow-up|0|||
94733042|NCT04508309|324481227|FG001|Overall Study|Lost to Follow-up|0|||
94733043|NCT04508309|324481228|FG002|Overall Study|Lost to Follow-up|1|||
94733044|NCT04508309|324481229|FG003|Overall Study|Lost to Follow-up|1|||
94733045|NCT04508309|324481230|FG004|Overall Study|Lost to Follow-up|0|||
94733046|NCT04508309|324481226|FG000|Overall Study|Withdrawal by Subject|0|||
94733047|NCT04508309|324481227|FG001|Overall Study|Withdrawal by Subject|0|||
94733048|NCT04508309|324481228|FG002|Overall Study|Withdrawal by Subject|0|||
94733049|NCT04508309|324481229|FG003|Overall Study|Withdrawal by Subject|0|||
94733050|NCT04508309|324481230|FG004|Overall Study|Withdrawal by Subject|1|||
94733051|NCT02460458|324481236|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
94733052|NCT02460458|324481236|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
94733053|NCT02460458|324481236|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
94733054|NCT02460458|324481236|FG000|First Prospective Phase|Lost to Follow-up|84|||
94733055|NCT02460458|324481236|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
94733056|NCT00950742|324481237|FG000|Overall Study|Other Adverse Event|1|||
94733057|NCT00950742|324481238|FG001|Overall Study|Other Adverse Event|0|||
94733058|NCT00950742|324481237|FG000|Overall Study|Withdrawal by Subject|3|||
94733059|NCT00950742|324481238|FG001|Overall Study|Withdrawal by Subject|0|||
94733060|NCT00950742|324481237|FG000|Overall Study|Progressive Disease|6|||
94733061|NCT00950742|324481238|FG001|Overall Study|Progressive Disease|2|||
94733062|NCT00950742|324481237|FG000|Overall Study|Dose limiting toxicity|6|||
94733063|NCT00950742|324481238|FG001|Overall Study|Dose limiting toxicity|0|||
94733064|NCT02433379|324481239|FG000|Overall Study|Screen Failures|55|||
94733065|NCT02433379|324481239|FG000|Overall Study|Death|57|||
94733066|NCT02433379|324481239|FG000|Overall Study|Total Withdrawals|209|||
94733067|NCT03952338|324481240|FG000|Overall Study|Lost to Follow-up|11|||
94733068|NCT03952338|324481241|FG001|Overall Study|Lost to Follow-up|17|||
94733069|NCT03952338|324481240|FG000|Overall Study|Withdrawal by Subject|1|||
94733070|NCT03952338|324481241|FG001|Overall Study|Withdrawal by Subject|1|||
94733071|NCT03952338|324481240|FG000|Overall Study|Protocol Violation|1|||
94733072|NCT03952338|324481241|FG001|Overall Study|Protocol Violation|0|||
94733073|NCT03701763|324481242|FG000|Placebo-controlled Phase|Adverse Event|1|||
94733074|NCT03701763|324481243|FG001|Placebo-controlled Phase|Adverse Event|5|||
94733075|NCT03701763|324481244|FG002|Placebo-controlled Phase|Adverse Event|0|||
94733076|NCT03701763|324481245|FG003|Placebo-controlled Phase|Adverse Event|0|||
94733077|NCT03701763|324481242|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
94733078|NCT03701763|324481243|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
94733079|NCT03701763|324481244|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
94733080|NCT03701763|324481245|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
94733081|NCT03701763|324481242|FG000|Placebo-controlled Phase|Miscellaneous|2|||
94733082|NCT03701763|324481243|FG001|Placebo-controlled Phase|Miscellaneous|0|||
94733083|NCT03701763|324481244|FG002|Placebo-controlled Phase|Miscellaneous|0|||
94368710|NCT00837577|323136529|FG001|Open-label Period|Clinical Adverse Event|2|||
94733084|NCT03701763|324481245|FG003|Placebo-controlled Phase|Miscellaneous|0|||
94733085|NCT03701763|324481242|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
94733086|NCT03701763|324481243|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
94733087|NCT03701763|324481244|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
94733088|NCT03701763|324481245|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
94733089|NCT03701763|324481242|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
94733090|NCT03701763|324481243|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
94733091|NCT03701763|324481244|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
94733092|NCT03701763|324481245|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
94733093|NCT03701763|324481242|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
94733094|NCT03701763|324481243|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
94733095|NCT03701763|324481244|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
94733096|NCT03701763|324481245|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
94733097|NCT03701763|324481242|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
94733098|NCT03701763|324481243|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
94733099|NCT03701763|324481244|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
94733100|NCT03701763|324481245|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
94733101|NCT03701763|324481242|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
94368711|NCT00837577|323136528|FG000|Open-label Period|Laboratory Adverse Event|0|||
94368712|NCT00837577|323136529|FG001|Open-label Period|Laboratory Adverse Event|1|||
94368713|NCT00837577|323136528|FG000|Open-label Period|Lack of Efficacy|4|||
94368714|NCT00837577|323136529|FG001|Open-label Period|Lack of Efficacy|3|||
94368715|NCT00837577|323136528|FG000|Open-label Period|Withdrawal by Subject|1|||
94368716|NCT00837577|323136529|FG001|Open-label Period|Withdrawal by Subject|2|||
94733102|NCT03701763|324481243|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
94733103|NCT03701763|324481244|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
94733104|NCT03701763|324481245|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
94733105|NCT03701763|324481242|FG000|Apremilast Extension Phase|Adverse Event|0|||
94733106|NCT03701763|324481243|FG001|Apremilast Extension Phase|Adverse Event|0|||
94733107|NCT03701763|324481244|FG002|Apremilast Extension Phase|Adverse Event|3|||
94733108|NCT03701763|324481245|FG003|Apremilast Extension Phase|Adverse Event|1|||
94733109|NCT03701763|324481242|FG000|Apremilast Extension Phase|Miscellaneous|0|||
94733110|NCT03701763|324481243|FG001|Apremilast Extension Phase|Miscellaneous|0|||
94733111|NCT03701763|324481244|FG002|Apremilast Extension Phase|Miscellaneous|2|||
94733112|NCT03701763|324481245|FG003|Apremilast Extension Phase|Miscellaneous|1|||
94733113|NCT03701763|324481242|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
94733114|NCT03701763|324481243|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
94733115|NCT03701763|324481244|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
94733116|NCT03701763|324481245|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
94733117|NCT03701763|324481242|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
94733118|NCT03701763|324481243|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
94733119|NCT03701763|324481244|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
94733120|NCT03701763|324481245|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
94733121|NCT03701763|324481242|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
94733122|NCT03701763|324481243|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
94733123|NCT03701763|324481244|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
94733124|NCT03701763|324481245|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
94733125|NCT03701763|324481242|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
94733126|NCT03701763|324481243|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
94733127|NCT03701763|324481244|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
94733128|NCT03701763|324481245|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
94733129|NCT03701763|324481242|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
94733130|NCT03701763|324481243|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
94733131|NCT03701763|324481244|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
94733132|NCT03701763|324481245|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
94733133|NCT03701763|324481242|FG000|14-Week Observational Follow-up Phase|Other|0|||
94733134|NCT03701763|324481243|FG001|14-Week Observational Follow-up Phase|Other|0|||
94733135|NCT03701763|324481244|FG002|14-Week Observational Follow-up Phase|Other|1|||
94733136|NCT03701763|324481245|FG003|14-Week Observational Follow-up Phase|Other|0|||
94733137|NCT03701763|324481242|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
94733138|NCT03701763|324481243|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
94733139|NCT03701763|324481244|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
94733140|NCT03701763|324481245|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
94733141|NCT03701763|324481242|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
94733142|NCT03701763|324481243|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
94733143|NCT03701763|324481244|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
94733144|NCT03701763|324481245|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
94733145|NCT05070728|324481248|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
94733146|NCT05070728|324481249|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
94733147|NCT03852719|324481250|FG000|Overall Study|Still on study after Week 192|37|||
94733148|NCT03852719|324481251|FG001|Overall Study|Still on study after Week 192|35|||
94733149|NCT03852719|324481252|FG002|Overall Study|Still on study after Week 192|35|||
94733150|NCT03852719|324481250|FG000|Overall Study|Withdrawal of consent|5|||
94733151|NCT03852719|324481251|FG001|Overall Study|Withdrawal of consent|8|||
94733152|NCT03852719|324481252|FG002|Overall Study|Withdrawal of consent|7|||
94733153|NCT03852719|324481250|FG000|Overall Study|Physician Decision|0|||
94733154|NCT03852719|324481251|FG001|Overall Study|Physician Decision|1|||
94368717|NCT00837577|323136528|FG000|Open-label Period|Other Reason|1|||
94368718|NCT00837577|323136529|FG001|Open-label Period|Other Reason|1|||
94368719|NCT02567266|323136530|FG000|Overall Study|Withdrawal by Subject|10|||
94368720|NCT02567266|323136531|FG001|Overall Study|Withdrawal by Subject|7|||
94368721|NCT02567266|323136532|FG002|Overall Study|Withdrawal by Subject|6|||
94368722|NCT02567266|323136530|FG000|Overall Study|Lost to Follow-up|13|||
94368723|NCT02567266|323136531|FG001|Overall Study|Lost to Follow-up|8|||
94368724|NCT02567266|323136532|FG002|Overall Study|Lost to Follow-up|10|||
94368725|NCT04476017|323136533|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
94368726|NCT04476017|323136534|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
94368727|NCT01706770|323136535|FG000|Overall Study|Lost to Follow-up|1|||
94368728|NCT01706770|323136536|FG001|Overall Study|Lost to Follow-up|0|||
94368729|NCT01706770|323136535|FG000|Overall Study|Physician Decision|1|||
94368730|NCT01706770|323136536|FG001|Overall Study|Physician Decision|0|||
94368731|NCT01749033|323136538|FG000|Overall Study|Did not receive allocated intervention|3|||
94368732|NCT01749033|323136539|FG001|Overall Study|Did not receive allocated intervention|3|||
94368733|NCT01749033|323136540|FG002|Overall Study|Did not receive allocated intervention|0|||
94368734|NCT01749033|323136538|FG000|Overall Study|Lost to Follow-up|0|||
94368735|NCT01749033|323136539|FG001|Overall Study|Lost to Follow-up|2|||
94368736|NCT01749033|323136540|FG002|Overall Study|Lost to Follow-up|1|||
94368737|NCT00061945|323136541|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
94368738|NCT00061945|323136542|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
94368739|NCT00061945|323136541|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
94368740|NCT00061945|323136542|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
94368741|NCT00061945|323136541|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
94368742|NCT00061945|323136542|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
94368743|NCT00061945|323136541|FG000|Course IV: Alemtuzumab|Early exits|6|||
94368744|NCT00061945|323136542|FG001|Course IV: Alemtuzumab|Early exits|15|||
94368745|NCT03276962|323136543|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
94368746|NCT03276962|323136544|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
94368747|NCT03276962|323136545|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
94368748|NCT03276962|323136546|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
94368749|NCT03276962|323136547|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
94368750|NCT03276962|323136543|FG000|Overall Study|Protocol Deviation|2|||
94368751|NCT03276962|323136544|FG001|Overall Study|Protocol Deviation|0|||
94368752|NCT03276962|323136545|FG002|Overall Study|Protocol Deviation|1|||
94368753|NCT03276962|323136546|FG003|Overall Study|Protocol Deviation|2|||
94368754|NCT03276962|323136547|FG004|Overall Study|Protocol Deviation|1|||
94368755|NCT03276962|323136543|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
94368756|NCT03276962|323136544|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
94733155|NCT03852719|324481252|FG002|Overall Study|Physician Decision|1|||
94733156|NCT03852719|324481250|FG000|Overall Study|Pregnancy|2|||
94733157|NCT03852719|324481251|FG001|Overall Study|Pregnancy|1|||
94733158|NCT03852719|324481252|FG002|Overall Study|Pregnancy|0|||
94733159|NCT03852719|324481250|FG000|Overall Study|Death|1|||
94733160|NCT03852719|324481251|FG001|Overall Study|Death|0|||
94733161|NCT03852719|324481252|FG002|Overall Study|Death|0|||
94733162|NCT03852719|324481250|FG000|Overall Study|Reason not Specified|3|||
94733163|NCT03852719|324481251|FG001|Overall Study|Reason not Specified|2|||
94733164|NCT03852719|324481252|FG002|Overall Study|Reason not Specified|2|||
94733165|NCT03852719|324481250|FG000|Overall Study|Adverse Event|1|||
94733166|NCT03852719|324481251|FG001|Overall Study|Adverse Event|0|||
94733167|NCT03852719|324481252|FG002|Overall Study|Adverse Event|4|||
94733168|NCT03852719|324481250|FG000|Overall Study|Progressive disease|1|||
94733169|NCT03852719|324481251|FG001|Overall Study|Progressive disease|2|||
94733170|NCT03852719|324481252|FG002|Overall Study|Progressive disease|1|||
94733171|NCT03852719|324481250|FG000|Overall Study|Lost to Follow-up|1|||
94733172|NCT03852719|324481251|FG001|Overall Study|Lost to Follow-up|0|||
94733173|NCT03852719|324481252|FG002|Overall Study|Lost to Follow-up|0|||
94733174|NCT02589795|324481253|FG000|Overall Study|Lost to Follow-up|1|||
94733175|NCT02589795|324481254|FG001|Overall Study|Lost to Follow-up|0|||
94733176|NCT02589795|324481255|FG002|Overall Study|Lost to Follow-up|0|||
94733177|NCT02589795|324481253|FG000|Overall Study|Withdrawal by Subject|0|||
94733178|NCT02589795|324481254|FG001|Overall Study|Withdrawal by Subject|0|||
94733179|NCT02589795|324481255|FG002|Overall Study|Withdrawal by Subject|2|||
94733180|NCT02589795|324481253|FG000|Overall Study|Protocol Violation|0|||
94733181|NCT02589795|324481254|FG001|Overall Study|Protocol Violation|0|||
94733182|NCT02589795|324481255|FG002|Overall Study|Protocol Violation|1|||
94733183|NCT04550221|324481256|FG000|Overall Study|Lost to Follow-up|0|||
94733184|NCT04550221|324481257|FG001|Overall Study|Lost to Follow-up|4|||
94733185|NCT04550221|324481256|FG000|Overall Study|Withdrawn|3|||
94733186|NCT04550221|324481257|FG001|Overall Study|Withdrawn|0|||
94733187|NCT04550221|324481256|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
94733188|NCT04550221|324481257|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
94733189|NCT04811040|324481258|FG000|Overall Study|Lost to Follow-up|2|||
94733190|NCT04811040|324481259|FG001|Overall Study|Lost to Follow-up|0|||
94733191|NCT04811040|324481260|FG002|Overall Study|Lost to Follow-up|0|||
94733192|NCT04811040|324481261|FG003|Overall Study|Lost to Follow-up|0|||
94733193|NCT04811040|324481258|FG000|Overall Study|Withdrew consent|1|||
94733194|NCT04811040|324481259|FG001|Overall Study|Withdrew consent|1|||
94733195|NCT04811040|324481260|FG002|Overall Study|Withdrew consent|0|||
94733196|NCT04811040|324481261|FG003|Overall Study|Withdrew consent|0|||
94733197|NCT05194956|324481262|FG000|Washout Period|Withdrawal by Subject|0|||
94733198|NCT05194956|324481263|FG001|Washout Period|Withdrawal by Subject|2|||
94733199|NCT05246670|324481277|FG000|Overall Study|Withdrawal by Subject|2|||
94733200|NCT05246670|324481278|FG001|Overall Study|Withdrawal by Subject|3|||
94733201|NCT05246670|324481279|FG002|Overall Study|Withdrawal by Subject|0|||
94733202|NCT05246670|324481280|FG003|Overall Study|Withdrawal by Subject|1|||
94733203|NCT05246670|324481277|FG000|Overall Study|Adverse Event|0|||
94733204|NCT05246670|324481278|FG001|Overall Study|Adverse Event|0|||
94733205|NCT05246670|324481279|FG002|Overall Study|Adverse Event|1|||
94733206|NCT05246670|324481280|FG003|Overall Study|Adverse Event|0|||
94733207|NCT05246670|324481277|FG000|Overall Study|Physician Decision|1|||
94733208|NCT05246670|324481278|FG001|Overall Study|Physician Decision|0|||
94733209|NCT05246670|324481279|FG002|Overall Study|Physician Decision|0|||
94733210|NCT05246670|324481280|FG003|Overall Study|Physician Decision|0|||
94733211|NCT05246670|324481277|FG000|Overall Study|Protocol Violation|1|||
94733212|NCT05246670|324481278|FG001|Overall Study|Protocol Violation|0|||
94733213|NCT05246670|324481279|FG002|Overall Study|Protocol Violation|0|||
94733214|NCT05246670|324481280|FG003|Overall Study|Protocol Violation|0|||
94733215|NCT05446870|324481284|FG000|Overall Study|Death|6|||
94733216|NCT05446870|324481285|FG001|Overall Study|Death|2|||
94733217|NCT05446870|324481284|FG000|Overall Study|Lost to Follow-up|0|||
94733218|NCT05446870|324481285|FG001|Overall Study|Lost to Follow-up|1|||
94733219|NCT05446870|324481284|FG000|Overall Study|Physician Decision|27|||
94733220|NCT05446870|324481285|FG001|Overall Study|Physician Decision|25|||
94733221|NCT05446870|324481284|FG000|Overall Study|Withdrawal by Subject|3|||
94733222|NCT05446870|324481285|FG001|Overall Study|Withdrawal by Subject|2|||
94733223|NCT05446870|324481284|FG000|Overall Study|Study Ongoing|37|||
94733224|NCT05446870|324481285|FG001|Overall Study|Study Ongoing|43|||
94733225|NCT05485779|324481290|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
94733226|NCT05485779|324481291|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
94274286|NCT01979536|322795798|FG000|Overall Study|Did not start treatment|0|||
94274287|NCT01979536|322795799|FG001|Overall Study|Did not start treatment|1|||
94274288|NCT04360551|322797326|FG000|Overall Study|Withdrawal by Subject|1|||
94274289|NCT04360551|322797327|FG001|Overall Study|Withdrawal by Subject|0|||
94274290|NCT02322125|322797328|FG000|Overall Study|Withdrawal by Subject|2|||
94274291|NCT00736255|322797329|FG000|Overall Study|Adverse Event|1|||
94274292|NCT00736255|322797330|FG001|Overall Study|Adverse Event|0|||
94274293|NCT00736255|322797329|FG000|Overall Study|Physician Decision|1|||
94274294|NCT00736255|322797330|FG001|Overall Study|Physician Decision|0|||
94274295|NCT00736255|322797329|FG000|Overall Study|Non-compliance|1|||
94274296|NCT00736255|322797330|FG001|Overall Study|Non-compliance|1|||
94274297|NCT01439282|322797331|FG000|Overall Study|Adverse Event|5|||
94274298|NCT01439282|322797332|FG001|Overall Study|Adverse Event|0|||
94274299|NCT01439282|322797331|FG000|Overall Study|Withdrawal by Subject|2|||
94274300|NCT01439282|322797332|FG001|Overall Study|Withdrawal by Subject|0|||
94274301|NCT01439282|322797331|FG000|Overall Study|Other|1|||
94274302|NCT01439282|322797332|FG001|Overall Study|Other|1|||
94274303|NCT02232802|322797333|FG000|Period 1|Sponsor request|1|||
94274304|NCT02232802|322797334|FG001|Period 1|Sponsor request|0|||
94274305|NCT02232802|322797333|FG000|Period 1|Adverse Event|1|||
94274306|NCT02232802|322797334|FG001|Period 1|Adverse Event|1|||
94274307|NCT01183143|322797340|FG000|Overall Study|Protocol Violation|115|||
94274308|NCT01183143|322797340|FG000|Overall Study|Withdrawal by Subject|19|||
94274309|NCT01183143|322797340|FG000|Overall Study|Subject Questionnaires not returned|5|||
94274310|NCT01183143|322797340|FG000|Overall Study|Subjects enrolled, but not treated|11|||
94274311|NCT00346073|322797342|FG000|Overall Study|Serious Adverse Event|2|||
94274312|NCT00346073|322797343|FG001|Overall Study|Serious Adverse Event|0|||
94274313|NCT00346073|322797342|FG000|Overall Study|Lost to Follow-up|39|||
94274314|NCT00346073|322797343|FG001|Overall Study|Lost to Follow-up|24|||
94274315|NCT01617460|322797344|FG000|Overall Study|Adverse Event|10|||
94274316|NCT01617460|322797344|FG000|Overall Study|Physician Decision|16|||
94274317|NCT01617460|322797344|FG000|Overall Study|Protocol Violation|5|||
94274318|NCT01617460|322797344|FG000|Overall Study|Withdrawal by Subject|9|||
94274319|NCT01566773|322797345|FG000|Overall Study|Protocol specified criteria|4|||
94274320|NCT01566773|322797345|FG000|Overall Study|Protocol Violation|4|||
94274321|NCT01566773|322797345|FG000|Overall Study|Withdrawal by Subject|9|||
94274322|NCT01566773|322797345|FG000|Overall Study|Administrative reason|1|||
94274323|NCT01566773|322797345|FG000|Overall Study|Adverse Event|10|||
94274324|NCT01566773|322797345|FG000|Overall Study|Physician Decision|2|||
94274325|NCT01239342|322797346|FG000|Overall Study|Adverse Event|1|||
94274326|NCT01239342|322797347|FG001|Overall Study|Adverse Event|0|||
94274327|NCT01239342|322797346|FG000|Overall Study|Withdrawal by Subject|1|||
94274328|NCT01239342|322797347|FG001|Overall Study|Withdrawal by Subject|5|||
94274329|NCT01239342|322797346|FG000|Overall Study|Reason Unknown|1|||
94274330|NCT01239342|322797347|FG001|Overall Study|Reason Unknown|1|||
94274331|NCT02187172|322797348|FG000|Overall Study|Lost to Follow-up|1|||
94274332|NCT02187172|322797349|FG001|Overall Study|Lost to Follow-up|2|||
94274333|NCT02187172|322797348|FG000|Overall Study|Lack of Efficacy|1|||
94274334|NCT02187172|322797349|FG001|Overall Study|Lack of Efficacy|2|||
94733227|NCT05485779|324481292|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
94733228|NCT05485779|324481293|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
94733229|NCT05485779|324481294|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
94733230|NCT05485779|324481295|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
94733231|NCT05485779|324481296|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
94733232|NCT05485779|324481297|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
94733233|NCT05485779|324481298|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
94733234|NCT05485779|324481299|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
94733235|NCT05485779|324481300|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
94733236|NCT05485779|324481290|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
94733237|NCT05485779|324481291|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
94733238|NCT05485779|324481292|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
94733239|NCT05485779|324481293|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
94733240|NCT05485779|324481294|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
94274335|NCT02187172|322797348|FG000|Overall Study|Adverse Event|0|||
94274336|NCT02187172|322797349|FG001|Overall Study|Adverse Event|1|||
94274337|NCT02187172|322797348|FG000|Overall Study|Physician Decision|1|||
94274338|NCT02187172|322797349|FG001|Overall Study|Physician Decision|1|||
94274339|NCT01111851|322797352|FG000|Overall Study|All planned PET scans were not obtained.|2|||
94274340|NCT01111851|322797353|FG001|Overall Study|All planned PET scans were not obtained.|0|||
94274341|NCT01967628|322797361|FG000|Overall Study|Withdrawal by Subject|2|||
94274342|NCT01967628|322797362|FG001|Overall Study|Withdrawal by Subject|0|||
94274343|NCT01967628|322797361|FG000|Overall Study|Unable to complete bronchoscopy|4|||
94733241|NCT05485779|324481295|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
94733242|NCT05485779|324481296|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
94733243|NCT05485779|324481297|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
94733244|NCT05485779|324481298|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
94733245|NCT05485779|324481299|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
94467432|NCT04015518|323500562|FG001|Overall Study|Patient did not come for consecutive visits|1|||
94467433|NCT04015518|323500563|FG002|Overall Study|Patient did not come for consecutive visits|0|||
94467434|NCT04015518|323500564|FG003|Overall Study|Patient did not come for consecutive visits|0|||
94467435|NCT04015518|323500565|FG004|Overall Study|Patient did not come for consecutive visits|0|||
94467436|NCT04015518|323500561|FG000|Overall Study|not willing to travel due to Covid-19|0|||
94467437|NCT04015518|323500562|FG001|Overall Study|not willing to travel due to Covid-19|0|||
94467438|NCT04015518|323500563|FG002|Overall Study|not willing to travel due to Covid-19|1|||
94467439|NCT04015518|323500564|FG003|Overall Study|not willing to travel due to Covid-19|0|||
94467440|NCT04015518|323500565|FG004|Overall Study|not willing to travel due to Covid-19|0|||
94467441|NCT04015518|323500561|FG000|Overall Study|Patient wants to discontinue treatment|0|||
94467442|NCT04015518|323500562|FG001|Overall Study|Patient wants to discontinue treatment|0|||
94467443|NCT04015518|323500563|FG002|Overall Study|Patient wants to discontinue treatment|0|||
94467444|NCT04015518|323500564|FG003|Overall Study|Patient wants to discontinue treatment|1|||
94467445|NCT04015518|323500565|FG004|Overall Study|Patient wants to discontinue treatment|0|||
94467446|NCT04015518|323500561|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
94733246|NCT05485779|324481300|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
94467447|NCT04015518|323500562|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
94733247|NCT05485779|324481290|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
94733248|NCT05485779|324481291|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
94733249|NCT05485779|324481292|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
94733250|NCT05485779|324481293|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
94733251|NCT05485779|324481294|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
94467448|NCT04015518|323500563|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
94733252|NCT05485779|324481295|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
94733253|NCT05485779|324481296|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
94733254|NCT05485779|324481297|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
94733255|NCT05485779|324481298|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
94733256|NCT05485779|324481299|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
94274344|NCT01967628|322797362|FG001|Overall Study|Unable to complete bronchoscopy|6|||
94274345|NCT01967628|322797361|FG000|Overall Study|Lost to Follow-up|1|||
94274346|NCT01967628|322797362|FG001|Overall Study|Lost to Follow-up|0|||
94274347|NCT01967628|322797361|FG000|Overall Study|Low protein concentration in sample|20|||
94274348|NCT01967628|322797362|FG001|Overall Study|Low protein concentration in sample|25|||
94274349|NCT04712110|322797363|FG000|Overall Study|Lost to Follow-up|0|||
94274350|NCT04712110|322797364|FG001|Overall Study|Lost to Follow-up|1|||
94274351|NCT04712110|322797363|FG000|Overall Study|Withdrawal by Subject|0|||
94274352|NCT04712110|322797364|FG001|Overall Study|Withdrawal by Subject|4|||
94274353|NCT04712110|322797363|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
94274354|NCT04712110|322797364|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
94274355|NCT01197521|322797369|FG000|Overall Study|Not reported|24|||
94274356|NCT01197521|322797370|FG001|Overall Study|Not reported|25|||
94274357|NCT01197521|322797371|FG002|Overall Study|Not reported|21|||
94274358|NCT01197521|322797369|FG000|Overall Study|Enrolment in long term extension|42|||
94274359|NCT01197521|322797370|FG001|Overall Study|Enrolment in long term extension|36|||
94274360|NCT01197521|322797371|FG002|Overall Study|Enrolment in long term extension|87|||
94274361|NCT01197521|322797369|FG000|Overall Study|Severe non-compliance to protocol|1|||
94274362|NCT01197521|322797370|FG001|Overall Study|Severe non-compliance to protocol|3|||
94274363|NCT01197521|322797371|FG002|Overall Study|Severe non-compliance to protocol|3|||
94274364|NCT01197521|322797369|FG000|Overall Study|Lack of therapeutic response|2|||
94274365|NCT01197521|322797370|FG001|Overall Study|Lack of therapeutic response|3|||
94274366|NCT01197521|322797371|FG002|Overall Study|Lack of therapeutic response|4|||
94274367|NCT01197521|322797369|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
94274368|NCT01197521|322797370|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
94274369|NCT01197521|322797371|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
94274370|NCT01197521|322797369|FG000|Overall Study|Lost to Follow-up|3|||
94274371|NCT01197521|322797370|FG001|Overall Study|Lost to Follow-up|2|||
94274372|NCT01197521|322797371|FG002|Overall Study|Lost to Follow-up|2|||
94274373|NCT01197521|322797369|FG000|Overall Study|Adverse Event|25|||
94274374|NCT01197521|322797370|FG001|Overall Study|Adverse Event|28|||
94274375|NCT01197521|322797371|FG002|Overall Study|Adverse Event|24|||
94274376|NCT03462576|322797373|FG000|Overall Study|Protocol Violation|5|||
94274377|NCT03462576|322797374|FG001|Overall Study|Protocol Violation|11|||
94274378|NCT03462576|322797375|FG002|Overall Study|Protocol Violation|7|||
94274379|NCT03462576|322797373|FG000|Overall Study|Device Malfunction|0|||
94274380|NCT03462576|322797374|FG001|Overall Study|Device Malfunction|0|||
94274381|NCT03462576|322797375|FG002|Overall Study|Device Malfunction|1|||
94274382|NCT03201458|322797376|FG000|Overall Study|No longer eligible|2|||
94733257|NCT05485779|324481300|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
94733258|NCT05318937|324481305|FG000|Overall Study|Non-Compliance with Study Drug|1|||
94733259|NCT05318937|324481306|FG001|Overall Study|Non-Compliance with Study Drug|0|||
94733260|NCT05318937|324481305|FG000|Overall Study|Lost to Follow-up|0|||
94733261|NCT05318937|324481306|FG001|Overall Study|Lost to Follow-up|1|||
94733262|NCT05318937|324481305|FG000|Overall Study|Withdrawal by Subject|0|||
94733263|NCT05318937|324481306|FG001|Overall Study|Withdrawal by Subject|2|||
94733264|NCT05318937|324481305|FG000|Overall Study|Protocol Violation|0|||
94733265|NCT05318937|324481306|FG001|Overall Study|Protocol Violation|1|||
94733266|NCT01868997|324481307|FG000|Overall Study|Adverse Event|2|||
94733267|NCT01868997|324481308|FG001|Overall Study|Adverse Event|5|||
94733268|NCT01868997|324481307|FG000|Overall Study|Lack of Efficacy|2|||
94733269|NCT01868997|324481308|FG001|Overall Study|Lack of Efficacy|0|||
94733270|NCT01868997|324481307|FG000|Overall Study|Other|3|||
94733271|NCT01868997|324481308|FG001|Overall Study|Other|1|||
94733272|NCT04766892|324481312|FG000|Overall Study|Withdrawal by Subject|1|||
94274383|NCT03201458|322797377|FG001|Overall Study|No longer eligible|5|||
94368757|NCT03276962|323136545|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
94368758|NCT03276962|323136546|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
94274384|NCT03201458|322797376|FG000|Overall Study|Health event before starting|1|||
94274385|NCT03201458|322797377|FG001|Overall Study|Health event before starting|0|||
94274386|NCT03201458|322797376|FG000|Overall Study|Physician Decision|1|||
94274387|NCT03201458|322797377|FG001|Overall Study|Physician Decision|0|||
94274388|NCT03962101|322797382|FG000|Overall Study|Adverse Event|1|||
94274389|NCT03962101|322797382|FG000|Overall Study|Physician Decision|2|||
94368759|NCT03276962|323136547|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
94274390|NCT03962101|322797382|FG000|Overall Study|Not related to medical events|1|||
94274391|NCT00552175|322797383|FG000|Overall Study|Lack of Efficacy|2|||
94274392|NCT00552175|322797384|FG001|Overall Study|Lack of Efficacy|0|||
94274393|NCT00552175|322797385|FG002|Overall Study|Lack of Efficacy|1|||
94274394|NCT00552175|322797383|FG000|Overall Study|Adverse Event|9|||
94274395|NCT00552175|322797384|FG001|Overall Study|Adverse Event|9|||
94274396|NCT00552175|322797385|FG002|Overall Study|Adverse Event|10|||
94274397|NCT00552175|322797383|FG000|Overall Study|Withdrawal by Subject|2|||
94274398|NCT00552175|322797384|FG001|Overall Study|Withdrawal by Subject|2|||
94274399|NCT00552175|322797385|FG002|Overall Study|Withdrawal by Subject|1|||
94274400|NCT00552175|322797383|FG000|Overall Study|Lost to Follow-up|0|||
94274401|NCT00552175|322797384|FG001|Overall Study|Lost to Follow-up|0|||
94274402|NCT00552175|322797385|FG002|Overall Study|Lost to Follow-up|1|||
94274403|NCT00552175|322797383|FG000|Overall Study|Entry Criteria Not Met|1|||
94274404|NCT00552175|322797384|FG001|Overall Study|Entry Criteria Not Met|1|||
94274405|NCT00552175|322797385|FG002|Overall Study|Entry Criteria Not Met|0|||
94274406|NCT00552175|322797383|FG000|Overall Study|Reason Not Specified|3|||
94274407|NCT00552175|322797384|FG001|Overall Study|Reason Not Specified|1|||
94274408|NCT00552175|322797385|FG002|Overall Study|Reason Not Specified|1|||
94733273|NCT04766892|324481312|FG000|Overall Study|Lost to Follow-up|1|||
94733274|NCT04766892|324481312|FG000|Overall Study|Adverse Event|3|||
94733275|NCT04766892|324481312|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
94733276|NCT06122194|324481319|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
94733277|NCT06122194|324481320|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
94733278|NCT06122194|324481321|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
94733279|NCT06122194|324481322|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
94733280|NCT04409353|324481323|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
94733281|NCT04409353|324481324|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
94733282|NCT04409353|324481325|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
94733283|NCT04409353|324481323|FG000|Overall Study|Lost to Follow-up|6|||
94733284|NCT04409353|324481324|FG001|Overall Study|Lost to Follow-up|8|||
94733285|NCT04409353|324481325|FG002|Overall Study|Lost to Follow-up|7|||
94733286|NCT04409353|324481323|FG000|Overall Study|Major surgery during participation window|4|||
94733287|NCT04409353|324481324|FG001|Overall Study|Major surgery during participation window|3|||
94733288|NCT04409353|324481325|FG002|Overall Study|Major surgery during participation window|3|||
94733289|NCT04409353|324481323|FG000|Overall Study|Life event occurred during participation window|3|||
94733290|NCT04409353|324481324|FG001|Overall Study|Life event occurred during participation window|2|||
94733291|NCT04409353|324481325|FG002|Overall Study|Life event occurred during participation window|4|||
94733292|NCT04409353|324481323|FG000|Overall Study|Lack of Efficacy|4|||
94733293|NCT04409353|324481324|FG001|Overall Study|Lack of Efficacy|1|||
94733294|NCT04409353|324481325|FG002|Overall Study|Lack of Efficacy|3|||
94733295|NCT04409353|324481323|FG000|Overall Study|Adverse Event|2|||
94733296|NCT04409353|324481324|FG001|Overall Study|Adverse Event|1|||
94733297|NCT04409353|324481325|FG002|Overall Study|Adverse Event|1|||
94733298|NCT04409353|324481323|FG000|Overall Study|Disease burden - unable to participate|0|||
94733299|NCT04409353|324481324|FG001|Overall Study|Disease burden - unable to participate|1|||
94733300|NCT04409353|324481325|FG002|Overall Study|Disease burden - unable to participate|1|||
94733301|NCT04409353|324481323|FG000|Overall Study|Intervention too complicated|1|||
94733302|NCT04409353|324481324|FG001|Overall Study|Intervention too complicated|0|||
94733303|NCT04409353|324481325|FG002|Overall Study|Intervention too complicated|1|||
94274409|NCT02614859|322797394|FG000|Overall Study|Physician Decision|0|||
94274410|NCT02614859|322797395|FG001|Overall Study|Physician Decision|1|||
94733304|NCT02315703|324481326|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
94733305|NCT02315703|324481327|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
94274411|NCT03975920|322797405|FG000|Overall Study|Lost to Follow-up|1|||
94274412|NCT03975920|322797406|FG001|Overall Study|Lost to Follow-up|2|||
94274413|NCT03975920|322797405|FG000|Overall Study|Protocol Violation|1|||
94274414|NCT03975920|322797406|FG001|Overall Study|Protocol Violation|1|||
94274415|NCT03975920|322797405|FG000|Overall Study|Did not complete survey|2|||
94274416|NCT03975920|322797406|FG001|Overall Study|Did not complete survey|1|||
94274417|NCT04251910|322797409|FG000|Overall Study|Covid 19 lockdown|0|||
94274418|NCT04251910|322797410|FG001|Overall Study|Covid 19 lockdown|5|||
94274419|NCT04251910|322797411|FG002|Overall Study|Covid 19 lockdown|0|||
94274420|NCT04251910|322797412|FG003|Overall Study|Covid 19 lockdown|4|||
94274421|NCT04251910|322797413|FG004|Overall Study|Covid 19 lockdown|0|||
94274422|NCT04251910|322797414|FG005|Overall Study|Covid 19 lockdown|0|||
94733306|NCT02315703|324481328|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
94733307|NCT02315703|324481329|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
94733308|NCT02315703|324481330|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
94733309|NCT02315703|324481331|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
94733310|NCT02315703|324481332|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
94733311|NCT02315703|324481333|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
94733312|NCT02315703|324481326|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
94733313|NCT02315703|324481327|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
94733314|NCT02315703|324481328|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
94733315|NCT02315703|324481329|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
94733316|NCT02315703|324481330|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
94733317|NCT02315703|324481331|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
94733318|NCT02315703|324481332|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
94733319|NCT02315703|324481333|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
94733320|NCT02315703|324481326|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
94733321|NCT02315703|324481327|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
94733322|NCT02315703|324481328|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
94733323|NCT02315703|324481329|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
94733324|NCT02315703|324481330|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
94733325|NCT02315703|324481331|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
94733326|NCT02315703|324481332|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
94733327|NCT02315703|324481333|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
94733328|NCT02315703|324481326|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
94733329|NCT02315703|324481327|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
94733330|NCT02315703|324481328|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
94733331|NCT02315703|324481329|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
94733332|NCT02315703|324481330|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
94733333|NCT02315703|324481331|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
94733334|NCT02315703|324481332|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
94733335|NCT02315703|324481333|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
94733336|NCT02315703|324481326|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
94733337|NCT02315703|324481327|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
94733338|NCT02315703|324481328|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
94733339|NCT02315703|324481329|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
94733340|NCT02315703|324481330|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
94733341|NCT02315703|324481331|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
94733342|NCT02315703|324481332|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
94733343|NCT02315703|324481333|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
94733344|NCT02315703|324481326|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
94733345|NCT02315703|324481327|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
94733346|NCT02315703|324481328|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
94733347|NCT02315703|324481329|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
94733348|NCT02315703|324481330|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
94733349|NCT02315703|324481331|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
94733350|NCT02315703|324481332|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
94733351|NCT02315703|324481333|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
94733352|NCT02315703|324481326|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
94733353|NCT02315703|324481327|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
94733354|NCT02315703|324481328|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
94733355|NCT02315703|324481329|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
94733356|NCT02315703|324481330|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
94733357|NCT02315703|324481331|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
94274423|NCT04251910|322797409|FG000|Overall Study|Assisted living facility was closed|0|||
94274424|NCT04251910|322797410|FG001|Overall Study|Assisted living facility was closed|0|||
94274425|NCT04251910|322797411|FG002|Overall Study|Assisted living facility was closed|0|||
94274426|NCT04251910|322797412|FG003|Overall Study|Assisted living facility was closed|0|||
94368760|NCT03276962|323136543|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
94733358|NCT02315703|324481332|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
94733359|NCT02315703|324481333|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
94733360|NCT02315703|324481326|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
94733361|NCT02315703|324481327|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
94733362|NCT02315703|324481328|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
94733363|NCT02315703|324481329|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
94733364|NCT02315703|324481330|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
94733365|NCT02315703|324481331|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
94733366|NCT02315703|324481332|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
94733367|NCT02315703|324481333|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
94733368|NCT02315703|324481326|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
94733369|NCT02315703|324481327|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
94733370|NCT02315703|324481328|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
94733371|NCT02315703|324481329|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
94733372|NCT02315703|324481330|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
94733373|NCT02315703|324481331|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
94733374|NCT02315703|324481332|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
94733375|NCT02315703|324481333|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
94733376|NCT03519178|324481334|FG000|PF-06873600 Treatment|Adverse Event|0|||
94733377|NCT03519178|324481335|FG001|PF-06873600 Treatment|Adverse Event|0|||
94733378|NCT03519178|324481336|FG002|PF-06873600 Treatment|Adverse Event|0|||
94733379|NCT03519178|324481337|FG003|PF-06873600 Treatment|Adverse Event|0|||
94733380|NCT03519178|324481338|FG004|PF-06873600 Treatment|Adverse Event|0|||
94733381|NCT03519178|324481339|FG005|PF-06873600 Treatment|Adverse Event|0|||
94733382|NCT03519178|324481340|FG006|PF-06873600 Treatment|Adverse Event|0|||
94733383|NCT03519178|324481341|FG007|PF-06873600 Treatment|Adverse Event|2|||
94733384|NCT03519178|324481342|FG008|PF-06873600 Treatment|Adverse Event|1|||
94733385|NCT03519178|324481343|FG009|PF-06873600 Treatment|Adverse Event|0|||
94733386|NCT03519178|324481344|FG010|PF-06873600 Treatment|Adverse Event|0|||
94733387|NCT03519178|324481345|FG011|PF-06873600 Treatment|Adverse Event|0|||
94733388|NCT03519178|324481346|FG012|PF-06873600 Treatment|Adverse Event|1|||
94733389|NCT03519178|324481347|FG013|PF-06873600 Treatment|Adverse Event|3|||
94733390|NCT03519178|324481348|FG014|PF-06873600 Treatment|Adverse Event|2|||
94733391|NCT03519178|324481334|FG000|PF-06873600 Treatment|Death|0|||
94733392|NCT03519178|324481335|FG001|PF-06873600 Treatment|Death|0|||
94733393|NCT03519178|324481336|FG002|PF-06873600 Treatment|Death|0|||
94733394|NCT03519178|324481337|FG003|PF-06873600 Treatment|Death|0|||
94733395|NCT03519178|324481338|FG004|PF-06873600 Treatment|Death|0|||
94733396|NCT03519178|324481339|FG005|PF-06873600 Treatment|Death|0|||
94733397|NCT03519178|324481340|FG006|PF-06873600 Treatment|Death|0|||
94733398|NCT03519178|324481341|FG007|PF-06873600 Treatment|Death|0|||
94733399|NCT03519178|324481342|FG008|PF-06873600 Treatment|Death|1|||
94733400|NCT03519178|324481343|FG009|PF-06873600 Treatment|Death|1|||
94733401|NCT03519178|324481344|FG010|PF-06873600 Treatment|Death|0|||
94733402|NCT03519178|324481345|FG011|PF-06873600 Treatment|Death|0|||
94733403|NCT03519178|324481346|FG012|PF-06873600 Treatment|Death|0|||
94733404|NCT03519178|324481347|FG013|PF-06873600 Treatment|Death|0|||
94733405|NCT03519178|324481348|FG014|PF-06873600 Treatment|Death|1|||
94733406|NCT03519178|324481334|FG000|PF-06873600 Treatment|Physician Decision|0|||
94733407|NCT03519178|324481335|FG001|PF-06873600 Treatment|Physician Decision|0|||
94733408|NCT03519178|324481336|FG002|PF-06873600 Treatment|Physician Decision|0|||
94733409|NCT03519178|324481337|FG003|PF-06873600 Treatment|Physician Decision|0|||
94733410|NCT03519178|324481338|FG004|PF-06873600 Treatment|Physician Decision|0|||
94733411|NCT03519178|324481339|FG005|PF-06873600 Treatment|Physician Decision|0|||
94733412|NCT03519178|324481340|FG006|PF-06873600 Treatment|Physician Decision|0|||
94733413|NCT03519178|324481341|FG007|PF-06873600 Treatment|Physician Decision|1|||
94733414|NCT03519178|324481342|FG008|PF-06873600 Treatment|Physician Decision|0|||
94733415|NCT03519178|324481343|FG009|PF-06873600 Treatment|Physician Decision|0|||
94733416|NCT03519178|324481344|FG010|PF-06873600 Treatment|Physician Decision|1|||
94733417|NCT03519178|324481345|FG011|PF-06873600 Treatment|Physician Decision|0|||
94733418|NCT03519178|324481346|FG012|PF-06873600 Treatment|Physician Decision|0|||
94733419|NCT03519178|324481347|FG013|PF-06873600 Treatment|Physician Decision|4|||
94733420|NCT03519178|324481348|FG014|PF-06873600 Treatment|Physician Decision|1|||
94733421|NCT03519178|324481334|FG000|PF-06873600 Treatment|Progressive disease|1|||
94733422|NCT03519178|324481335|FG001|PF-06873600 Treatment|Progressive disease|1|||
94733423|NCT03519178|324481336|FG002|PF-06873600 Treatment|Progressive disease|1|||
94733424|NCT03519178|324481337|FG003|PF-06873600 Treatment|Progressive disease|1|||
94733425|NCT03519178|324481338|FG004|PF-06873600 Treatment|Progressive disease|6|||
94733426|NCT03519178|324481339|FG005|PF-06873600 Treatment|Progressive disease|7|||
94733427|NCT03519178|324481340|FG006|PF-06873600 Treatment|Progressive disease|3|||
94733428|NCT03519178|324481341|FG007|PF-06873600 Treatment|Progressive disease|7|||
94733429|NCT03519178|324481342|FG008|PF-06873600 Treatment|Progressive disease|3|||
94733430|NCT03519178|324481343|FG009|PF-06873600 Treatment|Progressive disease|5|||
94733431|NCT03519178|324481344|FG010|PF-06873600 Treatment|Progressive disease|4|||
94733432|NCT03519178|324481345|FG011|PF-06873600 Treatment|Progressive disease|3|||
94368761|NCT03276962|323136544|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
94274427|NCT04251910|322797413|FG004|Overall Study|Assisted living facility was closed|1|||
94274428|NCT04251910|322797414|FG005|Overall Study|Assisted living facility was closed|0|||
94274429|NCT00841568|322797419|FG000|Overall Study|Adverse Event|1|||
94274430|NCT00841568|322797419|FG000|Overall Study|Death|1|||
94274431|NCT00841568|322797419|FG000|Overall Study|Withdrawal by Subject|2|||
94274432|NCT00841568|322797419|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
94274433|NCT00950664|322797440|FG000|First Intervention|Lost to Follow-up|1|||
94274434|NCT00950664|322797441|FG001|First Intervention|Lost to Follow-up|3|||
94274435|NCT00950664|322797440|FG000|First Intervention|Withdrawal by Subject|2|||
94274436|NCT00950664|322797441|FG001|First Intervention|Withdrawal by Subject|2|||
94274437|NCT02374099|322797444|FG000|Overall Study|Adverse Event|1|||
94274438|NCT02374099|322797445|FG001|Overall Study|Adverse Event|0|||
94274439|NCT02374099|322797444|FG000|Overall Study|Progressive Disease|35|||
94274440|NCT02374099|322797445|FG001|Overall Study|Progressive Disease|40|||
94467449|NCT04015518|323500564|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
94733433|NCT03519178|324481346|FG012|PF-06873600 Treatment|Progressive disease|4|||
94733434|NCT03519178|324481347|FG013|PF-06873600 Treatment|Progressive disease|28|||
94733435|NCT03519178|324481348|FG014|PF-06873600 Treatment|Progressive disease|7|||
94733436|NCT03519178|324481334|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
94733437|NCT03519178|324481335|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
94733438|NCT03519178|324481336|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
94733439|NCT03519178|324481337|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
94733440|NCT03519178|324481338|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
94733441|NCT03519178|324481339|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
94733442|NCT03519178|324481340|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
94733443|NCT03519178|324481341|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
94733444|NCT03519178|324481342|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
94733445|NCT03519178|324481343|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
94733446|NCT03519178|324481344|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
94733447|NCT03519178|324481345|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
94733448|NCT03519178|324481346|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
94733449|NCT03519178|324481347|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
94733450|NCT03519178|324481348|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
94733451|NCT03519178|324481334|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
94733452|NCT03519178|324481335|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
94733453|NCT03519178|324481336|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
94733454|NCT03519178|324481337|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
94733455|NCT03519178|324481338|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
94733456|NCT03519178|324481339|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
94733457|NCT03519178|324481340|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
94733458|NCT03519178|324481341|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
94733459|NCT03519178|324481342|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
94733460|NCT03519178|324481343|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
94733461|NCT03519178|324481344|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
94733462|NCT03519178|324481345|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
94733463|NCT03519178|324481346|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
94733464|NCT03519178|324481347|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
94733465|NCT03519178|324481348|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
94733466|NCT03519178|324481334|FG000|PF-06873600 Treatment|Refused further treatment|0|||
94733467|NCT03519178|324481335|FG001|PF-06873600 Treatment|Refused further treatment|1|||
94733468|NCT03519178|324481336|FG002|PF-06873600 Treatment|Refused further treatment|0|||
94733469|NCT03519178|324481337|FG003|PF-06873600 Treatment|Refused further treatment|0|||
94733470|NCT03519178|324481338|FG004|PF-06873600 Treatment|Refused further treatment|1|||
94733471|NCT03519178|324481339|FG005|PF-06873600 Treatment|Refused further treatment|0|||
94733472|NCT03519178|324481340|FG006|PF-06873600 Treatment|Refused further treatment|0|||
94733473|NCT03519178|324481341|FG007|PF-06873600 Treatment|Refused further treatment|0|||
94733474|NCT03519178|324481342|FG008|PF-06873600 Treatment|Refused further treatment|0|||
94733475|NCT03519178|324481343|FG009|PF-06873600 Treatment|Refused further treatment|0|||
94733476|NCT03519178|324481344|FG010|PF-06873600 Treatment|Refused further treatment|0|||
94733477|NCT03519178|324481345|FG011|PF-06873600 Treatment|Refused further treatment|0|||
94733478|NCT03519178|324481346|FG012|PF-06873600 Treatment|Refused further treatment|0|||
94733479|NCT03519178|324481347|FG013|PF-06873600 Treatment|Refused further treatment|0|||
94733480|NCT03519178|324481348|FG014|PF-06873600 Treatment|Refused further treatment|1|||
94733481|NCT03519178|324481334|FG000|PF-06873600 Treatment|Other|0|||
94733482|NCT03519178|324481335|FG001|PF-06873600 Treatment|Other|0|||
94733483|NCT03519178|324481336|FG002|PF-06873600 Treatment|Other|0|||
94274441|NCT02374099|322797444|FG000|Overall Study|Withdrawal by Subject|5|||
94274442|NCT02374099|322797445|FG001|Overall Study|Withdrawal by Subject|1|||
94274443|NCT02374099|322797444|FG000|Overall Study|Miscellaneous|2|||
94274444|NCT02374099|322797445|FG001|Overall Study|Miscellaneous|3|||
94733484|NCT03519178|324481337|FG003|PF-06873600 Treatment|Other|0|||
94733485|NCT03519178|324481338|FG004|PF-06873600 Treatment|Other|0|||
94733486|NCT03519178|324481339|FG005|PF-06873600 Treatment|Other|0|||
94733487|NCT03519178|324481340|FG006|PF-06873600 Treatment|Other|0|||
94733488|NCT03519178|324481341|FG007|PF-06873600 Treatment|Other|0|||
94733489|NCT03519178|324481342|FG008|PF-06873600 Treatment|Other|1|||
94733490|NCT03519178|324481343|FG009|PF-06873600 Treatment|Other|0|||
94733491|NCT03519178|324481344|FG010|PF-06873600 Treatment|Other|0|||
94733492|NCT03519178|324481345|FG011|PF-06873600 Treatment|Other|0|||
94733493|NCT03519178|324481346|FG012|PF-06873600 Treatment|Other|0|||
94733494|NCT03519178|324481347|FG013|PF-06873600 Treatment|Other|1|||
94733495|NCT03519178|324481348|FG014|PF-06873600 Treatment|Other|3|||
94733496|NCT03519178|324481334|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
94733497|NCT03519178|324481335|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
94733498|NCT03519178|324481336|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
94733499|NCT03519178|324481337|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
94733500|NCT03519178|324481338|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
94733501|NCT03519178|324481339|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
94733502|NCT03519178|324481340|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
94733503|NCT03519178|324481341|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
94733504|NCT03519178|324481342|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
94733505|NCT03519178|324481343|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
94733506|NCT03519178|324481344|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
94733507|NCT03519178|324481345|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
94733508|NCT03519178|324481346|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
94733509|NCT03519178|324481347|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
94733510|NCT03519178|324481348|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
94733511|NCT03519178|324481334|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
94733512|NCT03519178|324481335|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
94733513|NCT03519178|324481336|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
94733514|NCT03519178|324481337|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
94733515|NCT03519178|324481338|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
94733516|NCT03519178|324481339|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
94733517|NCT03519178|324481340|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
94733518|NCT03519178|324481341|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
94733519|NCT03519178|324481342|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
94733520|NCT03519178|324481343|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
94733521|NCT03519178|324481344|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
94733522|NCT03519178|324481345|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
94733523|NCT03519178|324481346|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
94733524|NCT03519178|324481347|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
94733525|NCT03519178|324481348|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
94733526|NCT03519178|324481334|FG000|PF-06873600 Treatment|Ongoing|0|||
94733527|NCT03519178|324481335|FG001|PF-06873600 Treatment|Ongoing|0|||
94733528|NCT03519178|324481336|FG002|PF-06873600 Treatment|Ongoing|0|||
94733529|NCT03519178|324481337|FG003|PF-06873600 Treatment|Ongoing|0|||
94733530|NCT03519178|324481338|FG004|PF-06873600 Treatment|Ongoing|0|||
94733531|NCT03519178|324481339|FG005|PF-06873600 Treatment|Ongoing|0|||
94733532|NCT03519178|324481340|FG006|PF-06873600 Treatment|Ongoing|0|||
94733533|NCT03519178|324481341|FG007|PF-06873600 Treatment|Ongoing|0|||
94733534|NCT03519178|324481342|FG008|PF-06873600 Treatment|Ongoing|0|||
94733535|NCT03519178|324481343|FG009|PF-06873600 Treatment|Ongoing|0|||
94733536|NCT03519178|324481344|FG010|PF-06873600 Treatment|Ongoing|0|||
94733537|NCT03519178|324481345|FG011|PF-06873600 Treatment|Ongoing|0|||
94733538|NCT03519178|324481346|FG012|PF-06873600 Treatment|Ongoing|0|||
94733539|NCT03519178|324481347|FG013|PF-06873600 Treatment|Ongoing|1|||
94733540|NCT03519178|324481348|FG014|PF-06873600 Treatment|Ongoing|6|||
94733541|NCT03519178|324481334|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
94733542|NCT03519178|324481335|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
94733543|NCT03519178|324481336|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
94733544|NCT03519178|324481337|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
94733545|NCT03519178|324481338|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
94733546|NCT03519178|324481339|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
94733547|NCT03519178|324481340|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
94733548|NCT03519178|324481341|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
94733549|NCT03519178|324481342|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
94733550|NCT03519178|324481343|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
94733551|NCT03519178|324481344|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
94733552|NCT03519178|324481345|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
94733553|NCT03519178|324481346|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
94733554|NCT03519178|324481347|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
94274445|NCT02374099|322797444|FG000|Overall Study|Randomized, but not treated|2|||
94274446|NCT02374099|322797445|FG001|Overall Study|Randomized, but not treated|1|||
94274447|NCT02374099|322797444|FG000|Overall Study|Study Terminated by Sponsor|3|||
94733555|NCT03519178|324481348|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
94733556|NCT03519178|324481334|FG000|Disposition for Fluvestrant Treatment|Death|0|||
94733557|NCT03519178|324481335|FG001|Disposition for Fluvestrant Treatment|Death|0|||
94733558|NCT03519178|324481336|FG002|Disposition for Fluvestrant Treatment|Death|0|||
94733559|NCT03519178|324481337|FG003|Disposition for Fluvestrant Treatment|Death|0|||
94733560|NCT03519178|324481338|FG004|Disposition for Fluvestrant Treatment|Death|0|||
94733561|NCT03519178|324481339|FG005|Disposition for Fluvestrant Treatment|Death|0|||
94733562|NCT03519178|324481340|FG006|Disposition for Fluvestrant Treatment|Death|0|||
94733563|NCT03519178|324481341|FG007|Disposition for Fluvestrant Treatment|Death|0|||
94733564|NCT03519178|324481342|FG008|Disposition for Fluvestrant Treatment|Death|0|||
94733565|NCT03519178|324481343|FG009|Disposition for Fluvestrant Treatment|Death|1|||
94733566|NCT03519178|324481344|FG010|Disposition for Fluvestrant Treatment|Death|0|||
94733567|NCT03519178|324481345|FG011|Disposition for Fluvestrant Treatment|Death|0|||
94733568|NCT03519178|324481346|FG012|Disposition for Fluvestrant Treatment|Death|0|||
94733569|NCT03519178|324481347|FG013|Disposition for Fluvestrant Treatment|Death|0|||
94733570|NCT03519178|324481348|FG014|Disposition for Fluvestrant Treatment|Death|1|||
94733571|NCT03519178|324481334|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
94733572|NCT03519178|324481335|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
94733573|NCT03519178|324481336|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
94733574|NCT03519178|324481337|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
94733575|NCT03519178|324481338|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
94733576|NCT03519178|324481339|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
94733577|NCT03519178|324481340|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
94733578|NCT03519178|324481341|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
94733579|NCT03519178|324481342|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
94733580|NCT03519178|324481343|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
94733581|NCT03519178|324481344|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
94733582|NCT03519178|324481345|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
94733583|NCT03519178|324481346|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
94733584|NCT03519178|324481347|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
94733585|NCT03519178|324481348|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
94733586|NCT03519178|324481334|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
94733587|NCT03519178|324481335|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
94733588|NCT03519178|324481336|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
94733589|NCT03519178|324481337|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
94733590|NCT03519178|324481338|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
94733591|NCT03519178|324481339|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
94733592|NCT03519178|324481340|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
94733593|NCT03519178|324481341|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
94733594|NCT03519178|324481342|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
94733595|NCT03519178|324481343|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
94733596|NCT03519178|324481344|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
94733597|NCT03519178|324481345|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
94733598|NCT03519178|324481346|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
94733599|NCT03519178|324481347|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
94733600|NCT03519178|324481348|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
94733601|NCT03519178|324481334|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
94733602|NCT03519178|324481335|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
94733603|NCT03519178|324481336|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
94733604|NCT03519178|324481337|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
94733605|NCT03519178|324481338|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
94733606|NCT03519178|324481339|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
94733607|NCT03519178|324481340|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
94733608|NCT03519178|324481341|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
94733609|NCT03519178|324481342|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
94733610|NCT03519178|324481343|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
94733611|NCT03519178|324481344|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
94733612|NCT03519178|324481345|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
94733613|NCT03519178|324481346|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
94733614|NCT03519178|324481347|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
94733615|NCT03519178|324481348|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
94733616|NCT03519178|324481334|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
94733617|NCT03519178|324481335|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
94368762|NCT03276962|323136545|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
94368763|NCT03276962|323136546|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
94274448|NCT02374099|322797445|FG001|Overall Study|Study Terminated by Sponsor|4|||
94274449|NCT03693625|322797446|FG000|Overall Study|Adverse Event|2|||
94274450|NCT03693625|322797447|FG001|Overall Study|Adverse Event|0|||
94274451|NCT03693625|322797446|FG000|Overall Study|Study Terminated By Sponsor|20|||
94274452|NCT03693625|322797447|FG001|Overall Study|Study Terminated By Sponsor|7|||
94274453|NCT03693625|322797446|FG000|Overall Study|Withdrawal by Subject|1|||
94274454|NCT03693625|322797447|FG001|Overall Study|Withdrawal by Subject|1|||
94274455|NCT01553136|322797450|FG000|Overall Study|Adverse Event|3|||
94274456|NCT01553136|322797451|FG001|Overall Study|Adverse Event|2|||
94274457|NCT01553136|322797450|FG000|Overall Study|Withdrawal by Subject|2|||
94274458|NCT01553136|322797451|FG001|Overall Study|Withdrawal by Subject|3|||
94274459|NCT01553136|322797450|FG000|Overall Study|Lost to Follow-up|4|||
94274460|NCT01553136|322797451|FG001|Overall Study|Lost to Follow-up|10|||
94274461|NCT01553136|322797450|FG000|Overall Study|Physician Decision|2|||
94274462|NCT01553136|322797451|FG001|Overall Study|Physician Decision|3|||
94274463|NCT01553136|322797450|FG000|Overall Study|Scheduling Difficulties|5|||
94274464|NCT01553136|322797451|FG001|Overall Study|Scheduling Difficulties|4|||
94733618|NCT03519178|324481336|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
94733619|NCT03519178|324481337|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
94733620|NCT03519178|324481338|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
94733621|NCT03519178|324481339|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
94733622|NCT03519178|324481340|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
94733623|NCT03519178|324481341|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
94733624|NCT03519178|324481342|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
94733625|NCT03519178|324481343|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
94733626|NCT03519178|324481344|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
94733627|NCT03519178|324481345|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
94733628|NCT03519178|324481346|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
94733629|NCT03519178|324481347|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
94733630|NCT03519178|324481348|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
94733631|NCT03519178|324481334|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
94733632|NCT03519178|324481335|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
94733633|NCT03519178|324481336|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
94733634|NCT03519178|324481337|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
94733635|NCT03519178|324481338|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
94733636|NCT03519178|324481339|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
94733637|NCT03519178|324481340|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
94274465|NCT04096274|322798501|FG000|Phase I|Lost to Follow-up|5|||
94274466|NCT04096274|322798502|FG001|Phase I|Lost to Follow-up|5|||
94733638|NCT03519178|324481341|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
94733639|NCT03519178|324481342|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
94733640|NCT03519178|324481343|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
94274467|NCT04096274|322798501|FG000|Phase II|Lost to Follow-up|11|||
94274468|NCT04096274|322798502|FG001|Phase II|Lost to Follow-up|11|||
94274469|NCT00750698|322798505|FG000|Overall Study|Withdrawal by Subject|1|||
94274470|NCT00750698|322798506|FG001|Overall Study|Withdrawal by Subject|0|||
94274471|NCT00750698|322798505|FG000|Overall Study|Progressive disease|5|||
94274472|NCT00750698|322798506|FG001|Overall Study|Progressive disease|2|||
94274473|NCT02263079|322798507|FG000|Overall Study|Physician Decision|1|||
94274474|NCT02263079|322798508|FG001|Overall Study|Physician Decision|0|||
94274475|NCT02263079|322798509|FG002|Overall Study|Physician Decision|0|||
94274476|NCT02263079|322798507|FG000|Overall Study|Withdrawal by Subject|2|||
94733641|NCT03519178|324481344|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
94733642|NCT03519178|324481345|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
94733643|NCT03519178|324481346|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
94733644|NCT03519178|324481347|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
94733645|NCT03519178|324481348|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
94733646|NCT03519178|324481334|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
94733647|NCT03519178|324481335|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
94733648|NCT03519178|324481336|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
94733649|NCT03519178|324481337|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
94733650|NCT03519178|324481338|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
94733651|NCT03519178|324481339|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
94733652|NCT03519178|324481340|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
94733653|NCT03519178|324481341|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
94733654|NCT03519178|324481342|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
94733655|NCT03519178|324481343|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
94733656|NCT03519178|324481344|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
94733657|NCT03519178|324481345|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
94733658|NCT03519178|324481346|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
94733659|NCT03519178|324481347|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
94733660|NCT03519178|324481348|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
94733661|NCT03519178|324481334|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
94733662|NCT03519178|324481335|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
94733663|NCT03519178|324481336|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
94733664|NCT03519178|324481337|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
94733665|NCT03519178|324481338|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
94733666|NCT03519178|324481339|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
94733667|NCT03519178|324481340|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
94733668|NCT03519178|324481341|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
94733669|NCT03519178|324481342|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
94733670|NCT03519178|324481343|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
94733671|NCT03519178|324481344|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
94733672|NCT03519178|324481345|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
94733673|NCT03519178|324481346|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
94733674|NCT03519178|324481347|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
94733675|NCT03519178|324481348|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
94733676|NCT03519178|324481334|FG000|Disposition for Fluvestrant Treatment|Other|0|||
94733677|NCT03519178|324481335|FG001|Disposition for Fluvestrant Treatment|Other|0|||
94733678|NCT03519178|324481336|FG002|Disposition for Fluvestrant Treatment|Other|0|||
94733679|NCT03519178|324481337|FG003|Disposition for Fluvestrant Treatment|Other|0|||
94733680|NCT03519178|324481338|FG004|Disposition for Fluvestrant Treatment|Other|0|||
94733681|NCT03519178|324481339|FG005|Disposition for Fluvestrant Treatment|Other|0|||
94733682|NCT03519178|324481340|FG006|Disposition for Fluvestrant Treatment|Other|0|||
94733683|NCT03519178|324481341|FG007|Disposition for Fluvestrant Treatment|Other|0|||
94733684|NCT03519178|324481342|FG008|Disposition for Fluvestrant Treatment|Other|0|||
94733685|NCT03519178|324481343|FG009|Disposition for Fluvestrant Treatment|Other|0|||
94733686|NCT03519178|324481344|FG010|Disposition for Fluvestrant Treatment|Other|0|||
94733687|NCT03519178|324481345|FG011|Disposition for Fluvestrant Treatment|Other|0|||
94733688|NCT03519178|324481346|FG012|Disposition for Fluvestrant Treatment|Other|0|||
94733689|NCT03519178|324481347|FG013|Disposition for Fluvestrant Treatment|Other|1|||
94274477|NCT02263079|322798508|FG001|Overall Study|Withdrawal by Subject|8|||
94274478|NCT02263079|322798509|FG002|Overall Study|Withdrawal by Subject|0|||
94733690|NCT03519178|324481348|FG014|Disposition for Fluvestrant Treatment|Other|3|||
94733691|NCT03519178|324481334|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
94274479|NCT02603120|322798510|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
94274480|NCT02603120|322798511|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
94733692|NCT03519178|324481335|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
94733693|NCT03519178|324481336|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
94733694|NCT03519178|324481337|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
94733695|NCT03519178|324481338|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
94733696|NCT03519178|324481339|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
94733697|NCT03519178|324481340|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
94733698|NCT03519178|324481341|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
94733699|NCT03519178|324481342|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
94733700|NCT03519178|324481343|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
94733701|NCT03519178|324481344|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
94733702|NCT03519178|324481345|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
94733703|NCT03519178|324481346|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
94733704|NCT03519178|324481347|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
94733705|NCT03519178|324481348|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
94733706|NCT03519178|324481334|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
94733707|NCT03519178|324481335|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
94733708|NCT03519178|324481336|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
94733709|NCT03519178|324481337|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
94733710|NCT03519178|324481338|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
94733711|NCT03519178|324481339|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
94733712|NCT03519178|324481340|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
94733713|NCT03519178|324481341|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
94733714|NCT03519178|324481342|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
94733715|NCT03519178|324481343|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
94274481|NCT02603120|322798510|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
94274482|NCT02603120|322798511|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
94274483|NCT02603120|322798510|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
94274484|NCT02603120|322798511|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
94274485|NCT02603120|322798510|FG000|Double-Blind Treatment Phase|Death|2|||
94274486|NCT02603120|322798511|FG001|Double-Blind Treatment Phase|Death|0|||
94274487|NCT02603120|322798510|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
94274488|NCT02603120|322798511|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
94274489|NCT02603120|322798510|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
94274490|NCT02603120|322798511|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
94274491|NCT02603120|322798510|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
94274492|NCT02603120|322798511|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
94274493|NCT02603120|322798510|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
94274494|NCT02603120|322798511|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
94274495|NCT02603120|322798510|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
94274496|NCT02603120|322798511|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
94274497|NCT02603120|322798510|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
94274498|NCT02603120|322798511|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
94274499|NCT02603120|322798510|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
94274500|NCT02603120|322798511|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
94274501|NCT02603120|322798510|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
94274502|NCT02603120|322798511|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
94274503|NCT02603120|322798510|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
94274504|NCT02603120|322798511|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
94274505|NCT02603120|322798510|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
94274506|NCT02603120|322798511|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
94274507|NCT00176605|322798514|FG000|Overall Study|Withdrawal by Subject|2|||
94274508|NCT01321710|322798515|FG000|Overall Study|Lost to Follow-up|4|||
94274509|NCT01321710|322798516|FG001|Overall Study|Lost to Follow-up|5|||
94274510|NCT01321710|322798517|FG002|Overall Study|Lost to Follow-up|0|||
94274511|NCT01761292|322798518|FG000|Part 1|Adverse Event|1|||
94274512|NCT01761292|322798518|FG000|Part 1|not receiving treatment in Part 1|1|||
94274513|NCT01761292|322798518|FG000|Extension 1|Withdrawal by Subject|1|||
94274514|NCT01611974|322798519|FG000|Overall Study|Death|10|||
94274515|NCT01611974|322798520|FG001|Overall Study|Death|12|||
94274516|NCT01611974|322798521|FG002|Overall Study|Death|10|||
94274517|NCT01611974|322798519|FG000|Overall Study|Lost to Follow-up|0|||
94274518|NCT01611974|322798520|FG001|Overall Study|Lost to Follow-up|1|||
94274519|NCT01611974|322798521|FG002|Overall Study|Lost to Follow-up|0|||
94274520|NCT01611974|322798519|FG000|Overall Study|Physician Decision|5|||
94274521|NCT01611974|322798520|FG001|Overall Study|Physician Decision|1|||
94274522|NCT01611974|322798521|FG002|Overall Study|Physician Decision|2|||
94274523|NCT01611974|322798519|FG000|Overall Study|Withdrawal by Subject|0|||
94274524|NCT01611974|322798520|FG001|Overall Study|Withdrawal by Subject|1|||
94274525|NCT01611974|322798521|FG002|Overall Study|Withdrawal by Subject|4|||
94274526|NCT01785160|322798522|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
94274527|NCT01785160|322798522|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
94274528|NCT00957528|322798523|FG000|Overall Study|Protocol Violation|0|||
94274529|NCT00957528|322798524|FG001|Overall Study|Protocol Violation|1|||
94274530|NCT00957528|322798525|FG002|Overall Study|Protocol Violation|0|||
94274531|NCT00957528|322798523|FG000|Overall Study|Withdrawal by Subject|0|||
94274532|NCT00957528|322798524|FG001|Overall Study|Withdrawal by Subject|0|||
94274533|NCT00957528|322798525|FG002|Overall Study|Withdrawal by Subject|1|||
94274534|NCT02463409|322798526|FG000|Overall Study|Withdrawal by Subject|1|||
94274535|NCT02463409|322798526|FG000|Overall Study|Screen failure|1|||
94274536|NCT02081534|322798527|FG000|Overall Study|Adverse Event|5|||
94274537|NCT02081534|322798528|FG001|Overall Study|Adverse Event|4|||
94274538|NCT02081534|322798529|FG002|Overall Study|Adverse Event|3|||
94274539|NCT02081534|322798530|FG003|Overall Study|Adverse Event|10|||
94274540|NCT02081534|322798531|FG004|Overall Study|Adverse Event|2|||
94467450|NCT04015518|323500565|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
94733716|NCT03519178|324481344|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
94274541|NCT02081534|322798532|FG005|Overall Study|Adverse Event|8|||
94274542|NCT02081534|322798533|FG006|Overall Study|Adverse Event|2|||
94274543|NCT02081534|322798527|FG000|Overall Study|Withdrawal by Subject|0|||
94274544|NCT02081534|322798528|FG001|Overall Study|Withdrawal by Subject|1|||
94274545|NCT02081534|322798529|FG002|Overall Study|Withdrawal by Subject|1|||
94274546|NCT02081534|322798530|FG003|Overall Study|Withdrawal by Subject|1|||
94274547|NCT02081534|322798531|FG004|Overall Study|Withdrawal by Subject|1|||
94274548|NCT02081534|322798532|FG005|Overall Study|Withdrawal by Subject|0|||
94274549|NCT02081534|322798533|FG006|Overall Study|Withdrawal by Subject|1|||
94274550|NCT02081534|322798527|FG000|Overall Study|Protocol Violation|0|||
94274551|NCT02081534|322798528|FG001|Overall Study|Protocol Violation|3|||
94274552|NCT02081534|322798529|FG002|Overall Study|Protocol Violation|0|||
94274553|NCT02081534|322798530|FG003|Overall Study|Protocol Violation|0|||
94274554|NCT02081534|322798531|FG004|Overall Study|Protocol Violation|0|||
94274555|NCT02081534|322798532|FG005|Overall Study|Protocol Violation|0|||
94274556|NCT02081534|322798533|FG006|Overall Study|Protocol Violation|1|||
94274557|NCT02081534|322798527|FG000|Overall Study|Lost to Follow-up|0|||
94274558|NCT02081534|322798528|FG001|Overall Study|Lost to Follow-up|0|||
94274559|NCT02081534|322798529|FG002|Overall Study|Lost to Follow-up|0|||
94274560|NCT02081534|322798530|FG003|Overall Study|Lost to Follow-up|2|||
94274561|NCT02081534|322798531|FG004|Overall Study|Lost to Follow-up|1|||
94274562|NCT02081534|322798532|FG005|Overall Study|Lost to Follow-up|1|||
94274563|NCT02081534|322798533|FG006|Overall Study|Lost to Follow-up|0|||
94274564|NCT00762892|322798534|FG000|Overall Study|Lost to Follow-up|2|||
94274565|NCT00762892|322798535|FG001|Overall Study|Lost to Follow-up|5|||
94274566|NCT00762892|322798534|FG000|Overall Study|Withdrawal by Subject|0|||
94274567|NCT00762892|322798535|FG001|Overall Study|Withdrawal by Subject|1|||
94274568|NCT00762892|322798534|FG000|Overall Study|Death|1|||
94274569|NCT00762892|322798535|FG001|Overall Study|Death|0|||
94274570|NCT00762892|322798534|FG000|Overall Study|Pregnancy|1|||
94274571|NCT00762892|322798535|FG001|Overall Study|Pregnancy|0|||
94274572|NCT00762892|322798534|FG000|Overall Study|Incarceration|1|||
94274573|NCT00762892|322798535|FG001|Overall Study|Incarceration|0|||
94274574|NCT01417195|322798536|FG000|Overall Study|Stimulation failure|1|||
94274575|NCT01417195|322798537|FG001|Overall Study|Stimulation failure|0|||
94274576|NCT01417195|322798536|FG000|Overall Study|No embryos for transfer|0|||
94274577|NCT01417195|322798537|FG001|Overall Study|No embryos for transfer|1|||
94274578|NCT01417195|322798536|FG000|Overall Study|No transfer due to risk of OHSS|1|||
94274579|NCT01417195|322798537|FG001|Overall Study|No transfer due to risk of OHSS|0|||
94274580|NCT01417195|322798536|FG000|Overall Study|No transfer due to elevated progesterone|1|||
94274581|NCT01417195|322798537|FG001|Overall Study|No transfer due to elevated progesterone|0|||
94274582|NCT04766021|322798538|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
94274583|NCT04766021|322798538|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
94274584|NCT01033734|322798539|FG000|Overall Study|Withdrawal by Subject|1|||
94274585|NCT00294060|322798540|FG000|Overall Study|Death|225|||
94274586|NCT00294060|322798540|FG000|Overall Study|Other|59|||
94274587|NCT00294060|322798540|FG000|Overall Study|Lost to Follow-up|55|||
94274588|NCT00294060|322798540|FG000|Overall Study|Withdrawal by Subject|11|||
94274589|NCT00294060|322798540|FG000|Overall Study|Physician Decision|797|||
94274590|NCT00294060|322798540|FG000|Overall Study|Medical condition|3|||
94274591|NCT00294060|322798540|FG000|Overall Study|Device explanted/not replaced|23|||
94274592|NCT00094770|322798546|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
94274593|NCT00094770|322798547|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
94274594|NCT00094770|322798546|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
94274595|NCT00094770|322798547|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
94274596|NCT00094770|322798546|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
94274597|NCT00094770|322798547|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
94274598|NCT00094770|322798546|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
94274599|NCT00094770|322798547|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
94274600|NCT00094770|322798546|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
94274601|NCT00094770|322798547|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
94274602|NCT00094770|322798546|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
94274603|NCT00094770|322798547|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
94274604|NCT00094770|322798546|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
94274605|NCT00094770|322798547|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
94274606|NCT00094770|322798546|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
94274607|NCT00094770|322798547|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
94274608|NCT00094770|322798546|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
94274609|NCT00094770|322798547|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
94274610|NCT00094770|322798546|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
94274611|NCT00094770|322798547|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
94274612|NCT00094770|322798546|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
94274613|NCT00094770|322798547|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
94274614|NCT00094770|322798546|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
94274615|NCT00094770|322798547|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
94274616|NCT00094770|322798546|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
94274617|NCT00094770|322798547|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
94274618|NCT00094770|322798546|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
94274619|NCT00094770|322798547|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
94274620|NCT00094770|322798546|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
94274621|NCT00094770|322798547|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
94274622|NCT00094770|322798546|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
94274623|NCT00094770|322798547|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
94274624|NCT00094770|322798546|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
94274625|NCT00094770|322798547|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
94274626|NCT00094770|322798546|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
94274627|NCT00094770|322798547|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
94274628|NCT00253643|322798548|FG000|Overall Study|Withdrawal by Subject|0|||
94274629|NCT00253643|322798549|FG001|Overall Study|Withdrawal by Subject|0|||
94274630|NCT00253643|322798550|FG002|Overall Study|Withdrawal by Subject|1|||
94368764|NCT03276962|323136547|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
94368765|NCT03276962|323136543|FG000|Overall Study|Lost to Follow-up|10|||
94274631|NCT00253643|322798551|FG003|Overall Study|Withdrawal by Subject|1|||
94274632|NCT00253643|322798548|FG000|Overall Study|Non-Compliance|0|||
94274633|NCT00253643|322798549|FG001|Overall Study|Non-Compliance|0|||
94274634|NCT00253643|322798550|FG002|Overall Study|Non-Compliance|0|||
94274635|NCT00253643|322798551|FG003|Overall Study|Non-Compliance|2|||
94274636|NCT01549275|322798554|FG000|Overall Study|Lost to Follow-up|1|||
94274637|NCT01549275|322798555|FG001|Overall Study|Lost to Follow-up|0|||
94274638|NCT01040351|322798556|FG000|Overall Study|poor ovarian response|1|||
94274639|NCT01040351|322798557|FG001|Overall Study|poor ovarian response|2|||
94274640|NCT03179891|322798563|FG000|First Intervention|Withdrawal by Subject|1|||
94274641|NCT03179891|322798564|FG001|First Intervention|Withdrawal by Subject|1|||
94274642|NCT03179891|322798563|FG000|First Intervention|Unspecified reason|1|||
94274643|NCT03179891|322798564|FG001|First Intervention|Unspecified reason|0|||
94274644|NCT03179891|322798563|FG000|First Intervention|Protocol Violation|0|||
94274645|NCT03179891|322798564|FG001|First Intervention|Protocol Violation|1|||
94274646|NCT01349465|322798565|FG000|Overall Study|Adverse Event|1|||
94368766|NCT03276962|323136544|FG001|Overall Study|Lost to Follow-up|10|||
94368767|NCT03276962|323136545|FG002|Overall Study|Lost to Follow-up|4|||
94368768|NCT03276962|323136546|FG003|Overall Study|Lost to Follow-up|6|||
94467451|NCT04015518|323500561|FG000|Overall Study|Pregnancy|0|||
94274647|NCT01349465|322798566|FG001|Overall Study|Adverse Event|0|||
94274648|NCT01349465|322798565|FG000|Overall Study|Death|3|||
94274649|NCT01349465|322798566|FG001|Overall Study|Death|0|||
94274650|NCT01349465|322798565|FG000|Overall Study|Lost to Follow-up|10|||
94274651|NCT01349465|322798566|FG001|Overall Study|Lost to Follow-up|1|||
94274652|NCT01349465|322798565|FG000|Overall Study|Withdrawal by Subject|4|||
94274653|NCT01349465|322798566|FG001|Overall Study|Withdrawal by Subject|2|||
94274654|NCT01349465|322798565|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
94274655|NCT01349465|322798566|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
94274656|NCT01148537|322798571|FG000|Overall Study|Withdrawal by Subject|1|||
94274657|NCT01148537|322798572|FG001|Overall Study|Withdrawal by Subject|0|||
94274658|NCT01148537|322798573|FG002|Overall Study|Withdrawal by Subject|2|||
94274659|NCT01148537|322798571|FG000|Overall Study|Adverse Event|2|||
94274660|NCT01148537|322798572|FG001|Overall Study|Adverse Event|0|||
94274661|NCT01148537|322798573|FG002|Overall Study|Adverse Event|1|||
94274662|NCT04091087|322798574|FG000|Overall Study|Not treated|1|||
94274663|NCT04091087|322798575|FG001|Overall Study|Not treated|0|||
94274664|NCT04091087|322798574|FG000|Overall Study|Adverse Event|4|||
94274665|NCT04091087|322798575|FG001|Overall Study|Adverse Event|4|||
94274666|NCT04091087|322798574|FG000|Overall Study|Protocol Violation|0|||
94274667|NCT04091087|322798575|FG001|Overall Study|Protocol Violation|1|||
94274668|NCT04091087|322798574|FG000|Overall Study|Withdrawal by Subject|5|||
94274669|NCT04091087|322798575|FG001|Overall Study|Withdrawal by Subject|2|||
94274670|NCT03134599|322798576|FG000|Week 1|Lost to Follow-up|0|||
94274671|NCT03134599|322798577|FG001|Week 1|Lost to Follow-up|0|||
94733717|NCT03519178|324481345|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
94733718|NCT03519178|324481346|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
94733719|NCT03519178|324481347|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
94733720|NCT03519178|324481348|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
94733721|NCT03519178|324481334|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
94733722|NCT03519178|324481335|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
94733723|NCT03519178|324481336|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
94733724|NCT03519178|324481337|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
94733725|NCT03519178|324481338|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
94733726|NCT03519178|324481339|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
94733727|NCT03519178|324481340|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
94733728|NCT03519178|324481341|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
94733729|NCT03519178|324481342|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
94733730|NCT03519178|324481343|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
94733731|NCT03519178|324481344|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
94733732|NCT03519178|324481345|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
94733733|NCT03519178|324481346|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
94733734|NCT03519178|324481347|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
94733735|NCT03519178|324481348|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
94733736|NCT03519178|324481334|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
94733737|NCT03519178|324481335|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
94733738|NCT03519178|324481336|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
94733739|NCT03519178|324481337|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
94733740|NCT03519178|324481338|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
94733741|NCT03519178|324481339|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
94733742|NCT03519178|324481340|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
94733743|NCT03519178|324481341|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
94733744|NCT03519178|324481342|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
94733745|NCT03519178|324481343|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
94733746|NCT03519178|324481344|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
94733747|NCT03519178|324481345|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
94733748|NCT03519178|324481346|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
94733749|NCT03519178|324481347|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
94733750|NCT03519178|324481348|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
94733751|NCT03519178|324481334|FG000|Follow-Up|Death|0|||
94733752|NCT03519178|324481335|FG001|Follow-Up|Death|0|||
94733753|NCT03519178|324481336|FG002|Follow-Up|Death|1|||
94733754|NCT03519178|324481337|FG003|Follow-Up|Death|0|||
94733755|NCT03519178|324481338|FG004|Follow-Up|Death|0|||
94733756|NCT03519178|324481339|FG005|Follow-Up|Death|0|||
94733757|NCT03519178|324481340|FG006|Follow-Up|Death|0|||
94274672|NCT03134599|322798578|FG002|Week 1|Lost to Follow-up|0|||
94274673|NCT03134599|322798579|FG003|Week 1|Lost to Follow-up|0|||
94274674|NCT03134599|322798580|FG004|Week 1|Lost to Follow-up|1|||
94274675|NCT03134599|322798581|FG005|Week 1|Lost to Follow-up|0|||
94733758|NCT03519178|324481341|FG007|Follow-Up|Death|0|||
94733759|NCT03519178|324481342|FG008|Follow-Up|Death|3|||
94733760|NCT03519178|324481343|FG009|Follow-Up|Death|1|||
94733761|NCT03519178|324481344|FG010|Follow-Up|Death|0|||
94733762|NCT03519178|324481345|FG011|Follow-Up|Death|0|||
94733763|NCT03519178|324481346|FG012|Follow-Up|Death|2|||
94733764|NCT03519178|324481347|FG013|Follow-Up|Death|0|||
94733765|NCT03519178|324481348|FG014|Follow-Up|Death|0|||
94733766|NCT03519178|324481334|FG000|Follow-Up|Lost to Follow-up|0|||
94733767|NCT03519178|324481335|FG001|Follow-Up|Lost to Follow-up|0|||
94733768|NCT03519178|324481336|FG002|Follow-Up|Lost to Follow-up|0|||
94733769|NCT03519178|324481337|FG003|Follow-Up|Lost to Follow-up|0|||
94733770|NCT03519178|324481338|FG004|Follow-Up|Lost to Follow-up|0|||
94733771|NCT03519178|324481339|FG005|Follow-Up|Lost to Follow-up|3|||
94733772|NCT03519178|324481340|FG006|Follow-Up|Lost to Follow-up|1|||
94733773|NCT03519178|324481341|FG007|Follow-Up|Lost to Follow-up|4|||
94733774|NCT03519178|324481342|FG008|Follow-Up|Lost to Follow-up|1|||
94733775|NCT03519178|324481343|FG009|Follow-Up|Lost to Follow-up|0|||
94733776|NCT03519178|324481344|FG010|Follow-Up|Lost to Follow-up|0|||
94733777|NCT03519178|324481345|FG011|Follow-Up|Lost to Follow-up|0|||
94733778|NCT03519178|324481346|FG012|Follow-Up|Lost to Follow-up|0|||
94733779|NCT03519178|324481347|FG013|Follow-Up|Lost to Follow-up|0|||
94733780|NCT03519178|324481348|FG014|Follow-Up|Lost to Follow-up|0|||
94733781|NCT03519178|324481334|FG000|Follow-Up|Withdrawal by Subject|1|||
94733782|NCT03519178|324481335|FG001|Follow-Up|Withdrawal by Subject|2|||
94733783|NCT03519178|324481336|FG002|Follow-Up|Withdrawal by Subject|2|||
94733784|NCT03519178|324481337|FG003|Follow-Up|Withdrawal by Subject|3|||
94733785|NCT03519178|324481338|FG004|Follow-Up|Withdrawal by Subject|5|||
94733786|NCT03519178|324481339|FG005|Follow-Up|Withdrawal by Subject|1|||
94733787|NCT03519178|324481340|FG006|Follow-Up|Withdrawal by Subject|2|||
94733788|NCT03519178|324481341|FG007|Follow-Up|Withdrawal by Subject|6|||
94733789|NCT03519178|324481342|FG008|Follow-Up|Withdrawal by Subject|5|||
94733790|NCT03519178|324481343|FG009|Follow-Up|Withdrawal by Subject|2|||
94733791|NCT03519178|324481344|FG010|Follow-Up|Withdrawal by Subject|3|||
94733792|NCT03519178|324481345|FG011|Follow-Up|Withdrawal by Subject|5|||
94733793|NCT03519178|324481346|FG012|Follow-Up|Withdrawal by Subject|2|||
94733794|NCT03519178|324481347|FG013|Follow-Up|Withdrawal by Subject|0|||
94733795|NCT03519178|324481348|FG014|Follow-Up|Withdrawal by Subject|0|||
94733796|NCT03519178|324481334|FG000|Follow-Up|Other|0|||
94733797|NCT03519178|324481335|FG001|Follow-Up|Other|0|||
94733798|NCT03519178|324481336|FG002|Follow-Up|Other|0|||
94733799|NCT03519178|324481337|FG003|Follow-Up|Other|0|||
94733800|NCT03519178|324481338|FG004|Follow-Up|Other|0|||
94733801|NCT03519178|324481339|FG005|Follow-Up|Other|0|||
94733802|NCT03519178|324481340|FG006|Follow-Up|Other|0|||
94733803|NCT03519178|324481341|FG007|Follow-Up|Other|1|||
94733804|NCT03519178|324481342|FG008|Follow-Up|Other|0|||
94733805|NCT03519178|324481343|FG009|Follow-Up|Other|0|||
94733806|NCT03519178|324481344|FG010|Follow-Up|Other|0|||
94733807|NCT03519178|324481345|FG011|Follow-Up|Other|0|||
94733808|NCT03519178|324481346|FG012|Follow-Up|Other|0|||
94733809|NCT03519178|324481347|FG013|Follow-Up|Other|0|||
94733810|NCT03519178|324481348|FG014|Follow-Up|Other|0|||
94733811|NCT03519178|324481334|FG000|Long-term Follow-up|Death|0|||
94733812|NCT03519178|324481335|FG001|Long-term Follow-up|Death|0|||
94733813|NCT03519178|324481336|FG002|Long-term Follow-up|Death|0|||
94733814|NCT03519178|324481337|FG003|Long-term Follow-up|Death|0|||
94733815|NCT03519178|324481338|FG004|Long-term Follow-up|Death|0|||
94733816|NCT03519178|324481339|FG005|Long-term Follow-up|Death|0|||
94733817|NCT03519178|324481340|FG006|Long-term Follow-up|Death|0|||
94274676|NCT03134599|322798576|FG000|Week 2|Lost to Follow-up|1|||
94733818|NCT03519178|324481341|FG007|Long-term Follow-up|Death|0|||
94733819|NCT03519178|324481342|FG008|Long-term Follow-up|Death|0|||
94733820|NCT03519178|324481343|FG009|Long-term Follow-up|Death|0|||
94733821|NCT03519178|324481344|FG010|Long-term Follow-up|Death|0|||
94733822|NCT03519178|324481345|FG011|Long-term Follow-up|Death|0|||
94733823|NCT03519178|324481346|FG012|Long-term Follow-up|Death|0|||
94733824|NCT03519178|324481347|FG013|Long-term Follow-up|Death|4|||
94733825|NCT03519178|324481348|FG014|Long-term Follow-up|Death|4|||
94733826|NCT03519178|324481334|FG000|Long-term Follow-up|Lost to Follow-up|0|||
94733827|NCT03519178|324481335|FG001|Long-term Follow-up|Lost to Follow-up|0|||
94733828|NCT03519178|324481336|FG002|Long-term Follow-up|Lost to Follow-up|0|||
94733829|NCT03519178|324481337|FG003|Long-term Follow-up|Lost to Follow-up|0|||
94733830|NCT03519178|324481338|FG004|Long-term Follow-up|Lost to Follow-up|0|||
94733831|NCT03519178|324481339|FG005|Long-term Follow-up|Lost to Follow-up|0|||
94733832|NCT03519178|324481340|FG006|Long-term Follow-up|Lost to Follow-up|0|||
94733833|NCT03519178|324481341|FG007|Long-term Follow-up|Lost to Follow-up|0|||
94733834|NCT03519178|324481342|FG008|Long-term Follow-up|Lost to Follow-up|0|||
94733835|NCT03519178|324481343|FG009|Long-term Follow-up|Lost to Follow-up|0|||
94733836|NCT03519178|324481344|FG010|Long-term Follow-up|Lost to Follow-up|0|||
94733837|NCT03519178|324481345|FG011|Long-term Follow-up|Lost to Follow-up|0|||
94733838|NCT03519178|324481346|FG012|Long-term Follow-up|Lost to Follow-up|0|||
94733839|NCT03519178|324481347|FG013|Long-term Follow-up|Lost to Follow-up|1|||
94733840|NCT03519178|324481348|FG014|Long-term Follow-up|Lost to Follow-up|1|||
94274677|NCT03134599|322798577|FG001|Week 2|Lost to Follow-up|0|||
94274678|NCT03134599|322798578|FG002|Week 2|Lost to Follow-up|0|||
94733841|NCT03519178|324481334|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
94733842|NCT03519178|324481335|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
94733843|NCT03519178|324481336|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
94733844|NCT03519178|324481337|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
94733845|NCT03519178|324481338|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
94733846|NCT03519178|324481339|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
94733847|NCT03519178|324481340|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
94733848|NCT03519178|324481341|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
94733849|NCT03519178|324481342|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
94733850|NCT03519178|324481343|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
94733851|NCT03519178|324481344|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
94733852|NCT03519178|324481345|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
94733853|NCT03519178|324481346|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
94733854|NCT03519178|324481347|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
94733855|NCT03519178|324481348|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
94733856|NCT03519178|324481334|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
94733857|NCT03519178|324481335|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
94733858|NCT03519178|324481336|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
94733859|NCT03519178|324481337|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
94733860|NCT03519178|324481338|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
94733861|NCT03519178|324481339|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
94733862|NCT03519178|324481340|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
94733863|NCT03519178|324481341|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
94733864|NCT03519178|324481342|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
94733865|NCT03519178|324481343|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
94733866|NCT03519178|324481344|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
94733867|NCT03519178|324481345|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
94733868|NCT03519178|324481346|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
94733869|NCT03519178|324481347|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
94733870|NCT03519178|324481348|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
94733871|NCT03519178|324481334|FG000|Long-term Follow-up|Other|0|||
94733872|NCT03519178|324481335|FG001|Long-term Follow-up|Other|0|||
94733873|NCT03519178|324481336|FG002|Long-term Follow-up|Other|0|||
94733874|NCT03519178|324481337|FG003|Long-term Follow-up|Other|0|||
94733875|NCT03519178|324481338|FG004|Long-term Follow-up|Other|0|||
94733876|NCT03519178|324481339|FG005|Long-term Follow-up|Other|0|||
94733877|NCT03519178|324481340|FG006|Long-term Follow-up|Other|0|||
94733878|NCT03519178|324481341|FG007|Long-term Follow-up|Other|0|||
94733879|NCT03519178|324481342|FG008|Long-term Follow-up|Other|0|||
94733880|NCT03519178|324481343|FG009|Long-term Follow-up|Other|0|||
94733881|NCT03519178|324481344|FG010|Long-term Follow-up|Other|0|||
94733882|NCT03519178|324481345|FG011|Long-term Follow-up|Other|0|||
94733883|NCT03519178|324481346|FG012|Long-term Follow-up|Other|0|||
94733884|NCT03519178|324481347|FG013|Long-term Follow-up|Other|0|||
94733885|NCT03519178|324481348|FG014|Long-term Follow-up|Other|1|||
94733886|NCT03519178|324481334|FG000|Long-term Follow-up|Ongoing|0|||
94733887|NCT03519178|324481335|FG001|Long-term Follow-up|Ongoing|0|||
94733888|NCT03519178|324481336|FG002|Long-term Follow-up|Ongoing|0|||
94733889|NCT03519178|324481337|FG003|Long-term Follow-up|Ongoing|0|||
94733890|NCT03519178|324481338|FG004|Long-term Follow-up|Ongoing|0|||
94733891|NCT03519178|324481339|FG005|Long-term Follow-up|Ongoing|0|||
94733892|NCT03519178|324481340|FG006|Long-term Follow-up|Ongoing|0|||
94733893|NCT03519178|324481341|FG007|Long-term Follow-up|Ongoing|0|||
94733894|NCT03519178|324481342|FG008|Long-term Follow-up|Ongoing|0|||
94733895|NCT03519178|324481343|FG009|Long-term Follow-up|Ongoing|0|||
94274679|NCT03134599|322798579|FG003|Week 2|Lost to Follow-up|1|||
94274680|NCT03134599|322798580|FG004|Week 2|Lost to Follow-up|1|||
94274681|NCT03134599|322798581|FG005|Week 2|Lost to Follow-up|0|||
94274682|NCT03134599|322798576|FG000|Week 3|Lost to Follow-up|0|||
94274683|NCT03134599|322798577|FG001|Week 3|Lost to Follow-up|0|||
94733896|NCT03519178|324481344|FG010|Long-term Follow-up|Ongoing|0|||
94733897|NCT03519178|324481345|FG011|Long-term Follow-up|Ongoing|0|||
94733898|NCT03519178|324481346|FG012|Long-term Follow-up|Ongoing|0|||
94733899|NCT03519178|324481347|FG013|Long-term Follow-up|Ongoing|1|||
94733900|NCT03519178|324481348|FG014|Long-term Follow-up|Ongoing|0|||
94733901|NCT04230681|324481349|FG000|Overall Study|Physician Decision|2|||
94733902|NCT04230681|324481350|FG001|Overall Study|Physician Decision|3|||
94733903|NCT04230681|324481349|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
94733904|NCT04230681|324481350|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
94733905|NCT04230681|324481349|FG000|Overall Study|IV inadvertently removed|0|||
94733906|NCT04230681|324481350|FG001|Overall Study|IV inadvertently removed|1|||
94733907|NCT03819153|324483124|FG000|Overall Study|Withdrawal by Subject|20|||
94733908|NCT03819153|324483125|FG001|Overall Study|Withdrawal by Subject|28|||
94733909|NCT03819153|324483124|FG000|Overall Study|Lost to Follow-up|23|||
94733910|NCT03819153|324483125|FG001|Overall Study|Lost to Follow-up|30|||
94733911|NCT03527043|324483126|FG000|Overall Study|Withdrawal by Subject|1|||
94733912|NCT03527043|324483127|FG001|Overall Study|Withdrawal by Subject|0|||
94733913|NCT02860130|324483132|FG000|Overall Study|Adverse Event|2|||
94733914|NCT02860130|324483133|FG001|Overall Study|Adverse Event|3|||
94733915|NCT02860130|324483132|FG000|Overall Study|Protocol Violation|1|||
94733916|NCT02860130|324483133|FG001|Overall Study|Protocol Violation|1|||
94733917|NCT02860130|324483132|FG000|Overall Study|Withdrawal by Subject|0|||
94733918|NCT02860130|324483133|FG001|Overall Study|Withdrawal by Subject|2|||
94733919|NCT02860130|324483132|FG000|Overall Study|Physician Decision|2|||
94733920|NCT02860130|324483133|FG001|Overall Study|Physician Decision|2|||
94733921|NCT02860130|324483132|FG000|Overall Study|Other|2|||
94733922|NCT02860130|324483133|FG001|Overall Study|Other|1|||
94733923|NCT03213691|324483134|FG000|Overall Study|Adverse Event|2|||
94733924|NCT03213691|324483134|FG000|Overall Study|Death|3|||
94733925|NCT03213691|324483134|FG000|Overall Study|Physician Decision|1|||
94733926|NCT03213691|324483134|FG000|Overall Study|Progressive Disease|14|||
94733927|NCT03213691|324483134|FG000|Overall Study|Ineligible|1|||
94733928|NCT03604692|324483135|FG000|Overall Study|Investigator's Decision|0|||
94733929|NCT03604692|324483136|FG001|Overall Study|Investigator's Decision|0|||
94733930|NCT03604692|324483137|FG002|Overall Study|Investigator's Decision|0|||
94733931|NCT03604692|324483138|FG003|Overall Study|Investigator's Decision|1|||
94733932|NCT03604692|324483139|FG004|Overall Study|Investigator's Decision|0|||
94733933|NCT03604692|324483140|FG005|Overall Study|Investigator's Decision|7|||
94733934|NCT03604692|324483135|FG000|Overall Study|Withdrawal by Subject|0|||
94733935|NCT03604692|324483136|FG001|Overall Study|Withdrawal by Subject|0|||
94733936|NCT03604692|324483137|FG002|Overall Study|Withdrawal by Subject|0|||
94733937|NCT03604692|324483138|FG003|Overall Study|Withdrawal by Subject|0|||
94733938|NCT03604692|324483139|FG004|Overall Study|Withdrawal by Subject|0|||
94733939|NCT03604692|324483140|FG005|Overall Study|Withdrawal by Subject|2|||
94733940|NCT03604692|324483135|FG000|Overall Study|Progressive Disease|1|||
94733941|NCT03604692|324483136|FG001|Overall Study|Progressive Disease|0|||
94733942|NCT03604692|324483137|FG002|Overall Study|Progressive Disease|1|||
94733943|NCT03604692|324483138|FG003|Overall Study|Progressive Disease|0|||
94733944|NCT03604692|324483139|FG004|Overall Study|Progressive Disease|3|||
94733945|NCT03604692|324483140|FG005|Overall Study|Progressive Disease|4|||
94733946|NCT03604692|324483135|FG000|Overall Study|Difficulty Coming into Site.|0|||
94733947|NCT03604692|324483136|FG001|Overall Study|Difficulty Coming into Site.|0|||
94733948|NCT03604692|324483137|FG002|Overall Study|Difficulty Coming into Site.|0|||
94733949|NCT03604692|324483138|FG003|Overall Study|Difficulty Coming into Site.|0|||
94733950|NCT03604692|324483139|FG004|Overall Study|Difficulty Coming into Site.|0|||
94733951|NCT03604692|324483140|FG005|Overall Study|Difficulty Coming into Site.|1|||
94733952|NCT03604692|324483135|FG000|Overall Study|Death|0|||
94733953|NCT03604692|324483136|FG001|Overall Study|Death|0|||
94733954|NCT03604692|324483137|FG002|Overall Study|Death|1|||
94733955|NCT03604692|324483138|FG003|Overall Study|Death|0|||
94733956|NCT03604692|324483139|FG004|Overall Study|Death|0|||
94733957|NCT03604692|324483140|FG005|Overall Study|Death|0|||
94733958|NCT03604692|324483135|FG000|Overall Study|Drug Intolerance|0|||
94733959|NCT03604692|324483136|FG001|Overall Study|Drug Intolerance|0|||
94733960|NCT03604692|324483137|FG002|Overall Study|Drug Intolerance|0|||
94733961|NCT03604692|324483138|FG003|Overall Study|Drug Intolerance|1|||
94733962|NCT03604692|324483139|FG004|Overall Study|Drug Intolerance|0|||
94733963|NCT03604692|324483140|FG005|Overall Study|Drug Intolerance|0|||
94733964|NCT03604692|324483135|FG000|Overall Study|Noncompliance with follow-up visit|0|||
94733965|NCT03604692|324483136|FG001|Overall Study|Noncompliance with follow-up visit|0|||
94733966|NCT03604692|324483137|FG002|Overall Study|Noncompliance with follow-up visit|0|||
94733967|NCT03604692|324483138|FG003|Overall Study|Noncompliance with follow-up visit|1|||
94733968|NCT03604692|324483139|FG004|Overall Study|Noncompliance with follow-up visit|0|||
94733969|NCT03604692|324483140|FG005|Overall Study|Noncompliance with follow-up visit|0|||
94733970|NCT03604692|324483135|FG000|Overall Study|Continuing Treatment/In Follow-Up|0|||
94733971|NCT03604692|324483136|FG001|Overall Study|Continuing Treatment/In Follow-Up|0|||
94733972|NCT03604692|324483137|FG002|Overall Study|Continuing Treatment/In Follow-Up|1|||
94733973|NCT03604692|324483138|FG003|Overall Study|Continuing Treatment/In Follow-Up|1|||
94733974|NCT03604692|324483139|FG004|Overall Study|Continuing Treatment/In Follow-Up|0|||
94733975|NCT03604692|324483140|FG005|Overall Study|Continuing Treatment/In Follow-Up|0|||
94733976|NCT03604692|324483135|FG000|Overall Study|Not Treated|0|||
94733977|NCT03604692|324483136|FG001|Overall Study|Not Treated|0|||
94733978|NCT03604692|324483137|FG002|Overall Study|Not Treated|0|||
94733979|NCT03604692|324483138|FG003|Overall Study|Not Treated|0|||
94733980|NCT03604692|324483139|FG004|Overall Study|Not Treated|1|||
94733981|NCT03604692|324483140|FG005|Overall Study|Not Treated|0|||
94733982|NCT01733316|324483144|FG000|RP103 Phase|Non-compliance|1|||
94733983|NCT01733316|324483144|FG000|Long Term Extension Phase|Adverse Event|1|||
94274684|NCT03134599|322798578|FG002|Week 3|Lost to Follow-up|0|||
94274685|NCT03134599|322798579|FG003|Week 3|Lost to Follow-up|1|||
94274686|NCT03134599|322798580|FG004|Week 3|Lost to Follow-up|0|||
94274687|NCT03134599|322798581|FG005|Week 3|Lost to Follow-up|1|||
94274688|NCT00750737|322798584|FG000|Overall Study|Withdrawal by Subject|3|||
94274689|NCT00750737|322798585|FG001|Overall Study|Withdrawal by Subject|3|||
94274690|NCT03972969|322798586|FG000|3-month Follow-up|Death|1|||
94274691|NCT03972969|322798587|FG001|3-month Follow-up|Death|1|||
94274692|NCT03972969|322798588|FG002|3-month Follow-up|Death|0|||
94274693|NCT03972969|322798586|FG000|6-month Follow-up|Death|1|||
94274694|NCT03972969|322798587|FG001|6-month Follow-up|Death|1|||
94274695|NCT03972969|322798588|FG002|6-month Follow-up|Death|1|||
94274696|NCT03972969|322798586|FG000|6-month Follow-up|Lost to Follow-up|2|||
94274697|NCT03972969|322798587|FG001|6-month Follow-up|Lost to Follow-up|2|||
94274698|NCT03972969|322798588|FG002|6-month Follow-up|Lost to Follow-up|2|||
94274699|NCT01576549|322798595|FG000|Overall Study|Sponsor Decision|2|||
94274700|NCT04037748|322798596|FG000|Treatment Period 1|Withdrawal by Subject|3|||
94274701|NCT04037748|322798597|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94274702|NCT04037748|322798596|FG000|Treatment Period 1|Adverse Event|1|||
94274703|NCT04037748|322798597|FG001|Treatment Period 1|Adverse Event|1|||
94274704|NCT04037748|322798596|FG000|Treatment Period 1|Protocol Violation|4|||
94274705|NCT04037748|322798597|FG001|Treatment Period 1|Protocol Violation|5|||
94274706|NCT04037748|322798596|FG000|Treatment Period 2|Adverse Event|0|||
94274707|NCT04037748|322798597|FG001|Treatment Period 2|Adverse Event|1|||
94274708|NCT04037748|322798596|FG000|Treatment Period 2|Protocol Violation|2|||
94274709|NCT04037748|322798597|FG001|Treatment Period 2|Protocol Violation|0|||
94274710|NCT00879645|322798598|FG000|Overall Study|Adverse Event|1|||
94274711|NCT00879645|322798599|FG001|Overall Study|Adverse Event|0|||
94368769|NCT03276962|323136547|FG004|Overall Study|Lost to Follow-up|10|||
94368770|NCT03276962|323136543|FG000|Overall Study|Other|0|||
94368771|NCT03276962|323136544|FG001|Overall Study|Other|2|||
94368772|NCT03276962|323136545|FG002|Overall Study|Other|0|||
94368773|NCT03276962|323136546|FG003|Overall Study|Other|2|||
94368774|NCT03276962|323136547|FG004|Overall Study|Other|1|||
94368775|NCT03611751|323136548|FG000|Pre-treatment|Randomized but not treated|1|||
94368776|NCT03611751|323136549|FG001|Pre-treatment|Randomized but not treated|1|||
94733984|NCT01733316|324483144|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
94274712|NCT00879645|322798600|FG002|Overall Study|Adverse Event|0|||
94274713|NCT00879645|322798601|FG003|Overall Study|Adverse Event|0|||
94274714|NCT03775421|322798602|FG000|Overall Study|Lost to Follow-up|2|||
94274715|NCT03775421|322798602|FG000|Overall Study|Withdrawal by Subject|10|||
94274716|NCT03775421|322798602|FG000|Overall Study|Physician Decision|3|||
94274717|NCT03775421|322798602|FG000|Overall Study|Death|1|||
94274718|NCT03775421|322798602|FG000|Overall Study|Study Terminated by Sponsor|94|||
94274719|NCT03917823|322798603|FG000|Overall Study|Lost to Follow-up|1|||
94274720|NCT03917823|322798604|FG001|Overall Study|Lost to Follow-up|1|||
94274721|NCT03917823|322798603|FG000|Overall Study|Withdrawal by Subject|0|||
94274722|NCT03917823|322798604|FG001|Overall Study|Withdrawal by Subject|1|||
94733985|NCT01733316|324483144|FG000|Long Term Extension Phase|Sponsor Decision|2|||
94733986|NCT03240016|324483148|FG000|Overall Study|Adverse Event|9|||
94733987|NCT03240016|324483148|FG000|Overall Study|Withdrawal by Subject|7|||
94733988|NCT03240016|324483148|FG000|Overall Study|Death|1|||
94733989|NCT03240016|324483148|FG000|Overall Study|Physician Decision|2|||
94733990|NCT05299723|324483149|FG000|Overall Study|Withdrawal by Subject|0|||
94733991|NCT05299723|324483150|FG001|Overall Study|Withdrawal by Subject|2|||
94733992|NCT05299723|324483151|FG002|Overall Study|Withdrawal by Subject|0|||
94733993|NCT01959607|324483152|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
94733994|NCT01959607|324483153|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
94733995|NCT01959607|324483154|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
94733996|NCT01959607|324483155|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
94733997|NCT05546411|324483156|FG000|Overall Study|Progressive Disease|1|||
94733998|NCT05546411|324483157|FG001|Overall Study|Progressive Disease|0|||
94733999|NCT05546411|324483156|FG000|Overall Study|Adverse Event|0|||
94274723|NCT00884273|322798605|FG000|Overall Study|Adverse Event|0|||
94368777|NCT03611751|323136550|FG002|Pre-treatment|Randomized but not treated|0|||
94368778|NCT03611751|323136548|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
94368779|NCT03611751|323136549|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
94368780|NCT03611751|323136550|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
94274724|NCT00884273|322798606|FG001|Overall Study|Adverse Event|2|||
94274725|NCT00884273|322798605|FG000|Overall Study|Protocol Violation|1|||
94274726|NCT00884273|322798606|FG001|Overall Study|Protocol Violation|3|||
94274727|NCT00884273|322798605|FG000|Overall Study|Practical reasons|1|||
94274728|NCT00884273|322798606|FG001|Overall Study|Practical reasons|0|||
94274729|NCT00473343|322798607|FG000|Overall Study|Adverse Event|9|||
94274730|NCT00473343|322798607|FG000|Overall Study|Lost to Follow-up|8|||
94274731|NCT00473343|322798607|FG000|Overall Study|Treatment failure|27|||
94734000|NCT05546411|324483157|FG001|Overall Study|Adverse Event|1|||
94734001|NCT05546411|324483156|FG000|Overall Study|Metastatic disease|1|||
94734002|NCT05546411|324483157|FG001|Overall Study|Metastatic disease|0|||
94734003|NCT03913442|324483158|FG000|Overall Study|Adverse Event|0|||
94274732|NCT00473343|322798607|FG000|Overall Study|Withdrew consent|3|||
94734004|NCT03913442|324483159|FG001|Overall Study|Adverse Event|3|||
94734005|NCT03913442|324483158|FG000|Overall Study|Withdrawal by Subject|5|||
94734006|NCT03913442|324483159|FG001|Overall Study|Withdrawal by Subject|5|||
94734007|NCT03913442|324483158|FG000|Overall Study|Terminations|2|||
94734008|NCT03913442|324483159|FG001|Overall Study|Terminations|1|||
94734009|NCT03913442|324483158|FG000|Overall Study|Lost to Follow-up|2|||
94734010|NCT03913442|324483159|FG001|Overall Study|Lost to Follow-up|2|||
94734011|NCT02966873|324483168|FG000|Overall Study|Lost to Follow-up|16|||
94734012|NCT02966873|324483169|FG001|Overall Study|Lost to Follow-up|15|||
94734013|NCT03710603|324483170|FG000|Overall Study|Adverse Event|1|||
94734014|NCT03710603|324483171|FG001|Overall Study|Adverse Event|0|||
94734015|NCT03710603|324483170|FG000|Overall Study|Death|44|||
94734016|NCT03710603|324483171|FG001|Overall Study|Death|34|||
94734017|NCT03710603|324483170|FG000|Overall Study|Lost to Follow-up|3|||
94734018|NCT03710603|324483171|FG001|Overall Study|Lost to Follow-up|5|||
94734019|NCT03710603|324483170|FG000|Overall Study|Withdrawal by Subject|11|||
94734020|NCT03710603|324483171|FG001|Overall Study|Withdrawal by Subject|10|||
94734021|NCT01456949|324483172|FG000|Enrollment|PI death- incomplete data|6|||
94734022|NCT01456949|324483172|FG000|Enrollment|Death|1|||
94734023|NCT01456949|324483172|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
94734024|NCT01456949|324483172|FG000|Enrollment|Physician Decision|10|||
94734025|NCT01456949|324483172|FG000|Enrollment|Withdrawal by Subject|7|||
94734026|NCT01456949|324483172|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
94734027|NCT01456949|324483172|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
94734028|NCT01456949|324483172|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
94734029|NCT01456949|324483172|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
94734030|NCT01456949|324483172|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
94734031|NCT01456949|324483172|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
94734032|NCT01456949|324483172|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
94734033|NCT01456949|324483172|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
94734034|NCT02626533|324483173|FG000|Overall Study|Protocol Violation|14|||
94734035|NCT02626533|324483173|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
94734036|NCT02626533|324483173|FG000|Overall Study|Withdrawal by Subject|1|||
94734037|NCT04200456|324483176|FG000|Overall Study|Physician Decision|0|||
94734038|NCT04200456|324483177|FG001|Overall Study|Physician Decision|1|||
94734039|NCT04200456|324483176|FG000|Overall Study|Withdrawal by Subject|2|||
94734040|NCT04200456|324483177|FG001|Overall Study|Withdrawal by Subject|2|||
94734041|NCT04200456|324483176|FG000|Overall Study|Lack of Efficacy|1|||
94734042|NCT04200456|324483177|FG001|Overall Study|Lack of Efficacy|1|||
94734043|NCT04200456|324483176|FG000|Overall Study|Adverse event, non-fatal|0|||
94734044|NCT04200456|324483177|FG001|Overall Study|Adverse event, non-fatal|1|||
94734045|NCT04200456|324483176|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
94734046|NCT04200456|324483177|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
94734047|NCT00592852|324483178|FG000|Overall Study|Non-compliance|1|||
94734048|NCT00592852|324483178|FG000|Overall Study|Adverse Event|3|||
94734049|NCT00592852|324483178|FG000|Overall Study|Found ineligible|1|||
94734050|NCT00592852|324483178|FG000|Overall Study|Withdrawal by Subject|1|||
94734051|NCT05002088|324483180|FG000|Overall Study|Withdrawal by Subject|9|||
94734052|NCT05002088|324483181|FG001|Overall Study|Withdrawal by Subject|0|||
94734053|NCT05002088|324483180|FG000|Overall Study|Lost to Follow-up|0|||
94734054|NCT05002088|324483181|FG001|Overall Study|Lost to Follow-up|1|||
94734055|NCT05002088|324483180|FG000|Overall Study|Death|16|||
94734056|NCT05002088|324483181|FG001|Overall Study|Death|2|||
94734057|NCT05002088|324483180|FG000|Overall Study|Protocol Violation|25|||
94734058|NCT05002088|324483181|FG001|Overall Study|Protocol Violation|7|||
94734059|NCT02723591|324483182|FG000|Overall Study|Adverse Event|48|||
94734060|NCT02723591|324483183|FG001|Overall Study|Adverse Event|40|||
94734061|NCT02723591|324483182|FG000|Overall Study|Death|2|||
94734062|NCT02723591|324483183|FG001|Overall Study|Death|2|||
94734063|NCT02723591|324483182|FG000|Overall Study|Lack of Efficacy|4|||
94734064|NCT02723591|324483183|FG001|Overall Study|Lack of Efficacy|3|||
94734065|NCT02723591|324483182|FG000|Overall Study|Lost to Follow-up|1|||
94734066|NCT02723591|324483183|FG001|Overall Study|Lost to Follow-up|7|||
94734067|NCT02723591|324483182|FG000|Overall Study|Protocol Violation|20|||
94734068|NCT02723591|324483183|FG001|Overall Study|Protocol Violation|23|||
94734069|NCT02723591|324483182|FG000|Overall Study|Withdrawal by Subject|4|||
94734070|NCT02723591|324483183|FG001|Overall Study|Withdrawal by Subject|8|||
94734071|NCT02723591|324483182|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
94734072|NCT02723591|324483183|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
94734073|NCT02723591|324483182|FG000|Overall Study|Miscellaneous|5|||
94734074|NCT02723591|324483183|FG001|Overall Study|Miscellaneous|6|||
94734075|NCT04117347|324483184|FG000|Overall Study|Adverse Event|0|||
94734076|NCT04117347|324483185|FG001|Overall Study|Adverse Event|0|||
94734077|NCT04117347|324483186|FG002|Overall Study|Adverse Event|1|||
94734078|NCT04117347|324483184|FG000|Overall Study|No time for study|0|||
94734079|NCT04117347|324483185|FG001|Overall Study|No time for study|2|||
94734080|NCT04117347|324483186|FG002|Overall Study|No time for study|0|||
94734081|NCT04117347|324483184|FG000|Overall Study|Family emergency|1|||
94734082|NCT04117347|324483185|FG001|Overall Study|Family emergency|0|||
94734083|NCT04117347|324483186|FG002|Overall Study|Family emergency|0|||
94734084|NCT03463044|324483191|FG000|Overall Study|Lost to Follow-up|0|||
94734085|NCT03463044|324483192|FG001|Overall Study|Lost to Follow-up|0|||
94734086|NCT03463044|324483193|FG002|Overall Study|Lost to Follow-up|0|||
94734087|NCT03463044|324483194|FG003|Overall Study|Lost to Follow-up|0|||
94734088|NCT03463044|324483195|FG004|Overall Study|Lost to Follow-up|0|||
94734089|NCT03463044|324483196|FG005|Overall Study|Lost to Follow-up|0|||
94734090|NCT03463044|324483197|FG006|Overall Study|Lost to Follow-up|0|||
94734091|NCT03463044|324483198|FG007|Overall Study|Lost to Follow-up|1|||
94734092|NCT03463044|324483199|FG008|Overall Study|Lost to Follow-up|0|||
94734093|NCT05764525|324483200|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
94734094|NCT05764525|324483201|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
94734095|NCT05764525|324483200|FG000|Overall Study|Withdrawal by Subject|4|||
94734096|NCT05764525|324483201|FG001|Overall Study|Withdrawal by Subject|8|||
94734097|NCT05764525|324483200|FG000|Overall Study|Physician Decision|1|||
94734098|NCT05764525|324483201|FG001|Overall Study|Physician Decision|0|||
94734099|NCT01712490|324483206|FG000|Overall Study|Ongoing|601|||
94734100|NCT01712490|324483207|FG001|Overall Study|Ongoing|586|||
94734101|NCT01712490|324483206|FG000|Overall Study|Other|11|||
94734102|NCT01712490|324483207|FG001|Overall Study|Other|11|||
94734103|NCT01712490|324483206|FG000|Overall Study|Withdrawal by Subject|36|||
94734104|NCT01712490|324483207|FG001|Overall Study|Withdrawal by Subject|44|||
94734105|NCT01712490|324483206|FG000|Overall Study|Lost to Follow-up|16|||
94734106|NCT01712490|324483207|FG001|Overall Study|Lost to Follow-up|29|||
94734107|NCT04294641|324483208|FG000|Overall Study|Screen failure|4|||
94734108|NCT03987022|324483209|FG000|Overall Study|Lost to Follow-up|2|||
94734109|NCT03987022|324483210|FG001|Overall Study|Lost to Follow-up|2|||
94734110|NCT03987022|324483209|FG000|Overall Study|Withdrawal by Subject|1|||
94734111|NCT03987022|324483210|FG001|Overall Study|Withdrawal by Subject|0|||
94734112|NCT04800211|324483214|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
94734113|NCT04800211|324483215|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
94734114|NCT04800211|324483216|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
94734115|NCT04800211|324483214|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
94734116|NCT04800211|324483215|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
94734117|NCT04800211|324483216|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
94734118|NCT04800211|324483214|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
94734119|NCT04800211|324483215|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
94734120|NCT04800211|324483216|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
94734121|NCT04800211|324483214|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
94734122|NCT04800211|324483215|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
94734123|NCT04800211|324483216|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
94734124|NCT04800211|324483214|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
94734125|NCT04800211|324483215|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
94734126|NCT04800211|324483216|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
94734127|NCT04800211|324483214|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
94734128|NCT04800211|324483215|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
94734129|NCT04800211|324483216|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
94734130|NCT04800211|324483214|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
94734131|NCT04800211|324483215|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
94734132|NCT04800211|324483216|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
94734133|NCT04800211|324483214|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
94734134|NCT04800211|324483215|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
94734135|NCT04800211|324483216|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
94467452|NCT04015518|323500562|FG001|Overall Study|Pregnancy|0|||
94467453|NCT04015518|323500563|FG002|Overall Study|Pregnancy|0|||
94467454|NCT04015518|323500564|FG003|Overall Study|Pregnancy|0|||
94274733|NCT00473343|322798607|FG000|Overall Study|Other un-specified reason|3|||
94274734|NCT02290873|322798608|FG000|Overall Study|Withdrawal by Subject|0|||
94274735|NCT02290873|322798609|FG001|Overall Study|Withdrawal by Subject|1|||
94274736|NCT02290873|322798610|FG002|Overall Study|Withdrawal by Subject|1|||
94274737|NCT02290873|322798608|FG000|Overall Study|Nellcor device error|1|||
94274738|NCT02290873|322798609|FG001|Overall Study|Nellcor device error|0|||
94274739|NCT02290873|322798610|FG002|Overall Study|Nellcor device error|0|||
94274740|NCT02290873|322798608|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
94274741|NCT02290873|322798609|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
94274742|NCT02290873|322798610|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
94274743|NCT02290873|322798608|FG000|Overall Study|Protocol Violation|0|||
94274744|NCT02290873|322798609|FG001|Overall Study|Protocol Violation|0|||
94274745|NCT02290873|322798610|FG002|Overall Study|Protocol Violation|1|||
94274746|NCT02354222|322798613|FG000|Overall Study|Adverse Event|0|||
94274747|NCT02354222|322798614|FG001|Overall Study|Adverse Event|3|||
94274748|NCT02354222|322798613|FG000|Overall Study|Physician Decision|1|||
94274749|NCT02354222|322798614|FG001|Overall Study|Physician Decision|1|||
94274750|NCT02354222|322798613|FG000|Overall Study|Pregnancy|1|||
94274751|NCT02354222|322798614|FG001|Overall Study|Pregnancy|0|||
94274752|NCT02354222|322798613|FG000|Overall Study|Withdrawal by Subject|2|||
94274753|NCT02354222|322798614|FG001|Overall Study|Withdrawal by Subject|3|||
94274754|NCT02354222|322798613|FG000|Overall Study|Conflict with the stopping criteria|0|||
94274755|NCT02354222|322798614|FG001|Overall Study|Conflict with the stopping criteria|4|||
94274756|NCT00075400|322800241|FG000|Overall Study|Ineligible: wrong primary|1|||
94274757|NCT00075400|322800241|FG000|Overall Study|Never treated|2|||
94274758|NCT00075023|322800243|FG000|Pilot Study|Physician Decision|1|||
94734136|NCT04800211|324483214|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
94734137|NCT04800211|324483215|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
94734138|NCT04800211|324483216|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
94734139|NCT04800211|324483214|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
94734140|NCT04800211|324483215|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
94734141|NCT04800211|324483216|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
94734142|NCT04800211|324483214|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
94734143|NCT04800211|324483215|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
94734144|NCT04800211|324483216|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
94734145|NCT04907357|324483217|FG000|Overall Study|Death|0|||
94734146|NCT04907357|324483218|FG001|Overall Study|Death|1|||
94734147|NCT04907357|324483217|FG000|Overall Study|Lost to Follow-up|9|||
94734148|NCT04907357|324483218|FG001|Overall Study|Lost to Follow-up|18|||
94734149|NCT04907357|324483217|FG000|Overall Study|Physician Decision|1|||
94734150|NCT04907357|324483218|FG001|Overall Study|Physician Decision|0|||
94734151|NCT04907357|324483217|FG000|Overall Study|Withdrawal by Subject|0|||
94734152|NCT04907357|324483218|FG001|Overall Study|Withdrawal by Subject|1|||
94734153|NCT04907357|324483217|FG000|Overall Study|Unable to attend visits|1|||
94734154|NCT04907357|324483218|FG001|Overall Study|Unable to attend visits|0|||
94734155|NCT04907357|324483217|FG000|Overall Study|Incarcerated|1|||
94734156|NCT04907357|324483218|FG001|Overall Study|Incarcerated|1|||
94734157|NCT04875195|324483219|FG000|Overall Study|Death|9|||
94734158|NCT04875195|324483220|FG001|Overall Study|Death|3|||
94734159|NCT04875195|324483219|FG000|Overall Study|Withdrawal by Subject|2|||
94734160|NCT04875195|324483220|FG001|Overall Study|Withdrawal by Subject|1|||
94734161|NCT04875195|324483219|FG000|Overall Study|Ongoing in study|49|||
94734162|NCT04875195|324483220|FG001|Overall Study|Ongoing in study|2|||
94734163|NCT04730739|324483221|FG000|Overall Study|Death|1|||
94734164|NCT05975840|324483223|FG000|Overall Study|Other|1|||
94734165|NCT05975840|324483224|FG001|Overall Study|Other|0|||
94734166|NCT05975840|324483225|FG002|Overall Study|Other|0|||
94734167|NCT05975840|324483226|FG003|Overall Study|Other|0|||
94734168|NCT05975840|324483227|FG004|Overall Study|Other|1|||
94734169|NCT05975840|324483228|FG005|Overall Study|Other|0|||
94734170|NCT05975840|324483229|FG006|Overall Study|Other|0|||
94734171|NCT05975840|324483230|FG007|Overall Study|Other|0|||
94734172|NCT05975840|324483223|FG000|Overall Study|Lost to Follow-up|3|||
94734173|NCT05975840|324483224|FG001|Overall Study|Lost to Follow-up|6|||
94734174|NCT05975840|324483225|FG002|Overall Study|Lost to Follow-up|3|||
94734175|NCT05975840|324483226|FG003|Overall Study|Lost to Follow-up|1|||
94734176|NCT05975840|324483227|FG004|Overall Study|Lost to Follow-up|4|||
94734177|NCT05975840|324483228|FG005|Overall Study|Lost to Follow-up|1|||
94734178|NCT05975840|324483229|FG006|Overall Study|Lost to Follow-up|2|||
94734179|NCT05975840|324483230|FG007|Overall Study|Lost to Follow-up|4|||
94734180|NCT05975840|324483223|FG000|Overall Study|Migrated/moved from the study area|1|||
94734181|NCT05975840|324483224|FG001|Overall Study|Migrated/moved from the study area|0|||
94734182|NCT05975840|324483225|FG002|Overall Study|Migrated/moved from the study area|0|||
94734183|NCT05975840|324483226|FG003|Overall Study|Migrated/moved from the study area|0|||
94734184|NCT05975840|324483227|FG004|Overall Study|Migrated/moved from the study area|0|||
94734185|NCT05975840|324483228|FG005|Overall Study|Migrated/moved from the study area|0|||
94734186|NCT05975840|324483229|FG006|Overall Study|Migrated/moved from the study area|0|||
94734187|NCT05975840|324483230|FG007|Overall Study|Migrated/moved from the study area|0|||
94734188|NCT05975840|324483223|FG000|Overall Study|Withdrawal by Subject|0|||
94734189|NCT05975840|324483224|FG001|Overall Study|Withdrawal by Subject|5|||
94734190|NCT05975840|324483225|FG002|Overall Study|Withdrawal by Subject|2|||
94734191|NCT05975840|324483226|FG003|Overall Study|Withdrawal by Subject|2|||
94734192|NCT05975840|324483227|FG004|Overall Study|Withdrawal by Subject|0|||
94734193|NCT05975840|324483228|FG005|Overall Study|Withdrawal by Subject|2|||
94734194|NCT05975840|324483229|FG006|Overall Study|Withdrawal by Subject|2|||
94734195|NCT05975840|324483230|FG007|Overall Study|Withdrawal by Subject|1|||
94734196|NCT05975840|324483223|FG000|Overall Study|Protocol Violation|0|||
94734197|NCT05975840|324483224|FG001|Overall Study|Protocol Violation|1|||
94734198|NCT05975840|324483225|FG002|Overall Study|Protocol Violation|0|||
94734199|NCT05975840|324483226|FG003|Overall Study|Protocol Violation|0|||
94734200|NCT05975840|324483227|FG004|Overall Study|Protocol Violation|0|||
94734201|NCT05975840|324483228|FG005|Overall Study|Protocol Violation|0|||
94734202|NCT05975840|324483229|FG006|Overall Study|Protocol Violation|0|||
94734203|NCT05975840|324483230|FG007|Overall Study|Protocol Violation|0|||
94734204|NCT05975840|324483223|FG000|Overall Study|Adverse Event|0|||
94734205|NCT05975840|324483224|FG001|Overall Study|Adverse Event|0|||
94734206|NCT05975840|324483225|FG002|Overall Study|Adverse Event|0|||
94734207|NCT05975840|324483226|FG003|Overall Study|Adverse Event|1|||
94734208|NCT05975840|324483227|FG004|Overall Study|Adverse Event|0|||
94734209|NCT05975840|324483228|FG005|Overall Study|Adverse Event|0|||
94274759|NCT00075023|322800244|FG001|Pilot Study|Physician Decision|2|||
94274760|NCT00075023|322800243|FG000|Pilot Study|Withdrawal by Subject|1|||
94274761|NCT00075023|322800244|FG001|Pilot Study|Withdrawal by Subject|0|||
94274762|NCT04342871|322800245|FG000|Overall Study|Death|4|||
94274763|NCT04342871|322800245|FG000|Overall Study|Clinical deterioration/illness progression|2|||
94274764|NCT04342871|322800245|FG000|Overall Study|Did not complete baseline assessments|5|||
94274765|NCT04342871|322800245|FG000|Overall Study|Lost to Follow-up|13|||
94274766|NCT04179734|322800246|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
94274767|NCT04179734|322800247|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
94274768|NCT04179734|322800246|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
94274769|NCT04179734|322800247|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
94274770|NCT02982954|322800249|FG000|Overall Study|Death|55|||
94274771|NCT02982954|322800250|FG001|Overall Study|Death|29|||
94274772|NCT02982954|322800251|FG002|Overall Study|Death|15|||
94274773|NCT02982954|322800252|FG003|Overall Study|Death|20|||
94274774|NCT02982954|322800249|FG000|Overall Study|Lost to Follow-up|2|||
94274775|NCT02982954|322800250|FG001|Overall Study|Lost to Follow-up|1|||
94274776|NCT02982954|322800251|FG002|Overall Study|Lost to Follow-up|0|||
94274777|NCT02982954|322800252|FG003|Overall Study|Lost to Follow-up|0|||
94274778|NCT02982954|322800249|FG000|Overall Study|Participant withdrew consent|7|||
94274779|NCT02982954|322800250|FG001|Overall Study|Participant withdrew consent|5|||
94274780|NCT02982954|322800251|FG002|Overall Study|Participant withdrew consent|1|||
94274781|NCT02982954|322800252|FG003|Overall Study|Participant withdrew consent|1|||
94274782|NCT02982954|322800249|FG000|Overall Study|Other reasons|42|||
94274783|NCT02982954|322800250|FG001|Overall Study|Other reasons|17|||
94274784|NCT02982954|322800251|FG002|Overall Study|Other reasons|12|||
94274785|NCT02982954|322800252|FG003|Overall Study|Other reasons|3|||
94274786|NCT02982954|322800249|FG000|Overall Study|Premature site closure|0|||
94274787|NCT02982954|322800250|FG001|Overall Study|Premature site closure|0|||
94274788|NCT02982954|322800251|FG002|Overall Study|Premature site closure|0|||
94274789|NCT02982954|322800252|FG003|Overall Study|Premature site closure|1|||
94274790|NCT01429584|322800253|FG000|Overall Study|Withdrawal by Subject|1|||
94274791|NCT01429584|322800254|FG001|Overall Study|Withdrawal by Subject|0|||
94274792|NCT01429584|322800253|FG000|Overall Study|Protocol Violation|0|||
94274793|NCT01429584|322800254|FG001|Overall Study|Protocol Violation|1|||
94274794|NCT00916357|322800261|FG000|Period 1|Withdrawal by Subject|1|||
94274795|NCT00916357|322800262|FG001|Period 1|Withdrawal by Subject|0|||
94274796|NCT00916357|322800263|FG002|Period 1|Withdrawal by Subject|0|||
94274797|NCT00916357|322800264|FG003|Period 1|Withdrawal by Subject|0|||
94274798|NCT00916357|322800265|FG004|Period 1|Withdrawal by Subject|0|||
94274799|NCT00916357|322800266|FG005|Period 1|Withdrawal by Subject|0|||
94274800|NCT00916357|322800261|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
94274801|NCT00916357|322800262|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
94274802|NCT00916357|322800263|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
94274803|NCT00916357|322800264|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
94274804|NCT00916357|322800265|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
94368781|NCT03611751|323136548|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
94734210|NCT05975840|324483229|FG006|Overall Study|Adverse Event|0|||
94734211|NCT05975840|324483230|FG007|Overall Study|Adverse Event|0|||
94734212|NCT05975840|324483223|FG000|Overall Study|Death|0|||
94734213|NCT05975840|324483224|FG001|Overall Study|Death|1|||
94734214|NCT05975840|324483225|FG002|Overall Study|Death|0|||
94734215|NCT05975840|324483226|FG003|Overall Study|Death|0|||
94734216|NCT05975840|324483227|FG004|Overall Study|Death|0|||
94734217|NCT05975840|324483228|FG005|Overall Study|Death|0|||
94734218|NCT05975840|324483229|FG006|Overall Study|Death|0|||
94734219|NCT05975840|324483230|FG007|Overall Study|Death|1|||
94734220|NCT04707469|324483235|FG000|Overall Study|Site closure|0|||
94734221|NCT04707469|324483236|FG001|Overall Study|Site closure|2|||
94734222|NCT04707469|324483237|FG002|Overall Study|Site closure|0|||
94734223|NCT04707469|324483235|FG000|Overall Study|Physician Decision|2|||
94734224|NCT04707469|324483236|FG001|Overall Study|Physician Decision|2|||
94734225|NCT04707469|324483237|FG002|Overall Study|Physician Decision|2|||
94734226|NCT04707469|324483235|FG000|Overall Study|Death|1|||
94734227|NCT04707469|324483236|FG001|Overall Study|Death|6|||
94734228|NCT04707469|324483237|FG002|Overall Study|Death|2|||
94734229|NCT04707469|324483235|FG000|Overall Study|Lost to Follow-up|9|||
94467455|NCT04015518|323500565|FG004|Overall Study|Pregnancy|1|||
94734230|NCT04707469|324483236|FG001|Overall Study|Lost to Follow-up|19|||
94734231|NCT04707469|324483237|FG002|Overall Study|Lost to Follow-up|14|||
94274805|NCT00916357|322800266|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
94274806|NCT03577730|322800269|FG000|Overall Study|Physician Decision|3|||
94274807|NCT03577730|322800270|FG001|Overall Study|Physician Decision|1|||
94274808|NCT03577730|322800269|FG000|Overall Study|Did not receive allocated intervention|1|||
94274809|NCT03577730|322800270|FG001|Overall Study|Did not receive allocated intervention|0|||
94274810|NCT00632099|322800273|FG000|Overall Study|Lost to Follow-up|3|||
94734232|NCT04707469|324483235|FG000|Overall Study|Withdrawal by Subject|17|||
94734233|NCT04707469|324483236|FG001|Overall Study|Withdrawal by Subject|16|||
94274811|NCT00632099|322800274|FG001|Overall Study|Lost to Follow-up|3|||
94274812|NCT00530270|322800275|FG000|Overall Study|Protocol Violation|1|||
94274813|NCT00530270|322800276|FG001|Overall Study|Protocol Violation|0|||
94274814|NCT03703102|322800279|FG000|Overall Study|Adverse Event|4|||
94274815|NCT03703102|322800280|FG001|Overall Study|Adverse Event|3|||
94274816|NCT03703102|322800281|FG002|Overall Study|Adverse Event|7|||
94274817|NCT03703102|322800282|FG003|Overall Study|Adverse Event|3|||
94274818|NCT03703102|322800283|FG004|Overall Study|Adverse Event|13|||
94274819|NCT03703102|322800279|FG000|Overall Study|Lack of Efficacy|4|||
94274820|NCT03703102|322800280|FG001|Overall Study|Lack of Efficacy|0|||
94274821|NCT03703102|322800281|FG002|Overall Study|Lack of Efficacy|1|||
94274822|NCT03703102|322800282|FG003|Overall Study|Lack of Efficacy|4|||
94274823|NCT03703102|322800283|FG004|Overall Study|Lack of Efficacy|1|||
94274824|NCT03703102|322800279|FG000|Overall Study|Lost to Follow-up|0|||
94274825|NCT03703102|322800280|FG001|Overall Study|Lost to Follow-up|0|||
94274826|NCT03703102|322800281|FG002|Overall Study|Lost to Follow-up|1|||
94274827|NCT03703102|322800282|FG003|Overall Study|Lost to Follow-up|2|||
94274828|NCT03703102|322800283|FG004|Overall Study|Lost to Follow-up|2|||
94274829|NCT03703102|322800279|FG000|Overall Study|Physician Decision|2|||
94274830|NCT03703102|322800280|FG001|Overall Study|Physician Decision|2|||
94274831|NCT03703102|322800281|FG002|Overall Study|Physician Decision|2|||
94274832|NCT03703102|322800282|FG003|Overall Study|Physician Decision|2|||
94274833|NCT03703102|322800283|FG004|Overall Study|Physician Decision|4|||
94274834|NCT03703102|322800279|FG000|Overall Study|Withdrawal by Subject|7|||
94274835|NCT03703102|322800280|FG001|Overall Study|Withdrawal by Subject|5|||
94274836|NCT03703102|322800281|FG002|Overall Study|Withdrawal by Subject|5|||
94274837|NCT03703102|322800282|FG003|Overall Study|Withdrawal by Subject|5|||
94274838|NCT03703102|322800283|FG004|Overall Study|Withdrawal by Subject|9|||
94274839|NCT03703102|322800279|FG000|Overall Study|Ineligibility|0|||
94274840|NCT03703102|322800280|FG001|Overall Study|Ineligibility|0|||
94274841|NCT03703102|322800281|FG002|Overall Study|Ineligibility|1|||
94274842|NCT03703102|322800282|FG003|Overall Study|Ineligibility|0|||
94274843|NCT03703102|322800283|FG004|Overall Study|Ineligibility|0|||
94274844|NCT03703102|322800279|FG000|Overall Study|Protocol Deviation|4|||
94274845|NCT03703102|322800280|FG001|Overall Study|Protocol Deviation|4|||
94274846|NCT03703102|322800281|FG002|Overall Study|Protocol Deviation|3|||
94274847|NCT03703102|322800282|FG003|Overall Study|Protocol Deviation|0|||
94274848|NCT03703102|322800283|FG004|Overall Study|Protocol Deviation|0|||
94274849|NCT03703102|322800279|FG000|Overall Study|Non-Compliance with Study Drug|1|||
94274850|NCT03703102|322800280|FG001|Overall Study|Non-Compliance with Study Drug|1|||
94274851|NCT03703102|322800281|FG002|Overall Study|Non-Compliance with Study Drug|2|||
94274852|NCT03703102|322800282|FG003|Overall Study|Non-Compliance with Study Drug|1|||
94274853|NCT03703102|322800283|FG004|Overall Study|Non-Compliance with Study Drug|4|||
94274854|NCT02311153|322800284|FG000|Overall Study|Lost to Follow-up|5|||
94274855|NCT02311153|322800285|FG001|Overall Study|Lost to Follow-up|7|||
94274856|NCT01356407|322800286|FG000|Overall Study|Lost to Follow-up|2|||
94274857|NCT01356407|322800287|FG001|Overall Study|Lost to Follow-up|0|||
94274858|NCT01356407|322800286|FG000|Overall Study|Patient Withdrew Consent|2|||
94274859|NCT01356407|322800287|FG001|Overall Study|Patient Withdrew Consent|1|||
94274860|NCT01356407|322800286|FG000|Overall Study|Could not afford IMP administration|0|||
94274861|NCT01356407|322800287|FG001|Overall Study|Could not afford IMP administration|1|||
94274862|NCT01356407|322800286|FG000|Overall Study|Not complete Endoscopy|2|||
94274863|NCT01356407|322800287|FG001|Overall Study|Not complete Endoscopy|2|||
94274864|NCT02055820|322800294|FG000|Phase I: Dose-Finding|Death|1|||
94274865|NCT02055820|322800295|FG001|Phase I: Dose-Finding|Death|0|||
94274866|NCT02055820|322800296|FG002|Phase I: Dose-Finding|Death|1|||
94734234|NCT04707469|324483237|FG002|Overall Study|Withdrawal by Subject|12|||
94274867|NCT02055820|322800297|FG003|Phase I: Dose-Finding|Death|2|||
94274868|NCT02055820|322800298|FG004|Phase I: Dose-Finding|Death|0|||
94274869|NCT02055820|322800299|FG005|Phase I: Dose-Finding|Death|1|||
94274870|NCT02055820|322800300|FG006|Phase I: Dose-Finding|Death|1|||
94274871|NCT02055820|322800301|FG007|Phase I: Dose-Finding|Death|0|||
94274872|NCT02055820|322800302|FG008|Phase I: Dose-Finding|Death|0|||
94274873|NCT02055820|322800303|FG009|Phase I: Dose-Finding|Death|0|||
94274874|NCT02055820|322800294|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
94274875|NCT02055820|322800295|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
94274876|NCT02055820|322800296|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
94274877|NCT02055820|322800297|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
94734235|NCT03734679|324483240|FG000|Overall Study|Missed Visit|1|||
94734236|NCT01346540|324483248|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
94734237|NCT01346540|324483249|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
94274878|NCT02055820|322800298|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
94467456|NCT04015518|323500561|FG000|Overall Study|Personal reasons|1|||
94274879|NCT02055820|322800299|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
94274880|NCT02055820|322800300|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
94274881|NCT02055820|322800301|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
94274882|NCT02055820|322800302|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
94734238|NCT01346540|324483248|FG000|Overall Study|Adverse Event|0|||
94734239|NCT01346540|324483249|FG001|Overall Study|Adverse Event|4|||
94734240|NCT03058289|324485241|FG000|Overall Study|Radiographic Deterioration|0|||
94734241|NCT03058289|324485242|FG001|Overall Study|Radiographic Deterioration|3|||
94734242|NCT03058289|324485243|FG002|Overall Study|Radiographic Deterioration|1|||
94734243|NCT03058289|324485244|FG003|Overall Study|Radiographic Deterioration|2|||
94734244|NCT03058289|324485245|FG004|Overall Study|Radiographic Deterioration|6|||
94734245|NCT03058289|324485246|FG005|Overall Study|Radiographic Deterioration|3|||
94734246|NCT03058289|324485247|FG006|Overall Study|Radiographic Deterioration|0|||
94734247|NCT03058289|324485248|FG007|Overall Study|Radiographic Deterioration|4|||
94734248|NCT03058289|324485249|FG008|Overall Study|Radiographic Deterioration|2|||
94734249|NCT03058289|324485241|FG000|Overall Study|Adverse Event|2|||
94734250|NCT03058289|324485242|FG001|Overall Study|Adverse Event|0|||
94734251|NCT03058289|324485243|FG002|Overall Study|Adverse Event|1|||
94734252|NCT03058289|324485244|FG003|Overall Study|Adverse Event|3|||
94734253|NCT03058289|324485245|FG004|Overall Study|Adverse Event|1|||
94734254|NCT03058289|324485246|FG005|Overall Study|Adverse Event|0|||
94734255|NCT03058289|324485247|FG006|Overall Study|Adverse Event|1|||
94734256|NCT03058289|324485248|FG007|Overall Study|Adverse Event|3|||
94734257|NCT03058289|324485249|FG008|Overall Study|Adverse Event|0|||
94734258|NCT03058289|324485241|FG000|Overall Study|Withdrawal by Subject|0|||
94734259|NCT03058289|324485242|FG001|Overall Study|Withdrawal by Subject|0|||
94274883|NCT02055820|322800303|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
94274884|NCT02055820|322800294|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
94274885|NCT02055820|322800295|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
94274886|NCT02055820|322800296|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
94274887|NCT02055820|322800297|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
94274888|NCT02055820|322800298|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
94274889|NCT02055820|322800299|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
94274890|NCT02055820|322800300|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
94274891|NCT02055820|322800301|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
94274892|NCT02055820|322800302|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
94274893|NCT02055820|322800303|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
94274894|NCT02055820|322800294|FG000|Phase II: Expansion|Death|0|||
94274895|NCT02055820|322800295|FG001|Phase II: Expansion|Death|0|||
94274896|NCT02055820|322800296|FG002|Phase II: Expansion|Death|0|||
94274897|NCT02055820|322800297|FG003|Phase II: Expansion|Death|0|||
94274898|NCT02055820|322800298|FG004|Phase II: Expansion|Death|33|||
94274899|NCT02055820|322800299|FG005|Phase II: Expansion|Death|0|||
94274900|NCT02055820|322800300|FG006|Phase II: Expansion|Death|0|||
94274901|NCT02055820|322800301|FG007|Phase II: Expansion|Death|0|||
94274902|NCT02055820|322800302|FG008|Phase II: Expansion|Death|0|||
94274903|NCT02055820|322800303|FG009|Phase II: Expansion|Death|0|||
94274904|NCT02055820|322800294|FG000|Phase II: Expansion|Lost to Follow-up|0|||
94274905|NCT02055820|322800295|FG001|Phase II: Expansion|Lost to Follow-up|0|||
94368782|NCT03611751|323136549|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
94734260|NCT03058289|324485243|FG002|Overall Study|Withdrawal by Subject|0|||
94734261|NCT03058289|324485244|FG003|Overall Study|Withdrawal by Subject|2|||
94734262|NCT03058289|324485245|FG004|Overall Study|Withdrawal by Subject|0|||
94734263|NCT03058289|324485246|FG005|Overall Study|Withdrawal by Subject|2|||
94734264|NCT03058289|324485247|FG006|Overall Study|Withdrawal by Subject|0|||
94734265|NCT03058289|324485248|FG007|Overall Study|Withdrawal by Subject|4|||
94734266|NCT03058289|324485249|FG008|Overall Study|Withdrawal by Subject|1|||
94734267|NCT03058289|324485241|FG000|Overall Study|Physician Decision|1|||
94734268|NCT03058289|324485242|FG001|Overall Study|Physician Decision|0|||
94734269|NCT03058289|324485243|FG002|Overall Study|Physician Decision|0|||
94734270|NCT03058289|324485244|FG003|Overall Study|Physician Decision|2|||
94734271|NCT03058289|324485245|FG004|Overall Study|Physician Decision|1|||
94734272|NCT03058289|324485246|FG005|Overall Study|Physician Decision|0|||
94734273|NCT03058289|324485247|FG006|Overall Study|Physician Decision|2|||
94734274|NCT03058289|324485248|FG007|Overall Study|Physician Decision|3|||
94734275|NCT03058289|324485249|FG008|Overall Study|Physician Decision|0|||
94274906|NCT02055820|322800296|FG002|Phase II: Expansion|Lost to Follow-up|0|||
94274907|NCT02055820|322800297|FG003|Phase II: Expansion|Lost to Follow-up|0|||
94274908|NCT02055820|322800298|FG004|Phase II: Expansion|Lost to Follow-up|4|||
94734276|NCT03058289|324485241|FG000|Overall Study|Clinical Deterioration|2|||
94734277|NCT03058289|324485242|FG001|Overall Study|Clinical Deterioration|0|||
94734278|NCT03058289|324485243|FG002|Overall Study|Clinical Deterioration|0|||
94734279|NCT03058289|324485244|FG003|Overall Study|Clinical Deterioration|2|||
94734280|NCT03058289|324485245|FG004|Overall Study|Clinical Deterioration|1|||
94734281|NCT03058289|324485246|FG005|Overall Study|Clinical Deterioration|1|||
94734282|NCT03058289|324485247|FG006|Overall Study|Clinical Deterioration|0|||
94734283|NCT03058289|324485248|FG007|Overall Study|Clinical Deterioration|3|||
94734284|NCT03058289|324485249|FG008|Overall Study|Clinical Deterioration|2|||
94734285|NCT03058289|324485241|FG000|Overall Study|Lost to Follow-up|0|||
94734286|NCT03058289|324485242|FG001|Overall Study|Lost to Follow-up|0|||
94734287|NCT03058289|324485243|FG002|Overall Study|Lost to Follow-up|0|||
94734288|NCT03058289|324485244|FG003|Overall Study|Lost to Follow-up|0|||
94734289|NCT03058289|324485245|FG004|Overall Study|Lost to Follow-up|1|||
94734290|NCT03058289|324485246|FG005|Overall Study|Lost to Follow-up|0|||
94734291|NCT03058289|324485247|FG006|Overall Study|Lost to Follow-up|0|||
94734292|NCT03058289|324485248|FG007|Overall Study|Lost to Follow-up|0|||
94734293|NCT03058289|324485249|FG008|Overall Study|Lost to Follow-up|0|||
94734294|NCT03058289|324485241|FG000|Overall Study|Refused Further Treatment|0|||
94734295|NCT03058289|324485242|FG001|Overall Study|Refused Further Treatment|0|||
94734296|NCT03058289|324485243|FG002|Overall Study|Refused Further Treatment|1|||
94734297|NCT03058289|324485244|FG003|Overall Study|Refused Further Treatment|0|||
94734298|NCT03058289|324485245|FG004|Overall Study|Refused Further Treatment|1|||
94734299|NCT03058289|324485246|FG005|Overall Study|Refused Further Treatment|0|||
94734300|NCT03058289|324485247|FG006|Overall Study|Refused Further Treatment|0|||
94734301|NCT03058289|324485248|FG007|Overall Study|Refused Further Treatment|0|||
94734302|NCT03058289|324485249|FG008|Overall Study|Refused Further Treatment|0|||
94734303|NCT03058289|324485241|FG000|Overall Study|Rapid Progression of Disease|0|||
94734304|NCT03058289|324485242|FG001|Overall Study|Rapid Progression of Disease|0|||
94734305|NCT03058289|324485243|FG002|Overall Study|Rapid Progression of Disease|0|||
94734306|NCT03058289|324485244|FG003|Overall Study|Rapid Progression of Disease|1|||
94734307|NCT03058289|324485245|FG004|Overall Study|Rapid Progression of Disease|0|||
94734308|NCT03058289|324485246|FG005|Overall Study|Rapid Progression of Disease|0|||
94734309|NCT03058289|324485247|FG006|Overall Study|Rapid Progression of Disease|0|||
94734310|NCT03058289|324485248|FG007|Overall Study|Rapid Progression of Disease|0|||
94734311|NCT03058289|324485249|FG008|Overall Study|Rapid Progression of Disease|0|||
94734312|NCT03235544|324485250|FG000|Overall Study|Death|11|||
94734313|NCT03235544|324485251|FG001|Overall Study|Death|31|||
94734314|NCT03235544|324485252|FG002|Overall Study|Death|19|||
94734315|NCT03235544|324485253|FG003|Overall Study|Death|34|||
94734316|NCT03235544|324485250|FG000|Overall Study|Lost to Follow-up|0|||
94734317|NCT03235544|324485251|FG001|Overall Study|Lost to Follow-up|1|||
94734318|NCT03235544|324485252|FG002|Overall Study|Lost to Follow-up|1|||
94734319|NCT03235544|324485253|FG003|Overall Study|Lost to Follow-up|1|||
94734320|NCT03235544|324485250|FG000|Overall Study|Withdrawal by Subject|0|||
94734321|NCT03235544|324485251|FG001|Overall Study|Withdrawal by Subject|3|||
94734322|NCT03235544|324485252|FG002|Overall Study|Withdrawal by Subject|1|||
94734323|NCT03235544|324485253|FG003|Overall Study|Withdrawal by Subject|5|||
94734324|NCT03235544|324485250|FG000|Overall Study|Disease Progression|0|||
94734325|NCT03235544|324485251|FG001|Overall Study|Disease Progression|1|||
94734326|NCT03235544|324485252|FG002|Overall Study|Disease Progression|0|||
94734327|NCT03235544|324485253|FG003|Overall Study|Disease Progression|2|||
94734328|NCT03235544|324485250|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
94734329|NCT03235544|324485251|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
94734330|NCT03235544|324485252|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
94734331|NCT03235544|324485253|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
94734332|NCT03235544|324485250|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
94734333|NCT03235544|324485251|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
94734334|NCT03235544|324485252|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
94734335|NCT03235544|324485253|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
94734336|NCT03220035|324485254|FG000|Overall Study|Adverse Event|1|||
94734337|NCT03220035|324485254|FG000|Overall Study|Protocol Violation|1|||
94734338|NCT03220035|324485254|FG000|Overall Study|Progressive Disease|2|||
94734339|NCT00696111|324485255|FG000|Overall Study|Withdrawal by Subject|17|||
94734340|NCT05299073|324485259|FG000|Overall Study|Withdrawal by Subject|0|||
94734341|NCT05299073|324485260|FG001|Overall Study|Withdrawal by Subject|0|||
94734342|NCT05299073|324485261|FG002|Overall Study|Withdrawal by Subject|1|||
94734343|NCT05299073|324485259|FG000|Overall Study|Adverse Event|0|||
94734344|NCT05299073|324485260|FG001|Overall Study|Adverse Event|1|||
94734345|NCT05299073|324485261|FG002|Overall Study|Adverse Event|0|||
94734346|NCT05299073|324485259|FG000|Overall Study|Lost to Follow-up|0|||
94734347|NCT05299073|324485260|FG001|Overall Study|Lost to Follow-up|1|||
94734348|NCT05299073|324485261|FG002|Overall Study|Lost to Follow-up|0|||
94734349|NCT03816332|324485262|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
94734350|NCT03816332|324485262|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
94467457|NCT04015518|323500562|FG001|Overall Study|Personal reasons|0|||
94734351|NCT04753697|324485263|FG000|Induction Phase|Withdrawal by Subject|12|||
94734352|NCT04753697|324485264|FG001|Induction Phase|Withdrawal by Subject|5|||
94734353|NCT04753697|324485265|FG002|Induction Phase|Withdrawal by Subject|6|||
94734354|NCT04753697|324485263|FG000|Induction Phase|Physician Decision|1|||
94734355|NCT04753697|324485264|FG001|Induction Phase|Physician Decision|0|||
94734356|NCT04753697|324485265|FG002|Induction Phase|Physician Decision|0|||
94734357|NCT04753697|324485263|FG000|Induction Phase|Lost to Follow-up|2|||
94734358|NCT04753697|324485264|FG001|Induction Phase|Lost to Follow-up|2|||
94734359|NCT04753697|324485265|FG002|Induction Phase|Lost to Follow-up|1|||
94734360|NCT04753697|324485263|FG000|Induction Phase|Lack of Efficacy|1|||
94734361|NCT04753697|324485264|FG001|Induction Phase|Lack of Efficacy|0|||
94734362|NCT04753697|324485265|FG002|Induction Phase|Lack of Efficacy|0|||
94734363|NCT04753697|324485263|FG000|Maintenance Phase|Physician Decision|0|||
94734364|NCT04753697|324485264|FG001|Maintenance Phase|Physician Decision|0|||
94734365|NCT04753697|324485265|FG002|Maintenance Phase|Physician Decision|1|||
94734366|NCT04753697|324485263|FG000|Maintenance Phase|Withdrawal by Subject|3|||
94734367|NCT04753697|324485264|FG001|Maintenance Phase|Withdrawal by Subject|4|||
94734368|NCT04753697|324485265|FG002|Maintenance Phase|Withdrawal by Subject|6|||
94734369|NCT04753697|324485263|FG000|Maintenance Phase|Lost to Follow-up|2|||
94734370|NCT04753697|324485264|FG001|Maintenance Phase|Lost to Follow-up|2|||
94467458|NCT04015518|323500563|FG002|Overall Study|Personal reasons|0|||
94734371|NCT04753697|324485265|FG002|Maintenance Phase|Lost to Follow-up|0|||
94734372|NCT04753697|324485263|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
94734373|NCT04753697|324485264|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
94734374|NCT04753697|324485265|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
94734375|NCT04753697|324485263|FG000|Maintenance Phase|Adverse Event|0|||
94734376|NCT04753697|324485264|FG001|Maintenance Phase|Adverse Event|1|||
94734377|NCT04753697|324485265|FG002|Maintenance Phase|Adverse Event|1|||
94734378|NCT04753697|324485263|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
94734379|NCT04753697|324485264|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
94734380|NCT04753697|324485265|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
94734381|NCT03483038|324485266|FG000|Overall Study|Subjects still in follow-up|18|||
94734382|NCT04850898|324485267|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
94734383|NCT04850898|324485268|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
94734384|NCT04068181|324485270|FG000|Overall Study|Death|17|||
94734385|NCT04068181|324485271|FG001|Overall Study|Death|12|||
94734386|NCT04068181|324485272|FG002|Overall Study|Death|4|||
94734387|NCT04068181|324485273|FG003|Overall Study|Death|7|||
94734388|NCT04068181|324485270|FG000|Overall Study|Lost to Follow-up|1|||
94734389|NCT04068181|324485271|FG001|Overall Study|Lost to Follow-up|0|||
94734390|NCT04068181|324485272|FG002|Overall Study|Lost to Follow-up|0|||
94734391|NCT04068181|324485273|FG003|Overall Study|Lost to Follow-up|0|||
94734392|NCT04068181|324485270|FG000|Overall Study|Withdrawal of consent from study|3|||
94734393|NCT04068181|324485271|FG001|Overall Study|Withdrawal of consent from study|0|||
94734394|NCT04068181|324485272|FG002|Overall Study|Withdrawal of consent from study|0|||
94734395|NCT04068181|324485273|FG003|Overall Study|Withdrawal of consent from study|0|||
94734396|NCT04770402|324485282|FG000|Overall Study|Lost to Follow-up|1|||
94734397|NCT04770402|324485283|FG001|Overall Study|Lost to Follow-up|2|||
94734398|NCT04770402|324485282|FG000|Overall Study|Non-compliance|1|||
94734399|NCT04770402|324485283|FG001|Overall Study|Non-compliance|0|||
94734400|NCT04770402|324485282|FG000|Overall Study|Withdrawal by Subject|0|||
94734401|NCT04770402|324485283|FG001|Overall Study|Withdrawal by Subject|1|||
94734402|NCT05274074|324485284|FG000|Overall Study|Lost to Follow-up|2|||
94734403|NCT05274074|324485285|FG001|Overall Study|Lost to Follow-up|3|||
94734404|NCT05274074|324485284|FG000|Overall Study|Withdrawal by Subject|1|||
94734405|NCT05274074|324485285|FG001|Overall Study|Withdrawal by Subject|2|||
94734406|NCT03687086|324485286|FG000|Overall Study|Withdrawal by Subject|3|||
94734407|NCT03687086|324485287|FG001|Overall Study|Withdrawal by Subject|4|||
94734408|NCT03687086|324485286|FG000|Overall Study|Lost to Follow-up|1|||
94734409|NCT03687086|324485287|FG001|Overall Study|Lost to Follow-up|1|||
94734410|NCT03687086|324485286|FG000|Overall Study|Death|1|||
94734411|NCT03687086|324485287|FG001|Overall Study|Death|0|||
94734412|NCT03687086|324485286|FG000|Overall Study|Incomplete assessment|0|||
94734413|NCT03687086|324485287|FG001|Overall Study|Incomplete assessment|2|||
94734414|NCT03691935|324485291|FG000|Overall Study|Physician Decision|2|||
94734415|NCT03691935|324485292|FG001|Overall Study|Physician Decision|1|||
94734416|NCT03691935|324485291|FG000|Overall Study|Adverse Event|3|||
94734417|NCT03691935|324485292|FG001|Overall Study|Adverse Event|0|||
94734418|NCT02593773|324485295|FG000|Overall Study|Voluntary Withdrawal|3|||
94734419|NCT02593773|324485295|FG000|Overall Study|Study Terminated by Sponsor|31|||
94734420|NCT02593773|324485295|FG000|Overall Study|Death|1|||
94734421|NCT04201262|324485296|FG000|Overall Study|Adverse Event|1|||
94734422|NCT04201262|324485297|FG001|Overall Study|Adverse Event|2|||
94734423|NCT04201262|324485296|FG000|Overall Study|Continuing in the study|57|||
94734424|NCT04201262|324485297|FG001|Overall Study|Continuing in the study|0|||
94734425|NCT04201262|324485296|FG000|Overall Study|Withdrawal by Subject|0|||
94734426|NCT04201262|324485297|FG001|Overall Study|Withdrawal by Subject|1|||
94734427|NCT02151981|324485298|FG000|Overall Study|Death|184|||
94734428|NCT02151981|324485299|FG001|Overall Study|Death|88|||
94734429|NCT02151981|324485298|FG000|Overall Study|Lost to Follow-up|7|||
94734430|NCT02151981|324485299|FG001|Overall Study|Lost to Follow-up|1|||
94734431|NCT02151981|324485298|FG000|Overall Study|Withdrawal by Subject|27|||
94734432|NCT02151981|324485299|FG001|Overall Study|Withdrawal by Subject|21|||
94734433|NCT02151981|324485298|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
94734434|NCT02151981|324485299|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
94734435|NCT02151981|324485298|FG000|Overall Study|Other reasons|1|||
94734436|NCT02151981|324485299|FG001|Overall Study|Other reasons|2|||
94734437|NCT05452460|324485304|FG000|Overall Study|Lost to Follow-up|3|||
94734438|NCT05452460|324485305|FG001|Overall Study|Lost to Follow-up|3|||
94368783|NCT03611751|323136550|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
94368784|NCT03611751|323136548|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
94368785|NCT03611751|323136549|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
94368786|NCT03611751|323136550|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
94368787|NCT03611751|323136548|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
94734439|NCT05452460|324485304|FG000|Overall Study|Did not receive intervention|1|||
94734440|NCT05452460|324485305|FG001|Overall Study|Did not receive intervention|0|||
94734441|NCT03511664|324485311|FG000|Overall Study|Death|457|||
94734442|NCT03511664|324485312|FG001|Overall Study|Death|201|||
94734443|NCT03511664|324485313|FG002|Overall Study|Death|21|||
94734444|NCT03511664|324485311|FG000|Overall Study|Withdrew consent|40|||
94734445|NCT03511664|324485312|FG001|Overall Study|Withdrew consent|63|||
94734446|NCT03511664|324485313|FG002|Overall Study|Withdrew consent|3|||
94734447|NCT03511664|324485311|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
94734448|NCT03511664|324485312|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
94734449|NCT03511664|324485313|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
94734450|NCT03511664|324485311|FG000|Overall Study|Lost to Follow-up|8|||
94734451|NCT03511664|324485312|FG001|Overall Study|Lost to Follow-up|5|||
94734452|NCT03511664|324485313|FG002|Overall Study|Lost to Follow-up|0|||
94734453|NCT03511664|324485311|FG000|Overall Study|Physician Decision|2|||
94734454|NCT03511664|324485312|FG001|Overall Study|Physician Decision|1|||
94734455|NCT03511664|324485313|FG002|Overall Study|Physician Decision|0|||
94734456|NCT03511664|324485311|FG000|Overall Study|Patient non-compliance|1|||
94734457|NCT03511664|324485312|FG001|Overall Study|Patient non-compliance|0|||
94734458|NCT03511664|324485313|FG002|Overall Study|Patient non-compliance|0|||
94734459|NCT01946789|324485315|FG000|Overall Study|Death|0|||
94734460|NCT01946789|324485316|FG001|Overall Study|Death|2|||
94734461|NCT01946789|324485317|FG002|Overall Study|Death|1|||
94734462|NCT01946789|324485318|FG003|Overall Study|Death|1|||
94734463|NCT01946789|324485319|FG004|Overall Study|Death|1|||
94734464|NCT01946789|324485320|FG005|Overall Study|Death|1|||
94734465|NCT01946789|324485321|FG006|Overall Study|Death|3|||
94734466|NCT01946789|324485322|FG007|Overall Study|Death|1|||
94734467|NCT01946789|324485323|FG008|Overall Study|Death|2|||
94734468|NCT01946789|324485315|FG000|Overall Study|Progressive Disease|0|||
94734469|NCT01946789|324485316|FG001|Overall Study|Progressive Disease|0|||
94734470|NCT01946789|324485317|FG002|Overall Study|Progressive Disease|1|||
94734471|NCT01946789|324485318|FG003|Overall Study|Progressive Disease|0|||
94734472|NCT01946789|324485319|FG004|Overall Study|Progressive Disease|0|||
94734473|NCT01946789|324485320|FG005|Overall Study|Progressive Disease|2|||
94734474|NCT01946789|324485321|FG006|Overall Study|Progressive Disease|0|||
94734475|NCT01946789|324485322|FG007|Overall Study|Progressive Disease|0|||
94734476|NCT01946789|324485323|FG008|Overall Study|Progressive Disease|0|||
94734477|NCT01946789|324485315|FG000|Overall Study|Withdrawal by Subject|0|||
94734478|NCT01946789|324485316|FG001|Overall Study|Withdrawal by Subject|0|||
94734479|NCT01946789|324485317|FG002|Overall Study|Withdrawal by Subject|0|||
94734480|NCT01946789|324485318|FG003|Overall Study|Withdrawal by Subject|2|||
94734481|NCT01946789|324485319|FG004|Overall Study|Withdrawal by Subject|1|||
94734482|NCT01946789|324485320|FG005|Overall Study|Withdrawal by Subject|0|||
94734483|NCT01946789|324485321|FG006|Overall Study|Withdrawal by Subject|1|||
94734484|NCT01946789|324485322|FG007|Overall Study|Withdrawal by Subject|0|||
94734485|NCT01946789|324485323|FG008|Overall Study|Withdrawal by Subject|0|||
94734486|NCT01828099|324485324|FG000|Treatment Period|Adverse Event|24|||
94734487|NCT01828099|324485325|FG001|Treatment Period|Adverse Event|23|||
94734488|NCT01828099|324485324|FG000|Treatment Period|Death|10|||
94734489|NCT01828099|324485325|FG001|Treatment Period|Death|12|||
94734490|NCT01828099|324485324|FG000|Treatment Period|Lost to Follow-up|2|||
94734491|NCT01828099|324485325|FG001|Treatment Period|Lost to Follow-up|1|||
94734492|NCT01828099|324485324|FG000|Treatment Period|Non-compliance with study treatment|1|||
94734493|NCT01828099|324485325|FG001|Treatment Period|Non-compliance with study treatment|0|||
94368788|NCT03611751|323136549|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
94467459|NCT04015518|323500564|FG003|Overall Study|Personal reasons|0|||
94734494|NCT01828099|324485324|FG000|Treatment Period|Physician Decision|17|||
94734495|NCT01828099|324485325|FG001|Treatment Period|Physician Decision|16|||
94734496|NCT01828099|324485324|FG000|Treatment Period|Progressive disease|99|||
94734497|NCT01828099|324485325|FG001|Treatment Period|Progressive disease|107|||
94734498|NCT01828099|324485324|FG000|Treatment Period|Subject/guardian decision|22|||
94734499|NCT01828099|324485325|FG001|Treatment Period|Subject/guardian decision|26|||
94734500|NCT01828099|324485324|FG000|Treatment Period|Study terminated by Sponsor|13|||
94734501|NCT01828099|324485325|FG001|Treatment Period|Study terminated by Sponsor|1|||
94734502|NCT01828099|324485324|FG000|Treatment Period|Protocol deviation|1|||
94734503|NCT01828099|324485325|FG001|Treatment Period|Protocol deviation|0|||
94734504|NCT01828099|324485324|FG000|Treatment Period|No longer requires treatment|0|||
94734505|NCT01828099|324485325|FG001|Treatment Period|No longer requires treatment|1|||
94734506|NCT01828099|324485324|FG000|Extension-treatment Phase|Adverse Event|0|||
94734507|NCT01828099|324485325|FG001|Extension-treatment Phase|Adverse Event|17|||
94368789|NCT03611751|323136550|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
94368790|NCT03611751|323136548|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
94734508|NCT01828099|324485324|FG000|Extension-treatment Phase|Death|0|||
94734509|NCT01828099|324485325|FG001|Extension-treatment Phase|Death|11|||
94734510|NCT01828099|324485324|FG000|Extension-treatment Phase|Physician Decision|0|||
94734511|NCT01828099|324485325|FG001|Extension-treatment Phase|Physician Decision|5|||
94734512|NCT01828099|324485324|FG000|Extension-treatment Phase|Progressive disease|0|||
94734513|NCT01828099|324485325|FG001|Extension-treatment Phase|Progressive disease|54|||
94734514|NCT01828099|324485324|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
94734515|NCT01828099|324485325|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
94734516|NCT01828099|324485324|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
94734517|NCT01828099|324485325|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
94734518|NCT05934942|324485328|FG000|Run-in Period|Not treated|1|||
94734519|NCT05934942|324485328|FG000|Run-in Period|Withdrawal by Subject|1|||
94734520|NCT05645757|324485343|FG000|Overall Study|Enrolled but treatment not administered|0|||
94734521|NCT05645757|324485344|FG001|Overall Study|Enrolled but treatment not administered|0|||
94734522|NCT05645757|324485345|FG002|Overall Study|Enrolled but treatment not administered|0|||
94734523|NCT05645757|324485346|FG003|Overall Study|Enrolled but treatment not administered|0|||
94734524|NCT05645757|324485347|FG004|Overall Study|Enrolled but treatment not administered|1|||
94734525|NCT05645757|324485348|FG005|Overall Study|Enrolled but treatment not administered|1|||
94734526|NCT05645757|324485349|FG006|Overall Study|Enrolled but treatment not administered|0|||
94734527|NCT05645757|324485350|FG007|Overall Study|Enrolled but treatment not administered|0|||
94734528|NCT04362254|324485351|FG000|Overall Study|Adverse Event|1|||
94734529|NCT04362254|324485351|FG000|Overall Study|Protocol Violation|1|||
94734530|NCT04362254|324485351|FG000|Overall Study|Due to early termination of the trial|10|||
94734531|NCT04498390|324485358|FG000|Overall Study|Adverse Event|0|||
94734532|NCT04498390|324485359|FG001|Overall Study|Adverse Event|0|||
94734533|NCT04498390|324485360|FG002|Overall Study|Adverse Event|1|||
94734534|NCT04498390|324485361|FG003|Overall Study|Adverse Event|0|||
94734535|NCT04498390|324485362|FG004|Overall Study|Adverse Event|0|||
94734536|NCT04498390|324485358|FG000|Overall Study|Withdrawal by Subject|0|||
94734537|NCT04498390|324485359|FG001|Overall Study|Withdrawal by Subject|0|||
94734538|NCT04498390|324485360|FG002|Overall Study|Withdrawal by Subject|0|||
94734539|NCT04498390|324485361|FG003|Overall Study|Withdrawal by Subject|1|||
94734540|NCT04498390|324485362|FG004|Overall Study|Withdrawal by Subject|0|||
94734541|NCT04515849|324485367|FG000|Overall Study|Adverse Event|0|||
94734542|NCT04515849|324485368|FG001|Overall Study|Adverse Event|0|||
94734543|NCT04515849|324485369|FG002|Overall Study|Adverse Event|0|||
94734544|NCT04515849|324485370|FG003|Overall Study|Adverse Event|1|||
94734545|NCT04515849|324485371|FG004|Overall Study|Adverse Event|2|||
94734546|NCT04515849|324485367|FG000|Overall Study|Death|2|||
94734547|NCT04515849|324485368|FG001|Overall Study|Death|0|||
94734548|NCT04515849|324485369|FG002|Overall Study|Death|0|||
94734549|NCT04515849|324485370|FG003|Overall Study|Death|0|||
94734550|NCT04515849|324485371|FG004|Overall Study|Death|0|||
94274909|NCT02055820|322800299|FG005|Phase II: Expansion|Lost to Follow-up|0|||
94274910|NCT02055820|322800300|FG006|Phase II: Expansion|Lost to Follow-up|0|||
94274911|NCT02055820|322800301|FG007|Phase II: Expansion|Lost to Follow-up|0|||
94274912|NCT02055820|322800302|FG008|Phase II: Expansion|Lost to Follow-up|0|||
94274913|NCT02055820|322800303|FG009|Phase II: Expansion|Lost to Follow-up|0|||
94274914|NCT02055820|322800294|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
94274915|NCT02055820|322800295|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
94274916|NCT02055820|322800296|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
94274917|NCT02055820|322800297|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
94274918|NCT02055820|322800298|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
94274919|NCT02055820|322800299|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
94274920|NCT02055820|322800300|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
94274921|NCT02055820|322800301|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
94274922|NCT02055820|322800302|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
94274923|NCT02055820|322800303|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
94274924|NCT01560780|322800304|FG000|Overall Study|Death|2|||
94274925|NCT01560780|322800305|FG001|Overall Study|Death|1|||
94274926|NCT01560780|322800304|FG000|Overall Study|Patient Preference|11|||
94274927|NCT01560780|322800305|FG001|Overall Study|Patient Preference|11|||
94734551|NCT04515849|324485367|FG000|Overall Study|Other:family emergency|0|||
94734552|NCT04515849|324485368|FG001|Overall Study|Other:family emergency|0|||
94734553|NCT04515849|324485369|FG002|Overall Study|Other:family emergency|0|||
94734554|NCT04515849|324485370|FG003|Overall Study|Other:family emergency|1|||
94734555|NCT04515849|324485371|FG004|Overall Study|Other:family emergency|0|||
94734556|NCT04515849|324485367|FG000|Overall Study|Other:randomised by error|0|||
94734557|NCT04515849|324485368|FG001|Overall Study|Other:randomised by error|1|||
94734558|NCT04515849|324485369|FG002|Overall Study|Other:randomised by error|0|||
94734559|NCT04515849|324485370|FG003|Overall Study|Other:randomised by error|0|||
94734560|NCT04515849|324485371|FG004|Overall Study|Other:randomised by error|0|||
94734561|NCT04515849|324485367|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
94734562|NCT04515849|324485368|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
94734563|NCT04515849|324485369|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
94734564|NCT04515849|324485370|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
94734565|NCT04515849|324485371|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
94734566|NCT04515849|324485367|FG000|Overall Study|Physician Decision|0|||
94734567|NCT04515849|324485368|FG001|Overall Study|Physician Decision|1|||
94734568|NCT04515849|324485369|FG002|Overall Study|Physician Decision|0|||
94734569|NCT04515849|324485370|FG003|Overall Study|Physician Decision|0|||
94734570|NCT04515849|324485371|FG004|Overall Study|Physician Decision|0|||
94734571|NCT04515849|324485367|FG000|Overall Study|Withdrawal by Subject|1|||
94734572|NCT04515849|324485368|FG001|Overall Study|Withdrawal by Subject|2|||
94734573|NCT04515849|324485369|FG002|Overall Study|Withdrawal by Subject|1|||
94734574|NCT04515849|324485370|FG003|Overall Study|Withdrawal by Subject|0|||
94734575|NCT04515849|324485371|FG004|Overall Study|Withdrawal by Subject|0|||
94734576|NCT05170841|324485372|FG000|Single Dose Phase|Adverse Event|1|||
94734577|NCT05170841|324485373|FG001|Single Dose Phase|Adverse Event|2|||
94734578|NCT05170841|324485374|FG002|Single Dose Phase|Adverse Event|0|||
94734579|NCT05170841|324485375|FG003|Single Dose Phase|Adverse Event|2|||
94734580|NCT05170841|324485372|FG000|Multiple Dose Phase|Adverse Event|1|||
94734581|NCT05170841|324485373|FG001|Multiple Dose Phase|Adverse Event|2|||
94734582|NCT05170841|324485374|FG002|Multiple Dose Phase|Adverse Event|1|||
94734583|NCT05170841|324485375|FG003|Multiple Dose Phase|Adverse Event|4|||
94734584|NCT05170841|324485372|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
94734585|NCT05170841|324485373|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
94734586|NCT05170841|324485374|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
94734587|NCT05170841|324485375|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
94734588|NCT03308877|324485378|FG000|Overall Study|Lost to Follow-up|32|||
94734589|NCT03308877|324485379|FG001|Overall Study|Lost to Follow-up|28|||
94734590|NCT05123586|324485380|FG000|Overall Study|Physician Decision|1|||
94734591|NCT05123586|324485381|FG001|Overall Study|Physician Decision|1|||
94734592|NCT05123586|324485380|FG000|Overall Study|Withdrawal by Subject|0|||
94734593|NCT05123586|324485381|FG001|Overall Study|Withdrawal by Subject|3|||
94734594|NCT04865289|324485382|FG000|Overall Study|Participant ongoing in study|47|||
94734595|NCT04865289|324485383|FG001|Overall Study|Participant ongoing in study|35|||
94734596|NCT04865289|324485382|FG000|Overall Study|Death|27|||
94734597|NCT04865289|324485383|FG001|Overall Study|Death|21|||
94734598|NCT04635423|324485398|FG000|Overall Study|Ongoing|493|||
94734599|NCT04635423|324485399|FG001|Overall Study|Ongoing|501|||
94734600|NCT04635423|324485398|FG000|Overall Study|Withdrawal by Subject|36|||
94734601|NCT04635423|324485399|FG001|Overall Study|Withdrawal by Subject|29|||
94734602|NCT03476343|324485409|FG000|Overall Study|Clinical exam moved to another scanner|7|||
94734603|NCT03476343|324485409|FG000|Overall Study|Clinical order cancelled|4|||
94734604|NCT03476343|324485409|FG000|Overall Study|Neonate did not settle down for the scan|1|||
94734605|NCT05216406|324485410|FG000|Overall Study|Lost to Follow-up|8|||
94734606|NCT05216406|324485411|FG001|Overall Study|Lost to Follow-up|9|||
94734607|NCT03711474|324485414|FG000|Overall Study|Physician Decision|2|||
94734608|NCT03711474|324485415|FG001|Overall Study|Physician Decision|0|||
94734609|NCT05974501|324485416|FG000|Overall Study|Physician Decision|0|||
94734610|NCT05974501|324485417|FG001|Overall Study|Physician Decision|1|||
94734611|NCT05962814|324485418|FG000|Overall Study|failed eligibility|1|||
94734612|NCT00539591|324486953|FG000|Overall Study|Toxicity|3|||
94734613|NCT00539591|324486954|FG001|Overall Study|Toxicity|0|||
94734614|NCT00539591|324486955|FG002|Overall Study|Toxicity|0|||
94734615|NCT00539591|324486953|FG000|Overall Study|Disease progression|2|||
94734616|NCT00539591|324486954|FG001|Overall Study|Disease progression|2|||
94734617|NCT00539591|324486955|FG002|Overall Study|Disease progression|3|||
94734618|NCT03924635|324486956|FG000|Overall Study|Withdrawal by Subject|2|||
94734619|NCT03924635|324486957|FG001|Overall Study|Withdrawal by Subject|4|||
94734620|NCT04295759|324486958|FG000|Overall Study|Lack of Efficacy|9|||
94734621|NCT04295759|324486958|FG000|Overall Study|Death|1|||
94734622|NCT04295759|324486958|FG000|Overall Study|Withdrawal by Subject|2|||
94734623|NCT04295759|324486958|FG000|Overall Study|Deemed ineligible|1|||
94274928|NCT01032915|322800306|FG000|Overall Study|Adverse Event|2|||
94734624|NCT04447040|324486959|FG000|Overall Study|Lost to Follow-up|2|||
94274929|NCT01032915|322800307|FG001|Overall Study|Adverse Event|2|||
94274930|NCT01032915|322800308|FG002|Overall Study|Adverse Event|1|||
94274931|NCT01032915|322800309|FG003|Overall Study|Adverse Event|1|||
94274932|NCT01032915|322800306|FG000|Overall Study|Abnormal test procedure result|0|||
94274933|NCT01032915|322800307|FG001|Overall Study|Abnormal test procedure result|0|||
94274934|NCT01032915|322800308|FG002|Overall Study|Abnormal test procedure result|1|||
94274935|NCT01032915|322800309|FG003|Overall Study|Abnormal test procedure result|0|||
94274936|NCT01032915|322800306|FG000|Overall Study|Withdrawal by Subject|0|||
94274937|NCT01032915|322800307|FG001|Overall Study|Withdrawal by Subject|3|||
94274938|NCT01032915|322800308|FG002|Overall Study|Withdrawal by Subject|1|||
94274939|NCT01032915|322800309|FG003|Overall Study|Withdrawal by Subject|1|||
94274940|NCT01032915|322800306|FG000|Overall Study|Administrative reasons|5|||
94274941|NCT01032915|322800307|FG001|Overall Study|Administrative reasons|6|||
94274942|NCT01032915|322800308|FG002|Overall Study|Administrative reasons|4|||
94274943|NCT01032915|322800309|FG003|Overall Study|Administrative reasons|4|||
94274944|NCT01032915|322800306|FG000|Overall Study|Protocol Violation|1|||
94274945|NCT01032915|322800307|FG001|Overall Study|Protocol Violation|0|||
94274946|NCT01032915|322800308|FG002|Overall Study|Protocol Violation|0|||
94274947|NCT01032915|322800309|FG003|Overall Study|Protocol Violation|1|||
94274948|NCT03363321|322800310|FG000|Overall Study|Withdrawal by Subject|0|||
94274949|NCT03363321|322800311|FG001|Overall Study|Withdrawal by Subject|1|||
94274950|NCT03363321|322800312|FG002|Overall Study|Withdrawal by Subject|0|||
94274951|NCT03363321|322800313|FG003|Overall Study|Withdrawal by Subject|1|||
94274952|NCT03363321|322800314|FG004|Overall Study|Withdrawal by Subject|0|||
94274953|NCT00715026|322800316|FG000|Overall Study|Withdrawal by Subject|5|||
94274954|NCT00715026|322800316|FG000|Overall Study|Lost to Follow-up|3|||
94274955|NCT00715026|322800316|FG000|Overall Study|Protocol Violation|1|||
94274956|NCT00715026|322800316|FG000|Overall Study|Surgery done on non-study consented hip|1|||
94274957|NCT02915523|322800317|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
94274958|NCT02915523|322800318|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
94274959|NCT02915523|322800319|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
94274960|NCT02915523|322800320|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
94274961|NCT02915523|322800317|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
94274962|NCT02915523|322800318|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
94274963|NCT02915523|322800319|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
94274964|NCT02915523|322800320|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
94274965|NCT02915523|322800317|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
94274966|NCT02915523|322800318|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
94274967|NCT02915523|322800319|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
94274968|NCT02915523|322800320|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
94274969|NCT02915523|322800317|FG000|Expansion Phase (Phase 2)|Death|0|||
94274970|NCT02915523|322800318|FG001|Expansion Phase (Phase 2)|Death|0|||
94274971|NCT02915523|322800319|FG002|Expansion Phase (Phase 2)|Death|26|||
94274972|NCT02915523|322800320|FG003|Expansion Phase (Phase 2)|Death|53|||
94274973|NCT02915523|322800317|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
94274974|NCT02915523|322800318|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
94274975|NCT02915523|322800319|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
94274976|NCT02915523|322800320|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
94274977|NCT02915523|322800317|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
94274978|NCT02915523|322800318|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
94274979|NCT02915523|322800319|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
94274980|NCT02915523|322800320|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
94274981|NCT02915523|322800317|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
94274982|NCT02915523|322800318|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
94274983|NCT02915523|322800319|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
94274984|NCT02915523|322800320|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
94274985|NCT00290342|322800321|FG000|Overall Study|Other|0|||
94274986|NCT00290342|322800322|FG001|Overall Study|Other|1|||
94274987|NCT00290342|322800321|FG000|Overall Study|Withdrawal by Subject|6|||
94274988|NCT00290342|322800322|FG001|Overall Study|Withdrawal by Subject|4|||
94274989|NCT00290342|322800321|FG000|Overall Study|Lost to Follow-up|1|||
94274990|NCT00290342|322800322|FG001|Overall Study|Lost to Follow-up|0|||
94274991|NCT01765920|322800323|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
94274992|NCT01765920|322800324|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
94274993|NCT01765920|322800323|FG000|Overall Study|Patient code disclosure|0|||
94274994|NCT01765920|322800324|FG001|Overall Study|Patient code disclosure|1|||
94274995|NCT02411539|322800331|FG000|Overall Study|Lost to Follow-up|2|||
94274996|NCT02411539|322800332|FG001|Overall Study|Lost to Follow-up|0|||
94274997|NCT02411539|322800331|FG000|Overall Study|Confounding medical condition|0|||
94274998|NCT02411539|322800332|FG001|Overall Study|Confounding medical condition|1|||
94274999|NCT01265797|322800333|FG000|Run-in Month|Withdrawal by Subject|0|||
94275000|NCT01265797|322800334|FG001|Run-in Month|Withdrawal by Subject|4|||
94275001|NCT01265797|322800333|FG000|Run-in Month|1st seizure during run-in month|0|||
94275002|NCT01265797|322800334|FG001|Run-in Month|1st seizure during run-in month|1|||
94275003|NCT01265797|322800333|FG000|Blinded Month|Lack of Efficacy|5|||
94275004|NCT01265797|322800334|FG001|Blinded Month|Lack of Efficacy|0|||
94275005|NCT01265797|322800333|FG000|Blinded Month|Lost to Follow-up|1|||
94275006|NCT01265797|322800334|FG001|Blinded Month|Lost to Follow-up|0|||
94275007|NCT01265797|322800333|FG000|Blinded Month|Protocol Violation|2|||
94275008|NCT01265797|322800334|FG001|Blinded Month|Protocol Violation|1|||
94275009|NCT01265797|322800333|FG000|Blinded Month|Adverse Event|2|||
94275010|NCT01265797|322800334|FG001|Blinded Month|Adverse Event|0|||
94275011|NCT01265797|322800333|FG000|Blinded Month|Diary data incomplete|0|||
94275012|NCT01265797|322800334|FG001|Blinded Month|Diary data incomplete|1|||
94275013|NCT01265797|322800333|FG000|Open Label Month|Lost to Follow-up|0|||
94275014|NCT01265797|322800334|FG001|Open Label Month|Lost to Follow-up|1|||
94275015|NCT03317795|322800335|FG000|Overall Study|IUD Expulsion|1|||
94275016|NCT03317795|322800336|FG001|Overall Study|IUD Expulsion|0|||
94275017|NCT03317795|322800335|FG000|Overall Study|Lost to Follow-up|1|||
94275018|NCT03317795|322800336|FG001|Overall Study|Lost to Follow-up|3|||
94275019|NCT03317795|322800335|FG000|Overall Study|Treatment change|0|||
94275020|NCT03317795|322800336|FG001|Overall Study|Treatment change|3|||
94368791|NCT03611751|323136549|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
94368792|NCT03611751|323136550|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
94368793|NCT03611751|323136548|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
94368794|NCT03611751|323136549|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
94368795|NCT03611751|323136550|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
94368796|NCT03611751|323136548|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
94275021|NCT03317795|322800335|FG000|Overall Study|Intolerance of medication|0|||
94275022|NCT03317795|322800336|FG001|Overall Study|Intolerance of medication|1|||
94275023|NCT01549002|322800337|FG000|Overall Study|Excessive pain|0|||
94275024|NCT01549002|322800338|FG001|Overall Study|Excessive pain|2|||
94275025|NCT01549002|322800337|FG000|Overall Study|Moderate sedation required|0|||
94467460|NCT04015518|323500565|FG004|Overall Study|Personal reasons|1|||
94734625|NCT04447040|324486960|FG001|Overall Study|Lost to Follow-up|1|||
94734626|NCT04447040|324486961|FG002|Overall Study|Lost to Follow-up|3|||
94734627|NCT04447040|324486962|FG003|Overall Study|Lost to Follow-up|3|||
94734628|NCT04447040|324486963|FG004|Overall Study|Lost to Follow-up|1|||
94734629|NCT04447040|324486964|FG005|Overall Study|Lost to Follow-up|3|||
94734630|NCT04447040|324486959|FG000|Overall Study|Withdrawal by Subject|0|||
94734631|NCT04447040|324486960|FG001|Overall Study|Withdrawal by Subject|1|||
94734632|NCT04447040|324486961|FG002|Overall Study|Withdrawal by Subject|1|||
94734633|NCT04447040|324486962|FG003|Overall Study|Withdrawal by Subject|1|||
94734634|NCT04447040|324486963|FG004|Overall Study|Withdrawal by Subject|0|||
94734635|NCT04447040|324486964|FG005|Overall Study|Withdrawal by Subject|0|||
94734636|NCT04568434|324486965|FG000|Overall Study|Voluntary Withdrawal|0|||
94734637|NCT04568434|324486966|FG001|Overall Study|Voluntary Withdrawal|1|||
94734638|NCT04568434|324486967|FG002|Overall Study|Voluntary Withdrawal|1|||
94734639|NCT04568434|324486965|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
94734640|NCT04568434|324486966|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
94734641|NCT04568434|324486967|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
94734642|NCT04568434|324486965|FG000|Overall Study|Investigator Judgement|1|||
94734643|NCT04568434|324486966|FG001|Overall Study|Investigator Judgement|0|||
94734644|NCT04568434|324486967|FG002|Overall Study|Investigator Judgement|0|||
94734645|NCT05469464|324486968|FG000|Overall Study|Withdrawal by Subject|8|||
94734646|NCT05469464|324486969|FG001|Overall Study|Withdrawal by Subject|7|||
94734647|NCT05469464|324486970|FG002|Overall Study|Withdrawal by Subject|4|||
94734648|NCT05469464|324486971|FG003|Overall Study|Withdrawal by Subject|5|||
94734649|NCT05469464|324486968|FG000|Overall Study|Adverse Event|8|||
94734650|NCT05469464|324486969|FG001|Overall Study|Adverse Event|14|||
94734651|NCT05469464|324486970|FG002|Overall Study|Adverse Event|13|||
94734652|NCT05469464|324486971|FG003|Overall Study|Adverse Event|2|||
94734653|NCT05469464|324486968|FG000|Overall Study|Lost to Follow-up|2|||
94734654|NCT05469464|324486969|FG001|Overall Study|Lost to Follow-up|5|||
94734655|NCT05469464|324486970|FG002|Overall Study|Lost to Follow-up|3|||
94734656|NCT05469464|324486971|FG003|Overall Study|Lost to Follow-up|3|||
94734657|NCT05469464|324486968|FG000|Overall Study|Lack of Efficacy|4|||
94734658|NCT05469464|324486969|FG001|Overall Study|Lack of Efficacy|1|||
94734659|NCT05469464|324486970|FG002|Overall Study|Lack of Efficacy|2|||
94734660|NCT05469464|324486971|FG003|Overall Study|Lack of Efficacy|2|||
94734661|NCT05469464|324486968|FG000|Overall Study|Physician Decision|0|||
94734662|NCT05469464|324486969|FG001|Overall Study|Physician Decision|0|||
94734663|NCT05469464|324486970|FG002|Overall Study|Physician Decision|0|||
94734664|NCT05469464|324486971|FG003|Overall Study|Physician Decision|1|||
94734665|NCT03905798|324486972|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
94734666|NCT01208662|324486973|FG000|Induction and Consolidation|Disease Progression|23|||
94734667|NCT01208662|324486974|FG001|Induction and Consolidation|Disease Progression|13|||
94734668|NCT01208662|324486975|FG002|Induction and Consolidation|Disease Progression|0|||
94734669|NCT01208662|324486973|FG000|Induction and Consolidation|Adverse Event|16|||
94734670|NCT01208662|324486974|FG001|Induction and Consolidation|Adverse Event|18|||
94734671|NCT01208662|324486975|FG002|Induction and Consolidation|Adverse Event|2|||
94734672|NCT01208662|324486973|FG000|Induction and Consolidation|MD or Participant Decision|16|||
94734673|NCT01208662|324486974|FG001|Induction and Consolidation|MD or Participant Decision|34|||
94734674|NCT01208662|324486975|FG002|Induction and Consolidation|MD or Participant Decision|4|||
94734675|NCT01208662|324486973|FG000|Induction and Consolidation|Death|1|||
94734676|NCT01208662|324486974|FG001|Induction and Consolidation|Death|3|||
94734677|NCT01208662|324486975|FG002|Induction and Consolidation|Death|1|||
94734678|NCT01208662|324486973|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
94734679|NCT01208662|324486974|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
94734680|NCT01208662|324486975|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
94734681|NCT01208662|324486973|FG000|Maintenance|Disease Progression|156|||
94734682|NCT01208662|324486974|FG001|Maintenance|Disease Progression|102|||
94734683|NCT01208662|324486975|FG002|Maintenance|Disease Progression|0|||
94734684|NCT01208662|324486973|FG000|Maintenance|Adverse Event|12|||
94734685|NCT01208662|324486974|FG001|Maintenance|Adverse Event|28|||
94734686|NCT01208662|324486975|FG002|Maintenance|Adverse Event|0|||
94734687|NCT01208662|324486973|FG000|Maintenance|MD or Participant Decision|24|||
94734688|NCT01208662|324486974|FG001|Maintenance|MD or Participant Decision|36|||
94734689|NCT01208662|324486975|FG002|Maintenance|MD or Participant Decision|0|||
94734690|NCT01208662|324486973|FG000|Maintenance|Death|0|||
94734691|NCT01208662|324486974|FG001|Maintenance|Death|3|||
94734692|NCT01208662|324486975|FG002|Maintenance|Death|0|||
94734693|NCT01208662|324486973|FG000|Maintenance|Discontinued for other reasons|21|||
94734694|NCT01208662|324486974|FG001|Maintenance|Discontinued for other reasons|31|||
94734695|NCT01208662|324486975|FG002|Maintenance|Discontinued for other reasons|0|||
94734696|NCT01208662|324486973|FG000|Maintenance|Still on Treatment|78|||
94734697|NCT01208662|324486974|FG001|Maintenance|Still on Treatment|89|||
94734698|NCT01208662|324486975|FG002|Maintenance|Still on Treatment|0|||
94734699|NCT01928394|324486976|FG000|Treatment Period|Disease progression|17|||
94734700|NCT01928394|324486977|FG001|Treatment Period|Disease progression|2|||
94368797|NCT03611751|323136549|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
94734701|NCT01928394|324486978|FG002|Treatment Period|Disease progression|12|||
94734702|NCT01928394|324486979|FG003|Treatment Period|Disease progression|48|||
94734703|NCT01928394|324486980|FG004|Treatment Period|Disease progression|3|||
94734704|NCT01928394|324486981|FG005|Treatment Period|Disease progression|25|||
94734705|NCT01928394|324486982|FG006|Treatment Period|Disease progression|38|||
94734706|NCT01928394|324486983|FG007|Treatment Period|Disease progression|16|||
94734707|NCT01928394|324486984|FG008|Treatment Period|Disease progression|3|||
94734708|NCT01928394|324486985|FG009|Treatment Period|Disease progression|11|||
94734709|NCT01928394|324486986|FG010|Treatment Period|Disease progression|22|||
94734710|NCT01928394|324486987|FG011|Treatment Period|Disease progression|73|||
94734711|NCT01928394|324486988|FG012|Treatment Period|Disease progression|38|||
94734712|NCT01928394|324486989|FG013|Treatment Period|Disease progression|118|||
94734713|NCT01928394|324486990|FG014|Treatment Period|Disease progression|59|||
94734714|NCT01928394|324486991|FG015|Treatment Period|Disease progression|1|||
94734715|NCT01928394|324486992|FG016|Treatment Period|Disease progression|43|||
94734716|NCT01928394|324486993|FG017|Treatment Period|Disease progression|56|||
94734717|NCT01928394|324486994|FG018|Treatment Period|Disease progression|50|||
94734718|NCT01928394|324486995|FG019|Treatment Period|Disease progression|71|||
94734719|NCT01928394|324486996|FG020|Treatment Period|Disease progression|30|||
94734720|NCT01928394|324486997|FG021|Treatment Period|Disease progression|31|||
94734721|NCT01928394|324486998|FG022|Treatment Period|Disease progression|31|||
94734722|NCT01928394|324486976|FG000|Treatment Period|Study drug toxicity|1|||
94734723|NCT01928394|324486977|FG001|Treatment Period|Study drug toxicity|1|||
94734724|NCT01928394|324486978|FG002|Treatment Period|Study drug toxicity|3|||
94734725|NCT01928394|324486979|FG003|Treatment Period|Study drug toxicity|3|||
94734726|NCT01928394|324486980|FG004|Treatment Period|Study drug toxicity|0|||
94734727|NCT01928394|324486981|FG005|Treatment Period|Study drug toxicity|9|||
94734728|NCT01928394|324486982|FG006|Treatment Period|Study drug toxicity|7|||
94734729|NCT01928394|324486983|FG007|Treatment Period|Study drug toxicity|1|||
94734730|NCT01928394|324486984|FG008|Treatment Period|Study drug toxicity|0|||
94734731|NCT01928394|324486985|FG009|Treatment Period|Study drug toxicity|5|||
94734732|NCT01928394|324486986|FG010|Treatment Period|Study drug toxicity|2|||
94734733|NCT01928394|324486987|FG011|Treatment Period|Study drug toxicity|3|||
94734734|NCT01928394|324486988|FG012|Treatment Period|Study drug toxicity|7|||
94734735|NCT01928394|324486989|FG013|Treatment Period|Study drug toxicity|5|||
94734736|NCT01928394|324486990|FG014|Treatment Period|Study drug toxicity|12|||
94734737|NCT01928394|324486991|FG015|Treatment Period|Study drug toxicity|0|||
94734738|NCT01928394|324486992|FG016|Treatment Period|Study drug toxicity|3|||
94734739|NCT01928394|324486993|FG017|Treatment Period|Study drug toxicity|3|||
94734740|NCT01928394|324486994|FG018|Treatment Period|Study drug toxicity|12|||
94734741|NCT01928394|324486995|FG019|Treatment Period|Study drug toxicity|15|||
94734742|NCT01928394|324486996|FG020|Treatment Period|Study drug toxicity|4|||
94734743|NCT01928394|324486997|FG021|Treatment Period|Study drug toxicity|7|||
94734744|NCT01928394|324486998|FG022|Treatment Period|Study drug toxicity|4|||
94734745|NCT01928394|324486976|FG000|Treatment Period|AE unrelated to study drug|0|||
94734746|NCT01928394|324486977|FG001|Treatment Period|AE unrelated to study drug|0|||
94734747|NCT01928394|324486978|FG002|Treatment Period|AE unrelated to study drug|2|||
94734748|NCT01928394|324486979|FG003|Treatment Period|AE unrelated to study drug|3|||
94734749|NCT01928394|324486980|FG004|Treatment Period|AE unrelated to study drug|0|||
94734750|NCT01928394|324486981|FG005|Treatment Period|AE unrelated to study drug|5|||
94734751|NCT01928394|324486982|FG006|Treatment Period|AE unrelated to study drug|1|||
94734752|NCT01928394|324486983|FG007|Treatment Period|AE unrelated to study drug|0|||
94734753|NCT01928394|324486984|FG008|Treatment Period|AE unrelated to study drug|0|||
94734754|NCT01928394|324486985|FG009|Treatment Period|AE unrelated to study drug|2|||
94734755|NCT01928394|324486986|FG010|Treatment Period|AE unrelated to study drug|0|||
94734756|NCT01928394|324486987|FG011|Treatment Period|AE unrelated to study drug|12|||
94734757|NCT01928394|324486988|FG012|Treatment Period|AE unrelated to study drug|6|||
94734758|NCT01928394|324486989|FG013|Treatment Period|AE unrelated to study drug|13|||
94734759|NCT01928394|324486990|FG014|Treatment Period|AE unrelated to study drug|6|||
94734760|NCT01928394|324486991|FG015|Treatment Period|AE unrelated to study drug|1|||
94734761|NCT01928394|324486992|FG016|Treatment Period|AE unrelated to study drug|1|||
94734762|NCT01928394|324486993|FG017|Treatment Period|AE unrelated to study drug|6|||
94734763|NCT01928394|324486994|FG018|Treatment Period|AE unrelated to study drug|3|||
94734764|NCT01928394|324486995|FG019|Treatment Period|AE unrelated to study drug|5|||
94734765|NCT01928394|324486996|FG020|Treatment Period|AE unrelated to study drug|1|||
94734766|NCT01928394|324486997|FG021|Treatment Period|AE unrelated to study drug|1|||
94734767|NCT01928394|324486998|FG022|Treatment Period|AE unrelated to study drug|0|||
94734768|NCT01928394|324486976|FG000|Treatment Period|Participant request to stop therapy|0|||
94734769|NCT01928394|324486977|FG001|Treatment Period|Participant request to stop therapy|0|||
94734770|NCT01928394|324486978|FG002|Treatment Period|Participant request to stop therapy|0|||
94368798|NCT03611751|323136550|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
94368799|NCT03611751|323136548|FG000|Treatment Week 0 - Week 16|Death|0|||
94734771|NCT01928394|324486979|FG003|Treatment Period|Participant request to stop therapy|0|||
94734772|NCT01928394|324486980|FG004|Treatment Period|Participant request to stop therapy|0|||
94734773|NCT01928394|324486981|FG005|Treatment Period|Participant request to stop therapy|3|||
94734774|NCT01928394|324486982|FG006|Treatment Period|Participant request to stop therapy|3|||
94734775|NCT01928394|324486983|FG007|Treatment Period|Participant request to stop therapy|0|||
94734776|NCT01928394|324486984|FG008|Treatment Period|Participant request to stop therapy|0|||
94734777|NCT01928394|324486985|FG009|Treatment Period|Participant request to stop therapy|0|||
94734778|NCT01928394|324486986|FG010|Treatment Period|Participant request to stop therapy|3|||
94734779|NCT01928394|324486987|FG011|Treatment Period|Participant request to stop therapy|2|||
94734780|NCT01928394|324486988|FG012|Treatment Period|Participant request to stop therapy|1|||
94734781|NCT01928394|324486989|FG013|Treatment Period|Participant request to stop therapy|2|||
94368800|NCT03611751|323136549|FG001|Treatment Week 0 - Week 16|Death|0|||
94368801|NCT03611751|323136550|FG002|Treatment Week 0 - Week 16|Death|1|||
94734782|NCT01928394|324486990|FG014|Treatment Period|Participant request to stop therapy|4|||
94734783|NCT01928394|324486991|FG015|Treatment Period|Participant request to stop therapy|0|||
94734784|NCT01928394|324486992|FG016|Treatment Period|Participant request to stop therapy|1|||
94734785|NCT01928394|324486993|FG017|Treatment Period|Participant request to stop therapy|3|||
94734786|NCT01928394|324486994|FG018|Treatment Period|Participant request to stop therapy|1|||
94734787|NCT01928394|324486995|FG019|Treatment Period|Participant request to stop therapy|1|||
94734788|NCT01928394|324486996|FG020|Treatment Period|Participant request to stop therapy|3|||
94734789|NCT01928394|324486997|FG021|Treatment Period|Participant request to stop therapy|1|||
94734790|NCT01928394|324486998|FG022|Treatment Period|Participant request to stop therapy|3|||
94734791|NCT01928394|324486976|FG000|Treatment Period|Participant withdrew consent|0|||
94734792|NCT01928394|324486977|FG001|Treatment Period|Participant withdrew consent|0|||
94734793|NCT01928394|324486978|FG002|Treatment Period|Participant withdrew consent|1|||
94734794|NCT01928394|324486979|FG003|Treatment Period|Participant withdrew consent|1|||
94734795|NCT01928394|324486980|FG004|Treatment Period|Participant withdrew consent|0|||
94734796|NCT01928394|324486981|FG005|Treatment Period|Participant withdrew consent|1|||
94734797|NCT01928394|324486982|FG006|Treatment Period|Participant withdrew consent|0|||
94734798|NCT01928394|324486983|FG007|Treatment Period|Participant withdrew consent|1|||
94734799|NCT01928394|324486984|FG008|Treatment Period|Participant withdrew consent|0|||
94734800|NCT01928394|324486985|FG009|Treatment Period|Participant withdrew consent|0|||
94734801|NCT01928394|324486986|FG010|Treatment Period|Participant withdrew consent|1|||
94734802|NCT01928394|324486987|FG011|Treatment Period|Participant withdrew consent|1|||
94734803|NCT01928394|324486988|FG012|Treatment Period|Participant withdrew consent|1|||
94734804|NCT01928394|324486989|FG013|Treatment Period|Participant withdrew consent|0|||
94734805|NCT01928394|324486990|FG014|Treatment Period|Participant withdrew consent|2|||
94734806|NCT01928394|324486991|FG015|Treatment Period|Participant withdrew consent|0|||
94734807|NCT01928394|324486992|FG016|Treatment Period|Participant withdrew consent|2|||
94734808|NCT01928394|324486993|FG017|Treatment Period|Participant withdrew consent|1|||
94734809|NCT01928394|324486994|FG018|Treatment Period|Participant withdrew consent|1|||
94734810|NCT01928394|324486995|FG019|Treatment Period|Participant withdrew consent|1|||
94734811|NCT01928394|324486996|FG020|Treatment Period|Participant withdrew consent|0|||
94734812|NCT01928394|324486997|FG021|Treatment Period|Participant withdrew consent|2|||
94734813|NCT01928394|324486998|FG022|Treatment Period|Participant withdrew consent|0|||
94734814|NCT01928394|324486976|FG000|Treatment Period|Poor/non-compliance|0|||
94734815|NCT01928394|324486977|FG001|Treatment Period|Poor/non-compliance|0|||
94734816|NCT01928394|324486978|FG002|Treatment Period|Poor/non-compliance|0|||
94734817|NCT01928394|324486979|FG003|Treatment Period|Poor/non-compliance|1|||
94734818|NCT01928394|324486980|FG004|Treatment Period|Poor/non-compliance|0|||
94734819|NCT01928394|324486981|FG005|Treatment Period|Poor/non-compliance|0|||
94734820|NCT01928394|324486982|FG006|Treatment Period|Poor/non-compliance|0|||
94734821|NCT01928394|324486983|FG007|Treatment Period|Poor/non-compliance|0|||
94734822|NCT01928394|324486984|FG008|Treatment Period|Poor/non-compliance|0|||
94734823|NCT01928394|324486985|FG009|Treatment Period|Poor/non-compliance|0|||
94734824|NCT01928394|324486986|FG010|Treatment Period|Poor/non-compliance|0|||
94734825|NCT01928394|324486987|FG011|Treatment Period|Poor/non-compliance|0|||
94734826|NCT01928394|324486988|FG012|Treatment Period|Poor/non-compliance|1|||
94734827|NCT01928394|324486989|FG013|Treatment Period|Poor/non-compliance|0|||
94734828|NCT01928394|324486990|FG014|Treatment Period|Poor/non-compliance|1|||
94275026|NCT01549002|322800338|FG001|Overall Study|Moderate sedation required|2|||
94275027|NCT00135668|322800340|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
94734829|NCT01928394|324486991|FG015|Treatment Period|Poor/non-compliance|0|||
94734830|NCT01928394|324486992|FG016|Treatment Period|Poor/non-compliance|0|||
94734831|NCT01928394|324486993|FG017|Treatment Period|Poor/non-compliance|1|||
94734832|NCT01928394|324486994|FG018|Treatment Period|Poor/non-compliance|0|||
94734833|NCT01928394|324486995|FG019|Treatment Period|Poor/non-compliance|1|||
94275028|NCT00135668|322800341|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
94275029|NCT00135668|322800342|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
94275030|NCT00135668|322800343|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
94275031|NCT00583362|322800344|FG000|Overall Study|Adverse Event|44|||
94275032|NCT00583362|322800344|FG000|Overall Study|Lack of Efficacy|22|||
94275033|NCT00583362|322800344|FG000|Overall Study|Lost to Follow-up|4|||
94275034|NCT00583362|322800344|FG000|Overall Study|Non-compliance with study drug|28|||
94275035|NCT00583362|322800344|FG000|Overall Study|Pregnancy|7|||
94275036|NCT00583362|322800344|FG000|Overall Study|Miscommunication of visit window|5|||
94275037|NCT00583362|322800344|FG000|Overall Study|Current site closed|7|||
94368802|NCT03611751|323136548|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
94368803|NCT03611751|323136549|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
94368804|NCT03611751|323136550|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
94275038|NCT00583362|322800344|FG000|Overall Study|Subject not dosed in LBSL99|1|||
94368805|NCT03611751|323136548|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
94368806|NCT03611751|323136549|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
94368807|NCT03611751|323136550|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
94368808|NCT03611751|323136548|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
94275039|NCT00583362|322800344|FG000|Overall Study|Subject moved out of the country/state|2|||
94275040|NCT00583362|322800344|FG000|Overall Study|Missed visits due to staff changes|1|||
94275041|NCT00583362|322800344|FG000|Overall Study|Misunderstanding of protocol|1|||
94275042|NCT00583362|322800344|FG000|Overall Study|Behavioral problems and non-compliance|1|||
94275043|NCT00583362|322800344|FG000|Overall Study|Sponsor request due to missed doses|1|||
94275044|NCT00583362|322800344|FG000|Overall Study|Physician Decision|19|||
94275045|NCT00583362|322800344|FG000|Overall Study|Protocol Violation|2|||
94275046|NCT00583362|322800344|FG000|Overall Study|Withdrawal by Subject|57|||
94275047|NCT02287623|322800345|FG000|Overall Study|Protocol Violation|0|||
94467461|NCT04015518|323500561|FG000|Overall Study|Withdrew consent|1|||
94467462|NCT04015518|323500562|FG001|Overall Study|Withdrew consent|0|||
94275048|NCT02287623|322800346|FG001|Overall Study|Protocol Violation|1|||
94275049|NCT02700997|322800347|FG000|Overall Study|Did not undergo CT imaging|1|||
94275050|NCT02700997|322800347|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
94275051|NCT00455013|322800348|FG000|Short Term Period|Adverse Event|2|||
94275052|NCT00455013|322800349|FG001|Short Term Period|Adverse Event|5|||
94275053|NCT00455013|322800350|FG002|Short Term Period|Adverse Event|0|||
94275054|NCT00455013|322800348|FG000|Short Term Period|Withdrawal by Subject|0|||
94275055|NCT00455013|322800349|FG001|Short Term Period|Withdrawal by Subject|0|||
94275056|NCT00455013|322800350|FG002|Short Term Period|Withdrawal by Subject|1|||
94275057|NCT00455013|322800348|FG000|Short Term Period|Lack of Efficacy|4|||
94275058|NCT00455013|322800349|FG001|Short Term Period|Lack of Efficacy|0|||
94734834|NCT01928394|324486996|FG020|Treatment Period|Poor/non-compliance|0|||
94734835|NCT01928394|324486997|FG021|Treatment Period|Poor/non-compliance|0|||
94734836|NCT01928394|324486998|FG022|Treatment Period|Poor/non-compliance|0|||
94734837|NCT01928394|324486976|FG000|Treatment Period|other reason|0|||
94734838|NCT01928394|324486977|FG001|Treatment Period|other reason|0|||
94734839|NCT01928394|324486978|FG002|Treatment Period|other reason|0|||
94734840|NCT01928394|324486979|FG003|Treatment Period|other reason|0|||
94734841|NCT01928394|324486980|FG004|Treatment Period|other reason|0|||
94734842|NCT01928394|324486981|FG005|Treatment Period|other reason|0|||
94734843|NCT01928394|324486982|FG006|Treatment Period|other reason|0|||
94734844|NCT01928394|324486983|FG007|Treatment Period|other reason|0|||
94734845|NCT01928394|324486984|FG008|Treatment Period|other reason|0|||
94734846|NCT01928394|324486985|FG009|Treatment Period|other reason|0|||
94734847|NCT01928394|324486986|FG010|Treatment Period|other reason|1|||
94734848|NCT01928394|324486987|FG011|Treatment Period|other reason|1|||
94734849|NCT01928394|324486988|FG012|Treatment Period|other reason|1|||
94734850|NCT01928394|324486989|FG013|Treatment Period|other reason|0|||
94734851|NCT01928394|324486990|FG014|Treatment Period|other reason|1|||
94734852|NCT01928394|324486991|FG015|Treatment Period|other reason|0|||
94734853|NCT01928394|324486992|FG016|Treatment Period|other reason|0|||
94734854|NCT01928394|324486993|FG017|Treatment Period|other reason|0|||
94734855|NCT01928394|324486994|FG018|Treatment Period|other reason|2|||
94734856|NCT01928394|324486995|FG019|Treatment Period|other reason|2|||
94734857|NCT01928394|324486996|FG020|Treatment Period|other reason|0|||
94734858|NCT01928394|324486997|FG021|Treatment Period|other reason|0|||
94734859|NCT01928394|324486998|FG022|Treatment Period|other reason|0|||
94734860|NCT01928394|324486976|FG000|Treatment Period|Maximum clinical benefit|0|||
94734861|NCT01928394|324486977|FG001|Treatment Period|Maximum clinical benefit|0|||
94734862|NCT01928394|324486978|FG002|Treatment Period|Maximum clinical benefit|0|||
94734863|NCT01928394|324486979|FG003|Treatment Period|Maximum clinical benefit|0|||
94734864|NCT01928394|324486980|FG004|Treatment Period|Maximum clinical benefit|0|||
94734865|NCT01928394|324486981|FG005|Treatment Period|Maximum clinical benefit|0|||
94734866|NCT01928394|324486982|FG006|Treatment Period|Maximum clinical benefit|0|||
94734867|NCT01928394|324486983|FG007|Treatment Period|Maximum clinical benefit|0|||
94275059|NCT00455013|322800350|FG002|Short Term Period|Lack of Efficacy|0|||
94275060|NCT00455013|322800348|FG000|Short Term Period|Other|0|||
94368809|NCT03611751|323136549|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
94734868|NCT01928394|324486984|FG008|Treatment Period|Maximum clinical benefit|0|||
94734869|NCT01928394|324486985|FG009|Treatment Period|Maximum clinical benefit|0|||
94734870|NCT01928394|324486986|FG010|Treatment Period|Maximum clinical benefit|1|||
94734871|NCT01928394|324486987|FG011|Treatment Period|Maximum clinical benefit|1|||
94275061|NCT00455013|322800349|FG001|Short Term Period|Other|0|||
94275062|NCT00455013|322800350|FG002|Short Term Period|Other|1|||
94275063|NCT00455013|322800348|FG000|Long Term Extension (LTE)|Adverse Event|0|||
94275064|NCT00455013|322800349|FG001|Long Term Extension (LTE)|Adverse Event|1|||
94275065|NCT00455013|322800350|FG002|Long Term Extension (LTE)|Adverse Event|1|||
94275066|NCT00455013|322800348|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
94275067|NCT00455013|322800349|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
94275068|NCT00455013|322800350|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
94275069|NCT00455013|322800348|FG000|Long Term Extension (LTE)|Death|1|||
94275070|NCT00455013|322800349|FG001|Long Term Extension (LTE)|Death|1|||
94275071|NCT00455013|322800350|FG002|Long Term Extension (LTE)|Death|0|||
94275072|NCT00455013|322800348|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
94734872|NCT01928394|324486988|FG012|Treatment Period|Maximum clinical benefit|0|||
94734873|NCT01928394|324486989|FG013|Treatment Period|Maximum clinical benefit|0|||
94734874|NCT01928394|324486990|FG014|Treatment Period|Maximum clinical benefit|1|||
94734875|NCT01928394|324486991|FG015|Treatment Period|Maximum clinical benefit|0|||
94734876|NCT01928394|324486992|FG016|Treatment Period|Maximum clinical benefit|0|||
94734877|NCT01928394|324486993|FG017|Treatment Period|Maximum clinical benefit|1|||
94734878|NCT01928394|324486994|FG018|Treatment Period|Maximum clinical benefit|1|||
94734879|NCT01928394|324486995|FG019|Treatment Period|Maximum clinical benefit|0|||
94734880|NCT01928394|324486996|FG020|Treatment Period|Maximum clinical benefit|2|||
94734881|NCT01928394|324486997|FG021|Treatment Period|Maximum clinical benefit|0|||
94734882|NCT01928394|324486998|FG022|Treatment Period|Maximum clinical benefit|0|||
94734883|NCT01928394|324486976|FG000|Treatment Period|Lost to Follow-up|0|||
94734884|NCT01928394|324486977|FG001|Treatment Period|Lost to Follow-up|0|||
94734885|NCT01928394|324486978|FG002|Treatment Period|Lost to Follow-up|0|||
94734886|NCT01928394|324486979|FG003|Treatment Period|Lost to Follow-up|0|||
94734887|NCT01928394|324486980|FG004|Treatment Period|Lost to Follow-up|0|||
94734888|NCT01928394|324486981|FG005|Treatment Period|Lost to Follow-up|0|||
94734889|NCT01928394|324486982|FG006|Treatment Period|Lost to Follow-up|0|||
94734890|NCT01928394|324486983|FG007|Treatment Period|Lost to Follow-up|0|||
94734891|NCT01928394|324486984|FG008|Treatment Period|Lost to Follow-up|0|||
94734892|NCT01928394|324486985|FG009|Treatment Period|Lost to Follow-up|0|||
94734893|NCT01928394|324486986|FG010|Treatment Period|Lost to Follow-up|0|||
94734894|NCT01928394|324486987|FG011|Treatment Period|Lost to Follow-up|0|||
94734895|NCT01928394|324486988|FG012|Treatment Period|Lost to Follow-up|0|||
94734896|NCT01928394|324486989|FG013|Treatment Period|Lost to Follow-up|0|||
94734897|NCT01928394|324486990|FG014|Treatment Period|Lost to Follow-up|0|||
94734898|NCT01928394|324486991|FG015|Treatment Period|Lost to Follow-up|0|||
94734899|NCT01928394|324486992|FG016|Treatment Period|Lost to Follow-up|0|||
94734900|NCT01928394|324486993|FG017|Treatment Period|Lost to Follow-up|0|||
94734901|NCT01928394|324486994|FG018|Treatment Period|Lost to Follow-up|0|||
94734902|NCT01928394|324486995|FG019|Treatment Period|Lost to Follow-up|0|||
94734903|NCT01928394|324486996|FG020|Treatment Period|Lost to Follow-up|0|||
94734904|NCT01928394|324486997|FG021|Treatment Period|Lost to Follow-up|0|||
94734905|NCT01928394|324486998|FG022|Treatment Period|Lost to Follow-up|1|||
94734906|NCT01928394|324486976|FG000|Treatment Period|Death|0|||
94734907|NCT01928394|324486977|FG001|Treatment Period|Death|0|||
94734908|NCT01928394|324486978|FG002|Treatment Period|Death|0|||
94734909|NCT01928394|324486979|FG003|Treatment Period|Death|0|||
94734910|NCT01928394|324486980|FG004|Treatment Period|Death|0|||
94734911|NCT01928394|324486981|FG005|Treatment Period|Death|0|||
94734912|NCT01928394|324486982|FG006|Treatment Period|Death|0|||
94734913|NCT01928394|324486983|FG007|Treatment Period|Death|0|||
94734914|NCT01928394|324486984|FG008|Treatment Period|Death|0|||
94734915|NCT01928394|324486985|FG009|Treatment Period|Death|0|||
94734916|NCT01928394|324486986|FG010|Treatment Period|Death|0|||
94734917|NCT01928394|324486987|FG011|Treatment Period|Death|0|||
94734918|NCT01928394|324486988|FG012|Treatment Period|Death|0|||
94734919|NCT01928394|324486989|FG013|Treatment Period|Death|1|||
94734920|NCT01928394|324486990|FG014|Treatment Period|Death|2|||
94734921|NCT01928394|324486991|FG015|Treatment Period|Death|0|||
94734922|NCT01928394|324486992|FG016|Treatment Period|Death|0|||
94734923|NCT01928394|324486993|FG017|Treatment Period|Death|0|||
94275073|NCT00455013|322800349|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
94734924|NCT01928394|324486994|FG018|Treatment Period|Death|0|||
94734925|NCT01928394|324486995|FG019|Treatment Period|Death|0|||
94734926|NCT01928394|324486996|FG020|Treatment Period|Death|0|||
94734927|NCT01928394|324486997|FG021|Treatment Period|Death|0|||
94734928|NCT01928394|324486998|FG022|Treatment Period|Death|0|||
94734929|NCT01928394|324486976|FG000|Follow-up Period|Participant withdrew consent|3|||
94734930|NCT01928394|324486977|FG001|Follow-up Period|Participant withdrew consent|0|||
94734931|NCT01928394|324486978|FG002|Follow-up Period|Participant withdrew consent|1|||
94734932|NCT01928394|324486979|FG003|Follow-up Period|Participant withdrew consent|4|||
94734933|NCT01928394|324486980|FG004|Follow-up Period|Participant withdrew consent|0|||
94734934|NCT01928394|324486981|FG005|Follow-up Period|Participant withdrew consent|2|||
94734935|NCT01928394|324486982|FG006|Follow-up Period|Participant withdrew consent|5|||
94734936|NCT01928394|324486983|FG007|Follow-up Period|Participant withdrew consent|1|||
94734937|NCT01928394|324486984|FG008|Follow-up Period|Participant withdrew consent|0|||
94734938|NCT01928394|324486985|FG009|Follow-up Period|Participant withdrew consent|0|||
94734939|NCT01928394|324486986|FG010|Follow-up Period|Participant withdrew consent|5|||
94734940|NCT01928394|324486987|FG011|Follow-up Period|Participant withdrew consent|8|||
94734941|NCT01928394|324486988|FG012|Follow-up Period|Participant withdrew consent|2|||
94734942|NCT01928394|324486989|FG013|Follow-up Period|Participant withdrew consent|12|||
94734943|NCT01928394|324486990|FG014|Follow-up Period|Participant withdrew consent|7|||
94734944|NCT01928394|324486991|FG015|Follow-up Period|Participant withdrew consent|0|||
94734945|NCT01928394|324486992|FG016|Follow-up Period|Participant withdrew consent|5|||
94734946|NCT01928394|324486993|FG017|Follow-up Period|Participant withdrew consent|3|||
94734947|NCT01928394|324486994|FG018|Follow-up Period|Participant withdrew consent|2|||
94734948|NCT01928394|324486995|FG019|Follow-up Period|Participant withdrew consent|7|||
94734949|NCT01928394|324486996|FG020|Follow-up Period|Participant withdrew consent|4|||
94734950|NCT01928394|324486997|FG021|Follow-up Period|Participant withdrew consent|6|||
94734951|NCT01928394|324486998|FG022|Follow-up Period|Participant withdrew consent|2|||
94734952|NCT01928394|324486976|FG000|Follow-up Period|Death|0|||
94734953|NCT01928394|324486977|FG001|Follow-up Period|Death|0|||
94734954|NCT01928394|324486978|FG002|Follow-up Period|Death|2|||
94734955|NCT01928394|324486979|FG003|Follow-up Period|Death|6|||
94734956|NCT01928394|324486980|FG004|Follow-up Period|Death|0|||
94734957|NCT01928394|324486981|FG005|Follow-up Period|Death|6|||
94734958|NCT01928394|324486982|FG006|Follow-up Period|Death|6|||
94734959|NCT01928394|324486983|FG007|Follow-up Period|Death|2|||
94734960|NCT01928394|324486984|FG008|Follow-up Period|Death|1|||
94734961|NCT01928394|324486985|FG009|Follow-up Period|Death|2|||
94734962|NCT01928394|324486986|FG010|Follow-up Period|Death|4|||
94734963|NCT01928394|324486987|FG011|Follow-up Period|Death|12|||
94734964|NCT01928394|324486988|FG012|Follow-up Period|Death|11|||
94734965|NCT01928394|324486989|FG013|Follow-up Period|Death|25|||
94734966|NCT01928394|324486990|FG014|Follow-up Period|Death|18|||
94734967|NCT01928394|324486991|FG015|Follow-up Period|Death|0|||
94734968|NCT01928394|324486992|FG016|Follow-up Period|Death|6|||
94734969|NCT01928394|324486993|FG017|Follow-up Period|Death|5|||
94734970|NCT01928394|324486994|FG018|Follow-up Period|Death|13|||
94734971|NCT01928394|324486995|FG019|Follow-up Period|Death|13|||
94734972|NCT01928394|324486996|FG020|Follow-up Period|Death|5|||
94734973|NCT01928394|324486997|FG021|Follow-up Period|Death|3|||
94734974|NCT01928394|324486998|FG022|Follow-up Period|Death|2|||
94734975|NCT01928394|324486976|FG000|Follow-up Period|other reason|0|||
94734976|NCT01928394|324486977|FG001|Follow-up Period|other reason|0|||
94734977|NCT01928394|324486978|FG002|Follow-up Period|other reason|0|||
94734978|NCT01928394|324486979|FG003|Follow-up Period|other reason|0|||
94734979|NCT01928394|324486980|FG004|Follow-up Period|other reason|0|||
94734980|NCT01928394|324486981|FG005|Follow-up Period|other reason|0|||
94734981|NCT01928394|324486982|FG006|Follow-up Period|other reason|1|||
94734982|NCT01928394|324486983|FG007|Follow-up Period|other reason|3|||
94734983|NCT01928394|324486984|FG008|Follow-up Period|other reason|0|||
94734984|NCT01928394|324486985|FG009|Follow-up Period|other reason|0|||
94734985|NCT01928394|324486986|FG010|Follow-up Period|other reason|2|||
94734986|NCT01928394|324486987|FG011|Follow-up Period|other reason|1|||
94734987|NCT01928394|324486988|FG012|Follow-up Period|other reason|0|||
94734988|NCT01928394|324486989|FG013|Follow-up Period|other reason|1|||
94734989|NCT01928394|324486990|FG014|Follow-up Period|other reason|4|||
94734990|NCT01928394|324486991|FG015|Follow-up Period|other reason|0|||
94734991|NCT01928394|324486992|FG016|Follow-up Period|other reason|2|||
94734992|NCT01928394|324486993|FG017|Follow-up Period|other reason|0|||
94734993|NCT01928394|324486994|FG018|Follow-up Period|other reason|1|||
94734994|NCT01928394|324486995|FG019|Follow-up Period|other reason|1|||
94734995|NCT01928394|324486996|FG020|Follow-up Period|other reason|0|||
94734996|NCT01928394|324486997|FG021|Follow-up Period|other reason|0|||
94734997|NCT01928394|324486998|FG022|Follow-up Period|other reason|1|||
94734998|NCT01928394|324486976|FG000|Follow-up Period|Lost to Follow-up|0|||
94734999|NCT01928394|324486977|FG001|Follow-up Period|Lost to Follow-up|0|||
94735000|NCT01928394|324486978|FG002|Follow-up Period|Lost to Follow-up|0|||
94735001|NCT01928394|324486979|FG003|Follow-up Period|Lost to Follow-up|0|||
94735002|NCT01928394|324486980|FG004|Follow-up Period|Lost to Follow-up|0|||
94735003|NCT01928394|324486981|FG005|Follow-up Period|Lost to Follow-up|0|||
94735004|NCT01928394|324486982|FG006|Follow-up Period|Lost to Follow-up|0|||
94735005|NCT01928394|324486983|FG007|Follow-up Period|Lost to Follow-up|0|||
94275074|NCT00455013|322800350|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
94275075|NCT00455013|322800348|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
94275076|NCT00455013|322800349|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
94275077|NCT00455013|322800350|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
94275078|NCT00455013|322800348|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
94275079|NCT00455013|322800349|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
94275080|NCT00455013|322800350|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
94275081|NCT00455013|322800348|FG000|Long Term Extension (LTE)|non-specified|0|||
94275082|NCT00455013|322800349|FG001|Long Term Extension (LTE)|non-specified|0|||
94275083|NCT00455013|322800350|FG002|Long Term Extension (LTE)|non-specified|1|||
94275084|NCT00754793|322800351|FG000|Overall Study|voluntary withdrawn from study|0|||
94275085|NCT00754793|322800352|FG001|Overall Study|voluntary withdrawn from study|1|||
94275086|NCT01585272|322800353|FG000|Overall Study|Adverse Event|22|||
94275087|NCT01585272|322800353|FG000|Overall Study|Protocol Violation|7|||
94275088|NCT01585272|322800353|FG000|Overall Study|Withdrawal by Subject|10|||
94275089|NCT01714687|322800355|FG000|Overall Study|Withdrawal by Subject|1|||
94275090|NCT01714687|322800356|FG001|Overall Study|Withdrawal by Subject|0|||
94275091|NCT01714687|322800355|FG000|Overall Study|Lost to Follow-up|2|||
94275092|NCT01714687|322800356|FG001|Overall Study|Lost to Follow-up|4|||
94275093|NCT03075527|322800357|FG000|Overall Study|Ongoing treatment|2|||
94275094|NCT00923130|322800358|FG000|Overall Study|Stopped treatment due to progression|17|||
94275095|NCT00923130|322800358|FG000|Overall Study|Death|1|||
94275096|NCT00923130|322800358|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
94275097|NCT00923130|322800358|FG000|Overall Study|Switched to alternative treatment|2|||
94275098|NCT00923130|322800358|FG000|Overall Study|Refused further treatment|2|||
94275099|NCT00550680|322800359|FG000|Overall Study|Administrative Reasons|1|||
94275100|NCT00550680|322800359|FG000|Overall Study|Adverse Event|5|||
94275101|NCT00550680|322800359|FG000|Overall Study|Death|3|||
94275102|NCT00550680|322800359|FG000|Overall Study|Early Improvement|1|||
94275103|NCT00550680|322800359|FG000|Overall Study|Lost to Follow-up|3|||
94275104|NCT00550680|322800359|FG000|Overall Study|Lack of Efficacy|1|||
94275105|NCT00550680|322800359|FG000|Overall Study|Other|10|||
94275106|NCT00550680|322800359|FG000|Overall Study|Protocol Violation|7|||
94275107|NCT00550680|322800359|FG000|Overall Study|Refused Treatment|19|||
94735006|NCT01928394|324486984|FG008|Follow-up Period|Lost to Follow-up|0|||
94735007|NCT01928394|324486985|FG009|Follow-up Period|Lost to Follow-up|0|||
94735008|NCT01928394|324486986|FG010|Follow-up Period|Lost to Follow-up|0|||
94735009|NCT01928394|324486987|FG011|Follow-up Period|Lost to Follow-up|1|||
94735010|NCT01928394|324486988|FG012|Follow-up Period|Lost to Follow-up|1|||
94735011|NCT01928394|324486989|FG013|Follow-up Period|Lost to Follow-up|0|||
94735012|NCT01928394|324486990|FG014|Follow-up Period|Lost to Follow-up|1|||
94735013|NCT01928394|324486991|FG015|Follow-up Period|Lost to Follow-up|0|||
94735014|NCT01928394|324486992|FG016|Follow-up Period|Lost to Follow-up|1|||
94735015|NCT01928394|324486993|FG017|Follow-up Period|Lost to Follow-up|0|||
94735016|NCT01928394|324486994|FG018|Follow-up Period|Lost to Follow-up|0|||
94735017|NCT01928394|324486995|FG019|Follow-up Period|Lost to Follow-up|0|||
94735018|NCT01928394|324486996|FG020|Follow-up Period|Lost to Follow-up|0|||
94735019|NCT01928394|324486997|FG021|Follow-up Period|Lost to Follow-up|0|||
94735020|NCT01928394|324486998|FG022|Follow-up Period|Lost to Follow-up|1|||
94735021|NCT00321048|324486999|FG000|Overall Study|Withdrawal by Subject|6|||
94735022|NCT00321048|324487000|FG001|Overall Study|Withdrawal by Subject|8|||
94735023|NCT04707625|324487001|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
94735024|NCT04177394|324487002|FG000|Overall Study|Death|16|||
94735025|NCT04177394|324487002|FG000|Overall Study|Withdrawal by Subject|19|||
94735026|NCT04177394|324487002|FG000|Overall Study|Missed visits|61|||
94735027|NCT04177394|324487002|FG000|Overall Study|Expected Visits|15|||
94735028|NCT04433208|324487003|FG000|Overall Study|Withdrawal by Subject|0|||
94735029|NCT04433208|324487004|FG001|Overall Study|Withdrawal by Subject|1|||
94735030|NCT04433208|324487005|FG002|Overall Study|Withdrawal by Subject|1|||
94275108|NCT00550680|322800359|FG000|Overall Study|Screen Failure|6|||
94275109|NCT00788372|322800360|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
94275110|NCT00788372|322800360|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
94275111|NCT00788372|322800360|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
94275112|NCT00788372|322800360|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
94275113|NCT00788372|322800360|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
94275114|NCT00788372|322800360|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
94275115|NCT00788372|322800360|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
94735031|NCT04433208|324487006|FG003|Overall Study|Withdrawal by Subject|0|||
94735032|NCT04433208|324487007|FG004|Overall Study|Withdrawal by Subject|2|||
94735033|NCT04433208|324487008|FG005|Overall Study|Withdrawal by Subject|1|||
94735034|NCT04433208|324487003|FG000|Overall Study|Lost to Follow-up|0|||
94735035|NCT04433208|324487004|FG001|Overall Study|Lost to Follow-up|0|||
94735036|NCT04433208|324487005|FG002|Overall Study|Lost to Follow-up|0|||
94275116|NCT00562354|322800361|FG000|Overall Study|Physician Decision|0|||
94275117|NCT00562354|322800362|FG001|Overall Study|Physician Decision|1|||
94275118|NCT00562354|322800361|FG000|Overall Study|Lost to Follow-up|0|||
94275119|NCT00562354|322800362|FG001|Overall Study|Lost to Follow-up|1|||
94275120|NCT01508702|322800364|FG000|Overall Study|Adverse Event|7|||
94275121|NCT01508702|322800365|FG001|Overall Study|Adverse Event|3|||
94275122|NCT01508702|322800364|FG000|Overall Study|Gout flare|2|||
94275123|NCT01508702|322800365|FG001|Overall Study|Gout flare|0|||
94275124|NCT01508702|322800364|FG000|Overall Study|Protocol Violation|2|||
94275125|NCT01508702|322800365|FG001|Overall Study|Protocol Violation|1|||
94275126|NCT01508702|322800364|FG000|Overall Study|Lost to Follow-up|1|||
94275127|NCT01508702|322800365|FG001|Overall Study|Lost to Follow-up|2|||
94275128|NCT01508702|322800364|FG000|Overall Study|Withdrawal by Subject|11|||
94275129|NCT01508702|322800365|FG001|Overall Study|Withdrawal by Subject|7|||
94275130|NCT00250835|322800366|FG000|Overall Study|Withdrawal by Subject|1|||
94275131|NCT01187953|322800367|FG000|Overall Study|Death|11|||
94275132|NCT01187953|322800368|FG001|Overall Study|Death|13|||
94275133|NCT01187953|322800367|FG000|Overall Study|Adverse Event|1|||
94275134|NCT01187953|322800368|FG001|Overall Study|Adverse Event|2|||
94275135|NCT01187953|322800367|FG000|Overall Study|Lost to Follow-up|0|||
94275136|NCT01187953|322800368|FG001|Overall Study|Lost to Follow-up|3|||
94275137|NCT01187953|322800367|FG000|Overall Study|Withdrawal by Subject|3|||
94275138|NCT01187953|322800368|FG001|Overall Study|Withdrawal by Subject|3|||
94275139|NCT00761514|322800369|FG000|Overall Study|Adverse Event|1|||
94275140|NCT00761514|322800369|FG000|Overall Study|Withdrawal by Subject|2|||
94735037|NCT04433208|324487006|FG003|Overall Study|Lost to Follow-up|0|||
94735038|NCT04433208|324487007|FG004|Overall Study|Lost to Follow-up|0|||
94735039|NCT04433208|324487008|FG005|Overall Study|Lost to Follow-up|1|||
94735040|NCT02038777|324487009|FG000|Overall Study|Death|0|||
94735041|NCT02038777|324487010|FG001|Overall Study|Death|2|||
94735042|NCT02038777|324487011|FG002|Overall Study|Death|0|||
94735043|NCT02038777|324487012|FG003|Overall Study|Death|1|||
94735044|NCT02038777|324487013|FG004|Overall Study|Death|2|||
94735045|NCT02038777|324487014|FG005|Overall Study|Death|4|||
94735046|NCT02038777|324487015|FG006|Overall Study|Death|0|||
94735047|NCT02038777|324487016|FG007|Overall Study|Death|11|||
94735048|NCT02038777|324487009|FG000|Overall Study|Lost to Follow-up|0|||
94735049|NCT02038777|324487010|FG001|Overall Study|Lost to Follow-up|0|||
94735050|NCT02038777|324487011|FG002|Overall Study|Lost to Follow-up|0|||
94735051|NCT02038777|324487012|FG003|Overall Study|Lost to Follow-up|1|||
94735052|NCT02038777|324487013|FG004|Overall Study|Lost to Follow-up|0|||
94735053|NCT02038777|324487014|FG005|Overall Study|Lost to Follow-up|0|||
94735054|NCT02038777|324487015|FG006|Overall Study|Lost to Follow-up|0|||
94735055|NCT02038777|324487016|FG007|Overall Study|Lost to Follow-up|0|||
94735056|NCT02038777|324487009|FG000|Overall Study|Other|0|||
94735057|NCT02038777|324487010|FG001|Overall Study|Other|1|||
94735058|NCT02038777|324487011|FG002|Overall Study|Other|0|||
94735059|NCT02038777|324487012|FG003|Overall Study|Other|2|||
94735060|NCT02038777|324487013|FG004|Overall Study|Other|1|||
94735061|NCT02038777|324487014|FG005|Overall Study|Other|0|||
94735062|NCT02038777|324487015|FG006|Overall Study|Other|0|||
94735063|NCT02038777|324487016|FG007|Overall Study|Other|0|||
94735064|NCT02038777|324487009|FG000|Overall Study|Randomized but not treated|0|||
94735065|NCT02038777|324487010|FG001|Overall Study|Randomized but not treated|1|||
94735066|NCT02038777|324487011|FG002|Overall Study|Randomized but not treated|0|||
94735067|NCT02038777|324487012|FG003|Overall Study|Randomized but not treated|0|||
94735068|NCT02038777|324487013|FG004|Overall Study|Randomized but not treated|0|||
94735069|NCT02038777|324487014|FG005|Overall Study|Randomized but not treated|0|||
94735070|NCT02038777|324487015|FG006|Overall Study|Randomized but not treated|0|||
94735071|NCT02038777|324487016|FG007|Overall Study|Randomized but not treated|0|||
94735072|NCT02038777|324487009|FG000|Overall Study|Started Chemotherapy|1|||
94735073|NCT02038777|324487010|FG001|Overall Study|Started Chemotherapy|0|||
94735074|NCT02038777|324487011|FG002|Overall Study|Started Chemotherapy|3|||
94735075|NCT02038777|324487012|FG003|Overall Study|Started Chemotherapy|0|||
94735076|NCT02038777|324487013|FG004|Overall Study|Started Chemotherapy|0|||
94735077|NCT02038777|324487014|FG005|Overall Study|Started Chemotherapy|0|||
94275141|NCT00761514|322800369|FG000|Overall Study|Lost to Follow-up|1|||
94275142|NCT00761514|322800369|FG000|Overall Study|Health insurance didn't cover study drug|1|||
94275143|NCT00761514|322800369|FG000|Overall Study|Problem complying with study visit|1|||
94275144|NCT00761514|322800369|FG000|Overall Study|Unable to pay for medications|1|||
94275145|NCT01328951|322800370|FG000|Overall Study|Disease Progression|17|||
94735078|NCT02038777|324487015|FG006|Overall Study|Started Chemotherapy|0|||
94735079|NCT02038777|324487016|FG007|Overall Study|Started Chemotherapy|0|||
94735080|NCT02038777|324487009|FG000|Overall Study|participation terminated by sponsor|0|||
94735081|NCT02038777|324487010|FG001|Overall Study|participation terminated by sponsor|0|||
94735082|NCT02038777|324487011|FG002|Overall Study|participation terminated by sponsor|0|||
94735083|NCT02038777|324487012|FG003|Overall Study|participation terminated by sponsor|0|||
94735084|NCT02038777|324487013|FG004|Overall Study|participation terminated by sponsor|0|||
94735085|NCT02038777|324487014|FG005|Overall Study|participation terminated by sponsor|0|||
94275146|NCT01328951|322800371|FG001|Overall Study|Disease Progression|14|||
94735086|NCT02038777|324487015|FG006|Overall Study|participation terminated by sponsor|1|||
94735087|NCT02038777|324487016|FG007|Overall Study|participation terminated by sponsor|1|||
94735088|NCT04299464|324487017|FG000|Overall Study|Adverse Event|1|||
94735089|NCT04299464|324487018|FG001|Overall Study|Adverse Event|0|||
94735090|NCT04299464|324487019|FG002|Overall Study|Adverse Event|2|||
94735091|NCT04299464|324487017|FG000|Overall Study|Non-compliance with Study Drug|1|||
94735092|NCT04299464|324487018|FG001|Overall Study|Non-compliance with Study Drug|0|||
94735093|NCT04299464|324487019|FG002|Overall Study|Non-compliance with Study Drug|0|||
94735094|NCT04299464|324487017|FG000|Overall Study|Reason not Specified|0|||
94735095|NCT04299464|324487018|FG001|Overall Study|Reason not Specified|1|||
94735096|NCT04299464|324487019|FG002|Overall Study|Reason not Specified|3|||
94735097|NCT04299464|324487017|FG000|Overall Study|Physician Decision|0|||
94735098|NCT04299464|324487018|FG001|Overall Study|Physician Decision|1|||
94735099|NCT04299464|324487019|FG002|Overall Study|Physician Decision|1|||
94735100|NCT04299464|324487017|FG000|Overall Study|Withdrawal by Subject|0|||
94735101|NCT04299464|324487018|FG001|Overall Study|Withdrawal by Subject|2|||
94735102|NCT04299464|324487019|FG002|Overall Study|Withdrawal by Subject|1|||
94735103|NCT04471246|324487020|FG000|Overall Study|Lost to Follow-up|2|||
94735104|NCT04471246|324487021|FG001|Overall Study|Lost to Follow-up|2|||
94735105|NCT03334630|324487022|FG000|Overall Study|Withdrawal by Subject|7|||
94735106|NCT03334630|324487023|FG001|Overall Study|Withdrawal by Subject|7|||
94735107|NCT03334630|324487022|FG000|Overall Study|Lost to Follow-up|3|||
94735108|NCT03334630|324487023|FG001|Overall Study|Lost to Follow-up|1|||
94735109|NCT03334630|324487022|FG000|Overall Study|Adverse Event|0|||
94735110|NCT03334630|324487023|FG001|Overall Study|Adverse Event|1|||
94735111|NCT03334630|324487022|FG000|Overall Study|Physician Decision|1|||
94735112|NCT03334630|324487023|FG001|Overall Study|Physician Decision|1|||
94735113|NCT03334630|324487022|FG000|Overall Study|Enrollment closed|2|||
94735114|NCT03334630|324487023|FG001|Overall Study|Enrollment closed|1|||
94735115|NCT03334630|324487022|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
94735116|NCT03334630|324487023|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
94735117|NCT03334630|324487022|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
94735118|NCT03334630|324487023|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
94735119|NCT02424617|324487025|FG000|Overall Study|Adverse Event|0|||
94735120|NCT02424617|324487026|FG001|Overall Study|Adverse Event|1|||
94735121|NCT02424617|324487027|FG002|Overall Study|Adverse Event|0|||
94735122|NCT02424617|324487028|FG003|Overall Study|Adverse Event|0|||
94735123|NCT02424617|324487025|FG000|Overall Study|Investigator Decision|0|||
94735124|NCT02424617|324487026|FG001|Overall Study|Investigator Decision|0|||
94735125|NCT02424617|324487027|FG002|Overall Study|Investigator Decision|0|||
94735126|NCT02424617|324487028|FG003|Overall Study|Investigator Decision|1|||
94735127|NCT02424617|324487025|FG000|Overall Study|Withdrawal by Subject|1|||
94735128|NCT02424617|324487026|FG001|Overall Study|Withdrawal by Subject|1|||
94735129|NCT02424617|324487027|FG002|Overall Study|Withdrawal by Subject|0|||
94735130|NCT02424617|324487028|FG003|Overall Study|Withdrawal by Subject|1|||
94735131|NCT02424617|324487025|FG000|Overall Study|Progressive Disease|7|||
94735132|NCT02424617|324487026|FG001|Overall Study|Progressive Disease|6|||
94735133|NCT02424617|324487027|FG002|Overall Study|Progressive Disease|11|||
94735134|NCT02424617|324487028|FG003|Overall Study|Progressive Disease|10|||
94735135|NCT02424617|324487025|FG000|Overall Study|Other|0|||
94735136|NCT02424617|324487026|FG001|Overall Study|Other|0|||
94735137|NCT02424617|324487027|FG002|Overall Study|Other|0|||
94735138|NCT02424617|324487028|FG003|Overall Study|Other|1|||
94735139|NCT01960452|324487029|FG000|Overall Study|Withdrawal by Subject|2|||
94735140|NCT01960452|324487030|FG001|Overall Study|Withdrawal by Subject|1|||
94735141|NCT01960452|324487029|FG000|Overall Study|Sleep apnea in Night 1|1|||
94735142|NCT01960452|324487030|FG001|Overall Study|Sleep apnea in Night 1|0|||
94735143|NCT01960452|324487029|FG000|Overall Study|Poor Sleep in Night 1|0|||
94735144|NCT01960452|324487030|FG001|Overall Study|Poor Sleep in Night 1|2|||
94735145|NCT01960452|324487029|FG000|Overall Study|No Sex/Age Match Night 1|1|||
94735146|NCT01960452|324487030|FG001|Overall Study|No Sex/Age Match Night 1|0|||
94735147|NCT01960452|324487029|FG000|Overall Study|No Sex/Age Match Night 2|0|||
94735148|NCT01960452|324487030|FG001|Overall Study|No Sex/Age Match Night 2|2|||
94735149|NCT01960452|324487029|FG000|Overall Study|Technical Difficulties Night 2|2|||
94735150|NCT01960452|324487030|FG001|Overall Study|Technical Difficulties Night 2|0|||
94735151|NCT05370040|324487031|FG000|Overall Study|Lost to Follow-up|0|||
94735152|NCT05370040|324487032|FG001|Overall Study|Lost to Follow-up|0|||
94735153|NCT05370040|324487033|FG002|Overall Study|Lost to Follow-up|1|||
94735154|NCT05370040|324487034|FG003|Overall Study|Lost to Follow-up|0|||
94735155|NCT05370040|324487035|FG004|Overall Study|Lost to Follow-up|1|||
94735156|NCT05370040|324487036|FG005|Overall Study|Lost to Follow-up|0|||
94735157|NCT05093842|324487044|FG000|Overall Study|Pregnancy loss|1|||
94735158|NCT05093842|324487045|FG001|Overall Study|Pregnancy loss|1|||
94735159|NCT05093842|324487044|FG000|Overall Study|Lost to Follow-up|6|||
94735160|NCT05093842|324487045|FG001|Overall Study|Lost to Follow-up|0|||
94735161|NCT05093842|324487044|FG000|Overall Study|Physician Decision|0|||
94735162|NCT05093842|324487045|FG001|Overall Study|Physician Decision|1|||
94735163|NCT03910478|324487046|FG000|Overall Study|Death|13|||
94735164|NCT03910478|324487047|FG001|Overall Study|Death|6|||
94735165|NCT03910478|324487046|FG000|Overall Study|Withdrawal by Subject|23|||
94735166|NCT03910478|324487047|FG001|Overall Study|Withdrawal by Subject|2|||
94275147|NCT01328951|322800370|FG000|Overall Study|Adverse Event|2|||
94275148|NCT01328951|322800371|FG001|Overall Study|Adverse Event|0|||
94275149|NCT01328951|322800370|FG000|Overall Study|Death|243|||
94275150|NCT01328951|322800371|FG001|Overall Study|Death|258|||
94275151|NCT01328951|322800370|FG000|Overall Study|Lost to Follow-up|6|||
94275152|NCT01328951|322800371|FG001|Overall Study|Lost to Follow-up|7|||
94275153|NCT01328951|322800370|FG000|Overall Study|Withdrawal by Subject|6|||
94275154|NCT01328951|322800371|FG001|Overall Study|Withdrawal by Subject|6|||
94275155|NCT01328951|322800370|FG000|Overall Study|Study Closed by the Sponsor|36|||
94275156|NCT01328951|322800371|FG001|Overall Study|Study Closed by the Sponsor|31|||
94275157|NCT01328951|322800370|FG000|Overall Study|Other|11|||
94275158|NCT01328951|322800371|FG001|Overall Study|Other|6|||
94275159|NCT03099187|322800372|FG000|Double-blind Treatment|Adverse Event|19|||
94275160|NCT03099187|322800373|FG001|Double-blind Treatment|Adverse Event|1|||
94275161|NCT03099187|322800374|FG002|Double-blind Treatment|Adverse Event|0|||
94275162|NCT03099187|322800375|FG003|Double-blind Treatment|Adverse Event|0|||
94275163|NCT03099187|322800372|FG000|Double-blind Treatment|Death|1|||
94275164|NCT03099187|322800373|FG001|Double-blind Treatment|Death|3|||
94275165|NCT03099187|322800374|FG002|Double-blind Treatment|Death|0|||
94275166|NCT03099187|322800375|FG003|Double-blind Treatment|Death|0|||
94275167|NCT03099187|322800372|FG000|Double-blind Treatment|Lack of Efficacy|1|||
94275168|NCT03099187|322800373|FG001|Double-blind Treatment|Lack of Efficacy|0|||
94275169|NCT03099187|322800374|FG002|Double-blind Treatment|Lack of Efficacy|0|||
94275170|NCT03099187|322800375|FG003|Double-blind Treatment|Lack of Efficacy|0|||
94275171|NCT03099187|322800372|FG000|Double-blind Treatment|Physician Decision|2|||
94275172|NCT03099187|322800373|FG001|Double-blind Treatment|Physician Decision|1|||
94275173|NCT03099187|322800374|FG002|Double-blind Treatment|Physician Decision|0|||
94275174|NCT03099187|322800375|FG003|Double-blind Treatment|Physician Decision|0|||
94275175|NCT03099187|322800372|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
94275176|NCT03099187|322800373|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
94275177|NCT03099187|322800374|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
94275178|NCT03099187|322800375|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
94275179|NCT03099187|322800372|FG000|Double-blind Treatment|Lung transplantation|0|||
94275180|NCT03099187|322800373|FG001|Double-blind Treatment|Lung transplantation|1|||
94275181|NCT03099187|322800374|FG002|Double-blind Treatment|Lung transplantation|0|||
94275182|NCT03099187|322800375|FG003|Double-blind Treatment|Lung transplantation|0|||
94275183|NCT03099187|322800372|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
94275184|NCT03099187|322800373|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
94275185|NCT03099187|322800374|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
94275186|NCT03099187|322800375|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
94275187|NCT03099187|322800372|FG000|Double-blind Treatment|Disease progression|0|||
94275188|NCT03099187|322800373|FG001|Double-blind Treatment|Disease progression|1|||
94275189|NCT03099187|322800374|FG002|Double-blind Treatment|Disease progression|0|||
94275190|NCT03099187|322800375|FG003|Double-blind Treatment|Disease progression|0|||
94275191|NCT03099187|322800372|FG000|Double-blind Treatment|Randomization error|0|||
94275192|NCT03099187|322800373|FG001|Double-blind Treatment|Randomization error|2|||
94275193|NCT03099187|322800374|FG002|Double-blind Treatment|Randomization error|0|||
94275194|NCT03099187|322800375|FG003|Double-blind Treatment|Randomization error|0|||
94275195|NCT03099187|322800372|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
94275196|NCT03099187|322800373|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
94275197|NCT03099187|322800374|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
94275198|NCT03099187|322800375|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
94275199|NCT03099187|322800372|FG000|12-month Safety Follow-up|Adverse Event|0|||
94275200|NCT03099187|322800373|FG001|12-month Safety Follow-up|Adverse Event|0|||
94275201|NCT03099187|322800374|FG002|12-month Safety Follow-up|Adverse Event|5|||
94275202|NCT03099187|322800375|FG003|12-month Safety Follow-up|Adverse Event|12|||
94275203|NCT03099187|322800372|FG000|12-month Safety Follow-up|Death|0|||
94735167|NCT03910478|324487046|FG000|Overall Study|Physician Decision|5|||
94735168|NCT03910478|324487047|FG001|Overall Study|Physician Decision|0|||
94275204|NCT03099187|322800373|FG001|12-month Safety Follow-up|Death|0|||
94275205|NCT03099187|322800374|FG002|12-month Safety Follow-up|Death|7|||
94275206|NCT03099187|322800375|FG003|12-month Safety Follow-up|Death|9|||
94275207|NCT03099187|322800372|FG000|12-month Safety Follow-up|Lung transplantation|0|||
94275208|NCT03099187|322800373|FG001|12-month Safety Follow-up|Lung transplantation|0|||
94275209|NCT03099187|322800374|FG002|12-month Safety Follow-up|Lung transplantation|2|||
94275210|NCT03099187|322800375|FG003|12-month Safety Follow-up|Lung transplantation|1|||
94275211|NCT03099187|322800372|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
94275212|NCT03099187|322800373|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
94275213|NCT03099187|322800374|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
94735169|NCT03910478|324487046|FG000|Overall Study|Protocol Violation|1|||
94275214|NCT03099187|322800375|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
94275215|NCT03099187|322800372|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
94275216|NCT03099187|322800373|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
94275217|NCT03099187|322800374|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
94275218|NCT03099187|322800375|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
94275219|NCT03099187|322800372|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
94275220|NCT03099187|322800373|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
94275221|NCT03099187|322800374|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
94275222|NCT03099187|322800375|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
94275223|NCT03099187|322800372|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
94275224|NCT03099187|322800373|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
94275225|NCT03099187|322800374|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
94275226|NCT03099187|322800375|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
94275227|NCT01100437|322800376|FG000|Titration/Stabilization|Adverse Event|0|||
94275228|NCT01100437|322800377|FG001|Titration/Stabilization|Adverse Event|0|||
94275229|NCT01100437|322800378|FG002|Titration/Stabilization|Adverse Event|4|||
94275230|NCT01100437|322800376|FG000|Titration/Stabilization|Non-compliance|0|||
94275231|NCT01100437|322800377|FG001|Titration/Stabilization|Non-compliance|0|||
94275232|NCT01100437|322800378|FG002|Titration/Stabilization|Non-compliance|1|||
94275233|NCT01100437|322800376|FG000|Titration/Stabilization|Sponsor canceled study|0|||
94275234|NCT01100437|322800377|FG001|Titration/Stabilization|Sponsor canceled study|0|||
94275235|NCT01100437|322800378|FG002|Titration/Stabilization|Sponsor canceled study|1|||
94275236|NCT01100437|322800376|FG000|Maintenance|Withdrawal by Subject|0|||
94275237|NCT01100437|322800377|FG001|Maintenance|Withdrawal by Subject|0|||
94275238|NCT01100437|322800378|FG002|Maintenance|Withdrawal by Subject|1|||
94275239|NCT01100437|322800376|FG000|Maintenance|Sponsor termination of study|0|||
94275240|NCT01100437|322800377|FG001|Maintenance|Sponsor termination of study|0|||
94275241|NCT01100437|322800378|FG002|Maintenance|Sponsor termination of study|1|||
94275242|NCT01439555|322800381|FG000|Overall Study|Protocol Violation|1|||
94275243|NCT03077685|322800382|FG000|Overall Study|Lost to Follow-up|0|||
94275244|NCT03077685|322800383|FG001|Overall Study|Lost to Follow-up|0|||
94275245|NCT03077685|322800384|FG002|Overall Study|Lost to Follow-up|0|||
94275246|NCT03077685|322800385|FG003|Overall Study|Lost to Follow-up|0|||
94275247|NCT03077685|322800386|FG004|Overall Study|Lost to Follow-up|1|||
94275248|NCT03077685|322800382|FG000|Overall Study|Death|0|||
94275249|NCT03077685|322800383|FG001|Overall Study|Death|0|||
94735170|NCT03910478|324487047|FG001|Overall Study|Protocol Violation|0|||
94735171|NCT03910478|324487046|FG000|Overall Study|Failure to meet continuation criteria|2|||
94735172|NCT03910478|324487047|FG001|Overall Study|Failure to meet continuation criteria|0|||
94735173|NCT03910478|324487046|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
94735174|NCT03910478|324487047|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
94735175|NCT04971109|324487048|FG000|Overall Study|Adverse Event|4|||
94735176|NCT04971109|324487049|FG001|Overall Study|Adverse Event|3|||
94735177|NCT04971109|324487048|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
94735178|NCT04971109|324487049|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
94735179|NCT04971109|324487048|FG000|Overall Study|Lost to Follow-up|8|||
94735180|NCT04971109|324487049|FG001|Overall Study|Lost to Follow-up|2|||
94735181|NCT04971109|324487048|FG000|Overall Study|Physician Decision|5|||
94275250|NCT03077685|322800384|FG002|Overall Study|Death|1|||
94275251|NCT03077685|322800385|FG003|Overall Study|Death|1|||
94275252|NCT03077685|322800386|FG004|Overall Study|Death|3|||
94275253|NCT03077685|322800382|FG000|Overall Study|Withdrawal by Subject|0|||
94735182|NCT04971109|324487049|FG001|Overall Study|Physician Decision|0|||
94735183|NCT04971109|324487048|FG000|Overall Study|Protocol Violation|0|||
94735184|NCT04971109|324487049|FG001|Overall Study|Protocol Violation|1|||
94735185|NCT04971109|324487048|FG000|Overall Study|Withdrawal by Subject|18|||
94735186|NCT04971109|324487049|FG001|Overall Study|Withdrawal by Subject|3|||
94735187|NCT04971109|324487048|FG000|Overall Study|Subject was randomized in error|1|||
94735188|NCT04971109|324487049|FG001|Overall Study|Subject was randomized in error|0|||
94735189|NCT03209973|324487050|FG000|Overall Study|Withdrawal by Subject|7|||
94735190|NCT03209973|324487050|FG000|Overall Study|Lost to Follow-up|2|||
94735191|NCT03209973|324487050|FG000|Overall Study|Death|8|||
94735192|NCT03209973|324487050|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
94735193|NCT03209973|324487050|FG000|Overall Study|Sponsor Decision|18|||
94735194|NCT03209973|324487050|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
94735195|NCT03209973|324487050|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
94275254|NCT03077685|322800383|FG001|Overall Study|Withdrawal by Subject|0|||
94275255|NCT03077685|322800384|FG002|Overall Study|Withdrawal by Subject|0|||
94735196|NCT04066205|324487051|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
94275256|NCT03077685|322800385|FG003|Overall Study|Withdrawal by Subject|2|||
94275257|NCT03077685|322800386|FG004|Overall Study|Withdrawal by Subject|1|||
94275258|NCT03077685|322800382|FG000|Overall Study|Physician Decision|0|||
94368810|NCT03611751|323136550|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
94368811|NCT03611751|323136548|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
94368812|NCT03611751|323136549|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
94275259|NCT03077685|322800383|FG001|Overall Study|Physician Decision|0|||
94275260|NCT03077685|322800384|FG002|Overall Study|Physician Decision|1|||
94275261|NCT03077685|322800385|FG003|Overall Study|Physician Decision|0|||
94275262|NCT03077685|322800386|FG004|Overall Study|Physician Decision|3|||
94275263|NCT03077685|322800382|FG000|Overall Study|Disease Progression|1|||
94275264|NCT03077685|322800383|FG001|Overall Study|Disease Progression|0|||
94275265|NCT03077685|322800384|FG002|Overall Study|Disease Progression|0|||
94275266|NCT03077685|322800385|FG003|Overall Study|Disease Progression|2|||
94275267|NCT03077685|322800386|FG004|Overall Study|Disease Progression|1|||
94275268|NCT03077685|322800382|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
94275269|NCT03077685|322800383|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
94275270|NCT03077685|322800384|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
94275271|NCT03077685|322800385|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
94275272|NCT03077685|322800386|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
94275273|NCT03077685|322800382|FG000|Overall Study|Subject entered hospice care|0|||
94275274|NCT03077685|322800383|FG001|Overall Study|Subject entered hospice care|0|||
94275275|NCT03077685|322800384|FG002|Overall Study|Subject entered hospice care|0|||
94275276|NCT03077685|322800385|FG003|Overall Study|Subject entered hospice care|0|||
94275277|NCT03077685|322800386|FG004|Overall Study|Subject entered hospice care|1|||
94275278|NCT01014689|322800391|FG000|Overall Study|Lack of Efficacy|0|||
94275279|NCT01014689|322800392|FG001|Overall Study|Lack of Efficacy|1|||
94275280|NCT01014689|322800391|FG000|Overall Study|Adverse Event|3|||
94275281|NCT01014689|322800392|FG001|Overall Study|Adverse Event|0|||
94275282|NCT01014689|322800391|FG000|Overall Study|Withdrawal by Subject|5|||
94275283|NCT01014689|322800392|FG001|Overall Study|Withdrawal by Subject|4|||
94275284|NCT01014689|322800391|FG000|Overall Study|Protocol Violation|1|||
94275285|NCT01014689|322800392|FG001|Overall Study|Protocol Violation|1|||
94275286|NCT01014689|322800391|FG000|Overall Study|Lost to Follow-up|3|||
94275287|NCT01014689|322800392|FG001|Overall Study|Lost to Follow-up|7|||
94275288|NCT01014689|322800391|FG000|Overall Study|Pregnancy|1|||
94275289|NCT01014689|322800392|FG001|Overall Study|Pregnancy|0|||
94275290|NCT03921424|322800393|FG000|Overall Study|Lost to Follow-up|0|||
94275291|NCT03921424|322800394|FG001|Overall Study|Lost to Follow-up|1|||
94275292|NCT03921424|322800393|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
94275293|NCT03921424|322800394|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
94275294|NCT02581202|322800397|FG000|Overall Study|Lack of Efficacy|2|||
94275295|NCT02581202|322800397|FG000|Overall Study|Withdrawal by Subject|4|||
94275296|NCT02581202|322800397|FG000|Overall Study|Lost to Follow-up|5|||
94275297|NCT02581202|322800397|FG000|Overall Study|Pregnancy|3|||
94275298|NCT04050982|322800402|FG000|Overall Study|Did not meet eligibility criteria|0|||
94275299|NCT04050982|322800403|FG001|Overall Study|Did not meet eligibility criteria|1|||
94275300|NCT04050982|322800404|FG002|Overall Study|Did not meet eligibility criteria|0|||
94275301|NCT04050982|322800402|FG000|Overall Study|Withdrawal by Subject|1|||
94275302|NCT04050982|322800403|FG001|Overall Study|Withdrawal by Subject|0|||
94275303|NCT04050982|322800404|FG002|Overall Study|Withdrawal by Subject|0|||
94275304|NCT04050982|322800402|FG000|Overall Study|Unable to enroll on platform|1|||
94275305|NCT04050982|322800403|FG001|Overall Study|Unable to enroll on platform|0|||
94275306|NCT04050982|322800404|FG002|Overall Study|Unable to enroll on platform|0|||
94275307|NCT01246583|322800405|FG000|Overall Study|Lost to Follow-up|0|||
94275308|NCT01246583|322800406|FG001|Overall Study|Lost to Follow-up|0|||
94275309|NCT01246583|322800407|FG002|Overall Study|Lost to Follow-up|0|||
94275310|NCT01246583|322800408|FG003|Overall Study|Lost to Follow-up|1|||
94275311|NCT01246583|322800405|FG000|Overall Study|Protocol Violation|0|||
94275312|NCT01246583|322800406|FG001|Overall Study|Protocol Violation|0|||
94275313|NCT01246583|322800407|FG002|Overall Study|Protocol Violation|1|||
94275314|NCT01246583|322800408|FG003|Overall Study|Protocol Violation|0|||
94275315|NCT01246583|322800405|FG000|Overall Study|Withdrawal by Subject|1|||
94275316|NCT01246583|322800406|FG001|Overall Study|Withdrawal by Subject|0|||
94275317|NCT01246583|322800407|FG002|Overall Study|Withdrawal by Subject|0|||
94275318|NCT01246583|322800408|FG003|Overall Study|Withdrawal by Subject|0|||
94275319|NCT05038020|322800411|FG000|Overall Study|Early Termination|3|||
94275320|NCT05038020|322800412|FG001|Overall Study|Early Termination|0|||
94275321|NCT04649255|322802375|FG000|Overall Study|Death|9|||
94275322|NCT04649255|322802375|FG000|Overall Study|Withdrawal by Subject|1|||
94275323|NCT03723707|322802376|FG000|Overall Study|Death|32|||
94275324|NCT03723707|322802377|FG001|Overall Study|Death|32|||
94275325|NCT03723707|322802376|FG000|Overall Study|Admitted to long term care|12|||
94275326|NCT03723707|322802377|FG001|Overall Study|Admitted to long term care|12|||
94275327|NCT03723707|322802376|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
94275328|NCT03723707|322802377|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
94275329|NCT03723707|322802376|FG000|Overall Study|Lost to Follow-up|40|||
94275330|NCT03723707|322802377|FG001|Overall Study|Lost to Follow-up|22|||
94275331|NCT03723707|322802376|FG000|Overall Study|Discontinued after study closure|24|||
94275332|NCT03723707|322802377|FG001|Overall Study|Discontinued after study closure|12|||
94275333|NCT05121480|322802378|FG000|Overall Study|Lack of Efficacy|2|||
94368813|NCT03611751|323136550|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
94467463|NCT04015518|323500563|FG002|Overall Study|Withdrew consent|0|||
94275334|NCT05121480|322802379|FG001|Overall Study|Lack of Efficacy|2|||
94275335|NCT05121480|322802380|FG002|Overall Study|Lack of Efficacy|1|||
94275336|NCT05121480|322802381|FG003|Overall Study|Lack of Efficacy|4|||
94275337|NCT05121480|322802382|FG004|Overall Study|Lack of Efficacy|0|||
94275338|NCT05121480|322802383|FG005|Overall Study|Lack of Efficacy|1|||
94275339|NCT05121480|322802384|FG006|Overall Study|Lack of Efficacy|0|||
94275340|NCT05121480|322802385|FG007|Overall Study|Lack of Efficacy|2|||
94275341|NCT05121480|322802378|FG000|Overall Study|Treatment Failure|0|||
94275342|NCT05121480|322802379|FG001|Overall Study|Treatment Failure|2|||
94275343|NCT05121480|322802380|FG002|Overall Study|Treatment Failure|0|||
94275344|NCT05121480|322802381|FG003|Overall Study|Treatment Failure|1|||
94275345|NCT05121480|322802382|FG004|Overall Study|Treatment Failure|0|||
94275346|NCT05121480|322802383|FG005|Overall Study|Treatment Failure|0|||
94275347|NCT05121480|322802384|FG006|Overall Study|Treatment Failure|0|||
94275348|NCT05121480|322802385|FG007|Overall Study|Treatment Failure|0|||
94275349|NCT05121480|322802378|FG000|Overall Study|Adverse Event|0|||
94275350|NCT05121480|322802379|FG001|Overall Study|Adverse Event|1|||
94275351|NCT05121480|322802380|FG002|Overall Study|Adverse Event|0|||
94275352|NCT05121480|322802381|FG003|Overall Study|Adverse Event|5|||
94275353|NCT05121480|322802382|FG004|Overall Study|Adverse Event|3|||
94275354|NCT05121480|322802383|FG005|Overall Study|Adverse Event|2|||
94275355|NCT05121480|322802384|FG006|Overall Study|Adverse Event|0|||
94275356|NCT05121480|322802385|FG007|Overall Study|Adverse Event|4|||
94275357|NCT05121480|322802378|FG000|Overall Study|Withdrawal by Subject|4|||
94275358|NCT05121480|322802379|FG001|Overall Study|Withdrawal by Subject|9|||
94275359|NCT05121480|322802380|FG002|Overall Study|Withdrawal by Subject|1|||
94275360|NCT05121480|322802381|FG003|Overall Study|Withdrawal by Subject|8|||
94275361|NCT05121480|322802382|FG004|Overall Study|Withdrawal by Subject|0|||
94735197|NCT04066205|324487052|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
94275362|NCT05121480|322802383|FG005|Overall Study|Withdrawal by Subject|9|||
94275363|NCT05121480|322802384|FG006|Overall Study|Withdrawal by Subject|0|||
94735198|NCT04066205|324487051|FG000|T2 Immediate Post-Intervention|did not respond|5|||
94735199|NCT04066205|324487052|FG001|T2 Immediate Post-Intervention|did not respond|3|||
94735200|NCT04778397|324487055|FG000|Overall Study|Death|59|||
94735201|NCT04778397|324487056|FG001|Overall Study|Death|54|||
94735202|NCT04778397|324487057|FG002|Overall Study|Death|11|||
94735203|NCT04778397|324487058|FG003|Overall Study|Death|9|||
94735204|NCT04778397|324487055|FG000|Overall Study|Study Terminated by Sponsor|34|||
94735205|NCT04778397|324487056|FG001|Overall Study|Study Terminated by Sponsor|42|||
94735206|NCT04778397|324487057|FG002|Overall Study|Study Terminated by Sponsor|15|||
94735207|NCT04778397|324487058|FG003|Overall Study|Study Terminated by Sponsor|12|||
94735208|NCT04778397|324487055|FG000|Overall Study|Withdrew Consent|5|||
94735209|NCT04778397|324487056|FG001|Overall Study|Withdrew Consent|4|||
94735210|NCT04778397|324487057|FG002|Overall Study|Withdrew Consent|1|||
94735211|NCT04778397|324487058|FG003|Overall Study|Withdrew Consent|1|||
94735212|NCT04778397|324487055|FG000|Overall Study|Reason Not Specified|1|||
94735213|NCT04778397|324487056|FG001|Overall Study|Reason Not Specified|3|||
94735214|NCT04778397|324487057|FG002|Overall Study|Reason Not Specified|0|||
94735215|NCT04778397|324487058|FG003|Overall Study|Reason Not Specified|2|||
94735216|NCT04778397|324487055|FG000|Overall Study|Lost to Follow-up|2|||
94735217|NCT04778397|324487056|FG001|Overall Study|Lost to Follow-up|1|||
94735218|NCT04778397|324487057|FG002|Overall Study|Lost to Follow-up|0|||
94735219|NCT04778397|324487058|FG003|Overall Study|Lost to Follow-up|1|||
94735220|NCT02668692|324487059|FG000|Overall Study|Adverse Event|1|||
94735221|NCT02668692|324487060|FG001|Overall Study|Adverse Event|0|||
94735222|NCT03478956|324487063|FG000|Randomized Treatment Period|Adverse Event|1|||
94735223|NCT03478956|324487064|FG001|Randomized Treatment Period|Adverse Event|0|||
94735224|NCT03478956|324487065|FG002|Randomized Treatment Period|Adverse Event|0|||
94735225|NCT03478956|324487066|FG003|Randomized Treatment Period|Adverse Event|0|||
94735226|NCT03478956|324487063|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
94735227|NCT03478956|324487064|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
94735228|NCT03478956|324487065|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
94735229|NCT03478956|324487066|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
94735230|NCT03478956|324487063|FG000|Open Label Extension Period|Adverse Event|0|||
94735231|NCT03478956|324487064|FG001|Open Label Extension Period|Adverse Event|0|||
94735232|NCT03478956|324487065|FG002|Open Label Extension Period|Adverse Event|4|||
94735233|NCT03478956|324487066|FG003|Open Label Extension Period|Adverse Event|0|||
94735234|NCT03478956|324487063|FG000|Open Label Extension Period|Lack of Efficacy|0|||
94735235|NCT03478956|324487064|FG001|Open Label Extension Period|Lack of Efficacy|0|||
94735236|NCT03478956|324487065|FG002|Open Label Extension Period|Lack of Efficacy|8|||
94735237|NCT03478956|324487066|FG003|Open Label Extension Period|Lack of Efficacy|0|||
94735238|NCT03478956|324487063|FG000|Open Label Extension Period|Reason Not Provided|0|||
94735239|NCT03478956|324487064|FG001|Open Label Extension Period|Reason Not Provided|0|||
94735240|NCT03478956|324487065|FG002|Open Label Extension Period|Reason Not Provided|1|||
94735241|NCT03478956|324487066|FG003|Open Label Extension Period|Reason Not Provided|0|||
94735242|NCT03478956|324487063|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
94735243|NCT03478956|324487064|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
94735244|NCT03478956|324487065|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
94275364|NCT05121480|322802385|FG007|Overall Study|Withdrawal by Subject|4|||
94275365|NCT05121480|322802378|FG000|Overall Study|Non-compliance with the protocol|0|||
94275366|NCT05121480|322802379|FG001|Overall Study|Non-compliance with the protocol|0|||
94735245|NCT03478956|324487066|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
94735246|NCT03478956|324487063|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
94735247|NCT03478956|324487064|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
94275367|NCT05121480|322802380|FG002|Overall Study|Non-compliance with the protocol|0|||
94275368|NCT05121480|322802381|FG003|Overall Study|Non-compliance with the protocol|0|||
94275369|NCT05121480|322802382|FG004|Overall Study|Non-compliance with the protocol|1|||
94275370|NCT05121480|322802383|FG005|Overall Study|Non-compliance with the protocol|6|||
94275371|NCT05121480|322802384|FG006|Overall Study|Non-compliance with the protocol|0|||
94275372|NCT05121480|322802385|FG007|Overall Study|Non-compliance with the protocol|1|||
94275373|NCT05121480|322802378|FG000|Overall Study|Lost to Follow-up|0|||
94275374|NCT05121480|322802379|FG001|Overall Study|Lost to Follow-up|4|||
94275375|NCT05121480|322802380|FG002|Overall Study|Lost to Follow-up|1|||
94275376|NCT05121480|322802381|FG003|Overall Study|Lost to Follow-up|3|||
94275377|NCT05121480|322802382|FG004|Overall Study|Lost to Follow-up|1|||
94275378|NCT05121480|322802383|FG005|Overall Study|Lost to Follow-up|1|||
94275379|NCT05121480|322802384|FG006|Overall Study|Lost to Follow-up|1|||
94275380|NCT05121480|322802385|FG007|Overall Study|Lost to Follow-up|4|||
94275381|NCT05121480|322802378|FG000|Overall Study|Physician Decision|0|||
94275382|NCT05121480|322802379|FG001|Overall Study|Physician Decision|0|||
94275383|NCT05121480|322802380|FG002|Overall Study|Physician Decision|0|||
94275384|NCT05121480|322802381|FG003|Overall Study|Physician Decision|0|||
94275385|NCT05121480|322802382|FG004|Overall Study|Physician Decision|0|||
94275386|NCT05121480|322802383|FG005|Overall Study|Physician Decision|1|||
94275387|NCT05121480|322802384|FG006|Overall Study|Physician Decision|0|||
94275388|NCT05121480|322802385|FG007|Overall Study|Physician Decision|1|||
94275389|NCT05121480|322802378|FG000|Overall Study|Other Reason|0|||
94275390|NCT05121480|322802379|FG001|Overall Study|Other Reason|0|||
94275391|NCT05121480|322802380|FG002|Overall Study|Other Reason|0|||
94275392|NCT05121480|322802381|FG003|Overall Study|Other Reason|0|||
94275393|NCT05121480|322802382|FG004|Overall Study|Other Reason|0|||
94275394|NCT05121480|322802383|FG005|Overall Study|Other Reason|1|||
94275395|NCT05121480|322802384|FG006|Overall Study|Other Reason|1|||
94275396|NCT05121480|322802385|FG007|Overall Study|Other Reason|1|||
94275397|NCT03332498|322802386|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
94275398|NCT03332498|322802387|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
94275399|NCT03332498|322802388|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
94275400|NCT02187471|322802389|FG000|Overall Study|Protocol Violation|4|||
94275401|NCT02187471|322802390|FG001|Overall Study|Protocol Violation|5|||
94275402|NCT02187471|322802391|FG002|Overall Study|Protocol Violation|4|||
94275403|NCT02187471|322802392|FG003|Overall Study|Protocol Violation|4|||
94275404|NCT02187471|322802389|FG000|Overall Study|Missing|0|||
94735248|NCT03478956|324487065|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
94735249|NCT03478956|324487066|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
94735250|NCT03478956|324487063|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
94735251|NCT03478956|324487064|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
94735252|NCT03478956|324487065|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
94735253|NCT03478956|324487066|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
94735254|NCT05646355|324487071|FG000|Overall Study|Lost to Follow-up|1|||
94735255|NCT05646355|324487072|FG001|Overall Study|Lost to Follow-up|0|||
94735256|NCT05646355|324487071|FG000|Overall Study|translated materials not available for pilot|2|||
94735257|NCT05646355|324487072|FG001|Overall Study|translated materials not available for pilot|0|||
94735258|NCT05646355|324487071|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
94735259|NCT05646355|324487072|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
94735260|NCT05259033|324487073|FG000|Overall Study|Withdrawal by Subject|10|||
94275405|NCT02187471|322802390|FG001|Overall Study|Missing|0|||
94275406|NCT02187471|322802391|FG002|Overall Study|Missing|0|||
94275407|NCT02187471|322802392|FG003|Overall Study|Missing|1|||
94275408|NCT02187471|322802389|FG000|Overall Study|Lack of Efficacy|18|||
94275409|NCT02187471|322802390|FG001|Overall Study|Lack of Efficacy|9|||
94275410|NCT02187471|322802391|FG002|Overall Study|Lack of Efficacy|13|||
94275411|NCT02187471|322802392|FG003|Overall Study|Lack of Efficacy|11|||
94275412|NCT02187471|322802389|FG000|Overall Study|Adverse Event|24|||
94275413|NCT02187471|322802390|FG001|Overall Study|Adverse Event|34|||
94275414|NCT02187471|322802391|FG002|Overall Study|Adverse Event|44|||
94275415|NCT02187471|322802392|FG003|Overall Study|Adverse Event|36|||
94275416|NCT02187471|322802389|FG000|Overall Study|Withdrawal by Subject|23|||
94735261|NCT05259033|324487074|FG001|Overall Study|Withdrawal by Subject|5|||
94735262|NCT05259033|324487073|FG000|Overall Study|Lost to Follow-up|1|||
94735263|NCT05259033|324487074|FG001|Overall Study|Lost to Follow-up|0|||
94275417|NCT02187471|322802390|FG001|Overall Study|Withdrawal by Subject|29|||
94275418|NCT02187471|322802391|FG002|Overall Study|Withdrawal by Subject|22|||
94275419|NCT02187471|322802392|FG003|Overall Study|Withdrawal by Subject|24|||
94275420|NCT02187471|322802389|FG000|Overall Study|Other|7|||
94275421|NCT02187471|322802390|FG001|Overall Study|Other|5|||
94275422|NCT02187471|322802391|FG002|Overall Study|Other|3|||
94275423|NCT02187471|322802392|FG003|Overall Study|Other|4|||
94275424|NCT01308008|322802393|FG000|4 Weeks|Illness, disinterest, time|9|||
94275425|NCT01308008|322802394|FG001|4 Weeks|Illness, disinterest, time|2|||
94275426|NCT03357731|322802395|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
94275427|NCT03357731|322802396|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
94275428|NCT03357731|322802397|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
94275429|NCT03357731|322802398|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
94275430|NCT03357731|322802399|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
94275431|NCT03357731|322802400|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
94275432|NCT03357731|322802395|FG000|Overall Study|Acute bradycardia and hypotension|0|||
94275433|NCT03357731|322802396|FG001|Overall Study|Acute bradycardia and hypotension|0|||
94275434|NCT03357731|322802397|FG002|Overall Study|Acute bradycardia and hypotension|0|||
94275435|NCT03357731|322802398|FG003|Overall Study|Acute bradycardia and hypotension|1|||
94275436|NCT03357731|322802399|FG004|Overall Study|Acute bradycardia and hypotension|0|||
94275437|NCT03357731|322802400|FG005|Overall Study|Acute bradycardia and hypotension|0|||
94275438|NCT03357731|322802395|FG000|Overall Study|Adverse Event|0|||
94275439|NCT03357731|322802396|FG001|Overall Study|Adverse Event|0|||
94275440|NCT03357731|322802397|FG002|Overall Study|Adverse Event|0|||
94275441|NCT03357731|322802398|FG003|Overall Study|Adverse Event|0|||
94275442|NCT03357731|322802399|FG004|Overall Study|Adverse Event|0|||
94275443|NCT03357731|322802400|FG005|Overall Study|Adverse Event|1|||
94275444|NCT03357731|322802395|FG000|Overall Study|Hypotension|0|||
94275445|NCT03357731|322802396|FG001|Overall Study|Hypotension|0|||
94275446|NCT03357731|322802397|FG002|Overall Study|Hypotension|1|||
94275447|NCT03357731|322802398|FG003|Overall Study|Hypotension|1|||
94275448|NCT03357731|322802399|FG004|Overall Study|Hypotension|0|||
94275449|NCT03357731|322802400|FG005|Overall Study|Hypotension|0|||
94275450|NCT03357731|322802395|FG000|Overall Study|Lost to Follow-up|0|||
94275451|NCT03357731|322802396|FG001|Overall Study|Lost to Follow-up|0|||
94275452|NCT03357731|322802397|FG002|Overall Study|Lost to Follow-up|0|||
94275453|NCT03357731|322802398|FG003|Overall Study|Lost to Follow-up|1|||
94275454|NCT03357731|322802399|FG004|Overall Study|Lost to Follow-up|0|||
94275455|NCT03357731|322802400|FG005|Overall Study|Lost to Follow-up|0|||
94275456|NCT00772954|322802401|FG000|Overall Study|Adverse Event|0|||
94275457|NCT00772954|322802402|FG001|Overall Study|Adverse Event|0|||
94275458|NCT00772954|322802403|FG002|Overall Study|Adverse Event|1|||
94275459|NCT01773109|322802404|FG000|Overall Study|Symptomatic Progression|2|||
94275460|NCT01773109|322802404|FG000|Overall Study|Death|1|||
94275461|NCT02495844|322802405|FG000|Overall Study|Lack of Efficacy|1|||
94467464|NCT04015518|323500564|FG003|Overall Study|Withdrew consent|0|||
94275462|NCT02495844|322802406|FG001|Overall Study|Lack of Efficacy|2|||
94275463|NCT02495844|322802405|FG000|Overall Study|AE, non-fatal|0|||
94275464|NCT02495844|322802406|FG001|Overall Study|AE, non-fatal|1|||
94275465|NCT02495844|322802405|FG000|Overall Study|Hepatitis Positivity|0|||
94275466|NCT02495844|322802406|FG001|Overall Study|Hepatitis Positivity|1|||
94275467|NCT02325219|322802409|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
94275468|NCT02325219|322802410|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
94275469|NCT02325219|322802411|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
94275470|NCT02325219|322802412|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
94275471|NCT02325219|322802413|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
94275472|NCT02325219|322802409|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
94275473|NCT02325219|322802410|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
94275474|NCT02325219|322802411|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
94275475|NCT02325219|322802412|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
94275476|NCT02325219|322802413|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
94275477|NCT02325219|322802409|FG000|Controlled Period (Week 0 - 16)|Other|0|||
94275478|NCT02325219|322802410|FG001|Controlled Period (Week 0 - 16)|Other|0|||
94275479|NCT02325219|322802411|FG002|Controlled Period (Week 0 - 16)|Other|1|||
94275480|NCT02325219|322802412|FG003|Controlled Period (Week 0 - 16)|Other|0|||
94275481|NCT02325219|322802413|FG004|Controlled Period (Week 0 - 16)|Other|0|||
94275482|NCT02325219|322802409|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
94275483|NCT02325219|322802410|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
94275484|NCT02325219|322802411|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
94275485|NCT02325219|322802412|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
94275486|NCT02325219|322802413|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
94275487|NCT02325219|322802409|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
94275488|NCT02325219|322802410|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
94275489|NCT02325219|322802411|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
94275490|NCT02325219|322802412|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
94275491|NCT02325219|322802413|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
94275492|NCT02325219|322802409|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
94275493|NCT02325219|322802410|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
94275494|NCT02325219|322802411|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
94275495|NCT02325219|322802412|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
94275496|NCT02325219|322802413|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
94275497|NCT04036708|322802417|FG000|Overall Study|Lost to Follow-up|14|||
94275498|NCT04036708|322802418|FG001|Overall Study|Lost to Follow-up|4|||
94275499|NCT04036708|322802419|FG002|Overall Study|Lost to Follow-up|14|||
94275500|NCT04036708|322802420|FG003|Overall Study|Lost to Follow-up|4|||
94275501|NCT02918864|322802421|FG000|Overall Study|Withdrawal by Subject|1|||
94275502|NCT02918864|322802422|FG001|Overall Study|Withdrawal by Subject|1|||
94275503|NCT02918864|322802421|FG000|Overall Study|Lost to Follow-up|3|||
94275504|NCT02918864|322802422|FG001|Overall Study|Lost to Follow-up|2|||
94275505|NCT02257372|322802424|FG000|Overall Study|Adverse Event|3|||
94275506|NCT02257372|322802425|FG001|Overall Study|Adverse Event|7|||
94275507|NCT02257372|322802424|FG000|Overall Study|Lack of Efficacy|2|||
94275508|NCT02257372|322802425|FG001|Overall Study|Lack of Efficacy|1|||
94275509|NCT02257372|322802424|FG000|Overall Study|Protocol Violation|1|||
94275510|NCT02257372|322802425|FG001|Overall Study|Protocol Violation|1|||
94735264|NCT05259033|324487073|FG000|Overall Study|Death|2|||
94735265|NCT05259033|324487074|FG001|Overall Study|Death|0|||
94735266|NCT05089357|324487086|FG000|Overall Study|Withdrawal by Subject|23|||
94735267|NCT05089357|324487086|FG000|Overall Study|Lost to Follow-up|6|||
94735268|NCT05089357|324487086|FG000|Overall Study|Medical reason|1|||
94735269|NCT05089357|324487086|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
94735270|NCT05089357|324487086|FG000|Overall Study|Pregnancy|2|||
94735271|NCT05863156|324487087|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
94735272|NCT05863156|324487088|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
94735273|NCT05863156|324487089|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
94735274|NCT03362476|324487091|FG000|Overall Study|Withdrawal by Subject|0|||
94735275|NCT03362476|324487092|FG001|Overall Study|Withdrawal by Subject|1|||
94735276|NCT05526430|324488356|FG000|Overall Study|Withdrawal by Subject|0|||
94735277|NCT05526430|324488357|FG001|Overall Study|Withdrawal by Subject|2|||
94735278|NCT05526430|324488358|FG002|Overall Study|Withdrawal by Subject|0|||
94735279|NCT05526430|324488359|FG003|Overall Study|Withdrawal by Subject|0|||
94735280|NCT02134925|324488360|FG000|Overall Study|Withdrawal by Subject|1|||
94735281|NCT02134925|324488361|FG001|Overall Study|Withdrawal by Subject|0|||
94735282|NCT02134925|324488360|FG000|Overall Study|Cancel|1|||
94735283|NCT02134925|324488361|FG001|Overall Study|Cancel|6|||
94735284|NCT02505984|324488362|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
94735285|NCT02505984|324488363|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
94735286|NCT02505984|324488362|FG000|Overall Study|Unreliable self-report data|1|||
94735287|NCT02505984|324488363|FG001|Overall Study|Unreliable self-report data|0|||
94735288|NCT02505984|324488362|FG000|Overall Study|Study blind opened during assessment|0|||
94735289|NCT02505984|324488363|FG001|Overall Study|Study blind opened during assessment|1|||
94735290|NCT02505984|324488362|FG000|Overall Study|Noncompliance with study protocol|0|||
94735291|NCT02505984|324488363|FG001|Overall Study|Noncompliance with study protocol|1|||
94735292|NCT05446168|324488364|FG000|Overall Study|Physician Decision|0|||
94735293|NCT05446168|324488365|FG001|Overall Study|Physician Decision|1|||
94735294|NCT06473662|324488371|FG000|Overall Study|Withdrawal by Subject|1|||
94735295|NCT06473662|324488372|FG001|Overall Study|Withdrawal by Subject|6|||
94735296|NCT06473662|324488373|FG002|Overall Study|Withdrawal by Subject|5|||
94735297|NCT06473662|324488371|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
94735298|NCT06473662|324488372|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
94735299|NCT06473662|324488373|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
94735300|NCT06473662|324488371|FG000|Overall Study|Starting HbA1c below 7%|0|||
94735301|NCT06473662|324488372|FG001|Overall Study|Starting HbA1c below 7%|1|||
94735302|NCT06473662|324488373|FG002|Overall Study|Starting HbA1c below 7%|1|||
94735303|NCT06473662|324488371|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
94735304|NCT06473662|324488372|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
94735305|NCT06473662|324488373|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
94735306|NCT06473662|324488371|FG000|Overall Study|Did not take medication|2|||
94735307|NCT06473662|324488372|FG001|Overall Study|Did not take medication|3|||
94735308|NCT06473662|324488373|FG002|Overall Study|Did not take medication|2|||
94735309|NCT03676192|324488374|FG000|Induction Study Period|Adverse Event|21|||
94735310|NCT03676192|324488375|FG001|Induction Study Period|Adverse Event|20|||
94735311|NCT03676192|324488374|FG000|Induction Study Period|Death|23|||
94735312|NCT03676192|324488375|FG001|Induction Study Period|Death|20|||
94735313|NCT03676192|324488374|FG000|Induction Study Period|Lost to Follow-up|3|||
94735314|NCT03676192|324488375|FG001|Induction Study Period|Lost to Follow-up|3|||
94735315|NCT03676192|324488374|FG000|Induction Study Period|Physician Decision|6|||
94735316|NCT03676192|324488375|FG001|Induction Study Period|Physician Decision|3|||
94735317|NCT03676192|324488374|FG000|Induction Study Period|Progressive Disease|32|||
94735318|NCT03676192|324488375|FG001|Induction Study Period|Progressive Disease|21|||
94735319|NCT03676192|324488374|FG000|Induction Study Period|Protocol Violation|1|||
94735320|NCT03676192|324488375|FG001|Induction Study Period|Protocol Violation|2|||
94735321|NCT03676192|324488374|FG000|Induction Study Period|Withdrawal by Subject|20|||
94735322|NCT03676192|324488375|FG001|Induction Study Period|Withdrawal by Subject|15|||
94735323|NCT04826471|324488376|FG000|Overall Study|Lost to Follow-up|2|||
94735324|NCT04826471|324488376|FG000|Overall Study|Protocol Violation|3|||
94735325|NCT04826471|324488376|FG000|Overall Study|Withdrawal by Subject|1|||
94735326|NCT04079218|324488380|FG000|Overall Study|Death|1|||
94735327|NCT04079218|324488381|FG001|Overall Study|Death|0|||
94368814|NCT03611751|323136548|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
94735328|NCT04079218|324488380|FG000|Overall Study|Withdrawal by Subject|3|||
94735329|NCT04079218|324488381|FG001|Overall Study|Withdrawal by Subject|0|||
94735330|NCT04079218|324488380|FG000|Overall Study|Physician Decision|4|||
94735331|NCT04079218|324488381|FG001|Overall Study|Physician Decision|0|||
94735332|NCT04079218|324488380|FG000|Overall Study|Lost to Follow-up|0|||
94368815|NCT03611751|323136549|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
94368816|NCT03611751|323136550|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
94735333|NCT04079218|324488381|FG001|Overall Study|Lost to Follow-up|1|||
94735334|NCT03030261|324488382|FG000|Overall Study|Still receiving continuation therapy|5|||
94735335|NCT03386578|324488385|FG000|PK Component|Lost to Follow-up|0|||
94735336|NCT03386578|324488386|FG001|PK Component|Lost to Follow-up|1|||
94735337|NCT03386578|324488387|FG002|PK Component|Lost to Follow-up|0|||
94735338|NCT03386578|324488388|FG003|PK Component|Lost to Follow-up|0|||
94735339|NCT03386578|324488389|FG004|PK Component|Lost to Follow-up|0|||
94735340|NCT03386578|324488390|FG005|PK Component|Lost to Follow-up|0|||
94735341|NCT03386578|324488391|FG006|PK Component|Lost to Follow-up|1|||
94735342|NCT03386578|324488392|FG007|PK Component|Lost to Follow-up|0|||
94735343|NCT03386578|324488393|FG008|PK Component|Lost to Follow-up|0|||
94735344|NCT03386578|324488394|FG009|PK Component|Lost to Follow-up|0|||
94735345|NCT03386578|324488385|FG000|PK Component|Stillbirth/Abortion|0|||
94735346|NCT03386578|324488386|FG001|PK Component|Stillbirth/Abortion|0|||
94735347|NCT03386578|324488387|FG002|PK Component|Stillbirth/Abortion|0|||
94735348|NCT03386578|324488388|FG003|PK Component|Stillbirth/Abortion|0|||
94735349|NCT03386578|324488389|FG004|PK Component|Stillbirth/Abortion|0|||
94735350|NCT03386578|324488390|FG005|PK Component|Stillbirth/Abortion|2|||
94735351|NCT03386578|324488391|FG006|PK Component|Stillbirth/Abortion|0|||
94735352|NCT03386578|324488392|FG007|PK Component|Stillbirth/Abortion|0|||
94735353|NCT03386578|324488393|FG008|PK Component|Stillbirth/Abortion|0|||
94735354|NCT03386578|324488394|FG009|PK Component|Stillbirth/Abortion|0|||
94735355|NCT03386578|324488385|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
94735356|NCT03386578|324488386|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
94735357|NCT03386578|324488387|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
94735358|NCT03386578|324488388|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
94735359|NCT03386578|324488389|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
94735360|NCT03386578|324488390|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
94735361|NCT03386578|324488391|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
94735362|NCT03386578|324488392|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
94735363|NCT03386578|324488393|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
94735364|NCT03386578|324488394|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
94735365|NCT03386578|324488385|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
94735366|NCT03386578|324488386|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
94735367|NCT03386578|324488387|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
94735368|NCT03386578|324488388|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
94735369|NCT03386578|324488389|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
94735370|NCT03386578|324488390|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
94735371|NCT03386578|324488391|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
94735372|NCT03386578|324488392|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
94735373|NCT03386578|324488393|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
94735374|NCT03386578|324488394|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
94735375|NCT03386578|324488385|FG000|PrEP Comparison Component Step 1|Death|0|||
94735376|NCT03386578|324488386|FG001|PrEP Comparison Component Step 1|Death|0|||
94735377|NCT03386578|324488387|FG002|PrEP Comparison Component Step 1|Death|1|||
94735378|NCT03386578|324488388|FG003|PrEP Comparison Component Step 1|Death|0|||
94735379|NCT03386578|324488389|FG004|PrEP Comparison Component Step 1|Death|0|||
94735380|NCT03386578|324488390|FG005|PrEP Comparison Component Step 1|Death|0|||
94735381|NCT03386578|324488391|FG006|PrEP Comparison Component Step 1|Death|0|||
94735382|NCT03386578|324488392|FG007|PrEP Comparison Component Step 1|Death|9|||
94735383|NCT03386578|324488393|FG008|PrEP Comparison Component Step 1|Death|5|||
94735384|NCT03386578|324488394|FG009|PrEP Comparison Component Step 1|Death|0|||
94735385|NCT03386578|324488385|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
94735386|NCT03386578|324488386|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
94735387|NCT03386578|324488387|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
94735388|NCT03386578|324488388|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
94735389|NCT03386578|324488389|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
94735390|NCT03386578|324488390|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
94735391|NCT03386578|324488391|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
94735392|NCT03386578|324488392|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
94735393|NCT03386578|324488393|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
94735394|NCT03386578|324488394|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
94735395|NCT03386578|324488385|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
94735396|NCT03386578|324488386|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
94735397|NCT03386578|324488387|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
94735398|NCT03386578|324488388|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
94735399|NCT03386578|324488389|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
94735400|NCT03386578|324488390|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
94467465|NCT04015518|323500565|FG004|Overall Study|Withdrew consent|0|||
94467466|NCT04015518|323500561|FG000|Overall Study|Prostate carcinoma|1|||
94467467|NCT04015518|323500562|FG001|Overall Study|Prostate carcinoma|0|||
94467468|NCT04015518|323500563|FG002|Overall Study|Prostate carcinoma|0|||
94467469|NCT04015518|323500564|FG003|Overall Study|Prostate carcinoma|0|||
94467470|NCT04015518|323500565|FG004|Overall Study|Prostate carcinoma|0|||
94467471|NCT04015518|323500561|FG000|Overall Study|Could not keep appointments due to work|1|||
94467472|NCT04015518|323500562|FG001|Overall Study|Could not keep appointments due to work|0|||
94467473|NCT04015518|323500563|FG002|Overall Study|Could not keep appointments due to work|0|||
94467474|NCT04015518|323500564|FG003|Overall Study|Could not keep appointments due to work|0|||
94467475|NCT04015518|323500565|FG004|Overall Study|Could not keep appointments due to work|0|||
94467476|NCT01324570|323500575|FG000|Overall Study|Adverse Event|4|||
94467477|NCT01324570|323500576|FG001|Overall Study|Adverse Event|7|||
94467478|NCT01324570|323500575|FG000|Overall Study|Withdrawal by Subject|0|||
94467479|NCT01324570|323500576|FG001|Overall Study|Withdrawal by Subject|3|||
94735401|NCT03386578|324488391|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
94735402|NCT03386578|324488392|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
94735403|NCT03386578|324488393|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
94735404|NCT03386578|324488394|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
94735405|NCT03386578|324488385|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
94735406|NCT03386578|324488386|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
94735407|NCT03386578|324488387|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
94735408|NCT03386578|324488388|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
94735409|NCT03386578|324488389|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
94735410|NCT03386578|324488390|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
94735411|NCT03386578|324488391|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
94735412|NCT03386578|324488392|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
94735413|NCT03386578|324488393|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
94735414|NCT03386578|324488394|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
94735415|NCT05576155|324488395|FG000|Overall Study|Withdrawal by Subject|1|||
94735416|NCT05576155|324488396|FG001|Overall Study|Withdrawal by Subject|1|||
94735417|NCT05192109|324488397|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
94735418|NCT05192109|324488398|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
94735419|NCT05192109|324488399|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
94735420|NCT05192109|324488400|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
94735421|NCT05192109|324488397|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
94735422|NCT05192109|324488398|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
94735423|NCT05192109|324488399|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
94735424|NCT05192109|324488400|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
94735425|NCT05907174|324488401|FG000|3-Month Assessment|Withdrawal by Subject|0|||
94735426|NCT05907174|324488402|FG001|3-Month Assessment|Withdrawal by Subject|0|||
94735427|NCT05907174|324488403|FG002|3-Month Assessment|Withdrawal by Subject|0|||
94735428|NCT05907174|324488404|FG003|3-Month Assessment|Withdrawal by Subject|1|||
94735429|NCT05907174|324488401|FG000|3-Month Assessment|Lost to Follow-up|1|||
94735430|NCT05907174|324488402|FG001|3-Month Assessment|Lost to Follow-up|1|||
94735431|NCT05907174|324488403|FG002|3-Month Assessment|Lost to Follow-up|1|||
94735432|NCT05907174|324488404|FG003|3-Month Assessment|Lost to Follow-up|1|||
94467480|NCT01324570|323500575|FG000|Overall Study|Lack of Efficacy|0|||
94467481|NCT01324570|323500576|FG001|Overall Study|Lack of Efficacy|1|||
94368817|NCT03611751|323136548|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
94368818|NCT03611751|323136549|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
94368819|NCT03611751|323136550|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
94368820|NCT03611751|323136548|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
94735433|NCT05907174|324488401|FG000|6-Month Assessment|Death|0|||
94735434|NCT05907174|324488402|FG001|6-Month Assessment|Death|0|||
94735435|NCT05907174|324488403|FG002|6-Month Assessment|Death|3|||
94735436|NCT05907174|324488404|FG003|6-Month Assessment|Death|0|||
94735437|NCT05907174|324488401|FG000|6-Month Assessment|Withdrawal by Subject|0|||
94735438|NCT05907174|324488402|FG001|6-Month Assessment|Withdrawal by Subject|0|||
94735439|NCT05907174|324488403|FG002|6-Month Assessment|Withdrawal by Subject|1|||
94735440|NCT05907174|324488404|FG003|6-Month Assessment|Withdrawal by Subject|1|||
94735441|NCT05907174|324488401|FG000|6-Month Assessment|Lost to Follow-up|0|||
94735442|NCT05907174|324488402|FG001|6-Month Assessment|Lost to Follow-up|1|||
94735443|NCT05907174|324488403|FG002|6-Month Assessment|Lost to Follow-up|1|||
94735444|NCT05907174|324488404|FG003|6-Month Assessment|Lost to Follow-up|1|||
94735445|NCT02694822|324488407|FG000|Phase 1|Death|2|||
94735446|NCT02694822|324488408|FG001|Phase 1|Death|1|||
94735447|NCT02694822|324488409|FG002|Phase 1|Death|6|||
94735448|NCT02694822|324488410|FG003|Phase 1|Death|6|||
94735449|NCT02694822|324488411|FG004|Phase 1|Death|3|||
94735450|NCT02694822|324488412|FG005|Phase 1|Death|0|||
94735451|NCT02694822|324488407|FG000|Phase 1|Withdrawal by Subject|2|||
94735452|NCT02694822|324488408|FG001|Phase 1|Withdrawal by Subject|2|||
94735453|NCT02694822|324488409|FG002|Phase 1|Withdrawal by Subject|4|||
94735454|NCT02694822|324488410|FG003|Phase 1|Withdrawal by Subject|8|||
94735455|NCT02694822|324488411|FG004|Phase 1|Withdrawal by Subject|1|||
94735456|NCT02694822|324488412|FG005|Phase 1|Withdrawal by Subject|0|||
94735457|NCT02694822|324488407|FG000|Phase 2|Death|0|||
94735458|NCT02694822|324488408|FG001|Phase 2|Death|0|||
94735459|NCT02694822|324488409|FG002|Phase 2|Death|0|||
94735460|NCT02694822|324488410|FG003|Phase 2|Death|0|||
94735461|NCT02694822|324488411|FG004|Phase 2|Death|0|||
94735462|NCT02694822|324488412|FG005|Phase 2|Death|26|||
94735463|NCT02694822|324488407|FG000|Phase 2|Withdrawal by Subject|0|||
94735464|NCT02694822|324488408|FG001|Phase 2|Withdrawal by Subject|0|||
94735465|NCT02694822|324488409|FG002|Phase 2|Withdrawal by Subject|0|||
94735466|NCT02694822|324488410|FG003|Phase 2|Withdrawal by Subject|0|||
94735467|NCT02694822|324488411|FG004|Phase 2|Withdrawal by Subject|0|||
94735468|NCT02694822|324488412|FG005|Phase 2|Withdrawal by Subject|13|||
94735469|NCT02694822|324488407|FG000|Phase 2|Administrative Study Closure|0|||
94735470|NCT02694822|324488408|FG001|Phase 2|Administrative Study Closure|0|||
94735471|NCT02694822|324488409|FG002|Phase 2|Administrative Study Closure|0|||
94735472|NCT02694822|324488410|FG003|Phase 2|Administrative Study Closure|0|||
94735473|NCT02694822|324488411|FG004|Phase 2|Administrative Study Closure|0|||
94735474|NCT02694822|324488412|FG005|Phase 2|Administrative Study Closure|2|||
94735475|NCT02694822|324488407|FG000|Phase 2|Lost to Follow-up|0|||
94735476|NCT02694822|324488408|FG001|Phase 2|Lost to Follow-up|0|||
94735477|NCT02694822|324488409|FG002|Phase 2|Lost to Follow-up|0|||
94735478|NCT02694822|324488410|FG003|Phase 2|Lost to Follow-up|0|||
94735479|NCT02694822|324488411|FG004|Phase 2|Lost to Follow-up|0|||
94735480|NCT02694822|324488412|FG005|Phase 2|Lost to Follow-up|1|||
94735481|NCT02694822|324488407|FG000|Phase 2|Participant Transferred to Another Site|0|||
94735482|NCT02694822|324488408|FG001|Phase 2|Participant Transferred to Another Site|0|||
94735483|NCT02694822|324488409|FG002|Phase 2|Participant Transferred to Another Site|0|||
94735484|NCT02694822|324488410|FG003|Phase 2|Participant Transferred to Another Site|0|||
94735485|NCT02694822|324488411|FG004|Phase 2|Participant Transferred to Another Site|0|||
94735486|NCT02694822|324488412|FG005|Phase 2|Participant Transferred to Another Site|1|||
94735487|NCT05906784|324488413|FG000|Overall Study|Lost to Follow-up|2|||
94735488|NCT05906784|324488414|FG001|Overall Study|Lost to Follow-up|1|||
94735489|NCT05906784|324488415|FG002|Overall Study|Lost to Follow-up|1|||
94735490|NCT05906784|324488416|FG003|Overall Study|Lost to Follow-up|1|||
94735491|NCT04677738|324488417|FG000|Overall Study|Withdrawal by Subject|4|||
94735492|NCT04677738|324488418|FG001|Overall Study|Withdrawal by Subject|2|||
94735493|NCT04314778|324488419|FG000|Overall Study|Lost to Follow-up|5|||
94735494|NCT04314778|324488420|FG001|Overall Study|Lost to Follow-up|3|||
94735495|NCT04024020|324488421|FG000|Overall Study|Withdrawal by Subject|2|||
94735496|NCT04024020|324488422|FG001|Overall Study|Withdrawal by Subject|2|||
94735497|NCT02152995|324488435|FG000|Overall Study|Withdrawal by Subject|1|||
94735498|NCT02152995|324488436|FG001|Overall Study|Withdrawal by Subject|0|||
94735499|NCT05147116|324488443|FG000|Overall Study|Withdrawal by Subject|0|||
94735500|NCT05147116|324488444|FG001|Overall Study|Withdrawal by Subject|1|||
94735501|NCT05868382|324488445|FG000|Overall Study|Lost to Follow-up|5|||
94735502|NCT05868382|324488446|FG001|Overall Study|Lost to Follow-up|0|||
94735503|NCT05868382|324488447|FG002|Overall Study|Lost to Follow-up|6|||
94368821|NCT03611751|323136549|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
94735504|NCT05868382|324488448|FG003|Overall Study|Lost to Follow-up|4|||
94735505|NCT05868382|324488449|FG004|Overall Study|Lost to Follow-up|2|||
94735506|NCT05868382|324488450|FG005|Overall Study|Lost to Follow-up|6|||
94735507|NCT05868382|324488445|FG000|Overall Study|Withdrawal by Subject|1|||
94735508|NCT05868382|324488446|FG001|Overall Study|Withdrawal by Subject|0|||
94735509|NCT05868382|324488447|FG002|Overall Study|Withdrawal by Subject|0|||
94735510|NCT05868382|324488448|FG003|Overall Study|Withdrawal by Subject|0|||
94735511|NCT05868382|324488449|FG004|Overall Study|Withdrawal by Subject|1|||
94735512|NCT05868382|324488450|FG005|Overall Study|Withdrawal by Subject|0|||
94735513|NCT04585815|324488451|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
94735514|NCT04585815|324488452|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
94735515|NCT04585815|324488453|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
94735516|NCT04585815|324488454|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
94735517|NCT04585815|324488455|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
94735518|NCT04585815|324488456|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
94735519|NCT04585815|324488457|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
94735520|NCT04585815|324488451|FG000|Sub-study A- Treatment Phase|Death|0|||
94735521|NCT04585815|324488452|FG001|Sub-study A- Treatment Phase|Death|1|||
94735522|NCT04585815|324488453|FG002|Sub-study A- Treatment Phase|Death|0|||
94735523|NCT04585815|324488454|FG003|Sub-study A- Treatment Phase|Death|0|||
94735524|NCT04585815|324488455|FG004|Sub-study A- Treatment Phase|Death|0|||
94735525|NCT04585815|324488456|FG005|Sub-study A- Treatment Phase|Death|0|||
94735526|NCT04585815|324488457|FG006|Sub-study A- Treatment Phase|Death|0|||
94735527|NCT04585815|324488451|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
94735528|NCT04585815|324488452|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
94735529|NCT04585815|324488453|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
94735530|NCT04585815|324488454|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
94735531|NCT04585815|324488455|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
94735532|NCT04585815|324488456|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
94735533|NCT04585815|324488457|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
94735534|NCT04585815|324488451|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
94735535|NCT04585815|324488452|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
94735536|NCT04585815|324488453|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
94735537|NCT04585815|324488454|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
94735538|NCT04585815|324488455|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
94275511|NCT02257372|322802424|FG000|Overall Study|Lost to Follow-up|0|||
94735539|NCT04585815|324488456|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
94735540|NCT04585815|324488457|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
94735541|NCT04585815|324488451|FG000|Sub-study A- Treatment Phase|Other|1|||
94735542|NCT04585815|324488452|FG001|Sub-study A- Treatment Phase|Other|0|||
94735543|NCT04585815|324488453|FG002|Sub-study A- Treatment Phase|Other|0|||
94735544|NCT04585815|324488454|FG003|Sub-study A- Treatment Phase|Other|0|||
94735545|NCT04585815|324488455|FG004|Sub-study A- Treatment Phase|Other|0|||
94735546|NCT04585815|324488456|FG005|Sub-study A- Treatment Phase|Other|0|||
94735547|NCT04585815|324488457|FG006|Sub-study A- Treatment Phase|Other|0|||
94735548|NCT04585815|324488451|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
94735549|NCT04585815|324488452|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
94735550|NCT04585815|324488453|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
94735551|NCT04585815|324488454|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
94735552|NCT04585815|324488455|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
94735553|NCT04585815|324488456|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
94735554|NCT04585815|324488457|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
94735555|NCT04585815|324488451|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
94735556|NCT04585815|324488452|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
94735557|NCT04585815|324488453|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
94735558|NCT04585815|324488454|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
94735559|NCT04585815|324488455|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
94735560|NCT04585815|324488456|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
94735561|NCT04585815|324488457|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
94735562|NCT04585815|324488451|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
94735563|NCT04585815|324488452|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
94735564|NCT04585815|324488453|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
94735565|NCT04585815|324488454|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
94735566|NCT04585815|324488455|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
94735567|NCT04585815|324488456|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
94735568|NCT04585815|324488457|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
94735569|NCT04585815|324488451|FG000|Sub-study B- Treatment Phase|Death|0|||
94735570|NCT04585815|324488452|FG001|Sub-study B- Treatment Phase|Death|0|||
94735571|NCT04585815|324488453|FG002|Sub-study B- Treatment Phase|Death|0|||
94735572|NCT04585815|324488454|FG003|Sub-study B- Treatment Phase|Death|1|||
94735573|NCT04585815|324488455|FG004|Sub-study B- Treatment Phase|Death|0|||
94735574|NCT04585815|324488456|FG005|Sub-study B- Treatment Phase|Death|0|||
94735575|NCT04585815|324488457|FG006|Sub-study B- Treatment Phase|Death|0|||
94735576|NCT04585815|324488451|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
94735577|NCT04585815|324488452|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
94368822|NCT03611751|323136550|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
94735578|NCT04585815|324488453|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
94735579|NCT04585815|324488454|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
94735580|NCT04585815|324488455|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
94735581|NCT04585815|324488456|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
94735582|NCT04585815|324488457|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
94735583|NCT04585815|324488451|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
94735584|NCT04585815|324488452|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
94735585|NCT04585815|324488453|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
94735586|NCT04585815|324488454|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
94735587|NCT04585815|324488455|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
94735588|NCT04585815|324488456|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
94735589|NCT04585815|324488457|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
94735590|NCT04585815|324488451|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
94735591|NCT04585815|324488452|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
94735592|NCT04585815|324488453|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
94735593|NCT04585815|324488454|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
94735594|NCT04585815|324488455|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
94735595|NCT04585815|324488456|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
94735596|NCT04585815|324488457|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
94735597|NCT04585815|324488451|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
94735598|NCT04585815|324488452|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
94735599|NCT04585815|324488453|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
94735600|NCT04585815|324488454|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
94735601|NCT04585815|324488455|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
94735602|NCT04585815|324488456|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
94735603|NCT04585815|324488457|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
94735604|NCT04585815|324488451|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
94735605|NCT04585815|324488452|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
94735606|NCT04585815|324488453|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
94735607|NCT04585815|324488454|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
94735608|NCT04585815|324488455|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
94368823|NCT03611751|323136548|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
94735609|NCT04585815|324488456|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
94735610|NCT04585815|324488457|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
94735611|NCT04585815|324488451|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
94735612|NCT04585815|324488452|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
94735613|NCT04585815|324488453|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
94735614|NCT04585815|324488454|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
94735615|NCT04585815|324488455|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
94735616|NCT04585815|324488456|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
94735617|NCT04585815|324488457|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
94735618|NCT04585815|324488451|FG000|Sub-study B- Follow-up Phase|Death|0|||
94735619|NCT04585815|324488452|FG001|Sub-study B- Follow-up Phase|Death|0|||
94735620|NCT04585815|324488453|FG002|Sub-study B- Follow-up Phase|Death|1|||
94735621|NCT04585815|324488454|FG003|Sub-study B- Follow-up Phase|Death|3|||
94735622|NCT04585815|324488455|FG004|Sub-study B- Follow-up Phase|Death|0|||
94735623|NCT04585815|324488456|FG005|Sub-study B- Follow-up Phase|Death|0|||
94735624|NCT04585815|324488457|FG006|Sub-study B- Follow-up Phase|Death|1|||
94735625|NCT04032847|324488462|FG000|Overall Study|Study termination by sponsor|8|||
94735626|NCT04032847|324488463|FG001|Overall Study|Study termination by sponsor|0|||
94735627|NCT04032847|324488464|FG002|Overall Study|Study termination by sponsor|4|||
94735628|NCT04032847|324488462|FG000|Overall Study|Death|12|||
94735629|NCT04032847|324488463|FG001|Overall Study|Death|0|||
94735630|NCT04032847|324488464|FG002|Overall Study|Death|0|||
94735631|NCT04032847|324488462|FG000|Overall Study|Progressive disease|2|||
94735632|NCT04032847|324488463|FG001|Overall Study|Progressive disease|0|||
94735633|NCT04032847|324488464|FG002|Overall Study|Progressive disease|1|||
94735634|NCT03213665|324488465|FG000|Overall Study|Adverse Event|1|||
94735635|NCT03213665|324488465|FG000|Overall Study|Physician Decision|2|||
94735636|NCT03213665|324488465|FG000|Overall Study|Withdrawal by Subject|3|||
94735637|NCT03213665|324488465|FG000|Overall Study|Progressive Disease|13|||
94735638|NCT03325985|324488466|FG000|Overall Study|Lost to Follow-up|122|||
94735639|NCT03325985|324488467|FG001|Overall Study|Lost to Follow-up|26|||
94735640|NCT03325985|324488468|FG002|Overall Study|Lost to Follow-up|141|||
94735641|NCT03325985|324488469|FG003|Overall Study|Lost to Follow-up|28|||
94735642|NCT03325985|324488466|FG000|Overall Study|Death|99|||
94735643|NCT03325985|324488467|FG001|Overall Study|Death|36|||
94735644|NCT03325985|324488468|FG002|Overall Study|Death|94|||
94735645|NCT03325985|324488469|FG003|Overall Study|Death|32|||
94735646|NCT01796197|324488470|FG000|Overall Study|Lost to Follow-up|1|||
94735647|NCT01796197|324488470|FG000|Overall Study|Lack of Efficacy|1|||
94735648|NCT05873556|324488471|FG000|Overall Study|Lost to Follow-up|4|||
94735649|NCT05873556|324488472|FG001|Overall Study|Lost to Follow-up|1|||
94735650|NCT05104463|324488473|FG000|Overall Study|Adverse Event|1|||
94735651|NCT05104463|324488474|FG001|Overall Study|Adverse Event|1|||
94735652|NCT05104463|324488473|FG000|Overall Study|Lost to Follow-up|1|||
94735653|NCT05104463|324488474|FG001|Overall Study|Lost to Follow-up|1|||
94735654|NCT05104463|324488473|FG000|Overall Study|Physician Decision|1|||
94735655|NCT05104463|324488474|FG001|Overall Study|Physician Decision|0|||
94735656|NCT05104463|324488473|FG000|Overall Study|Protocol Violation|0|||
94735657|NCT05104463|324488474|FG001|Overall Study|Protocol Violation|2|||
94735658|NCT05104463|324488473|FG000|Overall Study|Withdrawal by Subject|1|||
94735659|NCT05104463|324488474|FG001|Overall Study|Withdrawal by Subject|1|||
94735660|NCT03381586|324488476|FG000|Overall Study|Adverse Event|1|||
94735661|NCT03381586|324488477|FG001|Overall Study|Adverse Event|1|||
94735662|NCT03381586|324488476|FG000|Overall Study|Protocol Violation|1|||
94735663|NCT03381586|324488477|FG001|Overall Study|Protocol Violation|0|||
94735664|NCT03381586|324488476|FG000|Overall Study|Withdrawal by Subject|1|||
94735665|NCT03381586|324488477|FG001|Overall Study|Withdrawal by Subject|2|||
94735666|NCT05293171|324490039|FG000|Washout 5 to 7 Days|Adverse Event|1|||
94735667|NCT05293171|324490040|FG001|Washout 5 to 7 Days|Adverse Event|1|||
94735668|NCT05293171|324490041|FG002|Washout 5 to 7 Days|Adverse Event|0|||
94735669|NCT05293171|324490042|FG003|Washout 5 to 7 Days|Adverse Event|0|||
94735670|NCT05293171|324490043|FG004|Washout 5 to 7 Days|Adverse Event|0|||
94735671|NCT05293171|324490044|FG005|Washout 5 to 7 Days|Adverse Event|0|||
94735672|NCT05293171|324490045|FG006|Washout 5 to 7 Days|Adverse Event|0|||
94735673|NCT05293171|324490046|FG007|Washout 5 to 7 Days|Adverse Event|0|||
94735674|NCT05293171|324490047|FG008|Washout 5 to 7 Days|Adverse Event|0|||
94735675|NCT05293171|324490048|FG009|Washout 5 to 7 Days|Adverse Event|0|||
94735676|NCT05293171|324490049|FG010|Washout 5 to 7 Days|Adverse Event|0|||
94735677|NCT05293171|324490050|FG011|Washout 5 to 7 Days|Adverse Event|0|||
94735678|NCT05293171|324490039|FG000|Washout 5 to 7 Days|Adverse Event|0|||
94735679|NCT05293171|324490040|FG001|Washout 5 to 7 Days|Adverse Event|0|||
94735680|NCT05293171|324490041|FG002|Washout 5 to 7 Days|Adverse Event|0|||
94735681|NCT05293171|324490042|FG003|Washout 5 to 7 Days|Adverse Event|0|||
94735682|NCT05293171|324490043|FG004|Washout 5 to 7 Days|Adverse Event|0|||
94735683|NCT05293171|324490044|FG005|Washout 5 to 7 Days|Adverse Event|1|||
94735684|NCT05293171|324490045|FG006|Washout 5 to 7 Days|Adverse Event|0|||
94735685|NCT05293171|324490046|FG007|Washout 5 to 7 Days|Adverse Event|0|||
94735686|NCT05293171|324490047|FG008|Washout 5 to 7 Days|Adverse Event|0|||
94735687|NCT05293171|324490048|FG009|Washout 5 to 7 Days|Adverse Event|0|||
94735688|NCT05293171|324490049|FG010|Washout 5 to 7 Days|Adverse Event|0|||
94735689|NCT05293171|324490050|FG011|Washout 5 to 7 Days|Adverse Event|0|||
94735690|NCT03249090|324490053|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
94735691|NCT03249090|324490054|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
94735692|NCT03249090|324490053|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
94735693|NCT03249090|324490054|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
94735694|NCT03249090|324490053|FG000|3 Month Time Point|Voluntary withdrawal|6|||
94735695|NCT03249090|324490054|FG001|3 Month Time Point|Voluntary withdrawal|3|||
94735696|NCT03249090|324490053|FG000|3 Month Time Point|Changed oncology practice|4|||
94735697|NCT03249090|324490054|FG001|3 Month Time Point|Changed oncology practice|2|||
94735698|NCT03249090|324490053|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
94735699|NCT03249090|324490054|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
94735700|NCT03249090|324490053|FG000|12 Month Time Point|Voluntary withdrawal|35|||
94735701|NCT03249090|324490054|FG001|12 Month Time Point|Voluntary withdrawal|4|||
94735702|NCT03249090|324490053|FG000|12 Month Time Point|Changed oncology practice|20|||
94735703|NCT03249090|324490054|FG001|12 Month Time Point|Changed oncology practice|9|||
94735704|NCT04359654|324490061|FG000|Overall Study|Withdrawal by Subject|1|||
94735705|NCT04359654|324490062|FG001|Overall Study|Withdrawal by Subject|0|||
94735706|NCT04359654|324490061|FG000|Overall Study|Adverse Event|0|||
94735707|NCT04359654|324490062|FG001|Overall Study|Adverse Event|1|||
94735708|NCT02733159|324490063|FG000|Overall Study|Adverse Event|1|||
94735709|NCT02733159|324490063|FG000|Overall Study|Lack of disease progression|1|||
94735710|NCT02603887|324490074|FG000|Stage 1|Adverse Event|4|||
94735711|NCT02603887|324490074|FG000|Stage 1|Disease progression|1|||
94735712|NCT02603887|324490074|FG000|Stage 2|FDA guidance|1|||
94735713|NCT02724969|324490075|FG000|Overall Study|Lost to Follow-up|12|||
94735714|NCT02724969|324490076|FG001|Overall Study|Lost to Follow-up|6|||
94735715|NCT02724969|324490075|FG000|Overall Study|Withdrawal by Subject|3|||
94735716|NCT02724969|324490076|FG001|Overall Study|Withdrawal by Subject|3|||
94735717|NCT02724969|324490075|FG000|Overall Study|Infant demise|0|||
94735718|NCT02724969|324490076|FG001|Overall Study|Infant demise|2|||
94735719|NCT04690582|324490079|FG000|Overall Study|Withdrawal by Subject|6|||
94735720|NCT04690582|324490080|FG001|Overall Study|Withdrawal by Subject|4|||
94735721|NCT03069352|324490083|FG000|Overall Study|Ongoing|12|||
94735722|NCT03069352|324490084|FG001|Overall Study|Ongoing|40|||
94735723|NCT04270942|324490085|FG000|Overall Study|Death|1|||
94735724|NCT03625115|324490086|FG000|Overall Study|Withdrawal by Subject|4|||
94275512|NCT02257372|322802425|FG001|Overall Study|Lost to Follow-up|1|||
94275513|NCT02257372|322802424|FG000|Overall Study|Withdrew consent|1|||
94735725|NCT03625115|324490087|FG001|Overall Study|Withdrawal by Subject|7|||
94735726|NCT03625115|324490086|FG000|Overall Study|Lost to Follow-up|17|||
94735727|NCT03625115|324490087|FG001|Overall Study|Lost to Follow-up|24|||
94735728|NCT04197336|324490088|FG000|Overall Study|Withdrawal by Subject|1|||
94735729|NCT04101357|324490089|FG000|Overall Study|Death|1|||
94735730|NCT04101357|324490090|FG001|Overall Study|Death|1|||
94735731|NCT04101357|324490091|FG002|Overall Study|Death|1|||
94735732|NCT04101357|324490092|FG003|Overall Study|Death|2|||
94735733|NCT04101357|324490093|FG004|Overall Study|Death|4|||
94735734|NCT04101357|324490094|FG005|Overall Study|Death|11|||
94275514|NCT02257372|322802425|FG001|Overall Study|Withdrew consent|0|||
94275515|NCT02104583|322802426|FG000|Overall Study|New ICD or CRT-D implanted|2|||
94275516|NCT02104583|322802427|FG001|Overall Study|New ICD or CRT-D implanted|0|||
94275517|NCT02104583|322802428|FG002|Overall Study|New ICD or CRT-D implanted|1|||
94275518|NCT02104583|322802429|FG003|Overall Study|New ICD or CRT-D implanted|0|||
94275519|NCT02104583|322802430|FG004|Overall Study|New ICD or CRT-D implanted|0|||
94275520|NCT02104583|322802426|FG000|Overall Study|Death|2|||
94275521|NCT02104583|322802427|FG001|Overall Study|Death|1|||
94275522|NCT02104583|322802428|FG002|Overall Study|Death|3|||
94275523|NCT02104583|322802429|FG003|Overall Study|Death|3|||
94275524|NCT02104583|322802430|FG004|Overall Study|Death|5|||
94735735|NCT04101357|324490095|FG006|Overall Study|Death|4|||
94735736|NCT04101357|324490096|FG007|Overall Study|Death|4|||
94735737|NCT04101357|324490097|FG008|Overall Study|Death|5|||
94735738|NCT04101357|324490098|FG009|Overall Study|Death|2|||
94735739|NCT04101357|324490099|FG010|Overall Study|Death|3|||
94735740|NCT04101357|324490089|FG000|Overall Study|Trial closure|0|||
94735741|NCT04101357|324490090|FG001|Overall Study|Trial closure|0|||
94735742|NCT04101357|324490091|FG002|Overall Study|Trial closure|0|||
94735743|NCT04101357|324490092|FG003|Overall Study|Trial closure|0|||
94735744|NCT04101357|324490093|FG004|Overall Study|Trial closure|0|||
94735745|NCT04101357|324490094|FG005|Overall Study|Trial closure|2|||
94735746|NCT04101357|324490095|FG006|Overall Study|Trial closure|2|||
94735747|NCT04101357|324490096|FG007|Overall Study|Trial closure|0|||
94735748|NCT04101357|324490097|FG008|Overall Study|Trial closure|0|||
94735749|NCT04101357|324490098|FG009|Overall Study|Trial closure|0|||
94735750|NCT04101357|324490099|FG010|Overall Study|Trial closure|1|||
94735751|NCT04101357|324490089|FG000|Overall Study|Lost to Follow-up|0|||
94735752|NCT04101357|324490090|FG001|Overall Study|Lost to Follow-up|0|||
94735753|NCT04101357|324490091|FG002|Overall Study|Lost to Follow-up|0|||
94735754|NCT04101357|324490092|FG003|Overall Study|Lost to Follow-up|1|||
94735755|NCT04101357|324490093|FG004|Overall Study|Lost to Follow-up|0|||
94735756|NCT04101357|324490094|FG005|Overall Study|Lost to Follow-up|0|||
94735757|NCT04101357|324490095|FG006|Overall Study|Lost to Follow-up|0|||
94735758|NCT04101357|324490096|FG007|Overall Study|Lost to Follow-up|1|||
94735759|NCT04101357|324490097|FG008|Overall Study|Lost to Follow-up|0|||
94735760|NCT04101357|324490098|FG009|Overall Study|Lost to Follow-up|0|||
94735761|NCT04101357|324490099|FG010|Overall Study|Lost to Follow-up|0|||
94735762|NCT04101357|324490089|FG000|Overall Study|Withdrawal by Subject|1|||
94735763|NCT04101357|324490090|FG001|Overall Study|Withdrawal by Subject|0|||
94735764|NCT04101357|324490091|FG002|Overall Study|Withdrawal by Subject|0|||
94735765|NCT04101357|324490092|FG003|Overall Study|Withdrawal by Subject|0|||
94735766|NCT04101357|324490093|FG004|Overall Study|Withdrawal by Subject|0|||
94735767|NCT04101357|324490094|FG005|Overall Study|Withdrawal by Subject|0|||
94735768|NCT04101357|324490095|FG006|Overall Study|Withdrawal by Subject|0|||
94735769|NCT04101357|324490096|FG007|Overall Study|Withdrawal by Subject|0|||
94735770|NCT04101357|324490097|FG008|Overall Study|Withdrawal by Subject|1|||
94735771|NCT04101357|324490098|FG009|Overall Study|Withdrawal by Subject|1|||
94735772|NCT04101357|324490099|FG010|Overall Study|Withdrawal by Subject|0|||
94735773|NCT04101357|324490089|FG000|Overall Study|Other|0|||
94735774|NCT04101357|324490090|FG001|Overall Study|Other|0|||
94735775|NCT04101357|324490091|FG002|Overall Study|Other|0|||
94735776|NCT04101357|324490092|FG003|Overall Study|Other|0|||
94735777|NCT04101357|324490093|FG004|Overall Study|Other|0|||
94735778|NCT04101357|324490094|FG005|Overall Study|Other|1|||
94735779|NCT04101357|324490095|FG006|Overall Study|Other|2|||
94735780|NCT04101357|324490096|FG007|Overall Study|Other|1|||
94735781|NCT04101357|324490097|FG008|Overall Study|Other|0|||
94735782|NCT04101357|324490098|FG009|Overall Study|Other|0|||
94735783|NCT04101357|324490099|FG010|Overall Study|Other|0|||
94735784|NCT04101357|324490089|FG000|Overall Study|Enrolled but not treated|0|||
94735785|NCT04101357|324490090|FG001|Overall Study|Enrolled but not treated|0|||
94735786|NCT04101357|324490091|FG002|Overall Study|Enrolled but not treated|0|||
94735787|NCT04101357|324490092|FG003|Overall Study|Enrolled but not treated|0|||
94735788|NCT04101357|324490093|FG004|Overall Study|Enrolled but not treated|0|||
94735789|NCT04101357|324490094|FG005|Overall Study|Enrolled but not treated|1|||
94735790|NCT04101357|324490095|FG006|Overall Study|Enrolled but not treated|1|||
94735791|NCT04101357|324490096|FG007|Overall Study|Enrolled but not treated|0|||
94735792|NCT04101357|324490097|FG008|Overall Study|Enrolled but not treated|0|||
94735793|NCT04101357|324490098|FG009|Overall Study|Enrolled but not treated|0|||
94735794|NCT04101357|324490099|FG010|Overall Study|Enrolled but not treated|0|||
94735795|NCT02497950|324490104|FG000|Overall Study|Death|209|||
94735796|NCT02497950|324490104|FG000|Overall Study|Transplanted|85|||
94735797|NCT02497950|324490104|FG000|Overall Study|Explanted|8|||
94735798|NCT02497950|324490104|FG000|Overall Study|Device Permanently Deactivated|4|||
94735799|NCT02497950|324490104|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
94735800|NCT02497950|324490104|FG000|Overall Study|Lost to Follow-up|6|||
94735801|NCT02497950|324490104|FG000|Overall Study|Withdrawal by Subject|2|||
94735802|NCT02497950|324490104|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
94735803|NCT02497950|324490104|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
94735804|NCT02827877|324490112|FG000|Overall Study|Withdrawal by Subject|1|||
94735805|NCT05167864|324490113|FG000|Overall Study|Lost to Follow-up|7|||
94735806|NCT05167864|324490114|FG001|Overall Study|Lost to Follow-up|6|||
94735807|NCT05167864|324490115|FG002|Overall Study|Lost to Follow-up|7|||
94735808|NCT05167864|324490116|FG003|Overall Study|Lost to Follow-up|9|||
94735809|NCT03852550|324490117|FG000|Overall Study|Lost to Follow-up|4|||
94735810|NCT03852550|324490118|FG001|Overall Study|Lost to Follow-up|3|||
94735811|NCT03852550|324490117|FG000|Overall Study|Only parent outcomes completed|0|||
94735812|NCT03852550|324490118|FG001|Overall Study|Only parent outcomes completed|1|||
94735813|NCT03852550|324490117|FG000|Overall Study|Withdrawal by Subject|1|||
94735814|NCT03852550|324490118|FG001|Overall Study|Withdrawal by Subject|0|||
94735815|NCT04059185|324490119|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
94735816|NCT04059185|324490120|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
94735817|NCT04059185|324490121|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
94735818|NCT04059185|324490119|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
94735819|NCT04059185|324490120|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
94735820|NCT04059185|324490121|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
94735821|NCT04059185|324490119|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
94735822|NCT04059185|324490120|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
94735823|NCT04059185|324490121|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
94735824|NCT04059185|324490119|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
94735825|NCT04059185|324490120|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
94735826|NCT04059185|324490121|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
94735827|NCT04059185|324490119|FG000|Longitudinal Assessment-Adults Only|Death|4|||
94368824|NCT03611751|323136549|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
94368825|NCT03611751|323136550|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
94368826|NCT03611751|323136548|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
94368827|NCT03611751|323136549|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
94368828|NCT03611751|323136550|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
94368829|NCT03611751|323136548|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
94368830|NCT03611751|323136549|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
94368831|NCT03611751|323136550|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
94368832|NCT03611751|323136548|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
94368833|NCT03611751|323136549|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
94368834|NCT03611751|323136550|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
94368835|NCT03611751|323136548|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
94368836|NCT03611751|323136549|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
94368837|NCT03611751|323136550|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
94368838|NCT03611751|323136548|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
94368839|NCT03611751|323136549|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
94735828|NCT04059185|324490120|FG001|Longitudinal Assessment-Adults Only|Death|4|||
94735829|NCT04059185|324490121|FG002|Longitudinal Assessment-Adults Only|Death|3|||
94735830|NCT04295512|324490122|FG000|Overall Study|Lack of family response to schedule assessment|0|||
94735831|NCT04295512|324490123|FG001|Overall Study|Lack of family response to schedule assessment|0|||
94735832|NCT04295512|324490124|FG002|Overall Study|Lack of family response to schedule assessment|0|||
94735833|NCT04295512|324490125|FG003|Overall Study|Lack of family response to schedule assessment|2|||
94735834|NCT04295512|324490122|FG000|Overall Study|Therapist did not refer eligible family|7|||
94735835|NCT04295512|324490123|FG001|Overall Study|Therapist did not refer eligible family|7|||
94735836|NCT04295512|324490124|FG002|Overall Study|Therapist did not refer eligible family|0|||
94735837|NCT04295512|324490125|FG003|Overall Study|Therapist did not refer eligible family|0|||
94735838|NCT04587453|324490134|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
94735839|NCT04587453|324490135|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
94735840|NCT03626220|324490137|FG000|Overall Study|Withdrawal by Subject|2|||
94735841|NCT03626220|324490138|FG001|Overall Study|Withdrawal by Subject|0|||
94735842|NCT04737330|324490139|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
94735843|NCT04737330|324490140|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
94735844|NCT04737330|324490139|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
94735845|NCT04737330|324490140|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
94735846|NCT04737330|324490139|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
94735847|NCT04737330|324490140|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
94735848|NCT04737330|324490139|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
94735849|NCT04737330|324490140|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
94735850|NCT04737330|324490139|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
94735851|NCT04737330|324490140|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
94735852|NCT04737330|324490139|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
94735853|NCT04737330|324490140|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
94735854|NCT04625725|324490141|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
94735855|NCT04625725|324490142|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
94735856|NCT04625725|324490143|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
94368840|NCT03611751|323136550|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
94368841|NCT03611751|323136548|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
94467482|NCT01324570|323500575|FG000|Overall Study|Confirmed or suspected diversion|0|||
94467483|NCT01324570|323500576|FG001|Overall Study|Confirmed or suspected diversion|1|||
94735857|NCT04625725|324490144|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
94467484|NCT01324570|323500575|FG000|Overall Study|Administrative|0|||
94735858|NCT04625725|324490145|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
94735859|NCT04625725|324490146|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
94735860|NCT04625725|324490141|FG000|Provent Main Study|Withdrawal by Subject|242|||
94735861|NCT04625725|324490142|FG001|Provent Main Study|Withdrawal by Subject|144|||
94735862|NCT04625725|324490143|FG002|Provent Main Study|Withdrawal by Subject|0|||
94735863|NCT04625725|324490144|FG003|Provent Main Study|Withdrawal by Subject|0|||
94735864|NCT04625725|324490145|FG004|Provent Main Study|Withdrawal by Subject|0|||
94735865|NCT04625725|324490146|FG005|Provent Main Study|Withdrawal by Subject|0|||
94735866|NCT04625725|324490141|FG000|Provent Main Study|Physician Decision|5|||
94735867|NCT04625725|324490142|FG001|Provent Main Study|Physician Decision|0|||
94735868|NCT04625725|324490143|FG002|Provent Main Study|Physician Decision|0|||
94735869|NCT04625725|324490144|FG003|Provent Main Study|Physician Decision|0|||
94735870|NCT04625725|324490145|FG004|Provent Main Study|Physician Decision|0|||
94735871|NCT04625725|324490146|FG005|Provent Main Study|Physician Decision|0|||
94735872|NCT04625725|324490141|FG000|Provent Main Study|Protocol Violation|1|||
94735873|NCT04625725|324490142|FG001|Provent Main Study|Protocol Violation|0|||
94735874|NCT04625725|324490143|FG002|Provent Main Study|Protocol Violation|0|||
94735875|NCT04625725|324490144|FG003|Provent Main Study|Protocol Violation|0|||
94735876|NCT04625725|324490145|FG004|Provent Main Study|Protocol Violation|0|||
94735877|NCT04625725|324490146|FG005|Provent Main Study|Protocol Violation|0|||
94735878|NCT04625725|324490141|FG000|Provent Main Study|Lost to Follow-up|357|||
94735879|NCT04625725|324490142|FG001|Provent Main Study|Lost to Follow-up|200|||
94735880|NCT04625725|324490143|FG002|Provent Main Study|Lost to Follow-up|0|||
94735881|NCT04625725|324490144|FG003|Provent Main Study|Lost to Follow-up|0|||
94735882|NCT04625725|324490145|FG004|Provent Main Study|Lost to Follow-up|0|||
94735883|NCT04625725|324490146|FG005|Provent Main Study|Lost to Follow-up|0|||
94735884|NCT04625725|324490141|FG000|Provent Main Study|Death|22|||
94735885|NCT04625725|324490142|FG001|Provent Main Study|Death|10|||
94467485|NCT01324570|323500576|FG001|Overall Study|Administrative|2|||
94735886|NCT04625725|324490143|FG002|Provent Main Study|Death|0|||
94735887|NCT04625725|324490144|FG003|Provent Main Study|Death|0|||
94735888|NCT04625725|324490145|FG004|Provent Main Study|Death|0|||
94735889|NCT04625725|324490146|FG005|Provent Main Study|Death|0|||
94735890|NCT04625725|324490141|FG000|Provent Main Study|Adverse Event|2|||
94735891|NCT04625725|324490142|FG001|Provent Main Study|Adverse Event|1|||
94735892|NCT04625725|324490143|FG002|Provent Main Study|Adverse Event|0|||
94735893|NCT04625725|324490144|FG003|Provent Main Study|Adverse Event|0|||
94735894|NCT04625725|324490145|FG004|Provent Main Study|Adverse Event|0|||
94735895|NCT04625725|324490146|FG005|Provent Main Study|Adverse Event|0|||
94735896|NCT04625725|324490141|FG000|Provent Main Study|Participants dosed in sub-study|310|||
94735897|NCT04625725|324490142|FG001|Provent Main Study|Participants dosed in sub-study|193|||
94735898|NCT04625725|324490143|FG002|Provent Main Study|Participants dosed in sub-study|0|||
94735899|NCT04625725|324490144|FG003|Provent Main Study|Participants dosed in sub-study|0|||
94735900|NCT04625725|324490145|FG004|Provent Main Study|Participants dosed in sub-study|0|||
94368842|NCT03611751|323136549|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
94368843|NCT03611751|323136550|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
94368844|NCT03672396|323136551|FG000|Overall Study|Withdrawal by Subject|4|||
94368845|NCT03672396|323136551|FG000|Overall Study|Physician Decision|1|||
94368846|NCT03672396|323136551|FG000|Overall Study|Adverse Event|1|||
94368847|NCT02702271|323136552|FG000|Overall Study|Death|36|||
94368848|NCT02702271|323136553|FG001|Overall Study|Death|7|||
94735901|NCT04625725|324490146|FG005|Provent Main Study|Participants dosed in sub-study|0|||
94735902|NCT04625725|324490141|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
94735903|NCT04625725|324490142|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
94368849|NCT02702271|323136552|FG000|Overall Study|Lost to Follow-up|12|||
94368850|NCT02702271|323136553|FG001|Overall Study|Lost to Follow-up|0|||
94368851|NCT02702271|323136552|FG000|Overall Study|Withdrawal by Subject|8|||
94735904|NCT04625725|324490143|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
94735905|NCT04625725|324490144|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
94735906|NCT04625725|324490145|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
94735907|NCT04625725|324490146|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
94735908|NCT04625725|324490141|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
94735909|NCT04625725|324490142|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
94735910|NCT04625725|324490143|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
94735911|NCT04625725|324490144|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
94735912|NCT04625725|324490145|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
94735913|NCT04625725|324490146|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
94735914|NCT04625725|324490141|FG000|Provent Main Study|INCARCERATION|3|||
94735915|NCT04625725|324490142|FG001|Provent Main Study|INCARCERATION|0|||
94735916|NCT04625725|324490143|FG002|Provent Main Study|INCARCERATION|0|||
94735917|NCT04625725|324490144|FG003|Provent Main Study|INCARCERATION|0|||
94735918|NCT04625725|324490145|FG004|Provent Main Study|INCARCERATION|0|||
94735919|NCT04625725|324490146|FG005|Provent Main Study|INCARCERATION|0|||
94735920|NCT04625725|324490141|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
94735921|NCT04625725|324490142|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
94735922|NCT04625725|324490143|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
94735923|NCT04625725|324490144|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
94735924|NCT04625725|324490145|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
94735925|NCT04625725|324490146|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
94735926|NCT04625725|324490141|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
94735927|NCT04625725|324490142|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
94735928|NCT04625725|324490143|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
94735929|NCT04625725|324490144|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
94735930|NCT04625725|324490145|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
94735931|NCT04625725|324490146|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
94735932|NCT04625725|324490141|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
94735933|NCT04625725|324490142|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
94735934|NCT04625725|324490143|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
94735935|NCT04625725|324490144|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
94735936|NCT04625725|324490145|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
94735937|NCT04625725|324490146|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
94735938|NCT04625725|324490141|FG000|Provent Main Study|MISSING REASON|0|||
94735939|NCT04625725|324490142|FG001|Provent Main Study|MISSING REASON|1|||
94735940|NCT04625725|324490143|FG002|Provent Main Study|MISSING REASON|0|||
94735941|NCT04625725|324490144|FG003|Provent Main Study|MISSING REASON|0|||
94735942|NCT04625725|324490145|FG004|Provent Main Study|MISSING REASON|0|||
94735943|NCT04625725|324490146|FG005|Provent Main Study|MISSING REASON|0|||
94735944|NCT04625725|324490141|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
94735945|NCT04625725|324490142|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
94735946|NCT04625725|324490143|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
94735947|NCT04625725|324490144|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
94735948|NCT04625725|324490145|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
94735949|NCT04625725|324490146|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
94735950|NCT04625725|324490141|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
94735951|NCT04625725|324490142|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
94735952|NCT04625725|324490143|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
94735953|NCT04625725|324490144|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
94735954|NCT04625725|324490145|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
94368852|NCT02702271|323136553|FG001|Overall Study|Withdrawal by Subject|1|||
94735955|NCT04625725|324490146|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
94735956|NCT04625725|324490141|FG000|Provent Sub Study|Lost to Follow-up|0|||
94735957|NCT04625725|324490142|FG001|Provent Sub Study|Lost to Follow-up|0|||
94735958|NCT04625725|324490143|FG002|Provent Sub Study|Lost to Follow-up|20|||
94735959|NCT04625725|324490144|FG003|Provent Sub Study|Lost to Follow-up|10|||
94735960|NCT04625725|324490145|FG004|Provent Sub Study|Lost to Follow-up|6|||
94735961|NCT04625725|324490146|FG005|Provent Sub Study|Lost to Follow-up|4|||
94735962|NCT04625725|324490141|FG000|Provent Sub Study|Death|0|||
94735963|NCT04625725|324490142|FG001|Provent Sub Study|Death|0|||
94735964|NCT04625725|324490143|FG002|Provent Sub Study|Death|8|||
94735965|NCT04625725|324490144|FG003|Provent Sub Study|Death|5|||
94735966|NCT04625725|324490145|FG004|Provent Sub Study|Death|0|||
94735967|NCT04625725|324490146|FG005|Provent Sub Study|Death|1|||
94735968|NCT04625725|324490141|FG000|Provent Sub Study|Adverse Event|0|||
94735969|NCT04625725|324490142|FG001|Provent Sub Study|Adverse Event|0|||
94735970|NCT04625725|324490143|FG002|Provent Sub Study|Adverse Event|0|||
94735971|NCT04625725|324490144|FG003|Provent Sub Study|Adverse Event|0|||
94735972|NCT04625725|324490145|FG004|Provent Sub Study|Adverse Event|0|||
94735973|NCT04625725|324490146|FG005|Provent Sub Study|Adverse Event|1|||
94735974|NCT04625725|324490141|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
94735975|NCT04625725|324490142|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
94735976|NCT04625725|324490143|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
94735977|NCT04625725|324490144|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
94735978|NCT04625725|324490145|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
94735979|NCT04625725|324490146|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
94735980|NCT04625725|324490141|FG000|Provent Sub Study|Withdrawal by Subject|0|||
94735981|NCT04625725|324490142|FG001|Provent Sub Study|Withdrawal by Subject|0|||
94735982|NCT04625725|324490143|FG002|Provent Sub Study|Withdrawal by Subject|11|||
94735983|NCT04625725|324490144|FG003|Provent Sub Study|Withdrawal by Subject|13|||
94735984|NCT04625725|324490145|FG004|Provent Sub Study|Withdrawal by Subject|5|||
94735985|NCT04625725|324490146|FG005|Provent Sub Study|Withdrawal by Subject|6|||
94735986|NCT04625725|324490141|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
94735987|NCT04625725|324490142|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
94735988|NCT04625725|324490143|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
94735989|NCT04625725|324490144|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
94735990|NCT04625725|324490145|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
94735991|NCT04625725|324490146|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
94735992|NCT03298451|324490151|FG000|Overall Study|Death|275|||
94735993|NCT03298451|324490152|FG001|Overall Study|Death|260|||
94735994|NCT03298451|324490153|FG002|Overall Study|Death|122|||
94735995|NCT03298451|324490154|FG003|Overall Study|Death|280|||
94735996|NCT03298451|324490151|FG000|Overall Study|Lost to Follow-up|1|||
94735997|NCT03298451|324490152|FG001|Overall Study|Lost to Follow-up|1|||
94735998|NCT03298451|324490153|FG002|Overall Study|Lost to Follow-up|0|||
94735999|NCT03298451|324490154|FG003|Overall Study|Lost to Follow-up|7|||
94736000|NCT03298451|324490151|FG000|Overall Study|Withdrawal by Subject|9|||
94736001|NCT03298451|324490152|FG001|Overall Study|Withdrawal by Subject|7|||
94736002|NCT03298451|324490153|FG002|Overall Study|Withdrawal by Subject|1|||
94736003|NCT03298451|324490154|FG003|Overall Study|Withdrawal by Subject|20|||
94736004|NCT04308681|324490161|FG000|Pre-Treatment|Not reported|1|||
94736005|NCT04308681|324490162|FG001|Pre-Treatment|Not reported|1|||
94736006|NCT04308681|324490163|FG002|Pre-Treatment|Not reported|0|||
94736007|NCT04308681|324490164|FG003|Pre-Treatment|Not reported|0|||
94736008|NCT04308681|324490165|FG004|Pre-Treatment|Not reported|0|||
94736009|NCT04308681|324490166|FG005|Pre-Treatment|Not reported|2|||
94736010|NCT04308681|324490167|FG006|Pre-Treatment|Not reported|0|||
94736011|NCT04308681|324490168|FG007|Pre-Treatment|Not reported|0|||
94736012|NCT04308681|324490161|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
94736013|NCT04308681|324490162|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
94736014|NCT04308681|324490163|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
94736015|NCT04308681|324490164|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
94368853|NCT02702271|323136552|FG000|Overall Study|Physician Decision|2|||
94368854|NCT02702271|323136553|FG001|Overall Study|Physician Decision|0|||
94368855|NCT02702271|323136552|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
94736016|NCT04308681|324490165|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
94736017|NCT04308681|324490166|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
94736018|NCT04308681|324490167|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
94736019|NCT04308681|324490168|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
94368856|NCT02702271|323136553|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
94736020|NCT04308681|324490161|FG000|Treatment up to Week 26|Other reasons|2|||
94736021|NCT04308681|324490162|FG001|Treatment up to Week 26|Other reasons|0|||
94736022|NCT04308681|324490163|FG002|Treatment up to Week 26|Other reasons|0|||
94736023|NCT04308681|324490164|FG003|Treatment up to Week 26|Other reasons|0|||
94736024|NCT04308681|324490165|FG004|Treatment up to Week 26|Other reasons|1|||
94736025|NCT04308681|324490166|FG005|Treatment up to Week 26|Other reasons|1|||
94736026|NCT04308681|324490167|FG006|Treatment up to Week 26|Other reasons|0|||
94736027|NCT04308681|324490168|FG007|Treatment up to Week 26|Other reasons|0|||
94736028|NCT04308681|324490161|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
94736029|NCT04308681|324490162|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
94736030|NCT04308681|324490163|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
94736031|NCT04308681|324490164|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
94736032|NCT04308681|324490165|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
94736033|NCT04308681|324490166|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
94736034|NCT04308681|324490167|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
94736035|NCT04308681|324490168|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
94736036|NCT04308681|324490161|FG000|Treatment up to Week 26|Adverse Event|6|||
94736037|NCT04308681|324490162|FG001|Treatment up to Week 26|Adverse Event|5|||
94736038|NCT04308681|324490163|FG002|Treatment up to Week 26|Adverse Event|5|||
94736039|NCT04308681|324490164|FG003|Treatment up to Week 26|Adverse Event|0|||
94736040|NCT04308681|324490165|FG004|Treatment up to Week 26|Adverse Event|6|||
94736041|NCT04308681|324490166|FG005|Treatment up to Week 26|Adverse Event|1|||
94736042|NCT04308681|324490167|FG006|Treatment up to Week 26|Adverse Event|0|||
94736043|NCT04308681|324490168|FG007|Treatment up to Week 26|Adverse Event|0|||
94736044|NCT04308681|324490161|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
94736045|NCT04308681|324490162|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
94736046|NCT04308681|324490163|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
94736047|NCT04308681|324490164|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
94736048|NCT04308681|324490165|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
94736049|NCT04308681|324490166|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
94736050|NCT04308681|324490167|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
94736051|NCT04308681|324490168|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
94736052|NCT04308681|324490161|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
94736053|NCT04308681|324490162|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
94736054|NCT04308681|324490163|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
94736055|NCT04308681|324490164|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
94736056|NCT04308681|324490165|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
94736057|NCT04308681|324490166|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
94736058|NCT04308681|324490167|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
94736059|NCT04308681|324490168|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
94467486|NCT01416155|323500582|FG000|Overall Study|Adverse Event|8|||
94368857|NCT03091400|323136554|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
94736060|NCT04308681|324490161|FG000|OTE - 26 Weeks|Death|0|||
94736061|NCT04308681|324490162|FG001|OTE - 26 Weeks|Death|1|||
94736062|NCT04308681|324490163|FG002|OTE - 26 Weeks|Death|0|||
94736063|NCT04308681|324490164|FG003|OTE - 26 Weeks|Death|0|||
94736064|NCT04308681|324490165|FG004|OTE - 26 Weeks|Death|0|||
94736065|NCT04308681|324490166|FG005|OTE - 26 Weeks|Death|0|||
94736066|NCT04308681|324490167|FG006|OTE - 26 Weeks|Death|1|||
94736067|NCT04308681|324490168|FG007|OTE - 26 Weeks|Death|0|||
94736068|NCT04308681|324490161|FG000|OTE - 26 Weeks|Adverse Event|0|||
94736069|NCT04308681|324490162|FG001|OTE - 26 Weeks|Adverse Event|2|||
94736070|NCT04308681|324490163|FG002|OTE - 26 Weeks|Adverse Event|8|||
94736071|NCT04308681|324490164|FG003|OTE - 26 Weeks|Adverse Event|3|||
94736072|NCT04308681|324490165|FG004|OTE - 26 Weeks|Adverse Event|0|||
94736073|NCT04308681|324490166|FG005|OTE - 26 Weeks|Adverse Event|1|||
94736074|NCT04308681|324490167|FG006|OTE - 26 Weeks|Adverse Event|2|||
94736075|NCT04308681|324490168|FG007|OTE - 26 Weeks|Adverse Event|0|||
94736076|NCT04308681|324490161|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
94736077|NCT04308681|324490162|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
94736078|NCT04308681|324490163|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
94736079|NCT04308681|324490164|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
94736080|NCT04308681|324490165|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
94736081|NCT04308681|324490166|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
94736082|NCT04308681|324490167|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
94736083|NCT04308681|324490168|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
94736084|NCT02446236|324490169|FG000|Overall Study|Screen Failure|1|||
94736085|NCT02446236|324490170|FG001|Overall Study|Screen Failure|0|||
94736086|NCT02446236|324490171|FG002|Overall Study|Screen Failure|1|||
94736087|NCT02446236|324490169|FG000|Overall Study|Actively Receiving Therapy|0|||
94736088|NCT02446236|324490170|FG001|Overall Study|Actively Receiving Therapy|0|||
94736089|NCT02446236|324490171|FG002|Overall Study|Actively Receiving Therapy|1|||
94736090|NCT02684227|324490178|FG000|Overall Study|Adverse Event|1|||
94736091|NCT02684227|324490179|FG001|Overall Study|Adverse Event|7|||
94736092|NCT02684227|324490178|FG000|Overall Study|Death|0|||
94736093|NCT02684227|324490179|FG001|Overall Study|Death|2|||
94736094|NCT02684227|324490178|FG000|Overall Study|Withdrawal by Subject|0|||
94736095|NCT02684227|324490179|FG001|Overall Study|Withdrawal by Subject|1|||
94736096|NCT02684227|324490178|FG000|Overall Study|Progressive Disease|0|||
94736097|NCT02684227|324490179|FG001|Overall Study|Progressive Disease|2|||
94736098|NCT03556293|324490180|FG000|Overall Study|Ineligible for analysis|1904|||
94736099|NCT03556293|324490181|FG001|Overall Study|Ineligible for analysis|1471|||
94736100|NCT03556293|324490182|FG002|Overall Study|Ineligible for analysis|1091|||
94736101|NCT03556293|324490183|FG003|Overall Study|Ineligible for analysis|1269|||
94736102|NCT05012163|324490191|FG000|Overall Study|Protocol Violation|0|||
94736103|NCT05012163|324490192|FG001|Overall Study|Protocol Violation|0|||
94736104|NCT05012163|324490193|FG002|Overall Study|Protocol Violation|1|||
94736105|NCT05012163|324490194|FG003|Overall Study|Protocol Violation|1|||
94736106|NCT05524402|324490195|FG000|Overall Study|Withdrawal by Subject|3|||
94736107|NCT05524402|324490196|FG001|Overall Study|Withdrawal by Subject|1|||
94736108|NCT05524402|324490195|FG000|Overall Study|Lost to Follow-up|2|||
94736109|NCT05524402|324490196|FG001|Overall Study|Lost to Follow-up|1|||
94736110|NCT04076618|324491472|FG000|Overall Study|Lost to Follow-up|2|||
94736111|NCT04076618|324491473|FG001|Overall Study|Lost to Follow-up|1|||
94736112|NCT04076618|324491474|FG002|Overall Study|Lost to Follow-up|3|||
94736113|NCT04076618|324491472|FG000|Overall Study|Withdrawal by Subject|3|||
94736114|NCT04076618|324491473|FG001|Overall Study|Withdrawal by Subject|1|||
94736115|NCT04076618|324491474|FG002|Overall Study|Withdrawal by Subject|2|||
94736116|NCT04076618|324491472|FG000|Overall Study|Relocated out of state|0|||
94736117|NCT04076618|324491473|FG001|Overall Study|Relocated out of state|2|||
94736118|NCT04076618|324491474|FG002|Overall Study|Relocated out of state|0|||
94736119|NCT04076618|324491472|FG000|Overall Study|COVID concerns|0|||
94736120|NCT04076618|324491473|FG001|Overall Study|COVID concerns|1|||
94736121|NCT04076618|324491474|FG002|Overall Study|COVID concerns|0|||
94736122|NCT04076618|324491472|FG000|Overall Study|Adverse Event|0|||
94736123|NCT04076618|324491473|FG001|Overall Study|Adverse Event|0|||
94736124|NCT04076618|324491474|FG002|Overall Study|Adverse Event|2|||
94736125|NCT04414722|324491475|FG000|Overall Study|Lost to Follow-up|3|||
94736126|NCT04414722|324491476|FG001|Overall Study|Lost to Follow-up|4|||
94736127|NCT04414722|324491477|FG002|Overall Study|Lost to Follow-up|3|||
94736128|NCT04414722|324491478|FG003|Overall Study|Lost to Follow-up|2|||
94736129|NCT04414722|324491479|FG004|Overall Study|Lost to Follow-up|3|||
94736130|NCT04414722|324491475|FG000|Overall Study|Withdrawal by Subject|6|||
94736131|NCT04414722|324491476|FG001|Overall Study|Withdrawal by Subject|3|||
94736132|NCT04414722|324491477|FG002|Overall Study|Withdrawal by Subject|1|||
94736133|NCT04414722|324491478|FG003|Overall Study|Withdrawal by Subject|5|||
94736134|NCT04414722|324491479|FG004|Overall Study|Withdrawal by Subject|1|||
94736135|NCT04414722|324491475|FG000|Overall Study|Physician Decision|0|||
94736136|NCT04414722|324491476|FG001|Overall Study|Physician Decision|1|||
94736137|NCT04414722|324491477|FG002|Overall Study|Physician Decision|2|||
94736138|NCT04414722|324491478|FG003|Overall Study|Physician Decision|0|||
94736139|NCT04414722|324491479|FG004|Overall Study|Physician Decision|0|||
94736140|NCT04414722|324491475|FG000|Overall Study|Non-participatory|0|||
94736141|NCT04414722|324491476|FG001|Overall Study|Non-participatory|1|||
94736142|NCT04414722|324491477|FG002|Overall Study|Non-participatory|1|||
94736143|NCT04414722|324491478|FG003|Overall Study|Non-participatory|0|||
94736144|NCT04414722|324491479|FG004|Overall Study|Non-participatory|0|||
94736145|NCT03260894|324491486|FG000|Overall Study|Death|6|||
94736146|NCT03260894|324491487|FG001|Overall Study|Death|8|||
94736147|NCT03260894|324491486|FG000|Overall Study|Withdrawal by Subject|4|||
94736148|NCT03260894|324491487|FG001|Overall Study|Withdrawal by Subject|11|||
94736149|NCT03260894|324491486|FG000|Overall Study|On-going at clinical cut off date|36|||
94736150|NCT03260894|324491487|FG001|Overall Study|On-going at clinical cut off date|31|||
94736151|NCT00792948|324491491|FG000|Overall Study|Adverse Event|6|||
94736152|NCT00792948|324491491|FG000|Overall Study|Death|4|||
94736153|NCT00792948|324491491|FG000|Overall Study|Withdrawal by Subject|3|||
94736154|NCT00792948|324491491|FG000|Overall Study|Ineligible|2|||
94736155|NCT00792948|324491491|FG000|Overall Study|Insurance denial - not treated|1|||
94736156|NCT00792948|324491491|FG000|Overall Study|Physician Decision|11|||
94736157|NCT00792948|324491491|FG000|Overall Study|Protocol Violation|1|||
94736158|NCT05218096|324491500|FG000|Primary Evaluation|Withdrawal by Subject|0|||
94736159|NCT05218096|324491501|FG001|Primary Evaluation|Withdrawal by Subject|0|||
94736160|NCT05218096|324491502|FG002|Primary Evaluation|Withdrawal by Subject|2|||
94736161|NCT05218096|324491503|FG003|Primary Evaluation|Withdrawal by Subject|0|||
94736162|NCT05218096|324491504|FG004|Primary Evaluation|Withdrawal by Subject|0|||
94736163|NCT05218096|324491500|FG000|Primary Evaluation|Physician Decision|1|||
94736164|NCT05218096|324491501|FG001|Primary Evaluation|Physician Decision|0|||
94736165|NCT05218096|324491502|FG002|Primary Evaluation|Physician Decision|0|||
94736166|NCT05218096|324491503|FG003|Primary Evaluation|Physician Decision|0|||
94736167|NCT05218096|324491504|FG004|Primary Evaluation|Physician Decision|0|||
94736168|NCT05218096|324491500|FG000|Extended Treatment|Clinical Deterioration|1|||
94736169|NCT05218096|324491501|FG001|Extended Treatment|Clinical Deterioration|1|||
94736170|NCT05218096|324491502|FG002|Extended Treatment|Clinical Deterioration|0|||
94736171|NCT05218096|324491503|FG003|Extended Treatment|Clinical Deterioration|0|||
94736172|NCT05218096|324491504|FG004|Extended Treatment|Clinical Deterioration|0|||
94736173|NCT05218096|324491500|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
94736174|NCT05218096|324491501|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
94736175|NCT05218096|324491502|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
94736176|NCT05218096|324491503|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
94736177|NCT05218096|324491504|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
94736178|NCT05218096|324491500|FG000|Extended Treatment|Withdrawal by Subject|1|||
94736179|NCT05218096|324491501|FG001|Extended Treatment|Withdrawal by Subject|3|||
94736180|NCT05218096|324491502|FG002|Extended Treatment|Withdrawal by Subject|0|||
94736181|NCT05218096|324491503|FG003|Extended Treatment|Withdrawal by Subject|2|||
94736182|NCT05218096|324491504|FG004|Extended Treatment|Withdrawal by Subject|2|||
94736183|NCT05218096|324491500|FG000|Extended Treatment|Lack of Efficacy|3|||
94736184|NCT05218096|324491501|FG001|Extended Treatment|Lack of Efficacy|0|||
94736185|NCT05218096|324491502|FG002|Extended Treatment|Lack of Efficacy|0|||
94736186|NCT05218096|324491503|FG003|Extended Treatment|Lack of Efficacy|0|||
94736187|NCT05218096|324491504|FG004|Extended Treatment|Lack of Efficacy|0|||
94736188|NCT05218096|324491500|FG000|Extended Treatment|Physician Decision|0|||
94736189|NCT05218096|324491501|FG001|Extended Treatment|Physician Decision|1|||
94736190|NCT05218096|324491502|FG002|Extended Treatment|Physician Decision|0|||
94736191|NCT05218096|324491503|FG003|Extended Treatment|Physician Decision|0|||
94736192|NCT05218096|324491504|FG004|Extended Treatment|Physician Decision|0|||
94736193|NCT05218096|324491500|FG000|Open-label Extension|Adverse Event|1|||
94736194|NCT05218096|324491501|FG001|Open-label Extension|Adverse Event|0|||
94736195|NCT05218096|324491502|FG002|Open-label Extension|Adverse Event|0|||
94736196|NCT05218096|324491503|FG003|Open-label Extension|Adverse Event|0|||
94736197|NCT05218096|324491504|FG004|Open-label Extension|Adverse Event|1|||
94736198|NCT05218096|324491500|FG000|Open-label Extension|Pregnancy|0|||
94736199|NCT05218096|324491501|FG001|Open-label Extension|Pregnancy|0|||
94736200|NCT05218096|324491502|FG002|Open-label Extension|Pregnancy|0|||
94736201|NCT05218096|324491503|FG003|Open-label Extension|Pregnancy|0|||
94736202|NCT05218096|324491504|FG004|Open-label Extension|Pregnancy|1|||
94736203|NCT05218096|324491500|FG000|Open-label Extension|Lack of Efficacy|1|||
94736204|NCT05218096|324491501|FG001|Open-label Extension|Lack of Efficacy|2|||
94736205|NCT05218096|324491502|FG002|Open-label Extension|Lack of Efficacy|0|||
94736206|NCT05218096|324491503|FG003|Open-label Extension|Lack of Efficacy|0|||
94736207|NCT05218096|324491504|FG004|Open-label Extension|Lack of Efficacy|0|||
94736208|NCT05218096|324491500|FG000|Open-label Extension|Lost to Follow-up|1|||
94736209|NCT05218096|324491501|FG001|Open-label Extension|Lost to Follow-up|0|||
94736210|NCT05218096|324491502|FG002|Open-label Extension|Lost to Follow-up|0|||
94736211|NCT05218096|324491503|FG003|Open-label Extension|Lost to Follow-up|0|||
94736212|NCT05218096|324491504|FG004|Open-label Extension|Lost to Follow-up|0|||
94736213|NCT05218096|324491500|FG000|Open-label Extension|Death|0|||
94736214|NCT05218096|324491501|FG001|Open-label Extension|Death|0|||
94736215|NCT05218096|324491502|FG002|Open-label Extension|Death|0|||
94736216|NCT05218096|324491503|FG003|Open-label Extension|Death|1|||
94736217|NCT05218096|324491504|FG004|Open-label Extension|Death|0|||
94736218|NCT05218096|324491500|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
94736219|NCT05218096|324491501|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
94736220|NCT05218096|324491502|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
94736221|NCT05218096|324491503|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
94736222|NCT05218096|324491504|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
94275525|NCT02104583|322802426|FG000|Overall Study|Subject required cardiac ablation|6|||
94736223|NCT01864018|324491505|FG000|Overall Study|Ineligible|3|||
94736224|NCT01864018|324491506|FG001|Overall Study|Ineligible|1|||
94736225|NCT03523572|324491509|FG000|Dose Escalation|Progressive disease|1|||
94736226|NCT03523572|324491510|FG001|Dose Escalation|Progressive disease|0|||
94736227|NCT03523572|324491511|FG002|Dose Escalation|Progressive disease|0|||
94736228|NCT03523572|324491512|FG003|Dose Escalation|Progressive disease|0|||
94736229|NCT03523572|324491513|FG004|Dose Escalation|Progressive disease|0|||
94736230|NCT03523572|324491514|FG005|Dose Escalation|Progressive disease|0|||
94736231|NCT03523572|324491509|FG000|Dose Escalation|Clinical Progression|0|||
94736232|NCT03523572|324491510|FG001|Dose Escalation|Clinical Progression|1|||
94736233|NCT03523572|324491511|FG002|Dose Escalation|Clinical Progression|0|||
94736234|NCT03523572|324491512|FG003|Dose Escalation|Clinical Progression|0|||
94736235|NCT03523572|324491513|FG004|Dose Escalation|Clinical Progression|0|||
94736236|NCT03523572|324491514|FG005|Dose Escalation|Clinical Progression|0|||
94736237|NCT03523572|324491509|FG000|Dose Escalation|Adverse Event|2|||
94736238|NCT03523572|324491510|FG001|Dose Escalation|Adverse Event|0|||
94736239|NCT03523572|324491511|FG002|Dose Escalation|Adverse Event|0|||
94736240|NCT03523572|324491512|FG003|Dose Escalation|Adverse Event|0|||
94736241|NCT03523572|324491513|FG004|Dose Escalation|Adverse Event|0|||
94736242|NCT03523572|324491514|FG005|Dose Escalation|Adverse Event|0|||
94736243|NCT03523572|324491509|FG000|Dose Escalation|Physician Decision|1|||
94736244|NCT03523572|324491510|FG001|Dose Escalation|Physician Decision|1|||
94736245|NCT03523572|324491511|FG002|Dose Escalation|Physician Decision|0|||
94736246|NCT03523572|324491512|FG003|Dose Escalation|Physician Decision|0|||
94736247|NCT03523572|324491513|FG004|Dose Escalation|Physician Decision|0|||
94736248|NCT03523572|324491514|FG005|Dose Escalation|Physician Decision|0|||
94736249|NCT03523572|324491509|FG000|Dose Expansion|Progressive Disease|0|||
94736250|NCT03523572|324491510|FG001|Dose Expansion|Progressive Disease|0|||
94736251|NCT03523572|324491511|FG002|Dose Expansion|Progressive Disease|9|||
94736252|NCT03523572|324491512|FG003|Dose Expansion|Progressive Disease|11|||
94736253|NCT03523572|324491513|FG004|Dose Expansion|Progressive Disease|15|||
94736254|NCT03523572|324491514|FG005|Dose Expansion|Progressive Disease|2|||
94736255|NCT03523572|324491509|FG000|Dose Expansion|Clinical Progression|0|||
94736256|NCT03523572|324491510|FG001|Dose Expansion|Clinical Progression|0|||
94736257|NCT03523572|324491511|FG002|Dose Expansion|Clinical Progression|2|||
94736258|NCT03523572|324491512|FG003|Dose Expansion|Clinical Progression|2|||
94736259|NCT03523572|324491513|FG004|Dose Expansion|Clinical Progression|2|||
94736260|NCT03523572|324491514|FG005|Dose Expansion|Clinical Progression|0|||
94736261|NCT03523572|324491509|FG000|Dose Expansion|Adverse Event|0|||
94736262|NCT03523572|324491510|FG001|Dose Expansion|Adverse Event|0|||
94736263|NCT03523572|324491511|FG002|Dose Expansion|Adverse Event|10|||
94736264|NCT03523572|324491512|FG003|Dose Expansion|Adverse Event|1|||
94736265|NCT03523572|324491513|FG004|Dose Expansion|Adverse Event|5|||
94736266|NCT03523572|324491514|FG005|Dose Expansion|Adverse Event|2|||
94736267|NCT03523572|324491509|FG000|Dose Expansion|Withdrawal by Subject|0|||
94736268|NCT03523572|324491510|FG001|Dose Expansion|Withdrawal by Subject|0|||
94736269|NCT03523572|324491511|FG002|Dose Expansion|Withdrawal by Subject|1|||
94736270|NCT03523572|324491512|FG003|Dose Expansion|Withdrawal by Subject|1|||
94736271|NCT03523572|324491513|FG004|Dose Expansion|Withdrawal by Subject|0|||
94736272|NCT03523572|324491514|FG005|Dose Expansion|Withdrawal by Subject|0|||
94736273|NCT03523572|324491509|FG000|Dose Expansion|Physician Decision|0|||
94736274|NCT03523572|324491510|FG001|Dose Expansion|Physician Decision|0|||
94368858|NCT03091400|323136555|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
94736275|NCT03523572|324491511|FG002|Dose Expansion|Physician Decision|1|||
94736276|NCT03523572|324491512|FG003|Dose Expansion|Physician Decision|0|||
94736277|NCT03523572|324491513|FG004|Dose Expansion|Physician Decision|1|||
94736278|NCT03523572|324491514|FG005|Dose Expansion|Physician Decision|0|||
94736279|NCT03523572|324491509|FG000|Dose Expansion|Miscellaneous|0|||
94736280|NCT03523572|324491510|FG001|Dose Expansion|Miscellaneous|0|||
94736281|NCT03523572|324491511|FG002|Dose Expansion|Miscellaneous|0|||
94736282|NCT03523572|324491512|FG003|Dose Expansion|Miscellaneous|0|||
94736283|NCT03523572|324491513|FG004|Dose Expansion|Miscellaneous|3|||
94736284|NCT03523572|324491514|FG005|Dose Expansion|Miscellaneous|0|||
94736285|NCT05269966|324491515|FG000|Overall Study|Adverse Event|4|||
94736286|NCT05269966|324491515|FG000|Overall Study|Withdrawal by Subject|1|||
94736287|NCT05269966|324491515|FG000|Overall Study|Lost to Follow-up|4|||
94736288|NCT05269966|324491515|FG000|Overall Study|Physician Decision|1|||
94736289|NCT04685135|324491526|FG000|Overall Study|Death|126|||
94736290|NCT04685135|324491527|FG001|Overall Study|Death|53|||
94736291|NCT04685135|324491526|FG000|Overall Study|Withdrawal by Subject|12|||
94736292|NCT04685135|324491527|FG001|Overall Study|Withdrawal by Subject|16|||
94736293|NCT03088878|324491529|FG000|Overall Study|Adverse Event|0|||
94736294|NCT03088878|324491530|FG001|Overall Study|Adverse Event|0|||
94736295|NCT03088878|324491531|FG002|Overall Study|Adverse Event|0|||
94736296|NCT03088878|324491532|FG003|Overall Study|Adverse Event|0|||
94736297|NCT03088878|324491533|FG004|Overall Study|Adverse Event|4|||
94736298|NCT03088878|324491534|FG005|Overall Study|Adverse Event|2|||
94736299|NCT03088878|324491535|FG006|Overall Study|Adverse Event|1|||
94736300|NCT03088878|324491536|FG007|Overall Study|Adverse Event|0|||
94736301|NCT03088878|324491537|FG008|Overall Study|Adverse Event|0|||
94736302|NCT03088878|324491538|FG009|Overall Study|Adverse Event|0|||
94736303|NCT03088878|324491539|FG010|Overall Study|Adverse Event|0|||
94736304|NCT03088878|324491540|FG011|Overall Study|Adverse Event|0|||
94736305|NCT03088878|324491541|FG012|Overall Study|Adverse Event|5|||
94736306|NCT03088878|324491542|FG013|Overall Study|Adverse Event|3|||
94736307|NCT03088878|324491529|FG000|Overall Study|Clinical Progression|0|||
94736308|NCT03088878|324491530|FG001|Overall Study|Clinical Progression|0|||
94736309|NCT03088878|324491531|FG002|Overall Study|Clinical Progression|0|||
94736310|NCT03088878|324491532|FG003|Overall Study|Clinical Progression|0|||
94736311|NCT03088878|324491533|FG004|Overall Study|Clinical Progression|2|||
94736312|NCT03088878|324491534|FG005|Overall Study|Clinical Progression|0|||
94736313|NCT03088878|324491535|FG006|Overall Study|Clinical Progression|0|||
94736314|NCT03088878|324491536|FG007|Overall Study|Clinical Progression|0|||
94736315|NCT03088878|324491537|FG008|Overall Study|Clinical Progression|0|||
94736316|NCT03088878|324491538|FG009|Overall Study|Clinical Progression|0|||
94736317|NCT03088878|324491539|FG010|Overall Study|Clinical Progression|0|||
94736318|NCT03088878|324491540|FG011|Overall Study|Clinical Progression|0|||
94736319|NCT03088878|324491541|FG012|Overall Study|Clinical Progression|0|||
94736320|NCT03088878|324491542|FG013|Overall Study|Clinical Progression|0|||
94736321|NCT03088878|324491529|FG000|Overall Study|Death|0|||
94736322|NCT03088878|324491530|FG001|Overall Study|Death|0|||
94736323|NCT03088878|324491531|FG002|Overall Study|Death|0|||
94736324|NCT03088878|324491532|FG003|Overall Study|Death|0|||
94736325|NCT03088878|324491533|FG004|Overall Study|Death|2|||
94736326|NCT03088878|324491534|FG005|Overall Study|Death|0|||
94736327|NCT03088878|324491535|FG006|Overall Study|Death|0|||
94736328|NCT03088878|324491536|FG007|Overall Study|Death|0|||
94736329|NCT03088878|324491537|FG008|Overall Study|Death|0|||
94736330|NCT03088878|324491538|FG009|Overall Study|Death|0|||
94736331|NCT03088878|324491539|FG010|Overall Study|Death|0|||
94736332|NCT03088878|324491540|FG011|Overall Study|Death|1|||
94736333|NCT03088878|324491541|FG012|Overall Study|Death|0|||
94736334|NCT03088878|324491542|FG013|Overall Study|Death|0|||
94736335|NCT03088878|324491529|FG000|Overall Study|Disease Progression|1|||
94736336|NCT03088878|324491530|FG001|Overall Study|Disease Progression|2|||
94736337|NCT03088878|324491531|FG002|Overall Study|Disease Progression|3|||
94736338|NCT03088878|324491532|FG003|Overall Study|Disease Progression|0|||
94736339|NCT03088878|324491533|FG004|Overall Study|Disease Progression|3|||
94736340|NCT03088878|324491534|FG005|Overall Study|Disease Progression|0|||
94736341|NCT03088878|324491535|FG006|Overall Study|Disease Progression|0|||
94736342|NCT03088878|324491536|FG007|Overall Study|Disease Progression|0|||
94736343|NCT03088878|324491537|FG008|Overall Study|Disease Progression|0|||
94736344|NCT03088878|324491538|FG009|Overall Study|Disease Progression|0|||
94736345|NCT03088878|324491539|FG010|Overall Study|Disease Progression|0|||
94736346|NCT03088878|324491540|FG011|Overall Study|Disease Progression|0|||
94736347|NCT03088878|324491541|FG012|Overall Study|Disease Progression|1|||
94736348|NCT03088878|324491542|FG013|Overall Study|Disease Progression|1|||
94736349|NCT03088878|324491529|FG000|Overall Study|Initiation of Alternative Treatment|0|||
94736350|NCT03088878|324491530|FG001|Overall Study|Initiation of Alternative Treatment|0|||
94736351|NCT03088878|324491531|FG002|Overall Study|Initiation of Alternative Treatment|0|||
94736352|NCT03088878|324491532|FG003|Overall Study|Initiation of Alternative Treatment|1|||
94736353|NCT03088878|324491533|FG004|Overall Study|Initiation of Alternative Treatment|0|||
94736354|NCT03088878|324491534|FG005|Overall Study|Initiation of Alternative Treatment|0|||
94736355|NCT03088878|324491535|FG006|Overall Study|Initiation of Alternative Treatment|0|||
94736356|NCT03088878|324491536|FG007|Overall Study|Initiation of Alternative Treatment|1|||
94736357|NCT03088878|324491537|FG008|Overall Study|Initiation of Alternative Treatment|1|||
94736358|NCT03088878|324491538|FG009|Overall Study|Initiation of Alternative Treatment|0|||
94736359|NCT03088878|324491539|FG010|Overall Study|Initiation of Alternative Treatment|0|||
94736360|NCT03088878|324491540|FG011|Overall Study|Initiation of Alternative Treatment|0|||
94736361|NCT03088878|324491541|FG012|Overall Study|Initiation of Alternative Treatment|0|||
94736362|NCT03088878|324491542|FG013|Overall Study|Initiation of Alternative Treatment|0|||
94736363|NCT03088878|324491529|FG000|Overall Study|Withdrawal by Subject|0|||
94736364|NCT03088878|324491530|FG001|Overall Study|Withdrawal by Subject|0|||
94736365|NCT03088878|324491531|FG002|Overall Study|Withdrawal by Subject|0|||
94736366|NCT03088878|324491532|FG003|Overall Study|Withdrawal by Subject|1|||
94736367|NCT03088878|324491533|FG004|Overall Study|Withdrawal by Subject|4|||
94736368|NCT03088878|324491534|FG005|Overall Study|Withdrawal by Subject|1|||
94736369|NCT03088878|324491535|FG006|Overall Study|Withdrawal by Subject|1|||
94736370|NCT03088878|324491536|FG007|Overall Study|Withdrawal by Subject|0|||
94736371|NCT03088878|324491537|FG008|Overall Study|Withdrawal by Subject|1|||
94736372|NCT03088878|324491538|FG009|Overall Study|Withdrawal by Subject|2|||
94736373|NCT03088878|324491539|FG010|Overall Study|Withdrawal by Subject|0|||
94736374|NCT03088878|324491540|FG011|Overall Study|Withdrawal by Subject|2|||
94736375|NCT03088878|324491541|FG012|Overall Study|Withdrawal by Subject|1|||
94736376|NCT03088878|324491542|FG013|Overall Study|Withdrawal by Subject|0|||
94736377|NCT03088878|324491529|FG000|Overall Study|Terminated by Sponsor|2|||
94736378|NCT03088878|324491530|FG001|Overall Study|Terminated by Sponsor|1|||
94736379|NCT03088878|324491531|FG002|Overall Study|Terminated by Sponsor|0|||
94736380|NCT03088878|324491532|FG003|Overall Study|Terminated by Sponsor|1|||
94736381|NCT03088878|324491533|FG004|Overall Study|Terminated by Sponsor|6|||
94736382|NCT03088878|324491534|FG005|Overall Study|Terminated by Sponsor|0|||
94736383|NCT03088878|324491535|FG006|Overall Study|Terminated by Sponsor|0|||
94736384|NCT03088878|324491536|FG007|Overall Study|Terminated by Sponsor|0|||
94736385|NCT03088878|324491537|FG008|Overall Study|Terminated by Sponsor|0|||
94736386|NCT03088878|324491538|FG009|Overall Study|Terminated by Sponsor|0|||
94736387|NCT03088878|324491539|FG010|Overall Study|Terminated by Sponsor|3|||
94736388|NCT03088878|324491540|FG011|Overall Study|Terminated by Sponsor|13|||
94736389|NCT03088878|324491541|FG012|Overall Study|Terminated by Sponsor|2|||
94736390|NCT03088878|324491542|FG013|Overall Study|Terminated by Sponsor|1|||
94736391|NCT03088878|324491529|FG000|Overall Study|Completed 2 years of Treatment|0|||
94736392|NCT03088878|324491530|FG001|Overall Study|Completed 2 years of Treatment|0|||
94736393|NCT03088878|324491531|FG002|Overall Study|Completed 2 years of Treatment|0|||
94736394|NCT03088878|324491532|FG003|Overall Study|Completed 2 years of Treatment|0|||
94736395|NCT03088878|324491533|FG004|Overall Study|Completed 2 years of Treatment|0|||
94736396|NCT03088878|324491534|FG005|Overall Study|Completed 2 years of Treatment|0|||
94736397|NCT03088878|324491535|FG006|Overall Study|Completed 2 years of Treatment|1|||
94736398|NCT03088878|324491536|FG007|Overall Study|Completed 2 years of Treatment|0|||
94736399|NCT03088878|324491537|FG008|Overall Study|Completed 2 years of Treatment|0|||
94736400|NCT03088878|324491538|FG009|Overall Study|Completed 2 years of Treatment|1|||
94736401|NCT03088878|324491539|FG010|Overall Study|Completed 2 years of Treatment|0|||
94736402|NCT03088878|324491540|FG011|Overall Study|Completed 2 years of Treatment|0|||
94736403|NCT03088878|324491541|FG012|Overall Study|Completed 2 years of Treatment|8|||
94736404|NCT03088878|324491542|FG013|Overall Study|Completed 2 years of Treatment|3|||
94736405|NCT03088878|324491529|FG000|Overall Study|Physician Decision|0|||
94736406|NCT03088878|324491530|FG001|Overall Study|Physician Decision|0|||
94736407|NCT03088878|324491531|FG002|Overall Study|Physician Decision|0|||
94736408|NCT03088878|324491532|FG003|Overall Study|Physician Decision|0|||
94736409|NCT03088878|324491533|FG004|Overall Study|Physician Decision|0|||
94736410|NCT03088878|324491534|FG005|Overall Study|Physician Decision|0|||
94736411|NCT03088878|324491535|FG006|Overall Study|Physician Decision|0|||
94736412|NCT03088878|324491536|FG007|Overall Study|Physician Decision|2|||
94736413|NCT03088878|324491537|FG008|Overall Study|Physician Decision|1|||
94736414|NCT03088878|324491538|FG009|Overall Study|Physician Decision|0|||
94736415|NCT03088878|324491539|FG010|Overall Study|Physician Decision|0|||
94736416|NCT03088878|324491540|FG011|Overall Study|Physician Decision|0|||
94736417|NCT03088878|324491541|FG012|Overall Study|Physician Decision|0|||
94736418|NCT03088878|324491542|FG013|Overall Study|Physician Decision|1|||
94736419|NCT03088878|324491529|FG000|Overall Study|COVID Related noncompliance|0|||
94736420|NCT03088878|324491530|FG001|Overall Study|COVID Related noncompliance|0|||
94736421|NCT03088878|324491531|FG002|Overall Study|COVID Related noncompliance|0|||
94736422|NCT03088878|324491532|FG003|Overall Study|COVID Related noncompliance|0|||
94736423|NCT03088878|324491533|FG004|Overall Study|COVID Related noncompliance|0|||
94736424|NCT03088878|324491534|FG005|Overall Study|COVID Related noncompliance|0|||
94736425|NCT03088878|324491535|FG006|Overall Study|COVID Related noncompliance|0|||
94736426|NCT03088878|324491536|FG007|Overall Study|COVID Related noncompliance|0|||
94736427|NCT03088878|324491537|FG008|Overall Study|COVID Related noncompliance|0|||
94736428|NCT03088878|324491538|FG009|Overall Study|COVID Related noncompliance|0|||
94736429|NCT03088878|324491539|FG010|Overall Study|COVID Related noncompliance|0|||
94736430|NCT03088878|324491540|FG011|Overall Study|COVID Related noncompliance|0|||
94736431|NCT03088878|324491541|FG012|Overall Study|COVID Related noncompliance|0|||
94736432|NCT03088878|324491542|FG013|Overall Study|COVID Related noncompliance|1|||
94736433|NCT03088878|324491529|FG000|Overall Study|Drug or Study Noncompliance|0|||
94736434|NCT03088878|324491530|FG001|Overall Study|Drug or Study Noncompliance|0|||
94736435|NCT03088878|324491531|FG002|Overall Study|Drug or Study Noncompliance|0|||
94736436|NCT03088878|324491532|FG003|Overall Study|Drug or Study Noncompliance|0|||
94736437|NCT03088878|324491533|FG004|Overall Study|Drug or Study Noncompliance|0|||
94736438|NCT03088878|324491534|FG005|Overall Study|Drug or Study Noncompliance|0|||
94736439|NCT03088878|324491535|FG006|Overall Study|Drug or Study Noncompliance|0|||
94736440|NCT03088878|324491536|FG007|Overall Study|Drug or Study Noncompliance|0|||
94736441|NCT03088878|324491537|FG008|Overall Study|Drug or Study Noncompliance|0|||
94736442|NCT03088878|324491538|FG009|Overall Study|Drug or Study Noncompliance|0|||
94736443|NCT03088878|324491539|FG010|Overall Study|Drug or Study Noncompliance|0|||
94736444|NCT03088878|324491540|FG011|Overall Study|Drug or Study Noncompliance|0|||
94736445|NCT03088878|324491541|FG012|Overall Study|Drug or Study Noncompliance|1|||
94736446|NCT03088878|324491542|FG013|Overall Study|Drug or Study Noncompliance|0|||
94736447|NCT01236781|324491548|FG000|Overall Study|Ineligible|2|||
94736448|NCT01236781|324491549|FG001|Overall Study|Ineligible|1|||
94736449|NCT01236781|324491548|FG000|Overall Study|Did not complete study imaging|5|||
94736450|NCT01236781|324491549|FG001|Overall Study|Did not complete study imaging|0|||
94736451|NCT02887521|324491550|FG000|Overall Study|Withdrawal by Subject|0|||
94736452|NCT02887521|324491551|FG001|Overall Study|Withdrawal by Subject|3|||
94736453|NCT02709161|324491554|FG000|Overall Study|Withdrawal by Subject|1|||
94736454|NCT02709161|324491555|FG001|Overall Study|Withdrawal by Subject|0|||
94736455|NCT05565820|324491558|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
94736456|NCT05565820|324491559|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
94736457|NCT05565820|324491558|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
94736458|NCT05565820|324491559|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
94736459|NCT04786119|324491562|FG000|Overall Study|Withdrawal by Subject|2|||
94736460|NCT03056573|324491563|FG000|Overall Study|Death|2|||
94368859|NCT03467971|323136556|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94736461|NCT03056573|324491564|FG001|Overall Study|Death|4|||
94736462|NCT03056573|324491563|FG000|Overall Study|Withdrawal by Subject|2|||
94736463|NCT03056573|324491564|FG001|Overall Study|Withdrawal by Subject|0|||
94736464|NCT03056573|324491563|FG000|Overall Study|Lost to Follow-up|1|||
94736465|NCT03056573|324491564|FG001|Overall Study|Lost to Follow-up|1|||
94736466|NCT03606408|324491565|FG000|Overall Study|Adverse Event|13|||
94736467|NCT03606408|324491565|FG000|Overall Study|Withdrawal by Subject|7|||
94736468|NCT03606408|324491565|FG000|Overall Study|Physician Decision|4|||
94736469|NCT03606408|324491565|FG000|Overall Study|Lack of Efficacy|2|||
94736470|NCT03606408|324491565|FG000|Overall Study|Death|1|||
94736471|NCT03606408|324491565|FG000|Overall Study|new therapy for study indication|1|||
94736472|NCT03292484|324491568|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
94736473|NCT03292484|324491568|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
94736474|NCT03292484|324491568|FG000|Overall Study|Protocol Violation|2|||
94736475|NCT03292484|324491568|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
94736476|NCT03292484|324491568|FG000|Overall Study|Sponsor decision|349|||
94736477|NCT03292484|324491568|FG000|Overall Study|Lost to Follow-up|7|||
94736478|NCT03292484|324491568|FG000|Overall Study|Coronavirus Disease 2019|1|||
94736479|NCT03292484|324491568|FG000|Overall Study|Other|20|||
94736480|NCT05076266|324491569|FG000|Overall Study|Survey not complete - Participant refusal|2|||
94736481|NCT05076266|324491570|FG001|Overall Study|Survey not complete - Participant refusal|0|||
94736482|NCT04003246|324491571|FG000|Overall Study|Death|9|||
94736483|NCT05245071|324491575|FG000|Overall Study|Progressive disease|16|||
94736484|NCT05245071|324491575|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
94736485|NCT05245071|324491575|FG000|Overall Study|Ongoing study intervention|4|||
94736486|NCT02631746|324491581|FG000|Overall Study|Lack of Efficacy|3|||
94736487|NCT02361216|324491582|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
94736488|NCT02361216|324491583|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
94736489|NCT02361216|324491582|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
94736490|NCT02361216|324491583|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
94736491|NCT02361216|324491582|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
94736492|NCT02361216|324491583|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
94736493|NCT02361216|324491582|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
94736494|NCT02361216|324491583|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
94736495|NCT02361216|324491582|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
94736496|NCT02361216|324491583|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
94736497|NCT02361216|324491582|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
94736498|NCT02361216|324491583|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
94736499|NCT02224144|324491587|FG000|Overall Study|Lost to Follow-up|3|||
94736500|NCT02224144|324491588|FG001|Overall Study|Lost to Follow-up|1|||
94736501|NCT02224144|324491587|FG000|Overall Study|Death|2|||
94736502|NCT02224144|324491588|FG001|Overall Study|Death|0|||
94736503|NCT02224144|324491587|FG000|Overall Study|Withdrawal by Subject|0|||
94736504|NCT02224144|324491588|FG001|Overall Study|Withdrawal by Subject|1|||
94736505|NCT02437136|324491589|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
94736506|NCT02437136|324491590|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
94736507|NCT02437136|324491591|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
94736508|NCT02437136|324491592|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
94736509|NCT02437136|324491593|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
94736510|NCT02437136|324491594|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
94736511|NCT02437136|324491595|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
94736512|NCT02437136|324491589|FG000|Expansion (Phase 2)|Death|0|||
94736513|NCT02437136|324491590|FG001|Expansion (Phase 2)|Death|0|||
94736514|NCT02437136|324491591|FG002|Expansion (Phase 2)|Death|0|||
94736515|NCT02437136|324491592|FG003|Expansion (Phase 2)|Death|6|||
94736516|NCT02437136|324491593|FG004|Expansion (Phase 2)|Death|37|||
94736517|NCT02437136|324491594|FG005|Expansion (Phase 2)|Death|29|||
94736518|NCT02437136|324491595|FG006|Expansion (Phase 2)|Death|24|||
94736519|NCT02437136|324491589|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
94736520|NCT02437136|324491590|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
94736521|NCT02437136|324491591|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
94736522|NCT02437136|324491592|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
94736523|NCT02437136|324491593|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
94736524|NCT02437136|324491594|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
94736525|NCT02437136|324491595|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
94736526|NCT02437136|324491589|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
94736527|NCT02437136|324491590|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
94736528|NCT02437136|324491591|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
94736529|NCT02437136|324491592|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
94736530|NCT02437136|324491593|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
94736531|NCT02437136|324491594|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
94736532|NCT02437136|324491595|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
94736533|NCT03358472|324491596|FG000|Overall Study|Death|6|||
94736534|NCT03358472|324491597|FG001|Overall Study|Death|3|||
94736535|NCT03358472|324491598|FG002|Overall Study|Death|10|||
94736536|NCT03358472|324491596|FG000|Overall Study|Physician Decision|0|||
94736537|NCT03358472|324491597|FG001|Overall Study|Physician Decision|1|||
94736538|NCT03358472|324491598|FG002|Overall Study|Physician Decision|0|||
94736539|NCT03358472|324491596|FG000|Overall Study|Withdrawal by Subject|0|||
94736540|NCT03358472|324491597|FG001|Overall Study|Withdrawal by Subject|0|||
94736541|NCT03358472|324491598|FG002|Overall Study|Withdrawal by Subject|1|||
94736542|NCT03358472|324491596|FG000|Overall Study|On-going at clinical cut off date|9|||
94736543|NCT03358472|324491597|FG001|Overall Study|On-going at clinical cut off date|6|||
94736544|NCT03358472|324491598|FG002|Overall Study|On-going at clinical cut off date|5|||
94736545|NCT02056834|324491599|FG000|Overall Study|Lost to Follow-up|7|||
94736546|NCT04186845|324491607|FG000|Overall Study|Death|2|||
94736547|NCT04186845|324491607|FG000|Overall Study|Lost to Follow-up|1|||
94736548|NCT04186845|324491607|FG000|Overall Study|Physician Decision|1|||
94736549|NCT04186845|324491607|FG000|Overall Study|Protocol Violation|1|||
94736550|NCT04186845|324491607|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
94736551|NCT04186845|324491607|FG000|Overall Study|Biopsy ordered but not done|1|||
94736552|NCT04186845|324491607|FG000|Overall Study|It was previously confirmed|1|||
94736553|NCT04186845|324491607|FG000|Overall Study|Patient cancelled scheduled scans|2|||
94736554|NCT04186845|324491607|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
94736555|NCT04186845|324491607|FG000|Overall Study|Subject refused confirmatory imaging|1|||
94736556|NCT04186845|324491607|FG000|Overall Study|Too small to biopsy|1|||
94736557|NCT04068831|324491610|FG000|Overall Study|Disease Progression|10|||
94736558|NCT04068831|324491611|FG001|Overall Study|Disease Progression|8|||
94736559|NCT03580356|324491617|FG000|Treatment Period|Withdrawal by Subject|13|||
94736560|NCT03580356|324491618|FG001|Treatment Period|Withdrawal by Subject|0|||
94736561|NCT03580356|324491619|FG002|Treatment Period|Withdrawal by Subject|13|||
94736562|NCT03580356|324491620|FG003|Treatment Period|Withdrawal by Subject|1|||
94736563|NCT03580356|324491621|FG004|Treatment Period|Withdrawal by Subject|17|||
94736564|NCT03580356|324491622|FG005|Treatment Period|Withdrawal by Subject|0|||
94736565|NCT03580356|324491623|FG006|Treatment Period|Withdrawal by Subject|5|||
94736566|NCT03580356|324491624|FG007|Treatment Period|Withdrawal by Subject|0|||
94736567|NCT03580356|324491617|FG000|Treatment Period|Adverse Event|10|||
94736568|NCT03580356|324491618|FG001|Treatment Period|Adverse Event|0|||
94736569|NCT03580356|324491619|FG002|Treatment Period|Adverse Event|13|||
94736570|NCT03580356|324491620|FG003|Treatment Period|Adverse Event|0|||
94736571|NCT03580356|324491621|FG004|Treatment Period|Adverse Event|5|||
94736572|NCT03580356|324491622|FG005|Treatment Period|Adverse Event|0|||
94736573|NCT03580356|324491623|FG006|Treatment Period|Adverse Event|8|||
94736574|NCT03580356|324491624|FG007|Treatment Period|Adverse Event|0|||
94736575|NCT03580356|324491617|FG000|Treatment Period|Protocol Violation|5|||
94736576|NCT03580356|324491618|FG001|Treatment Period|Protocol Violation|0|||
94736577|NCT03580356|324491619|FG002|Treatment Period|Protocol Violation|6|||
94736578|NCT03580356|324491620|FG003|Treatment Period|Protocol Violation|1|||
94736579|NCT03580356|324491621|FG004|Treatment Period|Protocol Violation|9|||
94736580|NCT03580356|324491622|FG005|Treatment Period|Protocol Violation|1|||
94736581|NCT03580356|324491623|FG006|Treatment Period|Protocol Violation|1|||
94736582|NCT03580356|324491624|FG007|Treatment Period|Protocol Violation|0|||
94736583|NCT03580356|324491617|FG000|Treatment Period|Lack of Efficacy|6|||
94736584|NCT03580356|324491618|FG001|Treatment Period|Lack of Efficacy|0|||
94736585|NCT03580356|324491619|FG002|Treatment Period|Lack of Efficacy|2|||
94736586|NCT03580356|324491620|FG003|Treatment Period|Lack of Efficacy|0|||
94736587|NCT03580356|324491621|FG004|Treatment Period|Lack of Efficacy|3|||
94736588|NCT03580356|324491622|FG005|Treatment Period|Lack of Efficacy|0|||
94368860|NCT03467971|323136557|FG001|Treatment Period 2|Withdrawal by Subject|1|||
94368861|NCT01238211|323136558|FG000|Overall Study|Continues active treatment|31|||
94368862|NCT01238211|323136558|FG000|Overall Study|Adverse Event|7|||
94368863|NCT01238211|323136558|FG000|Overall Study|Death|4|||
94368864|NCT01238211|323136558|FG000|Overall Study|Relapse/Progression|2|||
94368865|NCT01238211|323136558|FG000|Overall Study|Withdrawal by Subject|7|||
94368866|NCT01238211|323136558|FG000|Overall Study|Non-protocol treatment|4|||
94368867|NCT01238211|323136558|FG000|Overall Study|Investigator/Patient Decision|3|||
94736589|NCT03580356|324491623|FG006|Treatment Period|Lack of Efficacy|3|||
94736590|NCT03580356|324491624|FG007|Treatment Period|Lack of Efficacy|0|||
94736591|NCT03580356|324491617|FG000|Treatment Period|Pregnancy|1|||
94736592|NCT03580356|324491618|FG001|Treatment Period|Pregnancy|0|||
94736593|NCT03580356|324491619|FG002|Treatment Period|Pregnancy|7|||
94736594|NCT03580356|324491620|FG003|Treatment Period|Pregnancy|0|||
94736595|NCT03580356|324491621|FG004|Treatment Period|Pregnancy|2|||
94736596|NCT03580356|324491622|FG005|Treatment Period|Pregnancy|0|||
94736597|NCT03580356|324491623|FG006|Treatment Period|Pregnancy|1|||
94736598|NCT03580356|324491624|FG007|Treatment Period|Pregnancy|0|||
94736599|NCT03580356|324491617|FG000|Treatment Period|Physician Decision|2|||
94736600|NCT03580356|324491618|FG001|Treatment Period|Physician Decision|0|||
94736601|NCT03580356|324491619|FG002|Treatment Period|Physician Decision|1|||
94736602|NCT03580356|324491620|FG003|Treatment Period|Physician Decision|0|||
94736603|NCT03580356|324491621|FG004|Treatment Period|Physician Decision|4|||
94736604|NCT03580356|324491622|FG005|Treatment Period|Physician Decision|0|||
94736605|NCT03580356|324491623|FG006|Treatment Period|Physician Decision|2|||
94736606|NCT03580356|324491624|FG007|Treatment Period|Physician Decision|0|||
94736607|NCT03580356|324491617|FG000|Treatment Period|Lost to Follow-up|1|||
94736608|NCT03580356|324491618|FG001|Treatment Period|Lost to Follow-up|1|||
94368868|NCT03056001|323136561|FG000|Overall Study|Death|24|||
94368869|NCT01364298|323136562|FG000|Overall Study|Adverse Event|3|||
94368870|NCT01364298|323136563|FG001|Overall Study|Adverse Event|4|||
94736609|NCT03580356|324491619|FG002|Treatment Period|Lost to Follow-up|1|||
94736610|NCT03580356|324491620|FG003|Treatment Period|Lost to Follow-up|0|||
94736611|NCT03580356|324491621|FG004|Treatment Period|Lost to Follow-up|3|||
94736612|NCT03580356|324491622|FG005|Treatment Period|Lost to Follow-up|0|||
94736613|NCT03580356|324491623|FG006|Treatment Period|Lost to Follow-up|1|||
94275526|NCT02104583|322802427|FG001|Overall Study|Subject required cardiac ablation|4|||
94736614|NCT03580356|324491624|FG007|Treatment Period|Lost to Follow-up|0|||
94736615|NCT03580356|324491617|FG000|Treatment Period|Death|0|||
94736616|NCT03580356|324491618|FG001|Treatment Period|Death|0|||
94736617|NCT03580356|324491619|FG002|Treatment Period|Death|1|||
94736618|NCT03580356|324491620|FG003|Treatment Period|Death|0|||
94736619|NCT03580356|324491621|FG004|Treatment Period|Death|0|||
94736620|NCT03580356|324491622|FG005|Treatment Period|Death|0|||
94736621|NCT03580356|324491623|FG006|Treatment Period|Death|0|||
94736622|NCT03580356|324491624|FG007|Treatment Period|Death|0|||
94736623|NCT03580356|324491617|FG000|Treatment Period|Technical problems|0|||
94736624|NCT03580356|324491618|FG001|Treatment Period|Technical problems|0|||
94736625|NCT03580356|324491619|FG002|Treatment Period|Technical problems|0|||
94736626|NCT03580356|324491620|FG003|Treatment Period|Technical problems|0|||
94736627|NCT03580356|324491621|FG004|Treatment Period|Technical problems|1|||
94736628|NCT03580356|324491622|FG005|Treatment Period|Technical problems|0|||
94736629|NCT03580356|324491623|FG006|Treatment Period|Technical problems|0|||
94736630|NCT03580356|324491624|FG007|Treatment Period|Technical problems|0|||
94275527|NCT02104583|322802428|FG002|Overall Study|Subject required cardiac ablation|4|||
94736631|NCT03580356|324491617|FG000|Treatment Period|Misrandomized, no treatment|0|||
94736632|NCT03580356|324491618|FG001|Treatment Period|Misrandomized, no treatment|0|||
94736633|NCT03580356|324491619|FG002|Treatment Period|Misrandomized, no treatment|1|||
94275528|NCT02104583|322802429|FG003|Overall Study|Subject required cardiac ablation|5|||
94736634|NCT03580356|324491620|FG003|Treatment Period|Misrandomized, no treatment|0|||
94736635|NCT03580356|324491621|FG004|Treatment Period|Misrandomized, no treatment|2|||
94736636|NCT03580356|324491622|FG005|Treatment Period|Misrandomized, no treatment|0|||
94736637|NCT03580356|324491623|FG006|Treatment Period|Misrandomized, no treatment|0|||
94736638|NCT03580356|324491624|FG007|Treatment Period|Misrandomized, no treatment|0|||
94736639|NCT03580356|324491617|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
94736640|NCT03580356|324491618|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
94736641|NCT03580356|324491619|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
94736642|NCT03580356|324491620|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
94736643|NCT03580356|324491621|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
94736644|NCT03580356|324491622|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
94736645|NCT03580356|324491623|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
94736646|NCT03580356|324491624|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
94736647|NCT03580356|324491617|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
94736648|NCT03580356|324491618|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
94736649|NCT03580356|324491619|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
94736650|NCT03580356|324491620|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
94736651|NCT03580356|324491621|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
94736652|NCT03580356|324491622|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
94736653|NCT03580356|324491623|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
94736654|NCT03580356|324491624|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
94736655|NCT03580356|324491617|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
94736656|NCT03580356|324491618|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
94736657|NCT03580356|324491619|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
94736658|NCT03580356|324491620|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
94736659|NCT03580356|324491621|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
94736660|NCT03580356|324491622|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
94736661|NCT03580356|324491623|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
94736662|NCT03580356|324491624|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
94736663|NCT03580356|324491617|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
94736664|NCT03580356|324491618|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
94736665|NCT03580356|324491619|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
94736666|NCT03580356|324491620|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
94736667|NCT03580356|324491621|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
94736668|NCT03580356|324491622|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
94736669|NCT03580356|324491623|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
94736670|NCT03580356|324491624|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
94736671|NCT03580356|324491617|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
94736672|NCT03580356|324491618|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
94736673|NCT03580356|324491619|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
94736674|NCT03580356|324491620|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
94736675|NCT03580356|324491621|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
94736676|NCT03580356|324491622|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
94736677|NCT03580356|324491623|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
94736678|NCT03580356|324491624|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
94736679|NCT03580356|324491617|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
94736680|NCT03580356|324491618|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
94736681|NCT03580356|324491619|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
94736682|NCT03580356|324491620|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
94736683|NCT03580356|324491621|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
94736684|NCT03580356|324491622|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
94736685|NCT03580356|324491623|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
94736686|NCT03580356|324491624|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
94736687|NCT03580356|324491617|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
94736688|NCT03580356|324491618|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
94736689|NCT03580356|324491619|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
94736690|NCT03580356|324491620|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
94736691|NCT03580356|324491621|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
94736692|NCT03580356|324491622|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
94736693|NCT03580356|324491623|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
94736694|NCT03580356|324491624|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
94736695|NCT04678856|324491628|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
94736696|NCT04678856|324491629|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
94736697|NCT04678856|324491628|FG000|Overall Study|Withdrawal by Subject|5|||
94736698|NCT04678856|324491629|FG001|Overall Study|Withdrawal by Subject|1|||
94736699|NCT02052882|324493108|FG000|Overall Study|Not treated|11|||
94736700|NCT02052882|324493108|FG000|Overall Study|Protocol Violation|1|||
94736701|NCT02052882|324493108|FG000|Overall Study|Inadequate testing|1|||
94736702|NCT01627574|324493112|FG000|Overall Study|Withdrawal by Subject|8|||
94736703|NCT01627574|324493113|FG001|Overall Study|Withdrawal by Subject|5|||
94736704|NCT01627574|324493112|FG000|Overall Study|Lost to Follow-up|13|||
94736705|NCT01627574|324493113|FG001|Overall Study|Lost to Follow-up|13|||
94275529|NCT02104583|322802430|FG004|Overall Study|Subject required cardiac ablation|4|||
94275530|NCT02104583|322802426|FG000|Overall Study|Subject required prohibited medication|0|||
94275531|NCT02104583|322802427|FG001|Overall Study|Subject required prohibited medication|1|||
94275532|NCT02104583|322802428|FG002|Overall Study|Subject required prohibited medication|1|||
94275533|NCT02104583|322802429|FG003|Overall Study|Subject required prohibited medication|0|||
94275534|NCT02104583|322802430|FG004|Overall Study|Subject required prohibited medication|1|||
94275535|NCT02104583|322802426|FG000|Overall Study|Withdrew Consent|3|||
94275536|NCT02104583|322802427|FG001|Overall Study|Withdrew Consent|2|||
94275537|NCT02104583|322802428|FG002|Overall Study|Withdrew Consent|0|||
94275538|NCT02104583|322802429|FG003|Overall Study|Withdrew Consent|2|||
94275539|NCT02104583|322802430|FG004|Overall Study|Withdrew Consent|1|||
94275540|NCT02104583|322802426|FG000|Overall Study|Investigator's Discretion|1|||
94275541|NCT02104583|322802427|FG001|Overall Study|Investigator's Discretion|0|||
94275542|NCT02104583|322802428|FG002|Overall Study|Investigator's Discretion|0|||
94275543|NCT02104583|322802429|FG003|Overall Study|Investigator's Discretion|0|||
94275544|NCT02104583|322802430|FG004|Overall Study|Investigator's Discretion|0|||
94275545|NCT02104583|322802426|FG000|Overall Study|Protocol Violation|0|||
94275546|NCT02104583|322802427|FG001|Overall Study|Protocol Violation|0|||
94275547|NCT02104583|322802428|FG002|Overall Study|Protocol Violation|1|||
94275548|NCT02104583|322802429|FG003|Overall Study|Protocol Violation|0|||
94275549|NCT02104583|322802430|FG004|Overall Study|Protocol Violation|0|||
94736706|NCT03389802|324493114|FG000|Overall Study|Lack of Efficacy|3|||
94736707|NCT03389802|324493115|FG001|Overall Study|Lack of Efficacy|3|||
94736708|NCT03389802|324493116|FG002|Overall Study|Lack of Efficacy|13|||
94736709|NCT03389802|324493117|FG003|Overall Study|Lack of Efficacy|6|||
94736710|NCT03389802|324493118|FG004|Overall Study|Lack of Efficacy|1|||
94736711|NCT03389802|324493114|FG000|Overall Study|Adverse Event|0|||
94736712|NCT03389802|324493115|FG001|Overall Study|Adverse Event|0|||
94736713|NCT03389802|324493116|FG002|Overall Study|Adverse Event|1|||
94736714|NCT03389802|324493117|FG003|Overall Study|Adverse Event|0|||
94736715|NCT03389802|324493118|FG004|Overall Study|Adverse Event|4|||
94736716|NCT03389802|324493114|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
94736717|NCT03389802|324493115|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
94736718|NCT03389802|324493116|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
94736719|NCT03389802|324493117|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
94736720|NCT03389802|324493118|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
94736721|NCT04278417|324493125|FG000|Overall Study|Withdrawal by Subject|13|||
94736722|NCT04278417|324493126|FG001|Overall Study|Withdrawal by Subject|12|||
94736723|NCT04278417|324493125|FG000|Overall Study|Progressive disease|0|||
94736724|NCT04278417|324493126|FG001|Overall Study|Progressive disease|1|||
94736725|NCT04278417|324493125|FG000|Overall Study|Physician Decision|2|||
94736726|NCT04278417|324493126|FG001|Overall Study|Physician Decision|1|||
94736727|NCT04278417|324493125|FG000|Overall Study|Lost to Follow-up|7|||
94736728|NCT04278417|324493126|FG001|Overall Study|Lost to Follow-up|8|||
94736729|NCT04278417|324493125|FG000|Overall Study|Death|6|||
94736730|NCT04278417|324493126|FG001|Overall Study|Death|3|||
94736731|NCT04278417|324493125|FG000|Overall Study|Adverse Event|2|||
94736732|NCT04278417|324493126|FG001|Overall Study|Adverse Event|4|||
94736733|NCT04278417|324493125|FG000|Overall Study|Ongoing, did not complete Week 54|31|||
94736734|NCT04278417|324493126|FG001|Overall Study|Ongoing, did not complete Week 54|27|||
94736735|NCT03295721|324493133|FG000|Overall Study|Adverse Event|1|||
94736736|NCT03295721|324493134|FG001|Overall Study|Adverse Event|0|||
94736737|NCT03295721|324493135|FG002|Overall Study|Adverse Event|0|||
94736738|NCT03295721|324493133|FG000|Overall Study|Lost to Follow-up|1|||
94736739|NCT03295721|324493134|FG001|Overall Study|Lost to Follow-up|1|||
94736740|NCT03295721|324493135|FG002|Overall Study|Lost to Follow-up|1|||
94736741|NCT03295721|324493133|FG000|Overall Study|Withdrawal by Subject|1|||
94736742|NCT03295721|324493134|FG001|Overall Study|Withdrawal by Subject|0|||
94736743|NCT03295721|324493135|FG002|Overall Study|Withdrawal by Subject|1|||
94736744|NCT03295721|324493133|FG000|Overall Study|Death|0|||
94736745|NCT03295721|324493134|FG001|Overall Study|Death|0|||
94736746|NCT03295721|324493135|FG002|Overall Study|Death|1|||
94736747|NCT05090683|324493140|FG000|Overall Study|Lost to Follow-up|10|||
94736748|NCT05090683|324493141|FG001|Overall Study|Lost to Follow-up|2|||
94736749|NCT05090683|324493140|FG000|Overall Study|Withdrawal by Subject|15|||
94736750|NCT05090683|324493141|FG001|Overall Study|Withdrawal by Subject|0|||
94736751|NCT00429364|324493142|FG000|Overall Study|Withdrawal by Subject|11|||
94736752|NCT00429364|324493143|FG001|Overall Study|Withdrawal by Subject|5|||
94736753|NCT00429364|324493142|FG000|Overall Study|Physician Decision|4|||
94736754|NCT00429364|324493143|FG001|Overall Study|Physician Decision|2|||
94736755|NCT00429364|324493142|FG000|Overall Study|Lost to Follow-up|7|||
94736756|NCT00429364|324493143|FG001|Overall Study|Lost to Follow-up|6|||
94736757|NCT00429364|324493142|FG000|Overall Study|Death|0|||
94736758|NCT00429364|324493143|FG001|Overall Study|Death|1|||
94736759|NCT00429364|324493142|FG000|Overall Study|Underwent aortic root surgery|10|||
94736760|NCT00429364|324493143|FG001|Overall Study|Underwent aortic root surgery|18|||
94736761|NCT00429364|324493142|FG000|Overall Study|Pregnancy|0|||
94736762|NCT00429364|324493143|FG001|Overall Study|Pregnancy|1|||
94736763|NCT04871529|324493144|FG000|Overall Study|Withdrawal by Subject|0|||
94736764|NCT04871529|324493145|FG001|Overall Study|Withdrawal by Subject|1|||
94736765|NCT04871529|324493144|FG000|Overall Study|Death|0|||
94736766|NCT04871529|324493145|FG001|Overall Study|Death|1|||
94736767|NCT04871529|324493144|FG000|Overall Study|Not protocol specified|0|||
94736768|NCT04871529|324493145|FG001|Overall Study|Not protocol specified|1|||
94736769|NCT05586490|324493146|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
94736770|NCT05586490|324493147|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
94736771|NCT05586490|324493148|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
94736772|NCT05586490|324493149|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
94736773|NCT05586490|324493150|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
94736774|NCT05586490|324493146|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
94736775|NCT05586490|324493147|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
94736776|NCT05586490|324493148|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
94736777|NCT05586490|324493149|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
94736778|NCT05586490|324493150|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
94736779|NCT05586490|324493146|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
94736780|NCT05586490|324493147|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
94736781|NCT05586490|324493148|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
94736782|NCT05586490|324493149|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
94736783|NCT05586490|324493150|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
94736784|NCT04689256|324493153|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
94736785|NCT04689256|324493154|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
94736786|NCT04862234|324493155|FG000|Overall Study|Surgery cancellation|1|||
94736787|NCT04862234|324493156|FG001|Overall Study|Surgery cancellation|2|||
94736788|NCT04862234|324493155|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
94736789|NCT04862234|324493156|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
94736790|NCT04862234|324493155|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
94736791|NCT04862234|324493156|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
94736792|NCT05267470|324493157|FG000|Overall Study|Decision by sponsor|0|||
94736793|NCT05267470|324493158|FG001|Overall Study|Decision by sponsor|3|||
94736794|NCT05267470|324493159|FG002|Overall Study|Decision by sponsor|19|||
94736795|NCT05267470|324493160|FG003|Overall Study|Decision by sponsor|7|||
94736796|NCT05267470|324493161|FG004|Overall Study|Decision by sponsor|3|||
94736797|NCT05267470|324493157|FG000|Overall Study|Withdrawal by Subject|1|||
94736798|NCT05267470|324493158|FG001|Overall Study|Withdrawal by Subject|1|||
94736799|NCT05267470|324493159|FG002|Overall Study|Withdrawal by Subject|2|||
94736800|NCT05267470|324493160|FG003|Overall Study|Withdrawal by Subject|2|||
94736801|NCT05267470|324493161|FG004|Overall Study|Withdrawal by Subject|0|||
94736802|NCT05267470|324493157|FG000|Overall Study|Death|3|||
94736803|NCT05267470|324493158|FG001|Overall Study|Death|5|||
94736804|NCT05267470|324493159|FG002|Overall Study|Death|8|||
94736805|NCT05267470|324493160|FG003|Overall Study|Death|18|||
94736806|NCT05267470|324493161|FG004|Overall Study|Death|1|||
94736807|NCT05267470|324493157|FG000|Overall Study|Lost to Follow-up|0|||
94736808|NCT05267470|324493158|FG001|Overall Study|Lost to Follow-up|0|||
94736809|NCT05267470|324493159|FG002|Overall Study|Lost to Follow-up|0|||
94736810|NCT05267470|324493160|FG003|Overall Study|Lost to Follow-up|1|||
94736811|NCT05267470|324493161|FG004|Overall Study|Lost to Follow-up|0|||
94275550|NCT02104583|322802426|FG000|Overall Study|Adverse Event|3|||
94275551|NCT02104583|322802427|FG001|Overall Study|Adverse Event|3|||
94275552|NCT02104583|322802428|FG002|Overall Study|Adverse Event|6|||
94275553|NCT02104583|322802429|FG003|Overall Study|Adverse Event|6|||
94275554|NCT02104583|322802430|FG004|Overall Study|Adverse Event|1|||
94275555|NCT02104583|322802426|FG000|Overall Study|Lost to Follow-up|1|||
94368871|NCT01364298|323136562|FG000|Overall Study|Lack of adherence to treatment|1|||
94368872|NCT01364298|323136563|FG001|Overall Study|Lack of adherence to treatment|3|||
94368873|NCT01364298|323136562|FG000|Overall Study|Lack of Efficacy|1|||
94368874|NCT01364298|323136563|FG001|Overall Study|Lack of Efficacy|0|||
94368875|NCT01364298|323136562|FG000|Overall Study|Lost to Follow-up|5|||
94736812|NCT05828017|324493162|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
94736813|NCT02142803|324493163|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
94736814|NCT02142803|324493164|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
94736815|NCT02142803|324493165|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
94736816|NCT02142803|324493166|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
94736817|NCT04132518|324493173|FG000|Overall Study|Prematurely withdrawn from the study|0|||
94736818|NCT04132518|324493174|FG001|Overall Study|Prematurely withdrawn from the study|9|||
94736819|NCT04132518|324493175|FG002|Overall Study|Prematurely withdrawn from the study|1|||
94736820|NCT05425420|324493176|FG000|Overall Study|Physician Decision|1|||
94736821|NCT05425420|324493176|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
94736822|NCT04428203|324493178|FG000|Overall Study|Adverse Event|1|||
94736823|NCT04428203|324493179|FG001|Overall Study|Adverse Event|0|||
94736824|NCT04428203|324493180|FG002|Overall Study|Adverse Event|0|||
94736825|NCT04428203|324493178|FG000|Overall Study|Withdrawal by Subject|1|||
94736826|NCT04428203|324493179|FG001|Overall Study|Withdrawal by Subject|0|||
94736827|NCT04428203|324493180|FG002|Overall Study|Withdrawal by Subject|1|||
94736828|NCT04056611|324493183|FG000|Overall Study|Physician Decision|1|||
94736829|NCT03733925|324493184|FG000|Overall Study|Lost to Follow-up|1|||
94736830|NCT03733925|324493184|FG000|Overall Study|Withdrawal by Subject|2|||
94736831|NCT03733925|324493184|FG000|Overall Study|Adverse Event|2|||
94736832|NCT03733925|324493184|FG000|Overall Study|Non-Compliance with Study Drug|1|||
94736833|NCT03213873|324493185|FG000|Overall Study|Withdrawal by Subject|8|||
94736834|NCT03213873|324493186|FG001|Overall Study|Withdrawal by Subject|9|||
94736835|NCT03213873|324493185|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
94736836|NCT03213873|324493186|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
94736837|NCT03213873|324493185|FG000|Overall Study|Lost to Follow-up|0|||
94736838|NCT03213873|324493186|FG001|Overall Study|Lost to Follow-up|2|||
94736839|NCT02676973|324493187|FG000|Overall Study|Withdrawal by Subject|9|||
94736840|NCT02676973|324493188|FG001|Overall Study|Withdrawal by Subject|8|||
94736841|NCT02676973|324493189|FG002|Overall Study|Withdrawal by Subject|11|||
94736842|NCT02676973|324493187|FG000|Overall Study|Lost to Follow-up|8|||
94736843|NCT02676973|324493188|FG001|Overall Study|Lost to Follow-up|12|||
94736844|NCT02676973|324493189|FG002|Overall Study|Lost to Follow-up|8|||
94736845|NCT02676973|324493187|FG000|Overall Study|Death|2|||
94736846|NCT02676973|324493188|FG001|Overall Study|Death|1|||
94736847|NCT02676973|324493189|FG002|Overall Study|Death|5|||
94736848|NCT04571619|324493190|FG000|Phase 1|Death|22|||
94736849|NCT04571619|324493191|FG001|Phase 1|Death|18|||
94736850|NCT04571619|324493190|FG000|Phase 1|Withdrawal by Subject|7|||
94736851|NCT04571619|324493191|FG001|Phase 1|Withdrawal by Subject|2|||
94736852|NCT04571619|324493190|FG000|Phase 2|Death|13|||
94736853|NCT04571619|324493191|FG001|Phase 2|Death|16|||
94736854|NCT04571619|324493190|FG000|Phase 2|Withdrawal by Subject|6|||
94736855|NCT04571619|324493191|FG001|Phase 2|Withdrawal by Subject|4|||
94736856|NCT04709419|324493193|FG000|Overall Study|Physician Decision|1|||
94736857|NCT04709419|324493194|FG001|Overall Study|Physician Decision|0|||
94736858|NCT05683340|324493195|FG000|Overall Study|Adverse Event|1|||
94736859|NCT05683340|324493196|FG001|Overall Study|Adverse Event|1|||
94736860|NCT05683340|324493195|FG000|Overall Study|Protocol Violation|1|||
94736861|NCT05683340|324493196|FG001|Overall Study|Protocol Violation|0|||
94736862|NCT05683340|324493195|FG000|Overall Study|Withdrawal by Subject|0|||
94736863|NCT05683340|324493196|FG001|Overall Study|Withdrawal by Subject|2|||
94736864|NCT03536884|324493199|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
94736865|NCT03536884|324493200|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
94736866|NCT03536884|324493201|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
94736867|NCT03536884|324493202|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
94736868|NCT03536884|324493203|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
94736869|NCT03536884|324493204|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
94736870|NCT03536884|324493205|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
94736871|NCT03536884|324493206|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
94736872|NCT03536884|324493207|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
94736873|NCT03536884|324493208|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
94736874|NCT03536884|324493209|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
94736875|NCT03536884|324493210|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
94736876|NCT03536884|324493199|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
94736877|NCT03536884|324493200|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
94736878|NCT03536884|324493201|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
94736879|NCT03536884|324493202|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
94736880|NCT03536884|324493203|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
94275556|NCT02104583|322802427|FG001|Overall Study|Lost to Follow-up|0|||
94736881|NCT03536884|324493204|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
94736882|NCT03536884|324493205|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
94736883|NCT03536884|324493206|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
94736884|NCT03536884|324493207|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
94736885|NCT03536884|324493208|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
94736886|NCT03536884|324493209|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
94736887|NCT03536884|324493210|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
94736888|NCT03536884|324493199|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
94736889|NCT03536884|324493200|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
94736890|NCT03536884|324493201|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
94736891|NCT03536884|324493202|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
94736892|NCT03536884|324493203|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
94736893|NCT03536884|324493204|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
94736894|NCT03536884|324493205|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
94736895|NCT03536884|324493206|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
94736896|NCT03536884|324493207|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
94736897|NCT03536884|324493208|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
94736898|NCT03536884|324493209|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
94736899|NCT03536884|324493210|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
94736900|NCT03536884|324493199|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
94736901|NCT03536884|324493200|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
94736902|NCT03536884|324493201|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
94736903|NCT03536884|324493202|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
94736904|NCT03536884|324493203|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
94736905|NCT03536884|324493204|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
94736906|NCT03536884|324493205|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
94736907|NCT03536884|324493206|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
94736908|NCT03536884|324493207|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
94736909|NCT03536884|324493208|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
94736910|NCT03536884|324493209|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
94736911|NCT03536884|324493210|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
94736912|NCT03536884|324493199|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
94736913|NCT03536884|324493200|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
94736914|NCT03536884|324493201|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
94736915|NCT03536884|324493202|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
94736916|NCT03536884|324493203|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
94736917|NCT03536884|324493204|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
94736918|NCT03536884|324493205|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
94736919|NCT03536884|324493206|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
94736920|NCT03536884|324493207|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
94736921|NCT03536884|324493208|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
94736922|NCT03536884|324493209|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
94736923|NCT03536884|324493210|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
94736924|NCT03536884|324493199|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
94736925|NCT03536884|324493200|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
94736926|NCT03536884|324493201|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
94736927|NCT03536884|324493202|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
94736928|NCT03536884|324493203|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
94736929|NCT03536884|324493204|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
94736930|NCT03536884|324493205|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
94736931|NCT03536884|324493206|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
94736932|NCT03536884|324493207|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
94736933|NCT03536884|324493208|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
94736934|NCT03536884|324493209|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
94736935|NCT03536884|324493210|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
94736936|NCT03536884|324493199|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
94736937|NCT03536884|324493200|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
94736938|NCT03536884|324493201|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
94275557|NCT02104583|322802428|FG002|Overall Study|Lost to Follow-up|0|||
94736939|NCT03536884|324493202|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
94736940|NCT03536884|324493203|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
94736941|NCT03536884|324493204|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
94736942|NCT03536884|324493205|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
94736943|NCT03536884|324493206|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
94736944|NCT03536884|324493207|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
94736945|NCT03536884|324493208|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
94736946|NCT03536884|324493209|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
94736947|NCT03536884|324493210|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
94736948|NCT03536884|324493199|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
94368876|NCT01364298|323136563|FG001|Overall Study|Lost to Follow-up|10|||
94736949|NCT03536884|324493200|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
94736950|NCT03536884|324493201|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
94736951|NCT03536884|324493202|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
94736952|NCT03536884|324493203|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
94736953|NCT03536884|324493204|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
94736954|NCT03536884|324493205|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
94736955|NCT03536884|324493206|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
94736956|NCT03536884|324493207|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
94736957|NCT03536884|324493208|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
94736958|NCT03536884|324493209|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
94736959|NCT03536884|324493210|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
94736960|NCT03536884|324493199|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
94736961|NCT03536884|324493200|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
94736962|NCT03536884|324493201|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
94736963|NCT03536884|324493202|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
94736964|NCT03536884|324493203|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
94736965|NCT03536884|324493204|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
94736966|NCT03536884|324493205|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
94736967|NCT03536884|324493206|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
94736968|NCT03536884|324493207|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
94736969|NCT03536884|324493208|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
94736970|NCT03536884|324493209|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
94736971|NCT03536884|324493210|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
94736972|NCT03536884|324493199|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
94736973|NCT03536884|324493200|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
94736974|NCT03536884|324493201|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
94736975|NCT03536884|324493202|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
94736976|NCT03536884|324493203|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
94736977|NCT03536884|324493204|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
94736978|NCT03536884|324493205|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
94736979|NCT03536884|324493206|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
94736980|NCT03536884|324493207|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
94736981|NCT03536884|324493208|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
94736982|NCT03536884|324493209|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
94736983|NCT03536884|324493210|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
94736984|NCT03536884|324493199|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
94736985|NCT03536884|324493200|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
94736986|NCT03536884|324493201|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
94736987|NCT03536884|324493202|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
94736988|NCT03536884|324493203|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
94736989|NCT03536884|324493204|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
94736990|NCT03536884|324493205|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
94736991|NCT03536884|324493206|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
94736992|NCT03536884|324493207|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
94736993|NCT03536884|324493208|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
94736994|NCT03536884|324493209|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
94736995|NCT03536884|324493210|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
94736996|NCT03536884|324493199|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
94736997|NCT03536884|324493200|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
94736998|NCT03536884|324493201|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
94736999|NCT03536884|324493202|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
94737000|NCT03536884|324493203|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
94737001|NCT03536884|324493204|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
94737002|NCT03536884|324493205|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
94737003|NCT03536884|324493206|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
94737004|NCT03536884|324493207|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
94737005|NCT03536884|324493208|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
94737006|NCT03536884|324493209|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
94737007|NCT03536884|324493210|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
94737008|NCT03536884|324493199|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
94737009|NCT03536884|324493200|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
94737010|NCT03536884|324493201|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
94737011|NCT03536884|324493202|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
94737012|NCT03536884|324493203|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
94737013|NCT03536884|324493204|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
94737014|NCT03536884|324493205|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
94737015|NCT03536884|324493206|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
94737016|NCT03536884|324493207|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
94737017|NCT03536884|324493208|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
94737018|NCT03536884|324493209|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
94737019|NCT03536884|324493210|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
94737020|NCT03536884|324493199|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
94737021|NCT03536884|324493200|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
94737022|NCT03536884|324493201|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
94275558|NCT02104583|322802429|FG003|Overall Study|Lost to Follow-up|0|||
94275559|NCT02104583|322802430|FG004|Overall Study|Lost to Follow-up|0|||
94275560|NCT02104583|322802426|FG000|Overall Study|Randomized but Never Treated|0|||
94368877|NCT01364298|323136562|FG000|Overall Study|Withdrawal by Subject|3|||
94368878|NCT01364298|323136563|FG001|Overall Study|Withdrawal by Subject|3|||
94737023|NCT03536884|324493202|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
94737024|NCT03536884|324493203|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
94737025|NCT03536884|324493204|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
94737026|NCT03536884|324493205|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
94368879|NCT01364298|323136562|FG000|Overall Study|Other|1|||
94368880|NCT01364298|323136563|FG001|Overall Study|Other|3|||
94737027|NCT03536884|324493206|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
94737028|NCT03536884|324493207|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
94737029|NCT03536884|324493208|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
94737030|NCT03536884|324493209|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
94737031|NCT03536884|324493210|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
94737032|NCT03536884|324493199|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
94737033|NCT03536884|324493200|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
94737034|NCT03536884|324493201|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
94737035|NCT03536884|324493202|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
94737036|NCT03536884|324493203|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
94737037|NCT03536884|324493204|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
94737038|NCT03536884|324493205|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
94737039|NCT03536884|324493206|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
94737040|NCT03536884|324493207|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
94737041|NCT03536884|324493208|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
94737042|NCT03536884|324493209|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
94737043|NCT03536884|324493210|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
94737044|NCT03536884|324493199|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
94737045|NCT03536884|324493200|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
94737046|NCT03536884|324493201|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
94737047|NCT03536884|324493202|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
94737048|NCT03536884|324493203|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
94737049|NCT03536884|324493204|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
94737050|NCT03536884|324493205|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
94737051|NCT03536884|324493206|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
94737052|NCT03536884|324493207|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
94737053|NCT03536884|324493208|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
94737054|NCT03536884|324493209|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
94737055|NCT03536884|324493210|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
94737056|NCT03536884|324493199|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
94737057|NCT03536884|324493200|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
94737058|NCT03536884|324493201|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
94737059|NCT03536884|324493202|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
94737060|NCT03536884|324493203|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
94737061|NCT03536884|324493204|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
94737062|NCT03536884|324493205|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
94368881|NCT03707522|323136564|FG000|Overall Study|Lost to Follow-up|24|||
94737063|NCT03536884|324493206|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
94737064|NCT03536884|324493207|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
94737065|NCT03536884|324493208|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
94737066|NCT03536884|324493209|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
94737067|NCT03536884|324493210|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
94737068|NCT03536884|324493199|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
94737069|NCT03536884|324493200|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
94737070|NCT03536884|324493201|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
94737071|NCT03536884|324493202|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
94737072|NCT03536884|324493203|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
94737073|NCT03536884|324493204|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
94737074|NCT03536884|324493205|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
94737075|NCT03536884|324493206|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
94737076|NCT03536884|324493207|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
94737077|NCT03536884|324493208|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
94737078|NCT03536884|324493209|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
94737079|NCT03536884|324493210|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
94737080|NCT03536884|324493199|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
94467487|NCT01416155|323500582|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
94737081|NCT03536884|324493200|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
94737082|NCT03536884|324493201|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
94737083|NCT03536884|324493202|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
94737084|NCT03536884|324493203|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
94737085|NCT03536884|324493204|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
94737086|NCT03536884|324493205|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
94737087|NCT03536884|324493206|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
94737088|NCT03536884|324493207|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
94737089|NCT03536884|324493208|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
94737090|NCT03536884|324493209|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
94737091|NCT03536884|324493210|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
94737092|NCT03536884|324493199|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
94737093|NCT03536884|324493200|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
94737094|NCT03536884|324493201|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
94737095|NCT03536884|324493202|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
94737096|NCT03536884|324493203|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
94737097|NCT03536884|324493204|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
94737098|NCT03536884|324493205|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
94737099|NCT03536884|324493206|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
94737100|NCT03536884|324493207|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
94737101|NCT03536884|324493208|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
94737102|NCT03536884|324493209|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
94737103|NCT03536884|324493210|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
94737104|NCT03536884|324493199|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
94737105|NCT03536884|324493200|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
94737106|NCT03536884|324493201|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
94737107|NCT03536884|324493202|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
94737108|NCT03536884|324493203|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
94737109|NCT03536884|324493204|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
94737110|NCT03536884|324493205|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
94737111|NCT03536884|324493206|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
94737112|NCT03536884|324493207|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
94737113|NCT03536884|324493208|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
94737114|NCT03536884|324493209|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
94737115|NCT03536884|324493210|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
94737116|NCT03536884|324493199|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
94737117|NCT03536884|324493200|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
94737118|NCT03536884|324493201|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
94737119|NCT03536884|324493202|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
94737120|NCT03536884|324493203|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
94737121|NCT03536884|324493204|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
94737122|NCT03536884|324493205|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
94737123|NCT03536884|324493206|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
94737124|NCT03536884|324493207|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
94737125|NCT03536884|324493208|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
94737126|NCT03536884|324493209|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
94737127|NCT03536884|324493210|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
94737128|NCT03536884|324493199|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
94737129|NCT03536884|324493200|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
94737130|NCT03536884|324493201|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
94737131|NCT03536884|324493202|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
94737132|NCT03536884|324493203|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
94737133|NCT03536884|324493204|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
94737134|NCT03536884|324493205|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
94737135|NCT03536884|324493206|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
94737136|NCT03536884|324493207|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
94737137|NCT03536884|324493208|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
94737138|NCT03536884|324493209|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
94368882|NCT03707522|323136565|FG001|Overall Study|Lost to Follow-up|27|||
94737139|NCT03536884|324493210|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
94737140|NCT03536884|324493199|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
94737141|NCT03536884|324493200|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
94737142|NCT03536884|324493201|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
94737143|NCT03536884|324493202|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
94737144|NCT03536884|324493203|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
94737145|NCT03536884|324493204|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
94737146|NCT03536884|324493205|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
94737147|NCT03536884|324493206|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
94737148|NCT03536884|324493207|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
94737149|NCT03536884|324493208|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
94737150|NCT03536884|324493209|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
94737151|NCT03536884|324493210|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
94737152|NCT03536884|324493199|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
94737153|NCT03536884|324493200|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
94737154|NCT03536884|324493201|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
94737155|NCT03536884|324493202|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
94737156|NCT03536884|324493203|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
94737157|NCT03536884|324493204|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
94737158|NCT03536884|324493205|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
94737159|NCT03536884|324493206|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
94737160|NCT03536884|324493207|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
94737161|NCT03536884|324493208|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
94737162|NCT03536884|324493209|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
94737163|NCT03536884|324493210|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
94737164|NCT03536884|324493199|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
94737165|NCT03536884|324493200|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
94737166|NCT03536884|324493201|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
94737167|NCT03536884|324493202|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
94737168|NCT03536884|324493203|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
94737169|NCT03536884|324493204|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
94275561|NCT02104583|322802427|FG001|Overall Study|Randomized but Never Treated|0|||
94737170|NCT03536884|324493205|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
94737171|NCT03536884|324493206|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
94737172|NCT03536884|324493207|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
94737173|NCT03536884|324493208|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
94737174|NCT03536884|324493209|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
94737175|NCT03536884|324493210|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
94737176|NCT02003924|324493211|FG000|Double-blind Phase|Lost to Follow-up|2|||
94737177|NCT02003924|324493212|FG001|Double-blind Phase|Lost to Follow-up|1|||
94737178|NCT02003924|324493213|FG002|Double-blind Phase|Lost to Follow-up|0|||
94737179|NCT02003924|324493211|FG000|Double-blind Phase|Protocol Violation|1|||
94737180|NCT02003924|324493212|FG001|Double-blind Phase|Protocol Violation|2|||
94737181|NCT02003924|324493213|FG002|Double-blind Phase|Protocol Violation|0|||
94737182|NCT02003924|324493211|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
94737183|NCT02003924|324493212|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
94737184|NCT02003924|324493213|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
94737185|NCT02003924|324493211|FG000|Double-blind Phase|Disease Progression|229|||
94737186|NCT02003924|324493212|FG001|Double-blind Phase|Disease Progression|247|||
94737187|NCT02003924|324493213|FG002|Double-blind Phase|Disease Progression|0|||
94737188|NCT02003924|324493211|FG000|Double-blind Phase|Adverse Event|120|||
94737189|NCT02003924|324493212|FG001|Double-blind Phase|Adverse Event|31|||
94737190|NCT02003924|324493213|FG002|Double-blind Phase|Adverse Event|0|||
94737191|NCT02003924|324493211|FG000|Double-blind Phase|Randomized But not Treated|3|||
94737192|NCT02003924|324493212|FG001|Double-blind Phase|Randomized But not Treated|3|||
94737193|NCT02003924|324493213|FG002|Double-blind Phase|Randomized But not Treated|0|||
94737194|NCT02003924|324493211|FG000|Double-blind Phase|Other|29|||
94737195|NCT02003924|324493212|FG001|Double-blind Phase|Other|50|||
94737196|NCT02003924|324493213|FG002|Double-blind Phase|Other|0|||
94737197|NCT02003924|324493211|FG000|Open-label Phase|Lost to Follow-up|0|||
94737198|NCT02003924|324493212|FG001|Open-label Phase|Lost to Follow-up|0|||
94737199|NCT02003924|324493213|FG002|Open-label Phase|Lost to Follow-up|1|||
94737200|NCT02003924|324493211|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
94737201|NCT02003924|324493212|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
94737202|NCT02003924|324493213|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
94737203|NCT02003924|324493211|FG000|Open-label Phase|Disease Progression|59|||
94737204|NCT02003924|324493212|FG001|Open-label Phase|Disease Progression|0|||
94737205|NCT02003924|324493213|FG002|Open-label Phase|Disease Progression|5|||
94737206|NCT02003924|324493211|FG000|Open-label Phase|Adverse Event|25|||
94737207|NCT02003924|324493212|FG001|Open-label Phase|Adverse Event|0|||
94737208|NCT02003924|324493213|FG002|Open-label Phase|Adverse Event|10|||
94737209|NCT02003924|324493211|FG000|Open-label Phase|Other|7|||
94737210|NCT02003924|324493212|FG001|Open-label Phase|Other|0|||
94737211|NCT02003924|324493213|FG002|Open-label Phase|Other|0|||
94737212|NCT02003924|324493211|FG000|Long-term Follow-up Phase|Death|288|||
94737213|NCT02003924|324493212|FG001|Long-term Follow-up Phase|Death|174|||
94275562|NCT02104583|322802428|FG002|Overall Study|Randomized but Never Treated|0|||
94275563|NCT02104583|322802429|FG003|Overall Study|Randomized but Never Treated|1|||
94275564|NCT02104583|322802430|FG004|Overall Study|Randomized but Never Treated|0|||
94737214|NCT02003924|324493213|FG002|Long-term Follow-up Phase|Death|4|||
94737215|NCT02003924|324493211|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
94275565|NCT02347098|322802431|FG000|Overall Study|Death|1|||
94275566|NCT02347098|322802432|FG001|Overall Study|Death|0|||
94737216|NCT02003924|324493212|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
94737217|NCT02003924|324493213|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
94737218|NCT02003924|324493211|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
94737219|NCT02003924|324493212|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
94737220|NCT02003924|324493213|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
94737221|NCT02003924|324493211|FG000|Long-term Follow-up Phase|Other|5|||
94737222|NCT02003924|324493212|FG001|Long-term Follow-up Phase|Other|2|||
94368883|NCT03707522|323136566|FG002|Overall Study|Lost to Follow-up|41|||
94368884|NCT03707522|323136567|FG003|Overall Study|Lost to Follow-up|36|||
94368885|NCT00420849|323136571|FG000|Overall Study|Lack of Efficacy|154|||
94368886|NCT00420849|323136571|FG000|Overall Study|Adverse Event|107|||
94368887|NCT00420849|323136571|FG000|Overall Study|Withdrawal by Subject|28|||
94368888|NCT00420849|323136571|FG000|Overall Study|Death|18|||
94368889|NCT00420849|323136571|FG000|Overall Study|Other|14|||
94368890|NCT00420849|323136571|FG000|Overall Study|Transplant|8|||
94368891|NCT00420849|323136571|FG000|Overall Study|Protocol Violation|1|||
94368892|NCT00420849|323136571|FG000|Overall Study|Lost to Follow-up|1|||
94368893|NCT01619085|323136576|FG000|Overall Study|Adverse Event|231|||
94368894|NCT01619085|323136576|FG000|Overall Study|Protocol Violation|4|||
94368895|NCT01619085|323136576|FG000|Overall Study|Lost to Follow-up|3|||
94368896|NCT01619085|323136576|FG000|Overall Study|Withdrawal by Subject|45|||
94368897|NCT01619085|323136576|FG000|Overall Study|Other than specified|96|||
94368898|NCT01619085|323136576|FG000|Overall Study|Not treated|1|||
94368899|NCT01619085|323136576|FG000|Overall Study|Death|145|||
94368900|NCT01169844|323136579|FG000|Overall Study|Adverse Event|0|||
94368901|NCT01169844|323136580|FG001|Overall Study|Adverse Event|1|||
94737223|NCT02003924|324493213|FG002|Long-term Follow-up Phase|Other|1|||
94737224|NCT02865538|324493221|FG000|Overall Study|Withdrawal by Subject|0|||
94737225|NCT02865538|324493222|FG001|Overall Study|Withdrawal by Subject|0|||
94737226|NCT02865538|324493223|FG002|Overall Study|Withdrawal by Subject|1|||
94737227|NCT02865538|324493224|FG003|Overall Study|Withdrawal by Subject|0|||
94737228|NCT02865538|324493225|FG004|Overall Study|Withdrawal by Subject|0|||
94737229|NCT02865538|324493221|FG000|Overall Study|Lost to Follow-up|1|||
94737230|NCT02865538|324493222|FG001|Overall Study|Lost to Follow-up|0|||
94737231|NCT02865538|324493223|FG002|Overall Study|Lost to Follow-up|0|||
94737232|NCT02865538|324493224|FG003|Overall Study|Lost to Follow-up|0|||
94737233|NCT02865538|324493225|FG004|Overall Study|Lost to Follow-up|0|||
94737234|NCT05618587|324494539|FG000|Overall Study|Lost to Follow-up|2|||
94737235|NCT05618587|324494540|FG001|Overall Study|Lost to Follow-up|0|||
94737236|NCT05256654|324494541|FG000|Overall Study|Adverse Event|0|||
94737237|NCT05256654|324494542|FG001|Overall Study|Adverse Event|0|||
94737238|NCT05256654|324494543|FG002|Overall Study|Adverse Event|1|||
94737239|NCT05256654|324494544|FG003|Overall Study|Adverse Event|0|||
94737240|NCT05256654|324494541|FG000|Overall Study|Lost to Follow-up|0|||
94737241|NCT05256654|324494542|FG001|Overall Study|Lost to Follow-up|0|||
94737242|NCT05256654|324494543|FG002|Overall Study|Lost to Follow-up|0|||
94737243|NCT05256654|324494544|FG003|Overall Study|Lost to Follow-up|1|||
94737244|NCT05256654|324494541|FG000|Overall Study|Withdrawal by Subject|1|||
94737245|NCT05256654|324494542|FG001|Overall Study|Withdrawal by Subject|2|||
94737246|NCT05256654|324494543|FG002|Overall Study|Withdrawal by Subject|1|||
94737247|NCT05256654|324494544|FG003|Overall Study|Withdrawal by Subject|3|||
94737248|NCT05256654|324494541|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
94737249|NCT05256654|324494542|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
94737250|NCT05256654|324494543|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
94737251|NCT05256654|324494544|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
94737252|NCT05256654|324494541|FG000|Overall Study|Other|0|||
94737253|NCT05256654|324494542|FG001|Overall Study|Other|0|||
94737254|NCT05256654|324494543|FG002|Overall Study|Other|0|||
94737255|NCT05256654|324494544|FG003|Overall Study|Other|1|||
94737256|NCT04862416|324494549|FG000|Overall Study|Withdrawal by Subject|0|||
94737257|NCT04862416|324494550|FG001|Overall Study|Withdrawal by Subject|1|||
94737258|NCT04862416|324494551|FG002|Overall Study|Withdrawal by Subject|0|||
94737259|NCT04862416|324494552|FG003|Overall Study|Withdrawal by Subject|1|||
94737260|NCT04862416|324494553|FG004|Overall Study|Withdrawal by Subject|0|||
94737261|NCT04862416|324494554|FG005|Overall Study|Withdrawal by Subject|0|||
94737262|NCT04862416|324494555|FG006|Overall Study|Withdrawal by Subject|0|||
94368902|NCT01169844|323136579|FG000|Overall Study|Patient withdrew consent|4|||
94368903|NCT01169844|323136580|FG001|Overall Study|Patient withdrew consent|0|||
94368904|NCT01169844|323136579|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94368905|NCT01169844|323136580|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94368906|NCT04071626|323136581|FG000|Overall Study|Withdrawal by Subject|1|||
94737263|NCT04862416|324494556|FG007|Overall Study|Withdrawal by Subject|0|||
94737264|NCT03442309|324494557|FG000|Overall Study|Lost to Follow-up|1676|||
94737265|NCT03442309|324494558|FG001|Overall Study|Lost to Follow-up|1642|||
94737266|NCT05204654|324494559|FG000|Overall Study|Study terminated due to time restraint|2|||
94737267|NCT05204654|324494560|FG001|Overall Study|Study terminated due to time restraint|2|||
94737268|NCT05207956|324494566|FG000|Overall Study|Lost to follow up|1|||
94737269|NCT05207956|324494567|FG001|Overall Study|Lost to follow up|2|||
94737270|NCT01309672|324494570|FG000|Overall Study|Lack of Efficacy|20|||
94737271|NCT01309672|324494570|FG000|Overall Study|Other|9|||
94737272|NCT01309672|324494570|FG000|Overall Study|Adverse Event|5|||
94737273|NCT01309672|324494570|FG000|Overall Study|Withdrawal by Subject|3|||
94737274|NCT04141891|324494571|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
94737275|NCT04141891|324494572|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
94737276|NCT04141891|324494571|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
94737277|NCT04141891|324494572|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
94737278|NCT04141891|324494571|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
94737279|NCT04141891|324494572|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
94737280|NCT04141891|324494571|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
94737281|NCT04141891|324494572|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
94737282|NCT04141891|324494571|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
94737283|NCT04141891|324494572|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
94737284|NCT04141891|324494571|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
94737285|NCT04141891|324494572|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
94737286|NCT04141891|324494571|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
94737287|NCT04141891|324494572|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
94737288|NCT04141891|324494571|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
94737289|NCT04141891|324494572|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
94737290|NCT04141891|324494571|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
94737291|NCT04141891|324494572|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
94737292|NCT04141891|324494571|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
94737293|NCT04141891|324494572|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
94737294|NCT04141891|324494571|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
94737295|NCT04141891|324494572|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
94737296|NCT04141891|324494571|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
94737297|NCT04141891|324494572|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
94737298|NCT04141891|324494571|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
94737299|NCT04141891|324494572|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
94737300|NCT04141891|324494571|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
94737301|NCT04141891|324494572|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
94737302|NCT01828112|324494576|FG000|Treatment Phase|Adverse Event|7|||
94737303|NCT01828112|324494577|FG001|Treatment Phase|Adverse Event|8|||
94737304|NCT01828112|324494578|FG002|Treatment Phase|Adverse Event|0|||
94737305|NCT01828112|324494576|FG000|Treatment Phase|Death|9|||
94737306|NCT01828112|324494577|FG001|Treatment Phase|Death|5|||
94737307|NCT01828112|324494578|FG002|Treatment Phase|Death|0|||
94737308|NCT01828112|324494576|FG000|Treatment Phase|No longer required treatment|0|||
94737309|NCT01828112|324494577|FG001|Treatment Phase|No longer required treatment|1|||
94737310|NCT01828112|324494578|FG002|Treatment Phase|No longer required treatment|0|||
94737311|NCT01828112|324494576|FG000|Treatment Phase|Physician Decision|6|||
94737312|NCT01828112|324494577|FG001|Treatment Phase|Physician Decision|7|||
94737313|NCT01828112|324494578|FG002|Treatment Phase|Physician Decision|0|||
94737314|NCT01828112|324494576|FG000|Treatment Phase|Pregnancy|1|||
94737315|NCT01828112|324494577|FG001|Treatment Phase|Pregnancy|0|||
94737316|NCT01828112|324494578|FG002|Treatment Phase|Pregnancy|0|||
94737317|NCT01828112|324494576|FG000|Treatment Phase|Progressive disease|79|||
94737318|NCT01828112|324494577|FG001|Treatment Phase|Progressive disease|87|||
94737319|NCT01828112|324494578|FG002|Treatment Phase|Progressive disease|0|||
94737320|NCT01828112|324494576|FG000|Treatment Phase|Study terminated by sponsor|1|||
94737321|NCT01828112|324494577|FG001|Treatment Phase|Study terminated by sponsor|0|||
94737322|NCT01828112|324494578|FG002|Treatment Phase|Study terminated by sponsor|0|||
94737323|NCT01828112|324494576|FG000|Treatment Phase|Subject/guardian decision|12|||
94737324|NCT01828112|324494577|FG001|Treatment Phase|Subject/guardian decision|8|||
94737325|NCT01828112|324494578|FG002|Treatment Phase|Subject/guardian decision|0|||
94737326|NCT01828112|324494576|FG000|Extension Treatment Phase|Adverse Event|0|||
94737327|NCT01828112|324494577|FG001|Extension Treatment Phase|Adverse Event|0|||
94737328|NCT01828112|324494578|FG002|Extension Treatment Phase|Adverse Event|6|||
94737329|NCT01828112|324494576|FG000|Extension Treatment Phase|Death|0|||
94737330|NCT01828112|324494577|FG001|Extension Treatment Phase|Death|0|||
94737331|NCT01828112|324494578|FG002|Extension Treatment Phase|Death|17|||
94737332|NCT01828112|324494576|FG000|Extension Treatment Phase|Physician Decision|0|||
94737333|NCT01828112|324494577|FG001|Extension Treatment Phase|Physician Decision|0|||
94737334|NCT01828112|324494578|FG002|Extension Treatment Phase|Physician Decision|5|||
94737335|NCT01828112|324494576|FG000|Extension Treatment Phase|Progressive disease|0|||
94737336|NCT01828112|324494577|FG001|Extension Treatment Phase|Progressive disease|0|||
94737337|NCT01828112|324494578|FG002|Extension Treatment Phase|Progressive disease|46|||
94737338|NCT01828112|324494576|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
94737339|NCT01828112|324494577|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
94737340|NCT01828112|324494578|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
94737341|NCT01828112|324494576|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
94737342|NCT01828112|324494577|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
94737343|NCT01828112|324494578|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
94737344|NCT01651403|324494581|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
94737345|NCT01651403|324494582|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
94737346|NCT01651403|324494581|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
94737347|NCT01651403|324494582|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
94368907|NCT04071626|323136582|FG001|Overall Study|Withdrawal by Subject|1|||
94368908|NCT04071626|323136581|FG000|Overall Study|Protocol Violation|0|||
94368909|NCT04071626|323136582|FG001|Overall Study|Protocol Violation|1|||
94368910|NCT03120520|323136587|FG000|Overall Study|Lost to Follow-up|1|||
94737348|NCT01651403|324494581|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
94737349|NCT01651403|324494582|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
94737350|NCT01651403|324494581|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
94737351|NCT01651403|324494582|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
94737352|NCT01651403|324494581|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
94737353|NCT01651403|324494582|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
94737354|NCT01651403|324494581|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
94737355|NCT01651403|324494582|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
94737370|NCT05184452|324494585|FG000|Overall Study|Lost to Follow-up|0|||
94737371|NCT05184452|324494586|FG001|Overall Study|Lost to Follow-up|0|||
94737372|NCT05184452|324494587|FG002|Overall Study|Lost to Follow-up|0|||
94737373|NCT05184452|324494588|FG003|Overall Study|Lost to Follow-up|0|||
94737374|NCT05184452|324494589|FG004|Overall Study|Lost to Follow-up|0|||
94737375|NCT05184452|324494590|FG005|Overall Study|Lost to Follow-up|2|||
94737376|NCT05184452|324494591|FG006|Overall Study|Lost to Follow-up|0|||
94737377|NCT05184452|324494592|FG007|Overall Study|Lost to Follow-up|0|||
94737378|NCT05184452|324494593|FG008|Overall Study|Lost to Follow-up|0|||
94737379|NCT05184452|324494594|FG009|Overall Study|Lost to Follow-up|1|||
94737380|NCT05184452|324494585|FG000|Overall Study|Withdrawal by Subject|0|||
94737381|NCT05184452|324494586|FG001|Overall Study|Withdrawal by Subject|0|||
94737382|NCT05184452|324494587|FG002|Overall Study|Withdrawal by Subject|0|||
94737383|NCT05184452|324494588|FG003|Overall Study|Withdrawal by Subject|0|||
94737384|NCT05184452|324494589|FG004|Overall Study|Withdrawal by Subject|0|||
94737385|NCT05184452|324494590|FG005|Overall Study|Withdrawal by Subject|1|||
94737386|NCT05184452|324494591|FG006|Overall Study|Withdrawal by Subject|0|||
94737387|NCT05184452|324494592|FG007|Overall Study|Withdrawal by Subject|0|||
94737388|NCT05184452|324494593|FG008|Overall Study|Withdrawal by Subject|0|||
94737389|NCT05184452|324494594|FG009|Overall Study|Withdrawal by Subject|1|||
94368911|NCT03120520|323136588|FG001|Overall Study|Lost to Follow-up|1|||
94368912|NCT03120520|323136589|FG002|Overall Study|Lost to Follow-up|1|||
94737390|NCT04439201|324494595|FG000|Overall Study|Ineligible|2|||
94737391|NCT04439201|324494595|FG000|Overall Study|Never start protocol therapy|1|||
94737392|NCT04439201|324494595|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
94737393|NCT04439201|324494595|FG000|Overall Study|Mutation status not confirmed|4|||
94737394|NCT04439201|324494595|FG000|Overall Study|Adverse Event|1|||
94737395|NCT04439201|324494595|FG000|Overall Study|Death|7|||
94737396|NCT04439201|324494595|FG000|Overall Study|Withdrawal by Subject|2|||
94737397|NCT04439201|324494595|FG000|Overall Study|Disease progression|20|||
94737398|NCT04439201|324494595|FG000|Overall Study|Alternative therapy|1|||
94737399|NCT04439201|324494595|FG000|Overall Study|Physician Decision|1|||
94368913|NCT03120520|323136590|FG003|Overall Study|Lost to Follow-up|1|||
94737400|NCT05280574|324494599|FG000|Overall Study|Withdrawal by Subject|0|||
94737401|NCT05280574|324494600|FG001|Overall Study|Withdrawal by Subject|2|||
94737402|NCT05280574|324494601|FG002|Overall Study|Withdrawal by Subject|0|||
94737403|NCT03505008|324494602|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
94737404|NCT03505008|324494603|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
94737405|NCT03505008|324494604|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
94737406|NCT03505008|324494605|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
94737407|NCT03505008|324494602|FG000|Before Week 24 Randomization|Adverse Event|10|||
94737408|NCT03505008|324494603|FG001|Before Week 24 Randomization|Adverse Event|0|||
94737409|NCT03505008|324494604|FG002|Before Week 24 Randomization|Adverse Event|0|||
94737410|NCT03505008|324494605|FG003|Before Week 24 Randomization|Adverse Event|0|||
94737411|NCT03505008|324494602|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
94737412|NCT03505008|324494603|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
94737413|NCT03505008|324494604|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
94737414|NCT03505008|324494605|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
94737415|NCT03505008|324494602|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
94737416|NCT03505008|324494603|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
94737417|NCT03505008|324494604|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
94737418|NCT03505008|324494605|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
94737419|NCT03505008|324494602|FG000|Before Week 24 Randomization|Physician Decision|2|||
94737420|NCT03505008|324494603|FG001|Before Week 24 Randomization|Physician Decision|0|||
94737421|NCT03505008|324494604|FG002|Before Week 24 Randomization|Physician Decision|0|||
94737422|NCT03505008|324494605|FG003|Before Week 24 Randomization|Physician Decision|0|||
94737423|NCT03505008|324494602|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
94737424|NCT03505008|324494603|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
94737425|NCT03505008|324494604|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
94737426|NCT03505008|324494605|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
94737427|NCT03505008|324494602|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
94737428|NCT03505008|324494603|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
94737429|NCT03505008|324494604|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
94737430|NCT03505008|324494605|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
94737431|NCT03505008|324494602|FG000|Before Week 24 Randomization|Complication|1|||
94737432|NCT03505008|324494603|FG001|Before Week 24 Randomization|Complication|0|||
94737433|NCT03505008|324494604|FG002|Before Week 24 Randomization|Complication|0|||
94737434|NCT03505008|324494605|FG003|Before Week 24 Randomization|Complication|0|||
94737435|NCT03505008|324494602|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
94737436|NCT03505008|324494603|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
94737437|NCT03505008|324494604|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
94737438|NCT03505008|324494605|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
94737439|NCT03505008|324494602|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
94737440|NCT03505008|324494603|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
94737441|NCT03505008|324494604|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
94737442|NCT03505008|324494605|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
94737443|NCT03505008|324494602|FG000|After Week 24 Randomization|Adverse Event|0|||
94737444|NCT03505008|324494603|FG001|After Week 24 Randomization|Adverse Event|1|||
94737445|NCT03505008|324494604|FG002|After Week 24 Randomization|Adverse Event|2|||
94737446|NCT03505008|324494605|FG003|After Week 24 Randomization|Adverse Event|2|||
94737447|NCT03505008|324494602|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
94737448|NCT03505008|324494603|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
94737449|NCT03505008|324494604|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
94737450|NCT03505008|324494605|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
94737451|NCT03505008|324494602|FG000|After Week 24 Randomization|Protocol Violation|0|||
94737452|NCT03505008|324494603|FG001|After Week 24 Randomization|Protocol Violation|0|||
94737453|NCT03505008|324494604|FG002|After Week 24 Randomization|Protocol Violation|1|||
94737454|NCT03505008|324494605|FG003|After Week 24 Randomization|Protocol Violation|0|||
94737455|NCT02619682|324494606|FG000|Overall Study|Withdrawal by Subject|3|||
94737456|NCT02619682|324494606|FG000|Overall Study|Lack of Efficacy|8|||
94737457|NCT02619682|324494606|FG000|Overall Study|new secondary cancer|1|||
94737458|NCT02619682|324494606|FG000|Overall Study|post surgery complications|2|||
94737459|NCT05524116|324494612|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
94737460|NCT05524116|324494613|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
94737461|NCT05524116|324494612|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
94737462|NCT05524116|324494613|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
94737463|NCT05524116|324494612|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
94737464|NCT05524116|324494613|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
94737465|NCT05524116|324494612|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
94737466|NCT05524116|324494613|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
94737467|NCT05524116|324494612|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
94737468|NCT05524116|324494613|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
94737469|NCT03118518|324494623|FG000|Overall Study|Early Exit after treatment|2|||
94737470|NCT03118518|324494624|FG001|Overall Study|Early Exit after treatment|8|||
94737471|NCT03118518|324494623|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
94737472|NCT03118518|324494624|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
94737473|NCT03485729|324494634|FG000|Overall Study|Withdrawal by Subject|0|||
94737474|NCT03485729|324494635|FG001|Overall Study|Withdrawal by Subject|0|||
94737475|NCT03485729|324494636|FG002|Overall Study|Withdrawal by Subject|1|||
94737476|NCT03485729|324494634|FG000|Overall Study|Disease progression|8|||
94737477|NCT03485729|324494635|FG001|Overall Study|Disease progression|13|||
94737478|NCT03485729|324494636|FG002|Overall Study|Disease progression|1|||
94737479|NCT03485729|324494634|FG000|Overall Study|Hospice care|1|||
94737480|NCT03485729|324494635|FG001|Overall Study|Hospice care|0|||
94737481|NCT03485729|324494636|FG002|Overall Study|Hospice care|0|||
94737482|NCT03485729|324494634|FG000|Overall Study|Poor performance status|1|||
94737483|NCT03485729|324494635|FG001|Overall Study|Poor performance status|0|||
94368914|NCT03120520|323136587|FG000|Overall Study|Withdrawal by Subject|3|||
94368915|NCT03120520|323136588|FG001|Overall Study|Withdrawal by Subject|2|||
94737484|NCT03485729|324494636|FG002|Overall Study|Poor performance status|0|||
94368916|NCT03120520|323136589|FG002|Overall Study|Withdrawal by Subject|3|||
94368917|NCT03120520|323136590|FG003|Overall Study|Withdrawal by Subject|2|||
94368918|NCT03120520|323136587|FG000|Overall Study|Other|0|||
94368919|NCT03120520|323136588|FG001|Overall Study|Other|1|||
94368920|NCT03120520|323136589|FG002|Overall Study|Other|0|||
94737485|NCT03485729|324494634|FG000|Overall Study|Illness|0|||
94737486|NCT03485729|324494635|FG001|Overall Study|Illness|1|||
94737487|NCT03485729|324494636|FG002|Overall Study|Illness|0|||
94737488|NCT04880733|324494637|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
94737489|NCT04880733|324494638|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
94737490|NCT04880733|324494639|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
94737491|NCT04880733|324494637|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
94737492|NCT04880733|324494638|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
94737493|NCT04880733|324494639|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
94737494|NCT04880733|324494637|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
94737495|NCT04880733|324494638|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
94737496|NCT04880733|324494639|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
94737497|NCT04880733|324494637|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
94737498|NCT04880733|324494638|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
94737499|NCT04880733|324494639|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
94737500|NCT04880733|324494637|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
94737501|NCT04880733|324494638|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
94737502|NCT04880733|324494639|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
94737503|NCT05172232|324494642|FG000|Overall Study|Lost to Follow-up|3|||
94737504|NCT01828021|324494643|FG000|Overall Study|Adverse Event|5|||
94737505|NCT01828021|324494643|FG000|Overall Study|Lack of Efficacy|17|||
94737506|NCT01828021|324494643|FG000|Overall Study|Withdrawal by Subject|2|||
94737507|NCT01828021|324494643|FG000|Overall Study|Ileal obstruction, unrelated|1|||
94737508|NCT04456296|324494644|FG000|Overall Study|Withdrawal by Subject|14|||
94737509|NCT04456296|324494645|FG001|Overall Study|Withdrawal by Subject|21|||
94737510|NCT04456296|324494646|FG002|Overall Study|Withdrawal by Subject|21|||
94737511|NCT04456296|324494644|FG000|Overall Study|Adverse Event|2|||
94737512|NCT04456296|324494645|FG001|Overall Study|Adverse Event|2|||
94737513|NCT04456296|324494646|FG002|Overall Study|Adverse Event|2|||
94737514|NCT04456296|324494644|FG000|Overall Study|Death|1|||
94737515|NCT04456296|324494645|FG001|Overall Study|Death|0|||
94737516|NCT04456296|324494646|FG002|Overall Study|Death|0|||
94737517|NCT04456296|324494644|FG000|Overall Study|Lost to Follow-up|3|||
94737518|NCT04456296|324494645|FG001|Overall Study|Lost to Follow-up|5|||
94737519|NCT04456296|324494646|FG002|Overall Study|Lost to Follow-up|6|||
94737520|NCT04456296|324494644|FG000|Overall Study|Other than specified|0|||
94737521|NCT04456296|324494645|FG001|Overall Study|Other than specified|1|||
94737522|NCT04456296|324494646|FG002|Overall Study|Other than specified|4|||
94737523|NCT04456296|324494644|FG000|Overall Study|Randomized, not treated|2|||
94737524|NCT04456296|324494645|FG001|Overall Study|Randomized, not treated|1|||
94737525|NCT04456296|324494646|FG002|Overall Study|Randomized, not treated|0|||
94737526|NCT02990338|324494647|FG000|Overall Study|Randomized and not treated|4|||
94737527|NCT02990338|324494648|FG001|Overall Study|Randomized and not treated|2|||
94737528|NCT02990338|324494647|FG000|Overall Study|Adverse Event|23|||
94737529|NCT02990338|324494648|FG001|Overall Study|Adverse Event|22|||
94737530|NCT02990338|324494647|FG000|Overall Study|Progressive disease|118|||
94737531|NCT02990338|324494648|FG001|Overall Study|Progressive disease|107|||
94737532|NCT02990338|324494647|FG000|Overall Study|Poor compliance to protocol|0|||
94737533|NCT02990338|324494648|FG001|Overall Study|Poor compliance to protocol|1|||
94737534|NCT02990338|324494647|FG000|Overall Study|Withdrawal by Subject|6|||
94737535|NCT02990338|324494648|FG001|Overall Study|Withdrawal by Subject|8|||
94737536|NCT02990338|324494647|FG000|Overall Study|Physician's decision|2|||
94737537|NCT02990338|324494648|FG001|Overall Study|Physician's decision|6|||
94737538|NCT02990338|324494647|FG000|Overall Study|Treatment extension study|0|||
94737539|NCT02990338|324494648|FG001|Overall Study|Treatment extension study|6|||
94737540|NCT02990338|324494647|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
94737541|NCT02990338|324494648|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
94737542|NCT02990338|324494647|FG000|Overall Study|Continue with therapy available commercially|0|||
94737543|NCT02990338|324494648|FG001|Overall Study|Continue with therapy available commercially|1|||
94737544|NCT03964454|324494652|FG000|Overall Study|Lost to Follow-up|13|||
94737545|NCT03964454|324494653|FG001|Overall Study|Lost to Follow-up|7|||
94737546|NCT03964454|324494652|FG000|Overall Study|Withdrawal by Subject|4|||
94737547|NCT03964454|324494653|FG001|Overall Study|Withdrawal by Subject|11|||
94737548|NCT04797195|324496372|FG000|Overall Study|Death|8|||
94737549|NCT04797195|324496373|FG001|Overall Study|Death|15|||
94737550|NCT04797195|324496372|FG000|Overall Study|Change from PD|15|||
94737551|NCT04797195|324496373|FG001|Overall Study|Change from PD|15|||
94737552|NCT04797195|324496372|FG000|Overall Study|Withdrawal by Subject|3|||
94737553|NCT04797195|324496373|FG001|Overall Study|Withdrawal by Subject|2|||
94737554|NCT04304144|324496374|FG000|DLT Observation Period|Physician Decision|0|||
94737555|NCT04304144|324496375|FG001|DLT Observation Period|Physician Decision|1|||
94368921|NCT03120520|323136590|FG003|Overall Study|Other|0|||
94737556|NCT04304144|324496376|FG002|DLT Observation Period|Physician Decision|0|||
94737557|NCT04304144|324496377|FG003|DLT Observation Period|Physician Decision|0|||
94737558|NCT04304144|324496374|FG000|Continued Treatment Period|Adverse Event|0|||
94737559|NCT04304144|324496375|FG001|Continued Treatment Period|Adverse Event|1|||
94737560|NCT04304144|324496376|FG002|Continued Treatment Period|Adverse Event|0|||
94737561|NCT04304144|324496377|FG003|Continued Treatment Period|Adverse Event|0|||
94737562|NCT04304144|324496374|FG000|Continued Treatment Period|Death|0|||
94737563|NCT04304144|324496375|FG001|Continued Treatment Period|Death|0|||
94737564|NCT04304144|324496376|FG002|Continued Treatment Period|Death|1|||
94737565|NCT04304144|324496377|FG003|Continued Treatment Period|Death|2|||
94737566|NCT04304144|324496374|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
94737567|NCT04304144|324496375|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
94737568|NCT04304144|324496376|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
94737569|NCT04304144|324496377|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
94737570|NCT04304144|324496374|FG000|Continued Treatment Period|Other than specified|2|||
94737571|NCT04304144|324496375|FG001|Continued Treatment Period|Other than specified|0|||
94737572|NCT04304144|324496376|FG002|Continued Treatment Period|Other than specified|1|||
94737573|NCT04304144|324496377|FG003|Continued Treatment Period|Other than specified|1|||
94737574|NCT02970318|324496378|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
94737575|NCT02970318|324496379|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
94737576|NCT02970318|324496380|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
94737577|NCT02970318|324496381|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
94737578|NCT02970318|324496378|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
94737579|NCT02970318|324496379|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
94737580|NCT02970318|324496380|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
94737581|NCT02970318|324496381|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
94737582|NCT02970318|324496378|FG000|Overall for Arm A & Main for Arm B|Death|41|||
94737583|NCT02970318|324496379|FG001|Overall for Arm A & Main for Arm B|Death|33|||
94737584|NCT02970318|324496380|FG002|Overall for Arm A & Main for Arm B|Death|0|||
94368922|NCT02842086|323136591|FG000|Overall Study|Randomized but Never Treated|6|||
94737585|NCT02970318|324496381|FG003|Overall for Arm A & Main for Arm B|Death|0|||
94737586|NCT02970318|324496378|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
94737587|NCT02970318|324496379|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
94737588|NCT02970318|324496380|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
94737589|NCT02970318|324496381|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
94737590|NCT02970318|324496378|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
94737591|NCT02970318|324496379|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
94737592|NCT02970318|324496380|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
94737593|NCT02970318|324496381|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
94737594|NCT02970318|324496378|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
94737595|NCT02970318|324496379|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
94737596|NCT02970318|324496380|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
94737597|NCT02970318|324496381|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
94737598|NCT02970318|324496378|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
94737599|NCT02970318|324496379|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
94737600|NCT02970318|324496380|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
94737601|NCT02970318|324496381|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
94737602|NCT03756662|324496382|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
94737603|NCT01009788|324496389|FG000|Overall Study|Withdrawal by Subject|1|||
94737604|NCT01009788|324496390|FG001|Overall Study|Withdrawal by Subject|0|||
94737605|NCT02296684|324496391|FG000|Overall Study|Withdrawal by Subject|0|||
94737606|NCT02296684|324496392|FG001|Overall Study|Withdrawal by Subject|1|||
94737607|NCT02296684|324496393|FG002|Overall Study|Withdrawal by Subject|1|||
94737608|NCT02296684|324496391|FG000|Overall Study|Death|2|||
94737609|NCT02296684|324496392|FG001|Overall Study|Death|0|||
94737610|NCT02296684|324496393|FG002|Overall Study|Death|0|||
94737611|NCT02974621|324496394|FG000|Overall Study|Didn't receive study treatment|1|||
94737612|NCT02974621|324496395|FG001|Overall Study|Didn't receive study treatment|10|||
94737613|NCT01254864|324496396|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
94737614|NCT01254864|324496397|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
94737615|NCT01254864|324496398|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
94737616|NCT01254864|324496396|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
94737617|NCT01254864|324496397|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
94737618|NCT01254864|324496398|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
94737619|NCT01254864|324496396|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
94737620|NCT01254864|324496397|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
94737621|NCT01254864|324496398|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
94737622|NCT01254864|324496396|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
94737623|NCT01254864|324496397|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
94737624|NCT01254864|324496398|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
94737625|NCT01254864|324496396|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
94737626|NCT01254864|324496397|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
94737627|NCT01254864|324496398|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
94737628|NCT01254864|324496396|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
94737629|NCT01254864|324496397|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
94737630|NCT01254864|324496398|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
94737631|NCT01254864|324496396|FG000|Randomization Phase|Adverse Event|0|||
94737632|NCT01254864|324496397|FG001|Randomization Phase|Adverse Event|5|||
94737633|NCT01254864|324496398|FG002|Randomization Phase|Adverse Event|17|||
94737634|NCT01254864|324496396|FG000|Randomization Phase|Death|0|||
94737635|NCT01254864|324496397|FG001|Randomization Phase|Death|1|||
94737636|NCT01254864|324496398|FG002|Randomization Phase|Death|0|||
94737637|NCT01254864|324496396|FG000|Randomization Phase|Lost to Follow-up|0|||
94737638|NCT01254864|324496397|FG001|Randomization Phase|Lost to Follow-up|0|||
94737639|NCT01254864|324496398|FG002|Randomization Phase|Lost to Follow-up|1|||
94737640|NCT01254864|324496396|FG000|Randomization Phase|Physician Decision|0|||
94737641|NCT01254864|324496397|FG001|Randomization Phase|Physician Decision|20|||
94737642|NCT01254864|324496398|FG002|Randomization Phase|Physician Decision|25|||
94737643|NCT01254864|324496396|FG000|Randomization Phase|Withdrawal by Subject|0|||
94737644|NCT01254864|324496397|FG001|Randomization Phase|Withdrawal by Subject|4|||
94737645|NCT01254864|324496398|FG002|Randomization Phase|Withdrawal by Subject|2|||
94737646|NCT01254864|324496396|FG000|Randomization Phase|Non-Compliance|0|||
94737647|NCT01254864|324496397|FG001|Randomization Phase|Non-Compliance|1|||
94737648|NCT01254864|324496398|FG002|Randomization Phase|Non-Compliance|0|||
94737649|NCT01254864|324496396|FG000|Randomization Phase|Comorbidities|0|||
94737650|NCT01254864|324496397|FG001|Randomization Phase|Comorbidities|2|||
94737651|NCT01254864|324496398|FG002|Randomization Phase|Comorbidities|1|||
94737652|NCT05623228|324496402|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
94737653|NCT05623228|324496403|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
94737654|NCT05623228|324496404|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
94737655|NCT05623228|324496405|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
94737656|NCT05623228|324496406|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
94737657|NCT05623228|324496407|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
94737658|NCT05623228|324496408|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
94737659|NCT05623228|324496409|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
94737660|NCT05623228|324496402|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
94737661|NCT05623228|324496403|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
94737662|NCT05623228|324496404|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
94737663|NCT05623228|324496405|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
94737664|NCT05623228|324496406|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
94467488|NCT01416155|323500582|FG000|Overall Study|Withdrawal by Subject|33|||
94467489|NCT01416155|323500582|FG000|Overall Study|Investigator decision|8|||
94737665|NCT05623228|324496407|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
94737666|NCT05623228|324496408|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
94737667|NCT05623228|324496409|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
94737668|NCT00567489|324496412|FG000|Overall Study|Adverse Event|6|||
94737669|NCT00567489|324496413|FG001|Overall Study|Adverse Event|14|||
94737670|NCT00567489|324496412|FG000|Overall Study|Physician Decision|0|||
94737671|NCT00567489|324496413|FG001|Overall Study|Physician Decision|4|||
94737672|NCT00567489|324496412|FG000|Overall Study|Withdrawal by Subject|0|||
94737673|NCT00567489|324496413|FG001|Overall Study|Withdrawal by Subject|2|||
94737674|NCT00567489|324496412|FG000|Overall Study|Renal Transplantation|0|||
94737675|NCT00567489|324496413|FG001|Overall Study|Renal Transplantation|3|||
94737676|NCT00567489|324496412|FG000|Overall Study|Other|1|||
94737677|NCT00567489|324496413|FG001|Overall Study|Other|0|||
94737678|NCT03496662|324496420|FG000|Overall Study|Adverse Event|1|||
94737679|NCT03496662|324496421|FG001|Overall Study|Adverse Event|0|||
94737680|NCT03496662|324496422|FG002|Overall Study|Adverse Event|1|||
94737681|NCT03496662|324496420|FG000|Overall Study|Physician Decision|1|||
94737682|NCT03496662|324496421|FG001|Overall Study|Physician Decision|0|||
94737683|NCT03496662|324496422|FG002|Overall Study|Physician Decision|3|||
94737684|NCT03496662|324496420|FG000|Overall Study|Withdrawal by Subject|0|||
94737685|NCT03496662|324496421|FG001|Overall Study|Withdrawal by Subject|0|||
94737686|NCT03496662|324496422|FG002|Overall Study|Withdrawal by Subject|2|||
94737687|NCT03496662|324496420|FG000|Overall Study|Death|0|||
94737688|NCT03496662|324496421|FG001|Overall Study|Death|0|||
94737689|NCT03496662|324496422|FG002|Overall Study|Death|2|||
94737690|NCT03496662|324496420|FG000|Overall Study|Noncompliance|0|||
94737691|NCT03496662|324496421|FG001|Overall Study|Noncompliance|0|||
94737692|NCT03496662|324496422|FG002|Overall Study|Noncompliance|1|||
94737693|NCT05290493|324496423|FG000|Overall Study|Withdrawal by Subject|2|||
94737694|NCT05290493|324496424|FG001|Overall Study|Withdrawal by Subject|2|||
94737695|NCT05290493|324496423|FG000|Overall Study|Adverse Event|1|||
94737696|NCT05290493|324496424|FG001|Overall Study|Adverse Event|0|||
94737697|NCT04615273|324496428|FG000|Overall Study|Withdrawal by Subject|3|||
94737698|NCT04615273|324496429|FG001|Overall Study|Withdrawal by Subject|1|||
94737699|NCT04615273|324496430|FG002|Overall Study|Withdrawal by Subject|2|||
94737700|NCT04615273|324496428|FG000|Overall Study|Adverse Event|1|||
94737701|NCT04615273|324496429|FG001|Overall Study|Adverse Event|0|||
94737702|NCT04615273|324496430|FG002|Overall Study|Adverse Event|1|||
94737703|NCT04615273|324496428|FG000|Overall Study|Lost to Follow-up|0|||
94737704|NCT04615273|324496429|FG001|Overall Study|Lost to Follow-up|1|||
94737705|NCT04615273|324496430|FG002|Overall Study|Lost to Follow-up|0|||
94737706|NCT04615273|324496428|FG000|Overall Study|Physician Decision|0|||
94737707|NCT04615273|324496429|FG001|Overall Study|Physician Decision|0|||
94737708|NCT04615273|324496430|FG002|Overall Study|Physician Decision|1|||
94737709|NCT04615273|324496428|FG000|Overall Study|Other|0|||
94737710|NCT04615273|324496429|FG001|Overall Study|Other|1|||
94737711|NCT04615273|324496430|FG002|Overall Study|Other|0|||
94737712|NCT04615273|324496428|FG000|Overall Study|Randomized but not treated|1|||
94737713|NCT04615273|324496429|FG001|Overall Study|Randomized but not treated|3|||
94737714|NCT04615273|324496430|FG002|Overall Study|Randomized but not treated|1|||
94275567|NCT02347098|322802431|FG000|Overall Study|Withdrawal by Subject|1|||
94275568|NCT02347098|322802432|FG001|Overall Study|Withdrawal by Subject|0|||
94275569|NCT02347098|322802431|FG000|Overall Study|Lost to Follow-up|2|||
94275570|NCT02347098|322802432|FG001|Overall Study|Lost to Follow-up|2|||
94275571|NCT02347098|322802431|FG000|Overall Study|Refuse Follow-up Visit|1|||
94275572|NCT02347098|322802432|FG001|Overall Study|Refuse Follow-up Visit|5|||
94275573|NCT02347098|322802431|FG000|Overall Study|no visit due to illness|2|||
94275574|NCT02347098|322802432|FG001|Overall Study|no visit due to illness|1|||
94275575|NCT01230307|322802433|FG000|Overall Study|LVAD Placement|0|||
94275576|NCT01230307|322802434|FG001|Overall Study|LVAD Placement|2|||
94275577|NCT00530894|322802436|FG000|Overall Study|Death|84|||
94737715|NCT03677141|324496434|FG000|Overall Study|Death|2|||
94737716|NCT03677141|324496435|FG001|Overall Study|Death|1|||
94737717|NCT03677141|324496436|FG002|Overall Study|Death|6|||
94737718|NCT03677141|324496437|FG003|Overall Study|Death|9|||
94737719|NCT03677141|324496438|FG004|Overall Study|Death|5|||
94737720|NCT03677141|324496439|FG005|Overall Study|Death|3|||
94275578|NCT00530894|322802437|FG001|Overall Study|Death|89|||
94737721|NCT03677141|324496434|FG000|Overall Study|Lost to Follow-up|0|||
94737722|NCT03677141|324496435|FG001|Overall Study|Lost to Follow-up|0|||
94737723|NCT03677141|324496436|FG002|Overall Study|Lost to Follow-up|0|||
94737724|NCT03677141|324496437|FG003|Overall Study|Lost to Follow-up|2|||
94737725|NCT03677141|324496438|FG004|Overall Study|Lost to Follow-up|0|||
94737726|NCT03677141|324496439|FG005|Overall Study|Lost to Follow-up|0|||
94737727|NCT03677141|324496434|FG000|Overall Study|Screen failure or enrolled in error|0|||
94737728|NCT03677141|324496435|FG001|Overall Study|Screen failure or enrolled in error|0|||
94737729|NCT03677141|324496436|FG002|Overall Study|Screen failure or enrolled in error|0|||
94737730|NCT03677141|324496437|FG003|Overall Study|Screen failure or enrolled in error|0|||
94737731|NCT03677141|324496438|FG004|Overall Study|Screen failure or enrolled in error|2|||
94737732|NCT03677141|324496439|FG005|Overall Study|Screen failure or enrolled in error|0|||
94737733|NCT03677141|324496434|FG000|Overall Study|Physician Decision|0|||
94737734|NCT03677141|324496435|FG001|Overall Study|Physician Decision|0|||
94737735|NCT03677141|324496436|FG002|Overall Study|Physician Decision|0|||
94737736|NCT03677141|324496437|FG003|Overall Study|Physician Decision|0|||
94737737|NCT03677141|324496438|FG004|Overall Study|Physician Decision|1|||
94737738|NCT03677141|324496439|FG005|Overall Study|Physician Decision|0|||
94737739|NCT03677141|324496434|FG000|Overall Study|Withdrawal by Subject|0|||
94737740|NCT03677141|324496435|FG001|Overall Study|Withdrawal by Subject|0|||
94737741|NCT03677141|324496436|FG002|Overall Study|Withdrawal by Subject|1|||
94737742|NCT03677141|324496437|FG003|Overall Study|Withdrawal by Subject|1|||
94737743|NCT03677141|324496438|FG004|Overall Study|Withdrawal by Subject|1|||
94737744|NCT03677141|324496439|FG005|Overall Study|Withdrawal by Subject|0|||
94737745|NCT05838027|324496454|FG000|Overall Study|Lost to Follow-up|5|||
94737746|NCT05838027|324496455|FG001|Overall Study|Lost to Follow-up|1|||
94737747|NCT05838027|324496454|FG000|Overall Study|Withdrawal by Subject|1|||
94737748|NCT05838027|324496455|FG001|Overall Study|Withdrawal by Subject|0|||
94737749|NCT05237284|324496456|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
94737750|NCT05237284|324496457|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
94737751|NCT05237284|324496458|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
94737752|NCT05237284|324496459|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
94737753|NCT05237284|324496456|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
94737754|NCT05237284|324496457|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
94737755|NCT05237284|324496458|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
94737756|NCT05237284|324496459|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
94737757|NCT05237284|324496456|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
94737758|NCT05237284|324496457|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
94737759|NCT05237284|324496458|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
94737760|NCT05237284|324496459|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
94737761|NCT05237284|324496456|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
94737762|NCT05237284|324496457|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
94737763|NCT05237284|324496458|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
94737764|NCT05237284|324496459|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
94737765|NCT05237284|324496456|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
94737766|NCT05237284|324496457|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
94737767|NCT05237284|324496458|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
94737768|NCT05237284|324496459|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
94737769|NCT05237284|324496456|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
94737770|NCT05237284|324496457|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
94737771|NCT05237284|324496458|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
94737772|NCT05237284|324496459|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
94737773|NCT05237284|324496456|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
94737774|NCT05237284|324496457|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
94737775|NCT05237284|324496458|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
94737776|NCT05237284|324496459|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
94737777|NCT05237284|324496456|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
94737778|NCT05237284|324496457|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
94737779|NCT05237284|324496458|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
94737780|NCT05237284|324496459|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
94737781|NCT05237284|324496456|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
94737782|NCT05237284|324496457|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
94737783|NCT05237284|324496458|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
94737784|NCT05237284|324496459|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
94737785|NCT03714815|324496465|FG000|Overall Study|Physician Decision|2|||
94737786|NCT03714815|324496465|FG000|Overall Study|Withdrawal by Subject|2|||
94737787|NCT03714815|324496465|FG000|Overall Study|Death|11|||
94737788|NCT01909934|324496476|FG000|Overall Study|Ongoing|23|||
94737789|NCT01909934|324496476|FG000|Overall Study|Withdrawal by Subject|3|||
94737790|NCT01909934|324496476|FG000|Overall Study|Lost to Follow-up|1|||
94368923|NCT02842086|323136592|FG001|Overall Study|Randomized but Never Treated|6|||
94737791|NCT01909934|324496476|FG000|Overall Study|Withdrawal of Informed Consent|1|||
94737792|NCT01909934|324496476|FG000|Overall Study|Death|22|||
94737793|NCT02867592|324496477|FG000|Overall Study|Adverse Event|3|||
94368924|NCT02842086|323136591|FG000|Overall Study|Still in Double-Blind Phase|7|||
94737794|NCT02867592|324496478|FG001|Overall Study|Adverse Event|0|||
94737795|NCT02867592|324496479|FG002|Overall Study|Adverse Event|2|||
94737796|NCT02867592|324496480|FG003|Overall Study|Adverse Event|1|||
94737797|NCT02867592|324496481|FG004|Overall Study|Adverse Event|1|||
94737798|NCT02867592|324496482|FG005|Overall Study|Adverse Event|5|||
94737799|NCT02867592|324496477|FG000|Overall Study|Death|0|||
94737800|NCT02867592|324496478|FG001|Overall Study|Death|0|||
94737801|NCT02867592|324496479|FG002|Overall Study|Death|0|||
94737802|NCT02867592|324496480|FG003|Overall Study|Death|1|||
94737803|NCT02867592|324496481|FG004|Overall Study|Death|0|||
94737804|NCT02867592|324496482|FG005|Overall Study|Death|1|||
94737805|NCT02867592|324496477|FG000|Overall Study|Lack of Efficacy|8|||
94737806|NCT02867592|324496478|FG001|Overall Study|Lack of Efficacy|10|||
94737807|NCT02867592|324496479|FG002|Overall Study|Lack of Efficacy|8|||
94737808|NCT02867592|324496480|FG003|Overall Study|Lack of Efficacy|8|||
94737809|NCT02867592|324496481|FG004|Overall Study|Lack of Efficacy|12|||
94737810|NCT02867592|324496482|FG005|Overall Study|Lack of Efficacy|17|||
94737811|NCT02867592|324496477|FG000|Overall Study|Physician Decision|1|||
94737812|NCT02867592|324496478|FG001|Overall Study|Physician Decision|2|||
94737813|NCT02867592|324496479|FG002|Overall Study|Physician Decision|2|||
94737814|NCT02867592|324496480|FG003|Overall Study|Physician Decision|0|||
94737815|NCT02867592|324496481|FG004|Overall Study|Physician Decision|5|||
94737816|NCT02867592|324496482|FG005|Overall Study|Physician Decision|1|||
94737817|NCT02867592|324496477|FG000|Overall Study|Protocol Violation|0|||
94737818|NCT02867592|324496478|FG001|Overall Study|Protocol Violation|0|||
94737819|NCT02867592|324496479|FG002|Overall Study|Protocol Violation|0|||
94737820|NCT02867592|324496480|FG003|Overall Study|Protocol Violation|0|||
94737821|NCT02867592|324496481|FG004|Overall Study|Protocol Violation|1|||
94737822|NCT02867592|324496482|FG005|Overall Study|Protocol Violation|1|||
94737823|NCT02867592|324496477|FG000|Overall Study|Withdrawal by Subject|0|||
94737824|NCT02867592|324496478|FG001|Overall Study|Withdrawal by Subject|1|||
94737825|NCT02867592|324496479|FG002|Overall Study|Withdrawal by Subject|0|||
94737826|NCT02867592|324496480|FG003|Overall Study|Withdrawal by Subject|1|||
94737827|NCT02867592|324496481|FG004|Overall Study|Withdrawal by Subject|3|||
94737828|NCT02867592|324496482|FG005|Overall Study|Withdrawal by Subject|3|||
94737829|NCT02867592|324496477|FG000|Overall Study|Ineligible|1|||
94368925|NCT02842086|323136592|FG001|Overall Study|Still in Double-Blind Phase|3|||
94368926|NCT02842086|323136591|FG000|Overall Study|Adverse Event|18|||
94737830|NCT02867592|324496478|FG001|Overall Study|Ineligible|1|||
94737831|NCT02867592|324496479|FG002|Overall Study|Ineligible|0|||
94737832|NCT02867592|324496480|FG003|Overall Study|Ineligible|0|||
94368927|NCT02842086|323136592|FG001|Overall Study|Adverse Event|20|||
94368928|NCT02842086|323136591|FG000|Overall Study|Death|3|||
94467490|NCT01416155|323500582|FG000|Overall Study|Other|7|||
94467491|NCT01714609|323500583|FG000|Overall Study|Protocol Violation|1|||
94467492|NCT01714609|323500584|FG001|Overall Study|Protocol Violation|0|||
94737833|NCT02867592|324496481|FG004|Overall Study|Ineligible|2|||
94737834|NCT02867592|324496482|FG005|Overall Study|Ineligible|0|||
94737835|NCT02867592|324496477|FG000|Overall Study|No Treatment|1|||
94737836|NCT02867592|324496478|FG001|Overall Study|No Treatment|0|||
94368929|NCT02842086|323136592|FG001|Overall Study|Death|3|||
94368930|NCT02842086|323136591|FG000|Overall Study|Investigator's Discretion|9|||
94737837|NCT02867592|324496479|FG002|Overall Study|No Treatment|0|||
94737838|NCT02867592|324496480|FG003|Overall Study|No Treatment|0|||
94737839|NCT02867592|324496481|FG004|Overall Study|No Treatment|0|||
94737840|NCT02867592|324496482|FG005|Overall Study|No Treatment|0|||
94737841|NCT02867592|324496477|FG000|Overall Study|Still on Therapy|0|||
94737842|NCT02867592|324496478|FG001|Overall Study|Still on Therapy|0|||
94737843|NCT02867592|324496479|FG002|Overall Study|Still on Therapy|0|||
94737844|NCT02867592|324496480|FG003|Overall Study|Still on Therapy|0|||
94737845|NCT02867592|324496481|FG004|Overall Study|Still on Therapy|1|||
94737846|NCT02867592|324496482|FG005|Overall Study|Still on Therapy|0|||
94737847|NCT02867592|324496477|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
94737848|NCT02867592|324496478|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
94737849|NCT02867592|324496479|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
94737850|NCT02867592|324496480|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
94737851|NCT02867592|324496481|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
94737852|NCT02867592|324496482|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
94737853|NCT02867592|324496477|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
94737854|NCT02867592|324496478|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
94737855|NCT02867592|324496479|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
94737856|NCT02867592|324496480|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
94737857|NCT02867592|324496481|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
94737858|NCT02867592|324496482|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
94737859|NCT02906007|324496483|FG000|Overall Study|Physician Decision|0|||
94737860|NCT02906007|324496484|FG001|Overall Study|Physician Decision|0|||
94737861|NCT02906007|324496485|FG002|Overall Study|Physician Decision|1|||
94737862|NCT02906007|324496483|FG000|Overall Study|Died|1|||
94737863|NCT02906007|324496484|FG001|Overall Study|Died|0|||
94737864|NCT02906007|324496485|FG002|Overall Study|Died|0|||
94737865|NCT02780700|324496489|FG000|Overall Study|Progressive disease|1|||
94737866|NCT03926130|324496492|FG000|Overall Study|Adverse Event|9|||
94737867|NCT03926130|324496493|FG001|Overall Study|Adverse Event|11|||
94737868|NCT03926130|324496494|FG002|Overall Study|Adverse Event|2|||
94737869|NCT03926130|324496495|FG003|Overall Study|Adverse Event|0|||
94737870|NCT03926130|324496492|FG000|Overall Study|Death|2|||
94737871|NCT03926130|324496493|FG001|Overall Study|Death|0|||
94737872|NCT03926130|324496494|FG002|Overall Study|Death|1|||
94737873|NCT03926130|324496495|FG003|Overall Study|Death|0|||
94737874|NCT03926130|324496492|FG000|Overall Study|Lack of Efficacy|14|||
94737875|NCT03926130|324496493|FG001|Overall Study|Lack of Efficacy|11|||
94737876|NCT03926130|324496494|FG002|Overall Study|Lack of Efficacy|7|||
94737877|NCT03926130|324496495|FG003|Overall Study|Lack of Efficacy|1|||
94737878|NCT03926130|324496492|FG000|Overall Study|Lost to Follow-up|0|||
94737879|NCT03926130|324496493|FG001|Overall Study|Lost to Follow-up|7|||
94737880|NCT03926130|324496494|FG002|Overall Study|Lost to Follow-up|1|||
94737881|NCT03926130|324496495|FG003|Overall Study|Lost to Follow-up|0|||
94737882|NCT03926130|324496492|FG000|Overall Study|As Reported by Investigator|2|||
94737883|NCT03926130|324496493|FG001|Overall Study|As Reported by Investigator|6|||
94737884|NCT03926130|324496494|FG002|Overall Study|As Reported by Investigator|6|||
94737885|NCT03926130|324496495|FG003|Overall Study|As Reported by Investigator|0|||
94737886|NCT03926130|324496492|FG000|Overall Study|Physician Decision|3|||
94737887|NCT03926130|324496493|FG001|Overall Study|Physician Decision|2|||
94737888|NCT03926130|324496494|FG002|Overall Study|Physician Decision|1|||
94737889|NCT03926130|324496495|FG003|Overall Study|Physician Decision|0|||
94737890|NCT03926130|324496492|FG000|Overall Study|Pregnancy|2|||
94737891|NCT03926130|324496493|FG001|Overall Study|Pregnancy|2|||
94737892|NCT03926130|324496494|FG002|Overall Study|Pregnancy|1|||
94737893|NCT03926130|324496495|FG003|Overall Study|Pregnancy|0|||
94737894|NCT03926130|324496492|FG000|Overall Study|Withdrawal by Subject|20|||
94737895|NCT03926130|324496493|FG001|Overall Study|Withdrawal by Subject|28|||
94737896|NCT03926130|324496494|FG002|Overall Study|Withdrawal by Subject|18|||
94737897|NCT03926130|324496495|FG003|Overall Study|Withdrawal by Subject|1|||
94737898|NCT03926130|324496492|FG000|Overall Study|Non-Compliance|1|||
94737899|NCT03926130|324496493|FG001|Overall Study|Non-Compliance|1|||
94737900|NCT03926130|324496494|FG002|Overall Study|Non-Compliance|0|||
94737901|NCT03926130|324496495|FG003|Overall Study|Non-Compliance|0|||
94737902|NCT03926130|324496492|FG000|Overall Study|Disposition Not Captured|0|||
94737903|NCT03926130|324496493|FG001|Overall Study|Disposition Not Captured|2|||
94737904|NCT03926130|324496494|FG002|Overall Study|Disposition Not Captured|1|||
94737905|NCT03926130|324496495|FG003|Overall Study|Disposition Not Captured|0|||
94737906|NCT01730937|324496496|FG000|Overall Study|Protocol Violation|5|||
94737907|NCT01730937|324496497|FG001|Overall Study|Protocol Violation|11|||
94737908|NCT04209855|324496508|FG000|Overall Study|Adverse Event|20|||
94737909|NCT04209855|324496509|FG001|Overall Study|Adverse Event|28|||
94737910|NCT04209855|324496508|FG000|Overall Study|Death|3|||
94737911|NCT04209855|324496509|FG001|Overall Study|Death|1|||
94737912|NCT04209855|324496508|FG000|Overall Study|Principal Investigator (PI) Discretion|4|||
94737913|NCT04209855|324496509|FG001|Overall Study|Principal Investigator (PI) Discretion|9|||
94737914|NCT04209855|324496508|FG000|Overall Study|Participant Withdrew Consent to Treatment|4|||
94737915|NCT04209855|324496509|FG001|Overall Study|Participant Withdrew Consent to Treatment|11|||
94737916|NCT04209855|324496508|FG000|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|4|||
94737917|NCT04209855|324496509|FG001|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|15|||
94737918|NCT04209855|324496508|FG000|Overall Study|Progressive Disease|154|||
94737919|NCT04209855|324496509|FG001|Overall Study|Progressive Disease|145|||
94737920|NCT04209855|324496508|FG000|Overall Study|Protocol Deviation|1|||
94737921|NCT04209855|324496509|FG001|Overall Study|Protocol Deviation|1|||
94737922|NCT04209855|324496508|FG000|Overall Study|Other Than Specified|5|||
94737923|NCT04209855|324496509|FG001|Overall Study|Other Than Specified|10|||
94737924|NCT03824366|324496519|FG000|Overall Study|Death|1|||
94737925|NCT03824366|324496519|FG000|Overall Study|Previously unidentified metal artifact|1|||
94737926|NCT03824366|324496519|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
94737927|NCT03824366|324496519|FG000|Overall Study|Withdrawal by Subject|1|||
94737928|NCT04820322|324496524|FG000|Overall Study|Adverse Event|1|||
94737929|NCT04820322|324496525|FG001|Overall Study|Adverse Event|0|||
94737930|NCT04086121|324496526|FG000|Overall Study|Other than listed|8|||
94737931|NCT04086121|324496526|FG000|Overall Study|Withdrawal by Subject|3|||
94737932|NCT04086121|324496526|FG000|Overall Study|Lost to Follow-up|2|||
94737933|NCT04086121|324496526|FG000|Overall Study|Adverse Event|1|||
94737934|NCT02888743|324496529|FG000|Overall Study|Withdrawal by Subject|1|||
94737935|NCT02888743|324496530|FG001|Overall Study|Withdrawal by Subject|2|||
94737936|NCT02888743|324496531|FG002|Overall Study|Withdrawal by Subject|2|||
94737937|NCT02888743|324496532|FG003|Overall Study|Withdrawal by Subject|0|||
94737938|NCT02888743|324496533|FG004|Overall Study|Withdrawal by Subject|1|||
94737939|NCT02888743|324496529|FG000|Overall Study|Disease progression before treatment|2|||
94737940|NCT02888743|324496530|FG001|Overall Study|Disease progression before treatment|0|||
94737941|NCT02888743|324496531|FG002|Overall Study|Disease progression before treatment|2|||
94737942|NCT02888743|324496532|FG003|Overall Study|Disease progression before treatment|0|||
94737943|NCT02888743|324496533|FG004|Overall Study|Disease progression before treatment|0|||
94737944|NCT02888743|324496529|FG000|Overall Study|Patient ineligible|1|||
94737945|NCT02888743|324496530|FG001|Overall Study|Patient ineligible|2|||
94737946|NCT02888743|324496531|FG002|Overall Study|Patient ineligible|0|||
94737947|NCT02888743|324496532|FG003|Overall Study|Patient ineligible|0|||
94737948|NCT02888743|324496533|FG004|Overall Study|Patient ineligible|0|||
94737949|NCT05715528|324496534|FG000|Overall Study|Randomized but never treated|11|||
94737950|NCT05715528|324496535|FG001|Overall Study|Randomized but never treated|13|||
94737951|NCT05715528|324496534|FG000|Overall Study|Withdrew consent|7|||
94737952|NCT05715528|324496535|FG001|Overall Study|Withdrew consent|15|||
94737953|NCT05715528|324496534|FG000|Overall Study|Lost to Follow-up|5|||
94737954|NCT05715528|324496535|FG001|Overall Study|Lost to Follow-up|13|||
94737955|NCT05715528|324496534|FG000|Overall Study|Investigator's discretion|3|||
94737956|NCT05715528|324496535|FG001|Overall Study|Investigator's discretion|1|||
94737957|NCT05715528|324496534|FG000|Overall Study|Protocol Violation|2|||
94737958|NCT05715528|324496535|FG001|Overall Study|Protocol Violation|0|||
94737959|NCT05715528|324496534|FG000|Overall Study|Non-compliance with study drug|0|||
94737960|NCT05715528|324496535|FG001|Overall Study|Non-compliance with study drug|1|||
94737961|NCT02834390|324496536|FG000|Induction Phase|Progressive disease|0|||
94737962|NCT02834390|324496537|FG001|Induction Phase|Progressive disease|1|||
94737963|NCT02834390|324496536|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
94737964|NCT02834390|324496537|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
94737965|NCT02834390|324496536|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
94737966|NCT02834390|324496537|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
94737967|NCT02834390|324496536|FG000|Consolidation Phase|Physician Decision|1|||
94737968|NCT02834390|324496537|FG001|Consolidation Phase|Physician Decision|1|||
94737969|NCT04544007|324496538|FG000|Overall Study|Withdrawal by Subject|1|||
94737970|NCT04544007|324496538|FG000|Overall Study|Confirmed Progressive Disease|1|||
94737971|NCT02998528|324496543|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
94737972|NCT02998528|324496544|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
94737973|NCT02998528|324496545|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
94737974|NCT02998528|324496543|FG000|Randomization Period|Participant withdrew consent|0|||
94737975|NCT02998528|324496544|FG001|Randomization Period|Participant withdrew consent|3|||
94737976|NCT02998528|324496545|FG002|Randomization Period|Participant withdrew consent|0|||
94737977|NCT02998528|324496543|FG000|Randomization Period|Participant no longer meets study criteria|1|||
94737978|NCT02998528|324496544|FG001|Randomization Period|Participant no longer meets study criteria|3|||
94737979|NCT02998528|324496545|FG002|Randomization Period|Participant no longer meets study criteria|2|||
94737980|NCT02998528|324496543|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
94737981|NCT02998528|324496544|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
94737982|NCT02998528|324496545|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
94737983|NCT02998528|324496543|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
94737984|NCT02998528|324496544|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
94737985|NCT02998528|324496545|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
94737986|NCT02998528|324496543|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
94275579|NCT00530894|322802438|FG002|Overall Study|Death|55|||
94737987|NCT02998528|324496544|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
94737988|NCT02998528|324496545|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
94737989|NCT02998528|324496543|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
94737990|NCT02998528|324496544|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
94737991|NCT02998528|324496545|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
94737992|NCT02998528|324496543|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
94737993|NCT02998528|324496544|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
94737994|NCT02998528|324496545|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
94737995|NCT02998528|324496543|FG000|Neoadjuvant Treatment Period|Death|1|||
94737996|NCT02998528|324496544|FG001|Neoadjuvant Treatment Period|Death|0|||
94737997|NCT02998528|324496545|FG002|Neoadjuvant Treatment Period|Death|0|||
94737998|NCT02998528|324496543|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
94737999|NCT02998528|324496544|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
94738000|NCT02998528|324496545|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
94738001|NCT02998528|324496543|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
94738002|NCT02998528|324496544|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
94738003|NCT02998528|324496545|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
94738004|NCT02998528|324496543|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
94738005|NCT02998528|324496544|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
94738006|NCT02998528|324496545|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
94738007|NCT02998528|324496543|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
94738008|NCT02998528|324496544|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
94738009|NCT02998528|324496545|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
94738010|NCT02998528|324496543|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
94738011|NCT02998528|324496544|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
94738012|NCT02998528|324496545|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
94738013|NCT02998528|324496543|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
94738014|NCT02998528|324496544|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
94738015|NCT02998528|324496545|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
94738016|NCT02240238|324497820|FG000|Phase 1|Adverse Event|0|||
94738017|NCT02240238|324497821|FG001|Phase 1|Adverse Event|0|||
94738018|NCT02240238|324497822|FG002|Phase 1|Adverse Event|0|||
94738019|NCT02240238|324497823|FG003|Phase 1|Adverse Event|0|||
94738020|NCT02240238|324497824|FG004|Phase 1|Adverse Event|0|||
94738021|NCT02240238|324497825|FG005|Phase 1|Adverse Event|0|||
94738022|NCT02240238|324497826|FG006|Phase 1|Adverse Event|3|||
94738023|NCT02240238|324497827|FG007|Phase 1|Adverse Event|1|||
94738024|NCT02240238|324497828|FG008|Phase 1|Adverse Event|0|||
94738025|NCT02240238|324497829|FG009|Phase 1|Adverse Event|0|||
94738026|NCT02240238|324497830|FG010|Phase 1|Adverse Event|0|||
94738027|NCT02240238|324497831|FG011|Phase 1|Adverse Event|0|||
94738028|NCT02240238|324497820|FG000|Phase 1|Death|0|||
94738029|NCT02240238|324497821|FG001|Phase 1|Death|0|||
94738030|NCT02240238|324497822|FG002|Phase 1|Death|0|||
94738031|NCT02240238|324497823|FG003|Phase 1|Death|0|||
94738032|NCT02240238|324497824|FG004|Phase 1|Death|0|||
94738033|NCT02240238|324497825|FG005|Phase 1|Death|1|||
94738034|NCT02240238|324497826|FG006|Phase 1|Death|0|||
94738035|NCT02240238|324497827|FG007|Phase 1|Death|0|||
94738036|NCT02240238|324497828|FG008|Phase 1|Death|0|||
94738037|NCT02240238|324497829|FG009|Phase 1|Death|0|||
94738038|NCT02240238|324497830|FG010|Phase 1|Death|0|||
94738039|NCT02240238|324497831|FG011|Phase 1|Death|0|||
94738040|NCT02240238|324497820|FG000|Phase 1|Sponsor termination|0|||
94738041|NCT02240238|324497821|FG001|Phase 1|Sponsor termination|0|||
94738042|NCT02240238|324497822|FG002|Phase 1|Sponsor termination|0|||
94738043|NCT02240238|324497823|FG003|Phase 1|Sponsor termination|0|||
94738044|NCT02240238|324497824|FG004|Phase 1|Sponsor termination|0|||
94738045|NCT02240238|324497825|FG005|Phase 1|Sponsor termination|1|||
94738046|NCT02240238|324497826|FG006|Phase 1|Sponsor termination|0|||
94738047|NCT02240238|324497827|FG007|Phase 1|Sponsor termination|0|||
94738048|NCT02240238|324497828|FG008|Phase 1|Sponsor termination|0|||
94738049|NCT02240238|324497829|FG009|Phase 1|Sponsor termination|0|||
94738050|NCT02240238|324497830|FG010|Phase 1|Sponsor termination|0|||
94738051|NCT02240238|324497831|FG011|Phase 1|Sponsor termination|0|||
94738052|NCT02240238|324497820|FG000|Phase 1|Withdrawal by Subject|0|||
94738053|NCT02240238|324497821|FG001|Phase 1|Withdrawal by Subject|0|||
94738054|NCT02240238|324497822|FG002|Phase 1|Withdrawal by Subject|0|||
94738055|NCT02240238|324497823|FG003|Phase 1|Withdrawal by Subject|0|||
94467493|NCT00539032|323500585|FG000|Overall Study|Withdrawal by Subject|2|||
94738056|NCT02240238|324497824|FG004|Phase 1|Withdrawal by Subject|0|||
94738057|NCT02240238|324497825|FG005|Phase 1|Withdrawal by Subject|2|||
94738058|NCT02240238|324497826|FG006|Phase 1|Withdrawal by Subject|0|||
94738059|NCT02240238|324497827|FG007|Phase 1|Withdrawal by Subject|0|||
94738060|NCT02240238|324497828|FG008|Phase 1|Withdrawal by Subject|0|||
94738061|NCT02240238|324497829|FG009|Phase 1|Withdrawal by Subject|0|||
94738062|NCT02240238|324497830|FG010|Phase 1|Withdrawal by Subject|0|||
94738063|NCT02240238|324497831|FG011|Phase 1|Withdrawal by Subject|0|||
94738064|NCT02240238|324497820|FG000|Phase 1|Physician Decision|0|||
94738065|NCT02240238|324497821|FG001|Phase 1|Physician Decision|0|||
94738066|NCT02240238|324497822|FG002|Phase 1|Physician Decision|0|||
94738067|NCT02240238|324497823|FG003|Phase 1|Physician Decision|0|||
94738068|NCT02240238|324497824|FG004|Phase 1|Physician Decision|0|||
94738069|NCT02240238|324497825|FG005|Phase 1|Physician Decision|2|||
94738070|NCT02240238|324497826|FG006|Phase 1|Physician Decision|0|||
94738071|NCT02240238|324497827|FG007|Phase 1|Physician Decision|0|||
94738072|NCT02240238|324497828|FG008|Phase 1|Physician Decision|0|||
94738073|NCT02240238|324497829|FG009|Phase 1|Physician Decision|0|||
94738074|NCT02240238|324497830|FG010|Phase 1|Physician Decision|0|||
94738075|NCT02240238|324497831|FG011|Phase 1|Physician Decision|0|||
94738076|NCT02240238|324497820|FG000|Phase 2|Adverse Event|0|||
94738077|NCT02240238|324497821|FG001|Phase 2|Adverse Event|0|||
94738078|NCT02240238|324497822|FG002|Phase 2|Adverse Event|0|||
94738079|NCT02240238|324497823|FG003|Phase 2|Adverse Event|0|||
94738080|NCT02240238|324497824|FG004|Phase 2|Adverse Event|0|||
94738081|NCT02240238|324497825|FG005|Phase 2|Adverse Event|0|||
94738082|NCT02240238|324497826|FG006|Phase 2|Adverse Event|0|||
94738083|NCT02240238|324497827|FG007|Phase 2|Adverse Event|0|||
94738084|NCT02240238|324497828|FG008|Phase 2|Adverse Event|0|||
94738085|NCT02240238|324497829|FG009|Phase 2|Adverse Event|7|||
94738086|NCT02240238|324497830|FG010|Phase 2|Adverse Event|14|||
94738087|NCT02240238|324497831|FG011|Phase 2|Adverse Event|2|||
94738088|NCT02240238|324497820|FG000|Phase 2|Death|0|||
94738089|NCT02240238|324497821|FG001|Phase 2|Death|0|||
94738090|NCT02240238|324497822|FG002|Phase 2|Death|0|||
94738091|NCT02240238|324497823|FG003|Phase 2|Death|0|||
94368931|NCT02842086|323136592|FG001|Overall Study|Investigator's Discretion|13|||
94368932|NCT02842086|323136591|FG000|Overall Study|Non-Compliance with Study Drug|9|||
94368933|NCT02842086|323136592|FG001|Overall Study|Non-Compliance with Study Drug|8|||
94738092|NCT02240238|324497824|FG004|Phase 2|Death|0|||
94738093|NCT02240238|324497825|FG005|Phase 2|Death|0|||
94738094|NCT02240238|324497826|FG006|Phase 2|Death|0|||
94738095|NCT02240238|324497827|FG007|Phase 2|Death|0|||
94738096|NCT02240238|324497828|FG008|Phase 2|Death|0|||
94738097|NCT02240238|324497829|FG009|Phase 2|Death|3|||
94738098|NCT02240238|324497830|FG010|Phase 2|Death|2|||
94738099|NCT02240238|324497831|FG011|Phase 2|Death|1|||
94738100|NCT02240238|324497820|FG000|Phase 2|Disease progression|0|||
94738101|NCT02240238|324497821|FG001|Phase 2|Disease progression|0|||
94738102|NCT02240238|324497822|FG002|Phase 2|Disease progression|0|||
94738103|NCT02240238|324497823|FG003|Phase 2|Disease progression|0|||
94738104|NCT02240238|324497824|FG004|Phase 2|Disease progression|0|||
94738105|NCT02240238|324497825|FG005|Phase 2|Disease progression|0|||
94738106|NCT02240238|324497826|FG006|Phase 2|Disease progression|0|||
94738107|NCT02240238|324497827|FG007|Phase 2|Disease progression|0|||
94738108|NCT02240238|324497828|FG008|Phase 2|Disease progression|0|||
94738109|NCT02240238|324497829|FG009|Phase 2|Disease progression|5|||
94738110|NCT02240238|324497830|FG010|Phase 2|Disease progression|11|||
94738111|NCT02240238|324497831|FG011|Phase 2|Disease progression|1|||
94738112|NCT02240238|324497820|FG000|Phase 2|Withdrawal by Subject|0|||
94738113|NCT02240238|324497821|FG001|Phase 2|Withdrawal by Subject|0|||
94738114|NCT02240238|324497822|FG002|Phase 2|Withdrawal by Subject|0|||
94738115|NCT02240238|324497823|FG003|Phase 2|Withdrawal by Subject|0|||
94738116|NCT02240238|324497824|FG004|Phase 2|Withdrawal by Subject|0|||
94738117|NCT02240238|324497825|FG005|Phase 2|Withdrawal by Subject|0|||
94738118|NCT02240238|324497826|FG006|Phase 2|Withdrawal by Subject|0|||
94738119|NCT02240238|324497827|FG007|Phase 2|Withdrawal by Subject|0|||
94738120|NCT02240238|324497828|FG008|Phase 2|Withdrawal by Subject|0|||
94738121|NCT02240238|324497829|FG009|Phase 2|Withdrawal by Subject|1|||
94738122|NCT02240238|324497830|FG010|Phase 2|Withdrawal by Subject|1|||
94738123|NCT02240238|324497831|FG011|Phase 2|Withdrawal by Subject|0|||
94738124|NCT02240238|324497820|FG000|Phase 2|Physician Decision|0|||
94738125|NCT02240238|324497821|FG001|Phase 2|Physician Decision|0|||
94738126|NCT02240238|324497822|FG002|Phase 2|Physician Decision|0|||
94738127|NCT02240238|324497823|FG003|Phase 2|Physician Decision|0|||
94738128|NCT02240238|324497824|FG004|Phase 2|Physician Decision|0|||
94368934|NCT02842086|323136591|FG000|Overall Study|Protocol Violation|8|||
94738129|NCT02240238|324497825|FG005|Phase 2|Physician Decision|0|||
94738130|NCT02240238|324497826|FG006|Phase 2|Physician Decision|0|||
94738131|NCT02240238|324497827|FG007|Phase 2|Physician Decision|0|||
94738132|NCT02240238|324497828|FG008|Phase 2|Physician Decision|0|||
94738133|NCT02240238|324497829|FG009|Phase 2|Physician Decision|1|||
94738134|NCT02240238|324497830|FG010|Phase 2|Physician Decision|3|||
94738135|NCT02240238|324497831|FG011|Phase 2|Physician Decision|0|||
94738136|NCT02240238|324497820|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
94738137|NCT02240238|324497821|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
94738138|NCT02240238|324497822|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
94738139|NCT02240238|324497823|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
94368935|NCT02842086|323136592|FG001|Overall Study|Protocol Violation|4|||
94738140|NCT02240238|324497824|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
94738141|NCT02240238|324497825|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
94738142|NCT02240238|324497826|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
94738143|NCT02240238|324497827|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
94738144|NCT02240238|324497828|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
94738145|NCT02240238|324497829|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
94738146|NCT02240238|324497830|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
94738147|NCT02240238|324497831|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
94738148|NCT02240238|324497820|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
94738149|NCT02240238|324497821|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
94738150|NCT02240238|324497822|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
94738151|NCT02240238|324497823|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
94738152|NCT02240238|324497824|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
94738153|NCT02240238|324497825|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
94738154|NCT02240238|324497826|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
94738155|NCT02240238|324497827|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
94738156|NCT02240238|324497828|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
94738157|NCT02240238|324497829|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
94738158|NCT02240238|324497830|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
94738159|NCT02240238|324497831|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
94738160|NCT02240238|324497820|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
94738161|NCT02240238|324497821|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
94738162|NCT02240238|324497822|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
94738163|NCT02240238|324497823|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
94738164|NCT02240238|324497824|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
94738165|NCT02240238|324497825|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
94738166|NCT02240238|324497826|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
94738167|NCT02240238|324497827|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
94738168|NCT02240238|324497828|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
94738169|NCT02240238|324497829|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
94738170|NCT02240238|324497830|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
94738171|NCT02240238|324497831|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
94738172|NCT02240238|324497820|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
94738173|NCT02240238|324497821|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
94738174|NCT02240238|324497822|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
94738175|NCT02240238|324497823|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
94738176|NCT02240238|324497824|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
94738177|NCT02240238|324497825|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
94738178|NCT02240238|324497826|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
94738179|NCT02240238|324497827|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
94738180|NCT02240238|324497828|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
94738181|NCT02240238|324497829|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
94738182|NCT02240238|324497830|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
94738183|NCT02240238|324497831|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
94738184|NCT02240238|324497820|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
94738185|NCT02240238|324497821|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
94738186|NCT02240238|324497822|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
94738187|NCT02240238|324497823|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
94738188|NCT02240238|324497824|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
94738189|NCT02240238|324497825|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
94738190|NCT02240238|324497826|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
94738191|NCT02240238|324497827|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
94738192|NCT02240238|324497828|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
94738193|NCT02240238|324497829|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
94738194|NCT02240238|324497830|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
94738195|NCT02240238|324497831|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
94738196|NCT02240238|324497820|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
94738197|NCT02240238|324497821|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
94738198|NCT02240238|324497822|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
94738199|NCT02240238|324497823|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
94738200|NCT02240238|324497824|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
94738201|NCT02240238|324497825|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
94738202|NCT02240238|324497826|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
94738203|NCT02240238|324497827|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
94738204|NCT02240238|324497828|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
94738205|NCT02240238|324497829|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
94738206|NCT02240238|324497830|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
94738207|NCT02240238|324497831|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
94738208|NCT02240238|324497820|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
94738209|NCT02240238|324497821|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
94738210|NCT02240238|324497822|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
94738211|NCT02240238|324497823|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
94738212|NCT02240238|324497824|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
94738213|NCT02240238|324497825|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
94738214|NCT02240238|324497826|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
94738215|NCT02240238|324497827|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
94738216|NCT02240238|324497828|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
94738217|NCT02240238|324497829|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
94738218|NCT02240238|324497830|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
94738219|NCT02240238|324497831|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
94738220|NCT02240238|324497820|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
94738221|NCT02240238|324497821|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
94738222|NCT02240238|324497822|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
94738223|NCT02240238|324497823|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
94738224|NCT02240238|324497824|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
94738225|NCT02240238|324497825|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
94738226|NCT02240238|324497826|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
94738227|NCT02240238|324497827|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
94738228|NCT02240238|324497828|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
94738229|NCT02240238|324497829|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
94738230|NCT02240238|324497830|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
94738231|NCT02240238|324497831|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
94738232|NCT03672916|324497832|FG000|Overall Study|Death|6|||
94738233|NCT03672916|324497832|FG000|Overall Study|Lost to Follow-up|29|||
94738234|NCT03672916|324497832|FG000|Overall Study|Adverse Event|6|||
94738235|NCT03672916|324497832|FG000|Overall Study|Withdrawal by Subject|11|||
94738236|NCT04660539|324497833|FG000|Overall Study|Adverse Event|10|||
94738237|NCT04660539|324497833|FG000|Overall Study|Lack of Efficacy|4|||
94738238|NCT04660539|324497833|FG000|Overall Study|Lost to Follow-up|5|||
94738239|NCT04660539|324497833|FG000|Overall Study|Non-Compliance With Study Drug|3|||
94738240|NCT04660539|324497833|FG000|Overall Study|Reason not Specified|12|||
94738241|NCT04660539|324497833|FG000|Overall Study|Pregnancy|2|||
94738242|NCT04660539|324497833|FG000|Overall Study|Protocol Violation|2|||
94738243|NCT04660539|324497833|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
94738244|NCT04660539|324497833|FG000|Overall Study|Withdrawal by Subject|21|||
94738245|NCT03655028|324497834|FG000|12-weeks Follow up|Death|1|||
94738246|NCT03655028|324497835|FG001|12-weeks Follow up|Death|0|||
94738247|NCT03655028|324497834|FG000|12-weeks Follow up|Physician Decision|3|||
94738248|NCT03655028|324497835|FG001|12-weeks Follow up|Physician Decision|3|||
94738249|NCT03655028|324497834|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
94738250|NCT03655028|324497835|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
94738251|NCT03655028|324497834|FG000|12-weeks Follow up|Lost to Follow-up|4|||
94738252|NCT03655028|324497835|FG001|12-weeks Follow up|Lost to Follow-up|4|||
94738253|NCT03655028|324497834|FG000|24-weeks|Lost to Follow-up|1|||
94738254|NCT03655028|324497835|FG001|24-weeks|Lost to Follow-up|1|||
94738255|NCT03655028|324497834|FG000|24-weeks|Death|0|||
94738256|NCT03655028|324497835|FG001|24-weeks|Death|1|||
94738257|NCT03513302|324497836|FG000|First Intervention (14 Days)|Screen failure|15|||
94738258|NCT03513302|324497837|FG001|First Intervention (14 Days)|Screen failure|16|||
94738259|NCT04428476|324497838|FG000|Overall Study|Withdrawal by Subject|1|||
94738260|NCT04428476|324497838|FG000|Overall Study|Still on treatment|12|||
94738261|NCT01221948|324497839|FG000|Overall Study|Physician Decision|5|||
94738262|NCT01221948|324497839|FG000|Overall Study|Withdrawal by Subject|2|||
94738263|NCT01221948|324497839|FG000|Overall Study|not disclosed|2|||
94738264|NCT01221948|324497839|FG000|Overall Study|Death|1|||
94738265|NCT01221948|324497839|FG000|Overall Study|Protocol Violation|4|||
94738266|NCT02466971|324497842|FG000|Overall Study|eligible and never treated|14|||
94738267|NCT02466971|324497843|FG001|Overall Study|eligible and never treated|20|||
94738268|NCT02466971|324497842|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
94738269|NCT02466971|324497843|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
94738270|NCT02466971|324497842|FG000|Overall Study|ineligible and treated|1|||
94738271|NCT02466971|324497843|FG001|Overall Study|ineligible and treated|0|||
94738272|NCT02466971|324497842|FG000|Overall Study|ineligible and never treated|0|||
94738273|NCT02466971|324497843|FG001|Overall Study|ineligible and never treated|1|||
94738274|NCT00746096|324497844|FG000|Overall Study|Adverse Event|1|||
94738275|NCT00746096|324497845|FG001|Overall Study|Adverse Event|0|||
94738276|NCT00746096|324497844|FG000|Overall Study|Withdrawal by Subject|5|||
94738277|NCT00746096|324497845|FG001|Overall Study|Withdrawal by Subject|1|||
94738278|NCT00746096|324497844|FG000|Overall Study|Lost to Follow-up|2|||
94738279|NCT00746096|324497845|FG001|Overall Study|Lost to Follow-up|1|||
94738280|NCT00746096|324497844|FG000|Overall Study|Protocol Violation|1|||
94738281|NCT00746096|324497845|FG001|Overall Study|Protocol Violation|0|||
94738282|NCT00746096|324497844|FG000|Overall Study|No study drug treatment|1|||
94738283|NCT00746096|324497845|FG001|Overall Study|No study drug treatment|1|||
94738284|NCT05363163|324497855|FG000|Overall Study|Withdrawal by Subject|13|||
94738285|NCT03673501|324497858|FG000|Overall Study|Participants ongoing.|36|||
94738286|NCT03673501|324497859|FG001|Overall Study|Participants ongoing.|24|||
94738287|NCT04599634|324497860|FG000|Overall Study|Dose limiting toxicity|0|||
94738288|NCT04599634|324497861|FG001|Overall Study|Dose limiting toxicity|0|||
94738289|NCT04599634|324497862|FG002|Overall Study|Dose limiting toxicity|2|||
94738290|NCT04599634|324497863|FG003|Overall Study|Dose limiting toxicity|0|||
94738291|NCT02000115|324497864|FG000|Overall Study|Death|56|||
94738292|NCT02000115|324497865|FG001|Overall Study|Death|45|||
94738293|NCT02000115|324497866|FG002|Overall Study|Death|0|||
94738294|NCT02000115|324497867|FG003|Overall Study|Death|0|||
94738295|NCT02000115|324497864|FG000|Overall Study|Missed Visit|6|||
94738296|NCT02000115|324497865|FG001|Overall Study|Missed Visit|8|||
94738297|NCT02000115|324497866|FG002|Overall Study|Missed Visit|1|||
94738298|NCT02000115|324497867|FG003|Overall Study|Missed Visit|0|||
94738299|NCT02000115|324497864|FG000|Overall Study|Protocol Violation|2|||
94738300|NCT02000115|324497865|FG001|Overall Study|Protocol Violation|1|||
94738301|NCT02000115|324497866|FG002|Overall Study|Protocol Violation|0|||
94738302|NCT02000115|324497867|FG003|Overall Study|Protocol Violation|0|||
94738303|NCT02000115|324497864|FG000|Overall Study|Physician Decision|2|||
94738304|NCT02000115|324497865|FG001|Overall Study|Physician Decision|0|||
94738305|NCT02000115|324497866|FG002|Overall Study|Physician Decision|0|||
94738306|NCT02000115|324497867|FG003|Overall Study|Physician Decision|0|||
94738307|NCT02000115|324497864|FG000|Overall Study|Withdrawal by Subject|11|||
94738308|NCT02000115|324497865|FG001|Overall Study|Withdrawal by Subject|11|||
94738309|NCT02000115|324497866|FG002|Overall Study|Withdrawal by Subject|0|||
94738310|NCT02000115|324497867|FG003|Overall Study|Withdrawal by Subject|0|||
94738311|NCT02000115|324497864|FG000|Overall Study|Lost to Follow-up|0|||
94738312|NCT02000115|324497865|FG001|Overall Study|Lost to Follow-up|1|||
94738313|NCT02000115|324497866|FG002|Overall Study|Lost to Follow-up|0|||
94738314|NCT02000115|324497867|FG003|Overall Study|Lost to Follow-up|0|||
94738315|NCT02000115|324497864|FG000|Overall Study|Non-compliance|2|||
94738316|NCT02000115|324497865|FG001|Overall Study|Non-compliance|1|||
94738317|NCT02000115|324497866|FG002|Overall Study|Non-compliance|0|||
94738318|NCT02000115|324497867|FG003|Overall Study|Non-compliance|0|||
94738319|NCT02000115|324497864|FG000|Overall Study|Withdrawn on day of randomization|0|||
94738320|NCT02000115|324497865|FG001|Overall Study|Withdrawn on day of randomization|1|||
94738321|NCT02000115|324497866|FG002|Overall Study|Withdrawn on day of randomization|0|||
94738322|NCT02000115|324497867|FG003|Overall Study|Withdrawn on day of randomization|0|||
94738323|NCT02000115|324497864|FG000|Overall Study|Still on Study|0|||
94738324|NCT02000115|324497865|FG001|Overall Study|Still on Study|0|||
94738325|NCT02000115|324497866|FG002|Overall Study|Still on Study|0|||
94738326|NCT02000115|324497867|FG003|Overall Study|Still on Study|53|||
94738327|NCT04282980|324497868|FG000|Overall Study|Remained on treatment|6|||
94738328|NCT04282980|324497868|FG000|Overall Study|Survival follow-up|11|||
94738329|NCT04282980|324497868|FG000|Overall Study|Withdrawal of informed consent|1|||
94738330|NCT04282980|324497868|FG000|Overall Study|Lost to Follow-up|1|||
94738331|NCT05035654|324497870|FG000|Overall Study|Physician Decision|0|||
94738332|NCT05035654|324497871|FG001|Overall Study|Physician Decision|1|||
94738333|NCT05035654|324497872|FG002|Overall Study|Physician Decision|0|||
94738334|NCT05035654|324497870|FG000|Overall Study|Adverse Event|0|||
94738335|NCT05035654|324497871|FG001|Overall Study|Adverse Event|1|||
94738336|NCT05035654|324497872|FG002|Overall Study|Adverse Event|0|||
94738337|NCT05035654|324497870|FG000|Overall Study|Withdrawal by Subject|0|||
94738338|NCT05035654|324497871|FG001|Overall Study|Withdrawal by Subject|0|||
94738339|NCT05035654|324497872|FG002|Overall Study|Withdrawal by Subject|4|||
94738340|NCT05035654|324497870|FG000|Overall Study|Bilateral Dislodgement|1|||
94738341|NCT05035654|324497871|FG001|Overall Study|Bilateral Dislodgement|0|||
94738342|NCT05035654|324497872|FG002|Overall Study|Bilateral Dislodgement|0|||
94738343|NCT01917084|324497881|FG000|Overall Study|Withdrawal by Subject|1|||
94738344|NCT04451772|324497882|FG000|Overall Study|Adverse Event|1|||
94738345|NCT04451772|324497883|FG001|Overall Study|Adverse Event|0|||
94738346|NCT04451772|324497884|FG002|Overall Study|Adverse Event|1|||
94738347|NCT04451772|324497885|FG003|Overall Study|Adverse Event|1|||
94738348|NCT04451772|324497886|FG004|Overall Study|Adverse Event|0|||
94738349|NCT04451772|324497887|FG005|Overall Study|Adverse Event|3|||
94738350|NCT04451772|324497882|FG000|Overall Study|Withdrawal by Subject|2|||
94738351|NCT04451772|324497883|FG001|Overall Study|Withdrawal by Subject|7|||
94738352|NCT04451772|324497884|FG002|Overall Study|Withdrawal by Subject|2|||
94738353|NCT04451772|324497885|FG003|Overall Study|Withdrawal by Subject|1|||
94738354|NCT04451772|324497886|FG004|Overall Study|Withdrawal by Subject|1|||
94738355|NCT04451772|324497887|FG005|Overall Study|Withdrawal by Subject|0|||
94738356|NCT04451772|324497882|FG000|Overall Study|Other, not specified|1|||
94738357|NCT04451772|324497883|FG001|Overall Study|Other, not specified|2|||
94738358|NCT04451772|324497884|FG002|Overall Study|Other, not specified|1|||
94738359|NCT04451772|324497885|FG003|Overall Study|Other, not specified|0|||
94738360|NCT04451772|324497886|FG004|Overall Study|Other, not specified|0|||
94738361|NCT04451772|324497887|FG005|Overall Study|Other, not specified|1|||
94738362|NCT04451772|324497882|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
94738363|NCT04451772|324497883|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
94738364|NCT04451772|324497884|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
94738365|NCT04451772|324497885|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
94738366|NCT04451772|324497886|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
94738367|NCT04451772|324497887|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
94738368|NCT04311632|324497888|FG000|Overall Study|Withdrawal by Subject|0|||
94738369|NCT04311632|324497889|FG001|Overall Study|Withdrawal by Subject|0|||
94738370|NCT04311632|324497890|FG002|Overall Study|Withdrawal by Subject|1|||
94738371|NCT05424380|324497896|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
94738372|NCT05424380|324497897|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
94738373|NCT05424380|324497898|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
94738374|NCT05424380|324497899|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
94738375|NCT05424380|324497900|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
94738376|NCT05424380|324497901|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
94738377|NCT05424380|324497896|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
94738378|NCT05424380|324497897|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
94738379|NCT05424380|324497898|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
94738380|NCT05424380|324497899|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
94738381|NCT05424380|324497900|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
94738382|NCT05424380|324497901|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
94738383|NCT05424380|324497896|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
94738384|NCT05424380|324497897|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
94738385|NCT05424380|324497898|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
94738386|NCT05424380|324497899|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
94738387|NCT05424380|324497900|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
94738388|NCT05424380|324497901|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
94738389|NCT05424380|324497896|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
94738390|NCT05424380|324497897|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
94738391|NCT05424380|324497898|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
94738392|NCT05424380|324497899|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
94738393|NCT05424380|324497900|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
94738394|NCT05424380|324497901|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
94738395|NCT05424380|324497896|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
94738396|NCT05424380|324497897|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
94738397|NCT05424380|324497898|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
94738398|NCT05424380|324497899|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
94738399|NCT05424380|324497900|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
94738400|NCT05424380|324497901|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
94738401|NCT05424380|324497896|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
94738402|NCT05424380|324497897|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
94738403|NCT05424380|324497898|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
94738404|NCT05424380|324497899|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
94738405|NCT05424380|324497900|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
94738406|NCT05424380|324497901|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
94738407|NCT05424380|324497896|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
94738408|NCT05424380|324497897|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
94738409|NCT05424380|324497898|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
94738410|NCT05424380|324497899|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
94738411|NCT05424380|324497900|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
94738412|NCT05424380|324497901|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
94738413|NCT05424380|324497896|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
94738414|NCT05424380|324497897|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
94738415|NCT05424380|324497898|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
94738416|NCT05424380|324497899|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
94738417|NCT05424380|324497900|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
94738418|NCT05424380|324497901|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
94738419|NCT05424380|324497896|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
94368936|NCT02842086|323136591|FG000|Overall Study|Withdrew Consent|205|||
94368937|NCT02842086|323136592|FG001|Overall Study|Withdrew Consent|194|||
94368938|NCT02842086|323136591|FG000|Overall Study|Lost to Follow-up|274|||
94368939|NCT02842086|323136592|FG001|Overall Study|Lost to Follow-up|236|||
94368940|NCT02842086|323136591|FG000|Overall Study|HIV-1 Infection|5|||
94368941|NCT02842086|323136592|FG001|Overall Study|HIV-1 Infection|6|||
94368942|NCT00555399|323136593|FG000|Overall Study|Withdrawal by Subject|0|||
94368943|NCT00555399|323136594|FG001|Overall Study|Withdrawal by Subject|0|||
94368944|NCT00555399|323136595|FG002|Overall Study|Withdrawal by Subject|1|||
94467494|NCT00539032|323500586|FG001|Overall Study|Withdrawal by Subject|1|||
94467495|NCT02306694|323500587|FG000|Overall Study|Withdrawal by Subject|3|||
94467496|NCT02306694|323500587|FG000|Overall Study|Lost to Follow-up|1|||
94467497|NCT00583102|323500592|FG000|Overall Study|Adverse Event|3|||
94738420|NCT05424380|324497897|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
94738421|NCT05424380|324497898|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
94738422|NCT05424380|324497899|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
94738423|NCT05424380|324497900|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
94738424|NCT05424380|324497901|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
94738425|NCT05424380|324497896|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
94738426|NCT05424380|324497897|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
94738427|NCT05424380|324497898|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
94738428|NCT05424380|324497899|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
94738429|NCT05424380|324497900|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
94738430|NCT05424380|324497901|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
94738431|NCT05424380|324497896|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
94738432|NCT05424380|324497897|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
94738433|NCT05424380|324497898|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
94738434|NCT05424380|324497899|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
94738435|NCT05424380|324497900|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
94738436|NCT05424380|324497901|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
94738437|NCT05424380|324497896|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
94738438|NCT05424380|324497897|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
94738439|NCT05424380|324497898|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
94738440|NCT05424380|324497899|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
94738441|NCT05424380|324497900|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
94738442|NCT05424380|324497901|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
94738443|NCT05424380|324497896|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
94738444|NCT05424380|324497897|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
94738445|NCT05424380|324497898|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
94738446|NCT05424380|324497899|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
94738447|NCT05424380|324497900|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
94738448|NCT05424380|324497901|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
94738449|NCT05424380|324497896|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
94738450|NCT05424380|324497897|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
94738451|NCT05424380|324497898|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
94738452|NCT05424380|324497899|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
94738453|NCT05424380|324497900|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
94738454|NCT05424380|324497901|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
94738455|NCT02909686|324497902|FG000|Overall Study|Physician Decision|3|||
94738456|NCT02909686|324497902|FG000|Overall Study|Withdrawal by Subject|2|||
94738457|NCT03858517|324497905|FG000|Overall Study|Adverse Event|1|||
94738458|NCT03858517|324497905|FG000|Overall Study|Lost to Follow-up|1|||
94738459|NCT03858517|324497905|FG000|Overall Study|removed for being incarcerated|1|||
94738460|NCT03858517|324497905|FG000|Overall Study|Sponsor Closure|48|||
94738461|NCT02828358|324497909|FG000|Overall Study|Physician Decision|7|||
94738462|NCT02828358|324497910|FG001|Overall Study|Physician Decision|1|||
94738463|NCT02828358|324497909|FG000|Overall Study|Treatment Failure|6|||
94738464|NCT02828358|324497910|FG001|Overall Study|Treatment Failure|0|||
94738465|NCT02828358|324497909|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
94738466|NCT02828358|324497910|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
94738467|NCT02828358|324497909|FG000|Overall Study|Refusal of further protocol therapy|2|||
94738468|NCT02828358|324497910|FG001|Overall Study|Refusal of further protocol therapy|0|||
94738469|NCT02828358|324497909|FG000|Overall Study|Relapse|25|||
94738470|NCT02828358|324497910|FG001|Overall Study|Relapse|0|||
94738471|NCT02828358|324497909|FG000|Overall Study|Still on therapy|5|||
94738472|NCT02828358|324497910|FG001|Overall Study|Still on therapy|0|||
94738473|NCT06037668|324497911|FG000|Overall Study|Lost to Follow-up|1|||
94738474|NCT06037668|324497912|FG001|Overall Study|Lost to Follow-up|1|||
94738475|NCT06037668|324497911|FG000|Overall Study|Protocol Violation|1|||
94738476|NCT06037668|324497912|FG001|Overall Study|Protocol Violation|0|||
94738477|NCT06037668|324497911|FG000|Overall Study|Withdrawal by Subject|1|||
94738478|NCT06037668|324497912|FG001|Overall Study|Withdrawal by Subject|0|||
94738479|NCT06037668|324497911|FG000|Overall Study|Other Study Discontinuation Reason|1|||
94738480|NCT06037668|324497912|FG001|Overall Study|Other Study Discontinuation Reason|0|||
94738481|NCT04804540|324497913|FG000|Overall Study|Adverse Event|26|||
94738482|NCT04804540|324497914|FG001|Overall Study|Adverse Event|13|||
94738483|NCT05285137|324497915|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
94738484|NCT05285137|324497916|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
94738485|NCT05285137|324497917|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
94738486|NCT05285137|324497918|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
94738487|NCT05285137|324497919|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
94738488|NCT05285137|324497920|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
94738489|NCT05285137|324497921|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
94738490|NCT05285137|324497922|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
94738491|NCT05285137|324497923|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
94738492|NCT05285137|324497915|FG000|Overall Study|Lost to Follow-up|0|||
94738493|NCT05285137|324497916|FG001|Overall Study|Lost to Follow-up|0|||
94738494|NCT05285137|324497917|FG002|Overall Study|Lost to Follow-up|1|||
94738495|NCT05285137|324497918|FG003|Overall Study|Lost to Follow-up|3|||
94738496|NCT05285137|324497919|FG004|Overall Study|Lost to Follow-up|0|||
94738497|NCT05285137|324497920|FG005|Overall Study|Lost to Follow-up|0|||
94738498|NCT05285137|324497921|FG006|Overall Study|Lost to Follow-up|1|||
94738499|NCT05285137|324497922|FG007|Overall Study|Lost to Follow-up|0|||
94738500|NCT05285137|324497923|FG008|Overall Study|Lost to Follow-up|0|||
94738501|NCT05285137|324497915|FG000|Overall Study|Physician Decision|0|||
94738502|NCT05285137|324497916|FG001|Overall Study|Physician Decision|1|||
94738503|NCT05285137|324497917|FG002|Overall Study|Physician Decision|0|||
94738504|NCT05285137|324497918|FG003|Overall Study|Physician Decision|0|||
94738505|NCT05285137|324497919|FG004|Overall Study|Physician Decision|0|||
94738506|NCT05285137|324497920|FG005|Overall Study|Physician Decision|0|||
94738507|NCT05285137|324497921|FG006|Overall Study|Physician Decision|0|||
94738508|NCT05285137|324497922|FG007|Overall Study|Physician Decision|0|||
94738509|NCT05285137|324497923|FG008|Overall Study|Physician Decision|0|||
94738510|NCT05285137|324497915|FG000|Overall Study|Pregnancy|0|||
94738511|NCT05285137|324497916|FG001|Overall Study|Pregnancy|0|||
94738512|NCT05285137|324497917|FG002|Overall Study|Pregnancy|0|||
94738513|NCT05285137|324497918|FG003|Overall Study|Pregnancy|0|||
94738514|NCT05285137|324497919|FG004|Overall Study|Pregnancy|0|||
94738515|NCT05285137|324497920|FG005|Overall Study|Pregnancy|0|||
94738516|NCT05285137|324497921|FG006|Overall Study|Pregnancy|1|||
94738517|NCT05285137|324497922|FG007|Overall Study|Pregnancy|0|||
94738518|NCT05285137|324497923|FG008|Overall Study|Pregnancy|0|||
94738519|NCT05285137|324497915|FG000|Overall Study|Withdrawal by Subject|0|||
94738520|NCT05285137|324497916|FG001|Overall Study|Withdrawal by Subject|1|||
94738521|NCT05285137|324497917|FG002|Overall Study|Withdrawal by Subject|2|||
94738522|NCT05285137|324497918|FG003|Overall Study|Withdrawal by Subject|1|||
94738523|NCT05285137|324497919|FG004|Overall Study|Withdrawal by Subject|0|||
94738524|NCT05285137|324497920|FG005|Overall Study|Withdrawal by Subject|0|||
94738525|NCT05285137|324497921|FG006|Overall Study|Withdrawal by Subject|0|||
94738526|NCT05285137|324497922|FG007|Overall Study|Withdrawal by Subject|0|||
94738527|NCT05285137|324497923|FG008|Overall Study|Withdrawal by Subject|1|||
94738528|NCT03484819|324497924|FG000|Overall Study|Death|2|||
94738529|NCT03484819|324497924|FG000|Overall Study|Adverse Event|2|||
94738530|NCT03484819|324497924|FG000|Overall Study|Physician Decision|1|||
94738531|NCT03484819|324497924|FG000|Overall Study|Withdrawal by Subject|2|||
94738532|NCT03484819|324497924|FG000|Overall Study|Disease Progression|4|||
94738533|NCT03484819|324497924|FG000|Overall Study|Complicating Condition|1|||
94738534|NCT04479761|324497925|FG000|Overall Study|could not perform the balance tasks|1|||
94738535|NCT04479761|324497926|FG001|Overall Study|could not perform the balance tasks|0|||
94738536|NCT04479761|324497927|FG002|Overall Study|could not perform the balance tasks|0|||
94738537|NCT04479761|324497925|FG000|Overall Study|Adverse Event|1|||
94738538|NCT04479761|324497926|FG001|Overall Study|Adverse Event|0|||
94738539|NCT04479761|324497927|FG002|Overall Study|Adverse Event|0|||
94738540|NCT04479761|324497925|FG000|Overall Study|one control did not meet screening criteria|0|||
94738541|NCT04479761|324497926|FG001|Overall Study|one control did not meet screening criteria|0|||
94738542|NCT04479761|324497927|FG002|Overall Study|one control did not meet screening criteria|1|||
94738543|NCT04479761|324497925|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
94738544|NCT04479761|324497926|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
94738545|NCT04479761|324497927|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
94738546|NCT01199133|324497931|FG000|Year 1|Adverse Event|16|||
94738547|NCT01199133|324497932|FG001|Year 1|Adverse Event|4|||
94738548|NCT01199133|324497931|FG000|Year 1|Withdrawal by Subject|8|||
94738549|NCT01199133|324497932|FG001|Year 1|Withdrawal by Subject|4|||
94738550|NCT01199133|324497931|FG000|Year 1|Any other reason not above-mentioned|6|||
94738551|NCT01199133|324497932|FG001|Year 1|Any other reason not above-mentioned|7|||
94738552|NCT01199133|324497931|FG000|Year 2|Adverse Event|1|||
94738553|NCT01199133|324497932|FG001|Year 2|Adverse Event|0|||
94738554|NCT01199133|324497931|FG000|Year 2|Withdrawal by Subject|1|||
94738555|NCT01199133|324497932|FG001|Year 2|Withdrawal by Subject|1|||
94738556|NCT01199133|324497931|FG000|Year 2|Any other reason not above-mentioned|1|||
94738557|NCT01199133|324497932|FG001|Year 2|Any other reason not above-mentioned|2|||
94467498|NCT03403621|323500593|FG000|Overall Study|Withdrawal by Subject|2|||
94738558|NCT04247802|324497933|FG000|Overall Study|Withdrawal by Subject|1|||
94738559|NCT04247802|324497934|FG001|Overall Study|Withdrawal by Subject|3|||
94738560|NCT04247802|324497933|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
94738561|NCT04247802|324497934|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
94738562|NCT04629339|324497935|FG000|Overall Study|Death|1|||
94738563|NCT04629339|324497936|FG001|Overall Study|Death|0|||
94738564|NCT04629339|324497937|FG002|Overall Study|Death|2|||
94738565|NCT04629339|324497938|FG003|Overall Study|Death|2|||
94738566|NCT04629339|324497939|FG004|Overall Study|Death|0|||
94738567|NCT04629339|324497935|FG000|Overall Study|Disease Progression|0|||
94738568|NCT04629339|324497936|FG001|Overall Study|Disease Progression|0|||
94738569|NCT04629339|324497937|FG002|Overall Study|Disease Progression|1|||
94738570|NCT04629339|324497938|FG003|Overall Study|Disease Progression|1|||
94738571|NCT04629339|324497939|FG004|Overall Study|Disease Progression|0|||
94738572|NCT04629339|324497935|FG000|Overall Study|Lost to Follow-up|0|||
94738573|NCT04629339|324497936|FG001|Overall Study|Lost to Follow-up|0|||
94738574|NCT04629339|324497937|FG002|Overall Study|Lost to Follow-up|0|||
94738575|NCT04629339|324497938|FG003|Overall Study|Lost to Follow-up|1|||
94738576|NCT04629339|324497939|FG004|Overall Study|Lost to Follow-up|0|||
94738577|NCT04629339|324497935|FG000|Overall Study|Physician Decision|0|||
94738578|NCT04629339|324497936|FG001|Overall Study|Physician Decision|1|||
94738579|NCT04629339|324497937|FG002|Overall Study|Physician Decision|0|||
94738580|NCT04629339|324497938|FG003|Overall Study|Physician Decision|0|||
94738581|NCT04629339|324497939|FG004|Overall Study|Physician Decision|0|||
94738582|NCT04629339|324497935|FG000|Overall Study|Study Terminated by Sponsor|0|||
94738583|NCT04629339|324497936|FG001|Overall Study|Study Terminated by Sponsor|0|||
94738584|NCT04629339|324497937|FG002|Overall Study|Study Terminated by Sponsor|0|||
94738585|NCT04629339|324497938|FG003|Overall Study|Study Terminated by Sponsor|1|||
94738586|NCT04629339|324497939|FG004|Overall Study|Study Terminated by Sponsor|0|||
94738587|NCT04629339|324497935|FG000|Overall Study|Withdrawal by Subject|0|||
94738588|NCT04629339|324497936|FG001|Overall Study|Withdrawal by Subject|0|||
94738589|NCT04629339|324497937|FG002|Overall Study|Withdrawal by Subject|2|||
94738590|NCT04629339|324497938|FG003|Overall Study|Withdrawal by Subject|2|||
94738591|NCT04629339|324497939|FG004|Overall Study|Withdrawal by Subject|0|||
94738592|NCT04158739|324497942|FG000|Overall Study|Adverse Event|1|||
94738593|NCT04158739|324497943|FG001|Overall Study|Adverse Event|0|||
94738594|NCT04158739|324497942|FG000|Overall Study|Death|0|||
94738595|NCT04158739|324497943|FG001|Overall Study|Death|1|||
94738596|NCT04158739|324497942|FG000|Overall Study|Lack of Efficacy|3|||
94738597|NCT04158739|324497943|FG001|Overall Study|Lack of Efficacy|7|||
94738598|NCT04158739|324497942|FG000|Overall Study|Physician Decision|0|||
94738599|NCT04158739|324497943|FG001|Overall Study|Physician Decision|1|||
94467499|NCT03403621|323500594|FG001|Overall Study|Withdrawal by Subject|2|||
94738600|NCT04158739|324497942|FG000|Overall Study|Withdrawal by Subject|3|||
94738601|NCT04158739|324497943|FG001|Overall Study|Withdrawal by Subject|0|||
94738602|NCT05309291|324497944|FG000|Overall Study|Adverse Event|0|||
94738603|NCT05309291|324497945|FG001|Overall Study|Adverse Event|1|||
94738604|NCT03691298|324497948|FG000|Overall Study|Lost to Follow-up|8|||
94738605|NCT03691298|324497948|FG000|Overall Study|Sponsor terminated study|2|||
94738606|NCT04999111|324499645|FG000|Overall Study|Lost to Follow-up|21|||
94738607|NCT04999111|324499646|FG001|Overall Study|Lost to Follow-up|16|||
94738608|NCT04999111|324499647|FG002|Overall Study|Lost to Follow-up|2|||
94738609|NCT04999111|324499648|FG003|Overall Study|Lost to Follow-up|26|||
94738610|NCT04999111|324499649|FG004|Overall Study|Lost to Follow-up|30|||
94738611|NCT04999111|324499650|FG005|Overall Study|Lost to Follow-up|6|||
94738612|NCT04999111|324499645|FG000|Overall Study|Physician Decision|1|||
94738613|NCT04999111|324499646|FG001|Overall Study|Physician Decision|3|||
94738614|NCT04999111|324499647|FG002|Overall Study|Physician Decision|0|||
94738615|NCT04999111|324499648|FG003|Overall Study|Physician Decision|1|||
94738616|NCT04999111|324499649|FG004|Overall Study|Physician Decision|2|||
94738617|NCT04999111|324499650|FG005|Overall Study|Physician Decision|0|||
94738618|NCT04999111|324499645|FG000|Overall Study|Withdrawal by Subject|23|||
94738619|NCT04999111|324499646|FG001|Overall Study|Withdrawal by Subject|29|||
94738620|NCT04999111|324499647|FG002|Overall Study|Withdrawal by Subject|15|||
94738621|NCT04999111|324499648|FG003|Overall Study|Withdrawal by Subject|30|||
94738622|NCT04999111|324499649|FG004|Overall Study|Withdrawal by Subject|35|||
94738623|NCT04999111|324499650|FG005|Overall Study|Withdrawal by Subject|10|||
94738624|NCT04999111|324499645|FG000|Overall Study|Other|6|||
94738625|NCT04999111|324499646|FG001|Overall Study|Other|6|||
94738626|NCT04999111|324499647|FG002|Overall Study|Other|3|||
94738627|NCT04999111|324499648|FG003|Overall Study|Other|8|||
94738628|NCT04999111|324499649|FG004|Overall Study|Other|8|||
94738629|NCT04999111|324499650|FG005|Overall Study|Other|5|||
94738630|NCT04999111|324499645|FG000|Overall Study|Non-compliance with study schedule|1|||
94738631|NCT04999111|324499646|FG001|Overall Study|Non-compliance with study schedule|0|||
94738632|NCT04999111|324499647|FG002|Overall Study|Non-compliance with study schedule|0|||
94738633|NCT04999111|324499648|FG003|Overall Study|Non-compliance with study schedule|1|||
94738634|NCT04999111|324499649|FG004|Overall Study|Non-compliance with study schedule|1|||
94738635|NCT04999111|324499650|FG005|Overall Study|Non-compliance with study schedule|1|||
94738636|NCT04999111|324499645|FG000|Overall Study|Randomized but not vaccinated|1|||
94738637|NCT04999111|324499646|FG001|Overall Study|Randomized but not vaccinated|2|||
94738638|NCT04999111|324499647|FG002|Overall Study|Randomized but not vaccinated|0|||
94738639|NCT04999111|324499648|FG003|Overall Study|Randomized but not vaccinated|3|||
94738640|NCT04999111|324499649|FG004|Overall Study|Randomized but not vaccinated|3|||
94738641|NCT04999111|324499650|FG005|Overall Study|Randomized but not vaccinated|0|||
94738642|NCT04999111|324499645|FG000|Overall Study|Adverse Event|1|||
94738643|NCT04999111|324499646|FG001|Overall Study|Adverse Event|1|||
94738644|NCT04999111|324499647|FG002|Overall Study|Adverse Event|0|||
94738645|NCT04999111|324499648|FG003|Overall Study|Adverse Event|0|||
94738646|NCT04999111|324499649|FG004|Overall Study|Adverse Event|0|||
94738647|NCT04999111|324499650|FG005|Overall Study|Adverse Event|0|||
94738648|NCT04999111|324499645|FG000|Overall Study|Initiated prohibited medication|0|||
94738649|NCT04999111|324499646|FG001|Overall Study|Initiated prohibited medication|0|||
94738650|NCT04999111|324499647|FG002|Overall Study|Initiated prohibited medication|0|||
94738651|NCT04999111|324499648|FG003|Overall Study|Initiated prohibited medication|0|||
94738652|NCT04999111|324499649|FG004|Overall Study|Initiated prohibited medication|1|||
94738653|NCT04999111|324499650|FG005|Overall Study|Initiated prohibited medication|0|||
94738654|NCT02962076|324499651|FG000|Overall Study|MHED tracer not available|5|||
94738655|NCT02962076|324499651|FG000|Overall Study|Protocol Violation|1|||
94738656|NCT02962076|324499651|FG000|Overall Study|Physician Decision|1|||
94738657|NCT04741776|324499652|FG000|Overall Study|Withdrawal by Subject|7|||
94738658|NCT04741776|324499653|FG001|Overall Study|Withdrawal by Subject|10|||
94738659|NCT04741776|324499654|FG002|Overall Study|Withdrawal by Subject|10|||
94738660|NCT04741776|324499655|FG003|Overall Study|Withdrawal by Subject|17|||
94738661|NCT04741776|324499652|FG000|Overall Study|Death|0|||
94738662|NCT04741776|324499653|FG001|Overall Study|Death|0|||
94738663|NCT04741776|324499654|FG002|Overall Study|Death|1|||
94738664|NCT04741776|324499655|FG003|Overall Study|Death|0|||
94738665|NCT04469270|324499656|FG000|Overall Study|Adverse Event|2|||
94738666|NCT04469270|324499657|FG001|Overall Study|Adverse Event|0|||
94738667|NCT04469270|324499656|FG000|Overall Study|Lost to Follow-up|4|||
94738668|NCT04469270|324499657|FG001|Overall Study|Lost to Follow-up|3|||
94738669|NCT04469270|324499656|FG000|Overall Study|Withdrawal by Subject|7|||
94738670|NCT04469270|324499657|FG001|Overall Study|Withdrawal by Subject|3|||
94738671|NCT04469270|324499656|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
94738672|NCT04469270|324499657|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
94738673|NCT04469270|324499656|FG000|Overall Study|missing|1|||
94738674|NCT04469270|324499657|FG001|Overall Study|missing|0|||
94738675|NCT02852655|324499658|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
94738676|NCT02852655|324499659|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
94738677|NCT02852655|324499660|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
94738678|NCT02852655|324499658|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
94738679|NCT02852655|324499659|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
94738680|NCT02852655|324499660|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
94738681|NCT02852655|324499658|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
94738682|NCT02852655|324499659|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
94467500|NCT00505661|323500595|FG000|Overall Study|Not Eligible|4|||
94738683|NCT02852655|324499660|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
94275580|NCT00530894|322802439|FG003|Overall Study|Death|89|||
94467501|NCT01738191|323500596|FG000|Overall Study|Withdrawal by Subject|4|||
94738684|NCT02852655|324499658|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
94738685|NCT02852655|324499659|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
94738686|NCT02852655|324499660|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
94738687|NCT02852655|324499658|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
94738688|NCT02852655|324499659|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
94738689|NCT02852655|324499660|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
94738690|NCT02852655|324499658|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
94738691|NCT02852655|324499659|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
94738692|NCT02852655|324499660|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
94738693|NCT02852655|324499658|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
94738694|NCT02852655|324499659|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
94738695|NCT02852655|324499660|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
94738696|NCT02852655|324499658|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
94738697|NCT02852655|324499659|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
94738698|NCT02852655|324499660|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
94368945|NCT00555399|323136596|FG003|Overall Study|Withdrawal by Subject|0|||
94368946|NCT00555399|323136597|FG004|Overall Study|Withdrawal by Subject|0|||
94368947|NCT00555399|323136598|FG005|Overall Study|Withdrawal by Subject|0|||
94368948|NCT00555399|323136599|FG006|Overall Study|Withdrawal by Subject|0|||
94738699|NCT02852655|324499658|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
94738700|NCT02852655|324499659|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
94738701|NCT02852655|324499660|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
94738702|NCT05069896|324499663|FG000|Overall Study|Adverse Event|0|||
94738703|NCT05069896|324499664|FG001|Overall Study|Adverse Event|1|||
94738704|NCT05069896|324499665|FG002|Overall Study|Adverse Event|1|||
94738705|NCT05069896|324499666|FG003|Overall Study|Adverse Event|0|||
94738706|NCT05069896|324499667|FG004|Overall Study|Adverse Event|0|||
94738707|NCT05069896|324499668|FG005|Overall Study|Adverse Event|0|||
94738708|NCT05069896|324499663|FG000|Overall Study|Lost to Follow-up|0|||
94738709|NCT05069896|324499664|FG001|Overall Study|Lost to Follow-up|0|||
94738710|NCT05069896|324499665|FG002|Overall Study|Lost to Follow-up|1|||
94738711|NCT05069896|324499666|FG003|Overall Study|Lost to Follow-up|0|||
94738712|NCT05069896|324499667|FG004|Overall Study|Lost to Follow-up|1|||
94738713|NCT05069896|324499668|FG005|Overall Study|Lost to Follow-up|2|||
94738714|NCT00323856|324499669|FG000|Overall Study|Withdrawal by Subject|1|||
94738715|NCT00323856|324499669|FG000|Overall Study|Was uncooperative and noncompliant|1|||
94738716|NCT00323856|324499669|FG000|Overall Study|Reason not specified|1|||
94738717|NCT00323856|324499669|FG000|Overall Study|Missing|2|||
94738718|NCT03156465|324499670|FG000|Overall Study|Withdrawal by Subject|2|||
94738719|NCT03640286|324499671|FG000|Overall Study|Adverse Event|6|||
94738720|NCT03640286|324499672|FG001|Overall Study|Adverse Event|6|||
94738721|NCT03640286|324499671|FG000|Overall Study|Lost to Follow-up|3|||
94738722|NCT03640286|324499672|FG001|Overall Study|Lost to Follow-up|6|||
94738723|NCT03640286|324499671|FG000|Overall Study|Pregnancy|1|||
94738724|NCT03640286|324499672|FG001|Overall Study|Pregnancy|0|||
94738725|NCT03640286|324499671|FG000|Overall Study|Withdrawal by Subject|10|||
94738726|NCT03640286|324499672|FG001|Overall Study|Withdrawal by Subject|10|||
94738727|NCT03640286|324499671|FG000|Overall Study|Non-compliance|4|||
94738728|NCT03640286|324499672|FG001|Overall Study|Non-compliance|10|||
94738729|NCT03640286|324499671|FG000|Overall Study|Medication change|1|||
94738730|NCT03640286|324499672|FG001|Overall Study|Medication change|0|||
94738731|NCT03640286|324499671|FG000|Overall Study|Other|1|||
94738732|NCT03640286|324499672|FG001|Overall Study|Other|2|||
94738733|NCT03640286|324499671|FG000|Overall Study|Joined another lifestyle program|0|||
94738734|NCT03640286|324499672|FG001|Overall Study|Joined another lifestyle program|1|||
94738735|NCT03181516|324499673|FG000|Overall Study|Withdrawal by Subject|14|||
94738736|NCT03181516|324499674|FG001|Overall Study|Withdrawal by Subject|7|||
94738737|NCT03181516|324499673|FG000|Overall Study|Lost to Follow-up|2|||
94738738|NCT03181516|324499674|FG001|Overall Study|Lost to Follow-up|2|||
94738739|NCT04580914|324499675|FG000|Overall Study|Withdrawal by Subject|6|||
94738740|NCT04580914|324499675|FG000|Overall Study|Lost to Follow-up|2|||
94738741|NCT04659603|324499676|FG000|Overall Study|Ongoing study treatment at the time of primary analysis completion|0|||
94738742|NCT04659603|324499677|FG001|Overall Study|Ongoing study treatment at the time of primary analysis completion|0|||
94738743|NCT04659603|324499678|FG002|Overall Study|Ongoing study treatment at the time of primary analysis completion|6|||
94738744|NCT04659603|324499676|FG000|Overall Study|Withdrawal by Subject|0|||
94738745|NCT04659603|324499677|FG001|Overall Study|Withdrawal by Subject|5|||
94738746|NCT04659603|324499678|FG002|Overall Study|Withdrawal by Subject|0|||
94738747|NCT04659603|324499676|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
94738748|NCT04659603|324499677|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
94368949|NCT00555399|323136600|FG007|Overall Study|Withdrawal by Subject|0|||
94738749|NCT04659603|324499678|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
94738750|NCT05405985|324499679|FG000|Overall Study|Withdrawal by Subject|1|||
94368950|NCT00555399|323136601|FG008|Overall Study|Withdrawal by Subject|0|||
94368951|NCT00555399|323136602|FG009|Overall Study|Withdrawal by Subject|0|||
94738751|NCT05405985|324499680|FG001|Overall Study|Withdrawal by Subject|0|||
94368952|NCT00555399|323136603|FG010|Overall Study|Withdrawal by Subject|0|||
94368953|NCT00555399|323136604|FG011|Overall Study|Withdrawal by Subject|1|||
94368954|NCT00555399|323136593|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
94368955|NCT00555399|323136594|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
94368956|NCT00555399|323136595|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
94738752|NCT04679935|324499681|FG000|Overall Study|Death|0|||
94738753|NCT04679935|324499682|FG001|Overall Study|Death|1|||
94738754|NCT02988661|324499683|FG000|Overall Study|Death|2|||
94738755|NCT02988661|324499684|FG001|Overall Study|Death|18|||
94738756|NCT02988661|324499683|FG000|Overall Study|Lost to Follow-up|0|||
94738757|NCT02988661|324499684|FG001|Overall Study|Lost to Follow-up|33|||
94738758|NCT02988661|324499683|FG000|Overall Study|Withdrawal by Subject|0|||
94738759|NCT02988661|324499684|FG001|Overall Study|Withdrawal by Subject|6|||
94738760|NCT02988661|324499683|FG000|Overall Study|Unable to complete the 18-month survey|1|||
94738761|NCT02988661|324499684|FG001|Overall Study|Unable to complete the 18-month survey|27|||
94738762|NCT04113018|324499685|FG000|Overall Study|Death|2|||
94738763|NCT04113018|324499685|FG000|Overall Study|Lost to Follow-up|1|||
94738764|NCT04113018|324499685|FG000|Overall Study|Still On Study (on study treatment)|24|||
94738765|NCT04113018|324499685|FG000|Overall Study|Still On Study (in follow up)|12|||
94738766|NCT05856435|324499697|FG000|Overall Study|Lost to Follow-up|6|||
94738767|NCT04934072|324499698|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
94738768|NCT04934072|324499699|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
94738769|NCT04934072|324499700|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
94738770|NCT04934072|324499701|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
94738771|NCT04934072|324499702|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
94738772|NCT04934072|324499698|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
94738773|NCT04934072|324499699|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
94738774|NCT04934072|324499700|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
94738775|NCT04934072|324499701|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
94738776|NCT04934072|324499702|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
94738777|NCT04934072|324499698|FG000|Day 0 to Week 52|Other|3|||
94738778|NCT04934072|324499699|FG001|Day 0 to Week 52|Other|1|||
94738779|NCT04934072|324499700|FG002|Day 0 to Week 52|Other|0|||
94738780|NCT04934072|324499701|FG003|Day 0 to Week 52|Other|0|||
94738781|NCT04934072|324499702|FG004|Day 0 to Week 52|Other|0|||
94738782|NCT04934072|324499698|FG000|Day 0 to Week 52|Adverse Event|1|||
94738783|NCT04934072|324499699|FG001|Day 0 to Week 52|Adverse Event|3|||
94738784|NCT04934072|324499700|FG002|Day 0 to Week 52|Adverse Event|0|||
94738785|NCT04934072|324499701|FG003|Day 0 to Week 52|Adverse Event|0|||
94738786|NCT04934072|324499702|FG004|Day 0 to Week 52|Adverse Event|0|||
94738787|NCT04934072|324499698|FG000|Week 52 to Week 78|Adverse Event|0|||
94738788|NCT04934072|324499699|FG001|Week 52 to Week 78|Adverse Event|0|||
94738789|NCT04934072|324499700|FG002|Week 52 to Week 78|Adverse Event|0|||
94738790|NCT04934072|324499701|FG003|Week 52 to Week 78|Adverse Event|1|||
94738791|NCT04934072|324499702|FG004|Week 52 to Week 78|Adverse Event|1|||
94738792|NCT04934072|324499698|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
94738793|NCT04934072|324499699|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
94738794|NCT04934072|324499700|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
94738795|NCT04934072|324499701|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
94738796|NCT04934072|324499702|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
94738797|NCT04934072|324499698|FG000|Week 52 to Week 78|Other|0|||
94738798|NCT04934072|324499699|FG001|Week 52 to Week 78|Other|0|||
94738799|NCT04934072|324499700|FG002|Week 52 to Week 78|Other|1|||
94738800|NCT04934072|324499701|FG003|Week 52 to Week 78|Other|0|||
94738801|NCT04934072|324499702|FG004|Week 52 to Week 78|Other|0|||
94738802|NCT03213678|324499704|FG000|Overall Study|Death|1|||
94738803|NCT03213678|324499704|FG000|Overall Study|Physician Decision|1|||
94738804|NCT03213678|324499704|FG000|Overall Study|Progressive disease|16|||
94738805|NCT04218851|324499705|FG000|Overall Study|Death|1|||
94738806|NCT04218851|324499706|FG001|Overall Study|Death|3|||
94738807|NCT03174275|324499711|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
94738808|NCT03174275|324499711|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
94368957|NCT00555399|323136596|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
94368958|NCT00555399|323136597|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
94738809|NCT03174275|324499711|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
94738810|NCT03174275|324499711|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
94738811|NCT03174275|324499711|FG000|Adjuvant Chemotherapy|Progression|1|||
94738812|NCT03174275|324499711|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
94738813|NCT03174275|324499711|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
94738814|NCT03174275|324499711|FG000|Adjuvant Durvalumab|Progression|1|||
94738815|NCT03174275|324499711|FG000|Adjuvant Durvalumab|Adverse Event|3|||
94738816|NCT03174275|324499711|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
94738817|NCT03174275|324499711|FG000|Adjuvant Radiotherapy|Progression|1|||
94738818|NCT03174275|324499711|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
94738819|NCT02413489|324499724|FG000|Overall Study|Death|11|||
94738820|NCT02413489|324499725|FG001|Overall Study|Death|3|||
94738821|NCT02413489|324499726|FG002|Overall Study|Death|4|||
94738822|NCT02413489|324499724|FG000|Overall Study|Withdrawal by Subject|2|||
94738823|NCT02413489|324499725|FG001|Overall Study|Withdrawal by Subject|0|||
94738824|NCT02413489|324499726|FG002|Overall Study|Withdrawal by Subject|0|||
94738825|NCT02413489|324499724|FG000|Overall Study|Study Terminated By Sponsor|2|||
94738826|NCT02413489|324499725|FG001|Overall Study|Study Terminated By Sponsor|13|||
94738827|NCT02413489|324499726|FG002|Overall Study|Study Terminated By Sponsor|1|||
94738828|NCT02473445|324499731|FG000|Overall Study|Withdrawal by Subject|2|||
94738829|NCT02473445|324499731|FG000|Overall Study|Sponsor Decision|20|||
94738830|NCT03015532|324499732|FG000|Overall Study|Adverse Event|0|||
94738831|NCT03015532|324499733|FG001|Overall Study|Adverse Event|0|||
94738832|NCT03015532|324499734|FG002|Overall Study|Adverse Event|0|||
94738833|NCT03015532|324499735|FG003|Overall Study|Adverse Event|0|||
94738834|NCT03015532|324499736|FG004|Overall Study|Adverse Event|0|||
94738835|NCT03015532|324499737|FG005|Overall Study|Adverse Event|2|||
94738836|NCT03015532|324499738|FG006|Overall Study|Adverse Event|1|||
94738837|NCT03015532|324499739|FG007|Overall Study|Adverse Event|0|||
94738838|NCT03015532|324499732|FG000|Overall Study|Withdrawal by Subject|0|||
94738839|NCT03015532|324499733|FG001|Overall Study|Withdrawal by Subject|0|||
94738840|NCT03015532|324499734|FG002|Overall Study|Withdrawal by Subject|0|||
94738841|NCT03015532|324499735|FG003|Overall Study|Withdrawal by Subject|0|||
94738842|NCT03015532|324499736|FG004|Overall Study|Withdrawal by Subject|0|||
94738843|NCT03015532|324499737|FG005|Overall Study|Withdrawal by Subject|0|||
94738844|NCT03015532|324499738|FG006|Overall Study|Withdrawal by Subject|1|||
94738845|NCT03015532|324499739|FG007|Overall Study|Withdrawal by Subject|0|||
94738846|NCT05736458|324499740|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
94738847|NCT05736458|324499741|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
94738848|NCT05736458|324499742|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
94738849|NCT05736458|324499740|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
94738850|NCT05736458|324499741|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
94738851|NCT05736458|324499742|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
94738852|NCT05736458|324499740|FG000|TMS/fMRI #1|Physician Decision|0|||
94738853|NCT05736458|324499741|FG001|TMS/fMRI #1|Physician Decision|0|||
94738854|NCT05736458|324499742|FG002|TMS/fMRI #1|Physician Decision|2|||
94738855|NCT05736458|324499740|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
94738856|NCT05736458|324499741|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
94738857|NCT05736458|324499742|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
94738858|NCT04063878|324499743|FG000|Overall Study|Withdrawal by Subject|2|||
94738859|NCT04063878|324499743|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
94738860|NCT02997202|324499744|FG000|Overall Study|Miscellaneous|2|||
94738861|NCT02997202|324499745|FG001|Overall Study|Miscellaneous|2|||
94738862|NCT02997202|324499744|FG000|Overall Study|Withdrawal by Subject|8|||
94738863|NCT02997202|324499745|FG001|Overall Study|Withdrawal by Subject|12|||
94738864|NCT02997202|324499744|FG000|Overall Study|Lost to Follow-up|5|||
94738865|NCT02997202|324499745|FG001|Overall Study|Lost to Follow-up|3|||
94738866|NCT02997202|324499744|FG000|Overall Study|Death|41|||
94738867|NCT02997202|324499745|FG001|Overall Study|Death|45|||
94738868|NCT02575950|324499746|FG000|Overall Study|Withdrawal by Subject|0|||
94738869|NCT02575950|324499747|FG001|Overall Study|Withdrawal by Subject|0|||
94738870|NCT02575950|324499748|FG002|Overall Study|Withdrawal by Subject|0|||
94738871|NCT02575950|324499749|FG003|Overall Study|Withdrawal by Subject|2|||
94738872|NCT02575950|324499746|FG000|Overall Study|Lost to Follow-up|0|||
94738873|NCT02575950|324499747|FG001|Overall Study|Lost to Follow-up|1|||
94738874|NCT02575950|324499748|FG002|Overall Study|Lost to Follow-up|0|||
94738875|NCT02575950|324499749|FG003|Overall Study|Lost to Follow-up|3|||
94738876|NCT05569954|324499750|FG000|Overall Study|Lost to Follow-up|3|||
94738877|NCT05569954|324499751|FG001|Overall Study|Lost to Follow-up|4|||
94738878|NCT05569954|324499750|FG000|Overall Study|Protocol Violation|1|||
94738879|NCT05569954|324499751|FG001|Overall Study|Protocol Violation|2|||
94738880|NCT05569954|324499750|FG000|Overall Study|Withdrawal by Subject|4|||
94738881|NCT05569954|324499751|FG001|Overall Study|Withdrawal by Subject|2|||
94738882|NCT00677365|324499752|FG000|Overall Study|Adverse Event|2|||
94738883|NCT00677365|324499753|FG001|Overall Study|Adverse Event|1|||
94738884|NCT00677365|324499754|FG002|Overall Study|Adverse Event|1|||
94738885|NCT00677365|324499755|FG003|Overall Study|Adverse Event|2|||
94738886|NCT00677365|324499752|FG000|Overall Study|Withdrawal by Subject|0|||
94738887|NCT00677365|324499753|FG001|Overall Study|Withdrawal by Subject|0|||
94738888|NCT00677365|324499754|FG002|Overall Study|Withdrawal by Subject|1|||
94738889|NCT00677365|324499755|FG003|Overall Study|Withdrawal by Subject|0|||
94738890|NCT00677365|324499752|FG000|Overall Study|Other reason|0|||
94738891|NCT00677365|324499753|FG001|Overall Study|Other reason|0|||
94738892|NCT00677365|324499754|FG002|Overall Study|Other reason|0|||
94738893|NCT00677365|324499755|FG003|Overall Study|Other reason|1|||
94738894|NCT01121588|324499756|FG000|Overall Study|Death|5|||
94738895|NCT01121588|324499757|FG001|Overall Study|Death|3|||
94738896|NCT01121588|324499758|FG002|Overall Study|Death|13|||
94738897|NCT01121588|324499756|FG000|Overall Study|Study Terminated by Sponsor|1|||
94738898|NCT01121588|324499757|FG001|Overall Study|Study Terminated by Sponsor|1|||
94738899|NCT01121588|324499758|FG002|Overall Study|Study Terminated by Sponsor|0|||
94738900|NCT01121588|324499756|FG000|Overall Study|Participant Refused Further Followup|2|||
94738901|NCT01121588|324499757|FG001|Overall Study|Participant Refused Further Followup|0|||
94738902|NCT01121588|324499758|FG002|Overall Study|Participant Refused Further Followup|2|||
94738903|NCT01121588|324499756|FG000|Overall Study|Lost to Follow-up|0|||
94738904|NCT01121588|324499757|FG001|Overall Study|Lost to Follow-up|1|||
94738905|NCT01121588|324499758|FG002|Overall Study|Lost to Follow-up|1|||
94738906|NCT01121588|324499756|FG000|Overall Study|Non-Specified Reasons|9|||
94738907|NCT01121588|324499757|FG001|Overall Study|Non-Specified Reasons|4|||
94738908|NCT01121588|324499758|FG002|Overall Study|Non-Specified Reasons|2|||
94738909|NCT02095691|324499759|FG000|Overall Study|Physician Decision|1|||
94738910|NCT03681262|324499760|FG000|Overall Study|Continuing on study|3|||
94738911|NCT03681262|324499761|FG001|Overall Study|Continuing on study|3|||
94738912|NCT03681262|324499760|FG000|Overall Study|Lost to Follow-up|1|||
94738913|NCT03681262|324499761|FG001|Overall Study|Lost to Follow-up|0|||
94738914|NCT04102111|324499763|FG000|Overall Study|Withdrawal by Subject|2|||
94738915|NCT04102111|324499764|FG001|Overall Study|Withdrawal by Subject|3|||
94738916|NCT04102111|324499763|FG000|Overall Study|Adverse Event|1|||
94738917|NCT04102111|324499764|FG001|Overall Study|Adverse Event|1|||
94738918|NCT04102111|324499763|FG000|Overall Study|Study terminated by sponsor|1|||
94738919|NCT04102111|324499764|FG001|Overall Study|Study terminated by sponsor|3|||
94738920|NCT00887198|324499765|FG000|Randomized Period|Ongoing|42|||
94738921|NCT00887198|324499766|FG001|Randomized Period|Ongoing|0|||
94738922|NCT00887198|324499767|FG002|Randomized Period|Ongoing|0|||
94738923|NCT00887198|324499765|FG000|Randomized Period|Adverse Event|50|||
94467502|NCT01738191|323500597|FG001|Overall Study|Withdrawal by Subject|1|||
94467503|NCT00422292|323500598|FG000|Overall Study|Serious adverse events|1|||
94738924|NCT00887198|324499766|FG001|Randomized Period|Adverse Event|33|||
94738925|NCT00887198|324499767|FG002|Randomized Period|Adverse Event|0|||
94738926|NCT00887198|324499765|FG000|Randomized Period|Lost to Follow-up|1|||
94738927|NCT00887198|324499766|FG001|Randomized Period|Lost to Follow-up|0|||
94738928|NCT00887198|324499767|FG002|Randomized Period|Lost to Follow-up|0|||
94738929|NCT00887198|324499765|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
94738930|NCT00887198|324499766|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
94738931|NCT00887198|324499767|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
94738932|NCT00887198|324499765|FG000|Randomized Period|Withdrawal by Subject|41|||
94738933|NCT00887198|324499766|FG001|Randomized Period|Withdrawal by Subject|56|||
94738934|NCT00887198|324499767|FG002|Randomized Period|Withdrawal by Subject|0|||
94738935|NCT00887198|324499765|FG000|Randomized Period|Progressive disease|366|||
94738936|NCT00887198|324499766|FG001|Randomized Period|Progressive disease|370|||
94738937|NCT00887198|324499767|FG002|Randomized Period|Progressive disease|0|||
94738938|NCT00887198|324499765|FG000|Randomized Period|Other|42|||
94738939|NCT00887198|324499766|FG001|Randomized Period|Other|30|||
94738940|NCT00887198|324499767|FG002|Randomized Period|Other|0|||
94738941|NCT00887198|324499765|FG000|Randomized Period|Randomized, Not treated|4|||
94738942|NCT00887198|324499766|FG001|Randomized Period|Randomized, Not treated|2|||
94738943|NCT00887198|324499767|FG002|Randomized Period|Randomized, Not treated|0|||
94738944|NCT00887198|324499765|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
94738945|NCT00887198|324499766|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
94738946|NCT00887198|324499767|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
94738947|NCT00887198|324499765|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
94738948|NCT00887198|324499766|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
94738949|NCT00887198|324499767|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
94738950|NCT00887198|324499765|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
94738951|NCT00887198|324499766|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
94738952|NCT00887198|324499767|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
94738953|NCT00887198|324499765|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
94738954|NCT00887198|324499766|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
94738955|NCT00887198|324499767|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
94738956|NCT00887198|324499765|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
94738957|NCT00887198|324499766|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
94738958|NCT00887198|324499767|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
94738959|NCT00887198|324499765|FG000|Cross Over (Placebo to AA)|Other|0|||
94738960|NCT00887198|324499766|FG001|Cross Over (Placebo to AA)|Other|0|||
94738961|NCT00887198|324499767|FG002|Cross Over (Placebo to AA)|Other|19|||
94738962|NCT02782676|324499768|FG000|Overall Study|Lost to Follow-up|0|||
94738963|NCT02782676|324499769|FG001|Overall Study|Lost to Follow-up|1|||
94738964|NCT05007080|324499770|FG000|Overall Study|Lost to Follow-up|0|||
94738965|NCT05007080|324499771|FG001|Overall Study|Lost to Follow-up|1|||
94738966|NCT05007080|324499772|FG002|Overall Study|Lost to Follow-up|0|||
94467504|NCT00422292|323500599|FG001|Overall Study|Serious adverse events|4|||
94738967|NCT05007080|324499773|FG003|Overall Study|Lost to Follow-up|1|||
94738968|NCT05007080|324499774|FG004|Overall Study|Lost to Follow-up|1|||
94738969|NCT05007080|324499775|FG005|Overall Study|Lost to Follow-up|1|||
94738970|NCT05007080|324499770|FG000|Overall Study|Death|0|||
94738971|NCT05007080|324499771|FG001|Overall Study|Death|1|||
94738972|NCT05007080|324499772|FG002|Overall Study|Death|0|||
94738973|NCT05007080|324499773|FG003|Overall Study|Death|0|||
94738974|NCT05007080|324499774|FG004|Overall Study|Death|0|||
94738975|NCT05007080|324499775|FG005|Overall Study|Death|0|||
94738976|NCT05007080|324499770|FG000|Overall Study|Withdrawal by Subject|1|||
94738977|NCT05007080|324499771|FG001|Overall Study|Withdrawal by Subject|2|||
94738978|NCT05007080|324499772|FG002|Overall Study|Withdrawal by Subject|0|||
94738979|NCT05007080|324499773|FG003|Overall Study|Withdrawal by Subject|2|||
94738980|NCT05007080|324499774|FG004|Overall Study|Withdrawal by Subject|1|||
94738981|NCT05007080|324499775|FG005|Overall Study|Withdrawal by Subject|1|||
94738982|NCT05007080|324499770|FG000|Overall Study|Other|1|||
94738983|NCT05007080|324499771|FG001|Overall Study|Other|0|||
94738984|NCT05007080|324499772|FG002|Overall Study|Other|1|||
94738985|NCT05007080|324499773|FG003|Overall Study|Other|1|||
94738986|NCT05007080|324499774|FG004|Overall Study|Other|0|||
94738987|NCT05007080|324499775|FG005|Overall Study|Other|2|||
94738988|NCT05007080|324499770|FG000|Overall Study|Randomized not vaccinated|0|||
94738989|NCT05007080|324499771|FG001|Overall Study|Randomized not vaccinated|0|||
94738990|NCT05007080|324499772|FG002|Overall Study|Randomized not vaccinated|0|||
94738991|NCT05007080|324499773|FG003|Overall Study|Randomized not vaccinated|0|||
94738992|NCT05007080|324499774|FG004|Overall Study|Randomized not vaccinated|0|||
94738993|NCT05007080|324499775|FG005|Overall Study|Randomized not vaccinated|1|||
94738994|NCT05147584|324499776|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
94738995|NCT04623775|324499783|FG000|Randomization|No Longer Meets Study Criteria|2|||
94738996|NCT04623775|324499784|FG001|Randomization|No Longer Meets Study Criteria|1|||
94738997|NCT04623775|324499785|FG002|Randomization|No Longer Meets Study Criteria|0|||
94738998|NCT04623775|324499786|FG003|Randomization|No Longer Meets Study Criteria|0|||
94738999|NCT04623775|324499783|FG000|Randomization|Withdrew Consent|0|||
94739000|NCT04623775|324499784|FG001|Randomization|Withdrew Consent|0|||
94739001|NCT04623775|324499785|FG002|Randomization|Withdrew Consent|0|||
94739002|NCT04623775|324499786|FG003|Randomization|Withdrew Consent|1|||
94739003|NCT04623775|324499783|FG000|Randomization|Other Reasons|0|||
94739004|NCT04623775|324499784|FG001|Randomization|Other Reasons|0|||
94739005|NCT04623775|324499785|FG002|Randomization|Other Reasons|0|||
94739006|NCT04623775|324499786|FG003|Randomization|Other Reasons|1|||
94739007|NCT04623775|324499783|FG000|Treatment Period|participant withdrew consent|4|||
94739008|NCT04623775|324499784|FG001|Treatment Period|participant withdrew consent|0|||
94739009|NCT04623775|324499785|FG002|Treatment Period|participant withdrew consent|1|||
94739010|NCT04623775|324499786|FG003|Treatment Period|participant withdrew consent|2|||
94739011|NCT04623775|324499783|FG000|Treatment Period|Death|3|||
94739012|NCT04623775|324499784|FG001|Treatment Period|Death|1|||
94739013|NCT04623775|324499785|FG002|Treatment Period|Death|4|||
94739014|NCT04623775|324499786|FG003|Treatment Period|Death|2|||
94739015|NCT04623775|324499783|FG000|Treatment Period|Lost to Follow-up|0|||
94739016|NCT04623775|324499784|FG001|Treatment Period|Lost to Follow-up|2|||
94739017|NCT04623775|324499785|FG002|Treatment Period|Lost to Follow-up|0|||
94739018|NCT04623775|324499786|FG003|Treatment Period|Lost to Follow-up|0|||
94739019|NCT04623775|324499783|FG000|Treatment Period|poor/non compliance|0|||
94739020|NCT04623775|324499784|FG001|Treatment Period|poor/non compliance|0|||
94739021|NCT04623775|324499785|FG002|Treatment Period|poor/non compliance|1|||
94739022|NCT04623775|324499786|FG003|Treatment Period|poor/non compliance|0|||
94739023|NCT04623775|324499783|FG000|Treatment Period|participant no longer meets study criteria|0|||
94739024|NCT04623775|324499784|FG001|Treatment Period|participant no longer meets study criteria|1|||
94739025|NCT04623775|324499785|FG002|Treatment Period|participant no longer meets study criteria|0|||
94739026|NCT04623775|324499786|FG003|Treatment Period|participant no longer meets study criteria|0|||
94739027|NCT04623775|324499783|FG000|Treatment Period|administrative reasons by sponsor|3|||
94739028|NCT04623775|324499784|FG001|Treatment Period|administrative reasons by sponsor|2|||
94739029|NCT04623775|324499785|FG002|Treatment Period|administrative reasons by sponsor|0|||
94739030|NCT04623775|324499786|FG003|Treatment Period|administrative reasons by sponsor|0|||
94739031|NCT04623775|324499783|FG000|Treatment Period|other reasons|2|||
94739032|NCT04623775|324499784|FG001|Treatment Period|other reasons|0|||
94739033|NCT04623775|324499785|FG002|Treatment Period|other reasons|1|||
94739034|NCT04623775|324499786|FG003|Treatment Period|other reasons|1|||
94739035|NCT04623775|324499783|FG000|Treatment Period|disease progression|40|||
94739036|NCT04623775|324499784|FG001|Treatment Period|disease progression|35|||
94739037|NCT04623775|324499785|FG002|Treatment Period|disease progression|63|||
94739038|NCT04623775|324499786|FG003|Treatment Period|disease progression|63|||
94739039|NCT04623775|324499783|FG000|Treatment Period|study drug toxicity|12|||
94739040|NCT04623775|324499784|FG001|Treatment Period|study drug toxicity|15|||
94739041|NCT04623775|324499785|FG002|Treatment Period|study drug toxicity|13|||
94739042|NCT04623775|324499786|FG003|Treatment Period|study drug toxicity|12|||
94739043|NCT04623775|324499783|FG000|Treatment Period|AE unrelated to study drug|4|||
94739044|NCT04623775|324499784|FG001|Treatment Period|AE unrelated to study drug|9|||
94739045|NCT04623775|324499785|FG002|Treatment Period|AE unrelated to study drug|12|||
94739046|NCT04623775|324499786|FG003|Treatment Period|AE unrelated to study drug|9|||
94739047|NCT04623775|324499783|FG000|Treatment Period|participant request to discontinue treatment|0|||
94739048|NCT04623775|324499784|FG001|Treatment Period|participant request to discontinue treatment|2|||
94739049|NCT04623775|324499785|FG002|Treatment Period|participant request to discontinue treatment|2|||
94739050|NCT04623775|324499786|FG003|Treatment Period|participant request to discontinue treatment|0|||
94739051|NCT04583280|324499788|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
94739052|NCT04583280|324499789|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
94739053|NCT00964392|324499790|FG000|Overall Study|Withdrawal by Subject|4|||
94739054|NCT00964392|324499791|FG001|Overall Study|Withdrawal by Subject|6|||
94739055|NCT00964392|324499790|FG000|Overall Study|Lost to Follow-up|4|||
94739056|NCT00964392|324499791|FG001|Overall Study|Lost to Follow-up|10|||
94739057|NCT00964392|324499790|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
94739058|NCT00964392|324499791|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
94739059|NCT00964392|324499790|FG000|Overall Study|Not completed|44|||
94739060|NCT00964392|324499791|FG001|Overall Study|Not completed|168|||
94368959|NCT00555399|323136598|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
94739061|NCT01314105|324501003|FG000|Overall Study|Progressive Disease|6|||
94739062|NCT01314105|324501004|FG001|Overall Study|Progressive Disease|10|||
94739063|NCT01314105|324501003|FG000|Overall Study|Refused to continue taking medication|0|||
94739064|NCT01314105|324501004|FG001|Overall Study|Refused to continue taking medication|1|||
94739065|NCT01314105|324501003|FG000|Overall Study|Other Adverse Event|1|||
94739066|NCT01314105|324501004|FG001|Overall Study|Other Adverse Event|1|||
94739067|NCT04089865|324501005|FG000|Overall Study|Withdrawal by Subject|2|||
94739068|NCT04089865|324501006|FG001|Overall Study|Withdrawal by Subject|2|||
94739069|NCT04089865|324501007|FG002|Overall Study|Withdrawal by Subject|7|||
94739070|NCT04089865|324501008|FG003|Overall Study|Withdrawal by Subject|2|||
94739071|NCT02839265|324501025|FG000|Overall Study|Screen Failure|2|||
94739072|NCT02839265|324501025|FG000|Overall Study|Death|1|||
94739073|NCT02839265|324501025|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
94739074|NCT05533190|324501026|FG000|Overall Study|Lost to Follow-up|19|||
94739075|NCT05533190|324501027|FG001|Overall Study|Lost to Follow-up|7|||
94739076|NCT05533190|324501026|FG000|Overall Study|Failed to download app|1|||
94739077|NCT05533190|324501027|FG001|Overall Study|Failed to download app|0|||
94739078|NCT05533190|324501026|FG000|Overall Study|Thought app was a scam|1|||
94739079|NCT05533190|324501027|FG001|Overall Study|Thought app was a scam|0|||
94739080|NCT05533190|324501026|FG000|Overall Study|Withdrawal by Subject|2|||
94739081|NCT05533190|324501027|FG001|Overall Study|Withdrawal by Subject|0|||
94739082|NCT02367040|324501028|FG000|Overall Study|Lost to Follow-up|1|||
94739083|NCT02367040|324501029|FG001|Overall Study|Lost to Follow-up|1|||
94739084|NCT02367040|324501028|FG000|Overall Study|Lack of Efficacy|1|||
94739085|NCT02367040|324501029|FG001|Overall Study|Lack of Efficacy|0|||
94739086|NCT02367040|324501028|FG000|Overall Study|Additional primary malignancy|0|||
94739087|NCT02367040|324501029|FG001|Overall Study|Additional primary malignancy|1|||
94739088|NCT02367040|324501028|FG000|Overall Study|AE not associated with clinical disease progression|114|||
94739089|NCT02367040|324501029|FG001|Overall Study|AE not associated with clinical disease progression|11|||
94739090|NCT02367040|324501028|FG000|Overall Study|AE associated with clinical disease progression|1|||
94739091|NCT02367040|324501029|FG001|Overall Study|AE associated with clinical disease progression|3|||
94739092|NCT02367040|324501028|FG000|Overall Study|Physician Decision|2|||
94739093|NCT02367040|324501029|FG001|Overall Study|Physician Decision|8|||
94739094|NCT02367040|324501028|FG000|Overall Study|Non-compliance with study drug|1|||
94739095|NCT02367040|324501029|FG001|Overall Study|Non-compliance with study drug|0|||
94739096|NCT02367040|324501028|FG000|Overall Study|Failure to meet continuation criteria|1|||
94739097|NCT02367040|324501029|FG001|Overall Study|Failure to meet continuation criteria|0|||
94739098|NCT02367040|324501028|FG000|Overall Study|Switching to other therapy|2|||
94739099|NCT02367040|324501029|FG001|Overall Study|Switching to other therapy|0|||
94739100|NCT02367040|324501028|FG000|Overall Study|Withdrawal by Subject|46|||
94739101|NCT02367040|324501029|FG001|Overall Study|Withdrawal by Subject|16|||
94739102|NCT02367040|324501028|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
94739103|NCT02367040|324501029|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
94739104|NCT02367040|324501028|FG000|Overall Study|Patient decision|39|||
94739105|NCT02367040|324501029|FG001|Overall Study|Patient decision|14|||
94739106|NCT02367040|324501028|FG000|Overall Study|Required procedure failed|1|||
94739107|NCT02367040|324501029|FG001|Overall Study|Required procedure failed|0|||
94739108|NCT02367040|324501028|FG000|Overall Study|Randomized by mistake with study treatment|1|||
94739109|NCT02367040|324501029|FG001|Overall Study|Randomized by mistake with study treatment|0|||
94739110|NCT02367040|324501028|FG000|Overall Study|Protocol Violation|1|||
94739111|NCT02367040|324501029|FG001|Overall Study|Protocol Violation|0|||
94739112|NCT02367040|324501028|FG000|Overall Study|Progressive disease - radiological progression|51|||
94739113|NCT02367040|324501029|FG001|Overall Study|Progressive disease - radiological progression|78|||
94739114|NCT02367040|324501028|FG000|Overall Study|Progressive disease - clinical progression|6|||
94739115|NCT02367040|324501029|FG001|Overall Study|Progressive disease - clinical progression|6|||
94739116|NCT02367040|324501028|FG000|Overall Study|Drug not administered|3|||
94739117|NCT02367040|324501029|FG001|Overall Study|Drug not administered|2|||
94739118|NCT02367040|324501028|FG000|Overall Study|Progressive disease|0|||
94739119|NCT02367040|324501029|FG001|Overall Study|Progressive disease|1|||
94739120|NCT02367040|324501028|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
94739121|NCT02367040|324501029|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
94739122|NCT02367040|324501028|FG000|Overall Study|Death|2|||
94739123|NCT02367040|324501029|FG001|Overall Study|Death|0|||
94739124|NCT03571386|324501030|FG000|Overall Study|scheduling conflict|4|||
94739125|NCT03571386|324501031|FG001|Overall Study|scheduling conflict|0|||
94739126|NCT03571386|324501030|FG000|Overall Study|Withdrawal by Subject|15|||
94739127|NCT03571386|324501031|FG001|Overall Study|Withdrawal by Subject|5|||
94739128|NCT04605159|324501032|FG000|Overall Study|Adverse Event|6|||
94739129|NCT04605159|324501033|FG001|Overall Study|Adverse Event|3|||
94739130|NCT04605159|324501034|FG002|Overall Study|Adverse Event|21|||
94739131|NCT04605159|324501035|FG003|Overall Study|Adverse Event|4|||
94739132|NCT04605159|324501032|FG000|Overall Study|Lost to Follow-up|74|||
94739133|NCT04605159|324501033|FG001|Overall Study|Lost to Follow-up|45|||
94739134|NCT04605159|324501034|FG002|Overall Study|Lost to Follow-up|119|||
94739135|NCT04605159|324501035|FG003|Overall Study|Lost to Follow-up|80|||
94739136|NCT04605159|324501032|FG000|Overall Study|Protocol Violation|4|||
94739137|NCT04605159|324501033|FG001|Overall Study|Protocol Violation|5|||
94739138|NCT04605159|324501034|FG002|Overall Study|Protocol Violation|2|||
94739139|NCT04605159|324501035|FG003|Overall Study|Protocol Violation|0|||
94739140|NCT04605159|324501032|FG000|Overall Study|Withdrawal by Subject|66|||
94739141|NCT04605159|324501033|FG001|Overall Study|Withdrawal by Subject|37|||
94739142|NCT04605159|324501034|FG002|Overall Study|Withdrawal by Subject|68|||
94739143|NCT04605159|324501035|FG003|Overall Study|Withdrawal by Subject|50|||
94739144|NCT04605159|324501032|FG000|Overall Study|Migrated / moved from the study area|32|||
94739145|NCT04605159|324501033|FG001|Overall Study|Migrated / moved from the study area|22|||
94739146|NCT04605159|324501034|FG002|Overall Study|Migrated / moved from the study area|41|||
94739147|NCT04605159|324501035|FG003|Overall Study|Migrated / moved from the study area|21|||
94739148|NCT04605159|324501032|FG000|Overall Study|Other|1|||
94739149|NCT04605159|324501033|FG001|Overall Study|Other|2|||
94739150|NCT04605159|324501034|FG002|Overall Study|Other|7|||
94739151|NCT04605159|324501035|FG003|Overall Study|Other|3|||
94739152|NCT04167553|324501036|FG000|Overall Study|Withdrawal by Subject|1|||
94739153|NCT04167553|324501037|FG001|Overall Study|Withdrawal by Subject|0|||
94739154|NCT04167553|324501038|FG002|Overall Study|Withdrawal by Subject|1|||
94739155|NCT04167553|324501039|FG003|Overall Study|Withdrawal by Subject|2|||
94368960|NCT00555399|323136599|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
94368961|NCT00555399|323136600|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
94368962|NCT00555399|323136601|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
94368963|NCT00555399|323136602|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
94368964|NCT00555399|323136603|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
94368965|NCT00555399|323136604|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
94368966|NCT05166421|323136605|FG000|Overall Study|Other|3|||
94368967|NCT05166421|323136606|FG001|Overall Study|Other|1|||
94368968|NCT05166421|323136607|FG002|Overall Study|Other|1|||
94739156|NCT04167553|324501040|FG004|Overall Study|Withdrawal by Subject|1|||
94739157|NCT04167553|324501041|FG005|Overall Study|Withdrawal by Subject|0|||
94739158|NCT04167553|324501042|FG006|Overall Study|Withdrawal by Subject|0|||
94739159|NCT04167553|324501036|FG000|Overall Study|Physician Decision|0|||
94739160|NCT04167553|324501037|FG001|Overall Study|Physician Decision|0|||
94739161|NCT04167553|324501038|FG002|Overall Study|Physician Decision|0|||
94739162|NCT04167553|324501039|FG003|Overall Study|Physician Decision|0|||
94739163|NCT04167553|324501040|FG004|Overall Study|Physician Decision|2|||
94739164|NCT04167553|324501041|FG005|Overall Study|Physician Decision|2|||
94739165|NCT04167553|324501042|FG006|Overall Study|Physician Decision|0|||
94739166|NCT04167553|324501036|FG000|Overall Study|Lost to Follow-up|0|||
94739167|NCT04167553|324501037|FG001|Overall Study|Lost to Follow-up|0|||
94739168|NCT04167553|324501038|FG002|Overall Study|Lost to Follow-up|2|||
94739169|NCT04167553|324501039|FG003|Overall Study|Lost to Follow-up|0|||
94739170|NCT04167553|324501040|FG004|Overall Study|Lost to Follow-up|0|||
94739171|NCT04167553|324501041|FG005|Overall Study|Lost to Follow-up|0|||
94739172|NCT04167553|324501042|FG006|Overall Study|Lost to Follow-up|0|||
94739173|NCT05224544|324501044|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
94739174|NCT05224544|324501045|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
94739175|NCT03717935|324501047|FG000|Overall Study|Withdrawal by Subject|0|||
94739176|NCT03717935|324501048|FG001|Overall Study|Withdrawal by Subject|2|||
94739177|NCT01820611|324501049|FG000|Overall Study|Death|8|||
94739178|NCT01820611|324501049|FG000|Overall Study|Adverse Event|1|||
94739179|NCT01820611|324501049|FG000|Overall Study|Withdrawal by Subject|9|||
94739180|NCT04881461|324501050|FG000|Overall Study|Adverse Event|2|||
94739181|NCT04881461|324501051|FG001|Overall Study|Adverse Event|4|||
94739182|NCT04881461|324501050|FG000|Overall Study|Withdrawal by Subject|19|||
94739183|NCT04881461|324501051|FG001|Overall Study|Withdrawal by Subject|19|||
94739184|NCT04881461|324501050|FG000|Overall Study|Lost to Follow-up|4|||
94739185|NCT04881461|324501051|FG001|Overall Study|Lost to Follow-up|4|||
94739186|NCT04881461|324501050|FG000|Overall Study|Lack of Efficacy|1|||
94739187|NCT04881461|324501051|FG001|Overall Study|Lack of Efficacy|0|||
94739188|NCT04881461|324501050|FG000|Overall Study|"Reason stated as other in CRF"|1|||
94739189|NCT04881461|324501051|FG001|Overall Study|"Reason stated as other in CRF"|2|||
94739190|NCT05970861|324501052|FG000|Overall Study|Physician Decision|4|||
94739191|NCT05970861|324501053|FG001|Overall Study|Physician Decision|4|||
94739192|NCT05970861|324501052|FG000|Overall Study|Lost to Follow-up|4|||
94739193|NCT05970861|324501053|FG001|Overall Study|Lost to Follow-up|3|||
94739194|NCT04186819|324501054|FG000|Overall Study|Adverse Event|1|||
94739195|NCT04186819|324501054|FG000|Overall Study|Lost to Follow-up|1|||
94739196|NCT04186819|324501054|FG000|Overall Study|Opted for EBRT|1|||
94368969|NCT05166421|323136605|FG000|Overall Study|Withdrawal by Subject|5|||
94739197|NCT04186819|324501054|FG000|Overall Study|Opted SBRT|1|||
94739198|NCT04186819|324501054|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
94739199|NCT04186819|324501054|FG000|Overall Study|Physician Decision|1|||
94739200|NCT04186819|324501054|FG000|Overall Study|RP Delayed|1|||
94739201|NCT04186819|324501054|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
94739202|NCT04186819|324501054|FG000|Overall Study|Subject declined for financial reasons|1|||
94739203|NCT04186819|324501054|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
94739204|NCT04186819|324501054|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
94739205|NCT04186819|324501054|FG000|Overall Study|The subject opted for other treatment option|2|||
94739206|NCT04186819|324501054|FG000|Overall Study|The subject opted for other treatment options|1|||
94739207|NCT04186819|324501054|FG000|Overall Study|Withdrawal by Subject|3|||
94739208|NCT04186819|324501054|FG000|Overall Study|Reason not specified|1|||
94739209|NCT05013385|324501061|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
94739210|NCT04271046|324501062|FG000|Overall Study|Death|0|||
94739211|NCT04271046|324501063|FG001|Overall Study|Death|2|||
94739212|NCT04271046|324501064|FG002|Overall Study|Death|0|||
94739213|NCT04271046|324501065|FG003|Overall Study|Death|2|||
94739214|NCT04271046|324501062|FG000|Overall Study|Lost to Follow-up|12|||
94739215|NCT04271046|324501063|FG001|Overall Study|Lost to Follow-up|12|||
94739216|NCT04271046|324501064|FG002|Overall Study|Lost to Follow-up|11|||
94739217|NCT04271046|324501065|FG003|Overall Study|Lost to Follow-up|11|||
94739218|NCT04271046|324501062|FG000|Overall Study|Patient with Dementia Died|2|||
94739219|NCT04271046|324501063|FG001|Overall Study|Patient with Dementia Died|0|||
94739220|NCT04271046|324501064|FG002|Overall Study|Patient with Dementia Died|2|||
94739221|NCT04271046|324501065|FG003|Overall Study|Patient with Dementia Died|0|||
94739222|NCT04271046|324501062|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
94739223|NCT04271046|324501063|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
94739224|NCT04271046|324501064|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
94739225|NCT04271046|324501065|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
94739226|NCT00303459|324501066|FG000|Overall Study|Death|33|||
94739227|NCT00303459|324501067|FG001|Overall Study|Death|44|||
94739228|NCT00303459|324501066|FG000|Overall Study|Withdrawal of consent|32|||
94739229|NCT00303459|324501067|FG001|Overall Study|Withdrawal of consent|26|||
94739230|NCT00303459|324501066|FG000|Overall Study|Lost to Follow-up|5|||
94739231|NCT00303459|324501067|FG001|Overall Study|Lost to Follow-up|4|||
94739232|NCT00303459|324501066|FG000|Overall Study|Administrative reason|7|||
94739233|NCT00303459|324501067|FG001|Overall Study|Administrative reason|7|||
94739234|NCT00303459|324501066|FG000|Overall Study|Decision by the investigator|5|||
94739235|NCT00303459|324501067|FG001|Overall Study|Decision by the investigator|7|||
94739236|NCT00303459|324501066|FG000|Overall Study|Lung transplantation|1|||
94739237|NCT00303459|324501067|FG001|Overall Study|Lung transplantation|1|||
94739238|NCT01570361|324501068|FG000|Overall Study|Subject discontinued|1|||
94739239|NCT01570361|324501069|FG001|Overall Study|Subject discontinued|2|||
94739240|NCT01570361|324501068|FG000|Overall Study|Sponsor closing the study|51|||
94739241|NCT01570361|324501069|FG001|Overall Study|Sponsor closing the study|50|||
94739242|NCT01570361|324501068|FG000|Overall Study|Subject excluded|5|||
94739243|NCT01570361|324501069|FG001|Overall Study|Subject excluded|3|||
94739244|NCT01570361|324501068|FG000|Overall Study|Subject withdrew consent|14|||
94739245|NCT01570361|324501069|FG001|Overall Study|Subject withdrew consent|9|||
94739246|NCT01570361|324501068|FG000|Overall Study|Adverse Event|2|||
94739247|NCT01570361|324501069|FG001|Overall Study|Adverse Event|1|||
94739248|NCT01570361|324501068|FG000|Overall Study|Lost to Follow-up|4|||
94739249|NCT01570361|324501069|FG001|Overall Study|Lost to Follow-up|4|||
94739250|NCT01570361|324501068|FG000|Overall Study|Death|5|||
94739251|NCT01570361|324501069|FG001|Overall Study|Death|4|||
94739252|NCT01570361|324501068|FG000|Overall Study|Other|0|||
94739253|NCT01570361|324501069|FG001|Overall Study|Other|2|||
94739254|NCT04129554|324501070|FG000|Overall Study|Withdrawal by Subject|4|||
94739255|NCT04129554|324501071|FG001|Overall Study|Withdrawal by Subject|3|||
94739256|NCT04129554|324501070|FG000|Overall Study|Other|0|||
94739257|NCT04129554|324501071|FG001|Overall Study|Other|2|||
94739258|NCT03663205|324501072|FG000|Overall Study|Death|144|||
94739259|NCT03663205|324501073|FG001|Overall Study|Death|69|||
94739260|NCT03663205|324501072|FG000|Overall Study|Sponsor decision|53|||
94739261|NCT03663205|324501073|FG001|Overall Study|Sponsor decision|19|||
94739262|NCT03663205|324501072|FG000|Overall Study|Withdrawal by Subject|8|||
94739263|NCT03663205|324501073|FG001|Overall Study|Withdrawal by Subject|11|||
94739264|NCT03663205|324501072|FG000|Overall Study|Lost to Follow-up|7|||
94739265|NCT03663205|324501073|FG001|Overall Study|Lost to Follow-up|9|||
94739266|NCT03663205|324501072|FG000|Overall Study|Transferred to long term extension study|11|||
94739267|NCT03663205|324501073|FG001|Overall Study|Transferred to long term extension study|3|||
94739268|NCT03652272|324501074|FG000|3 Month|Withdrawal by Subject|1|||
94739269|NCT03652272|324501075|FG001|3 Month|Withdrawal by Subject|1|||
94739270|NCT03652272|324501074|FG000|3 Month|Lost to Follow-up|16|||
94739271|NCT03652272|324501075|FG001|3 Month|Lost to Follow-up|14|||
94739272|NCT02326974|324501079|FG000|Overall Study|Withdrawal by Subject|2|||
94739273|NCT02326974|324501079|FG000|Overall Study|failed heterogenity evaluation|5|||
94739274|NCT02577354|324501080|FG000|Overall Study|Lack of Efficacy|4|||
94739275|NCT02577354|324501081|FG001|Overall Study|Lack of Efficacy|4|||
94739276|NCT02577354|324501080|FG000|Overall Study|Lost to Follow-up|3|||
94739277|NCT02577354|324501081|FG001|Overall Study|Lost to Follow-up|1|||
94739278|NCT02577354|324501080|FG000|Overall Study|Missed Visit|4|||
94739279|NCT02577354|324501081|FG001|Overall Study|Missed Visit|3|||
94739280|NCT02577354|324501080|FG000|Overall Study|Adverse Event|4|||
94739281|NCT02577354|324501081|FG001|Overall Study|Adverse Event|5|||
94739282|NCT04173247|324501082|FG000|Overall Study|Withdrawal by Subject|0|||
94739283|NCT04173247|324501083|FG001|Overall Study|Withdrawal by Subject|2|||
94739284|NCT04173247|324501082|FG000|Overall Study|Death|1|||
94739285|NCT04173247|324501083|FG001|Overall Study|Death|0|||
94739286|NCT04173247|324501082|FG000|Overall Study|Physician Decision|1|||
94739287|NCT04173247|324501083|FG001|Overall Study|Physician Decision|0|||
94739288|NCT03993392|324501087|FG000|Overall Study|Withdrawal by Subject|3|||
94739289|NCT03993392|324501087|FG000|Overall Study|Lost to Follow-up|2|||
94739290|NCT03993392|324501087|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
94739291|NCT05525104|324501088|FG000|Overall Study|Failed caudal analgesia|1|||
94739292|NCT05525104|324501089|FG001|Overall Study|Failed caudal analgesia|3|||
94739293|NCT05525104|324501088|FG000|Overall Study|Premedication needed|0|||
94739294|NCT05525104|324501089|FG001|Overall Study|Premedication needed|1|||
94739295|NCT05525104|324501088|FG000|Overall Study|Protocol Violation|10|||
94739296|NCT05525104|324501089|FG001|Overall Study|Protocol Violation|0|||
94739297|NCT05525104|324501088|FG000|Overall Study|Cancelled operation|1|||
94739298|NCT05525104|324501089|FG001|Overall Study|Cancelled operation|0|||
94739299|NCT03990883|324501090|FG000|Blinded Treatment Phase|Adverse Event|1|||
94739300|NCT03990883|324501091|FG001|Blinded Treatment Phase|Adverse Event|1|||
94739301|NCT03990883|324501092|FG002|Blinded Treatment Phase|Adverse Event|0|||
94739302|NCT03990883|324501090|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
94739303|NCT03990883|324501091|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
94739304|NCT03990883|324501092|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
94739305|NCT03990883|324501090|FG000|Blinded Treatment Phase|Physician Decision|1|||
94739306|NCT03990883|324501091|FG001|Blinded Treatment Phase|Physician Decision|0|||
94739307|NCT03990883|324501092|FG002|Blinded Treatment Phase|Physician Decision|0|||
94739308|NCT03990883|324501090|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
94739309|NCT03990883|324501091|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
94739310|NCT03990883|324501092|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
94739311|NCT03990883|324501090|FG000|Blinded Treatment Phase|COVID-19|3|||
94739312|NCT03990883|324501091|FG001|Blinded Treatment Phase|COVID-19|2|||
94739313|NCT03990883|324501092|FG002|Blinded Treatment Phase|COVID-19|0|||
94739314|NCT03990883|324501090|FG000|Blinded Treatment Phase|Personal Reasons|6|||
94739315|NCT03990883|324501091|FG001|Blinded Treatment Phase|Personal Reasons|3|||
94739316|NCT03990883|324501092|FG002|Blinded Treatment Phase|Personal Reasons|0|||
94739317|NCT03990883|324501090|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
94739318|NCT03990883|324501091|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
94739319|NCT03990883|324501092|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
94739320|NCT03990883|324501090|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
94739321|NCT03990883|324501091|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
94739322|NCT03990883|324501092|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
94739323|NCT03990883|324501090|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
94739324|NCT03990883|324501091|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
94739325|NCT03990883|324501092|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
94739326|NCT06106022|324502339|FG000|Overall Study|Lost to Follow-up|1|||
94739327|NCT06106022|324502340|FG001|Overall Study|Lost to Follow-up|0|||
94739328|NCT06106022|324502339|FG000|Overall Study|Voluntary Withdrawal|0|||
94739329|NCT06106022|324502340|FG001|Overall Study|Voluntary Withdrawal|2|||
94739330|NCT03276676|324502341|FG000|Overall Study|Withdrawal by Subject|2|||
94739331|NCT03276676|324502342|FG001|Overall Study|Withdrawal by Subject|1|||
94739332|NCT03583333|324502344|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
94739333|NCT03583333|324502345|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
94739334|NCT03583333|324502344|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
94739335|NCT03583333|324502345|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
94739336|NCT03583333|324502344|FG000|Overall Study|Withdrawal by Subject|9|||
94739337|NCT03583333|324502345|FG001|Overall Study|Withdrawal by Subject|5|||
94739338|NCT03583333|324502344|FG000|Overall Study|Physician Decision|3|||
94739339|NCT03583333|324502345|FG001|Overall Study|Physician Decision|2|||
94739340|NCT03583333|324502344|FG000|Overall Study|Death|12|||
94739341|NCT03583333|324502345|FG001|Overall Study|Death|7|||
94739342|NCT05552508|324502346|FG000|Overall Study|Adverse Event|3|||
94739343|NCT02323880|324502353|FG000|Overall Study|Adverse Event|2|||
94739344|NCT02323880|324502354|FG001|Overall Study|Adverse Event|0|||
94739345|NCT02323880|324502355|FG002|Overall Study|Adverse Event|1|||
94739346|NCT02323880|324502356|FG003|Overall Study|Adverse Event|1|||
94739347|NCT02323880|324502357|FG004|Overall Study|Adverse Event|1|||
94739348|NCT02323880|324502358|FG005|Overall Study|Adverse Event|0|||
94739349|NCT02323880|324502359|FG006|Overall Study|Adverse Event|1|||
94739350|NCT02323880|324502360|FG007|Overall Study|Adverse Event|0|||
94739351|NCT02323880|324502353|FG000|Overall Study|Death|0|||
94739352|NCT02323880|324502354|FG001|Overall Study|Death|0|||
94739353|NCT02323880|324502355|FG002|Overall Study|Death|0|||
94739354|NCT02323880|324502356|FG003|Overall Study|Death|0|||
94739355|NCT02323880|324502357|FG004|Overall Study|Death|0|||
94739356|NCT02323880|324502358|FG005|Overall Study|Death|1|||
94739357|NCT02323880|324502359|FG006|Overall Study|Death|0|||
94739358|NCT02323880|324502360|FG007|Overall Study|Death|0|||
94739359|NCT02323880|324502353|FG000|Overall Study|Lack of Efficacy|4|||
94739360|NCT02323880|324502354|FG001|Overall Study|Lack of Efficacy|11|||
94739361|NCT02323880|324502355|FG002|Overall Study|Lack of Efficacy|5|||
94739362|NCT02323880|324502356|FG003|Overall Study|Lack of Efficacy|5|||
94739363|NCT02323880|324502357|FG004|Overall Study|Lack of Efficacy|4|||
94739364|NCT02323880|324502358|FG005|Overall Study|Lack of Efficacy|8|||
94739365|NCT02323880|324502359|FG006|Overall Study|Lack of Efficacy|4|||
94739366|NCT02323880|324502360|FG007|Overall Study|Lack of Efficacy|6|||
94739367|NCT02323880|324502353|FG000|Overall Study|Physician Decision|0|||
94739368|NCT02323880|324502354|FG001|Overall Study|Physician Decision|0|||
94739369|NCT02323880|324502355|FG002|Overall Study|Physician Decision|0|||
94739370|NCT02323880|324502356|FG003|Overall Study|Physician Decision|0|||
94739371|NCT02323880|324502357|FG004|Overall Study|Physician Decision|1|||
94739372|NCT02323880|324502358|FG005|Overall Study|Physician Decision|1|||
94739373|NCT02323880|324502359|FG006|Overall Study|Physician Decision|1|||
94739374|NCT02323880|324502360|FG007|Overall Study|Physician Decision|0|||
94739375|NCT02323880|324502353|FG000|Overall Study|Withdrawal by Subject|0|||
94739376|NCT02323880|324502354|FG001|Overall Study|Withdrawal by Subject|2|||
94739377|NCT02323880|324502355|FG002|Overall Study|Withdrawal by Subject|0|||
94739378|NCT02323880|324502356|FG003|Overall Study|Withdrawal by Subject|0|||
94739379|NCT02323880|324502357|FG004|Overall Study|Withdrawal by Subject|0|||
94739380|NCT02323880|324502358|FG005|Overall Study|Withdrawal by Subject|0|||
94739381|NCT02323880|324502359|FG006|Overall Study|Withdrawal by Subject|0|||
94739382|NCT02323880|324502360|FG007|Overall Study|Withdrawal by Subject|0|||
94739383|NCT02278211|324502361|FG000|Overall Study|Unable to analyse PET scan|2|||
94739384|NCT02916771|324502364|FG000|Overall Study|Withdrawal by Subject|3|||
94739385|NCT02916771|324502364|FG000|Overall Study|Physician Decision|1|||
94739386|NCT02916771|324502364|FG000|Overall Study|Began treatment for another active malignancy|1|||
94739387|NCT05100628|324502366|FG000|Overall Study|Progressive Disease|1|||
94739388|NCT05100628|324502367|FG001|Overall Study|Progressive Disease|0|||
94739389|NCT05100628|324502368|FG002|Overall Study|Progressive Disease|0|||
94739390|NCT05100628|324502369|FG003|Overall Study|Progressive Disease|0|||
94739391|NCT05100628|324502366|FG000|Overall Study|Study Terminated by Sponsor|0|||
94739392|NCT05100628|324502367|FG001|Overall Study|Study Terminated by Sponsor|0|||
94739393|NCT05100628|324502368|FG002|Overall Study|Study Terminated by Sponsor|3|||
94739394|NCT05100628|324502369|FG003|Overall Study|Study Terminated by Sponsor|0|||
94739395|NCT05100628|324502366|FG000|Overall Study|unkown|0|||
94739396|NCT05100628|324502367|FG001|Overall Study|unkown|1|||
94739397|NCT05100628|324502368|FG002|Overall Study|unkown|0|||
94739398|NCT05100628|324502369|FG003|Overall Study|unkown|0|||
94739399|NCT03914469|324502370|FG000|Overall Study|Lost to Follow-up|1|||
94739400|NCT03914469|324502371|FG001|Overall Study|Lost to Follow-up|4|||
94739401|NCT04778410|324502372|FG000|Safety Run-in Period|Death|5|||
94739402|NCT04778410|324502373|FG001|Safety Run-in Period|Death|6|||
94739403|NCT04778410|324502374|FG002|Safety Run-in Period|Death|0|||
94739404|NCT04778410|324502375|FG003|Safety Run-in Period|Death|0|||
94739405|NCT04778410|324502376|FG004|Safety Run-in Period|Death|0|||
94739406|NCT04778410|324502377|FG005|Safety Run-in Period|Death|0|||
94739407|NCT04778410|324502372|FG000|Phase 2 Period|Death|0|||
94739408|NCT04778410|324502373|FG001|Phase 2 Period|Death|0|||
94739409|NCT04778410|324502374|FG002|Phase 2 Period|Death|0|||
94739410|NCT04778410|324502375|FG003|Phase 2 Period|Death|5|||
94739411|NCT04778410|324502376|FG004|Phase 2 Period|Death|18|||
94739412|NCT04778410|324502377|FG005|Phase 2 Period|Death|0|||
94739413|NCT04778410|324502372|FG000|Phase 2 Period|Lost to Follow-up|0|||
94739414|NCT04778410|324502373|FG001|Phase 2 Period|Lost to Follow-up|0|||
94739415|NCT04778410|324502374|FG002|Phase 2 Period|Lost to Follow-up|0|||
94739416|NCT04778410|324502375|FG003|Phase 2 Period|Lost to Follow-up|1|||
94739417|NCT04778410|324502376|FG004|Phase 2 Period|Lost to Follow-up|1|||
94739418|NCT04778410|324502377|FG005|Phase 2 Period|Lost to Follow-up|0|||
94739419|NCT04778410|324502372|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
94739420|NCT04778410|324502373|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
94739421|NCT04778410|324502374|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
94739422|NCT04778410|324502375|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
94739423|NCT04778410|324502376|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
94739424|NCT04778410|324502377|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
94739425|NCT04778410|324502372|FG000|Phase 2 Period|Withdrew Consent|0|||
94739426|NCT04778410|324502373|FG001|Phase 2 Period|Withdrew Consent|0|||
94739427|NCT04778410|324502374|FG002|Phase 2 Period|Withdrew Consent|0|||
94739428|NCT04778410|324502375|FG003|Phase 2 Period|Withdrew Consent|0|||
94739429|NCT04778410|324502376|FG004|Phase 2 Period|Withdrew Consent|2|||
94739430|NCT04778410|324502377|FG005|Phase 2 Period|Withdrew Consent|0|||
94739431|NCT03252288|324502382|FG000|Overall Study|Death|1|||
94739432|NCT03252288|324502383|FG001|Overall Study|Death|0|||
94739433|NCT03252288|324502384|FG002|Overall Study|Death|0|||
94739434|NCT03252288|324502382|FG000|Overall Study|Death|11|||
94739435|NCT03252288|324502383|FG001|Overall Study|Death|0|||
94739436|NCT03252288|324502384|FG002|Overall Study|Death|0|||
94739437|NCT03252288|324502382|FG000|Overall Study|Withdrawal by Subject|2|||
94739438|NCT03252288|324502383|FG001|Overall Study|Withdrawal by Subject|0|||
94739439|NCT03252288|324502384|FG002|Overall Study|Withdrawal by Subject|0|||
94739440|NCT03252288|324502382|FG000|Overall Study|Lost to Follow-up|79|||
94739441|NCT03252288|324502383|FG001|Overall Study|Lost to Follow-up|0|||
94739442|NCT03252288|324502384|FG002|Overall Study|Lost to Follow-up|0|||
94739443|NCT03252288|324502382|FG000|Overall Study|Loss of baseline data on tablets|6|||
94739444|NCT03252288|324502383|FG001|Overall Study|Loss of baseline data on tablets|0|||
94739445|NCT03252288|324502384|FG002|Overall Study|Loss of baseline data on tablets|0|||
94739446|NCT05422885|324502385|FG000|Overall Study|Lost to Follow-up|1|||
94739447|NCT05422885|324502385|FG000|Overall Study|Withdrawal by Subject|2|||
94739448|NCT05900154|324502386|FG000|Follow-Up Period|Lost to Follow-up|1|||
94739449|NCT05900154|324502387|FG001|Follow-Up Period|Lost to Follow-up|2|||
94739450|NCT05900154|324502388|FG002|Follow-Up Period|Lost to Follow-up|1|||
94739451|NCT05900154|324502389|FG003|Follow-Up Period|Lost to Follow-up|0|||
94739452|NCT05900154|324502390|FG004|Follow-Up Period|Lost to Follow-up|1|||
94739453|NCT05900154|324502391|FG005|Follow-Up Period|Lost to Follow-up|1|||
94739454|NCT03334695|324502399|FG000|Overall Study|Lost to Follow-up|3|||
94739455|NCT03334695|324502400|FG001|Overall Study|Lost to Follow-up|3|||
94739456|NCT03334695|324502399|FG000|Overall Study|Physician Decision|1|||
94739457|NCT03334695|324502400|FG001|Overall Study|Physician Decision|2|||
94739458|NCT03334695|324502399|FG000|Overall Study|Protocol Violation|0|||
94739459|NCT03334695|324502400|FG001|Overall Study|Protocol Violation|1|||
94739460|NCT02641730|324502401|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
94739461|NCT02641730|324502402|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
94739462|NCT02641730|324502403|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
94739463|NCT02641730|324502404|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
94739464|NCT02641730|324502405|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
94739465|NCT02641730|324502401|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
94739466|NCT02641730|324502402|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
94739467|NCT02641730|324502403|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
94739468|NCT02641730|324502404|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
94739469|NCT02641730|324502405|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
94739470|NCT02641730|324502401|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
94739471|NCT02641730|324502402|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
94739472|NCT02641730|324502403|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
94739473|NCT02641730|324502404|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
94739474|NCT02641730|324502405|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
94739475|NCT02641730|324502401|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
94739476|NCT02641730|324502402|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
94739477|NCT02641730|324502403|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
94739478|NCT02641730|324502404|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
94739479|NCT02641730|324502405|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
94739480|NCT02641730|324502401|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
94739481|NCT02641730|324502402|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
94739482|NCT02641730|324502403|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
94739483|NCT02641730|324502404|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
94739484|NCT02641730|324502405|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
94739485|NCT02641730|324502401|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
94739486|NCT02641730|324502402|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
94739487|NCT02641730|324502403|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
94739488|NCT02641730|324502404|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
94739489|NCT02641730|324502405|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
94739490|NCT00319046|324502406|FG000|Overall Study|withdrawal of subject's consent|7|||
94739491|NCT00319046|324502406|FG000|Overall Study|administrative reason|1|||
94739492|NCT05460871|324502407|FG000|Overall Study|Withdrawal by Subject|1|||
94739493|NCT05460871|324502408|FG001|Overall Study|Withdrawal by Subject|2|||
94739494|NCT00721149|324502409|FG000|Overall Study|Physician Decision|1|||
94739495|NCT02874742|324502410|FG000|Overall Study|Death|0|||
94739496|NCT02874742|324502411|FG001|Overall Study|Death|1|||
94739497|NCT02874742|324502412|FG002|Overall Study|Death|0|||
94739498|NCT02874742|324502410|FG000|Overall Study|Lost to Follow-up|5|||
94739499|NCT02874742|324502411|FG001|Overall Study|Lost to Follow-up|4|||
94739500|NCT02874742|324502412|FG002|Overall Study|Lost to Follow-up|1|||
94739501|NCT02874742|324502410|FG000|Overall Study|Withdrawal by Subject|17|||
94739502|NCT02874742|324502411|FG001|Overall Study|Withdrawal by Subject|8|||
94739503|NCT02874742|324502412|FG002|Overall Study|Withdrawal by Subject|0|||
94739504|NCT02874742|324502410|FG000|Overall Study|Other|4|||
94739505|NCT02874742|324502411|FG001|Overall Study|Other|1|||
94739506|NCT02874742|324502412|FG002|Overall Study|Other|0|||
94739507|NCT02874742|324502410|FG000|Overall Study|Progressive Disease|1|||
94739508|NCT02874742|324502411|FG001|Overall Study|Progressive Disease|0|||
94739509|NCT02874742|324502412|FG002|Overall Study|Progressive Disease|0|||
94739510|NCT02874742|324502410|FG000|Overall Study|Screen Failure|0|||
94739511|NCT02874742|324502411|FG001|Overall Study|Screen Failure|2|||
94739512|NCT02874742|324502412|FG002|Overall Study|Screen Failure|0|||
94739513|NCT04614948|324502415|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
94739514|NCT04614948|324502416|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
94739515|NCT04614948|324502417|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
94739516|NCT04614948|324502415|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
94739517|NCT04614948|324502416|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
94739518|NCT04614948|324502417|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
94739519|NCT04614948|324502415|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
94739520|NCT04614948|324502416|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
94739521|NCT04614948|324502417|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
94739522|NCT04614948|324502415|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
94739523|NCT04614948|324502416|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
94739524|NCT04614948|324502417|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
94739525|NCT04614948|324502415|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
94739526|NCT04614948|324502416|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
94739527|NCT04614948|324502417|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
94739528|NCT04614948|324502415|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
94739529|NCT04614948|324502416|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
94739530|NCT04614948|324502417|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
94739531|NCT04614948|324502415|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
94739532|NCT04614948|324502416|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
94739533|NCT04614948|324502417|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
94739534|NCT04614948|324502415|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
94739535|NCT04614948|324502416|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
94739536|NCT04614948|324502417|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
94739537|NCT04614948|324502415|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
94739538|NCT04614948|324502416|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
94739539|NCT04614948|324502417|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
94739540|NCT04614948|324502415|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
94739541|NCT04614948|324502416|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
94739542|NCT04614948|324502417|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
94739543|NCT04614948|324502415|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
94739544|NCT04614948|324502416|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
94739545|NCT04614948|324502417|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
94739546|NCT04614948|324502415|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
94739547|NCT04614948|324502416|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
94739548|NCT04614948|324502417|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
94739549|NCT04614948|324502415|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
94739550|NCT04614948|324502416|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
94739551|NCT04614948|324502417|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
94739552|NCT04614948|324502415|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
94739553|NCT04614948|324502416|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
94739554|NCT04614948|324502417|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
94739555|NCT04614948|324502415|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
94739556|NCT04614948|324502416|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
94739557|NCT04614948|324502417|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
94739558|NCT04614948|324502415|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
94739559|NCT04614948|324502416|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
94739560|NCT04614948|324502417|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
94739561|NCT04614948|324502415|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
94739562|NCT04614948|324502416|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
94739563|NCT04614948|324502417|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
94739564|NCT04614948|324502415|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
94739565|NCT04614948|324502416|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
94739566|NCT04614948|324502417|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
94739567|NCT04614948|324502415|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
94739568|NCT04614948|324502416|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
94739569|NCT04614948|324502417|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
94739570|NCT04614948|324502415|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
94739571|NCT04614948|324502416|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
94739572|NCT04614948|324502417|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
94739573|NCT04614948|324502415|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
94739574|NCT04614948|324502416|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
94739575|NCT04614948|324502417|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
94739576|NCT04614948|324502415|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
94739577|NCT04614948|324502416|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
94739578|NCT04614948|324502417|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
94739579|NCT04614948|324502415|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
94739580|NCT04614948|324502416|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
94739581|NCT04614948|324502417|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
94739582|NCT02101853|324502418|FG000|Block 1 Induction|Adverse Event|11|||
94739583|NCT02101853|324502419|FG001|Block 1 Induction|Adverse Event|0|||
94739584|NCT02101853|324502420|FG002|Block 1 Induction|Adverse Event|0|||
94739585|NCT02101853|324502421|FG003|Block 1 Induction|Adverse Event|0|||
94739586|NCT02101853|324502422|FG004|Block 1 Induction|Adverse Event|0|||
94739587|NCT02101853|324502423|FG005|Block 1 Induction|Adverse Event|0|||
94739588|NCT02101853|324502418|FG000|Block 1 Induction|Death|20|||
94739589|NCT02101853|324502419|FG001|Block 1 Induction|Death|0|||
94739590|NCT02101853|324502420|FG002|Block 1 Induction|Death|0|||
94739591|NCT02101853|324502421|FG003|Block 1 Induction|Death|0|||
94739592|NCT02101853|324502422|FG004|Block 1 Induction|Death|0|||
94739593|NCT02101853|324502423|FG005|Block 1 Induction|Death|0|||
94739594|NCT02101853|324502418|FG000|Block 1 Induction|Lack of Efficacy|6|||
94739595|NCT02101853|324502419|FG001|Block 1 Induction|Lack of Efficacy|0|||
94739596|NCT02101853|324502420|FG002|Block 1 Induction|Lack of Efficacy|0|||
94739597|NCT02101853|324502421|FG003|Block 1 Induction|Lack of Efficacy|0|||
94739598|NCT02101853|324502422|FG004|Block 1 Induction|Lack of Efficacy|0|||
94739599|NCT02101853|324502423|FG005|Block 1 Induction|Lack of Efficacy|0|||
94739600|NCT02101853|324502418|FG000|Block 1 Induction|Physician Decision|61|||
94739601|NCT02101853|324502419|FG001|Block 1 Induction|Physician Decision|0|||
94739602|NCT02101853|324502420|FG002|Block 1 Induction|Physician Decision|0|||
94739603|NCT02101853|324502421|FG003|Block 1 Induction|Physician Decision|0|||
94739604|NCT02101853|324502422|FG004|Block 1 Induction|Physician Decision|0|||
94739605|NCT02101853|324502423|FG005|Block 1 Induction|Physician Decision|0|||
94739606|NCT02101853|324502418|FG000|Block 1 Induction|Protocol Violation|2|||
94739607|NCT02101853|324502419|FG001|Block 1 Induction|Protocol Violation|0|||
94739608|NCT02101853|324502420|FG002|Block 1 Induction|Protocol Violation|0|||
94739609|NCT02101853|324502421|FG003|Block 1 Induction|Protocol Violation|0|||
94739610|NCT02101853|324502422|FG004|Block 1 Induction|Protocol Violation|0|||
94739611|NCT02101853|324502423|FG005|Block 1 Induction|Protocol Violation|0|||
94739612|NCT02101853|324502418|FG000|Block 1 Induction|Withdrawal by Subject|65|||
94739613|NCT02101853|324502419|FG001|Block 1 Induction|Withdrawal by Subject|0|||
94739614|NCT02101853|324502420|FG002|Block 1 Induction|Withdrawal by Subject|0|||
94739615|NCT02101853|324502421|FG003|Block 1 Induction|Withdrawal by Subject|0|||
94739616|NCT02101853|324502422|FG004|Block 1 Induction|Withdrawal by Subject|0|||
94739617|NCT02101853|324502423|FG005|Block 1 Induction|Withdrawal by Subject|0|||
94739618|NCT02101853|324502418|FG000|Block 1 Induction|Ineligible|8|||
94739619|NCT02101853|324502419|FG001|Block 1 Induction|Ineligible|0|||
94739620|NCT02101853|324502420|FG002|Block 1 Induction|Ineligible|0|||
94739621|NCT02101853|324502421|FG003|Block 1 Induction|Ineligible|0|||
94739622|NCT02101853|324502422|FG004|Block 1 Induction|Ineligible|0|||
94739623|NCT02101853|324502423|FG005|Block 1 Induction|Ineligible|0|||
94739624|NCT02101853|324502418|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
94739625|NCT02101853|324502419|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
94739626|NCT02101853|324502420|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
94739627|NCT02101853|324502421|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
94739628|NCT02101853|324502422|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
94739629|NCT02101853|324502423|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
94739630|NCT02101853|324502418|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
94739631|NCT02101853|324502419|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
94739632|NCT02101853|324502420|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
94739633|NCT02101853|324502421|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
94739634|NCT02101853|324502422|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
94739635|NCT02101853|324502423|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
94739636|NCT02101853|324502418|FG000|Post Induction Randomization|Adverse Event|0|||
94739637|NCT02101853|324502419|FG001|Post Induction Randomization|Adverse Event|3|||
94739638|NCT02101853|324502420|FG002|Post Induction Randomization|Adverse Event|8|||
94739639|NCT02101853|324502421|FG003|Post Induction Randomization|Adverse Event|4|||
94739640|NCT02101853|324502422|FG004|Post Induction Randomization|Adverse Event|4|||
94739641|NCT02101853|324502423|FG005|Post Induction Randomization|Adverse Event|0|||
94739642|NCT02101853|324502418|FG000|Post Induction Randomization|Death|0|||
94739643|NCT02101853|324502419|FG001|Post Induction Randomization|Death|9|||
94739644|NCT02101853|324502420|FG002|Post Induction Randomization|Death|2|||
94739645|NCT02101853|324502421|FG003|Post Induction Randomization|Death|2|||
94739646|NCT02101853|324502422|FG004|Post Induction Randomization|Death|0|||
94739647|NCT02101853|324502423|FG005|Post Induction Randomization|Death|0|||
94739648|NCT02101853|324502418|FG000|Post Induction Randomization|Lack of Efficacy|0|||
94739649|NCT02101853|324502419|FG001|Post Induction Randomization|Lack of Efficacy|14|||
94739650|NCT02101853|324502420|FG002|Post Induction Randomization|Lack of Efficacy|23|||
94739651|NCT02101853|324502421|FG003|Post Induction Randomization|Lack of Efficacy|18|||
94739652|NCT02101853|324502422|FG004|Post Induction Randomization|Lack of Efficacy|21|||
94739653|NCT02101853|324502423|FG005|Post Induction Randomization|Lack of Efficacy|0|||
94739654|NCT02101853|324502418|FG000|Post Induction Randomization|Physician Decision|0|||
94739655|NCT02101853|324502419|FG001|Post Induction Randomization|Physician Decision|43|||
94739656|NCT02101853|324502420|FG002|Post Induction Randomization|Physician Decision|23|||
94739657|NCT02101853|324502421|FG003|Post Induction Randomization|Physician Decision|14|||
94739658|NCT02101853|324502422|FG004|Post Induction Randomization|Physician Decision|14|||
94739659|NCT02101853|324502423|FG005|Post Induction Randomization|Physician Decision|0|||
94739660|NCT02101853|324502418|FG000|Post Induction Randomization|Protocol Violation|0|||
94739661|NCT02101853|324502419|FG001|Post Induction Randomization|Protocol Violation|3|||
94739662|NCT02101853|324502420|FG002|Post Induction Randomization|Protocol Violation|0|||
94739663|NCT02101853|324502421|FG003|Post Induction Randomization|Protocol Violation|0|||
94739664|NCT02101853|324502422|FG004|Post Induction Randomization|Protocol Violation|0|||
94368970|NCT05166421|323136606|FG001|Overall Study|Withdrawal by Subject|3|||
94368971|NCT05166421|323136607|FG002|Overall Study|Withdrawal by Subject|6|||
94368972|NCT05166421|323136605|FG000|Overall Study|Lost to Follow-up|4|||
94739665|NCT02101853|324502423|FG005|Post Induction Randomization|Protocol Violation|0|||
94739666|NCT02101853|324502418|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
94739667|NCT02101853|324502419|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
94739668|NCT02101853|324502420|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
94739669|NCT02101853|324502421|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
94739670|NCT02101853|324502422|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
94739671|NCT02101853|324502423|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
94739672|NCT02101853|324502418|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
94739673|NCT02101853|324502419|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
94739674|NCT02101853|324502420|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
94368973|NCT05166421|323136606|FG001|Overall Study|Lost to Follow-up|1|||
94739675|NCT02101853|324502421|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
94739676|NCT02101853|324502422|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
94739677|NCT02101853|324502423|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
94739678|NCT02101853|324502418|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
94739679|NCT02101853|324502419|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
94739680|NCT02101853|324502420|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
94739681|NCT02101853|324502421|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
94739682|NCT02101853|324502422|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
94739683|NCT02101853|324502423|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
94739684|NCT02101853|324502418|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
94739685|NCT02101853|324502419|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
94739686|NCT02101853|324502420|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
94739687|NCT02101853|324502421|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
94739688|NCT02101853|324502422|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
94739689|NCT02101853|324502423|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
94739690|NCT02101853|324502418|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
94739691|NCT02101853|324502419|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
94739692|NCT02101853|324502420|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
94739693|NCT02101853|324502421|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
94739694|NCT02101853|324502422|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
94739695|NCT02101853|324502423|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
94739696|NCT02101853|324502418|FG000|Blinatumomab Salvage Therapy|Death|0|||
94739697|NCT02101853|324502419|FG001|Blinatumomab Salvage Therapy|Death|0|||
94739698|NCT02101853|324502420|FG002|Blinatumomab Salvage Therapy|Death|0|||
94739699|NCT02101853|324502421|FG003|Blinatumomab Salvage Therapy|Death|0|||
94739700|NCT02101853|324502422|FG004|Blinatumomab Salvage Therapy|Death|0|||
94739701|NCT02101853|324502423|FG005|Blinatumomab Salvage Therapy|Death|2|||
94739702|NCT02101853|324502418|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
94739703|NCT02101853|324502419|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
94739704|NCT02101853|324502420|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
94739705|NCT02101853|324502421|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
94739706|NCT02101853|324502422|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
94739707|NCT02101853|324502423|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
94739708|NCT02101853|324502418|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
94739709|NCT02101853|324502419|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
94739710|NCT02101853|324502420|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
94739711|NCT02101853|324502421|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
94739712|NCT02101853|324502422|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
94739713|NCT02101853|324502423|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
94739714|NCT02101853|324502418|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
94739715|NCT02101853|324502419|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
94739716|NCT02101853|324502420|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
94739717|NCT02101853|324502421|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
94739718|NCT02101853|324502422|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
94739719|NCT02101853|324502423|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
94739720|NCT04055012|324502424|FG000|Overall Study|Withdrawal by Subject|1|||
94739721|NCT04055012|324502425|FG001|Overall Study|Withdrawal by Subject|3|||
94739722|NCT04055012|324502426|FG002|Overall Study|Withdrawal by Subject|1|||
94739723|NCT04055012|324502427|FG003|Overall Study|Withdrawal by Subject|0|||
94739724|NCT04055012|324502424|FG000|Overall Study|Metformin Recall|1|||
94739725|NCT04055012|324502425|FG001|Overall Study|Metformin Recall|1|||
94739726|NCT04055012|324502426|FG002|Overall Study|Metformin Recall|1|||
94739727|NCT04055012|324502427|FG003|Overall Study|Metformin Recall|0|||
94739728|NCT05158504|324502428|FG000|Overall Study|Lost to Follow-up|2|||
94739729|NCT05158504|324502429|FG001|Overall Study|Lost to Follow-up|3|||
94739730|NCT03606512|324502430|FG000|Overall Study|Lost to Follow-up|0|||
94739731|NCT03606512|324502431|FG001|Overall Study|Lost to Follow-up|1|||
94739732|NCT03606512|324502430|FG000|Overall Study|'moved from study area|0|||
94739733|NCT03606512|324502431|FG001|Overall Study|'moved from study area|1|||
94739734|NCT02112916|324502432|FG000|Overall Study|Adverse Event|6|||
94739735|NCT02112916|324502433|FG001|Overall Study|Adverse Event|9|||
94739736|NCT02112916|324502434|FG002|Overall Study|Adverse Event|3|||
94739737|NCT02112916|324502435|FG003|Overall Study|Adverse Event|2|||
94739738|NCT02112916|324502432|FG000|Overall Study|Death|9|||
94739739|NCT02112916|324502433|FG001|Overall Study|Death|9|||
94739740|NCT02112916|324502434|FG002|Overall Study|Death|3|||
94739741|NCT02112916|324502435|FG003|Overall Study|Death|4|||
94739742|NCT02112916|324502432|FG000|Overall Study|Lost to Follow-up|1|||
94739743|NCT02112916|324502433|FG001|Overall Study|Lost to Follow-up|0|||
94739744|NCT02112916|324502434|FG002|Overall Study|Lost to Follow-up|0|||
94739745|NCT02112916|324502435|FG003|Overall Study|Lost to Follow-up|0|||
94739746|NCT02112916|324502432|FG000|Overall Study|Physician Decision|94|||
94739747|NCT02112916|324502433|FG001|Overall Study|Physician Decision|72|||
94739748|NCT02112916|324502434|FG002|Overall Study|Physician Decision|24|||
94739749|NCT02112916|324502435|FG003|Overall Study|Physician Decision|15|||
94739750|NCT02112916|324502432|FG000|Overall Study|Withdrawal by Subject|5|||
94739751|NCT02112916|324502433|FG001|Overall Study|Withdrawal by Subject|3|||
94739752|NCT02112916|324502434|FG002|Overall Study|Withdrawal by Subject|1|||
94739753|NCT02112916|324502435|FG003|Overall Study|Withdrawal by Subject|1|||
94275581|NCT00530894|322802436|FG000|Overall Study|Lost to Follow-up|1|||
94739754|NCT02112916|324502432|FG000|Overall Study|Ineligible|4|||
94739755|NCT02112916|324502433|FG001|Overall Study|Ineligible|8|||
94739756|NCT02112916|324502434|FG002|Overall Study|Ineligible|3|||
94739757|NCT02112916|324502435|FG003|Overall Study|Ineligible|8|||
94739758|NCT02112916|324502432|FG000|Overall Study|Inevaluable|6|||
94739759|NCT02112916|324502433|FG001|Overall Study|Inevaluable|4|||
94739760|NCT02112916|324502434|FG002|Overall Study|Inevaluable|5|||
94739761|NCT02112916|324502435|FG003|Overall Study|Inevaluable|5|||
94739762|NCT02112916|324502432|FG000|Overall Study|Refusal of further protocol therapy|19|||
94739763|NCT02112916|324502433|FG001|Overall Study|Refusal of further protocol therapy|16|||
94739764|NCT02112916|324502434|FG002|Overall Study|Refusal of further protocol therapy|1|||
94739765|NCT02112916|324502435|FG003|Overall Study|Refusal of further protocol therapy|7|||
94739766|NCT02112916|324502432|FG000|Overall Study|Development of SMN|1|||
94467505|NCT00422292|323500600|FG002|Overall Study|Serious adverse events|0|||
94467506|NCT00422292|323500601|FG003|Overall Study|Serious adverse events|0|||
94739767|NCT02112916|324502433|FG001|Overall Study|Development of SMN|0|||
94739768|NCT02112916|324502434|FG002|Overall Study|Development of SMN|0|||
94739769|NCT02112916|324502435|FG003|Overall Study|Development of SMN|1|||
94739770|NCT02112916|324502432|FG000|Overall Study|Relapse/Progression|10|||
94739771|NCT02112916|324502433|FG001|Overall Study|Relapse/Progression|18|||
94739772|NCT02112916|324502434|FG002|Overall Study|Relapse/Progression|15|||
94739773|NCT02112916|324502435|FG003|Overall Study|Relapse/Progression|2|||
94739774|NCT02112916|324502432|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
94739775|NCT02112916|324502433|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
94739776|NCT02112916|324502434|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
94739777|NCT02112916|324502435|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
94739778|NCT02112916|324502432|FG000|Overall Study|Still on Therapy|44|||
94739779|NCT02112916|324502433|FG001|Overall Study|Still on Therapy|47|||
94739780|NCT02112916|324502434|FG002|Overall Study|Still on Therapy|3|||
94739781|NCT02112916|324502435|FG003|Overall Study|Still on Therapy|2|||
94739782|NCT02112916|324502432|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
94739783|NCT02112916|324502433|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
94739784|NCT02112916|324502434|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
94739785|NCT02112916|324502435|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
94739786|NCT02112916|324502432|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
94739787|NCT02112916|324502433|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
94739788|NCT02112916|324502434|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
94739789|NCT02112916|324502435|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
94739790|NCT05513937|324502438|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
94739791|NCT05513937|324502439|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
94739792|NCT05513937|324502440|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
94739793|NCT05513937|324502441|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
94739794|NCT05513937|324502438|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
94739795|NCT05513937|324502439|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
94739796|NCT05513937|324502440|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
94739797|NCT05513937|324502441|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
94739798|NCT05513937|324502438|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
94739799|NCT05513937|324502439|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
94739800|NCT05513937|324502440|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
94739801|NCT05513937|324502441|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
94739802|NCT05513937|324502438|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
94739803|NCT05513937|324502439|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
94739804|NCT05513937|324502440|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
94739805|NCT05513937|324502441|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
94739806|NCT05513937|324502438|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
94739807|NCT05513937|324502439|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
94739808|NCT05513937|324502440|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
94739809|NCT05513937|324502441|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
94739810|NCT05513937|324502438|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
94739811|NCT05513937|324502439|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
94739812|NCT05513937|324502440|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
94739813|NCT05513937|324502441|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
94739814|NCT02492711|324502442|FG000|Overall Study|Adverse Event|9|||
94739815|NCT02492711|324502443|FG001|Overall Study|Adverse Event|9|||
94739816|NCT02492711|324502444|FG002|Overall Study|Adverse Event|2|||
94739817|NCT02492711|324502442|FG000|Overall Study|Death|3|||
94739818|NCT02492711|324502443|FG001|Overall Study|Death|3|||
94739819|NCT02492711|324502444|FG002|Overall Study|Death|0|||
94739820|NCT02492711|324502442|FG000|Overall Study|Withdrawal by Subject|10|||
94467507|NCT00422292|323500598|FG000|Overall Study|Adverse Event|1|||
94739821|NCT02492711|324502443|FG001|Overall Study|Withdrawal by Subject|16|||
94467508|NCT00422292|323500599|FG001|Overall Study|Adverse Event|0|||
94739822|NCT02492711|324502444|FG002|Overall Study|Withdrawal by Subject|5|||
94739823|NCT02492711|324502442|FG000|Overall Study|Physician Decision|10|||
94739824|NCT02492711|324502443|FG001|Overall Study|Physician Decision|6|||
94739825|NCT02492711|324502444|FG002|Overall Study|Physician Decision|4|||
94739826|NCT02492711|324502442|FG000|Overall Study|Lost to Follow-up|0|||
94739827|NCT02492711|324502443|FG001|Overall Study|Lost to Follow-up|0|||
94739828|NCT02492711|324502444|FG002|Overall Study|Lost to Follow-up|1|||
94739829|NCT02492711|324502442|FG000|Overall Study|study treatment delay|2|||
94739830|NCT02492711|324502443|FG001|Overall Study|study treatment delay|1|||
94739831|NCT02492711|324502444|FG002|Overall Study|study treatment delay|0|||
94739832|NCT02492711|324502442|FG000|Overall Study|change in chemotherapy|0|||
94739833|NCT02492711|324502443|FG001|Overall Study|change in chemotherapy|1|||
94739834|NCT02492711|324502444|FG002|Overall Study|change in chemotherapy|0|||
94739835|NCT02492711|324502442|FG000|Overall Study|never treated|2|||
94739836|NCT02492711|324502443|FG001|Overall Study|never treated|4|||
94739837|NCT02492711|324502444|FG002|Overall Study|never treated|0|||
94739838|NCT02492711|324502442|FG000|Overall Study|Other|0|||
94739839|NCT02492711|324502443|FG001|Overall Study|Other|0|||
94739840|NCT02492711|324502444|FG002|Overall Study|Other|1|||
94739841|NCT05830799|324502445|FG000|Overall Study|Withdrawal by Subject|1|||
94739842|NCT03370913|324502446|FG000|Overall Study|Death|1|||
94739843|NCT03370913|324502446|FG000|Overall Study|Lost to Follow-up|1|||
94739844|NCT04633538|324502447|FG000|Overall Study|Death|1|||
94739845|NCT04633538|324502447|FG000|Overall Study|Lost to Follow-up|3|||
94739846|NCT04633538|324502447|FG000|Overall Study|Withdrawal by Subject|1|||
94739847|NCT02938520|324502450|FG000|Overall Study|On-going at the time of analysis|258|||
94739848|NCT02938520|324502451|FG001|Overall Study|On-going at the time of analysis|261|||
94739849|NCT02938520|324502450|FG000|Overall Study|Physician Decision|2|||
94739850|NCT02938520|324502451|FG001|Overall Study|Physician Decision|5|||
94739851|NCT02938520|324502450|FG000|Overall Study|Lost to Follow-up|2|||
94739852|NCT02938520|324502451|FG001|Overall Study|Lost to Follow-up|2|||
94739853|NCT02938520|324502450|FG000|Overall Study|Withdrawal by Subject|7|||
94739854|NCT02938520|324502451|FG001|Overall Study|Withdrawal by Subject|7|||
94739855|NCT02938520|324502450|FG000|Overall Study|Protocol Violation|0|||
94739856|NCT02938520|324502451|FG001|Overall Study|Protocol Violation|1|||
94739857|NCT02938520|324502450|FG000|Overall Study|Lack of Efficacy|5|||
94739858|NCT02938520|324502451|FG001|Overall Study|Lack of Efficacy|3|||
94739859|NCT02938520|324502450|FG000|Overall Study|Adverse Event|9|||
94739860|NCT02938520|324502451|FG001|Overall Study|Adverse Event|4|||
94739861|NCT03880955|324502454|FG000|Overall Study|Adverse Event|1|||
94739862|NCT03880955|324502454|FG000|Overall Study|Death|1|||
94739863|NCT03880955|324502454|FG000|Overall Study|Lost to Follow-up|12|||
94739864|NCT03880955|324502454|FG000|Overall Study|Withdrawal by Subject|4|||
94739865|NCT03880955|324502454|FG000|Overall Study|Missing- Study Site Closed|27|||
94739866|NCT05660434|324503538|FG000|Overall Study|Never obtained study materials|2|||
94739867|NCT05660434|324503539|FG001|Overall Study|Never obtained study materials|1|||
94739868|NCT00844415|324503540|FG000|Overall Study|Withdrawal by Subject|1|||
94739869|NCT06655818|324503550|FG000|Overall Study|Withdrawal by Subject|1|||
94739870|NCT02944968|324503551|FG000|Overall Study|Subject excluded before study procedure|1|||
94739871|NCT02944968|324503551|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
94739872|NCT02890329|324503552|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
94739873|NCT02890329|324503553|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
94739874|NCT02890329|324503554|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
94739875|NCT02890329|324503555|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
94739876|NCT02890329|324503556|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
94739877|NCT02890329|324503557|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
94739878|NCT02890329|324503552|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
94739879|NCT02890329|324503553|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
94739880|NCT02890329|324503554|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
94739881|NCT02890329|324503555|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
94739882|NCT02890329|324503556|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
94739883|NCT02890329|324503557|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
94739884|NCT02890329|324503552|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
94739885|NCT02890329|324503553|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
94739886|NCT02890329|324503554|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
94739887|NCT02890329|324503555|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
94275582|NCT00530894|322802437|FG001|Overall Study|Lost to Follow-up|3|||
94739888|NCT02890329|324503556|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
94739889|NCT02890329|324503557|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
94739890|NCT02890329|324503552|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
94739891|NCT02890329|324503553|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
94739892|NCT02890329|324503554|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
94739893|NCT02890329|324503555|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
94739894|NCT02890329|324503556|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
94739895|NCT02890329|324503557|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
94739896|NCT02542631|324503558|FG000|Overall Study|Adverse Event|1|||
94739897|NCT02542631|324503559|FG001|Overall Study|Adverse Event|1|||
94739898|NCT02542631|324503558|FG000|Overall Study|Sponsor Termination|1|||
94739899|NCT02542631|324503559|FG001|Overall Study|Sponsor Termination|0|||
94739900|NCT02542631|324503558|FG000|Overall Study|Withdrawal by Subject|11|||
94739901|NCT02542631|324503559|FG001|Overall Study|Withdrawal by Subject|16|||
94739902|NCT02542631|324503558|FG000|Overall Study|Protocol Violation|1|||
94368974|NCT05166421|323136607|FG002|Overall Study|Lost to Follow-up|7|||
94739903|NCT02542631|324503559|FG001|Overall Study|Protocol Violation|1|||
94739904|NCT02542631|324503558|FG000|Overall Study|Physician Decision|6|||
94739905|NCT02542631|324503559|FG001|Overall Study|Physician Decision|4|||
94739906|NCT02542631|324503558|FG000|Overall Study|Lost to Follow-up|6|||
94739907|NCT02542631|324503559|FG001|Overall Study|Lost to Follow-up|5|||
94739908|NCT02542631|324503558|FG000|Overall Study|Death|1|||
94739909|NCT02542631|324503559|FG001|Overall Study|Death|2|||
94739910|NCT02542631|324503558|FG000|Overall Study|Other|2|||
94739911|NCT02542631|324503559|FG001|Overall Study|Other|1|||
94739912|NCT02542631|324503558|FG000|Overall Study|Used Prohibited Medication|2|||
94739913|NCT02542631|324503559|FG001|Overall Study|Used Prohibited Medication|1|||
94739914|NCT02938923|324503560|FG000|Overall Study|Death|1|||
94739915|NCT02938923|324503561|FG001|Overall Study|Death|0|||
94739916|NCT02938923|324503562|FG002|Overall Study|Death|0|||
94739917|NCT02938923|324503560|FG000|Overall Study|Physician Decision|0|||
94739918|NCT02938923|324503561|FG001|Overall Study|Physician Decision|2|||
94739919|NCT02938923|324503562|FG002|Overall Study|Physician Decision|0|||
94739920|NCT02938923|324503560|FG000|Overall Study|Withdrawal by Subject|0|||
94739921|NCT02938923|324503561|FG001|Overall Study|Withdrawal by Subject|1|||
94739922|NCT02938923|324503562|FG002|Overall Study|Withdrawal by Subject|1|||
94739923|NCT00631475|324503568|FG000|Overall Study|Death|18|||
94739924|NCT00631475|324503568|FG000|Overall Study|Adverse Event|14|||
94739925|NCT00631475|324503568|FG000|Overall Study|Withdrew consent|5|||
94739926|NCT00631475|324503568|FG000|Overall Study|Preparation for lung transplant|8|||
94739927|NCT03218826|324503570|FG000|Overall Study|Non-compliance with protocol|1|||
94739928|NCT03218826|324503571|FG001|Overall Study|Non-compliance with protocol|0|||
94739929|NCT03218826|324503572|FG002|Overall Study|Non-compliance with protocol|2|||
94739930|NCT03218826|324503573|FG003|Overall Study|Non-compliance with protocol|1|||
94739931|NCT03218826|324503574|FG004|Overall Study|Non-compliance with protocol|1|||
94739932|NCT02846545|324503579|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
94739933|NCT02846545|324503580|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
94739934|NCT02846545|324503579|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
94739935|NCT02846545|324503580|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
94739936|NCT02846545|324503579|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
94739937|NCT02846545|324503580|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
94739938|NCT02846545|324503579|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
94739939|NCT02846545|324503580|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
94739940|NCT02846545|324503579|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
94739941|NCT02846545|324503580|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
94739942|NCT02254278|324503590|FG000|Overall Study|Protocol Violation|1|||
94739943|NCT02254278|324503591|FG001|Overall Study|Protocol Violation|1|||
94739944|NCT04214834|324503592|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
94739945|NCT04214834|324503593|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
94739946|NCT04924400|324503594|FG000|Overall Study|Lost to Follow-up|3|||
94739947|NCT04924400|324503595|FG001|Overall Study|Lost to Follow-up|0|||
94739948|NCT02163694|324503596|FG000|Overall Study|Adverse event- related to progression|4|||
94739949|NCT02163694|324503597|FG001|Overall Study|Adverse event- related to progression|10|||
94739950|NCT02163694|324503596|FG000|Overall Study|Adverse event- not related to progression|7|||
94739951|NCT02163694|324503597|FG001|Overall Study|Adverse event- not related to progression|22|||
94739952|NCT02163694|324503596|FG000|Overall Study|Withdrew consent|13|||
94739953|NCT02163694|324503597|FG001|Overall Study|Withdrew consent|28|||
94739954|NCT02163694|324503596|FG000|Overall Study|Lost to Follow-up|2|||
94739955|NCT02163694|324503597|FG001|Overall Study|Lost to Follow-up|2|||
94739956|NCT02163694|324503596|FG000|Overall Study|Sponsor discontinued study|3|||
94739957|NCT02163694|324503597|FG001|Overall Study|Sponsor discontinued study|29|||
94739958|NCT02163694|324503596|FG000|Overall Study|Progressive disease per protocol|125|||
94739959|NCT02163694|324503597|FG001|Overall Study|Progressive disease per protocol|224|||
94739960|NCT02163694|324503596|FG000|Overall Study|Other, not specified|17|||
94739961|NCT02163694|324503597|FG001|Overall Study|Other, not specified|22|||
94739962|NCT02163694|324503596|FG000|Overall Study|Randomized but Not Treated|1|||
94739963|NCT02163694|324503597|FG001|Overall Study|Randomized but Not Treated|0|||
94739964|NCT02163694|324503596|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
94368975|NCT02156466|323137899|FG000|Overall Study|Adverse Event|0|||
94368976|NCT02156466|323137900|FG001|Overall Study|Adverse Event|0|||
94368977|NCT02156466|323137901|FG002|Overall Study|Adverse Event|1|||
94368978|NCT02156466|323137902|FG003|Overall Study|Adverse Event|1|||
94368979|NCT02156466|323137903|FG004|Overall Study|Adverse Event|0|||
94368980|NCT02156466|323137899|FG000|Overall Study|Quantiferon Positivity|0|||
94368981|NCT02156466|323137900|FG001|Overall Study|Quantiferon Positivity|0|||
94368982|NCT02156466|323137901|FG002|Overall Study|Quantiferon Positivity|0|||
94368983|NCT02156466|323137902|FG003|Overall Study|Quantiferon Positivity|1|||
94368984|NCT02156466|323137903|FG004|Overall Study|Quantiferon Positivity|0|||
94368985|NCT03724968|323137904|FG000|Overall Study|Insurance issues|0|||
94368986|NCT03724968|323137905|FG001|Overall Study|Insurance issues|1|||
94368987|NCT03724968|323137904|FG000|Overall Study|Study closed|0|||
94368988|NCT03724968|323137905|FG001|Overall Study|Study closed|1|||
94368989|NCT01858558|323137908|FG000|Overall Study|Death|1|||
94368990|NCT01858558|323137909|FG001|Overall Study|Death|1|||
94368991|NCT01858558|323137908|FG000|Overall Study|Lost to Follow-up|1|||
94368992|NCT01858558|323137909|FG001|Overall Study|Lost to Follow-up|0|||
94368993|NCT01858558|323137908|FG000|Overall Study|Disease progression|3|||
94368994|NCT01858558|323137909|FG001|Overall Study|Disease progression|1|||
94368995|NCT01858558|323137908|FG000|Overall Study|Product contamination|2|||
94739965|NCT02163694|324503597|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
94739966|NCT04424316|324503604|FG000|Overall Study|Adverse Event|0|||
94739967|NCT04424316|324503605|FG001|Overall Study|Adverse Event|1|||
94739968|NCT04424316|324503606|FG002|Overall Study|Adverse Event|0|||
94739969|NCT04424316|324503607|FG003|Overall Study|Adverse Event|0|||
94739970|NCT04424316|324503604|FG000|Overall Study|Death|1|||
94739971|NCT04424316|324503605|FG001|Overall Study|Death|0|||
94739972|NCT04424316|324503606|FG002|Overall Study|Death|8|||
94739973|NCT04424316|324503607|FG003|Overall Study|Death|14|||
94739974|NCT04424316|324503604|FG000|Overall Study|Lost to Follow-up|93|||
94739975|NCT04424316|324503605|FG001|Overall Study|Lost to Follow-up|88|||
94739976|NCT04424316|324503606|FG002|Overall Study|Lost to Follow-up|224|||
94739977|NCT04424316|324503607|FG003|Overall Study|Lost to Follow-up|211|||
94739978|NCT04424316|324503604|FG000|Overall Study|No longer met eligibility criteria|1|||
94739979|NCT04424316|324503605|FG001|Overall Study|No longer met eligibility criteria|0|||
94739980|NCT04424316|324503606|FG002|Overall Study|No longer met eligibility criteria|0|||
94739981|NCT04424316|324503607|FG003|Overall Study|No longer met eligibility criteria|0|||
94739982|NCT04424316|324503604|FG000|Overall Study|Other|15|||
94739983|NCT04424316|324503605|FG001|Overall Study|Other|11|||
94739984|NCT04424316|324503606|FG002|Overall Study|Other|34|||
94739985|NCT04424316|324503607|FG003|Overall Study|Other|45|||
94739986|NCT04424316|324503604|FG000|Overall Study|Physician Decision|1|||
94739987|NCT04424316|324503605|FG001|Overall Study|Physician Decision|0|||
94739988|NCT04424316|324503606|FG002|Overall Study|Physician Decision|1|||
94739989|NCT04424316|324503607|FG003|Overall Study|Physician Decision|1|||
94739990|NCT04424316|324503604|FG000|Overall Study|Protocol Violation|0|||
94739991|NCT04424316|324503605|FG001|Overall Study|Protocol Violation|1|||
94739992|NCT04424316|324503606|FG002|Overall Study|Protocol Violation|0|||
94739993|NCT04424316|324503607|FG003|Overall Study|Protocol Violation|0|||
94739994|NCT04424316|324503604|FG000|Overall Study|Withdrawal by Subject|71|||
94739995|NCT04424316|324503605|FG001|Overall Study|Withdrawal by Subject|77|||
94739996|NCT04424316|324503606|FG002|Overall Study|Withdrawal by Subject|0|||
94739997|NCT04424316|324503607|FG003|Overall Study|Withdrawal by Subject|0|||
94739998|NCT04424316|324503604|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94739999|NCT04424316|324503605|FG001|Overall Study|Withdrawal by parent/guardian|0|||
94740000|NCT04424316|324503606|FG002|Overall Study|Withdrawal by parent/guardian|74|||
94740001|NCT04424316|324503607|FG003|Overall Study|Withdrawal by parent/guardian|81|||
94740002|NCT04424316|324503604|FG000|Overall Study|Randomized but not vaccinated|13|||
94740003|NCT04424316|324503605|FG001|Overall Study|Randomized but not vaccinated|21|||
94740004|NCT04424316|324503606|FG002|Overall Study|Randomized but not vaccinated|0|||
94740005|NCT04424316|324503607|FG003|Overall Study|Randomized but not vaccinated|0|||
94740006|NCT04424316|324503604|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
94740007|NCT04424316|324503605|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
94740008|NCT04424316|324503606|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
94740009|NCT04424316|324503607|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
94740010|NCT05070741|324503610|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
94740011|NCT03582033|324503612|FG000|Part A|Other|0|||
94740012|NCT03582033|324503613|FG001|Part A|Other|0|||
94740013|NCT03582033|324503614|FG002|Part A|Other|0|||
94740014|NCT03582033|324503615|FG003|Part A|Other|0|||
94368996|NCT01858558|323137909|FG001|Overall Study|Product contamination|0|||
94368997|NCT01858558|323137908|FG000|Overall Study|Failed expansion of cell product|2|||
94368998|NCT01858558|323137909|FG001|Overall Study|Failed expansion of cell product|0|||
94368999|NCT00080288|323137910|FG000|Overall Study|Adverse Event|7|||
94369000|NCT00080288|323137911|FG001|Overall Study|Adverse Event|4|||
94369001|NCT00080288|323137910|FG000|Overall Study|Lost to Follow-up|3|||
94369002|NCT00080288|323137911|FG001|Overall Study|Lost to Follow-up|5|||
94369003|NCT00080288|323137910|FG000|Overall Study|Physician Decision|6|||
94369004|NCT00080288|323137911|FG001|Overall Study|Physician Decision|2|||
94369005|NCT00080288|323137910|FG000|Overall Study|Withdrawal by Subject|3|||
94369006|NCT00080288|323137911|FG001|Overall Study|Withdrawal by Subject|16|||
94369007|NCT00080288|323137910|FG000|Overall Study|Miscellaneous|11|||
94369008|NCT00080288|323137911|FG001|Overall Study|Miscellaneous|11|||
94369009|NCT00569231|323137914|FG000|Overall Study|Study unrelated surgery|1|||
94369010|NCT00569231|323137914|FG000|Overall Study|Airfare expense|2|||
94369011|NCT00569231|323137914|FG000|Overall Study|Withdrawal by Subject|1|||
94369012|NCT00569231|323137914|FG000|Overall Study|Car accident injury|1|||
94369013|NCT00569231|323137914|FG000|Overall Study|Non-compliance|2|||
94369014|NCT01614925|323137915|FG000|Overall Study|Withdrawal by Subject|1|||
94369015|NCT01614925|323137916|FG001|Overall Study|Withdrawal by Subject|0|||
94369016|NCT01614925|323137915|FG000|Overall Study|Protocol Violation|3|||
94369017|NCT01614925|323137916|FG001|Overall Study|Protocol Violation|2|||
94369018|NCT00700310|323137917|FG000|Overall Study|Adverse Event|6|||
94369019|NCT00700310|323137918|FG001|Overall Study|Adverse Event|10|||
94369020|NCT00700310|323137919|FG002|Overall Study|Adverse Event|5|||
94369021|NCT00700310|323137920|FG003|Overall Study|Adverse Event|11|||
94369022|NCT00700310|323137917|FG000|Overall Study|Lost to Follow-up|4|||
94369023|NCT00700310|323137918|FG001|Overall Study|Lost to Follow-up|1|||
94740015|NCT03582033|324503616|FG004|Part A|Other|2|||
94740016|NCT03582033|324503617|FG005|Part A|Other|0|||
94740017|NCT03582033|324503618|FG006|Part A|Other|0|||
94740018|NCT03582033|324503619|FG007|Part A|Other|0|||
94740019|NCT03582033|324503620|FG008|Part A|Other|0|||
94740020|NCT03582033|324503621|FG009|Part A|Other|0|||
94740021|NCT03582033|324503612|FG000|Part A|Death|1|||
94740022|NCT03582033|324503613|FG001|Part A|Death|1|||
94740023|NCT03582033|324503614|FG002|Part A|Death|2|||
94740024|NCT03582033|324503615|FG003|Part A|Death|4|||
94740025|NCT03582033|324503616|FG004|Part A|Death|11|||
94740026|NCT03582033|324503617|FG005|Part A|Death|0|||
94740027|NCT03582033|324503618|FG006|Part A|Death|0|||
94740028|NCT03582033|324503619|FG007|Part A|Death|0|||
94740029|NCT03582033|324503620|FG008|Part A|Death|0|||
94740030|NCT03582033|324503621|FG009|Part A|Death|0|||
94740031|NCT03582033|324503612|FG000|Part A|Lost to Follow-up|0|||
94740032|NCT03582033|324503613|FG001|Part A|Lost to Follow-up|0|||
94740033|NCT03582033|324503614|FG002|Part A|Lost to Follow-up|0|||
94740034|NCT03582033|324503615|FG003|Part A|Lost to Follow-up|0|||
94740035|NCT03582033|324503616|FG004|Part A|Lost to Follow-up|1|||
94740036|NCT03582033|324503617|FG005|Part A|Lost to Follow-up|0|||
94740037|NCT03582033|324503618|FG006|Part A|Lost to Follow-up|0|||
94740038|NCT03582033|324503619|FG007|Part A|Lost to Follow-up|0|||
94740039|NCT03582033|324503620|FG008|Part A|Lost to Follow-up|0|||
94740040|NCT03582033|324503621|FG009|Part A|Lost to Follow-up|0|||
94740041|NCT03582033|324503612|FG000|Part A|Study terminated by sponsor|0|||
94740042|NCT03582033|324503613|FG001|Part A|Study terminated by sponsor|0|||
94740043|NCT03582033|324503614|FG002|Part A|Study terminated by sponsor|0|||
94740044|NCT03582033|324503615|FG003|Part A|Study terminated by sponsor|2|||
94740045|NCT03582033|324503616|FG004|Part A|Study terminated by sponsor|1|||
94740046|NCT03582033|324503617|FG005|Part A|Study terminated by sponsor|0|||
94740047|NCT03582033|324503618|FG006|Part A|Study terminated by sponsor|0|||
94740048|NCT03582033|324503619|FG007|Part A|Study terminated by sponsor|0|||
94740049|NCT03582033|324503620|FG008|Part A|Study terminated by sponsor|0|||
94740050|NCT03582033|324503621|FG009|Part A|Study terminated by sponsor|0|||
94740051|NCT03582033|324503612|FG000|Part A|Withdrawal by Subject|1|||
94740052|NCT03582033|324503613|FG001|Part A|Withdrawal by Subject|1|||
94740053|NCT03582033|324503614|FG002|Part A|Withdrawal by Subject|0|||
94740054|NCT03582033|324503615|FG003|Part A|Withdrawal by Subject|1|||
94740055|NCT03582033|324503616|FG004|Part A|Withdrawal by Subject|7|||
94740056|NCT03582033|324503617|FG005|Part A|Withdrawal by Subject|0|||
94369024|NCT00700310|323137919|FG002|Overall Study|Lost to Follow-up|0|||
94369025|NCT00700310|323137920|FG003|Overall Study|Lost to Follow-up|1|||
94369026|NCT00700310|323137917|FG000|Overall Study|Withdrawal by Subject|8|||
94369027|NCT00700310|323137918|FG001|Overall Study|Withdrawal by Subject|9|||
94369028|NCT00700310|323137919|FG002|Overall Study|Withdrawal by Subject|8|||
94369029|NCT00700310|323137920|FG003|Overall Study|Withdrawal by Subject|8|||
94369030|NCT00700310|323137917|FG000|Overall Study|Lack of Efficacy|0|||
94369031|NCT00700310|323137918|FG001|Overall Study|Lack of Efficacy|3|||
94740057|NCT03582033|324503618|FG006|Part A|Withdrawal by Subject|0|||
94740058|NCT03582033|324503619|FG007|Part A|Withdrawal by Subject|0|||
94740059|NCT03582033|324503620|FG008|Part A|Withdrawal by Subject|0|||
94740060|NCT03582033|324503621|FG009|Part A|Withdrawal by Subject|0|||
94740061|NCT03582033|324503612|FG000|Part B|Death|0|||
94740062|NCT03582033|324503613|FG001|Part B|Death|0|||
94740063|NCT03582033|324503614|FG002|Part B|Death|0|||
94740064|NCT03582033|324503615|FG003|Part B|Death|0|||
94740065|NCT03582033|324503616|FG004|Part B|Death|0|||
94740066|NCT03582033|324503617|FG005|Part B|Death|2|||
94740067|NCT03582033|324503618|FG006|Part B|Death|0|||
94740068|NCT03582033|324503619|FG007|Part B|Death|0|||
94740069|NCT03582033|324503620|FG008|Part B|Death|0|||
94740070|NCT03582033|324503621|FG009|Part B|Death|0|||
94740071|NCT03582033|324503612|FG000|Part B|Study terminated by sponsor|0|||
94740072|NCT03582033|324503613|FG001|Part B|Study terminated by sponsor|0|||
94740073|NCT03582033|324503614|FG002|Part B|Study terminated by sponsor|0|||
94740074|NCT03582033|324503615|FG003|Part B|Study terminated by sponsor|0|||
94740075|NCT03582033|324503616|FG004|Part B|Study terminated by sponsor|0|||
94740076|NCT03582033|324503617|FG005|Part B|Study terminated by sponsor|12|||
94740077|NCT03582033|324503618|FG006|Part B|Study terminated by sponsor|0|||
94740078|NCT03582033|324503619|FG007|Part B|Study terminated by sponsor|0|||
94740079|NCT03582033|324503620|FG008|Part B|Study terminated by sponsor|0|||
94740080|NCT03582033|324503621|FG009|Part B|Study terminated by sponsor|0|||
94740081|NCT03582033|324503612|FG000|Part B|Withdrawal by Subject|0|||
94740082|NCT03582033|324503613|FG001|Part B|Withdrawal by Subject|0|||
94740083|NCT03582033|324503614|FG002|Part B|Withdrawal by Subject|0|||
94740084|NCT03582033|324503615|FG003|Part B|Withdrawal by Subject|0|||
94740085|NCT03582033|324503616|FG004|Part B|Withdrawal by Subject|0|||
94740086|NCT03582033|324503617|FG005|Part B|Withdrawal by Subject|6|||
94740087|NCT03582033|324503618|FG006|Part B|Withdrawal by Subject|0|||
94369032|NCT00700310|323137919|FG002|Overall Study|Lack of Efficacy|0|||
94369033|NCT00700310|323137920|FG003|Overall Study|Lack of Efficacy|1|||
94740088|NCT03582033|324503619|FG007|Part B|Withdrawal by Subject|0|||
94369034|NCT00700310|323137917|FG000|Overall Study|Administrative/Other|1|||
94369035|NCT00700310|323137918|FG001|Overall Study|Administrative/Other|3|||
94369036|NCT00700310|323137919|FG002|Overall Study|Administrative/Other|1|||
94369037|NCT00700310|323137920|FG003|Overall Study|Administrative/Other|3|||
94369038|NCT00700310|323137917|FG000|Overall Study|Randomized, Not Treated|2|||
94369039|NCT00700310|323137918|FG001|Overall Study|Randomized, Not Treated|0|||
94369040|NCT00700310|323137919|FG002|Overall Study|Randomized, Not Treated|2|||
94369041|NCT00700310|323137920|FG003|Overall Study|Randomized, Not Treated|2|||
94369042|NCT00606801|323137921|FG000|Intervention|Protocol Violation|3|||
94369043|NCT00606801|323137922|FG001|Intervention|Protocol Violation|3|||
94369044|NCT00563524|323137928|FG000|Overall Study|Adverse Event|0|||
94369045|NCT00563524|323137929|FG001|Overall Study|Adverse Event|1|||
94369046|NCT00563524|323137930|FG002|Overall Study|Adverse Event|0|||
94369047|NCT00563524|323137931|FG003|Overall Study|Adverse Event|0|||
94369048|NCT00563524|323137932|FG004|Overall Study|Adverse Event|2|||
94369049|NCT00563524|323137933|FG005|Overall Study|Adverse Event|0|||
94369050|NCT00563524|323137928|FG000|Overall Study|Lost to Follow-up|1|||
94369051|NCT00563524|323137929|FG001|Overall Study|Lost to Follow-up|0|||
94740089|NCT03582033|324503620|FG008|Part B|Withdrawal by Subject|0|||
94740090|NCT03582033|324503621|FG009|Part B|Withdrawal by Subject|0|||
94740091|NCT03582033|324503612|FG000|Part C|Other|0|||
94740092|NCT03582033|324503613|FG001|Part C|Other|0|||
94740093|NCT03582033|324503614|FG002|Part C|Other|0|||
94740094|NCT03582033|324503615|FG003|Part C|Other|0|||
94740095|NCT03582033|324503616|FG004|Part C|Other|0|||
94740096|NCT03582033|324503617|FG005|Part C|Other|0|||
94740097|NCT03582033|324503618|FG006|Part C|Other|2|||
94740098|NCT03582033|324503619|FG007|Part C|Other|0|||
94740099|NCT03582033|324503620|FG008|Part C|Other|0|||
94740100|NCT03582033|324503621|FG009|Part C|Other|0|||
94740101|NCT03582033|324503612|FG000|Part C|Death|0|||
94740102|NCT03582033|324503613|FG001|Part C|Death|0|||
94740103|NCT03582033|324503614|FG002|Part C|Death|0|||
94740104|NCT03582033|324503615|FG003|Part C|Death|0|||
94740105|NCT03582033|324503616|FG004|Part C|Death|0|||
94740106|NCT03582033|324503617|FG005|Part C|Death|0|||
94740107|NCT03582033|324503618|FG006|Part C|Death|6|||
94740108|NCT03582033|324503619|FG007|Part C|Death|1|||
94740109|NCT03582033|324503620|FG008|Part C|Death|2|||
94740110|NCT03582033|324503621|FG009|Part C|Death|0|||
94740111|NCT03582033|324503612|FG000|Part C|Study terminated by sponsor|0|||
94740112|NCT03582033|324503613|FG001|Part C|Study terminated by sponsor|0|||
94740113|NCT03582033|324503614|FG002|Part C|Study terminated by sponsor|0|||
94740114|NCT03582033|324503615|FG003|Part C|Study terminated by sponsor|0|||
94740115|NCT03582033|324503616|FG004|Part C|Study terminated by sponsor|0|||
94740116|NCT03582033|324503617|FG005|Part C|Study terminated by sponsor|0|||
94740117|NCT03582033|324503618|FG006|Part C|Study terminated by sponsor|3|||
94740118|NCT03582033|324503619|FG007|Part C|Study terminated by sponsor|3|||
94740119|NCT03582033|324503620|FG008|Part C|Study terminated by sponsor|2|||
94740120|NCT03582033|324503621|FG009|Part C|Study terminated by sponsor|0|||
94740121|NCT03582033|324503612|FG000|Part C|Withdrawal by Subject|0|||
94740122|NCT03582033|324503613|FG001|Part C|Withdrawal by Subject|0|||
94740123|NCT03582033|324503614|FG002|Part C|Withdrawal by Subject|0|||
94740124|NCT03582033|324503615|FG003|Part C|Withdrawal by Subject|0|||
94740125|NCT03582033|324503616|FG004|Part C|Withdrawal by Subject|0|||
94740126|NCT03582033|324503617|FG005|Part C|Withdrawal by Subject|0|||
94740127|NCT03582033|324503618|FG006|Part C|Withdrawal by Subject|1|||
94740128|NCT03582033|324503619|FG007|Part C|Withdrawal by Subject|2|||
94740129|NCT03582033|324503620|FG008|Part C|Withdrawal by Subject|1|||
94740130|NCT03582033|324503621|FG009|Part C|Withdrawal by Subject|0|||
94369052|NCT00563524|323137930|FG002|Overall Study|Lost to Follow-up|0|||
94740131|NCT03582033|324503612|FG000|Part D|Death|0|||
94740132|NCT03582033|324503613|FG001|Part D|Death|0|||
94740133|NCT03582033|324503614|FG002|Part D|Death|0|||
94740134|NCT03582033|324503615|FG003|Part D|Death|0|||
94740135|NCT03582033|324503616|FG004|Part D|Death|0|||
94740136|NCT03582033|324503617|FG005|Part D|Death|0|||
94740137|NCT03582033|324503618|FG006|Part D|Death|0|||
94369053|NCT00563524|323137931|FG003|Overall Study|Lost to Follow-up|0|||
94740138|NCT03582033|324503619|FG007|Part D|Death|0|||
94740139|NCT03582033|324503620|FG008|Part D|Death|0|||
94740140|NCT03582033|324503621|FG009|Part D|Death|1|||
94740141|NCT03582033|324503612|FG000|Part D|Study terminated by sponsor|0|||
94369054|NCT00563524|323137932|FG004|Overall Study|Lost to Follow-up|0|||
94740142|NCT03582033|324503613|FG001|Part D|Study terminated by sponsor|0|||
94740143|NCT03582033|324503614|FG002|Part D|Study terminated by sponsor|0|||
94740144|NCT03582033|324503615|FG003|Part D|Study terminated by sponsor|0|||
94369055|NCT00563524|323137933|FG005|Overall Study|Lost to Follow-up|0|||
94369056|NCT00563524|323137928|FG000|Overall Study|Protocol Violation|0|||
94369057|NCT00563524|323137929|FG001|Overall Study|Protocol Violation|1|||
94740145|NCT03582033|324503616|FG004|Part D|Study terminated by sponsor|0|||
94740146|NCT03582033|324503617|FG005|Part D|Study terminated by sponsor|0|||
94740147|NCT03582033|324503618|FG006|Part D|Study terminated by sponsor|0|||
94740148|NCT03582033|324503619|FG007|Part D|Study terminated by sponsor|0|||
94740149|NCT03582033|324503620|FG008|Part D|Study terminated by sponsor|0|||
94740150|NCT03582033|324503621|FG009|Part D|Study terminated by sponsor|4|||
94740151|NCT05836012|324503632|FG000|Overall Study|Lost to Follow-up|1|||
94740152|NCT05836012|324503633|FG001|Overall Study|Lost to Follow-up|0|||
94740153|NCT05836012|324503632|FG000|Overall Study|Withdrawal by Subject|1|||
94740154|NCT05836012|324503633|FG001|Overall Study|Withdrawal by Subject|3|||
94740155|NCT05836012|324503632|FG000|Overall Study|Reason not included in pre-specified categories|2|||
94740156|NCT05836012|324503633|FG001|Overall Study|Reason not included in pre-specified categories|1|||
94740157|NCT04477304|324503634|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
94740158|NCT04477304|324503635|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
94740159|NCT02510235|324503636|FG000|Overall Study|Withdrawal by Subject|1|||
94740160|NCT02510235|324503637|FG001|Overall Study|Withdrawal by Subject|0|||
94740161|NCT04505410|324503638|FG000|Overall Study|Adverse Event|2|||
94740162|NCT04505410|324503639|FG001|Overall Study|Adverse Event|0|||
94740163|NCT04505410|324503638|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
94740164|NCT04505410|324503639|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
94740165|NCT04505410|324503638|FG000|Overall Study|did not want to follow diet|1|||
94740166|NCT04505410|324503639|FG001|Overall Study|did not want to follow diet|0|||
94740167|NCT04505410|324503638|FG000|Overall Study|flare up of ulcerative colitis|0|||
94740168|NCT04505410|324503639|FG001|Overall Study|flare up of ulcerative colitis|1|||
94740169|NCT04505410|324503638|FG000|Overall Study|Lost to Follow-up|0|||
94740170|NCT04505410|324503639|FG001|Overall Study|Lost to Follow-up|2|||
94740171|NCT04505410|324503638|FG000|Overall Study|Lost to Follow-up|1|||
94740172|NCT04505410|324503639|FG001|Overall Study|Lost to Follow-up|0|||
94740173|NCT04505410|324503638|FG000|Overall Study|initiated another diet on their own|0|||
94740174|NCT04505410|324503639|FG001|Overall Study|initiated another diet on their own|2|||
94740175|NCT03547271|324503646|FG000|Overall Study|Adverse Event|1|||
94740176|NCT03547271|324503647|FG001|Overall Study|Adverse Event|1|||
94740177|NCT03547271|324503648|FG002|Overall Study|Adverse Event|0|||
94740178|NCT03547271|324503649|FG003|Overall Study|Adverse Event|0|||
94740179|NCT03547271|324503646|FG000|Overall Study|Protocol deviation|5|||
94740180|NCT03547271|324503647|FG001|Overall Study|Protocol deviation|7|||
94740181|NCT03547271|324503648|FG002|Overall Study|Protocol deviation|3|||
94740182|NCT03547271|324503649|FG003|Overall Study|Protocol deviation|0|||
94740183|NCT03547271|324503646|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
94740184|NCT03547271|324503647|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
94740185|NCT03547271|324503648|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
94740186|NCT03547271|324503649|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
94740187|NCT03547271|324503646|FG000|Overall Study|Lost to Follow-up|3|||
94740188|NCT03547271|324503647|FG001|Overall Study|Lost to Follow-up|3|||
94740189|NCT03547271|324503648|FG002|Overall Study|Lost to Follow-up|1|||
94369058|NCT00563524|323137930|FG002|Overall Study|Protocol Violation|0|||
94369059|NCT00563524|323137931|FG003|Overall Study|Protocol Violation|0|||
94369060|NCT00563524|323137932|FG004|Overall Study|Protocol Violation|0|||
94369061|NCT00563524|323137933|FG005|Overall Study|Protocol Violation|0|||
94369062|NCT00563524|323137928|FG000|Overall Study|Withdrawal by Subject|1|||
94369063|NCT00563524|323137929|FG001|Overall Study|Withdrawal by Subject|1|||
94369064|NCT00563524|323137930|FG002|Overall Study|Withdrawal by Subject|3|||
94369065|NCT00563524|323137931|FG003|Overall Study|Withdrawal by Subject|0|||
94369066|NCT00563524|323137932|FG004|Overall Study|Withdrawal by Subject|0|||
94369067|NCT00563524|323137933|FG005|Overall Study|Withdrawal by Subject|1|||
94369068|NCT00550420|323137937|FG000|Overall Study|Adverse Event|28|||
94369069|NCT00550420|323137937|FG000|Overall Study|Lost to Follow-up|8|||
94369070|NCT00550420|323137937|FG000|Overall Study|Protocol Violation|11|||
94369071|NCT00550420|323137937|FG000|Overall Study|Withdrawal by Subject|30|||
94369072|NCT00550420|323137937|FG000|Overall Study|Still in study at termination|206|||
94369073|NCT00550420|323137937|FG000|Overall Study|Missing|2|||
94369074|NCT00550420|323137937|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
94369075|NCT00550420|323137937|FG000|Overall Study|Investigators opinion|1|||
94467509|NCT00422292|323500600|FG002|Overall Study|Adverse Event|1|||
94467510|NCT00422292|323500601|FG003|Overall Study|Adverse Event|0|||
94467511|NCT00422292|323500598|FG000|Overall Study|Protocol Violation|4|||
94369076|NCT00550420|323137937|FG000|Overall Study|Lack of curative effect|1|||
94369077|NCT00550420|323137937|FG000|Overall Study|Unethical stop of enrollment|2|||
94369078|NCT00550420|323137937|FG000|Overall Study|Caregiver's decision to withdraw|1|||
94369079|NCT00550420|323137937|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
94369080|NCT00550420|323137937|FG000|Overall Study|Exclusion criteria|1|||
94467512|NCT00422292|323500599|FG001|Overall Study|Protocol Violation|25|||
94740190|NCT03547271|324503649|FG003|Overall Study|Lost to Follow-up|0|||
94740191|NCT01447719|324504097|FG000|Overall Study|Image acquisition failure|2|||
94369081|NCT00550420|323137937|FG000|Overall Study|Prohibited medicine|1|||
94369082|NCT03471182|323137938|FG000|Overall Study|Withdrawal by Subject|1|||
94740192|NCT01447719|324504097|FG000|Overall Study|Invalid image or not imaged|3|||
94740193|NCT01447719|324504097|FG000|Overall Study|Subject still living at end of study|79|||
94740194|NCT01447719|324504097|FG000|Overall Study|Withdrawal by Subject|2|||
94369083|NCT03471182|323137939|FG001|Overall Study|Withdrawal by Subject|1|||
94369084|NCT03471182|323137940|FG002|Overall Study|Withdrawal by Subject|0|||
94369085|NCT03471182|323137938|FG000|Overall Study|Technical failure|2|||
94369086|NCT03471182|323137939|FG001|Overall Study|Technical failure|0|||
94369087|NCT03471182|323137940|FG002|Overall Study|Technical failure|0|||
94369088|NCT02018042|323137942|FG000|Overall Study|Withdrawal by Subject|1|||
94740195|NCT01447719|324504097|FG000|Overall Study|Family withdrew autopsy consent|7|||
94740196|NCT01385202|324504104|FG000|Overall Study|Lost to Follow-up|6|||
94740197|NCT01385202|324504104|FG000|Overall Study|Not Eligible|11|||
94740198|NCT01385202|324504104|FG000|Overall Study|Withdrawn|1|||
94740199|NCT03884101|324504114|FG000|Overall Study|Participant Ongoing in Study|202|||
94740200|NCT03884101|324504115|FG001|Overall Study|Participant Ongoing in Study|186|||
94740201|NCT03884101|324504114|FG000|Overall Study|Death|212|||
94740202|NCT03884101|324504115|FG001|Overall Study|Death|224|||
94740203|NCT03884101|324504114|FG000|Overall Study|Lost to Follow-up|0|||
94740204|NCT03884101|324504115|FG001|Overall Study|Lost to Follow-up|1|||
94740205|NCT03884101|324504114|FG000|Overall Study|Withdrawal by Subject|6|||
94740206|NCT03884101|324504115|FG001|Overall Study|Withdrawal by Subject|11|||
94740207|NCT00412607|324504116|FG000|Overall Study|Withdrawal by Subject|9|||
94740208|NCT00412607|324504116|FG000|Overall Study|Lost to Follow-up|19|||
94740209|NCT00412607|324504116|FG000|Overall Study|Death|61|||
94740210|NCT00412607|324504116|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
94740211|NCT04707768|324504121|FG000|Overall Study|Adverse Event|9|||
94740212|NCT04707768|324504122|FG001|Overall Study|Adverse Event|18|||
94740213|NCT04707768|324504123|FG002|Overall Study|Adverse Event|3|||
94740214|NCT04707768|324504121|FG000|Overall Study|Investigator's Discretion|8|||
94740215|NCT04707768|324504122|FG001|Overall Study|Investigator's Discretion|4|||
94740216|NCT04707768|324504123|FG002|Overall Study|Investigator's Discretion|3|||
94740217|NCT04707768|324504121|FG000|Overall Study|Withdrawal by Subject|6|||
94740218|NCT04707768|324504122|FG001|Overall Study|Withdrawal by Subject|8|||
94740219|NCT04707768|324504123|FG002|Overall Study|Withdrawal by Subject|2|||
94740220|NCT04707768|324504121|FG000|Overall Study|Lack of Efficacy|1|||
94740221|NCT04707768|324504122|FG001|Overall Study|Lack of Efficacy|3|||
94740222|NCT04707768|324504123|FG002|Overall Study|Lack of Efficacy|0|||
94740223|NCT04707768|324504121|FG000|Overall Study|Lost to Follow-up|0|||
94740224|NCT04707768|324504122|FG001|Overall Study|Lost to Follow-up|0|||
94740225|NCT04707768|324504123|FG002|Overall Study|Lost to Follow-up|3|||
94740226|NCT04707768|324504121|FG000|Overall Study|Death|13|||
94740227|NCT04707768|324504122|FG001|Overall Study|Death|11|||
94740228|NCT04707768|324504123|FG002|Overall Study|Death|13|||
94740229|NCT04707768|324504121|FG000|Overall Study|Protocol Violation|2|||
94740230|NCT04707768|324504122|FG001|Overall Study|Protocol Violation|1|||
94740231|NCT04707768|324504123|FG002|Overall Study|Protocol Violation|0|||
94740232|NCT04707768|324504121|FG000|Overall Study|Non Compliance with Study Drug|1|||
94740233|NCT04707768|324504122|FG001|Overall Study|Non Compliance with Study Drug|0|||
94740234|NCT04707768|324504123|FG002|Overall Study|Non Compliance with Study Drug|0|||
94740235|NCT04707768|324504121|FG000|Overall Study|Transplant|4|||
94740236|NCT04707768|324504122|FG001|Overall Study|Transplant|4|||
94740237|NCT04707768|324504123|FG002|Overall Study|Transplant|8|||
94740238|NCT04707768|324504121|FG000|Overall Study|Other|9|||
94740239|NCT04707768|324504122|FG001|Overall Study|Other|5|||
94740240|NCT04707768|324504123|FG002|Overall Study|Other|2|||
94740241|NCT04214418|324504124|FG000|Overall Study|Withdrawal by Subject|1|||
94740242|NCT04214418|324504125|FG001|Overall Study|Withdrawal by Subject|0|||
94740243|NCT04214418|324504126|FG002|Overall Study|Withdrawal by Subject|0|||
94740244|NCT04214418|324504127|FG003|Overall Study|Withdrawal by Subject|0|||
94740245|NCT04214418|324504128|FG004|Overall Study|Withdrawal by Subject|0|||
94740246|NCT04214418|324504129|FG005|Overall Study|Withdrawal by Subject|0|||
94740247|NCT04214418|324504124|FG000|Overall Study|Adverse Event|0|||
94740248|NCT04214418|324504125|FG001|Overall Study|Adverse Event|2|||
94740249|NCT04214418|324504126|FG002|Overall Study|Adverse Event|0|||
94369089|NCT02609178|323137945|FG000|First Crown|Withdrawal by Subject|0|||
94369090|NCT02609178|323137946|FG001|First Crown|Withdrawal by Subject|0|||
94740250|NCT04214418|324504127|FG003|Overall Study|Adverse Event|0|||
94740251|NCT04214418|324504128|FG004|Overall Study|Adverse Event|0|||
94740252|NCT04214418|324504129|FG005|Overall Study|Adverse Event|0|||
94740253|NCT04214418|324504124|FG000|Overall Study|Death|1|||
94740254|NCT04214418|324504125|FG001|Overall Study|Death|0|||
94740255|NCT04214418|324504126|FG002|Overall Study|Death|0|||
94740256|NCT04214418|324504127|FG003|Overall Study|Death|0|||
94740257|NCT04214418|324504128|FG004|Overall Study|Death|0|||
94740258|NCT04214418|324504129|FG005|Overall Study|Death|0|||
94740259|NCT02518048|324504134|FG000|Overall Study|Withdrawal by Subject|1|||
94740260|NCT04679389|324504137|FG000|Overall Study|Adverse Event|1|||
94467513|NCT00422292|323500600|FG002|Overall Study|Protocol Violation|8|||
94740261|NCT04679389|324504138|FG001|Overall Study|Adverse Event|0|||
94740262|NCT04679389|324504137|FG000|Overall Study|Protocol Violation|2|||
94740263|NCT04679389|324504138|FG001|Overall Study|Protocol Violation|0|||
94369091|NCT02609178|323137947|FG002|First Crown|Withdrawal by Subject|1|||
94740264|NCT04679389|324504137|FG000|Overall Study|Physician Decision|3|||
94275583|NCT00530894|322802438|FG002|Overall Study|Lost to Follow-up|0|||
94275584|NCT00530894|322802439|FG003|Overall Study|Lost to Follow-up|0|||
94275585|NCT00530894|322802436|FG000|Overall Study|Withdrawal by Subject|1|||
94275586|NCT00530894|322802437|FG001|Overall Study|Withdrawal by Subject|23|||
94275587|NCT00530894|322802438|FG002|Overall Study|Withdrawal by Subject|0|||
94275588|NCT00530894|322802439|FG003|Overall Study|Withdrawal by Subject|5|||
94275589|NCT00530894|322802436|FG000|Overall Study|Alive and censored prior to 1 year|2|||
94275590|NCT00530894|322802437|FG001|Overall Study|Alive and censored prior to 1 year|0|||
94275591|NCT00530894|322802438|FG002|Overall Study|Alive and censored prior to 1 year|0|||
94275592|NCT00530894|322802439|FG003|Overall Study|Alive and censored prior to 1 year|0|||
94275593|NCT01230242|322802440|FG000|Overall Study|Physician Decision|2|||
94275594|NCT01230242|322802440|FG000|Overall Study|Withdrawal by Subject|1|||
94275595|NCT02256540|322802441|FG000|Overall Study|Withdrawal by Subject|0|||
94275596|NCT02256540|322802442|FG001|Overall Study|Withdrawal by Subject|1|||
94275597|NCT02256540|322802443|FG002|Overall Study|Withdrawal by Subject|1|||
94275598|NCT02256540|322802441|FG000|Overall Study|Back pain preventing exercise|0|||
94275599|NCT02256540|322802442|FG001|Overall Study|Back pain preventing exercise|0|||
94275600|NCT02256540|322802443|FG002|Overall Study|Back pain preventing exercise|1|||
94275601|NCT04329702|322802453|FG000|Overall Study|illness|3|||
94275602|NCT04329702|322802454|FG001|Overall Study|illness|4|||
94275603|NCT04329702|322802455|FG002|Overall Study|illness|0|||
94275604|NCT04329702|322802453|FG000|Overall Study|Lost to Follow-up|0|||
94275605|NCT04329702|322802454|FG001|Overall Study|Lost to Follow-up|0|||
94275606|NCT04329702|322802455|FG002|Overall Study|Lost to Follow-up|2|||
94275607|NCT04329702|322802453|FG000|Overall Study|Death|0|||
94275608|NCT04329702|322802454|FG001|Overall Study|Death|2|||
94275609|NCT04329702|322802455|FG002|Overall Study|Death|0|||
94275610|NCT00751400|322802460|FG000|Overall Study|Lost to Follow-up|10|||
94275611|NCT02770547|322802463|FG000|Overall Study|Patient non-compliant|1|||
94275612|NCT02770547|322802464|FG001|Overall Study|Patient non-compliant|0|||
94275613|NCT02770547|322802463|FG000|Overall Study|Adverse Event|0|||
94275614|NCT02770547|322802464|FG001|Overall Study|Adverse Event|1|||
94275615|NCT00847912|322802470|FG000|Overall Study|Protocol Violation|6|||
94275616|NCT00847912|322802471|FG001|Overall Study|Protocol Violation|7|||
94275617|NCT00847912|322802470|FG000|Overall Study|Withdrawal by Subject|3|||
94275618|NCT00847912|322802471|FG001|Overall Study|Withdrawal by Subject|6|||
94467514|NCT00422292|323500601|FG003|Overall Study|Protocol Violation|5|||
94740265|NCT04679389|324504138|FG001|Overall Study|Physician Decision|5|||
94740266|NCT04679389|324504137|FG000|Overall Study|Withdrawal by Subject|5|||
94740267|NCT04679389|324504138|FG001|Overall Study|Withdrawal by Subject|7|||
94740268|NCT02905331|324504970|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
94740269|NCT02905331|324504971|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
94740270|NCT02905331|324504972|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
94740271|NCT02905331|324504970|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
94740272|NCT02905331|324504971|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
94740273|NCT02905331|324504972|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
94740274|NCT02905331|324504970|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
94740275|NCT02905331|324504971|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
94740276|NCT02905331|324504972|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
94740277|NCT02905331|324504970|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
94740278|NCT02905331|324504971|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
94740279|NCT02905331|324504972|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
94740280|NCT02905331|324504970|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
94740281|NCT02905331|324504971|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
94740282|NCT02905331|324504972|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
94740283|NCT03932331|324504973|FG000|Overall Study|Death|0|||
94740284|NCT03932331|324504974|FG001|Overall Study|Death|7|||
94740285|NCT03932331|324504975|FG002|Overall Study|Death|2|||
94740286|NCT03932331|324504973|FG000|Overall Study|Withdrawal by Subject|0|||
94740287|NCT03932331|324504974|FG001|Overall Study|Withdrawal by Subject|3|||
94740288|NCT03932331|324504975|FG002|Overall Study|Withdrawal by Subject|0|||
94740289|NCT03932331|324504973|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
94275619|NCT00661531|322802472|FG000|Overall Study|Withdrawal by Subject|3|||
94275620|NCT04962022|322802479|FG000|Period 1|Withdrawal by Subject|1|||
94275621|NCT04962022|322802480|FG001|Period 1|Withdrawal by Subject|0|||
94275622|NCT01309659|322802485|FG000|Overall Study|Protocol Violation|0|||
94275623|NCT01309659|322802486|FG001|Overall Study|Protocol Violation|1|||
94275624|NCT01650636|322802487|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
94275625|NCT01650636|322802488|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
94275626|NCT01650636|322802487|FG000|Washout up to 5 Months|Physician Decision|2|||
94467515|NCT00422292|323500598|FG000|Overall Study|Lost to Follow-up|6|||
94275627|NCT01650636|322802488|FG001|Washout up to 5 Months|Physician Decision|2|||
94275628|NCT01650636|322802487|FG000|Washout up to 5 Months|Death|1|||
94467516|NCT00422292|323500599|FG001|Overall Study|Lost to Follow-up|12|||
94275629|NCT01650636|322802488|FG001|Washout up to 5 Months|Death|0|||
94275630|NCT01650636|322802487|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
94275631|NCT01650636|322802488|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
94467517|NCT00422292|323500600|FG002|Overall Study|Lost to Follow-up|6|||
94275632|NCT01650636|322802487|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
94275633|NCT01650636|322802488|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
94275634|NCT01650636|322802487|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
94740290|NCT03932331|324504974|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
94740291|NCT03932331|324504975|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
94740292|NCT03932331|324504973|FG000|Overall Study|Progressive disease|3|||
94740293|NCT03932331|324504974|FG001|Overall Study|Progressive disease|0|||
94740294|NCT03932331|324504975|FG002|Overall Study|Progressive disease|0|||
94740295|NCT03932331|324504973|FG000|Overall Study|Lung infection|1|||
94740296|NCT03932331|324504974|FG001|Overall Study|Lung infection|0|||
94740297|NCT03932331|324504975|FG002|Overall Study|Lung infection|0|||
94740298|NCT03932331|324504973|FG000|Overall Study|Other|0|||
94740299|NCT03932331|324504974|FG001|Overall Study|Other|0|||
94740300|NCT03932331|324504975|FG002|Overall Study|Other|58|||
94740301|NCT03498521|324504979|FG000|Overall Study|Death|191|||
94740302|NCT03498521|324504980|FG001|Overall Study|Death|64|||
94740303|NCT03498521|324504981|FG002|Overall Study|Death|72|||
94740304|NCT03498521|324504979|FG000|Overall Study|Exclusion criteria|1|||
94740305|NCT03498521|324504980|FG001|Overall Study|Exclusion criteria|0|||
94740306|NCT03498521|324504981|FG002|Overall Study|Exclusion criteria|0|||
94740307|NCT03498521|324504979|FG000|Overall Study|Lost to Follow-up|3|||
94740308|NCT03498521|324504980|FG001|Overall Study|Lost to Follow-up|3|||
94740309|NCT03498521|324504981|FG002|Overall Study|Lost to Follow-up|3|||
94740310|NCT03498521|324504979|FG000|Overall Study|No profile due to technical failure|1|||
94740311|NCT03498521|324504980|FG001|Overall Study|No profile due to technical failure|0|||
94740312|NCT03498521|324504981|FG002|Overall Study|No profile due to technical failure|0|||
94740313|NCT03498521|324504979|FG000|Overall Study|Physician Decision|0|||
94740314|NCT03498521|324504980|FG001|Overall Study|Physician Decision|1|||
94740315|NCT03498521|324504981|FG002|Overall Study|Physician Decision|0|||
94740316|NCT03498521|324504979|FG000|Overall Study|Withdrawal by Subject|9|||
94740317|NCT03498521|324504980|FG001|Overall Study|Withdrawal by Subject|6|||
94740318|NCT03498521|324504981|FG002|Overall Study|Withdrawal by Subject|2|||
94740319|NCT03498521|324504979|FG000|Overall Study|Study ongoing|121|||
94740320|NCT03498521|324504980|FG001|Overall Study|Study ongoing|36|||
94740321|NCT03498521|324504981|FG002|Overall Study|Study ongoing|15|||
94740322|NCT04560179|324504986|FG000|Overall Study|Physician Decision|1|||
94740323|NCT04560179|324504987|FG001|Overall Study|Physician Decision|0|||
94740324|NCT04560179|324504988|FG002|Overall Study|Physician Decision|0|||
94740325|NCT04560179|324504989|FG003|Overall Study|Physician Decision|0|||
94740326|NCT04560179|324504990|FG004|Overall Study|Physician Decision|0|||
94740327|NCT04560179|324504986|FG000|Overall Study|Adverse Event|0|||
94740328|NCT04560179|324504987|FG001|Overall Study|Adverse Event|0|||
94740329|NCT04560179|324504988|FG002|Overall Study|Adverse Event|0|||
94740330|NCT04560179|324504989|FG003|Overall Study|Adverse Event|1|||
94740331|NCT04560179|324504990|FG004|Overall Study|Adverse Event|0|||
94740332|NCT04524689|324504993|FG000|Overall Study|Withdrawal by Subject|1|||
94740333|NCT04524689|324504994|FG001|Overall Study|Withdrawal by Subject|1|||
94740334|NCT04524689|324504995|FG002|Overall Study|Withdrawal by Subject|0|||
94740335|NCT04524689|324504996|FG003|Overall Study|Withdrawal by Subject|0|||
94740336|NCT04524689|324504997|FG004|Overall Study|Withdrawal by Subject|1|||
94740337|NCT04524689|324504998|FG005|Overall Study|Withdrawal by Subject|0|||
94740338|NCT04524689|324504993|FG000|Overall Study|Not related to Coronavirus disease 2019|2|||
94740339|NCT04524689|324504994|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
94740340|NCT04524689|324504995|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
94740341|NCT04524689|324504996|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
94740342|NCT04524689|324504997|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
94740343|NCT04524689|324504998|FG005|Overall Study|Not related to Coronavirus disease 2019|0|||
94740344|NCT04524689|324504993|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|12|||
94740345|NCT04524689|324504994|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
94740346|NCT04524689|324504995|FG002|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
94740347|NCT04524689|324504996|FG003|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
94740348|NCT04524689|324504997|FG004|Overall Study|Ongoing study treatment at the time of primary analysis|5|||
94740349|NCT04524689|324504998|FG005|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
94740350|NCT04369911|324504999|FG000|Overall Study|Lost to Follow-up|3|||
94740351|NCT04369911|324505000|FG001|Overall Study|Lost to Follow-up|3|||
94740352|NCT04369911|324504999|FG000|Overall Study|Withdrawal by Subject|1|||
94740353|NCT04369911|324505000|FG001|Overall Study|Withdrawal by Subject|2|||
94740354|NCT05451693|324505003|FG000|Overall Study|Withdrawal by Subject|1|||
94740355|NCT05451693|324505004|FG001|Overall Study|Withdrawal by Subject|1|||
94740356|NCT03372057|324505007|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
94740357|NCT03372057|324505008|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
94740358|NCT03372057|324505009|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
94740359|NCT03372057|324505007|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
94740360|NCT03372057|324505008|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
94740361|NCT03372057|324505009|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
94369092|NCT02609178|323137948|FG003|First Crown|Withdrawal by Subject|1|||
94369093|NCT02609178|323137949|FG004|First Crown|Withdrawal by Subject|0|||
94369094|NCT02609178|323137950|FG005|First Crown|Withdrawal by Subject|0|||
94369095|NCT02773446|323137951|FG000|First Admission|Withdrawal by Subject|0|||
94369096|NCT02773446|323137952|FG001|First Admission|Withdrawal by Subject|0|||
94369097|NCT02773446|323137953|FG002|First Admission|Withdrawal by Subject|0|||
94369098|NCT02773446|323137954|FG003|First Admission|Withdrawal by Subject|1|||
94369099|NCT02773446|323137955|FG004|First Admission|Withdrawal by Subject|0|||
94369100|NCT02773446|323137956|FG005|First Admission|Withdrawal by Subject|0|||
94369101|NCT02773446|323137951|FG000|First Admission|Lost to Follow-up|1|||
94369102|NCT02773446|323137952|FG001|First Admission|Lost to Follow-up|0|||
94369103|NCT02773446|323137953|FG002|First Admission|Lost to Follow-up|0|||
94369104|NCT02773446|323137954|FG003|First Admission|Lost to Follow-up|0|||
94369105|NCT02773446|323137955|FG004|First Admission|Lost to Follow-up|0|||
94740362|NCT03372057|324505007|FG000|Dose Optimization Phase|Death|16|||
94740363|NCT03372057|324505008|FG001|Dose Optimization Phase|Death|11|||
94740364|NCT03372057|324505009|FG002|Dose Optimization Phase|Death|0|||
94740365|NCT03372057|324505007|FG000|Expansion Phase|Withdrawal by Subject|0|||
94740366|NCT03372057|324505008|FG001|Expansion Phase|Withdrawal by Subject|0|||
94740367|NCT03372057|324505009|FG002|Expansion Phase|Withdrawal by Subject|4|||
94740368|NCT03372057|324505007|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
94740369|NCT03372057|324505008|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
94740370|NCT03372057|324505009|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
94740371|NCT03372057|324505007|FG000|Expansion Phase|Death|0|||
94740372|NCT03372057|324505008|FG001|Expansion Phase|Death|0|||
94740373|NCT03372057|324505009|FG002|Expansion Phase|Death|78|||
94740374|NCT03372057|324505007|FG000|Expansion Phase|Progressive Disease|0|||
94740375|NCT03372057|324505008|FG001|Expansion Phase|Progressive Disease|0|||
94740376|NCT03372057|324505009|FG002|Expansion Phase|Progressive Disease|1|||
94740377|NCT03372057|324505007|FG000|Expansion Phase|Adverse Event|0|||
94740378|NCT03372057|324505008|FG001|Expansion Phase|Adverse Event|0|||
94740379|NCT03372057|324505009|FG002|Expansion Phase|Adverse Event|1|||
94740380|NCT05890105|324505010|FG000|Overall Study|Adverse Event|1|||
94740381|NCT05890105|324505011|FG001|Overall Study|Adverse Event|0|||
94740382|NCT05890105|324505012|FG002|Overall Study|Adverse Event|0|||
94740383|NCT05890105|324505010|FG000|Overall Study|Other|1|||
94740384|NCT05890105|324505011|FG001|Overall Study|Other|2|||
94740385|NCT05890105|324505012|FG002|Overall Study|Other|0|||
94740386|NCT00450216|324505013|FG000|Overall Study|Adverse Event|38|||
94740387|NCT00450216|324505014|FG001|Overall Study|Adverse Event|23|||
94740388|NCT00450216|324505013|FG000|Overall Study|Withdrawal by Subject|48|||
94740389|NCT00450216|324505014|FG001|Overall Study|Withdrawal by Subject|26|||
94740390|NCT00450216|324505013|FG000|Overall Study|Lost to Follow-up|16|||
94740391|NCT00450216|324505014|FG001|Overall Study|Lost to Follow-up|9|||
94740392|NCT00450216|324505013|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
94740393|NCT00450216|324505014|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
94740394|NCT00450216|324505013|FG000|Overall Study|misc|21|||
94740395|NCT00450216|324505014|FG001|Overall Study|misc|20|||
94740396|NCT04206787|324505017|FG000|Overall Study|Other than listed|2|||
94740397|NCT04206787|324505017|FG000|Overall Study|Investigator decision|1|||
94740398|NCT04206787|324505017|FG000|Overall Study|Death|25|||
94740399|NCT04206787|324505017|FG000|Overall Study|Lost to Follow-up|9|||
94740400|NCT04206787|324505017|FG000|Overall Study|Withdrawal of consent|9|||
94740401|NCT05008055|324505018|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
94740402|NCT05008055|324505019|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
94740403|NCT05008055|324505020|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
94740404|NCT03248479|324505028|FG000|Overall Study|Death|12|||
94740405|NCT03248479|324505029|FG001|Overall Study|Death|44|||
94740406|NCT03248479|324505030|FG002|Overall Study|Death|1|||
94740407|NCT03248479|324505031|FG003|Overall Study|Death|72|||
94740408|NCT03248479|324505032|FG004|Overall Study|Death|17|||
94740409|NCT03248479|324505033|FG005|Overall Study|Death|6|||
94740410|NCT03248479|324505034|FG006|Overall Study|Death|1|||
94740411|NCT03248479|324505035|FG007|Overall Study|Death|14|||
94369106|NCT02773446|323137956|FG005|First Admission|Lost to Follow-up|0|||
94369107|NCT00736333|323137957|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
94740412|NCT03248479|324505036|FG008|Overall Study|Death|3|||
94740413|NCT03248479|324505037|FG009|Overall Study|Death|7|||
94740414|NCT03248479|324505038|FG010|Overall Study|Death|3|||
94740415|NCT03248479|324505039|FG011|Overall Study|Death|1|||
94740416|NCT03248479|324505040|FG012|Overall Study|Death|1|||
94740417|NCT03248479|324505028|FG000|Overall Study|Study terminated by sponsor|12|||
94740418|NCT03248479|324505029|FG001|Overall Study|Study terminated by sponsor|15|||
94369108|NCT00736333|323137957|FG000|Overall Study|Data Missing|2|||
94740419|NCT03248479|324505030|FG002|Overall Study|Study terminated by sponsor|0|||
94369109|NCT00736333|323137957|FG000|Overall Study|Tumor Progression|75|||
94369110|NCT00736333|323137957|FG000|Overall Study|Toxicity|6|||
94740420|NCT03248479|324505031|FG003|Overall Study|Study terminated by sponsor|5|||
94740421|NCT03248479|324505032|FG004|Overall Study|Study terminated by sponsor|0|||
94740422|NCT03248479|324505033|FG005|Overall Study|Study terminated by sponsor|0|||
94740423|NCT03248479|324505034|FG006|Overall Study|Study terminated by sponsor|0|||
94740424|NCT03248479|324505035|FG007|Overall Study|Study terminated by sponsor|1|||
94740425|NCT03248479|324505036|FG008|Overall Study|Study terminated by sponsor|1|||
94740426|NCT03248479|324505037|FG009|Overall Study|Study terminated by sponsor|0|||
94740427|NCT03248479|324505038|FG010|Overall Study|Study terminated by sponsor|5|||
94740428|NCT03248479|324505039|FG011|Overall Study|Study terminated by sponsor|4|||
94740429|NCT03248479|324505040|FG012|Overall Study|Study terminated by sponsor|0|||
94740430|NCT03248479|324505028|FG000|Overall Study|Consent withdrawn|6|||
94740431|NCT03248479|324505029|FG001|Overall Study|Consent withdrawn|3|||
94740432|NCT03248479|324505030|FG002|Overall Study|Consent withdrawn|0|||
94740433|NCT03248479|324505031|FG003|Overall Study|Consent withdrawn|9|||
94740434|NCT03248479|324505032|FG004|Overall Study|Consent withdrawn|1|||
94275635|NCT01650636|322802488|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
94275636|NCT02018822|322802489|FG000|Overall Study|filling replaced by crown|0|||
94275637|NCT02018822|322802490|FG001|Overall Study|filling replaced by crown|1|||
94275638|NCT02018822|322802491|FG002|Overall Study|filling replaced by crown|0|||
94275639|NCT02018822|322802489|FG000|Overall Study|Physician Decision|0|||
94275640|NCT02018822|322802490|FG001|Overall Study|Physician Decision|1|||
94275641|NCT02018822|322802491|FG002|Overall Study|Physician Decision|1|||
94275642|NCT02018822|322802489|FG000|Overall Study|Lost to Follow-up|6|||
94275643|NCT02018822|322802490|FG001|Overall Study|Lost to Follow-up|6|||
94275644|NCT02018822|322802491|FG002|Overall Study|Lost to Follow-up|5|||
94275645|NCT00930761|322802494|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
94275646|NCT00930761|322802495|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
94275647|NCT00930761|322802494|FG000|Overall Study|less than 3 music therapy sessions|0|||
94275648|NCT00930761|322802495|FG001|Overall Study|less than 3 music therapy sessions|3|||
94275649|NCT03571646|322802496|FG000|Overall Study|Adverse Event|1|||
94275650|NCT03571646|322802497|FG001|Overall Study|Adverse Event|0|||
94275651|NCT03571646|322802496|FG000|Overall Study|Withdrawal by Subject|1|||
94275652|NCT03571646|322802497|FG001|Overall Study|Withdrawal by Subject|1|||
94275653|NCT03548935|322802498|FG000|Overall Study|Withdrawal by Subject|26|||
94275654|NCT03548935|322802499|FG001|Overall Study|Withdrawal by Subject|17|||
94275655|NCT03548935|322802498|FG000|Overall Study|Lost to Follow-up|39|||
94275656|NCT03548935|322802499|FG001|Overall Study|Lost to Follow-up|28|||
94275657|NCT03548935|322802498|FG000|Overall Study|Death|1|||
94275658|NCT03548935|322802499|FG001|Overall Study|Death|1|||
94369111|NCT00736333|323137957|FG000|Overall Study|Withdrawal by Subject|10|||
94275659|NCT04677959|322802500|FG000|Overall Study|Adverse Event|1|||
94275660|NCT04677959|322802501|FG001|Overall Study|Adverse Event|9|||
94275661|NCT04677959|322802500|FG000|Overall Study|Withdrawal by Subject|2|||
94275662|NCT04677959|322802501|FG001|Overall Study|Withdrawal by Subject|15|||
94740435|NCT03248479|324505033|FG005|Overall Study|Consent withdrawn|0|||
94740436|NCT03248479|324505034|FG006|Overall Study|Consent withdrawn|0|||
94275663|NCT04677959|322802500|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94275664|NCT04677959|322802501|FG001|Overall Study|Withdrawal by parent/guardian|1|||
94275665|NCT04677959|322802500|FG000|Overall Study|Non-compliance with study drug|0|||
94275666|NCT04677959|322802501|FG001|Overall Study|Non-compliance with study drug|2|||
94275667|NCT04677959|322802500|FG000|Overall Study|Protocol deviation|0|||
94275668|NCT04677959|322802501|FG001|Overall Study|Protocol deviation|11|||
94467518|NCT00422292|323500601|FG003|Overall Study|Lost to Follow-up|6|||
94275669|NCT04677959|322802500|FG000|Overall Study|Lost to Follow-up|9|||
94275670|NCT04677959|322802501|FG001|Overall Study|Lost to Follow-up|13|||
94275671|NCT04677959|322802500|FG000|Overall Study|Other than specified|0|||
94275672|NCT04677959|322802501|FG001|Overall Study|Other than specified|8|||
94740437|NCT03248479|324505035|FG007|Overall Study|Consent withdrawn|1|||
94740438|NCT03248479|324505036|FG008|Overall Study|Consent withdrawn|0|||
94740439|NCT03248479|324505037|FG009|Overall Study|Consent withdrawn|3|||
94740440|NCT03248479|324505038|FG010|Overall Study|Consent withdrawn|1|||
94740441|NCT03248479|324505039|FG011|Overall Study|Consent withdrawn|0|||
94740442|NCT03248479|324505040|FG012|Overall Study|Consent withdrawn|1|||
94740443|NCT03248479|324505028|FG000|Overall Study|Lost to Follow-up|2|||
94740444|NCT03248479|324505029|FG001|Overall Study|Lost to Follow-up|1|||
94740445|NCT03248479|324505030|FG002|Overall Study|Lost to Follow-up|0|||
94740446|NCT03248479|324505031|FG003|Overall Study|Lost to Follow-up|0|||
94740447|NCT03248479|324505032|FG004|Overall Study|Lost to Follow-up|0|||
94740448|NCT03248479|324505033|FG005|Overall Study|Lost to Follow-up|0|||
94740449|NCT03248479|324505034|FG006|Overall Study|Lost to Follow-up|0|||
94740450|NCT03248479|324505035|FG007|Overall Study|Lost to Follow-up|0|||
94740451|NCT03248479|324505036|FG008|Overall Study|Lost to Follow-up|0|||
94740452|NCT03248479|324505037|FG009|Overall Study|Lost to Follow-up|0|||
94740453|NCT03248479|324505038|FG010|Overall Study|Lost to Follow-up|0|||
94740454|NCT03248479|324505039|FG011|Overall Study|Lost to Follow-up|0|||
94740455|NCT03248479|324505040|FG012|Overall Study|Lost to Follow-up|1|||
94740456|NCT03248479|324505028|FG000|Overall Study|Not reported|0|||
94740457|NCT03248479|324505029|FG001|Overall Study|Not reported|0|||
94740458|NCT03248479|324505030|FG002|Overall Study|Not reported|0|||
94740459|NCT03248479|324505031|FG003|Overall Study|Not reported|1|||
94740460|NCT03248479|324505032|FG004|Overall Study|Not reported|1|||
94740461|NCT03248479|324505033|FG005|Overall Study|Not reported|0|||
94740462|NCT03248479|324505034|FG006|Overall Study|Not reported|0|||
94740463|NCT03248479|324505035|FG007|Overall Study|Not reported|1|||
94740464|NCT03248479|324505036|FG008|Overall Study|Not reported|1|||
94740465|NCT03248479|324505037|FG009|Overall Study|Not reported|0|||
94740466|NCT03248479|324505038|FG010|Overall Study|Not reported|0|||
94740467|NCT03248479|324505039|FG011|Overall Study|Not reported|0|||
94740468|NCT03248479|324505040|FG012|Overall Study|Not reported|0|||
94740469|NCT03011034|324505041|FG000|Overall Study|Adverse Event|1|||
94740470|NCT03011034|324505042|FG001|Overall Study|Adverse Event|0|||
94740471|NCT02777593|324505045|FG000|Overall Study|Still in study|1|||
94740472|NCT02777593|324505046|FG001|Overall Study|Still in study|32|||
94740473|NCT02777593|324505047|FG002|Overall Study|Still in study|3|||
94740474|NCT02777593|324505048|FG003|Overall Study|Still in study|6|||
94740475|NCT02777593|324505049|FG004|Overall Study|Still in study|5|||
94740476|NCT02777593|324505045|FG000|Overall Study|Death|21|||
94740477|NCT02777593|324505046|FG001|Overall Study|Death|28|||
94740478|NCT02777593|324505047|FG002|Overall Study|Death|0|||
94740479|NCT02777593|324505048|FG003|Overall Study|Death|5|||
94740480|NCT02777593|324505049|FG004|Overall Study|Death|0|||
94740481|NCT02777593|324505045|FG000|Overall Study|Withdrawal by Subject|8|||
94740482|NCT02777593|324505046|FG001|Overall Study|Withdrawal by Subject|4|||
94740483|NCT02777593|324505047|FG002|Overall Study|Withdrawal by Subject|1|||
94740484|NCT02777593|324505048|FG003|Overall Study|Withdrawal by Subject|1|||
94740485|NCT02777593|324505049|FG004|Overall Study|Withdrawal by Subject|0|||
94740486|NCT02777593|324505045|FG000|Overall Study|Lost to Follow-up|8|||
94740487|NCT02777593|324505046|FG001|Overall Study|Lost to Follow-up|16|||
94740488|NCT02777593|324505047|FG002|Overall Study|Lost to Follow-up|5|||
94740489|NCT02777593|324505048|FG003|Overall Study|Lost to Follow-up|0|||
94740490|NCT02777593|324505049|FG004|Overall Study|Lost to Follow-up|1|||
94740491|NCT02777593|324505045|FG000|Overall Study|Physician Decision|2|||
94740492|NCT02777593|324505046|FG001|Overall Study|Physician Decision|2|||
94740493|NCT02777593|324505047|FG002|Overall Study|Physician Decision|0|||
94740494|NCT02777593|324505048|FG003|Overall Study|Physician Decision|0|||
94740495|NCT02777593|324505049|FG004|Overall Study|Physician Decision|0|||
94740496|NCT02777593|324505045|FG000|Overall Study|Discontinued due to Other|1|||
94740497|NCT02777593|324505046|FG001|Overall Study|Discontinued due to Other|0|||
94740498|NCT02777593|324505047|FG002|Overall Study|Discontinued due to Other|0|||
94740499|NCT02777593|324505048|FG003|Overall Study|Discontinued due to Other|0|||
94740500|NCT02777593|324505049|FG004|Overall Study|Discontinued due to Other|0|||
94740501|NCT05123027|324505051|FG000|Overall Study|Lost to Follow-up|17|||
94740502|NCT05123027|324505052|FG001|Overall Study|Lost to Follow-up|22|||
94740503|NCT05123027|324505051|FG000|Overall Study|Incarceration|3|||
94740504|NCT05123027|324505052|FG001|Overall Study|Incarceration|4|||
94740505|NCT05123027|324505051|FG000|Overall Study|Death|2|||
94740506|NCT05123027|324505052|FG001|Overall Study|Death|2|||
94740507|NCT05123027|324505051|FG000|Overall Study|Other|2|||
94740508|NCT05123027|324505052|FG001|Overall Study|Other|0|||
94740509|NCT03988621|324505975|FG000|Overall Study|Lost to Follow-up|16|||
94740510|NCT03988621|324505976|FG001|Overall Study|Lost to Follow-up|17|||
94740511|NCT03988621|324505975|FG000|Overall Study|Withdrawal by Subject|14|||
94740512|NCT03988621|324505976|FG001|Overall Study|Withdrawal by Subject|7|||
94740513|NCT03988621|324505975|FG000|Overall Study|Patient Lost to Follow Up|15|||
94740514|NCT03988621|324505976|FG001|Overall Study|Patient Lost to Follow Up|15|||
94740515|NCT03988621|324505975|FG000|Overall Study|Patient death|1|||
94740516|NCT03988621|324505976|FG001|Overall Study|Patient death|5|||
94740517|NCT04084574|324505979|FG000|Overall Study|Lost to Follow-up|1|||
94740518|NCT04084574|324505980|FG001|Overall Study|Lost to Follow-up|0|||
94740519|NCT04084574|324505979|FG000|Overall Study|Physician Decision|1|||
94740520|NCT04084574|324505980|FG001|Overall Study|Physician Decision|0|||
94740521|NCT04084574|324505979|FG000|Overall Study|Relocated out of state|1|||
94740522|NCT04084574|324505980|FG001|Overall Study|Relocated out of state|0|||
94740523|NCT00942877|324505981|FG000|Overall Study|Refused further treatment|1|||
94740524|NCT00942877|324505982|FG001|Overall Study|Refused further treatment|1|||
94740525|NCT00942877|324505981|FG000|Overall Study|Patient was not treated|1|||
94740526|NCT00942877|324505982|FG001|Overall Study|Patient was not treated|0|||
94740527|NCT00942877|324505981|FG000|Overall Study|Adverse Event|1|||
94740528|NCT00942877|324505982|FG001|Overall Study|Adverse Event|0|||
94740529|NCT00942877|324505981|FG000|Overall Study|Progressive disease|42|||
94740530|NCT00942877|324505982|FG001|Overall Study|Progressive disease|3|||
94740531|NCT03245840|324505990|FG000|Overall Study|Adverse Event|6|||
94740532|NCT03245840|324505991|FG001|Overall Study|Adverse Event|0|||
94740533|NCT03245840|324505990|FG000|Overall Study|Death|2|||
94740534|NCT03245840|324505991|FG001|Overall Study|Death|0|||
94740535|NCT03245840|324505990|FG000|Overall Study|Withdrawal by Subject|31|||
94740536|NCT03245840|324505991|FG001|Overall Study|Withdrawal by Subject|1|||
94740537|NCT03245840|324505990|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
94740538|NCT03245840|324505991|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94740539|NCT03245840|324505990|FG000|Overall Study|Physician Decision|4|||
94740540|NCT03245840|324505991|FG001|Overall Study|Physician Decision|1|||
94275673|NCT00535132|322802502|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
94275674|NCT00535132|322802503|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
94275675|NCT00535132|322802502|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
94275676|NCT00535132|322802503|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
94275677|NCT00264875|322802504|FG000|Overall Study|Adverse Event|6|||
94275678|NCT00264875|322802504|FG000|Overall Study|Lost to Follow-up|6|||
94275679|NCT00264875|322802504|FG000|Overall Study|Protocol Violation|11|||
94275680|NCT00264875|322802504|FG000|Overall Study|Withdrawal by Subject|7|||
94275681|NCT01074190|322802505|FG000|Overall Study|Emergency Cesarean Delivery|1|||
94275682|NCT01074190|322802506|FG001|Overall Study|Emergency Cesarean Delivery|2|||
94275683|NCT01074190|322802507|FG002|Overall Study|Emergency Cesarean Delivery|1|||
94275684|NCT01074190|322802505|FG000|Overall Study|Protocol Violation|2|||
94275685|NCT01074190|322802506|FG001|Overall Study|Protocol Violation|1|||
94275686|NCT01074190|322802507|FG002|Overall Study|Protocol Violation|0|||
94275687|NCT01074190|322802505|FG000|Overall Study|Delivered in under 90 minutes|0|||
94275688|NCT01074190|322802506|FG001|Overall Study|Delivered in under 90 minutes|2|||
94275689|NCT01074190|322802507|FG002|Overall Study|Delivered in under 90 minutes|1|||
94275690|NCT01074190|322802505|FG000|Overall Study|Subject withdrew consent|1|||
94275691|NCT01074190|322802506|FG001|Overall Study|Subject withdrew consent|1|||
94275692|NCT01074190|322802507|FG002|Overall Study|Subject withdrew consent|1|||
94275693|NCT02025907|322802508|FG000|Overall Study|Lack of Efficacy|1|||
94275694|NCT02025907|322802509|FG001|Overall Study|Lack of Efficacy|0|||
94275695|NCT02025907|322802508|FG000|Overall Study|Withdrawal by Subject|15|||
94275696|NCT02025907|322802509|FG001|Overall Study|Withdrawal by Subject|8|||
94275697|NCT02025907|322802508|FG000|Overall Study|Protocol Violation|2|||
94275698|NCT02025907|322802509|FG001|Overall Study|Protocol Violation|0|||
94275699|NCT02025907|322802508|FG000|Overall Study|Physician Decision|2|||
94275700|NCT02025907|322802509|FG001|Overall Study|Physician Decision|0|||
94275701|NCT02025907|322802508|FG000|Overall Study|Lost to Follow-up|2|||
94369112|NCT00736333|323137957|FG000|Overall Study|Death|7|||
94369113|NCT00736333|323137957|FG000|Overall Study|Other|4|||
94369114|NCT01106352|323137959|FG000|Overall Study|Subjects untreated|0|||
94369115|NCT01106352|323137960|FG001|Overall Study|Subjects untreated|0|||
94369116|NCT01106352|323137961|FG002|Overall Study|Subjects untreated|0|||
94369117|NCT01106352|323137962|FG003|Overall Study|Subjects untreated|3|||
94369118|NCT01106352|323137963|FG004|Overall Study|Subjects untreated|4|||
94369119|NCT01106352|323137959|FG000|Overall Study|Sponsor Decision|1|||
94369120|NCT01106352|323137960|FG001|Overall Study|Sponsor Decision|0|||
94369121|NCT01106352|323137961|FG002|Overall Study|Sponsor Decision|0|||
94369122|NCT01106352|323137962|FG003|Overall Study|Sponsor Decision|0|||
94369123|NCT01106352|323137963|FG004|Overall Study|Sponsor Decision|0|||
94369124|NCT01106352|323137959|FG000|Overall Study|Too ill to come in for the visit|0|||
94369125|NCT01106352|323137960|FG001|Overall Study|Too ill to come in for the visit|0|||
94369126|NCT01106352|323137961|FG002|Overall Study|Too ill to come in for the visit|1|||
94369127|NCT01106352|323137962|FG003|Overall Study|Too ill to come in for the visit|0|||
94369128|NCT01106352|323137963|FG004|Overall Study|Too ill to come in for the visit|0|||
94369129|NCT01106352|323137959|FG000|Overall Study|Lost to Follow-up|0|||
94369130|NCT01106352|323137960|FG001|Overall Study|Lost to Follow-up|0|||
94369131|NCT01106352|323137961|FG002|Overall Study|Lost to Follow-up|0|||
94369132|NCT01106352|323137962|FG003|Overall Study|Lost to Follow-up|0|||
94369133|NCT01106352|323137963|FG004|Overall Study|Lost to Follow-up|1|||
94369134|NCT01106352|323137959|FG000|Overall Study|Death|0|||
94369135|NCT01106352|323137960|FG001|Overall Study|Death|0|||
94369136|NCT01106352|323137961|FG002|Overall Study|Death|1|||
94369137|NCT01106352|323137962|FG003|Overall Study|Death|3|||
94369138|NCT01106352|323137963|FG004|Overall Study|Death|1|||
94369139|NCT01106352|323137959|FG000|Overall Study|Disease progression|0|||
94369140|NCT01106352|323137960|FG001|Overall Study|Disease progression|0|||
94369141|NCT01106352|323137961|FG002|Overall Study|Disease progression|0|||
94369142|NCT01106352|323137962|FG003|Overall Study|Disease progression|1|||
94369143|NCT01106352|323137963|FG004|Overall Study|Disease progression|0|||
94369144|NCT01106352|323137959|FG000|Overall Study|Withdrawal by Subject|0|||
94369145|NCT01106352|323137960|FG001|Overall Study|Withdrawal by Subject|0|||
94369146|NCT01106352|323137961|FG002|Overall Study|Withdrawal by Subject|0|||
94369147|NCT01106352|323137962|FG003|Overall Study|Withdrawal by Subject|3|||
94369148|NCT01106352|323137963|FG004|Overall Study|Withdrawal by Subject|2|||
94369149|NCT01106352|323137959|FG000|Overall Study|Went on hospice|0|||
94369150|NCT01106352|323137960|FG001|Overall Study|Went on hospice|0|||
94369151|NCT01106352|323137961|FG002|Overall Study|Went on hospice|0|||
94369152|NCT01106352|323137962|FG003|Overall Study|Went on hospice|1|||
94369153|NCT01106352|323137963|FG004|Overall Study|Went on hospice|0|||
94369154|NCT01106352|323137959|FG000|Overall Study|Subject entered hospice|0|||
94369155|NCT01106352|323137960|FG001|Overall Study|Subject entered hospice|0|||
94369156|NCT01106352|323137961|FG002|Overall Study|Subject entered hospice|0|||
94369157|NCT01106352|323137962|FG003|Overall Study|Subject entered hospice|1|||
94275702|NCT02025907|322802509|FG001|Overall Study|Lost to Follow-up|2|||
94275703|NCT02025907|322802508|FG000|Overall Study|Adverse Event|3|||
94467519|NCT00422292|323500598|FG000|Overall Study|Withdrawal by Subject|6|||
94467520|NCT00422292|323500599|FG001|Overall Study|Withdrawal by Subject|25|||
94275704|NCT02025907|322802509|FG001|Overall Study|Adverse Event|1|||
94275705|NCT02025907|322802508|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
94275706|NCT02025907|322802509|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
94369158|NCT01106352|323137963|FG004|Overall Study|Subject entered hospice|0|||
94369159|NCT01106352|323137959|FG000|Overall Study|Home hospice since July 2013|0|||
94369160|NCT01106352|323137960|FG001|Overall Study|Home hospice since July 2013|0|||
94369161|NCT01106352|323137961|FG002|Overall Study|Home hospice since July 2013|0|||
94369162|NCT01106352|323137962|FG003|Overall Study|Home hospice since July 2013|1|||
94369163|NCT01106352|323137963|FG004|Overall Study|Home hospice since July 2013|0|||
94369164|NCT02117479|323137964|FG000|Overall Study|Death|13|||
94369165|NCT02117479|323137965|FG001|Overall Study|Death|8|||
94369166|NCT02117479|323137964|FG000|Overall Study|Adverse Event|8|||
94369167|NCT02117479|323137965|FG001|Overall Study|Adverse Event|16|||
94740541|NCT03245840|324505990|FG000|Overall Study|Study Terminated by Sponsor|56|||
94740542|NCT03245840|324505991|FG001|Overall Study|Study Terminated by Sponsor|6|||
94740543|NCT03245840|324505990|FG000|Overall Study|Site Terminated by Sponsor|4|||
94740544|NCT03245840|324505991|FG001|Overall Study|Site Terminated by Sponsor|0|||
94740545|NCT03245840|324505990|FG000|Overall Study|Lost to Follow-up|12|||
94740546|NCT03245840|324505991|FG001|Overall Study|Lost to Follow-up|2|||
94740547|NCT03245840|324505990|FG000|Overall Study|Pregnancy|2|||
94740548|NCT03245840|324505991|FG001|Overall Study|Pregnancy|0|||
94740549|NCT03245840|324505990|FG000|Overall Study|Non-Compliance with Study Drug|2|||
94740550|NCT03245840|324505991|FG001|Overall Study|Non-Compliance with Study Drug|0|||
94740551|NCT03245840|324505990|FG000|Overall Study|Not treated|1|||
94740552|NCT03245840|324505991|FG001|Overall Study|Not treated|1|||
94740553|NCT04631016|324505999|FG000|Overall Study|Adverse Event|3|||
94740554|NCT04631016|324506000|FG001|Overall Study|Adverse Event|0|||
94740555|NCT04631016|324505999|FG000|Overall Study|Withdrawal by Subject|5|||
94740556|NCT04631016|324506000|FG001|Overall Study|Withdrawal by Subject|4|||
94740557|NCT04631016|324505999|FG000|Overall Study|Reason unspecified|1|||
94740558|NCT04631016|324506000|FG001|Overall Study|Reason unspecified|0|||
94740559|NCT04631016|324505999|FG000|Overall Study|Failure to meet randomization criteria|2|||
94740560|NCT04631016|324506000|FG001|Overall Study|Failure to meet randomization criteria|1|||
94740561|NCT04109066|324506001|FG000|Pre-treatment|Participant withdrew consent|2|||
94740562|NCT04109066|324506002|FG001|Pre-treatment|Participant withdrew consent|0|||
94369168|NCT02117479|323137964|FG000|Overall Study|Subject decision|8|||
94275707|NCT00777101|322802510|FG000|Overall Study|Death|48|||
94275708|NCT00777101|322802511|FG001|Overall Study|Death|43|||
94275709|NCT00777101|322802510|FG000|Overall Study|Withdrawal by Subject|11|||
94275710|NCT00777101|322802511|FG001|Overall Study|Withdrawal by Subject|6|||
94275711|NCT00777101|322802510|FG000|Overall Study|Lost to Follow-up|2|||
94275712|NCT00777101|322802511|FG001|Overall Study|Lost to Follow-up|1|||
94275713|NCT00777101|322802510|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
94275714|NCT00777101|322802511|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
94275715|NCT00777101|322802510|FG000|Overall Study|Failed to Return|0|||
94275716|NCT00777101|322802511|FG001|Overall Study|Failed to Return|1|||
94275717|NCT00961220|322802512|FG000|Overall Study|Adverse Event|3|||
94275718|NCT00961220|322802512|FG000|Overall Study|Lack of Efficacy|1|||
94275719|NCT00961220|322802512|FG000|Overall Study|No IV access for O6BG|1|||
94275720|NCT00961220|322802512|FG000|Overall Study|O6BG no longer supplied|1|||
94275721|NCT00961220|322802512|FG000|Overall Study|Complete Response prior to 12 courses|1|||
94275722|NCT00282334|322802513|FG000|Overall Study|Withdrawal by Subject|8|||
94275723|NCT00282334|322802514|FG001|Overall Study|Withdrawal by Subject|5|||
94275724|NCT01347554|322802517|FG000|Overall Study|Lack of Efficacy|7|||
94275725|NCT01347554|322802518|FG001|Overall Study|Lack of Efficacy|11|||
94275726|NCT00513500|322802519|FG000|Overall Study|Lost to Follow-up|35|||
94275727|NCT00513500|322802520|FG001|Overall Study|Lost to Follow-up|39|||
94275728|NCT00513500|322802519|FG000|Overall Study|Death|2|||
94275729|NCT00513500|322802520|FG001|Overall Study|Death|1|||
94275730|NCT00513500|322802519|FG000|Overall Study|Hospitalized|4|||
94275731|NCT00513500|322802520|FG001|Overall Study|Hospitalized|14|||
94275732|NCT01439204|322802521|FG000|Overall Study|Withdrawal by Subject|0|||
94275733|NCT01439204|322802522|FG001|Overall Study|Withdrawal by Subject|1|||
94275734|NCT01439204|322802521|FG000|Overall Study|Lost to Follow-up|0|||
94275735|NCT01439204|322802522|FG001|Overall Study|Lost to Follow-up|2|||
94275736|NCT01439204|322802521|FG000|Overall Study|No longer meets study criteria|1|||
94275737|NCT01439204|322802522|FG001|Overall Study|No longer meets study criteria|0|||
94275738|NCT01439204|322802521|FG000|Overall Study|poor/non-compliance|3|||
94275739|NCT01439204|322802522|FG001|Overall Study|poor/non-compliance|0|||
94275740|NCT04288154|322802523|FG000|Overall Study|Withdrawal by Subject|9|||
94275741|NCT04288154|322802524|FG001|Overall Study|Withdrawal by Subject|9|||
94275742|NCT01227044|322802527|FG000|Overall Study|Lost to Follow-up|5|||
94275743|NCT01227044|322802528|FG001|Overall Study|Lost to Follow-up|7|||
94275744|NCT01227044|322802527|FG000|Overall Study|Discontinued Intervention|1|||
94275745|NCT01227044|322802528|FG001|Overall Study|Discontinued Intervention|2|||
94275746|NCT01277549|322802531|FG000|Overall Study|Failed to meet eligibility criteria|13|||
94275747|NCT01277549|322802532|FG001|Overall Study|Failed to meet eligibility criteria|9|||
94275748|NCT01277549|322802531|FG000|Overall Study|Withdrawal by Subject|1|||
94275749|NCT01277549|322802532|FG001|Overall Study|Withdrawal by Subject|3|||
94275750|NCT01277549|322802531|FG000|Overall Study|Protocol Violation|10|||
94275751|NCT01277549|322802532|FG001|Overall Study|Protocol Violation|1|||
94275752|NCT01277549|322802531|FG000|Overall Study|Physician Decision|2|||
94275753|NCT01277549|322802532|FG001|Overall Study|Physician Decision|1|||
94275754|NCT00645593|322802539|FG000|Overall Study|Later found to be ineligible|1|||
94275755|NCT00645593|322802540|FG001|Overall Study|Later found to be ineligible|0|||
94275756|NCT03028870|322802541|FG000|Overall Study|Adverse Event|7|||
94275757|NCT03028870|322802542|FG001|Overall Study|Adverse Event|4|||
94275758|NCT03028870|322802543|FG002|Overall Study|Adverse Event|3|||
94275759|NCT03028870|322802544|FG003|Overall Study|Adverse Event|3|||
94275760|NCT03028870|322802541|FG000|Overall Study|Withdrawal by Subject|1|||
94275761|NCT03028870|322802542|FG001|Overall Study|Withdrawal by Subject|1|||
94275762|NCT03028870|322802543|FG002|Overall Study|Withdrawal by Subject|1|||
94275763|NCT03028870|322802544|FG003|Overall Study|Withdrawal by Subject|2|||
94275764|NCT03028870|322802541|FG000|Overall Study|Lost to Follow-up|1|||
94275765|NCT03028870|322802542|FG001|Overall Study|Lost to Follow-up|0|||
94275766|NCT03028870|322802543|FG002|Overall Study|Lost to Follow-up|0|||
94275767|NCT03028870|322802544|FG003|Overall Study|Lost to Follow-up|0|||
94275768|NCT03028870|322802541|FG000|Overall Study|Lack of Efficacy|3|||
94275769|NCT03028870|322802542|FG001|Overall Study|Lack of Efficacy|0|||
94275770|NCT03028870|322802543|FG002|Overall Study|Lack of Efficacy|0|||
94467521|NCT00422292|323500600|FG002|Overall Study|Withdrawal by Subject|7|||
94467522|NCT00422292|323500601|FG003|Overall Study|Withdrawal by Subject|13|||
94467523|NCT00958412|323500602|FG000|Overall Study|Study prematurely terminated|18|||
94740563|NCT04109066|324506001|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
94740564|NCT04109066|324506002|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
94740565|NCT04109066|324506001|FG000|Treatment|Lack of Efficacy|2|||
94740566|NCT04109066|324506002|FG001|Treatment|Lack of Efficacy|4|||
94740567|NCT04109066|324506001|FG000|Treatment|Adverse Event|23|||
94740568|NCT04109066|324506002|FG001|Treatment|Adverse Event|7|||
94740569|NCT04109066|324506001|FG000|Treatment|Participant request to discontinue Study treatment|15|||
94740570|NCT04109066|324506002|FG001|Treatment|Participant request to discontinue Study treatment|14|||
94740571|NCT04109066|324506001|FG000|Treatment|Withdrawal by Subject|8|||
94740572|NCT04109066|324506002|FG001|Treatment|Withdrawal by Subject|8|||
94740573|NCT04109066|324506001|FG000|Treatment|Death|3|||
94740574|NCT04109066|324506002|FG001|Treatment|Death|0|||
94740575|NCT04109066|324506001|FG000|Treatment|Participant no longer meets study criteria|2|||
94740576|NCT04109066|324506002|FG001|Treatment|Participant no longer meets study criteria|2|||
94740577|NCT04109066|324506001|FG000|Treatment|Administrative reasons by sponsor|2|||
94740578|NCT04109066|324506002|FG001|Treatment|Administrative reasons by sponsor|3|||
94740579|NCT04109066|324506001|FG000|Treatment|Other reasons|17|||
94740580|NCT04109066|324506002|FG001|Treatment|Other reasons|23|||
94740581|NCT04109066|324506001|FG000|Treatment|Disease Progression|4|||
94740582|NCT04109066|324506002|FG001|Treatment|Disease Progression|7|||
94740583|NCT04109066|324506001|FG000|Treatment|Study drug toxicity|12|||
94740584|NCT04109066|324506002|FG001|Treatment|Study drug toxicity|5|||
94740585|NCT04109066|324506001|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
94740586|NCT04109066|324506002|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
94740587|NCT04109066|324506001|FG000|Treatment|Disease Recurrence|0|||
94740588|NCT04109066|324506002|FG001|Treatment|Disease Recurrence|2|||
94740589|NCT04109066|324506001|FG000|Treatment|Not reported|4|||
94740590|NCT04109066|324506002|FG001|Treatment|Not reported|8|||
94740591|NCT05652010|324506003|FG000|First Intervention|Withdrawal by Subject|0|||
94740592|NCT05652010|324506004|FG001|First Intervention|Withdrawal by Subject|1|||
94740593|NCT05652010|324506003|FG000|Second Intervention|Withdrawal by Subject|1|||
94740594|NCT05652010|324506004|FG001|Second Intervention|Withdrawal by Subject|0|||
94740595|NCT05205161|324506005|FG000|Overall Study|Study terminated by sponsor|3|||
94740596|NCT05205161|324506006|FG001|Overall Study|Study terminated by sponsor|3|||
94740597|NCT05205161|324506007|FG002|Overall Study|Study terminated by sponsor|1|||
94740598|NCT05741294|324506016|FG000|Overall Study|Lost to Follow-up|3|||
94740599|NCT05741294|324506016|FG000|Overall Study|Protocol deviation|3|||
94740600|NCT05741294|324506016|FG000|Overall Study|Withdrawal by Subject|1|||
94740601|NCT05953740|324506019|FG000|Period 1|Physician Decision|0|||
94740602|NCT05953740|324506020|FG001|Period 1|Physician Decision|1|||
94740603|NCT05953740|324506021|FG002|Period 1|Physician Decision|0|||
94740604|NCT05953740|324506022|FG003|Period 1|Physician Decision|0|||
94740605|NCT05953740|324506023|FG004|Period 1|Physician Decision|0|||
94740606|NCT05953740|324506024|FG005|Period 1|Physician Decision|0|||
94740607|NCT05953740|324506025|FG006|Period 1|Physician Decision|0|||
94740608|NCT05953740|324506026|FG007|Period 1|Physician Decision|0|||
94740609|NCT05953740|324506019|FG000|Period 2|Withdrawal by Subject|0|||
94740610|NCT05953740|324506020|FG001|Period 2|Withdrawal by Subject|1|||
94740611|NCT05953740|324506021|FG002|Period 2|Withdrawal by Subject|1|||
94740612|NCT05953740|324506022|FG003|Period 2|Withdrawal by Subject|0|||
94740613|NCT05953740|324506023|FG004|Period 2|Withdrawal by Subject|0|||
94740614|NCT05953740|324506024|FG005|Period 2|Withdrawal by Subject|0|||
94740615|NCT05953740|324506025|FG006|Period 2|Withdrawal by Subject|0|||
94740616|NCT05953740|324506026|FG007|Period 2|Withdrawal by Subject|0|||
94740617|NCT03333915|324506027|FG000|Overall Study|Lost to Follow-up|0|||
94740618|NCT03333915|324506028|FG001|Overall Study|Lost to Follow-up|0|||
94740619|NCT03333915|324506029|FG002|Overall Study|Lost to Follow-up|1|||
94740620|NCT03333915|324506030|FG003|Overall Study|Lost to Follow-up|0|||
94740621|NCT03333915|324506031|FG004|Overall Study|Lost to Follow-up|0|||
94740622|NCT03333915|324506027|FG000|Overall Study|Disease Progression|0|||
94740623|NCT03333915|324506028|FG001|Overall Study|Disease Progression|1|||
94740624|NCT03333915|324506029|FG002|Overall Study|Disease Progression|0|||
94740625|NCT03333915|324506030|FG003|Overall Study|Disease Progression|0|||
94740626|NCT03333915|324506031|FG004|Overall Study|Disease Progression|0|||
94740627|NCT03333915|324506027|FG000|Overall Study|Death|0|||
94740628|NCT03333915|324506028|FG001|Overall Study|Death|0|||
94740629|NCT03333915|324506029|FG002|Overall Study|Death|0|||
94740630|NCT03333915|324506030|FG003|Overall Study|Death|37|||
94740631|NCT03333915|324506031|FG004|Overall Study|Death|18|||
94740632|NCT03333915|324506027|FG000|Overall Study|Sponsor's Decision|0|||
94740633|NCT03333915|324506028|FG001|Overall Study|Sponsor's Decision|0|||
94740634|NCT03333915|324506029|FG002|Overall Study|Sponsor's Decision|0|||
94740635|NCT03333915|324506030|FG003|Overall Study|Sponsor's Decision|48|||
94740636|NCT03333915|324506031|FG004|Overall Study|Sponsor's Decision|4|||
94740637|NCT03333915|324506027|FG000|Overall Study|Withdrawal by Subject|0|||
94740638|NCT03333915|324506028|FG001|Overall Study|Withdrawal by Subject|0|||
94275771|NCT03028870|322802544|FG003|Overall Study|Lack of Efficacy|0|||
94275772|NCT03028870|322802541|FG000|Overall Study|Administrative|5|||
94275773|NCT03028870|322802542|FG001|Overall Study|Administrative|5|||
94275774|NCT03028870|322802543|FG002|Overall Study|Administrative|12|||
94275775|NCT03028870|322802544|FG003|Overall Study|Administrative|4|||
94275776|NCT01970501|322802545|FG000|Overall Study|Discontinuation of study by sponsor|16|||
94275777|NCT01970501|322802546|FG001|Overall Study|Discontinuation of study by sponsor|14|||
94275778|NCT01970501|322802545|FG000|Overall Study|Withdrawal by Subject|6|||
94275779|NCT01970501|322802546|FG001|Overall Study|Withdrawal by Subject|7|||
94275780|NCT01970501|322802545|FG000|Overall Study|Adverse Event|2|||
94275781|NCT01970501|322802546|FG001|Overall Study|Adverse Event|4|||
94275782|NCT01970501|322802545|FG000|Overall Study|Death|1|||
94275783|NCT01970501|322802546|FG001|Overall Study|Death|3|||
94275784|NCT01970501|322802545|FG000|Overall Study|Physician Decision|2|||
94275785|NCT01970501|322802546|FG001|Overall Study|Physician Decision|0|||
94275786|NCT01430455|322802547|FG000|Overall Study|Withdrawal by Subject|1|||
94275787|NCT01430455|322802547|FG000|Overall Study|Switched to follow-up phase|1|||
94275788|NCT04194528|322802549|FG000|Overall Study|Adverse Event|1|||
94275789|NCT00631371|322804413|FG000|Overall Study|Lost to Follow-up|24|||
94275790|NCT00631371|322804414|FG001|Overall Study|Lost to Follow-up|19|||
94275791|NCT00631371|322804413|FG000|Overall Study|Other reason|5|||
94275792|NCT00631371|322804414|FG001|Overall Study|Other reason|12|||
94275793|NCT00631371|322804413|FG000|Overall Study|subject request|38|||
94275794|NCT00631371|322804414|FG001|Overall Study|subject request|45|||
94275795|NCT00631371|322804413|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
94275796|NCT00631371|322804414|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
94275797|NCT00631371|322804413|FG000|Overall Study|Death|263|||
94275798|NCT00631371|322804414|FG001|Overall Study|Death|239|||
94275799|NCT00129766|322804417|FG000|Overall Study|Death|3|||
94275800|NCT00129766|322804418|FG001|Overall Study|Death|8|||
94275801|NCT00129766|322804417|FG000|Overall Study|Withdrawal of consent|31|||
94275802|NCT00129766|322804418|FG001|Overall Study|Withdrawal of consent|30|||
94275803|NCT00129766|322804417|FG000|Overall Study|Lost to Follow-up|26|||
94275804|NCT00129766|322804418|FG001|Overall Study|Lost to Follow-up|21|||
94275805|NCT01140451|322804419|FG000|Overall Study|Withdrawal by Subject|26|||
94275806|NCT01140451|322804420|FG001|Overall Study|Withdrawal by Subject|33|||
94275807|NCT01140451|322804419|FG000|Overall Study|Adverse Event|2|||
94275808|NCT01140451|322804420|FG001|Overall Study|Adverse Event|6|||
94275809|NCT01140451|322804419|FG000|Overall Study|Physician Decision|5|||
94275810|NCT01140451|322804420|FG001|Overall Study|Physician Decision|3|||
94275811|NCT01140451|322804419|FG000|Overall Study|Lost to Follow-up|2|||
94275812|NCT01140451|322804420|FG001|Overall Study|Lost to Follow-up|0|||
94275813|NCT01140451|322804419|FG000|Overall Study|Participants Planning Pregnancy|3|||
94275814|NCT01140451|322804420|FG001|Overall Study|Participants Planning Pregnancy|0|||
94275815|NCT01324232|322804421|FG000|Overall Study|Protocol Violation|0|||
94275816|NCT01324232|322804422|FG001|Overall Study|Protocol Violation|0|||
94275817|NCT01324232|322804423|FG002|Overall Study|Protocol Violation|0|||
94275818|NCT01324232|322804424|FG003|Overall Study|Protocol Violation|2|||
94275819|NCT01324232|322804421|FG000|Overall Study|Missing|0|||
94275820|NCT01324232|322804422|FG001|Overall Study|Missing|0|||
94275821|NCT01324232|322804423|FG002|Overall Study|Missing|1|||
94275822|NCT01324232|322804424|FG003|Overall Study|Missing|0|||
94275823|NCT01324232|322804421|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
94275824|NCT01324232|322804422|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
94275825|NCT01324232|322804423|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
94275826|NCT01324232|322804424|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
94275827|NCT01324232|322804421|FG000|Overall Study|Lack of Efficacy|2|||
94275828|NCT01324232|322804422|FG001|Overall Study|Lack of Efficacy|1|||
94275829|NCT01324232|322804423|FG002|Overall Study|Lack of Efficacy|2|||
94275830|NCT01324232|322804424|FG003|Overall Study|Lack of Efficacy|2|||
94275831|NCT01324232|322804421|FG000|Overall Study|Participant Refused Medication|0|||
94275832|NCT01324232|322804422|FG001|Overall Study|Participant Refused Medication|1|||
94275833|NCT01324232|322804423|FG002|Overall Study|Participant Refused Medication|0|||
94275834|NCT01324232|322804424|FG003|Overall Study|Participant Refused Medication|0|||
94275835|NCT01324232|322804421|FG000|Overall Study|Intercurrent illness|0|||
94275836|NCT01324232|322804422|FG001|Overall Study|Intercurrent illness|0|||
94275837|NCT01324232|322804423|FG002|Overall Study|Intercurrent illness|0|||
94275838|NCT01324232|322804424|FG003|Overall Study|Intercurrent illness|1|||
94275839|NCT01324232|322804421|FG000|Overall Study|Adverse Event|2|||
94275840|NCT01324232|322804422|FG001|Overall Study|Adverse Event|5|||
94275841|NCT01324232|322804423|FG002|Overall Study|Adverse Event|6|||
94275842|NCT01324232|322804424|FG003|Overall Study|Adverse Event|6|||
94275843|NCT01324232|322804421|FG000|Overall Study|Withdrawal by Subject|0|||
94275844|NCT01324232|322804422|FG001|Overall Study|Withdrawal by Subject|3|||
94275845|NCT01324232|322804423|FG002|Overall Study|Withdrawal by Subject|4|||
94275846|NCT01324232|322804424|FG003|Overall Study|Withdrawal by Subject|0|||
94275847|NCT01324232|322804421|FG000|Overall Study|Lost to Follow-up|1|||
94275848|NCT01324232|322804422|FG001|Overall Study|Lost to Follow-up|0|||
94275849|NCT01324232|322804423|FG002|Overall Study|Lost to Follow-up|0|||
94275850|NCT01324232|322804424|FG003|Overall Study|Lost to Follow-up|0|||
94275851|NCT00405067|322804425|FG000|Overall Study|Adverse Event|4|||
94275852|NCT00405067|322804426|FG001|Overall Study|Adverse Event|9|||
94275853|NCT00405067|322804427|FG002|Overall Study|Adverse Event|4|||
94275854|NCT00405067|322804425|FG000|Overall Study|Lost to Follow-up|0|||
94275855|NCT00405067|322804426|FG001|Overall Study|Lost to Follow-up|0|||
94275856|NCT00405067|322804427|FG002|Overall Study|Lost to Follow-up|1|||
94275857|NCT03287219|322804429|FG000|Overall Study|Protocol Violation|0|||
94275858|NCT03287219|322804430|FG001|Overall Study|Protocol Violation|2|||
94275859|NCT01118351|322804431|FG000|Overall Study|Adverse Event|3|||
94275860|NCT01118351|322804431|FG000|Overall Study|Withdrawal by Subject|1|||
94275861|NCT03221751|322804432|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
94275862|NCT03221751|322804433|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
94275863|NCT01399788|322804437|FG000|First Intervention Period|Adverse Event|1|||
94275864|NCT01399788|322804438|FG001|First Intervention Period|Adverse Event|0|||
94275865|NCT01500278|322804439|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
94275866|NCT01500278|322804440|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
94275867|NCT01500278|322804439|FG000|Week 0 - Week 12|Protocol Violation|10|||
94275868|NCT01500278|322804440|FG001|Week 0 - Week 12|Protocol Violation|16|||
94275869|NCT01500278|322804439|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
94275870|NCT01500278|322804440|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
94275871|NCT01500278|322804439|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
94275872|NCT01500278|322804440|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
94275873|NCT01500278|322804439|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
94275874|NCT01500278|322804440|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
94275875|NCT01500278|322804439|FG000|Week 0 - Week 12|Patient decision|1|||
94275876|NCT01500278|322804440|FG001|Week 0 - Week 12|Patient decision|0|||
94275877|NCT01500278|322804439|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
94275878|NCT01500278|322804440|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
94275879|NCT01500278|322804439|FG000|Week 0 - Week 12|Investigator decision|1|||
94275880|NCT01500278|322804440|FG001|Week 0 - Week 12|Investigator decision|0|||
94275881|NCT01500278|322804439|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
94275882|NCT01500278|322804440|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
94275883|NCT01500278|322804439|FG000|Week 0 - Week 12|Sponsor decision|1|||
94275884|NCT01500278|322804440|FG001|Week 0 - Week 12|Sponsor decision|0|||
94275885|NCT01500278|322804439|FG000|Week 0 - Week 12|Personal reason|0|||
94275886|NCT01500278|322804440|FG001|Week 0 - Week 12|Personal reason|1|||
94275887|NCT01500278|322804439|FG000|Week 0 - Week 12|Other serious disease|0|||
94275888|NCT01500278|322804440|FG001|Week 0 - Week 12|Other serious disease|1|||
94275889|NCT01500278|322804439|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
94275890|NCT01500278|322804440|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
94275891|NCT01500278|322804439|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
94275892|NCT01500278|322804440|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
94275893|NCT01500278|322804439|FG000|Week 13 - Week 104|Protocol Violation|6|||
94275894|NCT01500278|322804440|FG001|Week 13 - Week 104|Protocol Violation|6|||
94275895|NCT01500278|322804439|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
94275896|NCT01500278|322804440|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
94275897|NCT01500278|322804439|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
94275898|NCT01500278|322804440|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
94275899|NCT01500278|322804439|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
94275900|NCT01500278|322804440|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
94275901|NCT01500278|322804439|FG000|Week 13 - Week 104|Non/bad compliance|7|||
94275902|NCT01500278|322804440|FG001|Week 13 - Week 104|Non/bad compliance|5|||
94275903|NCT01500278|322804439|FG000|Week 13 - Week 104|Recurrent infections|1|||
94275904|NCT01500278|322804440|FG001|Week 13 - Week 104|Recurrent infections|0|||
94275905|NCT01500278|322804439|FG000|Week 13 - Week 104|False positive test|1|||
94275906|NCT01500278|322804440|FG001|Week 13 - Week 104|False positive test|2|||
94275907|NCT01500278|322804439|FG000|Week 13 - Week 104|Sponsor request|4|||
94369169|NCT02117479|323137965|FG001|Overall Study|Subject decision|9|||
94369170|NCT02117479|323137964|FG000|Overall Study|Disease progression|104|||
94369171|NCT02117479|323137965|FG001|Overall Study|Disease progression|108|||
94369172|NCT02117479|323137964|FG000|Overall Study|Noncompliance with study treatment|1|||
94369173|NCT02117479|323137965|FG001|Overall Study|Noncompliance with study treatment|0|||
94369174|NCT02117479|323137964|FG000|Overall Study|Study terminated by the sponsor|4|||
94369175|NCT02117479|323137965|FG001|Overall Study|Study terminated by the sponsor|6|||
94369176|NCT02117479|323137964|FG000|Overall Study|Physician Decision|7|||
94369177|NCT02117479|323137965|FG001|Overall Study|Physician Decision|2|||
94369178|NCT02117479|323137964|FG000|Overall Study|Other unspecified|11|||
94369179|NCT02117479|323137965|FG001|Overall Study|Other unspecified|7|||
94369180|NCT02444182|323137966|FG000|Overall Study|non-compliance|2|||
94369181|NCT02444182|323137967|FG001|Overall Study|non-compliance|1|||
94369182|NCT02444182|323137966|FG000|Overall Study|Lost to Follow-up|0|||
94369183|NCT02444182|323137967|FG001|Overall Study|Lost to Follow-up|4|||
94369184|NCT00572156|323137970|FG000|Overall Study|Adverse Event|3|||
94369185|NCT00572156|323137971|FG001|Overall Study|Adverse Event|1|||
94369186|NCT00572156|323137972|FG002|Overall Study|Adverse Event|5|||
94369187|NCT00572156|323137973|FG003|Overall Study|Adverse Event|1|||
94369188|NCT00572156|323137970|FG000|Overall Study|Lost to Follow-up|1|||
94369189|NCT00572156|323137971|FG001|Overall Study|Lost to Follow-up|1|||
94369190|NCT00572156|323137972|FG002|Overall Study|Lost to Follow-up|1|||
94369191|NCT00572156|323137973|FG003|Overall Study|Lost to Follow-up|0|||
94369192|NCT00572156|323137970|FG000|Overall Study|Protocol Violation|1|||
94369193|NCT00572156|323137971|FG001|Overall Study|Protocol Violation|2|||
94369194|NCT00572156|323137972|FG002|Overall Study|Protocol Violation|0|||
94369195|NCT00572156|323137973|FG003|Overall Study|Protocol Violation|2|||
94369196|NCT00572156|323137970|FG000|Overall Study|Patient/Parent Decision|1|||
94369197|NCT00572156|323137971|FG001|Overall Study|Patient/Parent Decision|6|||
94369198|NCT00572156|323137972|FG002|Overall Study|Patient/Parent Decision|4|||
94369199|NCT00572156|323137973|FG003|Overall Study|Patient/Parent Decision|3|||
94369200|NCT00572156|323137970|FG000|Overall Study|Sponsor Decision|20|||
94369201|NCT00572156|323137971|FG001|Overall Study|Sponsor Decision|16|||
94369202|NCT00572156|323137972|FG002|Overall Study|Sponsor Decision|17|||
94369203|NCT00572156|323137973|FG003|Overall Study|Sponsor Decision|19|||
94369204|NCT02030834|323137974|FG000|Overall Study|Death|4|||
94369205|NCT02030834|323137975|FG001|Overall Study|Death|0|||
94369206|NCT02030834|323137976|FG002|Overall Study|Death|0|||
94369207|NCT02030834|323137974|FG000|Overall Study|Manufacturing failure|2|||
94369208|NCT02030834|323137975|FG001|Overall Study|Manufacturing failure|0|||
94369209|NCT02030834|323137976|FG002|Overall Study|Manufacturing failure|1|||
94369210|NCT02030834|323137974|FG000|Overall Study|Disease progression|2|||
94369211|NCT02030834|323137975|FG001|Overall Study|Disease progression|0|||
94467524|NCT00908596|323502329|FG000|Overall Study|Other reasons|46|||
94369212|NCT02030834|323137976|FG002|Overall Study|Disease progression|2|||
94369213|NCT02030834|323137974|FG000|Overall Study|Lost to Follow-up|1|||
94369214|NCT02030834|323137975|FG001|Overall Study|Lost to Follow-up|0|||
94467525|NCT00908596|323502330|FG001|Overall Study|Other reasons|6|||
94275908|NCT01500278|322804440|FG001|Week 13 - Week 104|Sponsor request|0|||
94369215|NCT02030834|323137976|FG002|Overall Study|Lost to Follow-up|0|||
94369216|NCT02030834|323137974|FG000|Overall Study|Withdrawal by Subject|1|||
94369217|NCT02030834|323137975|FG001|Overall Study|Withdrawal by Subject|0|||
94369218|NCT02030834|323137976|FG002|Overall Study|Withdrawal by Subject|0|||
94369219|NCT02030834|323137974|FG000|Overall Study|Lack of funding|1|||
94369220|NCT02030834|323137975|FG001|Overall Study|Lack of funding|0|||
94369221|NCT02030834|323137976|FG002|Overall Study|Lack of funding|0|||
94369222|NCT01453374|323137977|FG000|Overall Study|Adverse Event|7|||
94369223|NCT01453374|323137977|FG000|Overall Study|Lack of Efficacy|1|||
94369224|NCT01453374|323137977|FG000|Overall Study|Lost to Follow-up|3|||
94369225|NCT01453374|323137977|FG000|Overall Study|Withdrawal by Subject|5|||
94369226|NCT01453374|323137977|FG000|Overall Study|Incarcerated|2|||
94369227|NCT00103259|323137978|FG000|Overall Study|Death|3|||
94369228|NCT00103259|323137979|FG001|Overall Study|Death|2|||
94467526|NCT00908596|323502331|FG002|Overall Study|Other reasons|2|||
94740639|NCT03333915|324506029|FG002|Overall Study|Withdrawal by Subject|0|||
94740640|NCT03333915|324506030|FG003|Overall Study|Withdrawal by Subject|5|||
94740641|NCT03333915|324506031|FG004|Overall Study|Withdrawal by Subject|1|||
94740642|NCT04078152|324506032|FG000|Overall Study|Other|83|||
94740643|NCT04078152|324506033|FG001|Overall Study|Other|22|||
94740644|NCT04078152|324506034|FG002|Overall Study|Other|25|||
94740645|NCT04078152|324506032|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
94740646|NCT04078152|324506033|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
94740647|NCT04078152|324506034|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
94740648|NCT04078152|324506032|FG000|Overall Study|Withdrawal by Subject|5|||
94275909|NCT01500278|322804439|FG000|Week 13 - Week 104|Withdrawn in error|1|||
94275910|NCT01500278|322804440|FG001|Week 13 - Week 104|Withdrawn in error|0|||
94275911|NCT01500278|322804439|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
94275912|NCT01500278|322804440|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
94275913|NCT01500278|322804439|FG000|Week 13 - Week 104|Protocol deviation|1|||
94275914|NCT01500278|322804440|FG001|Week 13 - Week 104|Protocol deviation|0|||
94275915|NCT01500278|322804439|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
94275916|NCT01500278|322804440|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
94275917|NCT01500278|322804439|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
94275918|NCT01500278|322804440|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
94275919|NCT01500278|322804439|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
94275920|NCT01500278|322804440|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
94275921|NCT01500278|322804439|FG000|Week 13 - Week 104|Relocation|0|||
94275922|NCT01500278|322804440|FG001|Week 13 - Week 104|Relocation|1|||
94275923|NCT01500278|322804439|FG000|Week 13 - Week 104|Sponsor decision|0|||
94275924|NCT01500278|322804440|FG001|Week 13 - Week 104|Sponsor decision|2|||
94275925|NCT01500278|322804439|FG000|Week 13 - Week 104|Medical monitor decision|0|||
94275926|NCT01500278|322804440|FG001|Week 13 - Week 104|Medical monitor decision|2|||
94275927|NCT01500278|322804439|FG000|Week 13 - Week 104|Personal reason|0|||
94275928|NCT01500278|322804440|FG001|Week 13 - Week 104|Personal reason|1|||
94275929|NCT01500278|322804439|FG000|Week 13 - Week 104|Not completed|0|||
94275930|NCT01500278|322804440|FG001|Week 13 - Week 104|Not completed|1|||
94275931|NCT01500278|322804439|FG000|Week 13 - Week 104|Death|2|||
94275932|NCT01500278|322804440|FG001|Week 13 - Week 104|Death|4|||
94275933|NCT01500278|322804439|FG000|Week 13 - Week 104|Adverse Event|54|||
94275934|NCT01500278|322804440|FG001|Week 13 - Week 104|Adverse Event|54|||
94275935|NCT03699007|322804441|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
94275936|NCT03699007|322804442|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
94275937|NCT03699007|322804441|FG000|6-month Follow Up|Lost to Follow-up|2|||
94275938|NCT03699007|322804442|FG001|6-month Follow Up|Lost to Follow-up|3|||
94275939|NCT04718974|322804445|FG000|Overall Study|Death|0|||
94275940|NCT04718974|322804446|FG001|Overall Study|Death|2|||
94275941|NCT04718974|322804445|FG000|Overall Study|Lost to Follow-up|10|||
94275942|NCT04718974|322804446|FG001|Overall Study|Lost to Follow-up|20|||
94275943|NCT04718974|322804445|FG000|Overall Study|Transferred out|2|||
94275944|NCT04718974|322804446|FG001|Overall Study|Transferred out|4|||
94275945|NCT01389752|322804447|FG000|Study Period 1|Sponsor decision|0|||
94275946|NCT01389752|322804448|FG001|Study Period 1|Sponsor decision|2|||
94275947|NCT01389752|322804447|FG000|Study Period 2|Sponsor decision|1|||
94275948|NCT01389752|322804448|FG001|Study Period 2|Sponsor decision|0|||
94275949|NCT01157364|322804449|FG000|Overall Study|Other Reasons|1|||
94275950|NCT01157364|322804450|FG001|Overall Study|Other Reasons|1|||
94275951|NCT01157364|322804451|FG002|Overall Study|Other Reasons|2|||
94275952|NCT01157364|322804452|FG003|Overall Study|Other Reasons|1|||
94275953|NCT01157364|322804453|FG004|Overall Study|Other Reasons|0|||
94275954|NCT01157364|322804454|FG005|Overall Study|Other Reasons|0|||
94275955|NCT01157364|322804449|FG000|Overall Study|Personal Reasons|0|||
94275956|NCT01157364|322804450|FG001|Overall Study|Personal Reasons|2|||
94275957|NCT01157364|322804451|FG002|Overall Study|Personal Reasons|0|||
94275958|NCT01157364|322804452|FG003|Overall Study|Personal Reasons|0|||
94275959|NCT01157364|322804453|FG004|Overall Study|Personal Reasons|1|||
94275960|NCT01157364|322804454|FG005|Overall Study|Personal Reasons|1|||
94275961|NCT01157364|322804449|FG000|Overall Study|Lost to Follow-up|1|||
94275962|NCT01157364|322804450|FG001|Overall Study|Lost to Follow-up|0|||
94275963|NCT01157364|322804451|FG002|Overall Study|Lost to Follow-up|1|||
94275964|NCT01157364|322804452|FG003|Overall Study|Lost to Follow-up|0|||
94275965|NCT01157364|322804453|FG004|Overall Study|Lost to Follow-up|0|||
94275966|NCT01157364|322804454|FG005|Overall Study|Lost to Follow-up|0|||
94275967|NCT01157364|322804449|FG000|Overall Study|Lack of Efficacy|0|||
94275968|NCT01157364|322804450|FG001|Overall Study|Lack of Efficacy|0|||
94275969|NCT01157364|322804451|FG002|Overall Study|Lack of Efficacy|0|||
94275970|NCT01157364|322804452|FG003|Overall Study|Lack of Efficacy|1|||
94275971|NCT01157364|322804453|FG004|Overall Study|Lack of Efficacy|0|||
94369229|NCT00103259|323137978|FG000|Overall Study|Withdrawal by Subject|2|||
94369230|NCT00103259|323137979|FG001|Overall Study|Withdrawal by Subject|3|||
94369231|NCT00103259|323137978|FG000|Overall Study|alternative therapy|1|||
94369232|NCT00103259|323137979|FG001|Overall Study|alternative therapy|0|||
94369233|NCT00103259|323137978|FG000|Overall Study|other (reasons were not specified)|2|||
94369234|NCT00103259|323137979|FG001|Overall Study|other (reasons were not specified)|1|||
94369235|NCT00103259|323137978|FG000|Overall Study|ineligible/no protocol therapy|4|||
94369236|NCT00103259|323137979|FG001|Overall Study|ineligible/no protocol therapy|6|||
94369237|NCT01238822|323137982|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
94369238|NCT00068445|323137988|FG000|Randomization|Cancel|1|||
94369239|NCT00068445|323137989|FG001|Randomization|Cancel|3|||
94740649|NCT04078152|324506033|FG001|Overall Study|Withdrawal by Subject|0|||
94740650|NCT04078152|324506034|FG002|Overall Study|Withdrawal by Subject|1|||
94740651|NCT04078152|324506032|FG000|Overall Study|Death|10|||
94740652|NCT04078152|324506033|FG001|Overall Study|Death|2|||
94740653|NCT04078152|324506034|FG002|Overall Study|Death|12|||
94740654|NCT04078152|324506032|FG000|Overall Study|Adverse Event|1|||
94740655|NCT04078152|324506033|FG001|Overall Study|Adverse Event|0|||
94740656|NCT04078152|324506034|FG002|Overall Study|Adverse Event|0|||
94740657|NCT04635059|324506035|FG000|Overall Study|Study terminated early.|4|||
94740658|NCT05112900|324506036|FG000|Overall Study|Withdrawal by Subject|960|||
94740659|NCT05112900|324506037|FG001|Overall Study|Withdrawal by Subject|921|||
94369240|NCT00068445|323137988|FG000|Randomization|Ineligible|1|||
94369241|NCT00068445|323137989|FG001|Randomization|Ineligible|1|||
94740660|NCT05112900|324506038|FG002|Overall Study|Withdrawal by Subject|968|||
94740661|NCT00319111|324506041|FG000|Overall Study|Adverse Event|20|||
94740662|NCT00319111|324506041|FG000|Overall Study|Withdrawal of consent|11|||
94740663|NCT00319111|324506041|FG000|Overall Study|Death|9|||
94740664|NCT00319111|324506041|FG000|Overall Study|Lack of clinical improvement|4|||
94740665|NCT00319111|324506041|FG000|Overall Study|Administrative|2|||
94740666|NCT00319111|324506041|FG000|Overall Study|Treatment failure|1|||
94740667|NCT03884439|324506045|FG000|Overall Study|No informed consent for publication of study results|38|||
94740668|NCT03884439|324506045|FG000|Overall Study|Contract violation/deficiency|7|||
94740669|NCT06010836|324506895|FG000|Overall Study|Lost to Follow-up|2|||
94740670|NCT06010836|324506896|FG001|Overall Study|Lost to Follow-up|2|||
94740671|NCT06010836|324506895|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
94740672|NCT06010836|324506896|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
94740673|NCT06010836|324506895|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
94740674|NCT06010836|324506896|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
94740675|NCT06010836|324506895|FG000|Overall Study|Did not receive intervention discussion|0|||
94740676|NCT06010836|324506896|FG001|Overall Study|Did not receive intervention discussion|4|||
94740677|NCT04496752|324506897|FG000|Second Assessment|Lost to Follow-up|3|||
94740678|NCT04496752|324506898|FG001|Second Assessment|Lost to Follow-up|3|||
94740679|NCT04496752|324506897|FG000|Second Assessment|Adverse Event|2|||
94740680|NCT04496752|324506898|FG001|Second Assessment|Adverse Event|0|||
94740681|NCT03662022|324506899|FG000|Year 1 2019|prevalent case|83|||
94740682|NCT03662022|324506900|FG001|Year 1 2019|prevalent case|116|||
94740683|NCT03662022|324506901|FG002|Year 1 2019|prevalent case|158|||
94740684|NCT03662022|324506902|FG003|Year 1 2019|prevalent case|99|||
94740685|NCT03662022|324506899|FG000|Year 2 2020|incident case|18|||
94740686|NCT03662022|324506900|FG001|Year 2 2020|incident case|18|||
94740687|NCT03662022|324506901|FG002|Year 2 2020|incident case|16|||
94740688|NCT03662022|324506902|FG003|Year 2 2020|incident case|26|||
94740689|NCT03662022|324506899|FG000|Year 2 2020|other case|18|||
94740690|NCT03662022|324506900|FG001|Year 2 2020|other case|16|||
94740691|NCT03662022|324506901|FG002|Year 2 2020|other case|16|||
94740692|NCT03662022|324506902|FG003|Year 2 2020|other case|24|||
94740693|NCT03662022|324506899|FG000|Year 2 2020|Lost to Follow-up|1633|||
94740694|NCT03662022|324506900|FG001|Year 2 2020|Lost to Follow-up|1183|||
94740695|NCT03662022|324506901|FG002|Year 2 2020|Lost to Follow-up|1381|||
94740696|NCT03662022|324506902|FG003|Year 2 2020|Lost to Follow-up|2858|||
94740697|NCT03662022|324506899|FG000|Year 3 2021|incident case|24|||
94740698|NCT03662022|324506900|FG001|Year 3 2021|incident case|27|||
94740699|NCT03662022|324506901|FG002|Year 3 2021|incident case|24|||
94740700|NCT03662022|324506902|FG003|Year 3 2021|incident case|11|||
94740701|NCT03662022|324506899|FG000|Year 3 2021|other case|4|||
94740702|NCT03662022|324506900|FG001|Year 3 2021|other case|15|||
94740703|NCT03662022|324506901|FG002|Year 3 2021|other case|10|||
94740704|NCT03662022|324506902|FG003|Year 3 2021|other case|14|||
94740705|NCT03662022|324506899|FG000|Year 3 2021|Lost to Follow-up|179|||
94740706|NCT03662022|324506900|FG001|Year 3 2021|Lost to Follow-up|244|||
94740707|NCT03662022|324506901|FG002|Year 3 2021|Lost to Follow-up|480|||
94740708|NCT03662022|324506902|FG003|Year 3 2021|Lost to Follow-up|477|||
94740709|NCT03662022|324506899|FG000|Year 4 2022|incident case|25|||
94740710|NCT03662022|324506900|FG001|Year 4 2022|incident case|41|||
94369242|NCT00068445|323137988|FG000|Treatment|Refused Further Treatment|13|||
94369243|NCT00068445|323137989|FG001|Treatment|Refused Further Treatment|10|||
94740711|NCT03662022|324506901|FG002|Year 4 2022|incident case|28|||
94740712|NCT03662022|324506902|FG003|Year 4 2022|incident case|7|||
94275972|NCT01157364|322804454|FG005|Overall Study|Lack of Efficacy|0|||
94275973|NCT01157364|322804449|FG000|Overall Study|Adverse Event|0|||
94275974|NCT01157364|322804450|FG001|Overall Study|Adverse Event|1|||
94275975|NCT01157364|322804451|FG002|Overall Study|Adverse Event|1|||
94740713|NCT03662022|324506899|FG000|Year 4 2022|other case|8|||
94740714|NCT03662022|324506900|FG001|Year 4 2022|other case|19|||
94740715|NCT03662022|324506901|FG002|Year 4 2022|other case|13|||
94740716|NCT03662022|324506902|FG003|Year 4 2022|other case|7|||
94740717|NCT03662022|324506899|FG000|Year 4 2022|Lost to Follow-up|986|||
94740718|NCT03662022|324506900|FG001|Year 4 2022|Lost to Follow-up|1079|||
94740719|NCT03662022|324506901|FG002|Year 4 2022|Lost to Follow-up|1236|||
94740720|NCT03662022|324506902|FG003|Year 4 2022|Lost to Follow-up|1826|||
94740721|NCT04490109|324506903|FG000|Overall Study|Lost to Follow-up|3|||
94740722|NCT04490109|324506904|FG001|Overall Study|Lost to Follow-up|10|||
94740723|NCT04490109|324506905|FG002|Overall Study|Lost to Follow-up|4|||
94740724|NCT04490109|324506903|FG000|Overall Study|Withdrawal by Subject|8|||
94740725|NCT04490109|324506904|FG001|Overall Study|Withdrawal by Subject|6|||
94740726|NCT04490109|324506905|FG002|Overall Study|Withdrawal by Subject|9|||
94740727|NCT04490109|324506903|FG000|Overall Study|Physician Decision|0|||
94740728|NCT04490109|324506904|FG001|Overall Study|Physician Decision|2|||
94740729|NCT04490109|324506905|FG002|Overall Study|Physician Decision|3|||
94740730|NCT04490109|324506903|FG000|Overall Study|Adverse Event|2|||
94740731|NCT04490109|324506904|FG001|Overall Study|Adverse Event|1|||
94740732|NCT04490109|324506905|FG002|Overall Study|Adverse Event|0|||
94740733|NCT04490109|324506903|FG000|Overall Study|Significant Non-Compliance|2|||
94740734|NCT04490109|324506904|FG001|Overall Study|Significant Non-Compliance|4|||
94740735|NCT04490109|324506905|FG002|Overall Study|Significant Non-Compliance|4|||
94740736|NCT04490109|324506903|FG000|Overall Study|Significant Clinical Event|0|||
94740737|NCT04490109|324506904|FG001|Overall Study|Significant Clinical Event|1|||
94740738|NCT04490109|324506905|FG002|Overall Study|Significant Clinical Event|0|||
94740739|NCT04490109|324506903|FG000|Overall Study|Other Reason|4|||
94740740|NCT04490109|324506904|FG001|Overall Study|Other Reason|1|||
94740741|NCT04490109|324506905|FG002|Overall Study|Other Reason|1|||
94740742|NCT04675034|324506906|FG000|Overall Study|Lost to Follow-up|1|||
94740743|NCT04675034|324506907|FG001|Overall Study|Lost to Follow-up|1|||
94740744|NCT04675034|324506908|FG002|Overall Study|Lost to Follow-up|0|||
94740745|NCT04675034|324506909|FG003|Overall Study|Lost to Follow-up|2|||
94740746|NCT04675034|324506910|FG004|Overall Study|Lost to Follow-up|0|||
94740747|NCT04675034|324506906|FG000|Overall Study|Protocol Violation|1|||
94740748|NCT04675034|324506907|FG001|Overall Study|Protocol Violation|0|||
94740749|NCT04675034|324506908|FG002|Overall Study|Protocol Violation|0|||
94740750|NCT04675034|324506909|FG003|Overall Study|Protocol Violation|1|||
94740751|NCT04675034|324506910|FG004|Overall Study|Protocol Violation|3|||
94740752|NCT04675034|324506906|FG000|Overall Study|Withdrawal by Subject|9|||
94740753|NCT04675034|324506907|FG001|Overall Study|Withdrawal by Subject|3|||
94740754|NCT04675034|324506908|FG002|Overall Study|Withdrawal by Subject|4|||
94740755|NCT04675034|324506909|FG003|Overall Study|Withdrawal by Subject|8|||
94740756|NCT04675034|324506910|FG004|Overall Study|Withdrawal by Subject|6|||
94740757|NCT04163991|324506911|FG000|Overall Study|Adverse Event|0|||
94740758|NCT04163991|324506912|FG001|Overall Study|Adverse Event|0|||
94740759|NCT04163991|324506913|FG002|Overall Study|Adverse Event|0|||
94740760|NCT04163991|324506914|FG003|Overall Study|Adverse Event|1|||
94740761|NCT04163991|324506915|FG004|Overall Study|Adverse Event|0|||
94740762|NCT04163991|324506911|FG000|Overall Study|Death|0|||
94740763|NCT04163991|324506912|FG001|Overall Study|Death|0|||
94740764|NCT04163991|324506913|FG002|Overall Study|Death|1|||
94740765|NCT04163991|324506914|FG003|Overall Study|Death|0|||
94740766|NCT04163991|324506915|FG004|Overall Study|Death|0|||
94740767|NCT04163991|324506911|FG000|Overall Study|Lost to Follow-up|0|||
94740768|NCT04163991|324506912|FG001|Overall Study|Lost to Follow-up|1|||
94740769|NCT04163991|324506913|FG002|Overall Study|Lost to Follow-up|0|||
94740770|NCT04163991|324506914|FG003|Overall Study|Lost to Follow-up|0|||
94740771|NCT04163991|324506915|FG004|Overall Study|Lost to Follow-up|0|||
94740772|NCT04163991|324506911|FG000|Overall Study|Withdrawal by Subject|1|||
94740773|NCT04163991|324506912|FG001|Overall Study|Withdrawal by Subject|1|||
94740774|NCT04163991|324506913|FG002|Overall Study|Withdrawal by Subject|3|||
94740775|NCT04163991|324506914|FG003|Overall Study|Withdrawal by Subject|1|||
94740776|NCT04163991|324506915|FG004|Overall Study|Withdrawal by Subject|1|||
94740777|NCT04163991|324506911|FG000|Overall Study|Other, Not Specified|0|||
94740778|NCT04163991|324506912|FG001|Overall Study|Other, Not Specified|1|||
94740779|NCT04163991|324506913|FG002|Overall Study|Other, Not Specified|1|||
94740780|NCT04163991|324506914|FG003|Overall Study|Other, Not Specified|1|||
94740781|NCT04163991|324506915|FG004|Overall Study|Other, Not Specified|0|||
94740782|NCT05985395|324506916|FG000|Overall Study|Physician Decision|2|||
94740783|NCT05985395|324506917|FG001|Overall Study|Physician Decision|1|||
94740784|NCT05985395|324506916|FG000|Overall Study|Withdrawal by Subject|1|||
94740785|NCT05985395|324506917|FG001|Overall Study|Withdrawal by Subject|0|||
94740786|NCT03817983|324506918|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
94740787|NCT03817983|324506919|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
94740788|NCT03817983|324506920|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
94740789|NCT05541484|324506922|FG000|Overall Study|Withdrawal by Subject|1|||
94740790|NCT05541484|324506923|FG001|Overall Study|Withdrawal by Subject|0|||
94740791|NCT02624050|324506926|FG000|Overall Study|Physician Decision|4|||
94740792|NCT02624050|324506927|FG001|Overall Study|Physician Decision|0|||
94740793|NCT02624050|324506926|FG000|Overall Study|Protocol Violation|2|||
94740794|NCT02624050|324506927|FG001|Overall Study|Protocol Violation|0|||
94740795|NCT04743973|324506934|FG000|Overall Study|Withdrawal by Subject|5|||
94369244|NCT00068445|323137988|FG000|Treatment|Adverse Event|7|||
94369245|NCT00068445|323137989|FG001|Treatment|Adverse Event|1|||
94369246|NCT00068445|323137988|FG000|Treatment|Other (Specifics not available)|9|||
94369247|NCT00068445|323137989|FG001|Treatment|Other (Specifics not available)|5|||
94369248|NCT00123487|323137990|FG000|Randomized|Death prior to starting treatment|0|||
94369249|NCT00123487|323137991|FG001|Randomized|Death prior to starting treatment|1|||
94369250|NCT00123487|323137990|FG000|Randomized|SAE prior to starting treatment|1|||
94369251|NCT00123487|323137991|FG001|Randomized|SAE prior to starting treatment|0|||
94369252|NCT00123487|323137990|FG000|Treated With Study Drug|Adverse Event|23|||
94369253|NCT00123487|323137991|FG001|Treated With Study Drug|Adverse Event|22|||
94369254|NCT00123487|323137990|FG000|Treated With Study Drug|Disease Progression|141|||
94369255|NCT00123487|323137991|FG001|Treated With Study Drug|Disease Progression|122|||
94369256|NCT00123487|323137990|FG000|Treated With Study Drug|Physician Decision|8|||
94369257|NCT00123487|323137991|FG001|Treated With Study Drug|Physician Decision|9|||
94369258|NCT00123487|323137990|FG000|Treated With Study Drug|Other|59|||
94369259|NCT00123487|323137991|FG001|Treated With Study Drug|Other|58|||
94369260|NCT00123487|323137990|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
94369261|NCT00123487|323137991|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
94369262|NCT00123487|323137990|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
94369263|NCT00123487|323137991|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
94369264|NCT00123487|323137990|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
94369265|NCT00123487|323137991|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
94369266|NCT01612702|323137995|FG000|Overall Study|Protocol Violation|11|||
94369267|NCT01612702|323137996|FG001|Overall Study|Protocol Violation|11|||
94369268|NCT03636542|323137997|FG000|Overall Study|Lost to Follow-up|1|||
94369269|NCT03636542|323137998|FG001|Overall Study|Lost to Follow-up|1|||
94369270|NCT03636542|323137997|FG000|Overall Study|Physician Decision|0|||
94369271|NCT03636542|323137998|FG001|Overall Study|Physician Decision|1|||
94369272|NCT03636542|323137997|FG000|Overall Study|Withdrawal by Subject|1|||
94369273|NCT03636542|323137998|FG001|Overall Study|Withdrawal by Subject|0|||
94740796|NCT05654662|324506935|FG000|Overall Study|Withdrawal by Subject|1|||
94275976|NCT01157364|322804452|FG003|Overall Study|Adverse Event|0|||
94275977|NCT01157364|322804453|FG004|Overall Study|Adverse Event|1|||
94275978|NCT01157364|322804454|FG005|Overall Study|Adverse Event|0|||
94275979|NCT01709435|322804455|FG000|Overall Study|Adverse Event|1|||
94275980|NCT01709435|322804456|FG001|Overall Study|Adverse Event|1|||
94275981|NCT01709435|322804457|FG002|Overall Study|Adverse Event|1|||
94275982|NCT01709435|322804458|FG003|Overall Study|Adverse Event|0|||
94275983|NCT01709435|322804459|FG004|Overall Study|Adverse Event|0|||
94275984|NCT01709435|322804460|FG005|Overall Study|Adverse Event|1|||
94275985|NCT01709435|322804455|FG000|Overall Study|Lack of Efficacy|5|||
94275986|NCT01709435|322804456|FG001|Overall Study|Lack of Efficacy|7|||
94275987|NCT01709435|322804457|FG002|Overall Study|Lack of Efficacy|2|||
94275988|NCT01709435|322804458|FG003|Overall Study|Lack of Efficacy|2|||
94275989|NCT01709435|322804459|FG004|Overall Study|Lack of Efficacy|6|||
94275990|NCT01709435|322804460|FG005|Overall Study|Lack of Efficacy|3|||
94275991|NCT01709435|322804455|FG000|Overall Study|Physician Decision|0|||
94275992|NCT01709435|322804456|FG001|Overall Study|Physician Decision|1|||
94275993|NCT01709435|322804457|FG002|Overall Study|Physician Decision|0|||
94275994|NCT01709435|322804458|FG003|Overall Study|Physician Decision|1|||
94275995|NCT01709435|322804459|FG004|Overall Study|Physician Decision|2|||
94275996|NCT01709435|322804460|FG005|Overall Study|Physician Decision|0|||
94275997|NCT01709435|322804455|FG000|Overall Study|Withdrawal by Subject|0|||
94275998|NCT01709435|322804456|FG001|Overall Study|Withdrawal by Subject|0|||
94275999|NCT01709435|322804457|FG002|Overall Study|Withdrawal by Subject|3|||
94276000|NCT01709435|322804458|FG003|Overall Study|Withdrawal by Subject|0|||
94276001|NCT01709435|322804459|FG004|Overall Study|Withdrawal by Subject|2|||
94276002|NCT01709435|322804460|FG005|Overall Study|Withdrawal by Subject|2|||
94276003|NCT01263639|322804461|FG000|Overall Study|Lost to Follow-up|66|||
94276004|NCT01263639|322804462|FG001|Overall Study|Lost to Follow-up|70|||
94276005|NCT01263639|322804461|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
94276006|NCT01263639|322804462|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
94276007|NCT01780662|322804463|FG000|Overall Study|Adverse Event|1|||
94276008|NCT01780662|322804464|FG001|Overall Study|Adverse Event|0|||
94369274|NCT03070431|323137999|FG000|Overall Study|Withdrawal by Subject|2|||
94369275|NCT03070431|323137999|FG000|Overall Study|Lost to Follow-up|2|||
94369276|NCT02624518|323138002|FG000|Overall Study|Physician Decision|1|||
94369277|NCT00370396|323138003|FG000|Overall Study|Withdrawal by Subject|0|||
94369278|NCT00370396|323138004|FG001|Overall Study|Withdrawal by Subject|0|||
94740797|NCT05654662|324506936|FG001|Overall Study|Withdrawal by Subject|0|||
94276009|NCT01780662|322804465|FG002|Overall Study|Adverse Event|2|||
94276010|NCT01780662|322804463|FG000|Overall Study|Physician Decision|0|||
94276011|NCT01780662|322804464|FG001|Overall Study|Physician Decision|5|||
94276012|NCT01780662|322804465|FG002|Overall Study|Physician Decision|7|||
94276013|NCT01780662|322804463|FG000|Overall Study|Protocol Violation|0|||
94276014|NCT01780662|322804464|FG001|Overall Study|Protocol Violation|1|||
94276015|NCT01780662|322804465|FG002|Overall Study|Protocol Violation|0|||
94276016|NCT01780662|322804463|FG000|Overall Study|Ineligible|0|||
94276017|NCT01780662|322804464|FG001|Overall Study|Ineligible|0|||
94276018|NCT01780662|322804465|FG002|Overall Study|Ineligible|1|||
94276019|NCT00053417|322804466|FG000|Overall Study|Adverse Event|1|||
94276020|NCT00053417|322804467|FG001|Overall Study|Adverse Event|0|||
94276021|NCT00053417|322804468|FG002|Overall Study|Adverse Event|1|||
94276022|NCT00053417|322804469|FG003|Overall Study|Adverse Event|5|||
94276023|NCT00053417|322804466|FG000|Overall Study|Non-Compliance|0|||
94276024|NCT00053417|322804467|FG001|Overall Study|Non-Compliance|0|||
94276025|NCT00053417|322804468|FG002|Overall Study|Non-Compliance|0|||
94276026|NCT00053417|322804469|FG003|Overall Study|Non-Compliance|1|||
94276027|NCT00053417|322804466|FG000|Overall Study|Withdrawal by Subject|0|||
94276028|NCT00053417|322804467|FG001|Overall Study|Withdrawal by Subject|1|||
94276029|NCT00053417|322804468|FG002|Overall Study|Withdrawal by Subject|0|||
94276030|NCT00053417|322804469|FG003|Overall Study|Withdrawal by Subject|0|||
94276031|NCT00053417|322804466|FG000|Overall Study|Lost to Follow-up|1|||
94276032|NCT00053417|322804467|FG001|Overall Study|Lost to Follow-up|1|||
94276033|NCT00053417|322804468|FG002|Overall Study|Lost to Follow-up|0|||
94276034|NCT00053417|322804469|FG003|Overall Study|Lost to Follow-up|0|||
94276035|NCT04951037|322804470|FG000|Overall Study|Lost to Follow-up|16|||
94276036|NCT04951037|322804470|FG000|Overall Study|Withdrawal by Subject|5|||
94276037|NCT04951037|322804470|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
94276038|NCT00708500|322804471|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
94467527|NCT00908596|323502332|FG003|Overall Study|Other reasons|0|||
94740798|NCT05654662|324506935|FG000|Overall Study|A death in the family|1|||
94740799|NCT05654662|324506936|FG001|Overall Study|A death in the family|0|||
94740800|NCT01897441|324506937|FG000|Overall Study|Lost to Follow-up|0|||
94740801|NCT01897441|324506938|FG001|Overall Study|Lost to Follow-up|0|||
94740802|NCT01897441|324506939|FG002|Overall Study|Lost to Follow-up|1|||
94740803|NCT01897441|324506940|FG003|Overall Study|Lost to Follow-up|0|||
94740804|NCT01897441|324506941|FG004|Overall Study|Lost to Follow-up|0|||
94740805|NCT01897441|324506942|FG005|Overall Study|Lost to Follow-up|0|||
94740806|NCT01897441|324506937|FG000|Overall Study|Withdrawal by Subject|0|||
94740807|NCT01897441|324506938|FG001|Overall Study|Withdrawal by Subject|0|||
94740808|NCT01897441|324506939|FG002|Overall Study|Withdrawal by Subject|0|||
94740809|NCT01897441|324506940|FG003|Overall Study|Withdrawal by Subject|0|||
94740810|NCT01897441|324506941|FG004|Overall Study|Withdrawal by Subject|1|||
94740811|NCT01897441|324506942|FG005|Overall Study|Withdrawal by Subject|0|||
94740812|NCT01897441|324506937|FG000|Overall Study|Withdrawn by Provider|0|||
94740813|NCT01897441|324506938|FG001|Overall Study|Withdrawn by Provider|2|||
94740814|NCT01897441|324506939|FG002|Overall Study|Withdrawn by Provider|0|||
94740815|NCT01897441|324506940|FG003|Overall Study|Withdrawn by Provider|0|||
94740816|NCT01897441|324506941|FG004|Overall Study|Withdrawn by Provider|0|||
94740817|NCT01897441|324506942|FG005|Overall Study|Withdrawn by Provider|0|||
94740818|NCT04157517|324506943|FG000|Overall Study|Death|1|||
94740819|NCT04157517|324506944|FG001|Overall Study|Death|2|||
94740820|NCT04157517|324506945|FG002|Overall Study|Death|2|||
94740821|NCT04157517|324506946|FG003|Overall Study|Death|3|||
94740822|NCT04157517|324506947|FG004|Overall Study|Death|3|||
94740823|NCT04157517|324506948|FG005|Overall Study|Death|4|||
94740824|NCT04157517|324506949|FG006|Overall Study|Death|1|||
94740825|NCT04157517|324506950|FG007|Overall Study|Death|2|||
94740826|NCT04157517|324506951|FG008|Overall Study|Death|4|||
94740827|NCT04157517|324506952|FG009|Overall Study|Death|0|||
94740828|NCT04157517|324506943|FG000|Overall Study|Withdrawal by Subject|1|||
94740829|NCT04157517|324506944|FG001|Overall Study|Withdrawal by Subject|1|||
94740830|NCT04157517|324506945|FG002|Overall Study|Withdrawal by Subject|1|||
94740831|NCT04157517|324506946|FG003|Overall Study|Withdrawal by Subject|0|||
94740832|NCT04157517|324506947|FG004|Overall Study|Withdrawal by Subject|0|||
94740833|NCT04157517|324506948|FG005|Overall Study|Withdrawal by Subject|1|||
94740834|NCT04157517|324506949|FG006|Overall Study|Withdrawal by Subject|0|||
94740835|NCT04157517|324506950|FG007|Overall Study|Withdrawal by Subject|0|||
94740836|NCT04157517|324506951|FG008|Overall Study|Withdrawal by Subject|1|||
94740837|NCT04157517|324506952|FG009|Overall Study|Withdrawal by Subject|0|||
94740838|NCT04157517|324506943|FG000|Overall Study|Other|1|||
94276039|NCT00708500|322804472|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
94276040|NCT00708500|322804473|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
94740839|NCT04157517|324506944|FG001|Overall Study|Other|0|||
94740840|NCT04157517|324506945|FG002|Overall Study|Other|0|||
94740841|NCT04157517|324506946|FG003|Overall Study|Other|0|||
94740842|NCT04157517|324506947|FG004|Overall Study|Other|0|||
94740843|NCT04157517|324506948|FG005|Overall Study|Other|1|||
94740844|NCT04157517|324506949|FG006|Overall Study|Other|2|||
94740845|NCT04157517|324506950|FG007|Overall Study|Other|7|||
94740846|NCT04157517|324506951|FG008|Overall Study|Other|7|||
94740847|NCT04157517|324506952|FG009|Overall Study|Other|0|||
94740848|NCT03279978|324506953|FG000|Overall Study|Withdrawal by Subject|0|||
94740849|NCT03279978|324506954|FG001|Overall Study|Withdrawal by Subject|1|||
94740850|NCT03279978|324506955|FG002|Overall Study|Withdrawal by Subject|0|||
94740851|NCT03279978|324506956|FG003|Overall Study|Withdrawal by Subject|0|||
94740852|NCT03279978|324506957|FG004|Overall Study|Withdrawal by Subject|0|||
94740853|NCT03279978|324506958|FG005|Overall Study|Withdrawal by Subject|0|||
94740854|NCT03279978|324506959|FG006|Overall Study|Withdrawal by Subject|0|||
94740855|NCT03279978|324506960|FG007|Overall Study|Withdrawal by Subject|0|||
94740856|NCT03279978|324506961|FG008|Overall Study|Withdrawal by Subject|0|||
94740857|NCT03279978|324506962|FG009|Overall Study|Withdrawal by Subject|1|||
94740858|NCT03279978|324506953|FG000|Overall Study|Lost to Follow-up|1|||
94740859|NCT03279978|324506954|FG001|Overall Study|Lost to Follow-up|0|||
94740860|NCT03279978|324506955|FG002|Overall Study|Lost to Follow-up|1|||
94740861|NCT03279978|324506956|FG003|Overall Study|Lost to Follow-up|0|||
94740862|NCT03279978|324506957|FG004|Overall Study|Lost to Follow-up|0|||
94740863|NCT03279978|324506958|FG005|Overall Study|Lost to Follow-up|0|||
94740864|NCT03279978|324506959|FG006|Overall Study|Lost to Follow-up|0|||
94740865|NCT03279978|324506960|FG007|Overall Study|Lost to Follow-up|0|||
94740866|NCT03279978|324506961|FG008|Overall Study|Lost to Follow-up|0|||
94276041|NCT00708500|322804471|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
94276042|NCT00708500|322804472|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
94276043|NCT00708500|322804473|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
94276044|NCT00708500|322804471|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
94276045|NCT00708500|322804472|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
94276046|NCT00708500|322804473|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
94276047|NCT00708500|322804471|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
94276048|NCT00708500|322804472|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
94276049|NCT00708500|322804473|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
94276050|NCT00708500|322804471|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
94276051|NCT00708500|322804472|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
94276052|NCT00708500|322804473|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
94276053|NCT00708500|322804471|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
94276054|NCT00708500|322804472|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
94276055|NCT00708500|322804473|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
94276056|NCT00708500|322804471|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
94276057|NCT00708500|322804472|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
94276058|NCT00708500|322804473|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
94276059|NCT00708500|322804471|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
94276060|NCT00708500|322804472|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
94276061|NCT00708500|322804473|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
94276062|NCT00708500|322804471|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
94276063|NCT00708500|322804472|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
94276064|NCT00708500|322804473|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
94276065|NCT00708500|322804471|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
94276066|NCT00708500|322804472|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
94276067|NCT00708500|322804473|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
94276068|NCT00708500|322804471|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
94276069|NCT00708500|322804472|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
94276070|NCT00708500|322804473|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
94276071|NCT00708500|322804471|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
94276072|NCT00708500|322804472|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
94276073|NCT00708500|322804473|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
94276074|NCT00708500|322804471|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
94276075|NCT00708500|322804472|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
94276076|NCT00708500|322804473|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
94276077|NCT00708500|322804471|FG000|FOLLOWUP|Adverse Event|0|||
94276078|NCT00708500|322804472|FG001|FOLLOWUP|Adverse Event|1|||
94276079|NCT00708500|322804473|FG002|FOLLOWUP|Adverse Event|0|||
94276080|NCT00708500|322804471|FG000|FOLLOWUP|Lost to Follow-up|1|||
94276081|NCT00708500|322804472|FG001|FOLLOWUP|Lost to Follow-up|6|||
94276082|NCT00708500|322804473|FG002|FOLLOWUP|Lost to Follow-up|4|||
94276083|NCT00708500|322804471|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
94276084|NCT00708500|322804472|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
94276085|NCT00708500|322804473|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
94276086|NCT00708500|322804471|FG000|FOLLOWUP|Subject withdrew consent|31|||
94740867|NCT03279978|324506962|FG009|Overall Study|Lost to Follow-up|0|||
94740868|NCT03279978|324506953|FG000|Overall Study|Other than stated above|0|||
94740869|NCT03279978|324506954|FG001|Overall Study|Other than stated above|0|||
94740870|NCT03279978|324506955|FG002|Overall Study|Other than stated above|0|||
94740871|NCT03279978|324506956|FG003|Overall Study|Other than stated above|0|||
94740872|NCT03279978|324506957|FG004|Overall Study|Other than stated above|0|||
94740873|NCT03279978|324506958|FG005|Overall Study|Other than stated above|0|||
94740874|NCT03279978|324506959|FG006|Overall Study|Other than stated above|1|||
94276087|NCT00708500|322804472|FG001|FOLLOWUP|Subject withdrew consent|4|||
94276088|NCT00708500|322804473|FG002|FOLLOWUP|Subject withdrew consent|5|||
94276089|NCT00708500|322804471|FG000|FOLLOWUP|Non-compliance with protocol|5|||
94276090|NCT00708500|322804472|FG001|FOLLOWUP|Non-compliance with protocol|0|||
94276091|NCT00708500|322804473|FG002|FOLLOWUP|Non-compliance with protocol|1|||
94276092|NCT00827606|322804474|FG000|Overall Study|Protocol Violation|4|||
94276093|NCT00827606|322804475|FG001|Overall Study|Protocol Violation|3|||
94276094|NCT00827606|322804474|FG000|Overall Study|Lost to Follow-up|3|||
94276095|NCT00827606|322804475|FG001|Overall Study|Lost to Follow-up|1|||
94276096|NCT00827606|322804474|FG000|Overall Study|Withdrawal by Subject|7|||
94276097|NCT00827606|322804475|FG001|Overall Study|Withdrawal by Subject|6|||
94276098|NCT00827606|322804474|FG000|Overall Study|Pregnancy|0|||
94276099|NCT00827606|322804475|FG001|Overall Study|Pregnancy|1|||
94276100|NCT00827606|322804474|FG000|Overall Study|Other|5|||
94276101|NCT00827606|322804475|FG001|Overall Study|Other|13|||
94276102|NCT00827606|322804474|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
94276103|NCT00827606|322804475|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
94276104|NCT00827606|322804474|FG000|Overall Study|Adverse Event|4|||
94276105|NCT00827606|322804475|FG001|Overall Study|Adverse Event|2|||
94276106|NCT03882970|322804479|FG000|Overall Study|Adverse Event|5|||
94276107|NCT03882970|322804480|FG001|Overall Study|Adverse Event|7|||
94276108|NCT03882970|322804481|FG002|Overall Study|Adverse Event|3|||
94276109|NCT03882970|322804482|FG003|Overall Study|Adverse Event|1|||
94276110|NCT03882970|322804479|FG000|Overall Study|Death|1|||
94276111|NCT03882970|322804480|FG001|Overall Study|Death|2|||
94276112|NCT03882970|322804481|FG002|Overall Study|Death|1|||
94276113|NCT03882970|322804482|FG003|Overall Study|Death|1|||
94276114|NCT03882970|322804479|FG000|Overall Study|Lost to Follow-up|8|||
94276115|NCT03882970|322804480|FG001|Overall Study|Lost to Follow-up|9|||
94276116|NCT03882970|322804481|FG002|Overall Study|Lost to Follow-up|5|||
94276117|NCT03882970|322804482|FG003|Overall Study|Lost to Follow-up|5|||
94276118|NCT03882970|322804479|FG000|Overall Study|Physician Decision|0|||
94276119|NCT03882970|322804480|FG001|Overall Study|Physician Decision|2|||
94276120|NCT03882970|322804481|FG002|Overall Study|Physician Decision|2|||
94276121|NCT03882970|322804482|FG003|Overall Study|Physician Decision|2|||
94276122|NCT03882970|322804479|FG000|Overall Study|Protocol Violation|2|||
94276123|NCT03882970|322804480|FG001|Overall Study|Protocol Violation|0|||
94276124|NCT03882970|322804481|FG002|Overall Study|Protocol Violation|0|||
94276125|NCT03882970|322804482|FG003|Overall Study|Protocol Violation|0|||
94276126|NCT03882970|322804479|FG000|Overall Study|Withdrawal by Subject|8|||
94276127|NCT03882970|322804480|FG001|Overall Study|Withdrawal by Subject|17|||
94276128|NCT03882970|322804481|FG002|Overall Study|Withdrawal by Subject|7|||
94276129|NCT03882970|322804482|FG003|Overall Study|Withdrawal by Subject|22|||
94276130|NCT03882970|322804479|FG000|Overall Study|Personal Reason|2|||
94276131|NCT03882970|322804480|FG001|Overall Study|Personal Reason|3|||
94276132|NCT03882970|322804481|FG002|Overall Study|Personal Reason|1|||
94276133|NCT03882970|322804482|FG003|Overall Study|Personal Reason|3|||
94276134|NCT00133991|322804486|FG000|Overall Study|Death|4|||
94276135|NCT03002155|322804487|FG000|Overall Study|Lost to Follow-up|1|||
94276136|NCT03002155|322804488|FG001|Overall Study|Lost to Follow-up|2|||
94276137|NCT03002155|322804487|FG000|Overall Study|Withdrawal by Subject|1|||
94276138|NCT03002155|322804488|FG001|Overall Study|Withdrawal by Subject|0|||
94740875|NCT03279978|324506960|FG007|Overall Study|Other than stated above|0|||
94740876|NCT03279978|324506961|FG008|Overall Study|Other than stated above|0|||
94740877|NCT03279978|324506962|FG009|Overall Study|Other than stated above|0|||
94740878|NCT04330040|324506963|FG000|Overall Study|Other: Adverse event|5|||
94740879|NCT04330040|324506964|FG001|Overall Study|Other: Adverse event|0|||
94740880|NCT04330040|324506965|FG002|Overall Study|Other: Adverse event|0|||
94740881|NCT04330040|324506963|FG000|Overall Study|Disease progression|38|||
94740882|NCT04330040|324506964|FG001|Overall Study|Disease progression|10|||
94740883|NCT04330040|324506965|FG002|Overall Study|Disease progression|0|||
94740884|NCT04330040|324506963|FG000|Overall Study|Physician Decision|5|||
94740885|NCT04330040|324506964|FG001|Overall Study|Physician Decision|3|||
94740886|NCT04330040|324506965|FG002|Overall Study|Physician Decision|0|||
94740887|NCT04330040|324506963|FG000|Overall Study|Lost to Follow-up|1|||
94740888|NCT04330040|324506964|FG001|Overall Study|Lost to Follow-up|1|||
94740889|NCT04330040|324506965|FG002|Overall Study|Lost to Follow-up|0|||
94740890|NCT04330040|324506963|FG000|Overall Study|Death|2|||
94740891|NCT04330040|324506964|FG001|Overall Study|Death|1|||
94740892|NCT04330040|324506965|FG002|Overall Study|Death|0|||
94740893|NCT04330040|324506963|FG000|Overall Study|Withdrawal by Subject|3|||
94740894|NCT04330040|324506964|FG001|Overall Study|Withdrawal by Subject|3|||
94740895|NCT04330040|324506965|FG002|Overall Study|Withdrawal by Subject|0|||
94740896|NCT04330040|324506963|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
94276139|NCT03002155|322804487|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
94276140|NCT03002155|322804488|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
94276141|NCT00978029|322804489|FG000|Overall Study|Adverse Event|1|||
94276142|NCT00978029|322804490|FG001|Overall Study|Adverse Event|2|||
94276143|NCT00978029|322804491|FG002|Overall Study|Adverse Event|5|||
94276144|NCT00978029|322804489|FG000|Overall Study|Withdrawal by Subject|0|||
94276145|NCT00978029|322804490|FG001|Overall Study|Withdrawal by Subject|0|||
94740897|NCT04330040|324506964|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
94740898|NCT04330040|324506965|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
94740899|NCT04330040|324506963|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
94276146|NCT00978029|322804491|FG002|Overall Study|Withdrawal by Subject|1|||
94740900|NCT04330040|324506964|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
94740901|NCT04330040|324506965|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
94740902|NCT04330040|324506963|FG000|Overall Study|Other: Disease progression|1|||
94740903|NCT04330040|324506964|FG001|Overall Study|Other: Disease progression|0|||
94740904|NCT04330040|324506965|FG002|Overall Study|Other: Disease progression|0|||
94740905|NCT04330040|324506963|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
94740906|NCT04330040|324506964|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
94740907|NCT04330040|324506965|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
94740908|NCT04330040|324506963|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
94740909|NCT04330040|324506964|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
94740910|NCT04330040|324506965|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
94740911|NCT04330040|324506963|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
94740912|NCT04330040|324506964|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
94740913|NCT04330040|324506965|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
94740914|NCT03587805|324506966|FG000|Overall Study|Adverse Event|72|||
94740915|NCT03587805|324506966|FG000|Overall Study|Death|1|||
94740916|NCT03587805|324506966|FG000|Overall Study|Lost to Follow-up|78|||
94740917|NCT03587805|324506966|FG000|Overall Study|Withdrawal by Subject|105|||
94740918|NCT03587805|324506966|FG000|Overall Study|Lack of Efficacy|119|||
94740919|NCT03587805|324506966|FG000|Overall Study|Reason unknown|26|||
94740920|NCT03587805|324506966|FG000|Overall Study|COVID_19 pandemic|4|||
94740921|NCT03587805|324506966|FG000|Overall Study|Various reasons|121|||
94740922|NCT03587805|324506966|FG000|Overall Study|Withdrawal by parent/guardian|3|||
94740923|NCT04908930|324507758|FG000|Overall Study|Lost to Follow-up|1|||
94740924|NCT04908930|324507759|FG001|Overall Study|Lost to Follow-up|1|||
94740925|NCT04908930|324507760|FG002|Overall Study|Lost to Follow-up|0|||
94740926|NCT04908930|324507761|FG003|Overall Study|Lost to Follow-up|0|||
94740927|NCT04908930|324507762|FG004|Overall Study|Lost to Follow-up|0|||
94740928|NCT04908930|324507758|FG000|Overall Study|hardware in mouth|1|||
94740929|NCT04908930|324507759|FG001|Overall Study|hardware in mouth|1|||
94740930|NCT04908930|324507760|FG002|Overall Study|hardware in mouth|0|||
94740931|NCT04908930|324507761|FG003|Overall Study|hardware in mouth|0|||
94740932|NCT04908930|324507762|FG004|Overall Study|hardware in mouth|0|||
94740933|NCT04908930|324507758|FG000|Overall Study|wrong team|1|||
94740934|NCT04908930|324507759|FG001|Overall Study|wrong team|0|||
94740935|NCT04908930|324507760|FG002|Overall Study|wrong team|0|||
94740936|NCT04908930|324507761|FG003|Overall Study|wrong team|0|||
94740937|NCT04908930|324507762|FG004|Overall Study|wrong team|0|||
94740938|NCT04908930|324507758|FG000|Overall Study|quit team|2|||
94740939|NCT04908930|324507759|FG001|Overall Study|quit team|4|||
94740940|NCT04908930|324507760|FG002|Overall Study|quit team|0|||
94276147|NCT00978029|322804489|FG000|Overall Study|Protocol Violation|0|||
94276148|NCT00978029|322804490|FG001|Overall Study|Protocol Violation|1|||
94740941|NCT04908930|324507761|FG003|Overall Study|quit team|0|||
94740942|NCT04908930|324507762|FG004|Overall Study|quit team|0|||
94740943|NCT04908930|324507758|FG000|Overall Study|Withdrawal by Subject|1|||
94740944|NCT04908930|324507759|FG001|Overall Study|Withdrawal by Subject|2|||
94740945|NCT04908930|324507760|FG002|Overall Study|Withdrawal by Subject|0|||
94740946|NCT04908930|324507761|FG003|Overall Study|Withdrawal by Subject|0|||
94740947|NCT04908930|324507762|FG004|Overall Study|Withdrawal by Subject|0|||
94740948|NCT04908930|324507758|FG000|Overall Study|parent not liking program|0|||
94740949|NCT04908930|324507759|FG001|Overall Study|parent not liking program|1|||
94740950|NCT04908930|324507760|FG002|Overall Study|parent not liking program|0|||
94740951|NCT04908930|324507761|FG003|Overall Study|parent not liking program|0|||
94740952|NCT04908930|324507762|FG004|Overall Study|parent not liking program|0|||
94740953|NCT03735979|324507767|FG000|Overall Study|Lost to Follow-up|1|||
94740954|NCT03735979|324507768|FG001|Overall Study|Lost to Follow-up|12|||
94740955|NCT03735979|324507769|FG002|Overall Study|Lost to Follow-up|14|||
94740956|NCT03735979|324507767|FG000|Overall Study|Withdrawal by Subject|1|||
94740957|NCT03735979|324507768|FG001|Overall Study|Withdrawal by Subject|5|||
94740958|NCT03735979|324507769|FG002|Overall Study|Withdrawal by Subject|2|||
94740959|NCT03735979|324507767|FG000|Overall Study|Not due to the above reasons|1|||
94740960|NCT03735979|324507768|FG001|Overall Study|Not due to the above reasons|0|||
94740961|NCT03735979|324507769|FG002|Overall Study|Not due to the above reasons|0|||
94740962|NCT01949662|324507779|FG000|Overall Study|Death|9|||
94740963|NCT01949662|324507780|FG001|Overall Study|Death|7|||
94740964|NCT01949662|324507779|FG000|Overall Study|Discharged before an agitation event|8|||
94740965|NCT01949662|324507780|FG001|Overall Study|Discharged before an agitation event|3|||
94740966|NCT01949662|324507779|FG000|Overall Study|Dropped out|1|||
94740967|NCT01949662|324507780|FG001|Overall Study|Dropped out|3|||
94740968|NCT01949662|324507779|FG000|Overall Study|Ineligible|0|||
94276149|NCT00978029|322804491|FG002|Overall Study|Protocol Violation|0|||
94276150|NCT01029366|322804492|FG000|Overall Study|Withdrawal by Subject|1|||
94276151|NCT01029366|322804493|FG001|Overall Study|Withdrawal by Subject|0|||
94276152|NCT01029366|322804492|FG000|Overall Study|Death|1|||
94276153|NCT01029366|322804493|FG001|Overall Study|Death|1|||
94276154|NCT01029366|322804492|FG000|Overall Study|disease progression|2|||
94276155|NCT01029366|322804493|FG001|Overall Study|disease progression|0|||
94276156|NCT01029366|322804492|FG000|Overall Study|manufacturing failure|0|||
94276157|NCT01029366|322804493|FG001|Overall Study|manufacturing failure|1|||
94276158|NCT02830776|322804494|FG000|Overall Study|Lost to Follow-up|1|||
94276159|NCT03029143|322804495|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
94276160|NCT03029143|322804496|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
94276161|NCT03029143|322804497|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
94276162|NCT03029143|322804495|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
94276163|NCT03029143|322804496|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
94369279|NCT00370396|323138005|FG002|Overall Study|Withdrawal by Subject|1|||
94369280|NCT00370396|323138003|FG000|Overall Study|Lost to Follow-up|11|||
94369281|NCT00370396|323138004|FG001|Overall Study|Lost to Follow-up|1|||
94276164|NCT03029143|322804497|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
94276165|NCT03029143|322804495|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
94276166|NCT03029143|322804496|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
94276167|NCT03029143|322804497|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
94276168|NCT03029143|322804495|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
94276169|NCT03029143|322804496|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
94276170|NCT03029143|322804497|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
94276171|NCT03029143|322804495|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
94276172|NCT03029143|322804496|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
94276173|NCT03029143|322804497|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
94276174|NCT03029143|322804495|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
94276175|NCT03029143|322804496|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
94276176|NCT03029143|322804497|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
94276177|NCT03029143|322804495|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
94276178|NCT03029143|322804496|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
94276179|NCT03029143|322804497|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
94276180|NCT03029143|322804495|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94276181|NCT03029143|322804496|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
94276182|NCT03029143|322804497|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
94276183|NCT03029143|322804495|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
94276184|NCT03029143|322804496|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
94276185|NCT03029143|322804497|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
94276186|NCT03029143|322804495|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
94276187|NCT03029143|322804496|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
94276188|NCT03029143|322804497|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
94276189|NCT03029143|322804495|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
94276190|NCT03029143|322804496|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
94276191|NCT03029143|322804497|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
94276192|NCT00607386|322804498|FG000|Overall Study|Physician Decision|1|||
94276193|NCT00440947|322804499|FG000|36-Week Induction Phase|Adverse Event|16|||
94276194|NCT00440947|322804500|FG001|36-Week Induction Phase|Adverse Event|0|||
94276195|NCT00440947|322804501|FG002|36-Week Induction Phase|Adverse Event|0|||
94276196|NCT00440947|322804502|FG003|36-Week Induction Phase|Adverse Event|0|||
94276197|NCT00440947|322804503|FG004|36-Week Induction Phase|Adverse Event|0|||
94276198|NCT00440947|322804499|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
94276199|NCT00440947|322804500|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
94276200|NCT00440947|322804501|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
94276201|NCT00440947|322804502|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
94276202|NCT00440947|322804503|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
94276203|NCT00440947|322804499|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
94276204|NCT00440947|322804500|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
94276205|NCT00440947|322804501|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
94276206|NCT00440947|322804502|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
94276207|NCT00440947|322804503|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
94276208|NCT00440947|322804499|FG000|36-Week Induction Phase|Non-compliance|10|||
94276209|NCT00440947|322804500|FG001|36-Week Induction Phase|Non-compliance|0|||
94276210|NCT00440947|322804501|FG002|36-Week Induction Phase|Non-compliance|0|||
94276211|NCT00440947|322804502|FG003|36-Week Induction Phase|Non-compliance|0|||
94276212|NCT00440947|322804503|FG004|36-Week Induction Phase|Non-compliance|0|||
94276213|NCT00440947|322804499|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
94276214|NCT00440947|322804500|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
94276215|NCT00440947|322804501|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
94276216|NCT00440947|322804502|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
94276217|NCT00440947|322804503|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
94276218|NCT00440947|322804499|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
94276219|NCT00440947|322804500|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
94276220|NCT00440947|322804501|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
94276221|NCT00440947|322804502|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
94276222|NCT00440947|322804503|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
94276223|NCT00440947|322804499|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
94276224|NCT00440947|322804500|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
94276225|NCT00440947|322804501|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
94276226|NCT00440947|322804502|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
94276227|NCT00440947|322804503|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
94276228|NCT00440947|322804499|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
94276229|NCT00440947|322804500|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
94369282|NCT00370396|323138005|FG002|Overall Study|Lost to Follow-up|0|||
94740969|NCT01949662|324507780|FG001|Overall Study|Ineligible|1|||
94740970|NCT03522298|324507791|FG000|Overall Study|Adverse Event|1|||
94740971|NCT03522298|324507792|FG001|Overall Study|Adverse Event|0|||
94740972|NCT03522298|324507793|FG002|Overall Study|Adverse Event|0|||
94740973|NCT03522298|324507794|FG003|Overall Study|Adverse Event|1|||
94740974|NCT03522298|324507791|FG000|Overall Study|Death|2|||
94740975|NCT03522298|324507792|FG001|Overall Study|Death|4|||
94740976|NCT03522298|324507793|FG002|Overall Study|Death|8|||
94740977|NCT03522298|324507794|FG003|Overall Study|Death|8|||
94740978|NCT03522298|324507791|FG000|Overall Study|Patient decision|0|||
94740979|NCT03522298|324507792|FG001|Overall Study|Patient decision|2|||
94740980|NCT03522298|324507793|FG002|Overall Study|Patient decision|2|||
94740981|NCT03522298|324507794|FG003|Overall Study|Patient decision|2|||
94740982|NCT03418740|324507795|FG000|Overall Study|Lost to Follow-up|13|||
94740983|NCT03418740|324507795|FG000|Overall Study|Scheduling Issues|7|||
94740984|NCT03418740|324507795|FG000|Overall Study|Withdrawal by Subject|2|||
94740985|NCT03418740|324507795|FG000|Overall Study|Unable to Continue Consent|1|||
94740986|NCT01207492|324507796|FG000|Overall Study|Still on study|1|||
94740987|NCT01207492|324507796|FG000|Overall Study|Withdrawal by Subject|9|||
94740988|NCT01207492|324507796|FG000|Overall Study|Physician Decision|1|||
94740989|NCT01207492|324507796|FG000|Overall Study|Progressive disease|3|||
94740990|NCT01207492|324507796|FG000|Overall Study|Toxicity|1|||
94740991|NCT05215054|324507797|FG000|Overall Study|Lost to Follow-up|1|||
94740992|NCT05215054|324507798|FG001|Overall Study|Lost to Follow-up|1|||
94740993|NCT05215054|324507797|FG000|Overall Study|Protocol Violation|1|||
94740994|NCT05215054|324507798|FG001|Overall Study|Protocol Violation|1|||
94740995|NCT05215054|324507797|FG000|Overall Study|Withdrawal by Subject|4|||
94740996|NCT05215054|324507798|FG001|Overall Study|Withdrawal by Subject|4|||
94740997|NCT02933489|324507800|FG000|Overall Study|Ineligible|3|||
94740998|NCT02933489|324507801|FG001|Overall Study|Ineligible|3|||
94740999|NCT02933489|324507800|FG000|Overall Study|Withdrawal by Subject|27|||
94276230|NCT00440947|322804501|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
94276231|NCT00440947|322804502|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
94276232|NCT00440947|322804503|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
94276233|NCT00440947|322804499|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
94276234|NCT00440947|322804500|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
94741000|NCT02933489|324507801|FG001|Overall Study|Withdrawal by Subject|18|||
94741001|NCT02933489|324507800|FG000|Overall Study|Unable to complete exams (other)|14|||
94741002|NCT02933489|324507801|FG001|Overall Study|Unable to complete exams (other)|7|||
94741003|NCT04622046|324507802|FG000|Intervention Period|Adverse Event|1|||
94741004|NCT04622046|324507802|FG000|Intervention Period|Withdrawal by Subject|2|||
94741005|NCT04622046|324507802|FG000|Extension Period|Ongoing in the Extension Period|21|||
94741006|NCT03165955|324507803|FG000|Treatment|Withdrawal by Subject|3|||
94741007|NCT03165955|324507803|FG000|Treatment|Death|1|||
94741008|NCT03165955|324507803|FG000|Treatment|Adverse Event|1|||
94741009|NCT03165955|324507803|FG000|Treatment|Progressive disease|3|||
94741010|NCT02994927|324507804|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94741011|NCT02994927|324507805|FG001|Overall Study|Withdrawal by parent/guardian|1|||
94741012|NCT02994927|324507804|FG000|Overall Study|Did not meet eligibility criteria|0|||
94741013|NCT02994927|324507805|FG001|Overall Study|Did not meet eligibility criteria|1|||
94741014|NCT02994927|324507804|FG000|Overall Study|Physician Decision|4|||
94741015|NCT02994927|324507805|FG001|Overall Study|Physician Decision|3|||
94741016|NCT02994927|324507804|FG000|Overall Study|Death|4|||
94741017|NCT02994927|324507805|FG001|Overall Study|Death|2|||
94741018|NCT02994927|324507804|FG000|Overall Study|Adverse Event|2|||
94741019|NCT02994927|324507805|FG001|Overall Study|Adverse Event|1|||
94741020|NCT02994927|324507804|FG000|Overall Study|Withdrawal by Subject|3|||
94741021|NCT02994927|324507805|FG001|Overall Study|Withdrawal by Subject|6|||
94741022|NCT02994927|324507804|FG000|Overall Study|Lost to Follow-up|2|||
94741023|NCT02994927|324507805|FG001|Overall Study|Lost to Follow-up|1|||
94741024|NCT00626795|324507806|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
94741025|NCT00626795|324507807|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
94741026|NCT00626795|324507808|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
94741027|NCT00626795|324507806|FG000|Blinded Treatment|Lack of Efficacy|2|||
94741028|NCT00626795|324507807|FG001|Blinded Treatment|Lack of Efficacy|0|||
94741029|NCT00626795|324507808|FG002|Blinded Treatment|Lack of Efficacy|0|||
94741030|NCT00626795|324507806|FG000|Blinded Treatment|Unacceptable adverse event|0|||
94741031|NCT00626795|324507807|FG001|Blinded Treatment|Unacceptable adverse event|0|||
94741032|NCT00626795|324507808|FG002|Blinded Treatment|Unacceptable adverse event|1|||
94741033|NCT00626795|324507806|FG000|Blinded Treatment|Protocol Violation|0|||
94741034|NCT00626795|324507807|FG001|Blinded Treatment|Protocol Violation|1|||
94741035|NCT00626795|324507808|FG002|Blinded Treatment|Protocol Violation|1|||
94741036|NCT00626795|324507806|FG000|Blinded Treatment|Withdrawal by Subject|1|||
94741037|NCT00626795|324507807|FG001|Blinded Treatment|Withdrawal by Subject|1|||
94741038|NCT00626795|324507808|FG002|Blinded Treatment|Withdrawal by Subject|0|||
94741039|NCT00626795|324507806|FG000|Blinded Treatment|Other reasons|2|||
94741040|NCT00626795|324507807|FG001|Blinded Treatment|Other reasons|0|||
94741041|NCT00626795|324507808|FG002|Blinded Treatment|Other reasons|2|||
94741042|NCT00626795|324507806|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
94741043|NCT00626795|324507807|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
94741044|NCT00626795|324507808|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
94741045|NCT03533257|324507816|FG000|Overall Study|Adverse Event|4|||
94741046|NCT03533257|324507817|FG001|Overall Study|Adverse Event|2|||
94741047|NCT03533257|324507816|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
94741048|NCT03533257|324507817|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
94741049|NCT03141359|324507820|FG000|Overall Study|Death|32|||
94741050|NCT03141359|324507820|FG000|Overall Study|Still On Study (in follow up)|29|||
94741051|NCT03493542|324507821|FG000|Base Study|Withdrawal by Subject|0|||
94741052|NCT03493542|324507822|FG001|Base Study|Withdrawal by Subject|4|||
94741053|NCT03493542|324507823|FG002|Base Study|Withdrawal by Subject|0|||
94741054|NCT03493542|324507821|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
94741055|NCT03493542|324507822|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
94741056|NCT03493542|324507823|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
94741057|NCT03493542|324507821|FG000|Extension Study|Withdrawal by Subject|0|||
94276235|NCT00440947|322804501|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
94741058|NCT03493542|324507822|FG001|Extension Study|Withdrawal by Subject|0|||
94276236|NCT00440947|322804502|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
94276237|NCT00440947|322804503|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
94741059|NCT03493542|324507823|FG002|Extension Study|Withdrawal by Subject|25|||
94741060|NCT05485935|324507824|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
94741061|NCT05485935|324507825|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
94741062|NCT05485935|324507824|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
94741063|NCT05485935|324507825|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
94741064|NCT05485935|324507824|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
94741065|NCT05485935|324507825|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
94741066|NCT05485935|324507824|FG000|Period 2 (T2 and V3)|loss of contact|0|||
94369283|NCT01462695|323138006|FG000|Overall Study|Adverse Event|1|||
94369284|NCT01462695|323138007|FG001|Overall Study|Adverse Event|1|||
94369285|NCT01462695|323138006|FG000|Overall Study|Death|2|||
94369286|NCT01462695|323138007|FG001|Overall Study|Death|0|||
94276238|NCT00440947|322804499|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
94276239|NCT00440947|322804500|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
94276240|NCT00440947|322804501|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
94276241|NCT00440947|322804502|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
94276242|NCT00440947|322804503|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
94276243|NCT00440947|322804499|FG000|36-Week Induction Phase|Incarceration|3|||
94276244|NCT00440947|322804500|FG001|36-Week Induction Phase|Incarceration|0|||
94276245|NCT00440947|322804501|FG002|36-Week Induction Phase|Incarceration|0|||
94276246|NCT00440947|322804502|FG003|36-Week Induction Phase|Incarceration|0|||
94276247|NCT00440947|322804503|FG004|36-Week Induction Phase|Incarceration|0|||
94276248|NCT00440947|322804499|FG000|36-Week Induction Phase|Pregnancy|1|||
94276249|NCT00440947|322804500|FG001|36-Week Induction Phase|Pregnancy|0|||
94276250|NCT00440947|322804501|FG002|36-Week Induction Phase|Pregnancy|0|||
94276251|NCT00440947|322804502|FG003|36-Week Induction Phase|Pregnancy|0|||
94276252|NCT00440947|322804503|FG004|36-Week Induction Phase|Pregnancy|0|||
94276253|NCT00440947|322804499|FG000|48-Week Randomization Phase|Adverse Event|0|||
94276254|NCT00440947|322804500|FG001|48-Week Randomization Phase|Adverse Event|2|||
94276255|NCT00440947|322804501|FG002|48-Week Randomization Phase|Adverse Event|5|||
94276256|NCT00440947|322804502|FG003|48-Week Randomization Phase|Adverse Event|0|||
94276257|NCT00440947|322804503|FG004|48-Week Randomization Phase|Adverse Event|0|||
94276258|NCT00440947|322804499|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
94276259|NCT00440947|322804500|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
94276260|NCT00440947|322804501|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
94276261|NCT00440947|322804502|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
94276262|NCT00440947|322804503|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
94276263|NCT00440947|322804499|FG000|48-Week Randomization Phase|Non-compliance|0|||
94276264|NCT00440947|322804500|FG001|48-Week Randomization Phase|Non-compliance|3|||
94276265|NCT00440947|322804501|FG002|48-Week Randomization Phase|Non-compliance|4|||
94276266|NCT00440947|322804502|FG003|48-Week Randomization Phase|Non-compliance|0|||
94276267|NCT00440947|322804503|FG004|48-Week Randomization Phase|Non-compliance|0|||
94276268|NCT00440947|322804499|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
94276269|NCT00440947|322804500|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
94276270|NCT00440947|322804501|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
94276271|NCT00440947|322804502|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
94276272|NCT00440947|322804503|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
94276273|NCT00440947|322804499|FG000|48-Week Randomization Phase|Protocol Violation|0|||
94276274|NCT00440947|322804500|FG001|48-Week Randomization Phase|Protocol Violation|0|||
94276275|NCT00440947|322804501|FG002|48-Week Randomization Phase|Protocol Violation|1|||
94276276|NCT00440947|322804502|FG003|48-Week Randomization Phase|Protocol Violation|0|||
94276277|NCT00440947|322804503|FG004|48-Week Randomization Phase|Protocol Violation|0|||
94276278|NCT00440947|322804499|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
94276279|NCT00440947|322804500|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
94276280|NCT00440947|322804501|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
94276281|NCT00440947|322804502|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
94276282|NCT00440947|322804503|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
94276283|NCT00440947|322804499|FG000|48-Week Randomization Phase|Pregnancy|0|||
94276284|NCT00440947|322804500|FG001|48-Week Randomization Phase|Pregnancy|0|||
94276285|NCT00440947|322804501|FG002|48-Week Randomization Phase|Pregnancy|1|||
94276286|NCT00440947|322804502|FG003|48-Week Randomization Phase|Pregnancy|0|||
94276287|NCT00440947|322804503|FG004|48-Week Randomization Phase|Pregnancy|0|||
94276288|NCT00440947|322804499|FG000|48-Week Randomization Phase|Incarceration|0|||
94276289|NCT00440947|322804500|FG001|48-Week Randomization Phase|Incarceration|3|||
94276290|NCT00440947|322804501|FG002|48-Week Randomization Phase|Incarceration|0|||
94276291|NCT00440947|322804502|FG003|48-Week Randomization Phase|Incarceration|0|||
94276292|NCT00440947|322804503|FG004|48-Week Randomization Phase|Incarceration|0|||
94276293|NCT00440947|322804499|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
94276294|NCT00440947|322804500|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
94276295|NCT00440947|322804501|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
94276296|NCT00440947|322804502|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
94276297|NCT00440947|322804503|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
94369287|NCT01462695|323138006|FG000|Overall Study|Lack of Efficacy|6|||
94276298|NCT00440947|322804499|FG000|48-Week Randomization Phase|Physician Decision|0|||
94276299|NCT00440947|322804500|FG001|48-Week Randomization Phase|Physician Decision|2|||
94276300|NCT00440947|322804501|FG002|48-Week Randomization Phase|Physician Decision|0|||
94276301|NCT00440947|322804502|FG003|48-Week Randomization Phase|Physician Decision|0|||
94276302|NCT00440947|322804503|FG004|48-Week Randomization Phase|Physician Decision|0|||
94369288|NCT01462695|323138007|FG001|Overall Study|Lack of Efficacy|12|||
94369289|NCT01462695|323138006|FG000|Overall Study|Physician Decision|5|||
94369290|NCT01462695|323138007|FG001|Overall Study|Physician Decision|0|||
94369291|NCT01462695|323138006|FG000|Overall Study|Withdrawal by Subject|2|||
94369292|NCT01462695|323138007|FG001|Overall Study|Withdrawal by Subject|0|||
94369293|NCT01462695|323138006|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
94467528|NCT00908596|323502329|FG000|Overall Study|Lost to Follow-up|0|||
94369294|NCT01462695|323138007|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
94369295|NCT01814137|323138008|FG000|Overall Study|Adverse Event|0|||
94369296|NCT01814137|323138009|FG001|Overall Study|Adverse Event|1|||
94369297|NCT01814137|323138008|FG000|Overall Study|Withdrawal by Subject|2|||
94369298|NCT01814137|323138009|FG001|Overall Study|Withdrawal by Subject|2|||
94369299|NCT01814137|323138008|FG000|Overall Study|Physician Decision|1|||
94369300|NCT01814137|323138009|FG001|Overall Study|Physician Decision|1|||
94369301|NCT01814137|323138008|FG000|Overall Study|Unclassified|2|||
94369302|NCT01814137|323138009|FG001|Overall Study|Unclassified|1|||
94369303|NCT06371079|323138011|FG000|Overall Study|Missing data|88|||
94369304|NCT06371079|323138012|FG001|Overall Study|Missing data|247|||
94369305|NCT00411762|323138014|FG000|Overall Study|Withdrawal by Subject|5|||
94369306|NCT04428502|323138015|FG000|Overall Study|Did not meet entrance criteria|14|||
94369307|NCT01142466|323139095|FG000|Overall Study|Adverse Event|2|||
94369308|NCT01142466|323139096|FG001|Overall Study|Adverse Event|1|||
94369309|NCT01142466|323139095|FG000|Overall Study|Withdrawal by Subject|1|||
94369310|NCT01142466|323139096|FG001|Overall Study|Withdrawal by Subject|1|||
94369311|NCT00343642|323139097|FG000|Overall Study|Lost to Follow-up|0|||
94369312|NCT00343642|323139098|FG001|Overall Study|Lost to Follow-up|1|||
94369313|NCT00343642|323139099|FG002|Overall Study|Lost to Follow-up|0|||
94369314|NCT00343642|323139097|FG000|Overall Study|Pregnancy|1|||
94369315|NCT00343642|323139098|FG001|Overall Study|Pregnancy|0|||
94369316|NCT00343642|323139099|FG002|Overall Study|Pregnancy|2|||
94369317|NCT00343642|323139097|FG000|Overall Study|Withdrawal by Subject|2|||
94369318|NCT00343642|323139098|FG001|Overall Study|Withdrawal by Subject|3|||
94369319|NCT00343642|323139099|FG002|Overall Study|Withdrawal by Subject|4|||
94369320|NCT00343642|323139097|FG000|Overall Study|Adverse Event|0|||
94369321|NCT00343642|323139098|FG001|Overall Study|Adverse Event|0|||
94369322|NCT00343642|323139099|FG002|Overall Study|Adverse Event|1|||
94276303|NCT00440947|322804499|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
94276304|NCT00440947|322804500|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
94276305|NCT00440947|322804501|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
94276306|NCT00440947|322804502|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
94276307|NCT00440947|322804503|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
94276308|NCT00440947|322804499|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
94369323|NCT00343642|323139097|FG000|Overall Study|Flare up|6|||
94369324|NCT00343642|323139098|FG001|Overall Study|Flare up|4|||
94369325|NCT00343642|323139099|FG002|Overall Study|Flare up|0|||
94369326|NCT02082262|323139102|FG000|Overall Study|Withdrawal by Subject|3|||
94369327|NCT02082262|323139102|FG000|Overall Study|Adverse Event|48|||
94369328|NCT00305110|323139103|FG000|Overall Study|Missing data|29|||
94369329|NCT02595528|323139104|FG000|Overall Study|Withdrawal by Subject|1|||
94276309|NCT00440947|322804500|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
94276310|NCT00440947|322804501|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
94276311|NCT00440947|322804502|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
94276312|NCT00440947|322804503|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
94276313|NCT00440947|322804499|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
94276314|NCT00440947|322804500|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
94276315|NCT00440947|322804501|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
94276316|NCT00440947|322804502|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
94276317|NCT00440947|322804503|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
94276318|NCT00440947|322804499|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
94276319|NCT00440947|322804500|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
94276320|NCT00440947|322804501|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
94276321|NCT00440947|322804502|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
94276322|NCT00440947|322804503|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
94276323|NCT00440947|322804499|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
94276324|NCT00440947|322804500|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
94276325|NCT00440947|322804501|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
94276326|NCT00440947|322804502|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
94276327|NCT00440947|322804503|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
94276328|NCT00440947|322804499|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
94276329|NCT00440947|322804500|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
94276330|NCT00440947|322804501|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
94276331|NCT00440947|322804502|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
94276332|NCT00440947|322804503|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
94276333|NCT00440947|322804499|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
94276334|NCT00440947|322804500|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
94276335|NCT00440947|322804501|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
94276336|NCT00440947|322804502|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
94276337|NCT00440947|322804503|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
94276338|NCT00440947|322804499|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
94276339|NCT00440947|322804500|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
94276340|NCT00440947|322804501|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
94276341|NCT00440947|322804502|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
94276342|NCT00440947|322804503|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
94276343|NCT00440947|322804499|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
94276344|NCT00440947|322804500|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
94276345|NCT00440947|322804501|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
94276346|NCT00440947|322804502|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
94276347|NCT00440947|322804503|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
94276348|NCT00440947|322804499|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
94276349|NCT00440947|322804500|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
94276350|NCT00440947|322804501|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
94276351|NCT00440947|322804502|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
94276352|NCT00440947|322804503|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
94276353|NCT00440947|322804499|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
94276354|NCT00440947|322804500|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
94276355|NCT00440947|322804501|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
94276356|NCT00440947|322804502|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
94276357|NCT00440947|322804503|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
94276358|NCT00440947|322804499|FG000|Optional 60-Week Extension Phase|Other|0|||
94276359|NCT00440947|322804500|FG001|Optional 60-Week Extension Phase|Other|0|||
94276360|NCT00440947|322804501|FG002|Optional 60-Week Extension Phase|Other|0|||
94276361|NCT00440947|322804502|FG003|Optional 60-Week Extension Phase|Other|1|||
94276362|NCT00440947|322804503|FG004|Optional 60-Week Extension Phase|Other|0|||
94276363|NCT00440947|322804499|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
94276364|NCT00440947|322804500|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
94276365|NCT00440947|322804501|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
94276366|NCT00440947|322804502|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
94276367|NCT00440947|322804503|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
94276368|NCT00440947|322804499|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
94741067|NCT05485935|324507825|FG001|Period 2 (T2 and V3)|loss of contact|1|||
94741068|NCT04626427|324507830|FG000|Overall Study|Death|1|||
94741069|NCT04626427|324507830|FG000|Overall Study|Withdrawal by Subject|1|||
94741070|NCT04626427|324507830|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
94741071|NCT04626427|324507830|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
94741072|NCT04797858|324508341|FG000|Overall Study|Withdrawal by Subject|0|||
94741073|NCT04797858|324508342|FG001|Overall Study|Withdrawal by Subject|1|||
94741074|NCT04797858|324508341|FG000|Overall Study|Excluded due to administrative error|7|||
94741075|NCT04797858|324508342|FG001|Overall Study|Excluded due to administrative error|8|||
94741076|NCT03812614|324508348|FG000|Intervention|Withdrawal by Subject|7|||
94741077|NCT03812614|324508349|FG001|Intervention|Withdrawal by Subject|2|||
94741078|NCT03812614|324508350|FG002|Intervention|Withdrawal by Subject|7|||
94741079|NCT03812614|324508351|FG003|Intervention|Withdrawal by Subject|2|||
94741080|NCT03812614|324508348|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
94741081|NCT03812614|324508349|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
94741082|NCT03812614|324508350|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
94741083|NCT03812614|324508351|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
94741084|NCT03812614|324508348|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
94741085|NCT03812614|324508349|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
94741086|NCT03812614|324508350|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
94741087|NCT03812614|324508351|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
94741088|NCT03812614|324508348|FG000|6-month Follow-up|Lost to Follow-up|0|||
94741089|NCT03812614|324508349|FG001|6-month Follow-up|Lost to Follow-up|0|||
94741090|NCT03812614|324508350|FG002|6-month Follow-up|Lost to Follow-up|12|||
94741091|NCT03812614|324508351|FG003|6-month Follow-up|Lost to Follow-up|8|||
94741092|NCT03812614|324508348|FG000|12-month Follow-up|Lost to Follow-up|18|||
94741093|NCT03812614|324508349|FG001|12-month Follow-up|Lost to Follow-up|17|||
94741094|NCT03812614|324508350|FG002|12-month Follow-up|Lost to Follow-up|5|||
94741095|NCT03812614|324508351|FG003|12-month Follow-up|Lost to Follow-up|2|||
94741096|NCT03744676|324508352|FG000|Pre-Treatment Phase|Disease related complications|2|||
94741097|NCT03744676|324508352|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
94741098|NCT03744676|324508352|FG000|Pre-Treatment Phase|Death|7|||
94741099|NCT03744676|324508352|FG000|Pre-Treatment Phase|Other Reasons|7|||
94741100|NCT03744676|324508352|FG000|Treatment Phase|Participant withdrew consent|8|||
94741101|NCT03744676|324508352|FG000|Treatment Phase|Death|33|||
94741102|NCT03744676|324508352|FG000|Treatment Phase|other reasons|6|||
94741103|NCT05454514|324508364|FG000|Overall Study|Withdrawal by Subject|4|||
94741104|NCT05785130|324508367|FG000|Overall Study|Withdrawal by Subject|1|||
94741105|NCT05785130|324508368|FG001|Overall Study|Withdrawal by Subject|0|||
94741106|NCT05785130|324508367|FG000|Overall Study|Lack of Efficacy|0|||
94741107|NCT05785130|324508368|FG001|Overall Study|Lack of Efficacy|1|||
94741108|NCT01438853|324508369|FG000|Overall Study|Death|0|||
94741109|NCT01438853|324508370|FG001|Overall Study|Death|0|||
94741110|NCT01438853|324508371|FG002|Overall Study|Death|0|||
94741111|NCT01438853|324508372|FG003|Overall Study|Death|1|||
94741112|NCT01438853|324508369|FG000|Overall Study|Withdrawal by Subject|0|||
94741113|NCT01438853|324508370|FG001|Overall Study|Withdrawal by Subject|0|||
94741114|NCT01438853|324508371|FG002|Overall Study|Withdrawal by Subject|1|||
94741115|NCT01438853|324508372|FG003|Overall Study|Withdrawal by Subject|0|||
94741116|NCT06065735|324508373|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
94741117|NCT06065735|324508374|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
94741118|NCT06065735|324508375|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
94741119|NCT06065735|324508373|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
94741120|NCT06065735|324508374|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
94741121|NCT06065735|324508375|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
94741122|NCT06065735|324508373|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
94741123|NCT06065735|324508374|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
94741124|NCT06065735|324508375|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
94741125|NCT06065735|324508373|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
94741126|NCT06065735|324508374|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
94741127|NCT06065735|324508375|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
94741128|NCT06065735|324508373|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
94741129|NCT06065735|324508374|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
94741130|NCT06065735|324508375|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
94741131|NCT02532621|324508376|FG000|Overall Study|Death|3|||
94741132|NCT02532621|324508376|FG000|Overall Study|Lost to Follow-up|3|||
94741133|NCT02532621|324508376|FG000|Overall Study|Withdrawal by Subject|6|||
94741134|NCT02532621|324508376|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
94741135|NCT02532621|324508376|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
94741136|NCT04795245|324508377|FG000|Overall Study|Unkown reason|7|||
94741137|NCT04795245|324508377|FG000|Overall Study|Death|17|||
94741138|NCT04795245|324508377|FG000|Overall Study|Other than listed|19|||
94741139|NCT04795245|324508377|FG000|Overall Study|Adverse Event|143|||
94741140|NCT04795245|324508377|FG000|Overall Study|Progressive disease|512|||
94741141|NCT04795245|324508377|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
94741142|NCT04499521|324508386|FG000|Overall Study|Disease Progression|1|||
94741143|NCT04499521|324508387|FG001|Overall Study|Disease Progression|0|||
94276369|NCT00440947|322804500|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
94276370|NCT00440947|322804501|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
94276371|NCT00440947|322804502|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
94276372|NCT00440947|322804503|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
94276373|NCT00974675|322804504|FG000|Overall Study|Adverse Event|2|||
94276374|NCT00974675|322804505|FG001|Overall Study|Adverse Event|1|||
94276375|NCT00974675|322804506|FG002|Overall Study|Adverse Event|1|||
94741144|NCT04281498|324508389|FG000|Overall Study|Progression of disease|1|||
94741145|NCT04281498|324508389|FG000|Overall Study|Planned SCT|1|||
94276376|NCT00974675|322804507|FG003|Overall Study|Adverse Event|1|||
94276377|NCT00974675|322804504|FG000|Overall Study|Physician Decision|0|||
94741146|NCT04281498|324508389|FG000|Overall Study|Alternative Treatment|1|||
94741147|NCT03092674|324508392|FG000|Overall Study|Adverse Event or Side Effects|1|||
94741148|NCT03092674|324508393|FG001|Overall Study|Adverse Event or Side Effects|4|||
94276378|NCT00974675|322804505|FG001|Overall Study|Physician Decision|0|||
94276379|NCT00974675|322804506|FG002|Overall Study|Physician Decision|1|||
94276380|NCT00974675|322804507|FG003|Overall Study|Physician Decision|0|||
94276381|NCT00974675|322804504|FG000|Overall Study|Participant on holiday; unable to attend|0|||
94276382|NCT00974675|322804505|FG001|Overall Study|Participant on holiday; unable to attend|0|||
94276383|NCT00974675|322804506|FG002|Overall Study|Participant on holiday; unable to attend|0|||
94276384|NCT00974675|322804507|FG003|Overall Study|Participant on holiday; unable to attend|1|||
94276385|NCT02121262|322804508|FG000|Overall Study|Adverse Event|6|||
94276386|NCT02121262|322804509|FG001|Overall Study|Adverse Event|3|||
94276387|NCT02121262|322804508|FG000|Overall Study|Lack of Efficacy|3|||
94276388|NCT02121262|322804509|FG001|Overall Study|Lack of Efficacy|0|||
94276389|NCT02121262|322804508|FG000|Overall Study|Personal Reasons|19|||
94276390|NCT02121262|322804509|FG001|Overall Study|Personal Reasons|5|||
94276391|NCT02121262|322804508|FG000|Overall Study|Protocol Violation|1|||
94276392|NCT02121262|322804509|FG001|Overall Study|Protocol Violation|1|||
94276393|NCT02121262|322804508|FG000|Overall Study|Participant Dropped-out|0|||
94276394|NCT02121262|322804509|FG001|Overall Study|Participant Dropped-out|1|||
94276395|NCT02121262|322804508|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
94276396|NCT02121262|322804509|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
94276397|NCT02121262|322804508|FG000|Overall Study|Consent Withdrawn|1|||
94276398|NCT02121262|322804509|FG001|Overall Study|Consent Withdrawn|0|||
94276399|NCT02829138|322804510|FG000|Overall Study|Withdrawal by Subject|1|||
94276400|NCT02829138|322804511|FG001|Overall Study|Withdrawal by Subject|0|||
94276401|NCT01394627|322804512|FG000|First Intervention (1 Day)|poor intravenous access|0|||
94276402|NCT01394627|322804513|FG001|First Intervention (1 Day)|poor intravenous access|1|||
94276403|NCT01394627|322804512|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
94276404|NCT01394627|322804513|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
94276405|NCT04744207|322804516|FG000|Treatment|Withdrawal by Subject|2|||
94276406|NCT04744207|322804517|FG001|Treatment|Withdrawal by Subject|0|||
94276407|NCT04744207|322804516|FG000|Treatment|Adverse Event|1|||
94276408|NCT04744207|322804517|FG001|Treatment|Adverse Event|2|||
94276409|NCT03681119|322804522|FG000|Overall Study|No specific reason|4|||
94276410|NCT03681119|322804523|FG001|Overall Study|No specific reason|0|||
94276411|NCT03681119|322804522|FG000|Overall Study|Sickness|2|||
94369330|NCT02595528|323139105|FG001|Overall Study|Withdrawal by Subject|2|||
94369331|NCT02595528|323139106|FG002|Overall Study|Withdrawal by Subject|1|||
94276412|NCT03681119|322804523|FG001|Overall Study|Sickness|0|||
94276413|NCT02813694|322804526|FG000|Overall Study|Physician Decision|0|||
94276414|NCT02813694|322804527|FG001|Overall Study|Physician Decision|1|||
94276415|NCT02813694|322804526|FG000|Overall Study|Withdrawal by Subject|10|||
94276416|NCT02813694|322804527|FG001|Overall Study|Withdrawal by Subject|9|||
94276417|NCT02813694|322804526|FG000|Overall Study|Lost to Follow-up|1|||
94276418|NCT02813694|322804527|FG001|Overall Study|Lost to Follow-up|1|||
94276419|NCT02813694|322804526|FG000|Overall Study|Death|3|||
94276420|NCT02813694|322804527|FG001|Overall Study|Death|3|||
94276421|NCT02813694|322804526|FG000|Overall Study|Randomized- did not receive study drug|2|||
94276422|NCT02813694|322804527|FG001|Overall Study|Randomized- did not receive study drug|0|||
94276423|NCT02813694|322804526|FG000|Overall Study|Patient hospitalized|1|||
94276424|NCT02813694|322804527|FG001|Overall Study|Patient hospitalized|0|||
94276425|NCT01422915|322804528|FG000|Overall Study|Adverse Event|1|||
94276426|NCT00606320|322804530|FG000|Overall Study|Adverse Event|3|||
94276427|NCT00606320|322804530|FG000|Overall Study|Lack of Efficacy|5|||
94276428|NCT00606320|322804530|FG000|Overall Study|Physician Decision|7|||
94276429|NCT00606320|322804530|FG000|Overall Study|Protocol Violation|8|||
94276430|NCT00606320|322804530|FG000|Overall Study|Withdrawal by Subject|10|||
94369332|NCT02595528|323139107|FG003|Overall Study|Withdrawal by Subject|3|||
94276431|NCT00606320|322804530|FG000|Overall Study|Progression to depressive phase|4|||
94276432|NCT03631732|322804534|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
94276433|NCT03631732|322804535|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
94276434|NCT03631732|322804534|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
94276435|NCT03631732|322804535|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
94276436|NCT03631732|322804534|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
94276437|NCT03631732|322804535|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
94276438|NCT03631732|322804534|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
94276439|NCT03631732|322804535|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
94276440|NCT03631732|322804534|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
94276441|NCT03631732|322804535|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
94276442|NCT03631732|322804534|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
94276443|NCT03631732|322804535|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
94276444|NCT03631732|322804534|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
94276445|NCT03631732|322804535|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
94276446|NCT03631732|322804534|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
94276447|NCT03631732|322804535|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
94276448|NCT03631732|322804534|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
94276449|NCT03631732|322804535|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
94276450|NCT03631732|322804534|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
94276451|NCT03631732|322804535|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
94276452|NCT01251367|322804536|FG000|Overall Study|Protocol Violation|1|||
94276453|NCT01251367|322804536|FG000|Overall Study|Lack of Efficacy|2|||
94276454|NCT01251367|322804536|FG000|Overall Study|Adverse Event|19|||
94276455|NCT01251367|322804536|FG000|Overall Study|Withdrawal by Subject|36|||
94276456|NCT01251367|322804536|FG000|Overall Study|Lost to Follow-up|5|||
94276457|NCT01251367|322804536|FG000|Overall Study|Subject Required Alternative Treatment|7|||
94276458|NCT01251367|322804536|FG000|Overall Study|No Study Drug Available|1|||
94276459|NCT01251367|322804536|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
94276460|NCT01251367|322804536|FG000|Overall Study|End of Study Visit Performed in Error|1|||
94276461|NCT00004259|322804537|FG000|Overall Study|Protocol Violation|1|||
94276462|NCT00004259|322804538|FG001|Overall Study|Protocol Violation|2|||
94276463|NCT00004259|322804539|FG002|Overall Study|Protocol Violation|0|||
94276464|NCT00004259|322804540|FG003|Overall Study|Protocol Violation|0|||
94276465|NCT00004259|322804537|FG000|Overall Study|Withdrawal by Subject|0|||
94276466|NCT00004259|322804538|FG001|Overall Study|Withdrawal by Subject|2|||
94276467|NCT00004259|322804539|FG002|Overall Study|Withdrawal by Subject|0|||
94276468|NCT00004259|322804540|FG003|Overall Study|Withdrawal by Subject|0|||
94276469|NCT02943564|322804545|FG000|Overall Study|Miscellaneous Reasons|0|||
94276470|NCT02943564|322804546|FG001|Overall Study|Miscellaneous Reasons|0|||
94276471|NCT02943564|322804547|FG002|Overall Study|Miscellaneous Reasons|3|||
94276472|NCT02943564|322804545|FG000|Overall Study|Site terminated by sponsor|0|||
94276473|NCT02943564|322804546|FG001|Overall Study|Site terminated by sponsor|1|||
94276474|NCT02943564|322804547|FG002|Overall Study|Site terminated by sponsor|0|||
94276475|NCT02943564|322804545|FG000|Overall Study|Non-compliance with study drug|0|||
94276476|NCT02943564|322804546|FG001|Overall Study|Non-compliance with study drug|1|||
94276477|NCT02943564|322804547|FG002|Overall Study|Non-compliance with study drug|0|||
94276478|NCT02943564|322804545|FG000|Overall Study|Pregnancy|0|||
94276479|NCT02943564|322804546|FG001|Overall Study|Pregnancy|1|||
94276480|NCT02943564|322804547|FG002|Overall Study|Pregnancy|1|||
94276481|NCT02943564|322804545|FG000|Overall Study|Protocol Violation|2|||
94276482|NCT02943564|322804546|FG001|Overall Study|Protocol Violation|2|||
94276483|NCT02943564|322804547|FG002|Overall Study|Protocol Violation|2|||
94276484|NCT02943564|322804545|FG000|Overall Study|Lost to Follow-up|1|||
94276485|NCT02943564|322804546|FG001|Overall Study|Lost to Follow-up|0|||
94276486|NCT02943564|322804547|FG002|Overall Study|Lost to Follow-up|0|||
94276487|NCT02943564|322804545|FG000|Overall Study|Withdrawal by Subject|6|||
94276488|NCT02943564|322804546|FG001|Overall Study|Withdrawal by Subject|5|||
94276489|NCT02943564|322804547|FG002|Overall Study|Withdrawal by Subject|2|||
94276490|NCT02943564|322804545|FG000|Overall Study|Adverse Event|1|||
94276491|NCT02943564|322804546|FG001|Overall Study|Adverse Event|2|||
94276492|NCT02943564|322804547|FG002|Overall Study|Adverse Event|1|||
94276493|NCT02943564|322804545|FG000|Overall Study|Lack of Efficacy|0|||
94741149|NCT03092674|324508394|FG002|Overall Study|Adverse Event or Side Effects|4|||
94741150|NCT03092674|324508392|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
94741151|NCT03092674|324508393|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
94741152|NCT03092674|324508394|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
94741153|NCT03092674|324508392|FG000|Overall Study|Progression/Relapse|5|||
94741154|NCT03092674|324508393|FG001|Overall Study|Progression/Relapse|4|||
94741155|NCT03092674|324508394|FG002|Overall Study|Progression/Relapse|8|||
94741156|NCT03092674|324508392|FG000|Overall Study|Death|4|||
94741157|NCT03092674|324508393|FG001|Overall Study|Death|8|||
94741158|NCT03092674|324508394|FG002|Overall Study|Death|2|||
94741159|NCT03092674|324508392|FG000|Overall Study|Other - Not Protocol Specified|11|||
94369333|NCT02595528|323139104|FG000|Overall Study|Lost to Follow-up|1|||
94369334|NCT02595528|323139105|FG001|Overall Study|Lost to Follow-up|1|||
94369335|NCT02595528|323139106|FG002|Overall Study|Lost to Follow-up|0|||
94369336|NCT02595528|323139107|FG003|Overall Study|Lost to Follow-up|1|||
94369337|NCT02360397|323139108|FG000|Overall Study|Incomplete screening|3|||
94369338|NCT02360397|323139108|FG000|Overall Study|Adverse Event|1|||
94369339|NCT01537549|323139109|FG000|Overall Study|Lost to Follow-up|1|||
94276494|NCT02943564|322804546|FG001|Overall Study|Lack of Efficacy|1|||
94276495|NCT02943564|322804547|FG002|Overall Study|Lack of Efficacy|0|||
94276496|NCT00577642|322804548|FG000|Overall Study|Clinical Disease Progression|1|||
94741160|NCT03092674|324508393|FG001|Overall Study|Other - Not Protocol Specified|8|||
94741161|NCT03092674|324508394|FG002|Overall Study|Other - Not Protocol Specified|8|||
94741162|NCT00070499|324508960|FG000|Overall Study|Adverse Event|6|||
94741163|NCT00070499|324508961|FG001|Overall Study|Adverse Event|6|||
94741164|NCT00070499|324508962|FG002|Overall Study|Adverse Event|19|||
94741165|NCT00070499|324508963|FG003|Overall Study|Adverse Event|15|||
94741166|NCT00070499|324508960|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
94741167|NCT00070499|324508961|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
94741168|NCT00070499|324508962|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
94741169|NCT00070499|324508963|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
94741170|NCT00070499|324508960|FG000|Overall Study|Progression/relapse|4|||
94741171|NCT00070499|324508961|FG001|Overall Study|Progression/relapse|2|||
94741172|NCT00070499|324508962|FG002|Overall Study|Progression/relapse|1|||
94741173|NCT00070499|324508963|FG003|Overall Study|Progression/relapse|4|||
94741174|NCT00070499|324508960|FG000|Overall Study|Death|1|||
94741175|NCT00070499|324508961|FG001|Overall Study|Death|1|||
94741176|NCT00070499|324508962|FG002|Overall Study|Death|1|||
94741177|NCT00070499|324508963|FG003|Overall Study|Death|2|||
94741178|NCT00070499|324508960|FG000|Overall Study|Other - not protocol specified|7|||
94741179|NCT00070499|324508961|FG001|Overall Study|Other - not protocol specified|3|||
94741180|NCT00070499|324508962|FG002|Overall Study|Other - not protocol specified|12|||
94741181|NCT00070499|324508963|FG003|Overall Study|Other - not protocol specified|20|||
94741182|NCT00070499|324508960|FG000|Overall Study|Still on protocol treatment|10|||
94741183|NCT00070499|324508961|FG001|Overall Study|Still on protocol treatment|4|||
94741184|NCT00070499|324508962|FG002|Overall Study|Still on protocol treatment|79|||
94741185|NCT00070499|324508963|FG003|Overall Study|Still on protocol treatment|57|||
94741186|NCT00070499|324508960|FG000|Overall Study|Did not start treatment|1|||
94741187|NCT00070499|324508961|FG001|Overall Study|Did not start treatment|0|||
94741188|NCT00070499|324508962|FG002|Overall Study|Did not start treatment|0|||
94741189|NCT00070499|324508963|FG003|Overall Study|Did not start treatment|2|||
94741190|NCT00070499|324508960|FG000|Overall Study|Not eligible|2|||
94741191|NCT00070499|324508961|FG001|Overall Study|Not eligible|5|||
94741192|NCT00070499|324508962|FG002|Overall Study|Not eligible|3|||
94741193|NCT00070499|324508963|FG003|Overall Study|Not eligible|2|||
94741194|NCT05718687|324508968|FG000|Overall Study|Withdrawal by Subject|3|||
94741195|NCT04174560|324508969|FG000|Overall Study|Lost to Follow-up|1|||
94741196|NCT04174560|324508970|FG001|Overall Study|Lost to Follow-up|0|||
94741197|NCT04174560|324508971|FG002|Overall Study|Lost to Follow-up|0|||
94741198|NCT04174560|324508972|FG003|Overall Study|Lost to Follow-up|0|||
94741199|NCT04174560|324508969|FG000|Overall Study|Withdrawal by Subject|0|||
94741200|NCT04174560|324508970|FG001|Overall Study|Withdrawal by Subject|0|||
94741201|NCT04174560|324508971|FG002|Overall Study|Withdrawal by Subject|2|||
94741202|NCT04174560|324508972|FG003|Overall Study|Withdrawal by Subject|0|||
94741203|NCT04159519|324508975|FG000|Overall Study|Adverse Event|1|||
94741204|NCT04159519|324508976|FG001|Overall Study|Adverse Event|1|||
94741205|NCT04159519|324508975|FG000|Overall Study|Lack of Efficacy|1|||
94741206|NCT04159519|324508976|FG001|Overall Study|Lack of Efficacy|0|||
94741207|NCT04159519|324508975|FG000|Overall Study|Discontinued from study|1|||
94741208|NCT04159519|324508976|FG001|Overall Study|Discontinued from study|0|||
94741209|NCT04159519|324508975|FG000|Overall Study|Protocol Violation|1|||
94741210|NCT04159519|324508976|FG001|Overall Study|Protocol Violation|1|||
94741211|NCT04159519|324508975|FG000|Overall Study|Withdrawal by Subject|4|||
94741212|NCT04159519|324508976|FG001|Overall Study|Withdrawal by Subject|4|||
94741213|NCT03250676|324508978|FG000|Overall Study|Adverse Event|0|||
94276497|NCT02039375|322804549|FG000|Overall Study|Lost to Follow-up|2|||
94276498|NCT00889265|322804552|FG000|Overall Study|Adverse Event|1|||
94276499|NCT00889265|322804552|FG000|Overall Study|Lost to Follow-up|5|||
94276500|NCT00889265|322804552|FG000|Overall Study|Protocol Violation|1|||
94276501|NCT00794157|322804553|FG000|Overall Study|Adverse Event|4|||
94276502|NCT00794157|322804554|FG001|Overall Study|Adverse Event|1|||
94276503|NCT00794157|322804555|FG002|Overall Study|Adverse Event|8|||
94276504|NCT00794157|322804553|FG000|Overall Study|Subject withdrew consent|2|||
94276505|NCT00794157|322804554|FG001|Overall Study|Subject withdrew consent|0|||
94276506|NCT00794157|322804555|FG002|Overall Study|Subject withdrew consent|3|||
94276507|NCT00794157|322804553|FG000|Overall Study|Lost to Follow-up|2|||
94276508|NCT00794157|322804554|FG001|Overall Study|Lost to Follow-up|0|||
94276509|NCT00794157|322804555|FG002|Overall Study|Lost to Follow-up|1|||
94741214|NCT03250676|324508979|FG001|Overall Study|Adverse Event|0|||
94741215|NCT03250676|324508980|FG002|Overall Study|Adverse Event|0|||
94741216|NCT03250676|324508981|FG003|Overall Study|Adverse Event|1|||
94741217|NCT03250676|324508982|FG004|Overall Study|Adverse Event|2|||
94741218|NCT03250676|324508983|FG005|Overall Study|Adverse Event|9|||
94741219|NCT03250676|324508978|FG000|Overall Study|Withdrawal by Subject|1|||
94741220|NCT03250676|324508979|FG001|Overall Study|Withdrawal by Subject|0|||
94741221|NCT03250676|324508980|FG002|Overall Study|Withdrawal by Subject|0|||
94369340|NCT01537549|323139109|FG000|Overall Study|Withdrawal by Subject|2|||
94369341|NCT01637961|323139110|FG000|Overall Study|Ineligible: wrong primary|1|||
94369342|NCT01637961|323139110|FG000|Overall Study|Ineligible: inadequate pathology|1|||
94369343|NCT03555890|323139111|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
94467529|NCT00908596|323502330|FG001|Overall Study|Lost to Follow-up|1|||
94369344|NCT03555890|323139112|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
94369345|NCT03555890|323139113|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
94369346|NCT03555890|323139114|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
94369347|NCT00782275|323139119|FG000|Overall Study|Adverse Event|11|||
94369348|NCT00782275|323139119|FG000|Overall Study|Withdrawal by Subject|1|||
94369349|NCT00782275|323139119|FG000|Overall Study|Progressive Disease|21|||
94369350|NCT00782275|323139119|FG000|Overall Study|Physician Decision|4|||
94369351|NCT00782275|323139119|FG000|Overall Study|Not started treatment|1|||
94369352|NCT00782275|323139119|FG000|Overall Study|Other|3|||
94369353|NCT01875991|323139123|FG000|Overall Study|Withdrawal by Subject|6|||
94369354|NCT01875991|323139124|FG001|Overall Study|Withdrawal by Subject|6|||
94369355|NCT01875991|323139123|FG000|Overall Study|Sponsor Decision|1|||
94369356|NCT01875991|323139124|FG001|Overall Study|Sponsor Decision|0|||
94369357|NCT03402126|323139129|FG000|Overall Study|Lost to Follow-up|6|||
94369358|NCT03402126|323139129|FG000|Overall Study|Protocol Violation|10|||
94369359|NCT03402126|323139129|FG000|Overall Study|Sponsor request/Study termination|29|||
94369360|NCT03402126|323139129|FG000|Overall Study|Study product no longer in use|1|||
94369361|NCT03402126|323139129|FG000|Overall Study|Technical problems|1|||
94369362|NCT03402126|323139129|FG000|Overall Study|Withdrawal by Subject|6|||
94369363|NCT03402126|323139129|FG000|Overall Study|Physician Decision|2|||
94369364|NCT03402126|323139129|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
94369365|NCT03402126|323139129|FG000|Overall Study|Death|4|||
94369366|NCT01959230|323139130|FG000|Overall Study|Failure to follow study procedures|0|||
94369367|NCT01959230|323139131|FG001|Overall Study|Failure to follow study procedures|1|||
94369368|NCT01959230|323139130|FG000|Overall Study|Administrative reasons|2|||
94369369|NCT01959230|323139131|FG001|Overall Study|Administrative reasons|0|||
94369370|NCT01959230|323139130|FG000|Overall Study|Withdrawal by Subject|2|||
94369371|NCT01959230|323139131|FG001|Overall Study|Withdrawal by Subject|0|||
94369372|NCT01347879|323139132|FG000|Overall Study|Adverse Event|0|||
94369373|NCT01347879|323139133|FG001|Overall Study|Adverse Event|12|||
94369374|NCT01347879|323139132|FG000|Overall Study|Lost to Follow-up|2|||
94369375|NCT01347879|323139133|FG001|Overall Study|Lost to Follow-up|0|||
94369376|NCT01347879|323139132|FG000|Overall Study|Withdrawal by Subject|3|||
94369377|NCT01347879|323139133|FG001|Overall Study|Withdrawal by Subject|2|||
94369378|NCT01347879|323139132|FG000|Overall Study|Other|2|||
94369379|NCT01347879|323139133|FG001|Overall Study|Other|3|||
94369380|NCT02629133|323139135|FG000|Overall Study|Lost to Follow-up|3|||
94369381|NCT02629133|323139136|FG001|Overall Study|Lost to Follow-up|1|||
94369382|NCT02629133|323139135|FG000|Overall Study|Withdrawal by Subject|1|||
94369383|NCT02629133|323139136|FG001|Overall Study|Withdrawal by Subject|1|||
94741222|NCT03250676|324508981|FG003|Overall Study|Withdrawal by Subject|1|||
94741223|NCT03250676|324508982|FG004|Overall Study|Withdrawal by Subject|1|||
94741224|NCT03250676|324508983|FG005|Overall Study|Withdrawal by Subject|2|||
94741225|NCT03250676|324508978|FG000|Overall Study|Physician Decision|0|||
94741226|NCT03250676|324508979|FG001|Overall Study|Physician Decision|0|||
94741227|NCT03250676|324508980|FG002|Overall Study|Physician Decision|0|||
94741228|NCT03250676|324508981|FG003|Overall Study|Physician Decision|2|||
94741229|NCT03250676|324508982|FG004|Overall Study|Physician Decision|0|||
94741230|NCT03250676|324508983|FG005|Overall Study|Physician Decision|3|||
94741231|NCT03250676|324508978|FG000|Overall Study|Withdrawal of consent|0|||
94741232|NCT03250676|324508979|FG001|Overall Study|Withdrawal of consent|0|||
94741233|NCT03250676|324508980|FG002|Overall Study|Withdrawal of consent|2|||
94741234|NCT03250676|324508981|FG003|Overall Study|Withdrawal of consent|0|||
94741235|NCT03250676|324508982|FG004|Overall Study|Withdrawal of consent|0|||
94741236|NCT03250676|324508983|FG005|Overall Study|Withdrawal of consent|2|||
94741237|NCT03250676|324508978|FG000|Overall Study|Other|1|||
94741238|NCT03250676|324508979|FG001|Overall Study|Other|0|||
94741239|NCT03250676|324508980|FG002|Overall Study|Other|0|||
94741240|NCT03250676|324508981|FG003|Overall Study|Other|0|||
94741241|NCT03250676|324508982|FG004|Overall Study|Other|0|||
94741242|NCT03250676|324508983|FG005|Overall Study|Other|0|||
94741243|NCT03250676|324508978|FG000|Overall Study|Disease progression|4|||
94369384|NCT03216954|323139137|FG000|Overall Study|Adverse Event|0|||
94369385|NCT03216954|323139138|FG001|Overall Study|Adverse Event|0|||
94369386|NCT03216954|323139139|FG002|Overall Study|Adverse Event|1|||
94369387|NCT03216954|323139140|FG003|Overall Study|Adverse Event|0|||
94369388|NCT03216954|323139141|FG004|Overall Study|Adverse Event|1|||
94369389|NCT03216954|323139137|FG000|Overall Study|Withdrawal by Subject|2|||
94369390|NCT03216954|323139138|FG001|Overall Study|Withdrawal by Subject|0|||
94369391|NCT03216954|323139139|FG002|Overall Study|Withdrawal by Subject|0|||
94369392|NCT03216954|323139140|FG003|Overall Study|Withdrawal by Subject|0|||
94369393|NCT03216954|323139141|FG004|Overall Study|Withdrawal by Subject|0|||
94741244|NCT03250676|324508979|FG001|Overall Study|Disease progression|12|||
94741245|NCT03250676|324508980|FG002|Overall Study|Disease progression|9|||
94741246|NCT03250676|324508981|FG003|Overall Study|Disease progression|7|||
94741247|NCT03250676|324508982|FG004|Overall Study|Disease progression|4|||
94741248|NCT03250676|324508983|FG005|Overall Study|Disease progression|88|||
94741249|NCT05129501|324508984|FG000|Overall Study|Lost to Follow-up|54|||
94369394|NCT03216954|323139137|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
94369395|NCT03216954|323139138|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
94741250|NCT05129501|324508985|FG001|Overall Study|Lost to Follow-up|41|||
94741251|NCT04166513|324508986|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
94741252|NCT04166513|324508987|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
94741253|NCT04166513|324508988|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
94741254|NCT04166513|324508989|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
94741255|NCT04166513|324508986|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
94741256|NCT04166513|324508987|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
94741257|NCT04166513|324508988|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
94741258|NCT04166513|324508989|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
94741259|NCT04166513|324508986|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
94741260|NCT04166513|324508987|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
94741261|NCT04166513|324508988|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
94741262|NCT04166513|324508989|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
94741263|NCT04166513|324508986|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
94741264|NCT04166513|324508987|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
94741265|NCT04166513|324508988|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
94741266|NCT04166513|324508989|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
94741267|NCT04166513|324508986|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
94741268|NCT04166513|324508987|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
94741269|NCT04166513|324508988|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
94741270|NCT04166513|324508989|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
94741271|NCT01756300|324508991|FG000|Overall Study|Death|1|||
94741272|NCT01756300|324508991|FG000|Overall Study|Withdrawal by Subject|1|||
94741273|NCT04780581|324508992|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
94741274|NCT04780581|324508993|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
94741275|NCT04780581|324508992|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
94741276|NCT04780581|324508993|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
94741277|NCT00709956|324508996|FG000|Overall Study|Withdrawal by Subject|1|||
94741278|NCT00709956|324508997|FG001|Overall Study|Withdrawal by Subject|1|||
94741279|NCT00709956|324508996|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
94741280|NCT00709956|324508997|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
94741281|NCT01105091|324508998|FG000|Overall Study|Death|2|||
94741282|NCT01105091|324508999|FG001|Overall Study|Death|0|||
94741283|NCT02765412|324509000|FG000|Overall Study|Death|482|||
94741284|NCT02765412|324509001|FG001|Overall Study|Death|855|||
94741285|NCT05507437|324509776|FG000|Overall Study|Withdrawal by Subject|1|||
94741286|NCT05507437|324509777|FG001|Overall Study|Withdrawal by Subject|1|||
94741287|NCT05507437|324509776|FG000|Overall Study|Death|3|||
94741288|NCT05507437|324509777|FG001|Overall Study|Death|0|||
94741289|NCT04967599|324509778|FG000|Overall Study|Lost to Follow-up|35|||
94741290|NCT04967599|324509779|FG001|Overall Study|Lost to Follow-up|19|||
94741291|NCT04967599|324509780|FG002|Overall Study|Lost to Follow-up|23|||
94741292|NCT04586244|324509785|FG000|Overall Study|Lost to Follow-up|1|||
94741293|NCT04586244|324509786|FG001|Overall Study|Lost to Follow-up|0|||
94741294|NCT04586244|324509787|FG002|Overall Study|Lost to Follow-up|0|||
94741295|NCT04586244|324509788|FG003|Overall Study|Lost to Follow-up|1|||
94741296|NCT04586244|324509789|FG004|Overall Study|Lost to Follow-up|0|||
94741297|NCT04586244|324509785|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
94741298|NCT04586244|324509786|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
94741299|NCT04586244|324509787|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
94741300|NCT04586244|324509788|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
94741301|NCT04586244|324509789|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
94741302|NCT05424718|324509795|FG000|Overall Study|Lost to Follow-up|5|||
94741303|NCT05424718|324509796|FG001|Overall Study|Lost to Follow-up|4|||
94741304|NCT02461134|324509797|FG000|Overall Study|Adverse Event|1|||
94741305|NCT04761198|324509798|FG000|Overall Study|Progressive Disease|1|||
94741306|NCT04761198|324509799|FG001|Overall Study|Progressive Disease|0|||
94741307|NCT04761198|324509800|FG002|Overall Study|Progressive Disease|0|||
94741308|NCT04761198|324509801|FG003|Overall Study|Progressive Disease|1|||
94741309|NCT04761198|324509802|FG004|Overall Study|Progressive Disease|4|||
94741310|NCT04761198|324509803|FG005|Overall Study|Progressive Disease|1|||
94741311|NCT04761198|324509804|FG006|Overall Study|Progressive Disease|2|||
94741312|NCT04761198|324509798|FG000|Overall Study|Protocol Violation|0|||
94741313|NCT04761198|324509799|FG001|Overall Study|Protocol Violation|0|||
94741314|NCT04761198|324509800|FG002|Overall Study|Protocol Violation|0|||
94741315|NCT04761198|324509801|FG003|Overall Study|Protocol Violation|0|||
94741316|NCT04761198|324509802|FG004|Overall Study|Protocol Violation|1|||
94741317|NCT04761198|324509803|FG005|Overall Study|Protocol Violation|0|||
94741318|NCT04761198|324509804|FG006|Overall Study|Protocol Violation|0|||
94741319|NCT04761198|324509798|FG000|Overall Study|Death|2|||
94741320|NCT04761198|324509799|FG001|Overall Study|Death|1|||
94741321|NCT04761198|324509800|FG002|Overall Study|Death|2|||
94276510|NCT00794157|322804553|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94276511|NCT00794157|322804554|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94276512|NCT00794157|322804555|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
94276513|NCT00794157|322804553|FG000|Overall Study|Administrative problems|1|||
94276514|NCT00794157|322804554|FG001|Overall Study|Administrative problems|7|||
94276515|NCT00794157|322804555|FG002|Overall Study|Administrative problems|4|||
94276516|NCT00794157|322804553|FG000|Overall Study|Abnormal test procedure result(s)|0|||
94276517|NCT00794157|322804554|FG001|Overall Study|Abnormal test procedure result(s)|1|||
94276518|NCT00794157|322804555|FG002|Overall Study|Abnormal test procedure result(s)|0|||
94276519|NCT00794157|322804553|FG000|Overall Study|Protocol deviation|0|||
94276520|NCT00794157|322804554|FG001|Overall Study|Protocol deviation|1|||
94276521|NCT00794157|322804555|FG002|Overall Study|Protocol deviation|1|||
94276522|NCT01692275|322804556|FG000|Overall Study|Lost to Follow-up|57|||
94276523|NCT01692275|322804557|FG001|Overall Study|Lost to Follow-up|48|||
94276524|NCT01692275|322804556|FG000|Overall Study|Withdrawal by Subject|9|||
94276525|NCT01692275|322804557|FG001|Overall Study|Withdrawal by Subject|11|||
94276526|NCT00708123|322804561|FG000|Period 1|Protocol Violation|0|||
94276527|NCT00708123|322804562|FG001|Period 1|Protocol Violation|1|||
94276528|NCT00708123|322804563|FG002|Period 1|Protocol Violation|0|||
94276529|NCT00708123|322804564|FG003|Period 1|Protocol Violation|1|||
94276530|NCT00708123|322804565|FG004|Period 1|Protocol Violation|0|||
94276531|NCT00708123|322804561|FG000|Period 1|Adverse Event|0|||
94276532|NCT00708123|322804562|FG001|Period 1|Adverse Event|0|||
94276533|NCT00708123|322804563|FG002|Period 1|Adverse Event|1|||
94276534|NCT00708123|322804564|FG003|Period 1|Adverse Event|0|||
94276535|NCT00708123|322804565|FG004|Period 1|Adverse Event|0|||
94276536|NCT00708123|322804561|FG000|Period 2|Protocol Violation|0|||
94276537|NCT00708123|322804562|FG001|Period 2|Protocol Violation|0|||
94276538|NCT00708123|322804563|FG002|Period 2|Protocol Violation|0|||
94276539|NCT00708123|322804564|FG003|Period 2|Protocol Violation|1|||
94276540|NCT00708123|322804565|FG004|Period 2|Protocol Violation|0|||
94276541|NCT00708123|322804561|FG000|Period 2|Other Reason|1|||
94276542|NCT00708123|322804562|FG001|Period 2|Other Reason|0|||
94276543|NCT00708123|322804563|FG002|Period 2|Other Reason|0|||
94276544|NCT00708123|322804564|FG003|Period 2|Other Reason|0|||
94276545|NCT00708123|322804565|FG004|Period 2|Other Reason|0|||
94276546|NCT00708123|322804561|FG000|Period 3|Lost to Follow-up|0|||
94276547|NCT00708123|322804562|FG001|Period 3|Lost to Follow-up|0|||
94276548|NCT00708123|322804563|FG002|Period 3|Lost to Follow-up|1|||
94276549|NCT00708123|322804564|FG003|Period 3|Lost to Follow-up|1|||
94276550|NCT00708123|322804565|FG004|Period 3|Lost to Follow-up|0|||
94276551|NCT00708123|322804561|FG000|Period 4|Protocol Violation|0|||
94276552|NCT00708123|322804562|FG001|Period 4|Protocol Violation|1|||
94276553|NCT00708123|322804563|FG002|Period 4|Protocol Violation|0|||
94276554|NCT00708123|322804564|FG003|Period 4|Protocol Violation|0|||
94276555|NCT00708123|322804565|FG004|Period 4|Protocol Violation|0|||
94276556|NCT00137111|322804566|FG000|Total Therapy|Death|35|||
94276557|NCT00137111|322804567|FG001|Total Therapy|Death|0|||
94276558|NCT00137111|322804568|FG002|Total Therapy|Death|0|||
94276559|NCT00137111|322804569|FG003|Total Therapy|Death|0|||
94276560|NCT00137111|322804566|FG000|Total Therapy|Non Compliance|5|||
94276561|NCT00137111|322804567|FG001|Total Therapy|Non Compliance|0|||
94276562|NCT00137111|322804568|FG002|Total Therapy|Non Compliance|0|||
94276563|NCT00137111|322804569|FG003|Total Therapy|Non Compliance|0|||
94276564|NCT01326546|322804570|FG000|Overall Study|Lost to Follow-up|8|||
94276565|NCT01326546|322804571|FG001|Overall Study|Lost to Follow-up|7|||
94276566|NCT01326546|322804570|FG000|Overall Study|Protocol Violation|3|||
94276567|NCT01326546|322804571|FG001|Overall Study|Protocol Violation|4|||
94276568|NCT01326546|322804570|FG000|Overall Study|Pregnancy|0|||
94276569|NCT01326546|322804571|FG001|Overall Study|Pregnancy|1|||
94276570|NCT01326546|322804570|FG000|Overall Study|Adverse Event|1|||
94276571|NCT01326546|322804571|FG001|Overall Study|Adverse Event|0|||
94276572|NCT01326546|322804570|FG000|Overall Study|Withdrawal by Subject|5|||
94276573|NCT01326546|322804571|FG001|Overall Study|Withdrawal by Subject|1|||
94276574|NCT00317109|322804572|FG000|Overall Study|Withdrawal by Subject|2|||
94276575|NCT00317109|322804573|FG001|Overall Study|Withdrawal by Subject|0|||
94369396|NCT03216954|323139139|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
94369397|NCT03216954|323139140|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
94369398|NCT03216954|323139141|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
94369399|NCT01946282|323139146|FG000|Year 1|Did not return FIT kit|4186|||
94369400|NCT01946282|323139147|FG001|Year 1|Did not return FIT kit|608|||
94369401|NCT01946282|323139148|FG002|Year 1|Did not return FIT kit|654|||
94369402|NCT01946282|323139146|FG000|Year 2|Did not return FIT kit|803|||
94369403|NCT01946282|323139147|FG001|Year 2|Did not return FIT kit|131|||
94369404|NCT01946282|323139148|FG002|Year 2|Did not return FIT kit|115|||
94369405|NCT01946282|323139146|FG000|Year 3|Did not return FIT kit|288|||
94369406|NCT01946282|323139147|FG001|Year 3|Did not return FIT kit|43|||
94369407|NCT01946282|323139148|FG002|Year 3|Did not return FIT kit|30|||
94369408|NCT01027884|323139149|FG000|Overall Study|Adverse Event|2|||
94369409|NCT01027884|323139150|FG001|Overall Study|Adverse Event|1|||
94369410|NCT01027884|323139149|FG000|Overall Study|Protocol Violation|1|||
94369411|NCT01027884|323139150|FG001|Overall Study|Protocol Violation|0|||
94369412|NCT01027884|323139149|FG000|Overall Study|Non-compliance|1|||
94369413|NCT01027884|323139150|FG001|Overall Study|Non-compliance|1|||
94369414|NCT01027884|323139149|FG000|Overall Study|Withdrawal by Subject|0|||
94369415|NCT01027884|323139150|FG001|Overall Study|Withdrawal by Subject|1|||
94369416|NCT01027884|323139149|FG000|Overall Study|Lost to Follow-up|0|||
94369417|NCT01027884|323139150|FG001|Overall Study|Lost to Follow-up|1|||
94369418|NCT01027884|323139149|FG000|Overall Study|Spinal fixation surgery|0|||
94369419|NCT01027884|323139150|FG001|Overall Study|Spinal fixation surgery|3|||
94369420|NCT01783483|323139152|FG000|Overall Study|Death|3|||
94369421|NCT01783483|323139153|FG001|Overall Study|Death|3|||
94369422|NCT01783483|323139152|FG000|Overall Study|Lost to Follow-up|14|||
94369423|NCT01783483|323139153|FG001|Overall Study|Lost to Follow-up|10|||
94369424|NCT01783483|323139152|FG000|Overall Study|Withdrawal by Subject|2|||
94369425|NCT01783483|323139153|FG001|Overall Study|Withdrawal by Subject|1|||
94369426|NCT01783483|323139152|FG000|Overall Study|Physician Decision|1|||
94369427|NCT01783483|323139153|FG001|Overall Study|Physician Decision|1|||
94369428|NCT01610167|323139154|FG000|Overall Study|Scheduling conflict.|0|||
94369429|NCT01610167|323139155|FG001|Overall Study|Scheduling conflict.|0|||
94369430|NCT01610167|323139156|FG002|Overall Study|Scheduling conflict.|2|||
94369431|NCT01256398|323139158|FG000|Overall Study|Withdrawal by Subject|1|||
94369432|NCT01864525|323139160|FG000|Overall Study|Adverse Event|1|||
94369433|NCT01864525|323139161|FG001|Overall Study|Adverse Event|0|||
94369434|NCT00363129|323139162|FG000|Overall Study|Withdrawal by Subject|11|||
94369435|NCT00363129|323139163|FG001|Overall Study|Withdrawal by Subject|18|||
94369436|NCT00363129|323139162|FG000|Overall Study|Adverse Event|8|||
94369437|NCT00363129|323139163|FG001|Overall Study|Adverse Event|3|||
94369438|NCT00363129|323139162|FG000|Overall Study|Alternate Treatment|2|||
94369439|NCT00363129|323139163|FG001|Overall Study|Alternate Treatment|4|||
94369440|NCT00363129|323139162|FG000|Overall Study|Other Medical Problems|2|||
94369441|NCT00363129|323139163|FG001|Overall Study|Other Medical Problems|4|||
94369442|NCT00363129|323139162|FG000|Overall Study|Death|0|||
94369443|NCT00363129|323139163|FG001|Overall Study|Death|1|||
94369444|NCT00363129|323139162|FG000|Overall Study|Other Reasons|6|||
94369445|NCT00363129|323139163|FG001|Overall Study|Other Reasons|3|||
94369446|NCT03296553|323139164|FG000|Overall Study|Withdrawal by Subject|1|||
94369447|NCT03296553|323139165|FG001|Overall Study|Withdrawal by Subject|1|||
94369448|NCT03296553|323139164|FG000|Overall Study|Death|1|||
94369449|NCT03296553|323139165|FG001|Overall Study|Death|0|||
94369450|NCT00558519|323139166|FG000|Overall Study|Ph+|20|||
94369451|NCT00558519|323139166|FG000|Overall Study|Ineligible|1|||
94369452|NCT00558519|323139166|FG000|Overall Study|Insufficient data|1|||
94467530|NCT00908596|323502331|FG002|Overall Study|Lost to Follow-up|12|||
94741322|NCT04761198|324509801|FG003|Overall Study|Death|5|||
94369453|NCT00558519|323139166|FG000|Overall Study|Never received treatment|1|||
94369454|NCT00383019|323139167|FG000|Overall Study|Adverse Event|5|||
94369455|NCT00383019|323139168|FG001|Overall Study|Adverse Event|1|||
94369456|NCT00383019|323139167|FG000|Overall Study|Withdrawal by Subject|0|||
94369457|NCT00383019|323139168|FG001|Overall Study|Withdrawal by Subject|1|||
94369458|NCT03797222|323139169|FG000|Overall Study|Withdrawal by Subject|1|||
94369459|NCT03439293|323139177|FG000|Overall Study|Death|22|||
94369460|NCT03439293|323139177|FG000|Overall Study|Withdrawal by Subject|8|||
94369461|NCT03439293|323139177|FG000|Overall Study|Lost to Follow-up|2|||
94741323|NCT04761198|324509802|FG004|Overall Study|Death|14|||
94741324|NCT04761198|324509803|FG005|Overall Study|Death|2|||
94741325|NCT04761198|324509804|FG006|Overall Study|Death|5|||
94741326|NCT04761198|324509798|FG000|Overall Study|Lost to Follow-up|0|||
94369462|NCT03439293|323139177|FG000|Overall Study|Reason Not Specified|28|||
94741327|NCT04761198|324509799|FG001|Overall Study|Lost to Follow-up|0|||
94741328|NCT04761198|324509800|FG002|Overall Study|Lost to Follow-up|0|||
94369463|NCT03439293|323139177|FG000|Overall Study|Missing|1|||
94467531|NCT00908596|323502332|FG003|Overall Study|Lost to Follow-up|4|||
94369464|NCT04288115|323139180|FG000|Overall Study|Withdrawal by Subject|0|||
94467532|NCT00908596|323502329|FG000|Overall Study|Death|0|||
94369465|NCT04288115|323139181|FG001|Overall Study|Withdrawal by Subject|1|||
94369466|NCT04288115|323139180|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
94369467|NCT04288115|323139181|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
94369468|NCT03182686|323139182|FG000|Overall Study|Lost to Follow-up|2|||
94369469|NCT03182686|323139183|FG001|Overall Study|Lost to Follow-up|0|||
94369470|NCT03182686|323139182|FG000|Overall Study|Adverse Event|2|||
94369471|NCT03182686|323139183|FG001|Overall Study|Adverse Event|0|||
94369472|NCT03182686|323139182|FG000|Overall Study|Withdrawal by Subject|3|||
94369473|NCT03182686|323139183|FG001|Overall Study|Withdrawal by Subject|0|||
94369474|NCT01697449|323139184|FG000|Overall Study|Disease progression|47|||
94369475|NCT01697449|323139184|FG000|Overall Study|Adverse Event|7|||
94369476|NCT01697449|323139184|FG000|Overall Study|Lost to Follow-up|5|||
94369477|NCT01697449|323139184|FG000|Overall Study|Withdrawal by Subject|2|||
94369478|NCT01697449|323139184|FG000|Overall Study|Physician Decision|1|||
94369479|NCT01697449|323139184|FG000|Overall Study|Death|2|||
94467533|NCT00908596|323502330|FG001|Overall Study|Death|5|||
94369480|NCT01697449|323139184|FG000|Overall Study|Other|1|||
94369481|NCT01697449|323139184|FG000|Overall Study|Missing|25|||
94467534|NCT00908596|323502331|FG002|Overall Study|Death|57|||
94276576|NCT00317109|322804572|FG000|Overall Study|Migated/moved from study area|1|||
94276577|NCT00317109|322804573|FG001|Overall Study|Migated/moved from study area|0|||
94276578|NCT00278993|322804576|FG000|Overall Study|Adverse Event|24|||
94276579|NCT00278993|322804576|FG000|Overall Study|Withdrawal by Subject|5|||
94276580|NCT00278993|322804576|FG000|Overall Study|Progressive Disease|65|||
94276581|NCT00278993|322804576|FG000|Overall Study|Physician Decision|9|||
94276582|NCT00278993|322804576|FG000|Overall Study|Not Otherwise Specified|4|||
94276583|NCT02043548|322804577|FG000|Overall Study|Lack of Efficacy|1|||
94276584|NCT02043548|322804578|FG001|Overall Study|Lack of Efficacy|0|||
94276585|NCT02043548|322804577|FG000|Overall Study|Adverse Event|0|||
94276586|NCT02043548|322804578|FG001|Overall Study|Adverse Event|1|||
94276587|NCT00894556|322804579|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
94276588|NCT00894556|322804580|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
94276589|NCT00894556|322804581|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
94276590|NCT00894556|322804582|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
94276591|NCT00894556|322804579|FG000|Treatment Phase|Lost to Follow-up|2|||
94276592|NCT00894556|322804580|FG001|Treatment Phase|Lost to Follow-up|3|||
94276593|NCT00894556|322804581|FG002|Treatment Phase|Lost to Follow-up|1|||
94276594|NCT00894556|322804582|FG003|Treatment Phase|Lost to Follow-up|0|||
94276595|NCT00894556|322804579|FG000|Treatment Phase|Lack of Qualifying Event|2|||
94276596|NCT00894556|322804580|FG001|Treatment Phase|Lack of Qualifying Event|1|||
94276597|NCT00894556|322804581|FG002|Treatment Phase|Lack of Qualifying Event|0|||
94276598|NCT00894556|322804582|FG003|Treatment Phase|Lack of Qualifying Event|0|||
94276599|NCT00333359|322804587|FG000|Overall Study|Adverse Event|29|||
94276600|NCT00333359|322804588|FG001|Overall Study|Adverse Event|35|||
94276601|NCT00333359|322804587|FG000|Overall Study|Withdrawal by Subject|19|||
94276602|NCT00333359|322804588|FG001|Overall Study|Withdrawal by Subject|37|||
94276603|NCT00333359|322804587|FG000|Overall Study|Physician Decision|2|||
94276604|NCT00333359|322804588|FG001|Overall Study|Physician Decision|2|||
94276605|NCT00333359|322804587|FG000|Overall Study|Protocol Non-compliance|2|||
94276606|NCT00333359|322804588|FG001|Overall Study|Protocol Non-compliance|8|||
94276607|NCT00333359|322804587|FG000|Overall Study|Lost to Follow-up|15|||
94276608|NCT00333359|322804588|FG001|Overall Study|Lost to Follow-up|25|||
94276609|NCT00333359|322804587|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
94276610|NCT00333359|322804588|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
94276611|NCT00333359|322804587|FG000|Overall Study|Treatment Failure|3|||
94276612|NCT00333359|322804588|FG001|Overall Study|Treatment Failure|8|||
94276613|NCT00333359|322804587|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
94276614|NCT00333359|322804588|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
94330885|NCT01522443|322991750|FG000|Overall Study|No longer receiving clinical benefit|36|||
94330886|NCT01522443|322991751|FG001|Overall Study|No longer receiving clinical benefit|28|||
94330887|NCT01522443|322991750|FG000|Overall Study|Adverse Event|10|||
94741329|NCT04761198|324509801|FG003|Overall Study|Lost to Follow-up|0|||
94741330|NCT04761198|324509802|FG004|Overall Study|Lost to Follow-up|1|||
94741331|NCT04761198|324509803|FG005|Overall Study|Lost to Follow-up|0|||
94741332|NCT04761198|324509804|FG006|Overall Study|Lost to Follow-up|0|||
94741333|NCT04761198|324509798|FG000|Overall Study|Withdrawal by Subject|2|||
94741334|NCT04761198|324509799|FG001|Overall Study|Withdrawal by Subject|0|||
94741335|NCT04761198|324509800|FG002|Overall Study|Withdrawal by Subject|1|||
94741336|NCT04761198|324509801|FG003|Overall Study|Withdrawal by Subject|0|||
94741337|NCT04761198|324509802|FG004|Overall Study|Withdrawal by Subject|2|||
94741338|NCT04761198|324509803|FG005|Overall Study|Withdrawal by Subject|0|||
94741339|NCT04761198|324509804|FG006|Overall Study|Withdrawal by Subject|1|||
94741340|NCT04761198|324509798|FG000|Overall Study|Study Terminated by Sponsor|6|||
94741341|NCT04761198|324509799|FG001|Overall Study|Study Terminated by Sponsor|0|||
94741342|NCT04761198|324509800|FG002|Overall Study|Study Terminated by Sponsor|5|||
94741343|NCT04761198|324509801|FG003|Overall Study|Study Terminated by Sponsor|3|||
94741344|NCT04761198|324509802|FG004|Overall Study|Study Terminated by Sponsor|10|||
94741345|NCT04761198|324509803|FG005|Overall Study|Study Terminated by Sponsor|1|||
94741346|NCT04761198|324509804|FG006|Overall Study|Study Terminated by Sponsor|2|||
94741347|NCT01560416|324509808|FG000|Randomized Phase|Crossover Participants|7|||
94741348|NCT01560416|324509809|FG001|Randomized Phase|Crossover Participants|0|||
94741349|NCT03982186|324509812|FG000|Overall Study|Lost to Follow-up|0|||
94741350|NCT03982186|324509813|FG001|Overall Study|Lost to Follow-up|1|||
94741351|NCT03982186|324509814|FG002|Overall Study|Lost to Follow-up|2|||
94741352|NCT03982186|324509815|FG003|Overall Study|Lost to Follow-up|1|||
94741353|NCT03982186|324509816|FG004|Overall Study|Lost to Follow-up|1|||
94741354|NCT03982186|324509817|FG005|Overall Study|Lost to Follow-up|0|||
94741355|NCT03982186|324509812|FG000|Overall Study|Physician Decision|0|||
94741356|NCT03982186|324509813|FG001|Overall Study|Physician Decision|1|||
94741357|NCT03982186|324509814|FG002|Overall Study|Physician Decision|0|||
94741358|NCT03982186|324509815|FG003|Overall Study|Physician Decision|0|||
94741359|NCT03982186|324509816|FG004|Overall Study|Physician Decision|0|||
94741360|NCT03982186|324509817|FG005|Overall Study|Physician Decision|0|||
94741361|NCT03982186|324509812|FG000|Overall Study|Withdrawal by Subject|3|||
94741362|NCT03982186|324509813|FG001|Overall Study|Withdrawal by Subject|4|||
94741363|NCT03982186|324509814|FG002|Overall Study|Withdrawal by Subject|1|||
94741364|NCT03982186|324509815|FG003|Overall Study|Withdrawal by Subject|7|||
94741365|NCT03982186|324509816|FG004|Overall Study|Withdrawal by Subject|2|||
94741366|NCT03982186|324509817|FG005|Overall Study|Withdrawal by Subject|0|||
94741367|NCT03982186|324509812|FG000|Overall Study|Randomized and not treated|0|||
94741368|NCT03982186|324509813|FG001|Overall Study|Randomized and not treated|0|||
94741369|NCT03982186|324509814|FG002|Overall Study|Randomized and not treated|0|||
94741370|NCT03982186|324509815|FG003|Overall Study|Randomized and not treated|1|||
94741371|NCT03982186|324509816|FG004|Overall Study|Randomized and not treated|0|||
94741372|NCT03982186|324509817|FG005|Overall Study|Randomized and not treated|0|||
94741373|NCT02951052|324509818|FG000|Overall Study|Adverse Event|13|||
94741374|NCT02951052|324509819|FG001|Overall Study|Adverse Event|5|||
94741375|NCT02951052|324509818|FG000|Overall Study|Withdrawal by Subject|1|||
94741376|NCT02951052|324509819|FG001|Overall Study|Withdrawal by Subject|5|||
94741377|NCT02951052|324509818|FG000|Overall Study|Physician Decision|2|||
94741378|NCT02951052|324509819|FG001|Overall Study|Physician Decision|0|||
94741379|NCT02951052|324509818|FG000|Overall Study|Lost to Follow-up|1|||
94741380|NCT02951052|324509819|FG001|Overall Study|Lost to Follow-up|1|||
94741381|NCT02951052|324509818|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
94741382|NCT02951052|324509819|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
94741383|NCT02951052|324509818|FG000|Overall Study|Protocol Violation|5|||
94741384|NCT02951052|324509819|FG001|Overall Study|Protocol Violation|3|||
94741385|NCT02951052|324509818|FG000|Overall Study|Lack of Efficacy|3|||
94741386|NCT02951052|324509819|FG001|Overall Study|Lack of Efficacy|4|||
94741387|NCT02951052|324509818|FG000|Overall Study|Ongoing|1|||
94741388|NCT02951052|324509819|FG001|Overall Study|Ongoing|0|||
94741389|NCT02325154|324509824|FG000|Overall Study|Physician Decision|1|||
94741390|NCT05866926|324509825|FG000|Overall Study|Death|16|||
94741391|NCT05866926|324509826|FG001|Overall Study|Death|9|||
94741392|NCT05866926|324509825|FG000|Overall Study|Lost to Follow-up|0|||
94741393|NCT05866926|324509826|FG001|Overall Study|Lost to Follow-up|1|||
94741394|NCT05866926|324509825|FG000|Overall Study|Adverse Event|1|||
94741395|NCT05866926|324509826|FG001|Overall Study|Adverse Event|0|||
94741396|NCT05866926|324509825|FG000|Overall Study|Withdrawal by Subject|5|||
94741397|NCT05866926|324509826|FG001|Overall Study|Withdrawal by Subject|1|||
94741398|NCT05866926|324509825|FG000|Overall Study|Disease progression|1|||
94741399|NCT05866926|324509826|FG001|Overall Study|Disease progression|0|||
94741400|NCT05866926|324509825|FG000|Overall Study|other causes|2|||
94741401|NCT05866926|324509826|FG001|Overall Study|other causes|1|||
94741402|NCT03008382|324509827|FG000|Overall Study|Withdrawal by Subject|2|||
94741403|NCT03008382|324509828|FG001|Overall Study|Withdrawal by Subject|5|||
94741404|NCT03008382|324509829|FG002|Overall Study|Withdrawal by Subject|2|||
94741405|NCT03008382|324509830|FG003|Overall Study|Withdrawal by Subject|0|||
94741406|NCT03008382|324509827|FG000|Overall Study|Protocol Violation|1|||
94741407|NCT03008382|324509828|FG001|Overall Study|Protocol Violation|0|||
94741408|NCT03008382|324509829|FG002|Overall Study|Protocol Violation|0|||
94741409|NCT03008382|324509830|FG003|Overall Study|Protocol Violation|0|||
94741410|NCT03008382|324509827|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
94741411|NCT03008382|324509828|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
94741412|NCT03008382|324509829|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
94741413|NCT03008382|324509830|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
94741414|NCT03008382|324509827|FG000|Overall Study|Lost to Follow-up|0|||
94741415|NCT03008382|324509828|FG001|Overall Study|Lost to Follow-up|0|||
94741416|NCT03008382|324509829|FG002|Overall Study|Lost to Follow-up|1|||
94741417|NCT03008382|324509830|FG003|Overall Study|Lost to Follow-up|0|||
94741418|NCT03008382|324509827|FG000|Overall Study|Screenfail|0|||
94741419|NCT03008382|324509828|FG001|Overall Study|Screenfail|0|||
94741420|NCT03008382|324509829|FG002|Overall Study|Screenfail|2|||
94741421|NCT03008382|324509830|FG003|Overall Study|Screenfail|0|||
94741422|NCT04565990|324510153|FG000|Overall Study|Death|5|||
94741423|NCT04565990|324510153|FG000|Overall Study|Lost to Follow-up|1|||
94741424|NCT04565990|324510153|FG000|Overall Study|Withdrawal by Subject|1|||
94741425|NCT04427007|324510156|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
94741426|NCT04427007|324510157|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
94741427|NCT05311176|324510158|FG000|Overall Study|Death|6|||
94741428|NCT05311176|324510158|FG000|Overall Study|Sponsor discontinued the study|1|||
94741429|NCT02003222|324510166|FG000|Induction|Never started treatment|0|||
94741430|NCT02003222|324510167|FG001|Induction|Never started treatment|0|||
94741431|NCT02003222|324510168|FG002|Induction|Never started treatment|0|||
94741432|NCT02003222|324510169|FG003|Induction|Never started treatment|0|||
94741433|NCT02003222|324510170|FG004|Induction|Never started treatment|8|||
94741434|NCT02003222|324510166|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
94741435|NCT02003222|324510167|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
94741436|NCT02003222|324510168|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
94741437|NCT02003222|324510169|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
94741438|NCT02003222|324510170|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
94741439|NCT02003222|324510166|FG000|Induction|Adverse Event|0|||
94741440|NCT02003222|324510167|FG001|Induction|Adverse Event|0|||
94276615|NCT00666458|322806260|FG000|Overall Study|Adverse Event|8|||
94276616|NCT00666458|322806261|FG001|Overall Study|Adverse Event|7|||
94276617|NCT00666458|322806260|FG000|Overall Study|Withdrawal by Subject|5|||
94741441|NCT02003222|324510168|FG002|Induction|Adverse Event|0|||
94741442|NCT02003222|324510169|FG003|Induction|Adverse Event|0|||
94741443|NCT02003222|324510170|FG004|Induction|Adverse Event|13|||
94741444|NCT02003222|324510166|FG000|Induction|Alternative therapy|0|||
94741445|NCT02003222|324510167|FG001|Induction|Alternative therapy|0|||
94741446|NCT02003222|324510168|FG002|Induction|Alternative therapy|0|||
94741447|NCT02003222|324510169|FG003|Induction|Alternative therapy|0|||
94741448|NCT02003222|324510170|FG004|Induction|Alternative therapy|12|||
94741449|NCT02003222|324510166|FG000|Induction|Disease progression|0|||
94741450|NCT02003222|324510167|FG001|Induction|Disease progression|0|||
94276618|NCT00666458|322806261|FG001|Overall Study|Withdrawal by Subject|4|||
94276619|NCT00666458|322806260|FG000|Overall Study|Lost to Follow-up|0|||
94276620|NCT00666458|322806261|FG001|Overall Study|Lost to Follow-up|3|||
94276621|NCT00666458|322806260|FG000|Overall Study|Administrative reason by sponsor|1|||
94276622|NCT00666458|322806261|FG001|Overall Study|Administrative reason by sponsor|1|||
94276623|NCT00666458|322806260|FG000|Overall Study|Incorrect enrollment|7|||
94276624|NCT00666458|322806261|FG001|Overall Study|Incorrect enrollment|1|||
94276625|NCT00666458|322806260|FG000|Overall Study|Study specific discontinuation criteria|14|||
94276626|NCT00666458|322806261|FG001|Overall Study|Study specific discontinuation criteria|7|||
94276627|NCT00666458|322806260|FG000|Overall Study|Severe non-compliance to the protocol|1|||
94276628|NCT00666458|322806261|FG001|Overall Study|Severe non-compliance to the protocol|1|||
94276629|NCT00666458|322806260|FG000|Overall Study|Safety reasons|1|||
94276630|NCT00666458|322806261|FG001|Overall Study|Safety reasons|0|||
94276631|NCT00666458|322806260|FG000|Overall Study|Medical history of anemia|1|||
94276632|NCT00666458|322806261|FG001|Overall Study|Medical history of anemia|0|||
94276633|NCT02222207|322806262|FG000|Overall Study|Death|1|||
94276634|NCT02222207|322806262|FG000|Overall Study|Other reasons|2|||
94276635|NCT02222207|322806262|FG000|Overall Study|Adverse Event|1|||
94276636|NCT01157078|322806263|FG000|Overall Study|Withdrawal by Subject|12|||
94276637|NCT01157078|322806264|FG001|Overall Study|Withdrawal by Subject|14|||
94276638|NCT01157078|322806263|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
94276639|NCT01157078|322806264|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
94276640|NCT01157078|322806263|FG000|Overall Study|Adverse Event|6|||
94276641|NCT01157078|322806264|FG001|Overall Study|Adverse Event|6|||
94741451|NCT02003222|324510168|FG002|Induction|Disease progression|0|||
94741452|NCT02003222|324510169|FG003|Induction|Disease progression|0|||
94741453|NCT02003222|324510170|FG004|Induction|Disease progression|22|||
94741454|NCT02003222|324510166|FG000|Induction|Death|0|||
94741455|NCT02003222|324510167|FG001|Induction|Death|0|||
94741456|NCT02003222|324510168|FG002|Induction|Death|0|||
94741457|NCT02003222|324510169|FG003|Induction|Death|0|||
94741458|NCT02003222|324510170|FG004|Induction|Death|3|||
94741459|NCT02003222|324510166|FG000|Induction|Withdrawal by Subject|0|||
94741460|NCT02003222|324510167|FG001|Induction|Withdrawal by Subject|0|||
94741461|NCT02003222|324510168|FG002|Induction|Withdrawal by Subject|0|||
94741462|NCT02003222|324510169|FG003|Induction|Withdrawal by Subject|0|||
94741463|NCT02003222|324510170|FG004|Induction|Withdrawal by Subject|8|||
94741464|NCT02003222|324510166|FG000|Induction|Other reasons|0|||
94741465|NCT02003222|324510167|FG001|Induction|Other reasons|0|||
94741466|NCT02003222|324510168|FG002|Induction|Other reasons|0|||
94741467|NCT02003222|324510169|FG003|Induction|Other reasons|0|||
94741468|NCT02003222|324510170|FG004|Induction|Other reasons|22|||
94741469|NCT02003222|324510166|FG000|Intensification|Never started treatment|0|||
94741470|NCT02003222|324510167|FG001|Intensification|Never started treatment|0|||
94741471|NCT02003222|324510168|FG002|Intensification|Never started treatment|0|||
94741472|NCT02003222|324510169|FG003|Intensification|Never started treatment|0|||
94741473|NCT02003222|324510170|FG004|Intensification|Never started treatment|2|||
94741474|NCT02003222|324510166|FG000|Intensification|Adverse Event|0|||
94741475|NCT02003222|324510167|FG001|Intensification|Adverse Event|0|||
94741476|NCT02003222|324510168|FG002|Intensification|Adverse Event|0|||
94741477|NCT02003222|324510169|FG003|Intensification|Adverse Event|0|||
94741478|NCT02003222|324510170|FG004|Intensification|Adverse Event|6|||
94741479|NCT02003222|324510166|FG000|Intensification|Alternative therapy|0|||
94741480|NCT02003222|324510167|FG001|Intensification|Alternative therapy|0|||
94741481|NCT02003222|324510168|FG002|Intensification|Alternative therapy|0|||
94741482|NCT02003222|324510169|FG003|Intensification|Alternative therapy|0|||
94741483|NCT02003222|324510170|FG004|Intensification|Alternative therapy|8|||
94741484|NCT02003222|324510166|FG000|Intensification|Disease progression|0|||
94741485|NCT02003222|324510167|FG001|Intensification|Disease progression|0|||
94741486|NCT02003222|324510168|FG002|Intensification|Disease progression|0|||
94741487|NCT02003222|324510169|FG003|Intensification|Disease progression|0|||
94741488|NCT02003222|324510170|FG004|Intensification|Disease progression|18|||
94741489|NCT02003222|324510166|FG000|Intensification|Withdrawal by Subject|0|||
94741490|NCT02003222|324510167|FG001|Intensification|Withdrawal by Subject|0|||
94741491|NCT02003222|324510168|FG002|Intensification|Withdrawal by Subject|0|||
94741492|NCT02003222|324510169|FG003|Intensification|Withdrawal by Subject|0|||
94741493|NCT02003222|324510170|FG004|Intensification|Withdrawal by Subject|5|||
94741494|NCT02003222|324510166|FG000|Intensification|Other reasons|0|||
94741495|NCT02003222|324510167|FG001|Intensification|Other reasons|0|||
94741496|NCT02003222|324510168|FG002|Intensification|Other reasons|0|||
94741497|NCT02003222|324510169|FG003|Intensification|Other reasons|0|||
94741498|NCT02003222|324510170|FG004|Intensification|Other reasons|8|||
94741503|NCT03505710|324510173|FG000|Overall Study|Progressive Disease|24|||
94741504|NCT03505710|324510174|FG001|Overall Study|Progressive Disease|17|||
94741505|NCT03505710|324510175|FG002|Overall Study|Progressive Disease|43|||
94741506|NCT03505710|324510173|FG000|Overall Study|Clinical Progression|6|||
94741507|NCT03505710|324510174|FG001|Overall Study|Clinical Progression|8|||
94741508|NCT03505710|324510175|FG002|Overall Study|Clinical Progression|3|||
94741509|NCT03505710|324510173|FG000|Overall Study|Adverse Event|12|||
94741510|NCT03505710|324510174|FG001|Overall Study|Adverse Event|6|||
94741511|NCT03505710|324510175|FG002|Overall Study|Adverse Event|28|||
94741512|NCT03505710|324510173|FG000|Overall Study|Withdrawal by Subject|1|||
94741513|NCT03505710|324510174|FG001|Overall Study|Withdrawal by Subject|3|||
94741514|NCT03505710|324510175|FG002|Overall Study|Withdrawal by Subject|7|||
94741515|NCT03505710|324510173|FG000|Overall Study|Physician Decision|1|||
94741516|NCT03505710|324510174|FG001|Overall Study|Physician Decision|1|||
94741517|NCT03505710|324510175|FG002|Overall Study|Physician Decision|2|||
94741518|NCT03505710|324510173|FG000|Overall Study|Death|4|||
94741519|NCT03505710|324510174|FG001|Overall Study|Death|5|||
94741520|NCT03505710|324510175|FG002|Overall Study|Death|6|||
94741521|NCT03505710|324510173|FG000|Overall Study|Other Reasons|1|||
94741522|NCT03505710|324510174|FG001|Overall Study|Other Reasons|1|||
94741523|NCT03505710|324510175|FG002|Overall Study|Other Reasons|1|||
94741524|NCT03505710|324510173|FG000|Overall Study|Study Terminated by Sponsor|0|||
94741525|NCT03505710|324510174|FG001|Overall Study|Study Terminated by Sponsor|0|||
94741526|NCT03505710|324510175|FG002|Overall Study|Study Terminated by Sponsor|1|||
94741527|NCT04544956|324510178|FG000|Overall Study|Withdrawal by Subject|1|||
94741528|NCT03904576|324510179|FG000|Washout Period|Protocol Violation|1|||
94741529|NCT03904576|324510180|FG001|Washout Period|Protocol Violation|1|||
94741530|NCT02919917|324510181|FG000|Overall Study|Withdrawal by Subject|4|||
94741531|NCT02919917|324510182|FG001|Overall Study|Withdrawal by Subject|8|||
94741532|NCT04093869|324510192|FG000|Overall Study|Death|0|||
94741533|NCT04093869|324510193|FG001|Overall Study|Death|1|||
94741534|NCT04093869|324510192|FG000|Overall Study|Withdrawal by Subject|1|||
94741535|NCT04093869|324510193|FG001|Overall Study|Withdrawal by Subject|0|||
94741536|NCT02806726|324510194|FG000|Overall Study|Lost to Follow-up|1|||
94741537|NCT01220531|324510197|FG000|Overall Study|Death|7|||
94741538|NCT01220531|324510197|FG000|Overall Study|Lost to Follow-up|1|||
94741539|NCT03367156|324510628|FG000|Overall Study|Lack of interest|3|||
94741540|NCT03367156|324510629|FG001|Overall Study|Lack of interest|1|||
94741541|NCT03367156|324510628|FG000|Overall Study|Death|2|||
94741542|NCT03367156|324510629|FG001|Overall Study|Death|0|||
94741543|NCT03367156|324510628|FG000|Overall Study|Lost to Follow-up|2|||
94741544|NCT03367156|324510629|FG001|Overall Study|Lost to Follow-up|1|||
94741545|NCT03367156|324510628|FG000|Overall Study|Became ineligible|1|||
94741546|NCT03367156|324510629|FG001|Overall Study|Became ineligible|2|||
94741547|NCT03367156|324510628|FG000|Overall Study|Hospitalization|1|||
94741548|NCT03367156|324510629|FG001|Overall Study|Hospitalization|0|||
94741549|NCT03367156|324510628|FG000|Overall Study|Concerned about Treatment|11|||
94741550|NCT03367156|324510629|FG001|Overall Study|Concerned about Treatment|3|||
94741551|NCT03367156|324510628|FG000|Overall Study|Started new treatment|4|||
94741552|NCT03367156|324510629|FG001|Overall Study|Started new treatment|1|||
94741553|NCT03106740|324510630|FG000|Overall Study|Lost to Follow-up|2|||
94741554|NCT03106740|324510631|FG001|Overall Study|Lost to Follow-up|2|||
94741555|NCT03106740|324510630|FG000|Overall Study|Withdrawal by Subject|2|||
94741556|NCT03106740|324510631|FG001|Overall Study|Withdrawal by Subject|4|||
94741557|NCT03106740|324510630|FG000|Overall Study|Physician Decision|0|||
94741558|NCT03106740|324510631|FG001|Overall Study|Physician Decision|1|||
94741559|NCT03106740|324510630|FG000|Overall Study|Partial data|1|||
94741560|NCT03106740|324510631|FG001|Overall Study|Partial data|0|||
94741561|NCT01586910|324510633|FG000|Overall Study|Death|4|||
94741562|NCT01586910|324510634|FG001|Overall Study|Death|4|||
94741563|NCT01586910|324510633|FG000|Overall Study|Withdrawal by Subject|6|||
94741564|NCT01586910|324510634|FG001|Overall Study|Withdrawal by Subject|43|||
94741565|NCT01586910|324510633|FG000|Overall Study|Physician withdrew Subject|5|||
94741566|NCT01586910|324510634|FG001|Overall Study|Physician withdrew Subject|24|||
94741567|NCT00937937|324510635|FG000|Overall Study|Adverse Event|6|||
94741568|NCT00937937|324510635|FG000|Overall Study|Withdrawal by Subject|2|||
94741569|NCT00937937|324510635|FG000|Overall Study|Progression/relapse|61|||
94741570|NCT00937937|324510635|FG000|Overall Study|Death|1|||
94276642|NCT01157078|322806263|FG000|Overall Study|Severe non-compliance to protocol|2|||
94276643|NCT01157078|322806264|FG001|Overall Study|Severe non-compliance to protocol|4|||
94276644|NCT01157078|322806263|FG000|Overall Study|Condition under investigation worsened|0|||
94276645|NCT01157078|322806264|FG001|Overall Study|Condition under investigation worsened|1|||
94276646|NCT01157078|322806263|FG000|Overall Study|Lack of Efficacy|2|||
94276647|NCT01157078|322806264|FG001|Overall Study|Lack of Efficacy|0|||
94276648|NCT01157078|322806263|FG000|Overall Study|Study-specific withdrawal criteria|2|||
94276649|NCT01157078|322806264|FG001|Overall Study|Study-specific withdrawal criteria|2|||
94741571|NCT00937937|324510635|FG000|Overall Study|Other|2|||
94741572|NCT03781089|324510636|FG000|Overall Study|Constipation|1|||
94741573|NCT03781089|324510637|FG001|Overall Study|Constipation|0|||
94741574|NCT03781089|324510636|FG000|Overall Study|Positive pregnancy test|0|||
94741575|NCT03781089|324510637|FG001|Overall Study|Positive pregnancy test|1|||
94276650|NCT01157078|322806263|FG000|Overall Study|Lost to Follow-up|7|||
94276651|NCT01157078|322806264|FG001|Overall Study|Lost to Follow-up|5|||
94276652|NCT01157078|322806263|FG000|Overall Study|Other|2|||
94276653|NCT01157078|322806264|FG001|Overall Study|Other|4|||
94276654|NCT03557281|322806265|FG000|Overall Study|Investigator discretion|0|||
94276655|NCT03557281|322806266|FG001|Overall Study|Investigator discretion|0|||
94276656|NCT03557281|322806267|FG002|Overall Study|Investigator discretion|1|||
94276657|NCT03557281|322806268|FG003|Overall Study|Investigator discretion|0|||
94276658|NCT03557281|322806269|FG004|Overall Study|Investigator discretion|0|||
94276659|NCT03557281|322806265|FG000|Overall Study|Withdrawal by Subject|0|||
94276660|NCT03557281|322806266|FG001|Overall Study|Withdrawal by Subject|1|||
94276661|NCT03557281|322806267|FG002|Overall Study|Withdrawal by Subject|1|||
94276662|NCT03557281|322806268|FG003|Overall Study|Withdrawal by Subject|1|||
94276663|NCT03557281|322806269|FG004|Overall Study|Withdrawal by Subject|2|||
94276664|NCT03557281|322806265|FG000|Overall Study|Randomized, but did not receive treatment|0|||
94276665|NCT03557281|322806266|FG001|Overall Study|Randomized, but did not receive treatment|0|||
94276666|NCT03557281|322806267|FG002|Overall Study|Randomized, but did not receive treatment|0|||
94276667|NCT03557281|322806268|FG003|Overall Study|Randomized, but did not receive treatment|0|||
94276668|NCT03557281|322806269|FG004|Overall Study|Randomized, but did not receive treatment|1|||
94276669|NCT01097746|322806281|FG000|Overall Study|Adverse Event|4|||
94276670|NCT01097746|322806281|FG000|Overall Study|taken off study before any treatment given|1|||
94276671|NCT02634151|322806283|FG000|Overall Study|Withdrawal by Subject|1|||
94276672|NCT02634151|322806284|FG001|Overall Study|Withdrawal by Subject|0|||
94276673|NCT02634151|322806283|FG000|Overall Study|Non-Compliance|0|||
94369482|NCT05037409|323139191|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
94369483|NCT05037409|323139192|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
94741576|NCT05020353|324510638|FG000|Overall Study|Protocol Violation|7|||
94741577|NCT05020353|324510638|FG000|Overall Study|Withdrawal by Subject|33|||
94741578|NCT03636490|324510639|FG000|Overall Study|Dropped out or incomplete data|141|||
94741579|NCT02246127|324510640|FG000|First Course Treatment|Adverse Event|9|||
94741580|NCT02246127|324510641|FG001|First Course Treatment|Adverse Event|7|||
94741581|NCT02246127|324510640|FG000|First Course Treatment|Withdrawal by Subject|6|||
94741582|NCT02246127|324510641|FG001|First Course Treatment|Withdrawal by Subject|7|||
94741583|NCT02246127|324510640|FG000|First Course Treatment|Physician Decision|9|||
94741584|NCT02246127|324510641|FG001|First Course Treatment|Physician Decision|9|||
94741585|NCT02246127|324510640|FG000|First Course Treatment|Death|3|||
94741586|NCT02246127|324510641|FG001|First Course Treatment|Death|3|||
94741587|NCT02246127|324510640|FG000|First Course Treatment|Not reported reasons|6|||
94741588|NCT02246127|324510641|FG001|First Course Treatment|Not reported reasons|7|||
94741589|NCT02246127|324510640|FG000|First Course Treatment|Not treated|3|||
94741590|NCT02246127|324510641|FG001|First Course Treatment|Not treated|3|||
94741591|NCT04227899|324510642|FG000|Overall Study|Withdrawal by Subject|6|||
94741592|NCT04227899|324510643|FG001|Overall Study|Withdrawal by Subject|3|||
94741593|NCT04227899|324510642|FG000|Overall Study|Death|12|||
94741594|NCT04227899|324510643|FG001|Overall Study|Death|6|||
94741595|NCT04227899|324510642|FG000|Overall Study|Lost to Follow-up|2|||
94741596|NCT04227899|324510643|FG001|Overall Study|Lost to Follow-up|1|||
94741597|NCT02076009|324510644|FG000|Overall Study|Death|172|||
94741598|NCT02076009|324510645|FG001|Overall Study|Death|153|||
94741599|NCT02076009|324510644|FG000|Overall Study|Withdrawal by Subject|16|||
94741600|NCT02076009|324510645|FG001|Overall Study|Withdrawal by Subject|12|||
94741601|NCT02076009|324510644|FG000|Overall Study|Lost to Follow-up|4|||
94741602|NCT02076009|324510645|FG001|Overall Study|Lost to Follow-up|2|||
94741603|NCT02076009|324510644|FG000|Overall Study|Progressive Disease|1|||
94741604|NCT02076009|324510645|FG001|Overall Study|Progressive Disease|0|||
94741605|NCT02076009|324510644|FG000|Overall Study|Physician Decision|0|||
94741606|NCT02076009|324510645|FG001|Overall Study|Physician Decision|1|||
94741607|NCT02076009|324510644|FG000|Overall Study|End of data collection|90|||
94741608|NCT02076009|324510645|FG001|Overall Study|End of data collection|118|||
94741609|NCT03983382|324510646|FG000|Overall Study|Death|1|||
94741610|NCT03983382|324510646|FG000|Overall Study|Lost to Follow-up|3|||
94741611|NCT03983382|324510646|FG000|Overall Study|Physician Decision|2|||
94741612|NCT03983382|324510646|FG000|Overall Study|Withdrawal by Subject|10|||
94741613|NCT03983382|324510646|FG000|Overall Study|Change in cancer treatment|2|||
94741614|NCT02048813|324510647|FG000|Overall Study|Still on treatment|279|||
94741615|NCT02048813|324510648|FG001|Overall Study|Still on treatment|0|||
94741616|NCT02048813|324510647|FG000|Overall Study|Adverse Event|40|||
94741617|NCT02048813|324510648|FG001|Overall Study|Adverse Event|38|||
94741618|NCT02048813|324510647|FG000|Overall Study|Disease progression|13|||
94276674|NCT02634151|322806284|FG001|Overall Study|Non-Compliance|1|||
94276675|NCT02634151|322806283|FG000|Overall Study|Other|0|||
94369484|NCT05037409|323139193|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
94369485|NCT03499249|323139194|FG000|Overall Study|Physician Decision|1|||
94741619|NCT02048813|324510648|FG001|Overall Study|Disease progression|3|||
94741620|NCT02048813|324510647|FG000|Overall Study|Withdrawal by Subject|7|||
94741621|NCT02048813|324510648|FG001|Overall Study|Withdrawal by Subject|8|||
94276676|NCT02634151|322806284|FG001|Overall Study|Other|1|||
94276677|NCT01918007|322806293|FG000|Overall Study|Baseline oximetry not acceptable|11|||
94276678|NCT01918007|322806294|FG001|Overall Study|Baseline oximetry not acceptable|7|||
94276679|NCT01918007|322806293|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
94276680|NCT01918007|322806294|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
94276681|NCT01918007|322806293|FG000|Overall Study|Lost to Follow-up|4|||
94276682|NCT01918007|322806294|FG001|Overall Study|Lost to Follow-up|7|||
94276683|NCT00838331|322806296|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
94276684|NCT04081363|322806297|FG000|Overall Study|Withdrawal by Subject|1|||
94276685|NCT04081363|322806298|FG001|Overall Study|Withdrawal by Subject|0|||
94276686|NCT00794677|322806299|FG000|First Intervention|Withdrawal by Subject|2|||
94276687|NCT00794677|322806300|FG001|First Intervention|Withdrawal by Subject|0|||
94276688|NCT04041284|322806302|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
94276689|NCT04041284|322806303|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
94276690|NCT04041284|322806302|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
94276691|NCT04041284|322806303|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
94276692|NCT04041284|322806302|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
94276693|NCT04041284|322806303|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
94276694|NCT04041284|322806302|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
94276695|NCT04041284|322806303|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
94276696|NCT04041284|322806302|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
94276697|NCT04041284|322806303|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
94276698|NCT04041284|322806302|FG000|DB Phase (12 Weeks)|Other than specified|1|||
94276699|NCT04041284|322806303|FG001|DB Phase (12 Weeks)|Other than specified|0|||
94276700|NCT04041284|322806302|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
94276701|NCT04041284|322806303|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
94369486|NCT03125629|323139195|FG000|Overall Study|Withdrawal by Subject|2|||
94741622|NCT02048813|324510647|FG000|Overall Study|Death|2|||
94741623|NCT02048813|324510648|FG001|Overall Study|Death|1|||
94741624|NCT02048813|324510647|FG000|Overall Study|Complication|2|||
94741625|NCT02048813|324510648|FG001|Overall Study|Complication|2|||
94741626|NCT02048813|324510647|FG000|Overall Study|Non-protocol therapy|0|||
94741627|NCT02048813|324510648|FG001|Overall Study|Non-protocol therapy|1|||
94741628|NCT02048813|324510647|FG000|Overall Study|Second primary cancer|2|||
94741629|NCT02048813|324510648|FG001|Overall Study|Second primary cancer|0|||
94741630|NCT02048813|324510647|FG000|Overall Study|Insurance|2|||
94741631|NCT02048813|324510648|FG001|Overall Study|Insurance|0|||
94741632|NCT02048813|324510647|FG000|Overall Study|Wound infection/healing|2|||
94741633|NCT02048813|324510648|FG001|Overall Study|Wound infection/healing|0|||
94741634|NCT02048813|324510647|FG000|Overall Study|Missed appointment|3|||
94741635|NCT02048813|324510648|FG001|Overall Study|Missed appointment|0|||
94741636|NCT02048813|324510647|FG000|Overall Study|Never started treatment|2|||
94741637|NCT02048813|324510648|FG001|Overall Study|Never started treatment|17|||
94741638|NCT00972478|324510649|FG000|Overall Study|Adverse Event|3|||
94741639|NCT00972478|324510650|FG001|Overall Study|Adverse Event|16|||
94741640|NCT00972478|324510649|FG000|Overall Study|Withdrawal by Subject|1|||
94741641|NCT00972478|324510650|FG001|Overall Study|Withdrawal by Subject|8|||
94741642|NCT00972478|324510649|FG000|Overall Study|Progression/Relapse|0|||
94741643|NCT00972478|324510650|FG001|Overall Study|Progression/Relapse|2|||
94741644|NCT00972478|324510649|FG000|Overall Study|Death|0|||
94741645|NCT00972478|324510650|FG001|Overall Study|Death|2|||
94741646|NCT00972478|324510649|FG000|Overall Study|Not protocol specified|1|||
94741647|NCT00972478|324510650|FG001|Overall Study|Not protocol specified|1|||
94741648|NCT00972478|324510649|FG000|Overall Study|Ineligible|1|||
94741649|NCT00972478|324510650|FG001|Overall Study|Ineligible|7|||
94741650|NCT00972478|324510649|FG000|Overall Study|Not start protocol treatment|1|||
94741651|NCT00972478|324510650|FG001|Overall Study|Not start protocol treatment|2|||
94741652|NCT01013649|324510653|FG000|First Step|Withdrawal by Subject|36|||
94741653|NCT01013649|324510654|FG001|First Step|Withdrawal by Subject|19|||
94741654|NCT01013649|324510655|FG002|First Step|Withdrawal by Subject|0|||
94741655|NCT01013649|324510656|FG003|First Step|Withdrawal by Subject|0|||
94741656|NCT01013649|324510653|FG000|First Step|Progression|58|||
94741657|NCT01013649|324510654|FG001|First Step|Progression|23|||
94741658|NCT01013649|324510655|FG002|First Step|Progression|0|||
94741659|NCT01013649|324510656|FG003|First Step|Progression|0|||
94741660|NCT01013649|324510653|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
94741661|NCT01013649|324510654|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
94741662|NCT01013649|324510655|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
94741663|NCT01013649|324510656|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
94741664|NCT01013649|324510653|FG000|First Step|Death|3|||
94741665|NCT01013649|324510654|FG001|First Step|Death|4|||
94741666|NCT01013649|324510655|FG002|First Step|Death|0|||
94741667|NCT01013649|324510656|FG003|First Step|Death|0|||
94741668|NCT01013649|324510653|FG000|First Step|Adverse Event|9|||
94741669|NCT01013649|324510654|FG001|First Step|Adverse Event|5|||
94741670|NCT01013649|324510655|FG002|First Step|Adverse Event|0|||
94741671|NCT01013649|324510656|FG003|First Step|Adverse Event|0|||
94741672|NCT01013649|324510653|FG000|First Step|Other|4|||
94741673|NCT01013649|324510654|FG001|First Step|Other|6|||
94741674|NCT01013649|324510655|FG002|First Step|Other|0|||
94741675|NCT01013649|324510656|FG003|First Step|Other|0|||
94741676|NCT04174170|324510657|FG000|Placebo Run-in Period|Not Randomized|38|||
94741677|NCT04174170|324510658|FG001|Placebo Run-in Period|Not Randomized|0|||
94741678|NCT04174170|324510659|FG002|Placebo Run-in Period|Not Randomized|0|||
94741679|NCT04174170|324510660|FG003|Placebo Run-in Period|Not Randomized|0|||
94741680|NCT04174170|324510657|FG000|Double Blind Treatment Period|Adverse Event|0|||
94741681|NCT04174170|324510658|FG001|Double Blind Treatment Period|Adverse Event|9|||
94741682|NCT04174170|324510659|FG002|Double Blind Treatment Period|Adverse Event|9|||
94741683|NCT04174170|324510660|FG003|Double Blind Treatment Period|Adverse Event|8|||
94369487|NCT03125629|323139195|FG000|Overall Study|Equipment malfunction|1|||
94741684|NCT04174170|324510657|FG000|Double Blind Treatment Period|Death|0|||
94369488|NCT00743119|323139196|FG000|Overall Study|unreliable|3|||
94741685|NCT04174170|324510658|FG001|Double Blind Treatment Period|Death|1|||
94741686|NCT04174170|324510659|FG002|Double Blind Treatment Period|Death|0|||
94741687|NCT04174170|324510660|FG003|Double Blind Treatment Period|Death|0|||
94741688|NCT04174170|324510657|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
94741689|NCT04174170|324510658|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
94741690|NCT04174170|324510659|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
94741691|NCT04174170|324510660|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
94741692|NCT04174170|324510657|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
94741693|NCT04174170|324510658|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
94741694|NCT04174170|324510659|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
94369489|NCT00743119|323139196|FG000|Overall Study|Withdrawal by Subject|1|||
94741695|NCT04174170|324510660|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
94276702|NCT04041284|322806302|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
94276703|NCT04041284|322806303|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
94276704|NCT04041284|322806302|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
94276705|NCT04041284|322806303|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
94276706|NCT04041284|322806302|FG000|OL Phase (12 Weeks)|Other than specified|6|||
94276707|NCT04041284|322806303|FG001|OL Phase (12 Weeks)|Other than specified|2|||
94276708|NCT01152021|322806304|FG000|Overall Study|Adverse Event|4|||
94276709|NCT01152021|322806305|FG001|Overall Study|Adverse Event|4|||
94276710|NCT01152021|322806304|FG000|Overall Study|Study drug had expired|1|||
94276711|NCT01152021|322806305|FG001|Overall Study|Study drug had expired|0|||
94276712|NCT01152021|322806304|FG000|Overall Study|Physician Decision|1|||
94276713|NCT01152021|322806305|FG001|Overall Study|Physician Decision|1|||
94276714|NCT01152021|322806304|FG000|Overall Study|No access to study drug in Pharmacy|0|||
94276715|NCT01152021|322806305|FG001|Overall Study|No access to study drug in Pharmacy|1|||
94276716|NCT04839380|322806306|FG000|Overall Study|Withdrawal by Subject|2|||
94276717|NCT04839380|322806306|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
94276718|NCT00886600|322806307|FG000|Double-blind Monotherapy|Adverse Event|1|||
94276719|NCT00886600|322806308|FG001|Double-blind Monotherapy|Adverse Event|1|||
94276720|NCT00886600|322806309|FG002|Double-blind Monotherapy|Adverse Event|1|||
94276721|NCT00886600|322806310|FG003|Double-blind Monotherapy|Adverse Event|1|||
94276722|NCT00886600|322806307|FG000|Double-blind Monotherapy|Protocol Violation|0|||
94276723|NCT00886600|322806308|FG001|Double-blind Monotherapy|Protocol Violation|0|||
94276724|NCT00886600|322806309|FG002|Double-blind Monotherapy|Protocol Violation|0|||
94276725|NCT00886600|322806310|FG003|Double-blind Monotherapy|Protocol Violation|1|||
94276726|NCT00886600|322806307|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
94276727|NCT00886600|322806308|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
94276728|NCT00886600|322806309|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
94276729|NCT00886600|322806310|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
94276730|NCT00886600|322806307|FG000|Combination Therapy Period|Adverse Event|0|||
94276731|NCT00886600|322806308|FG001|Combination Therapy Period|Adverse Event|0|||
94276732|NCT00886600|322806309|FG002|Combination Therapy Period|Adverse Event|1|||
94276733|NCT00886600|322806310|FG003|Combination Therapy Period|Adverse Event|0|||
94276734|NCT00886600|322806307|FG000|Combination Therapy Period|Protocol Violation|0|||
94276735|NCT00886600|322806308|FG001|Combination Therapy Period|Protocol Violation|0|||
94276736|NCT00886600|322806309|FG002|Combination Therapy Period|Protocol Violation|1|||
94276737|NCT00886600|322806310|FG003|Combination Therapy Period|Protocol Violation|0|||
94276738|NCT02424253|322806313|FG000|Overall Study|Other, unspecified|1|||
94276739|NCT02424253|322806314|FG001|Overall Study|Other, unspecified|0|||
94276740|NCT02424253|322806313|FG000|Overall Study|Compliance problems|1|||
94276741|NCT02424253|322806314|FG001|Overall Study|Compliance problems|0|||
94276742|NCT02424253|322806313|FG000|Overall Study|Physician Decision|2|||
94276743|NCT02424253|322806314|FG001|Overall Study|Physician Decision|0|||
94276744|NCT02424253|322806313|FG000|Overall Study|Lack of Efficacy|0|||
94276745|NCT02424253|322806314|FG001|Overall Study|Lack of Efficacy|7|||
94276746|NCT02424253|322806313|FG000|Overall Study|Adverse Event|2|||
94276747|NCT02424253|322806314|FG001|Overall Study|Adverse Event|0|||
94369490|NCT01374906|323139198|FG000|Overall Study|Abnormal laboratory value(s)|0|||
94369491|NCT01374906|323139199|FG001|Overall Study|Abnormal laboratory value(s)|3|||
94369492|NCT01374906|323139198|FG000|Overall Study|Administrative problems|2|||
94369493|NCT01374906|323139199|FG001|Overall Study|Administrative problems|2|||
94369494|NCT01374906|323139198|FG000|Overall Study|Adverse Event|10|||
94369495|NCT01374906|323139199|FG001|Overall Study|Adverse Event|11|||
94369496|NCT01374906|323139198|FG000|Overall Study|Death|0|||
94369497|NCT01374906|323139199|FG001|Overall Study|Death|2|||
94369498|NCT01374906|323139198|FG000|Overall Study|Protocol Violation|2|||
94369499|NCT01374906|323139199|FG001|Overall Study|Protocol Violation|2|||
94369500|NCT01374906|323139198|FG000|Overall Study|Withdrawal by Subject|15|||
94369501|NCT01374906|323139199|FG001|Overall Study|Withdrawal by Subject|9|||
94369502|NCT01374906|323139198|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
94369503|NCT01374906|323139199|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
94369504|NCT01309828|323139200|FG000|Overall Study|Adverse Event|10|||
94369505|NCT01309828|323139201|FG001|Overall Study|Adverse Event|11|||
94276748|NCT02424253|322806313|FG000|Overall Study|Consent withdrawn by subject|4|||
94276749|NCT02424253|322806314|FG001|Overall Study|Consent withdrawn by subject|1|||
94276750|NCT02424253|322806313|FG000|Overall Study|Lost to Follow-up|1|||
94276751|NCT02424253|322806314|FG001|Overall Study|Lost to Follow-up|1|||
94276752|NCT02370615|322806317|FG000|Overall Study|Adverse Event|1|||
94276753|NCT02370615|322806318|FG001|Overall Study|Adverse Event|0|||
94276754|NCT00205855|322806330|FG000|Overall Study|Only received temporary implants|16|||
94276755|NCT00205855|322806330|FG000|Overall Study|Withdrawal by Subject|5|||
94276756|NCT01445951|322806332|FG000|Overall Study|Adverse Event|16|||
94276757|NCT01445951|322806333|FG001|Overall Study|Adverse Event|9|||
94276758|NCT01445951|322806334|FG002|Overall Study|Adverse Event|0|||
94276759|NCT01445951|322806332|FG000|Overall Study|Protocol Violation|2|||
94276760|NCT01445951|322806333|FG001|Overall Study|Protocol Violation|2|||
94276761|NCT01445951|322806334|FG002|Overall Study|Protocol Violation|2|||
94369506|NCT01309828|323139200|FG000|Overall Study|Voluntary Withdrawal|5|||
94369507|NCT01309828|323139201|FG001|Overall Study|Voluntary Withdrawal|4|||
94369508|NCT01309828|323139200|FG000|Overall Study|Major Protocol Deviation|0|||
94369509|NCT01309828|323139201|FG001|Overall Study|Major Protocol Deviation|1|||
94369510|NCT01309828|323139200|FG000|Overall Study|Other|1|||
94369511|NCT01309828|323139201|FG001|Overall Study|Other|0|||
94369512|NCT00217971|323139202|FG000|Overall Study|Adverse Event|1|||
94369513|NCT00217971|323139203|FG001|Overall Study|Adverse Event|1|||
94369514|NCT00217971|323139202|FG000|Overall Study|Lost to Follow-up|15|||
94276762|NCT01445951|322806332|FG000|Overall Study|Withdrawal by Subject|21|||
94276763|NCT01445951|322806333|FG001|Overall Study|Withdrawal by Subject|16|||
94276764|NCT01445951|322806334|FG002|Overall Study|Withdrawal by Subject|8|||
94276765|NCT01445951|322806332|FG000|Overall Study|Physician Decision|3|||
94276766|NCT01445951|322806333|FG001|Overall Study|Physician Decision|1|||
94276767|NCT01445951|322806334|FG002|Overall Study|Physician Decision|0|||
94276768|NCT01445951|322806332|FG000|Overall Study|Lost to Follow-up|1|||
94276769|NCT01445951|322806333|FG001|Overall Study|Lost to Follow-up|2|||
94276770|NCT01445951|322806334|FG002|Overall Study|Lost to Follow-up|4|||
94276771|NCT01445951|322806332|FG000|Overall Study|Pregnancy|0|||
94369515|NCT00217971|323139203|FG001|Overall Study|Lost to Follow-up|19|||
94369516|NCT00217971|323139202|FG000|Overall Study|Physician Decision|0|||
94369517|NCT00217971|323139203|FG001|Overall Study|Physician Decision|1|||
94369518|NCT00217971|323139202|FG000|Overall Study|Withdrawal by Subject|7|||
94369519|NCT00217971|323139203|FG001|Overall Study|Withdrawal by Subject|12|||
94369520|NCT00217971|323139202|FG000|Overall Study|non compliant|1|||
94369521|NCT00217971|323139203|FG001|Overall Study|non compliant|0|||
94369522|NCT02574260|323139206|FG000|Overall Study|Disease Progression|1|||
94369523|NCT00084617|323139207|FG000|Overall Study|Withdrawal by Subject|7|||
94369524|NCT00084617|323139207|FG000|Overall Study|Lack of Efficacy|1|||
94369525|NCT00084617|323139207|FG000|Overall Study|Protocol Violation|1|||
94369526|NCT05003167|323139208|FG000|Overall Study|Withdrawal by Subject|1|||
94369527|NCT02046369|323139211|FG000|Overall Study|Adverse Event|3|||
94369528|NCT02046369|323139212|FG001|Overall Study|Adverse Event|3|||
94369529|NCT02046369|323139211|FG000|Overall Study|Lack of Efficacy|3|||
94369530|NCT02046369|323139212|FG001|Overall Study|Lack of Efficacy|3|||
94369531|NCT02046369|323139211|FG000|Overall Study|Lost to Follow-up|3|||
94369532|NCT02046369|323139212|FG001|Overall Study|Lost to Follow-up|3|||
94369533|NCT02046369|323139211|FG000|Overall Study|Protocol Violation|1|||
94369534|NCT02046369|323139212|FG001|Overall Study|Protocol Violation|2|||
94369535|NCT02046369|323139211|FG000|Overall Study|Withdrawal by Subject|3|||
94369536|NCT02046369|323139212|FG001|Overall Study|Withdrawal by Subject|6|||
94369537|NCT02046369|323139211|FG000|Overall Study|never received study drug|0|||
94369538|NCT02046369|323139212|FG001|Overall Study|never received study drug|1|||
94369539|NCT02046369|323139211|FG000|Overall Study|non compliance|1|||
94369540|NCT02046369|323139212|FG001|Overall Study|non compliance|0|||
94369541|NCT01123980|323139213|FG000|Overall Study|Adverse Event|1|||
94369542|NCT01123980|323139214|FG001|Overall Study|Adverse Event|1|||
94369543|NCT01123980|323139213|FG000|Overall Study|Lack of Efficacy|1|||
94369544|NCT01123980|323139214|FG001|Overall Study|Lack of Efficacy|0|||
94369545|NCT01123980|323139213|FG000|Overall Study|Physician Decision|0|||
94369546|NCT01123980|323139214|FG001|Overall Study|Physician Decision|1|||
94369547|NCT01123980|323139213|FG000|Overall Study|Lost to Follow-up|0|||
94369548|NCT01123980|323139214|FG001|Overall Study|Lost to Follow-up|6|||
94369549|NCT01123980|323139213|FG000|Overall Study|Protocol Violation|6|||
94369550|NCT01123980|323139214|FG001|Overall Study|Protocol Violation|6|||
94369551|NCT01123980|323139213|FG000|Overall Study|Withdrawal by Subject|5|||
94369552|NCT01123980|323139214|FG001|Overall Study|Withdrawal by Subject|3|||
94369553|NCT01123980|323139213|FG000|Overall Study|Unclassified|6|||
94369554|NCT01123980|323139214|FG001|Overall Study|Unclassified|7|||
94369555|NCT01225991|323139215|FG000|Overall Study|Withdrawal by Subject|6|||
94369556|NCT00267020|323140900|FG000|Overall Study|Adverse Event|22|||
94369557|NCT00267020|323140901|FG001|Overall Study|Adverse Event|5|||
94369558|NCT00267020|323140900|FG000|Overall Study|Death|2|||
94369559|NCT00267020|323140901|FG001|Overall Study|Death|1|||
94369560|NCT00267020|323140900|FG000|Overall Study|Withdrawal by Subject|17|||
94369561|NCT00267020|323140901|FG001|Overall Study|Withdrawal by Subject|7|||
94369562|NCT00267020|323140900|FG000|Overall Study|Physician Decision|3|||
94369563|NCT00267020|323140901|FG001|Overall Study|Physician Decision|2|||
94369564|NCT00267020|323140900|FG000|Overall Study|Disease Progression|39|||
94369565|NCT00267020|323140901|FG001|Overall Study|Disease Progression|25|||
94369566|NCT00267020|323140900|FG000|Overall Study|Unrelated Complication|1|||
94369567|NCT00267020|323140901|FG001|Overall Study|Unrelated Complication|1|||
94369568|NCT00267020|323140900|FG000|Overall Study|Sponsor Request|1|||
94369569|NCT00267020|323140901|FG001|Overall Study|Sponsor Request|0|||
94369570|NCT00267020|323140900|FG000|Overall Study|Other|1|||
94369571|NCT00267020|323140901|FG001|Overall Study|Other|2|||
94369572|NCT02239692|323140902|FG000|Overall Study|Incomplete colonoscopy|1|||
94369573|NCT02239692|323140903|FG001|Overall Study|Incomplete colonoscopy|2|||
94369574|NCT02239692|323140902|FG000|Overall Study|Adverse Event|0|||
94369575|NCT02239692|323140903|FG001|Overall Study|Adverse Event|1|||
94369576|NCT02239692|323140902|FG000|Overall Study|Physician Decision|0|||
94369577|NCT02239692|323140903|FG001|Overall Study|Physician Decision|1|||
94369578|NCT02239692|323140902|FG000|Overall Study|Lost to Follow-up|1|||
94369579|NCT02239692|323140903|FG001|Overall Study|Lost to Follow-up|4|||
94369580|NCT02239692|323140902|FG000|Overall Study|Withdrawal by Subject|3|||
94369581|NCT02239692|323140903|FG001|Overall Study|Withdrawal by Subject|5|||
94369582|NCT02239692|323140902|FG000|Overall Study|Other reason|1|||
94369583|NCT02239692|323140903|FG001|Overall Study|Other reason|0|||
94369584|NCT00640614|323140906|FG000|Overall Study|Lost to Follow-up|1|||
94369585|NCT00640614|323140907|FG001|Overall Study|Lost to Follow-up|0|||
94369586|NCT00399490|323140917|FG000|Overall Study|Adverse Event|19|||
94369587|NCT00399490|323140917|FG000|Overall Study|Lack of Efficacy|31|||
94369588|NCT00399490|323140917|FG000|Overall Study|Lost to Follow-up|5|||
94369589|NCT00399490|323140917|FG000|Overall Study|Withdrawal by Subject|18|||
94369590|NCT00399490|323140917|FG000|Overall Study|Other|25|||
94369591|NCT03053622|323140918|FG000|Overall Study|Lost to Follow-up|0|||
94369592|NCT03053622|323140919|FG001|Overall Study|Lost to Follow-up|0|||
94369593|NCT03053622|323140920|FG002|Overall Study|Lost to Follow-up|0|||
94369594|NCT03053622|323140921|FG003|Overall Study|Lost to Follow-up|1|||
94369595|NCT04575038|323140925|FG000|Overall Study|Withdrawal by Subject|1|||
94276772|NCT01445951|322806333|FG001|Overall Study|Pregnancy|1|||
94276773|NCT01445951|322806334|FG002|Overall Study|Pregnancy|4|||
94276774|NCT01445951|322806332|FG000|Overall Study|Death|0|||
94276775|NCT01445951|322806333|FG001|Overall Study|Death|0|||
94276776|NCT01445951|322806334|FG002|Overall Study|Death|1|||
94276777|NCT01445951|322806332|FG000|Overall Study|Non-compliance with study drug|1|||
94276778|NCT01445951|322806333|FG001|Overall Study|Non-compliance with study drug|2|||
94276779|NCT01445951|322806334|FG002|Overall Study|Non-compliance with study drug|0|||
94276780|NCT01445951|322806332|FG000|Overall Study|Non-compliance with protocol|0|||
94276781|NCT01445951|322806333|FG001|Overall Study|Non-compliance with protocol|1|||
94276782|NCT01445951|322806334|FG002|Overall Study|Non-compliance with protocol|0|||
94276783|NCT01445951|322806332|FG000|Overall Study|Sponsor decision - subject travel|0|||
94276784|NCT01445951|322806333|FG001|Overall Study|Sponsor decision - subject travel|1|||
94276785|NCT01445951|322806334|FG002|Overall Study|Sponsor decision - subject travel|0|||
94276786|NCT01445951|322806332|FG000|Overall Study|Cough|0|||
94276787|NCT01445951|322806333|FG001|Overall Study|Cough|1|||
94276788|NCT01445951|322806334|FG002|Overall Study|Cough|0|||
94276789|NCT00917150|322806335|FG000|Overall Study|Adverse Event|12|||
94276790|NCT00917150|322806336|FG001|Overall Study|Adverse Event|7|||
94276791|NCT00917150|322806337|FG002|Overall Study|Adverse Event|12|||
94276792|NCT00917150|322806338|FG003|Overall Study|Adverse Event|11|||
94276793|NCT00917150|322806335|FG000|Overall Study|Death|1|||
94276794|NCT00917150|322806336|FG001|Overall Study|Death|4|||
94276795|NCT00917150|322806337|FG002|Overall Study|Death|3|||
94276796|NCT00917150|322806338|FG003|Overall Study|Death|2|||
94276797|NCT00917150|322806335|FG000|Overall Study|Lost to Follow-up|1|||
94276798|NCT00917150|322806336|FG001|Overall Study|Lost to Follow-up|0|||
94276799|NCT00917150|322806337|FG002|Overall Study|Lost to Follow-up|4|||
94276800|NCT00917150|322806338|FG003|Overall Study|Lost to Follow-up|2|||
94276801|NCT00917150|322806335|FG000|Overall Study|Physician Decision|0|||
94276802|NCT00917150|322806336|FG001|Overall Study|Physician Decision|2|||
94276803|NCT00917150|322806337|FG002|Overall Study|Physician Decision|0|||
94276804|NCT00917150|322806338|FG003|Overall Study|Physician Decision|1|||
94276805|NCT00917150|322806335|FG000|Overall Study|Protocol Violation|5|||
94276806|NCT00917150|322806336|FG001|Overall Study|Protocol Violation|5|||
94276807|NCT00917150|322806337|FG002|Overall Study|Protocol Violation|3|||
94276808|NCT00917150|322806338|FG003|Overall Study|Protocol Violation|5|||
94276809|NCT00917150|322806335|FG000|Overall Study|Withdrawal by Subject|15|||
94276810|NCT00917150|322806336|FG001|Overall Study|Withdrawal by Subject|16|||
94276811|NCT00917150|322806337|FG002|Overall Study|Withdrawal by Subject|18|||
94276812|NCT00917150|322806338|FG003|Overall Study|Withdrawal by Subject|11|||
94276813|NCT00917150|322806335|FG000|Overall Study|Other than specified|3|||
94369596|NCT04575038|323140926|FG001|Overall Study|Withdrawal by Subject|1|||
94369597|NCT01726335|323140931|FG000|Overall Study|Lost to Follow-up|2|||
94369598|NCT01726335|323140931|FG000|Overall Study|Withdrawal by Subject|15|||
94369599|NCT01726335|323140931|FG000|Overall Study|Adverse Event|4|||
94369600|NCT01726335|323140931|FG000|Overall Study|Lost to Follow-up|2|||
94369601|NCT01726335|323140931|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
94741696|NCT04174170|324510657|FG000|Double Blind Treatment Period|Physician Decision|0|||
94741697|NCT04174170|324510658|FG001|Double Blind Treatment Period|Physician Decision|1|||
94741698|NCT04174170|324510659|FG002|Double Blind Treatment Period|Physician Decision|0|||
94741699|NCT04174170|324510660|FG003|Double Blind Treatment Period|Physician Decision|1|||
94741700|NCT04174170|324510657|FG000|Double Blind Treatment Period|Pregnancy|0|||
94741701|NCT04174170|324510658|FG001|Double Blind Treatment Period|Pregnancy|1|||
94741702|NCT04174170|324510659|FG002|Double Blind Treatment Period|Pregnancy|0|||
94741703|NCT04174170|324510660|FG003|Double Blind Treatment Period|Pregnancy|1|||
94741704|NCT04174170|324510657|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
94741705|NCT04174170|324510658|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
94741706|NCT04174170|324510659|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
94741707|NCT04174170|324510660|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
94369602|NCT01586624|323140932|FG000|Overall Study|Adverse Event|3|||
94369603|NCT01586624|323140933|FG001|Overall Study|Adverse Event|0|||
94467535|NCT00908596|323502332|FG003|Overall Study|Death|32|||
94276814|NCT00917150|322806336|FG001|Overall Study|Other than specified|3|||
94276815|NCT00917150|322806337|FG002|Overall Study|Other than specified|2|||
94276816|NCT00917150|322806338|FG003|Overall Study|Other than specified|2|||
94276817|NCT03891264|322806339|FG000|Overall Study|Adverse Event|1|||
94276818|NCT03891264|322806339|FG000|Overall Study|Withdrawal by Subject|2|||
94276819|NCT03891264|322806339|FG000|Overall Study|Physician Decision|2|||
94276820|NCT02054897|322806341|FG000|Overall Study|Withdrawal by Subject|2|||
94276821|NCT02054897|322806342|FG001|Overall Study|Withdrawal by Subject|0|||
94276822|NCT02054897|322806343|FG002|Overall Study|Withdrawal by Subject|2|||
94276823|NCT02054897|322806341|FG000|Overall Study|Missing follow-up information|3|||
94276824|NCT02054897|322806342|FG001|Overall Study|Missing follow-up information|5|||
94369604|NCT01586624|323140934|FG002|Overall Study|Adverse Event|2|||
94369605|NCT01586624|323140935|FG003|Overall Study|Adverse Event|1|||
94467536|NCT00908596|323502329|FG000|Overall Study|Protocol Violation|1|||
94276825|NCT02054897|322806343|FG002|Overall Study|Missing follow-up information|3|||
94276826|NCT02054897|322806341|FG000|Overall Study|Lost to Follow-up|4|||
94276827|NCT02054897|322806342|FG001|Overall Study|Lost to Follow-up|2|||
94276828|NCT02054897|322806343|FG002|Overall Study|Lost to Follow-up|7|||
94276829|NCT02054897|322806341|FG000|Overall Study|Randomized but not exposed|1|||
94276830|NCT02054897|322806342|FG001|Overall Study|Randomized but not exposed|0|||
94276831|NCT02054897|322806343|FG002|Overall Study|Randomized but not exposed|0|||
94276832|NCT00652366|322806344|FG000|Overall Study|Adverse Event|8|||
94276833|NCT00652366|322806345|FG001|Overall Study|Adverse Event|4|||
94276834|NCT00652366|322806346|FG002|Overall Study|Adverse Event|7|||
94276835|NCT00652366|322806347|FG003|Overall Study|Adverse Event|17|||
94276836|NCT00652366|322806348|FG004|Overall Study|Adverse Event|13|||
94276837|NCT00652366|322806344|FG000|Overall Study|Death|5|||
94276838|NCT00652366|322806345|FG001|Overall Study|Death|4|||
94276839|NCT00652366|322806346|FG002|Overall Study|Death|1|||
94276840|NCT00652366|322806347|FG003|Overall Study|Death|8|||
94276841|NCT00652366|322806348|FG004|Overall Study|Death|5|||
94276842|NCT00652366|322806344|FG000|Overall Study|Lack of Efficacy|84|||
94276843|NCT00652366|322806345|FG001|Overall Study|Lack of Efficacy|58|||
94276844|NCT00652366|322806346|FG002|Overall Study|Lack of Efficacy|53|||
94276845|NCT00652366|322806347|FG003|Overall Study|Lack of Efficacy|133|||
94276846|NCT00652366|322806348|FG004|Overall Study|Lack of Efficacy|13|||
94276847|NCT00652366|322806344|FG000|Overall Study|Violation of Selection Criteria|0|||
94276848|NCT00652366|322806345|FG001|Overall Study|Violation of Selection Criteria|0|||
94276849|NCT00652366|322806346|FG002|Overall Study|Violation of Selection Criteria|1|||
94276850|NCT00652366|322806347|FG003|Overall Study|Violation of Selection Criteria|0|||
94276851|NCT00652366|322806348|FG004|Overall Study|Violation of Selection Criteria|0|||
94276852|NCT00652366|322806344|FG000|Overall Study|Protocol Violation|1|||
94276853|NCT00652366|322806345|FG001|Overall Study|Protocol Violation|0|||
94276854|NCT00652366|322806346|FG002|Overall Study|Protocol Violation|0|||
94276855|NCT00652366|322806347|FG003|Overall Study|Protocol Violation|0|||
94276856|NCT00652366|322806348|FG004|Overall Study|Protocol Violation|0|||
94276857|NCT00652366|322806344|FG000|Overall Study|Refused treatment|3|||
94276858|NCT00652366|322806345|FG001|Overall Study|Refused treatment|7|||
94276859|NCT00652366|322806346|FG002|Overall Study|Refused treatment|6|||
94276860|NCT00652366|322806347|FG003|Overall Study|Refused treatment|17|||
94276861|NCT00652366|322806348|FG004|Overall Study|Refused treatment|5|||
94276862|NCT00652366|322806344|FG000|Overall Study|Other|5|||
94276863|NCT00652366|322806345|FG001|Overall Study|Other|2|||
94276864|NCT00652366|322806346|FG002|Overall Study|Other|3|||
94276865|NCT00652366|322806347|FG003|Overall Study|Other|4|||
94276866|NCT00652366|322806348|FG004|Overall Study|Other|0|||
94276867|NCT00677014|322806354|FG000|Overall Study|Lost to Follow-up|20|||
94276868|NCT00677014|322806355|FG001|Overall Study|Lost to Follow-up|12|||
94276869|NCT00677014|322806356|FG002|Overall Study|Lost to Follow-up|24|||
94276870|NCT00677014|322806354|FG000|Overall Study|Death|6|||
94276871|NCT00677014|322806355|FG001|Overall Study|Death|15|||
94276872|NCT00677014|322806356|FG002|Overall Study|Death|7|||
94276873|NCT00677014|322806354|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
94276874|NCT00677014|322806355|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
94276875|NCT00677014|322806356|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
94276876|NCT02821715|322806357|FG000|Overall Study|Protocol Violation|1|||
94276877|NCT02821715|322806358|FG001|Overall Study|Protocol Violation|0|||
94276878|NCT02821715|322806359|FG002|Overall Study|Protocol Violation|0|||
94276879|NCT02821715|322806360|FG003|Overall Study|Protocol Violation|0|||
94276880|NCT02821715|322806361|FG004|Overall Study|Protocol Violation|0|||
94276881|NCT02821715|322806362|FG005|Overall Study|Protocol Violation|0|||
94467537|NCT00908596|323502330|FG001|Overall Study|Protocol Violation|0|||
94276882|NCT00640328|322806363|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
94276883|NCT00640328|322806364|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
94276884|NCT00640328|322806365|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
94276885|NCT00640328|322806366|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
94276886|NCT00640328|322806367|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
94276887|NCT00640328|322806368|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
94276888|NCT00640328|322806363|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
94276889|NCT00640328|322806364|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
94276890|NCT00640328|322806365|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
94276891|NCT00640328|322806366|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
94276892|NCT00640328|322806367|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
94276893|NCT00640328|322806368|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
94276894|NCT00640328|322806363|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
94276895|NCT00640328|322806364|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
94276896|NCT00640328|322806365|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
94276897|NCT00640328|322806366|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
94276898|NCT00640328|322806367|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
94276899|NCT00640328|322806368|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
94369606|NCT01586624|323140936|FG004|Overall Study|Adverse Event|3|||
94369607|NCT01586624|323140937|FG005|Overall Study|Adverse Event|3|||
94369608|NCT01586624|323140938|FG006|Overall Study|Adverse Event|2|||
94369609|NCT01586624|323140939|FG007|Overall Study|Adverse Event|3|||
94369610|NCT01586624|323140932|FG000|Overall Study|Physician Decision|0|||
94369611|NCT01586624|323140933|FG001|Overall Study|Physician Decision|1|||
94369612|NCT01586624|323140934|FG002|Overall Study|Physician Decision|1|||
94369613|NCT01586624|323140935|FG003|Overall Study|Physician Decision|0|||
94369614|NCT01586624|323140936|FG004|Overall Study|Physician Decision|2|||
94369615|NCT01586624|323140937|FG005|Overall Study|Physician Decision|0|||
94369616|NCT01586624|323140938|FG006|Overall Study|Physician Decision|1|||
94369617|NCT01586624|323140939|FG007|Overall Study|Physician Decision|1|||
94369618|NCT01586624|323140932|FG000|Overall Study|Withdrawal by Subject|0|||
94369619|NCT01586624|323140933|FG001|Overall Study|Withdrawal by Subject|0|||
94369620|NCT01586624|323140934|FG002|Overall Study|Withdrawal by Subject|0|||
94369621|NCT01586624|323140935|FG003|Overall Study|Withdrawal by Subject|1|||
94369622|NCT01586624|323140936|FG004|Overall Study|Withdrawal by Subject|0|||
94369623|NCT01586624|323140937|FG005|Overall Study|Withdrawal by Subject|0|||
94369624|NCT01586624|323140938|FG006|Overall Study|Withdrawal by Subject|0|||
94369625|NCT01586624|323140939|FG007|Overall Study|Withdrawal by Subject|0|||
94369626|NCT01586624|323140932|FG000|Overall Study|Evidence of disease progression|1|||
94369627|NCT01586624|323140933|FG001|Overall Study|Evidence of disease progression|3|||
94369628|NCT01586624|323140934|FG002|Overall Study|Evidence of disease progression|2|||
94369629|NCT01586624|323140935|FG003|Overall Study|Evidence of disease progression|5|||
94369630|NCT01586624|323140936|FG004|Overall Study|Evidence of disease progression|3|||
94369631|NCT01586624|323140937|FG005|Overall Study|Evidence of disease progression|5|||
94369632|NCT01586624|323140938|FG006|Overall Study|Evidence of disease progression|4|||
94369633|NCT01586624|323140939|FG007|Overall Study|Evidence of disease progression|6|||
94369634|NCT01586624|323140932|FG000|Overall Study|Screen failure (no treatment received)|0|||
94369635|NCT01586624|323140933|FG001|Overall Study|Screen failure (no treatment received)|0|||
94369636|NCT01586624|323140934|FG002|Overall Study|Screen failure (no treatment received)|0|||
94369637|NCT01586624|323140935|FG003|Overall Study|Screen failure (no treatment received)|0|||
94369638|NCT01586624|323140936|FG004|Overall Study|Screen failure (no treatment received)|0|||
94369639|NCT01586624|323140937|FG005|Overall Study|Screen failure (no treatment received)|0|||
94369640|NCT01586624|323140938|FG006|Overall Study|Screen failure (no treatment received)|1|||
94369641|NCT01586624|323140939|FG007|Overall Study|Screen failure (no treatment received)|0|||
94369642|NCT02496221|323140941|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
94369643|NCT02496221|323140942|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
94741708|NCT04174170|324510657|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
94741709|NCT04174170|324510658|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
94741710|NCT04174170|324510659|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
94741711|NCT04174170|324510660|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
94741712|NCT04174170|324510657|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
94741713|NCT04174170|324510658|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
94741714|NCT04174170|324510659|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
94741715|NCT04174170|324510660|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
94741716|NCT01784068|324510661|FG000|NTCS Phase|Adverse Event|5|||
94741717|NCT01784068|324510662|FG001|NTCS Phase|Adverse Event|0|||
94741718|NCT01784068|324510661|FG000|NTCS Phase|Physician Decision|2|||
94741719|NCT01784068|324510662|FG001|NTCS Phase|Physician Decision|0|||
94741720|NCT01784068|324510661|FG000|NTCS Phase|Patient/guardian decision|3|||
94741721|NCT01784068|324510662|FG001|NTCS Phase|Patient/guardian decision|0|||
94741722|NCT01784068|324510661|FG000|NTCS Phase|Death|2|||
94741723|NCT01784068|324510662|FG001|NTCS Phase|Death|0|||
94741724|NCT01784068|324510661|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
94741725|NCT01784068|324510662|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
94741726|NCT01784068|324510661|FG000|TFR Phase|Physician Decision|0|||
94741727|NCT01784068|324510662|FG001|TFR Phase|Physician Decision|1|||
94741728|NCT01784068|324510661|FG000|TFR Phase|Patient/guardian decision|0|||
94741729|NCT01784068|324510662|FG001|TFR Phase|Patient/guardian decision|3|||
94741730|NCT01784068|324510661|FG000|TFR Phase|Death|0|||
94741731|NCT01784068|324510662|FG001|TFR Phase|Death|1|||
94741732|NCT01784068|324510661|FG000|TFR Phase|Lack of Efficacy|0|||
94741733|NCT01784068|324510662|FG001|TFR Phase|Lack of Efficacy|88|||
94741734|NCT04180696|324510665|FG000|Overall Study|Death|5|||
94369644|NCT02496221|323140941|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
94369645|NCT02496221|323140942|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
94369646|NCT02496221|323140941|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
94369647|NCT02496221|323140942|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
94369648|NCT01335399|323140943|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
94369649|NCT01335399|323140944|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
94369650|NCT01335399|323140943|FG000|Pre-treatment Period|Participant request to discontinue|0|||
94369651|NCT01335399|323140944|FG001|Pre-treatment Period|Participant request to discontinue|1|||
94369652|NCT01335399|323140943|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
94369653|NCT01335399|323140944|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
94369654|NCT01335399|323140943|FG000|Pre-treatment Period|Consent withdrawal|3|||
94369655|NCT01335399|323140944|FG001|Pre-treatment Period|Consent withdrawal|0|||
94369656|NCT01335399|323140943|FG000|Treatment Period|Disease progression|117|||
94369657|NCT01335399|323140944|FG001|Treatment Period|Disease progression|145|||
94369658|NCT01335399|323140943|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
94369659|NCT01335399|323140944|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
94369660|NCT01335399|323140943|FG000|Treatment Period|Study drug toxicity|52|||
94369661|NCT01335399|323140944|FG001|Treatment Period|Study drug toxicity|64|||
94276900|NCT00640328|322806363|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
94276901|NCT00640328|322806364|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
94276902|NCT00640328|322806365|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
94276903|NCT00640328|322806366|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
94276904|NCT00640328|322806367|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
94276905|NCT00640328|322806368|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
94276906|NCT03152019|322806369|FG000|Overall Study|Adverse Event|0|||
94276907|NCT03152019|322806370|FG001|Overall Study|Adverse Event|1|||
94276908|NCT04294719|322806371|FG000|Overall Study|Withdrawal by Subject|1|||
94276909|NCT00254501|322806374|FG000|Overall Study|Lost to Follow-up|1|||
94276910|NCT00254501|322806375|FG001|Overall Study|Lost to Follow-up|1|||
94276911|NCT03861559|322806376|FG000|Overall Study|Adverse Event|0|||
94276912|NCT03861559|322806377|FG001|Overall Study|Adverse Event|2|||
94276913|NCT03861559|322806376|FG000|Overall Study|Treatment failure|0|||
94276914|NCT03861559|322806377|FG001|Overall Study|Treatment failure|2|||
94276915|NCT03861559|322806376|FG000|Overall Study|Noncompliance|1|||
94276916|NCT03861559|322806377|FG001|Overall Study|Noncompliance|1|||
94276917|NCT03861559|322806376|FG000|Overall Study|Did not meet eligibility requirements|1|||
94276918|NCT03861559|322806377|FG001|Overall Study|Did not meet eligibility requirements|0|||
94276919|NCT02500121|322806383|FG000|Overall Study|Lost to Follow-up|0|||
94276920|NCT02500121|322806384|FG001|Overall Study|Lost to Follow-up|1|||
94276921|NCT02500121|322806383|FG000|Overall Study|Withdrawal by Subject|1|||
94276922|NCT02500121|322806384|FG001|Overall Study|Withdrawal by Subject|1|||
94276923|NCT02500121|322806383|FG000|Overall Study|Death|26|||
94276924|NCT02500121|322806384|FG001|Overall Study|Death|24|||
94276925|NCT02678390|322806385|FG000|AE (1 Day)|Withdrawal by Subject|0|||
94276926|NCT02678390|322806386|FG001|AE (1 Day)|Withdrawal by Subject|1|||
94276927|NCT01273883|322806388|FG000|First Intervention|Adverse Event|2|||
94276928|NCT01273883|322806389|FG001|First Intervention|Adverse Event|1|||
94276929|NCT01273883|322806388|FG000|Second Intervention|Lost to Follow-up|1|||
94276930|NCT01273883|322806389|FG001|Second Intervention|Lost to Follow-up|1|||
94369662|NCT01335399|323140943|FG000|Treatment Period|Participant request to discontinue|30|||
94369663|NCT01335399|323140944|FG001|Treatment Period|Participant request to discontinue|22|||
94276931|NCT01273883|322806388|FG000|Second Intervention|Lack of Efficacy|1|||
94276932|NCT01273883|322806389|FG001|Second Intervention|Lack of Efficacy|0|||
94276933|NCT00371865|322806390|FG000|Overall Study|Lack of Efficacy|0|||
94276934|NCT00371865|322806391|FG001|Overall Study|Lack of Efficacy|2|||
94276935|NCT00371865|322806390|FG000|Overall Study|Protocol Violation|3|||
94276936|NCT00371865|322806391|FG001|Overall Study|Protocol Violation|2|||
94276937|NCT00371865|322806390|FG000|Overall Study|Withdrawal by Subject|12|||
94276938|NCT00371865|322806391|FG001|Overall Study|Withdrawal by Subject|10|||
94276939|NCT04518462|322806394|FG000|Overall Study|Withdrawal by Subject|0|||
94276940|NCT04518462|322806395|FG001|Overall Study|Withdrawal by Subject|0|||
94276941|NCT04518462|322806396|FG002|Overall Study|Withdrawal by Subject|1|||
94276942|NCT04518462|322806394|FG000|Overall Study|Physician Decision|1|||
94276943|NCT04518462|322806395|FG001|Overall Study|Physician Decision|1|||
94276944|NCT04518462|322806396|FG002|Overall Study|Physician Decision|0|||
94276945|NCT04153188|322806399|FG000|Overall Study|Lost to Follow-up|1|||
94276946|NCT04153188|322806400|FG001|Overall Study|Lost to Follow-up|1|||
94276947|NCT04153188|322806399|FG000|Overall Study|Withdrawal by Subject|2|||
94276948|NCT04153188|322806400|FG001|Overall Study|Withdrawal by Subject|0|||
94276949|NCT04153188|322806399|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
94276950|NCT04153188|322806400|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
94276951|NCT01806779|322806402|FG000|Overall Study|Physician Decision|2|||
94276952|NCT01806779|322806403|FG001|Overall Study|Physician Decision|0|||
94276953|NCT01806779|322806404|FG002|Overall Study|Physician Decision|1|||
94276954|NCT01806779|322806402|FG000|Overall Study|Lack of Efficacy|1|||
94276955|NCT01806779|322806403|FG001|Overall Study|Lack of Efficacy|1|||
94276956|NCT01806779|322806404|FG002|Overall Study|Lack of Efficacy|0|||
94276957|NCT01806779|322806402|FG000|Overall Study|Lost to Follow-up|19|||
94276958|NCT01806779|322806403|FG001|Overall Study|Lost to Follow-up|20|||
94276959|NCT01806779|322806404|FG002|Overall Study|Lost to Follow-up|0|||
94276960|NCT01806779|322806402|FG000|Overall Study|Withdrawal by Subject|20|||
94276961|NCT01806779|322806403|FG001|Overall Study|Withdrawal by Subject|23|||
94276962|NCT01806779|322806404|FG002|Overall Study|Withdrawal by Subject|22|||
94276963|NCT02595450|322806407|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
94276964|NCT02595450|322806407|FG000|Overall Study|Enrolled, but not treated|8|||
94276965|NCT01934556|322806408|FG000|Overall Study|Withdrawal by Subject|0|||
94276966|NCT01934556|322806409|FG001|Overall Study|Withdrawal by Subject|1|||
94276967|NCT01934556|322806410|FG002|Overall Study|Withdrawal by Subject|1|||
94276968|NCT01934556|322806408|FG000|Overall Study|Lost to Follow-up|4|||
94276969|NCT01934556|322806409|FG001|Overall Study|Lost to Follow-up|10|||
94276970|NCT01934556|322806410|FG002|Overall Study|Lost to Follow-up|7|||
94276971|NCT01934556|322806408|FG000|Overall Study|Death|1|||
94276972|NCT01934556|322806409|FG001|Overall Study|Death|5|||
94276973|NCT01934556|322806410|FG002|Overall Study|Death|2|||
94276974|NCT02356562|322808045|FG000|Overall Study|Withdrawal by Subject|0|||
94276975|NCT02356562|322808046|FG001|Overall Study|Withdrawal by Subject|1|||
94276976|NCT02356562|322808045|FG000|Overall Study|Re-entered treatment in a previous study|1|||
94276977|NCT02356562|322808046|FG001|Overall Study|Re-entered treatment in a previous study|0|||
94276978|NCT02356562|322808045|FG000|Overall Study|site closure|1|||
94741735|NCT04180696|324510666|FG001|Overall Study|Death|6|||
94741736|NCT04180696|324510665|FG000|Overall Study|Lost to Follow-up|1|||
94741737|NCT04180696|324510666|FG001|Overall Study|Lost to Follow-up|0|||
94741738|NCT04180696|324510665|FG000|Overall Study|Withdrawal by Subject|0|||
94741739|NCT04180696|324510666|FG001|Overall Study|Withdrawal by Subject|1|||
94741740|NCT04046549|324510672|FG000|Overall Study|Adverse Event|1|||
94741741|NCT04046549|324510672|FG000|Overall Study|Physician Decision|1|||
94741742|NCT04046549|324510672|FG000|Overall Study|Withdrawal by Subject|3|||
94741743|NCT04046549|324510672|FG000|Overall Study|Other, Not Specified|5|||
94276979|NCT02356562|322808046|FG001|Overall Study|site closure|0|||
94276980|NCT03311711|322808047|FG000|Overall Study|Death|1|||
94276981|NCT03311711|322808048|FG001|Overall Study|Death|0|||
94276982|NCT03311711|322808049|FG002|Overall Study|Death|0|||
94276983|NCT03311711|322808050|FG003|Overall Study|Death|0|||
94276984|NCT03311711|322808051|FG004|Overall Study|Death|0|||
94276985|NCT03311711|322808052|FG005|Overall Study|Death|0|||
94276986|NCT03311711|322808053|FG006|Overall Study|Death|1|||
94276987|NCT03311711|322808054|FG007|Overall Study|Death|0|||
94276988|NCT03311711|322808055|FG008|Overall Study|Death|1|||
94276989|NCT03311711|322808056|FG009|Overall Study|Death|0|||
94276990|NCT03311711|322808047|FG000|Overall Study|Death of dyad partner|0|||
94276991|NCT03311711|322808048|FG001|Overall Study|Death of dyad partner|1|||
94276992|NCT03311711|322808049|FG002|Overall Study|Death of dyad partner|0|||
94276993|NCT03311711|322808050|FG003|Overall Study|Death of dyad partner|0|||
94276994|NCT03311711|322808051|FG004|Overall Study|Death of dyad partner|0|||
94276995|NCT03311711|322808052|FG005|Overall Study|Death of dyad partner|0|||
94276996|NCT03311711|322808053|FG006|Overall Study|Death of dyad partner|0|||
94276997|NCT03311711|322808054|FG007|Overall Study|Death of dyad partner|1|||
94276998|NCT03311711|322808055|FG008|Overall Study|Death of dyad partner|0|||
94276999|NCT03311711|322808056|FG009|Overall Study|Death of dyad partner|1|||
94277000|NCT03311711|322808047|FG000|Overall Study|Lost to Follow-up|2|||
94277001|NCT03311711|322808048|FG001|Overall Study|Lost to Follow-up|2|||
94277002|NCT03311711|322808049|FG002|Overall Study|Lost to Follow-up|0|||
94277003|NCT03311711|322808050|FG003|Overall Study|Lost to Follow-up|0|||
94277004|NCT03311711|322808051|FG004|Overall Study|Lost to Follow-up|0|||
94277005|NCT03311711|322808052|FG005|Overall Study|Lost to Follow-up|0|||
94277006|NCT03311711|322808053|FG006|Overall Study|Lost to Follow-up|1|||
94277007|NCT03311711|322808054|FG007|Overall Study|Lost to Follow-up|1|||
94277008|NCT03311711|322808055|FG008|Overall Study|Lost to Follow-up|0|||
94277009|NCT03311711|322808056|FG009|Overall Study|Lost to Follow-up|0|||
94277010|NCT03311711|322808047|FG000|Overall Study|Withdrawal by Subject|1|||
94741744|NCT01366092|324510673|FG000|Overall Study|Progressive cGVHD|2|||
94277011|NCT03311711|322808048|FG001|Overall Study|Withdrawal by Subject|1|||
94277012|NCT03311711|322808049|FG002|Overall Study|Withdrawal by Subject|0|||
94277013|NCT03311711|322808050|FG003|Overall Study|Withdrawal by Subject|0|||
94277014|NCT03311711|322808051|FG004|Overall Study|Withdrawal by Subject|0|||
94277015|NCT03311711|322808052|FG005|Overall Study|Withdrawal by Subject|0|||
94277016|NCT03311711|322808053|FG006|Overall Study|Withdrawal by Subject|3|||
94277017|NCT03311711|322808054|FG007|Overall Study|Withdrawal by Subject|3|||
94277018|NCT03311711|322808055|FG008|Overall Study|Withdrawal by Subject|0|||
94277019|NCT03311711|322808056|FG009|Overall Study|Withdrawal by Subject|0|||
94277020|NCT01081912|322808058|FG000|Conversion/Titration|Adverse Event|47|||
94277021|NCT01081912|322808059|FG001|Conversion/Titration|Adverse Event|0|||
94277022|NCT01081912|322808060|FG002|Conversion/Titration|Adverse Event|0|||
94277023|NCT01081912|322808058|FG000|Conversion/Titration|Lack of Efficacy|17|||
94277024|NCT01081912|322808059|FG001|Conversion/Titration|Lack of Efficacy|0|||
94277025|NCT01081912|322808060|FG002|Conversion/Titration|Lack of Efficacy|0|||
94277026|NCT01081912|322808058|FG000|Conversion/Titration|Lost to Follow-up|5|||
94277027|NCT01081912|322808059|FG001|Conversion/Titration|Lost to Follow-up|0|||
94277028|NCT01081912|322808060|FG002|Conversion/Titration|Lost to Follow-up|0|||
94277029|NCT01081912|322808058|FG000|Conversion/Titration|Physician Decision|2|||
94277030|NCT01081912|322808059|FG001|Conversion/Titration|Physician Decision|0|||
94277031|NCT01081912|322808060|FG002|Conversion/Titration|Physician Decision|0|||
94277032|NCT01081912|322808058|FG000|Conversion/Titration|Protocol Violation|67|||
94277033|NCT01081912|322808059|FG001|Conversion/Titration|Protocol Violation|0|||
94277034|NCT01081912|322808060|FG002|Conversion/Titration|Protocol Violation|0|||
94277035|NCT01081912|322808058|FG000|Conversion/Titration|Withdrawal by Subject|23|||
94277036|NCT01081912|322808059|FG001|Conversion/Titration|Withdrawal by Subject|0|||
94277037|NCT01081912|322808060|FG002|Conversion/Titration|Withdrawal by Subject|0|||
94277038|NCT01081912|322808058|FG000|Conversion/Titration|Non-Compliance|47|||
94277039|NCT01081912|322808059|FG001|Conversion/Titration|Non-Compliance|0|||
94277040|NCT01081912|322808060|FG002|Conversion/Titration|Non-Compliance|0|||
94277041|NCT01081912|322808058|FG000|Maintenance Treatment|Adverse Event|0|||
94277042|NCT01081912|322808059|FG001|Maintenance Treatment|Adverse Event|2|||
94741745|NCT01366092|324510673|FG000|Overall Study|Physician Decision|1|||
94277043|NCT01081912|322808060|FG002|Maintenance Treatment|Adverse Event|12|||
94277044|NCT01081912|322808058|FG000|Maintenance Treatment|Lack of Efficacy|0|||
94741746|NCT01366092|324510673|FG000|Overall Study|Withdrawal by Subject|1|||
94741747|NCT03142009|324510674|FG000|Overall Study|Lost to Follow-up|45|||
94741748|NCT03142009|324510675|FG001|Overall Study|Lost to Follow-up|30|||
94741749|NCT03872466|324510676|FG000|Overall Study|Withdrawal by Subject|1|||
94741750|NCT03872466|324510677|FG001|Overall Study|Withdrawal by Subject|0|||
94741751|NCT03872466|324510676|FG000|Overall Study|Physician Decision|2|||
94741752|NCT03872466|324510677|FG001|Overall Study|Physician Decision|0|||
94741753|NCT01553149|324510678|FG000|Overall Study|Adverse Event|0|||
94741754|NCT01553149|324510679|FG001|Overall Study|Adverse Event|9|||
94741755|NCT01553149|324510678|FG000|Overall Study|Physician Decision|5|||
94277045|NCT01081912|322808059|FG001|Maintenance Treatment|Lack of Efficacy|14|||
94741756|NCT01553149|324510679|FG001|Overall Study|Physician Decision|10|||
94741757|NCT01553149|324510678|FG000|Overall Study|Ineligible|0|||
94277046|NCT01081912|322808060|FG002|Maintenance Treatment|Lack of Efficacy|64|||
94277047|NCT01081912|322808058|FG000|Maintenance Treatment|Lost to Follow-up|0|||
94277048|NCT01081912|322808059|FG001|Maintenance Treatment|Lost to Follow-up|1|||
94277049|NCT01081912|322808060|FG002|Maintenance Treatment|Lost to Follow-up|0|||
94277050|NCT01081912|322808058|FG000|Maintenance Treatment|Physician Decision|0|||
94277051|NCT01081912|322808059|FG001|Maintenance Treatment|Physician Decision|0|||
94277052|NCT01081912|322808060|FG002|Maintenance Treatment|Physician Decision|1|||
94277053|NCT01081912|322808058|FG000|Maintenance Treatment|Protocol Violation|0|||
94277054|NCT01081912|322808059|FG001|Maintenance Treatment|Protocol Violation|1|||
94277055|NCT01081912|322808060|FG002|Maintenance Treatment|Protocol Violation|2|||
94277056|NCT01081912|322808058|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
94277057|NCT01081912|322808059|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
94277058|NCT01081912|322808060|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
94277059|NCT01081912|322808058|FG000|Maintenance Treatment|Non-Compliance|0|||
94277060|NCT01081912|322808059|FG001|Maintenance Treatment|Non-Compliance|4|||
94277061|NCT01081912|322808060|FG002|Maintenance Treatment|Non-Compliance|7|||
94277062|NCT01081912|322808058|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
94277063|NCT01081912|322808059|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
94277064|NCT01081912|322808060|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
94277065|NCT01877187|322808061|FG000|Overall Study|Death|2|||
94277066|NCT01877187|322808061|FG000|Overall Study|Withdrawal by Subject|4|||
94277067|NCT01877187|322808061|FG000|Overall Study|Lost to Follow-up|3|||
94277068|NCT01877187|322808061|FG000|Overall Study|Declining clinical status|11|||
94277069|NCT01877187|322808061|FG000|Overall Study|Liver transplant|2|||
94277070|NCT03923426|322808062|FG000|Overall Study|Other|19|||
94741758|NCT01553149|324510679|FG001|Overall Study|Ineligible|1|||
94741759|NCT04633278|324511095|FG000|Overall Study|Adverse Event|1|||
94741760|NCT04633278|324511096|FG001|Overall Study|Adverse Event|0|||
94741761|NCT04633278|324511095|FG000|Overall Study|Withdrawal by Subject|1|||
94741762|NCT04633278|324511096|FG001|Overall Study|Withdrawal by Subject|0|||
94741763|NCT04633278|324511095|FG000|Overall Study|Death|11|||
94741764|NCT04633278|324511096|FG001|Overall Study|Death|7|||
94741765|NCT04633278|324511095|FG000|Overall Study|Sponsor Decision|3|||
94741766|NCT04633278|324511096|FG001|Overall Study|Sponsor Decision|0|||
94741767|NCT04633278|324511095|FG000|Overall Study|Not Listed|1|||
94741768|NCT04633278|324511096|FG001|Overall Study|Not Listed|0|||
94741769|NCT02506153|324511097|FG000|Overall Study|Adverse Event|359|||
94741770|NCT02506153|324511098|FG001|Overall Study|Adverse Event|114|||
94741771|NCT02506153|324511097|FG000|Overall Study|Refused unrelated to adverse event|127|||
94741772|NCT02506153|324511098|FG001|Overall Study|Refused unrelated to adverse event|18|||
94741773|NCT02506153|324511097|FG000|Overall Study|Progression/relapse|91|||
94741774|NCT02506153|324511098|FG001|Overall Study|Progression/relapse|136|||
94741775|NCT02506153|324511097|FG000|Overall Study|Death|2|||
94741776|NCT02506153|324511098|FG001|Overall Study|Death|1|||
94741777|NCT02506153|324511097|FG000|Overall Study|Other - not protocol specified|23|||
94741778|NCT02506153|324511098|FG001|Overall Study|Other - not protocol specified|12|||
94741779|NCT00861705|324511099|FG000|Overall Study|Never Began Treatment|7|||
94741780|NCT00861705|324511100|FG001|Overall Study|Never Began Treatment|3|||
94741781|NCT00861705|324511101|FG002|Overall Study|Never Began Treatment|0|||
94741782|NCT00861705|324511102|FG003|Overall Study|Never Began Treatment|1|||
94741783|NCT00447980|324511103|FG000|Overall Study|Withdrawal by Subject|1|||
94741784|NCT00447980|324511104|FG001|Overall Study|Withdrawal by Subject|1|||
94741785|NCT00447980|324511105|FG002|Overall Study|Withdrawal by Subject|4|||
94741786|NCT00447980|324511106|FG003|Overall Study|Withdrawal by Subject|4|||
94277071|NCT03923426|322808062|FG000|Overall Study|Lost to Follow-up|16|||
94277072|NCT03923426|322808062|FG000|Overall Study|Death|107|||
94277073|NCT03923426|322808062|FG000|Overall Study|Incomplete response to question|13|||
94277074|NCT00766532|322808063|FG000|Overall Study|Protocol Violation|2|||
94277075|NCT00573430|322808064|FG000|Overall Study|Incorrect enrollment of randomization|0|||
94277076|NCT00573430|322808065|FG001|Overall Study|Incorrect enrollment of randomization|4|||
94277077|NCT00573430|322808066|FG002|Overall Study|Incorrect enrollment of randomization|3|||
94277078|NCT00573430|322808064|FG000|Overall Study|Adverse Event|0|||
94277079|NCT00573430|322808065|FG001|Overall Study|Adverse Event|0|||
94277080|NCT00573430|322808066|FG002|Overall Study|Adverse Event|2|||
94277081|NCT00573430|322808064|FG000|Overall Study|Withdrawal by Subject|1|||
94277082|NCT00573430|322808065|FG001|Overall Study|Withdrawal by Subject|0|||
94277083|NCT00573430|322808066|FG002|Overall Study|Withdrawal by Subject|1|||
94277084|NCT00573430|322808064|FG000|Overall Study|Protocol Violation|0|||
94277085|NCT00573430|322808065|FG001|Overall Study|Protocol Violation|1|||
94741787|NCT00447980|324511103|FG000|Overall Study|Lost to Follow-up|1|||
94741788|NCT00447980|324511104|FG001|Overall Study|Lost to Follow-up|1|||
94741789|NCT00447980|324511105|FG002|Overall Study|Lost to Follow-up|0|||
94277086|NCT00573430|322808066|FG002|Overall Study|Protocol Violation|1|||
94277087|NCT00573430|322808064|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
94277088|NCT00573430|322808065|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
94277089|NCT00573430|322808066|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
94277090|NCT03719690|322808068|FG000|Overall Study|Withdrawal by Subject|5|||
94741790|NCT00447980|324511106|FG003|Overall Study|Lost to Follow-up|0|||
94741791|NCT00447980|324511103|FG000|Overall Study|Did not proceed with surgery|3|||
94369664|NCT01335399|323140943|FG000|Treatment Period|Other reasons|30|||
94369665|NCT01335399|323140944|FG001|Treatment Period|Other reasons|30|||
94369666|NCT01335399|323140943|FG000|Treatment Period|Consent withdrawal|10|||
94369667|NCT01335399|323140944|FG001|Treatment Period|Consent withdrawal|7|||
94369668|NCT01335399|323140943|FG000|Treatment Period|Death|7|||
94369669|NCT01335399|323140944|FG001|Treatment Period|Death|6|||
94369670|NCT01335399|323140943|FG000|Treatment Period|Poor/Non-compliance|3|||
94369671|NCT01335399|323140944|FG001|Treatment Period|Poor/Non-compliance|4|||
94369672|NCT01335399|323140943|FG000|Treatment Period|Lost to Follow-up|2|||
94369673|NCT01335399|323140944|FG001|Treatment Period|Lost to Follow-up|2|||
94369674|NCT01335399|323140943|FG000|Treatment Period|Maximum clinical benefit|1|||
94369675|NCT01335399|323140944|FG001|Treatment Period|Maximum clinical benefit|1|||
94369676|NCT01335399|323140943|FG000|Treatment Period|No longer meet study criteria|1|||
94369677|NCT01335399|323140944|FG001|Treatment Period|No longer meet study criteria|1|||
94369678|NCT01335399|323140943|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
94369679|NCT01335399|323140944|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
94369680|NCT01074307|323140945|FG000|Overall Study|No primary endpoint evaluation|14|||
94369681|NCT01074307|323140946|FG001|Overall Study|No primary endpoint evaluation|6|||
94369682|NCT01074307|323140945|FG000|Overall Study|Exclusion criterion|0|||
94369683|NCT01074307|323140946|FG001|Overall Study|Exclusion criterion|1|||
94369684|NCT01074307|323140945|FG000|Overall Study|Protocol Violation|8|||
94369685|NCT01074307|323140946|FG001|Overall Study|Protocol Violation|5|||
94369686|NCT01796860|323140952|FG000|Overall Study|Withdrawal by Subject|3|||
94369687|NCT01835470|323140958|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
94369688|NCT01835470|323140958|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
94369689|NCT04335110|323140963|FG000|Overall Study|Withdrawal by Subject|1|||
94369690|NCT04335110|323140964|FG001|Overall Study|Withdrawal by Subject|1|||
94369691|NCT04335110|323140963|FG000|Overall Study|Death|0|||
94369692|NCT04335110|323140964|FG001|Overall Study|Death|1|||
94369693|NCT02766088|323140968|FG000|Overall Study|Sponsor study termination|498|||
94369694|NCT02766088|323140968|FG000|Overall Study|Migrated/moved from the study area|1|||
94369695|NCT02766088|323140968|FG000|Overall Study|Lost to Follow-up|5|||
94369696|NCT02766088|323140968|FG000|Overall Study|Other|1|||
94369697|NCT02766088|323140968|FG000|Overall Study|Death|1|||
94369698|NCT01690520|323140971|FG000|Overall Study|Death|25|||
94369699|NCT01690520|323140972|FG001|Overall Study|Death|21|||
94369700|NCT01690520|323140971|FG000|Overall Study|Lost to Follow-up|2|||
94369701|NCT01690520|323140972|FG001|Overall Study|Lost to Follow-up|3|||
94369702|NCT01690520|323140971|FG000|Overall Study|Withdrawal by Subject|2|||
94369703|NCT01690520|323140972|FG001|Overall Study|Withdrawal by Subject|0|||
94369704|NCT01690520|323140971|FG000|Overall Study|Relapse|0|||
94369705|NCT01690520|323140972|FG001|Overall Study|Relapse|1|||
94369706|NCT01690520|323140971|FG000|Overall Study|Other|0|||
94369707|NCT01690520|323140972|FG001|Overall Study|Other|1|||
94369708|NCT01690520|323140971|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
94741792|NCT00447980|324511104|FG001|Overall Study|Did not proceed with surgery|3|||
94741793|NCT00447980|324511105|FG002|Overall Study|Did not proceed with surgery|2|||
94741794|NCT00447980|324511106|FG003|Overall Study|Did not proceed with surgery|2|||
94741795|NCT03803774|324511110|FG000|Dose Escalation|Withdrawal by Subject|0|||
94741796|NCT03803774|324511111|FG001|Dose Escalation|Withdrawal by Subject|0|||
94741797|NCT03803774|324511112|FG002|Dose Escalation|Withdrawal by Subject|0|||
94741798|NCT03803774|324511113|FG003|Dose Escalation|Withdrawal by Subject|1|||
94741799|NCT03803774|324511114|FG004|Dose Escalation|Withdrawal by Subject|0|||
94741800|NCT04389957|324511117|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
94741801|NCT04389957|324511118|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
94741802|NCT04389957|324511119|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
94741803|NCT04389957|324511120|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
94741804|NCT04389957|324511121|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
94741805|NCT00942734|324511122|FG000|Overall Study|Adverse Event|2|||
94741806|NCT00942734|324511122|FG000|Overall Study|Protocol Violation|3|||
94741807|NCT00942734|324511122|FG000|Overall Study|Disease Progression|2|||
94741808|NCT00942734|324511122|FG000|Overall Study|Physician Decision|1|||
94741809|NCT03552965|324511128|FG000|Overall Study|Death|1|||
94741810|NCT03552965|324511129|FG001|Overall Study|Death|1|||
94369709|NCT01690520|323140972|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
94369710|NCT03543046|323140977|FG000|Overall Study|Adverse Event|1|||
94369711|NCT03543046|323140978|FG001|Overall Study|Adverse Event|1|||
94369712|NCT03543046|323140977|FG000|Overall Study|Physician Decision|1|||
94369713|NCT03543046|323140978|FG001|Overall Study|Physician Decision|1|||
94369714|NCT03543046|323140977|FG000|Overall Study|Protocol Violation|1|||
94369715|NCT03543046|323140978|FG001|Overall Study|Protocol Violation|0|||
94369716|NCT02019979|323140983|FG000|Overall Study|study terminated|14|||
94369717|NCT00923195|323140988|FG000|Overall Study|Death|0|||
94369718|NCT00923195|323140989|FG001|Overall Study|Death|1|||
94369719|NCT03137082|323140992|FG000|Overall Study|Withdrawal by Subject|1|||
94741811|NCT03552965|324511128|FG000|Overall Study|Lost to Follow-up|1|||
94277091|NCT03719690|322808069|FG001|Overall Study|Withdrawal by Subject|10|||
94277092|NCT03719690|322808068|FG000|Overall Study|Death|40|||
94277093|NCT03719690|322808069|FG001|Overall Study|Death|149|||
94277094|NCT03719690|322808068|FG000|Overall Study|Miscellaneous|12|||
94277095|NCT03719690|322808069|FG001|Overall Study|Miscellaneous|56|||
94277096|NCT03719690|322808068|FG000|Overall Study|Lost to Follow-up|2|||
94277097|NCT03719690|322808069|FG001|Overall Study|Lost to Follow-up|18|||
94277098|NCT03719690|322808068|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
94277099|NCT03719690|322808069|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
94277100|NCT02363686|322808073|FG000|Overall Study|Withdrawal by Subject|22|||
94277101|NCT02363686|322808073|FG000|Overall Study|incomplete FEES examinations|13|||
94277102|NCT01294670|322808079|FG000|Overall Study|Not treated|1|||
94277103|NCT01294670|322808080|FG001|Overall Study|Not treated|0|||
94277104|NCT01294670|322808081|FG002|Overall Study|Not treated|0|||
94277105|NCT01294670|322808082|FG003|Overall Study|Not treated|0|||
94277106|NCT01294670|322808083|FG004|Overall Study|Not treated|0|||
94277107|NCT02669017|322808087|FG000|Overall Study|Death|1|||
94277108|NCT02669017|322808088|FG001|Overall Study|Death|2|||
94277109|NCT02669017|322808089|FG002|Overall Study|Death|2|||
94277110|NCT02669017|322808090|FG003|Overall Study|Death|3|||
94277111|NCT02669017|322808091|FG004|Overall Study|Death|8|||
94277112|NCT02669017|322808092|FG005|Overall Study|Death|18|||
94467538|NCT00908596|323502331|FG002|Overall Study|Protocol Violation|0|||
94277113|NCT02669017|322808093|FG006|Overall Study|Death|10|||
94277114|NCT02669017|322808094|FG007|Overall Study|Death|47|||
94277115|NCT02669017|322808095|FG008|Overall Study|Death|20|||
94369720|NCT03137082|323140993|FG001|Overall Study|Withdrawal by Subject|1|||
94369721|NCT03137082|323140992|FG000|Overall Study|Lost to Follow-up|1|||
94369722|NCT03137082|323140993|FG001|Overall Study|Lost to Follow-up|0|||
94369723|NCT03944707|323140994|FG000|Overall Study|Adverse Event|0|||
94369724|NCT03944707|323140995|FG001|Overall Study|Adverse Event|2|||
94277116|NCT02669017|322808087|FG000|Overall Study|Withdrawal by Subject|0|||
94277117|NCT02669017|322808088|FG001|Overall Study|Withdrawal by Subject|0|||
94277118|NCT02669017|322808089|FG002|Overall Study|Withdrawal by Subject|0|||
94277119|NCT02669017|322808090|FG003|Overall Study|Withdrawal by Subject|1|||
94277120|NCT02669017|322808091|FG004|Overall Study|Withdrawal by Subject|2|||
94277121|NCT02669017|322808092|FG005|Overall Study|Withdrawal by Subject|0|||
94277122|NCT02669017|322808093|FG006|Overall Study|Withdrawal by Subject|0|||
94277123|NCT02669017|322808094|FG007|Overall Study|Withdrawal by Subject|2|||
94277124|NCT02669017|322808095|FG008|Overall Study|Withdrawal by Subject|2|||
94277125|NCT02669017|322808087|FG000|Overall Study|Lost to Follow-up|0|||
94277126|NCT02669017|322808088|FG001|Overall Study|Lost to Follow-up|0|||
94277127|NCT02669017|322808089|FG002|Overall Study|Lost to Follow-up|0|||
94277128|NCT02669017|322808090|FG003|Overall Study|Lost to Follow-up|0|||
94277129|NCT02669017|322808091|FG004|Overall Study|Lost to Follow-up|0|||
94277130|NCT02669017|322808092|FG005|Overall Study|Lost to Follow-up|0|||
94277131|NCT02669017|322808093|FG006|Overall Study|Lost to Follow-up|0|||
94277132|NCT02669017|322808094|FG007|Overall Study|Lost to Follow-up|0|||
94277133|NCT02669017|322808095|FG008|Overall Study|Lost to Follow-up|1|||
94277134|NCT02669017|322808087|FG000|Overall Study|Miscellaneous|0|||
94277135|NCT02669017|322808088|FG001|Overall Study|Miscellaneous|0|||
94277136|NCT02669017|322808089|FG002|Overall Study|Miscellaneous|0|||
94277137|NCT02669017|322808090|FG003|Overall Study|Miscellaneous|0|||
94277138|NCT02669017|322808091|FG004|Overall Study|Miscellaneous|2|||
94277139|NCT02669017|322808092|FG005|Overall Study|Miscellaneous|1|||
94277140|NCT02669017|322808093|FG006|Overall Study|Miscellaneous|1|||
94277141|NCT02669017|322808094|FG007|Overall Study|Miscellaneous|13|||
94277142|NCT02669017|322808095|FG008|Overall Study|Miscellaneous|2|||
94277143|NCT01146873|322808099|FG000|Overall Study|Transfer out|0|||
94277144|NCT01146873|322808100|FG001|Overall Study|Transfer out|6|||
94369725|NCT03944707|323140994|FG000|Overall Study|Study terminated by sponsor|12|||
94369726|NCT03944707|323140995|FG001|Overall Study|Study terminated by sponsor|7|||
94369727|NCT03944707|323140994|FG000|Overall Study|Subject decision|0|||
94277145|NCT00876187|322808101|FG000|Overall Study|Adverse Event|14|||
94277146|NCT00876187|322808102|FG001|Overall Study|Adverse Event|12|||
94277147|NCT00876187|322808103|FG002|Overall Study|Adverse Event|19|||
94277148|NCT00876187|322808104|FG003|Overall Study|Adverse Event|29|||
94277149|NCT00876187|322808105|FG004|Overall Study|Adverse Event|10|||
94277150|NCT00876187|322808101|FG000|Overall Study|Lack of Efficacy|59|||
94277151|NCT00876187|322808102|FG001|Overall Study|Lack of Efficacy|34|||
94277152|NCT00876187|322808103|FG002|Overall Study|Lack of Efficacy|45|||
94277153|NCT00876187|322808104|FG003|Overall Study|Lack of Efficacy|34|||
94369728|NCT03944707|323140995|FG001|Overall Study|Subject decision|1|||
94369729|NCT01440595|323141012|FG000|Overall Study|Lost to Follow-up|0|||
94369730|NCT01440595|323141013|FG001|Overall Study|Lost to Follow-up|1|||
94369731|NCT01440595|323141014|FG002|Overall Study|Lost to Follow-up|0|||
94369732|NCT01440595|323141012|FG000|Overall Study|Study terminated by sponsor.|1|||
94369733|NCT01440595|323141013|FG001|Overall Study|Study terminated by sponsor.|2|||
94369734|NCT01440595|323141014|FG002|Overall Study|Study terminated by sponsor.|1|||
94369735|NCT00751998|323141015|FG000|Overall Study|Lost to Follow-up|7|||
94369736|NCT00751998|323141015|FG000|Overall Study|Death|11|||
94369737|NCT00751998|323141015|FG000|Overall Study|Withdrawal by Subject|2|||
94369738|NCT02622074|323141016|FG000|Overall Study|Death|4|||
94369739|NCT02622074|323141017|FG001|Overall Study|Death|0|||
94369740|NCT02622074|323141018|FG002|Overall Study|Death|0|||
94369741|NCT02622074|323141019|FG003|Overall Study|Death|1|||
94369742|NCT02622074|323141020|FG004|Overall Study|Death|1|||
94369743|NCT02622074|323141021|FG005|Overall Study|Death|0|||
94369744|NCT02622074|323141016|FG000|Overall Study|Withdrawal by Subject|0|||
94369745|NCT02622074|323141017|FG001|Overall Study|Withdrawal by Subject|1|||
94369746|NCT02622074|323141018|FG002|Overall Study|Withdrawal by Subject|0|||
94369747|NCT02622074|323141019|FG003|Overall Study|Withdrawal by Subject|0|||
94369748|NCT02622074|323141020|FG004|Overall Study|Withdrawal by Subject|0|||
94369749|NCT02622074|323141021|FG005|Overall Study|Withdrawal by Subject|0|||
94369750|NCT01223196|323141022|FG000|Overall Study|Lost to Follow-up|2|||
94369751|NCT01223196|323141023|FG001|Overall Study|Lost to Follow-up|0|||
94369752|NCT01223196|323141022|FG000|Overall Study|Physician Decision|1|||
94369753|NCT01223196|323141023|FG001|Overall Study|Physician Decision|0|||
94369754|NCT01223196|323141022|FG000|Overall Study|Withdrawal by Subject|1|||
94369755|NCT01223196|323141023|FG001|Overall Study|Withdrawal by Subject|0|||
94369756|NCT02983227|323141024|FG000|Overall Study|Adverse Event|21|||
94369757|NCT02983227|323141025|FG001|Overall Study|Adverse Event|3|||
94369758|NCT02983227|323141024|FG000|Overall Study|Death|3|||
94369759|NCT02983227|323141025|FG001|Overall Study|Death|0|||
94369760|NCT02983227|323141024|FG000|Overall Study|Lack of Efficacy|8|||
94369761|NCT02983227|323141025|FG001|Overall Study|Lack of Efficacy|1|||
94369762|NCT02983227|323141024|FG000|Overall Study|Lost to Follow-up|3|||
94369763|NCT02983227|323141025|FG001|Overall Study|Lost to Follow-up|0|||
94369764|NCT02983227|323141024|FG000|Overall Study|Multiple Reasons|2|||
94369765|NCT02983227|323141025|FG001|Overall Study|Multiple Reasons|1|||
94369766|NCT02983227|323141024|FG000|Overall Study|Physician Decision|3|||
94369767|NCT02983227|323141025|FG001|Overall Study|Physician Decision|1|||
94369768|NCT02983227|323141024|FG000|Overall Study|Withdrawal by Subject|19|||
94369769|NCT02983227|323141025|FG001|Overall Study|Withdrawal by Subject|8|||
94369770|NCT01255722|323141026|FG000|Overall Study|Adverse Event|0|||
94369771|NCT01255722|323141027|FG001|Overall Study|Adverse Event|1|||
94369772|NCT01255722|323141028|FG002|Overall Study|Adverse Event|1|||
94369773|NCT01255722|323141026|FG000|Overall Study|asymptomatic patient|1|||
94369774|NCT01255722|323141027|FG001|Overall Study|asymptomatic patient|0|||
94369775|NCT01255722|323141028|FG002|Overall Study|asymptomatic patient|0|||
94369776|NCT01255722|323141026|FG000|Overall Study|beta-blocker contraindicated|2|||
94369777|NCT01255722|323141027|FG001|Overall Study|beta-blocker contraindicated|0|||
94741812|NCT03552965|324511129|FG001|Overall Study|Lost to Follow-up|1|||
94369778|NCT01255722|323141028|FG002|Overall Study|beta-blocker contraindicated|0|||
94741813|NCT03552965|324511128|FG000|Overall Study|Physician Decision|1|||
94741814|NCT03552965|324511129|FG001|Overall Study|Physician Decision|1|||
94741815|NCT03552965|324511128|FG000|Overall Study|Withdrawal by Subject|0|||
94741816|NCT03552965|324511129|FG001|Overall Study|Withdrawal by Subject|2|||
94741817|NCT03552965|324511128|FG000|Overall Study|Continuation not in patient best interest|1|||
94741818|NCT03552965|324511129|FG001|Overall Study|Continuation not in patient best interest|0|||
94741819|NCT03552965|324511128|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
94369779|NCT05478603|323141029|FG000|Overall Study|Withdrawal by Subject|0|||
94369780|NCT05478603|323141030|FG001|Overall Study|Withdrawal by Subject|1|||
94467539|NCT00908596|323502332|FG003|Overall Study|Protocol Violation|0|||
94741820|NCT03552965|324511129|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
94369781|NCT05478603|323141031|FG002|Overall Study|Withdrawal by Subject|0|||
94369782|NCT05478603|323141032|FG003|Overall Study|Withdrawal by Subject|0|||
94369783|NCT01829295|323141033|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
94369784|NCT01829295|323141034|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
94369785|NCT01829295|323141035|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
94369786|NCT01829295|323141036|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
94369787|NCT01829295|323141033|FG000|6-12 Months|Adverse Event|0|||
94369788|NCT01829295|323141034|FG001|6-12 Months|Adverse Event|0|||
94369789|NCT01829295|323141035|FG002|6-12 Months|Adverse Event|3|||
94369790|NCT01829295|323141036|FG003|6-12 Months|Adverse Event|2|||
94369791|NCT01829295|323141033|FG000|6-12 Months|Lost to Follow-up|2|||
94369792|NCT01829295|323141034|FG001|6-12 Months|Lost to Follow-up|0|||
94277154|NCT00876187|322808105|FG004|Overall Study|Lack of Efficacy|59|||
94277155|NCT00876187|322808101|FG000|Overall Study|Lost to Follow-up|9|||
94277156|NCT00876187|322808102|FG001|Overall Study|Lost to Follow-up|10|||
94277157|NCT00876187|322808103|FG002|Overall Study|Lost to Follow-up|8|||
94277158|NCT00876187|322808104|FG003|Overall Study|Lost to Follow-up|8|||
94277159|NCT00876187|322808105|FG004|Overall Study|Lost to Follow-up|11|||
94277160|NCT00876187|322808101|FG000|Overall Study|Protocol Violation|6|||
94277161|NCT00876187|322808102|FG001|Overall Study|Protocol Violation|7|||
94277162|NCT00876187|322808103|FG002|Overall Study|Protocol Violation|7|||
94277163|NCT00876187|322808104|FG003|Overall Study|Protocol Violation|6|||
94277164|NCT00876187|322808105|FG004|Overall Study|Protocol Violation|3|||
94277165|NCT00876187|322808101|FG000|Overall Study|Withdrawal by Subject|16|||
94277166|NCT00876187|322808102|FG001|Overall Study|Withdrawal by Subject|26|||
94277167|NCT00876187|322808103|FG002|Overall Study|Withdrawal by Subject|32|||
94277168|NCT00876187|322808104|FG003|Overall Study|Withdrawal by Subject|38|||
94277169|NCT00876187|322808105|FG004|Overall Study|Withdrawal by Subject|37|||
94277170|NCT00876187|322808101|FG000|Overall Study|Entered extension study|101|||
94277171|NCT00876187|322808102|FG001|Overall Study|Entered extension study|120|||
94277172|NCT00876187|322808103|FG002|Overall Study|Entered extension study|156|||
94277173|NCT00876187|322808104|FG003|Overall Study|Entered extension study|151|||
94277174|NCT00876187|322808105|FG004|Overall Study|Entered extension study|144|||
94277175|NCT00876187|322808101|FG000|Overall Study|Randomized but not treated|3|||
94277176|NCT00876187|322808102|FG001|Overall Study|Randomized but not treated|1|||
94277177|NCT00876187|322808103|FG002|Overall Study|Randomized but not treated|3|||
94277178|NCT00876187|322808104|FG003|Overall Study|Randomized but not treated|2|||
94277179|NCT00876187|322808105|FG004|Overall Study|Randomized but not treated|3|||
94277180|NCT00876187|322808101|FG000|Overall Study|Other|2|||
94369793|NCT01829295|323141035|FG002|6-12 Months|Lost to Follow-up|0|||
94369794|NCT01829295|323141036|FG003|6-12 Months|Lost to Follow-up|0|||
94369795|NCT01829295|323141033|FG000|6-12 Months|Withdrawal by Subject|2|||
94369796|NCT01829295|323141034|FG001|6-12 Months|Withdrawal by Subject|2|||
94277181|NCT00876187|322808102|FG001|Overall Study|Other|5|||
94277182|NCT00876187|322808103|FG002|Overall Study|Other|9|||
94277183|NCT00876187|322808104|FG003|Overall Study|Other|7|||
94277184|NCT00876187|322808105|FG004|Overall Study|Other|4|||
94277185|NCT01379274|322808106|FG000|Overall Study|funding withdrawn|1|||
94277186|NCT02590588|322808107|FG000|Overall Study|Adverse Event|1|||
94277187|NCT00763815|322808112|FG000|Overall Study|Adverse Event|14|||
94369797|NCT01829295|323141035|FG002|6-12 Months|Withdrawal by Subject|0|||
94369798|NCT01829295|323141036|FG003|6-12 Months|Withdrawal by Subject|0|||
94277188|NCT00763815|322808113|FG001|Overall Study|Adverse Event|29|||
94277189|NCT00763815|322808112|FG000|Overall Study|Lack of Efficacy|10|||
94277190|NCT00763815|322808113|FG001|Overall Study|Lack of Efficacy|11|||
94277191|NCT00763815|322808112|FG000|Overall Study|Poor Compliance to Protocol|6|||
94277192|NCT00763815|322808113|FG001|Overall Study|Poor Compliance to Protocol|6|||
94277193|NCT00763815|322808112|FG000|Overall Study|Lost to Follow-up|2|||
94277194|NCT00763815|322808113|FG001|Overall Study|Lost to Follow-up|4|||
94277195|NCT00763815|322808112|FG000|Overall Study|Early Termination|1|||
94277196|NCT00763815|322808113|FG001|Overall Study|Early Termination|0|||
94277197|NCT00763815|322808112|FG000|Overall Study|Familial and Personal Reasons|9|||
94277198|NCT00763815|322808113|FG001|Overall Study|Familial and Personal Reasons|16|||
94369799|NCT01154127|323141037|FG000|Period 1 (21 Days)|Adverse Event|3|||
94369800|NCT01154127|323141038|FG001|Period 1 (21 Days)|Adverse Event|4|||
94369801|NCT01154127|323141037|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
94369802|NCT01154127|323141038|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
94369803|NCT01154127|323141037|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
94369804|NCT01154127|323141038|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
94369805|NCT01154127|323141037|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
94369806|NCT01154127|323141038|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
94369807|NCT01154127|323141037|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
94369808|NCT01154127|323141038|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
94369809|NCT02766400|323141040|FG000|Overall Study|Death|1|||
94369810|NCT02766400|323141041|FG001|Overall Study|Death|2|||
94369811|NCT02766400|323141040|FG000|Overall Study|Withdrawal by Subject|1|||
94369812|NCT02766400|323141041|FG001|Overall Study|Withdrawal by Subject|0|||
94369813|NCT02556632|323141045|FG000|Overall Study|Lost to Follow-up|1|||
94369814|NCT02556632|323141046|FG001|Overall Study|Lost to Follow-up|0|||
94369815|NCT02556632|323141047|FG002|Overall Study|Lost to Follow-up|0|||
94369816|NCT02556632|323141045|FG000|Overall Study|Disliked Intervention|1|||
94369817|NCT02556632|323141046|FG001|Overall Study|Disliked Intervention|1|||
94369818|NCT02556632|323141047|FG002|Overall Study|Disliked Intervention|1|||
94369819|NCT02556632|323141045|FG000|Overall Study|No Reason|1|||
94369820|NCT02556632|323141046|FG001|Overall Study|No Reason|0|||
94369821|NCT02556632|323141047|FG002|Overall Study|No Reason|1|||
94467540|NCT00908596|323502329|FG000|Overall Study|Withdrawal by Subject|0|||
94741821|NCT02701283|324511130|FG000|Overall Study|Death|25|||
94741822|NCT02701283|324511131|FG001|Overall Study|Death|29|||
94369822|NCT02556632|323141045|FG000|Overall Study|Personal Issues|0|||
94741823|NCT02701283|324511132|FG002|Overall Study|Death|19|||
94741824|NCT02701283|324511130|FG000|Overall Study|Lost to Follow-up|3|||
94741825|NCT02701283|324511131|FG001|Overall Study|Lost to Follow-up|8|||
94741826|NCT02701283|324511132|FG002|Overall Study|Lost to Follow-up|1|||
94741827|NCT02701283|324511130|FG000|Overall Study|Withdrawal by Subject|12|||
94741828|NCT02701283|324511131|FG001|Overall Study|Withdrawal by Subject|41|||
94741829|NCT02701283|324511132|FG002|Overall Study|Withdrawal by Subject|1|||
94741830|NCT02701283|324511130|FG000|Overall Study|Missed 2-year visit|22|||
94741831|NCT02701283|324511131|FG001|Overall Study|Missed 2-year visit|27|||
94741832|NCT02701283|324511132|FG002|Overall Study|Missed 2-year visit|0|||
94741833|NCT02701283|324511130|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
94741834|NCT02701283|324511131|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
94741835|NCT02701283|324511132|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
94741836|NCT05707351|324511133|FG000|Overall Study|Withdrawal by Subject|2|||
94741837|NCT05707351|324511133|FG000|Overall Study|Reason Not Specified|1|||
94741838|NCT04873232|324511135|FG000|Overall Study|Lost to Follow-up|1|||
94741839|NCT04873232|324511136|FG001|Overall Study|Lost to Follow-up|4|||
94741840|NCT04873232|324511135|FG000|Overall Study|Withdrawal by Subject|1|||
94741841|NCT04873232|324511136|FG001|Overall Study|Withdrawal by Subject|0|||
94741842|NCT01651000|324511137|FG000|Overall Study|Adverse Event|2|||
94741843|NCT01651000|324511138|FG001|Overall Study|Adverse Event|8|||
94741844|NCT01651000|324511137|FG000|Overall Study|Lost to Follow-up|3|||
94741845|NCT01651000|324511138|FG001|Overall Study|Lost to Follow-up|2|||
94741846|NCT01651000|324511137|FG000|Overall Study|Protocol Violation|0|||
94741847|NCT01651000|324511138|FG001|Overall Study|Protocol Violation|3|||
94741848|NCT01651000|324511137|FG000|Overall Study|Withdrawal by Subject|2|||
94741849|NCT01651000|324511138|FG001|Overall Study|Withdrawal by Subject|10|||
94741850|NCT01651000|324511137|FG000|Overall Study|Subject noncompliance|0|||
94741851|NCT01651000|324511138|FG001|Overall Study|Subject noncompliance|3|||
94741852|NCT01651000|324511137|FG000|Overall Study|Lack of Efficacy|1|||
94741853|NCT01651000|324511138|FG001|Overall Study|Lack of Efficacy|1|||
94369823|NCT02556632|323141046|FG001|Overall Study|Personal Issues|1|||
94369824|NCT02556632|323141047|FG002|Overall Study|Personal Issues|1|||
94277199|NCT00763815|322808112|FG000|Overall Study|Physician Decision|1|||
94277200|NCT00763815|322808113|FG001|Overall Study|Physician Decision|0|||
94741854|NCT01651000|324511137|FG000|Overall Study|Physician Decision|1|||
94741855|NCT01651000|324511138|FG001|Overall Study|Physician Decision|0|||
94741856|NCT01651000|324511137|FG000|Overall Study|Administrative reason|1|||
94741857|NCT01651000|324511138|FG001|Overall Study|Administrative reason|0|||
94741858|NCT01651000|324511137|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
94741859|NCT01651000|324511138|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
94741860|NCT01274338|324511678|FG000|Overall Study|Lack of Efficacy|72|||
94741861|NCT01274338|324511679|FG001|Overall Study|Lack of Efficacy|108|||
94741862|NCT01274338|324511680|FG002|Overall Study|Lack of Efficacy|116|||
94741863|NCT01274338|324511681|FG003|Overall Study|Lack of Efficacy|0|||
94741864|NCT01274338|324511682|FG004|Overall Study|Lack of Efficacy|0|||
94741865|NCT01274338|324511683|FG005|Overall Study|Lack of Efficacy|0|||
94741866|NCT01274338|324511678|FG000|Overall Study|Adverse Event|272|||
94741867|NCT01274338|324511679|FG001|Overall Study|Adverse Event|105|||
94741868|NCT01274338|324511680|FG002|Overall Study|Adverse Event|180|||
94741869|NCT01274338|324511681|FG003|Overall Study|Adverse Event|1|||
94741870|NCT01274338|324511682|FG004|Overall Study|Adverse Event|0|||
94741871|NCT01274338|324511683|FG005|Overall Study|Adverse Event|0|||
94741872|NCT01274338|324511678|FG000|Overall Study|Death|8|||
94741873|NCT01274338|324511679|FG001|Overall Study|Death|1|||
94741874|NCT01274338|324511680|FG002|Overall Study|Death|0|||
94741875|NCT01274338|324511681|FG003|Overall Study|Death|0|||
94741876|NCT01274338|324511682|FG004|Overall Study|Death|0|||
94741877|NCT01274338|324511683|FG005|Overall Study|Death|0|||
94741878|NCT01274338|324511678|FG000|Overall Study|Withdrawal by Subject|27|||
94741879|NCT01274338|324511679|FG001|Overall Study|Withdrawal by Subject|99|||
94741880|NCT01274338|324511680|FG002|Overall Study|Withdrawal by Subject|17|||
94741881|NCT01274338|324511681|FG003|Overall Study|Withdrawal by Subject|0|||
94741882|NCT01274338|324511682|FG004|Overall Study|Withdrawal by Subject|0|||
94741883|NCT01274338|324511683|FG005|Overall Study|Withdrawal by Subject|0|||
94741884|NCT01274338|324511678|FG000|Overall Study|Did not start treatment|8|||
94741885|NCT01274338|324511679|FG001|Overall Study|Did not start treatment|116|||
94741886|NCT01274338|324511680|FG002|Overall Study|Did not start treatment|7|||
94741887|NCT01274338|324511681|FG003|Overall Study|Did not start treatment|0|||
94741888|NCT01274338|324511682|FG004|Overall Study|Did not start treatment|0|||
94741889|NCT01274338|324511683|FG005|Overall Study|Did not start treatment|0|||
94741890|NCT01274338|324511678|FG000|Overall Study|Alternative therapy|0|||
94741891|NCT01274338|324511679|FG001|Overall Study|Alternative therapy|1|||
94741892|NCT01274338|324511680|FG002|Overall Study|Alternative therapy|0|||
94741893|NCT01274338|324511681|FG003|Overall Study|Alternative therapy|0|||
94741894|NCT01274338|324511682|FG004|Overall Study|Alternative therapy|0|||
94741895|NCT01274338|324511683|FG005|Overall Study|Alternative therapy|0|||
94741896|NCT01274338|324511678|FG000|Overall Study|Other complicating diseases|0|||
94741897|NCT01274338|324511679|FG001|Overall Study|Other complicating diseases|3|||
94741898|NCT01274338|324511680|FG002|Overall Study|Other complicating diseases|1|||
94741899|NCT01274338|324511681|FG003|Overall Study|Other complicating diseases|0|||
94741900|NCT01274338|324511682|FG004|Overall Study|Other complicating diseases|0|||
94741901|NCT01274338|324511683|FG005|Overall Study|Other complicating diseases|0|||
94741902|NCT01274338|324511678|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
94741903|NCT01274338|324511679|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
94741904|NCT01274338|324511680|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
94741905|NCT01274338|324511681|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
94741906|NCT01274338|324511682|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
94741907|NCT01274338|324511683|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
94741908|NCT01274338|324511678|FG000|Overall Study|Pregnancy|0|||
94741909|NCT01274338|324511679|FG001|Overall Study|Pregnancy|0|||
94741910|NCT01274338|324511680|FG002|Overall Study|Pregnancy|1|||
94741911|NCT01274338|324511681|FG003|Overall Study|Pregnancy|0|||
94741912|NCT01274338|324511682|FG004|Overall Study|Pregnancy|0|||
94741913|NCT01274338|324511683|FG005|Overall Study|Pregnancy|0|||
94741914|NCT01274338|324511678|FG000|Overall Study|Reason not reported|12|||
94741915|NCT01274338|324511679|FG001|Overall Study|Reason not reported|21|||
94741916|NCT01274338|324511680|FG002|Overall Study|Reason not reported|3|||
94741917|NCT01274338|324511681|FG003|Overall Study|Reason not reported|0|||
94741918|NCT01274338|324511682|FG004|Overall Study|Reason not reported|1|||
94741919|NCT01274338|324511683|FG005|Overall Study|Reason not reported|0|||
94741920|NCT04244175|324511687|FG000|Overall Study|Adverse Event|3|||
94741921|NCT04244175|324511688|FG001|Overall Study|Adverse Event|2|||
94741922|NCT04244175|324511689|FG002|Overall Study|Adverse Event|5|||
94741923|NCT04244175|324511687|FG000|Overall Study|Lack of Efficacy|1|||
94741924|NCT04244175|324511688|FG001|Overall Study|Lack of Efficacy|0|||
94741925|NCT04244175|324511689|FG002|Overall Study|Lack of Efficacy|1|||
94741926|NCT04244175|324511687|FG000|Overall Study|Lost to Follow-up|1|||
94741927|NCT04244175|324511688|FG001|Overall Study|Lost to Follow-up|0|||
94741928|NCT04244175|324511689|FG002|Overall Study|Lost to Follow-up|0|||
94741929|NCT04244175|324511687|FG000|Overall Study|Non-compliance with study drug|1|||
94741930|NCT04244175|324511688|FG001|Overall Study|Non-compliance with study drug|0|||
94741931|NCT04244175|324511689|FG002|Overall Study|Non-compliance with study drug|1|||
94741932|NCT04244175|324511687|FG000|Overall Study|Protocol deviation|0|||
94741933|NCT04244175|324511688|FG001|Overall Study|Protocol deviation|1|||
94741934|NCT04244175|324511689|FG002|Overall Study|Protocol deviation|0|||
94741935|NCT04244175|324511687|FG000|Overall Study|Withdrawal by Subject|1|||
94369825|NCT02556632|323141045|FG000|Overall Study|Changed Mind|0|||
94369826|NCT02556632|323141046|FG001|Overall Study|Changed Mind|1|||
94369827|NCT02556632|323141047|FG002|Overall Study|Changed Mind|0|||
94369828|NCT02556632|323141045|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
94369829|NCT02556632|323141046|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
94369830|NCT02556632|323141047|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
94467541|NCT00908596|323502330|FG001|Overall Study|Withdrawal by Subject|1|||
94467542|NCT00908596|323502331|FG002|Overall Study|Withdrawal by Subject|3|||
94467543|NCT00908596|323502332|FG003|Overall Study|Withdrawal by Subject|1|||
94467544|NCT01390428|323502333|FG000|Overall Study|Elective Surgery|0|||
94467545|NCT01390428|323502334|FG001|Overall Study|Elective Surgery|0|||
94467546|NCT01390428|323502335|FG002|Overall Study|Elective Surgery|0|||
94369831|NCT02556632|323141045|FG000|Overall Study|Unrelated Adverse Event|1|||
94369832|NCT02556632|323141046|FG001|Overall Study|Unrelated Adverse Event|0|||
94369833|NCT02556632|323141047|FG002|Overall Study|Unrelated Adverse Event|3|||
94369834|NCT02556632|323141045|FG000|Overall Study|Related Adverse Event|0|||
94369835|NCT02556632|323141046|FG001|Overall Study|Related Adverse Event|1|||
94369836|NCT02556632|323141047|FG002|Overall Study|Related Adverse Event|0|||
94369837|NCT02556632|323141045|FG000|Overall Study|Possibly Related Adverse Event|0|||
94369838|NCT02556632|323141046|FG001|Overall Study|Possibly Related Adverse Event|0|||
94369839|NCT02556632|323141047|FG002|Overall Study|Possibly Related Adverse Event|1|||
94369840|NCT02556632|323141045|FG000|Overall Study|Did Not Start RT|0|||
94369841|NCT02556632|323141046|FG001|Overall Study|Did Not Start RT|1|||
94369842|NCT02556632|323141047|FG002|Overall Study|Did Not Start RT|0|||
94369843|NCT02556632|323141045|FG000|Overall Study|Ineligible|0|||
94369844|NCT02556632|323141046|FG001|Overall Study|Ineligible|1|||
94369845|NCT02556632|323141047|FG002|Overall Study|Ineligible|0|||
94369846|NCT02556632|323141045|FG000|Overall Study|Disliked Study Procedures|0|||
94369847|NCT02556632|323141046|FG001|Overall Study|Disliked Study Procedures|0|||
94369848|NCT02556632|323141047|FG002|Overall Study|Disliked Study Procedures|1|||
94369849|NCT02556632|323141045|FG000|Overall Study|Treatment or Change Delay|0|||
94369850|NCT02556632|323141046|FG001|Overall Study|Treatment or Change Delay|0|||
94369851|NCT02556632|323141047|FG002|Overall Study|Treatment or Change Delay|1|||
94369852|NCT00811070|323141048|FG000|Overall Study|Death|0|||
94369853|NCT00811070|323141049|FG001|Overall Study|Death|0|||
94369854|NCT00811070|323141050|FG002|Overall Study|Death|0|||
94369855|NCT00811070|323141051|FG003|Overall Study|Death|2|||
94369856|NCT00811070|323141052|FG004|Overall Study|Death|5|||
94369857|NCT00811070|323141053|FG005|Overall Study|Death|0|||
94369858|NCT00811070|323141048|FG000|Overall Study|Other|1|||
94369859|NCT00811070|323141049|FG001|Overall Study|Other|0|||
94369860|NCT00811070|323141050|FG002|Overall Study|Other|0|||
94369861|NCT00811070|323141051|FG003|Overall Study|Other|0|||
94369862|NCT00811070|323141052|FG004|Overall Study|Other|0|||
94369863|NCT00811070|323141053|FG005|Overall Study|Other|0|||
94369864|NCT00811070|323141048|FG000|Overall Study|Withdrawal by Subject|0|||
94369865|NCT00811070|323141049|FG001|Overall Study|Withdrawal by Subject|1|||
94369866|NCT00811070|323141050|FG002|Overall Study|Withdrawal by Subject|0|||
94369867|NCT00811070|323141051|FG003|Overall Study|Withdrawal by Subject|0|||
94369868|NCT00811070|323141052|FG004|Overall Study|Withdrawal by Subject|0|||
94369869|NCT00811070|323141053|FG005|Overall Study|Withdrawal by Subject|0|||
94369870|NCT00811070|323141048|FG000|Overall Study|Physician Decision|0|||
94369871|NCT00811070|323141049|FG001|Overall Study|Physician Decision|0|||
94369872|NCT00811070|323141050|FG002|Overall Study|Physician Decision|0|||
94369873|NCT00811070|323141051|FG003|Overall Study|Physician Decision|0|||
94369874|NCT00811070|323141052|FG004|Overall Study|Physician Decision|0|||
94369875|NCT00811070|323141053|FG005|Overall Study|Physician Decision|1|||
94369876|NCT04523831|323141056|FG000|Overall Study|Lost to Follow-up|15|||
94369877|NCT04523831|323141057|FG001|Overall Study|Lost to Follow-up|17|||
94369878|NCT04523831|323141056|FG000|Overall Study|Death|0|||
94369879|NCT04523831|323141057|FG001|Overall Study|Death|3|||
94369880|NCT04523831|323141056|FG000|Overall Study|Adverse Event|2|||
94369881|NCT04523831|323141057|FG001|Overall Study|Adverse Event|0|||
94369882|NCT00665626|323141061|FG000|Overall Study|Lack of Efficacy|8|||
94369883|NCT00665626|323141062|FG001|Overall Study|Lack of Efficacy|5|||
94467547|NCT01390428|323502336|FG003|Overall Study|Elective Surgery|0|||
94369884|NCT00665626|323141061|FG000|Overall Study|Lost to Follow-up|0|||
94369885|NCT00665626|323141062|FG001|Overall Study|Lost to Follow-up|2|||
94369886|NCT00665626|323141061|FG000|Overall Study|Withdrawal by Subject|0|||
94369887|NCT00665626|323141062|FG001|Overall Study|Withdrawal by Subject|1|||
94369888|NCT00665626|323141061|FG000|Overall Study|Protocol Violation|0|||
94369889|NCT00665626|323141062|FG001|Overall Study|Protocol Violation|2|||
94369890|NCT00665626|323141061|FG000|Overall Study|Adverse Event|1|||
94369891|NCT00665626|323141062|FG001|Overall Study|Adverse Event|9|||
94369892|NCT00665626|323141061|FG000|Overall Study|Due to exclusion criteria|0|||
94369893|NCT00665626|323141062|FG001|Overall Study|Due to exclusion criteria|1|||
94369894|NCT00665626|323141061|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
94369895|NCT00665626|323141062|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
94369896|NCT00665626|323141061|FG000|Overall Study|Unably to comply with dosing regimen|0|||
94741936|NCT04244175|324511688|FG001|Overall Study|Withdrawal by Subject|3|||
94277201|NCT00763815|322808112|FG000|Overall Study|Withdrawal by Subject|7|||
94277202|NCT00763815|322808113|FG001|Overall Study|Withdrawal by Subject|12|||
94277203|NCT00763815|322808112|FG000|Overall Study|Protocol Violation|2|||
94277204|NCT00763815|322808113|FG001|Overall Study|Protocol Violation|5|||
94277205|NCT00763815|322808112|FG000|Overall Study|Sponsor's Decision|0|||
94277206|NCT00763815|322808113|FG001|Overall Study|Sponsor's Decision|1|||
94277207|NCT00183274|322808117|FG000|Phase 1: Open-Label|Adverse Event|31|||
94277208|NCT00183274|322808118|FG001|Phase 1: Open-Label|Adverse Event|0|||
94277209|NCT00183274|322808119|FG002|Phase 1: Open-Label|Adverse Event|0|||
94277210|NCT00183274|322808120|FG003|Phase 1: Open-Label|Adverse Event|0|||
94277211|NCT00183274|322808121|FG004|Phase 1: Open-Label|Adverse Event|0|||
94277212|NCT00183274|322808122|FG005|Phase 1: Open-Label|Adverse Event|0|||
94277213|NCT00183274|322808117|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
94277214|NCT00183274|322808118|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
94277215|NCT00183274|322808119|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
94277216|NCT00183274|322808120|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
94277217|NCT00183274|322808121|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
94277218|NCT00183274|322808122|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
94277219|NCT00183274|322808117|FG000|Phase 1: Open-Label|Protocol Violation|11|||
94277220|NCT00183274|322808118|FG001|Phase 1: Open-Label|Protocol Violation|0|||
94277221|NCT00183274|322808119|FG002|Phase 1: Open-Label|Protocol Violation|0|||
94277222|NCT00183274|322808120|FG003|Phase 1: Open-Label|Protocol Violation|0|||
94277223|NCT00183274|322808121|FG004|Phase 1: Open-Label|Protocol Violation|0|||
94277224|NCT00183274|322808122|FG005|Phase 1: Open-Label|Protocol Violation|0|||
94277225|NCT00183274|322808117|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
94277226|NCT00183274|322808118|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
94277227|NCT00183274|322808119|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
94277228|NCT00183274|322808120|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
94277229|NCT00183274|322808121|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
94277230|NCT00183274|322808122|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
94277231|NCT00183274|322808117|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
94277232|NCT00183274|322808118|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
94277233|NCT00183274|322808119|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
94277234|NCT00183274|322808120|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
94277235|NCT00183274|322808121|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
94277236|NCT00183274|322808122|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
94277237|NCT00183274|322808117|FG000|Phase 1: Open-Label|Other|9|||
94277238|NCT00183274|322808118|FG001|Phase 1: Open-Label|Other|0|||
94277239|NCT00183274|322808119|FG002|Phase 1: Open-Label|Other|0|||
94277240|NCT00183274|322808120|FG003|Phase 1: Open-Label|Other|0|||
94277241|NCT00183274|322808121|FG004|Phase 1: Open-Label|Other|0|||
94277242|NCT00183274|322808122|FG005|Phase 1: Open-Label|Other|0|||
94277243|NCT00183274|322808117|FG000|Phase 2: Double-Blind|Relapsed|0|||
94277244|NCT00183274|322808118|FG001|Phase 2: Double-Blind|Relapsed|8|||
94741937|NCT04244175|324511689|FG002|Overall Study|Withdrawal by Subject|1|||
94741938|NCT04244175|324511687|FG000|Overall Study|Other, not specified|0|||
94741939|NCT04244175|324511688|FG001|Overall Study|Other, not specified|1|||
94741940|NCT04244175|324511689|FG002|Overall Study|Other, not specified|2|||
94741941|NCT03635567|324511691|FG000|Overall Study|Lost to Follow-up|4|||
94741942|NCT03635567|324511692|FG001|Overall Study|Lost to Follow-up|1|||
94741943|NCT03635567|324511691|FG000|Overall Study|Withdrawal by Subject|11|||
94741944|NCT03635567|324511692|FG001|Overall Study|Withdrawal by Subject|16|||
94741945|NCT03635567|324511691|FG000|Overall Study|Sponsor Decision|99|||
94741946|NCT03635567|324511692|FG001|Overall Study|Sponsor Decision|57|||
94741947|NCT03635567|324511691|FG000|Overall Study|Death|194|||
94741948|NCT03635567|324511692|FG001|Overall Study|Death|235|||
94741949|NCT02467270|324511693|FG000|Overall Study|Participants Never Treated|0|||
94741950|NCT02467270|324511694|FG001|Overall Study|Participants Never Treated|1|||
94741951|NCT02467270|324511695|FG002|Overall Study|Participants Never Treated|0|||
94741952|NCT02467270|324511693|FG000|Overall Study|Ongoing|50|||
94741953|NCT02467270|324511694|FG001|Overall Study|Ongoing|41|||
94741954|NCT02467270|324511695|FG002|Overall Study|Ongoing|43|||
94741955|NCT02467270|324511693|FG000|Overall Study|Adverse Event|16|||
94467548|NCT01390428|323502337|FG004|Overall Study|Elective Surgery|1|||
94741956|NCT02467270|324511694|FG001|Overall Study|Adverse Event|15|||
94277245|NCT00183274|322808119|FG002|Phase 2: Double-Blind|Relapsed|29|||
94277246|NCT00183274|322808120|FG003|Phase 2: Double-Blind|Relapsed|0|||
94277247|NCT00183274|322808121|FG004|Phase 2: Double-Blind|Relapsed|0|||
94277248|NCT00183274|322808122|FG005|Phase 2: Double-Blind|Relapsed|0|||
94277249|NCT00183274|322808117|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
94277250|NCT00183274|322808118|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
94277251|NCT00183274|322808119|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
94741957|NCT02467270|324511695|FG002|Overall Study|Adverse Event|14|||
94741958|NCT02467270|324511693|FG000|Overall Study|Progressive Disease|7|||
94741959|NCT02467270|324511694|FG001|Overall Study|Progressive Disease|7|||
94741960|NCT02467270|324511695|FG002|Overall Study|Progressive Disease|4|||
94741961|NCT02467270|324511693|FG000|Overall Study|Death|2|||
94741962|NCT02467270|324511694|FG001|Overall Study|Death|0|||
94277252|NCT00183274|322808120|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
94277253|NCT00183274|322808121|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
94277254|NCT00183274|322808122|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
94277255|NCT00183274|322808117|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
94277256|NCT00183274|322808118|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
94277257|NCT00183274|322808119|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
94277258|NCT00183274|322808120|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
94277259|NCT00183274|322808121|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
94277260|NCT00183274|322808122|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
94277261|NCT00183274|322808117|FG000|Phase 3: Double-Blind|Relapsed|0|||
94277262|NCT00183274|322808118|FG001|Phase 3: Double-Blind|Relapsed|0|||
94277263|NCT00183274|322808119|FG002|Phase 3: Double-Blind|Relapsed|0|||
94277264|NCT00183274|322808120|FG003|Phase 3: Double-Blind|Relapsed|1|||
94277265|NCT00183274|322808121|FG004|Phase 3: Double-Blind|Relapsed|11|||
94277266|NCT00183274|322808122|FG005|Phase 3: Double-Blind|Relapsed|2|||
94277267|NCT01604265|322808126|FG000|Overall Study|Adverse Event|1|||
94277268|NCT01604265|322808127|FG001|Overall Study|Adverse Event|0|||
94277269|NCT01604265|322808126|FG000|Overall Study|Withdrawal by Subject|1|||
94277270|NCT01604265|322808127|FG001|Overall Study|Withdrawal by Subject|0|||
94277271|NCT00705783|322808138|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
94277272|NCT00705783|322808139|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
94277273|NCT00705783|322808140|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
94277274|NCT00705783|322808138|FG000|Conversion Phase|Lost to Follow-up|13|||
94277275|NCT00705783|322808139|FG001|Conversion Phase|Lost to Follow-up|0|||
94277276|NCT00705783|322808140|FG002|Conversion Phase|Lost to Follow-up|0|||
94277277|NCT00705783|322808138|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
94277278|NCT00705783|322808139|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
94277279|NCT00705783|322808140|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
94277280|NCT00705783|322808138|FG000|Conversion Phase|Withdrawn by Investigator|4|||
94277281|NCT00705783|322808139|FG001|Conversion Phase|Withdrawn by Investigator|0|||
94277282|NCT00705783|322808140|FG002|Conversion Phase|Withdrawn by Investigator|0|||
94277283|NCT00705783|322808138|FG000|Conversion Phase|Withdrew Consent|24|||
94277284|NCT00705783|322808139|FG001|Conversion Phase|Withdrew Consent|0|||
94277285|NCT00705783|322808140|FG002|Conversion Phase|Withdrew Consent|0|||
94277286|NCT00705783|322808138|FG000|Conversion Phase|Protocol Deviation|2|||
94277287|NCT00705783|322808139|FG001|Conversion Phase|Protocol Deviation|0|||
94277288|NCT00705783|322808140|FG002|Conversion Phase|Protocol Deviation|0|||
94277289|NCT00705783|322808138|FG000|Conversion Phase|Adverse Event|11|||
94277290|NCT00705783|322808139|FG001|Conversion Phase|Adverse Event|0|||
94277291|NCT00705783|322808140|FG002|Conversion Phase|Adverse Event|0|||
94277292|NCT00705783|322808138|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
94277293|NCT00705783|322808139|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
94277294|NCT00705783|322808140|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
94277295|NCT00705783|322808138|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
94277296|NCT00705783|322808139|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
94277297|NCT00705783|322808140|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
94277298|NCT00705783|322808138|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
94277299|NCT00705783|322808139|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
94277300|NCT00705783|322808140|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
94277301|NCT00705783|322808138|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
94277302|NCT00705783|322808139|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
94277303|NCT00705783|322808140|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
94277304|NCT00705783|322808138|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
94277305|NCT00705783|322808139|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
94277306|NCT00705783|322808140|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
94277307|NCT00705783|322808138|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
94277308|NCT00705783|322808139|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
94277309|NCT00705783|322808140|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
94277310|NCT00705783|322808138|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
94277311|NCT00705783|322808139|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
94277312|NCT00705783|322808140|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
94277313|NCT00705783|322808138|FG000|Oral Stabilization Phase|Adverse Event|14|||
94277314|NCT00705783|322808139|FG001|Oral Stabilization Phase|Adverse Event|0|||
94277315|NCT00705783|322808140|FG002|Oral Stabilization Phase|Adverse Event|0|||
94277316|NCT00705783|322808138|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
94277317|NCT00705783|322808139|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
94277318|NCT00705783|322808140|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
94277319|NCT00705783|322808138|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
94277320|NCT00705783|322808139|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
94277321|NCT00705783|322808140|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
94277322|NCT00705783|322808138|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
94277323|NCT00705783|322808139|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
94277324|NCT00705783|322808140|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
94277325|NCT00705783|322808138|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
94277326|NCT00705783|322808139|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
94277327|NCT00705783|322808140|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
94277328|NCT00705783|322808138|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
94277329|NCT00705783|322808139|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
94277330|NCT00705783|322808140|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
94277331|NCT00705783|322808138|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
94467549|NCT01390428|323502338|FG005|Overall Study|Elective Surgery|0|||
94741963|NCT02467270|324511695|FG002|Overall Study|Death|2|||
94741964|NCT02467270|324511693|FG000|Overall Study|Lack of Efficacy|12|||
94741965|NCT02467270|324511694|FG001|Overall Study|Lack of Efficacy|18|||
94741966|NCT02467270|324511695|FG002|Overall Study|Lack of Efficacy|23|||
94741967|NCT02467270|324511693|FG000|Overall Study|Non-compliance With Study Drug|0|||
94741968|NCT02467270|324511694|FG001|Overall Study|Non-compliance With Study Drug|2|||
94741969|NCT02467270|324511695|FG002|Overall Study|Non-compliance With Study Drug|1|||
94741970|NCT02467270|324511693|FG000|Overall Study|Lost to Follow-up|2|||
94741971|NCT02467270|324511694|FG001|Overall Study|Lost to Follow-up|1|||
94741972|NCT02467270|324511695|FG002|Overall Study|Lost to Follow-up|0|||
94741973|NCT02467270|324511693|FG000|Overall Study|Pregnancy|0|||
94741974|NCT02467270|324511694|FG001|Overall Study|Pregnancy|1|||
94741975|NCT02467270|324511695|FG002|Overall Study|Pregnancy|0|||
94741976|NCT02467270|324511693|FG000|Overall Study|Physician Decision|0|||
94741977|NCT02467270|324511694|FG001|Overall Study|Physician Decision|4|||
94741978|NCT02467270|324511695|FG002|Overall Study|Physician Decision|1|||
94741979|NCT02467270|324511693|FG000|Overall Study|Withdrawal by Subject|4|||
94741980|NCT02467270|324511694|FG001|Overall Study|Withdrawal by Subject|3|||
94741981|NCT02467270|324511695|FG002|Overall Study|Withdrawal by Subject|5|||
94741982|NCT02467270|324511693|FG000|Overall Study|Reason not Specified|1|||
94741983|NCT02467270|324511694|FG001|Overall Study|Reason not Specified|2|||
94741984|NCT02467270|324511695|FG002|Overall Study|Reason not Specified|1|||
94741985|NCT01880515|324511698|FG000|Overall Study|Lost to Follow-up|3|||
94741986|NCT01880515|324511699|FG001|Overall Study|Lost to Follow-up|2|||
94741987|NCT01880515|324511698|FG000|Overall Study|Disease Progression|5|||
94741988|NCT01880515|324511699|FG001|Overall Study|Disease Progression|7|||
94741989|NCT02075840|324511700|FG000|Overall Study|Withdrawal by Subject|13|||
94741990|NCT02075840|324511701|FG001|Overall Study|Withdrawal by Subject|22|||
94741991|NCT02075840|324511700|FG000|Overall Study|Reason not specified|1|||
94741992|NCT02075840|324511701|FG001|Overall Study|Reason not specified|0|||
94741993|NCT02075840|324511700|FG000|Overall Study|Adverse Event|0|||
94741994|NCT02075840|324511701|FG001|Overall Study|Adverse Event|2|||
94741995|NCT02075840|324511700|FG000|Overall Study|Death|35|||
94741996|NCT02075840|324511701|FG001|Overall Study|Death|40|||
94741997|NCT02075840|324511700|FG000|Overall Study|Lost to Follow-up|3|||
94741998|NCT02075840|324511701|FG001|Overall Study|Lost to Follow-up|2|||
94741999|NCT02075840|324511700|FG000|Overall Study|Physician Decision|1|||
94742000|NCT02075840|324511701|FG001|Overall Study|Physician Decision|3|||
94742001|NCT02075840|324511700|FG000|Overall Study|Ongoing at CCOD|99|||
94742002|NCT02075840|324511701|FG001|Overall Study|Ongoing at CCOD|82|||
94742003|NCT05247034|324511702|FG000|Overall Study|Lost to Follow-up|3|||
94277332|NCT00705783|322808139|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
94277333|NCT00705783|322808140|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
94277334|NCT00705783|322808138|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
94277335|NCT00705783|322808139|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
94277336|NCT00705783|322808140|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
94277337|NCT00705783|322808138|FG000|Depot Stabilization Phase|Adverse Event|17|||
94277338|NCT00705783|322808139|FG001|Depot Stabilization Phase|Adverse Event|0|||
94277339|NCT00705783|322808140|FG002|Depot Stabilization Phase|Adverse Event|0|||
94277340|NCT00705783|322808138|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
94277341|NCT00705783|322808139|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
94277342|NCT00705783|322808140|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
94277343|NCT00705783|322808138|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
94277344|NCT00705783|322808139|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
94330888|NCT01522443|322991751|FG001|Overall Study|Adverse Event|15|||
94369897|NCT00665626|323141062|FG001|Overall Study|Unably to comply with dosing regimen|1|||
94369898|NCT00665626|323141061|FG000|Overall Study|Death|1|||
94369899|NCT00665626|323141062|FG001|Overall Study|Death|0|||
94369900|NCT00585039|323141063|FG000|Overall Study|medication spilled|2|||
94369901|NCT00585039|323141064|FG001|Overall Study|medication spilled|0|||
94369902|NCT01458119|323141065|FG000|Overall Study|Physician Decision|4|||
94467550|NCT01390428|323502333|FG000|Overall Study|Withdrawal by Subject|0|||
94369903|NCT01458119|323141065|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
94369904|NCT01458119|323141065|FG000|Overall Study|Pregnancy|1|||
94369905|NCT01458119|323141065|FG000|Overall Study|Death|2|||
94369906|NCT01458119|323141065|FG000|Overall Study|Adverse Event|1|||
94369907|NCT01458119|323141065|FG000|Overall Study|Consent Withdrawn by Participant|8|||
94369908|NCT01458119|323141065|FG000|Overall Study|Non-compliance With Study Drug|3|||
94369909|NCT01010230|323141066|FG000|Overall Study|Withdrawal by Subject|6|||
94369910|NCT01010230|323141067|FG001|Overall Study|Withdrawal by Subject|5|||
94369911|NCT01010230|323141066|FG000|Overall Study|Lost to Follow-up|4|||
94369912|NCT01010230|323141067|FG001|Overall Study|Lost to Follow-up|2|||
94369913|NCT00530439|323141068|FG000|Overall Study|GDM|9|||
94369914|NCT00530439|323141069|FG001|Overall Study|GDM|3|||
94369915|NCT00530439|323141068|FG000|Overall Study|Withdraw|18|||
94369916|NCT00530439|323141069|FG001|Overall Study|Withdraw|14|||
94369917|NCT00530439|323141068|FG000|Overall Study|Missed abortion|1|||
94369918|NCT00530439|323141069|FG001|Overall Study|Missed abortion|4|||
94369919|NCT00530439|323141068|FG000|Overall Study|Misclassification|2|||
94369920|NCT00530439|323141069|FG001|Overall Study|Misclassification|0|||
94369921|NCT00530439|323141068|FG000|Overall Study|Twin pregnancy|0|||
94369922|NCT00530439|323141069|FG001|Overall Study|Twin pregnancy|2|||
94369923|NCT00530439|323141068|FG000|Overall Study|Severe malformation/abortion|0|||
94369924|NCT00530439|323141069|FG001|Overall Study|Severe malformation/abortion|3|||
94369925|NCT00430638|323141070|FG000|Overall Study|Adverse Event|15|||
94369926|NCT00430638|323141071|FG001|Overall Study|Adverse Event|15|||
94369927|NCT00430638|323141070|FG000|Overall Study|Uncontrolled blood pressure|48|||
94369928|NCT00430638|323141071|FG001|Overall Study|Uncontrolled blood pressure|13|||
94369929|NCT00430638|323141070|FG000|Overall Study|Lost to Follow-up|1|||
94369930|NCT00430638|323141071|FG001|Overall Study|Lost to Follow-up|7|||
94369931|NCT00430638|323141070|FG000|Overall Study|Protocol Violation|6|||
94369932|NCT00430638|323141071|FG001|Overall Study|Protocol Violation|4|||
94369933|NCT00430638|323141070|FG000|Overall Study|Withdrawal by Subject|4|||
94369934|NCT00430638|323141071|FG001|Overall Study|Withdrawal by Subject|6|||
94369935|NCT00430638|323141070|FG000|Overall Study|Non-compliant|2|||
94369936|NCT00430638|323141071|FG001|Overall Study|Non-compliant|1|||
94369937|NCT00430638|323141070|FG000|Overall Study|Other|2|||
94369938|NCT00430638|323141071|FG001|Overall Study|Other|2|||
94369939|NCT01629693|323141074|FG000|Overall Study|Lost to Follow-up|2|||
94369940|NCT01629693|323141075|FG001|Overall Study|Lost to Follow-up|4|||
94369941|NCT01629693|323141074|FG000|Overall Study|Withdrawal by Subject|2|||
94369942|NCT01629693|323141075|FG001|Overall Study|Withdrawal by Subject|2|||
94369943|NCT01629693|323141074|FG000|Overall Study|Adverse Event|1|||
94369944|NCT01629693|323141075|FG001|Overall Study|Adverse Event|0|||
94369945|NCT01629693|323141074|FG000|Overall Study|Investigator decision|0|||
94369946|NCT01629693|323141075|FG001|Overall Study|Investigator decision|1|||
94369947|NCT01629693|323141074|FG000|Overall Study|Poor comfort of study lenses|0|||
94369948|NCT01629693|323141075|FG001|Overall Study|Poor comfort of study lenses|2|||
94369949|NCT01629693|323141074|FG000|Overall Study|Subject decision unrelated to AE|0|||
94369950|NCT01629693|323141075|FG001|Overall Study|Subject decision unrelated to AE|1|||
94369951|NCT01529749|323141076|FG000|Overall Study|Lost to Follow-up|0|||
94369952|NCT01529749|323141077|FG001|Overall Study|Lost to Follow-up|1|||
94369953|NCT01529749|323141078|FG002|Overall Study|Lost to Follow-up|1|||
94369954|NCT01529749|323141079|FG003|Overall Study|Lost to Follow-up|0|||
94369955|NCT01529749|323141076|FG000|Overall Study|Physician Decision|0|||
94369956|NCT01529749|323141077|FG001|Overall Study|Physician Decision|0|||
94369957|NCT01529749|323141078|FG002|Overall Study|Physician Decision|0|||
94369958|NCT01529749|323141079|FG003|Overall Study|Physician Decision|1|||
94369959|NCT01529749|323141076|FG000|Overall Study|Withdrawal by Subject|0|||
94369960|NCT01529749|323141077|FG001|Overall Study|Withdrawal by Subject|1|||
94369961|NCT01529749|323141078|FG002|Overall Study|Withdrawal by Subject|1|||
94369962|NCT01529749|323141079|FG003|Overall Study|Withdrawal by Subject|0|||
94369963|NCT01529749|323141076|FG000|Overall Study|Protocol Violation|0|||
94369964|NCT01529749|323141077|FG001|Overall Study|Protocol Violation|0|||
94369965|NCT01529749|323141078|FG002|Overall Study|Protocol Violation|0|||
94369966|NCT01529749|323141079|FG003|Overall Study|Protocol Violation|1|||
94467551|NCT01390428|323502334|FG001|Overall Study|Withdrawal by Subject|0|||
94369967|NCT04385199|323141080|FG000|Overall Study|Withdrawal by Subject|1|||
94369968|NCT04385199|323141081|FG001|Overall Study|Withdrawal by Subject|0|||
94369969|NCT00789828|323141084|FG000|Core Period (48 Weeks)|Administrative problems|0|||
94369970|NCT00789828|323141085|FG001|Core Period (48 Weeks)|Administrative problems|1|||
94369971|NCT00789828|323141084|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
94369972|NCT00789828|323141085|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
94369973|NCT00789828|323141084|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
94369974|NCT00789828|323141085|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
94369975|NCT00789828|323141084|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
94742004|NCT05247034|324511703|FG001|Overall Study|Lost to Follow-up|2|||
94742005|NCT05247034|324511702|FG000|Overall Study|Organizational problems when attending appointments|1|||
94742006|NCT05247034|324511703|FG001|Overall Study|Organizational problems when attending appointments|0|||
94742007|NCT04408755|324511706|FG000|Period A (Placebo lead-in)|Other|11|||
94742008|NCT04408755|324511707|FG001|Period A (Placebo lead-in)|Other|0|||
94742009|NCT04408755|324511708|FG002|Period A (Placebo lead-in)|Other|0|||
94742010|NCT04408755|324511709|FG003|Period A (Placebo lead-in)|Other|0|||
94742011|NCT04408755|324511706|FG000|Period B (Randomization Period)|Adverse Event|0|||
94742012|NCT04408755|324511707|FG001|Period B (Randomization Period)|Adverse Event|3|||
94742013|NCT04408755|324511708|FG002|Period B (Randomization Period)|Adverse Event|0|||
94742014|NCT04408755|324511709|FG003|Period B (Randomization Period)|Adverse Event|1|||
94742015|NCT04408755|324511706|FG000|Period B (Randomization Period)|Death|0|||
94742016|NCT04408755|324511707|FG001|Period B (Randomization Period)|Death|0|||
94742017|NCT04408755|324511708|FG002|Period B (Randomization Period)|Death|1|||
94742018|NCT04408755|324511709|FG003|Period B (Randomization Period)|Death|0|||
94742019|NCT04408755|324511706|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
94742020|NCT04408755|324511707|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
94742021|NCT04408755|324511708|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
94742022|NCT04408755|324511709|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
94742023|NCT04408755|324511706|FG000|Period B (Randomization Period)|Physician Decision|0|||
94742024|NCT04408755|324511707|FG001|Period B (Randomization Period)|Physician Decision|0|||
94742025|NCT04408755|324511708|FG002|Period B (Randomization Period)|Physician Decision|1|||
94742026|NCT04408755|324511709|FG003|Period B (Randomization Period)|Physician Decision|0|||
94742027|NCT04408755|324511706|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
94742028|NCT04408755|324511707|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
94742029|NCT04408755|324511708|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
94742030|NCT04408755|324511709|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
94742031|NCT04408755|324511706|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
94277345|NCT00705783|322808140|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
94277346|NCT00705783|322808138|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
94277347|NCT00705783|322808139|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
94277348|NCT00705783|322808140|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
94277349|NCT00705783|322808138|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
94277350|NCT00705783|322808139|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
94277351|NCT00705783|322808140|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
94277352|NCT00705783|322808138|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
94277353|NCT00705783|322808139|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
94277354|NCT00705783|322808140|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
94277355|NCT00705783|322808138|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
94277356|NCT00705783|322808139|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
94277357|NCT00705783|322808140|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
94277358|NCT00705783|322808138|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
94277359|NCT00705783|322808139|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
94277360|NCT00705783|322808140|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
94277361|NCT00705783|322808138|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
94277362|NCT00705783|322808139|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
94277363|NCT00705783|322808140|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
94277364|NCT00705783|322808138|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
94277365|NCT00705783|322808139|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
94277366|NCT00705783|322808140|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
94277367|NCT00705783|322808138|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
94277368|NCT00705783|322808139|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
94277369|NCT00705783|322808140|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
94277370|NCT00705783|322808138|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
94277371|NCT00705783|322808139|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
94277372|NCT00705783|322808140|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
94277373|NCT01297270|322808144|FG000|Overall Study|Adverse Event|19|||
94277374|NCT01297270|322808145|FG001|Overall Study|Adverse Event|32|||
94277375|NCT01297270|322808146|FG002|Overall Study|Adverse Event|5|||
94277376|NCT01297270|322808144|FG000|Overall Study|Lack of Efficacy|15|||
94277377|NCT01297270|322808145|FG001|Overall Study|Lack of Efficacy|17|||
94277378|NCT01297270|322808146|FG002|Overall Study|Lack of Efficacy|15|||
94742032|NCT04408755|324511707|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
94277379|NCT01297270|322808144|FG000|Overall Study|Lost to Follow-up|1|||
94277380|NCT01297270|322808145|FG001|Overall Study|Lost to Follow-up|2|||
94277381|NCT01297270|322808146|FG002|Overall Study|Lost to Follow-up|1|||
94742033|NCT04408755|324511708|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
94742034|NCT04408755|324511709|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
94369976|NCT00789828|323141085|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
94369977|NCT00789828|323141084|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
94369978|NCT00789828|323141085|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
94369979|NCT00789828|323141084|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
94369980|NCT00789828|323141085|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
94369981|NCT00789828|323141084|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
94369982|NCT00789828|323141085|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
94369983|NCT00789828|323141084|FG000|Open-label Extension Period (4 Years)|Death|1|||
94369984|NCT00789828|323141085|FG001|Open-label Extension Period (4 Years)|Death|0|||
94369985|NCT00789828|323141084|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
94369986|NCT00789828|323141085|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
94369987|NCT00789828|323141084|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
94369988|NCT00789828|323141085|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
94369989|NCT01606137|323141086|FG000|Overall Study|Adverse Event|85|||
94369990|NCT01606137|323141086|FG000|Overall Study|Withdrawal by Subject|74|||
94369991|NCT01606137|323141086|FG000|Overall Study|Lack of Efficacy|56|||
94369992|NCT01606137|323141086|FG000|Overall Study|Lost to Follow-up|15|||
94369993|NCT01606137|323141086|FG000|Overall Study|Protocol Violation|1|||
94369994|NCT01606137|323141086|FG000|Overall Study|Patient non-compliance|9|||
94369995|NCT01606137|323141086|FG000|Overall Study|Death|1|||
94369996|NCT01606137|323141086|FG000|Overall Study|Decreased/no pain|4|||
94369997|NCT01606137|323141086|FG000|Overall Study|Issues with driving|4|||
94369998|NCT01606137|323141086|FG000|Overall Study|multiple sclerosis less stable|1|||
94369999|NCT01606137|323141086|FG000|Overall Study|Increased bilirubin|1|||
94370000|NCT01606137|323141086|FG000|Overall Study|Spray causes nausea|1|||
94370001|NCT01606137|323141086|FG000|Overall Study|Not enough improvement|4|||
94370002|NCT01606137|323141086|FG000|Overall Study|Wanted to try another treatment|1|||
94370003|NCT01606137|323141086|FG000|Overall Study|Patient leaving country|1|||
94370004|NCT01606137|323141086|FG000|Overall Study|Personal reasons|1|||
94370005|NCT01606137|323141086|FG000|Overall Study|Unable to tolerate study med. taste|1|||
94370006|NCT01606137|323141086|FG000|Overall Study|Patient moving|1|||
94370007|NCT01606137|323141086|FG000|Overall Study|Unable to collect consistent data|1|||
94370008|NCT00420290|323141087|FG000|Overall Study|Adverse Event|3|||
94370009|NCT00420290|323141088|FG001|Overall Study|Adverse Event|1|||
94370010|NCT00420290|323141087|FG000|Overall Study|Withdrawal by Subject|0|||
94370011|NCT00420290|323141088|FG001|Overall Study|Withdrawal by Subject|2|||
94370012|NCT00420290|323141087|FG000|Overall Study|did not meet inclusion/exclusion|1|||
94370013|NCT00420290|323141088|FG001|Overall Study|did not meet inclusion/exclusion|1|||
94370014|NCT02598622|323142796|FG000|Overall Study|Withdrawal by Subject|3|||
94370015|NCT02598622|323142797|FG001|Overall Study|Withdrawal by Subject|0|||
94370016|NCT02598622|323142796|FG000|Overall Study|Physician Decision|3|||
94370017|NCT02598622|323142797|FG001|Overall Study|Physician Decision|0|||
94370018|NCT00681824|323142798|FG000|Overall Study|withdrawn by investigator|0|||
94370019|NCT00681824|323142799|FG001|Overall Study|withdrawn by investigator|0|||
94370020|NCT00681824|323142800|FG002|Overall Study|withdrawn by investigator|1|||
94370021|NCT00681824|323142798|FG000|Overall Study|scheduling conflict|1|||
94370022|NCT00681824|323142799|FG001|Overall Study|scheduling conflict|0|||
94370023|NCT00681824|323142800|FG002|Overall Study|scheduling conflict|0|||
94370024|NCT00681824|323142798|FG000|Overall Study|Death|0|||
94370025|NCT00681824|323142799|FG001|Overall Study|Death|1|||
94370026|NCT00681824|323142800|FG002|Overall Study|Death|0|||
94742035|NCT04408755|324511706|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
94370027|NCT03724916|323142801|FG000|Overall Study|Withdrawal by Subject|0|||
94742036|NCT04408755|324511707|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
94742037|NCT04408755|324511708|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
94742038|NCT04408755|324511709|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
94742039|NCT04408755|324511706|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
94742040|NCT04408755|324511707|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
94742041|NCT04408755|324511708|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
94742042|NCT04408755|324511709|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
94742043|NCT04408755|324511706|FG000|Period B (Randomization Period)|Reason not Specified|0|||
94742044|NCT04408755|324511707|FG001|Period B (Randomization Period)|Reason not Specified|1|||
94742045|NCT04408755|324511708|FG002|Period B (Randomization Period)|Reason not Specified|0|||
94370028|NCT03724916|323142802|FG001|Overall Study|Withdrawal by Subject|1|||
94370029|NCT03724916|323142803|FG002|Overall Study|Withdrawal by Subject|1|||
94370030|NCT03724916|323142804|FG003|Overall Study|Withdrawal by Subject|2|||
94370031|NCT03724916|323142801|FG000|Overall Study|Randomized but not Treated|1|||
94370032|NCT03724916|323142802|FG001|Overall Study|Randomized but not Treated|0|||
94370033|NCT03724916|323142803|FG002|Overall Study|Randomized but not Treated|0|||
94370034|NCT03724916|323142804|FG003|Overall Study|Randomized but not Treated|0|||
94370035|NCT00678379|323142808|FG000|Overall Study|Injection performed after tonsillectomy|2|||
94370036|NCT00678379|323142809|FG001|Overall Study|Injection performed after tonsillectomy|0|||
94370037|NCT00678379|323142810|FG002|Overall Study|Injection performed after tonsillectomy|1|||
94370038|NCT00678379|323142808|FG000|Overall Study|Incomplete Data|4|||
94370039|NCT00678379|323142809|FG001|Overall Study|Incomplete Data|3|||
94370040|NCT00678379|323142810|FG002|Overall Study|Incomplete Data|3|||
94370041|NCT00736099|323142819|FG000|Overall Study|Adverse Event|61|||
94370042|NCT00736099|323142820|FG001|Overall Study|Adverse Event|18|||
94370043|NCT00736099|323142819|FG000|Overall Study|Protocol Violation|10|||
94370044|NCT00736099|323142820|FG001|Overall Study|Protocol Violation|4|||
94370045|NCT00736099|323142819|FG000|Overall Study|Lost to Follow-up|12|||
94370046|NCT00736099|323142820|FG001|Overall Study|Lost to Follow-up|5|||
94370047|NCT00736099|323142819|FG000|Overall Study|Withdrawal by Subject|42|||
94370048|NCT00736099|323142820|FG001|Overall Study|Withdrawal by Subject|13|||
94370049|NCT00736099|323142819|FG000|Overall Study|Lack of Efficacy|15|||
94370050|NCT00736099|323142820|FG001|Overall Study|Lack of Efficacy|8|||
94370051|NCT00736099|323142819|FG000|Overall Study|Other reason|43|||
94277382|NCT01297270|322808144|FG000|Overall Study|Protocol Violation|0|||
94277383|NCT01297270|322808145|FG001|Overall Study|Protocol Violation|2|||
94277384|NCT01297270|322808146|FG002|Overall Study|Protocol Violation|0|||
94277385|NCT01297270|322808144|FG000|Overall Study|Withdrawal by Subject|7|||
94277386|NCT01297270|322808145|FG001|Overall Study|Withdrawal by Subject|15|||
94277387|NCT01297270|322808146|FG002|Overall Study|Withdrawal by Subject|7|||
94277388|NCT01297270|322808144|FG000|Overall Study|Other reason not defined above|3|||
94370052|NCT00736099|323142820|FG001|Overall Study|Other reason|10|||
94370053|NCT02598193|323142823|FG000|Overall Study|Adverse Event|13|||
94370054|NCT02598193|323142823|FG000|Overall Study|Withdrawal by Subject|1|||
94370055|NCT02598193|323142823|FG000|Overall Study|Listed in active lung transplant list|1|||
94370056|NCT02598193|323142823|FG000|Overall Study|Does not want to take Nintedanib|1|||
94370057|NCT02410837|323142824|FG000|Overall Study|Death|387|||
94370058|NCT02410837|323142824|FG000|Overall Study|Lost to Follow-up|50|||
94370059|NCT02410837|323142824|FG000|Overall Study|Withdrawal by Subject|44|||
94370060|NCT02410837|323142824|FG000|Overall Study|Physician Decision|6|||
94370061|NCT02410837|323142824|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
94370062|NCT02354976|323142827|FG000|Overall Study|Other - reason not specified|1|||
94277389|NCT01297270|322808145|FG001|Overall Study|Other reason not defined above|3|||
94277390|NCT01297270|322808146|FG002|Overall Study|Other reason not defined above|1|||
94277391|NCT01297270|322808144|FG000|Overall Study|Not treated|0|||
94277392|NCT01297270|322808145|FG001|Overall Study|Not treated|1|||
94277393|NCT01297270|322808146|FG002|Overall Study|Not treated|0|||
94277394|NCT02863809|322808150|FG000|Overall Study|Adverse Event|8|||
94277395|NCT02863809|322808151|FG001|Overall Study|Adverse Event|8|||
94277396|NCT02863809|322808150|FG000|Overall Study|Withdrawal by Subject|0|||
94370063|NCT02354976|323142828|FG001|Overall Study|Other - reason not specified|0|||
94370064|NCT02354976|323142829|FG002|Overall Study|Other - reason not specified|1|||
94370065|NCT02354976|323142827|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
94370066|NCT02354976|323142828|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
94370067|NCT02354976|323142829|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
94370068|NCT02354976|323142827|FG000|Overall Study|Adverse Event|1|||
94370069|NCT02354976|323142828|FG001|Overall Study|Adverse Event|0|||
94370070|NCT02354976|323142829|FG002|Overall Study|Adverse Event|2|||
94370071|NCT03118765|323142833|FG000|Overall Study|Withdrawal by Subject|0|||
94742046|NCT04408755|324511709|FG003|Period B (Randomization Period)|Reason not Specified|2|||
94742047|NCT01778686|324511710|FG000|Overall Study|Adverse Event|0|||
94742048|NCT01778686|324511711|FG001|Overall Study|Adverse Event|0|||
94742049|NCT01778686|324511712|FG002|Overall Study|Adverse Event|1|||
94742050|NCT04012567|324511713|FG000|Overall Study|Lost to Follow-up|0|||
94742051|NCT04012567|324511714|FG001|Overall Study|Lost to Follow-up|1|||
94742052|NCT04012567|324511713|FG000|Overall Study|Withdrawal by Subject|1|||
94742053|NCT04012567|324511714|FG001|Overall Study|Withdrawal by Subject|0|||
94742054|NCT01499368|324511715|FG000|Overall Study|Did not meet I/E criteria|8|||
94742055|NCT01499368|324511716|FG001|Overall Study|Did not meet I/E criteria|4|||
94742056|NCT01499368|324511717|FG002|Overall Study|Did not meet I/E criteria|4|||
94277397|NCT02863809|322808151|FG001|Overall Study|Withdrawal by Subject|1|||
94370072|NCT03118765|323142834|FG001|Overall Study|Withdrawal by Subject|0|||
94277398|NCT02863809|322808150|FG000|Overall Study|Lost to Follow-up|1|||
94277399|NCT02863809|322808151|FG001|Overall Study|Lost to Follow-up|1|||
94370073|NCT03118765|323142835|FG002|Overall Study|Withdrawal by Subject|1|||
94370074|NCT03118765|323142836|FG003|Overall Study|Withdrawal by Subject|0|||
94370075|NCT03118765|323142837|FG004|Overall Study|Withdrawal by Subject|0|||
94370076|NCT03118765|323142833|FG000|Overall Study|Adverse Event|1|||
94370077|NCT03118765|323142834|FG001|Overall Study|Adverse Event|1|||
94742057|NCT01499368|324511715|FG000|Overall Study|Prohibited Concomitant medication|1|||
94742058|NCT01499368|324511716|FG001|Overall Study|Prohibited Concomitant medication|1|||
94742059|NCT01499368|324511717|FG002|Overall Study|Prohibited Concomitant medication|0|||
94742060|NCT01499368|324511715|FG000|Overall Study|Withdrawal by Subject|11|||
94370078|NCT03118765|323142835|FG002|Overall Study|Adverse Event|1|||
94370079|NCT03118765|323142836|FG003|Overall Study|Adverse Event|1|||
94370080|NCT03118765|323142837|FG004|Overall Study|Adverse Event|1|||
94370081|NCT03118765|323142833|FG000|Overall Study|Non compliance with Study Procedures|0|||
94370082|NCT03118765|323142834|FG001|Overall Study|Non compliance with Study Procedures|0|||
94370083|NCT03118765|323142835|FG002|Overall Study|Non compliance with Study Procedures|0|||
94370084|NCT03118765|323142836|FG003|Overall Study|Non compliance with Study Procedures|1|||
94370085|NCT03118765|323142837|FG004|Overall Study|Non compliance with Study Procedures|0|||
94370086|NCT03118765|323142833|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
94370087|NCT03118765|323142834|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
94370088|NCT03118765|323142835|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
94370089|NCT03118765|323142836|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
94370090|NCT03118765|323142837|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
94370091|NCT03118765|323142833|FG000|Overall Study|COPD Exacerbation|1|||
94277400|NCT02863809|322808150|FG000|Overall Study|Death|1|||
94277401|NCT02863809|322808151|FG001|Overall Study|Death|0|||
94277402|NCT00769184|322808157|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
94277403|NCT00769184|322808158|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
94277404|NCT00769184|322808157|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
94277405|NCT00769184|322808158|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
94277406|NCT00769184|322808157|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
94277407|NCT00769184|322808158|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
94277408|NCT00517829|322808159|FG000|Overall Study|Adverse Event|22|||
94277409|NCT00517829|322808160|FG001|Overall Study|Adverse Event|34|||
94277410|NCT00517829|322808159|FG000|Overall Study|Disease Progression|39|||
94277411|NCT00517829|322808160|FG001|Overall Study|Disease Progression|32|||
94277412|NCT00517829|322808159|FG000|Overall Study|Patient Request|6|||
94277413|NCT00517829|322808160|FG001|Overall Study|Patient Request|5|||
94277414|NCT00517829|322808159|FG000|Overall Study|Investigator Request|5|||
94277415|NCT00517829|322808160|FG001|Overall Study|Investigator Request|3|||
94277416|NCT00517829|322808159|FG000|Overall Study|Other|3|||
94277417|NCT00517829|322808160|FG001|Overall Study|Other|1|||
94277418|NCT00623428|322808163|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
94277419|NCT00623428|322808164|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
94277420|NCT00623428|322808163|FG000|Treatment Period|Death|0|||
94277421|NCT00623428|322808164|FG001|Treatment Period|Death|1|||
94277422|NCT00623428|322808163|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
94277423|NCT00623428|322808164|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
94277424|NCT00623428|322808163|FG000|Treatment Period|Insufficient therapeutic response|0|||
94277425|NCT00623428|322808164|FG001|Treatment Period|Insufficient therapeutic response|2|||
94277426|NCT00623428|322808163|FG000|Treatment Period|Other|0|||
94277427|NCT00623428|322808164|FG001|Treatment Period|Other|1|||
94277428|NCT00623428|322808163|FG000|Treatment Period|Withdrawal by Subject|0|||
94277429|NCT00623428|322808164|FG001|Treatment Period|Withdrawal by Subject|1|||
94277430|NCT00623428|322808163|FG000|Follow-up Period|Relapse post-treatment|11|||
94277431|NCT00623428|322808164|FG001|Follow-up Period|Relapse post-treatment|3|||
94277432|NCT00623428|322808163|FG000|Follow-up Period|Failure to return|10|||
94277433|NCT00623428|322808164|FG001|Follow-up Period|Failure to return|2|||
94277434|NCT00623428|322808163|FG000|Follow-up Period|Patient withdrew consent|5|||
94277435|NCT00623428|322808164|FG001|Follow-up Period|Patient withdrew consent|4|||
94277436|NCT00623428|322808163|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
94277437|NCT00623428|322808164|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
94277438|NCT00623428|322808163|FG000|Follow-up Period|Did not cooperate|0|||
94277439|NCT00623428|322808164|FG001|Follow-up Period|Did not cooperate|3|||
94277440|NCT00623428|322808163|FG000|Follow-up Period|Reason not specified|1|||
94277441|NCT00623428|322808164|FG001|Follow-up Period|Reason not specified|1|||
94277442|NCT00623428|322808163|FG000|Follow-up Period|Death|0|||
94277443|NCT00623428|322808164|FG001|Follow-up Period|Death|1|||
94277444|NCT00814892|322808172|FG000|Overall Study|Disease Progression|1|||
94277445|NCT00814892|322808172|FG000|Overall Study|Study Termination|1|||
94370092|NCT03118765|323142834|FG001|Overall Study|COPD Exacerbation|0|||
94277446|NCT00531752|322808173|FG000|First Double-blind Intervention Period|Adverse Event|2|||
94277447|NCT00531752|322808174|FG001|First Double-blind Intervention Period|Adverse Event|0|||
94277448|NCT00531752|322808175|FG002|First Double-blind Intervention Period|Adverse Event|1|||
94277449|NCT00531752|322808176|FG003|First Double-blind Intervention Period|Adverse Event|1|||
94277450|NCT00531752|322808173|FG000|First Double-blind Intervention Period|Other|1|||
94277451|NCT00531752|322808174|FG001|First Double-blind Intervention Period|Other|4|||
94277452|NCT00531752|322808175|FG002|First Double-blind Intervention Period|Other|4|||
94277453|NCT00531752|322808176|FG003|First Double-blind Intervention Period|Other|0|||
94277454|NCT00531752|322808173|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
94370093|NCT03118765|323142835|FG002|Overall Study|COPD Exacerbation|0|||
94370094|NCT03118765|323142836|FG003|Overall Study|COPD Exacerbation|1|||
94370095|NCT03118765|323142837|FG004|Overall Study|COPD Exacerbation|0|||
94370096|NCT03118765|323142833|FG000|Overall Study|Lost to Follow-up|1|||
94370097|NCT03118765|323142834|FG001|Overall Study|Lost to Follow-up|0|||
94370098|NCT03118765|323142835|FG002|Overall Study|Lost to Follow-up|1|||
94370099|NCT03118765|323142836|FG003|Overall Study|Lost to Follow-up|0|||
94370100|NCT03118765|323142837|FG004|Overall Study|Lost to Follow-up|0|||
94370101|NCT03118765|323142833|FG000|Overall Study|Sponsor Decision|1|||
94370102|NCT03118765|323142834|FG001|Overall Study|Sponsor Decision|0|||
94370103|NCT03118765|323142835|FG002|Overall Study|Sponsor Decision|1|||
94370104|NCT03118765|323142836|FG003|Overall Study|Sponsor Decision|0|||
94370105|NCT03118765|323142837|FG004|Overall Study|Sponsor Decision|1|||
94370106|NCT02164539|323142838|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
94370107|NCT02164539|323142839|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
94370108|NCT02164539|323142840|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
94370109|NCT02164539|323142841|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
94370110|NCT02164539|323142842|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
94370111|NCT02164539|323142843|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
94370112|NCT02164539|323142844|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
94370113|NCT02164539|323142838|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
94370114|NCT02164539|323142839|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
94370115|NCT02164539|323142840|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
94370116|NCT02164539|323142841|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
94370117|NCT02164539|323142842|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
94370118|NCT02164539|323142843|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
94370119|NCT02164539|323142844|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
94370120|NCT02164539|323142838|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
94370121|NCT02164539|323142839|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
94370122|NCT02164539|323142840|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
94370123|NCT02164539|323142841|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
94370124|NCT02164539|323142842|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
94370125|NCT02164539|323142843|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
94370126|NCT02164539|323142844|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
94370127|NCT02164539|323142838|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
94370128|NCT02164539|323142839|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
94370129|NCT02164539|323142840|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
94370130|NCT02164539|323142841|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
94370131|NCT02164539|323142842|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
94370132|NCT02164539|323142843|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
94370133|NCT02164539|323142844|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
94370134|NCT02164539|323142838|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
94370135|NCT02164539|323142839|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
94370136|NCT02164539|323142840|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
94370137|NCT02164539|323142841|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
94370138|NCT02164539|323142842|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
94370139|NCT02164539|323142843|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
94370140|NCT02164539|323142844|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
94277455|NCT00531752|322808174|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
94277456|NCT00531752|322808175|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
94277457|NCT00531752|322808176|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
94277458|NCT00531752|322808173|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
94277459|NCT00531752|322808174|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
94277460|NCT00531752|322808175|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
94277461|NCT00531752|322808176|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
94277462|NCT00531752|322808173|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
94277463|NCT00531752|322808174|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
94277464|NCT00531752|322808175|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
94277465|NCT00531752|322808176|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
94277466|NCT00531752|322808173|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
94277467|NCT00531752|322808174|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
94370141|NCT02164539|323142838|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
94370142|NCT02164539|323142839|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
94370143|NCT02164539|323142840|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
94370144|NCT02164539|323142841|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
94370145|NCT02164539|323142842|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
94370146|NCT02164539|323142843|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
94370147|NCT02164539|323142844|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
94370148|NCT03835975|323142847|FG000|Overall Study|Lost to Follow-up|1|||
94370149|NCT03835975|323142848|FG001|Overall Study|Lost to Follow-up|1|||
94370150|NCT03835975|323142849|FG002|Overall Study|Lost to Follow-up|0|||
94370151|NCT03835975|323142850|FG003|Overall Study|Lost to Follow-up|0|||
94370152|NCT03835975|323142851|FG004|Overall Study|Lost to Follow-up|0|||
94370153|NCT03835975|323142847|FG000|Overall Study|No longer met eligibility criteria|0|||
94370154|NCT03835975|323142848|FG001|Overall Study|No longer met eligibility criteria|1|||
94277468|NCT00531752|322808175|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
94277469|NCT00531752|322808176|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
94277470|NCT00531752|322808173|FG000|Second Double-blind Intervention Period|Other|1|||
94277471|NCT00531752|322808174|FG001|Second Double-blind Intervention Period|Other|1|||
94277472|NCT00531752|322808175|FG002|Second Double-blind Intervention Period|Other|0|||
94277473|NCT00531752|322808176|FG003|Second Double-blind Intervention Period|Other|0|||
94277474|NCT00531752|322808173|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
94277475|NCT00531752|322808174|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
94277476|NCT00531752|322808175|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
94277477|NCT00531752|322808176|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
94277478|NCT00531752|322808173|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
94277479|NCT00531752|322808174|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
94277480|NCT00531752|322808175|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
94277481|NCT00531752|322808176|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
94277482|NCT04486950|322808178|FG000|Overall Study|Lost to Follow-up|0|||
94277483|NCT04486950|322808179|FG001|Overall Study|Lost to Follow-up|0|||
94277484|NCT04486950|322808180|FG002|Overall Study|Lost to Follow-up|0|||
94277485|NCT04486950|322808181|FG003|Overall Study|Lost to Follow-up|0|||
94277486|NCT04486950|322808182|FG004|Overall Study|Lost to Follow-up|0|||
94277487|NCT04486950|322808183|FG005|Overall Study|Lost to Follow-up|1|||
94277488|NCT04486950|322808184|FG006|Overall Study|Lost to Follow-up|0|||
94277489|NCT00490451|322808185|FG000|Overall Study|Adverse Event|3|||
94277490|NCT00490451|322808186|FG001|Overall Study|Adverse Event|3|||
94277491|NCT00490451|322808185|FG000|Overall Study|Death|3|||
94277492|NCT00490451|322808186|FG001|Overall Study|Death|1|||
94277493|NCT00490451|322808185|FG000|Overall Study|Withdrawal by Subject|2|||
94277494|NCT00490451|322808186|FG001|Overall Study|Withdrawal by Subject|0|||
94277495|NCT00490451|322808185|FG000|Overall Study|Investigator Decision|1|||
94277496|NCT00490451|322808186|FG001|Overall Study|Investigator Decision|0|||
94277497|NCT00490451|322808185|FG000|Overall Study|Protocol Violation|1|||
94277498|NCT00490451|322808186|FG001|Overall Study|Protocol Violation|0|||
94277499|NCT00490451|322808185|FG000|Overall Study|Progressive Disease|53|||
94277500|NCT00490451|322808186|FG001|Overall Study|Progressive Disease|34|||
94277501|NCT01181011|322808187|FG000|Overall Study|Adverse Event|2|||
94277502|NCT01181011|322808187|FG000|Overall Study|Lost to Follow-up|1|||
94277503|NCT00401375|322808188|FG000|Overall Study|Protocol Violation|2|||
94277504|NCT00401375|322808189|FG001|Overall Study|Protocol Violation|2|||
94277505|NCT00401375|322808190|FG002|Overall Study|Protocol Violation|1|||
94277506|NCT00401375|322808188|FG000|Overall Study|Adverse Event|6|||
94277507|NCT00401375|322808189|FG001|Overall Study|Adverse Event|11|||
94277508|NCT00401375|322808190|FG002|Overall Study|Adverse Event|10|||
94277509|NCT00401375|322808188|FG000|Overall Study|Withdrawal by Subject|9|||
94277510|NCT00401375|322808189|FG001|Overall Study|Withdrawal by Subject|7|||
94277511|NCT00401375|322808190|FG002|Overall Study|Withdrawal by Subject|7|||
94277512|NCT00401375|322808188|FG000|Overall Study|Lost to Follow-up|0|||
94277513|NCT00401375|322808189|FG001|Overall Study|Lost to Follow-up|1|||
94277514|NCT00401375|322808190|FG002|Overall Study|Lost to Follow-up|1|||
94277515|NCT00401375|322808188|FG000|Overall Study|Other than specified|2|||
94277516|NCT00401375|322808189|FG001|Overall Study|Other than specified|1|||
94277517|NCT00401375|322808190|FG002|Overall Study|Other than specified|3|||
94277518|NCT00401375|322808188|FG000|Overall Study|Randomized but not treated|3|||
94277519|NCT00401375|322808189|FG001|Overall Study|Randomized but not treated|3|||
94277520|NCT00401375|322808190|FG002|Overall Study|Randomized but not treated|3|||
94277521|NCT00361270|322808191|FG000|Overall Study|Death|0|||
94277522|NCT00361270|322808192|FG001|Overall Study|Death|0|||
94277523|NCT00361270|322808193|FG002|Overall Study|Death|0|||
94370155|NCT03835975|323142849|FG002|Overall Study|No longer met eligibility criteria|0|||
94370156|NCT03835975|323142850|FG003|Overall Study|No longer met eligibility criteria|0|||
94370157|NCT03835975|323142851|FG004|Overall Study|No longer met eligibility criteria|0|||
94467552|NCT01390428|323502335|FG002|Overall Study|Withdrawal by Subject|1|||
94277524|NCT00361270|322808194|FG003|Overall Study|Death|2|||
94277525|NCT00361270|322808191|FG000|Overall Study|Lost to Follow-up|4|||
94277526|NCT00361270|322808192|FG001|Overall Study|Lost to Follow-up|1|||
94370158|NCT03835975|323142847|FG000|Overall Study|Protocol Violation|1|||
94277527|NCT00361270|322808193|FG002|Overall Study|Lost to Follow-up|0|||
94277528|NCT00361270|322808194|FG003|Overall Study|Lost to Follow-up|0|||
94277529|NCT00361270|322808191|FG000|Overall Study|Physician Decision|0|||
94277530|NCT00361270|322808192|FG001|Overall Study|Physician Decision|0|||
94277531|NCT00361270|322808193|FG002|Overall Study|Physician Decision|1|||
94277532|NCT00361270|322808194|FG003|Overall Study|Physician Decision|0|||
94277533|NCT00361270|322808191|FG000|Overall Study|Protocol Violation|9|||
94277534|NCT00361270|322808192|FG001|Overall Study|Protocol Violation|4|||
94277535|NCT00361270|322808193|FG002|Overall Study|Protocol Violation|5|||
94467553|NCT01390428|323502336|FG003|Overall Study|Withdrawal by Subject|0|||
94742061|NCT01499368|324511716|FG001|Overall Study|Withdrawal by Subject|10|||
94742062|NCT01499368|324511717|FG002|Overall Study|Withdrawal by Subject|8|||
94742063|NCT01499368|324511715|FG000|Overall Study|Lost to Follow-up|3|||
94742064|NCT01499368|324511716|FG001|Overall Study|Lost to Follow-up|2|||
94742065|NCT01499368|324511717|FG002|Overall Study|Lost to Follow-up|5|||
94742066|NCT01499368|324511715|FG000|Overall Study|Adverse Event|4|||
94742067|NCT01499368|324511716|FG001|Overall Study|Adverse Event|0|||
94742068|NCT01499368|324511717|FG002|Overall Study|Adverse Event|2|||
94742069|NCT01499368|324511715|FG000|Overall Study|Physician Decision|0|||
94742070|NCT01499368|324511716|FG001|Overall Study|Physician Decision|1|||
94742071|NCT01499368|324511717|FG002|Overall Study|Physician Decision|0|||
94742072|NCT01499368|324511715|FG000|Overall Study|Deviation from visit window|0|||
94742073|NCT01499368|324511716|FG001|Overall Study|Deviation from visit window|0|||
94742074|NCT01499368|324511717|FG002|Overall Study|Deviation from visit window|1|||
94742075|NCT01499368|324511715|FG000|Overall Study|Error of Prescriptions|0|||
94742076|NCT01499368|324511716|FG001|Overall Study|Error of Prescriptions|0|||
94742077|NCT01499368|324511717|FG002|Overall Study|Error of Prescriptions|1|||
94742078|NCT06059443|324511718|FG000|Overall Study|Withdrawal by Subject|2|||
94742079|NCT06059443|324511719|FG001|Overall Study|Withdrawal by Subject|0|||
94277536|NCT00361270|322808194|FG003|Overall Study|Protocol Violation|4|||
94277537|NCT00361270|322808191|FG000|Overall Study|Withdrawal by Subject|6|||
94277538|NCT00361270|322808192|FG001|Overall Study|Withdrawal by Subject|6|||
94277539|NCT00361270|322808193|FG002|Overall Study|Withdrawal by Subject|3|||
94277540|NCT00361270|322808194|FG003|Overall Study|Withdrawal by Subject|7|||
94277541|NCT00361270|322808191|FG000|Overall Study|Afraid of Hypnosis|1|||
94277542|NCT00361270|322808192|FG001|Overall Study|Afraid of Hypnosis|2|||
94277543|NCT00361270|322808193|FG002|Overall Study|Afraid of Hypnosis|0|||
94277544|NCT00361270|322808194|FG003|Overall Study|Afraid of Hypnosis|0|||
94277545|NCT00361270|322808191|FG000|Overall Study|Problems with Transportation|4|||
94277546|NCT00361270|322808192|FG001|Overall Study|Problems with Transportation|0|||
94277547|NCT00361270|322808193|FG002|Overall Study|Problems with Transportation|0|||
94277548|NCT00361270|322808194|FG003|Overall Study|Problems with Transportation|0|||
94277549|NCT00361270|322808191|FG000|Overall Study|Adverse Event|0|||
94277550|NCT00361270|322808192|FG001|Overall Study|Adverse Event|1|||
94277551|NCT00361270|322808193|FG002|Overall Study|Adverse Event|1|||
94277552|NCT00361270|322808194|FG003|Overall Study|Adverse Event|0|||
94277553|NCT02788747|322808201|FG000|Overall Study|Adverse Event|1|||
94277554|NCT02788747|322808202|FG001|Overall Study|Adverse Event|0|||
94277555|NCT02788747|322808203|FG002|Overall Study|Adverse Event|0|||
94277556|NCT01119248|322808204|FG000|Overall Study|Physician Decision|5|||
94277557|NCT01026831|322808205|FG000|Overall Study|Adverse Event|4|||
94277558|NCT01026831|322808206|FG001|Overall Study|Adverse Event|3|||
94277559|NCT01026831|322808205|FG000|Overall Study|Lost to Follow-up|2|||
94277560|NCT01026831|322808206|FG001|Overall Study|Lost to Follow-up|0|||
94277561|NCT01026831|322808205|FG000|Overall Study|Physician Decision|1|||
94277562|NCT01026831|322808206|FG001|Overall Study|Physician Decision|1|||
94277563|NCT01026831|322808205|FG000|Overall Study|Protocol Violation|0|||
94277564|NCT01026831|322808206|FG001|Overall Study|Protocol Violation|2|||
94277565|NCT01026831|322808205|FG000|Overall Study|Withdrawal by Subject|7|||
94277566|NCT01026831|322808206|FG001|Overall Study|Withdrawal by Subject|5|||
94277567|NCT00159861|322808216|FG000|Core Study - 16 Weeks|Death|3|||
94277568|NCT00159861|322808217|FG001|Core Study - 16 Weeks|Death|0|||
94277569|NCT00159861|322808216|FG000|Core Study - 16 Weeks|Adverse Event|12|||
94277570|NCT00159861|322808217|FG001|Core Study - 16 Weeks|Adverse Event|6|||
94277571|NCT00159861|322808216|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
94277572|NCT00159861|322808217|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
94277573|NCT00159861|322808216|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
94277574|NCT00159861|322808217|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
94277575|NCT00159861|322808216|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
94277576|NCT00159861|322808217|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
94277577|NCT00159861|322808216|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
94277578|NCT00159861|322808217|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
94277579|NCT00159861|322808216|FG000|Extension Study - up to 3 Years|Death|24|||
94277580|NCT00159861|322808217|FG001|Extension Study - up to 3 Years|Death|28|||
94277581|NCT00159861|322808216|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
94277582|NCT00159861|322808217|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
94742080|NCT06059443|324511718|FG000|Overall Study|Lost to Follow-up|2|||
94277583|NCT00159861|322808216|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
94277584|NCT00159861|322808217|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
94742081|NCT06059443|324511719|FG001|Overall Study|Lost to Follow-up|2|||
94277585|NCT00159861|322808216|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
94277586|NCT00159861|322808217|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
94277587|NCT00159861|322808216|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
94277588|NCT00159861|322808217|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
94742082|NCT01527188|324511720|FG000|Overall Study|Adverse Event|5|||
94742083|NCT01527188|324511721|FG001|Overall Study|Adverse Event|5|||
94742084|NCT01527188|324511722|FG002|Overall Study|Adverse Event|11|||
94370159|NCT03835975|323142848|FG001|Overall Study|Protocol Violation|1|||
94277589|NCT01632566|322808219|FG000|Overall Study|Withdrawal by Subject|0|||
94277590|NCT01632566|322808220|FG001|Overall Study|Withdrawal by Subject|1|||
94277591|NCT01632566|322808221|FG002|Overall Study|Withdrawal by Subject|0|||
94277592|NCT01632566|322808222|FG003|Overall Study|Withdrawal by Subject|0|||
94277593|NCT01632566|322808223|FG004|Overall Study|Withdrawal by Subject|0|||
94277594|NCT01632566|322808219|FG000|Overall Study|Sponsor Decision|0|||
94277595|NCT01632566|322808220|FG001|Overall Study|Sponsor Decision|2|||
94277596|NCT01632566|322808221|FG002|Overall Study|Sponsor Decision|9|||
94277597|NCT01632566|322808222|FG003|Overall Study|Sponsor Decision|2|||
94277598|NCT01632566|322808223|FG004|Overall Study|Sponsor Decision|2|||
94277599|NCT02124564|322808224|FG000|Treatment Period|Adverse Event|2|||
94277600|NCT02124564|322808224|FG000|Treatment Period|Lack of Efficacy|3|||
94277601|NCT02124564|322808224|FG000|Treatment Period|Withdrawal by Subject|2|||
94277602|NCT03349099|322808225|FG000|Overall Study|Physician Decision|3|||
94277603|NCT03349099|322808226|FG001|Overall Study|Physician Decision|4|||
94277604|NCT03349099|322808225|FG000|Overall Study|Stone migrated from the kidney|1|||
94277605|NCT03349099|322808226|FG001|Overall Study|Stone migrated from the kidney|0|||
94277606|NCT04579380|322809541|FG000|Overall Study|Death|9|||
94277607|NCT04579380|322809542|FG001|Overall Study|Death|22|||
94277608|NCT04579380|322809543|FG002|Overall Study|Death|22|||
94277609|NCT04579380|322809544|FG003|Overall Study|Death|17|||
94277610|NCT04579380|322809545|FG004|Overall Study|Death|6|||
94277611|NCT04579380|322809546|FG005|Overall Study|Death|21|||
94277612|NCT04579380|322809547|FG006|Overall Study|Death|10|||
94277613|NCT04579380|322809548|FG007|Overall Study|Death|11|||
94277614|NCT04579380|322809549|FG008|Overall Study|Death|25|||
94277615|NCT04579380|322809541|FG000|Overall Study|Withdrawal by Subject|0|||
94277616|NCT04579380|322809542|FG001|Overall Study|Withdrawal by Subject|3|||
94277617|NCT04579380|322809543|FG002|Overall Study|Withdrawal by Subject|4|||
94277618|NCT04579380|322809544|FG003|Overall Study|Withdrawal by Subject|0|||
94277619|NCT04579380|322809545|FG004|Overall Study|Withdrawal by Subject|1|||
94277620|NCT04579380|322809546|FG005|Overall Study|Withdrawal by Subject|2|||
94277621|NCT04579380|322809547|FG006|Overall Study|Withdrawal by Subject|0|||
94277622|NCT04579380|322809548|FG007|Overall Study|Withdrawal by Subject|1|||
94277623|NCT04579380|322809549|FG008|Overall Study|Withdrawal by Subject|2|||
94277624|NCT04579380|322809541|FG000|Overall Study|Ongoing|2|||
94277625|NCT04579380|322809542|FG001|Overall Study|Ongoing|6|||
94277626|NCT04579380|322809543|FG002|Overall Study|Ongoing|4|||
94277627|NCT04579380|322809544|FG003|Overall Study|Ongoing|8|||
94277628|NCT04579380|322809545|FG004|Overall Study|Ongoing|5|||
94277629|NCT04579380|322809546|FG005|Overall Study|Ongoing|8|||
94277630|NCT04579380|322809547|FG006|Overall Study|Ongoing|3|||
94277631|NCT04579380|322809548|FG007|Overall Study|Ongoing|19|||
94277632|NCT04579380|322809549|FG008|Overall Study|Ongoing|6|||
94277633|NCT03770260|322809550|FG000|Overall Study|Disease progression|0|||
94277634|NCT03770260|322809551|FG001|Overall Study|Disease progression|1|||
94277635|NCT03770260|322809552|FG002|Overall Study|Disease progression|0|||
94277636|NCT03770260|322809553|FG003|Overall Study|Disease progression|0|||
94277637|NCT01395394|322809555|FG000|Baseline Study Visit|Protocol Violation|1|||
94277638|NCT01395394|322809556|FG001|Baseline Study Visit|Protocol Violation|0|||
94277639|NCT01395394|322809557|FG002|Baseline Study Visit|Protocol Violation|0|||
94277640|NCT03670953|322809565|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
94277641|NCT03670953|322809566|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
94277642|NCT03670953|322809567|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
94277643|NCT03670953|322809568|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
94277644|NCT03670953|322809565|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
94277645|NCT03670953|322809566|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
94277646|NCT03670953|322809567|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
94277647|NCT03670953|322809568|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
94370160|NCT03835975|323142849|FG002|Overall Study|Protocol Violation|2|||
94370161|NCT03835975|323142850|FG003|Overall Study|Protocol Violation|0|||
94370162|NCT03835975|323142851|FG004|Overall Study|Protocol Violation|0|||
94277648|NCT03670953|322809565|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
94277649|NCT03670953|322809566|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
94370163|NCT03835975|323142847|FG000|Overall Study|Withdrawal by Subject|1|||
94277650|NCT03670953|322809567|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
94370164|NCT03835975|323142848|FG001|Overall Study|Withdrawal by Subject|0|||
94277651|NCT03670953|322809568|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
94277652|NCT03670953|322809565|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
94370165|NCT03835975|323142849|FG002|Overall Study|Withdrawal by Subject|1|||
94370166|NCT03835975|323142850|FG003|Overall Study|Withdrawal by Subject|1|||
94370167|NCT03835975|323142851|FG004|Overall Study|Withdrawal by Subject|0|||
94370168|NCT03670537|323142854|FG000|Overall Study|Protocol Violation|1|||
94370169|NCT00033631|323142855|FG000|Overall Study|Protocol Violation|14|||
94277653|NCT03670953|322809566|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
94277654|NCT03670953|322809567|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
94277655|NCT03670953|322809568|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
94742085|NCT01527188|324511723|FG003|Overall Study|Adverse Event|0|||
94742086|NCT01527188|324511720|FG000|Overall Study|Withdrawal by Subject|3|||
94742087|NCT01527188|324511721|FG001|Overall Study|Withdrawal by Subject|6|||
94742088|NCT01527188|324511722|FG002|Overall Study|Withdrawal by Subject|4|||
94742089|NCT01527188|324511723|FG003|Overall Study|Withdrawal by Subject|4|||
94742090|NCT01527188|324511720|FG000|Overall Study|Any other reason not above-mentioned|6|||
94742091|NCT01527188|324511721|FG001|Overall Study|Any other reason not above-mentioned|7|||
94742092|NCT01527188|324511722|FG002|Overall Study|Any other reason not above-mentioned|8|||
94742093|NCT01527188|324511723|FG003|Overall Study|Any other reason not above-mentioned|8|||
94742094|NCT05771467|324511724|FG000|Overall Study|Lost to Follow-up|6|||
94370170|NCT00033631|323142856|FG001|Overall Study|Protocol Violation|11|||
94370171|NCT00033631|323142855|FG000|Overall Study|Withdrawal by Subject|4|||
94742095|NCT05771467|324511725|FG001|Overall Study|Lost to Follow-up|3|||
94742096|NCT01265537|324511732|FG000|Overall Study|Adverse Event|2|||
94742097|NCT01265537|324511733|FG001|Overall Study|Adverse Event|1|||
94742098|NCT01265537|324511732|FG000|Overall Study|Physician Decision|0|||
94742099|NCT01265537|324511733|FG001|Overall Study|Physician Decision|1|||
94742100|NCT03286114|324512091|FG000|Overall Study|Adverse Event|6|||
94742101|NCT03286114|324512091|FG000|Overall Study|Death|3|||
94742102|NCT04464564|324512092|FG000|Period A (Placebo lead-in)|Other|5|||
94742103|NCT04464564|324512093|FG001|Period A (Placebo lead-in)|Other|0|||
94742104|NCT04464564|324512094|FG002|Period A (Placebo lead-in)|Other|0|||
94742105|NCT04464564|324512095|FG003|Period A (Placebo lead-in)|Other|0|||
94742106|NCT04464564|324512092|FG000|Period B (Randomization Period)|Adverse Event|0|||
94742107|NCT04464564|324512093|FG001|Period B (Randomization Period)|Adverse Event|1|||
94742108|NCT04464564|324512094|FG002|Period B (Randomization Period)|Adverse Event|2|||
94742109|NCT04464564|324512095|FG003|Period B (Randomization Period)|Adverse Event|8|||
94742110|NCT04464564|324512092|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
94742111|NCT04464564|324512093|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
94742112|NCT04464564|324512094|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
94742113|NCT04464564|324512095|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
94742114|NCT04464564|324512092|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
94742115|NCT04464564|324512093|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
94742116|NCT04464564|324512094|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
94742117|NCT04464564|324512095|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
94742118|NCT04464564|324512092|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
94742119|NCT04464564|324512093|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
94742120|NCT04464564|324512094|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
94742121|NCT04464564|324512095|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
94742122|NCT04464564|324512092|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
94742123|NCT04464564|324512093|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
94742124|NCT04464564|324512094|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
94742125|NCT04464564|324512095|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
94742126|NCT04464564|324512092|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
94742127|NCT04464564|324512093|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
94742128|NCT04464564|324512094|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
94742129|NCT04464564|324512095|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
94742130|NCT04464564|324512092|FG000|Period B (Randomization Period)|Reason not Specified|0|||
94742131|NCT04464564|324512093|FG001|Period B (Randomization Period)|Reason not Specified|3|||
94742132|NCT04464564|324512094|FG002|Period B (Randomization Period)|Reason not Specified|3|||
94742133|NCT04464564|324512095|FG003|Period B (Randomization Period)|Reason not Specified|3|||
94742134|NCT00644228|324512100|FG000|Randomization & Eligibility|Ineligible|31|||
94742135|NCT00644228|324512101|FG001|Randomization & Eligibility|Ineligible|21|||
94742136|NCT00644228|324512100|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
94742137|NCT00644228|324512101|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
94742138|NCT00644228|324512100|FG000|Randomization & Eligibility|Invalid Consent|0|||
94742139|NCT00644228|324512101|FG001|Randomization & Eligibility|Invalid Consent|1|||
94742140|NCT00644228|324512100|FG000|Induction Therapy|Adverse Event|22|||
94742141|NCT00644228|324512101|FG001|Induction Therapy|Adverse Event|55|||
94742142|NCT00644228|324512100|FG000|Induction Therapy|Withdrawal by Subject|10|||
94742143|NCT00644228|324512101|FG001|Induction Therapy|Withdrawal by Subject|3|||
94742144|NCT00644228|324512100|FG000|Induction Therapy|Progression/Relapse|24|||
94742145|NCT00644228|324512101|FG001|Induction Therapy|Progression/Relapse|12|||
94742146|NCT00644228|324512100|FG000|Induction Therapy|Death|3|||
94742147|NCT00644228|324512101|FG001|Induction Therapy|Death|7|||
94742148|NCT00644228|324512100|FG000|Induction Therapy|Not Protocol-Specified|24|||
94742149|NCT00644228|324512101|FG001|Induction Therapy|Not Protocol-Specified|28|||
94742150|NCT00644228|324512100|FG000|Maintenance|Adverse Event|27|||
94742151|NCT00644228|324512101|FG001|Maintenance|Adverse Event|31|||
94742152|NCT00644228|324512100|FG000|Maintenance|Withdrawal by Subject|6|||
94742153|NCT00644228|324512101|FG001|Maintenance|Withdrawal by Subject|4|||
94370172|NCT00033631|323142856|FG001|Overall Study|Withdrawal by Subject|4|||
94370173|NCT01507831|323142859|FG000|Overall Study|Randomized but not treated|0|||
94370174|NCT01507831|323142860|FG001|Overall Study|Randomized but not treated|3|||
94370175|NCT01507831|323142859|FG000|Overall Study|Adverse Event|48|||
94370176|NCT01507831|323142860|FG001|Overall Study|Adverse Event|113|||
94370177|NCT01507831|323142859|FG000|Overall Study|Death|6|||
94370178|NCT01507831|323142860|FG001|Overall Study|Death|2|||
94370179|NCT01507831|323142859|FG000|Overall Study|Poor compliance to protocol|38|||
94370180|NCT01507831|323142860|FG001|Overall Study|Poor compliance to protocol|60|||
94370181|NCT01507831|323142859|FG000|Overall Study|Physician Decision|0|||
94370182|NCT01507831|323142860|FG001|Overall Study|Physician Decision|4|||
94370183|NCT01507831|323142859|FG000|Overall Study|Participant moved|5|||
94370184|NCT01507831|323142860|FG001|Overall Study|Participant moved|19|||
94370185|NCT01507831|323142859|FG000|Overall Study|Consent withdrawn by participant|34|||
94370186|NCT01507831|323142860|FG001|Overall Study|Consent withdrawn by participant|72|||
94370187|NCT01507831|323142859|FG000|Overall Study|Related to study drug administration|5|||
94370188|NCT01507831|323142860|FG001|Overall Study|Related to study drug administration|14|||
94370189|NCT01507831|323142859|FG000|Overall Study|Last visit outside protocol visit window|51|||
94370190|NCT01507831|323142860|FG001|Overall Study|Last visit outside protocol visit window|143|||
94370191|NCT01507831|323142859|FG000|Overall Study|Selection criteria finally not met|0|||
94370192|NCT01507831|323142860|FG001|Overall Study|Selection criteria finally not met|1|||
94370193|NCT01507831|323142859|FG000|Overall Study|Site closure|0|||
94370194|NCT01507831|323142860|FG001|Overall Study|Site closure|3|||
94370195|NCT01507831|323142859|FG000|Overall Study|Potential lost to follow-up|3|||
94370196|NCT01507831|323142860|FG001|Overall Study|Potential lost to follow-up|0|||
94370197|NCT01507831|323142859|FG000|Overall Study|Other|3|||
94742154|NCT00644228|324512100|FG000|Maintenance|Progression/Relapse|67|||
94742155|NCT00644228|324512101|FG001|Maintenance|Progression/Relapse|42|||
94742156|NCT00644228|324512100|FG000|Maintenance|Death|3|||
94742157|NCT00644228|324512101|FG001|Maintenance|Death|3|||
94742158|NCT00644228|324512100|FG000|Maintenance|Not Protocol-Specified|14|||
94742159|NCT00644228|324512101|FG001|Maintenance|Not Protocol-Specified|15|||
94742160|NCT00644228|324512100|FG000|Maintenance|On Treatment|26|||
94742161|NCT00644228|324512101|FG001|Maintenance|On Treatment|40|||
94742162|NCT00658814|324512102|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
94742163|NCT00658814|324512103|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
94742164|NCT00658814|324512102|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
94742165|NCT00658814|324512103|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
94742166|NCT00658814|324512102|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
94742167|NCT00658814|324512103|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
94742168|NCT00658814|324512102|FG000|Remission Induction Chemotherapy|Death|1|||
94742169|NCT00658814|324512103|FG001|Remission Induction Chemotherapy|Death|4|||
94742170|NCT00658814|324512102|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
94742171|NCT00658814|324512103|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
94742172|NCT00658814|324512102|FG000|Remission Induction Chemotherapy|Not eligible|1|||
94742173|NCT00658814|324512103|FG001|Remission Induction Chemotherapy|Not eligible|2|||
94742174|NCT00658814|324512102|FG000|Consolidation Therapy|Not protocol specified|0|||
94742175|NCT00658814|324512103|FG001|Consolidation Therapy|Not protocol specified|1|||
94742176|NCT00658814|324512102|FG000|Consolidation Therapy|Not eligible|2|||
94742177|NCT00658814|324512103|FG001|Consolidation Therapy|Not eligible|2|||
94742178|NCT00658814|324512102|FG000|Maintenance Therapy|Adverse Event|1|||
94742179|NCT00658814|324512103|FG001|Maintenance Therapy|Adverse Event|1|||
94742180|NCT00658814|324512102|FG000|Maintenance Therapy|Not protocol specified|1|||
94742181|NCT00658814|324512103|FG001|Maintenance Therapy|Not protocol specified|0|||
94742182|NCT00658814|324512102|FG000|Maintenance Therapy|Not eligible|1|||
94742183|NCT00658814|324512103|FG001|Maintenance Therapy|Not eligible|0|||
94742184|NCT02989662|324512104|FG000|Overall Study|Lost to Follow-up|0|||
94742185|NCT02989662|324512105|FG001|Overall Study|Lost to Follow-up|0|||
94742186|NCT02989662|324512106|FG002|Overall Study|Lost to Follow-up|0|||
94742187|NCT02989662|324512107|FG003|Overall Study|Lost to Follow-up|2|||
94742188|NCT02989662|324512104|FG000|Overall Study|Physician Decision|3|||
94742189|NCT02989662|324512105|FG001|Overall Study|Physician Decision|0|||
94742190|NCT02989662|324512106|FG002|Overall Study|Physician Decision|0|||
94742191|NCT02989662|324512107|FG003|Overall Study|Physician Decision|0|||
94742192|NCT02989662|324512104|FG000|Overall Study|Withdrawal by Subject|1|||
94742193|NCT02989662|324512105|FG001|Overall Study|Withdrawal by Subject|0|||
94742194|NCT02989662|324512106|FG002|Overall Study|Withdrawal by Subject|0|||
94742195|NCT02989662|324512107|FG003|Overall Study|Withdrawal by Subject|0|||
94742196|NCT06262347|324512108|FG000|Overall Study|Lost to Follow-up|4|||
94370198|NCT01507831|323142860|FG001|Overall Study|Other|6|||
94370199|NCT00068237|323142866|FG000|Overall Study|Ineligible|3|||
94370200|NCT00068237|323142866|FG000|Overall Study|No protocol treatment received|2|||
94370201|NCT04380701|323142876|FG000|Overall Study|Pregnancy|0|||
94370202|NCT04380701|323142877|FG001|Overall Study|Pregnancy|0|||
94370203|NCT04380701|323142878|FG002|Overall Study|Pregnancy|0|||
94370204|NCT04380701|323142879|FG003|Overall Study|Pregnancy|0|||
94742197|NCT06262347|324512109|FG001|Overall Study|Lost to Follow-up|3|||
94277656|NCT03670953|322809565|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
94277657|NCT03670953|322809566|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
94277658|NCT03670953|322809567|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
94277659|NCT03670953|322809568|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
94277660|NCT03670953|322809565|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
94277661|NCT03670953|322809566|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
94277662|NCT03670953|322809567|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
94277663|NCT03670953|322809568|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
94277664|NCT03670953|322809565|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
94277665|NCT03670953|322809566|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
94277666|NCT03670953|322809567|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
94277667|NCT03670953|322809568|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
94277668|NCT03670953|322809565|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
94277669|NCT03670953|322809566|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
94277670|NCT03670953|322809567|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
94277671|NCT03670953|322809568|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
94277672|NCT03670953|322809565|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
94277673|NCT03670953|322809566|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
94277674|NCT03670953|322809567|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
94277675|NCT03670953|322809568|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
94277676|NCT03670953|322809565|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
94277677|NCT03670953|322809566|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
94277678|NCT03670953|322809567|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
94277679|NCT03670953|322809568|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
94277680|NCT03670953|322809565|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
94277681|NCT03670953|322809566|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
94277682|NCT03670953|322809567|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
94277683|NCT03670953|322809568|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
94277684|NCT03670953|322809565|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
94277685|NCT03670953|322809566|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
94277686|NCT03670953|322809567|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
94277687|NCT03670953|322809568|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
94277688|NCT03670953|322809565|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
94277689|NCT03670953|322809566|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
94277690|NCT03670953|322809567|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
94277691|NCT03670953|322809568|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
94277692|NCT03670953|322809565|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
94277693|NCT03670953|322809566|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
94277694|NCT03670953|322809567|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
94277695|NCT03670953|322809568|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
94277696|NCT03670953|322809565|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
94277697|NCT03670953|322809566|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
94277698|NCT03670953|322809567|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
94277699|NCT03670953|322809568|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
94277700|NCT03670953|322809565|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
94277701|NCT03670953|322809566|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
94277702|NCT03670953|322809567|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
94277703|NCT03670953|322809568|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
94277704|NCT03670953|322809565|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
94277705|NCT03670953|322809566|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
94277706|NCT03670953|322809567|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
94277707|NCT03670953|322809568|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
94277708|NCT03670953|322809565|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
94277709|NCT03670953|322809566|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
94277710|NCT03670953|322809567|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
94277711|NCT03670953|322809568|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
94277712|NCT00390546|322809569|FG000|Overall Study|Renal impairment|1|||
94277713|NCT00390546|322809570|FG001|Overall Study|Renal impairment|0|||
94277714|NCT00390546|322809569|FG000|Overall Study|Physician Decision|5|||
94277715|NCT00390546|322809570|FG001|Overall Study|Physician Decision|5|||
94277716|NCT00513409|322809571|FG000|Overall Study|Adverse Event|0|||
94277717|NCT00513409|322809572|FG001|Overall Study|Adverse Event|1|||
94277718|NCT00513409|322809571|FG000|Overall Study|Withdrawal by Subject|0|||
94277719|NCT00513409|322809572|FG001|Overall Study|Withdrawal by Subject|2|||
94277720|NCT00513409|322809571|FG000|Overall Study|Lost to Follow-up|0|||
94277721|NCT00513409|322809572|FG001|Overall Study|Lost to Follow-up|1|||
94277722|NCT00513409|322809571|FG000|Overall Study|Physician Decision|1|||
94277723|NCT00513409|322809572|FG001|Overall Study|Physician Decision|0|||
94277724|NCT00513409|322809571|FG000|Overall Study|Visit 3 not done|1|||
94277725|NCT00513409|322809572|FG001|Overall Study|Visit 3 not done|2|||
94277726|NCT01135498|322809574|FG000|Overall Study|Adverse Event|20|||
94277727|NCT01135498|322809574|FG000|Overall Study|Progressive disease|38|||
94277728|NCT01135498|322809574|FG000|Overall Study|Investigator judgement|25|||
94277729|NCT01135498|322809574|FG000|Overall Study|Withdrawal by Subject|4|||
94277730|NCT01135498|322809574|FG000|Overall Study|Death|1|||
94277731|NCT01135498|322809574|FG000|Overall Study|Ongoing at time of analysis|2|||
94277732|NCT02646982|322809576|FG000|Overall Study|Adverse Event|1|||
94277733|NCT02646982|322809577|FG001|Overall Study|Adverse Event|1|||
94277734|NCT02646982|322809576|FG000|Overall Study|Withdrawal by Subject|2|||
94277735|NCT02646982|322809577|FG001|Overall Study|Withdrawal by Subject|1|||
94277736|NCT03709654|322809578|FG000|Overall Study|Lost to Follow-up|1|||
94277737|NCT03709654|322809579|FG001|Overall Study|Lost to Follow-up|1|||
94277738|NCT03709654|322809578|FG000|Overall Study|Withdrawal by Subject|1|||
94277739|NCT03709654|322809579|FG001|Overall Study|Withdrawal by Subject|1|||
94277740|NCT03709654|322809578|FG000|Overall Study|Adverse Event|1|||
94277741|NCT03709654|322809579|FG001|Overall Study|Adverse Event|0|||
94277742|NCT04458922|322809580|FG000|Overall Study|Withdrawal by Subject|1|||
94277743|NCT04458922|322809581|FG001|Overall Study|Withdrawal by Subject|0|||
94277744|NCT04458922|322809582|FG002|Overall Study|Withdrawal by Subject|2|||
94277745|NCT04458922|322809580|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
94277746|NCT04458922|322809581|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
94277747|NCT04458922|322809582|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
94277748|NCT04458922|322809580|FG000|Overall Study|Adverse Event|1|||
94277749|NCT04458922|322809581|FG001|Overall Study|Adverse Event|0|||
94277750|NCT04458922|322809582|FG002|Overall Study|Adverse Event|0|||
94277751|NCT04458922|322809580|FG000|Overall Study|Started new study|0|||
94277752|NCT04458922|322809581|FG001|Overall Study|Started new study|0|||
94277753|NCT04458922|322809582|FG002|Overall Study|Started new study|1|||
94277754|NCT04458922|322809580|FG000|Overall Study|Progressive disease|6|||
94277755|NCT04458922|322809581|FG001|Overall Study|Progressive disease|8|||
94277756|NCT04458922|322809582|FG002|Overall Study|Progressive disease|2|||
94277757|NCT04458922|322809580|FG000|Overall Study|Death|1|||
94277758|NCT04458922|322809581|FG001|Overall Study|Death|0|||
94277759|NCT04458922|322809582|FG002|Overall Study|Death|2|||
94277760|NCT04458922|322809580|FG000|Overall Study|Participant started chemotherapy|0|||
94277761|NCT04458922|322809581|FG001|Overall Study|Participant started chemotherapy|1|||
94277762|NCT04458922|322809582|FG002|Overall Study|Participant started chemotherapy|0|||
94277763|NCT00143312|322809587|FG000|Overall Study|Death|11|||
94277764|NCT00143312|322809587|FG000|Overall Study|Adverse Event|2|||
94277765|NCT00143312|322809587|FG000|Overall Study|Lost to Follow-up|1|||
94277766|NCT00143312|322809587|FG000|Overall Study|Other|1|||
94277767|NCT00143312|322809587|FG000|Overall Study|Withdrawal by Subject|1|||
94277768|NCT02716987|322809588|FG000|Overall Study|Ligand synthesis failure|0|||
94277769|NCT02716987|322809589|FG001|Overall Study|Ligand synthesis failure|0|||
94277770|NCT02716987|322809590|FG002|Overall Study|Ligand synthesis failure|1|||
94277771|NCT02716987|322809591|FG003|Overall Study|Ligand synthesis failure|0|||
94277772|NCT02716987|322809592|FG004|Overall Study|Ligand synthesis failure|0|||
94277773|NCT02716987|322809593|FG005|Overall Study|Ligand synthesis failure|0|||
94277774|NCT02716987|322809588|FG000|Overall Study|Withdrawal by Subject|0|||
94277775|NCT02716987|322809589|FG001|Overall Study|Withdrawal by Subject|0|||
94277776|NCT02716987|322809590|FG002|Overall Study|Withdrawal by Subject|0|||
94277777|NCT02716987|322809591|FG003|Overall Study|Withdrawal by Subject|0|||
94277778|NCT02716987|322809592|FG004|Overall Study|Withdrawal by Subject|1|||
94277779|NCT02716987|322809593|FG005|Overall Study|Withdrawal by Subject|1|||
94277780|NCT03223428|322809595|FG000|Overall Study|No longer taking Xermelo|27|||
94277781|NCT03223428|322809595|FG000|Overall Study|Declined Consent|1|||
94277782|NCT03223428|322809595|FG000|Overall Study|Non-responders|56|||
94277783|NCT03223428|322809595|FG000|Overall Study|Withdrawal by Subject|14|||
94277784|NCT01834274|322809596|FG000|Overall Study|Study Termination|41|||
94277785|NCT01834274|322809597|FG001|Overall Study|Study Termination|38|||
94370205|NCT04380701|323142880|FG004|Overall Study|Pregnancy|0|||
94370206|NCT04380701|323142881|FG005|Overall Study|Pregnancy|0|||
94277786|NCT01834274|322809596|FG000|Overall Study|Withdrawal by Subject|1|||
94277787|NCT01834274|322809597|FG001|Overall Study|Withdrawal by Subject|1|||
94277788|NCT01834274|322809596|FG000|Overall Study|Lost to Follow-up|3|||
94742198|NCT06262347|324512108|FG000|Overall Study|Withdrawal by Subject|0|||
94742199|NCT06262347|324512109|FG001|Overall Study|Withdrawal by Subject|1|||
94742200|NCT03242915|324512115|FG000|Overall Study|Adverse Event|5|||
94742201|NCT03242915|324512116|FG001|Overall Study|Adverse Event|1|||
94742202|NCT03242915|324512115|FG000|Overall Study|Withdrawal by Subject|0|||
94742203|NCT03242915|324512116|FG001|Overall Study|Withdrawal by Subject|2|||
94742204|NCT03242915|324512115|FG000|Overall Study|Physician Decision|4|||
94742205|NCT03242915|324512116|FG001|Overall Study|Physician Decision|1|||
94742206|NCT03834740|324512125|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
94742207|NCT03834740|324512126|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
94742208|NCT03834740|324512127|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
94742209|NCT02206828|324512128|FG000|Overall Study|Lost to Follow-up|7|||
94742210|NCT03417284|324512801|FG000|Overall Study|Inadequate supply on study drug|1|||
94742211|NCT03417284|324512802|FG001|Overall Study|Inadequate supply on study drug|0|||
94742212|NCT03417284|324512803|FG002|Overall Study|Inadequate supply on study drug|0|||
94742213|NCT03417284|324512804|FG003|Overall Study|Inadequate supply on study drug|0|||
94742214|NCT03417284|324512801|FG000|Overall Study|Disease Progression|0|||
94742215|NCT03417284|324512802|FG001|Overall Study|Disease Progression|0|||
94742216|NCT03417284|324512803|FG002|Overall Study|Disease Progression|1|||
94742217|NCT03417284|324512804|FG003|Overall Study|Disease Progression|0|||
94742218|NCT05132400|324512805|FG000|Overall Study|Withdrawal by Subject|14|||
94742219|NCT05132400|324512806|FG001|Overall Study|Withdrawal by Subject|8|||
94742220|NCT05132400|324512805|FG000|Overall Study|Lost to Follow-up|132|||
94742221|NCT05132400|324512806|FG001|Overall Study|Lost to Follow-up|121|||
94742222|NCT03934931|324512809|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
94742223|NCT03934931|324512810|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
94742224|NCT03934931|324512811|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
94742225|NCT02720068|324512814|FG000|Overall Study|Adverse Event|0|||
94277789|NCT01834274|322809597|FG001|Overall Study|Lost to Follow-up|1|||
94277790|NCT01834274|322809596|FG000|Overall Study|Other|2|||
94277791|NCT01834274|322809597|FG001|Overall Study|Other|1|||
94277792|NCT01081249|322809602|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
94277793|NCT01081249|322809603|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
94277794|NCT03016325|322809606|FG000|Treatment Period|Participant withdrew consent|0|||
94277795|NCT03016325|322809607|FG001|Treatment Period|Participant withdrew consent|1|||
94277796|NCT03016325|322809608|FG002|Treatment Period|Participant withdrew consent|0|||
94277797|NCT03016325|322809609|FG003|Treatment Period|Participant withdrew consent|0|||
94277798|NCT03016325|322809610|FG004|Treatment Period|Participant withdrew consent|0|||
94277799|NCT03016325|322809611|FG005|Treatment Period|Participant withdrew consent|0|||
94277800|NCT03016325|322809612|FG006|Treatment Period|Participant withdrew consent|0|||
94277801|NCT03016325|322809613|FG007|Treatment Period|Participant withdrew consent|0|||
94277802|NCT03016325|322809606|FG000|Treatment Period|Death|0|||
94277803|NCT03016325|322809607|FG001|Treatment Period|Death|0|||
94277804|NCT03016325|322809608|FG002|Treatment Period|Death|0|||
94277805|NCT03016325|322809609|FG003|Treatment Period|Death|0|||
94277806|NCT03016325|322809610|FG004|Treatment Period|Death|2|||
94277807|NCT03016325|322809611|FG005|Treatment Period|Death|0|||
94277808|NCT03016325|322809612|FG006|Treatment Period|Death|0|||
94277809|NCT03016325|322809613|FG007|Treatment Period|Death|0|||
94277810|NCT03016325|322809606|FG000|Treatment Period|Participant refuses assessments|0|||
94277811|NCT03016325|322809607|FG001|Treatment Period|Participant refuses assessments|0|||
94277812|NCT03016325|322809608|FG002|Treatment Period|Participant refuses assessments|1|||
94277813|NCT03016325|322809609|FG003|Treatment Period|Participant refuses assessments|0|||
94277814|NCT03016325|322809610|FG004|Treatment Period|Participant refuses assessments|0|||
94277815|NCT03016325|322809611|FG005|Treatment Period|Participant refuses assessments|0|||
94277816|NCT03016325|322809612|FG006|Treatment Period|Participant refuses assessments|0|||
94277817|NCT03016325|322809613|FG007|Treatment Period|Participant refuses assessments|0|||
94277818|NCT03016325|322809606|FG000|32-Day Follow-Up Period|Death|2|||
94277819|NCT03016325|322809607|FG001|32-Day Follow-Up Period|Death|0|||
94277820|NCT03016325|322809608|FG002|32-Day Follow-Up Period|Death|5|||
94277821|NCT03016325|322809609|FG003|32-Day Follow-Up Period|Death|6|||
94277822|NCT03016325|322809610|FG004|32-Day Follow-Up Period|Death|3|||
94277823|NCT03016325|322809611|FG005|32-Day Follow-Up Period|Death|0|||
94277824|NCT03016325|322809612|FG006|32-Day Follow-Up Period|Death|0|||
94277825|NCT03016325|322809613|FG007|32-Day Follow-Up Period|Death|0|||
94277826|NCT03016325|322809606|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
94277827|NCT03016325|322809607|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
94277828|NCT03016325|322809608|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
94277829|NCT03016325|322809609|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
94277830|NCT03016325|322809610|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
94277831|NCT03016325|322809611|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
94370207|NCT04380701|323142882|FG006|Overall Study|Pregnancy|0|||
94277832|NCT03016325|322809612|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
94277833|NCT03016325|322809613|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
94277834|NCT03016325|322809606|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
94277835|NCT03016325|322809607|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
94277836|NCT03016325|322809608|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
94277837|NCT03016325|322809609|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
94277838|NCT03016325|322809610|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
94277839|NCT03016325|322809611|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
94277840|NCT03016325|322809612|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
94277841|NCT03016325|322809613|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
94277842|NCT03016325|322809606|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
94277843|NCT03016325|322809607|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
94277844|NCT03016325|322809608|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
94277845|NCT03016325|322809609|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
94277846|NCT03016325|322809610|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
94742226|NCT02720068|324512815|FG001|Overall Study|Adverse Event|0|||
94742227|NCT02720068|324512816|FG002|Overall Study|Adverse Event|0|||
94742228|NCT02720068|324512817|FG003|Overall Study|Adverse Event|0|||
94742229|NCT02720068|324512818|FG004|Overall Study|Adverse Event|0|||
94742230|NCT02720068|324512819|FG005|Overall Study|Adverse Event|0|||
94277847|NCT03016325|322809611|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
94277848|NCT03016325|322809612|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
94277849|NCT03016325|322809613|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
94742231|NCT02720068|324512820|FG006|Overall Study|Adverse Event|0|||
94277850|NCT03016325|322809606|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
94742232|NCT02720068|324512821|FG007|Overall Study|Adverse Event|0|||
94742233|NCT02720068|324512822|FG008|Overall Study|Adverse Event|0|||
94742234|NCT02720068|324512823|FG009|Overall Study|Adverse Event|0|||
94742235|NCT02720068|324512824|FG010|Overall Study|Adverse Event|0|||
94742236|NCT02720068|324512825|FG011|Overall Study|Adverse Event|1|||
94742237|NCT02720068|324512826|FG012|Overall Study|Adverse Event|0|||
94742238|NCT02720068|324512827|FG013|Overall Study|Adverse Event|0|||
94742239|NCT02720068|324512828|FG014|Overall Study|Adverse Event|0|||
94742240|NCT02720068|324512829|FG015|Overall Study|Adverse Event|0|||
94742241|NCT02720068|324512830|FG016|Overall Study|Adverse Event|0|||
94742242|NCT02720068|324512831|FG017|Overall Study|Adverse Event|0|||
94742243|NCT02720068|324512814|FG000|Overall Study|Death|1|||
94742244|NCT02720068|324512815|FG001|Overall Study|Death|3|||
94742245|NCT02720068|324512816|FG002|Overall Study|Death|2|||
94742246|NCT02720068|324512817|FG003|Overall Study|Death|1|||
94742247|NCT02720068|324512818|FG004|Overall Study|Death|2|||
94742248|NCT02720068|324512819|FG005|Overall Study|Death|1|||
94742249|NCT02720068|324512820|FG006|Overall Study|Death|2|||
94742250|NCT02720068|324512821|FG007|Overall Study|Death|2|||
94277851|NCT03016325|322809607|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
94277852|NCT03016325|322809608|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
94277853|NCT03016325|322809609|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
94277854|NCT03016325|322809610|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
94277855|NCT03016325|322809611|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
94277856|NCT03016325|322809612|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
94277857|NCT03016325|322809613|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
94277858|NCT03016325|322809606|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
94277859|NCT03016325|322809607|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
94277860|NCT03016325|322809608|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
94742251|NCT02720068|324512822|FG008|Overall Study|Death|3|||
94742252|NCT02720068|324512823|FG009|Overall Study|Death|1|||
94742253|NCT02720068|324512824|FG010|Overall Study|Death|20|||
94742254|NCT02720068|324512825|FG011|Overall Study|Death|166|||
94742255|NCT02720068|324512826|FG012|Overall Study|Death|34|||
94742256|NCT02720068|324512827|FG013|Overall Study|Death|30|||
94742257|NCT02720068|324512828|FG014|Overall Study|Death|45|||
94742258|NCT02720068|324512829|FG015|Overall Study|Death|16|||
94742259|NCT02720068|324512830|FG016|Overall Study|Death|20|||
94742260|NCT02720068|324512831|FG017|Overall Study|Death|28|||
94742261|NCT02720068|324512814|FG000|Overall Study|Lost to Follow-up|0|||
94742262|NCT02720068|324512815|FG001|Overall Study|Lost to Follow-up|0|||
94742263|NCT02720068|324512816|FG002|Overall Study|Lost to Follow-up|0|||
94742264|NCT02720068|324512817|FG003|Overall Study|Lost to Follow-up|0|||
94742265|NCT02720068|324512818|FG004|Overall Study|Lost to Follow-up|0|||
94742266|NCT02720068|324512819|FG005|Overall Study|Lost to Follow-up|0|||
94742267|NCT02720068|324512820|FG006|Overall Study|Lost to Follow-up|0|||
94742268|NCT02720068|324512821|FG007|Overall Study|Lost to Follow-up|0|||
94742269|NCT02720068|324512822|FG008|Overall Study|Lost to Follow-up|0|||
94277861|NCT03016325|322809609|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
94277862|NCT03016325|322809610|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
94277863|NCT03016325|322809611|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
94277864|NCT03016325|322809612|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
94277865|NCT03016325|322809613|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
94277866|NCT03016325|322809606|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
94277867|NCT03016325|322809607|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
94277868|NCT03016325|322809608|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
94277869|NCT03016325|322809609|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
94277870|NCT03016325|322809610|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
94277871|NCT03016325|322809611|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
94277872|NCT03016325|322809612|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
94277873|NCT03016325|322809613|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
94277874|NCT03016325|322809606|FG000|182-Day Follow-Up Period|Death|3|||
94277875|NCT03016325|322809607|FG001|182-Day Follow-Up Period|Death|3|||
94277876|NCT03016325|322809608|FG002|182-Day Follow-Up Period|Death|11|||
94277877|NCT03016325|322809609|FG003|182-Day Follow-Up Period|Death|12|||
94277878|NCT03016325|322809610|FG004|182-Day Follow-Up Period|Death|9|||
94277879|NCT03016325|322809611|FG005|182-Day Follow-Up Period|Death|0|||
94277880|NCT03016325|322809612|FG006|182-Day Follow-Up Period|Death|0|||
94277881|NCT03016325|322809613|FG007|182-Day Follow-Up Period|Death|1|||
94277882|NCT03016325|322809606|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
94277883|NCT03016325|322809607|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
94277884|NCT03016325|322809608|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
94277885|NCT03016325|322809609|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
94277886|NCT03016325|322809610|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
94277887|NCT03016325|322809611|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
94277888|NCT03016325|322809612|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
94277889|NCT03016325|322809613|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
94277890|NCT03016325|322809606|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
94277891|NCT03016325|322809607|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
94277892|NCT03016325|322809608|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
94277893|NCT03016325|322809609|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
94277894|NCT03016325|322809610|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
94277895|NCT03016325|322809611|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
94277896|NCT03016325|322809612|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
94277897|NCT03016325|322809613|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
94277898|NCT03016325|322809606|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
94277899|NCT03016325|322809607|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
94277900|NCT03016325|322809608|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
94277901|NCT03016325|322809609|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
94277902|NCT03016325|322809610|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
94277903|NCT03016325|322809611|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
94277904|NCT03016325|322809612|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
94277905|NCT03016325|322809613|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
94277906|NCT03016325|322809606|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
94277907|NCT03016325|322809607|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
94277908|NCT03016325|322809608|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
94277909|NCT03016325|322809609|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
94277910|NCT03016325|322809610|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
94277911|NCT03016325|322809611|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
94277912|NCT03016325|322809612|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
94277913|NCT03016325|322809613|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
94277914|NCT03016325|322809606|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
94277915|NCT03016325|322809607|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
94370208|NCT04380701|323142883|FG007|Overall Study|Pregnancy|0|||
94370209|NCT04380701|323142884|FG008|Overall Study|Pregnancy|0|||
94742270|NCT02720068|324512823|FG009|Overall Study|Lost to Follow-up|0|||
94742271|NCT02720068|324512824|FG010|Overall Study|Lost to Follow-up|0|||
94370210|NCT04380701|323142885|FG009|Overall Study|Pregnancy|0|||
94370211|NCT04380701|323142886|FG010|Overall Study|Pregnancy|0|||
94370212|NCT04380701|323142887|FG011|Overall Study|Pregnancy|0|||
94370213|NCT04380701|323142888|FG012|Overall Study|Pregnancy|0|||
94370214|NCT04380701|323142889|FG013|Overall Study|Pregnancy|0|||
94370215|NCT04380701|323142890|FG014|Overall Study|Pregnancy|0|||
94370216|NCT04380701|323142891|FG015|Overall Study|Pregnancy|0|||
94370217|NCT04380701|323142892|FG016|Overall Study|Pregnancy|0|||
94370218|NCT04380701|323142893|FG017|Overall Study|Pregnancy|0|||
94370219|NCT04380701|323142894|FG018|Overall Study|Pregnancy|0|||
94370220|NCT04380701|323142895|FG019|Overall Study|Pregnancy|0|||
94370221|NCT04380701|323142896|FG020|Overall Study|Pregnancy|0|||
94370222|NCT04380701|323142897|FG021|Overall Study|Pregnancy|0|||
94370223|NCT04380701|323142898|FG022|Overall Study|Pregnancy|0|||
94370224|NCT04380701|323142899|FG023|Overall Study|Pregnancy|0|||
94370225|NCT04380701|323142900|FG024|Overall Study|Pregnancy|0|||
94370226|NCT04380701|323142901|FG025|Overall Study|Pregnancy|0|||
94370227|NCT04380701|323142902|FG026|Overall Study|Pregnancy|0|||
94370228|NCT04380701|323142903|FG027|Overall Study|Pregnancy|0|||
94370229|NCT04380701|323142904|FG028|Overall Study|Pregnancy|0|||
94370230|NCT04380701|323142905|FG029|Overall Study|Pregnancy|0|||
94370231|NCT04380701|323142906|FG030|Overall Study|Pregnancy|0|||
94370232|NCT04380701|323142907|FG031|Overall Study|Pregnancy|0|||
94370233|NCT04380701|323142908|FG032|Overall Study|Pregnancy|1|||
94370234|NCT04380701|323142909|FG033|Overall Study|Pregnancy|0|||
94370235|NCT04380701|323142876|FG000|Overall Study|Lost to Follow-up|0|||
94370236|NCT04380701|323142877|FG001|Overall Study|Lost to Follow-up|0|||
94370237|NCT04380701|323142878|FG002|Overall Study|Lost to Follow-up|0|||
94370238|NCT04380701|323142879|FG003|Overall Study|Lost to Follow-up|0|||
94370239|NCT04380701|323142880|FG004|Overall Study|Lost to Follow-up|0|||
94370240|NCT04380701|323142881|FG005|Overall Study|Lost to Follow-up|0|||
94370241|NCT04380701|323142882|FG006|Overall Study|Lost to Follow-up|0|||
94370242|NCT04380701|323142883|FG007|Overall Study|Lost to Follow-up|0|||
94370243|NCT04380701|323142884|FG008|Overall Study|Lost to Follow-up|0|||
94370244|NCT04380701|323142885|FG009|Overall Study|Lost to Follow-up|0|||
94370245|NCT04380701|323142886|FG010|Overall Study|Lost to Follow-up|0|||
94370246|NCT04380701|323142887|FG011|Overall Study|Lost to Follow-up|0|||
94370247|NCT04380701|323142888|FG012|Overall Study|Lost to Follow-up|0|||
94370248|NCT04380701|323142889|FG013|Overall Study|Lost to Follow-up|0|||
94370249|NCT04380701|323142890|FG014|Overall Study|Lost to Follow-up|0|||
94370250|NCT04380701|323142891|FG015|Overall Study|Lost to Follow-up|0|||
94370251|NCT04380701|323142892|FG016|Overall Study|Lost to Follow-up|0|||
94370252|NCT04380701|323142893|FG017|Overall Study|Lost to Follow-up|0|||
94370253|NCT04380701|323142894|FG018|Overall Study|Lost to Follow-up|0|||
94370254|NCT04380701|323142895|FG019|Overall Study|Lost to Follow-up|0|||
94370255|NCT04380701|323142896|FG020|Overall Study|Lost to Follow-up|1|||
94370256|NCT04380701|323142897|FG021|Overall Study|Lost to Follow-up|0|||
94370257|NCT04380701|323142898|FG022|Overall Study|Lost to Follow-up|0|||
94370258|NCT04380701|323142899|FG023|Overall Study|Lost to Follow-up|1|||
94370259|NCT04380701|323142900|FG024|Overall Study|Lost to Follow-up|0|||
94370260|NCT04380701|323142901|FG025|Overall Study|Lost to Follow-up|0|||
94370261|NCT04380701|323142902|FG026|Overall Study|Lost to Follow-up|0|||
94370262|NCT04380701|323142903|FG027|Overall Study|Lost to Follow-up|0|||
94370263|NCT04380701|323142904|FG028|Overall Study|Lost to Follow-up|0|||
94370264|NCT04380701|323142905|FG029|Overall Study|Lost to Follow-up|1|||
94370265|NCT04380701|323142906|FG030|Overall Study|Lost to Follow-up|0|||
94370266|NCT04380701|323142907|FG031|Overall Study|Lost to Follow-up|0|||
94370267|NCT04380701|323142908|FG032|Overall Study|Lost to Follow-up|0|||
94370268|NCT04380701|323142909|FG033|Overall Study|Lost to Follow-up|1|||
94370269|NCT04380701|323142876|FG000|Overall Study|Private reason(s)|0|||
94370270|NCT04380701|323142877|FG001|Overall Study|Private reason(s)|0|||
94370271|NCT04380701|323142878|FG002|Overall Study|Private reason(s)|0|||
94370272|NCT04380701|323142879|FG003|Overall Study|Private reason(s)|0|||
94370273|NCT04380701|323142880|FG004|Overall Study|Private reason(s)|0|||
94370274|NCT04380701|323142881|FG005|Overall Study|Private reason(s)|0|||
94370275|NCT04380701|323142882|FG006|Overall Study|Private reason(s)|1|||
94370276|NCT04380701|323142883|FG007|Overall Study|Private reason(s)|0|||
94370277|NCT04380701|323142884|FG008|Overall Study|Private reason(s)|1|||
94370278|NCT04380701|323142885|FG009|Overall Study|Private reason(s)|1|||
94370279|NCT04380701|323142886|FG010|Overall Study|Private reason(s)|0|||
94370280|NCT04380701|323142887|FG011|Overall Study|Private reason(s)|0|||
94370281|NCT04380701|323142888|FG012|Overall Study|Private reason(s)|0|||
94370282|NCT04380701|323142889|FG013|Overall Study|Private reason(s)|0|||
94370283|NCT04380701|323142890|FG014|Overall Study|Private reason(s)|0|||
94370284|NCT04380701|323142891|FG015|Overall Study|Private reason(s)|0|||
94370285|NCT04380701|323142892|FG016|Overall Study|Private reason(s)|0|||
94370286|NCT04380701|323142893|FG017|Overall Study|Private reason(s)|0|||
94370287|NCT04380701|323142894|FG018|Overall Study|Private reason(s)|0|||
94370288|NCT04380701|323142895|FG019|Overall Study|Private reason(s)|0|||
94370289|NCT04380701|323142896|FG020|Overall Study|Private reason(s)|0|||
94370290|NCT04380701|323142897|FG021|Overall Study|Private reason(s)|0|||
94370291|NCT04380701|323142898|FG022|Overall Study|Private reason(s)|0|||
94370292|NCT04380701|323142899|FG023|Overall Study|Private reason(s)|1|||
94370293|NCT04380701|323142900|FG024|Overall Study|Private reason(s)|0|||
94370294|NCT04380701|323142901|FG025|Overall Study|Private reason(s)|0|||
94370295|NCT04380701|323142902|FG026|Overall Study|Private reason(s)|0|||
94742272|NCT02720068|324512825|FG011|Overall Study|Lost to Follow-up|1|||
94742273|NCT02720068|324512826|FG012|Overall Study|Lost to Follow-up|0|||
94742274|NCT02720068|324512827|FG013|Overall Study|Lost to Follow-up|1|||
94742275|NCT02720068|324512828|FG014|Overall Study|Lost to Follow-up|2|||
94742276|NCT02720068|324512829|FG015|Overall Study|Lost to Follow-up|0|||
94742277|NCT02720068|324512830|FG016|Overall Study|Lost to Follow-up|0|||
94742278|NCT02720068|324512831|FG017|Overall Study|Lost to Follow-up|1|||
94742279|NCT02720068|324512814|FG000|Overall Study|Physician Decision|0|||
94742280|NCT02720068|324512815|FG001|Overall Study|Physician Decision|0|||
94742281|NCT02720068|324512816|FG002|Overall Study|Physician Decision|0|||
94742282|NCT02720068|324512817|FG003|Overall Study|Physician Decision|1|||
94742283|NCT02720068|324512818|FG004|Overall Study|Physician Decision|0|||
94742284|NCT02720068|324512819|FG005|Overall Study|Physician Decision|0|||
94742285|NCT02720068|324512820|FG006|Overall Study|Physician Decision|0|||
94742286|NCT02720068|324512821|FG007|Overall Study|Physician Decision|0|||
94742287|NCT02720068|324512822|FG008|Overall Study|Physician Decision|0|||
94742288|NCT02720068|324512823|FG009|Overall Study|Physician Decision|0|||
94742289|NCT02720068|324512824|FG010|Overall Study|Physician Decision|0|||
94742290|NCT02720068|324512825|FG011|Overall Study|Physician Decision|1|||
94742291|NCT02720068|324512826|FG012|Overall Study|Physician Decision|0|||
94742292|NCT02720068|324512827|FG013|Overall Study|Physician Decision|0|||
94742293|NCT02720068|324512828|FG014|Overall Study|Physician Decision|0|||
94742294|NCT02720068|324512829|FG015|Overall Study|Physician Decision|0|||
94742295|NCT02720068|324512830|FG016|Overall Study|Physician Decision|0|||
94742296|NCT02720068|324512831|FG017|Overall Study|Physician Decision|1|||
94742297|NCT02720068|324512814|FG000|Overall Study|Progressive Disease|2|||
94742298|NCT02720068|324512815|FG001|Overall Study|Progressive Disease|3|||
94742299|NCT02720068|324512816|FG002|Overall Study|Progressive Disease|1|||
94742300|NCT02720068|324512817|FG003|Overall Study|Progressive Disease|1|||
94742301|NCT02720068|324512818|FG004|Overall Study|Progressive Disease|1|||
94742302|NCT02720068|324512819|FG005|Overall Study|Progressive Disease|2|||
94742303|NCT02720068|324512820|FG006|Overall Study|Progressive Disease|1|||
94742304|NCT02720068|324512821|FG007|Overall Study|Progressive Disease|1|||
94742305|NCT02720068|324512822|FG008|Overall Study|Progressive Disease|0|||
94742306|NCT02720068|324512823|FG009|Overall Study|Progressive Disease|1|||
94742307|NCT02720068|324512824|FG010|Overall Study|Progressive Disease|0|||
94742308|NCT02720068|324512825|FG011|Overall Study|Progressive Disease|4|||
94742309|NCT02720068|324512826|FG012|Overall Study|Progressive Disease|1|||
94742310|NCT02720068|324512827|FG013|Overall Study|Progressive Disease|0|||
94742311|NCT02720068|324512828|FG014|Overall Study|Progressive Disease|0|||
94742312|NCT02720068|324512829|FG015|Overall Study|Progressive Disease|0|||
94742313|NCT02720068|324512830|FG016|Overall Study|Progressive Disease|0|||
94742314|NCT02720068|324512831|FG017|Overall Study|Progressive Disease|0|||
94742315|NCT02720068|324512814|FG000|Overall Study|Sponsor Decision|0|||
94742316|NCT02720068|324512815|FG001|Overall Study|Sponsor Decision|0|||
94742317|NCT02720068|324512816|FG002|Overall Study|Sponsor Decision|0|||
94742318|NCT02720068|324512817|FG003|Overall Study|Sponsor Decision|0|||
94742319|NCT02720068|324512818|FG004|Overall Study|Sponsor Decision|0|||
94742320|NCT02720068|324512819|FG005|Overall Study|Sponsor Decision|0|||
94742321|NCT02720068|324512820|FG006|Overall Study|Sponsor Decision|0|||
94742322|NCT02720068|324512821|FG007|Overall Study|Sponsor Decision|0|||
94742323|NCT02720068|324512822|FG008|Overall Study|Sponsor Decision|0|||
94742324|NCT02720068|324512823|FG009|Overall Study|Sponsor Decision|0|||
94742325|NCT02720068|324512824|FG010|Overall Study|Sponsor Decision|0|||
94742326|NCT02720068|324512825|FG011|Overall Study|Sponsor Decision|6|||
94742327|NCT02720068|324512826|FG012|Overall Study|Sponsor Decision|3|||
94742328|NCT02720068|324512827|FG013|Overall Study|Sponsor Decision|2|||
94742329|NCT02720068|324512828|FG014|Overall Study|Sponsor Decision|4|||
94742330|NCT02720068|324512829|FG015|Overall Study|Sponsor Decision|4|||
94742331|NCT02720068|324512830|FG016|Overall Study|Sponsor Decision|0|||
94742332|NCT02720068|324512831|FG017|Overall Study|Sponsor Decision|8|||
94742333|NCT02720068|324512814|FG000|Overall Study|Withdrawal by Subject|0|||
94742334|NCT02720068|324512815|FG001|Overall Study|Withdrawal by Subject|0|||
94742335|NCT02720068|324512816|FG002|Overall Study|Withdrawal by Subject|0|||
94742336|NCT02720068|324512817|FG003|Overall Study|Withdrawal by Subject|0|||
94742337|NCT02720068|324512818|FG004|Overall Study|Withdrawal by Subject|0|||
94742338|NCT02720068|324512819|FG005|Overall Study|Withdrawal by Subject|0|||
94742339|NCT02720068|324512820|FG006|Overall Study|Withdrawal by Subject|0|||
94742340|NCT02720068|324512821|FG007|Overall Study|Withdrawal by Subject|0|||
94370296|NCT04380701|323142903|FG027|Overall Study|Private reason(s)|0|||
94370297|NCT04380701|323142904|FG028|Overall Study|Private reason(s)|0|||
94742341|NCT02720068|324512822|FG008|Overall Study|Withdrawal by Subject|0|||
94742342|NCT02720068|324512823|FG009|Overall Study|Withdrawal by Subject|1|||
94742343|NCT02720068|324512824|FG010|Overall Study|Withdrawal by Subject|0|||
94277916|NCT03016325|322809608|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
94277917|NCT03016325|322809609|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
94277918|NCT03016325|322809610|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
94277919|NCT03016325|322809611|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
94277920|NCT03016325|322809612|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
94277921|NCT03016325|322809613|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
94277922|NCT03016325|322809606|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
94277923|NCT03016325|322809607|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
94277924|NCT03016325|322809608|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
94277925|NCT03016325|322809609|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
94277926|NCT03016325|322809610|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
94277927|NCT03016325|322809611|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
94277928|NCT03016325|322809612|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
94277929|NCT03016325|322809613|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
94277930|NCT03016325|322809606|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
94277931|NCT03016325|322809607|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
94277932|NCT03016325|322809608|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
94277933|NCT03016325|322809609|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
94277934|NCT03016325|322809610|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
94277935|NCT03016325|322809611|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
94277936|NCT03016325|322809612|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
94277937|NCT03016325|322809613|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
94277938|NCT02595723|322809616|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
94277939|NCT02595723|322809617|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
94277940|NCT02595723|322809618|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
94277941|NCT02595723|322809616|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
94277942|NCT02595723|322809617|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
94277943|NCT02595723|322809618|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
94277944|NCT00996944|322809620|FG000|Double-blind Treatment Period|Adverse Event|2|||
94277945|NCT00996944|322809621|FG001|Double-blind Treatment Period|Adverse Event|1|||
94277946|NCT00996944|322809620|FG000|Double-blind Treatment Period|Protocol Violation|1|||
94277947|NCT00996944|322809621|FG001|Double-blind Treatment Period|Protocol Violation|0|||
94277948|NCT00996944|322809620|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
94277949|NCT00996944|322809621|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
94277950|NCT00996944|322809620|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
94277951|NCT00996944|322809621|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
94277952|NCT00996944|322809620|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
94277953|NCT00996944|322809621|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
94277954|NCT02250274|322809622|FG000|Overall Study|Insufficient blood draw amount|7|||
94277955|NCT02250274|322809623|FG001|Overall Study|Insufficient blood draw amount|6|||
94277956|NCT00419380|322809625|FG000|Overall Study|Lack of Efficacy|1|||
94277957|NCT00419380|322809626|FG001|Overall Study|Lack of Efficacy|7|||
94277958|NCT00419380|322809625|FG000|Overall Study|Physician Decision|0|||
94277959|NCT00419380|322809626|FG001|Overall Study|Physician Decision|1|||
94277960|NCT00419380|322809625|FG000|Overall Study|Lost to Follow-up|0|||
94277961|NCT00419380|322809626|FG001|Overall Study|Lost to Follow-up|1|||
94277962|NCT00419380|322809625|FG000|Overall Study|Withdrawal by Subject|0|||
94277963|NCT00419380|322809626|FG001|Overall Study|Withdrawal by Subject|1|||
94277964|NCT04770389|322809627|FG000|Overall Study|Adverse Event|1|||
94277965|NCT04770389|322809628|FG001|Overall Study|Adverse Event|2|||
94277966|NCT04770389|322809629|FG002|Overall Study|Adverse Event|0|||
94277967|NCT04770389|322809630|FG003|Overall Study|Adverse Event|1|||
94277968|NCT04770389|322809627|FG000|Overall Study|Withdrawal by Subject|0|||
94277969|NCT04770389|322809628|FG001|Overall Study|Withdrawal by Subject|2|||
94277970|NCT04770389|322809629|FG002|Overall Study|Withdrawal by Subject|1|||
94277971|NCT04770389|322809630|FG003|Overall Study|Withdrawal by Subject|0|||
94277972|NCT04770389|322809627|FG000|Overall Study|Failed attempt to draw blood|1|||
94277973|NCT04770389|322809628|FG001|Overall Study|Failed attempt to draw blood|0|||
94277974|NCT04770389|322809629|FG002|Overall Study|Failed attempt to draw blood|0|||
94277975|NCT04770389|322809630|FG003|Overall Study|Failed attempt to draw blood|0|||
94277976|NCT04770389|322809627|FG000|Overall Study|Left the country|0|||
94277977|NCT04770389|322809628|FG001|Overall Study|Left the country|0|||
94277978|NCT04770389|322809629|FG002|Overall Study|Left the country|1|||
94277979|NCT04770389|322809630|FG003|Overall Study|Left the country|2|||
94277980|NCT04770389|322809627|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
94277981|NCT04770389|322809628|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
94277982|NCT04770389|322809629|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
94277983|NCT04770389|322809630|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
94277984|NCT04770389|322809627|FG000|Overall Study|Lost to Follow-up|0|||
94277985|NCT04770389|322809628|FG001|Overall Study|Lost to Follow-up|0|||
94277986|NCT04770389|322809629|FG002|Overall Study|Lost to Follow-up|0|||
94277987|NCT04770389|322809630|FG003|Overall Study|Lost to Follow-up|1|||
94277988|NCT04770389|322809627|FG000|Overall Study|Moved away from study site|0|||
94277989|NCT04770389|322809628|FG001|Overall Study|Moved away from study site|1|||
94277990|NCT04770389|322809629|FG002|Overall Study|Moved away from study site|0|||
94277991|NCT04770389|322809630|FG003|Overall Study|Moved away from study site|0|||
94742344|NCT02720068|324512825|FG011|Overall Study|Withdrawal by Subject|27|||
94277992|NCT00574275|322809633|FG000|Overall Study|Randomized but not treated|2|||
94277993|NCT00574275|322809634|FG001|Overall Study|Randomized but not treated|3|||
94277994|NCT00574275|322809633|FG000|Overall Study|Adverse Event|32|||
94277995|NCT00574275|322809634|FG001|Overall Study|Adverse Event|76|||
94277996|NCT00574275|322809633|FG000|Overall Study|Disease progression|160|||
94277997|NCT00574275|322809634|FG001|Overall Study|Disease progression|146|||
94277998|NCT00574275|322809633|FG000|Overall Study|Lost to Follow-up|2|||
94277999|NCT00574275|322809634|FG001|Overall Study|Lost to Follow-up|1|||
94278000|NCT00574275|322809633|FG000|Overall Study|Study stopped based on DMC decision|62|||
94278001|NCT00574275|322809634|FG001|Overall Study|Study stopped based on DMC decision|23|||
94278002|NCT00574275|322809633|FG000|Overall Study|Withdrawal by Subject|15|||
94278003|NCT00574275|322809634|FG001|Overall Study|Withdrawal by Subject|17|||
94278004|NCT00574275|322809633|FG000|Overall Study|Error calculating tumor measurement|1|||
94278005|NCT00574275|322809634|FG001|Overall Study|Error calculating tumor measurement|0|||
94278006|NCT00574275|322809633|FG000|Overall Study|Physician Decision|1|||
94278007|NCT00574275|322809634|FG001|Overall Study|Physician Decision|1|||
94278008|NCT00574275|322809633|FG000|Overall Study|Protocol Violation|0|||
94278009|NCT00574275|322809634|FG001|Overall Study|Protocol Violation|1|||
94278010|NCT00574275|322809633|FG000|Overall Study|Patient and Investigator decision|0|||
94278011|NCT00574275|322809634|FG001|Overall Study|Patient and Investigator decision|1|||
94278012|NCT00574275|322809633|FG000|Overall Study|Insurance change|0|||
94278013|NCT00574275|322809634|FG001|Overall Study|Insurance change|1|||
94278014|NCT00574275|322809633|FG000|Overall Study|Operation for curative intent|0|||
94278015|NCT00574275|322809634|FG001|Overall Study|Operation for curative intent|1|||
94278016|NCT01505634|322809638|FG000|Overall Study|Withdrawal by Subject|2|||
94278017|NCT01505634|322809639|FG001|Overall Study|Withdrawal by Subject|5|||
94278018|NCT01505634|322809640|FG002|Overall Study|Withdrawal by Subject|1|||
94278019|NCT01505634|322809638|FG000|Overall Study|Physician Decision|1|||
94278020|NCT01505634|322809639|FG001|Overall Study|Physician Decision|1|||
94278021|NCT01505634|322809640|FG002|Overall Study|Physician Decision|0|||
94278022|NCT01505634|322809638|FG000|Overall Study|Adverse Event|1|||
94278023|NCT01505634|322809639|FG001|Overall Study|Adverse Event|0|||
94278024|NCT01505634|322809640|FG002|Overall Study|Adverse Event|0|||
94278025|NCT01505634|322809638|FG000|Overall Study|Insufficient supply of drug at site|1|||
94278026|NCT01505634|322809639|FG001|Overall Study|Insufficient supply of drug at site|0|||
94278027|NCT01505634|322809640|FG002|Overall Study|Insufficient supply of drug at site|0|||
94278028|NCT01505634|322809638|FG000|Overall Study|Protocol Violation|2|||
94742345|NCT02720068|324512826|FG012|Overall Study|Withdrawal by Subject|2|||
94278029|NCT01505634|322809639|FG001|Overall Study|Protocol Violation|0|||
94742346|NCT02720068|324512827|FG013|Overall Study|Withdrawal by Subject|8|||
94742347|NCT02720068|324512828|FG014|Overall Study|Withdrawal by Subject|7|||
94742348|NCT02720068|324512829|FG015|Overall Study|Withdrawal by Subject|0|||
94742349|NCT02720068|324512830|FG016|Overall Study|Withdrawal by Subject|0|||
94742350|NCT02720068|324512831|FG017|Overall Study|Withdrawal by Subject|2|||
94742351|NCT02720068|324512814|FG000|Overall Study|Protocol Violation|0|||
94742352|NCT02720068|324512815|FG001|Overall Study|Protocol Violation|0|||
94742353|NCT02720068|324512816|FG002|Overall Study|Protocol Violation|0|||
94742354|NCT02720068|324512817|FG003|Overall Study|Protocol Violation|0|||
94742355|NCT02720068|324512818|FG004|Overall Study|Protocol Violation|0|||
94742356|NCT02720068|324512819|FG005|Overall Study|Protocol Violation|0|||
94278030|NCT01505634|322809640|FG002|Overall Study|Protocol Violation|0|||
94278031|NCT01505634|322809638|FG000|Overall Study|Lost to Follow-up|1|||
94278032|NCT01505634|322809639|FG001|Overall Study|Lost to Follow-up|4|||
94278033|NCT01505634|322809640|FG002|Overall Study|Lost to Follow-up|4|||
94278034|NCT01505634|322809638|FG000|Overall Study|Death|1|||
94278035|NCT01505634|322809639|FG001|Overall Study|Death|0|||
94278036|NCT01505634|322809640|FG002|Overall Study|Death|0|||
94278037|NCT01505634|322809638|FG000|Overall Study|In a conflict zone|0|||
94278038|NCT01505634|322809639|FG001|Overall Study|In a conflict zone|0|||
94278039|NCT01505634|322809640|FG002|Overall Study|In a conflict zone|1|||
94278040|NCT00542269|322809641|FG000|Overall Study|Adverse Event|10|||
94278041|NCT00542269|322809642|FG001|Overall Study|Adverse Event|4|||
94278042|NCT00542269|322809643|FG002|Overall Study|Adverse Event|5|||
94742357|NCT02720068|324512820|FG006|Overall Study|Protocol Violation|0|||
94278043|NCT00542269|322809641|FG000|Overall Study|Protocol Violation|1|||
94278044|NCT00542269|322809642|FG001|Overall Study|Protocol Violation|1|||
94278045|NCT00542269|322809643|FG002|Overall Study|Protocol Violation|0|||
94278046|NCT00542269|322809641|FG000|Overall Study|Withdrawal by Subject|1|||
94278047|NCT00542269|322809642|FG001|Overall Study|Withdrawal by Subject|0|||
94278048|NCT00542269|322809643|FG002|Overall Study|Withdrawal by Subject|0|||
94370298|NCT04380701|323142905|FG029|Overall Study|Private reason(s)|1|||
94370299|NCT04380701|323142906|FG030|Overall Study|Private reason(s)|0|||
94370300|NCT04380701|323142907|FG031|Overall Study|Private reason(s)|0|||
94370301|NCT04380701|323142908|FG032|Overall Study|Private reason(s)|0|||
94370302|NCT04380701|323142909|FG033|Overall Study|Private reason(s)|0|||
94370303|NCT04380701|323142876|FG000|Overall Study|Withdrawal by Subject|0|||
94370304|NCT04380701|323142877|FG001|Overall Study|Withdrawal by Subject|0|||
94370305|NCT04380701|323142878|FG002|Overall Study|Withdrawal by Subject|0|||
94370306|NCT04380701|323142879|FG003|Overall Study|Withdrawal by Subject|0|||
94278049|NCT00542269|322809641|FG000|Overall Study|Administrative problems|1|||
94278050|NCT00542269|322809642|FG001|Overall Study|Administrative problems|1|||
94278051|NCT00542269|322809643|FG002|Overall Study|Administrative problems|1|||
94278052|NCT00845650|322809644|FG000|Overall Study|Withdrawal by Subject|0|||
94278053|NCT00845650|322809645|FG001|Overall Study|Withdrawal by Subject|0|||
94278054|NCT00845650|322809646|FG002|Overall Study|Withdrawal by Subject|0|||
94278055|NCT00845650|322809647|FG003|Overall Study|Withdrawal by Subject|0|||
94278056|NCT00845650|322809648|FG004|Overall Study|Withdrawal by Subject|2|||
94278057|NCT00845650|322809649|FG005|Overall Study|Withdrawal by Subject|0|||
94278058|NCT00845650|322809644|FG000|Overall Study|Lost to Follow-up|0|||
94278059|NCT00845650|322809645|FG001|Overall Study|Lost to Follow-up|0|||
94278060|NCT00845650|322809646|FG002|Overall Study|Lost to Follow-up|3|||
94278061|NCT00845650|322809647|FG003|Overall Study|Lost to Follow-up|1|||
94278062|NCT00845650|322809648|FG004|Overall Study|Lost to Follow-up|0|||
94278063|NCT00845650|322809649|FG005|Overall Study|Lost to Follow-up|1|||
94278064|NCT00845650|322809644|FG000|Overall Study|Sponsor hold on dosing|0|||
94278065|NCT00845650|322809645|FG001|Overall Study|Sponsor hold on dosing|0|||
94278066|NCT00845650|322809646|FG002|Overall Study|Sponsor hold on dosing|0|||
94278067|NCT00845650|322809647|FG003|Overall Study|Sponsor hold on dosing|0|||
94278068|NCT00845650|322809648|FG004|Overall Study|Sponsor hold on dosing|1|||
94278069|NCT00845650|322809649|FG005|Overall Study|Sponsor hold on dosing|1|||
94278070|NCT00845650|322809644|FG000|Overall Study|Unable to access IV line|1|||
94278071|NCT00845650|322809645|FG001|Overall Study|Unable to access IV line|0|||
94278072|NCT00845650|322809646|FG002|Overall Study|Unable to access IV line|0|||
94278073|NCT00845650|322809647|FG003|Overall Study|Unable to access IV line|0|||
94278074|NCT00845650|322809648|FG004|Overall Study|Unable to access IV line|0|||
94278075|NCT00845650|322809649|FG005|Overall Study|Unable to access IV line|0|||
94278076|NCT00844753|322809652|FG000|Overall Study|Lack of Efficacy|1|||
94278077|NCT00844753|322809653|FG001|Overall Study|Lack of Efficacy|0|||
94278078|NCT00844753|322809654|FG002|Overall Study|Lack of Efficacy|2|||
94278079|NCT00844753|322809655|FG003|Overall Study|Lack of Efficacy|2|||
94278080|NCT00844753|322809652|FG000|Overall Study|Adverse Event|3|||
94278081|NCT00844753|322809653|FG001|Overall Study|Adverse Event|2|||
94278082|NCT00844753|322809654|FG002|Overall Study|Adverse Event|5|||
94278083|NCT00844753|322809655|FG003|Overall Study|Adverse Event|5|||
94278084|NCT00844753|322809652|FG000|Overall Study|Lost to Follow-up|1|||
94278085|NCT00844753|322809653|FG001|Overall Study|Lost to Follow-up|1|||
94278086|NCT00844753|322809654|FG002|Overall Study|Lost to Follow-up|0|||
94278087|NCT00844753|322809655|FG003|Overall Study|Lost to Follow-up|1|||
94278088|NCT00844753|322809652|FG000|Overall Study|could not swallow medication|2|||
94278089|NCT00844753|322809653|FG001|Overall Study|could not swallow medication|0|||
94278090|NCT00844753|322809654|FG002|Overall Study|could not swallow medication|0|||
94278091|NCT00844753|322809655|FG003|Overall Study|could not swallow medication|0|||
94278092|NCT00844753|322809652|FG000|Overall Study|Withdrawal by Subject|1|||
94278093|NCT00844753|322809653|FG001|Overall Study|Withdrawal by Subject|0|||
94278094|NCT00844753|322809654|FG002|Overall Study|Withdrawal by Subject|0|||
94278095|NCT00844753|322809655|FG003|Overall Study|Withdrawal by Subject|3|||
94278096|NCT03440814|322809656|FG000|Overall Study|Adverse Event|2|||
94278097|NCT03440814|322809657|FG001|Overall Study|Adverse Event|1|||
94278098|NCT03440814|322809656|FG000|Overall Study|Lost to Follow-up|2|||
94278099|NCT03440814|322809657|FG001|Overall Study|Lost to Follow-up|0|||
94742358|NCT02720068|324512821|FG007|Overall Study|Protocol Violation|0|||
94742359|NCT02720068|324512822|FG008|Overall Study|Protocol Violation|0|||
94742360|NCT02720068|324512823|FG009|Overall Study|Protocol Violation|0|||
94742361|NCT02720068|324512824|FG010|Overall Study|Protocol Violation|1|||
94742362|NCT02720068|324512825|FG011|Overall Study|Protocol Violation|0|||
94742363|NCT02720068|324512826|FG012|Overall Study|Protocol Violation|0|||
94742364|NCT02720068|324512827|FG013|Overall Study|Protocol Violation|0|||
94742365|NCT02720068|324512828|FG014|Overall Study|Protocol Violation|1|||
94742366|NCT02720068|324512829|FG015|Overall Study|Protocol Violation|0|||
94742367|NCT02720068|324512830|FG016|Overall Study|Protocol Violation|1|||
94742368|NCT02720068|324512831|FG017|Overall Study|Protocol Violation|0|||
94742369|NCT03868930|324512833|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
94742370|NCT03868930|324512834|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
94742371|NCT03868930|324512833|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
94742372|NCT03868930|324512834|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
94742373|NCT03868930|324512833|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
94742374|NCT03868930|324512834|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
94742375|NCT03868930|324512833|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
94742376|NCT03868930|324512834|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
94742377|NCT03868930|324512833|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
94742378|NCT03868930|324512834|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
94278100|NCT03440814|322809656|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
94278101|NCT03440814|322809657|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
94278102|NCT02457637|322809658|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
94278103|NCT01437397|322809659|FG000|Overall Study|Lost to Follow-up|9|||
94742379|NCT03258593|324512835|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
94742380|NCT03258593|324512836|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
94742381|NCT03258593|324512837|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
94742382|NCT03258593|324512838|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
94742383|NCT03258593|324512835|FG000|Run-In Maintenance Phase|Disease progression|3|||
94742384|NCT03258593|324512836|FG001|Run-In Maintenance Phase|Disease progression|0|||
94742385|NCT03258593|324512837|FG002|Run-In Maintenance Phase|Disease progression|0|||
94742386|NCT03258593|324512838|FG003|Run-In Maintenance Phase|Disease progression|0|||
94742387|NCT03258593|324512835|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
94742388|NCT03258593|324512836|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
94742389|NCT03258593|324512837|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
94742390|NCT03258593|324512838|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
94742391|NCT03258593|324512835|FG000|Expansion Maintenance Phase|Physician Decision|0|||
94742392|NCT03258593|324512836|FG001|Expansion Maintenance Phase|Physician Decision|1|||
94742393|NCT03258593|324512837|FG002|Expansion Maintenance Phase|Physician Decision|0|||
94742394|NCT03258593|324512838|FG003|Expansion Maintenance Phase|Physician Decision|0|||
94742395|NCT01046825|324512839|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
94742396|NCT01046825|324512840|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
94742397|NCT01046825|324512841|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
94742398|NCT01046825|324512842|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
94742399|NCT01046825|324512843|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
94742400|NCT01046825|324512839|FG000|Overall Study|Physician Decision|0|||
94742401|NCT01046825|324512840|FG001|Overall Study|Physician Decision|1|||
94742402|NCT01046825|324512841|FG002|Overall Study|Physician Decision|2|||
94742403|NCT01046825|324512842|FG003|Overall Study|Physician Decision|0|||
94742404|NCT01046825|324512843|FG004|Overall Study|Physician Decision|0|||
94742405|NCT01046825|324512839|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
94742406|NCT01046825|324512840|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
94742407|NCT01046825|324512841|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
94742408|NCT01046825|324512842|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
94742409|NCT01046825|324512843|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
94742410|NCT01046825|324512839|FG000|Overall Study|Found to be ineligible|0|||
94742411|NCT01046825|324512840|FG001|Overall Study|Found to be ineligible|1|||
94742412|NCT01046825|324512841|FG002|Overall Study|Found to be ineligible|0|||
94742413|NCT01046825|324512842|FG003|Overall Study|Found to be ineligible|0|||
94742414|NCT01046825|324512843|FG004|Overall Study|Found to be ineligible|0|||
94742415|NCT01046825|324512839|FG000|Overall Study|Death|0|||
94742416|NCT01046825|324512840|FG001|Overall Study|Death|0|||
94742417|NCT01046825|324512841|FG002|Overall Study|Death|0|||
94742418|NCT01046825|324512842|FG003|Overall Study|Death|1|||
94742419|NCT01046825|324512843|FG004|Overall Study|Death|0|||
94742420|NCT01046825|324512839|FG000|Overall Study|Did not submit biology samples|0|||
94742421|NCT01046825|324512840|FG001|Overall Study|Did not submit biology samples|0|||
94742422|NCT01046825|324512841|FG002|Overall Study|Did not submit biology samples|0|||
94742423|NCT01046825|324512842|FG003|Overall Study|Did not submit biology samples|0|||
94742424|NCT01046825|324512843|FG004|Overall Study|Did not submit biology samples|13|||
94742425|NCT04993677|324512845|FG000|Overall Study|Lost to Follow-up|1|||
94742426|NCT04993677|324512846|FG001|Overall Study|Lost to Follow-up|0|||
94742427|NCT04993677|324512847|FG002|Overall Study|Lost to Follow-up|0|||
94742428|NCT04993677|324512848|FG003|Overall Study|Lost to Follow-up|0|||
94742429|NCT04993677|324512845|FG000|Overall Study|Death|11|||
94742430|NCT04993677|324512846|FG001|Overall Study|Death|8|||
94742431|NCT04993677|324512847|FG002|Overall Study|Death|3|||
94742432|NCT04993677|324512848|FG003|Overall Study|Death|1|||
94742433|NCT04993677|324512845|FG000|Overall Study|Subject withdrawal of consent|4|||
94742434|NCT04993677|324512846|FG001|Overall Study|Subject withdrawal of consent|3|||
94742435|NCT04993677|324512847|FG002|Overall Study|Subject withdrawal of consent|0|||
94278104|NCT01437397|322809660|FG001|Overall Study|Lost to Follow-up|4|||
94278105|NCT01437397|322809661|FG002|Overall Study|Lost to Follow-up|2|||
94278106|NCT01437397|322809662|FG003|Overall Study|Lost to Follow-up|4|||
94278107|NCT01437397|322809663|FG004|Overall Study|Lost to Follow-up|5|||
94278108|NCT01437397|322809659|FG000|Overall Study|Withdrawal by Subject|11|||
94742436|NCT04993677|324512848|FG003|Overall Study|Subject withdrawal of consent|2|||
94742437|NCT04993677|324512845|FG000|Overall Study|Study termination by sponsor|3|||
94742438|NCT04993677|324512846|FG001|Overall Study|Study termination by sponsor|25|||
94742439|NCT04993677|324512847|FG002|Overall Study|Study termination by sponsor|3|||
94742440|NCT04993677|324512848|FG003|Overall Study|Study termination by sponsor|3|||
94742441|NCT04993677|324512845|FG000|Overall Study|Other|2|||
94742442|NCT04993677|324512846|FG001|Overall Study|Other|3|||
94278109|NCT01437397|322809660|FG001|Overall Study|Withdrawal by Subject|12|||
94278110|NCT01437397|322809661|FG002|Overall Study|Withdrawal by Subject|24|||
94278111|NCT01437397|322809662|FG003|Overall Study|Withdrawal by Subject|11|||
94278112|NCT01437397|322809663|FG004|Overall Study|Withdrawal by Subject|22|||
94278113|NCT01437397|322809659|FG000|Overall Study|Protocol Violation|10|||
94278114|NCT01437397|322809660|FG001|Overall Study|Protocol Violation|12|||
94278115|NCT01437397|322809661|FG002|Overall Study|Protocol Violation|13|||
94278116|NCT01437397|322809662|FG003|Overall Study|Protocol Violation|21|||
94278117|NCT01437397|322809663|FG004|Overall Study|Protocol Violation|19|||
94278118|NCT01437397|322809659|FG000|Overall Study|Lack of Efficacy|5|||
94278119|NCT01437397|322809660|FG001|Overall Study|Lack of Efficacy|4|||
94278120|NCT01437397|322809661|FG002|Overall Study|Lack of Efficacy|8|||
94278121|NCT01437397|322809662|FG003|Overall Study|Lack of Efficacy|10|||
94278122|NCT01437397|322809663|FG004|Overall Study|Lack of Efficacy|20|||
94278123|NCT01437397|322809659|FG000|Overall Study|Adverse Event|21|||
94278124|NCT01437397|322809660|FG001|Overall Study|Adverse Event|22|||
94278125|NCT01437397|322809661|FG002|Overall Study|Adverse Event|16|||
94278126|NCT01437397|322809662|FG003|Overall Study|Adverse Event|14|||
94278127|NCT01437397|322809663|FG004|Overall Study|Adverse Event|21|||
94278128|NCT01437397|322809659|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
94278129|NCT01437397|322809660|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
94278130|NCT01437397|322809661|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
94278131|NCT01437397|322809662|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
94278132|NCT01437397|322809663|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
94278133|NCT01318109|322809664|FG000|Overall Study|Adverse Event|0|||
94278134|NCT01318109|322809665|FG001|Overall Study|Adverse Event|2|||
94278135|NCT01318109|322809666|FG002|Overall Study|Adverse Event|0|||
94278136|NCT01318109|322809664|FG000|Overall Study|Withdrawal by Subject|1|||
94278137|NCT01318109|322809665|FG001|Overall Study|Withdrawal by Subject|0|||
94278138|NCT01318109|322809666|FG002|Overall Study|Withdrawal by Subject|0|||
94278139|NCT01318109|322809664|FG000|Overall Study|Schedule Conflict|0|||
94278140|NCT01318109|322809665|FG001|Overall Study|Schedule Conflict|1|||
94278141|NCT01318109|322809666|FG002|Overall Study|Schedule Conflict|0|||
94278142|NCT01003210|322809667|FG000|Overall Study|Lost to Follow-up|1|||
94278143|NCT01003210|322809668|FG001|Overall Study|Lost to Follow-up|3|||
94278144|NCT03829657|322809669|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
94278145|NCT03829657|322809670|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
94278146|NCT03829657|322809671|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
94278147|NCT03829657|322809672|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
94278148|NCT03829657|322809673|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
94278149|NCT03829657|322809669|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
94278150|NCT03829657|322809670|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
94278151|NCT03829657|322809671|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
94278152|NCT03829657|322809672|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
94278153|NCT03829657|322809673|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
94278154|NCT03829657|322809669|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
94278155|NCT03829657|322809670|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
94278156|NCT03829657|322809671|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
94278157|NCT03829657|322809672|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
94278158|NCT03829657|322809673|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
94278159|NCT03829657|322809669|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
94278160|NCT03829657|322809670|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
94278161|NCT03829657|322809671|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
94278162|NCT03829657|322809672|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
94278163|NCT03829657|322809673|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
94278164|NCT03829657|322809669|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
94278165|NCT03829657|322809670|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
94278166|NCT03829657|322809671|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
94278167|NCT03829657|322809672|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
94278168|NCT03829657|322809673|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
94201952|NCT04772534|322536988|FG000|Overall Study|Physician Decision|1|||
94201953|NCT04772534|322536989|FG001|Overall Study|Physician Decision|0|||
94201954|NCT04772534|322536990|FG002|Overall Study|Physician Decision|0|||
94201955|NCT04772534|322536988|FG000|Overall Study|Withdrawal by Subject|3|||
94201956|NCT04772534|322536989|FG001|Overall Study|Withdrawal by Subject|0|||
94201957|NCT04772534|322536990|FG002|Overall Study|Withdrawal by Subject|1|||
94201958|NCT04194450|322536991|FG000|Overall Study|not eligible|1|||
94201959|NCT04194450|322536992|FG001|Overall Study|not eligible|0|||
94201960|NCT06152224|322536994|FG000|Overall Study|Withdrawal by Subject|1|||
94201961|NCT06152224|322536995|FG001|Overall Study|Withdrawal by Subject|0|||
94201962|NCT06152224|322536994|FG000|Overall Study|Lost to Follow-up|0|||
94201963|NCT06152224|322536995|FG001|Overall Study|Lost to Follow-up|1|||
94201964|NCT06152224|322536994|FG000|Overall Study|On Follow Up|18|||
94201965|NCT06152224|322536995|FG001|Overall Study|On Follow Up|18|||
94201966|NCT04495621|322536999|FG000|Overall Study|Withdrawal by Subject|0|||
94201967|NCT04495621|322537000|FG001|Overall Study|Withdrawal by Subject|3|||
94467554|NCT01390428|323502337|FG004|Overall Study|Withdrawal by Subject|0|||
94201968|NCT04495621|322536999|FG000|Overall Study|Death|7|||
94201969|NCT04495621|322537000|FG001|Overall Study|Death|11|||
94201970|NCT04495621|322536999|FG000|Overall Study|Investigator Decision|0|||
94201971|NCT04495621|322537000|FG001|Overall Study|Investigator Decision|7|||
94201972|NCT04495621|322536999|FG000|Overall Study|Lost to Follow-up|0|||
94201973|NCT04495621|322537000|FG001|Overall Study|Lost to Follow-up|1|||
94201974|NCT00357682|322537001|FG000|Overall Study|Did not receive allocated Treatment|10|||
94201975|NCT00357682|322537002|FG001|Overall Study|Did not receive allocated Treatment|9|||
94201976|NCT00357682|322537003|FG002|Overall Study|Did not receive allocated Treatment|9|||
94201977|NCT00357682|322537004|FG003|Overall Study|Did not receive allocated Treatment|10|||
94201978|NCT00357682|322537001|FG000|Overall Study|Withdrew consent|6|||
94201979|NCT00357682|322537002|FG001|Overall Study|Withdrew consent|6|||
94201980|NCT00357682|322537003|FG002|Overall Study|Withdrew consent|5|||
94201981|NCT00357682|322537004|FG003|Overall Study|Withdrew consent|5|||
94201982|NCT00357682|322537001|FG000|Overall Study|Lost to Follow-up|39|||
94201983|NCT00357682|322537002|FG001|Overall Study|Lost to Follow-up|33|||
94278169|NCT03829657|322809669|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
94278170|NCT03829657|322809670|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
94278171|NCT03829657|322809671|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
94278172|NCT03829657|322809672|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
94278173|NCT03829657|322809673|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
94278174|NCT03829657|322809669|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
94278175|NCT03829657|322809670|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
94278176|NCT03829657|322809671|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
94278177|NCT03829657|322809672|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
94278178|NCT03829657|322809673|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
94278179|NCT03829657|322809669|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
94278180|NCT03829657|322809670|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
94278181|NCT03829657|322809671|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
94278182|NCT03829657|322809672|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
94278183|NCT03829657|322809673|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
94278184|NCT03829657|322809669|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
94278185|NCT03829657|322809670|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
94278186|NCT03829657|322809671|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
94278187|NCT03829657|322809672|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
94278188|NCT03829657|322809673|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
94278189|NCT03829657|322809669|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
94278190|NCT03829657|322809670|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
94278191|NCT03829657|322809671|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
94278192|NCT03829657|322809672|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
94278193|NCT03829657|322809673|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
94278194|NCT00271817|322809674|FG000|Part 1|Adverse Event|68|||
94278195|NCT00271817|322809675|FG001|Part 1|Adverse Event|25|||
94278196|NCT00271817|322809676|FG002|Part 1|Adverse Event|156|||
94278197|NCT00271817|322809674|FG000|Part 1|Lost to Follow-up|6|||
94278198|NCT00271817|322809675|FG001|Part 1|Lost to Follow-up|8|||
94278199|NCT00271817|322809676|FG002|Part 1|Lost to Follow-up|24|||
94278200|NCT00271817|322809674|FG000|Part 1|Protocol Violation|5|||
94278201|NCT00271817|322809675|FG001|Part 1|Protocol Violation|4|||
94278202|NCT00271817|322809676|FG002|Part 1|Protocol Violation|7|||
94278203|NCT00271817|322809674|FG000|Part 1|Patient Moved|3|||
94278204|NCT00271817|322809675|FG001|Part 1|Patient Moved|1|||
94278205|NCT00271817|322809676|FG002|Part 1|Patient Moved|5|||
94278206|NCT00271817|322809674|FG000|Part 1|Withdrawal by Subject|23|||
94278207|NCT00271817|322809675|FG001|Part 1|Withdrawal by Subject|17|||
94201984|NCT00357682|322537003|FG002|Overall Study|Lost to Follow-up|26|||
94278208|NCT00271817|322809676|FG002|Part 1|Withdrawal by Subject|45|||
94278209|NCT00271817|322809674|FG000|Part 1|LDL < 50 mg/dL|1|||
94278210|NCT00271817|322809675|FG001|Part 1|LDL < 50 mg/dL|4|||
94278211|NCT00271817|322809676|FG002|Part 1|LDL < 50 mg/dL|48|||
94278212|NCT00271817|322809674|FG000|Part 2|Adverse Event|0|||
94467555|NCT01390428|323502338|FG005|Overall Study|Withdrawal by Subject|0|||
94201985|NCT00357682|322537004|FG003|Overall Study|Lost to Follow-up|35|||
94201986|NCT00357682|322537001|FG000|Overall Study|Adverse Event|24|||
94201987|NCT00357682|322537002|FG001|Overall Study|Adverse Event|32|||
94278213|NCT00271817|322809675|FG001|Part 2|Adverse Event|17|||
94278214|NCT00271817|322809676|FG002|Part 2|Adverse Event|33|||
94278215|NCT00271817|322809674|FG000|Part 2|Lack of Efficacy|0|||
94278216|NCT00271817|322809675|FG001|Part 2|Lack of Efficacy|1|||
94278217|NCT00271817|322809676|FG002|Part 2|Lack of Efficacy|6|||
94278218|NCT00271817|322809674|FG000|Part 2|Lost to Follow-up|0|||
94278219|NCT00271817|322809675|FG001|Part 2|Lost to Follow-up|6|||
94201988|NCT00357682|322537003|FG002|Overall Study|Adverse Event|22|||
94201989|NCT00357682|322537004|FG003|Overall Study|Adverse Event|27|||
94467556|NCT01556997|323502339|FG000|Overall Study|Adverse Event|10|||
94467557|NCT01556997|323502340|FG001|Overall Study|Adverse Event|12|||
94278220|NCT00271817|322809676|FG002|Part 2|Lost to Follow-up|18|||
94278221|NCT00271817|322809674|FG000|Part 2|Protocol Violation|0|||
94278222|NCT00271817|322809675|FG001|Part 2|Protocol Violation|3|||
94278223|NCT00271817|322809676|FG002|Part 2|Protocol Violation|5|||
94278224|NCT00271817|322809674|FG000|Part 2|Patient Moved|0|||
94278225|NCT00271817|322809675|FG001|Part 2|Patient Moved|0|||
94278226|NCT00271817|322809676|FG002|Part 2|Patient Moved|5|||
94278227|NCT00271817|322809674|FG000|Part 2|Withdrawal by Subject|0|||
94278228|NCT00271817|322809675|FG001|Part 2|Withdrawal by Subject|2|||
94278229|NCT00271817|322809676|FG002|Part 2|Withdrawal by Subject|13|||
94278230|NCT00271817|322809674|FG000|Part 2|LDL < 50 mg/dL|0|||
94278231|NCT00271817|322809675|FG001|Part 2|LDL < 50 mg/dL|3|||
94278232|NCT00271817|322809676|FG002|Part 2|LDL < 50 mg/dL|4|||
94278233|NCT01452152|322809677|FG000|Overall Study|Study termination by sponsor|5|||
94278234|NCT01452152|322809678|FG001|Overall Study|Study termination by sponsor|0|||
94278235|NCT01452152|322809679|FG002|Overall Study|Study termination by sponsor|4|||
94278236|NCT00609791|322811176|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
94278237|NCT03737994|322811177|FG000|Overall Study|Withdrawal by Subject|0|||
94278238|NCT03737994|322811178|FG001|Overall Study|Withdrawal by Subject|0|||
94278239|NCT03737994|322811179|FG002|Overall Study|Withdrawal by Subject|0|||
94278240|NCT03737994|322811180|FG003|Overall Study|Withdrawal by Subject|0|||
94278241|NCT03737994|322811181|FG004|Overall Study|Withdrawal by Subject|0|||
94278242|NCT03737994|322811182|FG005|Overall Study|Withdrawal by Subject|0|||
94278243|NCT03737994|322811183|FG006|Overall Study|Withdrawal by Subject|1|||
94278244|NCT03217266|322811184|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
94278245|NCT03217266|322811185|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
94278246|NCT03217266|322811186|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
94278247|NCT03217266|322811187|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
94278248|NCT03217266|322811184|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
94278249|NCT03217266|322811185|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
94278250|NCT03217266|322811186|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
94278251|NCT03217266|322811187|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
94278252|NCT03217266|322811184|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
94278253|NCT03217266|322811185|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
94278254|NCT03217266|322811186|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
94278255|NCT03217266|322811187|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
94278256|NCT04218201|322811188|FG000|Overall Study|Death|0|||
94278257|NCT04218201|322811189|FG001|Overall Study|Death|0|||
94278258|NCT04218201|322811190|FG002|Overall Study|Death|2|||
94278259|NCT04218201|322811191|FG003|Overall Study|Death|0|||
94278260|NCT04218201|322811188|FG000|Overall Study|Unable to contact participant|4|||
94278261|NCT04218201|322811189|FG001|Overall Study|Unable to contact participant|0|||
94278262|NCT04218201|322811190|FG002|Overall Study|Unable to contact participant|3|||
94278263|NCT04218201|322811191|FG003|Overall Study|Unable to contact participant|0|||
94278264|NCT04218201|322811188|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
94278265|NCT04218201|322811189|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
94278266|NCT04218201|322811190|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
94278267|NCT04218201|322811191|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
94278268|NCT04218201|322811188|FG000|Overall Study|Withdrawal by Subject|2|||
94278269|NCT04218201|322811189|FG001|Overall Study|Withdrawal by Subject|0|||
94278270|NCT04218201|322811190|FG002|Overall Study|Withdrawal by Subject|0|||
94278271|NCT04218201|322811191|FG003|Overall Study|Withdrawal by Subject|0|||
94278272|NCT04218201|322811188|FG000|Overall Study|PCP plans to leave practice|0|||
94278273|NCT04218201|322811189|FG001|Overall Study|PCP plans to leave practice|8|||
94278274|NCT04218201|322811190|FG002|Overall Study|PCP plans to leave practice|0|||
94278275|NCT04218201|322811191|FG003|Overall Study|PCP plans to leave practice|5|||
94278276|NCT04218201|322811188|FG000|Overall Study|Reduced panel|0|||
94278277|NCT04218201|322811189|FG001|Overall Study|Reduced panel|0|||
94278278|NCT04218201|322811190|FG002|Overall Study|Reduced panel|0|||
94278279|NCT04218201|322811191|FG003|Overall Study|Reduced panel|1|||
94278280|NCT04218201|322811188|FG000|Overall Study|No longer interested in participating|0|||
94278281|NCT04218201|322811189|FG001|Overall Study|No longer interested in participating|1|||
94278282|NCT04218201|322811190|FG002|Overall Study|No longer interested in participating|0|||
94278283|NCT04218201|322811191|FG003|Overall Study|No longer interested in participating|0|||
94278284|NCT02484911|322811193|FG000|Overall Study|Withdrawal by Subject|2|||
94278285|NCT02484911|322811194|FG001|Overall Study|Withdrawal by Subject|1|||
94278286|NCT02484911|322811193|FG000|Overall Study|Protocol Violation|2|||
94278287|NCT02484911|322811194|FG001|Overall Study|Protocol Violation|1|||
94278288|NCT01652885|322811197|FG000|Overall Study|Adverse Event|1|||
94278289|NCT03451773|322811198|FG000|Overall Study|Death on study|1|||
94278290|NCT03451773|322811199|FG001|Overall Study|Death on study|5|||
94467558|NCT01556997|323502341|FG002|Overall Study|Adverse Event|12|||
94742443|NCT04993677|324512847|FG002|Overall Study|Other|3|||
94201990|NCT00357682|322537001|FG000|Overall Study|Physician Decision|32|||
94201991|NCT00357682|322537002|FG001|Overall Study|Physician Decision|20|||
94201992|NCT00357682|322537003|FG002|Overall Study|Physician Decision|24|||
94201993|NCT00357682|322537004|FG003|Overall Study|Physician Decision|30|||
94201994|NCT00357682|322537001|FG000|Overall Study|Patient decision|73|||
94201995|NCT00357682|322537002|FG001|Overall Study|Patient decision|80|||
94201996|NCT00357682|322537003|FG002|Overall Study|Patient decision|51|||
94201997|NCT00357682|322537004|FG003|Overall Study|Patient decision|59|||
94201998|NCT00357682|322537001|FG000|Overall Study|Other reason|157|||
94201999|NCT00357682|322537002|FG001|Overall Study|Other reason|130|||
94202000|NCT00357682|322537003|FG002|Overall Study|Other reason|114|||
94202001|NCT00357682|322537004|FG003|Overall Study|Other reason|99|||
94202002|NCT03213457|322537005|FG000|Screening Period|Withdrawal by Subject|0|||
94202003|NCT03213457|322537006|FG001|Screening Period|Withdrawal by Subject|1|||
94202004|NCT03213457|322537007|FG002|Screening Period|Withdrawal by Subject|0|||
94202005|NCT03213457|322537005|FG000|Screening Period|Other|1|||
94202006|NCT03213457|322537006|FG001|Screening Period|Other|0|||
94202007|NCT03213457|322537007|FG002|Screening Period|Other|0|||
94202008|NCT03213457|322537005|FG000|Double-Blind Period|Adverse Event|3|||
94202009|NCT03213457|322537006|FG001|Double-Blind Period|Adverse Event|2|||
94202010|NCT03213457|322537007|FG002|Double-Blind Period|Adverse Event|7|||
94202011|NCT03213457|322537005|FG000|Double-Blind Period|Withdrawal by Subject|14|||
94202012|NCT03213457|322537006|FG001|Double-Blind Period|Withdrawal by Subject|2|||
94278291|NCT03451773|322811198|FG000|Overall Study|Death during follow-up period|0|||
94278292|NCT03451773|322811199|FG001|Overall Study|Death during follow-up period|1|||
94278293|NCT00412750|322811205|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94278294|NCT00412750|322811206|FG001|Overall Study|Abnormal laboratory value(s)|0|||
94278295|NCT00412750|322811207|FG002|Overall Study|Abnormal laboratory value(s)|0|||
94278296|NCT00412750|322811205|FG000|Overall Study|Administrative problems|21|||
94278297|NCT00412750|322811206|FG001|Overall Study|Administrative problems|17|||
94278298|NCT00412750|322811207|FG002|Overall Study|Administrative problems|14|||
94278299|NCT00412750|322811205|FG000|Overall Study|Adverse Event|8|||
94278300|NCT00412750|322811206|FG001|Overall Study|Adverse Event|3|||
94278301|NCT00412750|322811207|FG002|Overall Study|Adverse Event|3|||
94278302|NCT00412750|322811205|FG000|Overall Study|Lost to Follow-up|1|||
94278303|NCT00412750|322811206|FG001|Overall Study|Lost to Follow-up|0|||
94278304|NCT00412750|322811207|FG002|Overall Study|Lost to Follow-up|1|||
94278305|NCT00412750|322811205|FG000|Overall Study|Withdrawal by Subject|0|||
94278306|NCT00412750|322811206|FG001|Overall Study|Withdrawal by Subject|1|||
94278307|NCT00412750|322811207|FG002|Overall Study|Withdrawal by Subject|2|||
94278308|NCT00412750|322811205|FG000|Overall Study|Lack of Efficacy|0|||
94278309|NCT00412750|322811206|FG001|Overall Study|Lack of Efficacy|0|||
94278310|NCT00412750|322811207|FG002|Overall Study|Lack of Efficacy|3|||
94278311|NCT04329806|322811208|FG000|Overall Study|Physician Decision|3|||
94278312|NCT04329806|322811209|FG001|Overall Study|Physician Decision|4|||
94278313|NCT01982292|322811210|FG000|Overall Study|Adverse Event|2|||
94278314|NCT01982292|322811211|FG001|Overall Study|Adverse Event|0|||
94278315|NCT01982292|322811210|FG000|Overall Study|Death|1|||
94742444|NCT04993677|324512848|FG003|Overall Study|Other|2|||
94742445|NCT04664881|324512849|FG000|Overall Study|Withdrawal by Subject|1|||
94742446|NCT04664881|324512850|FG001|Overall Study|Withdrawal by Subject|8|||
94742447|NCT04664881|324512849|FG000|Overall Study|Physician Decision|0|||
94742448|NCT04664881|324512850|FG001|Overall Study|Physician Decision|5|||
94742449|NCT04664881|324512849|FG000|Overall Study|Lost to Follow-up|1|||
94742450|NCT04664881|324512850|FG001|Overall Study|Lost to Follow-up|0|||
94742451|NCT01886872|324512856|FG000|Overall Study|Ineligible|7|||
94742452|NCT01886872|324512857|FG001|Overall Study|Ineligible|4|||
94742453|NCT01886872|324512858|FG002|Overall Study|Ineligible|12|||
94742454|NCT05224141|324512861|FG000|Overall Study|Ongoing|75|||
94742455|NCT05224141|324512862|FG001|Overall Study|Ongoing|88|||
94742456|NCT05224141|324512861|FG000|Overall Study|Withdrawal by Subject|2|||
94742457|NCT05224141|324512862|FG001|Overall Study|Withdrawal by Subject|4|||
94742458|NCT05224141|324512861|FG000|Overall Study|Death|153|||
94742459|NCT05224141|324512862|FG001|Overall Study|Death|138|||
94202013|NCT03213457|322537007|FG002|Double-Blind Period|Withdrawal by Subject|14|||
94202014|NCT03213457|322537005|FG000|Double-Blind Period|Lost to Follow-up|2|||
94202015|NCT03213457|322537006|FG001|Double-Blind Period|Lost to Follow-up|3|||
94202016|NCT03213457|322537007|FG002|Double-Blind Period|Lost to Follow-up|9|||
94202017|NCT03213457|322537005|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
94202018|NCT03213457|322537006|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
94202019|NCT03213457|322537007|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
94278316|NCT01982292|322811211|FG001|Overall Study|Death|0|||
94278317|NCT01982292|322811210|FG000|Overall Study|Lost to Follow-up|2|||
94742460|NCT00588770|324512863|FG000|Overall Study|Disease progression|85|||
94742461|NCT00588770|324512864|FG001|Overall Study|Disease progression|68|||
94742462|NCT00588770|324512863|FG000|Overall Study|Adverse Event|29|||
94742463|NCT00588770|324512864|FG001|Overall Study|Adverse Event|58|||
94467559|NCT01556997|323502339|FG000|Overall Study|Lost to Follow-up|6|||
94742464|NCT00588770|324512863|FG000|Overall Study|Death|13|||
94742465|NCT00588770|324512864|FG001|Overall Study|Death|22|||
94742466|NCT00588770|324512863|FG000|Overall Study|Withdrawal by Subject|15|||
94742467|NCT00588770|324512864|FG001|Overall Study|Withdrawal by Subject|25|||
94742468|NCT00588770|324512863|FG000|Overall Study|Alternative therapy|2|||
94742469|NCT00588770|324512864|FG001|Overall Study|Alternative therapy|4|||
94742470|NCT00588770|324512863|FG000|Overall Study|Other complicating disease|3|||
94742471|NCT00588770|324512864|FG001|Overall Study|Other complicating disease|2|||
94742472|NCT00588770|324512863|FG000|Overall Study|Not start protocol therapy|0|||
94742473|NCT00588770|324512864|FG001|Overall Study|Not start protocol therapy|9|||
94742474|NCT00588770|324512863|FG000|Overall Study|Lack of Efficacy|8|||
94742475|NCT00588770|324512864|FG001|Overall Study|Lack of Efficacy|10|||
94742476|NCT00588770|324512863|FG000|Overall Study|Physician discretion|2|||
94742477|NCT00588770|324512864|FG001|Overall Study|Physician discretion|0|||
94742478|NCT00588770|324512863|FG000|Overall Study|Patient non-compliance|2|||
94742479|NCT00588770|324512864|FG001|Overall Study|Patient non-compliance|2|||
94742480|NCT03635424|324512867|FG000|Overall Study|Adverse Event|1|||
94278318|NCT01982292|322811211|FG001|Overall Study|Lost to Follow-up|0|||
94278319|NCT01982292|322811210|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
94278320|NCT01982292|322811211|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
94278321|NCT01982292|322811210|FG000|Overall Study|Protocol Deviation|1|||
94278322|NCT01982292|322811211|FG001|Overall Study|Protocol Deviation|0|||
94278323|NCT01982292|322811210|FG000|Overall Study|Patient/Guardian Decision|3|||
94278324|NCT01982292|322811211|FG001|Overall Study|Patient/Guardian Decision|1|||
94278325|NCT01982292|322811210|FG000|Overall Study|Technical Problems|2|||
94278326|NCT01982292|322811211|FG001|Overall Study|Technical Problems|0|||
94278327|NCT01137773|322811215|FG000|Overall Study|Death|3|||
94278328|NCT01137773|322811216|FG001|Overall Study|Death|3|||
94278329|NCT01137773|322811215|FG000|Overall Study|Lost to Follow-up|6|||
94278330|NCT01137773|322811216|FG001|Overall Study|Lost to Follow-up|0|||
94278331|NCT00812214|322811217|FG000|Overall Study|Lost to Follow-up|3|||
94278332|NCT00812214|322811218|FG001|Overall Study|Lost to Follow-up|1|||
94278333|NCT00789529|322811219|FG000|Overall Study|Withdrawal by Subject|0|||
94278334|NCT00789529|322811220|FG001|Overall Study|Withdrawal by Subject|1|||
94278335|NCT00789529|322811219|FG000|Overall Study|Other Reason|1|||
94278336|NCT00789529|322811220|FG001|Overall Study|Other Reason|0|||
94278337|NCT01849874|322811221|FG000|Overall Study|Death|89|||
94278338|NCT01849874|322811222|FG001|Overall Study|Death|42|||
94278339|NCT01849874|322811221|FG000|Overall Study|Withdrawal by Subject|17|||
94278340|NCT01849874|322811222|FG001|Overall Study|Withdrawal by Subject|16|||
94278341|NCT01849874|322811221|FG000|Overall Study|Lost to Follow-up|3|||
94278342|NCT01849874|322811222|FG001|Overall Study|Lost to Follow-up|2|||
94278343|NCT01849874|322811221|FG000|Overall Study|Study Termination By Sponsor|93|||
94278344|NCT01849874|322811222|FG001|Overall Study|Study Termination By Sponsor|48|||
94278345|NCT01849874|322811221|FG000|Overall Study|Completed as per protocol amendment 6|3|||
94278346|NCT01849874|322811222|FG001|Overall Study|Completed as per protocol amendment 6|0|||
94278347|NCT01849874|322811221|FG000|Overall Study|Physician Decision|7|||
94278348|NCT01849874|322811222|FG001|Overall Study|Physician Decision|1|||
94278349|NCT01849874|322811221|FG000|Overall Study|Other|16|||
94278350|NCT01849874|322811222|FG001|Overall Study|Other|4|||
94278351|NCT02145741|322811223|FG000|Overall Study|Progressive disease|3|||
94278352|NCT02145741|322811224|FG001|Overall Study|Progressive disease|6|||
94278353|NCT02145741|322811225|FG002|Overall Study|Progressive disease|6|||
94278354|NCT02145741|322811223|FG000|Overall Study|quality issue with the administered drug|3|||
94278355|NCT02145741|322811224|FG001|Overall Study|quality issue with the administered drug|0|||
94278356|NCT02145741|322811225|FG002|Overall Study|quality issue with the administered drug|0|||
94278357|NCT05634577|322811226|FG000|Overall Study|Lost to Follow-up|1|||
94278358|NCT05634577|322811226|FG000|Overall Study|Withdrawal by Subject|1|||
94278359|NCT00781456|322811229|FG000|Overall Study|Adverse Event|3|||
94278360|NCT00781456|322811230|FG001|Overall Study|Adverse Event|3|||
94278361|NCT00781456|322811229|FG000|Overall Study|Withdrawal by Subject|3|||
94278362|NCT00781456|322811230|FG001|Overall Study|Withdrawal by Subject|5|||
94278363|NCT00781456|322811229|FG000|Overall Study|Protocol Violation|4|||
94278364|NCT00781456|322811230|FG001|Overall Study|Protocol Violation|1|||
94278365|NCT00781456|322811229|FG000|Overall Study|Noncompliance With Protocol|1|||
94467560|NCT01556997|323502340|FG001|Overall Study|Lost to Follow-up|6|||
94742481|NCT03635424|324512867|FG000|Overall Study|Death|1|||
94742482|NCT03635424|324512867|FG000|Overall Study|Device not implanted|1|||
94742483|NCT02726386|324512868|FG000|Overall Study|Adverse Event|17|||
94278366|NCT00781456|322811230|FG001|Overall Study|Noncompliance With Protocol|1|||
94278367|NCT00781456|322811229|FG000|Overall Study|Lost to Follow-up|10|||
94278368|NCT00781456|322811230|FG001|Overall Study|Lost to Follow-up|5|||
94467561|NCT01556997|323502341|FG002|Overall Study|Lost to Follow-up|4|||
94742484|NCT02726386|324512869|FG001|Overall Study|Adverse Event|20|||
94278369|NCT00781456|322811229|FG000|Overall Study|Other Reason, Unknown|0|||
94742485|NCT02726386|324512868|FG000|Overall Study|Withdrawal by Subject|14|||
94742486|NCT02726386|324512869|FG001|Overall Study|Withdrawal by Subject|28|||
94370307|NCT04380701|323142880|FG004|Overall Study|Withdrawal by Subject|0|||
94370308|NCT04380701|323142881|FG005|Overall Study|Withdrawal by Subject|0|||
94370309|NCT04380701|323142882|FG006|Overall Study|Withdrawal by Subject|1|||
94370310|NCT04380701|323142883|FG007|Overall Study|Withdrawal by Subject|1|||
94370311|NCT04380701|323142884|FG008|Overall Study|Withdrawal by Subject|0|||
94370312|NCT04380701|323142885|FG009|Overall Study|Withdrawal by Subject|0|||
94370313|NCT04380701|323142886|FG010|Overall Study|Withdrawal by Subject|0|||
94370314|NCT04380701|323142887|FG011|Overall Study|Withdrawal by Subject|1|||
94370315|NCT04380701|323142888|FG012|Overall Study|Withdrawal by Subject|0|||
94370316|NCT04380701|323142889|FG013|Overall Study|Withdrawal by Subject|1|||
94467562|NCT01556997|323502339|FG000|Overall Study|Physician Decision|1|||
94467563|NCT01556997|323502340|FG001|Overall Study|Physician Decision|1|||
94467564|NCT01556997|323502341|FG002|Overall Study|Physician Decision|1|||
94467565|NCT01556997|323502339|FG000|Overall Study|Withdrawal by Subject|7|||
94467566|NCT01556997|323502340|FG001|Overall Study|Withdrawal by Subject|6|||
94467567|NCT01556997|323502341|FG002|Overall Study|Withdrawal by Subject|8|||
94467568|NCT01556997|323502339|FG000|Overall Study|Other|2|||
94467569|NCT01556997|323502340|FG001|Overall Study|Other|3|||
94467570|NCT01556997|323502341|FG002|Overall Study|Other|7|||
94467571|NCT02437188|323502342|FG000|Overall Study|Randomized but did not receive surgery|4|||
94467572|NCT02437188|323502343|FG001|Overall Study|Randomized but did not receive surgery|8|||
94467573|NCT02437188|323502342|FG000|Overall Study|Adverse Event|0|||
94467574|NCT02437188|323502343|FG001|Overall Study|Adverse Event|1|||
94467575|NCT01937715|323502350|FG000|Overall Study|Death|0|||
94467576|NCT01937715|323502351|FG001|Overall Study|Death|0|||
94467577|NCT01937715|323502352|FG002|Overall Study|Death|0|||
94467578|NCT01937715|323502353|FG003|Overall Study|Death|1|||
94467579|NCT01937715|323502354|FG004|Overall Study|Death|0|||
94467580|NCT01937715|323502350|FG000|Overall Study|Withdrawal by Subject|0|||
94467581|NCT01937715|323502351|FG001|Overall Study|Withdrawal by Subject|1|||
94467582|NCT01937715|323502352|FG002|Overall Study|Withdrawal by Subject|0|||
94467583|NCT01937715|323502353|FG003|Overall Study|Withdrawal by Subject|0|||
94467584|NCT01937715|323502354|FG004|Overall Study|Withdrawal by Subject|2|||
94467585|NCT01937715|323502350|FG000|Overall Study|Other|0|||
94467586|NCT01937715|323502351|FG001|Overall Study|Other|0|||
94467587|NCT01937715|323502352|FG002|Overall Study|Other|0|||
94467588|NCT01937715|323502353|FG003|Overall Study|Other|3|||
94467589|NCT01937715|323502354|FG004|Overall Study|Other|0|||
94467590|NCT00153816|323502355|FG000|Overall Study|Death|6|||
94467591|NCT00153816|323502356|FG001|Overall Study|Death|5|||
94467592|NCT00153816|323502357|FG002|Overall Study|Death|4|||
94467593|NCT00153816|323502358|FG003|Overall Study|Death|6|||
94467594|NCT00153816|323502359|FG004|Overall Study|Death|0|||
94467595|NCT00153816|323502360|FG005|Overall Study|Death|2|||
94467596|NCT00153816|323502355|FG000|Overall Study|Lost to Follow-up|7|||
94467597|NCT00153816|323502356|FG001|Overall Study|Lost to Follow-up|8|||
94467598|NCT00153816|323502357|FG002|Overall Study|Lost to Follow-up|5|||
94467599|NCT00153816|323502358|FG003|Overall Study|Lost to Follow-up|8|||
94467600|NCT00153816|323502359|FG004|Overall Study|Lost to Follow-up|7|||
94467601|NCT00153816|323502360|FG005|Overall Study|Lost to Follow-up|9|||
94467602|NCT00153816|323502355|FG000|Overall Study|Withdrawal by Subject|9|||
94467603|NCT00153816|323502356|FG001|Overall Study|Withdrawal by Subject|9|||
94467604|NCT00153816|323502357|FG002|Overall Study|Withdrawal by Subject|9|||
94467605|NCT00153816|323502358|FG003|Overall Study|Withdrawal by Subject|4|||
94467606|NCT00153816|323502359|FG004|Overall Study|Withdrawal by Subject|1|||
94467607|NCT00153816|323502360|FG005|Overall Study|Withdrawal by Subject|5|||
94467608|NCT00153816|323502355|FG000|Overall Study|Follow-up exam not done|8|||
94467609|NCT00153816|323502356|FG001|Overall Study|Follow-up exam not done|7|||
94467610|NCT00153816|323502357|FG002|Overall Study|Follow-up exam not done|11|||
94370317|NCT04380701|323142890|FG014|Overall Study|Withdrawal by Subject|0|||
94467611|NCT00153816|323502358|FG003|Overall Study|Follow-up exam not done|10|||
94467612|NCT00153816|323502359|FG004|Overall Study|Follow-up exam not done|8|||
94467613|NCT00153816|323502360|FG005|Overall Study|Follow-up exam not done|9|||
94467614|NCT00153816|323502355|FG000|Overall Study|Follow-up exam done, histology missing|2|||
94467615|NCT00153816|323502356|FG001|Overall Study|Follow-up exam done, histology missing|3|||
94467616|NCT00153816|323502357|FG002|Overall Study|Follow-up exam done, histology missing|3|||
94467617|NCT00153816|323502358|FG003|Overall Study|Follow-up exam done, histology missing|3|||
94467618|NCT00153816|323502359|FG004|Overall Study|Follow-up exam done, histology missing|1|||
94467619|NCT00153816|323502360|FG005|Overall Study|Follow-up exam done, histology missing|2|||
94467620|NCT01937884|323502361|FG000|Overall Study|Withdrawal by Subject|1|||
94467621|NCT01937884|323502362|FG001|Overall Study|Withdrawal by Subject|0|||
94467622|NCT01451164|323502363|FG000|Overall Study|Adverse Event|19|||
94370318|NCT04380701|323142891|FG015|Overall Study|Withdrawal by Subject|0|||
94370319|NCT04380701|323142892|FG016|Overall Study|Withdrawal by Subject|1|||
94467623|NCT01451164|323502364|FG001|Overall Study|Adverse Event|12|||
94467624|NCT01451164|323502365|FG002|Overall Study|Adverse Event|18|||
94467625|NCT01451164|323502366|FG003|Overall Study|Adverse Event|21|||
94467626|NCT01451164|323502363|FG000|Overall Study|Withdrawal Criteria|1|||
94202020|NCT03213457|322537005|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
94202021|NCT03213457|322537006|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
94202022|NCT03213457|322537007|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
94202023|NCT03213457|322537005|FG000|Double-Blind Period|Pregnancy|5|||
94202024|NCT03213457|322537006|FG001|Double-Blind Period|Pregnancy|0|||
94202025|NCT03213457|322537007|FG002|Double-Blind Period|Pregnancy|0|||
94202026|NCT03213457|322537005|FG000|Double-Blind Period|Other|10|||
94202027|NCT03213457|322537006|FG001|Double-Blind Period|Other|3|||
94202028|NCT03213457|322537007|FG002|Double-Blind Period|Other|17|||
94202029|NCT03213457|322537005|FG000|Open-Label Period|Adverse Event|1|||
94202030|NCT03213457|322537006|FG001|Open-Label Period|Adverse Event|2|||
94467627|NCT01451164|323502364|FG001|Overall Study|Withdrawal Criteria|1|||
94202031|NCT03213457|322537007|FG002|Open-Label Period|Adverse Event|2|||
94202032|NCT03213457|322537005|FG000|Open-Label Period|Withdrawal by Subject|12|||
94202033|NCT03213457|322537006|FG001|Open-Label Period|Withdrawal by Subject|5|||
94202034|NCT03213457|322537007|FG002|Open-Label Period|Withdrawal by Subject|24|||
94202035|NCT03213457|322537005|FG000|Open-Label Period|Lost to Follow-up|1|||
94202036|NCT03213457|322537006|FG001|Open-Label Period|Lost to Follow-up|2|||
94202037|NCT03213457|322537007|FG002|Open-Label Period|Lost to Follow-up|8|||
94202038|NCT03213457|322537005|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
94202039|NCT03213457|322537006|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
94202040|NCT03213457|322537007|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
94202041|NCT03213457|322537005|FG000|Open-Label Period|Non-compliance with study procedures|1|||
94202042|NCT03213457|322537006|FG001|Open-Label Period|Non-compliance with study procedures|1|||
94202043|NCT03213457|322537007|FG002|Open-Label Period|Non-compliance with study procedures|2|||
94202044|NCT03213457|322537005|FG000|Open-Label Period|Exclusionary medications|0|||
94202045|NCT03213457|322537006|FG001|Open-Label Period|Exclusionary medications|0|||
94202046|NCT03213457|322537007|FG002|Open-Label Period|Exclusionary medications|1|||
94202047|NCT03213457|322537005|FG000|Open-Label Period|Other|1|||
94202048|NCT03213457|322537006|FG001|Open-Label Period|Other|1|||
94202049|NCT03213457|322537007|FG002|Open-Label Period|Other|6|||
94202050|NCT03213457|322537005|FG000|Follow-Up Period|Adverse Event|16|||
94202051|NCT03213457|322537006|FG001|Follow-Up Period|Adverse Event|8|||
94202052|NCT03213457|322537007|FG002|Follow-Up Period|Adverse Event|37|||
94202053|NCT03213457|322537005|FG000|Follow-Up Period|Withdrawal by Subject|18|||
94202054|NCT03213457|322537006|FG001|Follow-Up Period|Withdrawal by Subject|11|||
94202055|NCT03213457|322537007|FG002|Follow-Up Period|Withdrawal by Subject|55|||
94202056|NCT03213457|322537005|FG000|Follow-Up Period|Lost to Follow-up|28|||
94202057|NCT03213457|322537006|FG001|Follow-Up Period|Lost to Follow-up|15|||
94202058|NCT03213457|322537007|FG002|Follow-Up Period|Lost to Follow-up|50|||
94202059|NCT03213457|322537005|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
94202060|NCT03213457|322537006|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
94202061|NCT03213457|322537007|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
94202062|NCT03213457|322537005|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
94202063|NCT03213457|322537006|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
94202064|NCT03213457|322537007|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
94202065|NCT03213457|322537005|FG000|Follow-Up Period|Pregnancy|7|||
94202066|NCT03213457|322537006|FG001|Follow-Up Period|Pregnancy|0|||
94202067|NCT03213457|322537007|FG002|Follow-Up Period|Pregnancy|18|||
94202068|NCT03213457|322537005|FG000|Follow-Up Period|Exclusionary medications|1|||
94202069|NCT03213457|322537006|FG001|Follow-Up Period|Exclusionary medications|1|||
94202070|NCT03213457|322537007|FG002|Follow-Up Period|Exclusionary medications|5|||
94202071|NCT03213457|322537005|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
94202072|NCT03213457|322537006|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
94202073|NCT03213457|322537007|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
94202074|NCT03213457|322537005|FG000|Follow-Up Period|Other|14|||
94202075|NCT03213457|322537006|FG001|Follow-Up Period|Other|10|||
94202076|NCT03213457|322537007|FG002|Follow-Up Period|Other|31|||
94202077|NCT01830595|322537008|FG000|First Period|Withdrawal by Subject|1|||
94202078|NCT01830595|322537009|FG001|First Period|Withdrawal by Subject|3|||
94202079|NCT01830595|322537008|FG000|Washout|Withdrawal by Subject|2|||
94202080|NCT01830595|322537009|FG001|Washout|Withdrawal by Subject|2|||
94202081|NCT05018143|322537010|FG000|Overall Study|Lost to Follow-up|5|||
94202082|NCT05018143|322537011|FG001|Overall Study|Lost to Follow-up|4|||
94202083|NCT05018143|322537010|FG000|Overall Study|Withdrawal by Subject|0|||
94202084|NCT05018143|322537011|FG001|Overall Study|Withdrawal by Subject|1|||
94202085|NCT04940624|322537012|FG000|Overall Study|Adverse Event|4|||
94202086|NCT04940624|322537013|FG001|Overall Study|Adverse Event|11|||
94202087|NCT04940624|322537012|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
94202088|NCT04940624|322537013|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
94202089|NCT04940624|322537012|FG000|Overall Study|Physician Decision|1|||
94202090|NCT04940624|322537013|FG001|Overall Study|Physician Decision|0|||
94202091|NCT04940624|322537012|FG000|Overall Study|Lost to Follow-up|1|||
94202092|NCT04940624|322537013|FG001|Overall Study|Lost to Follow-up|0|||
94202093|NCT04940624|322537012|FG000|Overall Study|Reason Not Specified|1|||
94202094|NCT04940624|322537013|FG001|Overall Study|Reason Not Specified|0|||
94202095|NCT03414684|322537014|FG000|First-course Treatment|Complete response|0|||
94202096|NCT03414684|322537015|FG001|First-course Treatment|Complete response|1|||
94202097|NCT03414684|322537014|FG000|First-course Treatment|Intercurrent illness|1|||
94202098|NCT03414684|322537015|FG001|First-course Treatment|Intercurrent illness|0|||
94202099|NCT03414684|322537014|FG000|First-course Treatment|Progressive Disease|31|||
94202100|NCT03414684|322537015|FG001|First-course Treatment|Progressive Disease|32|||
94202101|NCT03414684|322537014|FG000|First-course Treatment|Adverse Event|1|||
94742487|NCT02726386|324512868|FG000|Overall Study|Other reasons|7|||
94742488|NCT02726386|324512869|FG001|Overall Study|Other reasons|8|||
94742489|NCT03881696|324513812|FG000|Overall Study|Adverse Event|2|||
94742490|NCT03881696|324513813|FG001|Overall Study|Adverse Event|0|||
94742491|NCT03881696|324513812|FG000|Overall Study|Withdrawal by Subject|2|||
94742492|NCT03881696|324513813|FG001|Overall Study|Withdrawal by Subject|0|||
94742493|NCT03881696|324513812|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
94742494|NCT03881696|324513813|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
94742495|NCT03881696|324513812|FG000|Overall Study|Failure to meet continuation criteria|1|||
94742496|NCT03881696|324513813|FG001|Overall Study|Failure to meet continuation criteria|0|||
94202102|NCT03414684|322537015|FG001|First-course Treatment|Adverse Event|2|||
94202103|NCT03414684|322537014|FG000|First-course Treatment|Physician Decision|0|||
94202104|NCT03414684|322537015|FG001|First-course Treatment|Physician Decision|1|||
94202105|NCT03414684|322537014|FG000|First-course Treatment|Withdrawal by Subject|0|||
94202106|NCT03414684|322537015|FG001|First-course Treatment|Withdrawal by Subject|1|||
94202107|NCT03414684|322537014|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
94202108|NCT03414684|322537015|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
94202109|NCT03414684|322537014|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
94202110|NCT03414684|322537015|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
94202111|NCT03414684|322537014|FG000|First-course Treatment|Still on treatment|3|||
94202112|NCT03414684|322537015|FG001|First-course Treatment|Still on treatment|0|||
94202113|NCT03414684|322537014|FG000|First-course Treatment|Never started protocol therapy|2|||
94278370|NCT00781456|322811230|FG001|Overall Study|Other Reason, Unknown|1|||
94278371|NCT03551509|322811235|FG000|Overall Study|Lost to Follow-up|0|||
94278372|NCT03551509|322811236|FG001|Overall Study|Lost to Follow-up|1|||
94278373|NCT03551509|322811237|FG002|Overall Study|Lost to Follow-up|0|||
94278374|NCT01594853|322811238|FG000|Overall Study|Withdrawal by Subject|1|||
94278375|NCT01594853|322811239|FG001|Overall Study|Withdrawal by Subject|1|||
94278376|NCT01594853|322811238|FG000|Overall Study|Lost to Follow-up|1|||
94278377|NCT01594853|322811239|FG001|Overall Study|Lost to Follow-up|1|||
94278378|NCT01594853|322811238|FG000|Overall Study|noncompliance with exercise|0|||
94278379|NCT01594853|322811239|FG001|Overall Study|noncompliance with exercise|1|||
94278380|NCT03400332|322811240|FG000|Pre-Treatment|Other reasons|0|||
94278381|NCT03400332|322811241|FG001|Pre-Treatment|Other reasons|0|||
94278382|NCT03400332|322811242|FG002|Pre-Treatment|Other reasons|0|||
94278383|NCT03400332|322811243|FG003|Pre-Treatment|Other reasons|0|||
94278384|NCT03400332|322811244|FG004|Pre-Treatment|Other reasons|0|||
94278385|NCT03400332|322811245|FG005|Pre-Treatment|Other reasons|0|||
94278386|NCT03400332|322811246|FG006|Pre-Treatment|Other reasons|0|||
94742497|NCT05934292|324513815|FG000|Overall Study|Lost to Follow-up|0|||
94742498|NCT05934292|324513816|FG001|Overall Study|Lost to Follow-up|0|||
94742499|NCT05934292|324513817|FG002|Overall Study|Lost to Follow-up|1|||
94742500|NCT05934292|324513818|FG003|Overall Study|Lost to Follow-up|0|||
94742501|NCT04479787|324513819|FG000|Through 6 Months|Withdrawal by Subject|16|||
94202114|NCT03414684|322537015|FG001|First-course Treatment|Never started protocol therapy|1|||
94202115|NCT03414684|322537014|FG000|Crossover Treatment|Progressive disease|0|||
94202116|NCT03414684|322537015|FG001|Crossover Treatment|Progressive disease|12|||
94202117|NCT03414684|322537014|FG000|Crossover Treatment|Adverse Event|0|||
94202118|NCT03414684|322537015|FG001|Crossover Treatment|Adverse Event|3|||
94202119|NCT03414684|322537014|FG000|Crossover Treatment|Physician Decision|0|||
94202120|NCT03414684|322537015|FG001|Crossover Treatment|Physician Decision|1|||
94202121|NCT03414684|322537014|FG000|Crossover Treatment|Still on treatment|0|||
94202122|NCT03414684|322537015|FG001|Crossover Treatment|Still on treatment|2|||
94202123|NCT06688357|322537016|FG000|Overall Study|Adverse Event|0|||
94202124|NCT06688357|322537017|FG001|Overall Study|Adverse Event|1|||
94370320|NCT04380701|323142893|FG017|Overall Study|Withdrawal by Subject|0|||
94742502|NCT04479787|324513820|FG001|Through 6 Months|Withdrawal by Subject|14|||
94742503|NCT04479787|324513819|FG000|Through 6 Months|Unsuccessful Trial|17|||
94742504|NCT04479787|324513820|FG001|Through 6 Months|Unsuccessful Trial|0|||
94370321|NCT04380701|323142894|FG018|Overall Study|Withdrawal by Subject|0|||
94742505|NCT04479787|324513819|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
94742506|NCT04479787|324513820|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
94742507|NCT04479787|324513819|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
94742508|NCT04479787|324513820|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
94742509|NCT04479787|324513819|FG000|Through 6 Months|Lost to Follow-up|3|||
94742510|NCT04479787|324513820|FG001|Through 6 Months|Lost to Follow-up|2|||
94742511|NCT04479787|324513819|FG000|Through 6 Months|Death|3|||
94742512|NCT04479787|324513820|FG001|Through 6 Months|Death|0|||
94742513|NCT04479787|324513819|FG000|Through 6 Months|Inclusion/Exclusion|2|||
94742514|NCT04479787|324513820|FG001|Through 6 Months|Inclusion/Exclusion|1|||
94742515|NCT04479787|324513819|FG000|Through 6 Months|Subject Became Pregnant|1|||
94742516|NCT04479787|324513820|FG001|Through 6 Months|Subject Became Pregnant|1|||
94742517|NCT04479787|324513819|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
94742518|NCT04479787|324513820|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
94742519|NCT04479787|324513819|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
94742520|NCT04479787|324513820|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
94742521|NCT04479787|324513819|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
94742522|NCT04479787|324513820|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
94742523|NCT04479787|324513819|FG000|After 6 Months|Withdrawal by Subject|3|||
94742524|NCT04479787|324513820|FG001|After 6 Months|Withdrawal by Subject|13|||
94742525|NCT04479787|324513819|FG000|After 6 Months|Unsuccessful Trial|0|||
94742526|NCT04479787|324513820|FG001|After 6 Months|Unsuccessful Trial|7|||
94742527|NCT04479787|324513819|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
94742528|NCT04479787|324513820|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
94742529|NCT04479787|324513819|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
94742530|NCT04479787|324513820|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
94742531|NCT04479787|324513819|FG000|After 6 Months|Death|2|||
94742532|NCT04479787|324513820|FG001|After 6 Months|Death|0|||
94742533|NCT04479787|324513819|FG000|After 6 Months|Lost to Follow-up|1|||
94742534|NCT04479787|324513820|FG001|After 6 Months|Lost to Follow-up|1|||
94742535|NCT04479787|324513819|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
94742536|NCT04479787|324513820|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
94742537|NCT04479787|324513819|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
94742538|NCT04479787|324513820|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
94742539|NCT04479787|324513819|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
94742540|NCT04479787|324513820|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
94742541|NCT04479787|324513819|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
94742542|NCT04479787|324513820|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
94742543|NCT05116774|324513824|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
94742544|NCT05116774|324513825|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
94742545|NCT05116774|324513824|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
94742546|NCT05116774|324513825|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
94742547|NCT05116774|324513824|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
94742548|NCT05116774|324513825|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
94742549|NCT05116774|324513824|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
94742550|NCT05116774|324513825|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
94742551|NCT05289037|324513829|FG000|Overall Study|Withdrawal by Subject|7|||
94742552|NCT05289037|324513830|FG001|Overall Study|Withdrawal by Subject|0|||
94742553|NCT05289037|324513831|FG002|Overall Study|Withdrawal by Subject|3|||
94742554|NCT05289037|324513832|FG003|Overall Study|Withdrawal by Subject|3|||
94742555|NCT05289037|324513833|FG004|Overall Study|Withdrawal by Subject|1|||
94742556|NCT05289037|324513834|FG005|Overall Study|Withdrawal by Subject|5|||
94742557|NCT05289037|324513835|FG006|Overall Study|Withdrawal by Subject|2|||
94742558|NCT05289037|324513836|FG007|Overall Study|Withdrawal by Subject|1|||
94742559|NCT05289037|324513837|FG008|Overall Study|Withdrawal by Subject|2|||
94742560|NCT05289037|324513838|FG009|Overall Study|Withdrawal by Subject|2|||
94742561|NCT05289037|324513839|FG010|Overall Study|Withdrawal by Subject|1|||
94742562|NCT05289037|324513840|FG011|Overall Study|Withdrawal by Subject|0|||
94742563|NCT05289037|324513841|FG012|Overall Study|Withdrawal by Subject|1|||
94742564|NCT05289037|324513842|FG013|Overall Study|Withdrawal by Subject|2|||
94742565|NCT05289037|324513843|FG014|Overall Study|Withdrawal by Subject|0|||
94742566|NCT05289037|324513844|FG015|Overall Study|Withdrawal by Subject|3|||
94742567|NCT05289037|324513845|FG016|Overall Study|Withdrawal by Subject|3|||
94742568|NCT05289037|324513829|FG000|Overall Study|Lost to Follow-up|1|||
94742569|NCT05289037|324513830|FG001|Overall Study|Lost to Follow-up|4|||
94742570|NCT05289037|324513831|FG002|Overall Study|Lost to Follow-up|3|||
94742571|NCT05289037|324513832|FG003|Overall Study|Lost to Follow-up|3|||
94742572|NCT05289037|324513833|FG004|Overall Study|Lost to Follow-up|3|||
94742573|NCT05289037|324513834|FG005|Overall Study|Lost to Follow-up|2|||
94742574|NCT05289037|324513835|FG006|Overall Study|Lost to Follow-up|3|||
94370322|NCT04380701|323142895|FG019|Overall Study|Withdrawal by Subject|0|||
94742575|NCT05289037|324513836|FG007|Overall Study|Lost to Follow-up|2|||
94742576|NCT05289037|324513837|FG008|Overall Study|Lost to Follow-up|2|||
94742577|NCT05289037|324513838|FG009|Overall Study|Lost to Follow-up|1|||
94742578|NCT05289037|324513839|FG010|Overall Study|Lost to Follow-up|3|||
94742579|NCT05289037|324513840|FG011|Overall Study|Lost to Follow-up|4|||
94742580|NCT05289037|324513841|FG012|Overall Study|Lost to Follow-up|2|||
94742581|NCT05289037|324513842|FG013|Overall Study|Lost to Follow-up|7|||
94742582|NCT05289037|324513843|FG014|Overall Study|Lost to Follow-up|4|||
94742583|NCT05289037|324513844|FG015|Overall Study|Lost to Follow-up|6|||
94742584|NCT05289037|324513845|FG016|Overall Study|Lost to Follow-up|4|||
94742585|NCT05289037|324513829|FG000|Overall Study|Death|0|||
94742586|NCT05289037|324513830|FG001|Overall Study|Death|0|||
94742587|NCT05289037|324513831|FG002|Overall Study|Death|0|||
94742588|NCT05289037|324513832|FG003|Overall Study|Death|0|||
94742589|NCT05289037|324513833|FG004|Overall Study|Death|0|||
94742590|NCT05289037|324513834|FG005|Overall Study|Death|1|||
94742591|NCT05289037|324513835|FG006|Overall Study|Death|0|||
94742592|NCT05289037|324513836|FG007|Overall Study|Death|0|||
94742593|NCT05289037|324513837|FG008|Overall Study|Death|0|||
94742594|NCT05289037|324513838|FG009|Overall Study|Death|0|||
94742595|NCT05289037|324513839|FG010|Overall Study|Death|0|||
94742596|NCT05289037|324513840|FG011|Overall Study|Death|0|||
94742597|NCT05289037|324513841|FG012|Overall Study|Death|0|||
94742598|NCT05289037|324513842|FG013|Overall Study|Death|0|||
94742599|NCT05289037|324513843|FG014|Overall Study|Death|1|||
94742600|NCT05289037|324513844|FG015|Overall Study|Death|0|||
94742601|NCT05289037|324513845|FG016|Overall Study|Death|0|||
94742602|NCT05289037|324513829|FG000|Overall Study|Did not receive vaccine|0|||
94742603|NCT05289037|324513830|FG001|Overall Study|Did not receive vaccine|3|||
94742604|NCT05289037|324513831|FG002|Overall Study|Did not receive vaccine|0|||
94278387|NCT03400332|322811247|FG007|Pre-Treatment|Other reasons|0|||
94278388|NCT03400332|322811248|FG008|Pre-Treatment|Other reasons|1|||
94278389|NCT03400332|322811240|FG000|Pre-Treatment|No longer met study criteria|0|||
94278390|NCT03400332|322811241|FG001|Pre-Treatment|No longer met study criteria|0|||
94278391|NCT03400332|322811242|FG002|Pre-Treatment|No longer met study criteria|0|||
94278392|NCT03400332|322811243|FG003|Pre-Treatment|No longer met study criteria|0|||
94278393|NCT03400332|322811244|FG004|Pre-Treatment|No longer met study criteria|0|||
94278394|NCT03400332|322811245|FG005|Pre-Treatment|No longer met study criteria|0|||
94278395|NCT03400332|322811246|FG006|Pre-Treatment|No longer met study criteria|0|||
94278396|NCT03400332|322811247|FG007|Pre-Treatment|No longer met study criteria|0|||
94278397|NCT03400332|322811248|FG008|Pre-Treatment|No longer met study criteria|1|||
94278398|NCT03400332|322811240|FG000|Pre-Treatment|Withdrawal by Subject|0|||
94278399|NCT03400332|322811241|FG001|Pre-Treatment|Withdrawal by Subject|0|||
94278400|NCT03400332|322811242|FG002|Pre-Treatment|Withdrawal by Subject|0|||
94278401|NCT03400332|322811243|FG003|Pre-Treatment|Withdrawal by Subject|0|||
94278402|NCT03400332|322811244|FG004|Pre-Treatment|Withdrawal by Subject|0|||
94278403|NCT03400332|322811245|FG005|Pre-Treatment|Withdrawal by Subject|0|||
94278404|NCT03400332|322811246|FG006|Pre-Treatment|Withdrawal by Subject|0|||
94278405|NCT03400332|322811247|FG007|Pre-Treatment|Withdrawal by Subject|0|||
94278406|NCT03400332|322811248|FG008|Pre-Treatment|Withdrawal by Subject|1|||
94278407|NCT03400332|322811240|FG000|Treatment|Participant withdrew consent|2|||
94278408|NCT03400332|322811241|FG001|Treatment|Participant withdrew consent|2|||
94278409|NCT03400332|322811242|FG002|Treatment|Participant withdrew consent|0|||
94278410|NCT03400332|322811243|FG003|Treatment|Participant withdrew consent|0|||
94278411|NCT03400332|322811244|FG004|Treatment|Participant withdrew consent|3|||
94278412|NCT03400332|322811245|FG005|Treatment|Participant withdrew consent|3|||
94278413|NCT03400332|322811246|FG006|Treatment|Participant withdrew consent|1|||
94278414|NCT03400332|322811247|FG007|Treatment|Participant withdrew consent|1|||
94278415|NCT03400332|322811248|FG008|Treatment|Participant withdrew consent|1|||
94278416|NCT03400332|322811240|FG000|Treatment|Other reasons|0|||
94278417|NCT03400332|322811241|FG001|Treatment|Other reasons|1|||
94278418|NCT03400332|322811242|FG002|Treatment|Other reasons|1|||
94278419|NCT03400332|322811243|FG003|Treatment|Other reasons|0|||
94278420|NCT03400332|322811244|FG004|Treatment|Other reasons|3|||
94278421|NCT03400332|322811245|FG005|Treatment|Other reasons|1|||
94370323|NCT04380701|323142896|FG020|Overall Study|Withdrawal by Subject|0|||
94370324|NCT04380701|323142897|FG021|Overall Study|Withdrawal by Subject|0|||
94370325|NCT04380701|323142898|FG022|Overall Study|Withdrawal by Subject|2|||
94742605|NCT05289037|324513832|FG003|Overall Study|Did not receive vaccine|0|||
94742606|NCT05289037|324513833|FG004|Overall Study|Did not receive vaccine|1|||
94742607|NCT05289037|324513834|FG005|Overall Study|Did not receive vaccine|1|||
94278422|NCT03400332|322811246|FG006|Treatment|Other reasons|2|||
94278423|NCT03400332|322811247|FG007|Treatment|Other reasons|0|||
94742608|NCT05289037|324513835|FG006|Overall Study|Did not receive vaccine|1|||
94742609|NCT05289037|324513836|FG007|Overall Study|Did not receive vaccine|0|||
94742610|NCT05289037|324513837|FG008|Overall Study|Did not receive vaccine|0|||
94742611|NCT05289037|324513838|FG009|Overall Study|Did not receive vaccine|0|||
94742612|NCT05289037|324513839|FG010|Overall Study|Did not receive vaccine|0|||
94742613|NCT05289037|324513840|FG011|Overall Study|Did not receive vaccine|0|||
94202141|NCT04487080|322537027|FG000|Overall Study|Withdrawal by Subject|19|||
94202142|NCT04487080|322537028|FG001|Overall Study|Withdrawal by Subject|18|||
94202143|NCT04487080|322537029|FG002|Overall Study|Withdrawal by Subject|13|||
94202144|NCT04487080|322537027|FG000|Overall Study|Lost to Follow-up|3|||
94278424|NCT03400332|322811248|FG008|Treatment|Other reasons|1|||
94278425|NCT03400332|322811240|FG000|Treatment|Lost to Follow-up|0|||
94278426|NCT03400332|322811241|FG001|Treatment|Lost to Follow-up|1|||
94278427|NCT03400332|322811242|FG002|Treatment|Lost to Follow-up|0|||
94278428|NCT03400332|322811243|FG003|Treatment|Lost to Follow-up|0|||
94278429|NCT03400332|322811244|FG004|Treatment|Lost to Follow-up|0|||
94278430|NCT03400332|322811245|FG005|Treatment|Lost to Follow-up|0|||
94278431|NCT03400332|322811246|FG006|Treatment|Lost to Follow-up|0|||
94278432|NCT03400332|322811247|FG007|Treatment|Lost to Follow-up|0|||
94278433|NCT03400332|322811248|FG008|Treatment|Lost to Follow-up|0|||
94278434|NCT03400332|322811240|FG000|Treatment|Death|3|||
94278435|NCT03400332|322811241|FG001|Treatment|Death|1|||
94278436|NCT03400332|322811242|FG002|Treatment|Death|2|||
94278437|NCT03400332|322811243|FG003|Treatment|Death|3|||
94278438|NCT03400332|322811244|FG004|Treatment|Death|6|||
94278439|NCT03400332|322811245|FG005|Treatment|Death|2|||
94278440|NCT03400332|322811246|FG006|Treatment|Death|1|||
94278441|NCT03400332|322811247|FG007|Treatment|Death|3|||
94278442|NCT03400332|322811248|FG008|Treatment|Death|6|||
94278443|NCT03776175|322811249|FG000|Treatment Period (42 Days)|Adverse Event|0|||
94278444|NCT03776175|322811250|FG001|Treatment Period (42 Days)|Adverse Event|1|||
94278445|NCT03776175|322811251|FG002|Treatment Period (42 Days)|Adverse Event|1|||
94278446|NCT03776175|322811252|FG003|Treatment Period (42 Days)|Adverse Event|0|||
94278447|NCT03776175|322811249|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
94278448|NCT03776175|322811250|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
94278449|NCT03776175|322811251|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
94278450|NCT03776175|322811252|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
94278451|NCT03776175|322811249|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
94278452|NCT03776175|322811250|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
94278453|NCT03776175|322811251|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
94278454|NCT03776175|322811252|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
94278455|NCT03776175|322811249|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
94278456|NCT03776175|322811250|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
94278457|NCT03776175|322811251|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
94278458|NCT03776175|322811252|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
94278459|NCT03776175|322811249|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
94278460|NCT03776175|322811250|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
94278461|NCT03776175|322811251|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
94278462|NCT03776175|322811252|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
94278463|NCT03776175|322811249|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
94278464|NCT03776175|322811250|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
94278465|NCT03776175|322811251|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
94278466|NCT03776175|322811252|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
94278467|NCT05440539|322811253|FG000|Overall Study|Lost to Follow-up|4|||
94278468|NCT05440539|322811254|FG001|Overall Study|Lost to Follow-up|4|||
94278469|NCT05440539|322811253|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
94278470|NCT05440539|322811254|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
94278471|NCT03808077|322811255|FG000|Overall Study|Physician Decision|2|||
94278472|NCT03808077|322811256|FG001|Overall Study|Physician Decision|3|||
94278473|NCT03808077|322811255|FG000|Overall Study|Withdrawal by Subject|1|||
94278474|NCT03808077|322811256|FG001|Overall Study|Withdrawal by Subject|0|||
94278475|NCT03808077|322811255|FG000|Overall Study|Equipment Issues|2|||
94278476|NCT03808077|322811256|FG001|Overall Study|Equipment Issues|1|||
94278477|NCT04152161|322811257|FG000|Overall Study|Death|0|||
94278478|NCT04152161|322811258|FG001|Overall Study|Death|1|||
94278479|NCT04152161|322811257|FG000|Overall Study|Physician Decision|0|||
94278480|NCT04152161|322811258|FG001|Overall Study|Physician Decision|1|||
94370326|NCT04380701|323142899|FG023|Overall Study|Withdrawal by Subject|2|||
94202145|NCT04487080|322537028|FG001|Overall Study|Lost to Follow-up|1|||
94202146|NCT04487080|322537029|FG002|Overall Study|Lost to Follow-up|0|||
94202147|NCT04487080|322537027|FG000|Overall Study|Ongoing|313|||
94370327|NCT04380701|323142900|FG024|Overall Study|Withdrawal by Subject|1|||
94370328|NCT04380701|323142901|FG025|Overall Study|Withdrawal by Subject|1|||
94370329|NCT04380701|323142902|FG026|Overall Study|Withdrawal by Subject|0|||
94370330|NCT04380701|323142903|FG027|Overall Study|Withdrawal by Subject|0|||
94370331|NCT04380701|323142904|FG028|Overall Study|Withdrawal by Subject|0|||
94370332|NCT04380701|323142905|FG029|Overall Study|Withdrawal by Subject|0|||
94370333|NCT04380701|323142906|FG030|Overall Study|Withdrawal by Subject|0|||
94370334|NCT04380701|323142907|FG031|Overall Study|Withdrawal by Subject|0|||
94370335|NCT04380701|323142908|FG032|Overall Study|Withdrawal by Subject|0|||
94370336|NCT04380701|323142909|FG033|Overall Study|Withdrawal by Subject|0|||
94370337|NCT04380701|323142876|FG000|Overall Study|Adverse Event|0|||
94370338|NCT04380701|323142877|FG001|Overall Study|Adverse Event|0|||
94370339|NCT04380701|323142878|FG002|Overall Study|Adverse Event|0|||
94370340|NCT04380701|323142879|FG003|Overall Study|Adverse Event|0|||
94370341|NCT04380701|323142880|FG004|Overall Study|Adverse Event|0|||
94370342|NCT04380701|323142881|FG005|Overall Study|Adverse Event|1|||
94370343|NCT04380701|323142882|FG006|Overall Study|Adverse Event|0|||
94370344|NCT04380701|323142883|FG007|Overall Study|Adverse Event|0|||
94370345|NCT04380701|323142884|FG008|Overall Study|Adverse Event|0|||
94370346|NCT04380701|323142885|FG009|Overall Study|Adverse Event|0|||
94370347|NCT04380701|323142886|FG010|Overall Study|Adverse Event|0|||
94370348|NCT04380701|323142887|FG011|Overall Study|Adverse Event|0|||
94370349|NCT04380701|323142888|FG012|Overall Study|Adverse Event|0|||
94370350|NCT04380701|323142889|FG013|Overall Study|Adverse Event|0|||
94370351|NCT04380701|323142890|FG014|Overall Study|Adverse Event|0|||
94370352|NCT04380701|323142891|FG015|Overall Study|Adverse Event|1|||
94370353|NCT04380701|323142892|FG016|Overall Study|Adverse Event|0|||
94370354|NCT04380701|323142893|FG017|Overall Study|Adverse Event|0|||
94370355|NCT04380701|323142894|FG018|Overall Study|Adverse Event|0|||
94370356|NCT04380701|323142895|FG019|Overall Study|Adverse Event|1|||
94370357|NCT04380701|323142896|FG020|Overall Study|Adverse Event|0|||
94370358|NCT04380701|323142897|FG021|Overall Study|Adverse Event|0|||
94370359|NCT04380701|323142898|FG022|Overall Study|Adverse Event|0|||
94370360|NCT04380701|323142899|FG023|Overall Study|Adverse Event|0|||
94370361|NCT04380701|323142900|FG024|Overall Study|Adverse Event|0|||
94370362|NCT04380701|323142901|FG025|Overall Study|Adverse Event|0|||
94370363|NCT04380701|323142902|FG026|Overall Study|Adverse Event|0|||
94370364|NCT04380701|323142903|FG027|Overall Study|Adverse Event|0|||
94370365|NCT04380701|323142904|FG028|Overall Study|Adverse Event|0|||
94370366|NCT04380701|323142905|FG029|Overall Study|Adverse Event|0|||
94370367|NCT04380701|323142906|FG030|Overall Study|Adverse Event|0|||
94370368|NCT04380701|323142907|FG031|Overall Study|Adverse Event|0|||
94370369|NCT04380701|323142908|FG032|Overall Study|Adverse Event|0|||
94370370|NCT04380701|323142909|FG033|Overall Study|Adverse Event|0|||
94370371|NCT04380701|323142876|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
94370372|NCT04380701|323142877|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
94370373|NCT04380701|323142878|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
94370374|NCT04380701|323142879|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
94370375|NCT04380701|323142880|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
94370376|NCT04380701|323142881|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
94742614|NCT05289037|324513841|FG012|Overall Study|Did not receive vaccine|0|||
94742615|NCT05289037|324513842|FG013|Overall Study|Did not receive vaccine|0|||
94742616|NCT05289037|324513843|FG014|Overall Study|Did not receive vaccine|1|||
94742617|NCT05289037|324513844|FG015|Overall Study|Did not receive vaccine|0|||
94742618|NCT05289037|324513845|FG016|Overall Study|Did not receive vaccine|0|||
94742619|NCT05289037|324513829|FG000|Overall Study|Unable to make last visit|0|||
94742620|NCT05289037|324513830|FG001|Overall Study|Unable to make last visit|0|||
94742621|NCT05289037|324513831|FG002|Overall Study|Unable to make last visit|1|||
94742622|NCT05289037|324513832|FG003|Overall Study|Unable to make last visit|0|||
94742623|NCT05289037|324513833|FG004|Overall Study|Unable to make last visit|0|||
94742624|NCT05289037|324513834|FG005|Overall Study|Unable to make last visit|0|||
94742625|NCT05289037|324513835|FG006|Overall Study|Unable to make last visit|0|||
94202148|NCT04487080|322537028|FG001|Overall Study|Ongoing|297|||
94370377|NCT04380701|323142882|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
94370378|NCT04380701|323142883|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
94370379|NCT04380701|323142884|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
94370380|NCT04380701|323142885|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
94370381|NCT04380701|323142886|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
94370382|NCT04380701|323142887|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
94370383|NCT04380701|323142888|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
94370384|NCT04380701|323142889|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
94370385|NCT04380701|323142890|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
94370386|NCT04380701|323142891|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
94370387|NCT04380701|323142892|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
94467628|NCT01451164|323502365|FG002|Overall Study|Withdrawal Criteria|1|||
94742626|NCT05289037|324513836|FG007|Overall Study|Unable to make last visit|0|||
94742627|NCT05289037|324513837|FG008|Overall Study|Unable to make last visit|0|||
94202149|NCT04487080|322537029|FG002|Overall Study|Ongoing|149|||
94202150|NCT00227266|322537030|FG000|Overall Study|Withdrawal by Subject|0|||
94202151|NCT00227266|322537031|FG001|Overall Study|Withdrawal by Subject|0|||
94202152|NCT00227266|322537032|FG002|Overall Study|Withdrawal by Subject|1|||
94370388|NCT04380701|323142893|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
94370389|NCT04380701|323142894|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
94202153|NCT00227266|322537030|FG000|Overall Study|Protocol Violation|1|||
94202154|NCT00227266|322537031|FG001|Overall Study|Protocol Violation|0|||
94202155|NCT00227266|322537032|FG002|Overall Study|Protocol Violation|1|||
94202156|NCT00227266|322537030|FG000|Overall Study|Excessive weight gain|0|||
94202157|NCT00227266|322537031|FG001|Overall Study|Excessive weight gain|0|||
94202158|NCT00227266|322537032|FG002|Overall Study|Excessive weight gain|2|||
94202159|NCT00593840|322537033|FG000|Overall Study|Withdrawal by Subject|1|||
94202160|NCT00113360|322537572|FG000|Overall Study|Adverse Event|3|||
94202161|NCT00113360|322537572|FG000|Overall Study|Subject required surgery|1|||
94202162|NCT00113360|322537572|FG000|Overall Study|Did not meet eligibility criteria|3|||
94202163|NCT03725332|322537575|FG000|Overall Study|Adverse Event|5|||
94202164|NCT03725332|322537576|FG001|Overall Study|Adverse Event|10|||
94202165|NCT03725332|322537575|FG000|Overall Study|Death|1|||
94202166|NCT03725332|322537576|FG001|Overall Study|Death|3|||
94202167|NCT03725332|322537575|FG000|Overall Study|Lost to Follow-up|43|||
94202168|NCT03725332|322537576|FG001|Overall Study|Lost to Follow-up|122|||
94202169|NCT03725332|322537575|FG000|Overall Study|Withdrawal by Subject|0|||
94202170|NCT03725332|322537576|FG001|Overall Study|Withdrawal by Subject|1|||
94202171|NCT03725332|322537575|FG000|Overall Study|Duplicate enrollment|0|||
94202172|NCT03725332|322537576|FG001|Overall Study|Duplicate enrollment|1|||
94202173|NCT03725332|322537575|FG000|Overall Study|Did not consent|0|||
94202174|NCT03725332|322537576|FG001|Overall Study|Did not consent|1|||
94202175|NCT05988398|322537579|FG000|Overall Study|Lack of time|21|||
94202176|NCT05988398|322537580|FG001|Overall Study|Lack of time|0|||
94202177|NCT05988398|322537579|FG000|Overall Study|Absent from school|0|||
94202178|NCT05988398|322537580|FG001|Overall Study|Absent from school|38|||
94202179|NCT05988398|322537579|FG000|Overall Study|Chose not to participate|0|||
94202180|NCT05988398|322537580|FG001|Overall Study|Chose not to participate|42|||
94202181|NCT05988398|322537579|FG000|Overall Study|Other commitments (e.g., sports)|0|||
94202182|NCT05988398|322537580|FG001|Overall Study|Other commitments (e.g., sports)|25|||
94202183|NCT00087685|322537588|FG000|Overall Study|Adverse Event|5|||
94202184|NCT00087685|322537588|FG000|Overall Study|Non-Compliance|1|||
94202185|NCT00087685|322537588|FG000|Overall Study|Progressive Disease|5|||
94202186|NCT00087685|322537588|FG000|Overall Study|Withdrawal by Subject|3|||
94202187|NCT02553460|322537592|FG000|Overall Study|Death|3|||
94202188|NCT02553460|322537592|FG000|Overall Study|Withdrawal by Subject|1|||
94202189|NCT02553460|322537592|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
94202190|NCT02553460|322537592|FG000|Overall Study|Relapse or Transplant|14|||
94202191|NCT02553460|322537592|FG000|Overall Study|No response to treatment|2|||
94202192|NCT02553460|322537592|FG000|Overall Study|CAR T cells|2|||
94202193|NCT04899674|322537601|FG000|Test|Adverse Event|1|||
94202194|NCT03774472|322537602|FG000|Overall Study|Physician Decision|1|||
94202195|NCT03774472|322537603|FG001|Overall Study|Physician Decision|0|||
94202196|NCT03774472|322537604|FG002|Overall Study|Physician Decision|0|||
94202197|NCT03774472|322537602|FG000|Overall Study|Progression prior to 4 weeks|0|||
94202198|NCT03774472|322537603|FG001|Overall Study|Progression prior to 4 weeks|1|||
94202199|NCT03774472|322537604|FG002|Overall Study|Progression prior to 4 weeks|0|||
94202200|NCT03774472|322537602|FG000|Overall Study|Withdrawal by Subject|0|||
94202201|NCT03774472|322537603|FG001|Overall Study|Withdrawal by Subject|1|||
94202202|NCT03774472|322537604|FG002|Overall Study|Withdrawal by Subject|0|||
94202203|NCT03280030|322537607|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
94202204|NCT03280030|322537608|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
94202205|NCT03280030|322537609|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
94202206|NCT03280030|322537607|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
94202207|NCT03280030|322537608|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
94202208|NCT03280030|322537609|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
94202209|NCT03280030|322537607|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
94202210|NCT03280030|322537608|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
94202211|NCT03280030|322537609|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
94202212|NCT03280030|322537607|FG000|Part 2 - Efficacy|Adverse Event|0|||
94202213|NCT03280030|322537608|FG001|Part 2 - Efficacy|Adverse Event|4|||
94202214|NCT03280030|322537609|FG002|Part 2 - Efficacy|Adverse Event|6|||
94202215|NCT03280030|322537607|FG000|Part 2 - Efficacy|Death|0|||
94202216|NCT03280030|322537608|FG001|Part 2 - Efficacy|Death|3|||
94370390|NCT04380701|323142895|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
94370391|NCT04380701|323142896|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
94370392|NCT04380701|323142897|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
94370393|NCT04380701|323142898|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
94202217|NCT03280030|322537609|FG002|Part 2 - Efficacy|Death|0|||
94202218|NCT03280030|322537607|FG000|Part 2 - Efficacy|Physician Decision|0|||
94202219|NCT03280030|322537608|FG001|Part 2 - Efficacy|Physician Decision|10|||
94202220|NCT03280030|322537609|FG002|Part 2 - Efficacy|Physician Decision|16|||
94202221|NCT03280030|322537607|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
94202222|NCT03280030|322537608|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
94202223|NCT03280030|322537609|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
94202224|NCT03280030|322537607|FG000|Part 2 - Efficacy|Progressive disease|0|||
94202225|NCT03280030|322537608|FG001|Part 2 - Efficacy|Progressive disease|7|||
94202226|NCT03280030|322537609|FG002|Part 2 - Efficacy|Progressive disease|5|||
94202227|NCT05601882|322537610|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
94202228|NCT05601882|322537611|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
94202229|NCT05601882|322537612|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
94202230|NCT05601882|322537613|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
94202231|NCT05601882|322537610|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
94202232|NCT05601882|322537611|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
94202233|NCT05601882|322537612|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
94202234|NCT05601882|322537613|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
94202235|NCT05601882|322537610|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
94202236|NCT05601882|322537611|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
94202237|NCT05601882|322537612|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
94202238|NCT05601882|322537613|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
94202239|NCT05601882|322537610|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
94202240|NCT05601882|322537611|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
94202241|NCT05601882|322537612|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
94202242|NCT05601882|322537613|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
94202243|NCT05601882|322537610|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
94202244|NCT05601882|322537611|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
94202245|NCT05601882|322537612|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
94202246|NCT05601882|322537613|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
94202247|NCT05601882|322537610|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
94202248|NCT05601882|322537611|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
94202249|NCT05601882|322537612|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
94202250|NCT05601882|322537613|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
94202251|NCT04303780|322537615|FG000|Overall Study|Death|104|||
94202252|NCT04303780|322537616|FG001|Overall Study|Death|85|||
94202253|NCT04303780|322537615|FG000|Overall Study|Lost to Follow-up|5|||
94202254|NCT04303780|322537616|FG001|Overall Study|Lost to Follow-up|2|||
94202255|NCT04303780|322537615|FG000|Overall Study|Withdrawal by Subject|12|||
94202256|NCT04303780|322537616|FG001|Overall Study|Withdrawal by Subject|39|||
94202257|NCT04303780|322537615|FG000|Overall Study|Ongoing in study|50|||
94202258|NCT04303780|322537616|FG001|Overall Study|Ongoing in study|45|||
94202259|NCT05521516|322537617|FG000|Overall Study|Withdrawal by Subject|1|||
94202260|NCT05521516|322537618|FG001|Overall Study|Withdrawal by Subject|1|||
94202261|NCT04305327|322537619|FG000|Overall Study|Study early termination|2|||
94202262|NCT04305327|322537620|FG001|Overall Study|Study early termination|5|||
94202263|NCT04305327|322537621|FG002|Overall Study|Study early termination|2|||
94202264|NCT04305327|322537622|FG003|Overall Study|Study early termination|2|||
94202265|NCT04305327|322537619|FG000|Overall Study|Withdrawal by Subject|0|||
94202266|NCT04305327|322537620|FG001|Overall Study|Withdrawal by Subject|1|||
94202267|NCT04305327|322537621|FG002|Overall Study|Withdrawal by Subject|0|||
94202268|NCT04305327|322537622|FG003|Overall Study|Withdrawal by Subject|0|||
94202269|NCT02075554|322537916|FG000|Overall Study|Lost to Follow-up|7|||
94202270|NCT02075554|322537916|FG000|Overall Study|Withdrawal by Subject|5|||
94202271|NCT02075554|322537916|FG000|Overall Study|Physician Decision|3|||
94202272|NCT03782116|322537917|FG000|Completed Intervetion|Lost to Follow-up|11|||
94202273|NCT03782116|322537918|FG001|Completed Intervetion|Lost to Follow-up|7|||
94202274|NCT03782116|322537917|FG000|Completed Intervetion|Withdrawal by Subject|6|||
94202275|NCT03782116|322537918|FG001|Completed Intervetion|Withdrawal by Subject|5|||
94202276|NCT03782116|322537917|FG000|Included in Analysis|Protocol Violation|5|||
94202277|NCT03782116|322537918|FG001|Included in Analysis|Protocol Violation|5|||
94202278|NCT01084863|322537922|FG000|Main Study Treatment Period|Disease progression|11|||
94202279|NCT01084863|322537923|FG001|Main Study Treatment Period|Disease progression|7|||
94202280|NCT01084863|322537922|FG000|Main Study Treatment Period|Adverse Event|5|||
94202281|NCT01084863|322537923|FG001|Main Study Treatment Period|Adverse Event|3|||
94202282|NCT01084863|322537922|FG000|Main Study Treatment Period|Other Reason|0|||
94202283|NCT01084863|322537923|FG001|Main Study Treatment Period|Other Reason|1|||
94202284|NCT01084863|322537922|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
94467629|NCT01451164|323502366|FG003|Overall Study|Withdrawal Criteria|1|||
94202285|NCT01084863|322537923|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
94202286|NCT01084863|322537922|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
94202287|NCT01084863|322537923|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
94202288|NCT01084863|322537922|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
94202289|NCT01084863|322537923|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
94202290|NCT01084863|322537922|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
94202291|NCT01084863|322537923|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
94202292|NCT01084863|322537922|FG000|Treatment Period Beyond Cycle 8|Other|0|||
94202293|NCT01084863|322537923|FG001|Treatment Period Beyond Cycle 8|Other|1|||
94202294|NCT01084863|322537922|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
94202295|NCT01084863|322537923|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
94202296|NCT04505722|322537924|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
94202297|NCT04505722|322537925|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
94202298|NCT04505722|322537926|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
94202299|NCT04505722|322537924|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
94202300|NCT04505722|322537925|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
94202301|NCT04505722|322537926|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
94202302|NCT04505722|322537924|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
94202303|NCT04505722|322537925|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
94202304|NCT04505722|322537926|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
94202305|NCT04505722|322537924|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
94202306|NCT04505722|322537925|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
94202307|NCT04505722|322537926|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
94202308|NCT04505722|322537924|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
94202309|NCT04505722|322537925|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
94202310|NCT04505722|322537926|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
94202311|NCT04505722|322537924|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
94202312|NCT04505722|322537925|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
94202313|NCT04505722|322537926|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
94202314|NCT04505722|322537924|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
94202315|NCT04505722|322537925|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
94202316|NCT04505722|322537926|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
94202317|NCT04505722|322537924|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
94202318|NCT04505722|322537925|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
94202319|NCT04505722|322537926|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
94202320|NCT04505722|322537924|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
94202321|NCT04505722|322537925|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
94202322|NCT04505722|322537926|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
94202323|NCT04505722|322537924|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
94202324|NCT04505722|322537925|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
94202325|NCT04505722|322537926|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
94202326|NCT04505722|322537924|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
94202327|NCT04505722|322537925|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
94202328|NCT04505722|322537926|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
94202329|NCT04505722|322537924|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
94202330|NCT04505722|322537925|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
94202331|NCT04505722|322537926|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
94202332|NCT04505722|322537924|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
94202333|NCT04505722|322537925|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
94202334|NCT04505722|322537926|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
94202335|NCT04505722|322537924|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
94202336|NCT04505722|322537925|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
94202337|NCT04505722|322537926|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
94202338|NCT04505722|322537924|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
94202339|NCT04505722|322537925|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
94202340|NCT04505722|322537926|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
94202341|NCT03473223|322537927|FG000|Overall Study|Lost to Follow-up|1|||
94202342|NCT03473223|322537928|FG001|Overall Study|Lost to Follow-up|1|||
94202343|NCT03473223|322537927|FG000|Overall Study|Withdrawal by Subject|47|||
94202344|NCT03473223|322537928|FG001|Overall Study|Withdrawal by Subject|42|||
94202345|NCT03473223|322537927|FG000|Overall Study|Indirect contact|32|||
94202346|NCT03473223|322537928|FG001|Overall Study|Indirect contact|29|||
94202347|NCT03473223|322537927|FG000|Overall Study|Other (Not specified)|32|||
94202348|NCT03473223|322537928|FG001|Overall Study|Other (Not specified)|20|||
94202349|NCT03867201|322537929|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
94202350|NCT03867201|322537930|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
94202351|NCT03867201|322537929|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
94202352|NCT03867201|322537930|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
94202353|NCT03867201|322537929|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
94202354|NCT03867201|322537930|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
94202355|NCT03867201|322537929|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
94278481|NCT04152161|322811257|FG000|Overall Study|Lost to Follow-up|9|||
94278482|NCT04152161|322811258|FG001|Overall Study|Lost to Follow-up|3|||
94278483|NCT04152161|322811257|FG000|Overall Study|Protocol Violation|1|||
94278484|NCT04152161|322811258|FG001|Overall Study|Protocol Violation|0|||
94202356|NCT03867201|322537930|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
94370394|NCT04380701|323142899|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
94370395|NCT04380701|323142900|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
94370396|NCT04380701|323142901|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
94370397|NCT04380701|323142902|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
94370398|NCT04380701|323142903|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
94370399|NCT04380701|323142904|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
94370400|NCT04380701|323142905|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
94370401|NCT04380701|323142906|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
94202357|NCT03867201|322537929|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
94202358|NCT03867201|322537930|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
94202359|NCT03867201|322537929|FG000|Open-Label Period From Week 12|Adverse Event|5|||
94202360|NCT03867201|322537930|FG001|Open-Label Period From Week 12|Adverse Event|11|||
94202361|NCT03867201|322537929|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
94202362|NCT03867201|322537930|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
94202363|NCT03867201|322537929|FG000|Open-Label Period From Week 12|Physician Decision|6|||
94202364|NCT03867201|322537930|FG001|Open-Label Period From Week 12|Physician Decision|3|||
94202365|NCT03867201|322537929|FG000|Open-Label Period From Week 12|Pregnancy|2|||
94202366|NCT03867201|322537930|FG001|Open-Label Period From Week 12|Pregnancy|2|||
94202367|NCT03867201|322537929|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
94202368|NCT03867201|322537930|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
94202369|NCT03867201|322537929|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
94202370|NCT03867201|322537930|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
94202371|NCT03867201|322537929|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
94202372|NCT03867201|322537930|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
94202373|NCT03867201|322537929|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
94202374|NCT03867201|322537930|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
94202375|NCT03959423|322537931|FG000|Overall Study|Withdrawal by Subject|2|||
94202376|NCT03959423|322537932|FG001|Overall Study|Withdrawal by Subject|3|||
94202377|NCT03959423|322537931|FG000|Overall Study|Physician Decision|0|||
94202378|NCT03959423|322537932|FG001|Overall Study|Physician Decision|1|||
94202379|NCT03959423|322537931|FG000|Overall Study|Lost to Follow-up|1|||
94202380|NCT03959423|322537932|FG001|Overall Study|Lost to Follow-up|0|||
94202381|NCT03959423|322537931|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
94202382|NCT03959423|322537932|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94202383|NCT00994643|322538455|FG000|Overall Study|Withdrawal by Subject|1|||
94202384|NCT00495677|322538456|FG000|Stage 1 (25 Days)|Adverse Event|0|||
94202385|NCT00495677|322538457|FG001|Stage 1 (25 Days)|Adverse Event|0|||
94202386|NCT00495677|322538458|FG002|Stage 1 (25 Days)|Adverse Event|1|||
94202387|NCT00495677|322538459|FG003|Stage 1 (25 Days)|Adverse Event|0|||
94202388|NCT00495677|322538460|FG004|Stage 1 (25 Days)|Adverse Event|0|||
94202389|NCT00495677|322538461|FG005|Stage 1 (25 Days)|Adverse Event|0|||
94202390|NCT00495677|322538462|FG006|Stage 1 (25 Days)|Adverse Event|0|||
94202391|NCT03875313|322538463|FG000|Overall Study|Withdrawal by Subject|1|||
94370402|NCT04380701|323142907|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
94370403|NCT04380701|323142908|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
94370404|NCT04380701|323142909|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
94370405|NCT04380701|323142876|FG000|Overall Study|Physician Decision|0|||
94370406|NCT04380701|323142877|FG001|Overall Study|Physician Decision|0|||
94370407|NCT04380701|323142878|FG002|Overall Study|Physician Decision|0|||
94370408|NCT04380701|323142879|FG003|Overall Study|Physician Decision|0|||
94370409|NCT04380701|323142880|FG004|Overall Study|Physician Decision|0|||
94370410|NCT04380701|323142881|FG005|Overall Study|Physician Decision|0|||
94202392|NCT03875313|322538464|FG001|Overall Study|Withdrawal by Subject|3|||
94202393|NCT03875313|322538465|FG002|Overall Study|Withdrawal by Subject|0|||
94467630|NCT01451164|323502363|FG000|Overall Study|Physician Decision|2|||
94467631|NCT01451164|323502364|FG001|Overall Study|Physician Decision|0|||
94742628|NCT05289037|324513838|FG009|Overall Study|Unable to make last visit|0|||
94742629|NCT05289037|324513839|FG010|Overall Study|Unable to make last visit|0|||
94742630|NCT05289037|324513840|FG011|Overall Study|Unable to make last visit|0|||
94742631|NCT05289037|324513841|FG012|Overall Study|Unable to make last visit|0|||
94742632|NCT05289037|324513842|FG013|Overall Study|Unable to make last visit|0|||
94742633|NCT05289037|324513843|FG014|Overall Study|Unable to make last visit|0|||
94202394|NCT03875313|322538466|FG003|Overall Study|Withdrawal by Subject|0|||
94202395|NCT03875313|322538467|FG004|Overall Study|Withdrawal by Subject|0|||
94202396|NCT03875313|322538463|FG000|Overall Study|Death|0|||
94202397|NCT03875313|322538464|FG001|Overall Study|Death|0|||
94202398|NCT03875313|322538465|FG002|Overall Study|Death|0|||
94202399|NCT03875313|322538466|FG003|Overall Study|Death|0|||
94202400|NCT03875313|322538467|FG004|Overall Study|Death|1|||
94370411|NCT04380701|323142882|FG006|Overall Study|Physician Decision|0|||
94467632|NCT01451164|323502365|FG002|Overall Study|Physician Decision|1|||
94370412|NCT04380701|323142883|FG007|Overall Study|Physician Decision|0|||
94742634|NCT05289037|324513844|FG015|Overall Study|Unable to make last visit|0|||
94742635|NCT05289037|324513845|FG016|Overall Study|Unable to make last visit|0|||
94742636|NCT05289037|324513829|FG000|Overall Study|Protocol deviation|0|||
94278485|NCT04152161|322811257|FG000|Overall Study|Withdrawal by Subject|29|||
94467633|NCT01451164|323502366|FG003|Overall Study|Physician Decision|0|||
94467634|NCT01451164|323502363|FG000|Overall Study|Withdrawal by Subject|14|||
94742637|NCT05289037|324513830|FG001|Overall Study|Protocol deviation|0|||
94742638|NCT05289037|324513831|FG002|Overall Study|Protocol deviation|0|||
94742639|NCT05289037|324513832|FG003|Overall Study|Protocol deviation|0|||
94742640|NCT05289037|324513833|FG004|Overall Study|Protocol deviation|0|||
94742641|NCT05289037|324513834|FG005|Overall Study|Protocol deviation|0|||
94742642|NCT05289037|324513835|FG006|Overall Study|Protocol deviation|0|||
94742643|NCT05289037|324513836|FG007|Overall Study|Protocol deviation|0|||
94742644|NCT05289037|324513837|FG008|Overall Study|Protocol deviation|0|||
94742645|NCT05289037|324513838|FG009|Overall Study|Protocol deviation|0|||
94742646|NCT05289037|324513839|FG010|Overall Study|Protocol deviation|0|||
94742647|NCT05289037|324513840|FG011|Overall Study|Protocol deviation|0|||
94742648|NCT05289037|324513841|FG012|Overall Study|Protocol deviation|0|||
94742649|NCT05289037|324513842|FG013|Overall Study|Protocol deviation|0|||
94742650|NCT05289037|324513843|FG014|Overall Study|Protocol deviation|0|||
94742651|NCT05289037|324513844|FG015|Overall Study|Protocol deviation|1|||
94742652|NCT05289037|324513845|FG016|Overall Study|Protocol deviation|0|||
94742653|NCT03891758|324513847|FG000|Overall Study|Adverse Event|2|||
94742654|NCT03891758|324513848|FG001|Overall Study|Adverse Event|0|||
94742655|NCT03891758|324513847|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94742656|NCT03891758|324513848|FG001|Overall Study|Withdrawal by parent/guardian|2|||
94742657|NCT00115934|324513849|FG000|Overall Study|Lost to Follow-up|1|||
94742658|NCT00115934|324513850|FG001|Overall Study|Lost to Follow-up|0|||
94742659|NCT00115934|324513849|FG000|Overall Study|Did not receive intervention|3|||
94742660|NCT00115934|324513850|FG001|Overall Study|Did not receive intervention|2|||
94742661|NCT00945724|324513853|FG000|Overall Study|Withdrawal by Subject|2|||
94742662|NCT00945724|324513853|FG000|Overall Study|Physician Decision|1|||
94742663|NCT00945724|324513853|FG000|Overall Study|Adverse Event|5|||
94742664|NCT00945724|324513853|FG000|Overall Study|Second malignancy|1|||
94742665|NCT03759379|324515312|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
94742666|NCT03759379|324515313|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
94742667|NCT03759379|324515312|FG000|Treatment Period|Death|2|||
94742668|NCT03759379|324515313|FG001|Treatment Period|Death|3|||
94742669|NCT03759379|324515312|FG000|Treatment Period|Lost to Follow-up|1|||
94742670|NCT03759379|324515313|FG001|Treatment Period|Lost to Follow-up|0|||
94742671|NCT03759379|324515312|FG000|Treatment Period|Physician Decision|0|||
94742672|NCT03759379|324515313|FG001|Treatment Period|Physician Decision|1|||
94742673|NCT03081858|324515314|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
94742674|NCT03081858|324515315|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
94742675|NCT03081858|324515316|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
94742676|NCT03081858|324515317|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
94742677|NCT03459196|324515318|FG000|Overall Study|Subject didn't receive study catheter|2|||
94742678|NCT05665595|324515319|FG000|Overall Study|Ongoing|692|||
94742679|NCT05665595|324515320|FG001|Overall Study|Ongoing|698|||
94742680|NCT05665595|324515319|FG000|Overall Study|Withdrawal by Subject|2|||
94742681|NCT05665595|324515320|FG001|Overall Study|Withdrawal by Subject|2|||
94742682|NCT05665595|324515319|FG000|Overall Study|Lost to Follow-up|1|||
94742683|NCT05665595|324515320|FG001|Overall Study|Lost to Follow-up|0|||
94742684|NCT05665595|324515319|FG000|Overall Study|Death|6|||
94742685|NCT05665595|324515320|FG001|Overall Study|Death|1|||
94742686|NCT04269161|324515321|FG000|Overall Study|Change of modality and no longer eligible|3|||
94742687|NCT04269161|324515322|FG001|Overall Study|Change of modality and no longer eligible|3|||
94742688|NCT04269161|324515321|FG000|Overall Study|Required procedure outside of NICU|1|||
94742689|NCT04269161|324515322|FG001|Overall Study|Required procedure outside of NICU|0|||
94742690|NCT04269161|324515321|FG000|Overall Study|Equipment issue|1|||
94742691|NCT04269161|324515322|FG001|Overall Study|Equipment issue|1|||
94742692|NCT05267639|324515324|FG000|Overall Study|Withdrawal by Subject|1|||
94742693|NCT05267639|324515325|FG001|Overall Study|Withdrawal by Subject|0|||
94742694|NCT04530487|324515336|FG000|Overall Study|Death|1|||
94742695|NCT05013424|324515337|FG000|Overall Study|Lost to Follow-up|1|||
94742696|NCT05013424|324515338|FG001|Overall Study|Lost to Follow-up|1|||
94742697|NCT05013424|324515339|FG002|Overall Study|Lost to Follow-up|1|||
94742698|NCT05013424|324515337|FG000|Overall Study|Withdrawal by Subject|0|||
94742699|NCT05013424|324515338|FG001|Overall Study|Withdrawal by Subject|1|||
94742700|NCT05013424|324515339|FG002|Overall Study|Withdrawal by Subject|0|||
94742701|NCT03512301|324515340|FG000|Overall Study|Protocol Violation|2|||
94742702|NCT03512301|324515340|FG000|Overall Study|Did Not Qualify|3|||
94467635|NCT01451164|323502364|FG001|Overall Study|Withdrawal by Subject|11|||
94742703|NCT03512301|324515340|FG000|Overall Study|Age-ineligible|1|||
94742704|NCT03512301|324515340|FG000|Overall Study|Inadequate fluency with the English language|3|||
94742705|NCT04595331|324515346|FG000|Overall Study|Withdrawal by Subject|0|||
94742706|NCT04595331|324515347|FG001|Overall Study|Withdrawal by Subject|1|||
94742707|NCT04595331|324515346|FG000|Overall Study|Lost to Follow-up|0|||
94202401|NCT03875313|322538463|FG000|Overall Study|Lost to Follow-up|0|||
94202402|NCT03875313|322538464|FG001|Overall Study|Lost to Follow-up|0|||
94202403|NCT03875313|322538465|FG002|Overall Study|Lost to Follow-up|0|||
94202404|NCT03875313|322538466|FG003|Overall Study|Lost to Follow-up|0|||
94202405|NCT03875313|322538467|FG004|Overall Study|Lost to Follow-up|1|||
94202406|NCT03875313|322538463|FG000|Overall Study|Study Termination by Sponsor|0|||
94202407|NCT03875313|322538464|FG001|Overall Study|Study Termination by Sponsor|1|||
94202408|NCT03875313|322538465|FG002|Overall Study|Study Termination by Sponsor|1|||
94202409|NCT03875313|322538466|FG003|Overall Study|Study Termination by Sponsor|0|||
94278486|NCT04152161|322811258|FG001|Overall Study|Withdrawal by Subject|28|||
94278487|NCT04152161|322811257|FG000|Overall Study|Sponsor termination of study|750|||
94278488|NCT04152161|322811258|FG001|Overall Study|Sponsor termination of study|755|||
94278489|NCT04152161|322811257|FG000|Overall Study|Other|20|||
94278490|NCT04152161|322811258|FG001|Overall Study|Other|18|||
94370413|NCT04380701|323142884|FG008|Overall Study|Physician Decision|0|||
94370414|NCT04380701|323142885|FG009|Overall Study|Physician Decision|0|||
94370415|NCT04380701|323142886|FG010|Overall Study|Physician Decision|0|||
94370416|NCT04380701|323142887|FG011|Overall Study|Physician Decision|0|||
94370417|NCT04380701|323142888|FG012|Overall Study|Physician Decision|0|||
94370418|NCT04380701|323142889|FG013|Overall Study|Physician Decision|0|||
94370419|NCT04380701|323142890|FG014|Overall Study|Physician Decision|0|||
94370420|NCT04380701|323142891|FG015|Overall Study|Physician Decision|0|||
94370421|NCT04380701|323142892|FG016|Overall Study|Physician Decision|0|||
94370422|NCT04380701|323142893|FG017|Overall Study|Physician Decision|0|||
94370423|NCT04380701|323142894|FG018|Overall Study|Physician Decision|0|||
94370424|NCT04380701|323142895|FG019|Overall Study|Physician Decision|0|||
94370425|NCT04380701|323142896|FG020|Overall Study|Physician Decision|0|||
94370426|NCT04380701|323142897|FG021|Overall Study|Physician Decision|0|||
94370427|NCT04380701|323142898|FG022|Overall Study|Physician Decision|0|||
94278491|NCT00001379|322811262|FG000|Initial Treatment|Disease progression|21|||
94278492|NCT00001379|322811263|FG001|Initial Treatment|Disease progression|3|||
94278493|NCT00001379|322811264|FG002|Initial Treatment|Disease progression|0|||
94278494|NCT00001379|322811265|FG003|Initial Treatment|Disease progression|0|||
94278495|NCT00001379|322811262|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
94278496|NCT00001379|322811263|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
94278497|NCT00001379|322811264|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
94278498|NCT00001379|322811265|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
94278499|NCT00001379|322811262|FG000|Initial Treatment|Received alternative treatment|2|||
94278500|NCT00001379|322811263|FG001|Initial Treatment|Received alternative treatment|1|||
94278501|NCT00001379|322811264|FG002|Initial Treatment|Received alternative treatment|0|||
94278502|NCT00001379|322811265|FG003|Initial Treatment|Received alternative treatment|0|||
94278503|NCT00001379|322811262|FG000|Initial Treatment|Refused further treatment|2|||
94278504|NCT00001379|322811263|FG001|Initial Treatment|Refused further treatment|0|||
94278505|NCT00001379|322811264|FG002|Initial Treatment|Refused further treatment|0|||
94278506|NCT00001379|322811265|FG003|Initial Treatment|Refused further treatment|0|||
94278507|NCT00001379|322811262|FG000|Initial Treatment|Did not receive protocol treatment|0|||
94278508|NCT00001379|322811263|FG001|Initial Treatment|Did not receive protocol treatment|0|||
94278509|NCT00001379|322811264|FG002|Initial Treatment|Did not receive protocol treatment|5|||
94278510|NCT00001379|322811265|FG003|Initial Treatment|Did not receive protocol treatment|0|||
94278511|NCT00001379|322811262|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
94278512|NCT00001379|322811263|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
94278513|NCT00001379|322811264|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
94278514|NCT00001379|322811265|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
94278515|NCT00001379|322811262|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
94278516|NCT00001379|322811263|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
94278517|NCT00001379|322811264|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
94278518|NCT00001379|322811265|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
94278519|NCT00001379|322811262|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
94278520|NCT00001379|322811263|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
94370428|NCT04380701|323142899|FG023|Overall Study|Physician Decision|0|||
94370429|NCT04380701|323142900|FG024|Overall Study|Physician Decision|2|||
94370430|NCT04380701|323142901|FG025|Overall Study|Physician Decision|0|||
94202410|NCT03875313|322538467|FG004|Overall Study|Study Termination by Sponsor|1|||
94202411|NCT03875313|322538463|FG000|Overall Study|New Anticancer Treatment|0|||
94202412|NCT03875313|322538464|FG001|Overall Study|New Anticancer Treatment|1|||
94202413|NCT03875313|322538465|FG002|Overall Study|New Anticancer Treatment|2|||
94278521|NCT00001379|322811264|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
94370431|NCT04380701|323142902|FG026|Overall Study|Physician Decision|0|||
94370432|NCT04380701|323142903|FG027|Overall Study|Physician Decision|0|||
94370433|NCT04380701|323142904|FG028|Overall Study|Physician Decision|0|||
94370434|NCT04380701|323142905|FG029|Overall Study|Physician Decision|0|||
94370435|NCT04380701|323142906|FG030|Overall Study|Physician Decision|0|||
94370436|NCT04380701|323142907|FG031|Overall Study|Physician Decision|0|||
94370437|NCT04380701|323142908|FG032|Overall Study|Physician Decision|0|||
94370438|NCT04380701|323142909|FG033|Overall Study|Physician Decision|0|||
94370439|NCT04380701|323142876|FG000|Overall Study|Death|0|||
94370440|NCT04380701|323142877|FG001|Overall Study|Death|0|||
94370441|NCT04380701|323142878|FG002|Overall Study|Death|0|||
94370442|NCT04380701|323142879|FG003|Overall Study|Death|0|||
94370443|NCT04380701|323142880|FG004|Overall Study|Death|0|||
94370444|NCT04380701|323142881|FG005|Overall Study|Death|0|||
94370445|NCT04380701|323142882|FG006|Overall Study|Death|0|||
94370446|NCT04380701|323142883|FG007|Overall Study|Death|0|||
94370447|NCT04380701|323142884|FG008|Overall Study|Death|0|||
94370448|NCT04380701|323142885|FG009|Overall Study|Death|0|||
94370449|NCT04380701|323142886|FG010|Overall Study|Death|0|||
94370450|NCT04380701|323142887|FG011|Overall Study|Death|0|||
94370451|NCT04380701|323142888|FG012|Overall Study|Death|0|||
94370452|NCT04380701|323142889|FG013|Overall Study|Death|0|||
94370453|NCT04380701|323142890|FG014|Overall Study|Death|0|||
94370454|NCT04380701|323142891|FG015|Overall Study|Death|0|||
94370455|NCT04380701|323142892|FG016|Overall Study|Death|0|||
94370456|NCT04380701|323142893|FG017|Overall Study|Death|0|||
94370457|NCT04380701|323142894|FG018|Overall Study|Death|0|||
94370458|NCT04380701|323142895|FG019|Overall Study|Death|0|||
94370459|NCT04380701|323142896|FG020|Overall Study|Death|0|||
94370460|NCT04380701|323142897|FG021|Overall Study|Death|0|||
94742708|NCT04595331|324515347|FG001|Overall Study|Lost to Follow-up|5|||
94742709|NCT04595331|324515346|FG000|Overall Study|Medical reason|0|||
94742710|NCT04595331|324515347|FG001|Overall Study|Medical reason|1|||
94742711|NCT04177355|324515348|FG000|Overall Study|Lost to Follow-up|0|||
94742712|NCT04177355|324515349|FG001|Overall Study|Lost to Follow-up|2|||
94742713|NCT04177355|324515350|FG002|Overall Study|Lost to Follow-up|0|||
94742714|NCT04177355|324515351|FG003|Overall Study|Lost to Follow-up|1|||
94742715|NCT04177355|324515352|FG004|Overall Study|Lost to Follow-up|2|||
94742716|NCT04177355|324515353|FG005|Overall Study|Lost to Follow-up|0|||
94742717|NCT04177355|324515354|FG006|Overall Study|Lost to Follow-up|1|||
94742718|NCT04177355|324515355|FG007|Overall Study|Lost to Follow-up|0|||
94742719|NCT04177355|324515356|FG008|Overall Study|Lost to Follow-up|0|||
94742720|NCT04177355|324515357|FG009|Overall Study|Lost to Follow-up|0|||
94742721|NCT04177355|324515358|FG010|Overall Study|Lost to Follow-up|0|||
94742722|NCT04177355|324515348|FG000|Overall Study|Withdrawal by Subject|0|||
94742723|NCT04177355|324515349|FG001|Overall Study|Withdrawal by Subject|0|||
94742724|NCT04177355|324515350|FG002|Overall Study|Withdrawal by Subject|0|||
94742725|NCT04177355|324515351|FG003|Overall Study|Withdrawal by Subject|1|||
94742726|NCT04177355|324515352|FG004|Overall Study|Withdrawal by Subject|1|||
94742727|NCT04177355|324515353|FG005|Overall Study|Withdrawal by Subject|0|||
94742728|NCT04177355|324515354|FG006|Overall Study|Withdrawal by Subject|0|||
94742729|NCT04177355|324515355|FG007|Overall Study|Withdrawal by Subject|0|||
94742730|NCT04177355|324515356|FG008|Overall Study|Withdrawal by Subject|1|||
94742731|NCT04177355|324515357|FG009|Overall Study|Withdrawal by Subject|0|||
94742732|NCT04177355|324515358|FG010|Overall Study|Withdrawal by Subject|0|||
94742733|NCT04644029|324515359|FG000|Overall Study|Death|1|||
94742734|NCT04644029|324515360|FG001|Overall Study|Death|0|||
94742735|NCT04644029|324515359|FG000|Overall Study|Physician Decision|1|||
94742736|NCT04644029|324515360|FG001|Overall Study|Physician Decision|2|||
94742737|NCT04644029|324515359|FG000|Overall Study|Withdrawal by Subject|21|||
94742738|NCT04644029|324515360|FG001|Overall Study|Withdrawal by Subject|19|||
94742739|NCT04644029|324515359|FG000|Overall Study|Lost to Follow-up|31|||
94742740|NCT04644029|324515360|FG001|Overall Study|Lost to Follow-up|34|||
94742741|NCT04644029|324515359|FG000|Overall Study|Study Terminated by Sponsor|308|||
94742742|NCT04644029|324515360|FG001|Overall Study|Study Terminated by Sponsor|309|||
94742743|NCT04644029|324515359|FG000|Overall Study|Randomized in Error|2|||
94742744|NCT04644029|324515360|FG001|Overall Study|Randomized in Error|1|||
94742745|NCT04644029|324515359|FG000|Overall Study|Other|0|||
94742746|NCT04644029|324515360|FG001|Overall Study|Other|1|||
94742747|NCT05029284|324515361|FG000|Overall Study|Lost to Follow-up|1|||
94742748|NCT04001829|324515362|FG000|Overall Study|Never start protocol therapy|5|||
94742749|NCT04001829|324515363|FG001|Overall Study|Never start protocol therapy|5|||
94742750|NCT04001829|324515362|FG000|Overall Study|Adverse Event|11|||
94742751|NCT04001829|324515363|FG001|Overall Study|Adverse Event|7|||
94742752|NCT04001829|324515362|FG000|Overall Study|Alternative therapy|1|||
94742753|NCT04001829|324515363|FG001|Overall Study|Alternative therapy|2|||
94370461|NCT04380701|323142898|FG022|Overall Study|Death|0|||
94370462|NCT04380701|323142899|FG023|Overall Study|Death|0|||
94370463|NCT04380701|323142900|FG024|Overall Study|Death|1|||
94370464|NCT04380701|323142901|FG025|Overall Study|Death|0|||
94370465|NCT04380701|323142902|FG026|Overall Study|Death|0|||
94742754|NCT04001829|324515362|FG000|Overall Study|Disease progression/relapse|2|||
94742755|NCT04001829|324515363|FG001|Overall Study|Disease progression/relapse|1|||
94742756|NCT04001829|324515362|FG000|Overall Study|Other complicating disease|1|||
94742757|NCT04001829|324515363|FG001|Overall Study|Other complicating disease|0|||
94742758|NCT04001829|324515362|FG000|Overall Study|Withdrawal by Subject|1|||
94278522|NCT00001379|322811265|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
94742759|NCT04001829|324515363|FG001|Overall Study|Withdrawal by Subject|4|||
94742760|NCT04001829|324515362|FG000|Overall Study|Ineligible|2|||
94742761|NCT04001829|324515363|FG001|Overall Study|Ineligible|2|||
94278523|NCT00001379|322811262|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
94278524|NCT00001379|322811263|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
94278525|NCT00001379|322811264|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
94278526|NCT00001379|322811265|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
94278527|NCT00001379|322811262|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
94278528|NCT00001379|322811263|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
94278529|NCT00001379|322811264|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
94278530|NCT00001379|322811265|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
94278531|NCT03246958|322811266|FG000|Overall Study|Withdrawal by Subject|0|||
94278532|NCT03246958|322811267|FG001|Overall Study|Withdrawal by Subject|1|||
94278533|NCT03246958|322811268|FG002|Overall Study|Withdrawal by Subject|0|||
94278534|NCT03246958|322811269|FG003|Overall Study|Withdrawal by Subject|0|||
94278535|NCT03246958|322811270|FG004|Overall Study|Withdrawal by Subject|0|||
94278536|NCT03246958|322811271|FG005|Overall Study|Withdrawal by Subject|1|||
94278537|NCT03246958|322811272|FG006|Overall Study|Withdrawal by Subject|0|||
94278538|NCT03246958|322811266|FG000|Overall Study|Progression|13|||
94278539|NCT03246958|322811267|FG001|Overall Study|Progression|9|||
94278540|NCT03246958|322811268|FG002|Overall Study|Progression|3|||
94278541|NCT03246958|322811269|FG003|Overall Study|Progression|2|||
94278542|NCT03246958|322811270|FG004|Overall Study|Progression|1|||
94278543|NCT03246958|322811271|FG005|Overall Study|Progression|2|||
94278544|NCT03246958|322811272|FG006|Overall Study|Progression|1|||
94278545|NCT03246958|322811266|FG000|Overall Study|Adverse Event|2|||
94742762|NCT04001829|324515362|FG000|Overall Study|Reason missing due to delinquent data|1|||
94742763|NCT04001829|324515363|FG001|Overall Study|Reason missing due to delinquent data|0|||
94742764|NCT02611687|324515366|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
94742765|NCT02611687|324515367|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
94742766|NCT03705793|324515371|FG000|Overall Study|Lost to Follow-up|3|||
94742767|NCT03705793|324515372|FG001|Overall Study|Lost to Follow-up|4|||
94742768|NCT03705793|324515371|FG000|Overall Study|Withdrawal by Subject|2|||
94742769|NCT03705793|324515372|FG001|Overall Study|Withdrawal by Subject|1|||
94742770|NCT03437733|324515373|FG000|Overall Study|Eligibility criteria not met|0|||
94742771|NCT03437733|324515374|FG001|Overall Study|Eligibility criteria not met|3|||
94742772|NCT02719574|324515380|FG000|Phase 1 (Dose Escalation)|Other|0|||
94742773|NCT02719574|324515381|FG001|Phase 1 (Dose Escalation)|Other|2|||
94742774|NCT02719574|324515382|FG002|Phase 1 (Dose Escalation)|Other|1|||
94742775|NCT02719574|324515383|FG003|Phase 1 (Dose Escalation)|Other|2|||
94742776|NCT02719574|324515384|FG004|Phase 1 (Dose Escalation)|Other|2|||
94742777|NCT02719574|324515385|FG005|Phase 1 (Dose Escalation)|Other|0|||
94742778|NCT02719574|324515386|FG006|Phase 1 (Dose Escalation)|Other|0|||
94742779|NCT02719574|324515387|FG007|Phase 1 (Dose Escalation)|Other|0|||
94742780|NCT02719574|324515388|FG008|Phase 1 (Dose Escalation)|Other|0|||
94742781|NCT02719574|324515389|FG009|Phase 1 (Dose Escalation)|Other|0|||
94742782|NCT02719574|324515390|FG010|Phase 1 (Dose Escalation)|Other|0|||
94742783|NCT02719574|324515391|FG011|Phase 1 (Dose Escalation)|Other|0|||
94742784|NCT02719574|324515392|FG012|Phase 1 (Dose Escalation)|Other|0|||
94742785|NCT02719574|324515393|FG013|Phase 1 (Dose Escalation)|Other|0|||
94742786|NCT02719574|324515394|FG014|Phase 1 (Dose Escalation)|Other|0|||
94742787|NCT02719574|324515395|FG015|Phase 1 (Dose Escalation)|Other|0|||
94742788|NCT02719574|324515396|FG016|Phase 1 (Dose Escalation)|Other|0|||
94742789|NCT02719574|324515380|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
94202414|NCT03875313|322538466|FG003|Overall Study|New Anticancer Treatment|1|||
94202415|NCT03875313|322538467|FG004|Overall Study|New Anticancer Treatment|0|||
94202416|NCT03875313|322538463|FG000|Overall Study|Other, Not Specified|2|||
94202417|NCT03875313|322538464|FG001|Overall Study|Other, Not Specified|11|||
94202418|NCT03875313|322538465|FG002|Overall Study|Other, Not Specified|3|||
94202419|NCT03875313|322538466|FG003|Overall Study|Other, Not Specified|3|||
94202420|NCT03875313|322538467|FG004|Overall Study|Other, Not Specified|1|||
94202421|NCT04121546|322538468|FG000|Overall Study|Lost to Follow-up|1|||
94202422|NCT04121546|322538469|FG001|Overall Study|Lost to Follow-up|3|||
94278546|NCT03246958|322811267|FG001|Overall Study|Adverse Event|2|||
94278547|NCT03246958|322811268|FG002|Overall Study|Adverse Event|0|||
94278548|NCT03246958|322811269|FG003|Overall Study|Adverse Event|1|||
94278549|NCT03246958|322811270|FG004|Overall Study|Adverse Event|1|||
94278550|NCT03246958|322811271|FG005|Overall Study|Adverse Event|0|||
94742790|NCT02719574|324515381|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
94742791|NCT02719574|324515382|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
94742792|NCT02719574|324515383|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
94742793|NCT02719574|324515384|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
94742794|NCT02719574|324515385|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
94742795|NCT02719574|324515386|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
94202423|NCT01773993|322538470|FG000|Overall Study|No Visit After Treatment|35|||
94202424|NCT00308997|322538471|FG000|Overall Study|Subject feigned clinical data|0|||
94202425|NCT00308997|322538472|FG001|Overall Study|Subject feigned clinical data|1|||
94202426|NCT00308997|322538471|FG000|Overall Study|Unable to tolerate intervention|1|||
94202427|NCT00308997|322538472|FG001|Overall Study|Unable to tolerate intervention|0|||
94202428|NCT03816397|322538473|FG000|Overall Study|Censored at interim analysis date.|13|||
94202429|NCT03816397|322538474|FG001|Overall Study|Censored at interim analysis date.|6|||
94202430|NCT03816397|322538473|FG000|Overall Study|Withdrawal by Subject|1|||
94202431|NCT03816397|322538474|FG001|Overall Study|Withdrawal by Subject|1|||
94202432|NCT03357952|322538475|FG000|Overall Study|Withdrawal by Subject|0|||
94202433|NCT03357952|322538476|FG001|Overall Study|Withdrawal by Subject|1|||
94202434|NCT03357952|322538475|FG000|Overall Study|Sponsor Decision|9|||
94202435|NCT03357952|322538476|FG001|Overall Study|Sponsor Decision|0|||
94202436|NCT05714059|322538478|FG000|Overall Study|Withdrawal by Subject|2|||
94202437|NCT05714059|322538479|FG001|Overall Study|Withdrawal by Subject|2|||
94202438|NCT05714059|322538478|FG000|Overall Study|Adverse Event|0|||
94202439|NCT05714059|322538479|FG001|Overall Study|Adverse Event|1|||
94202440|NCT05714059|322538478|FG000|Overall Study|Lost to Follow-up|0|||
94202441|NCT05714059|322538479|FG001|Overall Study|Lost to Follow-up|1|||
94202442|NCT05714059|322538478|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
94202443|NCT05714059|322538479|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
94202444|NCT05714059|322538478|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
94202445|NCT05714059|322538479|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
94202446|NCT04059406|322538480|FG000|Overall Study|Early Treatment Termination|5|||
94202447|NCT04059406|322538481|FG001|Overall Study|Early Treatment Termination|5|||
94202448|NCT04059406|322538482|FG002|Overall Study|Early Treatment Termination|15|||
94202449|NCT05155306|322538487|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
94202450|NCT05155306|322538488|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
94202451|NCT05155306|322538489|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
94202452|NCT05155306|322538490|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
94202453|NCT05155306|322538487|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
94202454|NCT05155306|322538488|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
94202455|NCT05155306|322538489|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
94202456|NCT05155306|322538490|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
94202457|NCT03150862|322538491|FG000|Overall Study|Death|2|||
94202458|NCT03150862|322538492|FG001|Overall Study|Death|7|||
94202459|NCT03150862|322538493|FG002|Overall Study|Death|8|||
94202460|NCT03150862|322538494|FG003|Overall Study|Death|27|||
94202461|NCT03150862|322538495|FG004|Overall Study|Death|4|||
94202462|NCT03150862|322538496|FG005|Overall Study|Death|8|||
94202463|NCT03150862|322538497|FG006|Overall Study|Death|6|||
94202464|NCT03150862|322538498|FG007|Overall Study|Death|21|||
94467636|NCT01451164|323502365|FG002|Overall Study|Withdrawal by Subject|16|||
94202465|NCT03150862|322538491|FG000|Overall Study|Withdrawal by Subject|1|||
94202466|NCT03150862|322538492|FG001|Overall Study|Withdrawal by Subject|1|||
94202467|NCT03150862|322538493|FG002|Overall Study|Withdrawal by Subject|0|||
94202468|NCT03150862|322538494|FG003|Overall Study|Withdrawal by Subject|3|||
94202469|NCT03150862|322538495|FG004|Overall Study|Withdrawal by Subject|1|||
94202470|NCT03150862|322538496|FG005|Overall Study|Withdrawal by Subject|1|||
94202471|NCT03150862|322538497|FG006|Overall Study|Withdrawal by Subject|1|||
94202472|NCT03150862|322538498|FG007|Overall Study|Withdrawal by Subject|3|||
94202473|NCT03150862|322538491|FG000|Overall Study|Lost to Follow-up|0|||
94202474|NCT03150862|322538492|FG001|Overall Study|Lost to Follow-up|0|||
94202475|NCT03150862|322538493|FG002|Overall Study|Lost to Follow-up|1|||
94202476|NCT03150862|322538494|FG003|Overall Study|Lost to Follow-up|0|||
94202477|NCT03150862|322538495|FG004|Overall Study|Lost to Follow-up|0|||
94202478|NCT03150862|322538496|FG005|Overall Study|Lost to Follow-up|0|||
94202479|NCT03150862|322538497|FG006|Overall Study|Lost to Follow-up|0|||
94202480|NCT03150862|322538498|FG007|Overall Study|Lost to Follow-up|2|||
94202481|NCT03150862|322538491|FG000|Overall Study|Sponsor's decision|0|||
94202482|NCT03150862|322538492|FG001|Overall Study|Sponsor's decision|0|||
94202483|NCT03150862|322538493|FG002|Overall Study|Sponsor's decision|0|||
94202484|NCT03150862|322538494|FG003|Overall Study|Sponsor's decision|10|||
94202485|NCT03150862|322538495|FG004|Overall Study|Sponsor's decision|3|||
94202486|NCT03150862|322538496|FG005|Overall Study|Sponsor's decision|0|||
94202487|NCT03150862|322538497|FG006|Overall Study|Sponsor's decision|1|||
94202488|NCT03150862|322538498|FG007|Overall Study|Sponsor's decision|1|||
94202489|NCT03150862|322538491|FG000|Overall Study|Change in Methylation status|0|||
94202490|NCT03150862|322538492|FG001|Overall Study|Change in Methylation status|0|||
94202491|NCT03150862|322538493|FG002|Overall Study|Change in Methylation status|0|||
94202492|NCT03150862|322538494|FG003|Overall Study|Change in Methylation status|0|||
94202493|NCT03150862|322538495|FG004|Overall Study|Change in Methylation status|1|||
94202494|NCT03150862|322538496|FG005|Overall Study|Change in Methylation status|0|||
94202495|NCT03150862|322538497|FG006|Overall Study|Change in Methylation status|0|||
94202496|NCT03150862|322538498|FG007|Overall Study|Change in Methylation status|0|||
94467637|NCT01451164|323502366|FG003|Overall Study|Withdrawal by Subject|17|||
94202497|NCT03150862|322538491|FG000|Overall Study|Roll over in to Long Term Extension|0|||
94202498|NCT03150862|322538492|FG001|Overall Study|Roll over in to Long Term Extension|0|||
94202499|NCT03150862|322538493|FG002|Overall Study|Roll over in to Long Term Extension|0|||
94202500|NCT03150862|322538494|FG003|Overall Study|Roll over in to Long Term Extension|0|||
94202501|NCT03150862|322538495|FG004|Overall Study|Roll over in to Long Term Extension|0|||
94202502|NCT03150862|322538496|FG005|Overall Study|Roll over in to Long Term Extension|0|||
94202503|NCT03150862|322538497|FG006|Overall Study|Roll over in to Long Term Extension|0|||
94202504|NCT03150862|322538498|FG007|Overall Study|Roll over in to Long Term Extension|1|||
94202505|NCT03150862|322538491|FG000|Overall Study|Progressive Disease|0|||
94202506|NCT03150862|322538492|FG001|Overall Study|Progressive Disease|0|||
94202507|NCT03150862|322538493|FG002|Overall Study|Progressive Disease|0|||
94278551|NCT03246958|322811272|FG006|Overall Study|Adverse Event|2|||
94278552|NCT03246958|322811266|FG000|Overall Study|Death|0|||
94278553|NCT03246958|322811267|FG001|Overall Study|Death|1|||
94278554|NCT03246958|322811268|FG002|Overall Study|Death|0|||
94278555|NCT03246958|322811269|FG003|Overall Study|Death|0|||
94278556|NCT03246958|322811270|FG004|Overall Study|Death|0|||
94278557|NCT03246958|322811271|FG005|Overall Study|Death|0|||
94278558|NCT03246958|322811272|FG006|Overall Study|Death|0|||
94278559|NCT03246958|322811266|FG000|Overall Study|Physician Decision|0|||
94278560|NCT03246958|322811267|FG001|Overall Study|Physician Decision|0|||
94278561|NCT03246958|322811268|FG002|Overall Study|Physician Decision|0|||
94278562|NCT03246958|322811269|FG003|Overall Study|Physician Decision|1|||
94278563|NCT03246958|322811270|FG004|Overall Study|Physician Decision|0|||
94278564|NCT03246958|322811271|FG005|Overall Study|Physician Decision|0|||
94278565|NCT03246958|322811272|FG006|Overall Study|Physician Decision|0|||
94278566|NCT03246958|322811266|FG000|Overall Study|Never start treatment|1|||
94278567|NCT03246958|322811267|FG001|Overall Study|Never start treatment|0|||
94278568|NCT03246958|322811268|FG002|Overall Study|Never start treatment|0|||
94742796|NCT02719574|324515387|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
94742797|NCT02719574|324515388|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
94742798|NCT02719574|324515389|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
94742799|NCT02719574|324515390|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
94742800|NCT02719574|324515391|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
94742801|NCT02719574|324515392|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
94742802|NCT02719574|324515393|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
94742803|NCT02719574|324515394|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
94742804|NCT02719574|324515395|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
94742805|NCT02719574|324515396|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
94742806|NCT02719574|324515380|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
94742807|NCT02719574|324515381|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
94742808|NCT02719574|324515382|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
94742809|NCT02719574|324515383|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
94742810|NCT02719574|324515384|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
94742811|NCT02719574|324515385|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
94742812|NCT02719574|324515386|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
94742813|NCT02719574|324515387|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
94742814|NCT02719574|324515388|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
94742815|NCT02719574|324515389|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
94742816|NCT02719574|324515390|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
94742817|NCT02719574|324515391|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
94742818|NCT02719574|324515392|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
94742819|NCT02719574|324515393|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
94742820|NCT02719574|324515394|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
94742821|NCT02719574|324515395|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
94742822|NCT02719574|324515396|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
94742823|NCT02719574|324515380|FG000|Phase 1 (Dose Escalation)|Death|2|||
94742824|NCT02719574|324515381|FG001|Phase 1 (Dose Escalation)|Death|1|||
94742825|NCT02719574|324515382|FG002|Phase 1 (Dose Escalation)|Death|1|||
94742826|NCT02719574|324515383|FG003|Phase 1 (Dose Escalation)|Death|0|||
94742827|NCT02719574|324515384|FG004|Phase 1 (Dose Escalation)|Death|0|||
94742828|NCT02719574|324515385|FG005|Phase 1 (Dose Escalation)|Death|0|||
94742829|NCT02719574|324515386|FG006|Phase 1 (Dose Escalation)|Death|0|||
94742830|NCT02719574|324515387|FG007|Phase 1 (Dose Escalation)|Death|0|||
94742831|NCT02719574|324515388|FG008|Phase 1 (Dose Escalation)|Death|0|||
94742832|NCT02719574|324515389|FG009|Phase 1 (Dose Escalation)|Death|0|||
94278569|NCT03246958|322811269|FG003|Overall Study|Never start treatment|0|||
94742833|NCT02719574|324515390|FG010|Phase 1 (Dose Escalation)|Death|0|||
94742834|NCT02719574|324515391|FG011|Phase 1 (Dose Escalation)|Death|0|||
94370466|NCT04380701|323142903|FG027|Overall Study|Death|0|||
94370467|NCT04380701|323142904|FG028|Overall Study|Death|0|||
94278570|NCT03246958|322811270|FG004|Overall Study|Never start treatment|0|||
94278571|NCT03246958|322811271|FG005|Overall Study|Never start treatment|0|||
94742835|NCT02719574|324515392|FG012|Phase 1 (Dose Escalation)|Death|0|||
94278572|NCT03246958|322811272|FG006|Overall Study|Never start treatment|0|||
94742836|NCT02719574|324515393|FG013|Phase 1 (Dose Escalation)|Death|0|||
94742837|NCT02719574|324515394|FG014|Phase 1 (Dose Escalation)|Death|0|||
94278573|NCT03246958|322811266|FG000|Overall Study|Over enrollment|0|||
94202508|NCT03150862|322538494|FG003|Overall Study|Progressive Disease|0|||
94202509|NCT03150862|322538495|FG004|Overall Study|Progressive Disease|0|||
94202510|NCT03150862|322538496|FG005|Overall Study|Progressive Disease|0|||
94202511|NCT03150862|322538497|FG006|Overall Study|Progressive Disease|0|||
94202512|NCT03150862|322538498|FG007|Overall Study|Progressive Disease|2|||
94202513|NCT03222609|322538499|FG000|Overall Study|Withdrew consent|2|||
94202514|NCT03222609|322538500|FG001|Overall Study|Withdrew consent|3|||
94202515|NCT03222609|322538501|FG002|Overall Study|Withdrew consent|4|||
94202516|NCT03222609|322538502|FG003|Overall Study|Withdrew consent|2|||
94202517|NCT03222609|322538499|FG000|Overall Study|Lost to Follow-up|1|||
94202518|NCT03222609|322538500|FG001|Overall Study|Lost to Follow-up|0|||
94202519|NCT03222609|322538501|FG002|Overall Study|Lost to Follow-up|0|||
94202520|NCT03222609|322538502|FG003|Overall Study|Lost to Follow-up|0|||
94202521|NCT03222609|322538499|FG000|Overall Study|Death|16|||
94202522|NCT03222609|322538500|FG001|Overall Study|Death|13|||
94202523|NCT03222609|322538501|FG002|Overall Study|Death|9|||
94202524|NCT03222609|322538502|FG003|Overall Study|Death|6|||
94202525|NCT03222609|322538499|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
94202526|NCT03222609|322538500|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
94202527|NCT03222609|322538501|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
94202528|NCT03222609|322538502|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
94202529|NCT03656718|322538504|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
94202530|NCT03656718|322538505|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
94202531|NCT03656718|322538506|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
94202532|NCT03656718|322538507|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
94202533|NCT03656718|322538508|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
94202534|NCT03656718|322538509|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
94202535|NCT03656718|322538510|FG006|Treatment Period Parts A, B, D, and E|Disease progression|14|||
94202536|NCT03656718|322538504|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
94202537|NCT03656718|322538505|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
94202538|NCT03656718|322538506|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
94202539|NCT03656718|322538507|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
94202540|NCT03656718|322538508|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
94202541|NCT03656718|322538509|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
94202542|NCT03656718|322538510|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
94202543|NCT03656718|322538504|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
94202544|NCT03656718|322538505|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
94202545|NCT03656718|322538506|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
94202546|NCT03656718|322538507|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
94202547|NCT03656718|322538508|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
94202548|NCT03656718|322538509|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
94202549|NCT03656718|322538510|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
94202550|NCT03656718|322538504|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
94202551|NCT03656718|322538505|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
94202552|NCT03656718|322538506|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
94202553|NCT03656718|322538507|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
94202554|NCT03656718|322538508|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
94202555|NCT03656718|322538509|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
94202556|NCT03656718|322538510|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
94202557|NCT03656718|322538504|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
94202558|NCT03656718|322538505|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
94202559|NCT03656718|322538506|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
94202560|NCT03656718|322538507|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
94202561|NCT03656718|322538508|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
94202562|NCT03656718|322538509|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
94202563|NCT03656718|322538510|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
94202564|NCT03656718|322538504|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
94202565|NCT03656718|322538505|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
94202566|NCT03656718|322538506|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
94202567|NCT03656718|322538507|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
94202568|NCT03656718|322538508|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
94202569|NCT03656718|322538509|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
94202570|NCT03656718|322538510|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
94202571|NCT03656718|322538504|FG000|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
94202572|NCT03656718|322538505|FG001|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
94202573|NCT03656718|322538506|FG002|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
94278574|NCT03246958|322811267|FG001|Overall Study|Over enrollment|2|||
94278575|NCT03246958|322811268|FG002|Overall Study|Over enrollment|0|||
94278576|NCT03246958|322811269|FG003|Overall Study|Over enrollment|0|||
94278577|NCT03246958|322811270|FG004|Overall Study|Over enrollment|0|||
94278578|NCT03246958|322811271|FG005|Overall Study|Over enrollment|0|||
94278579|NCT03246958|322811272|FG006|Overall Study|Over enrollment|0|||
94278580|NCT05630937|322811279|FG000|Overall Study|Study terminated by sponsor|1|||
94278581|NCT05630937|322811280|FG001|Overall Study|Study terminated by sponsor|1|||
94278582|NCT05630937|322811281|FG002|Overall Study|Study terminated by sponsor|8|||
94278583|NCT05630937|322811282|FG003|Overall Study|Study terminated by sponsor|0|||
94278584|NCT05630937|322811279|FG000|Overall Study|Lost to Follow-up|0|||
94278585|NCT05630937|322811280|FG001|Overall Study|Lost to Follow-up|0|||
94278586|NCT05630937|322811281|FG002|Overall Study|Lost to Follow-up|1|||
94278587|NCT05630937|322811282|FG003|Overall Study|Lost to Follow-up|0|||
94278588|NCT05630937|322811279|FG000|Overall Study|Enrolled but not treated|0|||
94278589|NCT05630937|322811280|FG001|Overall Study|Enrolled but not treated|0|||
94278590|NCT05630937|322811281|FG002|Overall Study|Enrolled but not treated|0|||
94278591|NCT05630937|322811282|FG003|Overall Study|Enrolled but not treated|1|||
94278592|NCT03965689|322811283|FG000|Overall Study|Too sick to get study intervention|2|||
94278593|NCT02728830|322811290|FG000|Overall Study|Exclusionary Surgery|9|||
94278594|NCT02728830|322811290|FG000|Overall Study|Exclusionary Pathology|6|||
94278595|NCT02728830|322811290|FG000|Overall Study|Physician Decision|3|||
94278596|NCT02728830|322811290|FG000|Overall Study|Withdrawal by Subject|2|||
94278597|NCT02728830|322811290|FG000|Overall Study|Lost to Follow-up|1|||
94278598|NCT02728830|322811290|FG000|Overall Study|Exclusionary Lab Values|1|||
94278599|NCT02728830|322811290|FG000|Overall Study|Contraindicated Illness|1|||
94278600|NCT02728830|322811290|FG000|Overall Study|Language Barrier|1|||
94278601|NCT01087905|322811293|FG000|Overall Study|Lost to Follow-up|24|||
94278602|NCT01087905|322811294|FG001|Overall Study|Lost to Follow-up|28|||
94278603|NCT01087905|322811295|FG002|Overall Study|Lost to Follow-up|18|||
94278604|NCT01087905|322811296|FG003|Overall Study|Lost to Follow-up|31|||
94278605|NCT01087905|322811297|FG004|Overall Study|Lost to Follow-up|27|||
94278606|NCT01087905|322811298|FG005|Overall Study|Lost to Follow-up|25|||
94278607|NCT01087905|322811299|FG006|Overall Study|Lost to Follow-up|20|||
94278608|NCT01087905|322811300|FG007|Overall Study|Lost to Follow-up|24|||
94278609|NCT01087905|322811293|FG000|Overall Study|Withdrawal by Subject|5|||
94278610|NCT01087905|322811294|FG001|Overall Study|Withdrawal by Subject|4|||
94278611|NCT01087905|322811295|FG002|Overall Study|Withdrawal by Subject|4|||
94278612|NCT01087905|322811296|FG003|Overall Study|Withdrawal by Subject|5|||
94278613|NCT01087905|322811297|FG004|Overall Study|Withdrawal by Subject|4|||
94278614|NCT01087905|322811298|FG005|Overall Study|Withdrawal by Subject|3|||
94278615|NCT01087905|322811299|FG006|Overall Study|Withdrawal by Subject|3|||
94278616|NCT01087905|322811300|FG007|Overall Study|Withdrawal by Subject|5|||
94278617|NCT02199080|322811305|FG000|Overall Study|Protocol Violation|12|||
94278618|NCT02228590|322811307|FG000|Overall Study|Withdrawal by Subject|1|||
94278619|NCT03215771|322811308|FG000|Overall Study|Withdrawal by Subject|2|||
94278620|NCT03215771|322811308|FG000|Overall Study|Physician Decision|1|||
94278621|NCT03127384|322811309|FG000|Overall Study|Lost to Follow-up|4|||
94278622|NCT03127384|322811309|FG000|Overall Study|Subject request|2|||
94278623|NCT04703075|322811317|FG000|Overall Study|Adverse Event|11|||
94278624|NCT04703075|322811318|FG001|Overall Study|Adverse Event|7|||
94278625|NCT04703075|322811317|FG000|Overall Study|Lost to Follow-up|6|||
94278626|NCT04703075|322811318|FG001|Overall Study|Lost to Follow-up|12|||
94278627|NCT04703075|322811317|FG000|Overall Study|Physician Decision|3|||
94278628|NCT04703075|322811318|FG001|Overall Study|Physician Decision|0|||
94278629|NCT04703075|322811317|FG000|Overall Study|Moved|0|||
94278630|NCT04703075|322811318|FG001|Overall Study|Moved|2|||
94278631|NCT04703075|322811317|FG000|Overall Study|Index INH Resistant|0|||
94278632|NCT04703075|322811318|FG001|Overall Study|Index INH Resistant|1|||
94278633|NCT04703075|322811317|FG000|Overall Study|Lack of Efficacy|6|||
94370468|NCT04380701|323142905|FG029|Overall Study|Death|0|||
94278634|NCT04703075|322811318|FG001|Overall Study|Lack of Efficacy|18|||
94278635|NCT03499028|322811319|FG000|Overall Study|Lost to Follow-up|12|||
94278636|NCT03499028|322811320|FG001|Overall Study|Lost to Follow-up|9|||
94278637|NCT03499028|322811319|FG000|Overall Study|Withdrawal by Subject|5|||
94370469|NCT04380701|323142906|FG030|Overall Study|Death|0|||
94278638|NCT03499028|322811320|FG001|Overall Study|Withdrawal by Subject|8|||
94278639|NCT03499028|322811319|FG000|Overall Study|Unplanned SNF discharge|5|||
94278640|NCT03499028|322811320|FG001|Overall Study|Unplanned SNF discharge|8|||
94278641|NCT03885089|322811323|FG000|Overall Study|No informed consent for publication of study results|2|||
94278642|NCT04489888|322811324|FG000|Overall Study|Death|75|||
94278643|NCT04489888|322811324|FG000|Overall Study|Sponsor Decision|26|||
94278644|NCT04042103|322811327|FG000|Overall Study|Lost to Follow-up|1|||
94278645|NCT04042103|322811327|FG000|Overall Study|Withdrawal by Subject|1|||
94278646|NCT04994509|322811328|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
94278647|NCT04994509|322811329|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
94278648|NCT04994509|322811330|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
94278649|NCT04994509|322811328|FG000|Overall Study|Withdrew Consent|73|||
94278650|NCT04994509|322811329|FG001|Overall Study|Withdrew Consent|72|||
94278651|NCT04994509|322811330|FG002|Overall Study|Withdrew Consent|46|||
94278652|NCT04994509|322811328|FG000|Overall Study|Lost to Follow-up|39|||
94278653|NCT04994509|322811329|FG001|Overall Study|Lost to Follow-up|36|||
94278654|NCT04994509|322811330|FG002|Overall Study|Lost to Follow-up|26|||
94278655|NCT04994509|322811328|FG000|Overall Study|HIV-1 Infection|4|||
94278656|NCT04994509|322811329|FG001|Overall Study|HIV-1 Infection|20|||
94278657|NCT04994509|322811330|FG002|Overall Study|HIV-1 Infection|12|||
94278658|NCT04994509|322811328|FG000|Overall Study|Investigator's Discretion|9|||
94278659|NCT04994509|322811329|FG001|Overall Study|Investigator's Discretion|8|||
94278660|NCT04994509|322811330|FG002|Overall Study|Investigator's Discretion|11|||
94278661|NCT04994509|322811328|FG000|Overall Study|Randomized but Never Treated|10|||
94278662|NCT04994509|322811329|FG001|Overall Study|Randomized but Never Treated|10|||
94278663|NCT04994509|322811330|FG002|Overall Study|Randomized but Never Treated|3|||
94278664|NCT04994509|322811328|FG000|Overall Study|Pregnancy|5|||
94278665|NCT04994509|322811329|FG001|Overall Study|Pregnancy|5|||
94278666|NCT04994509|322811330|FG002|Overall Study|Pregnancy|0|||
94278667|NCT04994509|322811328|FG000|Overall Study|Death|0|||
94278668|NCT04994509|322811329|FG001|Overall Study|Death|5|||
94742838|NCT02719574|324515395|FG015|Phase 1 (Dose Escalation)|Death|0|||
94742839|NCT02719574|324515396|FG016|Phase 1 (Dose Escalation)|Death|0|||
94742840|NCT02719574|324515380|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
94742841|NCT02719574|324515381|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
94742842|NCT02719574|324515382|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
94742843|NCT02719574|324515383|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
94742844|NCT02719574|324515384|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
94742845|NCT02719574|324515385|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
94742846|NCT02719574|324515386|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
94742847|NCT02719574|324515387|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
94742848|NCT02719574|324515388|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
94742849|NCT02719574|324515389|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
94742850|NCT02719574|324515390|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
94742851|NCT02719574|324515391|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
94742852|NCT02719574|324515392|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
94742853|NCT02719574|324515393|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
94742854|NCT02719574|324515394|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
94742855|NCT02719574|324515395|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
94742856|NCT02719574|324515396|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
94742857|NCT02719574|324515380|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
94742858|NCT02719574|324515381|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
94742859|NCT02719574|324515382|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
94742860|NCT02719574|324515383|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
94742861|NCT02719574|324515384|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
94742862|NCT02719574|324515385|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
94742863|NCT02719574|324515386|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
94742864|NCT02719574|324515387|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
94742865|NCT02719574|324515388|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
94742866|NCT02719574|324515389|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
94742867|NCT02719574|324515390|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
94742868|NCT02719574|324515391|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
94742869|NCT02719574|324515392|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
94742870|NCT02719574|324515393|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
94742871|NCT02719574|324515394|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
94742872|NCT02719574|324515395|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
94742873|NCT02719574|324515396|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
94742874|NCT02719574|324515380|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94742875|NCT02719574|324515381|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94742876|NCT02719574|324515382|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
94742877|NCT02719574|324515383|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94742878|NCT02719574|324515384|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94742879|NCT02719574|324515385|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94742880|NCT02719574|324515386|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94742881|NCT02719574|324515387|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94742882|NCT02719574|324515388|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94742883|NCT02719574|324515389|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94742884|NCT02719574|324515390|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94278669|NCT04994509|322811330|FG002|Overall Study|Death|0|||
94278670|NCT04994509|322811328|FG000|Overall Study|Adverse Event|2|||
94278671|NCT04994509|322811329|FG001|Overall Study|Adverse Event|1|||
94278672|NCT04994509|322811330|FG002|Overall Study|Adverse Event|0|||
94278673|NCT04994509|322811328|FG000|Overall Study|Non-compliance With Study Drug|1|||
94742885|NCT02719574|324515391|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94742886|NCT02719574|324515392|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94202574|NCT03656718|322538507|FG003|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
94202575|NCT03656718|322538508|FG004|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
94202576|NCT03656718|322538509|FG005|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
94202577|NCT03656718|322538510|FG006|Treatment Period Parts A, B, D, and E|Continuing study treatment|14|||
94202578|NCT03656718|322538504|FG000|Treatment Period Part C|Disease progression|0|||
94202579|NCT03656718|322538505|FG001|Treatment Period Part C|Disease progression|0|||
94202580|NCT03656718|322538506|FG002|Treatment Period Part C|Disease progression|0|||
94370470|NCT04380701|323142907|FG031|Overall Study|Death|0|||
94202581|NCT03656718|322538507|FG003|Treatment Period Part C|Disease progression|0|||
94202582|NCT03656718|322538508|FG004|Treatment Period Part C|Disease progression|12|||
94202583|NCT03656718|322538509|FG005|Treatment Period Part C|Disease progression|0|||
94202584|NCT03656718|322538510|FG006|Treatment Period Part C|Disease progression|0|||
94202585|NCT03656718|322538504|FG000|Treatment Period Part C|Death|0|||
94202586|NCT03656718|322538505|FG001|Treatment Period Part C|Death|0|||
94202587|NCT03656718|322538506|FG002|Treatment Period Part C|Death|0|||
94202588|NCT03656718|322538507|FG003|Treatment Period Part C|Death|0|||
94202589|NCT03656718|322538508|FG004|Treatment Period Part C|Death|1|||
94202590|NCT03656718|322538509|FG005|Treatment Period Part C|Death|0|||
94202591|NCT03656718|322538510|FG006|Treatment Period Part C|Death|0|||
94202592|NCT03656718|322538504|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
94202593|NCT03656718|322538505|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
94202594|NCT03656718|322538506|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
94202595|NCT03656718|322538507|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
94202596|NCT03656718|322538508|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
94202597|NCT03656718|322538509|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
94202598|NCT03656718|322538510|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
94202599|NCT03656718|322538504|FG000|Treatment Period Part C|Other reasons|0|||
94202600|NCT03656718|322538505|FG001|Treatment Period Part C|Other reasons|0|||
94202601|NCT03656718|322538506|FG002|Treatment Period Part C|Other reasons|0|||
94202602|NCT03656718|322538507|FG003|Treatment Period Part C|Other reasons|0|||
94202603|NCT03656718|322538508|FG004|Treatment Period Part C|Other reasons|1|||
94202604|NCT03656718|322538509|FG005|Treatment Period Part C|Other reasons|0|||
94202605|NCT03656718|322538510|FG006|Treatment Period Part C|Other reasons|0|||
94202606|NCT03656718|322538504|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
94202607|NCT03656718|322538505|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
94202608|NCT03656718|322538506|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
94202609|NCT03656718|322538507|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
94202610|NCT03656718|322538508|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
94202611|NCT03656718|322538509|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
94202612|NCT03656718|322538510|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
94202613|NCT02039401|322538511|FG000|Overall Study|Adverse Event|0|||
94202614|NCT02039401|322538512|FG001|Overall Study|Adverse Event|1|||
94202615|NCT03777657|322538513|FG000|Overall Study|Death|397|||
94202616|NCT03777657|322538514|FG001|Overall Study|Death|431|||
94202617|NCT03777657|322538513|FG000|Overall Study|Study Closed by Sponsor|77|||
94202618|NCT03777657|322538514|FG001|Overall Study|Study Closed by Sponsor|38|||
94202619|NCT03777657|322538513|FG000|Overall Study|Withdrawal by Subject|20|||
94202620|NCT03777657|322538514|FG001|Overall Study|Withdrawal by Subject|17|||
94202621|NCT03777657|322538513|FG000|Overall Study|Lost to Follow-up|6|||
94202622|NCT03777657|322538514|FG001|Overall Study|Lost to Follow-up|10|||
94202623|NCT05795153|322539063|FG000|Overall Study|Adverse Event|2|||
94202624|NCT05795153|322539063|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
94202625|NCT05795153|322539063|FG000|Overall Study|Lost to Follow-up|1|||
94202626|NCT05795153|322539063|FG000|Overall Study|Subject decision|2|||
94202627|NCT05039021|322539064|FG000|Overall Study|Death|1|||
94202628|NCT05039021|322539064|FG000|Overall Study|Lost to Follow-up|3|||
94202629|NCT02566889|322539069|FG000|Overall Study|Withdrawal by Subject|3|||
94202630|NCT02566889|322539070|FG001|Overall Study|Withdrawal by Subject|1|||
94202631|NCT02566889|322539069|FG000|Overall Study|Adverse Event|4|||
94202632|NCT02566889|322539070|FG001|Overall Study|Adverse Event|2|||
94202633|NCT02566889|322539069|FG000|Overall Study|Other|6|||
94202634|NCT02566889|322539070|FG001|Overall Study|Other|2|||
94202635|NCT00739908|322539072|FG000|Overall Study|Adverse Event|5|||
94202636|NCT00739908|322539073|FG001|Overall Study|Adverse Event|6|||
94202637|NCT00739908|322539072|FG000|Overall Study|Withdrawal by Subject|4|||
94202638|NCT00739908|322539073|FG001|Overall Study|Withdrawal by Subject|2|||
94202639|NCT00739908|322539072|FG000|Overall Study|Lost to Follow-up|14|||
94202640|NCT00739908|322539073|FG001|Overall Study|Lost to Follow-up|9|||
94202641|NCT00739908|322539072|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
94202642|NCT00739908|322539073|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
94202643|NCT00739908|322539072|FG000|Overall Study|Non-Compliance With Study Medication|0|||
94202644|NCT00739908|322539073|FG001|Overall Study|Non-Compliance With Study Medication|3|||
94370471|NCT04380701|323142908|FG032|Overall Study|Death|0|||
94278674|NCT04994509|322811329|FG001|Overall Study|Non-compliance With Study Drug|1|||
94278675|NCT04994509|322811330|FG002|Overall Study|Non-compliance With Study Drug|1|||
94278676|NCT04994509|322811328|FG000|Overall Study|Withdrew Assent|3|||
94278677|NCT04994509|322811329|FG001|Overall Study|Withdrew Assent|0|||
94278678|NCT04994509|322811330|FG002|Overall Study|Withdrew Assent|0|||
94278679|NCT04994509|322811328|FG000|Overall Study|Protocol Violation|1|||
94278680|NCT04994509|322811329|FG001|Overall Study|Protocol Violation|0|||
94278681|NCT04994509|322811330|FG002|Overall Study|Protocol Violation|0|||
94278682|NCT03578367|322811331|FG000|Overall Study|Adverse Event|0|||
94742887|NCT02719574|324515393|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94742888|NCT02719574|324515394|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94742889|NCT02719574|324515395|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94742890|NCT02719574|324515396|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94742891|NCT02719574|324515380|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
94742892|NCT02719574|324515381|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
94742893|NCT02719574|324515382|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
94742894|NCT02719574|324515383|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
94742895|NCT02719574|324515384|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
94742896|NCT02719574|324515385|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
94742897|NCT02719574|324515386|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
94742898|NCT02719574|324515387|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
94742899|NCT02719574|324515388|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
94742900|NCT02719574|324515389|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
94742901|NCT02719574|324515390|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
94742902|NCT02719574|324515391|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
94742903|NCT02719574|324515392|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
94742904|NCT02719574|324515393|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
94742905|NCT02719574|324515394|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
94742906|NCT02719574|324515395|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
94742907|NCT02719574|324515396|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
94742908|NCT02719574|324515380|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
94742909|NCT02719574|324515381|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
94742910|NCT02719574|324515382|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
94742911|NCT02719574|324515383|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
94742912|NCT02719574|324515384|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
94742913|NCT02719574|324515385|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
94742914|NCT02719574|324515386|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
94742915|NCT02719574|324515387|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
94742916|NCT02719574|324515388|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
94742917|NCT02719574|324515389|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
94742918|NCT02719574|324515390|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
94742919|NCT02719574|324515391|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
94742920|NCT02719574|324515392|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
94742921|NCT02719574|324515393|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
94742922|NCT02719574|324515394|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
94742923|NCT02719574|324515395|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
94742924|NCT02719574|324515396|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
94742925|NCT02719574|324515380|FG000|Phase 1 (Dose Expansion)|Death|0|||
94742926|NCT02719574|324515381|FG001|Phase 1 (Dose Expansion)|Death|0|||
94742927|NCT02719574|324515382|FG002|Phase 1 (Dose Expansion)|Death|0|||
94742928|NCT02719574|324515383|FG003|Phase 1 (Dose Expansion)|Death|0|||
94742929|NCT02719574|324515384|FG004|Phase 1 (Dose Expansion)|Death|0|||
94742930|NCT02719574|324515385|FG005|Phase 1 (Dose Expansion)|Death|0|||
94742931|NCT02719574|324515386|FG006|Phase 1 (Dose Expansion)|Death|1|||
94742932|NCT02719574|324515387|FG007|Phase 1 (Dose Expansion)|Death|6|||
94742933|NCT02719574|324515388|FG008|Phase 1 (Dose Expansion)|Death|0|||
94742934|NCT02719574|324515389|FG009|Phase 1 (Dose Expansion)|Death|0|||
94742935|NCT02719574|324515390|FG010|Phase 1 (Dose Expansion)|Death|0|||
94742936|NCT02719574|324515391|FG011|Phase 1 (Dose Expansion)|Death|0|||
94742937|NCT02719574|324515392|FG012|Phase 1 (Dose Expansion)|Death|0|||
94742938|NCT02719574|324515393|FG013|Phase 1 (Dose Expansion)|Death|0|||
94742939|NCT02719574|324515394|FG014|Phase 1 (Dose Expansion)|Death|0|||
94742940|NCT02719574|324515395|FG015|Phase 1 (Dose Expansion)|Death|0|||
94742941|NCT02719574|324515396|FG016|Phase 1 (Dose Expansion)|Death|0|||
94742942|NCT02719574|324515380|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
94742943|NCT02719574|324515381|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
94742944|NCT02719574|324515382|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
94742945|NCT02719574|324515383|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
94742946|NCT02719574|324515384|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
94742947|NCT02719574|324515385|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
94278683|NCT03578367|322811332|FG001|Overall Study|Adverse Event|3|||
94278684|NCT03578367|322811333|FG002|Overall Study|Adverse Event|0|||
94742948|NCT02719574|324515386|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
94742949|NCT02719574|324515387|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
94742950|NCT02719574|324515388|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
94202645|NCT00739908|322539072|FG000|Overall Study|Lack of Efficacy|0|||
94202646|NCT00739908|322539073|FG001|Overall Study|Lack of Efficacy|1|||
94202647|NCT00739908|322539072|FG000|Overall Study|Relocation|0|||
94202648|NCT00739908|322539073|FG001|Overall Study|Relocation|1|||
94202649|NCT00439270|322539075|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
94202650|NCT00439270|322539076|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
94202651|NCT00439270|322539077|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
94202652|NCT00439270|322539078|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
94202653|NCT00439270|322539079|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
94202654|NCT00439270|322539075|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
94202655|NCT00439270|322539076|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
94202656|NCT00439270|322539077|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
94202657|NCT00439270|322539078|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
94202658|NCT00439270|322539079|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
94202659|NCT00439270|322539075|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
94202660|NCT00439270|322539076|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
94202661|NCT00439270|322539077|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
94202662|NCT00439270|322539078|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
94202663|NCT00439270|322539079|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
94202664|NCT00439270|322539075|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
94202665|NCT00439270|322539076|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
94202666|NCT00439270|322539077|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
94202667|NCT00439270|322539078|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
94202668|NCT00439270|322539079|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
94202669|NCT00439270|322539075|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
94202670|NCT00439270|322539076|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
94202671|NCT00439270|322539077|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
94202672|NCT00439270|322539078|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
94202673|NCT00439270|322539079|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
94202674|NCT00439270|322539075|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
94202675|NCT00439270|322539076|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
94202676|NCT00439270|322539077|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
94202677|NCT00439270|322539078|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
94202678|NCT00439270|322539079|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
94202679|NCT00439270|322539075|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
94202680|NCT00439270|322539076|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
94202681|NCT00439270|322539077|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
94202682|NCT00439270|322539078|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
94202683|NCT00439270|322539079|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
94202684|NCT00439270|322539075|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
94202685|NCT00439270|322539076|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
94202686|NCT00439270|322539077|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
94202687|NCT00439270|322539078|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
94202688|NCT00439270|322539079|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
94202689|NCT00439270|322539075|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
94202690|NCT00439270|322539076|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
94202691|NCT00439270|322539077|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
94202692|NCT00439270|322539078|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
94202693|NCT00439270|322539079|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
94202694|NCT00439270|322539075|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
94202695|NCT00439270|322539076|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
94202696|NCT00439270|322539077|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
94202697|NCT00439270|322539078|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
94202698|NCT00439270|322539079|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
94202699|NCT04018495|322539090|FG000|Overall Study|Physician Decision|1|||
94202700|NCT04908514|322539093|FG000|Overall Study|Lost to Follow-up|2|||
94202701|NCT04908514|322539093|FG000|Overall Study|Withdrawal by Subject|1|||
94202702|NCT00319696|322539094|FG000|Overall Study|Adverse Event|36|||
94202703|NCT00319696|322539094|FG000|Overall Study|withdrawal of consent|14|||
94202704|NCT00319696|322539094|FG000|Overall Study|administrative|7|||
94202705|NCT00319696|322539094|FG000|Overall Study|Lost to Follow-up|3|||
94202706|NCT03593226|322539112|FG000|Overall Study|Disease progression|6|||
94202707|NCT03593226|322539113|FG001|Overall Study|Disease progression|13|||
94202708|NCT03593226|322539114|FG002|Overall Study|Disease progression|5|||
94202709|NCT03593226|322539115|FG003|Overall Study|Disease progression|6|||
94202710|NCT03593226|322539112|FG000|Overall Study|Adverse Event|0|||
94202711|NCT03593226|322539113|FG001|Overall Study|Adverse Event|1|||
94202712|NCT03593226|322539114|FG002|Overall Study|Adverse Event|0|||
94278685|NCT03578367|322811334|FG003|Overall Study|Adverse Event|5|||
94278686|NCT03578367|322811331|FG000|Overall Study|Withdrawal by Subject|2|||
94278687|NCT03578367|322811332|FG001|Overall Study|Withdrawal by Subject|2|||
94278688|NCT03578367|322811333|FG002|Overall Study|Withdrawal by Subject|1|||
94202713|NCT03593226|322539115|FG003|Overall Study|Adverse Event|0|||
94202714|NCT03593226|322539112|FG000|Overall Study|Withdrawal by Subject|0|||
94202715|NCT03593226|322539113|FG001|Overall Study|Withdrawal by Subject|4|||
94202716|NCT03593226|322539114|FG002|Overall Study|Withdrawal by Subject|1|||
94202717|NCT03593226|322539115|FG003|Overall Study|Withdrawal by Subject|0|||
94202718|NCT03593226|322539112|FG000|Overall Study|Physician Decision|0|||
94202719|NCT03593226|322539113|FG001|Overall Study|Physician Decision|1|||
94202720|NCT03593226|322539114|FG002|Overall Study|Physician Decision|0|||
94202721|NCT03593226|322539115|FG003|Overall Study|Physician Decision|0|||
94202722|NCT03593226|322539112|FG000|Overall Study|Clinical disease progression|0|||
94202723|NCT03593226|322539113|FG001|Overall Study|Clinical disease progression|0|||
94202724|NCT03593226|322539114|FG002|Overall Study|Clinical disease progression|1|||
94202725|NCT03593226|322539115|FG003|Overall Study|Clinical disease progression|0|||
94202726|NCT01038778|322539116|FG000|Overall Study|Withdrawal by Subject|0|||
94202727|NCT01038778|322539117|FG001|Overall Study|Withdrawal by Subject|2|||
94202728|NCT01038778|322539118|FG002|Overall Study|Withdrawal by Subject|3|||
94202729|NCT06191679|322539119|FG000|Baseline|Lost to Follow-up|1|||
94202730|NCT06191679|322539120|FG001|Baseline|Lost to Follow-up|0|||
94202731|NCT06191679|322539121|FG002|Baseline|Lost to Follow-up|1|||
94202732|NCT06191679|322539122|FG003|Baseline|Lost to Follow-up|0|||
94202733|NCT06191679|322539119|FG000|Allocation to Group|Withdrawal by Subject|0|||
94202734|NCT06191679|322539120|FG001|Allocation to Group|Withdrawal by Subject|1|||
94202735|NCT06191679|322539121|FG002|Allocation to Group|Withdrawal by Subject|2|||
94202736|NCT06191679|322539122|FG003|Allocation to Group|Withdrawal by Subject|0|||
94202737|NCT06191679|322539119|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
94202738|NCT06191679|322539120|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
94202739|NCT06191679|322539121|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
94202740|NCT06191679|322539122|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
94202741|NCT06191679|322539119|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
94202742|NCT06191679|322539120|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
94202743|NCT06191679|322539121|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
94202744|NCT06191679|322539122|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
94202745|NCT06191679|322539119|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
94202746|NCT06191679|322539120|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
94202747|NCT06191679|322539121|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
94202748|NCT06191679|322539122|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
94202749|NCT00545545|322539123|FG000|Overall Study|Progressive Neoplastic Disease|1|||
94202750|NCT00545545|322539124|FG001|Overall Study|Progressive Neoplastic Disease|5|||
94202751|NCT00545545|322539125|FG002|Overall Study|Progressive Neoplastic Disease|0|||
94202752|NCT00545545|322539126|FG003|Overall Study|Progressive Neoplastic Disease|4|||
94202753|NCT00545545|322539127|FG004|Overall Study|Progressive Neoplastic Disease|8|||
94202754|NCT00545545|322539128|FG005|Overall Study|Progressive Neoplastic Disease|7|||
94202755|NCT00545545|322539123|FG000|Overall Study|Withdrawal by Subject|0|||
94202756|NCT00545545|322539124|FG001|Overall Study|Withdrawal by Subject|1|||
94202757|NCT00545545|322539125|FG002|Overall Study|Withdrawal by Subject|0|||
94202758|NCT00545545|322539126|FG003|Overall Study|Withdrawal by Subject|0|||
94202759|NCT00545545|322539127|FG004|Overall Study|Withdrawal by Subject|0|||
94202760|NCT00545545|322539128|FG005|Overall Study|Withdrawal by Subject|0|||
94202761|NCT00545545|322539123|FG000|Overall Study|Physician Decision|1|||
94202762|NCT00545545|322539124|FG001|Overall Study|Physician Decision|0|||
94202763|NCT00545545|322539125|FG002|Overall Study|Physician Decision|0|||
94202764|NCT00545545|322539126|FG003|Overall Study|Physician Decision|0|||
94742951|NCT02719574|324515389|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
94742952|NCT02719574|324515390|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
94742953|NCT02719574|324515391|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
94742954|NCT02719574|324515392|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
94742955|NCT02719574|324515393|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
94742956|NCT02719574|324515394|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
94742957|NCT02719574|324515395|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
94742958|NCT02719574|324515396|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
94742959|NCT02719574|324515380|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
94742960|NCT02719574|324515381|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
94742961|NCT02719574|324515382|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
94742962|NCT02719574|324515383|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
94742963|NCT02719574|324515384|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
94742964|NCT02719574|324515385|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
94742965|NCT02719574|324515386|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
94742966|NCT02719574|324515387|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
94742967|NCT02719574|324515388|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
94202765|NCT00545545|322539127|FG004|Overall Study|Physician Decision|0|||
94202766|NCT00545545|322539128|FG005|Overall Study|Physician Decision|1|||
94202767|NCT00545545|322539123|FG000|Overall Study|Irinotecan intolerance|1|||
94202768|NCT00545545|322539124|FG001|Overall Study|Irinotecan intolerance|1|||
94202769|NCT00545545|322539125|FG002|Overall Study|Irinotecan intolerance|0|||
94202770|NCT00545545|322539126|FG003|Overall Study|Irinotecan intolerance|0|||
94202771|NCT00545545|322539127|FG004|Overall Study|Irinotecan intolerance|0|||
94202772|NCT00545545|322539128|FG005|Overall Study|Irinotecan intolerance|0|||
94202773|NCT00545545|322539123|FG000|Overall Study|No target lesions to track post surgery|0|||
94202774|NCT00545545|322539124|FG001|Overall Study|No target lesions to track post surgery|0|||
94202775|NCT00545545|322539125|FG002|Overall Study|No target lesions to track post surgery|0|||
94202776|NCT00545545|322539126|FG003|Overall Study|No target lesions to track post surgery|0|||
94202777|NCT00545545|322539127|FG004|Overall Study|No target lesions to track post surgery|1|||
94202778|NCT00545545|322539128|FG005|Overall Study|No target lesions to track post surgery|1|||
94202779|NCT03997474|322539129|FG000|Overall Study|Death|6|||
94202780|NCT03997474|322539130|FG001|Overall Study|Death|2|||
94202781|NCT03997474|322539131|FG002|Overall Study|Death|1|||
94202782|NCT03997474|322539129|FG000|Overall Study|Physician Decision|2|||
94202783|NCT03997474|322539130|FG001|Overall Study|Physician Decision|0|||
94202784|NCT03997474|322539131|FG002|Overall Study|Physician Decision|0|||
94202785|NCT03997474|322539129|FG000|Overall Study|study terminated by sponsor|1|||
94202786|NCT03997474|322539130|FG001|Overall Study|study terminated by sponsor|0|||
94202787|NCT03997474|322539131|FG002|Overall Study|study terminated by sponsor|1|||
94202788|NCT00748709|322539138|FG000|Overall Study|Progressive disease|15|||
94202789|NCT00748709|322539138|FG000|Overall Study|Drug reducing Toxity|2|||
94202790|NCT00748709|322539138|FG000|Overall Study|Other Adverse Event|1|||
94202791|NCT00748709|322539138|FG000|Overall Study|Withdrawal by Subject|1|||
94202792|NCT00748709|322539138|FG000|Overall Study|Other Reasons|1|||
94202793|NCT06140290|322539139|FG000|Period 1|Adverse Event|1|||
94202794|NCT06140290|322539140|FG001|Period 1|Adverse Event|0|||
94202795|NCT06140290|322539139|FG000|Period 2|Assigned but not treated|0|||
94202796|NCT06140290|322539140|FG001|Period 2|Assigned but not treated|1|||
94202797|NCT06140290|322539139|FG000|Period 2|Withdrawal by Subject|0|||
94202798|NCT06140290|322539140|FG001|Period 2|Withdrawal by Subject|1|||
94202799|NCT04121741|322539466|FG000|Overall Study|Protocol Violation|1|||
94202800|NCT04121741|322539467|FG001|Overall Study|Protocol Violation|0|||
94202801|NCT04121741|322539468|FG002|Overall Study|Protocol Violation|0|||
94202802|NCT04121741|322539469|FG003|Overall Study|Protocol Violation|0|||
94202803|NCT04121741|322539470|FG004|Overall Study|Protocol Violation|0|||
94202804|NCT04121741|322539471|FG005|Overall Study|Protocol Violation|0|||
94202805|NCT04755595|322539472|FG000|Overall Study|Lost to Follow-up|1|||
94202806|NCT03477175|322539473|FG000|Overall Study|Unable to travel due to COVID-19|0|||
94202807|NCT03477175|322539474|FG001|Overall Study|Unable to travel due to COVID-19|1|||
94202808|NCT03477175|322539473|FG000|Overall Study|Physician Decision|1|||
94202809|NCT03477175|322539474|FG001|Overall Study|Physician Decision|0|||
94202810|NCT03477175|322539473|FG000|Overall Study|Transitioned to commercial drug|6|||
94202811|NCT03477175|322539474|FG001|Overall Study|Transitioned to commercial drug|6|||
94202812|NCT03477175|322539473|FG000|Overall Study|Lost to Follow-up|1|||
94202813|NCT03477175|322539474|FG001|Overall Study|Lost to Follow-up|1|||
94202814|NCT03477175|322539473|FG000|Overall Study|Withdrawal by Subject|3|||
94202815|NCT03477175|322539474|FG001|Overall Study|Withdrawal by Subject|1|||
94202816|NCT03477175|322539473|FG000|Overall Study|Adverse Event|1|||
94202817|NCT03477175|322539474|FG001|Overall Study|Adverse Event|5|||
94202818|NCT03477175|322539473|FG000|Overall Study|Disease Progression|7|||
94202819|NCT03477175|322539474|FG001|Overall Study|Disease Progression|7|||
94202820|NCT03524092|322539475|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
94202821|NCT03524092|322539476|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
94202822|NCT03524092|322539477|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
94202823|NCT03524092|322539478|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
94202824|NCT03524092|322539479|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
94202825|NCT03524092|322539480|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
94202826|NCT03524092|322539475|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
94202827|NCT03524092|322539476|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
94202828|NCT03524092|322539477|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
94202829|NCT03524092|322539478|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
94202830|NCT03524092|322539479|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
94202831|NCT03524092|322539480|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
94202832|NCT03524092|322539475|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
94202833|NCT03524092|322539476|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
94202834|NCT03524092|322539477|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
94202835|NCT03524092|322539478|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
94202836|NCT03524092|322539479|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
94202837|NCT03524092|322539480|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
94202838|NCT03524092|322539475|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
94278689|NCT03578367|322811334|FG003|Overall Study|Withdrawal by Subject|3|||
94278690|NCT03578367|322811331|FG000|Overall Study|Physician Decision|0|||
94278691|NCT03578367|322811332|FG001|Overall Study|Physician Decision|0|||
94202839|NCT03524092|322539476|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
94202840|NCT03524092|322539477|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
94202841|NCT03524092|322539478|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
94202842|NCT03524092|322539479|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
94202843|NCT03524092|322539480|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
94202844|NCT03524092|322539475|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
94202845|NCT03524092|322539476|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
94202846|NCT03524092|322539477|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
94202847|NCT03524092|322539478|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
94202848|NCT03524092|322539479|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
94202849|NCT03524092|322539480|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
94202850|NCT03524092|322539475|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
94202851|NCT03524092|322539476|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
94202852|NCT03524092|322539477|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
94202853|NCT03524092|322539478|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
94202854|NCT03524092|322539479|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
94202855|NCT03524092|322539480|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
94202856|NCT03524092|322539475|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
94202857|NCT03524092|322539476|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
94202858|NCT03524092|322539477|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
94202859|NCT03524092|322539478|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
94202860|NCT03524092|322539479|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
94202861|NCT03524092|322539480|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
94202862|NCT03524092|322539475|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
94202863|NCT03524092|322539476|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
94202864|NCT03524092|322539477|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
94278692|NCT03578367|322811333|FG002|Overall Study|Physician Decision|14|||
94278693|NCT03578367|322811334|FG003|Overall Study|Physician Decision|0|||
94278694|NCT03578367|322811331|FG000|Overall Study|Death|1|||
94278695|NCT03578367|322811332|FG001|Overall Study|Death|0|||
94278696|NCT03578367|322811333|FG002|Overall Study|Death|0|||
94278697|NCT03578367|322811334|FG003|Overall Study|Death|0|||
94278698|NCT03578367|322811331|FG000|Overall Study|Not treated|0|||
94278699|NCT03578367|322811332|FG001|Overall Study|Not treated|0|||
94278700|NCT03578367|322811333|FG002|Overall Study|Not treated|1|||
94278701|NCT03578367|322811334|FG003|Overall Study|Not treated|0|||
94278702|NCT02135692|322812762|FG000|Overall Study|Adverse Event|3|||
94278703|NCT02135692|322812762|FG000|Overall Study|Lack of Efficacy|2|||
94278704|NCT02135692|322812762|FG000|Overall Study|Protocol Violation|2|||
94278705|NCT02135692|322812762|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
94278706|NCT02135692|322812762|FG000|Overall Study|Product commercially available|159|||
94278707|NCT02135692|322812762|FG000|Overall Study|Study closed/terminated|153|||
94278708|NCT02135692|322812762|FG000|Overall Study|Lost to Follow-up|4|||
94278709|NCT02135692|322812762|FG000|Overall Study|Withdrawal by Subject|15|||
94278710|NCT01042600|322812763|FG000|Overall Study|Ineligible|1|||
94278711|NCT01042600|322812764|FG001|Overall Study|Ineligible|0|||
94278712|NCT01351389|322812767|FG000|Overall Study|Withdrawal by Subject|7|||
94278713|NCT01351389|322812768|FG001|Overall Study|Withdrawal by Subject|0|||
94278714|NCT01351389|322812767|FG000|Overall Study|did not complete intervention|23|||
94278715|NCT01351389|322812768|FG001|Overall Study|did not complete intervention|15|||
94278716|NCT04839978|322812769|FG000|Overall Study|Lost to Follow-up|135|||
94278717|NCT04839978|322812770|FG001|Overall Study|Lost to Follow-up|147|||
94278718|NCT03865706|322812771|FG000|Overall Study|Death|0|||
94278719|NCT03865706|322812772|FG001|Overall Study|Death|3|||
94278720|NCT03865706|322812773|FG002|Overall Study|Death|1|||
94370472|NCT04380701|323142909|FG033|Overall Study|Death|0|||
94370473|NCT04380701|323142876|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94202865|NCT03524092|322539478|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
94202866|NCT03524092|322539479|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
94202867|NCT03524092|322539480|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
94202868|NCT03524092|322539475|FG000|Loss of Response Rescue Period|Adverse Event|0|||
94202869|NCT03524092|322539476|FG001|Loss of Response Rescue Period|Adverse Event|0|||
94202870|NCT03524092|322539477|FG002|Loss of Response Rescue Period|Adverse Event|0|||
94278721|NCT00179309|322812774|FG000|Treatment|Toxicity|2|||
94278722|NCT00179309|322812775|FG001|Treatment|Toxicity|3|||
94278723|NCT00179309|322812774|FG000|Treatment|Withdrawal by Subject|1|||
94278724|NCT00179309|322812775|FG001|Treatment|Withdrawal by Subject|2|||
94370474|NCT04380701|323142877|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370475|NCT04380701|323142878|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94278725|NCT00179309|322812774|FG000|Treatment|Allergy|1|||
94278726|NCT00179309|322812775|FG001|Treatment|Allergy|0|||
94278727|NCT00769002|322812778|FG000|Overall Study|Study was not completed, no data|9|||
94278728|NCT00769002|322812779|FG001|Overall Study|Study was not completed, no data|9|||
94278729|NCT03548558|322812782|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
94278730|NCT03548558|322812783|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
94278731|NCT03548558|322812784|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
94278732|NCT03548558|322812785|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
94278733|NCT03548558|322812786|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
94278734|NCT03548558|322812787|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
94278735|NCT03548558|322812788|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
94278736|NCT03548558|322812782|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
94278737|NCT03548558|322812783|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
94278738|NCT03548558|322812784|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
94278739|NCT03548558|322812785|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
94278740|NCT03548558|322812786|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
94278741|NCT03548558|322812787|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
94278742|NCT03548558|322812788|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
94278743|NCT03548558|322812782|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
94278744|NCT03548558|322812783|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
94278745|NCT03548558|322812784|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
94278746|NCT03548558|322812785|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
94278747|NCT03548558|322812786|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
94278748|NCT03548558|322812787|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
94278749|NCT03548558|322812788|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
94278750|NCT03548558|322812782|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
94278751|NCT03548558|322812783|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
94278752|NCT03548558|322812784|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
94278753|NCT03548558|322812785|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
94278754|NCT03548558|322812786|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
94278755|NCT03548558|322812787|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
94278756|NCT03548558|322812788|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
94278757|NCT03548558|322812782|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
94278758|NCT03548558|322812783|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
94278759|NCT03548558|322812784|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
94278760|NCT03548558|322812785|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
94278761|NCT03548558|322812786|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
94278762|NCT03548558|322812787|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
94278763|NCT03548558|322812788|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
94278764|NCT03548558|322812782|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
94278765|NCT03548558|322812783|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
94278766|NCT03548558|322812784|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
94278767|NCT03548558|322812785|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
94278768|NCT03548558|322812786|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
94278769|NCT03548558|322812787|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
94278770|NCT03548558|322812788|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
94278771|NCT02412787|322812789|FG000|Overall Study|Withdrawal by Subject|9|||
94278772|NCT02412787|322812789|FG000|Overall Study|Participation Terminated by Investigator|1|||
94278773|NCT02412787|322812789|FG000|Overall Study|Site Terminated by Sponsor|21|||
94278774|NCT02412787|322812789|FG000|Overall Study|Technical Problems|1|||
94278775|NCT02412787|322812789|FG000|Overall Study|Reason Not Specified|1|||
94278776|NCT01780831|322812796|FG000|Overall Study|Withdrawal by Subject|0|||
94278777|NCT01780831|322812797|FG001|Overall Study|Withdrawal by Subject|0|||
94278778|NCT01780831|322812798|FG002|Overall Study|Withdrawal by Subject|4|||
94278779|NCT01780831|322812799|FG003|Overall Study|Withdrawal by Subject|0|||
94278780|NCT01780831|322812796|FG000|Overall Study|Lost to Follow-up|0|||
94278781|NCT01780831|322812797|FG001|Overall Study|Lost to Follow-up|0|||
94278782|NCT01780831|322812798|FG002|Overall Study|Lost to Follow-up|0|||
94278783|NCT01780831|322812799|FG003|Overall Study|Lost to Follow-up|1|||
94742968|NCT02719574|324515389|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
94742969|NCT02719574|324515390|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
94742970|NCT02719574|324515391|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
94742971|NCT02719574|324515392|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
94742972|NCT02719574|324515393|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
94742973|NCT02719574|324515394|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
94742974|NCT02719574|324515395|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
94742975|NCT02719574|324515396|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
94278784|NCT02706873|322812800|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
94278785|NCT02706873|322812801|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
94278786|NCT02706873|322812802|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
94278787|NCT02706873|322812803|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
94370476|NCT04380701|323142879|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370477|NCT04380701|323142880|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370478|NCT04380701|323142881|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370479|NCT04380701|323142882|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370480|NCT04380701|323142883|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370481|NCT04380701|323142884|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370482|NCT04380701|323142885|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370483|NCT04380701|323142886|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370484|NCT04380701|323142887|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370485|NCT04380701|323142888|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370486|NCT04380701|323142889|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370487|NCT04380701|323142890|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370488|NCT04380701|323142891|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370489|NCT04380701|323142892|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370490|NCT04380701|323142893|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370491|NCT04380701|323142894|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370492|NCT04380701|323142895|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370493|NCT04380701|323142896|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370494|NCT04380701|323142897|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
94370495|NCT04380701|323142898|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
94370496|NCT04380701|323142899|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
94370497|NCT04380701|323142900|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
94370498|NCT04380701|323142901|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370499|NCT04380701|323142902|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370500|NCT04380701|323142903|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370501|NCT04380701|323142904|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370502|NCT04380701|323142905|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370503|NCT04380701|323142906|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370504|NCT04380701|323142907|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370505|NCT04380701|323142908|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370506|NCT04380701|323142909|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
94370507|NCT03550794|323142910|FG000|Overall Study|No longer met inclusion criteria|1|||
94370508|NCT03550794|323142911|FG001|Overall Study|No longer met inclusion criteria|2|||
94370509|NCT03550794|323142910|FG000|Overall Study|Goals of care changed|1|||
94370510|NCT03550794|323142911|FG001|Overall Study|Goals of care changed|0|||
94370511|NCT03550794|323142910|FG000|Overall Study|Withdrawal by Subject|2|||
94370512|NCT03550794|323142911|FG001|Overall Study|Withdrawal by Subject|0|||
94370513|NCT03550794|323142910|FG000|Overall Study|Death|0|||
94370514|NCT03550794|323142911|FG001|Overall Study|Death|1|||
94370515|NCT01890785|323142912|FG000|Third Intervention|Withdrawal by Subject|0|||
94742976|NCT02719574|324515380|FG000|Phase 1 (Dose Expansion)|Other|0|||
94742977|NCT02719574|324515381|FG001|Phase 1 (Dose Expansion)|Other|0|||
94278788|NCT02706873|322812800|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
94278789|NCT02706873|322812801|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
94278790|NCT02706873|322812802|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
94278791|NCT02706873|322812803|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
94278792|NCT02706873|322812800|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
94278793|NCT02706873|322812801|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
94278794|NCT02706873|322812802|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
94278795|NCT02706873|322812803|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
94278796|NCT02706873|322812800|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
94278797|NCT02706873|322812801|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
94278798|NCT02706873|322812802|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
94278799|NCT02706873|322812803|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
94278800|NCT02706873|322812800|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
94278801|NCT02706873|322812801|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
94278802|NCT02706873|322812802|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
94278803|NCT02706873|322812803|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
94278804|NCT02706873|322812800|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
94278805|NCT02706873|322812801|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
94278806|NCT02706873|322812802|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
94370516|NCT01890785|323142913|FG001|Third Intervention|Withdrawal by Subject|1|||
94370517|NCT01890785|323142914|FG002|Third Intervention|Withdrawal by Subject|0|||
94742978|NCT02719574|324515382|FG002|Phase 1 (Dose Expansion)|Other|0|||
94742979|NCT02719574|324515383|FG003|Phase 1 (Dose Expansion)|Other|0|||
94278807|NCT02706873|322812803|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
94278808|NCT02706873|322812800|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
94278809|NCT02706873|322812801|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
94202871|NCT03524092|322539478|FG003|Loss of Response Rescue Period|Adverse Event|2|||
94202872|NCT03524092|322539479|FG004|Loss of Response Rescue Period|Adverse Event|0|||
94202873|NCT03524092|322539480|FG005|Loss of Response Rescue Period|Adverse Event|0|||
94202874|NCT03524092|322539475|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
94202875|NCT03524092|322539476|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
94202876|NCT03524092|322539477|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
94202877|NCT03524092|322539478|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
94202878|NCT03524092|322539479|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
94202879|NCT03524092|322539480|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
94278810|NCT02706873|322812802|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
94278811|NCT02706873|322812803|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
94278812|NCT02706873|322812800|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
94278813|NCT02706873|322812801|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
94278814|NCT02706873|322812802|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
94278815|NCT02706873|322812803|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
94278816|NCT02706873|322812800|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
94278817|NCT02706873|322812801|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
94278818|NCT02706873|322812802|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
94278819|NCT02706873|322812803|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
94278820|NCT02706873|322812800|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
94278821|NCT02706873|322812801|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
94278822|NCT02706873|322812802|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
94278823|NCT02706873|322812803|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
94278824|NCT02706873|322812800|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
94278825|NCT02706873|322812801|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
94278826|NCT02706873|322812802|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
94370518|NCT01890785|323142915|FG003|Third Intervention|Withdrawal by Subject|0|||
94370519|NCT01890785|323142916|FG004|Third Intervention|Withdrawal by Subject|0|||
94370520|NCT01890785|323142917|FG005|Third Intervention|Withdrawal by Subject|0|||
94370521|NCT02295280|323142921|FG000|Overall Study|Adverse Event|0|||
94742980|NCT02719574|324515384|FG004|Phase 1 (Dose Expansion)|Other|0|||
94742981|NCT02719574|324515385|FG005|Phase 1 (Dose Expansion)|Other|0|||
94742982|NCT02719574|324515386|FG006|Phase 1 (Dose Expansion)|Other|1|||
94742983|NCT02719574|324515387|FG007|Phase 1 (Dose Expansion)|Other|7|||
94742984|NCT02719574|324515388|FG008|Phase 1 (Dose Expansion)|Other|0|||
94742985|NCT02719574|324515389|FG009|Phase 1 (Dose Expansion)|Other|0|||
94742986|NCT02719574|324515390|FG010|Phase 1 (Dose Expansion)|Other|0|||
94742987|NCT02719574|324515391|FG011|Phase 1 (Dose Expansion)|Other|0|||
94742988|NCT02719574|324515392|FG012|Phase 1 (Dose Expansion)|Other|0|||
94742989|NCT02719574|324515393|FG013|Phase 1 (Dose Expansion)|Other|0|||
94742990|NCT02719574|324515394|FG014|Phase 1 (Dose Expansion)|Other|0|||
94742991|NCT02719574|324515395|FG015|Phase 1 (Dose Expansion)|Other|0|||
94742992|NCT02719574|324515396|FG016|Phase 1 (Dose Expansion)|Other|0|||
94742993|NCT02719574|324515380|FG000|Phase 2|Protocol Defined Disease Progression|0|||
94742994|NCT02719574|324515381|FG001|Phase 2|Protocol Defined Disease Progression|0|||
94742995|NCT02719574|324515382|FG002|Phase 2|Protocol Defined Disease Progression|0|||
94742996|NCT02719574|324515383|FG003|Phase 2|Protocol Defined Disease Progression|0|||
94742997|NCT02719574|324515384|FG004|Phase 2|Protocol Defined Disease Progression|0|||
94742998|NCT02719574|324515385|FG005|Phase 2|Protocol Defined Disease Progression|0|||
94742999|NCT02719574|324515386|FG006|Phase 2|Protocol Defined Disease Progression|0|||
94743000|NCT02719574|324515387|FG007|Phase 2|Protocol Defined Disease Progression|0|||
94743001|NCT02719574|324515388|FG008|Phase 2|Protocol Defined Disease Progression|0|||
94743002|NCT02719574|324515389|FG009|Phase 2|Protocol Defined Disease Progression|65|||
94743003|NCT02719574|324515390|FG010|Phase 2|Protocol Defined Disease Progression|8|||
94743004|NCT02719574|324515391|FG011|Phase 2|Protocol Defined Disease Progression|2|||
94743005|NCT02719574|324515392|FG012|Phase 2|Protocol Defined Disease Progression|4|||
94743006|NCT02719574|324515393|FG013|Phase 2|Protocol Defined Disease Progression|9|||
94743007|NCT02719574|324515394|FG014|Phase 2|Protocol Defined Disease Progression|11|||
94743008|NCT02719574|324515395|FG015|Phase 2|Protocol Defined Disease Progression|3|||
94743009|NCT02719574|324515396|FG016|Phase 2|Protocol Defined Disease Progression|4|||
94202880|NCT03524092|322539475|FG000|Loss of Response Rescue Period|Pregnancy|0|||
94202881|NCT03524092|322539476|FG001|Loss of Response Rescue Period|Pregnancy|0|||
94278827|NCT02706873|322812803|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
94278828|NCT02706873|322812800|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
94370522|NCT02295280|323142922|FG001|Overall Study|Adverse Event|1|||
94370523|NCT03001011|323142923|FG000|Overall Study|Adverse Event|9|||
94743010|NCT02719574|324515380|FG000|Phase 2|Adverse Event|0|||
94743011|NCT02719574|324515381|FG001|Phase 2|Adverse Event|0|||
94743012|NCT02719574|324515382|FG002|Phase 2|Adverse Event|0|||
94743013|NCT02719574|324515383|FG003|Phase 2|Adverse Event|0|||
94743014|NCT02719574|324515384|FG004|Phase 2|Adverse Event|0|||
94278829|NCT02706873|322812801|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
94743015|NCT02719574|324515385|FG005|Phase 2|Adverse Event|0|||
94202882|NCT03524092|322539477|FG002|Loss of Response Rescue Period|Pregnancy|0|||
94202883|NCT03524092|322539478|FG003|Loss of Response Rescue Period|Pregnancy|1|||
94202884|NCT03524092|322539479|FG004|Loss of Response Rescue Period|Pregnancy|0|||
94202885|NCT03524092|322539480|FG005|Loss of Response Rescue Period|Pregnancy|0|||
94202886|NCT03524092|322539475|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
94202887|NCT03524092|322539476|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
94202888|NCT03524092|322539477|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
94202889|NCT03524092|322539478|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
94202890|NCT03524092|322539479|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
94202891|NCT03524092|322539480|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
94202892|NCT03524092|322539475|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
94202893|NCT03524092|322539476|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
94202894|NCT03524092|322539477|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
94202895|NCT03524092|322539478|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
94278830|NCT02706873|322812802|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
94278831|NCT02706873|322812803|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
94278832|NCT02706873|322812800|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
94278833|NCT02706873|322812801|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
94278834|NCT02706873|322812802|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
94278835|NCT02706873|322812803|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
94278836|NCT02432235|322812804|FG000|Overall Study|Death|1|||
94278837|NCT02432235|322812805|FG001|Overall Study|Death|1|||
94278838|NCT02432235|322812806|FG002|Overall Study|Death|2|||
94278839|NCT02432235|322812807|FG003|Overall Study|Death|2|||
94278840|NCT02432235|322812808|FG004|Overall Study|Death|1|||
94278841|NCT02432235|322812809|FG005|Overall Study|Death|3|||
94278842|NCT02432235|322812810|FG006|Overall Study|Death|11|||
94278843|NCT02432235|322812811|FG007|Overall Study|Death|15|||
94278844|NCT02432235|322812812|FG008|Overall Study|Death|15|||
94278845|NCT02432235|322812813|FG009|Overall Study|Death|3|||
94278846|NCT02432235|322812814|FG010|Overall Study|Death|1|||
94278847|NCT02432235|322812815|FG011|Overall Study|Death|0|||
94278848|NCT02432235|322812804|FG000|Overall Study|Withdrawal by Subject|0|||
94278849|NCT02432235|322812805|FG001|Overall Study|Withdrawal by Subject|1|||
94278850|NCT02432235|322812806|FG002|Overall Study|Withdrawal by Subject|0|||
94278851|NCT02432235|322812807|FG003|Overall Study|Withdrawal by Subject|0|||
94278852|NCT02432235|322812808|FG004|Overall Study|Withdrawal by Subject|0|||
94278853|NCT02432235|322812809|FG005|Overall Study|Withdrawal by Subject|2|||
94278854|NCT02432235|322812810|FG006|Overall Study|Withdrawal by Subject|5|||
94278855|NCT02432235|322812811|FG007|Overall Study|Withdrawal by Subject|3|||
94278856|NCT02432235|322812812|FG008|Overall Study|Withdrawal by Subject|1|||
94278857|NCT02432235|322812813|FG009|Overall Study|Withdrawal by Subject|0|||
94278858|NCT02432235|322812814|FG010|Overall Study|Withdrawal by Subject|0|||
94278859|NCT02432235|322812815|FG011|Overall Study|Withdrawal by Subject|0|||
94278860|NCT02432235|322812804|FG000|Overall Study|Lost to Follow-up|0|||
94278861|NCT02432235|322812805|FG001|Overall Study|Lost to Follow-up|0|||
94278862|NCT02432235|322812806|FG002|Overall Study|Lost to Follow-up|0|||
94278863|NCT02432235|322812807|FG003|Overall Study|Lost to Follow-up|0|||
94278864|NCT02432235|322812808|FG004|Overall Study|Lost to Follow-up|0|||
94278865|NCT02432235|322812809|FG005|Overall Study|Lost to Follow-up|1|||
94278866|NCT02432235|322812810|FG006|Overall Study|Lost to Follow-up|0|||
94278867|NCT02432235|322812811|FG007|Overall Study|Lost to Follow-up|0|||
94278868|NCT02432235|322812812|FG008|Overall Study|Lost to Follow-up|1|||
94278869|NCT02432235|322812813|FG009|Overall Study|Lost to Follow-up|0|||
94278870|NCT02432235|322812814|FG010|Overall Study|Lost to Follow-up|0|||
94278871|NCT02432235|322812815|FG011|Overall Study|Lost to Follow-up|0|||
94278872|NCT02432235|322812804|FG000|Overall Study|Miscellaneous|0|||
94278873|NCT02432235|322812805|FG001|Overall Study|Miscellaneous|0|||
94278874|NCT02432235|322812806|FG002|Overall Study|Miscellaneous|0|||
94278875|NCT02432235|322812807|FG003|Overall Study|Miscellaneous|0|||
94202896|NCT03524092|322539479|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
94278876|NCT02432235|322812808|FG004|Overall Study|Miscellaneous|1|||
94467638|NCT01451164|323502363|FG000|Overall Study|Protocol Violation|0|||
94202897|NCT03524092|322539480|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
94278877|NCT02432235|322812809|FG005|Overall Study|Miscellaneous|6|||
94278878|NCT02432235|322812810|FG006|Overall Study|Miscellaneous|2|||
94278879|NCT02432235|322812811|FG007|Overall Study|Miscellaneous|2|||
94278880|NCT02432235|322812812|FG008|Overall Study|Miscellaneous|4|||
94278881|NCT02432235|322812813|FG009|Overall Study|Miscellaneous|0|||
94278882|NCT02432235|322812814|FG010|Overall Study|Miscellaneous|0|||
94278883|NCT02432235|322812815|FG011|Overall Study|Miscellaneous|1|||
94278884|NCT00563186|322812831|FG000|Overall Study|LOS<48 hours|97|||
94278885|NCT00563186|322812832|FG001|Overall Study|LOS<48 hours|74|||
94467639|NCT01451164|323502364|FG001|Overall Study|Protocol Violation|1|||
94278886|NCT00563186|322812831|FG000|Overall Study|Incomplete data|1|||
94278887|NCT00563186|322812832|FG001|Overall Study|Incomplete data|1|||
94278888|NCT01902290|322812835|FG000|Overall Study|Withdrawal by Subject|19|||
94202898|NCT03524092|322539475|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
94202899|NCT03524092|322539476|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
94202900|NCT03524092|322539477|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
94202901|NCT03524092|322539478|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
94202902|NCT03524092|322539479|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
94202903|NCT03524092|322539480|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
94202904|NCT03524092|322539475|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
94202905|NCT03524092|322539476|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
94202906|NCT03524092|322539477|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
94202907|NCT03524092|322539478|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
94202908|NCT03524092|322539479|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
94202909|NCT03524092|322539480|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
94202910|NCT03524092|322539475|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
94202911|NCT03524092|322539476|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
94202912|NCT03524092|322539477|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
94202913|NCT03524092|322539478|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
94202914|NCT03524092|322539479|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
94202915|NCT03524092|322539480|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
94202916|NCT03524092|322539475|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
94202917|NCT03524092|322539476|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
94202918|NCT03524092|322539477|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
94202919|NCT03524092|322539478|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
94202920|NCT03524092|322539479|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
94202921|NCT03524092|322539480|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
94202922|NCT03524092|322539475|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
94202923|NCT03524092|322539476|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
94202924|NCT03524092|322539477|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
94202925|NCT03524092|322539478|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
94202926|NCT03524092|322539479|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
94202927|NCT03524092|322539480|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
94202928|NCT03524092|322539475|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
94202929|NCT03524092|322539476|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
94202930|NCT03524092|322539477|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
94202931|NCT03524092|322539478|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
94202932|NCT03524092|322539479|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
94202933|NCT03524092|322539480|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
94202934|NCT03524092|322539475|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
94202935|NCT03524092|322539476|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
94202936|NCT03524092|322539477|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
94202937|NCT03524092|322539478|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
94202938|NCT03524092|322539479|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
94202939|NCT03524092|322539480|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
94202940|NCT03524092|322539475|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
94202941|NCT03524092|322539476|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
94202942|NCT03524092|322539477|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
94370524|NCT03001011|323142924|FG001|Overall Study|Adverse Event|3|||
94370525|NCT03001011|323142923|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
94370526|NCT03001011|323142924|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
94370527|NCT03001011|323142923|FG000|Overall Study|Other than specified above|3|||
94370528|NCT03001011|323142924|FG001|Overall Study|Other than specified above|8|||
94370529|NCT02875067|323142925|FG000|Overall Study|Withdrawal by Subject|1|||
94370530|NCT02875067|323142925|FG000|Overall Study|Withdrawal by Termination of Study|5|||
94370531|NCT02124746|323142926|FG000|Overall Study|Adverse Event|2|||
94370532|NCT02124746|323142927|FG001|Overall Study|Adverse Event|1|||
94370533|NCT02124746|323142928|FG002|Overall Study|Adverse Event|2|||
94370534|NCT02124746|323142926|FG000|Overall Study|Death|2|||
94370535|NCT02124746|323142927|FG001|Overall Study|Death|1|||
94370536|NCT02124746|323142928|FG002|Overall Study|Death|3|||
94370537|NCT02124746|323142926|FG000|Overall Study|Lack of Efficacy|3|||
94370538|NCT02124746|323142927|FG001|Overall Study|Lack of Efficacy|2|||
94370539|NCT02124746|323142928|FG002|Overall Study|Lack of Efficacy|2|||
94370540|NCT02124746|323142926|FG000|Overall Study|Physician Decision|6|||
94370541|NCT02124746|323142927|FG001|Overall Study|Physician Decision|4|||
94370542|NCT02124746|323142928|FG002|Overall Study|Physician Decision|5|||
94370543|NCT02124746|323142926|FG000|Overall Study|Non-Compliance with Study Drug|0|||
94370544|NCT02124746|323142927|FG001|Overall Study|Non-Compliance with Study Drug|1|||
94743016|NCT02719574|324515386|FG006|Phase 2|Adverse Event|0|||
94743017|NCT02719574|324515387|FG007|Phase 2|Adverse Event|0|||
94743018|NCT02719574|324515388|FG008|Phase 2|Adverse Event|0|||
94743019|NCT02719574|324515389|FG009|Phase 2|Adverse Event|27|||
94743020|NCT02719574|324515390|FG010|Phase 2|Adverse Event|0|||
94743021|NCT02719574|324515391|FG011|Phase 2|Adverse Event|1|||
94743022|NCT02719574|324515392|FG012|Phase 2|Adverse Event|1|||
94743023|NCT02719574|324515393|FG013|Phase 2|Adverse Event|1|||
94743024|NCT02719574|324515394|FG014|Phase 2|Adverse Event|2|||
94743025|NCT02719574|324515395|FG015|Phase 2|Adverse Event|2|||
94743026|NCT02719574|324515396|FG016|Phase 2|Adverse Event|3|||
94743027|NCT02719574|324515380|FG000|Phase 2|Other|0|||
94743028|NCT02719574|324515381|FG001|Phase 2|Other|0|||
94743029|NCT02719574|324515382|FG002|Phase 2|Other|0|||
94743030|NCT02719574|324515383|FG003|Phase 2|Other|0|||
94743031|NCT02719574|324515384|FG004|Phase 2|Other|0|||
94743032|NCT02719574|324515385|FG005|Phase 2|Other|0|||
94743033|NCT02719574|324515386|FG006|Phase 2|Other|0|||
94743034|NCT02719574|324515387|FG007|Phase 2|Other|0|||
94743035|NCT02719574|324515388|FG008|Phase 2|Other|0|||
94743036|NCT02719574|324515389|FG009|Phase 2|Other|20|||
94743037|NCT02719574|324515390|FG010|Phase 2|Other|7|||
94743038|NCT02719574|324515391|FG011|Phase 2|Other|0|||
94743039|NCT02719574|324515392|FG012|Phase 2|Other|5|||
94743040|NCT02719574|324515393|FG013|Phase 2|Other|7|||
94743041|NCT02719574|324515394|FG014|Phase 2|Other|0|||
94743042|NCT02719574|324515395|FG015|Phase 2|Other|1|||
94743043|NCT02719574|324515396|FG016|Phase 2|Other|4|||
94743044|NCT02719574|324515380|FG000|Phase 2|Transplant|0|||
94743045|NCT02719574|324515381|FG001|Phase 2|Transplant|0|||
94743046|NCT02719574|324515382|FG002|Phase 2|Transplant|0|||
94743047|NCT02719574|324515383|FG003|Phase 2|Transplant|0|||
94743048|NCT02719574|324515384|FG004|Phase 2|Transplant|0|||
94743049|NCT02719574|324515385|FG005|Phase 2|Transplant|0|||
94743050|NCT02719574|324515386|FG006|Phase 2|Transplant|0|||
94743051|NCT02719574|324515387|FG007|Phase 2|Transplant|0|||
94743052|NCT02719574|324515388|FG008|Phase 2|Transplant|0|||
94743053|NCT02719574|324515389|FG009|Phase 2|Transplant|15|||
94743054|NCT02719574|324515390|FG010|Phase 2|Transplant|2|||
94743055|NCT02719574|324515391|FG011|Phase 2|Transplant|0|||
94743056|NCT02719574|324515392|FG012|Phase 2|Transplant|6|||
94743057|NCT02719574|324515393|FG013|Phase 2|Transplant|1|||
94743058|NCT02719574|324515394|FG014|Phase 2|Transplant|1|||
94743059|NCT02719574|324515395|FG015|Phase 2|Transplant|0|||
94202943|NCT03524092|322539478|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
94202944|NCT03524092|322539479|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
94202945|NCT03524092|322539480|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
94202946|NCT03524092|322539475|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
94202947|NCT03524092|322539476|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
94202948|NCT03524092|322539477|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
94202949|NCT03524092|322539478|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
94202950|NCT03524092|322539479|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
94202951|NCT03524092|322539480|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
94202952|NCT03524092|322539475|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
94202953|NCT03524092|322539476|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
94202954|NCT03524092|322539477|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
94202955|NCT03524092|322539478|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
94202956|NCT03524092|322539479|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
94202957|NCT03524092|322539480|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
94202958|NCT00747565|322539483|FG000|Overall Study|Withdrawal by Subject|10|||
94202959|NCT00747565|322539484|FG001|Overall Study|Withdrawal by Subject|6|||
94202960|NCT00747565|322539483|FG000|Overall Study|Lost to Follow-up|4|||
94202961|NCT00747565|322539484|FG001|Overall Study|Lost to Follow-up|1|||
94202962|NCT03789110|322539485|FG000|Overall Study|Adverse Event|2|||
94202963|NCT03789110|322539485|FG000|Overall Study|Physician Decision|1|||
94202964|NCT03789110|322539485|FG000|Overall Study|Withdrawal by Subject|2|||
94202965|NCT03789110|322539485|FG000|Overall Study|Lack of Efficacy|22|||
94370545|NCT02124746|323142928|FG002|Overall Study|Non-Compliance with Study Drug|0|||
94743060|NCT02719574|324515396|FG016|Phase 2|Transplant|0|||
94743061|NCT02719574|324515380|FG000|Phase 2|Death|0|||
94743062|NCT02719574|324515381|FG001|Phase 2|Death|0|||
94743063|NCT02719574|324515382|FG002|Phase 2|Death|0|||
94743064|NCT02719574|324515383|FG003|Phase 2|Death|0|||
94743065|NCT02719574|324515384|FG004|Phase 2|Death|0|||
94743066|NCT02719574|324515385|FG005|Phase 2|Death|0|||
94743067|NCT02719574|324515386|FG006|Phase 2|Death|0|||
94743068|NCT02719574|324515387|FG007|Phase 2|Death|0|||
94743069|NCT02719574|324515388|FG008|Phase 2|Death|0|||
94743070|NCT02719574|324515389|FG009|Phase 2|Death|14|||
94743071|NCT02719574|324515390|FG010|Phase 2|Death|0|||
94743072|NCT02719574|324515391|FG011|Phase 2|Death|0|||
94743073|NCT02719574|324515392|FG012|Phase 2|Death|1|||
94278889|NCT01902290|322812836|FG001|Overall Study|Withdrawal by Subject|27|||
94278890|NCT01902290|322812835|FG000|Overall Study|Lost to Follow-up|2|||
94278891|NCT01902290|322812836|FG001|Overall Study|Lost to Follow-up|2|||
94278892|NCT01902290|322812835|FG000|Overall Study|Death|1|||
94278893|NCT01902290|322812836|FG001|Overall Study|Death|0|||
94278894|NCT01902290|322812835|FG000|Overall Study|Sponsor Decision|26|||
94278895|NCT01902290|322812836|FG001|Overall Study|Sponsor Decision|24|||
94278896|NCT01888640|322812837|FG000|Overall Study|Lost to Follow-up|1|||
94278897|NCT01888640|322812838|FG001|Overall Study|Lost to Follow-up|2|||
94278898|NCT01888640|322812839|FG002|Overall Study|Lost to Follow-up|0|||
94278899|NCT01888640|322812837|FG000|Overall Study|Withdrawal by Subject|15|||
94278900|NCT01888640|322812838|FG001|Overall Study|Withdrawal by Subject|11|||
94278901|NCT01888640|322812839|FG002|Overall Study|Withdrawal by Subject|4|||
94278902|NCT01888640|322812837|FG000|Overall Study|Minimum dose not met|10|||
94278903|NCT01888640|322812838|FG001|Overall Study|Minimum dose not met|16|||
94278904|NCT01888640|322812839|FG002|Overall Study|Minimum dose not met|0|||
94278905|NCT01888640|322812837|FG000|Overall Study|Given wrong unit (placebo)|1|||
94278906|NCT01888640|322812838|FG001|Overall Study|Given wrong unit (placebo)|0|||
94278907|NCT01888640|322812839|FG002|Overall Study|Given wrong unit (placebo)|0|||
94278908|NCT01888640|322812837|FG000|Overall Study|Excluded for prior TENS|0|||
94278909|NCT01888640|322812838|FG001|Overall Study|Excluded for prior TENS|1|||
94278910|NCT01888640|322812839|FG002|Overall Study|Excluded for prior TENS|0|||
94278911|NCT01888640|322812837|FG000|Overall Study|Researcher Termination of Participant|0|||
94278912|NCT01888640|322812838|FG001|Overall Study|Researcher Termination of Participant|1|||
94278913|NCT01888640|322812839|FG002|Overall Study|Researcher Termination of Participant|1|||
94278914|NCT00385255|322812840|FG000|Overall Study|Serious Adverse Event|1|||
94278915|NCT00385255|322812841|FG001|Overall Study|Serious Adverse Event|2|||
94278916|NCT00385255|322812840|FG000|Overall Study|Protocol Violation|0|||
94278917|NCT00385255|322812841|FG001|Overall Study|Protocol Violation|4|||
94278918|NCT00385255|322812840|FG000|Overall Study|Withdrawal by Subject|0|||
94278919|NCT00385255|322812841|FG001|Overall Study|Withdrawal by Subject|8|||
94278920|NCT00385255|322812840|FG000|Overall Study|Migrated/moved from study area|0|||
94278921|NCT00385255|322812841|FG001|Overall Study|Migrated/moved from study area|1|||
94278922|NCT00385255|322812840|FG000|Overall Study|Lost to Follow-up|20|||
94278923|NCT00385255|322812841|FG001|Overall Study|Lost to Follow-up|58|||
94278924|NCT01265550|322812842|FG000|Pre Randomization|Withdrawal by Subject|0|||
94278925|NCT01265550|322812843|FG001|Pre Randomization|Withdrawal by Subject|0|||
94278926|NCT01265550|322812844|FG002|Pre Randomization|Withdrawal by Subject|0|||
94278927|NCT01265550|322812845|FG003|Pre Randomization|Withdrawal by Subject|70|||
94278928|NCT01265550|322812842|FG000|Pre Randomization|Technical Exclusions|0|||
94278929|NCT01265550|322812843|FG001|Pre Randomization|Technical Exclusions|0|||
94278930|NCT01265550|322812844|FG002|Pre Randomization|Technical Exclusions|0|||
94278931|NCT01265550|322812845|FG003|Pre Randomization|Technical Exclusions|54|||
94278932|NCT01265550|322812842|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
94278933|NCT01265550|322812843|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
94278934|NCT01265550|322812844|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
94278935|NCT01265550|322812845|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
94278936|NCT01265550|322812842|FG000|Pre Randomization|Non-GERD organic disorders|0|||
94278937|NCT01265550|322812843|FG001|Pre Randomization|Non-GERD organic disorders|0|||
94743074|NCT02719574|324515393|FG013|Phase 2|Death|1|||
94743075|NCT02719574|324515394|FG014|Phase 2|Death|2|||
94743076|NCT02719574|324515395|FG015|Phase 2|Death|0|||
94743077|NCT02719574|324515396|FG016|Phase 2|Death|0|||
94743078|NCT02719574|324515380|FG000|Phase 2|Investigator Decision|0|||
94743079|NCT02719574|324515381|FG001|Phase 2|Investigator Decision|0|||
94743080|NCT02719574|324515382|FG002|Phase 2|Investigator Decision|0|||
94743081|NCT02719574|324515383|FG003|Phase 2|Investigator Decision|0|||
94743082|NCT02719574|324515384|FG004|Phase 2|Investigator Decision|0|||
94743083|NCT02719574|324515385|FG005|Phase 2|Investigator Decision|0|||
94743084|NCT02719574|324515386|FG006|Phase 2|Investigator Decision|0|||
94743085|NCT02719574|324515387|FG007|Phase 2|Investigator Decision|0|||
94743086|NCT02719574|324515388|FG008|Phase 2|Investigator Decision|0|||
94743087|NCT02719574|324515389|FG009|Phase 2|Investigator Decision|6|||
94743088|NCT02719574|324515390|FG010|Phase 2|Investigator Decision|1|||
94743089|NCT02719574|324515391|FG011|Phase 2|Investigator Decision|2|||
94743090|NCT02719574|324515392|FG012|Phase 2|Investigator Decision|3|||
94743091|NCT02719574|324515393|FG013|Phase 2|Investigator Decision|1|||
94278938|NCT01265550|322812844|FG002|Pre Randomization|Non-GERD organic disorders|0|||
94278939|NCT01265550|322812845|FG003|Pre Randomization|Non-GERD organic disorders|23|||
94278940|NCT01265550|322812842|FG000|Pre Randomization|Functional heartburn|0|||
94278941|NCT01265550|322812843|FG001|Pre Randomization|Functional heartburn|0|||
94278942|NCT01265550|322812844|FG002|Pre Randomization|Functional heartburn|0|||
94278943|NCT01265550|322812845|FG003|Pre Randomization|Functional heartburn|99|||
94278944|NCT00689871|322812851|FG000|Overall Study|Lost to Follow-up|123|||
94743092|NCT02719574|324515394|FG014|Phase 2|Investigator Decision|3|||
94743093|NCT02719574|324515395|FG015|Phase 2|Investigator Decision|2|||
94743094|NCT02719574|324515396|FG016|Phase 2|Investigator Decision|0|||
94743095|NCT02719574|324515380|FG000|Phase 2|Withdrawal by Subject|0|||
94202966|NCT03789110|322539485|FG000|Overall Study|still on treatment|3|||
94202967|NCT03160885|322539488|FG000|Initial Treatment Period|Not dosed|2|||
94202968|NCT03160885|322539489|FG001|Initial Treatment Period|Not dosed|0|||
94202969|NCT03160885|322539490|FG002|Initial Treatment Period|Not dosed|0|||
94202970|NCT03160885|322539491|FG003|Initial Treatment Period|Not dosed|0|||
94202971|NCT03160885|322539492|FG004|Initial Treatment Period|Not dosed|0|||
94202972|NCT03160885|322539493|FG005|Initial Treatment Period|Not dosed|0|||
94202973|NCT03160885|322539494|FG006|Initial Treatment Period|Not dosed|0|||
94202974|NCT03160885|322539488|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
94202975|NCT03160885|322539489|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
94202976|NCT03160885|322539490|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
94202977|NCT03160885|322539491|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
94202978|NCT03160885|322539492|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
94202979|NCT03160885|322539493|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
94202980|NCT03160885|322539494|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
94202981|NCT03160885|322539488|FG000|Open-label Treatment|Not dosed|0|||
94202982|NCT03160885|322539489|FG001|Open-label Treatment|Not dosed|0|||
94202983|NCT03160885|322539490|FG002|Open-label Treatment|Not dosed|0|||
94202984|NCT03160885|322539491|FG003|Open-label Treatment|Not dosed|0|||
94202985|NCT03160885|322539492|FG004|Open-label Treatment|Not dosed|0|||
94202986|NCT03160885|322539493|FG005|Open-label Treatment|Not dosed|0|||
94202987|NCT03160885|322539494|FG006|Open-label Treatment|Not dosed|2|||
94202988|NCT03160885|322539488|FG000|Open-label Treatment|Discontinued IMP|0|||
94202989|NCT03160885|322539489|FG001|Open-label Treatment|Discontinued IMP|0|||
94202990|NCT03160885|322539490|FG002|Open-label Treatment|Discontinued IMP|0|||
94202991|NCT03160885|322539491|FG003|Open-label Treatment|Discontinued IMP|0|||
94202992|NCT03160885|322539492|FG004|Open-label Treatment|Discontinued IMP|0|||
94202993|NCT03160885|322539493|FG005|Open-label Treatment|Discontinued IMP|0|||
94202994|NCT03160885|322539494|FG006|Open-label Treatment|Discontinued IMP|131|||
94202995|NCT03160885|322539488|FG000|Open-label Treatment|Completed Week 50|0|||
94202996|NCT03160885|322539489|FG001|Open-label Treatment|Completed Week 50|0|||
94202997|NCT03160885|322539490|FG002|Open-label Treatment|Completed Week 50|0|||
94202998|NCT03160885|322539491|FG003|Open-label Treatment|Completed Week 50|0|||
94202999|NCT03160885|322539492|FG004|Open-label Treatment|Completed Week 50|0|||
94203000|NCT03160885|322539493|FG005|Open-label Treatment|Completed Week 50|0|||
94203001|NCT03160885|322539494|FG006|Open-label Treatment|Completed Week 50|4|||
94203002|NCT03160885|322539488|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
94203003|NCT03160885|322539489|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
94203004|NCT03160885|322539490|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
94203005|NCT03160885|322539491|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
94203006|NCT03160885|322539492|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
94203007|NCT03160885|322539493|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
94203008|NCT03160885|322539494|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
94203009|NCT03160885|322539488|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
94278945|NCT00689871|322812852|FG001|Overall Study|Lost to Follow-up|13|||
94278946|NCT00689871|322812853|FG002|Overall Study|Lost to Follow-up|37|||
94278947|NCT00689871|322812854|FG003|Overall Study|Lost to Follow-up|1|||
94278948|NCT00689871|322812851|FG000|Overall Study|Explanted of All Study Devices|36|||
94278949|NCT00689871|322812852|FG001|Overall Study|Explanted of All Study Devices|25|||
94278950|NCT00689871|322812853|FG002|Overall Study|Explanted of All Study Devices|29|||
94278951|NCT00689871|322812854|FG003|Overall Study|Explanted of All Study Devices|3|||
94278952|NCT00689871|322812851|FG000|Overall Study|Withdrawal by Subject|13|||
94278953|NCT00689871|322812852|FG001|Overall Study|Withdrawal by Subject|3|||
94278954|NCT00689871|322812853|FG002|Overall Study|Withdrawal by Subject|4|||
94278955|NCT00689871|322812854|FG003|Overall Study|Withdrawal by Subject|1|||
94278956|NCT00689871|322812851|FG000|Overall Study|Death|1|||
94278957|NCT00689871|322812852|FG001|Overall Study|Death|10|||
94278958|NCT00689871|322812853|FG002|Overall Study|Death|2|||
94278959|NCT00689871|322812854|FG003|Overall Study|Death|2|||
94278960|NCT00689871|322812851|FG000|Overall Study|Physician Decision|2|||
94278961|NCT00689871|322812852|FG001|Overall Study|Physician Decision|1|||
94203010|NCT03160885|322539489|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
94203011|NCT03160885|322539490|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
94203012|NCT03160885|322539491|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
94203013|NCT03160885|322539492|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
94203014|NCT03160885|322539493|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
94203015|NCT03160885|322539494|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
94203016|NCT03160885|322539488|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
94203017|NCT03160885|322539489|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
94203018|NCT03160885|322539490|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
94278962|NCT00689871|322812853|FG002|Overall Study|Physician Decision|1|||
94278963|NCT00689871|322812854|FG003|Overall Study|Physician Decision|0|||
94278964|NCT02703311|322812855|FG000|Overall Study|Death|5|||
94203019|NCT03160885|322539491|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
94203020|NCT03160885|322539492|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
94203021|NCT03160885|322539493|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
94203022|NCT03160885|322539494|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
94203023|NCT03160885|322539488|FG000|Maintenance Treatment Period|Completed Week 50|0|||
94203024|NCT03160885|322539489|FG001|Maintenance Treatment Period|Completed Week 50|0|||
94203025|NCT03160885|322539490|FG002|Maintenance Treatment Period|Completed Week 50|1|||
94370546|NCT02124746|323142926|FG000|Overall Study|Withdrawal by Subject|3|||
94370547|NCT02124746|323142927|FG001|Overall Study|Withdrawal by Subject|3|||
94370548|NCT02124746|323142928|FG002|Overall Study|Withdrawal by Subject|0|||
94370549|NCT02124746|323142926|FG000|Overall Study|Study Terminated by Sponsor|0|||
94370550|NCT02124746|323142927|FG001|Overall Study|Study Terminated by Sponsor|0|||
94370551|NCT02124746|323142928|FG002|Overall Study|Study Terminated by Sponsor|6|||
94370552|NCT02124746|323142926|FG000|Overall Study|Disease Progression|3|||
94370553|NCT02124746|323142927|FG001|Overall Study|Disease Progression|6|||
94370554|NCT02124746|323142928|FG002|Overall Study|Disease Progression|4|||
94370555|NCT00065065|323142929|FG000|Overall Study|Adverse Event|3|||
94370556|NCT00065065|323142930|FG001|Overall Study|Adverse Event|2|||
94370557|NCT00065065|323142929|FG000|Overall Study|Withdrawal by Subject|1|||
94370558|NCT00065065|323142930|FG001|Overall Study|Withdrawal by Subject|5|||
94370559|NCT00065065|323142929|FG000|Overall Study|Lack of Efficacy|4|||
94370560|NCT00065065|323142930|FG001|Overall Study|Lack of Efficacy|11|||
94370561|NCT00065065|323142929|FG000|Overall Study|Other|2|||
94370562|NCT00065065|323142930|FG001|Overall Study|Other|2|||
94370563|NCT02713243|323142934|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
94370564|NCT02713243|323142935|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
94370565|NCT02713243|323142934|FG000|Overall Study|Administrative problems|0|||
94370566|NCT02713243|323142935|FG001|Overall Study|Administrative problems|1|||
94370567|NCT02713243|323142934|FG000|Overall Study|Protocol deviation|0|||
94370568|NCT02713243|323142935|FG001|Overall Study|Protocol deviation|1|||
94370569|NCT02139306|323142940|FG000|Overall Study|Withdrawal by Subject|4|||
94370570|NCT02139306|323142941|FG001|Overall Study|Withdrawal by Subject|6|||
94370571|NCT02139306|323142940|FG000|Overall Study|Adverse Event|3|||
94370572|NCT02139306|323142941|FG001|Overall Study|Adverse Event|4|||
94370573|NCT02139306|323142940|FG000|Overall Study|Physician Decision|0|||
94370574|NCT02139306|323142941|FG001|Overall Study|Physician Decision|1|||
94370575|NCT02139306|323142940|FG000|Overall Study|Other Unspecified|2|||
94370576|NCT02139306|323142941|FG001|Overall Study|Other Unspecified|3|||
94370577|NCT02139306|323142940|FG000|Overall Study|Protocol Violation|4|||
94370578|NCT02139306|323142941|FG001|Overall Study|Protocol Violation|0|||
94370579|NCT01021137|323142942|FG000|Overall Study|Lost to Follow-up|9|||
94370580|NCT01021137|323142943|FG001|Overall Study|Lost to Follow-up|4|||
94370581|NCT01021137|323142944|FG002|Overall Study|Lost to Follow-up|2|||
94370582|NCT01021137|323142945|FG003|Overall Study|Lost to Follow-up|6|||
94370583|NCT01021137|323142942|FG000|Overall Study|Withdrawal by Subject|1|||
94370584|NCT01021137|323142943|FG001|Overall Study|Withdrawal by Subject|0|||
94370585|NCT01021137|323142944|FG002|Overall Study|Withdrawal by Subject|0|||
94370586|NCT01021137|323142945|FG003|Overall Study|Withdrawal by Subject|3|||
94370587|NCT02475980|323142947|FG000|Overall Study|Lost to Follow-up|4|||
94370588|NCT02475980|323142947|FG000|Overall Study|Withdrawal by Subject|1|||
94370589|NCT02173301|323142948|FG000|Overall Study|Adverse Event|7|||
94370590|NCT02173301|323142949|FG001|Overall Study|Adverse Event|8|||
94370591|NCT02173301|323142950|FG002|Overall Study|Adverse Event|13|||
94370592|NCT02173301|323142951|FG003|Overall Study|Adverse Event|5|||
94203026|NCT03160885|322539491|FG003|Maintenance Treatment Period|Completed Week 50|0|||
94203027|NCT03160885|322539492|FG004|Maintenance Treatment Period|Completed Week 50|0|||
94203028|NCT03160885|322539493|FG005|Maintenance Treatment Period|Completed Week 50|0|||
94203029|NCT03160885|322539494|FG006|Maintenance Treatment Period|Completed Week 50|0|||
94203030|NCT03425682|322539495|FG000|Overall Study|Lost to Follow-up|2|||
94203031|NCT03425682|322539496|FG001|Overall Study|Lost to Follow-up|4|||
94203032|NCT03425682|322539495|FG000|Overall Study|Withdrawal by Subject|0|||
94203033|NCT03425682|322539496|FG001|Overall Study|Withdrawal by Subject|3|||
94203034|NCT03425682|322539495|FG000|Overall Study|Subject did not meet I/E|4|||
94203035|NCT03425682|322539496|FG001|Overall Study|Subject did not meet I/E|10|||
94203036|NCT00353496|322539497|FG000|Overall Study|Adverse Event|1|||
94203037|NCT00353496|322539498|FG001|Overall Study|Adverse Event|0|||
94203038|NCT00353496|322539497|FG000|Overall Study|Protocol Violation|2|||
94370593|NCT02173301|323142948|FG000|Overall Study|Withdrawal by Subject|8|||
94370594|NCT02173301|323142949|FG001|Overall Study|Withdrawal by Subject|10|||
94370595|NCT02173301|323142950|FG002|Overall Study|Withdrawal by Subject|4|||
94370596|NCT02173301|323142951|FG003|Overall Study|Withdrawal by Subject|8|||
94370597|NCT02173301|323142948|FG000|Overall Study|Lost to Follow-up|4|||
94370598|NCT02173301|323142949|FG001|Overall Study|Lost to Follow-up|4|||
94370599|NCT02173301|323142950|FG002|Overall Study|Lost to Follow-up|2|||
94370600|NCT02173301|323142951|FG003|Overall Study|Lost to Follow-up|2|||
94370601|NCT02173301|323142948|FG000|Overall Study|Protocol Violation|0|||
94370602|NCT02173301|323142949|FG001|Overall Study|Protocol Violation|1|||
94370603|NCT02173301|323142950|FG002|Overall Study|Protocol Violation|0|||
94370604|NCT02173301|323142951|FG003|Overall Study|Protocol Violation|0|||
94370605|NCT02173301|323142948|FG000|Overall Study|Physician Decision|0|||
94370606|NCT02173301|323142949|FG001|Overall Study|Physician Decision|0|||
94370607|NCT02173301|323142950|FG002|Overall Study|Physician Decision|1|||
94370608|NCT02173301|323142951|FG003|Overall Study|Physician Decision|0|||
94370609|NCT02173301|323142948|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
94370610|NCT02173301|323142949|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
94370611|NCT02173301|323142950|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
94370612|NCT02173301|323142951|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
94370613|NCT00435825|323142952|FG000|Overall Study|Abnormality of Laboratory Test|0|||
94370614|NCT00435825|323142953|FG001|Overall Study|Abnormality of Laboratory Test|1|||
94370615|NCT00435825|323142954|FG002|Overall Study|Abnormality of Laboratory Test|0|||
94370616|NCT00435825|323142955|FG003|Overall Study|Abnormality of Laboratory Test|0|||
94370617|NCT00435825|323142952|FG000|Overall Study|Insufficient Therapeutic Response|3|||
94370618|NCT00435825|323142953|FG001|Overall Study|Insufficient Therapeutic Response|1|||
94370619|NCT00435825|323142954|FG002|Overall Study|Insufficient Therapeutic Response|0|||
94370620|NCT00435825|323142955|FG003|Overall Study|Insufficient Therapeutic Response|3|||
94370621|NCT00435825|323142952|FG000|Overall Study|Other Protocol Violation|1|||
94370622|NCT00435825|323142953|FG001|Overall Study|Other Protocol Violation|0|||
94370623|NCT00435825|323142954|FG002|Overall Study|Other Protocol Violation|0|||
94370624|NCT00435825|323142955|FG003|Overall Study|Other Protocol Violation|0|||
94370625|NCT00435825|323142952|FG000|Overall Study|Refused treatment|2|||
94370626|NCT00435825|323142953|FG001|Overall Study|Refused treatment|0|||
94370627|NCT00435825|323142954|FG002|Overall Study|Refused treatment|0|||
94370628|NCT00435825|323142955|FG003|Overall Study|Refused treatment|5|||
94370629|NCT00435825|323142952|FG000|Overall Study|Failure to return|5|||
94370630|NCT00435825|323142953|FG001|Overall Study|Failure to return|0|||
94370631|NCT00435825|323142954|FG002|Overall Study|Failure to return|4|||
94370632|NCT00435825|323142955|FG003|Overall Study|Failure to return|0|||
94370633|NCT00435825|323142952|FG000|Overall Study|Did not receive study drug|1|||
94370634|NCT00435825|323142953|FG001|Overall Study|Did not receive study drug|0|||
94370635|NCT00435825|323142954|FG002|Overall Study|Did not receive study drug|2|||
94370636|NCT00435825|323142955|FG003|Overall Study|Did not receive study drug|0|||
94370637|NCT00435825|323142952|FG000|Overall Study|Did not enter follow-up|0|||
94370638|NCT00435825|323142953|FG001|Overall Study|Did not enter follow-up|4|||
94370639|NCT00435825|323142954|FG002|Overall Study|Did not enter follow-up|1|||
94370640|NCT00435825|323142955|FG003|Overall Study|Did not enter follow-up|3|||
94370641|NCT00435825|323142952|FG000|Overall Study|Did not complete full follow-up period|6|||
94743096|NCT02719574|324515381|FG001|Phase 2|Withdrawal by Subject|0|||
94743097|NCT02719574|324515382|FG002|Phase 2|Withdrawal by Subject|0|||
94743098|NCT02719574|324515383|FG003|Phase 2|Withdrawal by Subject|0|||
94743099|NCT02719574|324515384|FG004|Phase 2|Withdrawal by Subject|0|||
94743100|NCT02719574|324515385|FG005|Phase 2|Withdrawal by Subject|0|||
94743101|NCT02719574|324515386|FG006|Phase 2|Withdrawal by Subject|0|||
94743102|NCT02719574|324515387|FG007|Phase 2|Withdrawal by Subject|0|||
94743103|NCT02719574|324515388|FG008|Phase 2|Withdrawal by Subject|0|||
94743104|NCT02719574|324515389|FG009|Phase 2|Withdrawal by Subject|5|||
94743105|NCT02719574|324515390|FG010|Phase 2|Withdrawal by Subject|0|||
94743106|NCT02719574|324515391|FG011|Phase 2|Withdrawal by Subject|0|||
94743107|NCT02719574|324515392|FG012|Phase 2|Withdrawal by Subject|0|||
94743108|NCT02719574|324515393|FG013|Phase 2|Withdrawal by Subject|1|||
94743109|NCT02719574|324515394|FG014|Phase 2|Withdrawal by Subject|1|||
94743110|NCT02719574|324515395|FG015|Phase 2|Withdrawal by Subject|2|||
94743111|NCT02719574|324515396|FG016|Phase 2|Withdrawal by Subject|0|||
94743112|NCT02719574|324515380|FG000|Phase 2|Protocol Violation|0|||
94743113|NCT02719574|324515381|FG001|Phase 2|Protocol Violation|0|||
94743114|NCT02719574|324515382|FG002|Phase 2|Protocol Violation|0|||
94743115|NCT02719574|324515383|FG003|Phase 2|Protocol Violation|0|||
94743116|NCT02719574|324515384|FG004|Phase 2|Protocol Violation|0|||
94743117|NCT02719574|324515385|FG005|Phase 2|Protocol Violation|0|||
94743118|NCT02719574|324515386|FG006|Phase 2|Protocol Violation|0|||
94743119|NCT02719574|324515387|FG007|Phase 2|Protocol Violation|0|||
94743120|NCT02719574|324515388|FG008|Phase 2|Protocol Violation|0|||
94743121|NCT02719574|324515389|FG009|Phase 2|Protocol Violation|1|||
94743122|NCT02719574|324515390|FG010|Phase 2|Protocol Violation|0|||
94743123|NCT02719574|324515391|FG011|Phase 2|Protocol Violation|0|||
94743124|NCT02719574|324515392|FG012|Phase 2|Protocol Violation|0|||
94743125|NCT02719574|324515393|FG013|Phase 2|Protocol Violation|0|||
94370642|NCT00435825|323142953|FG001|Overall Study|Did not complete full follow-up period|6|||
94467640|NCT01451164|323502365|FG002|Overall Study|Protocol Violation|0|||
94743126|NCT02719574|324515394|FG014|Phase 2|Protocol Violation|0|||
94743127|NCT02719574|324515395|FG015|Phase 2|Protocol Violation|0|||
94743128|NCT02719574|324515396|FG016|Phase 2|Protocol Violation|0|||
94743129|NCT04921358|324515397|FG000|Overall Study|Withdrawal by Subject|6|||
94743130|NCT04921358|324515398|FG001|Overall Study|Withdrawal by Subject|13|||
94743131|NCT04921358|324515397|FG000|Overall Study|Lost to Follow-up|3|||
94743132|NCT04921358|324515398|FG001|Overall Study|Lost to Follow-up|6|||
94743133|NCT04921358|324515397|FG000|Overall Study|Study Terminated by Sponsor|86|||
94743134|NCT04921358|324515398|FG001|Overall Study|Study Terminated by Sponsor|89|||
94743135|NCT04921358|324515397|FG000|Overall Study|Death|92|||
94743136|NCT04921358|324515398|FG001|Overall Study|Death|82|||
94743137|NCT04411420|324515402|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
94743138|NCT04411420|324515403|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
94743139|NCT04411420|324515402|FG000|Survey Subset|Lost to Follow-up|134|||
94743140|NCT04411420|324515403|FG001|Survey Subset|Lost to Follow-up|120|||
94743141|NCT05070429|324515406|FG000|Overall Study|Death|0|||
94743142|NCT05070429|324515407|FG001|Overall Study|Death|4|||
94743143|NCT05070429|324515406|FG000|Overall Study|Withdrawal by Subject|2|||
94743144|NCT05070429|324515407|FG001|Overall Study|Withdrawal by Subject|1|||
94743145|NCT05070429|324515406|FG000|Overall Study|Other|15|||
94743146|NCT05070429|324515407|FG001|Overall Study|Other|5|||
94743147|NCT05171816|324515408|FG000|Overall Study|Death|18|||
94743148|NCT05171816|324515409|FG001|Overall Study|Death|16|||
94743149|NCT05157841|324515414|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
94743150|NCT05157841|324515415|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
94743151|NCT05157841|324515416|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
94743152|NCT05157841|324515414|FG000|Part A (14 Days)|Adverse Event|1|||
94743153|NCT05157841|324515415|FG001|Part A (14 Days)|Adverse Event|0|||
94743154|NCT05157841|324515416|FG002|Part A (14 Days)|Adverse Event|0|||
94743155|NCT05157841|324515414|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
94743156|NCT05157841|324515415|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
94743157|NCT05157841|324515416|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
94743158|NCT04608409|324515419|FG000|Overall Study|Physician Decision|1|||
94743159|NCT04608409|324515420|FG001|Overall Study|Physician Decision|1|||
94743160|NCT04608409|324515421|FG002|Overall Study|Physician Decision|2|||
94743161|NCT04545619|324515425|FG000|Overall Study|due to equipment challenges|1|||
94743162|NCT03362502|324515431|FG000|Overall Study|Death|0|||
94743163|NCT03362502|324515432|FG001|Overall Study|Death|0|||
94743164|NCT03362502|324515433|FG002|Overall Study|Death|1|||
94743165|NCT03521154|324515434|FG000|Overall Study|Ongoing study at data cut-off|111|||
94743166|NCT03521154|324515435|FG001|Overall Study|Ongoing study at data cut-off|52|||
94743167|NCT03747120|324515438|FG000|Overall Study|treatment related toxicity|3|||
94743168|NCT03747120|324515439|FG001|Overall Study|treatment related toxicity|0|||
94743169|NCT03747120|324515440|FG002|Overall Study|treatment related toxicity|0|||
94743170|NCT03747120|324515438|FG000|Overall Study|Withdrawal by Subject|0|||
94743171|NCT03747120|324515439|FG001|Overall Study|Withdrawal by Subject|1|||
94743172|NCT03747120|324515440|FG002|Overall Study|Withdrawal by Subject|2|||
94743173|NCT04165213|324515441|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
94743174|NCT04165213|324515442|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
94743175|NCT04165213|324515441|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
94743176|NCT04165213|324515442|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
94743177|NCT04165213|324515441|FG000|Clinician Enrollment|Termination from site|0|||
94743178|NCT04165213|324515442|FG001|Clinician Enrollment|Termination from site|1|||
94743179|NCT04165213|324515441|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
94743180|NCT04165213|324515442|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
94743181|NCT04165213|324515441|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
94743182|NCT04165213|324515442|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
94743183|NCT04165213|324515441|FG000|Caregiver Enrollment|Physician Decision|1|||
94743184|NCT04165213|324515442|FG001|Caregiver Enrollment|Physician Decision|0|||
94743185|NCT04165213|324515441|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
94743186|NCT04165213|324515442|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
94743187|NCT04165213|324515441|FG000|Caregiver Enrollment|PLWD death|2|||
94743188|NCT04165213|324515442|FG001|Caregiver Enrollment|PLWD death|0|||
94743189|NCT04165213|324515441|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
94743190|NCT04165213|324515442|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
94743191|NCT04165213|324515441|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
94743192|NCT04165213|324515442|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
94743193|NCT04165213|324515441|FG000|PLWD Enrollment|Lost to Follow-up|1|||
94743194|NCT04165213|324515442|FG001|PLWD Enrollment|Lost to Follow-up|1|||
94743195|NCT04165213|324515441|FG000|PLWD Enrollment|Physician Decision|1|||
94743196|NCT04165213|324515442|FG001|PLWD Enrollment|Physician Decision|0|||
94743197|NCT04165213|324515441|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
94743198|NCT04165213|324515442|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
94743199|NCT04165213|324515441|FG000|PLWD Enrollment|Death|2|||
94743200|NCT04165213|324515442|FG001|PLWD Enrollment|Death|0|||
94743201|NCT04165213|324515441|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
94743202|NCT04165213|324515442|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
94370643|NCT00435825|323142954|FG002|Overall Study|Did not complete full follow-up period|4|||
94370644|NCT00435825|323142955|FG003|Overall Study|Did not complete full follow-up period|5|||
94370645|NCT04578548|323142956|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
94370646|NCT04578548|323142957|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
94370647|NCT04578548|323142956|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
94370648|NCT04578548|323142957|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
94370649|NCT04578548|323142956|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
94370650|NCT04578548|323142957|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
94370651|NCT04578548|323142956|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
94370652|NCT04578548|323142957|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
94370653|NCT04578548|323142956|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
94370654|NCT04578548|323142957|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
94370655|NCT04578548|323142956|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
94370656|NCT04578548|323142957|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
94370657|NCT05788237|323142958|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
94370658|NCT05788237|323142959|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
94370659|NCT05788237|323142960|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
94370660|NCT05788237|323142961|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
94370661|NCT05788237|323142958|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
94370662|NCT05788237|323142959|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
94370663|NCT05788237|323142960|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
94370664|NCT05788237|323142961|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
94370665|NCT05788237|323142958|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
94370666|NCT05788237|323142959|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
94203039|NCT00353496|322539498|FG001|Overall Study|Protocol Violation|2|||
94203040|NCT00353496|322539497|FG000|Overall Study|Withdrawal by Subject|3|||
94203041|NCT00353496|322539498|FG001|Overall Study|Withdrawal by Subject|4|||
94203042|NCT00353496|322539497|FG000|Overall Study|Physician Decision|6|||
94203043|NCT00353496|322539498|FG001|Overall Study|Physician Decision|9|||
94203044|NCT00353496|322539497|FG000|Overall Study|Not otherwise specified|4|||
94203045|NCT00353496|322539498|FG001|Overall Study|Not otherwise specified|2|||
94203046|NCT04980300|322539499|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
94203047|NCT04980300|322539500|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
94203048|NCT04980300|322539499|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
94203049|NCT04980300|322539500|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
94203050|NCT04980300|322539499|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
94203051|NCT04980300|322539500|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
94203052|NCT04980300|322539499|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
94203053|NCT04980300|322539500|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
94203054|NCT03215706|322539501|FG000|Randomization|Adverse Event unrelated to study drug|1|||
94203055|NCT03215706|322539502|FG001|Randomization|Adverse Event unrelated to study drug|0|||
94203056|NCT03215706|322539501|FG000|Randomization|participant withdrew consent|1|||
94203057|NCT03215706|322539502|FG001|Randomization|participant withdrew consent|3|||
94203058|NCT03215706|322539501|FG000|Randomization|no longer meets study criteria|1|||
94203059|NCT03215706|322539502|FG001|Randomization|no longer meets study criteria|4|||
94203060|NCT03215706|322539501|FG000|Randomization|other reasons|0|||
94203061|NCT03215706|322539502|FG001|Randomization|other reasons|2|||
94203062|NCT03215706|322539501|FG000|Treatment Period|Disease Progression|150|||
94203063|NCT03215706|322539502|FG001|Treatment Period|Disease Progression|142|||
94203064|NCT03215706|322539501|FG000|Treatment Period|Study Drug Toxicity|53|||
94203065|NCT03215706|322539502|FG001|Treatment Period|Study Drug Toxicity|21|||
94203066|NCT03215706|322539501|FG000|Treatment Period|Death|2|||
94203067|NCT03215706|322539502|FG001|Treatment Period|Death|1|||
94203068|NCT03215706|322539501|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
94203069|NCT03215706|322539502|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
94203070|NCT03215706|322539501|FG000|Treatment Period|Request to D/C treatment|1|||
94203071|NCT03215706|322539502|FG001|Treatment Period|Request to D/C treatment|6|||
94370667|NCT05788237|323142960|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
94370668|NCT05788237|323142961|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
94203072|NCT03215706|322539501|FG000|Treatment Period|Participant withdrew consent|3|||
94370669|NCT05788237|323142958|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
94370670|NCT05788237|323142959|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
94370671|NCT05788237|323142960|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
94203073|NCT03215706|322539502|FG001|Treatment Period|Participant withdrew consent|4|||
94203074|NCT03215706|322539501|FG000|Treatment Period|Lost to Follow-up|0|||
94203075|NCT03215706|322539502|FG001|Treatment Period|Lost to Follow-up|1|||
94203076|NCT03215706|322539501|FG000|Treatment Period|Other Reasons|4|||
94203077|NCT03215706|322539502|FG001|Treatment Period|Other Reasons|5|||
94203078|NCT03215706|322539501|FG000|Treatment Period|Ongoing in the treatment period|105|||
94203079|NCT03215706|322539502|FG001|Treatment Period|Ongoing in the treatment period|43|||
94203080|NCT01470144|322539505|FG000|Overall Study|Adverse Event|2|||
94203081|NCT01470144|322539505|FG000|Overall Study|Death|1|||
94203082|NCT01470144|322539505|FG000|Overall Study|Lung transplant|6|||
94203083|NCT01470144|322539505|FG000|Overall Study|Patient's and investigator's decision|1|||
94203084|NCT01639131|322540221|FG000|Overall Study|Disease Progression|6|||
94203085|NCT02633215|322540224|FG000|Overall Study|Lost to Follow-up|2|||
94203086|NCT02633215|322540225|FG001|Overall Study|Lost to Follow-up|3|||
94203087|NCT02866942|322540226|FG000|Overall Study|Invalid consent|1|||
94203088|NCT04129164|322540230|FG000|Overall Study|Non-compliance with procedures|0|||
94203089|NCT04129164|322540231|FG001|Overall Study|Non-compliance with procedures|0|||
94203090|NCT04129164|322540232|FG002|Overall Study|Non-compliance with procedures|2|||
94203091|NCT04129164|322540233|FG003|Overall Study|Non-compliance with procedures|0|||
94203092|NCT04129164|322540230|FG000|Overall Study|Adverse Event|0|||
94203093|NCT04129164|322540231|FG001|Overall Study|Adverse Event|0|||
94203094|NCT04129164|322540232|FG002|Overall Study|Adverse Event|2|||
94203095|NCT04129164|322540233|FG003|Overall Study|Adverse Event|0|||
94203096|NCT04129164|322540230|FG000|Overall Study|Pregnancy|0|||
94203097|NCT04129164|322540231|FG001|Overall Study|Pregnancy|0|||
94203098|NCT04129164|322540232|FG002|Overall Study|Pregnancy|0|||
94203099|NCT04129164|322540233|FG003|Overall Study|Pregnancy|1|||
94203100|NCT04129164|322540230|FG000|Overall Study|Withdrawal by Subject|3|||
94203101|NCT04129164|322540231|FG001|Overall Study|Withdrawal by Subject|2|||
94203102|NCT04129164|322540232|FG002|Overall Study|Withdrawal by Subject|4|||
94203103|NCT04129164|322540233|FG003|Overall Study|Withdrawal by Subject|6|||
94203104|NCT04129164|322540230|FG000|Overall Study|Death|0|||
94203105|NCT04129164|322540231|FG001|Overall Study|Death|1|||
94203106|NCT04129164|322540232|FG002|Overall Study|Death|0|||
94203107|NCT04129164|322540233|FG003|Overall Study|Death|0|||
94203108|NCT04129164|322540230|FG000|Overall Study|Lost to Follow-up|0|||
94203109|NCT04129164|322540231|FG001|Overall Study|Lost to Follow-up|1|||
94203110|NCT04129164|322540232|FG002|Overall Study|Lost to Follow-up|0|||
94203111|NCT04129164|322540233|FG003|Overall Study|Lost to Follow-up|0|||
94203112|NCT01313559|322540247|FG000|Overall Study|Withdrawal by Subject|1|||
94743203|NCT04933474|324515444|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
94743204|NCT04933474|324515445|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
94743205|NCT04933474|324515444|FG000|Overall Study|Lost to Follow-up|19|||
94743206|NCT04933474|324515445|FG001|Overall Study|Lost to Follow-up|9|||
94743207|NCT04933474|324515444|FG000|Overall Study|Life Burden - unable to participate|6|||
94743208|NCT04933474|324515445|FG001|Overall Study|Life Burden - unable to participate|2|||
94743209|NCT04933474|324515444|FG000|Overall Study|Disease Burden - unable to participate|4|||
94743210|NCT04933474|324515445|FG001|Overall Study|Disease Burden - unable to participate|1|||
94743211|NCT04933474|324515444|FG000|Overall Study|Surgery/Hospitalization|1|||
94743212|NCT04933474|324515445|FG001|Overall Study|Surgery/Hospitalization|2|||
94743213|NCT04933474|324515444|FG000|Overall Study|Dissatisfied with Intervention|1|||
94743214|NCT04933474|324515445|FG001|Overall Study|Dissatisfied with Intervention|1|||
94743215|NCT04933474|324515444|FG000|Overall Study|Withdrew interest in participation|1|||
94743216|NCT04933474|324515445|FG001|Overall Study|Withdrew interest in participation|0|||
94743217|NCT04933474|324515444|FG000|Overall Study|Had previously enrolled in the study|0|||
94743218|NCT04933474|324515445|FG001|Overall Study|Had previously enrolled in the study|1|||
94743219|NCT04191499|324515453|FG000|Overall Study|Adverse Event|1|||
94743220|NCT04191499|324515454|FG001|Overall Study|Adverse Event|0|||
94743221|NCT04191499|324515453|FG000|Overall Study|Death|42|||
94743222|NCT04191499|324515454|FG001|Overall Study|Death|55|||
94743223|NCT04191499|324515453|FG000|Overall Study|Lost to Follow-up|4|||
94743224|NCT04191499|324515454|FG001|Overall Study|Lost to Follow-up|1|||
94743225|NCT04191499|324515453|FG000|Overall Study|Physician Decision|1|||
94743226|NCT04191499|324515454|FG001|Overall Study|Physician Decision|0|||
94743227|NCT04191499|324515453|FG000|Overall Study|Progressive Disease|1|||
94203113|NCT01313559|322540248|FG001|Overall Study|Withdrawal by Subject|2|||
94203114|NCT01313559|322540247|FG000|Overall Study|Disease progression|1|||
94203115|NCT01313559|322540248|FG001|Overall Study|Disease progression|0|||
94203116|NCT01313559|322540247|FG000|Overall Study|Rising PSA|2|||
94743228|NCT04191499|324515454|FG001|Overall Study|Progressive Disease|0|||
94203117|NCT01313559|322540248|FG001|Overall Study|Rising PSA|0|||
94203118|NCT00328783|322540249|FG000|Overall Study|Could not tolerate ABC|21|||
94203119|NCT00328783|322540249|FG000|Overall Study|No heart in RT field|4|||
94743229|NCT04191499|324515453|FG000|Overall Study|Symptomatic Deterioration|1|||
94743230|NCT04191499|324515454|FG001|Overall Study|Symptomatic Deterioration|0|||
94743231|NCT04191499|324515453|FG000|Overall Study|Withdrawal by Subject|7|||
94743232|NCT04191499|324515454|FG001|Overall Study|Withdrawal by Subject|11|||
94743233|NCT04191499|324515453|FG000|Overall Study|Ongoing in the study|104|||
94203120|NCT00328783|322540249|FG000|Overall Study|Withdrawal by Subject|1|||
94203121|NCT04517435|322540250|FG000|Overall Study|Withdrawal by Subject|0|||
94203122|NCT04517435|322540251|FG001|Overall Study|Withdrawal by Subject|0|||
94203123|NCT04517435|322540252|FG002|Overall Study|Withdrawal by Subject|1|||
94203124|NCT04517435|322540250|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
94467641|NCT01451164|323502366|FG003|Overall Study|Protocol Violation|0|||
94203125|NCT04517435|322540251|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
94203126|NCT04517435|322540252|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
94203127|NCT04926740|322540253|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
94203128|NCT04926740|322540254|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
94203129|NCT04926740|322540253|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
94203130|NCT04926740|322540254|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
94203131|NCT03275285|322540255|FG000|Overall Study|Ongoing|45|||
94203132|NCT03275285|322540256|FG001|Overall Study|Ongoing|69|||
94203133|NCT02500576|322540257|FG000|Overall Study|Adverse Event|0|||
94203134|NCT02500576|322540258|FG001|Overall Study|Adverse Event|1|||
94203135|NCT02500576|322540257|FG000|Overall Study|Death|2|||
94203136|NCT02500576|322540258|FG001|Overall Study|Death|1|||
94203137|NCT02500576|322540257|FG000|Overall Study|Lack of Efficacy|5|||
94203138|NCT02500576|322540258|FG001|Overall Study|Lack of Efficacy|5|||
94203139|NCT02500576|322540257|FG000|Overall Study|Withdrawal by Subject|1|||
94203140|NCT02500576|322540258|FG001|Overall Study|Withdrawal by Subject|1|||
94203141|NCT05827068|322540261|FG000|Overall Study|Lost to Follow-up|1|||
94203142|NCT05827068|322540262|FG001|Overall Study|Lost to Follow-up|4|||
94203143|NCT05827068|322540263|FG002|Overall Study|Lost to Follow-up|1|||
94203144|NCT05827068|322540264|FG003|Overall Study|Lost to Follow-up|1|||
94203145|NCT05827068|322540265|FG004|Overall Study|Lost to Follow-up|2|||
94203146|NCT05827068|322540266|FG005|Overall Study|Lost to Follow-up|4|||
94203147|NCT05827068|322540267|FG006|Overall Study|Lost to Follow-up|1|||
94203148|NCT05827068|322540261|FG000|Overall Study|Withdrawal by Subject|4|||
94203149|NCT05827068|322540262|FG001|Overall Study|Withdrawal by Subject|0|||
94203150|NCT05827068|322540263|FG002|Overall Study|Withdrawal by Subject|1|||
94203151|NCT05827068|322540264|FG003|Overall Study|Withdrawal by Subject|2|||
94203152|NCT05827068|322540265|FG004|Overall Study|Withdrawal by Subject|3|||
94203153|NCT05827068|322540266|FG005|Overall Study|Withdrawal by Subject|0|||
94203154|NCT05827068|322540267|FG006|Overall Study|Withdrawal by Subject|1|||
94203155|NCT05827068|322540261|FG000|Overall Study|Physician Decision|0|||
94203156|NCT05827068|322540262|FG001|Overall Study|Physician Decision|0|||
94278965|NCT02703311|322812855|FG000|Overall Study|Withdrawal by Subject|3|||
94278966|NCT00960843|322812856|FG000|Overall Study|Lost to Follow-up|2|||
94278967|NCT00960843|322812857|FG001|Overall Study|Lost to Follow-up|0|||
94278968|NCT00960843|322812856|FG000|Overall Study|Protocol Violation|0|||
94278969|NCT00960843|322812857|FG001|Overall Study|Protocol Violation|4|||
94278970|NCT00960843|322812856|FG000|Overall Study|Repeated needle dislodgment|0|||
94278971|NCT00960843|322812857|FG001|Overall Study|Repeated needle dislodgment|1|||
94278972|NCT03873714|322812858|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
94278973|NCT01180660|322812863|FG000|Overall Study|Changed to open surgery|1|||
94278974|NCT01180660|322812864|FG001|Overall Study|Changed to open surgery|0|||
94278975|NCT00088374|322812865|FG000|Overall Study|patient did not receive any 17AAG|1|||
94278976|NCT00088374|322812865|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
94278977|NCT00852995|322812866|FG000|Overall Study|Adverse Event|1|||
94278978|NCT00852995|322812867|FG001|Overall Study|Adverse Event|0|||
94278979|NCT00852995|322812868|FG002|Overall Study|Adverse Event|4|||
94278980|NCT00852995|322812869|FG003|Overall Study|Adverse Event|0|||
94278981|NCT00852995|322812870|FG004|Overall Study|Adverse Event|0|||
94278982|NCT00852995|322812866|FG000|Overall Study|Lost to Follow-up|0|||
94278983|NCT00852995|322812867|FG001|Overall Study|Lost to Follow-up|1|||
94278984|NCT00852995|322812868|FG002|Overall Study|Lost to Follow-up|1|||
94278985|NCT00852995|322812869|FG003|Overall Study|Lost to Follow-up|0|||
94370672|NCT05788237|323142961|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
94370673|NCT05788237|323142958|FG000|SSA (Approximately 2 Months)|Death|0|||
94370674|NCT05788237|323142959|FG001|SSA (Approximately 2 Months)|Death|1|||
94370675|NCT05788237|323142960|FG002|SSA (Approximately 2 Months)|Death|0|||
94370676|NCT05788237|323142961|FG003|SSA (Approximately 2 Months)|Death|0|||
94370677|NCT05788237|323142958|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
94370678|NCT05788237|323142959|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
94370679|NCT05788237|323142960|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
94370680|NCT05788237|323142961|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
94370681|NCT05788237|323142958|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
94370682|NCT05788237|323142959|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
94203157|NCT05827068|322540263|FG002|Overall Study|Physician Decision|0|||
94203158|NCT05827068|322540264|FG003|Overall Study|Physician Decision|0|||
94203159|NCT05827068|322540265|FG004|Overall Study|Physician Decision|1|||
94203160|NCT05827068|322540266|FG005|Overall Study|Physician Decision|0|||
94203161|NCT05827068|322540267|FG006|Overall Study|Physician Decision|1|||
94203162|NCT05827068|322540261|FG000|Overall Study|Other Than Specified|0|||
94203163|NCT05827068|322540262|FG001|Overall Study|Other Than Specified|1|||
94203164|NCT05827068|322540263|FG002|Overall Study|Other Than Specified|0|||
94203165|NCT05827068|322540264|FG003|Overall Study|Other Than Specified|0|||
94278986|NCT00852995|322812870|FG004|Overall Study|Lost to Follow-up|0|||
94278987|NCT00852995|322812866|FG000|Overall Study|Withdrawal by Subject|4|||
94203166|NCT05827068|322540265|FG004|Overall Study|Other Than Specified|0|||
94203167|NCT05827068|322540266|FG005|Overall Study|Other Than Specified|0|||
94203168|NCT05827068|322540267|FG006|Overall Study|Other Than Specified|0|||
94203169|NCT05464732|322540277|FG000|Overall Study|Lost to Follow-up|0|||
94203170|NCT05464732|322540278|FG001|Overall Study|Lost to Follow-up|1|||
94203171|NCT05464732|322540277|FG000|Overall Study|Adverse Event|1|||
94203172|NCT05464732|322540278|FG001|Overall Study|Adverse Event|0|||
94203173|NCT01855750|322540279|FG000|Overall Study|Death|78|||
94203174|NCT01855750|322540280|FG001|Overall Study|Death|78|||
94203175|NCT01855750|322540279|FG000|Overall Study|Lost to Follow-up|9|||
94203176|NCT01855750|322540280|FG001|Overall Study|Lost to Follow-up|23|||
94203177|NCT01855750|322540279|FG000|Overall Study|Withdrawal by Subject|35|||
94203178|NCT01855750|322540280|FG001|Overall Study|Withdrawal by Subject|28|||
94203179|NCT01855750|322540279|FG000|Overall Study|Sponsor ends the study|297|||
94203180|NCT01855750|322540280|FG001|Overall Study|Sponsor ends the study|290|||
94203181|NCT04300023|322540281|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
94203182|NCT04300023|322540282|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
94203183|NCT01983683|322540283|FG000|Overall Study|Withdrawal by Subject|14|||
94203184|NCT01983683|322540284|FG001|Overall Study|Withdrawal by Subject|18|||
94203185|NCT01983683|322540283|FG000|Overall Study|Death|11|||
94203186|NCT01983683|322540284|FG001|Overall Study|Death|15|||
94203187|NCT01983683|322540283|FG000|Overall Study|Physician Decision|8|||
94203188|NCT01983683|322540284|FG001|Overall Study|Physician Decision|9|||
94203189|NCT01983683|322540283|FG000|Overall Study|Lost to Follow-up|4|||
94203190|NCT01983683|322540284|FG001|Overall Study|Lost to Follow-up|8|||
94203191|NCT01983683|322540283|FG000|Overall Study|Sponsor Decision|1|||
94203192|NCT01983683|322540284|FG001|Overall Study|Sponsor Decision|1|||
94203193|NCT04882917|322540287|FG000|Overall Study|Adverse Event|0|||
94203194|NCT04882917|322540288|FG001|Overall Study|Adverse Event|1|||
94203195|NCT04882917|322540289|FG002|Overall Study|Adverse Event|2|||
94203196|NCT04882917|322540290|FG003|Overall Study|Adverse Event|2|||
94203197|NCT04882917|322540287|FG000|Overall Study|Withdrawal by Subject|1|||
94203198|NCT04882917|322540288|FG001|Overall Study|Withdrawal by Subject|0|||
94203199|NCT04882917|322540289|FG002|Overall Study|Withdrawal by Subject|2|||
94203200|NCT04882917|322540290|FG003|Overall Study|Withdrawal by Subject|1|||
94203201|NCT04882917|322540287|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
94203202|NCT04882917|322540288|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
94203203|NCT04882917|322540289|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
94203204|NCT04882917|322540290|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
94203205|NCT01574716|322541054|FG000|Part 1|Death|3|||
94203206|NCT01574716|322541055|FG001|Part 1|Death|1|||
94203207|NCT01574716|322541056|FG002|Part 1|Death|8|||
94203208|NCT01574716|322541057|FG003|Part 1|Death|0|||
94203209|NCT01574716|322541058|FG004|Part 1|Death|0|||
94203210|NCT01574716|322541054|FG000|Part 1|Discontinuation of study by sponsor|0|||
94203211|NCT01574716|322541055|FG001|Part 1|Discontinuation of study by sponsor|0|||
94203212|NCT01574716|322541056|FG002|Part 1|Discontinuation of study by sponsor|1|||
94203213|NCT01574716|322541057|FG003|Part 1|Discontinuation of study by sponsor|0|||
94203214|NCT01574716|322541058|FG004|Part 1|Discontinuation of study by sponsor|0|||
94203215|NCT01574716|322541054|FG000|Part 1|Withdrawal by Subject|0|||
94203216|NCT01574716|322541055|FG001|Part 1|Withdrawal by Subject|2|||
94203217|NCT01574716|322541056|FG002|Part 1|Withdrawal by Subject|0|||
94203218|NCT01574716|322541057|FG003|Part 1|Withdrawal by Subject|0|||
94203219|NCT01574716|322541058|FG004|Part 1|Withdrawal by Subject|0|||
94203220|NCT01574716|322541054|FG000|Part 1|Lost to Follow-up|0|||
94203221|NCT01574716|322541055|FG001|Part 1|Lost to Follow-up|1|||
94203222|NCT01574716|322541056|FG002|Part 1|Lost to Follow-up|0|||
94203223|NCT01574716|322541057|FG003|Part 1|Lost to Follow-up|0|||
94203224|NCT01574716|322541058|FG004|Part 1|Lost to Follow-up|0|||
94203225|NCT01574716|322541054|FG000|Part 2|Progressive disease|0|||
94203226|NCT01574716|322541055|FG001|Part 2|Progressive disease|0|||
94203227|NCT01574716|322541056|FG002|Part 2|Progressive disease|0|||
94370683|NCT05788237|323142960|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
94203228|NCT01574716|322541057|FG003|Part 2|Progressive disease|1|||
94203229|NCT01574716|322541058|FG004|Part 2|Progressive disease|0|||
94203230|NCT01574716|322541054|FG000|Part 2|Death|0|||
94203231|NCT01574716|322541055|FG001|Part 2|Death|0|||
94370684|NCT05788237|323142961|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
94203232|NCT01574716|322541056|FG002|Part 2|Death|0|||
94203233|NCT01574716|322541057|FG003|Part 2|Death|76|||
94203234|NCT01574716|322541058|FG004|Part 2|Death|35|||
94203235|NCT01574716|322541054|FG000|Part 2|Discontinuation of study by sponsor|0|||
94203236|NCT01574716|322541055|FG001|Part 2|Discontinuation of study by sponsor|0|||
94203237|NCT01574716|322541056|FG002|Part 2|Discontinuation of study by sponsor|0|||
94203238|NCT01574716|322541057|FG003|Part 2|Discontinuation of study by sponsor|51|||
94203239|NCT01574716|322541058|FG004|Part 2|Discontinuation of study by sponsor|31|||
94203240|NCT01574716|322541054|FG000|Part 2|Withdrawal by Subject|0|||
94203241|NCT01574716|322541055|FG001|Part 2|Withdrawal by Subject|0|||
94203242|NCT01574716|322541056|FG002|Part 2|Withdrawal by Subject|0|||
94743234|NCT04191499|324515454|FG001|Overall Study|Ongoing in the study|97|||
94278988|NCT00852995|322812867|FG001|Overall Study|Withdrawal by Subject|0|||
94278989|NCT00852995|322812868|FG002|Overall Study|Withdrawal by Subject|0|||
94278990|NCT00852995|322812869|FG003|Overall Study|Withdrawal by Subject|1|||
94278991|NCT00852995|322812870|FG004|Overall Study|Withdrawal by Subject|2|||
94278992|NCT00852995|322812866|FG000|Overall Study|Non-Compliance|0|||
94278993|NCT00852995|322812867|FG001|Overall Study|Non-Compliance|0|||
94743235|NCT02231749|324515458|FG000|Overall Study|Disease progression|229|||
94743236|NCT02231749|324515459|FG001|Overall Study|Disease progression|297|||
94743237|NCT02231749|324515458|FG000|Overall Study|Study Drug Toxicity|134|||
94743238|NCT02231749|324515459|FG001|Overall Study|Study Drug Toxicity|63|||
94743239|NCT02231749|324515458|FG000|Overall Study|Death|1|||
94743240|NCT02231749|324515459|FG001|Overall Study|Death|1|||
94743241|NCT02231749|324515458|FG000|Overall Study|AE unrelated to Study drug|32|||
94743242|NCT02231749|324515459|FG001|Overall Study|AE unrelated to Study drug|31|||
94743243|NCT02231749|324515458|FG000|Overall Study|Participant's request to discontinue|10|||
94743244|NCT02231749|324515459|FG001|Overall Study|Participant's request to discontinue|21|||
94743245|NCT02231749|324515458|FG000|Overall Study|Participant withdrew Consent|8|||
94743246|NCT02231749|324515459|FG001|Overall Study|Participant withdrew Consent|15|||
94743247|NCT02231749|324515458|FG000|Overall Study|Lost to Follow-up|1|||
94743248|NCT02231749|324515459|FG001|Overall Study|Lost to Follow-up|2|||
94743249|NCT02231749|324515458|FG000|Overall Study|Maximum Clinical Benefit|5|||
94743250|NCT02231749|324515459|FG001|Overall Study|Maximum Clinical Benefit|8|||
94743251|NCT02231749|324515458|FG000|Overall Study|Poor/Non-Compliance|0|||
94743252|NCT02231749|324515459|FG001|Overall Study|Poor/Non-Compliance|3|||
94743253|NCT02231749|324515458|FG000|Overall Study|Pregnancy|1|||
94743254|NCT02231749|324515459|FG001|Overall Study|Pregnancy|0|||
94743255|NCT02231749|324515458|FG000|Overall Study|other|0|||
94743256|NCT02231749|324515459|FG001|Overall Study|other|8|||
94743257|NCT02231749|324515458|FG000|Overall Study|No longer meets Study Criteria|1|||
94743258|NCT02231749|324515459|FG001|Overall Study|No longer meets Study Criteria|0|||
94743259|NCT05323656|324515464|FG000|Overall Study|Still On-Treatment|6|||
94743260|NCT05323656|324515465|FG001|Overall Study|Still On-Treatment|6|||
94743261|NCT05323656|324515464|FG000|Overall Study|Progressive Disease|15|||
94743262|NCT05323656|324515465|FG001|Overall Study|Progressive Disease|14|||
94743263|NCT05323656|324515464|FG000|Overall Study|Adverse Event|2|||
94743264|NCT05323656|324515465|FG001|Overall Study|Adverse Event|3|||
94743265|NCT05323656|324515464|FG000|Overall Study|Death|1|||
94743266|NCT05323656|324515465|FG001|Overall Study|Death|2|||
94743267|NCT05323656|324515464|FG000|Overall Study|Withdrawal by Subject|1|||
94743268|NCT05323656|324515465|FG001|Overall Study|Withdrawal by Subject|0|||
94743269|NCT05323656|324515464|FG000|Overall Study|Clinical disease progression|0|||
94743270|NCT05323656|324515465|FG001|Overall Study|Clinical disease progression|1|||
94743271|NCT05323656|324515464|FG000|Overall Study|Patient and Investigator decision|1|||
94743272|NCT05323656|324515465|FG001|Overall Study|Patient and Investigator decision|0|||
94743273|NCT05323656|324515464|FG000|Overall Study|Physician Decision|0|||
94743274|NCT05323656|324515465|FG001|Overall Study|Physician Decision|1|||
94743275|NCT04035447|324515468|FG000|Treatment Period|Lost to Follow-up|6|||
94743276|NCT04035447|324515469|FG001|Treatment Period|Lost to Follow-up|5|||
94743277|NCT04035447|324515468|FG000|Treatment Period|Physician Decision|0|||
94743278|NCT04035447|324515469|FG001|Treatment Period|Physician Decision|2|||
94743279|NCT05966155|324515475|FG000|Overall Study|Death|1|||
94743280|NCT05966155|324515476|FG001|Overall Study|Death|2|||
94743281|NCT05966155|324515475|FG000|Overall Study|Lost to Follow-up|63|||
94743282|NCT05966155|324515476|FG001|Overall Study|Lost to Follow-up|67|||
94743283|NCT05966155|324515475|FG000|Overall Study|Protocol Violation|1|||
94743284|NCT05966155|324515476|FG001|Overall Study|Protocol Violation|0|||
94743285|NCT05966155|324515475|FG000|Overall Study|Withdrawal by Subject|8|||
94743286|NCT05966155|324515476|FG001|Overall Study|Withdrawal by Subject|9|||
94743287|NCT05966155|324515475|FG000|Overall Study|Enrolled Erroneously|0|||
94743288|NCT05966155|324515476|FG001|Overall Study|Enrolled Erroneously|1|||
94743289|NCT05966155|324515475|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
94743290|NCT05966155|324515476|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
94743291|NCT03248492|324516991|FG000|Overall Study|Progressive Disease|24|||
94743292|NCT03248492|324516992|FG001|Overall Study|Progressive Disease|23|||
94743293|NCT03248492|324516993|FG002|Overall Study|Progressive Disease|11|||
94743294|NCT03248492|324516994|FG003|Overall Study|Progressive Disease|66|||
94743295|NCT03248492|324516995|FG004|Overall Study|Progressive Disease|1|||
94743296|NCT03248492|324516991|FG000|Overall Study|Adverse Event|14|||
94743297|NCT03248492|324516992|FG001|Overall Study|Adverse Event|13|||
94743298|NCT03248492|324516993|FG002|Overall Study|Adverse Event|9|||
94743299|NCT03248492|324516994|FG003|Overall Study|Adverse Event|22|||
94743300|NCT03248492|324516995|FG004|Overall Study|Adverse Event|2|||
94743301|NCT03248492|324516991|FG000|Overall Study|Withdrawal by Subject|5|||
94743302|NCT03248492|324516992|FG001|Overall Study|Withdrawal by Subject|4|||
94743303|NCT03248492|324516993|FG002|Overall Study|Withdrawal by Subject|0|||
94278994|NCT00852995|322812868|FG002|Overall Study|Non-Compliance|0|||
94278995|NCT00852995|322812869|FG003|Overall Study|Non-Compliance|2|||
94203243|NCT01574716|322541057|FG003|Part 2|Withdrawal by Subject|5|||
94203244|NCT01574716|322541058|FG004|Part 2|Withdrawal by Subject|4|||
94203245|NCT01574716|322541054|FG000|Part 2|Brain metastases|0|||
94203246|NCT01574716|322541055|FG001|Part 2|Brain metastases|0|||
94203247|NCT01574716|322541056|FG002|Part 2|Brain metastases|0|||
94203248|NCT01574716|322541057|FG003|Part 2|Brain metastases|1|||
94203249|NCT01574716|322541058|FG004|Part 2|Brain metastases|0|||
94203250|NCT01574716|322541054|FG000|Part 2|Lost to Follow-up|0|||
94203251|NCT01574716|322541055|FG001|Part 2|Lost to Follow-up|0|||
94203252|NCT01574716|322541056|FG002|Part 2|Lost to Follow-up|0|||
94203253|NCT01574716|322541057|FG003|Part 2|Lost to Follow-up|3|||
94203254|NCT01574716|322541058|FG004|Part 2|Lost to Follow-up|0|||
94203255|NCT03183050|322541059|FG000|Overall Study|Lost to Follow-up|23|||
94203256|NCT00312208|322541060|FG000|Overall Study|Adverse Event|97|||
94203257|NCT00312208|322541061|FG001|Overall Study|Adverse Event|61|||
94203258|NCT00312208|322541060|FG000|Overall Study|Protocol Violation|5|||
94203259|NCT00312208|322541061|FG001|Overall Study|Protocol Violation|3|||
94203260|NCT00312208|322541060|FG000|Overall Study|Death|2|||
94203261|NCT00312208|322541061|FG001|Overall Study|Death|1|||
94203262|NCT00312208|322541060|FG000|Overall Study|Lack of Efficacy|7|||
94203263|NCT00312208|322541061|FG001|Overall Study|Lack of Efficacy|4|||
94203264|NCT00312208|322541060|FG000|Overall Study|Lost to Follow-up|3|||
94203265|NCT00312208|322541061|FG001|Overall Study|Lost to Follow-up|5|||
94203266|NCT00312208|322541060|FG000|Overall Study|Withdrawal by Subject|53|||
94278996|NCT00852995|322812870|FG004|Overall Study|Non-Compliance|0|||
94278997|NCT00852995|322812866|FG000|Overall Study|Progressive Disease|1|||
94278998|NCT00852995|322812867|FG001|Overall Study|Progressive Disease|0|||
94278999|NCT00852995|322812868|FG002|Overall Study|Progressive Disease|0|||
94279000|NCT00852995|322812869|FG003|Overall Study|Progressive Disease|2|||
94279001|NCT00852995|322812870|FG004|Overall Study|Progressive Disease|1|||
94279002|NCT00852995|322812866|FG000|Overall Study|Physician Decision|1|||
94743304|NCT03248492|324516994|FG003|Overall Study|Withdrawal by Subject|8|||
94743305|NCT03248492|324516995|FG004|Overall Study|Withdrawal by Subject|1|||
94743306|NCT03248492|324516991|FG000|Overall Study|Physician Decision|1|||
94743307|NCT03248492|324516992|FG001|Overall Study|Physician Decision|1|||
94743308|NCT03248492|324516993|FG002|Overall Study|Physician Decision|1|||
94743309|NCT03248492|324516994|FG003|Overall Study|Physician Decision|7|||
94743310|NCT03248492|324516995|FG004|Overall Study|Physician Decision|0|||
94743311|NCT03248492|324516991|FG000|Overall Study|Death|1|||
94743312|NCT03248492|324516992|FG001|Overall Study|Death|1|||
94743313|NCT03248492|324516993|FG002|Overall Study|Death|0|||
94743314|NCT03248492|324516994|FG003|Overall Study|Death|6|||
94743315|NCT03248492|324516995|FG004|Overall Study|Death|0|||
94743316|NCT03248492|324516991|FG000|Overall Study|Study Terminated by Sponsor|3|||
94743317|NCT03248492|324516992|FG001|Overall Study|Study Terminated by Sponsor|1|||
94743318|NCT03248492|324516993|FG002|Overall Study|Study Terminated by Sponsor|0|||
94743319|NCT03248492|324516994|FG003|Overall Study|Study Terminated by Sponsor|7|||
94743320|NCT03248492|324516995|FG004|Overall Study|Study Terminated by Sponsor|0|||
94743321|NCT03248492|324516991|FG000|Overall Study|Other|2|||
94743322|NCT03248492|324516992|FG001|Overall Study|Other|5|||
94743323|NCT03248492|324516993|FG002|Overall Study|Other|0|||
94743324|NCT03248492|324516994|FG003|Overall Study|Other|14|||
94743325|NCT03248492|324516995|FG004|Overall Study|Other|0|||
94743326|NCT03786926|324516996|FG000|Overall Study|Adverse Event|0|||
94743327|NCT03786926|324516997|FG001|Overall Study|Adverse Event|0|||
94743328|NCT03786926|324516998|FG002|Overall Study|Adverse Event|0|||
94743329|NCT03786926|324516999|FG003|Overall Study|Adverse Event|0|||
94743330|NCT03786926|324517000|FG004|Overall Study|Adverse Event|0|||
94743331|NCT03786926|324517001|FG005|Overall Study|Adverse Event|0|||
94743332|NCT03786926|324517002|FG006|Overall Study|Adverse Event|0|||
94743333|NCT03786926|324517003|FG007|Overall Study|Adverse Event|1|||
94743334|NCT03786926|324517004|FG008|Overall Study|Adverse Event|1|||
94743335|NCT03786926|324517005|FG009|Overall Study|Adverse Event|0|||
94743336|NCT03786926|324517006|FG010|Overall Study|Adverse Event|1|||
94743337|NCT03786926|324516996|FG000|Overall Study|Progressive disease|3|||
94743338|NCT03786926|324516997|FG001|Overall Study|Progressive disease|0|||
94743339|NCT03786926|324516998|FG002|Overall Study|Progressive disease|3|||
94743340|NCT03786926|324516999|FG003|Overall Study|Progressive disease|1|||
94743341|NCT03786926|324517000|FG004|Overall Study|Progressive disease|2|||
94743342|NCT03786926|324517001|FG005|Overall Study|Progressive disease|2|||
94743343|NCT03786926|324517002|FG006|Overall Study|Progressive disease|1|||
94203267|NCT00312208|322541061|FG001|Overall Study|Withdrawal by Subject|42|||
94203268|NCT00312208|322541060|FG000|Overall Study|Other|5|||
94203269|NCT00312208|322541061|FG001|Overall Study|Other|7|||
94203270|NCT03691493|322541064|FG000|Overall Study|Withdrawal by Subject|1|||
94203271|NCT02678689|322541065|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
94203272|NCT02678689|322541066|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
94279003|NCT00852995|322812867|FG001|Overall Study|Physician Decision|0|||
94279004|NCT00852995|322812868|FG002|Overall Study|Physician Decision|0|||
94743344|NCT03786926|324517003|FG007|Overall Study|Progressive disease|6|||
94743345|NCT03786926|324517004|FG008|Overall Study|Progressive disease|1|||
94203273|NCT04567615|322541067|FG000|Randomization|Participant withdrew consent|1|||
94203274|NCT04567615|322541068|FG001|Randomization|Participant withdrew consent|0|||
94203275|NCT04567615|322541069|FG002|Randomization|Participant withdrew consent|0|||
94203276|NCT04567615|322541067|FG000|Randomization|Adverse event unrelated to study drug|0|||
94203277|NCT04567615|322541068|FG001|Randomization|Adverse event unrelated to study drug|1|||
94203278|NCT04567615|322541069|FG002|Randomization|Adverse event unrelated to study drug|0|||
94203279|NCT04567615|322541067|FG000|Treatment Period|Participant Withdrew Consent|2|||
94203280|NCT04567615|322541068|FG001|Treatment Period|Participant Withdrew Consent|5|||
94203281|NCT04567615|322541069|FG002|Treatment Period|Participant Withdrew Consent|1|||
94203282|NCT04567615|322541067|FG000|Treatment Period|Death|1|||
94203283|NCT04567615|322541068|FG001|Treatment Period|Death|2|||
94203284|NCT04567615|322541069|FG002|Treatment Period|Death|0|||
94203285|NCT04567615|322541067|FG000|Treatment Period|Lost to Follow-up|0|||
94203286|NCT04567615|322541068|FG001|Treatment Period|Lost to Follow-up|1|||
94203287|NCT04567615|322541069|FG002|Treatment Period|Lost to Follow-up|0|||
94203288|NCT04567615|322541067|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
94203289|NCT04567615|322541068|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
94203290|NCT04567615|322541069|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
94203291|NCT04567615|322541067|FG000|Treatment Period|Disease Progression|85|||
94203292|NCT04567615|322541068|FG001|Treatment Period|Disease Progression|63|||
94203293|NCT04567615|322541069|FG002|Treatment Period|Disease Progression|16|||
94203294|NCT04567615|322541067|FG000|Treatment Period|Study Drug Toxicity|3|||
94203295|NCT04567615|322541068|FG001|Treatment Period|Study Drug Toxicity|10|||
94203296|NCT04567615|322541069|FG002|Treatment Period|Study Drug Toxicity|4|||
94203297|NCT04567615|322541067|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
94203298|NCT04567615|322541068|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
94203299|NCT04567615|322541069|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
94203300|NCT04567615|322541067|FG000|Treatment Period|Other Reasons|1|||
94203301|NCT04567615|322541068|FG001|Treatment Period|Other Reasons|2|||
94203302|NCT04567615|322541069|FG002|Treatment Period|Other Reasons|0|||
94203303|NCT04567615|322541067|FG000|Treatment Period|Still On-going Treatment|21|||
94203304|NCT04567615|322541068|FG001|Treatment Period|Still On-going Treatment|22|||
94203305|NCT04567615|322541069|FG002|Treatment Period|Still On-going Treatment|2|||
94203306|NCT04153890|322541070|FG000|Overall Study|Lost to Follow-up|9|||
94203307|NCT04153890|322541071|FG001|Overall Study|Lost to Follow-up|0|||
94203308|NCT04153890|322541072|FG002|Overall Study|Lost to Follow-up|9|||
94203309|NCT04153890|322541073|FG003|Overall Study|Lost to Follow-up|0|||
94279005|NCT00852995|322812869|FG003|Overall Study|Physician Decision|0|||
94203310|NCT04153890|322541070|FG000|Overall Study|Death|0|||
94203311|NCT04153890|322541071|FG001|Overall Study|Death|2|||
94203312|NCT04153890|322541072|FG002|Overall Study|Death|0|||
94203313|NCT04153890|322541073|FG003|Overall Study|Death|0|||
94203314|NCT04153890|322541070|FG000|Overall Study|Withdrawal by Subject|0|||
94203315|NCT04153890|322541071|FG001|Overall Study|Withdrawal by Subject|0|||
94203316|NCT04153890|322541072|FG002|Overall Study|Withdrawal by Subject|0|||
94203317|NCT04153890|322541073|FG003|Overall Study|Withdrawal by Subject|2|||
94203318|NCT04039113|322541076|FG000|Overall Study|Withdrawal by Subject|8|||
94203319|NCT04039113|322541077|FG001|Overall Study|Withdrawal by Subject|11|||
94203320|NCT04039113|322541076|FG000|Overall Study|Lost to Follow-up|1|||
94203321|NCT04039113|322541077|FG001|Overall Study|Lost to Follow-up|1|||
94203322|NCT04039113|322541076|FG000|Overall Study|Adverse Event|2|||
94203323|NCT04039113|322541077|FG001|Overall Study|Adverse Event|2|||
94203324|NCT04039113|322541076|FG000|Overall Study|Death|2|||
94203325|NCT04039113|322541077|FG001|Overall Study|Death|4|||
94279006|NCT00852995|322812870|FG004|Overall Study|Physician Decision|0|||
94279007|NCT00852995|322812866|FG000|Overall Study|Protocol Violation|0|||
94279008|NCT00852995|322812867|FG001|Overall Study|Protocol Violation|0|||
94279009|NCT00852995|322812868|FG002|Overall Study|Protocol Violation|0|||
94279010|NCT00852995|322812869|FG003|Overall Study|Protocol Violation|0|||
94279011|NCT00852995|322812870|FG004|Overall Study|Protocol Violation|1|||
94279012|NCT00852995|322812866|FG000|Overall Study|Moved Out of Area|1|||
94203326|NCT04039113|322541076|FG000|Overall Study|Site Closure|6|||
94203327|NCT04039113|322541077|FG001|Overall Study|Site Closure|0|||
94203328|NCT04039113|322541076|FG000|Overall Study|Failure to meet randomisation criteria|4|||
94203329|NCT04039113|322541077|FG001|Overall Study|Failure to meet randomisation criteria|0|||
94203330|NCT03227861|322541078|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
94203331|NCT03227861|322541078|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
94203332|NCT03227861|322541078|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
94203333|NCT03227861|322541078|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
94203334|NCT03227861|322541078|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
94203335|NCT03227861|322541078|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
94203336|NCT03227861|322541078|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
94279013|NCT00852995|322812867|FG001|Overall Study|Moved Out of Area|0|||
94279014|NCT00852995|322812868|FG002|Overall Study|Moved Out of Area|0|||
94279015|NCT00852995|322812869|FG003|Overall Study|Moved Out of Area|0|||
94203337|NCT03227861|322541078|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
94203338|NCT03227861|322541078|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
94203339|NCT03227861|322541078|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
94203340|NCT03170349|322541082|FG000|From Implant to the 30-Day Visit|Death|1|||
94203341|NCT03170349|322541082|FG000|From 30-Day to 6-Month Visit|Death|3|||
94203342|NCT03170349|322541082|FG000|From 30-Day to 6-Month Visit|Withdrawal by Subject|1|||
94203343|NCT03170349|322541082|FG000|From 30-Day to 6-Month Visit|Exited for Other Reasons|5|||
94203344|NCT03170349|322541082|FG000|From 6-Month to 1-Year Visit|Death|6|||
94203345|NCT03170349|322541082|FG000|From 6-Month to 1-Year Visit|Exited for Other Reasons|2|||
94203346|NCT03170349|322541082|FG000|From 1-Year to 2-Year Visit|Death|13|||
94203347|NCT03170349|322541082|FG000|From 1-Year to 2-Year Visit|Withdrawal by Subject|1|||
94203348|NCT03170349|322541082|FG000|From 1-Year to 2-Year Visit|Missed Visit|4|||
94203349|NCT03170349|322541082|FG000|From 2-Year to 3-Year Visit|Death|10|||
94203350|NCT03170349|322541082|FG000|From 2-Year to 3-Year Visit|Lost to Follow-up|2|||
94203351|NCT03170349|322541082|FG000|From 2-Year to 3-Year Visit|Withdrawal by Subject|2|||
94203352|NCT03170349|322541082|FG000|From 2-Year to 3-Year Visit|Missed Visit|1|||
94203353|NCT02751528|322541083|FG000|Overall Study|Withdrawal by Subject|1|||
94203354|NCT02751528|322541083|FG000|Overall Study|Adverse Event|1|||
94203355|NCT05485805|322541086|FG000|Overall Study|Withdrawal by Subject|1|||
94203356|NCT05485805|322541087|FG001|Overall Study|Withdrawal by Subject|2|||
94203357|NCT05485805|322541088|FG002|Overall Study|Withdrawal by Subject|2|||
94203358|NCT05485805|322541089|FG003|Overall Study|Withdrawal by Subject|0|||
94203359|NCT05485805|322541090|FG004|Overall Study|Withdrawal by Subject|2|||
94203360|NCT05485805|322541086|FG000|Overall Study|Adverse Event|0|||
94203361|NCT05485805|322541087|FG001|Overall Study|Adverse Event|1|||
94203362|NCT05485805|322541088|FG002|Overall Study|Adverse Event|0|||
94203363|NCT05485805|322541089|FG003|Overall Study|Adverse Event|0|||
94203364|NCT05485805|322541090|FG004|Overall Study|Adverse Event|0|||
94203365|NCT05485805|322541086|FG000|Overall Study|Lost to Follow-up|1|||
94203366|NCT05485805|322541087|FG001|Overall Study|Lost to Follow-up|1|||
94203367|NCT05485805|322541088|FG002|Overall Study|Lost to Follow-up|3|||
94203368|NCT05485805|322541089|FG003|Overall Study|Lost to Follow-up|1|||
94203369|NCT05485805|322541090|FG004|Overall Study|Lost to Follow-up|0|||
94203370|NCT04218357|322541091|FG000|1st Allocation|Withdrawal by Subject|1|||
94203371|NCT04218357|322541092|FG001|1st Allocation|Withdrawal by Subject|0|||
94203372|NCT00490139|322541096|FG000|Overall Study|Lost to Follow-up|249|||
94203373|NCT00490139|322541097|FG001|Overall Study|Lost to Follow-up|216|||
94203374|NCT00490139|322541098|FG002|Overall Study|Lost to Follow-up|205|||
94203375|NCT00490139|322541099|FG003|Overall Study|Lost to Follow-up|229|||
94203376|NCT00490139|322541096|FG000|Overall Study|Withdrawal by Subject|333|||
94370685|NCT05788237|323142958|FG000|SSB (Approximately 1 Month)|Other|0|||
94370686|NCT05788237|323142959|FG001|SSB (Approximately 1 Month)|Other|0|||
94203377|NCT00490139|322541097|FG001|Overall Study|Withdrawal by Subject|322|||
94203378|NCT00490139|322541098|FG002|Overall Study|Withdrawal by Subject|396|||
94203379|NCT00490139|322541099|FG003|Overall Study|Withdrawal by Subject|295|||
94203380|NCT00490139|322541096|FG000|Overall Study|Patient did not sign ICF 12|169|||
94203381|NCT00490139|322541097|FG001|Overall Study|Patient did not sign ICF 12|176|||
94203382|NCT00490139|322541098|FG002|Overall Study|Patient did not sign ICF 12|139|||
94203383|NCT00490139|322541099|FG003|Overall Study|Patient did not sign ICF 12|167|||
94203384|NCT00490139|322541096|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
94203385|NCT00490139|322541097|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
94203386|NCT00490139|322541098|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
94203387|NCT00490139|322541099|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
94203388|NCT00490139|322541096|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
94203389|NCT00490139|322541097|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
94203390|NCT00490139|322541098|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
94203391|NCT00490139|322541099|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
94203392|NCT00490139|322541096|FG000|Overall Study|Other reasons as defined per protocol|98|||
94203393|NCT00490139|322541097|FG001|Overall Study|Other reasons as defined per protocol|84|||
94203394|NCT00490139|322541098|FG002|Overall Study|Other reasons as defined per protocol|82|||
94203395|NCT00490139|322541099|FG003|Overall Study|Other reasons as defined per protocol|105|||
94203396|NCT05810285|322541101|FG000|Overall Study|Death|4|||
94203397|NCT05810285|322541102|FG001|Overall Study|Death|21|||
94203398|NCT05810285|322541101|FG000|Overall Study|Adverse Event|18|||
94203399|NCT05810285|322541102|FG001|Overall Study|Adverse Event|16|||
94203400|NCT04484623|322541103|FG000|Overall Study|Lost to Follow-up|0|||
94203401|NCT04484623|322541104|FG001|Overall Study|Lost to Follow-up|1|||
94203402|NCT04484623|322541103|FG000|Overall Study|Protocol Deviation|1|||
94203403|NCT04484623|322541104|FG001|Overall Study|Protocol Deviation|0|||
94370687|NCT05788237|323142960|FG002|SSB (Approximately 1 Month)|Other|0|||
94203404|NCT04484623|322541103|FG000|Overall Study|Physician Decision|1|||
94203405|NCT04484623|322541104|FG001|Overall Study|Physician Decision|0|||
94203406|NCT04484623|322541103|FG000|Overall Study|Withdrawal by Subject|11|||
94203407|NCT04484623|322541104|FG001|Overall Study|Withdrawal by Subject|8|||
94203408|NCT04484623|322541103|FG000|Overall Study|Ongoing|94|||
94203409|NCT04484623|322541104|FG001|Overall Study|Ongoing|84|||
94203410|NCT05470114|322541105|FG000|Overall Study|Withdrawal by Subject|1|||
94203411|NCT05470114|322541106|FG001|Overall Study|Withdrawal by Subject|0|||
94203412|NCT05470114|322541105|FG000|Overall Study|Lost to Follow-up|1|||
94203413|NCT05470114|322541106|FG001|Overall Study|Lost to Follow-up|0|||
94203414|NCT04649047|322541107|FG000|Overall Study|Withdrawal by Subject|3|||
94203415|NCT02488408|322541108|FG000|Part A|Adverse Event|2|||
94203416|NCT02488408|322541109|FG001|Part A|Adverse Event|0|||
94203417|NCT02488408|322541110|FG002|Part A|Adverse Event|0|||
94203418|NCT02488408|322541111|FG003|Part A|Adverse Event|0|||
94203419|NCT02488408|322541112|FG004|Part A|Adverse Event|0|||
94370688|NCT05788237|323142961|FG003|SSB (Approximately 1 Month)|Other|1|||
94203420|NCT02488408|322541113|FG005|Part A|Adverse Event|0|||
94203421|NCT02488408|322541114|FG006|Part A|Adverse Event|0|||
94203422|NCT02488408|322541115|FG007|Part A|Adverse Event|0|||
94203423|NCT02488408|322541116|FG008|Part A|Adverse Event|0|||
94203424|NCT02488408|322541117|FG009|Part A|Adverse Event|0|||
94203425|NCT02488408|322541108|FG000|Part A|Death|1|||
94203426|NCT02488408|322541109|FG001|Part A|Death|5|||
94203427|NCT02488408|322541110|FG002|Part A|Death|0|||
94203428|NCT02488408|322541111|FG003|Part A|Death|0|||
94203429|NCT02488408|322541112|FG004|Part A|Death|3|||
94203430|NCT02488408|322541113|FG005|Part A|Death|0|||
94203431|NCT02488408|322541114|FG006|Part A|Death|0|||
94203432|NCT02488408|322541115|FG007|Part A|Death|0|||
94203433|NCT02488408|322541116|FG008|Part A|Death|0|||
94203434|NCT02488408|322541117|FG009|Part A|Death|0|||
94203435|NCT02488408|322541108|FG000|Part A|Disease Progression|2|||
94203436|NCT02488408|322541109|FG001|Part A|Disease Progression|8|||
94203437|NCT02488408|322541110|FG002|Part A|Disease Progression|2|||
94203438|NCT02488408|322541111|FG003|Part A|Disease Progression|3|||
94203439|NCT02488408|322541112|FG004|Part A|Disease Progression|4|||
94203440|NCT02488408|322541113|FG005|Part A|Disease Progression|0|||
94203441|NCT02488408|322541114|FG006|Part A|Disease Progression|0|||
94203442|NCT02488408|322541115|FG007|Part A|Disease Progression|0|||
94203443|NCT02488408|322541116|FG008|Part A|Disease Progression|0|||
94203444|NCT02488408|322541117|FG009|Part A|Disease Progression|0|||
94370689|NCT00628745|323142962|FG000|Overall Study|Withdrawal by Subject|63|||
94370690|NCT00628745|323142963|FG001|Overall Study|Withdrawal by Subject|3|||
94370691|NCT00628745|323142964|FG002|Overall Study|Withdrawal by Subject|9|||
94370692|NCT00628745|323142965|FG003|Overall Study|Withdrawal by Subject|2|||
94370693|NCT00628745|323142966|FG004|Overall Study|Withdrawal by Subject|69|||
94370694|NCT00628745|323142962|FG000|Overall Study|Does not meet inclusion criteria|0|||
94203445|NCT02488408|322541108|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
94203446|NCT02488408|322541109|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
94203447|NCT02488408|322541110|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
94203448|NCT02488408|322541111|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
94203449|NCT02488408|322541112|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
94203450|NCT02488408|322541113|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
94203451|NCT02488408|322541114|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
94203452|NCT02488408|322541115|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
94203453|NCT02488408|322541116|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
94203454|NCT02488408|322541117|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
94203455|NCT02488408|322541108|FG000|Part A|Investigator Decision|0|||
94203456|NCT02488408|322541109|FG001|Part A|Investigator Decision|1|||
94203457|NCT02488408|322541110|FG002|Part A|Investigator Decision|1|||
94203458|NCT02488408|322541111|FG003|Part A|Investigator Decision|0|||
94203459|NCT02488408|322541112|FG004|Part A|Investigator Decision|0|||
94203460|NCT02488408|322541113|FG005|Part A|Investigator Decision|0|||
94203461|NCT02488408|322541114|FG006|Part A|Investigator Decision|0|||
94203462|NCT02488408|322541115|FG007|Part A|Investigator Decision|0|||
94203463|NCT02488408|322541116|FG008|Part A|Investigator Decision|0|||
94203464|NCT02488408|322541117|FG009|Part A|Investigator Decision|0|||
94203465|NCT02488408|322541108|FG000|Part A|Withdrawal by Subject|0|||
94203466|NCT02488408|322541109|FG001|Part A|Withdrawal by Subject|0|||
94203467|NCT02488408|322541110|FG002|Part A|Withdrawal by Subject|2|||
94203468|NCT02488408|322541111|FG003|Part A|Withdrawal by Subject|0|||
94203469|NCT02488408|322541112|FG004|Part A|Withdrawal by Subject|0|||
94203470|NCT02488408|322541113|FG005|Part A|Withdrawal by Subject|0|||
94203471|NCT02488408|322541114|FG006|Part A|Withdrawal by Subject|0|||
94203472|NCT02488408|322541115|FG007|Part A|Withdrawal by Subject|0|||
94203473|NCT02488408|322541116|FG008|Part A|Withdrawal by Subject|0|||
94203474|NCT02488408|322541117|FG009|Part A|Withdrawal by Subject|0|||
94203475|NCT02488408|322541108|FG000|Part A|Other|1|||
94203476|NCT02488408|322541109|FG001|Part A|Other|0|||
94203477|NCT02488408|322541110|FG002|Part A|Other|0|||
94467642|NCT01451164|323502363|FG000|Overall Study|Lack of Efficacy|7|||
94203478|NCT02488408|322541111|FG003|Part A|Other|0|||
94203479|NCT02488408|322541112|FG004|Part A|Other|0|||
94203480|NCT02488408|322541113|FG005|Part A|Other|0|||
94203481|NCT02488408|322541114|FG006|Part A|Other|0|||
94203482|NCT02488408|322541115|FG007|Part A|Other|0|||
94370695|NCT00628745|323142963|FG001|Overall Study|Does not meet inclusion criteria|12|||
94370696|NCT00628745|323142964|FG002|Overall Study|Does not meet inclusion criteria|0|||
94370697|NCT00628745|323142965|FG003|Overall Study|Does not meet inclusion criteria|0|||
94370698|NCT00628745|323142966|FG004|Overall Study|Does not meet inclusion criteria|18|||
94370699|NCT00628745|323142962|FG000|Overall Study|Participation in an interventional clinical trial|81|||
94370700|NCT00628745|323142963|FG001|Overall Study|Participation in an interventional clinical trial|4|||
94370701|NCT00628745|323142964|FG002|Overall Study|Participation in an interventional clinical trial|7|||
94370702|NCT00628745|323142965|FG003|Overall Study|Participation in an interventional clinical trial|0|||
94370703|NCT00628745|323142966|FG004|Overall Study|Participation in an interventional clinical trial|63|||
94370704|NCT00628745|323142962|FG000|Overall Study|Physician Decision|8|||
94370705|NCT00628745|323142963|FG001|Overall Study|Physician Decision|4|||
94370706|NCT00628745|323142964|FG002|Overall Study|Physician Decision|3|||
94370707|NCT00628745|323142965|FG003|Overall Study|Physician Decision|0|||
94370708|NCT00628745|323142966|FG004|Overall Study|Physician Decision|30|||
94370709|NCT00628745|323142962|FG000|Overall Study|Lost to Follow-up|109|||
94370710|NCT00628745|323142963|FG001|Overall Study|Lost to Follow-up|7|||
94370711|NCT00628745|323142964|FG002|Overall Study|Lost to Follow-up|7|||
94370712|NCT00628745|323142965|FG003|Overall Study|Lost to Follow-up|0|||
94370713|NCT00628745|323142966|FG004|Overall Study|Lost to Follow-up|498|||
94370714|NCT00628745|323142962|FG000|Overall Study|Death|197|||
94370715|NCT00628745|323142963|FG001|Overall Study|Death|81|||
94370716|NCT00628745|323142964|FG002|Overall Study|Death|12|||
94370717|NCT00628745|323142965|FG003|Overall Study|Death|4|||
94370718|NCT00628745|323142966|FG004|Overall Study|Death|939|||
94370719|NCT00628745|323142962|FG000|Overall Study|Participant transferred to another THAOS site|6|||
94370720|NCT00628745|323142963|FG001|Overall Study|Participant transferred to another THAOS site|0|||
94370721|NCT00628745|323142964|FG002|Overall Study|Participant transferred to another THAOS site|0|||
94370722|NCT00628745|323142965|FG003|Overall Study|Participant transferred to another THAOS site|0|||
94370723|NCT00628745|323142966|FG004|Overall Study|Participant transferred to another THAOS site|7|||
94370724|NCT00628745|323142962|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
94370725|NCT00628745|323142963|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
94370726|NCT00628745|323142964|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
94370727|NCT00628745|323142965|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
94370728|NCT00628745|323142966|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
94370729|NCT00628745|323142962|FG000|Overall Study|Site closure|152|||
94370730|NCT00628745|323142963|FG001|Overall Study|Site closure|146|||
94370731|NCT00628745|323142964|FG002|Overall Study|Site closure|6|||
94370732|NCT00628745|323142965|FG003|Overall Study|Site closure|8|||
94370733|NCT00628745|323142966|FG004|Overall Study|Site closure|691|||
94370734|NCT00628745|323142962|FG000|Overall Study|Duplicate participant|0|||
94370735|NCT00628745|323142963|FG001|Overall Study|Duplicate participant|0|||
94370736|NCT00628745|323142964|FG002|Overall Study|Duplicate participant|0|||
94370737|NCT00628745|323142965|FG003|Overall Study|Duplicate participant|0|||
94370738|NCT00628745|323142966|FG004|Overall Study|Duplicate participant|1|||
94370739|NCT00628745|323142962|FG000|Overall Study|Missing|4|||
94370740|NCT00628745|323142963|FG001|Overall Study|Missing|3|||
94467643|NCT01451164|323502364|FG001|Overall Study|Lack of Efficacy|9|||
94467644|NCT01451164|323502365|FG002|Overall Study|Lack of Efficacy|9|||
94467645|NCT01451164|323502366|FG003|Overall Study|Lack of Efficacy|7|||
94467646|NCT02305446|323502367|FG000|Overall Study|Adverse Event|1|||
94743346|NCT03786926|324517005|FG009|Overall Study|Progressive disease|1|||
94743347|NCT03786926|324517006|FG010|Overall Study|Progressive disease|1|||
94743348|NCT03786926|324516996|FG000|Overall Study|Death|0|||
94743349|NCT03786926|324516997|FG001|Overall Study|Death|1|||
94743350|NCT03786926|324516998|FG002|Overall Study|Death|1|||
94743351|NCT03786926|324516999|FG003|Overall Study|Death|0|||
94743352|NCT03786926|324517000|FG004|Overall Study|Death|0|||
94743353|NCT03786926|324517001|FG005|Overall Study|Death|0|||
94743354|NCT03786926|324517002|FG006|Overall Study|Death|0|||
94743355|NCT03786926|324517003|FG007|Overall Study|Death|0|||
94743356|NCT03786926|324517004|FG008|Overall Study|Death|0|||
94743357|NCT03786926|324517005|FG009|Overall Study|Death|1|||
94743358|NCT03786926|324517006|FG010|Overall Study|Death|2|||
94743359|NCT03786926|324516996|FG000|Overall Study|Physician Decision|0|||
94743360|NCT03786926|324516997|FG001|Overall Study|Physician Decision|1|||
94743361|NCT03786926|324516998|FG002|Overall Study|Physician Decision|0|||
94743362|NCT03786926|324516999|FG003|Overall Study|Physician Decision|1|||
94743363|NCT03786926|324517000|FG004|Overall Study|Physician Decision|2|||
94203483|NCT02488408|322541116|FG008|Part A|Other|0|||
94743364|NCT03786926|324517001|FG005|Overall Study|Physician Decision|0|||
94743365|NCT03786926|324517002|FG006|Overall Study|Physician Decision|0|||
94467647|NCT01492101|323502369|FG000|Overall Study|Death|323|||
94467648|NCT01492101|323502370|FG001|Overall Study|Death|322|||
94743366|NCT03786926|324517003|FG007|Overall Study|Physician Decision|2|||
94743367|NCT03786926|324517004|FG008|Overall Study|Physician Decision|1|||
94743368|NCT03786926|324517005|FG009|Overall Study|Physician Decision|1|||
94203484|NCT02488408|322541117|FG009|Part A|Other|0|||
94203485|NCT02488408|322541108|FG000|Part B|Adverse Event|0|||
94203486|NCT02488408|322541109|FG001|Part B|Adverse Event|0|||
94203487|NCT02488408|322541110|FG002|Part B|Adverse Event|0|||
94203488|NCT02488408|322541111|FG003|Part B|Adverse Event|0|||
94203489|NCT02488408|322541112|FG004|Part B|Adverse Event|0|||
94370741|NCT00628745|323142964|FG002|Overall Study|Missing|0|||
94370742|NCT00628745|323142965|FG003|Overall Study|Missing|0|||
94203490|NCT02488408|322541113|FG005|Part B|Adverse Event|2|||
94203491|NCT02488408|322541114|FG006|Part B|Adverse Event|2|||
94203492|NCT02488408|322541115|FG007|Part B|Adverse Event|7|||
94203493|NCT02488408|322541116|FG008|Part B|Adverse Event|2|||
94203494|NCT02488408|322541117|FG009|Part B|Adverse Event|2|||
94203495|NCT02488408|322541108|FG000|Part B|Death|0|||
94203496|NCT02488408|322541109|FG001|Part B|Death|0|||
94203497|NCT02488408|322541110|FG002|Part B|Death|0|||
94203498|NCT02488408|322541111|FG003|Part B|Death|0|||
94203499|NCT02488408|322541112|FG004|Part B|Death|0|||
94203500|NCT02488408|322541113|FG005|Part B|Death|3|||
94203501|NCT02488408|322541114|FG006|Part B|Death|1|||
94203502|NCT02488408|322541115|FG007|Part B|Death|2|||
94203503|NCT02488408|322541116|FG008|Part B|Death|2|||
94203504|NCT02488408|322541117|FG009|Part B|Death|2|||
94203505|NCT02488408|322541108|FG000|Part B|Death due to Disease Progression|0|||
94203506|NCT02488408|322541109|FG001|Part B|Death due to Disease Progression|0|||
94203507|NCT02488408|322541110|FG002|Part B|Death due to Disease Progression|0|||
94203508|NCT02488408|322541111|FG003|Part B|Death due to Disease Progression|0|||
94203509|NCT02488408|322541112|FG004|Part B|Death due to Disease Progression|0|||
94203510|NCT02488408|322541113|FG005|Part B|Death due to Disease Progression|2|||
94203511|NCT02488408|322541114|FG006|Part B|Death due to Disease Progression|2|||
94203512|NCT02488408|322541115|FG007|Part B|Death due to Disease Progression|1|||
94203513|NCT02488408|322541116|FG008|Part B|Death due to Disease Progression|1|||
94203514|NCT02488408|322541117|FG009|Part B|Death due to Disease Progression|1|||
94203515|NCT02488408|322541108|FG000|Part B|Disease Progression|0|||
94203516|NCT02488408|322541109|FG001|Part B|Disease Progression|0|||
94203517|NCT02488408|322541110|FG002|Part B|Disease Progression|0|||
94203518|NCT02488408|322541111|FG003|Part B|Disease Progression|0|||
94203519|NCT02488408|322541112|FG004|Part B|Disease Progression|0|||
94203520|NCT02488408|322541113|FG005|Part B|Disease Progression|6|||
94203521|NCT02488408|322541114|FG006|Part B|Disease Progression|9|||
94203522|NCT02488408|322541115|FG007|Part B|Disease Progression|7|||
94203523|NCT02488408|322541116|FG008|Part B|Disease Progression|9|||
94203524|NCT02488408|322541117|FG009|Part B|Disease Progression|11|||
94203525|NCT02488408|322541108|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
94203526|NCT02488408|322541109|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
94203527|NCT02488408|322541110|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
94203528|NCT02488408|322541111|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
94203529|NCT02488408|322541112|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
94203530|NCT02488408|322541113|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
94203531|NCT02488408|322541114|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
94203532|NCT02488408|322541115|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
94203533|NCT02488408|322541116|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
94203534|NCT02488408|322541117|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
94203535|NCT02488408|322541108|FG000|Part B|Investigator Decision|0|||
94203536|NCT02488408|322541109|FG001|Part B|Investigator Decision|0|||
94203537|NCT02488408|322541110|FG002|Part B|Investigator Decision|0|||
94203538|NCT02488408|322541111|FG003|Part B|Investigator Decision|0|||
94203539|NCT02488408|322541112|FG004|Part B|Investigator Decision|0|||
94203540|NCT02488408|322541113|FG005|Part B|Investigator Decision|0|||
94203541|NCT02488408|322541114|FG006|Part B|Investigator Decision|1|||
94203542|NCT02488408|322541115|FG007|Part B|Investigator Decision|0|||
94203543|NCT02488408|322541116|FG008|Part B|Investigator Decision|2|||
94203544|NCT02488408|322541117|FG009|Part B|Investigator Decision|1|||
94203545|NCT00719888|322541118|FG000|Overall Study|Death|24|||
94203546|NCT00719888|322541119|FG001|Overall Study|Death|9|||
94370743|NCT00628745|323142966|FG004|Overall Study|Missing|10|||
94203547|NCT00719888|322541118|FG000|Overall Study|Relapse|8|||
94203548|NCT00719888|322541119|FG001|Overall Study|Relapse|3|||
94203549|NCT00719888|322541118|FG000|Overall Study|Physician Decision|1|||
94203550|NCT00719888|322541119|FG001|Overall Study|Physician Decision|0|||
94203551|NCT00719888|322541118|FG000|Overall Study|Withdrawal by Subject|1|||
94203552|NCT00719888|322541119|FG001|Overall Study|Withdrawal by Subject|0|||
94203553|NCT05180539|322542149|FG000|Overall Study|Lost to Follow-up|27|||
94203554|NCT05180539|322542150|FG001|Overall Study|Lost to Follow-up|30|||
94203555|NCT04977583|322542151|FG000|Overall Study|Lost to Follow-up|8|||
94203556|NCT04977583|322542152|FG001|Overall Study|Lost to Follow-up|4|||
94203557|NCT04977583|322542153|FG002|Overall Study|Lost to Follow-up|13|||
94203558|NCT04977583|322542151|FG000|Overall Study|Withdrawal by Subject|3|||
94203559|NCT04977583|322542152|FG001|Overall Study|Withdrawal by Subject|2|||
94203560|NCT04977583|322542153|FG002|Overall Study|Withdrawal by Subject|1|||
94203561|NCT04518943|322542154|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
94279016|NCT00852995|322812870|FG004|Overall Study|Moved Out of Area|0|||
94279017|NCT00498173|322812872|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
94279018|NCT00498173|322812873|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
94279019|NCT00498173|322812874|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
94279020|NCT01836783|322812875|FG000|Overall Study|Withdrawal by Subject|0|||
94279021|NCT01836783|322812876|FG001|Overall Study|Withdrawal by Subject|2|||
94279022|NCT04942925|322812877|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
94279023|NCT04942925|322812878|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
94279024|NCT04942925|322812877|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
94279025|NCT04942925|322812878|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
94279026|NCT05574062|322812882|FG000|Pre Run-In|Screening failure|3|||
94279027|NCT05574062|322812883|FG001|Pre Run-In|Screening failure|0|||
94279028|NCT05574062|322812884|FG002|Pre Run-In|Screening failure|0|||
94279029|NCT05574062|322812885|FG003|Pre Run-In|Screening failure|0|||
94279030|NCT05574062|322812886|FG004|Pre Run-In|Screening failure|0|||
94279031|NCT05574062|322812882|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
94279032|NCT05574062|322812883|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
94279033|NCT05574062|322812884|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
94279034|NCT05574062|322812885|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
94279035|NCT05574062|322812886|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
94279036|NCT05574062|322812882|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
94279037|NCT05574062|322812883|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
94279038|NCT05574062|322812884|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
94279039|NCT05574062|322812885|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
94279040|NCT05574062|322812886|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
94279041|NCT05574062|322812882|FG000|Continuation Phase Period 1|Physician Decision|1|||
94279042|NCT05574062|322812883|FG001|Continuation Phase Period 1|Physician Decision|0|||
94279043|NCT05574062|322812884|FG002|Continuation Phase Period 1|Physician Decision|0|||
94467649|NCT01492101|323502369|FG000|Overall Study|Withdrawal by Subject|14|||
94279044|NCT05574062|322812885|FG003|Continuation Phase Period 1|Physician Decision|0|||
94279045|NCT05574062|322812886|FG004|Continuation Phase Period 1|Physician Decision|0|||
94279046|NCT05574062|322812882|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
94279047|NCT05574062|322812883|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
94279048|NCT05574062|322812884|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
94279049|NCT05574062|322812885|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
94279050|NCT05574062|322812886|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
94279051|NCT05574062|322812882|FG000|Continuation Phase Period 1|Adverse Event|1|||
94279052|NCT05574062|322812883|FG001|Continuation Phase Period 1|Adverse Event|0|||
94279053|NCT05574062|322812884|FG002|Continuation Phase Period 1|Adverse Event|0|||
94279054|NCT05574062|322812885|FG003|Continuation Phase Period 1|Adverse Event|0|||
94279055|NCT05574062|322812886|FG004|Continuation Phase Period 1|Adverse Event|0|||
94467650|NCT01492101|323502370|FG001|Overall Study|Withdrawal by Subject|18|||
94743369|NCT03786926|324517006|FG010|Overall Study|Physician Decision|0|||
94743370|NCT03786926|324516996|FG000|Overall Study|Withdrawal by Subject|0|||
94743371|NCT03786926|324516997|FG001|Overall Study|Withdrawal by Subject|1|||
94743372|NCT03786926|324516998|FG002|Overall Study|Withdrawal by Subject|1|||
94743373|NCT03786926|324516999|FG003|Overall Study|Withdrawal by Subject|0|||
94743374|NCT03786926|324517000|FG004|Overall Study|Withdrawal by Subject|0|||
94743375|NCT03786926|324517001|FG005|Overall Study|Withdrawal by Subject|0|||
94743376|NCT03786926|324517002|FG006|Overall Study|Withdrawal by Subject|1|||
94743377|NCT03786926|324517003|FG007|Overall Study|Withdrawal by Subject|0|||
94743378|NCT03786926|324517004|FG008|Overall Study|Withdrawal by Subject|1|||
94743379|NCT03786926|324517005|FG009|Overall Study|Withdrawal by Subject|0|||
94743380|NCT03786926|324517006|FG010|Overall Study|Withdrawal by Subject|1|||
94743381|NCT03786926|324516996|FG000|Overall Study|Study terminated by Sponsor|0|||
94743382|NCT03786926|324516997|FG001|Overall Study|Study terminated by Sponsor|0|||
94743383|NCT03786926|324516998|FG002|Overall Study|Study terminated by Sponsor|0|||
94743384|NCT03786926|324516999|FG003|Overall Study|Study terminated by Sponsor|0|||
94743385|NCT03786926|324517000|FG004|Overall Study|Study terminated by Sponsor|1|||
94743386|NCT03786926|324517001|FG005|Overall Study|Study terminated by Sponsor|0|||
94743387|NCT03786926|324517002|FG006|Overall Study|Study terminated by Sponsor|0|||
94743388|NCT03786926|324517003|FG007|Overall Study|Study terminated by Sponsor|4|||
94743389|NCT03786926|324517004|FG008|Overall Study|Study terminated by Sponsor|0|||
94743390|NCT03786926|324517005|FG009|Overall Study|Study terminated by Sponsor|0|||
94743391|NCT03786926|324517006|FG010|Overall Study|Study terminated by Sponsor|0|||
94743392|NCT03786926|324516996|FG000|Overall Study|Anti-neoplasm treatment|0|||
94743393|NCT03786926|324516997|FG001|Overall Study|Anti-neoplasm treatment|0|||
94743394|NCT03786926|324516998|FG002|Overall Study|Anti-neoplasm treatment|0|||
94743395|NCT03786926|324516999|FG003|Overall Study|Anti-neoplasm treatment|0|||
94743396|NCT03786926|324517000|FG004|Overall Study|Anti-neoplasm treatment|1|||
94743397|NCT03786926|324517001|FG005|Overall Study|Anti-neoplasm treatment|0|||
94743398|NCT03786926|324517002|FG006|Overall Study|Anti-neoplasm treatment|1|||
94743399|NCT03786926|324517003|FG007|Overall Study|Anti-neoplasm treatment|0|||
94743400|NCT03786926|324517004|FG008|Overall Study|Anti-neoplasm treatment|0|||
94743401|NCT03786926|324517005|FG009|Overall Study|Anti-neoplasm treatment|0|||
94743402|NCT03786926|324517006|FG010|Overall Study|Anti-neoplasm treatment|0|||
94743403|NCT03786926|324516996|FG000|Overall Study|Other|0|||
94743404|NCT03786926|324516997|FG001|Overall Study|Other|0|||
94743405|NCT03786926|324516998|FG002|Overall Study|Other|0|||
94743406|NCT03786926|324516999|FG003|Overall Study|Other|1|||
94743407|NCT03786926|324517000|FG004|Overall Study|Other|0|||
94743408|NCT03786926|324517001|FG005|Overall Study|Other|1|||
94743409|NCT03786926|324517002|FG006|Overall Study|Other|0|||
94743410|NCT03786926|324517003|FG007|Overall Study|Other|0|||
94203562|NCT04518943|322542155|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
94203563|NCT04518943|322542156|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
94203564|NCT04518943|322542157|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
94203565|NCT04518943|322542158|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
94203566|NCT04518943|322542159|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
94203567|NCT04518943|322542160|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
94203568|NCT04518943|322542161|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
94203569|NCT04518943|322542162|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
94203570|NCT04518943|322542163|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
94203571|NCT04518943|322542164|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
94203572|NCT04518943|322542165|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
94203573|NCT04518943|322542166|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
94203574|NCT04518943|322542167|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
94203575|NCT04518943|322542168|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
94203576|NCT04518943|322542169|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
94203577|NCT05412004|322542170|FG000|Overall Study|Adverse Event|0|||
94203578|NCT05412004|322542171|FG001|Overall Study|Adverse Event|2|||
94203579|NCT05412004|322542172|FG002|Overall Study|Adverse Event|1|||
94203580|NCT05412004|322542173|FG003|Overall Study|Adverse Event|5|||
94203581|NCT05412004|322542170|FG000|Overall Study|Assigned Treatment by Mistake|5|||
94203582|NCT05412004|322542171|FG001|Overall Study|Assigned Treatment by Mistake|10|||
94203583|NCT05412004|322542172|FG002|Overall Study|Assigned Treatment by Mistake|2|||
94203584|NCT05412004|322542173|FG003|Overall Study|Assigned Treatment by Mistake|5|||
94203585|NCT05412004|322542170|FG000|Overall Study|Lost to Follow-up|3|||
94203586|NCT05412004|322542171|FG001|Overall Study|Lost to Follow-up|0|||
94203587|NCT05412004|322542172|FG002|Overall Study|Lost to Follow-up|0|||
94203588|NCT05412004|322542173|FG003|Overall Study|Lost to Follow-up|0|||
94203589|NCT05412004|322542170|FG000|Overall Study|Patient could not travel to site|0|||
94203590|NCT05412004|322542171|FG001|Overall Study|Patient could not travel to site|1|||
94203591|NCT05412004|322542172|FG002|Overall Study|Patient could not travel to site|0|||
94203592|NCT05412004|322542173|FG003|Overall Study|Patient could not travel to site|0|||
94203593|NCT05412004|322542170|FG000|Overall Study|Physician Decision|0|||
94203594|NCT05412004|322542171|FG001|Overall Study|Physician Decision|1|||
94203595|NCT05412004|322542172|FG002|Overall Study|Physician Decision|0|||
94203596|NCT05412004|322542173|FG003|Overall Study|Physician Decision|0|||
94203597|NCT05412004|322542170|FG000|Overall Study|Pregnancy|0|||
94203598|NCT05412004|322542171|FG001|Overall Study|Pregnancy|1|||
94203599|NCT05412004|322542172|FG002|Overall Study|Pregnancy|0|||
94203600|NCT05412004|322542173|FG003|Overall Study|Pregnancy|0|||
94203601|NCT05412004|322542170|FG000|Overall Study|Protocol Violation|1|||
94203602|NCT05412004|322542171|FG001|Overall Study|Protocol Violation|0|||
94203603|NCT05412004|322542172|FG002|Overall Study|Protocol Violation|0|||
94203604|NCT05412004|322542173|FG003|Overall Study|Protocol Violation|0|||
94203605|NCT05412004|322542170|FG000|Overall Study|Withdrawal by Subject|4|||
94203606|NCT05412004|322542171|FG001|Overall Study|Withdrawal by Subject|19|||
94203607|NCT05412004|322542172|FG002|Overall Study|Withdrawal by Subject|4|||
94203608|NCT05412004|322542173|FG003|Overall Study|Withdrawal by Subject|14|||
94203609|NCT05412004|322542170|FG000|Overall Study|Screen Failure|0|||
94203610|NCT05412004|322542171|FG001|Overall Study|Screen Failure|0|||
94203611|NCT05412004|322542172|FG002|Overall Study|Screen Failure|0|||
94203612|NCT05412004|322542173|FG003|Overall Study|Screen Failure|1|||
94203613|NCT05412004|322542170|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
94203614|NCT05412004|322542171|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
94203615|NCT05412004|322542172|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
94203616|NCT05412004|322542173|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
94203617|NCT00968149|322542174|FG000|Overall Study|Adverse Event|5|||
94203618|NCT00968149|322542175|FG001|Overall Study|Adverse Event|1|||
94743411|NCT03786926|324517004|FG008|Overall Study|Other|2|||
94743412|NCT03786926|324517005|FG009|Overall Study|Other|0|||
94743413|NCT03786926|324517006|FG010|Overall Study|Other|0|||
94743414|NCT04431713|324517007|FG000|Overall Study|Withdrawal by Subject|2|||
94203619|NCT00968149|322542174|FG000|Overall Study|Lack of Efficacy|0|||
94203620|NCT00968149|322542175|FG001|Overall Study|Lack of Efficacy|4|||
94203621|NCT00968149|322542174|FG000|Overall Study|Lost to Follow-up|0|||
94203622|NCT00968149|322542175|FG001|Overall Study|Lost to Follow-up|1|||
94203623|NCT00968149|322542174|FG000|Overall Study|Protocol Violation|4|||
94203624|NCT00968149|322542175|FG001|Overall Study|Protocol Violation|0|||
94203625|NCT00968149|322542174|FG000|Overall Study|Withdrawal by Subject|2|||
94203626|NCT00968149|322542175|FG001|Overall Study|Withdrawal by Subject|0|||
94279056|NCT05574062|322812882|FG000|Continuation Phase Period 1|Death|1|||
94279057|NCT05574062|322812883|FG001|Continuation Phase Period 1|Death|0|||
94279058|NCT05574062|322812884|FG002|Continuation Phase Period 1|Death|0|||
94279059|NCT05574062|322812885|FG003|Continuation Phase Period 1|Death|0|||
94279060|NCT05574062|322812886|FG004|Continuation Phase Period 1|Death|0|||
94279061|NCT05574062|322812882|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
94279062|NCT05574062|322812883|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
94279063|NCT05574062|322812884|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
94279064|NCT05574062|322812885|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
94279065|NCT05574062|322812886|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
94279066|NCT04418076|322812893|FG000|Overall Study|Death|1|||
94279067|NCT04418076|322812894|FG001|Overall Study|Death|0|||
94279068|NCT04418076|322812895|FG002|Overall Study|Death|0|||
94279069|NCT04418076|322812896|FG003|Overall Study|Death|0|||
94279070|NCT04418076|322812893|FG000|Overall Study|Lost to Follow-up|2|||
94279071|NCT04418076|322812894|FG001|Overall Study|Lost to Follow-up|5|||
94279072|NCT04418076|322812895|FG002|Overall Study|Lost to Follow-up|1|||
94279073|NCT04418076|322812896|FG003|Overall Study|Lost to Follow-up|2|||
94279074|NCT04418076|322812893|FG000|Overall Study|Withdrawal by Subject|1|||
94279075|NCT04418076|322812894|FG001|Overall Study|Withdrawal by Subject|0|||
94279076|NCT04418076|322812895|FG002|Overall Study|Withdrawal by Subject|1|||
94279077|NCT04418076|322812896|FG003|Overall Study|Withdrawal by Subject|1|||
94279078|NCT04418076|322812893|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
94279079|NCT04418076|322812894|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
94279080|NCT04418076|322812895|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
94279081|NCT04418076|322812896|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
94279082|NCT03315871|322812901|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
94279083|NCT03315871|322812902|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
94279084|NCT03315871|322812903|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
94279085|NCT03315871|322812901|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
94279086|NCT03315871|322812902|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
94279087|NCT03315871|322812903|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
94279088|NCT03315871|322812901|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
94279089|NCT03315871|322812902|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
94279090|NCT03315871|322812903|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
94279091|NCT03315871|322812901|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
94279092|NCT03315871|322812902|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
94279093|NCT03315871|322812903|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
94279094|NCT03315871|322812901|FG000|PROSTVAC + CV301|Progressive disease|0|||
94279095|NCT03315871|322812902|FG001|PROSTVAC + CV301|Progressive disease|0|||
94279096|NCT03315871|322812903|FG002|PROSTVAC + CV301|Progressive disease|1|||
94279097|NCT03315871|322812901|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
94279098|NCT03315871|322812902|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
94279099|NCT03315871|322812903|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
94279100|NCT02095535|322814429|FG000|Recruitment|Protocol Violation|2|||
94279101|NCT01902966|322814430|FG000|Overall Study|Death|1|||
94279102|NCT01902966|322814430|FG000|Overall Study|Physician Decision|1|||
94279103|NCT01902966|322814430|FG000|Overall Study|Withdrawal by Subject|1|||
94279104|NCT04677712|322814431|FG000|Overall Study|Lost to Follow-up|0|||
94279105|NCT04677712|322814432|FG001|Overall Study|Lost to Follow-up|1|||
94370744|NCT00628745|323142962|FG000|Overall Study|Othe reasons|987|||
94370745|NCT00628745|323142963|FG001|Overall Study|Othe reasons|373|||
94370746|NCT00628745|323142964|FG002|Overall Study|Othe reasons|105|||
94203627|NCT03699163|322542177|FG000|Overall Study|Physician Decision|12|||
94279106|NCT04677712|322814433|FG002|Overall Study|Lost to Follow-up|0|||
94279107|NCT04677712|322814434|FG003|Overall Study|Lost to Follow-up|0|||
94279108|NCT04677712|322814435|FG004|Overall Study|Lost to Follow-up|0|||
94279109|NCT04677712|322814436|FG005|Overall Study|Lost to Follow-up|0|||
94279110|NCT00711100|322814437|FG000|Overall Study|Lack of Efficacy|5|||
94203628|NCT03699163|322542178|FG001|Overall Study|Physician Decision|0|||
94370747|NCT00628745|323142965|FG003|Overall Study|Othe reasons|1|||
94279111|NCT00711100|322814437|FG000|Overall Study|Withdrawal by Subject|8|||
94370748|NCT00628745|323142966|FG004|Overall Study|Othe reasons|1772|||
94370749|NCT01011907|323144476|FG000|Overall Study|Withdrawal by Subject|13|||
94279112|NCT00783094|322814440|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
94279113|NCT00783094|322814441|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
94203629|NCT03699163|322542177|FG000|Overall Study|failed QC measures|205|||
94203630|NCT03699163|322542178|FG001|Overall Study|failed QC measures|206|||
94203631|NCT01288443|322542184|FG000|Overall Study|Adverse Event|0|||
94203632|NCT01288443|322542185|FG001|Overall Study|Adverse Event|0|||
94203633|NCT01288443|322542186|FG002|Overall Study|Adverse Event|1|||
94203634|NCT01288443|322542187|FG003|Overall Study|Adverse Event|1|||
94203635|NCT01288443|322542188|FG004|Overall Study|Adverse Event|3|||
94203636|NCT01288443|322542189|FG005|Overall Study|Adverse Event|1|||
94203637|NCT01288443|322542184|FG000|Overall Study|Poor compliance to protocol|0|||
94203638|NCT01288443|322542185|FG001|Overall Study|Poor compliance to protocol|0|||
94203639|NCT01288443|322542186|FG002|Overall Study|Poor compliance to protocol|0|||
94203640|NCT01288443|322542187|FG003|Overall Study|Poor compliance to protocol|0|||
94203641|NCT01288443|322542188|FG004|Overall Study|Poor compliance to protocol|0|||
94203642|NCT01288443|322542189|FG005|Overall Study|Poor compliance to protocol|1|||
94203643|NCT01288443|322542184|FG000|Overall Study|Participant Moved|0|||
94203644|NCT01288443|322542185|FG001|Overall Study|Participant Moved|0|||
94203645|NCT01288443|322542186|FG002|Overall Study|Participant Moved|0|||
94203646|NCT01288443|322542187|FG003|Overall Study|Participant Moved|1|||
94203647|NCT01288443|322542188|FG004|Overall Study|Participant Moved|2|||
94203648|NCT01288443|322542189|FG005|Overall Study|Participant Moved|1|||
94203649|NCT01288443|322542184|FG000|Overall Study|Consent withdrawn by Participant|0|||
94203650|NCT01288443|322542185|FG001|Overall Study|Consent withdrawn by Participant|0|||
94203651|NCT01288443|322542186|FG002|Overall Study|Consent withdrawn by Participant|0|||
94279114|NCT00783094|322814442|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
94279115|NCT00783094|322814440|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
94279116|NCT00783094|322814441|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
94279117|NCT00783094|322814442|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
94279118|NCT00783094|322814440|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
94279119|NCT00783094|322814441|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
94279120|NCT00783094|322814442|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
94279121|NCT00783094|322814440|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
94279122|NCT00783094|322814441|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
94279123|NCT00783094|322814442|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
94279124|NCT00783094|322814440|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
94279125|NCT00783094|322814441|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
94279126|NCT00783094|322814442|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
94279127|NCT00783094|322814440|FG000|Open-Label Extension Period|Adverse Event|12|||
94279128|NCT00783094|322814441|FG001|Open-Label Extension Period|Adverse Event|7|||
94279129|NCT00783094|322814442|FG002|Open-Label Extension Period|Adverse Event|16|||
94279130|NCT00783094|322814440|FG000|Open-Label Extension Period|Death|0|||
94279131|NCT00783094|322814441|FG001|Open-Label Extension Period|Death|0|||
94279132|NCT00783094|322814442|FG002|Open-Label Extension Period|Death|1|||
94279133|NCT00783094|322814440|FG000|Open-Label Extension Period|Protocol Violation|4|||
94279134|NCT00783094|322814441|FG001|Open-Label Extension Period|Protocol Violation|5|||
94279135|NCT00783094|322814442|FG002|Open-Label Extension Period|Protocol Violation|7|||
94279136|NCT00783094|322814440|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
94279137|NCT00783094|322814441|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
94279138|NCT00783094|322814442|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
94279139|NCT00783094|322814440|FG000|Open-Label Extension Period|Physician Decision|4|||
94279140|NCT00783094|322814441|FG001|Open-Label Extension Period|Physician Decision|2|||
94279141|NCT00783094|322814442|FG002|Open-Label Extension Period|Physician Decision|3|||
94203652|NCT01288443|322542187|FG003|Overall Study|Consent withdrawn by Participant|0|||
94203653|NCT01288443|322542188|FG004|Overall Study|Consent withdrawn by Participant|0|||
94203654|NCT01288443|322542189|FG005|Overall Study|Consent withdrawn by Participant|1|||
94203655|NCT01288443|322542184|FG000|Overall Study|Lost to Follow-up|0|||
94203656|NCT01288443|322542185|FG001|Overall Study|Lost to Follow-up|1|||
94279142|NCT00783094|322814440|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
94279143|NCT00783094|322814441|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
94279144|NCT00783094|322814442|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
94279145|NCT01496885|322814443|FG000|Overall Study|Lost to Follow-up|13|||
94279146|NCT01496885|322814443|FG000|Overall Study|Withdrawal by Subject|7|||
94279147|NCT01496885|322814443|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
94279148|NCT01496885|322814443|FG000|Overall Study|Death|1|||
94279149|NCT02083380|322814444|FG000|Overall Study|Lack of Efficacy|68|||
94279150|NCT02083380|322814445|FG001|Overall Study|Lack of Efficacy|79|||
94203657|NCT01288443|322542186|FG002|Overall Study|Lost to Follow-up|0|||
94203658|NCT01288443|322542187|FG003|Overall Study|Lost to Follow-up|0|||
94203659|NCT01288443|322542188|FG004|Overall Study|Lost to Follow-up|0|||
94279151|NCT02083380|322814446|FG002|Overall Study|Lack of Efficacy|64|||
94279152|NCT02083380|322814444|FG000|Overall Study|Withdrawal by Subject|9|||
94279153|NCT02083380|322814445|FG001|Overall Study|Withdrawal by Subject|3|||
94203660|NCT01288443|322542189|FG005|Overall Study|Lost to Follow-up|0|||
94370750|NCT01011907|323144477|FG001|Overall Study|Withdrawal by Subject|11|||
94743415|NCT04431713|324517008|FG001|Overall Study|Withdrawal by Subject|0|||
94279154|NCT02083380|322814446|FG002|Overall Study|Withdrawal by Subject|7|||
94279155|NCT02083380|322814444|FG000|Overall Study|Physician Decision|1|||
94279156|NCT02083380|322814445|FG001|Overall Study|Physician Decision|6|||
94279157|NCT02083380|322814446|FG002|Overall Study|Physician Decision|3|||
94279158|NCT02083380|322814444|FG000|Overall Study|Adverse Event|0|||
94279159|NCT02083380|322814445|FG001|Overall Study|Adverse Event|0|||
94279160|NCT02083380|322814446|FG002|Overall Study|Adverse Event|1|||
94279161|NCT02083380|322814444|FG000|Overall Study|Lost to Follow-up|5|||
94279162|NCT02083380|322814445|FG001|Overall Study|Lost to Follow-up|3|||
94279163|NCT02083380|322814446|FG002|Overall Study|Lost to Follow-up|3|||
94279164|NCT02083380|322814444|FG000|Overall Study|Other|8|||
94279165|NCT02083380|322814445|FG001|Overall Study|Other|4|||
94279166|NCT02083380|322814446|FG002|Overall Study|Other|6|||
94279167|NCT01289015|322814447|FG000|Overall Study|Protocol Violation|12|||
94279168|NCT01289015|322814448|FG001|Overall Study|Protocol Violation|9|||
94279169|NCT01289015|322814447|FG000|Overall Study|Adverse Event|3|||
94279170|NCT01289015|322814448|FG001|Overall Study|Adverse Event|0|||
94279171|NCT01289015|322814447|FG000|Overall Study|Lost to Follow-up|33|||
94279172|NCT01289015|322814448|FG001|Overall Study|Lost to Follow-up|17|||
94279173|NCT01289015|322814447|FG000|Overall Study|Withdrawal by Subject|17|||
94279174|NCT01289015|322814448|FG001|Overall Study|Withdrawal by Subject|8|||
94279175|NCT01289015|322814447|FG000|Overall Study|Disease progression|1|||
94279176|NCT01289015|322814448|FG001|Overall Study|Disease progression|0|||
94279177|NCT01289015|322814447|FG000|Overall Study|Negative baseline culture and others|33|||
94279178|NCT01289015|322814448|FG001|Overall Study|Negative baseline culture and others|20|||
94279179|NCT01709149|322814449|FG000|Open-label Lead-in Phase|Adverse Event|109|||
94279180|NCT01709149|322814450|FG001|Open-label Lead-in Phase|Adverse Event|0|||
94279181|NCT01709149|322814451|FG002|Open-label Lead-in Phase|Adverse Event|0|||
94279182|NCT01709149|322814449|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
94279183|NCT01709149|322814450|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
94279184|NCT01709149|322814451|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
94279185|NCT01709149|322814449|FG000|Open-label Lead-in Phase|Death|1|||
94279186|NCT01709149|322814450|FG001|Open-label Lead-in Phase|Death|0|||
94279187|NCT01709149|322814451|FG002|Open-label Lead-in Phase|Death|0|||
94279188|NCT01709149|322814449|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
94279189|NCT01709149|322814450|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
94279190|NCT01709149|322814451|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
94279191|NCT01709149|322814449|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
94279192|NCT01709149|322814450|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
94279193|NCT01709149|322814451|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
94279194|NCT01709149|322814449|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
94279195|NCT01709149|322814450|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
94279196|NCT01709149|322814451|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
94279197|NCT01709149|322814449|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
94279198|NCT01709149|322814450|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
94279199|NCT01709149|322814451|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
94279200|NCT01709149|322814449|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
94279201|NCT01709149|322814450|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
94279202|NCT01709149|322814451|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
94279203|NCT01709149|322814449|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
94279204|NCT01709149|322814450|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
94279205|NCT01709149|322814451|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
94279206|NCT01709149|322814449|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
94279207|NCT01709149|322814450|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
94279208|NCT01709149|322814451|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
94279209|NCT01577186|322814452|FG000|Overall Study|Adverse Event|23|||
94279210|NCT01577186|322814452|FG000|Overall Study|Death|1|||
94279211|NCT01577186|322814452|FG000|Overall Study|Lost to Follow-up|28|||
94279212|NCT01577186|322814452|FG000|Overall Study|Withdrawal by Subject|35|||
94279213|NCT01577186|322814452|FG000|Overall Study|Insufficient Response|18|||
94279214|NCT01577186|322814452|FG000|Overall Study|Ineligible to Continue|15|||
94279215|NCT01577186|322814452|FG000|Overall Study|Non-Compliant|8|||
94279216|NCT01577186|322814452|FG000|Overall Study|Other|2|||
94279217|NCT00957008|322814453|FG000|Overall Study|Withdrawal by Subject|13|||
94279218|NCT00957008|322814454|FG001|Overall Study|Withdrawal by Subject|10|||
94279219|NCT00957008|322814455|FG002|Overall Study|Withdrawal by Subject|12|||
94279220|NCT00957008|322814456|FG003|Overall Study|Withdrawal by Subject|16|||
94279221|NCT00957008|322814453|FG000|Overall Study|Lost to Follow-up|3|||
94279222|NCT00957008|322814454|FG001|Overall Study|Lost to Follow-up|1|||
94743416|NCT04431713|324517007|FG000|Overall Study|Death|2|||
94279223|NCT00957008|322814455|FG002|Overall Study|Lost to Follow-up|3|||
94279224|NCT00957008|322814456|FG003|Overall Study|Lost to Follow-up|4|||
94370751|NCT01011907|323144476|FG000|Overall Study|Adverse Event|1|||
94203661|NCT01288443|322542184|FG000|Overall Study|Study drug auto-injector administration|0|||
94203662|NCT01288443|322542185|FG001|Overall Study|Study drug auto-injector administration|0|||
94203663|NCT01288443|322542186|FG002|Overall Study|Study drug auto-injector administration|0|||
94203664|NCT01288443|322542187|FG003|Overall Study|Study drug auto-injector administration|0|||
94203665|NCT01288443|322542188|FG004|Overall Study|Study drug auto-injector administration|1|||
94203666|NCT01288443|322542189|FG005|Overall Study|Study drug auto-injector administration|1|||
94203667|NCT01288443|322542184|FG000|Overall Study|Other than above|0|||
94203668|NCT01288443|322542185|FG001|Overall Study|Other than above|0|||
94203669|NCT01288443|322542186|FG002|Overall Study|Other than above|0|||
94203670|NCT01288443|322542187|FG003|Overall Study|Other than above|2|||
94203671|NCT01288443|322542188|FG004|Overall Study|Other than above|1|||
94203672|NCT01288443|322542189|FG005|Overall Study|Other than above|0|||
94203673|NCT03776812|322542190|FG000|Overall Study|Death|27|||
94203674|NCT03776812|322542191|FG001|Overall Study|Death|19|||
94203675|NCT03776812|322542192|FG002|Overall Study|Death|29|||
94203676|NCT03776812|322542190|FG000|Overall Study|Withdrawal by Subject|1|||
94203677|NCT03776812|322542191|FG001|Overall Study|Withdrawal by Subject|7|||
94203678|NCT03776812|322542192|FG002|Overall Study|Withdrawal by Subject|1|||
94203679|NCT03776812|322542190|FG000|Overall Study|Lost to Follow-up|0|||
94203680|NCT03776812|322542191|FG001|Overall Study|Lost to Follow-up|1|||
94203681|NCT03776812|322542192|FG002|Overall Study|Lost to Follow-up|0|||
94203682|NCT03776812|322542190|FG000|Overall Study|Still on study as of March 22, 2021 data cutoff date|30|||
94203683|NCT03776812|322542191|FG001|Overall Study|Still on study as of March 22, 2021 data cutoff date|33|||
94203684|NCT03776812|322542192|FG002|Overall Study|Still on study as of March 22, 2021 data cutoff date|30|||
94203685|NCT00623194|322542195|FG000|Overall Study|Lack of Efficacy|1|||
94203686|NCT00623194|322542195|FG000|Overall Study|Protocol Violation|3|||
94203687|NCT00623194|322542195|FG000|Overall Study|Unclassified|1|||
94203688|NCT01394276|322542205|FG000|Overall Study|Related Adverse event (AEs)|15|||
94203689|NCT01394276|322542205|FG000|Overall Study|Not related AEs|9|||
94203690|NCT01394276|322542205|FG000|Overall Study|Remission of disease|2|||
94203691|NCT01394276|322542205|FG000|Overall Study|Insufficient therapeutic effect|17|||
94203692|NCT01394276|322542205|FG000|Overall Study|Insufficient compliance|9|||
94203693|NCT01394276|322542205|FG000|Overall Study|Lost to Follow-up|5|||
94203694|NCT01394276|322542205|FG000|Overall Study|Participant moved to another site|1|||
94203695|NCT01394276|322542205|FG000|Overall Study|Pregnancy|1|||
94203696|NCT01394276|322542205|FG000|Overall Study|unavailability of drug at the Hospital|2|||
94203697|NCT01394276|322542205|FG000|Overall Study|Symptoms of concurrent diseases|1|||
94203698|NCT00003222|322542206|FG000|Overall Study|Physician Decision|0|||
94203699|NCT00003222|322542207|FG001|Overall Study|Physician Decision|1|||
94203700|NCT03885232|322542211|FG000|Overall Study|Lost to Follow-up|74|||
94203701|NCT03885232|322542212|FG001|Overall Study|Lost to Follow-up|32|||
94203702|NCT03885232|322542211|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
94203703|NCT03885232|322542212|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
94203704|NCT01315132|322542213|FG000|Overall Study|not treated due to disease progression|1|||
94203705|NCT02397096|322542214|FG000|Day 1 to Week 24|Adverse Event|7|||
94203706|NCT02397096|322542215|FG001|Day 1 to Week 24|Adverse Event|1|||
94203707|NCT02397096|322542214|FG000|Day 1 to Week 24|Death|1|||
94203708|NCT02397096|322542215|FG001|Day 1 to Week 24|Death|0|||
94203709|NCT02397096|322542214|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
94203710|NCT02397096|322542215|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
94203711|NCT02397096|322542214|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
94203712|NCT02397096|322542215|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
94203713|NCT02397096|322542214|FG000|Day 1 to Week 24|Physician Decision|2|||
94203714|NCT02397096|322542215|FG001|Day 1 to Week 24|Physician Decision|3|||
94203715|NCT02397096|322542214|FG000|Day 1 to Week 24|Protocol Violation|1|||
94203716|NCT02397096|322542215|FG001|Day 1 to Week 24|Protocol Violation|4|||
94203717|NCT02397096|322542214|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
94203718|NCT02397096|322542215|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
94203719|NCT02397096|322542214|FG000|Day 1 to Week 24|Randomized, not treated|3|||
94203720|NCT02397096|322542215|FG001|Day 1 to Week 24|Randomized, not treated|0|||
94370752|NCT01011907|323144477|FG001|Overall Study|Adverse Event|4|||
94370753|NCT01272193|323144480|FG000|Overall Study|Adverse Event|1|||
94203721|NCT02397096|322542214|FG000|Week 24 to Week 48|Adverse Event|6|||
94203722|NCT02397096|322542215|FG001|Week 24 to Week 48|Adverse Event|2|||
94203723|NCT02397096|322542214|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
94203724|NCT02397096|322542215|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
94203725|NCT02397096|322542214|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
94203726|NCT02397096|322542215|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
94203727|NCT02397096|322542214|FG000|Week 24 to Week 48|Physician Decision|2|||
94203728|NCT02397096|322542215|FG001|Week 24 to Week 48|Physician Decision|1|||
94203729|NCT02397096|322542214|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
94370754|NCT01272193|323144481|FG001|Overall Study|Adverse Event|1|||
94203730|NCT02397096|322542215|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
94203731|NCT02397096|322542214|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
94203732|NCT02397096|322542215|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
94370755|NCT01272193|323144480|FG000|Overall Study|Lack of Efficacy|0|||
94203733|NCT02397096|322542214|FG000|Study Extension 1|Adverse Event|7|||
94203734|NCT02397096|322542215|FG001|Study Extension 1|Adverse Event|5|||
94203735|NCT02397096|322542214|FG000|Study Extension 1|Death|1|||
94203736|NCT02397096|322542215|FG001|Study Extension 1|Death|0|||
94203737|NCT02397096|322542214|FG000|Study Extension 1|Lack of Efficacy|2|||
94203738|NCT02397096|322542215|FG001|Study Extension 1|Lack of Efficacy|5|||
94203739|NCT02397096|322542214|FG000|Study Extension 1|Lost to Follow-up|2|||
94203740|NCT02397096|322542215|FG001|Study Extension 1|Lost to Follow-up|3|||
94203741|NCT02397096|322542214|FG000|Study Extension 1|Non-compliance with study drug|3|||
94203742|NCT02397096|322542215|FG001|Study Extension 1|Non-compliance with study drug|0|||
94203743|NCT02397096|322542214|FG000|Study Extension 1|Physician Decision|4|||
94203744|NCT02397096|322542215|FG001|Study Extension 1|Physician Decision|2|||
94203745|NCT02397096|322542214|FG000|Study Extension 1|Pregnancy|1|||
94203746|NCT02397096|322542215|FG001|Study Extension 1|Pregnancy|0|||
94203747|NCT02397096|322542214|FG000|Study Extension 1|Protocol Violation|0|||
94203748|NCT02397096|322542215|FG001|Study Extension 1|Protocol Violation|1|||
94203749|NCT02397096|322542214|FG000|Study Extension 1|Withdrawal by Subject|21|||
94203750|NCT02397096|322542215|FG001|Study Extension 1|Withdrawal by Subject|7|||
94203751|NCT02397096|322542214|FG000|Study Extension 2|Adverse Event|3|||
94203752|NCT02397096|322542215|FG001|Study Extension 2|Adverse Event|3|||
94279225|NCT00957008|322814453|FG000|Overall Study|Physician Decision|1|||
94279226|NCT00957008|322814454|FG001|Overall Study|Physician Decision|0|||
94279227|NCT00957008|322814455|FG002|Overall Study|Physician Decision|1|||
94279228|NCT00957008|322814456|FG003|Overall Study|Physician Decision|1|||
94279229|NCT00957008|322814453|FG000|Overall Study|Relocated; Family conflict|4|||
94279230|NCT00957008|322814454|FG001|Overall Study|Relocated; Family conflict|1|||
94279231|NCT00957008|322814455|FG002|Overall Study|Relocated; Family conflict|1|||
94279232|NCT00957008|322814456|FG003|Overall Study|Relocated; Family conflict|3|||
94279233|NCT00915681|322814457|FG000|Overall Study|Screening failures|46|||
94279234|NCT00811135|322814458|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
94279235|NCT00811135|322814458|FG000|Overall Study|Death|3|||
94279236|NCT00811135|322814458|FG000|Overall Study|Protocol Violation|2|||
94203753|NCT02397096|322542214|FG000|Study Extension 2|Availability of study medication locally|152|||
94203754|NCT02397096|322542215|FG001|Study Extension 2|Availability of study medication locally|64|||
94203755|NCT02397096|322542214|FG000|Study Extension 2|Death|2|||
94203756|NCT02397096|322542215|FG001|Study Extension 2|Death|0|||
94203757|NCT02397096|322542214|FG000|Study Extension 2|Lack of Efficacy|1|||
94279237|NCT00811135|322814458|FG000|Overall Study|Violation of Selection Criteria|1|||
94279238|NCT00811135|322814458|FG000|Overall Study|Refused Treatment|1|||
94279239|NCT00811135|322814458|FG000|Overall Study|Withdrawal by Subject|3|||
94279240|NCT00811135|322814458|FG000|Overall Study|Administrative/Other Unspecified|11|||
94279241|NCT00811135|322814458|FG000|Overall Study|Ongoing|59|||
94279242|NCT02797808|322814469|FG000|Overall Study|Withdrawal by Subject|1|||
94279243|NCT02797808|322814470|FG001|Overall Study|Withdrawal by Subject|1|||
94279244|NCT02797808|322814469|FG000|Overall Study|Physician Decision|6|||
94279245|NCT02797808|322814470|FG001|Overall Study|Physician Decision|2|||
94279246|NCT02192827|322814471|FG000|Overall Study|Lost to Follow-up|25|||
94279247|NCT02192827|322814472|FG001|Overall Study|Lost to Follow-up|27|||
94279248|NCT02192827|322814471|FG000|Overall Study|Given additional steroids with admission|13|||
94279249|NCT02192827|322814472|FG001|Overall Study|Given additional steroids with admission|11|||
94279250|NCT03509350|322814477|FG000|Overall Study|Withdrawal by Subject|0|||
94279251|NCT03509350|322814478|FG001|Overall Study|Withdrawal by Subject|2|||
94279252|NCT01425203|322814479|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
94279253|NCT01425203|322814480|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
94279254|NCT01425203|322814481|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
94279255|NCT01425203|322814479|FG000|Treatment Phase|Failure at futility timepoint|8|||
94279256|NCT01425203|322814480|FG001|Treatment Phase|Failure at futility timepoint|27|||
94279257|NCT01425203|322814481|FG002|Treatment Phase|Failure at futility timepoint|0|||
94279258|NCT01425203|322814479|FG000|Treatment Phase|Other virologic failure criteria|5|||
94279259|NCT01425203|322814480|FG001|Treatment Phase|Other virologic failure criteria|3|||
94279260|NCT01425203|322814481|FG002|Treatment Phase|Other virologic failure criteria|0|||
94279261|NCT01425203|322814479|FG000|Treatment Phase|Unidentified reasons|11|||
94279262|NCT01425203|322814480|FG001|Treatment Phase|Unidentified reasons|5|||
94279263|NCT01425203|322814481|FG002|Treatment Phase|Unidentified reasons|0|||
94279264|NCT01425203|322814479|FG000|Treatment Phase|Did not receive treatment|0|||
94279265|NCT01425203|322814480|FG001|Treatment Phase|Did not receive treatment|1|||
94279266|NCT01425203|322814481|FG002|Treatment Phase|Did not receive treatment|0|||
94279267|NCT01425203|322814479|FG000|Crossover Phase|Failure at futility timepoint|0|||
94279268|NCT01425203|322814480|FG001|Crossover Phase|Failure at futility timepoint|0|||
94279269|NCT01425203|322814481|FG002|Crossover Phase|Failure at futility timepoint|3|||
94279270|NCT01425203|322814479|FG000|Crossover Phase|Other virologic failure criteria|0|||
94279271|NCT01425203|322814480|FG001|Crossover Phase|Other virologic failure criteria|0|||
94279272|NCT01425203|322814481|FG002|Crossover Phase|Other virologic failure criteria|3|||
94279273|NCT00283595|322814488|FG000|Overall Study|Withdrawal by Subject|1|||
94279274|NCT00283595|322814489|FG001|Overall Study|Withdrawal by Subject|2|||
94370756|NCT01272193|323144481|FG001|Overall Study|Lack of Efficacy|3|||
94370757|NCT01272193|323144480|FG000|Overall Study|Withdrawal Criteria|1|||
94370758|NCT01272193|323144481|FG001|Overall Study|Withdrawal Criteria|1|||
94370759|NCT01272193|323144480|FG000|Overall Study|Unclassified|8|||
94370760|NCT01272193|323144481|FG001|Overall Study|Unclassified|7|||
94370761|NCT01084603|323144502|FG000|Baseline|Withdrawal by Subject|2|||
94370762|NCT01084603|323144502|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
94370763|NCT01084603|323144502|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
94370764|NCT01084603|323144502|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
94370765|NCT01084603|323144502|FG000|Washout Period 4|Adverse Event|1|||
94370766|NCT00350519|323144504|FG000|Overall Study|Death|0|||
94370767|NCT00350519|323144505|FG001|Overall Study|Death|1|||
94370768|NCT00350519|323144504|FG000|Overall Study|Physician Decision|0|||
94370769|NCT00350519|323144505|FG001|Overall Study|Physician Decision|1|||
94370770|NCT00350519|323144504|FG000|Overall Study|Protocol Violation|1|||
94370771|NCT00350519|323144505|FG001|Overall Study|Protocol Violation|2|||
94370772|NCT00350519|323144504|FG000|Overall Study|Withdrawal by Subject|3|||
94370773|NCT00350519|323144505|FG001|Overall Study|Withdrawal by Subject|2|||
94370774|NCT03770000|323144507|FG000|Overall Study|Premature discontinuation due to PD|0|||
94370775|NCT03770000|323144508|FG001|Overall Study|Premature discontinuation due to PD|0|||
94467651|NCT01492101|323502369|FG000|Overall Study|Lost to Follow-up|0|||
94743417|NCT04431713|324517008|FG001|Overall Study|Death|2|||
94743418|NCT02285114|324517009|FG000|Main Phase|Investigator's Discretion|0|||
94743419|NCT02285114|324517010|FG001|Main Phase|Investigator's Discretion|2|||
94743420|NCT02285114|324517011|FG002|Main Phase|Investigator's Discretion|0|||
94743421|NCT02285114|324517012|FG003|Main Phase|Investigator's Discretion|0|||
94743422|NCT02285114|324517013|FG004|Main Phase|Investigator's Discretion|0|||
94743423|NCT02285114|324517014|FG005|Main Phase|Investigator's Discretion|0|||
94743424|NCT02285114|324517009|FG000|Main Phase|Enrolled but Never Treated|1|||
94743425|NCT02285114|324517010|FG001|Main Phase|Enrolled but Never Treated|0|||
94743426|NCT02285114|324517011|FG002|Main Phase|Enrolled but Never Treated|0|||
94743427|NCT02285114|324517012|FG003|Main Phase|Enrolled but Never Treated|0|||
94743428|NCT02285114|324517013|FG004|Main Phase|Enrolled but Never Treated|0|||
94743429|NCT02285114|324517014|FG005|Main Phase|Enrolled but Never Treated|0|||
94743430|NCT02285114|324517009|FG000|Main Phase|Withdrew Consent|0|||
94743431|NCT02285114|324517010|FG001|Main Phase|Withdrew Consent|0|||
94743432|NCT02285114|324517011|FG002|Main Phase|Withdrew Consent|1|||
94743433|NCT02285114|324517012|FG003|Main Phase|Withdrew Consent|0|||
94743434|NCT02285114|324517013|FG004|Main Phase|Withdrew Consent|0|||
94743435|NCT02285114|324517014|FG005|Main Phase|Withdrew Consent|0|||
94743436|NCT02285114|324517009|FG000|Extension Phase|Investigator's Discretion|0|||
94743437|NCT02285114|324517010|FG001|Extension Phase|Investigator's Discretion|0|||
94743438|NCT02285114|324517011|FG002|Extension Phase|Investigator's Discretion|0|||
94743439|NCT02285114|324517012|FG003|Extension Phase|Investigator's Discretion|14|||
94743440|NCT02285114|324517013|FG004|Extension Phase|Investigator's Discretion|1|||
94743441|NCT02285114|324517014|FG005|Extension Phase|Investigator's Discretion|0|||
94743442|NCT02285114|324517009|FG000|Extension Phase|Lost to Follow-up|0|||
94743443|NCT02285114|324517010|FG001|Extension Phase|Lost to Follow-up|0|||
94743444|NCT02285114|324517011|FG002|Extension Phase|Lost to Follow-up|0|||
94743445|NCT02285114|324517012|FG003|Extension Phase|Lost to Follow-up|1|||
94743446|NCT02285114|324517013|FG004|Extension Phase|Lost to Follow-up|1|||
94743447|NCT02285114|324517014|FG005|Extension Phase|Lost to Follow-up|0|||
94743448|NCT02285114|324517009|FG000|Extension Phase|Non-compliance with Study Drug|0|||
94743449|NCT02285114|324517010|FG001|Extension Phase|Non-compliance with Study Drug|0|||
94743450|NCT02285114|324517011|FG002|Extension Phase|Non-compliance with Study Drug|0|||
94743451|NCT02285114|324517012|FG003|Extension Phase|Non-compliance with Study Drug|2|||
94279275|NCT01970995|322814490|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
94279276|NCT01970995|322814491|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
94279277|NCT01970995|322814492|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
94279278|NCT01970995|322814490|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
94279279|NCT01970995|322814491|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
94279280|NCT01970995|322814492|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
94279281|NCT00845728|322814493|FG000|Overall Study|Abnormal laboratory value (s)|2|||
94279282|NCT00845728|322814494|FG001|Overall Study|Abnormal laboratory value (s)|2|||
94279283|NCT00845728|322814493|FG000|Overall Study|Patient's inability to use the device|4|||
94279284|NCT00845728|322814494|FG001|Overall Study|Patient's inability to use the device|6|||
94370776|NCT03770000|323144509|FG002|Overall Study|Premature discontinuation due to PD|1|||
94370777|NCT03770000|323144510|FG003|Overall Study|Premature discontinuation due to PD|3|||
94743452|NCT02285114|324517013|FG004|Extension Phase|Non-compliance with Study Drug|0|||
94743453|NCT02285114|324517014|FG005|Extension Phase|Non-compliance with Study Drug|0|||
94743454|NCT02285114|324517009|FG000|Extension Phase|Pregnancy|0|||
94743455|NCT02285114|324517010|FG001|Extension Phase|Pregnancy|0|||
94743456|NCT02285114|324517011|FG002|Extension Phase|Pregnancy|0|||
94743457|NCT02285114|324517012|FG003|Extension Phase|Pregnancy|1|||
94370778|NCT03770000|323144511|FG004|Overall Study|Premature discontinuation due to PD|2|||
94743458|NCT02285114|324517013|FG004|Extension Phase|Pregnancy|0|||
94203758|NCT02397096|322542215|FG001|Study Extension 2|Lack of Efficacy|0|||
94203759|NCT02397096|322542214|FG000|Study Extension 2|Lost to Follow-up|2|||
94203760|NCT02397096|322542215|FG001|Study Extension 2|Lost to Follow-up|1|||
94203761|NCT02397096|322542214|FG000|Study Extension 2|Non-compliance with study drug|1|||
94203762|NCT02397096|322542215|FG001|Study Extension 2|Non-compliance with study drug|0|||
94203763|NCT02397096|322542214|FG000|Study Extension 2|Physician Decision|2|||
94203764|NCT02397096|322542215|FG001|Study Extension 2|Physician Decision|5|||
94203765|NCT02397096|322542214|FG000|Study Extension 2|Pregnancy|1|||
94203766|NCT02397096|322542215|FG001|Study Extension 2|Pregnancy|0|||
94203767|NCT02397096|322542214|FG000|Study Extension 2|Withdrawal by Subject|10|||
94203768|NCT02397096|322542215|FG001|Study Extension 2|Withdrawal by Subject|3|||
94203769|NCT02397096|322542214|FG000|Study Extension 3|Adverse Event|1|||
94203770|NCT02397096|322542215|FG001|Study Extension 3|Adverse Event|0|||
94203771|NCT02397096|322542214|FG000|Study Extension 3|Availability of study medication locally|11|||
94203772|NCT02397096|322542215|FG001|Study Extension 3|Availability of study medication locally|3|||
94203773|NCT02397096|322542214|FG000|Study Extension 3|Lost to Follow-up|1|||
94203774|NCT02397096|322542215|FG001|Study Extension 3|Lost to Follow-up|0|||
94203775|NCT02397096|322542214|FG000|Study Extension 3|Withdrawal by Subject|2|||
94203776|NCT02397096|322542215|FG001|Study Extension 3|Withdrawal by Subject|1|||
94203777|NCT02107261|322542218|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
94203778|NCT02107261|322542219|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
94203779|NCT02107261|322542218|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
94203780|NCT02107261|322542219|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
94203781|NCT04158141|322542220|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
94203782|NCT04158141|322542221|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
94203783|NCT04158141|322542222|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
94203784|NCT04158141|322542220|FG000|Step 1: Registration|Adverse Event|1|||
94203785|NCT04158141|322542221|FG001|Step 1: Registration|Adverse Event|0|||
94203786|NCT04158141|322542222|FG002|Step 1: Registration|Adverse Event|0|||
94203787|NCT04158141|322542220|FG000|Step 1: Registration|Withdrawal by Subject|1|||
94203788|NCT04158141|322542221|FG001|Step 1: Registration|Withdrawal by Subject|0|||
94203789|NCT04158141|322542222|FG002|Step 1: Registration|Withdrawal by Subject|0|||
94203790|NCT04158141|322542220|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
94203791|NCT04158141|322542221|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
94203792|NCT04158141|322542222|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
94203793|NCT05139992|322542223|FG000|Overall Study|Withdrawal by Subject|12|||
94203794|NCT05139992|322542223|FG000|Overall Study|Lost to Follow-up|6|||
94203795|NCT03211247|322542224|FG000|Overall Study|Adverse Event|8|||
94203796|NCT03211247|322542225|FG001|Overall Study|Adverse Event|0|||
94203797|NCT03211247|322542226|FG002|Overall Study|Adverse Event|1|||
94203798|NCT03211247|322542227|FG003|Overall Study|Adverse Event|0|||
94203799|NCT03211247|322542228|FG004|Overall Study|Adverse Event|0|||
94203800|NCT03211247|322542224|FG000|Overall Study|Lost to Follow-up|2|||
94203801|NCT03211247|322542225|FG001|Overall Study|Lost to Follow-up|1|||
94203802|NCT03211247|322542226|FG002|Overall Study|Lost to Follow-up|0|||
94203803|NCT03211247|322542227|FG003|Overall Study|Lost to Follow-up|0|||
94203804|NCT03211247|322542228|FG004|Overall Study|Lost to Follow-up|0|||
94203805|NCT03211247|322542224|FG000|Overall Study|Physician Decision|1|||
94203806|NCT03211247|322542225|FG001|Overall Study|Physician Decision|2|||
94203807|NCT03211247|322542226|FG002|Overall Study|Physician Decision|0|||
94203808|NCT03211247|322542227|FG003|Overall Study|Physician Decision|0|||
94203809|NCT03211247|322542228|FG004|Overall Study|Physician Decision|0|||
94203810|NCT03211247|322542224|FG000|Overall Study|Non-compliance with study drug|2|||
94203811|NCT03211247|322542225|FG001|Overall Study|Non-compliance with study drug|0|||
94203812|NCT03211247|322542226|FG002|Overall Study|Non-compliance with study drug|0|||
94370779|NCT02290028|323144512|FG000|Overall Study|Death|217|||
94370780|NCT02290028|323144512|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
94370781|NCT02290028|323144512|FG000|Overall Study|No longer under care of study physician|76|||
94203813|NCT03211247|322542227|FG003|Overall Study|Non-compliance with study drug|0|||
94203814|NCT03211247|322542228|FG004|Overall Study|Non-compliance with study drug|0|||
94203815|NCT03211247|322542224|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
94203816|NCT03211247|322542225|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
94203817|NCT03211247|322542226|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
94203818|NCT03211247|322542227|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
94203819|NCT03211247|322542228|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
94203820|NCT03211247|322542224|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
94203821|NCT03211247|322542225|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
94203822|NCT03211247|322542226|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
94203823|NCT03211247|322542227|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
94203824|NCT03211247|322542228|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
94203825|NCT03211247|322542224|FG000|Overall Study|Protocol Violation|0|||
94203826|NCT03211247|322542225|FG001|Overall Study|Protocol Violation|1|||
94203827|NCT03211247|322542226|FG002|Overall Study|Protocol Violation|0|||
94203828|NCT03211247|322542227|FG003|Overall Study|Protocol Violation|0|||
94203829|NCT03211247|322542228|FG004|Overall Study|Protocol Violation|0|||
94203830|NCT02415127|322542229|FG000|Overall Study|Adverse Event|1|||
94203831|NCT02415127|322542230|FG001|Overall Study|Adverse Event|0|||
94203832|NCT05025384|322542231|FG000|Overall Study|Physician Decision|5|||
94203833|NCT05025384|322542232|FG001|Overall Study|Physician Decision|6|||
94203834|NCT02307682|322542236|FG000|Overall Study|Adverse Event|9|||
94203835|NCT02307682|322542237|FG001|Overall Study|Adverse Event|8|||
94203836|NCT02307682|322542238|FG002|Overall Study|Adverse Event|12|||
94203837|NCT02307682|322542236|FG000|Overall Study|Lack of Efficacy|1|||
94203838|NCT02307682|322542237|FG001|Overall Study|Lack of Efficacy|0|||
94203839|NCT02307682|322542238|FG002|Overall Study|Lack of Efficacy|1|||
94203840|NCT02307682|322542236|FG000|Overall Study|Physician Decision|2|||
94203841|NCT02307682|322542237|FG001|Overall Study|Physician Decision|2|||
94203842|NCT02307682|322542238|FG002|Overall Study|Physician Decision|8|||
94203843|NCT02307682|322542236|FG000|Overall Study|Progressive Disease|1|||
94203844|NCT02307682|322542237|FG001|Overall Study|Progressive Disease|0|||
94203845|NCT02307682|322542238|FG002|Overall Study|Progressive Disease|0|||
94203846|NCT02307682|322542236|FG000|Overall Study|Withdrawal by Subject|26|||
94203847|NCT02307682|322542237|FG001|Overall Study|Withdrawal by Subject|34|||
94203848|NCT02307682|322542238|FG002|Overall Study|Withdrawal by Subject|23|||
94203849|NCT02307682|322542236|FG000|Overall Study|Death|9|||
94203850|NCT02307682|322542237|FG001|Overall Study|Death|7|||
94203851|NCT02307682|322542238|FG002|Overall Study|Death|12|||
94203852|NCT02307682|322542236|FG000|Overall Study|Lost to Follow-up|1|||
94203853|NCT02307682|322542237|FG001|Overall Study|Lost to Follow-up|5|||
94203854|NCT02307682|322542238|FG002|Overall Study|Lost to Follow-up|6|||
94203855|NCT02307682|322542236|FG000|Overall Study|Protocol Deviation|0|||
94203856|NCT02307682|322542237|FG001|Overall Study|Protocol Deviation|0|||
94203857|NCT02307682|322542238|FG002|Overall Study|Protocol Deviation|2|||
94203858|NCT02307682|322542236|FG000|Overall Study|Other|1|||
94203859|NCT02307682|322542237|FG001|Overall Study|Other|1|||
94279285|NCT00845728|322814493|FG000|Overall Study|Abnormal test procedure result (s)|7|||
94279286|NCT00845728|322814494|FG001|Overall Study|Abnormal test procedure result (s)|2|||
94279287|NCT00845728|322814493|FG000|Overall Study|Lost to Follow-up|22|||
94279288|NCT00845728|322814494|FG001|Overall Study|Lost to Follow-up|13|||
94279289|NCT00845728|322814493|FG000|Overall Study|Death|24|||
94279290|NCT00845728|322814494|FG001|Overall Study|Death|26|||
94279291|NCT00845728|322814493|FG000|Overall Study|Administrative Problems|34|||
94279292|NCT00845728|322814494|FG001|Overall Study|Administrative Problems|26|||
94279293|NCT00845728|322814493|FG000|Overall Study|Protocol Violation|36|||
94279294|NCT00845728|322814494|FG001|Overall Study|Protocol Violation|24|||
94279295|NCT00845728|322814493|FG000|Overall Study|Lack of Efficacy|51|||
94279296|NCT00845728|322814494|FG001|Overall Study|Lack of Efficacy|39|||
94279297|NCT00845728|322814493|FG000|Overall Study|Adverse Event|101|||
94279298|NCT00845728|322814494|FG001|Overall Study|Adverse Event|96|||
94279299|NCT00845728|322814493|FG000|Overall Study|Withdrawal by Subject|105|||
94279300|NCT00845728|322814494|FG001|Overall Study|Withdrawal by Subject|108|||
94279301|NCT03031301|322814495|FG000|Overall Study|Protocol Violation|4|||
94279302|NCT03031301|322814496|FG001|Overall Study|Protocol Violation|8|||
94279303|NCT03031301|322814495|FG000|Overall Study|Withdrawal by Subject|7|||
94279304|NCT03031301|322814496|FG001|Overall Study|Withdrawal by Subject|4|||
94279305|NCT03031301|322814495|FG000|Overall Study|Lost to Follow-up|4|||
94279306|NCT03031301|322814496|FG001|Overall Study|Lost to Follow-up|12|||
94279307|NCT03031301|322814495|FG000|Overall Study|Noncompliance|1|||
94279308|NCT03031301|322814496|FG001|Overall Study|Noncompliance|3|||
94279309|NCT03031301|322814495|FG000|Overall Study|Technical issue|1|||
94203860|NCT02307682|322542238|FG002|Overall Study|Other|0|||
94203861|NCT03277989|322542240|FG000|Overall Study|Lost to Follow-up|6|||
94279310|NCT03031301|322814496|FG001|Overall Study|Technical issue|1|||
94370782|NCT02290028|323144512|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
94279311|NCT03031301|322814495|FG000|Overall Study|Adverse Event|1|||
94370783|NCT02290028|323144512|FG000|Overall Study|Withdrawal by Subject|52|||
94370784|NCT02290028|323144512|FG000|Overall Study|Study site closure|44|||
94370785|NCT02290028|323144512|FG000|Overall Study|Lost to Follow-up|34|||
94279312|NCT03031301|322814496|FG001|Overall Study|Adverse Event|0|||
94279313|NCT01784861|322814499|FG000|Overall Study|Adverse Event|0|||
94203862|NCT03277989|322542240|FG000|Overall Study|Adverse Event|6|||
94203863|NCT03277989|322542240|FG000|Overall Study|Withdrawal by Subject|3|||
94203864|NCT03277989|322542240|FG000|Overall Study|Didn't Receive Study Device|7|||
94203865|NCT03277989|322542240|FG000|Overall Study|Site Closure|26|||
94203866|NCT03277989|322542240|FG000|Overall Study|Sponsor Closure|107|||
94203867|NCT05704725|322542241|FG000|Overall Study|Lost to Follow-up|0|||
94279314|NCT01784861|322814500|FG001|Overall Study|Adverse Event|0|||
94370786|NCT02290028|323144512|FG000|Overall Study|Miscellaneous|10|||
94370787|NCT02290028|323144512|FG000|Overall Study|Transition to EP PASSION|1295|||
94203868|NCT05704725|322542242|FG001|Overall Study|Lost to Follow-up|1|||
94203869|NCT05704725|322542241|FG000|Overall Study|Withdrawal by Subject|1|||
94203870|NCT05704725|322542242|FG001|Overall Study|Withdrawal by Subject|0|||
94203871|NCT03876457|322543058|FG000|Overall Study|Lost to Follow-up|1|||
94203872|NCT03876457|322543059|FG001|Overall Study|Lost to Follow-up|3|||
94203873|NCT02291913|322543065|FG000|Overall Study|Progressive Disease|32|||
94203874|NCT02291913|322543065|FG000|Overall Study|Adverse Event|11|||
94203875|NCT02291913|322543065|FG000|Overall Study|Death|2|||
94203876|NCT02291913|322543065|FG000|Overall Study|Physician Decision|1|||
94203877|NCT02291913|322543065|FG000|Overall Study|Withdrawal by Subject|1|||
94203878|NCT02291913|322543065|FG000|Overall Study|Protocol Violation|1|||
94203879|NCT01637402|322543066|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
94203880|NCT01637402|322543067|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
94203881|NCT01637402|322543066|FG000|Standard Dose Regimen|Adverse Event|1|||
94203882|NCT01637402|322543067|FG001|Standard Dose Regimen|Adverse Event|0|||
94203883|NCT01637402|322543066|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
94203884|NCT01637402|322543067|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
94203885|NCT01637402|322543066|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
94203886|NCT01637402|322543067|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
94203887|NCT01637402|322543066|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
94203888|NCT01637402|322543067|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
94203889|NCT01637402|322543066|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
94203890|NCT01637402|322543067|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
94203891|NCT04876417|322543068|FG000|Overall Study|Lost to Follow-up|5|||
94203892|NCT04876417|322543069|FG001|Overall Study|Lost to Follow-up|8|||
94203893|NCT04876417|322543070|FG002|Overall Study|Lost to Follow-up|0|||
94203894|NCT04876417|322543071|FG003|Overall Study|Lost to Follow-up|0|||
94203895|NCT02285270|322543072|FG000|Overall Study|Lost to Follow-up|1|||
94203896|NCT02285270|322543072|FG000|Overall Study|Physician Decision|3|||
94203897|NCT02285270|322543072|FG000|Overall Study|Determined to be ineligible|1|||
94203898|NCT03709706|322543073|FG000|Overall Study|Adverse Event|0|||
94203899|NCT03709706|322543074|FG001|Overall Study|Adverse Event|1|||
94203900|NCT03709706|322543073|FG000|Overall Study|Physician Decision|14|||
94203901|NCT03709706|322543074|FG001|Overall Study|Physician Decision|8|||
94203902|NCT03709706|322543073|FG000|Overall Study|Withdrawal by Subject|2|||
94203903|NCT03709706|322543074|FG001|Overall Study|Withdrawal by Subject|1|||
94203904|NCT03709706|322543073|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
94203905|NCT03709706|322543074|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
94203906|NCT04868617|322543075|FG000|Overall Study|Death|1|||
94203907|NCT04868617|322543076|FG001|Overall Study|Death|0|||
94203908|NCT04868617|322543075|FG000|Overall Study|Adverse Event|1|||
94203909|NCT04868617|322543076|FG001|Overall Study|Adverse Event|0|||
94203910|NCT04868617|322543075|FG000|Overall Study|Withdrawal by Subject|1|||
94203911|NCT04868617|322543076|FG001|Overall Study|Withdrawal by Subject|0|||
94467652|NCT01492101|323502370|FG001|Overall Study|Lost to Follow-up|2|||
94743459|NCT02285114|324517014|FG005|Extension Phase|Pregnancy|0|||
94743460|NCT03767335|324517015|FG000|Overall Study|Physician Decision|1|||
94743461|NCT03767335|324517016|FG001|Overall Study|Physician Decision|1|||
94743462|NCT03767335|324517017|FG002|Overall Study|Physician Decision|0|||
94743463|NCT03767335|324517015|FG000|Overall Study|Withdrawal by Subject|0|||
94743464|NCT03767335|324517016|FG001|Overall Study|Withdrawal by Subject|0|||
94743465|NCT03767335|324517017|FG002|Overall Study|Withdrawal by Subject|6|||
94743466|NCT03767335|324517015|FG000|Overall Study|Participant excluded from efficacy population|0|||
94743467|NCT03767335|324517016|FG001|Overall Study|Participant excluded from efficacy population|0|||
94743468|NCT03767335|324517017|FG002|Overall Study|Participant excluded from efficacy population|1|||
94743469|NCT03767335|324517015|FG000|Overall Study|Death|0|||
94743470|NCT03767335|324517016|FG001|Overall Study|Death|0|||
94743471|NCT03767335|324517017|FG002|Overall Study|Death|2|||
94743472|NCT03767335|324517015|FG000|Overall Study|Progressive Disease|2|||
94743473|NCT03767335|324517016|FG001|Overall Study|Progressive Disease|2|||
94743474|NCT03767335|324517017|FG002|Overall Study|Progressive Disease|2|||
94743475|NCT03767335|324517015|FG000|Overall Study|Disease progression needing additional medication|0|||
94743476|NCT03767335|324517016|FG001|Overall Study|Disease progression needing additional medication|0|||
94743477|NCT03767335|324517017|FG002|Overall Study|Disease progression needing additional medication|17|||
94743478|NCT03767335|324517015|FG000|Overall Study|Sponsor decision|0|||
94743479|NCT03767335|324517016|FG001|Overall Study|Sponsor decision|0|||
94743480|NCT03767335|324517017|FG002|Overall Study|Sponsor decision|2|||
94743481|NCT03767335|324517015|FG000|Overall Study|Other Medical Reasons|0|||
94743482|NCT03767335|324517016|FG001|Overall Study|Other Medical Reasons|0|||
94743483|NCT03767335|324517017|FG002|Overall Study|Other Medical Reasons|3|||
94743484|NCT04428151|324517018|FG000|Overall Study|Death|100|||
94743485|NCT04428151|324517019|FG001|Overall Study|Death|86|||
94279315|NCT01784861|322814501|FG002|Overall Study|Adverse Event|1|||
94203912|NCT04868617|322543075|FG000|Overall Study|Device deficiency|1|||
94203913|NCT04868617|322543076|FG001|Overall Study|Device deficiency|0|||
94203914|NCT01387516|322543087|FG000|Overall Study|Lost to Follow-up|4|||
94203915|NCT01387516|322543088|FG001|Overall Study|Lost to Follow-up|4|||
94203916|NCT01387516|322543089|FG002|Overall Study|Lost to Follow-up|2|||
94203917|NCT01387516|322543090|FG003|Overall Study|Lost to Follow-up|3|||
94203918|NCT01387516|322543087|FG000|Overall Study|Withdrawal by Subject|1|||
94203919|NCT01387516|322543088|FG001|Overall Study|Withdrawal by Subject|1|||
94203920|NCT01387516|322543089|FG002|Overall Study|Withdrawal by Subject|2|||
94203921|NCT01387516|322543090|FG003|Overall Study|Withdrawal by Subject|0|||
94203922|NCT01387516|322543087|FG000|Overall Study|Death|0|||
94203923|NCT01387516|322543088|FG001|Overall Study|Death|0|||
94203924|NCT01387516|322543089|FG002|Overall Study|Death|0|||
94203925|NCT01387516|322543090|FG003|Overall Study|Death|1|||
94203926|NCT03660930|322543091|FG000|Overall Study|Adverse Event|0|||
94203927|NCT03660930|322543092|FG001|Overall Study|Adverse Event|0|||
94203928|NCT03660930|322543093|FG002|Overall Study|Adverse Event|0|||
94279316|NCT01784861|322814502|FG003|Overall Study|Adverse Event|2|||
94279317|NCT01784861|322814503|FG004|Overall Study|Adverse Event|1|||
94279318|NCT01784861|322814504|FG005|Overall Study|Adverse Event|0|||
94279319|NCT01784861|322814499|FG000|Overall Study|Withdrawal by Subject|0|||
94279320|NCT01784861|322814500|FG001|Overall Study|Withdrawal by Subject|0|||
94279321|NCT01784861|322814501|FG002|Overall Study|Withdrawal by Subject|0|||
94279322|NCT01784861|322814502|FG003|Overall Study|Withdrawal by Subject|1|||
94279323|NCT01784861|322814503|FG004|Overall Study|Withdrawal by Subject|0|||
94279324|NCT01784861|322814504|FG005|Overall Study|Withdrawal by Subject|0|||
94279325|NCT01784861|322814499|FG000|Overall Study|Physician Decision|0|||
94279326|NCT01784861|322814500|FG001|Overall Study|Physician Decision|0|||
94279327|NCT01784861|322814501|FG002|Overall Study|Physician Decision|0|||
94279328|NCT01784861|322814502|FG003|Overall Study|Physician Decision|2|||
94279329|NCT01784861|322814503|FG004|Overall Study|Physician Decision|0|||
94279330|NCT01784861|322814504|FG005|Overall Study|Physician Decision|1|||
94279331|NCT00464334|322814508|FG000|Overall Study|Adverse Event|0|||
94279332|NCT00464334|322814509|FG001|Overall Study|Adverse Event|0|||
94279333|NCT00464334|322814510|FG002|Overall Study|Adverse Event|0|||
94279334|NCT00464334|322814511|FG003|Overall Study|Adverse Event|1|||
94279335|NCT00464334|322814512|FG004|Overall Study|Adverse Event|1|||
94279336|NCT00464334|322814513|FG005|Overall Study|Adverse Event|1|||
94279337|NCT00464334|322814514|FG006|Overall Study|Adverse Event|0|||
94279338|NCT00464334|322814515|FG007|Overall Study|Adverse Event|0|||
94279339|NCT00464334|322814516|FG008|Overall Study|Adverse Event|2|||
94279340|NCT00464334|322814517|FG009|Overall Study|Adverse Event|1|||
94279341|NCT00464334|322814518|FG010|Overall Study|Adverse Event|2|||
94279342|NCT00464334|322814508|FG000|Overall Study|Lack of Efficacy|0|||
94279343|NCT00464334|322814509|FG001|Overall Study|Lack of Efficacy|1|||
94279344|NCT00464334|322814510|FG002|Overall Study|Lack of Efficacy|0|||
94279345|NCT00464334|322814511|FG003|Overall Study|Lack of Efficacy|0|||
94279346|NCT00464334|322814512|FG004|Overall Study|Lack of Efficacy|0|||
94279347|NCT00464334|322814513|FG005|Overall Study|Lack of Efficacy|0|||
94279348|NCT00464334|322814514|FG006|Overall Study|Lack of Efficacy|0|||
94279349|NCT00464334|322814515|FG007|Overall Study|Lack of Efficacy|0|||
94279350|NCT00464334|322814516|FG008|Overall Study|Lack of Efficacy|0|||
94279351|NCT00464334|322814517|FG009|Overall Study|Lack of Efficacy|0|||
94279352|NCT00464334|322814518|FG010|Overall Study|Lack of Efficacy|0|||
94279353|NCT00464334|322814508|FG000|Overall Study|Lost to Follow-up|0|||
94279354|NCT00464334|322814509|FG001|Overall Study|Lost to Follow-up|0|||
94279355|NCT00464334|322814510|FG002|Overall Study|Lost to Follow-up|1|||
94279356|NCT00464334|322814511|FG003|Overall Study|Lost to Follow-up|0|||
94279357|NCT00464334|322814512|FG004|Overall Study|Lost to Follow-up|1|||
94279358|NCT00464334|322814513|FG005|Overall Study|Lost to Follow-up|0|||
94279359|NCT00464334|322814514|FG006|Overall Study|Lost to Follow-up|1|||
94279360|NCT00464334|322814515|FG007|Overall Study|Lost to Follow-up|0|||
94279361|NCT00464334|322814516|FG008|Overall Study|Lost to Follow-up|0|||
94279362|NCT00464334|322814517|FG009|Overall Study|Lost to Follow-up|0|||
94279363|NCT00464334|322814518|FG010|Overall Study|Lost to Follow-up|2|||
94279364|NCT00464334|322814508|FG000|Overall Study|Progressive Disease|0|||
94279365|NCT00464334|322814509|FG001|Overall Study|Progressive Disease|0|||
94279366|NCT00464334|322814510|FG002|Overall Study|Progressive Disease|0|||
94279367|NCT00464334|322814511|FG003|Overall Study|Progressive Disease|0|||
94279368|NCT00464334|322814512|FG004|Overall Study|Progressive Disease|0|||
94279369|NCT00464334|322814513|FG005|Overall Study|Progressive Disease|1|||
94279370|NCT00464334|322814514|FG006|Overall Study|Progressive Disease|0|||
94279371|NCT00464334|322814515|FG007|Overall Study|Progressive Disease|0|||
94203929|NCT03660930|322543094|FG003|Overall Study|Adverse Event|2|||
94203930|NCT03660930|322543095|FG004|Overall Study|Adverse Event|0|||
94203931|NCT03660930|322543096|FG005|Overall Study|Adverse Event|1|||
94279372|NCT00464334|322814516|FG008|Overall Study|Progressive Disease|1|||
94279373|NCT00464334|322814517|FG009|Overall Study|Progressive Disease|0|||
94279374|NCT00464334|322814518|FG010|Overall Study|Progressive Disease|0|||
94279375|NCT00464334|322814508|FG000|Overall Study|Study Terminated by Sponsor|0|||
94203932|NCT03660930|322543097|FG006|Overall Study|Adverse Event|0|||
94279376|NCT00464334|322814509|FG001|Overall Study|Study Terminated by Sponsor|0|||
94279377|NCT00464334|322814510|FG002|Overall Study|Study Terminated by Sponsor|0|||
94203933|NCT03660930|322543098|FG007|Overall Study|Adverse Event|0|||
94203934|NCT03660930|322543091|FG000|Overall Study|Withdrawal by Subject|0|||
94203935|NCT03660930|322543092|FG001|Overall Study|Withdrawal by Subject|0|||
94203936|NCT03660930|322543093|FG002|Overall Study|Withdrawal by Subject|0|||
94203937|NCT03660930|322543094|FG003|Overall Study|Withdrawal by Subject|0|||
94203938|NCT03660930|322543095|FG004|Overall Study|Withdrawal by Subject|0|||
94203939|NCT03660930|322543096|FG005|Overall Study|Withdrawal by Subject|1|||
94203940|NCT03660930|322543097|FG006|Overall Study|Withdrawal by Subject|0|||
94203941|NCT03660930|322543098|FG007|Overall Study|Withdrawal by Subject|0|||
94203942|NCT02656706|322543099|FG000|Overall Study|Insurance Denial|1|||
94203943|NCT02754596|322543103|FG000|Overall Study|Withdrawal by Subject|3|||
94203944|NCT02754596|322543104|FG001|Overall Study|Withdrawal by Subject|4|||
94203945|NCT02754596|322543105|FG002|Overall Study|Withdrawal by Subject|0|||
94203946|NCT02754596|322543103|FG000|Overall Study|Physician Decision|1|||
94203947|NCT02754596|322543104|FG001|Overall Study|Physician Decision|1|||
94203948|NCT02754596|322543105|FG002|Overall Study|Physician Decision|1|||
94203949|NCT02754596|322543103|FG000|Overall Study|Lost to Follow-up|1|||
94203950|NCT02754596|322543104|FG001|Overall Study|Lost to Follow-up|1|||
94203951|NCT02754596|322543105|FG002|Overall Study|Lost to Follow-up|2|||
94203952|NCT02754596|322543103|FG000|Overall Study|Death|0|||
94203953|NCT02754596|322543104|FG001|Overall Study|Death|2|||
94203954|NCT02754596|322543105|FG002|Overall Study|Death|0|||
94203955|NCT02754596|322543103|FG000|Overall Study|Adverse Event|1|||
94203956|NCT02754596|322543104|FG001|Overall Study|Adverse Event|0|||
94203957|NCT02754596|322543105|FG002|Overall Study|Adverse Event|1|||
94203958|NCT02754596|322543103|FG000|Overall Study|Other|1|||
94203959|NCT02754596|322543104|FG001|Overall Study|Other|0|||
94203960|NCT02754596|322543105|FG002|Overall Study|Other|0|||
94203961|NCT02078648|322543106|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
94203962|NCT02078648|322543107|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
94203963|NCT02078648|322543106|FG000|Overall Study|Adverse Event|0|||
94203964|NCT02078648|322543107|FG001|Overall Study|Adverse Event|1|||
94203965|NCT02078648|322543106|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
94203966|NCT02078648|322543107|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
94203967|NCT02078648|322543106|FG000|Overall Study|Withdrawal by Subject|3|||
94203968|NCT02078648|322543107|FG001|Overall Study|Withdrawal by Subject|1|||
94203969|NCT02078648|322543106|FG000|Overall Study|Investigator Decision|5|||
94203970|NCT02078648|322543107|FG001|Overall Study|Investigator Decision|7|||
94203971|NCT02078648|322543106|FG000|Overall Study|Death|1|||
94279378|NCT00464334|322814511|FG003|Overall Study|Study Terminated by Sponsor|1|||
94279379|NCT00464334|322814512|FG004|Overall Study|Study Terminated by Sponsor|0|||
94279380|NCT00464334|322814513|FG005|Overall Study|Study Terminated by Sponsor|0|||
94279381|NCT00464334|322814514|FG006|Overall Study|Study Terminated by Sponsor|0|||
94279382|NCT00464334|322814515|FG007|Overall Study|Study Terminated by Sponsor|0|||
94279383|NCT00464334|322814516|FG008|Overall Study|Study Terminated by Sponsor|0|||
94279384|NCT00464334|322814517|FG009|Overall Study|Study Terminated by Sponsor|0|||
94279385|NCT00464334|322814518|FG010|Overall Study|Study Terminated by Sponsor|0|||
94279386|NCT00464334|322814508|FG000|Overall Study|Withdrawal by Subject|1|||
94279387|NCT00464334|322814509|FG001|Overall Study|Withdrawal by Subject|7|||
94279388|NCT00464334|322814510|FG002|Overall Study|Withdrawal by Subject|4|||
94279389|NCT00464334|322814511|FG003|Overall Study|Withdrawal by Subject|2|||
94279390|NCT00464334|322814512|FG004|Overall Study|Withdrawal by Subject|2|||
94279391|NCT00464334|322814513|FG005|Overall Study|Withdrawal by Subject|2|||
94279392|NCT00464334|322814514|FG006|Overall Study|Withdrawal by Subject|2|||
94279393|NCT00464334|322814515|FG007|Overall Study|Withdrawal by Subject|1|||
94279394|NCT00464334|322814516|FG008|Overall Study|Withdrawal by Subject|3|||
94279395|NCT00464334|322814517|FG009|Overall Study|Withdrawal by Subject|0|||
94279396|NCT00464334|322814518|FG010|Overall Study|Withdrawal by Subject|0|||
94279397|NCT00797732|322814519|FG000|Overall Study|Withdrawal by Subject|3|||
94279398|NCT00797732|322814520|FG001|Overall Study|Withdrawal by Subject|3|||
94203972|NCT02078648|322543107|FG001|Overall Study|Death|1|||
94279399|NCT00797732|322814521|FG002|Overall Study|Withdrawal by Subject|0|||
94279400|NCT00797732|322814519|FG000|Overall Study|Lost to Follow-up|1|||
94279401|NCT00797732|322814520|FG001|Overall Study|Lost to Follow-up|0|||
94370788|NCT02290028|323144512|FG000|Overall Study|Planned study completion at 12 months|257|||
94370789|NCT03202511|323144513|FG000|Overall Study|Withdrawal by Subject|1|||
94370790|NCT03202511|323144514|FG001|Overall Study|Withdrawal by Subject|0|||
94203973|NCT02078648|322543106|FG000|Overall Study|Undefined|0|||
94203974|NCT02078648|322543107|FG001|Overall Study|Undefined|1|||
94203975|NCT01675492|322543108|FG000|Overall Study|study completed early - product approval|42|||
94203976|NCT05525572|322543112|FG000|Overall Study|Lost to Follow-up|2|||
94203977|NCT03978637|322543116|FG000|Overall Study|Death|0|||
94203978|NCT03978637|322543117|FG001|Overall Study|Death|2|||
94279402|NCT00797732|322814521|FG002|Overall Study|Lost to Follow-up|0|||
94279403|NCT00797732|322814519|FG000|Overall Study|Death|1|||
94370791|NCT00833547|323144515|FG000|Overall Study|Withdrawal by Subject|2|||
94370792|NCT00833547|323144516|FG001|Overall Study|Withdrawal by Subject|2|||
94203979|NCT03978637|322543118|FG002|Overall Study|Death|2|||
94203980|NCT03978637|322543119|FG003|Overall Study|Death|0|||
94203981|NCT03978637|322543116|FG000|Overall Study|Withdrawal by Subject|0|||
94203982|NCT03978637|322543117|FG001|Overall Study|Withdrawal by Subject|0|||
94203983|NCT03978637|322543118|FG002|Overall Study|Withdrawal by Subject|1|||
94203984|NCT03978637|322543119|FG003|Overall Study|Withdrawal by Subject|0|||
94203985|NCT03978637|322543116|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
94203986|NCT03978637|322543117|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
94203987|NCT03978637|322543118|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
94203988|NCT03978637|322543119|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
94203989|NCT05786612|322543122|FG000|Overall Study|Adverse Event|1|||
94203990|NCT05786612|322543123|FG001|Overall Study|Adverse Event|2|||
94203991|NCT05786612|322543122|FG000|Overall Study|one screening failure|0|||
94203992|NCT05786612|322543123|FG001|Overall Study|one screening failure|2|||
94203993|NCT02549352|322543126|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
94203994|NCT02549352|322543127|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
94203995|NCT02549352|322543126|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
94203996|NCT02549352|322543127|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
94203997|NCT02549352|322543126|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
94203998|NCT02549352|322543127|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
94203999|NCT02549352|322543126|FG000|12-month Follow-up|Withdrawal by Subject|4|||
94204000|NCT02549352|322543127|FG001|12-month Follow-up|Withdrawal by Subject|5|||
94204001|NCT02549352|322543126|FG000|12-month Follow-up|Lost to Follow-up|3|||
94204002|NCT02549352|322543127|FG001|12-month Follow-up|Lost to Follow-up|2|||
94204003|NCT02549352|322543126|FG000|12-month Follow-up|Death|0|||
94204004|NCT02549352|322543127|FG001|12-month Follow-up|Death|1|||
94204005|NCT02549352|322543126|FG000|12-month Follow-up|Protocol Violation|0|||
94204006|NCT02549352|322543127|FG001|12-month Follow-up|Protocol Violation|1|||
94204007|NCT02549352|322543126|FG000|12-month Follow-up|Other|1|||
94204008|NCT02549352|322543127|FG001|12-month Follow-up|Other|3|||
94204009|NCT02422615|322544409|FG000|Treatment Period|Progressive disease|314|||
94204010|NCT02422615|322544410|FG001|Treatment Period|Progressive disease|200|||
94204011|NCT02422615|322544409|FG000|Treatment Period|Adverse Event|51|||
94204012|NCT02422615|322544410|FG001|Treatment Period|Adverse Event|9|||
94204013|NCT02422615|322544409|FG000|Treatment Period|Physician Decision|32|||
94204014|NCT02422615|322544410|FG001|Treatment Period|Physician Decision|8|||
94204015|NCT02422615|322544409|FG000|Treatment Period|Subject/guardian decision|38|||
94204016|NCT02422615|322544410|FG001|Treatment Period|Subject/guardian decision|8|||
94204017|NCT02422615|322544409|FG000|Treatment Period|Death|2|||
94204018|NCT02422615|322544410|FG001|Treatment Period|Death|1|||
94204019|NCT02422615|322544409|FG000|Treatment Period|Technical problems|0|||
94204020|NCT02422615|322544410|FG001|Treatment Period|Technical problems|1|||
94204021|NCT02422615|322544409|FG000|Treatment Period|Protocol deviation|1|||
94204022|NCT02422615|322544410|FG001|Treatment Period|Protocol deviation|1|||
94204023|NCT02422615|322544409|FG000|Treatment Period|Study terminated as per protocol|46|||
94204024|NCT02422615|322544410|FG001|Treatment Period|Study terminated as per protocol|14|||
94204025|NCT02422615|322544409|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
94204026|NCT02422615|322544410|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
94204027|NCT02422615|322544409|FG000|Post-treatment Efficacy Follow-up|Death|2|||
94204028|NCT02422615|322544410|FG001|Post-treatment Efficacy Follow-up|Death|1|||
94204029|NCT02422615|322544409|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
94204030|NCT02422615|322544410|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
94204031|NCT02422615|322544409|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
94204032|NCT02422615|322544410|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
94204033|NCT02422615|322544409|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
94204034|NCT02422615|322544410|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
94204035|NCT02422615|322544409|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
94204036|NCT02422615|322544410|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
94204037|NCT01184326|322544411|FG000|Overall Study|Adverse Event|1|||
94204038|NCT01184326|322544412|FG001|Overall Study|Adverse Event|2|||
94204039|NCT01184326|322544413|FG002|Overall Study|Adverse Event|0|||
94204040|NCT01184326|322544411|FG000|Overall Study|Death|0|||
94204041|NCT01184326|322544412|FG001|Overall Study|Death|0|||
94204042|NCT01184326|322544413|FG002|Overall Study|Death|1|||
94370793|NCT00686790|323144517|FG000|Overall Study|Adverse Event|2|||
94370794|NCT00686790|323144517|FG000|Overall Study|Withdrawal by Subject|1|||
94204043|NCT01184326|322544411|FG000|Overall Study|Withdrawal by Subject|0|||
94204044|NCT01184326|322544412|FG001|Overall Study|Withdrawal by Subject|0|||
94204045|NCT01184326|322544413|FG002|Overall Study|Withdrawal by Subject|1|||
94204046|NCT01184326|322544411|FG000|Overall Study|Physician Decision|1|||
94204047|NCT01184326|322544412|FG001|Overall Study|Physician Decision|1|||
94204048|NCT01184326|322544413|FG002|Overall Study|Physician Decision|0|||
94204049|NCT01184326|322544411|FG000|Overall Study|Disease Progression|1|||
94204050|NCT01184326|322544412|FG001|Overall Study|Disease Progression|3|||
94204051|NCT01184326|322544413|FG002|Overall Study|Disease Progression|12|||
94204052|NCT01036724|322544414|FG000|Overall Study|Adverse Event|1|||
94204053|NCT01036724|322544415|FG001|Overall Study|Adverse Event|2|||
94204054|NCT01036724|322544414|FG000|Overall Study|Lack of Efficacy|1|||
94204055|NCT01036724|322544415|FG001|Overall Study|Lack of Efficacy|1|||
94204056|NCT01036724|322544414|FG000|Overall Study|Protocol Violation|4|||
94204057|NCT01036724|322544415|FG001|Overall Study|Protocol Violation|5|||
94204058|NCT00557492|322544419|FG000|Overall Study|Change in health insurance|1|||
94204059|NCT04334317|322544420|FG000|Overall Study|Adverse Event|1|||
94204060|NCT04334317|322544421|FG001|Overall Study|Adverse Event|2|||
94204061|NCT04334317|322544422|FG002|Overall Study|Adverse Event|0|||
94204062|NCT04334317|322544423|FG003|Overall Study|Adverse Event|0|||
94204063|NCT04334317|322544420|FG000|Overall Study|Protocol Deviation|0|||
94204064|NCT04334317|322544421|FG001|Overall Study|Protocol Deviation|1|||
94204065|NCT04334317|322544422|FG002|Overall Study|Protocol Deviation|0|||
94204066|NCT04334317|322544423|FG003|Overall Study|Protocol Deviation|0|||
94204067|NCT04334317|322544420|FG000|Overall Study|Withdrawal by Subject|2|||
94204068|NCT04334317|322544421|FG001|Overall Study|Withdrawal by Subject|2|||
94204069|NCT04334317|322544422|FG002|Overall Study|Withdrawal by Subject|0|||
94204070|NCT04334317|322544423|FG003|Overall Study|Withdrawal by Subject|0|||
94204071|NCT00605306|322544426|FG000|Overall Study|Adverse Event|0|||
94204072|NCT00605306|322544427|FG001|Overall Study|Adverse Event|1|||
94204073|NCT01105975|322544428|FG000|Overall Study|Adverse Event|2|||
94204074|NCT01105975|322544429|FG001|Overall Study|Adverse Event|1|||
94204075|NCT01105975|322544430|FG002|Overall Study|Adverse Event|5|||
94204076|NCT01105975|322544431|FG003|Overall Study|Adverse Event|1|||
94204077|NCT01105975|322544432|FG004|Overall Study|Adverse Event|0|||
94204078|NCT01105975|322544433|FG005|Overall Study|Adverse Event|1|||
94204079|NCT01105975|322544434|FG006|Overall Study|Adverse Event|2|||
94204080|NCT01105975|322544435|FG007|Overall Study|Adverse Event|4|||
94204081|NCT01105975|322544436|FG008|Overall Study|Adverse Event|1|||
94204082|NCT01105975|322544437|FG009|Overall Study|Adverse Event|4|||
94204083|NCT01105975|322544428|FG000|Overall Study|Withdrawal by Subject|2|||
94204084|NCT01105975|322544429|FG001|Overall Study|Withdrawal by Subject|2|||
94204085|NCT01105975|322544430|FG002|Overall Study|Withdrawal by Subject|2|||
94204086|NCT01105975|322544431|FG003|Overall Study|Withdrawal by Subject|0|||
94204087|NCT01105975|322544432|FG004|Overall Study|Withdrawal by Subject|4|||
94204088|NCT01105975|322544433|FG005|Overall Study|Withdrawal by Subject|1|||
94204089|NCT01105975|322544434|FG006|Overall Study|Withdrawal by Subject|2|||
94204090|NCT01105975|322544435|FG007|Overall Study|Withdrawal by Subject|1|||
94204091|NCT01105975|322544436|FG008|Overall Study|Withdrawal by Subject|0|||
94204092|NCT01105975|322544437|FG009|Overall Study|Withdrawal by Subject|3|||
94204093|NCT01105975|322544428|FG000|Overall Study|Lost to Follow-up|1|||
94204094|NCT01105975|322544429|FG001|Overall Study|Lost to Follow-up|0|||
94204095|NCT01105975|322544430|FG002|Overall Study|Lost to Follow-up|0|||
94204096|NCT01105975|322544431|FG003|Overall Study|Lost to Follow-up|1|||
94204097|NCT01105975|322544432|FG004|Overall Study|Lost to Follow-up|1|||
94279404|NCT00797732|322814520|FG001|Overall Study|Death|0|||
94279405|NCT00797732|322814521|FG002|Overall Study|Death|0|||
94279406|NCT00797732|322814519|FG000|Overall Study|Not meet inclusion criteria|0|||
94279407|NCT00797732|322814520|FG001|Overall Study|Not meet inclusion criteria|0|||
94279408|NCT00797732|322814521|FG002|Overall Study|Not meet inclusion criteria|7|||
94279409|NCT00797732|322814519|FG000|Overall Study|Excluded due to time constraints|0|||
94279410|NCT00797732|322814520|FG001|Overall Study|Excluded due to time constraints|0|||
94279411|NCT00797732|322814521|FG002|Overall Study|Excluded due to time constraints|24|||
94279412|NCT00797732|322814519|FG000|Overall Study|Refused to Participate|0|||
94279413|NCT00797732|322814520|FG001|Overall Study|Refused to Participate|0|||
94279414|NCT00797732|322814521|FG002|Overall Study|Refused to Participate|123|||
94279415|NCT02182687|322814524|FG000|Overall Study|Withdrawal by Subject|4|||
94279416|NCT02182687|322814525|FG001|Overall Study|Withdrawal by Subject|0|||
94279417|NCT02182687|322814524|FG000|Overall Study|Adverse Event|1|||
94279418|NCT02182687|322814525|FG001|Overall Study|Adverse Event|0|||
94370795|NCT00686790|323144517|FG000|Overall Study|Death|1|||
94370796|NCT00686790|323144517|FG000|Overall Study|Lost to Follow-up|12|||
94370797|NCT02513459|323144518|FG000|Overall Study|Adverse Event|7|||
94370798|NCT02513459|323144518|FG000|Overall Study|Withdrew consent|5|||
94370799|NCT02513459|323144518|FG000|Overall Study|Loss of efficacy|2|||
94204098|NCT01105975|322544433|FG005|Overall Study|Lost to Follow-up|0|||
94279419|NCT02182687|322814524|FG000|Overall Study|Lost to Follow-up|0|||
94370800|NCT02513459|323144518|FG000|Overall Study|Pregnancy|2|||
94204099|NCT01105975|322544434|FG006|Overall Study|Lost to Follow-up|0|||
94204100|NCT01105975|322544435|FG007|Overall Study|Lost to Follow-up|0|||
94204101|NCT01105975|322544436|FG008|Overall Study|Lost to Follow-up|1|||
94204102|NCT01105975|322544437|FG009|Overall Study|Lost to Follow-up|0|||
94204103|NCT01105975|322544428|FG000|Overall Study|Physician Decision|0|||
94204104|NCT01105975|322544429|FG001|Overall Study|Physician Decision|0|||
94204105|NCT01105975|322544430|FG002|Overall Study|Physician Decision|0|||
94204106|NCT01105975|322544431|FG003|Overall Study|Physician Decision|0|||
94204107|NCT01105975|322544432|FG004|Overall Study|Physician Decision|0|||
94279420|NCT02182687|322814525|FG001|Overall Study|Lost to Follow-up|1|||
94279421|NCT00401752|322814526|FG000|Overall Study|Adverse Event|2|||
94370801|NCT02513459|323144518|FG000|Overall Study|Subject decision|2|||
94370802|NCT02513459|323144518|FG000|Overall Study|Lack of response|1|||
94370803|NCT02513459|323144518|FG000|Overall Study|Reproductive plans|1|||
94370804|NCT02513459|323144518|FG000|Overall Study|Surgery planned-- not done|1|||
94370805|NCT03237611|323144519|FG000|Overall Study|Withdrawal by Subject|1|||
94370806|NCT03237611|323144519|FG000|Overall Study|Ineligible|1|||
94370807|NCT00707174|323144520|FG000|Overall Study|Adverse Event|1|||
94370808|NCT00707174|323144521|FG001|Overall Study|Adverse Event|6|||
94370809|NCT00707174|323144520|FG000|Overall Study|Withdrawal by Subject|4|||
94370810|NCT00707174|323144521|FG001|Overall Study|Withdrawal by Subject|1|||
94370811|NCT04126733|323144526|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
94370812|NCT04126733|323144526|FG000|Treatment Period|Adverse Event|8|||
94370813|NCT04126733|323144526|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
94370814|NCT04126733|323144526|FG000|Treatment Period|Physician Decision|5|||
94370815|NCT04126733|323144526|FG000|Treatment Period|Death|1|||
94370816|NCT04126733|323144526|FG000|Treatment Period|Other Reasons|2|||
94370817|NCT04126733|323144526|FG000|Active Follow-up Period|Death|13|||
94743486|NCT04428151|324517020|FG002|Overall Study|Death|57|||
94743487|NCT04428151|324517018|FG000|Overall Study|Lost to Follow-up|1|||
94743488|NCT04428151|324517019|FG001|Overall Study|Lost to Follow-up|1|||
94743489|NCT04428151|324517020|FG002|Overall Study|Lost to Follow-up|0|||
94743490|NCT04428151|324517018|FG000|Overall Study|Withdrawal by Subject|2|||
94743491|NCT04428151|324517019|FG001|Overall Study|Withdrawal by Subject|2|||
94743492|NCT04428151|324517020|FG002|Overall Study|Withdrawal by Subject|3|||
94743493|NCT04428151|324517018|FG000|Overall Study|Participant Ongoing in Study|41|||
94743494|NCT04428151|324517019|FG001|Overall Study|Participant Ongoing in Study|53|||
94743495|NCT04428151|324517020|FG002|Overall Study|Participant Ongoing in Study|28|||
94743496|NCT03705390|324517026|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
94743497|NCT03705390|324517026|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
94743498|NCT02781792|324517027|FG000|Overall Study|Adverse Event|1|||
94743499|NCT02781792|324517028|FG001|Overall Study|Adverse Event|2|||
94743500|NCT02781792|324517027|FG000|Overall Study|Withdrawal by Subject|3|||
94743501|NCT02781792|324517028|FG001|Overall Study|Withdrawal by Subject|1|||
94743502|NCT02781792|324517027|FG000|Overall Study|Lack of Efficacy|1|||
94743503|NCT02781792|324517028|FG001|Overall Study|Lack of Efficacy|1|||
94743504|NCT02781792|324517027|FG000|Overall Study|Hospice|0|||
94743505|NCT02781792|324517028|FG001|Overall Study|Hospice|1|||
94743506|NCT02838420|324517032|FG000|Overall Study|Ongoing in Study|113|||
94743507|NCT02838420|324517033|FG001|Overall Study|Ongoing in Study|45|||
94743508|NCT02838420|324517032|FG000|Overall Study|Lost to Follow-up|1|||
94743509|NCT02838420|324517033|FG001|Overall Study|Lost to Follow-up|0|||
94743510|NCT02838420|324517032|FG000|Overall Study|Withdrawal by Subject|3|||
94743511|NCT02838420|324517033|FG001|Overall Study|Withdrawal by Subject|4|||
94743512|NCT02838420|324517032|FG000|Overall Study|Death|8|||
94743513|NCT02838420|324517033|FG001|Overall Study|Death|13|||
94743514|NCT02443116|324517034|FG000|Part 1|Adverse Event|2|||
94743515|NCT02443116|324517035|FG001|Part 1|Adverse Event|3|||
94743516|NCT02443116|324517036|FG002|Part 1|Adverse Event|0|||
94743517|NCT02443116|324517037|FG003|Part 1|Adverse Event|0|||
94743518|NCT02443116|324517038|FG004|Part 1|Adverse Event|0|||
94743519|NCT02443116|324517039|FG005|Part 1|Adverse Event|0|||
94743520|NCT02443116|324517040|FG006|Part 1|Adverse Event|0|||
94743521|NCT02443116|324517041|FG007|Part 1|Adverse Event|0|||
94743522|NCT02443116|324517042|FG008|Part 1|Adverse Event|0|||
94743523|NCT02443116|324517034|FG000|Part 1|Withdrew informed consent|0|||
94743524|NCT02443116|324517035|FG001|Part 1|Withdrew informed consent|1|||
94743525|NCT02443116|324517036|FG002|Part 1|Withdrew informed consent|0|||
94743526|NCT02443116|324517037|FG003|Part 1|Withdrew informed consent|0|||
94743527|NCT02443116|324517038|FG004|Part 1|Withdrew informed consent|0|||
94743528|NCT02443116|324517039|FG005|Part 1|Withdrew informed consent|0|||
94743529|NCT02443116|324517040|FG006|Part 1|Withdrew informed consent|0|||
94743530|NCT02443116|324517041|FG007|Part 1|Withdrew informed consent|0|||
94743531|NCT02443116|324517042|FG008|Part 1|Withdrew informed consent|0|||
94743532|NCT02443116|324517034|FG000|Part 1|Lost to Follow-up|0|||
94743533|NCT02443116|324517035|FG001|Part 1|Lost to Follow-up|0|||
94743534|NCT02443116|324517036|FG002|Part 1|Lost to Follow-up|2|||
94743535|NCT02443116|324517037|FG003|Part 1|Lost to Follow-up|0|||
94743536|NCT02443116|324517038|FG004|Part 1|Lost to Follow-up|0|||
94743537|NCT02443116|324517039|FG005|Part 1|Lost to Follow-up|0|||
94743538|NCT02443116|324517040|FG006|Part 1|Lost to Follow-up|0|||
94743539|NCT02443116|324517041|FG007|Part 1|Lost to Follow-up|0|||
94743540|NCT02443116|324517042|FG008|Part 1|Lost to Follow-up|0|||
94743541|NCT02443116|324517034|FG000|Part 1|Participant moved out of state|0|||
94743542|NCT02443116|324517035|FG001|Part 1|Participant moved out of state|0|||
94743543|NCT02443116|324517036|FG002|Part 1|Participant moved out of state|1|||
94743544|NCT02443116|324517037|FG003|Part 1|Participant moved out of state|0|||
94467653|NCT00577005|323502371|FG000|Overall Study|Lost to Follow-up|3|||
94370818|NCT04126733|323144526|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
94743545|NCT02443116|324517038|FG004|Part 1|Participant moved out of state|0|||
94743546|NCT02443116|324517039|FG005|Part 1|Participant moved out of state|0|||
94204108|NCT01105975|322544433|FG005|Overall Study|Physician Decision|0|||
94204109|NCT01105975|322544434|FG006|Overall Study|Physician Decision|2|||
94204110|NCT01105975|322544435|FG007|Overall Study|Physician Decision|0|||
94204111|NCT01105975|322544436|FG008|Overall Study|Physician Decision|0|||
94204112|NCT01105975|322544437|FG009|Overall Study|Physician Decision|0|||
94204113|NCT01105975|322544428|FG000|Overall Study|Protocol Violation|0|||
94204114|NCT01105975|322544429|FG001|Overall Study|Protocol Violation|2|||
94204115|NCT01105975|322544430|FG002|Overall Study|Protocol Violation|2|||
94204116|NCT01105975|322544431|FG003|Overall Study|Protocol Violation|0|||
94204117|NCT01105975|322544432|FG004|Overall Study|Protocol Violation|1|||
94204118|NCT01105975|322544433|FG005|Overall Study|Protocol Violation|1|||
94204119|NCT01105975|322544434|FG006|Overall Study|Protocol Violation|1|||
94204120|NCT01105975|322544435|FG007|Overall Study|Protocol Violation|1|||
94204121|NCT01105975|322544436|FG008|Overall Study|Protocol Violation|2|||
94204122|NCT01105975|322544437|FG009|Overall Study|Protocol Violation|2|||
94204123|NCT01105975|322544428|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
94204124|NCT01105975|322544429|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
94204125|NCT01105975|322544430|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
94204126|NCT01105975|322544431|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
94204127|NCT01105975|322544432|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
94204128|NCT01105975|322544433|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
94204129|NCT01105975|322544434|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
94204130|NCT01105975|322544435|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
94204131|NCT01105975|322544436|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
94204132|NCT01105975|322544437|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
94204133|NCT01074294|322544444|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
94204134|NCT01074294|322544445|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
94204135|NCT01074294|322544446|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
94204136|NCT01074294|322544447|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
94204137|NCT01074294|322544444|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
94204138|NCT01074294|322544445|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
94204139|NCT01074294|322544446|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
94204140|NCT01074294|322544447|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
94204141|NCT01074294|322544444|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
94204142|NCT01074294|322544445|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
94204143|NCT01074294|322544446|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
94204144|NCT01074294|322544447|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
94279422|NCT00401752|322814527|FG001|Overall Study|Adverse Event|5|||
94279423|NCT00401752|322814526|FG000|Overall Study|Withdrawal by Subject|2|||
94279424|NCT00401752|322814527|FG001|Overall Study|Withdrawal by Subject|6|||
94279425|NCT00401752|322814526|FG000|Overall Study|Lost to Follow-up|1|||
94279426|NCT00401752|322814527|FG001|Overall Study|Lost to Follow-up|4|||
94279427|NCT00401752|322814526|FG000|Overall Study|Development of any exclusion criteria|4|||
94279428|NCT00401752|322814527|FG001|Overall Study|Development of any exclusion criteria|2|||
94279429|NCT00401752|322814526|FG000|Overall Study|Physician Decision|1|||
94279430|NCT00401752|322814527|FG001|Overall Study|Physician Decision|1|||
94279431|NCT01965262|322814531|FG000|Second Intervention (7 Days)|Discontinued|0|||
94279432|NCT01965262|322814532|FG001|Second Intervention (7 Days)|Discontinued|1|||
94279433|NCT01965262|322814531|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
94279434|NCT01965262|322814532|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
94279435|NCT01965262|322814531|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
94279436|NCT01965262|322814532|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
94279437|NCT00343889|322814535|FG000|Overall Study|Lost to Follow-up|2|||
94279438|NCT00343889|322814536|FG001|Overall Study|Lost to Follow-up|0|||
94279439|NCT00343889|322814535|FG000|Overall Study|Withdrawal by Subject|0|||
94279440|NCT00343889|322814536|FG001|Overall Study|Withdrawal by Subject|1|||
94279441|NCT00343889|322814535|FG000|Overall Study|Protocol Violation|1|||
94743547|NCT02443116|324517040|FG006|Part 1|Participant moved out of state|0|||
94743548|NCT02443116|324517041|FG007|Part 1|Participant moved out of state|0|||
94743549|NCT02443116|324517042|FG008|Part 1|Participant moved out of state|0|||
94743550|NCT02443116|324517034|FG000|Part 1|Participant enrolled in another clinical trial|0|||
94743551|NCT02443116|324517035|FG001|Part 1|Participant enrolled in another clinical trial|0|||
94743552|NCT02443116|324517036|FG002|Part 1|Participant enrolled in another clinical trial|1|||
94743553|NCT02443116|324517037|FG003|Part 1|Participant enrolled in another clinical trial|0|||
94743554|NCT02443116|324517038|FG004|Part 1|Participant enrolled in another clinical trial|0|||
94743555|NCT02443116|324517039|FG005|Part 1|Participant enrolled in another clinical trial|0|||
94743556|NCT02443116|324517040|FG006|Part 1|Participant enrolled in another clinical trial|0|||
94743557|NCT02443116|324517041|FG007|Part 1|Participant enrolled in another clinical trial|0|||
94279442|NCT00343889|322814536|FG001|Overall Study|Protocol Violation|0|||
94279443|NCT01967537|322814537|FG000|Overall Study|Withdrawal by Subject|52|||
94279444|NCT01967537|322814537|FG000|Overall Study|Refuse treatment|2|||
94279445|NCT01967537|322814537|FG000|Overall Study|Lost to Follow-up|6|||
94204145|NCT01074294|322544444|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
94204146|NCT01074294|322544445|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
94204147|NCT01074294|322544446|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
94204148|NCT01074294|322544447|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
94204149|NCT01074294|322544444|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
94204150|NCT01074294|322544445|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
94204151|NCT01074294|322544446|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
94204152|NCT01074294|322544447|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
94467654|NCT00577005|323502372|FG001|Overall Study|Lost to Follow-up|2|||
94204153|NCT01074294|322544444|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
94204154|NCT01074294|322544445|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
94204155|NCT01074294|322544446|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
94204156|NCT01074294|322544447|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
94204157|NCT01074294|322544444|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
94204158|NCT01074294|322544445|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
94204159|NCT01074294|322544446|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
94204160|NCT01074294|322544447|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
94204161|NCT01074294|322544444|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
94204162|NCT01074294|322544445|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
94204163|NCT01074294|322544446|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
94204164|NCT01074294|322544447|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
94204165|NCT01074294|322544444|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
94204166|NCT01074294|322544445|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
94204167|NCT01074294|322544446|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
94204168|NCT01074294|322544447|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
94204169|NCT01074294|322544444|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
94204170|NCT01074294|322544445|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
94204171|NCT01074294|322544446|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
94204172|NCT01074294|322544447|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
94204173|NCT01074294|322544444|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
94204174|NCT01074294|322544445|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
94204175|NCT01074294|322544446|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
94204176|NCT01074294|322544447|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
94204177|NCT01074294|322544444|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
94204178|NCT01074294|322544445|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
94204179|NCT01074294|322544446|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
94204180|NCT01074294|322544447|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
94204181|NCT01074294|322544444|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
94204182|NCT01074294|322544445|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
94204183|NCT01074294|322544446|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
94204184|NCT01074294|322544447|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
94204185|NCT01260896|322544454|FG000|First Intervention|Withdrawn Due to Emesis|2|||
94204186|NCT01260896|322544455|FG001|First Intervention|Withdrawn Due to Emesis|0|||
94204187|NCT01988402|322544457|FG000|Overall Study|Adverse Event|1|||
94204188|NCT01988402|322544458|FG001|Overall Study|Adverse Event|2|||
94204189|NCT01988402|322544457|FG000|Overall Study|Withdrawal by Subject|1|||
94204190|NCT01988402|322544458|FG001|Overall Study|Withdrawal by Subject|0|||
94204191|NCT01566890|322544462|FG000|Overall Study|Adverse Event|1|||
94204192|NCT01566890|322544463|FG001|Overall Study|Adverse Event|0|||
94204193|NCT01566890|322544464|FG002|Overall Study|Adverse Event|0|||
94204194|NCT01566890|322544465|FG003|Overall Study|Adverse Event|0|||
94204195|NCT01566890|322544466|FG004|Overall Study|Adverse Event|0|||
94204196|NCT01566890|322544462|FG000|Overall Study|Withdrawal by Subject|3|||
94204197|NCT01566890|322544463|FG001|Overall Study|Withdrawal by Subject|1|||
94204198|NCT01566890|322544464|FG002|Overall Study|Withdrawal by Subject|1|||
94204199|NCT01566890|322544465|FG003|Overall Study|Withdrawal by Subject|1|||
94204200|NCT01566890|322544466|FG004|Overall Study|Withdrawal by Subject|0|||
94204201|NCT01566890|322544462|FG000|Overall Study|Screen failure|6|||
94204202|NCT01566890|322544463|FG001|Overall Study|Screen failure|0|||
94204203|NCT01566890|322544464|FG002|Overall Study|Screen failure|1|||
94204204|NCT01566890|322544465|FG003|Overall Study|Screen failure|1|||
94204205|NCT01566890|322544466|FG004|Overall Study|Screen failure|0|||
94204206|NCT01566890|322544462|FG000|Overall Study|Incomplete CEU data|1|||
94204207|NCT01566890|322544463|FG001|Overall Study|Incomplete CEU data|3|||
94204208|NCT01566890|322544464|FG002|Overall Study|Incomplete CEU data|5|||
94204209|NCT01566890|322544465|FG003|Overall Study|Incomplete CEU data|8|||
94204210|NCT01566890|322544466|FG004|Overall Study|Incomplete CEU data|0|||
94204211|NCT01566890|322544462|FG000|Overall Study|Lost to Follow-up|0|||
94204212|NCT01566890|322544463|FG001|Overall Study|Lost to Follow-up|0|||
94204213|NCT01566890|322544464|FG002|Overall Study|Lost to Follow-up|4|||
94204214|NCT01566890|322544465|FG003|Overall Study|Lost to Follow-up|4|||
94204215|NCT01566890|322544466|FG004|Overall Study|Lost to Follow-up|0|||
94204216|NCT01566890|322544462|FG000|Overall Study|Other|0|||
94204217|NCT01566890|322544463|FG001|Overall Study|Other|0|||
94204218|NCT01566890|322544464|FG002|Overall Study|Other|0|||
94204219|NCT01566890|322544465|FG003|Overall Study|Other|0|||
94204220|NCT01566890|322544466|FG004|Overall Study|Other|7|||
94204221|NCT02284113|322544467|FG000|Overall Study|Adverse Event|1|||
94204222|NCT02284113|322544468|FG001|Overall Study|Adverse Event|0|||
94204223|NCT02284113|322544467|FG000|Overall Study|non-compliance|0|||
94204224|NCT02284113|322544468|FG001|Overall Study|non-compliance|1|||
94204225|NCT02284113|322544467|FG000|Overall Study|Withdrawal by Subject|0|||
94204226|NCT02284113|322544468|FG001|Overall Study|Withdrawal by Subject|1|||
94204227|NCT02284113|322544467|FG000|Overall Study|not provided|0|||
94204228|NCT02284113|322544468|FG001|Overall Study|not provided|1|||
94204229|NCT02284113|322544467|FG000|Overall Study|surgery cancelled|2|||
94204230|NCT02284113|322544468|FG001|Overall Study|surgery cancelled|0|||
94204231|NCT02844439|322544469|FG000|Overall Study|Withdrawal by Subject|1|||
94204232|NCT02844439|322544469|FG000|Overall Study|Lost to Follow-up|2|||
94204233|NCT02844439|322544469|FG000|Overall Study|Termination by Sponsor|4|||
94204234|NCT02844439|322544469|FG000|Overall Study|Death|28|||
94204235|NCT02844439|322544469|FG000|Overall Study|Other|5|||
94204236|NCT01458366|322544470|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
94204237|NCT01458366|322544471|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
94204238|NCT01458366|322544472|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
94204239|NCT01458366|322544473|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
94204240|NCT01458366|322544474|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
94204241|NCT01458366|322544470|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
94204242|NCT01458366|322544471|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
94204243|NCT01458366|322544472|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
94204244|NCT01458366|322544473|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
94204245|NCT01458366|322544474|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
94204246|NCT02787005|322544475|FG000|Overall Study|Adverse Event|24|||
94204247|NCT02787005|322544476|FG001|Overall Study|Adverse Event|9|||
94204248|NCT02787005|322544477|FG002|Overall Study|Adverse Event|9|||
94204249|NCT02787005|322544478|FG003|Overall Study|Adverse Event|7|||
94204250|NCT02787005|322544479|FG004|Overall Study|Adverse Event|2|||
94204251|NCT02787005|322544475|FG000|Overall Study|Death|100|||
94204252|NCT02787005|322544476|FG001|Overall Study|Death|53|||
94204253|NCT02787005|322544477|FG002|Overall Study|Death|48|||
94204254|NCT02787005|322544478|FG003|Overall Study|Death|69|||
94204255|NCT02787005|322544479|FG004|Overall Study|Death|38|||
94204256|NCT02787005|322544475|FG000|Overall Study|Sponsor Decision|7|||
94204257|NCT02787005|322544476|FG001|Overall Study|Sponsor Decision|4|||
94204258|NCT02787005|322544477|FG002|Overall Study|Sponsor Decision|0|||
94204259|NCT02787005|322544478|FG003|Overall Study|Sponsor Decision|4|||
94204260|NCT02787005|322544479|FG004|Overall Study|Sponsor Decision|5|||
94204261|NCT02787005|322544475|FG000|Overall Study|Withdrawal by Subject|2|||
94204262|NCT02787005|322544476|FG001|Overall Study|Withdrawal by Subject|1|||
94204263|NCT02787005|322544477|FG002|Overall Study|Withdrawal by Subject|1|||
94204264|NCT02787005|322544478|FG003|Overall Study|Withdrawal by Subject|0|||
94204265|NCT02787005|322544479|FG004|Overall Study|Withdrawal by Subject|1|||
94204266|NCT02787005|322544475|FG000|Overall Study|Screen Failure|0|||
94204267|NCT02787005|322544476|FG001|Overall Study|Screen Failure|2|||
94279446|NCT01967550|322814540|FG000|Overall Study|Withdrawal by Subject|1|||
94279447|NCT01967550|322814541|FG001|Overall Study|Withdrawal by Subject|0|||
94279448|NCT01967550|322814540|FG000|Overall Study|Adverse Event|2|||
94279449|NCT01967550|322814541|FG001|Overall Study|Adverse Event|0|||
94279450|NCT01967550|322814540|FG000|Overall Study|Protocol Violation|2|||
94279451|NCT01967550|322814541|FG001|Overall Study|Protocol Violation|1|||
94743558|NCT02443116|324517042|FG008|Part 1|Participant enrolled in another clinical trial|0|||
94204268|NCT02787005|322544477|FG002|Overall Study|Screen Failure|0|||
94204269|NCT02787005|322544478|FG003|Overall Study|Screen Failure|0|||
94204270|NCT02787005|322544479|FG004|Overall Study|Screen Failure|1|||
94204271|NCT02787005|322544475|FG000|Overall Study|Lost to Follow-up|0|||
94279452|NCT01967550|322814540|FG000|Overall Study|Non Compliance|0|||
94743559|NCT02443116|324517034|FG000|Part 2|Adverse Event|0|||
94743560|NCT02443116|324517035|FG001|Part 2|Adverse Event|0|||
94743561|NCT02443116|324517036|FG002|Part 2|Adverse Event|0|||
94743562|NCT02443116|324517037|FG003|Part 2|Adverse Event|0|||
94743563|NCT02443116|324517038|FG004|Part 2|Adverse Event|1|||
94743564|NCT02443116|324517039|FG005|Part 2|Adverse Event|1|||
94743565|NCT02443116|324517040|FG006|Part 2|Adverse Event|2|||
94743566|NCT02443116|324517041|FG007|Part 2|Adverse Event|0|||
94204272|NCT02787005|322544476|FG001|Overall Study|Lost to Follow-up|0|||
94204273|NCT02787005|322544477|FG002|Overall Study|Lost to Follow-up|0|||
94204274|NCT02787005|322544478|FG003|Overall Study|Lost to Follow-up|1|||
94204275|NCT02787005|322544479|FG004|Overall Study|Lost to Follow-up|0|||
94743567|NCT02443116|324517042|FG008|Part 2|Adverse Event|0|||
94204276|NCT04795167|322544480|FG000|Overall Study|Death|1|||
94204277|NCT04795167|322544481|FG001|Overall Study|Death|18|||
94204278|NCT04795167|322544482|FG002|Overall Study|Death|1|||
94204279|NCT04795167|322544480|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
94204280|NCT04795167|322544481|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
94204281|NCT04795167|322544482|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
94204282|NCT03840902|322544483|FG000|Overall Study|Randomized but not treated|1|||
94204283|NCT03840902|322544484|FG001|Overall Study|Randomized but not treated|1|||
94204284|NCT03170648|322544489|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
94204285|NCT03170648|322544489|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
94204286|NCT04337931|322544493|FG000|Overall Study|Death|4|||
94204287|NCT04337931|322544494|FG001|Overall Study|Death|1|||
94204288|NCT04337931|322544495|FG002|Overall Study|Death|7|||
94204289|NCT04337931|322544493|FG000|Overall Study|Withdrawal by Subject|0|||
94204290|NCT04337931|322544494|FG001|Overall Study|Withdrawal by Subject|1|||
94204291|NCT04337931|322544495|FG002|Overall Study|Withdrawal by Subject|0|||
94204292|NCT04337931|322544493|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
94204293|NCT04337931|322544494|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
94204294|NCT04337931|322544495|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
94204295|NCT04337931|322544493|FG000|Overall Study|Study terminated by sponsor|3|||
94204296|NCT04337931|322544494|FG001|Overall Study|Study terminated by sponsor|6|||
94204297|NCT04337931|322544495|FG002|Overall Study|Study terminated by sponsor|2|||
94204298|NCT04337931|322544493|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
94204299|NCT04337931|322544494|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
94204300|NCT04337931|322544495|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
94204301|NCT04337931|322544493|FG000|Overall Study|Colorectal cancer treatment|1|||
94204302|NCT04337931|322544494|FG001|Overall Study|Colorectal cancer treatment|0|||
94204303|NCT04337931|322544495|FG002|Overall Study|Colorectal cancer treatment|0|||
94204304|NCT04337931|322544493|FG000|Overall Study|Participant decision|0|||
94204305|NCT04337931|322544494|FG001|Overall Study|Participant decision|1|||
94204306|NCT04337931|322544495|FG002|Overall Study|Participant decision|0|||
94204307|NCT04088227|322544496|FG000|Overall Study|Withdrawal by Subject|1|||
94204308|NCT04088227|322544497|FG001|Overall Study|Withdrawal by Subject|0|||
94204309|NCT04088227|322544496|FG000|Overall Study|Surgery postponed >5weeks|1|||
94204310|NCT04088227|322544497|FG001|Overall Study|Surgery postponed >5weeks|0|||
94204311|NCT04021862|322544498|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
94204312|NCT04021862|322544499|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
94204313|NCT04021862|322544500|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
94204314|NCT04021862|322544501|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
94204315|NCT04021862|322544502|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
94204316|NCT04021862|322544503|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
94204317|NCT04021862|322544498|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
94204318|NCT04021862|322544499|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
94204319|NCT04021862|322544500|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
94204320|NCT04021862|322544501|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
94204321|NCT04021862|322544502|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
94204322|NCT04021862|322544503|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
94204323|NCT04021862|322544498|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
94204324|NCT04021862|322544499|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
94204325|NCT04021862|322544500|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
94204326|NCT04021862|322544501|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
94204327|NCT04021862|322544502|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
94204328|NCT04021862|322544503|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
94204329|NCT04021862|322544498|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
94204330|NCT04021862|322544499|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
94204331|NCT04021862|322544500|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
94204332|NCT04021862|322544501|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
94204333|NCT04021862|322544502|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
94204334|NCT04021862|322544503|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
94204335|NCT04021862|322544498|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
94279453|NCT01967550|322814541|FG001|Overall Study|Non Compliance|1|||
94279454|NCT01079182|322814542|FG000|Overall Study|Lost to Follow-up|1634|||
94279455|NCT01079182|322814542|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
94279456|NCT01079182|322814542|FG000|Overall Study|Lack of Efficacy|514|||
94279457|NCT01079182|322814542|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
94204336|NCT04021862|322544499|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
94204337|NCT04021862|322544500|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
94279458|NCT01079182|322814542|FG000|Overall Study|Reasons not Evaluated|271|||
94279459|NCT01883635|322814543|FG000|Overall Study|Withdrawal by Subject|4|||
94279460|NCT01883635|322814544|FG001|Overall Study|Withdrawal by Subject|0|||
94279461|NCT02425826|322814548|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
94279462|NCT02425826|322814549|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
94370819|NCT04126733|323144526|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
94279463|NCT02425826|322814550|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
94279464|NCT02425826|322814548|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
94279465|NCT02425826|322814549|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
94279466|NCT02425826|322814550|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
94279467|NCT02425826|322814548|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
94279468|NCT02425826|322814549|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
94279469|NCT02425826|322814550|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
94279470|NCT02425826|322814548|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
94279471|NCT02425826|322814549|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
94279472|NCT02425826|322814550|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
94279473|NCT02425826|322814548|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
94279474|NCT02425826|322814549|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
94279475|NCT02425826|322814550|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
94279476|NCT02425826|322814548|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
94279477|NCT02425826|322814549|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
94279478|NCT02425826|322814550|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
94279479|NCT02425826|322814548|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
94279480|NCT02425826|322814549|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
94279481|NCT02425826|322814550|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
94279482|NCT02425826|322814548|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
94279483|NCT02425826|322814549|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
94279484|NCT02425826|322814550|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
94279485|NCT02425826|322814548|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
94279486|NCT02425826|322814549|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
94279487|NCT02425826|322814550|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
94279488|NCT02425826|322814548|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
94279489|NCT02425826|322814549|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
94279490|NCT02425826|322814550|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
94279491|NCT02751502|322814551|FG000|Overall Study|Lack of funding|4|||
94279492|NCT02289950|322814556|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
94279493|NCT02289950|322814557|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
94279494|NCT02289950|322814556|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
94279495|NCT02289950|322814557|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
94279496|NCT02289950|322814556|FG000|Overall Study|Lost to Follow-up|1|||
94279497|NCT02289950|322814557|FG001|Overall Study|Lost to Follow-up|0|||
94279498|NCT02289950|322814556|FG000|Overall Study|Physician Decision|9|||
94279499|NCT02289950|322814557|FG001|Overall Study|Physician Decision|3|||
94370820|NCT04126733|323144526|FG000|Active Follow-up Period|Other Reasons|1|||
94370821|NCT04126733|323144526|FG000|Long-term Follow-up Period|Death|22|||
94743568|NCT02443116|324517034|FG000|Part 2|Withdrew informed consent|0|||
94743569|NCT02443116|324517035|FG001|Part 2|Withdrew informed consent|0|||
94743570|NCT02443116|324517036|FG002|Part 2|Withdrew informed consent|0|||
94743571|NCT02443116|324517037|FG003|Part 2|Withdrew informed consent|0|||
94743572|NCT02443116|324517038|FG004|Part 2|Withdrew informed consent|0|||
94743573|NCT02443116|324517039|FG005|Part 2|Withdrew informed consent|1|||
94743574|NCT02443116|324517040|FG006|Part 2|Withdrew informed consent|1|||
94743575|NCT02443116|324517041|FG007|Part 2|Withdrew informed consent|0|||
94743576|NCT02443116|324517042|FG008|Part 2|Withdrew informed consent|0|||
94743577|NCT02443116|324517034|FG000|Part 2|Inability to comply with protocol|0|||
94743578|NCT02443116|324517035|FG001|Part 2|Inability to comply with protocol|0|||
94743579|NCT02443116|324517036|FG002|Part 2|Inability to comply with protocol|0|||
94743580|NCT02443116|324517037|FG003|Part 2|Inability to comply with protocol|1|||
94743581|NCT02443116|324517038|FG004|Part 2|Inability to comply with protocol|0|||
94743582|NCT02443116|324517039|FG005|Part 2|Inability to comply with protocol|0|||
94743583|NCT02443116|324517040|FG006|Part 2|Inability to comply with protocol|0|||
94743584|NCT02443116|324517041|FG007|Part 2|Inability to comply with protocol|0|||
94743585|NCT02443116|324517042|FG008|Part 2|Inability to comply with protocol|0|||
94743586|NCT02443116|324517034|FG000|Part 2|Lost to Follow-up|0|||
94743587|NCT02443116|324517035|FG001|Part 2|Lost to Follow-up|0|||
94743588|NCT02443116|324517036|FG002|Part 2|Lost to Follow-up|0|||
94743589|NCT02443116|324517037|FG003|Part 2|Lost to Follow-up|1|||
94743590|NCT02443116|324517038|FG004|Part 2|Lost to Follow-up|0|||
94743591|NCT02443116|324517039|FG005|Part 2|Lost to Follow-up|0|||
94743592|NCT02443116|324517040|FG006|Part 2|Lost to Follow-up|0|||
94743593|NCT02443116|324517041|FG007|Part 2|Lost to Follow-up|0|||
94743594|NCT02443116|324517042|FG008|Part 2|Lost to Follow-up|0|||
94743595|NCT02443116|324517034|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
94743596|NCT02443116|324517035|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
94370822|NCT04126733|323144526|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
94370823|NCT04126733|323144526|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
94370824|NCT02981602|323144527|FG000|Overall Study|Adverse Event|0|||
94370825|NCT02981602|323144528|FG001|Overall Study|Adverse Event|0|||
94370826|NCT02981602|323144529|FG002|Overall Study|Adverse Event|0|||
94370827|NCT02981602|323144530|FG003|Overall Study|Adverse Event|1|||
94370828|NCT02981602|323144531|FG004|Overall Study|Adverse Event|0|||
94370829|NCT00986154|323144533|FG000|Overall Study|Death|136|||
94370830|NCT00986154|323144534|FG001|Overall Study|Death|127|||
94370831|NCT00986154|323144533|FG000|Overall Study|Lost to Follow-up|7|||
94370832|NCT00986154|323144534|FG001|Overall Study|Lost to Follow-up|4|||
94370833|NCT00986154|323144533|FG000|Overall Study|Withdrawal by Subject|32|||
94370834|NCT00986154|323144534|FG001|Overall Study|Withdrawal by Subject|33|||
94370835|NCT00986154|323144533|FG000|Overall Study|investigator/subject decide not continue|6|||
94370836|NCT00986154|323144534|FG001|Overall Study|investigator/subject decide not continue|3|||
94370837|NCT00986154|323144533|FG000|Overall Study|never received study drug|25|||
94370838|NCT00986154|323144534|FG001|Overall Study|never received study drug|27|||
94370839|NCT03726437|323144535|FG000|Overall Study|Lost to Follow-up|85|||
94370840|NCT03726437|323144536|FG001|Overall Study|Lost to Follow-up|76|||
94370841|NCT00423488|323144538|FG000|Overall Study|No evidence of study drug intake|2|||
94370842|NCT00423488|323144539|FG001|Overall Study|No evidence of study drug intake|1|||
94370843|NCT00423488|323144538|FG000|Overall Study|No post baseline data|3|||
94370844|NCT00423488|323144539|FG001|Overall Study|No post baseline data|0|||
94370845|NCT02643966|323144543|FG000|First Screening Round|ineligible|1|||
94370846|NCT02643966|323144543|FG000|First Screening Round|excluded from analysis|2|||
94370847|NCT02643966|323144543|FG000|First Screening Round|Lost to Follow-up|56|||
94370848|NCT02643966|323144543|FG000|First Screening Round|Withdrawal by Subject|28|||
94370849|NCT02643966|323144543|FG000|First Screening Round|Death|1|||
94370850|NCT02643966|323144543|FG000|Between First and Second Screening|Lost to Follow-up|65|||
94370851|NCT02643966|323144543|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
94370852|NCT02643966|323144543|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
94370853|NCT02643966|323144543|FG000|Second Screening Round|Withdrawal by Subject|20|||
94370854|NCT02643966|323144543|FG000|Second Screening Round|Lost to Follow-up|57|||
94370855|NCT02643966|323144543|FG000|Second Screening Round|Physician Decision|2|||
94370856|NCT02643966|323144543|FG000|Second Screening Round|Death|4|||
94370857|NCT02643966|323144543|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
94370858|NCT02643966|323144543|FG000|Between Second and Third Screening|Death|1|||
94370859|NCT02643966|323144543|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
94370860|NCT02643966|323144543|FG000|Third Screening Round|PI excluded|2|||
94370861|NCT02643966|323144543|FG000|Third Screening Round|Lost to Follow-up|241|||
94370862|NCT00827359|323144544|FG000|Overall Study|Progressive Diseas|19|||
94370863|NCT00827359|323144544|FG000|Overall Study|Unacceptable Toxicity|5|||
94370864|NCT00827359|323144544|FG000|Overall Study|Ineligible|1|||
94370865|NCT03031431|323144547|FG000|Overall Study|Infant removed by maternal request|1|||
94370866|NCT01825876|323144548|FG000|Period 2|Withdrawal by Subject|0|||
94743597|NCT02443116|324517036|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
94743598|NCT02443116|324517037|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
94743599|NCT02443116|324517038|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
94743600|NCT02443116|324517039|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
94743601|NCT02443116|324517040|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
94743602|NCT02443116|324517041|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
94743603|NCT02443116|324517042|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
94743604|NCT02443116|324517034|FG000|Part 3|Adverse Event|0|||
94743605|NCT02443116|324517035|FG001|Part 3|Adverse Event|0|||
94743606|NCT02443116|324517036|FG002|Part 3|Adverse Event|0|||
94743607|NCT02443116|324517037|FG003|Part 3|Adverse Event|0|||
94743608|NCT02443116|324517038|FG004|Part 3|Adverse Event|0|||
94743609|NCT02443116|324517039|FG005|Part 3|Adverse Event|0|||
94743610|NCT02443116|324517040|FG006|Part 3|Adverse Event|0|||
94743611|NCT02443116|324517041|FG007|Part 3|Adverse Event|0|||
94743612|NCT02443116|324517042|FG008|Part 3|Adverse Event|1|||
94743613|NCT02443116|324517034|FG000|Part 3|Withdrew informed consent|0|||
94743614|NCT02443116|324517035|FG001|Part 3|Withdrew informed consent|0|||
94743615|NCT02443116|324517036|FG002|Part 3|Withdrew informed consent|0|||
94743616|NCT02443116|324517037|FG003|Part 3|Withdrew informed consent|0|||
94743617|NCT02443116|324517038|FG004|Part 3|Withdrew informed consent|0|||
94370867|NCT01825876|323144549|FG001|Period 2|Withdrawal by Subject|1|||
94370868|NCT01542736|323144550|FG000|Overall Study|Death|1|||
94370869|NCT00527397|323144551|FG000|Overall Study|Adverse Event|3|||
94370870|NCT00527397|323144551|FG000|Overall Study|Lack of Efficacy|1|||
94370871|NCT00527397|323144551|FG000|Overall Study|Protocol Violation|1|||
94370872|NCT00527397|323144551|FG000|Overall Study|Withdrawal by Subject|6|||
94370873|NCT00527397|323144551|FG000|Overall Study|Study terminated by sponsor|13|||
94204338|NCT04021862|322544501|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
94204339|NCT04021862|322544502|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
94204340|NCT04021862|322544503|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
94204341|NCT04057131|322544509|FG000|Overall Study|Protocol Violation|24|||
94204342|NCT05251363|322544510|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
94204343|NCT05251363|322544510|FG000|Overall Study After Implant Period|Death|9|||
94204344|NCT05251363|322544510|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
94204345|NCT05251363|322544510|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
94204346|NCT05251363|322544510|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
94204347|NCT05251363|322544510|FG000|Overall Study After Implant Period|Physician Decision|1|||
94204348|NCT05251363|322544510|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
94204349|NCT01950390|322544511|FG000|Overall Study|Never started treatment|3|||
94204350|NCT01950390|322544512|FG001|Overall Study|Never started treatment|2|||
94204351|NCT01950390|322544511|FG000|Overall Study|Disease progression|45|||
94204352|NCT01950390|322544512|FG001|Overall Study|Disease progression|52|||
94204353|NCT01950390|322544511|FG000|Overall Study|Adverse Event|22|||
94204354|NCT01950390|322544512|FG001|Overall Study|Adverse Event|16|||
94204355|NCT01950390|322544511|FG000|Overall Study|Death|5|||
94204356|NCT01950390|322544512|FG001|Overall Study|Death|3|||
94204357|NCT01950390|322544511|FG000|Overall Study|Withdrawal by Subject|5|||
94204358|NCT01950390|322544512|FG001|Overall Study|Withdrawal by Subject|1|||
94204359|NCT01950390|322544511|FG000|Overall Study|Alternative therapy|0|||
94204360|NCT01950390|322544512|FG001|Overall Study|Alternative therapy|3|||
94204361|NCT01950390|322544511|FG000|Overall Study|Complicating disease|1|||
94204362|NCT01950390|322544512|FG001|Overall Study|Complicating disease|0|||
94204363|NCT01950390|322544511|FG000|Overall Study|On treatment|1|||
94204364|NCT01950390|322544512|FG001|Overall Study|On treatment|0|||
94204365|NCT01950390|322544511|FG000|Overall Study|Symptomatic deterioration|2|||
94204366|NCT01950390|322544512|FG001|Overall Study|Symptomatic deterioration|1|||
94204367|NCT01950390|322544511|FG000|Overall Study|Physician Decision|0|||
94204368|NCT01950390|322544512|FG001|Overall Study|Physician Decision|4|||
94204369|NCT01950390|322544511|FG000|Overall Study|Lack of clinical benefit|0|||
94204370|NCT01950390|322544512|FG001|Overall Study|Lack of clinical benefit|1|||
94204371|NCT01950390|322544511|FG000|Overall Study|Maintained PR and moved to observation only|0|||
94204372|NCT01950390|322544512|FG001|Overall Study|Maintained PR and moved to observation only|1|||
94204373|NCT03516942|322544517|FG000|Registration Through Baseline Survey Com|Withdrawal by Subject|36|||
94204374|NCT03516942|322544517|FG000|Registration Through Baseline Survey Com|Death|8|||
94204375|NCT03516942|322544517|FG000|Registration Through Baseline Survey Com|Could not contact patient after enrollment|58|||
94204376|NCT03516942|322544517|FG000|T0: Baseline|LOST|13|||
94204377|NCT03516942|322544517|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
94204378|NCT03516942|322544517|FG000|T1: 3 Months Survey|Death|10|||
94204379|NCT03516942|322544517|FG000|T1: 3 Months Survey|Lost|163|||
94204380|NCT03516942|322544517|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
94204381|NCT03516942|322544517|FG000|T2: 6 Month Survey|Death|14|||
94204382|NCT03516942|322544517|FG000|T2: 6 Month Survey|Lost|180|||
94204383|NCT03516942|322544517|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
94204384|NCT03516942|322544517|FG000|T3: 12 Month Survey|Death|19|||
94204385|NCT03516942|322544517|FG000|T3: 12 Month Survey|Lost|209|||
94204386|NCT02401815|322544518|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
94204387|NCT02401815|322544519|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
94204388|NCT02401815|322544520|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
94204389|NCT02401815|322544521|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
94204390|NCT02401815|322544522|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
94204391|NCT02401815|322544523|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
94204392|NCT02401815|322544524|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
94279500|NCT02289950|322814556|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
94279501|NCT02289950|322814557|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
94279502|NCT02289950|322814556|FG000|Overall Study|Withdrawal by Subject|1|||
94279503|NCT02289950|322814557|FG001|Overall Study|Withdrawal by Subject|3|||
94279504|NCT02289950|322814556|FG000|Overall Study|Test article held for greater than 28 days|0|||
94279505|NCT02289950|322814557|FG001|Overall Study|Test article held for greater than 28 days|1|||
94467655|NCT00577005|323502371|FG000|Overall Study|Withdrawal by Subject|2|||
94204393|NCT02401815|322544525|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
94204394|NCT02401815|322544526|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
94279506|NCT02289950|322814556|FG000|Overall Study|Adverse Event|11|||
94279507|NCT02289950|322814557|FG001|Overall Study|Adverse Event|3|||
94279508|NCT02289950|322814556|FG000|Overall Study|Death|1|||
94204395|NCT02401815|322544527|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
94204396|NCT02401815|322544518|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
94204397|NCT02401815|322544519|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
94204398|NCT02401815|322544520|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
94279509|NCT02289950|322814557|FG001|Overall Study|Death|1|||
94370874|NCT02400905|323144555|FG000|Overall Study|Death|24|||
94370875|NCT02400905|323144555|FG000|Overall Study|Lost to Follow-up|18|||
94370876|NCT02400905|323144555|FG000|Overall Study|Withdrawal by Subject|16|||
94370877|NCT02400905|323144555|FG000|Overall Study|Physician Decision|4|||
94370878|NCT02400905|323144555|FG000|Overall Study|Other|1|||
94370879|NCT00814658|323144558|FG000|Overall Study|Lost to Follow-up|0|||
94370880|NCT00814658|323144559|FG001|Overall Study|Lost to Follow-up|1|||
94370881|NCT00814658|323144558|FG000|Overall Study|Physician Decision|1|||
94370882|NCT00814658|323144559|FG001|Overall Study|Physician Decision|0|||
94370883|NCT00814658|323144558|FG000|Overall Study|Adverse Event|3|||
94370884|NCT00814658|323144559|FG001|Overall Study|Adverse Event|3|||
94370885|NCT01050673|323144560|FG000|Overall Study|Physician Decision|4|||
94370886|NCT01050673|323144561|FG001|Overall Study|Physician Decision|5|||
94370887|NCT01208402|323144562|FG000|Overall Study|Withdrawal by Subject|1|||
94370888|NCT01208402|323144563|FG001|Overall Study|Withdrawal by Subject|0|||
94370889|NCT04363736|323144564|FG000|Overall Study|Withdrawal by Subject|1|||
94370890|NCT04363736|323144565|FG001|Overall Study|Withdrawal by Subject|0|||
94370891|NCT04363736|323144564|FG000|Overall Study|Lost to Follow-up|10|||
94370892|NCT04363736|323144565|FG001|Overall Study|Lost to Follow-up|7|||
94370893|NCT04363736|323144564|FG000|Overall Study|Death|8|||
94370894|NCT04363736|323144565|FG001|Overall Study|Death|6|||
94370895|NCT03056352|323144566|FG000|Overall Study|Lost to Follow-up|1|||
94370896|NCT02191579|323144570|FG000|Treatment 1|Multiple Reasons Specified|27|||
94370897|NCT02191579|323144571|FG001|Treatment 1|Multiple Reasons Specified|58|||
94370898|NCT02191579|323144570|FG000|Treatment 2|Multiple Reasons Specified|0|||
94370899|NCT02191579|323144571|FG001|Treatment 2|Multiple Reasons Specified|25|||
94370900|NCT03940586|323144574|FG000|Overall Study|Death|3|||
94370901|NCT03940586|323144575|FG001|Overall Study|Death|2|||
94370902|NCT03940586|323144576|FG002|Overall Study|Death|0|||
94370903|NCT03940586|323144574|FG000|Overall Study|Physician Decision|1|||
94370904|NCT03940586|323144575|FG001|Overall Study|Physician Decision|0|||
94370905|NCT03940586|323144576|FG002|Overall Study|Physician Decision|1|||
94370906|NCT03940586|323144574|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
94370907|NCT03940586|323144575|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
94370908|NCT03940586|323144576|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
94370909|NCT03940586|323144574|FG000|Overall Study|Not Treated|0|||
94370910|NCT03940586|323144575|FG001|Overall Study|Not Treated|2|||
94370911|NCT03940586|323144576|FG002|Overall Study|Not Treated|0|||
94204399|NCT02401815|322544521|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
94204400|NCT02401815|322544522|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
94204401|NCT02401815|322544523|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
94204402|NCT02401815|322544524|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
94204403|NCT02401815|322544525|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
94204404|NCT02401815|322544526|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
94204405|NCT02401815|322544527|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
94204406|NCT02401815|322544518|FG000|Dose Escalation (up to 670 Days)|Death|1|||
94204407|NCT02401815|322544519|FG001|Dose Escalation (up to 670 Days)|Death|2|||
94204408|NCT02401815|322544520|FG002|Dose Escalation (up to 670 Days)|Death|3|||
94204409|NCT02401815|322544521|FG003|Dose Escalation (up to 670 Days)|Death|5|||
94204410|NCT02401815|322544522|FG004|Dose Escalation (up to 670 Days)|Death|4|||
94204411|NCT02401815|322544523|FG005|Dose Escalation (up to 670 Days)|Death|0|||
94204412|NCT02401815|322544524|FG006|Dose Escalation (up to 670 Days)|Death|0|||
94204413|NCT02401815|322544525|FG007|Dose Escalation (up to 670 Days)|Death|0|||
94204414|NCT02401815|322544526|FG008|Dose Escalation (up to 670 Days)|Death|0|||
94204415|NCT02401815|322544527|FG009|Dose Escalation (up to 670 Days)|Death|0|||
94204416|NCT02401815|322544518|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
94204417|NCT02401815|322544519|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
94204418|NCT02401815|322544520|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
94279510|NCT02289950|322814556|FG000|Overall Study|Other|5|||
94279511|NCT02289950|322814557|FG001|Overall Study|Other|2|||
94279512|NCT02289950|322814556|FG000|Overall Study|Not Treated|2|||
94279513|NCT02289950|322814557|FG001|Overall Study|Not Treated|1|||
94279514|NCT01471782|322814559|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
94279515|NCT01471782|322814560|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
94279516|NCT01471782|322814561|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
94279517|NCT01471782|322814562|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
94279518|NCT01471782|322814563|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
94279519|NCT01471782|322814564|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
94370912|NCT01261325|323144577|FG000|Overall Study|Lack of Efficacy|1|||
94370913|NCT01261325|323144578|FG001|Overall Study|Lack of Efficacy|1|||
94370914|NCT01261325|323144579|FG002|Overall Study|Lack of Efficacy|0|||
94370915|NCT01261325|323144577|FG000|Overall Study|Withdrawal by Subject|2|||
94370916|NCT01261325|323144578|FG001|Overall Study|Withdrawal by Subject|2|||
94370917|NCT01261325|323144579|FG002|Overall Study|Withdrawal by Subject|4|||
94370918|NCT01261325|323144577|FG000|Overall Study|SAE, non-fatal|1|||
94370919|NCT01261325|323144578|FG001|Overall Study|SAE, non-fatal|5|||
94204419|NCT02401815|322544521|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
94204420|NCT02401815|322544522|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
94204421|NCT02401815|322544523|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
94204422|NCT02401815|322544524|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
94204423|NCT02401815|322544525|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
94204424|NCT02401815|322544526|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
94204425|NCT02401815|322544527|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
94204426|NCT02401815|322544518|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
94204427|NCT02401815|322544519|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
94204428|NCT02401815|322544520|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
94204429|NCT02401815|322544521|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
94204430|NCT02401815|322544522|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
94204431|NCT02401815|322544523|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
94204432|NCT02401815|322544524|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
94204433|NCT02401815|322544525|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
94204434|NCT02401815|322544526|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
94204435|NCT02401815|322544527|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
94204436|NCT02401815|322544518|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
94204437|NCT02401815|322544519|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
94204438|NCT02401815|322544520|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
94204439|NCT02401815|322544521|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
94204440|NCT02401815|322544522|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
94204441|NCT02401815|322544523|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
94204442|NCT02401815|322544524|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
94204443|NCT02401815|322544525|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
94204444|NCT02401815|322544526|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
94204445|NCT02401815|322544527|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
94204446|NCT02401815|322544518|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
94204447|NCT02401815|322544519|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
94204448|NCT02401815|322544520|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
94204449|NCT02401815|322544521|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
94204450|NCT02401815|322544522|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
94204451|NCT02401815|322544523|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
94204452|NCT02401815|322544524|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
94204453|NCT02401815|322544525|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
94204454|NCT02401815|322544526|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
94204455|NCT02401815|322544527|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
94204456|NCT02401815|322544518|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
94204457|NCT02401815|322544519|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
94204458|NCT02401815|322544520|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
94204459|NCT02401815|322544521|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
94204460|NCT02401815|322544522|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
94204461|NCT02401815|322544523|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
94204462|NCT02401815|322544524|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
94204463|NCT02401815|322544525|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
94204464|NCT02401815|322544526|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
94204465|NCT02401815|322544527|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
94204466|NCT02401815|322544518|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
94204467|NCT02401815|322544519|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
94204468|NCT02401815|322544520|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
94204469|NCT02401815|322544521|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
94204470|NCT02401815|322544522|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
94204471|NCT02401815|322544523|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
94204472|NCT02401815|322544524|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
94204473|NCT02401815|322544525|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
94204474|NCT02401815|322544526|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
94204475|NCT02401815|322544527|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
94204476|NCT02401815|322544518|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
94204477|NCT02401815|322544519|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
94204478|NCT02401815|322544520|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
94204479|NCT02401815|322544521|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
94279520|NCT01471782|322814559|FG000|Overall Study|Lack of Efficacy|1|||
94279521|NCT01471782|322814560|FG001|Overall Study|Lack of Efficacy|2|||
94279522|NCT01471782|322814561|FG002|Overall Study|Lack of Efficacy|1|||
94279523|NCT01471782|322814562|FG003|Overall Study|Lack of Efficacy|1|||
94279524|NCT01471782|322814563|FG004|Overall Study|Lack of Efficacy|5|||
94279525|NCT01471782|322814564|FG005|Overall Study|Lack of Efficacy|18|||
94279526|NCT01471782|322814559|FG000|Overall Study|Adverse Event|1|||
94279527|NCT01471782|322814560|FG001|Overall Study|Adverse Event|1|||
94279528|NCT01471782|322814561|FG002|Overall Study|Adverse Event|2|||
94279529|NCT01471782|322814562|FG003|Overall Study|Adverse Event|2|||
94279530|NCT01471782|322814563|FG004|Overall Study|Adverse Event|3|||
94279531|NCT01471782|322814564|FG005|Overall Study|Adverse Event|1|||
94279532|NCT01471782|322814559|FG000|Overall Study|Other|0|||
94279533|NCT01471782|322814560|FG001|Overall Study|Other|0|||
94279534|NCT01471782|322814561|FG002|Overall Study|Other|1|||
94279535|NCT01471782|322814562|FG003|Overall Study|Other|1|||
94279536|NCT01471782|322814563|FG004|Overall Study|Other|6|||
94279537|NCT01471782|322814564|FG005|Overall Study|Other|5|||
94279538|NCT01471782|322814559|FG000|Overall Study|Change of Chemotherapy|1|||
94279539|NCT01471782|322814560|FG001|Overall Study|Change of Chemotherapy|1|||
94279540|NCT01471782|322814561|FG002|Overall Study|Change of Chemotherapy|0|||
94279541|NCT01471782|322814562|FG003|Overall Study|Change of Chemotherapy|0|||
94279542|NCT01471782|322814563|FG004|Overall Study|Change of Chemotherapy|1|||
94279543|NCT01471782|322814564|FG005|Overall Study|Change of Chemotherapy|4|||
94279544|NCT01471782|322814559|FG000|Overall Study|Disease Relapse|0|||
94279545|NCT01471782|322814560|FG001|Overall Study|Disease Relapse|0|||
94279546|NCT01471782|322814561|FG002|Overall Study|Disease Relapse|0|||
94279547|NCT01471782|322814562|FG003|Overall Study|Disease Relapse|1|||
94279548|NCT01471782|322814563|FG004|Overall Study|Disease Relapse|2|||
94279549|NCT01471782|322814564|FG005|Overall Study|Disease Relapse|1|||
94279550|NCT01471782|322814559|FG000|Overall Study|Physician Decision|0|||
94279551|NCT01471782|322814560|FG001|Overall Study|Physician Decision|0|||
94279552|NCT01471782|322814561|FG002|Overall Study|Physician Decision|0|||
94279553|NCT01471782|322814562|FG003|Overall Study|Physician Decision|0|||
94279554|NCT01471782|322814563|FG004|Overall Study|Physician Decision|3|||
94279555|NCT01471782|322814564|FG005|Overall Study|Physician Decision|8|||
94279556|NCT01471782|322814559|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94279557|NCT01471782|322814560|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94279558|NCT01471782|322814561|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
94279559|NCT01471782|322814562|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
94279560|NCT01471782|322814563|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
94279561|NCT01471782|322814564|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
94279562|NCT01471782|322814559|FG000|Overall Study|Death|0|||
94279563|NCT01471782|322814560|FG001|Overall Study|Death|0|||
94279564|NCT01471782|322814561|FG002|Overall Study|Death|0|||
94279565|NCT01471782|322814562|FG003|Overall Study|Death|0|||
94279566|NCT01471782|322814563|FG004|Overall Study|Death|0|||
94279567|NCT01471782|322814564|FG005|Overall Study|Death|1|||
94279568|NCT01425008|322814565|FG000|Dose Escalation Phase|Progressive Disease|2|||
94279569|NCT01425008|322814566|FG001|Dose Escalation Phase|Progressive Disease|3|||
94279570|NCT01425008|322814567|FG002|Dose Escalation Phase|Progressive Disease|2|||
94279571|NCT01425008|322814568|FG003|Dose Escalation Phase|Progressive Disease|3|||
94279572|NCT01425008|322814569|FG004|Dose Escalation Phase|Progressive Disease|5|||
94279573|NCT01425008|322814570|FG005|Dose Escalation Phase|Progressive Disease|4|||
94279574|NCT01425008|322814571|FG006|Dose Escalation Phase|Progressive Disease|0|||
94279575|NCT01425008|322814572|FG007|Dose Escalation Phase|Progressive Disease|2|||
94279576|NCT01425008|322814573|FG008|Dose Escalation Phase|Progressive Disease|6|||
94279577|NCT01425008|322814574|FG009|Dose Escalation Phase|Progressive Disease|2|||
94279578|NCT01425008|322814575|FG010|Dose Escalation Phase|Progressive Disease|0|||
94279579|NCT01425008|322814576|FG011|Dose Escalation Phase|Progressive Disease|0|||
94279580|NCT01425008|322814577|FG012|Dose Escalation Phase|Progressive Disease|0|||
94279581|NCT01425008|322814578|FG013|Dose Escalation Phase|Progressive Disease|0|||
94279582|NCT01425008|322814579|FG014|Dose Escalation Phase|Progressive Disease|0|||
94279583|NCT01425008|322814580|FG015|Dose Escalation Phase|Progressive Disease|0|||
94279584|NCT01425008|322814581|FG016|Dose Escalation Phase|Progressive Disease|0|||
94279585|NCT01425008|322814582|FG017|Dose Escalation Phase|Progressive Disease|0|||
94279586|NCT01425008|322814583|FG018|Dose Escalation Phase|Progressive Disease|0|||
94279587|NCT01425008|322814565|FG000|Dose Escalation Phase|Adverse Event|2|||
94279588|NCT01425008|322814566|FG001|Dose Escalation Phase|Adverse Event|0|||
94279589|NCT01425008|322814567|FG002|Dose Escalation Phase|Adverse Event|0|||
94279590|NCT01425008|322814568|FG003|Dose Escalation Phase|Adverse Event|0|||
94279591|NCT01425008|322814569|FG004|Dose Escalation Phase|Adverse Event|0|||
94279592|NCT01425008|322814570|FG005|Dose Escalation Phase|Adverse Event|2|||
94279593|NCT01425008|322814571|FG006|Dose Escalation Phase|Adverse Event|0|||
94279594|NCT01425008|322814572|FG007|Dose Escalation Phase|Adverse Event|0|||
94279595|NCT01425008|322814573|FG008|Dose Escalation Phase|Adverse Event|2|||
94279596|NCT01425008|322814574|FG009|Dose Escalation Phase|Adverse Event|0|||
94279597|NCT01425008|322814575|FG010|Dose Escalation Phase|Adverse Event|0|||
94279598|NCT01425008|322814576|FG011|Dose Escalation Phase|Adverse Event|0|||
94279599|NCT01425008|322814577|FG012|Dose Escalation Phase|Adverse Event|0|||
94279600|NCT01425008|322814578|FG013|Dose Escalation Phase|Adverse Event|0|||
94204480|NCT02401815|322544522|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
94204481|NCT02401815|322544523|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
94204482|NCT02401815|322544524|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
94204483|NCT02401815|322544525|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
94204484|NCT02401815|322544526|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
94204485|NCT02401815|322544527|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
94204486|NCT02401815|322544518|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
94204487|NCT02401815|322544519|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
94204488|NCT02401815|322544520|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
94204489|NCT02401815|322544521|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
94204490|NCT02401815|322544522|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
94204491|NCT02401815|322544523|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
94204492|NCT02401815|322544524|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
94370920|NCT01261325|323144579|FG002|Overall Study|SAE, non-fatal|1|||
94370921|NCT01261325|323144577|FG000|Overall Study|AE, non-serious non-fatal|9|||
94370922|NCT01261325|323144578|FG001|Overall Study|AE, non-serious non-fatal|15|||
94370923|NCT01261325|323144579|FG002|Overall Study|AE, non-serious non-fatal|13|||
94370924|NCT01261325|323144577|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
94370925|NCT01261325|323144578|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
94370926|NCT01261325|323144579|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
94370927|NCT01261325|323144577|FG000|Overall Study|Non Compliance|2|||
94370928|NCT01261325|323144578|FG001|Overall Study|Non Compliance|0|||
94370929|NCT01261325|323144579|FG002|Overall Study|Non Compliance|0|||
94370930|NCT01261325|323144577|FG000|Overall Study|Patient Randomized by Mistake|0|||
94370931|NCT01261325|323144578|FG001|Overall Study|Patient Randomized by Mistake|1|||
94370932|NCT01261325|323144579|FG002|Overall Study|Patient Randomized by Mistake|0|||
94370933|NCT01261325|323144577|FG000|Overall Study|Erroneously Randomized|1|||
94370934|NCT01261325|323144578|FG001|Overall Study|Erroneously Randomized|0|||
94370935|NCT01261325|323144579|FG002|Overall Study|Erroneously Randomized|0|||
94370936|NCT01261325|323144577|FG000|Overall Study|Screen Failure|1|||
94370937|NCT01261325|323144578|FG001|Overall Study|Screen Failure|0|||
94370938|NCT01261325|323144579|FG002|Overall Study|Screen Failure|0|||
94370939|NCT01261325|323144577|FG000|Overall Study|Randomized in Error|0|||
94370940|NCT01261325|323144578|FG001|Overall Study|Randomized in Error|0|||
94370941|NCT01261325|323144579|FG002|Overall Study|Randomized in Error|1|||
94370942|NCT01261325|323144577|FG000|Overall Study|Protocol Violation|0|||
94370943|NCT01261325|323144578|FG001|Overall Study|Protocol Violation|3|||
94370944|NCT01261325|323144579|FG002|Overall Study|Protocol Violation|1|||
94370945|NCT01261325|323144577|FG000|Overall Study|Lost to Follow-up|0|||
94370946|NCT01261325|323144578|FG001|Overall Study|Lost to Follow-up|1|||
94370947|NCT01261325|323144579|FG002|Overall Study|Lost to Follow-up|3|||
94370948|NCT01261325|323144577|FG000|Overall Study|AE, serious fatal|0|||
94370949|NCT01261325|323144578|FG001|Overall Study|AE, serious fatal|0|||
94370950|NCT01261325|323144579|FG002|Overall Study|AE, serious fatal|2|||
94370951|NCT00291330|323144584|FG000|Overall Study|Adverse Event|47|||
94370952|NCT00291330|323144585|FG001|Overall Study|Adverse Event|40|||
94370953|NCT00291330|323144584|FG000|Overall Study|Protocol Violation|13|||
94370954|NCT00291330|323144585|FG001|Overall Study|Protocol Violation|20|||
94370955|NCT00291330|323144584|FG000|Overall Study|Lost to Follow-up|16|||
94370956|NCT00291330|323144585|FG001|Overall Study|Lost to Follow-up|11|||
94370957|NCT00291330|323144584|FG000|Overall Study|Withdrawal by Subject|22|||
94204493|NCT02401815|322544525|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
94204494|NCT02401815|322544526|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
94204495|NCT02401815|322544527|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
94204496|NCT02401815|322544518|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
94204497|NCT02401815|322544519|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
94204498|NCT02401815|322544520|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
94204499|NCT02401815|322544521|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
94204500|NCT02401815|322544522|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
94204501|NCT02401815|322544523|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
94204502|NCT02401815|322544524|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
94204503|NCT02401815|322544525|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
94204504|NCT02401815|322544526|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
94370958|NCT00291330|323144585|FG001|Overall Study|Withdrawal by Subject|25|||
94370959|NCT00291330|323144584|FG000|Overall Study|Other|3|||
94370960|NCT00291330|323144585|FG001|Overall Study|Other|1|||
94370961|NCT00869089|323144586|FG000|Overall Study|Lost to Follow-up|1|||
94370962|NCT00869089|323144586|FG000|Overall Study|Withdrawal by Subject|1|||
94370963|NCT00869089|323144586|FG000|Overall Study|Screen Fail|1|||
94370964|NCT01559818|323144587|FG000|Overall Study|Physician Decision|1|||
94370965|NCT01559818|323144587|FG000|Overall Study|Pregnancy|1|||
94370966|NCT01559818|323144587|FG000|Overall Study|Study terminated by Sponsor|4|||
94370967|NCT01559818|323144587|FG000|Overall Study|Withdrawal by Subject|1|||
94370968|NCT01298596|323144588|FG000|Overall Study|Withdrawal by Subject|1|||
94370969|NCT01298596|323144589|FG001|Overall Study|Withdrawal by Subject|1|||
94370970|NCT01298596|323144588|FG000|Overall Study|Death|5|||
94370971|NCT01298596|323144589|FG001|Overall Study|Death|3|||
94370972|NCT01298596|323144588|FG000|Overall Study|Lost to Follow-up|6|||
94370973|NCT01298596|323144589|FG001|Overall Study|Lost to Follow-up|14|||
94204505|NCT02401815|322544527|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
94370974|NCT01298596|323144588|FG000|Overall Study|Referred for further management|16|||
94370975|NCT01298596|323144589|FG001|Overall Study|Referred for further management|15|||
94370976|NCT01625286|323144590|FG000|Overall Study|Adverse Event|0|||
94370977|NCT01625286|323144591|FG001|Overall Study|Adverse Event|0|||
94370978|NCT01625286|323144592|FG002|Overall Study|Adverse Event|0|||
94370979|NCT01625286|323144593|FG003|Overall Study|Adverse Event|0|||
94370980|NCT01625286|323144594|FG004|Overall Study|Adverse Event|1|||
94370981|NCT01625286|323144595|FG005|Overall Study|Adverse Event|2|||
94370982|NCT01625286|323144596|FG006|Overall Study|Adverse Event|1|||
94370983|NCT01625286|323144590|FG000|Overall Study|Death|0|||
94370984|NCT01625286|323144591|FG001|Overall Study|Death|0|||
94370985|NCT01625286|323144592|FG002|Overall Study|Death|1|||
94370986|NCT01625286|323144593|FG003|Overall Study|Death|1|||
94370987|NCT01625286|323144594|FG004|Overall Study|Death|0|||
94370988|NCT01625286|323144595|FG005|Overall Study|Death|11|||
94370989|NCT01625286|323144596|FG006|Overall Study|Death|16|||
94370990|NCT01625286|323144590|FG000|Overall Study|Withdrawal by Subject|0|||
94370991|NCT01625286|323144591|FG001|Overall Study|Withdrawal by Subject|1|||
94370992|NCT01625286|323144592|FG002|Overall Study|Withdrawal by Subject|0|||
94370993|NCT01625286|323144593|FG003|Overall Study|Withdrawal by Subject|1|||
94370994|NCT01625286|323144594|FG004|Overall Study|Withdrawal by Subject|0|||
94370995|NCT01625286|323144595|FG005|Overall Study|Withdrawal by Subject|0|||
94370996|NCT01625286|323144596|FG006|Overall Study|Withdrawal by Subject|1|||
94370997|NCT01625286|323144590|FG000|Overall Study|Any reason not specifically recorded|0|||
94370998|NCT01625286|323144591|FG001|Overall Study|Any reason not specifically recorded|0|||
94370999|NCT01625286|323144592|FG002|Overall Study|Any reason not specifically recorded|0|||
94371000|NCT01625286|323144593|FG003|Overall Study|Any reason not specifically recorded|0|||
94371001|NCT01625286|323144594|FG004|Overall Study|Any reason not specifically recorded|0|||
94371002|NCT01625286|323144595|FG005|Overall Study|Any reason not specifically recorded|1|||
94371003|NCT01625286|323144596|FG006|Overall Study|Any reason not specifically recorded|0|||
94371004|NCT01625286|323144590|FG000|Overall Study|Progressive disease|6|||
94371005|NCT01625286|323144591|FG001|Overall Study|Progressive disease|3|||
94204506|NCT02401815|322544518|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
94204507|NCT02401815|322544519|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
94204508|NCT02401815|322544520|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
94204509|NCT02401815|322544521|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
94204510|NCT02401815|322544522|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
94204511|NCT02401815|322544523|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
94279601|NCT01425008|322814579|FG014|Dose Escalation Phase|Adverse Event|0|||
94279602|NCT01425008|322814580|FG015|Dose Escalation Phase|Adverse Event|0|||
94279603|NCT01425008|322814581|FG016|Dose Escalation Phase|Adverse Event|0|||
94279604|NCT01425008|322814582|FG017|Dose Escalation Phase|Adverse Event|0|||
94279605|NCT01425008|322814583|FG018|Dose Escalation Phase|Adverse Event|0|||
94279606|NCT01425008|322814565|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94279607|NCT01425008|322814566|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94279608|NCT01425008|322814567|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94279609|NCT01425008|322814568|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94279610|NCT01425008|322814569|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
94371006|NCT01625286|323144592|FG002|Overall Study|Progressive disease|4|||
94371007|NCT01625286|323144593|FG003|Overall Study|Progressive disease|5|||
94371008|NCT01625286|323144594|FG004|Overall Study|Progressive disease|5|||
94371009|NCT01625286|323144595|FG005|Overall Study|Progressive disease|0|||
94371010|NCT01625286|323144596|FG006|Overall Study|Progressive disease|0|||
94371011|NCT01625286|323144590|FG000|Overall Study|Lost to Follow-up|0|||
94371012|NCT01625286|323144591|FG001|Overall Study|Lost to Follow-up|0|||
94371013|NCT01625286|323144592|FG002|Overall Study|Lost to Follow-up|0|||
94371014|NCT01625286|323144593|FG003|Overall Study|Lost to Follow-up|0|||
94371015|NCT01625286|323144594|FG004|Overall Study|Lost to Follow-up|0|||
94371016|NCT01625286|323144595|FG005|Overall Study|Lost to Follow-up|0|||
94279611|NCT01425008|322814570|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94279612|NCT01425008|322814571|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
94371017|NCT01625286|323144596|FG006|Overall Study|Lost to Follow-up|1|||
94371018|NCT04128696|323144601|FG000|Overall Study|Lost to Follow-up|3|||
94371019|NCT04128696|323144602|FG001|Overall Study|Lost to Follow-up|7|||
94371020|NCT04128696|323144601|FG000|Overall Study|Withdrawal by Subject|12|||
94204512|NCT02401815|322544524|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
94467656|NCT00577005|323502372|FG001|Overall Study|Withdrawal by Subject|1|||
94204513|NCT02401815|322544525|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
94204514|NCT02401815|322544526|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
94204515|NCT02401815|322544527|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
94204516|NCT02401815|322544518|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
94204517|NCT02401815|322544519|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
94204518|NCT02401815|322544520|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
94204519|NCT02401815|322544521|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
94204520|NCT02401815|322544522|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
94204521|NCT02401815|322544523|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
94204522|NCT02401815|322544524|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
94279613|NCT01425008|322814572|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
94279614|NCT01425008|322814573|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
94279615|NCT01425008|322814574|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94279616|NCT01425008|322814575|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94279617|NCT01425008|322814576|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94279618|NCT01425008|322814577|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94279619|NCT01425008|322814578|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94279620|NCT01425008|322814579|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94279621|NCT01425008|322814580|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94279622|NCT01425008|322814581|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94279623|NCT01425008|322814582|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94279624|NCT01425008|322814583|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
94279625|NCT01425008|322814565|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
94279626|NCT01425008|322814566|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
94279627|NCT01425008|322814567|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
94279628|NCT01425008|322814568|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
94279629|NCT01425008|322814569|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
94279630|NCT01425008|322814570|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
94279631|NCT01425008|322814571|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
94279632|NCT01425008|322814572|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
94279633|NCT01425008|322814573|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
94279634|NCT01425008|322814574|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
94279635|NCT01425008|322814575|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
94279636|NCT01425008|322814576|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
94279637|NCT01425008|322814577|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
94279638|NCT01425008|322814578|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
94279639|NCT01425008|322814579|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
94279640|NCT01425008|322814580|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
94279641|NCT01425008|322814581|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
94279642|NCT01425008|322814582|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
94279643|NCT01425008|322814583|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
94279644|NCT01425008|322814565|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
94279645|NCT01425008|322814566|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
94279646|NCT01425008|322814567|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
94279647|NCT01425008|322814568|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
94279648|NCT01425008|322814569|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
94279649|NCT01425008|322814570|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
94279650|NCT01425008|322814571|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
94279651|NCT01425008|322814572|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
94279652|NCT01425008|322814573|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
94279653|NCT01425008|322814574|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
94279654|NCT01425008|322814575|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
94279655|NCT01425008|322814576|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
94279656|NCT01425008|322814577|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
94279657|NCT01425008|322814578|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
94279658|NCT01425008|322814579|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
94279659|NCT01425008|322814580|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
94279660|NCT01425008|322814581|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
94279661|NCT01425008|322814582|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
94279662|NCT01425008|322814583|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
94279663|NCT01425008|322814565|FG000|Dose Escalation Phase|Other|0|||
94279664|NCT01425008|322814566|FG001|Dose Escalation Phase|Other|0|||
94279665|NCT01425008|322814567|FG002|Dose Escalation Phase|Other|0|||
94279666|NCT01425008|322814568|FG003|Dose Escalation Phase|Other|0|||
94279667|NCT01425008|322814569|FG004|Dose Escalation Phase|Other|0|||
94279668|NCT01425008|322814570|FG005|Dose Escalation Phase|Other|0|||
94279669|NCT01425008|322814571|FG006|Dose Escalation Phase|Other|0|||
94279670|NCT01425008|322814572|FG007|Dose Escalation Phase|Other|0|||
94204523|NCT02401815|322544525|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
94204524|NCT02401815|322544526|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
94204525|NCT02401815|322544527|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
94204526|NCT04912856|322544528|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
94204527|NCT04912856|322544529|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
94204528|NCT04912856|322544528|FG000|Overall Study|Not reported in synoptic CSR.|0|||
94279671|NCT01425008|322814573|FG008|Dose Escalation Phase|Other|1|||
94279672|NCT01425008|322814574|FG009|Dose Escalation Phase|Other|0|||
94279673|NCT01425008|322814575|FG010|Dose Escalation Phase|Other|0|||
94279674|NCT01425008|322814576|FG011|Dose Escalation Phase|Other|0|||
94279675|NCT01425008|322814577|FG012|Dose Escalation Phase|Other|0|||
94279676|NCT01425008|322814578|FG013|Dose Escalation Phase|Other|0|||
94279677|NCT01425008|322814579|FG014|Dose Escalation Phase|Other|0|||
94279678|NCT01425008|322814580|FG015|Dose Escalation Phase|Other|0|||
94279679|NCT01425008|322814581|FG016|Dose Escalation Phase|Other|0|||
94279680|NCT01425008|322814582|FG017|Dose Escalation Phase|Other|0|||
94279681|NCT01425008|322814583|FG018|Dose Escalation Phase|Other|0|||
94279682|NCT01425008|322814565|FG000|Dose Expansion Phase|Progressive Disease|0|||
94279683|NCT01425008|322814566|FG001|Dose Expansion Phase|Progressive Disease|0|||
94279684|NCT01425008|322814567|FG002|Dose Expansion Phase|Progressive Disease|0|||
94279685|NCT01425008|322814568|FG003|Dose Expansion Phase|Progressive Disease|0|||
94279686|NCT01425008|322814569|FG004|Dose Expansion Phase|Progressive Disease|0|||
94279687|NCT01425008|322814570|FG005|Dose Expansion Phase|Progressive Disease|0|||
94279688|NCT01425008|322814571|FG006|Dose Expansion Phase|Progressive Disease|0|||
94279689|NCT01425008|322814572|FG007|Dose Expansion Phase|Progressive Disease|0|||
94279690|NCT01425008|322814573|FG008|Dose Expansion Phase|Progressive Disease|0|||
94279691|NCT01425008|322814574|FG009|Dose Expansion Phase|Progressive Disease|0|||
94279692|NCT01425008|322814575|FG010|Dose Expansion Phase|Progressive Disease|10|||
94279693|NCT01425008|322814576|FG011|Dose Expansion Phase|Progressive Disease|4|||
94279694|NCT01425008|322814577|FG012|Dose Expansion Phase|Progressive Disease|12|||
94279695|NCT01425008|322814578|FG013|Dose Expansion Phase|Progressive Disease|1|||
94279696|NCT01425008|322814579|FG014|Dose Expansion Phase|Progressive Disease|5|||
94279697|NCT01425008|322814580|FG015|Dose Expansion Phase|Progressive Disease|8|||
94279698|NCT01425008|322814581|FG016|Dose Expansion Phase|Progressive Disease|9|||
94279699|NCT01425008|322814582|FG017|Dose Expansion Phase|Progressive Disease|2|||
94279700|NCT01425008|322814583|FG018|Dose Expansion Phase|Progressive Disease|10|||
94279701|NCT01425008|322814565|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
94279702|NCT01425008|322814566|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
94279703|NCT01425008|322814567|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
94279704|NCT01425008|322814568|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
94279705|NCT01425008|322814569|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
94279706|NCT01425008|322814570|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
94279707|NCT01425008|322814571|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
94279708|NCT01425008|322814572|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
94279709|NCT01425008|322814573|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
94279710|NCT01425008|322814574|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
94279711|NCT01425008|322814575|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
94279712|NCT01425008|322814576|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
94279713|NCT01425008|322814577|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
94279714|NCT01425008|322814578|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
94371021|NCT04128696|323144602|FG001|Overall Study|Withdrawal by Subject|11|||
94371022|NCT04128696|323144601|FG000|Overall Study|Study Closed/Terminated|26|||
94371023|NCT04128696|323144602|FG001|Overall Study|Study Closed/Terminated|38|||
94371024|NCT04128696|323144601|FG000|Overall Study|Physician Decision|2|||
94204529|NCT04912856|322544529|FG001|Overall Study|Not reported in synoptic CSR.|1|||
94204530|NCT05613907|322544530|FG000|Overall Study|Lost to Follow-up|5|||
94204531|NCT05613907|322544530|FG000|Overall Study|Death|3|||
94204532|NCT05613907|322544530|FG000|Overall Study|Withdrawal by Subject|2|||
94204533|NCT03789656|322544533|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
94204534|NCT03789656|322544534|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
94204535|NCT03789656|322544535|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
94204536|NCT03789656|322544536|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
94204537|NCT03789656|322544537|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
94204538|NCT03789656|322544533|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
94204539|NCT03789656|322544534|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
94204540|NCT03789656|322544535|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
94371025|NCT04128696|323144602|FG001|Overall Study|Physician Decision|3|||
94279715|NCT01425008|322814579|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
94279716|NCT01425008|322814580|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
94279717|NCT01425008|322814581|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
94279718|NCT01425008|322814582|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
94371026|NCT04147611|323144603|FG000|Overall Study|Physician Decision|0|||
94371027|NCT04147611|323144604|FG001|Overall Study|Physician Decision|1|||
94204541|NCT03789656|322544536|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
94204542|NCT03789656|322544537|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
94204543|NCT03789656|322544533|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
94204544|NCT03789656|322544534|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
94204545|NCT03789656|322544535|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
94204546|NCT03789656|322544536|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
94204547|NCT03789656|322544537|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
94204548|NCT03789656|322544533|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
94204549|NCT03789656|322544534|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
94204550|NCT03789656|322544535|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
94279719|NCT01425008|322814583|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
94279720|NCT01425008|322814565|FG000|Dose Expansion Phase|Other|0|||
94279721|NCT01425008|322814566|FG001|Dose Expansion Phase|Other|0|||
94204551|NCT03789656|322544536|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
94204552|NCT03789656|322544537|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
94204553|NCT05349838|322544538|FG000|Overall Study|Virological Failure|1|||
94204554|NCT05349838|322544539|FG001|Overall Study|Virological Failure|2|||
94204555|NCT05349838|322544538|FG000|Overall Study|Withdrawal by Subject|2|||
94204556|NCT05349838|322544539|FG001|Overall Study|Withdrawal by Subject|3|||
94204557|NCT05349838|322544538|FG000|Overall Study|Adverse Event|3|||
94204558|NCT05349838|322544539|FG001|Overall Study|Adverse Event|1|||
94204559|NCT05349838|322544538|FG000|Overall Study|Lost to Follow-up|1|||
94204560|NCT05349838|322544539|FG001|Overall Study|Lost to Follow-up|2|||
94204561|NCT05349838|322544538|FG000|Overall Study|Other reasons|5|||
94204562|NCT05349838|322544539|FG001|Overall Study|Other reasons|1|||
94204563|NCT01958021|322544540|FG000|Treatment|Progressive disease|206|||
94204564|NCT01958021|322544541|FG001|Treatment|Progressive disease|265|||
94204565|NCT01958021|322544540|FG000|Treatment|Adverse Event|38|||
94204566|NCT01958021|322544541|FG001|Treatment|Adverse Event|10|||
94204567|NCT01958021|322544540|FG000|Treatment|Subject/guardian decision|29|||
94204568|NCT01958021|322544541|FG001|Treatment|Subject/guardian decision|25|||
94204569|NCT01958021|322544540|FG000|Treatment|Physician Decision|28|||
94204570|NCT01958021|322544541|FG001|Treatment|Physician Decision|21|||
94204571|NCT01958021|322544540|FG000|Treatment|Death|6|||
94204572|NCT01958021|322544541|FG001|Treatment|Death|1|||
94204573|NCT01958021|322544540|FG000|Treatment|Protocol deviation|3|||
94204574|NCT01958021|322544541|FG001|Treatment|Protocol deviation|1|||
94204575|NCT01958021|322544540|FG000|Treatment|Sponsor decision|24|||
94204576|NCT01958021|322544541|FG001|Treatment|Sponsor decision|11|||
94204577|NCT01958021|322544540|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
94204578|NCT01958021|322544541|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
94204579|NCT01958021|322544540|FG000|Post-treatment Efficacy Follow-up|Death|1|||
94204580|NCT01958021|322544541|FG001|Post-treatment Efficacy Follow-up|Death|0|||
94204581|NCT01958021|322544540|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
94204582|NCT01958021|322544541|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
94204583|NCT01958021|322544540|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
94204584|NCT01958021|322544541|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
94204585|NCT01958021|322544540|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
94204586|NCT01958021|322544541|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
94204587|NCT01958021|322544540|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
94204588|NCT01958021|322544541|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
94204589|NCT01958021|322544540|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
94204590|NCT01958021|322544541|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
94204591|NCT04213807|322545895|FG000|Overall Study|Physician Decision|0|||
94204592|NCT04213807|322545896|FG001|Overall Study|Physician Decision|0|||
94204593|NCT04213807|322545897|FG002|Overall Study|Physician Decision|1|||
94204594|NCT02438137|322545898|FG000|Overall Study|Lost to Follow-up|3|||
94279722|NCT01425008|322814567|FG002|Dose Expansion Phase|Other|0|||
94279723|NCT01425008|322814568|FG003|Dose Expansion Phase|Other|0|||
94279724|NCT01425008|322814569|FG004|Dose Expansion Phase|Other|0|||
94204595|NCT02438137|322545899|FG001|Overall Study|Lost to Follow-up|2|||
94204596|NCT02438137|322545898|FG000|Overall Study|Adverse Event|1|||
94204597|NCT02438137|322545899|FG001|Overall Study|Adverse Event|0|||
94204598|NCT02438137|322545898|FG000|Overall Study|Withdrawal by Subject|4|||
94204599|NCT02438137|322545899|FG001|Overall Study|Withdrawal by Subject|3|||
94279725|NCT01425008|322814570|FG005|Dose Expansion Phase|Other|0|||
94279726|NCT01425008|322814571|FG006|Dose Expansion Phase|Other|0|||
94204600|NCT02438137|322545898|FG000|Overall Study|Physician Decision|0|||
94204601|NCT02438137|322545899|FG001|Overall Study|Physician Decision|1|||
94204602|NCT00945321|322545900|FG000|Period 1|Adverse Event|0|||
94204603|NCT00945321|322545901|FG001|Period 1|Adverse Event|0|||
94279727|NCT01425008|322814572|FG007|Dose Expansion Phase|Other|0|||
94279728|NCT01425008|322814573|FG008|Dose Expansion Phase|Other|0|||
94204604|NCT00945321|322545902|FG002|Period 1|Adverse Event|0|||
94204605|NCT00945321|322545903|FG003|Period 1|Adverse Event|0|||
94204606|NCT00945321|322545904|FG004|Period 1|Adverse Event|1|||
94204607|NCT00945321|322545905|FG005|Period 1|Adverse Event|0|||
94204608|NCT00945321|322545900|FG000|Period 4|Lost to Follow-up|0|||
94204609|NCT00945321|322545901|FG001|Period 4|Lost to Follow-up|0|||
94204610|NCT00945321|322545902|FG002|Period 4|Lost to Follow-up|0|||
94204611|NCT00945321|322545903|FG003|Period 4|Lost to Follow-up|0|||
94204612|NCT00945321|322545904|FG004|Period 4|Lost to Follow-up|0|||
94204613|NCT00945321|322545905|FG005|Period 4|Lost to Follow-up|1|||
94204614|NCT00372775|322545908|FG000|Overall Study|Adverse Event|8|||
94204615|NCT00372775|322545908|FG000|Overall Study|Death|15|||
94204616|NCT00372775|322545908|FG000|Overall Study|Objective progression or relapse|30|||
94204617|NCT00372775|322545908|FG000|Overall Study|Global deterioration of health status|6|||
94204618|NCT00372775|322545908|FG000|Overall Study|Withdrawal by Subject|1|||
94204619|NCT00372775|322545908|FG000|Overall Study|Other|1|||
94204620|NCT00372775|322545908|FG000|Overall Study|Not Treated|2|||
94204621|NCT03653364|322545910|FG000|Overall Study|Withdrawal by Subject|1|||
94204622|NCT03653364|322545910|FG000|Overall Study|Enrolled in Error|1|||
94204623|NCT03653364|322545910|FG000|Overall Study|Death|1|||
94204624|NCT02941549|322545913|FG000|Overall Study|Adverse Event|1|||
94279729|NCT01425008|322814574|FG009|Dose Expansion Phase|Other|0|||
94279730|NCT01425008|322814575|FG010|Dose Expansion Phase|Other|0|||
94279731|NCT01425008|322814576|FG011|Dose Expansion Phase|Other|0|||
94279732|NCT01425008|322814577|FG012|Dose Expansion Phase|Other|1|||
94279733|NCT01425008|322814578|FG013|Dose Expansion Phase|Other|0|||
94279734|NCT01425008|322814579|FG014|Dose Expansion Phase|Other|0|||
94279735|NCT01425008|322814580|FG015|Dose Expansion Phase|Other|0|||
94279736|NCT01425008|322814581|FG016|Dose Expansion Phase|Other|2|||
94279737|NCT01425008|322814582|FG017|Dose Expansion Phase|Other|0|||
94279738|NCT01425008|322814583|FG018|Dose Expansion Phase|Other|4|||
94279739|NCT01425008|322814565|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
94279740|NCT01425008|322814566|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
94279741|NCT01425008|322814567|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
94279742|NCT01425008|322814568|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
94279743|NCT01425008|322814569|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
94279744|NCT01425008|322814570|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
94279745|NCT01425008|322814571|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
94279746|NCT01425008|322814572|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
94279747|NCT01425008|322814573|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
94279748|NCT01425008|322814574|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
94279749|NCT01425008|322814575|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
94279750|NCT01425008|322814576|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
94279751|NCT01425008|322814577|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
94279752|NCT01425008|322814578|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
94279753|NCT01425008|322814579|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
94279754|NCT01425008|322814580|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
94279755|NCT01425008|322814581|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
94279756|NCT01425008|322814582|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
94279757|NCT01425008|322814583|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
94279758|NCT01425008|322814565|FG000|Dose Expansion Phase|Adverse Event|0|||
94279759|NCT01425008|322814566|FG001|Dose Expansion Phase|Adverse Event|0|||
94279760|NCT01425008|322814567|FG002|Dose Expansion Phase|Adverse Event|0|||
94279761|NCT01425008|322814568|FG003|Dose Expansion Phase|Adverse Event|0|||
94279762|NCT01425008|322814569|FG004|Dose Expansion Phase|Adverse Event|0|||
94279763|NCT01425008|322814570|FG005|Dose Expansion Phase|Adverse Event|0|||
94279764|NCT01425008|322814571|FG006|Dose Expansion Phase|Adverse Event|0|||
94279765|NCT01425008|322814572|FG007|Dose Expansion Phase|Adverse Event|0|||
94279766|NCT01425008|322814573|FG008|Dose Expansion Phase|Adverse Event|0|||
94279767|NCT01425008|322814574|FG009|Dose Expansion Phase|Adverse Event|0|||
94279768|NCT01425008|322814575|FG010|Dose Expansion Phase|Adverse Event|2|||
94279769|NCT01425008|322814576|FG011|Dose Expansion Phase|Adverse Event|3|||
94279770|NCT01425008|322814577|FG012|Dose Expansion Phase|Adverse Event|3|||
94279771|NCT01425008|322814578|FG013|Dose Expansion Phase|Adverse Event|0|||
94279772|NCT01425008|322814579|FG014|Dose Expansion Phase|Adverse Event|1|||
94204625|NCT02941549|322545914|FG001|Overall Study|Adverse Event|0|||
94204626|NCT02941549|322545915|FG002|Overall Study|Adverse Event|0|||
94279773|NCT01425008|322814580|FG015|Dose Expansion Phase|Adverse Event|1|||
94279774|NCT01425008|322814581|FG016|Dose Expansion Phase|Adverse Event|5|||
94204627|NCT02941549|322545913|FG000|Overall Study|Withdrawal by Subject|2|||
94279775|NCT01425008|322814582|FG017|Dose Expansion Phase|Adverse Event|0|||
94279776|NCT01425008|322814583|FG018|Dose Expansion Phase|Adverse Event|3|||
94204628|NCT02941549|322545914|FG001|Overall Study|Withdrawal by Subject|1|||
94279777|NCT01425008|322814565|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
94279778|NCT01425008|322814566|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
94279779|NCT01425008|322814567|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
94371028|NCT01585831|323144605|FG000|Overall Study|Physician Decision|0|||
94371029|NCT01585831|323144606|FG001|Overall Study|Physician Decision|1|||
94204629|NCT02941549|322545915|FG002|Overall Study|Withdrawal by Subject|2|||
94204630|NCT00112359|322545916|FG000|Overall Study|Unrelated adverse event|16|||
94204631|NCT00112359|322545917|FG001|Overall Study|Unrelated adverse event|8|||
94204632|NCT00112359|322545916|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
94204633|NCT00112359|322545917|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
94204634|NCT00112359|322545916|FG000|Overall Study|Related adverse event|5|||
94204635|NCT00112359|322545917|FG001|Overall Study|Related adverse event|3|||
94204636|NCT00112359|322545916|FG000|Overall Study|Lost to Follow-up|0|||
94204637|NCT00112359|322545917|FG001|Overall Study|Lost to Follow-up|1|||
94204638|NCT00112359|322545916|FG000|Overall Study|Personal/administrative|1|||
94204639|NCT00112359|322545917|FG001|Overall Study|Personal/administrative|1|||
94204640|NCT00112359|322545916|FG000|Overall Study|Other|3|||
94204641|NCT00112359|322545917|FG001|Overall Study|Other|0|||
94204642|NCT00571649|322545918|FG000|Treatment Period|Adverse Event|438|||
94204643|NCT00571649|322545919|FG001|Treatment Period|Adverse Event|385|||
94204644|NCT00571649|322545918|FG000|Treatment Period|Clinical endpoint reached|50|||
94204645|NCT00571649|322545919|FG001|Treatment Period|Clinical endpoint reached|56|||
94204646|NCT00571649|322545918|FG000|Treatment Period|Withdrawal by Subject|285|||
94204647|NCT00571649|322545919|FG001|Treatment Period|Withdrawal by Subject|255|||
94204648|NCT00571649|322545918|FG000|Treatment Period|Death|76|||
94204649|NCT00571649|322545919|FG001|Treatment Period|Death|59|||
94204650|NCT00571649|322545918|FG000|Treatment Period|Physician Decision|8|||
94279780|NCT01425008|322814568|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
94279781|NCT01425008|322814569|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
94279782|NCT01425008|322814570|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
94279783|NCT01425008|322814571|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
94279784|NCT01425008|322814572|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
94279785|NCT01425008|322814573|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
94279786|NCT01425008|322814574|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
94279787|NCT01425008|322814575|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
94279788|NCT01425008|322814576|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
94279789|NCT01425008|322814577|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
94279790|NCT01425008|322814578|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
94279791|NCT01425008|322814579|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
94279792|NCT01425008|322814580|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
94279793|NCT01425008|322814581|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
94279794|NCT01425008|322814582|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
94279795|NCT01425008|322814583|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
94279796|NCT01425008|322814565|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94279797|NCT01425008|322814566|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94279798|NCT01425008|322814567|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94279799|NCT01425008|322814568|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94279800|NCT01425008|322814569|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94279801|NCT01425008|322814570|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94279802|NCT01425008|322814571|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94279803|NCT01425008|322814572|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94279804|NCT01425008|322814573|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94279805|NCT01425008|322814574|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94279806|NCT01425008|322814575|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94279807|NCT01425008|322814576|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94279808|NCT01425008|322814577|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94279809|NCT01425008|322814578|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94279810|NCT01425008|322814579|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94279811|NCT01425008|322814580|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94279812|NCT01425008|322814581|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94279813|NCT01425008|322814582|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
94279814|NCT01425008|322814583|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
94279815|NCT00264238|322814585|FG000|Overall Study|Protocol Violation|1|||
94279816|NCT01314716|322814588|FG000|Double-Blind Phase|Randomized but not treated|1|||
94279817|NCT01314716|322814589|FG001|Double-Blind Phase|Randomized but not treated|1|||
94279818|NCT01314716|322814588|FG000|Double-Blind Phase|Adverse Event|10|||
94204651|NCT00571649|322545919|FG001|Treatment Period|Physician Decision|9|||
94204652|NCT00571649|322545918|FG000|Treatment Period|Lost to Follow-up|43|||
94279819|NCT01314716|322814589|FG001|Double-Blind Phase|Adverse Event|4|||
94743618|NCT02443116|324517039|FG005|Part 3|Withdrew informed consent|0|||
94204653|NCT00571649|322545919|FG001|Treatment Period|Lost to Follow-up|41|||
94204654|NCT00571649|322545918|FG000|Treatment Period|Non-compliant with study medication|88|||
94204655|NCT00571649|322545919|FG001|Treatment Period|Non-compliant with study medication|89|||
94204656|NCT00571649|322545918|FG000|Treatment Period|Patient convenience|11|||
94279820|NCT01314716|322814588|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
94279821|NCT01314716|322814589|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
94279822|NCT01314716|322814588|FG000|Double-Blind Phase|Lost to Follow-up|0|||
94279823|NCT01314716|322814589|FG001|Double-Blind Phase|Lost to Follow-up|1|||
94279824|NCT01314716|322814588|FG000|Double-Blind Phase|Sponsor request|1|||
94279825|NCT01314716|322814589|FG001|Double-Blind Phase|Sponsor request|2|||
94279826|NCT01314716|322814588|FG000|Double-Blind Phase|Physician Decision|0|||
94279827|NCT01314716|322814589|FG001|Double-Blind Phase|Physician Decision|1|||
94279828|NCT01314716|322814588|FG000|Open-Label Phase|Adverse Event|4|||
94279829|NCT01314716|322814589|FG001|Open-Label Phase|Adverse Event|6|||
94279830|NCT01314716|322814588|FG000|Open-Label Phase|Withdrawal by Subject|1|||
94279831|NCT01314716|322814589|FG001|Open-Label Phase|Withdrawal by Subject|2|||
94279832|NCT01314716|322814588|FG000|Open-Label Phase|Physician Decision|5|||
94279833|NCT01314716|322814589|FG001|Open-Label Phase|Physician Decision|4|||
94279834|NCT00805480|322814590|FG000|Overall Study|Withdrawal by Subject|13|||
94279835|NCT00805480|322814591|FG001|Overall Study|Withdrawal by Subject|5|||
94279836|NCT00805480|322814592|FG002|Overall Study|Withdrawal by Subject|11|||
94279837|NCT00805480|322814593|FG003|Overall Study|Withdrawal by Subject|5|||
94279838|NCT00805480|322814590|FG000|Overall Study|Lost to Follow-up|1|||
94279839|NCT00805480|322814591|FG001|Overall Study|Lost to Follow-up|2|||
94279840|NCT00805480|322814592|FG002|Overall Study|Lost to Follow-up|0|||
94279841|NCT00805480|322814593|FG003|Overall Study|Lost to Follow-up|0|||
94279842|NCT00805480|322814590|FG000|Overall Study|Adverse Event|0|||
94279843|NCT00805480|322814591|FG001|Overall Study|Adverse Event|0|||
94279844|NCT00805480|322814592|FG002|Overall Study|Adverse Event|1|||
94279845|NCT00805480|322814593|FG003|Overall Study|Adverse Event|0|||
94279846|NCT03164616|322814594|FG000|Overall Study|Death|250|||
94279847|NCT03164616|322814595|FG001|Overall Study|Death|264|||
94279848|NCT03164616|322814596|FG002|Overall Study|Death|279|||
94279849|NCT03164616|322814594|FG000|Overall Study|Lost to Follow-up|2|||
94279850|NCT03164616|322814595|FG001|Overall Study|Lost to Follow-up|2|||
94279851|NCT03164616|322814596|FG002|Overall Study|Lost to Follow-up|2|||
94279852|NCT03164616|322814594|FG000|Overall Study|Withdrawal by Subject|6|||
94279853|NCT03164616|322814595|FG001|Overall Study|Withdrawal by Subject|7|||
94279854|NCT03164616|322814596|FG002|Overall Study|Withdrawal by Subject|16|||
94279855|NCT01534533|322814597|FG000|Overall Study|Lost to Follow-up|3|||
94279856|NCT01534533|322814598|FG001|Overall Study|Lost to Follow-up|0|||
94279857|NCT01534533|322814599|FG002|Overall Study|Lost to Follow-up|4|||
94279858|NCT01534533|322814600|FG003|Overall Study|Lost to Follow-up|3|||
94279859|NCT01534533|322814597|FG000|Overall Study|Withdrawal by Subject|5|||
94279860|NCT01534533|322814598|FG001|Overall Study|Withdrawal by Subject|3|||
94279861|NCT01534533|322814599|FG002|Overall Study|Withdrawal by Subject|4|||
94279862|NCT01534533|322814600|FG003|Overall Study|Withdrawal by Subject|1|||
94279863|NCT01736579|322815925|FG000|Overall Study|Termination of Study by Sponsor|2|||
94279864|NCT01736579|322815926|FG001|Overall Study|Termination of Study by Sponsor|2|||
94279865|NCT05048719|322815928|FG000|Overall Study|Withdrawal by Subject|2|||
94279866|NCT05048719|322815929|FG001|Overall Study|Withdrawal by Subject|1|||
94279867|NCT05048719|322815930|FG002|Overall Study|Withdrawal by Subject|3|||
94279868|NCT05048719|322815931|FG003|Overall Study|Withdrawal by Subject|1|||
94279869|NCT05048719|322815932|FG004|Overall Study|Withdrawal by Subject|0|||
94279870|NCT05048719|322815933|FG005|Overall Study|Withdrawal by Subject|2|||
94279871|NCT05048719|322815934|FG006|Overall Study|Withdrawal by Subject|1|||
94279872|NCT05048719|322815935|FG007|Overall Study|Withdrawal by Subject|1|||
94279873|NCT05048719|322815936|FG008|Overall Study|Withdrawal by Subject|0|||
94279874|NCT05048719|322815928|FG000|Overall Study|Death|1|||
94279875|NCT05048719|322815929|FG001|Overall Study|Death|0|||
94279876|NCT05048719|322815930|FG002|Overall Study|Death|0|||
94279877|NCT05048719|322815931|FG003|Overall Study|Death|0|||
94279878|NCT05048719|322815932|FG004|Overall Study|Death|0|||
94279879|NCT05048719|322815933|FG005|Overall Study|Death|0|||
94743619|NCT02443116|324517040|FG006|Part 3|Withdrew informed consent|0|||
94743620|NCT02443116|324517041|FG007|Part 3|Withdrew informed consent|3|||
94743621|NCT02443116|324517042|FG008|Part 3|Withdrew informed consent|2|||
94743622|NCT02443116|324517034|FG000|Part 3|Lost to Follow-up|0|||
94743623|NCT02443116|324517035|FG001|Part 3|Lost to Follow-up|0|||
94743624|NCT02443116|324517036|FG002|Part 3|Lost to Follow-up|0|||
94743625|NCT02443116|324517037|FG003|Part 3|Lost to Follow-up|0|||
94743626|NCT02443116|324517038|FG004|Part 3|Lost to Follow-up|0|||
94743627|NCT02443116|324517039|FG005|Part 3|Lost to Follow-up|0|||
94743628|NCT02443116|324517040|FG006|Part 3|Lost to Follow-up|0|||
94743629|NCT02443116|324517041|FG007|Part 3|Lost to Follow-up|1|||
94743630|NCT02443116|324517042|FG008|Part 3|Lost to Follow-up|2|||
94743631|NCT04541589|324517050|FG000|Treatment Period|Adverse Event|8|||
94279880|NCT05048719|322815934|FG006|Overall Study|Death|0|||
94279881|NCT05048719|322815935|FG007|Overall Study|Death|0|||
94279882|NCT05048719|322815936|FG008|Overall Study|Death|0|||
94279883|NCT05048719|322815928|FG000|Overall Study|Adverse Event|0|||
94279884|NCT05048719|322815929|FG001|Overall Study|Adverse Event|1|||
94279885|NCT05048719|322815930|FG002|Overall Study|Adverse Event|2|||
94279886|NCT05048719|322815931|FG003|Overall Study|Adverse Event|0|||
94279887|NCT05048719|322815932|FG004|Overall Study|Adverse Event|1|||
94279888|NCT05048719|322815933|FG005|Overall Study|Adverse Event|0|||
94279889|NCT05048719|322815934|FG006|Overall Study|Adverse Event|0|||
94279890|NCT05048719|322815935|FG007|Overall Study|Adverse Event|0|||
94279891|NCT05048719|322815936|FG008|Overall Study|Adverse Event|0|||
94743632|NCT04541589|324517051|FG001|Treatment Period|Adverse Event|2|||
94743633|NCT04541589|324517050|FG000|Treatment Period|Physician Decision|3|||
94743634|NCT04541589|324517051|FG001|Treatment Period|Physician Decision|1|||
94743635|NCT04541589|324517050|FG000|Treatment Period|Subject decision|7|||
94743636|NCT04541589|324517051|FG001|Treatment Period|Subject decision|4|||
94743637|NCT04541589|324517050|FG000|Treatment Period|Withdrawal by Subject|1|||
94743638|NCT04541589|324517051|FG001|Treatment Period|Withdrawal by Subject|0|||
94743639|NCT04541589|324517050|FG000|Safety Follow-up Period|Adverse Event|2|||
94743640|NCT04541589|324517051|FG001|Safety Follow-up Period|Adverse Event|1|||
94743641|NCT04541589|324517050|FG000|Safety Follow-up Period|Physician Decision|1|||
94743642|NCT04541589|324517051|FG001|Safety Follow-up Period|Physician Decision|0|||
94743643|NCT04541589|324517050|FG000|Safety Follow-up Period|Subject decision|5|||
94743644|NCT04541589|324517051|FG001|Safety Follow-up Period|Subject decision|3|||
94743645|NCT04541589|324517050|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
94743646|NCT04541589|324517051|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
94204657|NCT00571649|322545919|FG001|Treatment Period|Patient convenience|13|||
94204658|NCT00571649|322545918|FG000|Treatment Period|Protocol Violation|90|||
94204659|NCT00571649|322545919|FG001|Treatment Period|Protocol Violation|92|||
94204660|NCT00571649|322545918|FG000|Treatment Period|Technical problems|3|||
94204661|NCT00571649|322545919|FG001|Treatment Period|Technical problems|5|||
94204662|NCT00571649|322545918|FG000|Follow-up Period|Adverse Event|46|||
94204663|NCT00571649|322545919|FG001|Follow-up Period|Adverse Event|40|||
94204664|NCT00571649|322545918|FG000|Follow-up Period|Clinical endpoint reached|5|||
94204665|NCT00571649|322545919|FG001|Follow-up Period|Clinical endpoint reached|2|||
94204666|NCT00571649|322545918|FG000|Follow-up Period|Withdrawal by Subject|119|||
94204667|NCT00571649|322545919|FG001|Follow-up Period|Withdrawal by Subject|115|||
94204668|NCT00571649|322545918|FG000|Follow-up Period|Death|132|||
94204669|NCT00571649|322545919|FG001|Follow-up Period|Death|133|||
94204670|NCT00571649|322545918|FG000|Follow-up Period|Physician Decision|7|||
94204671|NCT00571649|322545919|FG001|Follow-up Period|Physician Decision|13|||
94204672|NCT00571649|322545918|FG000|Follow-up Period|Lost to Follow-up|95|||
94204673|NCT00571649|322545919|FG001|Follow-up Period|Lost to Follow-up|92|||
94204674|NCT00571649|322545918|FG000|Follow-up Period|Patient convenience|136|||
94204675|NCT00571649|322545919|FG001|Follow-up Period|Patient convenience|121|||
94204676|NCT00571649|322545918|FG000|Follow-up Period|Protocol Violation|5|||
94204677|NCT00571649|322545919|FG001|Follow-up Period|Protocol Violation|12|||
94204678|NCT01211184|322545922|FG000|Overall Study|Withdrawal by Subject|0|||
94204679|NCT01211184|322545923|FG001|Overall Study|Withdrawal by Subject|2|||
94204680|NCT01211184|322545924|FG002|Overall Study|Withdrawal by Subject|1|||
94204681|NCT01324310|322545927|FG000|Overall Study|Adverse Event|1|||
94204682|NCT01324310|322545927|FG000|Overall Study|Disease Progression|1|||
94204683|NCT05580003|322545944|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204684|NCT05580003|322545945|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204685|NCT05580003|322545946|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204686|NCT05580003|322545947|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204687|NCT05580003|322545948|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204688|NCT05580003|322545949|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204689|NCT05580003|322545950|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
94204690|NCT05580003|322545951|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204691|NCT05580003|322545952|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204692|NCT05580003|322545953|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204693|NCT05580003|322545954|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204694|NCT05580003|322545955|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204695|NCT05580003|322545956|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204696|NCT05580003|322545957|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204697|NCT05580003|322545958|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204698|NCT05580003|322545959|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204699|NCT05580003|322545960|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204700|NCT05580003|322545961|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204701|NCT05580003|322545962|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204702|NCT05580003|322545963|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204703|NCT05580003|322545964|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204704|NCT05580003|322545965|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204705|NCT05580003|322545966|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204706|NCT05580003|322545967|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204707|NCT05580003|322545968|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204708|NCT05580003|322545969|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94743647|NCT04271475|324517052|FG000|DB Period: Day 1 up to EODBT|Death|1|||
94743648|NCT04271475|324517053|FG001|DB Period: Day 1 up to EODBT|Death|0|||
94279892|NCT05048719|322815928|FG000|Overall Study|Lost to Follow-up|0|||
94204709|NCT05580003|322545970|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204710|NCT05580003|322545971|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94204711|NCT05580003|322545944|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204712|NCT05580003|322545945|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204713|NCT05580003|322545946|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204714|NCT05580003|322545947|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204715|NCT05580003|322545948|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204716|NCT05580003|322545949|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
94204717|NCT05580003|322545950|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204718|NCT05580003|322545951|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204719|NCT05580003|322545952|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204720|NCT05580003|322545953|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204721|NCT05580003|322545954|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204722|NCT05580003|322545955|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204723|NCT05580003|322545956|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204724|NCT05580003|322545957|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204725|NCT05580003|322545958|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204726|NCT05580003|322545959|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204727|NCT05580003|322545960|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204728|NCT05580003|322545961|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204729|NCT05580003|322545962|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204730|NCT05580003|322545963|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204731|NCT05580003|322545964|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204732|NCT05580003|322545965|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204733|NCT05580003|322545966|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204734|NCT05580003|322545967|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204735|NCT05580003|322545968|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204736|NCT05580003|322545969|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204737|NCT05580003|322545970|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94204738|NCT05580003|322545971|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
94279893|NCT05048719|322815929|FG001|Overall Study|Lost to Follow-up|0|||
94279894|NCT05048719|322815930|FG002|Overall Study|Lost to Follow-up|1|||
94279895|NCT05048719|322815931|FG003|Overall Study|Lost to Follow-up|3|||
94279896|NCT05048719|322815932|FG004|Overall Study|Lost to Follow-up|1|||
94279897|NCT05048719|322815933|FG005|Overall Study|Lost to Follow-up|1|||
94279898|NCT05048719|322815934|FG006|Overall Study|Lost to Follow-up|1|||
94279899|NCT05048719|322815935|FG007|Overall Study|Lost to Follow-up|1|||
94279900|NCT05048719|322815936|FG008|Overall Study|Lost to Follow-up|0|||
94279901|NCT05048719|322815928|FG000|Overall Study|Physician Decision|0|||
94279902|NCT05048719|322815929|FG001|Overall Study|Physician Decision|0|||
94279903|NCT05048719|322815930|FG002|Overall Study|Physician Decision|0|||
94279904|NCT05048719|322815931|FG003|Overall Study|Physician Decision|0|||
94279905|NCT05048719|322815932|FG004|Overall Study|Physician Decision|0|||
94279906|NCT05048719|322815933|FG005|Overall Study|Physician Decision|0|||
94279907|NCT05048719|322815934|FG006|Overall Study|Physician Decision|0|||
94279908|NCT05048719|322815935|FG007|Overall Study|Physician Decision|1|||
94279909|NCT05048719|322815936|FG008|Overall Study|Physician Decision|1|||
94279910|NCT05048719|322815928|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
94279911|NCT05048719|322815929|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
94279912|NCT05048719|322815930|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
94279913|NCT05048719|322815931|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
94279914|NCT05048719|322815932|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
94279915|NCT05048719|322815933|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
94279916|NCT05048719|322815934|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
94279917|NCT05048719|322815935|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
94279918|NCT05048719|322815936|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
94279919|NCT05048719|322815928|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
94279920|NCT05048719|322815929|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
94279921|NCT05048719|322815930|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
94279922|NCT05048719|322815931|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
94279923|NCT05048719|322815932|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
94279924|NCT05048719|322815933|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
94279925|NCT05048719|322815934|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
94279926|NCT05048719|322815935|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
94279927|NCT05048719|322815936|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
94279928|NCT05048719|322815928|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
94204739|NCT05580003|322545944|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204740|NCT05580003|322545945|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204741|NCT05580003|322545946|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204742|NCT05580003|322545947|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
94204743|NCT05580003|322545948|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204744|NCT05580003|322545949|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204745|NCT05580003|322545950|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204746|NCT05580003|322545951|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204747|NCT05580003|322545952|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204748|NCT05580003|322545953|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204749|NCT05580003|322545954|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204750|NCT05580003|322545955|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204751|NCT05580003|322545956|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204752|NCT05580003|322545957|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204753|NCT05580003|322545958|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204754|NCT05580003|322545959|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204755|NCT05580003|322545960|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204756|NCT05580003|322545961|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204757|NCT05580003|322545962|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204758|NCT05580003|322545963|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204759|NCT05580003|322545964|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204760|NCT05580003|322545965|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204761|NCT05580003|322545966|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204762|NCT05580003|322545967|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204763|NCT05580003|322545968|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204764|NCT05580003|322545969|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204765|NCT05580003|322545970|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204766|NCT05580003|322545971|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
94204767|NCT05580003|322545944|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204768|NCT05580003|322545945|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
94204769|NCT05580003|322545946|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204770|NCT05580003|322545947|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204771|NCT05580003|322545948|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204772|NCT05580003|322545949|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204773|NCT05580003|322545950|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204774|NCT05580003|322545951|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204775|NCT05580003|322545952|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204776|NCT05580003|322545953|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204777|NCT05580003|322545954|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204778|NCT05580003|322545955|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204779|NCT05580003|322545956|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204780|NCT05580003|322545957|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204781|NCT05580003|322545958|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204782|NCT05580003|322545959|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204783|NCT05580003|322545960|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204784|NCT05580003|322545961|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204785|NCT05580003|322545962|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204786|NCT05580003|322545963|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204787|NCT05580003|322545964|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204788|NCT05580003|322545965|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204789|NCT05580003|322545966|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204790|NCT05580003|322545967|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204791|NCT05580003|322545968|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204792|NCT05580003|322545969|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204793|NCT05580003|322545970|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204794|NCT05580003|322545971|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
94204795|NCT05580003|322545944|FG000|Part 2 (up to 10 Days)|Other|0|||
94204796|NCT05580003|322545945|FG001|Part 2 (up to 10 Days)|Other|0|||
94204797|NCT05580003|322545946|FG002|Part 2 (up to 10 Days)|Other|0|||
94204798|NCT05580003|322545947|FG003|Part 2 (up to 10 Days)|Other|0|||
94204799|NCT05580003|322545948|FG004|Part 2 (up to 10 Days)|Other|0|||
94204800|NCT05580003|322545949|FG005|Part 2 (up to 10 Days)|Other|0|||
94279929|NCT05048719|322815929|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
94204801|NCT05580003|322545950|FG006|Part 2 (up to 10 Days)|Other|0|||
94204802|NCT05580003|322545951|FG007|Part 2 (up to 10 Days)|Other|0|||
94204803|NCT05580003|322545952|FG008|Part 2 (up to 10 Days)|Other|0|||
94204804|NCT05580003|322545953|FG009|Part 2 (up to 10 Days)|Other|1|||
94279930|NCT05048719|322815930|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
94204805|NCT05580003|322545954|FG010|Part 2 (up to 10 Days)|Other|0|||
94204806|NCT05580003|322545955|FG011|Part 2 (up to 10 Days)|Other|0|||
94279931|NCT05048719|322815931|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
94204807|NCT05580003|322545956|FG012|Part 2 (up to 10 Days)|Other|0|||
94204808|NCT05580003|322545957|FG013|Part 2 (up to 10 Days)|Other|0|||
94204809|NCT05580003|322545958|FG014|Part 2 (up to 10 Days)|Other|0|||
94204810|NCT05580003|322545959|FG015|Part 2 (up to 10 Days)|Other|0|||
94204811|NCT05580003|322545960|FG016|Part 2 (up to 10 Days)|Other|0|||
94204812|NCT05580003|322545961|FG017|Part 2 (up to 10 Days)|Other|0|||
94204813|NCT05580003|322545962|FG018|Part 2 (up to 10 Days)|Other|0|||
94204814|NCT05580003|322545963|FG019|Part 2 (up to 10 Days)|Other|0|||
94204815|NCT05580003|322545964|FG020|Part 2 (up to 10 Days)|Other|0|||
94204816|NCT05580003|322545965|FG021|Part 2 (up to 10 Days)|Other|0|||
94204817|NCT05580003|322545966|FG022|Part 2 (up to 10 Days)|Other|0|||
94204818|NCT05580003|322545967|FG023|Part 2 (up to 10 Days)|Other|0|||
94204819|NCT05580003|322545968|FG024|Part 2 (up to 10 Days)|Other|0|||
94204820|NCT05580003|322545969|FG025|Part 2 (up to 10 Days)|Other|0|||
94204821|NCT05580003|322545970|FG026|Part 2 (up to 10 Days)|Other|0|||
94204822|NCT05580003|322545971|FG027|Part 2 (up to 10 Days)|Other|0|||
94204823|NCT05580003|322545944|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204824|NCT05580003|322545945|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204825|NCT05580003|322545946|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204826|NCT05580003|322545947|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204827|NCT05580003|322545948|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204828|NCT05580003|322545949|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204829|NCT05580003|322545950|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204830|NCT05580003|322545951|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204831|NCT05580003|322545952|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204832|NCT05580003|322545953|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204833|NCT05580003|322545954|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204834|NCT05580003|322545955|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204835|NCT05580003|322545956|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204836|NCT05580003|322545957|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204837|NCT05580003|322545958|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204838|NCT05580003|322545959|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204839|NCT05580003|322545960|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204840|NCT05580003|322545961|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204841|NCT05580003|322545962|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204842|NCT05580003|322545963|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
94204843|NCT05580003|322545964|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204844|NCT05580003|322545965|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204845|NCT05580003|322545966|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204846|NCT05580003|322545967|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204847|NCT05580003|322545968|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204848|NCT05580003|322545969|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204849|NCT05580003|322545970|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204850|NCT05580003|322545971|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
94204851|NCT05580003|322545944|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204852|NCT05580003|322545945|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204853|NCT05580003|322545946|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204854|NCT05580003|322545947|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204855|NCT05580003|322545948|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204856|NCT05580003|322545949|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204857|NCT05580003|322545950|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204858|NCT05580003|322545951|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204859|NCT05580003|322545952|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204860|NCT05580003|322545953|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204861|NCT05580003|322545954|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204862|NCT05580003|322545955|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204863|NCT05580003|322545956|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204864|NCT05580003|322545957|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204865|NCT05580003|322545958|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204866|NCT05580003|322545959|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204867|NCT05580003|322545960|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204868|NCT05580003|322545961|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94371030|NCT01585831|323144605|FG000|Overall Study|Withdrawal by Subject|2|||
94204869|NCT05580003|322545962|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204870|NCT05580003|322545963|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204871|NCT05580003|322545964|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
94204872|NCT05580003|322545965|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204873|NCT05580003|322545966|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204874|NCT05580003|322545967|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204875|NCT05580003|322545968|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204876|NCT05580003|322545969|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204877|NCT05580003|322545970|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204878|NCT05580003|322545971|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
94204879|NCT05580003|322545944|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204880|NCT05580003|322545945|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204881|NCT05580003|322545946|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204882|NCT05580003|322545947|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204883|NCT05580003|322545948|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204884|NCT05580003|322545949|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204885|NCT05580003|322545950|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204886|NCT05580003|322545951|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204887|NCT05580003|322545952|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204888|NCT05580003|322545953|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204889|NCT05580003|322545954|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204890|NCT05580003|322545955|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204891|NCT05580003|322545956|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204892|NCT05580003|322545957|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204893|NCT05580003|322545958|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204894|NCT05580003|322545959|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204895|NCT05580003|322545960|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204896|NCT05580003|322545961|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204897|NCT05580003|322545962|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204898|NCT05580003|322545963|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94371031|NCT01585831|323144606|FG001|Overall Study|Withdrawal by Subject|1|||
94204899|NCT05580003|322545964|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94371032|NCT00579254|323144607|FG000|Overall Study|Lost to Follow-up|39|||
94371033|NCT00579254|323144607|FG000|Overall Study|Discontinued when study terminated|73|||
94371034|NCT00874757|323144608|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
94371035|NCT01963676|323146713|FG000|Overall Study|Withdrawal by Subject|1|||
94371036|NCT01963676|323146714|FG001|Overall Study|Withdrawal by Subject|0|||
94371037|NCT01246973|323146717|FG000|Overall Study|Other|38|||
94371038|NCT01246973|323146718|FG001|Overall Study|Other|25|||
94371039|NCT01246973|323146717|FG000|Overall Study|Adverse Event|16|||
94371040|NCT01246973|323146718|FG001|Overall Study|Adverse Event|9|||
94371041|NCT01246973|323146717|FG000|Overall Study|Withdrawal by Subject|7|||
94371042|NCT01246973|323146718|FG001|Overall Study|Withdrawal by Subject|13|||
94371043|NCT00766506|323146719|FG000|Overall Study|Use rescue medication after 3 hours|3|||
94371044|NCT00766506|323146720|FG001|Overall Study|Use rescue medication after 3 hours|0|||
94467657|NCT01004432|323502373|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
94204900|NCT05580003|322545965|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
94204901|NCT05580003|322545966|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204902|NCT05580003|322545967|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204903|NCT05580003|322545968|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94279932|NCT05048719|322815932|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
94279933|NCT05048719|322815933|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
94279934|NCT05048719|322815934|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
94279935|NCT05048719|322815935|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
94279936|NCT05048719|322815936|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
94279937|NCT05048719|322815928|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
94279938|NCT05048719|322815929|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
94279939|NCT05048719|322815930|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
94279940|NCT05048719|322815931|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
94279941|NCT05048719|322815932|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
94279942|NCT05048719|322815933|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
94279943|NCT05048719|322815934|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
94279944|NCT05048719|322815935|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
94279945|NCT05048719|322815936|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
94279946|NCT05048719|322815928|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
94279947|NCT05048719|322815929|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
94279948|NCT05048719|322815930|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
94279949|NCT05048719|322815931|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
94279950|NCT05048719|322815932|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
94371045|NCT00766506|323146719|FG000|Overall Study|Other|2|||
94371046|NCT00766506|323146720|FG001|Overall Study|Other|2|||
94371047|NCT01246986|323146721|FG000|Overall Study|Lost to Follow-up|0|||
94467658|NCT01004432|323502374|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
94204904|NCT05580003|322545969|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204905|NCT05580003|322545970|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204906|NCT05580003|322545971|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
94204907|NCT05580003|322545944|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204908|NCT05580003|322545945|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204909|NCT05580003|322545946|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204910|NCT05580003|322545947|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204911|NCT05580003|322545948|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204912|NCT05580003|322545949|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204913|NCT05580003|322545950|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204914|NCT05580003|322545951|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204915|NCT05580003|322545952|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94279951|NCT05048719|322815933|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
94279952|NCT05048719|322815934|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
94279953|NCT05048719|322815935|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
94279954|NCT05048719|322815936|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
94279955|NCT04623242|322815945|FG000|Overall Study|Withdrawal by Subject|7|||
94279956|NCT04623242|322815946|FG001|Overall Study|Withdrawal by Subject|12|||
94279957|NCT04623242|322815947|FG002|Overall Study|Withdrawal by Subject|5|||
94279958|NCT04623242|322815948|FG003|Overall Study|Withdrawal by Subject|7|||
94279959|NCT04623242|322815949|FG004|Overall Study|Withdrawal by Subject|0|||
94279960|NCT04623242|322815945|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
94279961|NCT04623242|322815946|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
94279962|NCT04623242|322815947|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
94279963|NCT04623242|322815948|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
94279964|NCT04623242|322815949|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
94279965|NCT04623242|322815945|FG000|Overall Study|Subject unblinded to mutation status|0|||
94279966|NCT04623242|322815946|FG001|Overall Study|Subject unblinded to mutation status|0|||
94279967|NCT04623242|322815947|FG002|Overall Study|Subject unblinded to mutation status|0|||
94279968|NCT04623242|322815948|FG003|Overall Study|Subject unblinded to mutation status|13|||
94279969|NCT04623242|322815949|FG004|Overall Study|Subject unblinded to mutation status|0|||
94279970|NCT00820898|322815950|FG000|Overall Study|Inelgible - wrong primary site|1|||
94279971|NCT00647556|322815951|FG000|Overall Study|Adverse Event|0|||
94279972|NCT00647556|322815952|FG001|Overall Study|Adverse Event|1|||
94279973|NCT00647556|322815951|FG000|Overall Study|Lost to Follow-up|1|||
94279974|NCT00647556|322815952|FG001|Overall Study|Lost to Follow-up|0|||
94279975|NCT00647556|322815951|FG000|Overall Study|Protocol Violation|0|||
94279976|NCT00647556|322815952|FG001|Overall Study|Protocol Violation|1|||
94279977|NCT00647556|322815951|FG000|Overall Study|Withdrawal by Subject|1|||
94279978|NCT00647556|322815952|FG001|Overall Study|Withdrawal by Subject|0|||
94279979|NCT00647556|322815951|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
94279980|NCT00647556|322815952|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
94279981|NCT01192022|322815953|FG000|Overall Study|Withdrawal of Consent|3|||
94279982|NCT01192022|322815954|FG001|Overall Study|Withdrawal of Consent|1|||
94279983|NCT01192022|322815955|FG002|Overall Study|Withdrawal of Consent|0|||
94279984|NCT01192022|322815956|FG003|Overall Study|Withdrawal of Consent|0|||
94279985|NCT01192022|322815957|FG004|Overall Study|Withdrawal of Consent|0|||
94279986|NCT01192022|322815953|FG000|Overall Study|Lost to Follow-up|4|||
94279987|NCT01192022|322815954|FG001|Overall Study|Lost to Follow-up|2|||
94279988|NCT01192022|322815955|FG002|Overall Study|Lost to Follow-up|1|||
94279989|NCT01192022|322815956|FG003|Overall Study|Lost to Follow-up|1|||
94279990|NCT01192022|322815957|FG004|Overall Study|Lost to Follow-up|0|||
94279991|NCT01192022|322815953|FG000|Overall Study|Adverse Event|1|||
94279992|NCT01192022|322815954|FG001|Overall Study|Adverse Event|0|||
94279993|NCT01192022|322815955|FG002|Overall Study|Adverse Event|0|||
94279994|NCT01192022|322815956|FG003|Overall Study|Adverse Event|0|||
94279995|NCT01192022|322815957|FG004|Overall Study|Adverse Event|0|||
94279996|NCT01192022|322815953|FG000|Overall Study|Fatal Adverse Event|4|||
94279997|NCT01192022|322815954|FG001|Overall Study|Fatal Adverse Event|6|||
94279998|NCT01192022|322815955|FG002|Overall Study|Fatal Adverse Event|0|||
94279999|NCT01192022|322815956|FG003|Overall Study|Fatal Adverse Event|0|||
94280000|NCT01192022|322815957|FG004|Overall Study|Fatal Adverse Event|1|||
94280001|NCT01192022|322815953|FG000|Overall Study|Physician withdrew-patient hardship|1|||
94280002|NCT01192022|322815954|FG001|Overall Study|Physician withdrew-patient hardship|0|||
94280003|NCT01192022|322815955|FG002|Overall Study|Physician withdrew-patient hardship|0|||
94280004|NCT01192022|322815956|FG003|Overall Study|Physician withdrew-patient hardship|0|||
94280005|NCT01192022|322815957|FG004|Overall Study|Physician withdrew-patient hardship|0|||
94371048|NCT01246986|323146722|FG001|Overall Study|Lost to Follow-up|1|||
94371049|NCT01246986|323146723|FG002|Overall Study|Lost to Follow-up|3|||
94371050|NCT01246986|323146724|FG003|Overall Study|Lost to Follow-up|0|||
94371051|NCT01246986|323146725|FG004|Overall Study|Lost to Follow-up|0|||
94204916|NCT05580003|322545953|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204917|NCT05580003|322545954|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204918|NCT05580003|322545955|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204919|NCT05580003|322545956|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204920|NCT05580003|322545957|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204921|NCT05580003|322545958|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204922|NCT05580003|322545959|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204923|NCT05580003|322545960|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204924|NCT05580003|322545961|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204925|NCT05580003|322545962|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204926|NCT05580003|322545963|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204927|NCT05580003|322545964|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204928|NCT05580003|322545965|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204929|NCT05580003|322545966|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204930|NCT05580003|322545967|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204931|NCT05580003|322545968|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204932|NCT05580003|322545969|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204933|NCT05580003|322545970|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
94204934|NCT05580003|322545971|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
94204935|NCT05580003|322545944|FG000|Part 6 Period 2 (Day 1)|Other|0|||
94204936|NCT05580003|322545945|FG001|Part 6 Period 2 (Day 1)|Other|0|||
94204937|NCT05580003|322545946|FG002|Part 6 Period 2 (Day 1)|Other|0|||
94204938|NCT05580003|322545947|FG003|Part 6 Period 2 (Day 1)|Other|0|||
94204939|NCT05580003|322545948|FG004|Part 6 Period 2 (Day 1)|Other|0|||
94204940|NCT05580003|322545949|FG005|Part 6 Period 2 (Day 1)|Other|0|||
94204941|NCT05580003|322545950|FG006|Part 6 Period 2 (Day 1)|Other|0|||
94204942|NCT05580003|322545951|FG007|Part 6 Period 2 (Day 1)|Other|0|||
94204943|NCT05580003|322545952|FG008|Part 6 Period 2 (Day 1)|Other|0|||
94204944|NCT05580003|322545953|FG009|Part 6 Period 2 (Day 1)|Other|0|||
94204945|NCT05580003|322545954|FG010|Part 6 Period 2 (Day 1)|Other|0|||
94204946|NCT05580003|322545955|FG011|Part 6 Period 2 (Day 1)|Other|0|||
94204947|NCT05580003|322545956|FG012|Part 6 Period 2 (Day 1)|Other|0|||
94204948|NCT05580003|322545957|FG013|Part 6 Period 2 (Day 1)|Other|0|||
94204949|NCT05580003|322545958|FG014|Part 6 Period 2 (Day 1)|Other|0|||
94204950|NCT05580003|322545959|FG015|Part 6 Period 2 (Day 1)|Other|0|||
94204951|NCT05580003|322545960|FG016|Part 6 Period 2 (Day 1)|Other|0|||
94204952|NCT05580003|322545961|FG017|Part 6 Period 2 (Day 1)|Other|0|||
94204953|NCT05580003|322545962|FG018|Part 6 Period 2 (Day 1)|Other|0|||
94204954|NCT05580003|322545963|FG019|Part 6 Period 2 (Day 1)|Other|0|||
94204955|NCT05580003|322545964|FG020|Part 6 Period 2 (Day 1)|Other|0|||
94204956|NCT05580003|322545965|FG021|Part 6 Period 2 (Day 1)|Other|0|||
94204957|NCT05580003|322545966|FG022|Part 6 Period 2 (Day 1)|Other|0|||
94204958|NCT05580003|322545967|FG023|Part 6 Period 2 (Day 1)|Other|0|||
94204959|NCT05580003|322545968|FG024|Part 6 Period 2 (Day 1)|Other|1|||
94204960|NCT05580003|322545969|FG025|Part 6 Period 2 (Day 1)|Other|0|||
94204961|NCT05580003|322545970|FG026|Part 6 Period 2 (Day 1)|Other|0|||
94204962|NCT05580003|322545971|FG027|Part 6 Period 2 (Day 1)|Other|0|||
94204963|NCT01400958|322545972|FG000|Overall Study|Physician Decision|0|||
94204964|NCT01400958|322545973|FG001|Overall Study|Physician Decision|1|||
94204965|NCT01400958|322545972|FG000|Overall Study|Withdrawal by Subject|0|||
94204966|NCT01400958|322545973|FG001|Overall Study|Withdrawal by Subject|1|||
94204967|NCT01400958|322545972|FG000|Overall Study|Adverse Event|1|||
94204968|NCT01400958|322545973|FG001|Overall Study|Adverse Event|0|||
94204969|NCT00309166|322545974|FG000|Overall Study|Adverse event, non-fatal|1|||
94204970|NCT00309166|322545975|FG001|Overall Study|Adverse event, non-fatal|0|||
94204971|NCT00309166|322545974|FG000|Overall Study|Withdrawal by Subject|4|||
94204972|NCT00309166|322545975|FG001|Overall Study|Withdrawal by Subject|3|||
94204973|NCT00701701|322545978|FG000|Overall Study|Withdrawal by Subject|0|||
94204974|NCT00701701|322545979|FG001|Overall Study|Withdrawal by Subject|1|||
94204975|NCT00701701|322545978|FG000|Overall Study|Adverse Event|0|||
94204976|NCT00701701|322545979|FG001|Overall Study|Adverse Event|1|||
94204977|NCT02598661|322545980|FG000|Overall Study|Death|27|||
94204978|NCT02598661|322545981|FG001|Overall Study|Death|34|||
94204979|NCT02598661|322545982|FG002|Overall Study|Death|14|||
94204980|NCT02598661|322545983|FG003|Overall Study|Death|1|||
94204981|NCT02598661|322545984|FG004|Overall Study|Death|0|||
94204982|NCT02598661|322545980|FG000|Overall Study|Lost to Follow-up|2|||
94204983|NCT02598661|322545981|FG001|Overall Study|Lost to Follow-up|3|||
94204984|NCT02598661|322545982|FG002|Overall Study|Lost to Follow-up|2|||
94204985|NCT02598661|322545983|FG003|Overall Study|Lost to Follow-up|0|||
94204986|NCT02598661|322545984|FG004|Overall Study|Lost to Follow-up|0|||
94204987|NCT02598661|322545980|FG000|Overall Study|Withdrawal by Subject|13|||
94204988|NCT02598661|322545981|FG001|Overall Study|Withdrawal by Subject|24|||
94204989|NCT02598661|322545982|FG002|Overall Study|Withdrawal by Subject|14|||
94204990|NCT02598661|322545983|FG003|Overall Study|Withdrawal by Subject|1|||
94204991|NCT02598661|322545984|FG004|Overall Study|Withdrawal by Subject|1|||
94204992|NCT02598661|322545980|FG000|Overall Study|Adverse Event|0|||
94204993|NCT02598661|322545981|FG001|Overall Study|Adverse Event|0|||
94204994|NCT02598661|322545982|FG002|Overall Study|Adverse Event|1|||
94204995|NCT02598661|322545983|FG003|Overall Study|Adverse Event|0|||
94467659|NCT01004432|323502375|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
94743649|NCT04271475|324517054|FG002|DB Period: Day 1 up to EODBT|Death|0|||
94280006|NCT01192022|322815953|FG000|Overall Study|Patient too sick from chemotherapy|0|||
94280007|NCT01192022|322815954|FG001|Overall Study|Patient too sick from chemotherapy|1|||
94280008|NCT01192022|322815955|FG002|Overall Study|Patient too sick from chemotherapy|0|||
94280009|NCT01192022|322815956|FG003|Overall Study|Patient too sick from chemotherapy|0|||
94280010|NCT01192022|322815957|FG004|Overall Study|Patient too sick from chemotherapy|0|||
94280011|NCT01192022|322815953|FG000|Overall Study|Patient needed surgery|0|||
94280012|NCT01192022|322815954|FG001|Overall Study|Patient needed surgery|1|||
94280013|NCT01192022|322815955|FG002|Overall Study|Patient needed surgery|0|||
94280014|NCT01192022|322815956|FG003|Overall Study|Patient needed surgery|0|||
94280015|NCT01192022|322815957|FG004|Overall Study|Patient needed surgery|0|||
94280016|NCT01192022|322815953|FG000|Overall Study|Parents did not allow all follow up|0|||
94280017|NCT01192022|322815954|FG001|Overall Study|Parents did not allow all follow up|0|||
94280018|NCT01192022|322815955|FG002|Overall Study|Parents did not allow all follow up|0|||
94280019|NCT01192022|322815956|FG003|Overall Study|Parents did not allow all follow up|1|||
94280020|NCT01192022|322815957|FG004|Overall Study|Parents did not allow all follow up|0|||
94280021|NCT00925015|322815961|FG000|Overall Study|Adverse Event|1|||
94280022|NCT00925015|322815962|FG001|Overall Study|Adverse Event|2|||
94280023|NCT00925015|322815963|FG002|Overall Study|Adverse Event|1|||
94280024|NCT00925015|322815961|FG000|Overall Study|Physician Decision|0|||
94280025|NCT00925015|322815962|FG001|Overall Study|Physician Decision|1|||
94280026|NCT00925015|322815963|FG002|Overall Study|Physician Decision|0|||
94280027|NCT00925015|322815961|FG000|Overall Study|Progressive Disease|7|||
94280028|NCT00925015|322815962|FG001|Overall Study|Progressive Disease|3|||
94280029|NCT00925015|322815963|FG002|Overall Study|Progressive Disease|4|||
94280030|NCT00925015|322815961|FG000|Overall Study|Withdrawal by Subject|0|||
94280031|NCT00925015|322815962|FG001|Overall Study|Withdrawal by Subject|0|||
94280032|NCT00925015|322815963|FG002|Overall Study|Withdrawal by Subject|1|||
94280033|NCT00713700|322815964|FG000|Overall Study|Lost to Follow-up|3|||
94280034|NCT00713700|322815964|FG000|Overall Study|Withdrawal by Subject|1|||
94280035|NCT00586495|322815978|FG000|Treatment Period|Adverse Event|11|||
94280036|NCT00586495|322815978|FG000|Treatment Period|Death|1|||
94280037|NCT00586495|322815978|FG000|Treatment Period|Protocol Violation|1|||
94280038|NCT00586495|322815978|FG000|Treatment Period|Withdrawal by Subject|1|||
94280039|NCT00586495|322815978|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
94280040|NCT00586495|322815978|FG000|Treatment Period|Switch to commercial drug|10|||
94280041|NCT00586495|322815978|FG000|Follow-up|Death|40|||
94280042|NCT00586495|322815978|FG000|Follow-up|Lost to Follow-up|1|||
94280043|NCT00586495|322815978|FG000|Follow-up|Withdrawal by Subject|4|||
94280044|NCT00586495|322815978|FG000|Follow-up|Protocol driven decision point|37|||
94280045|NCT00586495|322815978|FG000|Follow-up|Switch to commercial drug|10|||
94280046|NCT00906087|322815985|FG000|Initial Washout|Withdrawal by Subject|1|||
94280047|NCT00906087|322815985|FG000|Initial Washout|Physician Decision|1|||
94280048|NCT02898259|322815986|FG000|Overall Study|Adverse Event|0|||
94280049|NCT02898259|322815987|FG001|Overall Study|Adverse Event|0|||
94280050|NCT02898259|322815988|FG002|Overall Study|Adverse Event|1|||
94280051|NCT02898259|322815989|FG003|Overall Study|Adverse Event|0|||
94280052|NCT02898259|322815990|FG004|Overall Study|Adverse Event|0|||
94280053|NCT02898259|322815986|FG000|Overall Study|Lack of Efficacy|1|||
94280054|NCT02898259|322815987|FG001|Overall Study|Lack of Efficacy|1|||
94280055|NCT02898259|322815988|FG002|Overall Study|Lack of Efficacy|3|||
94280056|NCT02898259|322815989|FG003|Overall Study|Lack of Efficacy|0|||
94280057|NCT02898259|322815990|FG004|Overall Study|Lack of Efficacy|0|||
94280058|NCT02898259|322815986|FG000|Overall Study|Lost to Follow-up|0|||
94280059|NCT02898259|322815987|FG001|Overall Study|Lost to Follow-up|0|||
94280060|NCT02898259|322815988|FG002|Overall Study|Lost to Follow-up|1|||
94280061|NCT02898259|322815989|FG003|Overall Study|Lost to Follow-up|0|||
94280062|NCT02898259|322815990|FG004|Overall Study|Lost to Follow-up|0|||
94280063|NCT02898259|322815986|FG000|Overall Study|Transformation before study began|0|||
94280064|NCT02898259|322815987|FG001|Overall Study|Transformation before study began|0|||
94280065|NCT02898259|322815988|FG002|Overall Study|Transformation before study began|0|||
94280066|NCT02898259|322815989|FG003|Overall Study|Transformation before study began|1|||
94280067|NCT02898259|322815990|FG004|Overall Study|Transformation before study began|0|||
94280068|NCT01827670|322815991|FG000|Overall Study|Withdrawal of Consent|3|||
94280069|NCT01827670|322815992|FG001|Overall Study|Withdrawal of Consent|2|||
94280070|NCT01827670|322815991|FG000|Overall Study|Lost to Follow-up|0|||
94280071|NCT01827670|322815992|FG001|Overall Study|Lost to Follow-up|1|||
94280072|NCT02980224|322815997|FG000|Overall Study|Adverse Event|4|||
94743650|NCT04271475|324517055|FG003|DB Period: Day 1 up to EODBT|Death|0|||
94280073|NCT02980224|322815998|FG001|Overall Study|Adverse Event|1|||
94280074|NCT02980224|322815997|FG000|Overall Study|Withdrawal by Subject|0|||
94280075|NCT02980224|322815998|FG001|Overall Study|Withdrawal by Subject|2|||
94280076|NCT03594227|322816004|FG000|Overall Study|Adverse Event|2|||
94280077|NCT03594227|322816005|FG001|Overall Study|Adverse Event|1|||
94280078|NCT03594227|322816006|FG002|Overall Study|Adverse Event|0|||
94743651|NCT04271475|324517052|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
94280079|NCT03594227|322816007|FG003|Overall Study|Adverse Event|2|||
94280080|NCT03594227|322816004|FG000|Overall Study|Lost to Follow-up|1|||
94280081|NCT03594227|322816005|FG001|Overall Study|Lost to Follow-up|1|||
94280082|NCT03594227|322816006|FG002|Overall Study|Lost to Follow-up|1|||
94280083|NCT03594227|322816007|FG003|Overall Study|Lost to Follow-up|0|||
94280084|NCT03594227|322816004|FG000|Overall Study|Withdrawal by Subject|1|||
94280085|NCT03594227|322816005|FG001|Overall Study|Withdrawal by Subject|1|||
94280086|NCT03594227|322816006|FG002|Overall Study|Withdrawal by Subject|1|||
94280087|NCT03594227|322816007|FG003|Overall Study|Withdrawal by Subject|1|||
94280088|NCT03594227|322816004|FG000|Overall Study|Pregnancy|0|||
94280089|NCT03594227|322816005|FG001|Overall Study|Pregnancy|1|||
94280090|NCT03594227|322816006|FG002|Overall Study|Pregnancy|0|||
94280091|NCT03594227|322816007|FG003|Overall Study|Pregnancy|0|||
94280092|NCT03594227|322816004|FG000|Overall Study|Sponsor Decision|0|||
94280093|NCT03594227|322816005|FG001|Overall Study|Sponsor Decision|0|||
94280094|NCT03594227|322816006|FG002|Overall Study|Sponsor Decision|0|||
94280095|NCT03594227|322816007|FG003|Overall Study|Sponsor Decision|1|||
94280096|NCT03594227|322816004|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
94280097|NCT03594227|322816005|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
94280098|NCT03594227|322816006|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
94280099|NCT03594227|322816007|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
94280100|NCT00109707|322816012|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
94280101|NCT00109707|322816013|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
94280102|NCT00109707|322816014|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
94280103|NCT00109707|322816012|FG000|Overall Study|Abnormal laboratory values|1|||
94280104|NCT00109707|322816013|FG001|Overall Study|Abnormal laboratory values|0|||
94280105|NCT00109707|322816014|FG002|Overall Study|Abnormal laboratory values|0|||
94280106|NCT00109707|322816012|FG000|Overall Study|Administrative problems|2|||
94280107|NCT00109707|322816013|FG001|Overall Study|Administrative problems|0|||
94280108|NCT00109707|322816014|FG002|Overall Study|Administrative problems|1|||
94280109|NCT00109707|322816012|FG000|Overall Study|Adverse Event|10|||
94280110|NCT00109707|322816013|FG001|Overall Study|Adverse Event|2|||
94280111|NCT00109707|322816014|FG002|Overall Study|Adverse Event|3|||
94280112|NCT00109707|322816012|FG000|Overall Study|Death|4|||
94280113|NCT00109707|322816013|FG001|Overall Study|Death|0|||
94280114|NCT00109707|322816014|FG002|Overall Study|Death|0|||
94280115|NCT00109707|322816012|FG000|Overall Study|Disease progression|12|||
94280116|NCT00109707|322816013|FG001|Overall Study|Disease progression|4|||
94280117|NCT00109707|322816014|FG002|Overall Study|Disease progression|3|||
94280118|NCT00109707|322816012|FG000|Overall Study|Lost to Follow-up|3|||
94280119|NCT00109707|322816013|FG001|Overall Study|Lost to Follow-up|0|||
94280120|NCT00109707|322816014|FG002|Overall Study|Lost to Follow-up|0|||
94280121|NCT00109707|322816012|FG000|Overall Study|Protocol Violation|1|||
94280122|NCT00109707|322816013|FG001|Overall Study|Protocol Violation|0|||
94280123|NCT00109707|322816014|FG002|Overall Study|Protocol Violation|0|||
94280124|NCT00109707|322816012|FG000|Overall Study|Patient withdrew consent|6|||
94280125|NCT00109707|322816013|FG001|Overall Study|Patient withdrew consent|1|||
94280126|NCT00109707|322816014|FG002|Overall Study|Patient withdrew consent|0|||
94280127|NCT02443883|322816015|FG000|Overall Study|Adverse Event|0|||
94280128|NCT02443883|322816016|FG001|Overall Study|Adverse Event|1|||
94280129|NCT02443883|322816017|FG002|Overall Study|Adverse Event|0|||
94280130|NCT02443883|322816018|FG003|Overall Study|Adverse Event|0|||
94280131|NCT02443883|322816015|FG000|Overall Study|Lost to Follow-up|3|||
94280132|NCT02443883|322816016|FG001|Overall Study|Lost to Follow-up|2|||
94280133|NCT02443883|322816017|FG002|Overall Study|Lost to Follow-up|1|||
94280134|NCT02443883|322816018|FG003|Overall Study|Lost to Follow-up|0|||
94280135|NCT02443883|322816015|FG000|Overall Study|Physician Decision|1|||
94280136|NCT02443883|322816016|FG001|Overall Study|Physician Decision|1|||
94280137|NCT02443883|322816017|FG002|Overall Study|Physician Decision|0|||
94280138|NCT02443883|322816018|FG003|Overall Study|Physician Decision|3|||
94280139|NCT02443883|322816015|FG000|Overall Study|Withdrawal by Subject|1|||
94280140|NCT02443883|322816016|FG001|Overall Study|Withdrawal by Subject|0|||
94280141|NCT02443883|322816017|FG002|Overall Study|Withdrawal by Subject|0|||
94280142|NCT02443883|322816018|FG003|Overall Study|Withdrawal by Subject|2|||
94280143|NCT02443883|322816015|FG000|Overall Study|Randomized, but never treated|1|||
94280144|NCT02443883|322816016|FG001|Overall Study|Randomized, but never treated|0|||
94280145|NCT02443883|322816017|FG002|Overall Study|Randomized, but never treated|0|||
94280146|NCT02443883|322816018|FG003|Overall Study|Randomized, but never treated|0|||
94280147|NCT01929408|322816025|FG000|Overall Study|received HCT as initial treatment|8|||
94280148|NCT01568593|322816026|FG000|Overall Study|Lack of Efficacy|4|||
94371052|NCT01246986|323146726|FG005|Overall Study|Lost to Follow-up|1|||
94280149|NCT01568593|322816027|FG001|Overall Study|Lack of Efficacy|1|||
94280150|NCT01568593|322816026|FG000|Overall Study|Adverse Event|3|||
94280151|NCT01568593|322816027|FG001|Overall Study|Adverse Event|2|||
94280152|NCT00506883|322816030|FG000|Overall Study|Lost to Follow-up|1|||
94280153|NCT00506883|322816031|FG001|Overall Study|Lost to Follow-up|1|||
94280154|NCT00506883|322816032|FG002|Overall Study|Lost to Follow-up|1|||
94371053|NCT01246986|323146727|FG006|Overall Study|Lost to Follow-up|0|||
94743652|NCT04271475|324517053|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
94743653|NCT04271475|324517054|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
94743654|NCT04271475|324517055|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
94743655|NCT04271475|324517052|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
94743656|NCT04271475|324517053|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
94743657|NCT04271475|324517054|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
94743658|NCT04271475|324517055|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
94743659|NCT04271475|324517052|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
94743660|NCT04271475|324517053|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
94743661|NCT04271475|324517054|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
94743662|NCT04271475|324517055|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
94743663|NCT04271475|324517052|FG000|DB Period: Day 1 up to EODBT|Other|8|||
94743664|NCT04271475|324517053|FG001|DB Period: Day 1 up to EODBT|Other|5|||
94743665|NCT04271475|324517054|FG002|DB Period: Day 1 up to EODBT|Other|0|||
94743666|NCT04271475|324517055|FG003|DB Period: Day 1 up to EODBT|Other|0|||
94743667|NCT04271475|324517052|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
94743668|NCT04271475|324517053|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
94743669|NCT04271475|324517054|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
94743670|NCT04271475|324517055|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
94743671|NCT04271475|324517052|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
94743672|NCT04271475|324517053|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
94743673|NCT04271475|324517054|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
94743674|NCT04271475|324517055|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
94743675|NCT05875701|324517056|FG000|Overall Study|Lost to Follow-up|2|||
94743676|NCT05875701|324517057|FG001|Overall Study|Lost to Follow-up|0|||
94743677|NCT05875701|324517056|FG000|Overall Study|Withdrawal by Subject|1|||
94743678|NCT05875701|324517057|FG001|Overall Study|Withdrawal by Subject|1|||
94743679|NCT06048367|324517058|FG000|Overall Study|Withdrawal by Subject|0|||
94743680|NCT06048367|324517059|FG001|Overall Study|Withdrawal by Subject|1|||
94743681|NCT06048367|324517060|FG002|Overall Study|Withdrawal by Subject|0|||
94743682|NCT06048367|324517061|FG003|Overall Study|Withdrawal by Subject|0|||
94743683|NCT06048367|324517062|FG004|Overall Study|Withdrawal by Subject|0|||
94743684|NCT06048367|324517058|FG000|Overall Study|Withdrawal by Subject|0|||
94743685|NCT06048367|324517059|FG001|Overall Study|Withdrawal by Subject|0|||
94743686|NCT06048367|324517060|FG002|Overall Study|Withdrawal by Subject|1|||
94743687|NCT06048367|324517061|FG003|Overall Study|Withdrawal by Subject|0|||
94743688|NCT06048367|324517062|FG004|Overall Study|Withdrawal by Subject|0|||
94743689|NCT06048367|324517058|FG000|Overall Study|Withdrawal by Subject|0|||
94743690|NCT06048367|324517059|FG001|Overall Study|Withdrawal by Subject|0|||
94743691|NCT06048367|324517060|FG002|Overall Study|Withdrawal by Subject|0|||
94743692|NCT06048367|324517061|FG003|Overall Study|Withdrawal by Subject|1|||
94743693|NCT06048367|324517062|FG004|Overall Study|Withdrawal by Subject|0|||
94743694|NCT06048367|324517058|FG000|Overall Study|Withdrawal by Subject|0|||
94743695|NCT06048367|324517059|FG001|Overall Study|Withdrawal by Subject|0|||
94204996|NCT02598661|322545984|FG004|Overall Study|Adverse Event|0|||
94204997|NCT02598661|322545980|FG000|Overall Study|Randomized, Never Treated|0|||
94204998|NCT02598661|322545981|FG001|Overall Study|Randomized, Never Treated|0|||
94204999|NCT02598661|322545982|FG002|Overall Study|Randomized, Never Treated|0|||
94205000|NCT02598661|322545983|FG003|Overall Study|Randomized, Never Treated|0|||
94205001|NCT02598661|322545984|FG004|Overall Study|Randomized, Never Treated|1|||
94205002|NCT01371994|322545990|FG000|Overall Study|Adverse Event|3|||
94205003|NCT01371994|322545991|FG001|Overall Study|Adverse Event|6|||
94205004|NCT01371994|322545990|FG000|Overall Study|Lack of Efficacy|3|||
94205005|NCT01371994|322545991|FG001|Overall Study|Lack of Efficacy|0|||
94205006|NCT01371994|322545990|FG000|Overall Study|Withdrawal by Subject|13|||
94205007|NCT01371994|322545991|FG001|Overall Study|Withdrawal by Subject|7|||
94205008|NCT01371994|322545990|FG000|Overall Study|Lost to Follow-up|1|||
94205009|NCT01371994|322545991|FG001|Overall Study|Lost to Follow-up|1|||
94205010|NCT01371994|322545990|FG000|Overall Study|Protocol Violation|24|||
94205011|NCT01371994|322545991|FG001|Overall Study|Protocol Violation|17|||
94205012|NCT01371994|322545990|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
94205013|NCT01371994|322545991|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
94205014|NCT01371994|322545990|FG000|Overall Study|Physician Decision|1|||
94205015|NCT01371994|322545991|FG001|Overall Study|Physician Decision|1|||
94205016|NCT01371994|322545990|FG000|Overall Study|Miscellaneous Reasons|6|||
94205017|NCT01371994|322545991|FG001|Overall Study|Miscellaneous Reasons|4|||
94205018|NCT00319020|322545994|FG000|Overall Study|Death|2|||
94205019|NCT00319020|322545995|FG001|Overall Study|Death|2|||
94205020|NCT00319020|322545994|FG000|Overall Study|Withdrawal by Subject|4|||
94205021|NCT00319020|322545995|FG001|Overall Study|Withdrawal by Subject|1|||
94205022|NCT00319020|322545994|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
94371054|NCT01246986|323146721|FG000|Overall Study|Withdrawal by Subject|3|||
94743696|NCT06048367|324517060|FG002|Overall Study|Withdrawal by Subject|0|||
94743697|NCT06048367|324517061|FG003|Overall Study|Withdrawal by Subject|1|||
94743698|NCT06048367|324517062|FG004|Overall Study|Withdrawal by Subject|0|||
94743699|NCT06250738|324517063|FG000|Overall Study|Lost to Follow-up|1|||
94743700|NCT04757753|324517065|FG000|Overall Study|Lost to Follow-up|7|||
94743701|NCT04757753|324517066|FG001|Overall Study|Lost to Follow-up|7|||
94743702|NCT04757753|324517065|FG000|Overall Study|Withdrawal by Subject|0|||
94280155|NCT00506883|322816030|FG000|Overall Study|Withdrawal by Subject|1|||
94280156|NCT00506883|322816031|FG001|Overall Study|Withdrawal by Subject|0|||
94280157|NCT00506883|322816032|FG002|Overall Study|Withdrawal by Subject|1|||
94280158|NCT00506883|322816030|FG000|Overall Study|Lack of Efficacy|0|||
94280159|NCT00506883|322816031|FG001|Overall Study|Lack of Efficacy|1|||
94280160|NCT00506883|322816032|FG002|Overall Study|Lack of Efficacy|1|||
94280161|NCT00506883|322816030|FG000|Overall Study|Other|5|||
94280162|NCT00506883|322816031|FG001|Overall Study|Other|1|||
94280163|NCT00506883|322816032|FG002|Overall Study|Other|1|||
94280164|NCT02109484|322816033|FG000|Overall Study|Lost to Follow-up|0|||
94280165|NCT02109484|322816034|FG001|Overall Study|Lost to Follow-up|0|||
94280166|NCT02109484|322816035|FG002|Overall Study|Lost to Follow-up|0|||
94280167|NCT02109484|322816036|FG003|Overall Study|Lost to Follow-up|1|||
94280168|NCT02109484|322816037|FG004|Overall Study|Lost to Follow-up|1|||
94280169|NCT02109484|322816038|FG005|Overall Study|Lost to Follow-up|0|||
94280170|NCT02109484|322816039|FG006|Overall Study|Lost to Follow-up|1|||
94280171|NCT02109484|322816040|FG007|Overall Study|Lost to Follow-up|0|||
94280172|NCT02109484|322816033|FG000|Overall Study|Withdrawal by Subject|0|||
94280173|NCT02109484|322816034|FG001|Overall Study|Withdrawal by Subject|0|||
94280174|NCT02109484|322816035|FG002|Overall Study|Withdrawal by Subject|0|||
94280175|NCT02109484|322816036|FG003|Overall Study|Withdrawal by Subject|0|||
94280176|NCT02109484|322816037|FG004|Overall Study|Withdrawal by Subject|1|||
94280177|NCT02109484|322816038|FG005|Overall Study|Withdrawal by Subject|1|||
94280178|NCT02109484|322816039|FG006|Overall Study|Withdrawal by Subject|1|||
94280179|NCT02109484|322816040|FG007|Overall Study|Withdrawal by Subject|0|||
94280180|NCT02109484|322816033|FG000|Overall Study|Physician Decision|0|||
94280181|NCT02109484|322816034|FG001|Overall Study|Physician Decision|0|||
94280182|NCT02109484|322816035|FG002|Overall Study|Physician Decision|0|||
94280183|NCT02109484|322816036|FG003|Overall Study|Physician Decision|0|||
94280184|NCT02109484|322816037|FG004|Overall Study|Physician Decision|2|||
94280185|NCT02109484|322816038|FG005|Overall Study|Physician Decision|0|||
94280186|NCT02109484|322816039|FG006|Overall Study|Physician Decision|0|||
94280187|NCT02109484|322816040|FG007|Overall Study|Physician Decision|0|||
94280188|NCT02109484|322816033|FG000|Overall Study|Death|0|||
94280189|NCT02109484|322816034|FG001|Overall Study|Death|0|||
94280190|NCT02109484|322816035|FG002|Overall Study|Death|0|||
94280191|NCT02109484|322816036|FG003|Overall Study|Death|0|||
94280192|NCT02109484|322816037|FG004|Overall Study|Death|0|||
94280193|NCT02109484|322816038|FG005|Overall Study|Death|0|||
94280194|NCT02109484|322816039|FG006|Overall Study|Death|0|||
94280195|NCT02109484|322816040|FG007|Overall Study|Death|2|||
94280196|NCT02109484|322816033|FG000|Overall Study|Moved away from study area|0|||
94280197|NCT02109484|322816034|FG001|Overall Study|Moved away from study area|0|||
94280198|NCT02109484|322816035|FG002|Overall Study|Moved away from study area|0|||
94280199|NCT02109484|322816036|FG003|Overall Study|Moved away from study area|0|||
94280200|NCT02109484|322816037|FG004|Overall Study|Moved away from study area|0|||
94280201|NCT02109484|322816038|FG005|Overall Study|Moved away from study area|0|||
94280202|NCT02109484|322816039|FG006|Overall Study|Moved away from study area|1|||
94280203|NCT02109484|322816040|FG007|Overall Study|Moved away from study area|1|||
94280204|NCT00143455|322816041|FG000|Cohort 1|Adverse Event|8|||
94280205|NCT00143455|322816042|FG001|Cohort 1|Adverse Event|4|||
94280206|NCT00143455|322816043|FG002|Cohort 1|Adverse Event|0|||
94280207|NCT00143455|322816044|FG003|Cohort 1|Adverse Event|0|||
94280208|NCT00143455|322816041|FG000|Cohort 1|Death|5|||
94280209|NCT00143455|322816042|FG001|Cohort 1|Death|2|||
94280210|NCT00143455|322816043|FG002|Cohort 1|Death|0|||
94280211|NCT00143455|322816044|FG003|Cohort 1|Death|0|||
94280212|NCT00143455|322816041|FG000|Cohort 1|Progressive Disease|0|||
94280213|NCT00143455|322816042|FG001|Cohort 1|Progressive Disease|6|||
94280214|NCT00143455|322816043|FG002|Cohort 1|Progressive Disease|0|||
94280215|NCT00143455|322816044|FG003|Cohort 1|Progressive Disease|0|||
94280216|NCT00143455|322816041|FG000|Cohort 1|Withdrawal by Subject|1|||
94743703|NCT04757753|324517066|FG001|Overall Study|Withdrawal by Subject|3|||
94280217|NCT00143455|322816042|FG001|Cohort 1|Withdrawal by Subject|4|||
94280218|NCT00143455|322816043|FG002|Cohort 1|Withdrawal by Subject|0|||
94280219|NCT00143455|322816044|FG003|Cohort 1|Withdrawal by Subject|0|||
94280220|NCT00143455|322816041|FG000|Cohort 1|Randomized But Not Treated|0|||
94280221|NCT00143455|322816042|FG001|Cohort 1|Randomized But Not Treated|1|||
94743704|NCT04757753|324517065|FG000|Overall Study|Endodontic treatment failure|1|||
94743705|NCT04757753|324517066|FG001|Overall Study|Endodontic treatment failure|2|||
94280222|NCT00143455|322816043|FG002|Cohort 1|Randomized But Not Treated|0|||
94280223|NCT00143455|322816044|FG003|Cohort 1|Randomized But Not Treated|0|||
94280224|NCT00143455|322816041|FG000|Cohort 2|Adverse Event|0|||
94280225|NCT00143455|322816042|FG001|Cohort 2|Adverse Event|0|||
94280226|NCT00143455|322816043|FG002|Cohort 2|Adverse Event|42|||
94280227|NCT00143455|322816044|FG003|Cohort 2|Adverse Event|30|||
94280228|NCT00143455|322816041|FG000|Cohort 2|No Longer Required Study Treatment|0|||
94280229|NCT00143455|322816042|FG001|Cohort 2|No Longer Required Study Treatment|0|||
94280230|NCT00143455|322816043|FG002|Cohort 2|No Longer Required Study Treatment|1|||
94280231|NCT00143455|322816044|FG003|Cohort 2|No Longer Required Study Treatment|0|||
94280232|NCT00143455|322816041|FG000|Cohort 2|Protocol Violation|0|||
94280233|NCT00143455|322816042|FG001|Cohort 2|Protocol Violation|0|||
94280234|NCT00143455|322816043|FG002|Cohort 2|Protocol Violation|1|||
94280235|NCT00143455|322816044|FG003|Cohort 2|Protocol Violation|1|||
94280236|NCT00143455|322816041|FG000|Cohort 2|Lost to Follow-up|0|||
94280237|NCT00143455|322816042|FG001|Cohort 2|Lost to Follow-up|0|||
94280238|NCT00143455|322816043|FG002|Cohort 2|Lost to Follow-up|1|||
94280239|NCT00143455|322816044|FG003|Cohort 2|Lost to Follow-up|4|||
94280240|NCT00143455|322816041|FG000|Cohort 2|Death|0|||
94280241|NCT00143455|322816042|FG001|Cohort 2|Death|0|||
94280242|NCT00143455|322816043|FG002|Cohort 2|Death|20|||
94280243|NCT00143455|322816044|FG003|Cohort 2|Death|12|||
94280244|NCT00143455|322816041|FG000|Cohort 2|Progressive Disease|0|||
94280245|NCT00143455|322816042|FG001|Cohort 2|Progressive Disease|0|||
94280246|NCT00143455|322816043|FG002|Cohort 2|Progressive Disease|20|||
94280247|NCT00143455|322816044|FG003|Cohort 2|Progressive Disease|27|||
94280248|NCT00143455|322816041|FG000|Cohort 2|Withdrawal by Subject|0|||
94280249|NCT00143455|322816042|FG001|Cohort 2|Withdrawal by Subject|0|||
94280250|NCT00143455|322816043|FG002|Cohort 2|Withdrawal by Subject|13|||
94280251|NCT00143455|322816044|FG003|Cohort 2|Withdrawal by Subject|12|||
94280252|NCT00143455|322816041|FG000|Cohort 2|Other|0|||
94280253|NCT00143455|322816042|FG001|Cohort 2|Other|0|||
94280254|NCT00143455|322816043|FG002|Cohort 2|Other|7|||
94280255|NCT00143455|322816044|FG003|Cohort 2|Other|6|||
94280256|NCT00143455|322816041|FG000|Cohort 2|Randomized But Not Treated|0|||
94280257|NCT00143455|322816042|FG001|Cohort 2|Randomized But Not Treated|0|||
94280258|NCT00143455|322816043|FG002|Cohort 2|Randomized But Not Treated|1|||
94280259|NCT00143455|322816044|FG003|Cohort 2|Randomized But Not Treated|1|||
94280260|NCT01325428|322816045|FG000|Part A|Progressive disease according to RECIST|9|||
94280261|NCT01325428|322816045|FG000|Part A|Clinical signs, symptoms of progression|2|||
94280262|NCT01325428|322816045|FG000|Part A|Other adverse event|1|||
94280263|NCT01325428|322816045|FG000|Part A|Refused continue taking trial medication|2|||
94280264|NCT01325428|322816045|FG000|Part A|Other reason not defined above|2|||
94280265|NCT01325428|322816045|FG000|Part B|Refused continue taking trial medication|2|||
94280266|NCT01325428|322816045|FG000|Part B|Other reason not defined above|1|||
94280267|NCT03713944|322816050|FG000|Study Treatment|Patient non-compliance|1|||
94280268|NCT03713944|322816050|FG000|Study Treatment|Alternative Cancer Therapy|3|||
94280269|NCT03713944|322816050|FG000|Study Treatment|Disease Progression|18|||
94280270|NCT03713944|322816050|FG000|Study Treatment|AE/Side Effects/Complications|2|||
94280271|NCT03713944|322816050|FG000|Study Treatment|Death|2|||
94280272|NCT03713944|322816050|FG000|Study Treatment|Withdrawal by Subject|1|||
94280273|NCT03713944|322816050|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
94280274|NCT03713944|322816050|FG000|Study Treatment|Symptomatic Deterioration|2|||
94280275|NCT03713944|322816050|FG000|Follow up|Withdrawal by Subject|2|||
94280276|NCT03713944|322816050|FG000|Follow up|Death|11|||
94280277|NCT03713944|322816050|FG000|Follow up|Study Terminated|3|||
94280278|NCT00784654|322816069|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
94280279|NCT00784654|322816070|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
94280280|NCT00784654|322816071|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
94280281|NCT00784654|322816069|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
94280282|NCT00784654|322816070|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
94280283|NCT00784654|322816071|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
94280284|NCT00784654|322816069|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
94280285|NCT00784654|322816070|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
94280286|NCT00784654|322816071|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
94280287|NCT00784654|322816069|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
94280288|NCT00784654|322816070|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
94280289|NCT00784654|322816071|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
94280290|NCT00784654|322816069|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
94280291|NCT00784654|322816070|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
94280292|NCT00784654|322816071|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
94280293|NCT00784654|322816069|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
94280294|NCT00784654|322816070|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
94280295|NCT00784654|322816071|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
94280296|NCT00784654|322816069|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
94280297|NCT00784654|322816070|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
94371055|NCT01246986|323146722|FG001|Overall Study|Withdrawal by Subject|4|||
94280298|NCT00784654|322816071|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
94371056|NCT01246986|323146723|FG002|Overall Study|Withdrawal by Subject|3|||
94205023|NCT00319020|322545995|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
94205024|NCT00319020|322545994|FG000|Overall Study|Administrative reason|0|||
94205025|NCT00319020|322545995|FG001|Overall Study|Administrative reason|5|||
94205026|NCT00319020|322545994|FG000|Overall Study|Disease progression|0|||
94205027|NCT00319020|322545995|FG001|Overall Study|Disease progression|2|||
94205028|NCT00319020|322545994|FG000|Overall Study|Transplant|0|||
94205029|NCT00319020|322545995|FG001|Overall Study|Transplant|1|||
94205030|NCT00319020|322545994|FG000|Overall Study|Treatment failure|0|||
94205031|NCT00319020|322545995|FG001|Overall Study|Treatment failure|1|||
94205032|NCT00319020|322545994|FG000|Overall Study|Adverse Event|0|||
94205033|NCT00319020|322545995|FG001|Overall Study|Adverse Event|1|||
94205034|NCT05325294|322546002|FG000|Overall Study|Adverse Event|3|||
94205035|NCT05325294|322546003|FG001|Overall Study|Adverse Event|3|||
94205036|NCT05325294|322546002|FG000|Overall Study|Physician Decision|0|||
94205037|NCT05325294|322546003|FG001|Overall Study|Physician Decision|1|||
94205038|NCT05325294|322546002|FG000|Overall Study|Withdrawal by Subject|0|||
94205039|NCT05325294|322546003|FG001|Overall Study|Withdrawal by Subject|3|||
94205040|NCT05325294|322546002|FG000|Overall Study|Lost to Follow-up|1|||
94205041|NCT05325294|322546003|FG001|Overall Study|Lost to Follow-up|0|||
94205042|NCT05325294|322546002|FG000|Overall Study|Sponsor Request|0|||
94205043|NCT05325294|322546003|FG001|Overall Study|Sponsor Request|2|||
94205044|NCT04551066|322546004|FG000|Overall Study|Death|5|||
94205045|NCT04551066|322546005|FG001|Overall Study|Death|3|||
94205046|NCT04551066|322546004|FG000|Overall Study|Lost to Follow-up|1|||
94205047|NCT04551066|322546005|FG001|Overall Study|Lost to Follow-up|0|||
94205048|NCT04551066|322546004|FG000|Overall Study|Sponsor Decision|103|||
94205049|NCT04551066|322546005|FG001|Overall Study|Sponsor Decision|117|||
94205050|NCT04551066|322546004|FG000|Overall Study|Withdrawal by Subject|8|||
94205051|NCT04551066|322546005|FG001|Overall Study|Withdrawal by Subject|2|||
94205052|NCT04551066|322546004|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
94205053|NCT04551066|322546005|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
94205054|NCT04551066|322546004|FG000|Overall Study|Adverse Event|2|||
94205055|NCT04551066|322546005|FG001|Overall Study|Adverse Event|0|||
94205056|NCT04551066|322546004|FG000|Overall Study|Physician Decision|2|||
94205057|NCT04551066|322546005|FG001|Overall Study|Physician Decision|0|||
94205058|NCT04551066|322546004|FG000|Overall Study|Protocol Violation|1|||
94205059|NCT04551066|322546005|FG001|Overall Study|Protocol Violation|0|||
94205060|NCT04551066|322546004|FG000|Overall Study|Lack of Efficacy|0|||
94205061|NCT04551066|322546005|FG001|Overall Study|Lack of Efficacy|1|||
94205062|NCT04551066|322546004|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
94205063|NCT04551066|322546005|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
94205064|NCT03773107|322546007|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
94205065|NCT03773107|322546008|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
94205066|NCT03773107|322546009|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
94205067|NCT03773107|322546010|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
94205068|NCT03664804|322546011|FG000|Overall Study|Withdrawal by Subject|7|||
94205069|NCT04701203|322546012|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
94205070|NCT04701203|322546013|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
94205071|NCT04701203|322546014|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
94205072|NCT04701203|322546012|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
94205073|NCT04701203|322546013|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
94205074|NCT04701203|322546014|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
94205075|NCT04701203|322546012|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
94205076|NCT04701203|322546013|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
94205077|NCT04701203|322546014|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
94205078|NCT04701203|322546012|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
94205079|NCT04701203|322546013|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
94205080|NCT04701203|322546014|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
94205081|NCT02798471|322546020|FG000|Overall Study|Adverse Event|7|||
94205082|NCT02798471|322546021|FG001|Overall Study|Adverse Event|2|||
94205083|NCT02798471|322546020|FG000|Overall Study|Physician Decision|3|||
94205084|NCT02798471|322546021|FG001|Overall Study|Physician Decision|7|||
94205085|NCT02798471|322546020|FG000|Overall Study|Death|2|||
94205086|NCT02798471|322546021|FG001|Overall Study|Death|3|||
94205087|NCT02798471|322546020|FG000|Overall Study|Lost to Follow-up|0|||
94205088|NCT02798471|322546021|FG001|Overall Study|Lost to Follow-up|1|||
94205089|NCT02798471|322546020|FG000|Overall Study|Other|5|||
94205090|NCT02798471|322546021|FG001|Overall Study|Other|3|||
94205091|NCT02798471|322546020|FG000|Overall Study|Subject withdrew consent|0|||
94205092|NCT02798471|322546021|FG001|Overall Study|Subject withdrew consent|6|||
94205093|NCT02798471|322546020|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
94205094|NCT02798471|322546021|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
94205095|NCT02798471|322546020|FG000|Overall Study|Randomized, but not treated|0|||
94205096|NCT02798471|322546021|FG001|Overall Study|Randomized, but not treated|2|||
94371057|NCT01246986|323146724|FG003|Overall Study|Withdrawal by Subject|0|||
94371058|NCT01246986|323146725|FG004|Overall Study|Withdrawal by Subject|4|||
94371059|NCT01246986|323146726|FG005|Overall Study|Withdrawal by Subject|0|||
94371060|NCT01246986|323146727|FG006|Overall Study|Withdrawal by Subject|0|||
94371061|NCT01355523|323146728|FG000|Overall Study|Withdrawal by Subject|1|||
94371062|NCT01355523|323146729|FG001|Overall Study|Withdrawal by Subject|4|||
94371063|NCT01355523|323146728|FG000|Overall Study|Lost to Follow-up|0|||
94371064|NCT01355523|323146729|FG001|Overall Study|Lost to Follow-up|2|||
94371065|NCT01355523|323146728|FG000|Overall Study|Protocol Violation|0|||
94371066|NCT01355523|323146729|FG001|Overall Study|Protocol Violation|2|||
94371067|NCT01355523|323146728|FG000|Overall Study|Adverse Event|0|||
94371068|NCT01355523|323146729|FG001|Overall Study|Adverse Event|2|||
94371069|NCT01422720|323146731|FG000|Overall Study|Adverse Event|16|||
94371070|NCT01422720|323146731|FG000|Overall Study|Lack of Efficacy|1|||
94371071|NCT01422720|323146731|FG000|Overall Study|Withdrawal by Subject|4|||
94371072|NCT01422720|323146731|FG000|Overall Study|Ineligibility|1|||
94371073|NCT03262233|323146732|FG000|Overall Study|Withdrawal by Subject|12|||
94371074|NCT03262233|323146733|FG001|Overall Study|Withdrawal by Subject|8|||
94371075|NCT03262233|323146734|FG002|Overall Study|Withdrawal by Subject|21|||
94371076|NCT03262233|323146735|FG003|Overall Study|Withdrawal by Subject|13|||
94371077|NCT03262233|323146732|FG000|Overall Study|Declined due to shock|1|||
94371078|NCT03262233|323146733|FG001|Overall Study|Declined due to shock|2|||
94371079|NCT03262233|323146734|FG002|Overall Study|Declined due to shock|2|||
94371080|NCT03262233|323146735|FG003|Overall Study|Declined due to shock|3|||
94371081|NCT03262233|323146732|FG000|Overall Study|Protocol Violation|5|||
94371082|NCT03262233|323146733|FG001|Overall Study|Protocol Violation|10|||
94371083|NCT03262233|323146734|FG002|Overall Study|Protocol Violation|2|||
94371084|NCT03262233|323146735|FG003|Overall Study|Protocol Violation|13|||
94371085|NCT03262233|323146732|FG000|Overall Study|data collection artifact|0|||
94371086|NCT03262233|323146733|FG001|Overall Study|data collection artifact|1|||
94371087|NCT03262233|323146734|FG002|Overall Study|data collection artifact|0|||
94371088|NCT03262233|323146735|FG003|Overall Study|data collection artifact|0|||
94371089|NCT00802529|323146739|FG000|Overall Study|Lost to Follow-up|0|||
94371090|NCT00802529|323146740|FG001|Overall Study|Lost to Follow-up|1|||
94371091|NCT01902134|323146741|FG000|Overall Study|Adverse Event|3|||
94371092|NCT01902134|323146742|FG001|Overall Study|Adverse Event|1|||
94371093|NCT01902134|323146743|FG002|Overall Study|Adverse Event|2|||
94371094|NCT01902134|323146744|FG003|Overall Study|Adverse Event|1|||
94371095|NCT01902134|323146745|FG004|Overall Study|Adverse Event|1|||
94371096|NCT01902134|323146746|FG005|Overall Study|Adverse Event|3|||
94371097|NCT01902134|323146741|FG000|Overall Study|Lack of Efficacy|0|||
94371098|NCT01902134|323146742|FG001|Overall Study|Lack of Efficacy|0|||
94371099|NCT01902134|323146743|FG002|Overall Study|Lack of Efficacy|2|||
94371100|NCT01902134|323146744|FG003|Overall Study|Lack of Efficacy|0|||
94371101|NCT01902134|323146745|FG004|Overall Study|Lack of Efficacy|0|||
94371102|NCT01902134|323146746|FG005|Overall Study|Lack of Efficacy|1|||
94371103|NCT01902134|323146741|FG000|Overall Study|Physician Decision|0|||
94371104|NCT01902134|323146742|FG001|Overall Study|Physician Decision|1|||
94371105|NCT01902134|323146743|FG002|Overall Study|Physician Decision|0|||
94371106|NCT01902134|323146744|FG003|Overall Study|Physician Decision|0|||
94371107|NCT01902134|323146745|FG004|Overall Study|Physician Decision|0|||
94371108|NCT01902134|323146746|FG005|Overall Study|Physician Decision|0|||
94371109|NCT01902134|323146741|FG000|Overall Study|Protocol Violation|0|||
94371110|NCT01902134|323146742|FG001|Overall Study|Protocol Violation|0|||
94371111|NCT01902134|323146743|FG002|Overall Study|Protocol Violation|0|||
94743706|NCT04757753|324517065|FG000|Overall Study|Tooth fracture/extraction|3|||
94743707|NCT04757753|324517066|FG001|Overall Study|Tooth fracture/extraction|0|||
94743708|NCT03681678|324517068|FG000|Overall Study|Lost to Follow-up|20|||
94743709|NCT03775486|324517074|FG000|Initial Therapy Phase|Other reason provided|0|||
94743710|NCT03775486|324517075|FG001|Initial Therapy Phase|Other reason provided|15|||
94743711|NCT03775486|324517074|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
94371112|NCT01902134|323146744|FG003|Overall Study|Protocol Violation|0|||
94371113|NCT01902134|323146745|FG004|Overall Study|Protocol Violation|0|||
94371114|NCT01902134|323146746|FG005|Overall Study|Protocol Violation|1|||
94371115|NCT01902134|323146741|FG000|Overall Study|Withdrawal by Subject|4|||
94371116|NCT01902134|323146742|FG001|Overall Study|Withdrawal by Subject|8|||
94371117|NCT01902134|323146743|FG002|Overall Study|Withdrawal by Subject|9|||
94371118|NCT01902134|323146744|FG003|Overall Study|Withdrawal by Subject|1|||
94371119|NCT01902134|323146745|FG004|Overall Study|Withdrawal by Subject|5|||
94371120|NCT01902134|323146746|FG005|Overall Study|Withdrawal by Subject|4|||
94743712|NCT03775486|324517075|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
94371121|NCT01902134|323146741|FG000|Overall Study|no compliance|1|||
94371122|NCT01902134|323146742|FG001|Overall Study|no compliance|0|||
94371123|NCT01902134|323146743|FG002|Overall Study|no compliance|0|||
94371124|NCT01902134|323146744|FG003|Overall Study|no compliance|0|||
94371125|NCT01902134|323146745|FG004|Overall Study|no compliance|0|||
94371126|NCT01902134|323146746|FG005|Overall Study|no compliance|0|||
94371127|NCT01902134|323146741|FG000|Overall Study|Other|0|||
94205097|NCT05293717|322546022|FG000|Overall Study|Physician Decision|1|||
94205098|NCT01266642|322546023|FG000|Overall Study|Protocol Violation|0|||
94205099|NCT01266642|322546024|FG001|Overall Study|Protocol Violation|1|||
94205100|NCT02969356|322546025|FG000|Overall Study|Adverse Event|7|||
94205101|NCT02969356|322546025|FG000|Overall Study|Consent withdrawn|2|||
94205102|NCT02969356|322546025|FG000|Overall Study|Lost to Follow-up|3|||
94205103|NCT02969356|322546025|FG000|Overall Study|Did not need to be reinjected|6|||
94205104|NCT02969356|322546025|FG000|Overall Study|Personal reasons|5|||
94205105|NCT04439318|322546027|FG000|Overall Study|Ineligible|1|||
94205106|NCT04439318|322546027|FG000|Overall Study|Never Started Treatment|3|||
94205107|NCT04439318|322546027|FG000|Overall Study|Adverse Event|10|||
94205108|NCT04439318|322546027|FG000|Overall Study|Death|2|||
94205109|NCT04439318|322546027|FG000|Overall Study|Disease Progression|25|||
94205110|NCT04439318|322546027|FG000|Overall Study|Other Complicating Disease|2|||
94205111|NCT04439318|322546027|FG000|Overall Study|Withdrawal by Subject|4|||
94205112|NCT04439318|322546027|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
94205113|NCT04439318|322546027|FG000|Overall Study|Non-Compliance|1|||
94205114|NCT04439318|322546027|FG000|Overall Study|Still on Treatment|1|||
94205115|NCT00536120|322547879|FG000|Overall Study|Lost to Follow-up|1|||
94205116|NCT00536120|322547880|FG001|Overall Study|Lost to Follow-up|0|||
94205117|NCT00536120|322547879|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
94205118|NCT00536120|322547880|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
94205119|NCT00536120|322547879|FG000|Overall Study|Non-compliance|1|||
94205120|NCT00536120|322547880|FG001|Overall Study|Non-compliance|0|||
94205121|NCT00536120|322547879|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
94205122|NCT00536120|322547880|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
94205123|NCT00536120|322547879|FG000|Overall Study|Steroid Use|0|||
94205124|NCT00536120|322547880|FG001|Overall Study|Steroid Use|2|||
94205125|NCT00536120|322547879|FG000|Overall Study|Missed Study Visit|0|||
94205126|NCT00536120|322547880|FG001|Overall Study|Missed Study Visit|1|||
94205127|NCT03002194|322547881|FG000|Overall Study|Lost to Follow-up|6|||
94205128|NCT03002194|322547881|FG000|Overall Study|Adverse Event|1|||
94205129|NCT03002194|322547881|FG000|Overall Study|Lack of Efficacy|1|||
94205130|NCT03002194|322547881|FG000|Overall Study|Withdrawal by Subject|2|||
94205131|NCT01982682|322547884|FG000|Overall Study|Physician Decision|1|||
94205132|NCT00146172|322547885|FG000|Overall Study|Adverse Event|0|||
94205133|NCT00146172|322547886|FG001|Overall Study|Adverse Event|0|||
94205134|NCT00146172|322547887|FG002|Overall Study|Adverse Event|1|||
94205135|NCT00146172|322547888|FG003|Overall Study|Adverse Event|1|||
94205136|NCT00146172|322547889|FG004|Overall Study|Adverse Event|0|||
94205137|NCT00146172|322547890|FG005|Overall Study|Adverse Event|2|||
94205138|NCT00146172|322547891|FG006|Overall Study|Adverse Event|3|||
94205139|NCT00146172|322547892|FG007|Overall Study|Adverse Event|10|||
94205140|NCT00146172|322547885|FG000|Overall Study|Lost to Follow-up|0|||
94205141|NCT00146172|322547886|FG001|Overall Study|Lost to Follow-up|0|||
94205142|NCT00146172|322547887|FG002|Overall Study|Lost to Follow-up|0|||
94205143|NCT00146172|322547888|FG003|Overall Study|Lost to Follow-up|0|||
94205144|NCT00146172|322547889|FG004|Overall Study|Lost to Follow-up|0|||
94205145|NCT00146172|322547890|FG005|Overall Study|Lost to Follow-up|0|||
94205146|NCT00146172|322547891|FG006|Overall Study|Lost to Follow-up|0|||
94205147|NCT00146172|322547892|FG007|Overall Study|Lost to Follow-up|1|||
94205148|NCT00146172|322547885|FG000|Overall Study|Disease Progression|2|||
94205149|NCT00146172|322547886|FG001|Overall Study|Disease Progression|4|||
94205150|NCT00146172|322547887|FG002|Overall Study|Disease Progression|2|||
94205151|NCT00146172|322547888|FG003|Overall Study|Disease Progression|5|||
94205152|NCT00146172|322547889|FG004|Overall Study|Disease Progression|2|||
94205153|NCT00146172|322547890|FG005|Overall Study|Disease Progression|2|||
94205154|NCT00146172|322547891|FG006|Overall Study|Disease Progression|1|||
94205155|NCT00146172|322547892|FG007|Overall Study|Disease Progression|22|||
94205156|NCT00146172|322547885|FG000|Overall Study|Death|0|||
94205157|NCT00146172|322547886|FG001|Overall Study|Death|0|||
94205158|NCT00146172|322547887|FG002|Overall Study|Death|0|||
94205159|NCT00146172|322547888|FG003|Overall Study|Death|0|||
94205160|NCT00146172|322547889|FG004|Overall Study|Death|0|||
94205161|NCT00146172|322547890|FG005|Overall Study|Death|0|||
94205162|NCT00146172|322547891|FG006|Overall Study|Death|1|||
94205163|NCT00146172|322547892|FG007|Overall Study|Death|0|||
94205164|NCT00146172|322547885|FG000|Overall Study|Physician Decision|0|||
94205165|NCT00146172|322547886|FG001|Overall Study|Physician Decision|0|||
94205166|NCT00146172|322547887|FG002|Overall Study|Physician Decision|0|||
94205167|NCT00146172|322547888|FG003|Overall Study|Physician Decision|0|||
94205168|NCT00146172|322547889|FG004|Overall Study|Physician Decision|0|||
94205169|NCT00146172|322547890|FG005|Overall Study|Physician Decision|0|||
94205170|NCT00146172|322547891|FG006|Overall Study|Physician Decision|0|||
94205171|NCT00146172|322547892|FG007|Overall Study|Physician Decision|1|||
94205172|NCT00146172|322547885|FG000|Overall Study|Withdrawal by Subject|0|||
94205173|NCT00146172|322547886|FG001|Overall Study|Withdrawal by Subject|0|||
94205174|NCT00146172|322547887|FG002|Overall Study|Withdrawal by Subject|0|||
94205175|NCT00146172|322547888|FG003|Overall Study|Withdrawal by Subject|0|||
94205176|NCT00146172|322547889|FG004|Overall Study|Withdrawal by Subject|0|||
94205177|NCT00146172|322547890|FG005|Overall Study|Withdrawal by Subject|1|||
94205178|NCT00146172|322547891|FG006|Overall Study|Withdrawal by Subject|1|||
94205179|NCT00146172|322547892|FG007|Overall Study|Withdrawal by Subject|4|||
94205180|NCT00146172|322547885|FG000|Overall Study|Symptomatic Deterioration|1|||
94205181|NCT00146172|322547886|FG001|Overall Study|Symptomatic Deterioration|0|||
94205182|NCT00146172|322547887|FG002|Overall Study|Symptomatic Deterioration|1|||
94205183|NCT00146172|322547888|FG003|Overall Study|Symptomatic Deterioration|0|||
94205184|NCT00146172|322547889|FG004|Overall Study|Symptomatic Deterioration|1|||
94205185|NCT00146172|322547890|FG005|Overall Study|Symptomatic Deterioration|2|||
94205186|NCT00146172|322547891|FG006|Overall Study|Symptomatic Deterioration|0|||
94205187|NCT00146172|322547892|FG007|Overall Study|Symptomatic Deterioration|2|||
94205188|NCT01596972|322547893|FG000|Overall Study|Physician Decision|1|||
94205189|NCT01596972|322547894|FG001|Overall Study|Physician Decision|9|||
94205190|NCT01596972|322547893|FG000|Overall Study|Lost to Follow-up|0|||
94205191|NCT01596972|322547894|FG001|Overall Study|Lost to Follow-up|4|||
94205192|NCT01596972|322547893|FG000|Overall Study|Withdrawal by Subject|0|||
94205193|NCT01596972|322547894|FG001|Overall Study|Withdrawal by Subject|1|||
94205194|NCT01084694|322547895|FG000|Overall Study|Withdrawal by Subject|2|||
94205195|NCT01084694|322547896|FG001|Overall Study|Withdrawal by Subject|1|||
94205196|NCT01084694|322547895|FG000|Overall Study|Death|2|||
94205197|NCT01084694|322547896|FG001|Overall Study|Death|12|||
94205198|NCT01084694|322547895|FG000|Overall Study|eligibility not maintained|2|||
94205199|NCT01084694|322547896|FG001|Overall Study|eligibility not maintained|7|||
94205200|NCT03801148|322547897|FG000|Period 1 (2 Days)|Adverse Event|1|||
94205201|NCT03801148|322547898|FG001|Period 1 (2 Days)|Adverse Event|1|||
94205202|NCT03801148|322547899|FG002|Period 1 (2 Days)|Adverse Event|0|||
94205203|NCT03801148|322547900|FG003|Period 1 (2 Days)|Adverse Event|0|||
94205204|NCT03801148|322547897|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
94205205|NCT03801148|322547898|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
94205206|NCT03801148|322547899|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
94205207|NCT03801148|322547900|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
94205208|NCT03801148|322547897|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
94205209|NCT03801148|322547898|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
94205210|NCT03801148|322547899|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
94205211|NCT03801148|322547900|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
94205212|NCT03801148|322547897|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
94205213|NCT03801148|322547898|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
94205214|NCT03801148|322547899|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
94205215|NCT03801148|322547900|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
94205216|NCT01092416|322547901|FG000|Enrollment|Atherectomy device not inserted|3|||
94205217|NCT01092416|322547901|FG000|30-Day Follow-up|Death|2|||
94205218|NCT01092416|322547901|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
94205219|NCT01092416|322547901|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
94205220|NCT01092416|322547901|FG000|12-Month Follow-up|Death|16|||
94205221|NCT01092416|322547901|FG000|12-Month Follow-up|Lost to Follow-up|4|||
94205222|NCT01092416|322547901|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
94205223|NCT01092416|322547901|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
94205224|NCT01092416|322547901|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
94205225|NCT00366249|322547902|FG000|Overall Study|Adverse Event|53|||
94205226|NCT00366249|322547903|FG001|Overall Study|Adverse Event|28|||
94205227|NCT00366249|322547902|FG000|Overall Study|Death|0|||
94205228|NCT00366249|322547903|FG001|Overall Study|Death|1|||
94205229|NCT00366249|322547902|FG000|Overall Study|Physician Decision|5|||
94205230|NCT00366249|322547903|FG001|Overall Study|Physician Decision|2|||
94205231|NCT00366249|322547902|FG000|Overall Study|Lost to Follow-up|2|||
94205232|NCT00366249|322547903|FG001|Overall Study|Lost to Follow-up|0|||
94205233|NCT00366249|322547902|FG000|Overall Study|Protocol Violation|1|||
94205234|NCT00366249|322547903|FG001|Overall Study|Protocol Violation|2|||
94205235|NCT00366249|322547902|FG000|Overall Study|Withdrawal by Subject|18|||
94280299|NCT00784654|322816069|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
94280300|NCT00784654|322816070|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
94280301|NCT00784654|322816071|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
94280302|NCT00784654|322816069|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
94280303|NCT00784654|322816070|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
94280304|NCT00784654|322816071|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
94205236|NCT00366249|322547903|FG001|Overall Study|Withdrawal by Subject|4|||
94205237|NCT00366249|322547902|FG000|Overall Study|Lack of Efficacy|21|||
94205238|NCT00366249|322547903|FG001|Overall Study|Lack of Efficacy|21|||
94205239|NCT00366249|322547902|FG000|Overall Study|Most due to osteomylitis status|31|||
94205240|NCT00366249|322547903|FG001|Overall Study|Most due to osteomylitis status|20|||
94205241|NCT01627561|322547904|FG000|Overall Study|Lost to Follow-up|1|||
94205242|NCT01627561|322547905|FG001|Overall Study|Lost to Follow-up|0|||
94205243|NCT01627561|322547904|FG000|Overall Study|Withdrawal by Subject|0|||
94205244|NCT01627561|322547905|FG001|Overall Study|Withdrawal by Subject|1|||
94205245|NCT01627561|322547904|FG000|Overall Study|Migrated/moved from study area|0|||
94205246|NCT01627561|322547905|FG001|Overall Study|Migrated/moved from study area|2|||
94205247|NCT00686595|322547906|FG000|Overall Study|Adverse Event|3|||
94205248|NCT00686595|322547906|FG000|Overall Study|Protocol Violation|1|||
94205249|NCT00686595|322547906|FG000|Overall Study|Lost to Follow-up|1|||
94205250|NCT00686595|322547906|FG000|Overall Study|Lack of Efficacy|1|||
94205251|NCT00686595|322547906|FG000|Overall Study|Poor Compliance|1|||
94205252|NCT02347332|322547912|FG000|Overall Study|Not treated|5|||
94205253|NCT02347332|322547913|FG001|Overall Study|Not treated|2|||
94205254|NCT02347332|322547912|FG000|Overall Study|Progressive disease|141|||
94205255|NCT02347332|322547913|FG001|Overall Study|Progressive disease|159|||
94205256|NCT02347332|322547912|FG000|Overall Study|Adverse Event|50|||
94205257|NCT02347332|322547913|FG001|Overall Study|Adverse Event|41|||
94205258|NCT02347332|322547912|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
94205259|NCT02347332|322547913|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
94205260|NCT02347332|322547912|FG000|Overall Study|Protocol Violation|1|||
94205261|NCT02347332|322547913|FG001|Overall Study|Protocol Violation|1|||
94205262|NCT02347332|322547912|FG000|Overall Study|Lost to Follow-up|2|||
94205263|NCT02347332|322547913|FG001|Overall Study|Lost to Follow-up|1|||
94205264|NCT02347332|322547912|FG000|Overall Study|Physician Decision|4|||
94205265|NCT02347332|322547913|FG001|Overall Study|Physician Decision|3|||
94205266|NCT02347332|322547912|FG000|Overall Study|Withdrawal by Subject|20|||
94205267|NCT02347332|322547913|FG001|Overall Study|Withdrawal by Subject|14|||
94205268|NCT02347332|322547912|FG000|Overall Study|Protocol requirement|1|||
94205269|NCT02347332|322547913|FG001|Overall Study|Protocol requirement|1|||
94205270|NCT02347332|322547912|FG000|Overall Study|Switch Post-Trial program|0|||
94205271|NCT02347332|322547913|FG001|Overall Study|Switch Post-Trial program|1|||
94205272|NCT02502526|322547916|FG000|Overall Study|Lost to Follow-up|2|||
94205273|NCT02502526|322547917|FG001|Overall Study|Lost to Follow-up|2|||
94205274|NCT02502526|322547918|FG002|Overall Study|Lost to Follow-up|3|||
94205275|NCT02502526|322547916|FG000|Overall Study|Withdrawal by Subject|0|||
94205276|NCT02502526|322547917|FG001|Overall Study|Withdrawal by Subject|1|||
94205277|NCT02502526|322547918|FG002|Overall Study|Withdrawal by Subject|1|||
94205278|NCT02502526|322547916|FG000|Overall Study|Disqualified due to cataract grading|0|||
94205279|NCT02502526|322547917|FG001|Overall Study|Disqualified due to cataract grading|0|||
94205280|NCT02502526|322547918|FG002|Overall Study|Disqualified due to cataract grading|1|||
94205281|NCT02502526|322547916|FG000|Overall Study|Enrollment suspension|4|||
94205282|NCT02502526|322547917|FG001|Overall Study|Enrollment suspension|1|||
94205283|NCT02502526|322547918|FG002|Overall Study|Enrollment suspension|1|||
94205284|NCT00918333|322547919|FG000|Overall Study|Drug not taken per protocol|1|||
94205285|NCT00918333|322547920|FG001|Overall Study|Drug not taken per protocol|0|||
94205286|NCT00918333|322547919|FG000|Overall Study|Inadequate amount of drugs provided|1|||
94205287|NCT00918333|322547920|FG001|Overall Study|Inadequate amount of drugs provided|4|||
94205288|NCT00918333|322547919|FG000|Overall Study|Ineligible|1|||
94205289|NCT00918333|322547920|FG001|Overall Study|Ineligible|0|||
94205290|NCT00918333|322547919|FG000|Overall Study|Withdrawal by Subject|0|||
94205291|NCT00918333|322547920|FG001|Overall Study|Withdrawal by Subject|1|||
94205292|NCT01970007|322547922|FG000|Overall Study|Death|5|||
94205293|NCT01970007|322547922|FG000|Overall Study|Withdrawal by Subject|23|||
94205294|NCT01970007|322547922|FG000|Overall Study|Lost to Follow-up|24|||
94205295|NCT01970007|322547922|FG000|Overall Study|"Other endpoint"|3|||
94205296|NCT00754065|322547925|FG000|Overall Study|Never received treatment|12|||
94205297|NCT00754065|322547926|FG001|Overall Study|Never received treatment|2|||
94205298|NCT00754065|322547925|FG000|Overall Study|Adverse Event|19|||
94205299|NCT00754065|322547926|FG001|Overall Study|Adverse Event|25|||
94205300|NCT00754065|322547925|FG000|Overall Study|Lost to Follow-up|7|||
94205301|NCT00754065|322547926|FG001|Overall Study|Lost to Follow-up|11|||
94205302|NCT00754065|322547925|FG000|Overall Study|Protocol Violation|12|||
94205303|NCT00754065|322547926|FG001|Overall Study|Protocol Violation|10|||
94205304|NCT00754065|322547925|FG000|Overall Study|Withdrawal by Subject|4|||
94205305|NCT00754065|322547926|FG001|Overall Study|Withdrawal by Subject|5|||
94205306|NCT00754065|322547925|FG000|Overall Study|Pregnancy|6|||
94205307|NCT00754065|322547926|FG001|Overall Study|Pregnancy|0|||
94205308|NCT00754065|322547925|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
94205309|NCT00754065|322547926|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
94205310|NCT00795184|322547930|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
94205311|NCT00795184|322547931|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
94205312|NCT00586313|322547936|FG000|Overall Study|Lack of Efficacy|2|||
94205313|NCT01952366|322547937|FG000|Overall Study|Death|22|||
94205314|NCT01952366|322547937|FG000|Overall Study|Withdrawal by Subject|9|||
94205315|NCT01212744|322547938|FG000|Overall Study|Withdrawal by Subject|1|||
94205316|NCT01218659|322547939|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
94205317|NCT01218659|322547940|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
94205318|NCT01218659|322547941|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
94205319|NCT01218659|322547939|FG000|18-Month Randomized Period|Did not receive study drug|0|||
94205320|NCT01218659|322547940|FG001|18-Month Randomized Period|Did not receive study drug|3|||
94371128|NCT01902134|323146742|FG001|Overall Study|Other|1|||
94371129|NCT01902134|323146743|FG002|Overall Study|Other|2|||
94371130|NCT01902134|323146744|FG003|Overall Study|Other|0|||
94371131|NCT01902134|323146745|FG004|Overall Study|Other|1|||
94371132|NCT01902134|323146746|FG005|Overall Study|Other|0|||
94371133|NCT01120600|323146747|FG000|Overall Study|Adverse Event|7|||
94371134|NCT01120600|323146748|FG001|Overall Study|Adverse Event|7|||
94205321|NCT01218659|322547941|FG002|18-Month Randomized Period|Did not receive study drug|0|||
94205322|NCT01218659|322547939|FG000|12-Month OLE|Withdrawal by Subject|0|||
94205323|NCT01218659|322547940|FG001|12-Month OLE|Withdrawal by Subject|0|||
94205324|NCT01218659|322547941|FG002|12-Month OLE|Withdrawal by Subject|2|||
94205325|NCT01218659|322547939|FG000|12-Month OLE|Physician Decision|0|||
94205326|NCT01218659|322547940|FG001|12-Month OLE|Physician Decision|0|||
94205327|NCT01218659|322547941|FG002|12-Month OLE|Physician Decision|1|||
94205328|NCT01218659|322547939|FG000|12-Month OLE|Lost to Follow-up|0|||
94205329|NCT01218659|322547940|FG001|12-Month OLE|Lost to Follow-up|0|||
94205330|NCT01218659|322547941|FG002|12-Month OLE|Lost to Follow-up|1|||
94205331|NCT01218659|322547939|FG000|12-Month OLE|Pregnancy|0|||
94205332|NCT01218659|322547940|FG001|12-Month OLE|Pregnancy|0|||
94205333|NCT01218659|322547941|FG002|12-Month OLE|Pregnancy|1|||
94205334|NCT01218659|322547939|FG000|12-Month OLE|Lack of Efficacy|0|||
94205335|NCT01218659|322547940|FG001|12-Month OLE|Lack of Efficacy|0|||
94205336|NCT01218659|322547941|FG002|12-Month OLE|Lack of Efficacy|1|||
94205337|NCT01218659|322547939|FG000|12-Month OLE|Declined to participate in the OLE|0|||
94205338|NCT01218659|322547940|FG001|12-Month OLE|Declined to participate in the OLE|0|||
94205339|NCT01218659|322547941|FG002|12-Month OLE|Declined to participate in the OLE|4|||
94205340|NCT01640951|322547948|FG000|Overall Study|Adverse Event|8|||
94205341|NCT01640951|322547949|FG001|Overall Study|Adverse Event|3|||
94205342|NCT01640951|322547950|FG002|Overall Study|Adverse Event|10|||
94205343|NCT01640951|322547951|FG003|Overall Study|Adverse Event|6|||
94205344|NCT01640951|322547952|FG004|Overall Study|Adverse Event|1|||
94205345|NCT01640951|322547953|FG005|Overall Study|Adverse Event|11|||
94205346|NCT01640951|322547954|FG006|Overall Study|Adverse Event|1|||
94205347|NCT01640951|322547955|FG007|Overall Study|Adverse Event|3|||
94205348|NCT01640951|322547948|FG000|Overall Study|Lack of Efficacy|20|||
94205349|NCT01640951|322547949|FG001|Overall Study|Lack of Efficacy|1|||
94205350|NCT01640951|322547950|FG002|Overall Study|Lack of Efficacy|7|||
94205351|NCT01640951|322547951|FG003|Overall Study|Lack of Efficacy|14|||
94205352|NCT01640951|322547952|FG004|Overall Study|Lack of Efficacy|0|||
94205353|NCT01640951|322547953|FG005|Overall Study|Lack of Efficacy|6|||
94205354|NCT01640951|322547954|FG006|Overall Study|Lack of Efficacy|5|||
94205355|NCT01640951|322547955|FG007|Overall Study|Lack of Efficacy|6|||
94205356|NCT01640951|322547948|FG000|Overall Study|Lost to Follow-up|1|||
94205357|NCT01640951|322547949|FG001|Overall Study|Lost to Follow-up|0|||
94205358|NCT01640951|322547950|FG002|Overall Study|Lost to Follow-up|6|||
94205359|NCT01640951|322547951|FG003|Overall Study|Lost to Follow-up|2|||
94205360|NCT01640951|322547952|FG004|Overall Study|Lost to Follow-up|2|||
94205361|NCT01640951|322547953|FG005|Overall Study|Lost to Follow-up|3|||
94205362|NCT01640951|322547954|FG006|Overall Study|Lost to Follow-up|1|||
94205363|NCT01640951|322547955|FG007|Overall Study|Lost to Follow-up|1|||
94205364|NCT01640951|322547948|FG000|Overall Study|Non-compliance with study treatment|0|||
94205365|NCT01640951|322547949|FG001|Overall Study|Non-compliance with study treatment|0|||
94205366|NCT01640951|322547950|FG002|Overall Study|Non-compliance with study treatment|1|||
94205367|NCT01640951|322547951|FG003|Overall Study|Non-compliance with study treatment|1|||
94205368|NCT01640951|322547952|FG004|Overall Study|Non-compliance with study treatment|1|||
94205369|NCT01640951|322547953|FG005|Overall Study|Non-compliance with study treatment|4|||
94205370|NCT01640951|322547954|FG006|Overall Study|Non-compliance with study treatment|1|||
94205371|NCT01640951|322547955|FG007|Overall Study|Non-compliance with study treatment|0|||
94205372|NCT01640951|322547948|FG000|Overall Study|Physician Decision|2|||
94205373|NCT01640951|322547949|FG001|Overall Study|Physician Decision|5|||
94205374|NCT01640951|322547950|FG002|Overall Study|Physician Decision|2|||
94205375|NCT01640951|322547951|FG003|Overall Study|Physician Decision|2|||
94205376|NCT01640951|322547952|FG004|Overall Study|Physician Decision|2|||
94205377|NCT01640951|322547953|FG005|Overall Study|Physician Decision|3|||
94205378|NCT01640951|322547954|FG006|Overall Study|Physician Decision|3|||
94205379|NCT01640951|322547955|FG007|Overall Study|Physician Decision|0|||
94205380|NCT01640951|322547948|FG000|Overall Study|Pregnancy|3|||
94205381|NCT01640951|322547949|FG001|Overall Study|Pregnancy|0|||
94205382|NCT01640951|322547950|FG002|Overall Study|Pregnancy|0|||
94205383|NCT01640951|322547951|FG003|Overall Study|Pregnancy|4|||
94205384|NCT01640951|322547952|FG004|Overall Study|Pregnancy|0|||
94205385|NCT01640951|322547953|FG005|Overall Study|Pregnancy|0|||
94205386|NCT01640951|322547954|FG006|Overall Study|Pregnancy|2|||
94205387|NCT01640951|322547955|FG007|Overall Study|Pregnancy|0|||
94205388|NCT01640951|322547948|FG000|Overall Study|Protocol Deviation|0|||
94205389|NCT01640951|322547949|FG001|Overall Study|Protocol Deviation|1|||
94205390|NCT01640951|322547950|FG002|Overall Study|Protocol Deviation|2|||
94205391|NCT01640951|322547951|FG003|Overall Study|Protocol Deviation|1|||
94371135|NCT01120600|323146747|FG000|Overall Study|Excessive Bone Loss|0|||
94371136|NCT01120600|323146748|FG001|Overall Study|Excessive Bone Loss|4|||
94280305|NCT00784654|322816069|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
94280306|NCT00784654|322816070|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
94280307|NCT00784654|322816071|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
94280308|NCT00784654|322816069|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
94280309|NCT00784654|322816070|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
94280310|NCT00784654|322816071|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
94280311|NCT00784654|322816069|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
94280312|NCT00784654|322816070|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
94280313|NCT00784654|322816071|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
94280314|NCT00784654|322816069|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
94280315|NCT00784654|322816070|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
94280316|NCT00784654|322816071|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
94280317|NCT00784654|322816069|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
94280318|NCT00784654|322816070|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
94280319|NCT00784654|322816071|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
94280320|NCT00784654|322816069|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
94280321|NCT00784654|322816070|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
94280322|NCT00784654|322816071|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
94280323|NCT00784654|322816069|FG000|Randomized Withdrawal Period|Adverse Event|0|||
94280324|NCT00784654|322816070|FG001|Randomized Withdrawal Period|Adverse Event|1|||
94280325|NCT00784654|322816071|FG002|Randomized Withdrawal Period|Adverse Event|1|||
94280326|NCT00784654|322816069|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
94280327|NCT00784654|322816070|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
94280328|NCT00784654|322816071|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
94280329|NCT00784654|322816069|FG000|Randomized Withdrawal Period|Family reasons|0|||
94280330|NCT00784654|322816070|FG001|Randomized Withdrawal Period|Family reasons|0|||
94280331|NCT00784654|322816071|FG002|Randomized Withdrawal Period|Family reasons|1|||
94280332|NCT01411085|322816074|FG000|Overall Study|Physician Decision|1|||
94280333|NCT01411085|322816074|FG000|Overall Study|Protocol Violation|1|||
94280334|NCT01411085|322816074|FG000|Overall Study|Adverse Event|1|||
94280335|NCT00562588|322816075|FG000|Overall Study|Adverse Event|40|||
94280336|NCT00562588|322816076|FG001|Overall Study|Adverse Event|58|||
94280337|NCT00562588|322816075|FG000|Overall Study|Protocol Violation|30|||
94280338|NCT00562588|322816076|FG001|Overall Study|Protocol Violation|26|||
94280339|NCT00562588|322816075|FG000|Overall Study|Lost to Follow-up|12|||
94280340|NCT00562588|322816076|FG001|Overall Study|Lost to Follow-up|4|||
94280341|NCT00562588|322816075|FG000|Overall Study|Withdrawal by Subject|10|||
94280342|NCT00562588|322816076|FG001|Overall Study|Withdrawal by Subject|9|||
94280343|NCT00562588|322816075|FG000|Overall Study|Other|0|||
94280344|NCT00562588|322816076|FG001|Overall Study|Other|2|||
94280345|NCT03809611|322816077|FG000|Overall Study|Withdrawal by Subject|1|||
94280346|NCT03809611|322816078|FG001|Overall Study|Withdrawal by Subject|1|||
94280347|NCT03124563|322816079|FG000|Overall Study|Lost to Follow-up|1|||
94280348|NCT03124563|322816080|FG001|Overall Study|Lost to Follow-up|1|||
94280349|NCT03124563|322816079|FG000|Overall Study|Withdrawal by Subject|1|||
94280350|NCT03124563|322816080|FG001|Overall Study|Withdrawal by Subject|1|||
94280351|NCT01964352|322817374|FG000|Overall Study|Adverse Event|13|||
94280352|NCT01964352|322817375|FG001|Overall Study|Adverse Event|3|||
94280353|NCT01964352|322817376|FG002|Overall Study|Adverse Event|4|||
94280354|NCT01964352|322817377|FG003|Overall Study|Adverse Event|3|||
94280355|NCT01964352|322817374|FG000|Overall Study|Lack of Efficacy|6|||
94280356|NCT01964352|322817375|FG001|Overall Study|Lack of Efficacy|0|||
94280357|NCT01964352|322817376|FG002|Overall Study|Lack of Efficacy|0|||
94280358|NCT01964352|322817377|FG003|Overall Study|Lack of Efficacy|0|||
94280359|NCT01964352|322817374|FG000|Overall Study|Protocol Violation|2|||
94280360|NCT01964352|322817375|FG001|Overall Study|Protocol Violation|4|||
94280361|NCT01964352|322817376|FG002|Overall Study|Protocol Violation|0|||
94280362|NCT01964352|322817377|FG003|Overall Study|Protocol Violation|2|||
94280363|NCT01964352|322817374|FG000|Overall Study|Lost to Follow-up|1|||
94280364|NCT01964352|322817375|FG001|Overall Study|Lost to Follow-up|0|||
94280365|NCT01964352|322817376|FG002|Overall Study|Lost to Follow-up|0|||
94280366|NCT01964352|322817377|FG003|Overall Study|Lost to Follow-up|1|||
94743713|NCT03775486|324517074|FG000|Initial Therapy Phase|Protocol Violation|0|||
94371137|NCT01120600|323146747|FG000|Overall Study|Lost to Follow-up|1|||
94743714|NCT03775486|324517075|FG001|Initial Therapy Phase|Protocol Violation|2|||
94743715|NCT03775486|324517074|FG000|Initial Therapy Phase|Adverse Event|0|||
94743716|NCT03775486|324517075|FG001|Initial Therapy Phase|Adverse Event|34|||
94280367|NCT01964352|322817374|FG000|Overall Study|Withdrawal by Subject|4|||
94280368|NCT01964352|322817375|FG001|Overall Study|Withdrawal by Subject|2|||
94280369|NCT01964352|322817376|FG002|Overall Study|Withdrawal by Subject|1|||
94280370|NCT01964352|322817377|FG003|Overall Study|Withdrawal by Subject|0|||
94743717|NCT03775486|324517074|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
94743718|NCT03775486|324517075|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
94205392|NCT01640951|322547952|FG004|Overall Study|Protocol Deviation|0|||
94205393|NCT01640951|322547953|FG005|Overall Study|Protocol Deviation|1|||
94205394|NCT01640951|322547954|FG006|Overall Study|Protocol Deviation|0|||
94205395|NCT01640951|322547955|FG007|Overall Study|Protocol Deviation|0|||
94205396|NCT01640951|322547948|FG000|Overall Study|Subject/Guardian decision|12|||
94205397|NCT01640951|322547949|FG001|Overall Study|Subject/Guardian decision|4|||
94205398|NCT01640951|322547950|FG002|Overall Study|Subject/Guardian decision|13|||
94280371|NCT01964352|322817374|FG000|Overall Study|Other than stated above|0|||
94280372|NCT01964352|322817375|FG001|Overall Study|Other than stated above|2|||
94280373|NCT01964352|322817376|FG002|Overall Study|Other than stated above|1|||
94280374|NCT01964352|322817377|FG003|Overall Study|Other than stated above|2|||
94280375|NCT01394939|322817378|FG000|Overall Study|Adverse Event|1|||
94280376|NCT01394939|322817379|FG001|Overall Study|Adverse Event|3|||
94280377|NCT01394939|322817380|FG002|Overall Study|Adverse Event|0|||
94280378|NCT01394939|322817381|FG003|Overall Study|Adverse Event|2|||
94280379|NCT01394939|322817378|FG000|Overall Study|Death|0|||
94280380|NCT01394939|322817379|FG001|Overall Study|Death|2|||
94280381|NCT01394939|322817380|FG002|Overall Study|Death|0|||
94280382|NCT01394939|322817381|FG003|Overall Study|Death|0|||
94280383|NCT01394939|322817378|FG000|Overall Study|Physician Decision|0|||
94280384|NCT01394939|322817379|FG001|Overall Study|Physician Decision|1|||
94280385|NCT01394939|322817380|FG002|Overall Study|Physician Decision|0|||
94280386|NCT01394939|322817381|FG003|Overall Study|Physician Decision|0|||
94280387|NCT01394939|322817378|FG000|Overall Study|Withdrawal by Subject|0|||
94280388|NCT01394939|322817379|FG001|Overall Study|Withdrawal by Subject|2|||
94280389|NCT01394939|322817380|FG002|Overall Study|Withdrawal by Subject|0|||
94280390|NCT01394939|322817381|FG003|Overall Study|Withdrawal by Subject|2|||
94280391|NCT01394939|322817378|FG000|Overall Study|Others|0|||
94280392|NCT01394939|322817379|FG001|Overall Study|Others|2|||
94280393|NCT01394939|322817380|FG002|Overall Study|Others|0|||
94205399|NCT01640951|322547951|FG003|Overall Study|Subject/Guardian decision|15|||
94205400|NCT01640951|322547952|FG004|Overall Study|Subject/Guardian decision|7|||
94205401|NCT01640951|322547953|FG005|Overall Study|Subject/Guardian decision|19|||
94205402|NCT01640951|322547954|FG006|Overall Study|Subject/Guardian decision|5|||
94205403|NCT01640951|322547955|FG007|Overall Study|Subject/Guardian decision|4|||
94205404|NCT01640951|322547948|FG000|Overall Study|Death|0|||
94205405|NCT01640951|322547949|FG001|Overall Study|Death|1|||
94205406|NCT01640951|322547950|FG002|Overall Study|Death|1|||
94205407|NCT01640951|322547951|FG003|Overall Study|Death|0|||
94205408|NCT01640951|322547952|FG004|Overall Study|Death|0|||
94205409|NCT01640951|322547953|FG005|Overall Study|Death|0|||
94205410|NCT01640951|322547954|FG006|Overall Study|Death|0|||
94205411|NCT01640951|322547955|FG007|Overall Study|Death|2|||
94205412|NCT00582972|322547956|FG000|Overall Study|Protocol Violation|2|||
94205413|NCT03355573|322547957|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
94205414|NCT03355573|322547957|FG000|Overall Study|Sponsor's decision|1|||
94205415|NCT03355573|322547957|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
94205416|NCT03355573|322547957|FG000|Overall Study|PI's decision|2|||
94205417|NCT03355573|322547957|FG000|Overall Study|Withdrawal by Subject|23|||
94205418|NCT03355573|322547957|FG000|Overall Study|Lost to Follow-up|4|||
94205419|NCT03355573|322547957|FG000|Overall Study|Lack of Efficacy|2|||
94205420|NCT03355573|322547957|FG000|Overall Study|Adverse Event, non-fatal|17|||
94205421|NCT03355573|322547957|FG000|Overall Study|Adverse Event, serious fatal|2|||
94205422|NCT00822120|322547965|FG000|Initial Registration|Adverse Event|1|||
94205423|NCT00822120|322547966|FG001|Initial Registration|Adverse Event|0|||
94205424|NCT00822120|322547967|FG002|Initial Registration|Adverse Event|0|||
94205425|NCT00822120|322547968|FG003|Initial Registration|Adverse Event|0|||
94205426|NCT00822120|322547969|FG004|Initial Registration|Adverse Event|0|||
94205427|NCT00822120|322547970|FG005|Initial Registration|Adverse Event|0|||
94205428|NCT00822120|322547965|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
94205429|NCT00822120|322547966|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
94205430|NCT00822120|322547967|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
94205431|NCT00822120|322547968|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
94205432|NCT00822120|322547969|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
94205433|NCT00822120|322547970|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
94205434|NCT00822120|322547965|FG000|Initial Registration|Reasons not Protocol Specified|2|||
94205435|NCT00822120|322547966|FG001|Initial Registration|Reasons not Protocol Specified|0|||
94205436|NCT00822120|322547967|FG002|Initial Registration|Reasons not Protocol Specified|0|||
94205437|NCT00822120|322547968|FG003|Initial Registration|Reasons not Protocol Specified|0|||
94205438|NCT00822120|322547969|FG004|Initial Registration|Reasons not Protocol Specified|0|||
94205439|NCT00822120|322547970|FG005|Initial Registration|Reasons not Protocol Specified|0|||
94205440|NCT00822120|322547965|FG000|Initial Registration|Ineligible|22|||
94205441|NCT00822120|322547966|FG001|Initial Registration|Ineligible|1|||
94280394|NCT01394939|322817381|FG003|Overall Study|Others|3|||
94280395|NCT02164981|322817385|FG000|Started|Withdrawal by Subject|2|||
94280396|NCT02164981|322817386|FG001|Started|Withdrawal by Subject|1|||
94280397|NCT02164981|322817387|FG002|Started|Withdrawal by Subject|0|||
94280398|NCT02164981|322817385|FG000|Started|Protocol Violation|2|||
94280399|NCT02164981|322817386|FG001|Started|Protocol Violation|0|||
94280400|NCT02164981|322817387|FG002|Started|Protocol Violation|0|||
94280401|NCT02164981|322817385|FG000|Started|Adverse Event|1|||
94280402|NCT02164981|322817386|FG001|Started|Adverse Event|2|||
94280403|NCT02164981|322817387|FG002|Started|Adverse Event|0|||
94280404|NCT02164981|322817385|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
94280405|NCT02164981|322817386|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
94280406|NCT02164981|322817387|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
94280407|NCT02164981|322817385|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
94280408|NCT02164981|322817386|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
94280409|NCT02164981|322817387|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
94280410|NCT02164981|322817385|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
94280411|NCT02164981|322817386|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
94280412|NCT02164981|322817387|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
94280413|NCT01995071|322817388|FG000|Overall Study|Adverse Event|0|||
94280414|NCT01995071|322817389|FG001|Overall Study|Adverse Event|0|||
94280415|NCT01995071|322817390|FG002|Overall Study|Adverse Event|0|||
94280416|NCT01995071|322817391|FG003|Overall Study|Adverse Event|0|||
94280417|NCT01995071|322817392|FG004|Overall Study|Adverse Event|0|||
94371138|NCT01120600|323146748|FG001|Overall Study|Lost to Follow-up|3|||
94371139|NCT01120600|323146747|FG000|Overall Study|Physician Decision|1|||
94371140|NCT01120600|323146748|FG001|Overall Study|Physician Decision|3|||
94371141|NCT01120600|323146747|FG000|Overall Study|Protocol Violation|0|||
94371142|NCT01120600|323146748|FG001|Overall Study|Protocol Violation|4|||
94371143|NCT01120600|323146747|FG000|Overall Study|Withdrawal by Subject|10|||
94371144|NCT01120600|323146748|FG001|Overall Study|Withdrawal by Subject|11|||
94371145|NCT03990389|323146751|FG000|Overall Study|Lost to Follow-up|3|||
94371146|NCT03990389|323146752|FG001|Overall Study|Lost to Follow-up|0|||
94371147|NCT03627195|323146753|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
94371148|NCT03627195|323146754|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
94467660|NCT01004432|323502376|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
94743719|NCT03775486|324517074|FG000|Maintenance Phase|Withdrawal by Subject|13|||
94743720|NCT03775486|324517075|FG001|Maintenance Phase|Withdrawal by Subject|12|||
94743721|NCT03775486|324517074|FG000|Maintenance Phase|Death|44|||
94743722|NCT03775486|324517075|FG001|Maintenance Phase|Death|45|||
94743723|NCT04490356|324517088|FG000|Overall Study|Lost to Follow-up|1|||
94743724|NCT04066075|324517089|FG000|Overall Study|Lost to Follow-up|3|||
94743725|NCT04066075|324517090|FG001|Overall Study|Lost to Follow-up|3|||
94743726|NCT04066075|324517089|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
94743727|NCT04066075|324517090|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
94743728|NCT04066075|324517089|FG000|Overall Study|Withdrawal by Subject|2|||
94743729|NCT04066075|324517090|FG001|Overall Study|Withdrawal by Subject|2|||
94743730|NCT03733626|324517091|FG000|Overall Study|Physician Decision|4|||
94743731|NCT03733626|324517092|FG001|Overall Study|Physician Decision|4|||
94743732|NCT05288166|324517098|FG000|Overall Study|Adverse Event|1|||
94743733|NCT05288166|324517099|FG001|Overall Study|Adverse Event|0|||
94743734|NCT05288166|324517098|FG000|Overall Study|Lost to Follow-up|2|||
94743735|NCT05288166|324517099|FG001|Overall Study|Lost to Follow-up|0|||
94743736|NCT05288166|324517098|FG000|Overall Study|Physician Decision|0|||
94743737|NCT05288166|324517099|FG001|Overall Study|Physician Decision|2|||
94743738|NCT05288166|324517098|FG000|Overall Study|Screen Failure|1|||
94743739|NCT05288166|324517099|FG001|Overall Study|Screen Failure|1|||
94743740|NCT05288166|324517098|FG000|Overall Study|Withdrawal by Subject|4|||
94743741|NCT05288166|324517099|FG001|Overall Study|Withdrawal by Subject|2|||
94743742|NCT05288166|324517098|FG000|Overall Study|On Study Treatment|408|||
94743743|NCT05288166|324517099|FG001|Overall Study|On Study Treatment|418|||
94743744|NCT03201939|324517107|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
94743745|NCT03201939|324517108|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
94743746|NCT04602728|324517118|FG000|Overall Study|Lost to Follow-up|4|||
94743747|NCT04602728|324517119|FG001|Overall Study|Lost to Follow-up|4|||
94743748|NCT04639219|324517438|FG000|Overall Study|Withdrawal by Subject|8|||
94743749|NCT04639219|324517438|FG000|Overall Study|Lost to Follow-up|6|||
94743750|NCT04639219|324517438|FG000|Overall Study|Death|55|||
94743751|NCT03907488|324517439|FG000|Overall Study|Adverse Event|20|||
94743752|NCT03907488|324517440|FG001|Overall Study|Adverse Event|20|||
94743753|NCT03907488|324517439|FG000|Overall Study|Withdrawal by Subject|9|||
94743754|NCT03907488|324517440|FG001|Overall Study|Withdrawal by Subject|13|||
94743755|NCT03907488|324517439|FG000|Overall Study|Lack of Efficacy|0|||
94743756|NCT03907488|324517440|FG001|Overall Study|Lack of Efficacy|9|||
94743757|NCT03907488|324517439|FG000|Overall Study|Death|3|||
94743758|NCT03907488|324517440|FG001|Overall Study|Death|8|||
94743759|NCT03907488|324517439|FG000|Overall Study|not protocol specified|5|||
94743760|NCT03907488|324517440|FG001|Overall Study|not protocol specified|8|||
94371149|NCT03627195|323146755|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
94371150|NCT03627195|323146756|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
94371151|NCT03627195|323146757|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
94205442|NCT00822120|322547967|FG002|Initial Registration|Ineligible|0|||
94205443|NCT00822120|322547968|FG003|Initial Registration|Ineligible|0|||
94205444|NCT00822120|322547969|FG004|Initial Registration|Ineligible|0|||
94205445|NCT00822120|322547970|FG005|Initial Registration|Ineligible|0|||
94205446|NCT00822120|322547965|FG000|PET-directed Therapy|Adverse Event|0|||
94205447|NCT00822120|322547966|FG001|PET-directed Therapy|Adverse Event|0|||
94743761|NCT03907488|324517439|FG000|Overall Study|Ineligible|9|||
94743762|NCT03907488|324517440|FG001|Overall Study|Ineligible|15|||
94743763|NCT03106415|324517441|FG000|Phase 1|Withdrawal by Subject|1|||
94743764|NCT03106415|324517442|FG001|Phase 1|Withdrawal by Subject|0|||
94743765|NCT03106415|324517443|FG002|Phase 1|Withdrawal by Subject|0|||
94743766|NCT03106415|324517441|FG000|Phase 1|Adverse Event|1|||
94743767|NCT03106415|324517442|FG001|Phase 1|Adverse Event|1|||
94743768|NCT03106415|324517443|FG002|Phase 1|Adverse Event|0|||
94743769|NCT03106415|324517441|FG000|Phase 1|Protocol Violation|0|||
94743770|NCT03106415|324517442|FG001|Phase 1|Protocol Violation|1|||
94743771|NCT03106415|324517443|FG002|Phase 1|Protocol Violation|0|||
94743772|NCT01208974|324517444|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
94743773|NCT01208974|324517445|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
94743774|NCT01208974|324517446|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
94743775|NCT01208974|324517447|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
94743776|NCT01208974|324517444|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
94743777|NCT01208974|324517445|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
94743778|NCT01208974|324517446|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
94743779|NCT01208974|324517447|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
94743780|NCT01208974|324517444|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
94743781|NCT01208974|324517445|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
94743782|NCT01208974|324517446|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
94743783|NCT01208974|324517447|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
94743784|NCT02180867|324517456|FG000|Overall Study|Adverse Event|3|||
94743785|NCT02180867|324517457|FG001|Overall Study|Adverse Event|4|||
94743786|NCT02180867|324517458|FG002|Overall Study|Adverse Event|1|||
94743787|NCT02180867|324517459|FG003|Overall Study|Adverse Event|5|||
94743788|NCT02180867|324517460|FG004|Overall Study|Adverse Event|0|||
94743789|NCT02180867|324517461|FG005|Overall Study|Adverse Event|0|||
94743790|NCT02180867|324517462|FG006|Overall Study|Adverse Event|0|||
94743791|NCT02180867|324517456|FG000|Overall Study|Death|0|||
94743792|NCT02180867|324517457|FG001|Overall Study|Death|0|||
94743793|NCT02180867|324517458|FG002|Overall Study|Death|0|||
94743794|NCT02180867|324517459|FG003|Overall Study|Death|0|||
94743795|NCT02180867|324517460|FG004|Overall Study|Death|1|||
94743796|NCT02180867|324517461|FG005|Overall Study|Death|0|||
94743797|NCT02180867|324517462|FG006|Overall Study|Death|0|||
94743798|NCT02180867|324517456|FG000|Overall Study|Lack of Efficacy|0|||
94743799|NCT02180867|324517457|FG001|Overall Study|Lack of Efficacy|2|||
94743800|NCT02180867|324517458|FG002|Overall Study|Lack of Efficacy|0|||
94743801|NCT02180867|324517459|FG003|Overall Study|Lack of Efficacy|1|||
94743802|NCT02180867|324517460|FG004|Overall Study|Lack of Efficacy|6|||
94743803|NCT02180867|324517461|FG005|Overall Study|Lack of Efficacy|0|||
94743804|NCT02180867|324517462|FG006|Overall Study|Lack of Efficacy|1|||
94743805|NCT02180867|324517456|FG000|Overall Study|Physician Decision|1|||
94743806|NCT02180867|324517457|FG001|Overall Study|Physician Decision|3|||
94743807|NCT02180867|324517458|FG002|Overall Study|Physician Decision|1|||
94743808|NCT02180867|324517459|FG003|Overall Study|Physician Decision|10|||
94743809|NCT02180867|324517460|FG004|Overall Study|Physician Decision|9|||
94743810|NCT02180867|324517461|FG005|Overall Study|Physician Decision|3|||
94743811|NCT02180867|324517462|FG006|Overall Study|Physician Decision|4|||
94743812|NCT02180867|324517456|FG000|Overall Study|Withdrawal by Subject|0|||
94743813|NCT02180867|324517457|FG001|Overall Study|Withdrawal by Subject|0|||
94743814|NCT02180867|324517458|FG002|Overall Study|Withdrawal by Subject|0|||
94205448|NCT00822120|322547967|FG002|PET-directed Therapy|Adverse Event|0|||
94205449|NCT00822120|322547968|FG003|PET-directed Therapy|Adverse Event|1|||
94205450|NCT00822120|322547969|FG004|PET-directed Therapy|Adverse Event|0|||
94205451|NCT00822120|322547970|FG005|PET-directed Therapy|Adverse Event|0|||
94205452|NCT00822120|322547965|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
94205453|NCT00822120|322547966|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
94205454|NCT00822120|322547967|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
94743815|NCT02180867|324517459|FG003|Overall Study|Withdrawal by Subject|1|||
94743816|NCT02180867|324517460|FG004|Overall Study|Withdrawal by Subject|1|||
94743817|NCT02180867|324517461|FG005|Overall Study|Withdrawal by Subject|0|||
94743818|NCT02180867|324517462|FG006|Overall Study|Withdrawal by Subject|0|||
94743819|NCT02180867|324517456|FG000|Overall Study|Ineligible|1|||
94743820|NCT02180867|324517457|FG001|Overall Study|Ineligible|2|||
94743821|NCT02180867|324517458|FG002|Overall Study|Ineligible|0|||
94743822|NCT02180867|324517459|FG003|Overall Study|Ineligible|3|||
94743823|NCT02180867|324517460|FG004|Overall Study|Ineligible|5|||
94743824|NCT02180867|324517461|FG005|Overall Study|Ineligible|0|||
94743825|NCT02180867|324517462|FG006|Overall Study|Ineligible|0|||
94280418|NCT01995071|322817393|FG005|Overall Study|Adverse Event|0|||
94280419|NCT01995071|322817394|FG006|Overall Study|Adverse Event|1|||
94280420|NCT01995071|322817395|FG007|Overall Study|Adverse Event|0|||
94280421|NCT01995071|322817396|FG008|Overall Study|Adverse Event|0|||
94280422|NCT01995071|322817397|FG009|Overall Study|Adverse Event|0|||
94280423|NCT01995071|322817398|FG010|Overall Study|Adverse Event|0|||
94280424|NCT01995071|322817399|FG011|Overall Study|Adverse Event|0|||
94280425|NCT01995071|322817388|FG000|Overall Study|Moved|0|||
94280426|NCT01995071|322817389|FG001|Overall Study|Moved|0|||
94280427|NCT01995071|322817390|FG002|Overall Study|Moved|1|||
94280428|NCT01995071|322817391|FG003|Overall Study|Moved|0|||
94280429|NCT01995071|322817392|FG004|Overall Study|Moved|1|||
94280430|NCT01995071|322817393|FG005|Overall Study|Moved|0|||
94280431|NCT01995071|322817394|FG006|Overall Study|Moved|0|||
94280432|NCT01995071|322817395|FG007|Overall Study|Moved|0|||
94280433|NCT01995071|322817396|FG008|Overall Study|Moved|0|||
94280434|NCT01995071|322817397|FG009|Overall Study|Moved|0|||
94280435|NCT01995071|322817398|FG010|Overall Study|Moved|1|||
94280436|NCT01995071|322817399|FG011|Overall Study|Moved|0|||
94280437|NCT01995071|322817388|FG000|Overall Study|Lost to Follow-up|1|||
94743826|NCT02180867|324517456|FG000|Overall Study|Repeat Eligibility Studies|0|||
94743827|NCT02180867|324517457|FG001|Overall Study|Repeat Eligibility Studies|0|||
94743828|NCT02180867|324517458|FG002|Overall Study|Repeat Eligibility Studies|0|||
94743829|NCT02180867|324517459|FG003|Overall Study|Repeat Eligibility Studies|0|||
94743830|NCT02180867|324517460|FG004|Overall Study|Repeat Eligibility Studies|1|||
94743831|NCT02180867|324517461|FG005|Overall Study|Repeat Eligibility Studies|0|||
94743832|NCT02180867|324517462|FG006|Overall Study|Repeat Eligibility Studies|0|||
94743833|NCT02180867|324517456|FG000|Overall Study|Refusal of further protocol therapy|1|||
94743834|NCT02180867|324517457|FG001|Overall Study|Refusal of further protocol therapy|0|||
94743835|NCT02180867|324517458|FG002|Overall Study|Refusal of further protocol therapy|2|||
94743836|NCT02180867|324517459|FG003|Overall Study|Refusal of further protocol therapy|6|||
94743837|NCT02180867|324517460|FG004|Overall Study|Refusal of further protocol therapy|4|||
94743838|NCT02180867|324517461|FG005|Overall Study|Refusal of further protocol therapy|0|||
94743839|NCT02180867|324517462|FG006|Overall Study|Refusal of further protocol therapy|0|||
94743840|NCT05995977|324517463|FG000|Overall Study|Withdrawal by Subject|1|||
94743841|NCT05995977|324517464|FG001|Overall Study|Withdrawal by Subject|4|||
94743842|NCT05995977|324517463|FG000|Overall Study|Lost to Follow-up|2|||
94743843|NCT05995977|324517464|FG001|Overall Study|Lost to Follow-up|0|||
94743844|NCT04181788|324517465|FG000|TREATMENT|Adverse Event|0|||
94743845|NCT04181788|324517466|FG001|TREATMENT|Adverse Event|2|||
94743846|NCT04181788|324517467|FG002|TREATMENT|Adverse Event|1|||
94743847|NCT04181788|324517468|FG003|TREATMENT|Adverse Event|0|||
94743848|NCT04181788|324517469|FG004|TREATMENT|Adverse Event|1|||
94743849|NCT04181788|324517470|FG005|TREATMENT|Adverse Event|3|||
94743850|NCT04181788|324517465|FG000|TREATMENT|Death|0|||
94743851|NCT04181788|324517466|FG001|TREATMENT|Death|0|||
94743852|NCT04181788|324517467|FG002|TREATMENT|Death|0|||
94743853|NCT04181788|324517468|FG003|TREATMENT|Death|0|||
94743854|NCT04181788|324517469|FG004|TREATMENT|Death|8|||
94743855|NCT04181788|324517470|FG005|TREATMENT|Death|8|||
94743856|NCT04181788|324517465|FG000|TREATMENT|Physician Decision|0|||
94743857|NCT04181788|324517466|FG001|TREATMENT|Physician Decision|0|||
94743858|NCT04181788|324517467|FG002|TREATMENT|Physician Decision|0|||
94743859|NCT04181788|324517468|FG003|TREATMENT|Physician Decision|0|||
94743860|NCT04181788|324517469|FG004|TREATMENT|Physician Decision|0|||
94743861|NCT04181788|324517470|FG005|TREATMENT|Physician Decision|1|||
94743862|NCT04181788|324517465|FG000|TREATMENT|Progressive disease|3|||
94743863|NCT04181788|324517466|FG001|TREATMENT|Progressive disease|3|||
94743864|NCT04181788|324517467|FG002|TREATMENT|Progressive disease|5|||
94743865|NCT04181788|324517468|FG003|TREATMENT|Progressive disease|7|||
94743866|NCT04181788|324517469|FG004|TREATMENT|Progressive disease|20|||
94743867|NCT04181788|324517470|FG005|TREATMENT|Progressive disease|38|||
94743868|NCT04181788|324517465|FG000|TREATMENT|Global deterioration of health status|0|||
94743869|NCT04181788|324517466|FG001|TREATMENT|Global deterioration of health status|2|||
94280438|NCT01995071|322817389|FG001|Overall Study|Lost to Follow-up|0|||
94280439|NCT01995071|322817390|FG002|Overall Study|Lost to Follow-up|0|||
94280440|NCT01995071|322817391|FG003|Overall Study|Lost to Follow-up|0|||
94280441|NCT01995071|322817392|FG004|Overall Study|Lost to Follow-up|0|||
94280442|NCT01995071|322817393|FG005|Overall Study|Lost to Follow-up|0|||
94280443|NCT01995071|322817394|FG006|Overall Study|Lost to Follow-up|0|||
94280444|NCT01995071|322817395|FG007|Overall Study|Lost to Follow-up|1|||
94743870|NCT04181788|324517467|FG002|TREATMENT|Global deterioration of health status|0|||
94743871|NCT04181788|324517468|FG003|TREATMENT|Global deterioration of health status|0|||
94743872|NCT04181788|324517469|FG004|TREATMENT|Global deterioration of health status|2|||
94743873|NCT04181788|324517470|FG005|TREATMENT|Global deterioration of health status|8|||
94743874|NCT04181788|324517465|FG000|TREATMENT|Withdrawal by Subject|1|||
94743875|NCT04181788|324517466|FG001|TREATMENT|Withdrawal by Subject|2|||
94280445|NCT01995071|322817396|FG008|Overall Study|Lost to Follow-up|1|||
94280446|NCT01995071|322817397|FG009|Overall Study|Lost to Follow-up|0|||
94280447|NCT01995071|322817398|FG010|Overall Study|Lost to Follow-up|0|||
94743876|NCT04181788|324517467|FG002|TREATMENT|Withdrawal by Subject|0|||
94205455|NCT00822120|322547968|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
94205456|NCT00822120|322547969|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
94205457|NCT00822120|322547970|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
94205458|NCT00822120|322547965|FG000|PET-directed Therapy|Death|0|||
94205459|NCT00822120|322547966|FG001|PET-directed Therapy|Death|0|||
94205460|NCT00822120|322547967|FG002|PET-directed Therapy|Death|0|||
94205461|NCT00822120|322547968|FG003|PET-directed Therapy|Death|2|||
94205462|NCT00822120|322547969|FG004|PET-directed Therapy|Death|0|||
94205463|NCT00822120|322547970|FG005|PET-directed Therapy|Death|0|||
94205464|NCT00822120|322547965|FG000|PET-directed Therapy|Protocol Violation|0|||
94205465|NCT00822120|322547966|FG001|PET-directed Therapy|Protocol Violation|0|||
94205466|NCT00822120|322547967|FG002|PET-directed Therapy|Protocol Violation|0|||
94205467|NCT00822120|322547968|FG003|PET-directed Therapy|Protocol Violation|6|||
94205468|NCT00822120|322547969|FG004|PET-directed Therapy|Protocol Violation|0|||
94205469|NCT00822120|322547970|FG005|PET-directed Therapy|Protocol Violation|0|||
94205470|NCT04060212|322547974|FG000|Overall Study|Withdrawal by Subject|7|||
94205471|NCT00174252|322547975|FG000|Overall Study|Protocol Violation|2|||
94205472|NCT01171976|322547976|FG000|Overall Study|Protocol Violation|0|||
94205473|NCT01171976|322547977|FG001|Overall Study|Protocol Violation|0|||
94205474|NCT01171976|322547978|FG002|Overall Study|Protocol Violation|1|||
94205475|NCT01171976|322547976|FG000|Overall Study|Death|2|||
94205476|NCT01171976|322547977|FG001|Overall Study|Death|4|||
94205477|NCT01171976|322547978|FG002|Overall Study|Death|1|||
94205478|NCT01171976|322547976|FG000|Overall Study|Lost to Follow-up|4|||
94205479|NCT01171976|322547977|FG001|Overall Study|Lost to Follow-up|0|||
94205480|NCT01171976|322547978|FG002|Overall Study|Lost to Follow-up|2|||
94205481|NCT01171976|322547976|FG000|Overall Study|Withdrawal by Subject|1|||
94205482|NCT01171976|322547977|FG001|Overall Study|Withdrawal by Subject|5|||
94205483|NCT01171976|322547978|FG002|Overall Study|Withdrawal by Subject|6|||
94205484|NCT01171976|322547976|FG000|Overall Study|Abnormal test result|1|||
94205485|NCT01171976|322547977|FG001|Overall Study|Abnormal test result|0|||
94205486|NCT01171976|322547978|FG002|Overall Study|Abnormal test result|0|||
94205487|NCT01171976|322547976|FG000|Overall Study|Adverse Event|6|||
94205488|NCT01171976|322547977|FG001|Overall Study|Adverse Event|2|||
94205489|NCT01171976|322547978|FG002|Overall Study|Adverse Event|5|||
94205490|NCT03170882|322547979|FG000|Overall Study|Death|17|||
94205491|NCT03170882|322547980|FG001|Overall Study|Death|29|||
94205492|NCT03170882|322547979|FG000|Overall Study|Lost to Follow-up|0|||
94205493|NCT03170882|322547980|FG001|Overall Study|Lost to Follow-up|1|||
94205494|NCT03170882|322547979|FG000|Overall Study|Withdrawal by Subject|4|||
94205495|NCT03170882|322547980|FG001|Overall Study|Withdrawal by Subject|7|||
94205496|NCT03170882|322547979|FG000|Overall Study|Reason not Specified|28|||
94205497|NCT03170882|322547980|FG001|Overall Study|Reason not Specified|36|||
94205498|NCT03500549|322547982|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
94205499|NCT03500549|322547983|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
94205500|NCT03500549|322547982|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
94205501|NCT03500549|322547983|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
94205502|NCT03611075|322547985|FG000|Overall Study|Physician Decision|0|||
94205503|NCT03611075|322547986|FG001|Overall Study|Physician Decision|1|||
94205504|NCT03611075|322547987|FG002|Overall Study|Physician Decision|1|||
94205505|NCT03611075|322547988|FG003|Overall Study|Physician Decision|0|||
94205506|NCT03611075|322547989|FG004|Overall Study|Physician Decision|0|||
94205507|NCT03611075|322547990|FG005|Overall Study|Physician Decision|0|||
94205508|NCT03611075|322547991|FG006|Overall Study|Physician Decision|0|||
94205509|NCT03611075|322547992|FG007|Overall Study|Physician Decision|0|||
94205510|NCT03611075|322547993|FG008|Overall Study|Physician Decision|0|||
94205511|NCT03611075|322547985|FG000|Overall Study|Lost to Follow-up|1|||
94205512|NCT03611075|322547986|FG001|Overall Study|Lost to Follow-up|0|||
94205513|NCT03611075|322547987|FG002|Overall Study|Lost to Follow-up|0|||
94205514|NCT03611075|322547988|FG003|Overall Study|Lost to Follow-up|2|||
94205515|NCT03611075|322547989|FG004|Overall Study|Lost to Follow-up|0|||
94205516|NCT03611075|322547990|FG005|Overall Study|Lost to Follow-up|0|||
94205517|NCT03611075|322547991|FG006|Overall Study|Lost to Follow-up|0|||
94205518|NCT03611075|322547992|FG007|Overall Study|Lost to Follow-up|0|||
94205519|NCT03611075|322547993|FG008|Overall Study|Lost to Follow-up|0|||
94205520|NCT03611075|322547985|FG000|Overall Study|Withdrawal by Subject|0|||
94205521|NCT03611075|322547986|FG001|Overall Study|Withdrawal by Subject|1|||
94205522|NCT03611075|322547987|FG002|Overall Study|Withdrawal by Subject|1|||
94280448|NCT01995071|322817399|FG011|Overall Study|Lost to Follow-up|0|||
94205523|NCT03611075|322547988|FG003|Overall Study|Withdrawal by Subject|1|||
94205524|NCT03611075|322547989|FG004|Overall Study|Withdrawal by Subject|0|||
94205525|NCT03611075|322547990|FG005|Overall Study|Withdrawal by Subject|0|||
94205526|NCT03611075|322547991|FG006|Overall Study|Withdrawal by Subject|1|||
94205527|NCT03611075|322547992|FG007|Overall Study|Withdrawal by Subject|0|||
94205528|NCT03611075|322547993|FG008|Overall Study|Withdrawal by Subject|0|||
94205529|NCT03611075|322547985|FG000|Overall Study|Reason unknown|0|||
94205530|NCT03611075|322547986|FG001|Overall Study|Reason unknown|0|||
94205531|NCT03611075|322547987|FG002|Overall Study|Reason unknown|0|||
94205532|NCT03611075|322547988|FG003|Overall Study|Reason unknown|1|||
94205533|NCT03611075|322547989|FG004|Overall Study|Reason unknown|0|||
94205534|NCT03611075|322547990|FG005|Overall Study|Reason unknown|0|||
94205535|NCT03611075|322547991|FG006|Overall Study|Reason unknown|1|||
94205536|NCT03611075|322547992|FG007|Overall Study|Reason unknown|0|||
94205537|NCT03611075|322547993|FG008|Overall Study|Reason unknown|0|||
94205538|NCT02016872|322547994|FG000|Overall Study|Withdrawal by Subject|10|||
94205539|NCT02016872|322547994|FG000|Overall Study|Death Progression|2|||
94205540|NCT02016872|322547994|FG000|Overall Study|No FMISO scan|1|||
94205541|NCT02016872|322547994|FG000|Overall Study|Ineligible|2|||
94205542|NCT03221426|322547999|FG000|Overall Study|Ongoing in study|212|||
94205543|NCT03221426|322548000|FG001|Overall Study|Ongoing in study|193|||
94205544|NCT03221426|322548001|FG002|Overall Study|Ongoing in study|61|||
94205545|NCT03221426|322548002|FG003|Overall Study|Ongoing in study|55|||
94205546|NCT03221426|322547999|FG000|Overall Study|Withdrawal by Subject|12|||
94205547|NCT03221426|322548000|FG001|Overall Study|Withdrawal by Subject|4|||
94205548|NCT03221426|322548001|FG002|Overall Study|Withdrawal by Subject|2|||
94205549|NCT03221426|322548002|FG003|Overall Study|Withdrawal by Subject|3|||
94205550|NCT03221426|322547999|FG000|Overall Study|Lost to Follow-up|4|||
94205551|NCT03221426|322548000|FG001|Overall Study|Lost to Follow-up|1|||
94205552|NCT03221426|322548001|FG002|Overall Study|Lost to Follow-up|1|||
94205553|NCT03221426|322548002|FG003|Overall Study|Lost to Follow-up|0|||
94205554|NCT03221426|322547999|FG000|Overall Study|Death|174|||
94205555|NCT03221426|322548000|FG001|Overall Study|Death|204|||
94205556|NCT03221426|322548001|FG002|Overall Study|Death|36|||
94205557|NCT03221426|322548002|FG003|Overall Study|Death|45|||
94205558|NCT02831049|322548003|FG000|Overall Study|Lost to Follow-up|0|||
94205559|NCT02831049|322548004|FG001|Overall Study|Lost to Follow-up|0|||
94205560|NCT02831049|322548005|FG002|Overall Study|Lost to Follow-up|1|||
94205561|NCT02831049|322548003|FG000|Overall Study|Withdrawal by Subject|0|||
94205562|NCT02831049|322548004|FG001|Overall Study|Withdrawal by Subject|1|||
94205563|NCT02831049|322548005|FG002|Overall Study|Withdrawal by Subject|1|||
94205564|NCT02831049|322548003|FG000|Overall Study|Pandemic shutdown|1|||
94205565|NCT02831049|322548004|FG001|Overall Study|Pandemic shutdown|0|||
94205566|NCT02831049|322548005|FG002|Overall Study|Pandemic shutdown|0|||
94205567|NCT02761187|322548006|FG000|Overall Study|Too ill to Participate|13|||
94205568|NCT02761187|322548007|FG001|Overall Study|Too ill to Participate|8|||
94205569|NCT02761187|322548006|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
94205570|NCT02761187|322548007|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
94205571|NCT02761187|322548006|FG000|Overall Study|Patient withdrew consent|64|||
94205572|NCT02761187|322548007|FG001|Overall Study|Patient withdrew consent|58|||
94205573|NCT02761187|322548006|FG000|Overall Study|Physician discretion|4|||
94205574|NCT02761187|322548007|FG001|Overall Study|Physician discretion|8|||
94205575|NCT02761187|322548006|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
94205576|NCT02761187|322548007|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
94205577|NCT02761187|322548006|FG000|Overall Study|On Hospice|20|||
94205578|NCT02761187|322548007|FG001|Overall Study|On Hospice|26|||
94205579|NCT02761187|322548006|FG000|Overall Study|Deceased|474|||
94205580|NCT02761187|322548007|FG001|Overall Study|Deceased|642|||
94205581|NCT02761187|322548006|FG000|Overall Study|Lost to Follow-up|73|||
94205582|NCT02761187|322548007|FG001|Overall Study|Lost to Follow-up|63|||
94205583|NCT02761187|322548006|FG000|Overall Study|Due to study discontinued at site|100|||
94205584|NCT02761187|322548007|FG001|Overall Study|Due to study discontinued at site|85|||
94205585|NCT02761187|322548006|FG000|Overall Study|Reason not Specified|1484|||
94205586|NCT02761187|322548007|FG001|Overall Study|Reason not Specified|937|||
94205587|NCT03610581|322548008|FG000|Overall Study|Study terminated by sponsor|2|||
94205588|NCT03610581|322548009|FG001|Overall Study|Study terminated by sponsor|0|||
94205589|NCT03610581|322548008|FG000|Overall Study|Other|0|||
94205590|NCT03610581|322548009|FG001|Overall Study|Other|1|||
94205591|NCT03610581|322548008|FG000|Overall Study|Withdrawal by Subject|1|||
94205592|NCT03610581|322548009|FG001|Overall Study|Withdrawal by Subject|0|||
94205593|NCT03835754|322548010|FG000|Overall Study|Death|4|||
94205594|NCT02609048|322548011|FG000|Overall Study|Adverse Event|3|||
94205595|NCT02609048|322548012|FG001|Overall Study|Adverse Event|0|||
94280449|NCT01995071|322817388|FG000|Overall Study|Incarcerated|0|||
94280450|NCT01995071|322817389|FG001|Overall Study|Incarcerated|0|||
94280451|NCT01995071|322817390|FG002|Overall Study|Incarcerated|0|||
94280452|NCT01995071|322817391|FG003|Overall Study|Incarcerated|0|||
94205596|NCT02609048|322548013|FG002|Overall Study|Adverse Event|0|||
94205597|NCT02609048|322548011|FG000|Overall Study|Randomized but never treated|1|||
94205598|NCT02609048|322548012|FG001|Overall Study|Randomized but never treated|1|||
94205599|NCT02609048|322548013|FG002|Overall Study|Randomized but never treated|1|||
94205600|NCT02609048|322548011|FG000|Overall Study|Withdrawal of informed consent|1|||
94205601|NCT02609048|322548012|FG001|Overall Study|Withdrawal of informed consent|0|||
94205602|NCT02609048|322548013|FG002|Overall Study|Withdrawal of informed consent|0|||
94205603|NCT02609048|322548011|FG000|Overall Study|Reason not specified|6|||
94205604|NCT02609048|322548012|FG001|Overall Study|Reason not specified|9|||
94280453|NCT01995071|322817392|FG004|Overall Study|Incarcerated|0|||
94280454|NCT01995071|322817393|FG005|Overall Study|Incarcerated|0|||
94280455|NCT01995071|322817394|FG006|Overall Study|Incarcerated|0|||
94280456|NCT01995071|322817395|FG007|Overall Study|Incarcerated|1|||
94280457|NCT01995071|322817396|FG008|Overall Study|Incarcerated|0|||
94280458|NCT01995071|322817397|FG009|Overall Study|Incarcerated|0|||
94280459|NCT01995071|322817398|FG010|Overall Study|Incarcerated|0|||
94280460|NCT01995071|322817399|FG011|Overall Study|Incarcerated|0|||
94280461|NCT00621504|322817400|FG000|Overall Study|Adverse Event|1|||
94280462|NCT00621504|322817401|FG001|Overall Study|Adverse Event|3|||
94280463|NCT00621504|322817400|FG000|Overall Study|At the request of sponsor/investigator|1|||
94743877|NCT04181788|324517468|FG003|TREATMENT|Withdrawal by Subject|0|||
94743878|NCT04181788|324517469|FG004|TREATMENT|Withdrawal by Subject|3|||
94743879|NCT04181788|324517470|FG005|TREATMENT|Withdrawal by Subject|5|||
94743880|NCT04181788|324517465|FG000|TREATMENT|Other unspecified|0|||
94743881|NCT04181788|324517466|FG001|TREATMENT|Other unspecified|0|||
94743882|NCT04181788|324517467|FG002|TREATMENT|Other unspecified|0|||
94743883|NCT04181788|324517468|FG003|TREATMENT|Other unspecified|0|||
94743884|NCT04181788|324517469|FG004|TREATMENT|Other unspecified|0|||
94743885|NCT04181788|324517470|FG005|TREATMENT|Other unspecified|2|||
94743886|NCT04181788|324517465|FG000|TREATMENT|Ongoing|0|||
94743887|NCT04181788|324517466|FG001|TREATMENT|Ongoing|3|||
94743888|NCT04181788|324517467|FG002|TREATMENT|Ongoing|0|||
94743889|NCT04181788|324517468|FG003|TREATMENT|Ongoing|5|||
94743890|NCT04181788|324517469|FG004|TREATMENT|Ongoing|7|||
94743891|NCT04181788|324517470|FG005|TREATMENT|Ongoing|15|||
94743892|NCT04181788|324517465|FG000|FOLLOW-UP|Death|0|||
94743893|NCT04181788|324517466|FG001|FOLLOW-UP|Death|0|||
94743894|NCT04181788|324517467|FG002|FOLLOW-UP|Death|1|||
94743895|NCT04181788|324517468|FG003|FOLLOW-UP|Death|2|||
94743896|NCT04181788|324517469|FG004|FOLLOW-UP|Death|8|||
94743897|NCT04181788|324517470|FG005|FOLLOW-UP|Death|20|||
94743898|NCT04181788|324517465|FG000|FOLLOW-UP|Lost to Follow-up|0|||
94743899|NCT04181788|324517466|FG001|FOLLOW-UP|Lost to Follow-up|0|||
94743900|NCT04181788|324517467|FG002|FOLLOW-UP|Lost to Follow-up|0|||
94743901|NCT04181788|324517468|FG003|FOLLOW-UP|Lost to Follow-up|0|||
94743902|NCT04181788|324517469|FG004|FOLLOW-UP|Lost to Follow-up|0|||
94743903|NCT04181788|324517470|FG005|FOLLOW-UP|Lost to Follow-up|2|||
94743904|NCT04181788|324517465|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
94743905|NCT04181788|324517466|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
94743906|NCT04181788|324517467|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
94743907|NCT04181788|324517468|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
94743908|NCT04181788|324517469|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
94743909|NCT04181788|324517470|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
94743910|NCT04181788|324517465|FG000|FOLLOW-UP|Other unspecified|0|||
94743911|NCT04181788|324517466|FG001|FOLLOW-UP|Other unspecified|1|||
94743912|NCT04181788|324517467|FG002|FOLLOW-UP|Other unspecified|0|||
94743913|NCT04181788|324517468|FG003|FOLLOW-UP|Other unspecified|0|||
94743914|NCT04181788|324517469|FG004|FOLLOW-UP|Other unspecified|0|||
94743915|NCT04181788|324517470|FG005|FOLLOW-UP|Other unspecified|3|||
94743916|NCT04181788|324517465|FG000|FOLLOW-UP|Ongoing|0|||
94743917|NCT04181788|324517466|FG001|FOLLOW-UP|Ongoing|0|||
94743918|NCT04181788|324517467|FG002|FOLLOW-UP|Ongoing|1|||
94743919|NCT04181788|324517468|FG003|FOLLOW-UP|Ongoing|3|||
94743920|NCT04181788|324517469|FG004|FOLLOW-UP|Ongoing|2|||
94743921|NCT04181788|324517470|FG005|FOLLOW-UP|Ongoing|2|||
94743922|NCT04186247|324517654|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
94743923|NCT04186247|324517655|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
94743924|NCT04186247|324517656|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
94743925|NCT04186247|324517657|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
94743926|NCT04186247|324517658|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
94743927|NCT05529992|324517664|FG000|Overall Study|Withdrawal by Subject|1|||
94743928|NCT04573881|324517667|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
94743929|NCT02564978|324517670|FG000|Overall Study|Adverse Event|8|||
94743930|NCT02564978|324517670|FG000|Overall Study|Death|1|||
94280464|NCT00621504|322817401|FG001|Overall Study|At the request of sponsor/investigator|0|||
94280465|NCT00621504|322817400|FG000|Overall Study|Withdrew consent|9|||
94280466|NCT00621504|322817401|FG001|Overall Study|Withdrew consent|6|||
94743931|NCT02564978|324517670|FG000|Overall Study|Lost to Follow-up|1|||
94743932|NCT02564978|324517670|FG000|Overall Study|Withdrawal by Subject|15|||
94743933|NCT02564978|324517670|FG000|Overall Study|Early Study Closure|2|||
94280467|NCT00621504|322817400|FG000|Overall Study|Lost to Follow-up|8|||
94743934|NCT02564978|324517670|FG000|Overall Study|Other Reason|5|||
94280468|NCT00621504|322817401|FG001|Overall Study|Lost to Follow-up|10|||
94280469|NCT00621504|322817400|FG000|Overall Study|Other|1|||
94280470|NCT00621504|322817401|FG001|Overall Study|Other|0|||
94280471|NCT00621504|322817400|FG000|Overall Study|Death|6|||
94280472|NCT00621504|322817401|FG001|Overall Study|Death|6|||
94280473|NCT01391000|322817402|FG000|Overall Study|Lost to Follow-up|2|||
94280474|NCT01391000|322817403|FG001|Overall Study|Lost to Follow-up|0|||
94280475|NCT02239939|322817405|FG000|Overall Study|Adverse Event|1|||
94280476|NCT02239939|322817406|FG001|Overall Study|Adverse Event|0|||
94280477|NCT02239939|322817405|FG000|Overall Study|Withdrawal by Subject|1|||
94280478|NCT02239939|322817406|FG001|Overall Study|Withdrawal by Subject|1|||
94280479|NCT02239939|322817405|FG000|Overall Study|Lost to Follow-up|0|||
94280480|NCT02239939|322817406|FG001|Overall Study|Lost to Follow-up|1|||
94280481|NCT03733392|322817409|FG000|Overall Study|Withdrawal by Subject|11|||
94280482|NCT03733392|322817410|FG001|Overall Study|Withdrawal by Subject|1|||
94205605|NCT02609048|322548013|FG002|Overall Study|Reason not specified|9|||
94205606|NCT02517268|322548015|FG000|Overall Study|Withdrawal by Subject|1|||
94205607|NCT02517268|322548016|FG001|Overall Study|Withdrawal by Subject|0|||
94371152|NCT03627195|323146758|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
94371153|NCT00566098|323146762|FG000|Collection of MILs|Withdrawal by Subject|1|||
94371154|NCT00566098|323146762|FG000|Collection of MILs|Relapsed|1|||
94371155|NCT00566098|323146762|FG000|Generation of MILs Product|Relapsed|1|||
94371156|NCT00566098|323146762|FG000|Administration of ASCT+MILs|Death|10|||
94371157|NCT00566098|323146762|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
94371158|NCT00096382|323146763|FG000|Overall Study|Not treated|1|||
94371159|NCT00096382|323146764|FG001|Overall Study|Not treated|0|||
94371160|NCT00096382|323146763|FG000|Overall Study|Death during treatment|1|||
94371161|NCT00096382|323146764|FG001|Overall Study|Death during treatment|0|||
94371162|NCT03101293|323146765|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
94371163|NCT03101293|323146766|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
94371164|NCT03862625|323146772|FG000|Overall Study|Lost to Follow-up|0|||
94371165|NCT03862625|323146773|FG001|Overall Study|Lost to Follow-up|1|||
94371166|NCT02402933|323146777|FG000|Overall Study|Withdrawal by Subject|4|||
94371167|NCT02402933|323146777|FG000|Overall Study|Discontinued; Site Termination|10|||
94371168|NCT02544633|323146786|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
94371169|NCT02544633|323146787|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
94371170|NCT02544633|323146788|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
94371171|NCT02544633|323146789|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
94371172|NCT02544633|323146786|FG000|Treatment Period|Adverse Event|7|||
94371173|NCT02544633|323146787|FG001|Treatment Period|Adverse Event|4|||
94371174|NCT02544633|323146788|FG002|Treatment Period|Adverse Event|0|||
94371175|NCT02544633|323146789|FG003|Treatment Period|Adverse Event|5|||
94371176|NCT02544633|323146786|FG000|Treatment Period|Lack of Efficacy|17|||
94371177|NCT02544633|323146787|FG001|Treatment Period|Lack of Efficacy|11|||
94371178|NCT02544633|323146788|FG002|Treatment Period|Lack of Efficacy|5|||
94371179|NCT02544633|323146789|FG003|Treatment Period|Lack of Efficacy|5|||
94371180|NCT02544633|323146786|FG000|Treatment Period|Global Deterioration of Health|3|||
94371181|NCT02544633|323146787|FG001|Treatment Period|Global Deterioration of Health|3|||
94371182|NCT02544633|323146788|FG002|Treatment Period|Global Deterioration of Health|0|||
94371183|NCT02544633|323146789|FG003|Treatment Period|Global Deterioration of Health|1|||
94371184|NCT02544633|323146786|FG000|Treatment Period|Withdrawal by Subject|1|||
94371185|NCT02544633|323146787|FG001|Treatment Period|Withdrawal by Subject|0|||
94371186|NCT02544633|323146788|FG002|Treatment Period|Withdrawal by Subject|0|||
94371187|NCT02544633|323146789|FG003|Treatment Period|Withdrawal by Subject|0|||
94371188|NCT02544633|323146786|FG000|Treatment Period|Lost to Follow-up|0|||
94371189|NCT02544633|323146787|FG001|Treatment Period|Lost to Follow-up|1|||
94371190|NCT02544633|323146788|FG002|Treatment Period|Lost to Follow-up|0|||
94371191|NCT02544633|323146789|FG003|Treatment Period|Lost to Follow-up|0|||
94371192|NCT02544633|323146786|FG000|Treatment Period|Death|0|||
94371193|NCT02544633|323146787|FG001|Treatment Period|Death|0|||
94371194|NCT02544633|323146788|FG002|Treatment Period|Death|1|||
94467661|NCT01004432|323502377|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
94467662|NCT01004432|323502373|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
94371195|NCT02544633|323146789|FG003|Treatment Period|Death|0|||
94371196|NCT02544633|323146786|FG000|Treatment Period|Non-compliance|0|||
94371197|NCT02544633|323146787|FG001|Treatment Period|Non-compliance|0|||
94371198|NCT02544633|323146788|FG002|Treatment Period|Non-compliance|1|||
94371199|NCT02544633|323146789|FG003|Treatment Period|Non-compliance|0|||
94371200|NCT02544633|323146786|FG000|Treatment Period|Clinical Disease Progression|0|||
94371201|NCT02544633|323146787|FG001|Treatment Period|Clinical Disease Progression|0|||
94371202|NCT02544633|323146788|FG002|Treatment Period|Clinical Disease Progression|0|||
94371203|NCT02544633|323146789|FG003|Treatment Period|Clinical Disease Progression|1|||
94371204|NCT02544633|323146786|FG000|Survival Follow-up Period|Death|12|||
94371205|NCT02544633|323146787|FG001|Survival Follow-up Period|Death|14|||
94371206|NCT02544633|323146788|FG002|Survival Follow-up Period|Death|3|||
94371207|NCT02544633|323146789|FG003|Survival Follow-up Period|Death|9|||
94371208|NCT02544633|323146786|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
94371209|NCT02544633|323146787|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
94371210|NCT02544633|323146788|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
94371211|NCT02544633|323146789|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
94371212|NCT02544633|323146786|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
94371213|NCT02544633|323146787|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
94280483|NCT03733392|322817409|FG000|Overall Study|Death|1|||
94280484|NCT03733392|322817410|FG001|Overall Study|Death|0|||
94280485|NCT03733392|322817409|FG000|Overall Study|Lost to Follow-up|5|||
94280486|NCT03733392|322817410|FG001|Overall Study|Lost to Follow-up|0|||
94280487|NCT03733392|322817409|FG000|Overall Study|Protocol Violation|0|||
94280488|NCT03733392|322817410|FG001|Overall Study|Protocol Violation|1|||
94280489|NCT03733392|322817409|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
94280490|NCT03733392|322817410|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
94280491|NCT03733392|322817409|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
94280492|NCT03733392|322817410|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
94280493|NCT03733392|322817409|FG000|Overall Study|Patient Non-Compliance|2|||
94280494|NCT03733392|322817410|FG001|Overall Study|Patient Non-Compliance|1|||
94280495|NCT03733392|322817409|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
94280496|NCT03733392|322817410|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
94280497|NCT03733392|322817409|FG000|Overall Study|Withdrawal prior to procedure|5|||
94280498|NCT03733392|322817410|FG001|Overall Study|Withdrawal prior to procedure|2|||
94280499|NCT00356278|322817411|FG000|Overall Study|Withdrawal by Subject|25|||
94280500|NCT00356278|322817412|FG001|Overall Study|Withdrawal by Subject|15|||
94280501|NCT00356278|322817413|FG002|Overall Study|Withdrawal by Subject|19|||
94280502|NCT03189446|322817414|FG000|Overall Study|Adverse Event|2|||
94280503|NCT03189446|322817414|FG000|Overall Study|Withdrawal by Subject|2|||
94280504|NCT03189446|322817414|FG000|Overall Study|Physician Decision|1|||
94280505|NCT00883337|322817415|FG000|Core Treatment Period|Adverse Event|9|||
94280506|NCT00883337|322817416|FG001|Core Treatment Period|Adverse Event|12|||
94280507|NCT00883337|322817417|FG002|Core Treatment Period|Adverse Event|22|||
94280508|NCT00883337|322817415|FG000|Core Treatment Period|Lack of Efficacy|7|||
94280509|NCT00883337|322817416|FG001|Core Treatment Period|Lack of Efficacy|4|||
94280510|NCT00883337|322817417|FG002|Core Treatment Period|Lack of Efficacy|2|||
94280511|NCT00883337|322817415|FG000|Core Treatment Period|Lost to Follow-up|1|||
94280512|NCT00883337|322817416|FG001|Core Treatment Period|Lost to Follow-up|1|||
94280513|NCT00883337|322817417|FG002|Core Treatment Period|Lost to Follow-up|0|||
94280514|NCT00883337|322817415|FG000|Core Treatment Period|Withdrawal by Subject|2|||
94280515|NCT00883337|322817416|FG001|Core Treatment Period|Withdrawal by Subject|2|||
94280516|NCT00883337|322817417|FG002|Core Treatment Period|Withdrawal by Subject|6|||
94280517|NCT00883337|322817415|FG000|Core Treatment Period|Wish to be pregnant|1|||
94280518|NCT00883337|322817416|FG001|Core Treatment Period|Wish to be pregnant|2|||
94280519|NCT00883337|322817417|FG002|Core Treatment Period|Wish to be pregnant|1|||
94280520|NCT00883337|322817415|FG000|Core Treatment Period|Poor compliance to protocol|0|||
94280521|NCT00883337|322817416|FG001|Core Treatment Period|Poor compliance to protocol|0|||
94280522|NCT00883337|322817417|FG002|Core Treatment Period|Poor compliance to protocol|1|||
94280523|NCT00883337|322817415|FG000|Core Treatment Period|Other than above|0|||
94280524|NCT00883337|322817416|FG001|Core Treatment Period|Other than above|1|||
94280525|NCT00883337|322817417|FG002|Core Treatment Period|Other than above|1|||
94280526|NCT00883337|322817415|FG000|Extension Treatment Period|Adverse Event|8|||
94280527|NCT00883337|322817416|FG001|Extension Treatment Period|Adverse Event|5|||
94280528|NCT00883337|322817417|FG002|Extension Treatment Period|Adverse Event|5|||
94280529|NCT00883337|322817415|FG000|Extension Treatment Period|Lack of Efficacy|8|||
94280530|NCT00883337|322817416|FG001|Extension Treatment Period|Lack of Efficacy|8|||
94280531|NCT00883337|322817417|FG002|Extension Treatment Period|Lack of Efficacy|8|||
94280532|NCT00883337|322817415|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
94280533|NCT00883337|322817416|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
94280534|NCT00883337|322817417|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
94205686|NCT04445831|322548024|FG000|Overall Study|Withdrawal by Subject|2|||
94205687|NCT04445831|322548025|FG001|Overall Study|Withdrawal by Subject|1|||
94205688|NCT04445831|322548026|FG002|Overall Study|Withdrawal by Subject|1|||
94205689|NCT04445831|322548027|FG003|Overall Study|Withdrawal by Subject|0|||
94205690|NCT04445831|322548028|FG004|Overall Study|Withdrawal by Subject|0|||
94205691|NCT04445831|322548029|FG005|Overall Study|Withdrawal by Subject|0|||
94205692|NCT04445831|322548030|FG006|Overall Study|Withdrawal by Subject|0|||
94205693|NCT04445831|322548024|FG000|Overall Study|Subject withdrawal by caregiver|0|||
94205694|NCT04445831|322548025|FG001|Overall Study|Subject withdrawal by caregiver|1|||
94205695|NCT04445831|322548026|FG002|Overall Study|Subject withdrawal by caregiver|0|||
94205696|NCT04445831|322548027|FG003|Overall Study|Subject withdrawal by caregiver|0|||
94205697|NCT04445831|322548028|FG004|Overall Study|Subject withdrawal by caregiver|0|||
94205698|NCT04445831|322548029|FG005|Overall Study|Subject withdrawal by caregiver|0|||
94205699|NCT04445831|322548030|FG006|Overall Study|Subject withdrawal by caregiver|0|||
94205700|NCT04937504|322548031|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
94280535|NCT00883337|322817415|FG000|Extension Treatment Period|Lost to Follow-up|1|||
94280536|NCT00883337|322817416|FG001|Extension Treatment Period|Lost to Follow-up|0|||
94205701|NCT04937504|322548032|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
94205702|NCT04937504|322548031|FG000|9 Months Assessment|Lost to Follow-up|3|||
94205703|NCT04937504|322548032|FG001|9 Months Assessment|Lost to Follow-up|2|||
94205704|NCT04306367|322548033|FG000|Overall Study|Progression of Disease|9|||
94205705|NCT04306367|322548033|FG000|Overall Study|Adverse Event|3|||
94205706|NCT04306367|322548033|FG000|Overall Study|Withdrawal by Subject|1|||
94205707|NCT02337686|322548034|FG000|Overall Study|Adverse Event|1|||
94205708|NCT05037513|322548035|FG000|Intervention Period|Lost to Follow-up|1|||
94205709|NCT05037513|322548036|FG001|Intervention Period|Lost to Follow-up|2|||
94205710|NCT05037513|322548035|FG000|Follow Up Period|Lost to Follow-up|16|||
94205711|NCT05037513|322548036|FG001|Follow Up Period|Lost to Follow-up|21|||
94205712|NCT05037513|322548035|FG000|Follow Up Period|Death|0|||
94205713|NCT05037513|322548036|FG001|Follow Up Period|Death|1|||
94205714|NCT05037513|322548035|FG000|Follow Up Period|Incarcerated|4|||
94205715|NCT05037513|322548036|FG001|Follow Up Period|Incarcerated|2|||
94205716|NCT05886777|322548039|FG000|Overall Study|Lost to Follow-up|1|||
94205717|NCT05886777|322548040|FG001|Overall Study|Lost to Follow-up|0|||
94205718|NCT05886777|322548041|FG002|Overall Study|Lost to Follow-up|2|||
94205719|NCT05886777|322548042|FG003|Overall Study|Lost to Follow-up|1|||
94205720|NCT05886777|322548043|FG004|Overall Study|Lost to Follow-up|0|||
94205721|NCT05886777|322548044|FG005|Overall Study|Lost to Follow-up|2|||
94205722|NCT05886777|322548045|FG006|Overall Study|Lost to Follow-up|0|||
94205723|NCT05886777|322548039|FG000|Overall Study|Other|0|||
94205724|NCT05886777|322548040|FG001|Overall Study|Other|2|||
94205725|NCT05886777|322548041|FG002|Overall Study|Other|1|||
94205726|NCT05886777|322548042|FG003|Overall Study|Other|0|||
94205727|NCT05886777|322548043|FG004|Overall Study|Other|0|||
94205728|NCT05886777|322548044|FG005|Overall Study|Other|0|||
94205729|NCT05886777|322548045|FG006|Overall Study|Other|0|||
94205730|NCT05886777|322548039|FG000|Overall Study|Withdrawal by Subject|1|||
94205731|NCT05886777|322548040|FG001|Overall Study|Withdrawal by Subject|0|||
94205732|NCT05886777|322548041|FG002|Overall Study|Withdrawal by Subject|1|||
94205733|NCT05886777|322548042|FG003|Overall Study|Withdrawal by Subject|4|||
94205734|NCT05886777|322548043|FG004|Overall Study|Withdrawal by Subject|3|||
94205735|NCT05886777|322548044|FG005|Overall Study|Withdrawal by Subject|1|||
94205736|NCT05886777|322548045|FG006|Overall Study|Withdrawal by Subject|1|||
94205737|NCT05886777|322548039|FG000|Overall Study|Protocol Violation|0|||
94205738|NCT05886777|322548040|FG001|Overall Study|Protocol Violation|0|||
94205739|NCT05886777|322548041|FG002|Overall Study|Protocol Violation|1|||
94205740|NCT05886777|322548042|FG003|Overall Study|Protocol Violation|0|||
94205741|NCT05886777|322548043|FG004|Overall Study|Protocol Violation|0|||
94205742|NCT05886777|322548044|FG005|Overall Study|Protocol Violation|0|||
94205743|NCT05886777|322548045|FG006|Overall Study|Protocol Violation|0|||
94205744|NCT05886777|322548039|FG000|Overall Study|No longer met eligibility criteria|0|||
94205745|NCT05886777|322548040|FG001|Overall Study|No longer met eligibility criteria|1|||
94205746|NCT05886777|322548041|FG002|Overall Study|No longer met eligibility criteria|0|||
94205747|NCT05886777|322548042|FG003|Overall Study|No longer met eligibility criteria|0|||
94205748|NCT05886777|322548043|FG004|Overall Study|No longer met eligibility criteria|0|||
94205749|NCT05886777|322548044|FG005|Overall Study|No longer met eligibility criteria|0|||
94205750|NCT05886777|322548045|FG006|Overall Study|No longer met eligibility criteria|0|||
94205751|NCT03976323|322548046|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
94205752|NCT03976323|322548047|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
94205753|NCT03976323|322548048|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
94205754|NCT03976323|322548046|FG000|Induction Phase|Death|80|||
94205755|NCT03976323|322548047|FG001|Induction Phase|Death|0|||
94205756|NCT03976323|322548048|FG002|Induction Phase|Death|0|||
94205757|NCT03976323|322548046|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
94205758|NCT03976323|322548047|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
94205759|NCT03976323|322548048|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
94205760|NCT03976323|322548046|FG000|Maintenance Phase|Withdrawal by Subject|0|||
94205761|NCT03976323|322548047|FG001|Maintenance Phase|Withdrawal by Subject|9|||
94205762|NCT03976323|322548048|FG002|Maintenance Phase|Withdrawal by Subject|3|||
94205763|NCT03976323|322548046|FG000|Maintenance Phase|Physician Decision|0|||
94205764|NCT03976323|322548047|FG001|Maintenance Phase|Physician Decision|0|||
94205765|NCT03976323|322548048|FG002|Maintenance Phase|Physician Decision|1|||
94205766|NCT03976323|322548046|FG000|Maintenance Phase|Death|0|||
94205767|NCT03976323|322548047|FG001|Maintenance Phase|Death|228|||
94205768|NCT03976323|322548048|FG002|Maintenance Phase|Death|234|||
94205769|NCT02386098|322549682|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
94205770|NCT02386098|322549683|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
94205771|NCT02386098|322549684|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
94280537|NCT00883337|322817417|FG002|Extension Treatment Period|Lost to Follow-up|0|||
94280538|NCT00883337|322817415|FG000|Extension Treatment Period|Other than above|10|||
94205772|NCT02386098|322549685|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
94205773|NCT02386098|322549686|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
94205774|NCT02386098|322549682|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
94205775|NCT02386098|322549683|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
94205776|NCT02386098|322549684|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
94205777|NCT02386098|322549685|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
94280539|NCT00883337|322817416|FG001|Extension Treatment Period|Other than above|9|||
94280540|NCT00883337|322817417|FG002|Extension Treatment Period|Other than above|5|||
94205778|NCT02386098|322549686|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
94205779|NCT02386098|322549682|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
94205780|NCT02386098|322549683|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
94205781|NCT02386098|322549684|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
94205782|NCT02386098|322549685|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
94205783|NCT02386098|322549686|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
94280541|NCT00687362|322817421|FG000|Overall Study|Protocol Violation|2|||
94280542|NCT00687362|322817421|FG000|Overall Study|Withdrawal by Subject|1|||
94280543|NCT03468309|322817424|FG000|Overall Study|Lost to Follow-up|4|||
94280544|NCT03468309|322817424|FG000|Overall Study|Withdrawal by Subject|2|||
94280545|NCT02830880|322817425|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
94280546|NCT02830880|322817425|FG000|Overall Study|Death|1|||
94280547|NCT02830880|322817425|FG000|Overall Study|Physician Decision|1|||
94280548|NCT00623480|322817426|FG000|Overall Study|Lost to Follow-up|0|||
94280549|NCT00623480|322817427|FG001|Overall Study|Lost to Follow-up|1|||
94280550|NCT00623480|322817426|FG000|Overall Study|Withdrawal by Subject|2|||
94280551|NCT00623480|322817427|FG001|Overall Study|Withdrawal by Subject|4|||
94280552|NCT00623480|322817426|FG000|Overall Study|Lack of Efficacy|1|||
94280553|NCT00623480|322817427|FG001|Overall Study|Lack of Efficacy|0|||
94280554|NCT00623480|322817426|FG000|Overall Study|Non-compliant with study medication|4|||
94280555|NCT00623480|322817427|FG001|Overall Study|Non-compliant with study medication|0|||
94280556|NCT00623480|322817426|FG000|Overall Study|Protocol Violation|0|||
94280557|NCT00623480|322817427|FG001|Overall Study|Protocol Violation|1|||
94205784|NCT02386098|322549682|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
94205785|NCT02386098|322549683|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
94205786|NCT02386098|322549684|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
94205787|NCT02386098|322549685|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
94205788|NCT02386098|322549686|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
94205789|NCT02386098|322549682|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
94205790|NCT02386098|322549683|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
94205791|NCT02386098|322549684|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
94205792|NCT02386098|322549685|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
94205793|NCT02386098|322549686|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
94205794|NCT02386098|322549682|FG000|Stage 1 (96 Weeks)|Other|1|||
94205795|NCT02386098|322549683|FG001|Stage 1 (96 Weeks)|Other|0|||
94205796|NCT02386098|322549684|FG002|Stage 1 (96 Weeks)|Other|0|||
94205797|NCT02386098|322549685|FG003|Stage 1 (96 Weeks)|Other|0|||
94205798|NCT02386098|322549686|FG004|Stage 1 (96 Weeks)|Other|0|||
94205799|NCT02386098|322549682|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
94205800|NCT02386098|322549683|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
94205801|NCT02386098|322549684|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
94205802|NCT02386098|322549685|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
94205803|NCT02386098|322549686|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
94205804|NCT00655499|322549688|FG000|Overall Study|not eligible|4|||
94205805|NCT04503681|322549694|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
94205806|NCT04503681|322549695|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
94205807|NCT03140670|322549696|FG000|Overall Study|Withdrawal by Subject|2|||
94205808|NCT03140670|322549696|FG000|Overall Study|Lost to Follow-up|1|||
94205809|NCT03140670|322549696|FG000|Overall Study|Physician Decision|1|||
94205810|NCT00220805|322549697|FG000|Overall Study|Adverse Event|1|||
94205811|NCT00220805|322549698|FG001|Overall Study|Adverse Event|3|||
94205812|NCT00220805|322549697|FG000|Overall Study|Withdrawal by Subject|3|||
94205813|NCT00220805|322549698|FG001|Overall Study|Withdrawal by Subject|0|||
94205814|NCT00220805|322549697|FG000|Overall Study|Lack of Efficacy|1|||
94205815|NCT00220805|322549698|FG001|Overall Study|Lack of Efficacy|0|||
94205816|NCT00220805|322549697|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
94205817|NCT00220805|322549698|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
94205818|NCT02325466|322549699|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
94205819|NCT02325466|322549700|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
94205820|NCT02325466|322549701|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
94205821|NCT02325466|322549699|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
94205822|NCT02325466|322549700|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
94205823|NCT02325466|322549701|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
94205824|NCT02325466|322549699|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
94205825|NCT02325466|322549700|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
94205826|NCT02325466|322549701|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
94205827|NCT02325466|322549699|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
94205828|NCT02325466|322549700|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
94205829|NCT02325466|322549701|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
94205830|NCT02325466|322549699|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
94205831|NCT02325466|322549700|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
94205832|NCT02325466|322549701|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
94371214|NCT02544633|323146788|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
94371215|NCT02544633|323146789|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
94371216|NCT02544633|323146786|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
94371217|NCT02544633|323146787|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
94371218|NCT02544633|323146788|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
94371219|NCT02544633|323146789|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
94205833|NCT02325466|322549699|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
94205834|NCT02325466|322549700|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
94205835|NCT02325466|322549701|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
94205836|NCT02325466|322549699|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
94205837|NCT02325466|322549700|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
94205838|NCT02325466|322549701|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
94205839|NCT02325466|322549699|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
94205840|NCT02325466|322549700|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
94205841|NCT02325466|322549701|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
94205842|NCT02325466|322549699|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
94205843|NCT02325466|322549700|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
94205844|NCT02325466|322549701|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
94205845|NCT01812759|322549702|FG000|Overall Study|Physician Decision|0|||
94371220|NCT02024698|323146795|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
94371221|NCT02024698|323146796|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
94371222|NCT04023994|323146798|FG000|Overall Study|Lost to Follow-up|0|||
94371223|NCT04023994|323146799|FG001|Overall Study|Lost to Follow-up|1|||
94371224|NCT04023994|323146800|FG002|Overall Study|Lost to Follow-up|2|||
94205846|NCT01812759|322549703|FG001|Overall Study|Physician Decision|0|||
94205847|NCT01812759|322549704|FG002|Overall Study|Physician Decision|1|||
94205848|NCT00360269|322549705|FG000|Overall Study|Lost to Follow-up|7|||
94205849|NCT00360269|322549706|FG001|Overall Study|Lost to Follow-up|9|||
94205850|NCT00360269|322549705|FG000|Overall Study|Physician Decision|1|||
94205851|NCT00360269|322549706|FG001|Overall Study|Physician Decision|2|||
94205852|NCT00360269|322549705|FG000|Overall Study|Adverse Event|1|||
94205853|NCT00360269|322549706|FG001|Overall Study|Adverse Event|0|||
94205854|NCT00360269|322549705|FG000|Overall Study|Withdrawal by Subject|1|||
94205855|NCT00360269|322549706|FG001|Overall Study|Withdrawal by Subject|1|||
94205856|NCT02111096|322549707|FG000|Overall Study|Adverse Event|4|||
94205857|NCT02111096|322549708|FG001|Overall Study|Adverse Event|1|||
94205858|NCT02111096|322549709|FG002|Overall Study|Adverse Event|2|||
94205859|NCT02111096|322549707|FG000|Overall Study|Non-Compliance with Study Drug|1|||
94205860|NCT02111096|322549708|FG001|Overall Study|Non-Compliance with Study Drug|1|||
94205861|NCT02111096|322549709|FG002|Overall Study|Non-Compliance with Study Drug|0|||
94205862|NCT02111096|322549707|FG000|Overall Study|Lost to Follow Up|1|||
94205863|NCT02111096|322549708|FG001|Overall Study|Lost to Follow Up|1|||
94205864|NCT02111096|322549709|FG002|Overall Study|Lost to Follow Up|1|||
94205865|NCT02111096|322549707|FG000|Overall Study|Physician Decision|0|||
94205866|NCT02111096|322549708|FG001|Overall Study|Physician Decision|1|||
94205867|NCT02111096|322549709|FG002|Overall Study|Physician Decision|0|||
94205868|NCT02111096|322549707|FG000|Overall Study|Protocol Violation|1|||
94205869|NCT02111096|322549708|FG001|Overall Study|Protocol Violation|0|||
94205870|NCT02111096|322549709|FG002|Overall Study|Protocol Violation|1|||
94205871|NCT02111096|322549707|FG000|Overall Study|Terminated by Sponsor|53|||
94205872|NCT02111096|322549708|FG001|Overall Study|Terminated by Sponsor|35|||
94205873|NCT02111096|322549709|FG002|Overall Study|Terminated by Sponsor|54|||
94205874|NCT02111096|322549707|FG000|Overall Study|Withdrawal by Subject|4|||
94205875|NCT02111096|322549708|FG001|Overall Study|Withdrawal by Subject|2|||
94205876|NCT02111096|322549709|FG002|Overall Study|Withdrawal by Subject|8|||
94205877|NCT01268306|322549714|FG000|Overall Study|Lost to Follow-up|1|||
94205878|NCT03621735|322549715|FG000|Overall Study|Withdrawal by Subject|13|||
94205879|NCT03621735|322549716|FG001|Overall Study|Withdrawal by Subject|13|||
94205880|NCT01750684|322549719|FG000|Overall Study|Death|1|||
94205881|NCT01750684|322549720|FG001|Overall Study|Death|0|||
94205882|NCT01750684|322549719|FG000|Overall Study|Non-compliance with Study Drug|0|||
94205883|NCT01750684|322549720|FG001|Overall Study|Non-compliance with Study Drug|1|||
94205884|NCT01750684|322549719|FG000|Overall Study|Withdrawn by Sponsor|0|||
94205885|NCT01750684|322549720|FG001|Overall Study|Withdrawn by Sponsor|1|||
94205886|NCT01750684|322549719|FG000|Overall Study|Protocol Violation|1|||
94205887|NCT01750684|322549720|FG001|Overall Study|Protocol Violation|0|||
94205888|NCT02568215|322549725|FG000|Overall Study|Death|1|||
94205889|NCT02568215|322549726|FG001|Overall Study|Death|2|||
94205890|NCT02568215|322549727|FG002|Overall Study|Death|0|||
94205891|NCT02568215|322549725|FG000|Overall Study|Physician Decision|2|||
94205892|NCT02568215|322549726|FG001|Overall Study|Physician Decision|2|||
94205893|NCT02568215|322549727|FG002|Overall Study|Physician Decision|2|||
94205894|NCT02568215|322549725|FG000|Overall Study|Lost to Follow-up|29|||
94205895|NCT02568215|322549726|FG001|Overall Study|Lost to Follow-up|32|||
94205896|NCT02568215|322549727|FG002|Overall Study|Lost to Follow-up|41|||
94205897|NCT02568215|322549725|FG000|Overall Study|Withdrawal by Subject|21|||
94205898|NCT02568215|322549726|FG001|Overall Study|Withdrawal by Subject|19|||
94205899|NCT02568215|322549727|FG002|Overall Study|Withdrawal by Subject|22|||
94205900|NCT02568215|322549725|FG000|Overall Study|Protocol Violation|1|||
94205901|NCT02568215|322549726|FG001|Overall Study|Protocol Violation|1|||
94205902|NCT02568215|322549727|FG002|Overall Study|Protocol Violation|0|||
94205903|NCT02568215|322549725|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
94205904|NCT02568215|322549726|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
94205905|NCT02568215|322549727|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
94205906|NCT02568215|322549725|FG000|Overall Study|Other|0|||
94205907|NCT02568215|322549726|FG001|Overall Study|Other|1|||
94205908|NCT02568215|322549727|FG002|Overall Study|Other|4|||
94205909|NCT02185794|322549729|FG000|Overall Study|Enrolled but Never Dosed|1|||
94205910|NCT02185794|322549730|FG001|Overall Study|Enrolled but Never Dosed|6|||
94205911|NCT02185794|322549731|FG002|Overall Study|Enrolled but Never Dosed|3|||
94205912|NCT02185794|322549732|FG003|Overall Study|Enrolled but Never Dosed|1|||
94205913|NCT02185794|322549733|FG004|Overall Study|Enrolled but Never Dosed|1|||
94205914|NCT02185794|322549734|FG005|Overall Study|Enrolled but Never Dosed|0|||
94205915|NCT02185794|322549729|FG000|Overall Study|Investigator's Discretion|1|||
94205916|NCT02185794|322549730|FG001|Overall Study|Investigator's Discretion|0|||
94205917|NCT02185794|322549731|FG002|Overall Study|Investigator's Discretion|1|||
94205918|NCT02185794|322549732|FG003|Overall Study|Investigator's Discretion|2|||
94205919|NCT02185794|322549733|FG004|Overall Study|Investigator's Discretion|2|||
94205920|NCT02185794|322549734|FG005|Overall Study|Investigator's Discretion|15|||
94205921|NCT02185794|322549729|FG000|Overall Study|Withdrew Consent|2|||
94205922|NCT02185794|322549730|FG001|Overall Study|Withdrew Consent|5|||
94205923|NCT02185794|322549731|FG002|Overall Study|Withdrew Consent|10|||
94205924|NCT02185794|322549732|FG003|Overall Study|Withdrew Consent|2|||
94205925|NCT02185794|322549733|FG004|Overall Study|Withdrew Consent|0|||
94205926|NCT02185794|322549734|FG005|Overall Study|Withdrew Consent|0|||
94205927|NCT02185794|322549729|FG000|Overall Study|Lost to Follow-up|1|||
94205928|NCT02185794|322549730|FG001|Overall Study|Lost to Follow-up|2|||
94205929|NCT02185794|322549731|FG002|Overall Study|Lost to Follow-up|2|||
94205930|NCT02185794|322549732|FG003|Overall Study|Lost to Follow-up|3|||
94205931|NCT02185794|322549733|FG004|Overall Study|Lost to Follow-up|0|||
94205932|NCT02185794|322549734|FG005|Overall Study|Lost to Follow-up|1|||
94205933|NCT01561300|322549735|FG000|Run in on Placebo|Adverse Event|1|||
94205934|NCT01561300|322549736|FG001|Run in on Placebo|Adverse Event|0|||
94205935|NCT00246805|322549737|FG000|Phase 1|Lost to Follow-up|1|||
94205936|NCT00246805|322549738|FG001|Phase 1|Lost to Follow-up|0|||
94205937|NCT01555138|322549741|FG000|Overall Study|Death|0|||
94205938|NCT01555138|322549742|FG001|Overall Study|Death|1|||
94205939|NCT01555138|322549741|FG000|Overall Study|Lost to Follow-up|1|||
94205940|NCT01555138|322549742|FG001|Overall Study|Lost to Follow-up|0|||
94205941|NCT01555138|322549741|FG000|Overall Study|Abnormal Lab reults|1|||
94205942|NCT01555138|322549742|FG001|Overall Study|Abnormal Lab reults|3|||
94205943|NCT01555138|322549741|FG000|Overall Study|Lack of Efficacy|2|||
94205944|NCT01555138|322549742|FG001|Overall Study|Lack of Efficacy|2|||
94205945|NCT01555138|322549741|FG000|Overall Study|Protocol Violation|5|||
94205946|NCT01555138|322549742|FG001|Overall Study|Protocol Violation|3|||
94205947|NCT01555138|322549741|FG000|Overall Study|Administrative problems|8|||
94205948|NCT01555138|322549742|FG001|Overall Study|Administrative problems|0|||
94205949|NCT01555138|322549741|FG000|Overall Study|Withdrawal by Subject|16|||
94205950|NCT01555138|322549742|FG001|Overall Study|Withdrawal by Subject|15|||
94205951|NCT01555138|322549741|FG000|Overall Study|Adverse Event|14|||
94205952|NCT01555138|322549742|FG001|Overall Study|Adverse Event|14|||
94205953|NCT03244800|322549743|FG000|Overall Study|Adverse Event|0|||
94205954|NCT03244800|322549744|FG001|Overall Study|Adverse Event|1|||
94205955|NCT03244800|322549745|FG002|Overall Study|Adverse Event|0|||
94205956|NCT03244800|322549746|FG003|Overall Study|Adverse Event|1|||
94205957|NCT03244800|322549743|FG000|Overall Study|Withdrew treatment|0|||
94205958|NCT03244800|322549744|FG001|Overall Study|Withdrew treatment|0|||
94205959|NCT03244800|322549745|FG002|Overall Study|Withdrew treatment|0|||
94205960|NCT03244800|322549746|FG003|Overall Study|Withdrew treatment|1|||
94205961|NCT03478969|322549747|FG000|Overall Study|Withdrawal by Subject|4|||
94205962|NCT03478969|322549748|FG001|Overall Study|Withdrawal by Subject|7|||
94205963|NCT03478969|322549749|FG002|Overall Study|Withdrawal by Subject|6|||
94205964|NCT03478969|322549747|FG000|Overall Study|Adverse Event|2|||
94205965|NCT03478969|322549748|FG001|Overall Study|Adverse Event|0|||
94205966|NCT03478969|322549749|FG002|Overall Study|Adverse Event|1|||
94205967|NCT03478969|322549747|FG000|Overall Study|Pregnancy|1|||
94205968|NCT03478969|322549748|FG001|Overall Study|Pregnancy|0|||
94205969|NCT03478969|322549749|FG002|Overall Study|Pregnancy|0|||
94205970|NCT03478969|322549747|FG000|Overall Study|Personal Reasons|1|||
94205971|NCT03478969|322549748|FG001|Overall Study|Personal Reasons|0|||
94205972|NCT03478969|322549749|FG002|Overall Study|Personal Reasons|1|||
94205973|NCT03478969|322549747|FG000|Overall Study|Covid-19|1|||
94205974|NCT03478969|322549748|FG001|Overall Study|Covid-19|4|||
94205975|NCT03478969|322549749|FG002|Overall Study|Covid-19|3|||
94205976|NCT03478969|322549747|FG000|Overall Study|Multiple Reasons|0|||
94205977|NCT03478969|322549748|FG001|Overall Study|Multiple Reasons|1|||
94205978|NCT03478969|322549749|FG002|Overall Study|Multiple Reasons|1|||
94205979|NCT03478969|322549747|FG000|Overall Study|Eligibility Criteria|0|||
94205980|NCT03478969|322549748|FG001|Overall Study|Eligibility Criteria|0|||
94205981|NCT03478969|322549749|FG002|Overall Study|Eligibility Criteria|5|||
94205982|NCT03478969|322549747|FG000|Overall Study|Lost to Follow-up|0|||
94205983|NCT03478969|322549748|FG001|Overall Study|Lost to Follow-up|0|||
94205984|NCT03478969|322549749|FG002|Overall Study|Lost to Follow-up|1|||
94205985|NCT03220724|322549750|FG000|Overall Study|Lost to Follow-up|2|||
94205986|NCT03220724|322549751|FG001|Overall Study|Lost to Follow-up|2|||
94205987|NCT03220724|322549752|FG002|Overall Study|Lost to Follow-up|0|||
94205988|NCT03220724|322549753|FG003|Overall Study|Lost to Follow-up|3|||
94205989|NCT03220724|322549754|FG004|Overall Study|Lost to Follow-up|1|||
94205990|NCT03220724|322549755|FG005|Overall Study|Lost to Follow-up|0|||
94205991|NCT03220724|322549756|FG006|Overall Study|Lost to Follow-up|2|||
94205992|NCT03220724|322549757|FG007|Overall Study|Lost to Follow-up|1|||
94205993|NCT03220724|322549758|FG008|Overall Study|Lost to Follow-up|0|||
94205994|NCT03220724|322549750|FG000|Overall Study|Withdrawal by Subject|1|||
94205995|NCT03220724|322549751|FG001|Overall Study|Withdrawal by Subject|0|||
94205996|NCT03220724|322549752|FG002|Overall Study|Withdrawal by Subject|1|||
94205997|NCT03220724|322549753|FG003|Overall Study|Withdrawal by Subject|0|||
94205998|NCT03220724|322549754|FG004|Overall Study|Withdrawal by Subject|0|||
94205999|NCT03220724|322549755|FG005|Overall Study|Withdrawal by Subject|0|||
94206000|NCT03220724|322549756|FG006|Overall Study|Withdrawal by Subject|0|||
94371225|NCT04023994|323146801|FG003|Overall Study|Lost to Follow-up|0|||
94206001|NCT03220724|322549757|FG007|Overall Study|Withdrawal by Subject|0|||
94206002|NCT03220724|322549758|FG008|Overall Study|Withdrawal by Subject|0|||
94206003|NCT00890591|322549759|FG000|Overall Study|Lack of Efficacy|20|||
94206004|NCT00371345|322549760|FG000|Overall Study|Disease Progression|21|||
94206005|NCT00371345|322549761|FG001|Overall Study|Disease Progression|35|||
94206006|NCT00371345|322549760|FG000|Overall Study|Study Drug Toxicity|1|||
94206007|NCT00371345|322549761|FG001|Overall Study|Study Drug Toxicity|7|||
94206008|NCT00371345|322549760|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
94206009|NCT00371345|322549761|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
94206010|NCT00371345|322549760|FG000|Overall Study|Participant Request|1|||
94206011|NCT00371345|322549761|FG001|Overall Study|Participant Request|1|||
94206012|NCT00371345|322549760|FG000|Overall Study|Participant Withdrew Consent|0|||
94206013|NCT00371345|322549761|FG001|Overall Study|Participant Withdrew Consent|1|||
94206014|NCT00724126|322549762|FG000|Overall Study|Adverse Event|2|||
94206015|NCT00724126|322549763|FG001|Overall Study|Adverse Event|0|||
94206016|NCT00724126|322549762|FG000|Overall Study|Withdrawal by Subject|8|||
94206017|NCT00724126|322549763|FG001|Overall Study|Withdrawal by Subject|6|||
94206018|NCT00724126|322549762|FG000|Overall Study|Lost to Follow-up|6|||
94206019|NCT00724126|322549763|FG001|Overall Study|Lost to Follow-up|6|||
94206020|NCT00724126|322549762|FG000|Overall Study|Noncompliance|2|||
94206021|NCT00724126|322549763|FG001|Overall Study|Noncompliance|1|||
94206022|NCT00724126|322549762|FG000|Overall Study|Subject randomized although ineligible|1|||
94206023|NCT00724126|322549763|FG001|Overall Study|Subject randomized although ineligible|1|||
94206024|NCT00724126|322549762|FG000|Overall Study|Subject had to leave vicinity of site|0|||
94206025|NCT00724126|322549763|FG001|Overall Study|Subject had to leave vicinity of site|1|||
94206026|NCT01436175|322549765|FG000|Overall Study|Adverse Event|111|||
94206027|NCT01436175|322549765|FG000|Overall Study|Protocol Violation|49|||
94206028|NCT01436175|322549765|FG000|Overall Study|Withdrawal by Subject|108|||
94206029|NCT01436175|322549765|FG000|Overall Study|Lost to Follow-up|89|||
94206030|NCT01436175|322549765|FG000|Overall Study|Lack of Efficacy|24|||
94206031|NCT01436175|322549765|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
94206032|NCT01436175|322549765|FG000|Overall Study|Other|826|||
94206033|NCT03418922|322549771|FG000|Overall Study|Withdrawal by Subject|0|||
94206034|NCT03418922|322549772|FG001|Overall Study|Withdrawal by Subject|2|||
94206035|NCT03418922|322549771|FG000|Overall Study|Adverse Event|2|||
94206036|NCT03418922|322549772|FG001|Overall Study|Adverse Event|2|||
94206037|NCT03418922|322549771|FG000|Overall Study|Death|0|||
94206038|NCT03418922|322549772|FG001|Overall Study|Death|1|||
94206039|NCT03418922|322549771|FG000|Overall Study|Physician Decision|0|||
94206040|NCT03418922|322549772|FG001|Overall Study|Physician Decision|1|||
94206041|NCT03577106|322549773|FG000|Overall Study|Withdrawal by Subject|3|||
94206042|NCT01579318|322549774|FG000|Overall Study|Disease Progression|1|||
94206043|NCT00640159|322549775|FG000|Overall Study|Lost to Follow-up|2|||
94206044|NCT00857766|322549780|FG000|Overall Study|Adverse Event|13|||
94206045|NCT00857766|322549781|FG001|Overall Study|Adverse Event|12|||
94206046|NCT00857766|322549780|FG000|Overall Study|Protocol Violation|11|||
94206047|NCT00857766|322549781|FG001|Overall Study|Protocol Violation|11|||
94206048|NCT00857766|322549780|FG000|Overall Study|Lost to Follow-up|1|||
94206049|NCT00857766|322549781|FG001|Overall Study|Lost to Follow-up|0|||
94206050|NCT00857766|322549780|FG000|Overall Study|Investigator Discretion|2|||
94206051|NCT00857766|322549781|FG001|Overall Study|Investigator Discretion|3|||
94206052|NCT00857766|322549780|FG000|Overall Study|Participant Withdrew Consent|4|||
94206053|NCT00857766|322549781|FG001|Overall Study|Participant Withdrew Consent|4|||
94206054|NCT01961609|322549782|FG000|Initiation|Missing|3|||
94206055|NCT01961609|322549783|FG001|Initiation|Missing|2|||
94206056|NCT01961609|322549784|FG002|Initiation|Missing|0|||
94206057|NCT01961609|322549785|FG003|Initiation|Missing|0|||
94206058|NCT01961609|322549782|FG000|Initiation|Protocol deviation|1|||
94206059|NCT01961609|322549783|FG001|Initiation|Protocol deviation|0|||
94206060|NCT01961609|322549784|FG002|Initiation|Protocol deviation|0|||
94206061|NCT01961609|322549785|FG003|Initiation|Protocol deviation|0|||
94280558|NCT00623480|322817426|FG000|Overall Study|Site closed by sponsor|0|||
94280559|NCT00623480|322817427|FG001|Overall Study|Site closed by sponsor|1|||
94280560|NCT02631200|322817428|FG000|First Period|Death|1|||
94280561|NCT02631200|322817429|FG001|First Period|Death|2|||
94280562|NCT02631200|322817428|FG000|First Period|Patient ill-health|2|||
94280563|NCT02631200|322817429|FG001|First Period|Patient ill-health|4|||
94280564|NCT02631200|322817428|FG000|First Period|Withdrawal by Subject|4|||
94280565|NCT02631200|322817429|FG001|First Period|Withdrawal by Subject|1|||
94206062|NCT01961609|322549782|FG000|Initiation|Death|0|||
94206063|NCT01961609|322549783|FG001|Initiation|Death|1|||
94206064|NCT01961609|322549784|FG002|Initiation|Death|0|||
94206065|NCT01961609|322549785|FG003|Initiation|Death|0|||
94280566|NCT02631200|322817428|FG000|Deferred Period|Death|0|||
94280567|NCT02631200|322817429|FG001|Deferred Period|Death|1|||
94280568|NCT02631200|322817428|FG000|Deferred Period|Received kidney transplant|0|||
94280569|NCT02631200|322817429|FG001|Deferred Period|Received kidney transplant|1|||
94280570|NCT02631200|322817428|FG000|Deferred Period|Withdrawal by Subject|0|||
94206066|NCT01961609|322549782|FG000|Initiation|Administrative problems|1|||
94206067|NCT01961609|322549783|FG001|Initiation|Administrative problems|0|||
94206068|NCT01961609|322549784|FG002|Initiation|Administrative problems|0|||
94206069|NCT01961609|322549785|FG003|Initiation|Administrative problems|0|||
94280571|NCT02631200|322817429|FG001|Deferred Period|Withdrawal by Subject|2|||
94371226|NCT04023994|323146802|FG004|Overall Study|Lost to Follow-up|0|||
94371227|NCT04023994|323146803|FG005|Overall Study|Lost to Follow-up|0|||
94371228|NCT04023994|323146798|FG000|Overall Study|Withdrawal by Subject|0|||
94280572|NCT02631200|322817428|FG000|Deferred Period|Lost to Follow-up|0|||
94280573|NCT02631200|322817429|FG001|Deferred Period|Lost to Follow-up|1|||
94280574|NCT02513329|322817434|FG000|Overall Study|Lost to Follow-up|5|||
94280575|NCT02513329|322817435|FG001|Overall Study|Lost to Follow-up|2|||
94280576|NCT03273166|322817436|FG000|Overall Study|Withdrawn prior to Completion|31|||
94280577|NCT01485627|322817438|FG000|Overall Study|Patient withdrew|6|||
94206070|NCT01961609|322549782|FG000|Initiation|Withdrawal by Subject|1|||
94206071|NCT01961609|322549783|FG001|Initiation|Withdrawal by Subject|2|||
94206072|NCT01961609|322549784|FG002|Initiation|Withdrawal by Subject|0|||
94206073|NCT01961609|322549785|FG003|Initiation|Withdrawal by Subject|0|||
94206074|NCT01961609|322549782|FG000|Initiation|Lack of Efficacy|2|||
94206075|NCT01961609|322549783|FG001|Initiation|Lack of Efficacy|1|||
94206076|NCT01961609|322549784|FG002|Initiation|Lack of Efficacy|0|||
94206077|NCT01961609|322549785|FG003|Initiation|Lack of Efficacy|0|||
94206078|NCT01961609|322549782|FG000|Initiation|Abnormal lab values|0|||
94206079|NCT01961609|322549783|FG001|Initiation|Abnormal lab values|1|||
94206080|NCT01961609|322549784|FG002|Initiation|Abnormal lab values|0|||
94206081|NCT01961609|322549785|FG003|Initiation|Abnormal lab values|0|||
94206082|NCT01961609|322549782|FG000|Initiation|Adverse Event|3|||
94206083|NCT01961609|322549783|FG001|Initiation|Adverse Event|5|||
94206084|NCT01961609|322549784|FG002|Initiation|Adverse Event|0|||
94206085|NCT01961609|322549785|FG003|Initiation|Adverse Event|0|||
94206086|NCT01961609|322549782|FG000|Initiation|Randomized but not treated|1|||
94206087|NCT01961609|322549783|FG001|Initiation|Randomized but not treated|1|||
94206088|NCT01961609|322549784|FG002|Initiation|Randomized but not treated|0|||
94206089|NCT01961609|322549785|FG003|Initiation|Randomized but not treated|0|||
94206090|NCT01961609|322549782|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
94206091|NCT01961609|322549783|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
94206092|NCT01961609|322549784|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
94206093|NCT01961609|322549785|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
94206094|NCT01961609|322549782|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
94206095|NCT01961609|322549783|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
94206096|NCT01961609|322549784|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
94206097|NCT01961609|322549785|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
94206098|NCT01961609|322549782|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
94206099|NCT01961609|322549783|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
94206100|NCT01961609|322549784|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
94206101|NCT01961609|322549785|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
94206102|NCT01961609|322549782|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
94206103|NCT01961609|322549783|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
94206104|NCT01961609|322549784|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
94206105|NCT01961609|322549785|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
94206106|NCT01961609|322549782|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
94206107|NCT01961609|322549783|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
94206108|NCT01961609|322549784|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
94206109|NCT01961609|322549785|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
94206110|NCT01961609|322549782|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
94206111|NCT01961609|322549783|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
94206112|NCT01961609|322549784|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
94206113|NCT01961609|322549785|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
94206114|NCT01961609|322549782|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
94206115|NCT01961609|322549783|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
94206116|NCT01961609|322549784|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
94206117|NCT01961609|322549785|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
94206118|NCT01961609|322549782|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
94206119|NCT01961609|322549783|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
94206120|NCT01961609|322549784|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
94206121|NCT01961609|322549785|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
94206122|NCT01961609|322549782|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
94206123|NCT01961609|322549783|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
94206124|NCT01961609|322549784|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
94206125|NCT01961609|322549785|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
94206126|NCT01961609|322549782|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
94206127|NCT01961609|322549783|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
94206128|NCT01961609|322549784|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
94206129|NCT01961609|322549785|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
94206130|NCT01961609|322549782|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
94206131|NCT01961609|322549783|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
94206132|NCT01961609|322549784|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
94206133|NCT01961609|322549785|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
94206134|NCT01961609|322549782|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
94206135|NCT01961609|322549783|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
94206136|NCT01961609|322549784|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
94206137|NCT01961609|322549785|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
94206138|NCT04191824|322549788|FG000|Overall Study|Death|13|||
94206139|NCT04191824|322549789|FG001|Overall Study|Death|12|||
94206140|NCT04191824|322549788|FG000|Overall Study|Lost to Follow-up|456|||
94206141|NCT04191824|322549789|FG001|Overall Study|Lost to Follow-up|435|||
94206142|NCT04191824|322549788|FG000|Overall Study|Physician Decision|2|||
94206143|NCT04191824|322549789|FG001|Overall Study|Physician Decision|1|||
94206144|NCT04191824|322549788|FG000|Overall Study|Protocol Violation|0|||
94206145|NCT04191824|322549789|FG001|Overall Study|Protocol Violation|2|||
94206146|NCT04191824|322549788|FG000|Overall Study|Withdrawal by Subject|16|||
94206147|NCT04191824|322549789|FG001|Overall Study|Withdrawal by Subject|18|||
94206148|NCT04191824|322549788|FG000|Overall Study|Early site closure|24|||
94206149|NCT04191824|322549789|FG001|Overall Study|Early site closure|22|||
94206150|NCT01753999|322549792|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
94206151|NCT01753999|322549793|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
94206152|NCT01753999|322549792|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
94206153|NCT01753999|322549793|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
94206154|NCT01753999|322549792|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
94206155|NCT01753999|322549793|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
94206156|NCT01753999|322549792|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
94206157|NCT01753999|322549793|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
94206158|NCT01753999|322549792|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
94206159|NCT01753999|322549793|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
94206160|NCT01753999|322549792|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
94206161|NCT01753999|322549793|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
94206162|NCT02392234|322549794|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
94206163|NCT02392234|322549795|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
94206164|NCT02392234|322549796|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
94206165|NCT02392234|322549797|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
94206166|NCT02392234|322549798|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
94206167|NCT02392234|322549799|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
94206168|NCT02392234|322549794|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
94206169|NCT02392234|322549795|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
94206170|NCT02392234|322549796|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
94206171|NCT02392234|322549797|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
94206172|NCT02392234|322549798|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
94206173|NCT02392234|322549799|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
94206174|NCT02392234|322549794|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
94206175|NCT02392234|322549795|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
94206176|NCT02392234|322549796|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
94206177|NCT02392234|322549797|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
94206178|NCT02392234|322549798|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
94206179|NCT02392234|322549799|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
94206180|NCT02392234|322549794|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
94280578|NCT01485627|322817439|FG001|Overall Study|Patient withdrew|5|||
94280579|NCT01485627|322817438|FG000|Overall Study|Patient died|3|||
94280580|NCT01485627|322817439|FG001|Overall Study|Patient died|1|||
94280581|NCT01485627|322817438|FG000|Overall Study|Patient lost to followup|0|||
94280582|NCT01485627|322817439|FG001|Overall Study|Patient lost to followup|1|||
94280583|NCT01485627|322817438|FG000|Overall Study|Caregiver withdrew|3|||
94280584|NCT01485627|322817439|FG001|Overall Study|Caregiver withdrew|3|||
94280585|NCT01485627|322817438|FG000|Overall Study|Caregiver lost to follow up|11|||
94280586|NCT01485627|322817439|FG001|Overall Study|Caregiver lost to follow up|12|||
94280587|NCT01485627|322817438|FG000|Overall Study|Caregiver died|1|||
94280588|NCT01485627|322817439|FG001|Overall Study|Caregiver died|0|||
94371229|NCT04023994|323146799|FG001|Overall Study|Withdrawal by Subject|0|||
94206181|NCT02392234|322549795|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
94206182|NCT02392234|322549796|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
94206183|NCT02392234|322549797|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
94206184|NCT02392234|322549798|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
94206185|NCT02392234|322549799|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
94280589|NCT01485627|322817438|FG000|Overall Study|caregiver was not bereaved|42|||
94280590|NCT01485627|322817439|FG001|Overall Study|caregiver was not bereaved|35|||
94280591|NCT03286842|322817442|FG000|Overall Study|Patients rolled over to another study|80|||
94371230|NCT04023994|323146800|FG002|Overall Study|Withdrawal by Subject|0|||
94206186|NCT02392234|322549794|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
94206187|NCT02392234|322549795|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
94206188|NCT02392234|322549796|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
94206189|NCT02392234|322549797|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
94206190|NCT02392234|322549798|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
94206191|NCT02392234|322549799|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
94206192|NCT02392234|322549794|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
94206193|NCT02392234|322549795|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
94206194|NCT02392234|322549796|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
94206195|NCT02392234|322549797|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
94206196|NCT02392234|322549798|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
94206197|NCT02392234|322549799|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
94206198|NCT02392234|322549794|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
94206199|NCT02392234|322549795|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
94206200|NCT02392234|322549796|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
94206201|NCT02392234|322549797|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
94206202|NCT02392234|322549798|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
94206203|NCT02392234|322549799|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
94206204|NCT02392234|322549794|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
94206205|NCT02392234|322549795|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
94206206|NCT02392234|322549796|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
94206207|NCT02392234|322549797|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
94206208|NCT02392234|322549798|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
94206209|NCT02392234|322549799|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
94206210|NCT02052440|322549801|FG000|Overall Study|Withdrawal by Subject|0|||
94206211|NCT02052440|322549802|FG001|Overall Study|Withdrawal by Subject|1|||
94206212|NCT03509909|322549803|FG000|Overall Study|Withdrawal by Subject|16|||
94206213|NCT03509909|322549804|FG001|Overall Study|Withdrawal by Subject|9|||
94206214|NCT03509909|322549803|FG000|Overall Study|Lost to Follow-up|3|||
94206215|NCT03509909|322549804|FG001|Overall Study|Lost to Follow-up|4|||
94206216|NCT03509909|322549803|FG000|Overall Study|Adverse Event|2|||
94206217|NCT03509909|322549804|FG001|Overall Study|Adverse Event|0|||
94206218|NCT01367236|322549805|FG000|Overall Study|Withdrawal by Subject|3|||
94206219|NCT01367236|322549806|FG001|Overall Study|Withdrawal by Subject|1|||
94206220|NCT04436289|322549811|FG000|Overall Study|Death prior to hospital discharge|8|||
94206221|NCT04436289|322549812|FG001|Overall Study|Death prior to hospital discharge|5|||
94206222|NCT04436289|322549813|FG002|Overall Study|Death prior to hospital discharge|0|||
94206223|NCT04436289|322549814|FG003|Overall Study|Death prior to hospital discharge|1|||
94206224|NCT04436289|322549811|FG000|Overall Study|Withdrawal by Subject|0|||
94206225|NCT04436289|322549812|FG001|Overall Study|Withdrawal by Subject|1|||
94206226|NCT04436289|322549813|FG002|Overall Study|Withdrawal by Subject|4|||
94206227|NCT04436289|322549814|FG003|Overall Study|Withdrawal by Subject|0|||
94206228|NCT04436289|322549811|FG000|Overall Study|Extended hospital stay|0|||
94206229|NCT04436289|322549812|FG001|Overall Study|Extended hospital stay|1|||
94206230|NCT04436289|322549813|FG002|Overall Study|Extended hospital stay|0|||
94206231|NCT04436289|322549814|FG003|Overall Study|Extended hospital stay|0|||
94206232|NCT04436289|322549811|FG000|Overall Study|Lost to Follow-up|0|||
94206233|NCT04436289|322549812|FG001|Overall Study|Lost to Follow-up|4|||
94206234|NCT04436289|322549813|FG002|Overall Study|Lost to Follow-up|1|||
94206235|NCT04436289|322549814|FG003|Overall Study|Lost to Follow-up|3|||
94206236|NCT00676091|322549816|FG000|Infant Series|Parent or legal guardian request|10|||
94206237|NCT00676091|322549817|FG001|Infant Series|Parent or legal guardian request|8|||
94206238|NCT00676091|322549816|FG000|Infant Series|Protocol Violation|6|||
94206239|NCT00676091|322549817|FG001|Infant Series|Protocol Violation|3|||
94206240|NCT00676091|322549816|FG000|Infant Series|Adverse Event|2|||
94206241|NCT00676091|322549817|FG001|Infant Series|Adverse Event|3|||
94206242|NCT00676091|322549816|FG000|Infant Series|Failed to return|1|||
94206243|NCT00676091|322549817|FG001|Infant Series|Failed to return|3|||
94280592|NCT00290433|322817443|FG000|Overall Study|Disease Progression|13|||
94280593|NCT00290433|322817443|FG000|Overall Study|Adverse Event|14|||
94280594|NCT00290433|322817443|FG000|Overall Study|Withdrawal by Subject|1|||
94280595|NCT00290433|322817443|FG000|Overall Study|Non-Compliance|1|||
94280596|NCT00290433|322817443|FG000|Overall Study|Congestive Heart Failure|1|||
94206244|NCT00676091|322549816|FG000|Infant Series|Lost to Follow-up|1|||
94206245|NCT00676091|322549817|FG001|Infant Series|Lost to Follow-up|0|||
94206246|NCT00676091|322549816|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
94206247|NCT00676091|322549817|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
94206248|NCT00676091|322549816|FG000|After Infant Series|Adverse Event|0|||
94206249|NCT00676091|322549817|FG001|After Infant Series|Adverse Event|1|||
94206250|NCT00676091|322549816|FG000|After Infant Series|Protocol Violation|0|||
94206251|NCT00676091|322549817|FG001|After Infant Series|Protocol Violation|1|||
94206252|NCT00676091|322549816|FG000|After Infant Series|Failed to return|1|||
94280597|NCT00290433|322817443|FG000|Overall Study|Transplant in CR|5|||
94280598|NCT00290433|322817443|FG000|Overall Study|Unrelated Infection/Death|1|||
94371231|NCT04023994|323146801|FG003|Overall Study|Withdrawal by Subject|1|||
94371232|NCT04023994|323146802|FG004|Overall Study|Withdrawal by Subject|0|||
94371233|NCT04023994|323146803|FG005|Overall Study|Withdrawal by Subject|0|||
94371234|NCT01377233|323146804|FG000|Open-label|Adverse Event|1|||
94371235|NCT01377233|323146805|FG001|Open-label|Adverse Event|0|||
94371236|NCT01377233|323146806|FG002|Open-label|Adverse Event|0|||
94371237|NCT01377233|323146807|FG003|Open-label|Adverse Event|0|||
94371238|NCT01377233|323146808|FG004|Open-label|Adverse Event|0|||
94371239|NCT01377233|323146804|FG000|Open-label|Withdrawal by Subject|3|||
94371240|NCT01377233|323146805|FG001|Open-label|Withdrawal by Subject|0|||
94467663|NCT01004432|323502374|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
94206253|NCT00676091|322549817|FG001|After Infant Series|Failed to return|1|||
94467664|NCT01004432|323502375|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
94206254|NCT00676091|322549816|FG000|Toddler Dose|Failed to return|2|||
94206255|NCT00676091|322549817|FG001|Toddler Dose|Failed to return|0|||
94206256|NCT00676091|322549816|FG000|Toddler Dose|Parent or legal guardian request|1|||
94206257|NCT00676091|322549817|FG001|Toddler Dose|Parent or legal guardian request|0|||
94206258|NCT02063659|322549818|FG000|Double-Blind Treatment Period|Adverse Event|1|||
94206259|NCT02063659|322549819|FG001|Double-Blind Treatment Period|Adverse Event|2|||
94206260|NCT02063659|322549820|FG002|Double-Blind Treatment Period|Adverse Event|0|||
94206261|NCT02063659|322549821|FG003|Double-Blind Treatment Period|Adverse Event|0|||
94206262|NCT02063659|322549818|FG000|Double-Blind Treatment Period|Physician Decision|1|||
94206263|NCT02063659|322549819|FG001|Double-Blind Treatment Period|Physician Decision|0|||
94206264|NCT02063659|322549820|FG002|Double-Blind Treatment Period|Physician Decision|0|||
94206265|NCT02063659|322549821|FG003|Double-Blind Treatment Period|Physician Decision|0|||
94206266|NCT02063659|322549818|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
94206267|NCT02063659|322549819|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
94206268|NCT02063659|322549820|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
94206269|NCT02063659|322549821|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
94206270|NCT02063659|322549818|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
94206271|NCT02063659|322549819|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
94206272|NCT02063659|322549820|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
94206273|NCT02063659|322549821|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
94206274|NCT02063659|322549818|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
94206275|NCT02063659|322549819|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
94206276|NCT02063659|322549820|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
94206277|NCT02063659|322549821|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
94206278|NCT02063659|322549818|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
94206279|NCT02063659|322549819|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
94206280|NCT02063659|322549820|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
94206281|NCT02063659|322549821|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
94206282|NCT02063659|322549818|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
94206283|NCT02063659|322549819|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
94206284|NCT02063659|322549820|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
94206285|NCT02063659|322549821|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
94206286|NCT02063659|322549818|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
94206287|NCT02063659|322549819|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
94206288|NCT02063659|322549820|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
94206289|NCT02063659|322549821|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
94206290|NCT02972359|322549822|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
94206291|NCT02972359|322549822|FG000|Overall Study|Lack of Efficacy|1|||
94206292|NCT02972359|322549822|FG000|Overall Study|Adverse Event|4|||
94206293|NCT02972359|322549822|FG000|Overall Study|Death|1|||
94206294|NCT02972359|322549822|FG000|Overall Study|Withdrawal by Subject|30|||
94206295|NCT02972359|322549822|FG000|Overall Study|Protocol Violation|1|||
94206296|NCT02972359|322549822|FG000|Overall Study|Lost to Follow-up|26|||
94206297|NCT02972359|322549822|FG000|Overall Study|Other reasons|5|||
94206298|NCT02972359|322549822|FG000|Overall Study|Missing|1|||
94206299|NCT02928172|322549823|FG000|Overall Study|Device did not record data|1|||
94206300|NCT02408887|322549824|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
94206301|NCT02408887|322549825|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
94206302|NCT02408887|322549824|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
94206303|NCT02408887|322549825|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
94206304|NCT00914966|322549826|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
94206305|NCT00914966|322549826|FG000|Step 1: 1500 Units|Physician Decision|1|||
94206306|NCT00914966|322549826|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
94206307|NCT05071430|322549830|FG000|Overall Study|Adverse Event|1|||
94206308|NCT05071430|322549831|FG001|Overall Study|Adverse Event|2|||
94206309|NCT05071430|322549830|FG000|Overall Study|Lost to Follow-up|4|||
94206310|NCT05071430|322549831|FG001|Overall Study|Lost to Follow-up|4|||
94206311|NCT05071430|322549830|FG000|Overall Study|Protocol Violation|1|||
94206312|NCT05071430|322549831|FG001|Overall Study|Protocol Violation|0|||
94206313|NCT05071430|322549830|FG000|Overall Study|Withdrawal by Subject|3|||
94206314|NCT05071430|322549831|FG001|Overall Study|Withdrawal by Subject|2|||
94206315|NCT05071430|322549830|FG000|Overall Study|Other|1|||
94206316|NCT05071430|322549831|FG001|Overall Study|Other|1|||
94206317|NCT02972034|322551306|FG000|Overall Study|Death|11|||
94206318|NCT02972034|322551307|FG001|Overall Study|Death|1|||
94206319|NCT02972034|322551308|FG002|Overall Study|Death|3|||
94206320|NCT02972034|322551309|FG003|Overall Study|Death|3|||
94206321|NCT02972034|322551310|FG004|Overall Study|Death|2|||
94206322|NCT02972034|322551311|FG005|Overall Study|Death|2|||
94206323|NCT02972034|322551312|FG006|Overall Study|Death|3|||
94206324|NCT02972034|322551313|FG007|Overall Study|Death|4|||
94206325|NCT02972034|322551314|FG008|Overall Study|Death|8|||
94206326|NCT02972034|322551315|FG009|Overall Study|Death|11|||
94206327|NCT02972034|322551316|FG010|Overall Study|Death|3|||
94206328|NCT02972034|322551317|FG011|Overall Study|Death|2|||
94206329|NCT02972034|322551318|FG012|Overall Study|Death|11|||
94206330|NCT02972034|322551319|FG013|Overall Study|Death|10|||
94206331|NCT02972034|322551320|FG014|Overall Study|Death|9|||
94206332|NCT02972034|322551306|FG000|Overall Study|Lost to Follow-up|0|||
94206333|NCT02972034|322551307|FG001|Overall Study|Lost to Follow-up|0|||
94206334|NCT02972034|322551308|FG002|Overall Study|Lost to Follow-up|0|||
94206335|NCT02972034|322551309|FG003|Overall Study|Lost to Follow-up|0|||
94206336|NCT02972034|322551310|FG004|Overall Study|Lost to Follow-up|1|||
94206337|NCT02972034|322551311|FG005|Overall Study|Lost to Follow-up|0|||
94206338|NCT02972034|322551312|FG006|Overall Study|Lost to Follow-up|0|||
94206339|NCT02972034|322551313|FG007|Overall Study|Lost to Follow-up|1|||
94206340|NCT02972034|322551314|FG008|Overall Study|Lost to Follow-up|0|||
94206341|NCT02972034|322551315|FG009|Overall Study|Lost to Follow-up|0|||
94206342|NCT02972034|322551316|FG010|Overall Study|Lost to Follow-up|0|||
94206343|NCT02972034|322551317|FG011|Overall Study|Lost to Follow-up|0|||
94206344|NCT02972034|322551318|FG012|Overall Study|Lost to Follow-up|0|||
94206345|NCT02972034|322551319|FG013|Overall Study|Lost to Follow-up|0|||
94206346|NCT02972034|322551320|FG014|Overall Study|Lost to Follow-up|1|||
94206347|NCT02972034|322551306|FG000|Overall Study|Physician Decision|0|||
94206348|NCT02972034|322551307|FG001|Overall Study|Physician Decision|0|||
94206349|NCT02972034|322551308|FG002|Overall Study|Physician Decision|0|||
94206350|NCT02972034|322551309|FG003|Overall Study|Physician Decision|0|||
94206351|NCT02972034|322551310|FG004|Overall Study|Physician Decision|0|||
94206352|NCT02972034|322551311|FG005|Overall Study|Physician Decision|0|||
94206353|NCT02972034|322551312|FG006|Overall Study|Physician Decision|0|||
94206354|NCT02972034|322551313|FG007|Overall Study|Physician Decision|1|||
94206355|NCT02972034|322551314|FG008|Overall Study|Physician Decision|0|||
94206356|NCT02972034|322551315|FG009|Overall Study|Physician Decision|0|||
94206357|NCT02972034|322551316|FG010|Overall Study|Physician Decision|1|||
94206358|NCT02972034|322551317|FG011|Overall Study|Physician Decision|0|||
94280599|NCT02264990|322817444|FG000|Overall Study|Death|255|||
94280600|NCT02264990|322817445|FG001|Overall Study|Death|250|||
94280601|NCT02264990|322817444|FG000|Overall Study|Withdrawal by Subject|4|||
94280602|NCT02264990|322817445|FG001|Overall Study|Withdrawal by Subject|5|||
94280603|NCT02264990|322817444|FG000|Overall Study|Lost to Follow-up|1|||
94280604|NCT02264990|322817445|FG001|Overall Study|Lost to Follow-up|3|||
94280605|NCT02264990|322817444|FG000|Overall Study|Other|0|||
94280606|NCT02264990|322817445|FG001|Overall Study|Other|1|||
94280607|NCT00267748|322817447|FG000|Non-randomized Period|Progressive disease|10|||
94280608|NCT00267748|322817448|FG001|Non-randomized Period|Progressive disease|0|||
94280609|NCT00267748|322817449|FG002|Non-randomized Period|Progressive disease|0|||
94280610|NCT00267748|322817447|FG000|Non-randomized Period|Adverse Event|8|||
94206359|NCT02972034|322551318|FG012|Overall Study|Physician Decision|0|||
94206360|NCT02972034|322551319|FG013|Overall Study|Physician Decision|0|||
94206361|NCT02972034|322551320|FG014|Overall Study|Physician Decision|0|||
94206362|NCT02972034|322551306|FG000|Overall Study|Sponsor Decision|0|||
94280611|NCT00267748|322817448|FG001|Non-randomized Period|Adverse Event|0|||
94206363|NCT02972034|322551307|FG001|Overall Study|Sponsor Decision|0|||
94206364|NCT02972034|322551308|FG002|Overall Study|Sponsor Decision|0|||
94206365|NCT02972034|322551309|FG003|Overall Study|Sponsor Decision|1|||
94206366|NCT02972034|322551310|FG004|Overall Study|Sponsor Decision|0|||
94206367|NCT02972034|322551311|FG005|Overall Study|Sponsor Decision|0|||
94206368|NCT02972034|322551312|FG006|Overall Study|Sponsor Decision|1|||
94206369|NCT02972034|322551313|FG007|Overall Study|Sponsor Decision|1|||
94206370|NCT02972034|322551314|FG008|Overall Study|Sponsor Decision|1|||
94206371|NCT02972034|322551315|FG009|Overall Study|Sponsor Decision|2|||
94206372|NCT02972034|322551316|FG010|Overall Study|Sponsor Decision|2|||
94280612|NCT00267748|322817449|FG002|Non-randomized Period|Adverse Event|0|||
94280613|NCT00267748|322817447|FG000|Non-randomized Period|Death|1|||
94280614|NCT00267748|322817448|FG001|Non-randomized Period|Death|0|||
94371241|NCT01377233|323146806|FG002|Open-label|Withdrawal by Subject|0|||
94371242|NCT01377233|323146807|FG003|Open-label|Withdrawal by Subject|0|||
94371243|NCT01377233|323146808|FG004|Open-label|Withdrawal by Subject|0|||
94206373|NCT02972034|322551317|FG011|Overall Study|Sponsor Decision|0|||
94206374|NCT02972034|322551318|FG012|Overall Study|Sponsor Decision|1|||
94206375|NCT02972034|322551319|FG013|Overall Study|Sponsor Decision|0|||
94206376|NCT02972034|322551320|FG014|Overall Study|Sponsor Decision|1|||
94206377|NCT02972034|322551306|FG000|Overall Study|Withdrawal by Subject|3|||
94206378|NCT02972034|322551307|FG001|Overall Study|Withdrawal by Subject|0|||
94206379|NCT02972034|322551308|FG002|Overall Study|Withdrawal by Subject|0|||
94206380|NCT02972034|322551309|FG003|Overall Study|Withdrawal by Subject|0|||
94206381|NCT02972034|322551310|FG004|Overall Study|Withdrawal by Subject|1|||
94206382|NCT02972034|322551311|FG005|Overall Study|Withdrawal by Subject|1|||
94206383|NCT02972034|322551312|FG006|Overall Study|Withdrawal by Subject|0|||
94206384|NCT02972034|322551313|FG007|Overall Study|Withdrawal by Subject|0|||
94206385|NCT02972034|322551314|FG008|Overall Study|Withdrawal by Subject|1|||
94206386|NCT02972034|322551315|FG009|Overall Study|Withdrawal by Subject|1|||
94206387|NCT02972034|322551316|FG010|Overall Study|Withdrawal by Subject|2|||
94206388|NCT02972034|322551317|FG011|Overall Study|Withdrawal by Subject|1|||
94206389|NCT02972034|322551318|FG012|Overall Study|Withdrawal by Subject|1|||
94206390|NCT02972034|322551319|FG013|Overall Study|Withdrawal by Subject|1|||
94206391|NCT02972034|322551320|FG014|Overall Study|Withdrawal by Subject|0|||
94206392|NCT02972034|322551306|FG000|Overall Study|Screen Failure|0|||
94206393|NCT02972034|322551307|FG001|Overall Study|Screen Failure|0|||
94206394|NCT02972034|322551308|FG002|Overall Study|Screen Failure|0|||
94206395|NCT02972034|322551309|FG003|Overall Study|Screen Failure|0|||
94206396|NCT02972034|322551310|FG004|Overall Study|Screen Failure|0|||
94206397|NCT02972034|322551311|FG005|Overall Study|Screen Failure|0|||
94206398|NCT02972034|322551312|FG006|Overall Study|Screen Failure|0|||
94206399|NCT02972034|322551313|FG007|Overall Study|Screen Failure|0|||
94206400|NCT02972034|322551314|FG008|Overall Study|Screen Failure|0|||
94206401|NCT02972034|322551315|FG009|Overall Study|Screen Failure|0|||
94206402|NCT02972034|322551316|FG010|Overall Study|Screen Failure|0|||
94206403|NCT02972034|322551317|FG011|Overall Study|Screen Failure|0|||
94206404|NCT02972034|322551318|FG012|Overall Study|Screen Failure|1|||
94206405|NCT02972034|322551319|FG013|Overall Study|Screen Failure|0|||
94206406|NCT02972034|322551320|FG014|Overall Study|Screen Failure|0|||
94206407|NCT02200705|322551321|FG000|Overall Study|Excluded|12|||
94206408|NCT02200705|322551321|FG000|Overall Study|Death|21|||
94206409|NCT02200705|322551321|FG000|Overall Study|Withdrawal by Subject|22|||
94206410|NCT02200705|322551321|FG000|Overall Study|Lost to Follow-up|13|||
94206411|NCT02200705|322551321|FG000|Overall Study|Physician Decision|5|||
94206412|NCT02200705|322551321|FG000|Overall Study|Adverse Event|2|||
94206413|NCT04989816|322551322|FG000|Overall Study|Death|77|||
94206414|NCT04989816|322551322|FG000|Overall Study|Lost to Follow-up|3|||
94206415|NCT02760654|322551323|FG000|Overall Study|Lost to Follow-up|3|||
94206416|NCT02760654|322551324|FG001|Overall Study|Lost to Follow-up|3|||
94206417|NCT02760654|322551323|FG000|Overall Study|Withdrawal by Subject|4|||
94206418|NCT02760654|322551324|FG001|Overall Study|Withdrawal by Subject|3|||
94206419|NCT00210106|322551325|FG000|Overall Study|Death|1|||
94206420|NCT00210106|322551325|FG000|Overall Study|Protocol Violation|13|||
94206421|NCT00786864|322551326|FG000|Overall Study|Lost to Follow-up|0|||
94206422|NCT00786864|322551327|FG001|Overall Study|Lost to Follow-up|1|||
94206423|NCT00786864|322551326|FG000|Overall Study|Sustained serious back injury|1|||
94206424|NCT00786864|322551327|FG001|Overall Study|Sustained serious back injury|0|||
94206425|NCT00065182|322551337|FG000|Overall Study|Adverse Event|24|||
94206426|NCT00065182|322551338|FG001|Overall Study|Adverse Event|17|||
94206427|NCT00065182|322551337|FG000|Overall Study|Lost to Follow-up|0|||
94206428|NCT00065182|322551338|FG001|Overall Study|Lost to Follow-up|4|||
94206429|NCT00065182|322551337|FG000|Overall Study|Protocol Violation|3|||
94206430|NCT00065182|322551338|FG001|Overall Study|Protocol Violation|4|||
94206431|NCT00065182|322551337|FG000|Overall Study|Serious adverse events (SAE)|1|||
94206432|NCT00065182|322551338|FG001|Overall Study|Serious adverse events (SAE)|0|||
94206433|NCT00065182|322551337|FG000|Overall Study|Sponsor Decision|11|||
94206434|NCT00065182|322551338|FG001|Overall Study|Sponsor Decision|7|||
94206435|NCT00065182|322551337|FG000|Overall Study|Withdrawal by Subject|8|||
94206436|NCT00065182|322551338|FG001|Overall Study|Withdrawal by Subject|3|||
94206437|NCT00065182|322551337|FG000|Overall Study|No clinical benefit|1|||
94206438|NCT00065182|322551338|FG001|Overall Study|No clinical benefit|0|||
94206439|NCT00065182|322551337|FG000|Overall Study|Death|0|||
94206440|NCT00065182|322551338|FG001|Overall Study|Death|1|||
94206441|NCT00065182|322551337|FG000|Overall Study|Decline in Status|0|||
94206442|NCT00065182|322551338|FG001|Overall Study|Decline in Status|1|||
94206443|NCT03442777|322551339|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
94206444|NCT03442777|322551340|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
94206445|NCT03442777|322551341|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
94206446|NCT00713596|322551343|FG000|Overall Study|Study was terminated|2|||
94206447|NCT00713596|322551344|FG001|Overall Study|Study was terminated|3|||
94206448|NCT00713596|322551345|FG002|Overall Study|Study was terminated|2|||
94206449|NCT02157116|322551352|FG000|Overall Study|Withdrawal by Subject|4|||
94280615|NCT00267748|322817449|FG002|Non-randomized Period|Death|0|||
94280616|NCT00267748|322817447|FG000|Non-randomized Period|Participant not willing to participate|1|||
94280617|NCT00267748|322817448|FG001|Non-randomized Period|Participant not willing to participate|0|||
94280618|NCT00267748|322817449|FG002|Non-randomized Period|Participant not willing to participate|0|||
94280619|NCT00267748|322817447|FG000|Non-randomized Period|Other|3|||
94280620|NCT00267748|322817448|FG001|Non-randomized Period|Other|0|||
94280621|NCT00267748|322817449|FG002|Non-randomized Period|Other|0|||
94280622|NCT00267748|322817447|FG000|Randomized Period|Death|0|||
94280623|NCT00267748|322817448|FG001|Randomized Period|Death|2|||
94280624|NCT00267748|322817449|FG002|Randomized Period|Death|3|||
94280625|NCT00267748|322817447|FG000|Randomized Period|Adverse Event|0|||
94280626|NCT00267748|322817448|FG001|Randomized Period|Adverse Event|23|||
94280627|NCT00267748|322817449|FG002|Randomized Period|Adverse Event|25|||
94280628|NCT00267748|322817447|FG000|Randomized Period|Global deterioration of health status|0|||
94280629|NCT00267748|322817448|FG001|Randomized Period|Global deterioration of health status|6|||
94280630|NCT00267748|322817449|FG002|Randomized Period|Global deterioration of health status|7|||
94280631|NCT00267748|322817447|FG000|Randomized Period|Lost to Follow-up|0|||
94280632|NCT00267748|322817448|FG001|Randomized Period|Lost to Follow-up|1|||
94280633|NCT00267748|322817449|FG002|Randomized Period|Lost to Follow-up|0|||
94280634|NCT00267748|322817447|FG000|Randomized Period|Objective progression or relapse|0|||
94280635|NCT00267748|322817448|FG001|Randomized Period|Objective progression or relapse|77|||
94280636|NCT00267748|322817449|FG002|Randomized Period|Objective progression or relapse|86|||
94280637|NCT00267748|322817447|FG000|Randomized Period|Withdrawal by Subject|0|||
94280638|NCT00267748|322817448|FG001|Randomized Period|Withdrawal by Subject|9|||
94280639|NCT00267748|322817449|FG002|Randomized Period|Withdrawal by Subject|2|||
94280640|NCT00267748|322817447|FG000|Randomized Period|Other|0|||
94280641|NCT00267748|322817448|FG001|Randomized Period|Other|9|||
94280642|NCT00267748|322817449|FG002|Randomized Period|Other|6|||
94280643|NCT00267748|322817447|FG000|Randomized Period|randomized but not treated|0|||
94280644|NCT00267748|322817448|FG001|Randomized Period|randomized but not treated|0|||
94280645|NCT00267748|322817449|FG002|Randomized Period|randomized but not treated|3|||
94280646|NCT02429414|322817451|FG000|Overall Study|Physician Decision|0|||
94280647|NCT02429414|322817452|FG001|Overall Study|Physician Decision|1|||
94280648|NCT01098071|322817456|FG000|Overall Study|Surgery (adenoidectomy)|2|||
94280649|NCT01098071|322817456|FG000|Overall Study|Lost to Follow-up|13|||
94280650|NCT01662895|322817459|FG000|Overall Study|Lost to Follow-up|0|||
94280651|NCT01662895|322817460|FG001|Overall Study|Lost to Follow-up|1|||
94280652|NCT05098041|322817461|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
94280653|NCT02599961|322817462|FG000|Overall Study|Withdrawal by Subject|1|||
94206450|NCT02157116|322551352|FG000|Overall Study|Physician Decision|3|||
94206451|NCT02157116|322551352|FG000|Overall Study|Failed Screening|2|||
94206452|NCT02463448|322551353|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
94206453|NCT02463448|322551353|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
94206454|NCT02463448|322551353|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
94206455|NCT02463448|322551353|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
94206456|NCT00093496|322551354|FG000|Overall Study|Protocol Violation|1|||
94206457|NCT00093496|322551355|FG001|Overall Study|Protocol Violation|3|||
94206458|NCT02964741|322551356|FG000|Overall Study|Protocol Violation|1|||
94206459|NCT02964741|322551357|FG001|Overall Study|Protocol Violation|0|||
94206460|NCT02964741|322551358|FG002|Overall Study|Protocol Violation|0|||
94280654|NCT02599961|322817462|FG000|Overall Study|Subject Non-Compliance|2|||
94280655|NCT02599961|322817462|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
94280656|NCT02599961|322817462|FG000|Overall Study|Other, Not Specified|3|||
94280657|NCT02970292|322817463|FG000|Overall Study|Physician Decision|1|||
94280658|NCT02970292|322817464|FG001|Overall Study|Physician Decision|1|||
94280659|NCT02970292|322817463|FG000|Overall Study|Withdrawal by Subject|11|||
94371244|NCT01377233|323146804|FG000|Double-blind|Adverse Event|0|||
94371245|NCT01377233|323146805|FG001|Double-blind|Adverse Event|1|||
94206461|NCT02964741|322551356|FG000|Overall Study|Withdrawal by Subject|0|||
94206462|NCT02964741|322551357|FG001|Overall Study|Withdrawal by Subject|1|||
94206463|NCT02964741|322551358|FG002|Overall Study|Withdrawal by Subject|0|||
94206464|NCT02964741|322551356|FG000|Overall Study|claustrophobia|1|||
94206465|NCT02964741|322551357|FG001|Overall Study|claustrophobia|0|||
94206466|NCT02964741|322551358|FG002|Overall Study|claustrophobia|0|||
94206467|NCT00683800|322551359|FG000|Overall Study|Adverse Event|195|||
94206468|NCT00683800|322551360|FG001|Overall Study|Adverse Event|102|||
94206469|NCT00683800|322551359|FG000|Overall Study|Death|0|||
94206470|NCT00683800|322551360|FG001|Overall Study|Death|1|||
94206471|NCT00683800|322551359|FG000|Overall Study|Lost to Follow-up|57|||
94206472|NCT00683800|322551360|FG001|Overall Study|Lost to Follow-up|44|||
94206473|NCT00683800|322551359|FG000|Overall Study|Other|5|||
94206474|NCT00683800|322551360|FG001|Overall Study|Other|2|||
94206475|NCT00683800|322551359|FG000|Overall Study|Protocol Violation|13|||
94206476|NCT00683800|322551360|FG001|Overall Study|Protocol Violation|16|||
94206477|NCT00683800|322551359|FG000|Overall Study|Withdrawal by Subject|66|||
94206478|NCT00683800|322551360|FG001|Overall Study|Withdrawal by Subject|64|||
94206479|NCT00683800|322551359|FG000|Overall Study|Lack of Efficacy|61|||
94206480|NCT00683800|322551360|FG001|Overall Study|Lack of Efficacy|104|||
94206481|NCT00683800|322551359|FG000|Overall Study|Randomized, not treated|35|||
94206482|NCT00683800|322551360|FG001|Overall Study|Randomized, not treated|33|||
94206483|NCT01932970|322551361|FG000|Overall Study|Withdrawal by Subject|5|||
94206484|NCT01932970|322551361|FG000|Overall Study|Death|1|||
94206485|NCT01932970|322551361|FG000|Overall Study|Lost to Follow-up|2|||
94206486|NCT01932970|322551361|FG000|Overall Study|Protocol Specified Criteria|10|||
94206487|NCT03205566|322551362|FG000|Phase 1|Protocol Violation|1|||
94206488|NCT03205566|322551363|FG001|Phase 1|Protocol Violation|1|||
94206489|NCT01767467|322551364|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
94206490|NCT01767467|322551365|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
94371246|NCT01377233|323146806|FG002|Double-blind|Adverse Event|2|||
94371247|NCT01377233|323146807|FG003|Double-blind|Adverse Event|2|||
94371248|NCT01377233|323146808|FG004|Double-blind|Adverse Event|0|||
94206491|NCT01767467|322551364|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
94206492|NCT01767467|322551365|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
94206493|NCT01767467|322551364|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
94206494|NCT01767467|322551365|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
94206495|NCT01767467|322551364|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
94206496|NCT01767467|322551365|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
94206497|NCT01767467|322551364|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
94206498|NCT01767467|322551365|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
94206499|NCT01767467|322551364|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
94206500|NCT01767467|322551365|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
94206501|NCT01767467|322551364|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
94206502|NCT01767467|322551365|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
94206503|NCT01767467|322551364|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
94206504|NCT01767467|322551365|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
94206505|NCT01767467|322551364|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
94206506|NCT01767467|322551365|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
94206507|NCT01767467|322551364|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
94206508|NCT01767467|322551365|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
94206509|NCT01767467|322551364|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
94206510|NCT01767467|322551365|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
94206511|NCT01767467|322551364|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
94206512|NCT01767467|322551365|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
94206513|NCT01767467|322551364|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
94206514|NCT01767467|322551365|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
94206515|NCT01767467|322551364|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
94206516|NCT01767467|322551365|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
94206517|NCT03489369|322551372|FG000|Overall Study|Documented Progressive Disease|3|||
94206518|NCT03489369|322551373|FG001|Overall Study|Documented Progressive Disease|2|||
94206519|NCT03489369|322551374|FG002|Overall Study|Documented Progressive Disease|3|||
94206520|NCT03489369|322551375|FG003|Overall Study|Documented Progressive Disease|6|||
94206521|NCT03489369|322551372|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
94206522|NCT03489369|322551373|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
94206523|NCT03489369|322551374|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
94206524|NCT03489369|322551375|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
94206525|NCT02167451|322551376|FG000|Overall Study|Withdrawal by Subject|1|||
94206526|NCT03113409|322551379|FG000|Overall Study|Withdrawal by Subject|5|||
94206527|NCT03113409|322551380|FG001|Overall Study|Withdrawal by Subject|0|||
94206528|NCT03113409|322551381|FG002|Overall Study|Withdrawal by Subject|0|||
94371249|NCT01377233|323146804|FG000|Double-blind|Protocol Violation|0|||
94206529|NCT01787032|322551388|FG000|Overall Study|Protocol Violation|0|||
94206530|NCT01787032|322551389|FG001|Overall Study|Protocol Violation|0|||
94206531|NCT01787032|322551390|FG002|Overall Study|Protocol Violation|0|||
94206532|NCT01787032|322551391|FG003|Overall Study|Protocol Violation|0|||
94206533|NCT01787032|322551392|FG004|Overall Study|Protocol Violation|1|||
94206534|NCT01787032|322551393|FG005|Overall Study|Protocol Violation|1|||
94206535|NCT00776009|322551394|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
94206536|NCT00776009|322551395|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
94206537|NCT00776009|322551396|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
94206538|NCT00776009|322551397|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
94206539|NCT00776009|322551398|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
94206540|NCT00776009|322551399|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
94206541|NCT00776009|322551394|FG000|Period 1: First Intervention|Protocol Violation|0|||
94206542|NCT00776009|322551395|FG001|Period 1: First Intervention|Protocol Violation|1|||
94206543|NCT00776009|322551396|FG002|Period 1: First Intervention|Protocol Violation|0|||
94206544|NCT00776009|322551397|FG003|Period 1: First Intervention|Protocol Violation|0|||
94206545|NCT00776009|322551398|FG004|Period 1: First Intervention|Protocol Violation|1|||
94206546|NCT00776009|322551399|FG005|Period 1: First Intervention|Protocol Violation|0|||
94206547|NCT00776009|322551394|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
94206548|NCT00776009|322551395|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
94206549|NCT00776009|322551396|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
94206550|NCT00776009|322551397|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
94206551|NCT00776009|322551398|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
94206552|NCT00776009|322551399|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
94206553|NCT00776009|322551394|FG000|Period 2: Second Intervention|Protocol Violation|1|||
94206554|NCT00776009|322551395|FG001|Period 2: Second Intervention|Protocol Violation|0|||
94206555|NCT00776009|322551396|FG002|Period 2: Second Intervention|Protocol Violation|1|||
94206556|NCT00776009|322551397|FG003|Period 2: Second Intervention|Protocol Violation|0|||
94206557|NCT00776009|322551398|FG004|Period 2: Second Intervention|Protocol Violation|0|||
94206558|NCT00776009|322551399|FG005|Period 2: Second Intervention|Protocol Violation|0|||
94206559|NCT00776009|322551394|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
94206560|NCT00776009|322551395|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
94206561|NCT00776009|322551396|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
94206562|NCT00776009|322551397|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
94206563|NCT00776009|322551398|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
94206564|NCT00776009|322551399|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
94206565|NCT03066609|322551400|FG000|INDUCTION|Pregnancy|0|||
94206566|NCT03066609|322551401|FG001|INDUCTION|Pregnancy|0|||
94206567|NCT03066609|322551402|FG002|INDUCTION|Pregnancy|1|||
94206568|NCT03066609|322551403|FG003|INDUCTION|Pregnancy|0|||
94206569|NCT03066609|322551400|FG000|INDUCTION|Lack of Efficacy|0|||
94206570|NCT03066609|322551401|FG001|INDUCTION|Lack of Efficacy|0|||
94206571|NCT03066609|322551402|FG002|INDUCTION|Lack of Efficacy|1|||
94206572|NCT03066609|322551403|FG003|INDUCTION|Lack of Efficacy|0|||
94206573|NCT03066609|322551400|FG000|INDUCTION|Adverse Event|2|||
94206574|NCT03066609|322551401|FG001|INDUCTION|Adverse Event|2|||
94206575|NCT03066609|322551402|FG002|INDUCTION|Adverse Event|0|||
94206576|NCT03066609|322551403|FG003|INDUCTION|Adverse Event|0|||
94206577|NCT03066609|322551400|FG000|MAINTENANCE|Adverse Event|0|||
94206578|NCT03066609|322551401|FG001|MAINTENANCE|Adverse Event|0|||
94206579|NCT03066609|322551402|FG002|MAINTENANCE|Adverse Event|0|||
94206580|NCT03066609|322551403|FG003|MAINTENANCE|Adverse Event|1|||
94206581|NCT03066609|322551400|FG000|MAINTENANCE|Withdrawal by Subject|4|||
94206582|NCT03066609|322551401|FG001|MAINTENANCE|Withdrawal by Subject|2|||
94371250|NCT01377233|323146805|FG001|Double-blind|Protocol Violation|0|||
94206583|NCT03066609|322551402|FG002|MAINTENANCE|Withdrawal by Subject|1|||
94206584|NCT03066609|322551403|FG003|MAINTENANCE|Withdrawal by Subject|1|||
94206585|NCT03066609|322551400|FG000|MAINTENANCE|Lost to Follow-up|0|||
94280660|NCT02970292|322817464|FG001|Overall Study|Withdrawal by Subject|5|||
94280661|NCT02970292|322817463|FG000|Overall Study|Noncompliance with study drug|2|||
94280662|NCT02970292|322817464|FG001|Overall Study|Noncompliance with study drug|2|||
94280663|NCT02970292|322817463|FG000|Overall Study|Adverse Event|5|||
94280664|NCT02970292|322817464|FG001|Overall Study|Adverse Event|0|||
94280665|NCT02970292|322817463|FG000|Overall Study|Lack of Efficacy|1|||
94280666|NCT02970292|322817464|FG001|Overall Study|Lack of Efficacy|0|||
94280667|NCT02970292|322817463|FG000|Overall Study|Lost to Follow-up|1|||
94280668|NCT02970292|322817464|FG001|Overall Study|Lost to Follow-up|0|||
94280669|NCT02970292|322817463|FG000|Overall Study|Protocol Violation|2|||
94280670|NCT02970292|322817464|FG001|Overall Study|Protocol Violation|0|||
94280671|NCT02970292|322817463|FG000|Overall Study|Other|1|||
94280672|NCT02970292|322817464|FG001|Overall Study|Other|0|||
94280673|NCT02941627|322817466|FG000|Overall Study|Death|1|||
94280674|NCT02941627|322817466|FG000|Overall Study|Surgical failure|1|||
94280675|NCT02941627|322817466|FG000|Overall Study|cholesteatoma prevented implantation|1|||
94280676|NCT00411554|322817467|FG000|Overall Study|Adverse Event|2|||
94280677|NCT00411554|322817468|FG001|Overall Study|Adverse Event|4|||
94280678|NCT00411554|322817467|FG000|Overall Study|Lack of Efficacy|2|||
94280679|NCT00411554|322817468|FG001|Overall Study|Lack of Efficacy|5|||
94280680|NCT00411554|322817467|FG000|Overall Study|Withdrawal by Subject|3|||
94280681|NCT00411554|322817468|FG001|Overall Study|Withdrawal by Subject|0|||
94280682|NCT00411554|322817467|FG000|Overall Study|Patient Moved|1|||
94280683|NCT00411554|322817468|FG001|Overall Study|Patient Moved|0|||
94280684|NCT00749996|322817469|FG000|Overall Study|Lost to Follow-up|7|||
94280685|NCT00749996|322817470|FG001|Overall Study|Lost to Follow-up|4|||
94280686|NCT00749996|322817469|FG000|Overall Study|Withdrawal by Subject|5|||
94280687|NCT00749996|322817470|FG001|Overall Study|Withdrawal by Subject|4|||
94280688|NCT00749996|322817469|FG000|Overall Study|Protocol Violation|2|||
94280689|NCT00749996|322817470|FG001|Overall Study|Protocol Violation|3|||
94280690|NCT00749996|322817469|FG000|Overall Study|Physician Decision|2|||
94280691|NCT00749996|322817470|FG001|Overall Study|Physician Decision|0|||
94280692|NCT00749996|322817469|FG000|Overall Study|Pregnancy|0|||
94280693|NCT00749996|322817470|FG001|Overall Study|Pregnancy|2|||
94280694|NCT00749996|322817469|FG000|Overall Study|Adverse Event|1|||
94280695|NCT00749996|322817470|FG001|Overall Study|Adverse Event|0|||
94280696|NCT00749996|322817469|FG000|Overall Study|Death|1|||
94280697|NCT00749996|322817470|FG001|Overall Study|Death|0|||
94280698|NCT00790907|322817471|FG000|Overall Study|Adverse Event|9|||
94280699|NCT00790907|322817472|FG001|Overall Study|Adverse Event|7|||
94280700|NCT00790907|322817473|FG002|Overall Study|Adverse Event|6|||
94280701|NCT00790907|322817471|FG000|Overall Study|Physician Decision|304|||
94280702|NCT00790907|322817472|FG001|Overall Study|Physician Decision|271|||
94280703|NCT00790907|322817473|FG002|Overall Study|Physician Decision|255|||
94280704|NCT00790907|322817471|FG000|Overall Study|Withdrawal by Subject|1|||
94280705|NCT00790907|322817472|FG001|Overall Study|Withdrawal by Subject|7|||
94280706|NCT00790907|322817473|FG002|Overall Study|Withdrawal by Subject|5|||
94280707|NCT00790907|322817471|FG000|Overall Study|Bleeding Event|11|||
94280708|NCT00790907|322817472|FG001|Overall Study|Bleeding Event|16|||
94280709|NCT00790907|322817473|FG002|Overall Study|Bleeding Event|21|||
94280710|NCT00790907|322817471|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
94280711|NCT00790907|322817472|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
94280712|NCT00790907|322817473|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
94280713|NCT00790907|322817471|FG000|Overall Study|Qualifying Condition Not Present|29|||
94280714|NCT00790907|322817472|FG001|Overall Study|Qualifying Condition Not Present|14|||
94280715|NCT00790907|322817473|FG002|Overall Study|Qualifying Condition Not Present|16|||
94280716|NCT00790907|322817471|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
94280717|NCT00790907|322817472|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
94280718|NCT00790907|322817473|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
94280719|NCT00790907|322817471|FG000|Overall Study|Did Not Receive Study Drug|10|||
94280720|NCT00790907|322817472|FG001|Overall Study|Did Not Receive Study Drug|0|||
94280721|NCT00790907|322817473|FG002|Overall Study|Did Not Receive Study Drug|0|||
94280722|NCT02161211|322817477|FG000|Overall Study|Lost to Follow-up|21|||
94280723|NCT02161211|322817478|FG001|Overall Study|Lost to Follow-up|27|||
94280724|NCT02161211|322817479|FG002|Overall Study|Lost to Follow-up|21|||
94280725|NCT02161211|322817477|FG000|Overall Study|Dropped|12|||
94280726|NCT02161211|322817478|FG001|Overall Study|Dropped|5|||
94280727|NCT02161211|322817479|FG002|Overall Study|Dropped|9|||
94280728|NCT00606086|322817480|FG000|Overall Study|Adverse Event|1|||
94280729|NCT00606086|322817481|FG001|Overall Study|Adverse Event|1|||
94280730|NCT00606086|322817480|FG000|Overall Study|Lost to Follow-up|4|||
94280731|NCT00606086|322817481|FG001|Overall Study|Lost to Follow-up|8|||
94280732|NCT00606086|322817480|FG000|Overall Study|Protocol Violation|1|||
94280733|NCT00606086|322817481|FG001|Overall Study|Protocol Violation|0|||
94280734|NCT00606086|322817480|FG000|Overall Study|Withdrawal by Subject|5|||
94280735|NCT00606086|322817481|FG001|Overall Study|Withdrawal by Subject|3|||
94280736|NCT00606086|322817480|FG000|Overall Study|Non-compliance|0|||
94280737|NCT00606086|322817481|FG001|Overall Study|Non-compliance|1|||
94371251|NCT01377233|323146806|FG002|Double-blind|Protocol Violation|0|||
94371252|NCT01377233|323146807|FG003|Double-blind|Protocol Violation|0|||
94371253|NCT01377233|323146808|FG004|Double-blind|Protocol Violation|1|||
94371254|NCT01377233|323146804|FG000|Double-blind|Withdrawal by Subject|0|||
94371255|NCT01377233|323146805|FG001|Double-blind|Withdrawal by Subject|0|||
94371256|NCT01377233|323146806|FG002|Double-blind|Withdrawal by Subject|0|||
94371257|NCT01377233|323146807|FG003|Double-blind|Withdrawal by Subject|1|||
94371258|NCT01377233|323146808|FG004|Double-blind|Withdrawal by Subject|0|||
94371259|NCT01377233|323146804|FG000|Double-blind|Administrative or other|0|||
94371260|NCT01377233|323146805|FG001|Double-blind|Administrative or other|0|||
94371261|NCT01377233|323146806|FG002|Double-blind|Administrative or other|0|||
94371262|NCT01377233|323146807|FG003|Double-blind|Administrative or other|1|||
94371263|NCT01377233|323146808|FG004|Double-blind|Administrative or other|1|||
94371264|NCT01785875|323146809|FG000|Overall Study|Withdrawal by Subject|41|||
94371265|NCT01785875|323146810|FG001|Overall Study|Withdrawal by Subject|34|||
94371266|NCT01785875|323146811|FG002|Overall Study|Withdrawal by Subject|36|||
94371267|NCT01785875|323146809|FG000|Overall Study|Lost to Follow-up|19|||
94371268|NCT01785875|323146810|FG001|Overall Study|Lost to Follow-up|22|||
94371269|NCT01785875|323146811|FG002|Overall Study|Lost to Follow-up|6|||
94371270|NCT01785875|323146809|FG000|Overall Study|Death|27|||
94371271|NCT01785875|323146810|FG001|Overall Study|Death|16|||
94371272|NCT01785875|323146811|FG002|Overall Study|Death|7|||
94371273|NCT01785875|323146809|FG000|Overall Study|Sponsor Decision|0|||
94371274|NCT01785875|323146810|FG001|Overall Study|Sponsor Decision|2|||
94371275|NCT01785875|323146811|FG002|Overall Study|Sponsor Decision|0|||
94371276|NCT01785875|323146809|FG000|Overall Study|Protocol Specified Criteria|207|||
94371277|NCT01785875|323146810|FG001|Overall Study|Protocol Specified Criteria|214|||
94371278|NCT01785875|323146811|FG002|Overall Study|Protocol Specified Criteria|55|||
94371279|NCT01785875|323146809|FG000|Overall Study|Missing|0|||
94371280|NCT01785875|323146810|FG001|Overall Study|Missing|1|||
94371281|NCT01785875|323146811|FG002|Overall Study|Missing|3|||
94371282|NCT00417027|323146812|FG000|Overall Study|Protocol Violation|0|||
94371283|NCT00417027|323146813|FG001|Overall Study|Protocol Violation|5|||
94371284|NCT00417027|323146814|FG002|Overall Study|Protocol Violation|5|||
94371285|NCT00544557|323146815|FG000|Overall Study|Adverse Event|140|||
94371286|NCT00544557|323146815|FG000|Overall Study|Lack of Efficacy|196|||
94371287|NCT00544557|323146815|FG000|Overall Study|Other|98|||
94371288|NCT01155063|323146816|FG000|Overall Study|Adverse Event|1|||
94371289|NCT01155063|323146816|FG000|Overall Study|Withdrawal by Subject|1|||
94280738|NCT00606086|322817480|FG000|Overall Study|Randomized, not treated|1|||
94280739|NCT00606086|322817481|FG001|Overall Study|Randomized, not treated|2|||
94280740|NCT01464307|322817483|FG000|Main Period|Death|0|||
94280741|NCT01464307|322817484|FG001|Main Period|Death|1|||
94280742|NCT01464307|322817483|FG000|Main Period|Adverse Event|6|||
94280743|NCT01464307|322817484|FG001|Main Period|Adverse Event|1|||
94280744|NCT01464307|322817483|FG000|Main Period|Lack of Efficacy|2|||
94280745|NCT01464307|322817484|FG001|Main Period|Lack of Efficacy|0|||
94280746|NCT01464307|322817483|FG000|Main Period|Withdrawal by Subject|5|||
94280747|NCT01464307|322817484|FG001|Main Period|Withdrawal by Subject|2|||
94280748|NCT01464307|322817483|FG000|Main Period|Predefined discontinuation criteria|2|||
94280749|NCT01464307|322817484|FG001|Main Period|Predefined discontinuation criteria|1|||
94280750|NCT01464307|322817483|FG000|Open-Label Extension Period|Adverse Event|15|||
94280751|NCT01464307|322817484|FG001|Open-Label Extension Period|Adverse Event|0|||
94280752|NCT01464307|322817483|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
94280753|NCT01464307|322817484|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
94280754|NCT01464307|322817483|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
94280755|NCT01464307|322817484|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
94280756|NCT01464307|322817483|FG000|Open-Label Extension Period|Death|1|||
94280757|NCT01464307|322817484|FG001|Open-Label Extension Period|Death|0|||
94280758|NCT01464307|322817483|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
94280759|NCT01464307|322817484|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
94371290|NCT01155063|323146816|FG000|Overall Study|Study terminated by sponsor|87|||
94371291|NCT01314703|323146817|FG000|Overall Study|screen failure and closed enrollment|8|||
94371292|NCT00467818|323146818|FG000|Overall Study|Adverse Event|1|||
94280760|NCT01464307|322817483|FG000|Open-Label Extension Period|Non-compliance|9|||
94280761|NCT01464307|322817484|FG001|Open-Label Extension Period|Non-compliance|0|||
94371293|NCT00467818|323146819|FG001|Overall Study|Adverse Event|0|||
94371294|NCT00467818|323146818|FG000|Overall Study|Lost to Follow-up|2|||
94371295|NCT00467818|323146819|FG001|Overall Study|Lost to Follow-up|2|||
94206586|NCT03066609|322551401|FG001|MAINTENANCE|Lost to Follow-up|1|||
94206587|NCT03066609|322551402|FG002|MAINTENANCE|Lost to Follow-up|1|||
94206588|NCT03066609|322551403|FG003|MAINTENANCE|Lost to Follow-up|0|||
94206589|NCT03066609|322551400|FG000|MAINTENANCE|Pregnancy|1|||
94206590|NCT03066609|322551401|FG001|MAINTENANCE|Pregnancy|0|||
94206591|NCT03066609|322551402|FG002|MAINTENANCE|Pregnancy|0|||
94206592|NCT03066609|322551403|FG003|MAINTENANCE|Pregnancy|0|||
94206593|NCT03066609|322551400|FG000|MAINTENANCE|Lack of Efficacy|2|||
94206594|NCT03066609|322551401|FG001|MAINTENANCE|Lack of Efficacy|1|||
94206595|NCT03066609|322551402|FG002|MAINTENANCE|Lack of Efficacy|0|||
94206596|NCT03066609|322551403|FG003|MAINTENANCE|Lack of Efficacy|1|||
94206597|NCT03066609|322551400|FG000|OVERALL STUDY|Adverse Event|2|||
94206598|NCT03066609|322551401|FG001|OVERALL STUDY|Adverse Event|2|||
94206599|NCT03066609|322551402|FG002|OVERALL STUDY|Adverse Event|0|||
94206600|NCT03066609|322551403|FG003|OVERALL STUDY|Adverse Event|1|||
94206601|NCT03066609|322551400|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
94206602|NCT03066609|322551401|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
94206603|NCT03066609|322551402|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
94206604|NCT03066609|322551403|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
94206605|NCT03066609|322551400|FG000|OVERALL STUDY|Lost to Follow-up|1|||
94206606|NCT03066609|322551401|FG001|OVERALL STUDY|Lost to Follow-up|1|||
94206607|NCT03066609|322551402|FG002|OVERALL STUDY|Lost to Follow-up|1|||
94206608|NCT03066609|322551403|FG003|OVERALL STUDY|Lost to Follow-up|1|||
94206609|NCT03066609|322551400|FG000|OVERALL STUDY|Pregnancy|1|||
94206610|NCT03066609|322551401|FG001|OVERALL STUDY|Pregnancy|0|||
94206611|NCT03066609|322551402|FG002|OVERALL STUDY|Pregnancy|1|||
94206612|NCT03066609|322551403|FG003|OVERALL STUDY|Pregnancy|0|||
94206613|NCT03066609|322551400|FG000|OVERALL STUDY|Lack of Efficacy|2|||
94206614|NCT03066609|322551401|FG001|OVERALL STUDY|Lack of Efficacy|1|||
94206615|NCT03066609|322551402|FG002|OVERALL STUDY|Lack of Efficacy|1|||
94206616|NCT03066609|322551403|FG003|OVERALL STUDY|Lack of Efficacy|1|||
94206617|NCT03066609|322551400|FG000|OVERALL STUDY|discontinued follow up|0|||
94206618|NCT03066609|322551401|FG001|OVERALL STUDY|discontinued follow up|2|||
94206619|NCT03066609|322551402|FG002|OVERALL STUDY|discontinued follow up|0|||
94206620|NCT03066609|322551403|FG003|OVERALL STUDY|discontinued follow up|0|||
94206621|NCT00293397|322551406|FG000|Overall Study|Death|2|||
94280762|NCT01464307|322817483|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
94280763|NCT01464307|322817484|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
94280764|NCT00516737|322817487|FG000|Overall Study|Lost to Follow-up|2|||
94280765|NCT00516737|322817488|FG001|Overall Study|Lost to Follow-up|0|||
94280766|NCT00516737|322817487|FG000|Overall Study|Physician Decision|0|||
94280767|NCT00516737|322817488|FG001|Overall Study|Physician Decision|1|||
94280768|NCT00516737|322817487|FG000|Overall Study|Withdrawal by Subject|0|||
94280769|NCT00516737|322817488|FG001|Overall Study|Withdrawal by Subject|1|||
94280770|NCT00516737|322817487|FG000|Overall Study|Lack of Qualifying Event|9|||
94280771|NCT00516737|322817488|FG001|Overall Study|Lack of Qualifying Event|6|||
94280772|NCT01035905|322817489|FG000|Overall Study|Lack of Efficacy|1|||
94280773|NCT01035905|322817490|FG001|Overall Study|Lack of Efficacy|1|||
94280774|NCT00848354|322817491|FG000|Phase 1|Adverse Event|5|||
94280775|NCT00848354|322817492|FG001|Phase 1|Adverse Event|4|||
94280776|NCT00848354|322817491|FG000|Phase 1|Discontinuation of study by sponsor|2|||
94280777|NCT00848354|322817492|FG001|Phase 1|Discontinuation of study by sponsor|1|||
94280778|NCT00848354|322817491|FG000|Phase 1|Failed to return|0|||
94280779|NCT00848354|322817492|FG001|Phase 1|Failed to return|1|||
94280780|NCT00848354|322817491|FG000|Phase 1|Lost to Follow-up|1|||
94280781|NCT00848354|322817492|FG001|Phase 1|Lost to Follow-up|1|||
94280782|NCT00848354|322817491|FG000|Phase 1|Unspecified Reason|1|||
94280783|NCT00848354|322817492|FG001|Phase 1|Unspecified Reason|1|||
94280784|NCT00848354|322817491|FG000|Phase 1|Protocol Violation|1|||
94280785|NCT00848354|322817492|FG001|Phase 1|Protocol Violation|1|||
94280786|NCT00848354|322817491|FG000|Phase 1|Withdrawal by Subject|2|||
94280787|NCT00848354|322817492|FG001|Phase 1|Withdrawal by Subject|4|||
94280788|NCT00848354|322817491|FG000|Phase 1|Lack of Efficacy|0|||
94206622|NCT01421667|322551412|FG000|Overall Study|Withdrawal by Subject|0|||
94206623|NCT01421667|322551413|FG001|Overall Study|Withdrawal by Subject|1|||
94206624|NCT01421667|322551414|FG002|Overall Study|Withdrawal by Subject|2|||
94280789|NCT00848354|322817492|FG001|Phase 1|Lack of Efficacy|1|||
94280790|NCT00848354|322817491|FG000|Phase 2 Year 1|Adverse Event|7|||
94280791|NCT00848354|322817492|FG001|Phase 2 Year 1|Adverse Event|2|||
94206625|NCT01421667|322551415|FG003|Overall Study|Withdrawal by Subject|1|||
94206626|NCT01421667|322551412|FG000|Overall Study|Lost to Follow-up|0|||
94206627|NCT01421667|322551413|FG001|Overall Study|Lost to Follow-up|1|||
94206628|NCT01421667|322551414|FG002|Overall Study|Lost to Follow-up|0|||
94206629|NCT01421667|322551415|FG003|Overall Study|Lost to Follow-up|0|||
94206630|NCT00982644|322551416|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
94206631|NCT00982644|322551417|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
94280792|NCT00848354|322817491|FG000|Phase 2 Year 1|Death|1|||
94280793|NCT00848354|322817492|FG001|Phase 2 Year 1|Death|0|||
94280794|NCT00848354|322817491|FG000|Phase 2 Year 1|Failed to Return|1|||
94280795|NCT00848354|322817492|FG001|Phase 2 Year 1|Failed to Return|1|||
94206632|NCT00982644|322551416|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
94206633|NCT00982644|322551417|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
94206634|NCT00982644|322551416|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
94206635|NCT00982644|322551417|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
94206636|NCT00982644|322551416|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
94206637|NCT00982644|322551417|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
94206638|NCT00982644|322551416|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
94206639|NCT00982644|322551417|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
94206640|NCT00982644|322551416|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
94206641|NCT00982644|322551417|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
94206642|NCT00982644|322551416|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
94206643|NCT00982644|322551417|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
94206644|NCT00982644|322551416|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
94206645|NCT00982644|322551417|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
94206646|NCT00982644|322551416|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
94206647|NCT00982644|322551417|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
94206648|NCT00982644|322551416|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
94206649|NCT00982644|322551417|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
94206650|NCT01218009|322551418|FG000|Overall Study|Protocol Violation|2|||
94206651|NCT01218009|322551419|FG001|Overall Study|Protocol Violation|1|||
94206652|NCT01218009|322551418|FG000|Overall Study|Withdrawal by Subject|3|||
94206653|NCT01218009|322551419|FG001|Overall Study|Withdrawal by Subject|1|||
94206654|NCT01218009|322551418|FG000|Overall Study|Sponsor terminated study|161|||
94206655|NCT01218009|322551419|FG001|Overall Study|Sponsor terminated study|163|||
94206656|NCT00943917|322551420|FG000|Stage I|Adverse Event|1|||
94206657|NCT00943917|322551421|FG001|Stage I|Adverse Event|2|||
94206658|NCT00943917|322551422|FG002|Stage I|Adverse Event|2|||
94206659|NCT00943917|322551423|FG003|Stage I|Adverse Event|0|||
94206660|NCT00943917|322551424|FG004|Stage I|Adverse Event|0|||
94206661|NCT00943917|322551425|FG005|Stage I|Adverse Event|0|||
94206662|NCT00943917|322551426|FG006|Stage I|Adverse Event|0|||
94206663|NCT00943917|322551427|FG007|Stage I|Adverse Event|0|||
94206664|NCT00943917|322551428|FG008|Stage I|Adverse Event|0|||
94206665|NCT00943917|322551429|FG009|Stage I|Adverse Event|0|||
94206666|NCT00943917|322551430|FG010|Stage I|Adverse Event|0|||
94206667|NCT00943917|322551431|FG011|Stage I|Adverse Event|0|||
94206668|NCT00943917|322551432|FG012|Stage I|Adverse Event|0|||
94206669|NCT00943917|322551433|FG013|Stage I|Adverse Event|0|||
94206670|NCT00943917|322551434|FG014|Stage I|Adverse Event|0|||
94206671|NCT00943917|322551420|FG000|Stage I|Lost to Follow-up|0|||
94206672|NCT00943917|322551421|FG001|Stage I|Lost to Follow-up|0|||
94206673|NCT00943917|322551422|FG002|Stage I|Lost to Follow-up|1|||
94206674|NCT00943917|322551423|FG003|Stage I|Lost to Follow-up|0|||
94206675|NCT00943917|322551424|FG004|Stage I|Lost to Follow-up|0|||
94206676|NCT00943917|322551425|FG005|Stage I|Lost to Follow-up|0|||
94206677|NCT00943917|322551426|FG006|Stage I|Lost to Follow-up|0|||
94206678|NCT00943917|322551427|FG007|Stage I|Lost to Follow-up|0|||
94206679|NCT00943917|322551428|FG008|Stage I|Lost to Follow-up|0|||
94206680|NCT00943917|322551429|FG009|Stage I|Lost to Follow-up|0|||
94206681|NCT00943917|322551430|FG010|Stage I|Lost to Follow-up|0|||
94206682|NCT00943917|322551431|FG011|Stage I|Lost to Follow-up|0|||
94206683|NCT00943917|322551432|FG012|Stage I|Lost to Follow-up|0|||
94206684|NCT00943917|322551433|FG013|Stage I|Lost to Follow-up|0|||
94206685|NCT00943917|322551434|FG014|Stage I|Lost to Follow-up|0|||
94206686|NCT00943917|322551420|FG000|Stage I|hyperglycemia|0|||
94206687|NCT00943917|322551421|FG001|Stage I|hyperglycemia|0|||
94206688|NCT00943917|322551422|FG002|Stage I|hyperglycemia|1|||
94206689|NCT00943917|322551423|FG003|Stage I|hyperglycemia|0|||
94206690|NCT00943917|322551424|FG004|Stage I|hyperglycemia|0|||
94206691|NCT00943917|322551425|FG005|Stage I|hyperglycemia|0|||
94206692|NCT00943917|322551426|FG006|Stage I|hyperglycemia|0|||
94206693|NCT00943917|322551427|FG007|Stage I|hyperglycemia|0|||
94206694|NCT00943917|322551428|FG008|Stage I|hyperglycemia|0|||
94280796|NCT00848354|322817491|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
94280797|NCT00848354|322817492|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
94206695|NCT00943917|322551429|FG009|Stage I|hyperglycemia|0|||
94206696|NCT00943917|322551430|FG010|Stage I|hyperglycemia|0|||
94206697|NCT00943917|322551431|FG011|Stage I|hyperglycemia|0|||
94206698|NCT00943917|322551432|FG012|Stage I|hyperglycemia|0|||
94206699|NCT00943917|322551433|FG013|Stage I|hyperglycemia|0|||
94206700|NCT00943917|322551434|FG014|Stage I|hyperglycemia|0|||
94206701|NCT00943917|322551420|FG000|Stage I|A1C elevation|1|||
94206702|NCT00943917|322551421|FG001|Stage I|A1C elevation|0|||
94206703|NCT00943917|322551422|FG002|Stage I|A1C elevation|0|||
94206704|NCT00943917|322551423|FG003|Stage I|A1C elevation|0|||
94206705|NCT00943917|322551424|FG004|Stage I|A1C elevation|0|||
94206706|NCT00943917|322551425|FG005|Stage I|A1C elevation|0|||
94206707|NCT00943917|322551426|FG006|Stage I|A1C elevation|0|||
94206708|NCT00943917|322551427|FG007|Stage I|A1C elevation|0|||
94206709|NCT00943917|322551428|FG008|Stage I|A1C elevation|0|||
94206710|NCT00943917|322551429|FG009|Stage I|A1C elevation|0|||
94206711|NCT00943917|322551430|FG010|Stage I|A1C elevation|0|||
94206712|NCT00943917|322551431|FG011|Stage I|A1C elevation|0|||
94206713|NCT00943917|322551432|FG012|Stage I|A1C elevation|0|||
94206714|NCT00943917|322551433|FG013|Stage I|A1C elevation|0|||
94206715|NCT00943917|322551434|FG014|Stage I|A1C elevation|0|||
94206716|NCT00943917|322551420|FG000|Stage I|Withdrawal by Subject|2|||
94206717|NCT00943917|322551421|FG001|Stage I|Withdrawal by Subject|1|||
94206718|NCT00943917|322551422|FG002|Stage I|Withdrawal by Subject|2|||
94206719|NCT00943917|322551423|FG003|Stage I|Withdrawal by Subject|0|||
94206720|NCT00943917|322551424|FG004|Stage I|Withdrawal by Subject|0|||
94206721|NCT00943917|322551425|FG005|Stage I|Withdrawal by Subject|0|||
94206722|NCT00943917|322551426|FG006|Stage I|Withdrawal by Subject|0|||
94206723|NCT00943917|322551427|FG007|Stage I|Withdrawal by Subject|0|||
94206724|NCT00943917|322551428|FG008|Stage I|Withdrawal by Subject|0|||
94206725|NCT00943917|322551429|FG009|Stage I|Withdrawal by Subject|0|||
94206726|NCT00943917|322551430|FG010|Stage I|Withdrawal by Subject|0|||
94206727|NCT00943917|322551431|FG011|Stage I|Withdrawal by Subject|0|||
94206728|NCT00943917|322551432|FG012|Stage I|Withdrawal by Subject|0|||
94206729|NCT00943917|322551433|FG013|Stage I|Withdrawal by Subject|0|||
94206730|NCT00943917|322551434|FG014|Stage I|Withdrawal by Subject|0|||
94206731|NCT00943917|322551420|FG000|Stage II|Adverse Event|0|||
94206732|NCT00943917|322551421|FG001|Stage II|Adverse Event|0|||
94206733|NCT00943917|322551422|FG002|Stage II|Adverse Event|0|||
94206734|NCT00943917|322551423|FG003|Stage II|Adverse Event|0|||
94206735|NCT00943917|322551424|FG004|Stage II|Adverse Event|0|||
94206736|NCT00943917|322551425|FG005|Stage II|Adverse Event|1|||
94206737|NCT00943917|322551426|FG006|Stage II|Adverse Event|3|||
94206738|NCT00943917|322551427|FG007|Stage II|Adverse Event|0|||
94206739|NCT00943917|322551428|FG008|Stage II|Adverse Event|1|||
94206740|NCT00943917|322551429|FG009|Stage II|Adverse Event|0|||
94206741|NCT00943917|322551430|FG010|Stage II|Adverse Event|0|||
94206742|NCT00943917|322551431|FG011|Stage II|Adverse Event|0|||
94206743|NCT00943917|322551432|FG012|Stage II|Adverse Event|0|||
94206744|NCT00943917|322551433|FG013|Stage II|Adverse Event|0|||
94206745|NCT00943917|322551434|FG014|Stage II|Adverse Event|0|||
94206746|NCT00943917|322551420|FG000|Stage II|Withdrawal by Subject|0|||
94206747|NCT00943917|322551421|FG001|Stage II|Withdrawal by Subject|0|||
94206748|NCT00943917|322551422|FG002|Stage II|Withdrawal by Subject|0|||
94206749|NCT00943917|322551423|FG003|Stage II|Withdrawal by Subject|0|||
94206750|NCT00943917|322551424|FG004|Stage II|Withdrawal by Subject|0|||
94206751|NCT00943917|322551425|FG005|Stage II|Withdrawal by Subject|1|||
94206752|NCT00943917|322551426|FG006|Stage II|Withdrawal by Subject|0|||
94206753|NCT00943917|322551427|FG007|Stage II|Withdrawal by Subject|0|||
94206754|NCT00943917|322551428|FG008|Stage II|Withdrawal by Subject|0|||
94206755|NCT00943917|322551429|FG009|Stage II|Withdrawal by Subject|0|||
94206756|NCT00943917|322551430|FG010|Stage II|Withdrawal by Subject|0|||
94206757|NCT00943917|322551431|FG011|Stage II|Withdrawal by Subject|0|||
94206758|NCT00943917|322551432|FG012|Stage II|Withdrawal by Subject|0|||
94206759|NCT00943917|322551433|FG013|Stage II|Withdrawal by Subject|0|||
94206760|NCT00943917|322551434|FG014|Stage II|Withdrawal by Subject|0|||
94206761|NCT00943917|322551420|FG000|Stage II|Pregnancy|0|||
94206762|NCT00943917|322551421|FG001|Stage II|Pregnancy|0|||
94206763|NCT00943917|322551422|FG002|Stage II|Pregnancy|0|||
94206764|NCT00943917|322551423|FG003|Stage II|Pregnancy|0|||
94206765|NCT00943917|322551424|FG004|Stage II|Pregnancy|0|||
94206766|NCT00943917|322551425|FG005|Stage II|Pregnancy|1|||
94206767|NCT00943917|322551426|FG006|Stage II|Pregnancy|0|||
94206768|NCT00943917|322551427|FG007|Stage II|Pregnancy|0|||
94280798|NCT00848354|322817491|FG000|Phase 2 Year 1|Unspecified Reason|3|||
94280799|NCT00848354|322817492|FG001|Phase 2 Year 1|Unspecified Reason|0|||
94280800|NCT00848354|322817491|FG000|Phase 2 Year 1|Protocol Violation|4|||
94280801|NCT00848354|322817492|FG001|Phase 2 Year 1|Protocol Violation|1|||
94280802|NCT00848354|322817491|FG000|Phase 2 Year 1|Subject Request|1|||
94280803|NCT00848354|322817492|FG001|Phase 2 Year 1|Subject Request|2|||
94280804|NCT00848354|322817491|FG000|Phase 2 Year 2|Adverse Event|12|||
94280805|NCT00848354|322817492|FG001|Phase 2 Year 2|Adverse Event|2|||
94280806|NCT00848354|322817491|FG000|Phase 2 Year 2|Death|2|||
94280807|NCT00848354|322817492|FG001|Phase 2 Year 2|Death|0|||
94280808|NCT00848354|322817491|FG000|Phase 2 Year 2|Failed to return|3|||
94371296|NCT02753400|323146820|FG000|Overall Study|Adverse Event|3|||
94206769|NCT00943917|322551428|FG008|Stage II|Pregnancy|0|||
94206770|NCT00943917|322551429|FG009|Stage II|Pregnancy|0|||
94206771|NCT00943917|322551430|FG010|Stage II|Pregnancy|0|||
94206772|NCT00943917|322551431|FG011|Stage II|Pregnancy|0|||
94206773|NCT00943917|322551432|FG012|Stage II|Pregnancy|0|||
94206774|NCT00943917|322551433|FG013|Stage II|Pregnancy|0|||
94206775|NCT00943917|322551434|FG014|Stage II|Pregnancy|0|||
94206776|NCT00943917|322551420|FG000|Stage II Continuation|Adverse Event|0|||
94206777|NCT00943917|322551421|FG001|Stage II Continuation|Adverse Event|0|||
94206778|NCT00943917|322551422|FG002|Stage II Continuation|Adverse Event|0|||
94206779|NCT00943917|322551423|FG003|Stage II Continuation|Adverse Event|0|||
94206780|NCT00943917|322551424|FG004|Stage II Continuation|Adverse Event|0|||
94280809|NCT00848354|322817492|FG001|Phase 2 Year 2|Failed to return|0|||
94280810|NCT00848354|322817491|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
94206781|NCT00943917|322551425|FG005|Stage II Continuation|Adverse Event|0|||
94206782|NCT00943917|322551426|FG006|Stage II Continuation|Adverse Event|0|||
94206783|NCT00943917|322551427|FG007|Stage II Continuation|Adverse Event|0|||
94206784|NCT00943917|322551428|FG008|Stage II Continuation|Adverse Event|0|||
94206785|NCT00943917|322551429|FG009|Stage II Continuation|Adverse Event|0|||
94206786|NCT00943917|322551430|FG010|Stage II Continuation|Adverse Event|0|||
94206787|NCT00943917|322551431|FG011|Stage II Continuation|Adverse Event|1|||
94206788|NCT00943917|322551432|FG012|Stage II Continuation|Adverse Event|2|||
94206789|NCT00943917|322551433|FG013|Stage II Continuation|Adverse Event|1|||
94206790|NCT00943917|322551434|FG014|Stage II Continuation|Adverse Event|1|||
94206791|NCT00943917|322551420|FG000|Stage II Continuation|Withdrawal by Subject|0|||
94206792|NCT00943917|322551421|FG001|Stage II Continuation|Withdrawal by Subject|0|||
94206793|NCT00943917|322551422|FG002|Stage II Continuation|Withdrawal by Subject|0|||
94206794|NCT00943917|322551423|FG003|Stage II Continuation|Withdrawal by Subject|0|||
94206795|NCT00943917|322551424|FG004|Stage II Continuation|Withdrawal by Subject|0|||
94206796|NCT00943917|322551425|FG005|Stage II Continuation|Withdrawal by Subject|0|||
94206797|NCT00943917|322551426|FG006|Stage II Continuation|Withdrawal by Subject|0|||
94206798|NCT00943917|322551427|FG007|Stage II Continuation|Withdrawal by Subject|0|||
94206799|NCT00943917|322551428|FG008|Stage II Continuation|Withdrawal by Subject|0|||
94206800|NCT00943917|322551429|FG009|Stage II Continuation|Withdrawal by Subject|0|||
94206801|NCT00943917|322551430|FG010|Stage II Continuation|Withdrawal by Subject|0|||
94206802|NCT00943917|322551431|FG011|Stage II Continuation|Withdrawal by Subject|0|||
94206803|NCT00943917|322551432|FG012|Stage II Continuation|Withdrawal by Subject|0|||
94206804|NCT00943917|322551433|FG013|Stage II Continuation|Withdrawal by Subject|1|||
94206805|NCT00943917|322551434|FG014|Stage II Continuation|Withdrawal by Subject|3|||
94206806|NCT00943917|322551420|FG000|Stage II Continuation|Protocol Violation|0|||
94206807|NCT00943917|322551421|FG001|Stage II Continuation|Protocol Violation|0|||
94206808|NCT00943917|322551422|FG002|Stage II Continuation|Protocol Violation|0|||
94206809|NCT00943917|322551423|FG003|Stage II Continuation|Protocol Violation|0|||
94206810|NCT00943917|322551424|FG004|Stage II Continuation|Protocol Violation|0|||
94206811|NCT00943917|322551425|FG005|Stage II Continuation|Protocol Violation|0|||
94206812|NCT00943917|322551426|FG006|Stage II Continuation|Protocol Violation|0|||
94206813|NCT00943917|322551427|FG007|Stage II Continuation|Protocol Violation|0|||
94206814|NCT00943917|322551428|FG008|Stage II Continuation|Protocol Violation|0|||
94206815|NCT00943917|322551429|FG009|Stage II Continuation|Protocol Violation|1|||
94206816|NCT00943917|322551430|FG010|Stage II Continuation|Protocol Violation|0|||
94206817|NCT00943917|322551431|FG011|Stage II Continuation|Protocol Violation|1|||
94206818|NCT00943917|322551432|FG012|Stage II Continuation|Protocol Violation|0|||
94206819|NCT00943917|322551433|FG013|Stage II Continuation|Protocol Violation|0|||
94206820|NCT00943917|322551434|FG014|Stage II Continuation|Protocol Violation|0|||
94206821|NCT00943917|322551420|FG000|Stage II Continuation|hypoglycemia|0|||
94206822|NCT00943917|322551421|FG001|Stage II Continuation|hypoglycemia|0|||
94206823|NCT00943917|322551422|FG002|Stage II Continuation|hypoglycemia|0|||
94280811|NCT00848354|322817492|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
94280812|NCT00848354|322817491|FG000|Phase 2 Year 2|Unspecified Reason|1|||
94280813|NCT00848354|322817492|FG001|Phase 2 Year 2|Unspecified Reason|0|||
94280814|NCT00848354|322817491|FG000|Phase 2 Year 2|Protocol Violation|1|||
94280815|NCT00848354|322817492|FG001|Phase 2 Year 2|Protocol Violation|1|||
94280816|NCT00848354|322817491|FG000|Phase 2 Year 2|Subject Request|1|||
94280817|NCT00848354|322817492|FG001|Phase 2 Year 2|Subject Request|1|||
94280818|NCT00848354|322817491|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
94280819|NCT00848354|322817492|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
94280820|NCT00512798|322817493|FG000|Overall Study|Death|0|||
94280821|NCT00512798|322817494|FG001|Overall Study|Death|3|||
94280822|NCT00512798|322817493|FG000|Overall Study|Adverse Event|2|||
94280823|NCT00512798|322817494|FG001|Overall Study|Adverse Event|4|||
94280824|NCT00512798|322817493|FG000|Overall Study|Progression of disease|14|||
94280825|NCT00512798|322817494|FG001|Overall Study|Progression of disease|20|||
94280826|NCT00512798|322817493|FG000|Overall Study|Withdrawal by Subject|3|||
94280827|NCT00512798|322817494|FG001|Overall Study|Withdrawal by Subject|0|||
94280828|NCT01972074|322817495|FG000|Overall Study|Adverse Event|4|||
94280829|NCT01972074|322817496|FG001|Overall Study|Adverse Event|1|||
94280830|NCT01972074|322817497|FG002|Overall Study|Adverse Event|0|||
94280831|NCT01972074|322817495|FG000|Overall Study|Lack of Efficacy|1|||
94280832|NCT01972074|322817496|FG001|Overall Study|Lack of Efficacy|1|||
94280833|NCT01972074|322817497|FG002|Overall Study|Lack of Efficacy|0|||
94280834|NCT01972074|322817495|FG000|Overall Study|Lost to Follow-up|0|||
94280835|NCT01972074|322817496|FG001|Overall Study|Lost to Follow-up|1|||
94371297|NCT02753400|323146821|FG001|Overall Study|Adverse Event|0|||
94371298|NCT02753400|323146820|FG000|Overall Study|Withdrawal by Subject|2|||
94371299|NCT02753400|323146821|FG001|Overall Study|Withdrawal by Subject|1|||
94206824|NCT00943917|322551423|FG003|Stage II Continuation|hypoglycemia|0|||
94206825|NCT00943917|322551424|FG004|Stage II Continuation|hypoglycemia|0|||
94280836|NCT01972074|322817497|FG002|Overall Study|Lost to Follow-up|1|||
94280837|NCT01972074|322817495|FG000|Overall Study|Withdrawal by Subject|1|||
94280838|NCT01972074|322817496|FG001|Overall Study|Withdrawal by Subject|1|||
94280839|NCT01972074|322817497|FG002|Overall Study|Withdrawal by Subject|1|||
94280840|NCT01972074|322817495|FG000|Overall Study|Scanner Unavailable|0|||
94280841|NCT01972074|322817496|FG001|Overall Study|Scanner Unavailable|0|||
94280842|NCT01972074|322817497|FG002|Overall Study|Scanner Unavailable|1|||
94280843|NCT00511355|322817498|FG000|Overall Study|Adverse Event|4|||
94371300|NCT00447603|323146822|FG000|Screening|Withdrawal by Subject|1|||
94371301|NCT00447603|323146823|FG001|Screening|Withdrawal by Subject|0|||
94371302|NCT00447603|323146824|FG002|Screening|Withdrawal by Subject|0|||
94371303|NCT00447603|323146822|FG000|Screening|Protocol Violation|1|||
94371304|NCT00447603|323146823|FG001|Screening|Protocol Violation|0|||
94371305|NCT00447603|323146824|FG002|Screening|Protocol Violation|0|||
94371306|NCT00447603|323146822|FG000|Screening|Screen Failure|4|||
94371307|NCT00447603|323146823|FG001|Screening|Screen Failure|0|||
94371308|NCT00447603|323146824|FG002|Screening|Screen Failure|0|||
94371309|NCT00447603|323146822|FG000|Screening|Study Terminated by Sponsor|15|||
94371310|NCT00447603|323146823|FG001|Screening|Study Terminated by Sponsor|0|||
94371311|NCT00447603|323146824|FG002|Screening|Study Terminated by Sponsor|0|||
94371312|NCT00447603|323146822|FG000|Filter Period|Adverse Event|0|||
94371313|NCT00447603|323146823|FG001|Filter Period|Adverse Event|0|||
94371314|NCT00447603|323146824|FG002|Filter Period|Adverse Event|1|||
94371315|NCT00447603|323146822|FG000|Filter Period|Screen Failure|0|||
94371316|NCT00447603|323146823|FG001|Filter Period|Screen Failure|3|||
94371317|NCT00447603|323146824|FG002|Filter Period|Screen Failure|4|||
94371318|NCT00447603|323146822|FG000|Filter Period|Study terminated by Sponsor|0|||
94371319|NCT00447603|323146823|FG001|Filter Period|Study terminated by Sponsor|1|||
94371320|NCT00447603|323146824|FG002|Filter Period|Study terminated by Sponsor|10|||
94371321|NCT02059187|323146826|FG000|Overall Study|Adverse Event|0|||
94371322|NCT02059187|323146827|FG001|Overall Study|Adverse Event|3|||
94371323|NCT02059187|323146826|FG000|Overall Study|Death|1|||
94371324|NCT02059187|323146827|FG001|Overall Study|Death|1|||
94371325|NCT02059187|323146826|FG000|Overall Study|Lost to Follow-up|9|||
94371326|NCT02059187|323146827|FG001|Overall Study|Lost to Follow-up|8|||
94371327|NCT02059187|323146826|FG000|Overall Study|Non-compliance with study drug|1|||
94371328|NCT02059187|323146827|FG001|Overall Study|Non-compliance with study drug|0|||
94371329|NCT02059187|323146826|FG000|Overall Study|Physician Decision|1|||
94371330|NCT02059187|323146827|FG001|Overall Study|Physician Decision|2|||
94371331|NCT02059187|323146826|FG000|Overall Study|Protocol Violation|1|||
94371332|NCT02059187|323146827|FG001|Overall Study|Protocol Violation|0|||
94371333|NCT02059187|323146826|FG000|Overall Study|Withdrawal by Subject|12|||
94371334|NCT02059187|323146827|FG001|Overall Study|Withdrawal by Subject|8|||
94371335|NCT01889862|323146828|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
94371336|NCT01889862|323146829|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
94371337|NCT01889862|323146830|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
94371338|NCT01889862|323146831|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
94371339|NCT01889862|323146832|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
94371340|NCT01889862|323146828|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
94371341|NCT01889862|323146829|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
94371342|NCT01889862|323146830|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
94371343|NCT01889862|323146831|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
94371344|NCT01889862|323146832|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
94371345|NCT01889862|323146828|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
94371346|NCT01889862|323146829|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
94371347|NCT01889862|323146830|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
94371348|NCT01889862|323146831|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
94371349|NCT01889862|323146832|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
94371350|NCT01889862|323146828|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
94371351|NCT01889862|323146829|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
94371352|NCT01889862|323146830|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
94371353|NCT01889862|323146831|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
94371354|NCT01889862|323146832|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
94371355|NCT01889862|323146828|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
94371356|NCT01889862|323146829|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
94371357|NCT01889862|323146830|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
94371358|NCT01889862|323146831|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
94371359|NCT01889862|323146832|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
94371360|NCT01889862|323146828|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
94371361|NCT01889862|323146829|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
94371362|NCT01889862|323146830|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
94371363|NCT01889862|323146831|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
94371364|NCT01889862|323146832|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
94371365|NCT01889862|323146828|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
94371366|NCT01889862|323146829|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
94371367|NCT01889862|323146830|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
94371368|NCT01889862|323146831|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
94371369|NCT01889862|323146832|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
94371370|NCT01889862|323146828|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
94371371|NCT01889862|323146829|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
94371372|NCT01889862|323146830|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
94371373|NCT01889862|323146831|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
94371374|NCT01889862|323146832|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
94371375|NCT01889862|323146828|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
94371376|NCT01889862|323146829|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
94371377|NCT01889862|323146830|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
94371378|NCT01889862|323146831|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
94371379|NCT01889862|323146832|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
94371380|NCT01889862|323146828|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
94371381|NCT01889862|323146829|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
94371382|NCT01889862|323146830|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
94371383|NCT01889862|323146831|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
94371384|NCT01889862|323146832|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
94371385|NCT00528879|323146833|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
94371386|NCT00528879|323146834|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
94371387|NCT00528879|323146835|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
94206826|NCT00943917|322551425|FG005|Stage II Continuation|hypoglycemia|0|||
94206827|NCT00943917|322551426|FG006|Stage II Continuation|hypoglycemia|0|||
94206828|NCT00943917|322551427|FG007|Stage II Continuation|hypoglycemia|0|||
94206829|NCT00943917|322551428|FG008|Stage II Continuation|hypoglycemia|0|||
94206830|NCT00943917|322551429|FG009|Stage II Continuation|hypoglycemia|0|||
94206831|NCT00943917|322551430|FG010|Stage II Continuation|hypoglycemia|0|||
94206832|NCT00943917|322551431|FG011|Stage II Continuation|hypoglycemia|0|||
94206833|NCT00943917|322551432|FG012|Stage II Continuation|hypoglycemia|1|||
94206834|NCT00943917|322551433|FG013|Stage II Continuation|hypoglycemia|0|||
94206835|NCT00943917|322551434|FG014|Stage II Continuation|hypoglycemia|0|||
94206836|NCT00943917|322551420|FG000|Stage II Continuation|A1C elevation|0|||
94206837|NCT00943917|322551421|FG001|Stage II Continuation|A1C elevation|0|||
94206838|NCT00943917|322551422|FG002|Stage II Continuation|A1C elevation|0|||
94206839|NCT00943917|322551423|FG003|Stage II Continuation|A1C elevation|0|||
94206840|NCT00943917|322551424|FG004|Stage II Continuation|A1C elevation|0|||
94206841|NCT00943917|322551425|FG005|Stage II Continuation|A1C elevation|0|||
94206842|NCT00943917|322551426|FG006|Stage II Continuation|A1C elevation|0|||
94206843|NCT00943917|322551427|FG007|Stage II Continuation|A1C elevation|0|||
94206844|NCT00943917|322551428|FG008|Stage II Continuation|A1C elevation|0|||
94206845|NCT00943917|322551429|FG009|Stage II Continuation|A1C elevation|0|||
94206846|NCT00943917|322551430|FG010|Stage II Continuation|A1C elevation|0|||
94206847|NCT00943917|322551431|FG011|Stage II Continuation|A1C elevation|0|||
94206848|NCT00943917|322551432|FG012|Stage II Continuation|A1C elevation|0|||
94280844|NCT00511355|322817499|FG001|Overall Study|Adverse Event|4|||
94280845|NCT00511355|322817498|FG000|Overall Study|Pregnancy Wish|1|||
94280846|NCT00511355|322817499|FG001|Overall Study|Pregnancy Wish|0|||
94280847|NCT00511355|322817498|FG000|Overall Study|Lost to Follow-up|2|||
94280848|NCT00511355|322817499|FG001|Overall Study|Lost to Follow-up|1|||
94280849|NCT00511355|322817498|FG000|Overall Study|Other Reason|0|||
94467665|NCT01004432|323502376|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
94280850|NCT00511355|322817499|FG001|Overall Study|Other Reason|1|||
94371388|NCT00528879|323146836|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
94371389|NCT00528879|323146833|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
94371390|NCT00528879|323146834|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
94371391|NCT00528879|323146835|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
94371392|NCT00528879|323146836|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
94371393|NCT00528879|323146833|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
94371394|NCT00528879|323146834|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
94371395|NCT00528879|323146835|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
94371396|NCT00528879|323146836|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
94371397|NCT00528879|323146833|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
94371398|NCT00528879|323146834|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
94371399|NCT00528879|323146835|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
94371400|NCT00528879|323146836|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
94371401|NCT00528879|323146833|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
94371402|NCT00528879|323146834|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
94371403|NCT00528879|323146835|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
94371404|NCT00528879|323146836|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
94371405|NCT00528879|323146833|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
94371406|NCT00528879|323146834|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
94371407|NCT00528879|323146835|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
94371408|NCT00528879|323146836|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
94371409|NCT00528879|323146833|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
94371410|NCT00528879|323146834|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
94371411|NCT00528879|323146835|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
94371412|NCT00528879|323146836|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
94371413|NCT00528879|323146833|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
94371414|NCT00528879|323146834|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
94371415|NCT00528879|323146835|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
94371416|NCT00528879|323146836|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
94371417|NCT00528879|323146833|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
94371418|NCT00528879|323146834|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
94371419|NCT00528879|323146835|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
94371420|NCT00528879|323146836|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
94371421|NCT00528879|323146833|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
94371422|NCT00528879|323146834|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
94371423|NCT00528879|323146835|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
94371424|NCT00528879|323146836|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
94371425|NCT00528879|323146833|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
94371426|NCT00528879|323146834|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
94371427|NCT00528879|323146835|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
94371428|NCT00528879|323146836|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
94371429|NCT00528879|323146833|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
94371430|NCT00528879|323146834|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
94371431|NCT00528879|323146835|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
94371432|NCT00528879|323146836|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
94371433|NCT00528879|323146833|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
94371434|NCT00528879|323146834|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
94371435|NCT00528879|323146835|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
94371436|NCT00528879|323146836|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
94371437|NCT00528879|323146833|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
94371438|NCT00528879|323146834|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
94371439|NCT00528879|323146835|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
94371440|NCT00528879|323146836|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
94371441|NCT00528879|323146833|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
94371442|NCT00528879|323146834|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
94371443|NCT00528879|323146835|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
94371444|NCT00528879|323146836|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
94371445|NCT00528879|323146833|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
94371446|NCT00528879|323146834|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
94371447|NCT00528879|323146835|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
94371448|NCT00528879|323146836|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
94371449|NCT02217345|323146837|FG000|Overall Study|Lost to Follow-up|2|||
94371450|NCT02217345|323146838|FG001|Overall Study|Lost to Follow-up|1|||
94371451|NCT02217345|323146837|FG000|Overall Study|Withdrawal by Subject|3|||
94371452|NCT02217345|323146838|FG001|Overall Study|Withdrawal by Subject|2|||
94371453|NCT02217345|323146837|FG000|Overall Study|Adverse Event|2|||
94371454|NCT02217345|323146838|FG001|Overall Study|Adverse Event|1|||
94371455|NCT02217345|323146837|FG000|Overall Study|Physician Decision|0|||
94371456|NCT02217345|323146838|FG001|Overall Study|Physician Decision|1|||
94371457|NCT00950599|323146839|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
94371458|NCT00950599|323146840|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
94371459|NCT00950599|323146841|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
94371460|NCT00950599|323146842|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
94371461|NCT00950599|323146843|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
94371462|NCT00950599|323146844|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
94371463|NCT00950599|323146845|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
94371464|NCT00950599|323146846|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
94371465|NCT00950599|323146847|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
94371466|NCT00950599|323146848|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
94371467|NCT00950599|323146839|FG000|Double-Blind Treatment Period|Adverse Event|0|||
94371468|NCT00950599|323146840|FG001|Double-Blind Treatment Period|Adverse Event|1|||
94371469|NCT00950599|323146841|FG002|Double-Blind Treatment Period|Adverse Event|1|||
94371470|NCT00950599|323146842|FG003|Double-Blind Treatment Period|Adverse Event|1|||
94371471|NCT00950599|323146843|FG004|Double-Blind Treatment Period|Adverse Event|1|||
94371472|NCT00950599|323146844|FG005|Double-Blind Treatment Period|Adverse Event|1|||
94371473|NCT00950599|323146845|FG006|Double-Blind Treatment Period|Adverse Event|0|||
94371474|NCT00950599|323146846|FG007|Double-Blind Treatment Period|Adverse Event|0|||
94371475|NCT00950599|323146847|FG008|Double-Blind Treatment Period|Adverse Event|0|||
94371476|NCT00950599|323146848|FG009|Double-Blind Treatment Period|Adverse Event|0|||
94371477|NCT00950599|323146839|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
94371478|NCT00950599|323146840|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
94371479|NCT00950599|323146841|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
94371480|NCT00950599|323146842|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
94371481|NCT00950599|323146843|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
94371482|NCT00950599|323146844|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
94371483|NCT00950599|323146845|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
94371484|NCT00950599|323146846|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
94371485|NCT00950599|323146847|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
94371486|NCT00950599|323146848|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
94371487|NCT00950599|323146839|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
94371488|NCT00950599|323146840|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
94371489|NCT00950599|323146841|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
94371490|NCT00950599|323146842|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
94371491|NCT00950599|323146843|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
94371492|NCT00950599|323146844|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
94371493|NCT00950599|323146845|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
94371494|NCT00950599|323146846|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
94371495|NCT00950599|323146847|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
94371496|NCT00950599|323146848|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
94371497|NCT00950599|323146839|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
94371498|NCT00950599|323146840|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
94371499|NCT00950599|323146841|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
94371500|NCT00950599|323146842|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
94206849|NCT00943917|322551433|FG013|Stage II Continuation|A1C elevation|1|||
94206850|NCT00943917|322551434|FG014|Stage II Continuation|A1C elevation|0|||
94206851|NCT03631407|322551435|FG000|Overall Study|Withdrawal by Subject|3|||
94206852|NCT03631407|322551436|FG001|Overall Study|Withdrawal by Subject|2|||
94206853|NCT03631407|322551435|FG000|Overall Study|Sponsor Decision|0|||
94206854|NCT03631407|322551436|FG001|Overall Study|Sponsor Decision|2|||
94280851|NCT00511355|322817498|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
94280852|NCT00511355|322817499|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
94280853|NCT00511355|322817498|FG000|Overall Study|Withdrawal of informed consent|0|||
94280854|NCT00511355|322817499|FG001|Overall Study|Withdrawal of informed consent|1|||
94280855|NCT00511355|322817498|FG000|Overall Study|Other reason pre-treatment|0|||
94280856|NCT00511355|322817499|FG001|Overall Study|Other reason pre-treatment|1|||
94280857|NCT03434977|322817503|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
94280858|NCT03434977|322817504|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
94280859|NCT00490568|322819323|FG000|Overall Study|Adverse Event|116|||
94280860|NCT00490568|322819323|FG000|Overall Study|Lost to Follow-up|13|||
94280861|NCT00490568|322819323|FG000|Overall Study|Protocol Violation|45|||
94280862|NCT00490568|322819323|FG000|Overall Study|Withdrawal by Subject|135|||
94280863|NCT00490568|322819323|FG000|Overall Study|Still in the study at termination|974|||
94280864|NCT00490568|322819323|FG000|Overall Study|Other|1|||
94280865|NCT00490568|322819323|FG000|Overall Study|Exclusion criteria met|1|||
94280866|NCT00490568|322819323|FG000|Overall Study|Caregiver related|20|||
94280867|NCT00490568|322819323|FG000|Overall Study|Abnormal ECG|25|||
94280868|NCT00490568|322819323|FG000|Overall Study|Participant refused follow-up|9|||
94280869|NCT00490568|322819323|FG000|Overall Study|Legal representative withdrew consent|1|||
94280870|NCT00490568|322819323|FG000|Overall Study|Disease progression|4|||
94280871|NCT00490568|322819323|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
94280872|NCT00490568|322819323|FG000|Overall Study|Investigator decision|3|||
94280873|NCT00490568|322819323|FG000|Overall Study|Non-Compliance|7|||
94280874|NCT00490568|322819323|FG000|Overall Study|Efficacy related|3|||
94280875|NCT00490568|322819323|FG000|Overall Study|Participant died|1|||
94280876|NCT00490568|322819323|FG000|Overall Study|Participant withdrawal due to surgery|1|||
94280877|NCT00980200|322819324|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
94280878|NCT00980200|322819325|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
94280879|NCT00980200|322819326|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
94280880|NCT00980200|322819327|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
94280881|NCT00980200|322819328|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
94280882|NCT00980200|322819324|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
94280883|NCT00980200|322819325|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
94280884|NCT00980200|322819326|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
94280885|NCT00980200|322819327|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
94280886|NCT00980200|322819328|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
94280887|NCT03468855|322819333|FG000|Overall Study|Adverse Event|2|||
94280888|NCT03468855|322819333|FG000|Overall Study|Lost to Follow-up|5|||
94280889|NCT03468855|322819333|FG000|Overall Study|Withdrawal by Subject|3|||
94280890|NCT03468855|322819333|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
94280891|NCT01908101|322819334|FG000|Overall Study|Physician Decision|1|||
94280892|NCT01908101|322819334|FG000|Overall Study|Withdrawal by Subject|1|||
94280893|NCT01908101|322819334|FG000|Overall Study|Incorrect Diagnosis|2|||
94280894|NCT01908101|322819334|FG000|Overall Study|Incorrect Starting Dose|1|||
94280895|NCT01908101|322819334|FG000|Overall Study|Did not complete the first cycle|4|||
94280896|NCT01823679|322819344|FG000|Overall Study|Death|1|||
94280897|NCT00105443|322819350|FG000|Double-Blind Treatment|Adverse Event|1|||
94371501|NCT00950599|323146843|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
94371502|NCT00950599|323146844|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
94371503|NCT00950599|323146845|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
94371504|NCT00950599|323146846|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
94371505|NCT00950599|323146847|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
94371506|NCT00950599|323146848|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
94371507|NCT00950599|323146839|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
94371508|NCT00950599|323146840|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
94371509|NCT00950599|323146841|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
94371510|NCT00950599|323146842|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
94371511|NCT00950599|323146843|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
94206855|NCT03631407|322551435|FG000|Overall Study|Death|16|||
94206856|NCT03631407|322551436|FG001|Overall Study|Death|16|||
94206857|NCT03631407|322551435|FG000|Overall Study|Randomized by mistake without study treatment|1|||
94206858|NCT03631407|322551436|FG001|Overall Study|Randomized by mistake without study treatment|0|||
94206859|NCT03802994|322551440|FG000|Overall Study|Lost to Follow-up|0|||
94206860|NCT03802994|322551441|FG001|Overall Study|Lost to Follow-up|2|||
94206861|NCT03802994|322551442|FG002|Overall Study|Lost to Follow-up|3|||
94206862|NCT03802994|322551443|FG003|Overall Study|Lost to Follow-up|2|||
94206863|NCT03802994|322551444|FG004|Overall Study|Lost to Follow-up|2|||
94206864|NCT03343704|322551452|FG000|Overall Study|Refused to complete follow up|0|||
94206865|NCT03343704|322551453|FG001|Overall Study|Refused to complete follow up|1|||
94206866|NCT03343704|322551452|FG000|Overall Study|Death|0|||
94206867|NCT03343704|322551453|FG001|Overall Study|Death|1|||
94371512|NCT00950599|323146844|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
94280898|NCT00105443|322819351|FG001|Double-Blind Treatment|Adverse Event|0|||
94280899|NCT00105443|322819352|FG002|Double-Blind Treatment|Adverse Event|0|||
94280900|NCT00105443|322819353|FG003|Double-Blind Treatment|Adverse Event|0|||
94206868|NCT03343704|322551452|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
94280901|NCT00105443|322819350|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
94280902|NCT00105443|322819351|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
94280903|NCT00105443|322819352|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
94280904|NCT00105443|322819353|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
94280905|NCT00105443|322819350|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
94280906|NCT00105443|322819351|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
94280907|NCT00105443|322819352|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
94280908|NCT00105443|322819353|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
94280909|NCT00105443|322819350|FG000|Double-Blind Treatment|Physician Decision|1|||
94280910|NCT00105443|322819351|FG001|Double-Blind Treatment|Physician Decision|0|||
94280911|NCT00105443|322819352|FG002|Double-Blind Treatment|Physician Decision|2|||
94280912|NCT00105443|322819353|FG003|Double-Blind Treatment|Physician Decision|0|||
94280913|NCT00105443|322819350|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
94280914|NCT00105443|322819351|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
94280915|NCT00105443|322819352|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
94280916|NCT00105443|322819353|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
94280917|NCT00105443|322819350|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
94280918|NCT00105443|322819351|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
94280919|NCT00105443|322819352|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
94280920|NCT00105443|322819353|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
94280921|NCT00105443|322819350|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
94280922|NCT00105443|322819351|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
94280923|NCT00105443|322819352|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
94280924|NCT00105443|322819353|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
94280925|NCT00105443|322819350|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
94280926|NCT00105443|322819351|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
94280927|NCT00105443|322819352|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
94280928|NCT00105443|322819353|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
94280929|NCT00105443|322819350|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
94280930|NCT00105443|322819351|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
94280931|NCT00105443|322819352|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
94280932|NCT00105443|322819353|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
94280933|NCT00105443|322819350|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
94280934|NCT00105443|322819351|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
94280935|NCT00105443|322819352|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
94280936|NCT00105443|322819353|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
94280937|NCT00105443|322819350|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
94280938|NCT00105443|322819351|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
94280939|NCT00105443|322819352|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
94280940|NCT00105443|322819353|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
94280941|NCT00105443|322819350|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
94280942|NCT00105443|322819351|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
94280943|NCT00105443|322819352|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
94280944|NCT00105443|322819353|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
94280945|NCT00105443|322819350|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
94280946|NCT00105443|322819351|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
94280947|NCT00105443|322819352|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
94280948|NCT00105443|322819353|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
94280949|NCT00105443|322819350|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
94280950|NCT00105443|322819351|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
94280951|NCT00105443|322819352|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
94280952|NCT00105443|322819353|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
94280953|NCT00105443|322819350|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
94280954|NCT00105443|322819351|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
94280955|NCT00105443|322819352|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
94280956|NCT00105443|322819353|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
94280957|NCT00105443|322819350|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
94280958|NCT00105443|322819351|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
94280959|NCT00105443|322819352|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
94280960|NCT00105443|322819353|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
94280961|NCT00105443|322819350|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
94280962|NCT00105443|322819351|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
94280963|NCT00105443|322819352|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
94280964|NCT00105443|322819353|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
94280965|NCT00105443|322819350|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
94280966|NCT00105443|322819351|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
94280967|NCT00105443|322819352|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
94280968|NCT00105443|322819353|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
94280969|NCT00105443|322819350|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
94280970|NCT00105443|322819351|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
94280971|NCT00105443|322819352|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
94280972|NCT00105443|322819353|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
94280973|NCT04682405|322819359|FG000|Overall Study|Adverse Event|0|||
94280974|NCT04682405|322819360|FG001|Overall Study|Adverse Event|1|||
94280975|NCT04429061|322819362|FG000|Overall Study|Lost to Follow-up|62|||
94280976|NCT04429061|322819363|FG001|Overall Study|Lost to Follow-up|87|||
94280977|NCT04429061|322819362|FG000|Overall Study|Withdrawal by Subject|3|||
94280978|NCT04429061|322819363|FG001|Overall Study|Withdrawal by Subject|4|||
94280979|NCT01623271|322819364|FG000|Overall Study|Withdrawal by Subject|2|||
94280980|NCT00522431|322819365|FG000|Overall Study|Adverse Event|5|||
94280981|NCT00522431|322819365|FG000|Overall Study|Protocol Violation|2|||
94280982|NCT00522431|322819365|FG000|Overall Study|Withdrawal by Subject|2|||
94280983|NCT00522431|322819365|FG000|Overall Study|Subject non-compliance|1|||
94280984|NCT00522431|322819365|FG000|Overall Study|Other/unknown|1|||
94280985|NCT01339559|322819368|FG000|Overall Study|Adverse Event|92|||
94280986|NCT01339559|322819368|FG000|Overall Study|Death|5|||
94280987|NCT01339559|322819368|FG000|Overall Study|Lack of Efficacy|164|||
94280988|NCT01339559|322819368|FG000|Overall Study|Lost to Follow-up|22|||
94280989|NCT01339559|322819368|FG000|Overall Study|Subject choice|89|||
94280990|NCT01339559|322819368|FG000|Overall Study|Protocol Violation|15|||
94280991|NCT01339559|322819368|FG000|Overall Study|Study closure at site|1|||
94280992|NCT01339559|322819368|FG000|Overall Study|Incarcerated|2|||
94280993|NCT01339559|322819368|FG000|Overall Study|Epilepsy surgery|1|||
94280994|NCT01339559|322819368|FG000|Overall Study|Pregnancy planned|2|||
94280995|NCT01339559|322819368|FG000|Overall Study|Left the country|1|||
94280996|NCT01339559|322819368|FG000|Overall Study|Investigator decision|2|||
94280997|NCT01339559|322819368|FG000|Overall Study|Patient didn't wish to continue|1|||
94280998|NCT01339559|322819368|FG000|Overall Study|PI decision|1|||
94280999|NCT01661140|322819369|FG000|Open-Label Period|Adverse Event|44|||
94281000|NCT01661140|322819370|FG001|Open-Label Period|Adverse Event|0|||
94281001|NCT01661140|322819371|FG002|Open-Label Period|Adverse Event|0|||
94281002|NCT01661140|322819369|FG000|Open-Label Period|Protocol Violation|3|||
94281003|NCT01661140|322819370|FG001|Open-Label Period|Protocol Violation|0|||
94281004|NCT01661140|322819371|FG002|Open-Label Period|Protocol Violation|0|||
94281005|NCT01661140|322819369|FG000|Open-Label Period|Withdrawal by Subject|5|||
94281006|NCT01661140|322819370|FG001|Open-Label Period|Withdrawal by Subject|0|||
94281007|NCT01661140|322819371|FG002|Open-Label Period|Withdrawal by Subject|0|||
94281008|NCT01661140|322819369|FG000|Open-Label Period|Investigator Decision|3|||
94281009|NCT01661140|322819370|FG001|Open-Label Period|Investigator Decision|0|||
94281010|NCT01661140|322819371|FG002|Open-Label Period|Investigator Decision|0|||
94281011|NCT01661140|322819369|FG000|Open-Label Period|Death|1|||
94281012|NCT01661140|322819370|FG001|Open-Label Period|Death|0|||
94371513|NCT00950599|323146845|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
94281013|NCT01661140|322819371|FG002|Open-Label Period|Death|0|||
94281014|NCT01661140|322819369|FG000|Open-Label Period|Administrative/Other|1|||
94281015|NCT01661140|322819370|FG001|Open-Label Period|Administrative/Other|0|||
94281016|NCT01661140|322819371|FG002|Open-Label Period|Administrative/Other|0|||
94281017|NCT01661140|322819369|FG000|Open-Label Period|Sponsor termination|16|||
94281018|NCT01661140|322819370|FG001|Open-Label Period|Sponsor termination|0|||
94371514|NCT00950599|323146846|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
94371515|NCT00950599|323146847|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
94371516|NCT00950599|323146848|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
94371517|NCT00950599|323146839|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
94371518|NCT00950599|323146840|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
94371519|NCT00950599|323146841|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
94371520|NCT00950599|323146842|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
94371521|NCT00950599|323146843|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
94371522|NCT00950599|323146844|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
94371523|NCT00950599|323146845|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
94371524|NCT00950599|323146846|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
94371525|NCT00950599|323146847|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
94371526|NCT00950599|323146848|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
94371527|NCT00950599|323146839|FG000|Follow-Up Period|Adverse Event|0|||
94371528|NCT00950599|323146840|FG001|Follow-Up Period|Adverse Event|0|||
94371529|NCT00950599|323146841|FG002|Follow-Up Period|Adverse Event|0|||
94371530|NCT00950599|323146842|FG003|Follow-Up Period|Adverse Event|0|||
94371531|NCT00950599|323146843|FG004|Follow-Up Period|Adverse Event|0|||
94371532|NCT00950599|323146844|FG005|Follow-Up Period|Adverse Event|0|||
94371533|NCT00950599|323146845|FG006|Follow-Up Period|Adverse Event|0|||
94371534|NCT00950599|323146846|FG007|Follow-Up Period|Adverse Event|0|||
94371535|NCT00950599|323146847|FG008|Follow-Up Period|Adverse Event|1|||
94371536|NCT00950599|323146848|FG009|Follow-Up Period|Adverse Event|0|||
94371537|NCT00950599|323146839|FG000|Follow-Up Period|Lack of Efficacy|0|||
94371538|NCT00950599|323146840|FG001|Follow-Up Period|Lack of Efficacy|0|||
94371539|NCT00950599|323146841|FG002|Follow-Up Period|Lack of Efficacy|0|||
94371540|NCT00950599|323146842|FG003|Follow-Up Period|Lack of Efficacy|0|||
94371541|NCT00950599|323146843|FG004|Follow-Up Period|Lack of Efficacy|0|||
94371542|NCT00950599|323146844|FG005|Follow-Up Period|Lack of Efficacy|0|||
94371543|NCT00950599|323146845|FG006|Follow-Up Period|Lack of Efficacy|0|||
94371544|NCT00950599|323146846|FG007|Follow-Up Period|Lack of Efficacy|0|||
94371545|NCT00950599|323146847|FG008|Follow-Up Period|Lack of Efficacy|3|||
94371546|NCT00950599|323146848|FG009|Follow-Up Period|Lack of Efficacy|0|||
94371547|NCT00950599|323146839|FG000|Follow-Up Period|Lost to Follow-up|0|||
94371548|NCT00950599|323146840|FG001|Follow-Up Period|Lost to Follow-up|0|||
94371549|NCT00950599|323146841|FG002|Follow-Up Period|Lost to Follow-up|0|||
94371550|NCT00950599|323146842|FG003|Follow-Up Period|Lost to Follow-up|0|||
94371551|NCT00950599|323146843|FG004|Follow-Up Period|Lost to Follow-up|0|||
94371552|NCT00950599|323146844|FG005|Follow-Up Period|Lost to Follow-up|0|||
94371553|NCT00950599|323146845|FG006|Follow-Up Period|Lost to Follow-up|0|||
94371554|NCT00950599|323146846|FG007|Follow-Up Period|Lost to Follow-up|0|||
94371555|NCT00950599|323146847|FG008|Follow-Up Period|Lost to Follow-up|5|||
94371556|NCT00950599|323146848|FG009|Follow-Up Period|Lost to Follow-up|1|||
94371557|NCT00950599|323146839|FG000|Follow-Up Period|Physician Decision|0|||
94371558|NCT00950599|323146840|FG001|Follow-Up Period|Physician Decision|0|||
94371559|NCT00950599|323146841|FG002|Follow-Up Period|Physician Decision|0|||
94371560|NCT00950599|323146842|FG003|Follow-Up Period|Physician Decision|0|||
94371561|NCT00950599|323146843|FG004|Follow-Up Period|Physician Decision|0|||
94371562|NCT00950599|323146844|FG005|Follow-Up Period|Physician Decision|0|||
94371563|NCT00950599|323146845|FG006|Follow-Up Period|Physician Decision|0|||
94371564|NCT00950599|323146846|FG007|Follow-Up Period|Physician Decision|0|||
94371565|NCT00950599|323146847|FG008|Follow-Up Period|Physician Decision|1|||
94371566|NCT00950599|323146848|FG009|Follow-Up Period|Physician Decision|0|||
94371567|NCT00950599|323146839|FG000|Follow-Up Period|Poor/Noncompliance|0|||
94467666|NCT01004432|323502377|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
94281019|NCT01661140|322819371|FG002|Open-Label Period|Sponsor termination|0|||
94281020|NCT01661140|322819369|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
94281021|NCT01661140|322819370|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
94281022|NCT01661140|322819371|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
94281023|NCT01661140|322819369|FG000|Open-Label Period|Lost to Follow-up|2|||
94281024|NCT01661140|322819370|FG001|Open-Label Period|Lost to Follow-up|0|||
94281025|NCT01661140|322819371|FG002|Open-Label Period|Lost to Follow-up|0|||
94281026|NCT01661140|322819369|FG000|Double-Blind Period|Refused Treatment|0|||
94281027|NCT01661140|322819370|FG001|Double-Blind Period|Refused Treatment|0|||
94281028|NCT01661140|322819371|FG002|Double-Blind Period|Refused Treatment|1|||
94281029|NCT01661140|322819369|FG000|Double-Blind Period|Adverse Event|0|||
94281030|NCT01661140|322819370|FG001|Double-Blind Period|Adverse Event|16|||
94281031|NCT01661140|322819371|FG002|Double-Blind Period|Adverse Event|18|||
94467667|NCT01004432|323502373|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
94281032|NCT01661140|322819369|FG000|Double-Blind Period|Protocol Violation|0|||
94281033|NCT01661140|322819370|FG001|Double-Blind Period|Protocol Violation|2|||
94281034|NCT01661140|322819371|FG002|Double-Blind Period|Protocol Violation|3|||
94281035|NCT01661140|322819369|FG000|Double-Blind Period|Withdrawal by Subject|0|||
94281036|NCT01661140|322819370|FG001|Double-Blind Period|Withdrawal by Subject|1|||
94281037|NCT01661140|322819371|FG002|Double-Blind Period|Withdrawal by Subject|3|||
94281038|NCT01661140|322819369|FG000|Double-Blind Period|Investigator's Decision|0|||
94281039|NCT01661140|322819370|FG001|Double-Blind Period|Investigator's Decision|1|||
94281040|NCT01661140|322819371|FG002|Double-Blind Period|Investigator's Decision|2|||
94281041|NCT01661140|322819369|FG000|Double-Blind Period|Sponsor Termination|0|||
94281042|NCT01661140|322819370|FG001|Double-Blind Period|Sponsor Termination|14|||
94281043|NCT01661140|322819371|FG002|Double-Blind Period|Sponsor Termination|17|||
94281044|NCT01661140|322819369|FG000|Double-Blind Period|Administrative/Other|0|||
94281045|NCT01661140|322819370|FG001|Double-Blind Period|Administrative/Other|7|||
94281046|NCT01661140|322819371|FG002|Double-Blind Period|Administrative/Other|6|||
94281047|NCT00746252|322819372|FG000|Overall Study|weight gain >7.5 %|1|||
94281048|NCT00746252|322819373|FG001|Overall Study|weight gain >7.5 %|2|||
94281049|NCT01049035|322819374|FG000|Overall Study|Serious adverse event|0|||
94281050|NCT01049035|322819375|FG001|Overall Study|Serious adverse event|1|||
94281051|NCT01049035|322819376|FG002|Overall Study|Serious adverse event|1|||
94281052|NCT01049035|322819377|FG003|Overall Study|Serious adverse event|2|||
94281053|NCT01049035|322819378|FG004|Overall Study|Serious adverse event|0|||
94281054|NCT01049035|322819379|FG005|Overall Study|Serious adverse event|0|||
94281055|NCT01049035|322819380|FG006|Overall Study|Serious adverse event|0|||
94281056|NCT01049035|322819374|FG000|Overall Study|Other adverse event (AE)|0|||
94281057|NCT01049035|322819375|FG001|Overall Study|Other adverse event (AE)|0|||
94281058|NCT01049035|322819376|FG002|Overall Study|Other adverse event (AE)|0|||
94281059|NCT01049035|322819377|FG003|Overall Study|Other adverse event (AE)|1|||
94281060|NCT01049035|322819378|FG004|Overall Study|Other adverse event (AE)|0|||
94281061|NCT01049035|322819379|FG005|Overall Study|Other adverse event (AE)|0|||
94281062|NCT01049035|322819380|FG006|Overall Study|Other adverse event (AE)|0|||
94281063|NCT01049035|322819374|FG000|Overall Study|Non-compliance with the protocol|12|||
94281064|NCT01049035|322819375|FG001|Overall Study|Non-compliance with the protocol|6|||
94281065|NCT01049035|322819376|FG002|Overall Study|Non-compliance with the protocol|14|||
94281066|NCT01049035|322819377|FG003|Overall Study|Non-compliance with the protocol|5|||
94281067|NCT01049035|322819378|FG004|Overall Study|Non-compliance with the protocol|3|||
94281068|NCT01049035|322819379|FG005|Overall Study|Non-compliance with the protocol|4|||
94281069|NCT01049035|322819380|FG006|Overall Study|Non-compliance with the protocol|10|||
94281070|NCT01049035|322819374|FG000|Overall Study|Lost to Follow-up|5|||
94281071|NCT01049035|322819375|FG001|Overall Study|Lost to Follow-up|4|||
94281072|NCT01049035|322819376|FG002|Overall Study|Lost to Follow-up|4|||
94281073|NCT01049035|322819377|FG003|Overall Study|Lost to Follow-up|1|||
94281074|NCT01049035|322819378|FG004|Overall Study|Lost to Follow-up|0|||
94281075|NCT01049035|322819379|FG005|Overall Study|Lost to Follow-up|3|||
94281076|NCT01049035|322819380|FG006|Overall Study|Lost to Follow-up|3|||
94281077|NCT01049035|322819374|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
94281078|NCT01049035|322819375|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
94281079|NCT01049035|322819376|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
94281080|NCT01049035|322819377|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
94281081|NCT01049035|322819378|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
94281082|NCT01049035|322819379|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
94281083|NCT01049035|322819380|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
94281084|NCT03548051|322819382|FG000|Overall Study|Death|1|||
94281085|NCT03548051|322819383|FG001|Overall Study|Death|1|||
94281086|NCT03548051|322819382|FG000|Overall Study|Withdrawal by Subject|1|||
94281087|NCT03548051|322819383|FG001|Overall Study|Withdrawal by Subject|0|||
94281088|NCT00049673|322819384|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
94281089|NCT00049673|322819385|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
94281090|NCT00082888|322819386|FG000|Overall Study|Ineligible|1|||
94281091|NCT00082888|322819387|FG001|Overall Study|Ineligible|0|||
94281092|NCT00082888|322819388|FG002|Overall Study|Ineligible|0|||
94281093|NCT01870401|322819391|FG000|Overall Study|Death|48|||
94281094|NCT01870401|322819392|FG001|Overall Study|Death|24|||
94281095|NCT01870401|322819391|FG000|Overall Study|Withdrawal by Subject|39|||
94281096|NCT01870401|322819392|FG001|Overall Study|Withdrawal by Subject|26|||
94281097|NCT01870401|322819391|FG000|Overall Study|Lost to Follow-up|19|||
94281098|NCT01870401|322819392|FG001|Overall Study|Lost to Follow-up|14|||
94281099|NCT01870401|322819391|FG000|Overall Study|Other|9|||
94281100|NCT01870401|322819392|FG001|Overall Study|Other|7|||
94281101|NCT01870401|322819391|FG000|Overall Study|On-going in the Study|35|||
94281102|NCT01870401|322819392|FG001|Overall Study|On-going in the Study|25|||
94281103|NCT00452699|322819393|FG000|Overall Study|Adverse Event|10|||
94281104|NCT00452699|322819394|FG001|Overall Study|Adverse Event|3|||
94281105|NCT00452699|322819393|FG000|Overall Study|Lack of Efficacy|6|||
94281106|NCT00452699|322819394|FG001|Overall Study|Lack of Efficacy|4|||
94281107|NCT00452699|322819393|FG000|Overall Study|Lost to Follow-up|6|||
94371568|NCT00950599|323146840|FG001|Follow-Up Period|Poor/Noncompliance|0|||
94371569|NCT00950599|323146841|FG002|Follow-Up Period|Poor/Noncompliance|0|||
94206869|NCT03343704|322551453|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
94206870|NCT02830204|322551454|FG000|Overall Study|Death|9|||
94206871|NCT02830204|322551454|FG000|Overall Study|Withdrawal by Subject|1|||
94206928|NCT05630833|322551466|FG000|Overall Study|Adverse Event|3|||
94206929|NCT05630833|322551467|FG001|Overall Study|Adverse Event|0|||
94206930|NCT05630833|322551466|FG000|Overall Study|Lack of Efficacy|0|||
94206931|NCT05630833|322551467|FG001|Overall Study|Lack of Efficacy|1|||
94206932|NCT05630833|322551466|FG000|Overall Study|Lost to Follow-up|1|||
94206933|NCT05630833|322551467|FG001|Overall Study|Lost to Follow-up|0|||
94206934|NCT05630833|322551466|FG000|Overall Study|Withdrawal by Subject|3|||
94206935|NCT05630833|322551467|FG001|Overall Study|Withdrawal by Subject|1|||
94206936|NCT04535414|322551468|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
94206937|NCT04535414|322551469|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
94206938|NCT04535414|322551468|FG000|Overall Study|Cancelled appointment|1|||
94206939|NCT04535414|322551469|FG001|Overall Study|Cancelled appointment|0|||
94206940|NCT04535414|322551468|FG000|Overall Study|cancelled - food in stomach|2|||
94206941|NCT04535414|322551469|FG001|Overall Study|cancelled - food in stomach|0|||
94206942|NCT04535414|322551468|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
94371570|NCT00950599|323146842|FG003|Follow-Up Period|Poor/Noncompliance|0|||
94371571|NCT00950599|323146843|FG004|Follow-Up Period|Poor/Noncompliance|0|||
94371572|NCT00950599|323146844|FG005|Follow-Up Period|Poor/Noncompliance|0|||
94371573|NCT00950599|323146845|FG006|Follow-Up Period|Poor/Noncompliance|0|||
94371574|NCT00950599|323146846|FG007|Follow-Up Period|Poor/Noncompliance|0|||
94206943|NCT04535414|322551469|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
94206944|NCT04535414|322551468|FG000|Overall Study|Withdrawal by Subject|0|||
94206945|NCT04535414|322551469|FG001|Overall Study|Withdrawal by Subject|1|||
94206946|NCT01563185|322551470|FG000|Overall Study|Withdrawal by Subject|1|||
94206947|NCT01563185|322551470|FG000|Overall Study|Non-Compliance with study drug|1|||
94206948|NCT04577651|322551471|FG000|Overall Study|Screen Failure|7|||
94206949|NCT04577651|322551471|FG000|Overall Study|Adverse Event|1|||
94206950|NCT04577651|322551471|FG000|Overall Study|Death|1|||
94206951|NCT04577651|322551471|FG000|Overall Study|Physician Decision|1|||
94206952|NCT04577651|322551471|FG000|Overall Study|Withdrawal by Subject|3|||
94206953|NCT03752684|322553093|FG000|Overall Study|Lost to Follow-up|4|||
94206954|NCT00357994|322553100|FG000|Overall Study|Adverse Event|1|||
94206955|NCT00357994|322553101|FG001|Overall Study|Adverse Event|2|||
94206956|NCT00357994|322553100|FG000|Overall Study|Lack of Efficacy|0|||
94206957|NCT00357994|322553101|FG001|Overall Study|Lack of Efficacy|1|||
94206958|NCT00357994|322553100|FG000|Overall Study|Protocol Violation|1|||
94371575|NCT00950599|323146847|FG008|Follow-Up Period|Poor/Noncompliance|1|||
94281108|NCT00452699|322819394|FG001|Overall Study|Lost to Follow-up|9|||
94281109|NCT00452699|322819393|FG000|Overall Study|Protocol Violation|21|||
94281110|NCT00452699|322819394|FG001|Overall Study|Protocol Violation|25|||
94281111|NCT00452699|322819393|FG000|Overall Study|Withdrawal by Subject|26|||
94281112|NCT00452699|322819394|FG001|Overall Study|Withdrawal by Subject|25|||
94281113|NCT00452699|322819393|FG000|Overall Study|Other|12|||
94281114|NCT00452699|322819394|FG001|Overall Study|Other|7|||
94281115|NCT00493870|322819395|FG000|Overall Study|Lost to Follow-up|12|||
94281116|NCT00493870|322819396|FG001|Overall Study|Lost to Follow-up|15|||
94281117|NCT02721355|322819399|FG000|Overall Study|Lost to Follow-up|6|||
94281118|NCT02721355|322819400|FG001|Overall Study|Lost to Follow-up|1|||
94281119|NCT01784965|322819406|FG000|Overall Study|Withdrawal by Subject|6|||
94281120|NCT01784965|322819407|FG001|Overall Study|Withdrawal by Subject|3|||
94281121|NCT01784965|322819406|FG000|Overall Study|Adverse Event|0|||
94281122|NCT01784965|322819407|FG001|Overall Study|Adverse Event|8|||
94281123|NCT02469090|322819409|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
94281124|NCT02469090|322819410|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
94281125|NCT02469090|322819411|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
94281126|NCT02469090|322819409|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
94281127|NCT02469090|322819410|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
94281128|NCT02469090|322819411|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
94281129|NCT02469090|322819409|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
94281130|NCT02469090|322819410|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
94371576|NCT00950599|323146848|FG009|Follow-Up Period|Poor/Noncompliance|0|||
94281131|NCT02469090|322819411|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
94281132|NCT02469090|322819409|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
94281133|NCT02469090|322819410|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
94281134|NCT02469090|322819411|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
94281135|NCT02469090|322819409|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
94281136|NCT02469090|322819410|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
94281137|NCT02469090|322819411|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
94281138|NCT02469090|322819409|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
94281139|NCT02469090|322819410|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
94281140|NCT02469090|322819411|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
94281141|NCT02469090|322819409|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
94281142|NCT02469090|322819410|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
94281143|NCT02469090|322819411|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
94281144|NCT02469090|322819409|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
94281145|NCT02469090|322819410|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
94281146|NCT02469090|322819411|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
94281147|NCT03655756|322819415|FG000|Overall Study|Death|1|||
94281148|NCT00253630|322819416|FG000|Overall Study|ineligible|2|||
94281149|NCT01046877|322819425|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
94281150|NCT01046877|322819425|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
94281151|NCT00446511|322819430|FG000|Overall Study|Adverse Event|7|||
94281152|NCT00446511|322819431|FG001|Overall Study|Adverse Event|2|||
94281153|NCT00446511|322819432|FG002|Overall Study|Adverse Event|3|||
94281154|NCT00446511|322819433|FG003|Overall Study|Adverse Event|1|||
94281155|NCT00446511|322819430|FG000|Overall Study|Protocol Violation|0|||
94281156|NCT00446511|322819431|FG001|Overall Study|Protocol Violation|0|||
94467668|NCT01004432|323502374|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
94281157|NCT00446511|322819432|FG002|Overall Study|Protocol Violation|0|||
94281158|NCT00446511|322819433|FG003|Overall Study|Protocol Violation|1|||
94281159|NCT00446511|322819430|FG000|Overall Study|Withdrawal by Subject|0|||
94281160|NCT00446511|322819431|FG001|Overall Study|Withdrawal by Subject|0|||
94281161|NCT00446511|322819432|FG002|Overall Study|Withdrawal by Subject|0|||
94281162|NCT00446511|322819433|FG003|Overall Study|Withdrawal by Subject|3|||
94467669|NCT01004432|323502375|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
94371577|NCT00950599|323146839|FG000|Follow-Up Period|Subject withdrew Consent|0|||
94371578|NCT00950599|323146840|FG001|Follow-Up Period|Subject withdrew Consent|0|||
94371579|NCT00950599|323146841|FG002|Follow-Up Period|Subject withdrew Consent|0|||
94206959|NCT00357994|322553101|FG001|Overall Study|Protocol Violation|0|||
94281163|NCT00446511|322819430|FG000|Overall Study|Administrative Problems|3|||
94281164|NCT00446511|322819431|FG001|Overall Study|Administrative Problems|0|||
94281165|NCT00446511|322819432|FG002|Overall Study|Administrative Problems|4|||
94281166|NCT00446511|322819433|FG003|Overall Study|Administrative Problems|1|||
94281167|NCT01618214|322819434|FG000|Overall Study|Adverse Event|3|||
94281168|NCT01618214|322819435|FG001|Overall Study|Adverse Event|1|||
94281169|NCT01618214|322819434|FG000|Overall Study|Lack of Efficacy|1|||
94281170|NCT01618214|322819435|FG001|Overall Study|Lack of Efficacy|1|||
94281171|NCT01618214|322819434|FG000|Overall Study|Protocol Violation|1|||
94281172|NCT01618214|322819435|FG001|Overall Study|Protocol Violation|4|||
94281173|NCT01618214|322819434|FG000|Overall Study|Withdrawal Criteria|1|||
94281174|NCT01618214|322819435|FG001|Overall Study|Withdrawal Criteria|2|||
94281175|NCT01618214|322819434|FG000|Overall Study|Unclassified|4|||
94281176|NCT01618214|322819435|FG001|Overall Study|Unclassified|5|||
94281177|NCT00835237|322819436|FG000|Overall Study|Lost to Follow-up|4|||
94281178|NCT00835237|322819437|FG001|Overall Study|Lost to Follow-up|0|||
94281179|NCT00835237|322819436|FG000|Overall Study|Withdrawal by Subject|2|||
94281180|NCT00835237|322819437|FG001|Overall Study|Withdrawal by Subject|0|||
94281181|NCT00075504|322819440|FG000|Overall Study|Withdrawal by Subject|9|||
94281182|NCT00075504|322819441|FG001|Overall Study|Withdrawal by Subject|7|||
94281183|NCT03436862|322819442|FG000|Overall Study|Adverse Event|4|||
94281184|NCT03436862|322819442|FG000|Overall Study|Progressive Disease|2|||
94371580|NCT00950599|323146842|FG003|Follow-Up Period|Subject withdrew Consent|0|||
94371581|NCT00950599|323146843|FG004|Follow-Up Period|Subject withdrew Consent|0|||
94281185|NCT01142726|322819443|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
94281186|NCT01142726|322819444|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
94281187|NCT01142726|322819445|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
94281188|NCT01142726|322819443|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
94281189|NCT01142726|322819444|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
94371582|NCT00950599|323146844|FG005|Follow-Up Period|Subject withdrew Consent|0|||
94281190|NCT01142726|322819445|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
94281191|NCT01142726|322819443|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
94281192|NCT01142726|322819444|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
94281193|NCT01142726|322819445|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
94281194|NCT01142726|322819443|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
94281195|NCT01142726|322819444|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
94281196|NCT01142726|322819445|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
94281197|NCT01142726|322819443|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
94281198|NCT01142726|322819444|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
94281199|NCT01142726|322819445|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
94281200|NCT01142726|322819443|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
94281201|NCT01142726|322819444|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
94281202|NCT01142726|322819445|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
94281203|NCT01142726|322819443|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
94281204|NCT01142726|322819444|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
94281205|NCT01142726|322819445|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
94281206|NCT01142726|322819443|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
94281207|NCT01142726|322819444|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
94281208|NCT01142726|322819445|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
94281209|NCT01142726|322819443|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
94281210|NCT01142726|322819444|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
94281211|NCT01142726|322819445|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
94281212|NCT01142726|322819443|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
94281213|NCT01142726|322819444|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
94281214|NCT01142726|322819445|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
94281215|NCT01142726|322819443|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
94281216|NCT01142726|322819444|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
94281217|NCT01142726|322819445|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
94371583|NCT00950599|323146845|FG006|Follow-Up Period|Subject withdrew Consent|0|||
94371584|NCT00950599|323146846|FG007|Follow-Up Period|Subject withdrew Consent|0|||
94371585|NCT00950599|323146847|FG008|Follow-Up Period|Subject withdrew Consent|2|||
94371586|NCT00950599|323146848|FG009|Follow-Up Period|Subject withdrew Consent|1|||
94371587|NCT00971204|323146849|FG000|Overall Study|Did not meet all criteria-not treated|14|||
94371588|NCT00971204|323146849|FG000|Overall Study|Lost to Follow-up|10|||
94371589|NCT01325532|323146854|FG000|Overall Study|Withdrawal by Subject|2|||
94371590|NCT01325532|323146855|FG001|Overall Study|Withdrawal by Subject|0|||
94371591|NCT03012815|323146856|FG000|Overall Study|Lost to Follow-up|1|||
94371592|NCT03012815|323146857|FG001|Overall Study|Lost to Follow-up|0|||
94371593|NCT03012815|323146856|FG000|Overall Study|Physician Decision|3|||
94371594|NCT03012815|323146857|FG001|Overall Study|Physician Decision|2|||
94371595|NCT03012815|323146856|FG000|Overall Study|Adverse Event|1|||
94371596|NCT03012815|323146857|FG001|Overall Study|Adverse Event|0|||
94371597|NCT01252238|323146858|FG000|Overall Study|Sponsor terminated study|4|||
94371598|NCT01252238|323146859|FG001|Overall Study|Sponsor terminated study|4|||
94371599|NCT01252238|323146860|FG002|Overall Study|Sponsor terminated study|4|||
94371600|NCT01271933|323146862|FG000|Single-Blind Phase|Lack of Efficacy|37|||
94371601|NCT01271933|323146863|FG001|Single-Blind Phase|Lack of Efficacy|0|||
94371602|NCT01271933|323146864|FG002|Single-Blind Phase|Lack of Efficacy|0|||
94371603|NCT01271933|323146862|FG000|Single-Blind Phase|Lost to Follow-up|10|||
94371604|NCT01271933|323146863|FG001|Single-Blind Phase|Lost to Follow-up|0|||
94371605|NCT01271933|323146864|FG002|Single-Blind Phase|Lost to Follow-up|0|||
94371606|NCT01271933|323146862|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
94371607|NCT01271933|323146863|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
94371608|NCT01271933|323146864|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
94371609|NCT01271933|323146862|FG000|Single-Blind Phase|Protocol Violation|3|||
94371610|NCT01271933|323146863|FG001|Single-Blind Phase|Protocol Violation|0|||
94371611|NCT01271933|323146864|FG002|Single-Blind Phase|Protocol Violation|0|||
94371612|NCT01271933|323146862|FG000|Single-Blind Phase|Adverse Event|52|||
94371613|NCT01271933|323146863|FG001|Single-Blind Phase|Adverse Event|0|||
94371614|NCT01271933|323146864|FG002|Single-Blind Phase|Adverse Event|0|||
94371615|NCT01271933|323146862|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
94371616|NCT01271933|323146863|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
94371617|NCT01271933|323146864|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
94371618|NCT01271933|323146862|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
94281218|NCT01142726|322819443|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
94281219|NCT01142726|322819444|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
94371619|NCT01271933|323146863|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
94371620|NCT01271933|323146864|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
94371621|NCT01271933|323146862|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
94371622|NCT01271933|323146863|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
94371623|NCT01271933|323146864|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
94371624|NCT01271933|323146862|FG000|Double-Blind Phase|Randomized but not treated|0|||
94371625|NCT01271933|323146863|FG001|Double-Blind Phase|Randomized but not treated|0|||
94371626|NCT01271933|323146864|FG002|Double-Blind Phase|Randomized but not treated|1|||
94371627|NCT01271933|323146862|FG000|Double-Blind Phase|Lack of Efficacy|0|||
94371628|NCT01271933|323146863|FG001|Double-Blind Phase|Lack of Efficacy|6|||
94371629|NCT01271933|323146864|FG002|Double-Blind Phase|Lack of Efficacy|9|||
94371630|NCT01271933|323146862|FG000|Double-Blind Phase|Lost to Follow-up|0|||
94371631|NCT01271933|323146863|FG001|Double-Blind Phase|Lost to Follow-up|1|||
94371632|NCT01271933|323146864|FG002|Double-Blind Phase|Lost to Follow-up|1|||
94371633|NCT01271933|323146862|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
94371634|NCT01271933|323146863|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
94371635|NCT01271933|323146864|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
94371636|NCT01271933|323146862|FG000|Double-Blind Phase|Adverse Event|0|||
94371637|NCT01271933|323146863|FG001|Double-Blind Phase|Adverse Event|3|||
94371638|NCT01271933|323146864|FG002|Double-Blind Phase|Adverse Event|0|||
94371639|NCT01271933|323146862|FG000|Double-Blind Phase|Participant request-personal reason|0|||
94371640|NCT01271933|323146863|FG001|Double-Blind Phase|Participant request-personal reason|1|||
94371641|NCT01271933|323146864|FG002|Double-Blind Phase|Participant request-personal reason|0|||
94371642|NCT02862535|323146871|FG000|Overall Study|Death|7|||
94371643|NCT02862535|323146872|FG001|Overall Study|Death|3|||
94371644|NCT02862535|323146873|FG002|Overall Study|Death|2|||
94371645|NCT02862535|323146874|FG003|Overall Study|Death|5|||
94371646|NCT02862535|323146871|FG000|Overall Study|Study Terminated by Sponsor|1|||
94371647|NCT02862535|323146872|FG001|Overall Study|Study Terminated by Sponsor|3|||
94371648|NCT02862535|323146873|FG002|Overall Study|Study Terminated by Sponsor|8|||
94371649|NCT02862535|323146874|FG003|Overall Study|Study Terminated by Sponsor|5|||
94371650|NCT02862535|323146871|FG000|Overall Study|Enrolled, not Treated|1|||
94371651|NCT02862535|323146872|FG001|Overall Study|Enrolled, not Treated|0|||
94371652|NCT02862535|323146873|FG002|Overall Study|Enrolled, not Treated|0|||
94371653|NCT02862535|323146874|FG003|Overall Study|Enrolled, not Treated|1|||
94371654|NCT02278952|323146877|FG000|Overall Study|Insufficient Sample|6|||
94371655|NCT00964223|323146878|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
94371656|NCT03634488|323146879|FG000|Overall Study|Death|1|||
94371657|NCT03634488|323146880|FG001|Overall Study|Death|0|||
94371658|NCT03634488|323146881|FG002|Overall Study|Death|0|||
94371659|NCT03634488|323146879|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
94371660|NCT03634488|323146880|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
94371661|NCT03634488|323146881|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
94281220|NCT01142726|322819445|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
94281221|NCT01142726|322819443|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
94281222|NCT01142726|322819444|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
94281223|NCT01142726|322819445|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
94281224|NCT01142726|322819443|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
94281225|NCT01142726|322819444|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
94281226|NCT01142726|322819445|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
94281227|NCT01142726|322819443|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
94281228|NCT01142726|322819444|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
94281229|NCT01142726|322819445|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
94281230|NCT01142726|322819443|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
94281231|NCT01142726|322819444|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
94281232|NCT01142726|322819445|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
94281233|NCT03403205|322819446|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
94281234|NCT03403205|322819447|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
94371662|NCT00729365|323146882|FG000|Overall Study|Physician Decision|33|||
94371663|NCT00729365|323146883|FG001|Overall Study|Physician Decision|6|||
94371664|NCT00729365|323146884|FG002|Overall Study|Physician Decision|7|||
94371665|NCT02390219|323146885|FG000|Overall Study|Death|1|||
94371666|NCT02390219|323146885|FG000|Overall Study|Physician Decision|1|||
94371667|NCT02390219|323146885|FG000|Overall Study|Adverse Event|6|||
94371668|NCT02390219|323146885|FG000|Overall Study|Withdrawal by Subject|1|||
94371669|NCT02390219|323146885|FG000|Overall Study|Lost to Follow-up|2|||
94281235|NCT03403205|322819448|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
94281236|NCT03403205|322819449|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
94281237|NCT03403205|322819450|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
94281238|NCT03403205|322819451|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
94281239|NCT03403205|322819446|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
94281240|NCT03403205|322819447|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
94281241|NCT03403205|322819448|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
94281242|NCT03403205|322819449|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
94281243|NCT03403205|322819450|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
94281244|NCT03403205|322819451|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
94281245|NCT03403205|322819446|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
94281246|NCT03403205|322819447|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
94281247|NCT03403205|322819448|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
94281248|NCT03403205|322819449|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
94281249|NCT03403205|322819450|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
94281250|NCT03403205|322819451|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
94281251|NCT03403205|322819446|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
94281252|NCT03403205|322819447|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
94281253|NCT03403205|322819448|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
94281254|NCT03403205|322819449|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
94281255|NCT03403205|322819450|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
94281256|NCT03403205|322819451|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
94281257|NCT03403205|322819446|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
94371670|NCT02390219|323146885|FG000|Overall Study|Other|2|||
94371671|NCT00656019|323146886|FG000|Overall Study|Not Eligible|10|||
94371672|NCT00656019|323146887|FG001|Overall Study|Not Eligible|0|||
94371673|NCT00656019|323146888|FG002|Overall Study|Not Eligible|0|||
94371674|NCT00656019|323146889|FG003|Overall Study|Not Eligible|0|||
94371675|NCT00656019|323146886|FG000|Overall Study|Withdrawal by Subject|2|||
94371676|NCT00656019|323146887|FG001|Overall Study|Withdrawal by Subject|0|||
94371677|NCT00656019|323146888|FG002|Overall Study|Withdrawal by Subject|0|||
94371678|NCT00656019|323146889|FG003|Overall Study|Withdrawal by Subject|0|||
94371679|NCT00656019|323146886|FG000|Overall Study|Lost to Follow-up|2|||
94371680|NCT00656019|323146887|FG001|Overall Study|Lost to Follow-up|1|||
94371681|NCT00656019|323146888|FG002|Overall Study|Lost to Follow-up|0|||
94371682|NCT00656019|323146889|FG003|Overall Study|Lost to Follow-up|0|||
94371683|NCT01201356|323146892|FG000|Overall Study|Adverse Event|170|||
94371684|NCT01201356|323146892|FG000|Overall Study|Abnormal laboratory value(s)|51|||
94371685|NCT01201356|323146892|FG000|Overall Study|Abnormal test procedure result(s)|3|||
94371686|NCT01201356|323146892|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
94371687|NCT01201356|323146892|FG000|Overall Study|Condition no longer requires study drug|12|||
94371688|NCT01201356|323146892|FG000|Overall Study|Withdrawal by Subject|144|||
94371689|NCT01201356|323146892|FG000|Overall Study|Lost to Follow-up|50|||
94371690|NCT01201356|323146892|FG000|Overall Study|administrative problems|74|||
94371691|NCT01201356|323146892|FG000|Overall Study|Death|16|||
94371692|NCT01201356|323146892|FG000|Overall Study|Protocol Violation|12|||
94371693|NCT00738920|323146893|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
94371694|NCT00738920|323146894|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
94371695|NCT00738920|323146895|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
94371696|NCT00738920|323146893|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
94371697|NCT00738920|323146894|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
94371698|NCT00738920|323146895|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
94371699|NCT00738920|323146893|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
94371700|NCT00738920|323146894|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
94371701|NCT00738920|323146895|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
94371702|NCT00738920|323146893|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
94371703|NCT00738920|323146894|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
94371704|NCT00738920|323146895|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
94371705|NCT00738920|323146893|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
94371706|NCT00738920|323146894|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
94371707|NCT00738920|323146895|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
94371708|NCT00738920|323146893|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
94371709|NCT00738920|323146894|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
94371710|NCT00738920|323146895|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
94371711|NCT00738920|323146893|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
94467670|NCT01004432|323502376|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
94467671|NCT01004432|323502377|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
94467672|NCT01004432|323502373|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
94467673|NCT01004432|323502374|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
94371712|NCT00738920|323146894|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
94371713|NCT00738920|323146895|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
94371714|NCT00738920|323146893|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
94371715|NCT00738920|323146894|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
94206960|NCT02132949|322553102|FG000|Overall Study|Death|7|||
94206961|NCT02132949|322553103|FG001|Overall Study|Death|13|||
94206962|NCT02132949|322553102|FG000|Overall Study|Lost to Follow-up|14|||
94206963|NCT02132949|322553103|FG001|Overall Study|Lost to Follow-up|4|||
94206964|NCT02132949|322553102|FG000|Overall Study|Withdrawal by Subject|6|||
94206965|NCT02132949|322553103|FG001|Overall Study|Withdrawal by Subject|5|||
94206966|NCT02132949|322553102|FG000|Overall Study|Noncompliance|5|||
94206967|NCT02132949|322553103|FG001|Overall Study|Noncompliance|1|||
94206968|NCT02132949|322553102|FG000|Overall Study|Physician Decision|3|||
94206969|NCT02132949|322553103|FG001|Overall Study|Physician Decision|1|||
94206970|NCT02132949|322553102|FG000|Overall Study|Disease Progression|3|||
94206971|NCT02132949|322553103|FG001|Overall Study|Disease Progression|0|||
94206972|NCT02132949|322553102|FG000|Overall Study|Adverse Event|2|||
94206973|NCT02132949|322553103|FG001|Overall Study|Adverse Event|1|||
94206974|NCT02132949|322553102|FG000|Overall Study|Withdrew Prior to Treatment|1|||
94206975|NCT02132949|322553103|FG001|Overall Study|Withdrew Prior to Treatment|2|||
94206976|NCT02132949|322553102|FG000|Overall Study|Reason Unspecified|0|||
94206977|NCT02132949|322553103|FG001|Overall Study|Reason Unspecified|1|||
94206978|NCT01128595|322553107|FG000|Treatment Period 3|Withdrawal by Subject|0|||
94206979|NCT01128595|322553108|FG001|Treatment Period 3|Withdrawal by Subject|1|||
94206980|NCT01128595|322553109|FG002|Treatment Period 3|Withdrawal by Subject|0|||
94206981|NCT01128595|322553110|FG003|Treatment Period 3|Withdrawal by Subject|0|||
94206982|NCT00336505|322553111|FG000|Overall Study|Adverse Event|10|||
94206983|NCT00336505|322553112|FG001|Overall Study|Adverse Event|9|||
94206984|NCT00336505|322553111|FG000|Overall Study|Lack of Efficacy|8|||
94206985|NCT00336505|322553112|FG001|Overall Study|Lack of Efficacy|4|||
94206986|NCT00336505|322553111|FG000|Overall Study|Lost to Follow-up|7|||
94206987|NCT00336505|322553112|FG001|Overall Study|Lost to Follow-up|4|||
94206988|NCT00336505|322553111|FG000|Overall Study|Withdrawal by Subject|5|||
94206989|NCT00336505|322553112|FG001|Overall Study|Withdrawal by Subject|3|||
94206990|NCT00336505|322553111|FG000|Overall Study|Other|7|||
94206991|NCT00336505|322553112|FG001|Overall Study|Other|7|||
94206992|NCT01185600|322553118|FG000|Overall Study|Adverse Event|1|||
94206993|NCT01185600|322553119|FG001|Overall Study|Adverse Event|1|||
94206994|NCT01185600|322553118|FG000|Overall Study|Death|0|||
94206995|NCT01185600|322553119|FG001|Overall Study|Death|1|||
94206996|NCT01185600|322553118|FG000|Overall Study|Lost to Follow-up|0|||
94206997|NCT01185600|322553119|FG001|Overall Study|Lost to Follow-up|5|||
94206998|NCT01185600|322553118|FG000|Overall Study|Physician Decision|29|||
94206999|NCT01185600|322553119|FG001|Overall Study|Physician Decision|35|||
94207000|NCT01185600|322553118|FG000|Overall Study|Withdrawal by Subject|1|||
94207001|NCT01185600|322553119|FG001|Overall Study|Withdrawal by Subject|1|||
94207002|NCT01185600|322553118|FG000|Overall Study|Hold by DSMB|1|||
94207003|NCT01185600|322553119|FG001|Overall Study|Hold by DSMB|2|||
94207004|NCT03732807|322553121|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
94207005|NCT03732807|322553122|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
94207006|NCT03732807|322553123|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
94207007|NCT03732807|322553124|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
94207008|NCT03732807|322553125|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
94207009|NCT03732807|322553126|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
94207010|NCT03732807|322553127|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
94207011|NCT03732807|322553121|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
94207012|NCT03732807|322553122|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
94207013|NCT03732807|322553123|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
94207014|NCT03732807|322553124|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
94207015|NCT03732807|322553125|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
94207016|NCT03732807|322553126|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
94207017|NCT03732807|322553127|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
94207018|NCT03732807|322553121|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
94207019|NCT03732807|322553122|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
94207020|NCT03732807|322553123|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
94207021|NCT03732807|322553124|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
94371716|NCT00738920|323146895|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
94371717|NCT00738920|323146893|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
94371718|NCT00738920|323146894|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
94371719|NCT00738920|323146895|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
94371720|NCT00738920|323146893|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
94371721|NCT00738920|323146894|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
94371722|NCT00738920|323146895|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
94371723|NCT04444752|323146896|FG000|Overall Study|Adverse Event|1|||
94371724|NCT04444752|323146897|FG001|Overall Study|Adverse Event|0|||
94371725|NCT04444752|323146898|FG002|Overall Study|Adverse Event|0|||
94371726|NCT04444752|323146899|FG003|Overall Study|Adverse Event|2|||
94371727|NCT04444752|323146896|FG000|Overall Study|Lost to Follow-up|2|||
94371728|NCT04444752|323146897|FG001|Overall Study|Lost to Follow-up|6|||
94371729|NCT04444752|323146898|FG002|Overall Study|Lost to Follow-up|2|||
94371730|NCT04444752|323146899|FG003|Overall Study|Lost to Follow-up|5|||
94371731|NCT04444752|323146896|FG000|Overall Study|Physician Decision|0|||
94371732|NCT04444752|323146897|FG001|Overall Study|Physician Decision|0|||
94371733|NCT04444752|323146898|FG002|Overall Study|Physician Decision|0|||
94371734|NCT04444752|323146899|FG003|Overall Study|Physician Decision|2|||
94371735|NCT04444752|323146896|FG000|Overall Study|Pregnancy|0|||
94371736|NCT04444752|323146897|FG001|Overall Study|Pregnancy|0|||
94371737|NCT04444752|323146898|FG002|Overall Study|Pregnancy|0|||
94371738|NCT04444752|323146899|FG003|Overall Study|Pregnancy|1|||
94371739|NCT04444752|323146896|FG000|Overall Study|Withdrawal by Subject|6|||
94371740|NCT04444752|323146897|FG001|Overall Study|Withdrawal by Subject|5|||
94371741|NCT04444752|323146898|FG002|Overall Study|Withdrawal by Subject|3|||
94371742|NCT04444752|323146899|FG003|Overall Study|Withdrawal by Subject|4|||
94371743|NCT04444752|323146896|FG000|Overall Study|Protocol Violation|1|||
94371744|NCT04444752|323146897|FG001|Overall Study|Protocol Violation|1|||
94371745|NCT04444752|323146898|FG002|Overall Study|Protocol Violation|0|||
94371746|NCT04444752|323146899|FG003|Overall Study|Protocol Violation|0|||
94371747|NCT04444752|323146896|FG000|Overall Study|Patient moving out of town|1|||
94371748|NCT04444752|323146897|FG001|Overall Study|Patient moving out of town|0|||
94371749|NCT04444752|323146898|FG002|Overall Study|Patient moving out of town|0|||
94371750|NCT04444752|323146899|FG003|Overall Study|Patient moving out of town|1|||
94371751|NCT04444752|323146896|FG000|Overall Study|Lack of Efficacy|0|||
94371752|NCT04444752|323146897|FG001|Overall Study|Lack of Efficacy|0|||
94371753|NCT04444752|323146898|FG002|Overall Study|Lack of Efficacy|0|||
94371754|NCT04444752|323146899|FG003|Overall Study|Lack of Efficacy|1|||
94371755|NCT04444752|323146896|FG000|Overall Study|Death|0|||
94371756|NCT04444752|323146897|FG001|Overall Study|Death|0|||
94371757|NCT04444752|323146898|FG002|Overall Study|Death|1|||
94371758|NCT04444752|323146899|FG003|Overall Study|Death|0|||
94371759|NCT03705169|323146900|FG000|Overall Study|Lost to Follow-up|0|||
94371760|NCT03705169|323146901|FG001|Overall Study|Lost to Follow-up|0|||
94371761|NCT03705169|323146902|FG002|Overall Study|Lost to Follow-up|0|||
94371762|NCT03705169|323146903|FG003|Overall Study|Lost to Follow-up|2|||
94371763|NCT03705169|323146904|FG004|Overall Study|Lost to Follow-up|0|||
94371764|NCT03705169|323146905|FG005|Overall Study|Lost to Follow-up|2|||
94371765|NCT03705169|323146906|FG006|Overall Study|Lost to Follow-up|1|||
94371766|NCT03705169|323146907|FG007|Overall Study|Lost to Follow-up|0|||
94371767|NCT03705169|323146908|FG008|Overall Study|Lost to Follow-up|0|||
94371768|NCT03705169|323146909|FG009|Overall Study|Lost to Follow-up|1|||
94371769|NCT03705169|323146900|FG000|Overall Study|Adverse Event|0|||
94371770|NCT03705169|323146901|FG001|Overall Study|Adverse Event|0|||
94371771|NCT03705169|323146902|FG002|Overall Study|Adverse Event|0|||
94371772|NCT03705169|323146903|FG003|Overall Study|Adverse Event|1|||
94371773|NCT03705169|323146904|FG004|Overall Study|Adverse Event|0|||
94371774|NCT03705169|323146905|FG005|Overall Study|Adverse Event|0|||
94371775|NCT03705169|323146906|FG006|Overall Study|Adverse Event|0|||
94371776|NCT03705169|323146907|FG007|Overall Study|Adverse Event|0|||
94371777|NCT03705169|323146908|FG008|Overall Study|Adverse Event|0|||
94371778|NCT03705169|323146909|FG009|Overall Study|Adverse Event|0|||
94467674|NCT01004432|323502375|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
94371779|NCT03705169|323146900|FG000|Overall Study|Site Closure|0|||
94371780|NCT03705169|323146901|FG001|Overall Study|Site Closure|0|||
94371781|NCT03705169|323146902|FG002|Overall Study|Site Closure|0|||
94371782|NCT03705169|323146903|FG003|Overall Study|Site Closure|1|||
94371783|NCT03705169|323146904|FG004|Overall Study|Site Closure|0|||
94371784|NCT03705169|323146905|FG005|Overall Study|Site Closure|0|||
94371785|NCT03705169|323146906|FG006|Overall Study|Site Closure|0|||
94371786|NCT03705169|323146907|FG007|Overall Study|Site Closure|0|||
94371787|NCT03705169|323146908|FG008|Overall Study|Site Closure|0|||
94371788|NCT03705169|323146909|FG009|Overall Study|Site Closure|0|||
94371789|NCT03705169|323146900|FG000|Overall Study|Did not receive study treatment|0|||
94371790|NCT03705169|323146901|FG001|Overall Study|Did not receive study treatment|0|||
94371791|NCT03705169|323146902|FG002|Overall Study|Did not receive study treatment|0|||
94371792|NCT03705169|323146903|FG003|Overall Study|Did not receive study treatment|1|||
94371793|NCT03705169|323146904|FG004|Overall Study|Did not receive study treatment|0|||
94371794|NCT03705169|323146905|FG005|Overall Study|Did not receive study treatment|0|||
94371795|NCT03705169|323146906|FG006|Overall Study|Did not receive study treatment|0|||
94281258|NCT03403205|322819447|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
94281259|NCT03403205|322819448|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
94281260|NCT03403205|322819449|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
94281261|NCT03403205|322819450|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
94281262|NCT03403205|322819451|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
94281263|NCT03403205|322819446|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
94281264|NCT03403205|322819447|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
94281265|NCT03403205|322819448|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
94281266|NCT03403205|322819449|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
94281267|NCT03403205|322819450|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
94281268|NCT03403205|322819451|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
94281269|NCT03403205|322819446|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
94281270|NCT03403205|322819447|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
94281271|NCT03403205|322819448|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
94281272|NCT03403205|322819449|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
94281273|NCT03403205|322819450|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
94281274|NCT03403205|322819451|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
94281275|NCT03403205|322819446|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
94281276|NCT03403205|322819447|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
94281277|NCT03403205|322819448|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
94281278|NCT03403205|322819449|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
94281279|NCT03403205|322819450|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
94281280|NCT03403205|322819451|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
94281281|NCT03403205|322819446|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
94281282|NCT03403205|322819447|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
94281283|NCT03403205|322819448|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
94281284|NCT03403205|322819449|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
94281285|NCT03403205|322819450|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
94281286|NCT03403205|322819451|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
94281287|NCT03403205|322819446|FG000|Extension Period (Up to 60 Months)|Death|1|||
94281288|NCT03403205|322819447|FG001|Extension Period (Up to 60 Months)|Death|0|||
94281289|NCT03403205|322819448|FG002|Extension Period (Up to 60 Months)|Death|0|||
94371796|NCT03705169|323146907|FG007|Overall Study|Did not receive study treatment|0|||
94371797|NCT03705169|323146908|FG008|Overall Study|Did not receive study treatment|0|||
94371798|NCT03705169|323146909|FG009|Overall Study|Did not receive study treatment|0|||
94281290|NCT03403205|322819449|FG003|Extension Period (Up to 60 Months)|Death|0|||
94281291|NCT03403205|322819450|FG004|Extension Period (Up to 60 Months)|Death|0|||
94281292|NCT03403205|322819451|FG005|Extension Period (Up to 60 Months)|Death|0|||
94281293|NCT03403205|322819446|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
94281294|NCT03403205|322819447|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
94281295|NCT03403205|322819448|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
94281296|NCT03403205|322819449|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
94281297|NCT03403205|322819450|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
94281298|NCT03403205|322819451|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
94281299|NCT03403205|322819446|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
94281300|NCT03403205|322819447|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
94281301|NCT03403205|322819448|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
94281302|NCT03403205|322819449|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
94281303|NCT03403205|322819450|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
94281304|NCT03403205|322819451|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
94281305|NCT03403205|322819446|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
94281306|NCT03403205|322819447|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
94281307|NCT03403205|322819448|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
94281308|NCT03403205|322819449|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
94281309|NCT03403205|322819450|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
94281310|NCT03403205|322819451|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
94281311|NCT03403205|322819446|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
94281312|NCT03403205|322819447|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
94281313|NCT03403205|322819448|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
94281314|NCT03403205|322819449|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
94281315|NCT03403205|322819450|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
94281316|NCT03403205|322819451|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
94281317|NCT03403205|322819446|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
94281318|NCT03403205|322819447|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
94281319|NCT03403205|322819448|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
94281320|NCT03403205|322819449|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
94281321|NCT03403205|322819450|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
94281322|NCT03403205|322819451|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
94281323|NCT03403205|322819446|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
94281324|NCT03403205|322819447|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
94281325|NCT03403205|322819448|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
94281326|NCT03403205|322819449|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
94281327|NCT03403205|322819450|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
94281328|NCT03403205|322819451|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
94281329|NCT00391222|322819452|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
94281330|NCT00391222|322819453|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
94281331|NCT00391222|322819454|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
94281332|NCT00391222|322819455|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
94281333|NCT00391222|322819452|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
94281334|NCT00391222|322819453|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
94281335|NCT00391222|322819454|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
94281336|NCT00391222|322819455|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
94281337|NCT00391222|322819452|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
94281338|NCT00391222|322819453|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
94281339|NCT00391222|322819454|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
94281340|NCT00391222|322819455|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
94281341|NCT00391222|322819452|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
94281342|NCT00391222|322819453|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
94281343|NCT00391222|322819454|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
94467675|NCT01004432|323502376|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
94467676|NCT01004432|323502377|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
94371799|NCT03705169|323146900|FG000|Overall Study|Concerns about study visit compliance|0|||
94371800|NCT03705169|323146901|FG001|Overall Study|Concerns about study visit compliance|0|||
94371801|NCT03705169|323146902|FG002|Overall Study|Concerns about study visit compliance|0|||
94371802|NCT03705169|323146903|FG003|Overall Study|Concerns about study visit compliance|1|||
94371803|NCT03705169|323146904|FG004|Overall Study|Concerns about study visit compliance|0|||
94371804|NCT03705169|323146905|FG005|Overall Study|Concerns about study visit compliance|0|||
94371805|NCT03705169|323146906|FG006|Overall Study|Concerns about study visit compliance|0|||
94371806|NCT03705169|323146907|FG007|Overall Study|Concerns about study visit compliance|0|||
94371807|NCT03705169|323146908|FG008|Overall Study|Concerns about study visit compliance|0|||
94371808|NCT03705169|323146909|FG009|Overall Study|Concerns about study visit compliance|0|||
94371809|NCT04136626|323146910|FG000|Treatment Phase|Withdrawal by Subject|1|||
94371810|NCT04136626|323146911|FG001|Treatment Phase|Withdrawal by Subject|9|||
94371811|NCT04136626|323146910|FG000|Treatment Phase|Adverse Event|1|||
94281344|NCT00391222|322819455|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
94281345|NCT00391222|322819452|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
94281346|NCT00391222|322819453|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
94281347|NCT00391222|322819454|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
94281348|NCT00391222|322819455|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
94281349|NCT00391222|322819452|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
94281350|NCT00391222|322819453|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
94281351|NCT00391222|322819454|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
94371812|NCT04136626|323146911|FG001|Treatment Phase|Adverse Event|0|||
94371813|NCT04136626|323146910|FG000|Treatment Phase|Lost to Follow-up|1|||
94371814|NCT04136626|323146911|FG001|Treatment Phase|Lost to Follow-up|5|||
94281352|NCT00391222|322819455|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
94281353|NCT00391222|322819452|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
94371815|NCT04136626|323146910|FG000|12-month Follow-up|Lost to Follow-up|8|||
94371816|NCT04136626|323146911|FG001|12-month Follow-up|Lost to Follow-up|7|||
94371817|NCT00860574|323148386|FG000|Overall Study|Death|2|||
94371818|NCT00860574|323148386|FG000|Overall Study|Relapse|1|||
94371819|NCT01416142|323148387|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
94371820|NCT01416142|323148388|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
94371821|NCT01416142|323148389|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
94371822|NCT02464059|323148390|FG000|Overall Study|Lost to Follow-up|6|||
94371823|NCT01467570|323148393|FG000|Overall Study|Lost to Follow-up|8|||
94371824|NCT01467570|323148394|FG001|Overall Study|Lost to Follow-up|9|||
94371825|NCT01406873|323148397|FG000|Overall Study|Withdrawal by Subject|1|||
94371826|NCT01406873|323148398|FG001|Overall Study|Withdrawal by Subject|1|||
94371827|NCT00265083|323148406|FG000|Overall Study|Adverse Event|5|||
94371828|NCT00265083|323148407|FG001|Overall Study|Adverse Event|13|||
94371829|NCT00265083|323148408|FG002|Overall Study|Adverse Event|15|||
94371830|NCT00265083|323148406|FG000|Overall Study|Lost to Follow-up|3|||
94371831|NCT00265083|323148407|FG001|Overall Study|Lost to Follow-up|4|||
94371832|NCT00265083|323148408|FG002|Overall Study|Lost to Follow-up|4|||
94371833|NCT00265083|323148406|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
94371834|NCT00265083|323148407|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
94371835|NCT00265083|323148408|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
94371836|NCT00265083|323148406|FG000|Overall Study|Other|1|||
94371837|NCT00265083|323148407|FG001|Overall Study|Other|12|||
94371838|NCT00265083|323148408|FG002|Overall Study|Other|9|||
94371839|NCT04378010|323148411|FG000|Overall Study|Adverse Event|8|||
94371840|NCT04378010|323148412|FG001|Overall Study|Adverse Event|14|||
94371841|NCT04378010|323148413|FG002|Overall Study|Adverse Event|4|||
94371842|NCT04378010|323148411|FG000|Overall Study|Withdrawal by Subject|0|||
94371843|NCT04378010|323148412|FG001|Overall Study|Withdrawal by Subject|2|||
94371844|NCT04378010|323148413|FG002|Overall Study|Withdrawal by Subject|1|||
94371845|NCT04378010|323148411|FG000|Overall Study|Protocol Violation|2|||
94371846|NCT04378010|323148412|FG001|Overall Study|Protocol Violation|1|||
94371847|NCT04378010|323148413|FG002|Overall Study|Protocol Violation|4|||
94371848|NCT04378010|323148411|FG000|Overall Study|Study terminated by Sponsor|22|||
94371849|NCT04378010|323148412|FG001|Overall Study|Study terminated by Sponsor|16|||
94371850|NCT04378010|323148413|FG002|Overall Study|Study terminated by Sponsor|22|||
94281354|NCT00391222|322819453|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
94281355|NCT00391222|322819454|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
94281356|NCT00391222|322819455|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
94281357|NCT00391222|322819452|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
94281358|NCT00391222|322819453|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
94281359|NCT00391222|322819454|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
94281360|NCT00391222|322819455|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
94281361|NCT00391222|322819452|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
94281362|NCT00391222|322819453|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
94281363|NCT00391222|322819454|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
94281364|NCT00391222|322819455|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
94281365|NCT00391222|322819452|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
94281366|NCT00391222|322819453|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
94281367|NCT00391222|322819454|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
94281368|NCT00391222|322819455|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
94281369|NCT00391222|322819452|FG000|Period III (Double-Blind Treatment)|Other|6|||
94281370|NCT00391222|322819453|FG001|Period III (Double-Blind Treatment)|Other|1|||
94281371|NCT00391222|322819454|FG002|Period III (Double-Blind Treatment)|Other|6|||
94281372|NCT00391222|322819455|FG003|Period III (Double-Blind Treatment)|Other|0|||
94281373|NCT00796315|322819456|FG000|Overall Study|Protocol Violation|0|||
94281374|NCT00796315|322819457|FG001|Overall Study|Protocol Violation|1|||
94281375|NCT00796315|322819458|FG002|Overall Study|Protocol Violation|0|||
94281376|NCT03298022|322819459|FG000|Overall Study|Lack of Efficacy|4|||
94281377|NCT03298022|322819459|FG000|Overall Study|Withdrawal by Subject|7|||
94281378|NCT03298022|322819459|FG000|Overall Study|Adverse Event|1|||
94281379|NCT03298022|322819459|FG000|Overall Study|disease relapse|1|||
94281380|NCT02069899|322819463|FG000|Overall Study|Adverse Event|6|||
94281381|NCT02069899|322819464|FG001|Overall Study|Adverse Event|0|||
94281382|NCT02069899|322819465|FG002|Overall Study|Adverse Event|1|||
94281383|NCT02069899|322819463|FG000|Overall Study|Withdrawal by Participant|2|||
94281384|NCT02069899|322819464|FG001|Overall Study|Withdrawal by Participant|0|||
94281385|NCT02069899|322819465|FG002|Overall Study|Withdrawal by Participant|0|||
94281386|NCT02069899|322819463|FG000|Overall Study|Lost to Follow-up|1|||
94281387|NCT02069899|322819464|FG001|Overall Study|Lost to Follow-up|0|||
94281388|NCT02069899|322819465|FG002|Overall Study|Lost to Follow-up|1|||
94281389|NCT02069899|322819463|FG000|Overall Study|Other|4|||
94281390|NCT02069899|322819464|FG001|Overall Study|Other|0|||
94281391|NCT02069899|322819465|FG002|Overall Study|Other|0|||
94281392|NCT02069899|322819463|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
94281393|NCT02069899|322819464|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
94281394|NCT02069899|322819465|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
94281395|NCT02069899|322819463|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
94281396|NCT02069899|322819464|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
94281397|NCT02069899|322819465|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
94281398|NCT04417894|322819466|FG000|Overall Study|Lost to Follow-up|3|||
94281399|NCT04417894|322819467|FG001|Overall Study|Lost to Follow-up|0|||
94281400|NCT04417894|322819466|FG000|Overall Study|Withdrawal by Subject|7|||
94281401|NCT04417894|322819467|FG001|Overall Study|Withdrawal by Subject|6|||
94281402|NCT04417894|322819466|FG000|Overall Study|Lack of Efficacy|3|||
94281403|NCT04417894|322819467|FG001|Overall Study|Lack of Efficacy|1|||
94281404|NCT00993928|322819468|FG000|Overall Study|Withdrawal by Subject|4|||
94281405|NCT00993928|322819469|FG001|Overall Study|Withdrawal by Subject|7|||
94281406|NCT00993928|322819468|FG000|Overall Study|ineligible|1|||
94281407|NCT00993928|322819469|FG001|Overall Study|ineligible|0|||
94281408|NCT00879697|322819470|FG000|Overall Study|Physician Decision|2|||
94281409|NCT00879697|322819471|FG001|Overall Study|Physician Decision|2|||
94281410|NCT00720109|322819472|FG000|Induction Period|Did not meet eligibility criteria|3|||
94371851|NCT04378010|323148411|FG000|Overall Study|Subject inability to complete study visit|0|||
94371852|NCT04378010|323148412|FG001|Overall Study|Subject inability to complete study visit|0|||
94371853|NCT04378010|323148413|FG002|Overall Study|Subject inability to complete study visit|1|||
94371854|NCT04378010|323148411|FG000|Overall Study|Subject never dosed|0|||
94371855|NCT04378010|323148412|FG001|Overall Study|Subject never dosed|1|||
94371856|NCT04378010|323148413|FG002|Overall Study|Subject never dosed|0|||
94371857|NCT00379587|323148414|FG000|Overall Study|Lost to Follow-up|2|||
94371858|NCT00534092|323148415|FG000|Overall Study|Lost to Follow-up|1|||
94371859|NCT00534092|323148416|FG001|Overall Study|Lost to Follow-up|0|||
94371860|NCT00534092|323148415|FG000|Overall Study|personal reasons/family concerns|1|||
94371861|NCT00534092|323148416|FG001|Overall Study|personal reasons/family concerns|0|||
94371862|NCT01613131|323148418|FG000|Overall Study|Withdrawal by Subject|3|||
94371863|NCT01613131|323148419|FG001|Overall Study|Withdrawal by Subject|5|||
94371864|NCT01814761|323148422|FG000|Overall Study|Other Reasons|1|||
94371865|NCT01814761|323148423|FG001|Overall Study|Other Reasons|10|||
94371866|NCT01814761|323148422|FG000|Overall Study|Ocular Adverse Event|6|||
94371867|NCT01814761|323148423|FG001|Overall Study|Ocular Adverse Event|15|||
94371868|NCT01814761|323148422|FG000|Overall Study|Lost to Follow-up|1|||
94371869|NCT01814761|323148423|FG001|Overall Study|Lost to Follow-up|5|||
94371870|NCT00936884|323148424|FG000|Double-blind|Withdrawal by Subject|6|||
94371871|NCT00936884|323148425|FG001|Double-blind|Withdrawal by Subject|4|||
94371872|NCT00936884|323148426|FG002|Double-blind|Withdrawal by Subject|0|||
94371873|NCT00936884|323148424|FG000|Double-blind|Death|2|||
94371874|NCT00936884|323148425|FG001|Double-blind|Death|1|||
94371875|NCT00936884|323148426|FG002|Double-blind|Death|0|||
94371876|NCT00936884|323148424|FG000|Double-blind|Lack of Efficacy|1|||
94371877|NCT00936884|323148425|FG001|Double-blind|Lack of Efficacy|1|||
94371878|NCT00936884|323148426|FG002|Double-blind|Lack of Efficacy|0|||
94371879|NCT00936884|323148424|FG000|Double-blind|Adverse Event|1|||
94371880|NCT00936884|323148425|FG001|Double-blind|Adverse Event|0|||
94371881|NCT00936884|323148426|FG002|Double-blind|Adverse Event|0|||
94371882|NCT00936884|323148424|FG000|Double-blind|Physician Decision|1|||
94371883|NCT00936884|323148425|FG001|Double-blind|Physician Decision|0|||
94371884|NCT00936884|323148426|FG002|Double-blind|Physician Decision|0|||
94371885|NCT00936884|323148424|FG000|Double-blind|No post baseline diary entry|1|||
94371886|NCT00936884|323148425|FG001|Double-blind|No post baseline diary entry|0|||
94371887|NCT00936884|323148426|FG002|Double-blind|No post baseline diary entry|0|||
94371888|NCT00936884|323148424|FG000|Double-blind|Did not receive study drug|0|||
94371889|NCT00936884|323148425|FG001|Double-blind|Did not receive study drug|1|||
94371890|NCT00936884|323148426|FG002|Double-blind|Did not receive study drug|0|||
94371891|NCT01859390|323148427|FG000|Overall Study|Insufficient Sputum Collected|1|||
94371892|NCT01859390|323148428|FG001|Overall Study|Insufficient Sputum Collected|3|||
94371893|NCT01859390|323148427|FG000|Overall Study|Sample Missing Collection Date|0|||
94371894|NCT01859390|323148428|FG001|Overall Study|Sample Missing Collection Date|1|||
94371895|NCT01859390|323148427|FG000|Overall Study|Tube Cracked|0|||
94371896|NCT01859390|323148428|FG001|Overall Study|Tube Cracked|2|||
94371897|NCT01859390|323148427|FG000|Overall Study|Shipment Error|0|||
94371898|NCT01859390|323148428|FG001|Overall Study|Shipment Error|1|||
94371899|NCT01017029|323148435|FG000|Overall Study|Lost to Follow-up|1|||
94371900|NCT01017029|323148436|FG001|Overall Study|Lost to Follow-up|0|||
94371901|NCT01017029|323148435|FG000|Overall Study|Administrative problem|0|||
94371902|NCT01017029|323148436|FG001|Overall Study|Administrative problem|1|||
94371903|NCT01017029|323148435|FG000|Overall Study|Death|3|||
94371904|NCT01017029|323148436|FG001|Overall Study|Death|1|||
94371905|NCT00618774|323148441|FG000|Overall Study|Adverse Event|5|||
94371906|NCT00618774|323148442|FG001|Overall Study|Adverse Event|3|||
94371907|NCT00618774|323148441|FG000|Overall Study|Withdrawal by Subject|1|||
94371908|NCT00618774|323148442|FG001|Overall Study|Withdrawal by Subject|0|||
94371909|NCT00623623|323148444|FG000|Overall Study|Previous enrolment into this study|1|||
94371910|NCT00623623|323148445|FG001|Overall Study|Previous enrolment into this study|1|||
94281411|NCT00720109|322819473|FG001|Induction Period|Did not meet eligibility criteria|0|||
94281412|NCT00720109|322819474|FG002|Induction Period|Did not meet eligibility criteria|0|||
94281413|NCT00720109|322819472|FG000|Induction Period|Bone Marrow Transplant|2|||
94281414|NCT00720109|322819473|FG001|Induction Period|Bone Marrow Transplant|0|||
94281415|NCT00720109|322819474|FG002|Induction Period|Bone Marrow Transplant|0|||
94281416|NCT00720109|322819472|FG000|Induction Period|Physician Decision|1|||
94281417|NCT00720109|322819473|FG001|Induction Period|Physician Decision|0|||
94281418|NCT00720109|322819474|FG002|Induction Period|Physician Decision|0|||
94281419|NCT00720109|322819472|FG000|Risk Stratification Period|Adverse Event|0|||
94281420|NCT00720109|322819473|FG001|Risk Stratification Period|Adverse Event|1|||
94281421|NCT00720109|322819474|FG002|Risk Stratification Period|Adverse Event|0|||
94281422|NCT00720109|322819472|FG000|Risk Stratification Period|Physician Decision|0|||
94281423|NCT00720109|322819473|FG001|Risk Stratification Period|Physician Decision|2|||
94281424|NCT00720109|322819474|FG002|Risk Stratification Period|Physician Decision|1|||
94281425|NCT00720109|322819472|FG000|Risk Stratification Period|Bone marrow transplant|0|||
94281426|NCT00720109|322819473|FG001|Risk Stratification Period|Bone marrow transplant|9|||
94281427|NCT00720109|322819474|FG002|Risk Stratification Period|Bone marrow transplant|7|||
94281428|NCT00720109|322819472|FG000|Risk Stratification Period|Disease progression or relapse|0|||
94281429|NCT00720109|322819473|FG001|Risk Stratification Period|Disease progression or relapse|2|||
94281430|NCT00720109|322819474|FG002|Risk Stratification Period|Disease progression or relapse|0|||
94281431|NCT00720109|322819472|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
94281432|NCT00720109|322819473|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
94281433|NCT00720109|322819474|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
94281434|NCT03595553|322819475|FG000|Overall Study|Withdrawal by Subject|20|||
94281435|NCT03595553|322819476|FG001|Overall Study|Withdrawal by Subject|8|||
94281436|NCT03595553|322819475|FG000|Overall Study|Physician Decision|3|||
94281437|NCT03595553|322819476|FG001|Overall Study|Physician Decision|2|||
94281438|NCT03595553|322819475|FG000|Overall Study|Adverse Event|2|||
94281439|NCT03595553|322819476|FG001|Overall Study|Adverse Event|5|||
94281440|NCT03595553|322819475|FG000|Overall Study|Death|24|||
94281441|NCT03595553|322819476|FG001|Overall Study|Death|22|||
94281442|NCT03595553|322819475|FG000|Overall Study|Lost to Follow-up|6|||
94281443|NCT03595553|322819476|FG001|Overall Study|Lost to Follow-up|7|||
94281444|NCT03595553|322819475|FG000|Overall Study|Other as indicated in CSR|3|||
94281445|NCT03595553|322819476|FG001|Overall Study|Other as indicated in CSR|3|||
94281446|NCT03595553|322819475|FG000|Overall Study|Sponsor Decision|0|||
94281447|NCT03595553|322819476|FG001|Overall Study|Sponsor Decision|1|||
94281448|NCT00866307|322819477|FG000|Induction|Adverse Event|5|||
94281449|NCT00866307|322819478|FG001|Induction|Adverse Event|0|||
94281450|NCT00866307|322819479|FG002|Induction|Adverse Event|0|||
94281451|NCT00866307|322819477|FG000|Induction|Death|2|||
94281452|NCT00866307|322819478|FG001|Induction|Death|0|||
94281453|NCT00866307|322819479|FG002|Induction|Death|0|||
94281454|NCT00866307|322819477|FG000|Induction|Physician Decision|5|||
94281455|NCT00866307|322819478|FG001|Induction|Physician Decision|0|||
94281456|NCT00866307|322819479|FG002|Induction|Physician Decision|0|||
94281457|NCT00866307|322819477|FG000|Induction|Progressive Disease|1|||
94281458|NCT00866307|322819478|FG001|Induction|Progressive Disease|0|||
94281459|NCT00866307|322819479|FG002|Induction|Progressive Disease|0|||
94281460|NCT00866307|322819477|FG000|Induction|Identification of Patients with Day 29 M|3|||
94281461|NCT00866307|322819478|FG001|Induction|Identification of Patients with Day 29 M|0|||
94281462|NCT00866307|322819479|FG002|Induction|Identification of Patients with Day 29 M|0|||
94281463|NCT00866307|322819477|FG000|Induction|Inadequate cytognetic samples th|1|||
94281464|NCT00866307|322819478|FG001|Induction|Inadequate cytognetic samples th|0|||
94281465|NCT00866307|322819479|FG002|Induction|Inadequate cytognetic samples th|0|||
94281466|NCT00866307|322819477|FG000|Induction|Improper post-induction consent|2|||
94281467|NCT00866307|322819478|FG001|Induction|Improper post-induction consent|0|||
94281468|NCT00866307|322819479|FG002|Induction|Improper post-induction consent|0|||
94281469|NCT00866307|322819477|FG000|Induction|Study was closed at the time|1|||
94281470|NCT00866307|322819478|FG001|Induction|Study was closed at the time|0|||
94281471|NCT00866307|322819479|FG002|Induction|Study was closed at the time|0|||
94371911|NCT03989115|323148447|FG000|Overall Study|Withdrawal by Subject|2|||
94281472|NCT00866307|322819477|FG000|Consolidation/Maintenance|Adverse Event|0|||
94281473|NCT00866307|322819478|FG001|Consolidation/Maintenance|Adverse Event|0|||
94281474|NCT00866307|322819479|FG002|Consolidation/Maintenance|Adverse Event|8|||
94281475|NCT00866307|322819477|FG000|Consolidation/Maintenance|Death|0|||
94371912|NCT03989115|323148448|FG001|Overall Study|Withdrawal by Subject|1|||
94281476|NCT00866307|322819478|FG001|Consolidation/Maintenance|Death|0|||
94281477|NCT00866307|322819479|FG002|Consolidation/Maintenance|Death|1|||
94281478|NCT00866307|322819477|FG000|Consolidation/Maintenance|Physician Decision|0|||
94281479|NCT00866307|322819478|FG001|Consolidation/Maintenance|Physician Decision|3|||
94281480|NCT00866307|322819479|FG002|Consolidation/Maintenance|Physician Decision|2|||
94281481|NCT00866307|322819477|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
94281482|NCT00866307|322819478|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
94281483|NCT00866307|322819479|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
94207022|NCT03732807|322553125|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
94207023|NCT03732807|322553126|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
94207024|NCT03732807|322553127|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
94207025|NCT03732807|322553121|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
94207026|NCT03732807|322553122|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
94207027|NCT03732807|322553123|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
94207028|NCT03732807|322553124|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
94207029|NCT03732807|322553125|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
94207030|NCT03732807|322553126|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
94207031|NCT03732807|322553127|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
94207032|NCT03732807|322553121|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
94207033|NCT03732807|322553122|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
94207034|NCT03732807|322553123|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
94207035|NCT03732807|322553124|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
94207036|NCT03732807|322553125|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
94207037|NCT03732807|322553126|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
94207038|NCT03732807|322553127|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
94207039|NCT03732807|322553121|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
94207040|NCT03732807|322553122|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
94207041|NCT03732807|322553123|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
94207042|NCT03732807|322553124|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
94207043|NCT03732807|322553125|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
94207044|NCT03732807|322553126|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
94207045|NCT03732807|322553127|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
94207046|NCT03732807|322553121|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
94207047|NCT03732807|322553122|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
94207048|NCT03732807|322553123|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
94207049|NCT03732807|322553124|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
94207050|NCT03732807|322553125|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
94207051|NCT03732807|322553126|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
94207052|NCT03732807|322553127|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
94207053|NCT03732807|322553121|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
94207054|NCT03732807|322553122|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
94207055|NCT03732807|322553123|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
94207056|NCT03732807|322553124|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
94207057|NCT03732807|322553125|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
94207058|NCT03732807|322553126|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
94207059|NCT03732807|322553127|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
94207060|NCT03732807|322553121|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
94207061|NCT03732807|322553122|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
94207062|NCT03732807|322553123|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
94207063|NCT03732807|322553124|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
94207064|NCT03732807|322553125|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
94207065|NCT03732807|322553126|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
94207066|NCT03732807|322553127|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
94207067|NCT03732807|322553121|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
94207068|NCT03732807|322553122|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
94207069|NCT03732807|322553123|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
94207070|NCT03732807|322553124|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
94207071|NCT03732807|322553125|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
94207072|NCT03732807|322553126|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
94207073|NCT03732807|322553127|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
94207074|NCT03732807|322553121|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
94207075|NCT03732807|322553122|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
94207076|NCT03732807|322553123|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
94207077|NCT03732807|322553124|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
94207078|NCT03732807|322553125|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
94207079|NCT03732807|322553126|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
94207080|NCT03732807|322553127|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
94207081|NCT03732807|322553121|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
94207082|NCT03732807|322553122|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
94207083|NCT03732807|322553123|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
94207084|NCT03732807|322553124|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
94207085|NCT03732807|322553125|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
94207086|NCT03732807|322553126|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
94207087|NCT03732807|322553127|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
94207088|NCT03732807|322553121|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
94207089|NCT03732807|322553122|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
94207090|NCT03732807|322553123|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
94207091|NCT03732807|322553124|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
94207092|NCT03732807|322553125|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
94207093|NCT03732807|322553126|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
94207094|NCT03732807|322553127|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
94207095|NCT03732807|322553121|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
94207096|NCT03732807|322553122|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
94207097|NCT03732807|322553123|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
94207098|NCT03732807|322553124|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
94207099|NCT03732807|322553125|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
94207100|NCT03732807|322553126|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
94207101|NCT03732807|322553127|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
94207102|NCT05405244|322553128|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
94281484|NCT00866307|322819477|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
94281485|NCT00866307|322819478|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
94281486|NCT00866307|322819479|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
94281487|NCT00866307|322819477|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
94281488|NCT00866307|322819478|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
94281489|NCT00866307|322819479|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
94281490|NCT00866307|322819477|FG000|Consolidation/Maintenance|Therapy error|0|||
94281491|NCT00866307|322819478|FG001|Consolidation/Maintenance|Therapy error|1|||
94281492|NCT00866307|322819479|FG002|Consolidation/Maintenance|Therapy error|0|||
94207103|NCT05405244|322553129|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
94207104|NCT05405244|322553128|FG000|Washout (2 Weeks)|Adverse Event|2|||
94207105|NCT05405244|322553129|FG001|Washout (2 Weeks)|Adverse Event|0|||
94207106|NCT05405244|322553128|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
94207107|NCT05405244|322553129|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
94207108|NCT01779700|322553130|FG000|Overall Study|Adverse Event|4|||
94207109|NCT01779700|322553131|FG001|Overall Study|Adverse Event|3|||
94207110|NCT01779700|322553130|FG000|Overall Study|Withdrawal by Subject|0|||
94207111|NCT01779700|322553131|FG001|Overall Study|Withdrawal by Subject|2|||
94207112|NCT00739934|322553134|FG000|Voriconazole IV|Adverse Event|6|||
94281493|NCT00866307|322819477|FG000|Consolidation/Maintenance|Non-compliance|0|||
94207113|NCT00739934|322553134|FG000|Voriconazole Oral|Other|3|||
94207114|NCT03451422|322553135|FG000|Overall Study|Lost to Follow-up|0|||
94207115|NCT03451422|322553136|FG001|Overall Study|Lost to Follow-up|0|||
94207116|NCT03451422|322553137|FG002|Overall Study|Lost to Follow-up|0|||
94207117|NCT03451422|322553138|FG003|Overall Study|Lost to Follow-up|0|||
94207118|NCT03451422|322553139|FG004|Overall Study|Lost to Follow-up|0|||
94207119|NCT03451422|322553140|FG005|Overall Study|Lost to Follow-up|1|||
94207120|NCT03451422|322553135|FG000|Overall Study|Decision by sponsor|1|||
94207121|NCT03451422|322553136|FG001|Overall Study|Decision by sponsor|0|||
94207122|NCT03451422|322553137|FG002|Overall Study|Decision by sponsor|1|||
94207123|NCT03451422|322553138|FG003|Overall Study|Decision by sponsor|0|||
94207124|NCT03451422|322553139|FG004|Overall Study|Decision by sponsor|0|||
94207125|NCT03451422|322553140|FG005|Overall Study|Decision by sponsor|0|||
94207126|NCT03451422|322553135|FG000|Overall Study|Withdrawal by Subject|0|||
94207127|NCT03451422|322553136|FG001|Overall Study|Withdrawal by Subject|0|||
94281494|NCT00866307|322819478|FG001|Consolidation/Maintenance|Non-compliance|0|||
94281495|NCT00866307|322819479|FG002|Consolidation/Maintenance|Non-compliance|1|||
94207128|NCT03451422|322553137|FG002|Overall Study|Withdrawal by Subject|2|||
94207129|NCT03451422|322553138|FG003|Overall Study|Withdrawal by Subject|3|||
94207130|NCT03451422|322553139|FG004|Overall Study|Withdrawal by Subject|2|||
94207131|NCT03451422|322553140|FG005|Overall Study|Withdrawal by Subject|1|||
94207132|NCT02797132|322553141|FG000|Part A (15 Days)|Adverse Event|1|||
94281496|NCT00866307|322819477|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
94371913|NCT03989115|323148449|FG002|Overall Study|Withdrawal by Subject|3|||
94207133|NCT02797132|322553141|FG000|Part B (24 Weeks)|Adverse Event|3|||
94207134|NCT00442104|322553142|FG000|Overall Study|Adverse Event|5|||
94207135|NCT00442104|322553142|FG000|Overall Study|Death|2|||
94207136|NCT00442104|322553142|FG000|Overall Study|Lost to Follow-up|3|||
94207137|NCT00442104|322553142|FG000|Overall Study|Withdrawal by Subject|5|||
94207138|NCT00442104|322553142|FG000|Overall Study|Insufficient Clinical Response|10|||
94207139|NCT00442104|322553142|FG000|Overall Study|Other|21|||
94207140|NCT00442104|322553142|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
94207141|NCT03601715|322553143|FG000|Second Intervention|Lost to Follow-up|1|||
94207142|NCT03601715|322553144|FG001|Second Intervention|Lost to Follow-up|1|||
94207143|NCT03601715|322553145|FG002|Second Intervention|Lost to Follow-up|0|||
94207144|NCT01313884|322553149|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
94207145|NCT01342367|322553153|FG000|Overall Study|Death|1|||
94207146|NCT01342367|322553154|FG001|Overall Study|Death|0|||
94207147|NCT01342367|322553153|FG000|Overall Study|Withdrawal by Subject|1|||
94207148|NCT01342367|322553154|FG001|Overall Study|Withdrawal by Subject|2|||
94207149|NCT00229658|322553159|FG000|Overall Study|Administrative|2|||
94207150|NCT00229658|322553160|FG001|Overall Study|Administrative|1|||
94207151|NCT00229658|322553159|FG000|Overall Study|Investigator decision|13|||
94207152|NCT00229658|322553160|FG001|Overall Study|Investigator decision|10|||
94207153|NCT00229658|322553159|FG000|Overall Study|Other|80|||
94207154|NCT00229658|322553160|FG001|Overall Study|Other|60|||
94207155|NCT00229658|322553159|FG000|Overall Study|Lost to Follow-up|82|||
94207156|NCT00229658|322553160|FG001|Overall Study|Lost to Follow-up|55|||
94207157|NCT00229658|322553159|FG000|Overall Study|Serious Adverse Event|2|||
94207158|NCT00229658|322553160|FG001|Overall Study|Serious Adverse Event|2|||
94207159|NCT00229658|322553159|FG000|Overall Study|Withdrawal of consent|46|||
94207160|NCT00229658|322553160|FG001|Overall Study|Withdrawal of consent|39|||
94207161|NCT01034306|322553161|FG000|Overall Study|Adverse Event|1|||
94207162|NCT01034306|322553162|FG001|Overall Study|Adverse Event|0|||
94207163|NCT01034306|322553161|FG000|Overall Study|Lost to Follow-up|0|||
94207164|NCT01034306|322553162|FG001|Overall Study|Lost to Follow-up|1|||
94207165|NCT01034306|322553161|FG000|Overall Study|Withdrawal by Subject|2|||
94207166|NCT01034306|322553162|FG001|Overall Study|Withdrawal by Subject|2|||
94207167|NCT01034306|322553161|FG000|Overall Study|hospitalized and decided to stop|1|||
94207168|NCT01034306|322553162|FG001|Overall Study|hospitalized and decided to stop|0|||
94207169|NCT01034306|322553161|FG000|Overall Study|Noncomplience|1|||
94207170|NCT01034306|322553162|FG001|Overall Study|Noncomplience|0|||
94207171|NCT01728324|322553163|FG000|Termination of DBV|Adverse Event|14|||
94207172|NCT01728324|322553164|FG001|Termination of DBV|Adverse Event|13|||
94207173|NCT01728324|322553165|FG002|Termination of DBV|Adverse Event|4|||
94207174|NCT01728324|322553163|FG000|Termination of DBV|Lack of Efficacy|14|||
94207175|NCT01728324|322553164|FG001|Termination of DBV|Lack of Efficacy|12|||
94207176|NCT01728324|322553165|FG002|Termination of DBV|Lack of Efficacy|8|||
94207177|NCT01728324|322553163|FG000|Termination of DBV|Withdrawal by Subject|9|||
94207178|NCT01728324|322553164|FG001|Termination of DBV|Withdrawal by Subject|6|||
94207179|NCT01728324|322553165|FG002|Termination of DBV|Withdrawal by Subject|2|||
94207180|NCT01728324|322553163|FG000|Termination of DBV|Other than stated|1|||
94207181|NCT01728324|322553164|FG001|Termination of DBV|Other than stated|3|||
94207182|NCT01728324|322553165|FG002|Termination of DBV|Other than stated|0|||
94207183|NCT01728324|322553163|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
94207184|NCT01728324|322553164|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
94207185|NCT01728324|322553165|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
94207186|NCT01728324|322553163|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
94207187|NCT01728324|322553164|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
94207188|NCT01728324|322553165|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
94207189|NCT01728324|322553163|FG000|Termination of FDV|Adverse Event|14|||
94207190|NCT01728324|322553164|FG001|Termination of FDV|Adverse Event|13|||
94207191|NCT01728324|322553165|FG002|Termination of FDV|Adverse Event|4|||
94207192|NCT01728324|322553163|FG000|Termination of FDV|Lack of Efficacy|14|||
94207193|NCT01728324|322553164|FG001|Termination of FDV|Lack of Efficacy|12|||
94371914|NCT03989115|323148450|FG003|Overall Study|Withdrawal by Subject|0|||
94371915|NCT03989115|323148451|FG004|Overall Study|Withdrawal by Subject|17|||
94371916|NCT03989115|323148452|FG005|Overall Study|Withdrawal by Subject|1|||
94371917|NCT03989115|323148453|FG006|Overall Study|Withdrawal by Subject|0|||
94371918|NCT03989115|323148454|FG007|Overall Study|Withdrawal by Subject|0|||
94371919|NCT03989115|323148447|FG000|Overall Study|Sponsor decision to terminate the study|1|||
94371920|NCT03989115|323148448|FG001|Overall Study|Sponsor decision to terminate the study|1|||
94371921|NCT03989115|323148449|FG002|Overall Study|Sponsor decision to terminate the study|0|||
94371922|NCT03989115|323148450|FG003|Overall Study|Sponsor decision to terminate the study|1|||
94371923|NCT03989115|323148451|FG004|Overall Study|Sponsor decision to terminate the study|11|||
94371924|NCT03989115|323148452|FG005|Overall Study|Sponsor decision to terminate the study|0|||
94371925|NCT03989115|323148453|FG006|Overall Study|Sponsor decision to terminate the study|2|||
94371926|NCT03989115|323148454|FG007|Overall Study|Sponsor decision to terminate the study|1|||
94371927|NCT03989115|323148447|FG000|Overall Study|Lost to Follow-up|2|||
94371928|NCT03989115|323148448|FG001|Overall Study|Lost to Follow-up|0|||
94371929|NCT03989115|323148449|FG002|Overall Study|Lost to Follow-up|0|||
94371930|NCT03989115|323148450|FG003|Overall Study|Lost to Follow-up|0|||
94371931|NCT03989115|323148451|FG004|Overall Study|Lost to Follow-up|1|||
94207194|NCT01728324|322553165|FG002|Termination of FDV|Lack of Efficacy|8|||
94207195|NCT01728324|322553163|FG000|Termination of FDV|Withdrawal by Subject|9|||
94207196|NCT01728324|322553164|FG001|Termination of FDV|Withdrawal by Subject|6|||
94371932|NCT03989115|323148452|FG005|Overall Study|Lost to Follow-up|0|||
94371933|NCT03989115|323148453|FG006|Overall Study|Lost to Follow-up|0|||
94371934|NCT03989115|323148454|FG007|Overall Study|Lost to Follow-up|0|||
94371935|NCT03989115|323148447|FG000|Overall Study|Death|2|||
94371936|NCT03989115|323148448|FG001|Overall Study|Death|2|||
94371937|NCT03989115|323148449|FG002|Overall Study|Death|9|||
94371938|NCT03989115|323148450|FG003|Overall Study|Death|6|||
94371939|NCT03989115|323148451|FG004|Overall Study|Death|31|||
94371940|NCT03989115|323148452|FG005|Overall Study|Death|6|||
94371941|NCT03989115|323148453|FG006|Overall Study|Death|2|||
94371942|NCT03989115|323148454|FG007|Overall Study|Death|3|||
94371943|NCT03989115|323148447|FG000|Overall Study|Other|1|||
94371944|NCT03989115|323148448|FG001|Overall Study|Other|2|||
94371945|NCT03989115|323148449|FG002|Overall Study|Other|0|||
94371946|NCT03989115|323148450|FG003|Overall Study|Other|0|||
94371947|NCT03989115|323148451|FG004|Overall Study|Other|5|||
94371948|NCT03989115|323148452|FG005|Overall Study|Other|0|||
94371949|NCT03989115|323148453|FG006|Overall Study|Other|0|||
94371950|NCT03989115|323148454|FG007|Overall Study|Other|0|||
94371951|NCT01706198|323148455|FG000|Overall Study|Adverse Event|12|||
94371952|NCT01706198|323148456|FG001|Overall Study|Adverse Event|15|||
94371953|NCT01706198|323148455|FG000|Overall Study|Protocol Violation|7|||
94371954|NCT01706198|323148456|FG001|Overall Study|Protocol Violation|5|||
94371955|NCT01706198|323148455|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
94371956|NCT01706198|323148456|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
94371957|NCT01706198|323148455|FG000|Overall Study|Lost to Follow-up|97|||
94371958|NCT01706198|323148456|FG001|Overall Study|Lost to Follow-up|93|||
94371959|NCT01706198|323148455|FG000|Overall Study|Physician Decision|23|||
94371960|NCT01706198|323148456|FG001|Overall Study|Physician Decision|37|||
94207197|NCT01728324|322553165|FG002|Termination of FDV|Withdrawal by Subject|2|||
94207198|NCT01728324|322553163|FG000|Termination of FDV|Other than stated|1|||
94207199|NCT01728324|322553164|FG001|Termination of FDV|Other than stated|3|||
94207200|NCT01728324|322553165|FG002|Termination of FDV|Other than stated|0|||
94207201|NCT01728324|322553163|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
94207202|NCT01728324|322553164|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
94207203|NCT01728324|322553165|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
94207204|NCT01728324|322553163|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
94207205|NCT01728324|322553164|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
94207206|NCT01728324|322553165|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
94207207|NCT01728324|322553163|FG000|Termination of RBV|Adverse Event|15|||
94207208|NCT01728324|322553164|FG001|Termination of RBV|Adverse Event|16|||
94207209|NCT01728324|322553165|FG002|Termination of RBV|Adverse Event|5|||
94207210|NCT01728324|322553163|FG000|Termination of RBV|Lack of Efficacy|14|||
94207211|NCT01728324|322553164|FG001|Termination of RBV|Lack of Efficacy|11|||
94371961|NCT01706198|323148455|FG000|Overall Study|Withdrawal by Subject|23|||
94371962|NCT01706198|323148456|FG001|Overall Study|Withdrawal by Subject|31|||
94371963|NCT00910858|323148457|FG000|Pharmacokinetic Phase|Adverse Event|1|||
94371964|NCT00910858|323148458|FG001|Pharmacokinetic Phase|Adverse Event|0|||
94371965|NCT00910858|323148459|FG002|Pharmacokinetic Phase|Adverse Event|0|||
94371966|NCT00910858|323148457|FG000|Monotherapy Phase|Adverse Event|3|||
94371967|NCT00910858|323148458|FG001|Monotherapy Phase|Adverse Event|2|||
94371968|NCT00910858|323148459|FG002|Monotherapy Phase|Adverse Event|0|||
94371969|NCT00910858|323148457|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
94371970|NCT00910858|323148458|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
94371971|NCT00910858|323148459|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
94371972|NCT00910858|323148457|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
94207212|NCT01728324|322553165|FG002|Termination of RBV|Lack of Efficacy|7|||
94281497|NCT00866307|322819478|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
94281498|NCT00866307|322819479|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
94281499|NCT03074474|322819484|FG000|Overall Study|Lost to Follow-up|10|||
94281500|NCT03074474|322819484|FG000|Overall Study|Withdrawal by Subject|10|||
94281501|NCT03074474|322819484|FG000|Overall Study|Death|4|||
94281502|NCT03074474|322819484|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
94281503|NCT01627899|322819492|FG000|Overall Study|Study terminated early by sponsor.|5|||
94281504|NCT01358864|322819493|FG000|Overall Study|Adverse Event|0|||
94281505|NCT01358864|322819494|FG001|Overall Study|Adverse Event|6|||
94281506|NCT01358864|322819495|FG002|Overall Study|Adverse Event|9|||
94281507|NCT01358864|322819496|FG003|Overall Study|Adverse Event|0|||
94281508|NCT01358864|322819497|FG004|Overall Study|Adverse Event|4|||
94281509|NCT01358864|322819498|FG005|Overall Study|Adverse Event|8|||
94281510|NCT01358864|322819499|FG006|Overall Study|Adverse Event|12|||
94281511|NCT01358864|322819500|FG007|Overall Study|Adverse Event|7|||
94281512|NCT01358864|322819493|FG000|Overall Study|Lack of Efficacy|26|||
94281513|NCT01358864|322819494|FG001|Overall Study|Lack of Efficacy|3|||
94281514|NCT01358864|322819495|FG002|Overall Study|Lack of Efficacy|4|||
94281515|NCT01358864|322819496|FG003|Overall Study|Lack of Efficacy|19|||
94281516|NCT01358864|322819497|FG004|Overall Study|Lack of Efficacy|7|||
94281517|NCT01358864|322819498|FG005|Overall Study|Lack of Efficacy|4|||
94281518|NCT01358864|322819499|FG006|Overall Study|Lack of Efficacy|49|||
94281519|NCT01358864|322819500|FG007|Overall Study|Lack of Efficacy|44|||
94281520|NCT01358864|322819493|FG000|Overall Study|Lost to Follow-up|0|||
94281521|NCT01358864|322819494|FG001|Overall Study|Lost to Follow-up|0|||
94281522|NCT01358864|322819495|FG002|Overall Study|Lost to Follow-up|1|||
94281523|NCT01358864|322819496|FG003|Overall Study|Lost to Follow-up|0|||
94281524|NCT01358864|322819497|FG004|Overall Study|Lost to Follow-up|0|||
94281525|NCT01358864|322819498|FG005|Overall Study|Lost to Follow-up|0|||
94281526|NCT01358864|322819499|FG006|Overall Study|Lost to Follow-up|0|||
94281527|NCT01358864|322819500|FG007|Overall Study|Lost to Follow-up|1|||
94281528|NCT01358864|322819493|FG000|Overall Study|Withdrawal by Subject|3|||
94281529|NCT01358864|322819494|FG001|Overall Study|Withdrawal by Subject|4|||
94281530|NCT01358864|322819495|FG002|Overall Study|Withdrawal by Subject|2|||
94281531|NCT01358864|322819496|FG003|Overall Study|Withdrawal by Subject|0|||
94281532|NCT01358864|322819497|FG004|Overall Study|Withdrawal by Subject|0|||
94281533|NCT01358864|322819498|FG005|Overall Study|Withdrawal by Subject|1|||
94281534|NCT01358864|322819499|FG006|Overall Study|Withdrawal by Subject|1|||
94281535|NCT01358864|322819500|FG007|Overall Study|Withdrawal by Subject|3|||
94281536|NCT01358864|322819493|FG000|Overall Study|Other reason not defined above|2|||
94281537|NCT01358864|322819494|FG001|Overall Study|Other reason not defined above|0|||
94281538|NCT01358864|322819495|FG002|Overall Study|Other reason not defined above|0|||
94281539|NCT01358864|322819496|FG003|Overall Study|Other reason not defined above|0|||
94281540|NCT01358864|322819497|FG004|Overall Study|Other reason not defined above|0|||
94281541|NCT01358864|322819498|FG005|Overall Study|Other reason not defined above|0|||
94281542|NCT01358864|322819499|FG006|Overall Study|Other reason not defined above|2|||
94281543|NCT01358864|322819500|FG007|Overall Study|Other reason not defined above|0|||
94281544|NCT01358864|322819493|FG000|Overall Study|Not treated|0|||
94281545|NCT01358864|322819494|FG001|Overall Study|Not treated|0|||
94281546|NCT01358864|322819495|FG002|Overall Study|Not treated|0|||
94281547|NCT01358864|322819496|FG003|Overall Study|Not treated|0|||
94281548|NCT01358864|322819497|FG004|Overall Study|Not treated|0|||
94281549|NCT01358864|322819498|FG005|Overall Study|Not treated|0|||
94281550|NCT01358864|322819499|FG006|Overall Study|Not treated|1|||
94281551|NCT01358864|322819500|FG007|Overall Study|Not treated|0|||
94371973|NCT00910858|323148458|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
94371974|NCT00910858|323148459|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
94281552|NCT01250379|322819502|FG000|Overall Study|Death|141|||
94281553|NCT01250379|322819503|FG001|Overall Study|Death|148|||
94281554|NCT01250379|322819502|FG000|Overall Study|Withdrawal by Subject|32|||
94281555|NCT01250379|322819503|FG001|Overall Study|Withdrawal by Subject|20|||
94281556|NCT01250379|322819502|FG000|Overall Study|Physician Decision|11|||
94281557|NCT01250379|322819503|FG001|Overall Study|Physician Decision|3|||
94281558|NCT01250379|322819502|FG000|Overall Study|Protocol Violation|2|||
94281559|NCT01250379|322819503|FG001|Overall Study|Protocol Violation|8|||
94281560|NCT01250379|322819502|FG000|Overall Study|Lost to Follow-up|9|||
94207213|NCT01728324|322553163|FG000|Termination of RBV|Withdrawal by Subject|9|||
94207214|NCT01728324|322553164|FG001|Termination of RBV|Withdrawal by Subject|5|||
94207215|NCT01728324|322553165|FG002|Termination of RBV|Withdrawal by Subject|2|||
94207216|NCT01728324|322553163|FG000|Termination of RBV|Other than stated|1|||
94207217|NCT01728324|322553164|FG001|Termination of RBV|Other than stated|3|||
94207218|NCT01728324|322553165|FG002|Termination of RBV|Other than stated|1|||
94207219|NCT01728324|322553163|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
94207220|NCT01728324|322553164|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
94207221|NCT01728324|322553165|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
94207222|NCT01728324|322553163|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
94207223|NCT01728324|322553164|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
94207224|NCT01728324|322553165|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
94207225|NCT01968967|322553166|FG000|Treatment Period|Other|22|||
94467677|NCT01004432|323502373|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
94207226|NCT01968967|322553167|FG001|Treatment Period|Other|22|||
94207227|NCT01968967|322553168|FG002|Treatment Period|Other|0|||
94207228|NCT01968967|322553169|FG003|Treatment Period|Other|0|||
94207229|NCT01968967|322553170|FG004|Treatment Period|Other|0|||
94207230|NCT01968967|322553166|FG000|Treatment Period|Withdrawal by Subject|71|||
94207231|NCT01968967|322553167|FG001|Treatment Period|Withdrawal by Subject|61|||
94207232|NCT01968967|322553168|FG002|Treatment Period|Withdrawal by Subject|0|||
94207233|NCT01968967|322553169|FG003|Treatment Period|Withdrawal by Subject|0|||
94207234|NCT01968967|322553170|FG004|Treatment Period|Withdrawal by Subject|0|||
94207235|NCT01968967|322553166|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
94207236|NCT01968967|322553167|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
94207237|NCT01968967|322553168|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
94207238|NCT01968967|322553169|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
94207239|NCT01968967|322553170|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
94207240|NCT01968967|322553166|FG000|Treatment Period|Lost to Follow-up|26|||
94207241|NCT01968967|322553167|FG001|Treatment Period|Lost to Follow-up|31|||
94207242|NCT01968967|322553168|FG002|Treatment Period|Lost to Follow-up|0|||
94207243|NCT01968967|322553169|FG003|Treatment Period|Lost to Follow-up|0|||
94207244|NCT01968967|322553170|FG004|Treatment Period|Lost to Follow-up|0|||
94207245|NCT01968967|322553166|FG000|Treatment Period|Protocol Violation|1|||
94207246|NCT01968967|322553167|FG001|Treatment Period|Protocol Violation|2|||
94207247|NCT01968967|322553168|FG002|Treatment Period|Protocol Violation|0|||
94207248|NCT01968967|322553169|FG003|Treatment Period|Protocol Violation|0|||
94207249|NCT01968967|322553170|FG004|Treatment Period|Protocol Violation|0|||
94207250|NCT01968967|322553166|FG000|Treatment Period|Adverse Event|9|||
94207251|NCT01968967|322553167|FG001|Treatment Period|Adverse Event|8|||
94207252|NCT01968967|322553168|FG002|Treatment Period|Adverse Event|0|||
94207253|NCT01968967|322553169|FG003|Treatment Period|Adverse Event|0|||
94207254|NCT01968967|322553170|FG004|Treatment Period|Adverse Event|0|||
94207255|NCT01968967|322553166|FG000|Treatment Period|Death|9|||
94207256|NCT01968967|322553167|FG001|Treatment Period|Death|2|||
94207257|NCT01968967|322553168|FG002|Treatment Period|Death|0|||
94207258|NCT01968967|322553169|FG003|Treatment Period|Death|0|||
94207259|NCT01968967|322553170|FG004|Treatment Period|Death|0|||
94207260|NCT01968967|322553166|FG000|Treatment Period|Randomized Not Treated|6|||
94207261|NCT01968967|322553167|FG001|Treatment Period|Randomized Not Treated|5|||
94207262|NCT01968967|322553168|FG002|Treatment Period|Randomized Not Treated|0|||
94207263|NCT01968967|322553169|FG003|Treatment Period|Randomized Not Treated|0|||
94207264|NCT01968967|322553170|FG004|Treatment Period|Randomized Not Treated|0|||
94207265|NCT01968967|322553166|FG000|Extension Period|Withdrew Consent|0|||
94207266|NCT01968967|322553167|FG001|Extension Period|Withdrew Consent|0|||
94207267|NCT01968967|322553168|FG002|Extension Period|Withdrew Consent|2|||
94207268|NCT01968967|322553169|FG003|Extension Period|Withdrew Consent|0|||
94207269|NCT01968967|322553170|FG004|Extension Period|Withdrew Consent|5|||
94207270|NCT00388726|322553171|FG000|Overall Study|Adverse Event|50|||
94207271|NCT00388726|322553172|FG001|Overall Study|Adverse Event|24|||
94281561|NCT01250379|322819503|FG001|Overall Study|Lost to Follow-up|6|||
94281562|NCT01250379|322819502|FG000|Overall Study|Adverse Event|5|||
94281563|NCT01250379|322819503|FG001|Overall Study|Adverse Event|4|||
94281564|NCT01250379|322819502|FG000|Overall Study|Other|0|||
94281565|NCT01250379|322819503|FG001|Overall Study|Other|4|||
94281566|NCT01250379|322819502|FG000|Overall Study|Participant noncompliance|2|||
94281567|NCT01250379|322819503|FG001|Overall Study|Participant noncompliance|0|||
94281568|NCT02229552|322821327|FG000|Baseline|Withdrawal by Subject|6|||
94281569|NCT02229552|322821327|FG000|1-year Follow up|Withdrawal by Subject|7|||
94281570|NCT02229552|322821327|FG000|1-year Follow up|Lost to Follow-up|18|||
94281571|NCT02229552|322821327|FG000|2-Year Follow up|Withdrawal by Subject|9|||
94281572|NCT02229552|322821327|FG000|2-Year Follow up|Lost to Follow-up|17|||
94281573|NCT00706134|322821328|FG000|Overall Study|Adverse Event|8|||
94281574|NCT00706134|322821329|FG001|Overall Study|Adverse Event|7|||
94281575|NCT00706134|322821330|FG002|Overall Study|Adverse Event|2|||
94281576|NCT00706134|322821331|FG003|Overall Study|Adverse Event|3|||
94281577|NCT00706134|322821328|FG000|Overall Study|Lost to Follow-up|0|||
94281578|NCT00706134|322821329|FG001|Overall Study|Lost to Follow-up|1|||
94281579|NCT00706134|322821330|FG002|Overall Study|Lost to Follow-up|0|||
94281580|NCT00706134|322821331|FG003|Overall Study|Lost to Follow-up|0|||
94281581|NCT00706134|322821328|FG000|Overall Study|Protocol Violation|0|||
94281582|NCT00706134|322821329|FG001|Overall Study|Protocol Violation|6|||
94281583|NCT00706134|322821330|FG002|Overall Study|Protocol Violation|0|||
94281584|NCT00706134|322821331|FG003|Overall Study|Protocol Violation|3|||
94281585|NCT00706134|322821328|FG000|Overall Study|Withdrawal by Subject|1|||
94281586|NCT00706134|322821329|FG001|Overall Study|Withdrawal by Subject|2|||
94281587|NCT00706134|322821330|FG002|Overall Study|Withdrawal by Subject|1|||
94281588|NCT00706134|322821331|FG003|Overall Study|Withdrawal by Subject|0|||
94281589|NCT00706134|322821328|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
94281590|NCT00706134|322821329|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
94281591|NCT00706134|322821330|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
94281592|NCT00706134|322821331|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
94281593|NCT00706134|322821328|FG000|Overall Study|Did not meet study criteria|2|||
94281594|NCT00706134|322821329|FG001|Overall Study|Did not meet study criteria|0|||
94281595|NCT00706134|322821330|FG002|Overall Study|Did not meet study criteria|0|||
94281596|NCT00706134|322821331|FG003|Overall Study|Did not meet study criteria|0|||
94281597|NCT00879229|322821332|FG000|Overall Study|Study terminated by Sponsor|13|||
94281598|NCT00879229|322821333|FG001|Overall Study|Study terminated by Sponsor|12|||
94281599|NCT00879229|322821332|FG000|Overall Study|Death|4|||
94281600|NCT00879229|322821333|FG001|Overall Study|Death|2|||
94281601|NCT00879229|322821332|FG000|Overall Study|Adverse Event|2|||
94281602|NCT00879229|322821333|FG001|Overall Study|Adverse Event|0|||
94281603|NCT00879229|322821332|FG000|Overall Study|Withdrawal by Subject|1|||
94281604|NCT00879229|322821333|FG001|Overall Study|Withdrawal by Subject|0|||
94281605|NCT00879229|322821332|FG000|Overall Study|Clinical status did not improve|1|||
94207272|NCT00388726|322553171|FG000|Overall Study|Progressive Disease|336|||
94207273|NCT00388726|322553172|FG001|Overall Study|Progressive Disease|153|||
94207274|NCT00388726|322553171|FG000|Overall Study|Clinical Progression|61|||
94207275|NCT00388726|322553172|FG001|Overall Study|Clinical Progression|36|||
94207276|NCT00388726|322553171|FG000|Overall Study|Withdrawal by Subject|10|||
94207277|NCT00388726|322553172|FG001|Overall Study|Withdrawal by Subject|7|||
94207278|NCT00388726|322553171|FG000|Overall Study|Administrative|6|||
94207279|NCT00388726|322553172|FG001|Overall Study|Administrative|9|||
94207280|NCT00388726|322553171|FG000|Overall Study|Physician Decision|18|||
94281606|NCT00879229|322821333|FG001|Overall Study|Clinical status did not improve|0|||
94281607|NCT00879229|322821332|FG000|Overall Study|Other|1|||
94281608|NCT00879229|322821333|FG001|Overall Study|Other|0|||
94281609|NCT03354663|322821334|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
94281610|NCT03354663|322821334|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
94281611|NCT03354663|322821334|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
94281612|NCT03354663|322821334|FG000|Completed 30-day Visit|Missed Visit|1|||
94281613|NCT01659320|322821335|FG000|Overall Study|Withdrawal by Subject|2|||
94281614|NCT01659320|322821335|FG000|Overall Study|Physician Decision|1|||
94281615|NCT02792842|322821338|FG000|Overall Study|Adverse Event|4|||
94281616|NCT02792842|322821339|FG001|Overall Study|Adverse Event|2|||
94467678|NCT01004432|323502374|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
94207281|NCT00388726|322553172|FG001|Overall Study|Physician Decision|13|||
94207282|NCT00388726|322553171|FG000|Overall Study|Death|3|||
94281617|NCT02792842|322821340|FG002|Overall Study|Adverse Event|3|||
94281618|NCT02792842|322821338|FG000|Overall Study|Withdrawal by Subject|0|||
94281619|NCT02792842|322821339|FG001|Overall Study|Withdrawal by Subject|1|||
94281620|NCT02792842|322821340|FG002|Overall Study|Withdrawal by Subject|2|||
94281621|NCT02792842|322821338|FG000|Overall Study|Lost to Follow-up|0|||
94281622|NCT02792842|322821339|FG001|Overall Study|Lost to Follow-up|0|||
94281623|NCT02792842|322821340|FG002|Overall Study|Lost to Follow-up|1|||
94281624|NCT02792842|322821338|FG000|Overall Study|Schedule delay|0|||
94281625|NCT02792842|322821339|FG001|Overall Study|Schedule delay|1|||
94281626|NCT02792842|322821340|FG002|Overall Study|Schedule delay|1|||
94281627|NCT00424827|322821343|FG000|Overall Study|Adverse Event|1|||
94281628|NCT00414453|322821344|FG000|Overall Study|Abnormal lab work|16|||
94281629|NCT02559687|322821349|FG000|Overall Study|Death|112|||
94281630|NCT02559687|322821349|FG000|Overall Study|Sponsor Decision|5|||
94281631|NCT02559687|322821349|FG000|Overall Study|Withdrawal by Subject|4|||
94281632|NCT03245450|322821354|FG000|Overall Study|Radiological disease progression|3|||
94281633|NCT03245450|322821355|FG001|Overall Study|Radiological disease progression|3|||
94281634|NCT03245450|322821356|FG002|Overall Study|Radiological disease progression|2|||
94281635|NCT03245450|322821357|FG003|Overall Study|Radiological disease progression|2|||
94281636|NCT03245450|322821358|FG004|Overall Study|Radiological disease progression|7|||
94281637|NCT03245450|322821359|FG005|Overall Study|Radiological disease progression|6|||
94281638|NCT03245450|322821360|FG006|Overall Study|Radiological disease progression|6|||
94281639|NCT03245450|322821354|FG000|Overall Study|Clinical disease progression|0|||
94281640|NCT03245450|322821355|FG001|Overall Study|Clinical disease progression|0|||
94281641|NCT03245450|322821356|FG002|Overall Study|Clinical disease progression|1|||
94281642|NCT03245450|322821357|FG003|Overall Study|Clinical disease progression|0|||
94207283|NCT00388726|322553172|FG001|Overall Study|Death|2|||
94207284|NCT01953692|322553173|FG000|Overall Study|Adverse Event|5|||
94207285|NCT01953692|322553174|FG001|Overall Study|Adverse Event|2|||
94207286|NCT01953692|322553175|FG002|Overall Study|Adverse Event|4|||
94207287|NCT01953692|322553176|FG003|Overall Study|Adverse Event|2|||
94207288|NCT01953692|322553177|FG004|Overall Study|Adverse Event|1|||
94281643|NCT03245450|322821358|FG004|Overall Study|Clinical disease progression|0|||
94281644|NCT03245450|322821359|FG005|Overall Study|Clinical disease progression|2|||
94281645|NCT03245450|322821360|FG006|Overall Study|Clinical disease progression|0|||
94281646|NCT03245450|322821354|FG000|Overall Study|Other|0|||
94281647|NCT03245450|322821355|FG001|Overall Study|Other|0|||
94281648|NCT03245450|322821356|FG002|Overall Study|Other|0|||
94281649|NCT03245450|322821357|FG003|Overall Study|Other|1|||
94281650|NCT03245450|322821358|FG004|Overall Study|Other|1|||
94281651|NCT03245450|322821359|FG005|Overall Study|Other|1|||
94281652|NCT03245450|322821360|FG006|Overall Study|Other|1|||
94281653|NCT03245450|322821354|FG000|Overall Study|Withdrawal by Subject|0|||
94207289|NCT01953692|322553178|FG005|Overall Study|Adverse Event|2|||
94207290|NCT01953692|322553179|FG006|Overall Study|Adverse Event|0|||
94207291|NCT01953692|322553180|FG007|Overall Study|Adverse Event|0|||
94207292|NCT01953692|322553181|FG008|Overall Study|Adverse Event|0|||
94207293|NCT01953692|322553173|FG000|Overall Study|Clinical Progression|0|||
94207294|NCT01953692|322553174|FG001|Overall Study|Clinical Progression|15|||
94207295|NCT01953692|322553175|FG002|Overall Study|Clinical Progression|7|||
94207296|NCT01953692|322553176|FG003|Overall Study|Clinical Progression|5|||
94207297|NCT01953692|322553177|FG004|Overall Study|Clinical Progression|0|||
94207298|NCT01953692|322553178|FG005|Overall Study|Clinical Progression|7|||
94207299|NCT01953692|322553179|FG006|Overall Study|Clinical Progression|20|||
94281654|NCT03245450|322821355|FG001|Overall Study|Withdrawal by Subject|1|||
94281655|NCT03245450|322821356|FG002|Overall Study|Withdrawal by Subject|0|||
94281656|NCT03245450|322821357|FG003|Overall Study|Withdrawal by Subject|0|||
94281657|NCT03245450|322821358|FG004|Overall Study|Withdrawal by Subject|0|||
94281658|NCT03245450|322821359|FG005|Overall Study|Withdrawal by Subject|0|||
94281659|NCT03245450|322821360|FG006|Overall Study|Withdrawal by Subject|0|||
94281660|NCT03245450|322821354|FG000|Overall Study|Adverse Event|0|||
94281661|NCT03245450|322821355|FG001|Overall Study|Adverse Event|0|||
94281662|NCT03245450|322821356|FG002|Overall Study|Adverse Event|0|||
94281663|NCT03245450|322821357|FG003|Overall Study|Adverse Event|0|||
94281664|NCT03245450|322821358|FG004|Overall Study|Adverse Event|1|||
94281665|NCT03245450|322821359|FG005|Overall Study|Adverse Event|0|||
94281666|NCT03245450|322821360|FG006|Overall Study|Adverse Event|2|||
94207300|NCT01953692|322553180|FG007|Overall Study|Clinical Progression|3|||
94207301|NCT01953692|322553181|FG008|Overall Study|Clinical Progression|3|||
94207302|NCT01953692|322553173|FG000|Overall Study|Death|5|||
94281667|NCT00705939|322821362|FG000|Overall Study|Protocol Violation|0|||
94281668|NCT00705939|322821363|FG001|Overall Study|Protocol Violation|0|||
94281669|NCT00705939|322821364|FG002|Overall Study|Protocol Violation|1|||
94281670|NCT00705939|322821362|FG000|Overall Study|Withdrawal by Subject|0|||
94281671|NCT00705939|322821363|FG001|Overall Study|Withdrawal by Subject|1|||
94281672|NCT00705939|322821364|FG002|Overall Study|Withdrawal by Subject|3|||
94281673|NCT00705939|322821362|FG000|Overall Study|Physician Decision|0|||
94281674|NCT00705939|322821363|FG001|Overall Study|Physician Decision|1|||
94281675|NCT00705939|322821364|FG002|Overall Study|Physician Decision|0|||
94281676|NCT00193063|322821365|FG000|Overall Study|Lack of Efficacy|3|||
94281677|NCT00193063|322821365|FG000|Overall Study|Adverse Event|1|||
94281678|NCT01692301|322821366|FG000|Overall Study|Adverse Event|15|||
94281679|NCT01692301|322821367|FG001|Overall Study|Adverse Event|12|||
94281680|NCT01692301|322821366|FG000|Overall Study|Death|1|||
94281681|NCT01692301|322821367|FG001|Overall Study|Death|2|||
94207303|NCT01953692|322553174|FG001|Overall Study|Death|0|||
94207304|NCT01953692|322553175|FG002|Overall Study|Death|2|||
94207305|NCT01953692|322553176|FG003|Overall Study|Death|2|||
94207306|NCT01953692|322553177|FG004|Overall Study|Death|1|||
94207307|NCT01953692|322553178|FG005|Overall Study|Death|3|||
94281682|NCT01692301|322821366|FG000|Overall Study|Lack of Efficacy|0|||
94281683|NCT01692301|322821367|FG001|Overall Study|Lack of Efficacy|5|||
94281684|NCT01692301|322821366|FG000|Overall Study|Non-compliance with study treatment|1|||
94281685|NCT01692301|322821367|FG001|Overall Study|Non-compliance with study treatment|2|||
94281686|NCT01692301|322821366|FG000|Overall Study|Protocol deviation|9|||
94281687|NCT01692301|322821367|FG001|Overall Study|Protocol deviation|2|||
94281688|NCT01692301|322821366|FG000|Overall Study|Patient/guardian decision|16|||
94281689|NCT01692301|322821367|FG001|Overall Study|Patient/guardian decision|15|||
94281690|NCT01692301|322821366|FG000|Overall Study|Technical problems|0|||
94281691|NCT01692301|322821367|FG001|Overall Study|Technical problems|1|||
94281692|NCT01692301|322821366|FG000|Overall Study|Physician Decision|2|||
94281693|NCT01692301|322821367|FG001|Overall Study|Physician Decision|2|||
94281694|NCT01692301|322821366|FG000|Overall Study|Lost to Follow-up|1|||
94281695|NCT01692301|322821367|FG001|Overall Study|Lost to Follow-up|1|||
94281696|NCT02111993|322821368|FG000|Overall Study|Physician Decision|5|||
94281697|NCT02111993|322821369|FG001|Overall Study|Physician Decision|4|||
94281698|NCT03984305|322821370|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
94281699|NCT03984305|322821371|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
94281700|NCT03984305|322821370|FG000|Overall Study|Withdrawal by Subject|3|||
94281701|NCT03984305|322821371|FG001|Overall Study|Withdrawal by Subject|3|||
94281702|NCT03984305|322821370|FG000|Overall Study|Lost to Follow-up|1|||
94281703|NCT03984305|322821371|FG001|Overall Study|Lost to Follow-up|0|||
94281704|NCT00293579|322821372|FG000|Overall Study|Withdrawal by Subject|1|||
94281705|NCT01097863|322821373|FG000|Overall Study|Discomfort|1|||
94281706|NCT01097863|322821374|FG001|Overall Study|Discomfort|0|||
94281707|NCT01097863|322821375|FG002|Overall Study|Discomfort|1|||
94281708|NCT01097863|322821373|FG000|Overall Study|Did not return for final visit|0|||
94281709|NCT01097863|322821374|FG001|Overall Study|Did not return for final visit|0|||
94281710|NCT01097863|322821375|FG002|Overall Study|Did not return for final visit|1|||
94281711|NCT03847610|322821376|FG000|Overall Study|Withdrawal by Subject|1|||
94281712|NCT01445769|322821378|FG000|Overall Study|Consent Withdrawn|2|||
94281713|NCT01445769|322821378|FG000|Overall Study|Disease Progression|1|||
94281714|NCT01445769|322821378|FG000|Overall Study|Lost to Follow-up|5|||
94281715|NCT01400451|322821392|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
94281716|NCT01400451|322821393|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
94281717|NCT01400451|322821394|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
94281718|NCT01400451|322821392|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
94281719|NCT01400451|322821393|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
94371975|NCT00910858|323148457|FG000|Monotherapy Phase|Protocol Violation|1|||
94207308|NCT01953692|322553179|FG006|Overall Study|Death|6|||
94207309|NCT01953692|322553180|FG007|Overall Study|Death|2|||
94207310|NCT01953692|322553181|FG008|Overall Study|Death|1|||
94371976|NCT00910858|323148458|FG001|Monotherapy Phase|Protocol Violation|0|||
94371977|NCT00910858|323148459|FG002|Monotherapy Phase|Protocol Violation|0|||
94371978|NCT00910858|323148457|FG000|Monotherapy Phase|Other|3|||
94207311|NCT01953692|322553173|FG000|Overall Study|Excluded Medication|1|||
94207312|NCT01953692|322553174|FG001|Overall Study|Excluded Medication|0|||
94207313|NCT01953692|322553175|FG002|Overall Study|Excluded Medication|0|||
94371979|NCT00910858|323148458|FG001|Monotherapy Phase|Other|4|||
94371980|NCT00910858|323148459|FG002|Monotherapy Phase|Other|2|||
94281720|NCT01400451|322821394|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
94281721|NCT01400451|322821392|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
94281722|NCT01400451|322821393|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
94281723|NCT01400451|322821394|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
94281724|NCT01400451|322821392|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
94281725|NCT01400451|322821393|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
94281726|NCT01400451|322821394|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
94281727|NCT01400451|322821392|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
94281728|NCT01400451|322821393|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
94281729|NCT01400451|322821394|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
94281730|NCT01627860|322821395|FG000|Overall Study|Adverse Event|9|||
94207314|NCT01953692|322553176|FG003|Overall Study|Excluded Medication|0|||
94207315|NCT01953692|322553177|FG004|Overall Study|Excluded Medication|0|||
94207316|NCT01953692|322553178|FG005|Overall Study|Excluded Medication|0|||
94207317|NCT01953692|322553179|FG006|Overall Study|Excluded Medication|0|||
94207318|NCT01953692|322553180|FG007|Overall Study|Excluded Medication|0|||
94207319|NCT01953692|322553181|FG008|Overall Study|Excluded Medication|0|||
94207320|NCT01953692|322553173|FG000|Overall Study|Lost to Follow-up|1|||
94207321|NCT01953692|322553174|FG001|Overall Study|Lost to Follow-up|0|||
94207322|NCT01953692|322553175|FG002|Overall Study|Lost to Follow-up|3|||
94207323|NCT01953692|322553176|FG003|Overall Study|Lost to Follow-up|1|||
94207324|NCT01953692|322553177|FG004|Overall Study|Lost to Follow-up|0|||
94207325|NCT01953692|322553178|FG005|Overall Study|Lost to Follow-up|1|||
94207326|NCT01953692|322553179|FG006|Overall Study|Lost to Follow-up|0|||
94207327|NCT01953692|322553180|FG007|Overall Study|Lost to Follow-up|0|||
94207328|NCT01953692|322553181|FG008|Overall Study|Lost to Follow-up|0|||
94207329|NCT01953692|322553173|FG000|Overall Study|Physician Decision|11|||
94207330|NCT01953692|322553174|FG001|Overall Study|Physician Decision|4|||
94207331|NCT01953692|322553175|FG002|Overall Study|Physician Decision|2|||
94207332|NCT01953692|322553176|FG003|Overall Study|Physician Decision|2|||
94207333|NCT01953692|322553177|FG004|Overall Study|Physician Decision|1|||
94207334|NCT01953692|322553178|FG005|Overall Study|Physician Decision|2|||
94207335|NCT01953692|322553179|FG006|Overall Study|Physician Decision|4|||
94207336|NCT01953692|322553180|FG007|Overall Study|Physician Decision|1|||
94207337|NCT01953692|322553181|FG008|Overall Study|Physician Decision|0|||
94207338|NCT01953692|322553173|FG000|Overall Study|Protocol Violation|0|||
94207339|NCT01953692|322553174|FG001|Overall Study|Protocol Violation|2|||
94207340|NCT01953692|322553175|FG002|Overall Study|Protocol Violation|1|||
94207341|NCT01953692|322553176|FG003|Overall Study|Protocol Violation|0|||
94207342|NCT01953692|322553177|FG004|Overall Study|Protocol Violation|0|||
94207343|NCT01953692|322553178|FG005|Overall Study|Protocol Violation|0|||
94207344|NCT01953692|322553179|FG006|Overall Study|Protocol Violation|0|||
94281731|NCT01627860|322821396|FG001|Overall Study|Adverse Event|4|||
94281732|NCT01627860|322821395|FG000|Overall Study|Withdrawal by Subject|2|||
94281733|NCT01627860|322821396|FG001|Overall Study|Withdrawal by Subject|1|||
94281734|NCT01627860|322821395|FG000|Overall Study|Seizure frequency doubled|0|||
94281735|NCT01627860|322821396|FG001|Overall Study|Seizure frequency doubled|1|||
94281736|NCT01627860|322821395|FG000|Overall Study|Protocol Violation|1|||
94281737|NCT01627860|322821396|FG001|Overall Study|Protocol Violation|0|||
94281738|NCT03652662|322821399|FG000|Overall Study|Withdrawal by Subject|2|||
94281739|NCT03652662|322821400|FG001|Overall Study|Withdrawal by Subject|1|||
94281740|NCT03652662|322821399|FG000|Overall Study|Lost to Follow-up|1|||
94281741|NCT03652662|322821400|FG001|Overall Study|Lost to Follow-up|0|||
94281742|NCT00487539|322821401|FG000|Overall Study|Adverse Event|3|||
94281743|NCT00487539|322821402|FG001|Overall Study|Adverse Event|2|||
94281744|NCT00487539|322821403|FG002|Overall Study|Adverse Event|1|||
94281745|NCT00487539|322821404|FG003|Overall Study|Adverse Event|1|||
94281746|NCT00487539|322821401|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94281747|NCT00487539|322821402|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94281748|NCT00487539|322821403|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
94281749|NCT00487539|322821404|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
94281750|NCT00487539|322821401|FG000|Overall Study|Other|3|||
94281751|NCT00487539|322821402|FG001|Overall Study|Other|1|||
94281752|NCT00487539|322821403|FG002|Overall Study|Other|2|||
94281753|NCT00487539|322821404|FG003|Overall Study|Other|2|||
94281754|NCT04327388|322821405|FG000|Overall Study|Adverse Event|17|||
94281755|NCT04327388|322821406|FG001|Overall Study|Adverse Event|18|||
94281756|NCT04327388|322821407|FG002|Overall Study|Adverse Event|9|||
94281757|NCT04327388|322821405|FG000|Overall Study|Other|1|||
94281758|NCT04327388|322821406|FG001|Overall Study|Other|2|||
94281759|NCT04327388|322821407|FG002|Overall Study|Other|0|||
94281760|NCT04327388|322821405|FG000|Overall Study|Randomized and not treated|2|||
94281761|NCT04327388|322821406|FG001|Overall Study|Randomized and not treated|0|||
94281762|NCT04327388|322821407|FG002|Overall Study|Randomized and not treated|2|||
94467679|NCT01004432|323502375|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
94467680|NCT01004432|323502376|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
94207345|NCT01953692|322553180|FG007|Overall Study|Protocol Violation|1|||
94207346|NCT01953692|322553181|FG008|Overall Study|Protocol Violation|0|||
94207347|NCT01953692|322553173|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
94207348|NCT01953692|322553174|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
94281763|NCT01110200|322821408|FG000|Overall Study|Adverse Event|28|||
94281764|NCT01110200|322821409|FG001|Overall Study|Adverse Event|28|||
94281765|NCT01110200|322821408|FG000|Overall Study|Withdrawal by Subject|25|||
94281766|NCT01110200|322821409|FG001|Overall Study|Withdrawal by Subject|32|||
94281767|NCT01110200|322821408|FG000|Overall Study|Lack of Efficacy|16|||
94281768|NCT01110200|322821409|FG001|Overall Study|Lack of Efficacy|25|||
94281769|NCT01110200|322821408|FG000|Overall Study|Protocol Violation|14|||
94281770|NCT01110200|322821409|FG001|Overall Study|Protocol Violation|12|||
94207349|NCT01953692|322553175|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
94207350|NCT01953692|322553176|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
94281771|NCT01110200|322821408|FG000|Overall Study|Physician Decision|13|||
94207351|NCT01953692|322553177|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
94281772|NCT01110200|322821409|FG001|Overall Study|Physician Decision|17|||
94281773|NCT01110200|322821408|FG000|Overall Study|Lost to Follow-up|10|||
94281774|NCT01110200|322821409|FG001|Overall Study|Lost to Follow-up|7|||
94281775|NCT00903175|322821410|FG000|Period 1 - First Line|Adverse Event|36|||
94281776|NCT00903175|322821411|FG001|Period 1 - First Line|Adverse Event|50|||
94281777|NCT00903175|322821410|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
94281778|NCT00903175|322821411|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
94281779|NCT00903175|322821410|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
94281780|NCT00903175|322821411|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
94281781|NCT00903175|322821410|FG000|Period 1 - First Line|Protocol Violation|3|||
94281782|NCT00903175|322821411|FG001|Period 1 - First Line|Protocol Violation|3|||
94281783|NCT00903175|322821410|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
94281784|NCT00903175|322821411|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
94281785|NCT00903175|322821410|FG000|Period 1 - First Line|Administrative problems|12|||
94281786|NCT00903175|322821411|FG001|Period 1 - First Line|Administrative problems|13|||
94281787|NCT00903175|322821410|FG000|Period 1 - First Line|Death|17|||
94281788|NCT00903175|322821411|FG001|Period 1 - First Line|Death|10|||
94281789|NCT00903175|322821410|FG000|Period 2 - Second Line|Missing|1|||
94281790|NCT00903175|322821411|FG001|Period 2 - Second Line|Missing|0|||
94281791|NCT00903175|322821410|FG000|Period 2 - Second Line|Adverse Event|16|||
94281792|NCT00903175|322821411|FG001|Period 2 - Second Line|Adverse Event|20|||
94281793|NCT00903175|322821410|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
94281794|NCT00903175|322821411|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
94281795|NCT00903175|322821410|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
94281796|NCT00903175|322821411|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
94371981|NCT00910858|323148457|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
94371982|NCT00910858|323148458|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
94371983|NCT00910858|323148459|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
94371984|NCT00910858|323148457|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
94281797|NCT00903175|322821410|FG000|Period 2 - Second Line|Administrative problems|19|||
94281798|NCT00903175|322821411|FG001|Period 2 - Second Line|Administrative problems|9|||
94281799|NCT00903175|322821410|FG000|Period 2 - Second Line|Death|5|||
94281800|NCT00903175|322821411|FG001|Period 2 - Second Line|Death|2|||
94281801|NCT02286947|322821412|FG000|Overall Study|Withdrawal by Subject|2|||
94371985|NCT00910858|323148458|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
94371986|NCT00910858|323148459|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
94281802|NCT01687712|322821413|FG000|Cycle 1|Not Biochemically Pregnant|386|||
94281803|NCT01687712|322821414|FG001|Cycle 1|Not Biochemically Pregnant|348|||
94281804|NCT01687712|322821413|FG000|Cycle 1|Early Pregnancy Loss|43|||
94281805|NCT01687712|322821414|FG001|Cycle 1|Early Pregnancy Loss|60|||
94281806|NCT01687712|322821413|FG000|Cycle 1|Ectopic Pregnancy|5|||
94281807|NCT01687712|322821414|FG001|Cycle 1|Ectopic Pregnancy|5|||
94281808|NCT01687712|322821413|FG000|Cycle 1|Heterotropic Pregnancy|1|||
94281809|NCT01687712|322821414|FG001|Cycle 1|Heterotropic Pregnancy|0|||
94281810|NCT01687712|322821413|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
94281811|NCT01687712|322821414|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
94281812|NCT01687712|322821413|FG000|Cycle 1|Abortion|3|||
94281813|NCT01687712|322821414|FG001|Cycle 1|Abortion|0|||
94281814|NCT01687712|322821413|FG000|Cycle 1|Intrauterine Fetal Death|0|||
94281815|NCT01687712|322821414|FG001|Cycle 1|Intrauterine Fetal Death|1|||
94281816|NCT01687712|322821413|FG000|Cycle 1|Lost to Follow-up|1|||
94281817|NCT01687712|322821414|FG001|Cycle 1|Lost to Follow-up|1|||
94281818|NCT01687712|322821413|FG000|Cycle 2|Not Biochemically Pregnant|74|||
94281819|NCT01687712|322821414|FG001|Cycle 2|Not Biochemically Pregnant|77|||
94281820|NCT01687712|322821413|FG000|Cycle 2|Early Pregnancy Loss|18|||
94281821|NCT01687712|322821414|FG001|Cycle 2|Early Pregnancy Loss|16|||
94281822|NCT01687712|322821413|FG000|Cycle 2|Ectopic Pregnancy|0|||
94281823|NCT01687712|322821414|FG001|Cycle 2|Ectopic Pregnancy|1|||
94281824|NCT01687712|322821413|FG000|Cycle 2|Still Birth|1|||
94281825|NCT01687712|322821414|FG001|Cycle 2|Still Birth|0|||
94281826|NCT01687712|322821413|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
94281827|NCT01687712|322821414|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
94281828|NCT01687712|322821413|FG000|Cycle 3|Not Biochemically Pregnant|21|||
94281829|NCT01687712|322821414|FG001|Cycle 3|Not Biochemically Pregnant|22|||
94281830|NCT01687712|322821413|FG000|Cycle 3|Early Pregnancy Loss|1|||
94281831|NCT01687712|322821414|FG001|Cycle 3|Early Pregnancy Loss|2|||
94281832|NCT01687712|322821413|FG000|Cycle 3|Ectopic Pregnancy|1|||
94281833|NCT01687712|322821414|FG001|Cycle 3|Ectopic Pregnancy|0|||
94281834|NCT01687712|322821413|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
94281835|NCT01687712|322821414|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
94207352|NCT01953692|322553178|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
94207353|NCT01953692|322553179|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
94207354|NCT01953692|322553180|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
94207355|NCT01953692|322553181|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
94207356|NCT01953692|322553173|FG000|Overall Study|Withdrawal by Subject|4|||
94207357|NCT01953692|322553174|FG001|Overall Study|Withdrawal by Subject|2|||
94207358|NCT01953692|322553175|FG002|Overall Study|Withdrawal by Subject|1|||
94207359|NCT01953692|322553176|FG003|Overall Study|Withdrawal by Subject|2|||
94207360|NCT01953692|322553177|FG004|Overall Study|Withdrawal by Subject|0|||
94207361|NCT01953692|322553178|FG005|Overall Study|Withdrawal by Subject|3|||
94207362|NCT01953692|322553179|FG006|Overall Study|Withdrawal by Subject|2|||
94207363|NCT01953692|322553180|FG007|Overall Study|Withdrawal by Subject|1|||
94207364|NCT01953692|322553181|FG008|Overall Study|Withdrawal by Subject|1|||
94281836|NCT03979274|322821417|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94281837|NCT03979274|322821418|FG001|Treatment Period 2|Withdrawal by Subject|1|||
94281838|NCT02573155|322821419|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
94281839|NCT02573155|322821420|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
94281840|NCT02573155|322821419|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
94281841|NCT02573155|322821420|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
94281842|NCT02573155|322821419|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
94281843|NCT02573155|322821420|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
94281844|NCT02573155|322821419|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
94281845|NCT02573155|322821420|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
94281846|NCT02573155|322821419|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
94207365|NCT04638816|322553182|FG000|Overall Study|Withdrawal by Subject|0|||
94207366|NCT04638816|322553183|FG001|Overall Study|Withdrawal by Subject|1|||
94207367|NCT04638816|322553182|FG000|Overall Study|Lost to Follow-up|0|||
94207368|NCT04638816|322553183|FG001|Overall Study|Lost to Follow-up|1|||
94207369|NCT02251652|322553187|FG000|Overall Study|Withdrawal by Subject|1|||
94281847|NCT02573155|322821420|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
94281848|NCT02573155|322821419|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
94281849|NCT02573155|322821420|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
94281850|NCT02573155|322821419|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
94281851|NCT02573155|322821420|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
94281852|NCT02573155|322821419|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
94281853|NCT02573155|322821420|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
94281854|NCT01681433|322821421|FG000|Overall Study|Lack of Efficacy|23|||
94281855|NCT01681433|322821422|FG001|Overall Study|Lack of Efficacy|23|||
94281856|NCT01681433|322821421|FG000|Overall Study|Withdrawal by Subject|5|||
94281857|NCT01681433|322821422|FG001|Overall Study|Withdrawal by Subject|5|||
94281858|NCT01681433|322821421|FG000|Overall Study|Protocol Violation|2|||
94281859|NCT01681433|322821422|FG001|Overall Study|Protocol Violation|0|||
94281860|NCT01681433|322821421|FG000|Overall Study|Adverse Event|2|||
94281861|NCT01681433|322821422|FG001|Overall Study|Adverse Event|4|||
94281862|NCT01681433|322821421|FG000|Overall Study|Lost to Follow-up|0|||
94281863|NCT01681433|322821422|FG001|Overall Study|Lost to Follow-up|1|||
94281864|NCT02301403|322821423|FG000|Overall Study|Withdrawal by Subject|28|||
94281865|NCT02301403|322821424|FG001|Overall Study|Withdrawal by Subject|41|||
94281866|NCT00730639|322821425|FG000|Overall Study|Adverse Event|3|||
94281867|NCT00730639|322821426|FG001|Overall Study|Adverse Event|0|||
94281868|NCT00730639|322821427|FG002|Overall Study|Adverse Event|9|||
94281869|NCT00730639|322821428|FG003|Overall Study|Adverse Event|8|||
94281870|NCT00730639|322821429|FG004|Overall Study|Adverse Event|23|||
94281871|NCT00730639|322821425|FG000|Overall Study|Complete Response|0|||
94281872|NCT00730639|322821426|FG001|Overall Study|Complete Response|0|||
94281873|NCT00730639|322821427|FG002|Overall Study|Complete Response|2|||
94207370|NCT02275611|322553188|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
94207371|NCT02275611|322553189|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
94207372|NCT02275611|322553190|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
94207373|NCT02275611|322553191|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
94207374|NCT02406092|322553192|FG000|Overall Study|Screen failure|10|||
94207375|NCT02406092|322553193|FG001|Overall Study|Screen failure|7|||
94207376|NCT02406092|322553192|FG000|Overall Study|Death|22|||
94207377|NCT02406092|322553193|FG001|Overall Study|Death|5|||
94207378|NCT02406092|322553192|FG000|Overall Study|Lost to Follow-up|4|||
94207379|NCT02406092|322553193|FG001|Overall Study|Lost to Follow-up|1|||
94207380|NCT02406092|322553192|FG000|Overall Study|Adverse Event|1|||
94207381|NCT02406092|322553193|FG001|Overall Study|Adverse Event|0|||
94207382|NCT02406092|322553192|FG000|Overall Study|Withdrawal by Subject|1|||
94207383|NCT02406092|322553193|FG001|Overall Study|Withdrawal by Subject|0|||
94207384|NCT02646618|322553196|FG000|Overall Study|Lost to Follow-up|10|||
94207385|NCT02646618|322553197|FG001|Overall Study|Lost to Follow-up|14|||
94207386|NCT00390884|322553202|FG000|Overall Study|Withdrawal by Subject|2|||
94207387|NCT00390884|322553203|FG001|Overall Study|Withdrawal by Subject|2|||
94207388|NCT02816398|322553204|FG000|Overall Study|Death|5|||
94207389|NCT02816398|322553204|FG000|Overall Study|Lack of Efficacy|8|||
94207390|NCT02816398|322553204|FG000|Overall Study|Lost to Follow-up|1|||
94207391|NCT02130557|322553207|FG000|Overall Study|Withdrawal by Subject|12|||
94207392|NCT02130557|322553208|FG001|Overall Study|Withdrawal by Subject|12|||
94207393|NCT02130557|322553207|FG000|Overall Study|Investigator Request|0|||
94207394|NCT02130557|322553208|FG001|Overall Study|Investigator Request|2|||
94207395|NCT02130557|322553207|FG000|Overall Study|Deceased|14|||
94207396|NCT02130557|322553208|FG001|Overall Study|Deceased|14|||
94207397|NCT02130557|322553207|FG000|Overall Study|Lost to Follow-up|6|||
94207398|NCT02130557|322553208|FG001|Overall Study|Lost to Follow-up|7|||
94207399|NCT02130557|322553207|FG000|Overall Study|Other|2|||
94207400|NCT02130557|322553208|FG001|Overall Study|Other|1|||
94207401|NCT02130557|322553207|FG000|Overall Study|Missing|2|||
94207402|NCT02130557|322553208|FG001|Overall Study|Missing|1|||
94207403|NCT01532999|322553209|FG000|Overall Study|Lost to Follow-up|14|||
94207404|NCT01532999|322553210|FG001|Overall Study|Lost to Follow-up|8|||
94207405|NCT01532999|322553209|FG000|Overall Study|Physician Decision|1|||
94207406|NCT01532999|322553210|FG001|Overall Study|Physician Decision|2|||
94207407|NCT01532999|322553209|FG000|Overall Study|Withdrawal by Subject|5|||
94207408|NCT01532999|322553210|FG001|Overall Study|Withdrawal by Subject|0|||
94207409|NCT01532999|322553209|FG000|Overall Study|Relocated|2|||
94207410|NCT01532999|322553210|FG001|Overall Study|Relocated|0|||
94207411|NCT01532999|322553209|FG000|Overall Study|should not have been randomized|1|||
94207412|NCT01532999|322553210|FG001|Overall Study|should not have been randomized|0|||
94207413|NCT01532999|322553209|FG000|Overall Study|substantial noncompliance|2|||
94207414|NCT01532999|322553210|FG001|Overall Study|substantial noncompliance|0|||
94207415|NCT01532999|322553209|FG000|Overall Study|no show for week 9 assessments|6|||
94207416|NCT01532999|322553210|FG001|Overall Study|no show for week 9 assessments|4|||
94207417|NCT01532999|322553209|FG000|Overall Study|Adverse Event|0|||
94207418|NCT01532999|322553210|FG001|Overall Study|Adverse Event|1|||
94207419|NCT01532999|322553209|FG000|Overall Study|incarcerated|0|||
94281874|NCT00730639|322821428|FG003|Overall Study|Complete Response|2|||
94207420|NCT01532999|322553210|FG001|Overall Study|incarcerated|1|||
94207421|NCT01532999|322553209|FG000|Overall Study|New job|0|||
94207422|NCT01532999|322553210|FG001|Overall Study|New job|2|||
94207423|NCT03539952|322553211|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
94207424|NCT03539952|322553212|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
94207425|NCT03539952|322553211|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
94207426|NCT03539952|322553212|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
94207427|NCT03539952|322553211|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
94207428|NCT03539952|322553212|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
94207429|NCT03539952|322553211|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
94207430|NCT03539952|322553212|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
94207431|NCT03539952|322553211|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
94207432|NCT03539952|322553212|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
94207433|NCT03539952|322553211|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
94207434|NCT03539952|322553212|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
94207435|NCT03539952|322553211|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
94207436|NCT03539952|322553212|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
94207437|NCT03333109|322553214|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
94207438|NCT03333109|322553215|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
94207439|NCT03333109|322553216|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
94207440|NCT03333109|322553214|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
94207441|NCT03333109|322553215|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
94207442|NCT03333109|322553216|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
94207443|NCT03333109|322553214|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
94281875|NCT00730639|322821429|FG004|Overall Study|Complete Response|1|||
94281876|NCT00730639|322821425|FG000|Overall Study|Completed Maximum Cycles|0|||
94281877|NCT00730639|322821426|FG001|Overall Study|Completed Maximum Cycles|0|||
94281878|NCT00730639|322821427|FG002|Overall Study|Completed Maximum Cycles|11|||
94281879|NCT00730639|322821428|FG003|Overall Study|Completed Maximum Cycles|3|||
94281880|NCT00730639|322821429|FG004|Overall Study|Completed Maximum Cycles|6|||
94281881|NCT00730639|322821425|FG000|Overall Study|Death|0|||
94281882|NCT00730639|322821426|FG001|Overall Study|Death|0|||
94281883|NCT00730639|322821427|FG002|Overall Study|Death|0|||
94281884|NCT00730639|322821428|FG003|Overall Study|Death|0|||
94281885|NCT00730639|322821429|FG004|Overall Study|Death|2|||
94281886|NCT00730639|322821425|FG000|Overall Study|Disease Progression|12|||
94281887|NCT00730639|322821426|FG001|Overall Study|Disease Progression|13|||
94281888|NCT00730639|322821427|FG002|Overall Study|Disease Progression|48|||
94281889|NCT00730639|322821428|FG003|Overall Study|Disease Progression|32|||
94281890|NCT00730639|322821429|FG004|Overall Study|Disease Progression|88|||
94281891|NCT00730639|322821425|FG000|Overall Study|non-specified|0|||
94281892|NCT00730639|322821426|FG001|Overall Study|non-specified|0|||
94281893|NCT00730639|322821427|FG002|Overall Study|non-specified|4|||
94281894|NCT00730639|322821428|FG003|Overall Study|non-specified|2|||
94281895|NCT00730639|322821429|FG004|Overall Study|non-specified|3|||
94281896|NCT00730639|322821425|FG000|Overall Study|Protocol Violation|0|||
94281897|NCT00730639|322821426|FG001|Overall Study|Protocol Violation|0|||
94281898|NCT00730639|322821427|FG002|Overall Study|Protocol Violation|1|||
94281899|NCT00730639|322821428|FG003|Overall Study|Protocol Violation|0|||
94281900|NCT00730639|322821429|FG004|Overall Study|Protocol Violation|0|||
94281901|NCT00730639|322821425|FG000|Overall Study|Withdrawal by Subject|0|||
94281902|NCT00730639|322821426|FG001|Overall Study|Withdrawal by Subject|0|||
94281903|NCT00730639|322821427|FG002|Overall Study|Withdrawal by Subject|6|||
94281904|NCT00730639|322821428|FG003|Overall Study|Withdrawal by Subject|3|||
94281905|NCT00730639|322821429|FG004|Overall Study|Withdrawal by Subject|4|||
94281906|NCT00730639|322821425|FG000|Overall Study|Treatment on-going|2|||
94281907|NCT00730639|322821426|FG001|Overall Study|Treatment on-going|5|||
94281908|NCT00730639|322821427|FG002|Overall Study|Treatment on-going|5|||
94281909|NCT00730639|322821428|FG003|Overall Study|Treatment on-going|4|||
94281910|NCT00730639|322821429|FG004|Overall Study|Treatment on-going|4|||
94281911|NCT01060059|322821430|FG000|Overall Study|Adverse Event|1|||
94281912|NCT01060059|322821431|FG001|Overall Study|Adverse Event|1|||
94281913|NCT01060059|322821430|FG000|Overall Study|Death|2|||
94281914|NCT01060059|322821431|FG001|Overall Study|Death|3|||
94281915|NCT01060059|322821430|FG000|Overall Study|Lost to Follow-up|18|||
94281916|NCT01060059|322821431|FG001|Overall Study|Lost to Follow-up|34|||
94467681|NCT01004432|323502377|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
94467682|NCT01004432|323502373|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
94281917|NCT01060059|322821430|FG000|Overall Study|entry criteria not met|4|||
94281918|NCT01060059|322821431|FG001|Overall Study|entry criteria not met|3|||
94281919|NCT01060059|322821430|FG000|Overall Study|Withdrawal by Subject|35|||
94467683|NCT01004432|323502374|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
94467684|NCT01004432|323502375|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
94207444|NCT03333109|322553215|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
94207445|NCT03333109|322553216|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
94207446|NCT03333109|322553214|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
94207447|NCT03333109|322553215|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
94207448|NCT03333109|322553216|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
94207449|NCT03333109|322553214|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
94207450|NCT03333109|322553215|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
94207451|NCT03333109|322553216|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
94207452|NCT03333109|322553214|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
94207453|NCT03333109|322553215|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
94207454|NCT03333109|322553216|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
94207455|NCT03333109|322553214|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
94207456|NCT03333109|322553215|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
94207457|NCT03333109|322553216|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
94207458|NCT03333109|322553214|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
94207459|NCT03333109|322553215|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
94207460|NCT03333109|322553216|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
94207461|NCT00918203|322553219|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
94207462|NCT00918203|322553220|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
94207463|NCT00918203|322553221|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
94207464|NCT00918203|322553219|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
94207465|NCT00918203|322553220|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
94207466|NCT00918203|322553221|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
94207467|NCT00918203|322553219|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
94207468|NCT00918203|322553220|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
94207469|NCT00918203|322553221|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
94207470|NCT00918203|322553219|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
94207471|NCT00918203|322553220|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
94207472|NCT00918203|322553221|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
94207473|NCT02208362|322553224|FG000|Overall Study|Participant did not complete treatment|0|||
94207474|NCT02208362|322553225|FG001|Overall Study|Participant did not complete treatment|1|||
94207475|NCT02208362|322553226|FG002|Overall Study|Participant did not complete treatment|0|||
94207476|NCT02208362|322553227|FG003|Overall Study|Participant did not complete treatment|0|||
94207477|NCT02208362|322553228|FG004|Overall Study|Participant did not complete treatment|0|||
94207478|NCT02208362|322553229|FG005|Overall Study|Participant did not complete treatment|0|||
94207479|NCT02208362|322553230|FG006|Overall Study|Participant did not complete treatment|1|||
94207480|NCT02208362|322553231|FG007|Overall Study|Participant did not complete treatment|1|||
94207481|NCT02208362|322553232|FG008|Overall Study|Participant did not complete treatment|2|||
94207482|NCT02208362|322553233|FG009|Overall Study|Participant did not complete treatment|0|||
94207483|NCT02208362|322553234|FG010|Overall Study|Participant did not complete treatment|1|||
94207484|NCT02208362|322553235|FG011|Overall Study|Participant did not complete treatment|0|||
94207485|NCT02208362|322553224|FG000|Overall Study|Participant received disallowed treatment|0|||
94207486|NCT02208362|322553225|FG001|Overall Study|Participant received disallowed treatment|0|||
94207487|NCT02208362|322553226|FG002|Overall Study|Participant received disallowed treatment|0|||
94207488|NCT02208362|322553227|FG003|Overall Study|Participant received disallowed treatment|0|||
94207489|NCT02208362|322553228|FG004|Overall Study|Participant received disallowed treatment|0|||
94207490|NCT02208362|322553229|FG005|Overall Study|Participant received disallowed treatment|0|||
94207491|NCT02208362|322553230|FG006|Overall Study|Participant received disallowed treatment|0|||
94207492|NCT02208362|322553231|FG007|Overall Study|Participant received disallowed treatment|0|||
94207493|NCT02208362|322553232|FG008|Overall Study|Participant received disallowed treatment|1|||
94207494|NCT02208362|322553233|FG009|Overall Study|Participant received disallowed treatment|0|||
94207495|NCT02208362|322553234|FG010|Overall Study|Participant received disallowed treatment|0|||
94207496|NCT02208362|322553235|FG011|Overall Study|Participant received disallowed treatment|0|||
94207497|NCT01690624|322553238|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
94207498|NCT01690624|322553239|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
94207499|NCT01690624|322553240|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
94207500|NCT01690624|322553241|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
94207501|NCT01690624|322553238|FG000|Overall Study|Adverse event (other than DLT)|3|||
94207502|NCT01690624|322553239|FG001|Overall Study|Adverse event (other than DLT)|1|||
94207503|NCT01690624|322553240|FG002|Overall Study|Adverse event (other than DLT)|1|||
94207504|NCT01690624|322553241|FG003|Overall Study|Adverse event (other than DLT)|1|||
94207505|NCT01690624|322553238|FG000|Overall Study|Withdrawal by Subject|0|||
94207506|NCT01690624|322553239|FG001|Overall Study|Withdrawal by Subject|0|||
94371987|NCT00910858|323148457|FG000|Combined Treatment Phase|Protocol Violation|1|||
94371988|NCT00910858|323148458|FG001|Combined Treatment Phase|Protocol Violation|0|||
94371989|NCT00910858|323148459|FG002|Combined Treatment Phase|Protocol Violation|0|||
94207507|NCT01690624|322553240|FG002|Overall Study|Withdrawal by Subject|1|||
94207508|NCT01690624|322553241|FG003|Overall Study|Withdrawal by Subject|0|||
94207509|NCT01690624|322553238|FG000|Overall Study|Sponsor is ending trial|0|||
94207510|NCT01690624|322553239|FG001|Overall Study|Sponsor is ending trial|0|||
94207511|NCT01690624|322553240|FG002|Overall Study|Sponsor is ending trial|0|||
94207512|NCT01690624|322553241|FG003|Overall Study|Sponsor is ending trial|1|||
94207513|NCT01690624|322553238|FG000|Overall Study|Physician Decision|0|||
94207514|NCT01690624|322553239|FG001|Overall Study|Physician Decision|0|||
94207515|NCT01690624|322553240|FG002|Overall Study|Physician Decision|0|||
94207516|NCT01690624|322553241|FG003|Overall Study|Physician Decision|1|||
94207517|NCT01690624|322553238|FG000|Overall Study|Withdrawal by Subject|0|||
94207518|NCT01690624|322553239|FG001|Overall Study|Withdrawal by Subject|1|||
94207519|NCT01690624|322553240|FG002|Overall Study|Withdrawal by Subject|0|||
94207520|NCT01690624|322553241|FG003|Overall Study|Withdrawal by Subject|0|||
94207521|NCT01690624|322553238|FG000|Overall Study|Lack of Efficacy|1|||
94207522|NCT01690624|322553239|FG001|Overall Study|Lack of Efficacy|1|||
94207523|NCT01690624|322553240|FG002|Overall Study|Lack of Efficacy|3|||
94207524|NCT01690624|322553241|FG003|Overall Study|Lack of Efficacy|0|||
94207525|NCT03352713|322554920|FG000|Overall Study|Lost to Follow-up|8|||
94207526|NCT03352713|322554920|FG000|Overall Study|Withdrawn by investigator|5|||
94207527|NCT03352713|322554920|FG000|Overall Study|Completed 0 EMAs|8|||
94207528|NCT03352713|322554920|FG000|Overall Study|Device incompatible/stolen|5|||
94207529|NCT02722434|322554921|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
94207530|NCT02722434|322554922|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
94207531|NCT02722434|322554921|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
94207532|NCT02722434|322554922|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
94207533|NCT00048932|322554923|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
94207534|NCT00048932|322554924|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
94207535|NCT00048932|322554925|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
94207536|NCT00048932|322554923|FG000|Double Blind Period (DB)|Adverse Event|51|||
94207537|NCT00048932|322554924|FG001|Double Blind Period (DB)|Adverse Event|19|||
94207538|NCT00048932|322554925|FG002|Double Blind Period (DB)|Adverse Event|0|||
94207539|NCT00048932|322554923|FG000|Double Blind Period (DB)|Death|5|||
94207540|NCT00048932|322554924|FG001|Double Blind Period (DB)|Death|3|||
94207541|NCT00048932|322554925|FG002|Double Blind Period (DB)|Death|0|||
94207542|NCT00048932|322554923|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
94207543|NCT00048932|322554924|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
94207544|NCT00048932|322554925|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
94207545|NCT00048932|322554923|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
94207546|NCT00048932|322554924|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
94207547|NCT00048932|322554925|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
94207548|NCT00048932|322554923|FG000|Double Blind Period (DB)|Relocation|1|||
94207549|NCT00048932|322554924|FG001|Double Blind Period (DB)|Relocation|0|||
94207550|NCT00048932|322554925|FG002|Double Blind Period (DB)|Relocation|0|||
94207551|NCT00048932|322554923|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
94207552|NCT00048932|322554924|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
94207553|NCT00048932|322554925|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
94207554|NCT00048932|322554923|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
94207555|NCT00048932|322554924|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
94207556|NCT00048932|322554925|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
94207557|NCT00048932|322554923|FG000|Double Blind Period (DB)|Pregnancy|1|||
94371990|NCT00910858|323148457|FG000|Combined Treatment Phase|Other|0|||
94371991|NCT00910858|323148458|FG001|Combined Treatment Phase|Other|2|||
94371992|NCT00910858|323148459|FG002|Combined Treatment Phase|Other|1|||
94207558|NCT00048932|322554924|FG001|Double Blind Period (DB)|Pregnancy|0|||
94207559|NCT00048932|322554925|FG002|Double Blind Period (DB)|Pregnancy|0|||
94207560|NCT00048932|322554923|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
94207561|NCT00048932|322554924|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
94207562|NCT00048932|322554925|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
94207563|NCT00048932|322554923|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
94207564|NCT00048932|322554924|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
94207565|NCT00048932|322554925|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
94207566|NCT00048932|322554923|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
94207567|NCT00048932|322554924|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
94207568|NCT00048932|322554925|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
94207569|NCT00048932|322554923|FG000|Open Label Period (OL)|Death|0|||
94207570|NCT00048932|322554924|FG001|Open Label Period (OL)|Death|0|||
94207571|NCT00048932|322554925|FG002|Open Label Period (OL)|Death|25|||
94207572|NCT00048932|322554923|FG000|Open Label Period (OL)|Adverse Event|0|||
94207573|NCT00048932|322554924|FG001|Open Label Period (OL)|Adverse Event|0|||
94207574|NCT00048932|322554925|FG002|Open Label Period (OL)|Adverse Event|103|||
94207575|NCT00048932|322554923|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
94207576|NCT00048932|322554924|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
94207577|NCT00048932|322554925|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
94207578|NCT00048932|322554923|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
94207579|NCT00048932|322554924|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
94207580|NCT00048932|322554925|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
94207581|NCT00048932|322554923|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
94207582|NCT00048932|322554924|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
94207583|NCT00048932|322554925|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
94207584|NCT00048932|322554923|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
94207585|NCT00048932|322554924|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
94207586|NCT00048932|322554925|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
94207587|NCT00048932|322554923|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
94207588|NCT00048932|322554924|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
94207589|NCT00048932|322554925|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
94207590|NCT00048932|322554923|FG000|Open Label Period (OL)|Pregnancy|0|||
94207591|NCT00048932|322554924|FG001|Open Label Period (OL)|Pregnancy|0|||
94207592|NCT00048932|322554925|FG002|Open Label Period (OL)|Pregnancy|6|||
94207593|NCT00048932|322554923|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
94207594|NCT00048932|322554924|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
94207595|NCT00048932|322554925|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
94207596|NCT00048932|322554923|FG000|Open Label Period (OL)|Investigator Retiring|0|||
94207597|NCT00048932|322554924|FG001|Open Label Period (OL)|Investigator Retiring|0|||
94207598|NCT00048932|322554925|FG002|Open Label Period (OL)|Investigator Retiring|2|||
94207599|NCT00048932|322554923|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
94207600|NCT00048932|322554924|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
94207601|NCT00048932|322554925|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
94207602|NCT00048932|322554923|FG000|Open Label Period (OL)|Participant Relocated|0|||
94207603|NCT00048932|322554924|FG001|Open Label Period (OL)|Participant Relocated|0|||
94207604|NCT00048932|322554925|FG002|Open Label Period (OL)|Participant Relocated|6|||
94207605|NCT00048932|322554923|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
94207606|NCT00048932|322554924|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
94207607|NCT00048932|322554925|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
94207608|NCT00048932|322554923|FG000|Open Label Period (OL)|Site Closure|0|||
94207609|NCT00048932|322554924|FG001|Open Label Period (OL)|Site Closure|0|||
94207610|NCT00048932|322554925|FG002|Open Label Period (OL)|Site Closure|3|||
94207611|NCT00048932|322554923|FG000|Open Label Period (OL)|Trial Terminated|0|||
94207612|NCT00048932|322554924|FG001|Open Label Period (OL)|Trial Terminated|0|||
94207613|NCT00048932|322554925|FG002|Open Label Period (OL)|Trial Terminated|1|||
94207614|NCT00048932|322554923|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
94207615|NCT00048932|322554924|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
94207616|NCT00048932|322554925|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
94207617|NCT00048932|322554923|FG000|Open Label Period (OL)|Patient Decision|0|||
94207618|NCT00048932|322554924|FG001|Open Label Period (OL)|Patient Decision|0|||
94207619|NCT00048932|322554925|FG002|Open Label Period (OL)|Patient Decision|4|||
94207620|NCT00048932|322554923|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
94207621|NCT00048932|322554924|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
94207622|NCT00048932|322554925|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
94207623|NCT00048932|322554923|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
94207624|NCT00048932|322554924|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
94207625|NCT00048932|322554925|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
94207626|NCT00048932|322554923|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
94207627|NCT00048932|322554924|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
94467685|NCT01004432|323502376|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
94467686|NCT01004432|323502377|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
94207628|NCT00048932|322554925|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
94207629|NCT00048932|322554923|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
94207630|NCT00048932|322554924|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
94207631|NCT00048932|322554925|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
94207632|NCT00048932|322554923|FG000|Open Label Period (OL)|Investigator Decision|0|||
94207633|NCT00048932|322554924|FG001|Open Label Period (OL)|Investigator Decision|0|||
94207634|NCT00048932|322554925|FG002|Open Label Period (OL)|Investigator Decision|4|||
94207635|NCT00048932|322554923|FG000|Open Label Period (OL)|Site Staff Issues|0|||
94207636|NCT00048932|322554924|FG001|Open Label Period (OL)|Site Staff Issues|0|||
94207637|NCT00048932|322554925|FG002|Open Label Period (OL)|Site Staff Issues|2|||
94207638|NCT00048932|322554923|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
94207639|NCT00048932|322554924|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
94207640|NCT00048932|322554925|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
94207641|NCT00048932|322554923|FG000|Open Label Period (OL)|Participant Surgery|0|||
94207642|NCT00048932|322554924|FG001|Open Label Period (OL)|Participant Surgery|0|||
94207643|NCT00048932|322554925|FG002|Open Label Period (OL)|Participant Surgery|1|||
94207644|NCT04559698|322554926|FG000|Overall Study|Lost to Follow-up|14|||
94207645|NCT04559698|322554927|FG001|Overall Study|Lost to Follow-up|15|||
94207646|NCT04559698|322554926|FG000|Overall Study|Withdrawal by Subject|0|||
94207647|NCT04559698|322554927|FG001|Overall Study|Withdrawal by Subject|1|||
94207648|NCT00790569|322554935|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
94207649|NCT00790569|322554936|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
94207650|NCT00790569|322554937|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
94207651|NCT00790569|322554935|FG000|End of Treatment (6 Month Interview)|Death|0|||
94207652|NCT00790569|322554936|FG001|End of Treatment (6 Month Interview)|Death|2|||
94207653|NCT00790569|322554937|FG002|End of Treatment (6 Month Interview)|Death|1|||
94207654|NCT00790569|322554935|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
94207655|NCT00790569|322554936|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
94207656|NCT00790569|322554937|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
94207657|NCT00790569|322554935|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
94207658|NCT00790569|322554936|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
94207659|NCT00790569|322554937|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
94207660|NCT00790569|322554935|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
94207661|NCT00790569|322554936|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
94207662|NCT00790569|322554937|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
94207663|NCT00790569|322554935|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
94207664|NCT00790569|322554936|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
94207665|NCT00790569|322554937|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
94207666|NCT00609869|322554938|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
94207667|NCT00609869|322554938|FG000|Overall Study|Severe hematologic toxicity|1|||
94207668|NCT00609869|322554938|FG000|Overall Study|Withdrawal by Subject|1|||
94207669|NCT00609869|322554938|FG000|Overall Study|Seizures|1|||
94207670|NCT00609869|322554938|FG000|Overall Study|Severe tumor flare reaction|1|||
94207671|NCT00609869|322554938|FG000|Overall Study|Hepatitis B infection|1|||
94207672|NCT00609869|322554938|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
94207673|NCT00609869|322554938|FG000|Overall Study|Mantle cell: not evaluable|4|||
94207674|NCT00512252|322554943|FG000|Overall Study|Lost to Follow-up|0|||
94207675|NCT00512252|322554944|FG001|Overall Study|Lost to Follow-up|0|||
94207676|NCT00512252|322554945|FG002|Overall Study|Lost to Follow-up|1|||
94207677|NCT00512252|322554943|FG000|Overall Study|Protocol Violation|0|||
94207678|NCT00512252|322554944|FG001|Overall Study|Protocol Violation|0|||
94207679|NCT00512252|322554945|FG002|Overall Study|Protocol Violation|1|||
94207680|NCT00512252|322554943|FG000|Overall Study|Death|0|||
94207681|NCT00512252|322554944|FG001|Overall Study|Death|0|||
94207682|NCT00512252|322554945|FG002|Overall Study|Death|1|||
94207683|NCT01478594|322554947|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
94207684|NCT01478594|322554948|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
94207685|NCT01478594|322554947|FG000|Overall Study|Death|45|||
94207686|NCT01478594|322554948|FG001|Overall Study|Death|18|||
94207687|NCT01478594|322554947|FG000|Overall Study|Lost to Follow-up|3|||
94207688|NCT01478594|322554948|FG001|Overall Study|Lost to Follow-up|1|||
94281920|NCT01060059|322821431|FG001|Overall Study|Withdrawal by Subject|23|||
94281921|NCT01060059|322821430|FG000|Overall Study|lack of glycemic control|2|||
94281922|NCT01060059|322821431|FG001|Overall Study|lack of glycemic control|1|||
94281923|NCT01060059|322821430|FG000|Overall Study|lack of compliance|5|||
94281924|NCT01060059|322821431|FG001|Overall Study|lack of compliance|2|||
94281925|NCT03434379|322821435|FG000|Global Period|Lost to Follow-up|3|||
94281926|NCT03434379|322821436|FG001|Global Period|Lost to Follow-up|6|||
94281927|NCT03434379|322821437|FG002|Global Period|Lost to Follow-up|0|||
94281928|NCT03434379|322821438|FG003|Global Period|Lost to Follow-up|0|||
94281929|NCT03434379|322821435|FG000|Global Period|Death|115|||
94281930|NCT03434379|322821436|FG001|Global Period|Death|228|||
94281931|NCT03434379|322821437|FG002|Global Period|Death|0|||
94281932|NCT03434379|322821438|FG003|Global Period|Death|0|||
94281933|NCT03434379|322821435|FG000|Global Period|Withdrawal by Subject|20|||
94281934|NCT03434379|322821436|FG001|Global Period|Withdrawal by Subject|21|||
94281935|NCT03434379|322821437|FG002|Global Period|Withdrawal by Subject|0|||
94281936|NCT03434379|322821438|FG003|Global Period|Withdrawal by Subject|0|||
94281937|NCT03434379|322821435|FG000|Global Period|Reason Unspecified|0|||
94281938|NCT03434379|322821436|FG001|Global Period|Reason Unspecified|1|||
94281939|NCT03434379|322821437|FG002|Global Period|Reason Unspecified|0|||
94281940|NCT03434379|322821438|FG003|Global Period|Reason Unspecified|0|||
94281941|NCT03434379|322821435|FG000|Global Period|Study Ended by Sponsor|26|||
94281942|NCT03434379|322821436|FG001|Global Period|Study Ended by Sponsor|80|||
94281943|NCT03434379|322821437|FG002|Global Period|Study Ended by Sponsor|0|||
94281944|NCT03434379|322821438|FG003|Global Period|Study Ended by Sponsor|0|||
94281945|NCT03434379|322821435|FG000|Global Period|Physician Decision|1|||
94281946|NCT03434379|322821436|FG001|Global Period|Physician Decision|0|||
94281947|NCT03434379|322821437|FG002|Global Period|Physician Decision|0|||
94281948|NCT03434379|322821438|FG003|Global Period|Physician Decision|0|||
94281949|NCT03434379|322821435|FG000|China Extension Period|Lost to Follow-up|0|||
94281950|NCT03434379|322821436|FG001|China Extension Period|Lost to Follow-up|0|||
94281951|NCT03434379|322821437|FG002|China Extension Period|Lost to Follow-up|2|||
94281952|NCT03434379|322821438|FG003|China Extension Period|Lost to Follow-up|3|||
94281953|NCT03434379|322821435|FG000|China Extension Period|Death|0|||
94281954|NCT03434379|322821436|FG001|China Extension Period|Death|0|||
94281955|NCT03434379|322821437|FG002|China Extension Period|Death|46|||
94281956|NCT03434379|322821438|FG003|China Extension Period|Death|88|||
94281957|NCT03434379|322821435|FG000|China Extension Period|Withdrawal by Subject|0|||
94281958|NCT03434379|322821436|FG001|China Extension Period|Withdrawal by Subject|0|||
94281959|NCT03434379|322821437|FG002|China Extension Period|Withdrawal by Subject|8|||
94281960|NCT03434379|322821438|FG003|China Extension Period|Withdrawal by Subject|6|||
94281961|NCT03434379|322821435|FG000|China Extension Period|Study Ended by Sponsor|0|||
94281962|NCT03434379|322821436|FG001|China Extension Period|Study Ended by Sponsor|0|||
94371993|NCT01313728|323148460|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
94371994|NCT01965535|323148463|FG000|Overall Study|Lack of Efficacy|2|||
94371995|NCT01965535|323148464|FG001|Overall Study|Lack of Efficacy|1|||
94371996|NCT01896700|323148465|FG000|Overall Study|Adverse Event|4|||
94371997|NCT01896700|323148466|FG001|Overall Study|Adverse Event|5|||
94371998|NCT01896700|323148465|FG000|Overall Study|Withdrawal by Subject|0|||
94371999|NCT01896700|323148466|FG001|Overall Study|Withdrawal by Subject|1|||
94372000|NCT01493531|323148472|FG000|Overall Study|Adverse Event|4|||
94372001|NCT01493531|323148473|FG001|Overall Study|Adverse Event|12|||
94372002|NCT01493531|323148474|FG002|Overall Study|Adverse Event|9|||
94372003|NCT01493531|323148472|FG000|Overall Study|Gout flare|3|||
94372004|NCT01493531|323148473|FG001|Overall Study|Gout flare|0|||
94372005|NCT01493531|323148474|FG002|Overall Study|Gout flare|2|||
94372006|NCT01493531|323148472|FG000|Overall Study|Protocol Violation|8|||
94372007|NCT01493531|323148473|FG001|Overall Study|Protocol Violation|15|||
94372008|NCT01493531|323148474|FG002|Overall Study|Protocol Violation|12|||
94372009|NCT01493531|323148472|FG000|Overall Study|Sponsor terminated study|5|||
94372010|NCT01493531|323148473|FG001|Overall Study|Sponsor terminated study|2|||
94281963|NCT03434379|322821437|FG002|China Extension Period|Study Ended by Sponsor|5|||
94281964|NCT03434379|322821438|FG003|China Extension Period|Study Ended by Sponsor|36|||
94372011|NCT01493531|323148474|FG002|Overall Study|Sponsor terminated study|3|||
94372012|NCT01493531|323148472|FG000|Overall Study|Lost to Follow-up|5|||
94372013|NCT01493531|323148473|FG001|Overall Study|Lost to Follow-up|7|||
94281965|NCT03064841|322821439|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
94281966|NCT03064841|322821439|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
94281967|NCT03064841|322821439|FG000|Overall Study|Screen failure|2|||
94372014|NCT01493531|323148474|FG002|Overall Study|Lost to Follow-up|11|||
94372015|NCT01493531|323148472|FG000|Overall Study|Withdrawal by Subject|16|||
94372016|NCT01493531|323148473|FG001|Overall Study|Withdrawal by Subject|13|||
94372017|NCT01493531|323148474|FG002|Overall Study|Withdrawal by Subject|11|||
94281968|NCT03920670|322821441|FG000|Overall Study|Protocol Violation|2|||
94372018|NCT01493531|323148472|FG000|Overall Study|Death|0|||
94372019|NCT01493531|323148473|FG001|Overall Study|Death|1|||
94372020|NCT01493531|323148474|FG002|Overall Study|Death|0|||
94281969|NCT03920670|322821442|FG001|Overall Study|Protocol Violation|2|||
94207689|NCT01478594|322554947|FG000|Overall Study|Withdrawal by Subject|9|||
94207690|NCT01478594|322554948|FG001|Overall Study|Withdrawal by Subject|3|||
94207691|NCT01478594|322554947|FG000|Overall Study|Study Closed by Sponsor|8|||
94207692|NCT01478594|322554948|FG001|Overall Study|Study Closed by Sponsor|5|||
94207693|NCT00263757|322554958|FG000|Overall Study|Withdrawal by Subject|5|||
94207694|NCT00263757|322554959|FG001|Overall Study|Withdrawal by Subject|4|||
94207695|NCT00263757|322554958|FG000|Overall Study|Screen failure|0|||
94207696|NCT00263757|322554959|FG001|Overall Study|Screen failure|1|||
94207697|NCT00263757|322554958|FG000|Overall Study|Adverse Event|3|||
94207698|NCT00263757|322554959|FG001|Overall Study|Adverse Event|3|||
94207699|NCT03712371|322554962|FG000|Overall Study|Lack of Efficacy|0|||
94207700|NCT03712371|322554963|FG001|Overall Study|Lack of Efficacy|0|||
94207701|NCT03712371|322554964|FG002|Overall Study|Lack of Efficacy|0|||
94207702|NCT03712371|322554965|FG003|Overall Study|Lack of Efficacy|1|||
94207703|NCT00205179|322554967|FG000|Overall Study|Death|0|||
94207704|NCT00205179|322554968|FG001|Overall Study|Death|2|||
94207705|NCT00205179|322554967|FG000|Overall Study|Physician Decision|1|||
94207706|NCT00205179|322554968|FG001|Overall Study|Physician Decision|1|||
94207707|NCT00205179|322554967|FG000|Overall Study|Adverse Event|1|||
94207708|NCT00205179|322554968|FG001|Overall Study|Adverse Event|1|||
94207709|NCT02079649|322554971|FG000|Overall Study|Lost to Follow-up|0|||
94207710|NCT02079649|322554972|FG001|Overall Study|Lost to Follow-up|0|||
94207711|NCT02079649|322554973|FG002|Overall Study|Lost to Follow-up|0|||
94207712|NCT02079649|322554974|FG003|Overall Study|Lost to Follow-up|1|||
94207713|NCT02079649|322554971|FG000|Overall Study|Withdrawal by Subject|0|||
94207714|NCT02079649|322554972|FG001|Overall Study|Withdrawal by Subject|0|||
94207715|NCT02079649|322554973|FG002|Overall Study|Withdrawal by Subject|0|||
94207716|NCT02079649|322554974|FG003|Overall Study|Withdrawal by Subject|1|||
94207717|NCT02079649|322554971|FG000|Overall Study|Randomization error (prior to treatment)|1|||
94207718|NCT02079649|322554972|FG001|Overall Study|Randomization error (prior to treatment)|0|||
94207719|NCT02079649|322554973|FG002|Overall Study|Randomization error (prior to treatment)|1|||
94207720|NCT02079649|322554974|FG003|Overall Study|Randomization error (prior to treatment)|0|||
94207721|NCT01500200|322554995|FG000|Stage 1|Adverse Event|1|||
94207722|NCT01500200|322554996|FG001|Stage 1|Adverse Event|4|||
94207723|NCT01500200|322554997|FG002|Stage 1|Adverse Event|5|||
94207724|NCT01500200|322554998|FG003|Stage 1|Adverse Event|0|||
94207725|NCT01500200|322554999|FG004|Stage 1|Adverse Event|0|||
94207726|NCT01500200|322555000|FG005|Stage 1|Adverse Event|0|||
94207727|NCT01500200|322554995|FG000|Stage 1|Lost to Follow-up|2|||
94207728|NCT01500200|322554996|FG001|Stage 1|Lost to Follow-up|2|||
94207729|NCT01500200|322554997|FG002|Stage 1|Lost to Follow-up|1|||
94207730|NCT01500200|322554998|FG003|Stage 1|Lost to Follow-up|0|||
94281970|NCT03920670|322821441|FG000|Overall Study|Adverse Event|1|||
94281971|NCT03920670|322821442|FG001|Overall Study|Adverse Event|0|||
94281972|NCT03355300|322821453|FG000|Overall Study|Physician Decision|0|||
94207731|NCT01500200|322554999|FG004|Stage 1|Lost to Follow-up|0|||
94207732|NCT01500200|322555000|FG005|Stage 1|Lost to Follow-up|0|||
94281973|NCT03355300|322821454|FG001|Overall Study|Physician Decision|1|||
94207733|NCT01500200|322554995|FG000|Stage 1|Withdrawal by Subject|3|||
94281974|NCT03355300|322821453|FG000|Overall Study|Lack of Efficacy|2|||
94281975|NCT03355300|322821454|FG001|Overall Study|Lack of Efficacy|1|||
94281976|NCT03355300|322821453|FG000|Overall Study|Other reason|1|||
94281977|NCT03355300|322821454|FG001|Overall Study|Other reason|0|||
94281978|NCT03048422|322821455|FG000|Overall Study|Death|1|||
94281979|NCT03048422|322821456|FG001|Overall Study|Death|0|||
94281980|NCT03048422|322821457|FG002|Overall Study|Death|0|||
94281981|NCT03048422|322821455|FG000|Overall Study|Lost to Follow-up|5|||
94281982|NCT03048422|322821456|FG001|Overall Study|Lost to Follow-up|0|||
94281983|NCT03048422|322821457|FG002|Overall Study|Lost to Follow-up|1|||
94281984|NCT03048422|322821455|FG000|Overall Study|Withdrawal by Subject|5|||
94281985|NCT03048422|322821456|FG001|Overall Study|Withdrawal by Subject|7|||
94281986|NCT03048422|322821457|FG002|Overall Study|Withdrawal by Subject|4|||
94281987|NCT03048422|322821455|FG000|Overall Study|Moved|3|||
94281988|NCT03048422|322821456|FG001|Overall Study|Moved|2|||
94281989|NCT03048422|322821457|FG002|Overall Study|Moved|2|||
94281990|NCT03048422|322821455|FG000|Overall Study|Noncompliant with Study Requirements|2|||
94281991|NCT03048422|322821456|FG001|Overall Study|Noncompliant with Study Requirements|1|||
94281992|NCT03048422|322821457|FG002|Overall Study|Noncompliant with Study Requirements|2|||
94281993|NCT03048422|322821455|FG000|Overall Study|Not Able to Get to Clinic|1|||
94281994|NCT03048422|322821456|FG001|Overall Study|Not Able to Get to Clinic|0|||
94281995|NCT03048422|322821457|FG002|Overall Study|Not Able to Get to Clinic|0|||
94281996|NCT01984268|322821458|FG000|Overall Study|Study Terminated|15|||
94281997|NCT00936208|322821460|FG000|Overall Study|Protocol Violation|37|||
94281998|NCT00936208|322821461|FG001|Overall Study|Protocol Violation|22|||
94281999|NCT00861744|322821464|FG000|Overall Study|Adverse Event|0|||
94282000|NCT00861744|322821465|FG001|Overall Study|Adverse Event|0|||
94282001|NCT00861744|322821466|FG002|Overall Study|Adverse Event|0|||
94282002|NCT00861744|322821467|FG003|Overall Study|Adverse Event|1|||
94282003|NCT00861744|322821464|FG000|Overall Study|Lost to Follow-up|7|||
94282004|NCT00861744|322821465|FG001|Overall Study|Lost to Follow-up|19|||
94282005|NCT00861744|322821466|FG002|Overall Study|Lost to Follow-up|17|||
94282006|NCT00861744|322821467|FG003|Overall Study|Lost to Follow-up|12|||
94282007|NCT00861744|322821464|FG000|Overall Study|Withdrawal by Subject|10|||
94282008|NCT00861744|322821465|FG001|Overall Study|Withdrawal by Subject|6|||
94282009|NCT00861744|322821466|FG002|Overall Study|Withdrawal by Subject|6|||
94282010|NCT00861744|322821467|FG003|Overall Study|Withdrawal by Subject|19|||
94282011|NCT00861744|322821464|FG000|Overall Study|Protocol Violation|0|||
94282012|NCT00861744|322821465|FG001|Overall Study|Protocol Violation|1|||
94282013|NCT00861744|322821466|FG002|Overall Study|Protocol Violation|0|||
94282014|NCT00861744|322821467|FG003|Overall Study|Protocol Violation|0|||
94207734|NCT01500200|322554996|FG001|Stage 1|Withdrawal by Subject|0|||
94207735|NCT01500200|322554997|FG002|Stage 1|Withdrawal by Subject|0|||
94207736|NCT01500200|322554998|FG003|Stage 1|Withdrawal by Subject|0|||
94207737|NCT01500200|322554999|FG004|Stage 1|Withdrawal by Subject|0|||
94207738|NCT01500200|322555000|FG005|Stage 1|Withdrawal by Subject|0|||
94207739|NCT01500200|322554995|FG000|Stage 1|Noncompliance with Study Drug|1|||
94207740|NCT01500200|322554996|FG001|Stage 1|Noncompliance with Study Drug|0|||
94207741|NCT01500200|322554997|FG002|Stage 1|Noncompliance with Study Drug|0|||
94207742|NCT01500200|322554998|FG003|Stage 1|Noncompliance with Study Drug|0|||
94207743|NCT01500200|322554999|FG004|Stage 1|Noncompliance with Study Drug|0|||
94207744|NCT01500200|322555000|FG005|Stage 1|Noncompliance with Study Drug|0|||
94207745|NCT01500200|322554995|FG000|Stage 1|Physician Decision|1|||
94207746|NCT01500200|322554996|FG001|Stage 1|Physician Decision|0|||
94207747|NCT01500200|322554997|FG002|Stage 1|Physician Decision|0|||
94207748|NCT01500200|322554998|FG003|Stage 1|Physician Decision|0|||
94207749|NCT01500200|322554999|FG004|Stage 1|Physician Decision|0|||
94207750|NCT01500200|322555000|FG005|Stage 1|Physician Decision|0|||
94207751|NCT01500200|322554995|FG000|Stage 2|Adverse Event|0|||
94207752|NCT01500200|322554996|FG001|Stage 2|Adverse Event|0|||
94207753|NCT01500200|322554997|FG002|Stage 2|Adverse Event|0|||
94207754|NCT01500200|322554998|FG003|Stage 2|Adverse Event|0|||
94207755|NCT01500200|322554999|FG004|Stage 2|Adverse Event|5|||
94282015|NCT00861744|322821464|FG000|Overall Study|Migration from study area|0|||
94282016|NCT00861744|322821465|FG001|Overall Study|Migration from study area|3|||
94282017|NCT00861744|322821466|FG002|Overall Study|Migration from study area|1|||
94282018|NCT00861744|322821467|FG003|Overall Study|Migration from study area|0|||
94207756|NCT01500200|322555000|FG005|Stage 2|Adverse Event|4|||
94207757|NCT03739866|322555001|FG000|Overall Study|Lost to Follow-up|0|||
94207758|NCT03739866|322555002|FG001|Overall Study|Lost to Follow-up|0|||
94207759|NCT03739866|322555003|FG002|Overall Study|Lost to Follow-up|0|||
94207760|NCT03739866|322555004|FG003|Overall Study|Lost to Follow-up|1|||
94282019|NCT00861744|322821464|FG000|Overall Study|Blood draws|0|||
94282020|NCT00861744|322821465|FG001|Overall Study|Blood draws|0|||
94282021|NCT00861744|322821466|FG002|Overall Study|Blood draws|0|||
94282022|NCT00861744|322821467|FG003|Overall Study|Blood draws|1|||
94282023|NCT01344876|322821468|FG000|Overall Study|Adverse Event|0|||
94282024|NCT01344876|322821469|FG001|Overall Study|Adverse Event|0|||
94282025|NCT01344876|322821470|FG002|Overall Study|Adverse Event|0|||
94207761|NCT03739866|322555005|FG004|Overall Study|Lost to Follow-up|0|||
94282026|NCT01344876|322821471|FG003|Overall Study|Adverse Event|0|||
94282027|NCT01344876|322821472|FG004|Overall Study|Adverse Event|1|||
94282028|NCT01344876|322821468|FG000|Overall Study|Withdrawal by Subject|0|||
94282029|NCT01344876|322821469|FG001|Overall Study|Withdrawal by Subject|0|||
94282030|NCT01344876|322821470|FG002|Overall Study|Withdrawal by Subject|1|||
94282031|NCT01344876|322821471|FG003|Overall Study|Withdrawal by Subject|0|||
94282032|NCT01344876|322821472|FG004|Overall Study|Withdrawal by Subject|0|||
94282033|NCT01344876|322821468|FG000|Overall Study|Definite progression of primary disease|1|||
94282034|NCT01344876|322821469|FG001|Overall Study|Definite progression of primary disease|0|||
94282035|NCT01344876|322821470|FG002|Overall Study|Definite progression of primary disease|0|||
94282036|NCT01344876|322821471|FG003|Overall Study|Definite progression of primary disease|3|||
94282037|NCT01344876|322821472|FG004|Overall Study|Definite progression of primary disease|0|||
94282038|NCT04428424|322821473|FG000|Overall Study|Does not meet entrance criteria|132|||
94282039|NCT04428424|322821473|FG000|Overall Study|Lost to Follow-up|115|||
94282040|NCT01928381|322821474|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
94467687|NCT01004432|323502373|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
94207762|NCT03739866|322555006|FG005|Overall Study|Lost to Follow-up|0|||
94207763|NCT03739866|322555007|FG006|Overall Study|Lost to Follow-up|0|||
94207764|NCT03739866|322555008|FG007|Overall Study|Lost to Follow-up|0|||
94207765|NCT03739866|322555001|FG000|Overall Study|Enrolled but not treated|0|||
94207766|NCT03739866|322555002|FG001|Overall Study|Enrolled but not treated|0|||
94207767|NCT03739866|322555003|FG002|Overall Study|Enrolled but not treated|1|||
94207768|NCT03739866|322555004|FG003|Overall Study|Enrolled but not treated|0|||
94207769|NCT03739866|322555005|FG004|Overall Study|Enrolled but not treated|1|||
94207770|NCT03739866|322555006|FG005|Overall Study|Enrolled but not treated|0|||
94207771|NCT03739866|322555007|FG006|Overall Study|Enrolled but not treated|0|||
94207772|NCT03739866|322555008|FG007|Overall Study|Enrolled but not treated|0|||
94207773|NCT01359150|322555009|FG000|Overall Study|Lack of Efficacy|1|||
94207774|NCT01359150|322555010|FG001|Overall Study|Lack of Efficacy|1|||
94207775|NCT01359150|322555009|FG000|Overall Study|Withdrawal by Subject|1|||
94207776|NCT01359150|322555010|FG001|Overall Study|Withdrawal by Subject|1|||
94207777|NCT01359150|322555009|FG000|Overall Study|Adverse Event|4|||
94207778|NCT01359150|322555010|FG001|Overall Study|Adverse Event|3|||
94207779|NCT01359150|322555009|FG000|Overall Study|Other|1|||
94207780|NCT01359150|322555010|FG001|Overall Study|Other|0|||
94207781|NCT01700205|322555011|FG000|Overall Study|Withdrawal by Subject|13|||
94207782|NCT01700205|322555012|FG001|Overall Study|Withdrawal by Subject|13|||
94207783|NCT01700205|322555011|FG000|Overall Study|Protocol Violation|2|||
94207784|NCT01700205|322555012|FG001|Overall Study|Protocol Violation|2|||
94207785|NCT04860505|322555013|FG000|Overall Study|Lost to Follow-up|2|||
94207786|NCT01536093|322555014|FG000|Overall Study|Death|1|||
94207787|NCT01536093|322555015|FG001|Overall Study|Death|2|||
94207788|NCT01536093|322555014|FG000|Overall Study|absence of maternal colostrum|2|||
94207789|NCT01536093|322555015|FG001|Overall Study|absence of maternal colostrum|0|||
94207790|NCT01536093|322555014|FG000|Overall Study|Withdrawal by Subject|0|||
94207791|NCT01536093|322555015|FG001|Overall Study|Withdrawal by Subject|1|||
94207792|NCT02567435|322555016|FG000|Overall Study|Death|1|||
94207793|NCT02567435|322555017|FG001|Overall Study|Death|1|||
94207794|NCT02567435|322555018|FG002|Overall Study|Death|0|||
94207795|NCT02567435|322555019|FG003|Overall Study|Death|0|||
94207796|NCT02567435|322555016|FG000|Overall Study|Ineligible|1|||
94207797|NCT02567435|322555017|FG001|Overall Study|Ineligible|3|||
94207798|NCT02567435|322555018|FG002|Overall Study|Ineligible|0|||
94207799|NCT02567435|322555019|FG003|Overall Study|Ineligible|0|||
94207800|NCT02567435|322555016|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
94207801|NCT02567435|322555017|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
94207802|NCT02567435|322555018|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
94207803|NCT02567435|322555019|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
94207804|NCT00523419|322555022|FG000|Overall Study|Adverse Event|1|||
94207805|NCT00523419|322555022|FG000|Overall Study|Withdrawal by Subject|1|||
94207806|NCT00523419|322555022|FG000|Overall Study|Physician Decision|2|||
94207807|NCT00523419|322555022|FG000|Overall Study|Progressive Disease|22|||
94207808|NCT00523419|322555022|FG000|Overall Study|Death due to Study Disease|4|||
94207809|NCT00523419|322555022|FG000|Overall Study|Death due to Adverse Event|2|||
94207810|NCT01759862|322555023|FG000|Overall Study|Physician Decision|3|||
94207811|NCT01759862|322555024|FG001|Overall Study|Physician Decision|1|||
94207812|NCT01759862|322555023|FG000|Overall Study|Adverse Event|0|||
94207813|NCT01759862|322555024|FG001|Overall Study|Adverse Event|1|||
94207814|NCT03041233|322555025|FG000|Overall Study|Death|5|||
94207815|NCT03041233|322555025|FG000|Overall Study|Physician Decision|1|||
94207816|NCT03041233|322555025|FG000|Overall Study|Lost to Follow-up|16|||
94207817|NCT03041233|322555025|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
94207818|NCT03041233|322555025|FG000|Overall Study|Sponsor Request|1|||
94282041|NCT01928381|322821475|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
94282042|NCT01928381|322821476|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
94282043|NCT01928381|322821477|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
94282044|NCT01928381|322821478|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
94282045|NCT01928381|322821479|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
94282046|NCT01928381|322821480|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
94282047|NCT01928381|322821474|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
94282048|NCT01928381|322821475|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
94282049|NCT01928381|322821476|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
94282050|NCT01928381|322821477|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
94282051|NCT01928381|322821478|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
94282052|NCT01928381|322821479|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
94282053|NCT01928381|322821480|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
94282054|NCT01928381|322821474|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
94282055|NCT01928381|322821475|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
94282056|NCT01928381|322821476|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
94282057|NCT01928381|322821477|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
94282058|NCT01928381|322821478|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
94282059|NCT01928381|322821479|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
94282060|NCT01928381|322821480|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
94282061|NCT01928381|322821474|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
94282062|NCT01928381|322821475|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
94282063|NCT01928381|322821476|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
94282064|NCT01928381|322821477|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
94282065|NCT01928381|322821478|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
94282066|NCT01928381|322821479|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
94282067|NCT01928381|322821480|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
94282068|NCT01928381|322821474|FG000|Part 1 - Pain Training|Protocol Violation|1|||
94282069|NCT01928381|322821475|FG001|Part 1 - Pain Training|Protocol Violation|0|||
94282070|NCT01928381|322821476|FG002|Part 1 - Pain Training|Protocol Violation|0|||
94282071|NCT01928381|322821477|FG003|Part 1 - Pain Training|Protocol Violation|0|||
94282072|NCT01928381|322821478|FG004|Part 1 - Pain Training|Protocol Violation|0|||
94282073|NCT01928381|322821479|FG005|Part 1 - Pain Training|Protocol Violation|0|||
94282074|NCT01928381|322821480|FG006|Part 1 - Pain Training|Protocol Violation|0|||
94282075|NCT01928381|322821474|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
94282076|NCT01928381|322821475|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
94282077|NCT01928381|322821476|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
94282078|NCT01928381|322821477|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
94372021|NCT01205529|323148475|FG000|Overall Study|Procedure Cancelled|4|||
94282079|NCT01928381|322821478|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
94282080|NCT01928381|322821479|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
94282081|NCT01928381|322821480|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
94282082|NCT01928381|322821474|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
94282083|NCT01928381|322821475|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
94282084|NCT01928381|322821476|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
94282085|NCT01928381|322821477|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
94282086|NCT01928381|322821478|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
94282087|NCT01928381|322821479|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
94282088|NCT01928381|322821480|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
94282089|NCT01928381|322821474|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
94372022|NCT01205529|323148475|FG000|Overall Study|Withdrawal by Subject|2|||
94372023|NCT01205529|323148475|FG000|Overall Study|Physician Decision|4|||
94372024|NCT01205529|323148475|FG000|Overall Study|Unstable post op|15|||
94372025|NCT01205529|323148475|FG000|Overall Study|No longer met criteria|30|||
94372026|NCT02729194|323148479|FG000|Overall Study|Withdrawal by Subject|3|||
94372027|NCT00845026|323148480|FG000|Study Period III|Adverse Event|23|||
94372028|NCT00845026|323148481|FG001|Study Period III|Adverse Event|19|||
94372029|NCT00845026|323148480|FG000|Study Period III|Perceived lack of efficacy|27|||
94372030|NCT00845026|323148481|FG001|Study Period III|Perceived lack of efficacy|15|||
94372031|NCT00845026|323148480|FG000|Study Period III|Withdrawal by Subject|19|||
94372032|NCT00845026|323148481|FG001|Study Period III|Withdrawal by Subject|15|||
94372033|NCT00845026|323148480|FG000|Study Period III|Entry Criteria not met|8|||
94372034|NCT00845026|323148481|FG001|Study Period III|Entry Criteria not met|11|||
94372035|NCT00845026|323148480|FG000|Study Period III|Lost to Follow-up|4|||
94372036|NCT00845026|323148481|FG001|Study Period III|Lost to Follow-up|5|||
94372037|NCT00845026|323148480|FG000|Study Period III|Protocol Violation|8|||
94372038|NCT00845026|323148481|FG001|Study Period III|Protocol Violation|1|||
94372039|NCT00845026|323148480|FG000|Study Period III|Scheduled conflict|3|||
94372040|NCT00845026|323148481|FG001|Study Period III|Scheduled conflict|1|||
94372041|NCT00845026|323148480|FG000|Study Period III|Subject is moving or has moved|2|||
94372042|NCT00845026|323148481|FG001|Study Period III|Subject is moving or has moved|4|||
94372043|NCT00845026|323148480|FG000|Study Period III|Transportation issues|1|||
94372044|NCT00845026|323148481|FG001|Study Period III|Transportation issues|1|||
94372045|NCT00845026|323148480|FG000|Study Period IV|Adverse Event|4|||
94372046|NCT00845026|323148481|FG001|Study Period IV|Adverse Event|0|||
94372047|NCT00845026|323148480|FG000|Study Period IV|Perceived lack of efficacy|2|||
94372048|NCT00845026|323148481|FG001|Study Period IV|Perceived lack of efficacy|1|||
94372049|NCT00845026|323148480|FG000|Study Period IV|Protocol Violation|3|||
94372050|NCT00845026|323148481|FG001|Study Period IV|Protocol Violation|1|||
94372051|NCT00845026|323148480|FG000|Study Period IV|Lost to Follow-up|1|||
94372052|NCT00845026|323148481|FG001|Study Period IV|Lost to Follow-up|0|||
94372053|NCT00845026|323148480|FG000|Study Period IV|Withdrawal by Subject|4|||
94207819|NCT03041233|322555025|FG000|Overall Study|Duplicate subject|1|||
94207820|NCT03041233|322555025|FG000|Overall Study|Re-ablation|1|||
94207821|NCT00811941|322555028|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
94207822|NCT00811941|322555029|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
94207823|NCT00811941|322555028|FG000|All Treated Patients|Adverse Event|2|||
94207824|NCT00811941|322555029|FG001|All Treated Patients|Adverse Event|43|||
94207825|NCT00811941|322555028|FG000|All Treated Patients|Lack of Efficacy|2|||
94207826|NCT00811941|322555029|FG001|All Treated Patients|Lack of Efficacy|3|||
94207827|NCT00811941|322555028|FG000|All Treated Patients|Non-compliance|1|||
94207828|NCT00811941|322555029|FG001|All Treated Patients|Non-compliance|8|||
94207829|NCT00811941|322555028|FG000|All Treated Patients|Protocol Violation|5|||
94207830|NCT00811941|322555029|FG001|All Treated Patients|Protocol Violation|17|||
94207831|NCT00811941|322555028|FG000|All Treated Patients|Withdrawal by Subject|35|||
94207832|NCT00811941|322555029|FG001|All Treated Patients|Withdrawal by Subject|94|||
94207833|NCT00811941|322555028|FG000|All Treated Patients|Lost to Follow-up|3|||
94207834|NCT00811941|322555029|FG001|All Treated Patients|Lost to Follow-up|12|||
94207835|NCT00811941|322555028|FG000|All Treated Patients|Other Reason|4|||
94207836|NCT00811941|322555029|FG001|All Treated Patients|Other Reason|14|||
94207837|NCT02630966|322555031|FG000|Overall Study|Adverse Event|1|||
94207838|NCT02630966|322555032|FG001|Overall Study|Adverse Event|3|||
94207839|NCT02630966|322555031|FG000|Overall Study|Significant Protocol Deviation|0|||
94207840|NCT02630966|322555032|FG001|Overall Study|Significant Protocol Deviation|2|||
94207841|NCT02630966|322555031|FG000|Overall Study|Voluntary Withdrawal|1|||
94207842|NCT02630966|322555032|FG001|Overall Study|Voluntary Withdrawal|1|||
94207843|NCT02630966|322555031|FG000|Overall Study|Lack of Efficacy|0|||
94207844|NCT02630966|322555032|FG001|Overall Study|Lack of Efficacy|2|||
94207845|NCT00756574|322555033|FG000|Overall Study|Withdrawal by Subject|9|||
94207846|NCT00756574|322555034|FG001|Overall Study|Withdrawal by Subject|7|||
94207847|NCT00756574|322555033|FG000|Overall Study|Lost to Follow-up|4|||
94207848|NCT00756574|322555034|FG001|Overall Study|Lost to Follow-up|4|||
94207849|NCT02743819|322555036|FG000|Overall Study|Lack of Efficacy|5|||
94207850|NCT02743819|322555036|FG000|Overall Study|Death|2|||
94207851|NCT02743819|322555036|FG000|Overall Study|Adverse Event|1|||
94207852|NCT04200664|322555037|FG000|Overall Study|Withdrawal by Subject|1|||
94207853|NCT04200664|322555038|FG001|Overall Study|Withdrawal by Subject|0|||
94207854|NCT04200664|322555039|FG002|Overall Study|Withdrawal by Subject|0|||
94207855|NCT01638000|322555040|FG000|Overall Study|Randomized but Never Received Drug|7|||
94207856|NCT01638000|322555041|FG001|Overall Study|Randomized but Never Received Drug|10|||
94207857|NCT01638000|322555040|FG000|Overall Study|Adverse Event|14|||
94207858|NCT01638000|322555041|FG001|Overall Study|Adverse Event|16|||
94207859|NCT01638000|322555040|FG000|Overall Study|Lack of Efficacy|5|||
94207860|NCT01638000|322555041|FG001|Overall Study|Lack of Efficacy|6|||
94207861|NCT01638000|322555040|FG000|Overall Study|Protocol Violation|11|||
94207862|NCT01638000|322555041|FG001|Overall Study|Protocol Violation|13|||
94207863|NCT01638000|322555040|FG000|Overall Study|Withdrawal by Subject|21|||
94207864|NCT01638000|322555041|FG001|Overall Study|Withdrawal by Subject|24|||
94207865|NCT01638000|322555040|FG000|Overall Study|Miscellaneous|2|||
94207866|NCT01638000|322555041|FG001|Overall Study|Miscellaneous|2|||
94207867|NCT03890289|322555042|FG000|Overall Study|Adverse Event|1|||
94207868|NCT03890289|322555042|FG000|Overall Study|Physician Decision|1|||
94207869|NCT03890289|322555042|FG000|Overall Study|Lack of Efficacy|2|||
94207870|NCT00274261|322555043|FG000|Overall Study|Adverse Event|19|||
94207871|NCT00274261|322555044|FG001|Overall Study|Adverse Event|11|||
94207872|NCT00274261|322555043|FG000|Overall Study|Pregnancy|114|||
94207873|NCT00274261|322555044|FG001|Overall Study|Pregnancy|83|||
94207874|NCT00274261|322555043|FG000|Overall Study|Withdrawal by Subject|179|||
94207875|NCT00274261|322555044|FG001|Overall Study|Withdrawal by Subject|126|||
94207876|NCT00274261|322555043|FG000|Overall Study|Protocol Violation|71|||
94207877|NCT00274261|322555044|FG001|Overall Study|Protocol Violation|42|||
94207878|NCT00274261|322555043|FG000|Overall Study|Lost to Follow-up|106|||
94207879|NCT00274261|322555044|FG001|Overall Study|Lost to Follow-up|75|||
94207880|NCT02029235|322555049|FG000|Overall Study|Non-compliance with study meds or diary|4|||
94207881|NCT02029235|322555050|FG001|Overall Study|Non-compliance with study meds or diary|1|||
94207882|NCT02235298|322555055|FG000|Overall Study|Lost to Follow-up|6|||
94207883|NCT02235298|322555056|FG001|Overall Study|Lost to Follow-up|5|||
94207884|NCT02235298|322555055|FG000|Overall Study|Adverse Event|2|||
94207885|NCT02235298|322555056|FG001|Overall Study|Adverse Event|2|||
94207886|NCT02235298|322555055|FG000|Overall Study|Withdrawal by Subject|0|||
94207887|NCT02235298|322555056|FG001|Overall Study|Withdrawal by Subject|1|||
94207888|NCT03683576|322555058|FG000|Overall Study|Withdrawal by Subject|2|||
94207889|NCT03683576|322555059|FG001|Overall Study|Withdrawal by Subject|0|||
94207890|NCT03683576|322555060|FG002|Overall Study|Withdrawal by Subject|8|||
94207891|NCT03683576|322555061|FG003|Overall Study|Withdrawal by Subject|3|||
94207892|NCT03683576|322555058|FG000|Overall Study|Adverse Event|3|||
94207893|NCT03683576|322555059|FG001|Overall Study|Adverse Event|0|||
94207894|NCT03683576|322555060|FG002|Overall Study|Adverse Event|0|||
94207895|NCT03683576|322555061|FG003|Overall Study|Adverse Event|4|||
94207896|NCT03683576|322555058|FG000|Overall Study|Lack of Efficacy|1|||
94207897|NCT03683576|322555059|FG001|Overall Study|Lack of Efficacy|0|||
94467688|NCT01004432|323502374|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
94207898|NCT03683576|322555060|FG002|Overall Study|Lack of Efficacy|1|||
94207899|NCT03683576|322555061|FG003|Overall Study|Lack of Efficacy|1|||
94467689|NCT01004432|323502375|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
94207900|NCT03683576|322555058|FG000|Overall Study|Lost to Follow-up|0|||
94282090|NCT01928381|322821475|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
94282091|NCT01928381|322821476|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
94282092|NCT01928381|322821477|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
94282093|NCT01928381|322821478|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
94282094|NCT01928381|322821479|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
94282095|NCT01928381|322821480|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
94282096|NCT01928381|322821474|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
94282097|NCT01928381|322821475|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
94282098|NCT01928381|322821476|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
94282099|NCT01928381|322821477|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
94282100|NCT01928381|322821478|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
94282101|NCT01928381|322821479|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
94282102|NCT01928381|322821480|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
94282103|NCT01928381|322821474|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
94282104|NCT01928381|322821475|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
94282105|NCT01928381|322821476|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
94282106|NCT01928381|322821477|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
94282107|NCT01928381|322821478|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
94282108|NCT01928381|322821479|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
94282109|NCT01928381|322821480|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
94282110|NCT01928381|322821474|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
94282111|NCT01928381|322821475|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
94282112|NCT01928381|322821476|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
94282113|NCT01928381|322821477|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
94282114|NCT01928381|322821478|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
94282115|NCT01928381|322821479|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
94282116|NCT01928381|322821480|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
94467690|NCT01004432|323502376|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
94467691|NCT01004432|323502377|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
94282117|NCT01928381|322821474|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
94282118|NCT01928381|322821475|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
94282119|NCT01928381|322821476|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
94282120|NCT01928381|322821477|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
94282121|NCT01928381|322821478|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
94282122|NCT01928381|322821479|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
94282123|NCT01928381|322821480|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
94282124|NCT01928381|322821474|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
94282125|NCT01928381|322821475|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
94282126|NCT01928381|322821476|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
94282127|NCT01928381|322821477|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
94207901|NCT03683576|322555059|FG001|Overall Study|Lost to Follow-up|1|||
94207902|NCT03683576|322555060|FG002|Overall Study|Lost to Follow-up|2|||
94207903|NCT03683576|322555061|FG003|Overall Study|Lost to Follow-up|0|||
94207904|NCT03683576|322555058|FG000|Overall Study|Other, Not Specified|0|||
94207905|NCT03683576|322555059|FG001|Overall Study|Other, Not Specified|2|||
94207906|NCT03683576|322555060|FG002|Overall Study|Other, Not Specified|0|||
94207907|NCT03683576|322555061|FG003|Overall Study|Other, Not Specified|0|||
94207908|NCT03683576|322555058|FG000|Overall Study|Protocol Violation|0|||
94207909|NCT03683576|322555059|FG001|Overall Study|Protocol Violation|1|||
94207910|NCT03683576|322555060|FG002|Overall Study|Protocol Violation|1|||
94207911|NCT03683576|322555061|FG003|Overall Study|Protocol Violation|0|||
94207912|NCT01593020|322555065|FG000|Overall Study|Adverse Event|1|||
94207913|NCT01593020|322555066|FG001|Overall Study|Adverse Event|1|||
94207914|NCT01593020|322555065|FG000|Overall Study|Death|0|||
94207915|NCT01593020|322555066|FG001|Overall Study|Death|1|||
94207916|NCT01593020|322555065|FG000|Overall Study|Ineligible|1|||
94207917|NCT01593020|322555066|FG001|Overall Study|Ineligible|0|||
94207918|NCT02454959|322555067|FG000|Overall Study|Protocol-Specified Criteria|3|||
94207919|NCT02454959|322555067|FG000|Overall Study|Physician Decision|1|||
94207920|NCT02454959|322555067|FG000|Overall Study|Withdrawal by Subject|3|||
94207921|NCT02454959|322555067|FG000|Overall Study|Adverse Event|2|||
94207922|NCT01738438|322555070|FG000|Overall Study|Disease Progression|32|||
94207923|NCT01738438|322555070|FG000|Overall Study|Adverse Event|3|||
94207924|NCT00589875|322555078|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
94207925|NCT00589875|322555078|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
94207926|NCT03488719|322555081|FG000|Overall Study|Adverse Event|0|||
94207927|NCT03488719|322555082|FG001|Overall Study|Adverse Event|4|||
94207928|NCT03488719|322555083|FG002|Overall Study|Adverse Event|2|||
94207929|NCT03488719|322555081|FG000|Overall Study|Other|0|||
94207930|NCT03488719|322555082|FG001|Overall Study|Other|0|||
94207931|NCT03488719|322555083|FG002|Overall Study|Other|5|||
94207932|NCT05824559|322555085|FG000|Overall Study|Adverse Event|2|||
94207933|NCT05824559|322555085|FG000|Overall Study|Physician Decision|2|||
94207934|NCT05824559|322555085|FG000|Overall Study|Progressive Disease|16|||
94207935|NCT05824559|322555085|FG000|Overall Study|Study Terminated by Sponsor|1|||
94207936|NCT05824559|322555085|FG000|Overall Study|Withdrawal by Subject|2|||
94207937|NCT02409680|322555088|FG000|Overall Study|Lost to Follow-up|15|||
94207938|NCT02409680|322555089|FG001|Overall Study|Lost to Follow-up|30|||
94207939|NCT02485925|322555092|FG000|Overall Study|Withdrawal by Subject|3|||
94207940|NCT02485925|322555092|FG000|Overall Study|Death|1|||
94207941|NCT02485925|322555092|FG000|Overall Study|Lost to Follow-up|11|||
94207942|NCT04686266|322555093|FG000|Overall Study|Withdrawal by Subject|0|||
94207943|NCT04686266|322555094|FG001|Overall Study|Withdrawal by Subject|1|||
94207944|NCT03214081|322556643|FG000|Overall Study|Case Report Forms Uncollected|9|||
94207945|NCT03214081|322556643|FG000|Overall Study|Protocol Deviation|54|||
94372054|NCT00845026|323148481|FG001|Study Period IV|Withdrawal by Subject|1|||
94207946|NCT03116464|322556644|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
94207947|NCT00491400|322556645|FG000|Overall Study|Withdrawal by Subject|5|||
94207948|NCT00491400|322556646|FG001|Overall Study|Withdrawal by Subject|4|||
94207949|NCT01964300|322556647|FG000|Overall Study|Ineligible after enrollment|0|||
94207950|NCT01964300|322556648|FG001|Overall Study|Ineligible after enrollment|1|||
94207951|NCT01964300|322556647|FG000|Overall Study|Adverse Event|1|||
94207952|NCT01964300|322556648|FG001|Overall Study|Adverse Event|1|||
94207953|NCT01964300|322556647|FG000|Overall Study|Lack of Efficacy|3|||
94207954|NCT01964300|322556648|FG001|Overall Study|Lack of Efficacy|5|||
94207955|NCT01964300|322556647|FG000|Overall Study|Withdrawal by Subject|0|||
94207956|NCT01964300|322556648|FG001|Overall Study|Withdrawal by Subject|1|||
94207957|NCT01964300|322556647|FG000|Overall Study|To receive alternative therapy|1|||
94207958|NCT01964300|322556648|FG001|Overall Study|To receive alternative therapy|2|||
94207959|NCT01964300|322556647|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
94207960|NCT01964300|322556648|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
94282128|NCT01928381|322821478|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
94282129|NCT01928381|322821479|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
94282130|NCT01928381|322821480|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
94282131|NCT01928381|322821474|FG000|Washout First Intervention|Protocol Violation|0|||
94282132|NCT01928381|322821475|FG001|Washout First Intervention|Protocol Violation|0|||
94282133|NCT01928381|322821476|FG002|Washout First Intervention|Protocol Violation|0|||
94282134|NCT01928381|322821477|FG003|Washout First Intervention|Protocol Violation|0|||
94372055|NCT00845026|323148480|FG000|Study Period IV|Entry Criteria Not Met|1|||
94372056|NCT00845026|323148481|FG001|Study Period IV|Entry Criteria Not Met|0|||
94372057|NCT00845026|323148480|FG000|Study Period IV|Subject is moving or has moved|0|||
94207961|NCT01964300|322556647|FG000|Overall Study|Weight criteria not met|0|||
94207962|NCT01964300|322556648|FG001|Overall Study|Weight criteria not met|1|||
94207963|NCT00597376|322556649|FG000|Overall Study|Withdrawal by Subject|4|||
94207964|NCT00597376|322556650|FG001|Overall Study|Withdrawal by Subject|3|||
94372058|NCT00845026|323148481|FG001|Study Period IV|Subject is moving or has moved|1|||
94207965|NCT00597376|322556649|FG000|Overall Study|Adverse Event|4|||
94207966|NCT00597376|322556650|FG001|Overall Study|Adverse Event|1|||
94207967|NCT00747006|322556651|FG000|Overall Study|Adverse Event|1|||
94207968|NCT00747006|322556652|FG001|Overall Study|Adverse Event|0|||
94207969|NCT00747006|322556653|FG002|Overall Study|Adverse Event|0|||
94207970|NCT00747006|322556651|FG000|Overall Study|Lost to Follow-up|0|||
94207971|NCT00747006|322556652|FG001|Overall Study|Lost to Follow-up|1|||
94207972|NCT00747006|322556653|FG002|Overall Study|Lost to Follow-up|0|||
94207973|NCT00747006|322556651|FG000|Overall Study|Physician Decision|2|||
94207974|NCT00747006|322556652|FG001|Overall Study|Physician Decision|0|||
94207975|NCT00747006|322556653|FG002|Overall Study|Physician Decision|1|||
94207976|NCT00692913|322556654|FG000|Overall Study|Adverse Event|8|||
94207977|NCT00692913|322556655|FG001|Overall Study|Adverse Event|4|||
94207978|NCT00692913|322556654|FG000|Overall Study|Lost to Follow-up|3|||
94207979|NCT00692913|322556655|FG001|Overall Study|Lost to Follow-up|5|||
94207980|NCT00692913|322556654|FG000|Overall Study|Physician Decision|2|||
94282135|NCT01928381|322821478|FG004|Washout First Intervention|Protocol Violation|1|||
94282136|NCT01928381|322821479|FG005|Washout First Intervention|Protocol Violation|0|||
94282137|NCT01928381|322821480|FG006|Washout First Intervention|Protocol Violation|0|||
94282138|NCT01928381|322821474|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
94282139|NCT01928381|322821475|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
94207981|NCT00692913|322556655|FG001|Overall Study|Physician Decision|0|||
94207982|NCT00692913|322556654|FG000|Overall Study|Protocol Violation|1|||
94207983|NCT00692913|322556655|FG001|Overall Study|Protocol Violation|1|||
94207984|NCT00692913|322556654|FG000|Overall Study|Withdrawal by Subject|15|||
94207985|NCT00692913|322556655|FG001|Overall Study|Withdrawal by Subject|20|||
94207986|NCT04017611|322556656|FG000|Overall Study|Withdrawn prior to completion|1|||
94207987|NCT00754325|322556665|FG000|Initial Treatment|Continuing Active Treatment|4|||
94207988|NCT00754325|322556666|FG001|Initial Treatment|Continuing Active Treatment|5|||
94282140|NCT01928381|322821476|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
94282141|NCT01928381|322821477|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
94282142|NCT01928381|322821478|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
94207989|NCT00754325|322556665|FG000|Initial Treatment|Adverse Event|7|||
94207990|NCT00754325|322556666|FG001|Initial Treatment|Adverse Event|6|||
94207991|NCT00754325|322556665|FG000|Initial Treatment|Withdrawal by Subject|2|||
94207992|NCT00754325|322556666|FG001|Initial Treatment|Withdrawal by Subject|2|||
94207993|NCT00754325|322556665|FG000|Initial Treatment|Physician Decision|2|||
94207994|NCT00754325|322556666|FG001|Initial Treatment|Physician Decision|0|||
94207995|NCT00754325|322556665|FG000|Initial Treatment|Sponsor Request|0|||
94207996|NCT00754325|322556666|FG001|Initial Treatment|Sponsor Request|1|||
94282143|NCT01928381|322821479|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
94282144|NCT01928381|322821480|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
94282145|NCT01928381|322821474|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
94282146|NCT01928381|322821475|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
94282147|NCT01928381|322821476|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
94282148|NCT01928381|322821477|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
94282149|NCT01928381|322821478|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
94282150|NCT01928381|322821479|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
94282151|NCT01928381|322821480|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
94282152|NCT01564862|322821483|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
94282153|NCT01564862|322821484|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
94282154|NCT01564862|322821485|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
94282155|NCT01564862|322821483|FG000|Overall Study|Major Protocol Deviation|3|||
94282156|NCT01564862|322821484|FG001|Overall Study|Major Protocol Deviation|3|||
94282157|NCT01564862|322821485|FG002|Overall Study|Major Protocol Deviation|4|||
94207997|NCT00754325|322556665|FG000|Initial Treatment|Disease Progression|35|||
94207998|NCT00754325|322556666|FG001|Initial Treatment|Disease Progression|35|||
94207999|NCT01372085|322556669|FG000|Washout Period 2|Physician Decision|0|||
94208000|NCT01372085|322556670|FG001|Washout Period 2|Physician Decision|0|||
94208001|NCT01372085|322556671|FG002|Washout Period 2|Physician Decision|0|||
94208002|NCT01372085|322556672|FG003|Washout Period 2|Physician Decision|0|||
94282158|NCT01564862|322821483|FG000|Overall Study|Lost to Follow-up|10|||
94282159|NCT01564862|322821484|FG001|Overall Study|Lost to Follow-up|8|||
94282160|NCT01564862|322821485|FG002|Overall Study|Lost to Follow-up|6|||
94282161|NCT01564862|322821483|FG000|Overall Study|Voluntary Withdrawal|9|||
94282162|NCT01564862|322821484|FG001|Overall Study|Voluntary Withdrawal|6|||
94282163|NCT01564862|322821485|FG002|Overall Study|Voluntary Withdrawal|8|||
94282164|NCT01564862|322821483|FG000|Overall Study|Lack of Efficacy|1|||
94282165|NCT01564862|322821484|FG001|Overall Study|Lack of Efficacy|5|||
94282166|NCT01564862|322821485|FG002|Overall Study|Lack of Efficacy|6|||
94282167|NCT01564862|322821483|FG000|Overall Study|Other reason(s)|1|||
94282168|NCT01564862|322821484|FG001|Overall Study|Other reason(s)|0|||
94282169|NCT01564862|322821485|FG002|Overall Study|Other reason(s)|0|||
94282170|NCT02193074|322821488|FG000|Overall Study|Withdrawal by Subject|1|||
94282171|NCT02193074|322821489|FG001|Overall Study|Withdrawal by Subject|2|||
94282172|NCT02193074|322821488|FG000|Overall Study|Adverse Event|16|||
94282173|NCT02193074|322821489|FG001|Overall Study|Adverse Event|13|||
94282174|NCT02926950|322821490|FG000|Overall Study|Adverse Event|4|||
94282175|NCT02926950|322821491|FG001|Overall Study|Adverse Event|6|||
94282176|NCT02926950|322821490|FG000|Overall Study|At the participant's own request|21|||
94208003|NCT01372085|322556673|FG004|Washout Period 2|Physician Decision|1|||
94208004|NCT01372085|322556674|FG005|Washout Period 2|Physician Decision|0|||
94208005|NCT01372085|322556675|FG006|Washout Period 2|Physician Decision|0|||
94208006|NCT01372085|322556676|FG007|Washout Period 2|Physician Decision|0|||
94282177|NCT02926950|322821491|FG001|Overall Study|At the participant's own request|25|||
94282178|NCT02926950|322821490|FG000|Overall Study|Reason not Specified|17|||
94282179|NCT02926950|322821491|FG001|Overall Study|Reason not Specified|9|||
94282180|NCT02926950|322821490|FG000|Overall Study|Lost to Follow-up|7|||
94282181|NCT02926950|322821491|FG001|Overall Study|Lost to Follow-up|8|||
94282182|NCT02867995|322821492|FG000|Overall Study|Withdrawal by Subject|0|||
94282183|NCT02867995|322821493|FG001|Overall Study|Withdrawal by Subject|1|||
94282184|NCT02867995|322821492|FG000|Overall Study|Lost to Follow-up|0|||
94282185|NCT02867995|322821493|FG001|Overall Study|Lost to Follow-up|2|||
94282186|NCT02068547|322823392|FG000|Overall Study|Lost to Follow-up|3|||
94282187|NCT02068547|322823393|FG001|Overall Study|Lost to Follow-up|3|||
94282188|NCT02068547|322823392|FG000|Overall Study|Physician Decision|1|||
94282189|NCT02068547|322823393|FG001|Overall Study|Physician Decision|0|||
94208007|NCT01372085|322556677|FG008|Washout Period 2|Physician Decision|0|||
94208008|NCT01372085|322556678|FG009|Washout Period 2|Physician Decision|0|||
94282190|NCT00150592|322823394|FG000|Overall Study|Adverse Event|4|||
94282191|NCT00150592|322823395|FG001|Overall Study|Adverse Event|1|||
94282192|NCT00150592|322823394|FG000|Overall Study|Protocol Violation|1|||
94282193|NCT00150592|322823395|FG001|Overall Study|Protocol Violation|0|||
94282194|NCT00150592|322823394|FG000|Overall Study|Withdrawal by Subject|1|||
94282195|NCT00150592|322823395|FG001|Overall Study|Withdrawal by Subject|2|||
94282196|NCT00150592|322823394|FG000|Overall Study|Non-compliance|1|||
94282197|NCT00150592|322823395|FG001|Overall Study|Non-compliance|0|||
94282198|NCT00112905|322823399|FG000|Overall Study|Adverse Event|4|||
94282199|NCT00112905|322823399|FG000|Overall Study|Death|1|||
94282200|NCT00112905|322823399|FG000|Overall Study|Ineligibility|5|||
94282201|NCT00112905|322823399|FG000|Overall Study|Alternative treatment|1|||
94282202|NCT00112905|322823399|FG000|Overall Study|performance status was deteiorating|1|||
94282203|NCT04541004|322823400|FG000|Overall Study|Adverse Event|2|||
94282204|NCT03691974|322823403|FG000|Overall Study|Physician Decision|1|||
94282205|NCT03691974|322823404|FG001|Overall Study|Physician Decision|0|||
94282206|NCT03691974|322823403|FG000|Overall Study|Adverse Event|1|||
94282207|NCT03691974|322823404|FG001|Overall Study|Adverse Event|0|||
94282208|NCT03691974|322823403|FG000|Overall Study|Withdrawal by Subject|11|||
94282209|NCT03691974|322823404|FG001|Overall Study|Withdrawal by Subject|9|||
94282210|NCT03691974|322823403|FG000|Overall Study|Protocol Violation|1|||
94282211|NCT03691974|322823404|FG001|Overall Study|Protocol Violation|0|||
94282212|NCT03691974|322823403|FG000|Overall Study|Lost to Follow-up|8|||
94282213|NCT03691974|322823404|FG001|Overall Study|Lost to Follow-up|7|||
94282214|NCT03927105|322823407|FG000|Overall Study|Death|1|||
94282215|NCT03927105|322823407|FG000|Overall Study|In observation for potential re-treatment|2|||
94282216|NCT03927105|322823407|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
94282217|NCT01514682|322823412|FG000|Overall Study|Withdrawal by Subject|2|||
94282218|NCT01514682|322823413|FG001|Overall Study|Withdrawal by Subject|3|||
94282219|NCT01514682|322823412|FG000|Overall Study|Physician Decision|4|||
94282220|NCT01514682|322823413|FG001|Overall Study|Physician Decision|3|||
94282221|NCT05594173|322823414|FG000|Overall Study|Adverse Event|1|||
94282222|NCT05594173|322823414|FG000|Overall Study|COVID-19 Pandemic|2|||
94282223|NCT00527605|322823415|FG000|Overall Study|Adverse Event|3|||
94282224|NCT00527605|322823416|FG001|Overall Study|Adverse Event|0|||
94282225|NCT00527605|322823415|FG000|Overall Study|Withdrawal by Subject|3|||
94282226|NCT00527605|322823416|FG001|Overall Study|Withdrawal by Subject|7|||
94282227|NCT00527605|322823415|FG000|Overall Study|Lost to Follow-up|6|||
94282228|NCT00527605|322823416|FG001|Overall Study|Lost to Follow-up|2|||
94282229|NCT00527605|322823415|FG000|Overall Study|Protocol Violation|1|||
94282230|NCT00527605|322823416|FG001|Overall Study|Protocol Violation|2|||
94282231|NCT02615990|322823417|FG000|Overall Study|study terminated|1|||
94282232|NCT02615990|322823418|FG001|Overall Study|study terminated|1|||
94282233|NCT04312009|322823419|FG000|Overall Study|Withdrawal by Subject|2|||
94282234|NCT04312009|322823420|FG001|Overall Study|Withdrawal by Subject|1|||
94282235|NCT00130832|322823421|FG000|Overall Study|Adverse Event|1|||
94282236|NCT00130832|322823422|FG001|Overall Study|Adverse Event|1|||
94208009|NCT01372085|322556669|FG000|Washout Period 3|Withdrawal by Subject|0|||
94208010|NCT01372085|322556670|FG001|Washout Period 3|Withdrawal by Subject|0|||
94208011|NCT01372085|322556671|FG002|Washout Period 3|Withdrawal by Subject|0|||
94208012|NCT01372085|322556672|FG003|Washout Period 3|Withdrawal by Subject|0|||
94208013|NCT01372085|322556673|FG004|Washout Period 3|Withdrawal by Subject|0|||
94208014|NCT01372085|322556674|FG005|Washout Period 3|Withdrawal by Subject|2|||
94208015|NCT01372085|322556675|FG006|Washout Period 3|Withdrawal by Subject|0|||
94208016|NCT01372085|322556676|FG007|Washout Period 3|Withdrawal by Subject|0|||
94208017|NCT01372085|322556677|FG008|Washout Period 3|Withdrawal by Subject|0|||
94208018|NCT01372085|322556678|FG009|Washout Period 3|Withdrawal by Subject|0|||
94208019|NCT02824198|322556679|FG000|Overall Study|Non-compliance with the protocol|5|||
94208020|NCT02824198|322556680|FG001|Overall Study|Non-compliance with the protocol|1|||
94208021|NCT02824198|322556679|FG000|Overall Study|Lost to Follow-up|5|||
94208022|NCT02824198|322556680|FG001|Overall Study|Lost to Follow-up|2|||
94208023|NCT02824198|322556679|FG000|Overall Study|Withdrawal by Subject|5|||
94208024|NCT02824198|322556680|FG001|Overall Study|Withdrawal by Subject|0|||
94208025|NCT00777049|322556681|FG000|Overall Study|Withdrawal by Subject|1|||
94208026|NCT00777049|322556682|FG001|Overall Study|Withdrawal by Subject|0|||
94208027|NCT00777049|322556681|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
94208028|NCT00777049|322556682|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
94208029|NCT00562094|322556683|FG000|Overall Study|Lost to Follow-up|62|||
94208030|NCT03689946|322556684|FG000|Overall Study|Withdrawal by Subject|3|||
94208031|NCT03689946|322556684|FG000|Overall Study|Lost to Follow-up|3|||
94208032|NCT03689946|322556684|FG000|Overall Study|Data corruption|2|||
94208033|NCT00403494|322556688|FG000|Overall Study|Adverse Event|10|||
94208034|NCT00403494|322556689|FG001|Overall Study|Adverse Event|8|||
94208035|NCT00403494|322556688|FG000|Overall Study|Withdrew Consent|3|||
94208036|NCT00403494|322556689|FG001|Overall Study|Withdrew Consent|2|||
94208037|NCT00403494|322556688|FG000|Overall Study|Inappropriately enrolled|0|||
94208038|NCT00403494|322556689|FG001|Overall Study|Inappropriately enrolled|1|||
94208039|NCT00403494|322556688|FG000|Overall Study|Lost to Follow-up|0|||
94208040|NCT00403494|322556689|FG001|Overall Study|Lost to Follow-up|2|||
94208041|NCT00403494|322556688|FG000|Overall Study|Protocol noncompliance|0|||
94208042|NCT00403494|322556689|FG001|Overall Study|Protocol noncompliance|1|||
94208043|NCT00403494|322556688|FG000|Overall Study|Death|1|||
94208044|NCT00403494|322556689|FG001|Overall Study|Death|0|||
94208045|NCT00403494|322556688|FG000|Overall Study|Sponsor Request|1|||
94208046|NCT00403494|322556689|FG001|Overall Study|Sponsor Request|0|||
94208047|NCT00463229|322556695|FG000|Overall Study|Lost to Follow-up|5|||
94208048|NCT00463229|322556696|FG001|Overall Study|Lost to Follow-up|7|||
94208049|NCT00463229|322556695|FG000|Overall Study|Death|4|||
94208050|NCT00463229|322556696|FG001|Overall Study|Death|3|||
94208051|NCT04971733|322556704|FG000|Overall Study|Adverse Event|1|||
94208052|NCT04971733|322556705|FG001|Overall Study|Adverse Event|1|||
94208053|NCT04971733|322556704|FG000|Overall Study|Subject choice|2|||
94208054|NCT04971733|322556705|FG001|Overall Study|Subject choice|0|||
94208055|NCT04971733|322556704|FG000|Overall Study|Withdrawal by Subject|1|||
94208056|NCT04971733|322556705|FG001|Overall Study|Withdrawal by Subject|0|||
94208057|NCT04971733|322556704|FG000|Overall Study|Other|1|||
94208058|NCT04971733|322556705|FG001|Overall Study|Other|0|||
94208059|NCT00503906|322556706|FG000|Overall Study|Withdrawal by Subject|1|||
94372059|NCT00845026|323148480|FG000|Study Period IV|Scheduling conflict|1|||
94372060|NCT00845026|323148481|FG001|Study Period IV|Scheduling conflict|0|||
94372061|NCT00879970|323148482|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
94372062|NCT00879970|323148483|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
94372063|NCT00879970|323148484|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
94208060|NCT01499849|322556710|FG000|Overall Study|Adverse Event|28|||
94208061|NCT01499849|322556711|FG001|Overall Study|Adverse Event|32|||
94208062|NCT01499849|322556710|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
94208063|NCT01499849|322556711|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
94208064|NCT01499849|322556710|FG000|Overall Study|Withdrawal by Subject|43|||
94208065|NCT01499849|322556711|FG001|Overall Study|Withdrawal by Subject|43|||
94208066|NCT01499849|322556710|FG000|Overall Study|Death|5|||
94208067|NCT01499849|322556711|FG001|Overall Study|Death|7|||
94208068|NCT01499849|322556710|FG000|Overall Study|Disease Progression|11|||
94208069|NCT01499849|322556711|FG001|Overall Study|Disease Progression|10|||
94208070|NCT01499849|322556710|FG000|Overall Study|Protocol Violation|11|||
94372064|NCT00879970|323148485|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
94208071|NCT01499849|322556711|FG001|Overall Study|Protocol Violation|11|||
94208072|NCT01499849|322556710|FG000|Overall Study|Physician Decision|20|||
94208073|NCT01499849|322556711|FG001|Overall Study|Physician Decision|19|||
94208074|NCT01499849|322556710|FG000|Overall Study|Lack of Efficacy|3|||
94208075|NCT01499849|322556711|FG001|Overall Study|Lack of Efficacy|4|||
94208076|NCT01499849|322556710|FG000|Overall Study|Lost to Follow-up|6|||
94208077|NCT01499849|322556711|FG001|Overall Study|Lost to Follow-up|3|||
94208078|NCT01499849|322556710|FG000|Overall Study|Other Reasons|27|||
94208079|NCT01499849|322556711|FG001|Overall Study|Other Reasons|30|||
94282237|NCT00130832|322823421|FG000|Overall Study|Lost to Follow-up|1|||
94282238|NCT00130832|322823422|FG001|Overall Study|Lost to Follow-up|2|||
94282239|NCT00130832|322823421|FG000|Overall Study|Protocol Violation|6|||
94282240|NCT00130832|322823422|FG001|Overall Study|Protocol Violation|8|||
94282241|NCT00130832|322823421|FG000|Overall Study|Withdrawal by Subject|6|||
94282242|NCT00130832|322823422|FG001|Overall Study|Withdrawal by Subject|1|||
94282243|NCT00130832|322823421|FG000|Overall Study|Moved|2|||
94282244|NCT00130832|322823422|FG001|Overall Study|Moved|2|||
94282245|NCT00130832|322823421|FG000|Overall Study|Other|0|||
94282246|NCT00130832|322823422|FG001|Overall Study|Other|3|||
94208080|NCT01437319|322556712|FG000|Phase I|Lost to Follow-up|2|||
94208081|NCT01437319|322556713|FG001|Phase I|Lost to Follow-up|0|||
94208082|NCT01437319|322556714|FG002|Phase I|Lost to Follow-up|0|||
94208083|NCT01437319|322556712|FG000|Phase I|Protocol Violation|1|||
94208084|NCT01437319|322556713|FG001|Phase I|Protocol Violation|0|||
94208085|NCT01437319|322556714|FG002|Phase I|Protocol Violation|0|||
94208086|NCT01437319|322556712|FG000|Phase I|Study related symptoms/complaints|27|||
94208087|NCT01437319|322556713|FG001|Phase I|Study related symptoms/complaints|0|||
94208088|NCT01437319|322556714|FG002|Phase I|Study related symptoms/complaints|0|||
94208089|NCT01437319|322556712|FG000|Phase I|Withdrawal by Subject|25|||
94208090|NCT01437319|322556713|FG001|Phase I|Withdrawal by Subject|0|||
94208091|NCT01437319|322556714|FG002|Phase I|Withdrawal by Subject|0|||
94208092|NCT01437319|322556712|FG000|Phase II|Withdrawal by Subject|0|||
94208093|NCT01437319|322556713|FG001|Phase II|Withdrawal by Subject|8|||
94208094|NCT01437319|322556714|FG002|Phase II|Withdrawal by Subject|16|||
94208095|NCT01437319|322556712|FG000|Phase II|Lost to Follow-up|0|||
94208096|NCT01437319|322556713|FG001|Phase II|Lost to Follow-up|7|||
94282247|NCT02111564|322823423|FG000|Overall Study|Death|109|||
94282248|NCT02111564|322823424|FG001|Overall Study|Death|120|||
94282249|NCT02111564|322823423|FG000|Overall Study|Lost to Follow-up|2|||
94282250|NCT02111564|322823424|FG001|Overall Study|Lost to Follow-up|3|||
94282251|NCT02111564|322823423|FG000|Overall Study|Withdrawal by Subject|20|||
94282252|NCT02111564|322823424|FG001|Overall Study|Withdrawal by Subject|20|||
94282253|NCT02354703|322823425|FG000|Overall Study|Withdrawal by Subject|1|||
94282254|NCT02354703|322823426|FG001|Overall Study|Withdrawal by Subject|1|||
94282255|NCT02354703|322823427|FG002|Overall Study|Withdrawal by Subject|1|||
94282256|NCT02354703|322823428|FG003|Overall Study|Withdrawal by Subject|1|||
94208097|NCT01437319|322556714|FG002|Phase II|Lost to Follow-up|2|||
94208098|NCT01437319|322556712|FG000|Phase II|Study related symptoms/complaints|0|||
94208099|NCT01437319|322556713|FG001|Phase II|Study related symptoms/complaints|28|||
94208100|NCT01437319|322556714|FG002|Phase II|Study related symptoms/complaints|19|||
94282257|NCT02354703|322823425|FG000|Overall Study|Lost to Follow-up|2|||
94282258|NCT02354703|322823426|FG001|Overall Study|Lost to Follow-up|7|||
94282259|NCT02354703|322823427|FG002|Overall Study|Lost to Follow-up|9|||
94282260|NCT02354703|322823428|FG003|Overall Study|Lost to Follow-up|2|||
94208101|NCT01437319|322556712|FG000|Phase II|Protocol Violation|0|||
94208102|NCT01437319|322556713|FG001|Phase II|Protocol Violation|1|||
94208103|NCT01437319|322556714|FG002|Phase II|Protocol Violation|0|||
94208104|NCT00853593|322556715|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
94208105|NCT00853593|322556715|FG000|Overall Study|Model 4396 lead not attempted|29|||
94208106|NCT00853593|322556715|FG000|Overall Study|Implant not attempted|4|||
94208107|NCT00942266|322556716|FG000|Overall Study|Withdrawal by Subject|1|||
94208108|NCT00942266|322556717|FG001|Overall Study|Withdrawal by Subject|0|||
94208109|NCT00942266|322556716|FG000|Overall Study|Adverse Event|2|||
94208110|NCT00942266|322556717|FG001|Overall Study|Adverse Event|1|||
94208111|NCT00942266|322556716|FG000|Overall Study|Disease Progression|38|||
94208112|NCT00942266|322556717|FG001|Overall Study|Disease Progression|11|||
94208113|NCT00942266|322556716|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
94208114|NCT00942266|322556717|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
94208115|NCT00942266|322556716|FG000|Overall Study|Intercurrent illness|0|||
94208116|NCT00942266|322556717|FG001|Overall Study|Intercurrent illness|1|||
94208117|NCT00942266|322556716|FG000|Overall Study|Physician Decision|2|||
94208118|NCT00942266|322556717|FG001|Overall Study|Physician Decision|0|||
94208119|NCT00942266|322556716|FG000|Overall Study|medical deterioration (pneumonia)|0|||
94208120|NCT00942266|322556717|FG001|Overall Study|medical deterioration (pneumonia)|1|||
94208121|NCT00600353|322556719|FG000|Overall Study|history of malignancy within 5 years|1|||
94208122|NCT00600353|322556720|FG001|Overall Study|history of malignancy within 5 years|0|||
94208123|NCT00600353|322556719|FG000|Overall Study|History of prepartive regimen|0|||
94208124|NCT00600353|322556720|FG001|Overall Study|History of prepartive regimen|1|||
94282261|NCT02354703|322823425|FG000|Overall Study|Adverse Event|0|||
94282262|NCT02354703|322823426|FG001|Overall Study|Adverse Event|0|||
94282263|NCT02354703|322823427|FG002|Overall Study|Adverse Event|1|||
94282264|NCT02354703|322823428|FG003|Overall Study|Adverse Event|0|||
94208125|NCT03229408|322556721|FG000|Overall Study|Withdrawal by Subject|4|||
94208126|NCT03229408|322556722|FG001|Overall Study|Withdrawal by Subject|1|||
94208127|NCT03229408|322556721|FG000|Overall Study|Adverse Event|2|||
94208128|NCT03229408|322556722|FG001|Overall Study|Adverse Event|0|||
94208129|NCT03229408|322556721|FG000|Overall Study|Pregnancy|0|||
94208130|NCT03229408|322556722|FG001|Overall Study|Pregnancy|1|||
94372065|NCT00879970|323148486|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
94208131|NCT03229408|322556721|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
94208132|NCT03229408|322556722|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
94208133|NCT03304587|322556723|FG000|Overall Study|Headache after intervention|0|||
94208134|NCT03304587|322556724|FG001|Overall Study|Headache after intervention|1|||
94282265|NCT02944448|322823432|FG000|Overall Study|Adverse Event|37|||
94282266|NCT02944448|322823433|FG001|Overall Study|Adverse Event|6|||
94282267|NCT02944448|322823432|FG000|Overall Study|Lack of Efficacy|8|||
94282268|NCT02944448|322823433|FG001|Overall Study|Lack of Efficacy|5|||
94282269|NCT02944448|322823432|FG000|Overall Study|Lost to Follow-up|3|||
94282270|NCT02944448|322823433|FG001|Overall Study|Lost to Follow-up|1|||
94282271|NCT02944448|322823432|FG000|Overall Study|Protocol Violation|25|||
94282272|NCT02944448|322823433|FG001|Overall Study|Protocol Violation|7|||
94372066|NCT00879970|323148482|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
94372067|NCT00879970|323148483|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
94282273|NCT02944448|322823432|FG000|Overall Study|Withdrawal by Subject|14|||
94282274|NCT02944448|322823433|FG001|Overall Study|Withdrawal by Subject|4|||
94282275|NCT02944448|322823432|FG000|Overall Study|Sponsor did not supply drug in time|0|||
94282276|NCT02944448|322823433|FG001|Overall Study|Sponsor did not supply drug in time|1|||
94282277|NCT02944448|322823432|FG000|Overall Study|Noncompliant with dosing|1|||
94282278|NCT02944448|322823433|FG001|Overall Study|Noncompliant with dosing|0|||
94282279|NCT02944448|322823432|FG000|Overall Study|Abnormal laboratory values|1|||
94282280|NCT02944448|322823433|FG001|Overall Study|Abnormal laboratory values|0|||
94282281|NCT00559507|322823436|FG000|Overall Study|Not treated, patient ineligible|3|||
94282282|NCT02889796|322823439|FG000|Overall Study|Withdrew Consent|18|||
94282283|NCT02889796|322823440|FG001|Overall Study|Withdrew Consent|29|||
94282284|NCT02889796|322823441|FG002|Overall Study|Withdrew Consent|20|||
94282285|NCT02889796|322823442|FG003|Overall Study|Withdrew Consent|1|||
94282286|NCT02889796|322823443|FG004|Overall Study|Withdrew Consent|2|||
94282287|NCT02889796|322823444|FG005|Overall Study|Withdrew Consent|35|||
94282288|NCT02889796|322823439|FG000|Overall Study|Investigator's Discretion|10|||
94282289|NCT02889796|322823440|FG001|Overall Study|Investigator's Discretion|9|||
94282290|NCT02889796|322823441|FG002|Overall Study|Investigator's Discretion|10|||
94282291|NCT02889796|322823442|FG003|Overall Study|Investigator's Discretion|3|||
94282292|NCT02889796|322823443|FG004|Overall Study|Investigator's Discretion|0|||
94282293|NCT02889796|322823444|FG005|Overall Study|Investigator's Discretion|15|||
94282294|NCT02889796|322823439|FG000|Overall Study|Adverse Event|17|||
94282295|NCT02889796|322823440|FG001|Overall Study|Adverse Event|8|||
94282296|NCT02889796|322823441|FG002|Overall Study|Adverse Event|8|||
94282297|NCT02889796|322823442|FG003|Overall Study|Adverse Event|4|||
94282298|NCT02889796|322823443|FG004|Overall Study|Adverse Event|1|||
94282299|NCT02889796|322823444|FG005|Overall Study|Adverse Event|7|||
94282300|NCT02889796|322823439|FG000|Overall Study|Lost to Follow-up|5|||
94282301|NCT02889796|322823440|FG001|Overall Study|Lost to Follow-up|7|||
94282302|NCT02889796|322823441|FG002|Overall Study|Lost to Follow-up|2|||
94282303|NCT02889796|322823442|FG003|Overall Study|Lost to Follow-up|0|||
94282304|NCT02889796|322823443|FG004|Overall Study|Lost to Follow-up|2|||
94372068|NCT00879970|323148484|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
94372069|NCT00879970|323148485|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
94372070|NCT00879970|323148486|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
94372071|NCT00879970|323148482|FG000|Period 1 TZD Randomization|Death|2|||
94282305|NCT02889796|322823444|FG005|Overall Study|Lost to Follow-up|6|||
94282306|NCT02889796|322823439|FG000|Overall Study|Protocol Violation|0|||
94282307|NCT02889796|322823440|FG001|Overall Study|Protocol Violation|1|||
94282308|NCT02889796|322823441|FG002|Overall Study|Protocol Violation|3|||
94372072|NCT00879970|323148483|FG001|Period 1 TZD Randomization|Death|1|||
94282309|NCT02889796|322823442|FG003|Overall Study|Protocol Violation|0|||
94282310|NCT02889796|322823443|FG004|Overall Study|Protocol Violation|0|||
94282311|NCT02889796|322823444|FG005|Overall Study|Protocol Violation|4|||
94282312|NCT02889796|322823439|FG000|Overall Study|Non-compliance With Study Drug|0|||
94282313|NCT02889796|322823440|FG001|Overall Study|Non-compliance With Study Drug|2|||
94282314|NCT02889796|322823441|FG002|Overall Study|Non-compliance With Study Drug|0|||
94282315|NCT02889796|322823442|FG003|Overall Study|Non-compliance With Study Drug|0|||
94282316|NCT02889796|322823443|FG004|Overall Study|Non-compliance With Study Drug|1|||
94282317|NCT02889796|322823444|FG005|Overall Study|Non-compliance With Study Drug|2|||
94208135|NCT03304587|322556723|FG000|Overall Study|Withdrawal by Subject|1|||
94208136|NCT03304587|322556724|FG001|Overall Study|Withdrawal by Subject|0|||
94208137|NCT02426138|322556728|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
94208138|NCT02426138|322556729|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
94208139|NCT00687219|322556730|FG000|Overall Study|Adverse Event|8|||
94208140|NCT00687219|322556730|FG000|Overall Study|Discontinuance criteria met|7|||
94208141|NCT00687219|322556730|FG000|Overall Study|HCV-RNA positive conversion|34|||
94208142|NCT00687219|322556730|FG000|Overall Study|Withdrawal by Subject|1|||
94208143|NCT00687219|322556730|FG000|Overall Study|Lack of Efficacy|1|||
94208144|NCT04821271|322556735|FG000|Period 1|Withdrawal by Subject|2|||
94208145|NCT04821271|322556736|FG001|Period 1|Withdrawal by Subject|0|||
94208146|NCT00553332|322556737|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
94208147|NCT00467272|322556744|FG000|Overall Study|Pneumonia|2|||
94208148|NCT00467272|322556744|FG000|Overall Study|Thrombophlebitis|1|||
94208149|NCT03102034|322556745|FG000|Overall Study|Withdrawal by Subject|1|||
94208150|NCT03102034|322556746|FG001|Overall Study|Withdrawal by Subject|0|||
94208151|NCT02222493|322556747|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
94208152|NCT02222493|322556748|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
94208153|NCT02222493|322556747|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
94208154|NCT02222493|322556748|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
94208155|NCT02222493|322556747|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
94208156|NCT02222493|322556748|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
94208157|NCT02222493|322556747|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
94208158|NCT02222493|322556748|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
94208159|NCT02222493|322556747|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
94208160|NCT02222493|322556748|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
94208161|NCT02222493|322556747|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
94208162|NCT02222493|322556748|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
94208163|NCT02222493|322556747|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
94208164|NCT02222493|322556748|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
94208165|NCT02222493|322556747|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
94208166|NCT02222493|322556748|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
94208167|NCT02222493|322556747|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
94208168|NCT02222493|322556748|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
94208169|NCT02222493|322556747|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
94208170|NCT02222493|322556748|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
94208171|NCT02222493|322556747|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
94208172|NCT02222493|322556748|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
94208173|NCT02222493|322556747|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
94208174|NCT02222493|322556748|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
94208175|NCT02222493|322556747|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
94208176|NCT02222493|322556748|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
94208177|NCT02222493|322556747|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
94208178|NCT02222493|322556748|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
94208179|NCT02222493|322556747|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
94208180|NCT02222493|322556748|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
94208181|NCT02222493|322556747|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
94208182|NCT02222493|322556748|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
94208183|NCT02222493|322556747|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
94208184|NCT02222493|322556748|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
94208185|NCT02222493|322556747|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
94208186|NCT02222493|322556748|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
94208187|NCT02222493|322556747|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
94208188|NCT02222493|322556748|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
94208189|NCT02222493|322556747|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
94208190|NCT02222493|322556748|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
94208191|NCT02222493|322556747|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
94208192|NCT02222493|322556748|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
94208193|NCT02222493|322556747|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
94208194|NCT02222493|322556748|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
94208195|NCT03662659|322556752|FG000|Pre-treatment|Participant no longer met study criteria|1|||
94282318|NCT02889796|322823439|FG000|Overall Study|Death|1|||
94282319|NCT02889796|322823440|FG001|Overall Study|Death|1|||
94282320|NCT02889796|322823441|FG002|Overall Study|Death|0|||
94282321|NCT02889796|322823442|FG003|Overall Study|Death|1|||
94282322|NCT02889796|322823443|FG004|Overall Study|Death|0|||
94282323|NCT02889796|322823444|FG005|Overall Study|Death|1|||
94282324|NCT02889796|322823439|FG000|Overall Study|Pregnancy|0|||
94282325|NCT02889796|322823440|FG001|Overall Study|Pregnancy|1|||
94282326|NCT02889796|322823441|FG002|Overall Study|Pregnancy|1|||
94282327|NCT02889796|322823442|FG003|Overall Study|Pregnancy|0|||
94282328|NCT02889796|322823443|FG004|Overall Study|Pregnancy|0|||
94282329|NCT02889796|322823444|FG005|Overall Study|Pregnancy|0|||
94282330|NCT02889796|322823439|FG000|Overall Study|Randomized but not Dosed|2|||
94282331|NCT02889796|322823440|FG001|Overall Study|Randomized but not Dosed|0|||
94282332|NCT02889796|322823441|FG002|Overall Study|Randomized but not Dosed|0|||
94282333|NCT02889796|322823442|FG003|Overall Study|Randomized but not Dosed|0|||
94282334|NCT02889796|322823443|FG004|Overall Study|Randomized but not Dosed|0|||
94282335|NCT02889796|322823444|FG005|Overall Study|Randomized but not Dosed|2|||
94282336|NCT00488982|322823447|FG000|Course 1|Physician Decision|0|||
94282337|NCT00488982|322823448|FG001|Course 1|Physician Decision|2|||
94282338|NCT00488982|322823449|FG002|Course 1|Physician Decision|4|||
94282339|NCT00488982|322823447|FG000|Course 1|Withdrawal by Subject|0|||
94282340|NCT00488982|322823448|FG001|Course 1|Withdrawal by Subject|8|||
94282341|NCT00488982|322823449|FG002|Course 1|Withdrawal by Subject|2|||
94282342|NCT00488982|322823447|FG000|Course 1|nonprotocol therapy|0|||
94282343|NCT00488982|322823448|FG001|Course 1|nonprotocol therapy|2|||
94282344|NCT00488982|322823449|FG002|Course 1|nonprotocol therapy|2|||
94282345|NCT00488982|322823447|FG000|Course 1|Adverse Event|0|||
94282346|NCT00488982|322823448|FG001|Course 1|Adverse Event|0|||
94282347|NCT00488982|322823449|FG002|Course 1|Adverse Event|6|||
94282348|NCT02787863|322823450|FG000|Overall Study|Death|1|||
94282349|NCT02787863|322823451|FG001|Overall Study|Death|0|||
94282350|NCT02787863|322823452|FG002|Overall Study|Death|1|||
94282351|NCT02787863|322823453|FG003|Overall Study|Death|0|||
94282352|NCT02787863|322823454|FG004|Overall Study|Death|0|||
94282353|NCT02787863|322823455|FG005|Overall Study|Death|0|||
94282354|NCT02787863|322823456|FG006|Overall Study|Death|0|||
94282355|NCT02787863|322823457|FG007|Overall Study|Death|0|||
94282356|NCT02787863|322823450|FG000|Overall Study|Withdrawal by Subject|0|||
94282357|NCT02787863|322823451|FG001|Overall Study|Withdrawal by Subject|1|||
94282358|NCT02787863|322823452|FG002|Overall Study|Withdrawal by Subject|1|||
94282359|NCT02787863|322823453|FG003|Overall Study|Withdrawal by Subject|0|||
94282360|NCT02787863|322823454|FG004|Overall Study|Withdrawal by Subject|0|||
94282361|NCT02787863|322823455|FG005|Overall Study|Withdrawal by Subject|0|||
94208196|NCT03662659|322556753|FG001|Pre-treatment|Participant no longer met study criteria|1|||
94208197|NCT03662659|322556752|FG000|Pre-treatment|Other reasons|1|||
94208198|NCT03662659|322556753|FG001|Pre-treatment|Other reasons|0|||
94208199|NCT03662659|322556752|FG000|Treatment|Completed Treatment|0|||
94208200|NCT03662659|322556753|FG001|Treatment|Completed Treatment|2|||
94208201|NCT03662659|322556752|FG000|Treatment|Disease Progression|85|||
94208202|NCT03662659|322556753|FG001|Treatment|Disease Progression|97|||
94208203|NCT03662659|322556752|FG000|Treatment|Study Drug Toxicity|19|||
94208204|NCT03662659|322556753|FG001|Treatment|Study Drug Toxicity|9|||
94208205|NCT03662659|322556752|FG000|Treatment|Death|11|||
94208206|NCT03662659|322556753|FG001|Treatment|Death|9|||
94208207|NCT03662659|322556752|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
94208208|NCT03662659|322556753|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
94208209|NCT03662659|322556752|FG000|Treatment|Withdrawal by Subject|1|||
94208210|NCT03662659|322556753|FG001|Treatment|Withdrawal by Subject|1|||
94208211|NCT03662659|322556752|FG000|Treatment|Poor/Non-compliance|1|||
94208212|NCT03662659|322556753|FG001|Treatment|Poor/Non-compliance|0|||
94208213|NCT03662659|322556752|FG000|Treatment|Participant no longer meets study criteria|1|||
94208214|NCT03662659|322556753|FG001|Treatment|Participant no longer meets study criteria|0|||
94208215|NCT03662659|322556752|FG000|Treatment|Other reasons|10|||
94208216|NCT03662659|322556753|FG001|Treatment|Other reasons|8|||
94208217|NCT03662659|322556752|FG000|Treatment|Administrative reasons by sponsor|1|||
94282362|NCT02787863|322823456|FG006|Overall Study|Withdrawal by Subject|0|||
94282363|NCT02787863|322823457|FG007|Overall Study|Withdrawal by Subject|0|||
94282364|NCT01368835|322823458|FG000|Overall Study|Inclusion criteria/photography quality|22|||
94282365|NCT01368835|322823458|FG000|Overall Study|Lost to Follow-up|11|||
94282366|NCT01414257|322823459|FG000|Overall Study|No Visit After First Day of Treatment|12|||
94282367|NCT01414257|322823459|FG000|Overall Study|Protocol Violation|10|||
94282368|NCT01978093|322823461|FG000|Overall Study|Death|1|||
94282369|NCT01978093|322823462|FG001|Overall Study|Death|0|||
94282370|NCT01978093|322823461|FG000|Overall Study|Adverse Event|0|||
94282371|NCT01978093|322823462|FG001|Overall Study|Adverse Event|5|||
94282372|NCT01978093|322823461|FG000|Overall Study|Protocol Violation|8|||
94282373|NCT01978093|322823462|FG001|Overall Study|Protocol Violation|2|||
94282374|NCT01978093|322823461|FG000|Overall Study|Withdrawal by Subject|29|||
94282375|NCT01978093|322823462|FG001|Overall Study|Withdrawal by Subject|25|||
94282376|NCT01978093|322823461|FG000|Overall Study|Lost to Follow-up|11|||
94282377|NCT01978093|322823462|FG001|Overall Study|Lost to Follow-up|15|||
94282378|NCT01978093|322823461|FG000|Overall Study|Migrated/moved from study area|11|||
94282379|NCT01978093|322823462|FG001|Overall Study|Migrated/moved from study area|13|||
94282380|NCT01978093|322823461|FG000|Overall Study|Loss of kaiser coverage|4|||
94282381|NCT01978093|322823462|FG001|Overall Study|Loss of kaiser coverage|10|||
94282382|NCT01978093|322823461|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
94282383|NCT01978093|322823462|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
94282384|NCT01978093|322823461|FG000|Overall Study|Mother lost custody of child|0|||
94282385|NCT01978093|322823462|FG001|Overall Study|Mother lost custody of child|1|||
94282386|NCT01978093|322823461|FG000|Overall Study|Child was in care of grandmother|0|||
94282387|NCT01978093|322823462|FG001|Overall Study|Child was in care of grandmother|1|||
94282388|NCT01978093|322823461|FG000|Overall Study|N/A for vaccine administration|0|||
94282389|NCT01978093|322823462|FG001|Overall Study|N/A for vaccine administration|1|||
94282390|NCT03178487|322823465|FG000|Period 1|Adverse Event|1|||
94282391|NCT03178487|322823466|FG001|Period 1|Adverse Event|2|||
94282392|NCT03178487|322823465|FG000|Period 1|Withdrawal by Subject|2|||
94282393|NCT03178487|322823466|FG001|Period 1|Withdrawal by Subject|1|||
94282394|NCT03178487|322823465|FG000|Period 1|Lost to Follow-up|1|||
94282395|NCT03178487|322823466|FG001|Period 1|Lost to Follow-up|0|||
94282396|NCT03178487|322823465|FG000|Period 1|Other|0|||
94282397|NCT03178487|322823466|FG001|Period 1|Other|1|||
94282398|NCT03178487|322823465|FG000|Period 2|Adverse Event|4|||
94282399|NCT03178487|322823466|FG001|Period 2|Adverse Event|4|||
94372073|NCT00879970|323148484|FG002|Period 1 TZD Randomization|Death|0|||
94372074|NCT00879970|323148485|FG003|Period 1 TZD Randomization|Death|0|||
94372075|NCT00879970|323148486|FG004|Period 1 TZD Randomization|Death|0|||
94208218|NCT03662659|322556753|FG001|Treatment|Administrative reasons by sponsor|0|||
94208219|NCT03662659|322556752|FG000|Treatment|maximum clinical benefit|0|||
94208220|NCT03662659|322556753|FG001|Treatment|maximum clinical benefit|2|||
94208221|NCT02434328|322556755|FG000|Overall Study|Adverse Event|9|||
94208222|NCT02434328|322556756|FG001|Overall Study|Adverse Event|4|||
94208223|NCT02434328|322556755|FG000|Overall Study|Lack of Efficacy|0|||
94282400|NCT03178487|322823465|FG000|Period 2|Withdrawal by Subject|6|||
94282401|NCT03178487|322823466|FG001|Period 2|Withdrawal by Subject|6|||
94282402|NCT03178487|322823465|FG000|Period 2|Lost to Follow-up|2|||
94282403|NCT03178487|322823466|FG001|Period 2|Lost to Follow-up|2|||
94282404|NCT03178487|322823465|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
94208224|NCT02434328|322556756|FG001|Overall Study|Lack of Efficacy|2|||
94208225|NCT02434328|322556755|FG000|Overall Study|Physician Decision|0|||
94208226|NCT02434328|322556756|FG001|Overall Study|Physician Decision|1|||
94208227|NCT02434328|322556755|FG000|Overall Study|Withdrawal by Subject|12|||
94208228|NCT02434328|322556756|FG001|Overall Study|Withdrawal by Subject|21|||
94208229|NCT02434328|322556755|FG000|Overall Study|Death|4|||
94208230|NCT02434328|322556756|FG001|Overall Study|Death|7|||
94208231|NCT02434328|322556755|FG000|Overall Study|Lost to Follow-up|1|||
94208232|NCT02434328|322556756|FG001|Overall Study|Lost to Follow-up|6|||
94208233|NCT02434328|322556755|FG000|Overall Study|Other|4|||
94208234|NCT02434328|322556756|FG001|Overall Study|Other|1|||
94208235|NCT00647387|322556759|FG000|Overall Study|Lost to Follow-up|6|||
94208236|NCT00647387|322556759|FG000|Overall Study|Unsuccessful implant|5|||
94208237|NCT00647387|322556759|FG000|Overall Study|Device explanted|3|||
94208238|NCT00647387|322556759|FG000|Overall Study|Other Reason|3|||
94208239|NCT00647387|322556759|FG000|Overall Study|Death|2|||
94208240|NCT05432986|322556768|FG000|Overall Study|Withdrawal by Subject|2|||
94208241|NCT05432986|322556768|FG000|Overall Study|incomplete measurement|7|||
94208242|NCT03762850|322558500|FG000|Overall Study|Death|0|||
94208243|NCT03762850|322558501|FG001|Overall Study|Death|1|||
94208244|NCT03762850|322558500|FG000|Overall Study|Lost to Follow-up|0|||
94208245|NCT03762850|322558501|FG001|Overall Study|Lost to Follow-up|1|||
94208246|NCT03762850|322558500|FG000|Overall Study|Physician Decision|0|||
94208247|NCT03762850|322558501|FG001|Overall Study|Physician Decision|1|||
94208248|NCT03762850|322558500|FG000|Overall Study|Withdrawal by Subject|4|||
94208249|NCT03762850|322558501|FG001|Overall Study|Withdrawal by Subject|9|||
94208250|NCT03083366|322558502|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
94208251|NCT03083366|322558503|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
94208252|NCT03083366|322558502|FG000|Enrollment Period|Lack of Efficacy|1|||
94208253|NCT03083366|322558503|FG001|Enrollment Period|Lack of Efficacy|0|||
94208254|NCT02036970|322558504|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
94208255|NCT02036970|322558505|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
94208256|NCT02036970|322558506|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
94208257|NCT02036970|322558507|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
94208258|NCT02036970|322558508|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
94208259|NCT02036970|322558509|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
94208260|NCT02036970|322558510|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
94208261|NCT02036970|322558511|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
94208262|NCT02036970|322558512|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
94208263|NCT02036970|322558513|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
94208264|NCT02036970|322558504|FG000|Part 1: Day 1 Through Week 16|Death|0|||
94208265|NCT02036970|322558505|FG001|Part 1: Day 1 Through Week 16|Death|0|||
94282405|NCT03178487|322823466|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
94282406|NCT03178487|322823465|FG000|Period 2|Other|8|||
94282407|NCT03178487|322823466|FG001|Period 2|Other|7|||
94282408|NCT01453855|322823467|FG000|Overall Study|Adverse Event|3|||
94282409|NCT01453855|322823468|FG001|Overall Study|Adverse Event|4|||
94282410|NCT01453855|322823467|FG000|Overall Study|Lost to Follow-up|2|||
94282411|NCT01453855|322823468|FG001|Overall Study|Lost to Follow-up|1|||
94282412|NCT01453855|322823467|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
94282413|NCT01453855|322823468|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
94282414|NCT01453855|322823467|FG000|Overall Study|Noncompliance|1|||
94282415|NCT01453855|322823468|FG001|Overall Study|Noncompliance|0|||
94282416|NCT01453855|322823467|FG000|Overall Study|Inadequate Control of IOP|1|||
94282417|NCT01453855|322823468|FG001|Overall Study|Inadequate Control of IOP|5|||
94208266|NCT02036970|322558506|FG002|Part 1: Day 1 Through Week 16|Death|0|||
94208267|NCT02036970|322558507|FG003|Part 1: Day 1 Through Week 16|Death|0|||
94208268|NCT02036970|322558508|FG004|Part 1: Day 1 Through Week 16|Death|0|||
94208269|NCT02036970|322558509|FG005|Part 1: Day 1 Through Week 16|Death|0|||
94208270|NCT02036970|322558510|FG006|Part 1: Day 1 Through Week 16|Death|0|||
94208271|NCT02036970|322558511|FG007|Part 1: Day 1 Through Week 16|Death|0|||
94208272|NCT02036970|322558512|FG008|Part 1: Day 1 Through Week 16|Death|1|||
94208273|NCT02036970|322558513|FG009|Part 1: Day 1 Through Week 16|Death|0|||
94208274|NCT02036970|322558504|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
94282418|NCT01453855|322823467|FG000|Overall Study|Other|0|||
94282419|NCT01453855|322823468|FG001|Overall Study|Other|1|||
94282420|NCT00252057|322823469|FG000|Overall Study|Withdrawal by Subject|2|||
94282421|NCT00252057|322823470|FG001|Overall Study|Withdrawal by Subject|5|||
94372076|NCT00879970|323148482|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
94282422|NCT00252057|322823469|FG000|Overall Study|Death|1|||
94282423|NCT00252057|322823470|FG001|Overall Study|Death|2|||
94282424|NCT00252057|322823469|FG000|Overall Study|Participant previously enrolled|0|||
94282425|NCT00252057|322823470|FG001|Overall Study|Participant previously enrolled|1|||
94282426|NCT01587079|322823473|FG000|Overall Study|Protocol-specified criteria|9|||
94282427|NCT01587079|322823473|FG000|Overall Study|Protocol Violation|5|||
94282428|NCT01587079|322823473|FG000|Overall Study|Lost to Follow-up|2|||
94282429|NCT01587079|322823473|FG000|Overall Study|Physician Decision|2|||
94282430|NCT01587079|322823473|FG000|Overall Study|Withdrawal by Subject|7|||
94282431|NCT01587079|322823473|FG000|Overall Study|Adverse Event|14|||
94282432|NCT01294800|322823474|FG000|Overall Study|Adverse Event|7|||
94282433|NCT01294800|322823475|FG001|Overall Study|Adverse Event|6|||
94282434|NCT01294800|322823476|FG002|Overall Study|Adverse Event|12|||
94282435|NCT01294800|322823477|FG003|Overall Study|Adverse Event|5|||
94282436|NCT01294800|322823474|FG000|Overall Study|Subject Withdrew Consent|2|||
94282437|NCT01294800|322823475|FG001|Overall Study|Subject Withdrew Consent|2|||
94282438|NCT01294800|322823476|FG002|Overall Study|Subject Withdrew Consent|2|||
94282439|NCT01294800|322823477|FG003|Overall Study|Subject Withdrew Consent|11|||
94282440|NCT01294800|322823474|FG000|Overall Study|Lost to Follow-up|0|||
94282441|NCT01294800|322823475|FG001|Overall Study|Lost to Follow-up|0|||
94282442|NCT01294800|322823476|FG002|Overall Study|Lost to Follow-up|1|||
94282443|NCT01294800|322823477|FG003|Overall Study|Lost to Follow-up|0|||
94282444|NCT01294800|322823474|FG000|Overall Study|Non-compliance With Protocol|0|||
94208275|NCT02036970|322558505|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
94208276|NCT02036970|322558506|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
94208277|NCT02036970|322558507|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
94208278|NCT02036970|322558508|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
94208279|NCT02036970|322558509|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
94208280|NCT02036970|322558510|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
94208281|NCT02036970|322558511|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
94208282|NCT02036970|322558512|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
94208283|NCT02036970|322558513|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
94208284|NCT02036970|322558504|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
94208285|NCT02036970|322558505|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
94208286|NCT02036970|322558506|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
94208287|NCT02036970|322558507|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
94208288|NCT02036970|322558508|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
94208289|NCT02036970|322558509|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
94208290|NCT02036970|322558510|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
94208291|NCT02036970|322558511|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
94282445|NCT01294800|322823475|FG001|Overall Study|Non-compliance With Protocol|1|||
94282446|NCT01294800|322823476|FG002|Overall Study|Non-compliance With Protocol|1|||
94282447|NCT01294800|322823477|FG003|Overall Study|Non-compliance With Protocol|0|||
94282448|NCT01294800|322823474|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
94282449|NCT01294800|322823475|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
94282450|NCT01294800|322823476|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
94282451|NCT01294800|322823477|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
94282452|NCT01276236|322823487|FG000|Overall Study|Lack of Efficacy|2|||
94282453|NCT01276236|322823487|FG000|Overall Study|Withdrawal by Subject|4|||
94208292|NCT02036970|322558512|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
94282454|NCT01294579|322823488|FG000|Overall Study|Disease progression|12|||
94282455|NCT01294579|322823488|FG000|Overall Study|Adverse Event|11|||
94282456|NCT01294579|322823488|FG000|Overall Study|Study closed/terminated|3|||
94282457|NCT01294579|322823488|FG000|Overall Study|Lost to Follow-up|1|||
94372077|NCT00879970|323148483|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
94208293|NCT02036970|322558513|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
94282458|NCT01294579|322823488|FG000|Overall Study|Physician Decision|3|||
94282459|NCT01294579|322823488|FG000|Overall Study|Withdrawal by Subject|5|||
94282460|NCT00262873|322823491|FG000|Overall Study|Adverse Event|3|||
94282461|NCT00262873|322823491|FG000|Overall Study|Withdrawal by Subject|5|||
94282462|NCT03461757|322823494|FG000|Overall Study|Adverse Event|1|||
94282463|NCT03461757|322823495|FG001|Overall Study|Adverse Event|0|||
94282464|NCT03461757|322823494|FG000|Overall Study|Lost to Follow-up|13|||
94282465|NCT03461757|322823495|FG001|Overall Study|Lost to Follow-up|7|||
94282466|NCT03461757|322823494|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
94282467|NCT03461757|322823495|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
94282468|NCT03461757|322823494|FG000|Overall Study|Non-compliance with study treatment|0|||
94282469|NCT03461757|322823495|FG001|Overall Study|Non-compliance with study treatment|1|||
94282470|NCT03461757|322823494|FG000|Overall Study|Pregnancy|2|||
94282471|NCT03461757|322823495|FG001|Overall Study|Pregnancy|0|||
94282472|NCT03461757|322823494|FG000|Overall Study|Protocol Violation|1|||
94282473|NCT03461757|322823495|FG001|Overall Study|Protocol Violation|1|||
94282474|NCT03461757|322823494|FG000|Overall Study|Withdrawal by Subject|7|||
94282475|NCT03461757|322823495|FG001|Overall Study|Withdrawal by Subject|7|||
94282476|NCT03461757|322823494|FG000|Overall Study|Other Reasons|1|||
94282477|NCT03461757|322823495|FG001|Overall Study|Other Reasons|4|||
94282478|NCT00357500|322823496|FG000|Overall Study|Adverse Event|3|||
94282479|NCT00357500|322823496|FG000|Overall Study|Withdrawal by Subject|5|||
94208294|NCT02036970|322558504|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
94208295|NCT02036970|322558505|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
94208296|NCT02036970|322558506|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
94208297|NCT02036970|322558507|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
94208298|NCT02036970|322558508|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
94208299|NCT02036970|322558509|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
94208300|NCT02036970|322558510|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
94208301|NCT02036970|322558511|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
94208302|NCT02036970|322558512|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
94208303|NCT02036970|322558513|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
94208304|NCT02036970|322558504|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
94208305|NCT02036970|322558505|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
94208306|NCT02036970|322558506|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
94208307|NCT02036970|322558507|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
94208308|NCT02036970|322558508|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
94208309|NCT02036970|322558509|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
94208310|NCT02036970|322558510|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
94208311|NCT02036970|322558511|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
94208312|NCT02036970|322558512|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
94208313|NCT02036970|322558513|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
94208314|NCT02036970|322558504|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
94208315|NCT02036970|322558505|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
94208316|NCT02036970|322558506|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
94208317|NCT02036970|322558507|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
94208318|NCT02036970|322558508|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
94208319|NCT02036970|322558509|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
94208320|NCT02036970|322558510|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
94208321|NCT02036970|322558511|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
94208322|NCT02036970|322558512|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
94208323|NCT02036970|322558513|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
94208324|NCT02036970|322558504|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
94208325|NCT02036970|322558505|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
94208326|NCT02036970|322558506|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
94208327|NCT02036970|322558507|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
94208328|NCT02036970|322558508|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
94208329|NCT02036970|322558509|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
94208330|NCT02036970|322558510|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
94208331|NCT02036970|322558511|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
94208332|NCT02036970|322558512|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
94208333|NCT02036970|322558513|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
94282480|NCT00357500|322823496|FG000|Overall Study|Progressive Disease|65|||
94282481|NCT00357500|322823496|FG000|Overall Study|Not Started Protocol Therapy|4|||
94282482|NCT03033875|322823497|FG000|Overall Study|Withdrawal by Subject|5|||
94282483|NCT03033875|322823498|FG001|Overall Study|Withdrawal by Subject|9|||
94282484|NCT03033875|322823499|FG002|Overall Study|Withdrawal by Subject|4|||
94282485|NCT03033875|322823497|FG000|Overall Study|Other|14|||
94282486|NCT03033875|322823498|FG001|Overall Study|Other|15|||
94282487|NCT03033875|322823499|FG002|Overall Study|Other|8|||
94282488|NCT00903929|322823506|FG000|Overall Study|Withdrawal by Subject|0|||
94282489|NCT00903929|322823507|FG001|Overall Study|Withdrawal by Subject|0|||
94282490|NCT00903929|322823508|FG002|Overall Study|Withdrawal by Subject|1|||
94282491|NCT00903929|322823509|FG003|Overall Study|Withdrawal by Subject|2|||
94282492|NCT00903929|322823506|FG000|Overall Study|Adverse Event|0|||
94282493|NCT00903929|322823507|FG001|Overall Study|Adverse Event|0|||
94282494|NCT00903929|322823508|FG002|Overall Study|Adverse Event|0|||
94282495|NCT00903929|322823509|FG003|Overall Study|Adverse Event|1|||
94282496|NCT01913483|322823510|FG000|Overall Study|Withdrawal by Subject|1|||
94282497|NCT01913483|322823511|FG001|Overall Study|Withdrawal by Subject|2|||
94282498|NCT01913483|322823510|FG000|Overall Study|Lost to Follow-up|6|||
94282499|NCT01913483|322823511|FG001|Overall Study|Lost to Follow-up|3|||
94208334|NCT02036970|322558504|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
94208335|NCT02036970|322558505|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
94208336|NCT02036970|322558506|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
94208337|NCT02036970|322558507|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
94208338|NCT02036970|322558508|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
94208339|NCT02036970|322558509|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
94208340|NCT02036970|322558510|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
94208341|NCT02036970|322558511|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
94208342|NCT02036970|322558512|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
94208343|NCT02036970|322558513|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
94208344|NCT03861052|322558514|FG000|Overall Study|Adverse Event|1|||
94208345|NCT03861052|322558515|FG001|Overall Study|Adverse Event|1|||
94208346|NCT03861052|322558516|FG002|Overall Study|Adverse Event|2|||
94208347|NCT03861052|322558517|FG003|Overall Study|Adverse Event|4|||
94208348|NCT03861052|322558514|FG000|Overall Study|Lost to Follow-up|0|||
94208349|NCT03861052|322558515|FG001|Overall Study|Lost to Follow-up|0|||
94208350|NCT03861052|322558516|FG002|Overall Study|Lost to Follow-up|0|||
94208351|NCT03861052|322558517|FG003|Overall Study|Lost to Follow-up|1|||
94208352|NCT03861052|322558514|FG000|Overall Study|Physician Decision|0|||
94208353|NCT03861052|322558515|FG001|Overall Study|Physician Decision|1|||
94208354|NCT03861052|322558516|FG002|Overall Study|Physician Decision|0|||
94208355|NCT03861052|322558517|FG003|Overall Study|Physician Decision|0|||
94208356|NCT03861052|322558514|FG000|Overall Study|Withdrawal by Subject|2|||
94208357|NCT03861052|322558515|FG001|Overall Study|Withdrawal by Subject|5|||
94208358|NCT03861052|322558516|FG002|Overall Study|Withdrawal by Subject|3|||
94208359|NCT03861052|322558517|FG003|Overall Study|Withdrawal by Subject|0|||
94208360|NCT03861052|322558514|FG000|Overall Study|Relocation to other city|1|||
94208361|NCT03861052|322558515|FG001|Overall Study|Relocation to other city|0|||
94208362|NCT03861052|322558516|FG002|Overall Study|Relocation to other city|0|||
94208363|NCT03861052|322558517|FG003|Overall Study|Relocation to other city|0|||
94208364|NCT03009344|322558518|FG000|Overall Study|Lack of Efficacy|5|||
94208365|NCT03009344|322558518|FG000|Overall Study|Withdrawal by Subject|1|||
94208366|NCT03009344|322558518|FG000|Overall Study|Adverse Event|1|||
94208367|NCT03678688|322558519|FG000|Overall Study|Reason not Specified|0|||
94208368|NCT03678688|322558520|FG001|Overall Study|Reason not Specified|0|||
94208369|NCT03678688|322558521|FG002|Overall Study|Reason not Specified|3|||
94208370|NCT03678688|322558522|FG003|Overall Study|Reason not Specified|0|||
94208371|NCT03678688|322558523|FG004|Overall Study|Reason not Specified|1|||
94208372|NCT03678688|322558524|FG005|Overall Study|Reason not Specified|0|||
94208373|NCT03678688|322558525|FG006|Overall Study|Reason not Specified|0|||
94208374|NCT03678688|322558526|FG007|Overall Study|Reason not Specified|0|||
94208375|NCT03678688|322558527|FG008|Overall Study|Reason not Specified|0|||
94208376|NCT03678688|322558519|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
94208377|NCT03678688|322558520|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
94208378|NCT03678688|322558521|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
94208379|NCT03678688|322558522|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
94208380|NCT03678688|322558523|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
94208381|NCT03678688|322558524|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
94208382|NCT03678688|322558525|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
94208383|NCT03678688|322558526|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
94208384|NCT03678688|322558527|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
94208385|NCT03678688|322558519|FG000|Overall Study|Covid Related Adverse Event|0|||
94208386|NCT03678688|322558520|FG001|Overall Study|Covid Related Adverse Event|0|||
94208387|NCT03678688|322558521|FG002|Overall Study|Covid Related Adverse Event|0|||
94208388|NCT03678688|322558522|FG003|Overall Study|Covid Related Adverse Event|0|||
94208389|NCT03678688|322558523|FG004|Overall Study|Covid Related Adverse Event|0|||
94208390|NCT03678688|322558524|FG005|Overall Study|Covid Related Adverse Event|3|||
94208391|NCT03678688|322558525|FG006|Overall Study|Covid Related Adverse Event|1|||
94208392|NCT03678688|322558526|FG007|Overall Study|Covid Related Adverse Event|1|||
94208393|NCT03678688|322558527|FG008|Overall Study|Covid Related Adverse Event|0|||
94208394|NCT03678688|322558519|FG000|Overall Study|Physician Decision|0|||
94208395|NCT03678688|322558520|FG001|Overall Study|Physician Decision|0|||
94208396|NCT03678688|322558521|FG002|Overall Study|Physician Decision|0|||
94208397|NCT03678688|322558522|FG003|Overall Study|Physician Decision|0|||
94208398|NCT03678688|322558523|FG004|Overall Study|Physician Decision|0|||
94208399|NCT03678688|322558524|FG005|Overall Study|Physician Decision|1|||
94208400|NCT03678688|322558525|FG006|Overall Study|Physician Decision|0|||
94208401|NCT03678688|322558526|FG007|Overall Study|Physician Decision|0|||
94208402|NCT03678688|322558527|FG008|Overall Study|Physician Decision|0|||
94208403|NCT03678688|322558519|FG000|Overall Study|Withdrawal by Subject|0|||
94208404|NCT03678688|322558520|FG001|Overall Study|Withdrawal by Subject|0|||
94208405|NCT03678688|322558521|FG002|Overall Study|Withdrawal by Subject|0|||
94208406|NCT03678688|322558522|FG003|Overall Study|Withdrawal by Subject|0|||
94208407|NCT03678688|322558523|FG004|Overall Study|Withdrawal by Subject|0|||
94208408|NCT03678688|322558524|FG005|Overall Study|Withdrawal by Subject|0|||
94208409|NCT03678688|322558525|FG006|Overall Study|Withdrawal by Subject|2|||
94208410|NCT03678688|322558526|FG007|Overall Study|Withdrawal by Subject|1|||
94208411|NCT03678688|322558527|FG008|Overall Study|Withdrawal by Subject|0|||
94208412|NCT00551421|322558528|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
94208413|NCT03395197|322558529|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
94208414|NCT03395197|322558530|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
94208415|NCT03395197|322558531|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
94208416|NCT03395197|322558532|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
94208417|NCT03395197|322558533|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
94208418|NCT03395197|322558534|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
94208419|NCT03395197|322558529|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
94208420|NCT03395197|322558530|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
94208421|NCT03395197|322558531|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
94208422|NCT03395197|322558532|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
94208423|NCT03395197|322558533|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
94208424|NCT03395197|322558534|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
94208425|NCT03395197|322558529|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
94208426|NCT03395197|322558530|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
94208427|NCT03395197|322558531|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
94208428|NCT03395197|322558532|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
94208429|NCT03395197|322558533|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
94208430|NCT03395197|322558534|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
94208431|NCT03395197|322558529|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
94208432|NCT03395197|322558530|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
94208433|NCT03395197|322558531|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
94208434|NCT03395197|322558532|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
94208435|NCT03395197|322558533|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
94208436|NCT03395197|322558534|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
94208437|NCT03395197|322558529|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
94208438|NCT03395197|322558530|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
94208439|NCT03395197|322558531|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
94208440|NCT03395197|322558532|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
94208441|NCT03395197|322558533|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
94208442|NCT03395197|322558534|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
94208443|NCT03395197|322558529|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
94282500|NCT01913483|322823510|FG000|Overall Study|Death|14|||
94282501|NCT01913483|322823511|FG001|Overall Study|Death|17|||
94282502|NCT01844895|322823513|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
94282503|NCT01844895|322823513|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
94208444|NCT03395197|322558530|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
94282504|NCT01844895|322823513|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
94282505|NCT01844895|322823513|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
94208445|NCT03395197|322558531|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
94208446|NCT03395197|322558532|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
94208447|NCT03395197|322558533|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
94208448|NCT03395197|322558534|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
94208449|NCT03395197|322558529|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
94208450|NCT03395197|322558530|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
94208451|NCT03395197|322558531|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
94208452|NCT03395197|322558532|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
94208453|NCT03395197|322558533|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
94208454|NCT03395197|322558534|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
94208455|NCT03395197|322558529|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
94208456|NCT03395197|322558530|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
94208457|NCT03395197|322558531|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
94208458|NCT03395197|322558532|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
94208459|NCT03395197|322558533|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
94208460|NCT03395197|322558534|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
94208461|NCT03395197|322558529|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
94208462|NCT03395197|322558530|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
94208463|NCT03395197|322558531|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
94208464|NCT03395197|322558532|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
94208465|NCT03395197|322558533|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
94208466|NCT03395197|322558534|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
94208467|NCT03395197|322558529|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
94208468|NCT03395197|322558530|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
94208469|NCT03395197|322558531|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
94208470|NCT03395197|322558532|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
94208471|NCT03395197|322558533|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
94208472|NCT03395197|322558534|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
94208473|NCT03395197|322558529|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
94208474|NCT03395197|322558530|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
94208475|NCT03395197|322558531|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
94208476|NCT03395197|322558532|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
94208477|NCT03395197|322558533|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
94208478|NCT03395197|322558534|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
94208479|NCT03395197|322558529|FG000|Analysis for DDR-Deficient Participants|Death|0|||
94208480|NCT03395197|322558530|FG001|Analysis for DDR-Deficient Participants|Death|0|||
94208481|NCT03395197|322558531|FG002|Analysis for DDR-Deficient Participants|Death|0|||
94208482|NCT03395197|322558532|FG003|Analysis for DDR-Deficient Participants|Death|0|||
94208483|NCT03395197|322558533|FG004|Analysis for DDR-Deficient Participants|Death|1|||
94208484|NCT03395197|322558534|FG005|Analysis for DDR-Deficient Participants|Death|4|||
94208485|NCT03395197|322558529|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
94208486|NCT03395197|322558530|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
94208487|NCT03395197|322558531|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
94208488|NCT03395197|322558532|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
94208489|NCT03395197|322558533|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
94208490|NCT03395197|322558534|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
94208491|NCT03395197|322558529|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
94208492|NCT03395197|322558530|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
94208493|NCT03395197|322558531|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
94208494|NCT03395197|322558532|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
94208495|NCT03395197|322558533|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
94208496|NCT03395197|322558534|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
94208497|NCT03395197|322558529|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
94208498|NCT03395197|322558530|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
94208499|NCT03395197|322558531|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
94208500|NCT03395197|322558532|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
94208501|NCT03395197|322558533|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
94208502|NCT03395197|322558534|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
94208503|NCT03395197|322558529|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
94208504|NCT03395197|322558530|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
94208505|NCT03395197|322558531|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
94208506|NCT03395197|322558532|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
94208507|NCT03395197|322558533|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
94208508|NCT03395197|322558534|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
94208509|NCT03395197|322558529|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
94208510|NCT03395197|322558530|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
94208511|NCT03395197|322558531|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
94208512|NCT03395197|322558532|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
94208513|NCT03395197|322558533|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
94208514|NCT03395197|322558534|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
94208515|NCT03395197|322558529|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
94208516|NCT03395197|322558530|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
94208517|NCT03395197|322558531|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
94208518|NCT03395197|322558532|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
94208519|NCT03395197|322558533|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
94208520|NCT03395197|322558534|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
94208521|NCT03395197|322558529|FG000|Analysis for DDR-Deficient Participants|Other|0|||
94208522|NCT03395197|322558530|FG001|Analysis for DDR-Deficient Participants|Other|0|||
94208523|NCT03395197|322558531|FG002|Analysis for DDR-Deficient Participants|Other|0|||
94208524|NCT03395197|322558532|FG003|Analysis for DDR-Deficient Participants|Other|0|||
94208525|NCT03395197|322558533|FG004|Analysis for DDR-Deficient Participants|Other|3|||
94208526|NCT03395197|322558534|FG005|Analysis for DDR-Deficient Participants|Other|3|||
94208527|NCT03395197|322558529|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
94208528|NCT03395197|322558530|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
94208529|NCT03395197|322558531|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
94208530|NCT03395197|322558532|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
94208531|NCT03395197|322558533|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
94208532|NCT03395197|322558534|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
94208533|NCT02962284|322558536|FG000|Overall Study|Death|2|||
94208534|NCT02962284|322558537|FG001|Overall Study|Death|0|||
94208535|NCT02962284|322558536|FG000|Overall Study|Progressive disease|2|||
94208536|NCT02962284|322558537|FG001|Overall Study|Progressive disease|3|||
94208537|NCT02962284|322558536|FG000|Overall Study|Withdrawal by Subject|1|||
94208538|NCT02962284|322558537|FG001|Overall Study|Withdrawal by Subject|0|||
94208539|NCT02698475|322558542|FG000|Main Study Period|Lack of Efficacy|1|||
94208540|NCT02698475|322558542|FG000|Main Study Period|Protocol Violation|2|||
94208541|NCT02698475|322558542|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
94208542|NCT02698475|322558542|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
94208543|NCT02698475|322558542|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
94208544|NCT02698475|322558542|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
94208545|NCT02698475|322558542|FG000|Long-Term Extension Period|Other|1|||
94208546|NCT04162210|322558544|FG000|Overall Study|Lost to Follow-up|4|||
94208547|NCT04162210|322558545|FG001|Overall Study|Lost to Follow-up|1|||
94208548|NCT04162210|322558544|FG000|Overall Study|Withdrawal by Subject|17|||
94208549|NCT04162210|322558545|FG001|Overall Study|Withdrawal by Subject|9|||
94208550|NCT04162210|322558544|FG000|Overall Study|Ongoing|113|||
94208551|NCT04162210|322558545|FG001|Overall Study|Ongoing|59|||
94208552|NCT01641900|322558546|FG000|Overall Study|Withdrawal by Subject|2|||
94208553|NCT01641900|322558547|FG001|Overall Study|Withdrawal by Subject|2|||
94208554|NCT00599196|322558550|FG000|Overall Study|Lack of Efficacy|22|||
94208555|NCT00599196|322558550|FG000|Overall Study|Adverse Event|93|||
94208556|NCT00599196|322558550|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
94208557|NCT00599196|322558550|FG000|Overall Study|Subject withdrew consent|43|||
94208558|NCT00599196|322558550|FG000|Overall Study|Study ended per sponsor|197|||
94208559|NCT00599196|322558550|FG000|Overall Study|Lost to Follow-up|17|||
94208560|NCT00599196|322558550|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
94282506|NCT01844895|322823513|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
94282507|NCT01844895|322823513|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
94282508|NCT01844895|322823513|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
94282509|NCT02508194|322823517|FG000|Overall Study|Death|5|||
94282510|NCT02508194|322823518|FG001|Overall Study|Death|3|||
94282511|NCT02508194|322823517|FG000|Overall Study|Lost to Follow-up|25|||
94282512|NCT02508194|322823518|FG001|Overall Study|Lost to Follow-up|18|||
94282513|NCT02508194|322823517|FG000|Overall Study|Withdrawal by Subject|20|||
94282514|NCT02508194|322823518|FG001|Overall Study|Withdrawal by Subject|18|||
94282515|NCT02508194|322823517|FG000|Overall Study|Error in Randomization|1|||
94282516|NCT02508194|322823518|FG001|Overall Study|Error in Randomization|3|||
94282517|NCT02508194|322823517|FG000|Overall Study|Principal Investigator Decision|1|||
94282518|NCT02508194|322823518|FG001|Overall Study|Principal Investigator Decision|2|||
94282519|NCT01777581|322823543|FG000|Overall Study|Lost to Follow-up|1|||
94282520|NCT01777581|322823544|FG001|Overall Study|Lost to Follow-up|1|||
94282521|NCT01777581|322823543|FG000|Overall Study|Adverse Event|2|||
94282522|NCT01777581|322823544|FG001|Overall Study|Adverse Event|0|||
94282523|NCT01777581|322823543|FG000|Overall Study|Lack of Efficacy|0|||
94282524|NCT01777581|322823544|FG001|Overall Study|Lack of Efficacy|1|||
94208561|NCT00599196|322558550|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
94208562|NCT00599196|322558550|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
94208563|NCT00599196|322558550|FG000|Overall Study|Other: Pt Moved To Australia|1|||
94208564|NCT00599196|322558550|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
94208565|NCT00599196|322558550|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
94208566|NCT02788981|322558551|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
94208567|NCT02788981|322558552|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
94208568|NCT00249769|322558553|FG000|Overall Study|Withdrawal by Subject|1|||
94208569|NCT00249769|322558554|FG001|Overall Study|Withdrawal by Subject|10|||
94208570|NCT00249769|322558555|FG002|Overall Study|Withdrawal by Subject|6|||
94208571|NCT00249769|322558553|FG000|Overall Study|Migration from Study Area|1|||
94208572|NCT00249769|322558554|FG001|Overall Study|Migration from Study Area|3|||
94208573|NCT00249769|322558555|FG002|Overall Study|Migration from Study Area|14|||
94208574|NCT00249769|322558553|FG000|Overall Study|Miscellaneous|0|||
94208575|NCT00249769|322558554|FG001|Overall Study|Miscellaneous|2|||
94208576|NCT00249769|322558555|FG002|Overall Study|Miscellaneous|2|||
94208577|NCT00249769|322558553|FG000|Overall Study|Adverse Event|0|||
94208578|NCT00249769|322558554|FG001|Overall Study|Adverse Event|0|||
94208579|NCT00249769|322558555|FG002|Overall Study|Adverse Event|1|||
94208580|NCT00249769|322558553|FG000|Overall Study|Physician Decision|0|||
94208581|NCT00249769|322558554|FG001|Overall Study|Physician Decision|0|||
94208582|NCT00249769|322558555|FG002|Overall Study|Physician Decision|2|||
94208583|NCT00249769|322558553|FG000|Overall Study|Lost to Follow-up|0|||
94208584|NCT00249769|322558554|FG001|Overall Study|Lost to Follow-up|0|||
94208585|NCT00249769|322558555|FG002|Overall Study|Lost to Follow-up|3|||
94208586|NCT00975585|322558556|FG000|Overall Study|Adverse Event|0|||
94208587|NCT00975585|322558557|FG001|Overall Study|Adverse Event|4|||
94208588|NCT00975585|322558556|FG000|Overall Study|Lost to Follow-up|3|||
94208589|NCT00975585|322558557|FG001|Overall Study|Lost to Follow-up|5|||
94208590|NCT00975585|322558556|FG000|Overall Study|Withdrawal by Subject|2|||
94208591|NCT00975585|322558557|FG001|Overall Study|Withdrawal by Subject|1|||
94208592|NCT00975585|322558556|FG000|Overall Study|Lens issue|2|||
94208593|NCT00975585|322558557|FG001|Overall Study|Lens issue|2|||
94208594|NCT02022670|322558564|FG000|Overall Study|Adverse Event|1|||
94208595|NCT02022670|322558565|FG001|Overall Study|Adverse Event|0|||
94208596|NCT02022670|322558566|FG002|Overall Study|Adverse Event|1|||
94208597|NCT03698994|322558567|FG000|Overall Study|Adverse Event|2|||
94208598|NCT03698994|322558567|FG000|Overall Study|Death|1|||
94208599|NCT03698994|322558567|FG000|Overall Study|Physician Decision|1|||
94208600|NCT03698994|322558567|FG000|Overall Study|Withdrawal by Subject|3|||
94208601|NCT03698994|322558567|FG000|Overall Study|Progressive Disease|12|||
94208602|NCT04102098|322558568|FG000|Main Study Period|Ongoing in study|302|||
94208603|NCT04102098|322558569|FG001|Main Study Period|Ongoing in study|291|||
94208604|NCT04102098|322558568|FG000|Main Study Period|Death|20|||
94208605|NCT04102098|322558569|FG001|Main Study Period|Death|27|||
94208606|NCT04102098|322558568|FG000|Main Study Period|Lost to Follow-up|1|||
94208607|NCT04102098|322558569|FG001|Main Study Period|Lost to Follow-up|1|||
94208608|NCT04102098|322558568|FG000|Main Study Period|Physician Decision|0|||
94208609|NCT04102098|322558569|FG001|Main Study Period|Physician Decision|1|||
94208610|NCT04102098|322558568|FG000|Main Study Period|Withdrawal by Subject|11|||
94208611|NCT04102098|322558569|FG001|Main Study Period|Withdrawal by Subject|14|||
94208612|NCT04102098|322558568|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
94208613|NCT04102098|322558569|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
94208614|NCT04102098|322558568|FG000|Crossover: AS Who Crossed Over|Death|11|||
94208615|NCT04102098|322558569|FG001|Crossover: AS Who Crossed Over|Death|0|||
94208616|NCT04102098|322558568|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
94208617|NCT04102098|322558569|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
94282525|NCT02270242|322823550|FG000|Overall Study|Withdrawal by Subject|18|||
94282526|NCT02270242|322823551|FG001|Overall Study|Withdrawal by Subject|25|||
94282527|NCT02270242|322823550|FG000|Overall Study|Lost to Follow-up|41|||
94282528|NCT02270242|322823551|FG001|Overall Study|Lost to Follow-up|27|||
94282529|NCT02270242|322823550|FG000|Overall Study|Physician Decision|0|||
94208618|NCT01160354|322558570|FG000|Overall Study|Death|0|||
94208619|NCT01160354|322558571|FG001|Overall Study|Death|1|||
94208620|NCT01160354|322558572|FG002|Overall Study|Death|1|||
94208621|NCT01328496|322558573|FG000|Overall Study|Significant Change in Health Status|1|||
94208622|NCT01328496|322558574|FG001|Overall Study|Significant Change in Health Status|0|||
94208623|NCT00622700|322558575|FG000|Core Treatment Period|Randomized but Not Treated|0|||
94208624|NCT00622700|322558576|FG001|Core Treatment Period|Randomized but Not Treated|2|||
94208625|NCT00622700|322558577|FG002|Core Treatment Period|Randomized but Not Treated|2|||
94208626|NCT00622700|322558578|FG003|Core Treatment Period|Randomized but Not Treated|0|||
94282530|NCT02270242|322823551|FG001|Overall Study|Physician Decision|1|||
94282531|NCT02321436|322823554|FG000|Overall Study|Withdrawal by Subject|1|||
94282532|NCT02321436|322823555|FG001|Overall Study|Withdrawal by Subject|0|||
94208627|NCT00622700|322558579|FG004|Core Treatment Period|Randomized but Not Treated|0|||
94208628|NCT00622700|322558580|FG005|Core Treatment Period|Randomized but Not Treated|0|||
94208629|NCT00622700|322558581|FG006|Core Treatment Period|Randomized but Not Treated|0|||
94208630|NCT00622700|322558575|FG000|Core Treatment Period|Adverse Event|18|||
94208631|NCT00622700|322558576|FG001|Core Treatment Period|Adverse Event|25|||
94208632|NCT00622700|322558577|FG002|Core Treatment Period|Adverse Event|18|||
94208633|NCT00622700|322558578|FG003|Core Treatment Period|Adverse Event|0|||
94208634|NCT00622700|322558579|FG004|Core Treatment Period|Adverse Event|0|||
94208635|NCT00622700|322558580|FG005|Core Treatment Period|Adverse Event|0|||
94208636|NCT00622700|322558581|FG006|Core Treatment Period|Adverse Event|0|||
94208637|NCT00622700|322558575|FG000|Core Treatment Period|Lack of Efficacy|19|||
94208638|NCT00622700|322558576|FG001|Core Treatment Period|Lack of Efficacy|6|||
94208639|NCT00622700|322558577|FG002|Core Treatment Period|Lack of Efficacy|12|||
94208640|NCT00622700|322558578|FG003|Core Treatment Period|Lack of Efficacy|0|||
94208641|NCT00622700|322558579|FG004|Core Treatment Period|Lack of Efficacy|0|||
94208642|NCT00622700|322558580|FG005|Core Treatment Period|Lack of Efficacy|0|||
94208643|NCT00622700|322558581|FG006|Core Treatment Period|Lack of Efficacy|0|||
94208644|NCT00622700|322558575|FG000|Core Treatment Period|Lost to Follow-up|1|||
94208645|NCT00622700|322558576|FG001|Core Treatment Period|Lost to Follow-up|1|||
94208646|NCT00622700|322558577|FG002|Core Treatment Period|Lost to Follow-up|1|||
94208647|NCT00622700|322558578|FG003|Core Treatment Period|Lost to Follow-up|0|||
94208648|NCT00622700|322558579|FG004|Core Treatment Period|Lost to Follow-up|0|||
94208649|NCT00622700|322558580|FG005|Core Treatment Period|Lost to Follow-up|0|||
94208650|NCT00622700|322558581|FG006|Core Treatment Period|Lost to Follow-up|0|||
94208651|NCT00622700|322558575|FG000|Core Treatment Period|Death|1|||
94208652|NCT00622700|322558576|FG001|Core Treatment Period|Death|0|||
94208653|NCT00622700|322558577|FG002|Core Treatment Period|Death|0|||
94208654|NCT00622700|322558578|FG003|Core Treatment Period|Death|0|||
94208655|NCT00622700|322558579|FG004|Core Treatment Period|Death|0|||
94208656|NCT00622700|322558580|FG005|Core Treatment Period|Death|0|||
94208657|NCT00622700|322558581|FG006|Core Treatment Period|Death|0|||
94208658|NCT00622700|322558575|FG000|Core Treatment Period|Progressive Disease|3|||
94208659|NCT00622700|322558576|FG001|Core Treatment Period|Progressive Disease|1|||
94208660|NCT00622700|322558577|FG002|Core Treatment Period|Progressive Disease|0|||
94208661|NCT00622700|322558578|FG003|Core Treatment Period|Progressive Disease|0|||
94208662|NCT00622700|322558579|FG004|Core Treatment Period|Progressive Disease|0|||
94208663|NCT00622700|322558580|FG005|Core Treatment Period|Progressive Disease|0|||
94208664|NCT00622700|322558581|FG006|Core Treatment Period|Progressive Disease|0|||
94208665|NCT00622700|322558575|FG000|Core Treatment Period|Withdrawal by Subject|12|||
94208666|NCT00622700|322558576|FG001|Core Treatment Period|Withdrawal by Subject|18|||
94208667|NCT00622700|322558577|FG002|Core Treatment Period|Withdrawal by Subject|15|||
94208668|NCT00622700|322558578|FG003|Core Treatment Period|Withdrawal by Subject|0|||
94208669|NCT00622700|322558579|FG004|Core Treatment Period|Withdrawal by Subject|0|||
94208670|NCT00622700|322558580|FG005|Core Treatment Period|Withdrawal by Subject|0|||
94208671|NCT00622700|322558581|FG006|Core Treatment Period|Withdrawal by Subject|0|||
94208672|NCT00622700|322558575|FG000|Core Treatment Period|Other than specified above|2|||
94208673|NCT00622700|322558576|FG001|Core Treatment Period|Other than specified above|2|||
94467692|NCT01004432|323502373|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
94467693|NCT01004432|323502374|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
94208674|NCT00622700|322558577|FG002|Core Treatment Period|Other than specified above|5|||
94208675|NCT00622700|322558578|FG003|Core Treatment Period|Other than specified above|0|||
94208676|NCT00622700|322558579|FG004|Core Treatment Period|Other than specified above|0|||
94208677|NCT00622700|322558580|FG005|Core Treatment Period|Other than specified above|0|||
94208678|NCT00622700|322558581|FG006|Core Treatment Period|Other than specified above|0|||
94282533|NCT02321436|322823554|FG000|Overall Study|Lost to Follow-up|0|||
94282534|NCT02321436|322823555|FG001|Overall Study|Lost to Follow-up|1|||
94282535|NCT00644787|322823556|FG000|Period 1: Titration Phase|Adverse Event|11|||
94282536|NCT00644787|322823557|FG001|Period 1: Titration Phase|Adverse Event|0|||
94282537|NCT00644787|322823558|FG002|Period 1: Titration Phase|Adverse Event|0|||
94282538|NCT00644787|322823556|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
94282539|NCT00644787|322823557|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
94282540|NCT00644787|322823558|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
94208679|NCT00622700|322558575|FG000|Extension Treatment Period|Adverse Event|0|||
94208680|NCT00622700|322558576|FG001|Extension Treatment Period|Adverse Event|0|||
94208681|NCT00622700|322558577|FG002|Extension Treatment Period|Adverse Event|0|||
94208682|NCT00622700|322558578|FG003|Extension Treatment Period|Adverse Event|5|||
94208683|NCT00622700|322558579|FG004|Extension Treatment Period|Adverse Event|9|||
94208684|NCT00622700|322558580|FG005|Extension Treatment Period|Adverse Event|6|||
94208685|NCT00622700|322558581|FG006|Extension Treatment Period|Adverse Event|8|||
94208686|NCT00622700|322558575|FG000|Extension Treatment Period|Lack of Efficacy|0|||
94208687|NCT00622700|322558576|FG001|Extension Treatment Period|Lack of Efficacy|0|||
94208688|NCT00622700|322558577|FG002|Extension Treatment Period|Lack of Efficacy|0|||
94208689|NCT00622700|322558578|FG003|Extension Treatment Period|Lack of Efficacy|2|||
94208690|NCT00622700|322558579|FG004|Extension Treatment Period|Lack of Efficacy|8|||
94208691|NCT00622700|322558580|FG005|Extension Treatment Period|Lack of Efficacy|1|||
94208692|NCT00622700|322558581|FG006|Extension Treatment Period|Lack of Efficacy|9|||
94282541|NCT00644787|322823556|FG000|Period 1: Titration Phase|Physician Decision|1|||
94208693|NCT00622700|322558575|FG000|Extension Treatment Period|Protocol Violation|0|||
94208694|NCT00622700|322558576|FG001|Extension Treatment Period|Protocol Violation|0|||
94208695|NCT00622700|322558577|FG002|Extension Treatment Period|Protocol Violation|0|||
94208696|NCT00622700|322558578|FG003|Extension Treatment Period|Protocol Violation|0|||
94282542|NCT00644787|322823557|FG001|Period 1: Titration Phase|Physician Decision|0|||
94282543|NCT00644787|322823558|FG002|Period 1: Titration Phase|Physician Decision|0|||
94282544|NCT00644787|322823556|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
94282545|NCT00644787|322823557|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
94282546|NCT00644787|322823558|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
94282547|NCT00644787|322823556|FG000|Period 1: Titration Phase|Worsening of complications|1|||
94282548|NCT00644787|322823557|FG001|Period 1: Titration Phase|Worsening of complications|0|||
94282549|NCT00644787|322823558|FG002|Period 1: Titration Phase|Worsening of complications|0|||
94282550|NCT00644787|322823556|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
94282551|NCT00644787|322823557|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
94282552|NCT00644787|322823558|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
94282553|NCT00644787|322823556|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
94282554|NCT00644787|322823557|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
94282555|NCT00644787|322823558|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
94282556|NCT00644787|322823556|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
94282557|NCT00644787|322823557|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
94282558|NCT00644787|322823558|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
94282559|NCT00644787|322823556|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
94282560|NCT00644787|322823557|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
94282561|NCT00644787|322823558|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
94282562|NCT00644787|322823556|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
94282563|NCT00644787|322823557|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
94282564|NCT00644787|322823558|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
94282565|NCT00644787|322823556|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
94282566|NCT00644787|322823557|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
94282567|NCT00644787|322823558|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
94282568|NCT00644787|322823556|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
94282569|NCT00644787|322823557|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
94282570|NCT00644787|322823558|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
94282571|NCT01489527|322823560|FG000|Overall Study|Pregnancy|9|||
94282572|NCT01489527|322823561|FG001|Overall Study|Pregnancy|14|||
94282573|NCT01489527|322823560|FG000|Overall Study|Participant moved|6|||
94208697|NCT00622700|322558579|FG004|Extension Treatment Period|Protocol Violation|0|||
94208698|NCT00622700|322558580|FG005|Extension Treatment Period|Protocol Violation|2|||
94208699|NCT00622700|322558581|FG006|Extension Treatment Period|Protocol Violation|0|||
94208700|NCT00622700|322558575|FG000|Extension Treatment Period|Lost to Follow-up|0|||
94208701|NCT00622700|322558576|FG001|Extension Treatment Period|Lost to Follow-up|0|||
94208702|NCT00622700|322558577|FG002|Extension Treatment Period|Lost to Follow-up|0|||
94282574|NCT01489527|322823561|FG001|Overall Study|Participant moved|7|||
94282575|NCT01489527|322823560|FG000|Overall Study|Withdrawal by Subject|0|||
94282576|NCT01489527|322823561|FG001|Overall Study|Withdrawal by Subject|4|||
94282577|NCT01489527|322823560|FG000|Overall Study|Lost to Follow-up|5|||
94282578|NCT01489527|322823561|FG001|Overall Study|Lost to Follow-up|1|||
94208703|NCT00622700|322558578|FG003|Extension Treatment Period|Lost to Follow-up|0|||
94208704|NCT00622700|322558579|FG004|Extension Treatment Period|Lost to Follow-up|1|||
94208705|NCT00622700|322558580|FG005|Extension Treatment Period|Lost to Follow-up|0|||
94208706|NCT00622700|322558581|FG006|Extension Treatment Period|Lost to Follow-up|0|||
94208707|NCT00622700|322558575|FG000|Extension Treatment Period|Progressive Disease|0|||
94208708|NCT00622700|322558576|FG001|Extension Treatment Period|Progressive Disease|0|||
94208709|NCT00622700|322558577|FG002|Extension Treatment Period|Progressive Disease|0|||
94208710|NCT00622700|322558578|FG003|Extension Treatment Period|Progressive Disease|1|||
94208711|NCT00622700|322558579|FG004|Extension Treatment Period|Progressive Disease|2|||
94282579|NCT01489527|322823560|FG000|Overall Study|Procedures|1|||
94282580|NCT01489527|322823561|FG001|Overall Study|Procedures|0|||
94282581|NCT01489527|322823560|FG000|Overall Study|Not compliant|1|||
94282582|NCT01489527|322823561|FG001|Overall Study|Not compliant|0|||
94282583|NCT04899232|322823562|FG000|Screening Period|Physician Decision|1|||
94282584|NCT04899232|322823563|FG001|Screening Period|Physician Decision|0|||
94282585|NCT04899232|322823564|FG002|Screening Period|Physician Decision|0|||
94282586|NCT04899232|322823562|FG000|Screening Period|Withdrawal by Subject|1|||
94282587|NCT04899232|322823563|FG001|Screening Period|Withdrawal by Subject|0|||
94282588|NCT04899232|322823564|FG002|Screening Period|Withdrawal by Subject|0|||
94282589|NCT04899232|322823562|FG000|Screening Period|Participant discharged before receiving intervention|3|||
94282590|NCT04899232|322823563|FG001|Screening Period|Participant discharged before receiving intervention|0|||
94282591|NCT04899232|322823564|FG002|Screening Period|Participant discharged before receiving intervention|0|||
94282592|NCT01031446|322823571|FG000|Overall Study|Disease Progression|38|||
94282593|NCT01031446|322823571|FG000|Overall Study|Adverse Event|9|||
94282594|NCT01031446|322823571|FG000|Overall Study|Physician Decision|4|||
94282595|NCT01031446|322823571|FG000|Overall Study|Withdrawal by Subject|3|||
94282596|NCT01031446|322823571|FG000|Overall Study|Still on treatment|1|||
94282597|NCT04818593|322823575|FG000|Overall Study|Low Oocyte Yield|8|||
94282598|NCT04818593|322823576|FG001|Overall Study|Low Oocyte Yield|8|||
94282599|NCT04818593|322823575|FG000|Overall Study|Not ICSI Insemination|7|||
94282600|NCT04818593|322823576|FG001|Overall Study|Not ICSI Insemination|7|||
94282601|NCT04818593|322823575|FG000|Overall Study|Poor Sperm Quality|2|||
94282602|NCT04818593|322823576|FG001|Overall Study|Poor Sperm Quality|2|||
94282603|NCT04818593|322823575|FG000|Overall Study|Withdrawal by Subject|2|||
94282604|NCT04818593|322823576|FG001|Overall Study|Withdrawal by Subject|2|||
94282605|NCT04818593|322823575|FG000|Overall Study|Conversion to IUI due to low response|1|||
94282606|NCT04818593|322823576|FG001|Overall Study|Conversion to IUI due to low response|1|||
94282607|NCT03505021|322823577|FG000|Overall Study|Protocol Violation|1|||
94282608|NCT03505021|322823578|FG001|Overall Study|Protocol Violation|0|||
94282609|NCT03505021|322823577|FG000|Overall Study|Death|9|||
94282610|NCT03505021|322823578|FG001|Overall Study|Death|8|||
94282611|NCT03505021|322823577|FG000|Overall Study|Consent withdrawn by subject|6|||
94282612|NCT03505021|322823578|FG001|Overall Study|Consent withdrawn by subject|1|||
94282613|NCT03505021|322823577|FG000|Overall Study|Lost to Follow-up|5|||
94282614|NCT03505021|322823578|FG001|Overall Study|Lost to Follow-up|3|||
94282615|NCT03505021|322823577|FG000|Overall Study|Adverse Event|26|||
94282616|NCT03505021|322823578|FG001|Overall Study|Adverse Event|9|||
94282617|NCT03505021|322823577|FG000|Overall Study|Disease progression|33|||
94282618|NCT03505021|322823578|FG001|Overall Study|Disease progression|17|||
94282619|NCT03505021|322823577|FG000|Overall Study|Other|11|||
94282620|NCT03505021|322823578|FG001|Overall Study|Other|5|||
94282621|NCT03505021|322823577|FG000|Overall Study|Personal reason|21|||
94282622|NCT03505021|322823578|FG001|Overall Study|Personal reason|12|||
94282623|NCT05032157|322825333|FG000|Overall Study|Adverse Event|12|||
94282624|NCT05032157|322825334|FG001|Overall Study|Adverse Event|7|||
94282625|NCT05032157|322825333|FG000|Overall Study|Pregnancy|0|||
94282626|NCT05032157|322825334|FG001|Overall Study|Pregnancy|2|||
94282627|NCT05032157|322825333|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
94282628|NCT05032157|322825334|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
94282629|NCT05032157|322825333|FG000|Overall Study|Protocol Deviation|8|||
94282630|NCT05032157|322825334|FG001|Overall Study|Protocol Deviation|4|||
94282631|NCT05032157|322825333|FG000|Overall Study|Lost to Follow-up|1|||
94282632|NCT05032157|322825334|FG001|Overall Study|Lost to Follow-up|3|||
94282633|NCT05032157|322825333|FG000|Overall Study|Physician Decision|7|||
94282634|NCT05032157|322825334|FG001|Overall Study|Physician Decision|2|||
94282635|NCT05032157|322825333|FG000|Overall Study|Patient Decision|38|||
94282636|NCT05032157|322825334|FG001|Overall Study|Patient Decision|19|||
94282637|NCT04129528|322825335|FG000|Overall Study|Adverse Event|1|||
94282638|NCT04129528|322825336|FG001|Overall Study|Adverse Event|0|||
94282639|NCT04129528|322825335|FG000|Overall Study|Physician Decision|1|||
94282640|NCT04129528|322825336|FG001|Overall Study|Physician Decision|1|||
94282641|NCT04129528|322825335|FG000|Overall Study|Withdrawal by Subject|1|||
94282642|NCT04129528|322825336|FG001|Overall Study|Withdrawal by Subject|1|||
94282643|NCT03368170|322825337|FG000|Overall Study|Adverse Event|2|||
94282644|NCT03368170|322825338|FG001|Overall Study|Adverse Event|1|||
94282645|NCT03657043|322825339|FG000|Overall Study|Withdrawal by Subject|1|||
94282646|NCT03657043|322825340|FG001|Overall Study|Withdrawal by Subject|1|||
94208712|NCT00622700|322558580|FG005|Extension Treatment Period|Progressive Disease|0|||
94282647|NCT03657043|322825341|FG002|Overall Study|Withdrawal by Subject|0|||
94282648|NCT03657043|322825342|FG003|Overall Study|Withdrawal by Subject|0|||
94282649|NCT03657043|322825343|FG004|Overall Study|Withdrawal by Subject|4|||
94282650|NCT03657043|322825339|FG000|Overall Study|Study closure by Sponsor|0|||
94282651|NCT03657043|322825340|FG001|Overall Study|Study closure by Sponsor|2|||
94282652|NCT03657043|322825341|FG002|Overall Study|Study closure by Sponsor|0|||
94282653|NCT03657043|322825342|FG003|Overall Study|Study closure by Sponsor|0|||
94282654|NCT03657043|322825343|FG004|Overall Study|Study closure by Sponsor|17|||
94372078|NCT00879970|323148484|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
94372079|NCT00879970|323148485|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
94208713|NCT00622700|322558581|FG006|Extension Treatment Period|Progressive Disease|2|||
94208714|NCT00622700|322558575|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
94208715|NCT00622700|322558576|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
94208716|NCT00622700|322558577|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
94208717|NCT00622700|322558578|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
94208718|NCT00622700|322558579|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
94208719|NCT00622700|322558580|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
94208720|NCT00622700|322558581|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
94208721|NCT00622700|322558575|FG000|Extension Treatment Period|Missing|0|||
94208722|NCT00622700|322558576|FG001|Extension Treatment Period|Missing|0|||
94208723|NCT00622700|322558577|FG002|Extension Treatment Period|Missing|0|||
94208724|NCT00622700|322558578|FG003|Extension Treatment Period|Missing|2|||
94208725|NCT00622700|322558579|FG004|Extension Treatment Period|Missing|3|||
94208726|NCT00622700|322558580|FG005|Extension Treatment Period|Missing|1|||
94282655|NCT03657043|322825339|FG000|Overall Study|Lost to Follow-up|0|||
94208727|NCT00622700|322558581|FG006|Extension Treatment Period|Missing|0|||
94208728|NCT00622700|322558575|FG000|Extension Treatment Period|Other than specified above|0|||
94282656|NCT03657043|322825340|FG001|Overall Study|Lost to Follow-up|0|||
94282657|NCT03657043|322825341|FG002|Overall Study|Lost to Follow-up|0|||
94282658|NCT03657043|322825342|FG003|Overall Study|Lost to Follow-up|0|||
94282659|NCT03657043|322825343|FG004|Overall Study|Lost to Follow-up|4|||
94282660|NCT03657043|322825339|FG000|Overall Study|Death|6|||
94282661|NCT03657043|322825340|FG001|Overall Study|Death|5|||
94282662|NCT03657043|322825341|FG002|Overall Study|Death|0|||
94282663|NCT03657043|322825342|FG003|Overall Study|Death|0|||
94282664|NCT03657043|322825343|FG004|Overall Study|Death|53|||
94282665|NCT03657043|322825339|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
94282666|NCT03657043|322825340|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
94282667|NCT03657043|322825341|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
94282668|NCT03657043|322825342|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
94655497|NCT00813761|324196037|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
94655498|NCT00813761|324196038|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
94655499|NCT00813761|324196039|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
94655500|NCT00813761|324196036|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
94655501|NCT00813761|324196037|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
94655502|NCT00813761|324196038|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
94655503|NCT00813761|324196039|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
94655504|NCT00691210|324196040|FG000|Overall Study|Progression of Disease|0|||
94655505|NCT00691210|324196041|FG001|Overall Study|Progression of Disease|0|||
94655506|NCT00691210|324196042|FG002|Overall Study|Progression of Disease|0|||
94655507|NCT00691210|324196043|FG003|Overall Study|Progression of Disease|2|||
94655508|NCT00691210|324196044|FG004|Overall Study|Progression of Disease|0|||
94655509|NCT00691210|324196045|FG005|Overall Study|Progression of Disease|0|||
94655510|NCT00691210|324196046|FG006|Overall Study|Progression of Disease|0|||
94655511|NCT00691210|324196047|FG007|Overall Study|Progression of Disease|0|||
94655512|NCT00691210|324196040|FG000|Overall Study|Lack of Efficacy|0|||
94655513|NCT00691210|324196041|FG001|Overall Study|Lack of Efficacy|0|||
94655514|NCT00691210|324196042|FG002|Overall Study|Lack of Efficacy|0|||
94655515|NCT00691210|324196043|FG003|Overall Study|Lack of Efficacy|1|||
94655516|NCT00691210|324196044|FG004|Overall Study|Lack of Efficacy|0|||
94655517|NCT00691210|324196045|FG005|Overall Study|Lack of Efficacy|1|||
94282669|NCT03657043|322825343|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
94282670|NCT03657043|322825339|FG000|Overall Study|Adverse Event|0|||
94282671|NCT03657043|322825340|FG001|Overall Study|Adverse Event|0|||
94282672|NCT03657043|322825341|FG002|Overall Study|Adverse Event|0|||
94282673|NCT03657043|322825342|FG003|Overall Study|Adverse Event|0|||
94282674|NCT03657043|322825343|FG004|Overall Study|Adverse Event|2|||
94282675|NCT03657043|322825339|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
94282676|NCT03657043|322825340|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
94282677|NCT03657043|322825341|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
94282678|NCT03657043|322825342|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
94467694|NCT01004432|323502375|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
94655518|NCT00691210|324196046|FG006|Overall Study|Lack of Efficacy|0|||
94655519|NCT00691210|324196047|FG007|Overall Study|Lack of Efficacy|0|||
94655520|NCT00503685|324196057|FG000|Overall Study|Adverse Event|0|||
94655521|NCT00503685|324196058|FG001|Overall Study|Adverse Event|0|||
94655522|NCT00503685|324196059|FG002|Overall Study|Adverse Event|2|||
94655523|NCT00503685|324196057|FG000|Overall Study|Withdrawal by Subject|0|||
94655524|NCT00503685|324196058|FG001|Overall Study|Withdrawal by Subject|1|||
94655525|NCT00503685|324196059|FG002|Overall Study|Withdrawal by Subject|0|||
94655526|NCT00503685|324196057|FG000|Overall Study|Protocol Violation|0|||
94655527|NCT00503685|324196058|FG001|Overall Study|Protocol Violation|1|||
94655528|NCT00503685|324196059|FG002|Overall Study|Protocol Violation|0|||
94282679|NCT03657043|322825343|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
94282680|NCT03657043|322825339|FG000|Overall Study|Withdrawal - declined follow-up|0|||
94282681|NCT03657043|322825340|FG001|Overall Study|Withdrawal - declined follow-up|0|||
94655529|NCT00503685|324196057|FG000|Overall Study|Eligibility Criteria Not Met|0|||
94655530|NCT00503685|324196058|FG001|Overall Study|Eligibility Criteria Not Met|1|||
94655531|NCT00503685|324196059|FG002|Overall Study|Eligibility Criteria Not Met|0|||
94282682|NCT03657043|322825341|FG002|Overall Study|Withdrawal - declined follow-up|0|||
94282683|NCT03657043|322825342|FG003|Overall Study|Withdrawal - declined follow-up|0|||
94282684|NCT03657043|322825343|FG004|Overall Study|Withdrawal - declined follow-up|1|||
94282685|NCT02831673|322825344|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
94282686|NCT02831673|322825345|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
94282687|NCT02831673|322825346|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
94282688|NCT02831673|322825347|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
94208729|NCT00622700|322558576|FG001|Extension Treatment Period|Other than specified above|0|||
94208730|NCT00622700|322558577|FG002|Extension Treatment Period|Other than specified above|0|||
94208731|NCT00622700|322558578|FG003|Extension Treatment Period|Other than specified above|0|||
94208732|NCT00622700|322558579|FG004|Extension Treatment Period|Other than specified above|0|||
94208733|NCT00622700|322558580|FG005|Extension Treatment Period|Other than specified above|1|||
94208734|NCT00622700|322558581|FG006|Extension Treatment Period|Other than specified above|1|||
94208735|NCT02542293|322558587|FG000|Overall Study|Death|367|||
94208736|NCT02542293|322558588|FG001|Overall Study|Death|377|||
94208737|NCT02542293|322558587|FG000|Overall Study|Withdrawal by Subject|8|||
94208738|NCT02542293|322558588|FG001|Overall Study|Withdrawal by Subject|19|||
94208739|NCT06303167|322558594|FG000|Overall Study|Ineligible|1|||
94208740|NCT06303167|322558594|FG000|Overall Study|Never start protocol therapy|2|||
94208741|NCT06303167|322558594|FG000|Overall Study|Disease progression|16|||
94208742|NCT02453282|322558595|FG000|Overall Study|Death|275|||
94208743|NCT02453282|322558596|FG001|Overall Study|Death|277|||
94208744|NCT02453282|322558597|FG002|Overall Study|Death|296|||
94208745|NCT02453282|322558595|FG000|Overall Study|Lost to Follow-up|1|||
94208746|NCT02453282|322558596|FG001|Overall Study|Lost to Follow-up|0|||
94208747|NCT02453282|322558597|FG002|Overall Study|Lost to Follow-up|2|||
94208748|NCT02453282|322558595|FG000|Overall Study|Withdrawal by Subject|12|||
94208749|NCT02453282|322558596|FG001|Overall Study|Withdrawal by Subject|10|||
94208750|NCT02453282|322558597|FG002|Overall Study|Withdrawal by Subject|11|||
94282689|NCT02831673|322825348|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
94208751|NCT02453282|322558595|FG000|Overall Study|Participants ongoing at data cut-off|85|||
94282690|NCT02831673|322825344|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
94208752|NCT02453282|322558596|FG001|Overall Study|Participants ongoing at data cut-off|84|||
94282691|NCT02831673|322825345|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
94282692|NCT02831673|322825346|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
94282693|NCT02831673|322825347|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
94282694|NCT02831673|322825348|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
94208753|NCT02453282|322558597|FG002|Overall Study|Participants ongoing at data cut-off|62|||
94208754|NCT02453282|322558595|FG000|Overall Study|Other|1|||
94208755|NCT02453282|322558596|FG001|Overall Study|Other|1|||
94208756|NCT02453282|322558597|FG002|Overall Study|Other|1|||
94467695|NCT01004432|323502376|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
94467696|NCT01004432|323502377|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
94208757|NCT03362190|322558598|FG000|Overall Study|Adverse Event|0|||
94208758|NCT03362190|322558599|FG001|Overall Study|Adverse Event|0|||
94208759|NCT03362190|322558600|FG002|Overall Study|Adverse Event|0|||
94208760|NCT03362190|322558601|FG003|Overall Study|Adverse Event|1|||
94208761|NCT03362190|322558598|FG000|Overall Study|Withdrawal by Subject|0|||
94208762|NCT03362190|322558599|FG001|Overall Study|Withdrawal by Subject|0|||
94208763|NCT03362190|322558600|FG002|Overall Study|Withdrawal by Subject|0|||
94208764|NCT03362190|322558601|FG003|Overall Study|Withdrawal by Subject|1|||
94208765|NCT01588951|322558602|FG000|Overall Study|Ineligible in retrospect|0|||
94208766|NCT01588951|322558603|FG001|Overall Study|Ineligible in retrospect|0|||
94208767|NCT01588951|322558604|FG002|Overall Study|Ineligible in retrospect|1|||
94208768|NCT02744066|322558606|FG000|Overall Study|Withdrawal by parent|0|||
94208769|NCT02744066|322558607|FG001|Overall Study|Withdrawal by parent|1|||
94208770|NCT02744066|322558606|FG000|Overall Study|Discharged from NICU prior to completion|0|||
94208771|NCT02744066|322558607|FG001|Overall Study|Discharged from NICU prior to completion|4|||
94282695|NCT02831673|322825344|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
94208772|NCT02350634|322558608|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
94208773|NCT05426109|322558609|FG000|Overall Study|Withdrawal by Subject|0|||
94208774|NCT05426109|322558610|FG001|Overall Study|Withdrawal by Subject|1|||
94208775|NCT01701401|322558614|FG000|Overall Study|Randomized But Not Treated|3|||
94208776|NCT01701401|322558615|FG001|Overall Study|Randomized But Not Treated|1|||
94208777|NCT01701401|322558616|FG002|Overall Study|Randomized But Not Treated|0|||
94208778|NCT01701401|322558617|FG003|Overall Study|Randomized But Not Treated|1|||
94208779|NCT01701401|322558614|FG000|Overall Study|Lost to Follow-up|5|||
94208780|NCT01701401|322558615|FG001|Overall Study|Lost to Follow-up|5|||
94208781|NCT01701401|322558616|FG002|Overall Study|Lost to Follow-up|1|||
94208782|NCT01701401|322558617|FG003|Overall Study|Lost to Follow-up|3|||
94208783|NCT01701401|322558614|FG000|Overall Study|Withdrew Consent|0|||
94208784|NCT01701401|322558615|FG001|Overall Study|Withdrew Consent|3|||
94208785|NCT01701401|322558616|FG002|Overall Study|Withdrew Consent|1|||
94208786|NCT01701401|322558617|FG003|Overall Study|Withdrew Consent|2|||
94208787|NCT01701401|322558614|FG000|Overall Study|Lack of Efficacy|1|||
94208788|NCT01701401|322558615|FG001|Overall Study|Lack of Efficacy|0|||
94208789|NCT01701401|322558616|FG002|Overall Study|Lack of Efficacy|2|||
94208790|NCT01701401|322558617|FG003|Overall Study|Lack of Efficacy|0|||
94282696|NCT02831673|322825345|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
94282697|NCT02831673|322825346|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
94282698|NCT02831673|322825347|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
94282699|NCT02831673|322825348|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
94282700|NCT02831673|322825344|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
94282701|NCT02831673|322825345|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
94282702|NCT02831673|322825346|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
94282703|NCT02831673|322825347|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
94282704|NCT02831673|322825348|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
94282705|NCT02831673|322825344|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
94282706|NCT02831673|322825345|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
94282707|NCT02831673|322825346|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
94282708|NCT02831673|322825347|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
94282709|NCT02831673|322825348|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
94282710|NCT02831673|322825344|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
94282711|NCT02831673|322825345|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
94282712|NCT02831673|322825346|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
94282713|NCT02831673|322825347|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
94282714|NCT02831673|322825348|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
94282715|NCT02831673|322825344|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
94282716|NCT02831673|322825345|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
94282717|NCT02831673|322825346|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
94372080|NCT00879970|323148486|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
94372081|NCT00879970|323148482|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
94372082|NCT00879970|323148483|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
94372083|NCT00879970|323148484|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
94372084|NCT00879970|323148485|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
94372085|NCT00879970|323148486|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
94372086|NCT00879970|323148482|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
94372087|NCT00879970|323148483|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
94372088|NCT00879970|323148484|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
94372089|NCT00879970|323148485|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
94372090|NCT00879970|323148486|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
94372091|NCT00879970|323148482|FG000|Period 2 Vitamin D Randomization|Death|0|||
94372092|NCT00879970|323148483|FG001|Period 2 Vitamin D Randomization|Death|0|||
94372093|NCT00879970|323148484|FG002|Period 2 Vitamin D Randomization|Death|0|||
94372094|NCT00879970|323148485|FG003|Period 2 Vitamin D Randomization|Death|2|||
94208791|NCT01701401|322558614|FG000|Overall Study|Adverse Event|1|||
94208792|NCT01701401|322558615|FG001|Overall Study|Adverse Event|0|||
94208793|NCT01701401|322558616|FG002|Overall Study|Adverse Event|0|||
94208794|NCT01701401|322558617|FG003|Overall Study|Adverse Event|0|||
94208795|NCT01701401|322558614|FG000|Overall Study|Protocol Violation|0|||
94208796|NCT01701401|322558615|FG001|Overall Study|Protocol Violation|0|||
94208797|NCT01701401|322558616|FG002|Overall Study|Protocol Violation|1|||
94282718|NCT02831673|322825347|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
94282719|NCT02831673|322825348|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
94282720|NCT02831673|322825344|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
94282721|NCT02831673|322825345|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
94282722|NCT02831673|322825346|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
94282723|NCT02831673|322825347|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
94282724|NCT02831673|322825348|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
94282725|NCT02831673|322825344|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
94282726|NCT02831673|322825345|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
94282727|NCT02831673|322825346|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
94282728|NCT02831673|322825347|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
94282729|NCT02831673|322825348|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
94282730|NCT02831673|322825344|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
94282731|NCT02831673|322825345|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
94282732|NCT02831673|322825346|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
94282733|NCT02831673|322825347|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
94282734|NCT02831673|322825348|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
94282735|NCT02831673|322825344|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
94282736|NCT02831673|322825345|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
94282737|NCT02831673|322825346|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
94282738|NCT02831673|322825347|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
94282739|NCT02831673|322825348|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
94282740|NCT02831673|322825344|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
94282741|NCT02831673|322825345|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
94282742|NCT02831673|322825346|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
94282743|NCT02831673|322825347|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
94282744|NCT02831673|322825348|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
94282745|NCT02831673|322825344|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
94282746|NCT02831673|322825345|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
94282747|NCT02831673|322825346|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
94282748|NCT02831673|322825347|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
94372095|NCT00879970|323148486|FG004|Period 2 Vitamin D Randomization|Death|0|||
94372096|NCT01789281|323148494|FG000|Overall Study|Disease progression|15|||
94372097|NCT01789281|323148495|FG001|Overall Study|Disease progression|4|||
94372098|NCT01789281|323148494|FG000|Overall Study|Adverse Event|5|||
94372099|NCT01789281|323148495|FG001|Overall Study|Adverse Event|5|||
94372100|NCT01789281|323148494|FG000|Overall Study|Withdrawal by Subject|1|||
94372101|NCT01789281|323148495|FG001|Overall Study|Withdrawal by Subject|0|||
94372102|NCT01789281|323148494|FG000|Overall Study|Lost to Follow-up|1|||
94372103|NCT01789281|323148495|FG001|Overall Study|Lost to Follow-up|0|||
94372104|NCT01789281|323148494|FG000|Overall Study|Administrative problems|0|||
94372105|NCT01789281|323148495|FG001|Overall Study|Administrative problems|1|||
94372106|NCT00106028|323148496|FG000|Overall Study|Adverse Event|3|||
94372107|NCT00106028|323148497|FG001|Overall Study|Adverse Event|2|||
94372108|NCT00106028|323148496|FG000|Overall Study|Protocol Violation|1|||
94372109|NCT00106028|323148497|FG001|Overall Study|Protocol Violation|1|||
94372110|NCT00106028|323148496|FG000|Overall Study|Withdrawal by Subject|2|||
94372111|NCT00106028|323148497|FG001|Overall Study|Withdrawal by Subject|8|||
94372112|NCT00106028|323148496|FG000|Overall Study|Lost to Follow-up|0|||
94372113|NCT00106028|323148497|FG001|Overall Study|Lost to Follow-up|1|||
94372114|NCT00449930|323148498|FG000|Overall Study|Adverse Event|9|||
94372115|NCT00449930|323148499|FG001|Overall Study|Adverse Event|19|||
94372116|NCT00449930|323148498|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
94372117|NCT00449930|323148499|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
94372118|NCT00449930|323148498|FG000|Overall Study|Lack of Efficacy|10|||
94372119|NCT00449930|323148499|FG001|Overall Study|Lack of Efficacy|1|||
94372120|NCT00449930|323148498|FG000|Overall Study|Lost to Follow-up|9|||
94372121|NCT00449930|323148499|FG001|Overall Study|Lost to Follow-up|14|||
94372122|NCT00449930|323148498|FG000|Overall Study|Physician Decision|1|||
94372123|NCT00449930|323148499|FG001|Overall Study|Physician Decision|2|||
94372124|NCT00449930|323148498|FG000|Overall Study|Protocol Violation|14|||
94372125|NCT00449930|323148499|FG001|Overall Study|Protocol Violation|15|||
94282749|NCT02831673|322825348|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
94372126|NCT00449930|323148498|FG000|Overall Study|Withdrawal by Subject|16|||
94372127|NCT00449930|323148499|FG001|Overall Study|Withdrawal by Subject|23|||
94372128|NCT00449930|323148498|FG000|Overall Study|Glycemic discontinuation criteria|1|||
94372129|NCT00449930|323148499|FG001|Overall Study|Glycemic discontinuation criteria|1|||
94372130|NCT03712228|323148500|FG000|Treatment Period 1|Lack of Efficacy|0|||
94372131|NCT03712228|323148501|FG001|Treatment Period 1|Lack of Efficacy|0|||
94372132|NCT03712228|323148502|FG002|Treatment Period 1|Lack of Efficacy|0|||
94208798|NCT01701401|322558617|FG003|Overall Study|Protocol Violation|0|||
94208799|NCT00933270|322558618|FG000|Overall Study|Withdrawal by Subject|26|||
94208800|NCT00933270|322558618|FG000|Overall Study|Insufficient Follow-up|10|||
94208801|NCT00933270|322558618|FG000|Overall Study|Lost to Follow-up|14|||
94208802|NCT00933270|322558618|FG000|Overall Study|Adverse Event|1|||
94208803|NCT00933270|322558618|FG000|Overall Study|Missed Visit|2|||
94208804|NCT00933270|322558618|FG000|Overall Study|Death|24|||
94208805|NCT00933270|322558618|FG000|Overall Study|Moved or would not return|10|||
94208806|NCT00989196|322558619|FG000|Treatment Period|Lost to Follow-up|1|||
94208807|NCT00989196|322558620|FG001|Treatment Period|Lost to Follow-up|0|||
94208808|NCT01000805|322558621|FG000|Overall Study|Adverse Event|21|||
94208809|NCT01000805|322558622|FG001|Overall Study|Adverse Event|9|||
94208810|NCT01000805|322558621|FG000|Overall Study|Lack of Efficacy|5|||
94208811|NCT01000805|322558622|FG001|Overall Study|Lack of Efficacy|16|||
94208812|NCT01000805|322558621|FG000|Overall Study|Lost to Follow-up|16|||
94208813|NCT01000805|322558622|FG001|Overall Study|Lost to Follow-up|21|||
94208814|NCT01000805|322558621|FG000|Overall Study|Physician Decision|0|||
94208815|NCT01000805|322558622|FG001|Overall Study|Physician Decision|1|||
94208816|NCT01000805|322558621|FG000|Overall Study|Protocol Violation|12|||
94208817|NCT01000805|322558622|FG001|Overall Study|Protocol Violation|8|||
94208818|NCT01000805|322558621|FG000|Overall Study|Withdrawal by Subject|16|||
94208819|NCT01000805|322558622|FG001|Overall Study|Withdrawal by Subject|6|||
94208820|NCT01000805|322558621|FG000|Overall Study|Sponsor Decision|0|||
94208821|NCT01000805|322558622|FG001|Overall Study|Sponsor Decision|1|||
94208822|NCT03924869|322558623|FG000|Overall Study|Death|66|||
94208823|NCT03924869|322558624|FG001|Overall Study|Death|53|||
94208824|NCT03924869|322558623|FG000|Overall Study|Lost to Follow-up|2|||
94208825|NCT03924869|322558624|FG001|Overall Study|Lost to Follow-up|0|||
94208826|NCT03924869|322558623|FG000|Overall Study|Physician Decision|0|||
94208827|NCT03924869|322558624|FG001|Overall Study|Physician Decision|3|||
94208828|NCT03924869|322558623|FG000|Overall Study|Withdrawal by Subject|5|||
94208829|NCT03924869|322558624|FG001|Overall Study|Withdrawal by Subject|1|||
94208830|NCT03924869|322558623|FG000|Overall Study|Participants Ongoing|154|||
94208831|NCT03924869|322558624|FG001|Overall Study|Participants Ongoing|164|||
94208832|NCT04118894|322558631|FG000|Overall Study|Lost to Follow-up|21|||
94208833|NCT04118894|322558631|FG000|Overall Study|Withdrawal by Subject|10|||
94208834|NCT04118894|322558631|FG000|Overall Study|Adverse Event|4|||
94208835|NCT03675737|322558646|FG000|Overall Study|Death|593|||
94208836|NCT03675737|322558647|FG001|Overall Study|Death|660|||
94208837|NCT03675737|322558646|FG000|Overall Study|Lost to Follow-up|1|||
94208838|NCT03675737|322558647|FG001|Overall Study|Lost to Follow-up|5|||
94282750|NCT02831673|322825344|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
94282751|NCT02831673|322825345|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
94282752|NCT02831673|322825346|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
94282753|NCT02831673|322825347|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
94282754|NCT02831673|322825348|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
94282755|NCT02831673|322825344|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
94282756|NCT02831673|322825345|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
94282757|NCT02831673|322825346|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
94282758|NCT02831673|322825347|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
94282759|NCT02831673|322825348|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
94282760|NCT02831673|322825344|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
94208839|NCT03675737|322558646|FG000|Overall Study|Physician Decision|1|||
94208840|NCT03675737|322558647|FG001|Overall Study|Physician Decision|0|||
94208841|NCT03675737|322558646|FG000|Overall Study|Withdrawal by Subject|14|||
94208842|NCT03675737|322558647|FG001|Overall Study|Withdrawal by Subject|12|||
94208843|NCT03675737|322558646|FG000|Overall Study|Ongoing in Study|181|||
94208844|NCT03675737|322558647|FG001|Overall Study|Ongoing in Study|112|||
94208845|NCT00302211|322558650|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
94208846|NCT00302211|322558651|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
94282761|NCT02831673|322825345|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
94282762|NCT02831673|322825346|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
94282763|NCT02831673|322825347|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
94282764|NCT02831673|322825348|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
94282765|NCT02831673|322825344|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
94282766|NCT02831673|322825345|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
94282767|NCT02831673|322825346|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
94282768|NCT02831673|322825347|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
94282769|NCT02831673|322825348|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
94282770|NCT02831673|322825344|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
94282771|NCT02831673|322825345|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
94282772|NCT02831673|322825346|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
94282773|NCT02831673|322825347|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
94282774|NCT02831673|322825348|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
94282775|NCT02831673|322825344|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
94282776|NCT02831673|322825345|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
94282777|NCT02831673|322825346|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
94282778|NCT02831673|322825347|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
94282779|NCT02831673|322825348|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
94282780|NCT02831673|322825344|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
94282781|NCT02831673|322825345|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
94282782|NCT02831673|322825346|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
94282783|NCT02831673|322825347|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
94282784|NCT02831673|322825348|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
94282785|NCT03047980|322825349|FG000|Overall Study|Adverse Event|1|||
94282786|NCT02627495|322825352|FG000|Overall Study|Withdrawal by Subject|4|||
94282787|NCT00477165|322825353|FG000|Overall Study|Adverse Event|7|||
94282788|NCT00477165|322825354|FG001|Overall Study|Adverse Event|2|||
94282789|NCT01783678|322825359|FG000|Overall Study|Randomized but Not Treated|0|||
94282790|NCT01783678|322825360|FG001|Overall Study|Randomized but Not Treated|0|||
94282791|NCT01783678|322825361|FG002|Overall Study|Randomized but Not Treated|0|||
94282792|NCT01783678|322825362|FG003|Overall Study|Randomized but Not Treated|1|||
94282793|NCT01783678|322825363|FG004|Overall Study|Randomized but Not Treated|0|||
94282794|NCT01783678|322825364|FG005|Overall Study|Randomized but Not Treated|0|||
94282795|NCT01783678|322825359|FG000|Overall Study|Lack of Efficacy|1|||
94282796|NCT01783678|322825360|FG001|Overall Study|Lack of Efficacy|13|||
94282797|NCT01783678|322825361|FG002|Overall Study|Lack of Efficacy|1|||
94282798|NCT01783678|322825362|FG003|Overall Study|Lack of Efficacy|3|||
94282799|NCT01783678|322825363|FG004|Overall Study|Lack of Efficacy|6|||
94282800|NCT01783678|322825364|FG005|Overall Study|Lack of Efficacy|5|||
94282801|NCT01783678|322825359|FG000|Overall Study|Lost to Follow-up|0|||
94282802|NCT01783678|322825360|FG001|Overall Study|Lost to Follow-up|4|||
94282803|NCT01783678|322825361|FG002|Overall Study|Lost to Follow-up|0|||
94282804|NCT01783678|322825362|FG003|Overall Study|Lost to Follow-up|2|||
94282805|NCT01783678|322825363|FG004|Overall Study|Lost to Follow-up|1|||
94282806|NCT01783678|322825364|FG005|Overall Study|Lost to Follow-up|0|||
94282807|NCT01783678|322825359|FG000|Overall Study|Withdrew Consent|1|||
94282808|NCT01783678|322825360|FG001|Overall Study|Withdrew Consent|1|||
94282809|NCT01783678|322825361|FG002|Overall Study|Withdrew Consent|0|||
94282810|NCT01783678|322825362|FG003|Overall Study|Withdrew Consent|2|||
94282811|NCT01783678|322825363|FG004|Overall Study|Withdrew Consent|0|||
94282812|NCT01783678|322825364|FG005|Overall Study|Withdrew Consent|0|||
94282813|NCT00817531|322825367|FG000|Overall Study|Adverse Event|1|||
94282814|NCT00817531|322825367|FG000|Overall Study|Lack of Efficacy|1|||
94282815|NCT03325673|322825368|FG000|Overall Study|Adverse Event|4|||
94282816|NCT03325673|322825369|FG001|Overall Study|Adverse Event|0|||
94282817|NCT01496066|322825376|FG000|Overall Study|Lost to Follow-up|8|||
94282818|NCT01496066|322825377|FG001|Overall Study|Lost to Follow-up|5|||
94282819|NCT01496066|322825376|FG000|Overall Study|Explant|3|||
94372133|NCT03712228|323148503|FG003|Treatment Period 1|Lack of Efficacy|0|||
94372134|NCT03712228|323148504|FG004|Treatment Period 1|Lack of Efficacy|0|||
94372135|NCT03712228|323148505|FG005|Treatment Period 1|Lack of Efficacy|1|||
94372136|NCT03712228|323148500|FG000|Treatment Period 2|Pregnancy|0|||
94372137|NCT03712228|323148501|FG001|Treatment Period 2|Pregnancy|0|||
94372138|NCT03712228|323148502|FG002|Treatment Period 2|Pregnancy|0|||
94282820|NCT01496066|322825377|FG001|Overall Study|Explant|0|||
94282821|NCT01496066|322825376|FG000|Overall Study|Death|1|||
94282822|NCT01496066|322825377|FG001|Overall Study|Death|4|||
94282823|NCT03237065|322825378|FG000|Overall Study|Adverse Event|0|||
94282824|NCT03237065|322825379|FG001|Overall Study|Adverse Event|2|||
94282825|NCT03237065|322825378|FG000|Overall Study|Protocol Violation|0|||
94282826|NCT03237065|322825379|FG001|Overall Study|Protocol Violation|1|||
94282827|NCT03237065|322825378|FG000|Overall Study|Withdrawal by Subject|3|||
94208847|NCT00302211|322558652|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
94208848|NCT00302211|322558653|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
94208849|NCT00302211|322558654|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
94208850|NCT00302211|322558650|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
94208851|NCT00302211|322558651|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
94208852|NCT00302211|322558652|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
94208853|NCT00302211|322558653|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
94208854|NCT00302211|322558654|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
94208855|NCT00302211|322558650|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
94208856|NCT00302211|322558651|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
94208857|NCT00302211|322558652|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
94208858|NCT00302211|322558653|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
94208859|NCT00302211|322558654|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
94208860|NCT00302211|322558650|FG000|Double Blind Period (New Patients)|Disease progression|0|||
94208861|NCT00302211|322558651|FG001|Double Blind Period (New Patients)|Disease progression|1|||
94208862|NCT00302211|322558652|FG002|Double Blind Period (New Patients)|Disease progression|1|||
94208863|NCT00302211|322558653|FG003|Double Blind Period (New Patients)|Disease progression|0|||
94208864|NCT00302211|322558654|FG004|Double Blind Period (New Patients)|Disease progression|0|||
94208865|NCT00302211|322558650|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
94208866|NCT00302211|322558651|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
94208867|NCT00302211|322558652|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
94208868|NCT00302211|322558653|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
94208869|NCT00302211|322558654|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
94208870|NCT00302211|322558650|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
94208871|NCT00302211|322558651|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
94208872|NCT00302211|322558652|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
94208873|NCT00302211|322558653|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
94208874|NCT00302211|322558654|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
94282828|NCT03237065|322825379|FG001|Overall Study|Withdrawal by Subject|0|||
94282829|NCT03237065|322825378|FG000|Overall Study|Lost to Follow-up|1|||
94282830|NCT03237065|322825379|FG001|Overall Study|Lost to Follow-up|0|||
94282831|NCT03237065|322825378|FG000|Overall Study|Unable to obtain venous access|0|||
94282832|NCT03237065|322825379|FG001|Overall Study|Unable to obtain venous access|1|||
94282833|NCT00429858|322825380|FG000|Overall Study|Withdrawal by Subject|1|||
94282834|NCT00429858|322825380|FG000|Overall Study|Study Termination|1|||
94282835|NCT01789970|322825382|FG000|Open-label Titration Period|Adverse Event|68|||
94282836|NCT01789970|322825383|FG001|Open-label Titration Period|Adverse Event|0|||
94282837|NCT01789970|322825384|FG002|Open-label Titration Period|Adverse Event|0|||
94282838|NCT01789970|322825382|FG000|Open-label Titration Period|Lack of Efficacy|31|||
94282839|NCT01789970|322825383|FG001|Open-label Titration Period|Lack of Efficacy|0|||
94282840|NCT01789970|322825384|FG002|Open-label Titration Period|Lack of Efficacy|0|||
94282841|NCT01789970|322825382|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
94282842|NCT01789970|322825383|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
94282843|NCT01789970|322825384|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
94282844|NCT01789970|322825382|FG000|Open-label Titration Period|Protocol Violation|18|||
94282845|NCT01789970|322825383|FG001|Open-label Titration Period|Protocol Violation|0|||
94282846|NCT01789970|322825384|FG002|Open-label Titration Period|Protocol Violation|0|||
94282847|NCT01789970|322825382|FG000|Open-label Titration Period|Lost to Follow-up|5|||
94282848|NCT01789970|322825383|FG001|Open-label Titration Period|Lost to Follow-up|0|||
94282849|NCT01789970|322825384|FG002|Open-label Titration Period|Lost to Follow-up|0|||
94282850|NCT01789970|322825382|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
94282851|NCT01789970|322825383|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
94282852|NCT01789970|322825384|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
94282853|NCT01789970|322825382|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
94282854|NCT01789970|322825383|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
94282855|NCT01789970|322825384|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
94282856|NCT01789970|322825382|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
94282857|NCT01789970|322825383|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
94282858|NCT01789970|322825384|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
94282859|NCT01789970|322825382|FG000|Open-label Titration Period|Pregnancy|2|||
94282860|NCT01789970|322825383|FG001|Open-label Titration Period|Pregnancy|0|||
94282861|NCT01789970|322825384|FG002|Open-label Titration Period|Pregnancy|0|||
94282862|NCT01789970|322825382|FG000|Open-label Titration Period|Other|76|||
94282863|NCT01789970|322825383|FG001|Open-label Titration Period|Other|0|||
94282864|NCT01789970|322825384|FG002|Open-label Titration Period|Other|0|||
94282865|NCT01789970|322825382|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
94282866|NCT01789970|322825383|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
94372139|NCT03712228|323148503|FG003|Treatment Period 2|Pregnancy|1|||
94282867|NCT01789970|322825384|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
94282868|NCT01789970|322825382|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
94282869|NCT01789970|322825383|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
94282870|NCT01789970|322825384|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
94282871|NCT01789970|322825382|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
94282872|NCT01789970|322825383|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
94282873|NCT01789970|322825384|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
94282874|NCT01789970|322825382|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
94372140|NCT03712228|323148504|FG004|Treatment Period 2|Pregnancy|0|||
94372141|NCT03712228|323148505|FG005|Treatment Period 2|Pregnancy|0|||
94372142|NCT03712228|323148500|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94372143|NCT03712228|323148501|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94372144|NCT03712228|323148502|FG002|Treatment Period 2|Withdrawal by Subject|0|||
94372145|NCT03712228|323148503|FG003|Treatment Period 2|Withdrawal by Subject|1|||
94282875|NCT01789970|322825383|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
94282876|NCT01789970|322825384|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
94282877|NCT01789970|322825382|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
94282878|NCT01789970|322825383|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
94282879|NCT01789970|322825384|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
94282880|NCT01789970|322825382|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
94282881|NCT01789970|322825383|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
94282882|NCT01789970|322825384|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
94282883|NCT01789970|322825382|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
94282884|NCT01789970|322825383|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
94282885|NCT01789970|322825384|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
94282886|NCT01789970|322825382|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
94282887|NCT01789970|322825383|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
94282888|NCT01789970|322825384|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
94282889|NCT01789970|322825382|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
94282890|NCT01789970|322825383|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
94282891|NCT01789970|322825384|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
94282892|NCT01789970|322825382|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
94282893|NCT01789970|322825383|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
94282894|NCT01789970|322825384|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
94282895|NCT01789970|322825382|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
94282896|NCT01789970|322825383|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
94282897|NCT01789970|322825384|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
94282898|NCT03345472|322825388|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
94282899|NCT03345472|322825388|FG000|Implant to 3 Months|Physician Decision|1|||
94282900|NCT03345472|322825388|FG000|Implant to 3 Months|Adverse Event|1|||
94282901|NCT03345472|322825388|FG000|3 Months to 12 Months|Physician Decision|3|||
94282902|NCT03345472|322825388|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
94282903|NCT03345472|322825388|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
94282904|NCT03345472|322825388|FG000|3 Months to 12 Months|Adverse Event|1|||
94282905|NCT03345472|322825388|FG000|3 Months to 12 Months|Death|1|||
94282906|NCT01121393|322825389|FG000|Overall Study|Progressive disease|201|||
94282907|NCT01121393|322825390|FG001|Overall Study|Progressive disease|20|||
94282908|NCT01121393|322825389|FG000|Overall Study|Other Adverse events|24|||
94282909|NCT01121393|322825390|FG001|Overall Study|Other Adverse events|45|||
94282910|NCT01121393|322825389|FG000|Overall Study|Non-compliant with protocol|0|||
94282911|NCT01121393|322825390|FG001|Overall Study|Non-compliant with protocol|3|||
94282912|NCT01121393|322825389|FG000|Overall Study|Lost to Follow-up|1|||
94282913|NCT01121393|322825390|FG001|Overall Study|Lost to Follow-up|0|||
94282914|NCT01121393|322825389|FG000|Overall Study|Refused cont. medication|7|||
94282915|NCT01121393|322825390|FG001|Overall Study|Refused cont. medication|7|||
94282916|NCT01121393|322825389|FG000|Overall Study|Not treated|3|||
94282917|NCT01121393|322825390|FG001|Overall Study|Not treated|9|||
94282918|NCT01121393|322825389|FG000|Overall Study|Other than listed|6|||
94282919|NCT01121393|322825390|FG001|Overall Study|Other than listed|0|||
94282920|NCT01857869|322825393|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
94282921|NCT01857869|322825394|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
94282922|NCT01857869|322825395|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
94282923|NCT01857869|322825396|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
94282924|NCT01857869|322825397|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
94282925|NCT01857869|322825398|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
94282926|NCT01857869|322825399|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
94282927|NCT01857869|322825400|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
94282928|NCT01857869|322825401|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
94282929|NCT01857869|322825402|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
94282930|NCT01857869|322825393|FG000|Primary/Challenge Phase|Pregnancy|1|||
94282931|NCT01857869|322825394|FG001|Primary/Challenge Phase|Pregnancy|0|||
94282932|NCT01857869|322825395|FG002|Primary/Challenge Phase|Pregnancy|0|||
94282933|NCT01857869|322825396|FG003|Primary/Challenge Phase|Pregnancy|0|||
94282934|NCT01857869|322825397|FG004|Primary/Challenge Phase|Pregnancy|0|||
94282935|NCT01857869|322825398|FG005|Primary/Challenge Phase|Pregnancy|0|||
94282936|NCT01857869|322825399|FG006|Primary/Challenge Phase|Pregnancy|0|||
94372146|NCT03712228|323148504|FG004|Treatment Period 2|Withdrawal by Subject|0|||
94282937|NCT01857869|322825400|FG007|Primary/Challenge Phase|Pregnancy|0|||
94282938|NCT01857869|322825401|FG008|Primary/Challenge Phase|Pregnancy|0|||
94282939|NCT01857869|322825402|FG009|Primary/Challenge Phase|Pregnancy|0|||
94282940|NCT01857869|322825393|FG000|Primary/Challenge Phase|Protocol Violation|1|||
94282941|NCT01857869|322825394|FG001|Primary/Challenge Phase|Protocol Violation|0|||
94372147|NCT03712228|323148505|FG005|Treatment Period 2|Withdrawal by Subject|0|||
94372148|NCT00575328|323148506|FG000|Overall Study|Adverse Event|1|||
94282942|NCT01857869|322825395|FG002|Primary/Challenge Phase|Protocol Violation|0|||
94282943|NCT01857869|322825396|FG003|Primary/Challenge Phase|Protocol Violation|0|||
94282944|NCT01857869|322825397|FG004|Primary/Challenge Phase|Protocol Violation|0|||
94282945|NCT01857869|322825398|FG005|Primary/Challenge Phase|Protocol Violation|0|||
94282946|NCT01857869|322825399|FG006|Primary/Challenge Phase|Protocol Violation|0|||
94282947|NCT01857869|322825400|FG007|Primary/Challenge Phase|Protocol Violation|0|||
94282948|NCT01857869|322825401|FG008|Primary/Challenge Phase|Protocol Violation|0|||
94282949|NCT01857869|322825402|FG009|Primary/Challenge Phase|Protocol Violation|0|||
94282950|NCT01857869|322825393|FG000|Primary/Challenge Phase|Other|1|||
94282951|NCT01857869|322825394|FG001|Primary/Challenge Phase|Other|1|||
94282952|NCT01857869|322825395|FG002|Primary/Challenge Phase|Other|0|||
94282953|NCT01857869|322825396|FG003|Primary/Challenge Phase|Other|0|||
94282954|NCT01857869|322825397|FG004|Primary/Challenge Phase|Other|0|||
94282955|NCT01857869|322825398|FG005|Primary/Challenge Phase|Other|0|||
94282956|NCT01857869|322825399|FG006|Primary/Challenge Phase|Other|0|||
94282957|NCT01857869|322825400|FG007|Primary/Challenge Phase|Other|0|||
94208875|NCT00302211|322558650|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
94208876|NCT00302211|322558651|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
94208877|NCT00302211|322558652|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
94208878|NCT00302211|322558653|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
94208879|NCT00302211|322558654|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
94208880|NCT00302211|322558650|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
94208881|NCT00302211|322558651|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
94208882|NCT00302211|322558652|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
94208883|NCT00302211|322558653|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
94208884|NCT00302211|322558654|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
94208885|NCT00302211|322558650|FG000|Open Label-Patients From Double-Blind|Death|0|||
94208886|NCT00302211|322558651|FG001|Open Label-Patients From Double-Blind|Death|0|||
94208887|NCT00302211|322558652|FG002|Open Label-Patients From Double-Blind|Death|0|||
94208888|NCT00302211|322558653|FG003|Open Label-Patients From Double-Blind|Death|1|||
94208889|NCT00302211|322558654|FG004|Open Label-Patients From Double-Blind|Death|1|||
94208890|NCT00302211|322558650|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
94208891|NCT00302211|322558651|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
94208892|NCT00302211|322558652|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
94208893|NCT00302211|322558653|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
94208894|NCT00302211|322558654|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
94208895|NCT00302211|322558650|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
94208896|NCT00302211|322558651|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
94208897|NCT00302211|322558652|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
94208898|NCT00302211|322558653|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
94208899|NCT00302211|322558654|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
94208900|NCT00302211|322558650|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
94208901|NCT00302211|322558651|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
94208902|NCT00302211|322558652|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
94208903|NCT00302211|322558653|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
94208904|NCT00302211|322558654|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
94208905|NCT03659136|322558657|FG000|Overall Study|Not treated|2|||
94208906|NCT03659136|322558658|FG001|Overall Study|Not treated|0|||
94208907|NCT03659136|322558657|FG000|Overall Study|Covid-19 related|1|||
94208908|NCT03659136|322558658|FG001|Overall Study|Covid-19 related|1|||
94208909|NCT03659136|322558657|FG000|Overall Study|Withdrawal by Subject|1|||
94208910|NCT03659136|322558658|FG001|Overall Study|Withdrawal by Subject|6|||
94208911|NCT03659136|322558657|FG000|Overall Study|Adverse Event|4|||
94208912|NCT03659136|322558658|FG001|Overall Study|Adverse Event|6|||
94208913|NCT03659136|322558657|FG000|Overall Study|Progressive disease|37|||
94208914|NCT03659136|322558658|FG001|Overall Study|Progressive disease|31|||
94208915|NCT03659136|322558657|FG000|Overall Study|Study closure|2|||
94282958|NCT01857869|322825401|FG008|Primary/Challenge Phase|Other|0|||
94282959|NCT01857869|322825402|FG009|Primary/Challenge Phase|Other|0|||
94282960|NCT01857869|322825393|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
94282961|NCT01857869|322825394|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
94282962|NCT01857869|322825395|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
94282963|NCT01857869|322825396|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
94282964|NCT01857869|322825397|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
94282965|NCT01857869|322825398|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
94282966|NCT01857869|322825399|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
94282967|NCT01857869|322825400|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
94282968|NCT01857869|322825401|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
94282969|NCT01857869|322825402|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
94282970|NCT01857869|322825393|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
94282971|NCT01857869|322825394|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
94282972|NCT01857869|322825395|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
94282973|NCT01857869|322825396|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
94282974|NCT01857869|322825397|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
94282975|NCT01857869|322825398|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
94282976|NCT01857869|322825399|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
94282977|NCT01857869|322825400|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
94282978|NCT01857869|322825401|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
94282979|NCT01857869|322825402|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
94282980|NCT04372927|322825403|FG000|Overall Study|Death|1|||
94282981|NCT04607733|322825406|FG000|Overall Study|Lost to Follow-up|1|||
94282982|NCT04607733|322825407|FG001|Overall Study|Lost to Follow-up|0|||
94282983|NCT04607733|322825408|FG002|Overall Study|Lost to Follow-up|0|||
94282984|NCT04607733|322825409|FG003|Overall Study|Lost to Follow-up|1|||
94282985|NCT04607733|322825410|FG004|Overall Study|Lost to Follow-up|1|||
94282986|NCT04607733|322825411|FG005|Overall Study|Lost to Follow-up|0|||
94282987|NCT04607733|322825406|FG000|Overall Study|Withdrawal by Subject|0|||
94282988|NCT04607733|322825407|FG001|Overall Study|Withdrawal by Subject|0|||
94282989|NCT04607733|322825408|FG002|Overall Study|Withdrawal by Subject|0|||
94282990|NCT04607733|322825409|FG003|Overall Study|Withdrawal by Subject|0|||
94282991|NCT04607733|322825410|FG004|Overall Study|Withdrawal by Subject|1|||
94282992|NCT04607733|322825411|FG005|Overall Study|Withdrawal by Subject|0|||
94282993|NCT01847885|322825435|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
94282994|NCT01847885|322825436|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
94282995|NCT01847885|322825437|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
94282996|NCT01847885|322825435|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
94282997|NCT01847885|322825436|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
94282998|NCT01847885|322825437|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
94282999|NCT01847885|322825435|FG000|Initial Enrollment (Consented)|Screen failure|39|||
94283000|NCT01847885|322825436|FG001|Initial Enrollment (Consented)|Screen failure|0|||
94283001|NCT01847885|322825437|FG002|Initial Enrollment (Consented)|Screen failure|0|||
94283002|NCT01847885|322825435|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
94283003|NCT01847885|322825436|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
94283004|NCT01847885|322825437|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
94283005|NCT01847885|322825435|FG000|Randomization|Protocol Violation|0|||
94283006|NCT01847885|322825436|FG001|Randomization|Protocol Violation|1|||
94283007|NCT01847885|322825437|FG002|Randomization|Protocol Violation|0|||
94283008|NCT01847885|322825435|FG000|Randomization|Withdrawal by Subject|0|||
94283009|NCT01847885|322825436|FG001|Randomization|Withdrawal by Subject|0|||
94283010|NCT01847885|322825437|FG002|Randomization|Withdrawal by Subject|2|||
94283011|NCT01847885|322825435|FG000|Randomization|Screen Failure|0|||
94283012|NCT01847885|322825436|FG001|Randomization|Screen Failure|3|||
94283013|NCT01847885|322825437|FG002|Randomization|Screen Failure|0|||
94283014|NCT00774345|322825440|FG000|Pre-treatment|Other reasons|2|||
94283015|NCT00774345|322825441|FG001|Pre-treatment|Other reasons|0|||
94283016|NCT00774345|322825440|FG000|Treatment|Adverse Event|61|||
94283017|NCT00774345|322825441|FG001|Treatment|Adverse Event|15|||
94283018|NCT00774345|322825440|FG000|Treatment|Progressive Disease without histologic transformation|51|||
94283019|NCT00774345|322825441|FG001|Treatment|Progressive Disease without histologic transformation|111|||
94283020|NCT00774345|322825440|FG000|Treatment|Progressive Disease with histologic transformation|4|||
94283021|NCT00774345|322825441|FG001|Treatment|Progressive Disease with histologic transformation|2|||
94283022|NCT00774345|322825440|FG000|Treatment|Withdrawal by Subject|5|||
94283023|NCT00774345|322825441|FG001|Treatment|Withdrawal by Subject|2|||
94283024|NCT00774345|322825440|FG000|Treatment|Lost to Follow-up|1|||
94283025|NCT00774345|322825441|FG001|Treatment|Lost to Follow-up|1|||
94283026|NCT00774345|322825440|FG000|Treatment|Death|4|||
94283027|NCT00774345|322825441|FG001|Treatment|Death|0|||
94283028|NCT00774345|322825440|FG000|Treatment|Other Reasons|32|||
94283029|NCT00774345|322825441|FG001|Treatment|Other Reasons|26|||
94283030|NCT01536860|322825442|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
94283031|NCT01536860|322825443|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
94283032|NCT01536860|322825444|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
94283033|NCT02809833|322825445|FG000|Overall Study|Death|3|||
94283034|NCT02809833|322825445|FG000|Overall Study|Intolerance|54|||
94283035|NCT02809833|322825445|FG000|Overall Study|Lack of Efficacy|89|||
94283036|NCT02809833|322825445|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
94283037|NCT02809833|322825445|FG000|Overall Study|Noncompliance|1|||
94283038|NCT02809833|322825445|FG000|Overall Study|Withdrawal by Subject|34|||
94283039|NCT02809833|322825445|FG000|Overall Study|Lost to Follow-up|35|||
94283040|NCT02809833|322825445|FG000|Overall Study|Adverse Event (AE)|24|||
94283041|NCT02809833|322825445|FG000|Overall Study|Other|5|||
94283042|NCT02809833|322825445|FG000|Overall Study|Missing Information|52|||
94283043|NCT00744874|322825446|FG000|Overall Study|Lost to Follow-up|1|||
94372149|NCT00575328|323148507|FG001|Overall Study|Adverse Event|1|||
94372150|NCT00575328|323148506|FG000|Overall Study|Lost to Follow-up|2|||
94283044|NCT00744874|322825446|FG000|Overall Study|Withdrawal by Subject|1|||
94283045|NCT00744874|322825446|FG000|Overall Study|Study Device not available at procedure|1|||
94372151|NCT00575328|323148507|FG001|Overall Study|Lost to Follow-up|1|||
94283046|NCT00744874|322825446|FG000|Overall Study|Unable to accomodate schedule|1|||
94283047|NCT00288080|322825453|FG000|Overall Study|Withdrawal by Subject|1|||
94283048|NCT00288080|322825454|FG001|Overall Study|Withdrawal by Subject|3|||
94283049|NCT00288080|322825453|FG000|Overall Study|Protocol Violation|25|||
94283050|NCT00288080|322825454|FG001|Overall Study|Protocol Violation|20|||
94283051|NCT02387580|322825456|FG000|Overall Study|Withdrawal by Subject|0|||
94283052|NCT02387580|322825457|FG001|Overall Study|Withdrawal by Subject|0|||
94283053|NCT02387580|322825458|FG002|Overall Study|Withdrawal by Subject|0|||
94283054|NCT02387580|322825459|FG003|Overall Study|Withdrawal by Subject|1|||
94283055|NCT02387580|322825460|FG004|Overall Study|Withdrawal by Subject|0|||
94283056|NCT02387580|322825461|FG005|Overall Study|Withdrawal by Subject|0|||
94283057|NCT04849780|322825462|FG000|Period 1|Covid-19 Related|1|||
94208916|NCT03659136|322558658|FG001|Overall Study|Study closure|2|||
94208917|NCT03659136|322558657|FG000|Overall Study|Sponsor decision/recommendation|3|||
94208918|NCT03659136|322558658|FG001|Overall Study|Sponsor decision/recommendation|2|||
94208919|NCT03659136|322558657|FG000|Overall Study|Switched to other drug/therapy|2|||
94208920|NCT03659136|322558658|FG001|Overall Study|Switched to other drug/therapy|2|||
94208921|NCT03659136|322558657|FG000|Overall Study|Lack of clinical benefit|0|||
94208922|NCT03659136|322558658|FG001|Overall Study|Lack of clinical benefit|1|||
94208923|NCT04705051|322559745|FG000|Overall Study|Enrolled but not treated|1|||
94208924|NCT04705051|322559745|FG000|Overall Study|Study terminated by sponsor|23|||
94208925|NCT03136159|322559750|FG000|Overall Study|chorioamnionitis|2|||
94208926|NCT03136159|322559751|FG001|Overall Study|chorioamnionitis|0|||
94372152|NCT00580983|323148516|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
94372153|NCT01025193|323148517|FG000|Overall Study|Protocol Violation|1|||
94372154|NCT01025193|323148517|FG000|Overall Study|Adverse Event|3|||
94372155|NCT02557672|323148518|FG000|Overall Study|Withdrawal by Subject|4|||
94372156|NCT02557672|323148519|FG001|Overall Study|Withdrawal by Subject|2|||
94208927|NCT03136159|322559750|FG000|Overall Study|vertical skin incision|1|||
94208928|NCT03136159|322559751|FG001|Overall Study|vertical skin incision|0|||
94208929|NCT03136159|322559750|FG000|Overall Study|additional dressing|1|||
94208930|NCT03136159|322559751|FG001|Overall Study|additional dressing|0|||
94208931|NCT03136159|322559750|FG000|Overall Study|never got dressing placed|1|||
94208932|NCT03136159|322559751|FG001|Overall Study|never got dressing placed|0|||
94208933|NCT03137459|322559752|FG000|2-month Assessment|Withdrawal by Subject|13|||
94208934|NCT03137459|322559753|FG001|2-month Assessment|Withdrawal by Subject|3|||
94208935|NCT03137459|322559752|FG000|2-month Assessment|Unable to reach|42|||
94208936|NCT03137459|322559753|FG001|2-month Assessment|Unable to reach|32|||
94208937|NCT03137459|322559752|FG000|2-month Assessment|Refused assessment|7|||
94208938|NCT03137459|322559753|FG001|2-month Assessment|Refused assessment|5|||
94208939|NCT03137459|322559752|FG000|2-month Assessment|Acutely ill|6|||
94208940|NCT03137459|322559753|FG001|2-month Assessment|Acutely ill|2|||
94208941|NCT03137459|322559752|FG000|4-month Assessment|Death|4|||
94208942|NCT03137459|322559753|FG001|4-month Assessment|Death|2|||
94208943|NCT03137459|322559752|FG000|4-month Assessment|Withdrawal by Subject|4|||
94208944|NCT03137459|322559753|FG001|4-month Assessment|Withdrawal by Subject|2|||
94208945|NCT03137459|322559752|FG000|4-month Assessment|Unable to reach|44|||
94208946|NCT03137459|322559753|FG001|4-month Assessment|Unable to reach|29|||
94372157|NCT02378506|323148520|FG000|Overall Study|Lack of Efficacy|3|||
94372158|NCT02378506|323148520|FG000|Overall Study|Withdrawal by Subject|4|||
94372159|NCT02378506|323148520|FG000|Overall Study|Protocol Violation|2|||
94208947|NCT03137459|322559752|FG000|4-month Assessment|Refused assessment|24|||
94208948|NCT03137459|322559753|FG001|4-month Assessment|Refused assessment|10|||
94208949|NCT03137459|322559752|FG000|4-month Assessment|Acutely ill|2|||
94208950|NCT03137459|322559753|FG001|4-month Assessment|Acutely ill|3|||
94208951|NCT03137459|322559752|FG000|6-months|Lost to Follow-up|14|||
94208952|NCT03137459|322559753|FG001|6-months|Lost to Follow-up|11|||
94208953|NCT03137459|322559752|FG000|6-months|Death|0|||
94208954|NCT03137459|322559753|FG001|6-months|Death|2|||
94208955|NCT03137459|322559752|FG000|6-months|Refused assessment|6|||
94208956|NCT03137459|322559753|FG001|6-months|Refused assessment|3|||
94208957|NCT03137459|322559752|FG000|6-months|Acutely ill|1|||
94208958|NCT03137459|322559753|FG001|6-months|Acutely ill|1|||
94208959|NCT00667017|322559756|FG000|Overall Study|Withdrawal by Subject|1|||
94208960|NCT00345046|322559762|FG000|Overall Study|Protocol Violation|1|||
94208961|NCT00345046|322559763|FG001|Overall Study|Protocol Violation|1|||
94208962|NCT00345046|322559764|FG002|Overall Study|Protocol Violation|2|||
94208963|NCT01079806|322559765|FG000|Day 1 to Week 96|Adverse Event|0|||
94208964|NCT01079806|322559766|FG001|Day 1 to Week 96|Adverse Event|3|||
94208965|NCT01079806|322559765|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
94208966|NCT01079806|322559766|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
94208967|NCT01079806|322559765|FG000|Day 1 to Week 96|Pregnancy|0|||
94208968|NCT01079806|322559766|FG001|Day 1 to Week 96|Pregnancy|1|||
94208969|NCT01079806|322559765|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
94208970|NCT01079806|322559766|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
94208971|NCT01079806|322559765|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
94208972|NCT01079806|322559766|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
94208973|NCT01079806|322559765|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
94208974|NCT01079806|322559766|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
94208975|NCT01079806|322559765|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
94208976|NCT01079806|322559766|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
94208977|NCT01079806|322559765|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
94208978|NCT01079806|322559766|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
94208979|NCT01079806|322559765|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
94208980|NCT01079806|322559766|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
94208981|NCT01079806|322559765|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
94208982|NCT01079806|322559766|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
94208983|NCT01536704|322559767|FG000|Washout Period 1|Withdrawal by Subject|1|||
94208984|NCT01536704|322559768|FG001|Washout Period 1|Withdrawal by Subject|2|||
94208985|NCT01536704|322559769|FG002|Washout Period 1|Withdrawal by Subject|0|||
94208986|NCT01536704|322559770|FG003|Washout Period 1|Withdrawal by Subject|0|||
94208987|NCT01536704|322559767|FG000|Washout Period 2|Adverse Event|1|||
94208988|NCT01536704|322559768|FG001|Washout Period 2|Adverse Event|0|||
94208989|NCT01536704|322559769|FG002|Washout Period 2|Adverse Event|0|||
94208990|NCT01536704|322559770|FG003|Washout Period 2|Adverse Event|0|||
94208991|NCT01536704|322559767|FG000|Washout Period 2|Withdrawal by Subject|0|||
94208992|NCT01536704|322559768|FG001|Washout Period 2|Withdrawal by Subject|0|||
94208993|NCT01536704|322559769|FG002|Washout Period 2|Withdrawal by Subject|0|||
94208994|NCT01536704|322559770|FG003|Washout Period 2|Withdrawal by Subject|1|||
94208995|NCT01536704|322559767|FG000|Period 3|Adverse Event|0|||
94208996|NCT01536704|322559768|FG001|Period 3|Adverse Event|0|||
94208997|NCT01536704|322559769|FG002|Period 3|Adverse Event|0|||
94208998|NCT01536704|322559770|FG003|Period 3|Adverse Event|1|||
94208999|NCT01536704|322559767|FG000|Washout Period 3|Adverse Event|0|||
94209000|NCT01536704|322559768|FG001|Washout Period 3|Adverse Event|0|||
94209001|NCT01536704|322559769|FG002|Washout Period 3|Adverse Event|1|||
94209002|NCT01536704|322559770|FG003|Washout Period 3|Adverse Event|0|||
94209003|NCT01999335|322559771|FG000|Overall Study|Discontinued before receiving treatment|0|||
94209004|NCT01999335|322559772|FG001|Overall Study|Discontinued before receiving treatment|0|||
94283058|NCT04849780|322825463|FG001|Period 1|Covid-19 Related|0|||
94283059|NCT04849780|322825462|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
94372160|NCT02378506|323148520|FG000|Overall Study|Death|1|||
94283060|NCT04849780|322825463|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
94283061|NCT04849780|322825462|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
94283062|NCT04849780|322825463|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
94283063|NCT02682901|322825464|FG000|Overall Study|Adverse Event|10|||
94283064|NCT02682901|322825465|FG001|Overall Study|Adverse Event|3|||
94283065|NCT02682901|322825464|FG000|Overall Study|Lack of Efficacy|0|||
94283066|NCT02682901|322825465|FG001|Overall Study|Lack of Efficacy|1|||
94283067|NCT00725075|322825466|FG000|Overall Study|Use of Excluded Medication|0|||
94283068|NCT00725075|322825467|FG001|Overall Study|Use of Excluded Medication|1|||
94283069|NCT00725075|322825468|FG002|Overall Study|Use of Excluded Medication|0|||
94283070|NCT00725075|322825466|FG000|Overall Study|Protocol Violation|0|||
94283071|NCT00725075|322825467|FG001|Overall Study|Protocol Violation|0|||
94283072|NCT00725075|322825468|FG002|Overall Study|Protocol Violation|1|||
94283073|NCT00725075|322825466|FG000|Overall Study|Lost to Follow-up|1|||
94283074|NCT00725075|322825467|FG001|Overall Study|Lost to Follow-up|0|||
94283075|NCT00725075|322825468|FG002|Overall Study|Lost to Follow-up|0|||
94283076|NCT00725075|322825466|FG000|Overall Study|Withdrawal by Subject|4|||
94283077|NCT00725075|322825467|FG001|Overall Study|Withdrawal by Subject|5|||
94283078|NCT00725075|322825468|FG002|Overall Study|Withdrawal by Subject|4|||
94283079|NCT00725075|322825466|FG000|Overall Study|Adverse Event|2|||
94283080|NCT00725075|322825467|FG001|Overall Study|Adverse Event|1|||
94283081|NCT00725075|322825468|FG002|Overall Study|Adverse Event|1|||
94372161|NCT02378506|323148520|FG000|Overall Study|Adverse Event|14|||
94283082|NCT00725075|322825466|FG000|Overall Study|Worsening of Disease|2|||
94283083|NCT00725075|322825467|FG001|Overall Study|Worsening of Disease|1|||
94283084|NCT00725075|322825468|FG002|Overall Study|Worsening of Disease|2|||
94283085|NCT00725075|322825466|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
94283086|NCT00725075|322825467|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
94283087|NCT00725075|322825468|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
94283088|NCT00725075|322825466|FG000|Overall Study|Other|1|||
94283089|NCT00725075|322825467|FG001|Overall Study|Other|0|||
94283090|NCT00725075|322825468|FG002|Overall Study|Other|0|||
94283091|NCT03870555|322825469|FG000|Period 3 (2 Days)|Adverse Event|1|||
94283092|NCT03870555|322825470|FG001|Period 3 (2 Days)|Adverse Event|0|||
94283093|NCT03870555|322825471|FG002|Period 3 (2 Days)|Adverse Event|0|||
94283094|NCT00352105|322825472|FG000|Overall Study|Death|5|||
94283095|NCT00352105|322825472|FG000|Overall Study|Withdrawal by Subject|5|||
94283096|NCT00352105|322825472|FG000|Overall Study|Lack of Efficacy|9|||
94283097|NCT00352105|322825472|FG000|Overall Study|Adverse Event|19|||
94283098|NCT00352105|322825472|FG000|Overall Study|Protocol Violation|2|||
94283099|NCT01235962|322825473|FG000|Overall Study|Withdrawal by Subject|20|||
94372162|NCT02378506|323148520|FG000|Overall Study|Randomized But Not Treated|1|||
94372163|NCT02236754|323150194|FG000|Overall Study|Withdrawal by Subject|1|||
94283100|NCT01235962|322825474|FG001|Overall Study|Withdrawal by Subject|19|||
94283101|NCT01235962|322825475|FG002|Overall Study|Withdrawal by Subject|62|||
94283102|NCT01235962|322825476|FG003|Overall Study|Withdrawal by Subject|49|||
94283103|NCT01235962|322825473|FG000|Overall Study|Lost to Follow-up|21|||
94283104|NCT01235962|322825474|FG001|Overall Study|Lost to Follow-up|16|||
94283105|NCT01235962|322825475|FG002|Overall Study|Lost to Follow-up|47|||
94283106|NCT01235962|322825476|FG003|Overall Study|Lost to Follow-up|32|||
94283107|NCT01235962|322825473|FG000|Overall Study|Physician Decision|5|||
94283108|NCT01235962|322825474|FG001|Overall Study|Physician Decision|0|||
94283109|NCT01235962|322825475|FG002|Overall Study|Physician Decision|9|||
94283110|NCT01235962|322825476|FG003|Overall Study|Physician Decision|5|||
94283111|NCT01580397|322825477|FG000|Overall Study|Lack of Efficacy|14|||
94283112|NCT02004873|322825479|FG000|Overall Study|Implant unsuccessful|6|||
94283113|NCT02004873|322825479|FG000|Overall Study|Awaiting 6-month visit|390|||
94283114|NCT02004873|322825479|FG000|Overall Study|Missed 6-month visit|4|||
94283115|NCT02004873|322825479|FG000|Overall Study|Death|23|||
94283116|NCT02004873|322825479|FG000|Overall Study|Withdrawal by Subject|1|||
94283117|NCT03099707|322825480|FG000|Overall Study|Withdrawal by Subject|0|||
94283118|NCT03099707|322825481|FG001|Overall Study|Withdrawal by Subject|3|||
94283119|NCT03099707|322825480|FG000|Overall Study|Lost to Follow-up|0|||
94283120|NCT03099707|322825481|FG001|Overall Study|Lost to Follow-up|1|||
94283121|NCT03694925|322825482|FG000|Overall Study|Inadequate laboratory testing|0|||
94283122|NCT03694925|322825483|FG001|Overall Study|Inadequate laboratory testing|3|||
94283123|NCT03694925|322825484|FG002|Overall Study|Inadequate laboratory testing|0|||
94283124|NCT01422239|322825485|FG000|Overall Study|Lost to Follow-up|4|||
94283125|NCT01422239|322825486|FG001|Overall Study|Lost to Follow-up|3|||
94283126|NCT03167073|322825487|FG000|Overall Study|Stillbirth|1|||
94283127|NCT03167073|322825488|FG001|Overall Study|Stillbirth|0|||
94283128|NCT02799069|322825491|FG000|Overall Study|Adverse Event|0|||
94283129|NCT02799069|322825492|FG001|Overall Study|Adverse Event|2|||
94283130|NCT02799069|322825493|FG002|Overall Study|Adverse Event|2|||
94283131|NCT02799069|322825491|FG000|Overall Study|Lack of Efficacy|2|||
94283132|NCT02799069|322825492|FG001|Overall Study|Lack of Efficacy|0|||
94283133|NCT02799069|322825493|FG002|Overall Study|Lack of Efficacy|0|||
94283134|NCT02799069|322825491|FG000|Overall Study|Lost to Follow-up|1|||
94283135|NCT02799069|322825492|FG001|Overall Study|Lost to Follow-up|1|||
94283136|NCT02799069|322825493|FG002|Overall Study|Lost to Follow-up|0|||
94283137|NCT02799069|322825491|FG000|Overall Study|Withdrawal by Subject|4|||
94283138|NCT02799069|322825492|FG001|Overall Study|Withdrawal by Subject|4|||
94372164|NCT02236754|323150195|FG001|Overall Study|Withdrawal by Subject|0|||
94372165|NCT04006847|323150196|FG000|Overall Study|Product issue|1|||
94372166|NCT00382291|323150200|FG000|Overall Study|Adverse Event|1|||
94372167|NCT00382291|323150201|FG001|Overall Study|Adverse Event|2|||
94372168|NCT00382291|323150202|FG002|Overall Study|Adverse Event|2|||
94283139|NCT02799069|322825493|FG002|Overall Study|Withdrawal by Subject|3|||
94283140|NCT02799069|322825491|FG000|Overall Study|Protocol Violation|1|||
94283141|NCT02799069|322825492|FG001|Overall Study|Protocol Violation|0|||
94283142|NCT02799069|322825493|FG002|Overall Study|Protocol Violation|2|||
94283143|NCT02665286|322825499|FG000|Overall Study|Lost to Follow-up|3|||
94283144|NCT02665286|322825500|FG001|Overall Study|Lost to Follow-up|2|||
94283145|NCT02665286|322825501|FG002|Overall Study|Lost to Follow-up|1|||
94283146|NCT01725750|322825509|FG000|Overall Study|Adverse Event|1|||
94283147|NCT01725750|322825510|FG001|Overall Study|Adverse Event|0|||
94283148|NCT01725750|322825509|FG000|Overall Study|Lost to Follow-up|1|||
94283149|NCT01725750|322825510|FG001|Overall Study|Lost to Follow-up|1|||
94283150|NCT01725750|322825509|FG000|Overall Study|Withdrawal by Subject|0|||
94283151|NCT01725750|322825510|FG001|Overall Study|Withdrawal by Subject|9|||
94283152|NCT03864653|322825511|FG000|Overall Study|Withdrawal by Subject|1|||
94283153|NCT00700271|322825512|FG000|Overall Study|Adverse Event|4|||
94283154|NCT00700271|322825513|FG001|Overall Study|Adverse Event|6|||
94283155|NCT00700271|322825512|FG000|Overall Study|Protocol Violation|1|||
94283156|NCT00700271|322825513|FG001|Overall Study|Protocol Violation|0|||
94283157|NCT00700271|322825512|FG000|Overall Study|Administrative Reasons|1|||
94283158|NCT00700271|322825513|FG001|Overall Study|Administrative Reasons|0|||
94283159|NCT00700271|322825512|FG000|Overall Study|Withdrawal by Subject|6|||
94283160|NCT00700271|322825513|FG001|Overall Study|Withdrawal by Subject|4|||
94283161|NCT00700271|322825512|FG000|Overall Study|Lost to Follow-up|2|||
94283162|NCT00700271|322825513|FG001|Overall Study|Lost to Follow-up|2|||
94283163|NCT01634555|322825514|FG000|Overall Study|Adverse Event|3|||
94283164|NCT01634555|322825514|FG000|Overall Study|Physician Decision|1|||
94283165|NCT00772668|322825516|FG000|Overall Study|Physician Decision|3|||
94283166|NCT01535729|322827391|FG000|Overall Study|Withdrawal by Subject|2|||
94283167|NCT01535729|322827391|FG000|Overall Study|Disease progression|230|||
94283168|NCT01535729|322827391|FG000|Overall Study|Discontinued treatment|25|||
94283169|NCT01535729|322827391|FG000|Overall Study|Lost to Follow-up|8|||
94283170|NCT01535729|322827391|FG000|Overall Study|Death|52|||
94283171|NCT01535729|322827391|FG000|Overall Study|Other|19|||
94283172|NCT01535729|322827391|FG000|Overall Study|Did not sign informed consent|1|||
94283173|NCT01535729|322827391|FG000|Overall Study|No previous chemotherapy|33|||
94283174|NCT01535729|322827391|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
94283175|NCT01535729|322827391|FG000|Overall Study|Protocol Violation|11|||
94283176|NCT01535729|322827391|FG000|Overall Study|Screening failure|1|||
94283177|NCT01535729|322827391|FG000|Overall Study|Not treated|9|||
94283178|NCT01535729|322827391|FG000|Overall Study|No participant record available|5|||
94283179|NCT00590590|322827400|FG000|Overall Study|Lack of Efficacy|1|||
94283180|NCT00590590|322827401|FG001|Overall Study|Lack of Efficacy|2|||
94283181|NCT00590590|322827402|FG002|Overall Study|Lack of Efficacy|0|||
94283182|NCT00590590|322827400|FG000|Overall Study|Adverse Event|1|||
94283183|NCT00590590|322827401|FG001|Overall Study|Adverse Event|0|||
94283184|NCT00590590|322827402|FG002|Overall Study|Adverse Event|0|||
94283185|NCT00590590|322827400|FG000|Overall Study|Protocol Violation|0|||
94283186|NCT00590590|322827401|FG001|Overall Study|Protocol Violation|0|||
94283187|NCT00590590|322827402|FG002|Overall Study|Protocol Violation|2|||
94283188|NCT00590590|322827400|FG000|Overall Study|Lost to Follow-up|4|||
94283189|NCT00590590|322827401|FG001|Overall Study|Lost to Follow-up|1|||
94283190|NCT00590590|322827402|FG002|Overall Study|Lost to Follow-up|2|||
94283191|NCT00590590|322827400|FG000|Overall Study|Withdrawal by Subject|0|||
94283192|NCT00590590|322827401|FG001|Overall Study|Withdrawal by Subject|1|||
94283193|NCT00590590|322827402|FG002|Overall Study|Withdrawal by Subject|1|||
94283194|NCT00590590|322827400|FG000|Overall Study|Did not complete due to study closure|1|||
94283195|NCT00590590|322827401|FG001|Overall Study|Did not complete due to study closure|1|||
94283196|NCT00590590|322827402|FG002|Overall Study|Did not complete due to study closure|1|||
94283197|NCT00590590|322827400|FG000|Overall Study|Did not complete study|0|||
94283198|NCT00590590|322827401|FG001|Overall Study|Did not complete study|1|||
94283199|NCT00590590|322827402|FG002|Overall Study|Did not complete study|0|||
94283200|NCT00132132|322827403|FG000|Overall Study|Lost to Follow-up|7|||
94283201|NCT00132132|322827404|FG001|Overall Study|Lost to Follow-up|2|||
94283202|NCT02684981|322827406|FG000|Overall Study|Permanently discontinued the treatment|157|||
94283203|NCT02684981|322827407|FG001|Overall Study|Permanently discontinued the treatment|161|||
94283204|NCT02684981|322827408|FG002|Overall Study|Permanently discontinued the treatment|110|||
94283205|NCT02684981|322827406|FG000|Overall Study|Other|83|||
94283206|NCT02684981|322827407|FG001|Overall Study|Other|49|||
94283207|NCT02684981|322827408|FG002|Overall Study|Other|17|||
94283208|NCT01745146|322827409|FG000|Overall Study|Withdrawal by Subject|1|||
94283209|NCT01745146|322827410|FG001|Overall Study|Withdrawal by Subject|3|||
94283210|NCT01745146|322827409|FG000|Overall Study|Lost to Follow-up|2|||
94283211|NCT01745146|322827410|FG001|Overall Study|Lost to Follow-up|0|||
94283212|NCT01262365|322827411|FG000|Overall Study|Lack of Efficacy|35|||
94283213|NCT01262365|322827412|FG001|Overall Study|Lack of Efficacy|30|||
94283214|NCT01262365|322827413|FG002|Overall Study|Lack of Efficacy|47|||
94283215|NCT01262365|322827411|FG000|Overall Study|Protocol Violation|3|||
94283216|NCT01262365|322827412|FG001|Overall Study|Protocol Violation|1|||
94283217|NCT01262365|322827413|FG002|Overall Study|Protocol Violation|1|||
94283218|NCT01262365|322827411|FG000|Overall Study|Lost to Follow-up|3|||
94283219|NCT01262365|322827412|FG001|Overall Study|Lost to Follow-up|7|||
94283220|NCT01262365|322827413|FG002|Overall Study|Lost to Follow-up|6|||
94283221|NCT01262365|322827411|FG000|Overall Study|Withdrawal by Subject|17|||
94283222|NCT01262365|322827412|FG001|Overall Study|Withdrawal by Subject|22|||
94283223|NCT01262365|322827413|FG002|Overall Study|Withdrawal by Subject|22|||
94283224|NCT01262365|322827411|FG000|Overall Study|Death|1|||
94283225|NCT01262365|322827412|FG001|Overall Study|Death|2|||
94209005|NCT01999335|322559773|FG002|Overall Study|Discontinued before receiving treatment|0|||
94209006|NCT01999335|322559774|FG003|Overall Study|Discontinued before receiving treatment|0|||
94209007|NCT01999335|322559775|FG004|Overall Study|Discontinued before receiving treatment|2|||
94209008|NCT04652726|322559776|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
94209009|NCT04652726|322559777|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
94209010|NCT04652726|322559778|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
94209011|NCT04652726|322559776|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
94209012|NCT04652726|322559777|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
94209013|NCT04652726|322559778|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
94209014|NCT03274076|322559779|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
94209015|NCT03274076|322559780|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
94209016|NCT03274076|322559781|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
94209017|NCT03274076|322559782|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
94209018|NCT03274076|322559779|FG000|24 Weeks Open Label|Adverse Event|0|||
94209019|NCT03274076|322559780|FG001|24 Weeks Open Label|Adverse Event|0|||
94209020|NCT03274076|322559781|FG002|24 Weeks Open Label|Adverse Event|2|||
94209021|NCT03274076|322559782|FG003|24 Weeks Open Label|Adverse Event|0|||
94209022|NCT03274076|322559779|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
94209023|NCT03274076|322559780|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
94209024|NCT03274076|322559781|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
94209025|NCT03274076|322559782|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
94209026|NCT01953224|322559783|FG000|Overall Study|Lost to Follow-up|1|||
94209027|NCT01953224|322559784|FG001|Overall Study|Lost to Follow-up|1|||
94209028|NCT01953224|322559783|FG000|Overall Study|Withdrawal by Subject|1|||
94209029|NCT01953224|322559784|FG001|Overall Study|Withdrawal by Subject|2|||
94209030|NCT03381274|322559785|FG000|Overall Study|Death|2|||
94209031|NCT03381274|322559786|FG001|Overall Study|Death|9|||
94209032|NCT03381274|322559787|FG002|Overall Study|Death|3|||
94209033|NCT03381274|322559788|FG003|Overall Study|Death|2|||
94209034|NCT03381274|322559789|FG004|Overall Study|Death|3|||
94209035|NCT03381274|322559785|FG000|Overall Study|Lost to Follow-up|0|||
94209036|NCT03381274|322559786|FG001|Overall Study|Lost to Follow-up|0|||
94209037|NCT03381274|322559787|FG002|Overall Study|Lost to Follow-up|0|||
94209038|NCT03381274|322559788|FG003|Overall Study|Lost to Follow-up|1|||
94209039|NCT03381274|322559789|FG004|Overall Study|Lost to Follow-up|0|||
94209040|NCT03381274|322559785|FG000|Overall Study|Withdrawal by Subject|2|||
94209041|NCT03381274|322559786|FG001|Overall Study|Withdrawal by Subject|1|||
94209042|NCT03381274|322559787|FG002|Overall Study|Withdrawal by Subject|3|||
94209043|NCT03381274|322559788|FG003|Overall Study|Withdrawal by Subject|1|||
94209044|NCT03381274|322559789|FG004|Overall Study|Withdrawal by Subject|0|||
94209045|NCT03381274|322559785|FG000|Overall Study|Other|1|||
94209046|NCT03381274|322559786|FG001|Overall Study|Other|11|||
94209047|NCT03381274|322559787|FG002|Overall Study|Other|0|||
94209048|NCT03381274|322559788|FG003|Overall Study|Other|2|||
94209049|NCT03381274|322559789|FG004|Overall Study|Other|2|||
94209050|NCT01629589|322559790|FG000|Overall Study|Protocol Violation|4|||
94209051|NCT01629589|322559791|FG001|Overall Study|Protocol Violation|2|||
94209052|NCT01629589|322559790|FG000|Overall Study|Lost to Follow-up|2|||
94209053|NCT01629589|322559791|FG001|Overall Study|Lost to Follow-up|1|||
94209054|NCT01629589|322559790|FG000|Overall Study|Withdrawal by Subject|2|||
94209055|NCT01629589|322559791|FG001|Overall Study|Withdrawal by Subject|3|||
94209056|NCT01629589|322559790|FG000|Overall Study|Did not receive study vaccine|0|||
94209057|NCT01629589|322559791|FG001|Overall Study|Did not receive study vaccine|1|||
94209058|NCT02234141|322559792|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
94283226|NCT01262365|322827413|FG002|Overall Study|Death|1|||
94209059|NCT02234141|322559793|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
94467697|NCT01004432|323502373|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
94209060|NCT02234141|322559794|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
94209061|NCT02234141|322559795|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
94283227|NCT01262365|322827411|FG000|Overall Study|Adverse Event|26|||
94283228|NCT01262365|322827412|FG001|Overall Study|Adverse Event|16|||
94283229|NCT01262365|322827413|FG002|Overall Study|Adverse Event|11|||
94283230|NCT01262365|322827411|FG000|Overall Study|sponsor decision|1|||
94283231|NCT01262365|322827412|FG001|Overall Study|sponsor decision|1|||
94283232|NCT01262365|322827413|FG002|Overall Study|sponsor decision|0|||
94283233|NCT01262365|322827411|FG000|Overall Study|Randomization error|1|||
94283234|NCT01262365|322827412|FG001|Overall Study|Randomization error|0|||
94283235|NCT01262365|322827413|FG002|Overall Study|Randomization error|2|||
94283236|NCT01262365|322827411|FG000|Overall Study|Non-compliance|1|||
94283237|NCT01262365|322827412|FG001|Overall Study|Non-compliance|0|||
94283238|NCT01262365|322827413|FG002|Overall Study|Non-compliance|2|||
94283239|NCT01262365|322827411|FG000|Overall Study|Suspected pregnancy|1|||
94283240|NCT01262365|322827412|FG001|Overall Study|Suspected pregnancy|0|||
94283241|NCT01262365|322827413|FG002|Overall Study|Suspected pregnancy|0|||
94283242|NCT01262365|322827411|FG000|Overall Study|Patient pregnant|1|||
94283243|NCT01262365|322827412|FG001|Overall Study|Patient pregnant|0|||
94283244|NCT01262365|322827413|FG002|Overall Study|Patient pregnant|1|||
94283245|NCT01262365|322827411|FG000|Overall Study|Toxicity related to study drug|0|||
94283246|NCT01262365|322827412|FG001|Overall Study|Toxicity related to study drug|1|||
94283247|NCT01262365|322827413|FG002|Overall Study|Toxicity related to study drug|0|||
94283248|NCT01262365|322827411|FG000|Overall Study|Cannot tolerate the protocol|0|||
94283249|NCT01262365|322827412|FG001|Overall Study|Cannot tolerate the protocol|1|||
94283250|NCT01262365|322827413|FG002|Overall Study|Cannot tolerate the protocol|0|||
94283251|NCT01262365|322827411|FG000|Overall Study|Patient unavailable|0|||
94283252|NCT01262365|322827412|FG001|Overall Study|Patient unavailable|0|||
94283253|NCT01262365|322827413|FG002|Overall Study|Patient unavailable|1|||
94283254|NCT00494091|322827414|FG000|Overall Study|Death|5|||
94283255|NCT00494091|322827415|FG001|Overall Study|Death|54|||
94283256|NCT00494091|322827414|FG000|Overall Study|Lost to Follow-up|0|||
94283257|NCT00494091|322827415|FG001|Overall Study|Lost to Follow-up|4|||
94283258|NCT00494091|322827414|FG000|Overall Study|Other|1|||
94283259|NCT00494091|322827415|FG001|Overall Study|Other|11|||
94283260|NCT00494091|322827414|FG000|Overall Study|Withdrawal by Subject|0|||
94283261|NCT00494091|322827415|FG001|Overall Study|Withdrawal by Subject|7|||
94283262|NCT00326898|322827419|FG000|Overall Study|Disease progression|52|||
94467698|NCT01004432|323502374|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
94467699|NCT01004432|323502375|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
94283263|NCT00326898|322827420|FG001|Overall Study|Disease progression|54|||
94283264|NCT00326898|322827421|FG002|Overall Study|Disease progression|102|||
94283265|NCT00326898|322827419|FG000|Overall Study|Adverse Event|124|||
94283266|NCT00326898|322827420|FG001|Overall Study|Adverse Event|128|||
94283267|NCT00326898|322827421|FG002|Overall Study|Adverse Event|33|||
94283268|NCT00326898|322827419|FG000|Overall Study|Death|2|||
94283269|NCT00326898|322827420|FG001|Overall Study|Death|0|||
94283270|NCT00326898|322827421|FG002|Overall Study|Death|0|||
94283271|NCT00326898|322827419|FG000|Overall Study|Withdrawal by Subject|134|||
94283272|NCT00326898|322827420|FG001|Overall Study|Withdrawal by Subject|128|||
94283273|NCT00326898|322827421|FG002|Overall Study|Withdrawal by Subject|32|||
94372169|NCT00382291|323150200|FG000|Overall Study|Protocol Violation|1|||
94372170|NCT00382291|323150201|FG001|Overall Study|Protocol Violation|0|||
94372171|NCT00382291|323150202|FG002|Overall Study|Protocol Violation|0|||
94372172|NCT00382291|323150200|FG000|Overall Study|Temporary study suspension|2|||
94372173|NCT00382291|323150201|FG001|Overall Study|Temporary study suspension|2|||
94283274|NCT00326898|322827419|FG000|Overall Study|Alternative therapy|1|||
94283275|NCT00326898|322827420|FG001|Overall Study|Alternative therapy|0|||
94283276|NCT00326898|322827421|FG002|Overall Study|Alternative therapy|0|||
94283277|NCT00326898|322827419|FG000|Overall Study|Other complicating disease|5|||
94283278|NCT00326898|322827420|FG001|Overall Study|Other complicating disease|5|||
94283279|NCT00326898|322827421|FG002|Overall Study|Other complicating disease|4|||
94283280|NCT00326898|322827419|FG000|Overall Study|Other/Missing/Unknown|33|||
94283281|NCT00326898|322827420|FG001|Overall Study|Other/Missing/Unknown|28|||
94283282|NCT00326898|322827421|FG002|Overall Study|Other/Missing/Unknown|32|||
94283283|NCT00272038|322827422|FG000|Overall Study|withdrew before they received 2 cycles|7|||
94283284|NCT03605680|322827423|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
94283285|NCT03605680|322827424|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
94283286|NCT03605680|322827425|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
94283287|NCT03605680|322827426|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
94283288|NCT03605680|322827423|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
94283289|NCT03605680|322827424|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
94283290|NCT03605680|322827425|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
94372174|NCT00382291|323150202|FG002|Overall Study|Temporary study suspension|5|||
94372175|NCT00382291|323150200|FG000|Overall Study|Withdrawal by Subject|0|||
94372176|NCT00382291|323150201|FG001|Overall Study|Withdrawal by Subject|2|||
94209062|NCT02234141|322559796|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
94209063|NCT02234141|322559797|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
94209064|NCT02234141|322559798|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
94209065|NCT02234141|322559792|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
94209066|NCT02234141|322559793|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
94209067|NCT02234141|322559794|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
94209068|NCT02234141|322559795|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
94209069|NCT02234141|322559796|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
94209070|NCT02234141|322559797|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
94209071|NCT02234141|322559798|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
94209072|NCT02234141|322559792|FG000|Treatment Period (24 Weeks)|Death|1|||
94209073|NCT02234141|322559793|FG001|Treatment Period (24 Weeks)|Death|2|||
94283291|NCT03605680|322827426|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
94209074|NCT02234141|322559794|FG002|Treatment Period (24 Weeks)|Death|0|||
94209075|NCT02234141|322559795|FG003|Treatment Period (24 Weeks)|Death|1|||
94209076|NCT02234141|322559796|FG004|Treatment Period (24 Weeks)|Death|0|||
94283292|NCT03605680|322827423|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
94209077|NCT02234141|322559797|FG005|Treatment Period (24 Weeks)|Death|0|||
94209078|NCT02234141|322559798|FG006|Treatment Period (24 Weeks)|Death|0|||
94209079|NCT02234141|322559792|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
94209080|NCT02234141|322559793|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
94209081|NCT02234141|322559794|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
94209082|NCT02234141|322559795|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
94209083|NCT02234141|322559796|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
94209084|NCT02234141|322559797|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
94209085|NCT02234141|322559798|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
94209086|NCT02234141|322559792|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
94209087|NCT02234141|322559793|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
94209088|NCT02234141|322559794|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
94209089|NCT02234141|322559795|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
94209090|NCT02234141|322559796|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
94209091|NCT02234141|322559797|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
94209092|NCT02234141|322559798|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
94209093|NCT02234141|322559792|FG000|Long-Term Treatment Period|Death|0|||
94209094|NCT02234141|322559793|FG001|Long-Term Treatment Period|Death|0|||
94209095|NCT02234141|322559794|FG002|Long-Term Treatment Period|Death|0|||
94209096|NCT02234141|322559795|FG003|Long-Term Treatment Period|Death|0|||
94209097|NCT02234141|322559796|FG004|Long-Term Treatment Period|Death|0|||
94209098|NCT02234141|322559797|FG005|Long-Term Treatment Period|Death|1|||
94209099|NCT02234141|322559798|FG006|Long-Term Treatment Period|Death|0|||
94209100|NCT02234141|322559792|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
94209101|NCT02234141|322559793|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
94209102|NCT02234141|322559794|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
94209103|NCT02234141|322559795|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
94209104|NCT02234141|322559796|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
94209105|NCT02234141|322559797|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
94209106|NCT02234141|322559798|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
94209107|NCT02234141|322559792|FG000|Long-Term Treatment Period|Adverse Event|4|||
94209108|NCT02234141|322559793|FG001|Long-Term Treatment Period|Adverse Event|0|||
94209109|NCT02234141|322559794|FG002|Long-Term Treatment Period|Adverse Event|5|||
94209110|NCT02234141|322559795|FG003|Long-Term Treatment Period|Adverse Event|0|||
94209111|NCT02234141|322559796|FG004|Long-Term Treatment Period|Adverse Event|1|||
94209112|NCT02234141|322559797|FG005|Long-Term Treatment Period|Adverse Event|1|||
94209113|NCT02234141|322559798|FG006|Long-Term Treatment Period|Adverse Event|1|||
94209114|NCT02234141|322559792|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
94209115|NCT02234141|322559793|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
94209116|NCT02234141|322559794|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
94209117|NCT02234141|322559795|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
94209118|NCT02234141|322559796|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
94209119|NCT02234141|322559797|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
94209120|NCT02234141|322559798|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
94209121|NCT02234141|322559792|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
94209122|NCT02234141|322559793|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
94209123|NCT02234141|322559794|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
94209124|NCT02234141|322559795|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
94209125|NCT02234141|322559796|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
94209126|NCT02234141|322559797|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
94209127|NCT02234141|322559798|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
94209128|NCT03057600|322559799|FG000|Overall Study|Adverse Event|0|||
94209129|NCT03057600|322559800|FG001|Overall Study|Adverse Event|0|||
94209130|NCT03057600|322559801|FG002|Overall Study|Adverse Event|4|||
94209131|NCT03057600|322559802|FG003|Overall Study|Adverse Event|0|||
94209132|NCT03057600|322559799|FG000|Overall Study|Radiologic Disease Progression|8|||
94209133|NCT03057600|322559800|FG001|Overall Study|Radiologic Disease Progression|7|||
94209134|NCT03057600|322559801|FG002|Overall Study|Radiologic Disease Progression|13|||
94283293|NCT03605680|322827424|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
94209135|NCT03057600|322559802|FG003|Overall Study|Radiologic Disease Progression|10|||
94209136|NCT03057600|322559799|FG000|Overall Study|Symptomatic Deterioration|0|||
94209137|NCT03057600|322559800|FG001|Overall Study|Symptomatic Deterioration|1|||
94283294|NCT03605680|322827425|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
94209138|NCT03057600|322559801|FG002|Overall Study|Symptomatic Deterioration|1|||
94209139|NCT03057600|322559802|FG003|Overall Study|Symptomatic Deterioration|0|||
94209140|NCT03057600|322559799|FG000|Overall Study|Investigator Decision|0|||
94209141|NCT03057600|322559800|FG001|Overall Study|Investigator Decision|0|||
94209142|NCT03057600|322559801|FG002|Overall Study|Investigator Decision|1|||
94209143|NCT03057600|322559802|FG003|Overall Study|Investigator Decision|0|||
94209144|NCT03057600|322559799|FG000|Overall Study|Study Termination by Sponsor|0|||
94283295|NCT03605680|322827426|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
94283296|NCT03605680|322827423|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
94283297|NCT03605680|322827424|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
94283298|NCT03605680|322827425|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
94283299|NCT03605680|322827426|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
94283300|NCT03605680|322827423|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
94283301|NCT03605680|322827424|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
94283302|NCT03605680|322827425|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
94283303|NCT03605680|322827426|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
94283304|NCT03605680|322827423|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
94283305|NCT03605680|322827424|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
94283306|NCT03605680|322827425|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
94283307|NCT03605680|322827426|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
94283308|NCT03605680|322827423|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
94283309|NCT03605680|322827424|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
94209145|NCT03057600|322559800|FG001|Overall Study|Study Termination by Sponsor|0|||
94209146|NCT03057600|322559801|FG002|Overall Study|Study Termination by Sponsor|0|||
94209147|NCT03057600|322559802|FG003|Overall Study|Study Termination by Sponsor|2|||
94209148|NCT03057600|322559799|FG000|Overall Study|Withdrawal by Subject|0|||
94209149|NCT03057600|322559800|FG001|Overall Study|Withdrawal by Subject|1|||
94209150|NCT03057600|322559801|FG002|Overall Study|Withdrawal by Subject|0|||
94209151|NCT03057600|322559802|FG003|Overall Study|Withdrawal by Subject|0|||
94209152|NCT03057600|322559799|FG000|Overall Study|Other, Not Specified|1|||
94209153|NCT03057600|322559800|FG001|Overall Study|Other, Not Specified|1|||
94209154|NCT03057600|322559801|FG002|Overall Study|Other, Not Specified|1|||
94209155|NCT03057600|322559802|FG003|Overall Study|Other, Not Specified|1|||
94209156|NCT02113449|322559803|FG000|Overall Study|Adverse Event|4|||
94209157|NCT05169684|322559806|FG000|Overall Study|Adverse Event|1|||
94209158|NCT05169684|322559807|FG001|Overall Study|Adverse Event|3|||
94209159|NCT05169684|322559806|FG000|Overall Study|Physician Decision|0|||
94209160|NCT05169684|322559807|FG001|Overall Study|Physician Decision|1|||
94209161|NCT05169684|322559806|FG000|Overall Study|Progressive Disease|1|||
94209162|NCT05169684|322559807|FG001|Overall Study|Progressive Disease|1|||
94209163|NCT05169684|322559806|FG000|Overall Study|Participant request to discontinue treatment|0|||
94209164|NCT05169684|322559807|FG001|Overall Study|Participant request to discontinue treatment|1|||
94209165|NCT05169684|322559806|FG000|Overall Study|Other Reason|0|||
94209166|NCT05169684|322559807|FG001|Overall Study|Other Reason|1|||
94209167|NCT03582475|322559821|FG000|Treatment Period|Withdrawal by Subject|0|||
94209168|NCT03582475|322559822|FG001|Treatment Period|Withdrawal by Subject|1|||
94209169|NCT03582475|322559821|FG000|Follow-up Period|Withdrawal by Subject|0|||
94209170|NCT03582475|322559822|FG001|Follow-up Period|Withdrawal by Subject|1|||
94283310|NCT03605680|322827425|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
94283311|NCT03605680|322827426|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
94283312|NCT03605680|322827423|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
94283313|NCT03605680|322827424|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
94283314|NCT03605680|322827425|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
94283315|NCT03605680|322827426|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
94283316|NCT03605680|322827423|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
94283317|NCT03605680|322827424|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
94209171|NCT02686658|322559823|FG000|Overall Study|Adverse Event|0|||
94209172|NCT02686658|322559824|FG001|Overall Study|Adverse Event|0|||
94209173|NCT02686658|322559825|FG002|Overall Study|Adverse Event|1|||
94209174|NCT02686658|322559826|FG003|Overall Study|Adverse Event|1|||
94209175|NCT02686658|322559827|FG004|Overall Study|Adverse Event|2|||
94372177|NCT00382291|323150202|FG002|Overall Study|Withdrawal by Subject|0|||
94209176|NCT02686658|322559828|FG005|Overall Study|Adverse Event|1|||
94209177|NCT02686658|322559823|FG000|Overall Study|Investigator decision|0|||
94209178|NCT02686658|322559824|FG001|Overall Study|Investigator decision|0|||
94209179|NCT02686658|322559825|FG002|Overall Study|Investigator decision|0|||
94209180|NCT02686658|322559826|FG003|Overall Study|Investigator decision|1|||
94209181|NCT02686658|322559827|FG004|Overall Study|Investigator decision|2|||
94209182|NCT02686658|322559828|FG005|Overall Study|Investigator decision|1|||
94209183|NCT02686658|322559823|FG000|Overall Study|Sponsor decision|1|||
94209184|NCT02686658|322559824|FG001|Overall Study|Sponsor decision|2|||
94209185|NCT02686658|322559825|FG002|Overall Study|Sponsor decision|1|||
94209186|NCT02686658|322559826|FG003|Overall Study|Sponsor decision|5|||
94209187|NCT02686658|322559827|FG004|Overall Study|Sponsor decision|13|||
94209188|NCT02686658|322559828|FG005|Overall Study|Sponsor decision|2|||
94209189|NCT02686658|322559823|FG000|Overall Study|Lost to Follow-up|0|||
94209190|NCT02686658|322559824|FG001|Overall Study|Lost to Follow-up|0|||
94209191|NCT02686658|322559825|FG002|Overall Study|Lost to Follow-up|2|||
94209192|NCT02686658|322559826|FG003|Overall Study|Lost to Follow-up|0|||
94209193|NCT02686658|322559827|FG004|Overall Study|Lost to Follow-up|0|||
94209194|NCT02686658|322559828|FG005|Overall Study|Lost to Follow-up|1|||
94209195|NCT02686658|322559823|FG000|Overall Study|Death|1|||
94209196|NCT02686658|322559824|FG001|Overall Study|Death|0|||
94209197|NCT02686658|322559825|FG002|Overall Study|Death|0|||
94209198|NCT02686658|322559826|FG003|Overall Study|Death|1|||
94209199|NCT02686658|322559827|FG004|Overall Study|Death|1|||
94209200|NCT02686658|322559828|FG005|Overall Study|Death|1|||
94209201|NCT02686658|322559823|FG000|Overall Study|Withdrawal by Subject|2|||
94209202|NCT02686658|322559824|FG001|Overall Study|Withdrawal by Subject|5|||
94209203|NCT02686658|322559825|FG002|Overall Study|Withdrawal by Subject|4|||
94209204|NCT02686658|322559826|FG003|Overall Study|Withdrawal by Subject|4|||
94209205|NCT02686658|322559827|FG004|Overall Study|Withdrawal by Subject|17|||
94209206|NCT02686658|322559828|FG005|Overall Study|Withdrawal by Subject|8|||
94209207|NCT02686658|322559823|FG000|Overall Study|Placed in hospice care|0|||
94209208|NCT02686658|322559824|FG001|Overall Study|Placed in hospice care|0|||
94209209|NCT02686658|322559825|FG002|Overall Study|Placed in hospice care|1|||
94209210|NCT02686658|322559826|FG003|Overall Study|Placed in hospice care|0|||
94209211|NCT02686658|322559827|FG004|Overall Study|Placed in hospice care|0|||
94209212|NCT02686658|322559828|FG005|Overall Study|Placed in hospice care|0|||
94209213|NCT02686658|322559823|FG000|Overall Study|Participant non-compliance|0|||
94209214|NCT02686658|322559824|FG001|Overall Study|Participant non-compliance|0|||
94209215|NCT02686658|322559825|FG002|Overall Study|Participant non-compliance|0|||
94209216|NCT02686658|322559826|FG003|Overall Study|Participant non-compliance|0|||
94209217|NCT02686658|322559827|FG004|Overall Study|Participant non-compliance|0|||
94372178|NCT00382291|323150200|FG000|Overall Study|Physician Decision|0|||
94372179|NCT00382291|323150201|FG001|Overall Study|Physician Decision|1|||
94372180|NCT00382291|323150202|FG002|Overall Study|Physician Decision|0|||
94372181|NCT00382291|323150200|FG000|Overall Study|Lack of Efficacy|0|||
94372182|NCT00382291|323150201|FG001|Overall Study|Lack of Efficacy|0|||
94372183|NCT00382291|323150202|FG002|Overall Study|Lack of Efficacy|1|||
94372184|NCT01270841|323150203|FG000|Overall Study|Adverse Event|0|||
94372185|NCT01270841|323150204|FG001|Overall Study|Adverse Event|1|||
94372186|NCT01270841|323150205|FG002|Overall Study|Adverse Event|0|||
94372187|NCT01270841|323150206|FG003|Overall Study|Adverse Event|3|||
94372188|NCT01270841|323150203|FG000|Overall Study|Withdrawal by Subject|3|||
94372189|NCT01270841|323150204|FG001|Overall Study|Withdrawal by Subject|2|||
94372190|NCT01270841|323150205|FG002|Overall Study|Withdrawal by Subject|3|||
94372191|NCT01270841|323150206|FG003|Overall Study|Withdrawal by Subject|3|||
94372192|NCT01270841|323150203|FG000|Overall Study|Lost to Follow-up|3|||
94372193|NCT01270841|323150204|FG001|Overall Study|Lost to Follow-up|1|||
94372194|NCT01270841|323150205|FG002|Overall Study|Lost to Follow-up|4|||
94372195|NCT01270841|323150206|FG003|Overall Study|Lost to Follow-up|2|||
94372196|NCT01270841|323150203|FG000|Overall Study|Physician Decision|0|||
94372197|NCT01270841|323150204|FG001|Overall Study|Physician Decision|1|||
94372198|NCT01270841|323150205|FG002|Overall Study|Physician Decision|0|||
94372199|NCT01270841|323150206|FG003|Overall Study|Physician Decision|0|||
94209218|NCT02686658|322559828|FG005|Overall Study|Participant non-compliance|1|||
94209219|NCT02686658|322559823|FG000|Overall Study|Concern over coronavirus disease care|0|||
94209220|NCT02686658|322559824|FG001|Overall Study|Concern over coronavirus disease care|0|||
94209221|NCT02686658|322559825|FG002|Overall Study|Concern over coronavirus disease care|0|||
94209222|NCT02686658|322559826|FG003|Overall Study|Concern over coronavirus disease care|0|||
94209223|NCT02686658|322559827|FG004|Overall Study|Concern over coronavirus disease care|2|||
94209224|NCT02686658|322559828|FG005|Overall Study|Concern over coronavirus disease care|1|||
94209225|NCT00614614|322559831|FG000|Primary Vaccination Phase|Adverse Event|6|||
94209226|NCT00614614|322559832|FG001|Primary Vaccination Phase|Adverse Event|0|||
94209227|NCT00614614|322559833|FG002|Primary Vaccination Phase|Adverse Event|0|||
94209228|NCT00614614|322559834|FG003|Primary Vaccination Phase|Adverse Event|0|||
94209229|NCT00614614|322559835|FG004|Primary Vaccination Phase|Adverse Event|0|||
94209230|NCT00614614|322559831|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
94209231|NCT00614614|322559832|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
94209232|NCT00614614|322559833|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
94372200|NCT01270841|323150203|FG000|Overall Study|Did not qualify|6|||
94467700|NCT01004432|323502376|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
94372201|NCT01270841|323150204|FG001|Overall Study|Did not qualify|3|||
94372202|NCT01270841|323150205|FG002|Overall Study|Did not qualify|4|||
94372203|NCT01270841|323150206|FG003|Overall Study|Did not qualify|5|||
94372204|NCT01270841|323150203|FG000|Overall Study|Protocol Violation|1|||
94372205|NCT01270841|323150204|FG001|Overall Study|Protocol Violation|5|||
94372206|NCT01270841|323150205|FG002|Overall Study|Protocol Violation|0|||
94283318|NCT03605680|322827425|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
94283319|NCT03605680|322827426|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
94283320|NCT03605680|322827423|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
94283321|NCT03605680|322827424|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
94283322|NCT03605680|322827425|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
94283323|NCT03605680|322827426|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
94283324|NCT03605680|322827423|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
94283325|NCT03605680|322827424|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
94209233|NCT00614614|322559834|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
94209234|NCT00614614|322559835|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
94209235|NCT00614614|322559831|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
94209236|NCT00614614|322559832|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
94209237|NCT00614614|322559833|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
94209238|NCT00614614|322559834|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
94209239|NCT00614614|322559835|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
94283326|NCT03605680|322827425|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
94283327|NCT03605680|322827426|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
94283328|NCT03605680|322827423|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
94283329|NCT03605680|322827424|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
94283330|NCT03605680|322827425|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
94283331|NCT03605680|322827426|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
94283332|NCT03605680|322827423|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
94283333|NCT03605680|322827424|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
94283334|NCT03605680|322827425|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
94283335|NCT03605680|322827426|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
94283336|NCT03605680|322827423|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
94283337|NCT03605680|322827424|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
94283338|NCT03605680|322827425|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
94283339|NCT03605680|322827426|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
94283340|NCT03605680|322827423|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
94283341|NCT03605680|322827424|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
94283342|NCT03605680|322827425|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
94283343|NCT03605680|322827426|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
94283344|NCT03605680|322827423|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
94283345|NCT03605680|322827424|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
94283346|NCT03605680|322827425|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
94283347|NCT03605680|322827426|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
94283348|NCT03605680|322827423|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
94283349|NCT03605680|322827424|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
94283350|NCT03605680|322827425|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
94283351|NCT03605680|322827426|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
94283352|NCT03605680|322827423|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
94283353|NCT03605680|322827424|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
94283354|NCT03605680|322827425|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
94283355|NCT03605680|322827426|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
94283356|NCT03605680|322827423|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
94283357|NCT03605680|322827424|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
94283358|NCT03605680|322827425|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
94283359|NCT03605680|322827426|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
94283360|NCT02468648|322827430|FG000|Overall Study|Death|1|||
94283361|NCT01777152|322827431|FG000|Overall Study|Withdrawal by Subject|22|||
94283362|NCT01777152|322827432|FG001|Overall Study|Withdrawal by Subject|16|||
94283363|NCT01777152|322827431|FG000|Overall Study|Lost to Follow-up|3|||
94283364|NCT01777152|322827432|FG001|Overall Study|Lost to Follow-up|5|||
94283365|NCT01777152|322827431|FG000|Overall Study|Death|68|||
94283366|NCT01777152|322827432|FG001|Overall Study|Death|89|||
94283367|NCT01777152|322827431|FG000|Overall Study|Not eligible, no study drug received|1|||
94283368|NCT01777152|322827432|FG001|Overall Study|Not eligible, no study drug received|0|||
94283369|NCT01777152|322827431|FG000|Overall Study|Change of diagnosis|1|||
94283370|NCT01777152|322827432|FG001|Overall Study|Change of diagnosis|0|||
94372207|NCT01270841|323150206|FG003|Overall Study|Protocol Violation|0|||
94372208|NCT01270841|323150203|FG000|Overall Study|Enrolled in error|0|||
94372209|NCT01270841|323150204|FG001|Overall Study|Enrolled in error|1|||
94209240|NCT00614614|322559831|FG000|Primary Vaccination Phase|Protocol Violation|9|||
94209241|NCT00614614|322559832|FG001|Primary Vaccination Phase|Protocol Violation|3|||
94209242|NCT00614614|322559833|FG002|Primary Vaccination Phase|Protocol Violation|0|||
94209243|NCT00614614|322559834|FG003|Primary Vaccination Phase|Protocol Violation|0|||
94209244|NCT00614614|322559835|FG004|Primary Vaccination Phase|Protocol Violation|0|||
94209245|NCT00614614|322559831|FG000|Primary Vaccination Phase|Other|4|||
94209246|NCT00614614|322559832|FG001|Primary Vaccination Phase|Other|0|||
94209247|NCT00614614|322559833|FG002|Primary Vaccination Phase|Other|0|||
94209248|NCT00614614|322559834|FG003|Primary Vaccination Phase|Other|0|||
94209249|NCT00614614|322559835|FG004|Primary Vaccination Phase|Other|0|||
94209250|NCT00614614|322559831|FG000|Booster Vaccination Phase|Adverse Event|0|||
94209251|NCT00614614|322559832|FG001|Booster Vaccination Phase|Adverse Event|0|||
94209252|NCT00614614|322559833|FG002|Booster Vaccination Phase|Adverse Event|1|||
94209253|NCT00614614|322559834|FG003|Booster Vaccination Phase|Adverse Event|1|||
94209254|NCT00614614|322559835|FG004|Booster Vaccination Phase|Adverse Event|0|||
94209255|NCT00614614|322559831|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
94209256|NCT00614614|322559832|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
94209257|NCT00614614|322559833|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
94209258|NCT00614614|322559834|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
94209259|NCT00614614|322559835|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
94209260|NCT00614614|322559831|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
94209261|NCT00614614|322559832|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
94209262|NCT00614614|322559833|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
94209263|NCT00614614|322559834|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
94209264|NCT00614614|322559835|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
94209265|NCT00614614|322559831|FG000|Booster Vaccination Phase|Protocol Violation|0|||
94209266|NCT00614614|322559832|FG001|Booster Vaccination Phase|Protocol Violation|0|||
94209267|NCT00614614|322559833|FG002|Booster Vaccination Phase|Protocol Violation|2|||
94209268|NCT00614614|322559834|FG003|Booster Vaccination Phase|Protocol Violation|3|||
94209269|NCT00614614|322559835|FG004|Booster Vaccination Phase|Protocol Violation|0|||
94209270|NCT00614614|322559831|FG000|Booster Vaccination Phase|Other|0|||
94209271|NCT00614614|322559832|FG001|Booster Vaccination Phase|Other|1|||
94209272|NCT00614614|322559833|FG002|Booster Vaccination Phase|Other|3|||
94209273|NCT00614614|322559834|FG003|Booster Vaccination Phase|Other|2|||
94209274|NCT00614614|322559835|FG004|Booster Vaccination Phase|Other|1|||
94209275|NCT03476798|322559838|FG000|Overall Study|Death|1|||
94209276|NCT03476798|322559838|FG000|Overall Study|Withdrawal by Subject|2|||
94209277|NCT03476798|322559838|FG000|Overall Study|Protocol Violation|2|||
94209278|NCT03598907|322559841|FG000|Overall Study|Physician Decision|14|||
94209279|NCT03598907|322559842|FG001|Overall Study|Physician Decision|19|||
94209280|NCT03581292|322559843|FG000|Overall Study|Physician Decision|9|||
94209281|NCT03581292|322559844|FG001|Overall Study|Physician Decision|5|||
94209282|NCT03581292|322559843|FG000|Overall Study|Withdrawal by Subject|3|||
94209283|NCT03581292|322559844|FG001|Overall Study|Withdrawal by Subject|0|||
94209284|NCT03581292|322559843|FG000|Overall Study|Withdrawal before Therapy Start|1|||
94209285|NCT03581292|322559844|FG001|Overall Study|Withdrawal before Therapy Start|0|||
94209286|NCT00491894|322559845|FG000|Overall Study|Adverse Event|14|||
94209287|NCT00491894|322559845|FG000|Overall Study|Withdrawal by Subject|5|||
94209288|NCT00491894|322559845|FG000|Overall Study|Death|3|||
94209289|NCT00491894|322559845|FG000|Overall Study|Lost to Follow-up|3|||
94209290|NCT00491894|322559845|FG000|Overall Study|Lack of Efficacy|2|||
94209291|NCT00491894|322559845|FG000|Overall Study|Other-Failed to meet any criteria|2|||
94209292|NCT00491894|322559845|FG000|Overall Study|Physician Decision|2|||
94209293|NCT00491894|322559845|FG000|Overall Study|Protocol Violation|2|||
94209294|NCT00491894|322559845|FG000|Overall Study|Other-Intake of prohibited medication|1|||
94209295|NCT05864209|322561650|FG000|Overall Study|Lost to Follow-up|2|||
94209296|NCT05864209|322561651|FG001|Overall Study|Lost to Follow-up|3|||
94209297|NCT04179175|322561652|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
94209298|NCT04179175|322561653|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
94209299|NCT04179175|322561654|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
94209300|NCT04179175|322561655|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
94209301|NCT04179175|322561656|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
94209302|NCT04179175|322561657|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
94209303|NCT04179175|322561652|FG000|Overall Study|Adverse Event|5|||
94209304|NCT04179175|322561653|FG001|Overall Study|Adverse Event|3|||
94209305|NCT04179175|322561654|FG002|Overall Study|Adverse Event|3|||
94209306|NCT04179175|322561655|FG003|Overall Study|Adverse Event|4|||
94209307|NCT04179175|322561656|FG004|Overall Study|Adverse Event|6|||
94209308|NCT04179175|322561657|FG005|Overall Study|Adverse Event|6|||
94209309|NCT04179175|322561652|FG000|Overall Study|Lack of Efficacy|5|||
94209310|NCT04179175|322561653|FG001|Overall Study|Lack of Efficacy|1|||
94209311|NCT04179175|322561654|FG002|Overall Study|Lack of Efficacy|3|||
94209312|NCT04179175|322561655|FG003|Overall Study|Lack of Efficacy|2|||
94209313|NCT04179175|322561656|FG004|Overall Study|Lack of Efficacy|18|||
94209314|NCT04179175|322561657|FG005|Overall Study|Lack of Efficacy|7|||
94209315|NCT04179175|322561652|FG000|Overall Study|Lost to Follow-up|5|||
94209316|NCT04179175|322561653|FG001|Overall Study|Lost to Follow-up|3|||
94372210|NCT01270841|323150205|FG002|Overall Study|Enrolled in error|0|||
94372211|NCT01270841|323150206|FG003|Overall Study|Enrolled in error|0|||
94372212|NCT01326702|323150207|FG000|Overall Study|Other|1|||
94372213|NCT01326702|323150208|FG001|Overall Study|Other|0|||
94372214|NCT01326702|323150209|FG002|Overall Study|Other|0|||
94372215|NCT01326702|323150210|FG003|Overall Study|Other|0|||
94372216|NCT01326702|323150211|FG004|Overall Study|Other|0|||
94372217|NCT01326702|323150212|FG005|Overall Study|Other|1|||
94372218|NCT01326702|323150213|FG006|Overall Study|Other|0|||
94372219|NCT01326702|323150207|FG000|Overall Study|progressive disease|1|||
94372220|NCT01326702|323150208|FG001|Overall Study|progressive disease|1|||
94372221|NCT01326702|323150209|FG002|Overall Study|progressive disease|3|||
94372222|NCT01326702|323150210|FG003|Overall Study|progressive disease|1|||
94372223|NCT01326702|323150211|FG004|Overall Study|progressive disease|3|||
94372224|NCT01326702|323150212|FG005|Overall Study|progressive disease|2|||
94372225|NCT01326702|323150213|FG006|Overall Study|progressive disease|3|||
94209317|NCT04179175|322561654|FG002|Overall Study|Lost to Follow-up|2|||
94209318|NCT04179175|322561655|FG003|Overall Study|Lost to Follow-up|2|||
94209319|NCT04179175|322561656|FG004|Overall Study|Lost to Follow-up|4|||
94209320|NCT04179175|322561657|FG005|Overall Study|Lost to Follow-up|5|||
94209321|NCT04179175|322561652|FG000|Overall Study|Physician Decision|2|||
94209322|NCT04179175|322561653|FG001|Overall Study|Physician Decision|0|||
94209323|NCT04179175|322561654|FG002|Overall Study|Physician Decision|2|||
94209324|NCT04179175|322561655|FG003|Overall Study|Physician Decision|3|||
94209325|NCT04179175|322561656|FG004|Overall Study|Physician Decision|1|||
94209326|NCT04179175|322561657|FG005|Overall Study|Physician Decision|1|||
94209327|NCT04179175|322561652|FG000|Overall Study|Pregnancy|3|||
94209328|NCT04179175|322561653|FG001|Overall Study|Pregnancy|0|||
94209329|NCT04179175|322561654|FG002|Overall Study|Pregnancy|3|||
94209330|NCT04179175|322561655|FG003|Overall Study|Pregnancy|0|||
94209331|NCT04179175|322561656|FG004|Overall Study|Pregnancy|1|||
94209332|NCT04179175|322561657|FG005|Overall Study|Pregnancy|2|||
94209333|NCT04179175|322561652|FG000|Overall Study|Withdrawal by Subject|22|||
94209334|NCT04179175|322561653|FG001|Overall Study|Withdrawal by Subject|10|||
94209335|NCT04179175|322561654|FG002|Overall Study|Withdrawal by Subject|12|||
94209336|NCT04179175|322561655|FG003|Overall Study|Withdrawal by Subject|8|||
94209337|NCT04179175|322561656|FG004|Overall Study|Withdrawal by Subject|23|||
94209338|NCT04179175|322561657|FG005|Overall Study|Withdrawal by Subject|31|||
94209339|NCT04179175|322561652|FG000|Overall Study|Technical problems|0|||
94209340|NCT04179175|322561653|FG001|Overall Study|Technical problems|0|||
94209341|NCT04179175|322561654|FG002|Overall Study|Technical problems|1|||
94209342|NCT04179175|322561655|FG003|Overall Study|Technical problems|1|||
94209343|NCT04179175|322561656|FG004|Overall Study|Technical problems|0|||
94209344|NCT04179175|322561657|FG005|Overall Study|Technical problems|0|||
94209345|NCT02255435|322561658|FG000|Overall Study|Patient's Limited Time Availability|0|||
94372226|NCT01326702|323150207|FG000|Overall Study|Death|0|||
94372227|NCT01326702|323150208|FG001|Overall Study|Death|1|||
94372228|NCT01326702|323150209|FG002|Overall Study|Death|0|||
94372229|NCT01326702|323150210|FG003|Overall Study|Death|0|||
94372230|NCT01326702|323150211|FG004|Overall Study|Death|0|||
94209346|NCT02255435|322561659|FG001|Overall Study|Patient's Limited Time Availability|0|||
94372231|NCT01326702|323150212|FG005|Overall Study|Death|0|||
94209347|NCT02255435|322561660|FG002|Overall Study|Patient's Limited Time Availability|0|||
94209348|NCT02255435|322561661|FG003|Overall Study|Patient's Limited Time Availability|0|||
94209349|NCT02255435|322561662|FG004|Overall Study|Patient's Limited Time Availability|0|||
94209350|NCT02255435|322561663|FG005|Overall Study|Patient's Limited Time Availability|0|||
94209351|NCT02255435|322561664|FG006|Overall Study|Patient's Limited Time Availability|0|||
94209352|NCT02255435|322561665|FG007|Overall Study|Patient's Limited Time Availability|1|||
94209353|NCT02255435|322561666|FG008|Overall Study|Patient's Limited Time Availability|0|||
94209354|NCT02255435|322561667|FG009|Overall Study|Patient's Limited Time Availability|0|||
94209355|NCT02255435|322561658|FG000|Overall Study|Withdrawal by Subject|0|||
94209356|NCT02255435|322561659|FG001|Overall Study|Withdrawal by Subject|0|||
94209357|NCT02255435|322561660|FG002|Overall Study|Withdrawal by Subject|0|||
94209358|NCT02255435|322561661|FG003|Overall Study|Withdrawal by Subject|0|||
94209359|NCT02255435|322561662|FG004|Overall Study|Withdrawal by Subject|0|||
94209360|NCT02255435|322561663|FG005|Overall Study|Withdrawal by Subject|0|||
94209361|NCT02255435|322561664|FG006|Overall Study|Withdrawal by Subject|0|||
94209362|NCT02255435|322561665|FG007|Overall Study|Withdrawal by Subject|0|||
94209363|NCT02255435|322561666|FG008|Overall Study|Withdrawal by Subject|1|||
94209364|NCT02255435|322561667|FG009|Overall Study|Withdrawal by Subject|4|||
94209365|NCT02255435|322561658|FG000|Overall Study|Administrative reasons|0|||
94209366|NCT02255435|322561659|FG001|Overall Study|Administrative reasons|0|||
94209367|NCT02255435|322561660|FG002|Overall Study|Administrative reasons|0|||
94209368|NCT02255435|322561661|FG003|Overall Study|Administrative reasons|0|||
94209369|NCT02255435|322561662|FG004|Overall Study|Administrative reasons|0|||
94209370|NCT02255435|322561663|FG005|Overall Study|Administrative reasons|0|||
94209371|NCT02255435|322561664|FG006|Overall Study|Administrative reasons|0|||
94209372|NCT02255435|322561665|FG007|Overall Study|Administrative reasons|0|||
94209373|NCT02255435|322561666|FG008|Overall Study|Administrative reasons|0|||
94209374|NCT02255435|322561667|FG009|Overall Study|Administrative reasons|2|||
94209375|NCT00985088|322561670|FG000|Overall Study|Serious Adverse Event|1|||
94209376|NCT00985088|322561671|FG001|Overall Study|Serious Adverse Event|1|||
94209377|NCT00985088|322561672|FG002|Overall Study|Serious Adverse Event|0|||
94209378|NCT00985088|322561673|FG003|Overall Study|Serious Adverse Event|0|||
94209379|NCT00985088|322561674|FG004|Overall Study|Serious Adverse Event|0|||
94209380|NCT00985088|322561675|FG005|Overall Study|Serious Adverse Event|0|||
94209381|NCT00985088|322561676|FG006|Overall Study|Serious Adverse Event|0|||
94209382|NCT00985088|322561677|FG007|Overall Study|Serious Adverse Event|1|||
94209383|NCT00985088|322561670|FG000|Overall Study|Adverse Event|0|||
94209384|NCT00985088|322561671|FG001|Overall Study|Adverse Event|0|||
94209385|NCT00985088|322561672|FG002|Overall Study|Adverse Event|1|||
94209386|NCT00985088|322561673|FG003|Overall Study|Adverse Event|0|||
94209387|NCT00985088|322561674|FG004|Overall Study|Adverse Event|0|||
94209388|NCT00985088|322561675|FG005|Overall Study|Adverse Event|0|||
94209389|NCT00985088|322561676|FG006|Overall Study|Adverse Event|0|||
94209390|NCT00985088|322561677|FG007|Overall Study|Adverse Event|0|||
94209391|NCT00985088|322561670|FG000|Overall Study|Withdrawal by Subject|4|||
94209392|NCT00985088|322561671|FG001|Overall Study|Withdrawal by Subject|0|||
94209393|NCT00985088|322561672|FG002|Overall Study|Withdrawal by Subject|0|||
94209394|NCT00985088|322561673|FG003|Overall Study|Withdrawal by Subject|1|||
94209395|NCT00985088|322561674|FG004|Overall Study|Withdrawal by Subject|3|||
94209396|NCT00985088|322561675|FG005|Overall Study|Withdrawal by Subject|2|||
94209397|NCT00985088|322561676|FG006|Overall Study|Withdrawal by Subject|1|||
94209398|NCT00985088|322561677|FG007|Overall Study|Withdrawal by Subject|2|||
94209399|NCT00985088|322561670|FG000|Overall Study|Migrated/moved from study area|0|||
94209400|NCT00985088|322561671|FG001|Overall Study|Migrated/moved from study area|0|||
94209401|NCT00985088|322561672|FG002|Overall Study|Migrated/moved from study area|1|||
94209402|NCT00985088|322561673|FG003|Overall Study|Migrated/moved from study area|0|||
94209403|NCT00985088|322561674|FG004|Overall Study|Migrated/moved from study area|0|||
94209404|NCT00985088|322561675|FG005|Overall Study|Migrated/moved from study area|0|||
94209405|NCT00985088|322561676|FG006|Overall Study|Migrated/moved from study area|0|||
94209406|NCT00985088|322561677|FG007|Overall Study|Migrated/moved from study area|1|||
94209407|NCT00985088|322561670|FG000|Overall Study|Lost to Follow-up|6|||
94209408|NCT00985088|322561671|FG001|Overall Study|Lost to Follow-up|1|||
94209409|NCT00985088|322561672|FG002|Overall Study|Lost to Follow-up|2|||
94209410|NCT00985088|322561673|FG003|Overall Study|Lost to Follow-up|6|||
94209411|NCT00985088|322561674|FG004|Overall Study|Lost to Follow-up|6|||
94209412|NCT00985088|322561675|FG005|Overall Study|Lost to Follow-up|5|||
94209413|NCT00985088|322561676|FG006|Overall Study|Lost to Follow-up|3|||
94209414|NCT00985088|322561677|FG007|Overall Study|Lost to Follow-up|2|||
94209415|NCT01737398|322561678|FG000|Overall Study|Adverse event or SAE|16|||
94209416|NCT01737398|322561679|FG001|Overall Study|Adverse event or SAE|1|||
94209417|NCT01737398|322561678|FG000|Overall Study|Stopping rule met|2|||
94283371|NCT02926209|322827441|FG000|Study Cohort|Poor Bowel Preparation|1|||
94283372|NCT02926209|322827442|FG001|Study Cohort|Poor Bowel Preparation|0|||
94283373|NCT03948178|322827443|FG000|Overall Study|Protocol Violation|1|||
94209418|NCT01737398|322561679|FG001|Overall Study|Stopping rule met|1|||
94283374|NCT03948178|322827443|FG000|Overall Study|Lost to Follow-up|2|||
94283375|NCT03948178|322827443|FG000|Overall Study|Withdrawal by Subject|2|||
94283376|NCT03948178|322827443|FG000|Overall Study|Reason not known|2|||
94283377|NCT03948178|322827443|FG000|Overall Study|Personal reason|14|||
94283378|NCT03948178|322827443|FG000|Overall Study|Disease progression|30|||
94283379|NCT03948178|322827443|FG000|Overall Study|Adverse Event|12|||
94209419|NCT01737398|322561678|FG000|Overall Study|Voluntary withdrawal|2|||
94209420|NCT01737398|322561679|FG001|Overall Study|Voluntary withdrawal|3|||
94209421|NCT01737398|322561678|FG000|Overall Study|Ineligibility|1|||
94209422|NCT01737398|322561679|FG001|Overall Study|Ineligibility|0|||
94209423|NCT01737398|322561678|FG000|Overall Study|Liver transplant|1|||
94209424|NCT01737398|322561679|FG001|Overall Study|Liver transplant|0|||
94209425|NCT01737398|322561678|FG000|Overall Study|Disease progression|2|||
94209426|NCT01737398|322561679|FG001|Overall Study|Disease progression|3|||
94209427|NCT01737398|322561678|FG000|Overall Study|Sponsor's decision|2|||
94209428|NCT01737398|322561679|FG001|Overall Study|Sponsor's decision|0|||
94209429|NCT01532648|322561686|FG000|Overall Study|Lost to Follow-up|3|||
94209430|NCT01532648|322561687|FG001|Overall Study|Lost to Follow-up|4|||
94209431|NCT01532648|322561686|FG000|Overall Study|Lack of Efficacy|4|||
94209432|NCT01532648|322561687|FG001|Overall Study|Lack of Efficacy|1|||
94209433|NCT01532648|322561686|FG000|Overall Study|Protocol Violation|1|||
94209434|NCT01532648|322561687|FG001|Overall Study|Protocol Violation|1|||
94209435|NCT01532648|322561686|FG000|Overall Study|Adverse Event|12|||
94209436|NCT01532648|322561687|FG001|Overall Study|Adverse Event|9|||
94209437|NCT01532648|322561686|FG000|Overall Study|Withdrawal by Subject|16|||
94209438|NCT01532648|322561687|FG001|Overall Study|Withdrawal by Subject|2|||
94209439|NCT02148705|322561688|FG000|Overall Study|Death|2|||
94209440|NCT02148705|322561689|FG001|Overall Study|Death|0|||
94209441|NCT02148705|322561690|FG002|Overall Study|Death|0|||
94209442|NCT02148705|322561688|FG000|Overall Study|Lost to Follow-up|13|||
94209443|NCT02148705|322561689|FG001|Overall Study|Lost to Follow-up|4|||
94209444|NCT02148705|322561690|FG002|Overall Study|Lost to Follow-up|10|||
94209445|NCT02148705|322561688|FG000|Overall Study|Withdrawal by Subject|3|||
94209446|NCT02148705|322561689|FG001|Overall Study|Withdrawal by Subject|0|||
94209447|NCT02148705|322561690|FG002|Overall Study|Withdrawal by Subject|2|||
94283380|NCT03948178|322827443|FG000|Overall Study|Sponsor terminated study|164|||
94283381|NCT04418765|322827444|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
94283382|NCT04418765|322827445|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
94283383|NCT04418765|322827446|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
94283384|NCT04418765|322827444|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
94283385|NCT04418765|322827445|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
94209448|NCT02148705|322561688|FG000|Overall Study|Not Treated|0|||
94209449|NCT02148705|322561689|FG001|Overall Study|Not Treated|1|||
94209450|NCT02148705|322561690|FG002|Overall Study|Not Treated|5|||
94209451|NCT01737021|322561691|FG000|Overall Study|Lost to Follow-up|5|||
94209452|NCT01737021|322561692|FG001|Overall Study|Lost to Follow-up|3|||
94209453|NCT04652869|322561693|FG000|Overall Study|Withdrawal by Subject|0|||
94209454|NCT04652869|322561694|FG001|Overall Study|Withdrawal by Subject|2|||
94209455|NCT04652869|322561695|FG002|Overall Study|Withdrawal by Subject|0|||
94209456|NCT02605174|322561696|FG000|Overall Study|Adverse Event|0|||
94209457|NCT02605174|322561697|FG001|Overall Study|Adverse Event|0|||
94209458|NCT02605174|322561698|FG002|Overall Study|Adverse Event|1|||
94209459|NCT02605174|322561699|FG003|Overall Study|Adverse Event|0|||
94209460|NCT02605174|322561700|FG004|Overall Study|Adverse Event|4|||
94209461|NCT02605174|322561701|FG005|Overall Study|Adverse Event|0|||
94209462|NCT02605174|322561702|FG006|Overall Study|Adverse Event|0|||
94209463|NCT02605174|322561696|FG000|Overall Study|Lost to Follow-up|20|||
94209464|NCT02605174|322561697|FG001|Overall Study|Lost to Follow-up|7|||
94209465|NCT02605174|322561698|FG002|Overall Study|Lost to Follow-up|27|||
94209466|NCT02605174|322561699|FG003|Overall Study|Lost to Follow-up|10|||
94209467|NCT02605174|322561700|FG004|Overall Study|Lost to Follow-up|20|||
94209468|NCT02605174|322561701|FG005|Overall Study|Lost to Follow-up|10|||
94209469|NCT02605174|322561702|FG006|Overall Study|Lost to Follow-up|29|||
94209470|NCT02605174|322561696|FG000|Overall Study|Protocol Violation|10|||
94209471|NCT02605174|322561697|FG001|Overall Study|Protocol Violation|4|||
94209472|NCT02605174|322561698|FG002|Overall Study|Protocol Violation|14|||
94209473|NCT02605174|322561699|FG003|Overall Study|Protocol Violation|6|||
94209474|NCT02605174|322561700|FG004|Overall Study|Protocol Violation|7|||
94209475|NCT02605174|322561701|FG005|Overall Study|Protocol Violation|7|||
94209476|NCT02605174|322561702|FG006|Overall Study|Protocol Violation|12|||
94209477|NCT02605174|322561696|FG000|Overall Study|Pregnancy|1|||
94209478|NCT02605174|322561697|FG001|Overall Study|Pregnancy|0|||
94283386|NCT04418765|322827446|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
94283387|NCT04418765|322827444|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
94283388|NCT04418765|322827445|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
94283389|NCT04418765|322827446|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
94283390|NCT04418765|322827444|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
94283391|NCT04418765|322827445|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
94283392|NCT04418765|322827446|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
94283393|NCT04418765|322827444|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
94283394|NCT04418765|322827445|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
94283395|NCT04418765|322827446|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
94283396|NCT04418765|322827444|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
94283397|NCT04418765|322827445|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
94283398|NCT04418765|322827446|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
94283399|NCT04418765|322827444|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
94283400|NCT04418765|322827445|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
94283401|NCT04418765|322827446|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
94283402|NCT04418765|322827444|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
94283403|NCT04418765|322827445|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
94283404|NCT04418765|322827446|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
94283405|NCT04418765|322827444|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
94283406|NCT04418765|322827445|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
94283407|NCT04418765|322827446|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
94283408|NCT04418765|322827444|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
94283409|NCT04418765|322827445|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
94283410|NCT04418765|322827446|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
94283411|NCT04418765|322827444|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
94283412|NCT04418765|322827445|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
94283413|NCT04418765|322827446|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
94283414|NCT04418765|322827444|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
94372232|NCT01326702|323150213|FG006|Overall Study|Death|0|||
94209479|NCT02605174|322561698|FG002|Overall Study|Pregnancy|0|||
94209480|NCT02605174|322561699|FG003|Overall Study|Pregnancy|2|||
94209481|NCT02605174|322561700|FG004|Overall Study|Pregnancy|0|||
94372233|NCT01326702|323150207|FG000|Overall Study|Adverse Event|0|||
94372234|NCT01326702|323150208|FG001|Overall Study|Adverse Event|0|||
94372235|NCT01326702|323150209|FG002|Overall Study|Adverse Event|1|||
94372236|NCT01326702|323150210|FG003|Overall Study|Adverse Event|1|||
94372237|NCT01326702|323150211|FG004|Overall Study|Adverse Event|0|||
94209482|NCT02605174|322561701|FG005|Overall Study|Pregnancy|0|||
94372238|NCT01326702|323150212|FG005|Overall Study|Adverse Event|3|||
94372239|NCT01326702|323150213|FG006|Overall Study|Adverse Event|1|||
94372240|NCT01326702|323150207|FG000|Overall Study|Withdrawal by Subject|0|||
94372241|NCT01326702|323150208|FG001|Overall Study|Withdrawal by Subject|0|||
94209483|NCT02605174|322561702|FG006|Overall Study|Pregnancy|0|||
94209484|NCT02605174|322561696|FG000|Overall Study|Withdrawal by Subject|9|||
94209485|NCT02605174|322561697|FG001|Overall Study|Withdrawal by Subject|6|||
94283415|NCT04418765|322827445|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
94283416|NCT04418765|322827446|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
94372242|NCT01326702|323150209|FG002|Overall Study|Withdrawal by Subject|1|||
94372243|NCT01326702|323150210|FG003|Overall Study|Withdrawal by Subject|0|||
94372244|NCT01326702|323150211|FG004|Overall Study|Withdrawal by Subject|1|||
94372245|NCT01326702|323150212|FG005|Overall Study|Withdrawal by Subject|1|||
94283417|NCT04418765|322827444|FG000|Extension Period (48 Weeks)|Other than specified|0|||
94283418|NCT04418765|322827445|FG001|Extension Period (48 Weeks)|Other than specified|5|||
94283419|NCT04418765|322827446|FG002|Extension Period (48 Weeks)|Other than specified|2|||
94283420|NCT02062658|322827447|FG000|Overall Study|Withdrawal by Subject|1|||
94283421|NCT02062658|322827447|FG000|Overall Study|Lack of Efficacy|1|||
94283422|NCT01926782|322827452|FG000|Overall Study|Participant moved|2|||
94283423|NCT01926782|322827453|FG001|Overall Study|Participant moved|0|||
94283424|NCT01926782|322827454|FG002|Overall Study|Participant moved|1|||
94283425|NCT01926782|322827455|FG003|Overall Study|Participant moved|1|||
94283426|NCT01926782|322827456|FG004|Overall Study|Participant moved|0|||
94283427|NCT01926782|322827457|FG005|Overall Study|Participant moved|3|||
94283428|NCT01926782|322827452|FG000|Overall Study|Physician Decision|0|||
94283429|NCT01926782|322827453|FG001|Overall Study|Physician Decision|2|||
94283430|NCT01926782|322827454|FG002|Overall Study|Physician Decision|1|||
94283431|NCT01926782|322827455|FG003|Overall Study|Physician Decision|1|||
94283432|NCT01926782|322827456|FG004|Overall Study|Physician Decision|0|||
94283433|NCT01926782|322827457|FG005|Overall Study|Physician Decision|0|||
94283434|NCT01926782|322827452|FG000|Overall Study|Other than specified|2|||
94283435|NCT01926782|322827453|FG001|Overall Study|Other than specified|3|||
94283436|NCT01926782|322827454|FG002|Overall Study|Other than specified|5|||
94283437|NCT01926782|322827455|FG003|Overall Study|Other than specified|12|||
94283438|NCT01926782|322827456|FG004|Overall Study|Other than specified|4|||
94283439|NCT01926782|322827457|FG005|Overall Study|Other than specified|11|||
94283440|NCT01926782|322827452|FG000|Overall Study|Adverse Event|13|||
94372246|NCT01326702|323150213|FG006|Overall Study|Withdrawal by Subject|3|||
94372247|NCT01326702|323150207|FG000|Overall Study|Not Treated|0|||
94372248|NCT01326702|323150208|FG001|Overall Study|Not Treated|0|||
94283441|NCT01926782|322827453|FG001|Overall Study|Adverse Event|4|||
94372249|NCT01326702|323150209|FG002|Overall Study|Not Treated|0|||
94283442|NCT01926782|322827454|FG002|Overall Study|Adverse Event|17|||
94283443|NCT01926782|322827455|FG003|Overall Study|Adverse Event|4|||
94283444|NCT01926782|322827456|FG004|Overall Study|Adverse Event|3|||
94283445|NCT01926782|322827457|FG005|Overall Study|Adverse Event|14|||
94372250|NCT01326702|323150210|FG003|Overall Study|Not Treated|1|||
94372251|NCT01326702|323150211|FG004|Overall Study|Not Treated|0|||
94372252|NCT01326702|323150212|FG005|Overall Study|Not Treated|1|||
94372253|NCT01326702|323150213|FG006|Overall Study|Not Treated|0|||
94372254|NCT00787566|323150222|FG000|Overall Study|AE related to chemotherapy|0|||
94372255|NCT00787566|323150223|FG001|Overall Study|AE related to chemotherapy|1|||
94372256|NCT00787566|323150224|FG002|Overall Study|AE related to chemotherapy|0|||
94372257|NCT02140164|323150225|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
94209486|NCT02605174|322561698|FG002|Overall Study|Withdrawal by Subject|14|||
94209487|NCT02605174|322561699|FG003|Overall Study|Withdrawal by Subject|11|||
94209488|NCT02605174|322561700|FG004|Overall Study|Withdrawal by Subject|6|||
94209489|NCT02605174|322561701|FG005|Overall Study|Withdrawal by Subject|4|||
94209490|NCT02605174|322561702|FG006|Overall Study|Withdrawal by Subject|15|||
94209491|NCT02605174|322561696|FG000|Overall Study|Physician Decision|2|||
94209492|NCT02605174|322561697|FG001|Overall Study|Physician Decision|0|||
94209493|NCT02605174|322561698|FG002|Overall Study|Physician Decision|0|||
94209494|NCT02605174|322561699|FG003|Overall Study|Physician Decision|0|||
94209495|NCT02605174|322561700|FG004|Overall Study|Physician Decision|0|||
94209496|NCT02605174|322561701|FG005|Overall Study|Physician Decision|0|||
94209497|NCT02605174|322561702|FG006|Overall Study|Physician Decision|3|||
94209498|NCT02605174|322561696|FG000|Overall Study|Randomization Failure|22|||
94209499|NCT02605174|322561697|FG001|Overall Study|Randomization Failure|6|||
94209500|NCT02605174|322561698|FG002|Overall Study|Randomization Failure|20|||
94283446|NCT01926782|322827452|FG000|Overall Study|Poor compliance to protocol|5|||
94283447|NCT01926782|322827453|FG001|Overall Study|Poor compliance to protocol|3|||
94283448|NCT01926782|322827454|FG002|Overall Study|Poor compliance to protocol|8|||
94283449|NCT01926782|322827455|FG003|Overall Study|Poor compliance to protocol|0|||
94283450|NCT01926782|322827456|FG004|Overall Study|Poor compliance to protocol|1|||
94283451|NCT01926782|322827457|FG005|Overall Study|Poor compliance to protocol|6|||
94283452|NCT01926782|322827452|FG000|Overall Study|Randomized and not treated|0|||
94283453|NCT01926782|322827453|FG001|Overall Study|Randomized and not treated|0|||
94283454|NCT01926782|322827454|FG002|Overall Study|Randomized and not treated|0|||
94283455|NCT01926782|322827455|FG003|Overall Study|Randomized and not treated|1|||
94283456|NCT01926782|322827456|FG004|Overall Study|Randomized and not treated|0|||
94283457|NCT01926782|322827457|FG005|Overall Study|Randomized and not treated|0|||
94283458|NCT01926782|322827452|FG000|Overall Study|Withdrawal by Subject|6|||
94283459|NCT01926782|322827453|FG001|Overall Study|Withdrawal by Subject|1|||
94283460|NCT01926782|322827454|FG002|Overall Study|Withdrawal by Subject|8|||
94283461|NCT01926782|322827455|FG003|Overall Study|Withdrawal by Subject|1|||
94283462|NCT01926782|322827456|FG004|Overall Study|Withdrawal by Subject|0|||
94283463|NCT01926782|322827457|FG005|Overall Study|Withdrawal by Subject|5|||
94283464|NCT01926782|322827452|FG000|Overall Study|Related to study drug administration|0|||
94283465|NCT01926782|322827453|FG001|Overall Study|Related to study drug administration|0|||
94283466|NCT01926782|322827454|FG002|Overall Study|Related to study drug administration|0|||
94283467|NCT01926782|322827455|FG003|Overall Study|Related to study drug administration|0|||
94283468|NCT01926782|322827456|FG004|Overall Study|Related to study drug administration|0|||
94283469|NCT01926782|322827457|FG005|Overall Study|Related to study drug administration|2|||
94283470|NCT02275338|322827460|FG000|Overall Study|Adverse Event|15|||
94283471|NCT02275338|322827460|FG000|Overall Study|Lack of Efficacy|3|||
94283472|NCT02275338|322827460|FG000|Overall Study|Withdrawal by Subject|4|||
94283473|NCT02275338|322827460|FG000|Overall Study|Disease progression (death)|1|||
94283474|NCT02275338|322827460|FG000|Overall Study|Ineligible to start Phase 2|4|||
94283475|NCT02275338|322827460|FG000|Overall Study|Reason not specified|5|||
94283476|NCT02275338|322827460|FG000|Overall Study|Does not meet entry criteria|1|||
94283477|NCT00382993|322827461|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
94283478|NCT00382993|322827462|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
94283479|NCT00382993|322827461|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
94283480|NCT00382993|322827462|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
94283481|NCT00382993|322827461|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
94283482|NCT00382993|322827462|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
94283483|NCT00382993|322827461|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
94283484|NCT00382993|322827462|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
94372258|NCT03548207|323150226|FG000|Overall Study|Death|10|||
94209501|NCT02605174|322561699|FG003|Overall Study|Randomization Failure|7|||
94209502|NCT02605174|322561700|FG004|Overall Study|Randomization Failure|16|||
94209503|NCT02605174|322561701|FG005|Overall Study|Randomization Failure|11|||
94372259|NCT03548207|323150227|FG001|Overall Study|Death|23|||
94372260|NCT03548207|323150228|FG002|Overall Study|Death|3|||
94209504|NCT02605174|322561702|FG006|Overall Study|Randomization Failure|30|||
94209505|NCT01833455|322561703|FG000|Overall Study|Withdrawal by Subject|1|||
94209506|NCT01833455|322561704|FG001|Overall Study|Withdrawal by Subject|0|||
94283485|NCT00382993|322827461|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
94283486|NCT00382993|322827462|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
94283487|NCT00382993|322827461|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
94209507|NCT00887224|322561705|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
94209508|NCT00887224|322561706|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
94209509|NCT00887224|322561707|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
94209510|NCT00887224|322561705|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
94209511|NCT00887224|322561706|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
94209512|NCT00887224|322561707|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
94209513|NCT00887224|322561705|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
94209514|NCT00887224|322561706|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
94209515|NCT00887224|322561707|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
94209516|NCT00887224|322561705|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
94209517|NCT00887224|322561706|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
94209518|NCT00887224|322561707|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
94209519|NCT00887224|322561705|FG000|Open-label Response (OLR) Phase|Other|1|||
94209520|NCT00887224|322561706|FG001|Open-label Response (OLR) Phase|Other|0|||
94209521|NCT00887224|322561707|FG002|Open-label Response (OLR) Phase|Other|0|||
94209522|NCT00887224|322561705|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
94209523|NCT00887224|322561706|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
94209524|NCT00887224|322561707|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
94209525|NCT00887224|322561705|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
94209526|NCT00887224|322561706|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
94209527|NCT00887224|322561707|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
94209528|NCT00887224|322561705|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
94209529|NCT00887224|322561706|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
94209530|NCT00887224|322561707|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
94209531|NCT00887224|322561705|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
94209532|NCT00887224|322561706|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
94209533|NCT00887224|322561707|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
94209534|NCT00887224|322561705|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
94209535|NCT00887224|322561706|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
94209536|NCT00887224|322561707|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
94209537|NCT00887224|322561705|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
94209538|NCT00887224|322561706|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
94209539|NCT00887224|322561707|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
94209540|NCT00887224|322561705|FG000|Open-label Stability (OLS) Phase|Other|1|||
94209541|NCT00887224|322561706|FG001|Open-label Stability (OLS) Phase|Other|0|||
94209542|NCT00887224|322561707|FG002|Open-label Stability (OLS) Phase|Other|0|||
94209543|NCT00887224|322561705|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
94209544|NCT00887224|322561706|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
94209545|NCT00887224|322561707|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
94209546|NCT00887224|322561705|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
94209547|NCT00887224|322561706|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
94209548|NCT00887224|322561707|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
94209549|NCT00887224|322561705|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
94209550|NCT00887224|322561706|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
94209551|NCT00887224|322561707|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
94209552|NCT00887224|322561705|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
94209553|NCT00887224|322561706|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
94209554|NCT00887224|322561707|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
94209555|NCT00887224|322561705|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
94209556|NCT00887224|322561706|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
94209557|NCT00887224|322561707|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
94209558|NCT00887224|322561705|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
94209559|NCT00887224|322561706|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
94209560|NCT00887224|322561707|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
94283488|NCT00382993|322827462|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
94283489|NCT00382993|322827461|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
94283490|NCT00382993|322827462|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
94283491|NCT00382993|322827461|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
94283492|NCT00382993|322827462|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
94283493|NCT00382993|322827461|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
94283494|NCT00382993|322827462|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
94283495|NCT00382993|322827461|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
94209561|NCT00887224|322561705|FG000|OL Taper Phase / OL Follow Up|Other|30|||
94209562|NCT00887224|322561706|FG001|OL Taper Phase / OL Follow Up|Other|0|||
94209563|NCT00887224|322561707|FG002|OL Taper Phase / OL Follow Up|Other|0|||
94209564|NCT00887224|322561705|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
94467701|NCT01004432|323502377|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
94209565|NCT00887224|322561706|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
94209566|NCT00887224|322561707|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
94209567|NCT00887224|322561705|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
94209568|NCT00887224|322561706|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
94209569|NCT00887224|322561707|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
94209570|NCT00887224|322561705|FG000|Double-blind (DB) Phase|Adverse Event|0|||
94209571|NCT00887224|322561706|FG001|Double-blind (DB) Phase|Adverse Event|7|||
94209572|NCT00887224|322561707|FG002|Double-blind (DB) Phase|Adverse Event|2|||
94209573|NCT00887224|322561705|FG000|Double-blind (DB) Phase|Failed to return|0|||
94209574|NCT00887224|322561706|FG001|Double-blind (DB) Phase|Failed to return|2|||
94209575|NCT00887224|322561707|FG002|Double-blind (DB) Phase|Failed to return|2|||
94209576|NCT00887224|322561705|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
94209577|NCT00887224|322561706|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
94209578|NCT00887224|322561707|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
94209579|NCT00887224|322561705|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
94209580|NCT00887224|322561706|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
94209581|NCT00887224|322561707|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
94209582|NCT00887224|322561705|FG000|Double-blind (DB) Phase|Other|0|||
94209583|NCT00887224|322561706|FG001|Double-blind (DB) Phase|Other|2|||
94209584|NCT00887224|322561707|FG002|Double-blind (DB) Phase|Other|0|||
94209585|NCT00887224|322561705|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
94209586|NCT00887224|322561706|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
94209587|NCT00887224|322561707|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
94209588|NCT00887224|322561705|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
94209589|NCT00887224|322561706|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
94209590|NCT00887224|322561707|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
94209591|NCT00887224|322561705|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
94209592|NCT00887224|322561706|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
94209593|NCT00887224|322561707|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
94209594|NCT00887224|322561705|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
94209595|NCT00887224|322561706|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
94209596|NCT00887224|322561707|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
94209597|NCT00887224|322561705|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
94209598|NCT00887224|322561706|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
94209599|NCT00887224|322561707|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
94209600|NCT00887224|322561705|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
94209601|NCT00887224|322561706|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
94209602|NCT00887224|322561707|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
94209603|NCT00887224|322561705|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
94209604|NCT00887224|322561706|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
94209605|NCT00887224|322561707|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
94209606|NCT00887224|322561705|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
94209607|NCT00887224|322561706|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
94209608|NCT00887224|322561707|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
94209609|NCT00887224|322561705|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
94209610|NCT00887224|322561706|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
94209611|NCT00887224|322561707|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
94209612|NCT02827201|322561717|FG000|Overall Study|Death|1|||
94209613|NCT02827201|322561718|FG001|Overall Study|Death|2|||
94209614|NCT02827201|322561717|FG000|Overall Study|Patients not treated|1|||
94209615|NCT02827201|322561718|FG001|Overall Study|Patients not treated|1|||
94209616|NCT04497415|322561719|FG000|Overall Study|Lost to Follow-up|43|||
94209617|NCT04497415|322561720|FG001|Overall Study|Lost to Follow-up|27|||
94209618|NCT02404441|322561722|FG000|Phase 1 Part|Adverse Event|1|||
94209619|NCT02404441|322561723|FG001|Phase 1 Part|Adverse Event|0|||
94209620|NCT02404441|322561724|FG002|Phase 1 Part|Adverse Event|0|||
94209621|NCT02404441|322561725|FG003|Phase 1 Part|Adverse Event|0|||
94209622|NCT02404441|322561726|FG004|Phase 1 Part|Adverse Event|0|||
94209623|NCT02404441|322561727|FG005|Phase 1 Part|Adverse Event|0|||
94209624|NCT02404441|322561728|FG006|Phase 1 Part|Adverse Event|0|||
94209625|NCT02404441|322561729|FG007|Phase 1 Part|Adverse Event|0|||
94209626|NCT02404441|322561730|FG008|Phase 1 Part|Adverse Event|0|||
94209627|NCT02404441|322561731|FG009|Phase 1 Part|Adverse Event|0|||
94209628|NCT02404441|322561722|FG000|Phase 1 Part|Physician Decision|0|||
94209629|NCT02404441|322561723|FG001|Phase 1 Part|Physician Decision|1|||
94209630|NCT02404441|322561724|FG002|Phase 1 Part|Physician Decision|0|||
94209631|NCT02404441|322561725|FG003|Phase 1 Part|Physician Decision|0|||
94209632|NCT02404441|322561726|FG004|Phase 1 Part|Physician Decision|0|||
94209633|NCT02404441|322561727|FG005|Phase 1 Part|Physician Decision|0|||
94209634|NCT02404441|322561728|FG006|Phase 1 Part|Physician Decision|0|||
94209635|NCT02404441|322561729|FG007|Phase 1 Part|Physician Decision|0|||
94209636|NCT02404441|322561730|FG008|Phase 1 Part|Physician Decision|0|||
94209637|NCT02404441|322561731|FG009|Phase 1 Part|Physician Decision|0|||
94209638|NCT02404441|322561722|FG000|Phase 1 Part|Progressive Disease|14|||
94209639|NCT02404441|322561723|FG001|Phase 1 Part|Progressive Disease|11|||
94209640|NCT02404441|322561724|FG002|Phase 1 Part|Progressive Disease|7|||
94209641|NCT02404441|322561725|FG003|Phase 1 Part|Progressive Disease|6|||
94209642|NCT02404441|322561726|FG004|Phase 1 Part|Progressive Disease|9|||
94209643|NCT02404441|322561727|FG005|Phase 1 Part|Progressive Disease|0|||
94209644|NCT02404441|322561728|FG006|Phase 1 Part|Progressive Disease|0|||
94209645|NCT02404441|322561729|FG007|Phase 1 Part|Progressive Disease|0|||
94209646|NCT02404441|322561730|FG008|Phase 1 Part|Progressive Disease|0|||
94209647|NCT02404441|322561731|FG009|Phase 1 Part|Progressive Disease|0|||
94209648|NCT02404441|322561722|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
94209649|NCT02404441|322561723|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
94209650|NCT02404441|322561724|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
94209651|NCT02404441|322561725|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
94209652|NCT02404441|322561726|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
94209653|NCT02404441|322561727|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
94209654|NCT02404441|322561728|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
94209655|NCT02404441|322561729|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
94209656|NCT02404441|322561730|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
94209657|NCT02404441|322561731|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
94209658|NCT02404441|322561722|FG000|Phase 1 Part|Death|1|||
94209659|NCT02404441|322561723|FG001|Phase 1 Part|Death|1|||
94209660|NCT02404441|322561724|FG002|Phase 1 Part|Death|1|||
94209661|NCT02404441|322561725|FG003|Phase 1 Part|Death|0|||
94209662|NCT02404441|322561726|FG004|Phase 1 Part|Death|1|||
94209663|NCT02404441|322561727|FG005|Phase 1 Part|Death|0|||
94209664|NCT02404441|322561728|FG006|Phase 1 Part|Death|0|||
94209665|NCT02404441|322561729|FG007|Phase 1 Part|Death|0|||
94209666|NCT02404441|322561730|FG008|Phase 1 Part|Death|0|||
94209667|NCT02404441|322561731|FG009|Phase 1 Part|Death|0|||
94209668|NCT02404441|322561722|FG000|Phase 2 Part|Adverse Event|0|||
94209669|NCT02404441|322561723|FG001|Phase 2 Part|Adverse Event|0|||
94209670|NCT02404441|322561724|FG002|Phase 2 Part|Adverse Event|0|||
94209671|NCT02404441|322561725|FG003|Phase 2 Part|Adverse Event|0|||
94209672|NCT02404441|322561726|FG004|Phase 2 Part|Adverse Event|0|||
94209673|NCT02404441|322561727|FG005|Phase 2 Part|Adverse Event|2|||
94209674|NCT02404441|322561728|FG006|Phase 2 Part|Adverse Event|3|||
94209675|NCT02404441|322561729|FG007|Phase 2 Part|Adverse Event|3|||
94209676|NCT02404441|322561730|FG008|Phase 2 Part|Adverse Event|6|||
94209677|NCT02404441|322561731|FG009|Phase 2 Part|Adverse Event|1|||
94209678|NCT02404441|322561722|FG000|Phase 2 Part|Physician Decision|0|||
94209679|NCT02404441|322561723|FG001|Phase 2 Part|Physician Decision|0|||
94209680|NCT02404441|322561724|FG002|Phase 2 Part|Physician Decision|0|||
94209681|NCT02404441|322561725|FG003|Phase 2 Part|Physician Decision|0|||
94467702|NCT01004432|323502373|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
94209682|NCT02404441|322561726|FG004|Phase 2 Part|Physician Decision|0|||
94209683|NCT02404441|322561727|FG005|Phase 2 Part|Physician Decision|7|||
94209684|NCT02404441|322561728|FG006|Phase 2 Part|Physician Decision|9|||
94209685|NCT02404441|322561729|FG007|Phase 2 Part|Physician Decision|2|||
94209686|NCT02404441|322561730|FG008|Phase 2 Part|Physician Decision|1|||
94209687|NCT02404441|322561731|FG009|Phase 2 Part|Physician Decision|3|||
94209688|NCT02404441|322561722|FG000|Phase 2 Part|Progressive disease|0|||
94209689|NCT02404441|322561723|FG001|Phase 2 Part|Progressive disease|0|||
94209690|NCT02404441|322561724|FG002|Phase 2 Part|Progressive disease|0|||
94209691|NCT02404441|322561725|FG003|Phase 2 Part|Progressive disease|0|||
94209692|NCT02404441|322561726|FG004|Phase 2 Part|Progressive disease|0|||
94372261|NCT03548207|323150226|FG000|Overall Study|Lost to Follow-up|0|||
94209693|NCT02404441|322561727|FG005|Phase 2 Part|Progressive disease|43|||
94209694|NCT02404441|322561728|FG006|Phase 2 Part|Progressive disease|32|||
94209695|NCT02404441|322561729|FG007|Phase 2 Part|Progressive disease|31|||
94209696|NCT02404441|322561730|FG008|Phase 2 Part|Progressive disease|39|||
94209697|NCT02404441|322561731|FG009|Phase 2 Part|Progressive disease|27|||
94209698|NCT02404441|322561722|FG000|Phase 2 Part|Subject/guardian decision|0|||
94209699|NCT02404441|322561723|FG001|Phase 2 Part|Subject/guardian decision|0|||
94209700|NCT02404441|322561724|FG002|Phase 2 Part|Subject/guardian decision|0|||
94209701|NCT02404441|322561725|FG003|Phase 2 Part|Subject/guardian decision|0|||
94283496|NCT00382993|322827462|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
94209702|NCT02404441|322561726|FG004|Phase 2 Part|Subject/guardian decision|0|||
94209703|NCT02404441|322561727|FG005|Phase 2 Part|Subject/guardian decision|3|||
94209704|NCT02404441|322561728|FG006|Phase 2 Part|Subject/guardian decision|9|||
94209705|NCT02404441|322561729|FG007|Phase 2 Part|Subject/guardian decision|0|||
94209706|NCT02404441|322561730|FG008|Phase 2 Part|Subject/guardian decision|3|||
94209707|NCT02404441|322561731|FG009|Phase 2 Part|Subject/guardian decision|2|||
94209708|NCT02404441|322561722|FG000|Phase 2 Part|Death|0|||
94209709|NCT02404441|322561723|FG001|Phase 2 Part|Death|0|||
94209710|NCT02404441|322561724|FG002|Phase 2 Part|Death|0|||
94209711|NCT02404441|322561725|FG003|Phase 2 Part|Death|0|||
94209712|NCT02404441|322561726|FG004|Phase 2 Part|Death|0|||
94209713|NCT02404441|322561727|FG005|Phase 2 Part|Death|4|||
94209714|NCT02404441|322561728|FG006|Phase 2 Part|Death|8|||
94209715|NCT02404441|322561729|FG007|Phase 2 Part|Death|4|||
94283497|NCT01100944|322827463|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
94283498|NCT01100944|322827464|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
94283499|NCT01100944|322827465|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
94283500|NCT01100944|322827463|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
94283501|NCT01100944|322827464|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
94283502|NCT01100944|322827465|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
94283503|NCT01100944|322827463|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
94283504|NCT01100944|322827464|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
94283505|NCT01100944|322827465|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
94283506|NCT01100944|322827463|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
94283507|NCT01100944|322827464|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
94283508|NCT01100944|322827465|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
94283509|NCT01665807|322827469|FG000|Overall Study|Withdrawal by Subject|2|||
94283510|NCT01665807|322827470|FG001|Overall Study|Withdrawal by Subject|0|||
94283511|NCT01665807|322827471|FG002|Overall Study|Withdrawal by Subject|1|||
94283512|NCT00094055|322827485|FG000|Overall Study|Adverse Event|11|||
94283513|NCT00094055|322827485|FG000|Overall Study|Death|4|||
94283514|NCT00094055|322827485|FG000|Overall Study|Lack of Efficacy|17|||
94209716|NCT02404441|322561730|FG008|Phase 2 Part|Death|10|||
94209717|NCT02404441|322561731|FG009|Phase 2 Part|Death|9|||
94209718|NCT03418545|322561735|FG000|Overall Study|Withdrawal by Participant|2|||
94209719|NCT03418545|322561736|FG001|Overall Study|Withdrawal by Participant|4|||
94209720|NCT03418545|322561735|FG000|Overall Study|Lost to Follow-up|3|||
94209721|NCT03418545|322561736|FG001|Overall Study|Lost to Follow-up|5|||
94209722|NCT03418545|322561735|FG000|Overall Study|Reason Not Specified|0|||
94209723|NCT03418545|322561736|FG001|Overall Study|Reason Not Specified|1|||
94209724|NCT03418545|322561735|FG000|Overall Study|Missing Completion Status|0|||
94283515|NCT00094055|322827485|FG000|Overall Study|Lost to Follow-up|2|||
94283516|NCT00094055|322827485|FG000|Overall Study|progressive disease|2|||
94283517|NCT00094055|322827485|FG000|Overall Study|clinical progression|1|||
94283518|NCT00094055|322827485|FG000|Overall Study|roll-over to another study|14|||
94283519|NCT00094055|322827485|FG000|Overall Study|Withdrawal by Subject|9|||
94283520|NCT01081795|322827486|FG000|Overall Study|Adverse Event|18|||
94283521|NCT01081795|322827487|FG001|Overall Study|Adverse Event|23|||
94283522|NCT01081795|322827488|FG002|Overall Study|Adverse Event|6|||
94283523|NCT01081795|322827486|FG000|Overall Study|Lack of Efficacy|7|||
94283524|NCT01081795|322827487|FG001|Overall Study|Lack of Efficacy|5|||
94283525|NCT01081795|322827488|FG002|Overall Study|Lack of Efficacy|19|||
94283526|NCT01081795|322827486|FG000|Overall Study|Subject's schedule|1|||
94283527|NCT01081795|322827487|FG001|Overall Study|Subject's schedule|1|||
94283528|NCT01081795|322827488|FG002|Overall Study|Subject's schedule|2|||
94283529|NCT01081795|322827486|FG000|Overall Study|Revocation of informed consent|2|||
94283530|NCT01081795|322827487|FG001|Overall Study|Revocation of informed consent|0|||
94283531|NCT01081795|322827488|FG002|Overall Study|Revocation of informed consent|0|||
94283532|NCT01081795|322827486|FG000|Overall Study|Ineligible for participation|1|||
94372262|NCT03548207|323150227|FG001|Overall Study|Lost to Follow-up|2|||
94209725|NCT03418545|322561736|FG001|Overall Study|Missing Completion Status|1|||
94209726|NCT02040870|322561741|FG000|Overall Study|Completed treatment phase|6|||
94209727|NCT02040870|322561741|FG000|Overall Study|Adverse Event|7|||
94209728|NCT02040870|322561741|FG000|Overall Study|Progressive disease|58|||
94209729|NCT02040870|322561741|FG000|Overall Study|Physician Decision|6|||
94209730|NCT02040870|322561741|FG000|Overall Study|Subject/guardian decision|10|||
94209731|NCT02040870|322561741|FG000|Overall Study|Lost to Follow-up|3|||
94209732|NCT02040870|322561741|FG000|Overall Study|Death|13|||
94209733|NCT01822756|322561752|FG000|Overall Study|Adverse Event|0|||
94209734|NCT01822756|322561753|FG001|Overall Study|Adverse Event|0|||
94209735|NCT01822756|322561754|FG002|Overall Study|Adverse Event|0|||
94209736|NCT01822756|322561755|FG003|Overall Study|Adverse Event|2|||
94209737|NCT01822756|322561756|FG004|Overall Study|Adverse Event|0|||
94209738|NCT01822756|322561752|FG000|Overall Study|Disease progression|11|||
94209739|NCT01822756|322561753|FG001|Overall Study|Disease progression|1|||
94209740|NCT01822756|322561754|FG002|Overall Study|Disease progression|7|||
94209741|NCT01822756|322561755|FG003|Overall Study|Disease progression|2|||
94209742|NCT01822756|322561756|FG004|Overall Study|Disease progression|6|||
94209743|NCT01822756|322561752|FG000|Overall Study|Death|2|||
94209744|NCT01822756|322561753|FG001|Overall Study|Death|2|||
94209745|NCT01822756|322561754|FG002|Overall Study|Death|1|||
94209746|NCT01822756|322561755|FG003|Overall Study|Death|0|||
94209747|NCT01822756|322561756|FG004|Overall Study|Death|0|||
94209748|NCT01822756|322561752|FG000|Overall Study|Lost to Follow-up|1|||
94209749|NCT01822756|322561753|FG001|Overall Study|Lost to Follow-up|0|||
94209750|NCT01822756|322561754|FG002|Overall Study|Lost to Follow-up|1|||
94209751|NCT01822756|322561755|FG003|Overall Study|Lost to Follow-up|0|||
94209752|NCT01822756|322561756|FG004|Overall Study|Lost to Follow-up|1|||
94209753|NCT01822756|322561752|FG000|Overall Study|Physician Decision|0|||
94209754|NCT01822756|322561753|FG001|Overall Study|Physician Decision|1|||
94209755|NCT01822756|322561754|FG002|Overall Study|Physician Decision|0|||
94209756|NCT01822756|322561755|FG003|Overall Study|Physician Decision|0|||
94209757|NCT01822756|322561756|FG004|Overall Study|Physician Decision|0|||
94209758|NCT01822756|322561752|FG000|Overall Study|disease progression & patient preference|2|||
94209759|NCT01822756|322561753|FG001|Overall Study|disease progression & patient preference|0|||
94209760|NCT01822756|322561754|FG002|Overall Study|disease progression & patient preference|1|||
94209761|NCT01822756|322561755|FG003|Overall Study|disease progression & patient preference|0|||
94209762|NCT01822756|322561756|FG004|Overall Study|disease progression & patient preference|0|||
94209763|NCT03611556|322561757|FG000|Overall Study|Death|7|||
94209764|NCT03611556|322561758|FG001|Overall Study|Death|7|||
94209765|NCT03611556|322561759|FG002|Overall Study|Death|3|||
94209766|NCT03611556|322561760|FG003|Overall Study|Death|8|||
94209767|NCT03611556|322561761|FG004|Overall Study|Death|47|||
94209768|NCT03611556|322561762|FG005|Overall Study|Death|32|||
94209769|NCT03611556|322561763|FG006|Overall Study|Death|53|||
94209770|NCT03611556|322561757|FG000|Overall Study|Withdrawal by Subject|0|||
94209771|NCT03611556|322561758|FG001|Overall Study|Withdrawal by Subject|0|||
94209772|NCT03611556|322561759|FG002|Overall Study|Withdrawal by Subject|0|||
94209773|NCT03611556|322561760|FG003|Overall Study|Withdrawal by Subject|0|||
94209774|NCT03611556|322561761|FG004|Overall Study|Withdrawal by Subject|4|||
94209775|NCT03611556|322561762|FG005|Overall Study|Withdrawal by Subject|2|||
94209776|NCT03611556|322561763|FG006|Overall Study|Withdrawal by Subject|4|||
94209777|NCT03611556|322561757|FG000|Overall Study|Sponsor decision|0|||
94209778|NCT03611556|322561758|FG001|Overall Study|Sponsor decision|0|||
94283533|NCT01081795|322827487|FG001|Overall Study|Ineligible for participation|0|||
94209779|NCT03611556|322561759|FG002|Overall Study|Sponsor decision|0|||
94209780|NCT03611556|322561760|FG003|Overall Study|Sponsor decision|0|||
94209781|NCT03611556|322561761|FG004|Overall Study|Sponsor decision|9|||
94283534|NCT01081795|322827488|FG002|Overall Study|Ineligible for participation|0|||
94209782|NCT03611556|322561762|FG005|Overall Study|Sponsor decision|4|||
94209783|NCT03611556|322561763|FG006|Overall Study|Sponsor decision|12|||
94209784|NCT03611556|322561757|FG000|Overall Study|Reasons|0|||
94209785|NCT03611556|322561758|FG001|Overall Study|Reasons|0|||
94372263|NCT03548207|323150228|FG002|Overall Study|Lost to Follow-up|0|||
94372264|NCT03548207|323150226|FG000|Overall Study|Withdrawal by Subject|0|||
94372265|NCT03548207|323150227|FG001|Overall Study|Withdrawal by Subject|3|||
94209786|NCT03611556|322561759|FG002|Overall Study|Reasons|0|||
94209787|NCT03611556|322561760|FG003|Overall Study|Reasons|0|||
94209788|NCT03611556|322561761|FG004|Overall Study|Reasons|2|||
94209789|NCT03611556|322561762|FG005|Overall Study|Reasons|0|||
94209790|NCT03611556|322561763|FG006|Overall Study|Reasons|1|||
94209791|NCT03539055|322561764|FG000|Overall Study|Death|4|||
94209792|NCT03539055|322561764|FG000|Overall Study|Lost to Follow-up|1|||
94209793|NCT03539055|322561764|FG000|Overall Study|Withdrawal by Subject|2|||
94209794|NCT03539055|322561764|FG000|Overall Study|Screen Fail|7|||
94209795|NCT03539055|322561764|FG000|Overall Study|Drug Intolerance|2|||
94209796|NCT03347396|322561770|FG000|Part A (26 Weeks)|Adverse Event|1|||
94209797|NCT03347396|322561771|FG001|Part A (26 Weeks)|Adverse Event|0|||
94209798|NCT03347396|322561770|FG000|Part A (26 Weeks)|Death|0|||
94209799|NCT03347396|322561771|FG001|Part A (26 Weeks)|Death|1|||
94209800|NCT03347396|322561770|FG000|Part B (149 Weeks)|Adverse Event|1|||
94209801|NCT03347396|322561771|FG001|Part B (149 Weeks)|Adverse Event|1|||
94209802|NCT03347396|322561770|FG000|Part B (149 Weeks)|Death|1|||
94209803|NCT03347396|322561771|FG001|Part B (149 Weeks)|Death|0|||
94209804|NCT01880736|322561772|FG000|Overall Study|Adverse Event|0|||
94209805|NCT01880736|322561773|FG001|Overall Study|Adverse Event|0|||
94209806|NCT01880736|322561774|FG002|Overall Study|Adverse Event|0|||
94209807|NCT01880736|322561775|FG003|Overall Study|Adverse Event|1|||
94209808|NCT01880736|322561772|FG000|Overall Study|Withdrawal Criteria|1|||
94209809|NCT01880736|322561773|FG001|Overall Study|Withdrawal Criteria|2|||
94209810|NCT01880736|322561774|FG002|Overall Study|Withdrawal Criteria|1|||
94209811|NCT01880736|322561775|FG003|Overall Study|Withdrawal Criteria|5|||
94209812|NCT03520036|322561776|FG000|Overall Study|Adverse Event|1|||
94209813|NCT03520036|322561777|FG001|Overall Study|Adverse Event|2|||
94209814|NCT03520036|322561778|FG002|Overall Study|Adverse Event|0|||
94209815|NCT03520036|322561776|FG000|Overall Study|Protocol Violation|1|||
94209816|NCT03520036|322561777|FG001|Overall Study|Protocol Violation|0|||
94209817|NCT03520036|322561778|FG002|Overall Study|Protocol Violation|0|||
94209818|NCT03520036|322561776|FG000|Overall Study|Withdrawal by Subject|0|||
94209819|NCT03520036|322561777|FG001|Overall Study|Withdrawal by Subject|1|||
94283535|NCT01081795|322827486|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
94283536|NCT01081795|322827487|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
94283537|NCT01081795|322827488|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
94283538|NCT01081795|322827486|FG000|Overall Study|Using drug with restricted days of use|2|||
94283539|NCT01081795|322827487|FG001|Overall Study|Using drug with restricted days of use|3|||
94283540|NCT01081795|322827488|FG002|Overall Study|Using drug with restricted days of use|2|||
94283541|NCT01081795|322827486|FG000|Overall Study|Other|1|||
94283542|NCT01081795|322827487|FG001|Overall Study|Other|2|||
94283543|NCT01081795|322827488|FG002|Overall Study|Other|0|||
94283544|NCT03728309|322827495|FG000|Overall Study|Randomized but not Treated|0|||
94283545|NCT03728309|322827496|FG001|Overall Study|Randomized but not Treated|1|||
94283546|NCT03728309|322827495|FG000|Overall Study|Adverse Event|0|||
94283547|NCT03728309|322827496|FG001|Overall Study|Adverse Event|1|||
94283548|NCT03728309|322827495|FG000|Overall Study|Withdrawal by Subject|2|||
94283549|NCT03728309|322827496|FG001|Overall Study|Withdrawal by Subject|8|||
94283550|NCT03728309|322827495|FG000|Overall Study|Lost to Follow-up|9|||
94283551|NCT03728309|322827496|FG001|Overall Study|Lost to Follow-up|10|||
94283552|NCT03728309|322827495|FG000|Overall Study|Protocol Deviation|0|||
94283553|NCT03728309|322827496|FG001|Overall Study|Protocol Deviation|1|||
94283554|NCT03728309|322827495|FG000|Overall Study|Due to COVID|1|||
94283555|NCT03728309|322827496|FG001|Overall Study|Due to COVID|3|||
94283556|NCT02436876|322827497|FG000|Overall Study|Lost to Follow-up|0|||
94283557|NCT02436876|322827498|FG001|Overall Study|Lost to Follow-up|1|||
94283558|NCT02436876|322827499|FG002|Overall Study|Lost to Follow-up|1|||
94283559|NCT02436876|322827500|FG003|Overall Study|Lost to Follow-up|1|||
94283560|NCT02436876|322827497|FG000|Overall Study|Withdrawal by Subject|1|||
94283561|NCT02436876|322827498|FG001|Overall Study|Withdrawal by Subject|0|||
94283562|NCT02436876|322827499|FG002|Overall Study|Withdrawal by Subject|0|||
94467703|NCT01004432|323502374|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
94467704|NCT01004432|323502375|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
94283563|NCT02436876|322827500|FG003|Overall Study|Withdrawal by Subject|1|||
94467705|NCT01004432|323502376|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
94209820|NCT03520036|322561778|FG002|Overall Study|Withdrawal by Subject|4|||
94209821|NCT03520036|322561776|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
94283564|NCT02436876|322827497|FG000|Overall Study|Physician Decision|0|||
94283565|NCT02436876|322827498|FG001|Overall Study|Physician Decision|2|||
94283566|NCT02436876|322827499|FG002|Overall Study|Physician Decision|1|||
94467706|NCT01004432|323502377|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
94209822|NCT03520036|322561777|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
94209823|NCT03520036|322561778|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
94209824|NCT01263496|322561779|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
94209825|NCT01263496|322561780|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
94283567|NCT02436876|322827500|FG003|Overall Study|Physician Decision|0|||
94283568|NCT02436876|322827497|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
94209826|NCT01263496|322561781|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
94372266|NCT03548207|323150228|FG002|Overall Study|Withdrawal by Subject|0|||
94372267|NCT03548207|323150226|FG000|Overall Study|Sponsor decision|19|||
94372268|NCT03548207|323150227|FG001|Overall Study|Sponsor decision|40|||
94372269|NCT03548207|323150228|FG002|Overall Study|Sponsor decision|6|||
94372270|NCT03548207|323150226|FG000|Overall Study|Randomized but not treated|6|||
94372271|NCT03548207|323150227|FG001|Overall Study|Randomized but not treated|10|||
94372272|NCT03548207|323150228|FG002|Overall Study|Randomized but not treated|4|||
94372273|NCT04741503|323150229|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
94372274|NCT04741503|323150230|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
94372275|NCT04741503|323150231|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
94372276|NCT04741503|323150229|FG000|Initial Enrollment|Overquotas removed|0|||
94372277|NCT04741503|323150230|FG001|Initial Enrollment|Overquotas removed|0|||
94372278|NCT04741503|323150231|FG002|Initial Enrollment|Overquotas removed|186|||
94372279|NCT04741503|323150229|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
94372280|NCT04741503|323150230|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
94209827|NCT01263496|322561782|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
94209828|NCT01263496|322561783|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
94209829|NCT01263496|322561784|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
94209830|NCT01263496|322561785|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
94209831|NCT01263496|322561786|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
94209832|NCT01263496|322561787|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
94209833|NCT01263496|322561779|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
94209834|NCT01263496|322561780|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
94209835|NCT01263496|322561781|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
94209836|NCT01263496|322561782|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
94209837|NCT01263496|322561783|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
94209838|NCT01263496|322561784|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
94209839|NCT01263496|322561785|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
94209840|NCT01263496|322561786|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
94209841|NCT01263496|322561787|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
94283569|NCT02436876|322827498|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
94283570|NCT02436876|322827499|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
94283571|NCT02436876|322827500|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
94372281|NCT04741503|323150231|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
94372282|NCT01872689|323150240|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
94372283|NCT01872689|323150241|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
94372284|NCT01872689|323150242|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
94372285|NCT01872689|323150243|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
94372286|NCT01872689|323150240|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
94283572|NCT00953758|322827503|FG000|Overall Study|Death|2|||
94283573|NCT00953758|322827504|FG001|Overall Study|Death|0|||
94283574|NCT00953758|322827505|FG002|Overall Study|Death|1|||
94283575|NCT00953758|322827506|FG003|Overall Study|Death|1|||
94283576|NCT00953758|322827507|FG004|Overall Study|Death|1|||
94283577|NCT00953758|322827508|FG005|Overall Study|Death|1|||
94283578|NCT00953758|322827509|FG006|Overall Study|Death|1|||
94283579|NCT00953758|322827510|FG007|Overall Study|Death|3|||
94283580|NCT00953758|322827511|FG008|Overall Study|Death|1|||
94283581|NCT00953758|322827512|FG009|Overall Study|Death|0|||
94283582|NCT00953758|322827503|FG000|Overall Study|Participant refused further follow-up|0|||
94283583|NCT00953758|322827504|FG001|Overall Study|Participant refused further follow-up|0|||
94283584|NCT00953758|322827505|FG002|Overall Study|Participant refused further follow-up|1|||
94283585|NCT00953758|322827506|FG003|Overall Study|Participant refused further follow-up|0|||
94283586|NCT00953758|322827507|FG004|Overall Study|Participant refused further follow-up|3|||
94283587|NCT00953758|322827508|FG005|Overall Study|Participant refused further follow-up|0|||
94283588|NCT00953758|322827509|FG006|Overall Study|Participant refused further follow-up|0|||
94372287|NCT01872689|323150241|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
94372288|NCT01872689|323150242|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
94372289|NCT01872689|323150243|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
94372290|NCT01872689|323150240|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
94372291|NCT01872689|323150241|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
94372292|NCT01872689|323150242|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
94372293|NCT01872689|323150243|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
94372294|NCT01872689|323150240|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
94209842|NCT01263496|322561779|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
94283589|NCT00953758|322827510|FG007|Overall Study|Participant refused further follow-up|0|||
94283590|NCT00953758|322827511|FG008|Overall Study|Participant refused further follow-up|1|||
94283591|NCT00953758|322827512|FG009|Overall Study|Participant refused further follow-up|0|||
94283592|NCT00953758|322827503|FG000|Overall Study|Lost to Follow-up|0|||
94467707|NCT01004432|323502373|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
94209843|NCT01263496|322561780|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
94209844|NCT01263496|322561781|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
94209845|NCT01263496|322561782|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
94283593|NCT00953758|322827504|FG001|Overall Study|Lost to Follow-up|0|||
94283594|NCT00953758|322827505|FG002|Overall Study|Lost to Follow-up|0|||
94283595|NCT00953758|322827506|FG003|Overall Study|Lost to Follow-up|1|||
94283596|NCT00953758|322827507|FG004|Overall Study|Lost to Follow-up|0|||
94283597|NCT00953758|322827508|FG005|Overall Study|Lost to Follow-up|0|||
94283598|NCT00953758|322827509|FG006|Overall Study|Lost to Follow-up|0|||
94283599|NCT00953758|322827510|FG007|Overall Study|Lost to Follow-up|1|||
94283600|NCT00953758|322827511|FG008|Overall Study|Lost to Follow-up|0|||
94283601|NCT00953758|322827512|FG009|Overall Study|Lost to Follow-up|1|||
94283602|NCT00953758|322827503|FG000|Overall Study|Physician Decision|0|||
94283603|NCT00953758|322827504|FG001|Overall Study|Physician Decision|0|||
94283604|NCT00953758|322827505|FG002|Overall Study|Physician Decision|0|||
94209846|NCT01263496|322561783|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
94209847|NCT01263496|322561784|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
94209848|NCT01263496|322561785|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
94209849|NCT01263496|322561786|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
94209850|NCT01263496|322561787|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
94209851|NCT01263496|322561779|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
94209852|NCT01263496|322561780|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
94209853|NCT01263496|322561781|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
94209854|NCT01263496|322561782|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
94209855|NCT01263496|322561783|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
94283605|NCT00953758|322827506|FG003|Overall Study|Physician Decision|0|||
94283606|NCT00953758|322827507|FG004|Overall Study|Physician Decision|1|||
94283607|NCT00953758|322827508|FG005|Overall Study|Physician Decision|0|||
94209856|NCT01263496|322561784|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
94209857|NCT01263496|322561785|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
94209858|NCT01263496|322561786|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
94209859|NCT01263496|322561787|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
94209860|NCT01263496|322561779|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
94209861|NCT01263496|322561780|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
94209862|NCT01263496|322561781|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
94209863|NCT01263496|322561782|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
94209864|NCT01263496|322561783|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
94209865|NCT01263496|322561784|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
94209866|NCT01263496|322561785|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
94209867|NCT01263496|322561786|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
94209868|NCT01263496|322561787|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
94209869|NCT01263496|322561779|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
94209870|NCT01263496|322561780|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
94209871|NCT01263496|322561781|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
94209872|NCT01263496|322561782|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
94209873|NCT01263496|322561783|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
94209874|NCT01263496|322561784|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
94209875|NCT01263496|322561785|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
94209876|NCT01263496|322561786|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
94209877|NCT01263496|322561787|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
94209878|NCT01263496|322561779|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
94209879|NCT01263496|322561780|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
94209880|NCT01263496|322561781|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
94209881|NCT01263496|322561782|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
94209882|NCT01263496|322561783|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
94209883|NCT01263496|322561784|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
94209884|NCT01263496|322561785|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
94209885|NCT01263496|322561786|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
94209886|NCT01263496|322561787|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
94209887|NCT01827839|322561788|FG000|Overall Study|Adverse Event|1|||
94209888|NCT01827839|322561788|FG000|Overall Study|Consent Withdrawal|2|||
94209889|NCT02628626|322561789|FG000|Overall Study|Withdrawal by Subject|2|||
94283608|NCT00953758|322827509|FG006|Overall Study|Physician Decision|0|||
94467708|NCT01004432|323502374|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
94283609|NCT00953758|322827510|FG007|Overall Study|Physician Decision|0|||
94283610|NCT00953758|322827511|FG008|Overall Study|Physician Decision|0|||
94283611|NCT00953758|322827512|FG009|Overall Study|Physician Decision|0|||
94283612|NCT00953758|322827503|FG000|Overall Study|Disease progression|0|||
94467709|NCT01004432|323502375|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
94283613|NCT00953758|322827504|FG001|Overall Study|Disease progression|0|||
94283614|NCT00953758|322827505|FG002|Overall Study|Disease progression|0|||
94283615|NCT00953758|322827506|FG003|Overall Study|Disease progression|0|||
94283616|NCT00953758|322827507|FG004|Overall Study|Disease progression|1|||
94283617|NCT00953758|322827508|FG005|Overall Study|Disease progression|0|||
94283618|NCT00953758|322827509|FG006|Overall Study|Disease progression|0|||
94283619|NCT00953758|322827510|FG007|Overall Study|Disease progression|0|||
94283620|NCT00953758|322827511|FG008|Overall Study|Disease progression|0|||
94283621|NCT00953758|322827512|FG009|Overall Study|Disease progression|0|||
94283622|NCT00953758|322827503|FG000|Overall Study|Participant went for transplant|0|||
94283623|NCT00953758|322827504|FG001|Overall Study|Participant went for transplant|0|||
94283624|NCT00953758|322827505|FG002|Overall Study|Participant went for transplant|0|||
94283625|NCT00953758|322827506|FG003|Overall Study|Participant went for transplant|0|||
94283626|NCT00953758|322827507|FG004|Overall Study|Participant went for transplant|0|||
94283627|NCT00953758|322827508|FG005|Overall Study|Participant went for transplant|0|||
94283628|NCT00953758|322827509|FG006|Overall Study|Participant went for transplant|0|||
94283629|NCT00953758|322827510|FG007|Overall Study|Participant went for transplant|0|||
94283630|NCT00953758|322827511|FG008|Overall Study|Participant went for transplant|1|||
94283631|NCT00953758|322827512|FG009|Overall Study|Participant went for transplant|0|||
94283632|NCT00927095|322827514|FG000|Overall Study|Adverse Event|3|||
94283633|NCT00927095|322827515|FG001|Overall Study|Adverse Event|1|||
94283634|NCT00927095|322827516|FG002|Overall Study|Adverse Event|0|||
94283635|NCT00927095|322827514|FG000|Overall Study|Withdrawal by Subject|2|||
94283636|NCT00927095|322827515|FG001|Overall Study|Withdrawal by Subject|1|||
94283637|NCT00927095|322827516|FG002|Overall Study|Withdrawal by Subject|1|||
94283638|NCT00927095|322827514|FG000|Overall Study|Physician Decision|1|||
94283639|NCT00927095|322827515|FG001|Overall Study|Physician Decision|2|||
94283640|NCT00927095|322827516|FG002|Overall Study|Physician Decision|1|||
94283641|NCT01290692|322827523|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
94283642|NCT02556255|322827524|FG000|Overall Study|Lost to Follow-up|4|||
94283643|NCT00993031|322827525|FG000|Overall Study|Death|0|||
94283644|NCT00993031|322827526|FG001|Overall Study|Death|1|||
94283645|NCT00993031|322827525|FG000|Overall Study|Physician Decision|0|||
94283646|NCT00993031|322827526|FG001|Overall Study|Physician Decision|2|||
94283647|NCT00993031|322827525|FG000|Overall Study|Withdrawal by Subject|3|||
94283648|NCT00993031|322827526|FG001|Overall Study|Withdrawal by Subject|3|||
94283649|NCT00993031|322827525|FG000|Overall Study|Lost to Follow-up|19|||
94283650|NCT00993031|322827526|FG001|Overall Study|Lost to Follow-up|13|||
94283651|NCT03115151|322827529|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
94283652|NCT03115151|322827530|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
94283653|NCT03115151|322827529|FG000|Overall Study|Epidural catheter removal|1|||
94283654|NCT03115151|322827530|FG001|Overall Study|Epidural catheter removal|0|||
94283655|NCT03115151|322827529|FG000|Overall Study|Withdrawal by Subject|0|||
94283656|NCT03115151|322827530|FG001|Overall Study|Withdrawal by Subject|1|||
94283657|NCT03115151|322827529|FG000|Overall Study|Intervention not received according to the protocol.|1|||
94283658|NCT03115151|322827530|FG001|Overall Study|Intervention not received according to the protocol.|1|||
94283659|NCT03115151|322827529|FG000|Overall Study|Physician Decision|1|||
94283660|NCT03115151|322827530|FG001|Overall Study|Physician Decision|0|||
94283661|NCT03115151|322827529|FG000|Overall Study|Randomization not applied|1|||
94283662|NCT03115151|322827530|FG001|Overall Study|Randomization not applied|1|||
94283663|NCT02971670|322827531|FG000|Overall Study|Withdrawal by Subject|4|||
94283664|NCT02971670|322827532|FG001|Overall Study|Withdrawal by Subject|1|||
94283665|NCT02971670|322827533|FG002|Overall Study|Withdrawal by Subject|1|||
94283666|NCT02971670|322827534|FG003|Overall Study|Withdrawal by Subject|2|||
94283667|NCT00706030|322827535|FG000|Overall Study|Disease Progression|4|||
94283668|NCT00706030|322827536|FG001|Overall Study|Disease Progression|6|||
94283669|NCT00706030|322827537|FG002|Overall Study|Disease Progression|46|||
94283670|NCT00706030|322827538|FG003|Overall Study|Disease Progression|12|||
94283671|NCT00706030|322827535|FG000|Overall Study|Adverse Event|1|||
94283672|NCT00706030|322827536|FG001|Overall Study|Adverse Event|0|||
94283673|NCT00706030|322827537|FG002|Overall Study|Adverse Event|4|||
94283674|NCT00706030|322827538|FG003|Overall Study|Adverse Event|2|||
94283675|NCT00706030|322827535|FG000|Overall Study|Withdrawal by Subject|1|||
94283676|NCT00706030|322827536|FG001|Overall Study|Withdrawal by Subject|0|||
94283677|NCT00706030|322827537|FG002|Overall Study|Withdrawal by Subject|2|||
94283678|NCT00706030|322827538|FG003|Overall Study|Withdrawal by Subject|0|||
94283679|NCT00706030|322827535|FG000|Overall Study|Physician Decision|0|||
94283680|NCT00706030|322827536|FG001|Overall Study|Physician Decision|0|||
94283681|NCT00706030|322827537|FG002|Overall Study|Physician Decision|2|||
94283682|NCT00706030|322827538|FG003|Overall Study|Physician Decision|0|||
94283683|NCT00706030|322827535|FG000|Overall Study|Not recorded|0|||
94283684|NCT00706030|322827536|FG001|Overall Study|Not recorded|0|||
94283685|NCT00706030|322827537|FG002|Overall Study|Not recorded|2|||
94283686|NCT00706030|322827538|FG003|Overall Study|Not recorded|0|||
94283687|NCT00706030|322827535|FG000|Overall Study|Protocol Violation|0|||
94283688|NCT00706030|322827536|FG001|Overall Study|Protocol Violation|0|||
94283689|NCT00706030|322827537|FG002|Overall Study|Protocol Violation|1|||
94283690|NCT00706030|322827538|FG003|Overall Study|Protocol Violation|1|||
94283691|NCT00706030|322827535|FG000|Overall Study|Failed to return|0|||
94283692|NCT00706030|322827536|FG001|Overall Study|Failed to return|0|||
94283693|NCT00706030|322827537|FG002|Overall Study|Failed to return|1|||
94283694|NCT00706030|322827538|FG003|Overall Study|Failed to return|0|||
94283695|NCT00706030|322827535|FG000|Overall Study|Symptomatic Deterioration|0|||
94283696|NCT00706030|322827536|FG001|Overall Study|Symptomatic Deterioration|0|||
94283697|NCT00706030|322827537|FG002|Overall Study|Symptomatic Deterioration|1|||
94283698|NCT00706030|322827538|FG003|Overall Study|Symptomatic Deterioration|0|||
94283699|NCT00706030|322827535|FG000|Overall Study|No treatment received|0|||
94283700|NCT00706030|322827536|FG001|Overall Study|No treatment received|0|||
94283701|NCT00706030|322827537|FG002|Overall Study|No treatment received|0|||
94283702|NCT00706030|322827538|FG003|Overall Study|No treatment received|1|||
94283703|NCT00706030|322827535|FG000|Overall Study|Death|0|||
94283704|NCT00706030|322827536|FG001|Overall Study|Death|0|||
94283705|NCT00706030|322827537|FG002|Overall Study|Death|1|||
94283706|NCT00706030|322827538|FG003|Overall Study|Death|0|||
94283707|NCT05779072|322827540|FG000|Overall Study|Lost to Follow-up|0|||
94283708|NCT05779072|322827541|FG001|Overall Study|Lost to Follow-up|1|||
94283709|NCT05779072|322827540|FG000|Overall Study|Withdrawal by Subject|1|||
94283710|NCT05779072|322827541|FG001|Overall Study|Withdrawal by Subject|5|||
94283711|NCT01017952|322827542|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
94283712|NCT01017952|322827543|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
94283713|NCT01017952|322827544|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
94283714|NCT01017952|322827545|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
94283715|NCT01017952|322827546|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
94283716|NCT01017952|322827542|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
94283717|NCT01017952|322827543|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
94283718|NCT01017952|322827544|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
94283719|NCT01017952|322827545|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
94283720|NCT01017952|322827546|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
94283721|NCT01017952|322827542|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
94283722|NCT01017952|322827543|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
94283723|NCT01017952|322827544|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
94283724|NCT01017952|322827545|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
94283725|NCT01017952|322827546|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
94283726|NCT01017952|322827542|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
94283727|NCT01017952|322827543|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
94283728|NCT01017952|322827544|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
94283729|NCT01017952|322827545|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
94283730|NCT01017952|322827546|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
94283731|NCT01017952|322827542|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
94283732|NCT01017952|322827543|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
94283733|NCT01017952|322827544|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
94283734|NCT01017952|322827545|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
94283735|NCT01017952|322827546|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
94283736|NCT01017952|322827542|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
94283737|NCT01017952|322827543|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
94283738|NCT01017952|322827544|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
94283739|NCT01017952|322827545|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
94283740|NCT01017952|322827546|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
94283741|NCT01017952|322827542|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
94283742|NCT01017952|322827543|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
94283743|NCT01017952|322827544|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
94283744|NCT01017952|322827545|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
94283745|NCT01017952|322827546|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
94283746|NCT01017952|322827542|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
94283747|NCT01017952|322827543|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
94283748|NCT01017952|322827544|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
94283749|NCT01017952|322827545|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
94283750|NCT01017952|322827546|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
94283751|NCT01017952|322827542|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
94283752|NCT01017952|322827543|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
94283753|NCT01017952|322827544|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
94283754|NCT01017952|322827545|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
94283755|NCT01017952|322827546|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
94283756|NCT01017952|322827542|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
94283757|NCT01017952|322827543|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
94283758|NCT01017952|322827544|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
94283759|NCT01017952|322827545|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
94283760|NCT01017952|322827546|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
94283761|NCT01017952|322827542|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
94283762|NCT01017952|322827543|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
94283763|NCT01017952|322827544|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
94283764|NCT01017952|322827545|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
94283765|NCT01017952|322827546|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
94283766|NCT01017952|322827542|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
94283767|NCT01017952|322827543|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
94283768|NCT01017952|322827544|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
94283769|NCT01017952|322827545|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
94283770|NCT01017952|322827546|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
94283771|NCT01017952|322827542|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
94283772|NCT01017952|322827543|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
94283773|NCT01017952|322827544|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
94283774|NCT01017952|322827545|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
94283775|NCT01017952|322827546|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
94283776|NCT01017952|322827542|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
94283777|NCT01017952|322827543|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
94283778|NCT01017952|322827544|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
94283779|NCT01017952|322827545|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
94283780|NCT01017952|322827546|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
94283781|NCT01064167|322827549|FG000|Overall Study|Protocol Violation|14|||
94283782|NCT01064167|322827550|FG001|Overall Study|Protocol Violation|15|||
94283783|NCT02340663|322827551|FG000|Overall Study|Lost to Follow-up|1|||
94283784|NCT02340663|322827552|FG001|Overall Study|Lost to Follow-up|0|||
94283785|NCT02340663|322827551|FG000|Overall Study|Protocol Violation|1|||
94283786|NCT02340663|322827552|FG001|Overall Study|Protocol Violation|0|||
94283787|NCT02340663|322827551|FG000|Overall Study|Withdrawal by Subject|3|||
94283788|NCT02340663|322827552|FG001|Overall Study|Withdrawal by Subject|1|||
94283789|NCT01656434|322827553|FG000|Overall Study|Adverse Event|199|||
94283790|NCT01656434|322827554|FG001|Overall Study|Adverse Event|63|||
94283791|NCT01656434|322827553|FG000|Overall Study|Enrollment terminated at trial site|2|||
94283792|NCT01656434|322827554|FG001|Overall Study|Enrollment terminated at trial site|0|||
94283793|NCT01656434|322827553|FG000|Overall Study|Lost to Follow-up|309|||
94283794|NCT01656434|322827554|FG001|Overall Study|Lost to Follow-up|76|||
94283795|NCT01656434|322827553|FG000|Overall Study|Site discontinued study participation|24|||
94283796|NCT01656434|322827554|FG001|Overall Study|Site discontinued study participation|9|||
94283797|NCT01656434|322827553|FG000|Overall Study|Screen failure|2|||
94283798|NCT01656434|322827554|FG001|Overall Study|Screen failure|0|||
94283799|NCT01656434|322827553|FG000|Overall Study|Protocol Violation|7|||
94283800|NCT01656434|322827554|FG001|Overall Study|Protocol Violation|0|||
94283801|NCT01656434|322827553|FG000|Overall Study|Pregnancy wish|18|||
94283802|NCT01656434|322827554|FG001|Overall Study|Pregnancy wish|6|||
94283803|NCT01656434|322827553|FG000|Overall Study|Pregnancy|45|||
94283804|NCT01656434|322827554|FG001|Overall Study|Pregnancy|10|||
94283805|NCT01656434|322827553|FG000|Overall Study|Physician Decision|7|||
94283806|NCT01656434|322827554|FG001|Overall Study|Physician Decision|2|||
94283807|NCT01656434|322827553|FG000|Overall Study|Non-compliance with study drug|48|||
94283808|NCT01656434|322827554|FG001|Overall Study|Non-compliance with study drug|9|||
94283809|NCT01656434|322827553|FG000|Overall Study|Study terminated by sponsor|1501|||
94283810|NCT01656434|322827554|FG001|Overall Study|Study terminated by sponsor|348|||
94283811|NCT01656434|322827553|FG000|Overall Study|Participant discontinued; drug related|13|||
94283812|NCT01656434|322827554|FG001|Overall Study|Participant discontinued; drug related|4|||
94283813|NCT01656434|322827553|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
94283814|NCT01656434|322827554|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
94283815|NCT01656434|322827553|FG000|Overall Study|Non-compliance with protocol|39|||
94283816|NCT01656434|322827554|FG001|Overall Study|Non-compliance with protocol|15|||
94283817|NCT01656434|322827553|FG000|Overall Study|Participant moved|40|||
94283818|NCT01656434|322827554|FG001|Overall Study|Participant moved|12|||
94283819|NCT01656434|322827553|FG000|Overall Study|Participant withdrew consent|28|||
94283820|NCT01656434|322827554|FG001|Overall Study|Participant withdrew consent|9|||
94283821|NCT01656434|322827553|FG000|Overall Study|Withdrawal by Subject|64|||
94283822|NCT01656434|322827554|FG001|Overall Study|Withdrawal by Subject|7|||
94283823|NCT00044512|322827555|FG000|Follow Up|Lost to Follow-up|2|||
94283824|NCT01665144|322827557|FG000|Core Part|Withdrawal by Subject|96|||
94283825|NCT01665144|322827558|FG001|Core Part|Withdrawal by Subject|77|||
94283826|NCT01665144|322827559|FG002|Core Part|Withdrawal by Subject|0|||
94283827|NCT01665144|322827557|FG000|Core Part|Adverse Event|45|||
94283828|NCT01665144|322827558|FG001|Core Part|Adverse Event|18|||
94283829|NCT01665144|322827559|FG002|Core Part|Adverse Event|0|||
94283830|NCT01665144|322827557|FG000|Core Part|Lack of Efficacy|16|||
94283831|NCT01665144|322827558|FG001|Core Part|Lack of Efficacy|11|||
94283832|NCT01665144|322827559|FG002|Core Part|Lack of Efficacy|0|||
94283833|NCT01665144|322827557|FG000|Core Part|Lost to Follow-up|9|||
94467710|NCT01004432|323502376|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
94283834|NCT01665144|322827558|FG001|Core Part|Lost to Follow-up|8|||
94283835|NCT01665144|322827559|FG002|Core Part|Lost to Follow-up|0|||
94283836|NCT01665144|322827557|FG000|Core Part|Physician Decision|13|||
94283837|NCT01665144|322827558|FG001|Core Part|Physician Decision|1|||
94283838|NCT01665144|322827559|FG002|Core Part|Physician Decision|0|||
94283839|NCT01665144|322827557|FG000|Core Part|Progressive disease|8|||
94283840|NCT01665144|322827558|FG001|Core Part|Progressive disease|4|||
94283841|NCT01665144|322827559|FG002|Core Part|Progressive disease|0|||
94283842|NCT01665144|322827557|FG000|Core Part|Non-compliance with study treatment|5|||
94283843|NCT01665144|322827558|FG001|Core Part|Non-compliance with study treatment|0|||
94283844|NCT01665144|322827559|FG002|Core Part|Non-compliance with study treatment|0|||
94283845|NCT01665144|322827557|FG000|Core Part|Death|3|||
94283846|NCT01665144|322827558|FG001|Core Part|Death|1|||
94283847|NCT01665144|322827559|FG002|Core Part|Death|0|||
94283848|NCT01665144|322827557|FG000|Core Part|Protocol deviation|3|||
94283849|NCT01665144|322827558|FG001|Core Part|Protocol deviation|1|||
94283850|NCT01665144|322827559|FG002|Core Part|Protocol deviation|0|||
94283851|NCT01665144|322827557|FG000|Core Part|New therapy for study indication|2|||
94283852|NCT01665144|322827558|FG001|Core Part|New therapy for study indication|1|||
94283853|NCT01665144|322827559|FG002|Core Part|New therapy for study indication|0|||
94283854|NCT01665144|322827557|FG000|Core Part|Technical problems|2|||
94283855|NCT01665144|322827558|FG001|Core Part|Technical problems|0|||
94283856|NCT01665144|322827559|FG002|Core Part|Technical problems|0|||
94283857|NCT01665144|322827557|FG000|Extension Part|Patient/guardian decision|180|||
94283858|NCT01665144|322827558|FG001|Extension Part|Patient/guardian decision|0|||
94283859|NCT01665144|322827559|FG002|Extension Part|Patient/guardian decision|98|||
94283860|NCT01665144|322827557|FG000|Extension Part|Adverse Event|104|||
94283861|NCT01665144|322827558|FG001|Extension Part|Adverse Event|0|||
94283862|NCT01665144|322827559|FG002|Extension Part|Adverse Event|59|||
94283863|NCT01665144|322827557|FG000|Extension Part|Study closed early|42|||
94283864|NCT01665144|322827558|FG001|Extension Part|Study closed early|0|||
94283865|NCT01665144|322827559|FG002|Extension Part|Study closed early|19|||
94283866|NCT01665144|322827557|FG000|Extension Part|Progressive disease|36|||
94283867|NCT01665144|322827558|FG001|Extension Part|Progressive disease|0|||
94283868|NCT01665144|322827559|FG002|Extension Part|Progressive disease|14|||
94283869|NCT01665144|322827557|FG000|Extension Part|Lack of Efficacy|37|||
94283870|NCT01665144|322827558|FG001|Extension Part|Lack of Efficacy|0|||
94283871|NCT01665144|322827559|FG002|Extension Part|Lack of Efficacy|12|||
94283872|NCT01665144|322827557|FG000|Extension Part|Physician Decision|29|||
94283873|NCT01665144|322827558|FG001|Extension Part|Physician Decision|0|||
94283874|NCT01665144|322827559|FG002|Extension Part|Physician Decision|13|||
94283875|NCT01665144|322827557|FG000|Extension Part|Technical problems|20|||
94283876|NCT01665144|322827558|FG001|Extension Part|Technical problems|0|||
94283877|NCT01665144|322827559|FG002|Extension Part|Technical problems|8|||
94283878|NCT01665144|322827557|FG000|Extension Part|Death|20|||
94283879|NCT01665144|322827558|FG001|Extension Part|Death|0|||
94283880|NCT01665144|322827559|FG002|Extension Part|Death|4|||
94283881|NCT01665144|322827557|FG000|Extension Part|Missing|12|||
94283882|NCT01665144|322827558|FG001|Extension Part|Missing|0|||
94283883|NCT01665144|322827559|FG002|Extension Part|Missing|6|||
94283884|NCT01665144|322827557|FG000|Extension Part|Lost to Follow-up|9|||
94283885|NCT01665144|322827558|FG001|Extension Part|Lost to Follow-up|0|||
94283886|NCT01665144|322827559|FG002|Extension Part|Lost to Follow-up|5|||
94283887|NCT01665144|322827557|FG000|Extension Part|New therapy for study indication|3|||
94283888|NCT01665144|322827558|FG001|Extension Part|New therapy for study indication|0|||
94283889|NCT01665144|322827559|FG002|Extension Part|New therapy for study indication|2|||
94283890|NCT01665144|322827557|FG000|Extension Part|Protocol deviation|3|||
94283891|NCT01665144|322827558|FG001|Extension Part|Protocol deviation|0|||
94283892|NCT01665144|322827559|FG002|Extension Part|Protocol deviation|0|||
94283893|NCT02302963|322827560|FG000|Overall Study|Withdrawal by Subject|2|||
94283894|NCT02302963|322827561|FG001|Overall Study|Withdrawal by Subject|1|||
94467711|NCT01004432|323502377|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
94467712|NCT01004432|323502373|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
94283895|NCT02302963|322827560|FG000|Overall Study|Steroid injection|0|||
94283896|NCT02302963|322827561|FG001|Overall Study|Steroid injection|1|||
94283897|NCT02302963|322827560|FG000|Overall Study|Physician Decision|1|||
94283898|NCT02302963|322827561|FG001|Overall Study|Physician Decision|0|||
94283899|NCT00454805|322827562|FG000|Overall Study|Withdrawal by Subject|9|||
94283900|NCT00454805|322827563|FG001|Overall Study|Withdrawal by Subject|2|||
94283901|NCT00454805|322827562|FG000|Overall Study|Death|0|||
94283902|NCT00454805|322827563|FG001|Overall Study|Death|2|||
94283903|NCT00454805|322827562|FG000|Overall Study|Disease progression|16|||
94283904|NCT00454805|322827563|FG001|Overall Study|Disease progression|19|||
94283905|NCT00454805|322827562|FG000|Overall Study|In order to begin radiotherapy|1|||
94283906|NCT00454805|322827563|FG001|Overall Study|In order to begin radiotherapy|0|||
94209890|NCT02628626|322561790|FG001|Overall Study|Withdrawal by Subject|2|||
94209891|NCT00570505|322561791|FG000|Overall Study|Adverse Event|7|||
94209892|NCT00570505|322561791|FG000|Overall Study|Withdrawal by Subject|7|||
94209893|NCT00570505|322561791|FG000|Overall Study|Lost to Follow-up|23|||
94209894|NCT00570505|322561791|FG000|Overall Study|Other loss to follow-up|4|||
94209895|NCT00145470|322561792|FG000|Overall Study|Adverse Event|19|||
94209896|NCT00145470|322561793|FG001|Overall Study|Adverse Event|25|||
94209897|NCT00145470|322561792|FG000|Overall Study|Lack of Efficacy|27|||
94209898|NCT00145470|322561793|FG001|Overall Study|Lack of Efficacy|13|||
94209899|NCT00145470|322561792|FG000|Overall Study|Withdrawal by Subject|36|||
94209900|NCT00145470|322561793|FG001|Overall Study|Withdrawal by Subject|34|||
94209901|NCT00145470|322561792|FG000|Overall Study|Lost to Follow-up|21|||
94209902|NCT00145470|322561793|FG001|Overall Study|Lost to Follow-up|17|||
94209903|NCT00145470|322561792|FG000|Overall Study|Reason Not Reported|9|||
94209904|NCT00145470|322561793|FG001|Overall Study|Reason Not Reported|9|||
94209905|NCT02542943|322561794|FG000|Overall Study|Lost to Follow-up|1|||
94209906|NCT02542943|322561795|FG001|Overall Study|Lost to Follow-up|0|||
94209907|NCT02542943|322561796|FG002|Overall Study|Lost to Follow-up|0|||
94209908|NCT02542943|322561794|FG000|Overall Study|Withdrawal by Subject|0|||
94209909|NCT02542943|322561795|FG001|Overall Study|Withdrawal by Subject|1|||
94209910|NCT02542943|322561796|FG002|Overall Study|Withdrawal by Subject|0|||
94209911|NCT05865392|322561797|FG000|Overall Study|Withdrawal by Subject|4|||
94209912|NCT05865392|322561798|FG001|Overall Study|Withdrawal by Subject|0|||
94209913|NCT05865392|322561797|FG000|Overall Study|Didn't meet inclusion criteria|4|||
94209914|NCT05865392|322561798|FG001|Overall Study|Didn't meet inclusion criteria|0|||
94209915|NCT03905642|322561799|FG000|Overall Study|Withdrawal by Subject|3|||
94209916|NCT03905642|322561799|FG000|Overall Study|Pregnancy|1|||
94209917|NCT03905642|322561799|FG000|Overall Study|Adverse Event|1|||
94209918|NCT03905642|322561799|FG000|Overall Study|Lack of Efficacy|1|||
94209919|NCT03905642|322561799|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
94209920|NCT04131556|322563030|FG000|Overall Study|Adverse Event|1|||
94209921|NCT04131556|322563030|FG000|Overall Study|Withdrawal by Subject|1|||
94209922|NCT00799409|322563031|FG000|Overall Study|Withdrawal by Subject|1|||
94209923|NCT00799409|322563032|FG001|Overall Study|Withdrawal by Subject|0|||
94209924|NCT00799409|322563033|FG002|Overall Study|Withdrawal by Subject|0|||
94209925|NCT00799409|322563031|FG000|Overall Study|Lost to Follow-up|1|||
94209926|NCT00799409|322563032|FG001|Overall Study|Lost to Follow-up|0|||
94209927|NCT00799409|322563033|FG002|Overall Study|Lost to Follow-up|0|||
94209928|NCT00799409|322563031|FG000|Overall Study|Optimal Dose Not Achieved|2|||
94209929|NCT00799409|322563032|FG001|Overall Study|Optimal Dose Not Achieved|0|||
94209930|NCT00799409|322563033|FG002|Overall Study|Optimal Dose Not Achieved|0|||
94209931|NCT00799409|322563031|FG000|Overall Study|Failure to follow study protocol)|1|||
94209932|NCT00799409|322563032|FG001|Overall Study|Failure to follow study protocol)|0|||
94209933|NCT00799409|322563033|FG002|Overall Study|Failure to follow study protocol)|0|||
94209934|NCT00799409|322563031|FG000|Overall Study|Did not attend lab school day 1|1|||
94209935|NCT00799409|322563032|FG001|Overall Study|Did not attend lab school day 1|0|||
94209936|NCT00799409|322563033|FG002|Overall Study|Did not attend lab school day 1|0|||
94209937|NCT00799409|322563031|FG000|Overall Study|medication compliance|1|||
94209938|NCT00799409|322563032|FG001|Overall Study|medication compliance|0|||
94209939|NCT00799409|322563033|FG002|Overall Study|medication compliance|0|||
94209940|NCT03964974|322563034|FG000|Overall Study|Lost to Follow-up|3|||
94209941|NCT03964974|322563035|FG001|Overall Study|Lost to Follow-up|2|||
94209942|NCT03964974|322563034|FG000|Overall Study|Withdrawal by Subject|0|||
94209943|NCT03964974|322563035|FG001|Overall Study|Withdrawal by Subject|3|||
94209944|NCT00925548|322563036|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
94209945|NCT00925548|322563037|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
94209946|NCT01278030|322563040|FG000|Overall Study|Withdrawal by Subject|8|||
94209947|NCT01278030|322563041|FG001|Overall Study|Withdrawal by Subject|4|||
94209948|NCT06571695|322563042|FG000|Overall Study|Lost to Follow-up|1|||
94209949|NCT06571695|322563043|FG001|Overall Study|Lost to Follow-up|6|||
94209950|NCT01613417|322563051|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
94209951|NCT01613417|322563052|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
94209952|NCT02202317|322563053|FG000|Overall Study|Lost to Follow-up|1|||
94209953|NCT02701296|322563054|FG000|Overall Study|Incomplete Data|0|||
94209954|NCT02701296|322563055|FG001|Overall Study|Incomplete Data|2|||
94209955|NCT03675321|322563056|FG000|Overall Study|Lack of Efficacy|2|||
94209956|NCT03675321|322563057|FG001|Overall Study|Lack of Efficacy|2|||
94209957|NCT03675321|322563056|FG000|Overall Study|Withdrawal by Subject|1|||
94209958|NCT03675321|322563057|FG001|Overall Study|Withdrawal by Subject|3|||
94209959|NCT02357966|322563062|FG000|Overall Study|Death|0|||
94209960|NCT02357966|322563063|FG001|Overall Study|Death|0|||
94209961|NCT02357966|322563064|FG002|Overall Study|Death|1|||
94209962|NCT02357966|322563065|FG003|Overall Study|Death|0|||
94209963|NCT02357966|322563066|FG004|Overall Study|Death|2|||
94209964|NCT02357966|322563067|FG005|Overall Study|Death|0|||
94209965|NCT02357966|322563062|FG000|Overall Study|Physician Decision|1|||
94209966|NCT02357966|322563063|FG001|Overall Study|Physician Decision|0|||
94283907|NCT02049944|322829196|FG000|Overall Study|Protocol Violation|2|||
94283908|NCT01408147|322829197|FG000|Overall Study|Withdrawal by Subject|0|||
94283909|NCT01408147|322829198|FG001|Overall Study|Withdrawal by Subject|1|||
94283910|NCT00971945|322829203|FG000|Overall Study|Progressive Disease|3|||
94283911|NCT00971945|322829203|FG000|Overall Study|Change in treatment policy|1|||
94283912|NCT00971945|322829203|FG000|Overall Study|Other reasons|2|||
94283913|NCT00691483|322829204|FG000|Overall Study|Adverse Event|14|||
94283914|NCT00691483|322829205|FG001|Overall Study|Adverse Event|6|||
94283915|NCT00691483|322829204|FG000|Overall Study|Lost to Follow-up|17|||
94283916|NCT00691483|322829205|FG001|Overall Study|Lost to Follow-up|10|||
94283917|NCT00691483|322829204|FG000|Overall Study|Withdrawal by Subject|24|||
94283918|NCT00691483|322829205|FG001|Overall Study|Withdrawal by Subject|7|||
94283919|NCT00691483|322829204|FG000|Overall Study|Other known cause|6|||
94283920|NCT00691483|322829205|FG001|Overall Study|Other known cause|1|||
94283921|NCT00691483|322829204|FG000|Overall Study|Randomized by not treated|7|||
94283922|NCT00691483|322829205|FG001|Overall Study|Randomized by not treated|1|||
94283923|NCT03847987|322829206|FG000|Overall Study|Lost to Follow-up|1|||
94283924|NCT03847987|322829207|FG001|Overall Study|Lost to Follow-up|0|||
94283925|NCT03847987|322829206|FG000|Overall Study|Adverse Event|2|||
94283926|NCT03847987|322829207|FG001|Overall Study|Adverse Event|0|||
94283927|NCT04161131|322829208|FG000|Overall Study|Ineligible|2|||
94283928|NCT04161131|322829208|FG000|Overall Study|Lost to Follow-up|4|||
94283929|NCT00763139|322829212|FG000|Overall Study|Adverse Event|4|||
94283930|NCT00763139|322829213|FG001|Overall Study|Adverse Event|2|||
94283931|NCT00763139|322829212|FG000|Overall Study|Withdrawal by Subject|0|||
94283932|NCT00763139|322829213|FG001|Overall Study|Withdrawal by Subject|1|||
94283933|NCT00763139|322829212|FG000|Overall Study|med change not allowed by protocol|1|||
94283934|NCT00763139|322829213|FG001|Overall Study|med change not allowed by protocol|0|||
94283935|NCT01592760|322829214|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
94283936|NCT01592760|322829215|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
94283937|NCT01592760|322829216|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
94283938|NCT01363986|322829217|FG000|Overall Study|Disease progression|1|||
94283939|NCT01637142|322829218|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
94283940|NCT03905863|322829219|FG000|Overall Study|Adverse Event|2|||
94283941|NCT03905863|322829220|FG001|Overall Study|Adverse Event|4|||
94283942|NCT03905863|322829219|FG000|Overall Study|Withdrawal by Subject|2|||
94283943|NCT03905863|322829220|FG001|Overall Study|Withdrawal by Subject|2|||
94283944|NCT03905863|322829219|FG000|Overall Study|Physician Decision|0|||
94283945|NCT03905863|322829220|FG001|Overall Study|Physician Decision|3|||
94283946|NCT03905863|322829219|FG000|Overall Study|Lost to Follow-up|1|||
94283947|NCT03905863|322829220|FG001|Overall Study|Lost to Follow-up|0|||
94283948|NCT03905863|322829219|FG000|Overall Study|Protocol Violation|0|||
94283949|NCT03905863|322829220|FG001|Overall Study|Protocol Violation|2|||
94283950|NCT03905863|322829219|FG000|Overall Study|Death|0|||
94283951|NCT03905863|322829220|FG001|Overall Study|Death|1|||
94283952|NCT00223496|322829223|FG000|Overall Study|screen failure|9|||
94283953|NCT00223496|322829223|FG000|Overall Study|Lost to Follow-up|4|||
94283954|NCT00223496|322829223|FG000|Overall Study|Lack of Efficacy|6|||
94283955|NCT00223496|322829223|FG000|Overall Study|Withdrawal by Subject|1|||
94283956|NCT00223496|322829223|FG000|Overall Study|Physician Decision|2|||
94283957|NCT02814565|322829224|FG000|Overall Study|Lack of Efficacy|0|||
94283958|NCT02814565|322829225|FG001|Overall Study|Lack of Efficacy|1|||
94283959|NCT02814565|322829224|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
94283960|NCT02814565|322829225|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
94283961|NCT01678144|322829226|FG000|Stage 1: MAR Classic|Adverse Event|1|||
94283962|NCT01534676|322829227|FG000|Overall Study|Study closed due to poor enrollment|2|||
94283963|NCT01534676|322829228|FG001|Overall Study|Study closed due to poor enrollment|1|||
94283964|NCT03118297|322829229|FG000|Overall Study|Lost to Follow-up|0|||
94283965|NCT03118297|322829230|FG001|Overall Study|Lost to Follow-up|2|||
94283966|NCT01882907|322829232|FG000|Overall Study|Adverse Event|3|||
94467713|NCT01004432|323502374|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
94283967|NCT01882907|322829233|FG001|Overall Study|Adverse Event|1|||
94283968|NCT01882907|322829232|FG000|Overall Study|Lack of Efficacy|0|||
94283969|NCT01882907|322829233|FG001|Overall Study|Lack of Efficacy|3|||
94283970|NCT01882907|322829232|FG000|Overall Study|Lost to Follow-up|1|||
94283971|NCT01882907|322829233|FG001|Overall Study|Lost to Follow-up|4|||
94283972|NCT01882907|322829232|FG000|Overall Study|Protocol Violation|10|||
94283973|NCT01882907|322829233|FG001|Overall Study|Protocol Violation|14|||
94467714|NCT01004432|323502375|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
94467715|NCT01004432|323502376|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
94467716|NCT01004432|323502377|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
94283974|NCT01882907|322829232|FG000|Overall Study|Withdrawal by Subject|0|||
94283975|NCT01882907|322829233|FG001|Overall Study|Withdrawal by Subject|6|||
94283976|NCT03124784|322829236|FG000|Overall Study|Adverse Event|1|||
94283977|NCT03124784|322829236|FG000|Overall Study|Computer/Equip Malfunction|1|||
94283978|NCT05702515|322829237|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
94283979|NCT03757988|322829238|FG000|Overall Study|Withdrawal by Subject|1|||
94283980|NCT03446885|322829239|FG000|Overall Study|Lost to Follow-up|1|||
94283981|NCT03446885|322829240|FG001|Overall Study|Lost to Follow-up|0|||
94283982|NCT03446885|322829239|FG000|Overall Study|Did not complete entire visit|1|||
94283983|NCT03446885|322829240|FG001|Overall Study|Did not complete entire visit|0|||
94283984|NCT02450487|322829243|FG000|Overall Study|Lost to Follow-up|3|||
94283985|NCT01790048|322829244|FG000|Overall Study|Incorrect Age|9|||
94283986|NCT01790048|322829245|FG001|Overall Study|Incorrect Age|14|||
94283987|NCT01790048|322829244|FG000|Overall Study|data entry error|0|||
94283988|NCT01790048|322829245|FG001|Overall Study|data entry error|1|||
94283989|NCT01790048|322829244|FG000|Overall Study|Other|0|||
94209967|NCT02357966|322563064|FG002|Overall Study|Physician Decision|0|||
94209968|NCT02357966|322563065|FG003|Overall Study|Physician Decision|0|||
94209969|NCT02357966|322563066|FG004|Overall Study|Physician Decision|1|||
94209970|NCT02357966|322563067|FG005|Overall Study|Physician Decision|0|||
94209971|NCT00705406|322563068|FG000|Overall Study|Lost to Follow-up|3|||
94209972|NCT00705406|322563069|FG001|Overall Study|Lost to Follow-up|3|||
94209973|NCT00705406|322563068|FG000|Overall Study|Did not receive study drug|1|||
94209974|NCT00705406|322563069|FG001|Overall Study|Did not receive study drug|2|||
94209975|NCT01450007|322563070|FG000|Overall Study|Late exclusion before treatment|2|||
94209976|NCT01450007|322563071|FG001|Overall Study|Late exclusion before treatment|3|||
94209977|NCT01450007|322563072|FG002|Overall Study|Late exclusion before treatment|2|||
94209978|NCT01450007|322563070|FG000|Overall Study|Protocol Violation|0|||
94209979|NCT01450007|322563071|FG001|Overall Study|Protocol Violation|1|||
94209980|NCT01450007|322563072|FG002|Overall Study|Protocol Violation|1|||
94209981|NCT01450007|322563070|FG000|Overall Study|Adverse Event|0|||
94209982|NCT01450007|322563071|FG001|Overall Study|Adverse Event|1|||
94209983|NCT01450007|322563072|FG002|Overall Study|Adverse Event|0|||
94209984|NCT04658784|322563074|FG000|6-month Follow-up|Lost to Follow-up|2|||
94209985|NCT04658784|322563075|FG001|6-month Follow-up|Lost to Follow-up|5|||
94209986|NCT02575365|322563076|FG000|Overall Study|Lost to Follow-up|4|||
94209987|NCT01009645|322563081|FG000|Overall Study|Lost to Follow-up|2|||
94209988|NCT01009645|322563082|FG001|Overall Study|Lost to Follow-up|8|||
94209989|NCT01009645|322563083|FG002|Overall Study|Lost to Follow-up|4|||
94209990|NCT01009645|322563084|FG003|Overall Study|Lost to Follow-up|5|||
94209991|NCT00999596|322563085|FG000|Overall Study|Statistical population not required|101|||
94209992|NCT02736188|322563086|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
94209993|NCT02736188|322563086|FG000|Overall Study|Adverse Event|1|||
94209994|NCT02736188|322563086|FG000|Overall Study|Withdrawal by Subject|1|||
94209995|NCT02736188|322563086|FG000|Overall Study|Other|6|||
94209996|NCT03176407|322563090|FG000|Overall Study|Protocol Violation|1|||
94209997|NCT03176407|322563090|FG000|Overall Study|human failure|1|||
94209998|NCT03176407|322563090|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
94209999|NCT02128269|322563093|FG000|Treatment Period|Adverse Event|1|||
94210000|NCT02128269|322563093|FG000|Treatment Period|Physician Decision|1|||
94210001|NCT02085941|322563095|FG000|Overall Study|Lack of Efficacy|1|||
94210002|NCT02085941|322563096|FG001|Overall Study|Lack of Efficacy|0|||
94210003|NCT02085941|322563095|FG000|Overall Study|Death|6|||
94210004|NCT02085941|322563096|FG001|Overall Study|Death|1|||
94210005|NCT02085941|322563095|FG000|Overall Study|Lost to Follow-up|1|||
94210006|NCT02085941|322563096|FG001|Overall Study|Lost to Follow-up|0|||
94210007|NCT02085941|322563095|FG000|Overall Study|Physician Decision|0|||
94210008|NCT02085941|322563096|FG001|Overall Study|Physician Decision|2|||
94210009|NCT01124045|322563097|FG000|Overall Study|Lost to Follow-up|0|||
94210010|NCT01124045|322563098|FG001|Overall Study|Lost to Follow-up|1|||
94210011|NCT01124045|322563097|FG000|Overall Study|Physician Decision|0|||
94210012|NCT01124045|322563098|FG001|Overall Study|Physician Decision|2|||
94210013|NCT02022657|322563099|FG000|Overall Study|Withdrawal by Subject|2|||
94210014|NCT02022657|322563100|FG001|Overall Study|Withdrawal by Subject|0|||
94210015|NCT02022657|322563101|FG002|Overall Study|Withdrawal by Subject|1|||
94210016|NCT02022657|322563102|FG003|Overall Study|Withdrawal by Subject|0|||
94210017|NCT02022657|322563103|FG004|Overall Study|Withdrawal by Subject|0|||
94283990|NCT01790048|322829245|FG001|Overall Study|Other|2|||
94283991|NCT01790048|322829244|FG000|Overall Study|SAM at Enrollment|2|||
94283992|NCT01790048|322829245|FG001|Overall Study|SAM at Enrollment|0|||
94283993|NCT01790048|322829244|FG000|Overall Study|Measurement error|1|||
94372295|NCT01872689|323150241|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
94283994|NCT01790048|322829245|FG001|Overall Study|Measurement error|0|||
94210018|NCT02022657|322563104|FG005|Overall Study|Withdrawal by Subject|0|||
94210019|NCT02022657|322563099|FG000|Overall Study|Physician Decision|0|||
94210020|NCT02022657|322563100|FG001|Overall Study|Physician Decision|0|||
94210021|NCT02022657|322563101|FG002|Overall Study|Physician Decision|0|||
94210022|NCT02022657|322563102|FG003|Overall Study|Physician Decision|0|||
94210023|NCT02022657|322563103|FG004|Overall Study|Physician Decision|0|||
94210024|NCT02022657|322563104|FG005|Overall Study|Physician Decision|1|||
94210025|NCT01303510|322563105|FG000|Overall Study|Lost to Follow-up|1|||
94210026|NCT01303510|322563106|FG001|Overall Study|Lost to Follow-up|0|||
94210027|NCT00836498|322563107|FG000|Overall Study|Adverse Event|1|||
94210028|NCT00836498|322563108|FG001|Overall Study|Adverse Event|0|||
94210029|NCT00836498|322563107|FG000|Overall Study|Lost to Follow-up|1|||
94210030|NCT00836498|322563108|FG001|Overall Study|Lost to Follow-up|0|||
94210031|NCT00836498|322563107|FG000|Overall Study|Withdrawal by Subject|2|||
94283995|NCT03132636|322829247|FG000|Overall Study|Adverse Event|1|||
94283996|NCT03132636|322829248|FG001|Overall Study|Adverse Event|2|||
94283997|NCT03132636|322829247|FG000|Overall Study|Death|4|||
94283998|NCT03132636|322829248|FG001|Overall Study|Death|7|||
94283999|NCT03132636|322829247|FG000|Overall Study|Lost to Follow-up|3|||
94284000|NCT03132636|322829248|FG001|Overall Study|Lost to Follow-up|2|||
94284001|NCT03132636|322829247|FG000|Overall Study|Non compliance with protocol by participant|1|||
94284002|NCT03132636|322829248|FG001|Overall Study|Non compliance with protocol by participant|1|||
94284003|NCT03132636|322829247|FG000|Overall Study|Subject decision|1|||
94284004|NCT03132636|322829248|FG001|Overall Study|Subject decision|9|||
94284005|NCT03132636|322829247|FG000|Overall Study|Sponsor decision|0|||
94284006|NCT03132636|322829248|FG001|Overall Study|Sponsor decision|1|||
94284007|NCT03132636|322829247|FG000|Overall Study|Physician Decision|1|||
94284008|NCT03132636|322829248|FG001|Overall Study|Physician Decision|0|||
94284009|NCT03132636|322829247|FG000|Overall Study|Progressive disease|33|||
94284010|NCT03132636|322829248|FG001|Overall Study|Progressive disease|36|||
94284011|NCT03132636|322829247|FG000|Overall Study|Withdrawal of consent|2|||
94284012|NCT03132636|322829248|FG001|Overall Study|Withdrawal of consent|5|||
94284013|NCT03132636|322829247|FG000|Overall Study|Did not re-consent|1|||
94284014|NCT03132636|322829248|FG001|Overall Study|Did not re-consent|0|||
94284015|NCT03132636|322829247|FG000|Overall Study|Lost insurance coverage|1|||
94284016|NCT03132636|322829248|FG001|Overall Study|Lost insurance coverage|0|||
94284017|NCT03132636|322829247|FG000|Overall Study|Related to radiological outcomes|0|||
94284018|NCT03132636|322829248|FG001|Overall Study|Related to radiological outcomes|1|||
94284019|NCT03132636|322829247|FG000|Overall Study|Unable to come to site for continued visits|0|||
94284020|NCT03132636|322829248|FG001|Overall Study|Unable to come to site for continued visits|1|||
94284021|NCT01391507|322829252|FG000|Overall Study|Death|0|||
94284022|NCT01391507|322829253|FG001|Overall Study|Death|0|||
94284023|NCT01391507|322829254|FG002|Overall Study|Death|0|||
94284024|NCT01391507|322829255|FG003|Overall Study|Death|1|||
94284025|NCT01391507|322829252|FG000|Overall Study|Adverse Event|1|||
94284026|NCT01391507|322829253|FG001|Overall Study|Adverse Event|1|||
94284027|NCT01391507|322829254|FG002|Overall Study|Adverse Event|2|||
94284028|NCT01391507|322829255|FG003|Overall Study|Adverse Event|2|||
94284029|NCT01391507|322829252|FG000|Overall Study|Withdrawal by Subject|1|||
94284030|NCT01391507|322829253|FG001|Overall Study|Withdrawal by Subject|2|||
94284031|NCT01391507|322829254|FG002|Overall Study|Withdrawal by Subject|1|||
94284032|NCT01391507|322829255|FG003|Overall Study|Withdrawal by Subject|1|||
94284033|NCT01391507|322829252|FG000|Overall Study|Lack of Efficacy|0|||
94284034|NCT01391507|322829253|FG001|Overall Study|Lack of Efficacy|0|||
94284035|NCT01391507|322829254|FG002|Overall Study|Lack of Efficacy|0|||
94284036|NCT01391507|322829255|FG003|Overall Study|Lack of Efficacy|1|||
94284037|NCT01391507|322829252|FG000|Overall Study|Protocol Violation|2|||
94284038|NCT01391507|322829253|FG001|Overall Study|Protocol Violation|1|||
94284039|NCT01391507|322829254|FG002|Overall Study|Protocol Violation|1|||
94284040|NCT01391507|322829255|FG003|Overall Study|Protocol Violation|2|||
94284041|NCT01562548|322829256|FG000|Overall Study|Lost to Follow-up|0|||
94284042|NCT01562548|322829257|FG001|Overall Study|Lost to Follow-up|0|||
94284043|NCT01562548|322829258|FG002|Overall Study|Lost to Follow-up|1|||
94284044|NCT01562548|322829259|FG003|Overall Study|Lost to Follow-up|0|||
94284045|NCT03529773|322829260|FG000|Overall Study|Adverse Event|0|||
94284046|NCT03529773|322829261|FG001|Overall Study|Adverse Event|0|||
94284047|NCT03529773|322829262|FG002|Overall Study|Adverse Event|0|||
94284048|NCT03529773|322829263|FG003|Overall Study|Adverse Event|0|||
94284049|NCT03529773|322829264|FG004|Overall Study|Adverse Event|0|||
94284050|NCT03529773|322829265|FG005|Overall Study|Adverse Event|0|||
94284051|NCT03529773|322829266|FG006|Overall Study|Adverse Event|0|||
94284052|NCT03529773|322829267|FG007|Overall Study|Adverse Event|0|||
94284053|NCT03529773|322829268|FG008|Overall Study|Adverse Event|0|||
94284054|NCT03529773|322829269|FG009|Overall Study|Adverse Event|0|||
94284055|NCT03529773|322829270|FG010|Overall Study|Adverse Event|0|||
94284056|NCT03529773|322829271|FG011|Overall Study|Adverse Event|0|||
94284057|NCT03529773|322829272|FG012|Overall Study|Adverse Event|0|||
94284058|NCT03529773|322829273|FG013|Overall Study|Adverse Event|0|||
94284059|NCT03529773|322829274|FG014|Overall Study|Adverse Event|0|||
94284060|NCT03529773|322829275|FG015|Overall Study|Adverse Event|0|||
94284061|NCT03529773|322829276|FG016|Overall Study|Adverse Event|0|||
94284062|NCT03529773|322829277|FG017|Overall Study|Adverse Event|0|||
94284063|NCT03529773|322829278|FG018|Overall Study|Adverse Event|0|||
94284064|NCT03529773|322829279|FG019|Overall Study|Adverse Event|0|||
94284065|NCT03529773|322829280|FG020|Overall Study|Adverse Event|0|||
94284066|NCT03529773|322829281|FG021|Overall Study|Adverse Event|0|||
94284067|NCT03529773|322829282|FG022|Overall Study|Adverse Event|0|||
94284068|NCT03529773|322829283|FG023|Overall Study|Adverse Event|0|||
94284069|NCT03529773|322829284|FG024|Overall Study|Adverse Event|0|||
94284070|NCT03529773|322829285|FG025|Overall Study|Adverse Event|0|||
94284071|NCT03529773|322829286|FG026|Overall Study|Adverse Event|0|||
94284072|NCT03529773|322829287|FG027|Overall Study|Adverse Event|0|||
94284073|NCT03529773|322829288|FG028|Overall Study|Adverse Event|0|||
94284074|NCT03529773|322829289|FG029|Overall Study|Adverse Event|0|||
94284075|NCT03529773|322829290|FG030|Overall Study|Adverse Event|1|||
94210032|NCT00836498|322563108|FG001|Overall Study|Withdrawal by Subject|1|||
94210033|NCT01619059|322563109|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
94210034|NCT01619059|322563110|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
94210035|NCT01619059|322563109|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
94210036|NCT01619059|322563110|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
94210037|NCT01619059|322563109|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
94210038|NCT01619059|322563110|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
94210039|NCT01619059|322563109|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
94210040|NCT01619059|322563110|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
94210041|NCT01619059|322563109|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
94210042|NCT01619059|322563110|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
94210043|NCT01619059|322563109|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
94210044|NCT01619059|322563110|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
94210045|NCT01619059|322563109|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
94210046|NCT01619059|322563110|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
94210047|NCT01619059|322563109|FG000|Long-Term (LT) Treatment Period|Death|1|||
94210048|NCT01619059|322563110|FG001|Long-Term (LT) Treatment Period|Death|0|||
94210049|NCT01619059|322563109|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
94210050|NCT01619059|322563110|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
94210051|NCT01619059|322563109|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
94210052|NCT01619059|322563110|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
94210053|NCT01170208|322563111|FG000|Overall Study|Withdrawal by Subject|5|||
94210054|NCT01170208|322563112|FG001|Overall Study|Withdrawal by Subject|0|||
94210055|NCT01170208|322563113|FG002|Overall Study|Withdrawal by Subject|1|||
94210056|NCT01170208|322563111|FG000|Overall Study|Protocol Violation|1|||
94210057|NCT01170208|322563112|FG001|Overall Study|Protocol Violation|0|||
94210058|NCT01170208|322563113|FG002|Overall Study|Protocol Violation|1|||
94210059|NCT03335488|322563114|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
94210060|NCT03335488|322563115|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
94210061|NCT03335488|322563114|FG000|Safety Extension Period|Adverse Event|1|||
94210062|NCT03335488|322563115|FG001|Safety Extension Period|Adverse Event|0|||
94210063|NCT03335488|322563114|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
94210064|NCT03335488|322563115|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
94284076|NCT03529773|322829291|FG031|Overall Study|Adverse Event|0|||
94284077|NCT03529773|322829292|FG032|Overall Study|Adverse Event|0|||
94284078|NCT03529773|322829293|FG033|Overall Study|Adverse Event|0|||
94284079|NCT03529773|322829294|FG034|Overall Study|Adverse Event|0|||
94284080|NCT03529773|322829295|FG035|Overall Study|Adverse Event|1|||
94284081|NCT03529773|322829296|FG036|Overall Study|Adverse Event|0|||
94284082|NCT03529773|322829297|FG037|Overall Study|Adverse Event|0|||
94284083|NCT03529773|322829298|FG038|Overall Study|Adverse Event|1|||
94284084|NCT03529773|322829299|FG039|Overall Study|Adverse Event|1|||
94284085|NCT03529773|322829260|FG000|Overall Study|Death|0|||
94284086|NCT03529773|322829261|FG001|Overall Study|Death|0|||
94284087|NCT03529773|322829262|FG002|Overall Study|Death|0|||
94284088|NCT03529773|322829263|FG003|Overall Study|Death|0|||
94284089|NCT03529773|322829264|FG004|Overall Study|Death|0|||
94284090|NCT03529773|322829265|FG005|Overall Study|Death|0|||
94284091|NCT03529773|322829266|FG006|Overall Study|Death|0|||
94284092|NCT03529773|322829267|FG007|Overall Study|Death|0|||
94284093|NCT03529773|322829268|FG008|Overall Study|Death|0|||
94284094|NCT03529773|322829269|FG009|Overall Study|Death|0|||
94284095|NCT03529773|322829270|FG010|Overall Study|Death|0|||
94284096|NCT03529773|322829271|FG011|Overall Study|Death|0|||
94284097|NCT03529773|322829272|FG012|Overall Study|Death|1|||
94284098|NCT03529773|322829273|FG013|Overall Study|Death|0|||
94284099|NCT03529773|322829274|FG014|Overall Study|Death|0|||
94284100|NCT03529773|322829275|FG015|Overall Study|Death|0|||
94284101|NCT03529773|322829276|FG016|Overall Study|Death|0|||
94284102|NCT03529773|322829277|FG017|Overall Study|Death|0|||
94284103|NCT03529773|322829278|FG018|Overall Study|Death|0|||
94284104|NCT03529773|322829279|FG019|Overall Study|Death|1|||
94284105|NCT03529773|322829280|FG020|Overall Study|Death|0|||
94284106|NCT03529773|322829281|FG021|Overall Study|Death|0|||
94284107|NCT03529773|322829282|FG022|Overall Study|Death|1|||
94284108|NCT03529773|322829283|FG023|Overall Study|Death|0|||
94284109|NCT03529773|322829284|FG024|Overall Study|Death|0|||
94284110|NCT03529773|322829285|FG025|Overall Study|Death|0|||
94284111|NCT03529773|322829286|FG026|Overall Study|Death|0|||
94284112|NCT03529773|322829287|FG027|Overall Study|Death|0|||
94284113|NCT03529773|322829288|FG028|Overall Study|Death|0|||
94284114|NCT03529773|322829289|FG029|Overall Study|Death|0|||
94284115|NCT03529773|322829290|FG030|Overall Study|Death|0|||
94284116|NCT03529773|322829291|FG031|Overall Study|Death|0|||
94284117|NCT03529773|322829292|FG032|Overall Study|Death|0|||
94284118|NCT03529773|322829293|FG033|Overall Study|Death|1|||
94284119|NCT03529773|322829294|FG034|Overall Study|Death|1|||
94284120|NCT03529773|322829295|FG035|Overall Study|Death|0|||
94284121|NCT03529773|322829296|FG036|Overall Study|Death|1|||
94210065|NCT00705159|322563120|FG000|Overall Study|Withdrawal by Subject|0|||
94210066|NCT00705159|322563121|FG001|Overall Study|Withdrawal by Subject|1|||
94210067|NCT00705159|322563122|FG002|Overall Study|Withdrawal by Subject|1|||
94210068|NCT00705159|322563123|FG003|Overall Study|Withdrawal by Subject|1|||
94210069|NCT00705159|322563120|FG000|Overall Study|Protocol Violation|0|||
94210070|NCT00705159|322563121|FG001|Overall Study|Protocol Violation|1|||
94210071|NCT00705159|322563122|FG002|Overall Study|Protocol Violation|0|||
94210072|NCT00705159|322563123|FG003|Overall Study|Protocol Violation|0|||
94210073|NCT00705159|322563120|FG000|Overall Study|Adverse Event|0|||
94210074|NCT00705159|322563121|FG001|Overall Study|Adverse Event|0|||
94210075|NCT00705159|322563122|FG002|Overall Study|Adverse Event|1|||
94210076|NCT00705159|322563123|FG003|Overall Study|Adverse Event|0|||
94210077|NCT00705159|322563120|FG000|Overall Study|Lost to Follow-up|0|||
94210078|NCT00705159|322563121|FG001|Overall Study|Lost to Follow-up|0|||
94210079|NCT00705159|322563122|FG002|Overall Study|Lost to Follow-up|3|||
94210080|NCT00705159|322563123|FG003|Overall Study|Lost to Follow-up|2|||
94210081|NCT00705159|322563120|FG000|Overall Study|Screen Failure|0|||
94210082|NCT00705159|322563121|FG001|Overall Study|Screen Failure|0|||
94210083|NCT00705159|322563122|FG002|Overall Study|Screen Failure|0|||
94210084|NCT00705159|322563123|FG003|Overall Study|Screen Failure|1|||
94210085|NCT00983294|322563128|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
94210086|NCT00983294|322563128|FG000|Colchicine With Azithromycin|Adverse Event|1|||
94210087|NCT01989104|322563129|FG000|Overall Study|Withdrawal by Subject|3|||
94210088|NCT01989104|322563130|FG001|Overall Study|Withdrawal by Subject|0|||
94210089|NCT01989104|322563131|FG002|Overall Study|Withdrawal by Subject|0|||
94210090|NCT01989104|322563132|FG003|Overall Study|Withdrawal by Subject|0|||
94210091|NCT01989104|322563133|FG004|Overall Study|Withdrawal by Subject|0|||
94210092|NCT04029090|322563140|FG000|Overall Study|Protocol Violation|1|||
94210093|NCT04029090|322563141|FG001|Overall Study|Protocol Violation|0|||
94210094|NCT04029090|322563142|FG002|Overall Study|Protocol Violation|0|||
94210095|NCT04029090|322563140|FG000|Overall Study|Withdrawal by Subject|0|||
94210096|NCT04029090|322563141|FG001|Overall Study|Withdrawal by Subject|1|||
94210097|NCT04029090|322563142|FG002|Overall Study|Withdrawal by Subject|0|||
94210098|NCT01065779|322563146|FG000|Overall Study|Duplicate Investigation|1|||
94210099|NCT01065779|322563146|FG000|Overall Study|Investigation Before Contract Date|37|||
94210100|NCT01065779|322563146|FG000|Overall Study|Non-enrollment Period Administration|10|||
94210101|NCT01065779|322563146|FG000|Overall Study|Not Administered With Study Drug|17|||
94210102|NCT01065779|322563146|FG000|Overall Study|Failed to Follow-up|10|||
94210103|NCT01065779|322563146|FG000|Overall Study|Inclusion Criteria Violation|7|||
94210104|NCT01668719|322563147|FG000|Phase I|On treatment|1|||
94210105|NCT01668719|322563148|FG001|Phase I|On treatment|0|||
94210106|NCT01668719|322563149|FG002|Phase I|On treatment|0|||
94210107|NCT01668719|322563147|FG000|Phase I|Adverse Event|2|||
94210108|NCT01668719|322563148|FG001|Phase I|Adverse Event|0|||
94210109|NCT01668719|322563149|FG002|Phase I|Adverse Event|0|||
94210110|NCT01668719|322563147|FG000|Phase I|Progression/relapse|1|||
94210111|NCT01668719|322563148|FG001|Phase I|Progression/relapse|0|||
94210112|NCT01668719|322563149|FG002|Phase I|Progression/relapse|0|||
94210113|NCT01668719|322563147|FG000|Phase I|not protocol specified|2|||
94210114|NCT01668719|322563148|FG001|Phase I|not protocol specified|0|||
94210115|NCT01668719|322563149|FG002|Phase I|not protocol specified|0|||
94210116|NCT01668719|322563147|FG000|Phase II|On treatment|0|||
94210117|NCT01668719|322563148|FG001|Phase II|On treatment|4|||
94210118|NCT01668719|322563149|FG002|Phase II|On treatment|3|||
94210119|NCT01668719|322563147|FG000|Phase II|Adverse Event|0|||
94210120|NCT01668719|322563148|FG001|Phase II|Adverse Event|18|||
94210121|NCT01668719|322563149|FG002|Phase II|Adverse Event|18|||
94210122|NCT01668719|322563147|FG000|Phase II|Refusal unrelated to adverse event|0|||
94210123|NCT01668719|322563148|FG001|Phase II|Refusal unrelated to adverse event|4|||
94210124|NCT01668719|322563149|FG002|Phase II|Refusal unrelated to adverse event|1|||
94210125|NCT01668719|322563147|FG000|Phase II|Progression/relapse|0|||
94210126|NCT01668719|322563148|FG001|Phase II|Progression/relapse|13|||
94210127|NCT01668719|322563149|FG002|Phase II|Progression/relapse|17|||
94210128|NCT01668719|322563147|FG000|Phase II|Death|0|||
94467717|NCT01004432|323502373|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
94467718|NCT01004432|323502374|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
94467719|NCT01004432|323502375|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
94210129|NCT01668719|322563148|FG001|Phase II|Death|0|||
94210130|NCT01668719|322563149|FG002|Phase II|Death|2|||
94210131|NCT01668719|322563147|FG000|Phase II|not protocol specified|0|||
94210132|NCT01668719|322563148|FG001|Phase II|not protocol specified|13|||
94210133|NCT01668719|322563149|FG002|Phase II|not protocol specified|7|||
94467720|NCT01004432|323502376|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
94210134|NCT03697603|322563150|FG000|Overall Study|Adverse Event|3|||
94467721|NCT01004432|323502377|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
94210135|NCT03697603|322563151|FG001|Overall Study|Adverse Event|18|||
94210136|NCT03697603|322563152|FG002|Overall Study|Adverse Event|3|||
94210137|NCT03697603|322563150|FG000|Overall Study|Physician Decision|1|||
94210138|NCT03697603|322563151|FG001|Overall Study|Physician Decision|0|||
94467722|NCT01004432|323502373|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
94284122|NCT03529773|322829297|FG037|Overall Study|Death|0|||
94284123|NCT03529773|322829298|FG038|Overall Study|Death|0|||
94284124|NCT03529773|322829299|FG039|Overall Study|Death|0|||
94284125|NCT03529773|322829260|FG000|Overall Study|Lost to Follow-up|0|||
94210139|NCT03697603|322563152|FG002|Overall Study|Physician Decision|2|||
94210140|NCT03697603|322563150|FG000|Overall Study|Protocol Violation|3|||
94210141|NCT03697603|322563151|FG001|Overall Study|Protocol Violation|8|||
94210142|NCT03697603|322563152|FG002|Overall Study|Protocol Violation|5|||
94210143|NCT03697603|322563150|FG000|Overall Study|Withdrawal by Subject|5|||
94210144|NCT03697603|322563151|FG001|Overall Study|Withdrawal by Subject|1|||
94210145|NCT03697603|322563152|FG002|Overall Study|Withdrawal by Subject|1|||
94210146|NCT03697603|322563150|FG000|Overall Study|Protocol Violation|0|||
94210147|NCT03697603|322563151|FG001|Overall Study|Protocol Violation|0|||
94210148|NCT03697603|322563152|FG002|Overall Study|Protocol Violation|1|||
94210149|NCT01706159|322563159|FG000|Overall Study|Withdrawal Criteria|2|||
94210150|NCT01706159|322563160|FG001|Overall Study|Withdrawal Criteria|1|||
94210151|NCT01706159|322563159|FG000|Overall Study|Unclassified|6|||
94210152|NCT01706159|322563160|FG001|Overall Study|Unclassified|1|||
94210153|NCT03786471|322563168|FG000|Overall Study|Death|254|||
94210154|NCT03786471|322563169|FG001|Overall Study|Death|223|||
94210155|NCT03786471|322563170|FG002|Overall Study|Death|37|||
94210156|NCT03786471|322563168|FG000|Overall Study|Lost to Follow-up|63|||
94210157|NCT03786471|322563169|FG001|Overall Study|Lost to Follow-up|50|||
94210158|NCT03786471|322563170|FG002|Overall Study|Lost to Follow-up|15|||
94210159|NCT03786471|322563168|FG000|Overall Study|Withdrawal by Subject|99|||
94210160|NCT03786471|322563169|FG001|Overall Study|Withdrawal by Subject|81|||
94210161|NCT03786471|322563170|FG002|Overall Study|Withdrawal by Subject|11|||
94210162|NCT00378898|322564487|FG000|Overall Study|Withdrawal by Subject|10|||
94210163|NCT00378898|322564488|FG001|Overall Study|Withdrawal by Subject|5|||
94210164|NCT00378898|322564487|FG000|Overall Study|Protocol Violation|1|||
94210165|NCT00378898|322564488|FG001|Overall Study|Protocol Violation|1|||
94210166|NCT00949117|322564489|FG000|Overall Study|Lack of Efficacy|2|||
94210167|NCT00949117|322564490|FG001|Overall Study|Lack of Efficacy|3|||
94210168|NCT00949117|322564489|FG000|Overall Study|Protocol Violation|1|||
94210169|NCT00949117|322564490|FG001|Overall Study|Protocol Violation|1|||
94210170|NCT00949117|322564489|FG000|Overall Study|Adverse Event|0|||
94210171|NCT00949117|322564490|FG001|Overall Study|Adverse Event|1|||
94210172|NCT03823703|322564491|FG000|Overall Study|Sponsor request|0|||
94210173|NCT03823703|322564492|FG001|Overall Study|Sponsor request|3|||
94210174|NCT03823703|322564493|FG002|Overall Study|Sponsor request|4|||
94284126|NCT03529773|322829261|FG001|Overall Study|Lost to Follow-up|0|||
94284127|NCT03529773|322829262|FG002|Overall Study|Lost to Follow-up|1|||
94284128|NCT03529773|322829263|FG003|Overall Study|Lost to Follow-up|0|||
94284129|NCT03529773|322829264|FG004|Overall Study|Lost to Follow-up|1|||
94284130|NCT03529773|322829265|FG005|Overall Study|Lost to Follow-up|1|||
94284131|NCT03529773|322829266|FG006|Overall Study|Lost to Follow-up|0|||
94284132|NCT03529773|322829267|FG007|Overall Study|Lost to Follow-up|0|||
94284133|NCT03529773|322829268|FG008|Overall Study|Lost to Follow-up|0|||
94210175|NCT03823703|322564491|FG000|Overall Study|Adverse Event|3|||
94284134|NCT03529773|322829269|FG009|Overall Study|Lost to Follow-up|0|||
94284135|NCT03529773|322829270|FG010|Overall Study|Lost to Follow-up|0|||
94284136|NCT03529773|322829271|FG011|Overall Study|Lost to Follow-up|0|||
94284137|NCT03529773|322829272|FG012|Overall Study|Lost to Follow-up|0|||
94284138|NCT03529773|322829273|FG013|Overall Study|Lost to Follow-up|1|||
94284139|NCT03529773|322829274|FG014|Overall Study|Lost to Follow-up|4|||
94284140|NCT03529773|322829275|FG015|Overall Study|Lost to Follow-up|1|||
94284141|NCT03529773|322829276|FG016|Overall Study|Lost to Follow-up|1|||
94284142|NCT03529773|322829277|FG017|Overall Study|Lost to Follow-up|0|||
94284143|NCT03529773|322829278|FG018|Overall Study|Lost to Follow-up|1|||
94210176|NCT03823703|322564492|FG001|Overall Study|Adverse Event|1|||
94284144|NCT03529773|322829279|FG019|Overall Study|Lost to Follow-up|1|||
94284145|NCT03529773|322829280|FG020|Overall Study|Lost to Follow-up|2|||
94284146|NCT03529773|322829281|FG021|Overall Study|Lost to Follow-up|4|||
94284147|NCT03529773|322829282|FG022|Overall Study|Lost to Follow-up|3|||
94284148|NCT03529773|322829283|FG023|Overall Study|Lost to Follow-up|4|||
94284149|NCT03529773|322829284|FG024|Overall Study|Lost to Follow-up|3|||
94372296|NCT01872689|323150242|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
94372297|NCT01872689|323150243|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
94210177|NCT03823703|322564493|FG002|Overall Study|Adverse Event|0|||
94210178|NCT03823703|322564491|FG000|Overall Study|Withdrawal by Subject|0|||
94210179|NCT03823703|322564492|FG001|Overall Study|Withdrawal by Subject|1|||
94372298|NCT01872689|323150240|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
94210180|NCT03823703|322564493|FG002|Overall Study|Withdrawal by Subject|0|||
94210181|NCT01970878|322564494|FG000|Overall Study|Withdrawal by Subject|11|||
94210182|NCT01970878|322564495|FG001|Overall Study|Withdrawal by Subject|10|||
94284150|NCT03529773|322829285|FG025|Overall Study|Lost to Follow-up|5|||
94284151|NCT03529773|322829286|FG026|Overall Study|Lost to Follow-up|5|||
94284152|NCT03529773|322829287|FG027|Overall Study|Lost to Follow-up|0|||
94284153|NCT03529773|322829288|FG028|Overall Study|Lost to Follow-up|0|||
94284154|NCT03529773|322829289|FG029|Overall Study|Lost to Follow-up|0|||
94284155|NCT03529773|322829290|FG030|Overall Study|Lost to Follow-up|1|||
94284156|NCT03529773|322829291|FG031|Overall Study|Lost to Follow-up|0|||
94284157|NCT03529773|322829292|FG032|Overall Study|Lost to Follow-up|0|||
94284158|NCT03529773|322829293|FG033|Overall Study|Lost to Follow-up|1|||
94284159|NCT03529773|322829294|FG034|Overall Study|Lost to Follow-up|1|||
94284160|NCT03529773|322829295|FG035|Overall Study|Lost to Follow-up|0|||
94284161|NCT03529773|322829296|FG036|Overall Study|Lost to Follow-up|0|||
94284162|NCT03529773|322829297|FG037|Overall Study|Lost to Follow-up|3|||
94284163|NCT03529773|322829298|FG038|Overall Study|Lost to Follow-up|1|||
94284164|NCT03529773|322829299|FG039|Overall Study|Lost to Follow-up|1|||
94284165|NCT03529773|322829260|FG000|Overall Study|No longer meets eligibility criteria|0|||
94284166|NCT03529773|322829261|FG001|Overall Study|No longer meets eligibility criteria|0|||
94210183|NCT01970878|322564496|FG002|Overall Study|Withdrawal by Subject|14|||
94210184|NCT01970878|322564497|FG003|Overall Study|Withdrawal by Subject|7|||
94210185|NCT01970878|322564494|FG000|Overall Study|Lost to Follow-up|1|||
94210186|NCT01970878|322564495|FG001|Overall Study|Lost to Follow-up|3|||
94210187|NCT01970878|322564496|FG002|Overall Study|Lost to Follow-up|2|||
94210188|NCT01970878|322564497|FG003|Overall Study|Lost to Follow-up|4|||
94210189|NCT01970878|322564494|FG000|Overall Study|Administrative Reasons|1|||
94210190|NCT01970878|322564495|FG001|Overall Study|Administrative Reasons|0|||
94210191|NCT01970878|322564496|FG002|Overall Study|Administrative Reasons|0|||
94210192|NCT01970878|322564497|FG003|Overall Study|Administrative Reasons|4|||
94210193|NCT01970878|322564494|FG000|Overall Study|Lack of Efficacy|2|||
94210194|NCT01970878|322564495|FG001|Overall Study|Lack of Efficacy|1|||
94210195|NCT01970878|322564496|FG002|Overall Study|Lack of Efficacy|2|||
94210196|NCT01970878|322564497|FG003|Overall Study|Lack of Efficacy|0|||
94210197|NCT01970878|322564494|FG000|Overall Study|Adverse Event|12|||
94210198|NCT01970878|322564495|FG001|Overall Study|Adverse Event|7|||
94210199|NCT01970878|322564496|FG002|Overall Study|Adverse Event|4|||
94210200|NCT01970878|322564497|FG003|Overall Study|Adverse Event|3|||
94210201|NCT01970878|322564494|FG000|Overall Study|Protocol Specified Criteria|10|||
94210202|NCT01970878|322564495|FG001|Overall Study|Protocol Specified Criteria|4|||
94210203|NCT01970878|322564496|FG002|Overall Study|Protocol Specified Criteria|3|||
94210204|NCT01970878|322564497|FG003|Overall Study|Protocol Specified Criteria|6|||
94210205|NCT01970878|322564494|FG000|Overall Study|Physician Decision|0|||
94210206|NCT01970878|322564495|FG001|Overall Study|Physician Decision|1|||
94210207|NCT01970878|322564496|FG002|Overall Study|Physician Decision|1|||
94210208|NCT01970878|322564497|FG003|Overall Study|Physician Decision|0|||
94210209|NCT01970878|322564494|FG000|Overall Study|No Completion Status|0|||
94210210|NCT01970878|322564495|FG001|Overall Study|No Completion Status|1|||
94210211|NCT01970878|322564496|FG002|Overall Study|No Completion Status|0|||
94210212|NCT01970878|322564497|FG003|Overall Study|No Completion Status|0|||
94210213|NCT02232737|322564499|FG000|Overall Study|Lost to Follow-up|18|||
94210214|NCT02232737|322564500|FG001|Overall Study|Lost to Follow-up|28|||
94210215|NCT02232737|322564501|FG002|Overall Study|Lost to Follow-up|33|||
94210216|NCT02232737|322564499|FG000|Overall Study|Personal reasons|7|||
94210217|NCT02232737|322564500|FG001|Overall Study|Personal reasons|8|||
94210218|NCT02232737|322564501|FG002|Overall Study|Personal reasons|14|||
94210219|NCT02232737|322564499|FG000|Overall Study|Adverse Event|6|||
94210220|NCT02232737|322564500|FG001|Overall Study|Adverse Event|3|||
94210221|NCT02232737|322564501|FG002|Overall Study|Adverse Event|8|||
94210222|NCT02232737|322564499|FG000|Overall Study|Incarcerated|2|||
94210223|NCT02232737|322564500|FG001|Overall Study|Incarcerated|1|||
94210224|NCT02232737|322564501|FG002|Overall Study|Incarcerated|2|||
94210225|NCT02232737|322564499|FG000|Overall Study|Withdrawal by Subject|0|||
94210226|NCT02232737|322564500|FG001|Overall Study|Withdrawal by Subject|1|||
94210227|NCT02232737|322564501|FG002|Overall Study|Withdrawal by Subject|2|||
94210228|NCT02232737|322564499|FG000|Overall Study|Death|0|||
94210229|NCT02232737|322564500|FG001|Overall Study|Death|1|||
94210230|NCT02232737|322564501|FG002|Overall Study|Death|1|||
94210231|NCT02232737|322564499|FG000|Overall Study|Physician Decision|1|||
94210232|NCT02232737|322564500|FG001|Overall Study|Physician Decision|3|||
94210233|NCT02232737|322564501|FG002|Overall Study|Physician Decision|1|||
94210234|NCT02232737|322564499|FG000|Overall Study|Protocol Violation|1|||
94210235|NCT02232737|322564500|FG001|Overall Study|Protocol Violation|0|||
94284167|NCT03529773|322829262|FG002|Overall Study|No longer meets eligibility criteria|0|||
94284168|NCT03529773|322829263|FG003|Overall Study|No longer meets eligibility criteria|0|||
94284169|NCT03529773|322829264|FG004|Overall Study|No longer meets eligibility criteria|0|||
94284170|NCT03529773|322829265|FG005|Overall Study|No longer meets eligibility criteria|0|||
94284171|NCT03529773|322829266|FG006|Overall Study|No longer meets eligibility criteria|0|||
94284172|NCT03529773|322829267|FG007|Overall Study|No longer meets eligibility criteria|0|||
94284173|NCT03529773|322829268|FG008|Overall Study|No longer meets eligibility criteria|0|||
94284174|NCT03529773|322829269|FG009|Overall Study|No longer meets eligibility criteria|0|||
94372299|NCT01872689|323150241|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
94372300|NCT01872689|323150242|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
94372301|NCT01872689|323150243|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
94210236|NCT02232737|322564501|FG002|Overall Study|Protocol Violation|1|||
94210237|NCT02232737|322564499|FG000|Overall Study|Reason unknown|1|||
94210238|NCT02232737|322564500|FG001|Overall Study|Reason unknown|0|||
94210239|NCT02232737|322564501|FG002|Overall Study|Reason unknown|0|||
94210240|NCT01567852|322564502|FG000|Overall Study|Withdrawal by Subject|3|||
94210241|NCT01567852|322564503|FG001|Overall Study|Withdrawal by Subject|6|||
94210242|NCT01567852|322564502|FG000|Overall Study|ECT discontinued|1|||
94210243|NCT01567852|322564503|FG001|Overall Study|ECT discontinued|1|||
94210244|NCT00458783|322564504|FG000|Overall Study|Protocol Violation|1228|||
94210245|NCT00458783|322564505|FG001|Overall Study|Protocol Violation|1220|||
94284175|NCT03529773|322829270|FG010|Overall Study|No longer meets eligibility criteria|0|||
94284176|NCT03529773|322829271|FG011|Overall Study|No longer meets eligibility criteria|0|||
94210246|NCT04809623|322564506|FG000|Overall Study|Study Terminated by Sponsor|1|||
94210247|NCT04809623|322564507|FG001|Overall Study|Study Terminated by Sponsor|0|||
94210248|NCT02634307|322564512|FG000|Overall Study|Adverse Event|50|||
94210249|NCT02634307|322564513|FG001|Overall Study|Adverse Event|24|||
94210250|NCT02634307|322564514|FG002|Overall Study|Adverse Event|14|||
94210251|NCT02634307|322564512|FG000|Overall Study|Lost to Follow-up|21|||
94210252|NCT02634307|322564513|FG001|Overall Study|Lost to Follow-up|5|||
94210253|NCT02634307|322564514|FG002|Overall Study|Lost to Follow-up|6|||
94210254|NCT02634307|322564512|FG000|Overall Study|Pregnancy|5|||
94210255|NCT02634307|322564513|FG001|Overall Study|Pregnancy|1|||
94210256|NCT02634307|322564514|FG002|Overall Study|Pregnancy|3|||
94210257|NCT02634307|322564512|FG000|Overall Study|Withdrawal by Subject|38|||
94210258|NCT02634307|322564513|FG001|Overall Study|Withdrawal by Subject|24|||
94210259|NCT02634307|322564514|FG002|Overall Study|Withdrawal by Subject|18|||
94210260|NCT02634307|322564512|FG000|Overall Study|Non-Compliance with Study Drug|0|||
94210261|NCT02634307|322564513|FG001|Overall Study|Non-Compliance with Study Drug|2|||
94210262|NCT02634307|322564514|FG002|Overall Study|Non-Compliance with Study Drug|2|||
94210263|NCT02634307|322564512|FG000|Overall Study|Lack of Efficacy|1|||
94210264|NCT02634307|322564513|FG001|Overall Study|Lack of Efficacy|5|||
94210265|NCT02634307|322564514|FG002|Overall Study|Lack of Efficacy|3|||
94210266|NCT02634307|322564512|FG000|Overall Study|Physician Decision|7|||
94210267|NCT02634307|322564513|FG001|Overall Study|Physician Decision|5|||
94210268|NCT02634307|322564514|FG002|Overall Study|Physician Decision|5|||
94210269|NCT02634307|322564512|FG000|Overall Study|Reason not Specified|3|||
94210270|NCT02634307|322564513|FG001|Overall Study|Reason not Specified|5|||
94210271|NCT02634307|322564514|FG002|Overall Study|Reason not Specified|10|||
94210272|NCT01808534|322564516|FG000|Overall Study|Disease progression|3|||
94210273|NCT01808534|322564516|FG000|Overall Study|Physician Decision|1|||
94210274|NCT04938453|322564517|FG000|Washout Period 1|Adverse Event|1|||
94210275|NCT04938453|322564518|FG001|Washout Period 1|Adverse Event|0|||
94210276|NCT04938453|322564517|FG000|Washout Period 1|Physician Decision|0|||
94210277|NCT04938453|322564518|FG001|Washout Period 1|Physician Decision|1|||
94210278|NCT00019604|322564519|FG000|Overall Study|Death|1|||
94210279|NCT00019604|322564519|FG000|Overall Study|Progressive disease|23|||
94210280|NCT00019604|322564519|FG000|Overall Study|Refused treatment|1|||
94210281|NCT00019604|322564519|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
94210282|NCT00019604|322564519|FG000|Overall Study|Going to have liver transplant|1|||
94210283|NCT00019604|322564519|FG000|Overall Study|Move to a different study|1|||
94210284|NCT00019604|322564519|FG000|Overall Study|Non compliant on systemic CH|1|||
94210285|NCT00019604|322564519|FG000|Overall Study|Non compliant|1|||
94210286|NCT00019604|322564519|FG000|Overall Study|Resectable disease|1|||
94210287|NCT00019604|322564519|FG000|Overall Study|Started new chemo regimen|1|||
94210288|NCT00019604|322564519|FG000|Overall Study|Pt going to immunotherapy study|1|||
94210289|NCT00019604|322564519|FG000|Overall Study|Too much disease|1|||
94210290|NCT00019604|322564519|FG000|Overall Study|Unable to evaluate|1|||
94210291|NCT00019604|322564519|FG000|Overall Study|Details for other not available|4|||
94210292|NCT00734578|322564521|FG000|Overall Study|Adverse Event|4|||
94210293|NCT00734578|322564522|FG001|Overall Study|Adverse Event|6|||
94210294|NCT00734578|322564523|FG002|Overall Study|Adverse Event|1|||
94210295|NCT00734578|322564521|FG000|Overall Study|Protocol Violation|8|||
94210296|NCT00734578|322564522|FG001|Overall Study|Protocol Violation|6|||
94210297|NCT00734578|322564523|FG002|Overall Study|Protocol Violation|3|||
94210298|NCT00734578|322564521|FG000|Overall Study|Withdrawal by Subject|7|||
94210299|NCT00734578|322564522|FG001|Overall Study|Withdrawal by Subject|8|||
94210300|NCT00734578|322564523|FG002|Overall Study|Withdrawal by Subject|11|||
94210301|NCT00734578|322564521|FG000|Overall Study|Lost to Follow-up|9|||
94210302|NCT00734578|322564522|FG001|Overall Study|Lost to Follow-up|3|||
94210303|NCT00734578|322564523|FG002|Overall Study|Lost to Follow-up|5|||
94210304|NCT00734578|322564521|FG000|Overall Study|Lack of Efficacy|3|||
94210305|NCT00734578|322564522|FG001|Overall Study|Lack of Efficacy|2|||
94210306|NCT00734578|322564523|FG002|Overall Study|Lack of Efficacy|5|||
94210307|NCT00734578|322564521|FG000|Overall Study|Randomized in error|1|||
94210308|NCT00734578|322564522|FG001|Overall Study|Randomized in error|0|||
94210309|NCT00734578|322564523|FG002|Overall Study|Randomized in error|0|||
94210310|NCT00734578|322564521|FG000|Overall Study|Exclusion criteria|1|||
94210311|NCT00734578|322564522|FG001|Overall Study|Exclusion criteria|0|||
94210312|NCT00734578|322564523|FG002|Overall Study|Exclusion criteria|0|||
94210313|NCT01698918|322564524|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
94210314|NCT01698918|322564524|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
94210315|NCT01698918|322564524|FG000|First Line Treatment (Core+Extension)|Death|2|||
94210316|NCT01698918|322564524|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
94210317|NCT01698918|322564524|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
94210318|NCT01698918|322564524|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
94210319|NCT01698918|322564524|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
94210320|NCT01698918|322564524|FG000|Second Line Treatment (Core+Extension)|Death|1|||
94210321|NCT01698918|322564524|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
94210322|NCT01698918|322564524|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
94210323|NCT02630186|322564525|FG000|Overall Study|Withdrawal by Subject|1|||
94210324|NCT01829711|322564527|FG000|Overall Study|Lost to Follow-up|2|||
94210325|NCT01829711|322564527|FG000|Overall Study|Withdrawal by Subject|3|||
94210326|NCT01829711|322564527|FG000|Overall Study|Death|4|||
94210327|NCT01829711|322564527|FG000|Overall Study|Started new therapies|17|||
94210328|NCT01829711|322564527|FG000|Overall Study|Adverse Event|3|||
94210329|NCT01829711|322564527|FG000|Overall Study|Due to progression of disease|13|||
94210330|NCT01829711|322564527|FG000|Overall Study|Due to lack of response|1|||
94210331|NCT02169414|322564528|FG000|Overall Study|Withdrawal by Subject|1|||
94210332|NCT02169414|322564529|FG001|Overall Study|Withdrawal by Subject|0|||
94210333|NCT02169414|322564530|FG002|Overall Study|Withdrawal by Subject|0|||
94210334|NCT02169414|322564531|FG003|Overall Study|Withdrawal by Subject|0|||
94210335|NCT02169414|322564528|FG000|Overall Study|Adverse Event|0|||
94210336|NCT02169414|322564529|FG001|Overall Study|Adverse Event|1|||
94210337|NCT02169414|322564530|FG002|Overall Study|Adverse Event|0|||
94210338|NCT02169414|322564531|FG003|Overall Study|Adverse Event|0|||
94210339|NCT01485887|322564533|FG000|Overall Study|Withdrawal by Subject|2|||
94210340|NCT01485887|322564533|FG000|Overall Study|Adverse Event|8|||
94210341|NCT01485887|322564533|FG000|Overall Study|Deterioration of primary disease|1|||
94210342|NCT01485887|322564533|FG000|Overall Study|Primary disease markedly improved|1|||
94210343|NCT00853580|322564534|FG000|Overall Study|Lost to Follow-up|3|||
94210344|NCT00853580|322564535|FG001|Overall Study|Lost to Follow-up|5|||
94210345|NCT00853580|322564534|FG000|Overall Study|Protocol Violation|2|||
94210346|NCT00853580|322564535|FG001|Overall Study|Protocol Violation|1|||
94210347|NCT00853580|322564534|FG000|Overall Study|Withdrawal by Subject|2|||
94210348|NCT00853580|322564535|FG001|Overall Study|Withdrawal by Subject|8|||
94210349|NCT00853580|322564534|FG000|Overall Study|Commenced contraindicated therapy|0|||
94210350|NCT00853580|322564535|FG001|Overall Study|Commenced contraindicated therapy|2|||
94210351|NCT03567616|322564545|FG000|Overall Study|Disease progression|4|||
94210352|NCT03567616|322564545|FG000|Overall Study|Withdrawal by Subject|1|||
94210353|NCT03567616|322564545|FG000|Overall Study|Physician Decision|1|||
94210354|NCT03567616|322564545|FG000|Overall Study|Death|1|||
94210355|NCT03567616|322564545|FG000|Overall Study|Adverse Event|1|||
94210356|NCT01074242|322564546|FG000|Overall Study|Case report before date of contract|40|||
94210357|NCT01074242|322564546|FG000|Overall Study|Lost to Follow-up|1|||
94210358|NCT01074242|322564546|FG000|Overall Study|Case report unclear|6|||
94210359|NCT01074242|322564546|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
94210360|NCT01074242|322564546|FG000|Overall Study|Duplicate Case Report Form|5|||
94210361|NCT00109031|322564549|FG000|Overall Study|Adverse Event|0|||
94210362|NCT00109031|322564550|FG001|Overall Study|Adverse Event|0|||
94210363|NCT00109031|322564551|FG002|Overall Study|Adverse Event|1|||
94210364|NCT00109031|322564552|FG003|Overall Study|Adverse Event|0|||
94210365|NCT00109031|322564549|FG000|Overall Study|Withdrawal by Subject|0|||
94210366|NCT00109031|322564550|FG001|Overall Study|Withdrawal by Subject|1|||
94210367|NCT00109031|322564551|FG002|Overall Study|Withdrawal by Subject|0|||
94210368|NCT00109031|322564552|FG003|Overall Study|Withdrawal by Subject|0|||
94210369|NCT00109031|322564549|FG000|Overall Study|Physician Decision|0|||
94210370|NCT00109031|322564550|FG001|Overall Study|Physician Decision|1|||
94210371|NCT00109031|322564551|FG002|Overall Study|Physician Decision|0|||
94210372|NCT00109031|322564552|FG003|Overall Study|Physician Decision|0|||
94210373|NCT00109031|322564549|FG000|Overall Study|Protocol Violation|0|||
94210374|NCT00109031|322564550|FG001|Overall Study|Protocol Violation|0|||
94210375|NCT00109031|322564551|FG002|Overall Study|Protocol Violation|1|||
94210376|NCT00109031|322564552|FG003|Overall Study|Protocol Violation|0|||
94210377|NCT00526994|322564553|FG000|Overall Study|Lost to Follow-up|98|||
94210378|NCT00526994|322564554|FG001|Overall Study|Lost to Follow-up|108|||
94210379|NCT00526994|322564555|FG002|Overall Study|Lost to Follow-up|96|||
94210380|NCT00526994|322564553|FG000|Overall Study|Death|4|||
94210381|NCT00526994|322564554|FG001|Overall Study|Death|3|||
94210382|NCT00526994|322564555|FG002|Overall Study|Death|3|||
94210383|NCT00526994|322564553|FG000|Overall Study|Withdrawal by Subject|2|||
94210384|NCT00526994|322564554|FG001|Overall Study|Withdrawal by Subject|7|||
94210385|NCT00526994|322564555|FG002|Overall Study|Withdrawal by Subject|5|||
94210386|NCT00526994|322564553|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
94210387|NCT00526994|322564554|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
94210388|NCT00526994|322564555|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
94210389|NCT01957163|322564558|FG000|Overall Study|Adverse Event|5|||
94210390|NCT01957163|322564559|FG001|Overall Study|Adverse Event|2|||
94210391|NCT01957163|322564560|FG002|Overall Study|Adverse Event|4|||
94210392|NCT01957163|322564558|FG000|Overall Study|Lack of Efficacy|5|||
94210393|NCT01957163|322564559|FG001|Overall Study|Lack of Efficacy|4|||
94210394|NCT01957163|322564560|FG002|Overall Study|Lack of Efficacy|9|||
94210395|NCT01957163|322564558|FG000|Overall Study|Protocol Violation|1|||
94372302|NCT01872689|323150240|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
94210396|NCT01957163|322564559|FG001|Overall Study|Protocol Violation|2|||
94210397|NCT01957163|322564560|FG002|Overall Study|Protocol Violation|0|||
94210398|NCT01957163|322564558|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
94467723|NCT01004432|323502374|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
94467724|NCT01004432|323502375|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
94210399|NCT01957163|322564559|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
94210400|NCT01957163|322564560|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
94467725|NCT01004432|323502376|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
94467726|NCT01004432|323502377|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
94467727|NCT01004432|323502373|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
94467728|NCT01004432|323502374|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
94467729|NCT01004432|323502375|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
94467730|NCT01004432|323502376|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
94467731|NCT01004432|323502377|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
94467732|NCT00412217|323502379|FG000|Overall Study|Insufficient Data Available|8|||
94467733|NCT00412217|323502380|FG001|Overall Study|Insufficient Data Available|3|||
94467734|NCT00412217|323502379|FG000|Overall Study|Death|5|||
94210401|NCT01957163|322564558|FG000|Overall Study|Lost to Follow-up|0|||
94210402|NCT01957163|322564559|FG001|Overall Study|Lost to Follow-up|1|||
94467735|NCT00412217|323502380|FG001|Overall Study|Death|4|||
94210403|NCT01957163|322564560|FG002|Overall Study|Lost to Follow-up|0|||
94210404|NCT01957163|322564558|FG000|Overall Study|Withdrawal by Subject|4|||
94210405|NCT01957163|322564559|FG001|Overall Study|Withdrawal by Subject|2|||
94210406|NCT01957163|322564560|FG002|Overall Study|Withdrawal by Subject|4|||
94210407|NCT03026166|322564561|FG000|Overall Study|Death|22|||
94210408|NCT03026166|322564562|FG001|Overall Study|Death|7|||
94210409|NCT03026166|322564561|FG000|Overall Study|Physician Decision|2|||
94210410|NCT03026166|322564562|FG001|Overall Study|Physician Decision|0|||
94210411|NCT03026166|322564561|FG000|Overall Study|Withdrawal by Subject|1|||
94210412|NCT03026166|322564562|FG001|Overall Study|Withdrawal by Subject|2|||
94210413|NCT03026166|322564561|FG000|Overall Study|Lost to Follow-up|1|||
94210414|NCT03026166|322564562|FG001|Overall Study|Lost to Follow-up|0|||
94210415|NCT03026166|322564561|FG000|Overall Study|Study Terminated by Sponsor|3|||
94210416|NCT03026166|322564562|FG001|Overall Study|Study Terminated by Sponsor|3|||
94210417|NCT03026166|322564561|FG000|Overall Study|Other|1|||
94210418|NCT03026166|322564562|FG001|Overall Study|Other|0|||
94210419|NCT02833948|322564563|FG000|Overall Study|Death|2|||
94210420|NCT02833948|322564564|FG001|Overall Study|Death|3|||
94210421|NCT02833948|322564563|FG000|Overall Study|were not scanned|8|||
94210422|NCT02833948|322564564|FG001|Overall Study|were not scanned|13|||
94210423|NCT02833948|322564563|FG000|Overall Study|scans could not be evaluated|5|||
94210424|NCT02833948|322564564|FG001|Overall Study|scans could not be evaluated|2|||
94210425|NCT00680771|322564567|FG000|Overall Study|Withdrawal by Subject|1|||
94210426|NCT00680771|322564568|FG001|Overall Study|Withdrawal by Subject|0|||
94210427|NCT00680771|322564567|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
94210428|NCT00680771|322564568|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
94210429|NCT00680771|322564567|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
94210430|NCT00680771|322564568|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
94210431|NCT01316913|322564569|FG000|Overall Study|Adverse Event|17|||
94210432|NCT01316913|322564570|FG001|Overall Study|Adverse Event|20|||
94210433|NCT01316913|322564571|FG002|Overall Study|Adverse Event|15|||
94210434|NCT01316913|322564572|FG003|Overall Study|Adverse Event|11|||
94210435|NCT01316913|322564569|FG000|Overall Study|Lack of Efficacy|22|||
94210436|NCT01316913|322564570|FG001|Overall Study|Lack of Efficacy|12|||
94210437|NCT01316913|322564571|FG002|Overall Study|Lack of Efficacy|9|||
94210438|NCT01316913|322564572|FG003|Overall Study|Lack of Efficacy|13|||
94210439|NCT01316913|322564569|FG000|Overall Study|Protocol Violation|1|||
94210440|NCT01316913|322564570|FG001|Overall Study|Protocol Violation|4|||
94210441|NCT01316913|322564571|FG002|Overall Study|Protocol Violation|4|||
94210442|NCT01316913|322564572|FG003|Overall Study|Protocol Violation|1|||
94210443|NCT01316913|322564569|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
94210444|NCT01316913|322564570|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
94210445|NCT01316913|322564571|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
94210446|NCT01316913|322564572|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
94210447|NCT01316913|322564569|FG000|Overall Study|Lost to Follow-up|0|||
94210448|NCT01316913|322564570|FG001|Overall Study|Lost to Follow-up|1|||
94210449|NCT01316913|322564571|FG002|Overall Study|Lost to Follow-up|0|||
94210450|NCT01316913|322564572|FG003|Overall Study|Lost to Follow-up|2|||
94210451|NCT01316913|322564569|FG000|Overall Study|Withdrawal by Subject|10|||
94210452|NCT01316913|322564570|FG001|Overall Study|Withdrawal by Subject|9|||
94210453|NCT01316913|322564571|FG002|Overall Study|Withdrawal by Subject|10|||
94210454|NCT01316913|322564572|FG003|Overall Study|Withdrawal by Subject|6|||
94210455|NCT00641537|322564573|FG000|96-week Period|Adverse Event|0|||
94210456|NCT00641537|322564574|FG001|96-week Period|Adverse Event|1|||
94210457|NCT00641537|322564575|FG002|96-week Period|Adverse Event|3|||
94210458|NCT00641537|322564576|FG003|96-week Period|Adverse Event|0|||
94210459|NCT00641537|322564577|FG004|96-week Period|Adverse Event|2|||
94210460|NCT00641537|322564578|FG005|96-week Period|Adverse Event|0|||
94210461|NCT00641537|322564579|FG006|96-week Period|Adverse Event|0|||
94210462|NCT00641537|322564580|FG007|96-week Period|Adverse Event|0|||
94210463|NCT00641537|322564573|FG000|96-week Period|Lost to Follow-up|3|||
94210464|NCT00641537|322564574|FG001|96-week Period|Lost to Follow-up|1|||
94210465|NCT00641537|322564575|FG002|96-week Period|Lost to Follow-up|2|||
94210466|NCT00641537|322564576|FG003|96-week Period|Lost to Follow-up|2|||
94210467|NCT00641537|322564577|FG004|96-week Period|Lost to Follow-up|4|||
94210468|NCT00641537|322564578|FG005|96-week Period|Lost to Follow-up|0|||
94210469|NCT00641537|322564579|FG006|96-week Period|Lost to Follow-up|1|||
94210470|NCT00641537|322564580|FG007|96-week Period|Lost to Follow-up|0|||
94210471|NCT00641537|322564573|FG000|96-week Period|Protocol Violation|0|||
94210472|NCT00641537|322564574|FG001|96-week Period|Protocol Violation|1|||
94210473|NCT00641537|322564575|FG002|96-week Period|Protocol Violation|0|||
94210474|NCT00641537|322564576|FG003|96-week Period|Protocol Violation|1|||
94210475|NCT00641537|322564577|FG004|96-week Period|Protocol Violation|0|||
94210476|NCT00641537|322564578|FG005|96-week Period|Protocol Violation|1|||
94210477|NCT00641537|322564579|FG006|96-week Period|Protocol Violation|0|||
94210478|NCT00641537|322564580|FG007|96-week Period|Protocol Violation|0|||
94210479|NCT00641537|322564573|FG000|96-week Period|Death|2|||
94210480|NCT00641537|322564574|FG001|96-week Period|Death|0|||
94210481|NCT00641537|322564575|FG002|96-week Period|Death|1|||
94284177|NCT03529773|322829272|FG012|Overall Study|No longer meets eligibility criteria|0|||
94284178|NCT03529773|322829273|FG013|Overall Study|No longer meets eligibility criteria|0|||
94284179|NCT03529773|322829274|FG014|Overall Study|No longer meets eligibility criteria|0|||
94284180|NCT03529773|322829275|FG015|Overall Study|No longer meets eligibility criteria|0|||
94284181|NCT03529773|322829276|FG016|Overall Study|No longer meets eligibility criteria|0|||
94284182|NCT03529773|322829277|FG017|Overall Study|No longer meets eligibility criteria|0|||
94284183|NCT03529773|322829278|FG018|Overall Study|No longer meets eligibility criteria|0|||
94284184|NCT03529773|322829279|FG019|Overall Study|No longer meets eligibility criteria|0|||
94284185|NCT03529773|322829280|FG020|Overall Study|No longer meets eligibility criteria|0|||
94284186|NCT03529773|322829281|FG021|Overall Study|No longer meets eligibility criteria|0|||
94284187|NCT03529773|322829282|FG022|Overall Study|No longer meets eligibility criteria|1|||
94467736|NCT00412217|323502379|FG000|Overall Study|Disease Progression|2|||
94284188|NCT03529773|322829283|FG023|Overall Study|No longer meets eligibility criteria|0|||
94284189|NCT03529773|322829284|FG024|Overall Study|No longer meets eligibility criteria|0|||
94284190|NCT03529773|322829285|FG025|Overall Study|No longer meets eligibility criteria|0|||
94210482|NCT00641537|322564576|FG003|96-week Period|Death|0|||
94210483|NCT00641537|322564577|FG004|96-week Period|Death|0|||
94210484|NCT00641537|322564578|FG005|96-week Period|Death|0|||
94210485|NCT00641537|322564579|FG006|96-week Period|Death|0|||
94210486|NCT00641537|322564580|FG007|96-week Period|Death|0|||
94210487|NCT00641537|322564573|FG000|96-week Period|Other|4|||
94210488|NCT00641537|322564574|FG001|96-week Period|Other|7|||
94210489|NCT00641537|322564575|FG002|96-week Period|Other|14|||
94210490|NCT00641537|322564576|FG003|96-week Period|Other|9|||
94210491|NCT00641537|322564577|FG004|96-week Period|Other|11|||
94210492|NCT00641537|322564578|FG005|96-week Period|Other|6|||
94210493|NCT00641537|322564579|FG006|96-week Period|Other|4|||
94210494|NCT00641537|322564580|FG007|96-week Period|Other|6|||
94210495|NCT00641537|322564573|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
94210496|NCT00641537|322564574|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
94210497|NCT00641537|322564575|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
94210498|NCT00641537|322564576|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
94210499|NCT00641537|322564577|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
94210500|NCT00641537|322564578|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
94210501|NCT00641537|322564579|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
94210502|NCT00641537|322564580|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
94210503|NCT00641537|322564573|FG000|24-Week Supplemental Follow-up Period|Other|0|||
94210504|NCT00641537|322564574|FG001|24-Week Supplemental Follow-up Period|Other|2|||
94210505|NCT00641537|322564575|FG002|24-Week Supplemental Follow-up Period|Other|2|||
94467737|NCT00412217|323502380|FG001|Overall Study|Disease Progression|3|||
94210506|NCT00641537|322564576|FG003|24-Week Supplemental Follow-up Period|Other|1|||
94210507|NCT00641537|322564577|FG004|24-Week Supplemental Follow-up Period|Other|3|||
94210508|NCT00641537|322564578|FG005|24-Week Supplemental Follow-up Period|Other|0|||
94210509|NCT00641537|322564579|FG006|24-Week Supplemental Follow-up Period|Other|1|||
94210510|NCT00641537|322564580|FG007|24-Week Supplemental Follow-up Period|Other|1|||
94284191|NCT03529773|322829286|FG026|Overall Study|No longer meets eligibility criteria|0|||
94284192|NCT03529773|322829287|FG027|Overall Study|No longer meets eligibility criteria|0|||
94284193|NCT03529773|322829288|FG028|Overall Study|No longer meets eligibility criteria|0|||
94284194|NCT03529773|322829289|FG029|Overall Study|No longer meets eligibility criteria|0|||
94284195|NCT03529773|322829290|FG030|Overall Study|No longer meets eligibility criteria|0|||
94284196|NCT03529773|322829291|FG031|Overall Study|No longer meets eligibility criteria|0|||
94284197|NCT03529773|322829292|FG032|Overall Study|No longer meets eligibility criteria|0|||
94284198|NCT03529773|322829293|FG033|Overall Study|No longer meets eligibility criteria|0|||
94284199|NCT03529773|322829294|FG034|Overall Study|No longer meets eligibility criteria|0|||
94284200|NCT03529773|322829295|FG035|Overall Study|No longer meets eligibility criteria|0|||
94284201|NCT03529773|322829296|FG036|Overall Study|No longer meets eligibility criteria|0|||
94284202|NCT03529773|322829297|FG037|Overall Study|No longer meets eligibility criteria|0|||
94284203|NCT03529773|322829298|FG038|Overall Study|No longer meets eligibility criteria|1|||
94284204|NCT03529773|322829299|FG039|Overall Study|No longer meets eligibility criteria|0|||
94284205|NCT03529773|322829260|FG000|Overall Study|Other|0|||
94284206|NCT03529773|322829261|FG001|Overall Study|Other|0|||
94284207|NCT03529773|322829262|FG002|Overall Study|Other|0|||
94284208|NCT03529773|322829263|FG003|Overall Study|Other|0|||
94284209|NCT03529773|322829264|FG004|Overall Study|Other|0|||
94284210|NCT03529773|322829265|FG005|Overall Study|Other|0|||
94284211|NCT03529773|322829266|FG006|Overall Study|Other|0|||
94284212|NCT03529773|322829267|FG007|Overall Study|Other|0|||
94284213|NCT03529773|322829268|FG008|Overall Study|Other|0|||
94284214|NCT03529773|322829269|FG009|Overall Study|Other|0|||
94284215|NCT03529773|322829270|FG010|Overall Study|Other|0|||
94284216|NCT03529773|322829271|FG011|Overall Study|Other|0|||
94284217|NCT03529773|322829272|FG012|Overall Study|Other|1|||
94284218|NCT03529773|322829273|FG013|Overall Study|Other|0|||
94284219|NCT03529773|322829274|FG014|Overall Study|Other|2|||
94284220|NCT03529773|322829275|FG015|Overall Study|Other|0|||
94284221|NCT03529773|322829276|FG016|Overall Study|Other|0|||
94284222|NCT03529773|322829277|FG017|Overall Study|Other|3|||
94284223|NCT03529773|322829278|FG018|Overall Study|Other|0|||
94284224|NCT03529773|322829279|FG019|Overall Study|Other|0|||
94284225|NCT03529773|322829280|FG020|Overall Study|Other|1|||
94284226|NCT03529773|322829281|FG021|Overall Study|Other|0|||
94284227|NCT03529773|322829282|FG022|Overall Study|Other|1|||
94284228|NCT03529773|322829283|FG023|Overall Study|Other|0|||
94284229|NCT03529773|322829284|FG024|Overall Study|Other|3|||
94284230|NCT03529773|322829285|FG025|Overall Study|Other|2|||
94284231|NCT03529773|322829286|FG026|Overall Study|Other|2|||
94284232|NCT03529773|322829287|FG027|Overall Study|Other|0|||
94284233|NCT03529773|322829288|FG028|Overall Study|Other|0|||
94284234|NCT03529773|322829289|FG029|Overall Study|Other|0|||
94284235|NCT03529773|322829290|FG030|Overall Study|Other|0|||
94284236|NCT03529773|322829291|FG031|Overall Study|Other|0|||
94284237|NCT03529773|322829292|FG032|Overall Study|Other|0|||
94284238|NCT03529773|322829293|FG033|Overall Study|Other|0|||
94284239|NCT03529773|322829294|FG034|Overall Study|Other|1|||
94284240|NCT03529773|322829295|FG035|Overall Study|Other|1|||
94284241|NCT03529773|322829296|FG036|Overall Study|Other|0|||
94284242|NCT03529773|322829297|FG037|Overall Study|Other|0|||
94284243|NCT03529773|322829298|FG038|Overall Study|Other|0|||
94284244|NCT03529773|322829299|FG039|Overall Study|Other|0|||
94284245|NCT03529773|322829260|FG000|Overall Study|Physician Decision|0|||
94284246|NCT03529773|322829261|FG001|Overall Study|Physician Decision|0|||
94284247|NCT03529773|322829262|FG002|Overall Study|Physician Decision|0|||
94284248|NCT03529773|322829263|FG003|Overall Study|Physician Decision|0|||
94284249|NCT03529773|322829264|FG004|Overall Study|Physician Decision|0|||
94284250|NCT03529773|322829265|FG005|Overall Study|Physician Decision|0|||
94284251|NCT03529773|322829266|FG006|Overall Study|Physician Decision|0|||
94284252|NCT03529773|322829267|FG007|Overall Study|Physician Decision|0|||
94284253|NCT03529773|322829268|FG008|Overall Study|Physician Decision|0|||
94372303|NCT01872689|323150241|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
94372304|NCT01872689|323150242|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
94210511|NCT01683409|322564583|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
94210512|NCT01683409|322564584|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
94210513|NCT01683409|322564585|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
94210514|NCT01683409|322564586|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
94210515|NCT01683409|322564587|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
94210516|NCT01683409|322564583|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
94210517|NCT01683409|322564584|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
94210518|NCT01683409|322564585|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
94210519|NCT01683409|322564586|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
94210520|NCT01683409|322564587|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
94210521|NCT01683409|322564583|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
94210522|NCT01683409|322564584|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
94210523|NCT01683409|322564585|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
94210524|NCT01683409|322564586|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
94210525|NCT01683409|322564587|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
94210526|NCT01683409|322564583|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
94210527|NCT01683409|322564584|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
94210528|NCT01683409|322564585|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
94210529|NCT01683409|322564586|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
94210530|NCT01683409|322564587|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
94210531|NCT01683409|322564583|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
94210532|NCT01683409|322564584|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
94210533|NCT01683409|322564585|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
94210534|NCT01683409|322564586|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
94210535|NCT01683409|322564587|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
94210536|NCT01683409|322564583|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
94210537|NCT01683409|322564584|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
94210538|NCT01683409|322564585|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
94210539|NCT01683409|322564586|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
94210540|NCT01683409|322564587|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
94210541|NCT01683409|322564583|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
94210542|NCT01683409|322564584|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
94210543|NCT01683409|322564585|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
94210544|NCT01683409|322564586|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
94210545|NCT01683409|322564587|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
94210546|NCT01683409|322564583|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
94210547|NCT01683409|322564584|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
94210548|NCT01683409|322564585|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
94210549|NCT01683409|322564586|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
94210550|NCT01683409|322564587|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
94210551|NCT01683409|322564583|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
94210552|NCT01683409|322564584|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
94210553|NCT01683409|322564585|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
94210554|NCT01683409|322564586|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
94210555|NCT01683409|322564587|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
94210556|NCT01683409|322564583|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
94210557|NCT01683409|322564584|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
94210558|NCT01683409|322564585|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
94210559|NCT01683409|322564586|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
94210560|NCT01683409|322564587|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
94210561|NCT01683409|322564583|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
94210562|NCT01683409|322564584|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
94210563|NCT01683409|322564585|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
94210564|NCT01683409|322564586|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
94210565|NCT01683409|322564587|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
94210566|NCT02008916|322564590|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
94210567|NCT02008916|322564591|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
94210568|NCT02008916|322564592|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
94372305|NCT01872689|323150243|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
94372306|NCT01872689|323150240|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
94372307|NCT01872689|323150241|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
94210569|NCT02008916|322564590|FG000|Week 16 - 156|Adverse Event|4|||
94210570|NCT02008916|322564591|FG001|Week 16 - 156|Adverse Event|2|||
94210571|NCT02008916|322564592|FG002|Week 16 - 156|Adverse Event|3|||
94210572|NCT02008916|322564590|FG000|Week 16 - 156|Withdrawal by Subject|7|||
94210573|NCT02008916|322564591|FG001|Week 16 - 156|Withdrawal by Subject|3|||
94210574|NCT02008916|322564592|FG002|Week 16 - 156|Withdrawal by Subject|5|||
94210575|NCT02008916|322564590|FG000|Week 16 - 156|No longer requires treatment|0|||
94210576|NCT02008916|322564591|FG001|Week 16 - 156|No longer requires treatment|1|||
94210577|NCT02008916|322564592|FG002|Week 16 - 156|No longer requires treatment|0|||
94210578|NCT02008916|322564590|FG000|Week 16 - 156|Lost to Follow-up|5|||
94210579|NCT02008916|322564591|FG001|Week 16 - 156|Lost to Follow-up|0|||
94210580|NCT02008916|322564592|FG002|Week 16 - 156|Lost to Follow-up|0|||
94210581|NCT02008916|322564590|FG000|Week 16 - 156|Lack of Efficacy|3|||
94210582|NCT02008916|322564591|FG001|Week 16 - 156|Lack of Efficacy|5|||
94210583|NCT02008916|322564592|FG002|Week 16 - 156|Lack of Efficacy|2|||
94210584|NCT02008916|322564590|FG000|Week 16 - 156|Pregnancy|0|||
94210585|NCT02008916|322564591|FG001|Week 16 - 156|Pregnancy|1|||
94210586|NCT02008916|322564592|FG002|Week 16 - 156|Pregnancy|0|||
94210587|NCT02008916|322564590|FG000|Week 16 - 156|Physician Decision|0|||
94210588|NCT02008916|322564591|FG001|Week 16 - 156|Physician Decision|1|||
94210589|NCT02008916|322564592|FG002|Week 16 - 156|Physician Decision|0|||
94210590|NCT02309294|322564595|FG000|Overall Study|Withdrawal by Subject|2|||
94210591|NCT01227421|322564596|FG000|Overall Study|Lost to Follow-up|6|||
94210592|NCT01227421|322564597|FG001|Overall Study|Lost to Follow-up|7|||
94210593|NCT01227421|322564598|FG002|Overall Study|Lost to Follow-up|5|||
94210594|NCT01227421|322564596|FG000|Overall Study|Adverse Event|2|||
94210595|NCT01227421|322564597|FG001|Overall Study|Adverse Event|7|||
94210596|NCT01227421|322564598|FG002|Overall Study|Adverse Event|2|||
94210597|NCT01227421|322564596|FG000|Overall Study|Withdrawal by Subject|1|||
94210598|NCT01227421|322564597|FG001|Overall Study|Withdrawal by Subject|2|||
94210599|NCT01227421|322564598|FG002|Overall Study|Withdrawal by Subject|1|||
94210600|NCT01227421|322564596|FG000|Overall Study|Protocol Violation|1|||
94210601|NCT01227421|322564597|FG001|Overall Study|Protocol Violation|1|||
94210602|NCT01227421|322564598|FG002|Overall Study|Protocol Violation|2|||
94210603|NCT01227421|322564596|FG000|Overall Study|Randomized in error|1|||
94210604|NCT01227421|322564597|FG001|Overall Study|Randomized in error|1|||
94210605|NCT01227421|322564598|FG002|Overall Study|Randomized in error|0|||
94210606|NCT01218594|322564605|FG000|Overall Study|Death|1|||
94210607|NCT01218594|322564605|FG000|Overall Study|Withdrawal by Subject|3|||
94210608|NCT01218594|322564605|FG000|Overall Study|Adverse Event|2|||
94210609|NCT01218594|322564605|FG000|Overall Study|Physician Decision|6|||
94210610|NCT02326220|322564611|FG000|Double-blind Treatment Period|Adverse Event|1|||
94210611|NCT02326220|322564612|FG001|Double-blind Treatment Period|Adverse Event|2|||
94210612|NCT02326220|322564613|FG002|Double-blind Treatment Period|Adverse Event|0|||
94210613|NCT02326220|322564611|FG000|Double-blind Treatment Period|Protocol Violation|0|||
94210614|NCT02326220|322564612|FG001|Double-blind Treatment Period|Protocol Violation|1|||
94210615|NCT02326220|322564613|FG002|Double-blind Treatment Period|Protocol Violation|0|||
94210616|NCT02326220|322564611|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
94210617|NCT02326220|322564612|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
94210618|NCT02326220|322564613|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
94210619|NCT02326220|322564611|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
94210620|NCT02326220|322564612|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
94210621|NCT02326220|322564613|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
94210622|NCT02326220|322564611|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
94210623|NCT02326220|322564612|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
94210624|NCT02326220|322564613|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
94210625|NCT04520256|322564618|FG000|Overall Study|Lost to Follow-up|6|||
94210626|NCT04520256|322564619|FG001|Overall Study|Lost to Follow-up|4|||
94210627|NCT04520256|322564620|FG002|Overall Study|Lost to Follow-up|2|||
94210628|NCT04520256|322564621|FG003|Overall Study|Lost to Follow-up|3|||
94210629|NCT04520256|322564622|FG004|Overall Study|Lost to Follow-up|6|||
94210630|NCT04520256|322564623|FG005|Overall Study|Lost to Follow-up|6|||
94210631|NCT04520256|322564624|FG006|Overall Study|Lost to Follow-up|4|||
94210632|NCT04520256|322564625|FG007|Overall Study|Lost to Follow-up|6|||
94210633|NCT04520256|322564626|FG008|Overall Study|Lost to Follow-up|1|||
94210634|NCT04520256|322564627|FG009|Overall Study|Lost to Follow-up|3|||
94210635|NCT04520256|322564628|FG010|Overall Study|Lost to Follow-up|3|||
94210636|NCT04520256|322564629|FG011|Overall Study|Lost to Follow-up|2|||
94210637|NCT04520256|322564630|FG012|Overall Study|Lost to Follow-up|5|||
94210638|NCT04520256|322564631|FG013|Overall Study|Lost to Follow-up|3|||
94210639|NCT04520256|322564632|FG014|Overall Study|Lost to Follow-up|3|||
94210640|NCT04520256|322564633|FG015|Overall Study|Lost to Follow-up|6|||
94210641|NCT04520256|322564634|FG016|Overall Study|Lost to Follow-up|6|||
94210642|NCT04520256|322564635|FG017|Overall Study|Lost to Follow-up|4|||
94210643|NCT04520256|322564636|FG018|Overall Study|Lost to Follow-up|3|||
94210644|NCT04520256|322564637|FG019|Overall Study|Lost to Follow-up|3|||
94210645|NCT04520256|322564638|FG020|Overall Study|Lost to Follow-up|7|||
94210646|NCT04520256|322564639|FG021|Overall Study|Lost to Follow-up|3|||
94210647|NCT04520256|322564640|FG022|Overall Study|Lost to Follow-up|3|||
94210648|NCT04520256|322564641|FG023|Overall Study|Lost to Follow-up|8|||
94210649|NCT04520256|322564642|FG024|Overall Study|Lost to Follow-up|5|||
94210650|NCT04520256|322564643|FG025|Overall Study|Lost to Follow-up|4|||
94210651|NCT04520256|322564644|FG026|Overall Study|Lost to Follow-up|3|||
94210652|NCT04520256|322564645|FG027|Overall Study|Lost to Follow-up|4|||
94210653|NCT04520256|322564646|FG028|Overall Study|Lost to Follow-up|3|||
94210654|NCT04520256|322564647|FG029|Overall Study|Lost to Follow-up|4|||
94210655|NCT04520256|322564648|FG030|Overall Study|Lost to Follow-up|4|||
94210656|NCT04520256|322564649|FG031|Overall Study|Lost to Follow-up|4|||
94210657|NCT00492050|322564650|FG000|Overall Study|Adverse Event|1|||
94210658|NCT00492050|322564650|FG000|Overall Study|Lack of Efficacy|1|||
94210659|NCT00492050|322564650|FG000|Overall Study|Withdrawal by Subject|3|||
94210660|NCT00492050|322564650|FG000|Overall Study|Unable to collect SCT|2|||
94210661|NCT00492050|322564650|FG000|Overall Study|Progressive Disease|2|||
94210662|NCT01214200|322566060|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
94210663|NCT01214200|322566060|FG000|Overall Study|Withdrawal by Subject|2|||
94210664|NCT01823224|322566061|FG000|Overall Study|Lost to Follow-up|5|||
94210665|NCT01823224|322566062|FG001|Overall Study|Lost to Follow-up|6|||
94210666|NCT01823224|322566061|FG000|Overall Study|didn't qualify|1|||
94210667|NCT01823224|322566062|FG001|Overall Study|didn't qualify|2|||
94210668|NCT01823224|322566061|FG000|Overall Study|pharmacy error|0|||
94210669|NCT01823224|322566062|FG001|Overall Study|pharmacy error|1|||
94210670|NCT01823224|322566061|FG000|Overall Study|missed med dose|0|||
94210671|NCT01823224|322566062|FG001|Overall Study|missed med dose|1|||
94210672|NCT01823224|322566061|FG000|Overall Study|Withdrawal by Subject|0|||
94210673|NCT01823224|322566062|FG001|Overall Study|Withdrawal by Subject|1|||
94210674|NCT00745875|322566063|FG000|Overall Study|Continuing study treatment|4|||
94210675|NCT00745875|322566064|FG001|Overall Study|Continuing study treatment|4|||
94210676|NCT02310581|322566067|FG000|Overall Study|Adverse Event|1|||
94210677|NCT02310581|322566068|FG001|Overall Study|Adverse Event|1|||
94210678|NCT02310581|322566069|FG002|Overall Study|Adverse Event|1|||
94210679|NCT02310581|322566070|FG003|Overall Study|Adverse Event|0|||
94210680|NCT02310581|322566067|FG000|Overall Study|Withdrawal by Subject|2|||
94210681|NCT02310581|322566068|FG001|Overall Study|Withdrawal by Subject|1|||
94210682|NCT02310581|322566069|FG002|Overall Study|Withdrawal by Subject|0|||
94210683|NCT02310581|322566070|FG003|Overall Study|Withdrawal by Subject|1|||
94210684|NCT01673594|322566071|FG000|Overall Study|Adverse Event|3|||
94210685|NCT01673594|322566072|FG001|Overall Study|Adverse Event|1|||
94210686|NCT01673594|322566071|FG000|Overall Study|Lost to Follow-up|1|||
94210687|NCT01673594|322566072|FG001|Overall Study|Lost to Follow-up|0|||
94210688|NCT01673594|322566071|FG000|Overall Study|Physician Decision|2|||
94210689|NCT01673594|322566072|FG001|Overall Study|Physician Decision|4|||
94210690|NCT01673594|322566071|FG000|Overall Study|Withdrawal by Subject|0|||
94210691|NCT01673594|322566072|FG001|Overall Study|Withdrawal by Subject|1|||
94210692|NCT04250636|322566080|FG000|Overall Study|Lost to Follow-up|2|||
94210693|NCT03883828|322566081|FG000|Overall Study|Did not start radiotherapy|1|||
94210694|NCT03883828|322566082|FG001|Overall Study|Did not start radiotherapy|2|||
94210695|NCT01779050|322566084|FG000|Overall Study|Withdrawal by Subject|1|||
94467738|NCT00412217|323502379|FG000|Overall Study|Investigator Decision|1|||
94467739|NCT00412217|323502380|FG001|Overall Study|Investigator Decision|0|||
94210696|NCT01779050|322566085|FG001|Overall Study|Withdrawal by Subject|0|||
94210697|NCT01353274|322566086|FG000|Overall Study|No case report form (CRF) collected|28|||
94210698|NCT01128959|322566087|FG000|Lead in Period|Adverse Event|3|||
94210699|NCT01128959|322566087|FG000|Treatment Period|Adverse Event|3|||
94210700|NCT01128959|322566087|FG000|Treatment Period|Withdrawal by Subject|1|||
94210701|NCT01409837|322566088|FG000|Overall Study|Withdrawal by Subject|2|||
94210702|NCT01409837|322566089|FG001|Overall Study|Withdrawal by Subject|1|||
94210703|NCT01409837|322566088|FG000|Overall Study|Lost to Follow-up|1|||
94210704|NCT01409837|322566089|FG001|Overall Study|Lost to Follow-up|0|||
94210705|NCT01409837|322566088|FG000|Overall Study|Physician Decision|0|||
94210706|NCT01409837|322566089|FG001|Overall Study|Physician Decision|1|||
94210707|NCT03851094|322566093|FG000|Overall Study|Withdrawal by Subject|0|||
94210708|NCT03851094|322566094|FG001|Overall Study|Withdrawal by Subject|1|||
94210709|NCT03851094|322566093|FG000|Overall Study|Participant lost device|0|||
94210710|NCT03851094|322566094|FG001|Overall Study|Participant lost device|1|||
94284254|NCT03529773|322829269|FG009|Overall Study|Physician Decision|0|||
94284255|NCT03529773|322829270|FG010|Overall Study|Physician Decision|0|||
94284256|NCT03529773|322829271|FG011|Overall Study|Physician Decision|0|||
94284257|NCT03529773|322829272|FG012|Overall Study|Physician Decision|0|||
94284258|NCT03529773|322829273|FG013|Overall Study|Physician Decision|0|||
94284259|NCT03529773|322829274|FG014|Overall Study|Physician Decision|0|||
94284260|NCT03529773|322829275|FG015|Overall Study|Physician Decision|0|||
94284261|NCT03529773|322829276|FG016|Overall Study|Physician Decision|0|||
94284262|NCT03529773|322829277|FG017|Overall Study|Physician Decision|0|||
94284263|NCT03529773|322829278|FG018|Overall Study|Physician Decision|0|||
94284264|NCT03529773|322829279|FG019|Overall Study|Physician Decision|1|||
94284265|NCT03529773|322829280|FG020|Overall Study|Physician Decision|1|||
94284266|NCT03529773|322829281|FG021|Overall Study|Physician Decision|0|||
94284267|NCT03529773|322829282|FG022|Overall Study|Physician Decision|0|||
94284268|NCT03529773|322829283|FG023|Overall Study|Physician Decision|0|||
94284269|NCT03529773|322829284|FG024|Overall Study|Physician Decision|0|||
94284270|NCT03529773|322829285|FG025|Overall Study|Physician Decision|0|||
94284271|NCT03529773|322829286|FG026|Overall Study|Physician Decision|0|||
94284272|NCT03529773|322829287|FG027|Overall Study|Physician Decision|0|||
94284273|NCT03529773|322829288|FG028|Overall Study|Physician Decision|0|||
94284274|NCT03529773|322829289|FG029|Overall Study|Physician Decision|0|||
94284275|NCT03529773|322829290|FG030|Overall Study|Physician Decision|0|||
94284276|NCT03529773|322829291|FG031|Overall Study|Physician Decision|0|||
94284277|NCT03529773|322829292|FG032|Overall Study|Physician Decision|0|||
94284278|NCT03529773|322829293|FG033|Overall Study|Physician Decision|0|||
94284279|NCT03529773|322829294|FG034|Overall Study|Physician Decision|0|||
94284280|NCT03529773|322829295|FG035|Overall Study|Physician Decision|0|||
94284281|NCT03529773|322829296|FG036|Overall Study|Physician Decision|0|||
94284282|NCT03529773|322829297|FG037|Overall Study|Physician Decision|0|||
94284283|NCT03529773|322829298|FG038|Overall Study|Physician Decision|0|||
94284284|NCT03529773|322829299|FG039|Overall Study|Physician Decision|0|||
94284285|NCT03529773|322829260|FG000|Overall Study|Protocol Violation|0|||
94284286|NCT03529773|322829261|FG001|Overall Study|Protocol Violation|0|||
94284287|NCT03529773|322829262|FG002|Overall Study|Protocol Violation|0|||
94284288|NCT03529773|322829263|FG003|Overall Study|Protocol Violation|0|||
94284289|NCT03529773|322829264|FG004|Overall Study|Protocol Violation|0|||
94284290|NCT03529773|322829265|FG005|Overall Study|Protocol Violation|0|||
94284291|NCT03529773|322829266|FG006|Overall Study|Protocol Violation|0|||
94284292|NCT03529773|322829267|FG007|Overall Study|Protocol Violation|0|||
94284293|NCT03529773|322829268|FG008|Overall Study|Protocol Violation|0|||
94284294|NCT03529773|322829269|FG009|Overall Study|Protocol Violation|0|||
94284295|NCT03529773|322829270|FG010|Overall Study|Protocol Violation|0|||
94284296|NCT03529773|322829271|FG011|Overall Study|Protocol Violation|0|||
94284297|NCT03529773|322829272|FG012|Overall Study|Protocol Violation|0|||
94284298|NCT03529773|322829273|FG013|Overall Study|Protocol Violation|0|||
94284299|NCT03529773|322829274|FG014|Overall Study|Protocol Violation|0|||
94284300|NCT03529773|322829275|FG015|Overall Study|Protocol Violation|0|||
94284301|NCT03529773|322829276|FG016|Overall Study|Protocol Violation|0|||
94284302|NCT03529773|322829277|FG017|Overall Study|Protocol Violation|0|||
94284303|NCT03529773|322829278|FG018|Overall Study|Protocol Violation|0|||
94284304|NCT03529773|322829279|FG019|Overall Study|Protocol Violation|0|||
94284305|NCT03529773|322829280|FG020|Overall Study|Protocol Violation|0|||
94284306|NCT03529773|322829281|FG021|Overall Study|Protocol Violation|0|||
94284307|NCT03529773|322829282|FG022|Overall Study|Protocol Violation|0|||
94284308|NCT03529773|322829283|FG023|Overall Study|Protocol Violation|0|||
94284309|NCT03529773|322829284|FG024|Overall Study|Protocol Violation|0|||
94284310|NCT03529773|322829285|FG025|Overall Study|Protocol Violation|0|||
94284311|NCT03529773|322829286|FG026|Overall Study|Protocol Violation|0|||
94284312|NCT03529773|322829287|FG027|Overall Study|Protocol Violation|0|||
94284313|NCT03529773|322829288|FG028|Overall Study|Protocol Violation|0|||
94284314|NCT03529773|322829289|FG029|Overall Study|Protocol Violation|0|||
94284315|NCT03529773|322829290|FG030|Overall Study|Protocol Violation|1|||
94284316|NCT03529773|322829291|FG031|Overall Study|Protocol Violation|0|||
94284317|NCT03529773|322829292|FG032|Overall Study|Protocol Violation|0|||
94372308|NCT01872689|323150242|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
94372309|NCT01872689|323150243|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
94372310|NCT01872689|323150240|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
94284318|NCT03529773|322829293|FG033|Overall Study|Protocol Violation|0|||
94284319|NCT03529773|322829294|FG034|Overall Study|Protocol Violation|0|||
94284320|NCT03529773|322829295|FG035|Overall Study|Protocol Violation|0|||
94284321|NCT03529773|322829296|FG036|Overall Study|Protocol Violation|0|||
94284322|NCT03529773|322829297|FG037|Overall Study|Protocol Violation|0|||
94284323|NCT03529773|322829298|FG038|Overall Study|Protocol Violation|0|||
94284324|NCT03529773|322829299|FG039|Overall Study|Protocol Violation|0|||
94284325|NCT03529773|322829260|FG000|Overall Study|Withdrawal by Subject|0|||
94284326|NCT03529773|322829261|FG001|Overall Study|Withdrawal by Subject|0|||
94210711|NCT03851094|322566093|FG000|Overall Study|Participant returned device|0|||
94210712|NCT03851094|322566094|FG001|Overall Study|Participant returned device|2|||
94210713|NCT01332266|322566095|FG000|Phase 1b|Death|3|||
94210714|NCT01332266|322566096|FG001|Phase 1b|Death|3|||
94210715|NCT01332266|322566097|FG002|Phase 1b|Death|2|||
94210716|NCT01332266|322566098|FG003|Phase 1b|Death|0|||
94210717|NCT01332266|322566099|FG004|Phase 1b|Death|0|||
94210718|NCT01332266|322566095|FG000|Phase 1b|Lost to Follow-up|0|||
94210719|NCT01332266|322566096|FG001|Phase 1b|Lost to Follow-up|1|||
94210720|NCT01332266|322566097|FG002|Phase 1b|Lost to Follow-up|0|||
94210721|NCT01332266|322566098|FG003|Phase 1b|Lost to Follow-up|0|||
94210722|NCT01332266|322566099|FG004|Phase 1b|Lost to Follow-up|0|||
94210723|NCT01332266|322566095|FG000|Phase 1b|Withdrawal by Subject|1|||
94210724|NCT01332266|322566096|FG001|Phase 1b|Withdrawal by Subject|1|||
94210725|NCT01332266|322566097|FG002|Phase 1b|Withdrawal by Subject|1|||
94210726|NCT01332266|322566098|FG003|Phase 1b|Withdrawal by Subject|0|||
94210727|NCT01332266|322566099|FG004|Phase 1b|Withdrawal by Subject|0|||
94210728|NCT01332266|322566095|FG000|Phase 2|Death|0|||
94210729|NCT01332266|322566096|FG001|Phase 2|Death|0|||
94210730|NCT01332266|322566097|FG002|Phase 2|Death|0|||
94210731|NCT01332266|322566098|FG003|Phase 2|Death|33|||
94210732|NCT01332266|322566099|FG004|Phase 2|Death|36|||
94210733|NCT01332266|322566095|FG000|Phase 2|Lost to Follow-up|0|||
94210734|NCT01332266|322566096|FG001|Phase 2|Lost to Follow-up|0|||
94210735|NCT01332266|322566097|FG002|Phase 2|Lost to Follow-up|0|||
94210736|NCT01332266|322566098|FG003|Phase 2|Lost to Follow-up|2|||
94210737|NCT01332266|322566099|FG004|Phase 2|Lost to Follow-up|0|||
94210738|NCT01332266|322566095|FG000|Phase 2|Physician Decision|0|||
94210739|NCT01332266|322566096|FG001|Phase 2|Physician Decision|0|||
94210740|NCT01332266|322566097|FG002|Phase 2|Physician Decision|0|||
94210741|NCT01332266|322566098|FG003|Phase 2|Physician Decision|3|||
94210742|NCT01332266|322566099|FG004|Phase 2|Physician Decision|1|||
94210743|NCT01332266|322566095|FG000|Phase 2|Symptomatic deterioration|0|||
94210744|NCT01332266|322566096|FG001|Phase 2|Symptomatic deterioration|0|||
94210745|NCT01332266|322566097|FG002|Phase 2|Symptomatic deterioration|0|||
94210746|NCT01332266|322566098|FG003|Phase 2|Symptomatic deterioration|0|||
94210747|NCT01332266|322566099|FG004|Phase 2|Symptomatic deterioration|1|||
94210748|NCT01332266|322566095|FG000|Phase 2|Progression Disease|0|||
94210749|NCT01332266|322566096|FG001|Phase 2|Progression Disease|0|||
94210750|NCT01332266|322566097|FG002|Phase 2|Progression Disease|0|||
94210751|NCT01332266|322566098|FG003|Phase 2|Progression Disease|2|||
94210752|NCT01332266|322566099|FG004|Phase 2|Progression Disease|1|||
94210753|NCT01332266|322566095|FG000|Phase 2|Withdrawal by Subject|0|||
94210754|NCT01332266|322566096|FG001|Phase 2|Withdrawal by Subject|0|||
94210755|NCT01332266|322566097|FG002|Phase 2|Withdrawal by Subject|0|||
94210756|NCT01332266|322566098|FG003|Phase 2|Withdrawal by Subject|2|||
94210757|NCT01332266|322566099|FG004|Phase 2|Withdrawal by Subject|2|||
94210758|NCT00273052|322566110|FG000|Overall Study|Withdrawal by Subject|16|||
94210759|NCT00273052|322566111|FG001|Overall Study|Withdrawal by Subject|19|||
94210760|NCT00273052|322566110|FG000|Overall Study|Adverse Event|21|||
94210761|NCT00273052|322566111|FG001|Overall Study|Adverse Event|19|||
94210762|NCT00273052|322566110|FG000|Overall Study|Protocol Violation|14|||
94210763|NCT00273052|322566111|FG001|Overall Study|Protocol Violation|18|||
94210764|NCT00273052|322566110|FG000|Overall Study|Lost to Follow-up|7|||
94210765|NCT00273052|322566111|FG001|Overall Study|Lost to Follow-up|25|||
94210766|NCT00273052|322566110|FG000|Overall Study|Lack of Efficacy|6|||
94210767|NCT00273052|322566111|FG001|Overall Study|Lack of Efficacy|4|||
94210768|NCT00273052|322566110|FG000|Overall Study|Non-Compliance|3|||
94210769|NCT00273052|322566111|FG001|Overall Study|Non-Compliance|1|||
94210770|NCT00273052|322566110|FG000|Overall Study|Other|2|||
94210771|NCT00273052|322566111|FG001|Overall Study|Other|0|||
94210772|NCT00273052|322566110|FG000|Overall Study|Worsening serum lipid levels|0|||
94210773|NCT00273052|322566111|FG001|Overall Study|Worsening serum lipid levels|2|||
94210774|NCT00454194|322566113|FG000|Overall Study|Adverse Event|7|||
94210775|NCT00454194|322566114|FG001|Overall Study|Adverse Event|2|||
94210776|NCT00454194|322566113|FG000|Overall Study|Withdrawal by Subject|12|||
94210777|NCT00454194|322566114|FG001|Overall Study|Withdrawal by Subject|8|||
94210778|NCT00454194|322566113|FG000|Overall Study|Other Medical Problems|1|||
94210779|NCT00454194|322566114|FG001|Overall Study|Other Medical Problems|2|||
94210780|NCT00454194|322566113|FG000|Overall Study|Other Unspecified Reason|2|||
94372311|NCT01872689|323150241|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
94210781|NCT00454194|322566114|FG001|Overall Study|Other Unspecified Reason|2|||
94210782|NCT03345979|322566115|FG000|Overall Study|Withdrawal by Subject|20|||
94210783|NCT03345979|322566116|FG001|Overall Study|Withdrawal by Subject|31|||
94210784|NCT03345979|322566115|FG000|Overall Study|Adverse Event|10|||
94210785|NCT03345979|322566116|FG001|Overall Study|Adverse Event|11|||
94210786|NCT03345979|322566115|FG000|Overall Study|Lost to Follow-up|8|||
94210787|NCT03345979|322566116|FG001|Overall Study|Lost to Follow-up|9|||
94210788|NCT03345979|322566115|FG000|Overall Study|Lack of Efficacy|4|||
94372312|NCT01872689|323150242|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
94210789|NCT03345979|322566116|FG001|Overall Study|Lack of Efficacy|2|||
94210790|NCT03345979|322566115|FG000|Overall Study|Protocol Violation|1|||
94467740|NCT00412217|323502379|FG000|Overall Study|Withdrawal by Subject|2|||
94467741|NCT00412217|323502380|FG001|Overall Study|Withdrawal by Subject|0|||
94210791|NCT03345979|322566116|FG001|Overall Study|Protocol Violation|3|||
94210792|NCT03345979|322566115|FG000|Overall Study|Physician Decision|0|||
94210793|NCT03345979|322566116|FG001|Overall Study|Physician Decision|2|||
94210794|NCT01530334|322566117|FG000|Overall Study|Adverse Event|3|||
94467742|NCT00412217|323502379|FG000|Overall Study|Lost to Follow-up|1|||
94284327|NCT03529773|322829262|FG002|Overall Study|Withdrawal by Subject|0|||
94284328|NCT03529773|322829263|FG003|Overall Study|Withdrawal by Subject|0|||
94284329|NCT03529773|322829264|FG004|Overall Study|Withdrawal by Subject|0|||
94284330|NCT03529773|322829265|FG005|Overall Study|Withdrawal by Subject|0|||
94284331|NCT03529773|322829266|FG006|Overall Study|Withdrawal by Subject|0|||
94284332|NCT03529773|322829267|FG007|Overall Study|Withdrawal by Subject|1|||
94284333|NCT03529773|322829268|FG008|Overall Study|Withdrawal by Subject|0|||
94210795|NCT01530334|322566117|FG000|Overall Study|unknown reason|1|||
94210796|NCT01530334|322566117|FG000|Overall Study|Progressive disease|47|||
94210797|NCT03781375|322566118|FG000|Double-blind Phase|Adverse Event|0|||
94210798|NCT03781375|322566119|FG001|Double-blind Phase|Adverse Event|1|||
94210799|NCT03781375|322566118|FG000|Double-blind Phase|Lack of Response|6|||
94210800|NCT03781375|322566119|FG001|Double-blind Phase|Lack of Response|2|||
94210801|NCT03781375|322566118|FG000|Double-blind Phase|Other|1|||
94210802|NCT03781375|322566119|FG001|Double-blind Phase|Other|3|||
94210803|NCT03781375|322566118|FG000|Open-label Phase|Protocol Issues|0|||
94210804|NCT03781375|322566119|FG001|Open-label Phase|Protocol Issues|1|||
94210805|NCT03781375|322566118|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
94210806|NCT03781375|322566119|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
94210807|NCT03781375|322566118|FG000|Open-label Phase|Other|2|||
94210808|NCT03781375|322566119|FG001|Open-label Phase|Other|2|||
94210809|NCT01584648|322566122|FG000|Overall Study|Death|136|||
94210810|NCT01584648|322566123|FG001|Overall Study|Death|146|||
94210811|NCT01584648|322566122|FG000|Overall Study|Lost to Follow-up|9|||
94210812|NCT01584648|322566123|FG001|Overall Study|Lost to Follow-up|9|||
94210813|NCT01584648|322566122|FG000|Overall Study|Investigator discretion|3|||
94210814|NCT01584648|322566123|FG001|Overall Study|Investigator discretion|2|||
94210815|NCT01584648|322566122|FG000|Overall Study|Withdrew consent|13|||
94210816|NCT01584648|322566123|FG001|Overall Study|Withdrew consent|4|||
94210817|NCT01584648|322566122|FG000|Overall Study|Study closed/terminated|50|||
94210818|NCT01584648|322566123|FG001|Overall Study|Study closed/terminated|23|||
94210819|NCT01584648|322566122|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
94210820|NCT01584648|322566123|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
94210821|NCT03162614|322566124|FG000|Overall Study|Lost to Follow-up|2|||
94210822|NCT03162614|322566125|FG001|Overall Study|Lost to Follow-up|1|||
94210823|NCT03162614|322566126|FG002|Overall Study|Lost to Follow-up|1|||
94210824|NCT03162614|322566127|FG003|Overall Study|Lost to Follow-up|1|||
94210825|NCT03162614|322566128|FG004|Overall Study|Lost to Follow-up|2|||
94210826|NCT03162614|322566129|FG005|Overall Study|Lost to Follow-up|0|||
94210827|NCT03162614|322566124|FG000|Overall Study|Protocol Violation|0|||
94210828|NCT03162614|322566125|FG001|Overall Study|Protocol Violation|1|||
94210829|NCT03162614|322566126|FG002|Overall Study|Protocol Violation|0|||
94210830|NCT03162614|322566127|FG003|Overall Study|Protocol Violation|1|||
94210831|NCT03162614|322566128|FG004|Overall Study|Protocol Violation|0|||
94210832|NCT03162614|322566129|FG005|Overall Study|Protocol Violation|0|||
94210833|NCT03162614|322566124|FG000|Overall Study|Withdrawal by Subject|2|||
94210834|NCT03162614|322566125|FG001|Overall Study|Withdrawal by Subject|1|||
94210835|NCT03162614|322566126|FG002|Overall Study|Withdrawal by Subject|1|||
94210836|NCT03162614|322566127|FG003|Overall Study|Withdrawal by Subject|1|||
94210837|NCT03162614|322566128|FG004|Overall Study|Withdrawal by Subject|0|||
94210838|NCT03162614|322566129|FG005|Overall Study|Withdrawal by Subject|0|||
94210839|NCT03162614|322566124|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
94210840|NCT03162614|322566125|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
94210841|NCT03162614|322566126|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
94210842|NCT03162614|322566127|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
94210843|NCT03162614|322566128|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
94210844|NCT03162614|322566129|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
94210845|NCT03035942|322566134|FG000|Overall Study|Adverse Event|8|||
94210846|NCT03035942|322566135|FG001|Overall Study|Adverse Event|4|||
94210847|NCT03035942|322566136|FG002|Overall Study|Adverse Event|5|||
94284334|NCT03529773|322829269|FG009|Overall Study|Withdrawal by Subject|1|||
94284335|NCT03529773|322829270|FG010|Overall Study|Withdrawal by Subject|1|||
94284336|NCT03529773|322829271|FG011|Overall Study|Withdrawal by Subject|0|||
94467743|NCT00412217|323502380|FG001|Overall Study|Lost to Follow-up|4|||
94210848|NCT00380250|322566137|FG000|Overall Study|Withdrawal by Subject|39|||
94210849|NCT00380250|322566138|FG001|Overall Study|Withdrawal by Subject|28|||
94210850|NCT00380250|322566137|FG000|Overall Study|Adverse Event|20|||
94210851|NCT00380250|322566138|FG001|Overall Study|Adverse Event|9|||
94210852|NCT00380250|322566137|FG000|Overall Study|Lack of Efficacy|10|||
94210853|NCT00380250|322566138|FG001|Overall Study|Lack of Efficacy|8|||
94210854|NCT00380250|322566137|FG000|Overall Study|Protocol Violation|15|||
94284337|NCT03529773|322829272|FG012|Overall Study|Withdrawal by Subject|0|||
94467744|NCT00412217|323502379|FG000|Overall Study|Study Terminated by Sponsor|26|||
94284338|NCT03529773|322829273|FG013|Overall Study|Withdrawal by Subject|0|||
94210855|NCT00380250|322566138|FG001|Overall Study|Protocol Violation|5|||
94210856|NCT00380250|322566137|FG000|Overall Study|Lost to Follow-up|14|||
94284339|NCT03529773|322829274|FG014|Overall Study|Withdrawal by Subject|0|||
94210857|NCT00380250|322566138|FG001|Overall Study|Lost to Follow-up|5|||
94210858|NCT00380250|322566137|FG000|Overall Study|Physician Decision|1|||
94210859|NCT00380250|322566138|FG001|Overall Study|Physician Decision|0|||
94210860|NCT02091752|322566139|FG000|Overall Study|Study terminated by Sponsor|2|||
94210861|NCT02091752|322566139|FG000|Overall Study|Adverse Event|1|||
94210862|NCT03288506|322566140|FG000|Overall Study|Withdrawal by Subject|52|||
94210863|NCT03692871|322566142|FG000|Overall Study|Death|1|||
94210864|NCT03692871|322566143|FG001|Overall Study|Death|1|||
94284340|NCT03529773|322829275|FG015|Overall Study|Withdrawal by Subject|3|||
94284341|NCT03529773|322829276|FG016|Overall Study|Withdrawal by Subject|0|||
94284342|NCT03529773|322829277|FG017|Overall Study|Withdrawal by Subject|2|||
94284343|NCT03529773|322829278|FG018|Overall Study|Withdrawal by Subject|3|||
94284344|NCT03529773|322829279|FG019|Overall Study|Withdrawal by Subject|1|||
94284345|NCT03529773|322829280|FG020|Overall Study|Withdrawal by Subject|3|||
94284346|NCT03529773|322829281|FG021|Overall Study|Withdrawal by Subject|1|||
94284347|NCT03529773|322829282|FG022|Overall Study|Withdrawal by Subject|1|||
94284348|NCT03529773|322829283|FG023|Overall Study|Withdrawal by Subject|2|||
94284349|NCT03529773|322829284|FG024|Overall Study|Withdrawal by Subject|2|||
94467745|NCT00412217|323502380|FG001|Overall Study|Study Terminated by Sponsor|33|||
94284350|NCT03529773|322829285|FG025|Overall Study|Withdrawal by Subject|4|||
94284351|NCT03529773|322829286|FG026|Overall Study|Withdrawal by Subject|2|||
94284352|NCT03529773|322829287|FG027|Overall Study|Withdrawal by Subject|1|||
94284353|NCT03529773|322829288|FG028|Overall Study|Withdrawal by Subject|1|||
94210865|NCT03692871|322566142|FG000|Overall Study|Lost to Follow-up|24|||
94210866|NCT03692871|322566143|FG001|Overall Study|Lost to Follow-up|9|||
94210867|NCT03692871|322566142|FG000|Overall Study|Physician Decision|22|||
94210868|NCT03692871|322566143|FG001|Overall Study|Physician Decision|7|||
94210869|NCT03692871|322566142|FG000|Overall Study|Protocol Deviation|1|||
94210870|NCT03692871|322566143|FG001|Overall Study|Protocol Deviation|0|||
94210871|NCT03692871|322566142|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
94210872|NCT03692871|322566143|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
94210873|NCT02644122|322566147|FG000|Overall Study|Withdrawal by Subject|1|||
94210874|NCT02159352|322566150|FG000|Overall Study|Adverse Event|3|||
94210875|NCT02159352|322566151|FG001|Overall Study|Adverse Event|1|||
94210876|NCT02159352|322566150|FG000|Overall Study|Withdrawal by Subject|0|||
94210877|NCT02159352|322566151|FG001|Overall Study|Withdrawal by Subject|1|||
94210878|NCT01604824|322566152|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
94210879|NCT01604824|322566153|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
94210880|NCT01604824|322566154|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
94210881|NCT01604824|322566155|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
94210882|NCT01604824|322566156|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
94210883|NCT01604824|322566157|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
94210884|NCT01604824|322566152|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
94210885|NCT01604824|322566153|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
94210886|NCT01604824|322566154|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
94210887|NCT01604824|322566155|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
94210888|NCT01604824|322566156|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
94210889|NCT01604824|322566157|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
94210890|NCT01801007|322566158|FG000|Overall Study|Adverse Event|2|||
94210891|NCT01801007|322566158|FG000|Overall Study|Lost to Follow-up|4|||
94210892|NCT01801007|322566158|FG000|Overall Study|Withdrawal by Subject|5|||
94210893|NCT05484661|322566159|FG000|Overall Study|Withdrawal by Subject|1|||
94210894|NCT05484661|322566160|FG001|Overall Study|Withdrawal by Subject|0|||
94210895|NCT00875706|322566168|FG000|Overall Study|Withdrawal by Subject|1|||
94210896|NCT00875706|322566169|FG001|Overall Study|Withdrawal by Subject|0|||
94210897|NCT00875706|322566170|FG002|Overall Study|Withdrawal by Subject|0|||
94210898|NCT01856569|322566171|FG000|Overall Study|Other|1|||
94210899|NCT01856569|322566171|FG000|Overall Study|Changed Site/Structure|1|||
94210900|NCT01856569|322566171|FG000|Overall Study|Lost to Follow-up|3|||
94210901|NCT01856569|322566171|FG000|Overall Study|Did not met inclusion criteria|8|||
94210902|NCT03775213|322566172|FG000|Overall Study|Withdrawal by Subject|51|||
94210903|NCT03775213|322566173|FG001|Overall Study|Withdrawal by Subject|53|||
94210904|NCT03775213|322566172|FG000|Overall Study|Incomplete Survey|7|||
94210905|NCT03775213|322566173|FG001|Overall Study|Incomplete Survey|7|||
94210906|NCT01860079|322566175|FG000|Overall Study|Physician Decision|14|||
94210907|NCT01860079|322566176|FG001|Overall Study|Physician Decision|22|||
94210908|NCT00326183|322566177|FG000|Overall Study|Lost to Follow-up|104|||
94210909|NCT00326183|322566178|FG001|Overall Study|Lost to Follow-up|56|||
94210910|NCT00326183|322566177|FG000|Overall Study|Protocol Violation|6|||
94210911|NCT00326183|322566178|FG001|Overall Study|Protocol Violation|3|||
94210912|NCT00326183|322566177|FG000|Overall Study|Withdrawal by Subject|35|||
94210913|NCT00326183|322566178|FG001|Overall Study|Withdrawal by Subject|7|||
94210914|NCT00326183|322566177|FG000|Overall Study|Subject Moved|7|||
94210915|NCT00326183|322566178|FG001|Overall Study|Subject Moved|4|||
94210916|NCT00326183|322566177|FG000|Overall Study|Other|47|||
94210917|NCT00326183|322566178|FG001|Overall Study|Other|13|||
94210918|NCT00326183|322566177|FG000|Overall Study|Adverse Event|1|||
94210919|NCT00326183|322566178|FG001|Overall Study|Adverse Event|0|||
94210920|NCT00824408|322566179|FG000|Run-in Phase|Progressive disease|4|||
94210921|NCT00824408|322566180|FG001|Run-in Phase|Progressive disease|4|||
94210922|NCT00824408|322566181|FG002|Run-in Phase|Progressive disease|0|||
94210923|NCT00824408|322566182|FG003|Run-in Phase|Progressive disease|0|||
94210924|NCT00824408|322566183|FG004|Run-in Phase|Progressive disease|0|||
94210925|NCT00824408|322566179|FG000|Run-in Phase|Adverse Event|1|||
94210926|NCT00824408|322566180|FG001|Run-in Phase|Adverse Event|1|||
94210927|NCT00824408|322566181|FG002|Run-in Phase|Adverse Event|0|||
94210928|NCT00824408|322566182|FG003|Run-in Phase|Adverse Event|0|||
94210929|NCT00824408|322566183|FG004|Run-in Phase|Adverse Event|0|||
94210930|NCT00824408|322566179|FG000|Run-in Phase|Refused to continue medication|1|||
94210931|NCT00824408|322566180|FG001|Run-in Phase|Refused to continue medication|0|||
94210932|NCT00824408|322566181|FG002|Run-in Phase|Refused to continue medication|0|||
94210933|NCT00824408|322566182|FG003|Run-in Phase|Refused to continue medication|0|||
94210934|NCT00824408|322566183|FG004|Run-in Phase|Refused to continue medication|0|||
94210935|NCT00824408|322566179|FG000|Run-in Phase|Other reason not defined above|0|||
94210936|NCT00824408|322566180|FG001|Run-in Phase|Other reason not defined above|1|||
94210937|NCT00824408|322566181|FG002|Run-in Phase|Other reason not defined above|0|||
94210938|NCT00824408|322566182|FG003|Run-in Phase|Other reason not defined above|0|||
94210939|NCT00824408|322566183|FG004|Run-in Phase|Other reason not defined above|0|||
94210940|NCT00824408|322566179|FG000|Randomized Phase|Not treated|0|||
94284354|NCT03529773|322829289|FG029|Overall Study|Withdrawal by Subject|0|||
94284355|NCT03529773|322829290|FG030|Overall Study|Withdrawal by Subject|0|||
94284356|NCT03529773|322829291|FG031|Overall Study|Withdrawal by Subject|0|||
94284357|NCT03529773|322829292|FG032|Overall Study|Withdrawal by Subject|0|||
94284358|NCT03529773|322829293|FG033|Overall Study|Withdrawal by Subject|0|||
94284359|NCT03529773|322829294|FG034|Overall Study|Withdrawal by Subject|1|||
94284360|NCT03529773|322829295|FG035|Overall Study|Withdrawal by Subject|2|||
94284361|NCT03529773|322829296|FG036|Overall Study|Withdrawal by Subject|0|||
94284362|NCT03529773|322829297|FG037|Overall Study|Withdrawal by Subject|2|||
94284363|NCT03529773|322829298|FG038|Overall Study|Withdrawal by Subject|1|||
94284364|NCT03529773|322829299|FG039|Overall Study|Withdrawal by Subject|1|||
94284365|NCT03529773|322829260|FG000|Overall Study|Screen Failure|0|||
94284366|NCT03529773|322829261|FG001|Overall Study|Screen Failure|0|||
94284367|NCT03529773|322829262|FG002|Overall Study|Screen Failure|0|||
94284368|NCT03529773|322829263|FG003|Overall Study|Screen Failure|0|||
94284369|NCT03529773|322829264|FG004|Overall Study|Screen Failure|0|||
94284370|NCT03529773|322829265|FG005|Overall Study|Screen Failure|0|||
94284371|NCT03529773|322829266|FG006|Overall Study|Screen Failure|0|||
94284372|NCT03529773|322829267|FG007|Overall Study|Screen Failure|0|||
94284373|NCT03529773|322829268|FG008|Overall Study|Screen Failure|0|||
94284374|NCT03529773|322829269|FG009|Overall Study|Screen Failure|0|||
94284375|NCT03529773|322829270|FG010|Overall Study|Screen Failure|0|||
94284376|NCT03529773|322829271|FG011|Overall Study|Screen Failure|0|||
94284377|NCT03529773|322829272|FG012|Overall Study|Screen Failure|0|||
94284378|NCT03529773|322829273|FG013|Overall Study|Screen Failure|0|||
94284379|NCT03529773|322829274|FG014|Overall Study|Screen Failure|0|||
94284380|NCT03529773|322829275|FG015|Overall Study|Screen Failure|0|||
94284381|NCT03529773|322829276|FG016|Overall Study|Screen Failure|0|||
94284382|NCT03529773|322829277|FG017|Overall Study|Screen Failure|0|||
94284383|NCT03529773|322829278|FG018|Overall Study|Screen Failure|0|||
94284384|NCT03529773|322829279|FG019|Overall Study|Screen Failure|0|||
94284385|NCT03529773|322829280|FG020|Overall Study|Screen Failure|0|||
94284386|NCT03529773|322829281|FG021|Overall Study|Screen Failure|0|||
94210941|NCT00824408|322566180|FG001|Randomized Phase|Not treated|0|||
94210942|NCT00824408|322566181|FG002|Randomized Phase|Not treated|1|||
94210943|NCT00824408|322566182|FG003|Randomized Phase|Not treated|1|||
94210944|NCT00824408|322566183|FG004|Randomized Phase|Not treated|1|||
94210945|NCT00824408|322566179|FG000|Randomized Phase|Progressive disease|0|||
94210946|NCT00824408|322566180|FG001|Randomized Phase|Progressive disease|0|||
94210947|NCT00824408|322566181|FG002|Randomized Phase|Progressive disease|25|||
94210948|NCT00824408|322566182|FG003|Randomized Phase|Progressive disease|36|||
94210949|NCT00824408|322566183|FG004|Randomized Phase|Progressive disease|34|||
94210950|NCT00824408|322566179|FG000|Randomized Phase|Adverse Event|0|||
94210951|NCT00824408|322566180|FG001|Randomized Phase|Adverse Event|0|||
94210952|NCT00824408|322566181|FG002|Randomized Phase|Adverse Event|4|||
94284387|NCT03529773|322829282|FG022|Overall Study|Screen Failure|0|||
94284388|NCT03529773|322829283|FG023|Overall Study|Screen Failure|0|||
94210953|NCT00824408|322566182|FG003|Randomized Phase|Adverse Event|5|||
94210954|NCT00824408|322566183|FG004|Randomized Phase|Adverse Event|5|||
94210955|NCT00824408|322566179|FG000|Randomized Phase|Refused to continue medication|0|||
94210956|NCT00824408|322566180|FG001|Randomized Phase|Refused to continue medication|0|||
94210957|NCT00824408|322566181|FG002|Randomized Phase|Refused to continue medication|2|||
94210958|NCT00824408|322566182|FG003|Randomized Phase|Refused to continue medication|2|||
94210959|NCT00824408|322566183|FG004|Randomized Phase|Refused to continue medication|2|||
94210960|NCT00824408|322566179|FG000|Randomized Phase|Other reason not defined above|0|||
94210961|NCT00824408|322566180|FG001|Randomized Phase|Other reason not defined above|0|||
94210962|NCT00824408|322566181|FG002|Randomized Phase|Other reason not defined above|4|||
94210963|NCT00824408|322566182|FG003|Randomized Phase|Other reason not defined above|2|||
94210964|NCT00824408|322566183|FG004|Randomized Phase|Other reason not defined above|4|||
94210965|NCT05445557|322566184|FG000|Double Blind Part|Lost to Follow-up|1|||
94210966|NCT03803475|322566185|FG000|Overall Study|Physician Decision|1|||
94210967|NCT02203032|322566189|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
94210968|NCT02203032|322566190|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
94210969|NCT02203032|322566191|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
94210970|NCT02203032|322566192|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
94210971|NCT02203032|322566189|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
94210972|NCT02203032|322566190|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
94210973|NCT02203032|322566191|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
94210974|NCT02203032|322566192|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
94210975|NCT02203032|322566189|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
94210976|NCT02203032|322566190|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
94210977|NCT02203032|322566191|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
94210978|NCT02203032|322566192|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
94210979|NCT02203032|322566189|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
94210980|NCT02203032|322566190|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
94210981|NCT02203032|322566191|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
94210982|NCT02203032|322566192|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
94210983|NCT02203032|322566189|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
94210984|NCT02203032|322566190|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
94210985|NCT02203032|322566191|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
94210986|NCT02203032|322566192|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
94210987|NCT02203032|322566189|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
94210988|NCT02203032|322566190|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
94210989|NCT02203032|322566191|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
94210990|NCT02203032|322566192|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
94210991|NCT02203032|322566189|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
94210992|NCT02203032|322566190|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
94210993|NCT02203032|322566191|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
94210994|NCT02203032|322566192|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
94210995|NCT02203032|322566189|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
94210996|NCT02203032|322566190|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
94210997|NCT02203032|322566191|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
94210998|NCT02203032|322566192|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
94210999|NCT02203032|322566189|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
94211000|NCT02203032|322566190|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
94211001|NCT02203032|322566191|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
94211002|NCT02203032|322566192|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
94211003|NCT02203032|322566189|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
94284389|NCT03529773|322829284|FG024|Overall Study|Screen Failure|0|||
94284390|NCT03529773|322829285|FG025|Overall Study|Screen Failure|0|||
94284391|NCT03529773|322829286|FG026|Overall Study|Screen Failure|0|||
94284392|NCT03529773|322829287|FG027|Overall Study|Screen Failure|0|||
94284393|NCT03529773|322829288|FG028|Overall Study|Screen Failure|0|||
94284394|NCT03529773|322829289|FG029|Overall Study|Screen Failure|0|||
94284395|NCT03529773|322829290|FG030|Overall Study|Screen Failure|0|||
94284396|NCT03529773|322829291|FG031|Overall Study|Screen Failure|0|||
94284397|NCT03529773|322829292|FG032|Overall Study|Screen Failure|0|||
94284398|NCT03529773|322829293|FG033|Overall Study|Screen Failure|0|||
94211004|NCT02203032|322566190|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
94211005|NCT02203032|322566191|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
94211006|NCT02203032|322566192|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
94211007|NCT02203032|322566189|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
94284399|NCT03529773|322829294|FG034|Overall Study|Screen Failure|0|||
94284400|NCT03529773|322829295|FG035|Overall Study|Screen Failure|0|||
94284401|NCT03529773|322829296|FG036|Overall Study|Screen Failure|1|||
94284402|NCT03529773|322829297|FG037|Overall Study|Screen Failure|1|||
94284403|NCT03529773|322829298|FG038|Overall Study|Screen Failure|0|||
94467746|NCT00412217|323502379|FG000|Overall Study|Other|1|||
94211008|NCT02203032|322566190|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
94211009|NCT02203032|322566191|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
94211010|NCT02203032|322566192|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
94211011|NCT02203032|322566189|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
94211012|NCT02203032|322566190|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
94211013|NCT02203032|322566191|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
94211014|NCT02203032|322566192|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
94211015|NCT03055988|322566193|FG000|Period 1|Adverse Event|0|||
94211016|NCT03055988|322566194|FG001|Period 1|Adverse Event|1|||
94211017|NCT03055988|322566193|FG000|Period 1|Lost to Follow-up|1|||
94211018|NCT03055988|322566194|FG001|Period 1|Lost to Follow-up|0|||
94211019|NCT03055988|322566193|FG000|Period 1|Withdrawal by Subject|0|||
94211020|NCT03055988|322566194|FG001|Period 1|Withdrawal by Subject|4|||
94211021|NCT03055988|322566193|FG000|Period 2|Adverse Event|0|||
94211022|NCT03055988|322566194|FG001|Period 2|Adverse Event|1|||
94211023|NCT03055988|322566193|FG000|Period 2|Other than listed|1|||
94211024|NCT03055988|322566194|FG001|Period 2|Other than listed|1|||
94211025|NCT04748341|322566195|FG000|Overall Study|Lost to Follow-up|1|||
94211026|NCT04748341|322566196|FG001|Overall Study|Lost to Follow-up|1|||
94211027|NCT01915914|322566199|FG000|Acute Phase|Withdrawal by Subject|4|||
94211028|NCT01915914|322566200|FG001|Acute Phase|Withdrawal by Subject|0|||
94211029|NCT01915914|322566201|FG002|Acute Phase|Withdrawal by Subject|0|||
94211030|NCT01915914|322566202|FG003|Acute Phase|Withdrawal by Subject|0|||
94211031|NCT01915914|322566199|FG000|Acute Phase|Lost to Follow-up|4|||
94211032|NCT01915914|322566200|FG001|Acute Phase|Lost to Follow-up|0|||
94211033|NCT01915914|322566201|FG002|Acute Phase|Lost to Follow-up|0|||
94211034|NCT01915914|322566202|FG003|Acute Phase|Lost to Follow-up|0|||
94211035|NCT01915914|322566199|FG000|Acute Phase|Physician Decision|1|||
94467747|NCT00412217|323502380|FG001|Overall Study|Other|1|||
94211036|NCT01915914|322566200|FG001|Acute Phase|Physician Decision|0|||
94211037|NCT01915914|322566201|FG002|Acute Phase|Physician Decision|0|||
94211038|NCT01915914|322566202|FG003|Acute Phase|Physician Decision|0|||
94211039|NCT01915914|322566199|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
94211040|NCT01915914|322566200|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
94211041|NCT01915914|322566201|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
94211042|NCT01915914|322566202|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
94211043|NCT01915914|322566199|FG000|Acute Phase|"Not Achieved treatment success"|1|||
94211044|NCT01915914|322566200|FG001|Acute Phase|"Not Achieved treatment success"|0|||
94211045|NCT01915914|322566201|FG002|Acute Phase|"Not Achieved treatment success"|0|||
94211046|NCT01915914|322566202|FG003|Acute Phase|"Not Achieved treatment success"|0|||
94211047|NCT01915914|322566199|FG000|Acute Phase|Missing|1|||
94211048|NCT01915914|322566200|FG001|Acute Phase|Missing|0|||
94211049|NCT01915914|322566201|FG002|Acute Phase|Missing|0|||
94211050|NCT01915914|322566202|FG003|Acute Phase|Missing|0|||
94211051|NCT01915914|322566199|FG000|Maintenance Phase|Withdrawal by Subject|0|||
94211052|NCT01915914|322566200|FG001|Maintenance Phase|Withdrawal by Subject|1|||
94211053|NCT01915914|322566201|FG002|Maintenance Phase|Withdrawal by Subject|1|||
94211054|NCT01915914|322566202|FG003|Maintenance Phase|Withdrawal by Subject|0|||
94211055|NCT01915914|322566199|FG000|Maintenance Phase|Lost to Follow-up|0|||
94211056|NCT01915914|322566200|FG001|Maintenance Phase|Lost to Follow-up|4|||
94211057|NCT01915914|322566201|FG002|Maintenance Phase|Lost to Follow-up|1|||
94211058|NCT01915914|322566202|FG003|Maintenance Phase|Lost to Follow-up|0|||
94211059|NCT01915914|322566199|FG000|Maintenance Phase|Missing|0|||
94211060|NCT01915914|322566200|FG001|Maintenance Phase|Missing|1|||
94211061|NCT01915914|322566201|FG002|Maintenance Phase|Missing|0|||
94211062|NCT01915914|322566202|FG003|Maintenance Phase|Missing|0|||
94211063|NCT01915914|322566199|FG000|Follow-up Phase|Withdrawal by Subject|0|||
94211064|NCT01915914|322566200|FG001|Follow-up Phase|Withdrawal by Subject|0|||
94211065|NCT01915914|322566201|FG002|Follow-up Phase|Withdrawal by Subject|0|||
94211066|NCT01915914|322566202|FG003|Follow-up Phase|Withdrawal by Subject|1|||
94211067|NCT01915914|322566199|FG000|Follow-up Phase|Physician Decision|0|||
94211068|NCT01915914|322566200|FG001|Follow-up Phase|Physician Decision|0|||
94211069|NCT01915914|322566201|FG002|Follow-up Phase|Physician Decision|0|||
94211070|NCT01915914|322566202|FG003|Follow-up Phase|Physician Decision|1|||
94211071|NCT03246724|322566203|FG000|Overall Study|Withdrawal by Subject|5|||
94211072|NCT03246724|322566204|FG001|Overall Study|Withdrawal by Subject|2|||
94211073|NCT03246724|322566205|FG002|Overall Study|Withdrawal by Subject|4|||
94211074|NCT03246724|322566206|FG003|Overall Study|Withdrawal by Subject|2|||
94211075|NCT03246724|322566203|FG000|Overall Study|Ineligible on day of surgery|7|||
94211076|NCT03246724|322566204|FG001|Overall Study|Ineligible on day of surgery|2|||
94211077|NCT03246724|322566205|FG002|Overall Study|Ineligible on day of surgery|0|||
94211078|NCT03246724|322566206|FG003|Overall Study|Ineligible on day of surgery|3|||
94211079|NCT03246724|322566203|FG000|Overall Study|Study completed before surgical date|2|||
94211080|NCT03246724|322566204|FG001|Overall Study|Study completed before surgical date|1|||
94211081|NCT03246724|322566205|FG002|Overall Study|Study completed before surgical date|8|||
94211082|NCT03246724|322566206|FG003|Overall Study|Study completed before surgical date|1|||
94211083|NCT03246724|322566203|FG000|Overall Study|Transferred to other arm|0|||
94211084|NCT03246724|322566204|FG001|Overall Study|Transferred to other arm|0|||
94211085|NCT03246724|322566205|FG002|Overall Study|Transferred to other arm|1|||
94211086|NCT03246724|322566206|FG003|Overall Study|Transferred to other arm|0|||
94211087|NCT03246724|322566203|FG000|Overall Study|Unable to obtain medication timely|0|||
94211088|NCT03246724|322566204|FG001|Overall Study|Unable to obtain medication timely|2|||
94211089|NCT03246724|322566205|FG002|Overall Study|Unable to obtain medication timely|2|||
94211090|NCT03246724|322566206|FG003|Overall Study|Unable to obtain medication timely|1|||
94211091|NCT03246724|322566203|FG000|Overall Study|Re-consented to participate|0|||
94211092|NCT03246724|322566204|FG001|Overall Study|Re-consented to participate|0|||
94211093|NCT03246724|322566205|FG002|Overall Study|Re-consented to participate|0|||
94467748|NCT00085098|323502381|FG000|Overall Study|Withdrawal by Subject|0|||
94467749|NCT00085098|323502382|FG001|Overall Study|Withdrawal by Subject|1|||
94211094|NCT03246724|322566206|FG003|Overall Study|Re-consented to participate|1|||
94211095|NCT00116649|322566207|FG000|Overall Study|Adverse Event|20|||
94211096|NCT00116649|322566207|FG000|Overall Study|Lack of Efficacy|1|||
94211097|NCT00116649|322566207|FG000|Overall Study|Lost to Follow-up|32|||
94211098|NCT00116649|322566207|FG000|Overall Study|Withdrawal by Subject|68|||
94211099|NCT00116649|322566207|FG000|Overall Study|Local Skin Reaction|9|||
94211100|NCT00116649|322566207|FG000|Overall Study|Various Reasons|18|||
94211101|NCT00116649|322566207|FG000|Overall Study|Protocol Specified|7|||
94211102|NCT00452114|322566208|FG000|Overall Study|Physician Decision|3|||
94211103|NCT00452114|322566209|FG001|Overall Study|Physician Decision|3|||
94211104|NCT02334215|322566212|FG000|Overall Study|Death|1|||
94211105|NCT02334215|322566213|FG001|Overall Study|Death|1|||
94211106|NCT02334215|322566214|FG002|Overall Study|Death|0|||
94211107|NCT02334215|322566212|FG000|Overall Study|Lost to Follow-up|1|||
94211108|NCT02334215|322566213|FG001|Overall Study|Lost to Follow-up|0|||
94211109|NCT02334215|322566214|FG002|Overall Study|Lost to Follow-up|4|||
94211110|NCT02334215|322566212|FG000|Overall Study|Withdrawal by Subject|2|||
94211111|NCT02334215|322566213|FG001|Overall Study|Withdrawal by Subject|2|||
94211112|NCT02334215|322566214|FG002|Overall Study|Withdrawal by Subject|1|||
94211113|NCT02334215|322566212|FG000|Overall Study|Not released from incarceration on time|3|||
94211114|NCT02334215|322566213|FG001|Overall Study|Not released from incarceration on time|3|||
94211115|NCT02334215|322566214|FG002|Overall Study|Not released from incarceration on time|3|||
94211116|NCT02334215|322566212|FG000|Overall Study|Incarcerated|0|||
94211117|NCT02334215|322566213|FG001|Overall Study|Incarcerated|0|||
94211118|NCT02334215|322566214|FG002|Overall Study|Incarcerated|7|||
94211119|NCT00089609|322567484|FG000|Overall Study|Withdrawal by Subject|3|||
94211120|NCT00089609|322567485|FG001|Overall Study|Withdrawal by Subject|1|||
94211121|NCT02637063|322567486|FG000|Overall Study|Lost to Follow-up|3|||
94211122|NCT02637063|322567487|FG001|Overall Study|Lost to Follow-up|2|||
94211123|NCT02637063|322567488|FG002|Overall Study|Lost to Follow-up|3|||
94211124|NCT02637063|322567486|FG000|Overall Study|Withdrawal by Subject|2|||
94211125|NCT02637063|322567487|FG001|Overall Study|Withdrawal by Subject|2|||
94211126|NCT02637063|322567488|FG002|Overall Study|Withdrawal by Subject|3|||
94211127|NCT03292406|322567489|FG000|Overall Study|Progressive Disease|6|||
94211128|NCT03292406|322567490|FG001|Overall Study|Progressive Disease|3|||
94211129|NCT03292406|322567491|FG002|Overall Study|Progressive Disease|4|||
94211130|NCT03292406|322567489|FG000|Overall Study|Adverse Event|7|||
94211131|NCT03292406|322567490|FG001|Overall Study|Adverse Event|1|||
94211132|NCT03292406|322567491|FG002|Overall Study|Adverse Event|4|||
94211133|NCT03292406|322567489|FG000|Overall Study|Withdrawal by Subject|0|||
94211134|NCT03292406|322567490|FG001|Overall Study|Withdrawal by Subject|7|||
94211135|NCT03292406|322567491|FG002|Overall Study|Withdrawal by Subject|2|||
94211136|NCT03292406|322567489|FG000|Overall Study|Protocol Violation|0|||
94211137|NCT03292406|322567490|FG001|Overall Study|Protocol Violation|1|||
94211138|NCT03292406|322567491|FG002|Overall Study|Protocol Violation|1|||
94211139|NCT03292406|322567489|FG000|Overall Study|Other|0|||
94211140|NCT03292406|322567490|FG001|Overall Study|Other|1|||
94211141|NCT03292406|322567491|FG002|Overall Study|Other|2|||
94211142|NCT01205126|322567498|FG000|Titration Phase|Adverse Event|5|||
94211143|NCT01205126|322567499|FG001|Titration Phase|Adverse Event|3|||
94211144|NCT01205126|322567498|FG000|Titration Phase|Withdrawal by Subject|5|||
94211145|NCT01205126|322567499|FG001|Titration Phase|Withdrawal by Subject|5|||
94211146|NCT01205126|322567498|FG000|Titration Phase|Lost to Follow-up|2|||
94211147|NCT01205126|322567499|FG001|Titration Phase|Lost to Follow-up|2|||
94211148|NCT01205126|322567498|FG000|Titration Phase|No stable titration dose|1|||
94211149|NCT01205126|322567499|FG001|Titration Phase|No stable titration dose|0|||
94211150|NCT01205126|322567498|FG000|Titration Phase|More than maximum dosage required|2|||
94211151|NCT01205126|322567499|FG001|Titration Phase|More than maximum dosage required|3|||
94211152|NCT01205126|322567498|FG000|Titration Phase|Other|8|||
94211153|NCT01205126|322567499|FG001|Titration Phase|Other|6|||
94211154|NCT01205126|322567498|FG000|Between Titration & Maintenance Phase|Other|0|||
94211155|NCT01205126|322567499|FG001|Between Titration & Maintenance Phase|Other|4|||
94211156|NCT01205126|322567498|FG000|Maintenance Phase|Adverse Event|3|||
94211157|NCT01205126|322567499|FG001|Maintenance Phase|Adverse Event|7|||
94211158|NCT01205126|322567498|FG000|Maintenance Phase|Death|4|||
94211159|NCT01205126|322567499|FG001|Maintenance Phase|Death|4|||
94211160|NCT01205126|322567498|FG000|Maintenance Phase|More than the maximum dosage required|5|||
94211161|NCT01205126|322567499|FG001|Maintenance Phase|More than the maximum dosage required|5|||
94211162|NCT01205126|322567498|FG000|Maintenance Phase|Prohibited drugs used|1|||
94211163|NCT01205126|322567499|FG001|Maintenance Phase|Prohibited drugs used|0|||
94211164|NCT01205126|322567498|FG000|Maintenance Phase|Other|11|||
94211165|NCT01205126|322567499|FG001|Maintenance Phase|Other|8|||
94211166|NCT01205126|322567498|FG000|Maintenance Phase|Lost to Follow-up|5|||
94211167|NCT01205126|322567499|FG001|Maintenance Phase|Lost to Follow-up|5|||
94211168|NCT01205126|322567498|FG000|Maintenance Phase|Withdrawal by Subject|8|||
94211169|NCT01205126|322567499|FG001|Maintenance Phase|Withdrawal by Subject|11|||
94211170|NCT01021748|322567501|FG000|Overall Study|Adverse Event|2|||
94211171|NCT01021748|322567502|FG001|Overall Study|Adverse Event|1|||
94211172|NCT01021748|322567503|FG002|Overall Study|Adverse Event|2|||
94211173|NCT01021748|322567504|FG003|Overall Study|Adverse Event|0|||
94211174|NCT01021748|322567505|FG004|Overall Study|Adverse Event|2|||
94211175|NCT01021748|322567506|FG005|Overall Study|Adverse Event|0|||
94211176|NCT01021748|322567507|FG006|Overall Study|Adverse Event|1|||
94211177|NCT01021748|322567508|FG007|Overall Study|Adverse Event|0|||
94211178|NCT01021748|322567509|FG008|Overall Study|Adverse Event|7|||
94211179|NCT01021748|322567501|FG000|Overall Study|Physician Decision|1|||
94211180|NCT01021748|322567502|FG001|Overall Study|Physician Decision|0|||
94211181|NCT01021748|322567503|FG002|Overall Study|Physician Decision|1|||
94211182|NCT01021748|322567504|FG003|Overall Study|Physician Decision|1|||
94211183|NCT01021748|322567505|FG004|Overall Study|Physician Decision|0|||
94211184|NCT01021748|322567506|FG005|Overall Study|Physician Decision|0|||
94211185|NCT01021748|322567507|FG006|Overall Study|Physician Decision|1|||
94211186|NCT01021748|322567508|FG007|Overall Study|Physician Decision|1|||
94211187|NCT01021748|322567509|FG008|Overall Study|Physician Decision|2|||
94211188|NCT01021748|322567501|FG000|Overall Study|Progressive Disease|3|||
94211189|NCT01021748|322567502|FG001|Overall Study|Progressive Disease|3|||
94211190|NCT01021748|322567503|FG002|Overall Study|Progressive Disease|4|||
94211191|NCT01021748|322567504|FG003|Overall Study|Progressive Disease|6|||
94211192|NCT01021748|322567505|FG004|Overall Study|Progressive Disease|7|||
94211193|NCT01021748|322567506|FG005|Overall Study|Progressive Disease|3|||
94211194|NCT01021748|322567507|FG006|Overall Study|Progressive Disease|0|||
94211195|NCT01021748|322567508|FG007|Overall Study|Progressive Disease|5|||
94211196|NCT01021748|322567509|FG008|Overall Study|Progressive Disease|6|||
94211197|NCT01021748|322567501|FG000|Overall Study|Withdrawal by Subject|0|||
94211198|NCT01021748|322567502|FG001|Overall Study|Withdrawal by Subject|0|||
94211199|NCT01021748|322567503|FG002|Overall Study|Withdrawal by Subject|0|||
94211200|NCT01021748|322567504|FG003|Overall Study|Withdrawal by Subject|0|||
94211201|NCT01021748|322567505|FG004|Overall Study|Withdrawal by Subject|0|||
94211202|NCT01021748|322567506|FG005|Overall Study|Withdrawal by Subject|0|||
94211203|NCT01021748|322567507|FG006|Overall Study|Withdrawal by Subject|1|||
94211204|NCT01021748|322567508|FG007|Overall Study|Withdrawal by Subject|0|||
94211205|NCT01021748|322567509|FG008|Overall Study|Withdrawal by Subject|1|||
94211206|NCT01021748|322567501|FG000|Overall Study|Not Treated|0|||
94211207|NCT01021748|322567502|FG001|Overall Study|Not Treated|1|||
94211208|NCT01021748|322567503|FG002|Overall Study|Not Treated|0|||
94211209|NCT01021748|322567504|FG003|Overall Study|Not Treated|0|||
94211210|NCT01021748|322567505|FG004|Overall Study|Not Treated|0|||
94211211|NCT01021748|322567506|FG005|Overall Study|Not Treated|0|||
94211212|NCT01021748|322567507|FG006|Overall Study|Not Treated|0|||
94211213|NCT01021748|322567508|FG007|Overall Study|Not Treated|0|||
94211214|NCT01021748|322567509|FG008|Overall Study|Not Treated|0|||
94211215|NCT03374254|322567512|FG000|Overall Study|Death|5|||
94211216|NCT03374254|322567513|FG001|Overall Study|Death|16|||
94211217|NCT03374254|322567514|FG002|Overall Study|Death|13|||
94211218|NCT03374254|322567515|FG003|Overall Study|Death|11|||
94211219|NCT03374254|322567516|FG004|Overall Study|Death|9|||
94211220|NCT03374254|322567517|FG005|Overall Study|Death|12|||
94211221|NCT03374254|322567518|FG006|Overall Study|Death|11|||
94211222|NCT03374254|322567519|FG007|Overall Study|Death|6|||
94211223|NCT03374254|322567520|FG008|Overall Study|Death|7|||
94211224|NCT03374254|322567512|FG000|Overall Study|Lost to Follow-up|0|||
94211225|NCT03374254|322567513|FG001|Overall Study|Lost to Follow-up|0|||
94211226|NCT03374254|322567514|FG002|Overall Study|Lost to Follow-up|0|||
94211227|NCT03374254|322567515|FG003|Overall Study|Lost to Follow-up|0|||
94211228|NCT03374254|322567516|FG004|Overall Study|Lost to Follow-up|0|||
94211229|NCT03374254|322567517|FG005|Overall Study|Lost to Follow-up|0|||
94211230|NCT03374254|322567518|FG006|Overall Study|Lost to Follow-up|2|||
94211231|NCT03374254|322567519|FG007|Overall Study|Lost to Follow-up|0|||
94211232|NCT03374254|322567520|FG008|Overall Study|Lost to Follow-up|0|||
94211233|NCT03374254|322567512|FG000|Overall Study|Sponsor Decision|1|||
94211234|NCT03374254|322567513|FG001|Overall Study|Sponsor Decision|0|||
94211235|NCT03374254|322567514|FG002|Overall Study|Sponsor Decision|2|||
94211236|NCT03374254|322567515|FG003|Overall Study|Sponsor Decision|3|||
94211237|NCT03374254|322567516|FG004|Overall Study|Sponsor Decision|2|||
94211238|NCT03374254|322567517|FG005|Overall Study|Sponsor Decision|3|||
94211239|NCT03374254|322567518|FG006|Overall Study|Sponsor Decision|3|||
94211240|NCT03374254|322567519|FG007|Overall Study|Sponsor Decision|3|||
94211241|NCT03374254|322567520|FG008|Overall Study|Sponsor Decision|4|||
94211242|NCT03374254|322567512|FG000|Overall Study|Withdrawal by Subject|0|||
94211243|NCT03374254|322567513|FG001|Overall Study|Withdrawal by Subject|0|||
94211244|NCT03374254|322567514|FG002|Overall Study|Withdrawal by Subject|0|||
94211245|NCT03374254|322567515|FG003|Overall Study|Withdrawal by Subject|2|||
94211246|NCT03374254|322567516|FG004|Overall Study|Withdrawal by Subject|0|||
94211247|NCT03374254|322567517|FG005|Overall Study|Withdrawal by Subject|1|||
94211248|NCT03374254|322567518|FG006|Overall Study|Withdrawal by Subject|0|||
94211249|NCT03374254|322567519|FG007|Overall Study|Withdrawal by Subject|0|||
94211250|NCT03374254|322567520|FG008|Overall Study|Withdrawal by Subject|0|||
94211251|NCT04803734|322567521|FG000|Overall Study|Withdrawal by Subject|0|||
94211252|NCT04803734|322567522|FG001|Overall Study|Withdrawal by Subject|1|||
94211253|NCT04803734|322567521|FG000|Overall Study|Protocol Violation|0|||
94211254|NCT04803734|322567522|FG001|Overall Study|Protocol Violation|1|||
94211255|NCT02309515|322567523|FG000|Overall Study|Withdrawal by Subject|0|||
94211256|NCT02309515|322567524|FG001|Overall Study|Withdrawal by Subject|1|||
94211257|NCT00822900|322567534|FG000|Overall Study|Withdrawal by Subject|14|||
94284404|NCT03529773|322829299|FG039|Overall Study|Screen Failure|1|||
94284405|NCT03529773|322829260|FG000|Overall Study|Randomized but not vaccinated|0|||
94211258|NCT00822900|322567535|FG001|Overall Study|Withdrawal by Subject|14|||
94211259|NCT00822900|322567534|FG000|Overall Study|Lost to Follow-up|9|||
94211260|NCT00822900|322567535|FG001|Overall Study|Lost to Follow-up|9|||
94211261|NCT00822900|322567534|FG000|Overall Study|Death|83|||
94211262|NCT00822900|322567535|FG001|Overall Study|Death|69|||
94211263|NCT00822900|322567534|FG000|Overall Study|Became a ward of the state|2|||
94211264|NCT00822900|322567535|FG001|Overall Study|Became a ward of the state|1|||
94211265|NCT02095678|322567536|FG000|Overall Study|Withdrawal by Subject|0|||
94211266|NCT02095678|322567537|FG001|Overall Study|Withdrawal by Subject|1|||
94211267|NCT02095678|322567536|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
94211268|NCT02095678|322567537|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
94211269|NCT02095678|322567536|FG000|Overall Study|lesion impacted by previous treatment|1|||
94211270|NCT02095678|322567537|FG001|Overall Study|lesion impacted by previous treatment|1|||
94211271|NCT02095678|322567536|FG000|Overall Study|No Confirmed Diagnosis|0|||
94211272|NCT02095678|322567537|FG001|Overall Study|No Confirmed Diagnosis|3|||
94211273|NCT02095678|322567536|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
94211274|NCT02095678|322567537|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
94211275|NCT02095678|322567536|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
94211276|NCT02095678|322567537|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
94211277|NCT00666705|322567538|FG000|Overall Study|Withdrawal by Subject|1|||
94211278|NCT00681109|322567539|FG000|Overall Study|Lost to Follow-up|2|||
94211279|NCT00681109|322567540|FG001|Overall Study|Lost to Follow-up|6|||
94211280|NCT00681109|322567541|FG002|Overall Study|Lost to Follow-up|0|||
94211281|NCT04248868|322567542|FG000|Overall Study|Death|1|||
94211282|NCT04248868|322567542|FG000|Overall Study|Lost to Follow-up|3|||
94211283|NCT04248868|322567542|FG000|Overall Study|Protocol Violation|2|||
94211284|NCT02706483|322567543|FG000|Overall Study|Adverse Event|97|||
94211285|NCT02706483|322567543|FG000|Overall Study|Death|1|||
94211286|NCT02706483|322567543|FG000|Overall Study|Lack of Efficacy|39|||
94211287|NCT02706483|322567543|FG000|Overall Study|Lost to Follow-up|101|||
94211288|NCT02706483|322567543|FG000|Overall Study|Non-compliance with study drug|15|||
94211289|NCT02706483|322567543|FG000|Overall Study|Physician Decision|6|||
94211290|NCT02706483|322567543|FG000|Overall Study|Pregnancy|6|||
94211291|NCT02706483|322567543|FG000|Overall Study|Protocol Violation|18|||
94211292|NCT02706483|322567543|FG000|Overall Study|Withdrawal by Subject|136|||
94211293|NCT02706483|322567543|FG000|Overall Study|Non-compliance with visits|6|||
94211294|NCT02706483|322567543|FG000|Overall Study|Site closure|4|||
94211295|NCT02706483|322567543|FG000|Overall Study|Subject moved|1|||
94211296|NCT03456856|322567546|FG000|Overall Study|Lost to Follow-up|2|||
94211297|NCT03456856|322567546|FG000|Overall Study|Withdrawal by Subject|1|||
94211298|NCT02384382|322567547|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
94211299|NCT02384382|322567547|FG000|Overall Study|Death|1|||
94211300|NCT02384382|322567547|FG000|Overall Study|Adverse Event|1|||
94211301|NCT02384382|322567547|FG000|Overall Study|Disease progression|16|||
94211302|NCT02382640|322567552|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
94211303|NCT02382640|322567553|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
94211304|NCT02382640|322567554|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
94211305|NCT02382640|322567555|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
94211306|NCT01220999|322567556|FG000|Overall Study|Progressive disease|0|||
94211307|NCT01220999|322567557|FG001|Overall Study|Progressive disease|0|||
94211308|NCT01220999|322567558|FG002|Overall Study|Progressive disease|1|||
94211309|NCT01220999|322567559|FG003|Overall Study|Progressive disease|0|||
94211310|NCT01220999|322567560|FG004|Overall Study|Progressive disease|0|||
94211311|NCT01560429|322567563|FG000|Overall Study|Protocol Violation|3|||
94211312|NCT01560429|322567564|FG001|Overall Study|Protocol Violation|6|||
94211313|NCT02362789|322567565|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
94211314|NCT02362789|322567566|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
94211315|NCT02362789|322567567|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
94211316|NCT02362789|322567565|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
94211317|NCT02362789|322567566|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
94211318|NCT02362789|322567567|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
94211319|NCT02362789|322567565|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
94211320|NCT02362789|322567566|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
94211321|NCT02362789|322567567|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
94211322|NCT02362789|322567565|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
94211323|NCT02362789|322567566|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
94211324|NCT02362789|322567567|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
94211325|NCT02362789|322567565|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
94211326|NCT02362789|322567566|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
94211327|NCT02362789|322567567|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
94211328|NCT03861234|322567568|FG000|Overall Study|Not treated|0|||
94211329|NCT03861234|322567569|FG001|Overall Study|Not treated|0|||
94211330|NCT03861234|322567570|FG002|Overall Study|Not treated|0|||
94211331|NCT03861234|322567571|FG003|Overall Study|Not treated|0|||
94211332|NCT03861234|322567572|FG004|Overall Study|Not treated|0|||
94211333|NCT03861234|322567573|FG005|Overall Study|Not treated|1|||
94211334|NCT03861234|322567574|FG006|Overall Study|Not treated|0|||
94211335|NCT03861234|322567575|FG007|Overall Study|Not treated|0|||
94211336|NCT03861234|322567568|FG000|Overall Study|Adverse Event|0|||
94211337|NCT03861234|322567569|FG001|Overall Study|Adverse Event|0|||
94211338|NCT03861234|322567570|FG002|Overall Study|Adverse Event|0|||
94211339|NCT03861234|322567571|FG003|Overall Study|Adverse Event|0|||
94211340|NCT03861234|322567572|FG004|Overall Study|Adverse Event|0|||
94211341|NCT03861234|322567573|FG005|Overall Study|Adverse Event|1|||
94211342|NCT03861234|322567574|FG006|Overall Study|Adverse Event|0|||
94211343|NCT03861234|322567575|FG007|Overall Study|Adverse Event|0|||
94211344|NCT03861234|322567568|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
94211345|NCT03861234|322567569|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
94211346|NCT03861234|322567570|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
94211347|NCT03861234|322567571|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
94211348|NCT03861234|322567572|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
94211349|NCT03861234|322567573|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
94211350|NCT03861234|322567574|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
94211351|NCT03861234|322567575|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
94211352|NCT03861234|322567568|FG000|Overall Study|As per sponsor decision|0|||
94211353|NCT03861234|322567569|FG001|Overall Study|As per sponsor decision|0|||
94211354|NCT03861234|322567570|FG002|Overall Study|As per sponsor decision|0|||
94211355|NCT03861234|322567571|FG003|Overall Study|As per sponsor decision|0|||
94211356|NCT03861234|322567572|FG004|Overall Study|As per sponsor decision|0|||
94211357|NCT03861234|322567573|FG005|Overall Study|As per sponsor decision|0|||
94211358|NCT03861234|322567574|FG006|Overall Study|As per sponsor decision|1|||
94211359|NCT03861234|322567575|FG007|Overall Study|As per sponsor decision|0|||
94211360|NCT03861234|322567568|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
94211361|NCT03861234|322567569|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
94211362|NCT03861234|322567570|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
94211363|NCT03861234|322567571|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
94211364|NCT03861234|322567572|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
94211365|NCT03861234|322567573|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
94211366|NCT03861234|322567574|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
94211367|NCT03861234|322567575|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
94211368|NCT05270460|322567578|FG000|Overall Study|Adverse Event|0|||
94211369|NCT05270460|322567579|FG001|Overall Study|Adverse Event|1|||
94211370|NCT05270460|322567580|FG002|Overall Study|Adverse Event|0|||
94211371|NCT05270460|322567578|FG000|Overall Study|Early Termination|0|||
94211372|NCT05270460|322567579|FG001|Overall Study|Early Termination|1|||
94211373|NCT05270460|322567580|FG002|Overall Study|Early Termination|0|||
94211374|NCT00068107|322567581|FG000|Overall Study|end-stage renal disease|6|||
94211375|NCT00068107|322567581|FG000|Overall Study|Death|2|||
94211376|NCT00068107|322567581|FG000|Overall Study|Withdrawal by Subject|1|||
94211377|NCT01419184|322567584|FG000|Overall Study|Site data not available|3|||
94211378|NCT01419184|322567585|FG001|Overall Study|Site data not available|2|||
94211379|NCT01419184|322567584|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
94211380|NCT01419184|322567585|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
94211381|NCT01419184|322567584|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
94211382|NCT01419184|322567585|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
94211383|NCT01419184|322567584|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
94211384|NCT01419184|322567585|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
94211385|NCT01419184|322567584|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
94211386|NCT01419184|322567585|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
94211387|NCT01419184|322567584|FG000|Overall Study|Participant randomized, not treated|1|||
94211388|NCT01419184|322567585|FG001|Overall Study|Participant randomized, not treated|0|||
94211389|NCT02157948|322567589|FG000|Overall Study|Withdrawal by Subject|4|||
94211390|NCT02157948|322567590|FG001|Overall Study|Withdrawal by Subject|5|||
94211391|NCT02157948|322567589|FG000|Overall Study|Lost to Follow-up|3|||
94211392|NCT02157948|322567590|FG001|Overall Study|Lost to Follow-up|2|||
94211393|NCT02157948|322567589|FG000|Overall Study|Protocol Specified Criteria|2|||
94211394|NCT02157948|322567590|FG001|Overall Study|Protocol Specified Criteria|1|||
94211395|NCT02157948|322567589|FG000|Overall Study|Decision by Sponsor|0|||
94211396|NCT02157948|322567590|FG001|Overall Study|Decision by Sponsor|1|||
94211397|NCT03150589|322567591|FG000|Overall Study|Withdrawal by Subject|16|||
94211398|NCT03150589|322567592|FG001|Overall Study|Withdrawal by Subject|9|||
94211399|NCT03150589|322567591|FG000|Overall Study|Adverse Event|7|||
94211400|NCT03150589|322567592|FG001|Overall Study|Adverse Event|6|||
94211401|NCT03150589|322567591|FG000|Overall Study|Protocol Violation|4|||
94211402|NCT03150589|322567592|FG001|Overall Study|Protocol Violation|3|||
94211403|NCT03150589|322567591|FG000|Overall Study|Lost to Follow-up|3|||
94211404|NCT03150589|322567592|FG001|Overall Study|Lost to Follow-up|3|||
94211405|NCT03150589|322567591|FG000|Overall Study|Death|2|||
94211406|NCT03150589|322567592|FG001|Overall Study|Death|3|||
94211407|NCT03150589|322567591|FG000|Overall Study|IP non-compliance and other reasons|12|||
94211408|NCT03150589|322567592|FG001|Overall Study|IP non-compliance and other reasons|3|||
94211409|NCT02852824|322567593|FG000|Overall Study|Withdrawal by Subject|1|||
94211410|NCT02852824|322567594|FG001|Overall Study|Withdrawal by Subject|0|||
94211411|NCT02852824|322567595|FG002|Overall Study|Withdrawal by Subject|0|||
94211412|NCT02852824|322567596|FG003|Overall Study|Withdrawal by Subject|0|||
94211413|NCT02852824|322567597|FG004|Overall Study|Withdrawal by Subject|0|||
94211414|NCT02852824|322567598|FG005|Overall Study|Withdrawal by Subject|0|||
94211415|NCT02852824|322567599|FG006|Overall Study|Withdrawal by Subject|0|||
94211416|NCT02852824|322567593|FG000|Overall Study|Adverse Event|0|||
94211417|NCT02852824|322567594|FG001|Overall Study|Adverse Event|0|||
94211418|NCT02852824|322567595|FG002|Overall Study|Adverse Event|0|||
94211419|NCT02852824|322567596|FG003|Overall Study|Adverse Event|0|||
94211420|NCT02852824|322567597|FG004|Overall Study|Adverse Event|2|||
94211421|NCT02852824|322567598|FG005|Overall Study|Adverse Event|0|||
94211422|NCT02852824|322567599|FG006|Overall Study|Adverse Event|0|||
94211423|NCT02399449|322567604|FG000|Overall Study|Withdrawal by Subject|3|||
94211424|NCT02399449|322567605|FG001|Overall Study|Withdrawal by Subject|9|||
94211425|NCT02399449|322567604|FG000|Overall Study|Physician Decision|0|||
94211426|NCT02399449|322567605|FG001|Overall Study|Physician Decision|1|||
94211427|NCT02950961|322567613|FG000|Overall Study|Study had to stop due to COVID.|7|||
94211428|NCT02241785|322567614|FG000|Overall Study|Sponsor Termination|43|||
94211429|NCT02241785|322567614|FG000|Overall Study|Withdrawal by Subject|1|||
94211430|NCT02241785|322567614|FG000|Overall Study|Lost to Follow-up|2|||
94211431|NCT02241785|322567614|FG000|Overall Study|Adverse Event|1|||
94211432|NCT00960206|322567615|FG000|Overall Study|Death|7|||
94211433|NCT00960206|322567616|FG001|Overall Study|Death|4|||
94211434|NCT00960206|322567617|FG002|Overall Study|Death|1|||
94211435|NCT00960206|322567615|FG000|Overall Study|Unwilling/Unable to return|1|||
94211436|NCT00960206|322567616|FG001|Overall Study|Unwilling/Unable to return|2|||
94211437|NCT00960206|322567617|FG002|Overall Study|Unwilling/Unable to return|0|||
94211438|NCT00960206|322567615|FG000|Overall Study|Lost to Follow-up|8|||
94211439|NCT00960206|322567616|FG001|Overall Study|Lost to Follow-up|14|||
94211440|NCT00960206|322567617|FG002|Overall Study|Lost to Follow-up|8|||
94211441|NCT00960206|322567615|FG000|Overall Study|Withdrawal by Subject|2|||
94211442|NCT00960206|322567616|FG001|Overall Study|Withdrawal by Subject|4|||
94211443|NCT00960206|322567617|FG002|Overall Study|Withdrawal by Subject|0|||
94211444|NCT00960206|322567615|FG000|Overall Study|Revision of study component|2|||
94211445|NCT00960206|322567616|FG001|Overall Study|Revision of study component|2|||
94211446|NCT00960206|322567617|FG002|Overall Study|Revision of study component|2|||
94211447|NCT00960206|322567615|FG000|Overall Study|Missing 10 year data|20|||
94284406|NCT03529773|322829261|FG001|Overall Study|Randomized but not vaccinated|0|||
94284407|NCT03529773|322829262|FG002|Overall Study|Randomized but not vaccinated|0|||
94211448|NCT00960206|322567616|FG001|Overall Study|Missing 10 year data|1|||
94211449|NCT00960206|322567617|FG002|Overall Study|Missing 10 year data|1|||
94211450|NCT01736475|322567620|FG000|Overall Study|Adverse Event|4|||
94211451|NCT01736475|322567621|FG001|Overall Study|Adverse Event|0|||
94211452|NCT01736475|322567620|FG000|Overall Study|Withdrawal by Subject|2|||
94211453|NCT01736475|322567621|FG001|Overall Study|Withdrawal by Subject|0|||
94211454|NCT01736475|322567620|FG000|Overall Study|Protocol Violation|4|||
94211455|NCT01736475|322567621|FG001|Overall Study|Protocol Violation|0|||
94211456|NCT01736475|322567620|FG000|Overall Study|Other - Screen failure|1|||
94211457|NCT01736475|322567621|FG001|Overall Study|Other - Screen failure|0|||
94211458|NCT01736475|322567620|FG000|Overall Study|Other - Surgical procedure|1|||
94211459|NCT01736475|322567621|FG001|Overall Study|Other - Surgical procedure|0|||
94211460|NCT02659540|322567624|FG000|Overall Study|Adverse Event|3|||
94211461|NCT02659540|322567625|FG001|Overall Study|Adverse Event|2|||
94211462|NCT02659540|322567624|FG000|Overall Study|Death|1|||
94211463|NCT02659540|322567625|FG001|Overall Study|Death|0|||
94211464|NCT02659540|322567624|FG000|Overall Study|Progressive disease|2|||
94211465|NCT02659540|322567625|FG001|Overall Study|Progressive disease|6|||
94211466|NCT00489554|322569105|FG000|Overall Study|Adverse Event|2|||
94211467|NCT00489554|322569105|FG000|Overall Study|Withdrawal by Subject|1|||
94211468|NCT00489554|322569105|FG000|Overall Study|Lost to Follow-up|1|||
94211469|NCT00731692|322569106|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
94211470|NCT00731692|322569107|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
94211471|NCT00731692|322569108|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
94211472|NCT00731692|322569106|FG000|Core Study (36 Months)|Physician Decision|1|||
94211473|NCT00731692|322569107|FG001|Core Study (36 Months)|Physician Decision|0|||
94211474|NCT00731692|322569108|FG002|Core Study (36 Months)|Physician Decision|2|||
94211475|NCT00731692|322569106|FG000|Core Study (36 Months)|Death|2|||
94211476|NCT00731692|322569107|FG001|Core Study (36 Months)|Death|1|||
94211477|NCT00731692|322569108|FG002|Core Study (36 Months)|Death|2|||
94211478|NCT00731692|322569106|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
94211479|NCT00731692|322569107|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
94211480|NCT00731692|322569108|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
94211481|NCT00731692|322569106|FG000|Core Study (36 Months)|Administrative|2|||
94211482|NCT00731692|322569107|FG001|Core Study (36 Months)|Administrative|2|||
94211483|NCT00731692|322569108|FG002|Core Study (36 Months)|Administrative|6|||
94211484|NCT00731692|322569106|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
94211485|NCT00731692|322569107|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
94211486|NCT00731692|322569108|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
94211487|NCT00731692|322569106|FG000|Core Study (36 Months)|Protocol Violation|4|||
94211488|NCT00731692|322569107|FG001|Core Study (36 Months)|Protocol Violation|5|||
94211489|NCT00731692|322569108|FG002|Core Study (36 Months)|Protocol Violation|8|||
94211490|NCT00731692|322569106|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
94211491|NCT00731692|322569107|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
94211492|NCT00731692|322569108|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
94211493|NCT00731692|322569106|FG000|Core Study (36 Months)|Adverse Event|25|||
94211494|NCT00731692|322569107|FG001|Core Study (36 Months)|Adverse Event|28|||
94211495|NCT00731692|322569108|FG002|Core Study (36 Months)|Adverse Event|29|||
94211496|NCT00731692|322569106|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
94211497|NCT00731692|322569107|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
94211498|NCT00731692|322569108|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
94211499|NCT00731692|322569106|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
94211500|NCT00731692|322569107|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
94211501|NCT00731692|322569108|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
94211502|NCT00731692|322569106|FG000|Extension Phase|Abnormal test procedure|0|||
94211503|NCT00731692|322569107|FG001|Extension Phase|Abnormal test procedure|0|||
94211504|NCT00731692|322569108|FG002|Extension Phase|Abnormal test procedure|1|||
94211505|NCT00731692|322569106|FG000|Extension Phase|Abnormal lab values|0|||
94211506|NCT00731692|322569107|FG001|Extension Phase|Abnormal lab values|0|||
94211507|NCT00731692|322569108|FG002|Extension Phase|Abnormal lab values|1|||
94211508|NCT00731692|322569106|FG000|Extension Phase|Lost to Follow-up|0|||
94211509|NCT00731692|322569107|FG001|Extension Phase|Lost to Follow-up|1|||
94211510|NCT00731692|322569108|FG002|Extension Phase|Lost to Follow-up|4|||
94211511|NCT00731692|322569106|FG000|Extension Phase|Withdrawal by Subject|4|||
94211512|NCT00731692|322569107|FG001|Extension Phase|Withdrawal by Subject|5|||
94211513|NCT00731692|322569108|FG002|Extension Phase|Withdrawal by Subject|3|||
94211514|NCT00731692|322569106|FG000|Extension Phase|Adverse Event|1|||
94211515|NCT00731692|322569107|FG001|Extension Phase|Adverse Event|1|||
94372313|NCT01872689|323150243|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
94211516|NCT00731692|322569108|FG002|Extension Phase|Adverse Event|15|||
94211517|NCT01719172|322569111|FG000|Overall Study|Lost to Follow-up|1|||
94211518|NCT01719172|322569111|FG000|Overall Study|Death|1|||
94211519|NCT01583166|322569112|FG000|Overall Study|Withdrawal by Subject|4|||
94211520|NCT01583166|322569113|FG001|Overall Study|Withdrawal by Subject|6|||
94372314|NCT01872689|323150240|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
94467750|NCT00085098|323502381|FG000|Overall Study|Ineligible|1|||
94211521|NCT03041090|322569114|FG000|Overall Study|technical error|0|||
94211522|NCT03041090|322569115|FG001|Overall Study|technical error|3|||
94211523|NCT03403036|322569118|FG000|Overall Study|Lack of Efficacy|5|||
94211524|NCT03960645|322569119|FG000|Overall Study|Protocol Violation|1|||
94211525|NCT03960645|322569120|FG001|Overall Study|Protocol Violation|0|||
94211526|NCT01256359|322569121|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
94211527|NCT01256359|322569122|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
94211528|NCT01256359|322569121|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
94211529|NCT01256359|322569122|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
94211530|NCT02000752|322569123|FG000|Overall Study|Dystocic delivery|19|||
94284408|NCT03529773|322829263|FG003|Overall Study|Randomized but not vaccinated|0|||
94284409|NCT03529773|322829264|FG004|Overall Study|Randomized but not vaccinated|0|||
94284410|NCT03529773|322829265|FG005|Overall Study|Randomized but not vaccinated|0|||
94284411|NCT03529773|322829266|FG006|Overall Study|Randomized but not vaccinated|0|||
94284412|NCT03529773|322829267|FG007|Overall Study|Randomized but not vaccinated|0|||
94284413|NCT03529773|322829268|FG008|Overall Study|Randomized but not vaccinated|0|||
94284414|NCT03529773|322829269|FG009|Overall Study|Randomized but not vaccinated|0|||
94284415|NCT03529773|322829270|FG010|Overall Study|Randomized but not vaccinated|0|||
94284416|NCT03529773|322829271|FG011|Overall Study|Randomized but not vaccinated|0|||
94467751|NCT00085098|323502382|FG001|Overall Study|Ineligible|1|||
94211531|NCT02000752|322569124|FG001|Overall Study|Dystocic delivery|8|||
94211532|NCT02000752|322569123|FG000|Overall Study|Shift Changes|12|||
94211533|NCT02000752|322569124|FG001|Overall Study|Shift Changes|5|||
94211534|NCT00569166|322569127|FG000|Overall Study|Withdrawal by Subject|7|||
94211535|NCT00569166|322569128|FG001|Overall Study|Withdrawal by Subject|5|||
94211536|NCT00569166|322569129|FG002|Overall Study|Withdrawal by Subject|3|||
94211537|NCT00569166|322569127|FG000|Overall Study|Lost to Follow-up|2|||
94211538|NCT00569166|322569128|FG001|Overall Study|Lost to Follow-up|1|||
94211539|NCT00569166|322569129|FG002|Overall Study|Lost to Follow-up|1|||
94284417|NCT03529773|322829272|FG012|Overall Study|Randomized but not vaccinated|0|||
94284418|NCT03529773|322829273|FG013|Overall Study|Randomized but not vaccinated|0|||
94284419|NCT03529773|322829274|FG014|Overall Study|Randomized but not vaccinated|0|||
94284420|NCT03529773|322829275|FG015|Overall Study|Randomized but not vaccinated|0|||
94284421|NCT03529773|322829276|FG016|Overall Study|Randomized but not vaccinated|0|||
94284422|NCT03529773|322829277|FG017|Overall Study|Randomized but not vaccinated|1|||
94284423|NCT03529773|322829278|FG018|Overall Study|Randomized but not vaccinated|0|||
94284424|NCT03529773|322829279|FG019|Overall Study|Randomized but not vaccinated|0|||
94284425|NCT03529773|322829280|FG020|Overall Study|Randomized but not vaccinated|0|||
94284426|NCT03529773|322829281|FG021|Overall Study|Randomized but not vaccinated|0|||
94284427|NCT03529773|322829282|FG022|Overall Study|Randomized but not vaccinated|0|||
94284428|NCT03529773|322829283|FG023|Overall Study|Randomized but not vaccinated|0|||
94284429|NCT03529773|322829284|FG024|Overall Study|Randomized but not vaccinated|0|||
94211540|NCT00047385|322569130|FG000|Overall Study|Death before any screening|2|||
94211541|NCT00047385|322569131|FG001|Overall Study|Death before any screening|5|||
94211542|NCT00047385|322569130|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
94211543|NCT00047385|322569131|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
94211544|NCT00047385|322569130|FG000|Overall Study|Eligible for screening but had no screen|260|||
94211545|NCT00047385|322569131|FG001|Overall Study|Eligible for screening but had no screen|492|||
94211546|NCT03490032|322569132|FG000|Overall Study|family issue (child custody)|1|||
94211547|NCT03490032|322569133|FG001|Overall Study|family issue (child custody)|0|||
94211548|NCT03490032|322569134|FG002|Overall Study|family issue (child custody)|0|||
94211549|NCT02958553|322569135|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
94211550|NCT02958553|322569135|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
94211551|NCT03392194|322569137|FG000|Overall Study|Withdrawal by Subject|1|||
94211552|NCT03392194|322569138|FG001|Overall Study|Withdrawal by Subject|2|||
94211553|NCT03392194|322569137|FG000|Overall Study|Conflicts with personal schedule|1|||
94211554|NCT03392194|322569138|FG001|Overall Study|Conflicts with personal schedule|0|||
94211555|NCT03865732|322569139|FG000|Overall Study|Adverse Event|0|||
94211556|NCT03865732|322569140|FG001|Overall Study|Adverse Event|1|||
94211557|NCT03340961|322569141|FG000|Overall Study|Adverse Event|1|||
94211558|NCT03340961|322569142|FG001|Overall Study|Adverse Event|3|||
94211559|NCT03340961|322569143|FG002|Overall Study|Adverse Event|2|||
94211560|NCT03340961|322569144|FG003|Overall Study|Adverse Event|4|||
94211561|NCT03340961|322569141|FG000|Overall Study|Lost to Follow-up|0|||
94211562|NCT03340961|322569142|FG001|Overall Study|Lost to Follow-up|1|||
94211563|NCT03340961|322569143|FG002|Overall Study|Lost to Follow-up|0|||
94211564|NCT03340961|322569144|FG003|Overall Study|Lost to Follow-up|1|||
94211565|NCT03340961|322569141|FG000|Overall Study|Withdrawal by Subject|3|||
94211566|NCT03340961|322569142|FG001|Overall Study|Withdrawal by Subject|2|||
94211567|NCT03340961|322569143|FG002|Overall Study|Withdrawal by Subject|4|||
94211568|NCT03340961|322569144|FG003|Overall Study|Withdrawal by Subject|7|||
94211569|NCT03340961|322569141|FG000|Overall Study|Use of prohibited treatment|0|||
94211570|NCT03340961|322569142|FG001|Overall Study|Use of prohibited treatment|3|||
94211571|NCT03340961|322569143|FG002|Overall Study|Use of prohibited treatment|2|||
94211572|NCT03340961|322569144|FG003|Overall Study|Use of prohibited treatment|4|||
94211573|NCT03340961|322569141|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
94211574|NCT03340961|322569142|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
94211575|NCT03340961|322569143|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
94211576|NCT03340961|322569144|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
94211577|NCT03340961|322569141|FG000|Overall Study|Subject developed an exclusion criterion|0|||
94211578|NCT03340961|322569142|FG001|Overall Study|Subject developed an exclusion criterion|1|||
94211579|NCT03340961|322569143|FG002|Overall Study|Subject developed an exclusion criterion|0|||
94211580|NCT03340961|322569144|FG003|Overall Study|Subject developed an exclusion criterion|0|||
94211581|NCT03340961|322569141|FG000|Overall Study|Protocol Violation|1|||
94211582|NCT03340961|322569142|FG001|Overall Study|Protocol Violation|0|||
94211583|NCT03340961|322569143|FG002|Overall Study|Protocol Violation|1|||
94211584|NCT03340961|322569144|FG003|Overall Study|Protocol Violation|0|||
94211585|NCT03340961|322569141|FG000|Overall Study|Adverse Event|1|||
94211586|NCT03340961|322569142|FG001|Overall Study|Adverse Event|1|||
94211587|NCT03340961|322569143|FG002|Overall Study|Adverse Event|0|||
94211588|NCT03340961|322569144|FG003|Overall Study|Adverse Event|0|||
94211589|NCT03340961|322569141|FG000|Overall Study|Lack of Efficacy|0|||
94211590|NCT03340961|322569142|FG001|Overall Study|Lack of Efficacy|0|||
94211591|NCT03340961|322569143|FG002|Overall Study|Lack of Efficacy|0|||
94211592|NCT03340961|322569144|FG003|Overall Study|Lack of Efficacy|1|||
94211593|NCT00704340|322569145|FG000|Overall Study|Lost to Follow-up|2|||
94211594|NCT00704340|322569146|FG001|Overall Study|Lost to Follow-up|1|||
94211595|NCT00704340|322569145|FG000|Overall Study|Death|0|||
94211596|NCT00704340|322569146|FG001|Overall Study|Death|1|||
94211597|NCT00620854|322569147|FG000|Washout 1|Withdrawal by Subject|0|||
94211598|NCT00620854|322569148|FG001|Washout 1|Withdrawal by Subject|0|||
94211599|NCT00620854|322569149|FG002|Washout 1|Withdrawal by Subject|1|||
94211600|NCT00620854|322569150|FG003|Washout 1|Withdrawal by Subject|1|||
94211601|NCT00620854|322569151|FG004|Washout 1|Withdrawal by Subject|0|||
94467752|NCT03329248|323502383|FG000|Overall Study|Progressive Disease|6|||
94467753|NCT01886781|323502384|FG000|Overall Study|Protocol Violation|5|||
94467754|NCT01886781|323502385|FG001|Overall Study|Protocol Violation|0|||
94467755|NCT01886781|323502384|FG000|Overall Study|Adverse Event|1|||
94467756|NCT01886781|323502385|FG001|Overall Study|Adverse Event|0|||
94467757|NCT01886781|323502384|FG000|Overall Study|Lost to Follow-up|5|||
94467758|NCT01886781|323502385|FG001|Overall Study|Lost to Follow-up|0|||
94467759|NCT01886781|323502384|FG000|Overall Study|Withdrawal by Subject|2|||
94467760|NCT01886781|323502385|FG001|Overall Study|Withdrawal by Subject|1|||
94467761|NCT01886781|323502384|FG000|Overall Study|Worsening of symptoms|1|||
94211602|NCT00620854|322569152|FG005|Washout 1|Withdrawal by Subject|0|||
94211603|NCT00487240|322569153|FG000|Overall Study|Withdrawal by Subject|12|||
94467762|NCT01886781|323502385|FG001|Overall Study|Worsening of symptoms|1|||
94467763|NCT01522235|323502386|FG000|Overall Study|Physician Decision|1|||
94467764|NCT01522235|323502387|FG001|Overall Study|Physician Decision|1|||
94467765|NCT01254721|323502388|FG000|Overall Study|Lost to Follow-up|0|||
94467766|NCT01254721|323502389|FG001|Overall Study|Lost to Follow-up|4|||
94467767|NCT01254721|323502388|FG000|Overall Study|Lack of Efficacy|4|||
94467768|NCT01254721|323502389|FG001|Overall Study|Lack of Efficacy|2|||
94467769|NCT01254721|323502388|FG000|Overall Study|Death|0|||
94467770|NCT01254721|323502389|FG001|Overall Study|Death|1|||
94467771|NCT01254721|323502388|FG000|Overall Study|technical problum|1|||
94467772|NCT01254721|323502389|FG001|Overall Study|technical problum|0|||
94467773|NCT01254721|323502388|FG000|Overall Study|Adverse Event|2|||
94211604|NCT00487240|322569154|FG001|Overall Study|Withdrawal by Subject|6|||
94211605|NCT00487240|322569153|FG000|Overall Study|Lost to Follow-up|7|||
94211606|NCT00487240|322569154|FG001|Overall Study|Lost to Follow-up|6|||
94211607|NCT00487240|322569153|FG000|Overall Study|Adverse Event|0|||
94211608|NCT00487240|322569154|FG001|Overall Study|Adverse Event|4|||
94211609|NCT00487240|322569153|FG000|Overall Study|Protocol Violation|5|||
94211610|NCT00487240|322569154|FG001|Overall Study|Protocol Violation|5|||
94211611|NCT00487240|322569153|FG000|Overall Study|Entry Criteria Not Met|3|||
94211612|NCT00487240|322569154|FG001|Overall Study|Entry Criteria Not Met|4|||
94211613|NCT00487240|322569153|FG000|Overall Study|Sponsor Decision|2|||
94211614|NCT00487240|322569154|FG001|Overall Study|Sponsor Decision|1|||
94211615|NCT00487240|322569153|FG000|Overall Study|Physician Decision|2|||
94211616|NCT00487240|322569154|FG001|Overall Study|Physician Decision|0|||
94211617|NCT00240994|322569157|FG000|Overall Study|Lost to Follow-up|1|||
94211618|NCT00240994|322569157|FG000|Overall Study|Protocol Violation|1|||
94211619|NCT00240994|322569157|FG000|Overall Study|Graft failure|1|||
94211620|NCT02095145|322569158|FG000|Overall Study|Withdrawal by Subject|1|||
94211621|NCT02095145|322569159|FG001|Overall Study|Withdrawal by Subject|0|||
94211622|NCT01019135|322569161|FG000|Overall Study|Did not receive allocated intervention|12|||
94211623|NCT01019135|322569162|FG001|Overall Study|Did not receive allocated intervention|6|||
94211624|NCT01019135|322569163|FG002|Overall Study|Did not receive allocated intervention|25|||
94211625|NCT01019135|322569161|FG000|Overall Study|Did not attend CR|8|||
94211626|NCT01019135|322569162|FG001|Overall Study|Did not attend CR|13|||
94211627|NCT01019135|322569163|FG002|Overall Study|Did not attend CR|6|||
94211628|NCT00439218|322569164|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
94211629|NCT02007070|322569165|FG000|Overall Study|Adverse Event|4|||
94211630|NCT02007070|322569165|FG000|Overall Study|Clinical Progression|4|||
94211631|NCT02007070|322569165|FG000|Overall Study|Death|1|||
94211632|NCT02007070|322569165|FG000|Overall Study|Protocol Violation|2|||
94211633|NCT02007070|322569165|FG000|Overall Study|Physician Decision|1|||
94211634|NCT02007070|322569165|FG000|Overall Study|Progressive Disease|21|||
94211635|NCT02547974|322569171|FG000|Overall Study|Withdrawal by Subject|1|||
94211636|NCT02547974|322569172|FG001|Overall Study|Withdrawal by Subject|0|||
94211637|NCT02547974|322569173|FG002|Overall Study|Withdrawal by Subject|0|||
94211638|NCT02547974|322569174|FG003|Overall Study|Withdrawal by Subject|0|||
94211639|NCT02203799|322569183|FG000|Overall Study|Withdrawal by Subject|3|||
94211640|NCT04660799|322569186|FG000|Overall Study|Progressive Disease|1|||
94211641|NCT04660799|322569187|FG001|Overall Study|Progressive Disease|1|||
94211642|NCT04660799|322569186|FG000|Overall Study|Death|2|||
94211643|NCT04660799|322569187|FG001|Overall Study|Death|1|||
94211644|NCT04660799|322569186|FG000|Overall Study|Adverse Event|2|||
94211645|NCT04660799|322569187|FG001|Overall Study|Adverse Event|1|||
94211646|NCT04660799|322569186|FG000|Overall Study|Withdrawal by Subject|2|||
94211647|NCT04660799|322569187|FG001|Overall Study|Withdrawal by Subject|5|||
94211648|NCT00701415|322569190|FG000|Overall Study|Adverse Event|0|||
94211649|NCT00701415|322569191|FG001|Overall Study|Adverse Event|1|||
94211650|NCT00701415|322569190|FG000|Overall Study|Social/family issues and needle phobia|1|||
94211651|NCT00701415|322569191|FG001|Overall Study|Social/family issues and needle phobia|0|||
94211652|NCT02208843|322569194|FG000|Overall Study|Clinical symptoms of progression|2|||
94211653|NCT02208843|322569194|FG000|Overall Study|Progression disease according to RECIST|24|||
94211654|NCT02208843|322569194|FG000|Overall Study|Adverse Event|12|||
94284430|NCT03529773|322829285|FG025|Overall Study|Randomized but not vaccinated|0|||
94211655|NCT02208843|322569194|FG000|Overall Study|Protocol Violation|1|||
94211656|NCT02208843|322569194|FG000|Overall Study|Withdrawal by Subject|1|||
94211657|NCT02208843|322569194|FG000|Overall Study|Switched to commercial afatinib|20|||
94211658|NCT01972776|322569195|FG000|Part 1|Withdrawal by Subject|0|||
94211659|NCT01972776|322569196|FG001|Part 1|Withdrawal by Subject|0|||
94211660|NCT01972776|322569197|FG002|Part 1|Withdrawal by Subject|1|||
94211661|NCT01972776|322569198|FG003|Part 1|Withdrawal by Subject|0|||
94211662|NCT01972776|322569199|FG004|Part 1|Withdrawal by Subject|0|||
94211663|NCT01972776|322569200|FG005|Part 1|Withdrawal by Subject|0|||
94211664|NCT01972776|322569195|FG000|Part 1|Adverse Event|0|||
94467774|NCT01254721|323502389|FG001|Overall Study|Adverse Event|3|||
94211665|NCT01972776|322569196|FG001|Part 1|Adverse Event|0|||
94211666|NCT01972776|322569197|FG002|Part 1|Adverse Event|1|||
94211667|NCT01972776|322569198|FG003|Part 1|Adverse Event|1|||
94211668|NCT01972776|322569199|FG004|Part 1|Adverse Event|0|||
94467775|NCT01254721|323502388|FG000|Overall Study|Withdrawal by Subject|8|||
94211669|NCT01972776|322569200|FG005|Part 1|Adverse Event|0|||
94211670|NCT01972776|322569195|FG000|Part 2|Adverse Event|0|||
94211671|NCT01972776|322569196|FG001|Part 2|Adverse Event|0|||
94211672|NCT01972776|322569197|FG002|Part 2|Adverse Event|0|||
94211673|NCT01972776|322569198|FG003|Part 2|Adverse Event|0|||
94211674|NCT01972776|322569199|FG004|Part 2|Adverse Event|3|||
94211675|NCT01972776|322569200|FG005|Part 2|Adverse Event|0|||
94211676|NCT01972776|322569195|FG000|Part 2|Administrative problems|0|||
94211677|NCT01972776|322569196|FG001|Part 2|Administrative problems|0|||
94211678|NCT01972776|322569197|FG002|Part 2|Administrative problems|0|||
94211679|NCT01972776|322569198|FG003|Part 2|Administrative problems|0|||
94211680|NCT01972776|322569199|FG004|Part 2|Administrative problems|10|||
94211681|NCT01972776|322569200|FG005|Part 2|Administrative problems|7|||
94211682|NCT02106884|322569207|FG000|Overall Study|Change of diagnosis/exclusion|0|||
94211683|NCT02106884|322569208|FG001|Overall Study|Change of diagnosis/exclusion|1|||
94467776|NCT01254721|323502389|FG001|Overall Study|Withdrawal by Subject|11|||
94211684|NCT00687297|322569209|FG000|Randomization|Withdrawal by Subject|2|||
94467777|NCT01254721|323502388|FG000|Overall Study|Wrongly randomization|0|||
94467778|NCT01254721|323502389|FG001|Overall Study|Wrongly randomization|1|||
94211685|NCT00687297|322569210|FG001|Randomization|Withdrawal by Subject|0|||
94211686|NCT00687297|322569209|FG000|Randomization|Withdrew before treatment, ineligible|1|||
94211687|NCT00687297|322569210|FG001|Randomization|Withdrew before treatment, ineligible|1|||
94211688|NCT00687297|322569209|FG000|Induction|Withdrawal by Subject|4|||
94211689|NCT00687297|322569210|FG001|Induction|Withdrawal by Subject|4|||
94211690|NCT00687297|322569209|FG000|Induction|Adverse Event|16|||
94211691|NCT00687297|322569210|FG001|Induction|Adverse Event|15|||
94211692|NCT00687297|322569209|FG000|Induction|Death|7|||
94211693|NCT00687297|322569210|FG001|Induction|Death|11|||
94211694|NCT00687297|322569209|FG000|Induction|Lack of Efficacy|17|||
94211695|NCT00687297|322569210|FG001|Induction|Lack of Efficacy|21|||
94211696|NCT00687297|322569209|FG000|Induction|Ineligible|0|||
94211697|NCT00687297|322569210|FG001|Induction|Ineligible|1|||
94211698|NCT00687297|322569209|FG000|Induction|Patient Noncompliance|1|||
94211699|NCT00687297|322569210|FG001|Induction|Patient Noncompliance|0|||
94211700|NCT00687297|322569209|FG000|Induction|Physician Decision|0|||
94211701|NCT00687297|322569210|FG001|Induction|Physician Decision|2|||
94372315|NCT01872689|323150241|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
94372316|NCT01872689|323150242|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
94211702|NCT00687297|322569209|FG000|Induction|Other|0|||
94211703|NCT00687297|322569210|FG001|Induction|Other|1|||
94211704|NCT01228734|322569211|FG000|Overall Study|Randomized, but not treated|0|||
94211705|NCT01228734|322569212|FG001|Overall Study|Randomized, but not treated|4|||
94211706|NCT00807599|322569215|FG000|Overall Study|Not treated on protocol study|0|||
94211707|NCT00807599|322569216|FG001|Overall Study|Not treated on protocol study|0|||
94211708|NCT00807599|322569217|FG002|Overall Study|Not treated on protocol study|2|||
94211709|NCT00807599|322569215|FG000|Overall Study|Adverse Event|0|||
94211710|NCT00807599|322569216|FG001|Overall Study|Adverse Event|0|||
94211711|NCT00807599|322569217|FG002|Overall Study|Adverse Event|5|||
94211712|NCT00807599|322569215|FG000|Overall Study|Inadequate response to induction|0|||
94211713|NCT00807599|322569216|FG001|Overall Study|Inadequate response to induction|0|||
94211714|NCT00807599|322569217|FG002|Overall Study|Inadequate response to induction|9|||
94211715|NCT00807599|322569215|FG000|Overall Study|Withdrawal by Subject|0|||
94211716|NCT00807599|322569216|FG001|Overall Study|Withdrawal by Subject|0|||
94211717|NCT00807599|322569217|FG002|Overall Study|Withdrawal by Subject|1|||
94211718|NCT00089791|322569218|FG000|Overall Study|Physician Decision|6|||
94211719|NCT00089791|322569219|FG001|Overall Study|Physician Decision|3|||
94211720|NCT00089791|322569218|FG000|Overall Study|Adverse Event|81|||
94211721|NCT00089791|322569219|FG001|Overall Study|Adverse Event|93|||
94284431|NCT03529773|322829286|FG026|Overall Study|Randomized but not vaccinated|0|||
94284432|NCT03529773|322829287|FG027|Overall Study|Randomized but not vaccinated|1|||
94284433|NCT03529773|322829288|FG028|Overall Study|Randomized but not vaccinated|0|||
94284434|NCT03529773|322829289|FG029|Overall Study|Randomized but not vaccinated|0|||
94284435|NCT03529773|322829290|FG030|Overall Study|Randomized but not vaccinated|0|||
94284436|NCT03529773|322829291|FG031|Overall Study|Randomized but not vaccinated|0|||
94284437|NCT03529773|322829292|FG032|Overall Study|Randomized but not vaccinated|0|||
94284438|NCT03529773|322829293|FG033|Overall Study|Randomized but not vaccinated|0|||
94284439|NCT03529773|322829294|FG034|Overall Study|Randomized but not vaccinated|0|||
94284440|NCT03529773|322829295|FG035|Overall Study|Randomized but not vaccinated|0|||
94284441|NCT03529773|322829296|FG036|Overall Study|Randomized but not vaccinated|0|||
94284442|NCT03529773|322829297|FG037|Overall Study|Randomized but not vaccinated|0|||
94284443|NCT03529773|322829298|FG038|Overall Study|Randomized but not vaccinated|0|||
94284444|NCT03529773|322829299|FG039|Overall Study|Randomized but not vaccinated|0|||
94284445|NCT01340209|322829300|FG000|Overall Study|Adverse Event|1|||
94284446|NCT01340209|322829301|FG001|Overall Study|Adverse Event|1|||
94284447|NCT01340209|322829302|FG002|Overall Study|Adverse Event|2|||
94284448|NCT01340209|322829300|FG000|Overall Study|Protocol Violation|1|||
94284449|NCT01340209|322829301|FG001|Overall Study|Protocol Violation|2|||
94284450|NCT01340209|322829302|FG002|Overall Study|Protocol Violation|1|||
94284451|NCT01340209|322829300|FG000|Overall Study|Withdrawal by Subject|0|||
94284452|NCT01340209|322829301|FG001|Overall Study|Withdrawal by Subject|0|||
94284453|NCT01340209|322829302|FG002|Overall Study|Withdrawal by Subject|1|||
94372317|NCT01872689|323150243|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
94211722|NCT00089791|322569218|FG000|Overall Study|Withdrawal by Subject|403|||
94211723|NCT00089791|322569219|FG001|Overall Study|Withdrawal by Subject|344|||
94211724|NCT00089791|322569218|FG000|Overall Study|Death|78|||
94211725|NCT00089791|322569219|FG001|Overall Study|Death|62|||
94284454|NCT01340209|322829300|FG000|Overall Study|Other reason not defined above|3|||
94372318|NCT01872689|323150240|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
94211726|NCT00089791|322569218|FG000|Overall Study|Disease progression|7|||
94211727|NCT00089791|322569219|FG001|Overall Study|Disease progression|3|||
94211728|NCT00089791|322569218|FG000|Overall Study|Ineligibility determined|12|||
94211729|NCT00089791|322569219|FG001|Overall Study|Ineligibility determined|9|||
94211730|NCT00089791|322569218|FG000|Overall Study|Lost to Follow-up|57|||
94211731|NCT00089791|322569219|FG001|Overall Study|Lost to Follow-up|57|||
94211732|NCT00089791|322569218|FG000|Overall Study|Noncompliance|17|||
94211733|NCT00089791|322569219|FG001|Overall Study|Noncompliance|13|||
94211734|NCT00089791|322569218|FG000|Overall Study|Other|20|||
94211735|NCT00089791|322569219|FG001|Overall Study|Other|32|||
94211736|NCT00089791|322569218|FG000|Overall Study|Protocol deviation|12|||
94211737|NCT00089791|322569219|FG001|Overall Study|Protocol deviation|10|||
94211738|NCT00089791|322569218|FG000|Overall Study|Requirement for alternative therapy|7|||
94211739|NCT00089791|322569219|FG001|Overall Study|Requirement for alternative therapy|4|||
94211740|NCT02161458|322569223|FG000|Overall Study|Withdrawal by Subject|0|||
94211741|NCT02161458|322569224|FG001|Overall Study|Withdrawal by Subject|4|||
94211742|NCT02161458|322569225|FG002|Overall Study|Withdrawal by Subject|4|||
94211743|NCT02161458|322569226|FG003|Overall Study|Withdrawal by Subject|0|||
94211744|NCT02161458|322569223|FG000|Overall Study|Lost to Follow-up|0|||
94211745|NCT02161458|322569224|FG001|Overall Study|Lost to Follow-up|2|||
94211746|NCT02161458|322569225|FG002|Overall Study|Lost to Follow-up|1|||
94211747|NCT02161458|322569226|FG003|Overall Study|Lost to Follow-up|0|||
94211748|NCT02542696|322569229|FG000|Overall Study|Adverse Event|167|||
94211749|NCT02542696|322569229|FG000|Overall Study|Lack of Efficacy|26|||
94211750|NCT02542696|322569229|FG000|Overall Study|Lost to Follow-up|6|||
94211751|NCT02542696|322569229|FG000|Overall Study|Withdrawal by Subject|104|||
94211752|NCT02542696|322569229|FG000|Overall Study|Protocol Violation|5|||
94211753|NCT02542696|322569229|FG000|Overall Study|Death|8|||
94211754|NCT02542696|322569229|FG000|Overall Study|DECREASED OFF TIME|1|||
94211755|NCT02542696|322569229|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
94211756|NCT02542696|322569229|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
94211757|NCT02542696|322569229|FG000|Overall Study|MEDICAL HISTORY|1|||
94211758|NCT02542696|322569229|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
94211759|NCT02542696|322569229|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
94211760|NCT02542696|322569229|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
94211761|NCT02542696|322569229|FG000|Overall Study|SPONSOR DECISION|3|||
94211762|NCT02542696|322569229|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
94211763|NCT02542696|322569229|FG000|Overall Study|SUBJECT DECISION|2|||
94211764|NCT02410278|322569230|FG000|Run-in Period|Adverse Event|5|||
94211765|NCT02410278|322569231|FG001|Run-in Period|Adverse Event|0|||
94211766|NCT02410278|322569232|FG002|Run-in Period|Adverse Event|0|||
94211767|NCT02410278|322569230|FG000|Run-in Period|GSRS Threshold Not Met|30|||
94284455|NCT01340209|322829301|FG001|Overall Study|Other reason not defined above|5|||
94284456|NCT01340209|322829302|FG002|Overall Study|Other reason not defined above|4|||
94284457|NCT00209339|322829305|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
94284458|NCT00209339|322829305|FG000|At 12 Months Follow-up|Death|1|||
94211768|NCT02410278|322569231|FG001|Run-in Period|GSRS Threshold Not Met|0|||
94284459|NCT00209339|322829305|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
94284460|NCT00209339|322829305|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
94284461|NCT00209339|322829305|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
94284462|NCT00209339|322829305|FG000|At 24 Months Follow-up|Death|1|||
94284463|NCT00209339|322829305|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
94284464|NCT00209339|322829305|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
94284465|NCT00209339|322829305|FG000|At 4 Years Follow-up|Death|1|||
94284466|NCT00209339|322829305|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
94284467|NCT00209339|322829305|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
94284468|NCT00209339|322829305|FG000|At 5 Years Follow-up|Death|1|||
94284469|NCT01239160|322829306|FG000|Overall Study|Lost to Follow-up|3|||
94284470|NCT01239160|322829307|FG001|Overall Study|Lost to Follow-up|5|||
94284471|NCT01239160|322829308|FG002|Overall Study|Lost to Follow-up|0|||
94284472|NCT01239160|322829306|FG000|Overall Study|Withdrawal by Subject|17|||
94284473|NCT01239160|322829307|FG001|Overall Study|Withdrawal by Subject|6|||
94284474|NCT01239160|322829308|FG002|Overall Study|Withdrawal by Subject|2|||
94284475|NCT01239160|322829306|FG000|Overall Study|Physician Decision|5|||
94284476|NCT01239160|322829307|FG001|Overall Study|Physician Decision|7|||
94284477|NCT01239160|322829308|FG002|Overall Study|Physician Decision|2|||
94284478|NCT01239160|322829306|FG000|Overall Study|Early Termination Due to Study Closure|0|||
94284479|NCT01239160|322829307|FG001|Overall Study|Early Termination Due to Study Closure|1|||
94284480|NCT01239160|322829308|FG002|Overall Study|Early Termination Due to Study Closure|6|||
94284481|NCT02268058|322829309|FG000|Overall Study|Protocol Violation|1|||
94284482|NCT02268058|322829310|FG001|Overall Study|Protocol Violation|0|||
94284483|NCT02268058|322829311|FG002|Overall Study|Protocol Violation|0|||
94284484|NCT02268058|322829312|FG003|Overall Study|Protocol Violation|0|||
94284485|NCT01903837|322829313|FG000|Part A|Withdrawal by Subject|4|||
94284486|NCT01903837|322829314|FG001|Part A|Withdrawal by Subject|9|||
94284487|NCT01903837|322829315|FG002|Part A|Withdrawal by Subject|8|||
94284488|NCT01903837|322829316|FG003|Part A|Withdrawal by Subject|5|||
94284489|NCT01903837|322829313|FG000|Part A|Adverse Event|3|||
94284490|NCT01903837|322829314|FG001|Part A|Adverse Event|6|||
94284491|NCT01903837|322829315|FG002|Part A|Adverse Event|9|||
94211769|NCT02410278|322569232|FG002|Run-in Period|GSRS Threshold Not Met|0|||
94211770|NCT02410278|322569230|FG000|Run-in Period|Lost to Follow-up|1|||
94211771|NCT02410278|322569231|FG001|Run-in Period|Lost to Follow-up|0|||
94211772|NCT02410278|322569232|FG002|Run-in Period|Lost to Follow-up|0|||
94211773|NCT02410278|322569230|FG000|Run-in Period|Withdrawal by Subject|1|||
94211774|NCT02410278|322569231|FG001|Run-in Period|Withdrawal by Subject|0|||
94211775|NCT02410278|322569232|FG002|Run-in Period|Withdrawal by Subject|0|||
94211776|NCT02410278|322569230|FG000|Run-in Period|Pregnancy|1|||
94211777|NCT02410278|322569231|FG001|Run-in Period|Pregnancy|0|||
94211778|NCT02410278|322569232|FG002|Run-in Period|Pregnancy|0|||
94211779|NCT02410278|322569230|FG000|Study Treatment Period|Adverse Event|0|||
94211780|NCT02410278|322569231|FG001|Study Treatment Period|Adverse Event|6|||
94211781|NCT02410278|322569232|FG002|Study Treatment Period|Adverse Event|3|||
94211782|NCT02410278|322569230|FG000|Study Treatment Period|Physician Decision|0|||
94211783|NCT02410278|322569231|FG001|Study Treatment Period|Physician Decision|0|||
94211784|NCT02410278|322569232|FG002|Study Treatment Period|Physician Decision|1|||
94211785|NCT02410278|322569230|FG000|Study Treatment Period|Withdrawal by Subject|0|||
94211786|NCT02410278|322569231|FG001|Study Treatment Period|Withdrawal by Subject|1|||
94211787|NCT02410278|322569232|FG002|Study Treatment Period|Withdrawal by Subject|0|||
94211788|NCT02410278|322569230|FG000|Study Treatment Period|Other|0|||
94211789|NCT02410278|322569231|FG001|Study Treatment Period|Other|3|||
94211790|NCT02410278|322569232|FG002|Study Treatment Period|Other|0|||
94211791|NCT02410278|322569230|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
94211792|NCT02410278|322569231|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
94211793|NCT02410278|322569232|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
94211794|NCT00148122|322569233|FG000|Overall Study|Withdrawal by Subject|2|||
94211795|NCT00659373|322569236|FG000|Overall Study|Withdrawal by Subject|3|||
94211796|NCT00659373|322569237|FG001|Overall Study|Withdrawal by Subject|5|||
94284492|NCT01903837|322829316|FG003|Part A|Adverse Event|6|||
94284493|NCT01903837|322829313|FG000|Part A|Lost to Follow-up|9|||
94284494|NCT01903837|322829314|FG001|Part A|Lost to Follow-up|7|||
94211797|NCT00659373|322569236|FG000|Overall Study|Assessment Missed|2|||
94211798|NCT00659373|322569237|FG001|Overall Study|Assessment Missed|2|||
94211799|NCT03042767|322569240|FG000|Overall Study|Lost to Follow-up|1|||
94211800|NCT03042767|322569241|FG001|Overall Study|Lost to Follow-up|2|||
94211801|NCT00879710|322569243|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
94284495|NCT01903837|322829315|FG002|Part A|Lost to Follow-up|7|||
94284496|NCT01903837|322829316|FG003|Part A|Lost to Follow-up|2|||
94284497|NCT01903837|322829313|FG000|Part A|Non-compliance with study drug|1|||
94284498|NCT01903837|322829314|FG001|Part A|Non-compliance with study drug|4|||
94284499|NCT01903837|322829315|FG002|Part A|Non-compliance with study drug|4|||
94284500|NCT01903837|322829316|FG003|Part A|Non-compliance with study drug|0|||
94372319|NCT01872689|323150241|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
94211802|NCT00879710|322569244|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
94211803|NCT00879710|322569245|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
94211804|NCT00879710|322569246|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
94211805|NCT00879710|322569243|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
94211806|NCT00879710|322569244|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
94211807|NCT00879710|322569245|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
94211808|NCT00879710|322569246|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
94211809|NCT02066636|322569247|FG000|Overall Study|Disease progression|51|||
94211810|NCT02066636|322569248|FG001|Overall Study|Disease progression|60|||
94211811|NCT02066636|322569249|FG002|Overall Study|Disease progression|700|||
94211812|NCT02066636|322569247|FG000|Overall Study|Study drug toxicity|13|||
94211813|NCT02066636|322569248|FG001|Overall Study|Study drug toxicity|2|||
94211814|NCT02066636|322569249|FG002|Overall Study|Study drug toxicity|58|||
94211815|NCT02066636|322569247|FG000|Overall Study|Death|4|||
94211816|NCT02066636|322569248|FG001|Overall Study|Death|2|||
94211817|NCT02066636|322569249|FG002|Overall Study|Death|158|||
94211818|NCT02066636|322569247|FG000|Overall Study|Adverse event unrelated to study drug|6|||
94211819|NCT02066636|322569248|FG001|Overall Study|Adverse event unrelated to study drug|4|||
94211820|NCT02066636|322569249|FG002|Overall Study|Adverse event unrelated to study drug|45|||
94211821|NCT02066636|322569247|FG000|Overall Study|Participant request to discontinue treatment|12|||
94211822|NCT02066636|322569248|FG001|Overall Study|Participant request to discontinue treatment|12|||
94211823|NCT02066636|322569249|FG002|Overall Study|Participant request to discontinue treatment|70|||
94211824|NCT02066636|322569247|FG000|Overall Study|Participant withdrew consent|10|||
94211825|NCT02066636|322569248|FG001|Overall Study|Participant withdrew consent|18|||
94211826|NCT02066636|322569249|FG002|Overall Study|Participant withdrew consent|61|||
94211827|NCT02066636|322569247|FG000|Overall Study|Lost to Follow-up|0|||
94211828|NCT02066636|322569248|FG001|Overall Study|Lost to Follow-up|2|||
94211829|NCT02066636|322569249|FG002|Overall Study|Lost to Follow-up|2|||
94211830|NCT02066636|322569247|FG000|Overall Study|Maximum clinical benefit|2|||
94211831|NCT02066636|322569248|FG001|Overall Study|Maximum clinical benefit|2|||
94211832|NCT02066636|322569249|FG002|Overall Study|Maximum clinical benefit|3|||
94211833|NCT02066636|322569247|FG000|Overall Study|Poor/non-compliance|2|||
94211834|NCT02066636|322569248|FG001|Overall Study|Poor/non-compliance|1|||
94211835|NCT02066636|322569249|FG002|Overall Study|Poor/non-compliance|1|||
94211836|NCT02066636|322569247|FG000|Overall Study|Participant no loner meets study criteria|3|||
94284501|NCT01903837|322829313|FG000|Part A|Physician Decision|1|||
94284502|NCT01903837|322829314|FG001|Part A|Physician Decision|1|||
94284503|NCT01903837|322829315|FG002|Part A|Physician Decision|0|||
94284504|NCT01903837|322829316|FG003|Part A|Physician Decision|0|||
94284505|NCT01903837|322829313|FG000|Part A|Protocol Violation|1|||
94284506|NCT01903837|322829314|FG001|Part A|Protocol Violation|1|||
94284507|NCT01903837|322829315|FG002|Part A|Protocol Violation|0|||
94284508|NCT01903837|322829316|FG003|Part A|Protocol Violation|0|||
94284509|NCT01903837|322829313|FG000|Part B|Lost to Follow-up|0|||
94284510|NCT01903837|322829314|FG001|Part B|Lost to Follow-up|3|||
94284511|NCT01903837|322829315|FG002|Part B|Lost to Follow-up|3|||
94284512|NCT01903837|322829316|FG003|Part B|Lost to Follow-up|4|||
94284513|NCT01903837|322829313|FG000|Part B|Withdrawal by Subject|1|||
94284514|NCT01903837|322829314|FG001|Part B|Withdrawal by Subject|2|||
94284515|NCT01903837|322829315|FG002|Part B|Withdrawal by Subject|0|||
94284516|NCT01903837|322829316|FG003|Part B|Withdrawal by Subject|3|||
94284517|NCT01903837|322829313|FG000|Part B|Adverse Event|3|||
94284518|NCT01903837|322829314|FG001|Part B|Adverse Event|0|||
94284519|NCT01903837|322829315|FG002|Part B|Adverse Event|2|||
94284520|NCT01903837|322829316|FG003|Part B|Adverse Event|0|||
94284521|NCT01903837|322829313|FG000|Part B|Non-compliance with study drug|2|||
94284522|NCT01903837|322829314|FG001|Part B|Non-compliance with study drug|0|||
94284523|NCT01903837|322829315|FG002|Part B|Non-compliance with study drug|0|||
94284524|NCT01903837|322829316|FG003|Part B|Non-compliance with study drug|1|||
94284525|NCT01903837|322829313|FG000|Part B|Incarceration|2|||
94284526|NCT01903837|322829314|FG001|Part B|Incarceration|0|||
94284527|NCT01903837|322829315|FG002|Part B|Incarceration|0|||
94372320|NCT01872689|323150242|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
94284528|NCT01903837|322829316|FG003|Part B|Incarceration|1|||
94372321|NCT01872689|323150243|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
94211837|NCT02066636|322569248|FG001|Overall Study|Participant no loner meets study criteria|2|||
94284529|NCT01903837|322829313|FG000|Part B|Physician Decision|1|||
94372322|NCT01872689|323150240|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
94211838|NCT02066636|322569249|FG002|Overall Study|Participant no loner meets study criteria|28|||
94211839|NCT02066636|322569247|FG000|Overall Study|Administrative reasons by sponsor|8|||
94211840|NCT02066636|322569248|FG001|Overall Study|Administrative reasons by sponsor|5|||
94211841|NCT02066636|322569249|FG002|Overall Study|Administrative reasons by sponsor|0|||
94211842|NCT02066636|322569247|FG000|Overall Study|Other reasons|16|||
94284530|NCT01903837|322829314|FG001|Part B|Physician Decision|0|||
94284531|NCT01903837|322829315|FG002|Part B|Physician Decision|0|||
94284532|NCT01903837|322829316|FG003|Part B|Physician Decision|2|||
94284533|NCT01903837|322829313|FG000|Part B|Lack of Efficacy|0|||
94284534|NCT01903837|322829314|FG001|Part B|Lack of Efficacy|1|||
94284535|NCT01903837|322829315|FG002|Part B|Lack of Efficacy|0|||
94284536|NCT01903837|322829316|FG003|Part B|Lack of Efficacy|0|||
94284537|NCT01441063|322829317|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
94284538|NCT01441063|322829317|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
94284539|NCT01537211|322829318|FG000|Overall Study|Lost to Follow-up|0|||
94284540|NCT01537211|322829319|FG001|Overall Study|Lost to Follow-up|1|||
94284541|NCT01895322|322829321|FG000|Overall Study|Adverse Event|1|||
94284542|NCT01895322|322829321|FG000|Overall Study|Withdrawal by Subject|2|||
94284543|NCT01895322|322829321|FG000|Overall Study|Protocol Violation|10|||
94284544|NCT01298492|322829322|FG000|Overall Study|Death|2|||
94284545|NCT01298492|322829322|FG000|Overall Study|Insufficient Clinical Response|22|||
94284546|NCT01298492|322829322|FG000|Overall Study|Lost to Follow-up|12|||
94467779|NCT00312572|323502395|FG000|Overall Study|Adverse Event|10|||
94284547|NCT01298492|322829322|FG000|Overall Study|Withdrawal by Subject|47|||
94284548|NCT01298492|322829322|FG000|Overall Study|Other (Unspecified)|7|||
94284549|NCT01298492|322829322|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
94284550|NCT01298492|322829322|FG000|Overall Study|Protocol Violation|2|||
94284551|NCT01298492|322829322|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
94284552|NCT01298492|322829322|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
94284553|NCT02695628|322829326|FG000|Overall Study|Withdrawal by Subject|1|||
94284554|NCT01614093|322829329|FG000|Overall Study|Withdrawal by Subject|1|||
94284555|NCT01816243|322829330|FG000|Overall Study|Adverse Event|6|||
94284556|NCT01816243|322829330|FG000|Overall Study|Lost to Follow-up|1|||
94284557|NCT01816243|322829330|FG000|Overall Study|Lack of Efficacy|1|||
94284558|NCT01816243|322829330|FG000|Overall Study|Not eligible for the study|1|||
94284559|NCT01816243|322829330|FG000|Overall Study|Amputation|3|||
94284560|NCT02319044|322829334|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
94284561|NCT02319044|322829335|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
94284562|NCT02319044|322829336|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
94284563|NCT02319044|322829334|FG000|Overall Study|Withdrawal by Subject|3|||
94284564|NCT02319044|322829335|FG001|Overall Study|Withdrawal by Subject|3|||
94284565|NCT02319044|322829336|FG002|Overall Study|Withdrawal by Subject|6|||
94284566|NCT02319044|322829334|FG000|Overall Study|Condition under investigation worsened|100|||
94284567|NCT02319044|322829335|FG001|Overall Study|Condition under investigation worsened|50|||
94284568|NCT02319044|322829336|FG002|Overall Study|Condition under investigation worsened|46|||
94284569|NCT02319044|322829334|FG000|Overall Study|Adverse Event|17|||
94284570|NCT02319044|322829335|FG001|Overall Study|Adverse Event|2|||
94284571|NCT02319044|322829336|FG002|Overall Study|Adverse Event|8|||
94284572|NCT02319044|322829334|FG000|Overall Study|Study specific discontinuation criteria|2|||
94284573|NCT02319044|322829335|FG001|Overall Study|Study specific discontinuation criteria|2|||
94284574|NCT02319044|322829336|FG002|Overall Study|Study specific discontinuation criteria|1|||
94284575|NCT02319044|322829334|FG000|Overall Study|Not treated|0|||
94284576|NCT02319044|322829335|FG001|Overall Study|Not treated|2|||
94284577|NCT02319044|322829336|FG002|Overall Study|Not treated|2|||
94284578|NCT03891901|322829337|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
94284579|NCT03891901|322829338|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
94284580|NCT03891901|322829339|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
94284581|NCT03891901|322829340|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
94284582|NCT03891901|322829341|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
94284583|NCT03891901|322829342|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
94284584|NCT03891901|322829343|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
94284585|NCT03891901|322829344|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
94284586|NCT03891901|322829345|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
94284587|NCT03891901|322829337|FG000|Overall Study|Adverse Event|2|||
94284588|NCT03891901|322829338|FG001|Overall Study|Adverse Event|2|||
94284589|NCT03891901|322829339|FG002|Overall Study|Adverse Event|0|||
94284590|NCT03891901|322829340|FG003|Overall Study|Adverse Event|0|||
94284591|NCT03891901|322829341|FG004|Overall Study|Adverse Event|0|||
94284592|NCT03891901|322829342|FG005|Overall Study|Adverse Event|0|||
94284593|NCT03891901|322829343|FG006|Overall Study|Adverse Event|0|||
94284594|NCT03891901|322829344|FG007|Overall Study|Adverse Event|0|||
94284595|NCT03891901|322829345|FG008|Overall Study|Adverse Event|0|||
94284596|NCT03891901|322829337|FG000|Overall Study|Poor venous access|1|||
94284597|NCT03891901|322829338|FG001|Overall Study|Poor venous access|0|||
94284598|NCT03891901|322829339|FG002|Overall Study|Poor venous access|0|||
94284599|NCT03891901|322829340|FG003|Overall Study|Poor venous access|0|||
94284600|NCT03891901|322829341|FG004|Overall Study|Poor venous access|0|||
94284601|NCT03891901|322829342|FG005|Overall Study|Poor venous access|0|||
94284602|NCT03891901|322829343|FG006|Overall Study|Poor venous access|0|||
94284603|NCT03891901|322829344|FG007|Overall Study|Poor venous access|0|||
94284604|NCT03891901|322829345|FG008|Overall Study|Poor venous access|0|||
94284605|NCT03891901|322829337|FG000|Overall Study|Withdrawal by Subject|0|||
94284606|NCT03891901|322829338|FG001|Overall Study|Withdrawal by Subject|2|||
94284607|NCT03891901|322829339|FG002|Overall Study|Withdrawal by Subject|0|||
94284608|NCT03891901|322829340|FG003|Overall Study|Withdrawal by Subject|0|||
94284609|NCT03891901|322829341|FG004|Overall Study|Withdrawal by Subject|0|||
94284610|NCT03891901|322829342|FG005|Overall Study|Withdrawal by Subject|0|||
94372323|NCT01872689|323150241|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
94284611|NCT03891901|322829343|FG006|Overall Study|Withdrawal by Subject|0|||
94284612|NCT03891901|322829344|FG007|Overall Study|Withdrawal by Subject|0|||
94284613|NCT03891901|322829345|FG008|Overall Study|Withdrawal by Subject|0|||
94284614|NCT01145066|322829346|FG000|Overall Study|To resume NSAIDs|2|||
94284615|NCT01145066|322829347|FG001|Overall Study|To resume NSAIDs|2|||
94284616|NCT01145066|322829348|FG002|Overall Study|To resume NSAIDs|1|||
94284617|NCT01145066|322829346|FG000|Overall Study|Non-related surgery|0|||
94284618|NCT01145066|322829347|FG001|Overall Study|Non-related surgery|0|||
94284619|NCT01145066|322829348|FG002|Overall Study|Non-related surgery|1|||
94211843|NCT02066636|322569248|FG001|Overall Study|Other reasons|15|||
94211844|NCT02066636|322569249|FG002|Overall Study|Other reasons|50|||
94211845|NCT01075152|322569253|FG000|Overall Study|Withdrawal by Subject|1|||
94211846|NCT01075152|322569254|FG001|Overall Study|Withdrawal by Subject|0|||
94211847|NCT01079949|322569255|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
94211848|NCT01079949|322569256|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
94372324|NCT01872689|323150242|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
94372325|NCT01872689|323150243|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
94211849|NCT01079949|322569255|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
94211850|NCT01079949|322569256|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
94211851|NCT01079949|322569255|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
94211852|NCT01079949|322569256|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
94211853|NCT01079949|322569255|FG000|Overall Study|Randomized but not treated|1|||
94211854|NCT01079949|322569256|FG001|Overall Study|Randomized but not treated|0|||
94211855|NCT01529632|322569257|FG000|Overall Study|Administrative problem|2|||
94211856|NCT01529632|322569258|FG001|Overall Study|Administrative problem|1|||
94284620|NCT01145066|322829346|FG000|Overall Study|Withdrawal by Subject|0|||
94284621|NCT01145066|322829347|FG001|Overall Study|Withdrawal by Subject|0|||
94284622|NCT01145066|322829348|FG002|Overall Study|Withdrawal by Subject|2|||
94211857|NCT01529632|322569257|FG000|Overall Study|Protocol Violation|0|||
94284623|NCT01145066|322829346|FG000|Overall Study|To start new med|1|||
94211858|NCT01529632|322569258|FG001|Overall Study|Protocol Violation|1|||
94211859|NCT01529632|322569257|FG000|Overall Study|Adverse Event|1|||
94211860|NCT01529632|322569258|FG001|Overall Study|Adverse Event|1|||
94211861|NCT04919499|322569260|FG000|Overall Study|Adverse Event|0|||
94211862|NCT04919499|322569261|FG001|Overall Study|Adverse Event|0|||
94211863|NCT04919499|322569262|FG002|Overall Study|Adverse Event|0|||
94211864|NCT04919499|322569263|FG003|Overall Study|Adverse Event|0|||
94211865|NCT04919499|322569264|FG004|Overall Study|Adverse Event|2|||
94211866|NCT04919499|322569260|FG000|Overall Study|Not treated|0|||
94211867|NCT04919499|322569261|FG001|Overall Study|Not treated|0|||
94211868|NCT04919499|322569262|FG002|Overall Study|Not treated|0|||
94211869|NCT04919499|322569263|FG003|Overall Study|Not treated|1|||
94211870|NCT04919499|322569264|FG004|Overall Study|Not treated|0|||
94211871|NCT00535626|322571917|FG000|Overall Study|Death|15|||
94211872|NCT00535626|322571917|FG000|Overall Study|Lost to Follow-up|29|||
94211873|NCT00535626|322571917|FG000|Overall Study|Withdrawal by Subject|20|||
94211874|NCT00535626|322571917|FG000|Overall Study|Removal/revision of study component|8|||
94211875|NCT00535626|322571917|FG000|Overall Study|Subject terminated|31|||
94211876|NCT00535626|322571917|FG000|Overall Study|Unable to return|2|||
94211877|NCT02710669|322571918|FG000|Overall Study|Physician Decision|2|||
94211878|NCT02710669|322571919|FG001|Overall Study|Physician Decision|1|||
94211879|NCT02710669|322571920|FG002|Overall Study|Physician Decision|0|||
94211880|NCT02710669|322571918|FG000|Overall Study|Institutional delays (including COVID)|2|||
94211881|NCT02710669|322571919|FG001|Overall Study|Institutional delays (including COVID)|2|||
94211882|NCT02710669|322571920|FG002|Overall Study|Institutional delays (including COVID)|0|||
94211883|NCT02710669|322571918|FG000|Overall Study|arrived in afib/aflutter|10|||
94211884|NCT02710669|322571919|FG001|Overall Study|arrived in afib/aflutter|8|||
94211885|NCT02710669|322571920|FG002|Overall Study|arrived in afib/aflutter|2|||
94284624|NCT01145066|322829347|FG001|Overall Study|To start new med|0|||
94284625|NCT01145066|322829348|FG002|Overall Study|To start new med|0|||
94284626|NCT01145066|322829346|FG000|Overall Study|problems swallowing capsule|1|||
94284627|NCT01145066|322829347|FG001|Overall Study|problems swallowing capsule|0|||
94284628|NCT01145066|322829348|FG002|Overall Study|problems swallowing capsule|0|||
94284629|NCT01145066|322829346|FG000|Overall Study|Abdominal discomfort|0|||
94284630|NCT01145066|322829347|FG001|Overall Study|Abdominal discomfort|1|||
94284631|NCT01145066|322829348|FG002|Overall Study|Abdominal discomfort|0|||
94284632|NCT01145066|322829346|FG000|Overall Study|Low platelet count|0|||
94284633|NCT01145066|322829347|FG001|Overall Study|Low platelet count|1|||
94284634|NCT01145066|322829348|FG002|Overall Study|Low platelet count|0|||
94284635|NCT03742037|322829349|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
94284636|NCT03742037|322829350|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
94284637|NCT03742037|322829351|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
94284638|NCT03742037|322829352|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
94211886|NCT04323800|322571923|FG000|Overall Study|Withdrawal by Subject|4|||
94211887|NCT04323800|322571924|FG001|Overall Study|Withdrawal by Subject|4|||
94211888|NCT04323800|322571923|FG000|Overall Study|Incomplete transfusion|1|||
94211889|NCT04323800|322571924|FG001|Overall Study|Incomplete transfusion|0|||
94211890|NCT04323800|322571923|FG000|Overall Study|Other|0|||
94211891|NCT04323800|322571924|FG001|Overall Study|Other|1|||
94211892|NCT04323800|322571923|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
94211893|NCT04323800|322571924|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
94211894|NCT01732757|322571925|FG000|Overall Study|Lost to Follow-up|1|||
94284639|NCT03742037|322829353|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
94284640|NCT03742037|322829354|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
94284641|NCT03742037|322829355|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
94284642|NCT03742037|322829349|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
94284643|NCT03742037|322829350|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
94284644|NCT03742037|322829351|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
94284645|NCT03742037|322829352|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
94372326|NCT01872689|323150240|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
94211895|NCT01732757|322571926|FG001|Overall Study|Lost to Follow-up|0|||
94284646|NCT03742037|322829353|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
94211896|NCT01732757|322571927|FG002|Overall Study|Lost to Follow-up|0|||
94211897|NCT02372799|322571928|FG000|Treatment Period|Adverse Event|3|||
94211898|NCT02372799|322571929|FG001|Treatment Period|Adverse Event|10|||
94211899|NCT02372799|322571930|FG002|Treatment Period|Adverse Event|6|||
94211900|NCT02372799|322571928|FG000|Treatment Period|Insufficient therapeutic response|2|||
94211901|NCT02372799|322571929|FG001|Treatment Period|Insufficient therapeutic response|2|||
94211902|NCT02372799|322571930|FG002|Treatment Period|Insufficient therapeutic response|0|||
94211903|NCT02372799|322571928|FG000|Treatment Period|Withdrawal by Subject|10|||
94211904|NCT02372799|322571929|FG001|Treatment Period|Withdrawal by Subject|10|||
94211905|NCT02372799|322571930|FG002|Treatment Period|Withdrawal by Subject|2|||
94211906|NCT02372799|322571928|FG000|Treatment Period|Lost to Follow-up|11|||
94211907|NCT02372799|322571929|FG001|Treatment Period|Lost to Follow-up|5|||
94211908|NCT02372799|322571930|FG002|Treatment Period|Lost to Follow-up|3|||
94211909|NCT02372799|322571928|FG000|Treatment Period|Protocol Violation|3|||
94211910|NCT02372799|322571929|FG001|Treatment Period|Protocol Violation|0|||
94211911|NCT02372799|322571930|FG002|Treatment Period|Protocol Violation|0|||
94211912|NCT02372799|322571928|FG000|Treatment Period|Non-compliance with study drug|4|||
94211913|NCT02372799|322571929|FG001|Treatment Period|Non-compliance with study drug|4|||
94211914|NCT02372799|322571930|FG002|Treatment Period|Non-compliance with study drug|4|||
94211915|NCT02372799|322571928|FG000|Treatment Period|Miscellaneous Reasons|1|||
94211916|NCT02372799|322571929|FG001|Treatment Period|Miscellaneous Reasons|1|||
94211917|NCT02372799|322571930|FG002|Treatment Period|Miscellaneous Reasons|0|||
94211918|NCT02372799|322571928|FG000|Down-taper Period|Lost to Follow-up|1|||
94211919|NCT02372799|322571929|FG001|Down-taper Period|Lost to Follow-up|2|||
94211920|NCT02372799|322571930|FG002|Down-taper Period|Lost to Follow-up|2|||
94211921|NCT01523392|322571931|FG000|Treatment Period 1|Withdrawal by Subject|2|||
94211922|NCT01523392|322571932|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94211923|NCT01523392|322571931|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
94211924|NCT01523392|322571932|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
94211925|NCT01523392|322571931|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
94211926|NCT01523392|322571932|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
94211927|NCT01380145|322571933|FG000|Overall Study|Progressive disease|4|||
94211928|NCT02038049|322571934|FG000|Overall Study|Lost to Follow-up|1|||
94211929|NCT02038049|322571935|FG001|Overall Study|Lost to Follow-up|0|||
94211930|NCT02771366|322571936|FG000|Period 1|Withdrawal by Subject|0|||
94211931|NCT02771366|322571937|FG001|Period 1|Withdrawal by Subject|2|||
94211932|NCT02771366|322571936|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
94211933|NCT02771366|322571937|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
94211934|NCT00671853|322571938|FG000|Overall Study|Lack of Efficacy|3|||
94211935|NCT00671853|322571939|FG001|Overall Study|Lack of Efficacy|7|||
94211936|NCT00671853|322571938|FG000|Overall Study|Adverse Event|7|||
94211937|NCT00671853|322571939|FG001|Overall Study|Adverse Event|1|||
94211938|NCT00671853|322571938|FG000|Overall Study|Withdrawal by Subject|1|||
94211939|NCT00671853|322571939|FG001|Overall Study|Withdrawal by Subject|5|||
94211940|NCT00671853|322571938|FG000|Overall Study|Lost to Follow-up|8|||
94211941|NCT00671853|322571939|FG001|Overall Study|Lost to Follow-up|8|||
94211942|NCT00671853|322571938|FG000|Overall Study|Physician Decision|0|||
94211943|NCT00671853|322571939|FG001|Overall Study|Physician Decision|2|||
94211944|NCT00671853|322571938|FG000|Overall Study|Non-adherence with study procedures|1|||
94211945|NCT00671853|322571939|FG001|Overall Study|Non-adherence with study procedures|4|||
94211946|NCT02660086|322571940|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
94211947|NCT02660086|322571941|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
94211948|NCT02660086|322571940|FG000|Overall Study- 12-month|Left full-time employment|12|||
94211949|NCT02660086|322571941|FG001|Overall Study- 12-month|Left full-time employment|20|||
94211950|NCT02660086|322571940|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
94211951|NCT02660086|322571941|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
94211952|NCT02660086|322571940|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
94211953|NCT02660086|322571941|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
94211954|NCT02660086|322571940|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
94211955|NCT02660086|322571941|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
94211956|NCT02660086|322571940|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
94211957|NCT02660086|322571941|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
94211958|NCT03737110|322571942|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
94467780|NCT00312572|323502396|FG001|Overall Study|Adverse Event|16|||
94211959|NCT03737110|322571943|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
94211960|NCT03737110|322571944|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
94211961|NCT03737110|322571945|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
94211962|NCT03737110|322571946|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
94211963|NCT03737110|322571947|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
94211964|NCT03737110|322571942|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
94211965|NCT03737110|322571943|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
94211966|NCT03737110|322571944|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
94211967|NCT03737110|322571945|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
94211968|NCT03737110|322571946|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
94211969|NCT03737110|322571947|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
94211970|NCT03737110|322571942|FG000|Run-in (RI) Period|Adverse Event|4|||
94211971|NCT03737110|322571943|FG001|Run-in (RI) Period|Adverse Event|0|||
94211972|NCT03737110|322571944|FG002|Run-in (RI) Period|Adverse Event|0|||
94284647|NCT03742037|322829354|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
94284648|NCT03742037|322829355|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
94284649|NCT03742037|322829349|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
94211973|NCT03737110|322571945|FG003|Run-in (RI) Period|Adverse Event|0|||
94211974|NCT03737110|322571946|FG004|Run-in (RI) Period|Adverse Event|0|||
94211975|NCT03737110|322571947|FG005|Run-in (RI) Period|Adverse Event|0|||
94211976|NCT03737110|322571942|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
94211977|NCT03737110|322571943|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
94211978|NCT03737110|322571944|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
94211979|NCT03737110|322571945|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
94211980|NCT03737110|322571946|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
94211981|NCT03737110|322571947|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
94211982|NCT03737110|322571942|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
94211983|NCT03737110|322571943|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
94211984|NCT03737110|322571944|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
94211985|NCT03737110|322571945|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
94211986|NCT03737110|322571946|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
94211987|NCT03737110|322571947|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
94211988|NCT03737110|322571942|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
94211989|NCT03737110|322571943|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
94211990|NCT03737110|322571944|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
94211991|NCT03737110|322571945|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
94211992|NCT03737110|322571946|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
94211993|NCT03737110|322571947|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
94211994|NCT03737110|322571942|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
94211995|NCT03737110|322571943|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
94211996|NCT03737110|322571944|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
94284650|NCT03742037|322829350|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
94284651|NCT03742037|322829351|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
94284652|NCT03742037|322829352|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
94284653|NCT03742037|322829353|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
94284654|NCT03742037|322829354|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
94284655|NCT03742037|322829355|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
94284656|NCT03742037|322829349|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
94284657|NCT03742037|322829350|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
94284658|NCT03742037|322829351|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
94284659|NCT03742037|322829352|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
94284660|NCT03742037|322829353|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
94284661|NCT03742037|322829354|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
94284662|NCT03742037|322829355|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
94284663|NCT03742037|322829349|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
94284664|NCT03742037|322829350|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
94284665|NCT03742037|322829351|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
94284666|NCT03742037|322829352|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
94284667|NCT03742037|322829353|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
94211997|NCT03737110|322571945|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
94211998|NCT03737110|322571946|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
94211999|NCT03737110|322571947|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
94212000|NCT03737110|322571942|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
94284668|NCT03742037|322829354|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
94284669|NCT03742037|322829355|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
94284670|NCT03742037|322829349|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
94284671|NCT03742037|322829350|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
94284672|NCT03742037|322829351|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
94284673|NCT03742037|322829352|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
94284674|NCT03742037|322829353|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
94284675|NCT03742037|322829354|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
94212001|NCT03737110|322571943|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
94212002|NCT03737110|322571944|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
94212003|NCT03737110|322571945|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
94212004|NCT03737110|322571946|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
94212005|NCT03737110|322571947|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
94212006|NCT01852045|322571948|FG000|Overall Study|Adverse Event|1|||
94212007|NCT01852045|322571949|FG001|Overall Study|Adverse Event|0|||
94212008|NCT01852045|322571950|FG002|Overall Study|Adverse Event|0|||
94212009|NCT01852045|322571948|FG000|Overall Study|Lack of Efficacy|3|||
94212010|NCT01852045|322571949|FG001|Overall Study|Lack of Efficacy|0|||
94212011|NCT01852045|322571950|FG002|Overall Study|Lack of Efficacy|0|||
94212012|NCT01852045|322571948|FG000|Overall Study|Lost to Follow-up|0|||
94212013|NCT01852045|322571949|FG001|Overall Study|Lost to Follow-up|1|||
94212014|NCT01852045|322571950|FG002|Overall Study|Lost to Follow-up|1|||
94212015|NCT01852045|322571948|FG000|Overall Study|Withdrawal by Subject|1|||
94212016|NCT01852045|322571949|FG001|Overall Study|Withdrawal by Subject|0|||
94212017|NCT01852045|322571950|FG002|Overall Study|Withdrawal by Subject|1|||
94212018|NCT01852045|322571948|FG000|Overall Study|Other Miscellaneous Reasons|1|||
94212019|NCT01852045|322571949|FG001|Overall Study|Other Miscellaneous Reasons|3|||
94212020|NCT01852045|322571950|FG002|Overall Study|Other Miscellaneous Reasons|2|||
94212021|NCT05124210|322571951|FG000|Overall Study|Lost to Follow-up|1|||
94212022|NCT05124210|322571952|FG001|Overall Study|Lost to Follow-up|0|||
94212023|NCT05124210|322571951|FG000|Overall Study|Withdrawal by Subject|1|||
94212024|NCT05124210|322571952|FG001|Overall Study|Withdrawal by Subject|0|||
94212025|NCT01428583|322571954|FG000|Overall Study|Adverse Event|75|||
94212026|NCT01428583|322571954|FG000|Overall Study|Withdrawal by Subject|51|||
94212027|NCT01428583|322571954|FG000|Overall Study|Lack of Efficacy|37|||
94212028|NCT01428583|322571954|FG000|Overall Study|Lost to Follow-up|17|||
94212029|NCT01428583|322571954|FG000|Overall Study|Death|1|||
94212030|NCT01428583|322571954|FG000|Overall Study|Pregnancy|1|||
94212031|NCT01428583|322571954|FG000|Overall Study|Protocol Violation|1|||
94212032|NCT01428583|322571954|FG000|Overall Study|Physician Decision|12|||
94212033|NCT01428583|322571954|FG000|Overall Study|Non-compliant|25|||
94212034|NCT01428583|322571954|FG000|Overall Study|Confirmed positive urine drug test|8|||
94212035|NCT01428583|322571954|FG000|Overall Study|Sponsor's request|3|||
94212036|NCT01428583|322571954|FG000|Overall Study|Other|6|||
94212037|NCT00768755|322571957|FG000|Phase 1|Death|6|||
94212038|NCT00768755|322571958|FG001|Phase 1|Death|0|||
94284676|NCT03742037|322829355|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
94284677|NCT03742037|322829349|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
94284678|NCT03742037|322829350|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
94284679|NCT03742037|322829351|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
94284680|NCT03742037|322829352|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
94284681|NCT03742037|322829353|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
94284682|NCT03742037|322829354|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
94284683|NCT03742037|322829355|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
94284684|NCT03742037|322829349|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
94284685|NCT03742037|322829350|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
94284686|NCT03742037|322829351|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
94284687|NCT03742037|322829352|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
94284688|NCT03742037|322829353|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
94284689|NCT03742037|322829354|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
94284690|NCT03742037|322829355|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
94284691|NCT03742037|322829349|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
94284692|NCT03742037|322829350|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
94284693|NCT03742037|322829351|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
94212039|NCT00768755|322571959|FG002|Phase 1|Death|0|||
94212040|NCT00768755|322571960|FG003|Phase 1|Death|0|||
94212041|NCT00768755|322571957|FG000|Phase 1|Other|4|||
94212042|NCT00768755|322571958|FG001|Phase 1|Other|0|||
94212043|NCT00768755|322571959|FG002|Phase 1|Other|0|||
94212044|NCT00768755|322571960|FG003|Phase 1|Other|0|||
94212045|NCT00768755|322571957|FG000|Phase 2|Death|0|||
94212046|NCT00768755|322571958|FG001|Phase 2|Death|37|||
94212047|NCT00768755|322571959|FG002|Phase 2|Death|48|||
94284694|NCT03742037|322829352|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
94284695|NCT03742037|322829353|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
94284696|NCT03742037|322829354|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
94284697|NCT03742037|322829355|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
94284698|NCT03742037|322829349|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
94467781|NCT00312572|323502395|FG000|Overall Study|Lost to Follow-up|1|||
94212048|NCT00768755|322571960|FG003|Phase 2|Death|31|||
94212049|NCT00768755|322571957|FG000|Phase 2|Protocol Violation|0|||
94212050|NCT00768755|322571958|FG001|Phase 2|Protocol Violation|2|||
94212051|NCT00768755|322571959|FG002|Phase 2|Protocol Violation|0|||
94212052|NCT00768755|322571960|FG003|Phase 2|Protocol Violation|1|||
94212053|NCT00768755|322571957|FG000|Phase 2|Lost to Follow-up|0|||
94212054|NCT00768755|322571958|FG001|Phase 2|Lost to Follow-up|1|||
94212055|NCT00768755|322571959|FG002|Phase 2|Lost to Follow-up|1|||
94212056|NCT00768755|322571960|FG003|Phase 2|Lost to Follow-up|4|||
94212057|NCT00768755|322571957|FG000|Phase 2|Withdrawal by Subject|0|||
94212058|NCT00768755|322571958|FG001|Phase 2|Withdrawal by Subject|1|||
94212059|NCT00768755|322571959|FG002|Phase 2|Withdrawal by Subject|0|||
94212060|NCT00768755|322571960|FG003|Phase 2|Withdrawal by Subject|1|||
94212061|NCT00768755|322571957|FG000|Phase 2|Other|0|||
94212062|NCT00768755|322571958|FG001|Phase 2|Other|1|||
94212063|NCT00768755|322571959|FG002|Phase 2|Other|2|||
94212064|NCT00768755|322571960|FG003|Phase 2|Other|4|||
94212065|NCT00768755|322571957|FG000|Phase 2|Study Terminated by Sponsor|0|||
94212066|NCT00768755|322571958|FG001|Phase 2|Study Terminated by Sponsor|13|||
94212067|NCT00768755|322571959|FG002|Phase 2|Study Terminated by Sponsor|7|||
94212068|NCT00768755|322571960|FG003|Phase 2|Study Terminated by Sponsor|14|||
94212069|NCT00768755|322571957|FG000|Phase 2|Randomized but not treated|0|||
94212070|NCT00768755|322571958|FG001|Phase 2|Randomized but not treated|0|||
94212071|NCT00768755|322571959|FG002|Phase 2|Randomized but not treated|0|||
94212072|NCT00768755|322571960|FG003|Phase 2|Randomized but not treated|2|||
94212073|NCT00670488|322571962|FG000|Overall Study|Adverse Event|0|||
94212074|NCT00670488|322571963|FG001|Overall Study|Adverse Event|7|||
94212075|NCT00670488|322571964|FG002|Overall Study|Adverse Event|0|||
94212076|NCT00670488|322571965|FG003|Overall Study|Adverse Event|3|||
94212077|NCT00670488|322571966|FG004|Overall Study|Adverse Event|1|||
94212078|NCT00670488|322571967|FG005|Overall Study|Adverse Event|1|||
94212079|NCT00670488|322571968|FG006|Overall Study|Adverse Event|5|||
94212080|NCT00670488|322571969|FG007|Overall Study|Adverse Event|1|||
94212081|NCT00670488|322571970|FG008|Overall Study|Adverse Event|0|||
94212082|NCT00670488|322571971|FG009|Overall Study|Adverse Event|1|||
94212083|NCT00670488|322571962|FG000|Overall Study|Physician Decision|1|||
94212084|NCT00670488|322571963|FG001|Overall Study|Physician Decision|9|||
94212085|NCT00670488|322571964|FG002|Overall Study|Physician Decision|0|||
94212086|NCT00670488|322571965|FG003|Overall Study|Physician Decision|1|||
94212087|NCT00670488|322571966|FG004|Overall Study|Physician Decision|0|||
94212088|NCT00670488|322571967|FG005|Overall Study|Physician Decision|0|||
94212089|NCT00670488|322571968|FG006|Overall Study|Physician Decision|0|||
94212090|NCT00670488|322571969|FG007|Overall Study|Physician Decision|0|||
94212091|NCT00670488|322571970|FG008|Overall Study|Physician Decision|0|||
94212092|NCT00670488|322571971|FG009|Overall Study|Physician Decision|0|||
94212093|NCT00670488|322571962|FG000|Overall Study|Progressive Disease|2|||
94212094|NCT00670488|322571963|FG001|Overall Study|Progressive Disease|41|||
94212095|NCT00670488|322571964|FG002|Overall Study|Progressive Disease|3|||
94212096|NCT00670488|322571965|FG003|Overall Study|Progressive Disease|2|||
94212097|NCT00670488|322571966|FG004|Overall Study|Progressive Disease|2|||
94212098|NCT00670488|322571967|FG005|Overall Study|Progressive Disease|4|||
94212099|NCT00670488|322571968|FG006|Overall Study|Progressive Disease|11|||
94212100|NCT00670488|322571969|FG007|Overall Study|Progressive Disease|2|||
94212101|NCT00670488|322571970|FG008|Overall Study|Progressive Disease|2|||
94212102|NCT00670488|322571971|FG009|Overall Study|Progressive Disease|1|||
94212103|NCT00670488|322571962|FG000|Overall Study|Withdrawal by Subject|0|||
94212104|NCT00670488|322571963|FG001|Overall Study|Withdrawal by Subject|1|||
94212105|NCT00670488|322571964|FG002|Overall Study|Withdrawal by Subject|0|||
94212106|NCT00670488|322571965|FG003|Overall Study|Withdrawal by Subject|1|||
94212107|NCT00670488|322571966|FG004|Overall Study|Withdrawal by Subject|0|||
94212108|NCT00670488|322571967|FG005|Overall Study|Withdrawal by Subject|0|||
94212109|NCT00670488|322571968|FG006|Overall Study|Withdrawal by Subject|1|||
94467782|NCT00312572|323502396|FG001|Overall Study|Lost to Follow-up|1|||
94467783|NCT00312572|323502395|FG000|Overall Study|Administrative|4|||
94212110|NCT00670488|322571969|FG007|Overall Study|Withdrawal by Subject|0|||
94212111|NCT00670488|322571970|FG008|Overall Study|Withdrawal by Subject|1|||
94212112|NCT00670488|322571971|FG009|Overall Study|Withdrawal by Subject|0|||
94212113|NCT00310037|322571972|FG000|Overall Study|Adverse Event|7|||
94212114|NCT00310037|322571973|FG001|Overall Study|Adverse Event|14|||
94212115|NCT00310037|322571972|FG000|Overall Study|Withdrawal by Subject|4|||
94212116|NCT00310037|322571973|FG001|Overall Study|Withdrawal by Subject|3|||
94212117|NCT00310037|322571972|FG000|Overall Study|Progression|6|||
94212118|NCT00310037|322571973|FG001|Overall Study|Progression|0|||
94212119|NCT00310037|322571972|FG000|Overall Study|Non-protocol treatment|1|||
94212120|NCT00310037|322571973|FG001|Overall Study|Non-protocol treatment|0|||
94212121|NCT04693637|322571978|FG000|Overall Study|Death|4|||
94212122|NCT04693637|322571978|FG000|Overall Study|Withdrawal by Subject|3|||
94212123|NCT04693637|322571978|FG000|Overall Study|Physician Decision|2|||
94212124|NCT04693637|322571978|FG000|Overall Study|Lost to Follow-up|1|||
94212125|NCT04237792|322571979|FG000|Treatment (Day 1)|Adverse Event|1|||
94212126|NCT04237792|322571980|FG001|Treatment (Day 1)|Adverse Event|0|||
94212127|NCT04237792|322571981|FG002|Treatment (Day 1)|Adverse Event|0|||
94212128|NCT04237792|322571982|FG003|Treatment (Day 1)|Adverse Event|0|||
94467784|NCT00312572|323502396|FG001|Overall Study|Administrative|2|||
94284699|NCT03742037|322829350|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
94284700|NCT03742037|322829351|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
94284701|NCT03742037|322829352|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
94284702|NCT03742037|322829353|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
94284703|NCT03742037|322829354|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
94284704|NCT03742037|322829355|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
94284705|NCT03742037|322829349|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
94284706|NCT03742037|322829350|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
94212129|NCT04237792|322571983|FG004|Treatment (Day 1)|Adverse Event|1|||
94212130|NCT04237792|322571984|FG005|Treatment (Day 1)|Adverse Event|1|||
94212131|NCT04237792|322571979|FG000|Treatment (Day 1)|Other|0|||
94212132|NCT04237792|322571980|FG001|Treatment (Day 1)|Other|0|||
94212133|NCT04237792|322571981|FG002|Treatment (Day 1)|Other|1|||
94212134|NCT04237792|322571982|FG003|Treatment (Day 1)|Other|0|||
94212135|NCT04237792|322571983|FG004|Treatment (Day 1)|Other|0|||
94212136|NCT04237792|322571984|FG005|Treatment (Day 1)|Other|1|||
94212137|NCT04237792|322571979|FG000|Treatment (Day 1)|Not treated|1|||
94212138|NCT04237792|322571980|FG001|Treatment (Day 1)|Not treated|1|||
94212139|NCT04237792|322571981|FG002|Treatment (Day 1)|Not treated|2|||
94212140|NCT04237792|322571982|FG003|Treatment (Day 1)|Not treated|1|||
94212141|NCT04237792|322571983|FG004|Treatment (Day 1)|Not treated|0|||
94212142|NCT04237792|322571984|FG005|Treatment (Day 1)|Not treated|1|||
94284707|NCT03742037|322829351|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
94284708|NCT03742037|322829352|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
94284709|NCT03742037|322829353|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
94284710|NCT03742037|322829354|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
94284711|NCT03742037|322829355|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
94284712|NCT03742037|322829349|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
94284713|NCT03742037|322829350|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
94284714|NCT03742037|322829351|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
94284715|NCT03742037|322829352|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
94284716|NCT03742037|322829353|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
94284717|NCT03742037|322829354|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
94284718|NCT03742037|322829355|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
94284719|NCT03742037|322829349|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
94284720|NCT03742037|322829350|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
94284721|NCT03742037|322829351|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
94284722|NCT03742037|322829352|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
94284723|NCT03742037|322829353|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
94284724|NCT03742037|322829354|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
94284725|NCT03742037|322829355|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
94284726|NCT03742037|322829349|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
94284727|NCT03742037|322829350|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
94284728|NCT03742037|322829351|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
94284729|NCT03742037|322829352|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
94284730|NCT03742037|322829353|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
94284731|NCT03742037|322829354|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
94284732|NCT03742037|322829355|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
94330889|NCT01522443|322991750|FG000|Overall Study|Withdrawal by Subject|5|||
94212143|NCT00929526|322571985|FG000|Overall Study|Withdrawal by Subject|1|||
94212144|NCT00929526|322571986|FG001|Overall Study|Withdrawal by Subject|11|||
94212145|NCT00929526|322571985|FG000|Overall Study|Lost to Follow-up|8|||
94212146|NCT00929526|322571986|FG001|Overall Study|Lost to Follow-up|12|||
94212147|NCT00929526|322571985|FG000|Overall Study|Other|8|||
94212148|NCT00929526|322571986|FG001|Overall Study|Other|6|||
94212149|NCT01480258|322571989|FG000|Infant Series|Protocol Violation|2|||
94212150|NCT01480258|322571990|FG001|Infant Series|Protocol Violation|0|||
94212151|NCT01480258|322571989|FG000|Infant Series|Physician Decision|0|||
94212152|NCT01480258|322571990|FG001|Infant Series|Physician Decision|1|||
94212153|NCT01480258|322571989|FG000|Infant Series|Not Vaccinated|3|||
94212154|NCT01480258|322571990|FG001|Infant Series|Not Vaccinated|0|||
94212155|NCT01480258|322571989|FG000|Infant Series|Adverse Event|1|||
94212156|NCT01480258|322571990|FG001|Infant Series|Adverse Event|1|||
94212157|NCT01480258|322571989|FG000|Infant Series|Withdrawal by Subject|1|||
94212158|NCT01480258|322571990|FG001|Infant Series|Withdrawal by Subject|6|||
94212159|NCT01480258|322571989|FG000|Interim Period|Lost to Follow-up|0|||
94212160|NCT01480258|322571990|FG001|Interim Period|Lost to Follow-up|2|||
94212161|NCT01480258|322571989|FG000|Interim Period|Physician Decision|1|||
94212162|NCT01480258|322571990|FG001|Interim Period|Physician Decision|0|||
94212163|NCT01480258|322571989|FG000|Interim Period|Protocol Violation|0|||
94212164|NCT01480258|322571990|FG001|Interim Period|Protocol Violation|1|||
94212165|NCT01480258|322571989|FG000|Interim Period|Withdrawal by Subject|9|||
94212166|NCT01480258|322571990|FG001|Interim Period|Withdrawal by Subject|6|||
94212167|NCT00749944|322571999|FG000|Overall Study|Lost to Follow-up|2|||
94212168|NCT00749944|322572000|FG001|Overall Study|Lost to Follow-up|1|||
94212169|NCT00749944|322571999|FG000|Overall Study|Other|1|||
94212170|NCT00749944|322572000|FG001|Overall Study|Other|0|||
94212171|NCT00749944|322571999|FG000|Overall Study|Withdrawal by Subject|2|||
94212172|NCT00749944|322572000|FG001|Overall Study|Withdrawal by Subject|0|||
94212173|NCT00624377|322572001|FG000|Overall Study|Lost to Follow-up|355|||
94212174|NCT00624377|322572001|FG000|Overall Study|Withdrawal by Subject|100|||
94212175|NCT00624377|322572001|FG000|Overall Study|Adverse Event|14|||
94212176|NCT00624377|322572001|FG000|Overall Study|Other|91|||
94212177|NCT00624377|322572001|FG000|Overall Study|Non-evaluable population|84|||
94212178|NCT00910962|322572004|FG000|Overall Study|Adverse Event|5|||
94212179|NCT00910962|322572005|FG001|Overall Study|Adverse Event|20|||
94212180|NCT00910962|322572006|FG002|Overall Study|Adverse Event|17|||
94212181|NCT00910962|322572004|FG000|Overall Study|Protocol Violation|1|||
94212182|NCT00910962|322572005|FG001|Overall Study|Protocol Violation|3|||
94212183|NCT00910962|322572006|FG002|Overall Study|Protocol Violation|3|||
94212184|NCT00910962|322572004|FG000|Overall Study|Lost to Follow-up|0|||
94212185|NCT00910962|322572005|FG001|Overall Study|Lost to Follow-up|3|||
94212186|NCT00910962|322572006|FG002|Overall Study|Lost to Follow-up|1|||
94330890|NCT01522443|322991751|FG001|Overall Study|Withdrawal by Subject|8|||
94330891|NCT01522443|322991750|FG000|Overall Study|No study treatment given|1|||
94330892|NCT01522443|322991751|FG001|Overall Study|No study treatment given|1|||
94284733|NCT03742037|322829349|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
94284734|NCT03742037|322829350|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
94284735|NCT03742037|322829351|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
94284736|NCT03742037|322829352|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
94284737|NCT03742037|322829353|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
94284738|NCT03742037|322829354|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
94284739|NCT03742037|322829355|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
94284740|NCT00217087|322829356|FG000|Overall Study|decided to have esophagectomy|1|||
94284741|NCT00217087|322829357|FG001|Overall Study|decided to have esophagectomy|2|||
94284742|NCT00217087|322829356|FG000|Overall Study|completed less than 12 months return|10|||
94284743|NCT00217087|322829357|FG001|Overall Study|completed less than 12 months return|18|||
94284744|NCT03208231|322829358|FG000|Overall Study|Death|1|||
94284745|NCT03208231|322829359|FG001|Overall Study|Death|2|||
94284746|NCT03208231|322829358|FG000|Overall Study|Moved and unable to get to clinic|1|||
94284747|NCT03208231|322829359|FG001|Overall Study|Moved and unable to get to clinic|0|||
94212187|NCT00910962|322572004|FG000|Overall Study|Physician Decision|0|||
94212188|NCT00910962|322572005|FG001|Overall Study|Physician Decision|6|||
94212189|NCT00910962|322572006|FG002|Overall Study|Physician Decision|6|||
94212190|NCT00910962|322572004|FG000|Overall Study|Withdrawal by Subject|25|||
94212191|NCT00910962|322572005|FG001|Overall Study|Withdrawal by Subject|32|||
94212192|NCT00910962|322572006|FG002|Overall Study|Withdrawal by Subject|32|||
94212193|NCT00910962|322572004|FG000|Overall Study|Reached defined stopping criteria|12|||
94212194|NCT00910962|322572005|FG001|Overall Study|Reached defined stopping criteria|14|||
94212195|NCT00910962|322572006|FG002|Overall Study|Reached defined stopping criteria|17|||
94212196|NCT01858688|322572007|FG000|Overall Study|Withdrawal by Subject|8|||
94212197|NCT01858688|322572007|FG000|Overall Study|Participant began another therapy|3|||
94284748|NCT03208231|322829358|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
94284749|NCT03208231|322829359|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
94284750|NCT02937350|322829360|FG000|Overall Study|Withdrawal by Subject|0|||
94284751|NCT02937350|322829361|FG001|Overall Study|Withdrawal by Subject|1|||
94284752|NCT02937350|322829362|FG002|Overall Study|Withdrawal by Subject|0|||
94212198|NCT01858688|322572007|FG000|Overall Study|Physician Decision|2|||
94212199|NCT01858688|322572007|FG000|Overall Study|Progressive Disease|2|||
94212200|NCT01858688|322572007|FG000|Overall Study|Reason not reproted|5|||
94212201|NCT00195819|322572008|FG000|Double-Blind|Withdrawal by Subject|1|||
94212202|NCT00195819|322572009|FG001|Double-Blind|Withdrawal by Subject|0|||
94212203|NCT00195819|322572008|FG000|Double-Blind|Moved|1|||
94212204|NCT00195819|322572009|FG001|Double-Blind|Moved|0|||
94212205|NCT00195819|322572008|FG000|Open-label|Adverse Event|0|||
94212206|NCT00195819|322572009|FG001|Open-label|Adverse Event|9|||
94212207|NCT00195819|322572008|FG000|Open-label|Lack of Efficacy|0|||
94212208|NCT00195819|322572009|FG001|Open-label|Lack of Efficacy|2|||
94212209|NCT00195819|322572008|FG000|Open-label|Pregnancy|0|||
94212210|NCT00195819|322572009|FG001|Open-label|Pregnancy|1|||
94212211|NCT00195819|322572008|FG000|Open-label|Protocol Violation|0|||
94212212|NCT00195819|322572009|FG001|Open-label|Protocol Violation|2|||
94212213|NCT00195819|322572008|FG000|Open-label|Moved|0|||
94212214|NCT00195819|322572009|FG001|Open-label|Moved|1|||
94212215|NCT00195819|322572008|FG000|Open-label|Withdrawal by Subject|0|||
94212216|NCT00195819|322572009|FG001|Open-label|Withdrawal by Subject|5|||
94212217|NCT02245620|322572010|FG000|Overall Study|Physician Decision|1|||
94212218|NCT02245620|322572011|FG001|Overall Study|Physician Decision|1|||
94212219|NCT04361617|322572012|FG000|Overall Study|Withdrawal by Subject|0|||
94284753|NCT01106846|322829363|FG000|Overall Study|Change in surgical procedure|0|||
94284754|NCT01106846|322829364|FG001|Overall Study|Change in surgical procedure|1|||
94284755|NCT03110900|322829365|FG000|Overall Study|Sponsor withdrew|1|||
94284756|NCT03110900|322829366|FG001|Overall Study|Sponsor withdrew|1|||
94284757|NCT00546052|322829367|FG000|Overall Study|Adverse Event|47|||
94284758|NCT00546052|322829367|FG000|Overall Study|Lost to Follow-up|144|||
94212220|NCT04361617|322572013|FG001|Overall Study|Withdrawal by Subject|1|||
94212221|NCT03547154|322572017|FG000|Overall Study|Disease Progression/Recurrence|6|||
94212222|NCT03547154|322572018|FG001|Overall Study|Disease Progression/Recurrence|14|||
94212223|NCT03547154|322572017|FG000|Overall Study|Adverse Event|26|||
94212224|NCT03547154|322572018|FG001|Overall Study|Adverse Event|31|||
94212225|NCT03547154|322572017|FG000|Overall Study|Protocol Violation|6|||
94212226|NCT03547154|322572018|FG001|Overall Study|Protocol Violation|1|||
94212227|NCT03547154|322572017|FG000|Overall Study|Physician Decision|4|||
94212228|NCT03547154|322572018|FG001|Overall Study|Physician Decision|3|||
94212229|NCT03547154|322572017|FG000|Overall Study|Insufficient Therapeutic Response|13|||
94212230|NCT03547154|322572018|FG001|Overall Study|Insufficient Therapeutic Response|10|||
94212231|NCT03547154|322572017|FG000|Overall Study|Withdrawal by Subject|10|||
94212232|NCT03547154|322572018|FG001|Overall Study|Withdrawal by Subject|6|||
94212233|NCT03547154|322572017|FG000|Overall Study|Not Selected|0|||
94212234|NCT03547154|322572018|FG001|Overall Study|Not Selected|1|||
94212235|NCT03547154|322572017|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
94212236|NCT03547154|322572018|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
94212237|NCT04679675|322572019|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
94212238|NCT04679675|322572020|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
94212239|NCT04679675|322572021|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
94212240|NCT04679675|322572022|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
94212241|NCT04679675|322572019|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
94212242|NCT04679675|322572020|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
94212243|NCT04679675|322572021|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
94212244|NCT04679675|322572022|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
94212245|NCT03259568|322572026|FG000|Overall Study|Participant performance was low|3|||
94212246|NCT01794299|322572027|FG000|Overall Study|ATIR manufacturing not possible|1|||
94212247|NCT01794299|322572027|FG000|Overall Study|Death|14|||
94212248|NCT01794299|322572027|FG000|Overall Study|Graft failure|1|||
94212249|NCT01794299|322572027|FG000|Overall Study|ATIR batch rejected|2|||
94212250|NCT01794299|322572027|FG000|Overall Study|Relapse|2|||
94212251|NCT01794299|322572027|FG000|Overall Study|Discontinued from active follow-up|1|||
94212252|NCT01794299|322572027|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
94212253|NCT02137785|322572030|FG000|Overall Study|Lost to Follow-up|1|||
94212254|NCT02137785|322572031|FG001|Overall Study|Lost to Follow-up|0|||
94212255|NCT02137785|322572030|FG000|Overall Study|Withdrawal by Subject|1|||
94212256|NCT02137785|322572031|FG001|Overall Study|Withdrawal by Subject|4|||
94212257|NCT02137785|322572030|FG000|Overall Study|subject moved out of state|1|||
94212258|NCT02137785|322572031|FG001|Overall Study|subject moved out of state|0|||
94212259|NCT02525744|322572032|FG000|Period 1|Physician Decision|0|||
94212260|NCT02525744|322572033|FG001|Period 1|Physician Decision|0|||
94212261|NCT02525744|322572034|FG002|Period 1|Physician Decision|1|||
94212262|NCT02525744|322572035|FG003|Period 1|Physician Decision|0|||
94212263|NCT02525744|322572032|FG000|Period 3|Adverse Event|0|||
94212264|NCT02525744|322572033|FG001|Period 3|Adverse Event|1|||
94212265|NCT02525744|322572034|FG002|Period 3|Adverse Event|0|||
94212266|NCT02525744|322572035|FG003|Period 3|Adverse Event|0|||
94212267|NCT02525744|322572032|FG000|Period 4|Withdrawal by Subject|1|||
94212268|NCT02525744|322572033|FG001|Period 4|Withdrawal by Subject|0|||
94212269|NCT02525744|322572034|FG002|Period 4|Withdrawal by Subject|0|||
94212270|NCT02525744|322572035|FG003|Period 4|Withdrawal by Subject|0|||
94212271|NCT02525744|322572032|FG000|Period 5|Physician Decision|1|||
94212272|NCT02525744|322572033|FG001|Period 5|Physician Decision|0|||
94212273|NCT02525744|322572034|FG002|Period 5|Physician Decision|0|||
94212274|NCT02525744|322572035|FG003|Period 5|Physician Decision|0|||
94212275|NCT00621842|322572038|FG000|Overall Study|Adverse Event|6|||
94212276|NCT00621842|322572038|FG000|Overall Study|Withdrawal by Subject|7|||
94212277|NCT00621842|322572038|FG000|Overall Study|Protocol Violation|4|||
94212278|NCT00621842|322572038|FG000|Overall Study|Lack of Efficacy|2|||
94212279|NCT04617847|322572039|FG000|Overall Study|Withdrawal by Subject|1|||
94212280|NCT04617847|322572040|FG001|Overall Study|Withdrawal by Subject|0|||
94212281|NCT04617847|322572039|FG000|Overall Study|Adverse Event|0|||
94212282|NCT04617847|322572040|FG001|Overall Study|Adverse Event|2|||
94212283|NCT04617847|322572039|FG000|Overall Study|Death|0|||
94212284|NCT04617847|322572040|FG001|Overall Study|Death|1|||
94212285|NCT04617847|322572039|FG000|Overall Study|Termination of Study by Sponsor|2|||
94212286|NCT04617847|322572040|FG001|Overall Study|Termination of Study by Sponsor|21|||
94212287|NCT01989689|322572041|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
94212288|NCT01989689|322572042|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
94212289|NCT01989689|322572041|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
94212290|NCT01989689|322572042|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
94212291|NCT00761267|322572043|FG000|Overall Study|Death|1|||
94212292|NCT00761267|322572044|FG001|Overall Study|Death|2|||
94284759|NCT00546052|322829367|FG000|Overall Study|Protocol Violation|9|||
94284760|NCT00546052|322829367|FG000|Overall Study|Withdrawal by Subject|20|||
94284761|NCT00546052|322829367|FG000|Overall Study|Non Compliance|7|||
94284762|NCT00874120|322831676|FG000|First Intervention|Adverse Event|0|||
94284763|NCT00874120|322831677|FG001|First Intervention|Adverse Event|1|||
94284764|NCT00874120|322831676|FG000|First Intervention|Withdrawal by Subject|2|||
94284765|NCT00874120|322831677|FG001|First Intervention|Withdrawal by Subject|0|||
94284766|NCT00874120|322831676|FG000|First Intervention|Lost to Follow-up|0|||
94284767|NCT00874120|322831677|FG001|First Intervention|Lost to Follow-up|1|||
94284768|NCT00874120|322831676|FG000|First Intervention|Protocol Violation|3|||
94284769|NCT00874120|322831677|FG001|First Intervention|Protocol Violation|0|||
94284770|NCT00874120|322831676|FG000|First Intervention|positive drug test|1|||
94284771|NCT00874120|322831677|FG001|First Intervention|positive drug test|0|||
94284772|NCT00874120|322831676|FG000|Second Intervention|Withdrawal by Subject|1|||
94284773|NCT00874120|322831677|FG001|Second Intervention|Withdrawal by Subject|0|||
94284774|NCT00874120|322831676|FG000|Second Intervention|Protocol Violation|1|||
94284775|NCT00874120|322831677|FG001|Second Intervention|Protocol Violation|0|||
94284776|NCT00880893|322831678|FG000|Overall Study|Protocol Violation|13|||
94284777|NCT00880893|322831679|FG001|Overall Study|Protocol Violation|1|||
94284778|NCT00880893|322831678|FG000|Overall Study|Withdrawal by Subject|15|||
94284779|NCT00880893|322831679|FG001|Overall Study|Withdrawal by Subject|11|||
94284780|NCT00880893|322831678|FG000|Overall Study|Lost to Follow-up|76|||
94372327|NCT01872689|323150241|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
94372328|NCT01872689|323150242|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
94372329|NCT01872689|323150243|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
94372330|NCT01872689|323150240|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
94372331|NCT01872689|323150241|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
94372332|NCT01872689|323150242|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
94372333|NCT01872689|323150243|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
94372334|NCT01872689|323150240|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
94372335|NCT01872689|323150241|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
94372336|NCT01872689|323150242|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
94372337|NCT01872689|323150243|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
94372338|NCT02038634|323150244|FG000|Overall Study|Lost to Follow-up|0|||
94372339|NCT02038634|323150245|FG001|Overall Study|Lost to Follow-up|1|||
94372340|NCT01113710|323150246|FG000|Overall Study|Adverse Event|64|||
94372341|NCT01113710|323150246|FG000|Overall Study|Lack of Efficacy|41|||
94372342|NCT01113710|323150246|FG000|Overall Study|No Information Available|40|||
94372343|NCT01113710|323150246|FG000|Overall Study|Withdrawal by Subject|28|||
94372344|NCT01113710|323150246|FG000|Overall Study|Lost to Follow-up|20|||
94372345|NCT01113710|323150246|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
94372346|NCT01113710|323150246|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
94372347|NCT01113710|323150246|FG000|Overall Study|Lack of Patient's Compliance|8|||
94372348|NCT01113710|323150246|FG000|Overall Study|Other|7|||
94372349|NCT01113710|323150246|FG000|Overall Study|Adverse Event/Other|5|||
94372350|NCT01113710|323150246|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
94372351|NCT01113710|323150246|FG000|Overall Study|Lack of Efficacy/Other|4|||
94284781|NCT00880893|322831679|FG001|Overall Study|Lost to Follow-up|33|||
94284782|NCT00880893|322831678|FG000|Overall Study|Serious adverse event|3|||
94284783|NCT00880893|322831679|FG001|Overall Study|Serious adverse event|0|||
94284784|NCT02404103|322831682|FG000|Overall Study|Adverse Event|1|||
94284785|NCT02404103|322831683|FG001|Overall Study|Adverse Event|0|||
94284786|NCT02404103|322831682|FG000|Overall Study|Lost to Follow-up|3|||
94372352|NCT01113710|323150246|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
94372353|NCT01113710|323150246|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
94467785|NCT00312572|323502395|FG000|Overall Study|Lack of Efficacy|1|||
94284787|NCT02404103|322831683|FG001|Overall Study|Lost to Follow-up|3|||
94284788|NCT02543528|322831684|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
94284789|NCT02543528|322831685|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
94284790|NCT02543528|322831686|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
94284791|NCT02543528|322831687|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
94284792|NCT02543528|322831688|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
94284793|NCT02543528|322831684|FG000|Adaptation Period|Lens Handling Difficultes|0|||
94284794|NCT02543528|322831685|FG001|Adaptation Period|Lens Handling Difficultes|0|||
94372354|NCT01113710|323150246|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
94372355|NCT01113710|323150246|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
94212293|NCT00761267|322572045|FG002|Overall Study|Death|5|||
94212294|NCT00761267|322572043|FG000|Overall Study|Lost to Follow-up|0|||
94212295|NCT00761267|322572044|FG001|Overall Study|Lost to Follow-up|0|||
94212296|NCT00761267|322572045|FG002|Overall Study|Lost to Follow-up|1|||
94212297|NCT00761267|322572043|FG000|Overall Study|Randomized but not treated|1|||
94212298|NCT00761267|322572044|FG001|Overall Study|Randomized but not treated|1|||
94212299|NCT00761267|322572045|FG002|Overall Study|Randomized but not treated|0|||
94212300|NCT00761267|322572043|FG000|Overall Study|Withdrawal by Subject|0|||
94212301|NCT00761267|322572044|FG001|Overall Study|Withdrawal by Subject|1|||
94212302|NCT00761267|322572045|FG002|Overall Study|Withdrawal by Subject|0|||
94212303|NCT04492475|322572046|FG000|Overall Study|Enrolled but not treated|8|||
94212304|NCT04492475|322572047|FG001|Overall Study|Enrolled but not treated|8|||
94212305|NCT04492475|322572046|FG000|Overall Study|Withdrawal by Subject|4|||
94212306|NCT04492475|322572047|FG001|Overall Study|Withdrawal by Subject|0|||
94212307|NCT04492475|322572046|FG000|Overall Study|Became ineligible after enrollment|2|||
94212308|NCT04492475|322572047|FG001|Overall Study|Became ineligible after enrollment|0|||
94212309|NCT00391170|322572048|FG000|Overall Study|Withdrawal by Subject|1|||
94212310|NCT00391170|322572049|FG001|Overall Study|Withdrawal by Subject|0|||
94212311|NCT00391170|322572048|FG000|Overall Study|Adverse Event|3|||
94212312|NCT00391170|322572049|FG001|Overall Study|Adverse Event|2|||
94212313|NCT00391170|322572048|FG000|Overall Study|Physician Decision|2|||
94212314|NCT00391170|322572049|FG001|Overall Study|Physician Decision|2|||
94212315|NCT03200574|322572063|FG000|Overall Study|Death|4|||
94212316|NCT03200574|322572063|FG000|Overall Study|Withdrawal by Subject|8|||
94212317|NCT03200574|322572063|FG000|Overall Study|Long-Term need for anticoagulation|1|||
94212318|NCT03200574|322572063|FG000|Overall Study|Relocation|2|||
94212319|NCT03200574|322572063|FG000|Overall Study|Lost to Follow-up|2|||
94212320|NCT01262456|322572064|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
94212321|NCT01262456|322572065|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
94212322|NCT01262456|322572066|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
94212323|NCT01262456|322572064|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
94212324|NCT01262456|322572065|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
94212325|NCT01262456|322572066|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
94212326|NCT01262456|322572064|FG000|3-Month Double-Blind Period|Adverse Event|6|||
94212327|NCT01262456|322572065|FG001|3-Month Double-Blind Period|Adverse Event|4|||
94212328|NCT01262456|322572066|FG002|3-Month Double-Blind Period|Adverse Event|8|||
94212329|NCT01262456|322572064|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
94212330|NCT01262456|322572065|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
94212331|NCT01262456|322572066|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
94212332|NCT01262456|322572064|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
94212333|NCT01262456|322572065|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
94212334|NCT01262456|322572066|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
94212335|NCT01262456|322572064|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
94212336|NCT01262456|322572065|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
94212337|NCT01262456|322572066|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
94212338|NCT01262456|322572064|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
94212339|NCT01262456|322572065|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
94212340|NCT01262456|322572066|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
94212341|NCT01262456|322572064|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
94212342|NCT01262456|322572065|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
94212343|NCT01262456|322572066|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
94212344|NCT01262456|322572064|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
94212345|NCT01262456|322572065|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
94212346|NCT01262456|322572066|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
94212347|NCT03122860|322572067|FG000|Overall Study|Discontinued Before Treatment|1|||
94212348|NCT03122860|322572068|FG001|Overall Study|Discontinued Before Treatment|1|||
94212349|NCT03122860|322572069|FG002|Overall Study|Discontinued Before Treatment|2|||
94212350|NCT03122860|322572070|FG003|Overall Study|Discontinued Before Treatment|0|||
94212351|NCT03122860|322572071|FG004|Overall Study|Discontinued Before Treatment|1|||
94284795|NCT02543528|322831686|FG002|Adaptation Period|Lens Handling Difficultes|0|||
94284796|NCT02543528|322831687|FG003|Adaptation Period|Lens Handling Difficultes|0|||
94284797|NCT02543528|322831688|FG004|Adaptation Period|Lens Handling Difficultes|8|||
94330893|NCT01522443|322991750|FG000|Overall Study|Other|1|||
94212352|NCT03122860|322572072|FG005|Overall Study|Discontinued Before Treatment|0|||
94212353|NCT03122860|322572067|FG000|Overall Study|Adverse Event|1|||
94212354|NCT03122860|322572068|FG001|Overall Study|Adverse Event|0|||
94212355|NCT03122860|322572069|FG002|Overall Study|Adverse Event|1|||
94212356|NCT03122860|322572070|FG003|Overall Study|Adverse Event|1|||
94212357|NCT03122860|322572071|FG004|Overall Study|Adverse Event|0|||
94212358|NCT03122860|322572072|FG005|Overall Study|Adverse Event|0|||
94212359|NCT03122860|322572067|FG000|Overall Study|Lost to Follow-up|5|||
94212360|NCT03122860|322572068|FG001|Overall Study|Lost to Follow-up|2|||
94212361|NCT03122860|322572069|FG002|Overall Study|Lost to Follow-up|3|||
94212362|NCT03122860|322572070|FG003|Overall Study|Lost to Follow-up|3|||
94212363|NCT03122860|322572071|FG004|Overall Study|Lost to Follow-up|5|||
94212364|NCT03122860|322572072|FG005|Overall Study|Lost to Follow-up|4|||
94212365|NCT03122860|322572067|FG000|Overall Study|Subject Non-Compliance|0|||
94212366|NCT03122860|322572068|FG001|Overall Study|Subject Non-Compliance|0|||
94212367|NCT03122860|322572069|FG002|Overall Study|Subject Non-Compliance|1|||
94212368|NCT03122860|322572070|FG003|Overall Study|Subject Non-Compliance|0|||
94212369|NCT03122860|322572071|FG004|Overall Study|Subject Non-Compliance|0|||
94212370|NCT03122860|322572072|FG005|Overall Study|Subject Non-Compliance|0|||
94212371|NCT03122860|322572067|FG000|Overall Study|Withdrawal by Subject|3|||
94212372|NCT03122860|322572068|FG001|Overall Study|Withdrawal by Subject|2|||
94212373|NCT03122860|322572069|FG002|Overall Study|Withdrawal by Subject|5|||
94212374|NCT03122860|322572070|FG003|Overall Study|Withdrawal by Subject|7|||
94212375|NCT03122860|322572071|FG004|Overall Study|Withdrawal by Subject|9|||
94212376|NCT03122860|322572072|FG005|Overall Study|Withdrawal by Subject|8|||
94212377|NCT03541369|322572073|FG000|Overall Study|Death|0|||
94212378|NCT03541369|322572074|FG001|Overall Study|Death|0|||
94212379|NCT03541369|322572075|FG002|Overall Study|Death|0|||
94212380|NCT03541369|322572076|FG003|Overall Study|Death|0|||
94212381|NCT03541369|322572077|FG004|Overall Study|Death|1|||
94212382|NCT03541369|322572078|FG005|Overall Study|Death|1|||
94212383|NCT03541369|322572079|FG006|Overall Study|Death|0|||
94212384|NCT03541369|322572080|FG007|Overall Study|Death|2|||
94212385|NCT03541369|322572081|FG008|Overall Study|Death|1|||
94212386|NCT03541369|322572082|FG009|Overall Study|Death|2|||
94212387|NCT03541369|322572083|FG010|Overall Study|Death|1|||
94212388|NCT03541369|322572084|FG011|Overall Study|Death|0|||
94212389|NCT03541369|322572085|FG012|Overall Study|Death|2|||
94467786|NCT00312572|323502396|FG001|Overall Study|Lack of Efficacy|2|||
94467787|NCT00096993|323502399|FG000|Overall Study|Death|1|||
94467788|NCT00096993|323502400|FG001|Overall Study|Death|0|||
94467789|NCT00096993|323502399|FG000|Overall Study|Disease progression|56|||
94467790|NCT00096993|323502400|FG001|Overall Study|Disease progression|53|||
94467791|NCT00096993|323502399|FG000|Overall Study|Adverse Event|2|||
94467792|NCT00096993|323502400|FG001|Overall Study|Adverse Event|8|||
94467793|NCT00096993|323502399|FG000|Overall Study|Subject's decision|3|||
94467794|NCT00096993|323502400|FG001|Overall Study|Subject's decision|1|||
94467795|NCT00096993|323502399|FG000|Overall Study|Physician Decision|2|||
94467796|NCT00096993|323502400|FG001|Overall Study|Physician Decision|1|||
94467797|NCT00096993|323502399|FG000|Overall Study|Non-compliance|0|||
94467798|NCT00096993|323502400|FG001|Overall Study|Non-compliance|1|||
94467799|NCT00096993|323502399|FG000|Overall Study|Other unspecified|1|||
94212390|NCT03541369|322572086|FG013|Overall Study|Death|1|||
94212391|NCT03541369|322572087|FG014|Overall Study|Death|1|||
94212392|NCT03541369|322572088|FG015|Overall Study|Death|1|||
94212393|NCT03541369|322572089|FG016|Overall Study|Death|0|||
94212394|NCT03541369|322572090|FG017|Overall Study|Death|1|||
94212395|NCT03541369|322572073|FG000|Overall Study|Decision by sponsor|0|||
94212396|NCT03541369|322572074|FG001|Overall Study|Decision by sponsor|0|||
94212397|NCT03541369|322572075|FG002|Overall Study|Decision by sponsor|0|||
94212398|NCT03541369|322572076|FG003|Overall Study|Decision by sponsor|1|||
94212399|NCT03541369|322572077|FG004|Overall Study|Decision by sponsor|0|||
94212400|NCT03541369|322572078|FG005|Overall Study|Decision by sponsor|2|||
94212401|NCT03541369|322572079|FG006|Overall Study|Decision by sponsor|0|||
94212402|NCT03541369|322572080|FG007|Overall Study|Decision by sponsor|1|||
94212403|NCT03541369|322572081|FG008|Overall Study|Decision by sponsor|2|||
94212404|NCT03541369|322572082|FG009|Overall Study|Decision by sponsor|0|||
94212405|NCT03541369|322572083|FG010|Overall Study|Decision by sponsor|0|||
94212406|NCT03541369|322572084|FG011|Overall Study|Decision by sponsor|0|||
94212407|NCT03541369|322572085|FG012|Overall Study|Decision by sponsor|2|||
94212408|NCT03541369|322572086|FG013|Overall Study|Decision by sponsor|2|||
94212409|NCT03541369|322572087|FG014|Overall Study|Decision by sponsor|0|||
94212410|NCT03541369|322572088|FG015|Overall Study|Decision by sponsor|1|||
94212411|NCT03541369|322572089|FG016|Overall Study|Decision by sponsor|1|||
94212412|NCT03541369|322572090|FG017|Overall Study|Decision by sponsor|1|||
94212413|NCT03541369|322572073|FG000|Overall Study|Withdrawal by Subject|0|||
94212414|NCT03541369|322572074|FG001|Overall Study|Withdrawal by Subject|0|||
94212415|NCT03541369|322572075|FG002|Overall Study|Withdrawal by Subject|0|||
94212416|NCT03541369|322572076|FG003|Overall Study|Withdrawal by Subject|0|||
94212417|NCT03541369|322572077|FG004|Overall Study|Withdrawal by Subject|0|||
94212418|NCT03541369|322572078|FG005|Overall Study|Withdrawal by Subject|0|||
94212419|NCT03541369|322572079|FG006|Overall Study|Withdrawal by Subject|1|||
94212420|NCT03541369|322572080|FG007|Overall Study|Withdrawal by Subject|0|||
94212421|NCT03541369|322572081|FG008|Overall Study|Withdrawal by Subject|0|||
94212422|NCT03541369|322572082|FG009|Overall Study|Withdrawal by Subject|0|||
94212423|NCT03541369|322572083|FG010|Overall Study|Withdrawal by Subject|0|||
94212424|NCT03541369|322572084|FG011|Overall Study|Withdrawal by Subject|1|||
94212425|NCT03541369|322572085|FG012|Overall Study|Withdrawal by Subject|0|||
94212426|NCT03541369|322572086|FG013|Overall Study|Withdrawal by Subject|0|||
94212427|NCT03541369|322572087|FG014|Overall Study|Withdrawal by Subject|3|||
94212428|NCT03541369|322572088|FG015|Overall Study|Withdrawal by Subject|0|||
94212429|NCT03541369|322572089|FG016|Overall Study|Withdrawal by Subject|4|||
94212430|NCT03541369|322572090|FG017|Overall Study|Withdrawal by Subject|2|||
94212431|NCT03541369|322572073|FG000|Overall Study|Lost to Follow-up|0|||
94212432|NCT03541369|322572074|FG001|Overall Study|Lost to Follow-up|0|||
94212433|NCT03541369|322572075|FG002|Overall Study|Lost to Follow-up|0|||
94212434|NCT03541369|322572076|FG003|Overall Study|Lost to Follow-up|0|||
94212435|NCT03541369|322572077|FG004|Overall Study|Lost to Follow-up|1|||
94212436|NCT03541369|322572078|FG005|Overall Study|Lost to Follow-up|0|||
94212437|NCT03541369|322572079|FG006|Overall Study|Lost to Follow-up|0|||
94212438|NCT03541369|322572080|FG007|Overall Study|Lost to Follow-up|0|||
94212439|NCT03541369|322572081|FG008|Overall Study|Lost to Follow-up|1|||
94212440|NCT03541369|322572082|FG009|Overall Study|Lost to Follow-up|0|||
94212441|NCT03541369|322572083|FG010|Overall Study|Lost to Follow-up|0|||
94212442|NCT03541369|322572084|FG011|Overall Study|Lost to Follow-up|0|||
94212443|NCT03541369|322572085|FG012|Overall Study|Lost to Follow-up|1|||
94212444|NCT03541369|322572086|FG013|Overall Study|Lost to Follow-up|0|||
94284798|NCT02543528|322831684|FG000|Adaptation Period|Lost to Follow-up|0|||
94212445|NCT03541369|322572087|FG014|Overall Study|Lost to Follow-up|0|||
94212446|NCT03541369|322572088|FG015|Overall Study|Lost to Follow-up|0|||
94284799|NCT02543528|322831685|FG001|Adaptation Period|Lost to Follow-up|0|||
94284800|NCT02543528|322831686|FG002|Adaptation Period|Lost to Follow-up|0|||
94284801|NCT02543528|322831687|FG003|Adaptation Period|Lost to Follow-up|0|||
94212447|NCT03541369|322572089|FG016|Overall Study|Lost to Follow-up|0|||
94212448|NCT03541369|322572090|FG017|Overall Study|Lost to Follow-up|0|||
94212449|NCT02279732|322572091|FG000|Overall Study|Death|23|||
94212450|NCT02279732|322572092|FG001|Overall Study|Death|20|||
94212451|NCT02279732|322572091|FG000|Overall Study|Disease Progression|13|||
94212452|NCT02279732|322572092|FG001|Overall Study|Disease Progression|3|||
94212453|NCT02279732|322572091|FG000|Overall Study|Withdrawal by Subject|2|||
94212454|NCT02279732|322572092|FG001|Overall Study|Withdrawal by Subject|7|||
94212455|NCT02279732|322572091|FG000|Overall Study|Adverse Event|1|||
94212456|NCT02279732|322572092|FG001|Overall Study|Adverse Event|2|||
94212457|NCT02279732|322572091|FG000|Overall Study|Administrative Reason By Sponsor|0|||
94212458|NCT02279732|322572092|FG001|Overall Study|Administrative Reason By Sponsor|2|||
94212459|NCT02279732|322572091|FG000|Overall Study|Study Drug Toxicity|2|||
94212460|NCT02279732|322572092|FG001|Overall Study|Study Drug Toxicity|0|||
94212461|NCT02279732|322572091|FG000|Overall Study|Lost to Follow-up|0|||
94212462|NCT02279732|322572092|FG001|Overall Study|Lost to Follow-up|1|||
94212463|NCT02279732|322572091|FG000|Overall Study|Maximum Clinical Benefit|1|||
94212464|NCT02279732|322572092|FG001|Overall Study|Maximum Clinical Benefit|0|||
94284802|NCT02543528|322831688|FG004|Adaptation Period|Lost to Follow-up|14|||
94284803|NCT02543528|322831684|FG000|Adaptation Period|Adverse Event|0|||
94284804|NCT02543528|322831685|FG001|Adaptation Period|Adverse Event|0|||
94284805|NCT02543528|322831686|FG002|Adaptation Period|Adverse Event|0|||
94284806|NCT02543528|322831687|FG003|Adaptation Period|Adverse Event|0|||
94284807|NCT02543528|322831688|FG004|Adaptation Period|Adverse Event|2|||
94284808|NCT02543528|322831684|FG000|Extended Wear Period|Adverse Event|17|||
94284809|NCT02543528|322831685|FG001|Extended Wear Period|Adverse Event|11|||
94372356|NCT01113710|323150246|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
94372357|NCT01113710|323150246|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
94284810|NCT02543528|322831686|FG002|Extended Wear Period|Adverse Event|16|||
94284811|NCT02543528|322831687|FG003|Extended Wear Period|Adverse Event|3|||
94284812|NCT02543528|322831688|FG004|Extended Wear Period|Adverse Event|0|||
94284813|NCT02543528|322831684|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
94284814|NCT02543528|322831685|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
94284815|NCT02543528|322831686|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
94284816|NCT02543528|322831687|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
94284817|NCT02543528|322831688|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
94284818|NCT02543528|322831684|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
94284819|NCT02543528|322831685|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
94284820|NCT02543528|322831686|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
94284821|NCT02543528|322831687|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
94284822|NCT02543528|322831688|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
94284823|NCT02543528|322831684|FG000|Extended Wear Period|Lost to Follow-up|0|||
94284824|NCT02543528|322831685|FG001|Extended Wear Period|Lost to Follow-up|1|||
94284825|NCT02543528|322831686|FG002|Extended Wear Period|Lost to Follow-up|2|||
94284826|NCT02543528|322831687|FG003|Extended Wear Period|Lost to Follow-up|1|||
94284827|NCT02543528|322831688|FG004|Extended Wear Period|Lost to Follow-up|0|||
94284828|NCT02543528|322831684|FG000|Extended Wear Period|Withdrawal by Subject|10|||
94284829|NCT02543528|322831685|FG001|Extended Wear Period|Withdrawal by Subject|9|||
94284830|NCT02543528|322831686|FG002|Extended Wear Period|Withdrawal by Subject|4|||
94284831|NCT02543528|322831687|FG003|Extended Wear Period|Withdrawal by Subject|5|||
94284832|NCT02543528|322831688|FG004|Extended Wear Period|Withdrawal by Subject|0|||
94372358|NCT01113710|323150246|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
94372359|NCT01113710|323150246|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
94284833|NCT01761266|322831689|FG000|Overall Study|Death|415|||
94284834|NCT01761266|322831690|FG001|Overall Study|Death|402|||
94284835|NCT01761266|322831689|FG000|Overall Study|Lost to Follow-up|8|||
94284836|NCT01761266|322831690|FG001|Overall Study|Lost to Follow-up|12|||
94284837|NCT01761266|322831689|FG000|Overall Study|Withdrawal by Subject|14|||
94284838|NCT01761266|322831690|FG001|Overall Study|Withdrawal by Subject|10|||
94284839|NCT01761266|322831689|FG000|Overall Study|Sponsor Decision|41|||
94284840|NCT01761266|322831690|FG001|Overall Study|Sponsor Decision|52|||
94284841|NCT01662440|322831691|FG000|Overall Study|Adverse Event|1|||
94284842|NCT01662440|322831692|FG001|Overall Study|Adverse Event|0|||
94284843|NCT01662440|322831693|FG002|Overall Study|Adverse Event|0|||
94284844|NCT01662440|322831694|FG003|Overall Study|Adverse Event|1|||
94284845|NCT01662440|322831691|FG000|Overall Study|Death|0|||
94284846|NCT01662440|322831692|FG001|Overall Study|Death|1|||
94284847|NCT01662440|322831693|FG002|Overall Study|Death|0|||
94284848|NCT01662440|322831694|FG003|Overall Study|Death|0|||
94284849|NCT01662440|322831691|FG000|Overall Study|Lost to Follow-up|2|||
94284850|NCT01662440|322831692|FG001|Overall Study|Lost to Follow-up|2|||
94284851|NCT01662440|322831693|FG002|Overall Study|Lost to Follow-up|4|||
94212465|NCT02279732|322572091|FG000|Overall Study|Subject Requested to Discontinue|0|||
94212466|NCT02279732|322572092|FG001|Overall Study|Subject Requested to Discontinue|1|||
94212467|NCT02279732|322572091|FG000|Overall Study|Other|53|||
94212468|NCT02279732|322572092|FG001|Overall Study|Other|67|||
94212469|NCT02279732|322572091|FG000|Overall Study|Other|3|||
94212470|NCT02279732|322572092|FG001|Overall Study|Other|3|||
94212471|NCT03065400|322572093|FG000|Overall Study|Adverse Event|1|||
94284852|NCT01662440|322831694|FG003|Overall Study|Lost to Follow-up|1|||
94284853|NCT01662440|322831691|FG000|Overall Study|Subject moved to another country.|0|||
94284854|NCT01662440|322831692|FG001|Overall Study|Subject moved to another country.|1|||
94284855|NCT01662440|322831693|FG002|Overall Study|Subject moved to another country.|0|||
94284856|NCT01662440|322831694|FG003|Overall Study|Subject moved to another country.|0|||
94284857|NCT01662440|322831691|FG000|Overall Study|Protocol Violation|1|||
94284858|NCT01662440|322831692|FG001|Overall Study|Protocol Violation|0|||
94284859|NCT01662440|322831693|FG002|Overall Study|Protocol Violation|0|||
94284860|NCT01662440|322831694|FG003|Overall Study|Protocol Violation|0|||
94284861|NCT01662440|322831691|FG000|Overall Study|Withdrawal by Subject|5|||
94284862|NCT01662440|322831692|FG001|Overall Study|Withdrawal by Subject|2|||
94284863|NCT01662440|322831693|FG002|Overall Study|Withdrawal by Subject|2|||
94284864|NCT01662440|322831694|FG003|Overall Study|Withdrawal by Subject|2|||
94284865|NCT01765673|322831695|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
94284866|NCT02600507|322831696|FG000|Overall Study|Adverse Event|3|||
94284867|NCT02600507|322831697|FG001|Overall Study|Adverse Event|15|||
94284868|NCT02600507|322831698|FG002|Overall Study|Adverse Event|5|||
94284869|NCT02600507|322831696|FG000|Overall Study|Lack of Efficacy|3|||
94284870|NCT02600507|322831697|FG001|Overall Study|Lack of Efficacy|8|||
94284871|NCT02600507|322831698|FG002|Overall Study|Lack of Efficacy|5|||
94284872|NCT02600507|322831696|FG000|Overall Study|Lost to Follow-up|3|||
94284873|NCT02600507|322831697|FG001|Overall Study|Lost to Follow-up|5|||
94284874|NCT02600507|322831698|FG002|Overall Study|Lost to Follow-up|2|||
94284875|NCT02600507|322831696|FG000|Overall Study|Protocol Violation|12|||
94284876|NCT02600507|322831697|FG001|Overall Study|Protocol Violation|4|||
94284877|NCT02600507|322831698|FG002|Overall Study|Protocol Violation|4|||
94284878|NCT02600507|322831696|FG000|Overall Study|Physician Decision|1|||
94284879|NCT02600507|322831697|FG001|Overall Study|Physician Decision|0|||
94284880|NCT02600507|322831698|FG002|Overall Study|Physician Decision|1|||
94284881|NCT02600507|322831696|FG000|Overall Study|Withdrawal by Subject|7|||
94284882|NCT02600507|322831697|FG001|Overall Study|Withdrawal by Subject|11|||
94284883|NCT02600507|322831698|FG002|Overall Study|Withdrawal by Subject|7|||
94284884|NCT02600507|322831696|FG000|Overall Study|Other|0|||
94284885|NCT02600507|322831697|FG001|Overall Study|Other|1|||
94284886|NCT02600507|322831698|FG002|Overall Study|Other|1|||
94284887|NCT00975156|322831704|FG000|Overall Study|Protocol Violation|0|||
94284888|NCT00975156|322831705|FG001|Overall Study|Protocol Violation|1|||
94284889|NCT02475655|322831708|FG000|Overall Study|Lost to Follow-up|0|||
94284890|NCT02475655|322831709|FG001|Overall Study|Lost to Follow-up|1|||
94284891|NCT00577993|322831727|FG000|Overall Study|Adverse Event|1|||
94284892|NCT00577993|322831728|FG001|Overall Study|Adverse Event|0|||
94212472|NCT03065400|322572093|FG000|Overall Study|Physician Decision|3|||
94212473|NCT03065400|322572093|FG000|Overall Study|Withdrawal by Subject|1|||
94284893|NCT00577993|322831729|FG002|Overall Study|Adverse Event|0|||
94284894|NCT00577993|322831727|FG000|Overall Study|Death|0|||
94284895|NCT00577993|322831728|FG001|Overall Study|Death|1|||
94284896|NCT00577993|322831729|FG002|Overall Study|Death|1|||
94284897|NCT00577993|322831727|FG000|Overall Study|Lack of Efficacy|0|||
94284898|NCT00577993|322831728|FG001|Overall Study|Lack of Efficacy|1|||
94284899|NCT00577993|322831729|FG002|Overall Study|Lack of Efficacy|0|||
94284900|NCT00577993|322831727|FG000|Overall Study|Protocol Violation|2|||
94284901|NCT00577993|322831728|FG001|Overall Study|Protocol Violation|3|||
94212474|NCT03065400|322572093|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
94284902|NCT00577993|322831729|FG002|Overall Study|Protocol Violation|0|||
94284903|NCT00577993|322831727|FG000|Overall Study|Withdrawal by Subject|1|||
94284904|NCT00577993|322831728|FG001|Overall Study|Withdrawal by Subject|0|||
94284905|NCT00577993|322831729|FG002|Overall Study|Withdrawal by Subject|2|||
94284906|NCT00577993|322831727|FG000|Overall Study|Conversion|2|||
94284907|NCT00577993|322831728|FG001|Overall Study|Conversion|5|||
94284908|NCT00577993|322831729|FG002|Overall Study|Conversion|0|||
94284909|NCT00577993|322831727|FG000|Overall Study|Uninsured|1|||
94284910|NCT00577993|322831728|FG001|Overall Study|Uninsured|0|||
94284911|NCT00577993|322831729|FG002|Overall Study|Uninsured|0|||
94284912|NCT02296242|322831730|FG000|Overall Study|Death|1|||
94212475|NCT00266656|322572097|FG000|Overall Study|Death|1|||
94212476|NCT00266656|322572098|FG001|Overall Study|Death|0|||
94212477|NCT00266656|322572097|FG000|Overall Study|Lost to Follow-up|4|||
94212478|NCT00266656|322572098|FG001|Overall Study|Lost to Follow-up|1|||
94212479|NCT00266656|322572097|FG000|Overall Study|Withdrawal by Subject|4|||
94212480|NCT00266656|322572098|FG001|Overall Study|Withdrawal by Subject|2|||
94212481|NCT00266656|322572097|FG000|Overall Study|Did Not Reach Final Height|4|||
94212482|NCT00266656|322572098|FG001|Overall Study|Did Not Reach Final Height|8|||
94212483|NCT00266656|322572097|FG000|Overall Study|Parent/Caregiver Decision|1|||
94212484|NCT00266656|322572098|FG001|Overall Study|Parent/Caregiver Decision|2|||
94212485|NCT00392197|322572101|FG000|Overall Study|Adverse Event|4|||
94212486|NCT00392197|322572102|FG001|Overall Study|Adverse Event|12|||
94212487|NCT00392197|322572101|FG000|Overall Study|Lack of Efficacy|3|||
94212488|NCT00392197|322572102|FG001|Overall Study|Lack of Efficacy|4|||
94212489|NCT00392197|322572101|FG000|Overall Study|Lost to Follow-up|0|||
94212490|NCT00392197|322572102|FG001|Overall Study|Lost to Follow-up|1|||
94212491|NCT00392197|322572101|FG000|Overall Study|Physician Decision|3|||
94212492|NCT00392197|322572102|FG001|Overall Study|Physician Decision|2|||
94212493|NCT00392197|322572101|FG000|Overall Study|Protocol Violation|7|||
94212494|NCT00392197|322572102|FG001|Overall Study|Protocol Violation|5|||
94212495|NCT00392197|322572101|FG000|Overall Study|Withdrawal by Subject|4|||
94212496|NCT00392197|322572102|FG001|Overall Study|Withdrawal by Subject|6|||
94212497|NCT01964547|322572104|FG000|Overall Study|Adverse Event|8|||
94212498|NCT01964547|322572105|FG001|Overall Study|Adverse Event|2|||
94212499|NCT01964547|322572104|FG000|Overall Study|Withdrawal by Subject|4|||
94212500|NCT01964547|322572105|FG001|Overall Study|Withdrawal by Subject|7|||
94212501|NCT01964547|322572104|FG000|Overall Study|Lost to Follow-up|0|||
94212502|NCT01964547|322572105|FG001|Overall Study|Lost to Follow-up|1|||
94212503|NCT01964547|322572104|FG000|Overall Study|Withdrawal by Investigator|0|||
94212504|NCT01964547|322572105|FG001|Overall Study|Withdrawal by Investigator|1|||
94212505|NCT00912964|322572106|FG000|Overall Study|Eligibility criterion not met|1|||
94212506|NCT00912964|322572107|FG001|Overall Study|Eligibility criterion not met|1|||
94212507|NCT00912964|322572108|FG002|Overall Study|Eligibility criterion not met|0|||
94212508|NCT00912964|322572106|FG000|Overall Study|Adverse Event|15|||
94212509|NCT00912964|322572107|FG001|Overall Study|Adverse Event|18|||
94212510|NCT00912964|322572108|FG002|Overall Study|Adverse Event|12|||
94212511|NCT00912964|322572106|FG000|Overall Study|Lack of Efficacy|11|||
94212512|NCT00912964|322572107|FG001|Overall Study|Lack of Efficacy|4|||
94212513|NCT00912964|322572108|FG002|Overall Study|Lack of Efficacy|3|||
94212514|NCT00912964|322572106|FG000|Overall Study|Withdrawal by Subject|20|||
94212515|NCT00912964|322572107|FG001|Overall Study|Withdrawal by Subject|12|||
94212516|NCT00912964|322572108|FG002|Overall Study|Withdrawal by Subject|18|||
94212517|NCT00912964|322572106|FG000|Overall Study|Lost to Follow-up|4|||
94212518|NCT00912964|322572107|FG001|Overall Study|Lost to Follow-up|3|||
94212519|NCT00912964|322572108|FG002|Overall Study|Lost to Follow-up|3|||
94212520|NCT00912964|322572106|FG000|Overall Study|Protocol Violation|5|||
94212521|NCT00912964|322572107|FG001|Overall Study|Protocol Violation|3|||
94212522|NCT00912964|322572108|FG002|Overall Study|Protocol Violation|8|||
94212523|NCT00912964|322572106|FG000|Overall Study|Taking exclusionary medications|7|||
94212524|NCT00912964|322572107|FG001|Overall Study|Taking exclusionary medications|4|||
94212525|NCT00912964|322572108|FG002|Overall Study|Taking exclusionary medications|8|||
94212526|NCT00912964|322572106|FG000|Overall Study|Medical History|1|||
94284913|NCT02296242|322831731|FG001|Overall Study|Death|1|||
94284914|NCT02296242|322831732|FG002|Overall Study|Death|1|||
94284915|NCT02296242|322831733|FG003|Overall Study|Death|1|||
94284916|NCT02296242|322831734|FG004|Overall Study|Death|1|||
94284917|NCT02296242|322831730|FG000|Overall Study|Withdrawal by Subject|0|||
94284918|NCT02296242|322831731|FG001|Overall Study|Withdrawal by Subject|0|||
94284919|NCT02296242|322831732|FG002|Overall Study|Withdrawal by Subject|1|||
94284920|NCT02296242|322831733|FG003|Overall Study|Withdrawal by Subject|1|||
94284921|NCT02296242|322831734|FG004|Overall Study|Withdrawal by Subject|3|||
94284922|NCT02296242|322831730|FG000|Overall Study|Disease Progression|1|||
94284923|NCT02296242|322831731|FG001|Overall Study|Disease Progression|3|||
94284924|NCT02296242|322831732|FG002|Overall Study|Disease Progression|2|||
94467800|NCT00096993|323502400|FG001|Overall Study|Other unspecified|1|||
94212527|NCT00912964|322572107|FG001|Overall Study|Medical History|0|||
94212528|NCT00912964|322572108|FG002|Overall Study|Medical History|0|||
94212529|NCT00912964|322572106|FG000|Overall Study|Non-compliance with study procedures|2|||
94212530|NCT00912964|322572107|FG001|Overall Study|Non-compliance with study procedures|0|||
94212531|NCT00912964|322572108|FG002|Overall Study|Non-compliance with study procedures|0|||
94212532|NCT00912964|322572106|FG000|Overall Study|Violation of exclusion criterion|0|||
94212533|NCT00912964|322572107|FG001|Overall Study|Violation of exclusion criterion|0|||
94212534|NCT00912964|322572108|FG002|Overall Study|Violation of exclusion criterion|2|||
94212535|NCT00912964|322572106|FG000|Overall Study|Randomized but never received study drug|0|||
94212536|NCT00912964|322572107|FG001|Overall Study|Randomized but never received study drug|1|||
94212537|NCT00912964|322572108|FG002|Overall Study|Randomized but never received study drug|0|||
94212538|NCT02147093|322572109|FG000|Period 1|Lost to Follow-up|0|||
94212539|NCT02147093|322572110|FG001|Period 1|Lost to Follow-up|1|||
94212540|NCT02147093|322572109|FG000|Period 2|Protocol Violation|2|||
94212541|NCT02147093|322572110|FG001|Period 2|Protocol Violation|0|||
94212542|NCT02432274|322572111|FG000|Overall Study|Death|2|||
94212543|NCT02432274|322572112|FG001|Overall Study|Death|6|||
94212544|NCT02432274|322572113|FG002|Overall Study|Death|7|||
94212545|NCT02432274|322572114|FG003|Overall Study|Death|0|||
94212546|NCT02432274|322572115|FG004|Overall Study|Death|27|||
94212547|NCT02432274|322572116|FG005|Overall Study|Death|7|||
94212548|NCT02432274|322572117|FG006|Overall Study|Death|9|||
94212549|NCT02432274|322572118|FG007|Overall Study|Death|14|||
94212550|NCT02432274|322572111|FG000|Overall Study|Withdrawal of Consent|0|||
94212551|NCT02432274|322572112|FG001|Overall Study|Withdrawal of Consent|0|||
94212552|NCT02432274|322572113|FG002|Overall Study|Withdrawal of Consent|0|||
94212553|NCT02432274|322572114|FG003|Overall Study|Withdrawal of Consent|0|||
94284925|NCT02296242|322831733|FG003|Overall Study|Disease Progression|8|||
94284926|NCT02296242|322831734|FG004|Overall Study|Disease Progression|11|||
94284927|NCT02296242|322831730|FG000|Overall Study|Unacceptable Toxicity|0|||
94284928|NCT02296242|322831731|FG001|Overall Study|Unacceptable Toxicity|0|||
94284929|NCT02296242|322831732|FG002|Overall Study|Unacceptable Toxicity|0|||
94284930|NCT02296242|322831733|FG003|Overall Study|Unacceptable Toxicity|0|||
94284931|NCT02296242|322831734|FG004|Overall Study|Unacceptable Toxicity|1|||
94284932|NCT02296242|322831730|FG000|Overall Study|Patient Condition Changed|0|||
94284933|NCT02296242|322831731|FG001|Overall Study|Patient Condition Changed|0|||
94284934|NCT02296242|322831732|FG002|Overall Study|Patient Condition Changed|2|||
94284935|NCT02296242|322831733|FG003|Overall Study|Patient Condition Changed|0|||
94284936|NCT02296242|322831734|FG004|Overall Study|Patient Condition Changed|1|||
94284937|NCT02296242|322831730|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
94284938|NCT02296242|322831731|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
94284939|NCT02296242|322831732|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
94284940|NCT02296242|322831733|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
94284941|NCT02296242|322831734|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
94284942|NCT02296242|322831730|FG000|Overall Study|Lost to Follow-up|1|||
94284943|NCT02296242|322831731|FG001|Overall Study|Lost to Follow-up|0|||
94284944|NCT02296242|322831732|FG002|Overall Study|Lost to Follow-up|0|||
94284945|NCT02296242|322831733|FG003|Overall Study|Lost to Follow-up|0|||
94284946|NCT02296242|322831734|FG004|Overall Study|Lost to Follow-up|0|||
94284947|NCT02296242|322831730|FG000|Overall Study|Need for Hydroxyurea|2|||
94212554|NCT02432274|322572115|FG004|Overall Study|Withdrawal of Consent|2|||
94212555|NCT02432274|322572116|FG005|Overall Study|Withdrawal of Consent|0|||
94212556|NCT02432274|322572117|FG006|Overall Study|Withdrawal of Consent|1|||
94212557|NCT02432274|322572118|FG007|Overall Study|Withdrawal of Consent|2|||
94212558|NCT02892019|322572119|FG000|Overall Study|randomized but not treated|0|||
94212559|NCT02892019|322572120|FG001|Overall Study|randomized but not treated|1|||
94212560|NCT02892019|322572119|FG000|Overall Study|Withdrawal by Subject|0|||
94212561|NCT02892019|322572120|FG001|Overall Study|Withdrawal by Subject|1|||
94284948|NCT02296242|322831731|FG001|Overall Study|Need for Hydroxyurea|0|||
94284949|NCT02296242|322831732|FG002|Overall Study|Need for Hydroxyurea|0|||
94284950|NCT02296242|322831733|FG003|Overall Study|Need for Hydroxyurea|0|||
94284951|NCT02296242|322831734|FG004|Overall Study|Need for Hydroxyurea|0|||
94284952|NCT02296242|322831730|FG000|Overall Study|Screened for Other Protocol|0|||
94284953|NCT02296242|322831731|FG001|Overall Study|Screened for Other Protocol|1|||
94284954|NCT02296242|322831732|FG002|Overall Study|Screened for Other Protocol|0|||
94284955|NCT02296242|322831733|FG003|Overall Study|Screened for Other Protocol|0|||
94284956|NCT02296242|322831734|FG004|Overall Study|Screened for Other Protocol|0|||
94284957|NCT02296242|322831730|FG000|Overall Study|Physician Decision|0|||
94284958|NCT02296242|322831731|FG001|Overall Study|Physician Decision|1|||
94284959|NCT02296242|322831732|FG002|Overall Study|Physician Decision|0|||
94284960|NCT02296242|322831733|FG003|Overall Study|Physician Decision|1|||
94284961|NCT02296242|322831734|FG004|Overall Study|Physician Decision|0|||
94212562|NCT02892019|322572119|FG000|Overall Study|Adverse Event|1|||
94284962|NCT02296242|322831730|FG000|Overall Study|Alternative Treatment|0|||
94284963|NCT02296242|322831731|FG001|Overall Study|Alternative Treatment|0|||
94284964|NCT02296242|322831732|FG002|Overall Study|Alternative Treatment|0|||
94284965|NCT02296242|322831733|FG003|Overall Study|Alternative Treatment|1|||
94284966|NCT02296242|322831734|FG004|Overall Study|Alternative Treatment|0|||
94284967|NCT02296242|322831730|FG000|Overall Study|Adverse Event|0|||
94284968|NCT02296242|322831731|FG001|Overall Study|Adverse Event|0|||
94212563|NCT02892019|322572120|FG001|Overall Study|Adverse Event|1|||
94212564|NCT01662505|322572121|FG000|Overall Study|Progressive disease|6|||
94212565|NCT01662505|322572122|FG001|Overall Study|Progressive disease|1|||
94212566|NCT01662505|322572123|FG002|Overall Study|Progressive disease|5|||
94212567|NCT01662505|322572121|FG000|Overall Study|Refused cont. medication|0|||
94212568|NCT01662505|322572122|FG001|Overall Study|Refused cont. medication|0|||
94212569|NCT01662505|322572123|FG002|Overall Study|Refused cont. medication|1|||
94212570|NCT01662505|322572121|FG000|Overall Study|Not specified above|1|||
94212571|NCT01662505|322572122|FG001|Overall Study|Not specified above|3|||
94212572|NCT01662505|322572123|FG002|Overall Study|Not specified above|2|||
94212573|NCT03769090|322573808|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
94212574|NCT03769090|322573809|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
94212575|NCT03769090|322573810|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
94212576|NCT03769090|322573808|FG000|Overall Study|Withdrawal by Subject|52|||
94212577|NCT03769090|322573809|FG001|Overall Study|Withdrawal by Subject|62|||
94212578|NCT03769090|322573810|FG002|Overall Study|Withdrawal by Subject|74|||
94212579|NCT03769090|322573808|FG000|Overall Study|Death|4|||
94212580|NCT03769090|322573809|FG001|Overall Study|Death|2|||
94212581|NCT03769090|322573810|FG002|Overall Study|Death|2|||
94212582|NCT03769090|322573808|FG000|Overall Study|Adverse Event|7|||
94212583|NCT03769090|322573809|FG001|Overall Study|Adverse Event|7|||
94212584|NCT03769090|322573810|FG002|Overall Study|Adverse Event|8|||
94212585|NCT03769090|322573808|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
94212586|NCT03769090|322573809|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
94212587|NCT03769090|322573810|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
94212588|NCT03769090|322573808|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
94212589|NCT03769090|322573809|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
94212590|NCT03769090|322573810|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
94212591|NCT03769090|322573808|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
94212592|NCT03769090|322573809|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
94212593|NCT03769090|322573810|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
94212594|NCT03769090|322573808|FG000|Overall Study|Protocol Violation|5|||
94212595|NCT03769090|322573809|FG001|Overall Study|Protocol Violation|6|||
94212596|NCT03769090|322573810|FG002|Overall Study|Protocol Violation|8|||
94212597|NCT03769090|322573808|FG000|Overall Study|Pregnancy|1|||
94212598|NCT03769090|322573809|FG001|Overall Study|Pregnancy|0|||
94212599|NCT03769090|322573810|FG002|Overall Study|Pregnancy|3|||
94212600|NCT03769090|322573808|FG000|Overall Study|Lost to Follow-up|19|||
94212601|NCT03769090|322573809|FG001|Overall Study|Lost to Follow-up|25|||
94212602|NCT03769090|322573810|FG002|Overall Study|Lost to Follow-up|21|||
94212603|NCT03769090|322573808|FG000|Overall Study|Condition under investigation worsened|2|||
94212604|NCT03769090|322573809|FG001|Overall Study|Condition under investigation worsened|0|||
94212605|NCT03769090|322573810|FG002|Overall Study|Condition under investigation worsened|1|||
94212606|NCT03769090|322573808|FG000|Overall Study|Lack of Efficacy|1|||
94212607|NCT03769090|322573809|FG001|Overall Study|Lack of Efficacy|2|||
94212608|NCT03769090|322573810|FG002|Overall Study|Lack of Efficacy|2|||
94212609|NCT03769090|322573808|FG000|Overall Study|Other reasons|8|||
94212610|NCT03769090|322573809|FG001|Overall Study|Other reasons|12|||
94212611|NCT03769090|322573810|FG002|Overall Study|Other reasons|15|||
94212612|NCT02014402|322573811|FG000|Overall Study|Adverse Event|1|||
94212613|NCT02014402|322573812|FG001|Overall Study|Adverse Event|0|||
94212614|NCT02014402|322573813|FG002|Overall Study|Adverse Event|0|||
94212615|NCT02014402|322573814|FG003|Overall Study|Adverse Event|0|||
94212616|NCT02014402|322573811|FG000|Overall Study|Withdrawal by Subject|1|||
94212617|NCT02014402|322573812|FG001|Overall Study|Withdrawal by Subject|2|||
94212618|NCT02014402|322573813|FG002|Overall Study|Withdrawal by Subject|2|||
94212619|NCT02014402|322573814|FG003|Overall Study|Withdrawal by Subject|1|||
94212620|NCT02014402|322573811|FG000|Overall Study|Subject did not have transportation|0|||
94212621|NCT02014402|322573812|FG001|Overall Study|Subject did not have transportation|1|||
94212622|NCT02014402|322573813|FG002|Overall Study|Subject did not have transportation|0|||
94212623|NCT02014402|322573814|FG003|Overall Study|Subject did not have transportation|0|||
94212624|NCT02014402|322573811|FG000|Overall Study|Lost to Follow-up|0|||
94212625|NCT02014402|322573812|FG001|Overall Study|Lost to Follow-up|0|||
94212626|NCT02014402|322573813|FG002|Overall Study|Lost to Follow-up|1|||
94212627|NCT02014402|322573814|FG003|Overall Study|Lost to Follow-up|2|||
94212628|NCT01190124|322573816|FG000|Overall Study|Death|3|||
94212629|NCT01190124|322573817|FG001|Overall Study|Death|0|||
94212630|NCT01190124|322573818|FG002|Overall Study|Death|0|||
94212631|NCT01190124|322573816|FG000|Overall Study|Therapeutic Failure|12|||
94212632|NCT01190124|322573817|FG001|Overall Study|Therapeutic Failure|0|||
94212633|NCT01190124|322573818|FG002|Overall Study|Therapeutic Failure|1|||
94212634|NCT01190124|322573816|FG000|Overall Study|Lost to Follow-up|2|||
94212635|NCT01190124|322573817|FG001|Overall Study|Lost to Follow-up|0|||
94212636|NCT01190124|322573818|FG002|Overall Study|Lost to Follow-up|0|||
94212637|NCT02392507|322573819|FG000|Induction Regimen|Death|3|||
94212638|NCT02392507|322573819|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
94467801|NCT04933617|323502405|FG000|Dose Escalation|Early closure of study|0|||
94467802|NCT04933617|323502406|FG001|Dose Escalation|Early closure of study|3|||
94467803|NCT04933617|323502407|FG002|Dose Escalation|Early closure of study|0|||
94467804|NCT04933617|323502408|FG003|Dose Escalation|Early closure of study|0|||
94467805|NCT04933617|323502409|FG004|Dose Escalation|Early closure of study|0|||
94467806|NCT03887117|323502415|FG000|Overall Study|Discontinued prematurely|0|||
94212639|NCT02392507|322573819|FG000|Induction Regimen|Physician Decision|1|||
94212640|NCT02392507|322573819|FG000|Induction Regimen|Withdrawal by Subject|2|||
94212641|NCT02392507|322573819|FG000|Maintenance Regimen|Death|1|||
94212642|NCT02392507|322573819|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
94212643|NCT02224755|322573820|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
94212644|NCT02224755|322573821|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
94212645|NCT02224755|322573820|FG000|Two Year Follow up Post-implant|Death|103|||
94212646|NCT02224755|322573821|FG001|Two Year Follow up Post-implant|Death|98|||
94212647|NCT02224755|322573820|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
94212648|NCT02224755|322573821|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
94212649|NCT02224755|322573820|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
94212650|NCT02224755|322573821|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
94212651|NCT02224755|322573820|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
94212652|NCT02224755|322573821|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
94212653|NCT01951703|322573822|FG000|First Intervention|Withdrawal by Subject|1|||
94212654|NCT01951703|322573823|FG001|First Intervention|Withdrawal by Subject|0|||
94212655|NCT01951703|322573822|FG000|First Intervention|Subject was not compliant|1|||
94212656|NCT01951703|322573823|FG001|First Intervention|Subject was not compliant|1|||
94212657|NCT01951703|322573822|FG000|First Intervention|Physician Decision|1|||
94212658|NCT01951703|322573823|FG001|First Intervention|Physician Decision|0|||
94212659|NCT01951703|322573822|FG000|Second Intervention|Protocol Violation|0|||
94212660|NCT01951703|322573823|FG001|Second Intervention|Protocol Violation|1|||
94212661|NCT01951703|322573822|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
94212662|NCT01951703|322573823|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
94212663|NCT03137784|322573825|FG000|Overall Study|Adverse Event|1|||
94212664|NCT03137784|322573826|FG001|Overall Study|Adverse Event|1|||
94212665|NCT03137784|322573827|FG002|Overall Study|Adverse Event|0|||
94212666|NCT03137784|322573828|FG003|Overall Study|Adverse Event|0|||
94212667|NCT03137784|322573829|FG004|Overall Study|Adverse Event|0|||
94212668|NCT03137784|322573830|FG005|Overall Study|Adverse Event|0|||
94212669|NCT03137784|322573825|FG000|Overall Study|Subject/guardian decision|1|||
94212670|NCT03137784|322573826|FG001|Overall Study|Subject/guardian decision|0|||
94212671|NCT03137784|322573827|FG002|Overall Study|Subject/guardian decision|0|||
94212672|NCT03137784|322573828|FG003|Overall Study|Subject/guardian decision|0|||
94212673|NCT03137784|322573829|FG004|Overall Study|Subject/guardian decision|0|||
94212674|NCT03137784|322573830|FG005|Overall Study|Subject/guardian decision|0|||
94212675|NCT03137784|322573825|FG000|Overall Study|Non-compliance with study treatment|0|||
94212676|NCT03137784|322573826|FG001|Overall Study|Non-compliance with study treatment|0|||
94212677|NCT03137784|322573827|FG002|Overall Study|Non-compliance with study treatment|0|||
94212678|NCT03137784|322573828|FG003|Overall Study|Non-compliance with study treatment|0|||
94212679|NCT03137784|322573829|FG004|Overall Study|Non-compliance with study treatment|1|||
94212680|NCT03137784|322573830|FG005|Overall Study|Non-compliance with study treatment|0|||
94212681|NCT01437540|322573831|FG000|Overall Study|Not listed below|7|||
94212682|NCT01437540|322573832|FG001|Overall Study|Not listed below|6|||
94212683|NCT01437540|322573831|FG000|Overall Study|COPD exacerbation|13|||
94212684|NCT01437540|322573832|FG001|Overall Study|COPD exacerbation|3|||
94212685|NCT01437540|322573831|FG000|Overall Study|Lost to Follow-up|3|||
94212686|NCT01437540|322573832|FG001|Overall Study|Lost to Follow-up|5|||
94212687|NCT01437540|322573831|FG000|Overall Study|Lack of Efficacy|23|||
94212688|NCT01437540|322573832|FG001|Overall Study|Lack of Efficacy|11|||
94212689|NCT01437540|322573831|FG000|Overall Study|Protocol Violation|24|||
94212690|NCT01437540|322573832|FG001|Overall Study|Protocol Violation|12|||
94212691|NCT01437540|322573831|FG000|Overall Study|Adverse Event|26|||
94212692|NCT01437540|322573832|FG001|Overall Study|Adverse Event|13|||
94212693|NCT01437540|322573831|FG000|Overall Study|Withdrawal by Subject|31|||
94212694|NCT01437540|322573832|FG001|Overall Study|Withdrawal by Subject|15|||
94212695|NCT03622580|322573833|FG000|Overall Study|Death|16|||
94212696|NCT03622580|322573834|FG001|Overall Study|Death|21|||
94212697|NCT03622580|322573835|FG002|Overall Study|Death|13|||
94212698|NCT03622580|322573833|FG000|Overall Study|Adverse Event|6|||
94212699|NCT03622580|322573834|FG001|Overall Study|Adverse Event|6|||
94212700|NCT03622580|322573835|FG002|Overall Study|Adverse Event|5|||
94212701|NCT03622580|322573833|FG000|Overall Study|Withdrawal by Subject|12|||
94212702|NCT03622580|322573834|FG001|Overall Study|Withdrawal by Subject|7|||
94212703|NCT03622580|322573835|FG002|Overall Study|Withdrawal by Subject|19|||
94212704|NCT03622580|322573833|FG000|Overall Study|Lost to Follow-up|12|||
94212705|NCT03622580|322573834|FG001|Overall Study|Lost to Follow-up|9|||
94212706|NCT03622580|322573835|FG002|Overall Study|Lost to Follow-up|9|||
94212707|NCT03622580|322573833|FG000|Overall Study|Protocol Violation|1|||
94212708|NCT03622580|322573834|FG001|Overall Study|Protocol Violation|0|||
94212709|NCT03622580|322573835|FG002|Overall Study|Protocol Violation|1|||
94212710|NCT03622580|322573833|FG000|Overall Study|Physician Decision|3|||
94212711|NCT03622580|322573834|FG001|Overall Study|Physician Decision|0|||
94212712|NCT03622580|322573835|FG002|Overall Study|Physician Decision|1|||
94212713|NCT03622580|322573833|FG000|Overall Study|Pregnancy|0|||
94212714|NCT03622580|322573834|FG001|Overall Study|Pregnancy|1|||
94212715|NCT03622580|322573835|FG002|Overall Study|Pregnancy|0|||
94212716|NCT03622580|322573833|FG000|Overall Study|Lack of Efficacy|0|||
94212717|NCT03622580|322573834|FG001|Overall Study|Lack of Efficacy|0|||
94212718|NCT03622580|322573835|FG002|Overall Study|Lack of Efficacy|1|||
94212719|NCT03622580|322573833|FG000|Overall Study|Other|2|||
94372360|NCT01113710|323150246|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
94212720|NCT03622580|322573834|FG001|Overall Study|Other|0|||
94212721|NCT03622580|322573835|FG002|Overall Study|Other|3|||
94372361|NCT01113710|323150246|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
94212722|NCT00486954|322573836|FG000|Pilot Part|Adverse Event|4|||
94212723|NCT00486954|322573837|FG001|Pilot Part|Adverse Event|0|||
94212724|NCT00486954|322573838|FG002|Pilot Part|Adverse Event|5|||
94212725|NCT00486954|322573839|FG003|Pilot Part|Adverse Event|0|||
94212726|NCT00486954|322573840|FG004|Pilot Part|Adverse Event|0|||
94212727|NCT00486954|322573836|FG000|Pilot Part|Disease Progression|2|||
94212728|NCT00486954|322573837|FG001|Pilot Part|Disease Progression|0|||
94212729|NCT00486954|322573838|FG002|Pilot Part|Disease Progression|1|||
94212730|NCT00486954|322573839|FG003|Pilot Part|Disease Progression|0|||
94212731|NCT00486954|322573840|FG004|Pilot Part|Disease Progression|0|||
94212732|NCT00486954|322573836|FG000|Randomized Part|Lost to Follow-up|0|||
94212733|NCT00486954|322573837|FG001|Randomized Part|Lost to Follow-up|0|||
94212734|NCT00486954|322573838|FG002|Randomized Part|Lost to Follow-up|0|||
94212735|NCT00486954|322573839|FG003|Randomized Part|Lost to Follow-up|0|||
94212736|NCT00486954|322573840|FG004|Randomized Part|Lost to Follow-up|1|||
94212737|NCT00486954|322573836|FG000|Randomized Part|Withdrawal by Subject|0|||
94212738|NCT00486954|322573837|FG001|Randomized Part|Withdrawal by Subject|0|||
94212739|NCT00486954|322573838|FG002|Randomized Part|Withdrawal by Subject|0|||
94212740|NCT00486954|322573839|FG003|Randomized Part|Withdrawal by Subject|1|||
94212741|NCT00486954|322573840|FG004|Randomized Part|Withdrawal by Subject|0|||
94212742|NCT00486954|322573836|FG000|Randomized Part|Sponsor Terminated Study|0|||
94212743|NCT00486954|322573837|FG001|Randomized Part|Sponsor Terminated Study|0|||
94212744|NCT00486954|322573838|FG002|Randomized Part|Sponsor Terminated Study|0|||
94212745|NCT00486954|322573839|FG003|Randomized Part|Sponsor Terminated Study|19|||
94212746|NCT00486954|322573840|FG004|Randomized Part|Sponsor Terminated Study|13|||
94212747|NCT03142932|322573841|FG000|Overall Study|Lost to Follow-up|2|||
94212748|NCT03142932|322573842|FG001|Overall Study|Lost to Follow-up|11|||
94212749|NCT00878189|322573843|FG000|Overall Study|Death|0|||
94212750|NCT00878189|322573844|FG001|Overall Study|Death|1|||
94212751|NCT00878189|322573845|FG002|Overall Study|Death|0|||
94212752|NCT00878189|322573846|FG003|Overall Study|Death|1|||
94212753|NCT00878189|322573847|FG004|Overall Study|Death|0|||
94212754|NCT00878189|322573848|FG005|Overall Study|Death|0|||
94212755|NCT00878189|322573849|FG006|Overall Study|Death|0|||
94212756|NCT00878189|322573850|FG007|Overall Study|Death|0|||
94212757|NCT00878189|322573851|FG008|Overall Study|Death|1|||
94212758|NCT00878189|322573843|FG000|Overall Study|Participant Refused to Follow-up|0|||
94212759|NCT00878189|322573844|FG001|Overall Study|Participant Refused to Follow-up|0|||
94212760|NCT00878189|322573845|FG002|Overall Study|Participant Refused to Follow-up|0|||
94212761|NCT00878189|322573846|FG003|Overall Study|Participant Refused to Follow-up|0|||
94212762|NCT00878189|322573847|FG004|Overall Study|Participant Refused to Follow-up|0|||
94212763|NCT00878189|322573848|FG005|Overall Study|Participant Refused to Follow-up|4|||
94212764|NCT00878189|322573849|FG006|Overall Study|Participant Refused to Follow-up|0|||
94212765|NCT00878189|322573850|FG007|Overall Study|Participant Refused to Follow-up|0|||
94212766|NCT00878189|322573851|FG008|Overall Study|Participant Refused to Follow-up|0|||
94212767|NCT00878189|322573843|FG000|Overall Study|Other|3|||
94212768|NCT00878189|322573844|FG001|Overall Study|Other|2|||
94212769|NCT00878189|322573845|FG002|Overall Study|Other|4|||
94212770|NCT00878189|322573846|FG003|Overall Study|Other|7|||
94212771|NCT00878189|322573847|FG004|Overall Study|Other|4|||
94212772|NCT00878189|322573848|FG005|Overall Study|Other|18|||
94212773|NCT00878189|322573849|FG006|Overall Study|Other|15|||
94212774|NCT00878189|322573850|FG007|Overall Study|Other|3|||
94212775|NCT00878189|322573851|FG008|Overall Study|Other|4|||
94212776|NCT00878189|322573843|FG000|Overall Study|Lost to Follow-up|0|||
94212777|NCT00878189|322573844|FG001|Overall Study|Lost to Follow-up|0|||
94212778|NCT00878189|322573845|FG002|Overall Study|Lost to Follow-up|0|||
94212779|NCT00878189|322573846|FG003|Overall Study|Lost to Follow-up|0|||
94212780|NCT00878189|322573847|FG004|Overall Study|Lost to Follow-up|0|||
94212781|NCT00878189|322573848|FG005|Overall Study|Lost to Follow-up|1|||
94212782|NCT00878189|322573849|FG006|Overall Study|Lost to Follow-up|1|||
94212783|NCT00878189|322573850|FG007|Overall Study|Lost to Follow-up|0|||
94212784|NCT00878189|322573851|FG008|Overall Study|Lost to Follow-up|0|||
94212785|NCT00878189|322573843|FG000|Overall Study|Objection Progression or Relapse|0|||
94212786|NCT00878189|322573844|FG001|Overall Study|Objection Progression or Relapse|0|||
94212787|NCT00878189|322573845|FG002|Overall Study|Objection Progression or Relapse|0|||
94212788|NCT00878189|322573846|FG003|Overall Study|Objection Progression or Relapse|0|||
94212789|NCT00878189|322573847|FG004|Overall Study|Objection Progression or Relapse|0|||
94212790|NCT00878189|322573848|FG005|Overall Study|Objection Progression or Relapse|0|||
94212791|NCT00878189|322573849|FG006|Overall Study|Objection Progression or Relapse|0|||
94212792|NCT00878189|322573850|FG007|Overall Study|Objection Progression or Relapse|0|||
94212793|NCT00878189|322573851|FG008|Overall Study|Objection Progression or Relapse|3|||
94212794|NCT03316170|322573852|FG000|Overall Study|Death|1|||
94212795|NCT03316170|322573853|FG001|Overall Study|Death|0|||
94212796|NCT03316170|322573852|FG000|Overall Study|Lost to Follow-up|6|||
94212797|NCT03316170|322573853|FG001|Overall Study|Lost to Follow-up|7|||
94212798|NCT05260437|322573857|FG000|Overall Study|Lost to Follow-up|5|||
94212799|NCT05260437|322573858|FG001|Overall Study|Lost to Follow-up|2|||
94212800|NCT05260437|322573859|FG002|Overall Study|Lost to Follow-up|1|||
94212801|NCT05260437|322573860|FG003|Overall Study|Lost to Follow-up|2|||
94212802|NCT05260437|322573861|FG004|Overall Study|Lost to Follow-up|2|||
94212803|NCT05260437|322573857|FG000|Overall Study|Withdrawal by Subject|3|||
94212804|NCT05260437|322573858|FG001|Overall Study|Withdrawal by Subject|0|||
94212805|NCT05260437|322573859|FG002|Overall Study|Withdrawal by Subject|4|||
94212806|NCT05260437|322573860|FG003|Overall Study|Withdrawal by Subject|5|||
94212807|NCT05260437|322573861|FG004|Overall Study|Withdrawal by Subject|0|||
94212808|NCT05260437|322573857|FG000|Overall Study|Vaccine Not Administered|0|||
94212809|NCT05260437|322573858|FG001|Overall Study|Vaccine Not Administered|1|||
94212810|NCT05260437|322573859|FG002|Overall Study|Vaccine Not Administered|0|||
94212811|NCT05260437|322573860|FG003|Overall Study|Vaccine Not Administered|0|||
94212812|NCT05260437|322573861|FG004|Overall Study|Vaccine Not Administered|0|||
94212813|NCT00787176|322573863|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
94212814|NCT00787176|322573864|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
94212815|NCT00787176|322573865|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
94212816|NCT00787176|322573866|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
94212817|NCT00441168|322573871|FG000|Treatment Period|Death|3|||
94212818|NCT00441168|322573872|FG001|Treatment Period|Death|0|||
94212819|NCT00441168|322573871|FG000|Treatment Period|Adverse Event|1|||
94212820|NCT00441168|322573872|FG001|Treatment Period|Adverse Event|2|||
94284969|NCT02296242|322831732|FG002|Overall Study|Adverse Event|0|||
94284970|NCT02296242|322831733|FG003|Overall Study|Adverse Event|1|||
94284971|NCT02296242|322831734|FG004|Overall Study|Adverse Event|0|||
94284972|NCT02296242|322831730|FG000|Overall Study|Lack of Efficacy|0|||
94284973|NCT02296242|322831731|FG001|Overall Study|Lack of Efficacy|0|||
94284974|NCT02296242|322831732|FG002|Overall Study|Lack of Efficacy|0|||
94284975|NCT02296242|322831733|FG003|Overall Study|Lack of Efficacy|0|||
94212821|NCT00441168|322573871|FG000|Treatment Period|Progressive Disease|0|||
94212822|NCT00441168|322573872|FG001|Treatment Period|Progressive Disease|2|||
94212823|NCT00441168|322573871|FG000|Treatment Period|Protocol Violation|0|||
94212824|NCT00441168|322573872|FG001|Treatment Period|Protocol Violation|1|||
94212825|NCT00441168|322573871|FG000|Treatment Period|Lost to Follow-up|0|||
94212826|NCT00441168|322573872|FG001|Treatment Period|Lost to Follow-up|1|||
94284976|NCT02296242|322831734|FG004|Overall Study|Lack of Efficacy|3|||
94284977|NCT01639833|322831736|FG000|Overall Study|Death|4|||
94284978|NCT01639833|322831737|FG001|Overall Study|Death|2|||
94284979|NCT01639833|322831736|FG000|Overall Study|Withdrawal by Subject|2|||
94212827|NCT00441168|322573871|FG000|Treatment Period|Withdrawal by Subject|3|||
94212828|NCT00441168|322573872|FG001|Treatment Period|Withdrawal by Subject|0|||
94212829|NCT00441168|322573871|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
94212830|NCT00441168|322573872|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
94212831|NCT00441168|322573871|FG000|Treatment Period|refractory disease|1|||
94212832|NCT00441168|322573872|FG001|Treatment Period|refractory disease|0|||
94284980|NCT01639833|322831737|FG001|Overall Study|Withdrawal by Subject|2|||
94284981|NCT03033745|322831738|FG000|Overall Study|Protocol Violation|0|||
94284982|NCT03033745|322831739|FG001|Overall Study|Protocol Violation|0|||
94284983|NCT03033745|322831740|FG002|Overall Study|Protocol Violation|1|||
94284984|NCT03033745|322831738|FG000|Overall Study|Adverse Event|1|||
94284985|NCT03033745|322831739|FG001|Overall Study|Adverse Event|0|||
94284986|NCT03033745|322831740|FG002|Overall Study|Adverse Event|1|||
94284987|NCT03033745|322831738|FG000|Overall Study|Withdrawal by Subject|0|||
94284988|NCT03033745|322831739|FG001|Overall Study|Withdrawal by Subject|1|||
94284989|NCT03033745|322831740|FG002|Overall Study|Withdrawal by Subject|0|||
94284990|NCT00323557|322831741|FG000|Overall Study|Physician Decision|1|||
94284991|NCT00323557|322831742|FG001|Overall Study|Physician Decision|0|||
94284992|NCT00197054|322831743|FG000|Overall Study|Withdrawal by Subject|9|||
94284993|NCT00197054|322831744|FG001|Overall Study|Withdrawal by Subject|3|||
94284994|NCT00197054|322831745|FG002|Overall Study|Withdrawal by Subject|3|||
94284995|NCT00197054|322831743|FG000|Overall Study|Moved from area|7|||
94284996|NCT00197054|322831744|FG001|Overall Study|Moved from area|14|||
94284997|NCT00197054|322831745|FG002|Overall Study|Moved from area|9|||
94284998|NCT00197054|322831743|FG000|Overall Study|Lost to Follow-up|1|||
94284999|NCT00197054|322831744|FG001|Overall Study|Lost to Follow-up|4|||
94285000|NCT00197054|322831745|FG002|Overall Study|Lost to Follow-up|0|||
94285001|NCT02450578|322831746|FG000|Overall Study|ECG abnormality so not treated|1|||
94285002|NCT02450578|322831747|FG001|Overall Study|ECG abnormality so not treated|0|||
94285003|NCT02450578|322831748|FG002|Overall Study|ECG abnormality so not treated|0|||
94285004|NCT02450578|322831749|FG003|Overall Study|ECG abnormality so not treated|0|||
94285005|NCT02574637|322831750|FG000|Double-blind Period|Adverse Event|1|||
94285006|NCT02574637|322831751|FG001|Double-blind Period|Adverse Event|0|||
94285007|NCT02574637|322831752|FG002|Double-blind Period|Adverse Event|0|||
94285008|NCT02574637|322831753|FG003|Double-blind Period|Adverse Event|0|||
94285009|NCT02574637|322831754|FG004|Double-blind Period|Adverse Event|0|||
94285010|NCT02574637|322831755|FG005|Double-blind Period|Adverse Event|0|||
94285011|NCT02574637|322831756|FG006|Double-blind Period|Adverse Event|0|||
94285012|NCT02574637|322831757|FG007|Double-blind Period|Adverse Event|0|||
94285013|NCT02574637|322831758|FG008|Double-blind Period|Adverse Event|0|||
94285014|NCT02574637|322831759|FG009|Double-blind Period|Adverse Event|0|||
94285015|NCT02574637|322831750|FG000|Double-blind Period|Lack of Efficacy|0|||
94285016|NCT02574637|322831751|FG001|Double-blind Period|Lack of Efficacy|0|||
94285017|NCT02574637|322831752|FG002|Double-blind Period|Lack of Efficacy|2|||
94285018|NCT02574637|322831753|FG003|Double-blind Period|Lack of Efficacy|0|||
94285019|NCT02574637|322831754|FG004|Double-blind Period|Lack of Efficacy|0|||
94285020|NCT02574637|322831755|FG005|Double-blind Period|Lack of Efficacy|0|||
94285021|NCT02574637|322831756|FG006|Double-blind Period|Lack of Efficacy|0|||
94285022|NCT02574637|322831757|FG007|Double-blind Period|Lack of Efficacy|0|||
94285023|NCT02574637|322831758|FG008|Double-blind Period|Lack of Efficacy|0|||
94285024|NCT02574637|322831759|FG009|Double-blind Period|Lack of Efficacy|0|||
94285025|NCT02574637|322831750|FG000|Double-blind Period|Protocol Deviation|1|||
94285026|NCT02574637|322831751|FG001|Double-blind Period|Protocol Deviation|0|||
94285027|NCT02574637|322831752|FG002|Double-blind Period|Protocol Deviation|0|||
94285028|NCT02574637|322831753|FG003|Double-blind Period|Protocol Deviation|0|||
94285029|NCT02574637|322831754|FG004|Double-blind Period|Protocol Deviation|0|||
94285030|NCT02574637|322831755|FG005|Double-blind Period|Protocol Deviation|0|||
94285031|NCT02574637|322831756|FG006|Double-blind Period|Protocol Deviation|0|||
94285032|NCT02574637|322831757|FG007|Double-blind Period|Protocol Deviation|0|||
94285033|NCT02574637|322831758|FG008|Double-blind Period|Protocol Deviation|0|||
94285034|NCT02574637|322831759|FG009|Double-blind Period|Protocol Deviation|0|||
94285035|NCT02574637|322831750|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
94285036|NCT02574637|322831751|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
94285037|NCT02574637|322831752|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
94285038|NCT02574637|322831753|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
94285039|NCT02574637|322831754|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
94285040|NCT02574637|322831755|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
94285041|NCT02574637|322831756|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
94285042|NCT02574637|322831757|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
94285043|NCT02574637|322831758|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
94285044|NCT02574637|322831759|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
94285045|NCT02574637|322831750|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
94285046|NCT02574637|322831751|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
94285047|NCT02574637|322831752|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
94285048|NCT02574637|322831753|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
94285049|NCT02574637|322831754|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
94285050|NCT02574637|322831755|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
94285051|NCT02574637|322831756|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
94285052|NCT02574637|322831757|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
94285053|NCT02574637|322831758|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
94285054|NCT02574637|322831759|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
94285055|NCT02574637|322831750|FG000|Double-blind Period|Reason Not Specified|0|||
94285056|NCT02574637|322831751|FG001|Double-blind Period|Reason Not Specified|0|||
94285057|NCT02574637|322831752|FG002|Double-blind Period|Reason Not Specified|0|||
94285058|NCT02574637|322831753|FG003|Double-blind Period|Reason Not Specified|1|||
94285059|NCT02574637|322831754|FG004|Double-blind Period|Reason Not Specified|0|||
94285060|NCT02574637|322831755|FG005|Double-blind Period|Reason Not Specified|0|||
94285061|NCT02574637|322831756|FG006|Double-blind Period|Reason Not Specified|0|||
94285062|NCT02574637|322831757|FG007|Double-blind Period|Reason Not Specified|0|||
94285063|NCT02574637|322831758|FG008|Double-blind Period|Reason Not Specified|0|||
94285064|NCT02574637|322831759|FG009|Double-blind Period|Reason Not Specified|0|||
94285065|NCT02574637|322831750|FG000|Open-label (OL) Period|Adverse Event|0|||
94285066|NCT02574637|322831751|FG001|Open-label (OL) Period|Adverse Event|0|||
94285067|NCT02574637|322831752|FG002|Open-label (OL) Period|Adverse Event|0|||
94285068|NCT02574637|322831753|FG003|Open-label (OL) Period|Adverse Event|0|||
94285069|NCT02574637|322831754|FG004|Open-label (OL) Period|Adverse Event|0|||
94285070|NCT02574637|322831755|FG005|Open-label (OL) Period|Adverse Event|0|||
94285071|NCT02574637|322831756|FG006|Open-label (OL) Period|Adverse Event|0|||
94285072|NCT02574637|322831757|FG007|Open-label (OL) Period|Adverse Event|0|||
94285073|NCT02574637|322831758|FG008|Open-label (OL) Period|Adverse Event|1|||
94285074|NCT02574637|322831759|FG009|Open-label (OL) Period|Adverse Event|0|||
94285075|NCT02574637|322831750|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
94285076|NCT02574637|322831751|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
94285077|NCT02574637|322831752|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
94285078|NCT02574637|322831753|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
94285079|NCT02574637|322831754|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
94285080|NCT02574637|322831755|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
94285081|NCT02574637|322831756|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
94285082|NCT02574637|322831757|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
94285083|NCT02574637|322831758|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
94212833|NCT00441168|322573871|FG000|Follow-up Period|Death|3|||
94212834|NCT00441168|322573872|FG001|Follow-up Period|Death|0|||
94212835|NCT00441168|322573871|FG000|Follow-up Period|Lost to Follow-up|5|||
94212836|NCT00441168|322573872|FG001|Follow-up Period|Lost to Follow-up|6|||
94212837|NCT00441168|322573871|FG000|Follow-up Period|Withdrawal by Subject|3|||
94212838|NCT00441168|322573872|FG001|Follow-up Period|Withdrawal by Subject|0|||
94212839|NCT00441168|322573871|FG000|Follow-up Period|Other|1|||
94212840|NCT00441168|322573872|FG001|Follow-up Period|Other|3|||
94212841|NCT03006393|322573873|FG000|Overall Study|Withdrawal by Subject|1|||
94212842|NCT03006393|322573874|FG001|Overall Study|Withdrawal by Subject|1|||
94212843|NCT03006393|322573873|FG000|Overall Study|Pregnancy|0|||
94212844|NCT03006393|322573874|FG001|Overall Study|Pregnancy|1|||
94212845|NCT03006393|322573873|FG000|Overall Study|Lost to Follow-up|0|||
94212846|NCT03006393|322573874|FG001|Overall Study|Lost to Follow-up|1|||
94212847|NCT00721734|322573880|FG000|Overall Study|Progressive Disease|3|||
94212848|NCT00721734|322573881|FG001|Overall Study|Progressive Disease|10|||
94212849|NCT00721734|322573882|FG002|Overall Study|Progressive Disease|4|||
94212850|NCT00721734|322573883|FG003|Overall Study|Progressive Disease|5|||
94285084|NCT02574637|322831759|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
94285085|NCT02574637|322831750|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
94285086|NCT02574637|322831751|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
94285087|NCT02574637|322831752|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
94285088|NCT02574637|322831753|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
94285089|NCT02574637|322831754|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
94372362|NCT01113710|323150246|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
94212851|NCT00721734|322573884|FG004|Overall Study|Progressive Disease|2|||
94212852|NCT00721734|322573880|FG000|Overall Study|Adverse Event|3|||
94285090|NCT02574637|322831755|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
94285091|NCT02574637|322831756|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
94285092|NCT02574637|322831757|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
94285093|NCT02574637|322831758|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
94285094|NCT02574637|322831759|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
94372363|NCT01113710|323150246|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
94212853|NCT00721734|322573881|FG001|Overall Study|Adverse Event|1|||
94285095|NCT00272987|322831760|FG000|Overall Study|Adverse Event|1|||
94285096|NCT00272987|322831761|FG001|Overall Study|Adverse Event|0|||
94285097|NCT00272987|322831762|FG002|Overall Study|Adverse Event|0|||
94285098|NCT00272987|322831760|FG000|Overall Study|Lost to Follow-up|3|||
94285099|NCT00272987|322831761|FG001|Overall Study|Lost to Follow-up|1|||
94285100|NCT00272987|322831762|FG002|Overall Study|Lost to Follow-up|1|||
94285101|NCT00272987|322831760|FG000|Overall Study|Withdrawal by Subject|1|||
94285102|NCT00272987|322831761|FG001|Overall Study|Withdrawal by Subject|0|||
94285103|NCT00272987|322831762|FG002|Overall Study|Withdrawal by Subject|3|||
94285104|NCT00272987|322831760|FG000|Overall Study|Sponsor Terminated study|0|||
94285105|NCT00272987|322831761|FG001|Overall Study|Sponsor Terminated study|1|||
94285106|NCT00272987|322831762|FG002|Overall Study|Sponsor Terminated study|1|||
94285107|NCT00272987|322831760|FG000|Overall Study|Disease progression|1|||
94285108|NCT00272987|322831761|FG001|Overall Study|Disease progression|1|||
94285109|NCT00272987|322831762|FG002|Overall Study|Disease progression|2|||
94285110|NCT00272987|322831760|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
94285111|NCT00272987|322831761|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
94285112|NCT00272987|322831762|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
94285113|NCT00272987|322831760|FG000|Overall Study|Death|1|||
94285114|NCT00272987|322831761|FG001|Overall Study|Death|0|||
94285115|NCT00272987|322831762|FG002|Overall Study|Death|0|||
94285116|NCT02918019|322831763|FG000|Overall Study|Death|0|||
94285117|NCT02918019|322831764|FG001|Overall Study|Death|0|||
94285118|NCT02918019|322831765|FG002|Overall Study|Death|1|||
94285119|NCT02918019|322831766|FG003|Overall Study|Death|0|||
94285120|NCT02918019|322831763|FG000|Overall Study|Lost to Follow-up|1|||
94285121|NCT02918019|322831764|FG001|Overall Study|Lost to Follow-up|1|||
94285122|NCT02918019|322831765|FG002|Overall Study|Lost to Follow-up|0|||
94285123|NCT02918019|322831766|FG003|Overall Study|Lost to Follow-up|1|||
94285124|NCT02918019|322831763|FG000|Overall Study|Principal investigator request|0|||
94285125|NCT02918019|322831764|FG001|Overall Study|Principal investigator request|0|||
94285126|NCT02918019|322831765|FG002|Overall Study|Principal investigator request|0|||
94212854|NCT00721734|322573882|FG002|Overall Study|Adverse Event|4|||
94212855|NCT00721734|322573883|FG003|Overall Study|Adverse Event|0|||
94212856|NCT00721734|322573884|FG004|Overall Study|Adverse Event|3|||
94212857|NCT00721734|322573880|FG000|Overall Study|Withdrawal by Subject|2|||
94212858|NCT00721734|322573881|FG001|Overall Study|Withdrawal by Subject|1|||
94212859|NCT00721734|322573882|FG002|Overall Study|Withdrawal by Subject|0|||
94212860|NCT00721734|322573883|FG003|Overall Study|Withdrawal by Subject|0|||
94212861|NCT00721734|322573884|FG004|Overall Study|Withdrawal by Subject|1|||
94212862|NCT00721734|322573880|FG000|Overall Study|Other|0|||
94212863|NCT00721734|322573881|FG001|Overall Study|Other|0|||
94212864|NCT00721734|322573882|FG002|Overall Study|Other|0|||
94212865|NCT00721734|322573883|FG003|Overall Study|Other|1|||
94212866|NCT00721734|322573884|FG004|Overall Study|Other|0|||
94212867|NCT02060487|322573885|FG000|Overall Study|Other|1|||
94212868|NCT02060487|322573886|FG001|Overall Study|Other|2|||
94212869|NCT02060487|322573887|FG002|Overall Study|Other|1|||
94212870|NCT02060487|322573885|FG000|Overall Study|Lack of Efficacy|0|||
94212871|NCT02060487|322573886|FG001|Overall Study|Lack of Efficacy|1|||
94212872|NCT02060487|322573887|FG002|Overall Study|Lack of Efficacy|0|||
94212873|NCT02060487|322573885|FG000|Overall Study|Withdrawal by Subject|3|||
94212874|NCT02060487|322573886|FG001|Overall Study|Withdrawal by Subject|10|||
94212875|NCT02060487|322573887|FG002|Overall Study|Withdrawal by Subject|4|||
94212876|NCT02060487|322573885|FG000|Overall Study|Study Terminated By Sponsor|87|||
94212877|NCT02060487|322573886|FG001|Overall Study|Study Terminated By Sponsor|89|||
94212878|NCT02060487|322573887|FG002|Overall Study|Study Terminated By Sponsor|100|||
94212879|NCT02060487|322573885|FG000|Overall Study|Randomized in error|1|||
94212880|NCT02060487|322573886|FG001|Overall Study|Randomized in error|0|||
94212881|NCT02060487|322573887|FG002|Overall Study|Randomized in error|0|||
94212882|NCT02060487|322573885|FG000|Overall Study|Protocol Violation|0|||
94212883|NCT02060487|322573886|FG001|Overall Study|Protocol Violation|1|||
94285127|NCT02918019|322831766|FG003|Overall Study|Principal investigator request|1|||
94212884|NCT02060487|322573887|FG002|Overall Study|Protocol Violation|1|||
94212885|NCT02060487|322573885|FG000|Overall Study|Lost to Follow-up|3|||
94285128|NCT02918019|322831763|FG000|Overall Study|Physician Decision|1|||
94285129|NCT02918019|322831764|FG001|Overall Study|Physician Decision|3|||
94285130|NCT02918019|322831765|FG002|Overall Study|Physician Decision|2|||
94285131|NCT02918019|322831766|FG003|Overall Study|Physician Decision|0|||
94285132|NCT02918019|322831763|FG000|Overall Study|Protocol deviation|1|||
94285133|NCT02918019|322831764|FG001|Overall Study|Protocol deviation|1|||
94285134|NCT02918019|322831765|FG002|Overall Study|Protocol deviation|0|||
94285135|NCT02918019|322831766|FG003|Overall Study|Protocol deviation|2|||
94285136|NCT02918019|322831763|FG000|Overall Study|Withdrawal by Subject|3|||
94285137|NCT02918019|322831764|FG001|Overall Study|Withdrawal by Subject|4|||
94285138|NCT02918019|322831765|FG002|Overall Study|Withdrawal by Subject|6|||
94212886|NCT02060487|322573886|FG001|Overall Study|Lost to Follow-up|0|||
94212887|NCT02060487|322573887|FG002|Overall Study|Lost to Follow-up|2|||
94285139|NCT02918019|322831766|FG003|Overall Study|Withdrawal by Subject|4|||
94285140|NCT02918019|322831763|FG000|Overall Study|Adverse Event|0|||
94285141|NCT02918019|322831764|FG001|Overall Study|Adverse Event|1|||
94212888|NCT02060487|322573885|FG000|Overall Study|Death|34|||
94212889|NCT02060487|322573886|FG001|Overall Study|Death|25|||
94212890|NCT02060487|322573887|FG002|Overall Study|Death|19|||
94285142|NCT02918019|322831765|FG002|Overall Study|Adverse Event|0|||
94212891|NCT02060487|322573885|FG000|Overall Study|Adverse Event|0|||
94212892|NCT02060487|322573886|FG001|Overall Study|Adverse Event|0|||
94212893|NCT02060487|322573887|FG002|Overall Study|Adverse Event|1|||
94212894|NCT00786188|322573888|FG000|Overall Study|Adverse Event|3|||
94212895|NCT00786188|322573889|FG001|Overall Study|Adverse Event|1|||
94212896|NCT00786188|322573888|FG000|Overall Study|Withdrawal by Subject|2|||
94212897|NCT00786188|322573889|FG001|Overall Study|Withdrawal by Subject|0|||
94212898|NCT04867382|322573892|FG000|Overall Study|Did not complete the survey|2|||
94212899|NCT04867382|322573893|FG001|Overall Study|Did not complete the survey|1|||
94212900|NCT02513667|322573896|FG000|Overall Study|Withdrawal by Subject|0|||
94212901|NCT02513667|322573897|FG001|Overall Study|Withdrawal by Subject|1|||
94212902|NCT02915783|322573899|FG000|Overall Study|Death|21|||
94212903|NCT02915783|322573899|FG000|Overall Study|Lost to Follow-up|1|||
94212904|NCT02915783|322573899|FG000|Overall Study|Withdrawal by Subject|2|||
94212905|NCT01681511|322573900|FG000|Overall Study|No Treatment Received|1|||
94212906|NCT01681511|322573901|FG001|Overall Study|No Treatment Received|3|||
94212907|NCT01681511|322573900|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
94212908|NCT01681511|322573901|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
94212909|NCT01681511|322573900|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
94212910|NCT01681511|322573901|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
94212911|NCT01681511|322573900|FG000|Overall Study|No Daily Urine Sample Collected|0|||
94212912|NCT01681511|322573901|FG001|Overall Study|No Daily Urine Sample Collected|1|||
94212913|NCT01681511|322573900|FG000|Overall Study|No post-catheter sample collected|11|||
94212914|NCT01681511|322573901|FG001|Overall Study|No post-catheter sample collected|4|||
94212915|NCT00090519|322573902|FG000|Overall Study|Adverse Event|5|||
94212916|NCT00090519|322573903|FG001|Overall Study|Adverse Event|4|||
94212917|NCT00090519|322573902|FG000|Overall Study|Death|9|||
94212918|NCT00090519|322573903|FG001|Overall Study|Death|9|||
94212919|NCT00090519|322573902|FG000|Overall Study|Lost to Follow-up|26|||
94212920|NCT00090519|322573903|FG001|Overall Study|Lost to Follow-up|29|||
94212921|NCT00090519|322573902|FG000|Overall Study|Withdrawal by Subject|28|||
94212922|NCT00090519|322573903|FG001|Overall Study|Withdrawal by Subject|29|||
94212923|NCT00090519|322573902|FG000|Overall Study|Physician Decision|2|||
94212924|NCT00090519|322573903|FG001|Overall Study|Physician Decision|3|||
94212925|NCT00090519|322573902|FG000|Overall Study|Sponsor Decision|3|||
94212926|NCT00090519|322573903|FG001|Overall Study|Sponsor Decision|1|||
94212927|NCT00845520|322573905|FG000|Overall Study|Death|1|||
94212928|NCT00845520|322573906|FG001|Overall Study|Death|2|||
94212929|NCT00845520|322573907|FG002|Overall Study|Death|0|||
94212930|NCT00845520|322573905|FG000|Overall Study|Lost to Follow-up|1|||
94212931|NCT00845520|322573906|FG001|Overall Study|Lost to Follow-up|0|||
94212932|NCT00845520|322573907|FG002|Overall Study|Lost to Follow-up|0|||
94212933|NCT00845520|322573905|FG000|Overall Study|Adverse Event|0|||
94212934|NCT00845520|322573906|FG001|Overall Study|Adverse Event|0|||
94212935|NCT00845520|322573907|FG002|Overall Study|Adverse Event|1|||
94212936|NCT02613403|322573910|FG000|Overall Study|Lost to Follow-up|0|||
94212937|NCT02613403|322573911|FG001|Overall Study|Lost to Follow-up|1|||
94212938|NCT02613403|322573912|FG002|Overall Study|Lost to Follow-up|0|||
94212939|NCT02613403|322573913|FG003|Overall Study|Lost to Follow-up|0|||
94212940|NCT02613403|322573914|FG004|Overall Study|Lost to Follow-up|0|||
94212941|NCT02613403|322573910|FG000|Overall Study|Withdrawal by Subject|2|||
94212942|NCT02613403|322573911|FG001|Overall Study|Withdrawal by Subject|0|||
94212943|NCT02613403|322573912|FG002|Overall Study|Withdrawal by Subject|0|||
94212944|NCT02613403|322573913|FG003|Overall Study|Withdrawal by Subject|0|||
94212945|NCT02613403|322573914|FG004|Overall Study|Withdrawal by Subject|0|||
94212946|NCT02470806|322573915|FG000|Overall Study|Lost to Follow-up|1|||
94212947|NCT02470806|322573916|FG001|Overall Study|Lost to Follow-up|1|||
94212948|NCT02470806|322573915|FG000|Overall Study|Adverse Event|5|||
94212949|NCT02470806|322573916|FG001|Overall Study|Adverse Event|2|||
94212950|NCT02470806|322573915|FG000|Overall Study|Protocol Violation|4|||
94212951|NCT02470806|322573916|FG001|Overall Study|Protocol Violation|11|||
94212952|NCT02470806|322573915|FG000|Overall Study|Physician Decision|0|||
94212953|NCT02470806|322573916|FG001|Overall Study|Physician Decision|3|||
94212954|NCT02470806|322573915|FG000|Overall Study|Withdrawal by Subject|3|||
94212955|NCT02470806|322573916|FG001|Overall Study|Withdrawal by Subject|10|||
94212956|NCT02470806|322573915|FG000|Overall Study|Lack of Efficacy|5|||
94212957|NCT02470806|322573916|FG001|Overall Study|Lack of Efficacy|15|||
94212958|NCT00513071|322573919|FG000|Overall Study|Adverse Event|1|||
94285143|NCT02918019|322831766|FG003|Overall Study|Adverse Event|1|||
94285144|NCT04016311|322831769|FG000|Overall Study|Withdrawal by Subject|1|||
94285145|NCT04016311|322831770|FG001|Overall Study|Withdrawal by Subject|0|||
94285146|NCT04029519|322831773|FG000|Overall Study|Protocol Violation|1|||
94285147|NCT04029519|322831773|FG000|Overall Study|Withdrawal by Subject|3|||
94285148|NCT04029519|322831773|FG000|Overall Study|Lost to Follow-up|1|||
94285149|NCT01212185|322831774|FG000|Overall Study|Protocol Violation|2|||
94285150|NCT01212185|322831775|FG001|Overall Study|Protocol Violation|1|||
94285151|NCT03222349|322831776|FG000|Overall Study|Treatment B not done|5|||
94285152|NCT03222349|322831777|FG001|Overall Study|Treatment B not done|0|||
94285153|NCT03222349|322831776|FG000|Overall Study|Lost to Follow-up|1|||
94285154|NCT03222349|322831777|FG001|Overall Study|Lost to Follow-up|2|||
94285155|NCT03222349|322831776|FG000|Overall Study|Withdrawal by Subject|1|||
94285156|NCT03222349|322831777|FG001|Overall Study|Withdrawal by Subject|0|||
94285157|NCT03222349|322831776|FG000|Overall Study|Treatment A not done|0|||
94285158|NCT03222349|322831777|FG001|Overall Study|Treatment A not done|5|||
94285159|NCT03222349|322831776|FG000|Overall Study|Study terminated by sponsor|1|||
94285160|NCT03222349|322831777|FG001|Overall Study|Study terminated by sponsor|0|||
94285161|NCT00070941|322831780|FG000|Overall Study|Adverse Event|10|||
94285162|NCT00070941|322831781|FG001|Overall Study|Adverse Event|8|||
94285163|NCT00070941|322831782|FG002|Overall Study|Adverse Event|4|||
94285164|NCT02706730|322831783|FG000|Overall Study|Adverse Event|3|||
94285165|NCT02706730|322831783|FG000|Overall Study|Lack of Efficacy|5|||
94285166|NCT02706730|322831783|FG000|Overall Study|Withdrawal by Subject|11|||
94212959|NCT00513071|322573919|FG000|Overall Study|Withdrawal by Subject|1|||
94212960|NCT00513071|322573919|FG000|Overall Study|Physician Decision|3|||
94212961|NCT02255474|322573920|FG000|Overall Study|Lost to Follow-up|1|||
94212962|NCT02255474|322573921|FG001|Overall Study|Lost to Follow-up|1|||
94212963|NCT02255474|322573922|FG002|Overall Study|Lost to Follow-up|3|||
94212964|NCT02255474|322573920|FG000|Overall Study|Withdrawal by Subject|1|||
94212965|NCT02255474|322573921|FG001|Overall Study|Withdrawal by Subject|1|||
94212966|NCT02255474|322573922|FG002|Overall Study|Withdrawal by Subject|0|||
94212967|NCT03345095|322573924|FG000|Overall Study|Lack of Efficacy|184|||
94212968|NCT03345095|322573925|FG001|Overall Study|Lack of Efficacy|156|||
94212969|NCT03345095|322573924|FG000|Overall Study|Adverse Event|36|||
94212970|NCT03345095|322573925|FG001|Overall Study|Adverse Event|118|||
94212971|NCT03345095|322573924|FG000|Overall Study|Withdrawal by Subject|22|||
94285167|NCT02706730|322831783|FG000|Overall Study|Study Terminated by Sponsor|11|||
94285168|NCT02706730|322831783|FG000|Overall Study|Subject chose not to receive injection|3|||
94285169|NCT03021642|322831784|FG000|Washout Period (21 Days)|Adverse Event|1|||
94285170|NCT03021642|322831785|FG001|Washout Period (21 Days)|Adverse Event|1|||
94285171|NCT02064387|322831786|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
94212972|NCT03345095|322573925|FG001|Overall Study|Withdrawal by Subject|59|||
94212973|NCT03345095|322573924|FG000|Overall Study|Physician Decision|3|||
94212974|NCT03345095|322573925|FG001|Overall Study|Physician Decision|18|||
94212975|NCT03345095|322573924|FG000|Overall Study|Death|2|||
94212976|NCT03345095|322573925|FG001|Overall Study|Death|4|||
94212977|NCT03345095|322573924|FG000|Overall Study|Other reasons|2|||
94212978|NCT03345095|322573925|FG001|Overall Study|Other reasons|11|||
94212979|NCT03345095|322573924|FG000|Overall Study|Protocol Violation|0|||
94212980|NCT03345095|322573925|FG001|Overall Study|Protocol Violation|1|||
94212981|NCT02114515|322573927|FG000|Overall Study|Lost to Follow-up|52|||
94212982|NCT02114515|322573928|FG001|Overall Study|Lost to Follow-up|55|||
94212983|NCT02114515|322573927|FG000|Overall Study|Death|12|||
94212984|NCT02114515|322573928|FG001|Overall Study|Death|12|||
94212985|NCT02114515|322573927|FG000|Overall Study|Withdrawal by Subject|4|||
94212986|NCT02114515|322573928|FG001|Overall Study|Withdrawal by Subject|22|||
94212987|NCT02114515|322573927|FG000|Overall Study|Other|65|||
94212988|NCT02114515|322573928|FG001|Overall Study|Other|61|||
94212989|NCT00667732|322573931|FG000|Run -In (8 Weeks)|Adverse Event|4|||
94212990|NCT00667732|322573932|FG001|Run -In (8 Weeks)|Adverse Event|0|||
94212991|NCT00667732|322573933|FG002|Run -In (8 Weeks)|Adverse Event|0|||
94212992|NCT00667732|322573931|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
94212993|NCT00667732|322573932|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
94212994|NCT00667732|322573933|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
94212995|NCT00667732|322573931|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
94212996|NCT00667732|322573932|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
94212997|NCT00667732|322573933|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
94212998|NCT02106325|322573939|FG000|Phase 1|Lost to Follow-up|2|||
94212999|NCT02106325|322573940|FG001|Phase 1|Lost to Follow-up|2|||
94213000|NCT02106325|322573939|FG000|Phase 2|Lost to Follow-up|2|||
94213001|NCT02106325|322573940|FG001|Phase 2|Lost to Follow-up|3|||
94285172|NCT02064387|322831787|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
94285173|NCT02064387|322831788|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
94285174|NCT02064387|322831789|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
94285175|NCT02064387|322831790|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
94285176|NCT02064387|322831791|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
94285177|NCT02064387|322831792|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
94285178|NCT02064387|322831793|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
94285179|NCT02064387|322831794|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
94285180|NCT02064387|322831795|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
94285181|NCT02064387|322831796|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
94285182|NCT02064387|322831797|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
94285183|NCT02064387|322831786|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
94285184|NCT02064387|322831787|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
94285185|NCT02064387|322831788|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
94285186|NCT02064387|322831789|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
94285187|NCT02064387|322831790|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
94285188|NCT02064387|322831791|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
94285189|NCT02064387|322831792|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
94285190|NCT02064387|322831793|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
94285191|NCT02064387|322831794|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
94285192|NCT02064387|322831795|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
94285193|NCT02064387|322831796|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
94285194|NCT02064387|322831797|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
94285195|NCT02064387|322831786|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
94285196|NCT02064387|322831787|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
94285197|NCT02064387|322831788|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
94285198|NCT02064387|322831789|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
94285199|NCT02064387|322831790|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
94285200|NCT02064387|322831791|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
94285201|NCT02064387|322831792|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
94285202|NCT02064387|322831793|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
94285203|NCT02064387|322831794|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
94285204|NCT02064387|322831795|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
94285205|NCT02064387|322831796|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
94285206|NCT02064387|322831797|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
94285207|NCT02064387|322831786|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
94213002|NCT02106325|322573939|FG000|Phase 3|Lost to Follow-up|2|||
94213003|NCT02106325|322573940|FG001|Phase 3|Lost to Follow-up|1|||
94285208|NCT02064387|322831787|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
94285209|NCT02064387|322831788|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
94213004|NCT00518206|322573942|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
94213005|NCT00518206|322573943|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
94213006|NCT00518206|322573942|FG000|Overall Study|Withdrawal by Subject|2|||
94285210|NCT02064387|322831789|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
94285211|NCT02064387|322831790|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
94285212|NCT02064387|322831791|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
94285213|NCT02064387|322831792|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
94285214|NCT02064387|322831793|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
94285215|NCT02064387|322831794|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
94285216|NCT02064387|322831795|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
94285217|NCT02064387|322831796|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
94285218|NCT02064387|322831797|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
94372364|NCT01113710|323150246|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
94372365|NCT01725113|323150247|FG000|Overall Study|Kidney Transplant|1|||
94285219|NCT02064387|322831786|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
94372366|NCT01725113|323150248|FG001|Overall Study|Kidney Transplant|1|||
94285220|NCT02064387|322831787|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
94285221|NCT02064387|322831788|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
94285222|NCT02064387|322831789|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
94285223|NCT02064387|322831790|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
94285224|NCT02064387|322831791|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
94285225|NCT02064387|322831792|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
94285226|NCT02064387|322831793|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
94285227|NCT02064387|322831794|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
94285228|NCT02064387|322831795|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
94285229|NCT02064387|322831796|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
94285230|NCT02064387|322831797|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
94285231|NCT01058096|322831802|FG000|Double-blind Treatment Phase|Adverse Event|11|||
94285232|NCT01058096|322831803|FG001|Double-blind Treatment Phase|Adverse Event|15|||
94285233|NCT01058096|322831802|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
94285234|NCT01058096|322831803|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
94285235|NCT01058096|322831802|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
94285236|NCT01058096|322831803|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
94285237|NCT01058096|322831802|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
94285238|NCT01058096|322831803|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
94285239|NCT01058096|322831802|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
94285240|NCT01058096|322831803|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
94285241|NCT01058096|322831802|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
94285242|NCT01058096|322831803|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
94285243|NCT04317274|322831806|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
94285244|NCT04317274|322831807|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
94285245|NCT04317274|322831808|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
94285246|NCT04317274|322831809|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
94285247|NCT00999908|322831810|FG000|Treatment Period 1|Subject withdrew consent|2|||
94285248|NCT00999908|322831811|FG001|Treatment Period 1|Subject withdrew consent|0|||
94285249|NCT00999908|322831812|FG002|Treatment Period 1|Subject withdrew consent|0|||
94285250|NCT00999908|322831810|FG000|Treatment Period 2|Protocol Violation|1|||
94285251|NCT00999908|322831811|FG001|Treatment Period 2|Protocol Violation|0|||
94285252|NCT00999908|322831812|FG002|Treatment Period 2|Protocol Violation|0|||
94285253|NCT01707693|322831815|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
94285254|NCT01707693|322831816|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
94285255|NCT01707693|322831815|FG000|Overall Study Allocation|Protocol Violation|4|||
94285256|NCT01707693|322831816|FG001|Overall Study Allocation|Protocol Violation|3|||
94285257|NCT01707693|322831815|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
94285258|NCT01707693|322831816|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
94372367|NCT01725113|323150247|FG000|Overall Study|Withdrawal by Subject|0|||
94372368|NCT01725113|323150248|FG001|Overall Study|Withdrawal by Subject|1|||
94372369|NCT03066440|323150249|FG000|Overall Study|Physician Decision|1|||
94372370|NCT03066440|323150250|FG001|Overall Study|Physician Decision|1|||
94372371|NCT03066440|323150249|FG000|Overall Study|Protocol Violation|0|||
94372372|NCT03066440|323150250|FG001|Overall Study|Protocol Violation|2|||
94372373|NCT03751020|323150252|FG000|Overall Study|Withdrawal by Subject|2|||
94213007|NCT00518206|322573943|FG001|Overall Study|Withdrawal by Subject|0|||
94213008|NCT00518206|322573942|FG000|Overall Study|Drug Supply Issue|1|||
94213009|NCT00518206|322573943|FG001|Overall Study|Drug Supply Issue|0|||
94213010|NCT00518206|322573942|FG000|Overall Study|Reason Unknown|1|||
94213011|NCT00518206|322573943|FG001|Overall Study|Reason Unknown|0|||
94213012|NCT00518206|322573942|FG000|Overall Study|Completion Status Unknown|1|||
94213013|NCT00518206|322573943|FG001|Overall Study|Completion Status Unknown|0|||
94213014|NCT03075878|322573944|FG000|Overall Study|Physician Decision|1|||
94213015|NCT02935894|322573945|FG000|Overall Study|Subject dismissed|1|||
94285259|NCT01707693|322831815|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
94285260|NCT01707693|322831816|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
94285261|NCT03261531|322831817|FG000|Overall Study|Withdrawal by Subject|4|||
94285262|NCT01834729|322831822|FG000|Overall Study|Did not return bowel diaries|0|||
94285263|NCT01834729|322831823|FG001|Overall Study|Did not return bowel diaries|0|||
94285264|NCT01834729|322831824|FG002|Overall Study|Did not return bowel diaries|3|||
94285265|NCT01834729|322831825|FG003|Overall Study|Did not return bowel diaries|0|||
94285266|NCT01834729|322831822|FG000|Overall Study|Withdrawal by Subject|1|||
94285267|NCT01834729|322831823|FG001|Overall Study|Withdrawal by Subject|1|||
94285268|NCT01834729|322831824|FG002|Overall Study|Withdrawal by Subject|0|||
94285269|NCT01834729|322831825|FG003|Overall Study|Withdrawal by Subject|0|||
94285270|NCT01834729|322831822|FG000|Overall Study|Adverse Event|0|||
94285271|NCT01834729|322831823|FG001|Overall Study|Adverse Event|0|||
94285272|NCT01834729|322831824|FG002|Overall Study|Adverse Event|0|||
94285273|NCT01834729|322831825|FG003|Overall Study|Adverse Event|2|||
94285274|NCT02435849|322831827|FG000|Overall Study|Death|23|||
94285275|NCT02435849|322831828|FG001|Overall Study|Death|0|||
94285276|NCT02435849|322831827|FG000|Overall Study|Lack of Efficacy|10|||
94285277|NCT02435849|322831828|FG001|Overall Study|Lack of Efficacy|0|||
94285278|NCT02435849|322831827|FG000|Overall Study|New therapy for study indication|8|||
94285279|NCT02435849|322831828|FG001|Overall Study|New therapy for study indication|0|||
94285280|NCT02435849|322831827|FG000|Overall Study|Subject/guardian decision|5|||
94285281|NCT02435849|322831828|FG001|Overall Study|Subject/guardian decision|1|||
94285282|NCT02435849|322831827|FG000|Overall Study|Lost to Follow-up|1|||
94285283|NCT02435849|322831828|FG001|Overall Study|Lost to Follow-up|0|||
94285284|NCT02435849|322831827|FG000|Overall Study|Physician Decision|1|||
94285285|NCT02435849|322831828|FG001|Overall Study|Physician Decision|0|||
94285286|NCT02629159|322831830|FG000|Overall Study|Adverse Event|17|||
94285287|NCT02629159|322831831|FG001|Overall Study|Adverse Event|20|||
94285288|NCT02629159|322831832|FG002|Overall Study|Adverse Event|22|||
94285289|NCT02629159|322831830|FG000|Overall Study|Withdrawal by Subject|22|||
94285290|NCT02629159|322831831|FG001|Overall Study|Withdrawal by Subject|11|||
94285291|NCT02629159|322831832|FG002|Overall Study|Withdrawal by Subject|15|||
94285292|NCT02629159|322831830|FG000|Overall Study|Lost to Follow-up|7|||
94285293|NCT02629159|322831831|FG001|Overall Study|Lost to Follow-up|4|||
94285294|NCT02629159|322831832|FG002|Overall Study|Lost to Follow-up|5|||
94285295|NCT02629159|322831830|FG000|Overall Study|Lack of Efficacy|4|||
94285296|NCT02629159|322831831|FG001|Overall Study|Lack of Efficacy|0|||
94285297|NCT02629159|322831832|FG002|Overall Study|Lack of Efficacy|1|||
94285298|NCT02629159|322831830|FG000|Overall Study|Other|6|||
94285299|NCT02629159|322831831|FG001|Overall Study|Other|4|||
94285300|NCT02629159|322831832|FG002|Overall Study|Other|8|||
94285301|NCT00268242|322831833|FG000|Overall Study|Death|1|||
94285302|NCT04871711|322831837|FG000|Overall Study|Withdrawal by Subject|11|||
94285303|NCT04871711|322831838|FG001|Overall Study|Withdrawal by Subject|5|||
94285304|NCT04871711|322831837|FG000|Overall Study|Lack of Efficacy|5|||
94285305|NCT04871711|322831838|FG001|Overall Study|Lack of Efficacy|7|||
94285306|NCT04871711|322831837|FG000|Overall Study|Adverse Event|2|||
94285307|NCT04871711|322831838|FG001|Overall Study|Adverse Event|6|||
94285308|NCT04871711|322831837|FG000|Overall Study|Various reasons|2|||
94285309|NCT04871711|322831838|FG001|Overall Study|Various reasons|1|||
94285310|NCT04871711|322831837|FG000|Overall Study|Lost to Follow-up|0|||
94285311|NCT04871711|322831838|FG001|Overall Study|Lost to Follow-up|2|||
94285312|NCT00946309|322831839|FG000|Overall Study|Protocol Violation|1|||
94285313|NCT00946309|322831840|FG001|Overall Study|Protocol Violation|0|||
94285314|NCT00946309|322831839|FG000|Overall Study|Lost to Follow-up|0|||
94285315|NCT00946309|322831840|FG001|Overall Study|Lost to Follow-up|1|||
94285316|NCT00946309|322831839|FG000|Overall Study|Procedure cancelled/discontinued|0|||
94285317|NCT00946309|322831840|FG001|Overall Study|Procedure cancelled/discontinued|3|||
94285318|NCT03687502|322831846|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
94285319|NCT03687502|322831846|FG000|Overall Study|Lumason not available|1|||
94213016|NCT02158806|322573946|FG000|Overall Study|Death|2|||
94213017|NCT02158806|322573947|FG001|Overall Study|Death|0|||
94213018|NCT02158806|322573946|FG000|Overall Study|Withdrawal by Subject|2|||
94285320|NCT01116544|322831847|FG000|Overall Study|Protocol Violation|1|||
94285321|NCT01116544|322831848|FG001|Overall Study|Protocol Violation|0|||
94285322|NCT01116544|322831847|FG000|Overall Study|Withdrawal by Subject|1|||
94285323|NCT01116544|322831848|FG001|Overall Study|Withdrawal by Subject|1|||
94285324|NCT00486278|322831849|FG000|Overall Study|Adverse Event|5|||
94372374|NCT03751020|323150253|FG001|Overall Study|Withdrawal by Subject|0|||
94213019|NCT02158806|322573947|FG001|Overall Study|Withdrawal by Subject|0|||
94213020|NCT02158806|322573946|FG000|Overall Study|Lost to Follow-up|0|||
94213021|NCT02158806|322573947|FG001|Overall Study|Lost to Follow-up|3|||
94213022|NCT02158806|322573946|FG000|Overall Study|Moved out of area|0|||
94213023|NCT02158806|322573947|FG001|Overall Study|Moved out of area|1|||
94213024|NCT02158806|322573946|FG000|Overall Study|Transferred to palliative care|0|||
94213025|NCT02158806|322573947|FG001|Overall Study|Transferred to palliative care|1|||
94213026|NCT04895085|322573951|FG000|Overall Study|Death|1|||
94213027|NCT04895085|322573951|FG000|Overall Study|Withdrawal by Subject|1|||
94213028|NCT04895085|322573951|FG000|Overall Study|No longer eligible: Moved from area|1|||
94213029|NCT05184062|322573952|FG000|Overall Study|Lost to Follow-up|5|||
94213030|NCT05184062|322573953|FG001|Overall Study|Lost to Follow-up|1|||
94213031|NCT05184062|322573952|FG000|Overall Study|Withdrawal by Subject|1|||
94213032|NCT05184062|322573953|FG001|Overall Study|Withdrawal by Subject|0|||
94213033|NCT04633200|322575626|FG000|Overall Study|Lost to Follow-up|3|||
94213034|NCT04633200|322575627|FG001|Overall Study|Lost to Follow-up|5|||
94213035|NCT00022672|322575629|FG000|Main Phase: 24 Months|Adverse Event|6|||
94213036|NCT00022672|322575630|FG001|Main Phase: 24 Months|Adverse Event|0|||
94213037|NCT00022672|322575629|FG000|Main Phase: 24 Months|Death|0|||
94213038|NCT00022672|322575630|FG001|Main Phase: 24 Months|Death|3|||
94213039|NCT00022672|322575629|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
94213040|NCT00022672|322575630|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
94213041|NCT00022672|322575629|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
94213042|NCT00022672|322575630|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
94213043|NCT00022672|322575629|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
94213044|NCT00022672|322575630|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
94213045|NCT00022672|322575629|FG000|Main Phase: 24 Months|Refused Treatment|3|||
94213046|NCT00022672|322575630|FG001|Main Phase: 24 Months|Refused Treatment|4|||
94213047|NCT00022672|322575629|FG000|Main Phase: 24 Months|Failure to Return|1|||
94213048|NCT00022672|322575630|FG001|Main Phase: 24 Months|Failure to Return|1|||
94213049|NCT00022672|322575629|FG000|Main Phase: 24 Months|Other|1|||
94213050|NCT00022672|322575630|FG001|Main Phase: 24 Months|Other|0|||
94213051|NCT00022672|322575629|FG000|Extension Phase|Adverse Event|1|||
94213052|NCT00022672|322575630|FG001|Extension Phase|Adverse Event|3|||
94213053|NCT00022672|322575629|FG000|Extension Phase|Death|0|||
94213054|NCT00022672|322575630|FG001|Extension Phase|Death|1|||
94213055|NCT00022672|322575629|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
94213056|NCT00022672|322575630|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
94213057|NCT00022672|322575629|FG000|Extension Phase|Refused Treatment|0|||
94213058|NCT00022672|322575630|FG001|Extension Phase|Refused Treatment|2|||
94213059|NCT00022672|322575629|FG000|Extension Phase|Other|1|||
94213060|NCT00022672|322575630|FG001|Extension Phase|Other|1|||
94213061|NCT01947491|322575631|FG000|Overall Study|Lost to Follow-up|5|||
94213062|NCT01947491|322575632|FG001|Overall Study|Lost to Follow-up|3|||
94213063|NCT01947491|322575633|FG002|Overall Study|Lost to Follow-up|1|||
94213064|NCT01947491|322575634|FG003|Overall Study|Lost to Follow-up|2|||
94213065|NCT01947491|322575631|FG000|Overall Study|Lack of Efficacy|1|||
94213066|NCT01947491|322575632|FG001|Overall Study|Lack of Efficacy|0|||
94213067|NCT01947491|322575633|FG002|Overall Study|Lack of Efficacy|0|||
94213068|NCT01947491|322575634|FG003|Overall Study|Lack of Efficacy|1|||
94213069|NCT01947491|322575631|FG000|Overall Study|Protocol Violation|1|||
94213070|NCT01947491|322575632|FG001|Overall Study|Protocol Violation|0|||
94213071|NCT01947491|322575633|FG002|Overall Study|Protocol Violation|0|||
94213072|NCT01947491|322575634|FG003|Overall Study|Protocol Violation|0|||
94213073|NCT01947491|322575631|FG000|Overall Study|Withdrawal by Subject|1|||
94213074|NCT01947491|322575632|FG001|Overall Study|Withdrawal by Subject|1|||
94213075|NCT01947491|322575633|FG002|Overall Study|Withdrawal by Subject|1|||
94213076|NCT01947491|322575634|FG003|Overall Study|Withdrawal by Subject|0|||
94213077|NCT01947491|322575631|FG000|Overall Study|Worsening of condition|0|||
94213078|NCT01947491|322575632|FG001|Overall Study|Worsening of condition|1|||
94213079|NCT01947491|322575633|FG002|Overall Study|Worsening of condition|0|||
94213080|NCT01947491|322575634|FG003|Overall Study|Worsening of condition|0|||
94213081|NCT01947491|322575631|FG000|Overall Study|Adverse Event|0|||
94213082|NCT01947491|322575632|FG001|Overall Study|Adverse Event|1|||
94213083|NCT01947491|322575633|FG002|Overall Study|Adverse Event|0|||
94213084|NCT01947491|322575634|FG003|Overall Study|Adverse Event|2|||
94213085|NCT02067663|322575635|FG000|Overall Study|Lost to Follow-up|13|||
94213086|NCT02067663|322575636|FG001|Overall Study|Lost to Follow-up|14|||
94213087|NCT00638456|322575637|FG000|Overall Study|Withdrawal by Subject|6|||
94213088|NCT00638456|322575638|FG001|Overall Study|Withdrawal by Subject|2|||
94213089|NCT02708498|322575639|FG000|Overall Study|Death|20|||
94213090|NCT02708498|322575640|FG001|Overall Study|Death|19|||
94213091|NCT02708498|322575641|FG002|Overall Study|Death|0|||
94213092|NCT02708498|322575642|FG003|Overall Study|Death|0|||
94213093|NCT02708498|322575643|FG004|Overall Study|Death|1|||
94213094|NCT02708498|322575644|FG005|Overall Study|Death|0|||
94213095|NCT02708498|322575645|FG006|Overall Study|Death|0|||
94213096|NCT02708498|322575646|FG007|Overall Study|Death|0|||
94213097|NCT02708498|322575639|FG000|Overall Study|Unknown reason, missing data|0|||
94213098|NCT02708498|322575640|FG001|Overall Study|Unknown reason, missing data|0|||
94213099|NCT02708498|322575641|FG002|Overall Study|Unknown reason, missing data|62|||
94213100|NCT02708498|322575642|FG003|Overall Study|Unknown reason, missing data|51|||
94213101|NCT02708498|322575643|FG004|Overall Study|Unknown reason, missing data|195|||
94213102|NCT02708498|322575644|FG005|Overall Study|Unknown reason, missing data|132|||
94213103|NCT02708498|322575645|FG006|Overall Study|Unknown reason, missing data|0|||
94213104|NCT02708498|322575646|FG007|Overall Study|Unknown reason, missing data|0|||
94213105|NCT01416285|322575647|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
94213106|NCT01416285|322575648|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
94213107|NCT02165202|322575649|FG000|Oral Phase|Refused further participation|5|||
94213108|NCT02165202|322575650|FG001|Oral Phase|Refused further participation|1|||
94213109|NCT02165202|322575649|FG000|Oral Phase|Study product Related Toxicity|1|||
94213110|NCT02165202|322575650|FG001|Oral Phase|Study product Related Toxicity|0|||
94213111|NCT02165202|322575649|FG000|Oral Phase|Unable to contact Participant|1|||
94213112|NCT02165202|322575650|FG001|Oral Phase|Unable to contact Participant|1|||
94213113|NCT02165202|322575649|FG000|Oral Phase|Clinical reasons|1|||
94213114|NCT02165202|322575650|FG001|Oral Phase|Clinical reasons|0|||
94213115|NCT02165202|322575649|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
94213116|NCT02165202|322575650|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
94213117|NCT02165202|322575649|FG000|Oral Phase|CMC advised termination|1|||
94213118|NCT02165202|322575650|FG001|Oral Phase|CMC advised termination|0|||
94213119|NCT02165202|322575649|FG000|Oral Phase|Relocated, no follow-up planned|1|||
94213120|NCT02165202|322575650|FG001|Oral Phase|Relocated, no follow-up planned|0|||
94213121|NCT02165202|322575649|FG000|Oral Phase|Abnormal EKG|0|||
94213122|NCT02165202|322575650|FG001|Oral Phase|Abnormal EKG|1|||
94213123|NCT02165202|322575649|FG000|Injection Phase|Abnormal Lab Value|5|||
94213124|NCT02165202|322575650|FG001|Injection Phase|Abnormal Lab Value|1|||
94213125|NCT02165202|322575649|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
94213126|NCT02165202|322575650|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
94213127|NCT02165202|322575649|FG000|Injection Phase|Unable to attend within Visit Window|1|||
94213128|NCT02165202|322575650|FG001|Injection Phase|Unable to attend within Visit Window|0|||
94213129|NCT02165202|322575649|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
94213130|NCT02165202|322575650|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
94213131|NCT02165202|322575649|FG000|Injection Phase|End of Study|2|||
94213132|NCT02165202|322575650|FG001|Injection Phase|End of Study|1|||
94213133|NCT02165202|322575649|FG000|Injection Phase|Study Product related Toxicity|1|||
94213134|NCT02165202|322575650|FG001|Injection Phase|Study Product related Toxicity|0|||
94213135|NCT02165202|322575649|FG000|Injection Phase|No longer interested|0|||
94213136|NCT02165202|322575650|FG001|Injection Phase|No longer interested|1|||
94213137|NCT02165202|322575649|FG000|Injection Phase|Participant unwilling to comply|1|||
94213138|NCT02165202|322575650|FG001|Injection Phase|Participant unwilling to comply|0|||
94213139|NCT01836523|322575651|FG000|Overall Study|Adverse Event|15|||
94213140|NCT01836523|322575652|FG001|Overall Study|Adverse Event|41|||
94213141|NCT01836523|322575653|FG002|Overall Study|Adverse Event|49|||
94213142|NCT01836523|322575654|FG003|Overall Study|Adverse Event|14|||
94213143|NCT01836523|322575651|FG000|Overall Study|Protocol Violation|6|||
94213144|NCT01836523|322575652|FG001|Overall Study|Protocol Violation|3|||
94213145|NCT01836523|322575653|FG002|Overall Study|Protocol Violation|2|||
94213146|NCT01836523|322575654|FG003|Overall Study|Protocol Violation|4|||
94213147|NCT01836523|322575651|FG000|Overall Study|Met Withdrawal Criteria|13|||
94213148|NCT01836523|322575652|FG001|Overall Study|Met Withdrawal Criteria|13|||
94213149|NCT01836523|322575653|FG002|Overall Study|Met Withdrawal Criteria|21|||
94213150|NCT01836523|322575654|FG003|Overall Study|Met Withdrawal Criteria|27|||
94213151|NCT01836523|322575651|FG000|Overall Study|Unclassified|17|||
94213152|NCT01836523|322575652|FG001|Overall Study|Unclassified|28|||
94213153|NCT01836523|322575653|FG002|Overall Study|Unclassified|19|||
94213154|NCT01836523|322575654|FG003|Overall Study|Unclassified|29|||
94213155|NCT00923078|322575661|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
94213156|NCT00923078|322575662|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
94213157|NCT00923078|322575663|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
94213158|NCT00923078|322575661|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
94213159|NCT00923078|322575662|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
94213160|NCT00923078|322575663|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
94213161|NCT01918033|322575664|FG000|Overall Study|Adverse Event|1|||
94213162|NCT01918033|322575665|FG001|Overall Study|Adverse Event|0|||
94213163|NCT01918033|322575666|FG002|Overall Study|Adverse Event|2|||
94213164|NCT01918033|322575664|FG000|Overall Study|Lost to Follow-up|0|||
94213165|NCT01918033|322575665|FG001|Overall Study|Lost to Follow-up|1|||
94213166|NCT01918033|322575666|FG002|Overall Study|Lost to Follow-up|0|||
94213167|NCT01918033|322575664|FG000|Overall Study|Protocol Violation|2|||
94213168|NCT01918033|322575665|FG001|Overall Study|Protocol Violation|0|||
94213169|NCT01918033|322575666|FG002|Overall Study|Protocol Violation|1|||
94213170|NCT01918033|322575664|FG000|Overall Study|Withdrawal by Subject|2|||
94213171|NCT01918033|322575665|FG001|Overall Study|Withdrawal by Subject|1|||
94213172|NCT01918033|322575666|FG002|Overall Study|Withdrawal by Subject|0|||
94213173|NCT02823574|322575669|FG000|Randomization|Disease Progression|0|||
94213174|NCT02823574|322575670|FG001|Randomization|Disease Progression|0|||
94213175|NCT02823574|322575671|FG002|Randomization|Disease Progression|1|||
94213176|NCT02823574|322575672|FG003|Randomization|Disease Progression|0|||
94213177|NCT02823574|322575669|FG000|Randomization|AE unrelated to Study Drug|1|||
94213178|NCT02823574|322575670|FG001|Randomization|AE unrelated to Study Drug|0|||
94213179|NCT02823574|322575671|FG002|Randomization|AE unrelated to Study Drug|0|||
94213180|NCT02823574|322575672|FG003|Randomization|AE unrelated to Study Drug|0|||
94213181|NCT02823574|322575669|FG000|Treatment Period|Poor/Non Compliance|1|||
94213182|NCT02823574|322575670|FG001|Treatment Period|Poor/Non Compliance|0|||
94213183|NCT02823574|322575671|FG002|Treatment Period|Poor/Non Compliance|0|||
94213184|NCT02823574|322575672|FG003|Treatment Period|Poor/Non Compliance|1|||
94213185|NCT02823574|322575669|FG000|Treatment Period|Maximum Clinical Benefit|8|||
94213186|NCT02823574|322575670|FG001|Treatment Period|Maximum Clinical Benefit|4|||
94213187|NCT02823574|322575671|FG002|Treatment Period|Maximum Clinical Benefit|7|||
94213188|NCT02823574|322575672|FG003|Treatment Period|Maximum Clinical Benefit|1|||
94213189|NCT02823574|322575669|FG000|Treatment Period|Lost to Follow-up|1|||
94213190|NCT02823574|322575670|FG001|Treatment Period|Lost to Follow-up|1|||
94213191|NCT02823574|322575671|FG002|Treatment Period|Lost to Follow-up|0|||
94213192|NCT02823574|322575672|FG003|Treatment Period|Lost to Follow-up|0|||
94213193|NCT02823574|322575669|FG000|Treatment Period|Participant withdrew consent|4|||
94213194|NCT02823574|322575670|FG001|Treatment Period|Participant withdrew consent|0|||
94213195|NCT02823574|322575671|FG002|Treatment Period|Participant withdrew consent|0|||
94213196|NCT02823574|322575672|FG003|Treatment Period|Participant withdrew consent|1|||
94213197|NCT02823574|322575669|FG000|Treatment Period|Participant request to discontinue|5|||
94213198|NCT02823574|322575670|FG001|Treatment Period|Participant request to discontinue|0|||
94213199|NCT02823574|322575671|FG002|Treatment Period|Participant request to discontinue|3|||
94213200|NCT02823574|322575672|FG003|Treatment Period|Participant request to discontinue|2|||
94213201|NCT02823574|322575669|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
94213202|NCT02823574|322575670|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
94213203|NCT02823574|322575671|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
94213204|NCT02823574|322575672|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
94213205|NCT02823574|322575669|FG000|Treatment Period|Study Drug Toxicity|11|||
94213206|NCT02823574|322575670|FG001|Treatment Period|Study Drug Toxicity|2|||
94213207|NCT02823574|322575671|FG002|Treatment Period|Study Drug Toxicity|14|||
94213208|NCT02823574|322575672|FG003|Treatment Period|Study Drug Toxicity|4|||
94213209|NCT02823574|322575669|FG000|Treatment Period|Disease Progression|113|||
94213210|NCT02823574|322575670|FG001|Treatment Period|Disease Progression|64|||
94213211|NCT02823574|322575671|FG002|Treatment Period|Disease Progression|82|||
94213212|NCT02823574|322575672|FG003|Treatment Period|Disease Progression|43|||
94213213|NCT02823574|322575669|FG000|Treatment Period|Other reasons|5|||
94213214|NCT02823574|322575670|FG001|Treatment Period|Other reasons|9|||
94213215|NCT02823574|322575671|FG002|Treatment Period|Other reasons|3|||
94213216|NCT02823574|322575672|FG003|Treatment Period|Other reasons|6|||
94213217|NCT02823574|322575669|FG000|Treatment Period|Participant no longer meets study criteria|0|||
94213218|NCT02823574|322575670|FG001|Treatment Period|Participant no longer meets study criteria|0|||
94213219|NCT02823574|322575671|FG002|Treatment Period|Participant no longer meets study criteria|1|||
94213220|NCT02823574|322575672|FG003|Treatment Period|Participant no longer meets study criteria|0|||
94213221|NCT02823574|322575669|FG000|Treatment Period|Death|0|||
94213222|NCT02823574|322575670|FG001|Treatment Period|Death|0|||
94213223|NCT02823574|322575671|FG002|Treatment Period|Death|3|||
94213224|NCT02823574|322575672|FG003|Treatment Period|Death|1|||
94213225|NCT00895245|322575673|FG000|Overall Study|Lack of Efficacy|6|||
94213226|NCT03909100|322575674|FG000|Overall Study|Protocol Deviation|2|||
94213227|NCT03909100|322575674|FG000|Overall Study|Technical Problems|4|||
94213228|NCT03909100|322575674|FG000|Overall Study|Withdrawal by Subject|4|||
94213229|NCT03909100|322575674|FG000|Overall Study|Lost to Follow-up|1|||
94213230|NCT03909100|322575674|FG000|Overall Study|Reason not Specified|4|||
94213231|NCT02671266|322575675|FG000|Overall Study|Withdrawal by Subject|1|||
94213232|NCT02671266|322575676|FG001|Overall Study|Withdrawal by Subject|1|||
94213233|NCT01976507|322575677|FG000|Overall Study|Adverse Event|6|||
94213234|NCT01976507|322575677|FG000|Overall Study|ablation not done, drug not given|1|||
94213235|NCT01029704|322575678|FG000|Overall Study|Adverse Event|0|||
94213236|NCT01029704|322575679|FG001|Overall Study|Adverse Event|0|||
94213237|NCT01029704|322575680|FG002|Overall Study|Adverse Event|0|||
94213238|NCT01029704|322575681|FG003|Overall Study|Adverse Event|0|||
94213239|NCT01029704|322575682|FG004|Overall Study|Adverse Event|0|||
94213240|NCT01029704|322575683|FG005|Overall Study|Adverse Event|0|||
94213241|NCT01029704|322575684|FG006|Overall Study|Adverse Event|1|||
94213242|NCT01029704|322575685|FG007|Overall Study|Adverse Event|1|||
94213243|NCT01029704|322575686|FG008|Overall Study|Adverse Event|0|||
94213244|NCT01029704|322575678|FG000|Overall Study|Withdrawal by Subject|0|||
94213245|NCT01029704|322575679|FG001|Overall Study|Withdrawal by Subject|0|||
94213246|NCT01029704|322575680|FG002|Overall Study|Withdrawal by Subject|0|||
94213247|NCT01029704|322575681|FG003|Overall Study|Withdrawal by Subject|0|||
94213248|NCT01029704|322575682|FG004|Overall Study|Withdrawal by Subject|2|||
94213249|NCT01029704|322575683|FG005|Overall Study|Withdrawal by Subject|1|||
94213250|NCT01029704|322575684|FG006|Overall Study|Withdrawal by Subject|1|||
94213251|NCT01029704|322575685|FG007|Overall Study|Withdrawal by Subject|1|||
94213252|NCT01029704|322575686|FG008|Overall Study|Withdrawal by Subject|0|||
94213253|NCT01029704|322575678|FG000|Overall Study|Lost to Follow-up|0|||
94213254|NCT01029704|322575679|FG001|Overall Study|Lost to Follow-up|0|||
94213255|NCT01029704|322575680|FG002|Overall Study|Lost to Follow-up|0|||
94213256|NCT01029704|322575681|FG003|Overall Study|Lost to Follow-up|0|||
94213257|NCT01029704|322575682|FG004|Overall Study|Lost to Follow-up|0|||
94213258|NCT01029704|322575683|FG005|Overall Study|Lost to Follow-up|0|||
94213259|NCT01029704|322575684|FG006|Overall Study|Lost to Follow-up|1|||
94213260|NCT01029704|322575685|FG007|Overall Study|Lost to Follow-up|1|||
94213261|NCT01029704|322575686|FG008|Overall Study|Lost to Follow-up|1|||
94213262|NCT01029704|322575678|FG000|Overall Study|Lack of Efficacy|0|||
94213263|NCT01029704|322575679|FG001|Overall Study|Lack of Efficacy|0|||
94213264|NCT01029704|322575680|FG002|Overall Study|Lack of Efficacy|0|||
94213265|NCT01029704|322575681|FG003|Overall Study|Lack of Efficacy|0|||
94213266|NCT01029704|322575682|FG004|Overall Study|Lack of Efficacy|2|||
94213267|NCT01029704|322575683|FG005|Overall Study|Lack of Efficacy|3|||
94213268|NCT01029704|322575684|FG006|Overall Study|Lack of Efficacy|1|||
94213269|NCT01029704|322575685|FG007|Overall Study|Lack of Efficacy|2|||
94213270|NCT01029704|322575686|FG008|Overall Study|Lack of Efficacy|0|||
94213271|NCT01029704|322575678|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
94213272|NCT01029704|322575679|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
94213273|NCT01029704|322575680|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
94213274|NCT01029704|322575681|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
94213275|NCT01029704|322575682|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
94213276|NCT01029704|322575683|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
94213277|NCT01029704|322575684|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
94213278|NCT01029704|322575685|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
94213279|NCT01029704|322575686|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
94213280|NCT01328756|322575687|FG000|Overall Study|Protocol Violation|4|||
94213281|NCT01328756|322575687|FG000|Overall Study|Adverse Event|39|||
94213282|NCT01328756|322575687|FG000|Overall Study|Lack of Efficacy|5|||
94213283|NCT01328756|322575687|FG000|Overall Study|Withdrawal by Subject|41|||
94213284|NCT01328756|322575687|FG000|Overall Study|Lost to Follow-up|5|||
94213285|NCT01328756|322575687|FG000|Overall Study|Other|29|||
94213286|NCT01757288|322575691|FG000|Overall Study|Consent withdrawal|0|||
94213287|NCT01757288|322575692|FG001|Overall Study|Consent withdrawal|4|||
94213288|NCT01757288|322575693|FG002|Overall Study|Consent withdrawal|4|||
94213289|NCT01757288|322575691|FG000|Overall Study|Patient off study, IRB hold.|0|||
94213290|NCT01757288|322575692|FG001|Overall Study|Patient off study, IRB hold.|0|||
94213291|NCT01757288|322575693|FG002|Overall Study|Patient off study, IRB hold.|1|||
94213292|NCT01757288|322575691|FG000|Overall Study|Patient death prior to starting treatment|0|||
94213293|NCT01757288|322575692|FG001|Overall Study|Patient death prior to starting treatment|0|||
94213294|NCT01757288|322575693|FG002|Overall Study|Patient death prior to starting treatment|1|||
94213295|NCT01757288|322575691|FG000|Overall Study|Wrong medication administered|0|||
94213296|NCT01757288|322575692|FG001|Overall Study|Wrong medication administered|1|||
94213297|NCT01757288|322575693|FG002|Overall Study|Wrong medication administered|0|||
94213298|NCT01757288|322575691|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
94213299|NCT01757288|322575692|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
94213300|NCT01757288|322575693|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
94213301|NCT01757288|322575691|FG000|Overall Study|Not meeting protocol constraints|0|||
94213302|NCT01757288|322575692|FG001|Overall Study|Not meeting protocol constraints|1|||
94213303|NCT01757288|322575693|FG002|Overall Study|Not meeting protocol constraints|1|||
94213304|NCT01757288|322575691|FG000|Overall Study|Multiple missed appointments|0|||
94213305|NCT01757288|322575692|FG001|Overall Study|Multiple missed appointments|1|||
94213306|NCT01757288|322575693|FG002|Overall Study|Multiple missed appointments|0|||
94213307|NCT01757288|322575691|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
94213308|NCT01757288|322575692|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
94213309|NCT01757288|322575693|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
94213310|NCT01757288|322575691|FG000|Overall Study|>2 weeks treatment break|0|||
94213311|NCT01757288|322575692|FG001|Overall Study|>2 weeks treatment break|0|||
94213312|NCT01757288|322575693|FG002|Overall Study|>2 weeks treatment break|1|||
94213313|NCT02825550|322575694|FG000|Overall Study|Physician Decision|1|||
94213314|NCT00042939|322575695|FG000|Overall Study|Adverse Event|6|||
94213315|NCT00042939|322575696|FG001|Overall Study|Adverse Event|7|||
94213316|NCT00042939|322575695|FG000|Overall Study|Death|3|||
94213317|NCT00042939|322575696|FG001|Overall Study|Death|2|||
94213318|NCT00042939|322575695|FG000|Overall Study|Withdrawal by Subject|3|||
94213319|NCT00042939|322575696|FG001|Overall Study|Withdrawal by Subject|4|||
94213320|NCT00042939|322575695|FG000|Overall Study|Other disease|1|||
94213321|NCT00042939|322575696|FG001|Overall Study|Other disease|0|||
94213322|NCT00042939|322575695|FG000|Overall Study|Ineligible|2|||
94213323|NCT00042939|322575696|FG001|Overall Study|Ineligible|2|||
94285325|NCT00486278|322831849|FG000|Overall Study|Withdrawal by Subject|2|||
94213324|NCT00042939|322575695|FG000|Overall Study|Deterioration of health|3|||
94213325|NCT00042939|322575696|FG001|Overall Study|Deterioration of health|4|||
94213326|NCT00042939|322575695|FG000|Overall Study|QOL diminished|1|||
94213327|NCT00042939|322575696|FG001|Overall Study|QOL diminished|0|||
94213328|NCT00042939|322575695|FG000|Overall Study|Rising ca 19-9|1|||
94213329|NCT00042939|322575696|FG001|Overall Study|Rising ca 19-9|0|||
94213330|NCT00042939|322575695|FG000|Overall Study|Patient non-compliance|1|||
94213331|NCT00042939|322575696|FG001|Overall Study|Patient non-compliance|0|||
94213332|NCT00042939|322575695|FG000|Overall Study|Still on treatment|1|||
94213333|NCT00042939|322575696|FG001|Overall Study|Still on treatment|0|||
94213334|NCT00042939|322575695|FG000|Overall Study|Treatment break > 4 weeks|0|||
94213335|NCT00042939|322575696|FG001|Overall Study|Treatment break > 4 weeks|1|||
94213336|NCT00042939|322575695|FG000|Overall Study|Did not start treatment|2|||
94285326|NCT00486278|322831849|FG000|Overall Study|Physician Decision|2|||
94285327|NCT01724528|322831850|FG000|Overall Study|Death|3|||
94285328|NCT01724528|322831851|FG001|Overall Study|Death|0|||
94285329|NCT01724528|322831850|FG000|Overall Study|Withdrawal by Subject|0|||
94285330|NCT01724528|322831851|FG001|Overall Study|Withdrawal by Subject|2|||
94285331|NCT01724528|322831850|FG000|Overall Study|Protocol Violation|0|||
94285332|NCT01724528|322831851|FG001|Overall Study|Protocol Violation|1|||
94285333|NCT01724528|322831850|FG000|Overall Study|Patient refused to attend last visit|1|||
94285334|NCT01724528|322831851|FG001|Overall Study|Patient refused to attend last visit|0|||
94285335|NCT02183519|322831852|FG000|Overall Study|computer error|3|||
94285336|NCT02183519|322831853|FG001|Overall Study|computer error|0|||
94285337|NCT02183519|322831852|FG000|Overall Study|Did not respond to cough inducter|0|||
94285338|NCT02183519|322831853|FG001|Overall Study|Did not respond to cough inducter|3|||
94285339|NCT00654498|322831856|FG000|Overall Study|Not Treated|1|||
94285340|NCT00654498|322831857|FG001|Overall Study|Not Treated|0|||
94285341|NCT00654498|322831856|FG000|Overall Study|Adverse Event|6|||
94285342|NCT00654498|322831857|FG001|Overall Study|Adverse Event|1|||
94285343|NCT00654498|322831856|FG000|Overall Study|Protocol Violation|1|||
94285344|NCT00654498|322831857|FG001|Overall Study|Protocol Violation|1|||
94213337|NCT00042939|322575696|FG001|Overall Study|Did not start treatment|1|||
94213338|NCT02037568|322575697|FG000|Overall Study|Withdrawal by Subject|17|||
94213339|NCT02037568|322575698|FG001|Overall Study|Withdrawal by Subject|24|||
94213340|NCT02037568|322575697|FG000|Overall Study|Lost to Follow-up|16|||
94213341|NCT02037568|322575698|FG001|Overall Study|Lost to Follow-up|13|||
94213342|NCT02037568|322575697|FG000|Overall Study|Screen Failure|3|||
94213343|NCT02037568|322575698|FG001|Overall Study|Screen Failure|1|||
94213344|NCT02037568|322575697|FG000|Overall Study|Patient did not receive transplant|0|||
94213345|NCT02037568|322575698|FG001|Overall Study|Patient did not receive transplant|1|||
94213346|NCT02991118|322575700|FG000|Overall Study|Death|3|||
94213347|NCT02991118|322575701|FG001|Overall Study|Death|8|||
94213348|NCT02991118|322575700|FG000|Overall Study|Protocol Violation|0|||
94285345|NCT00654498|322831856|FG000|Overall Study|Lost to Follow-up|1|||
94285346|NCT00654498|322831857|FG001|Overall Study|Lost to Follow-up|5|||
94285347|NCT00654498|322831856|FG000|Overall Study|Withdrawal by Subject|1|||
94285348|NCT00654498|322831857|FG001|Overall Study|Withdrawal by Subject|0|||
94285349|NCT00654498|322831856|FG000|Overall Study|Other reason not defined above|4|||
94285350|NCT00654498|322831857|FG001|Overall Study|Other reason not defined above|5|||
94285351|NCT01462266|322831858|FG000|Overall Study|Adverse Event|7|||
94285352|NCT01462266|322831859|FG001|Overall Study|Adverse Event|6|||
94285353|NCT01462266|322831858|FG000|Overall Study|Death|2|||
94285354|NCT01462266|322831859|FG001|Overall Study|Death|1|||
94285355|NCT01462266|322831858|FG000|Overall Study|Lack of Efficacy|0|||
94213349|NCT02991118|322575701|FG001|Overall Study|Protocol Violation|3|||
94213350|NCT02991118|322575700|FG000|Overall Study|Physician Decision|0|||
94213351|NCT02991118|322575701|FG001|Overall Study|Physician Decision|1|||
94213352|NCT02991118|322575700|FG000|Overall Study|Moved out of the country|0|||
94213353|NCT02991118|322575701|FG001|Overall Study|Moved out of the country|1|||
94213354|NCT02991118|322575700|FG000|Overall Study|Adverse Event|2|||
94213355|NCT02991118|322575701|FG001|Overall Study|Adverse Event|2|||
94213356|NCT02991118|322575700|FG000|Overall Study|Withdrawal by Subject|1|||
94285356|NCT01462266|322831859|FG001|Overall Study|Lack of Efficacy|2|||
94285357|NCT01462266|322831858|FG000|Overall Study|Lost to Follow-up|4|||
94213357|NCT02991118|322575701|FG001|Overall Study|Withdrawal by Subject|7|||
94213358|NCT02991118|322575700|FG000|Overall Study|Could not attend study visits|0|||
94213359|NCT02991118|322575701|FG001|Overall Study|Could not attend study visits|1|||
94213360|NCT02991118|322575700|FG000|Overall Study|Lost to Follow-up|1|||
94213361|NCT02991118|322575701|FG001|Overall Study|Lost to Follow-up|9|||
94213362|NCT03938272|322575702|FG000|Overall Study|Withdrawal by Subject|1|||
94213363|NCT03938272|322575703|FG001|Overall Study|Withdrawal by Subject|0|||
94372375|NCT03751020|323150254|FG002|Overall Study|Withdrawal by Subject|0|||
94213364|NCT03938272|322575702|FG000|Overall Study|Physician Decision|0|||
94213365|NCT03938272|322575703|FG001|Overall Study|Physician Decision|2|||
94213366|NCT03938272|322575702|FG000|Overall Study|Study termination by sponsor|10|||
94213367|NCT03938272|322575703|FG001|Overall Study|Study termination by sponsor|8|||
94213368|NCT01930188|322575704|FG000|Overall Study|unclassified|4|||
94213369|NCT01930188|322575705|FG001|Overall Study|unclassified|5|||
94213370|NCT01930188|322575706|FG002|Overall Study|unclassified|3|||
94213371|NCT01930188|322575704|FG000|Overall Study|Missing follow-up information|2|||
94213372|NCT01930188|322575705|FG001|Overall Study|Missing follow-up information|2|||
94213373|NCT01930188|322575706|FG002|Overall Study|Missing follow-up information|3|||
94213374|NCT01930188|322575704|FG000|Overall Study|Lost to Follow-up|5|||
94213375|NCT01930188|322575705|FG001|Overall Study|Lost to Follow-up|2|||
94213376|NCT01930188|322575706|FG002|Overall Study|Lost to Follow-up|2|||
94213377|NCT01930188|322575704|FG000|Overall Study|Death|2|||
94213378|NCT01930188|322575705|FG001|Overall Study|Death|1|||
94213379|NCT01930188|322575706|FG002|Overall Study|Death|3|||
94213380|NCT01930188|322575704|FG000|Overall Study|Withdrawal by Subject|9|||
94213381|NCT01930188|322575705|FG001|Overall Study|Withdrawal by Subject|11|||
94213382|NCT01930188|322575706|FG002|Overall Study|Withdrawal by Subject|8|||
94213383|NCT00886834|322575708|FG000|Overall Study|Protocol Violation|0|||
94213384|NCT00886834|322575709|FG001|Overall Study|Protocol Violation|3|||
94213385|NCT04085614|322575713|FG000|Overall Study|Protocol Violation|9|||
94213386|NCT04085614|322575714|FG001|Overall Study|Protocol Violation|6|||
94213387|NCT00337610|322575715|FG000|Overall Study|Adverse Event|2|||
94213388|NCT00337610|322575716|FG001|Overall Study|Adverse Event|2|||
94213389|NCT00337610|322575715|FG000|Overall Study|Death|0|||
94213390|NCT00337610|322575716|FG001|Overall Study|Death|1|||
94213391|NCT00337610|322575715|FG000|Overall Study|Lack of Efficacy|6|||
94213392|NCT00337610|322575716|FG001|Overall Study|Lack of Efficacy|3|||
94213393|NCT00337610|322575715|FG000|Overall Study|Lost to Follow-up|3|||
94213394|NCT00337610|322575716|FG001|Overall Study|Lost to Follow-up|3|||
94213395|NCT00337610|322575715|FG000|Overall Study|Withdrawal by Subject|6|||
94213396|NCT00337610|322575716|FG001|Overall Study|Withdrawal by Subject|5|||
94213397|NCT00428714|322575718|FG000|Overall Study|Progressive Disease|28|||
94213398|NCT00428714|322575719|FG001|Overall Study|Progressive Disease|36|||
94213399|NCT00428714|322575718|FG000|Overall Study|Withdrawal by Subject|0|||
94213400|NCT00428714|322575719|FG001|Overall Study|Withdrawal by Subject|3|||
94213401|NCT00428714|322575718|FG000|Overall Study|Adverse Event|0|||
94213402|NCT00428714|322575719|FG001|Overall Study|Adverse Event|2|||
94213403|NCT00428714|322575718|FG000|Overall Study|Physician Decision|1|||
94213404|NCT00428714|322575719|FG001|Overall Study|Physician Decision|1|||
94213405|NCT00428714|322575718|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
94213406|NCT00428714|322575719|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
94213407|NCT00428714|322575718|FG000|Overall Study|Death due to other then PD|1|||
94213408|NCT00428714|322575719|FG001|Overall Study|Death due to other then PD|0|||
94213409|NCT03060525|322575720|FG000|Overall Study|moved out of state|1|||
94213410|NCT03060525|322575721|FG001|Overall Study|moved out of state|1|||
94213411|NCT03060525|322575722|FG002|Overall Study|moved out of state|1|||
94213412|NCT03060525|322575723|FG003|Overall Study|moved out of state|1|||
94213413|NCT03060525|322575720|FG000|Overall Study|unable to meet time commitment required of study|2|||
94213414|NCT03060525|322575721|FG001|Overall Study|unable to meet time commitment required of study|3|||
94372376|NCT03751020|323150252|FG000|Overall Study|Lost to Follow-up|7|||
94372377|NCT03751020|323150253|FG001|Overall Study|Lost to Follow-up|4|||
94372378|NCT03751020|323150254|FG002|Overall Study|Lost to Follow-up|10|||
94372379|NCT02436135|323150255|FG000|Overall Study|Progressive Disease|3|||
94372380|NCT02436135|323150256|FG001|Overall Study|Progressive Disease|1|||
94372381|NCT02436135|323150255|FG000|Overall Study|Investigator Discretion|1|||
94372382|NCT02436135|323150256|FG001|Overall Study|Investigator Discretion|2|||
94372383|NCT02436135|323150255|FG000|Overall Study|Adverse Event|1|||
94372384|NCT02436135|323150256|FG001|Overall Study|Adverse Event|0|||
94372385|NCT02436135|323150255|FG000|Overall Study|Withdrawal by Participant|1|||
94372386|NCT02436135|323150256|FG001|Overall Study|Withdrawal by Participant|0|||
94372387|NCT02436135|323150255|FG000|Overall Study|Study Terminated By Sponsor|0|||
94372388|NCT02436135|323150256|FG001|Overall Study|Study Terminated By Sponsor|1|||
94213415|NCT03060525|322575722|FG002|Overall Study|unable to meet time commitment required of study|3|||
94213416|NCT03060525|322575723|FG003|Overall Study|unable to meet time commitment required of study|1|||
94213417|NCT03060525|322575720|FG000|Overall Study|no longer interested in doing intervention|0|||
94213418|NCT03060525|322575721|FG001|Overall Study|no longer interested in doing intervention|0|||
94213419|NCT03060525|322575722|FG002|Overall Study|no longer interested in doing intervention|0|||
94213420|NCT03060525|322575723|FG003|Overall Study|no longer interested in doing intervention|1|||
94213421|NCT04447287|322575737|FG000|Period 1: Run-in Period|Adverse Event|3|||
94213422|NCT04447287|322575738|FG001|Period 1: Run-in Period|Adverse Event|0|||
94213423|NCT04447287|322575739|FG002|Period 1: Run-in Period|Adverse Event|0|||
94372389|NCT04130919|323150257|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
94372390|NCT04130919|323150258|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
94285358|NCT01462266|322831859|FG001|Overall Study|Lost to Follow-up|3|||
94285359|NCT01462266|322831858|FG000|Overall Study|Non-compliance with study drug|3|||
94285360|NCT01462266|322831859|FG001|Overall Study|Non-compliance with study drug|0|||
94285361|NCT01462266|322831858|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
94285362|NCT01462266|322831859|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
94285363|NCT01462266|322831858|FG000|Overall Study|Physician Decision|2|||
94285364|NCT01462266|322831859|FG001|Overall Study|Physician Decision|5|||
94285365|NCT01462266|322831858|FG000|Overall Study|Protocol Violation|1|||
94285366|NCT01462266|322831859|FG001|Overall Study|Protocol Violation|3|||
94285367|NCT01462266|322831858|FG000|Overall Study|Withdrawal by Subject|7|||
94285368|NCT01462266|322831859|FG001|Overall Study|Withdrawal by Subject|2|||
94285369|NCT01462266|322831858|FG000|Overall Study|Screen failure|1|||
94285370|NCT01462266|322831859|FG001|Overall Study|Screen failure|1|||
94285371|NCT02482129|322831865|FG000|Overall Study|Adverse Event-prior to treatment|0|||
94285372|NCT02482129|322831866|FG001|Overall Study|Adverse Event-prior to treatment|1|||
94285373|NCT02482129|322831865|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
94285374|NCT02482129|322831866|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
94285375|NCT02482129|322831865|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
94285376|NCT02482129|322831866|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
94285377|NCT02482129|322831865|FG000|Overall Study|Criteria not met-prior to treatment|1|||
94285378|NCT02482129|322831866|FG001|Overall Study|Criteria not met-prior to treatment|0|||
94285379|NCT02482129|322831865|FG000|Overall Study|Adverse Event|1|||
94285380|NCT02482129|322831866|FG001|Overall Study|Adverse Event|0|||
94285381|NCT02482129|322831865|FG000|Overall Study|Withdrawal by Subject|2|||
94285382|NCT02482129|322831866|FG001|Overall Study|Withdrawal by Subject|0|||
94285383|NCT02482129|322831865|FG000|Overall Study|Criteria not met|1|||
94285384|NCT02482129|322831866|FG001|Overall Study|Criteria not met|0|||
94285385|NCT01738971|322831867|FG000|Overall Study|Lost to Follow-up|19|||
94285386|NCT01738971|322831868|FG001|Overall Study|Lost to Follow-up|30|||
94285387|NCT01738971|322831869|FG002|Overall Study|Lost to Follow-up|17|||
94285388|NCT02447848|322831874|FG000|Overall Study|Patient discharged|3|||
94285389|NCT02447848|322831874|FG000|Overall Study|Lack of Efficacy|4|||
94285390|NCT02447848|322831874|FG000|Overall Study|Withdrawal by Subject|4|||
94285391|NCT01877083|322831875|FG000|Treatment Phase|Disease Progression|10|||
94285392|NCT01877083|322831875|FG000|Treatment Phase|Clinical Progression|1|||
94285393|NCT01877083|322831875|FG000|Treatment Phase|Adverse Event|6|||
94285394|NCT01877083|322831875|FG000|Treatment Phase|Withdrawal by Subject|2|||
94285395|NCT01877083|322831875|FG000|Treatment Phase|Lost to Follow-up|1|||
94285396|NCT01877083|322831875|FG000|Extension Phase|Disease Progression|3|||
94285397|NCT01877083|322831875|FG000|Extension Phase|Adverse Event|2|||
94285398|NCT02531646|322831878|FG000|Overall Study|equip. image processing issue|5|||
94285399|NCT02531646|322831879|FG001|Overall Study|equip. image processing issue|1|||
94285400|NCT02531646|322831880|FG002|Overall Study|equip. image processing issue|0|||
94285401|NCT00429585|322831881|FG000|Overall Study|Death|1|||
94285402|NCT00429585|322831882|FG001|Overall Study|Death|0|||
94285403|NCT00429585|322831881|FG000|Overall Study|Lost to Follow-up|27|||
94285404|NCT00429585|322831882|FG001|Overall Study|Lost to Follow-up|20|||
94372391|NCT04130919|323150259|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
94372392|NCT04130919|323150260|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
94372393|NCT04130919|323150261|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
94372394|NCT04130919|323150262|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
94372395|NCT04130919|323150257|FG000|Blinded Treatment Phase|Adverse Event|0|||
94372396|NCT04130919|323150258|FG001|Blinded Treatment Phase|Adverse Event|0|||
94372397|NCT04130919|323150259|FG002|Blinded Treatment Phase|Adverse Event|1|||
94372398|NCT04130919|323150260|FG003|Blinded Treatment Phase|Adverse Event|0|||
94372399|NCT04130919|323150261|FG004|Blinded Treatment Phase|Adverse Event|0|||
94372400|NCT04130919|323150262|FG005|Blinded Treatment Phase|Adverse Event|0|||
94372401|NCT04130919|323150257|FG000|Blinded Treatment Phase|Disease worsening|0|||
94372402|NCT04130919|323150258|FG001|Blinded Treatment Phase|Disease worsening|0|||
94372403|NCT04130919|323150259|FG002|Blinded Treatment Phase|Disease worsening|1|||
94372404|NCT04130919|323150260|FG003|Blinded Treatment Phase|Disease worsening|0|||
94372405|NCT04130919|323150261|FG004|Blinded Treatment Phase|Disease worsening|0|||
94372406|NCT04130919|323150262|FG005|Blinded Treatment Phase|Disease worsening|0|||
94372407|NCT04130919|323150257|FG000|Blinded Treatment Phase|Investigator's decision|0|||
94213424|NCT04447287|322575737|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
94213425|NCT04447287|322575738|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
94213426|NCT04447287|322575739|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
94213427|NCT04447287|322575737|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
94213428|NCT04447287|322575738|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
94213429|NCT04447287|322575739|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
94213430|NCT02978716|322575741|FG000|Overall Study|Death|25|||
94213431|NCT02978716|322575742|FG001|Overall Study|Death|13|||
94213432|NCT02978716|322575743|FG002|Overall Study|Death|20|||
94213433|NCT02978716|322575741|FG000|Overall Study|Lost to Follow-up|0|||
94213434|NCT02978716|322575742|FG001|Overall Study|Lost to Follow-up|0|||
94213435|NCT02978716|322575743|FG002|Overall Study|Lost to Follow-up|1|||
94213436|NCT02978716|322575741|FG000|Overall Study|Withdrawal by Subject|6|||
94213437|NCT02978716|322575742|FG001|Overall Study|Withdrawal by Subject|4|||
94213438|NCT02978716|322575743|FG002|Overall Study|Withdrawal by Subject|5|||
94213439|NCT02978716|322575741|FG000|Overall Study|Sponsor terminated|2|||
94213440|NCT02978716|322575742|FG001|Overall Study|Sponsor terminated|13|||
94213441|NCT02978716|322575743|FG002|Overall Study|Sponsor terminated|9|||
94213442|NCT02978716|322575741|FG000|Overall Study|Other|1|||
94213443|NCT02978716|322575742|FG001|Overall Study|Other|3|||
94213444|NCT02978716|322575743|FG002|Overall Study|Other|0|||
94213445|NCT02260154|322575744|FG000|Overall Study|Screening failure|2|||
94213446|NCT02161146|322575749|FG000|Overall Study|Adverse Event|1|||
94213447|NCT02161146|322575750|FG001|Overall Study|Adverse Event|1|||
94213448|NCT02161146|322575751|FG002|Overall Study|Adverse Event|0|||
94213449|NCT02161146|322575752|FG003|Overall Study|Adverse Event|1|||
94213450|NCT02161146|322575753|FG004|Overall Study|Adverse Event|0|||
94213451|NCT02161146|322575749|FG000|Overall Study|Lost to Follow-up|0|||
94213452|NCT02161146|322575750|FG001|Overall Study|Lost to Follow-up|1|||
94213453|NCT02161146|322575751|FG002|Overall Study|Lost to Follow-up|0|||
94213454|NCT02161146|322575752|FG003|Overall Study|Lost to Follow-up|0|||
94213455|NCT02161146|322575753|FG004|Overall Study|Lost to Follow-up|0|||
94213456|NCT02161146|322575749|FG000|Overall Study|Personal Reasons|0|||
94213457|NCT02161146|322575750|FG001|Overall Study|Personal Reasons|1|||
94213458|NCT02161146|322575751|FG002|Overall Study|Personal Reasons|0|||
94213459|NCT02161146|322575752|FG003|Overall Study|Personal Reasons|2|||
94213460|NCT02161146|322575753|FG004|Overall Study|Personal Reasons|1|||
94213461|NCT02161146|322575749|FG000|Overall Study|Other Miscellaneous Reasons|0|||
94213462|NCT02161146|322575750|FG001|Overall Study|Other Miscellaneous Reasons|1|||
94213463|NCT02161146|322575751|FG002|Overall Study|Other Miscellaneous Reasons|0|||
94213464|NCT02161146|322575752|FG003|Overall Study|Other Miscellaneous Reasons|0|||
94285405|NCT00429585|322831881|FG000|Overall Study|Physician Decision|2|||
94285406|NCT00429585|322831882|FG001|Overall Study|Physician Decision|0|||
94285407|NCT01582308|322831883|FG000|Period 1|Withdrawal by Subject|0|||
94285408|NCT01582308|322831884|FG001|Period 1|Withdrawal by Subject|0|||
94285409|NCT01582308|322831885|FG002|Period 1|Withdrawal by Subject|0|||
94285410|NCT01582308|322831886|FG003|Period 1|Withdrawal by Subject|0|||
94285411|NCT01582308|322831887|FG004|Period 1|Withdrawal by Subject|0|||
94285412|NCT01582308|322831888|FG005|Period 1|Withdrawal by Subject|0|||
94285413|NCT01582308|322831889|FG006|Period 1|Withdrawal by Subject|1|||
94213465|NCT02161146|322575753|FG004|Overall Study|Other Miscellaneous Reasons|0|||
94213466|NCT02807857|322575755|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
94213467|NCT02807857|322575755|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
94285414|NCT01582308|322831890|FG007|Period 1|Withdrawal by Subject|0|||
94285415|NCT01582308|322831891|FG008|Period 1|Withdrawal by Subject|0|||
94285416|NCT01582308|322831892|FG009|Period 1|Withdrawal by Subject|0|||
94372408|NCT04130919|323150258|FG001|Blinded Treatment Phase|Investigator's decision|1|||
94372409|NCT04130919|323150259|FG002|Blinded Treatment Phase|Investigator's decision|0|||
94213468|NCT02807857|322575755|FG000|Follow-Up Set|Withdrawal by Subject|8|||
94213469|NCT02807857|322575755|FG000|Follow-Up Set|Lost to Follow-up|7|||
94213470|NCT02807857|322575755|FG000|Follow-Up Set|Physician Decision|6|||
94213471|NCT02807857|322575755|FG000|Follow-Up Set|Adverse Event|3|||
94467807|NCT03887117|323502416|FG001|Overall Study|Discontinued prematurely|1|||
94467808|NCT03887117|323502417|FG002|Overall Study|Discontinued prematurely|1|||
94213472|NCT02807857|322575755|FG000|Follow-Up Set|Death|27|||
94213473|NCT02807857|322575755|FG000|Follow-Up Set|Relocation|2|||
94213474|NCT00736502|322575756|FG000|Overall Study|Adverse Event|22|||
94372410|NCT04130919|323150260|FG003|Blinded Treatment Phase|Investigator's decision|0|||
94213475|NCT00736502|322575756|FG000|Overall Study|Lack of Efficacy|16|||
94213476|NCT00736502|322575756|FG000|Overall Study|Lost to Follow-up|27|||
94213477|NCT03032198|322575757|FG000|Overall Study|Screen Fail|1|||
94213478|NCT01147471|322575758|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
94213479|NCT01147471|322575759|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
94213480|NCT01147471|322575758|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
94213481|NCT01147471|322575759|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
94213482|NCT01147471|322575758|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
94213483|NCT01147471|322575759|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
94213484|NCT01147471|322575758|FG000|3 Month Follow Up|Lost to Follow-up|1|||
94213485|NCT01147471|322575759|FG001|3 Month Follow Up|Lost to Follow-up|1|||
94213486|NCT01147471|322575758|FG000|3 Month Follow Up|Physician Decision|0|||
94213487|NCT01147471|322575759|FG001|3 Month Follow Up|Physician Decision|1|||
94213488|NCT01147471|322575758|FG000|6 Month Follow Up|Lost to Follow-up|4|||
94213489|NCT01147471|322575759|FG001|6 Month Follow Up|Lost to Follow-up|2|||
94213490|NCT02923349|322575761|FG000|Overall Study|Other|1|||
94213491|NCT02923349|322575762|FG001|Overall Study|Other|2|||
94213492|NCT02923349|322575763|FG002|Overall Study|Other|4|||
94213493|NCT02923349|322575764|FG003|Overall Study|Other|1|||
94213494|NCT02923349|322575765|FG004|Overall Study|Other|3|||
94213495|NCT02923349|322575766|FG005|Overall Study|Other|0|||
94213496|NCT02923349|322575767|FG006|Overall Study|Other|1|||
94213497|NCT02923349|322575761|FG000|Overall Study|Withdrawal by Subject|2|||
94213498|NCT02923349|322575762|FG001|Overall Study|Withdrawal by Subject|2|||
94213499|NCT02923349|322575763|FG002|Overall Study|Withdrawal by Subject|8|||
94213500|NCT02923349|322575764|FG003|Overall Study|Withdrawal by Subject|10|||
94213501|NCT02923349|322575765|FG004|Overall Study|Withdrawal by Subject|12|||
94213502|NCT02923349|322575766|FG005|Overall Study|Withdrawal by Subject|3|||
94213503|NCT02923349|322575767|FG006|Overall Study|Withdrawal by Subject|0|||
94213504|NCT02923349|322575761|FG000|Overall Study|Physician Decision|0|||
94213505|NCT02923349|322575762|FG001|Overall Study|Physician Decision|0|||
94213506|NCT02923349|322575763|FG002|Overall Study|Physician Decision|0|||
94213507|NCT02923349|322575764|FG003|Overall Study|Physician Decision|1|||
94372411|NCT04130919|323150261|FG004|Blinded Treatment Phase|Investigator's decision|0|||
94213508|NCT02923349|322575765|FG004|Overall Study|Physician Decision|1|||
94213509|NCT02923349|322575766|FG005|Overall Study|Physician Decision|0|||
94213510|NCT02923349|322575767|FG006|Overall Study|Physician Decision|2|||
94213511|NCT02923349|322575761|FG000|Overall Study|Lost to Follow-up|0|||
94213512|NCT02923349|322575762|FG001|Overall Study|Lost to Follow-up|0|||
94213513|NCT02923349|322575763|FG002|Overall Study|Lost to Follow-up|3|||
94213514|NCT02923349|322575764|FG003|Overall Study|Lost to Follow-up|0|||
94213515|NCT02923349|322575765|FG004|Overall Study|Lost to Follow-up|1|||
94213516|NCT02923349|322575766|FG005|Overall Study|Lost to Follow-up|1|||
94213517|NCT02923349|322575767|FG006|Overall Study|Lost to Follow-up|0|||
94213518|NCT02923349|322575761|FG000|Overall Study|Death|1|||
94213519|NCT02923349|322575762|FG001|Overall Study|Death|0|||
94213520|NCT02923349|322575763|FG002|Overall Study|Death|2|||
94213521|NCT02923349|322575764|FG003|Overall Study|Death|4|||
94213522|NCT02923349|322575765|FG004|Overall Study|Death|2|||
94213523|NCT02923349|322575766|FG005|Overall Study|Death|3|||
94213524|NCT02923349|322575767|FG006|Overall Study|Death|0|||
94213525|NCT00800176|322575770|FG000|Overall Study|Adverse Event|2|||
94213526|NCT00800176|322575771|FG001|Overall Study|Adverse Event|1|||
94213527|NCT00800176|322575772|FG002|Overall Study|Adverse Event|0|||
94213528|NCT00800176|322575773|FG003|Overall Study|Adverse Event|2|||
94213529|NCT00800176|322575774|FG004|Overall Study|Adverse Event|1|||
94213530|NCT00800176|322575775|FG005|Overall Study|Adverse Event|1|||
94213531|NCT00800176|322575770|FG000|Overall Study|Refused treatment|3|||
94213532|NCT00800176|322575771|FG001|Overall Study|Refused treatment|2|||
94213533|NCT00800176|322575772|FG002|Overall Study|Refused treatment|0|||
94213534|NCT00800176|322575773|FG003|Overall Study|Refused treatment|0|||
94213535|NCT00800176|322575774|FG004|Overall Study|Refused treatment|1|||
94213536|NCT00800176|322575775|FG005|Overall Study|Refused treatment|4|||
94213537|NCT00800176|322575770|FG000|Overall Study|Failure to return|3|||
94213538|NCT00800176|322575771|FG001|Overall Study|Failure to return|3|||
94213539|NCT00800176|322575772|FG002|Overall Study|Failure to return|0|||
94213540|NCT00800176|322575773|FG003|Overall Study|Failure to return|2|||
94213541|NCT00800176|322575774|FG004|Overall Study|Failure to return|0|||
94213542|NCT00800176|322575775|FG005|Overall Study|Failure to return|0|||
94213543|NCT00800176|322575770|FG000|Overall Study|Other|1|||
94213544|NCT00800176|322575771|FG001|Overall Study|Other|0|||
94213545|NCT00800176|322575772|FG002|Overall Study|Other|0|||
94213546|NCT00800176|322575773|FG003|Overall Study|Other|0|||
94213547|NCT00800176|322575774|FG004|Overall Study|Other|2|||
94213548|NCT00800176|322575775|FG005|Overall Study|Other|0|||
94213549|NCT03138499|322575778|FG000|Overall Study|Lost to Follow-up|1|||
94213550|NCT03138499|322575779|FG001|Overall Study|Lost to Follow-up|0|||
94213551|NCT03138499|322575778|FG000|Overall Study|Participants withdrew consent|1|||
94213552|NCT03138499|322575779|FG001|Overall Study|Participants withdrew consent|0|||
94213553|NCT03138499|322575778|FG000|Overall Study|Participant discontinued study before treatment|0|||
94213554|NCT03138499|322575779|FG001|Overall Study|Participant discontinued study before treatment|1|||
94213555|NCT03138499|322575778|FG000|Overall Study|Disease Progression|2|||
94213556|NCT03138499|322575779|FG001|Overall Study|Disease Progression|6|||
94213557|NCT03138499|322575778|FG000|Overall Study|Study drug toxicity|2|||
94213558|NCT03138499|322575779|FG001|Overall Study|Study drug toxicity|2|||
94213559|NCT03138499|322575778|FG000|Overall Study|Participant request to discontinue study treatment|1|||
94213560|NCT03138499|322575779|FG001|Overall Study|Participant request to discontinue study treatment|1|||
94213561|NCT03138499|322575778|FG000|Overall Study|Other reasons|2|||
94213562|NCT03138499|322575779|FG001|Overall Study|Other reasons|0|||
94213563|NCT01313663|322575780|FG000|Overall Study|Study Closed/Terminated|2|||
94213564|NCT01313663|322575781|FG001|Overall Study|Study Closed/Terminated|4|||
94213565|NCT01313663|322575780|FG000|Overall Study|Lost to Follow-up|0|||
94213566|NCT01313663|322575781|FG001|Overall Study|Lost to Follow-up|1|||
94213567|NCT01313663|322575780|FG000|Overall Study|Physician Decision|0|||
94213568|NCT01313663|322575781|FG001|Overall Study|Physician Decision|2|||
94213569|NCT01313663|322575780|FG000|Overall Study|Withdrawal by Subject|2|||
94285417|NCT01582308|322831883|FG000|10-day Washout Following Period 1|Physician Decision|0|||
94285418|NCT01582308|322831884|FG001|10-day Washout Following Period 1|Physician Decision|0|||
94285419|NCT01582308|322831885|FG002|10-day Washout Following Period 1|Physician Decision|0|||
94285420|NCT01582308|322831886|FG003|10-day Washout Following Period 1|Physician Decision|0|||
94285421|NCT01582308|322831887|FG004|10-day Washout Following Period 1|Physician Decision|1|||
94285422|NCT01582308|322831888|FG005|10-day Washout Following Period 1|Physician Decision|0|||
94213570|NCT01313663|322575781|FG001|Overall Study|Withdrawal by Subject|1|||
94213571|NCT02699099|322575782|FG000|Overall Study|Adverse Event|1|||
94213572|NCT02699099|322575783|FG001|Overall Study|Adverse Event|0|||
94285423|NCT01582308|322831889|FG006|10-day Washout Following Period 1|Physician Decision|0|||
94285424|NCT01582308|322831890|FG007|10-day Washout Following Period 1|Physician Decision|0|||
94285425|NCT01582308|322831891|FG008|10-day Washout Following Period 1|Physician Decision|0|||
94285426|NCT01582308|322831892|FG009|10-day Washout Following Period 1|Physician Decision|0|||
94285427|NCT01582308|322831883|FG000|Period 4|Physician Decision|1|||
94285428|NCT01582308|322831884|FG001|Period 4|Physician Decision|0|||
94285429|NCT01582308|322831885|FG002|Period 4|Physician Decision|0|||
94285430|NCT01582308|322831886|FG003|Period 4|Physician Decision|0|||
94285431|NCT01582308|322831887|FG004|Period 4|Physician Decision|0|||
94285432|NCT01582308|322831888|FG005|Period 4|Physician Decision|1|||
94213573|NCT02699099|322575784|FG002|Overall Study|Adverse Event|2|||
94213574|NCT02699099|322575782|FG000|Overall Study|Lost to Follow-up|0|||
94213575|NCT02699099|322575783|FG001|Overall Study|Lost to Follow-up|1|||
94213576|NCT02699099|322575784|FG002|Overall Study|Lost to Follow-up|0|||
94213577|NCT02699099|322575782|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
94213578|NCT02699099|322575783|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
94213579|NCT02699099|322575784|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
94213580|NCT01240590|322575785|FG000|Phase I|Refused further treatment|0|||
94213581|NCT01240590|322575786|FG001|Phase I|Refused further treatment|0|||
94213582|NCT01240590|322575787|FG002|Phase I|Refused further treatment|3|||
94213583|NCT01240590|322575788|FG003|Phase I|Refused further treatment|0|||
94213584|NCT01240590|322575789|FG004|Phase I|Refused further treatment|0|||
94213585|NCT01240590|322575785|FG000|Phase II|Refused further treatment|0|||
94213586|NCT01240590|322575786|FG001|Phase II|Refused further treatment|0|||
94213587|NCT01240590|322575787|FG002|Phase II|Refused further treatment|0|||
94213588|NCT01240590|322575788|FG003|Phase II|Refused further treatment|2|||
94213589|NCT01240590|322575789|FG004|Phase II|Refused further treatment|1|||
94213590|NCT03890484|322575790|FG000|Overall Study|Lost to Follow-up|1|||
94213591|NCT03890484|322575791|FG001|Overall Study|Lost to Follow-up|1|||
94213592|NCT01084772|322575792|FG000|Baseline|Withdrawal by Subject|7|||
94213593|NCT01084772|322575793|FG001|Baseline|Withdrawal by Subject|6|||
94213594|NCT01084772|322575792|FG000|3 Months|Death|1|||
94213595|NCT01084772|322575793|FG001|3 Months|Death|0|||
94213596|NCT01084772|322575792|FG000|3 Months|Study Termination|2|||
94213597|NCT01084772|322575793|FG001|3 Months|Study Termination|2|||
94213598|NCT01084772|322575792|FG000|1 Year|Withdrawal by Subject|0|||
94213599|NCT01084772|322575793|FG001|1 Year|Withdrawal by Subject|1|||
94213600|NCT01084772|322575792|FG000|1 Year|Lost to Follow-up|3|||
94213601|NCT01084772|322575793|FG001|1 Year|Lost to Follow-up|0|||
94213602|NCT01084772|322575792|FG000|1 Year|Study Termination|0|||
94213603|NCT01084772|322575793|FG001|1 Year|Study Termination|7|||
94213604|NCT01084772|322575792|FG000|2 Years|Withdrawal by Subject|1|||
94213605|NCT01084772|322575793|FG001|2 Years|Withdrawal by Subject|0|||
94213606|NCT01084772|322575792|FG000|2 Years|Lost to Follow-up|5|||
94213607|NCT01084772|322575793|FG001|2 Years|Lost to Follow-up|2|||
94213608|NCT01084772|322575792|FG000|2 Years|Study Termination|3|||
94213609|NCT01084772|322575793|FG001|2 Years|Study Termination|2|||
94213610|NCT02188459|322575794|FG000|Overall Study|Lost to Follow-up|3|||
94213611|NCT02188459|322575795|FG001|Overall Study|Lost to Follow-up|4|||
94213612|NCT02188459|322575794|FG000|Overall Study|Early Termination|0|||
94213613|NCT02188459|322575795|FG001|Overall Study|Early Termination|3|||
94213614|NCT04820491|322575802|FG000|Overall Study|Withdrawal by Subject|1|||
94213615|NCT04820491|322575803|FG001|Overall Study|Withdrawal by Subject|0|||
94213616|NCT02144285|322575807|FG000|Overall Study|Withdrawal by Subject|0|||
94213617|NCT02144285|322575808|FG001|Overall Study|Withdrawal by Subject|0|||
94213618|NCT02144285|322575809|FG002|Overall Study|Withdrawal by Subject|0|||
94213619|NCT02144285|322575810|FG003|Overall Study|Withdrawal by Subject|0|||
94285433|NCT01582308|322831889|FG006|Period 4|Physician Decision|0|||
94285434|NCT01582308|322831890|FG007|Period 4|Physician Decision|0|||
94285435|NCT01582308|322831891|FG008|Period 4|Physician Decision|0|||
94285436|NCT01582308|322831892|FG009|Period 4|Physician Decision|1|||
94213620|NCT02144285|322575811|FG004|Overall Study|Withdrawal by Subject|1|||
94285437|NCT00482014|322835284|FG000|Overall Study|Withdrawal by Subject|1|||
94285438|NCT00482014|322835285|FG001|Overall Study|Withdrawal by Subject|2|||
94285439|NCT00482014|322835286|FG002|Overall Study|Withdrawal by Subject|3|||
94213621|NCT02144285|322575812|FG005|Overall Study|Withdrawal by Subject|0|||
94213622|NCT02144285|322575813|FG006|Overall Study|Withdrawal by Subject|0|||
94213623|NCT02144285|322575814|FG007|Overall Study|Withdrawal by Subject|0|||
94213624|NCT02144285|322575815|FG008|Overall Study|Withdrawal by Subject|0|||
94213625|NCT02144285|322575816|FG009|Overall Study|Withdrawal by Subject|0|||
94213626|NCT00443820|322577691|FG000|Overall Study|Adverse Event|1|||
94213627|NCT00443820|322577692|FG001|Overall Study|Adverse Event|1|||
94213628|NCT00443820|322577693|FG002|Overall Study|Adverse Event|0|||
94213629|NCT00443820|322577694|FG003|Overall Study|Adverse Event|0|||
94213630|NCT00443820|322577691|FG000|Overall Study|Lack of Efficacy|3|||
94213631|NCT00443820|322577692|FG001|Overall Study|Lack of Efficacy|2|||
94213632|NCT00443820|322577693|FG002|Overall Study|Lack of Efficacy|1|||
94213633|NCT00443820|322577694|FG003|Overall Study|Lack of Efficacy|1|||
94213634|NCT00443820|322577691|FG000|Overall Study|Protocol Violation|2|||
94213635|NCT00443820|322577692|FG001|Overall Study|Protocol Violation|1|||
94213636|NCT00443820|322577693|FG002|Overall Study|Protocol Violation|2|||
94213637|NCT00443820|322577694|FG003|Overall Study|Protocol Violation|1|||
94213638|NCT00443820|322577691|FG000|Overall Study|Withdrawal by Subject|6|||
94213639|NCT00443820|322577692|FG001|Overall Study|Withdrawal by Subject|7|||
94213640|NCT00443820|322577693|FG002|Overall Study|Withdrawal by Subject|8|||
94213641|NCT00443820|322577694|FG003|Overall Study|Withdrawal by Subject|9|||
94213642|NCT00443820|322577691|FG000|Overall Study|Lost to Follow-up|9|||
94213643|NCT00443820|322577692|FG001|Overall Study|Lost to Follow-up|8|||
94213644|NCT00443820|322577693|FG002|Overall Study|Lost to Follow-up|6|||
94213645|NCT00443820|322577694|FG003|Overall Study|Lost to Follow-up|5|||
94213646|NCT00443820|322577691|FG000|Overall Study|Administrative problems|0|||
94213647|NCT00443820|322577692|FG001|Overall Study|Administrative problems|0|||
94213648|NCT00443820|322577693|FG002|Overall Study|Administrative problems|0|||
94213649|NCT00443820|322577694|FG003|Overall Study|Administrative problems|1|||
94213650|NCT00443820|322577691|FG000|Overall Study|Death|0|||
94213651|NCT00443820|322577692|FG001|Overall Study|Death|0|||
94213652|NCT00443820|322577693|FG002|Overall Study|Death|1|||
94213653|NCT00443820|322577694|FG003|Overall Study|Death|0|||
94213654|NCT00451906|322577695|FG000|Overall Study|Adverse Event|515|||
94213655|NCT00451906|322577695|FG000|Overall Study|Lost to Follow-up|31|||
94213656|NCT00451906|322577695|FG000|Overall Study|Withdrawal by Subject|111|||
94213657|NCT00451906|322577695|FG000|Overall Study|Protocol Violation|21|||
94213658|NCT00451906|322577695|FG000|Overall Study|Progressive disease|1328|||
94213659|NCT00451906|322577695|FG000|Overall Study|Termination of the study|108|||
94213660|NCT00451906|322577695|FG000|Overall Study|Other Reasons|121|||
94213661|NCT00451906|322577695|FG000|Overall Study|Did not complete final visit|4|||
94213662|NCT00587171|322577696|FG000|Overall Study|Lost to Follow-up|1|||
94213663|NCT00587171|322577697|FG001|Overall Study|Lost to Follow-up|1|||
94213664|NCT02236611|322577698|FG000|Overall Study|Adverse Event|10|||
94213665|NCT02236611|322577699|FG001|Overall Study|Adverse Event|16|||
94213666|NCT02236611|322577698|FG000|Overall Study|Lack of Efficacy|4|||
94213667|NCT02236611|322577699|FG001|Overall Study|Lack of Efficacy|7|||
94213668|NCT02236611|322577698|FG000|Overall Study|Lost to Follow-up|0|||
94213669|NCT02236611|322577699|FG001|Overall Study|Lost to Follow-up|2|||
94213670|NCT02236611|322577698|FG000|Overall Study|Protocol deviation|3|||
94213671|NCT02236611|322577699|FG001|Overall Study|Protocol deviation|5|||
94213672|NCT02236611|322577698|FG000|Overall Study|Withdrew consent|9|||
94213673|NCT02236611|322577699|FG001|Overall Study|Withdrew consent|4|||
94213674|NCT02338999|322577702|FG000|First Intervention|Withdrawal by Subject|3|||
94213675|NCT02338999|322577703|FG001|First Intervention|Withdrawal by Subject|1|||
94213676|NCT02338999|322577702|FG000|Washout Period|Withdrawal by Subject|0|||
94213677|NCT02338999|322577703|FG001|Washout Period|Withdrawal by Subject|2|||
94213678|NCT02338999|322577702|FG000|Second Intervention|Withdrawal by Subject|0|||
94213679|NCT02338999|322577703|FG001|Second Intervention|Withdrawal by Subject|2|||
94213680|NCT02889900|322577706|FG000|Overall Study|Adverse Event|11|||
94213681|NCT02889900|322577706|FG000|Overall Study|Condition under investigation worsened|32|||
94213682|NCT02889900|322577706|FG000|Overall Study|Other|5|||
94213683|NCT02889900|322577706|FG000|Overall Study|Withdrawal by Subject|7|||
94213684|NCT02889900|322577706|FG000|Overall Study|Not treated|2|||
94213685|NCT00578344|322577707|FG000|Overall Study|Insurance problems|1|||
94213686|NCT00578344|322577707|FG000|Overall Study|Graft failure|1|||
94213687|NCT02935673|322577708|FG000|Overall Study|Adverse Event|0|||
94213688|NCT02935673|322577709|FG001|Overall Study|Adverse Event|1|||
94285440|NCT00482014|322835287|FG003|Overall Study|Withdrawal by Subject|4|||
94285441|NCT00482014|322835284|FG000|Overall Study|Adverse Event|3|||
94285442|NCT00482014|322835285|FG001|Overall Study|Adverse Event|0|||
94285443|NCT00482014|322835286|FG002|Overall Study|Adverse Event|2|||
94285444|NCT00482014|322835287|FG003|Overall Study|Adverse Event|8|||
94285445|NCT00482014|322835284|FG000|Overall Study|Death|1|||
94285446|NCT00482014|322835285|FG001|Overall Study|Death|2|||
94285447|NCT00482014|322835286|FG002|Overall Study|Death|1|||
94285448|NCT00482014|322835287|FG003|Overall Study|Death|4|||
94285449|NCT00482014|322835284|FG000|Overall Study|Lack of Efficacy|1|||
94285450|NCT00482014|322835285|FG001|Overall Study|Lack of Efficacy|0|||
94285451|NCT00482014|322835286|FG002|Overall Study|Lack of Efficacy|4|||
94285452|NCT00482014|322835287|FG003|Overall Study|Lack of Efficacy|6|||
94285453|NCT00482014|322835284|FG000|Overall Study|Sponsor Decision|1|||
94285454|NCT00482014|322835285|FG001|Overall Study|Sponsor Decision|2|||
94285455|NCT00482014|322835286|FG002|Overall Study|Sponsor Decision|1|||
94285456|NCT00482014|322835287|FG003|Overall Study|Sponsor Decision|1|||
94285457|NCT03686397|322835289|FG000|Overall Study|Lack of Efficacy|3|||
94285458|NCT03686397|322835290|FG001|Overall Study|Lack of Efficacy|5|||
94285459|NCT03686397|322835289|FG000|Overall Study|Adverse Event|0|||
94285460|NCT03686397|322835290|FG001|Overall Study|Adverse Event|1|||
94285461|NCT03686397|322835289|FG000|Overall Study|Protocol Violation|0|||
94285462|NCT03686397|322835290|FG001|Overall Study|Protocol Violation|1|||
94285463|NCT03686397|322835289|FG000|Overall Study|Withdrawal by Subject|0|||
94285464|NCT03686397|322835290|FG001|Overall Study|Withdrawal by Subject|1|||
94285465|NCT03686397|322835289|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
94285466|NCT03686397|322835290|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
94285467|NCT00328627|322835291|FG000|Overall Study|Hyperglycemic Rescue|41|||
94285468|NCT00328627|322835292|FG001|Overall Study|Hyperglycemic Rescue|18|||
94285469|NCT00328627|322835293|FG002|Overall Study|Hyperglycemic Rescue|16|||
94285470|NCT00328627|322835294|FG003|Overall Study|Hyperglycemic Rescue|13|||
94285471|NCT00328627|322835295|FG004|Overall Study|Hyperglycemic Rescue|6|||
94285472|NCT00328627|322835296|FG005|Overall Study|Hyperglycemic Rescue|5|||
94285473|NCT00328627|322835297|FG006|Overall Study|Hyperglycemic Rescue|19|||
94372412|NCT04130919|323150262|FG005|Blinded Treatment Phase|Investigator's decision|0|||
94372413|NCT04130919|323150257|FG000|Blinded Treatment Phase|Withdrew consent|1|||
94372414|NCT04130919|323150258|FG001|Blinded Treatment Phase|Withdrew consent|0|||
94372415|NCT04130919|323150259|FG002|Blinded Treatment Phase|Withdrew consent|0|||
94372416|NCT04130919|323150260|FG003|Blinded Treatment Phase|Withdrew consent|0|||
94285474|NCT00328627|322835298|FG007|Overall Study|Hyperglycemic Rescue|6|||
94285475|NCT00328627|322835299|FG008|Overall Study|Hyperglycemic Rescue|6|||
94285476|NCT00328627|322835300|FG009|Overall Study|Hyperglycemic Rescue|11|||
94285477|NCT00328627|322835301|FG010|Overall Study|Hyperglycemic Rescue|3|||
94285478|NCT00328627|322835302|FG011|Overall Study|Hyperglycemic Rescue|2|||
94285479|NCT00328627|322835291|FG000|Overall Study|Adverse Event|3|||
94285480|NCT00328627|322835292|FG001|Overall Study|Adverse Event|1|||
94285481|NCT00328627|322835293|FG002|Overall Study|Adverse Event|2|||
94285482|NCT00328627|322835294|FG003|Overall Study|Adverse Event|3|||
94285483|NCT00328627|322835295|FG004|Overall Study|Adverse Event|1|||
94285484|NCT00328627|322835296|FG005|Overall Study|Adverse Event|2|||
94285485|NCT00328627|322835297|FG006|Overall Study|Adverse Event|1|||
94285486|NCT00328627|322835298|FG007|Overall Study|Adverse Event|2|||
94285487|NCT00328627|322835299|FG008|Overall Study|Adverse Event|0|||
94285488|NCT00328627|322835300|FG009|Overall Study|Adverse Event|7|||
94285489|NCT00328627|322835301|FG010|Overall Study|Adverse Event|5|||
94285490|NCT00328627|322835302|FG011|Overall Study|Adverse Event|4|||
94285491|NCT00328627|322835291|FG000|Overall Study|Protocol Violation|2|||
94285492|NCT00328627|322835292|FG001|Overall Study|Protocol Violation|2|||
94285493|NCT00328627|322835293|FG002|Overall Study|Protocol Violation|2|||
94285494|NCT00328627|322835294|FG003|Overall Study|Protocol Violation|8|||
94285495|NCT00328627|322835295|FG004|Overall Study|Protocol Violation|5|||
94285496|NCT00328627|322835296|FG005|Overall Study|Protocol Violation|5|||
94285497|NCT00328627|322835297|FG006|Overall Study|Protocol Violation|6|||
94285498|NCT00328627|322835298|FG007|Overall Study|Protocol Violation|2|||
94285499|NCT00328627|322835299|FG008|Overall Study|Protocol Violation|1|||
94285500|NCT00328627|322835300|FG009|Overall Study|Protocol Violation|4|||
94285501|NCT00328627|322835301|FG010|Overall Study|Protocol Violation|6|||
94285502|NCT00328627|322835302|FG011|Overall Study|Protocol Violation|2|||
94285503|NCT00328627|322835291|FG000|Overall Study|Lost to Follow-up|4|||
94285504|NCT00328627|322835292|FG001|Overall Study|Lost to Follow-up|2|||
94285505|NCT00328627|322835293|FG002|Overall Study|Lost to Follow-up|2|||
94285506|NCT00328627|322835294|FG003|Overall Study|Lost to Follow-up|4|||
94285507|NCT00328627|322835295|FG004|Overall Study|Lost to Follow-up|0|||
94285508|NCT00328627|322835296|FG005|Overall Study|Lost to Follow-up|2|||
94285509|NCT00328627|322835297|FG006|Overall Study|Lost to Follow-up|3|||
94372417|NCT04130919|323150261|FG004|Blinded Treatment Phase|Withdrew consent|0|||
94372418|NCT04130919|323150262|FG005|Blinded Treatment Phase|Withdrew consent|0|||
94372419|NCT04130919|323150257|FG000|Open-label Treatment Phase|Withdrew consent|0|||
94372420|NCT04130919|323150258|FG001|Open-label Treatment Phase|Withdrew consent|0|||
94372421|NCT04130919|323150259|FG002|Open-label Treatment Phase|Withdrew consent|0|||
94372422|NCT04130919|323150260|FG003|Open-label Treatment Phase|Withdrew consent|1|||
94285510|NCT00328627|322835298|FG007|Overall Study|Lost to Follow-up|0|||
94285511|NCT00328627|322835299|FG008|Overall Study|Lost to Follow-up|3|||
94285512|NCT00328627|322835300|FG009|Overall Study|Lost to Follow-up|2|||
94285513|NCT00328627|322835301|FG010|Overall Study|Lost to Follow-up|0|||
94213689|NCT02935673|322577710|FG002|Overall Study|Adverse Event|0|||
94213690|NCT02935673|322577708|FG000|Overall Study|Withdrawal by Subject|1|||
94213691|NCT02935673|322577709|FG001|Overall Study|Withdrawal by Subject|2|||
94213692|NCT02935673|322577710|FG002|Overall Study|Withdrawal by Subject|0|||
94213693|NCT03052517|322577711|FG000|Overall Study|Study Terminated By Sponsor|928|||
94213694|NCT03052517|322577712|FG001|Overall Study|Study Terminated By Sponsor|938|||
94213695|NCT03052517|322577713|FG002|Overall Study|Study Terminated By Sponsor|296|||
94213696|NCT03052517|322577711|FG000|Overall Study|Subject/Guardian Decision|50|||
94213697|NCT03052517|322577712|FG001|Overall Study|Subject/Guardian Decision|45|||
94213698|NCT03052517|322577713|FG002|Overall Study|Subject/Guardian Decision|22|||
94213699|NCT03052517|322577711|FG000|Overall Study|Lack of Efficacy|23|||
94213700|NCT03052517|322577712|FG001|Overall Study|Lack of Efficacy|14|||
94213701|NCT03052517|322577713|FG002|Overall Study|Lack of Efficacy|7|||
94213702|NCT03052517|322577711|FG000|Overall Study|Adverse Event|6|||
94213703|NCT03052517|322577712|FG001|Overall Study|Adverse Event|5|||
94213704|NCT03052517|322577713|FG002|Overall Study|Adverse Event|0|||
94213705|NCT03052517|322577711|FG000|Overall Study|Physician Decision|4|||
94213706|NCT03052517|322577712|FG001|Overall Study|Physician Decision|5|||
94213707|NCT03052517|322577713|FG002|Overall Study|Physician Decision|1|||
94213708|NCT03052517|322577711|FG000|Overall Study|Death|3|||
94213709|NCT03052517|322577712|FG001|Overall Study|Death|0|||
94213710|NCT03052517|322577713|FG002|Overall Study|Death|1|||
94213711|NCT03052517|322577711|FG000|Overall Study|Lost to Follow-up|2|||
94213712|NCT03052517|322577712|FG001|Overall Study|Lost to Follow-up|4|||
94213713|NCT03052517|322577713|FG002|Overall Study|Lost to Follow-up|0|||
94213714|NCT03052517|322577711|FG000|Overall Study|Pregnancy|1|||
94213715|NCT03052517|322577712|FG001|Overall Study|Pregnancy|0|||
94213716|NCT03052517|322577713|FG002|Overall Study|Pregnancy|1|||
94213717|NCT03052517|322577711|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
94213718|NCT03052517|322577712|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
94213719|NCT03052517|322577713|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
94213720|NCT03052517|322577711|FG000|Overall Study|Technical Problems|0|||
94213721|NCT03052517|322577712|FG001|Overall Study|Technical Problems|1|||
94213722|NCT03052517|322577713|FG002|Overall Study|Technical Problems|0|||
94213723|NCT01640288|322577716|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
94213724|NCT01640288|322577717|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
94213725|NCT01640288|322577716|FG000|Overall Study|Screen Failure|20|||
94213726|NCT01640288|322577717|FG001|Overall Study|Screen Failure|18|||
94213727|NCT01640288|322577716|FG000|Overall Study|Withdrawn by PI|5|||
94213728|NCT01640288|322577717|FG001|Overall Study|Withdrawn by PI|0|||
94213729|NCT01640288|322577716|FG000|Overall Study|Withdrawal by Subject|1|||
94213730|NCT01640288|322577717|FG001|Overall Study|Withdrawal by Subject|0|||
94213731|NCT04070105|322577718|FG000|Overall Study|Lost to Follow-up|0|||
94213732|NCT04070105|322577719|FG001|Overall Study|Lost to Follow-up|0|||
94213733|NCT04070105|322577720|FG002|Overall Study|Lost to Follow-up|0|||
94213734|NCT04070105|322577721|FG003|Overall Study|Lost to Follow-up|0|||
94213735|NCT04070105|322577722|FG004|Overall Study|Lost to Follow-up|0|||
94213736|NCT04070105|322577723|FG005|Overall Study|Lost to Follow-up|1|||
94213737|NCT01944774|322577724|FG000|Overall Study|Withdrawal by Subject|2|||
94213738|NCT01944774|322577725|FG001|Overall Study|Withdrawal by Subject|3|||
94213739|NCT01944774|322577726|FG002|Overall Study|Withdrawal by Subject|3|||
94213740|NCT01944774|322577724|FG000|Overall Study|Adverse Event|3|||
94213741|NCT01944774|322577725|FG001|Overall Study|Adverse Event|2|||
94213742|NCT01944774|322577726|FG002|Overall Study|Adverse Event|3|||
94213743|NCT01944774|322577724|FG000|Overall Study|Lack of Efficacy|1|||
94213744|NCT01944774|322577725|FG001|Overall Study|Lack of Efficacy|2|||
94213745|NCT01944774|322577726|FG002|Overall Study|Lack of Efficacy|2|||
94213746|NCT01944774|322577724|FG000|Overall Study|Lost to Follow-up|0|||
94213747|NCT01944774|322577725|FG001|Overall Study|Lost to Follow-up|1|||
94213748|NCT01944774|322577726|FG002|Overall Study|Lost to Follow-up|0|||
94213749|NCT01393600|322577730|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
94213750|NCT01393600|322577731|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
94213751|NCT01393600|322577732|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
94213752|NCT01393600|322577733|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
94213753|NCT01393600|322577730|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
94372423|NCT04130919|323150261|FG004|Open-label Treatment Phase|Withdrew consent|1|||
94213754|NCT01393600|322577731|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
94213755|NCT01393600|322577732|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
94213756|NCT01393600|322577733|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
94213757|NCT01393600|322577730|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
94213758|NCT01393600|322577731|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
94372424|NCT04130919|323150262|FG005|Open-label Treatment Phase|Withdrew consent|1|||
94213759|NCT01393600|322577732|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
94213760|NCT01393600|322577733|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
94213761|NCT01393600|322577730|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
94213762|NCT01393600|322577731|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
94213763|NCT01393600|322577732|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
94213764|NCT01393600|322577733|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
94213765|NCT01393600|322577730|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
94213766|NCT01393600|322577731|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
94213767|NCT01393600|322577732|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
94213768|NCT01393600|322577733|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
94213769|NCT01393600|322577730|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
94213770|NCT01393600|322577731|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
94372425|NCT04130919|323150257|FG000|Open-label Treatment Phase|Disease worsening|0|||
94213771|NCT01393600|322577732|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
94213772|NCT01393600|322577733|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
94213773|NCT01393600|322577730|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
94213774|NCT01393600|322577731|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
94213775|NCT01393600|322577732|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
94213776|NCT01393600|322577733|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
94213777|NCT00603798|322577734|FG000|Overall Study|Adverse Event|4|||
94213778|NCT00603798|322577735|FG001|Overall Study|Adverse Event|2|||
94213779|NCT00603798|322577736|FG002|Overall Study|Adverse Event|1|||
94213780|NCT00603798|322577734|FG000|Overall Study|Withdrawal by Subject|4|||
94213781|NCT00603798|322577735|FG001|Overall Study|Withdrawal by Subject|3|||
94213782|NCT00603798|322577736|FG002|Overall Study|Withdrawal by Subject|4|||
94213783|NCT00603798|322577734|FG000|Overall Study|Lost to Follow-up|1|||
94213784|NCT00603798|322577735|FG001|Overall Study|Lost to Follow-up|0|||
94213785|NCT00603798|322577736|FG002|Overall Study|Lost to Follow-up|1|||
94213786|NCT00603798|322577734|FG000|Overall Study|Non-compliance with study procedures|0|||
94213787|NCT00603798|322577735|FG001|Overall Study|Non-compliance with study procedures|1|||
94213788|NCT00603798|322577736|FG002|Overall Study|Non-compliance with study procedures|0|||
94213789|NCT00603798|322577734|FG000|Overall Study|Not due to AE|1|||
94213790|NCT00603798|322577735|FG001|Overall Study|Not due to AE|1|||
94213791|NCT00603798|322577736|FG002|Overall Study|Not due to AE|4|||
94213792|NCT04766996|322577737|FG000|Overall Study|Withdrawal by Subject|1|||
94213793|NCT04766996|322577738|FG001|Overall Study|Withdrawal by Subject|0|||
94213794|NCT04766996|322577739|FG002|Overall Study|Withdrawal by Subject|13|||
94213795|NCT03184987|322577745|FG000|Overall Study|Withdrawal by Subject|0|||
94213796|NCT03184987|322577746|FG001|Overall Study|Withdrawal by Subject|1|||
94213797|NCT03184987|322577747|FG002|Overall Study|Withdrawal by Subject|2|||
94213798|NCT03184987|322577745|FG000|Overall Study|Physician Decision|0|||
94213799|NCT03184987|322577746|FG001|Overall Study|Physician Decision|0|||
94213800|NCT03184987|322577747|FG002|Overall Study|Physician Decision|1|||
94213801|NCT03184987|322577745|FG000|Overall Study|Adverse Event|1|||
94213802|NCT03184987|322577746|FG001|Overall Study|Adverse Event|0|||
94213803|NCT03184987|322577747|FG002|Overall Study|Adverse Event|1|||
94213804|NCT03131713|322577749|FG000|Overall Study|Lost to Follow-up|5|||
94213805|NCT03131713|322577750|FG001|Overall Study|Lost to Follow-up|0|||
94213806|NCT03695185|322577751|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
94213807|NCT03695185|322577751|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
94213808|NCT03695185|322577751|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
94213809|NCT03695185|322577751|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
94213810|NCT03695185|322577751|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
94213811|NCT03695185|322577751|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
94213812|NCT02309892|322577752|FG000|Overall Study|Physician Decision|1|||
94213813|NCT02309892|322577753|FG001|Overall Study|Physician Decision|0|||
94213814|NCT02309892|322577754|FG002|Overall Study|Physician Decision|0|||
94213815|NCT02309892|322577755|FG003|Overall Study|Physician Decision|0|||
94213816|NCT02309892|322577756|FG004|Overall Study|Physician Decision|0|||
94213817|NCT02309892|322577757|FG005|Overall Study|Physician Decision|0|||
94213818|NCT02309892|322577758|FG006|Overall Study|Physician Decision|0|||
94213819|NCT02309892|322577752|FG000|Overall Study|Adverse Event|1|||
94213820|NCT02309892|322577753|FG001|Overall Study|Adverse Event|0|||
94213821|NCT02309892|322577754|FG002|Overall Study|Adverse Event|1|||
94213822|NCT02309892|322577755|FG003|Overall Study|Adverse Event|0|||
94213823|NCT02309892|322577756|FG004|Overall Study|Adverse Event|0|||
94213824|NCT02309892|322577757|FG005|Overall Study|Adverse Event|0|||
94213825|NCT02309892|322577758|FG006|Overall Study|Adverse Event|0|||
94213826|NCT02309892|322577752|FG000|Overall Study|Progressive Disease|0|||
94213827|NCT02309892|322577753|FG001|Overall Study|Progressive Disease|1|||
94213828|NCT02309892|322577754|FG002|Overall Study|Progressive Disease|0|||
94213829|NCT02309892|322577755|FG003|Overall Study|Progressive Disease|0|||
94213830|NCT02309892|322577756|FG004|Overall Study|Progressive Disease|1|||
94213831|NCT02309892|322577757|FG005|Overall Study|Progressive Disease|0|||
94213832|NCT02309892|322577758|FG006|Overall Study|Progressive Disease|0|||
94213833|NCT02309892|322577752|FG000|Overall Study|Death|0|||
94213834|NCT02309892|322577753|FG001|Overall Study|Death|0|||
94213835|NCT02309892|322577754|FG002|Overall Study|Death|0|||
94285514|NCT00328627|322835302|FG011|Overall Study|Lost to Follow-up|1|||
94285515|NCT00328627|322835291|FG000|Overall Study|Withdrawal by Subject|5|||
94213836|NCT02309892|322577755|FG003|Overall Study|Death|0|||
94213837|NCT02309892|322577756|FG004|Overall Study|Death|0|||
94213838|NCT02309892|322577757|FG005|Overall Study|Death|1|||
94213839|NCT02309892|322577758|FG006|Overall Study|Death|0|||
94213840|NCT05376397|322577761|FG000|Overall Study|Lost to Follow-up|1|||
94213841|NCT01365546|322577763|FG000|Overall Study|Withdrawal by Subject|1|||
94213842|NCT01365546|322577763|FG000|Overall Study|Screen failure|9|||
94213843|NCT01365546|322577763|FG000|Overall Study|Study termination|1|||
94213844|NCT04183491|322577769|FG000|Overall Study|Withdrawal by Subject|0|||
94213845|NCT04183491|322577770|FG001|Overall Study|Withdrawal by Subject|0|||
94213846|NCT04183491|322577771|FG002|Overall Study|Withdrawal by Subject|1|||
94213847|NCT04183491|322577772|FG003|Overall Study|Withdrawal by Subject|0|||
94213848|NCT04183491|322577773|FG004|Overall Study|Withdrawal by Subject|0|||
94213849|NCT04183491|322577774|FG005|Overall Study|Withdrawal by Subject|1|||
94213850|NCT04183491|322577775|FG006|Overall Study|Withdrawal by Subject|0|||
94213851|NCT01777932|322577776|FG000|Overall Study|Disease progression|136|||
94213852|NCT01777932|322577776|FG000|Overall Study|Death|3|||
94213853|NCT01777932|322577776|FG000|Overall Study|Adverse Event|34|||
94213854|NCT01777932|322577776|FG000|Overall Study|Lost to Follow-up|3|||
94213855|NCT01777932|322577776|FG000|Overall Study|Investigator decision|10|||
94213856|NCT01777932|322577776|FG000|Overall Study|Reimbursement limit|9|||
94213857|NCT01777932|322577776|FG000|Overall Study|Patient refused further treatment|10|||
94213858|NCT02538094|322577779|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
94213859|NCT02538094|322577780|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
94213860|NCT02538094|322577779|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
94213861|NCT02538094|322577780|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
94213862|NCT02170207|322577789|FG000|Overall Study|Case report forms unavailable|5|||
94213863|NCT01138657|322577790|FG000|Overall Study|Adverse Event|3|||
94213864|NCT01138657|322577791|FG001|Overall Study|Adverse Event|10|||
94213865|NCT01138657|322577790|FG000|Overall Study|Lack of Efficacy|2|||
94213866|NCT01138657|322577791|FG001|Overall Study|Lack of Efficacy|1|||
94213867|NCT01138657|322577790|FG000|Overall Study|Lost to Follow-up|0|||
94213868|NCT01138657|322577791|FG001|Overall Study|Lost to Follow-up|3|||
94213869|NCT01138657|322577790|FG000|Overall Study|Miscellaneous Reasons|3|||
94213870|NCT01138657|322577791|FG001|Overall Study|Miscellaneous Reasons|4|||
94213871|NCT02574286|322577792|FG000|Overall Study|Adverse Event|3|||
94213872|NCT02574286|322577792|FG000|Overall Study|Withdrawal by Subject|2|||
94213873|NCT04765046|322577793|FG000|Overall Study|Screen Failure|2|||
94213874|NCT04765046|322577793|FG000|Overall Study|Withdrawal by Subject|4|||
94213875|NCT04765046|322577793|FG000|Overall Study|Physician Decision|4|||
94213876|NCT04765046|322577793|FG000|Overall Study|Surgery Cancelled|8|||
94213877|NCT01405508|322577796|FG000|Overall Study|AE, non-serious non-fatal|1|||
94213878|NCT01405508|322577797|FG001|Overall Study|AE, non-serious non-fatal|1|||
94213879|NCT01405508|322577798|FG002|Overall Study|AE, non-serious non-fatal|0|||
94213880|NCT01405508|322577799|FG003|Overall Study|AE, non-serious non-fatal|0|||
94213881|NCT03205488|322577804|FG000|Overall Study|Adverse Event|1|||
94213882|NCT03205488|322577805|FG001|Overall Study|Adverse Event|2|||
94213883|NCT03205488|322577806|FG002|Overall Study|Adverse Event|4|||
94213884|NCT03205488|322577804|FG000|Overall Study|Protocol Violation|0|||
94213885|NCT03205488|322577805|FG001|Overall Study|Protocol Violation|0|||
94213886|NCT03205488|322577806|FG002|Overall Study|Protocol Violation|1|||
94213887|NCT01005914|322577809|FG000|Overall Study|Adverse Event|4|||
94213888|NCT01005914|322577809|FG000|Overall Study|Death|4|||
94213889|NCT01005914|322577809|FG000|Overall Study|Lack of Efficacy|1|||
94213890|NCT01005914|322577809|FG000|Overall Study|Withdrawal by Subject|1|||
94213891|NCT04108858|322577810|FG000|Overall Study|Adverse Event|1|||
94213892|NCT02006641|322577811|FG000|Overall Study|Withdrawal before treatment|2|||
94213893|NCT02006641|322577812|FG001|Overall Study|Withdrawal before treatment|5|||
94213894|NCT02006641|322577813|FG002|Overall Study|Withdrawal before treatment|3|||
94213895|NCT02006641|322577811|FG000|Overall Study|Adverse Event|15|||
94213896|NCT02006641|322577812|FG001|Overall Study|Adverse Event|11|||
94213897|NCT02006641|322577813|FG002|Overall Study|Adverse Event|15|||
94213898|NCT02006641|322577811|FG000|Overall Study|Protocol Violation|0|||
94213899|NCT02006641|322577812|FG001|Overall Study|Protocol Violation|2|||
94213900|NCT02006641|322577813|FG002|Overall Study|Protocol Violation|2|||
94213901|NCT02006641|322577811|FG000|Overall Study|Lost to Follow-up|0|||
94213902|NCT02006641|322577812|FG001|Overall Study|Lost to Follow-up|1|||
94213903|NCT02006641|322577813|FG002|Overall Study|Lost to Follow-up|0|||
94213904|NCT02006641|322577811|FG000|Overall Study|Withdrawal by Subject|7|||
94213905|NCT02006641|322577812|FG001|Overall Study|Withdrawal by Subject|12|||
94213906|NCT02006641|322577813|FG002|Overall Study|Withdrawal by Subject|11|||
94213907|NCT02006641|322577811|FG000|Overall Study|Other reason: patient didn't show up|1|||
94213908|NCT02006641|322577812|FG001|Overall Study|Other reason: patient didn't show up|0|||
94213909|NCT02006641|322577813|FG002|Overall Study|Other reason: patient didn't show up|0|||
94285516|NCT00328627|322835292|FG001|Overall Study|Withdrawal by Subject|4|||
94285517|NCT00328627|322835293|FG002|Overall Study|Withdrawal by Subject|5|||
94285518|NCT00328627|322835294|FG003|Overall Study|Withdrawal by Subject|6|||
94285519|NCT00328627|322835295|FG004|Overall Study|Withdrawal by Subject|2|||
94285520|NCT00328627|322835296|FG005|Overall Study|Withdrawal by Subject|5|||
94285521|NCT00328627|322835297|FG006|Overall Study|Withdrawal by Subject|4|||
94285522|NCT00328627|322835298|FG007|Overall Study|Withdrawal by Subject|4|||
94285523|NCT00328627|322835299|FG008|Overall Study|Withdrawal by Subject|4|||
94285524|NCT00328627|322835300|FG009|Overall Study|Withdrawal by Subject|5|||
94285525|NCT00328627|322835301|FG010|Overall Study|Withdrawal by Subject|2|||
94285526|NCT00328627|322835302|FG011|Overall Study|Withdrawal by Subject|7|||
94285527|NCT00328627|322835291|FG000|Overall Study|Pregnancy|0|||
94285528|NCT00328627|322835292|FG001|Overall Study|Pregnancy|1|||
94285529|NCT00328627|322835293|FG002|Overall Study|Pregnancy|0|||
94285530|NCT00328627|322835294|FG003|Overall Study|Pregnancy|0|||
94285531|NCT00328627|322835295|FG004|Overall Study|Pregnancy|0|||
94285532|NCT00328627|322835296|FG005|Overall Study|Pregnancy|0|||
94285533|NCT00328627|322835297|FG006|Overall Study|Pregnancy|0|||
94285534|NCT00328627|322835298|FG007|Overall Study|Pregnancy|0|||
94285535|NCT00328627|322835299|FG008|Overall Study|Pregnancy|0|||
94285536|NCT00328627|322835300|FG009|Overall Study|Pregnancy|0|||
94285537|NCT00328627|322835301|FG010|Overall Study|Pregnancy|0|||
94285538|NCT00328627|322835302|FG011|Overall Study|Pregnancy|0|||
94285539|NCT00328627|322835291|FG000|Overall Study|Physician Decision|4|||
94285540|NCT00328627|322835292|FG001|Overall Study|Physician Decision|3|||
94285541|NCT00328627|322835293|FG002|Overall Study|Physician Decision|1|||
94285542|NCT00328627|322835294|FG003|Overall Study|Physician Decision|2|||
94285543|NCT00328627|322835295|FG004|Overall Study|Physician Decision|1|||
94285544|NCT00328627|322835296|FG005|Overall Study|Physician Decision|1|||
94285545|NCT00328627|322835297|FG006|Overall Study|Physician Decision|1|||
94285546|NCT00328627|322835298|FG007|Overall Study|Physician Decision|0|||
94285547|NCT00328627|322835299|FG008|Overall Study|Physician Decision|3|||
94285548|NCT00328627|322835300|FG009|Overall Study|Physician Decision|2|||
94285549|NCT00328627|322835301|FG010|Overall Study|Physician Decision|1|||
94285550|NCT00328627|322835302|FG011|Overall Study|Physician Decision|0|||
94285551|NCT00328627|322835291|FG000|Overall Study|Other|0|||
94285552|NCT00328627|322835292|FG001|Overall Study|Other|0|||
94285553|NCT00328627|322835293|FG002|Overall Study|Other|0|||
94285554|NCT00328627|322835294|FG003|Overall Study|Other|1|||
94285555|NCT00328627|322835295|FG004|Overall Study|Other|0|||
94285556|NCT00328627|322835296|FG005|Overall Study|Other|0|||
94285557|NCT00328627|322835297|FG006|Overall Study|Other|1|||
94285558|NCT00328627|322835298|FG007|Overall Study|Other|0|||
94285559|NCT00328627|322835299|FG008|Overall Study|Other|0|||
94285560|NCT00328627|322835300|FG009|Overall Study|Other|1|||
94285561|NCT00328627|322835301|FG010|Overall Study|Other|1|||
94285562|NCT00328627|322835302|FG011|Overall Study|Other|0|||
94285563|NCT00930059|322835303|FG000|Overall Study|Death|1|||
94285564|NCT00930059|322835304|FG001|Overall Study|Death|0|||
94285565|NCT00930059|322835303|FG000|Overall Study|Did not meet entrance criteria|1|||
94285566|NCT00930059|322835304|FG001|Overall Study|Did not meet entrance criteria|1|||
94285567|NCT00930059|322835303|FG000|Overall Study|Withdrawal by Subject|3|||
94285568|NCT00930059|322835304|FG001|Overall Study|Withdrawal by Subject|4|||
94285569|NCT00930059|322835303|FG000|Overall Study|Other|1|||
94285570|NCT00930059|322835304|FG001|Overall Study|Other|0|||
94285571|NCT00930059|322835303|FG000|Overall Study|1 site terminated by sponsor|1|||
94285572|NCT00930059|322835304|FG001|Overall Study|1 site terminated by sponsor|1|||
94285573|NCT00930059|322835303|FG000|Overall Study|Adverse Event|1|||
94285574|NCT00930059|322835304|FG001|Overall Study|Adverse Event|6|||
94285575|NCT01284114|322835305|FG000|Overall Study|viral infection|1|||
94285576|NCT01284114|322835305|FG000|Overall Study|From the results of ALLTITUDE study|1|||
94285577|NCT01284114|322835305|FG000|Overall Study|Symptomatic hypotension|1|||
94285578|NCT01284114|322835305|FG000|Overall Study|dizziness|1|||
94285579|NCT00605085|322835306|FG000|Overall Study|Withdrawal by Subject|8|||
94285580|NCT00605085|322835307|FG001|Overall Study|Withdrawal by Subject|5|||
94285581|NCT00605085|322835306|FG000|Overall Study|Adverse Event|9|||
94285582|NCT00605085|322835307|FG001|Overall Study|Adverse Event|5|||
94285583|NCT00605085|322835306|FG000|Overall Study|Pregnancy|2|||
94285584|NCT00605085|322835307|FG001|Overall Study|Pregnancy|0|||
94285585|NCT00605085|322835306|FG000|Overall Study|Protocol Violation|3|||
94285586|NCT00605085|322835307|FG001|Overall Study|Protocol Violation|2|||
94285587|NCT00605085|322835306|FG000|Overall Study|Lost to Follow-up|10|||
94285588|NCT00605085|322835307|FG001|Overall Study|Lost to Follow-up|5|||
94285589|NCT00605085|322835306|FG000|Overall Study|administrative reasons|18|||
94285590|NCT00605085|322835307|FG001|Overall Study|administrative reasons|8|||
94285591|NCT01178138|322835308|FG000|Overall Study|Lost to Follow-up|8|||
94285592|NCT01178138|322835308|FG000|Overall Study|Withdrawal by Subject|7|||
94285593|NCT01178138|322835308|FG000|Overall Study|Physician Decision|8|||
94285594|NCT03257267|322835309|FG000|Overall Study|Adverse Event|17|||
94285595|NCT03257267|322835310|FG001|Overall Study|Adverse Event|7|||
94285596|NCT03257267|322835309|FG000|Overall Study|Death|96|||
94285597|NCT03257267|322835310|FG001|Overall Study|Death|98|||
94213910|NCT02006641|322577811|FG000|Overall Study|Other reason:patient didn't want to come|0|||
94213911|NCT02006641|322577812|FG001|Overall Study|Other reason:patient didn't want to come|0|||
94213912|NCT02006641|322577813|FG002|Overall Study|Other reason:patient didn't want to come|1|||
94213913|NCT02006641|322577811|FG000|Overall Study|Other reason: patient has moved|1|||
94213914|NCT02006641|322577812|FG001|Overall Study|Other reason: patient has moved|0|||
94213915|NCT02006641|322577813|FG002|Overall Study|Other reason: patient has moved|1|||
94213916|NCT02006641|322577811|FG000|Overall Study|Other reason: caregiver in hospital|0|||
94213917|NCT02006641|322577812|FG001|Overall Study|Other reason: caregiver in hospital|1|||
94213918|NCT02006641|322577813|FG002|Overall Study|Other reason: caregiver in hospital|0|||
94213919|NCT02006641|322577811|FG000|Overall Study|Other reason: patient's wife has died|0|||
94213920|NCT02006641|322577812|FG001|Overall Study|Other reason: patient's wife has died|0|||
94213921|NCT02006641|322577813|FG002|Overall Study|Other reason: patient's wife has died|1|||
94213922|NCT02006641|322577811|FG000|Overall Study|Other reason: hospitalisation|0|||
94213923|NCT02006641|322577812|FG001|Overall Study|Other reason: hospitalisation|1|||
94213924|NCT02006641|322577813|FG002|Overall Study|Other reason: hospitalisation|0|||
94213925|NCT02006641|322577811|FG000|Overall Study|Other reason: caregiver impossibility|0|||
94213926|NCT02006641|322577812|FG001|Overall Study|Other reason: caregiver impossibility|0|||
94213927|NCT02006641|322577813|FG002|Overall Study|Other reason: caregiver impossibility|1|||
94213928|NCT02006641|322577811|FG000|Overall Study|Other reason: protocol non-compliance|0|||
94213929|NCT02006641|322577812|FG001|Overall Study|Other reason: protocol non-compliance|0|||
94213930|NCT02006641|322577813|FG002|Overall Study|Other reason: protocol non-compliance|1|||
94213931|NCT02102724|322577815|FG000|Overall Study|Lost to Follow-up|1|||
94213932|NCT02102724|322577816|FG001|Overall Study|Lost to Follow-up|0|||
94213933|NCT02102724|322577815|FG000|Overall Study|surgery for brain aneurysm|1|||
94213934|NCT02102724|322577816|FG001|Overall Study|surgery for brain aneurysm|1|||
94213935|NCT03072862|322577819|FG000|Overall Study|Withdrawal by Subject|4|||
94213936|NCT03072862|322577819|FG000|Overall Study|Lost to Follow-up|6|||
94213937|NCT03072862|322577819|FG000|Overall Study|Protocol Violation|4|||
94213938|NCT03072862|322577819|FG000|Overall Study|Physician Decision|2|||
94213939|NCT03072862|322577819|FG000|Overall Study|Death|1|||
94213940|NCT03072862|322577819|FG000|Overall Study|Adverse Event|1|||
94213941|NCT02203513|322577820|FG000|Overall Study|Refused further treatment|2|||
94213942|NCT02203513|322577821|FG001|Overall Study|Refused further treatment|0|||
94213943|NCT02203513|322577822|FG002|Overall Study|Refused further treatment|1|||
94213944|NCT02203513|322577823|FG003|Overall Study|Refused further treatment|0|||
94213945|NCT02203513|322577824|FG004|Overall Study|Refused further treatment|0|||
94213946|NCT02203513|322577820|FG000|Overall Study|Switched to alternative treatment|3|||
94213947|NCT02203513|322577821|FG001|Overall Study|Switched to alternative treatment|4|||
94213948|NCT02203513|322577822|FG002|Overall Study|Switched to alternative treatment|0|||
94213949|NCT02203513|322577823|FG003|Overall Study|Switched to alternative treatment|0|||
94213950|NCT02203513|322577824|FG004|Overall Study|Switched to alternative treatment|4|||
94213951|NCT02203513|322577820|FG000|Overall Study|Did not receive investigational product (IP)|0|||
94213952|NCT02203513|322577821|FG001|Overall Study|Did not receive investigational product (IP)|1|||
94213953|NCT02203513|322577822|FG002|Overall Study|Did not receive investigational product (IP)|0|||
94213954|NCT02203513|322577823|FG003|Overall Study|Did not receive investigational product (IP)|0|||
94213955|NCT02203513|322577824|FG004|Overall Study|Did not receive investigational product (IP)|0|||
94213956|NCT02203513|322577820|FG000|Overall Study|Death (unrelated to study therapy)|1|||
94213957|NCT02203513|322577821|FG001|Overall Study|Death (unrelated to study therapy)|3|||
94213958|NCT02203513|322577822|FG002|Overall Study|Death (unrelated to study therapy)|1|||
94213959|NCT02203513|322577823|FG003|Overall Study|Death (unrelated to study therapy)|0|||
94213960|NCT02203513|322577824|FG004|Overall Study|Death (unrelated to study therapy)|2|||
94213961|NCT02203513|322577820|FG000|Overall Study|Lost to Follow-up|0|||
94213962|NCT02203513|322577821|FG001|Overall Study|Lost to Follow-up|0|||
94213963|NCT02203513|322577822|FG002|Overall Study|Lost to Follow-up|1|||
94213964|NCT02203513|322577823|FG003|Overall Study|Lost to Follow-up|1|||
94213965|NCT02203513|322577824|FG004|Overall Study|Lost to Follow-up|0|||
94213966|NCT01323790|322577825|FG000|Overall Study|Other|3|||
94213967|NCT01323790|322577826|FG001|Overall Study|Other|2|||
94213968|NCT01323790|322577827|FG002|Overall Study|Other|1|||
94213969|NCT01323790|322577825|FG000|Overall Study|Lost to Follow-up|11|||
94213970|NCT01323790|322577826|FG001|Overall Study|Lost to Follow-up|9|||
94213971|NCT01323790|322577827|FG002|Overall Study|Lost to Follow-up|9|||
94213972|NCT01323790|322577825|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
94213973|NCT01323790|322577826|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
94213974|NCT01323790|322577827|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
94213975|NCT01323790|322577825|FG000|Overall Study|Lack of Efficacy|3|||
94213976|NCT01323790|322577826|FG001|Overall Study|Lack of Efficacy|0|||
94213977|NCT01323790|322577827|FG002|Overall Study|Lack of Efficacy|3|||
94213978|NCT01323790|322577825|FG000|Overall Study|Adverse Event|11|||
94213979|NCT01323790|322577826|FG001|Overall Study|Adverse Event|24|||
94213980|NCT01323790|322577827|FG002|Overall Study|Adverse Event|12|||
94213981|NCT01323790|322577825|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
94213982|NCT01323790|322577826|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
94213983|NCT01323790|322577827|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
94213984|NCT01323790|322577825|FG000|Overall Study|Withdrawal by Subject|23|||
94213985|NCT01323790|322577826|FG001|Overall Study|Withdrawal by Subject|20|||
94213986|NCT01323790|322577827|FG002|Overall Study|Withdrawal by Subject|13|||
94213987|NCT01323790|322577825|FG000|Overall Study|Did Not Receive Treatment|2|||
94213988|NCT01323790|322577826|FG001|Overall Study|Did Not Receive Treatment|0|||
94213989|NCT01323790|322577827|FG002|Overall Study|Did Not Receive Treatment|1|||
94213990|NCT01323790|322577825|FG000|Overall Study|Severe non-compliance with protocol|2|||
94213991|NCT01323790|322577826|FG001|Overall Study|Severe non-compliance with protocol|2|||
94213992|NCT01323790|322577827|FG002|Overall Study|Severe non-compliance with protocol|2|||
94213993|NCT01156675|322577831|FG000|Overall Study|Death|5|||
94213994|NCT01156675|322577832|FG001|Overall Study|Death|3|||
94213995|NCT01156675|322577833|FG002|Overall Study|Death|0|||
94213996|NCT01156675|322577831|FG000|Overall Study|No data|29|||
94213997|NCT01156675|322577832|FG001|Overall Study|No data|22|||
94213998|NCT01156675|322577833|FG002|Overall Study|No data|2|||
94213999|NCT00655824|322577834|FG000|Overall Study|Adverse Event|3|||
94214000|NCT00655824|322577834|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
94214001|NCT00655824|322577834|FG000|Overall Study|Protocol Violation|1|||
94214002|NCT00655824|322577834|FG000|Overall Study|Withdrawal by Subject|4|||
94214003|NCT00655824|322577834|FG000|Overall Study|Deterioration of Trial Disease|2|||
94214004|NCT00589628|322577835|FG000|Overall Study|Lost to Follow-up|0|||
94214005|NCT00589628|322577836|FG001|Overall Study|Lost to Follow-up|1|||
94214006|NCT02189759|322577846|FG000|Overall Study|Lost to Follow-up|0|||
94214007|NCT02189759|322577847|FG001|Overall Study|Lost to Follow-up|0|||
94214008|NCT02189759|322577848|FG002|Overall Study|Lost to Follow-up|2|||
94214009|NCT02189759|322577849|FG003|Overall Study|Lost to Follow-up|5|||
94214010|NCT03987074|322577854|FG000|Overall Study|Withdrew Consent|1|||
94214011|NCT03987074|322577855|FG001|Overall Study|Withdrew Consent|1|||
94214012|NCT03987074|322577856|FG002|Overall Study|Withdrew Consent|0|||
94285598|NCT03257267|322835309|FG000|Overall Study|Lost to Follow-up|2|||
94285599|NCT03257267|322835310|FG001|Overall Study|Lost to Follow-up|2|||
94285600|NCT03257267|322835309|FG000|Overall Study|Non-compliance with Study Drug|0|||
94285601|NCT03257267|322835310|FG001|Overall Study|Non-compliance with Study Drug|2|||
94285602|NCT03257267|322835309|FG000|Overall Study|Participant Decision|35|||
94285603|NCT03257267|322835310|FG001|Overall Study|Participant Decision|43|||
94285604|NCT03257267|322835309|FG000|Overall Study|Sponsor Decision|1|||
94285605|NCT03257267|322835310|FG001|Overall Study|Sponsor Decision|0|||
94285606|NCT03257267|322835309|FG000|Overall Study|Physician Decision|1|||
94285607|NCT03257267|322835310|FG001|Overall Study|Physician Decision|3|||
94285608|NCT03257267|322835309|FG000|Overall Study|Disease Progression|109|||
94285609|NCT03257267|322835310|FG001|Overall Study|Disease Progression|121|||
94285610|NCT03257267|322835309|FG000|Overall Study|Withdrawal by Subject|8|||
94285611|NCT03257267|322835310|FG001|Overall Study|Withdrawal by Subject|26|||
94285612|NCT03257267|322835309|FG000|Overall Study|Other|0|||
94214013|NCT03987074|322577857|FG003|Overall Study|Withdrew Consent|2|||
94214014|NCT03987074|322577858|FG004|Overall Study|Withdrew Consent|1|||
94214015|NCT03987074|322577854|FG000|Overall Study|Adverse Event|2|||
94214016|NCT03987074|322577855|FG001|Overall Study|Adverse Event|1|||
94214017|NCT03987074|322577856|FG002|Overall Study|Adverse Event|0|||
94285613|NCT03257267|322835310|FG001|Overall Study|Other|2|||
94285614|NCT04872101|322835312|FG000|Overall Study|Withdrawal by Subject|10|||
94285615|NCT04872101|322835313|FG001|Overall Study|Withdrawal by Subject|16|||
94285616|NCT04872101|322835312|FG000|Overall Study|Lack of Efficacy|6|||
94214018|NCT03987074|322577857|FG003|Overall Study|Adverse Event|0|||
94214019|NCT03987074|322577858|FG004|Overall Study|Adverse Event|1|||
94214020|NCT03987074|322577854|FG000|Overall Study|Lost to Follow-up|0|||
94214021|NCT03987074|322577855|FG001|Overall Study|Lost to Follow-up|0|||
94214022|NCT03987074|322577856|FG002|Overall Study|Lost to Follow-up|1|||
94285617|NCT04872101|322835313|FG001|Overall Study|Lack of Efficacy|14|||
94285618|NCT04872101|322835312|FG000|Overall Study|Adverse Event|1|||
94285619|NCT04872101|322835313|FG001|Overall Study|Adverse Event|6|||
94285620|NCT04872101|322835312|FG000|Overall Study|Lost to Follow-up|2|||
94285621|NCT04872101|322835313|FG001|Overall Study|Lost to Follow-up|1|||
94285622|NCT04872101|322835312|FG000|Overall Study|Pregnancy|2|||
94285623|NCT04872101|322835313|FG001|Overall Study|Pregnancy|0|||
94285624|NCT04872101|322835312|FG000|Overall Study|Prohibited Medication|1|||
94285625|NCT04872101|322835313|FG001|Overall Study|Prohibited Medication|0|||
94285626|NCT04872101|322835312|FG000|Overall Study|Not dosed|1|||
94285627|NCT04872101|322835313|FG001|Overall Study|Not dosed|0|||
94285628|NCT00264004|322835315|FG000|Overall Study|Adverse Event|2|||
94285629|NCT00264004|322835316|FG001|Overall Study|Adverse Event|3|||
94285630|NCT00264004|322835317|FG002|Overall Study|Adverse Event|6|||
94285631|NCT00264004|322835318|FG003|Overall Study|Adverse Event|4|||
94285632|NCT00264004|322835315|FG000|Overall Study|Withdrawal by Subject|0|||
94285633|NCT00264004|322835316|FG001|Overall Study|Withdrawal by Subject|1|||
94285634|NCT00264004|322835317|FG002|Overall Study|Withdrawal by Subject|2|||
94285635|NCT00264004|322835318|FG003|Overall Study|Withdrawal by Subject|2|||
94285636|NCT00264004|322835315|FG000|Overall Study|Other|2|||
94285637|NCT00264004|322835316|FG001|Overall Study|Other|2|||
94285638|NCT00264004|322835317|FG002|Overall Study|Other|0|||
94285639|NCT00264004|322835318|FG003|Overall Study|Other|3|||
94285640|NCT00264004|322835315|FG000|Overall Study|Development study specific disc. crit.|1|||
94285641|NCT00264004|322835316|FG001|Overall Study|Development study specific disc. crit.|0|||
94285642|NCT00264004|322835317|FG002|Overall Study|Development study specific disc. crit.|1|||
94285643|NCT00264004|322835318|FG003|Overall Study|Development study specific disc. crit.|0|||
94285644|NCT00264004|322835315|FG000|Overall Study|Cond. under inv. worsened|9|||
94285645|NCT00264004|322835316|FG001|Overall Study|Cond. under inv. worsened|5|||
94285646|NCT00264004|322835317|FG002|Overall Study|Cond. under inv. worsened|3|||
94285647|NCT00264004|322835318|FG003|Overall Study|Cond. under inv. worsened|4|||
94285648|NCT00264004|322835315|FG000|Overall Study|Not treated|3|||
94285649|NCT00264004|322835316|FG001|Overall Study|Not treated|0|||
94285650|NCT00264004|322835317|FG002|Overall Study|Not treated|2|||
94285651|NCT00264004|322835318|FG003|Overall Study|Not treated|2|||
94285652|NCT01790503|322835319|FG000|Overall Study|Adverse Event|1|||
94285653|NCT01790503|322835320|FG001|Overall Study|Adverse Event|0|||
94285654|NCT01790503|322835321|FG002|Overall Study|Adverse Event|0|||
94285655|NCT01790503|322835322|FG003|Overall Study|Adverse Event|0|||
94285656|NCT01790503|322835323|FG004|Overall Study|Adverse Event|0|||
94285657|NCT01790503|322835324|FG005|Overall Study|Adverse Event|2|||
94285658|NCT01790503|322835325|FG006|Overall Study|Adverse Event|0|||
94285659|NCT01790503|322835326|FG007|Overall Study|Adverse Event|0|||
94285660|NCT01790503|322835327|FG008|Overall Study|Adverse Event|2|||
94285661|NCT01790503|322835328|FG009|Overall Study|Adverse Event|4|||
94285662|NCT01790503|322835329|FG010|Overall Study|Adverse Event|7|||
94285663|NCT01790503|322835319|FG000|Overall Study|Withdrawal by Subject|0|||
94285664|NCT01790503|322835320|FG001|Overall Study|Withdrawal by Subject|0|||
94285665|NCT01790503|322835321|FG002|Overall Study|Withdrawal by Subject|1|||
94285666|NCT01790503|322835322|FG003|Overall Study|Withdrawal by Subject|1|||
94285667|NCT01790503|322835323|FG004|Overall Study|Withdrawal by Subject|1|||
94285668|NCT01790503|322835324|FG005|Overall Study|Withdrawal by Subject|2|||
94285669|NCT01790503|322835325|FG006|Overall Study|Withdrawal by Subject|1|||
94285670|NCT01790503|322835326|FG007|Overall Study|Withdrawal by Subject|0|||
94285671|NCT01790503|322835327|FG008|Overall Study|Withdrawal by Subject|0|||
94285672|NCT01790503|322835328|FG009|Overall Study|Withdrawal by Subject|0|||
94285673|NCT01790503|322835329|FG010|Overall Study|Withdrawal by Subject|1|||
94285674|NCT01790503|322835319|FG000|Overall Study|Disease progression|2|||
94285675|NCT01790503|322835320|FG001|Overall Study|Disease progression|1|||
94285676|NCT01790503|322835321|FG002|Overall Study|Disease progression|0|||
94285677|NCT01790503|322835322|FG003|Overall Study|Disease progression|1|||
94285678|NCT01790503|322835323|FG004|Overall Study|Disease progression|2|||
94285679|NCT01790503|322835324|FG005|Overall Study|Disease progression|1|||
94285680|NCT01790503|322835325|FG006|Overall Study|Disease progression|0|||
94285681|NCT01790503|322835326|FG007|Overall Study|Disease progression|1|||
94285682|NCT01790503|322835327|FG008|Overall Study|Disease progression|0|||
94285683|NCT01790503|322835328|FG009|Overall Study|Disease progression|17|||
94285684|NCT01790503|322835329|FG010|Overall Study|Disease progression|7|||
94285685|NCT01790503|322835319|FG000|Overall Study|Protocol Violation|0|||
94285686|NCT01790503|322835320|FG001|Overall Study|Protocol Violation|0|||
94285687|NCT01790503|322835321|FG002|Overall Study|Protocol Violation|0|||
94285688|NCT01790503|322835322|FG003|Overall Study|Protocol Violation|0|||
94285689|NCT01790503|322835323|FG004|Overall Study|Protocol Violation|0|||
94285690|NCT01790503|322835324|FG005|Overall Study|Protocol Violation|0|||
94285691|NCT01790503|322835325|FG006|Overall Study|Protocol Violation|0|||
94285692|NCT01790503|322835326|FG007|Overall Study|Protocol Violation|0|||
94285693|NCT01790503|322835327|FG008|Overall Study|Protocol Violation|0|||
94285694|NCT01790503|322835328|FG009|Overall Study|Protocol Violation|1|||
94285695|NCT01790503|322835329|FG010|Overall Study|Protocol Violation|0|||
94285696|NCT01790503|322835319|FG000|Overall Study|Physician Decision|0|||
94285697|NCT01790503|322835320|FG001|Overall Study|Physician Decision|0|||
94214023|NCT03987074|322577857|FG003|Overall Study|Lost to Follow-up|1|||
94214024|NCT03987074|322577858|FG004|Overall Study|Lost to Follow-up|0|||
94214025|NCT03987074|322577854|FG000|Overall Study|Investigator's Discretion|0|||
94214026|NCT03987074|322577855|FG001|Overall Study|Investigator's Discretion|0|||
94214027|NCT03987074|322577856|FG002|Overall Study|Investigator's Discretion|0|||
94214028|NCT03987074|322577857|FG003|Overall Study|Investigator's Discretion|1|||
94214029|NCT03987074|322577858|FG004|Overall Study|Investigator's Discretion|0|||
94214030|NCT03820024|322577859|FG000|Overall Study|Physician Decision|1|||
94214031|NCT03820024|322577860|FG001|Overall Study|Physician Decision|2|||
94214032|NCT03100370|322577861|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
94214033|NCT03100370|322577862|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
94214034|NCT03100370|322577863|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
94214035|NCT03100370|322577864|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
94214036|NCT03100370|322577865|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
94214037|NCT03100370|322577866|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
94214038|NCT00738400|322577867|FG000|Overall Study|Adverse Event|3|||
94214039|NCT00738400|322577868|FG001|Overall Study|Adverse Event|1|||
94214040|NCT00738400|322577867|FG000|Overall Study|Withdrawal by Subject|0|||
94214041|NCT00738400|322577868|FG001|Overall Study|Withdrawal by Subject|1|||
94214042|NCT00738400|322577867|FG000|Overall Study|Lack of Efficacy|0|||
94214043|NCT00738400|322577868|FG001|Overall Study|Lack of Efficacy|1|||
94214044|NCT00738400|322577867|FG000|Overall Study|Lost to Follow-up|0|||
94214045|NCT00738400|322577868|FG001|Overall Study|Lost to Follow-up|3|||
94214046|NCT00738400|322577867|FG000|Overall Study|Protocol Violation|1|||
94214047|NCT00738400|322577868|FG001|Overall Study|Protocol Violation|0|||
94214048|NCT00738400|322577867|FG000|Overall Study|Non-compliant with study medication|0|||
94214049|NCT00738400|322577868|FG001|Overall Study|Non-compliant with study medication|1|||
94214050|NCT01307800|322577869|FG000|Overall Study|Adverse Event|9|||
94214051|NCT01307800|322577870|FG001|Overall Study|Adverse Event|8|||
94214052|NCT01307800|322577871|FG002|Overall Study|Adverse Event|10|||
94214053|NCT01307800|322577872|FG003|Overall Study|Adverse Event|14|||
94372426|NCT04130919|323150258|FG001|Open-label Treatment Phase|Disease worsening|0|||
94372427|NCT04130919|323150259|FG002|Open-label Treatment Phase|Disease worsening|0|||
94372428|NCT04130919|323150260|FG003|Open-label Treatment Phase|Disease worsening|1|||
94214054|NCT01307800|322577869|FG000|Overall Study|Entry Criteria Not Met|0|||
94214055|NCT01307800|322577870|FG001|Overall Study|Entry Criteria Not Met|0|||
94214056|NCT01307800|322577871|FG002|Overall Study|Entry Criteria Not Met|0|||
94214057|NCT01307800|322577872|FG003|Overall Study|Entry Criteria Not Met|2|||
94214058|NCT01307800|322577869|FG000|Overall Study|Lost to Follow-up|5|||
94214059|NCT01307800|322577870|FG001|Overall Study|Lost to Follow-up|6|||
94214060|NCT01307800|322577871|FG002|Overall Study|Lost to Follow-up|2|||
94214061|NCT01307800|322577872|FG003|Overall Study|Lost to Follow-up|8|||
94214062|NCT01307800|322577869|FG000|Overall Study|Perceived Lack of Efficacy|24|||
94214063|NCT01307800|322577870|FG001|Overall Study|Perceived Lack of Efficacy|23|||
94214064|NCT01307800|322577871|FG002|Overall Study|Perceived Lack of Efficacy|20|||
94214065|NCT01307800|322577872|FG003|Overall Study|Perceived Lack of Efficacy|33|||
94214066|NCT01307800|322577869|FG000|Overall Study|Protocol Violation|0|||
94214067|NCT01307800|322577870|FG001|Overall Study|Protocol Violation|3|||
94214068|NCT01307800|322577871|FG002|Overall Study|Protocol Violation|4|||
94214069|NCT01307800|322577872|FG003|Overall Study|Protocol Violation|5|||
94214070|NCT01307800|322577869|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
94214071|NCT01307800|322577870|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
94214072|NCT01307800|322577871|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
94214073|NCT01307800|322577872|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
94214074|NCT01307800|322577869|FG000|Overall Study|Sponsor Decision|6|||
94214075|NCT01307800|322577870|FG001|Overall Study|Sponsor Decision|9|||
94214076|NCT01307800|322577871|FG002|Overall Study|Sponsor Decision|12|||
94214077|NCT01307800|322577872|FG003|Overall Study|Sponsor Decision|28|||
94214078|NCT01307800|322577869|FG000|Overall Study|Withdrawal by Subject|10|||
94214079|NCT01307800|322577870|FG001|Overall Study|Withdrawal by Subject|11|||
94214080|NCT01307800|322577871|FG002|Overall Study|Withdrawal by Subject|8|||
94214081|NCT01307800|322577872|FG003|Overall Study|Withdrawal by Subject|15|||
94214082|NCT01307800|322577869|FG000|Overall Study|Participant Moved|0|||
94214083|NCT01307800|322577870|FG001|Overall Study|Participant Moved|2|||
94214084|NCT01307800|322577871|FG002|Overall Study|Participant Moved|1|||
94214085|NCT01307800|322577872|FG003|Overall Study|Participant Moved|3|||
94372429|NCT04130919|323150261|FG004|Open-label Treatment Phase|Disease worsening|0|||
94214086|NCT01766206|322577875|FG000|Overall Study|Withdrawal by Subject|22|||
94214087|NCT01766206|322577875|FG000|Overall Study|Lost to Follow-up|10|||
94214088|NCT01766206|322577875|FG000|Overall Study|Inappropriate enrollment|18|||
94214089|NCT01766206|322577875|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
94214090|NCT02993926|322577878|FG000|Enantone Treatment Phase|Adverse Event|1|||
94214091|NCT02993926|322577879|FG001|Enantone Treatment Phase|Adverse Event|0|||
94214092|NCT02993926|322577880|FG002|Enantone Treatment Phase|Adverse Event|0|||
94214093|NCT02993926|322577878|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
94214094|NCT02993926|322577879|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
94214095|NCT02993926|322577880|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
94214096|NCT02993926|322577878|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
94214097|NCT02993926|322577879|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
94214098|NCT02993926|322577880|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
94214099|NCT02993926|322577878|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
94214100|NCT02993926|322577879|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
94214101|NCT02993926|322577880|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
94214102|NCT01294644|322577882|FG000|Overall Study|Adverse Event|2|||
94214103|NCT01294644|322577883|FG001|Overall Study|Adverse Event|0|||
94214104|NCT01294644|322577884|FG002|Overall Study|Adverse Event|1|||
94214105|NCT01294644|322577882|FG000|Overall Study|Withdrawal by Subject|3|||
94214106|NCT01294644|322577883|FG001|Overall Study|Withdrawal by Subject|7|||
94214107|NCT01294644|322577884|FG002|Overall Study|Withdrawal by Subject|4|||
94214108|NCT01294644|322577882|FG000|Overall Study|Lost to Follow-up|3|||
94214109|NCT01294644|322577883|FG001|Overall Study|Lost to Follow-up|2|||
94214110|NCT01294644|322577884|FG002|Overall Study|Lost to Follow-up|5|||
94214111|NCT01294644|322577882|FG000|Overall Study|Miscellaneous Reason|2|||
94214112|NCT01294644|322577883|FG001|Overall Study|Miscellaneous Reason|1|||
94214113|NCT01294644|322577884|FG002|Overall Study|Miscellaneous Reason|4|||
94214114|NCT00824850|322577889|FG000|Overall Study|Withdrawal by Subject|0|||
94214115|NCT00824850|322577890|FG001|Overall Study|Withdrawal by Subject|1|||
94214116|NCT00882050|322577891|FG000|Overall Study|Physician Decision|1|||
94214117|NCT00882050|322577892|FG001|Overall Study|Physician Decision|0|||
94214118|NCT00882050|322577893|FG002|Overall Study|Physician Decision|0|||
94214119|NCT02367794|322577894|FG000|Overall Study|Death|252|||
94214120|NCT02367794|322577895|FG001|Overall Study|Death|245|||
94214121|NCT02367794|322577896|FG002|Overall Study|Death|243|||
94214122|NCT02367794|322577894|FG000|Overall Study|Lost to Follow-up|1|||
94214123|NCT02367794|322577895|FG001|Overall Study|Lost to Follow-up|2|||
94214124|NCT02367794|322577896|FG002|Overall Study|Lost to Follow-up|2|||
94214125|NCT02367794|322577894|FG000|Overall Study|Physician Decision|0|||
94214126|NCT02367794|322577895|FG001|Overall Study|Physician Decision|5|||
94214127|NCT02367794|322577896|FG002|Overall Study|Physician Decision|3|||
94214128|NCT02367794|322577894|FG000|Overall Study|Protocol Violation|1|||
94214129|NCT02367794|322577895|FG001|Overall Study|Protocol Violation|0|||
94214130|NCT02367794|322577896|FG002|Overall Study|Protocol Violation|1|||
94214131|NCT02367794|322577894|FG000|Overall Study|Withdrawal by Subject|25|||
94214132|NCT02367794|322577895|FG001|Overall Study|Withdrawal by Subject|12|||
94214133|NCT02367794|322577896|FG002|Overall Study|Withdrawal by Subject|20|||
94214134|NCT02367794|322577894|FG000|Overall Study|Brain metastasis|1|||
94214135|NCT02367794|322577895|FG001|Overall Study|Brain metastasis|0|||
94214136|NCT02367794|322577896|FG002|Overall Study|Brain metastasis|0|||
94214137|NCT02367794|322577894|FG000|Overall Study|Randomized in error|0|||
94214138|NCT02367794|322577895|FG001|Overall Study|Randomized in error|0|||
94214139|NCT02367794|322577896|FG002|Overall Study|Randomized in error|1|||
94214140|NCT02367794|322577894|FG000|Overall Study|Patient unable to receive carboplatin|0|||
94214141|NCT02367794|322577895|FG001|Overall Study|Patient unable to receive carboplatin|0|||
94214142|NCT02367794|322577896|FG002|Overall Study|Patient unable to receive carboplatin|1|||
94214143|NCT02367794|322577894|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
94214144|NCT02367794|322577895|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
94214145|NCT02367794|322577896|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
94214146|NCT02367794|322577894|FG000|Overall Study|Adverse Event|0|||
94214147|NCT02367794|322577895|FG001|Overall Study|Adverse Event|0|||
94214148|NCT02367794|322577896|FG002|Overall Study|Adverse Event|2|||
94214149|NCT02367794|322577894|FG000|Overall Study|Study Terminated By Sponsor|0|||
94214150|NCT02367794|322577895|FG001|Overall Study|Study Terminated By Sponsor|1|||
94214151|NCT02367794|322577896|FG002|Overall Study|Study Terminated By Sponsor|1|||
94214152|NCT02367794|322577894|FG000|Overall Study|Moved to Roll-Over Study|0|||
94214153|NCT02367794|322577895|FG001|Overall Study|Moved to Roll-Over Study|15|||
94214154|NCT02367794|322577896|FG002|Overall Study|Moved to Roll-Over Study|13|||
94214155|NCT02367794|322577894|FG000|Overall Study|Sponsor Request|60|||
94214156|NCT02367794|322577895|FG001|Overall Study|Sponsor Request|57|||
94214157|NCT02367794|322577896|FG002|Overall Study|Sponsor Request|45|||
94214158|NCT02367794|322577894|FG000|Overall Study|Moved into PTAP Study|0|||
94214159|NCT02367794|322577895|FG001|Overall Study|Moved into PTAP Study|2|||
94214160|NCT02367794|322577896|FG002|Overall Study|Moved into PTAP Study|3|||
94214161|NCT02367794|322577894|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
94214162|NCT02367794|322577895|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
94214163|NCT02367794|322577896|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
94214164|NCT02367794|322577894|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
94214165|NCT02367794|322577895|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
94214166|NCT02367794|322577896|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
94214167|NCT02367794|322577894|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
94214168|NCT02367794|322577895|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
94285698|NCT01790503|322835321|FG002|Overall Study|Physician Decision|0|||
94285699|NCT01790503|322835322|FG003|Overall Study|Physician Decision|0|||
94285700|NCT01790503|322835323|FG004|Overall Study|Physician Decision|0|||
94285701|NCT01790503|322835324|FG005|Overall Study|Physician Decision|0|||
94285702|NCT01790503|322835325|FG006|Overall Study|Physician Decision|0|||
94285703|NCT01790503|322835326|FG007|Overall Study|Physician Decision|0|||
94285704|NCT01790503|322835327|FG008|Overall Study|Physician Decision|0|||
94285705|NCT01790503|322835328|FG009|Overall Study|Physician Decision|1|||
94285706|NCT01790503|322835329|FG010|Overall Study|Physician Decision|1|||
94285707|NCT01790503|322835319|FG000|Overall Study|Death|0|||
94285708|NCT01790503|322835320|FG001|Overall Study|Death|0|||
94285709|NCT01790503|322835321|FG002|Overall Study|Death|0|||
94285710|NCT01790503|322835322|FG003|Overall Study|Death|0|||
94285711|NCT01790503|322835323|FG004|Overall Study|Death|0|||
94285712|NCT01790503|322835324|FG005|Overall Study|Death|0|||
94285713|NCT01790503|322835325|FG006|Overall Study|Death|0|||
94285714|NCT01790503|322835326|FG007|Overall Study|Death|0|||
94285715|NCT01790503|322835327|FG008|Overall Study|Death|0|||
94285716|NCT01790503|322835328|FG009|Overall Study|Death|1|||
94372430|NCT04130919|323150262|FG005|Open-label Treatment Phase|Disease worsening|1|||
94372431|NCT04130919|323150257|FG000|Open-label Treatment Phase|Investigator's decision|0|||
94285717|NCT01790503|322835329|FG010|Overall Study|Death|0|||
94372432|NCT04130919|323150258|FG001|Open-label Treatment Phase|Investigator's decision|0|||
94372433|NCT04130919|323150259|FG002|Open-label Treatment Phase|Investigator's decision|0|||
94372434|NCT04130919|323150260|FG003|Open-label Treatment Phase|Investigator's decision|1|||
94214169|NCT02367794|322577896|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
94214170|NCT02367794|322577894|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
94214171|NCT02367794|322577895|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
94214172|NCT02367794|322577896|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
94214173|NCT04097535|322577897|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
94467809|NCT03887117|323502418|FG003|Overall Study|Discontinued prematurely|2|||
94467810|NCT04908475|323502419|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
94467811|NCT04908475|323502420|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
94467812|NCT04908475|323502421|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
94467813|NCT04908475|323502422|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
94467814|NCT04908475|323502423|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
94467815|NCT04908475|323502424|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
94467816|NCT04908475|323502419|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
94467817|NCT04908475|323502420|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
94467818|NCT04908475|323502421|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
94285718|NCT01790503|322835319|FG000|Overall Study|Non Compliance|0|||
94285719|NCT01790503|322835320|FG001|Overall Study|Non Compliance|0|||
94285720|NCT01790503|322835321|FG002|Overall Study|Non Compliance|0|||
94285721|NCT01790503|322835322|FG003|Overall Study|Non Compliance|0|||
94285722|NCT01790503|322835323|FG004|Overall Study|Non Compliance|1|||
94285723|NCT01790503|322835324|FG005|Overall Study|Non Compliance|0|||
94285724|NCT01790503|322835325|FG006|Overall Study|Non Compliance|0|||
94285725|NCT01790503|322835326|FG007|Overall Study|Non Compliance|0|||
94285726|NCT01790503|322835327|FG008|Overall Study|Non Compliance|0|||
94285727|NCT01790503|322835328|FG009|Overall Study|Non Compliance|0|||
94285728|NCT01790503|322835329|FG010|Overall Study|Non Compliance|0|||
94285729|NCT01790503|322835319|FG000|Overall Study|Other|0|||
94285730|NCT01790503|322835320|FG001|Overall Study|Other|0|||
94285731|NCT01790503|322835321|FG002|Overall Study|Other|0|||
94285732|NCT01790503|322835322|FG003|Overall Study|Other|0|||
94285733|NCT01790503|322835323|FG004|Overall Study|Other|1|||
94285734|NCT01790503|322835324|FG005|Overall Study|Other|0|||
94285735|NCT01790503|322835325|FG006|Overall Study|Other|0|||
94285736|NCT01790503|322835326|FG007|Overall Study|Other|0|||
94285737|NCT01790503|322835327|FG008|Overall Study|Other|1|||
94285738|NCT01790503|322835328|FG009|Overall Study|Other|2|||
94285739|NCT01790503|322835329|FG010|Overall Study|Other|0|||
94285740|NCT03988907|322835330|FG000|Overall Study|Unable to complete visit|0|||
94285741|NCT03988907|322835331|FG001|Overall Study|Unable to complete visit|1|||
94285742|NCT02787850|322835335|FG000|Overall Study|Withdrawal by Subject|0|||
94285743|NCT02787850|322835336|FG001|Overall Study|Withdrawal by Subject|1|||
94285744|NCT03718143|322835339|FG000|Overall Study|Death|1|||
94285745|NCT03718143|322835340|FG001|Overall Study|Death|0|||
94285746|NCT03718143|322835341|FG002|Overall Study|Death|0|||
94285747|NCT03718143|322835339|FG000|Overall Study|Progression of Disease|1|||
94285748|NCT03718143|322835340|FG001|Overall Study|Progression of Disease|0|||
94285749|NCT03718143|322835341|FG002|Overall Study|Progression of Disease|0|||
94285750|NCT03718143|322835339|FG000|Overall Study|Withdrawal of Informed Consent|1|||
94285751|NCT03718143|322835340|FG001|Overall Study|Withdrawal of Informed Consent|2|||
94285752|NCT03718143|322835341|FG002|Overall Study|Withdrawal of Informed Consent|1|||
94285753|NCT02921971|322835344|FG000|Overall Study|Adverse Event|1|||
94285754|NCT02921971|322835345|FG001|Overall Study|Adverse Event|2|||
94285755|NCT02921971|322835344|FG000|Overall Study|Lack of Efficacy|3|||
94285756|NCT02921971|322835345|FG001|Overall Study|Lack of Efficacy|1|||
94285757|NCT02921971|322835344|FG000|Overall Study|Other than specified above|2|||
94285758|NCT02921971|322835345|FG001|Overall Study|Other than specified above|1|||
94285759|NCT01652287|322835351|FG000|Overall Study|Withdrawal by Subject|2|||
94285760|NCT01652287|322835352|FG001|Overall Study|Withdrawal by Subject|0|||
94285761|NCT04316585|322835353|FG000|Overall Study|Adverse Event|2|||
94285762|NCT04316585|322835354|FG001|Overall Study|Adverse Event|1|||
94285763|NCT04316585|322835353|FG000|Overall Study|Lost to Follow-up|1|||
94285764|NCT04316585|322835354|FG001|Overall Study|Lost to Follow-up|0|||
94285765|NCT04316585|322835353|FG000|Overall Study|Withdrawal by Subject|2|||
94285766|NCT04316585|322835354|FG001|Overall Study|Withdrawal by Subject|3|||
94372435|NCT04130919|323150261|FG004|Open-label Treatment Phase|Investigator's decision|0|||
94372436|NCT04130919|323150262|FG005|Open-label Treatment Phase|Investigator's decision|0|||
94214174|NCT02556918|322579955|FG000|Overall Study|Protocol Violation|5|||
94214175|NCT02556918|322579956|FG001|Overall Study|Protocol Violation|6|||
94214176|NCT02556918|322579955|FG000|Overall Study|Withdrawal by Subject|4|||
94214177|NCT02556918|322579956|FG001|Overall Study|Withdrawal by Subject|4|||
94214178|NCT02880293|322579961|FG000|Overall Study|Inevaluable|5|||
94214179|NCT01277302|322579967|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
94214180|NCT01277302|322579968|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
94214181|NCT01277302|322579969|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
94214182|NCT01277302|322579967|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
94214183|NCT01277302|322579968|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
94214184|NCT01277302|322579969|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
94214185|NCT01277302|322579967|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
94214186|NCT01277302|322579968|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
94214187|NCT01277302|322579969|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
94214188|NCT01277302|322579967|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
94214189|NCT01277302|322579968|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
94214190|NCT01277302|322579969|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
94214191|NCT01277302|322579967|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
94214192|NCT01277302|322579968|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
94214193|NCT01277302|322579969|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
94214194|NCT01277302|322579967|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
94214195|NCT01277302|322579968|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
94214196|NCT01277302|322579969|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
94214197|NCT01277302|322579967|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
94214198|NCT01277302|322579968|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
94214199|NCT01277302|322579969|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
94214200|NCT01277302|322579967|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
94214201|NCT01277302|322579968|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
94214202|NCT01277302|322579969|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
94214203|NCT01277302|322579967|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
94214204|NCT01277302|322579968|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
94214205|NCT01277302|322579969|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
94214206|NCT02713594|322579974|FG000|Overall Study|Withdrawal by Subject|32|||
94214207|NCT02713594|322579975|FG001|Overall Study|Withdrawal by Subject|22|||
94214208|NCT02713594|322579974|FG000|Overall Study|Lost to Follow-up|358|||
94214209|NCT02713594|322579975|FG001|Overall Study|Lost to Follow-up|374|||
94214210|NCT03493282|322579976|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
94214211|NCT03493282|322579977|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
94214212|NCT03493282|322579978|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
94214213|NCT03493282|322579976|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
94214214|NCT03493282|322579977|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
94214215|NCT03493282|322579978|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
94214216|NCT00070707|322579979|FG000|Overall Study|Adverse Event|1|||
94214217|NCT00070707|322579980|FG001|Overall Study|Adverse Event|2|||
94214218|NCT00070707|322579979|FG000|Overall Study|Lack of Efficacy|4|||
94214219|NCT00070707|322579980|FG001|Overall Study|Lack of Efficacy|1|||
94214220|NCT00070707|322579979|FG000|Overall Study|Protocol Violation|8|||
94214221|NCT00070707|322579980|FG001|Overall Study|Protocol Violation|4|||
94214222|NCT00070707|322579979|FG000|Overall Study|Unrelated to Study Medication|1|||
94214223|NCT00070707|322579980|FG001|Overall Study|Unrelated to Study Medication|0|||
94214224|NCT00670449|322579981|FG000|Overall Study|Adverse Event|6|||
94214225|NCT00670449|322579982|FG001|Overall Study|Adverse Event|2|||
94214226|NCT00670449|322579983|FG002|Overall Study|Adverse Event|8|||
94285767|NCT04316585|322835353|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
94285768|NCT04316585|322835354|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
94285769|NCT04316585|322835353|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
94285770|NCT04316585|322835354|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
94285771|NCT01407926|322835363|FG000|Overall Study|Lost to Follow-up|55|||
94214227|NCT00670449|322579984|FG003|Overall Study|Adverse Event|5|||
94214228|NCT00670449|322579981|FG000|Overall Study|Protocol Deviation|1|||
94214229|NCT00670449|322579982|FG001|Overall Study|Protocol Deviation|2|||
94214230|NCT00670449|322579983|FG002|Overall Study|Protocol Deviation|0|||
94214231|NCT00670449|322579984|FG003|Overall Study|Protocol Deviation|1|||
94214232|NCT00670449|322579981|FG000|Overall Study|Administrative Problems|0|||
94214233|NCT00670449|322579982|FG001|Overall Study|Administrative Problems|2|||
94214234|NCT00670449|322579983|FG002|Overall Study|Administrative Problems|0|||
94214235|NCT00670449|322579984|FG003|Overall Study|Administrative Problems|1|||
94214236|NCT00670449|322579981|FG000|Overall Study|Subject Withdrew Consent|0|||
94285772|NCT02634580|322835366|FG000|Double-blind Treatment Period|Subject Request|1|||
94285773|NCT02634580|322835367|FG001|Double-blind Treatment Period|Subject Request|0|||
94214237|NCT00670449|322579982|FG001|Overall Study|Subject Withdrew Consent|2|||
94214238|NCT00670449|322579983|FG002|Overall Study|Subject Withdrew Consent|0|||
94214239|NCT00670449|322579984|FG003|Overall Study|Subject Withdrew Consent|1|||
94214240|NCT00670449|322579981|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
94214241|NCT00670449|322579982|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
94214242|NCT00670449|322579983|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
94214243|NCT00670449|322579984|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
94214244|NCT00670449|322579981|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
94214245|NCT00670449|322579982|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
94214246|NCT00670449|322579983|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
94214247|NCT00670449|322579984|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
94214248|NCT00413283|322579988|FG000|Overall Study|Withdrawal by Subject|1|||
94214249|NCT00413283|322579989|FG001|Overall Study|Withdrawal by Subject|0|||
94214250|NCT00413283|322579990|FG002|Overall Study|Withdrawal by Subject|0|||
94214251|NCT00413283|322579991|FG003|Overall Study|Withdrawal by Subject|1|||
94214252|NCT00413283|322579988|FG000|Overall Study|Death|0|||
94214253|NCT00413283|322579989|FG001|Overall Study|Death|0|||
94214254|NCT00413283|322579990|FG002|Overall Study|Death|1|||
94214255|NCT00413283|322579991|FG003|Overall Study|Death|1|||
94214256|NCT00413283|322579988|FG000|Overall Study|Adverse Event|0|||
94214257|NCT00413283|322579989|FG001|Overall Study|Adverse Event|0|||
94214258|NCT00413283|322579990|FG002|Overall Study|Adverse Event|0|||
94214259|NCT00413283|322579991|FG003|Overall Study|Adverse Event|1|||
94214260|NCT00413283|322579988|FG000|Overall Study|Ineligibility determined|0|||
94214261|NCT00413283|322579989|FG001|Overall Study|Ineligibility determined|0|||
94214262|NCT00413283|322579990|FG002|Overall Study|Ineligibility determined|0|||
94214263|NCT00413283|322579991|FG003|Overall Study|Ineligibility determined|1|||
94214264|NCT00413283|322579988|FG000|Overall Study|Protocol deviation|0|||
94214265|NCT00413283|322579989|FG001|Overall Study|Protocol deviation|1|||
94214266|NCT00413283|322579990|FG002|Overall Study|Protocol deviation|0|||
94214267|NCT00413283|322579991|FG003|Overall Study|Protocol deviation|0|||
94214268|NCT00413283|322579988|FG000|Overall Study|Requirement for alternative therapy|0|||
94214269|NCT00413283|322579989|FG001|Overall Study|Requirement for alternative therapy|2|||
94214270|NCT00413283|322579990|FG002|Overall Study|Requirement for alternative therapy|0|||
94214271|NCT00413283|322579991|FG003|Overall Study|Requirement for alternative therapy|0|||
94214272|NCT00413283|322579988|FG000|Overall Study|Other|0|||
94214273|NCT00413283|322579989|FG001|Overall Study|Other|0|||
94214274|NCT00413283|322579990|FG002|Overall Study|Other|1|||
94214275|NCT00413283|322579991|FG003|Overall Study|Other|0|||
94214276|NCT02002689|322579996|FG000|Overall Study|Disease Progression|7|||
94214277|NCT02002689|322579996|FG000|Overall Study|Adverse Event|3|||
94214278|NCT02354417|322579997|FG000|Overall Study|Physician Decision|1|||
94214279|NCT01185340|322580000|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
94214280|NCT01185340|322580001|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
94214281|NCT01185340|322580002|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
94214282|NCT01185340|322580003|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
94214283|NCT01185340|322580000|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
94214284|NCT01185340|322580001|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
94214285|NCT01185340|322580002|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
94214286|NCT01185340|322580003|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
94214287|NCT01185340|322580000|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
94285774|NCT02634580|322835368|FG002|Double-blind Treatment Period|Subject Request|1|||
94285775|NCT02634580|322835369|FG003|Double-blind Treatment Period|Subject Request|1|||
94285776|NCT02634580|322835366|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
94285777|NCT02634580|322835367|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
94285778|NCT02634580|322835368|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
94285779|NCT02634580|322835369|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
94285780|NCT02479802|322835370|FG000|Overall Study|Lost to Follow-up|1|||
94285781|NCT02479802|322835370|FG000|Overall Study|Adverse Event|1|||
94285782|NCT00159432|322835376|FG000|Overall Study|Adverse Event|1|||
94285783|NCT00159432|322835376|FG000|Overall Study|Death|1|||
94285784|NCT00159432|322835376|FG000|Overall Study|Lack of Efficacy|8|||
94285785|NCT05048342|322835383|FG000|Overall Study|Adverse Event|1|||
94285786|NCT05048342|322835383|FG000|Overall Study|Subject decision|2|||
94214288|NCT01185340|322580001|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
94214289|NCT01185340|322580002|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
94214290|NCT01185340|322580003|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
94214291|NCT01185340|322580000|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
94214292|NCT01185340|322580001|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
94214293|NCT01185340|322580002|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
94214294|NCT01185340|322580003|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
94214295|NCT01185340|322580000|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
94285787|NCT00684957|322835384|FG000|Overall Study|Withdrawal by Subject|1|||
94285788|NCT00684957|322835385|FG001|Overall Study|Withdrawal by Subject|1|||
94285789|NCT00684957|322835384|FG000|Overall Study|Lost to Follow-up|1|||
94467819|NCT04908475|323502422|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
94467820|NCT04908475|323502423|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
94467821|NCT04908475|323502424|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
94285790|NCT00684957|322835385|FG001|Overall Study|Lost to Follow-up|0|||
94285791|NCT00191451|322835387|FG000|Overall Study|Withdrawal by Subject|2|||
94285792|NCT00191451|322835388|FG001|Overall Study|Withdrawal by Subject|3|||
94285793|NCT00191451|322835389|FG002|Overall Study|Withdrawal by Subject|5|||
94285794|NCT00191451|322835387|FG000|Overall Study|Physician Decision|2|||
94285795|NCT00191451|322835388|FG001|Overall Study|Physician Decision|9|||
94285796|NCT00191451|322835389|FG002|Overall Study|Physician Decision|6|||
94285797|NCT00191451|322835387|FG000|Overall Study|Sponsor Decision|1|||
94285798|NCT00191451|322835388|FG001|Overall Study|Sponsor Decision|0|||
94285799|NCT00191451|322835389|FG002|Overall Study|Sponsor Decision|0|||
94285800|NCT00191451|322835387|FG000|Overall Study|Ineligible|0|||
94285801|NCT00191451|322835388|FG001|Overall Study|Ineligible|1|||
94285802|NCT00191451|322835389|FG002|Overall Study|Ineligible|0|||
94285803|NCT00191451|322835387|FG000|Overall Study|Reason Not Specified|2|||
94285804|NCT00191451|322835388|FG001|Overall Study|Reason Not Specified|1|||
94285805|NCT00191451|322835389|FG002|Overall Study|Reason Not Specified|3|||
94285806|NCT00662792|322835392|FG000|Period 1|Personal Reasons|0|||
94285807|NCT00662792|322835393|FG001|Period 1|Personal Reasons|0|||
94285808|NCT00662792|322835394|FG002|Period 1|Personal Reasons|1|||
94285809|NCT00662792|322835395|FG003|Period 1|Personal Reasons|0|||
94285810|NCT00662792|322835392|FG000|Period 1|Refused continuing medication|0|||
94285811|NCT00662792|322835393|FG001|Period 1|Refused continuing medication|1|||
94285812|NCT00662792|322835394|FG002|Period 1|Refused continuing medication|1|||
94285813|NCT00662792|322835395|FG003|Period 1|Refused continuing medication|0|||
94285814|NCT00662792|322835392|FG000|Period 1|Lost to Follow-up|1|||
94285815|NCT00662792|322835393|FG001|Period 1|Lost to Follow-up|0|||
94285816|NCT00662792|322835394|FG002|Period 1|Lost to Follow-up|0|||
94285817|NCT00662792|322835395|FG003|Period 1|Lost to Follow-up|0|||
94285818|NCT00662792|322835392|FG000|Period 1|Other adverse event (AE)|0|||
94285819|NCT00662792|322835393|FG001|Period 1|Other adverse event (AE)|2|||
94285820|NCT00662792|322835394|FG002|Period 1|Other adverse event (AE)|0|||
94285821|NCT00662792|322835395|FG003|Period 1|Other adverse event (AE)|0|||
94285822|NCT00662792|322835392|FG000|Period 1|Worsening of disease under study (AE)|1|||
94285823|NCT00662792|322835393|FG001|Period 1|Worsening of disease under study (AE)|3|||
94285824|NCT00662792|322835394|FG002|Period 1|Worsening of disease under study (AE)|2|||
94285825|NCT00662792|322835395|FG003|Period 1|Worsening of disease under study (AE)|0|||
94285826|NCT00662792|322835392|FG000|Period 1|Not treated|0|||
94285827|NCT00662792|322835393|FG001|Period 1|Not treated|1|||
94285828|NCT00662792|322835394|FG002|Period 1|Not treated|0|||
94285829|NCT00662792|322835395|FG003|Period 1|Not treated|0|||
94285830|NCT00662792|322835392|FG000|Period 2|Worsening of disease under study|1|||
94285831|NCT00662792|322835393|FG001|Period 2|Worsening of disease under study|0|||
94285832|NCT00662792|322835394|FG002|Period 2|Worsening of disease under study|0|||
94285833|NCT00662792|322835395|FG003|Period 2|Worsening of disease under study|3|||
94467822|NCT04908475|323502419|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
94285834|NCT00662792|322835392|FG000|Period 3|Refused continuing medication|1|||
94285835|NCT00662792|322835393|FG001|Period 3|Refused continuing medication|0|||
94285836|NCT00662792|322835394|FG002|Period 3|Refused continuing medication|1|||
94285837|NCT00662792|322835395|FG003|Period 3|Refused continuing medication|0|||
94285838|NCT00662792|322835392|FG000|Period 3|Other adverse event (AE)|0|||
94214296|NCT01185340|322580001|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
94214297|NCT01185340|322580002|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
94214298|NCT01185340|322580003|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
94214299|NCT01185340|322580000|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
94214300|NCT01185340|322580001|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
94214301|NCT01185340|322580002|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
94214302|NCT01185340|322580003|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
94214303|NCT01185340|322580000|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
94214304|NCT01185340|322580001|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
94214305|NCT01185340|322580002|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
94214306|NCT01185340|322580003|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
94214307|NCT01185340|322580000|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
94214308|NCT01185340|322580001|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
94214309|NCT01185340|322580002|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
94214310|NCT01185340|322580003|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
94214311|NCT01185340|322580000|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
94214312|NCT01185340|322580001|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
94214313|NCT01185340|322580002|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
94214314|NCT01185340|322580003|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
94214315|NCT01185340|322580000|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
94214316|NCT01185340|322580001|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
94214317|NCT01185340|322580002|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
94214318|NCT01185340|322580003|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
94214319|NCT01185340|322580000|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
94214320|NCT01185340|322580001|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
94214321|NCT01185340|322580002|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
94214322|NCT01185340|322580003|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
94214323|NCT01185340|322580000|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
94214324|NCT01185340|322580001|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
94214325|NCT01185340|322580002|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
94214326|NCT01185340|322580003|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
94214327|NCT01185340|322580000|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
94214328|NCT01185340|322580001|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
94214329|NCT01185340|322580002|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
94214330|NCT01185340|322580003|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
94214331|NCT01185340|322580000|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
94214332|NCT01185340|322580001|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
94214333|NCT01185340|322580002|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
94214334|NCT01185340|322580003|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
94214335|NCT01148017|322580004|FG000|Overall Study|Withdrawal by Subject|31|||
94214336|NCT01148017|322580005|FG001|Overall Study|Withdrawal by Subject|14|||
94214337|NCT01148017|322580006|FG002|Overall Study|Withdrawal by Subject|0|||
94214338|NCT01148017|322580007|FG003|Overall Study|Withdrawal by Subject|0|||
94214339|NCT01148017|322580004|FG000|Overall Study|Lost to Follow-up|23|||
94214340|NCT01148017|322580005|FG001|Overall Study|Lost to Follow-up|10|||
94214341|NCT01148017|322580006|FG002|Overall Study|Lost to Follow-up|0|||
94214342|NCT01148017|322580007|FG003|Overall Study|Lost to Follow-up|0|||
94214343|NCT01148017|322580004|FG000|Overall Study|Inappropriate enrollment|1|||
94214344|NCT01148017|322580005|FG001|Overall Study|Inappropriate enrollment|0|||
94285839|NCT00662792|322835393|FG001|Period 3|Other adverse event (AE)|0|||
94285840|NCT00662792|322835394|FG002|Period 3|Other adverse event (AE)|1|||
94285841|NCT00662792|322835395|FG003|Period 3|Other adverse event (AE)|1|||
94285842|NCT00662792|322835392|FG000|Period 4|Refused continuing medication|0|||
94285843|NCT00662792|322835393|FG001|Period 4|Refused continuing medication|1|||
94285844|NCT00662792|322835394|FG002|Period 4|Refused continuing medication|0|||
94285845|NCT00662792|322835395|FG003|Period 4|Refused continuing medication|0|||
94285846|NCT00662792|322835392|FG000|Period 4|Other adverse event (AE)|1|||
94285847|NCT00662792|322835393|FG001|Period 4|Other adverse event (AE)|0|||
94285848|NCT00662792|322835394|FG002|Period 4|Other adverse event (AE)|0|||
94285849|NCT00662792|322835395|FG003|Period 4|Other adverse event (AE)|0|||
94285850|NCT00662792|322835392|FG000|Period 4|Worsening of disease under study (AE)|0|||
94285851|NCT00662792|322835393|FG001|Period 4|Worsening of disease under study (AE)|0|||
94285852|NCT00662792|322835394|FG002|Period 4|Worsening of disease under study (AE)|0|||
94285853|NCT00662792|322835395|FG003|Period 4|Worsening of disease under study (AE)|1|||
94285854|NCT01699087|322835396|FG000|Overall Study|Lost to Follow-up|7|||
94285855|NCT01699087|322835396|FG000|Overall Study|Screen failure (prior to treatment)|15|||
94285856|NCT01699087|322835396|FG000|Overall Study|Unable to make future visits|2|||
94285857|NCT02499029|322835397|FG000|Overall Study|Lost to Follow-up|2|||
94285858|NCT02499029|322835398|FG001|Overall Study|Lost to Follow-up|2|||
94285859|NCT02499029|322835397|FG000|Overall Study|Physician Decision|2|||
94285860|NCT02499029|322835398|FG001|Overall Study|Physician Decision|1|||
94285861|NCT02499029|322835397|FG000|Overall Study|Death|1|||
94285862|NCT02499029|322835398|FG001|Overall Study|Death|0|||
94285863|NCT01999582|322835399|FG000|Overall Study|Withdrawal by Subject|0|||
94285864|NCT01999582|322835400|FG001|Overall Study|Withdrawal by Subject|0|||
94285865|NCT01999582|322835401|FG002|Overall Study|Withdrawal by Subject|0|||
94285866|NCT01999582|322835402|FG003|Overall Study|Withdrawal by Subject|1|||
94285867|NCT01999582|322835403|FG004|Overall Study|Withdrawal by Subject|0|||
94285868|NCT01999582|322835404|FG005|Overall Study|Withdrawal by Subject|0|||
94285869|NCT01999582|322835399|FG000|Overall Study|Adverse Event|0|||
94285870|NCT01999582|322835400|FG001|Overall Study|Adverse Event|0|||
94285871|NCT01999582|322835401|FG002|Overall Study|Adverse Event|3|||
94285872|NCT01999582|322835402|FG003|Overall Study|Adverse Event|0|||
94285873|NCT01999582|322835403|FG004|Overall Study|Adverse Event|1|||
94285874|NCT01999582|322835404|FG005|Overall Study|Adverse Event|0|||
94285875|NCT01999582|322835399|FG000|Overall Study|Other Reasons|1|||
94285876|NCT01999582|322835400|FG001|Overall Study|Other Reasons|0|||
94285877|NCT01999582|322835401|FG002|Overall Study|Other Reasons|3|||
94285878|NCT01999582|322835402|FG003|Overall Study|Other Reasons|1|||
94285879|NCT01999582|322835403|FG004|Overall Study|Other Reasons|1|||
94285880|NCT01999582|322835404|FG005|Overall Study|Other Reasons|2|||
94285881|NCT01999582|322835399|FG000|Overall Study|Protocol Violation|1|||
94285882|NCT01999582|322835400|FG001|Overall Study|Protocol Violation|0|||
94285883|NCT01999582|322835401|FG002|Overall Study|Protocol Violation|0|||
94285884|NCT01999582|322835402|FG003|Overall Study|Protocol Violation|0|||
94285885|NCT01999582|322835403|FG004|Overall Study|Protocol Violation|0|||
94285886|NCT01999582|322835404|FG005|Overall Study|Protocol Violation|1|||
94214345|NCT01148017|322580006|FG002|Overall Study|Inappropriate enrollment|0|||
94214346|NCT01148017|322580007|FG003|Overall Study|Inappropriate enrollment|0|||
94214347|NCT01148017|322580004|FG000|Overall Study|Administrative reason|22|||
94214348|NCT01148017|322580005|FG001|Overall Study|Administrative reason|9|||
94214349|NCT01148017|322580006|FG002|Overall Study|Administrative reason|0|||
94214350|NCT01148017|322580007|FG003|Overall Study|Administrative reason|0|||
94214351|NCT01148017|322580004|FG000|Overall Study|Unable to classify|3|||
94214352|NCT01148017|322580005|FG001|Overall Study|Unable to classify|1|||
94214353|NCT01148017|322580006|FG002|Overall Study|Unable to classify|0|||
94214354|NCT01148017|322580007|FG003|Overall Study|Unable to classify|0|||
94214355|NCT01848483|322580008|FG000|Overall Study|Death|2|||
94214356|NCT01848483|322580009|FG001|Overall Study|Death|1|||
94214357|NCT01848483|322580008|FG000|Overall Study|Lost to Follow-up|6|||
94214358|NCT01848483|322580009|FG001|Overall Study|Lost to Follow-up|8|||
94214359|NCT01848483|322580008|FG000|Overall Study|Withdrawal by Subject|1|||
94214360|NCT01848483|322580009|FG001|Overall Study|Withdrawal by Subject|0|||
94214361|NCT01848483|322580008|FG000|Overall Study|Incarceration|2|||
94214362|NCT01848483|322580009|FG001|Overall Study|Incarceration|2|||
94214363|NCT00484198|322580020|FG000|Overall Study|Participant Withdrew Consent|12|||
94214364|NCT00484198|322580021|FG001|Overall Study|Participant Withdrew Consent|21|||
94214365|NCT00484198|322580022|FG002|Overall Study|Participant Withdrew Consent|47|||
94214366|NCT00484198|322580023|FG003|Overall Study|Participant Withdrew Consent|59|||
94214367|NCT00484198|322580020|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
94285887|NCT01999582|322835399|FG000|Overall Study|Lack of Efficacy|1|||
94285888|NCT01999582|322835400|FG001|Overall Study|Lack of Efficacy|3|||
94285889|NCT01999582|322835401|FG002|Overall Study|Lack of Efficacy|0|||
94285890|NCT01999582|322835402|FG003|Overall Study|Lack of Efficacy|1|||
94285891|NCT01999582|322835403|FG004|Overall Study|Lack of Efficacy|0|||
94285892|NCT01999582|322835404|FG005|Overall Study|Lack of Efficacy|0|||
94285893|NCT02239263|322835406|FG000|Overall Study|Protocol Violation|6|||
94285894|NCT03603496|322835408|FG000|Overall Study|Death|19|||
94285895|NCT03603496|322835409|FG001|Overall Study|Death|24|||
94285896|NCT03603496|322835408|FG000|Overall Study|Lost to Follow-up|141|||
94285897|NCT03603496|322835409|FG001|Overall Study|Lost to Follow-up|141|||
94285898|NCT03603496|322835408|FG000|Overall Study|Withdrawal by Subject|26|||
94285899|NCT03603496|322835409|FG001|Overall Study|Withdrawal by Subject|20|||
94285900|NCT01164722|322835416|FG000|Overall Study|Adverse Event|0|||
94285901|NCT01164722|322835417|FG001|Overall Study|Adverse Event|1|||
94285902|NCT01164722|322835416|FG000|Overall Study|Withdrawal by Subject|3|||
94285903|NCT01164722|322835417|FG001|Overall Study|Withdrawal by Subject|4|||
94285904|NCT01164722|322835416|FG000|Overall Study|Lost to Follow-up|3|||
94285905|NCT01164722|322835417|FG001|Overall Study|Lost to Follow-up|6|||
94285906|NCT01164722|322835416|FG000|Overall Study|met protocol criteria for non-treatment|11|||
94285907|NCT01164722|322835417|FG001|Overall Study|met protocol criteria for non-treatment|1|||
94285908|NCT01164722|322835416|FG000|Overall Study|enrolled on other study, concomitant med|1|||
94285909|NCT01164722|322835417|FG001|Overall Study|enrolled on other study, concomitant med|3|||
94285910|NCT02568046|322835418|FG000|Overall Study|Adverse Event|0|||
94285911|NCT02568046|322835419|FG001|Overall Study|Adverse Event|1|||
94285912|NCT02568046|322835418|FG000|Overall Study|Death|2|||
94285913|NCT02568046|322835419|FG001|Overall Study|Death|0|||
94285914|NCT02568046|322835418|FG000|Overall Study|Progressive Disease|1|||
94285915|NCT02568046|322835419|FG001|Overall Study|Progressive Disease|0|||
94285916|NCT02568046|322835418|FG000|Overall Study|Withdrawal by Subject|2|||
94285917|NCT02568046|322835419|FG001|Overall Study|Withdrawal by Subject|1|||
94285918|NCT02568046|322835418|FG000|Overall Study|Other Events|0|||
94285919|NCT02568046|322835419|FG001|Overall Study|Other Events|1|||
94285920|NCT00408694|322835423|FG000|Overall Study|Ineligible|1|||
94285921|NCT00408694|322835423|FG000|Overall Study|No protocol treatment|1|||
94285922|NCT00523991|322835424|FG000|Overall Study|Adverse Event|6|||
94285923|NCT00523991|322835425|FG001|Overall Study|Adverse Event|5|||
94285924|NCT00523991|322835424|FG000|Overall Study|Protocol Violation|1|||
94285925|NCT00523991|322835425|FG001|Overall Study|Protocol Violation|4|||
94285926|NCT00523991|322835424|FG000|Overall Study|Lost to Follow-up|4|||
94285927|NCT00523991|322835425|FG001|Overall Study|Lost to Follow-up|1|||
94285928|NCT00523991|322835424|FG000|Overall Study|Withdrawal by Subject|7|||
94285929|NCT00523991|322835425|FG001|Overall Study|Withdrawal by Subject|17|||
94285930|NCT00523991|322835424|FG000|Overall Study|Other reason (not specified)|3|||
94285931|NCT00523991|322835425|FG001|Overall Study|Other reason (not specified)|0|||
94285932|NCT01703858|322835427|FG000|Overall Study|Withdrawal by Subject|0|||
94285933|NCT01703858|322835428|FG001|Overall Study|Withdrawal by Subject|1|||
94285934|NCT01703858|322835429|FG002|Overall Study|Withdrawal by Subject|0|||
94285935|NCT01543087|322835432|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
94285936|NCT01543087|322835433|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
94285937|NCT01543087|322835434|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
94285938|NCT01543087|322835435|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
94285939|NCT01543087|322835436|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
94285940|NCT01543087|322835437|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
94285941|NCT01543087|322835432|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
94285942|NCT01543087|322835433|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
94285943|NCT01543087|322835434|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
94285944|NCT01543087|322835435|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
94285945|NCT01543087|322835436|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
94285946|NCT01543087|322835437|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
94285947|NCT01543087|322835432|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
94214368|NCT00484198|322580021|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
94214369|NCT00484198|322580022|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
94214370|NCT00484198|322580023|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
94214371|NCT00484198|322580020|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
94214372|NCT00484198|322580021|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
94214373|NCT00484198|322580022|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
94214374|NCT00484198|322580023|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
94214375|NCT00484198|322580020|FG000|Overall Study|Adverse Event|3|||
94214376|NCT00484198|322580021|FG001|Overall Study|Adverse Event|11|||
94214377|NCT00484198|322580022|FG002|Overall Study|Adverse Event|32|||
94214378|NCT00484198|322580023|FG003|Overall Study|Adverse Event|31|||
94214379|NCT00484198|322580020|FG000|Overall Study|Protocol Violation|0|||
94214380|NCT00484198|322580021|FG001|Overall Study|Protocol Violation|5|||
94214381|NCT00484198|322580022|FG002|Overall Study|Protocol Violation|6|||
94214382|NCT00484198|322580023|FG003|Overall Study|Protocol Violation|8|||
94214383|NCT00484198|322580020|FG000|Overall Study|Other|7|||
94214384|NCT00484198|322580021|FG001|Overall Study|Other|10|||
94214385|NCT00484198|322580022|FG002|Overall Study|Other|31|||
94214386|NCT00484198|322580023|FG003|Overall Study|Other|28|||
94214387|NCT00308308|322580024|FG000|Overall Study|Adverse Event|17|||
94214388|NCT00308308|322580025|FG001|Overall Study|Adverse Event|2|||
94214389|NCT00308308|322580024|FG000|Overall Study|Lost to Follow-up|5|||
94214390|NCT00308308|322580025|FG001|Overall Study|Lost to Follow-up|5|||
94214391|NCT00308308|322580024|FG000|Overall Study|Physician Decision|15|||
94214392|NCT00308308|322580025|FG001|Overall Study|Physician Decision|7|||
94214393|NCT00308308|322580024|FG000|Overall Study|Protocol Violation|3|||
94214394|NCT00308308|322580025|FG001|Overall Study|Protocol Violation|14|||
94214395|NCT00308308|322580024|FG000|Overall Study|Withdrawal by Subject|47|||
94214396|NCT00308308|322580025|FG001|Overall Study|Withdrawal by Subject|19|||
94214397|NCT00308308|322580024|FG000|Overall Study|Various|7|||
94214398|NCT00308308|322580025|FG001|Overall Study|Various|5|||
94214399|NCT00308308|322580024|FG000|Overall Study|Randomized but not dosed|8|||
94214400|NCT00308308|322580025|FG001|Overall Study|Randomized but not dosed|16|||
94214401|NCT00308308|322580024|FG000|Overall Study|Other|1|||
94214402|NCT00308308|322580025|FG001|Overall Study|Other|0|||
94214403|NCT01286311|322580026|FG000|Overall Study|Physician did not want outreach sent|14|||
94214404|NCT01286311|322580027|FG001|Overall Study|Physician did not want outreach sent|0|||
94214405|NCT01686152|322580028|FG000|Overall Study|Withdrawal by Subject|11|||
94214406|NCT01686152|322580029|FG001|Overall Study|Withdrawal by Subject|11|||
94214407|NCT01686152|322580030|FG002|Overall Study|Withdrawal by Subject|3|||
94214408|NCT01686152|322580028|FG000|Overall Study|Drug Code Unblinded|0|||
94214409|NCT01686152|322580029|FG001|Overall Study|Drug Code Unblinded|1|||
94214410|NCT01686152|322580030|FG002|Overall Study|Drug Code Unblinded|0|||
94214411|NCT01686152|322580028|FG000|Overall Study|Protocol Violation|6|||
94214412|NCT01686152|322580029|FG001|Overall Study|Protocol Violation|1|||
94214413|NCT01686152|322580030|FG002|Overall Study|Protocol Violation|0|||
94214414|NCT01686152|322580028|FG000|Overall Study|Adverse Event|12|||
94214415|NCT01686152|322580029|FG001|Overall Study|Adverse Event|11|||
94214416|NCT01686152|322580030|FG002|Overall Study|Adverse Event|0|||
94214417|NCT01686152|322580028|FG000|Overall Study|Lack of Efficacy|0|||
94214418|NCT01686152|322580029|FG001|Overall Study|Lack of Efficacy|0|||
94214419|NCT01686152|322580030|FG002|Overall Study|Lack of Efficacy|1|||
94214420|NCT01686152|322580028|FG000|Overall Study|IP Non-compliance|5|||
94214421|NCT01686152|322580029|FG001|Overall Study|IP Non-compliance|5|||
94214422|NCT01686152|322580030|FG002|Overall Study|IP Non-compliance|0|||
94214423|NCT01686152|322580028|FG000|Overall Study|Lost to Follow-up|7|||
94214424|NCT01686152|322580029|FG001|Overall Study|Lost to Follow-up|6|||
94214425|NCT01686152|322580030|FG002|Overall Study|Lost to Follow-up|5|||
94214426|NCT01853384|322580033|FG000|Randomized|Adverse Event|5|||
94214427|NCT01853384|322580034|FG001|Randomized|Adverse Event|3|||
94214428|NCT01853384|322580033|FG000|Randomized|Death|1|||
94214429|NCT01853384|322580034|FG001|Randomized|Death|2|||
94214430|NCT01853384|322580033|FG000|Randomized|Lost to Follow-up|1|||
94214431|NCT01853384|322580034|FG001|Randomized|Lost to Follow-up|1|||
94214432|NCT01853384|322580033|FG000|Randomized|Withdrawal by Subject|5|||
94214433|NCT01853384|322580034|FG001|Randomized|Withdrawal by Subject|3|||
94214434|NCT01853384|322580033|FG000|Randomized|Sponsor Decision|47|||
94214435|NCT01853384|322580034|FG001|Randomized|Sponsor Decision|34|||
94214436|NCT01853384|322580033|FG000|Randomized|Other|3|||
94214437|NCT01853384|322580034|FG001|Randomized|Other|3|||
94214438|NCT01853384|322580033|FG000|Completed Follow up Visit 1|Early Termination|13|||
94214439|NCT01853384|322580034|FG001|Completed Follow up Visit 1|Early Termination|9|||
94214440|NCT01853384|322580033|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
94214441|NCT01853384|322580034|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
94214442|NCT01853384|322580033|FG000|Completed Follow up Visit 2|Adverse Event|1|||
94214443|NCT01853384|322580034|FG001|Completed Follow up Visit 2|Adverse Event|0|||
94214444|NCT01853384|322580033|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
94214445|NCT01853384|322580034|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
94214446|NCT01853384|322580033|FG000|Completed Follow up Visit 2|Death|1|||
94214447|NCT01853384|322580034|FG001|Completed Follow up Visit 2|Death|0|||
94214448|NCT01853384|322580033|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
94214449|NCT01853384|322580034|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
94214450|NCT01802333|322580035|FG000|Overall Study|Ineligible|2|||
94214451|NCT01802333|322580036|FG001|Overall Study|Ineligible|6|||
94214452|NCT01802333|322580037|FG002|Overall Study|Ineligible|8|||
94214453|NCT01802333|322580035|FG000|Overall Study|Adverse Event|1|||
94214454|NCT01802333|322580036|FG001|Overall Study|Adverse Event|8|||
94214455|NCT01802333|322580037|FG002|Overall Study|Adverse Event|8|||
94214456|NCT01802333|322580035|FG000|Overall Study|Withdrawal by Subject|6|||
94214457|NCT01802333|322580036|FG001|Overall Study|Withdrawal by Subject|6|||
94214458|NCT01802333|322580037|FG002|Overall Study|Withdrawal by Subject|5|||
94214459|NCT01802333|322580035|FG000|Overall Study|Progression/relapse|1|||
94214460|NCT01802333|322580036|FG001|Overall Study|Progression/relapse|3|||
94214461|NCT01802333|322580037|FG002|Overall Study|Progression/relapse|0|||
94214462|NCT01802333|322580035|FG000|Overall Study|Death|7|||
94214463|NCT01802333|322580036|FG001|Overall Study|Death|14|||
94214464|NCT01802333|322580037|FG002|Overall Study|Death|13|||
94214465|NCT01802333|322580035|FG000|Overall Study|Other - not protocol specified|32|||
94214466|NCT01802333|322580036|FG001|Overall Study|Other - not protocol specified|22|||
94372437|NCT04130919|323150257|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
94214467|NCT01802333|322580037|FG002|Overall Study|Other - not protocol specified|24|||
94214468|NCT01802333|322580035|FG000|Overall Study|Did not start treatment|0|||
94214469|NCT01802333|322580036|FG001|Overall Study|Did not start treatment|2|||
94214470|NCT01802333|322580037|FG002|Overall Study|Did not start treatment|5|||
94214471|NCT00703092|322580044|FG000|Overall Study|Withdrawal by Subject|2|||
94214472|NCT01381549|322580045|FG000|Overall Study|Ineligible: No organisms isolated|0|||
94214473|NCT01381549|322580046|FG001|Overall Study|Ineligible: No organisms isolated|0|||
94372438|NCT04130919|323150258|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
94214474|NCT01381549|322580047|FG002|Overall Study|Ineligible: No organisms isolated|1|||
94214475|NCT00403845|322580048|FG000|Treatment Period 1|Subject withdrew consent|1|||
94214476|NCT00403845|322580049|FG001|Treatment Period 1|Subject withdrew consent|0|||
94214477|NCT00403845|322580050|FG002|Treatment Period 1|Subject withdrew consent|0|||
94214478|NCT00403845|322580051|FG003|Treatment Period 1|Subject withdrew consent|0|||
94214479|NCT00403845|322580048|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
94214480|NCT00403845|322580049|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
94214481|NCT00403845|322580050|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
94214482|NCT00403845|322580051|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
94214483|NCT00403845|322580048|FG000|Treatment Period 2|Subject withdrew consent|1|||
94214484|NCT00403845|322580049|FG001|Treatment Period 2|Subject withdrew consent|0|||
94214485|NCT00403845|322580050|FG002|Treatment Period 2|Subject withdrew consent|0|||
94214486|NCT00403845|322580051|FG003|Treatment Period 2|Subject withdrew consent|0|||
94214487|NCT00403845|322580048|FG000|Treatment Period 3|Subject withdrew consent|0|||
94214488|NCT00403845|322580049|FG001|Treatment Period 3|Subject withdrew consent|0|||
94214489|NCT00403845|322580050|FG002|Treatment Period 3|Subject withdrew consent|0|||
94214490|NCT00403845|322580051|FG003|Treatment Period 3|Subject withdrew consent|1|||
94214491|NCT00403845|322580048|FG000|Treatment Period 3|Adverse Event|0|||
94214492|NCT00403845|322580049|FG001|Treatment Period 3|Adverse Event|0|||
94214493|NCT00403845|322580050|FG002|Treatment Period 3|Adverse Event|0|||
94214494|NCT00403845|322580051|FG003|Treatment Period 3|Adverse Event|1|||
94214495|NCT00805792|322580052|FG000|Overall Study|Death|3|||
94214496|NCT00805792|322580052|FG000|Overall Study|Lost to Follow-up|2|||
94214497|NCT01005602|322580053|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
94214498|NCT01005602|322580054|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
94214499|NCT04328467|322580057|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
94214500|NCT04328467|322580058|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
94214501|NCT04328467|322580059|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
94214502|NCT00813709|322580060|FG000|Double Blind Period|Adverse Event|4|||
94214503|NCT00813709|322580061|FG001|Double Blind Period|Adverse Event|1|||
94214504|NCT00813709|322580062|FG002|Double Blind Period|Adverse Event|4|||
94214505|NCT00813709|322580063|FG003|Double Blind Period|Adverse Event|0|||
94214506|NCT00813709|322580064|FG004|Double Blind Period|Adverse Event|0|||
94214507|NCT00813709|322580065|FG005|Double Blind Period|Adverse Event|0|||
94214508|NCT00813709|322580060|FG000|Double Blind Period|Lost to Follow-up|3|||
94214509|NCT00813709|322580061|FG001|Double Blind Period|Lost to Follow-up|2|||
94214510|NCT00813709|322580062|FG002|Double Blind Period|Lost to Follow-up|2|||
94214511|NCT00813709|322580063|FG003|Double Blind Period|Lost to Follow-up|0|||
94214512|NCT00813709|322580064|FG004|Double Blind Period|Lost to Follow-up|0|||
94285948|NCT01543087|322835433|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
94214513|NCT00813709|322580065|FG005|Double Blind Period|Lost to Follow-up|0|||
94214514|NCT00813709|322580060|FG000|Double Blind Period|Switched to open label phase|9|||
94214515|NCT00813709|322580061|FG001|Double Blind Period|Switched to open label phase|26|||
94330894|NCT01522443|322991751|FG001|Overall Study|Other|3|||
94285949|NCT01543087|322835434|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
94285950|NCT01543087|322835435|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
94285951|NCT01543087|322835436|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
94285952|NCT01543087|322835437|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
94285953|NCT01543087|322835432|FG000|Stage 1 (48 Months)|Other than specified|5|||
94285954|NCT01543087|322835433|FG001|Stage 1 (48 Months)|Other than specified|0|||
94285955|NCT01543087|322835434|FG002|Stage 1 (48 Months)|Other than specified|9|||
94467823|NCT04908475|323502420|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
94467824|NCT04908475|323502421|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
94467825|NCT04908475|323502422|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
94467826|NCT04908475|323502423|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
94467827|NCT04908475|323502424|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
94285956|NCT01543087|322835435|FG003|Stage 1 (48 Months)|Other than specified|0|||
94285957|NCT01543087|322835436|FG004|Stage 1 (48 Months)|Other than specified|0|||
94285958|NCT01543087|322835437|FG005|Stage 1 (48 Months)|Other than specified|0|||
94285959|NCT01543087|322835432|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
94285960|NCT01543087|322835433|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
94285961|NCT01543087|322835434|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
94285962|NCT01543087|322835435|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
94285963|NCT01543087|322835436|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
94285964|NCT01543087|322835437|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
94285965|NCT01543087|322835432|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
94285966|NCT01543087|322835433|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
94285967|NCT01543087|322835434|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
94285968|NCT01543087|322835435|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
94285969|NCT01543087|322835436|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
94285970|NCT01543087|322835437|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
94285971|NCT01543087|322835432|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
94285972|NCT01543087|322835433|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
94285973|NCT01543087|322835434|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
94285974|NCT01543087|322835435|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
94285975|NCT01543087|322835436|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
94285976|NCT01543087|322835437|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
94285977|NCT00379795|322835438|FG000|Overall Study|Death|31|||
94285978|NCT00379795|322835439|FG001|Overall Study|Death|8|||
94285979|NCT00379795|322835440|FG002|Overall Study|Death|6|||
94285980|NCT00379795|322835441|FG003|Overall Study|Death|4|||
94285981|NCT00379795|322835442|FG004|Overall Study|Death|7|||
94285982|NCT00379795|322835438|FG000|Overall Study|Adverse Event|17|||
94285983|NCT00379795|322835439|FG001|Overall Study|Adverse Event|3|||
94285984|NCT00379795|322835440|FG002|Overall Study|Adverse Event|3|||
94285985|NCT00379795|322835441|FG003|Overall Study|Adverse Event|1|||
94285986|NCT00379795|322835442|FG004|Overall Study|Adverse Event|4|||
94285987|NCT00379795|322835438|FG000|Overall Study|Lost to Follow-up|8|||
94285988|NCT00379795|322835439|FG001|Overall Study|Lost to Follow-up|1|||
94285989|NCT00379795|322835440|FG002|Overall Study|Lost to Follow-up|2|||
94285990|NCT00379795|322835441|FG003|Overall Study|Lost to Follow-up|1|||
94285991|NCT00379795|322835442|FG004|Overall Study|Lost to Follow-up|4|||
94285992|NCT00379795|322835438|FG000|Overall Study|Physician Decision|25|||
94285993|NCT00379795|322835439|FG001|Overall Study|Physician Decision|0|||
94285994|NCT00379795|322835440|FG002|Overall Study|Physician Decision|2|||
94285995|NCT00379795|322835441|FG003|Overall Study|Physician Decision|2|||
94285996|NCT00379795|322835442|FG004|Overall Study|Physician Decision|2|||
94285997|NCT00379795|322835438|FG000|Overall Study|Withdrawal by Subject|94|||
94285998|NCT00379795|322835439|FG001|Overall Study|Withdrawal by Subject|11|||
94285999|NCT00379795|322835440|FG002|Overall Study|Withdrawal by Subject|19|||
94286000|NCT00379795|322835441|FG003|Overall Study|Withdrawal by Subject|7|||
94286001|NCT00379795|322835442|FG004|Overall Study|Withdrawal by Subject|14|||
94286002|NCT00379795|322835438|FG000|Overall Study|Subject non-compliance|7|||
94286003|NCT00379795|322835439|FG001|Overall Study|Subject non-compliance|2|||
94286004|NCT00379795|322835440|FG002|Overall Study|Subject non-compliance|0|||
94286005|NCT00379795|322835441|FG003|Overall Study|Subject non-compliance|0|||
94286006|NCT00379795|322835442|FG004|Overall Study|Subject non-compliance|1|||
94286007|NCT00379795|322835438|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
94286008|NCT00379795|322835439|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
94286009|NCT00379795|322835440|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
94286010|NCT00379795|322835441|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
94286011|NCT00379795|322835442|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
94286012|NCT00379795|322835438|FG000|Overall Study|Subjects condition mandated intervention|34|||
94286013|NCT00379795|322835439|FG001|Overall Study|Subjects condition mandated intervention|9|||
94286014|NCT00379795|322835440|FG002|Overall Study|Subjects condition mandated intervention|7|||
94286015|NCT00379795|322835441|FG003|Overall Study|Subjects condition mandated intervention|5|||
94286016|NCT00379795|322835442|FG004|Overall Study|Subjects condition mandated intervention|7|||
94286017|NCT00379795|322835438|FG000|Overall Study|Sponsor's decision|257|||
94286018|NCT00379795|322835439|FG001|Overall Study|Sponsor's decision|17|||
94286019|NCT00379795|322835440|FG002|Overall Study|Sponsor's decision|54|||
94286020|NCT00379795|322835441|FG003|Overall Study|Sponsor's decision|47|||
94286021|NCT00379795|322835442|FG004|Overall Study|Sponsor's decision|10|||
94286022|NCT02979431|322835443|FG000|Overall Study|Parent/guardian withdrew consent|2|||
94286023|NCT02979431|322835444|FG001|Overall Study|Parent/guardian withdrew consent|1|||
94286024|NCT02979431|322835445|FG002|Overall Study|Parent/guardian withdrew consent|1|||
94286025|NCT02979431|322835446|FG003|Overall Study|Parent/guardian withdrew consent|1|||
94286026|NCT02979431|322835443|FG000|Overall Study|Randomized but received no study drug|1|||
94286027|NCT02979431|322835444|FG001|Overall Study|Randomized but received no study drug|1|||
94286028|NCT02979431|322835445|FG002|Overall Study|Randomized but received no study drug|0|||
94286029|NCT02979431|322835446|FG003|Overall Study|Randomized but received no study drug|0|||
94286030|NCT02979431|322835443|FG000|Overall Study|Adverse Event|0|||
94286031|NCT02979431|322835444|FG001|Overall Study|Adverse Event|0|||
94286032|NCT02979431|322835445|FG002|Overall Study|Adverse Event|1|||
94286033|NCT02979431|322835446|FG003|Overall Study|Adverse Event|0|||
94286034|NCT02979431|322835443|FG000|Overall Study|Subject left country after Day14|1|||
94286035|NCT02979431|322835444|FG001|Overall Study|Subject left country after Day14|0|||
94286036|NCT02979431|322835445|FG002|Overall Study|Subject left country after Day14|0|||
94286037|NCT02979431|322835446|FG003|Overall Study|Subject left country after Day14|0|||
94286038|NCT02026063|322835447|FG000|Overall Study|Physician Decision|0|||
94286039|NCT02026063|322835448|FG001|Overall Study|Physician Decision|10|||
94286040|NCT02026063|322835447|FG000|Overall Study|Noncompliance with Study Drug|1|||
94286041|NCT02026063|322835448|FG001|Overall Study|Noncompliance with Study Drug|1|||
94286042|NCT02026063|322835447|FG000|Overall Study|Withdrawal of Consent|1|||
94286043|NCT02026063|322835448|FG001|Overall Study|Withdrawal of Consent|6|||
94467828|NCT04908475|323502419|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
94286044|NCT02026063|322835447|FG000|Overall Study|Adverse Event|5|||
94286045|NCT02026063|322835448|FG001|Overall Study|Adverse Event|20|||
94286046|NCT02026063|322835447|FG000|Overall Study|Lack of Efficacy|0|||
94214516|NCT00813709|322580062|FG002|Double Blind Period|Switched to open label phase|18|||
94214517|NCT00813709|322580063|FG003|Double Blind Period|Switched to open label phase|0|||
94214518|NCT00813709|322580064|FG004|Double Blind Period|Switched to open label phase|0|||
94214519|NCT00813709|322580065|FG005|Double Blind Period|Switched to open label phase|0|||
94214520|NCT00813709|322580060|FG000|Double Blind Period|Randomized but not treated|1|||
94214521|NCT00813709|322580061|FG001|Double Blind Period|Randomized but not treated|3|||
94214522|NCT00813709|322580062|FG002|Double Blind Period|Randomized but not treated|1|||
94214523|NCT00813709|322580063|FG003|Double Blind Period|Randomized but not treated|0|||
94214524|NCT00813709|322580064|FG004|Double Blind Period|Randomized but not treated|0|||
94214525|NCT00813709|322580065|FG005|Double Blind Period|Randomized but not treated|0|||
94214526|NCT00813709|322580060|FG000|Double Blind Period|Other|14|||
94214527|NCT00813709|322580061|FG001|Double Blind Period|Other|9|||
94214528|NCT00813709|322580062|FG002|Double Blind Period|Other|6|||
94214529|NCT00813709|322580063|FG003|Double Blind Period|Other|0|||
94214530|NCT00813709|322580064|FG004|Double Blind Period|Other|0|||
94214531|NCT00813709|322580065|FG005|Double Blind Period|Other|0|||
94214532|NCT00813709|322580060|FG000|Open Label Period|Adverse Event|0|||
94214533|NCT00813709|322580061|FG001|Open Label Period|Adverse Event|0|||
94214534|NCT00813709|322580062|FG002|Open Label Period|Adverse Event|0|||
94214535|NCT00813709|322580063|FG003|Open Label Period|Adverse Event|5|||
94214536|NCT00813709|322580064|FG004|Open Label Period|Adverse Event|4|||
94214537|NCT00813709|322580065|FG005|Open Label Period|Adverse Event|3|||
94214538|NCT00813709|322580060|FG000|Open Label Period|Lack of Efficacy|0|||
94214539|NCT00813709|322580061|FG001|Open Label Period|Lack of Efficacy|0|||
94214540|NCT00813709|322580062|FG002|Open Label Period|Lack of Efficacy|0|||
94214541|NCT00813709|322580063|FG003|Open Label Period|Lack of Efficacy|3|||
94214542|NCT00813709|322580064|FG004|Open Label Period|Lack of Efficacy|1|||
94214543|NCT00813709|322580065|FG005|Open Label Period|Lack of Efficacy|1|||
94214544|NCT00813709|322580060|FG000|Open Label Period|Randomized but not treated|0|||
94214545|NCT00813709|322580061|FG001|Open Label Period|Randomized but not treated|0|||
94214546|NCT00813709|322580062|FG002|Open Label Period|Randomized but not treated|0|||
94214547|NCT00813709|322580063|FG003|Open Label Period|Randomized but not treated|1|||
94214548|NCT00813709|322580064|FG004|Open Label Period|Randomized but not treated|0|||
94214549|NCT00813709|322580065|FG005|Open Label Period|Randomized but not treated|1|||
94214550|NCT00813709|322580060|FG000|Open Label Period|Other|0|||
94214551|NCT00813709|322580061|FG001|Open Label Period|Other|0|||
94214552|NCT00813709|322580062|FG002|Open Label Period|Other|0|||
94214553|NCT00813709|322580063|FG003|Open Label Period|Other|11|||
94214554|NCT00813709|322580064|FG004|Open Label Period|Other|5|||
94214555|NCT00813709|322580065|FG005|Open Label Period|Other|6|||
94214556|NCT03128099|322580071|FG000|Overall Study|High dose task was too long|0|||
94214557|NCT03128099|322580072|FG001|Overall Study|High dose task was too long|4|||
94214558|NCT03128099|322580073|FG002|Overall Study|High dose task was too long|0|||
94214559|NCT03128099|322580071|FG000|Overall Study|Participant got a full time job.|1|||
94214560|NCT03128099|322580072|FG001|Overall Study|Participant got a full time job.|0|||
94214561|NCT03128099|322580073|FG002|Overall Study|Participant got a full time job.|0|||
94214562|NCT03128099|322580071|FG000|Overall Study|Became homeless and lost contact|1|||
94214563|NCT03128099|322580072|FG001|Overall Study|Became homeless and lost contact|0|||
94214564|NCT03128099|322580073|FG002|Overall Study|Became homeless and lost contact|0|||
94214565|NCT03128099|322580071|FG000|Overall Study|Did not complete all the assessments|0|||
94467829|NCT04908475|323502420|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
94467830|NCT04908475|323502421|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
94214566|NCT03128099|322580072|FG001|Overall Study|Did not complete all the assessments|0|||
94214567|NCT03128099|322580073|FG002|Overall Study|Did not complete all the assessments|1|||
94214568|NCT01137682|322580075|FG000|Overall Study|Adverse Event-CORE|2|||
94214569|NCT01137682|322580076|FG001|Overall Study|Adverse Event-CORE|4|||
94214570|NCT01137682|322580077|FG002|Overall Study|Adverse Event-CORE|0|||
94214571|NCT01137682|322580075|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
94214572|NCT01137682|322580076|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
94214573|NCT01137682|322580077|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
94467831|NCT04908475|323502422|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
94467832|NCT04908475|323502423|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
94214574|NCT01137682|322580075|FG000|Overall Study|Administrative problems-CORE|2|||
94214575|NCT01137682|322580076|FG001|Overall Study|Administrative problems-CORE|1|||
94214576|NCT01137682|322580077|FG002|Overall Study|Administrative problems-CORE|0|||
94214577|NCT01137682|322580075|FG000|Overall Study|Protocol Violation-CORE|0|||
94214578|NCT01137682|322580076|FG001|Overall Study|Protocol Violation-CORE|1|||
94214579|NCT01137682|322580077|FG002|Overall Study|Protocol Violation-CORE|1|||
94214580|NCT01137682|322580075|FG000|Overall Study|Adverse Event-Extension|4|||
94214581|NCT01137682|322580076|FG001|Overall Study|Adverse Event-Extension|8|||
94214582|NCT01137682|322580077|FG002|Overall Study|Adverse Event-Extension|7|||
94214583|NCT01137682|322580075|FG000|Overall Study|Lack of Efficacy-Extension|15|||
94214584|NCT01137682|322580076|FG001|Overall Study|Lack of Efficacy-Extension|9|||
94214585|NCT01137682|322580077|FG002|Overall Study|Lack of Efficacy-Extension|13|||
94214586|NCT01137682|322580075|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
94214587|NCT01137682|322580076|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
94214588|NCT01137682|322580077|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
94214589|NCT01137682|322580075|FG000|Overall Study|Lost to Follow Up-Extension|0|||
94214590|NCT01137682|322580076|FG001|Overall Study|Lost to Follow Up-Extension|1|||
94214591|NCT01137682|322580077|FG002|Overall Study|Lost to Follow Up-Extension|0|||
94214592|NCT01137682|322580075|FG000|Overall Study|Administrative problems-Extension|0|||
94214593|NCT01137682|322580076|FG001|Overall Study|Administrative problems-Extension|2|||
94214594|NCT01137682|322580077|FG002|Overall Study|Administrative problems-Extension|0|||
94214595|NCT01137682|322580075|FG000|Overall Study|Death-Extension|2|||
94214596|NCT01137682|322580076|FG001|Overall Study|Death-Extension|0|||
94214597|NCT01137682|322580077|FG002|Overall Study|Death-Extension|0|||
94214598|NCT01137682|322580075|FG000|Overall Study|Protocol Violation-Extension|2|||
94214599|NCT01137682|322580076|FG001|Overall Study|Protocol Violation-Extension|1|||
94214600|NCT01137682|322580077|FG002|Overall Study|Protocol Violation-Extension|0|||
94214601|NCT01137682|322580075|FG000|Overall Study|Did not enter extension|2|||
94214602|NCT01137682|322580076|FG001|Overall Study|Did not enter extension|3|||
94214603|NCT01137682|322580077|FG002|Overall Study|Did not enter extension|2|||
94214604|NCT01137682|322580075|FG000|Overall Study|Did not receive treatment in extension|0|||
94214605|NCT01137682|322580076|FG001|Overall Study|Did not receive treatment in extension|0|||
94372439|NCT04130919|323150259|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
94372440|NCT04130919|323150260|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
94467833|NCT04908475|323502424|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
94286047|NCT02026063|322835448|FG001|Overall Study|Lack of Efficacy|4|||
94286048|NCT02026063|322835447|FG000|Overall Study|Lost to Follow-up|0|||
94286049|NCT02026063|322835448|FG001|Overall Study|Lost to Follow-up|1|||
94286050|NCT02026063|322835447|FG000|Overall Study|Reason not Specified|2|||
94286051|NCT02026063|322835448|FG001|Overall Study|Reason not Specified|7|||
94286052|NCT01356589|322835451|FG000|Overall Study|Enrolled, but not treated|3|||
94286053|NCT01356589|322835451|FG000|Overall Study|Dose data not recorded|2|||
94286054|NCT00803179|322835461|FG000|Overall Study|Lost to Follow-up|3|||
94467834|NCT04908475|323502419|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
94467835|NCT04908475|323502420|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
94286055|NCT01445678|322835464|FG000|Overall Study|Adverse Event|12|||
94286056|NCT01445678|322835465|FG001|Overall Study|Adverse Event|8|||
94286057|NCT01445678|322835464|FG000|Overall Study|Lack of Efficacy|0|||
94286058|NCT01445678|322835465|FG001|Overall Study|Lack of Efficacy|2|||
94286059|NCT01445678|322835464|FG000|Overall Study|Lost to Follow-up|8|||
94286060|NCT01445678|322835465|FG001|Overall Study|Lost to Follow-up|5|||
94286061|NCT01445678|322835464|FG000|Overall Study|Protocol Violation|1|||
94372441|NCT04130919|323150261|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
94286062|NCT01445678|322835465|FG001|Overall Study|Protocol Violation|1|||
94286063|NCT01445678|322835464|FG000|Overall Study|Withdrawal by Subject|9|||
94286064|NCT01445678|322835465|FG001|Overall Study|Withdrawal by Subject|5|||
94286065|NCT02307370|322835468|FG000|Overall Study|Death|5|||
94214606|NCT01137682|322580077|FG002|Overall Study|Did not receive treatment in extension|1|||
94214607|NCT02449902|322580078|FG000|Overall Study|Adverse Event|0|||
94214608|NCT02449902|322580079|FG001|Overall Study|Adverse Event|1|||
94214609|NCT02449902|322580078|FG000|Overall Study|Withdrawal by Subject|0|||
94214610|NCT02449902|322580079|FG001|Overall Study|Withdrawal by Subject|1|||
94214611|NCT03875729|322580082|FG000|Overall Study|Adverse Event|0|||
94214612|NCT03875729|322580083|FG001|Overall Study|Adverse Event|5|||
94214613|NCT03875729|322580082|FG000|Overall Study|Withdrawal by Subject|8|||
94214614|NCT03875729|322580083|FG001|Overall Study|Withdrawal by Subject|11|||
94214615|NCT03875729|322580082|FG000|Overall Study|Pregnancy|0|||
94214616|NCT03875729|322580083|FG001|Overall Study|Pregnancy|1|||
94214617|NCT03875729|322580082|FG000|Overall Study|Lost to Follow-up|0|||
94214618|NCT03875729|322580083|FG001|Overall Study|Lost to Follow-up|5|||
94214619|NCT03875729|322580082|FG000|Overall Study|Personal reasons|2|||
94214620|NCT03875729|322580083|FG001|Overall Study|Personal reasons|0|||
94286066|NCT02307370|322835468|FG000|Overall Study|Lost to Follow-up|1|||
94286067|NCT02307370|322835468|FG000|Overall Study|Withdrawal by Subject|1|||
94286068|NCT02307370|322835468|FG000|Overall Study|Declined Addendum ICF|6|||
94286069|NCT02307370|322835468|FG000|Overall Study|No response during telephone contact|5|||
94286070|NCT02307370|322835468|FG000|Overall Study|Protocol Violation|1|||
94286071|NCT03631706|322835471|FG000|Overall Study|Randomized, not treated|1|||
94286072|NCT03631706|322835472|FG001|Overall Study|Randomized, not treated|0|||
94286073|NCT01227902|322837377|FG000|Overall Study|Adverse Event|12|||
94286074|NCT01227902|322837378|FG001|Overall Study|Adverse Event|8|||
94286075|NCT01227902|322837379|FG002|Overall Study|Adverse Event|11|||
94286076|NCT01227902|322837380|FG003|Overall Study|Adverse Event|4|||
94286077|NCT01227902|322837377|FG000|Overall Study|Lack of Efficacy|1|||
94286078|NCT01227902|322837378|FG001|Overall Study|Lack of Efficacy|2|||
94286079|NCT01227902|322837379|FG002|Overall Study|Lack of Efficacy|2|||
94286080|NCT01227902|322837380|FG003|Overall Study|Lack of Efficacy|1|||
94286081|NCT01227902|322837377|FG000|Overall Study|Protocol Violation|1|||
94286082|NCT01227902|322837378|FG001|Overall Study|Protocol Violation|0|||
94286083|NCT01227902|322837379|FG002|Overall Study|Protocol Violation|0|||
94286084|NCT01227902|322837380|FG003|Overall Study|Protocol Violation|0|||
94286085|NCT01227902|322837377|FG000|Overall Study|Lost to Follow-up|0|||
94286086|NCT01227902|322837378|FG001|Overall Study|Lost to Follow-up|0|||
94286087|NCT01227902|322837379|FG002|Overall Study|Lost to Follow-up|1|||
94286088|NCT01227902|322837380|FG003|Overall Study|Lost to Follow-up|2|||
94286089|NCT01227902|322837377|FG000|Overall Study|Physician Decision|0|||
94286090|NCT01227902|322837378|FG001|Overall Study|Physician Decision|1|||
94286091|NCT01227902|322837379|FG002|Overall Study|Physician Decision|1|||
94286092|NCT01227902|322837380|FG003|Overall Study|Physician Decision|0|||
94286093|NCT01227902|322837377|FG000|Overall Study|Withdrawal by Subject|4|||
94286094|NCT01227902|322837378|FG001|Overall Study|Withdrawal by Subject|2|||
94286095|NCT01227902|322837379|FG002|Overall Study|Withdrawal by Subject|4|||
94286096|NCT01227902|322837380|FG003|Overall Study|Withdrawal by Subject|3|||
94286097|NCT03445000|322837381|FG000|Overall Study|Disease progression|8|||
94286098|NCT03445000|322837381|FG000|Overall Study|Adverse Event|3|||
94286099|NCT03445000|322837381|FG000|Overall Study|Death|2|||
94286100|NCT03445000|322837381|FG000|Overall Study|Physician Decision|1|||
94286101|NCT02105454|322837382|FG000|Overall Study|Withdrawal by Subject|1|||
94286102|NCT02322710|322837383|FG000|Overall Study|No efficacy assessment post-baseline|0|||
94286103|NCT02322710|322837384|FG001|Overall Study|No efficacy assessment post-baseline|1|||
94286104|NCT02322710|322837383|FG000|Overall Study|Protocol Violation|20|||
94286105|NCT02322710|322837384|FG001|Overall Study|Protocol Violation|25|||
94286106|NCT03269344|322837391|FG000|Overall Study|Protocol Violation|4|||
94286107|NCT03269344|322837392|FG001|Overall Study|Protocol Violation|3|||
94286108|NCT05131204|322837393|FG000|Overall Study|Sponsor request|2|||
94286109|NCT05131204|322837394|FG001|Overall Study|Sponsor request|1|||
94286110|NCT01885000|322837395|FG000|Overall Study|Adverse Event|1|||
94286111|NCT01885000|322837396|FG001|Overall Study|Adverse Event|0|||
94286112|NCT01885000|322837395|FG000|Overall Study|Withdrawal by Subject|1|||
94286113|NCT01885000|322837396|FG001|Overall Study|Withdrawal by Subject|1|||
94286114|NCT01885000|322837395|FG000|Overall Study|Protocol Violation|0|||
94286115|NCT01885000|322837396|FG001|Overall Study|Protocol Violation|1|||
94286116|NCT01396005|322837397|FG000|Overall Study|Withdrawal by Subject|0|||
94286117|NCT01396005|322837398|FG001|Overall Study|Withdrawal by Subject|1|||
94286118|NCT01396005|322837397|FG000|Overall Study|Non-compliance with protocol|0|||
94286119|NCT01396005|322837398|FG001|Overall Study|Non-compliance with protocol|1|||
94286120|NCT03555266|322837401|FG000|Overall Study|Protocol Violation|6|||
94286121|NCT03555266|322837402|FG001|Overall Study|Protocol Violation|4|||
94286122|NCT02614079|322837403|FG000|Overall Study|Withdrawal by Subject|1|||
94286123|NCT00756938|322837406|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
94286124|NCT00756938|322837407|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
94286125|NCT00756938|322837408|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
94286126|NCT00756938|322837409|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
94286127|NCT00756938|322837406|FG000|12-week Base Study|Protocol Violation|0|||
94286128|NCT00756938|322837407|FG001|12-week Base Study|Protocol Violation|0|||
94286129|NCT00756938|322837408|FG002|12-week Base Study|Protocol Violation|1|||
94286130|NCT00756938|322837409|FG003|12-week Base Study|Protocol Violation|0|||
94286131|NCT00756938|322837406|FG000|12-week Base Study|Lost to Follow-up|1|||
94286132|NCT00756938|322837407|FG001|12-week Base Study|Lost to Follow-up|0|||
94286133|NCT00756938|322837408|FG002|12-week Base Study|Lost to Follow-up|0|||
94286134|NCT00756938|322837409|FG003|12-week Base Study|Lost to Follow-up|0|||
94286135|NCT00756938|322837406|FG000|Optional Extension|Lack of Efficacy|0|||
94286136|NCT00756938|322837407|FG001|Optional Extension|Lack of Efficacy|0|||
94286137|NCT00756938|322837408|FG002|Optional Extension|Lack of Efficacy|0|||
94286138|NCT00756938|322837409|FG003|Optional Extension|Lack of Efficacy|1|||
94286139|NCT00756938|322837406|FG000|Optional Extension|End of Study|0|||
94286140|NCT00756938|322837407|FG001|Optional Extension|End of Study|0|||
94286141|NCT00756938|322837408|FG002|Optional Extension|End of Study|0|||
94286142|NCT00756938|322837409|FG003|Optional Extension|End of Study|11|||
94286143|NCT00756938|322837406|FG000|Optional Extension|Protocol-specific criteria met|0|||
94286144|NCT00756938|322837407|FG001|Optional Extension|Protocol-specific criteria met|0|||
94286145|NCT00756938|322837408|FG002|Optional Extension|Protocol-specific criteria met|0|||
94286146|NCT00756938|322837409|FG003|Optional Extension|Protocol-specific criteria met|9|||
94286147|NCT00756938|322837406|FG000|Optional Extension|Physician Decision|0|||
94286148|NCT00756938|322837407|FG001|Optional Extension|Physician Decision|0|||
94286149|NCT00756938|322837408|FG002|Optional Extension|Physician Decision|0|||
94286150|NCT00756938|322837409|FG003|Optional Extension|Physician Decision|3|||
94286151|NCT00756938|322837406|FG000|Optional Extension|Lost to Follow-up|0|||
94286152|NCT00756938|322837407|FG001|Optional Extension|Lost to Follow-up|0|||
94286153|NCT00756938|322837408|FG002|Optional Extension|Lost to Follow-up|0|||
94286154|NCT00756938|322837409|FG003|Optional Extension|Lost to Follow-up|1|||
94286155|NCT00756938|322837406|FG000|Optional Extension|Protocol Violation|0|||
94286156|NCT00756938|322837407|FG001|Optional Extension|Protocol Violation|0|||
94286157|NCT00756938|322837408|FG002|Optional Extension|Protocol Violation|0|||
94286158|NCT00756938|322837409|FG003|Optional Extension|Protocol Violation|1|||
94286159|NCT00756938|322837406|FG000|Optional Extension|Withdrawal by Subject|0|||
94286160|NCT00756938|322837407|FG001|Optional Extension|Withdrawal by Subject|0|||
94286161|NCT00756938|322837408|FG002|Optional Extension|Withdrawal by Subject|0|||
94286162|NCT00756938|322837409|FG003|Optional Extension|Withdrawal by Subject|10|||
94286163|NCT00756938|322837406|FG000|Optional Extension|Adverse Event|0|||
94286164|NCT00756938|322837407|FG001|Optional Extension|Adverse Event|0|||
94286165|NCT00756938|322837408|FG002|Optional Extension|Adverse Event|0|||
94286166|NCT00756938|322837409|FG003|Optional Extension|Adverse Event|1|||
94286167|NCT04823949|322837410|FG000|Overall Study|Withdrawal by Subject|0|||
94286168|NCT04823949|322837411|FG001|Overall Study|Withdrawal by Subject|4|||
94286169|NCT04823949|322837410|FG000|Overall Study|Physician Decision|0|||
94214621|NCT00476957|322580087|FG000|Overall Study|Lost to Follow-up|176|||
94214622|NCT00476957|322580088|FG001|Overall Study|Lost to Follow-up|193|||
94214623|NCT02516202|322580089|FG000|Overall Study|Withdrawal by Subject|1|||
94214624|NCT02516202|322580090|FG001|Overall Study|Withdrawal by Subject|0|||
94214625|NCT02516202|322580091|FG002|Overall Study|Withdrawal by Subject|1|||
94214626|NCT02516202|322580089|FG000|Overall Study|Lost to Follow-up|1|||
94214627|NCT02516202|322580090|FG001|Overall Study|Lost to Follow-up|1|||
94214628|NCT02516202|322580091|FG002|Overall Study|Lost to Follow-up|1|||
94214629|NCT02516202|322580089|FG000|Overall Study|Stopped Follow-up|0|||
94214630|NCT02516202|322580090|FG001|Overall Study|Stopped Follow-up|0|||
94214631|NCT02516202|322580091|FG002|Overall Study|Stopped Follow-up|1|||
94214632|NCT00103857|322580102|FG000|54-Week Base Study|Adverse Event|12|||
94214633|NCT00103857|322580103|FG001|54-Week Base Study|Adverse Event|9|||
94214634|NCT00103857|322580104|FG002|54-Week Base Study|Adverse Event|11|||
94214635|NCT00103857|322580105|FG003|54-Week Base Study|Adverse Event|6|||
94214636|NCT00103857|322580106|FG004|54-Week Base Study|Adverse Event|5|||
94214637|NCT00103857|322580107|FG005|54-Week Base Study|Adverse Event|11|||
94214638|NCT00103857|322580108|FG006|54-Week Base Study|Adverse Event|3|||
94214639|NCT00103857|322580102|FG000|54-Week Base Study|Death|0|||
94214640|NCT00103857|322580103|FG001|54-Week Base Study|Death|0|||
94214641|NCT00103857|322580104|FG002|54-Week Base Study|Death|0|||
94214642|NCT00103857|322580105|FG003|54-Week Base Study|Death|0|||
94214643|NCT00103857|322580106|FG004|54-Week Base Study|Death|1|||
94214644|NCT00103857|322580107|FG005|54-Week Base Study|Death|1|||
94214645|NCT00103857|322580108|FG006|54-Week Base Study|Death|0|||
94214646|NCT00103857|322580102|FG000|54-Week Base Study|Lack of Efficacy|11|||
94214647|NCT00103857|322580103|FG001|54-Week Base Study|Lack of Efficacy|14|||
94214648|NCT00103857|322580104|FG002|54-Week Base Study|Lack of Efficacy|8|||
94214649|NCT00103857|322580105|FG003|54-Week Base Study|Lack of Efficacy|4|||
94214650|NCT00103857|322580106|FG004|54-Week Base Study|Lack of Efficacy|3|||
94214651|NCT00103857|322580107|FG005|54-Week Base Study|Lack of Efficacy|14|||
94214652|NCT00103857|322580108|FG006|54-Week Base Study|Lack of Efficacy|19|||
94372442|NCT04130919|323150262|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
94214653|NCT00103857|322580102|FG000|54-Week Base Study|Lost to Follow-up|5|||
94467836|NCT04908475|323502421|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
94467837|NCT04908475|323502422|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
94467838|NCT04908475|323502423|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
94214654|NCT00103857|322580103|FG001|54-Week Base Study|Lost to Follow-up|4|||
94467839|NCT04908475|323502424|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
94467840|NCT04908475|323502419|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
94214655|NCT00103857|322580104|FG002|54-Week Base Study|Lost to Follow-up|7|||
94214656|NCT00103857|322580105|FG003|54-Week Base Study|Lost to Follow-up|5|||
94214657|NCT00103857|322580106|FG004|54-Week Base Study|Lost to Follow-up|10|||
94214658|NCT00103857|322580107|FG005|54-Week Base Study|Lost to Follow-up|9|||
94214659|NCT00103857|322580108|FG006|54-Week Base Study|Lost to Follow-up|3|||
94214660|NCT00103857|322580102|FG000|54-Week Base Study|Physician Decision|1|||
94214661|NCT00103857|322580103|FG001|54-Week Base Study|Physician Decision|1|||
94214662|NCT00103857|322580104|FG002|54-Week Base Study|Physician Decision|0|||
94214663|NCT00103857|322580105|FG003|54-Week Base Study|Physician Decision|0|||
94214664|NCT00103857|322580106|FG004|54-Week Base Study|Physician Decision|1|||
94214665|NCT00103857|322580107|FG005|54-Week Base Study|Physician Decision|0|||
94214666|NCT00103857|322580108|FG006|54-Week Base Study|Physician Decision|0|||
94214667|NCT00103857|322580102|FG000|54-Week Base Study|Pregnancy|1|||
94214668|NCT00103857|322580103|FG001|54-Week Base Study|Pregnancy|0|||
94214669|NCT00103857|322580104|FG002|54-Week Base Study|Pregnancy|0|||
94214670|NCT00103857|322580105|FG003|54-Week Base Study|Pregnancy|0|||
94214671|NCT00103857|322580106|FG004|54-Week Base Study|Pregnancy|1|||
94214672|NCT00103857|322580107|FG005|54-Week Base Study|Pregnancy|0|||
94467841|NCT04908475|323502420|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
94467842|NCT04908475|323502421|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
94467843|NCT04908475|323502422|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
94467844|NCT04908475|323502423|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
94467845|NCT04908475|323502424|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
94467846|NCT01739764|323502425|FG000|Overall Study|Adverse Event|0|||
94467847|NCT01739764|323502426|FG001|Overall Study|Adverse Event|3|||
94467848|NCT01739764|323502427|FG002|Overall Study|Adverse Event|4|||
94467849|NCT01739764|323502425|FG000|Overall Study|Death|4|||
94467850|NCT01739764|323502426|FG001|Overall Study|Death|6|||
94214673|NCT00103857|322580108|FG006|54-Week Base Study|Pregnancy|1|||
94214674|NCT00103857|322580102|FG000|54-Week Base Study|Protocol Violation|6|||
94214675|NCT00103857|322580103|FG001|54-Week Base Study|Protocol Violation|4|||
94214676|NCT00103857|322580104|FG002|54-Week Base Study|Protocol Violation|2|||
94214677|NCT00103857|322580105|FG003|54-Week Base Study|Protocol Violation|4|||
94214678|NCT00103857|322580106|FG004|54-Week Base Study|Protocol Violation|0|||
94214679|NCT00103857|322580107|FG005|54-Week Base Study|Protocol Violation|3|||
94214680|NCT00103857|322580108|FG006|54-Week Base Study|Protocol Violation|3|||
94214681|NCT00103857|322580102|FG000|54-Week Base Study|Withdrawal by Subject|17|||
94214682|NCT00103857|322580103|FG001|54-Week Base Study|Withdrawal by Subject|16|||
94214683|NCT00103857|322580104|FG002|54-Week Base Study|Withdrawal by Subject|16|||
94214684|NCT00103857|322580105|FG003|54-Week Base Study|Withdrawal by Subject|15|||
94214685|NCT00103857|322580106|FG004|54-Week Base Study|Withdrawal by Subject|10|||
94214686|NCT00103857|322580107|FG005|54-Week Base Study|Withdrawal by Subject|15|||
94214687|NCT00103857|322580108|FG006|54-Week Base Study|Withdrawal by Subject|4|||
94214688|NCT00103857|322580102|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
94214689|NCT00103857|322580103|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
94214690|NCT00103857|322580104|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
94214691|NCT00103857|322580105|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
94214692|NCT00103857|322580106|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
94214693|NCT00103857|322580107|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
94214694|NCT00103857|322580108|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
94214695|NCT00103857|322580102|FG000|54-Week Base Study|patient moved|0|||
94214696|NCT00103857|322580103|FG001|54-Week Base Study|patient moved|1|||
94214697|NCT00103857|322580104|FG002|54-Week Base Study|patient moved|1|||
94214698|NCT00103857|322580105|FG003|54-Week Base Study|patient moved|2|||
94214699|NCT00103857|322580106|FG004|54-Week Base Study|patient moved|3|||
94214700|NCT00103857|322580107|FG005|54-Week Base Study|patient moved|1|||
94214701|NCT00103857|322580108|FG006|54-Week Base Study|patient moved|0|||
94214702|NCT00103857|322580102|FG000|54-Week Base Study|non-compliance with study procedures|1|||
94214703|NCT00103857|322580103|FG001|54-Week Base Study|non-compliance with study procedures|2|||
94214704|NCT00103857|322580104|FG002|54-Week Base Study|non-compliance with study procedures|0|||
94214705|NCT00103857|322580105|FG003|54-Week Base Study|non-compliance with study procedures|0|||
94214706|NCT00103857|322580106|FG004|54-Week Base Study|non-compliance with study procedures|0|||
94214707|NCT00103857|322580107|FG005|54-Week Base Study|non-compliance with study procedures|2|||
94214708|NCT00103857|322580108|FG006|54-Week Base Study|non-compliance with study procedures|0|||
94214709|NCT00103857|322580102|FG000|54-Week Base Study|patient incarcerated|0|||
94214710|NCT00103857|322580103|FG001|54-Week Base Study|patient incarcerated|0|||
94214711|NCT00103857|322580104|FG002|54-Week Base Study|patient incarcerated|0|||
94214712|NCT00103857|322580105|FG003|54-Week Base Study|patient incarcerated|0|||
94214713|NCT00103857|322580106|FG004|54-Week Base Study|patient incarcerated|1|||
94214714|NCT00103857|322580107|FG005|54-Week Base Study|patient incarcerated|1|||
94214715|NCT00103857|322580108|FG006|54-Week Base Study|patient incarcerated|0|||
94214716|NCT00103857|322580102|FG000|54-Week Base Study|laboratory reporting error|0|||
94286170|NCT04823949|322837411|FG001|Overall Study|Physician Decision|1|||
94467851|NCT01739764|323502427|FG002|Overall Study|Death|38|||
94286171|NCT02347176|322837414|FG000|Overall Study|Lost to Follow-up|2|||
94214717|NCT00103857|322580103|FG001|54-Week Base Study|laboratory reporting error|0|||
94286172|NCT02347176|322837415|FG001|Overall Study|Lost to Follow-up|3|||
94286173|NCT02347176|322837416|FG002|Overall Study|Lost to Follow-up|1|||
94286174|NCT02347176|322837417|FG003|Overall Study|Lost to Follow-up|1|||
94286175|NCT02347176|322837414|FG000|Overall Study|Withdrawal by Subject|9|||
94286176|NCT02347176|322837415|FG001|Overall Study|Withdrawal by Subject|5|||
94286177|NCT02347176|322837416|FG002|Overall Study|Withdrawal by Subject|5|||
94286178|NCT02347176|322837417|FG003|Overall Study|Withdrawal by Subject|3|||
94286179|NCT02347176|322837414|FG000|Overall Study|Other|1|||
94286180|NCT02347176|322837415|FG001|Overall Study|Other|2|||
94286181|NCT02347176|322837416|FG002|Overall Study|Other|2|||
94286182|NCT02347176|322837417|FG003|Overall Study|Other|0|||
94286183|NCT01463098|322837422|FG000|Part A (11 Days)|Participant Choice|2|||
94286184|NCT01463098|322837423|FG001|Part A (11 Days)|Participant Choice|0|||
94286185|NCT01463098|322837424|FG002|Part A (11 Days)|Participant Choice|0|||
94286186|NCT01463098|322837425|FG003|Part A (11 Days)|Participant Choice|0|||
94286187|NCT01463098|322837426|FG004|Part A (11 Days)|Participant Choice|0|||
94286188|NCT01463098|322837427|FG005|Part A (11 Days)|Participant Choice|0|||
94286189|NCT01463098|322837428|FG006|Part A (11 Days)|Participant Choice|0|||
94286190|NCT01463098|322837429|FG007|Part A (11 Days)|Participant Choice|0|||
94286191|NCT01463098|322837430|FG008|Part A (11 Days)|Participant Choice|1|||
94286192|NCT01463098|322837431|FG009|Part A (11 Days)|Participant Choice|0|||
94286193|NCT01463098|322837432|FG010|Part A (11 Days)|Participant Choice|0|||
94286194|NCT01463098|322837433|FG011|Part A (11 Days)|Participant Choice|0|||
94286195|NCT01463098|322837434|FG012|Part A (11 Days)|Participant Choice|0|||
94286196|NCT01463098|322837435|FG013|Part A (11 Days)|Participant Choice|0|||
94286197|NCT01463098|322837422|FG000|Part A (11 Days)|Lost to Follow-up|0|||
94286198|NCT01463098|322837423|FG001|Part A (11 Days)|Lost to Follow-up|0|||
94286199|NCT01463098|322837424|FG002|Part A (11 Days)|Lost to Follow-up|0|||
94286200|NCT01463098|322837425|FG003|Part A (11 Days)|Lost to Follow-up|0|||
94286201|NCT01463098|322837426|FG004|Part A (11 Days)|Lost to Follow-up|1|||
94286202|NCT01463098|322837427|FG005|Part A (11 Days)|Lost to Follow-up|0|||
94286203|NCT01463098|322837428|FG006|Part A (11 Days)|Lost to Follow-up|0|||
94286204|NCT01463098|322837429|FG007|Part A (11 Days)|Lost to Follow-up|0|||
94286205|NCT01463098|322837430|FG008|Part A (11 Days)|Lost to Follow-up|0|||
94286206|NCT01463098|322837431|FG009|Part A (11 Days)|Lost to Follow-up|0|||
94214718|NCT00103857|322580104|FG002|54-Week Base Study|laboratory reporting error|0|||
94214719|NCT00103857|322580105|FG003|54-Week Base Study|laboratory reporting error|0|||
94214720|NCT00103857|322580106|FG004|54-Week Base Study|laboratory reporting error|1|||
94214721|NCT00103857|322580107|FG005|54-Week Base Study|laboratory reporting error|0|||
94214722|NCT00103857|322580108|FG006|54-Week Base Study|laboratory reporting error|0|||
94214723|NCT00103857|322580102|FG000|54-Week Base Study|site error|0|||
94214724|NCT00103857|322580103|FG001|54-Week Base Study|site error|0|||
94214725|NCT00103857|322580104|FG002|54-Week Base Study|site error|0|||
94214726|NCT00103857|322580105|FG003|54-Week Base Study|site error|0|||
94214727|NCT00103857|322580106|FG004|54-Week Base Study|site error|0|||
94214728|NCT00103857|322580107|FG005|54-Week Base Study|site error|1|||
94214729|NCT00103857|322580108|FG006|54-Week Base Study|site error|0|||
94214730|NCT00103857|322580102|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
94214731|NCT00103857|322580103|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
94214732|NCT00103857|322580104|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
94214733|NCT00103857|322580105|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
94214734|NCT00103857|322580106|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
94214735|NCT00103857|322580107|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
94214736|NCT00103857|322580108|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
94214737|NCT00103857|322580102|FG000|50-Week Extension Study|Adverse Event|2|||
94214738|NCT00103857|322580103|FG001|50-Week Extension Study|Adverse Event|3|||
94214739|NCT00103857|322580104|FG002|50-Week Extension Study|Adverse Event|2|||
94214740|NCT00103857|322580105|FG003|50-Week Extension Study|Adverse Event|0|||
94214741|NCT00103857|322580106|FG004|50-Week Extension Study|Adverse Event|1|||
94214742|NCT00103857|322580107|FG005|50-Week Extension Study|Adverse Event|1|||
94286207|NCT01463098|322837432|FG010|Part A (11 Days)|Lost to Follow-up|0|||
94286208|NCT01463098|322837433|FG011|Part A (11 Days)|Lost to Follow-up|0|||
94286209|NCT01463098|322837434|FG012|Part A (11 Days)|Lost to Follow-up|0|||
94286210|NCT01463098|322837435|FG013|Part A (11 Days)|Lost to Follow-up|0|||
94286211|NCT01463098|322837422|FG000|Part B (11 Days)|Participant Choice|0|||
94286212|NCT01463098|322837423|FG001|Part B (11 Days)|Participant Choice|0|||
94286213|NCT01463098|322837424|FG002|Part B (11 Days)|Participant Choice|0|||
94286214|NCT01463098|322837425|FG003|Part B (11 Days)|Participant Choice|0|||
94286215|NCT01463098|322837426|FG004|Part B (11 Days)|Participant Choice|0|||
94286216|NCT01463098|322837427|FG005|Part B (11 Days)|Participant Choice|0|||
94286217|NCT01463098|322837428|FG006|Part B (11 Days)|Participant Choice|0|||
94286218|NCT01463098|322837429|FG007|Part B (11 Days)|Participant Choice|0|||
94286219|NCT01463098|322837430|FG008|Part B (11 Days)|Participant Choice|0|||
94214743|NCT00103857|322580108|FG006|50-Week Extension Study|Adverse Event|0|||
94214744|NCT00103857|322580102|FG000|50-Week Extension Study|Death|0|||
94214745|NCT00103857|322580103|FG001|50-Week Extension Study|Death|0|||
94214746|NCT00103857|322580104|FG002|50-Week Extension Study|Death|0|||
94214747|NCT00103857|322580105|FG003|50-Week Extension Study|Death|1|||
94214748|NCT00103857|322580106|FG004|50-Week Extension Study|Death|0|||
94214749|NCT00103857|322580107|FG005|50-Week Extension Study|Death|1|||
94214750|NCT00103857|322580108|FG006|50-Week Extension Study|Death|0|||
94214751|NCT00103857|322580102|FG000|50-Week Extension Study|Lack of Efficacy|26|||
94214752|NCT00103857|322580103|FG001|50-Week Extension Study|Lack of Efficacy|15|||
94214753|NCT00103857|322580104|FG002|50-Week Extension Study|Lack of Efficacy|13|||
94214754|NCT00103857|322580105|FG003|50-Week Extension Study|Lack of Efficacy|16|||
94214755|NCT00103857|322580106|FG004|50-Week Extension Study|Lack of Efficacy|8|||
94214756|NCT00103857|322580107|FG005|50-Week Extension Study|Lack of Efficacy|8|||
94214757|NCT00103857|322580108|FG006|50-Week Extension Study|Lack of Efficacy|0|||
94214758|NCT00103857|322580102|FG000|50-Week Extension Study|Lost to Follow-up|4|||
94214759|NCT00103857|322580103|FG001|50-Week Extension Study|Lost to Follow-up|0|||
94214760|NCT00103857|322580104|FG002|50-Week Extension Study|Lost to Follow-up|1|||
94214761|NCT00103857|322580105|FG003|50-Week Extension Study|Lost to Follow-up|4|||
94214762|NCT00103857|322580106|FG004|50-Week Extension Study|Lost to Follow-up|3|||
94214763|NCT00103857|322580107|FG005|50-Week Extension Study|Lost to Follow-up|3|||
94214764|NCT00103857|322580108|FG006|50-Week Extension Study|Lost to Follow-up|0|||
94214765|NCT00103857|322580102|FG000|50-Week Extension Study|Physician Decision|0|||
94214766|NCT00103857|322580103|FG001|50-Week Extension Study|Physician Decision|1|||
94214767|NCT00103857|322580104|FG002|50-Week Extension Study|Physician Decision|1|||
94214768|NCT00103857|322580105|FG003|50-Week Extension Study|Physician Decision|0|||
94214769|NCT00103857|322580106|FG004|50-Week Extension Study|Physician Decision|0|||
94214770|NCT00103857|322580107|FG005|50-Week Extension Study|Physician Decision|0|||
94214771|NCT00103857|322580108|FG006|50-Week Extension Study|Physician Decision|0|||
94214772|NCT00103857|322580102|FG000|50-Week Extension Study|Pregnancy|0|||
94214773|NCT00103857|322580103|FG001|50-Week Extension Study|Pregnancy|0|||
94214774|NCT00103857|322580104|FG002|50-Week Extension Study|Pregnancy|1|||
94214775|NCT00103857|322580105|FG003|50-Week Extension Study|Pregnancy|0|||
94214776|NCT00103857|322580106|FG004|50-Week Extension Study|Pregnancy|1|||
94214777|NCT00103857|322580107|FG005|50-Week Extension Study|Pregnancy|0|||
94214778|NCT00103857|322580108|FG006|50-Week Extension Study|Pregnancy|0|||
94214779|NCT00103857|322580102|FG000|50-Week Extension Study|Protocol Violation|1|||
94214780|NCT00103857|322580103|FG001|50-Week Extension Study|Protocol Violation|1|||
94214781|NCT00103857|322580104|FG002|50-Week Extension Study|Protocol Violation|1|||
94214782|NCT00103857|322580105|FG003|50-Week Extension Study|Protocol Violation|2|||
94372443|NCT04130919|323150257|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
94467852|NCT01739764|323502425|FG000|Overall Study|Lost to Follow-up|0|||
94214783|NCT00103857|322580106|FG004|50-Week Extension Study|Protocol Violation|0|||
94214784|NCT00103857|322580107|FG005|50-Week Extension Study|Protocol Violation|1|||
94214785|NCT00103857|322580108|FG006|50-Week Extension Study|Protocol Violation|0|||
94214786|NCT00103857|322580102|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
94214787|NCT00103857|322580103|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
94214788|NCT00103857|322580104|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
94214789|NCT00103857|322580105|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
94214790|NCT00103857|322580106|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
94214791|NCT00103857|322580107|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
94214792|NCT00103857|322580108|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
94214793|NCT00103857|322580102|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
94214794|NCT00103857|322580103|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
94214795|NCT00103857|322580104|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
94214796|NCT00103857|322580105|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
94214797|NCT00103857|322580106|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
94286220|NCT01463098|322837431|FG009|Part B (11 Days)|Participant Choice|0|||
94214798|NCT00103857|322580107|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
94214799|NCT00103857|322580108|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
94467853|NCT01739764|323502426|FG001|Overall Study|Lost to Follow-up|0|||
94467854|NCT01739764|323502427|FG002|Overall Study|Lost to Follow-up|5|||
94467855|NCT01739764|323502425|FG000|Overall Study|Non-Compliance|0|||
94467856|NCT01739764|323502426|FG001|Overall Study|Non-Compliance|0|||
94286221|NCT01463098|322837432|FG010|Part B (11 Days)|Participant Choice|0|||
94286222|NCT01463098|322837433|FG011|Part B (11 Days)|Participant Choice|1|||
94286223|NCT01463098|322837434|FG012|Part B (11 Days)|Participant Choice|0|||
94286224|NCT01463098|322837435|FG013|Part B (11 Days)|Participant Choice|0|||
94286225|NCT04451330|322837438|FG000|Overall Study|Adverse Event|1|||
94286226|NCT04451330|322837439|FG001|Overall Study|Adverse Event|2|||
94286227|NCT04451330|322837438|FG000|Overall Study|Lost to Follow-up|5|||
94286228|NCT04451330|322837439|FG001|Overall Study|Lost to Follow-up|0|||
94286229|NCT04451330|322837438|FG000|Overall Study|Withdrawal by Subject|3|||
94286230|NCT04451330|322837439|FG001|Overall Study|Withdrawal by Subject|1|||
94286231|NCT04451330|322837438|FG000|Overall Study|Withdrawal by parent/guardian|1|||
94286232|NCT04451330|322837439|FG001|Overall Study|Withdrawal by parent/guardian|0|||
94286233|NCT04451330|322837438|FG000|Overall Study|Other than specified|0|||
94286234|NCT04451330|322837439|FG001|Overall Study|Other than specified|1|||
94286235|NCT00699907|322837440|FG000|Overall Study|Withdrawal by Subject|2|||
94286236|NCT00699907|322837441|FG001|Overall Study|Withdrawal by Subject|1|||
94286237|NCT00699907|322837442|FG002|Overall Study|Withdrawal by Subject|0|||
94286238|NCT00699907|322837440|FG000|Overall Study|No usable sample|0|||
94286239|NCT00699907|322837441|FG001|Overall Study|No usable sample|9|||
94286240|NCT00699907|322837442|FG002|Overall Study|No usable sample|8|||
94286241|NCT02462473|322837443|FG000|Overall Study|Death|1|||
94286242|NCT02462473|322837443|FG000|Overall Study|Other|3|||
94286243|NCT00661271|322837449|FG000|Overall Study|Lost to Follow-up|28|||
94286244|NCT00661271|322837450|FG001|Overall Study|Lost to Follow-up|25|||
94286245|NCT00430508|322837451|FG000|Overall Study|Adverse Event|2|||
94286246|NCT00430508|322837452|FG001|Overall Study|Adverse Event|3|||
94286247|NCT00430508|322837453|FG002|Overall Study|Adverse Event|5|||
94286248|NCT00430508|322837454|FG003|Overall Study|Adverse Event|3|||
94286249|NCT00430508|322837451|FG000|Overall Study|Withdrawal by Subject|0|||
94286250|NCT00430508|322837452|FG001|Overall Study|Withdrawal by Subject|1|||
94286251|NCT00430508|322837453|FG002|Overall Study|Withdrawal by Subject|1|||
94286252|NCT00430508|322837454|FG003|Overall Study|Withdrawal by Subject|1|||
94286253|NCT00430508|322837451|FG000|Overall Study|responder at visit 4|0|||
94286254|NCT00430508|322837452|FG001|Overall Study|responder at visit 4|0|||
94286255|NCT00430508|322837453|FG002|Overall Study|responder at visit 4|2|||
94286256|NCT00430508|322837454|FG003|Overall Study|responder at visit 4|0|||
94286257|NCT00430508|322837451|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
94286258|NCT00430508|322837452|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
94286259|NCT00430508|322837453|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
94286260|NCT00430508|322837454|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
94286261|NCT00430508|322837451|FG000|Overall Study|Other|1|||
94286262|NCT00430508|322837452|FG001|Overall Study|Other|1|||
94214800|NCT00103857|322580102|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
94214801|NCT00103857|322580103|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
94214802|NCT00103857|322580104|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
94214803|NCT00103857|322580105|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
94214804|NCT00103857|322580106|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
94214805|NCT00103857|322580107|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
94214806|NCT00103857|322580108|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
94214807|NCT00103857|322580102|FG000|50-Week Extension Study|patient moved|0|||
94214808|NCT00103857|322580103|FG001|50-Week Extension Study|patient moved|0|||
94214809|NCT00103857|322580104|FG002|50-Week Extension Study|patient moved|1|||
94214810|NCT00103857|322580105|FG003|50-Week Extension Study|patient moved|2|||
94214811|NCT00103857|322580106|FG004|50-Week Extension Study|patient moved|0|||
94214812|NCT00103857|322580107|FG005|50-Week Extension Study|patient moved|0|||
94214813|NCT00103857|322580108|FG006|50-Week Extension Study|patient moved|0|||
94214814|NCT00103857|322580102|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
94214815|NCT00103857|322580103|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
94214816|NCT00103857|322580104|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
94214817|NCT00103857|322580105|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
94214818|NCT00103857|322580106|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
94214819|NCT00103857|322580107|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
94214820|NCT00103857|322580108|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
94214821|NCT00103857|322580102|FG000|50-Week Extension Study|reason unspecified|0|||
94214822|NCT00103857|322580103|FG001|50-Week Extension Study|reason unspecified|0|||
94214823|NCT00103857|322580104|FG002|50-Week Extension Study|reason unspecified|0|||
94214824|NCT00103857|322580105|FG003|50-Week Extension Study|reason unspecified|0|||
94214825|NCT00103857|322580106|FG004|50-Week Extension Study|reason unspecified|1|||
94214826|NCT00103857|322580107|FG005|50-Week Extension Study|reason unspecified|0|||
94214827|NCT00103857|322580108|FG006|50-Week Extension Study|reason unspecified|0|||
94214828|NCT02691702|322580111|FG000|Overall Study|Adverse Event|1|||
94214829|NCT02691702|322580112|FG001|Overall Study|Adverse Event|0|||
94214830|NCT02691702|322580113|FG002|Overall Study|Adverse Event|0|||
94214831|NCT02691702|322580114|FG003|Overall Study|Adverse Event|0|||
94214832|NCT02691702|322580115|FG004|Overall Study|Adverse Event|0|||
94214833|NCT02691702|322580116|FG005|Overall Study|Adverse Event|0|||
94214834|NCT02691702|322580117|FG006|Overall Study|Adverse Event|0|||
94214835|NCT02691702|322580118|FG007|Overall Study|Adverse Event|0|||
94214836|NCT02691702|322580119|FG008|Overall Study|Adverse Event|1|||
94214837|NCT02691702|322580120|FG009|Overall Study|Adverse Event|0|||
94214838|NCT02691702|322580121|FG010|Overall Study|Adverse Event|1|||
94214839|NCT02691702|322580111|FG000|Overall Study|Lost to Follow-up|0|||
94214840|NCT02691702|322580112|FG001|Overall Study|Lost to Follow-up|0|||
94214841|NCT02691702|322580113|FG002|Overall Study|Lost to Follow-up|1|||
94286263|NCT00430508|322837453|FG002|Overall Study|Other|3|||
94214842|NCT02691702|322580114|FG003|Overall Study|Lost to Follow-up|0|||
94214843|NCT02691702|322580115|FG004|Overall Study|Lost to Follow-up|0|||
94214844|NCT02691702|322580116|FG005|Overall Study|Lost to Follow-up|2|||
94214845|NCT02691702|322580117|FG006|Overall Study|Lost to Follow-up|0|||
94214846|NCT02691702|322580118|FG007|Overall Study|Lost to Follow-up|0|||
94214847|NCT02691702|322580119|FG008|Overall Study|Lost to Follow-up|0|||
94214848|NCT02691702|322580120|FG009|Overall Study|Lost to Follow-up|0|||
94214849|NCT02691702|322580121|FG010|Overall Study|Lost to Follow-up|1|||
94214850|NCT02691702|322580111|FG000|Overall Study|Withdrawal by Subject|1|||
94214851|NCT02691702|322580112|FG001|Overall Study|Withdrawal by Subject|1|||
94214852|NCT02691702|322580113|FG002|Overall Study|Withdrawal by Subject|0|||
94214853|NCT02691702|322580114|FG003|Overall Study|Withdrawal by Subject|0|||
94214854|NCT02691702|322580115|FG004|Overall Study|Withdrawal by Subject|0|||
94214855|NCT02691702|322580116|FG005|Overall Study|Withdrawal by Subject|1|||
94214856|NCT02691702|322580117|FG006|Overall Study|Withdrawal by Subject|2|||
94214857|NCT02691702|322580118|FG007|Overall Study|Withdrawal by Subject|0|||
94214858|NCT02691702|322580119|FG008|Overall Study|Withdrawal by Subject|0|||
94214859|NCT02691702|322580120|FG009|Overall Study|Withdrawal by Subject|0|||
94214860|NCT02691702|322580121|FG010|Overall Study|Withdrawal by Subject|0|||
94286264|NCT00430508|322837454|FG003|Overall Study|Other|0|||
94214861|NCT02691702|322580111|FG000|Overall Study|Other|0|||
94214862|NCT02691702|322580112|FG001|Overall Study|Other|0|||
94214863|NCT02691702|322580113|FG002|Overall Study|Other|0|||
94214864|NCT02691702|322580114|FG003|Overall Study|Other|0|||
94214865|NCT02691702|322580115|FG004|Overall Study|Other|0|||
94214866|NCT02691702|322580116|FG005|Overall Study|Other|0|||
94214867|NCT02691702|322580117|FG006|Overall Study|Other|1|||
94214868|NCT02691702|322580118|FG007|Overall Study|Other|0|||
94286265|NCT00797823|322837455|FG000|First Period (Initial Randomization)|Physician Decision|1|||
94286266|NCT00797823|322837456|FG001|First Period (Initial Randomization)|Physician Decision|0|||
94330895|NCT00290589|322991753|FG000|Overall Study|Lost to Follow-up|2|||
94214869|NCT02691702|322580119|FG008|Overall Study|Other|1|||
94214870|NCT02691702|322580120|FG009|Overall Study|Other|0|||
94214871|NCT02691702|322580121|FG010|Overall Study|Other|0|||
94214872|NCT02691702|322580111|FG000|Overall Study|Protocol Violation|0|||
94214873|NCT02691702|322580112|FG001|Overall Study|Protocol Violation|0|||
94214874|NCT02691702|322580113|FG002|Overall Study|Protocol Violation|0|||
94214875|NCT02691702|322580114|FG003|Overall Study|Protocol Violation|0|||
94214876|NCT02691702|322580115|FG004|Overall Study|Protocol Violation|0|||
94214877|NCT02691702|322580116|FG005|Overall Study|Protocol Violation|0|||
94214878|NCT02691702|322580117|FG006|Overall Study|Protocol Violation|0|||
94214879|NCT02691702|322580118|FG007|Overall Study|Protocol Violation|0|||
94214880|NCT02691702|322580119|FG008|Overall Study|Protocol Violation|0|||
94214881|NCT02691702|322580120|FG009|Overall Study|Protocol Violation|2|||
94214882|NCT02691702|322580121|FG010|Overall Study|Protocol Violation|0|||
94214883|NCT01240785|322580122|FG000|Overall Study|Lost to Follow-up|1|||
94214884|NCT01240785|322580123|FG001|Overall Study|Lost to Follow-up|0|||
94214885|NCT01240785|322580122|FG000|Overall Study|Protocol Violation|0|||
94214886|NCT01240785|322580123|FG001|Overall Study|Protocol Violation|3|||
94214887|NCT00632736|322580124|FG000|Overall Study|Adverse Event|104|||
94214888|NCT00632736|322580124|FG000|Overall Study|Lost to Follow-up|15|||
94214889|NCT00632736|322580124|FG000|Overall Study|Protocol Violation|14|||
94214890|NCT00632736|322580124|FG000|Overall Study|Withdrawal by Subject|99|||
94214891|NCT00632736|322580124|FG000|Overall Study|Lack of Efficacy|5|||
94214892|NCT00632736|322580124|FG000|Overall Study|Sponsor terminated study|5|||
94214893|NCT00632736|322580124|FG000|Overall Study|Non-compliance|10|||
94214894|NCT00632736|322580124|FG000|Overall Study|Other|16|||
94214895|NCT05487300|322581826|FG000|Overall Study|Withdrawal by Subject|1|||
94214896|NCT05487300|322581827|FG001|Overall Study|Withdrawal by Subject|0|||
94214897|NCT02196259|322581828|FG000|Overall Study|Researcher choice|0|||
94214898|NCT02196259|322581829|FG001|Overall Study|Researcher choice|0|||
94214899|NCT02196259|322581830|FG002|Overall Study|Researcher choice|1|||
94214900|NCT02196259|322581828|FG000|Overall Study|Partial data analysis|0|||
94214901|NCT02196259|322581829|FG001|Overall Study|Partial data analysis|3|||
94214902|NCT02196259|322581830|FG002|Overall Study|Partial data analysis|0|||
94214903|NCT01377844|322581831|FG000|Overall Study|Withdrawal by Subject|25|||
94214904|NCT01377844|322581832|FG001|Overall Study|Withdrawal by Subject|28|||
94214905|NCT01377844|322581831|FG000|Overall Study|Protocol Violation|2|||
94214906|NCT01377844|322581832|FG001|Overall Study|Protocol Violation|3|||
94214907|NCT01377844|322581831|FG000|Overall Study|Adverse Event|3|||
94214908|NCT01377844|322581832|FG001|Overall Study|Adverse Event|0|||
94214909|NCT01377844|322581831|FG000|Overall Study|Physician Decision|6|||
94214910|NCT01377844|322581832|FG001|Overall Study|Physician Decision|3|||
94214911|NCT01377844|322581831|FG000|Overall Study|Study terminated by Sponsor|0|||
94214912|NCT01377844|322581832|FG001|Overall Study|Study terminated by Sponsor|1|||
94214913|NCT02753075|322581834|FG000|Overall Study|Adverse Event|2|||
94214914|NCT02753075|322581835|FG001|Overall Study|Adverse Event|1|||
94214915|NCT02753075|322581836|FG002|Overall Study|Adverse Event|0|||
94214916|NCT02753075|322581834|FG000|Overall Study|Lost to Follow-up|2|||
94214917|NCT02753075|322581835|FG001|Overall Study|Lost to Follow-up|0|||
94214918|NCT02753075|322581836|FG002|Overall Study|Lost to Follow-up|0|||
94214919|NCT02753075|322581834|FG000|Overall Study|Withdrawal of Consent|1|||
94214920|NCT02753075|322581835|FG001|Overall Study|Withdrawal of Consent|1|||
94214921|NCT02753075|322581836|FG002|Overall Study|Withdrawal of Consent|3|||
94214922|NCT02753075|322581834|FG000|Overall Study|Physician Decision|3|||
94214923|NCT02753075|322581835|FG001|Overall Study|Physician Decision|1|||
94214924|NCT02753075|322581836|FG002|Overall Study|Physician Decision|0|||
94214925|NCT00889863|322581837|FG000|Part I: Open Label|Death|1|||
94214926|NCT00889863|322581838|FG001|Part I: Open Label|Death|0|||
94214927|NCT00889863|322581837|FG000|Part I: Open Label|Adverse Event|4|||
94214928|NCT00889863|322581838|FG001|Part I: Open Label|Adverse Event|0|||
94286267|NCT00797823|322837457|FG002|First Period (Initial Randomization)|Physician Decision|0|||
94286268|NCT01127165|322837458|FG000|Overall Study|Adverse Event|2|||
94286269|NCT01127165|322837459|FG001|Overall Study|Adverse Event|2|||
94286270|NCT01127165|322837458|FG000|Overall Study|Lack of Efficacy|10|||
94214929|NCT00889863|322581837|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
94214930|NCT00889863|322581838|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
94214931|NCT00889863|322581837|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
94214932|NCT00889863|322581838|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
94214933|NCT00889863|322581837|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
94214934|NCT00889863|322581838|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
94214935|NCT00889863|322581837|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
94214936|NCT00889863|322581838|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
94214937|NCT00889863|322581837|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
94214938|NCT00889863|322581838|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
94214939|NCT04410445|322581847|FG000|Overall Study|Lost to Follow-up|3|||
94214940|NCT04410445|322581848|FG001|Overall Study|Lost to Follow-up|9|||
94214941|NCT04410445|322581847|FG000|Overall Study|Withdrawal by Subject|27|||
94214942|NCT04410445|322581848|FG001|Overall Study|Withdrawal by Subject|15|||
94214943|NCT01320683|322581849|FG000|Overall Study|Positive antibody response|1|||
94214944|NCT01123356|322581850|FG000|Overall Study|Adverse Event|2|||
94214945|NCT01123356|322581850|FG000|Overall Study|Lack of Efficacy|4|||
94214946|NCT01123356|322581850|FG000|Overall Study|Withdrawal by Subject|1|||
94214947|NCT02291861|322581851|FG000|Overall Study|Adverse Event|2|||
94214948|NCT02291861|322581852|FG001|Overall Study|Adverse Event|4|||
94214949|NCT02291861|322581853|FG002|Overall Study|Adverse Event|1|||
94214950|NCT02291861|322581854|FG003|Overall Study|Adverse Event|2|||
94214951|NCT02291861|322581851|FG000|Overall Study|Death|0|||
94214952|NCT02291861|322581852|FG001|Overall Study|Death|0|||
94214953|NCT02291861|322581853|FG002|Overall Study|Death|1|||
94214954|NCT02291861|322581854|FG003|Overall Study|Death|1|||
94214955|NCT02291861|322581851|FG000|Overall Study|Protocol Violation|1|||
94214956|NCT02291861|322581852|FG001|Overall Study|Protocol Violation|0|||
94214957|NCT02291861|322581853|FG002|Overall Study|Protocol Violation|0|||
94214958|NCT02291861|322581854|FG003|Overall Study|Protocol Violation|1|||
94214959|NCT02291861|322581851|FG000|Overall Study|Withdrawal by Subject|1|||
94214960|NCT02291861|322581852|FG001|Overall Study|Withdrawal by Subject|2|||
94214961|NCT02291861|322581853|FG002|Overall Study|Withdrawal by Subject|1|||
94214962|NCT02291861|322581854|FG003|Overall Study|Withdrawal by Subject|4|||
94214963|NCT02291861|322581851|FG000|Overall Study|Noncompliance|1|||
94214964|NCT02291861|322581852|FG001|Overall Study|Noncompliance|1|||
94214965|NCT02291861|322581853|FG002|Overall Study|Noncompliance|2|||
94214966|NCT02291861|322581854|FG003|Overall Study|Noncompliance|1|||
94214967|NCT02291861|322581851|FG000|Overall Study|Lost to Follow-up|2|||
94214968|NCT02291861|322581852|FG001|Overall Study|Lost to Follow-up|1|||
94214969|NCT02291861|322581853|FG002|Overall Study|Lost to Follow-up|4|||
94214970|NCT02291861|322581854|FG003|Overall Study|Lost to Follow-up|0|||
94214971|NCT02291861|322581851|FG000|Overall Study|Other|0|||
94286271|NCT01127165|322837459|FG001|Overall Study|Lack of Efficacy|8|||
94286272|NCT01127165|322837458|FG000|Overall Study|Lost to Follow-up|3|||
94286273|NCT01127165|322837459|FG001|Overall Study|Lost to Follow-up|5|||
94286274|NCT01127165|322837458|FG000|Overall Study|Withdrawal by Subject|1|||
94286275|NCT01127165|322837459|FG001|Overall Study|Withdrawal by Subject|3|||
94286276|NCT01127165|322837458|FG000|Overall Study|Protocol Violation|0|||
94286277|NCT01127165|322837459|FG001|Overall Study|Protocol Violation|1|||
94286278|NCT02486757|322837460|FG000|Overall Study|Lost to Follow-up|1|||
94286279|NCT02532855|322837461|FG000|Overall Study|Lost to Follow-up|4|||
94286280|NCT02532855|322837462|FG001|Overall Study|Lost to Follow-up|3|||
94286281|NCT02532855|322837461|FG000|Overall Study|Withdrawal by Subject|4|||
94286282|NCT02532855|322837462|FG001|Overall Study|Withdrawal by Subject|8|||
94286283|NCT01353703|322837463|FG000|Overall Study|Migrated/moved from study area|1|||
94286284|NCT01353703|322837464|FG001|Overall Study|Migrated/moved from study area|0|||
94286285|NCT01446419|322837467|FG000|Overall Study|Death|1|||
94286286|NCT01446419|322837468|FG001|Overall Study|Death|0|||
94286287|NCT01446419|322837467|FG000|Overall Study|Withdrawal by Subject|1|||
94286288|NCT01446419|322837468|FG001|Overall Study|Withdrawal by Subject|1|||
94286289|NCT01446419|322837467|FG000|Overall Study|Terminated per protocol|3|||
94286290|NCT01446419|322837468|FG001|Overall Study|Terminated per protocol|0|||
94286291|NCT01920711|322837469|FG000|Overall Study|Death|347|||
94286292|NCT01920711|322837470|FG001|Overall Study|Death|356|||
94286293|NCT01920711|322837469|FG000|Overall Study|Lost to Follow-up|13|||
94286294|NCT01920711|322837470|FG001|Overall Study|Lost to Follow-up|14|||
94286295|NCT01920711|322837469|FG000|Overall Study|Withdrawal by Subject|4|||
94286296|NCT01920711|322837470|FG001|Overall Study|Withdrawal by Subject|3|||
94286297|NCT03551743|322837472|FG000|Overall Study|Adverse Event|1|||
94286298|NCT03551743|322837473|FG001|Overall Study|Adverse Event|0|||
94286299|NCT03551743|322837474|FG002|Overall Study|Adverse Event|0|||
94286300|NCT03551743|322837475|FG003|Overall Study|Adverse Event|0|||
94286301|NCT03551743|322837472|FG000|Overall Study|Withdrawal by Subject|1|||
94286302|NCT03551743|322837473|FG001|Overall Study|Withdrawal by Subject|0|||
94286303|NCT03551743|322837474|FG002|Overall Study|Withdrawal by Subject|0|||
94286304|NCT03551743|322837475|FG003|Overall Study|Withdrawal by Subject|0|||
94372444|NCT04130919|323150258|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
94214972|NCT02291861|322581852|FG001|Overall Study|Other|0|||
94286305|NCT00626093|322837476|FG000|Overall Study|Lost to Follow-up|5|||
94286306|NCT00626093|322837476|FG000|Overall Study|Death|1|||
94286307|NCT00626093|322837476|FG000|Overall Study|Physician Decision|4|||
94286308|NCT00626093|322837476|FG000|Overall Study|Withdrawal by Subject|6|||
94286309|NCT00626093|322837476|FG000|Overall Study|Protocol Violation|1|||
94286310|NCT00626093|322837476|FG000|Overall Study|One of the required devices not implante|6|||
94286311|NCT00603915|322837477|FG000|Overall Study|Physician Decision|1|||
94286312|NCT02154087|322837480|FG000|Overall Study|Study Termination|1|||
94286313|NCT05501119|322837485|FG000|Overall Study|Withdrawal by Subject|2|||
94214973|NCT02291861|322581853|FG002|Overall Study|Other|0|||
94214974|NCT02291861|322581854|FG003|Overall Study|Other|1|||
94214975|NCT00930644|322581855|FG000|Overall Study|Withdrawal by Subject|4|||
94214976|NCT00930644|322581855|FG000|Overall Study|Physician Decision|2|||
94286314|NCT05501119|322837485|FG000|Overall Study|Lost to Follow-up|5|||
94214977|NCT00930644|322581855|FG000|Overall Study|Death|1|||
94214978|NCT00930644|322581855|FG000|Overall Study|Adverse Event|16|||
94214979|NCT00795639|322581866|FG000|Overall Study|Death|1|||
94214980|NCT00795639|322581867|FG001|Overall Study|Death|6|||
94214981|NCT00795639|322581866|FG000|Overall Study|Withdrawal by Subject|1|||
94214982|NCT00795639|322581867|FG001|Overall Study|Withdrawal by Subject|3|||
94214983|NCT00795639|322581866|FG000|Overall Study|Pregnancy|1|||
94214984|NCT00795639|322581867|FG001|Overall Study|Pregnancy|0|||
94214985|NCT00795639|322581866|FG000|Overall Study|Adverse Event|5|||
94214986|NCT00795639|322581867|FG001|Overall Study|Adverse Event|2|||
94214987|NCT00795639|322581866|FG000|Overall Study|Other|0|||
94214988|NCT00795639|322581867|FG001|Overall Study|Other|2|||
94214989|NCT00795639|322581866|FG000|Overall Study|Terminated by sponsor|13|||
94214990|NCT00795639|322581867|FG001|Overall Study|Terminated by sponsor|12|||
94214991|NCT00795639|322581866|FG000|Overall Study|Randomized and not treated|0|||
94214992|NCT00795639|322581867|FG001|Overall Study|Randomized and not treated|1|||
94214993|NCT00274287|322581868|FG000|Overall Study|Withdrawal by Subject|1|||
94214994|NCT00274287|322581868|FG000|Overall Study|subject non-compliance|1|||
94214995|NCT02514824|322581869|FG000|Overall Study|Withdrawal by Subject|1|||
94214996|NCT02514824|322581870|FG001|Overall Study|Withdrawal by Subject|0|||
94214997|NCT02514824|322581871|FG002|Overall Study|Withdrawal by Subject|0|||
94214998|NCT02514824|322581872|FG003|Overall Study|Withdrawal by Subject|0|||
94214999|NCT02514824|322581869|FG000|Overall Study|Dose-Limiting Toxicity|0|||
94215000|NCT02514824|322581870|FG001|Overall Study|Dose-Limiting Toxicity|1|||
94215001|NCT02514824|322581871|FG002|Overall Study|Dose-Limiting Toxicity|0|||
94215002|NCT02514824|322581872|FG003|Overall Study|Dose-Limiting Toxicity|0|||
94215003|NCT00529529|322581873|FG000|Overall Study|Adverse Event|12|||
94215004|NCT00529529|322581874|FG001|Overall Study|Adverse Event|17|||
94215005|NCT00529529|322581875|FG002|Overall Study|Adverse Event|8|||
94215006|NCT00529529|322581873|FG000|Overall Study|Subject withdrew consent|12|||
94215007|NCT00529529|322581874|FG001|Overall Study|Subject withdrew consent|9|||
94215008|NCT00529529|322581875|FG002|Overall Study|Subject withdrew consent|12|||
94215009|NCT00529529|322581873|FG000|Overall Study|Protocol deviation|8|||
94215010|NCT00529529|322581874|FG001|Overall Study|Protocol deviation|12|||
94215011|NCT00529529|322581875|FG002|Overall Study|Protocol deviation|5|||
94215012|NCT00529529|322581873|FG000|Overall Study|Lost to Follow-up|5|||
94215013|NCT00529529|322581874|FG001|Overall Study|Lost to Follow-up|3|||
94215014|NCT00529529|322581875|FG002|Overall Study|Lost to Follow-up|1|||
94215015|NCT00529529|322581873|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
94215016|NCT00529529|322581874|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
94215017|NCT00529529|322581875|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
94215018|NCT00529529|322581873|FG000|Overall Study|Death|2|||
94215019|NCT00529529|322581874|FG001|Overall Study|Death|0|||
94215020|NCT00529529|322581875|FG002|Overall Study|Death|0|||
94215021|NCT00529529|322581873|FG000|Overall Study|Abnormal test procedure result(s)|1|||
94215022|NCT00529529|322581874|FG001|Overall Study|Abnormal test procedure result(s)|0|||
94215023|NCT00529529|322581875|FG002|Overall Study|Abnormal test procedure result(s)|0|||
94215024|NCT00529529|322581873|FG000|Overall Study|Administrative problems|1|||
94215025|NCT00529529|322581874|FG001|Overall Study|Administrative problems|0|||
94215026|NCT00529529|322581875|FG002|Overall Study|Administrative problems|3|||
94215027|NCT01020435|322581876|FG000|Overall Study|Lost to Follow-up|0|||
94215028|NCT01020435|322581877|FG001|Overall Study|Lost to Follow-up|1|||
94215029|NCT00409747|322581878|FG000|Overall Study|Withdrawal by Subject|1|||
94215030|NCT01000649|322581879|FG000|Overall Study|Adverse Event|5|||
94215031|NCT01000649|322581880|FG001|Overall Study|Adverse Event|1|||
94215032|NCT01000649|322581881|FG002|Overall Study|Adverse Event|2|||
94215033|NCT01000649|322581882|FG003|Overall Study|Adverse Event|4|||
94215034|NCT01000649|322581879|FG000|Overall Study|Lost to Follow-up|0|||
94286315|NCT02542072|322837486|FG000|First Intervention (1 Month)|Adverse Event|1|||
94286316|NCT02542072|322837487|FG001|First Intervention (1 Month)|Adverse Event|1|||
94286317|NCT02542072|322837486|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
94286318|NCT02542072|322837487|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
94215035|NCT01000649|322581880|FG001|Overall Study|Lost to Follow-up|2|||
94215036|NCT01000649|322581881|FG002|Overall Study|Lost to Follow-up|0|||
94215037|NCT01000649|322581882|FG003|Overall Study|Lost to Follow-up|2|||
94215038|NCT00346398|322581888|FG000|Overall Study|Lost to Follow-up|3|||
94215039|NCT00346398|322581889|FG001|Overall Study|Lost to Follow-up|0|||
94215040|NCT00346398|322581888|FG000|Overall Study|Withdrawal by Subject|0|||
94286319|NCT02542072|322837486|FG000|First Intervention (1 Month)|Lens discomfort|1|||
94215041|NCT00346398|322581889|FG001|Overall Study|Withdrawal by Subject|2|||
94215042|NCT02607956|322581892|FG000|Double-Blinded Phase|Withdrew Consent|17|||
94215043|NCT02607956|322581893|FG001|Double-Blinded Phase|Withdrew Consent|19|||
94215044|NCT02607956|322581894|FG002|Double-Blinded Phase|Withdrew Consent|0|||
94215045|NCT02607956|322581895|FG003|Double-Blinded Phase|Withdrew Consent|0|||
94215046|NCT02607956|322581892|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
94215047|NCT02607956|322581893|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
94330896|NCT00290589|322991754|FG001|Overall Study|Lost to Follow-up|2|||
94215048|NCT02607956|322581894|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
94215049|NCT02607956|322581895|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
94215050|NCT02607956|322581892|FG000|Double-Blinded Phase|Randomized but never treated|7|||
94215051|NCT02607956|322581893|FG001|Double-Blinded Phase|Randomized but never treated|5|||
94215052|NCT02607956|322581894|FG002|Double-Blinded Phase|Randomized but never treated|0|||
94215053|NCT02607956|322581895|FG003|Double-Blinded Phase|Randomized but never treated|0|||
94215054|NCT02607956|322581892|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
94215055|NCT02607956|322581893|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
94215056|NCT02607956|322581894|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
94215057|NCT02607956|322581895|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
94215058|NCT02607956|322581892|FG000|Double-Blinded Phase|Death|4|||
94215059|NCT02607956|322581893|FG001|Double-Blinded Phase|Death|4|||
94215060|NCT02607956|322581894|FG002|Double-Blinded Phase|Death|0|||
94215061|NCT02607956|322581895|FG003|Double-Blinded Phase|Death|0|||
94215062|NCT02607956|322581892|FG000|Double-Blinded Phase|Adverse Event|4|||
94215063|NCT02607956|322581893|FG001|Double-Blinded Phase|Adverse Event|3|||
94215064|NCT02607956|322581894|FG002|Double-Blinded Phase|Adverse Event|0|||
94215065|NCT02607956|322581895|FG003|Double-Blinded Phase|Adverse Event|0|||
94215066|NCT02607956|322581892|FG000|Double-Blinded Phase|Protocol Violation|3|||
94215067|NCT02607956|322581893|FG001|Double-Blinded Phase|Protocol Violation|1|||
94215068|NCT02607956|322581894|FG002|Double-Blinded Phase|Protocol Violation|0|||
94215069|NCT02607956|322581895|FG003|Double-Blinded Phase|Protocol Violation|0|||
94215070|NCT02607956|322581892|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
94215071|NCT02607956|322581893|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
94215072|NCT02607956|322581894|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
94286320|NCT02542072|322837487|FG001|First Intervention (1 Month)|Lens discomfort|2|||
94215073|NCT02607956|322581895|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
94215074|NCT02607956|322581892|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
94215075|NCT02607956|322581893|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
94215076|NCT02607956|322581894|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
94215077|NCT02607956|322581895|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
94215078|NCT02607956|322581892|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
94215079|NCT02607956|322581893|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
94215080|NCT02607956|322581894|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
94215081|NCT02607956|322581895|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
94215082|NCT02607956|322581892|FG000|Open-Label Extension Phase|Death|0|||
94215083|NCT02607956|322581893|FG001|Open-Label Extension Phase|Death|0|||
94215084|NCT02607956|322581894|FG002|Open-Label Extension Phase|Death|1|||
94215085|NCT02607956|322581895|FG003|Open-Label Extension Phase|Death|3|||
94215086|NCT02607956|322581892|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
94215087|NCT02607956|322581893|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
94215088|NCT02607956|322581894|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
94215089|NCT02607956|322581895|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
94215090|NCT02607956|322581892|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
94215091|NCT02607956|322581893|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
94215092|NCT02607956|322581894|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
94215093|NCT02607956|322581895|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
94215094|NCT02607956|322581892|FG000|Open-Label Extension Phase|Protocol Violation|0|||
94215095|NCT02607956|322581893|FG001|Open-Label Extension Phase|Protocol Violation|0|||
94215096|NCT02607956|322581894|FG002|Open-Label Extension Phase|Protocol Violation|0|||
94215097|NCT02607956|322581895|FG003|Open-Label Extension Phase|Protocol Violation|2|||
94215098|NCT02607956|322581892|FG000|Open-Label Extension Phase|Pregnancy|0|||
94215099|NCT02607956|322581893|FG001|Open-Label Extension Phase|Pregnancy|0|||
94215100|NCT02607956|322581894|FG002|Open-Label Extension Phase|Pregnancy|0|||
94215101|NCT02607956|322581895|FG003|Open-Label Extension Phase|Pregnancy|1|||
94215102|NCT01916109|322581896|FG000|Overall Study|Withdrawal by Subject|1|||
94215103|NCT00636168|322581897|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
94215104|NCT00636168|322581898|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
94215105|NCT00636168|322581897|FG000|Randomized to Study Drug|Adverse Event|1|||
94215106|NCT00636168|322581898|FG001|Randomized to Study Drug|Adverse Event|0|||
94215107|NCT00636168|322581897|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
94215108|NCT00636168|322581898|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
94215109|NCT00636168|322581897|FG000|Treated With Study Drug|Recurrence of disease|135|||
94215110|NCT00636168|322581898|FG001|Treated With Study Drug|Recurrence of disease|282|||
94215111|NCT00636168|322581897|FG000|Treated With Study Drug|Adverse Event|250|||
94215112|NCT00636168|322581898|FG001|Treated With Study Drug|Adverse Event|22|||
94215113|NCT00636168|322581897|FG000|Treated With Study Drug|Participant withdrew consent|16|||
94215114|NCT00636168|322581898|FG001|Treated With Study Drug|Participant withdrew consent|21|||
94215115|NCT00636168|322581897|FG000|Treated With Study Drug|Poor/non-compliance|1|||
94215116|NCT00636168|322581898|FG001|Treated With Study Drug|Poor/non-compliance|3|||
94286321|NCT02542072|322837486|FG000|First Intervention (1 Month)|Protocol Violation|1|||
94286322|NCT02542072|322837487|FG001|First Intervention (1 Month)|Protocol Violation|0|||
94215117|NCT00636168|322581897|FG000|Treated With Study Drug|Death|3|||
94215118|NCT00636168|322581898|FG001|Treated With Study Drug|Death|0|||
94215119|NCT00636168|322581897|FG000|Treated With Study Drug|Pregnancy|1|||
94215120|NCT00636168|322581898|FG001|Treated With Study Drug|Pregnancy|0|||
94215121|NCT00636168|322581897|FG000|Treated With Study Drug|No longer meets study criteria|1|||
94215122|NCT00636168|322581898|FG001|Treated With Study Drug|No longer meets study criteria|0|||
94215123|NCT00636168|322581897|FG000|Treated With Study Drug|Other reason|1|||
94215124|NCT00636168|322581898|FG001|Treated With Study Drug|Other reason|3|||
94215125|NCT00636168|322581897|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
94215126|NCT00636168|322581898|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
94215127|NCT00636168|322581897|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
94215128|NCT00636168|322581898|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
94215129|NCT00636168|322581897|FG000|Long Term Follow-Up|Death|8|||
94215130|NCT00636168|322581898|FG001|Long Term Follow-Up|Death|9|||
94215131|NCT03652610|322581899|FG000|Overall Study|Lost to Follow-up|1|||
94215132|NCT03652610|322581900|FG001|Overall Study|Lost to Follow-up|0|||
94215133|NCT03652610|322581899|FG000|Overall Study|Withdrawal by Subject|3|||
94215134|NCT03652610|322581900|FG001|Overall Study|Withdrawal by Subject|5|||
94215135|NCT02707952|322581901|FG000|Overall Study|Adverse Event|1|||
94215136|NCT02707952|322581902|FG001|Overall Study|Adverse Event|0|||
94215137|NCT02707952|322581903|FG002|Overall Study|Adverse Event|0|||
94215138|NCT02707952|322581904|FG003|Overall Study|Adverse Event|0|||
94215139|NCT02707952|322581901|FG000|Overall Study|Lost to Follow-up|1|||
94215140|NCT02707952|322581902|FG001|Overall Study|Lost to Follow-up|0|||
94215141|NCT02707952|322581903|FG002|Overall Study|Lost to Follow-up|0|||
94215142|NCT02707952|322581904|FG003|Overall Study|Lost to Follow-up|0|||
94215143|NCT02707952|322581901|FG000|Overall Study|Withdrawal by Subject|0|||
94215144|NCT02707952|322581902|FG001|Overall Study|Withdrawal by Subject|1|||
94215145|NCT02707952|322581903|FG002|Overall Study|Withdrawal by Subject|2|||
94215146|NCT02707952|322581904|FG003|Overall Study|Withdrawal by Subject|0|||
94215147|NCT00237809|322581905|FG000|Overall Study|Lost to Follow-up|11|||
94215148|NCT00237809|322581906|FG001|Overall Study|Lost to Follow-up|10|||
94215149|NCT00237809|322581907|FG002|Overall Study|Lost to Follow-up|9|||
94215150|NCT00237809|322581908|FG003|Overall Study|Lost to Follow-up|9|||
94215151|NCT02991456|322581913|FG000|Overall Study|Adverse Event|2|||
94215152|NCT02991456|322581914|FG001|Overall Study|Adverse Event|0|||
94215153|NCT02991456|322581913|FG000|Overall Study|Lost to Follow-up|0|||
94215154|NCT02991456|322581914|FG001|Overall Study|Lost to Follow-up|2|||
94215155|NCT02991456|322581913|FG000|Overall Study|Withdrawal by Subject|1|||
94215156|NCT02991456|322581914|FG001|Overall Study|Withdrawal by Subject|0|||
94215157|NCT00070317|322581928|FG000|Overall Study|Inevaluable (Never Treated)|1|||
94215158|NCT00070317|322581928|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
94215159|NCT00070317|322581928|FG000|Overall Study|Ineligible required test not done|1|||
94215160|NCT00070317|322581928|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
94215161|NCT00070317|322581928|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
94215162|NCT00866619|322581929|FG000|Overall Study|Adverse Event|112|||
94215163|NCT00866619|322581930|FG001|Overall Study|Adverse Event|106|||
94215164|NCT00866619|322581931|FG002|Overall Study|Adverse Event|47|||
94215165|NCT00866619|322581932|FG003|Overall Study|Adverse Event|44|||
94215166|NCT00866619|322581929|FG000|Overall Study|Protocol Violation|2|||
94215167|NCT00866619|322581930|FG001|Overall Study|Protocol Violation|39|||
94215168|NCT00866619|322581931|FG002|Overall Study|Protocol Violation|2|||
94215169|NCT00866619|322581932|FG003|Overall Study|Protocol Violation|17|||
94215170|NCT00866619|322581929|FG000|Overall Study|Withdrawal by Subject|587|||
94215171|NCT00866619|322581930|FG001|Overall Study|Withdrawal by Subject|295|||
94215172|NCT00866619|322581931|FG002|Overall Study|Withdrawal by Subject|272|||
94215173|NCT00866619|322581932|FG003|Overall Study|Withdrawal by Subject|144|||
94215174|NCT00866619|322581929|FG000|Overall Study|Lost to Follow-up|1145|||
94215175|NCT00866619|322581930|FG001|Overall Study|Lost to Follow-up|830|||
94215176|NCT00866619|322581931|FG002|Overall Study|Lost to Follow-up|568|||
94215177|NCT00866619|322581932|FG003|Overall Study|Lost to Follow-up|425|||
94215178|NCT01334606|322581934|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
94215179|NCT02674399|322581935|FG000|Overall Study|Lost to Follow-up|2|||
94215180|NCT02674399|322581936|FG001|Overall Study|Lost to Follow-up|0|||
94215181|NCT01229176|322581937|FG000|Overall Study|Withdrawal by Subject|0|||
94215182|NCT01229176|322581938|FG001|Overall Study|Withdrawal by Subject|0|||
94215183|NCT01229176|322581939|FG002|Overall Study|Withdrawal by Subject|0|||
94215184|NCT01229176|322581940|FG003|Overall Study|Withdrawal by Subject|1|||
94215185|NCT01229176|322581941|FG004|Overall Study|Withdrawal by Subject|1|||
94215186|NCT01229176|322581942|FG005|Overall Study|Withdrawal by Subject|1|||
94215187|NCT01229176|322581943|FG006|Overall Study|Withdrawal by Subject|0|||
94215188|NCT01229176|322581944|FG007|Overall Study|Withdrawal by Subject|1|||
94215189|NCT01229176|322581937|FG000|Overall Study|Lost to Follow-up|0|||
94215190|NCT01229176|322581938|FG001|Overall Study|Lost to Follow-up|3|||
94215191|NCT01229176|322581939|FG002|Overall Study|Lost to Follow-up|0|||
94215192|NCT01229176|322581940|FG003|Overall Study|Lost to Follow-up|0|||
94215193|NCT01229176|322581941|FG004|Overall Study|Lost to Follow-up|1|||
94215194|NCT01229176|322581942|FG005|Overall Study|Lost to Follow-up|1|||
94215195|NCT01229176|322581943|FG006|Overall Study|Lost to Follow-up|0|||
94215196|NCT01229176|322581944|FG007|Overall Study|Lost to Follow-up|2|||
94215197|NCT02138838|322581945|FG000|Overall Study|Study Closure|7|||
94215198|NCT02138838|322581946|FG001|Overall Study|Study Closure|6|||
94215199|NCT02138838|322581945|FG000|Overall Study|Withdrawal by Subject|1|||
94215200|NCT02138838|322581946|FG001|Overall Study|Withdrawal by Subject|5|||
94215201|NCT01867307|322581949|FG000|Overall Study|Protocol Violation|2|||
94215202|NCT01867307|322581950|FG001|Overall Study|Protocol Violation|0|||
94215203|NCT01867307|322581949|FG000|Overall Study|Other Adverse Event|1|||
94215204|NCT01867307|322581950|FG001|Overall Study|Other Adverse Event|3|||
94215205|NCT01986348|322581951|FG000|Overall Study|Death|8|||
94215206|NCT01986348|322581952|FG001|Overall Study|Death|22|||
94215207|NCT01986348|322581953|FG002|Overall Study|Death|10|||
94215208|NCT01986348|322581954|FG003|Overall Study|Death|21|||
94215209|NCT01986348|322581951|FG000|Overall Study|Lost to Follow-up|0|||
94215210|NCT01986348|322581952|FG001|Overall Study|Lost to Follow-up|0|||
94215211|NCT01986348|322581953|FG002|Overall Study|Lost to Follow-up|0|||
94215212|NCT01986348|322581954|FG003|Overall Study|Lost to Follow-up|2|||
94215213|NCT01986348|322581951|FG000|Overall Study|Physician Decision|0|||
94215214|NCT01986348|322581952|FG001|Overall Study|Physician Decision|0|||
94215215|NCT01986348|322581953|FG002|Overall Study|Physician Decision|0|||
94215216|NCT01986348|322581954|FG003|Overall Study|Physician Decision|1|||
94215217|NCT01986348|322581951|FG000|Overall Study|Progressive Disease|0|||
94215218|NCT01986348|322581952|FG001|Overall Study|Progressive Disease|0|||
94215219|NCT01986348|322581953|FG002|Overall Study|Progressive Disease|2|||
94215220|NCT01986348|322581954|FG003|Overall Study|Progressive Disease|0|||
94215221|NCT01986348|322581951|FG000|Overall Study|Withdrawal by Participant|0|||
94215222|NCT01986348|322581952|FG001|Overall Study|Withdrawal by Participant|1|||
94215223|NCT01986348|322581953|FG002|Overall Study|Withdrawal by Participant|2|||
94215224|NCT01986348|322581954|FG003|Overall Study|Withdrawal by Participant|1|||
94215225|NCT01986348|322581951|FG000|Overall Study|Study Terminated by Sponsor|0|||
94467857|NCT01739764|323502427|FG002|Overall Study|Non-Compliance|1|||
94215226|NCT01986348|322581952|FG001|Overall Study|Study Terminated by Sponsor|0|||
94215227|NCT01986348|322581953|FG002|Overall Study|Study Terminated by Sponsor|0|||
94215228|NCT01986348|322581954|FG003|Overall Study|Study Terminated by Sponsor|3|||
94215229|NCT01986348|322581951|FG000|Overall Study|Other-unspecified|0|||
94215230|NCT01986348|322581952|FG001|Overall Study|Other-unspecified|1|||
94215231|NCT01986348|322581953|FG002|Overall Study|Other-unspecified|0|||
94215232|NCT01986348|322581954|FG003|Overall Study|Other-unspecified|2|||
94215233|NCT01884571|322581958|FG000|Overall Study|Adverse Event|1|||
94215234|NCT01884571|322581958|FG000|Overall Study|Death|2|||
94215235|NCT01884571|322581958|FG000|Overall Study|Withdrawal by Subject|2|||
94215236|NCT01884571|322581958|FG000|Overall Study|Disease progression|3|||
94215237|NCT03242863|322581959|FG000|Study Week 1|Withdrawal by Subject|0|||
94215238|NCT03242863|322581960|FG001|Study Week 1|Withdrawal by Subject|1|||
94215239|NCT03242863|322581961|FG002|Study Week 1|Withdrawal by Subject|0|||
94215240|NCT03242863|322581962|FG003|Study Week 1|Withdrawal by Subject|0|||
94215241|NCT03242863|322581963|FG004|Study Week 1|Withdrawal by Subject|3|||
94215242|NCT03242863|322581964|FG005|Study Week 1|Withdrawal by Subject|0|||
94215243|NCT00091572|322581965|FG000|Overall Study|Lost to Follow-up|1|||
94215244|NCT00091572|322581966|FG001|Overall Study|Lost to Follow-up|1|||
94215245|NCT00091572|322581965|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
94215246|NCT00091572|322581966|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
94215247|NCT00091572|322581965|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
94215248|NCT00091572|322581966|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
94215249|NCT00091572|322581965|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
94215250|NCT00091572|322581966|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
94215251|NCT00091572|322581965|FG000|Overall Study|Other Reason|6|||
94215252|NCT00091572|322581966|FG001|Overall Study|Other Reason|13|||
94215253|NCT00091572|322581965|FG000|Overall Study|Ongoing (still on treatment)|8|||
94215254|NCT00091572|322581966|FG001|Overall Study|Ongoing (still on treatment)|12|||
94215255|NCT00091572|322581965|FG000|Overall Study|Major Protocol Violation|2|||
94215256|NCT00091572|322581966|FG001|Overall Study|Major Protocol Violation|0|||
94215257|NCT00091572|322581965|FG000|Overall Study|Toxicity (Related AE)|53|||
94215258|NCT00091572|322581966|FG001|Overall Study|Toxicity (Related AE)|9|||
94215259|NCT02942771|322581967|FG000|Overall Study|Adverse Event|1|||
94215260|NCT02942771|322581968|FG001|Overall Study|Adverse Event|0|||
94215261|NCT02942771|322581969|FG002|Overall Study|Adverse Event|0|||
94215262|NCT02942771|322581970|FG003|Overall Study|Adverse Event|0|||
94215263|NCT02942771|322581971|FG004|Overall Study|Adverse Event|2|||
94215264|NCT02942771|322581967|FG000|Overall Study|Lost to Follow-up|1|||
94215265|NCT02942771|322581968|FG001|Overall Study|Lost to Follow-up|0|||
94215266|NCT02942771|322581969|FG002|Overall Study|Lost to Follow-up|0|||
94215267|NCT02942771|322581970|FG003|Overall Study|Lost to Follow-up|0|||
94215268|NCT02942771|322581971|FG004|Overall Study|Lost to Follow-up|0|||
94215269|NCT02942771|322581967|FG000|Overall Study|Withdrawal by Subject|1|||
94215270|NCT02942771|322581968|FG001|Overall Study|Withdrawal by Subject|0|||
94215271|NCT02942771|322581969|FG002|Overall Study|Withdrawal by Subject|0|||
94215272|NCT02942771|322581970|FG003|Overall Study|Withdrawal by Subject|0|||
94215273|NCT02942771|322581971|FG004|Overall Study|Withdrawal by Subject|2|||
94215274|NCT02340806|322581972|FG000|Overall Study|Protocol Violation|2|||
94215275|NCT02340806|322581973|FG001|Overall Study|Protocol Violation|0|||
94215276|NCT02340806|322581972|FG000|Overall Study|epidural catheter replaced|2|||
94215277|NCT02340806|322581973|FG001|Overall Study|epidural catheter replaced|1|||
94215278|NCT02340806|322581972|FG000|Overall Study|history of chronic pain medication|1|||
94215279|NCT02340806|322581973|FG001|Overall Study|history of chronic pain medication|0|||
94215280|NCT02340806|322581972|FG000|Overall Study|re-dose < 90 min of CSE|1|||
94215281|NCT02340806|322581973|FG001|Overall Study|re-dose < 90 min of CSE|3|||
94215282|NCT00452452|322581976|FG000|Overall Study|Protocol Violation|0|||
94215283|NCT00452452|322581977|FG001|Overall Study|Protocol Violation|0|||
94215284|NCT00452452|322581978|FG002|Overall Study|Protocol Violation|1|||
94215285|NCT00452452|322581976|FG000|Overall Study|Withdrawal by Subject|1|||
94215286|NCT00452452|322581977|FG001|Overall Study|Withdrawal by Subject|0|||
94215287|NCT00452452|322581978|FG002|Overall Study|Withdrawal by Subject|0|||
94215288|NCT00452452|322581976|FG000|Overall Study|Lost to Follow-up|1|||
94215289|NCT00452452|322581977|FG001|Overall Study|Lost to Follow-up|0|||
94215290|NCT00452452|322581978|FG002|Overall Study|Lost to Follow-up|0|||
94215291|NCT01634165|322581979|FG000|Period 2|Adverse Event|0|||
94215292|NCT01634165|322581980|FG001|Period 2|Adverse Event|1|||
94215293|NCT01634165|322581981|FG002|Period 2|Adverse Event|0|||
94215294|NCT01634165|322581982|FG003|Period 2|Adverse Event|0|||
94215295|NCT03332589|322583625|FG000|Overall Study|Lack of Efficacy|2|||
94215296|NCT03332589|322583626|FG001|Overall Study|Lack of Efficacy|0|||
94215297|NCT03332589|322583627|FG002|Overall Study|Lack of Efficacy|0|||
94215298|NCT03332589|322583625|FG000|Overall Study|Adverse Event|1|||
94215299|NCT03332589|322583626|FG001|Overall Study|Adverse Event|0|||
94215300|NCT03332589|322583627|FG002|Overall Study|Adverse Event|0|||
94215301|NCT03332589|322583625|FG000|Overall Study|Death|1|||
94215302|NCT03332589|322583626|FG001|Overall Study|Death|0|||
94215303|NCT03332589|322583627|FG002|Overall Study|Death|0|||
94215304|NCT04999020|322583629|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
94215305|NCT04999020|322583630|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
94372445|NCT04130919|323150259|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
94215306|NCT04999020|322583631|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
94215307|NCT04999020|322583632|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
94215308|NCT04999020|322583629|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
94215309|NCT04999020|322583630|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
94372446|NCT04130919|323150260|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
94215310|NCT04999020|322583631|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
94467858|NCT01739764|323502425|FG000|Overall Study|Multiple Reasons|3|||
94215311|NCT04999020|322583632|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
94215312|NCT04999020|322583629|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
94215313|NCT04999020|322583630|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
94215314|NCT04999020|322583631|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
94215315|NCT04999020|322583632|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
94215316|NCT04999020|322583629|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
94215317|NCT04999020|322583630|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
94215318|NCT04999020|322583631|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
94215319|NCT04999020|322583632|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
94215320|NCT04999020|322583629|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
94215321|NCT04999020|322583630|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
94215322|NCT04999020|322583631|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
94215323|NCT04999020|322583632|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
94215324|NCT04999020|322583629|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
94215325|NCT04999020|322583630|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
94215326|NCT04999020|322583631|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
94215327|NCT04999020|322583632|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
94215328|NCT04999020|322583629|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
94215329|NCT04999020|322583630|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
94215330|NCT04999020|322583631|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
94215331|NCT04999020|322583632|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
94215332|NCT04999020|322583629|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
94215333|NCT04999020|322583630|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
94215334|NCT04999020|322583631|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
94215335|NCT04999020|322583632|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
94215336|NCT00647699|322583633|FG000|Overall Study|Lost to Follow-up|5|||
94215337|NCT00647699|322583634|FG001|Overall Study|Lost to Follow-up|4|||
94215338|NCT00647699|322583633|FG000|Overall Study|Withdrawal by Subject|3|||
94215339|NCT00647699|322583634|FG001|Overall Study|Withdrawal by Subject|8|||
94215340|NCT03029585|322583635|FG000|Overall Study|Death|1|||
94215341|NCT03029585|322583636|FG001|Overall Study|Death|1|||
94215342|NCT03029585|322583635|FG000|Overall Study|Withdrawal by Subject|1|||
94215343|NCT03029585|322583636|FG001|Overall Study|Withdrawal by Subject|0|||
94215344|NCT00087516|322583637|FG000|Overall Study|Adverse Event|10|||
94215345|NCT00087516|322583638|FG001|Overall Study|Adverse Event|10|||
94215346|NCT00087516|322583639|FG002|Overall Study|Adverse Event|3|||
94215347|NCT00087516|322583640|FG003|Overall Study|Adverse Event|6|||
94215348|NCT00087516|322583637|FG000|Overall Study|Lack of Efficacy|82|||
94215349|NCT00087516|322583638|FG001|Overall Study|Lack of Efficacy|80|||
94215350|NCT00087516|322583639|FG002|Overall Study|Lack of Efficacy|39|||
94215351|NCT00087516|322583640|FG003|Overall Study|Lack of Efficacy|29|||
94215352|NCT00087516|322583637|FG000|Overall Study|Lost to Follow-up|8|||
94215353|NCT00087516|322583638|FG001|Overall Study|Lost to Follow-up|6|||
94215354|NCT00087516|322583639|FG002|Overall Study|Lost to Follow-up|5|||
94215355|NCT00087516|322583640|FG003|Overall Study|Lost to Follow-up|5|||
94215356|NCT00087516|322583637|FG000|Overall Study|Protocol Violation|4|||
94215357|NCT00087516|322583638|FG001|Overall Study|Protocol Violation|8|||
94215358|NCT00087516|322583639|FG002|Overall Study|Protocol Violation|3|||
94215359|NCT00087516|322583640|FG003|Overall Study|Protocol Violation|6|||
94215360|NCT00087516|322583637|FG000|Overall Study|Withdrawal by Subject|16|||
94215361|NCT00087516|322583638|FG001|Overall Study|Withdrawal by Subject|27|||
94215362|NCT00087516|322583639|FG002|Overall Study|Withdrawal by Subject|11|||
94215363|NCT00087516|322583640|FG003|Overall Study|Withdrawal by Subject|12|||
94215364|NCT00087516|322583637|FG000|Overall Study|Site terminated|0|||
94215365|NCT00087516|322583638|FG001|Overall Study|Site terminated|2|||
94215366|NCT00087516|322583639|FG002|Overall Study|Site terminated|1|||
94215367|NCT00087516|322583640|FG003|Overall Study|Site terminated|0|||
94215368|NCT00087516|322583637|FG000|Overall Study|Protocol specified discontinuation|35|||
94215369|NCT00087516|322583638|FG001|Overall Study|Protocol specified discontinuation|33|||
94215370|NCT00087516|322583639|FG002|Overall Study|Protocol specified discontinuation|33|||
94215371|NCT00087516|322583640|FG003|Overall Study|Protocol specified discontinuation|26|||
94215372|NCT00087516|322583637|FG000|Overall Study|Patient moved|3|||
94215373|NCT00087516|322583638|FG001|Overall Study|Patient moved|2|||
94215374|NCT00087516|322583639|FG002|Overall Study|Patient moved|1|||
94467859|NCT01739764|323502426|FG001|Overall Study|Multiple Reasons|2|||
94215375|NCT00087516|322583640|FG003|Overall Study|Patient moved|0|||
94215376|NCT00087516|322583637|FG000|Overall Study|Patient was non-compliant|3|||
94215377|NCT00087516|322583638|FG001|Overall Study|Patient was non-compliant|1|||
94215378|NCT00087516|322583639|FG002|Overall Study|Patient was non-compliant|0|||
94215379|NCT00087516|322583640|FG003|Overall Study|Patient was non-compliant|0|||
94215380|NCT00087516|322583637|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
94215381|NCT00087516|322583638|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
94215382|NCT00087516|322583639|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
94215383|NCT00087516|322583640|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
94215384|NCT00087516|322583637|FG000|Overall Study|Other|0|||
94215385|NCT00087516|322583638|FG001|Overall Study|Other|0|||
94215386|NCT00087516|322583639|FG002|Overall Study|Other|1|||
94215387|NCT00087516|322583640|FG003|Overall Study|Other|0|||
94215388|NCT00278395|322583641|FG000|Overall Study|Adverse Event|2|||
94215389|NCT00278395|322583641|FG000|Overall Study|Nonevaluable|1|||
94215390|NCT03236779|322583642|FG000|Overall Study|Lost to Follow-up|13|||
94286323|NCT02542072|322837486|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
94286324|NCT02542072|322837487|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
94286325|NCT02542072|322837486|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
94215391|NCT03236779|322583643|FG001|Overall Study|Lost to Follow-up|21|||
94215392|NCT00080119|322583644|FG000|Overall Study|Discontinued because of study closure|0|||
94215393|NCT00080119|322583645|FG001|Overall Study|Discontinued because of study closure|0|||
94215394|NCT00080119|322583646|FG002|Overall Study|Discontinued because of study closure|130|||
94215395|NCT00080119|322583647|FG003|Overall Study|Discontinued because of study closure|141|||
94215396|NCT00080119|322583644|FG000|Overall Study|Unable to get to clinic|24|||
94215397|NCT00080119|322583645|FG001|Overall Study|Unable to get to clinic|24|||
94215398|NCT00080119|322583646|FG002|Overall Study|Unable to get to clinic|7|||
94215399|NCT00080119|322583647|FG003|Overall Study|Unable to get to clinic|1|||
94215400|NCT00080119|322583644|FG000|Overall Study|Consent withdrawn|13|||
94215401|NCT00080119|322583645|FG001|Overall Study|Consent withdrawn|17|||
94215402|NCT00080119|322583646|FG002|Overall Study|Consent withdrawn|4|||
94215403|NCT00080119|322583647|FG003|Overall Study|Consent withdrawn|6|||
94215404|NCT00080119|322583644|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
94215405|NCT00080119|322583645|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
94215406|NCT00080119|322583646|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
94215407|NCT00080119|322583647|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
94215408|NCT00080119|322583644|FG000|Overall Study|Lost to Follow-up|16|||
94215409|NCT00080119|322583645|FG001|Overall Study|Lost to Follow-up|19|||
94215410|NCT00080119|322583646|FG002|Overall Study|Lost to Follow-up|19|||
94215411|NCT00080119|322583647|FG003|Overall Study|Lost to Follow-up|14|||
94215412|NCT00088166|322583651|FG000|Overall Study|Adverse Event|11|||
94215413|NCT00088166|322583652|FG001|Overall Study|Adverse Event|9|||
94215414|NCT00088166|322583651|FG000|Overall Study|Death|3|||
94215415|NCT00088166|322583652|FG001|Overall Study|Death|1|||
94215416|NCT00088166|322583651|FG000|Overall Study|Lost to Follow-up|0|||
94215417|NCT00088166|322583652|FG001|Overall Study|Lost to Follow-up|1|||
94215418|NCT00088166|322583651|FG000|Overall Study|Physician Decision|4|||
94215419|NCT00088166|322583652|FG001|Overall Study|Physician Decision|1|||
94215420|NCT00088166|322583651|FG000|Overall Study|Protocol Violation|1|||
94215421|NCT00088166|322583652|FG001|Overall Study|Protocol Violation|5|||
94215422|NCT00088166|322583651|FG000|Overall Study|Patient deterioration|29|||
94215423|NCT00088166|322583652|FG001|Overall Study|Patient deterioration|39|||
94215424|NCT00088166|322583651|FG000|Overall Study|Withdrawal by Subject|5|||
94215425|NCT00088166|322583652|FG001|Overall Study|Withdrawal by Subject|5|||
94215426|NCT01109979|322583663|FG000|Overall Study|Physician Decision|2|||
94286326|NCT02542072|322837487|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
94286327|NCT04556617|322837493|FG000|Overall Study|progressive disease|0|||
94286328|NCT04556617|322837494|FG001|Overall Study|progressive disease|2|||
94286329|NCT04556617|322837495|FG002|Overall Study|progressive disease|2|||
94286330|NCT04556617|322837496|FG003|Overall Study|progressive disease|1|||
94286331|NCT04556617|322837497|FG004|Overall Study|progressive disease|1|||
94286332|NCT04556617|322837493|FG000|Overall Study|Physician Decision|0|||
94286333|NCT04556617|322837494|FG001|Overall Study|Physician Decision|0|||
94286334|NCT04556617|322837495|FG002|Overall Study|Physician Decision|2|||
94286335|NCT04556617|322837496|FG003|Overall Study|Physician Decision|0|||
94215427|NCT01109979|322583664|FG001|Overall Study|Physician Decision|0|||
94215428|NCT01109979|322583663|FG000|Overall Study|Withdrawal by Subject|0|||
94215429|NCT01109979|322583664|FG001|Overall Study|Withdrawal by Subject|1|||
94215430|NCT02584257|322583666|FG000|Period 1|Withdrawal by Subject|0|||
94215431|NCT02584257|322583667|FG001|Period 1|Withdrawal by Subject|0|||
94215432|NCT02584257|322583668|FG002|Period 1|Withdrawal by Subject|0|||
94215433|NCT02584257|322583669|FG003|Period 1|Withdrawal by Subject|0|||
94215434|NCT02584257|322583670|FG004|Period 1|Withdrawal by Subject|0|||
94286336|NCT04556617|322837497|FG004|Overall Study|Physician Decision|0|||
94286337|NCT04556617|322837493|FG000|Overall Study|Adverse Event|0|||
94286338|NCT04556617|322837494|FG001|Overall Study|Adverse Event|0|||
94215435|NCT02584257|322583671|FG005|Period 1|Withdrawal by Subject|0|||
94215436|NCT02584257|322583672|FG006|Period 1|Withdrawal by Subject|1|||
94286339|NCT04556617|322837495|FG002|Overall Study|Adverse Event|2|||
94215437|NCT02584257|322583673|FG007|Period 1|Withdrawal by Subject|0|||
94215438|NCT02584257|322583674|FG008|Period 1|Withdrawal by Subject|0|||
94215439|NCT02584257|322583666|FG000|Period 2|Physician Decision|1|||
94215440|NCT02584257|322583667|FG001|Period 2|Physician Decision|0|||
94215441|NCT02584257|322583668|FG002|Period 2|Physician Decision|0|||
94215442|NCT02584257|322583669|FG003|Period 2|Physician Decision|0|||
94215443|NCT02584257|322583670|FG004|Period 2|Physician Decision|0|||
94215444|NCT02584257|322583671|FG005|Period 2|Physician Decision|0|||
94215445|NCT02584257|322583672|FG006|Period 2|Physician Decision|0|||
94215446|NCT02584257|322583673|FG007|Period 2|Physician Decision|0|||
94215447|NCT02584257|322583674|FG008|Period 2|Physician Decision|0|||
94215448|NCT02584257|322583666|FG000|Period 2|Adverse Event|0|||
94215449|NCT02584257|322583667|FG001|Period 2|Adverse Event|1|||
94215450|NCT02584257|322583668|FG002|Period 2|Adverse Event|0|||
94215451|NCT02584257|322583669|FG003|Period 2|Adverse Event|0|||
94215452|NCT02584257|322583670|FG004|Period 2|Adverse Event|0|||
94215453|NCT02584257|322583671|FG005|Period 2|Adverse Event|0|||
94215454|NCT02584257|322583672|FG006|Period 2|Adverse Event|0|||
94215455|NCT02584257|322583673|FG007|Period 2|Adverse Event|0|||
94215456|NCT02584257|322583674|FG008|Period 2|Adverse Event|0|||
94215457|NCT03136861|322583675|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
94215458|NCT03136861|322583676|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
94215459|NCT03136861|322583677|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
94215460|NCT03136861|322583678|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
94215461|NCT03136861|322583679|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
94215462|NCT03136861|322583680|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
94215463|NCT03136861|322583681|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
94215464|NCT03136861|322583675|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
94215465|NCT03136861|322583676|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
94215466|NCT03136861|322583677|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
94215467|NCT03136861|322583678|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
94215468|NCT03136861|322583679|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
94215469|NCT03136861|322583680|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
94215470|NCT03136861|322583681|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
94215471|NCT03136861|322583675|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
94215472|NCT03136861|322583676|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
94215473|NCT03136861|322583677|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
94215474|NCT03136861|322583678|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
94215475|NCT03136861|322583679|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
94215476|NCT03136861|322583680|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
94215477|NCT03136861|322583681|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
94215478|NCT03136861|322583675|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
94215479|NCT03136861|322583676|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
94215480|NCT03136861|322583677|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
94215481|NCT03136861|322583678|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
94215482|NCT03136861|322583679|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
94215483|NCT03136861|322583680|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
94215484|NCT03136861|322583681|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
94215485|NCT03136861|322583675|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
94215486|NCT03136861|322583676|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
94215487|NCT03136861|322583677|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
94215488|NCT03136861|322583678|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
94215489|NCT03136861|322583679|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
94215490|NCT03136861|322583680|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
94215491|NCT03136861|322583681|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
94215492|NCT03136861|322583675|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
94215493|NCT03136861|322583676|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
94215494|NCT03136861|322583677|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
94215495|NCT03136861|322583678|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
94215496|NCT03136861|322583679|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
94215497|NCT03136861|322583680|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
94215498|NCT03136861|322583681|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
94215499|NCT03136861|322583675|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
94215500|NCT03136861|322583676|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
94215501|NCT03136861|322583677|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
94215502|NCT03136861|322583678|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
94215503|NCT03136861|322583679|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
94215504|NCT03136861|322583680|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
94215505|NCT03136861|322583681|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
94215506|NCT03136861|322583675|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
94372447|NCT04130919|323150261|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
94215507|NCT03136861|322583676|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
94215508|NCT03136861|322583677|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
94215509|NCT03136861|322583678|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
94215510|NCT03136861|322583679|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
94215511|NCT03136861|322583680|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
94215512|NCT03136861|322583681|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
94215513|NCT01543204|322583683|FG000|Overall Study|Non-compliance|1|||
94215514|NCT01543204|322583683|FG000|Overall Study|Adverse Event|1|||
94215515|NCT01543204|322583683|FG000|Overall Study|Withdrawal by Subject|4|||
94215516|NCT01543204|322583683|FG000|Overall Study|Requirement for Alternative Therapy|1|||
94215517|NCT01543204|322583683|FG000|Overall Study|Lost to Follow-up|1|||
94215518|NCT03146845|322583684|FG000|Overall Study|Reference ulcer healed|1|||
94215519|NCT03146845|322583685|FG001|Overall Study|Reference ulcer healed|0|||
94215520|NCT03146845|322583684|FG000|Overall Study|Physician Decision|1|||
94215521|NCT03146845|322583685|FG001|Overall Study|Physician Decision|0|||
94215522|NCT03146845|322583684|FG000|Overall Study|Adverse Event|1|||
94215523|NCT03146845|322583685|FG001|Overall Study|Adverse Event|0|||
94215524|NCT03146845|322583684|FG000|Overall Study|Withdrawal by Subject|2|||
94467860|NCT01739764|323502427|FG002|Overall Study|Multiple Reasons|3|||
94467861|NCT01739764|323502425|FG000|Overall Study|Physician Decision|2|||
94467862|NCT01739764|323502426|FG001|Overall Study|Physician Decision|2|||
94467863|NCT01739764|323502427|FG002|Overall Study|Physician Decision|4|||
94467864|NCT01739764|323502425|FG000|Overall Study|Progressive Disease|3|||
94467865|NCT01739764|323502426|FG001|Overall Study|Progressive Disease|5|||
94467866|NCT01739764|323502427|FG002|Overall Study|Progressive Disease|16|||
94467867|NCT01739764|323502425|FG000|Overall Study|Protocol Violation|0|||
94215525|NCT03146845|322583685|FG001|Overall Study|Withdrawal by Subject|0|||
94215526|NCT03146845|322583684|FG000|Overall Study|Noncompliance|0|||
94215527|NCT03146845|322583685|FG001|Overall Study|Noncompliance|1|||
94215528|NCT03146845|322583684|FG000|Overall Study|Protocol Violation|0|||
94215529|NCT03146845|322583685|FG001|Overall Study|Protocol Violation|2|||
94215530|NCT03146845|322583684|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
94215531|NCT03146845|322583685|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
94215532|NCT01052272|322583686|FG000|Overall Study|Death|0|||
94215533|NCT01052272|322583687|FG001|Overall Study|Death|0|||
94215534|NCT01052272|322583688|FG002|Overall Study|Death|1|||
94215535|NCT01052272|322583689|FG003|Overall Study|Death|1|||
94215536|NCT01052272|322583686|FG000|Overall Study|Physician Decision|0|||
94215537|NCT01052272|322583687|FG001|Overall Study|Physician Decision|1|||
94215538|NCT01052272|322583688|FG002|Overall Study|Physician Decision|0|||
94215539|NCT01052272|322583689|FG003|Overall Study|Physician Decision|0|||
94215540|NCT01052272|322583686|FG000|Overall Study|patient refuses follow-up|5|||
94215541|NCT01052272|322583687|FG001|Overall Study|patient refuses follow-up|4|||
94215542|NCT01052272|322583688|FG002|Overall Study|patient refuses follow-up|2|||
94215543|NCT01052272|322583689|FG003|Overall Study|patient refuses follow-up|4|||
94215544|NCT01052272|322583686|FG000|Overall Study|Withdrawal by Subject|0|||
94215545|NCT01052272|322583687|FG001|Overall Study|Withdrawal by Subject|2|||
94215546|NCT01052272|322583688|FG002|Overall Study|Withdrawal by Subject|3|||
94215547|NCT01052272|322583689|FG003|Overall Study|Withdrawal by Subject|2|||
94215548|NCT01052272|322583686|FG000|Overall Study|placed in long-term care|0|||
94215549|NCT01052272|322583687|FG001|Overall Study|placed in long-term care|0|||
94215550|NCT01052272|322583688|FG002|Overall Study|placed in long-term care|1|||
94215551|NCT01052272|322583689|FG003|Overall Study|placed in long-term care|0|||
94215552|NCT01052272|322583686|FG000|Overall Study|decline in health|0|||
94215553|NCT01052272|322583687|FG001|Overall Study|decline in health|0|||
94215554|NCT01052272|322583688|FG002|Overall Study|decline in health|1|||
94215555|NCT01052272|322583689|FG003|Overall Study|decline in health|0|||
94215556|NCT00113529|322583690|FG000|Overall Study|Adverse Event|4|||
94215557|NCT00113529|322583690|FG000|Overall Study|Lack of Efficacy|20|||
94215558|NCT00113529|322583690|FG000|Overall Study|Decision of sponsor|6|||
94215559|NCT00113529|322583690|FG000|Overall Study|Withdrawal by Subject|4|||
94215560|NCT00096278|322583694|FG000|Overall Study|No follow-up data|15|||
94215561|NCT00096278|322583695|FG001|Overall Study|No follow-up data|18|||
94215562|NCT00096278|322583694|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
94215563|NCT00096278|322583695|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
94215564|NCT00472082|322583696|FG000|Overall Study|Study prematurely terminated|5|||
94215565|NCT00595959|322583703|FG000|Overall Study|Withdrawal by Subject|1|||
94215566|NCT00595959|322583703|FG000|Overall Study|Lost to Follow-up|1|||
94215567|NCT02077374|322583704|FG000|Overall Study|Withdrawal by Subject|0|||
94215568|NCT02077374|322583705|FG001|Overall Study|Withdrawal by Subject|1|||
94215569|NCT02077374|322583704|FG000|Overall Study|Protocol Violation|0|||
94215570|NCT02077374|322583705|FG001|Overall Study|Protocol Violation|1|||
94215571|NCT00963924|322583706|FG000|Overall Study|Adverse Event|1|||
94215572|NCT00963924|322583707|FG001|Overall Study|Adverse Event|0|||
94215573|NCT00963924|322583706|FG000|Overall Study|Withdrawal by Subject|0|||
94215574|NCT00963924|322583707|FG001|Overall Study|Withdrawal by Subject|1|||
94215575|NCT00963924|322583706|FG000|Overall Study|Changed antipsychotic|0|||
94215576|NCT00963924|322583707|FG001|Overall Study|Changed antipsychotic|1|||
94215577|NCT00963924|322583706|FG000|Overall Study|Lost to Follow-up|0|||
94215578|NCT00963924|322583707|FG001|Overall Study|Lost to Follow-up|1|||
94215579|NCT03989232|322583708|FG000|Overall Study|Lost to Follow-up|3|||
94215580|NCT03989232|322583709|FG001|Overall Study|Lost to Follow-up|10|||
94215581|NCT03989232|322583708|FG000|Overall Study|Withdrawal by Subject|6|||
94215582|NCT03989232|322583709|FG001|Overall Study|Withdrawal by Subject|6|||
94215583|NCT03989232|322583708|FG000|Overall Study|Death|1|||
94215584|NCT03989232|322583709|FG001|Overall Study|Death|2|||
94215585|NCT02764320|322583710|FG000|Overall Study|Withdrawal by Subject|35|||
94215586|NCT02764320|322583711|FG001|Overall Study|Withdrawal by Subject|38|||
94215587|NCT02764320|322583710|FG000|Overall Study|Protocol Violation|11|||
94215588|NCT02764320|322583711|FG001|Overall Study|Protocol Violation|6|||
94215589|NCT02764320|322583710|FG000|Overall Study|Adverse Event|2|||
94215590|NCT02764320|322583711|FG001|Overall Study|Adverse Event|0|||
94215591|NCT02764320|322583710|FG000|Overall Study|Health Issues unable to continue|2|||
94286340|NCT04556617|322837496|FG003|Overall Study|Adverse Event|3|||
94286341|NCT04556617|322837497|FG004|Overall Study|Adverse Event|0|||
94286342|NCT04556617|322837493|FG000|Overall Study|Withdrawal by Subject|0|||
94215592|NCT02764320|322583711|FG001|Overall Study|Health Issues unable to continue|0|||
94215593|NCT02764320|322583710|FG000|Overall Study|Did not meet inclusion criteria|1|||
94215594|NCT02764320|322583711|FG001|Overall Study|Did not meet inclusion criteria|0|||
94215595|NCT02764320|322583710|FG000|Overall Study|Subject moved|0|||
94467868|NCT01739764|323502426|FG001|Overall Study|Protocol Violation|0|||
94215596|NCT02764320|322583711|FG001|Overall Study|Subject moved|2|||
94467869|NCT01739764|323502427|FG002|Overall Study|Protocol Violation|2|||
94215597|NCT02764320|322583710|FG000|Overall Study|Overused medication unavailable|0|||
94215598|NCT02764320|322583711|FG001|Overall Study|Overused medication unavailable|1|||
94215599|NCT02764320|322583710|FG000|Overall Study|Seeking care outside site|0|||
94215600|NCT02764320|322583711|FG001|Overall Study|Seeking care outside site|1|||
94215601|NCT02764320|322583710|FG000|Overall Study|Technology barriers|0|||
94215602|NCT02764320|322583711|FG001|Overall Study|Technology barriers|1|||
94215603|NCT00696241|322583722|FG000|Overall Study|Adverse Event|11|||
94215604|NCT00696241|322583723|FG001|Overall Study|Adverse Event|3|||
94215605|NCT00696241|322583724|FG002|Overall Study|Adverse Event|6|||
94215606|NCT00696241|322583725|FG003|Overall Study|Adverse Event|4|||
94215607|NCT00696241|322583726|FG004|Overall Study|Adverse Event|5|||
94215608|NCT00696241|322583722|FG000|Overall Study|Protocol Violation|1|||
94215609|NCT00696241|322583723|FG001|Overall Study|Protocol Violation|1|||
94215610|NCT00696241|322583724|FG002|Overall Study|Protocol Violation|2|||
94215611|NCT00696241|322583725|FG003|Overall Study|Protocol Violation|0|||
94215612|NCT00696241|322583726|FG004|Overall Study|Protocol Violation|3|||
94215613|NCT00696241|322583722|FG000|Overall Study|Lost to Follow-up|1|||
94215614|NCT00696241|322583723|FG001|Overall Study|Lost to Follow-up|4|||
94215615|NCT00696241|322583724|FG002|Overall Study|Lost to Follow-up|1|||
94215616|NCT00696241|322583725|FG003|Overall Study|Lost to Follow-up|2|||
94215617|NCT00696241|322583726|FG004|Overall Study|Lost to Follow-up|0|||
94215618|NCT00696241|322583722|FG000|Overall Study|Withdrawal by Subject|4|||
94215619|NCT00696241|322583723|FG001|Overall Study|Withdrawal by Subject|8|||
94215620|NCT00696241|322583724|FG002|Overall Study|Withdrawal by Subject|6|||
94215621|NCT00696241|322583725|FG003|Overall Study|Withdrawal by Subject|1|||
94215622|NCT00696241|322583726|FG004|Overall Study|Withdrawal by Subject|0|||
94215623|NCT00696241|322583722|FG000|Overall Study|Lack of Efficacy|1|||
94215624|NCT00696241|322583723|FG001|Overall Study|Lack of Efficacy|5|||
94215625|NCT00696241|322583724|FG002|Overall Study|Lack of Efficacy|4|||
94215626|NCT00696241|322583725|FG003|Overall Study|Lack of Efficacy|5|||
94215627|NCT00696241|322583726|FG004|Overall Study|Lack of Efficacy|3|||
94215628|NCT00696241|322583722|FG000|Overall Study|Other|6|||
94215629|NCT00696241|322583723|FG001|Overall Study|Other|1|||
94215630|NCT00696241|322583724|FG002|Overall Study|Other|5|||
94215631|NCT00696241|322583725|FG003|Overall Study|Other|2|||
94215632|NCT00696241|322583726|FG004|Overall Study|Other|1|||
94215633|NCT02132195|322583729|FG000|Initial Assignment|Relapsed|14|||
94215634|NCT02132195|322583730|FG001|Initial Assignment|Relapsed|0|||
94215635|NCT02132195|322583731|FG002|Initial Assignment|Relapsed|0|||
94215636|NCT02132195|322583729|FG000|Rescue Therapy|Relapsed|0|||
94215637|NCT02132195|322583730|FG001|Rescue Therapy|Relapsed|0|||
94215638|NCT02132195|322583731|FG002|Rescue Therapy|Relapsed|7|||
94215639|NCT02132195|322583729|FG000|Rescue Therapy|Physician Decision|0|||
94215640|NCT02132195|322583730|FG001|Rescue Therapy|Physician Decision|0|||
94215641|NCT02132195|322583731|FG002|Rescue Therapy|Physician Decision|1|||
94215642|NCT02132195|322583729|FG000|Rescue Therapy|Withdrawal by Subject|0|||
94215643|NCT02132195|322583730|FG001|Rescue Therapy|Withdrawal by Subject|0|||
94215644|NCT02132195|322583731|FG002|Rescue Therapy|Withdrawal by Subject|1|||
94215645|NCT02132195|322583729|FG000|Rescue Therapy|Adverse Event|0|||
94215646|NCT02132195|322583730|FG001|Rescue Therapy|Adverse Event|0|||
94215647|NCT02132195|322583731|FG002|Rescue Therapy|Adverse Event|2|||
94215648|NCT00617708|322583732|FG000|Overall Study|Adverse Event|0|||
94215649|NCT00617708|322583733|FG001|Overall Study|Adverse Event|6|||
94215650|NCT00617708|322583734|FG002|Overall Study|Adverse Event|9|||
94215651|NCT00617708|322583732|FG000|Overall Study|Withdrawal by Subject|1|||
94215652|NCT00617708|322583733|FG001|Overall Study|Withdrawal by Subject|1|||
94215653|NCT00617708|322583734|FG002|Overall Study|Withdrawal by Subject|7|||
94215654|NCT00617708|322583732|FG000|Overall Study|Death|0|||
94215655|NCT00617708|322583733|FG001|Overall Study|Death|6|||
94215656|NCT00617708|322583734|FG002|Overall Study|Death|5|||
94215657|NCT00617708|322583732|FG000|Overall Study|Progression/Relapse|7|||
94215658|NCT00617708|322583733|FG001|Overall Study|Progression/Relapse|40|||
94286343|NCT04556617|322837494|FG001|Overall Study|Withdrawal by Subject|2|||
94215659|NCT00617708|322583734|FG002|Overall Study|Progression/Relapse|36|||
94215660|NCT00617708|322583732|FG000|Overall Study|Not protocol specified|1|||
94215661|NCT00617708|322583733|FG001|Overall Study|Not protocol specified|4|||
94215662|NCT00617708|322583734|FG002|Overall Study|Not protocol specified|2|||
94215663|NCT00617708|322583732|FG000|Overall Study|Not eligible|1|||
94215664|NCT00617708|322583733|FG001|Overall Study|Not eligible|3|||
94215665|NCT00617708|322583734|FG002|Overall Study|Not eligible|5|||
94215666|NCT00321555|322583735|FG000|Overall Study|Developed antibodies|1|||
94215667|NCT00321555|322583735|FG000|Overall Study|Switched to alternative treatment|3|||
94215668|NCT00321555|322583735|FG000|Overall Study|Physician Decision|1|||
94215669|NCT00321555|322583735|FG000|Overall Study|Disease progression on study|1|||
94215670|NCT04749797|322583738|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
94215671|NCT04749797|322583739|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
94215672|NCT04749797|322583740|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
94215673|NCT02291549|322583744|FG000|Overall Study|Lost to Follow-up|1|||
94215674|NCT02291549|322583745|FG001|Overall Study|Lost to Follow-up|0|||
94215675|NCT02291549|322583744|FG000|Overall Study|Withdrawal by Subject|0|||
94215676|NCT02291549|322583745|FG001|Overall Study|Withdrawal by Subject|1|||
94215677|NCT01697956|322583746|FG000|Overall Study|Protocol Violation|1|||
94215678|NCT01697956|322583747|FG001|Overall Study|Protocol Violation|1|||
94286344|NCT04556617|322837495|FG002|Overall Study|Withdrawal by Subject|1|||
94286345|NCT04556617|322837496|FG003|Overall Study|Withdrawal by Subject|1|||
94286346|NCT04556617|322837497|FG004|Overall Study|Withdrawal by Subject|0|||
94286347|NCT04556617|322837493|FG000|Overall Study|PSA increase|0|||
94286348|NCT04556617|322837494|FG001|Overall Study|PSA increase|1|||
94286349|NCT04556617|322837495|FG002|Overall Study|PSA increase|0|||
94286350|NCT04556617|322837496|FG003|Overall Study|PSA increase|0|||
94286351|NCT04556617|322837497|FG004|Overall Study|PSA increase|0|||
94215679|NCT02561195|322583749|FG000|Vaccination 1 to 3|Adverse Event|4|||
94215680|NCT02561195|322583750|FG001|Vaccination 1 to 3|Adverse Event|5|||
94215681|NCT02561195|322583751|FG002|Vaccination 1 to 3|Adverse Event|0|||
94215682|NCT02561195|322583752|FG003|Vaccination 1 to 3|Adverse Event|3|||
94215683|NCT02561195|322583753|FG004|Vaccination 1 to 3|Adverse Event|4|||
94215684|NCT02561195|322583754|FG005|Vaccination 1 to 3|Adverse Event|0|||
94215685|NCT02561195|322583755|FG006|Vaccination 1 to 3|Adverse Event|0|||
94215686|NCT02561195|322583756|FG007|Vaccination 1 to 3|Adverse Event|0|||
94215687|NCT02561195|322583757|FG008|Vaccination 1 to 3|Adverse Event|0|||
94215688|NCT02561195|322583758|FG009|Vaccination 1 to 3|Adverse Event|0|||
94215689|NCT02561195|322583759|FG010|Vaccination 1 to 3|Adverse Event|0|||
94215690|NCT02561195|322583760|FG011|Vaccination 1 to 3|Adverse Event|0|||
94215691|NCT02561195|322583761|FG012|Vaccination 1 to 3|Adverse Event|0|||
94215692|NCT02561195|322583762|FG013|Vaccination 1 to 3|Adverse Event|0|||
94215693|NCT02561195|322583749|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
94215694|NCT02561195|322583750|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
94215695|NCT02561195|322583751|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
94215696|NCT02561195|322583752|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
94215697|NCT02561195|322583753|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
94215698|NCT02561195|322583754|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
94215699|NCT02561195|322583755|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
94215700|NCT02561195|322583756|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
94215701|NCT02561195|322583757|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
94215702|NCT02561195|322583758|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
94215703|NCT02561195|322583759|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
94215704|NCT02561195|322583760|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
94215705|NCT02561195|322583761|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
94215706|NCT02561195|322583762|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
94215707|NCT02561195|322583749|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
94215708|NCT02561195|322583750|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
94215709|NCT02561195|322583751|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
94215710|NCT02561195|322583752|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
94215711|NCT02561195|322583753|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
94215712|NCT02561195|322583754|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
94215713|NCT02561195|322583755|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
94215714|NCT02561195|322583756|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
94215715|NCT02561195|322583757|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
94215716|NCT02561195|322583758|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
94215717|NCT02561195|322583759|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
94215718|NCT02561195|322583760|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
94215719|NCT02561195|322583761|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
94215720|NCT02561195|322583762|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
94215721|NCT02561195|322583749|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
94215722|NCT02561195|322583750|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
94286352|NCT04556617|322837493|FG000|Overall Study|Sponsor study termination|1|||
94215723|NCT02561195|322583751|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
94215724|NCT02561195|322583752|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
94215725|NCT02561195|322583753|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
94215726|NCT02561195|322583754|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
94215727|NCT02561195|322583755|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
94215728|NCT02561195|322583756|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
94215729|NCT02561195|322583757|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
94215730|NCT02561195|322583758|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
94215731|NCT02561195|322583759|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
94215732|NCT02561195|322583760|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
94215733|NCT02561195|322583761|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
94215734|NCT02561195|322583762|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
94286353|NCT04556617|322837494|FG001|Overall Study|Sponsor study termination|0|||
94286354|NCT04556617|322837495|FG002|Overall Study|Sponsor study termination|0|||
94286355|NCT04556617|322837496|FG003|Overall Study|Sponsor study termination|0|||
94215735|NCT02561195|322583749|FG000|Vaccination 1 to 3|Other|7|||
94215736|NCT02561195|322583750|FG001|Vaccination 1 to 3|Other|3|||
94215737|NCT02561195|322583751|FG002|Vaccination 1 to 3|Other|1|||
94215738|NCT02561195|322583752|FG003|Vaccination 1 to 3|Other|7|||
94215739|NCT02561195|322583753|FG004|Vaccination 1 to 3|Other|5|||
94215740|NCT02561195|322583754|FG005|Vaccination 1 to 3|Other|1|||
94215741|NCT02561195|322583755|FG006|Vaccination 1 to 3|Other|0|||
94215742|NCT02561195|322583756|FG007|Vaccination 1 to 3|Other|0|||
94215743|NCT02561195|322583757|FG008|Vaccination 1 to 3|Other|0|||
94215744|NCT02561195|322583758|FG009|Vaccination 1 to 3|Other|0|||
94215745|NCT02561195|322583759|FG010|Vaccination 1 to 3|Other|0|||
94215746|NCT02561195|322583760|FG011|Vaccination 1 to 3|Other|0|||
94215747|NCT02561195|322583761|FG012|Vaccination 1 to 3|Other|0|||
94215748|NCT02561195|322583762|FG013|Vaccination 1 to 3|Other|0|||
94215749|NCT02561195|322583749|FG000|Vaccination 1 to 3|Protocol Violation|1|||
94215750|NCT02561195|322583750|FG001|Vaccination 1 to 3|Protocol Violation|0|||
94215751|NCT02561195|322583751|FG002|Vaccination 1 to 3|Protocol Violation|1|||
94215752|NCT02561195|322583752|FG003|Vaccination 1 to 3|Protocol Violation|2|||
94215753|NCT02561195|322583753|FG004|Vaccination 1 to 3|Protocol Violation|5|||
94215754|NCT02561195|322583754|FG005|Vaccination 1 to 3|Protocol Violation|2|||
94215755|NCT02561195|322583755|FG006|Vaccination 1 to 3|Protocol Violation|0|||
94215756|NCT02561195|322583756|FG007|Vaccination 1 to 3|Protocol Violation|0|||
94215757|NCT02561195|322583757|FG008|Vaccination 1 to 3|Protocol Violation|0|||
94215758|NCT02561195|322583758|FG009|Vaccination 1 to 3|Protocol Violation|0|||
94215759|NCT02561195|322583759|FG010|Vaccination 1 to 3|Protocol Violation|0|||
94215760|NCT02561195|322583760|FG011|Vaccination 1 to 3|Protocol Violation|0|||
94215761|NCT02561195|322583761|FG012|Vaccination 1 to 3|Protocol Violation|0|||
94215762|NCT02561195|322583762|FG013|Vaccination 1 to 3|Protocol Violation|0|||
94215763|NCT02561195|322583749|FG000|Vaccination 1 to 3|Death|2|||
94215764|NCT02561195|322583750|FG001|Vaccination 1 to 3|Death|1|||
94215765|NCT02561195|322583751|FG002|Vaccination 1 to 3|Death|0|||
94215766|NCT02561195|322583752|FG003|Vaccination 1 to 3|Death|2|||
94215767|NCT02561195|322583753|FG004|Vaccination 1 to 3|Death|0|||
94215768|NCT02561195|322583754|FG005|Vaccination 1 to 3|Death|0|||
94215769|NCT02561195|322583755|FG006|Vaccination 1 to 3|Death|0|||
94215770|NCT02561195|322583756|FG007|Vaccination 1 to 3|Death|0|||
94215771|NCT02561195|322583757|FG008|Vaccination 1 to 3|Death|0|||
94215772|NCT02561195|322583758|FG009|Vaccination 1 to 3|Death|0|||
94215773|NCT02561195|322583759|FG010|Vaccination 1 to 3|Death|0|||
94215774|NCT02561195|322583760|FG011|Vaccination 1 to 3|Death|0|||
94215775|NCT02561195|322583761|FG012|Vaccination 1 to 3|Death|0|||
94215776|NCT02561195|322583762|FG013|Vaccination 1 to 3|Death|0|||
94215777|NCT02561195|322583749|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
94215778|NCT02561195|322583750|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
94215779|NCT02561195|322583751|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
94215780|NCT02561195|322583752|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
94215781|NCT02561195|322583753|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
94215782|NCT02561195|322583754|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
94215783|NCT02561195|322583755|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
94215784|NCT02561195|322583756|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
94215785|NCT02561195|322583757|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
94215786|NCT02561195|322583758|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
94286356|NCT04556617|322837497|FG004|Overall Study|Sponsor study termination|0|||
94286357|NCT04949841|322837498|FG000|Overall Study|Adverse Event|7|||
94286358|NCT04949841|322837498|FG000|Overall Study|Death|1|||
94215787|NCT02561195|322583759|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
94215788|NCT02561195|322583760|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
94215789|NCT02561195|322583761|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
94215790|NCT02561195|322583762|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
94215791|NCT02561195|322583749|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
94215792|NCT02561195|322583750|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
94215793|NCT02561195|322583751|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
94215794|NCT02561195|322583752|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
94215795|NCT02561195|322583753|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
94215796|NCT02561195|322583754|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
94215797|NCT02561195|322583755|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
94215798|NCT02561195|322583756|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
94215799|NCT02561195|322583757|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
94215800|NCT02561195|322583758|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
94215801|NCT02561195|322583759|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
94215802|NCT02561195|322583760|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
94215803|NCT02561195|322583761|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
94215804|NCT02561195|322583762|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
94215805|NCT02561195|322583749|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
94215806|NCT02561195|322583750|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
94215807|NCT02561195|322583751|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
94215808|NCT02561195|322583752|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
94215809|NCT02561195|322583753|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
94215810|NCT02561195|322583754|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
94215811|NCT02561195|322583755|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
94215812|NCT02561195|322583756|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
94215813|NCT02561195|322583757|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
94215814|NCT02561195|322583758|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
94215815|NCT02561195|322583759|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
94215816|NCT02561195|322583760|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
94215817|NCT02561195|322583761|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
94215818|NCT02561195|322583762|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
94215819|NCT02561195|322583749|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
94215820|NCT02561195|322583750|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
94215821|NCT02561195|322583751|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
94215822|NCT02561195|322583752|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
94215823|NCT02561195|322583753|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
94215824|NCT02561195|322583754|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
94215825|NCT02561195|322583755|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
94215826|NCT02561195|322583756|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
94215827|NCT02561195|322583757|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
94215828|NCT02561195|322583758|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
94215829|NCT02561195|322583759|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
94215830|NCT02561195|322583760|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
94215831|NCT02561195|322583761|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
94215832|NCT02561195|322583762|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
94215833|NCT02561195|322583749|FG000|Extension Stage (Vaccination 4)|Death|0|||
94215834|NCT02561195|322583750|FG001|Extension Stage (Vaccination 4)|Death|0|||
94215835|NCT02561195|322583751|FG002|Extension Stage (Vaccination 4)|Death|0|||
94215836|NCT02561195|322583752|FG003|Extension Stage (Vaccination 4)|Death|0|||
94215837|NCT02561195|322583753|FG004|Extension Stage (Vaccination 4)|Death|0|||
94286359|NCT04949841|322837498|FG000|Overall Study|Withdrawal by Subject|52|||
94286360|NCT04949841|322837498|FG000|Overall Study|Pregnancy|4|||
94286361|NCT04949841|322837498|FG000|Overall Study|Lost to Follow-up|9|||
94286362|NCT04949841|322837498|FG000|Overall Study|Lack of Efficacy|55|||
94286363|NCT04949841|322837498|FG000|Overall Study|Various reasons|9|||
94286364|NCT03179436|322837503|FG000|Overall Study|Withdrawal by Subject|1|||
94286365|NCT03179436|322837504|FG001|Overall Study|Withdrawal by Subject|0|||
94286366|NCT03179436|322837505|FG002|Overall Study|Withdrawal by Subject|0|||
94286367|NCT03179436|322837506|FG003|Overall Study|Withdrawal by Subject|4|||
94372448|NCT04130919|323150262|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
94372449|NCT02065791|323150263|FG000|Overall Study|Closed Site|1|||
94215838|NCT02561195|322583754|FG005|Extension Stage (Vaccination 4)|Death|0|||
94215839|NCT02561195|322583755|FG006|Extension Stage (Vaccination 4)|Death|0|||
94215840|NCT02561195|322583756|FG007|Extension Stage (Vaccination 4)|Death|0|||
94215841|NCT02561195|322583757|FG008|Extension Stage (Vaccination 4)|Death|0|||
94215842|NCT02561195|322583758|FG009|Extension Stage (Vaccination 4)|Death|1|||
94215843|NCT02561195|322583759|FG010|Extension Stage (Vaccination 4)|Death|0|||
94215844|NCT02561195|322583760|FG011|Extension Stage (Vaccination 4)|Death|0|||
94286368|NCT03179436|322837507|FG004|Overall Study|Withdrawal by Subject|2|||
94286369|NCT03179436|322837508|FG005|Overall Study|Withdrawal by Subject|2|||
94372450|NCT02065791|323150264|FG001|Overall Study|Closed Site|1|||
94215845|NCT02561195|322583761|FG012|Extension Stage (Vaccination 4)|Death|0|||
94215846|NCT02561195|322583762|FG013|Extension Stage (Vaccination 4)|Death|0|||
94215847|NCT02561195|322583749|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
94215848|NCT02561195|322583750|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
94215849|NCT02561195|322583751|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
94215850|NCT02561195|322583752|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
94215851|NCT02561195|322583753|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
94215852|NCT02561195|322583754|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
94215853|NCT02561195|322583755|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
94215854|NCT02561195|322583756|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
94215855|NCT02561195|322583757|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
94215856|NCT02561195|322583758|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
94215857|NCT02561195|322583759|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
94215858|NCT02561195|322583760|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
94215859|NCT02561195|322583761|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
94215860|NCT02561195|322583762|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
94215861|NCT02561195|322583749|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
94215862|NCT02561195|322583750|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
94215863|NCT02561195|322583751|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
94215864|NCT02561195|322583752|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
94215865|NCT02561195|322583753|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
94215866|NCT02561195|322583754|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
94215867|NCT02561195|322583755|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
94215868|NCT02561195|322583756|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
94215869|NCT02561195|322583757|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
94215870|NCT02561195|322583758|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
94215871|NCT02561195|322583759|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
94215872|NCT02561195|322583760|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
94215873|NCT02561195|322583761|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
94215874|NCT02561195|322583762|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
94215875|NCT02561195|322583749|FG000|Extension Stage (Vaccination 4)|Other|0|||
94215876|NCT02561195|322583750|FG001|Extension Stage (Vaccination 4)|Other|0|||
94215877|NCT02561195|322583751|FG002|Extension Stage (Vaccination 4)|Other|0|||
94215878|NCT02561195|322583752|FG003|Extension Stage (Vaccination 4)|Other|0|||
94215879|NCT02561195|322583753|FG004|Extension Stage (Vaccination 4)|Other|0|||
94215880|NCT02561195|322583754|FG005|Extension Stage (Vaccination 4)|Other|0|||
94215881|NCT02561195|322583755|FG006|Extension Stage (Vaccination 4)|Other|0|||
94215882|NCT02561195|322583756|FG007|Extension Stage (Vaccination 4)|Other|0|||
94215883|NCT02561195|322583757|FG008|Extension Stage (Vaccination 4)|Other|0|||
94215884|NCT02561195|322583758|FG009|Extension Stage (Vaccination 4)|Other|0|||
94215885|NCT02561195|322583759|FG010|Extension Stage (Vaccination 4)|Other|2|||
94215886|NCT02561195|322583760|FG011|Extension Stage (Vaccination 4)|Other|2|||
94215887|NCT02561195|322583761|FG012|Extension Stage (Vaccination 4)|Other|1|||
94215888|NCT02561195|322583762|FG013|Extension Stage (Vaccination 4)|Other|0|||
94215889|NCT02561195|322583749|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
94215890|NCT02561195|322583750|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
94215891|NCT02561195|322583751|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
94215892|NCT02561195|322583752|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
94215893|NCT02561195|322583753|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
94215894|NCT02561195|322583754|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
94215895|NCT02561195|322583755|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
94215896|NCT02561195|322583756|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
94215897|NCT02561195|322583757|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
94215898|NCT02561195|322583758|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
94215899|NCT02561195|322583759|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
94215900|NCT02561195|322583760|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
94215901|NCT02561195|322583761|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
94215902|NCT02561195|322583762|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
94215903|NCT02612285|322583764|FG000|Overall Study|Withdrawal by Subject|1|||
94215904|NCT02548585|322583765|FG000|Overall Study|Withdrawal by Subject|0|||
94372451|NCT02065791|323150263|FG000|Overall Study|Withdrawal by Subject|11|||
94372452|NCT02065791|323150264|FG001|Overall Study|Withdrawal by Subject|5|||
94215905|NCT02548585|322583766|FG001|Overall Study|Withdrawal by Subject|0|||
94372453|NCT02065791|323150263|FG000|Overall Study|Lost to Follow-up|13|||
94215906|NCT02548585|322583767|FG002|Overall Study|Withdrawal by Subject|0|||
94215907|NCT02548585|322583768|FG003|Overall Study|Withdrawal by Subject|0|||
94215908|NCT02548585|322583769|FG004|Overall Study|Withdrawal by Subject|0|||
94372454|NCT02065791|323150264|FG001|Overall Study|Lost to Follow-up|9|||
94215909|NCT02548585|322583770|FG005|Overall Study|Withdrawal by Subject|1|||
94215910|NCT02548585|322583771|FG006|Overall Study|Withdrawal by Subject|0|||
94215911|NCT02548585|322583765|FG000|Overall Study|Lost to Follow-up|1|||
94215912|NCT02548585|322583766|FG001|Overall Study|Lost to Follow-up|0|||
94215913|NCT02548585|322583767|FG002|Overall Study|Lost to Follow-up|0|||
94215914|NCT02548585|322583768|FG003|Overall Study|Lost to Follow-up|0|||
94215915|NCT02548585|322583769|FG004|Overall Study|Lost to Follow-up|0|||
94215916|NCT02548585|322583770|FG005|Overall Study|Lost to Follow-up|0|||
94215917|NCT02548585|322583771|FG006|Overall Study|Lost to Follow-up|0|||
94215918|NCT02548585|322583765|FG000|Overall Study|Other|1|||
94215919|NCT02548585|322583766|FG001|Overall Study|Other|0|||
94215920|NCT02548585|322583767|FG002|Overall Study|Other|0|||
94215921|NCT02548585|322583768|FG003|Overall Study|Other|2|||
94215922|NCT02548585|322583769|FG004|Overall Study|Other|3|||
94215923|NCT02548585|322583770|FG005|Overall Study|Other|0|||
94215924|NCT02548585|322583771|FG006|Overall Study|Other|1|||
94215925|NCT02548585|322583765|FG000|Overall Study|Randomized but not treated|0|||
94215926|NCT02548585|322583766|FG001|Overall Study|Randomized but not treated|0|||
94215927|NCT02548585|322583767|FG002|Overall Study|Randomized but not treated|0|||
94215928|NCT02548585|322583768|FG003|Overall Study|Randomized but not treated|0|||
94215929|NCT02548585|322583769|FG004|Overall Study|Randomized but not treated|0|||
94215930|NCT02548585|322583770|FG005|Overall Study|Randomized but not treated|1|||
94215931|NCT02548585|322583771|FG006|Overall Study|Randomized but not treated|0|||
94215932|NCT00853957|322583776|FG000|Overall Study|Adverse Event|9|||
94215933|NCT00853957|322583777|FG001|Overall Study|Adverse Event|3|||
94215934|NCT00853957|322583776|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94215935|NCT00853957|322583777|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
94215936|NCT00853957|322583776|FG000|Overall Study|Subject withdrew consent|4|||
94215937|NCT00853957|322583777|FG001|Overall Study|Subject withdrew consent|5|||
94215938|NCT00853957|322583776|FG000|Overall Study|Lost to Follow-up|1|||
94215939|NCT00853957|322583777|FG001|Overall Study|Lost to Follow-up|6|||
94215940|NCT00853957|322583776|FG000|Overall Study|Protocol deviation|0|||
94215941|NCT00853957|322583777|FG001|Overall Study|Protocol deviation|3|||
94215942|NCT01898299|322583780|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
94215943|NCT01898299|322583781|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
94215944|NCT01159600|322583783|FG000|Overall Study|Not treated|0|||
94215945|NCT01159600|322583784|FG001|Overall Study|Not treated|0|||
94215946|NCT01159600|322583785|FG002|Overall Study|Not treated|1|||
94215947|NCT01159600|322583786|FG003|Overall Study|Not treated|0|||
94215948|NCT01159600|322583787|FG004|Overall Study|Not treated|0|||
94215949|NCT01159600|322583788|FG005|Overall Study|Not treated|1|||
94215950|NCT01159600|322583789|FG006|Overall Study|Not treated|2|||
94215951|NCT01159600|322583790|FG007|Overall Study|Not treated|2|||
94215952|NCT01159600|322583783|FG000|Overall Study|Adverse Event|7|||
94215953|NCT01159600|322583784|FG001|Overall Study|Adverse Event|2|||
94215954|NCT01159600|322583785|FG002|Overall Study|Adverse Event|5|||
94215955|NCT01159600|322583786|FG003|Overall Study|Adverse Event|1|||
94215956|NCT01159600|322583787|FG004|Overall Study|Adverse Event|8|||
94215957|NCT01159600|322583788|FG005|Overall Study|Adverse Event|6|||
94215958|NCT01159600|322583789|FG006|Overall Study|Adverse Event|7|||
94215959|NCT01159600|322583790|FG007|Overall Study|Adverse Event|5|||
94215960|NCT01159600|322583783|FG000|Overall Study|Lack of Efficacy|0|||
94215961|NCT01159600|322583784|FG001|Overall Study|Lack of Efficacy|0|||
94215962|NCT01159600|322583785|FG002|Overall Study|Lack of Efficacy|0|||
94215963|NCT01159600|322583786|FG003|Overall Study|Lack of Efficacy|0|||
94215964|NCT01159600|322583787|FG004|Overall Study|Lack of Efficacy|2|||
94215965|NCT01159600|322583788|FG005|Overall Study|Lack of Efficacy|0|||
94215966|NCT01159600|322583789|FG006|Overall Study|Lack of Efficacy|0|||
94467870|NCT01739764|323502425|FG000|Overall Study|Study Terminated by Sponsor|8|||
94215967|NCT01159600|322583790|FG007|Overall Study|Lack of Efficacy|1|||
94215968|NCT01159600|322583783|FG000|Overall Study|Non compliant with protocol|2|||
94215969|NCT01159600|322583784|FG001|Overall Study|Non compliant with protocol|1|||
94215970|NCT01159600|322583785|FG002|Overall Study|Non compliant with protocol|0|||
94215971|NCT01159600|322583786|FG003|Overall Study|Non compliant with protocol|0|||
94215972|NCT01159600|322583787|FG004|Overall Study|Non compliant with protocol|2|||
94215973|NCT01159600|322583788|FG005|Overall Study|Non compliant with protocol|0|||
94215974|NCT01159600|322583789|FG006|Overall Study|Non compliant with protocol|2|||
94215975|NCT01159600|322583790|FG007|Overall Study|Non compliant with protocol|0|||
94215976|NCT01159600|322583783|FG000|Overall Study|Lost to Follow-up|2|||
94215977|NCT01159600|322583784|FG001|Overall Study|Lost to Follow-up|3|||
94215978|NCT01159600|322583785|FG002|Overall Study|Lost to Follow-up|4|||
94215979|NCT01159600|322583786|FG003|Overall Study|Lost to Follow-up|3|||
94215980|NCT01159600|322583787|FG004|Overall Study|Lost to Follow-up|3|||
94215981|NCT01159600|322583788|FG005|Overall Study|Lost to Follow-up|0|||
94215982|NCT01159600|322583789|FG006|Overall Study|Lost to Follow-up|3|||
94215983|NCT01159600|322583790|FG007|Overall Study|Lost to Follow-up|2|||
94215984|NCT01159600|322583783|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
94215985|NCT01159600|322583784|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
94215986|NCT01159600|322583785|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
94215987|NCT01159600|322583786|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
94215988|NCT01159600|322583787|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
94215989|NCT01159600|322583788|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
94215990|NCT01159600|322583789|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
94215991|NCT01159600|322583790|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
94215992|NCT01159600|322583783|FG000|Overall Study|Other reason not defined above|3|||
94215993|NCT01159600|322583784|FG001|Overall Study|Other reason not defined above|0|||
94215994|NCT01159600|322583785|FG002|Overall Study|Other reason not defined above|4|||
94215995|NCT01159600|322583786|FG003|Overall Study|Other reason not defined above|2|||
94215996|NCT01159600|322583787|FG004|Overall Study|Other reason not defined above|5|||
94215997|NCT01159600|322583788|FG005|Overall Study|Other reason not defined above|7|||
94215998|NCT01159600|322583789|FG006|Overall Study|Other reason not defined above|3|||
94215999|NCT01159600|322583790|FG007|Overall Study|Other reason not defined above|3|||
94216000|NCT04433091|322583791|FG000|Overall Study|Lost to Follow-up|1|||
94216001|NCT04433091|322583792|FG001|Overall Study|Lost to Follow-up|0|||
94216002|NCT04433091|322583791|FG000|Overall Study|Withdrawn .|2|||
94216003|NCT04433091|322583792|FG001|Overall Study|Withdrawn .|4|||
94216004|NCT04311983|322585143|FG000|Overall Study|Lost to Follow-up|421|||
94216005|NCT04311983|322585144|FG001|Overall Study|Lost to Follow-up|456|||
94216006|NCT04311983|322585143|FG000|Overall Study|Incomplete survey|7|||
94216007|NCT04311983|322585144|FG001|Overall Study|Incomplete survey|9|||
94216008|NCT04311983|322585143|FG000|Overall Study|Death|1|||
94216009|NCT04311983|322585144|FG001|Overall Study|Death|0|||
94216010|NCT02981953|322585145|FG000|Overall Study|Death|9|||
94216011|NCT02981953|322585145|FG000|Overall Study|Withdrawal by Subject|1|||
94216012|NCT02981953|322585145|FG000|Overall Study|Withdrawal to non-compliance|1|||
94216013|NCT01102426|322585154|FG000|Overall Study|Randomized but not treated|4|||
94216014|NCT01102426|322585155|FG001|Overall Study|Randomized but not treated|1|||
94216015|NCT01102426|322585154|FG000|Overall Study|Adverse Events (treatment-related)|15|||
94216016|NCT01102426|322585155|FG001|Overall Study|Adverse Events (treatment-related)|8|||
94216017|NCT01102426|322585154|FG000|Overall Study|Physician Decision|9|||
94216018|NCT01102426|322585155|FG001|Overall Study|Physician Decision|6|||
94216019|NCT01102426|322585154|FG000|Overall Study|Progressive Disease|85|||
94216020|NCT01102426|322585155|FG001|Overall Study|Progressive Disease|44|||
94216021|NCT01102426|322585154|FG000|Overall Study|Adverse Events (unrelated to|9|||
94216022|NCT01102426|322585155|FG001|Overall Study|Adverse Events (unrelated to|1|||
94216023|NCT01102426|322585154|FG000|Overall Study|Patient Refusal|24|||
94216024|NCT01102426|322585155|FG001|Overall Study|Patient Refusal|12|||
94216025|NCT01102426|322585154|FG000|Overall Study|Death (due to adverse events|0|||
94216026|NCT01102426|322585155|FG001|Overall Study|Death (due to adverse events|1|||
94216027|NCT01102426|322585154|FG000|Overall Study|Death (non-related to the study|19|||
94216028|NCT01102426|322585155|FG001|Overall Study|Death (non-related to the study|8|||
94216029|NCT03344458|322585156|FG000|Overall Study|Physician Decision|1|||
94216030|NCT03344458|322585156|FG000|Overall Study|Withdrawal by Subject|16|||
94216031|NCT03344458|322585156|FG000|Overall Study|Other reasons|10|||
94216032|NCT03344458|322585156|FG000|Overall Study|Lost to Follow-up|9|||
94216033|NCT03344458|322585156|FG000|Overall Study|Protocol Violation|3|||
94216034|NCT00476151|322585157|FG000|Overall Study|Adverse Event|0|||
94216035|NCT00476151|322585158|FG001|Overall Study|Adverse Event|2|||
94216036|NCT00476151|322585157|FG000|Overall Study|Protocol Violation|1|||
94216037|NCT00476151|322585158|FG001|Overall Study|Protocol Violation|3|||
94216038|NCT00476151|322585157|FG000|Overall Study|Withdrawal by Subject|2|||
94216039|NCT00476151|322585158|FG001|Overall Study|Withdrawal by Subject|0|||
94216040|NCT00476151|322585157|FG000|Overall Study|Physician Decision|0|||
94216041|NCT00476151|322585158|FG001|Overall Study|Physician Decision|2|||
94216042|NCT01393964|322585159|FG000|Overall Study|Disease Progression|4|||
94216043|NCT01393964|322585160|FG001|Overall Study|Disease Progression|3|||
94216044|NCT01393964|322585161|FG002|Overall Study|Disease Progression|5|||
94216045|NCT01393964|322585159|FG000|Overall Study|Study drug toxicity|1|||
94216046|NCT01393964|322585160|FG001|Overall Study|Study drug toxicity|0|||
94216047|NCT01393964|322585161|FG002|Overall Study|Study drug toxicity|0|||
94216048|NCT01393964|322585159|FG000|Overall Study|Withdrawal by Subject|0|||
94216049|NCT01393964|322585160|FG001|Overall Study|Withdrawal by Subject|0|||
94216050|NCT01393964|322585161|FG002|Overall Study|Withdrawal by Subject|1|||
94216051|NCT01393964|322585159|FG000|Overall Study|Adverse event unrelated to study drug|0|||
94216052|NCT01393964|322585160|FG001|Overall Study|Adverse event unrelated to study drug|3|||
94216053|NCT01393964|322585161|FG002|Overall Study|Adverse event unrelated to study drug|0|||
94216054|NCT01393964|322585159|FG000|Overall Study|Subject request stop study treatment|0|||
94216055|NCT01393964|322585160|FG001|Overall Study|Subject request stop study treatment|1|||
94216056|NCT01393964|322585161|FG002|Overall Study|Subject request stop study treatment|0|||
94216057|NCT01393964|322585159|FG000|Overall Study|Subject decided to move to transplant|1|||
94216058|NCT01393964|322585160|FG001|Overall Study|Subject decided to move to transplant|0|||
94216059|NCT01393964|322585161|FG002|Overall Study|Subject decided to move to transplant|0|||
94216060|NCT01393964|322585159|FG000|Overall Study|Subject switched to commercial supply|1|||
94216061|NCT01393964|322585160|FG001|Overall Study|Subject switched to commercial supply|0|||
94216062|NCT01393964|322585161|FG002|Overall Study|Subject switched to commercial supply|2|||
94216063|NCT01393964|322585159|FG000|Overall Study|Subject plateaued in terms of effect|1|||
94216064|NCT01393964|322585160|FG001|Overall Study|Subject plateaued in terms of effect|0|||
94216065|NCT01393964|322585161|FG002|Overall Study|Subject plateaued in terms of effect|0|||
94216066|NCT01393964|322585159|FG000|Overall Study|Investigator removed subject from study|0|||
94216067|NCT01393964|322585160|FG001|Overall Study|Investigator removed subject from study|1|||
94216068|NCT01393964|322585161|FG002|Overall Study|Investigator removed subject from study|0|||
94216069|NCT01393964|322585159|FG000|Overall Study|Subject converted to roll-over study|0|||
94216070|NCT01393964|322585160|FG001|Overall Study|Subject converted to roll-over study|1|||
94216071|NCT01393964|322585161|FG002|Overall Study|Subject converted to roll-over study|0|||
94216072|NCT01393964|322585159|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
94216073|NCT01393964|322585160|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
94216074|NCT01393964|322585161|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
94216075|NCT02988713|322585164|FG000|Overall Study|Withdrawal by Subject|1|||
94216076|NCT02988713|322585164|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
94216077|NCT03265132|322585165|FG000|Overall Study|Adverse Event|0|||
94216078|NCT03265132|322585166|FG001|Overall Study|Adverse Event|1|||
94216079|NCT03265132|322585165|FG000|Overall Study|Lack of Efficacy|0|||
94216080|NCT03265132|322585166|FG001|Overall Study|Lack of Efficacy|2|||
94216081|NCT03265132|322585165|FG000|Overall Study|Progressive disease|0|||
94216082|NCT03265132|322585166|FG001|Overall Study|Progressive disease|2|||
94216083|NCT03265132|322585165|FG000|Overall Study|Withdrawal by Subject|0|||
94216084|NCT03265132|322585166|FG001|Overall Study|Withdrawal by Subject|1|||
94216085|NCT00417885|322585170|FG000|Overall Study|Adverse Event|1|||
94216086|NCT00417885|322585170|FG000|Overall Study|Objective Progression or Relapse|3|||
94216087|NCT00417885|322585170|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
94216088|NCT03390166|322585171|FG000|Overall Study|Death|0|||
94216089|NCT03390166|322585172|FG001|Overall Study|Death|1|||
94216090|NCT03390166|322585171|FG000|Overall Study|Lost to Follow-up|6|||
94216091|NCT03390166|322585172|FG001|Overall Study|Lost to Follow-up|4|||
94216092|NCT03390166|322585171|FG000|Overall Study|Physician Decision|2|||
94216093|NCT03390166|322585172|FG001|Overall Study|Physician Decision|1|||
94216094|NCT03390166|322585171|FG000|Overall Study|Move from study area|3|||
94216095|NCT03390166|322585172|FG001|Overall Study|Move from study area|2|||
94216096|NCT03390166|322585171|FG000|Overall Study|To militarycamp for conscript|1|||
94216097|NCT03390166|322585172|FG001|Overall Study|To militarycamp for conscript|0|||
94216098|NCT03390166|322585171|FG000|Overall Study|To drug therapy course|0|||
94216099|NCT03390166|322585172|FG001|Overall Study|To drug therapy course|1|||
94216100|NCT03390166|322585171|FG000|Overall Study|Move to work oversea|0|||
94216101|NCT03390166|322585172|FG001|Overall Study|Move to work oversea|1|||
94216102|NCT03693989|322585173|FG000|Overall Study|Protocol Violation|3|||
94216103|NCT03693989|322585174|FG001|Overall Study|Protocol Violation|4|||
94216104|NCT02721147|322585177|FG000|Overall Study|Lost to Follow-up|2|||
94216105|NCT02721147|322585178|FG001|Overall Study|Lost to Follow-up|0|||
94216106|NCT02721147|322585179|FG002|Overall Study|Lost to Follow-up|0|||
94216107|NCT01722097|322585180|FG000|Overall Study|Patient sheets not returned|6|||
94216108|NCT01722097|322585181|FG001|Overall Study|Patient sheets not returned|5|||
94216109|NCT01535261|322585186|FG000|Overall Study|Physician Decision|8|||
94216110|NCT01535261|322585186|FG000|Overall Study|Protocol Violation|3|||
94216111|NCT01535261|322585186|FG000|Overall Study|Death|5|||
94216112|NCT01535261|322585186|FG000|Overall Study|Lost to Follow-up|8|||
94216113|NCT01535261|322585186|FG000|Overall Study|Withdrawal by Subject|14|||
94216114|NCT01535261|322585186|FG000|Overall Study|Adverse Event|12|||
94216115|NCT01912599|322585190|FG000|Overall Study|Withdrawal by Subject|0|||
94216116|NCT01912599|322585191|FG001|Overall Study|Withdrawal by Subject|1|||
94216117|NCT04739306|322585192|FG000|Main Study Period|Adverse Event|6|||
94216118|NCT04739306|322585193|FG001|Main Study Period|Adverse Event|7|||
94216119|NCT04739306|322585192|FG000|Main Study Period|Lost to Follow-up|4|||
94216120|NCT04739306|322585193|FG001|Main Study Period|Lost to Follow-up|6|||
94216121|NCT04739306|322585192|FG000|Main Study Period|Physician Decision|1|||
94216122|NCT04739306|322585193|FG001|Main Study Period|Physician Decision|1|||
94216123|NCT04739306|322585192|FG000|Main Study Period|Withdrawal by Subject|8|||
94216124|NCT04739306|322585193|FG001|Main Study Period|Withdrawal by Subject|6|||
94216125|NCT04739306|322585192|FG000|Main Study Period|Protocol Violation|0|||
94216126|NCT04739306|322585193|FG001|Main Study Period|Protocol Violation|1|||
94216127|NCT04739306|322585192|FG000|Main Study Period|War in Ukraine|1|||
94216128|NCT04739306|322585193|FG001|Main Study Period|War in Ukraine|1|||
94216129|NCT00648895|322585194|FG000|Overall Study|Lack of Efficacy|0|||
94216130|NCT00648895|322585195|FG001|Overall Study|Lack of Efficacy|1|||
94216131|NCT01280721|322585196|FG000|Overall Study|Adverse Event|4|||
94216132|NCT01280721|322585196|FG000|Overall Study|Physician Decision|3|||
94216133|NCT01280721|322585196|FG000|Overall Study|Withdrawal by Subject|6|||
94216134|NCT01280721|322585196|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
94216135|NCT01280721|322585196|FG000|Overall Study|No tolerability for the lowest dose|2|||
94286370|NCT03179436|322837509|FG006|Overall Study|Withdrawal by Subject|5|||
94286371|NCT03179436|322837510|FG007|Overall Study|Withdrawal by Subject|0|||
94286372|NCT03179436|322837511|FG008|Overall Study|Withdrawal by Subject|3|||
94286373|NCT03179436|322837512|FG009|Overall Study|Withdrawal by Subject|0|||
94286374|NCT03179436|322837513|FG010|Overall Study|Withdrawal by Subject|0|||
94286375|NCT03179436|322837514|FG011|Overall Study|Withdrawal by Subject|0|||
94286376|NCT03179436|322837503|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94286377|NCT03179436|322837504|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94286378|NCT03179436|322837505|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
94286379|NCT03179436|322837506|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
94286380|NCT03179436|322837507|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
94286381|NCT03179436|322837508|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
94467871|NCT01739764|323502426|FG001|Overall Study|Study Terminated by Sponsor|13|||
94467872|NCT01739764|323502427|FG002|Overall Study|Study Terminated by Sponsor|26|||
94467873|NCT01739764|323502425|FG000|Overall Study|Withdrawal by Subject|6|||
94216136|NCT01180400|322585197|FG000|Overall Study|Withdrawal by Subject|5|||
94216137|NCT01180400|322585198|FG001|Overall Study|Withdrawal by Subject|6|||
94216138|NCT01180400|322585197|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
94216139|NCT01180400|322585198|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
94216140|NCT01180400|322585197|FG000|Overall Study|Adverse Event|12|||
94216141|NCT01180400|322585198|FG001|Overall Study|Adverse Event|10|||
94216142|NCT01180400|322585197|FG000|Overall Study|Severe non-compliance to protocol|1|||
94216143|NCT01180400|322585198|FG001|Overall Study|Severe non-compliance to protocol|2|||
94216144|NCT01180400|322585197|FG000|Overall Study|Condition under investigation worsened|2|||
94216145|NCT01180400|322585198|FG001|Overall Study|Condition under investigation worsened|1|||
94216146|NCT01180400|322585197|FG000|Overall Study|Lack of Efficacy|2|||
94216147|NCT01180400|322585198|FG001|Overall Study|Lack of Efficacy|0|||
94216148|NCT01180400|322585197|FG000|Overall Study|Study-specific withdrawal criteria|1|||
94216149|NCT01180400|322585198|FG001|Overall Study|Study-specific withdrawal criteria|2|||
94216150|NCT01180400|322585197|FG000|Overall Study|Lost to Follow-up|2|||
94216151|NCT01180400|322585198|FG001|Overall Study|Lost to Follow-up|3|||
94216152|NCT01180400|322585197|FG000|Overall Study|Other|0|||
94216153|NCT01180400|322585198|FG001|Overall Study|Other|1|||
94216154|NCT03326856|322585199|FG000|Overall Study|Lost to Follow-up|1|||
94216155|NCT03326856|322585200|FG001|Overall Study|Lost to Follow-up|1|||
94216156|NCT03326856|322585201|FG002|Overall Study|Lost to Follow-up|0|||
94216157|NCT03326856|322585202|FG003|Overall Study|Lost to Follow-up|0|||
94216158|NCT03326856|322585203|FG004|Overall Study|Lost to Follow-up|0|||
94216159|NCT03349476|322585204|FG000|Overall Study|Physician Decision|3|||
94216160|NCT00700999|322585205|FG000|Overall Study|Lost to Follow-up|7|||
94216161|NCT00700999|322585206|FG001|Overall Study|Lost to Follow-up|7|||
94216162|NCT00700999|322585205|FG000|Overall Study|Excluded - did not meet study criteria|0|||
94216163|NCT00700999|322585206|FG001|Overall Study|Excluded - did not meet study criteria|1|||
94216164|NCT00700999|322585205|FG000|Overall Study|Withdrawal by Subject|8|||
94216165|NCT00700999|322585206|FG001|Overall Study|Withdrawal by Subject|1|||
94216166|NCT00244751|322585207|FG000|Overall Study|Adverse Event|7|||
94216167|NCT00244751|322585208|FG001|Overall Study|Adverse Event|7|||
94216168|NCT00244751|322585209|FG002|Overall Study|Adverse Event|5|||
94216169|NCT00244751|322585207|FG000|Overall Study|Lost to Follow-up|0|||
94216170|NCT00244751|322585208|FG001|Overall Study|Lost to Follow-up|1|||
94216171|NCT00244751|322585209|FG002|Overall Study|Lost to Follow-up|0|||
94216172|NCT00244751|322585207|FG000|Overall Study|Protocol Violation|1|||
94216173|NCT00244751|322585208|FG001|Overall Study|Protocol Violation|0|||
94216174|NCT00244751|322585209|FG002|Overall Study|Protocol Violation|1|||
94216175|NCT00244751|322585207|FG000|Overall Study|Withdrawal by Subject|7|||
94216176|NCT00244751|322585208|FG001|Overall Study|Withdrawal by Subject|5|||
94216177|NCT00244751|322585209|FG002|Overall Study|Withdrawal by Subject|3|||
94216178|NCT00244751|322585207|FG000|Overall Study|Elevated liver enzymes|1|||
94216179|NCT00244751|322585208|FG001|Overall Study|Elevated liver enzymes|0|||
94216180|NCT00244751|322585209|FG002|Overall Study|Elevated liver enzymes|0|||
94216181|NCT00244751|322585207|FG000|Overall Study|Lack of compliance with protocol|0|||
94216182|NCT00244751|322585208|FG001|Overall Study|Lack of compliance with protocol|1|||
94216183|NCT00244751|322585209|FG002|Overall Study|Lack of compliance with protocol|0|||
94216184|NCT00244751|322585207|FG000|Overall Study|Safety reasons|0|||
94216185|NCT00244751|322585208|FG001|Overall Study|Safety reasons|1|||
94216186|NCT00244751|322585209|FG002|Overall Study|Safety reasons|0|||
94216187|NCT00244751|322585207|FG000|Overall Study|Participant randomized by mistake|0|||
94216188|NCT00244751|322585208|FG001|Overall Study|Participant randomized by mistake|0|||
94216189|NCT00244751|322585209|FG002|Overall Study|Participant randomized by mistake|1|||
94216190|NCT04908488|322585210|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
94216191|NCT04908488|322585211|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
94216192|NCT04908488|322585210|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
94216193|NCT04908488|322585211|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
94216194|NCT02877680|322585216|FG000|Overall Study|Lost to Follow-up|1|||
94216195|NCT02877680|322585217|FG001|Overall Study|Lost to Follow-up|1|||
94286382|NCT03179436|322837509|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
94286383|NCT03179436|322837510|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
94286384|NCT03179436|322837511|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
94286385|NCT03179436|322837512|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
94286386|NCT03179436|322837513|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
94286387|NCT03179436|322837514|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
94286388|NCT03179436|322837503|FG000|Overall Study|Sponsor Decision|0|||
94216196|NCT02206607|322585218|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
94216197|NCT02206607|322585219|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
94216198|NCT02206607|322585220|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
94216199|NCT02206607|322585221|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
94216200|NCT02206607|322585222|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
94216201|NCT02206607|322585218|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
94216202|NCT02206607|322585219|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
94216203|NCT02206607|322585220|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
94216204|NCT02206607|322585221|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
94216205|NCT02206607|322585222|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
94216206|NCT01014013|322585223|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
94216207|NCT01014013|322585224|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
94216208|NCT01014013|322585223|FG000|Overall Study|Clinical adverse experience|4|||
94216209|NCT01014013|322585224|FG001|Overall Study|Clinical adverse experience|2|||
94216210|NCT01014013|322585223|FG000|Overall Study|Laboratory adverse experience|1|||
94216211|NCT01014013|322585224|FG001|Overall Study|Laboratory adverse experience|1|||
94216212|NCT01014013|322585223|FG000|Overall Study|Protocol Violation|1|||
94216213|NCT01014013|322585224|FG001|Overall Study|Protocol Violation|3|||
94216214|NCT01014013|322585223|FG000|Overall Study|Withdrawal by Subject|7|||
94216215|NCT01014013|322585224|FG001|Overall Study|Withdrawal by Subject|4|||
94216216|NCT01014013|322585223|FG000|Overall Study|Clinical/microbiologic failure|1|||
94216217|NCT01014013|322585224|FG001|Overall Study|Clinical/microbiologic failure|2|||
94216218|NCT01014013|322585223|FG000|Overall Study|Pathogen culture = no growth|26|||
94216219|NCT01014013|322585224|FG001|Overall Study|Pathogen culture = no growth|34|||
94216220|NCT01014013|322585223|FG000|Overall Study|Negative urine culture|2|||
94216221|NCT01014013|322585224|FG001|Overall Study|Negative urine culture|0|||
94216222|NCT01014013|322585223|FG000|Overall Study|Pathogen resistant|7|||
94216223|NCT01014013|322585224|FG001|Overall Study|Pathogen resistant|4|||
94216224|NCT01014013|322585223|FG000|Overall Study|Physician Decision|0|||
94216225|NCT01014013|322585224|FG001|Overall Study|Physician Decision|1|||
94216226|NCT01014013|322585223|FG000|Overall Study|Another antibiotic therapy required|0|||
94216227|NCT01014013|322585224|FG001|Overall Study|Another antibiotic therapy required|1|||
94216228|NCT01014013|322585223|FG000|Overall Study|Appendectomy|1|||
94216229|NCT01014013|322585224|FG001|Overall Study|Appendectomy|0|||
94216230|NCT01014013|322585223|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
94216231|NCT01014013|322585224|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
94216232|NCT00446095|322585227|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
94216233|NCT00446095|322585228|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
94216234|NCT00446095|322585229|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
94216235|NCT00446095|322585230|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
94216236|NCT00446095|322585231|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
94216237|NCT00446095|322585227|FG000|Phase II (8 Weeks)|Adverse Event|0|||
94216238|NCT00446095|322585228|FG001|Phase II (8 Weeks)|Adverse Event|1|||
94216239|NCT00446095|322585229|FG002|Phase II (8 Weeks)|Adverse Event|1|||
94216240|NCT00446095|322585230|FG003|Phase II (8 Weeks)|Adverse Event|0|||
94216241|NCT00446095|322585231|FG004|Phase II (8 Weeks)|Adverse Event|0|||
94216242|NCT00446095|322585227|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
94216243|NCT00446095|322585228|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
94216244|NCT00446095|322585229|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
94216245|NCT00446095|322585230|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
94216246|NCT00446095|322585231|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
94216247|NCT00446095|322585227|FG000|Phase II (8 Weeks)|Physician Decision|1|||
94216248|NCT00446095|322585228|FG001|Phase II (8 Weeks)|Physician Decision|0|||
94216249|NCT00446095|322585229|FG002|Phase II (8 Weeks)|Physician Decision|0|||
94216250|NCT00446095|322585230|FG003|Phase II (8 Weeks)|Physician Decision|0|||
94216251|NCT00446095|322585231|FG004|Phase II (8 Weeks)|Physician Decision|0|||
94216252|NCT00446095|322585227|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
94216253|NCT00446095|322585228|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
94216254|NCT00446095|322585229|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
94216255|NCT00446095|322585230|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
94216256|NCT00446095|322585231|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
94216257|NCT00446095|322585227|FG000|Phase II (8 Weeks)|Ongoing|0|||
94216258|NCT00446095|322585228|FG001|Phase II (8 Weeks)|Ongoing|0|||
94286389|NCT03179436|322837504|FG001|Overall Study|Sponsor Decision|0|||
94286390|NCT03179436|322837505|FG002|Overall Study|Sponsor Decision|1|||
94286391|NCT03179436|322837506|FG003|Overall Study|Sponsor Decision|3|||
94286392|NCT03179436|322837507|FG004|Overall Study|Sponsor Decision|9|||
94286393|NCT03179436|322837508|FG005|Overall Study|Sponsor Decision|7|||
94286394|NCT03179436|322837509|FG006|Overall Study|Sponsor Decision|2|||
94286395|NCT03179436|322837510|FG007|Overall Study|Sponsor Decision|4|||
94286396|NCT03179436|322837511|FG008|Overall Study|Sponsor Decision|23|||
94372455|NCT01664494|323150265|FG000|Overall Study|Withdrawal by Subject|27|||
94216259|NCT00446095|322585229|FG002|Phase II (8 Weeks)|Ongoing|1|||
94216260|NCT00446095|322585230|FG003|Phase II (8 Weeks)|Ongoing|0|||
94216261|NCT00446095|322585231|FG004|Phase II (8 Weeks)|Ongoing|0|||
94216262|NCT00446095|322585227|FG000|Phase I (28 Days)|Adverse Event|0|||
94216263|NCT00446095|322585228|FG001|Phase I (28 Days)|Adverse Event|0|||
94216264|NCT00446095|322585229|FG002|Phase I (28 Days)|Adverse Event|0|||
94216265|NCT00446095|322585230|FG003|Phase I (28 Days)|Adverse Event|1|||
94216266|NCT00446095|322585231|FG004|Phase I (28 Days)|Adverse Event|0|||
94216267|NCT00446095|322585227|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
94216268|NCT00446095|322585228|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
94286397|NCT03179436|322837512|FG009|Overall Study|Sponsor Decision|6|||
94286398|NCT03179436|322837513|FG010|Overall Study|Sponsor Decision|7|||
94216269|NCT00446095|322585229|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
94216270|NCT00446095|322585230|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
94216271|NCT00446095|322585231|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
94216272|NCT03031782|322585233|FG000|Treatment Period 1|Lack of Efficacy|3|||
94216273|NCT03031782|322585234|FG001|Treatment Period 1|Lack of Efficacy|0|||
94216274|NCT03031782|322585235|FG002|Treatment Period 1|Lack of Efficacy|0|||
94216275|NCT03031782|322585236|FG003|Treatment Period 1|Lack of Efficacy|0|||
94216276|NCT03031782|322585237|FG004|Treatment Period 1|Lack of Efficacy|0|||
94216277|NCT03031782|322585233|FG000|Treatment Period 2|Physician Decision|0|||
94216278|NCT03031782|322585234|FG001|Treatment Period 2|Physician Decision|1|||
94216279|NCT03031782|322585235|FG002|Treatment Period 2|Physician Decision|0|||
94216280|NCT03031782|322585236|FG003|Treatment Period 2|Physician Decision|0|||
94216281|NCT03031782|322585237|FG004|Treatment Period 2|Physician Decision|3|||
94216282|NCT03031782|322585233|FG000|Treatment Period 2|Lack of Efficacy|0|||
94216283|NCT03031782|322585234|FG001|Treatment Period 2|Lack of Efficacy|1|||
94216284|NCT03031782|322585235|FG002|Treatment Period 2|Lack of Efficacy|0|||
94216285|NCT03031782|322585236|FG003|Treatment Period 2|Lack of Efficacy|0|||
94216286|NCT03031782|322585237|FG004|Treatment Period 2|Lack of Efficacy|1|||
94216287|NCT03031782|322585233|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94216288|NCT03031782|322585234|FG001|Treatment Period 2|Withdrawal by Subject|3|||
94216289|NCT03031782|322585235|FG002|Treatment Period 2|Withdrawal by Subject|0|||
94216290|NCT03031782|322585236|FG003|Treatment Period 2|Withdrawal by Subject|0|||
94216291|NCT03031782|322585237|FG004|Treatment Period 2|Withdrawal by Subject|1|||
94216292|NCT03031782|322585233|FG000|Treatment Period 2|Adverse Event|0|||
94216293|NCT03031782|322585234|FG001|Treatment Period 2|Adverse Event|1|||
94216294|NCT03031782|322585235|FG002|Treatment Period 2|Adverse Event|2|||
94216295|NCT03031782|322585236|FG003|Treatment Period 2|Adverse Event|0|||
94216296|NCT03031782|322585237|FG004|Treatment Period 2|Adverse Event|0|||
94216297|NCT03031782|322585233|FG000|Treatment Period 3|Withdrawal by Subject|0|||
94216298|NCT03031782|322585234|FG001|Treatment Period 3|Withdrawal by Subject|0|||
94216299|NCT03031782|322585235|FG002|Treatment Period 3|Withdrawal by Subject|0|||
94216300|NCT03031782|322585236|FG003|Treatment Period 3|Withdrawal by Subject|1|||
94216301|NCT03031782|322585237|FG004|Treatment Period 3|Withdrawal by Subject|0|||
94216302|NCT00657709|322585238|FG000|Overall Study|AE or Death|7|||
94216303|NCT00657709|322585239|FG001|Overall Study|AE or Death|7|||
94216304|NCT00657709|322585240|FG002|Overall Study|AE or Death|6|||
94216305|NCT00657709|322585241|FG003|Overall Study|AE or Death|7|||
94216306|NCT00657709|322585242|FG004|Overall Study|AE or Death|1|||
94216307|NCT00657709|322585238|FG000|Overall Study|Withdrawal by Subject|7|||
94216308|NCT00657709|322585239|FG001|Overall Study|Withdrawal by Subject|15|||
94216309|NCT00657709|322585240|FG002|Overall Study|Withdrawal by Subject|15|||
94216310|NCT00657709|322585241|FG003|Overall Study|Withdrawal by Subject|5|||
94216311|NCT00657709|322585242|FG004|Overall Study|Withdrawal by Subject|9|||
94216312|NCT00657709|322585238|FG000|Overall Study|Lost to Follow-up|9|||
94216313|NCT00657709|322585239|FG001|Overall Study|Lost to Follow-up|9|||
94216314|NCT00657709|322585240|FG002|Overall Study|Lost to Follow-up|7|||
94216315|NCT00657709|322585241|FG003|Overall Study|Lost to Follow-up|1|||
94216316|NCT00657709|322585242|FG004|Overall Study|Lost to Follow-up|21|||
94216317|NCT00657709|322585238|FG000|Overall Study|Protocol Violation|0|||
94216318|NCT00657709|322585239|FG001|Overall Study|Protocol Violation|2|||
94216319|NCT00657709|322585240|FG002|Overall Study|Protocol Violation|0|||
94216320|NCT00657709|322585241|FG003|Overall Study|Protocol Violation|1|||
94216321|NCT00657709|322585242|FG004|Overall Study|Protocol Violation|2|||
94216322|NCT00442559|322585243|FG000|Overall Study|Lost to Follow-up|32|||
94216323|NCT00442559|322585244|FG001|Overall Study|Lost to Follow-up|34|||
94216324|NCT00442559|322585243|FG000|Overall Study|Protocol Violation|1|||
94216325|NCT00442559|322585244|FG001|Overall Study|Protocol Violation|1|||
94216326|NCT00442559|322585243|FG000|Overall Study|Withdrawal by Subject|1|||
94216327|NCT00442559|322585244|FG001|Overall Study|Withdrawal by Subject|0|||
94286399|NCT03179436|322837514|FG011|Overall Study|Sponsor Decision|5|||
94286400|NCT03179436|322837503|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
94286401|NCT03179436|322837504|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
94286402|NCT03179436|322837505|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
94286403|NCT03179436|322837506|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
94216328|NCT01280656|322585245|FG000|Overall Study|Adverse Event|1|||
94216329|NCT01280656|322585246|FG001|Overall Study|Adverse Event|14|||
94216330|NCT01280656|322585247|FG002|Overall Study|Adverse Event|13|||
94216331|NCT01280656|322585245|FG000|Overall Study|Lack of Efficacy|1|||
94216332|NCT01280656|322585246|FG001|Overall Study|Lack of Efficacy|22|||
94216333|NCT01280656|322585247|FG002|Overall Study|Lack of Efficacy|38|||
94216334|NCT01280656|322585245|FG000|Overall Study|Treatment shortening (RGT)|0|||
94216335|NCT01280656|322585246|FG001|Overall Study|Treatment shortening (RGT)|4|||
94216336|NCT01280656|322585247|FG002|Overall Study|Treatment shortening (RGT)|5|||
94216337|NCT01280656|322585245|FG000|Overall Study|Other|1|||
94216338|NCT01280656|322585246|FG001|Overall Study|Other|7|||
94216339|NCT01280656|322585247|FG002|Overall Study|Other|7|||
94216340|NCT04930263|322585248|FG000|Overall Study|Withdrawal by Subject|3|||
94216341|NCT04930263|322585249|FG001|Overall Study|Withdrawal by Subject|5|||
94216342|NCT03979040|322585250|FG000|Overall Study|Withdrawal by Subject|24|||
94216343|NCT03979040|322585251|FG001|Overall Study|Withdrawal by Subject|32|||
94216344|NCT03979040|322585250|FG000|Overall Study|randomized but never started treatment|32|||
94216345|NCT03979040|322585251|FG001|Overall Study|randomized but never started treatment|39|||
94216346|NCT03979040|322585250|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
94216347|NCT03979040|322585251|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
94216348|NCT01441596|322585252|FG000|Overall Study|Other reason not defined below|0|||
94216349|NCT01441596|322585253|FG001|Overall Study|Other reason not defined below|2|||
94216350|NCT01441596|322585254|FG002|Overall Study|Other reason not defined below|1|||
94216351|NCT01441596|322585252|FG000|Overall Study|Withdrawal by Subject|4|||
94216352|NCT01441596|322585253|FG001|Overall Study|Withdrawal by Subject|0|||
94216353|NCT01441596|322585254|FG002|Overall Study|Withdrawal by Subject|2|||
94216354|NCT01441596|322585252|FG000|Overall Study|Not treated|0|||
94216355|NCT01441596|322585253|FG001|Overall Study|Not treated|1|||
94216356|NCT01441596|322585254|FG002|Overall Study|Not treated|1|||
94216357|NCT00512902|322585255|FG000|Overall Study|Adverse Event|7|||
94286404|NCT03179436|322837507|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
94286405|NCT03179436|322837508|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
94286406|NCT03179436|322837509|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
94286407|NCT03179436|322837510|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
94286408|NCT03179436|322837511|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
94286409|NCT03179436|322837512|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
94286410|NCT03179436|322837513|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
94286411|NCT03179436|322837514|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
94286412|NCT03179436|322837503|FG000|Overall Study|Lost to Follow-up|1|||
94286413|NCT03179436|322837504|FG001|Overall Study|Lost to Follow-up|0|||
94286414|NCT03179436|322837505|FG002|Overall Study|Lost to Follow-up|0|||
94286415|NCT03179436|322837506|FG003|Overall Study|Lost to Follow-up|1|||
94286416|NCT03179436|322837507|FG004|Overall Study|Lost to Follow-up|0|||
94286417|NCT03179436|322837508|FG005|Overall Study|Lost to Follow-up|1|||
94286418|NCT03179436|322837509|FG006|Overall Study|Lost to Follow-up|0|||
94286419|NCT03179436|322837510|FG007|Overall Study|Lost to Follow-up|0|||
94286420|NCT03179436|322837511|FG008|Overall Study|Lost to Follow-up|1|||
94286421|NCT03179436|322837512|FG009|Overall Study|Lost to Follow-up|1|||
94286422|NCT03179436|322837513|FG010|Overall Study|Lost to Follow-up|0|||
94286423|NCT03179436|322837514|FG011|Overall Study|Lost to Follow-up|0|||
94286424|NCT03179436|322837503|FG000|Overall Study|Death|12|||
94286425|NCT03179436|322837504|FG001|Overall Study|Death|17|||
94286426|NCT03179436|322837505|FG002|Overall Study|Death|7|||
94286427|NCT03179436|322837506|FG003|Overall Study|Death|32|||
94286428|NCT03179436|322837507|FG004|Overall Study|Death|29|||
94286429|NCT03179436|322837508|FG005|Overall Study|Death|30|||
94286430|NCT03179436|322837509|FG006|Overall Study|Death|33|||
94286431|NCT03179436|322837510|FG007|Overall Study|Death|9|||
94286432|NCT03179436|322837511|FG008|Overall Study|Death|84|||
94286433|NCT03179436|322837512|FG009|Overall Study|Death|33|||
94286434|NCT03179436|322837513|FG010|Overall Study|Death|22|||
94286435|NCT03179436|322837514|FG011|Overall Study|Death|15|||
94286436|NCT01078805|322837515|FG000|Overall Study|Clinically significant abnormal lab|5|||
94286437|NCT01078805|322837515|FG000|Overall Study|Death|134|||
94286438|NCT01078805|322837515|FG000|Overall Study|Lost to Follow-up|676|||
94286439|NCT01078805|322837515|FG000|Overall Study|Physician Decision|169|||
94286440|NCT01078805|322837515|FG000|Overall Study|Serious adverse event|26|||
94286441|NCT01078805|322837515|FG000|Overall Study|Sponsor decision|46|||
94286442|NCT01078805|322837515|FG000|Overall Study|Withdrawal by Subject|739|||
94286443|NCT01078805|322837515|FG000|Overall Study|Other|173|||
94286444|NCT01078805|322837515|FG000|Overall Study|Didn't take study drug|82|||
94286445|NCT01609842|322837516|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
94286446|NCT01609842|322837517|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
94286447|NCT05168267|322837518|FG000|Overall Study|Withdrawal by Subject|2|||
94286448|NCT05168267|322837519|FG001|Overall Study|Withdrawal by Subject|1|||
94286449|NCT05168267|322837518|FG000|Overall Study|Withdrawn by Therapist|1|||
94467874|NCT01739764|323502426|FG001|Overall Study|Withdrawal by Subject|5|||
94216358|NCT00512902|322585255|FG000|Overall Study|Lost to Follow-up|1|||
94216359|NCT01794689|322585256|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
94286450|NCT05168267|322837519|FG001|Overall Study|Withdrawn by Therapist|1|||
94286451|NCT05168267|322837518|FG000|Overall Study|Left Facility|1|||
94467875|NCT01739764|323502427|FG002|Overall Study|Withdrawal by Subject|27|||
94216360|NCT01794689|322585257|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
94286452|NCT05168267|322837519|FG001|Overall Study|Left Facility|0|||
94286453|NCT05702736|322837520|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
94286454|NCT05702736|322837521|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
94286455|NCT05702736|322837520|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
94216361|NCT01794689|322585258|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
94286456|NCT05702736|322837521|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
94286457|NCT02419508|322837522|FG000|Overall Study|Adverse Event|9|||
94286458|NCT02419508|322837523|FG001|Overall Study|Adverse Event|3|||
94286459|NCT02419508|322837522|FG000|Overall Study|Withdrawal by Subject|1|||
94286460|NCT02419508|322837523|FG001|Overall Study|Withdrawal by Subject|0|||
94286461|NCT02419508|322837522|FG000|Overall Study|Other - Reason not specified|0|||
94286462|NCT02419508|322837523|FG001|Overall Study|Other - Reason not specified|1|||
94286463|NCT00598975|322838892|FG000|Overall Study|Adverse Event|1|||
94286464|NCT00598975|322838893|FG001|Overall Study|Adverse Event|1|||
94286465|NCT00598975|322838892|FG000|Overall Study|Brain metastases|1|||
94286466|NCT00598975|322838893|FG001|Overall Study|Brain metastases|0|||
94286467|NCT00598975|322838892|FG000|Overall Study|Withdrawal by Subject|1|||
94286468|NCT00598975|322838893|FG001|Overall Study|Withdrawal by Subject|1|||
94286469|NCT00598975|322838892|FG000|Overall Study|Withdrawal of consent|0|||
94286470|NCT00598975|322838893|FG001|Overall Study|Withdrawal of consent|1|||
94286471|NCT00598975|322838892|FG000|Overall Study|Disease progression|8|||
94286472|NCT00598975|322838893|FG001|Overall Study|Disease progression|3|||
94286473|NCT00598975|322838892|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
94286474|NCT00598975|322838893|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
94286475|NCT03409744|322838895|FG000|Overall Study|Death|2|||
94286476|NCT03409744|322838895|FG000|Overall Study|Physician Decision|5|||
94286477|NCT03409744|322838895|FG000|Overall Study|Pregnancy|1|||
94286478|NCT03409744|322838895|FG000|Overall Study|Lost to Follow-up|1|||
94286479|NCT03409744|322838895|FG000|Overall Study|Protocol Violation|1|||
94286480|NCT01430442|322838898|FG000|Overall Study|Subject Withdrew Consent|3|||
94286481|NCT01430442|322838899|FG001|Overall Study|Subject Withdrew Consent|0|||
94286482|NCT01430442|322838900|FG002|Overall Study|Subject Withdrew Consent|1|||
94286483|NCT01430442|322838901|FG003|Overall Study|Subject Withdrew Consent|0|||
94286484|NCT01430442|322838902|FG004|Overall Study|Subject Withdrew Consent|2|||
94286485|NCT01430442|322838903|FG005|Overall Study|Subject Withdrew Consent|1|||
94286486|NCT01430442|322838904|FG006|Overall Study|Subject Withdrew Consent|5|||
94286487|NCT01430442|322838905|FG007|Overall Study|Subject Withdrew Consent|2|||
94286488|NCT01430442|322838898|FG000|Overall Study|Lost to Follow-up|2|||
94286489|NCT01430442|322838899|FG001|Overall Study|Lost to Follow-up|0|||
94372456|NCT01664494|323150265|FG000|Overall Study|Death|18|||
94372457|NCT01664494|323150265|FG000|Overall Study|Other|49|||
94372458|NCT01664494|323150265|FG000|Overall Study|Lost to Follow-up|99|||
94216362|NCT01794689|322585259|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
94216363|NCT01794689|322585256|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
94216364|NCT01794689|322585257|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
94216365|NCT01794689|322585258|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
94216366|NCT01794689|322585259|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
94216367|NCT01794689|322585256|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
94216368|NCT01794689|322585257|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
94216369|NCT01794689|322585258|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
94216370|NCT01794689|322585259|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
94216371|NCT01794689|322585256|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
94216372|NCT01794689|322585257|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
94216373|NCT01794689|322585258|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
94216374|NCT01794689|322585259|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
94216375|NCT01970527|322585260|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
94216376|NCT01970527|322585261|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
94216377|NCT01970527|322585260|FG000|Treatment|Disease progression|0|||
94216378|NCT01970527|322585261|FG001|Treatment|Disease progression|1|||
94216379|NCT01970527|322585260|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
94216380|NCT01970527|322585261|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
94216381|NCT01970527|322585260|FG000|Treatment|Death|0|||
94216382|NCT01970527|322585261|FG001|Treatment|Death|1|||
94216383|NCT01970527|322585260|FG000|Follow-up Clinic Visit|Disease progression|1|||
94216384|NCT01970527|322585261|FG001|Follow-up Clinic Visit|Disease progression|1|||
94216385|NCT01970527|322585260|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
94467876|NCT00337779|323502428|FG000|Overall Study|Withdrawal by Subject|10|||
94216386|NCT01970527|322585261|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
94216387|NCT01970527|322585260|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
94216388|NCT01970527|322585261|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
94216389|NCT03905512|322585262|FG000|Overall Study|Withdrawal by Subject|9|||
94216390|NCT03905512|322585263|FG001|Overall Study|Withdrawal by Subject|8|||
94216391|NCT03905512|322585262|FG000|Overall Study|Adverse Event|1|||
94216392|NCT03905512|322585263|FG001|Overall Study|Adverse Event|2|||
94216393|NCT03905512|322585262|FG000|Overall Study|Lost to Follow-up|4|||
94216394|NCT03905512|322585263|FG001|Overall Study|Lost to Follow-up|3|||
94216395|NCT03905512|322585262|FG000|Overall Study|Other than Specified|7|||
94216396|NCT03905512|322585263|FG001|Overall Study|Other than Specified|4|||
94216397|NCT00645411|322585267|FG000|Overall Study|Adverse Event|0|||
94216398|NCT00645411|322585268|FG001|Overall Study|Adverse Event|0|||
94216399|NCT00645411|322585269|FG002|Overall Study|Adverse Event|0|||
94216400|NCT00645411|322585270|FG003|Overall Study|Adverse Event|2|||
94216401|NCT00645411|322585267|FG000|Overall Study|Withdrawal by Subject|2|||
94216402|NCT00645411|322585268|FG001|Overall Study|Withdrawal by Subject|1|||
94216403|NCT00645411|322585269|FG002|Overall Study|Withdrawal by Subject|19|||
94216404|NCT00645411|322585270|FG003|Overall Study|Withdrawal by Subject|21|||
94216405|NCT00645411|322585267|FG000|Overall Study|Lost to Follow-up|10|||
94216406|NCT00645411|322585268|FG001|Overall Study|Lost to Follow-up|5|||
94216407|NCT00645411|322585269|FG002|Overall Study|Lost to Follow-up|124|||
94216408|NCT00645411|322585270|FG003|Overall Study|Lost to Follow-up|75|||
94216409|NCT00645411|322585267|FG000|Overall Study|Protocol Violation|1|||
94216410|NCT00645411|322585268|FG001|Overall Study|Protocol Violation|0|||
94216411|NCT00645411|322585269|FG002|Overall Study|Protocol Violation|1|||
94216412|NCT00645411|322585270|FG003|Overall Study|Protocol Violation|0|||
94216413|NCT00645411|322585267|FG000|Overall Study|Inappropriate enrollment|0|||
94216414|NCT00645411|322585268|FG001|Overall Study|Inappropriate enrollment|0|||
94216415|NCT00645411|322585269|FG002|Overall Study|Inappropriate enrollment|4|||
94216416|NCT00645411|322585270|FG003|Overall Study|Inappropriate enrollment|1|||
94216417|NCT00645411|322585267|FG000|Overall Study|Unable to classify|0|||
94216418|NCT00645411|322585268|FG001|Overall Study|Unable to classify|0|||
94216419|NCT00645411|322585269|FG002|Overall Study|Unable to classify|3|||
94216420|NCT00645411|322585270|FG003|Overall Study|Unable to classify|4|||
94216421|NCT00689351|322585271|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
94216422|NCT00689351|322585272|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
94216423|NCT00689351|322585271|FG000|Infant Series of Dosing|Adverse Event|1|||
94216424|NCT00689351|322585272|FG001|Infant Series of Dosing|Adverse Event|0|||
94216425|NCT00689351|322585271|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
94216426|NCT00689351|322585272|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
94216427|NCT00689351|322585271|FG000|After Infant Series|Parent/legal guardian request|1|||
94216428|NCT00689351|322585272|FG001|After Infant Series|Parent/legal guardian request|0|||
94216429|NCT01661972|322585274|FG000|Overall Study|Adverse Event|1|||
94216430|NCT01661972|322585275|FG001|Overall Study|Adverse Event|2|||
94216431|NCT01661972|322585274|FG000|Overall Study|Death during Treatment period|1|||
94216432|NCT01661972|322585275|FG001|Overall Study|Death during Treatment period|1|||
94216433|NCT01661972|322585274|FG000|Overall Study|Withdrawal by Subject|0|||
94216434|NCT01661972|322585275|FG001|Overall Study|Withdrawal by Subject|1|||
94216435|NCT02010684|322585280|FG000|Overall Study|Lost to Follow-up|8|||
94216436|NCT02010684|322585281|FG001|Overall Study|Lost to Follow-up|18|||
94216437|NCT02010684|322585280|FG000|Overall Study|Withdrawal by Subject|4|||
94216438|NCT02010684|322585281|FG001|Overall Study|Withdrawal by Subject|5|||
94216439|NCT00990314|322585282|FG000|Overall Study|Death|2|||
94216440|NCT00990314|322585282|FG000|Overall Study|Adverse Event|2|||
94216441|NCT00990314|322585282|FG000|Overall Study|Withdrawal by Subject|3|||
94216442|NCT00990314|322585282|FG000|Overall Study|Non-Compliance|1|||
94216443|NCT00990314|322585282|FG000|Overall Study|Physician Decision|3|||
94216444|NCT00990314|322585282|FG000|Overall Study|Lack of Efficacy|1|||
94216445|NCT03070301|322585283|FG000|Overall Study|Progression of disease|16|||
94216446|NCT03070301|322585283|FG000|Overall Study|Physician Decision|3|||
94216447|NCT03070301|322585283|FG000|Overall Study|Withdrawal by Subject|1|||
94216448|NCT00264576|322586774|FG000|Overall Study|Lost to Follow-up|1|||
94216449|NCT00264576|322586775|FG001|Overall Study|Lost to Follow-up|1|||
94216450|NCT04783389|322586776|FG000|Overall Study|Withdrawal by Subject|2|||
94216451|NCT04783389|322586777|FG001|Overall Study|Withdrawal by Subject|0|||
94216452|NCT04783389|322586778|FG002|Overall Study|Withdrawal by Subject|0|||
94216453|NCT04783389|322586776|FG000|Overall Study|Termination of Study by Sponsor|10|||
94216454|NCT04783389|322586777|FG001|Overall Study|Termination of Study by Sponsor|12|||
94216455|NCT04783389|322586778|FG002|Overall Study|Termination of Study by Sponsor|14|||
94216456|NCT01562275|322586779|FG000|Stage 1|Adverse Event|0|||
94216457|NCT01562275|322586780|FG001|Stage 1|Adverse Event|0|||
94216458|NCT01562275|322586781|FG002|Stage 1|Adverse Event|0|||
94216459|NCT01562275|322586782|FG003|Stage 1|Adverse Event|1|||
94216460|NCT01562275|322586783|FG004|Stage 1|Adverse Event|1|||
94216461|NCT01562275|322586784|FG005|Stage 1|Adverse Event|0|||
94216462|NCT01562275|322586785|FG006|Stage 1|Adverse Event|0|||
94216463|NCT01562275|322586786|FG007|Stage 1|Adverse Event|0|||
94216464|NCT01562275|322586787|FG008|Stage 1|Adverse Event|0|||
94216465|NCT01562275|322586788|FG009|Stage 1|Adverse Event|1|||
94216466|NCT01562275|322586789|FG010|Stage 1|Adverse Event|0|||
94286490|NCT01430442|322838900|FG002|Overall Study|Lost to Follow-up|1|||
94286491|NCT01430442|322838901|FG003|Overall Study|Lost to Follow-up|2|||
94286492|NCT01430442|322838902|FG004|Overall Study|Lost to Follow-up|2|||
94286493|NCT01430442|322838903|FG005|Overall Study|Lost to Follow-up|1|||
94286494|NCT01430442|322838904|FG006|Overall Study|Lost to Follow-up|5|||
94286495|NCT01430442|322838905|FG007|Overall Study|Lost to Follow-up|1|||
94286496|NCT01430442|322838898|FG000|Overall Study|Pregnancy|1|||
94286497|NCT01430442|322838899|FG001|Overall Study|Pregnancy|0|||
94286498|NCT01430442|322838900|FG002|Overall Study|Pregnancy|0|||
94286499|NCT01430442|322838901|FG003|Overall Study|Pregnancy|0|||
94286500|NCT01430442|322838902|FG004|Overall Study|Pregnancy|0|||
94286501|NCT01430442|322838903|FG005|Overall Study|Pregnancy|1|||
94286502|NCT01430442|322838904|FG006|Overall Study|Pregnancy|0|||
94286503|NCT01430442|322838905|FG007|Overall Study|Pregnancy|0|||
94286504|NCT01430442|322838898|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
94286505|NCT01430442|322838899|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
94286506|NCT01430442|322838900|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
94286507|NCT01430442|322838901|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
94286508|NCT01430442|322838902|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
94286509|NCT01430442|322838903|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
94286510|NCT01430442|322838904|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
94286511|NCT01430442|322838905|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
94286512|NCT01641939|322838907|FG000|Overall Study|Death|90|||
94286513|NCT01641939|322838908|FG001|Overall Study|Death|187|||
94286514|NCT01641939|322838909|FG002|Overall Study|Death|61|||
94286515|NCT01641939|322838907|FG000|Overall Study|Lost to Follow-up|3|||
94286516|NCT01641939|322838908|FG001|Overall Study|Lost to Follow-up|2|||
94286517|NCT01641939|322838909|FG002|Overall Study|Lost to Follow-up|1|||
94286518|NCT01641939|322838907|FG000|Overall Study|Withdrawal by Subject|14|||
94286519|NCT01641939|322838908|FG001|Overall Study|Withdrawal by Subject|11|||
94286520|NCT01641939|322838909|FG002|Overall Study|Withdrawal by Subject|5|||
94216467|NCT01562275|322586790|FG011|Stage 1|Adverse Event|0|||
94216468|NCT01562275|322586791|FG012|Stage 1|Adverse Event|0|||
94216469|NCT01562275|322586779|FG000|Stage 1|Death|1|||
94216470|NCT01562275|322586780|FG001|Stage 1|Death|0|||
94216471|NCT01562275|322586781|FG002|Stage 1|Death|0|||
94216472|NCT01562275|322586782|FG003|Stage 1|Death|0|||
94216473|NCT01562275|322586783|FG004|Stage 1|Death|0|||
94216474|NCT01562275|322586784|FG005|Stage 1|Death|0|||
94216475|NCT01562275|322586785|FG006|Stage 1|Death|0|||
94216476|NCT01562275|322586786|FG007|Stage 1|Death|0|||
94216477|NCT01562275|322586787|FG008|Stage 1|Death|0|||
94216478|NCT01562275|322586788|FG009|Stage 1|Death|0|||
94216479|NCT01562275|322586789|FG010|Stage 1|Death|0|||
94216480|NCT01562275|322586790|FG011|Stage 1|Death|0|||
94216481|NCT01562275|322586791|FG012|Stage 1|Death|0|||
94216482|NCT01562275|322586779|FG000|Stage 1|Non Compliance|0|||
94216483|NCT01562275|322586780|FG001|Stage 1|Non Compliance|0|||
94286521|NCT01641939|322838907|FG000|Overall Study|Study Terminated by Sponsor|10|||
94286522|NCT01641939|322838908|FG001|Overall Study|Study Terminated by Sponsor|28|||
94286523|NCT01641939|322838909|FG002|Overall Study|Study Terminated by Sponsor|3|||
94216484|NCT01562275|322586781|FG002|Stage 1|Non Compliance|1|||
94216485|NCT01562275|322586782|FG003|Stage 1|Non Compliance|0|||
94216486|NCT01562275|322586783|FG004|Stage 1|Non Compliance|0|||
94216487|NCT01562275|322586784|FG005|Stage 1|Non Compliance|0|||
94216488|NCT01562275|322586785|FG006|Stage 1|Non Compliance|0|||
94216489|NCT01562275|322586786|FG007|Stage 1|Non Compliance|0|||
94216490|NCT01562275|322586787|FG008|Stage 1|Non Compliance|0|||
94216491|NCT01562275|322586788|FG009|Stage 1|Non Compliance|0|||
94216492|NCT01562275|322586789|FG010|Stage 1|Non Compliance|0|||
94216493|NCT01562275|322586790|FG011|Stage 1|Non Compliance|0|||
94216494|NCT01562275|322586791|FG012|Stage 1|Non Compliance|0|||
94216495|NCT01562275|322586779|FG000|Stage 1|Physician Decision|0|||
94216496|NCT01562275|322586780|FG001|Stage 1|Physician Decision|0|||
94216497|NCT01562275|322586781|FG002|Stage 1|Physician Decision|0|||
94216498|NCT01562275|322586782|FG003|Stage 1|Physician Decision|0|||
94216499|NCT01562275|322586783|FG004|Stage 1|Physician Decision|1|||
94216500|NCT01562275|322586784|FG005|Stage 1|Physician Decision|0|||
94216501|NCT01562275|322586785|FG006|Stage 1|Physician Decision|1|||
94216502|NCT01562275|322586786|FG007|Stage 1|Physician Decision|0|||
94216503|NCT01562275|322586787|FG008|Stage 1|Physician Decision|1|||
94216504|NCT01562275|322586788|FG009|Stage 1|Physician Decision|0|||
94216505|NCT01562275|322586789|FG010|Stage 1|Physician Decision|0|||
94216506|NCT01562275|322586790|FG011|Stage 1|Physician Decision|0|||
94216507|NCT01562275|322586791|FG012|Stage 1|Physician Decision|0|||
94216508|NCT01562275|322586779|FG000|Stage 1|Progression of Disease|2|||
94216509|NCT01562275|322586780|FG001|Stage 1|Progression of Disease|6|||
94216510|NCT01562275|322586781|FG002|Stage 1|Progression of Disease|2|||
94286524|NCT02740478|322838910|FG000|Overall Study|Withdrawal by Subject|1|||
94286525|NCT02605642|322838916|FG000|Overall Study|Other|11|||
94286526|NCT02605642|322838917|FG001|Overall Study|Other|1|||
94286527|NCT02605642|322838916|FG000|Overall Study|Participant non-compliance|2|||
94286528|NCT02605642|322838917|FG001|Overall Study|Participant non-compliance|4|||
94286529|NCT02605642|322838916|FG000|Overall Study|Physician Decision|10|||
94286530|NCT02605642|322838917|FG001|Overall Study|Physician Decision|0|||
94286531|NCT02605642|322838916|FG000|Overall Study|Lost to Follow-up|12|||
94286532|NCT02605642|322838917|FG001|Overall Study|Lost to Follow-up|1|||
94286533|NCT02605642|322838916|FG000|Overall Study|Adverse Event|14|||
94286534|NCT02605642|322838917|FG001|Overall Study|Adverse Event|2|||
94286535|NCT02605642|322838916|FG000|Overall Study|Withdrawal by Subject|23|||
94286536|NCT02605642|322838917|FG001|Overall Study|Withdrawal by Subject|2|||
94286537|NCT02605642|322838916|FG000|Overall Study|Lack of response|24|||
94286538|NCT02605642|322838917|FG001|Overall Study|Lack of response|11|||
94286539|NCT00568555|322838927|FG000|Overall Study|Withdrawal by Subject|1|||
94286540|NCT00568555|322838928|FG001|Overall Study|Withdrawal by Subject|1|||
94286541|NCT00984204|322838929|FG000|Overall Study|Death|1|||
94286542|NCT00984204|322838929|FG000|Overall Study|Lost to Follow-up|4|||
94286543|NCT00984204|322838929|FG000|Overall Study|Lack of Efficacy|10|||
94286544|NCT01934140|322838930|FG000|Persistence Phase (Year 6-10)|Other|24|||
94286545|NCT01934140|322838931|FG001|Persistence Phase (Year 6-10)|Other|6|||
94286546|NCT01934140|322838930|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
94286547|NCT01934140|322838931|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
94286548|NCT01934140|322838930|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
94286549|NCT01934140|322838931|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
94286550|NCT01934140|322838930|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
94286551|NCT01934140|322838931|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
94286552|NCT01934140|322838930|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
94286553|NCT01934140|322838931|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
94286554|NCT01934140|322838930|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
94286555|NCT01934140|322838931|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
94286556|NCT01934140|322838930|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
94286557|NCT01934140|322838931|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
94286558|NCT01934140|322838930|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
94286559|NCT01934140|322838931|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
94286560|NCT00122135|322838935|FG000|Overall Study|Withdrawal by Subject|3|||
94286561|NCT00122135|322838936|FG001|Overall Study|Withdrawal by Subject|0|||
94286562|NCT00618748|322838937|FG000|Overall Study|Adverse Event|4|||
94372459|NCT00903383|323150266|FG000|Overall Study|Adverse Event|1|||
94216511|NCT01562275|322586782|FG003|Stage 1|Progression of Disease|1|||
94216512|NCT01562275|322586783|FG004|Stage 1|Progression of Disease|2|||
94216513|NCT01562275|322586784|FG005|Stage 1|Progression of Disease|4|||
94216514|NCT01562275|322586785|FG006|Stage 1|Progression of Disease|1|||
94216515|NCT01562275|322586786|FG007|Stage 1|Progression of Disease|7|||
94216516|NCT01562275|322586787|FG008|Stage 1|Progression of Disease|2|||
94216517|NCT01562275|322586788|FG009|Stage 1|Progression of Disease|5|||
94216518|NCT01562275|322586789|FG010|Stage 1|Progression of Disease|3|||
94216519|NCT01562275|322586790|FG011|Stage 1|Progression of Disease|0|||
94216520|NCT01562275|322586791|FG012|Stage 1|Progression of Disease|0|||
94216521|NCT01562275|322586779|FG000|Stage 1|Withdrawal by Subject|0|||
94216522|NCT01562275|322586780|FG001|Stage 1|Withdrawal by Subject|1|||
94216523|NCT01562275|322586781|FG002|Stage 1|Withdrawal by Subject|0|||
94216524|NCT01562275|322586782|FG003|Stage 1|Withdrawal by Subject|2|||
94216525|NCT01562275|322586783|FG004|Stage 1|Withdrawal by Subject|0|||
94216526|NCT01562275|322586784|FG005|Stage 1|Withdrawal by Subject|0|||
94216527|NCT01562275|322586785|FG006|Stage 1|Withdrawal by Subject|1|||
94216528|NCT01562275|322586786|FG007|Stage 1|Withdrawal by Subject|0|||
94216529|NCT01562275|322586787|FG008|Stage 1|Withdrawal by Subject|0|||
94216530|NCT01562275|322586788|FG009|Stage 1|Withdrawal by Subject|1|||
94216531|NCT01562275|322586789|FG010|Stage 1|Withdrawal by Subject|0|||
94216532|NCT01562275|322586790|FG011|Stage 1|Withdrawal by Subject|0|||
94216533|NCT01562275|322586791|FG012|Stage 1|Withdrawal by Subject|0|||
94216534|NCT01562275|322586779|FG000|Stage 2|Death|0|||
94216535|NCT01562275|322586780|FG001|Stage 2|Death|0|||
94216536|NCT01562275|322586781|FG002|Stage 2|Death|0|||
94216537|NCT01562275|322586782|FG003|Stage 2|Death|0|||
94216538|NCT01562275|322586783|FG004|Stage 2|Death|0|||
94216539|NCT01562275|322586784|FG005|Stage 2|Death|0|||
94216540|NCT01562275|322586785|FG006|Stage 2|Death|0|||
94216541|NCT01562275|322586786|FG007|Stage 2|Death|0|||
94216542|NCT01562275|322586787|FG008|Stage 2|Death|0|||
94216543|NCT01562275|322586788|FG009|Stage 2|Death|0|||
94216544|NCT01562275|322586789|FG010|Stage 2|Death|0|||
94216545|NCT01562275|322586790|FG011|Stage 2|Death|2|||
94216546|NCT01562275|322586791|FG012|Stage 2|Death|1|||
94216547|NCT01562275|322586779|FG000|Stage 2|Progression of Disease|0|||
94216548|NCT01562275|322586780|FG001|Stage 2|Progression of Disease|0|||
94216549|NCT01562275|322586781|FG002|Stage 2|Progression of Disease|0|||
94216550|NCT01562275|322586782|FG003|Stage 2|Progression of Disease|0|||
94216551|NCT01562275|322586783|FG004|Stage 2|Progression of Disease|0|||
94216552|NCT01562275|322586784|FG005|Stage 2|Progression of Disease|0|||
94216553|NCT01562275|322586785|FG006|Stage 2|Progression of Disease|0|||
94216554|NCT01562275|322586786|FG007|Stage 2|Progression of Disease|0|||
94216555|NCT01562275|322586787|FG008|Stage 2|Progression of Disease|0|||
94216556|NCT01562275|322586788|FG009|Stage 2|Progression of Disease|0|||
94216557|NCT01562275|322586789|FG010|Stage 2|Progression of Disease|0|||
94216558|NCT01562275|322586790|FG011|Stage 2|Progression of Disease|12|||
94216559|NCT01562275|322586791|FG012|Stage 2|Progression of Disease|4|||
94216560|NCT01279447|322586798|FG000|Overall Study|Lost to Follow-up|3|||
94216561|NCT01279447|322586799|FG001|Overall Study|Lost to Follow-up|1|||
94216562|NCT01215253|322586800|FG000|Overall Study|Withdrawal by Subject|57|||
94216563|NCT01215253|322586801|FG001|Overall Study|Withdrawal by Subject|35|||
94216564|NCT01215253|322586800|FG000|Overall Study|Physician Decision|9|||
94216565|NCT01215253|322586801|FG001|Overall Study|Physician Decision|12|||
94216566|NCT01215253|322586800|FG000|Overall Study|Lost to Follow-up|6|||
94216567|NCT01215253|322586801|FG001|Overall Study|Lost to Follow-up|4|||
94216568|NCT01215253|322586800|FG000|Overall Study|Other|14|||
94216569|NCT01215253|322586801|FG001|Overall Study|Other|12|||
94216570|NCT00871494|322586802|FG000|Overall Study|Protocol Violation|5|||
94216571|NCT00871494|322586802|FG000|Overall Study|Lack of Efficacy|4|||
94216572|NCT00871494|322586802|FG000|Overall Study|Adverse Event|4|||
94216573|NCT00871494|322586802|FG000|Overall Study|Lost to Follow-up|1|||
94216574|NCT03884478|322586803|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
94216575|NCT03884478|322586804|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
94216576|NCT03884478|322586805|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
94216577|NCT03884478|322586803|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
94216578|NCT03884478|322586804|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
94286563|NCT00618748|322838938|FG001|Overall Study|Adverse Event|3|||
94286564|NCT00618748|322838939|FG002|Overall Study|Adverse Event|8|||
94216579|NCT03884478|322586805|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
94216580|NCT03884478|322586803|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
94216581|NCT03884478|322586804|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
94216582|NCT03884478|322586805|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
94216583|NCT03884478|322586803|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
94216584|NCT03884478|322586804|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
94216585|NCT03884478|322586805|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
94216586|NCT00988429|322586806|FG000|Overall Study|Adverse Event|9|||
94216587|NCT00988429|322586807|FG001|Overall Study|Adverse Event|21|||
94216588|NCT00988429|322586808|FG002|Overall Study|Adverse Event|45|||
94216589|NCT00988429|322586806|FG000|Overall Study|Lack of Efficacy|0|||
94216590|NCT00988429|322586807|FG001|Overall Study|Lack of Efficacy|0|||
94216591|NCT00988429|322586808|FG002|Overall Study|Lack of Efficacy|1|||
94216592|NCT00988429|322586806|FG000|Overall Study|Non-Compliance with Study Drug|5|||
94216593|NCT00988429|322586807|FG001|Overall Study|Non-Compliance with Study Drug|1|||
94216594|NCT00988429|322586808|FG002|Overall Study|Non-Compliance with Study Drug|3|||
94216595|NCT00988429|322586806|FG000|Overall Study|Physician Decision|1|||
94216596|NCT00988429|322586807|FG001|Overall Study|Physician Decision|0|||
94216597|NCT00988429|322586808|FG002|Overall Study|Physician Decision|3|||
94216598|NCT00988429|322586806|FG000|Overall Study|Pregnancy|2|||
94216599|NCT00988429|322586807|FG001|Overall Study|Pregnancy|1|||
94216600|NCT00988429|322586808|FG002|Overall Study|Pregnancy|0|||
94216601|NCT00988429|322586806|FG000|Overall Study|Protocol Violation|4|||
94216602|NCT00988429|322586807|FG001|Overall Study|Protocol Violation|3|||
94216603|NCT00988429|322586808|FG002|Overall Study|Protocol Violation|3|||
94216604|NCT00988429|322586806|FG000|Overall Study|Withdrawal by Subject|7|||
94216605|NCT00988429|322586807|FG001|Overall Study|Withdrawal by Subject|7|||
94216606|NCT00988429|322586808|FG002|Overall Study|Withdrawal by Subject|12|||
94216607|NCT00988429|322586806|FG000|Overall Study|Administrative Reasons|1|||
94216608|NCT00988429|322586807|FG001|Overall Study|Administrative Reasons|2|||
94216609|NCT00988429|322586808|FG002|Overall Study|Administrative Reasons|1|||
94216610|NCT00988429|322586806|FG000|Overall Study|other reasons|8|||
94216611|NCT00988429|322586807|FG001|Overall Study|other reasons|8|||
94216612|NCT00988429|322586808|FG002|Overall Study|other reasons|1|||
94216613|NCT02163499|322586809|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
94216614|NCT02163499|322586809|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
94216615|NCT02163499|322586809|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
94216616|NCT02163499|322586809|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
94216617|NCT02163499|322586809|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
94216618|NCT02163499|322586809|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
94216619|NCT02163499|322586809|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
94216620|NCT02163499|322586809|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
94216621|NCT02163499|322586809|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
94216622|NCT02163499|322586809|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
94216623|NCT02163499|322586809|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
94216624|NCT02163499|322586809|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
94216625|NCT02163499|322586809|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
94216626|NCT02163499|322586809|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
94216627|NCT02163499|322586809|FG000|Extended Dosing Phase: ZS|Death|8|||
94216628|NCT02163499|322586809|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
94216629|NCT02163499|322586809|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
94216630|NCT02163499|322586809|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
94216631|NCT00555620|322586810|FG000|Overall Study|Death|0|||
94216632|NCT00555620|322586811|FG001|Overall Study|Death|1|||
94216633|NCT00555620|322586812|FG002|Overall Study|Death|0|||
94216634|NCT00555620|322586813|FG003|Overall Study|Death|0|||
94216635|NCT00555620|322586814|FG004|Overall Study|Death|0|||
94216636|NCT00555620|322586815|FG005|Overall Study|Death|1|||
94216637|NCT00555620|322586810|FG000|Overall Study|Study terminated by sponsor|0|||
94216638|NCT00555620|322586811|FG001|Overall Study|Study terminated by sponsor|0|||
94216639|NCT00555620|322586812|FG002|Overall Study|Study terminated by sponsor|1|||
94216640|NCT00555620|322586813|FG003|Overall Study|Study terminated by sponsor|0|||
94216641|NCT00555620|322586814|FG004|Overall Study|Study terminated by sponsor|0|||
94216642|NCT00555620|322586815|FG005|Overall Study|Study terminated by sponsor|0|||
94216643|NCT00555620|322586810|FG000|Overall Study|Adverse Event|0|||
94216644|NCT00555620|322586811|FG001|Overall Study|Adverse Event|0|||
94216645|NCT00555620|322586812|FG002|Overall Study|Adverse Event|1|||
94216646|NCT00555620|322586813|FG003|Overall Study|Adverse Event|5|||
94216647|NCT00555620|322586814|FG004|Overall Study|Adverse Event|0|||
94216648|NCT00555620|322586815|FG005|Overall Study|Adverse Event|1|||
94216649|NCT00555620|322586810|FG000|Overall Study|Objective progression or relapse|6|||
94216650|NCT00555620|322586811|FG001|Overall Study|Objective progression or relapse|5|||
94216651|NCT00555620|322586812|FG002|Overall Study|Objective progression or relapse|12|||
94216652|NCT00555620|322586813|FG003|Overall Study|Objective progression or relapse|17|||
94216653|NCT00555620|322586814|FG004|Overall Study|Objective progression or relapse|3|||
94216654|NCT00555620|322586815|FG005|Overall Study|Objective progression or relapse|16|||
94216655|NCT00555620|322586810|FG000|Overall Study|Participant refused treatment|0|||
94216656|NCT00555620|322586811|FG001|Overall Study|Participant refused treatment|1|||
94216657|NCT00555620|322586812|FG002|Overall Study|Participant refused treatment|1|||
94216658|NCT00555620|322586813|FG003|Overall Study|Participant refused treatment|0|||
94216659|NCT00555620|322586814|FG004|Overall Study|Participant refused treatment|0|||
94216660|NCT00555620|322586815|FG005|Overall Study|Participant refused treatment|1|||
94372460|NCT00903383|323150267|FG001|Overall Study|Adverse Event|2|||
94216661|NCT00555620|322586810|FG000|Overall Study|Other|0|||
94216662|NCT00555620|322586811|FG001|Overall Study|Other|0|||
94216663|NCT00555620|322586812|FG002|Overall Study|Other|0|||
94216664|NCT00555620|322586813|FG003|Overall Study|Other|1|||
94216665|NCT00555620|322586814|FG004|Overall Study|Other|0|||
94216666|NCT00555620|322586815|FG005|Overall Study|Other|3|||
94216667|NCT01714947|322586816|FG000|Part B|Progressive Disease|3|||
94216668|NCT01345253|322586820|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
94216669|NCT01345253|322586821|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
94216670|NCT01345253|322586820|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
94216671|NCT01345253|322586821|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
94216672|NCT01345253|322586820|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
94216673|NCT01345253|322586821|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
94372461|NCT00903383|323150268|FG002|Overall Study|Adverse Event|3|||
94286565|NCT00618748|322838937|FG000|Overall Study|Physician Decision|3|||
94286566|NCT00618748|322838938|FG001|Overall Study|Physician Decision|1|||
94286567|NCT00618748|322838939|FG002|Overall Study|Physician Decision|1|||
94286568|NCT00618748|322838937|FG000|Overall Study|Withdrawal by Subject|4|||
94286569|NCT00618748|322838938|FG001|Overall Study|Withdrawal by Subject|1|||
94286570|NCT00618748|322838939|FG002|Overall Study|Withdrawal by Subject|5|||
94286571|NCT00860158|322838940|FG000|Overall Study|Study Terminated|1|||
94216674|NCT01345253|322586820|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
94216675|NCT01345253|322586821|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
94216676|NCT01345253|322586820|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
94216677|NCT01345253|322586821|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
94216678|NCT01345253|322586820|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
94216679|NCT01345253|322586821|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
94216680|NCT01345253|322586820|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
94216681|NCT01345253|322586821|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
94216682|NCT01345253|322586820|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
94216683|NCT01345253|322586821|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
94216684|NCT01345253|322586820|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
94216685|NCT01345253|322586821|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
94216686|NCT01345253|322586820|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
94216687|NCT01345253|322586821|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
94216688|NCT01345253|322586820|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
94216689|NCT01345253|322586821|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
94216690|NCT01345253|322586820|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
94216691|NCT01345253|322586821|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
94216692|NCT01345253|322586820|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
94216693|NCT01345253|322586821|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
94216694|NCT01345253|322586820|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
94216695|NCT01345253|322586821|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
94216696|NCT01345253|322586820|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
94216697|NCT01345253|322586821|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
94216698|NCT02005484|322586827|FG000|Overall Study|Death|1|||
94216699|NCT02005484|322586827|FG000|Overall Study|Disease progression|1|||
94216700|NCT02005484|322586827|FG000|Overall Study|Changed to a Different Study|1|||
94216701|NCT02005484|322586827|FG000|Overall Study|Sponsor decision|1|||
94216702|NCT01129011|322586828|FG000|Overall Study|Adverse Event|20|||
94216703|NCT01129011|322586829|FG001|Overall Study|Adverse Event|30|||
94216704|NCT01129011|322586828|FG000|Overall Study|Withdrawal by Subject|24|||
94216705|NCT01129011|322586829|FG001|Overall Study|Withdrawal by Subject|8|||
94216706|NCT01129011|322586828|FG000|Overall Study|Lost to Follow-up|6|||
94216707|NCT01129011|322586829|FG001|Overall Study|Lost to Follow-up|7|||
94216708|NCT01129011|322586828|FG000|Overall Study|Duodenal Ulcer|2|||
94216709|NCT01129011|322586829|FG001|Overall Study|Duodenal Ulcer|8|||
94216710|NCT01129011|322586828|FG000|Overall Study|misc|7|||
94216711|NCT01129011|322586829|FG001|Overall Study|misc|4|||
94216712|NCT02246647|322586830|FG000|Overall Study|Withdrawal by Subject|1|||
94216713|NCT02246647|322586831|FG001|Overall Study|Withdrawal by Subject|1|||
94216714|NCT01767376|322586835|FG000|Overall Study|Lost to Follow-up|3|||
94216715|NCT01767376|322586836|FG001|Overall Study|Lost to Follow-up|2|||
94216716|NCT01767376|322586837|FG002|Overall Study|Lost to Follow-up|0|||
94216717|NCT01767376|322586835|FG000|Overall Study|Withdrawal by Subject|1|||
94216718|NCT01767376|322586836|FG001|Overall Study|Withdrawal by Subject|1|||
94216719|NCT01767376|322586837|FG002|Overall Study|Withdrawal by Subject|0|||
94216720|NCT01670877|322586838|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
94216721|NCT01670877|322586839|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
94216722|NCT01670877|322586840|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
94216723|NCT01670877|322586841|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
94216724|NCT01670877|322586842|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
94216725|NCT01670877|322586843|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
94216726|NCT01670877|322586838|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
94216727|NCT01670877|322586839|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
94286572|NCT00200850|322838941|FG000|Overall Study|relocation|1|||
94286573|NCT00200850|322838942|FG001|Overall Study|relocation|0|||
94286574|NCT00200850|322838943|FG002|Overall Study|relocation|1|||
94286575|NCT00200850|322838941|FG000|Overall Study|too busy|1|||
94286576|NCT00200850|322838942|FG001|Overall Study|too busy|0|||
94286577|NCT00200850|322838943|FG002|Overall Study|too busy|0|||
94286578|NCT00200850|322838941|FG000|Overall Study|Pregnancy|0|||
94216728|NCT01670877|322586840|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
94216729|NCT01670877|322586841|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
94216730|NCT01670877|322586842|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
94216731|NCT01670877|322586843|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
94216732|NCT01670877|322586838|FG000|Part I and Part 2|Grade 2 vomiting|0|||
94216733|NCT01670877|322586839|FG001|Part I and Part 2|Grade 2 vomiting|0|||
94286579|NCT00200850|322838942|FG001|Overall Study|Pregnancy|0|||
94286580|NCT00200850|322838943|FG002|Overall Study|Pregnancy|1|||
94286581|NCT00200850|322838941|FG000|Overall Study|Poor adherence|0|||
94286582|NCT00200850|322838942|FG001|Overall Study|Poor adherence|0|||
94286583|NCT00200850|322838943|FG002|Overall Study|Poor adherence|1|||
94286584|NCT00200850|322838941|FG000|Overall Study|optic neuritis|0|||
94286585|NCT00200850|322838942|FG001|Overall Study|optic neuritis|0|||
94286586|NCT00200850|322838943|FG002|Overall Study|optic neuritis|1|||
94286587|NCT00200850|322838941|FG000|Overall Study|Adverse Event|1|||
94286588|NCT00200850|322838942|FG001|Overall Study|Adverse Event|1|||
94286589|NCT00200850|322838943|FG002|Overall Study|Adverse Event|2|||
94286590|NCT03472560|322838944|FG000|Overall Study|Subject transfer to continuation protocol|0|||
94286591|NCT03472560|322838945|FG001|Overall Study|Subject transfer to continuation protocol|1|||
94286592|NCT03472560|322838944|FG000|Overall Study|Withdrawal by Subject|4|||
94286593|NCT03472560|322838945|FG001|Overall Study|Withdrawal by Subject|0|||
94286594|NCT03472560|322838944|FG000|Overall Study|Progressive disease|24|||
94286595|NCT03472560|322838945|FG001|Overall Study|Progressive disease|8|||
94286596|NCT03472560|322838944|FG000|Overall Study|Physician Decision|1|||
94286597|NCT03472560|322838945|FG001|Overall Study|Physician Decision|0|||
94286598|NCT03472560|322838944|FG000|Overall Study|Death|7|||
94286599|NCT03472560|322838945|FG001|Overall Study|Death|4|||
94286600|NCT03472560|322838944|FG000|Overall Study|Adverse Event|5|||
94286601|NCT03472560|322838945|FG001|Overall Study|Adverse Event|3|||
94286602|NCT03472560|322838944|FG000|Overall Study|Global deterioration of health status|0|||
94286603|NCT03472560|322838945|FG001|Overall Study|Global deterioration of health status|4|||
94286604|NCT02118792|322838946|FG000|Overall Study|Withdrawal by Subject|6|||
94286605|NCT02118792|322838947|FG001|Overall Study|Withdrawal by Subject|3|||
94286606|NCT02118792|322838946|FG000|Overall Study|Lost to Follow-up|4|||
94286607|NCT02118792|322838947|FG001|Overall Study|Lost to Follow-up|4|||
94286608|NCT02118792|322838946|FG000|Overall Study|Adverse Event|5|||
94286609|NCT02118792|322838947|FG001|Overall Study|Adverse Event|4|||
94286610|NCT02118792|322838946|FG000|Overall Study|Withdrawal by parent/guardian|14|||
94286611|NCT02118792|322838947|FG001|Overall Study|Withdrawal by parent/guardian|20|||
94286612|NCT02118792|322838946|FG000|Overall Study|Other|1|||
94286613|NCT02118792|322838947|FG001|Overall Study|Other|6|||
94216734|NCT01670877|322586840|FG002|Part I and Part 2|Grade 2 vomiting|0|||
94216735|NCT01670877|322586841|FG003|Part I and Part 2|Grade 2 vomiting|1|||
94216736|NCT01670877|322586842|FG004|Part I and Part 2|Grade 2 vomiting|0|||
94216737|NCT01670877|322586843|FG005|Part I and Part 2|Grade 2 vomiting|0|||
94216738|NCT01670877|322586838|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
94286614|NCT02118792|322838946|FG000|Overall Study|Randomised but not treated|1|||
94286615|NCT02118792|322838947|FG001|Overall Study|Randomised but not treated|0|||
94286616|NCT00491179|322838949|FG000|Overall Study|Adverse Event|5|||
94286617|NCT00491179|322838950|FG001|Overall Study|Adverse Event|1|||
94286618|NCT00491179|322838949|FG000|Overall Study|Withdrawal by Subject|2|||
94286619|NCT00491179|322838950|FG001|Overall Study|Withdrawal by Subject|1|||
94286620|NCT03946670|322838952|FG000|Overall Study|Progressive Disease|26|||
94286621|NCT03946670|322838953|FG001|Overall Study|Progressive Disease|23|||
94286622|NCT03946670|322838952|FG000|Overall Study|Adverse Event|7|||
94286623|NCT03946670|322838953|FG001|Overall Study|Adverse Event|9|||
94286624|NCT03946670|322838952|FG000|Overall Study|Death|5|||
94286625|NCT03946670|322838953|FG001|Overall Study|Death|6|||
94286626|NCT03946670|322838952|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
94286627|NCT03946670|322838953|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
94286628|NCT03946670|322838952|FG000|Overall Study|Subject Decision|4|||
94286629|NCT03946670|322838953|FG001|Overall Study|Subject Decision|4|||
94216739|NCT01670877|322586839|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
94216740|NCT01670877|322586840|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
94286630|NCT03946670|322838952|FG000|Overall Study|Physician Decision|3|||
94286631|NCT03946670|322838953|FG001|Overall Study|Physician Decision|3|||
94286632|NCT03946670|322838952|FG000|Overall Study|New Therapy for Study Indication|1|||
94286633|NCT03946670|322838953|FG001|Overall Study|New Therapy for Study Indication|0|||
94286634|NCT03946670|322838952|FG000|Overall Study|Not treated|1|||
94286635|NCT03946670|322838953|FG001|Overall Study|Not treated|1|||
94286636|NCT01415752|322838954|FG000|Induction (Step 1)|Ineligible|4|||
94372462|NCT00903383|323150269|FG003|Overall Study|Adverse Event|1|||
94372463|NCT00903383|323150266|FG000|Overall Study|Physician Decision|1|||
94372464|NCT00903383|323150267|FG001|Overall Study|Physician Decision|2|||
94216741|NCT01670877|322586841|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
94216742|NCT01670877|322586842|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
94286637|NCT01415752|322838955|FG001|Induction (Step 1)|Ineligible|3|||
94286638|NCT01415752|322838956|FG002|Induction (Step 1)|Ineligible|4|||
94286639|NCT01415752|322838957|FG003|Induction (Step 1)|Ineligible|4|||
94286640|NCT01415752|322838954|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
94372465|NCT00903383|323150268|FG002|Overall Study|Physician Decision|0|||
94286641|NCT01415752|322838955|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
94286642|NCT01415752|322838956|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
94286643|NCT01415752|322838957|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
94286644|NCT01415752|322838954|FG000|Maintenance (Step 2)|Adverse Event|3|||
94286645|NCT01415752|322838955|FG001|Maintenance (Step 2)|Adverse Event|4|||
94286646|NCT01415752|322838956|FG002|Maintenance (Step 2)|Adverse Event|9|||
94286647|NCT01415752|322838957|FG003|Maintenance (Step 2)|Adverse Event|6|||
94286648|NCT01415752|322838954|FG000|Maintenance (Step 2)|Death|1|||
94286649|NCT01415752|322838955|FG001|Maintenance (Step 2)|Death|1|||
94286650|NCT01415752|322838956|FG002|Maintenance (Step 2)|Death|2|||
94286651|NCT01415752|322838957|FG003|Maintenance (Step 2)|Death|0|||
94286652|NCT01415752|322838954|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
94286653|NCT01415752|322838955|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
94286654|NCT01415752|322838956|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
94286655|NCT01415752|322838957|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
94286656|NCT01415752|322838954|FG000|Maintenance (Step 2)|Alternative therapy|0|||
94286657|NCT01415752|322838955|FG001|Maintenance (Step 2)|Alternative therapy|1|||
94286658|NCT01415752|322838956|FG002|Maintenance (Step 2)|Alternative therapy|0|||
94286659|NCT01415752|322838957|FG003|Maintenance (Step 2)|Alternative therapy|0|||
94286660|NCT01415752|322838954|FG000|Maintenance (Step 2)|Other reasons|3|||
94286661|NCT01415752|322838955|FG001|Maintenance (Step 2)|Other reasons|6|||
94286662|NCT01415752|322838956|FG002|Maintenance (Step 2)|Other reasons|4|||
94286663|NCT01415752|322838957|FG003|Maintenance (Step 2)|Other reasons|6|||
94286664|NCT01415752|322838954|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
94286665|NCT01415752|322838955|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
94286666|NCT01415752|322838956|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
94286667|NCT01415752|322838957|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
94286668|NCT01415752|322838954|FG000|Maintenance (Step 2)|ineligible|1|||
94286669|NCT01415752|322838955|FG001|Maintenance (Step 2)|ineligible|1|||
94286670|NCT01415752|322838956|FG002|Maintenance (Step 2)|ineligible|1|||
94286671|NCT01415752|322838957|FG003|Maintenance (Step 2)|ineligible|0|||
94286672|NCT01415752|322838954|FG000|Maintenance (Step 2)|Missing|4|||
94286673|NCT01415752|322838955|FG001|Maintenance (Step 2)|Missing|1|||
94286674|NCT01415752|322838956|FG002|Maintenance (Step 2)|Missing|4|||
94286675|NCT01415752|322838957|FG003|Maintenance (Step 2)|Missing|3|||
94286676|NCT00584194|322838958|FG000|Overall Study|Other|135|||
94286677|NCT01285908|322838959|FG000|Baseline Measurement|unable to insert catheter|1|||
94286678|NCT01285908|322838960|FG001|Baseline Measurement|unable to insert catheter|0|||
94286679|NCT01285908|322838961|FG002|Baseline Measurement|unable to insert catheter|0|||
94286680|NCT01285908|322838959|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
94286681|NCT01285908|322838960|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
94286682|NCT01285908|322838961|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
94286683|NCT01285908|322838959|FG000|Baseline Measurement|unable to tolerate procedure|1|||
94286684|NCT01285908|322838960|FG001|Baseline Measurement|unable to tolerate procedure|0|||
94286685|NCT01285908|322838961|FG002|Baseline Measurement|unable to tolerate procedure|0|||
94286686|NCT01764633|322838962|FG000|Overall Study|Withdrawal by Subject|105|||
94286687|NCT01764633|322838963|FG001|Overall Study|Withdrawal by Subject|88|||
94286688|NCT01764633|322838962|FG000|Overall Study|Lost to Follow-up|13|||
94286689|NCT01764633|322838963|FG001|Overall Study|Lost to Follow-up|5|||
94286690|NCT00493038|322838964|FG000|Treatment|Adverse Event|8|||
94286691|NCT00493038|322838965|FG001|Treatment|Adverse Event|4|||
94286692|NCT00493038|322838964|FG000|Treatment|Lost to Follow-up|5|||
94286693|NCT00493038|322838965|FG001|Treatment|Lost to Follow-up|3|||
94286694|NCT00493038|322838964|FG000|Treatment|Withdrawal by Subject|11|||
94286695|NCT00493038|322838965|FG001|Treatment|Withdrawal by Subject|12|||
94286696|NCT00493038|322838964|FG000|Treatment|Other|0|||
94286697|NCT00493038|322838965|FG001|Treatment|Other|1|||
94286698|NCT00493038|322838964|FG000|Follow-up|Lost to Follow-up|1|||
94286699|NCT00493038|322838965|FG001|Follow-up|Lost to Follow-up|0|||
94286700|NCT00704964|322838966|FG000|Overall Study|Not completed on time|328|||
94286701|NCT04142983|322838967|FG000|Overall Study|Lost to Follow-up|73|||
94286702|NCT04142983|322838967|FG000|Overall Study|Withdrawal by Subject|10|||
94286703|NCT04142983|322838967|FG000|Overall Study|Physician Decision|1|||
94286704|NCT04142983|322838967|FG000|Overall Study|Adverse Event|1|||
94286705|NCT04142983|322838967|FG000|Overall Study|No longer eligible|4|||
94286706|NCT04142983|322838967|FG000|Overall Study|Screen Failure|10|||
94286707|NCT00608985|322838969|FG000|Overall Study|Adverse Event|2|||
94286708|NCT00608985|322838970|FG001|Overall Study|Adverse Event|7|||
94286709|NCT00608985|322838971|FG002|Overall Study|Adverse Event|4|||
94286710|NCT00608985|322838972|FG003|Overall Study|Adverse Event|6|||
94286711|NCT00608985|322838969|FG000|Overall Study|Administrative/Other|7|||
94286712|NCT00608985|322838970|FG001|Overall Study|Administrative/Other|4|||
94286713|NCT00608985|322838971|FG002|Overall Study|Administrative/Other|1|||
94286714|NCT00608985|322838972|FG003|Overall Study|Administrative/Other|2|||
94286715|NCT00608985|322838969|FG000|Overall Study|Withdrawal of Consent|5|||
94286716|NCT00608985|322838970|FG001|Overall Study|Withdrawal of Consent|1|||
94372466|NCT00903383|323150269|FG003|Overall Study|Physician Decision|0|||
94216743|NCT01670877|322586843|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
94216744|NCT01670877|322586838|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
94216745|NCT01670877|322586839|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
94216746|NCT01670877|322586840|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
94216747|NCT01670877|322586841|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
94216748|NCT01670877|322586842|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
94216749|NCT01670877|322586843|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
94216750|NCT03262389|322586846|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
94216751|NCT03262389|322586846|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
94216752|NCT03262389|322586846|FG000|Overall Study|opted out of PET/MR|1|||
94216753|NCT02009332|322586850|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
94216754|NCT02009332|322586851|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
94216755|NCT02009332|322586852|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
94216756|NCT02009332|322586853|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
94216757|NCT02009332|322586854|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
94216758|NCT02009332|322586855|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
94216759|NCT02009332|322586850|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
94216760|NCT02009332|322586851|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
94216761|NCT02009332|322586852|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
94216762|NCT02009332|322586853|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
94216763|NCT02009332|322586854|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
94216764|NCT02009332|322586855|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
94216765|NCT02009332|322586850|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
94216766|NCT02009332|322586851|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
94216767|NCT02009332|322586852|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
94216768|NCT02009332|322586853|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
94216769|NCT02009332|322586854|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
94216770|NCT02009332|322586855|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
94216771|NCT02865083|322586857|FG000|Overall Study|Early Termination|3|||
94216772|NCT02865083|322586858|FG001|Overall Study|Early Termination|1|||
94216773|NCT04421456|322586859|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
94216774|NCT04421456|322586860|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
94216775|NCT04421456|322586861|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
94216776|NCT04421456|322586859|FG000|Randomized Treatment Period|Adverse Event|0|||
94216777|NCT04421456|322586860|FG001|Randomized Treatment Period|Adverse Event|1|||
94216778|NCT04421456|322586861|FG002|Randomized Treatment Period|Adverse Event|0|||
94216779|NCT04421456|322586859|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
94216780|NCT04421456|322586860|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
94216781|NCT04421456|322586861|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
94216782|NCT04421456|322586859|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
94216783|NCT04421456|322586860|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
94216784|NCT04421456|322586861|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
94216785|NCT04421456|322586859|FG000|Randomized Treatment Period|Participant non-compliance|1|||
94216786|NCT04421456|322586860|FG001|Randomized Treatment Period|Participant non-compliance|1|||
94216787|NCT04421456|322586861|FG002|Randomized Treatment Period|Participant non-compliance|2|||
94216788|NCT04421456|322586859|FG000|Randomized Treatment Period|Other|0|||
94216789|NCT04421456|322586860|FG001|Randomized Treatment Period|Other|1|||
94216790|NCT04421456|322586861|FG002|Randomized Treatment Period|Other|3|||
94216791|NCT00901459|322586865|FG000|Overall Study|Withdrawal by Subject|6|||
94216792|NCT00952523|322586867|FG000|Overall Study|Withdrawal by Subject|7|||
94216793|NCT01029925|322586868|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
94216794|NCT01029925|322586868|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
94216795|NCT01029925|322586868|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
94216796|NCT03529942|322586869|FG000|Overall Study|Withdrawal by Subject|13|||
94216797|NCT03529942|322586869|FG000|Overall Study|Physician Decision|1|||
94216798|NCT03529942|322586869|FG000|Overall Study|Lost to Follow-up|7|||
94216799|NCT03529942|322586869|FG000|Overall Study|Needle inserted but no drug administered|1|||
94286717|NCT00608985|322838971|FG002|Overall Study|Withdrawal of Consent|1|||
94286718|NCT00608985|322838972|FG003|Overall Study|Withdrawal of Consent|1|||
94286719|NCT00608985|322838969|FG000|Overall Study|Lost to Follow-up|2|||
94286720|NCT00608985|322838970|FG001|Overall Study|Lost to Follow-up|1|||
94286721|NCT00608985|322838971|FG002|Overall Study|Lost to Follow-up|0|||
94286722|NCT00608985|322838972|FG003|Overall Study|Lost to Follow-up|0|||
94286723|NCT00684515|322838973|FG000|Overall Study|Adverse Event|3|||
94216800|NCT03529942|322586869|FG000|Overall Study|Personal reasons|1|||
94216801|NCT00134056|322586872|FG000|Randomization|Not eligible for assigned treatment|22|||
94216802|NCT00134056|322586873|FG001|Randomization|Not eligible for assigned treatment|20|||
94216803|NCT00134056|322586872|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
94216804|NCT00134056|322586873|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
94286724|NCT00684515|322838974|FG001|Overall Study|Adverse Event|3|||
94286725|NCT00684515|322838975|FG002|Overall Study|Adverse Event|1|||
94216805|NCT00134056|322586872|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
94216806|NCT00134056|322586873|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
94216807|NCT00134056|322586872|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
94216808|NCT00134056|322586873|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
94216809|NCT00134056|322586872|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
94216810|NCT00134056|322586873|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
94216811|NCT02555397|322586877|FG000|Overall Study|Withdrawal by Subject|1|||
94216812|NCT02555397|322586878|FG001|Overall Study|Withdrawal by Subject|0|||
94216813|NCT02555397|322586879|FG002|Overall Study|Withdrawal by Subject|0|||
94216814|NCT02555397|322586880|FG003|Overall Study|Withdrawal by Subject|0|||
94216815|NCT02555397|322586881|FG004|Overall Study|Withdrawal by Subject|0|||
94216816|NCT01287832|322586882|FG000|Overall Study|Adverse Event|1|||
94216817|NCT01287832|322586883|FG001|Overall Study|Adverse Event|0|||
94216818|NCT01287832|322586882|FG000|Overall Study|Death|0|||
94216819|NCT01287832|322586883|FG001|Overall Study|Death|1|||
94216820|NCT00871715|322586884|FG000|Overall Study|Withdrawal by Subject|6|||
94216821|NCT00871715|322586885|FG001|Overall Study|Withdrawal by Subject|10|||
94216822|NCT00871715|322586886|FG002|Overall Study|Withdrawal by Subject|15|||
94216823|NCT00871715|322586884|FG000|Overall Study|Physician Decision|6|||
94216824|NCT00871715|322586885|FG001|Overall Study|Physician Decision|0|||
94216825|NCT00871715|322586886|FG002|Overall Study|Physician Decision|2|||
94216826|NCT00871715|322586884|FG000|Overall Study|Lost to Follow-up|3|||
94216827|NCT00871715|322586885|FG001|Overall Study|Lost to Follow-up|6|||
94216828|NCT00871715|322586886|FG002|Overall Study|Lost to Follow-up|9|||
94216829|NCT03015220|322586889|FG000|Overall Study|Withdrawal by Subject|3|||
94216830|NCT03015220|322586890|FG001|Overall Study|Withdrawal by Subject|2|||
94216831|NCT03015220|322586891|FG002|Overall Study|Withdrawal by Subject|2|||
94216832|NCT03015220|322586892|FG003|Overall Study|Withdrawal by Subject|2|||
94216833|NCT03015220|322586889|FG000|Overall Study|Lost to Follow-up|0|||
94216834|NCT03015220|322586890|FG001|Overall Study|Lost to Follow-up|0|||
94216835|NCT03015220|322586891|FG002|Overall Study|Lost to Follow-up|1|||
94216836|NCT03015220|322586892|FG003|Overall Study|Lost to Follow-up|0|||
94216837|NCT00537914|322586893|FG000|Overall Study|Death|1|||
94216838|NCT00537914|322586893|FG000|Overall Study|Adverse Event|7|||
94216839|NCT00537914|322586893|FG000|Overall Study|Treatment failure|10|||
94216840|NCT00537914|322586893|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
94216841|NCT00537914|322586893|FG000|Overall Study|Lost to Follow-up|19|||
94216842|NCT00537914|322586893|FG000|Overall Study|Withdrawal of informed consent|59|||
94216843|NCT02312258|322586894|FG000|Overall Study|Lost to Follow-up|8|||
94216844|NCT02312258|322586895|FG001|Overall Study|Lost to Follow-up|8|||
94216845|NCT02312258|322586894|FG000|Overall Study|Withdrawal by Patient|49|||
94216846|NCT02312258|322586895|FG001|Overall Study|Withdrawal by Patient|76|||
94216847|NCT02312258|322586894|FG000|Overall Study|Reason not Specified|107|||
94216848|NCT02312258|322586895|FG001|Overall Study|Reason not Specified|159|||
94216849|NCT02312258|322586894|FG000|Overall Study|Missing|2|||
94216850|NCT02312258|322586895|FG001|Overall Study|Missing|1|||
94216851|NCT02312258|322586894|FG000|Overall Study|Death|115|||
94216852|NCT02312258|322586895|FG001|Overall Study|Death|181|||
94216853|NCT01468597|322586897|FG000|Overall Study|Found ineligible|17|||
94216854|NCT01468597|322586897|FG000|Overall Study|concomitant valves|12|||
94216855|NCT01468597|322586897|FG000|Overall Study|off-pump CABG|1|||
94216856|NCT01468597|322586897|FG000|Overall Study|no platelet function data|5|||
94216857|NCT01115309|322586898|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
94216858|NCT01115309|322586898|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
94216859|NCT01115309|322586898|FG000|Long-term Follow-up|Lost to Follow-up|6|||
94216860|NCT05700851|322586899|FG000|Overall Study|Received a kidney transplant|1|||
94216861|NCT05700851|322586899|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
94216862|NCT05700851|322586899|FG000|Overall Study|Withdrawal by Subject|1|||
94216863|NCT03560206|322586900|FG000|Overall Study|Lost to Follow-up|19|||
94286726|NCT00684515|322838973|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
94286727|NCT00684515|322838974|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
94216864|NCT03560206|322586901|FG001|Overall Study|Lost to Follow-up|11|||
94216865|NCT03560206|322586900|FG000|Overall Study|Withdrawal by Subject|2|||
94216866|NCT03560206|322586901|FG001|Overall Study|Withdrawal by Subject|4|||
94286728|NCT00684515|322838975|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
94216867|NCT03560206|322586900|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
94216868|NCT03560206|322586901|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
94216869|NCT03560206|322586900|FG000|Overall Study|Busy schedule|14|||
94216870|NCT03560206|322586901|FG001|Overall Study|Busy schedule|2|||
94216871|NCT03560206|322586900|FG000|Overall Study|patients' new health condition such as cancer|10|||
94216872|NCT03560206|322586901|FG001|Overall Study|patients' new health condition such as cancer|1|||
94216873|NCT01549951|322586902|FG000|Overall Study|Adverse Event|15|||
94216874|NCT01549951|322586902|FG000|Overall Study|Withdrawal by Subject|2|||
94216875|NCT01549951|322586902|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
94216876|NCT01549951|322586902|FG000|Overall Study|Progressive disease|29|||
94216877|NCT01549951|322586902|FG000|Overall Study|Symptomatic deterioration|1|||
94216878|NCT01549951|322586902|FG000|Overall Study|Other|2|||
94216879|NCT01123200|322586908|FG000|Overall Study|Withdrawal by Subject|1|||
94216880|NCT00805441|322586909|FG000|Overall Study|Adverse Event|5|||
94216881|NCT00805441|322586910|FG001|Overall Study|Adverse Event|2|||
94216882|NCT00805441|322586909|FG000|Overall Study|Lack of Efficacy|0|||
94216883|NCT00805441|322586910|FG001|Overall Study|Lack of Efficacy|2|||
94216884|NCT00805441|322586909|FG000|Overall Study|Protocol Violation|4|||
94216885|NCT00805441|322586910|FG001|Overall Study|Protocol Violation|8|||
94216886|NCT00805441|322586909|FG000|Overall Study|Lost to Follow-up|10|||
94216887|NCT00805441|322586910|FG001|Overall Study|Lost to Follow-up|13|||
94216888|NCT00805441|322586909|FG000|Overall Study|Withdrawal by Subject|15|||
94216889|NCT00805441|322586910|FG001|Overall Study|Withdrawal by Subject|9|||
94216890|NCT00805441|322586909|FG000|Overall Study|Physician Decision|0|||
94216891|NCT00805441|322586910|FG001|Overall Study|Physician Decision|1|||
94216892|NCT00805441|322586909|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
94216893|NCT00805441|322586910|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
94216894|NCT02659059|322588043|FG000|Overall Study|Other reasons|6|||
94216895|NCT02659059|322588044|FG001|Overall Study|Other reasons|1|||
94216896|NCT02659059|322588043|FG000|Overall Study|Disease Progression|143|||
94216897|NCT02659059|322588044|FG001|Overall Study|Disease Progression|16|||
94216898|NCT02659059|322588043|FG000|Overall Study|Study Drug toxicity|56|||
94216899|NCT02659059|322588044|FG001|Overall Study|Study Drug toxicity|9|||
94216900|NCT02659059|322588043|FG000|Overall Study|Death|3|||
94216901|NCT02659059|322588044|FG001|Overall Study|Death|1|||
94216902|NCT02659059|322588043|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
94216903|NCT02659059|322588044|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
94216904|NCT02659059|322588043|FG000|Overall Study|Participant request to discontinue study treatment|5|||
94216905|NCT02659059|322588044|FG001|Overall Study|Participant request to discontinue study treatment|0|||
94216906|NCT02659059|322588043|FG000|Overall Study|Participant withdrew consent|6|||
94216907|NCT02659059|322588044|FG001|Overall Study|Participant withdrew consent|1|||
94216908|NCT02489799|322588045|FG000|Overall Study|Lost to Follow-up|4|||
94216909|NCT02489799|322588046|FG001|Overall Study|Lost to Follow-up|1|||
94216910|NCT02489799|322588045|FG000|Overall Study|Failure to Maintain Eligibility|4|||
94216911|NCT02489799|322588046|FG001|Overall Study|Failure to Maintain Eligibility|6|||
94216912|NCT02489799|322588045|FG000|Overall Study|Withdrawal by Subject|1|||
94216913|NCT02489799|322588046|FG001|Overall Study|Withdrawal by Subject|1|||
94216914|NCT02489799|322588045|FG000|Overall Study|Death|0|||
94216915|NCT02489799|322588046|FG001|Overall Study|Death|1|||
94216916|NCT01018992|322588047|FG000|Overall Study|Adverse Event|8|||
94216917|NCT01018992|322588048|FG001|Overall Study|Adverse Event|3|||
94216918|NCT01018992|322588047|FG000|Overall Study|Withdrawal by Subject|3|||
94216919|NCT01018992|322588048|FG001|Overall Study|Withdrawal by Subject|8|||
94216920|NCT01018992|322588047|FG000|Overall Study|Protocol Violation|0|||
94216921|NCT01018992|322588048|FG001|Overall Study|Protocol Violation|4|||
94216922|NCT01018992|322588047|FG000|Overall Study|Lost to Follow-up|5|||
94216923|NCT01018992|322588048|FG001|Overall Study|Lost to Follow-up|1|||
94216924|NCT02400749|322588049|FG000|Week 0 -16|Withdrawal by Subject|5|||
94216925|NCT02400749|322588050|FG001|Week 0 -16|Withdrawal by Subject|5|||
94216926|NCT02400749|322588049|FG000|Week 0 -16|Adverse Event|3|||
94216927|NCT02400749|322588050|FG001|Week 0 -16|Adverse Event|1|||
94216928|NCT02400749|322588049|FG000|Week 0 -16|Lost to Follow-up|2|||
94216929|NCT02400749|322588050|FG001|Week 0 -16|Lost to Follow-up|0|||
94216930|NCT02400749|322588049|FG000|Week 0 -16|Protocol Violation|1|||
94216931|NCT02400749|322588050|FG001|Week 0 -16|Protocol Violation|0|||
94216932|NCT02400749|322588049|FG000|Week 17 - 32|Withdrawal by Subject|3|||
94216933|NCT02400749|322588050|FG001|Week 17 - 32|Withdrawal by Subject|2|||
94216934|NCT02400749|322588049|FG000|Week 17 - 32|Adverse Event|2|||
94216935|NCT02400749|322588050|FG001|Week 17 - 32|Adverse Event|1|||
94216936|NCT01304940|322588051|FG000|Overall Study|not meet symptom severity requirement|3|||
94216937|NCT01304940|322588052|FG001|Overall Study|not meet symptom severity requirement|0|||
94216938|NCT01655498|322588053|FG000|Overall Study|Unrelated health issue|2|||
94216939|NCT01655498|322588053|FG000|Overall Study|Protocol Violation|2|||
94216940|NCT01655498|322588053|FG000|Overall Study|Withdrawal by Subject|1|||
94216941|NCT02011568|322588054|FG000|Overall Study|Withdrawal by Subject|8|||
94216942|NCT02011568|322588055|FG001|Overall Study|Withdrawal by Subject|10|||
94216943|NCT02011568|322588054|FG000|Overall Study|Physician Decision|1|||
94216944|NCT02011568|322588055|FG001|Overall Study|Physician Decision|3|||
94216945|NCT01072149|322588056|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94216946|NCT01072149|322588057|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94216947|NCT01072149|322588058|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
94216948|NCT01072149|322588059|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94216949|NCT01072149|322588060|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94216950|NCT01072149|322588061|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94372467|NCT00903383|323150266|FG000|Overall Study|Lost to Follow-up|0|||
94216951|NCT01072149|322588062|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94216952|NCT01072149|322588063|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94216953|NCT01072149|322588064|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94216954|NCT01072149|322588065|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94216955|NCT01072149|322588066|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94216956|NCT01072149|322588067|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94216957|NCT01072149|322588068|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94216958|NCT01072149|322588069|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94216959|NCT01072149|322588070|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94216960|NCT01072149|322588071|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94216961|NCT01072149|322588072|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94216962|NCT01072149|322588073|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94216963|NCT01072149|322588056|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
94216964|NCT01072149|322588057|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
94216965|NCT01072149|322588058|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
94216966|NCT01072149|322588059|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
94216967|NCT01072149|322588060|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
94216968|NCT01072149|322588061|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
94216969|NCT01072149|322588062|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
94216970|NCT01072149|322588063|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
94216971|NCT01072149|322588064|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
94216972|NCT01072149|322588065|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
94216973|NCT01072149|322588066|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
94216974|NCT01072149|322588067|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
94216975|NCT01072149|322588068|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
94216976|NCT01072149|322588069|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
94216977|NCT01072149|322588070|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
94216978|NCT01072149|322588071|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
94216979|NCT01072149|322588072|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
94216980|NCT01072149|322588073|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
94216981|NCT01072149|322588056|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94216982|NCT01072149|322588057|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94216983|NCT01072149|322588058|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94216984|NCT01072149|322588059|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94216985|NCT01072149|322588060|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94216986|NCT01072149|322588061|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94216987|NCT01072149|322588062|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94216988|NCT01072149|322588063|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94216989|NCT01072149|322588064|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94216990|NCT01072149|322588065|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94216991|NCT01072149|322588066|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
94216992|NCT01072149|322588067|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94216993|NCT01072149|322588068|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94216994|NCT01072149|322588069|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94216995|NCT01072149|322588070|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94216996|NCT01072149|322588071|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94216997|NCT01072149|322588072|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94216998|NCT01072149|322588073|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
94216999|NCT01072149|322588056|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94217000|NCT01072149|322588057|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
94217001|NCT01072149|322588058|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94217002|NCT01072149|322588059|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94217003|NCT01072149|322588060|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94286729|NCT01114529|322838976|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
94286730|NCT01114529|322838977|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
94286731|NCT01114529|322838978|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
94286732|NCT01114529|322838976|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
94286733|NCT01114529|322838977|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
94286734|NCT01114529|322838978|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
94286735|NCT01114529|322838976|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
94286736|NCT01114529|322838977|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
94286737|NCT01114529|322838978|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
94286738|NCT01114529|322838976|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
94217004|NCT01072149|322588061|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94217005|NCT01072149|322588062|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94286739|NCT01114529|322838977|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
94286740|NCT01114529|322838978|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
94372468|NCT00903383|323150267|FG001|Overall Study|Lost to Follow-up|0|||
94217006|NCT01072149|322588063|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94217007|NCT01072149|322588064|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94217008|NCT01072149|322588065|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94217009|NCT01072149|322588066|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94217010|NCT01072149|322588067|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94217011|NCT01072149|322588068|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94217012|NCT01072149|322588069|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94217013|NCT01072149|322588070|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94217014|NCT01072149|322588071|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94217015|NCT01072149|322588072|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94217016|NCT01072149|322588073|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
94217017|NCT01072149|322588056|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94217018|NCT01072149|322588057|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94217019|NCT01072149|322588058|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
94217020|NCT01072149|322588059|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94217021|NCT01072149|322588060|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94217022|NCT01072149|322588061|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94217023|NCT01072149|322588062|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94217024|NCT01072149|322588063|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94217025|NCT01072149|322588064|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94217026|NCT01072149|322588065|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94217027|NCT01072149|322588066|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94217028|NCT01072149|322588067|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94217029|NCT01072149|322588068|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94217030|NCT01072149|322588069|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94217031|NCT01072149|322588070|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94217032|NCT01072149|322588071|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94217033|NCT01072149|322588072|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94217034|NCT01072149|322588073|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
94217035|NCT01072149|322588056|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
94217036|NCT01072149|322588057|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
94217037|NCT01072149|322588058|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
94217038|NCT01072149|322588059|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
94217039|NCT01072149|322588060|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
94217040|NCT01072149|322588061|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
94217041|NCT01072149|322588062|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
94217042|NCT01072149|322588063|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
94217043|NCT01072149|322588064|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
94217044|NCT01072149|322588065|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
94217045|NCT01072149|322588066|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
94286741|NCT01114529|322838976|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
94286742|NCT01114529|322838977|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
94286743|NCT01114529|322838978|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
94286744|NCT01114529|322838976|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
94286745|NCT01114529|322838977|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
94286746|NCT01114529|322838978|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
94286747|NCT01114529|322838976|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
94286748|NCT01114529|322838977|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
94286749|NCT01114529|322838978|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
94286750|NCT01114529|322838976|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
94286751|NCT01114529|322838977|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
94286752|NCT01114529|322838978|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
94286753|NCT01114529|322838976|FG000|Completed Study Medication at Month 24|Death|2|||
94286754|NCT01114529|322838977|FG001|Completed Study Medication at Month 24|Death|1|||
94286755|NCT01114529|322838978|FG002|Completed Study Medication at Month 24|Death|2|||
94286756|NCT01114529|322838976|FG000|Completed Study Medication at Month 24|Graft loss|0|||
94286757|NCT01114529|322838977|FG001|Completed Study Medication at Month 24|Graft loss|2|||
94286758|NCT01114529|322838978|FG002|Completed Study Medication at Month 24|Graft loss|0|||
94286759|NCT01114529|322838976|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
94286760|NCT01114529|322838977|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
94286761|NCT01114529|322838978|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
94286762|NCT01114529|322838976|FG000|Completed Study Medication at Month 24|Missing|2|||
94286763|NCT01114529|322838977|FG001|Completed Study Medication at Month 24|Missing|0|||
94286764|NCT01114529|322838978|FG002|Completed Study Medication at Month 24|Missing|0|||
94286765|NCT01114529|322838976|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
94217046|NCT01072149|322588067|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
94217047|NCT01072149|322588068|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
94286766|NCT01114529|322838977|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
94286767|NCT01114529|322838978|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
94286768|NCT01114529|322838976|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
94217048|NCT01072149|322588069|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
94217049|NCT01072149|322588070|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
94217050|NCT01072149|322588071|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
94217051|NCT01072149|322588072|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
94217052|NCT01072149|322588073|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
94217053|NCT01072149|322588056|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
94217054|NCT01072149|322588057|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
94217055|NCT01072149|322588058|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
94217056|NCT01072149|322588059|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
94217057|NCT01072149|322588060|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
94217058|NCT01072149|322588061|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
94217059|NCT01072149|322588062|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
94217060|NCT01072149|322588063|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
94217061|NCT01072149|322588064|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
94217062|NCT01072149|322588065|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
94217063|NCT01072149|322588066|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
94217064|NCT01072149|322588067|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
94217065|NCT01072149|322588068|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
94217066|NCT01072149|322588069|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
94217067|NCT01072149|322588070|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
94217068|NCT01072149|322588071|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
94217069|NCT01072149|322588072|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
94217070|NCT01072149|322588073|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
94217071|NCT01072149|322588056|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
94217072|NCT01072149|322588057|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
94217073|NCT01072149|322588058|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
94217074|NCT01072149|322588059|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
94217075|NCT01072149|322588060|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
94217076|NCT01072149|322588061|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
94217077|NCT01072149|322588062|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
94217078|NCT01072149|322588063|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
94217079|NCT01072149|322588064|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
94217080|NCT01072149|322588065|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
94217081|NCT01072149|322588066|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
94217082|NCT01072149|322588067|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
94217083|NCT01072149|322588068|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
94217084|NCT01072149|322588069|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
94217085|NCT01072149|322588070|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
94217086|NCT01072149|322588071|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
94217087|NCT01072149|322588072|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
94217088|NCT01072149|322588073|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
94217089|NCT01072149|322588056|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
94217090|NCT01072149|322588057|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
94217091|NCT01072149|322588058|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
94217092|NCT01072149|322588059|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
94217093|NCT01072149|322588060|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
94217094|NCT01072149|322588061|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
94217095|NCT01072149|322588062|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
94217096|NCT01072149|322588063|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
94217097|NCT01072149|322588064|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
94217098|NCT01072149|322588065|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
94217099|NCT01072149|322588066|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
94217100|NCT01072149|322588067|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
94217101|NCT01072149|322588068|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
94217102|NCT01072149|322588069|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
94217103|NCT01072149|322588070|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
94217104|NCT01072149|322588071|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
94217105|NCT01072149|322588072|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
94217106|NCT01072149|322588073|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
94217107|NCT01072149|322588056|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
94217108|NCT01072149|322588057|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
94217109|NCT01072149|322588058|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
94217110|NCT01072149|322588059|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
94217111|NCT01072149|322588060|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
94217112|NCT01072149|322588061|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
94217113|NCT01072149|322588062|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
94286769|NCT01114529|322838977|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
94217114|NCT01072149|322588063|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
94217115|NCT01072149|322588064|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
94217116|NCT01072149|322588065|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
94217117|NCT01072149|322588066|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
94217118|NCT01072149|322588067|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
94217119|NCT01072149|322588068|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
94217120|NCT01072149|322588069|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
94217121|NCT01072149|322588070|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
94217122|NCT01072149|322588071|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
94217123|NCT01072149|322588072|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
94217124|NCT01072149|322588073|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
94217125|NCT01072149|322588056|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
94217126|NCT01072149|322588057|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
94217127|NCT01072149|322588058|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
94217128|NCT01072149|322588059|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
94217129|NCT01072149|322588060|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
94217130|NCT01072149|322588061|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
94217131|NCT01072149|322588062|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
94217132|NCT01072149|322588063|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
94217133|NCT01072149|322588064|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
94217134|NCT01072149|322588065|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
94217135|NCT01072149|322588066|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
94217136|NCT01072149|322588067|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
94217137|NCT01072149|322588068|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
94217138|NCT01072149|322588069|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
94217139|NCT01072149|322588070|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
94217140|NCT01072149|322588071|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
94217141|NCT01072149|322588072|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
94217142|NCT01072149|322588073|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
94217143|NCT02784834|322588076|FG000|Overall Study|Lack of Efficacy|1|||
94217144|NCT01919489|322588077|FG000|Overall Study|Rejected the need of injections|4|||
94217145|NCT01919489|322588078|FG001|Overall Study|Rejected the need of injections|7|||
94217146|NCT01919489|322588077|FG000|Overall Study|Adverse Event|10|||
94217147|NCT01919489|322588078|FG001|Overall Study|Adverse Event|0|||
94217148|NCT01919489|322588077|FG000|Overall Study|Hospital readmission|2|||
94217149|NCT01919489|322588078|FG001|Overall Study|Hospital readmission|9|||
94217150|NCT01919489|322588077|FG000|Overall Study|Death|2|||
94217151|NCT01919489|322588078|FG001|Overall Study|Death|1|||
94217152|NCT01919489|322588077|FG000|Overall Study|Lost to Follow-up|38|||
94217153|NCT01919489|322588078|FG001|Overall Study|Lost to Follow-up|27|||
94217154|NCT01322386|322588079|FG000|Overall Study|Protocol Violation|0|||
94217155|NCT01322386|322588080|FG001|Overall Study|Protocol Violation|1|||
94217156|NCT01322386|322588079|FG000|Overall Study|Physician Decision|0|||
94217157|NCT01322386|322588080|FG001|Overall Study|Physician Decision|1|||
94217158|NCT01090739|322588083|FG000|Enrollment|Withdrawal by Subject|24|||
94217159|NCT01090739|322588083|FG000|Enrollment|Protocol Violation|14|||
94217160|NCT01090739|322588083|FG000|Enrollment|Lost to Follow-up|5|||
94217161|NCT01090739|322588083|FG000|Enrollment|Physician Decision|5|||
94217162|NCT01090739|322588083|FG000|Enrollment|Sponsor termination of site|4|||
94217163|NCT01090739|322588083|FG000|Enrollment|Study implant limit reached|2|||
94217164|NCT01090739|322588083|FG000|Enrollment|Adverse Event|1|||
94217165|NCT01090739|322588083|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
94217166|NCT01090739|322588083|FG000|12 Month Follow-up|Lost to Follow-up|1|||
94217167|NCT01090739|322588083|FG000|12 Month Follow-up|Physician Decision|1|||
94217168|NCT01090739|322588083|FG000|12 Month Follow-up|Death|1|||
94217169|NCT01090739|322588083|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
94217170|NCT01090739|322588083|FG000|24 Month Follow-up|Lost to Follow-up|1|||
94217171|NCT01090739|322588083|FG000|24 Month Follow-up|Death|1|||
94217172|NCT01090739|322588083|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
94217173|NCT01090739|322588083|FG000|36 Month Follow-up|Visit still pending|17|||
94217174|NCT01074229|322588084|FG000|Overall Study|Lost to Follow-up|1|||
94217175|NCT01074229|322588085|FG001|Overall Study|Lost to Follow-up|0|||
94217176|NCT01074229|322588086|FG002|Overall Study|Lost to Follow-up|0|||
94217177|NCT01074229|322588084|FG000|Overall Study|Change to open surgical procedure|1|||
94217178|NCT01074229|322588085|FG001|Overall Study|Change to open surgical procedure|3|||
94217179|NCT01074229|322588086|FG002|Overall Study|Change to open surgical procedure|4|||
94217180|NCT02964234|322588087|FG000|Overall Study|Lost to Follow-up|22|||
94217181|NCT02964234|322588088|FG001|Overall Study|Lost to Follow-up|13|||
94217182|NCT04271254|322588090|FG000|Overall Study|Withdrawal by Subject|3|||
94217183|NCT00267956|322588095|FG000|Controlled Period|Adverse Event|4|||
94217184|NCT00267956|322588096|FG001|Controlled Period|Adverse Event|1|||
94217185|NCT00267956|322588097|FG002|Controlled Period|Adverse Event|0|||
94217186|NCT00267956|322588098|FG003|Controlled Period|Adverse Event|0|||
94217187|NCT00267956|322588095|FG000|Controlled Period|Lack of Efficacy|4|||
94217188|NCT00267956|322588096|FG001|Controlled Period|Lack of Efficacy|2|||
94217189|NCT00267956|322588097|FG002|Controlled Period|Lack of Efficacy|0|||
94217190|NCT00267956|322588098|FG003|Controlled Period|Lack of Efficacy|0|||
94217191|NCT00267956|322588095|FG000|Controlled Period|Lost to Follow-up|2|||
94217192|NCT00267956|322588096|FG001|Controlled Period|Lost to Follow-up|0|||
94217193|NCT00267956|322588097|FG002|Controlled Period|Lost to Follow-up|0|||
94217194|NCT00267956|322588098|FG003|Controlled Period|Lost to Follow-up|0|||
94217195|NCT00267956|322588095|FG000|Controlled Period|Withdrew consent|3|||
94217196|NCT00267956|322588096|FG001|Controlled Period|Withdrew consent|1|||
94217197|NCT00267956|322588097|FG002|Controlled Period|Withdrew consent|0|||
94217198|NCT00267956|322588098|FG003|Controlled Period|Withdrew consent|0|||
94217199|NCT00267956|322588095|FG000|After Controlled Period|Adverse Event|0|||
94217200|NCT00267956|322588096|FG001|After Controlled Period|Adverse Event|0|||
94217201|NCT00267956|322588097|FG002|After Controlled Period|Adverse Event|2|||
94217202|NCT00267956|322588098|FG003|After Controlled Period|Adverse Event|1|||
94217203|NCT00267956|322588095|FG000|After Controlled Period|Lack of Efficacy|0|||
94217204|NCT00267956|322588096|FG001|After Controlled Period|Lack of Efficacy|0|||
94217205|NCT00267956|322588097|FG002|After Controlled Period|Lack of Efficacy|1|||
94217206|NCT00267956|322588098|FG003|After Controlled Period|Lack of Efficacy|1|||
94217207|NCT00267956|322588095|FG000|After Controlled Period|Lost to Follow-up|0|||
94217208|NCT00267956|322588096|FG001|After Controlled Period|Lost to Follow-up|0|||
94217209|NCT00267956|322588097|FG002|After Controlled Period|Lost to Follow-up|1|||
94217210|NCT00267956|322588098|FG003|After Controlled Period|Lost to Follow-up|0|||
94217211|NCT00267956|322588095|FG000|After Controlled Period|Withdrew consent|0|||
94217212|NCT00267956|322588096|FG001|After Controlled Period|Withdrew consent|0|||
94217213|NCT00267956|322588097|FG002|After Controlled Period|Withdrew consent|1|||
94217214|NCT00267956|322588098|FG003|After Controlled Period|Withdrew consent|0|||
94217215|NCT01113541|322588099|FG000|Overall Study|Withdrawal by Subject|1|||
94217216|NCT01113541|322588099|FG000|Overall Study|Protocol Violation|1|||
94217217|NCT01113541|322588099|FG000|Overall Study|Study Terminated by Sponsor|7|||
94217218|NCT01113541|322588099|FG000|Overall Study|Adverse Event|4|||
94217219|NCT03651271|322588100|FG000|Overall Study|Death|4|||
94217220|NCT03651271|322588101|FG001|Overall Study|Death|37|||
94217221|NCT03651271|322588102|FG002|Overall Study|Death|0|||
94217222|NCT03651271|322588103|FG003|Overall Study|Death|2|||
94217223|NCT03651271|322588104|FG004|Overall Study|Death|6|||
94217224|NCT03651271|322588100|FG000|Overall Study|Lost to Follow-up|1|||
94217225|NCT03651271|322588101|FG001|Overall Study|Lost to Follow-up|5|||
94217226|NCT03651271|322588102|FG002|Overall Study|Lost to Follow-up|0|||
94217227|NCT03651271|322588103|FG003|Overall Study|Lost to Follow-up|1|||
94217228|NCT03651271|322588104|FG004|Overall Study|Lost to Follow-up|0|||
94217229|NCT03651271|322588100|FG000|Overall Study|Physician Decision|0|||
94217230|NCT03651271|322588101|FG001|Overall Study|Physician Decision|2|||
94217231|NCT03651271|322588102|FG002|Overall Study|Physician Decision|0|||
94217232|NCT03651271|322588103|FG003|Overall Study|Physician Decision|0|||
94217233|NCT03651271|322588104|FG004|Overall Study|Physician Decision|0|||
94217234|NCT03651271|322588100|FG000|Overall Study|Withdrawal by Subject|1|||
94217235|NCT03651271|322588101|FG001|Overall Study|Withdrawal by Subject|15|||
94217236|NCT03651271|322588102|FG002|Overall Study|Withdrawal by Subject|0|||
94217237|NCT03651271|322588103|FG003|Overall Study|Withdrawal by Subject|0|||
94217238|NCT03651271|322588104|FG004|Overall Study|Withdrawal by Subject|1|||
94217239|NCT03651271|322588100|FG000|Overall Study|Patient medically unable to continue|0|||
94217240|NCT03651271|322588101|FG001|Overall Study|Patient medically unable to continue|0|||
94217241|NCT03651271|322588102|FG002|Overall Study|Patient medically unable to continue|0|||
94217242|NCT03651271|322588103|FG003|Overall Study|Patient medically unable to continue|1|||
94217243|NCT03651271|322588104|FG004|Overall Study|Patient medically unable to continue|0|||
94217244|NCT01613599|322588109|FG000|Overall Study|Death|9|||
94217245|NCT01613599|322588109|FG000|Overall Study|Lost to Follow-up|5|||
94217246|NCT01613599|322588109|FG000|Overall Study|Withdrawal by Subject|8|||
94217247|NCT01613599|322588109|FG000|Overall Study|Reason not specified|3|||
94217248|NCT03503188|322588110|FG000|Overall Study|Non eligible in the sub study|0|||
94217249|NCT03503188|322588111|FG001|Overall Study|Non eligible in the sub study|1|||
94217250|NCT02924051|322588112|FG000|Overall Study|Withdrawal by Subject|1|||
94217251|NCT02924051|322588113|FG001|Overall Study|Withdrawal by Subject|9|||
94217252|NCT03005106|322588114|FG000|Overall Study|Lost to Follow-up|16|||
94217253|NCT03005106|322588114|FG000|Overall Study|Adverse Event|1|||
94217254|NCT03005106|322588114|FG000|Overall Study|Physician Decision|1|||
94217255|NCT03005106|322588114|FG000|Overall Study|Death|2|||
94217256|NCT01670526|322588115|FG000|Overall Study|Withdrawal by Subject|3|||
94217257|NCT01670526|322588116|FG001|Overall Study|Withdrawal by Subject|1|||
94217258|NCT01670526|322588115|FG000|Overall Study|Lost to Follow-up|9|||
94217259|NCT01670526|322588116|FG001|Overall Study|Lost to Follow-up|5|||
94217260|NCT03953079|322588117|FG000|Core Study|Withdrawal by Subject|1|||
94217261|NCT03953079|322588118|FG001|Core Study|Withdrawal by Subject|2|||
94217262|NCT03953079|322588119|FG002|Core Study|Withdrawal by Subject|1|||
94217263|NCT03953079|322588117|FG000|Core Study|COVID-19|0|||
94217264|NCT03953079|322588118|FG001|Core Study|COVID-19|1|||
94217265|NCT03953079|322588119|FG002|Core Study|COVID-19|0|||
94217266|NCT03953079|322588117|FG000|Core Study|Difficulties leaving the house|0|||
94217267|NCT03953079|322588118|FG001|Core Study|Difficulties leaving the house|1|||
94217268|NCT03953079|322588119|FG002|Core Study|Difficulties leaving the house|0|||
94217269|NCT03953079|322588117|FG000|Extension Study|Withdrawal by Subject|1|||
94217270|NCT03953079|322588118|FG001|Extension Study|Withdrawal by Subject|0|||
94217271|NCT03953079|322588119|FG002|Extension Study|Withdrawal by Subject|0|||
94217272|NCT03953079|322588117|FG000|Extension Study|Received Rescue Treatment|5|||
94217273|NCT03953079|322588118|FG001|Extension Study|Received Rescue Treatment|6|||
94217274|NCT03953079|322588119|FG002|Extension Study|Received Rescue Treatment|5|||
94217275|NCT03019289|322588120|FG000|Overall Study|Adverse Event|1|||
94217276|NCT03019289|322588121|FG001|Overall Study|Adverse Event|0|||
94217277|NCT03019289|322588122|FG002|Overall Study|Adverse Event|0|||
94217278|NCT03019289|322588123|FG003|Overall Study|Adverse Event|0|||
94286770|NCT01114529|322838978|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
94286771|NCT01114529|322838976|FG000|Completed Study Phase at Month 24|Death|8|||
94286772|NCT01114529|322838977|FG001|Completed Study Phase at Month 24|Death|5|||
94286773|NCT01114529|322838978|FG002|Completed Study Phase at Month 24|Death|4|||
94286774|NCT01114529|322838976|FG000|Completed Study Phase at Month 24|Other|2|||
94286775|NCT01114529|322838977|FG001|Completed Study Phase at Month 24|Other|0|||
94286776|NCT01114529|322838978|FG002|Completed Study Phase at Month 24|Other|0|||
94286777|NCT01114529|322838976|FG000|Completed Study Phase at Month 24|Missing|2|||
94286778|NCT01114529|322838977|FG001|Completed Study Phase at Month 24|Missing|0|||
94286779|NCT01114529|322838978|FG002|Completed Study Phase at Month 24|Missing|0|||
94286780|NCT02623335|322838980|FG000|Overall Study|Death|8|||
94286781|NCT02623335|322838981|FG001|Overall Study|Death|7|||
94286782|NCT02623335|322838980|FG000|Overall Study|Lost to Follow-up|15|||
94286783|NCT02623335|322838981|FG001|Overall Study|Lost to Follow-up|23|||
94286784|NCT02623335|322838980|FG000|Overall Study|Withdrawal by Subject|2|||
94286785|NCT02623335|322838981|FG001|Overall Study|Withdrawal by Subject|5|||
94286786|NCT02623335|322838980|FG000|Overall Study|Protocol Violation|2|||
94286787|NCT02623335|322838981|FG001|Overall Study|Protocol Violation|1|||
94286788|NCT02769624|322838982|FG000|Overall Study|Lost to Follow-up|0|||
94286789|NCT02769624|322838983|FG001|Overall Study|Lost to Follow-up|1|||
94286790|NCT00448708|322838986|FG000|Overall Study|Death|21|||
94286791|NCT00448708|322838987|FG001|Overall Study|Death|17|||
94286792|NCT00448708|322838986|FG000|Overall Study|Withdrawal by Subject|8|||
94286793|NCT00448708|322838987|FG001|Overall Study|Withdrawal by Subject|4|||
94286794|NCT00448708|322838986|FG000|Overall Study|Lost to Follow-up|6|||
94286795|NCT00448708|322838987|FG001|Overall Study|Lost to Follow-up|8|||
94286796|NCT00448708|322838986|FG000|Overall Study|not listed|0|||
94217279|NCT03019289|322588124|FG004|Overall Study|Adverse Event|0|||
94217280|NCT03019289|322588125|FG005|Overall Study|Adverse Event|0|||
94217281|NCT03019289|322588126|FG006|Overall Study|Adverse Event|0|||
94217282|NCT03019289|322588127|FG007|Overall Study|Adverse Event|0|||
94217283|NCT03019289|322588128|FG008|Overall Study|Adverse Event|1|||
94217284|NCT03019289|322588120|FG000|Overall Study|Other|1|||
94217285|NCT03019289|322588121|FG001|Overall Study|Other|0|||
94217286|NCT03019289|322588122|FG002|Overall Study|Other|0|||
94217287|NCT03019289|322588123|FG003|Overall Study|Other|0|||
94217288|NCT03019289|322588124|FG004|Overall Study|Other|0|||
94217289|NCT03019289|322588125|FG005|Overall Study|Other|0|||
94217290|NCT03019289|322588126|FG006|Overall Study|Other|0|||
94217291|NCT03019289|322588127|FG007|Overall Study|Other|0|||
94217292|NCT03019289|322588128|FG008|Overall Study|Other|0|||
94217293|NCT01528605|322588129|FG000|Overall Study|Lost to Follow-up|1|||
94217294|NCT01528605|322588130|FG001|Overall Study|Lost to Follow-up|0|||
94217295|NCT01528605|322588131|FG002|Overall Study|Lost to Follow-up|1|||
94217296|NCT01528605|322588132|FG003|Overall Study|Lost to Follow-up|1|||
94217297|NCT01528605|322588133|FG004|Overall Study|Lost to Follow-up|0|||
94217298|NCT01528605|322588134|FG005|Overall Study|Lost to Follow-up|0|||
94217299|NCT01528605|322588129|FG000|Overall Study|Death|1|||
94217300|NCT01528605|322588130|FG001|Overall Study|Death|0|||
94217301|NCT01528605|322588131|FG002|Overall Study|Death|0|||
94217302|NCT01528605|322588132|FG003|Overall Study|Death|0|||
94217303|NCT01528605|322588133|FG004|Overall Study|Death|0|||
94217304|NCT01528605|322588134|FG005|Overall Study|Death|0|||
94217305|NCT03547167|322588135|FG000|Overall Study|Withdrawal by Subject|34|||
94217306|NCT03547167|322588136|FG001|Overall Study|Withdrawal by Subject|12|||
94217307|NCT03547167|322588135|FG000|Overall Study|Screen Failure|0|||
94217308|NCT03547167|322588136|FG001|Overall Study|Screen Failure|1|||
94286797|NCT00448708|322838987|FG001|Overall Study|not listed|2|||
94286798|NCT00508391|322838988|FG000|First Treatment|Withdrawal by Subject|6|||
94286799|NCT00508391|322838989|FG001|First Treatment|Withdrawal by Subject|3|||
94286800|NCT00508391|322838988|FG000|Second Treatment|Withdrawal by Subject|2|||
94286801|NCT00508391|322838989|FG001|Second Treatment|Withdrawal by Subject|0|||
94217309|NCT03547167|322588135|FG000|Overall Study|Lost to Follow-up|59|||
94217310|NCT03547167|322588136|FG001|Overall Study|Lost to Follow-up|15|||
94286802|NCT00565617|322838994|FG000|Overall Study|Withdrawal by Subject|1|||
94217311|NCT03547167|322588135|FG000|Overall Study|Death|4|||
94286803|NCT02175680|322838995|FG000|Overall Study|non-compliance|1|||
94286804|NCT02175680|322838995|FG000|Overall Study|other non-medical reason|1|||
94286805|NCT02526550|322838998|FG000|Overall Study|Lost to Follow-up|1|||
94217312|NCT03547167|322588136|FG001|Overall Study|Death|2|||
94217313|NCT01429285|322588137|FG000|Overall Study|Protocol Violation|9|||
94217314|NCT01429285|322588138|FG001|Overall Study|Protocol Violation|4|||
94286806|NCT00091832|322838999|FG000|Overall Study|Physician Decision|1|||
94217315|NCT01429285|322588137|FG000|Overall Study|Missing Data|5|||
94217316|NCT01429285|322588138|FG001|Overall Study|Missing Data|3|||
94217317|NCT01429285|322588137|FG000|Overall Study|Erroneously Enrolled Twice|8|||
94217318|NCT01429285|322588138|FG001|Overall Study|Erroneously Enrolled Twice|2|||
94217319|NCT01885559|322588139|FG000|Overall Study|Lost to Follow-up|15|||
94217320|NCT01885559|322588140|FG001|Overall Study|Lost to Follow-up|16|||
94217321|NCT01885559|322588139|FG000|Overall Study|Less than full participation|9|||
94217322|NCT01885559|322588140|FG001|Overall Study|Less than full participation|19|||
94217323|NCT01885559|322588139|FG000|Overall Study|Protocol Violation|0|||
94217324|NCT01885559|322588140|FG001|Overall Study|Protocol Violation|1|||
94217325|NCT02312245|322588144|FG000|Overall Study|Death|0|||
94217326|NCT02312245|322588145|FG001|Overall Study|Death|0|||
94217327|NCT02312245|322588146|FG002|Overall Study|Death|0|||
94217328|NCT02312245|322588147|FG003|Overall Study|Death|1|||
94217329|NCT02312245|322588144|FG000|Overall Study|Withdrawal by Subject|1|||
94217330|NCT02312245|322588145|FG001|Overall Study|Withdrawal by Subject|1|||
94217331|NCT02312245|322588146|FG002|Overall Study|Withdrawal by Subject|0|||
94217332|NCT02312245|322588147|FG003|Overall Study|Withdrawal by Subject|2|||
94217333|NCT02312245|322588144|FG000|Overall Study|Alternative Therapy|1|||
94217334|NCT02312245|322588145|FG001|Overall Study|Alternative Therapy|0|||
94217335|NCT02312245|322588146|FG002|Overall Study|Alternative Therapy|0|||
94217336|NCT02312245|322588147|FG003|Overall Study|Alternative Therapy|0|||
94217337|NCT02312245|322588144|FG000|Overall Study|Progression|0|||
94217338|NCT02312245|322588145|FG001|Overall Study|Progression|0|||
94217339|NCT02312245|322588146|FG002|Overall Study|Progression|0|||
94286807|NCT00091832|322839000|FG001|Overall Study|Physician Decision|0|||
94286808|NCT00091832|322839001|FG002|Overall Study|Physician Decision|0|||
94286809|NCT00091832|322839002|FG003|Overall Study|Physician Decision|0|||
94286810|NCT00091832|322839003|FG004|Overall Study|Physician Decision|0|||
94286811|NCT00091832|322839004|FG005|Overall Study|Physician Decision|0|||
94286812|NCT00091832|322838999|FG000|Overall Study|Adverse Event|0|||
94286813|NCT00091832|322839000|FG001|Overall Study|Adverse Event|0|||
94286814|NCT00091832|322839001|FG002|Overall Study|Adverse Event|0|||
94286815|NCT00091832|322839002|FG003|Overall Study|Adverse Event|1|||
94286816|NCT00091832|322839003|FG004|Overall Study|Adverse Event|3|||
94286817|NCT00091832|322839004|FG005|Overall Study|Adverse Event|0|||
94286818|NCT00091832|322838999|FG000|Overall Study|Withdrawal by Subject|4|||
94286819|NCT00091832|322839000|FG001|Overall Study|Withdrawal by Subject|5|||
94286820|NCT00091832|322839001|FG002|Overall Study|Withdrawal by Subject|0|||
94286821|NCT00091832|322839002|FG003|Overall Study|Withdrawal by Subject|1|||
94286822|NCT00091832|322839003|FG004|Overall Study|Withdrawal by Subject|3|||
94286823|NCT00091832|322839004|FG005|Overall Study|Withdrawal by Subject|1|||
94286824|NCT00091832|322838999|FG000|Overall Study|Death|6|||
94286825|NCT00091832|322839000|FG001|Overall Study|Death|4|||
94286826|NCT00091832|322839001|FG002|Overall Study|Death|5|||
94286827|NCT00091832|322839002|FG003|Overall Study|Death|8|||
94286828|NCT00091832|322839003|FG004|Overall Study|Death|5|||
94286829|NCT00091832|322839004|FG005|Overall Study|Death|6|||
94286830|NCT00091832|322838999|FG000|Overall Study|Disease Progression|2|||
94286831|NCT00091832|322839000|FG001|Overall Study|Disease Progression|0|||
94286832|NCT00091832|322839001|FG002|Overall Study|Disease Progression|0|||
94286833|NCT00091832|322839002|FG003|Overall Study|Disease Progression|1|||
94286834|NCT00091832|322839003|FG004|Overall Study|Disease Progression|1|||
94217340|NCT02312245|322588147|FG003|Overall Study|Progression|5|||
94217341|NCT02312245|322588144|FG000|Overall Study|Patient went to hospice|0|||
94217342|NCT02312245|322588145|FG001|Overall Study|Patient went to hospice|0|||
94217343|NCT02312245|322588146|FG002|Overall Study|Patient went to hospice|0|||
94217344|NCT02312245|322588147|FG003|Overall Study|Patient went to hospice|1|||
94217345|NCT02312245|322588144|FG000|Overall Study|Ineligible|1|||
94286835|NCT00091832|322839004|FG005|Overall Study|Disease Progression|2|||
94286836|NCT00091832|322838999|FG000|Overall Study|Ineligibility Determined|0|||
94286837|NCT00091832|322839000|FG001|Overall Study|Ineligibility Determined|0|||
94286838|NCT00091832|322839001|FG002|Overall Study|Ineligibility Determined|1|||
94217346|NCT02312245|322588145|FG001|Overall Study|Ineligible|0|||
94217347|NCT02312245|322588146|FG002|Overall Study|Ineligible|0|||
94217348|NCT02312245|322588147|FG003|Overall Study|Ineligible|0|||
94217349|NCT00508144|322588148|FG000|Overall Study|Not eligible|6|||
94286839|NCT00091832|322839002|FG003|Overall Study|Ineligibility Determined|0|||
94286840|NCT00091832|322839003|FG004|Overall Study|Ineligibility Determined|1|||
94286841|NCT00091832|322839004|FG005|Overall Study|Ineligibility Determined|0|||
94286842|NCT00091832|322838999|FG000|Overall Study|Lost to Follow-up|1|||
94286843|NCT00091832|322839000|FG001|Overall Study|Lost to Follow-up|0|||
94286844|NCT00091832|322839001|FG002|Overall Study|Lost to Follow-up|3|||
94286845|NCT00091832|322839002|FG003|Overall Study|Lost to Follow-up|3|||
94217350|NCT00508144|322588148|FG000|Overall Study|Death|5|||
94217351|NCT02009865|322588153|FG000|Overall Study|Adverse Event|0|||
94217352|NCT02009865|322588154|FG001|Overall Study|Adverse Event|2|||
94217353|NCT02009865|322588153|FG000|Overall Study|Protocol Violation|0|||
94217354|NCT02009865|322588154|FG001|Overall Study|Protocol Violation|2|||
94217355|NCT02009865|322588153|FG000|Overall Study|Withdrawal by Subject|1|||
94286846|NCT00091832|322839003|FG004|Overall Study|Lost to Follow-up|2|||
94217356|NCT02009865|322588154|FG001|Overall Study|Withdrawal by Subject|1|||
94217357|NCT01052714|322588159|FG000|Overall Study|Adverse Event|6|||
94217358|NCT01052714|322588160|FG001|Overall Study|Adverse Event|3|||
94217359|NCT01052714|322588161|FG002|Overall Study|Adverse Event|0|||
94217360|NCT01052714|322588159|FG000|Overall Study|Death|1|||
94217361|NCT01052714|322588160|FG001|Overall Study|Death|2|||
94217362|NCT01052714|322588161|FG002|Overall Study|Death|0|||
94217363|NCT01052714|322588159|FG000|Overall Study|Lost to Follow-up|2|||
94217364|NCT01052714|322588160|FG001|Overall Study|Lost to Follow-up|3|||
94217365|NCT01052714|322588161|FG002|Overall Study|Lost to Follow-up|0|||
94217366|NCT01052714|322588159|FG000|Overall Study|Physician Decision|9|||
94217367|NCT01052714|322588160|FG001|Overall Study|Physician Decision|9|||
94217368|NCT01052714|322588161|FG002|Overall Study|Physician Decision|1|||
94217369|NCT01052714|322588159|FG000|Overall Study|Withdrawal by Subject|7|||
94217370|NCT01052714|322588160|FG001|Overall Study|Withdrawal by Subject|12|||
94217371|NCT01052714|322588161|FG002|Overall Study|Withdrawal by Subject|1|||
94217372|NCT01760876|322588162|FG000|Overall Study|Non-cardiac death (head injury)|1|||
94217373|NCT01760876|322588162|FG000|Overall Study|Carcinoma of prostate|1|||
94217374|NCT01760876|322588162|FG000|Overall Study|Impaired renal function|1|||
94217375|NCT01760876|322588162|FG000|Overall Study|Major depression|1|||
94217376|NCT01760876|322588162|FG000|Overall Study|Very poor baseline OCT quality|2|||
94217377|NCT01517282|322588163|FG000|Overall Study|Consent withdrawn|0|||
94217378|NCT01517282|322588164|FG001|Overall Study|Consent withdrawn|1|||
94217379|NCT01517282|322588165|FG002|Overall Study|Consent withdrawn|1|||
94217380|NCT01517282|322588166|FG003|Overall Study|Consent withdrawn|1|||
94217381|NCT01517282|322588163|FG000|Overall Study|Physician Decision|1|||
94217382|NCT01517282|322588164|FG001|Overall Study|Physician Decision|0|||
94217383|NCT01517282|322588165|FG002|Overall Study|Physician Decision|0|||
94217384|NCT01517282|322588166|FG003|Overall Study|Physician Decision|0|||
94217385|NCT03122548|322588173|FG000|Overall Study|Death|2|||
94217386|NCT03122548|322588173|FG000|Overall Study|Progression - subject went into hospice|1|||
94217387|NCT03122548|322588173|FG000|Overall Study|Study Terminated by Sponsor|2|||
94217388|NCT01199302|322588180|FG000|Overall Study|Adverse Event|1|||
94217389|NCT01199302|322588181|FG001|Overall Study|Adverse Event|1|||
94217390|NCT01199302|322588182|FG002|Overall Study|Adverse Event|2|||
94217391|NCT01199302|322588183|FG003|Overall Study|Adverse Event|0|||
94217392|NCT01199302|322588180|FG000|Overall Study|Withdrawal by Subject|2|||
94217393|NCT01199302|322588181|FG001|Overall Study|Withdrawal by Subject|2|||
94217394|NCT01199302|322588182|FG002|Overall Study|Withdrawal by Subject|3|||
94217395|NCT01199302|322588183|FG003|Overall Study|Withdrawal by Subject|0|||
94217396|NCT01199302|322588180|FG000|Overall Study|Disease Progression|3|||
94217397|NCT01199302|322588181|FG001|Overall Study|Disease Progression|4|||
94217398|NCT01199302|322588182|FG002|Overall Study|Disease Progression|4|||
94217399|NCT01199302|322588183|FG003|Overall Study|Disease Progression|2|||
94217400|NCT01199302|322588180|FG000|Overall Study|Study Termination|13|||
94217401|NCT01199302|322588181|FG001|Overall Study|Study Termination|8|||
94217402|NCT01199302|322588182|FG002|Overall Study|Study Termination|11|||
94217403|NCT01199302|322588183|FG003|Overall Study|Study Termination|9|||
94217404|NCT01199302|322588180|FG000|Overall Study|Lost to Follow-up|0|||
94217405|NCT01199302|322588181|FG001|Overall Study|Lost to Follow-up|1|||
94217406|NCT01199302|322588182|FG002|Overall Study|Lost to Follow-up|0|||
94217407|NCT01199302|322588183|FG003|Overall Study|Lost to Follow-up|0|||
94217408|NCT01199302|322588180|FG000|Overall Study|Other|1|||
94217409|NCT01199302|322588181|FG001|Overall Study|Other|0|||
94217410|NCT01199302|322588182|FG002|Overall Study|Other|0|||
94217411|NCT01199302|322588183|FG003|Overall Study|Other|0|||
94217412|NCT01186809|322588184|FG000|Overall Study|Death|30|||
94217413|NCT02135445|322588186|FG000|Overall Study|Lost to Follow-up|1|||
94217414|NCT02135445|322588187|FG001|Overall Study|Lost to Follow-up|0|||
94217415|NCT02135445|322588186|FG000|Overall Study|Withdrawal by Subject|1|||
94217416|NCT02135445|322588187|FG001|Overall Study|Withdrawal by Subject|0|||
94217417|NCT04448561|322588193|FG000|Overall Study|Noncompliance|1|||
94217418|NCT04448561|322588194|FG001|Overall Study|Noncompliance|0|||
94217419|NCT05006703|322589883|FG000|Overall Study|Withdrawal by Subject|1|||
94217420|NCT05006703|322589884|FG001|Overall Study|Withdrawal by Subject|0|||
94217421|NCT05006703|322589883|FG000|Overall Study|Lost to Follow-up|13|||
94217422|NCT05006703|322589884|FG001|Overall Study|Lost to Follow-up|5|||
94217423|NCT02830893|322589889|FG000|Overall Study|Relocation to out of the country|1|||
94217424|NCT02830893|322589890|FG001|Overall Study|Relocation to out of the country|0|||
94217425|NCT02830893|322589889|FG000|Overall Study|Lost to Follow-up|0|||
94217426|NCT02830893|322589890|FG001|Overall Study|Lost to Follow-up|2|||
94217427|NCT02830893|322589889|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
94217428|NCT02830893|322589890|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
94217429|NCT03976102|322589891|FG000|Overall Study|Withdrawal by Subject|4|||
94217430|NCT03976102|322589892|FG001|Overall Study|Withdrawal by Subject|4|||
94217431|NCT03976102|322589891|FG000|Overall Study|Adverse Event|2|||
94217432|NCT03976102|322589892|FG001|Overall Study|Adverse Event|4|||
94217433|NCT03976102|322589891|FG000|Overall Study|Not related to Covid-19|9|||
94217434|NCT03976102|322589892|FG001|Overall Study|Not related to Covid-19|13|||
94217435|NCT03976102|322589891|FG000|Overall Study|Lost to Follow-up|0|||
94217436|NCT03976102|322589892|FG001|Overall Study|Lost to Follow-up|2|||
94217437|NCT03976102|322589891|FG000|Overall Study|Death|3|||
94217438|NCT03976102|322589892|FG001|Overall Study|Death|2|||
94217439|NCT03976102|322589891|FG000|Overall Study|Physician Decision|1|||
94217440|NCT03976102|322589892|FG001|Overall Study|Physician Decision|1|||
94217441|NCT00092456|322589898|FG000|Overall Study|Adverse Event|0|||
94217442|NCT00092456|322589899|FG001|Overall Study|Adverse Event|0|||
94217443|NCT00092456|322589900|FG002|Overall Study|Adverse Event|1|||
94217444|NCT00092456|322589901|FG003|Overall Study|Adverse Event|1|||
94217445|NCT00092456|322589898|FG000|Overall Study|Lost to Follow-up|2|||
94217446|NCT00092456|322589899|FG001|Overall Study|Lost to Follow-up|2|||
94217447|NCT00092456|322589900|FG002|Overall Study|Lost to Follow-up|1|||
94217448|NCT00092456|322589901|FG003|Overall Study|Lost to Follow-up|2|||
94217449|NCT00092456|322589898|FG000|Overall Study|Protocol Violation|5|||
94217450|NCT00092456|322589899|FG001|Overall Study|Protocol Violation|7|||
94217451|NCT00092456|322589900|FG002|Overall Study|Protocol Violation|8|||
94217452|NCT00092456|322589901|FG003|Overall Study|Protocol Violation|6|||
94217453|NCT00092456|322589898|FG000|Overall Study|Withdrawal by Subject|13|||
94217454|NCT00092456|322589899|FG001|Overall Study|Withdrawal by Subject|5|||
94217455|NCT00092456|322589900|FG002|Overall Study|Withdrawal by Subject|16|||
94217456|NCT00092456|322589901|FG003|Overall Study|Withdrawal by Subject|6|||
94217457|NCT00092456|322589898|FG000|Overall Study|Moved|1|||
94217458|NCT00092456|322589899|FG001|Overall Study|Moved|1|||
94217459|NCT00092456|322589900|FG002|Overall Study|Moved|0|||
94217460|NCT00092456|322589901|FG003|Overall Study|Moved|1|||
94217461|NCT00092456|322589898|FG000|Overall Study|Other|4|||
94217462|NCT00092456|322589899|FG001|Overall Study|Other|2|||
94217463|NCT00092456|322589900|FG002|Overall Study|Other|3|||
94217464|NCT00092456|322589901|FG003|Overall Study|Other|0|||
94217465|NCT00215943|322589904|FG000|Overall Study|Disease Progression|3|||
94217466|NCT00215943|322589905|FG001|Overall Study|Disease Progression|5|||
94217467|NCT00215943|322589904|FG000|Overall Study|Alternate therapy|0|||
94217468|NCT00215943|322589905|FG001|Overall Study|Alternate therapy|1|||
94217469|NCT00215943|322589904|FG000|Overall Study|Adverse Event|3|||
94217470|NCT00215943|322589905|FG001|Overall Study|Adverse Event|6|||
94217471|NCT00215943|322589904|FG000|Overall Study|Other disease|0|||
94217472|NCT00215943|322589905|FG001|Overall Study|Other disease|1|||
94217473|NCT00215943|322589904|FG000|Overall Study|Other complications|3|||
94217474|NCT00215943|322589905|FG001|Overall Study|Other complications|1|||
94217475|NCT01241448|322589912|FG000|Overall Study|Adverse Event|1|||
94217476|NCT01241448|322589913|FG001|Overall Study|Adverse Event|0|||
94217477|NCT01241448|322589914|FG002|Overall Study|Adverse Event|2|||
94217478|NCT01241448|322589915|FG003|Overall Study|Adverse Event|2|||
94217479|NCT01241448|322589912|FG000|Overall Study|Lost to Follow-up|2|||
94217480|NCT01241448|322589913|FG001|Overall Study|Lost to Follow-up|1|||
94217481|NCT01241448|322589914|FG002|Overall Study|Lost to Follow-up|1|||
94217482|NCT01241448|322589915|FG003|Overall Study|Lost to Follow-up|1|||
94217483|NCT01241448|322589912|FG000|Overall Study|Physician Decision|0|||
94217484|NCT01241448|322589913|FG001|Overall Study|Physician Decision|2|||
94217485|NCT01241448|322589914|FG002|Overall Study|Physician Decision|0|||
94217486|NCT01241448|322589915|FG003|Overall Study|Physician Decision|0|||
94217487|NCT01241448|322589912|FG000|Overall Study|Protocol Violation|10|||
94217488|NCT01241448|322589913|FG001|Overall Study|Protocol Violation|5|||
94217489|NCT01241448|322589914|FG002|Overall Study|Protocol Violation|3|||
94217490|NCT01241448|322589915|FG003|Overall Study|Protocol Violation|6|||
94217491|NCT01241448|322589912|FG000|Overall Study|Sponsor Decision|17|||
94217492|NCT01241448|322589913|FG001|Overall Study|Sponsor Decision|14|||
94217493|NCT01241448|322589914|FG002|Overall Study|Sponsor Decision|12|||
94217494|NCT01241448|322589915|FG003|Overall Study|Sponsor Decision|6|||
94217495|NCT01241448|322589912|FG000|Overall Study|Withdrawal by Subject|4|||
94217496|NCT01241448|322589913|FG001|Overall Study|Withdrawal by Subject|5|||
94217497|NCT01241448|322589914|FG002|Overall Study|Withdrawal by Subject|3|||
94217498|NCT01241448|322589915|FG003|Overall Study|Withdrawal by Subject|6|||
94217499|NCT01241448|322589912|FG000|Overall Study|Excluded due to data integrity issues|3|||
94217500|NCT01241448|322589913|FG001|Overall Study|Excluded due to data integrity issues|2|||
94217501|NCT01241448|322589914|FG002|Overall Study|Excluded due to data integrity issues|2|||
94217502|NCT01241448|322589915|FG003|Overall Study|Excluded due to data integrity issues|2|||
94217503|NCT04425252|322589916|FG000|Overall Study|Withdrawal by Subject|2|||
94217504|NCT04425252|322589917|FG001|Overall Study|Withdrawal by Subject|1|||
94217505|NCT04425252|322589916|FG000|Overall Study|Lost to Follow-up|1|||
94217506|NCT04425252|322589917|FG001|Overall Study|Lost to Follow-up|0|||
94217507|NCT04425252|322589916|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
94217508|NCT04425252|322589917|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
94217509|NCT01945593|322589919|FG000|Overall Study|Adverse Event|0|||
94217510|NCT01945593|322589920|FG001|Overall Study|Adverse Event|0|||
94217511|NCT01945593|322589921|FG002|Overall Study|Adverse Event|0|||
94217512|NCT01945593|322589922|FG003|Overall Study|Adverse Event|5|||
94217513|NCT01945593|322589919|FG000|Overall Study|Physician Decision|0|||
94217514|NCT01945593|322589920|FG001|Overall Study|Physician Decision|0|||
94217515|NCT01945593|322589921|FG002|Overall Study|Physician Decision|1|||
94217516|NCT01945593|322589922|FG003|Overall Study|Physician Decision|1|||
94217517|NCT01945593|322589919|FG000|Overall Study|Withdrawal by Subject|0|||
94217518|NCT01945593|322589920|FG001|Overall Study|Withdrawal by Subject|2|||
94217519|NCT01945593|322589921|FG002|Overall Study|Withdrawal by Subject|0|||
94217520|NCT01945593|322589922|FG003|Overall Study|Withdrawal by Subject|4|||
94217521|NCT01945593|322589919|FG000|Overall Study|Protocol Violation|0|||
94217522|NCT01945593|322589920|FG001|Overall Study|Protocol Violation|2|||
94217523|NCT01945593|322589921|FG002|Overall Study|Protocol Violation|1|||
94217524|NCT01945593|322589922|FG003|Overall Study|Protocol Violation|3|||
94217525|NCT01945593|322589919|FG000|Overall Study|Death|0|||
94217526|NCT01945593|322589920|FG001|Overall Study|Death|0|||
94217527|NCT01945593|322589921|FG002|Overall Study|Death|1|||
94217528|NCT01945593|322589922|FG003|Overall Study|Death|0|||
94217529|NCT01945593|322589919|FG000|Overall Study|Other: Terminated|0|||
94217530|NCT01945593|322589920|FG001|Overall Study|Other: Terminated|0|||
94217531|NCT01945593|322589921|FG002|Overall Study|Other: Terminated|0|||
94217532|NCT01945593|322589922|FG003|Overall Study|Other: Terminated|1|||
94217533|NCT01945593|322589919|FG000|Overall Study|Other: Surgical Procedure|0|||
94217534|NCT01945593|322589920|FG001|Overall Study|Other: Surgical Procedure|2|||
94217535|NCT01945593|322589921|FG002|Overall Study|Other: Surgical Procedure|0|||
94217536|NCT01945593|322589922|FG003|Overall Study|Other: Surgical Procedure|6|||
94217537|NCT01945593|322589919|FG000|Overall Study|Other: Screen Failure|0|||
94217538|NCT01945593|322589920|FG001|Overall Study|Other: Screen Failure|2|||
94217539|NCT01945593|322589921|FG002|Overall Study|Other: Screen Failure|0|||
94217540|NCT01945593|322589922|FG003|Overall Study|Other: Screen Failure|0|||
94217541|NCT00246129|322589923|FG000|Overall Study|Lost to Follow-up|1|||
94217542|NCT00246129|322589924|FG001|Overall Study|Lost to Follow-up|0|||
94217543|NCT00246129|322589923|FG000|Overall Study|Death|2|||
94217544|NCT00246129|322589924|FG001|Overall Study|Death|1|||
94217545|NCT00246129|322589923|FG000|Overall Study|suffered primary non-function|1|||
94217546|NCT00246129|322589924|FG001|Overall Study|suffered primary non-function|0|||
94217547|NCT00246129|322589923|FG000|Overall Study|grafts failed|3|||
94217548|NCT00246129|322589924|FG001|Overall Study|grafts failed|1|||
94217549|NCT03740737|322589925|FG000|Overall Study|Protocol deviation|13|||
94467877|NCT00337779|323502429|FG001|Overall Study|Withdrawal by Subject|12|||
94217550|NCT03740737|322589926|FG001|Overall Study|Protocol deviation|0|||
94217551|NCT03740737|322589925|FG000|Overall Study|Adverse Event|2|||
94217552|NCT03740737|322589926|FG001|Overall Study|Adverse Event|0|||
94217553|NCT03740737|322589925|FG000|Overall Study|Lost to Follow-up|1|||
94217554|NCT03740737|322589926|FG001|Overall Study|Lost to Follow-up|0|||
94217555|NCT03740737|322589925|FG000|Overall Study|Randomization failure|1|||
94217556|NCT03740737|322589926|FG001|Overall Study|Randomization failure|0|||
94217557|NCT03740737|322589925|FG000|Overall Study|Participant withdrew consent|1|||
94217558|NCT03740737|322589926|FG001|Overall Study|Participant withdrew consent|0|||
94217559|NCT03740737|322589925|FG000|Overall Study|Participant withdrew from trial|2|||
94217560|NCT03740737|322589926|FG001|Overall Study|Participant withdrew from trial|1|||
94217561|NCT03469258|322589927|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
94217562|NCT05005247|322589928|FG000|Overall Study|Withdrawal by Subject|0|||
94217563|NCT05005247|322589929|FG001|Overall Study|Withdrawal by Subject|1|||
94217564|NCT05005247|322589930|FG002|Overall Study|Withdrawal by Subject|0|||
94217565|NCT00990184|322589936|FG000|Overall Study|Physician Decision|1|||
94217566|NCT03761849|322589937|FG000|Overall Study|transferred to OpenLabelExtension|35|||
94467878|NCT00337779|323502428|FG000|Overall Study|Sponsor decision|1|||
94217567|NCT03761849|322589938|FG001|Overall Study|transferred to OpenLabelExtension|34|||
94217568|NCT03761849|322589939|FG002|Overall Study|transferred to OpenLabelExtension|36|||
94217569|NCT03761849|322589940|FG003|Overall Study|transferred to OpenLabelExtension|0|||
94217570|NCT03761849|322589941|FG004|Overall Study|transferred to OpenLabelExtension|0|||
94217571|NCT03761849|322589942|FG005|Overall Study|transferred to OpenLabelExtension|0|||
94217572|NCT03761849|322589937|FG000|Overall Study|Adverse Event|1|||
94217573|NCT03761849|322589938|FG001|Overall Study|Adverse Event|0|||
94217574|NCT03761849|322589939|FG002|Overall Study|Adverse Event|0|||
94217575|NCT03761849|322589940|FG003|Overall Study|Adverse Event|0|||
94217576|NCT03761849|322589941|FG004|Overall Study|Adverse Event|2|||
94217577|NCT03761849|322589942|FG005|Overall Study|Adverse Event|3|||
94217578|NCT03761849|322589937|FG000|Overall Study|Withdrawal by Subject|0|||
94217579|NCT03761849|322589938|FG001|Overall Study|Withdrawal by Subject|0|||
94217580|NCT03761849|322589939|FG002|Overall Study|Withdrawal by Subject|0|||
94467879|NCT00337779|323502429|FG001|Overall Study|Sponsor decision|1|||
94217581|NCT03761849|322589940|FG003|Overall Study|Withdrawal by Subject|41|||
94217582|NCT03761849|322589941|FG004|Overall Study|Withdrawal by Subject|43|||
94217583|NCT03761849|322589942|FG005|Overall Study|Withdrawal by Subject|35|||
94217584|NCT03761849|322589937|FG000|Overall Study|Lost to Follow-up|0|||
94217585|NCT03761849|322589938|FG001|Overall Study|Lost to Follow-up|1|||
94217586|NCT03761849|322589939|FG002|Overall Study|Lost to Follow-up|0|||
94217587|NCT03761849|322589940|FG003|Overall Study|Lost to Follow-up|2|||
94217588|NCT03761849|322589941|FG004|Overall Study|Lost to Follow-up|4|||
94467880|NCT00337779|323502428|FG000|Overall Study|Physician Decision|3|||
94467881|NCT00337779|323502429|FG001|Overall Study|Physician Decision|6|||
94467882|NCT00337779|323502428|FG000|Overall Study|Protocol Violation|1|||
94217589|NCT03761849|322589942|FG005|Overall Study|Lost to Follow-up|5|||
94217590|NCT03761849|322589937|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
94217591|NCT03761849|322589938|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
94217592|NCT03761849|322589939|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
94217593|NCT03761849|322589940|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
94217594|NCT03761849|322589941|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
94217595|NCT03761849|322589942|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
94217596|NCT03761849|322589937|FG000|Overall Study|Physician Decision|0|||
94217597|NCT03761849|322589938|FG001|Overall Study|Physician Decision|0|||
94217598|NCT03761849|322589939|FG002|Overall Study|Physician Decision|0|||
94217599|NCT03761849|322589940|FG003|Overall Study|Physician Decision|1|||
94217600|NCT03761849|322589941|FG004|Overall Study|Physician Decision|4|||
94217601|NCT03761849|322589942|FG005|Overall Study|Physician Decision|4|||
94217602|NCT03761849|322589937|FG000|Overall Study|Death|0|||
94217603|NCT03761849|322589938|FG001|Overall Study|Death|0|||
94217604|NCT03761849|322589939|FG002|Overall Study|Death|0|||
94217605|NCT03761849|322589940|FG003|Overall Study|Death|1|||
94217606|NCT03761849|322589941|FG004|Overall Study|Death|1|||
94217607|NCT03761849|322589942|FG005|Overall Study|Death|3|||
94217608|NCT03761849|322589937|FG000|Overall Study|Protocol Violation|0|||
94217609|NCT03761849|322589938|FG001|Overall Study|Protocol Violation|0|||
94217610|NCT03761849|322589939|FG002|Overall Study|Protocol Violation|0|||
94217611|NCT03761849|322589940|FG003|Overall Study|Protocol Violation|2|||
94217612|NCT03761849|322589941|FG004|Overall Study|Protocol Violation|2|||
94217613|NCT03761849|322589942|FG005|Overall Study|Protocol Violation|1|||
94217614|NCT03761849|322589937|FG000|Overall Study|Participant could not come to site|0|||
94217615|NCT03761849|322589938|FG001|Overall Study|Participant could not come to site|0|||
94217616|NCT03761849|322589939|FG002|Overall Study|Participant could not come to site|0|||
94217617|NCT03761849|322589940|FG003|Overall Study|Participant could not come to site|0|||
94217618|NCT03761849|322589941|FG004|Overall Study|Participant could not come to site|1|||
94217619|NCT03761849|322589942|FG005|Overall Study|Participant could not come to site|0|||
94217620|NCT03761849|322589937|FG000|Overall Study|SF- safety Finding|0|||
94217621|NCT03761849|322589938|FG001|Overall Study|SF- safety Finding|0|||
94217622|NCT03761849|322589939|FG002|Overall Study|SF- safety Finding|0|||
94217623|NCT03761849|322589940|FG003|Overall Study|SF- safety Finding|0|||
94217624|NCT03761849|322589941|FG004|Overall Study|SF- safety Finding|0|||
94217625|NCT03761849|322589942|FG005|Overall Study|SF- safety Finding|1|||
94217626|NCT03761849|322589937|FG000|Overall Study|Patient did not attend visit|0|||
94217627|NCT03761849|322589938|FG001|Overall Study|Patient did not attend visit|0|||
94217628|NCT03761849|322589939|FG002|Overall Study|Patient did not attend visit|0|||
94217629|NCT03761849|322589940|FG003|Overall Study|Patient did not attend visit|0|||
94217630|NCT03761849|322589941|FG004|Overall Study|Patient did not attend visit|0|||
94217631|NCT03761849|322589942|FG005|Overall Study|Patient did not attend visit|1|||
94217632|NCT02213094|322589945|FG000|Overall Study|Adverse Event|1|||
94286847|NCT00091832|322839004|FG005|Overall Study|Lost to Follow-up|1|||
94217633|NCT02213094|322589946|FG001|Overall Study|Adverse Event|0|||
94217634|NCT00857311|322589947|FG000|Overall Study|Lost to Follow-up|1|||
94217635|NCT00857311|322589948|FG001|Overall Study|Lost to Follow-up|0|||
94217636|NCT00857311|322589949|FG002|Overall Study|Lost to Follow-up|0|||
94217637|NCT00857311|322589950|FG003|Overall Study|Lost to Follow-up|0|||
94217638|NCT01587703|322589955|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
94217639|NCT01587703|322589956|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
94217640|NCT01587703|322589957|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
94217641|NCT01587703|322589958|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
94217642|NCT01587703|322589959|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
94217643|NCT01587703|322589960|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
94217644|NCT01587703|322589961|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
94217645|NCT01587703|322589962|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
94217646|NCT01587703|322589963|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
94217647|NCT01587703|322589964|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
94217648|NCT01587703|322589965|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
94217649|NCT01587703|322589966|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
94217650|NCT01587703|322589967|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
94217651|NCT01587703|322589968|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
94217652|NCT01587703|322589969|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
94217653|NCT01587703|322589970|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
94217654|NCT01587703|322589971|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
94217655|NCT01587703|322589972|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
94217656|NCT01587703|322589973|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
94217657|NCT01587703|322589955|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
94217658|NCT01587703|322589956|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
94217659|NCT01587703|322589957|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
94217660|NCT01587703|322589958|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
94217661|NCT01587703|322589959|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
94217662|NCT01587703|322589960|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
94217663|NCT01587703|322589961|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
94217664|NCT01587703|322589962|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
94217665|NCT01587703|322589963|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
94217666|NCT01587703|322589964|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
94217667|NCT01587703|322589965|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
94217668|NCT01587703|322589966|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
94217669|NCT01587703|322589967|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
94217670|NCT01587703|322589968|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
94217671|NCT01587703|322589969|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
94217672|NCT01587703|322589970|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
94217673|NCT01587703|322589971|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
94217674|NCT01587703|322589972|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
94217675|NCT01587703|322589973|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
94217676|NCT01587703|322589955|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
94217677|NCT01587703|322589956|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
94217678|NCT01587703|322589957|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
94217679|NCT01587703|322589958|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
94217680|NCT01587703|322589959|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
94217681|NCT01587703|322589960|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
94217682|NCT01587703|322589961|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
94217683|NCT01587703|322589962|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
94217684|NCT01587703|322589963|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
94217685|NCT01587703|322589964|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
94217686|NCT01587703|322589965|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
94217687|NCT01587703|322589966|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
94217688|NCT01587703|322589967|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
94217689|NCT01587703|322589968|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
94217690|NCT01587703|322589969|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
94217691|NCT01587703|322589970|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
94217692|NCT01587703|322589971|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
94217693|NCT01587703|322589972|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
94217694|NCT01587703|322589973|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
94372469|NCT00903383|323150268|FG002|Overall Study|Lost to Follow-up|0|||
94372470|NCT00903383|323150269|FG003|Overall Study|Lost to Follow-up|1|||
94372471|NCT00903383|323150266|FG000|Overall Study|Decision of Sponsor|1|||
94372472|NCT00903383|323150267|FG001|Overall Study|Decision of Sponsor|0|||
94217695|NCT01587703|322589955|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
94217696|NCT01587703|322589956|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
94217697|NCT01587703|322589957|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
94217698|NCT01587703|322589958|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
94217699|NCT01587703|322589959|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
94217700|NCT01587703|322589960|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
94217701|NCT01587703|322589961|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
94217702|NCT01587703|322589962|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
94217703|NCT01587703|322589963|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
94217704|NCT01587703|322589964|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
94217705|NCT01587703|322589965|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
94217706|NCT01587703|322589966|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
94217707|NCT01587703|322589967|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
94217708|NCT01587703|322589968|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
94217709|NCT01587703|322589969|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
94217710|NCT01587703|322589970|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
94217711|NCT01587703|322589971|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
94217712|NCT01587703|322589972|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
94217713|NCT01587703|322589973|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
94217714|NCT01587703|322589955|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
94217715|NCT01587703|322589956|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
94217716|NCT01587703|322589957|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
94217717|NCT01587703|322589958|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
94217718|NCT01587703|322589959|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
94217719|NCT01587703|322589960|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
94217720|NCT01587703|322589961|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
94217721|NCT01587703|322589962|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
94217722|NCT01587703|322589963|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
94286848|NCT00091832|322838999|FG000|Overall Study|Noncompliance|0|||
94286849|NCT00091832|322839000|FG001|Overall Study|Noncompliance|1|||
94286850|NCT00091832|322839001|FG002|Overall Study|Noncompliance|0|||
94286851|NCT00091832|322839002|FG003|Overall Study|Noncompliance|0|||
94286852|NCT00091832|322839003|FG004|Overall Study|Noncompliance|0|||
94286853|NCT00091832|322839004|FG005|Overall Study|Noncompliance|0|||
94286854|NCT00091832|322838999|FG000|Overall Study|Other|0|||
94286855|NCT00091832|322839000|FG001|Overall Study|Other|1|||
94286856|NCT00091832|322839001|FG002|Overall Study|Other|2|||
94286857|NCT00091832|322839002|FG003|Overall Study|Other|0|||
94286858|NCT00091832|322839003|FG004|Overall Study|Other|0|||
94286859|NCT00091832|322839004|FG005|Overall Study|Other|0|||
94286860|NCT00091832|322838999|FG000|Overall Study|Protocol Violation|0|||
94286861|NCT00091832|322839000|FG001|Overall Study|Protocol Violation|0|||
94286862|NCT00091832|322839001|FG002|Overall Study|Protocol Violation|1|||
94286863|NCT00091832|322839002|FG003|Overall Study|Protocol Violation|0|||
94286864|NCT00091832|322839003|FG004|Overall Study|Protocol Violation|0|||
94286865|NCT00091832|322839004|FG005|Overall Study|Protocol Violation|1|||
94286866|NCT00464178|322839005|FG000|Overall Study|Protocol Violation|1|||
94286867|NCT00464178|322839005|FG000|Overall Study|Withdrawal by Subject|1|||
94286868|NCT00915343|322839006|FG000|Part B - Open Label Period|Treatment switch|0|||
94286869|NCT00915343|322839007|FG001|Part B - Open Label Period|Treatment switch|0|||
94286870|NCT00915343|322839008|FG002|Part B - Open Label Period|Treatment switch|1|||
94286871|NCT00915343|322839006|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
94286872|NCT00915343|322839007|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
94286873|NCT00915343|322839008|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
94286874|NCT01282229|322839010|FG000|Overall Study|Protocol Violation|2|||
94286875|NCT03519971|322839015|FG000|Overall Study|Death|142|||
94286876|NCT03519971|322839016|FG001|Overall Study|Death|69|||
94286877|NCT03519971|322839015|FG000|Overall Study|Lost to Follow-up|0|||
94286878|NCT03519971|322839016|FG001|Overall Study|Lost to Follow-up|1|||
94286879|NCT03519971|322839015|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
94286880|NCT03519971|322839016|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
94286881|NCT03519971|322839015|FG000|Overall Study|Withdrawal by Subject|3|||
94217723|NCT01587703|322589964|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
94217724|NCT01587703|322589965|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
94217725|NCT01587703|322589966|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
94217726|NCT01587703|322589967|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
94217727|NCT01587703|322589968|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
94217728|NCT01587703|322589969|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
94217729|NCT01587703|322589970|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
94286882|NCT03519971|322839016|FG001|Overall Study|Withdrawal by Subject|2|||
94286883|NCT03519971|322839015|FG000|Overall Study|Other|1|||
94286884|NCT03519971|322839016|FG001|Overall Study|Other|0|||
94286885|NCT02810964|322840521|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
94286886|NCT02810964|322840522|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
94217730|NCT01587703|322589971|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
94217731|NCT01587703|322589972|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
94217732|NCT01587703|322589973|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
94217733|NCT01587703|322589955|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
94217734|NCT01587703|322589956|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
94217735|NCT01587703|322589957|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
94217736|NCT01587703|322589958|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
94217737|NCT01587703|322589959|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
94217738|NCT01587703|322589960|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
94217739|NCT01587703|322589961|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
94217740|NCT01587703|322589962|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
94217741|NCT01587703|322589963|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
94217742|NCT01587703|322589964|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
94217743|NCT01587703|322589965|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
94217744|NCT01587703|322589966|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
94217745|NCT01587703|322589967|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
94217746|NCT01587703|322589968|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
94217747|NCT01587703|322589969|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
94217748|NCT01587703|322589970|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
94217749|NCT01587703|322589971|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
94217750|NCT01587703|322589972|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
94217751|NCT01587703|322589973|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
94217752|NCT01587703|322589955|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
94217753|NCT01587703|322589956|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
94217754|NCT01587703|322589957|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
94217755|NCT01587703|322589958|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
94217756|NCT01587703|322589959|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
94217757|NCT01587703|322589960|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
94217758|NCT01587703|322589961|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
94217759|NCT01587703|322589962|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
94217760|NCT01587703|322589963|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
94217761|NCT01587703|322589964|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
94217762|NCT01587703|322589965|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
94217763|NCT01587703|322589966|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
94217764|NCT01587703|322589967|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
94217765|NCT01587703|322589968|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
94217766|NCT01587703|322589969|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
94217767|NCT01587703|322589970|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
94217768|NCT01587703|322589971|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
94217769|NCT01587703|322589972|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
94217770|NCT01587703|322589973|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
94217771|NCT01587703|322589955|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
94217772|NCT01587703|322589956|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
94217773|NCT01587703|322589957|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
94217774|NCT01587703|322589958|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
94217775|NCT01587703|322589959|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
94217776|NCT01587703|322589960|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
94217777|NCT01587703|322589961|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
94217778|NCT01587703|322589962|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
94217779|NCT01587703|322589963|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
94217780|NCT01587703|322589964|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
94217781|NCT01587703|322589965|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
94217782|NCT01587703|322589966|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
94217783|NCT01587703|322589967|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
94217784|NCT01587703|322589968|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
94217785|NCT01587703|322589969|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
94217786|NCT01587703|322589970|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
94217787|NCT01587703|322589971|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
94217788|NCT01587703|322589972|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
94217789|NCT01587703|322589973|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
94217790|NCT01587703|322589955|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
94217791|NCT01587703|322589956|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
94217792|NCT01587703|322589957|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
94217793|NCT01587703|322589958|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
94217794|NCT01587703|322589959|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
94217795|NCT01587703|322589960|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
94217796|NCT01587703|322589961|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
94217797|NCT01587703|322589962|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
94217798|NCT01587703|322589963|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
94217799|NCT01587703|322589964|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
94217800|NCT01587703|322589965|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
94217801|NCT01587703|322589966|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
94217802|NCT01587703|322589967|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
94217803|NCT01587703|322589968|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
94217804|NCT01587703|322589969|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
94217805|NCT01587703|322589970|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
94217806|NCT01587703|322589971|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
94217807|NCT01587703|322589972|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
94217808|NCT01587703|322589973|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
94217809|NCT01587703|322589955|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
94217810|NCT01587703|322589956|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
94217811|NCT01587703|322589957|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
94217812|NCT01587703|322589958|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
94217813|NCT01587703|322589959|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
94217814|NCT01587703|322589960|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
94217815|NCT01587703|322589961|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
94217816|NCT01587703|322589962|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
94217817|NCT01587703|322589963|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
94217818|NCT01587703|322589964|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
94217819|NCT01587703|322589965|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
94217820|NCT01587703|322589966|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
94217821|NCT01587703|322589967|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
94217822|NCT01587703|322589968|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
94217823|NCT01587703|322589969|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
94217824|NCT01587703|322589970|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
94217825|NCT01587703|322589971|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
94217826|NCT01587703|322589972|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
94217827|NCT01587703|322589973|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
94217828|NCT01587703|322589955|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
94217829|NCT01587703|322589956|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
94217830|NCT01587703|322589957|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
94217831|NCT01587703|322589958|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
94217832|NCT01587703|322589959|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
94217833|NCT01587703|322589960|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
94217834|NCT01587703|322589961|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
94217835|NCT01587703|322589962|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
94217836|NCT01587703|322589963|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
94217837|NCT01587703|322589964|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
94217838|NCT01587703|322589965|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
94286887|NCT02810964|322840521|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
94286888|NCT02810964|322840522|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
94286889|NCT02810964|322840521|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
94286890|NCT02810964|322840522|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
94286891|NCT02810964|322840521|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
94286892|NCT02810964|322840522|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
94286893|NCT00669617|322840528|FG000|Period 1|Withdrawal by Subject|0|||
94286894|NCT00669617|322840529|FG001|Period 1|Withdrawal by Subject|0|||
94286895|NCT00669617|322840530|FG002|Period 1|Withdrawal by Subject|1|||
94286896|NCT00669617|322840531|FG003|Period 1|Withdrawal by Subject|0|||
94286897|NCT00669617|322840532|FG004|Period 1|Withdrawal by Subject|0|||
94286898|NCT00669617|322840528|FG000|Period 1|Protocol Deviation|0|||
94286899|NCT00669617|322840529|FG001|Period 1|Protocol Deviation|0|||
94286900|NCT00669617|322840530|FG002|Period 1|Protocol Deviation|0|||
94286901|NCT00669617|322840531|FG003|Period 1|Protocol Deviation|0|||
94286902|NCT00669617|322840532|FG004|Period 1|Protocol Deviation|1|||
94286903|NCT00669617|322840528|FG000|Period 3|Lost to Follow-up|1|||
94286904|NCT00669617|322840529|FG001|Period 3|Lost to Follow-up|0|||
94372473|NCT00903383|323150268|FG002|Overall Study|Decision of Sponsor|0|||
94372474|NCT00903383|323150269|FG003|Overall Study|Decision of Sponsor|0|||
94372475|NCT00903383|323150266|FG000|Overall Study|Withdrawal by Subject|4|||
94372476|NCT00903383|323150267|FG001|Overall Study|Withdrawal by Subject|1|||
94217839|NCT01587703|322589966|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
94217840|NCT01587703|322589967|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
94217841|NCT01587703|322589968|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
94217842|NCT01587703|322589969|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
94217843|NCT01587703|322589970|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
94217844|NCT01587703|322589971|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
94217845|NCT01587703|322589972|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
94217846|NCT01587703|322589973|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
94217847|NCT01587703|322589955|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
94217848|NCT01587703|322589956|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
94217849|NCT01587703|322589957|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
94217850|NCT01587703|322589958|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
94217851|NCT01587703|322589959|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
94217852|NCT01587703|322589960|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
94217853|NCT01587703|322589961|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
94217854|NCT01587703|322589962|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
94217855|NCT01587703|322589963|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
94217856|NCT01587703|322589964|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
94217857|NCT01587703|322589965|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
94217858|NCT01587703|322589966|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
94217859|NCT01587703|322589967|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
94217860|NCT01587703|322589968|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
94217861|NCT01587703|322589969|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
94217862|NCT01587703|322589970|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
94217863|NCT01587703|322589971|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
94217864|NCT01587703|322589972|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
94217865|NCT01587703|322589973|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
94217866|NCT01587703|322589955|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
94217867|NCT01587703|322589956|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
94217868|NCT01587703|322589957|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
94217869|NCT01587703|322589958|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
94217870|NCT01587703|322589959|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
94217871|NCT01587703|322589960|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
94217872|NCT01587703|322589961|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
94217873|NCT01587703|322589962|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
94217874|NCT01587703|322589963|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
94217875|NCT01587703|322589964|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
94217876|NCT01587703|322589965|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
94217877|NCT01587703|322589966|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
94217878|NCT01587703|322589967|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
94217879|NCT01587703|322589968|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
94217880|NCT01587703|322589969|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
94217881|NCT01587703|322589970|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
94217882|NCT01587703|322589971|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
94217883|NCT01587703|322589972|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
94217884|NCT01587703|322589973|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
94217885|NCT01587703|322589955|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
94217886|NCT01587703|322589956|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
94217887|NCT01587703|322589957|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
94217888|NCT01587703|322589958|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
94217889|NCT01587703|322589959|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
94217890|NCT01587703|322589960|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
94217891|NCT01587703|322589961|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
94217892|NCT01587703|322589962|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
94217893|NCT01587703|322589963|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
94217894|NCT01587703|322589964|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
94217895|NCT01587703|322589965|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
94286905|NCT00669617|322840530|FG002|Period 3|Lost to Follow-up|0|||
94286906|NCT00669617|322840531|FG003|Period 3|Lost to Follow-up|0|||
94286907|NCT00669617|322840532|FG004|Period 3|Lost to Follow-up|0|||
94217896|NCT01587703|322589966|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
94286908|NCT01449708|322840533|FG000|Overall Study|Protocol Violation|0|||
94286909|NCT01449708|322840534|FG001|Overall Study|Protocol Violation|1|||
94286910|NCT01449708|322840533|FG000|Overall Study|surgical complication|1|||
94286911|NCT01449708|322840534|FG001|Overall Study|surgical complication|2|||
94217897|NCT01587703|322589967|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
94286912|NCT01449708|322840533|FG000|Overall Study|respiratory failure|1|||
94286913|NCT01449708|322840534|FG001|Overall Study|respiratory failure|0|||
94286914|NCT05499520|322840535|FG000|Overall Study|Lost to Follow-up|0|||
94217898|NCT01587703|322589968|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
94217899|NCT01587703|322589969|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
94217900|NCT01587703|322589970|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
94217901|NCT01587703|322589971|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
94217902|NCT01587703|322589972|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
94217903|NCT01587703|322589973|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
94217904|NCT01587703|322589955|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
94217905|NCT01587703|322589956|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
94217906|NCT01587703|322589957|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
94217907|NCT01587703|322589958|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
94217908|NCT01587703|322589959|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
94217909|NCT01587703|322589960|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
94217910|NCT01587703|322589961|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
94217911|NCT01587703|322589962|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
94217912|NCT01587703|322589963|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
94217913|NCT01587703|322589964|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
94217914|NCT01587703|322589965|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
94217915|NCT01587703|322589966|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
94217916|NCT01587703|322589967|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
94217917|NCT01587703|322589968|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
94217918|NCT01587703|322589969|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
94217919|NCT01587703|322589970|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
94217920|NCT01587703|322589971|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
94217921|NCT01587703|322589972|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
94217922|NCT01587703|322589973|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
94217923|NCT00828139|322589974|FG000|Overall Study|Adverse Event|8|||
94217924|NCT00828139|322589975|FG001|Overall Study|Adverse Event|1|||
94217925|NCT00828139|322589976|FG002|Overall Study|Adverse Event|10|||
94217926|NCT00828139|322589977|FG003|Overall Study|Adverse Event|5|||
94217927|NCT00828139|322589974|FG000|Overall Study|Death|2|||
94217928|NCT00828139|322589975|FG001|Overall Study|Death|1|||
94217929|NCT00828139|322589976|FG002|Overall Study|Death|0|||
94217930|NCT00828139|322589977|FG003|Overall Study|Death|2|||
94217931|NCT00828139|322589974|FG000|Overall Study|Refusal unrelated to toxicity|3|||
94217932|NCT00828139|322589975|FG001|Overall Study|Refusal unrelated to toxicity|4|||
94217933|NCT00828139|322589976|FG002|Overall Study|Refusal unrelated to toxicity|5|||
94217934|NCT00828139|322589977|FG003|Overall Study|Refusal unrelated to toxicity|3|||
94217935|NCT00828139|322589974|FG000|Overall Study|Disease Progression|24|||
94217936|NCT00828139|322589975|FG001|Overall Study|Disease Progression|33|||
94217937|NCT00828139|322589976|FG002|Overall Study|Disease Progression|35|||
94217938|NCT00828139|322589977|FG003|Overall Study|Disease Progression|39|||
94217939|NCT00828139|322589974|FG000|Overall Study|Other|4|||
94217940|NCT00828139|322589975|FG001|Overall Study|Other|2|||
94217941|NCT00828139|322589976|FG002|Overall Study|Other|5|||
94217942|NCT00828139|322589977|FG003|Overall Study|Other|2|||
94217943|NCT05361304|322589978|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
94217944|NCT05361304|322589979|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
94217945|NCT05361304|322589978|FG000|Overall Study|COVID-19 Related|1|||
94217946|NCT05361304|322589979|FG001|Overall Study|COVID-19 Related|2|||
94217947|NCT05361304|322589978|FG000|Overall Study|Withdrawal by Subject|1|||
94217948|NCT05361304|322589979|FG001|Overall Study|Withdrawal by Subject|0|||
94217949|NCT00447499|322589980|FG000|Overall Study|Adverse Event|1|||
94217950|NCT00447499|322589980|FG000|Overall Study|Patient Decision|4|||
94217951|NCT00447499|322589980|FG000|Overall Study|Sponsor Decision|1|||
94217952|NCT00447499|322589980|FG000|Overall Study|Physician Decision|1|||
94217953|NCT03436797|322589984|FG000|Main Study|Withdrawal by Subject|2|||
94217954|NCT03436797|322589984|FG000|Main Study|Adverse Event|4|||
94217955|NCT03436797|322589984|FG000|Main Study|Lost to Follow-up|1|||
94217956|NCT03436797|322589984|FG000|Main Study|Death|1|||
94217957|NCT03436797|322589984|FG000|Main Study|Non-Specific|2|||
94217958|NCT03436797|322589984|FG000|Extended Dosing|Patient decision|1|||
94217959|NCT03386344|322589987|FG000|Overall Study|Adverse Event|6|||
94217960|NCT03386344|322589988|FG001|Overall Study|Adverse Event|3|||
94217961|NCT03386344|322589989|FG002|Overall Study|Adverse Event|1|||
94217962|NCT03386344|322589987|FG000|Overall Study|Poor Compliance to Protocol|0|||
94217963|NCT03386344|322589988|FG001|Overall Study|Poor Compliance to Protocol|1|||
94217964|NCT03386344|322589989|FG002|Overall Study|Poor Compliance to Protocol|0|||
94217965|NCT03386344|322589987|FG000|Overall Study|Study Terminated by Sponsor|101|||
94217966|NCT03386344|322589988|FG001|Overall Study|Study Terminated by Sponsor|102|||
94217967|NCT03386344|322589989|FG002|Overall Study|Study Terminated by Sponsor|106|||
94217968|NCT03386344|322589987|FG000|Overall Study|Lost to Follow-up|3|||
94217969|NCT03386344|322589988|FG001|Overall Study|Lost to Follow-up|2|||
94217970|NCT03386344|322589989|FG002|Overall Study|Lost to Follow-up|1|||
94217971|NCT03386344|322589987|FG000|Overall Study|At the Participant's own Request|7|||
94217972|NCT03386344|322589988|FG001|Overall Study|At the Participant's own Request|7|||
94217973|NCT03386344|322589989|FG002|Overall Study|At the Participant's own Request|8|||
94217974|NCT03386344|322589987|FG000|Overall Study|Reason not Specified|0|||
94217975|NCT03386344|322589988|FG001|Overall Study|Reason not Specified|1|||
94217976|NCT03386344|322589989|FG002|Overall Study|Reason not Specified|0|||
94217977|NCT00841321|322589996|FG000|Overall Study|Lost to Follow-up|1|||
94217978|NCT00841321|322589997|FG001|Overall Study|Lost to Follow-up|1|||
94217979|NCT00841321|322589996|FG000|Overall Study|Adverse Event|0|||
94217980|NCT00841321|322589997|FG001|Overall Study|Adverse Event|2|||
94217981|NCT00379210|322589998|FG000|Overall Study|Withdrawal by Subject|10|||
94217982|NCT00379210|322589999|FG001|Overall Study|Withdrawal by Subject|7|||
94217983|NCT02379078|322590000|FG000|Overall Study|Lost to Follow-up|33|||
94217984|NCT02379078|322590001|FG001|Overall Study|Lost to Follow-up|30|||
94217985|NCT02379078|322590000|FG000|Overall Study|Withdrawal by Subject|6|||
94217986|NCT02379078|322590001|FG001|Overall Study|Withdrawal by Subject|5|||
94217987|NCT01107912|322590002|FG000|Period 1|Adverse Event|0|||
94217988|NCT01107912|322590003|FG001|Period 1|Adverse Event|0|||
94217989|NCT01107912|322590004|FG002|Period 1|Adverse Event|0|||
94217990|NCT01107912|322590005|FG003|Period 1|Adverse Event|0|||
94217991|NCT01107912|322590006|FG004|Period 1|Adverse Event|2|||
94217992|NCT01107912|322590007|FG005|Period 1|Adverse Event|0|||
94217993|NCT01107912|322590002|FG000|Period 1|Physician Decision|0|||
94217994|NCT01107912|322590003|FG001|Period 1|Physician Decision|0|||
94217995|NCT01107912|322590004|FG002|Period 1|Physician Decision|0|||
94217996|NCT01107912|322590005|FG003|Period 1|Physician Decision|0|||
94217997|NCT01107912|322590006|FG004|Period 1|Physician Decision|1|||
94217998|NCT01107912|322590007|FG005|Period 1|Physician Decision|0|||
94217999|NCT01107912|322590002|FG000|Period 1|Withdrawal by Subject|1|||
94218000|NCT01107912|322590003|FG001|Period 1|Withdrawal by Subject|0|||
94218001|NCT01107912|322590004|FG002|Period 1|Withdrawal by Subject|0|||
94218002|NCT01107912|322590005|FG003|Period 1|Withdrawal by Subject|0|||
94218003|NCT01107912|322590006|FG004|Period 1|Withdrawal by Subject|0|||
94286915|NCT05499520|322840536|FG001|Overall Study|Lost to Follow-up|0|||
94286916|NCT05499520|322840537|FG002|Overall Study|Lost to Follow-up|38|||
94286917|NCT05499520|322840538|FG003|Overall Study|Lost to Follow-up|41|||
94286918|NCT05499520|322840539|FG004|Overall Study|Lost to Follow-up|46|||
94286919|NCT05499520|322840540|FG005|Overall Study|Lost to Follow-up|0|||
94286920|NCT05499520|322840541|FG006|Overall Study|Lost to Follow-up|31|||
94286921|NCT05499520|322840542|FG007|Overall Study|Lost to Follow-up|45|||
94286922|NCT05499520|322840543|FG008|Overall Study|Lost to Follow-up|42|||
94286923|NCT05499520|322840544|FG009|Overall Study|Lost to Follow-up|0|||
94286924|NCT05499520|322840545|FG010|Overall Study|Lost to Follow-up|0|||
94286925|NCT05499520|322840546|FG011|Overall Study|Lost to Follow-up|37|||
94286926|NCT05499520|322840547|FG012|Overall Study|Lost to Follow-up|53|||
94286927|NCT05499520|322840548|FG013|Overall Study|Lost to Follow-up|49|||
94286928|NCT05499520|322840549|FG014|Overall Study|Lost to Follow-up|0|||
94286929|NCT05499520|322840550|FG015|Overall Study|Lost to Follow-up|36|||
94286930|NCT05499520|322840551|FG016|Overall Study|Lost to Follow-up|58|||
94286931|NCT05499520|322840552|FG017|Overall Study|Lost to Follow-up|53|||
94286932|NCT00602641|322840553|FG000|Overall Study|Never started protocol therapy|6|||
94286933|NCT00602641|322840554|FG001|Overall Study|Never started protocol therapy|2|||
94286934|NCT00602641|322840553|FG000|Overall Study|Still on treatment at time of analysis|8|||
94286935|NCT00602641|322840554|FG001|Overall Study|Still on treatment at time of analysis|15|||
94286936|NCT00602641|322840553|FG000|Overall Study|Adverse Event|62|||
94286937|NCT00602641|322840554|FG001|Overall Study|Adverse Event|53|||
94286938|NCT00602641|322840553|FG000|Overall Study|Disease progression|38|||
94286939|NCT00602641|322840554|FG001|Overall Study|Disease progression|55|||
94286940|NCT00602641|322840553|FG000|Overall Study|Death|6|||
94286941|NCT00602641|322840554|FG001|Overall Study|Death|5|||
94218004|NCT01107912|322590007|FG005|Period 1|Withdrawal by Subject|0|||
94218005|NCT01107912|322590002|FG000|Period 2|Physician Decision|0|||
94218006|NCT01107912|322590003|FG001|Period 2|Physician Decision|0|||
94218007|NCT01107912|322590004|FG002|Period 2|Physician Decision|1|||
94218008|NCT01107912|322590005|FG003|Period 2|Physician Decision|0|||
94372477|NCT00903383|323150268|FG002|Overall Study|Withdrawal by Subject|0|||
94218009|NCT01107912|322590006|FG004|Period 2|Physician Decision|0|||
94218010|NCT01107912|322590007|FG005|Period 2|Physician Decision|0|||
94286942|NCT00602641|322840553|FG000|Overall Study|Withdrawal by Subject|15|||
94286943|NCT00602641|322840554|FG001|Overall Study|Withdrawal by Subject|12|||
94286944|NCT00602641|322840553|FG000|Overall Study|Alternative therapy|5|||
94286945|NCT00602641|322840554|FG001|Overall Study|Alternative therapy|2|||
94286946|NCT00602641|322840553|FG000|Overall Study|Other Complicating Disease|5|||
94286947|NCT00602641|322840554|FG001|Overall Study|Other Complicating Disease|2|||
94218011|NCT01107912|322590002|FG000|Period 3|Adverse Event|0|||
94218012|NCT01107912|322590003|FG001|Period 3|Adverse Event|1|||
94218013|NCT01107912|322590004|FG002|Period 3|Adverse Event|1|||
94218014|NCT01107912|322590005|FG003|Period 3|Adverse Event|0|||
94218015|NCT01107912|322590006|FG004|Period 3|Adverse Event|0|||
94218016|NCT01107912|322590007|FG005|Period 3|Adverse Event|0|||
94218017|NCT01107912|322590002|FG000|Period 3|Withdrawal by Subject|0|||
94218018|NCT01107912|322590003|FG001|Period 3|Withdrawal by Subject|0|||
94218019|NCT01107912|322590004|FG002|Period 3|Withdrawal by Subject|0|||
94218020|NCT01107912|322590005|FG003|Period 3|Withdrawal by Subject|1|||
94218021|NCT01107912|322590006|FG004|Period 3|Withdrawal by Subject|0|||
94218022|NCT01107912|322590007|FG005|Period 3|Withdrawal by Subject|0|||
94218023|NCT01601821|322590008|FG000|Overall Study|Death|2|||
94218024|NCT01601821|322590009|FG001|Overall Study|Death|5|||
94218025|NCT01601821|322590008|FG000|Overall Study|Protocol Violation|2|||
94218026|NCT01601821|322590009|FG001|Overall Study|Protocol Violation|2|||
94218027|NCT01601821|322590008|FG000|Overall Study|Lost to Follow-up|6|||
94218028|NCT01601821|322590009|FG001|Overall Study|Lost to Follow-up|14|||
94218029|NCT01601821|322590008|FG000|Overall Study|Withdrawal by Subject|1|||
94218030|NCT01601821|322590009|FG001|Overall Study|Withdrawal by Subject|0|||
94218031|NCT01601821|322590008|FG000|Overall Study|Graft Loss|6|||
94218032|NCT01601821|322590009|FG001|Overall Study|Graft Loss|6|||
94218033|NCT01601821|322590008|FG000|Overall Study|Study Events|7|||
94218034|NCT01601821|322590009|FG001|Overall Study|Study Events|1|||
94218035|NCT01601821|322590008|FG000|Overall Study|Other|5|||
94218036|NCT01601821|322590009|FG001|Overall Study|Other|1|||
94218037|NCT02959866|322590010|FG000|Overall Study|Withdrawal by Subject|1|||
94218038|NCT01989156|322590011|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
94218039|NCT01989156|322590012|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
94218040|NCT01989156|322590013|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
94218041|NCT01989156|322590011|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
94218042|NCT01989156|322590012|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
94218043|NCT01989156|322590013|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
94218044|NCT01989156|322590011|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
94218045|NCT01989156|322590012|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
94286948|NCT00602641|322840553|FG000|Overall Study|Physician Decision|5|||
94286949|NCT00602641|322840554|FG001|Overall Study|Physician Decision|4|||
94286950|NCT00602641|322840553|FG000|Overall Study|Administrative Closure|1|||
94286951|NCT00602641|322840554|FG001|Overall Study|Administrative Closure|1|||
94286952|NCT00602641|322840553|FG000|Overall Study|Other|3|||
94286953|NCT00602641|322840554|FG001|Overall Study|Other|1|||
94286954|NCT02770326|322840559|FG000|Overall Study|Death|3|||
94286955|NCT02770326|322840559|FG000|Overall Study|Lost to Follow-up|1|||
94286956|NCT01946178|322840562|FG000|Overall Study|Pregnancy|1|||
94286957|NCT01946178|322840562|FG000|Overall Study|Lost to Follow-up|1|||
94286958|NCT03569202|322840565|FG000|Part 3|Physician Decision|1|||
94286959|NCT03569202|322840566|FG001|Part 3|Physician Decision|0|||
94286960|NCT03569202|322840565|FG000|Part 3|Other|1|||
94286961|NCT03569202|322840566|FG001|Part 3|Other|1|||
94286962|NCT02161562|322840570|FG000|Overall Study|Withdrawal by Subject|5|||
94286963|NCT02161562|322840571|FG001|Overall Study|Withdrawal by Subject|8|||
94286964|NCT02161562|322840570|FG000|Overall Study|Protocol Violation|9|||
94286965|NCT02161562|322840571|FG001|Overall Study|Protocol Violation|4|||
94286966|NCT02161562|322840570|FG000|Overall Study|Pregnancy|1|||
94286967|NCT02161562|322840571|FG001|Overall Study|Pregnancy|2|||
94286968|NCT02161562|322840570|FG000|Overall Study|Lost to Follow-up|3|||
94286969|NCT02161562|322840571|FG001|Overall Study|Lost to Follow-up|1|||
94286970|NCT02161562|322840570|FG000|Overall Study|Lack of Efficacy|4|||
94286971|NCT02161562|322840571|FG001|Overall Study|Lack of Efficacy|1|||
94286972|NCT02161562|322840570|FG000|Overall Study|Adverse Event|1|||
94286973|NCT02161562|322840571|FG001|Overall Study|Adverse Event|1|||
94286974|NCT02161562|322840570|FG000|Overall Study|Participant moved back to home country|1|||
94286975|NCT02161562|322840571|FG001|Overall Study|Participant moved back to home country|0|||
94286976|NCT02161562|322840570|FG000|Overall Study|Withdrew due to being out of the country|1|||
94218046|NCT01989156|322590013|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
94218047|NCT01989156|322590011|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
94218048|NCT01989156|322590012|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
94218049|NCT01989156|322590013|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
94218050|NCT01989156|322590011|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
94218051|NCT01989156|322590012|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
94286977|NCT02161562|322840571|FG001|Overall Study|Withdrew due to being out of the country|0|||
94286978|NCT02161562|322840570|FG000|Overall Study|Participant moved out of province|1|||
94286979|NCT02161562|322840571|FG001|Overall Study|Participant moved out of province|0|||
94286980|NCT00331409|322840574|FG000|Overall Study|Lack of Efficacy|4|||
94286981|NCT04428411|322840575|FG000|Overall Study|Lost to Follow-up|114|||
94286982|NCT00634569|322840576|FG000|Overall Study|Withdrawal by Subject|0|||
94218052|NCT01989156|322590013|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
94286983|NCT00634569|322840577|FG001|Overall Study|Withdrawal by Subject|4|||
94286984|NCT00634569|322840576|FG000|Overall Study|Physician Decision|0|||
94286985|NCT00634569|322840577|FG001|Overall Study|Physician Decision|1|||
94286986|NCT00132730|322840584|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
94286987|NCT00132730|322840585|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
94286988|NCT00132730|322840586|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
94218053|NCT01989156|322590011|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
94218054|NCT01989156|322590012|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
94218055|NCT01989156|322590013|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
94218056|NCT01989156|322590011|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
94218057|NCT01989156|322590012|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
94218058|NCT01989156|322590013|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
94218059|NCT01989156|322590011|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
94218060|NCT01989156|322590012|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
94218061|NCT01989156|322590013|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
94218062|NCT01755598|322590018|FG000|Overall Study|Other|109|||
94218063|NCT01755598|322590019|FG001|Overall Study|Other|109|||
94218064|NCT01755598|322590018|FG000|Overall Study|Lost to Follow-up|32|||
94218065|NCT01755598|322590019|FG001|Overall Study|Lost to Follow-up|43|||
94218066|NCT01755598|322590018|FG000|Overall Study|Migrated/moved from study area|76|||
94218067|NCT01755598|322590019|FG001|Overall Study|Migrated/moved from study area|65|||
94218068|NCT01755598|322590018|FG000|Overall Study|Withdrawal by Subject|22|||
94218069|NCT01755598|322590019|FG001|Overall Study|Withdrawal by Subject|31|||
94218070|NCT01755598|322590018|FG000|Overall Study|Protocol Violation|7|||
94218071|NCT01755598|322590019|FG001|Overall Study|Protocol Violation|7|||
94218072|NCT01755598|322590018|FG000|Overall Study|Adverse Event|19|||
94218073|NCT01755598|322590019|FG001|Overall Study|Adverse Event|28|||
94218074|NCT03686176|322590023|FG000|Overall Study|Procedure cancelled|1|||
94218075|NCT03686176|322590024|FG001|Overall Study|Procedure cancelled|0|||
94218076|NCT03686176|322590025|FG002|Overall Study|Procedure cancelled|0|||
94218077|NCT03686176|322590023|FG000|Overall Study|VR Malfunction|1|||
94218078|NCT03686176|322590024|FG001|Overall Study|VR Malfunction|0|||
94218079|NCT03686176|322590025|FG002|Overall Study|VR Malfunction|0|||
94218080|NCT00390806|322590026|FG000|Overall Study|Lost to Follow-up|7|||
94218081|NCT00390806|322590027|FG001|Overall Study|Lost to Follow-up|6|||
94218082|NCT00390806|322590026|FG000|Overall Study|Protocol Violation|2|||
94218083|NCT00390806|322590027|FG001|Overall Study|Protocol Violation|2|||
94218084|NCT00390806|322590026|FG000|Overall Study|Withdrawal by Subject|12|||
94218085|NCT00390806|322590027|FG001|Overall Study|Withdrawal by Subject|15|||
94218086|NCT00390806|322590026|FG000|Overall Study|Investigator Decision|4|||
94218087|NCT00390806|322590027|FG001|Overall Study|Investigator Decision|6|||
94218088|NCT00390806|322590026|FG000|Overall Study|Death|1|||
94218089|NCT00390806|322590027|FG001|Overall Study|Death|0|||
94218090|NCT00390806|322590026|FG000|Overall Study|Physician Decision|0|||
94218091|NCT00390806|322590027|FG001|Overall Study|Physician Decision|1|||
94218092|NCT00390806|322590026|FG000|Overall Study|Ongoing|4|||
94218093|NCT00390806|322590027|FG001|Overall Study|Ongoing|2|||
94218094|NCT02332889|322590028|FG000|Overall Study|Physician Decision|1|||
94218095|NCT00383500|322590029|FG000|Overall Study|Withdrawal by Subject|8|||
94218096|NCT00383500|322590030|FG001|Overall Study|Withdrawal by Subject|3|||
94218097|NCT00383500|322590031|FG002|Overall Study|Withdrawal by Subject|0|||
94218098|NCT00383500|322590029|FG000|Overall Study|Lost to Follow-up|0|||
94218099|NCT00383500|322590030|FG001|Overall Study|Lost to Follow-up|0|||
94218100|NCT00383500|322590031|FG002|Overall Study|Lost to Follow-up|2|||
94286989|NCT00132730|322840587|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
94286990|NCT00132730|322840588|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
94286991|NCT00132730|322840589|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
94286992|NCT00132730|322840584|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
94286993|NCT00132730|322840585|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
94286994|NCT00132730|322840586|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
94286995|NCT00132730|322840587|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
94286996|NCT00132730|322840588|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
94286997|NCT00132730|322840589|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
94467883|NCT00337779|323502429|FG001|Overall Study|Protocol Violation|1|||
94218101|NCT03020914|322591418|FG000|Overall Study|Surgery Cancelled|1|||
94218102|NCT03020914|322591419|FG001|Overall Study|Surgery Cancelled|0|||
94218103|NCT00108355|322591420|FG000|Overall Study|Peritonitis at index paracentesis|1|||
94218104|NCT00108355|322591421|FG001|Overall Study|Peritonitis at index paracentesis|1|||
94218105|NCT00108355|322591420|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
94218106|NCT00108355|322591421|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
94218107|NCT02164578|322591422|FG000|Treatment Period|Withdrawal by Subject|3|||
94218108|NCT02164578|322591423|FG001|Treatment Period|Withdrawal by Subject|3|||
94218109|NCT02164578|322591422|FG000|Treatment Period|Adverse Event|13|||
94218110|NCT02164578|322591423|FG001|Treatment Period|Adverse Event|6|||
94218111|NCT02164578|322591422|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
94218112|NCT02164578|322591423|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
94218113|NCT02164578|322591422|FG000|Treatment Period|Protocol Violation|0|||
94218114|NCT02164578|322591423|FG001|Treatment Period|Protocol Violation|2|||
94218115|NCT02164578|322591422|FG000|Extension Period|Withdrawal by Subject|2|||
94218116|NCT02164578|322591423|FG001|Extension Period|Withdrawal by Subject|0|||
94218117|NCT02164578|322591422|FG000|Extension Period|Adverse Event|4|||
94218118|NCT02164578|322591423|FG001|Extension Period|Adverse Event|0|||
94218119|NCT02164578|322591422|FG000|Extension Period|Expiry of study medication|1|||
94218120|NCT02164578|322591423|FG001|Extension Period|Expiry of study medication|0|||
94218121|NCT02164578|322591422|FG000|Extension Period|Protocol Violation|0|||
94218122|NCT02164578|322591423|FG001|Extension Period|Protocol Violation|1|||
94218123|NCT02136797|322591424|FG000|Overall Study|Not Treated|8|||
94218124|NCT02507297|322591425|FG000|Overall Study|Withdrawal by Subject|1|||
94218125|NCT02507297|322591426|FG001|Overall Study|Withdrawal by Subject|0|||
94218126|NCT02507297|322591425|FG000|Overall Study|Lost to Follow-up|0|||
94218127|NCT02507297|322591426|FG001|Overall Study|Lost to Follow-up|1|||
94218128|NCT04909593|322591427|FG000|Overall Study|Withdrawal by Subject|1|||
94218129|NCT00307489|322591428|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
94218130|NCT00307489|322591429|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
94218131|NCT00307489|322591428|FG000|Baseline Through Week 48|Physician Decision|1|||
94218132|NCT00307489|322591429|FG001|Baseline Through Week 48|Physician Decision|0|||
94218133|NCT00307489|322591428|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
94218134|NCT00307489|322591429|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
94218135|NCT00307489|322591428|FG000|Week 48 Through Week 168|Adverse Event|1|||
94218136|NCT00307489|322591429|FG001|Week 48 Through Week 168|Adverse Event|0|||
94218137|NCT00307489|322591428|FG000|Week 48 Through Week 168|Physician Decision|1|||
94218138|NCT00307489|322591429|FG001|Week 48 Through Week 168|Physician Decision|0|||
94218139|NCT00307489|322591428|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
94218140|NCT00307489|322591429|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
94218141|NCT00307489|322591428|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
94218142|NCT00307489|322591429|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
94218143|NCT00307489|322591428|FG000|Week 48 Through Week 168|Death|0|||
94218144|NCT00307489|322591429|FG001|Week 48 Through Week 168|Death|1|||
94218145|NCT00307489|322591428|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
94218146|NCT00307489|322591429|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
94218147|NCT00307489|322591428|FG000|Week 48 Through Week 168|Seroconversion|1|||
94218148|NCT00307489|322591429|FG001|Week 48 Through Week 168|Seroconversion|0|||
94218149|NCT00409006|322591430|FG000|Overall Study|Death|15|||
94218150|NCT00409006|322591431|FG001|Overall Study|Death|6|||
94218151|NCT00409006|322591430|FG000|Overall Study|Lost to Follow-up|1|||
94218152|NCT00409006|322591431|FG001|Overall Study|Lost to Follow-up|2|||
94218153|NCT00409006|322591430|FG000|Overall Study|Withdrawal by Subject|3|||
94218154|NCT00409006|322591431|FG001|Overall Study|Withdrawal by Subject|2|||
94218155|NCT00409006|322591430|FG000|Overall Study|Physician Decision|1|||
94218156|NCT00409006|322591431|FG001|Overall Study|Physician Decision|2|||
94218157|NCT02065895|322591432|FG000|Overall Study|Protocol Violation|1|||
94218158|NCT02065895|322591433|FG001|Overall Study|Protocol Violation|0|||
94218159|NCT02065895|322591434|FG002|Overall Study|Protocol Violation|0|||
94218160|NCT02065895|322591435|FG003|Overall Study|Protocol Violation|1|||
94218161|NCT02065895|322591436|FG004|Overall Study|Protocol Violation|0|||
94218162|NCT02065895|322591437|FG005|Overall Study|Protocol Violation|0|||
94218163|NCT02065895|322591432|FG000|Overall Study|Scheduling conflicts|0|||
94218164|NCT02065895|322591433|FG001|Overall Study|Scheduling conflicts|1|||
94218165|NCT02065895|322591434|FG002|Overall Study|Scheduling conflicts|0|||
94218166|NCT02065895|322591435|FG003|Overall Study|Scheduling conflicts|0|||
94218167|NCT02065895|322591436|FG004|Overall Study|Scheduling conflicts|0|||
94218168|NCT02065895|322591437|FG005|Overall Study|Scheduling conflicts|0|||
94218169|NCT03928743|322591438|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
94218170|NCT03928743|322591439|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
94218171|NCT03928743|322591440|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
94218172|NCT03928743|322591438|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
94218173|NCT03928743|322591439|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
94218174|NCT03928743|322591440|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
94218175|NCT03928743|322591438|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
94218176|NCT03928743|322591439|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
94218177|NCT03928743|322591440|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
94218178|NCT03928743|322591438|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
94218179|NCT03928743|322591439|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
94218180|NCT03928743|322591440|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
94218181|NCT03928743|322591438|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
94218182|NCT03928743|322591439|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
94218183|NCT03928743|322591440|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
94218184|NCT03928743|322591438|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
94218185|NCT03928743|322591439|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
94218186|NCT03928743|322591440|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
94218187|NCT03928743|322591438|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
94218188|NCT03928743|322591439|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
94218189|NCT03928743|322591440|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
94218190|NCT03928743|322591438|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
94218191|NCT03928743|322591439|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
94218192|NCT03928743|322591440|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
94218193|NCT03928743|322591438|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
94218194|NCT03928743|322591439|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
94218195|NCT03928743|322591440|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
94218196|NCT03928743|322591438|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
94218197|NCT03928743|322591439|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
94218198|NCT03928743|322591440|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
94218199|NCT03928743|322591438|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
94218200|NCT03928743|322591439|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
94218201|NCT03928743|322591440|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
94218202|NCT00668746|322591443|FG000|Overall Study|Lost to Follow-up|2|||
94218203|NCT00668746|322591444|FG001|Overall Study|Lost to Follow-up|1|||
94218204|NCT00355784|322591445|FG000|Overall Study|Withdrawal by Subject|0|||
94218205|NCT00355784|322591446|FG001|Overall Study|Withdrawal by Subject|0|||
94218206|NCT00355784|322591447|FG002|Overall Study|Withdrawal by Subject|2|||
94218207|NCT02109172|322591448|FG000|Overall Study|Withdrawal by Subject|1|||
94218208|NCT02109172|322591449|FG001|Overall Study|Withdrawal by Subject|0|||
94218209|NCT02109172|322591450|FG002|Overall Study|Withdrawal by Subject|0|||
94218210|NCT02109172|322591451|FG003|Overall Study|Withdrawal by Subject|1|||
94218211|NCT02109172|322591452|FG004|Overall Study|Withdrawal by Subject|0|||
94218212|NCT02109172|322591453|FG005|Overall Study|Withdrawal by Subject|0|||
94218213|NCT02109172|322591448|FG000|Overall Study|Adverse Event|0|||
94218214|NCT02109172|322591449|FG001|Overall Study|Adverse Event|0|||
94218215|NCT02109172|322591450|FG002|Overall Study|Adverse Event|1|||
94218216|NCT02109172|322591451|FG003|Overall Study|Adverse Event|0|||
94218217|NCT02109172|322591452|FG004|Overall Study|Adverse Event|0|||
94218218|NCT02109172|322591453|FG005|Overall Study|Adverse Event|1|||
94218219|NCT02109172|322591448|FG000|Overall Study|Death|0|||
94218220|NCT02109172|322591449|FG001|Overall Study|Death|0|||
94218221|NCT02109172|322591450|FG002|Overall Study|Death|0|||
94218222|NCT02109172|322591451|FG003|Overall Study|Death|0|||
94218223|NCT02109172|322591452|FG004|Overall Study|Death|1|||
94218224|NCT02109172|322591453|FG005|Overall Study|Death|0|||
94218225|NCT03409276|322591454|FG000|Overall Study|Withdrawal by Subject|0|||
94218226|NCT03409276|322591455|FG001|Overall Study|Withdrawal by Subject|0|||
94218227|NCT03409276|322591456|FG002|Overall Study|Withdrawal by Subject|0|||
94218228|NCT03409276|322591457|FG003|Overall Study|Withdrawal by Subject|0|||
94218229|NCT03409276|322591458|FG004|Overall Study|Withdrawal by Subject|1|||
94286998|NCT00132730|322840584|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
94286999|NCT00132730|322840585|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
94287000|NCT00132730|322840586|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
94287001|NCT00132730|322840587|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
94287002|NCT00132730|322840588|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
94287003|NCT00132730|322840589|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
94287004|NCT00132730|322840584|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
94287005|NCT00132730|322840585|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
94287006|NCT00132730|322840586|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
94287007|NCT00132730|322840587|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
94287008|NCT00132730|322840588|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
94287009|NCT00132730|322840589|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
94287010|NCT00132730|322840584|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
94218230|NCT03409276|322591454|FG000|Overall Study|Lost to Follow-up|0|||
94218231|NCT03409276|322591455|FG001|Overall Study|Lost to Follow-up|0|||
94218232|NCT03409276|322591456|FG002|Overall Study|Lost to Follow-up|0|||
94218233|NCT03409276|322591457|FG003|Overall Study|Lost to Follow-up|2|||
94218234|NCT03409276|322591458|FG004|Overall Study|Lost to Follow-up|2|||
94218235|NCT02152384|322591459|FG000|Period 1|Withdrawal by Subject|0|||
94218236|NCT02152384|322591460|FG001|Period 1|Withdrawal by Subject|1|||
94218237|NCT02152384|322591459|FG000|Period 1|Adverse Event|1|||
94218238|NCT02152384|322591460|FG001|Period 1|Adverse Event|1|||
94218239|NCT02446015|322591462|FG000|Overall Study|Adverse Event|0|||
94218240|NCT02446015|322591463|FG001|Overall Study|Adverse Event|1|||
94218241|NCT02446015|322591462|FG000|Overall Study|Withdrawal by Subject|1|||
94287011|NCT00132730|322840585|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
94287012|NCT00132730|322840586|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
94218242|NCT02446015|322591463|FG001|Overall Study|Withdrawal by Subject|0|||
94218243|NCT01768572|322591464|FG000|Overall Study|Adverse Event|7|||
94218244|NCT01768572|322591465|FG001|Overall Study|Adverse Event|8|||
94287013|NCT00132730|322840587|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
94287014|NCT00132730|322840588|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
94287015|NCT00132730|322840589|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
94287016|NCT00132730|322840584|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
94287017|NCT00132730|322840585|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
94287018|NCT00132730|322840586|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
94287019|NCT00132730|322840587|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
94287020|NCT00132730|322840588|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
94287021|NCT00132730|322840589|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
94287022|NCT00132730|322840584|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
94287023|NCT00132730|322840585|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
94287024|NCT00132730|322840586|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
94287025|NCT00132730|322840587|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
94287026|NCT00132730|322840588|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
94287027|NCT00132730|322840589|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
94287028|NCT00132730|322840584|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
94287029|NCT00132730|322840585|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
94287030|NCT00132730|322840586|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
94287031|NCT00132730|322840587|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
94372478|NCT00903383|323150269|FG003|Overall Study|Withdrawal by Subject|2|||
94372479|NCT00903383|323150266|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
94372480|NCT00903383|323150267|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
94372481|NCT00903383|323150268|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
94372482|NCT00903383|323150269|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
94372483|NCT00903383|323150266|FG000|Overall Study|Patient Decision|0|||
94287032|NCT00132730|322840588|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
94287033|NCT00132730|322840589|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
94287034|NCT00132730|322840584|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
94287035|NCT00132730|322840585|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
94287036|NCT00132730|322840586|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
94287037|NCT00132730|322840587|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
94287038|NCT00132730|322840588|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
94287039|NCT00132730|322840589|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
94287040|NCT00132730|322840584|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
94467884|NCT00337779|323502428|FG000|Overall Study|Lost to Follow-up|6|||
94467885|NCT00337779|323502429|FG001|Overall Study|Lost to Follow-up|5|||
94218245|NCT01768572|322591466|FG002|Overall Study|Adverse Event|4|||
94218246|NCT01768572|322591464|FG000|Overall Study|Lack of Efficacy|1|||
94218247|NCT01768572|322591465|FG001|Overall Study|Lack of Efficacy|3|||
94218248|NCT01768572|322591466|FG002|Overall Study|Lack of Efficacy|1|||
94218249|NCT01768572|322591464|FG000|Overall Study|Other, Not due to an adverse event|1|||
94218250|NCT01768572|322591465|FG001|Overall Study|Other, Not due to an adverse event|1|||
94218251|NCT01768572|322591466|FG002|Overall Study|Other, Not due to an adverse event|1|||
94218252|NCT03840993|322591470|FG000|Overall Study|Adverse Event|1|||
94218253|NCT03840993|322591471|FG001|Overall Study|Adverse Event|0|||
94218254|NCT03840993|322591470|FG000|Overall Study|Lost to Follow-up|4|||
94218255|NCT03840993|322591471|FG001|Overall Study|Lost to Follow-up|0|||
94218256|NCT03840993|322591470|FG000|Overall Study|Physician Decision|0|||
94218257|NCT03840993|322591471|FG001|Overall Study|Physician Decision|1|||
94218258|NCT03840993|322591470|FG000|Overall Study|Pregnancy|0|||
94218259|NCT03840993|322591471|FG001|Overall Study|Pregnancy|1|||
94218260|NCT03840993|322591470|FG000|Overall Study|Withdrawal by Subject|1|||
94218261|NCT03840993|322591471|FG001|Overall Study|Withdrawal by Subject|3|||
94218262|NCT03840993|322591470|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
94218263|NCT03840993|322591471|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
94218264|NCT03672188|322591472|FG000|Overall Study|Withdrawal by Subject|0|||
94218265|NCT03672188|322591473|FG001|Overall Study|Withdrawal by Subject|0|||
94218266|NCT03672188|322591474|FG002|Overall Study|Withdrawal by Subject|0|||
94218267|NCT03672188|322591475|FG003|Overall Study|Withdrawal by Subject|3|||
94218268|NCT03672188|322591476|FG004|Overall Study|Withdrawal by Subject|0|||
94218269|NCT03672188|322591477|FG005|Overall Study|Withdrawal by Subject|0|||
94218270|NCT03672188|322591478|FG006|Overall Study|Withdrawal by Subject|0|||
94218271|NCT03672188|322591479|FG007|Overall Study|Withdrawal by Subject|0|||
94218272|NCT03672188|322591480|FG008|Overall Study|Withdrawal by Subject|0|||
94218273|NCT03672188|322591481|FG009|Overall Study|Withdrawal by Subject|0|||
94218274|NCT03672188|322591482|FG010|Overall Study|Withdrawal by Subject|0|||
94218275|NCT03672188|322591483|FG011|Overall Study|Withdrawal by Subject|0|||
94218276|NCT03672188|322591484|FG012|Overall Study|Withdrawal by Subject|0|||
94218277|NCT03672188|322591485|FG013|Overall Study|Withdrawal by Subject|0|||
94218278|NCT03672188|322591486|FG014|Overall Study|Withdrawal by Subject|0|||
94218279|NCT03672188|322591472|FG000|Overall Study|Death|0|||
94218280|NCT03672188|322591473|FG001|Overall Study|Death|0|||
94218281|NCT03672188|322591474|FG002|Overall Study|Death|0|||
94218282|NCT03672188|322591475|FG003|Overall Study|Death|0|||
94218283|NCT03672188|322591476|FG004|Overall Study|Death|0|||
94218284|NCT03672188|322591477|FG005|Overall Study|Death|0|||
94218285|NCT03672188|322591478|FG006|Overall Study|Death|0|||
94218286|NCT03672188|322591479|FG007|Overall Study|Death|0|||
94218287|NCT03672188|322591480|FG008|Overall Study|Death|0|||
94218288|NCT03672188|322591481|FG009|Overall Study|Death|0|||
94218289|NCT03672188|322591482|FG010|Overall Study|Death|0|||
94218290|NCT03672188|322591483|FG011|Overall Study|Death|0|||
94218291|NCT03672188|322591484|FG012|Overall Study|Death|1|||
94218292|NCT03672188|322591485|FG013|Overall Study|Death|0|||
94218293|NCT03672188|322591486|FG014|Overall Study|Death|0|||
94218294|NCT03672188|322591472|FG000|Overall Study|Lost to Follow-up|0|||
94218295|NCT03672188|322591473|FG001|Overall Study|Lost to Follow-up|0|||
94218296|NCT03672188|322591474|FG002|Overall Study|Lost to Follow-up|1|||
94467886|NCT00337779|323502428|FG000|Overall Study|Adverse Event|28|||
94218297|NCT03672188|322591475|FG003|Overall Study|Lost to Follow-up|0|||
94218298|NCT03672188|322591476|FG004|Overall Study|Lost to Follow-up|0|||
94218299|NCT03672188|322591477|FG005|Overall Study|Lost to Follow-up|0|||
94467887|NCT00337779|323502429|FG001|Overall Study|Adverse Event|51|||
94218300|NCT03672188|322591478|FG006|Overall Study|Lost to Follow-up|0|||
94218301|NCT03672188|322591479|FG007|Overall Study|Lost to Follow-up|0|||
94218302|NCT03672188|322591480|FG008|Overall Study|Lost to Follow-up|0|||
94218303|NCT03672188|322591481|FG009|Overall Study|Lost to Follow-up|0|||
94218304|NCT03672188|322591482|FG010|Overall Study|Lost to Follow-up|0|||
94218305|NCT03672188|322591483|FG011|Overall Study|Lost to Follow-up|0|||
94218306|NCT03672188|322591484|FG012|Overall Study|Lost to Follow-up|0|||
94218307|NCT03672188|322591485|FG013|Overall Study|Lost to Follow-up|0|||
94218308|NCT03672188|322591486|FG014|Overall Study|Lost to Follow-up|0|||
94218309|NCT04454125|322591489|FG000|Overall Study|Lost to Follow-up|0|||
94218310|NCT04454125|322591490|FG001|Overall Study|Lost to Follow-up|1|||
94218311|NCT01922102|322591491|FG000|Overall Study|Withdrawal by Subject|7|||
94218312|NCT01922102|322591492|FG001|Overall Study|Withdrawal by Subject|3|||
94218313|NCT01922102|322591493|FG002|Overall Study|Withdrawal by Subject|7|||
94218314|NCT01922102|322591491|FG000|Overall Study|Physician Decision|0|||
94218315|NCT01922102|322591492|FG001|Overall Study|Physician Decision|2|||
94218316|NCT01922102|322591493|FG002|Overall Study|Physician Decision|1|||
94218317|NCT01922102|322591491|FG000|Overall Study|Adverse Event|1|||
94218318|NCT01922102|322591492|FG001|Overall Study|Adverse Event|2|||
94218319|NCT01922102|322591493|FG002|Overall Study|Adverse Event|0|||
94218320|NCT01922102|322591491|FG000|Overall Study|Lost to Follow-up|1|||
94218321|NCT01922102|322591492|FG001|Overall Study|Lost to Follow-up|0|||
94218322|NCT01922102|322591493|FG002|Overall Study|Lost to Follow-up|0|||
94218323|NCT01922102|322591491|FG000|Overall Study|Administrative problems|0|||
94218324|NCT01922102|322591492|FG001|Overall Study|Administrative problems|2|||
94218325|NCT01922102|322591493|FG002|Overall Study|Administrative problems|0|||
94218326|NCT03557307|322591494|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
94218327|NCT03557307|322591494|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
94218328|NCT03557307|322591494|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
94218329|NCT03557307|322591494|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
94218330|NCT03557307|322591494|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
94218331|NCT03557307|322591494|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
94218332|NCT03557307|322591494|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
94218333|NCT03557307|322591494|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
94218334|NCT03557307|322591494|FG000|Period 2: Maintenance Phase|Death|3|||
94218335|NCT03557307|322591494|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
94218336|NCT03557307|322591494|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
94218337|NCT03557307|322591494|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
94218338|NCT03557307|322591494|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
94218339|NCT03557307|322591494|FG000|Period 2: Maintenance Phase|other|3|||
94218340|NCT04175834|322591495|FG000|Overall Study|Withdrawal by Subject|1|||
94218341|NCT04175834|322591496|FG001|Overall Study|Withdrawal by Subject|0|||
94218342|NCT02030847|322591500|FG000|Overall Study|Death|10|||
94218343|NCT02030847|322591500|FG000|Overall Study|Disease Progression|15|||
94218344|NCT02030847|322591500|FG000|Overall Study|New Cancer Therapy|8|||
94218345|NCT02030847|322591500|FG000|Overall Study|Physician Decision|3|||
94218346|NCT02030847|322591500|FG000|Overall Study|Withdrawal by Subject|1|||
94218347|NCT02256553|322591501|FG000|Period I|Adverse Event|5|||
94218348|NCT02256553|322591501|FG000|Period I|Protocol Violation|1|||
94218349|NCT02256553|322591501|FG000|Period II|Adverse Event|1|||
94218350|NCT02256553|322591501|FG000|Period II|Subject Moved|1|||
94218351|NCT02256553|322591501|FG000|Period III|Adverse Event|3|||
94218352|NCT00460434|322591502|FG000|Overall Study|Lost to Follow-up|3|||
94218353|NCT00460434|322591503|FG001|Overall Study|Lost to Follow-up|7|||
94218354|NCT02092909|322591504|FG000|Overall Study|Adverse Event|0|||
94218355|NCT02092909|322591505|FG001|Overall Study|Adverse Event|0|||
94218356|NCT02092909|322591506|FG002|Overall Study|Adverse Event|4|||
94218357|NCT02092909|322591507|FG003|Overall Study|Adverse Event|2|||
94218358|NCT02092909|322591504|FG000|Overall Study|Lack of Efficacy|0|||
94218359|NCT02092909|322591505|FG001|Overall Study|Lack of Efficacy|2|||
94218360|NCT02092909|322591506|FG002|Overall Study|Lack of Efficacy|1|||
94218361|NCT02092909|322591507|FG003|Overall Study|Lack of Efficacy|0|||
94218362|NCT02092909|322591504|FG000|Overall Study|Withdrawal by Subject|0|||
94218363|NCT02092909|322591505|FG001|Overall Study|Withdrawal by Subject|0|||
94218364|NCT02092909|322591506|FG002|Overall Study|Withdrawal by Subject|2|||
94218365|NCT02092909|322591507|FG003|Overall Study|Withdrawal by Subject|1|||
94218366|NCT02092909|322591504|FG000|Overall Study|Study terminated by Sponsor|0|||
94218367|NCT02092909|322591505|FG001|Overall Study|Study terminated by Sponsor|0|||
94218368|NCT02092909|322591506|FG002|Overall Study|Study terminated by Sponsor|0|||
94218369|NCT02092909|322591507|FG003|Overall Study|Study terminated by Sponsor|2|||
94218370|NCT02092909|322591504|FG000|Overall Study|Miscellaneous|1|||
94218371|NCT02092909|322591505|FG001|Overall Study|Miscellaneous|1|||
94218372|NCT02092909|322591506|FG002|Overall Study|Miscellaneous|2|||
94218373|NCT02092909|322591507|FG003|Overall Study|Miscellaneous|1|||
94218374|NCT00472199|322591508|FG000|Overall Study|Adverse Event|19|||
94218375|NCT00472199|322591509|FG001|Overall Study|Adverse Event|23|||
94218376|NCT00472199|322591508|FG000|Overall Study|Lack of Efficacy|4|||
94218377|NCT00472199|322591509|FG001|Overall Study|Lack of Efficacy|25|||
94218378|NCT00472199|322591508|FG000|Overall Study|Lost to Follow-up|2|||
94218379|NCT00472199|322591509|FG001|Overall Study|Lost to Follow-up|4|||
94218380|NCT00472199|322591508|FG000|Overall Study|Protocol Violation|3|||
94218381|NCT00472199|322591509|FG001|Overall Study|Protocol Violation|2|||
94218382|NCT00472199|322591508|FG000|Overall Study|Withdrawal by Subject|6|||
94218383|NCT00472199|322591509|FG001|Overall Study|Withdrawal by Subject|5|||
94218384|NCT00472199|322591508|FG000|Overall Study|personal reason|0|||
94218385|NCT00472199|322591509|FG001|Overall Study|personal reason|1|||
94287041|NCT00132730|322840585|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
94218386|NCT00472199|322591508|FG000|Overall Study|patient was asymptomatic|1|||
94218387|NCT00472199|322591509|FG001|Overall Study|patient was asymptomatic|0|||
94218388|NCT03444155|322591510|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
94218389|NCT03444155|322591511|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
94218390|NCT00821093|322591513|FG000|Overall Study|Adverse Event|20|||
94218391|NCT00821093|322591514|FG001|Overall Study|Adverse Event|12|||
94218392|NCT00821093|322591513|FG000|Overall Study|Withdrawal by Subject|9|||
94218393|NCT00821093|322591514|FG001|Overall Study|Withdrawal by Subject|13|||
94218394|NCT00821093|322591513|FG000|Overall Study|Lost to Follow-up|9|||
94218395|NCT00821093|322591514|FG001|Overall Study|Lost to Follow-up|3|||
94218396|NCT00821093|322591513|FG000|Overall Study|Protocol deviation|3|||
94218397|NCT00821093|322591514|FG001|Overall Study|Protocol deviation|6|||
94287042|NCT00132730|322840586|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
94287043|NCT00132730|322840587|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
94287044|NCT00132730|322840588|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
94287045|NCT00132730|322840589|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
94287046|NCT00132730|322840584|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
94287047|NCT00132730|322840585|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
94287048|NCT00132730|322840586|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
94287049|NCT00132730|322840587|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
94218398|NCT00821093|322591513|FG000|Overall Study|Abnormal laboratory value(s)|2|||
94218399|NCT00821093|322591514|FG001|Overall Study|Abnormal laboratory value(s)|0|||
94218400|NCT00821093|322591513|FG000|Overall Study|Lack of Efficacy|2|||
94218401|NCT00821093|322591514|FG001|Overall Study|Lack of Efficacy|2|||
94218402|NCT00821093|322591513|FG000|Overall Study|Death|2|||
94218403|NCT00821093|322591514|FG001|Overall Study|Death|1|||
94218404|NCT00821093|322591513|FG000|Overall Study|Abnormal test procedure result(s)|1|||
94218405|NCT00821093|322591514|FG001|Overall Study|Abnormal test procedure result(s)|1|||
94218406|NCT00821093|322591513|FG000|Overall Study|Administrative problems|1|||
94218407|NCT00821093|322591514|FG001|Overall Study|Administrative problems|2|||
94218408|NCT02446912|322591517|FG000|Overall Study|Adverse Event|3|||
94218409|NCT02446912|322591518|FG001|Overall Study|Adverse Event|13|||
94218410|NCT02446912|322591519|FG002|Overall Study|Adverse Event|5|||
94218411|NCT02446912|322591517|FG000|Overall Study|Condition under investigation worsened|0|||
94218412|NCT02446912|322591518|FG001|Overall Study|Condition under investigation worsened|1|||
94218413|NCT02446912|322591519|FG002|Overall Study|Condition under investigation worsened|1|||
94218414|NCT02446912|322591517|FG000|Overall Study|Study-specific withdrawal criteria|1|||
94218415|NCT02446912|322591518|FG001|Overall Study|Study-specific withdrawal criteria|0|||
94218416|NCT02446912|322591519|FG002|Overall Study|Study-specific withdrawal criteria|0|||
94218417|NCT02446912|322591517|FG000|Overall Study|Lack of Efficacy|1|||
94218418|NCT02446912|322591518|FG001|Overall Study|Lack of Efficacy|4|||
94218419|NCT02446912|322591519|FG002|Overall Study|Lack of Efficacy|7|||
94218420|NCT02446912|322591517|FG000|Overall Study|Lost to Follow-up|0|||
94218421|NCT02446912|322591518|FG001|Overall Study|Lost to Follow-up|0|||
94218422|NCT02446912|322591519|FG002|Overall Study|Lost to Follow-up|2|||
94218423|NCT02446912|322591517|FG000|Overall Study|Severe non-compliance to protocol|1|||
94218424|NCT02446912|322591518|FG001|Overall Study|Severe non-compliance to protocol|0|||
94218425|NCT02446912|322591519|FG002|Overall Study|Severe non-compliance to protocol|1|||
94218426|NCT02446912|322591517|FG000|Overall Study|Withdrawal by Subject|10|||
94218427|NCT02446912|322591518|FG001|Overall Study|Withdrawal by Subject|15|||
94218428|NCT02446912|322591519|FG002|Overall Study|Withdrawal by Subject|15|||
94218429|NCT02446912|322591517|FG000|Overall Study|Miscellaneous|2|||
94218430|NCT02446912|322591518|FG001|Overall Study|Miscellaneous|2|||
94218431|NCT02446912|322591519|FG002|Overall Study|Miscellaneous|4|||
94218432|NCT01268488|322591520|FG000|Overall Study|Adverse Event|3|||
94218433|NCT01268488|322591520|FG000|Overall Study|Physician Decision|2|||
94218434|NCT01133678|322591521|FG000|Overall Study|Death|1|||
94218435|NCT01133678|322591522|FG001|Overall Study|Death|1|||
94218436|NCT00316121|322591526|FG000|Overall Study|Death|1|||
94218437|NCT00316121|322591527|FG001|Overall Study|Death|0|||
94218438|NCT00316121|322591526|FG000|Overall Study|Lost to Follow-up|14|||
94218439|NCT00316121|322591527|FG001|Overall Study|Lost to Follow-up|8|||
94218440|NCT00316121|322591526|FG000|Overall Study|Withdrawal by Subject|2|||
94218441|NCT00316121|322591527|FG001|Overall Study|Withdrawal by Subject|0|||
94218442|NCT00316121|322591526|FG000|Overall Study|Reason is missing|1|||
94218443|NCT00316121|322591527|FG001|Overall Study|Reason is missing|0|||
94218444|NCT00316121|322591526|FG000|Overall Study|Subject relocated|1|||
94218445|NCT00316121|322591527|FG001|Overall Study|Subject relocated|1|||
94218446|NCT00316121|322591526|FG000|Overall Study|Subject refused to return|1|||
94218447|NCT00316121|322591527|FG001|Overall Study|Subject refused to return|0|||
94218448|NCT00316121|322591526|FG000|Overall Study|Subject no show for visit x 3|1|||
94218449|NCT00316121|322591527|FG001|Overall Study|Subject no show for visit x 3|0|||
94218450|NCT00316121|322591526|FG000|Overall Study|Subject did not have 24 month visit|1|||
94218451|NCT00316121|322591527|FG001|Overall Study|Subject did not have 24 month visit|0|||
94218452|NCT00424476|322591528|FG000|Overall Study|Withdrawal by Subject|7|||
94218453|NCT00424476|322591529|FG001|Overall Study|Withdrawal by Subject|6|||
94218454|NCT00424476|322591530|FG002|Overall Study|Withdrawal by Subject|3|||
94218455|NCT00424476|322591528|FG000|Overall Study|Adverse Event|19|||
94218456|NCT00424476|322591529|FG001|Overall Study|Adverse Event|16|||
94218457|NCT00424476|322591530|FG002|Overall Study|Adverse Event|15|||
94218458|NCT00424476|322591528|FG000|Overall Study|Lack of Efficacy|16|||
94218459|NCT00424476|322591529|FG001|Overall Study|Lack of Efficacy|12|||
94218460|NCT00424476|322591530|FG002|Overall Study|Lack of Efficacy|12|||
94218461|NCT00424476|322591528|FG000|Overall Study|Lack of Compliance|1|||
94218462|NCT00424476|322591529|FG001|Overall Study|Lack of Compliance|1|||
94218463|NCT00424476|322591530|FG002|Overall Study|Lack of Compliance|1|||
94218464|NCT00424476|322591528|FG000|Overall Study|Lost to Follow-up|4|||
94218465|NCT00424476|322591529|FG001|Overall Study|Lost to Follow-up|6|||
94218466|NCT00424476|322591530|FG002|Overall Study|Lost to Follow-up|3|||
94287050|NCT00132730|322840588|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
94287051|NCT00132730|322840589|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
94287052|NCT00132730|322840584|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
94287053|NCT00132730|322840585|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
94287054|NCT00132730|322840586|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
94287055|NCT00132730|322840587|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
94287056|NCT00132730|322840588|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
94287057|NCT00132730|322840589|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
94287058|NCT03739528|322840591|FG000|Overall Study|Not treated|8|||
94287059|NCT03739528|322840592|FG001|Overall Study|Not treated|12|||
94287060|NCT03739528|322840591|FG000|Overall Study|Treatment and study discontinued|6|||
94218467|NCT00424476|322591528|FG000|Overall Study|Protocol Violation|7|||
94218468|NCT00424476|322591529|FG001|Overall Study|Protocol Violation|2|||
94287061|NCT03739528|322840592|FG001|Overall Study|Treatment and study discontinued|2|||
94287062|NCT03739528|322840591|FG000|Overall Study|Treatment discontinued + study completed|1|||
94287063|NCT03739528|322840592|FG001|Overall Study|Treatment discontinued + study completed|3|||
94372484|NCT00903383|323150267|FG001|Overall Study|Patient Decision|0|||
94218469|NCT00424476|322591530|FG002|Overall Study|Protocol Violation|3|||
94218470|NCT00424476|322591528|FG000|Overall Study|Physician Decision|3|||
94218471|NCT00424476|322591529|FG001|Overall Study|Physician Decision|2|||
94218472|NCT00424476|322591530|FG002|Overall Study|Physician Decision|3|||
94218473|NCT00424476|322591528|FG000|Overall Study|Other|4|||
94218474|NCT00424476|322591529|FG001|Overall Study|Other|3|||
94218475|NCT00424476|322591530|FG002|Overall Study|Other|9|||
94218476|NCT00848198|322591531|FG000|Overall Study|Incomplete Case Report Forms|15|||
94218477|NCT04598776|322591541|FG000|Overall Study|Protocol Violation|5|||
94218478|NCT04598776|322591541|FG000|Overall Study|Physician Decision|4|||
94218479|NCT00658632|322591542|FG000|Overall Study|Adverse Event|13|||
94218480|NCT00658632|322591543|FG001|Overall Study|Adverse Event|11|||
94218481|NCT00658632|322591542|FG000|Overall Study|Lost to Follow-up|25|||
94218482|NCT00658632|322591543|FG001|Overall Study|Lost to Follow-up|23|||
94218483|NCT00658632|322591542|FG000|Overall Study|Withdrawal by Subject|10|||
94218484|NCT00658632|322591543|FG001|Overall Study|Withdrawal by Subject|7|||
94218485|NCT00658632|322591542|FG000|Overall Study|Lack of Efficacy|0|||
94218486|NCT00658632|322591543|FG001|Overall Study|Lack of Efficacy|1|||
94218487|NCT00658632|322591542|FG000|Overall Study|Withdrawal of consent|8|||
94218488|NCT00658632|322591543|FG001|Overall Study|Withdrawal of consent|14|||
94218489|NCT00658632|322591542|FG000|Overall Study|Pregnancy|1|||
94218490|NCT00658632|322591543|FG001|Overall Study|Pregnancy|1|||
94218491|NCT00658632|322591542|FG000|Overall Study|Other|7|||
94218492|NCT00658632|322591543|FG001|Overall Study|Other|8|||
94218493|NCT02632045|322591544|FG000|Overall Study|Withdrawal by Subject|1|||
94218494|NCT02632045|322591545|FG001|Overall Study|Withdrawal by Subject|2|||
94218495|NCT05878522|322591546|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
94218496|NCT05878522|322591547|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
94218497|NCT05878522|322591548|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
94218498|NCT05878522|322591549|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
94218499|NCT05878522|322591550|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
94218500|NCT05878522|322591551|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
94218501|NCT05878522|322591552|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
94218502|NCT05878522|322591553|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
94218503|NCT05878522|322591554|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
94218504|NCT05878522|322591555|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
94218505|NCT05878522|322591556|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
94218506|NCT05878522|322591557|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
94218507|NCT05878522|322591546|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
94218508|NCT05878522|322591547|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
94218509|NCT05878522|322591548|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
94218510|NCT05878522|322591549|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
94218511|NCT05878522|322591550|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
94218512|NCT05878522|322591551|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
94287064|NCT02474082|322840593|FG000|Overall Study|Adverse Event|2|||
94287065|NCT02474082|322840594|FG001|Overall Study|Adverse Event|32|||
94287066|NCT02474082|322840593|FG000|Overall Study|Withdrawal of informed consent|1|||
94372485|NCT00903383|323150268|FG002|Overall Study|Patient Decision|0|||
94218513|NCT05878522|322591552|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
94218514|NCT05878522|322591553|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
94218515|NCT05878522|322591554|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
94218516|NCT05878522|322591555|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
94218517|NCT05878522|322591556|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
94218518|NCT05878522|322591557|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
94218519|NCT05878522|322591546|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
94218520|NCT05878522|322591547|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
94218521|NCT05878522|322591548|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
94218522|NCT05878522|322591549|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
94218523|NCT05878522|322591550|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
94218524|NCT05878522|322591551|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
94218525|NCT05878522|322591552|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
94218526|NCT05878522|322591553|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
94218527|NCT05878522|322591554|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
94218528|NCT05878522|322591555|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
94218529|NCT05878522|322591556|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
94218530|NCT05878522|322591557|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
94218531|NCT05878522|322591546|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
94218532|NCT05878522|322591547|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
94218533|NCT05878522|322591548|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
94218534|NCT05878522|322591549|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
94218535|NCT05878522|322591550|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
94218536|NCT05878522|322591551|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
94218537|NCT05878522|322591552|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
94218538|NCT05878522|322591553|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
94218539|NCT05878522|322591554|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
94218540|NCT05878522|322591555|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
94218541|NCT05878522|322591556|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
94218542|NCT05878522|322591557|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
94218543|NCT01855399|322591559|FG000|6 Month|Lost to Follow-up|12|||
94218544|NCT01855399|322591560|FG001|6 Month|Lost to Follow-up|9|||
94218545|NCT01855399|322591559|FG000|6 Month|Withdrawal by Subject|8|||
94218546|NCT01855399|322591560|FG001|6 Month|Withdrawal by Subject|6|||
94218547|NCT01855399|322591559|FG000|12 Month|Lost to Follow-up|7|||
94218548|NCT01855399|322591560|FG001|12 Month|Lost to Follow-up|11|||
94218549|NCT02442622|322591570|FG000|Overall Study|Withdrawal by Subject|3|||
94218550|NCT02442622|322591571|FG001|Overall Study|Withdrawal by Subject|1|||
94218551|NCT03840200|322593039|FG000|Overall Study|Death|6|||
94218552|NCT03840200|322593040|FG001|Overall Study|Death|3|||
94218553|NCT03840200|322593041|FG002|Overall Study|Death|6|||
94218554|NCT03840200|322593042|FG003|Overall Study|Death|10|||
94218555|NCT03840200|322593039|FG000|Overall Study|Reason Not Specified|2|||
94218556|NCT03840200|322593040|FG001|Overall Study|Reason Not Specified|2|||
94218557|NCT03840200|322593041|FG002|Overall Study|Reason Not Specified|1|||
94218558|NCT03840200|322593042|FG003|Overall Study|Reason Not Specified|15|||
94218559|NCT03840200|322593039|FG000|Overall Study|Physician Decision|0|||
94218560|NCT03840200|322593040|FG001|Overall Study|Physician Decision|0|||
94218561|NCT03840200|322593041|FG002|Overall Study|Physician Decision|0|||
94218562|NCT03840200|322593042|FG003|Overall Study|Physician Decision|2|||
94218563|NCT03840200|322593039|FG000|Overall Study|Progressive Disease|0|||
94218564|NCT03840200|322593040|FG001|Overall Study|Progressive Disease|0|||
94218565|NCT03840200|322593041|FG002|Overall Study|Progressive Disease|0|||
94218566|NCT03840200|322593042|FG003|Overall Study|Progressive Disease|1|||
94218567|NCT03840200|322593039|FG000|Overall Study|Withdrawal by Subject|0|||
94218568|NCT03840200|322593040|FG001|Overall Study|Withdrawal by Subject|1|||
94218569|NCT03840200|322593041|FG002|Overall Study|Withdrawal by Subject|0|||
94218570|NCT03840200|322593042|FG003|Overall Study|Withdrawal by Subject|2|||
94218571|NCT05522777|322593043|FG000|Overall Study|Lack of Efficacy|1|||
94287067|NCT02474082|322840594|FG001|Overall Study|Withdrawal of informed consent|11|||
94287068|NCT02474082|322840593|FG000|Overall Study|Lost to Follow-up|2|||
94287069|NCT02474082|322840594|FG001|Overall Study|Lost to Follow-up|2|||
94287070|NCT02474082|322840593|FG000|Overall Study|Dose tapering not achieved|0|||
94218572|NCT05522777|322593043|FG000|Overall Study|Withdrawal by Subject|1|||
94218573|NCT01276509|322593044|FG000|Overall Study|Adverse Event|9|||
94287071|NCT02474082|322840594|FG001|Overall Study|Dose tapering not achieved|4|||
94218574|NCT01276509|322593045|FG001|Overall Study|Adverse Event|8|||
94218575|NCT01276509|322593046|FG002|Overall Study|Adverse Event|4|||
94218576|NCT01276509|322593047|FG003|Overall Study|Adverse Event|3|||
94218577|NCT01276509|322593044|FG000|Overall Study|Lack of Efficacy|2|||
94218578|NCT01276509|322593045|FG001|Overall Study|Lack of Efficacy|1|||
94218579|NCT01276509|322593046|FG002|Overall Study|Lack of Efficacy|1|||
94218580|NCT01276509|322593047|FG003|Overall Study|Lack of Efficacy|2|||
94218581|NCT01276509|322593044|FG000|Overall Study|Pregnancy|1|||
94218582|NCT01276509|322593045|FG001|Overall Study|Pregnancy|0|||
94218583|NCT01276509|322593046|FG002|Overall Study|Pregnancy|0|||
94218584|NCT01276509|322593047|FG003|Overall Study|Pregnancy|0|||
94218585|NCT01276509|322593044|FG000|Overall Study|Withdrawal by Subject|1|||
94218586|NCT01276509|322593045|FG001|Overall Study|Withdrawal by Subject|2|||
94218587|NCT01276509|322593046|FG002|Overall Study|Withdrawal by Subject|0|||
94218588|NCT01276509|322593047|FG003|Overall Study|Withdrawal by Subject|0|||
94218589|NCT01276509|322593044|FG000|Overall Study|Other|0|||
94218590|NCT01276509|322593045|FG001|Overall Study|Other|1|||
94218591|NCT01276509|322593046|FG002|Overall Study|Other|0|||
94218592|NCT01276509|322593047|FG003|Overall Study|Other|0|||
94218593|NCT01668355|322593054|FG000|Overall Study|Death|3|||
94218594|NCT01668355|322593055|FG001|Overall Study|Death|1|||
94218595|NCT01668355|322593054|FG000|Overall Study|Withdrawal by Subject|6|||
94218596|NCT01668355|322593055|FG001|Overall Study|Withdrawal by Subject|1|||
94218597|NCT02121808|322593056|FG000|Overall Study|Technical problem|3|||
94218598|NCT04820023|322593057|FG000|Overall Study|Death|0|||
94218599|NCT04820023|322593058|FG001|Overall Study|Death|0|||
94218600|NCT04820023|322593059|FG002|Overall Study|Death|0|||
94218601|NCT04820023|322593060|FG003|Overall Study|Death|0|||
94218602|NCT04820023|322593061|FG004|Overall Study|Death|0|||
94218603|NCT04820023|322593062|FG005|Overall Study|Death|0|||
94218604|NCT04820023|322593063|FG006|Overall Study|Death|1|||
94218605|NCT04820023|322593064|FG007|Overall Study|Death|0|||
94218606|NCT04820023|322593065|FG008|Overall Study|Death|1|||
94218607|NCT04820023|322593057|FG000|Overall Study|Withdrawal by Subject|1|||
94218608|NCT04820023|322593058|FG001|Overall Study|Withdrawal by Subject|2|||
94218609|NCT04820023|322593059|FG002|Overall Study|Withdrawal by Subject|2|||
94218610|NCT04820023|322593060|FG003|Overall Study|Withdrawal by Subject|1|||
94218611|NCT04820023|322593061|FG004|Overall Study|Withdrawal by Subject|4|||
94218612|NCT04820023|322593062|FG005|Overall Study|Withdrawal by Subject|3|||
94218613|NCT04820023|322593063|FG006|Overall Study|Withdrawal by Subject|3|||
94218614|NCT04820023|322593064|FG007|Overall Study|Withdrawal by Subject|6|||
94218615|NCT04820023|322593065|FG008|Overall Study|Withdrawal by Subject|5|||
94218616|NCT04820023|322593057|FG000|Overall Study|Progressive Disease|3|||
94218617|NCT04820023|322593058|FG001|Overall Study|Progressive Disease|0|||
94218618|NCT04820023|322593059|FG002|Overall Study|Progressive Disease|2|||
94218619|NCT04820023|322593060|FG003|Overall Study|Progressive Disease|2|||
94218620|NCT04820023|322593061|FG004|Overall Study|Progressive Disease|2|||
94218621|NCT04820023|322593062|FG005|Overall Study|Progressive Disease|0|||
94218622|NCT04820023|322593063|FG006|Overall Study|Progressive Disease|1|||
94218623|NCT04820023|322593064|FG007|Overall Study|Progressive Disease|1|||
94218624|NCT04820023|322593065|FG008|Overall Study|Progressive Disease|0|||
94218625|NCT04820023|322593057|FG000|Overall Study|New anti-cancer therapy|0|||
94218626|NCT04820023|322593058|FG001|Overall Study|New anti-cancer therapy|0|||
94218627|NCT04820023|322593059|FG002|Overall Study|New anti-cancer therapy|0|||
94218628|NCT04820023|322593060|FG003|Overall Study|New anti-cancer therapy|0|||
94218629|NCT04820023|322593061|FG004|Overall Study|New anti-cancer therapy|2|||
94218630|NCT04820023|322593062|FG005|Overall Study|New anti-cancer therapy|0|||
94218631|NCT04820023|322593063|FG006|Overall Study|New anti-cancer therapy|0|||
94218632|NCT04820023|322593064|FG007|Overall Study|New anti-cancer therapy|0|||
94218633|NCT04820023|322593065|FG008|Overall Study|New anti-cancer therapy|0|||
94218634|NCT04820023|322593057|FG000|Overall Study|Other|0|||
94218635|NCT04820023|322593058|FG001|Overall Study|Other|1|||
94218636|NCT04820023|322593059|FG002|Overall Study|Other|0|||
94218637|NCT04820023|322593060|FG003|Overall Study|Other|0|||
94218638|NCT04820023|322593061|FG004|Overall Study|Other|0|||
94218639|NCT04820023|322593062|FG005|Overall Study|Other|0|||
94218640|NCT04820023|322593063|FG006|Overall Study|Other|0|||
94218641|NCT04820023|322593064|FG007|Overall Study|Other|2|||
94218642|NCT04820023|322593065|FG008|Overall Study|Other|0|||
94218643|NCT00228813|322593068|FG000|Overall Study|Death|4|||
94218644|NCT04025762|322593071|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
94218645|NCT04025762|322593072|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
94218646|NCT00608959|322593073|FG000|Part 1|Did not meet eligibility criteria|1|||
94218647|NCT01248715|322593080|FG000|Overall Study|Not influenza positive|501|||
94218648|NCT01248715|322593081|FG001|Overall Study|Not influenza positive|510|||
94218649|NCT01975701|322593085|FG000|Overall Study|Lost to Follow-up|1|||
94218650|NCT01975701|322593085|FG000|Overall Study|Death|23|||
94218651|NCT01975701|322593085|FG000|Overall Study|Physician Decision|1|||
94218652|NCT04184622|322593091|FG000|Overall Study|Adverse Event|7|||
94218653|NCT04184622|322593092|FG001|Overall Study|Adverse Event|7|||
94218654|NCT04184622|322593093|FG002|Overall Study|Adverse Event|11|||
94218655|NCT04184622|322593094|FG003|Overall Study|Adverse Event|8|||
94218656|NCT04184622|322593091|FG000|Overall Study|Death|4|||
94218657|NCT04184622|322593092|FG001|Overall Study|Death|4|||
94218658|NCT04184622|322593093|FG002|Overall Study|Death|2|||
94218659|NCT04184622|322593094|FG003|Overall Study|Death|1|||
94218660|NCT04184622|322593091|FG000|Overall Study|Lost to Follow-up|41|||
94218661|NCT04184622|322593092|FG001|Overall Study|Lost to Follow-up|19|||
94218662|NCT04184622|322593093|FG002|Overall Study|Lost to Follow-up|20|||
94218663|NCT04184622|322593094|FG003|Overall Study|Lost to Follow-up|15|||
94218664|NCT04184622|322593091|FG000|Overall Study|Missing Weight at Week 72|1|||
94218665|NCT04184622|322593092|FG001|Overall Study|Missing Weight at Week 72|0|||
94218666|NCT04184622|322593093|FG002|Overall Study|Missing Weight at Week 72|1|||
94218667|NCT04184622|322593094|FG003|Overall Study|Missing Weight at Week 72|0|||
94218668|NCT04184622|322593091|FG000|Overall Study|Other - as reported by the investigator|22|||
94218669|NCT04184622|322593092|FG001|Overall Study|Other - as reported by the investigator|7|||
94218670|NCT04184622|322593093|FG002|Overall Study|Other - as reported by the investigator|5|||
94218671|NCT04184622|322593094|FG003|Overall Study|Other - as reported by the investigator|12|||
94218672|NCT04184622|322593091|FG000|Overall Study|Physician Decision|0|||
94218673|NCT04184622|322593092|FG001|Overall Study|Physician Decision|0|||
94218674|NCT04184622|322593093|FG002|Overall Study|Physician Decision|3|||
94218675|NCT04184622|322593094|FG003|Overall Study|Physician Decision|1|||
94218676|NCT04184622|322593091|FG000|Overall Study|Pregnancy|4|||
94218677|NCT04184622|322593092|FG001|Overall Study|Pregnancy|4|||
94218678|NCT04184622|322593093|FG002|Overall Study|Pregnancy|3|||
94218679|NCT04184622|322593094|FG003|Overall Study|Pregnancy|5|||
94218680|NCT04184622|322593091|FG000|Overall Study|Protocol Deviation|1|||
94218681|NCT04184622|322593092|FG001|Overall Study|Protocol Deviation|0|||
94218682|NCT04184622|322593093|FG002|Overall Study|Protocol Deviation|0|||
94218683|NCT04184622|322593094|FG003|Overall Study|Protocol Deviation|0|||
94218684|NCT04184622|322593091|FG000|Overall Study|Withdrawal by Subject|68|||
94287072|NCT02474082|322840593|FG000|Overall Study|Participant/guardian decision|1|||
94287073|NCT02474082|322840594|FG001|Overall Study|Participant/guardian decision|2|||
94287074|NCT02474082|322840593|FG000|Overall Study|Non-compliance with study treatment|0|||
94287075|NCT02474082|322840594|FG001|Overall Study|Non-compliance with study treatment|2|||
94287076|NCT02474082|322840593|FG000|Overall Study|Protocol deviation|0|||
94287077|NCT02474082|322840594|FG001|Overall Study|Protocol deviation|1|||
94287078|NCT03665285|322840595|FG000|Overall Study|Started New Anticancer Treatment|1|||
94287079|NCT03665285|322840596|FG001|Overall Study|Started New Anticancer Treatment|1|||
94287080|NCT03665285|322840597|FG002|Overall Study|Started New Anticancer Treatment|2|||
94287081|NCT03665285|322840598|FG003|Overall Study|Started New Anticancer Treatment|4|||
94287082|NCT03665285|322840599|FG004|Overall Study|Started New Anticancer Treatment|1|||
94287083|NCT03665285|322840600|FG005|Overall Study|Started New Anticancer Treatment|1|||
94287084|NCT03665285|322840601|FG006|Overall Study|Started New Anticancer Treatment|2|||
94287085|NCT03665285|322840602|FG007|Overall Study|Started New Anticancer Treatment|15|||
94218685|NCT04184622|322593092|FG001|Overall Study|Withdrawal by Subject|28|||
94218686|NCT04184622|322593093|FG002|Overall Study|Withdrawal by Subject|29|||
94218687|NCT04184622|322593094|FG003|Overall Study|Withdrawal by Subject|22|||
94218688|NCT01131325|322593096|FG000|Overall Study|Adverse Event|1|||
94218689|NCT01131325|322593096|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
94218690|NCT00538629|322593099|FG000|Overall Study|At subject's request|1|||
94218691|NCT00538629|322593099|FG000|Overall Study|Adverse Event|2|||
94218692|NCT00538629|322593099|FG000|Overall Study|Lack of Efficacy|12|||
94218693|NCT00538629|322593099|FG000|Overall Study|Lost to Follow-up|6|||
94218694|NCT00538629|322593099|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
94218695|NCT01540474|322593100|FG000|Vaccination Period|Lost to Follow-up|0|||
94218696|NCT01540474|322593101|FG001|Vaccination Period|Lost to Follow-up|1|||
94218697|NCT01540474|322593102|FG002|Vaccination Period|Lost to Follow-up|0|||
94218698|NCT01540474|322593103|FG003|Vaccination Period|Lost to Follow-up|0|||
94218699|NCT00396409|322593104|FG000|Period 1 - 2007|Adverse Event|0|||
94218700|NCT00396409|322593105|FG001|Period 1 - 2007|Adverse Event|1|||
94218701|NCT00396409|322593104|FG000|Period 1 - 2007|Lack of Efficacy|0|||
94218702|NCT00396409|322593105|FG001|Period 1 - 2007|Lack of Efficacy|1|||
94218703|NCT00396409|322593104|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
94218704|NCT00396409|322593105|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
94218705|NCT00396409|322593104|FG000|Period 1 - 2007|Lost to Follow-up|2|||
94218706|NCT00396409|322593105|FG001|Period 1 - 2007|Lost to Follow-up|3|||
94218707|NCT00396409|322593104|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
94218708|NCT00396409|322593105|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
94218709|NCT00396409|322593104|FG000|Period 2 - 2008|Protocol Violation|1|||
94218710|NCT00396409|322593105|FG001|Period 2 - 2008|Protocol Violation|0|||
94218711|NCT00396409|322593104|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
94218712|NCT00396409|322593105|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
94218713|NCT00396409|322593104|FG000|Period 2 - 2008|Lost to Follow-up|3|||
94287086|NCT03665285|322840603|FG008|Overall Study|Started New Anticancer Treatment|1|||
94287087|NCT03665285|322840595|FG000|Overall Study|Disease Progression|0|||
94218714|NCT00396409|322593105|FG001|Period 2 - 2008|Lost to Follow-up|1|||
94218715|NCT03696342|322593108|FG000|Overall Study|Lost to Follow-up|1|||
94218716|NCT03696342|322593109|FG001|Overall Study|Lost to Follow-up|0|||
94218717|NCT01799993|322593110|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
94218718|NCT01799993|322593111|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
94218719|NCT01799993|322593110|FG000|Overall Study|Death|61|||
94218720|NCT01799993|322593111|FG001|Overall Study|Death|45|||
94218721|NCT01799993|322593110|FG000|Overall Study|Withdrawal by Subject|23|||
94287088|NCT03665285|322840596|FG001|Overall Study|Disease Progression|0|||
94218722|NCT01799993|322593111|FG001|Overall Study|Withdrawal by Subject|24|||
94218723|NCT01799993|322593110|FG000|Overall Study|Lost to Follow-up|5|||
94218724|NCT01799993|322593111|FG001|Overall Study|Lost to Follow-up|8|||
94218725|NCT01799993|322593110|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
94218726|NCT01799993|322593111|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
94218727|NCT01799993|322593110|FG000|Overall Study|Protocol driven decision point|0|||
94218728|NCT01799993|322593111|FG001|Overall Study|Protocol driven decision point|3|||
94218729|NCT01799993|322593110|FG000|Overall Study|Protocol Violation|1|||
94218730|NCT01799993|322593111|FG001|Overall Study|Protocol Violation|1|||
94218731|NCT01799993|322593110|FG000|Overall Study|Deterioration of general conditions|2|||
94218732|NCT01799993|322593111|FG001|Overall Study|Deterioration of general conditions|0|||
94218733|NCT01799993|322593110|FG000|Overall Study|Screen failure|0|||
94218734|NCT01799993|322593111|FG001|Overall Study|Screen failure|1|||
94218735|NCT01799993|322593110|FG000|Overall Study|Adverse Event|1|||
94218736|NCT01799993|322593111|FG001|Overall Study|Adverse Event|0|||
94218737|NCT01799993|322593110|FG000|Overall Study|Lack of Efficacy|1|||
94218738|NCT01799993|322593111|FG001|Overall Study|Lack of Efficacy|0|||
94218739|NCT01799993|322593110|FG000|Overall Study|Recovery|0|||
94218740|NCT01799993|322593111|FG001|Overall Study|Recovery|1|||
94218741|NCT01799993|322593110|FG000|Overall Study|Logistical difficulties|1|||
94218742|NCT01799993|322593111|FG001|Overall Study|Logistical difficulties|0|||
94218743|NCT01799993|322593110|FG000|Overall Study|Protocol deviation|1|||
94218744|NCT01799993|322593111|FG001|Overall Study|Protocol deviation|0|||
94218745|NCT01799993|322593110|FG000|Overall Study|Non-compliance with medical device|1|||
94218746|NCT01799993|322593111|FG001|Overall Study|Non-compliance with medical device|0|||
94218747|NCT01799993|322593110|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94218748|NCT01799993|322593111|FG001|Overall Study|Withdrawal by parent/guardian|1|||
94218749|NCT01799993|322593110|FG000|Overall Study|Other|1|||
94218750|NCT01799993|322593111|FG001|Overall Study|Other|0|||
94218751|NCT01799993|322593110|FG000|Overall Study|Subject didn't return for follow-up|0|||
94218752|NCT01799993|322593111|FG001|Overall Study|Subject didn't return for follow-up|1|||
94218753|NCT01816165|322593112|FG000|Overall Study|Adverse Event|1|||
94218754|NCT01816165|322593113|FG001|Overall Study|Adverse Event|0|||
94218755|NCT01816165|322593114|FG002|Overall Study|Adverse Event|0|||
94218756|NCT01816165|322593115|FG003|Overall Study|Adverse Event|0|||
94218757|NCT00376259|322593120|FG000|Overall Study|Sponsor request - study termination|21|||
94218758|NCT00376259|322593121|FG001|Overall Study|Sponsor request - study termination|21|||
94218759|NCT00376259|322593120|FG000|Overall Study|Patient request|1|||
94218760|NCT00376259|322593121|FG001|Overall Study|Patient request|0|||
94218761|NCT00759681|322593123|FG000|Overall Study|Death|2|||
94218762|NCT00759681|322593124|FG001|Overall Study|Death|5|||
94218763|NCT00759681|322593123|FG000|Overall Study|Lost to Follow-up|8|||
94218764|NCT00759681|322593124|FG001|Overall Study|Lost to Follow-up|5|||
94218765|NCT01877720|322593126|FG000|Overall Study|Adverse Event|1|||
94218766|NCT01877720|322593127|FG001|Overall Study|Adverse Event|0|||
94218767|NCT01263223|322593128|FG000|Period 2|Withdrawal by Subject|0|||
94218768|NCT01263223|322593129|FG001|Period 2|Withdrawal by Subject|1|||
94218769|NCT01263223|322593128|FG000|7-day Follow-up|Withdrawal by Subject|0|||
94218770|NCT01263223|322593129|FG001|7-day Follow-up|Withdrawal by Subject|1|||
94218771|NCT01263223|322593128|FG000|7-day Follow-up|Lost to Follow-up|1|||
94218772|NCT01263223|322593129|FG001|7-day Follow-up|Lost to Follow-up|0|||
94218773|NCT01369147|322593130|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
94218774|NCT01369147|322593131|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
94218775|NCT01369147|322593132|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
94218776|NCT03184519|322593133|FG000|Overall Study|Lost to Follow-up|6|||
94218777|NCT03184519|322593133|FG000|Overall Study|Physician Decision|21|||
94218778|NCT04239911|322593137|FG000|Overall Study|Lost to Follow-up|2|||
94218779|NCT04239911|322593138|FG001|Overall Study|Lost to Follow-up|1|||
94218780|NCT01494467|322593139|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
94218781|NCT01494467|322593140|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
94218782|NCT01494467|322593139|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
94218783|NCT01494467|322593140|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
94218784|NCT01494467|322593139|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
94218785|NCT01494467|322593140|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
94218786|NCT01494467|322593139|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
94218787|NCT01494467|322593140|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
94218788|NCT01494467|322593139|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
94218789|NCT01494467|322593140|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
94218790|NCT01494467|322593139|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
94218791|NCT01494467|322593140|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
94218792|NCT01494467|322593139|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
94218793|NCT01494467|322593140|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
94218794|NCT01494467|322593139|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
94218795|NCT01494467|322593140|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
94218796|NCT01494467|322593139|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
94218797|NCT01494467|322593140|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
94218798|NCT01494467|322593139|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
94218799|NCT01494467|322593140|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
94218800|NCT01494467|322593139|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
94218801|NCT01494467|322593140|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
94218802|NCT01494467|322593139|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
94218803|NCT01494467|322593140|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
94218804|NCT01494467|322593139|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
94218805|NCT01494467|322593140|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
94218806|NCT01494467|322593139|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
94218807|NCT01494467|322593140|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
94218808|NCT00584909|322593141|FG000|Overall Study|Adverse Event|4|||
94218809|NCT01077284|322593146|FG000|Overall Study|Adverse Event|2|||
94218810|NCT01077284|322593147|FG001|Overall Study|Adverse Event|0|||
94218811|NCT01077284|322593148|FG002|Overall Study|Adverse Event|1|||
94218812|NCT01077284|322593146|FG000|Overall Study|Lost to Follow-up|1|||
94218813|NCT01077284|322593147|FG001|Overall Study|Lost to Follow-up|2|||
94218814|NCT01077284|322593148|FG002|Overall Study|Lost to Follow-up|0|||
94218815|NCT01077284|322593146|FG000|Overall Study|Withdrawal by Subject|2|||
94218816|NCT01077284|322593147|FG001|Overall Study|Withdrawal by Subject|3|||
94218817|NCT01077284|322593148|FG002|Overall Study|Withdrawal by Subject|1|||
94218818|NCT01077284|322593146|FG000|Overall Study|Other|0|||
94218819|NCT01077284|322593147|FG001|Overall Study|Other|0|||
94218820|NCT01077284|322593148|FG002|Overall Study|Other|1|||
94218821|NCT04626128|322593149|FG000|Overall Study|Withdrawal by Subject|0|||
94218822|NCT04626128|322593150|FG001|Overall Study|Withdrawal by Subject|1|||
94218823|NCT04626128|322593151|FG002|Overall Study|Withdrawal by Subject|0|||
94218824|NCT04626128|322593152|FG003|Overall Study|Withdrawal by Subject|0|||
94218825|NCT03708744|322593153|FG000|Overall Study|Withdrawal by Subject|0|||
94218826|NCT03708744|322593154|FG001|Overall Study|Withdrawal by Subject|0|||
94218827|NCT03708744|322593155|FG002|Overall Study|Withdrawal by Subject|1|||
94218828|NCT03708744|322593156|FG003|Overall Study|Withdrawal by Subject|0|||
94218829|NCT02604199|322593157|FG000|Overall Study|Pregnancy|0|||
94218830|NCT02604199|322593158|FG001|Overall Study|Pregnancy|0|||
94218831|NCT02604199|322593159|FG002|Overall Study|Pregnancy|0|||
94218832|NCT02604199|322593160|FG003|Overall Study|Pregnancy|1|||
94218833|NCT02604199|322593157|FG000|Overall Study|Study terminated by sponsor|0|||
94218834|NCT02604199|322593158|FG001|Overall Study|Study terminated by sponsor|2|||
94218835|NCT02604199|322593159|FG002|Overall Study|Study terminated by sponsor|0|||
94218836|NCT02604199|322593160|FG003|Overall Study|Study terminated by sponsor|2|||
94218837|NCT02604199|322593157|FG000|Overall Study|Withdrawal by Subject|0|||
94218838|NCT02604199|322593158|FG001|Overall Study|Withdrawal by Subject|1|||
94218839|NCT02604199|322593159|FG002|Overall Study|Withdrawal by Subject|0|||
94218840|NCT02604199|322593160|FG003|Overall Study|Withdrawal by Subject|0|||
94218841|NCT02812706|322593161|FG000|Phase 1|Adverse Event|0|||
94218842|NCT02812706|322593162|FG001|Phase 1|Adverse Event|2|||
94218843|NCT02812706|322593163|FG002|Phase 1|Adverse Event|0|||
94218844|NCT02812706|322593161|FG000|Phase 1|Progressive disease|3|||
94218845|NCT02812706|322593162|FG001|Phase 1|Progressive disease|3|||
94218846|NCT02812706|322593163|FG002|Phase 1|Progressive disease|0|||
94218847|NCT02812706|322593161|FG000|Phase 2|Adverse Event|0|||
94218848|NCT02812706|322593162|FG001|Phase 2|Adverse Event|0|||
94218849|NCT02812706|322593163|FG002|Phase 2|Adverse Event|2|||
94218850|NCT02812706|322593161|FG000|Phase 2|Progressive disease|0|||
94218851|NCT02812706|322593162|FG001|Phase 2|Progressive disease|0|||
94218852|NCT02812706|322593163|FG002|Phase 2|Progressive disease|22|||
94218853|NCT02812706|322593161|FG000|Phase 2|Other-Unspecified|0|||
94218854|NCT02812706|322593162|FG001|Phase 2|Other-Unspecified|0|||
94218855|NCT02812706|322593163|FG002|Phase 2|Other-Unspecified|4|||
94218856|NCT03166215|322593165|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
94218857|NCT03166215|322593166|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
94218858|NCT03166215|322593167|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
94218859|NCT03166215|322593165|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
94218860|NCT03166215|322593166|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
94218861|NCT03166215|322593167|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
94218862|NCT00742560|322593168|FG000|Overall Study|Adverse Event|0|||
94218863|NCT00742560|322593169|FG001|Overall Study|Adverse Event|0|||
94218864|NCT00742560|322593170|FG002|Overall Study|Adverse Event|1|||
94218865|NCT00742560|322593171|FG003|Overall Study|Adverse Event|1|||
94218866|NCT00742560|322593172|FG004|Overall Study|Adverse Event|1|||
94218867|NCT00742560|322593168|FG000|Overall Study|Death|0|||
94218868|NCT00742560|322593169|FG001|Overall Study|Death|2|||
94218869|NCT00742560|322593170|FG002|Overall Study|Death|0|||
94218870|NCT00742560|322593171|FG003|Overall Study|Death|2|||
94218871|NCT00742560|322593172|FG004|Overall Study|Death|3|||
94218872|NCT00742560|322593168|FG000|Overall Study|Subject's Decision|1|||
94218873|NCT00742560|322593169|FG001|Overall Study|Subject's Decision|0|||
94218874|NCT00742560|322593170|FG002|Overall Study|Subject's Decision|2|||
94218875|NCT00742560|322593171|FG003|Overall Study|Subject's Decision|3|||
94218876|NCT00742560|322593172|FG004|Overall Study|Subject's Decision|3|||
94218877|NCT00742560|322593168|FG000|Overall Study|Investigator's Decision|0|||
94218878|NCT00742560|322593169|FG001|Overall Study|Investigator's Decision|0|||
94218879|NCT00742560|322593170|FG002|Overall Study|Investigator's Decision|4|||
94218880|NCT00742560|322593171|FG003|Overall Study|Investigator's Decision|1|||
94218881|NCT00742560|322593172|FG004|Overall Study|Investigator's Decision|0|||
94218882|NCT00742560|322593168|FG000|Overall Study|Disease Progression|1|||
94218883|NCT00742560|322593169|FG001|Overall Study|Disease Progression|0|||
94218884|NCT00742560|322593170|FG002|Overall Study|Disease Progression|5|||
94218885|NCT00742560|322593171|FG003|Overall Study|Disease Progression|17|||
94218886|NCT00742560|322593172|FG004|Overall Study|Disease Progression|16|||
94218887|NCT00742560|322593168|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
94218888|NCT00742560|322593169|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
94218889|NCT00742560|322593170|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
94218890|NCT00742560|322593171|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
94218891|NCT00742560|322593172|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
94218892|NCT00742560|322593168|FG000|Overall Study|Other|0|||
94218893|NCT00742560|322593169|FG001|Overall Study|Other|1|||
94218894|NCT00742560|322593170|FG002|Overall Study|Other|8|||
94218895|NCT00742560|322593171|FG003|Overall Study|Other|9|||
94218896|NCT00742560|322593172|FG004|Overall Study|Other|9|||
94218897|NCT00742560|322593168|FG000|Overall Study|MIssing|0|||
94218898|NCT00742560|322593169|FG001|Overall Study|MIssing|0|||
94218899|NCT00742560|322593170|FG002|Overall Study|MIssing|0|||
94218900|NCT00742560|322593171|FG003|Overall Study|MIssing|0|||
94218901|NCT00742560|322593172|FG004|Overall Study|MIssing|1|||
94218902|NCT02058992|322593174|FG000|Overall Study|Lost to Follow-up|4|||
94218903|NCT02058992|322593174|FG000|Overall Study|Protocol Violation|92|||
94218904|NCT02058992|322593174|FG000|Overall Study|CRF Uncollected|20|||
94218905|NCT00141271|322593175|FG000|Overall Study|Adverse Event|31|||
94218906|NCT00141271|322593176|FG001|Overall Study|Adverse Event|19|||
94218907|NCT00141271|322593177|FG002|Overall Study|Adverse Event|17|||
94218908|NCT00141271|322593175|FG000|Overall Study|Laboratory Abnormality|2|||
94218909|NCT00141271|322593176|FG001|Overall Study|Laboratory Abnormality|1|||
94218910|NCT00141271|322593177|FG002|Overall Study|Laboratory Abnormality|1|||
94218911|NCT00141271|322593175|FG000|Overall Study|Lack of Efficacy|7|||
94218912|NCT00141271|322593176|FG001|Overall Study|Lack of Efficacy|7|||
94218913|NCT00141271|322593177|FG002|Overall Study|Lack of Efficacy|3|||
94218914|NCT00141271|322593175|FG000|Overall Study|Lost to Follow-up|15|||
94218915|NCT00141271|322593176|FG001|Overall Study|Lost to Follow-up|15|||
94218916|NCT00141271|322593177|FG002|Overall Study|Lost to Follow-up|21|||
94218917|NCT00141271|322593175|FG000|Overall Study|Withdrawal by Subject|14|||
94218918|NCT00141271|322593176|FG001|Overall Study|Withdrawal by Subject|9|||
94218919|NCT00141271|322593177|FG002|Overall Study|Withdrawal by Subject|10|||
94218920|NCT00141271|322593175|FG000|Overall Study|Other|11|||
94218921|NCT00141271|322593176|FG001|Overall Study|Other|12|||
94218922|NCT00141271|322593177|FG002|Overall Study|Other|5|||
94218923|NCT05379400|322595011|FG000|Overall Study|Lost to Follow-up|1|||
94218924|NCT05379400|322595012|FG001|Overall Study|Lost to Follow-up|1|||
94218925|NCT03978130|322595014|FG000|Overall Study|Lost to Follow-up|13|||
94218926|NCT03978130|322595015|FG001|Overall Study|Lost to Follow-up|14|||
94218927|NCT03978130|322595014|FG000|Overall Study|Withdrawal by Subject|12|||
94218928|NCT03978130|322595015|FG001|Overall Study|Withdrawal by Subject|2|||
94218929|NCT03978130|322595014|FG000|Overall Study|Adverse Event|2|||
94218930|NCT03978130|322595015|FG001|Overall Study|Adverse Event|1|||
94218931|NCT05356130|322595016|FG000|Overall Study|Withdrawal by Subject|0|||
94218932|NCT05356130|322595017|FG001|Overall Study|Withdrawal by Subject|0|||
94218933|NCT05356130|322595018|FG002|Overall Study|Withdrawal by Subject|3|||
94218934|NCT03141177|322595019|FG000|Overall Study|Death|62|||
94218935|NCT03141177|322595020|FG001|Overall Study|Death|13|||
94218936|NCT03141177|322595021|FG002|Overall Study|Death|84|||
94218937|NCT03141177|322595019|FG000|Overall Study|Participant withdrew consent|9|||
94218938|NCT03141177|322595020|FG001|Overall Study|Participant withdrew consent|2|||
94218939|NCT03141177|322595021|FG002|Overall Study|Participant withdrew consent|13|||
94218940|NCT03141177|322595019|FG000|Overall Study|Not reported|1|||
94218941|NCT03141177|322595020|FG001|Overall Study|Not reported|0|||
94218942|NCT03141177|322595021|FG002|Overall Study|Not reported|1|||
94218943|NCT03141177|322595019|FG000|Overall Study|Lost to Follow-up|2|||
94218944|NCT03141177|322595020|FG001|Overall Study|Lost to Follow-up|1|||
94218945|NCT03141177|322595021|FG002|Overall Study|Lost to Follow-up|1|||
94218946|NCT03141177|322595019|FG000|Overall Study|Other reasons|4|||
94218947|NCT03141177|322595020|FG001|Overall Study|Other reasons|0|||
94218948|NCT03141177|322595021|FG002|Overall Study|Other reasons|11|||
94218949|NCT03141177|322595019|FG000|Overall Study|Participants did not start treatment period|3|||
94218950|NCT03141177|322595020|FG001|Overall Study|Participants did not start treatment period|0|||
94218951|NCT03141177|322595021|FG002|Overall Study|Participants did not start treatment period|8|||
94218952|NCT04851587|322595022|FG000|Overall Study|Lost to Follow-up|18|||
94218953|NCT02092285|322595029|FG000|Induction Phase|Adverse Event|7|||
94218954|NCT02092285|322595029|FG000|Induction Phase|Physician Decision|4|||
94218955|NCT02092285|322595029|FG000|Induction Phase|Pregnancy|1|||
94218956|NCT02092285|322595029|FG000|Induction Phase|Relapse/Recurrence|7|||
94218957|NCT02092285|322595029|FG000|Induction Phase|Withdrawal by Subject|2|||
94218958|NCT02092285|322595029|FG000|Induction Phase|Lack of Efficacy|14|||
94218959|NCT02092285|322595029|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
94218960|NCT02092285|322595029|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
94218961|NCT02092285|322595029|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
94218962|NCT02092285|322595029|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
94218963|NCT02092285|322595029|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
94218964|NCT02092285|322595029|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
94218965|NCT02092285|322595029|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
94218966|NCT02092285|322595029|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
94218967|NCT02092285|322595029|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
94218968|NCT02143713|322595034|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
94218969|NCT02143713|322595035|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
94218970|NCT02143713|322595036|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
94218971|NCT02143713|322595037|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
94218972|NCT02143713|322595034|FG000|Treatment Period (6 Months)|Adverse Event|7|||
94218973|NCT02143713|322595035|FG001|Treatment Period (6 Months)|Adverse Event|8|||
94218974|NCT02143713|322595036|FG002|Treatment Period (6 Months)|Adverse Event|8|||
94218975|NCT02143713|322595037|FG003|Treatment Period (6 Months)|Adverse Event|9|||
94218976|NCT02143713|322595034|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
94218977|NCT02143713|322595035|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
94218978|NCT02143713|322595036|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
94218979|NCT02143713|322595037|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
94218980|NCT02143713|322595034|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
94218981|NCT02143713|322595035|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
94218982|NCT02143713|322595036|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
94218983|NCT02143713|322595037|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
94218984|NCT02143713|322595034|FG000|Treatment Period (6 Months)|Pregnancy|0|||
94218985|NCT02143713|322595035|FG001|Treatment Period (6 Months)|Pregnancy|2|||
94218986|NCT02143713|322595036|FG002|Treatment Period (6 Months)|Pregnancy|2|||
94218987|NCT02143713|322595037|FG003|Treatment Period (6 Months)|Pregnancy|0|||
94218988|NCT02143713|322595034|FG000|Treatment Period (6 Months)|Non-compliance|1|||
94218989|NCT02143713|322595035|FG001|Treatment Period (6 Months)|Non-compliance|0|||
94218990|NCT02143713|322595036|FG002|Treatment Period (6 Months)|Non-compliance|0|||
94218991|NCT02143713|322595037|FG003|Treatment Period (6 Months)|Non-compliance|3|||
94218992|NCT02143713|322595034|FG000|Treatment Period (6 Months)|Other|3|||
94218993|NCT02143713|322595035|FG001|Treatment Period (6 Months)|Other|0|||
94218994|NCT02143713|322595036|FG002|Treatment Period (6 Months)|Other|3|||
94218995|NCT02143713|322595037|FG003|Treatment Period (6 Months)|Other|2|||
94218996|NCT02143713|322595034|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
94218997|NCT02143713|322595035|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
94218998|NCT02143713|322595036|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
94218999|NCT02143713|322595037|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
94219000|NCT02143713|322595034|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
94219001|NCT02143713|322595035|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
94219002|NCT02143713|322595036|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
94219003|NCT02143713|322595037|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
94219004|NCT02143713|322595034|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
94219005|NCT02143713|322595035|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
94219006|NCT02143713|322595036|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
94219007|NCT02143713|322595037|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
94219008|NCT02143713|322595034|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
94219009|NCT02143713|322595035|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
94219010|NCT02143713|322595036|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
94219011|NCT02143713|322595037|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
94219012|NCT02143713|322595034|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
94219013|NCT02143713|322595035|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
94219014|NCT02143713|322595036|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
94219015|NCT02143713|322595037|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
94219016|NCT02143713|322595034|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
94219017|NCT02143713|322595035|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
94219018|NCT02143713|322595036|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
94219019|NCT02143713|322595037|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
94219020|NCT02143713|322595034|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
94219021|NCT02143713|322595035|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
94219022|NCT02143713|322595036|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
94219023|NCT02143713|322595037|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
94219024|NCT02143713|322595034|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
94219025|NCT02143713|322595035|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
94219026|NCT02143713|322595036|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
94219027|NCT02143713|322595037|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
94219028|NCT02143713|322595034|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
94219029|NCT02143713|322595035|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
94219030|NCT02143713|322595036|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
94219031|NCT02143713|322595037|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
94219032|NCT05203822|322595041|FG000|Overall Study|Adverse Event|1|||
94219033|NCT05203822|322595041|FG000|Overall Study|Withdrawal by Subject|1|||
94219034|NCT03614923|322595042|FG000|Overall Study|Withdrawal by Subject|2|||
94219035|NCT03614923|322595043|FG001|Overall Study|Withdrawal by Subject|1|||
94219036|NCT03614923|322595044|FG002|Overall Study|Withdrawal by Subject|1|||
94219037|NCT03614923|322595042|FG000|Overall Study|Adverse Event|0|||
94219038|NCT03614923|322595043|FG001|Overall Study|Adverse Event|2|||
94219039|NCT03614923|322595044|FG002|Overall Study|Adverse Event|1|||
94219040|NCT03614923|322595042|FG000|Overall Study|Lost to Follow-up|1|||
94219041|NCT03614923|322595043|FG001|Overall Study|Lost to Follow-up|0|||
94219042|NCT03614923|322595044|FG002|Overall Study|Lost to Follow-up|1|||
94219043|NCT03614923|322595042|FG000|Overall Study|Lack of Efficacy|2|||
94219044|NCT03614923|322595043|FG001|Overall Study|Lack of Efficacy|0|||
94219045|NCT03614923|322595044|FG002|Overall Study|Lack of Efficacy|1|||
94219046|NCT03614923|322595042|FG000|Overall Study|Non-compliance|0|||
94219047|NCT03614923|322595043|FG001|Overall Study|Non-compliance|1|||
94219048|NCT03614923|322595044|FG002|Overall Study|Non-compliance|0|||
94219049|NCT03614923|322595042|FG000|Overall Study|Other|0|||
94219050|NCT03614923|322595043|FG001|Overall Study|Other|1|||
94219051|NCT03614923|322595044|FG002|Overall Study|Other|1|||
94219052|NCT03745651|322595046|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
94219053|NCT03745651|322595047|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
94219054|NCT03745651|322595048|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
94219055|NCT03745651|322595049|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
94219056|NCT03745651|322595050|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
94219057|NCT03745651|322595051|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
94219058|NCT03745651|322595052|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
94219059|NCT03745651|322595046|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
94219060|NCT03745651|322595047|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
94219061|NCT03745651|322595048|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
94219062|NCT03745651|322595049|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94219063|NCT03745651|322595050|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94219064|NCT03745651|322595051|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94219065|NCT03745651|322595052|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94219066|NCT03745651|322595046|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
94219067|NCT03745651|322595047|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
94219068|NCT03745651|322595048|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
94219069|NCT03745651|322595049|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
94219070|NCT03745651|322595050|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
94219071|NCT03745651|322595051|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
94219072|NCT03745651|322595052|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
94219073|NCT03745651|322595046|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
94287089|NCT03665285|322840597|FG002|Overall Study|Disease Progression|3|||
94287090|NCT03665285|322840598|FG003|Overall Study|Disease Progression|1|||
94287091|NCT03665285|322840599|FG004|Overall Study|Disease Progression|0|||
94287092|NCT03665285|322840600|FG005|Overall Study|Disease Progression|0|||
94287093|NCT03665285|322840601|FG006|Overall Study|Disease Progression|0|||
94287094|NCT03665285|322840602|FG007|Overall Study|Disease Progression|7|||
94287095|NCT03665285|322840603|FG008|Overall Study|Disease Progression|1|||
94287096|NCT03665285|322840595|FG000|Overall Study|Hospice|0|||
94287097|NCT03665285|322840596|FG001|Overall Study|Hospice|0|||
94287098|NCT03665285|322840597|FG002|Overall Study|Hospice|0|||
94287099|NCT03665285|322840598|FG003|Overall Study|Hospice|0|||
94287100|NCT03665285|322840599|FG004|Overall Study|Hospice|0|||
94287101|NCT03665285|322840600|FG005|Overall Study|Hospice|0|||
94287102|NCT03665285|322840601|FG006|Overall Study|Hospice|0|||
94287103|NCT03665285|322840602|FG007|Overall Study|Hospice|2|||
94287104|NCT03665285|322840603|FG008|Overall Study|Hospice|0|||
94287105|NCT03665285|322840595|FG000|Overall Study|Withdrawal by Subject|0|||
94287106|NCT03665285|322840596|FG001|Overall Study|Withdrawal by Subject|0|||
94287107|NCT03665285|322840597|FG002|Overall Study|Withdrawal by Subject|0|||
94219074|NCT03745651|322595047|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
94219075|NCT03745651|322595048|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
94219076|NCT03745651|322595049|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
94219077|NCT03745651|322595050|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
94219078|NCT03745651|322595051|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
94219079|NCT03745651|322595052|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
94219080|NCT03745651|322595046|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
94219081|NCT03745651|322595047|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
94219082|NCT03745651|322595048|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
94219083|NCT03745651|322595049|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94219084|NCT03745651|322595050|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94219085|NCT03745651|322595051|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94219086|NCT03745651|322595052|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94219087|NCT03745651|322595046|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
94219088|NCT03745651|322595047|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
94219089|NCT03745651|322595048|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
94219090|NCT03745651|322595049|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
94219091|NCT03745651|322595050|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
94219092|NCT03745651|322595051|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
94219093|NCT03745651|322595052|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
94219094|NCT03745651|322595046|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
94219095|NCT03745651|322595047|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
94219096|NCT03745651|322595048|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
94219097|NCT03745651|322595049|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
94219098|NCT03745651|322595050|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
94219099|NCT03745651|322595051|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
94219100|NCT03745651|322595052|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
94219101|NCT03745651|322595046|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
94219102|NCT03745651|322595047|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
94219103|NCT03745651|322595048|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
94219104|NCT03745651|322595049|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
94219105|NCT03745651|322595050|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
94219106|NCT03745651|322595051|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
94219107|NCT03745651|322595052|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
94219108|NCT03745651|322595046|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
94219109|NCT03745651|322595047|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
94219110|NCT03745651|322595048|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
94219111|NCT03745651|322595049|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
94287108|NCT03665285|322840598|FG003|Overall Study|Withdrawal by Subject|0|||
94287109|NCT03665285|322840599|FG004|Overall Study|Withdrawal by Subject|1|||
94287110|NCT03665285|322840600|FG005|Overall Study|Withdrawal by Subject|0|||
94287111|NCT03665285|322840601|FG006|Overall Study|Withdrawal by Subject|0|||
94287112|NCT03665285|322840602|FG007|Overall Study|Withdrawal by Subject|2|||
94287113|NCT03665285|322840603|FG008|Overall Study|Withdrawal by Subject|0|||
94287114|NCT03665285|322840595|FG000|Overall Study|Physician Decision|0|||
94287115|NCT03665285|322840596|FG001|Overall Study|Physician Decision|0|||
94287116|NCT03665285|322840597|FG002|Overall Study|Physician Decision|0|||
94287117|NCT03665285|322840598|FG003|Overall Study|Physician Decision|0|||
94287118|NCT03665285|322840599|FG004|Overall Study|Physician Decision|0|||
94287119|NCT03665285|322840600|FG005|Overall Study|Physician Decision|0|||
94287120|NCT03665285|322840601|FG006|Overall Study|Physician Decision|0|||
94287121|NCT03665285|322840602|FG007|Overall Study|Physician Decision|2|||
94287122|NCT03665285|322840603|FG008|Overall Study|Physician Decision|0|||
94287123|NCT00763321|322840604|FG000|Open-label Period|Adverse Event|24|||
94287124|NCT00763321|322840605|FG001|Open-label Period|Adverse Event|0|||
94287125|NCT00763321|322840606|FG002|Open-label Period|Adverse Event|0|||
94287126|NCT00763321|322840604|FG000|Open-label Period|Lost to Follow-up|14|||
94287127|NCT00763321|322840605|FG001|Open-label Period|Lost to Follow-up|0|||
94287128|NCT00763321|322840606|FG002|Open-label Period|Lost to Follow-up|0|||
94219112|NCT03745651|322595050|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
94219113|NCT03745651|322595051|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
94287129|NCT00763321|322840604|FG000|Open-label Period|Withdrawal by Subject|7|||
94287130|NCT00763321|322840605|FG001|Open-label Period|Withdrawal by Subject|0|||
94287131|NCT00763321|322840606|FG002|Open-label Period|Withdrawal by Subject|0|||
94287132|NCT00763321|322840604|FG000|Open-label Period|Subject noncompliant|7|||
94287133|NCT00763321|322840605|FG001|Open-label Period|Subject noncompliant|0|||
94287134|NCT00763321|322840606|FG002|Open-label Period|Subject noncompliant|0|||
94287135|NCT00763321|322840604|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
94372486|NCT00903383|323150269|FG003|Overall Study|Patient Decision|1|||
94219114|NCT03745651|322595052|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
94219115|NCT03745651|322595046|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
94219116|NCT03745651|322595047|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
94219117|NCT03745651|322595048|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
94219118|NCT03745651|322595049|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
94219119|NCT03745651|322595050|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
94219120|NCT03745651|322595051|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
94219121|NCT03745651|322595052|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
94219122|NCT03745651|322595046|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
94219123|NCT03745651|322595047|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
94219124|NCT03745651|322595048|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
94219125|NCT03745651|322595049|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
94219126|NCT03745651|322595050|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
94219127|NCT03745651|322595051|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
94219128|NCT03745651|322595052|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
94219129|NCT03745651|322595046|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
94219130|NCT03745651|322595047|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
94219131|NCT03745651|322595048|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
94219132|NCT03745651|322595049|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
94219133|NCT03745651|322595050|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
94219134|NCT03745651|322595051|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
94219135|NCT03745651|322595052|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
94219136|NCT03745651|322595046|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
94219137|NCT03745651|322595047|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
94219138|NCT03745651|322595048|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
94219139|NCT03745651|322595049|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
94219140|NCT03745651|322595050|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
94219141|NCT03745651|322595051|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
94219142|NCT03745651|322595052|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
94219143|NCT03745651|322595046|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
94219144|NCT03745651|322595047|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
94219145|NCT03745651|322595048|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
94219146|NCT03745651|322595049|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
94219147|NCT03745651|322595050|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
94219148|NCT03745651|322595051|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
94219149|NCT03745651|322595052|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
94219150|NCT03360071|322595053|FG000|Overall Study|Lost to Follow-up|1|||
94219151|NCT03360071|322595054|FG001|Overall Study|Lost to Follow-up|0|||
94219152|NCT01322347|322595055|FG000|Overall Study|Adverse Event|7|||
94219153|NCT01322347|322595056|FG001|Overall Study|Adverse Event|2|||
94219154|NCT01322347|322595055|FG000|Overall Study|Death|5|||
94219155|NCT01322347|322595056|FG001|Overall Study|Death|3|||
94219156|NCT01322347|322595055|FG000|Overall Study|Physician Decision|2|||
94219157|NCT01322347|322595056|FG001|Overall Study|Physician Decision|1|||
94219158|NCT01322347|322595055|FG000|Overall Study|Protocol Violation|5|||
94219159|NCT01322347|322595056|FG001|Overall Study|Protocol Violation|2|||
94219160|NCT01322347|322595055|FG000|Overall Study|Withdrawal by Subject|1|||
94219161|NCT01322347|322595056|FG001|Overall Study|Withdrawal by Subject|4|||
94219162|NCT01322347|322595055|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
94219163|NCT01322347|322595056|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
94219164|NCT01322347|322595055|FG000|Overall Study|blood transfusion|5|||
94219165|NCT01322347|322595056|FG001|Overall Study|blood transfusion|5|||
94219166|NCT01322347|322595055|FG000|Overall Study|sponsor decision|1|||
94219167|NCT01322347|322595056|FG001|Overall Study|sponsor decision|3|||
94219168|NCT01322347|322595055|FG000|Overall Study|ineligible|6|||
94219169|NCT01322347|322595056|FG001|Overall Study|ineligible|3|||
94219170|NCT01322347|322595055|FG000|Overall Study|kidney transplant|3|||
94219171|NCT01322347|322595056|FG001|Overall Study|kidney transplant|1|||
94287136|NCT00763321|322840605|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
94287137|NCT00763321|322840606|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
94287138|NCT00763321|322840604|FG000|Open-label Period|Lack of Efficacy|2|||
94287139|NCT00763321|322840605|FG001|Open-label Period|Lack of Efficacy|0|||
94287140|NCT00763321|322840606|FG002|Open-label Period|Lack of Efficacy|0|||
94287141|NCT00763321|322840604|FG000|Open-label Period|Other|4|||
94287142|NCT00763321|322840605|FG001|Open-label Period|Other|0|||
94287143|NCT00763321|322840606|FG002|Open-label Period|Other|0|||
94219172|NCT01322347|322595055|FG000|Overall Study|study drug withheld > 12 wks|0|||
94287144|NCT00763321|322840604|FG000|Double-blind Period|Lack of Efficacy|0|||
94287145|NCT00763321|322840605|FG001|Double-blind Period|Lack of Efficacy|9|||
94287146|NCT00763321|322840606|FG002|Double-blind Period|Lack of Efficacy|17|||
94219173|NCT01322347|322595056|FG001|Overall Study|study drug withheld > 12 wks|1|||
94219174|NCT01322347|322595055|FG000|Overall Study|moved/changed dialysis|2|||
94219175|NCT01322347|322595056|FG001|Overall Study|moved/changed dialysis|4|||
94219176|NCT04883541|322595057|FG000|Overall Study|Not attending regular yoga class|16|||
94219177|NCT04883541|322595058|FG001|Overall Study|Not attending regular yoga class|0|||
94219178|NCT04883541|322595057|FG000|Overall Study|Not attending the pregnancy school|0|||
94219179|NCT04883541|322595058|FG001|Overall Study|Not attending the pregnancy school|9|||
94219180|NCT00590759|322595062|FG000|Overall Study|Death|52|||
94219181|NCT00590759|322595062|FG000|Overall Study|Lost to Follow-up|28|||
94219182|NCT03845517|322595063|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
94219183|NCT03845517|322595064|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
94219184|NCT03845517|322595065|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
94219185|NCT03845517|322595066|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
94219186|NCT03845517|322595063|FG000|Treatment Period (52 Weeks)|Death|0|||
94219187|NCT03845517|322595064|FG001|Treatment Period (52 Weeks)|Death|0|||
94219188|NCT03845517|322595065|FG002|Treatment Period (52 Weeks)|Death|1|||
94219189|NCT03845517|322595066|FG003|Treatment Period (52 Weeks)|Death|0|||
94219190|NCT03845517|322595063|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
94219191|NCT03845517|322595064|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
94219192|NCT03845517|322595065|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
94219193|NCT03845517|322595066|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
94219194|NCT03845517|322595063|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
94219195|NCT03845517|322595064|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
94219196|NCT03845517|322595065|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
94219197|NCT03845517|322595066|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
94219198|NCT03845517|322595063|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
94219199|NCT03845517|322595064|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
94219200|NCT03845517|322595065|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
94219201|NCT03845517|322595066|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
94219202|NCT03845517|322595063|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
94219203|NCT03845517|322595064|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
94219204|NCT03845517|322595065|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
94219205|NCT03845517|322595066|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
94219206|NCT03845517|322595063|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
94219207|NCT03845517|322595064|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
94219208|NCT03845517|322595065|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
94219209|NCT03845517|322595066|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
94219210|NCT03845517|322595063|FG000|Treatment Period (52 Weeks)|Other|2|||
94219211|NCT03845517|322595064|FG001|Treatment Period (52 Weeks)|Other|0|||
94219212|NCT03845517|322595065|FG002|Treatment Period (52 Weeks)|Other|0|||
94219213|NCT03845517|322595066|FG003|Treatment Period (52 Weeks)|Other|0|||
94219214|NCT03845517|322595063|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
94219215|NCT03845517|322595064|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
94219216|NCT03845517|322595065|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
94219217|NCT03845517|322595066|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
94219218|NCT03845517|322595063|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
94219219|NCT03845517|322595064|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
94219220|NCT03845517|322595065|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
94219221|NCT03845517|322595066|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
94219222|NCT03845517|322595063|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
94219223|NCT03845517|322595064|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
94219224|NCT03845517|322595065|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
94219225|NCT03845517|322595066|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
94219226|NCT03845517|322595063|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
94219227|NCT03845517|322595064|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
94219228|NCT03845517|322595065|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
94219229|NCT03845517|322595066|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
94219230|NCT03845517|322595063|FG000|Follow-up Period (4 Weeks)|Death|0|||
94219231|NCT03845517|322595064|FG001|Follow-up Period (4 Weeks)|Death|0|||
94219232|NCT03845517|322595065|FG002|Follow-up Period (4 Weeks)|Death|1|||
94219233|NCT03845517|322595066|FG003|Follow-up Period (4 Weeks)|Death|1|||
94219234|NCT03845517|322595063|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
94219235|NCT03845517|322595064|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
94219236|NCT03845517|322595065|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
94219237|NCT03845517|322595066|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
94219238|NCT03845517|322595063|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
94219239|NCT03845517|322595064|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
94219240|NCT03845517|322595065|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
94219241|NCT03845517|322595066|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
94219242|NCT03845517|322595063|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
94219243|NCT03845517|322595064|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
94287147|NCT00763321|322840604|FG000|Double-blind Period|Adverse Event|0|||
94219244|NCT03845517|322595065|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
94219245|NCT03845517|322595066|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
94219246|NCT03845517|322595063|FG000|Follow-up Period (4 Weeks)|Other|1|||
94219247|NCT03845517|322595064|FG001|Follow-up Period (4 Weeks)|Other|0|||
94219248|NCT03845517|322595065|FG002|Follow-up Period (4 Weeks)|Other|1|||
94219249|NCT03845517|322595066|FG003|Follow-up Period (4 Weeks)|Other|0|||
94219250|NCT03845517|322595063|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
94219251|NCT03845517|322595064|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
94219252|NCT03845517|322595065|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
94219253|NCT03845517|322595066|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
94219254|NCT03845517|322595063|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
94219255|NCT03845517|322595064|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
94219256|NCT03845517|322595065|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
94219257|NCT03845517|322595066|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
94219258|NCT03845517|322595063|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
94219259|NCT03845517|322595064|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
94219260|NCT03845517|322595065|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
94219261|NCT03845517|322595066|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
94219262|NCT03345407|322595068|FG000|Overall Study|Withdrawal by Subject|11|||
94219263|NCT03345407|322595069|FG001|Overall Study|Withdrawal by Subject|1|||
94219264|NCT03345407|322595070|FG002|Overall Study|Withdrawal by Subject|5|||
94219265|NCT03345407|322595071|FG003|Overall Study|Withdrawal by Subject|6|||
94219266|NCT03345407|322595072|FG004|Overall Study|Withdrawal by Subject|3|||
94219267|NCT03345407|322595073|FG005|Overall Study|Withdrawal by Subject|6|||
94219268|NCT03345407|322595074|FG006|Overall Study|Withdrawal by Subject|16|||
94219269|NCT03345407|322595068|FG000|Overall Study|Physician Decision|3|||
94219270|NCT03345407|322595069|FG001|Overall Study|Physician Decision|1|||
94219271|NCT03345407|322595070|FG002|Overall Study|Physician Decision|0|||
94219272|NCT03345407|322595071|FG003|Overall Study|Physician Decision|0|||
94219273|NCT03345407|322595072|FG004|Overall Study|Physician Decision|1|||
94219274|NCT03345407|322595073|FG005|Overall Study|Physician Decision|2|||
94219275|NCT03345407|322595074|FG006|Overall Study|Physician Decision|3|||
94219276|NCT03345407|322595068|FG000|Overall Study|Lost to Follow-up|2|||
94219277|NCT03345407|322595069|FG001|Overall Study|Lost to Follow-up|0|||
94219278|NCT03345407|322595070|FG002|Overall Study|Lost to Follow-up|1|||
94219279|NCT03345407|322595071|FG003|Overall Study|Lost to Follow-up|0|||
94219280|NCT03345407|322595072|FG004|Overall Study|Lost to Follow-up|1|||
94219281|NCT03345407|322595073|FG005|Overall Study|Lost to Follow-up|2|||
94219282|NCT03345407|322595074|FG006|Overall Study|Lost to Follow-up|3|||
94219283|NCT03345407|322595068|FG000|Overall Study|Protocol-defined stopping criteria|9|||
94219284|NCT03345407|322595069|FG001|Overall Study|Protocol-defined stopping criteria|0|||
94219285|NCT03345407|322595070|FG002|Overall Study|Protocol-defined stopping criteria|0|||
94219286|NCT03345407|322595071|FG003|Overall Study|Protocol-defined stopping criteria|0|||
94219287|NCT03345407|322595072|FG004|Overall Study|Protocol-defined stopping criteria|2|||
94219288|NCT03345407|322595073|FG005|Overall Study|Protocol-defined stopping criteria|1|||
94219289|NCT03345407|322595074|FG006|Overall Study|Protocol-defined stopping criteria|1|||
94219290|NCT03345407|322595068|FG000|Overall Study|Protocol Violation|2|||
94219291|NCT03345407|322595069|FG001|Overall Study|Protocol Violation|0|||
94219292|NCT03345407|322595070|FG002|Overall Study|Protocol Violation|0|||
94219293|NCT03345407|322595071|FG003|Overall Study|Protocol Violation|0|||
94219294|NCT03345407|322595072|FG004|Overall Study|Protocol Violation|1|||
94219295|NCT03345407|322595073|FG005|Overall Study|Protocol Violation|0|||
94219296|NCT03345407|322595074|FG006|Overall Study|Protocol Violation|3|||
94219297|NCT03345407|322595068|FG000|Overall Study|Lack of Efficacy|1|||
94467888|NCT00337779|323502428|FG000|Overall Study|Pregnancy|3|||
94467889|NCT00337779|323502429|FG001|Overall Study|Pregnancy|2|||
94467890|NCT00337779|323502428|FG000|Overall Study|Death|0|||
94467891|NCT00337779|323502429|FG001|Overall Study|Death|1|||
94219298|NCT03345407|322595069|FG001|Overall Study|Lack of Efficacy|1|||
94219299|NCT03345407|322595070|FG002|Overall Study|Lack of Efficacy|1|||
94219300|NCT03345407|322595071|FG003|Overall Study|Lack of Efficacy|1|||
94219301|NCT03345407|322595072|FG004|Overall Study|Lack of Efficacy|1|||
94219302|NCT03345407|322595073|FG005|Overall Study|Lack of Efficacy|0|||
94219303|NCT03345407|322595074|FG006|Overall Study|Lack of Efficacy|3|||
94219304|NCT03345407|322595068|FG000|Overall Study|Adverse Event|4|||
94219305|NCT03345407|322595069|FG001|Overall Study|Adverse Event|0|||
94219306|NCT03345407|322595070|FG002|Overall Study|Adverse Event|5|||
94219307|NCT03345407|322595071|FG003|Overall Study|Adverse Event|4|||
94219308|NCT03345407|322595072|FG004|Overall Study|Adverse Event|6|||
94219309|NCT03345407|322595073|FG005|Overall Study|Adverse Event|5|||
94219310|NCT03345407|322595074|FG006|Overall Study|Adverse Event|16|||
94219311|NCT01190436|322595075|FG000|Overall Study|Lost to Follow-up|35|||
94219312|NCT01190436|322595075|FG000|Overall Study|Other|4|||
94219313|NCT01182285|322595076|FG000|First Intervention Week 1-10|Disease progression|1|||
94219314|NCT01182285|322595077|FG001|First Intervention Week 1-10|Disease progression|0|||
94219315|NCT01182285|322595078|FG002|First Intervention Week 1-10|Disease progression|0|||
94467892|NCT00404924|323502432|FG000|Overall Study|Adverse Event|75|||
94219316|NCT01182285|322595076|FG000|First Intervention Week 1-10|Adverse Event|1|||
94219317|NCT01182285|322595077|FG001|First Intervention Week 1-10|Adverse Event|0|||
94219318|NCT01182285|322595078|FG002|First Intervention Week 1-10|Adverse Event|0|||
94219319|NCT01182285|322595076|FG000|First Intervention Week 1-10|Non-compliance|1|||
94219320|NCT01182285|322595077|FG001|First Intervention Week 1-10|Non-compliance|0|||
94219321|NCT01182285|322595078|FG002|First Intervention Week 1-10|Non-compliance|0|||
94219322|NCT01182285|322595076|FG000|Third Intervention Week 11-52|Disease Progression|0|||
94219323|NCT01182285|322595077|FG001|Third Intervention Week 11-52|Disease Progression|0|||
94219324|NCT01182285|322595078|FG002|Third Intervention Week 11-52|Disease Progression|6|||
94219325|NCT01182285|322595076|FG000|Third Intervention Week 11-52|Other|0|||
94219326|NCT01182285|322595077|FG001|Third Intervention Week 11-52|Other|0|||
94219327|NCT01182285|322595078|FG002|Third Intervention Week 11-52|Other|2|||
94219328|NCT02069379|322595079|FG000|Baseline Measurements|Lost to Follow-up|1|||
94219329|NCT02069379|322595080|FG001|Baseline Measurements|Lost to Follow-up|0|||
94219330|NCT02069379|322595081|FG002|Baseline Measurements|Lost to Follow-up|0|||
94219331|NCT02069379|322595082|FG003|Baseline Measurements|Lost to Follow-up|0|||
94219332|NCT02069379|322595079|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
94219333|NCT02069379|322595080|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
94219334|NCT02069379|322595081|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
94219335|NCT02069379|322595082|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
94219336|NCT02069379|322595079|FG000|First Treatment Arm|Lost to Follow-up|0|||
94219337|NCT02069379|322595080|FG001|First Treatment Arm|Lost to Follow-up|1|||
94219338|NCT02069379|322595081|FG002|First Treatment Arm|Lost to Follow-up|1|||
94219339|NCT02069379|322595082|FG003|First Treatment Arm|Lost to Follow-up|0|||
94219340|NCT02069379|322595079|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
94219341|NCT02069379|322595080|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
94219342|NCT02069379|322595081|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
94219343|NCT02069379|322595082|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
94219344|NCT02069379|322595079|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
94219345|NCT02069379|322595080|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
94219346|NCT02069379|322595081|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
94219347|NCT02069379|322595082|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
94219348|NCT02069379|322595079|FG000|Second Treatment Arm|Lost to Follow-up|0|||
94219349|NCT02069379|322595080|FG001|Second Treatment Arm|Lost to Follow-up|0|||
94219350|NCT02069379|322595081|FG002|Second Treatment Arm|Lost to Follow-up|1|||
94219351|NCT02069379|322595082|FG003|Second Treatment Arm|Lost to Follow-up|0|||
94219352|NCT00561678|322595083|FG000|Overall Study|Withdrawal by Subject|4|||
94219353|NCT00561678|322595084|FG001|Overall Study|Withdrawal by Subject|3|||
94219354|NCT00561678|322595083|FG000|Overall Study|surgery cancelled|1|||
94219355|NCT00561678|322595084|FG001|Overall Study|surgery cancelled|1|||
94219356|NCT00561678|322595083|FG000|Overall Study|surgery rescheduled to different site|2|||
94219357|NCT00561678|322595084|FG001|Overall Study|surgery rescheduled to different site|2|||
94219358|NCT00561678|322595083|FG000|Overall Study|anesthesia provider refusal|1|||
94219359|NCT00561678|322595084|FG001|Overall Study|anesthesia provider refusal|0|||
94219360|NCT01894620|322595085|FG000|Overall Study|Withdrawal by Subject|0|||
94219361|NCT01894620|322595086|FG001|Overall Study|Withdrawal by Subject|1|||
94219362|NCT01901302|322595087|FG000|Overall Study|Adverse Event|2|||
94219363|NCT01901302|322595088|FG001|Overall Study|Adverse Event|1|||
94219364|NCT01901302|322595087|FG000|Overall Study|Lack of Efficacy|0|||
94219365|NCT01901302|322595088|FG001|Overall Study|Lack of Efficacy|2|||
94219366|NCT01901302|322595087|FG000|Overall Study|Study Terminated by Sponsor|23|||
94219367|NCT01901302|322595088|FG001|Overall Study|Study Terminated by Sponsor|20|||
94219368|NCT01901302|322595087|FG000|Overall Study|Withdrawal by Subject|2|||
94219369|NCT01901302|322595088|FG001|Overall Study|Withdrawal by Subject|0|||
94219370|NCT00938041|322595089|FG000|Overall Study|Lost to Follow-up|6|||
94219371|NCT00938041|322595089|FG000|Overall Study|Received Alternative Therapy|1|||
94219372|NCT00938041|322595089|FG000|Overall Study|Progressive Disease|5|||
94219373|NCT00938041|322595089|FG000|Overall Study|Death|12|||
94219374|NCT00938041|322595089|FG000|Overall Study|Adrenal Insufficiency|3|||
94219375|NCT05104242|322595090|FG000|Overall Study|Withdrawal by Subject|1|||
94219376|NCT05104242|322595091|FG001|Overall Study|Withdrawal by Subject|5|||
94219377|NCT05104242|322595090|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
94219378|NCT05104242|322595091|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
94219379|NCT01864200|322595092|FG000|Overall Study|Lost to Follow-up|1|||
94219380|NCT01864200|322595093|FG001|Overall Study|Lost to Follow-up|3|||
94219381|NCT01864200|322595092|FG000|Overall Study|Protocol Violation|1|||
94219382|NCT01864200|322595093|FG001|Overall Study|Protocol Violation|0|||
94219383|NCT00753896|322595095|FG000|Overall Study|Adverse Event|4|||
94219384|NCT00753896|322595095|FG000|Overall Study|Death|1|||
94219385|NCT00753896|322595095|FG000|Overall Study|Lost to Follow-up|2|||
94219386|NCT00753896|322595095|FG000|Overall Study|Protocol Violation|1|||
94219387|NCT00753896|322595095|FG000|Overall Study|Withdrawal by Subject|4|||
94219388|NCT00753896|322595095|FG000|Overall Study|Entry Criteria Not Met|4|||
94219389|NCT05265247|322595097|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
94219390|NCT05265247|322595098|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
94219391|NCT05265247|322595097|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
94219392|NCT05265247|322595098|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
94219393|NCT05265247|322595097|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
94219394|NCT05265247|322595098|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
94219395|NCT02522299|322595099|FG000|Overall Study|Adverse Event|2|||
94219396|NCT02522299|322595100|FG001|Overall Study|Adverse Event|0|||
94219397|NCT02522299|322595099|FG000|Overall Study|Physician Decision|0|||
94219398|NCT02522299|322595100|FG001|Overall Study|Physician Decision|1|||
94219399|NCT02522299|322595099|FG000|Overall Study|Withdrawal by Subject|2|||
94219400|NCT02522299|322595100|FG001|Overall Study|Withdrawal by Subject|0|||
94219401|NCT04908800|322595105|FG000|Overall Study|Adverse Event|0|||
94219402|NCT04908800|322595106|FG001|Overall Study|Adverse Event|0|||
94219403|NCT04908800|322595107|FG002|Overall Study|Adverse Event|0|||
94219404|NCT04908800|322595108|FG003|Overall Study|Adverse Event|0|||
94219405|NCT04908800|322595109|FG004|Overall Study|Adverse Event|0|||
94219406|NCT04908800|322595110|FG005|Overall Study|Adverse Event|0|||
94219407|NCT04908800|322595111|FG006|Overall Study|Adverse Event|0|||
94219408|NCT04908800|322595112|FG007|Overall Study|Adverse Event|0|||
94219409|NCT04908800|322595113|FG008|Overall Study|Adverse Event|0|||
94219410|NCT04908800|322595114|FG009|Overall Study|Adverse Event|0|||
94219411|NCT04908800|322595115|FG010|Overall Study|Adverse Event|1|||
94219412|NCT04908800|322595116|FG011|Overall Study|Adverse Event|0|||
94219413|NCT04908800|322595117|FG012|Overall Study|Adverse Event|0|||
94219414|NCT00665392|322595118|FG000|Overall Study|not treated|1|||
94219415|NCT01426217|322595122|FG000|Overall Study|lost sample|8|||
94219416|NCT01426217|322595123|FG001|Overall Study|lost sample|14|||
94219417|NCT01536795|322595124|FG000|Overall Study|Lost to Follow-up|0|||
94219418|NCT01536795|322595125|FG001|Overall Study|Lost to Follow-up|2|||
94219419|NCT01536795|322595124|FG000|Overall Study|Lack of Efficacy|1|||
94219420|NCT01536795|322595125|FG001|Overall Study|Lack of Efficacy|0|||
94219421|NCT01812837|322595126|FG000|Overall Study|Lost to Follow-up|1|||
94219422|NCT01812837|322595127|FG001|Overall Study|Lost to Follow-up|1|||
94219423|NCT01812837|322595128|FG002|Overall Study|Lost to Follow-up|0|||
94219424|NCT01812837|322595126|FG000|Overall Study|Protocol Violation|1|||
94219425|NCT01812837|322595127|FG001|Overall Study|Protocol Violation|0|||
94219426|NCT01812837|322595128|FG002|Overall Study|Protocol Violation|0|||
94219427|NCT02510560|322595131|FG000|Overall Study|Discontinued from Treatment|27|||
94219428|NCT02510560|322595132|FG001|Overall Study|Discontinued from Treatment|18|||
94219429|NCT02510560|322595133|FG002|Overall Study|Discontinued from Treatment|19|||
94219430|NCT02510560|322595131|FG000|Overall Study|Other|4|||
94219431|NCT02510560|322595132|FG001|Overall Study|Other|4|||
94219432|NCT02510560|322595133|FG002|Overall Study|Other|3|||
94219433|NCT06312566|322595135|FG000|Overall Study|Protocol Violation|0|||
94219434|NCT06312566|322595136|FG001|Overall Study|Protocol Violation|1|||
94219435|NCT03747575|322595137|FG000|Overall Study|Withdrawal by Subject|6|||
94219436|NCT03747575|322595138|FG001|Overall Study|Withdrawal by Subject|3|||
94219437|NCT03747575|322595137|FG000|Overall Study|Lost to Follow-up|3|||
94219438|NCT03747575|322595138|FG001|Overall Study|Lost to Follow-up|3|||
94219439|NCT03747575|322595137|FG000|Overall Study|Adverse Event|0|||
94219440|NCT03747575|322595138|FG001|Overall Study|Adverse Event|1|||
94219441|NCT02130401|322595139|FG000|Overall Study|Poor enrollment|6|||
94219442|NCT03840148|322595140|FG000|Study Drug Disposition|Adverse Event|13|||
94219443|NCT03840148|322595141|FG001|Study Drug Disposition|Adverse Event|2|||
94219444|NCT03840148|322595140|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
94219445|NCT03840148|322595141|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
94219446|NCT03840148|322595140|FG000|Study Drug Disposition|Lack of Efficacy|3|||
94287148|NCT00763321|322840605|FG001|Double-blind Period|Adverse Event|4|||
94287149|NCT00763321|322840606|FG002|Double-blind Period|Adverse Event|4|||
94287150|NCT00763321|322840604|FG000|Double-blind Period|Lost to Follow-up|0|||
94287151|NCT00763321|322840605|FG001|Double-blind Period|Lost to Follow-up|4|||
94219447|NCT03840148|322595141|FG001|Study Drug Disposition|Lack of Efficacy|0|||
94219448|NCT03840148|322595140|FG000|Study Drug Disposition|Physician Decision|2|||
94219449|NCT03840148|322595141|FG001|Study Drug Disposition|Physician Decision|0|||
94219450|NCT03840148|322595140|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
94219451|NCT03840148|322595141|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
94219452|NCT03840148|322595140|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
94219453|NCT03840148|322595141|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
94219454|NCT03840148|322595140|FG000|Study Completion Disposition|Physician Decision|2|||
94219455|NCT03840148|322595141|FG001|Study Completion Disposition|Physician Decision|0|||
94219456|NCT03840148|322595140|FG000|Study Completion Disposition|Covid-19 related|2|||
94219457|NCT03840148|322595141|FG001|Study Completion Disposition|Covid-19 related|0|||
94287152|NCT00763321|322840606|FG002|Double-blind Period|Lost to Follow-up|2|||
94287153|NCT00763321|322840604|FG000|Double-blind Period|Withdrawal by Subject|0|||
94287154|NCT00763321|322840605|FG001|Double-blind Period|Withdrawal by Subject|2|||
94219458|NCT03840148|322595140|FG000|Study Completion Disposition|Lost to Follow-up|1|||
94219459|NCT03840148|322595141|FG001|Study Completion Disposition|Lost to Follow-up|1|||
94219460|NCT03840148|322595140|FG000|Study Completion Disposition|Death|1|||
94219461|NCT03840148|322595141|FG001|Study Completion Disposition|Death|0|||
94219462|NCT03840148|322595140|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
94219463|NCT03840148|322595141|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
94219464|NCT03615404|322595142|FG000|Overall Study|Death|1|||
94219465|NCT03615404|322595142|FG000|Overall Study|vaccine did not pass quality assurance|1|||
94219466|NCT04394624|322595146|FG000|Overall Study|Adverse Event|6|||
94219467|NCT04394624|322595147|FG001|Overall Study|Adverse Event|0|||
94219468|NCT04394624|322595146|FG000|Overall Study|Progressive disease|24|||
94219469|NCT04394624|322595147|FG001|Overall Study|Progressive disease|0|||
94219470|NCT04394624|322595146|FG000|Overall Study|Not related to COVID-19|1|||
94219471|NCT04394624|322595147|FG001|Overall Study|Not related to COVID-19|0|||
94219472|NCT00936065|322595148|FG000|Overall Study|Adverse Event|1|||
94219473|NCT00936065|322595149|FG001|Overall Study|Adverse Event|0|||
94219474|NCT00936065|322595150|FG002|Overall Study|Adverse Event|1|||
94219475|NCT00936065|322595148|FG000|Overall Study|Lack of Efficacy|1|||
94219476|NCT00936065|322595149|FG001|Overall Study|Lack of Efficacy|0|||
94219477|NCT00936065|322595150|FG002|Overall Study|Lack of Efficacy|1|||
94219478|NCT00936065|322595148|FG000|Overall Study|Lost to Follow-up|1|||
94219479|NCT00936065|322595149|FG001|Overall Study|Lost to Follow-up|0|||
94219480|NCT00936065|322595150|FG002|Overall Study|Lost to Follow-up|0|||
94219481|NCT00936065|322595148|FG000|Overall Study|Protocol Violation|1|||
94219482|NCT00936065|322595149|FG001|Overall Study|Protocol Violation|2|||
94219483|NCT00936065|322595150|FG002|Overall Study|Protocol Violation|1|||
94219484|NCT00936065|322595148|FG000|Overall Study|Withdrawal by Subject|0|||
94219485|NCT00936065|322595149|FG001|Overall Study|Withdrawal by Subject|2|||
94219486|NCT00936065|322595150|FG002|Overall Study|Withdrawal by Subject|4|||
94219487|NCT01774929|322595151|FG000|Overall Study|Adverse Event|3|||
94219488|NCT00747149|322596405|FG000|Overall Study|Adverse Event|0|||
94219489|NCT00747149|322596406|FG001|Overall Study|Adverse Event|15|||
94219490|NCT00747149|322596405|FG000|Overall Study|Lost to Follow-up|0|||
94219491|NCT00747149|322596406|FG001|Overall Study|Lost to Follow-up|10|||
94219492|NCT00747149|322596405|FG000|Overall Study|Withdrawal by Subject|0|||
94219493|NCT00747149|322596406|FG001|Overall Study|Withdrawal by Subject|6|||
94219494|NCT00747149|322596405|FG000|Overall Study|Did not receive treatment|0|||
94219495|NCT00747149|322596406|FG001|Overall Study|Did not receive treatment|1|||
94219496|NCT00747149|322596405|FG000|Overall Study|Incorrect enrollment|0|||
94219497|NCT00747149|322596406|FG001|Overall Study|Incorrect enrollment|6|||
94219498|NCT00747149|322596405|FG000|Overall Study|Severe non-compliance to protocol|0|||
94219499|NCT00747149|322596406|FG001|Overall Study|Severe non-compliance to protocol|1|||
94219500|NCT00747149|322596405|FG000|Overall Study|Not reported|1|||
94219501|NCT00747149|322596406|FG001|Overall Study|Not reported|4|||
94219502|NCT04369664|322596409|FG000|Overall Study|Physician Decision|1|||
94219503|NCT04369664|322596410|FG001|Overall Study|Physician Decision|0|||
94219504|NCT03072238|322596413|FG000|Overall Study|Withdrawal by Subject|44|||
94219505|NCT03072238|322596414|FG001|Overall Study|Withdrawal by Subject|64|||
94219506|NCT03072238|322596413|FG000|Overall Study|Lost to Follow-up|14|||
94219507|NCT03072238|322596414|FG001|Overall Study|Lost to Follow-up|5|||
94219508|NCT03072238|322596413|FG000|Overall Study|Physician Decision|4|||
94219509|NCT03072238|322596414|FG001|Overall Study|Physician Decision|6|||
94219510|NCT03072238|322596413|FG000|Overall Study|Death|351|||
94219511|NCT03072238|322596414|FG001|Overall Study|Death|318|||
94219512|NCT03072238|322596413|FG000|Overall Study|Progressive Disease|3|||
94219513|NCT03072238|322596414|FG001|Overall Study|Progressive Disease|4|||
94219514|NCT03072238|322596413|FG000|Overall Study|Reason Not Specified|138|||
94219515|NCT03072238|322596414|FG001|Overall Study|Reason Not Specified|150|||
94219516|NCT03924193|322596420|FG000|Overall Study|Adverse Event|10|||
94219517|NCT03924193|322596421|FG001|Overall Study|Adverse Event|0|||
94219518|NCT03924193|322596422|FG002|Overall Study|Adverse Event|10|||
94219519|NCT03924193|322596420|FG000|Overall Study|Withdrawal by Subject|5|||
94219520|NCT03924193|322596421|FG001|Overall Study|Withdrawal by Subject|10|||
94219521|NCT03924193|322596422|FG002|Overall Study|Withdrawal by Subject|2|||
94219522|NCT04049578|322596424|FG000|Overall Study|Physician Decision|1|||
94219523|NCT00304278|322596429|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
94219524|NCT00304278|322596429|FG000|Overall Study|PT had medical condition preventing TX|1|||
94219525|NCT03694210|322596431|FG000|Overall Study|Death|1|||
94219526|NCT03694210|322596431|FG000|Overall Study|Screen Failure|7|||
94219527|NCT03451292|322596434|FG000|Overall Study|Death|44|||
94219528|NCT03451292|322596435|FG001|Overall Study|Death|59|||
94219529|NCT03451292|322596434|FG000|Overall Study|Withdrawal by Subject|18|||
94219530|NCT03451292|322596435|FG001|Overall Study|Withdrawal by Subject|13|||
94219531|NCT03451292|322596434|FG000|Overall Study|Transplantation|18|||
94219532|NCT03451292|322596435|FG001|Overall Study|Transplantation|12|||
94219533|NCT03451292|322596434|FG000|Overall Study|Lost to Follow-up|4|||
94219534|NCT03451292|322596435|FG001|Overall Study|Lost to Follow-up|12|||
94219535|NCT03451292|322596434|FG000|Overall Study|Physician Decision|4|||
94219536|NCT03451292|322596435|FG001|Overall Study|Physician Decision|3|||
94219537|NCT03451292|322596434|FG000|Overall Study|Adverse Event|3|||
94219538|NCT03451292|322596435|FG001|Overall Study|Adverse Event|3|||
94219539|NCT03451292|322596434|FG000|Overall Study|Non-compliance with Study Drug|2|||
94219540|NCT03451292|322596435|FG001|Overall Study|Non-compliance with Study Drug|0|||
94219541|NCT03605745|322596436|FG000|Overall Study|Study was terminated for business reasons|47|||
94219542|NCT03960437|322596443|FG000|Overall Study|Removed by PI|4|||
94219543|NCT03960437|322596443|FG000|Overall Study|Lost to Follow-up|2|||
94219544|NCT03960437|322596443|FG000|Overall Study|Withdrawal by Subject|1|||
94219545|NCT03960437|322596443|FG000|Overall Study|Death|2|||
94219546|NCT03034772|322596445|FG000|Overall Study|Adverse Event|0|||
94219547|NCT03034772|322596446|FG001|Overall Study|Adverse Event|1|||
94219548|NCT03034772|322596445|FG000|Overall Study|Withdrawal by Subject|0|||
94219549|NCT03034772|322596446|FG001|Overall Study|Withdrawal by Subject|1|||
94219550|NCT01012999|322596447|FG000|Overall Study|Protocol Violation|1|||
94219551|NCT01136733|322596448|FG000|Phase 1b|Adverse Event|0|||
94219552|NCT01136733|322596449|FG001|Phase 1b|Adverse Event|3|||
94219553|NCT01136733|322596450|FG002|Phase 1b|Adverse Event|1|||
94219554|NCT01136733|322596451|FG003|Phase 1b|Adverse Event|0|||
94219555|NCT01136733|322596452|FG004|Phase 1b|Adverse Event|0|||
94219556|NCT01136733|322596453|FG005|Phase 1b|Adverse Event|0|||
94219557|NCT01136733|322596454|FG006|Phase 1b|Adverse Event|0|||
94219558|NCT01136733|322596448|FG000|Phase 1b|Participant Choice|0|||
94219559|NCT01136733|322596449|FG001|Phase 1b|Participant Choice|0|||
94219560|NCT01136733|322596450|FG002|Phase 1b|Participant Choice|1|||
94219561|NCT01136733|322596451|FG003|Phase 1b|Participant Choice|0|||
94219562|NCT01136733|322596452|FG004|Phase 1b|Participant Choice|0|||
94219563|NCT01136733|322596453|FG005|Phase 1b|Participant Choice|0|||
94219564|NCT01136733|322596454|FG006|Phase 1b|Participant Choice|0|||
94219565|NCT01136733|322596448|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
94219566|NCT01136733|322596449|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
94219567|NCT01136733|322596450|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
94219568|NCT01136733|322596451|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
94219569|NCT01136733|322596452|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
94219570|NCT01136733|322596453|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
94219571|NCT01136733|322596454|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
94219572|NCT01136733|322596448|FG000|Phase 1b|Clinical Progression|1|||
94219573|NCT01136733|322596449|FG001|Phase 1b|Clinical Progression|1|||
94219574|NCT01136733|322596450|FG002|Phase 1b|Clinical Progression|0|||
94219575|NCT01136733|322596451|FG003|Phase 1b|Clinical Progression|0|||
94219576|NCT01136733|322596452|FG004|Phase 1b|Clinical Progression|0|||
94219577|NCT01136733|322596453|FG005|Phase 1b|Clinical Progression|0|||
94219578|NCT01136733|322596454|FG006|Phase 1b|Clinical Progression|0|||
94219579|NCT01136733|322596448|FG000|Phase 2|Disease Progression|0|||
94219580|NCT01136733|322596449|FG001|Phase 2|Disease Progression|0|||
94219581|NCT01136733|322596450|FG002|Phase 2|Disease Progression|0|||
94219582|NCT01136733|322596451|FG003|Phase 2|Disease Progression|0|||
94219583|NCT01136733|322596452|FG004|Phase 2|Disease Progression|30|||
94219584|NCT01136733|322596453|FG005|Phase 2|Disease Progression|32|||
94219585|NCT01136733|322596454|FG006|Phase 2|Disease Progression|38|||
94219586|NCT01136733|322596448|FG000|Phase 2|Adverse Event|0|||
94219587|NCT01136733|322596449|FG001|Phase 2|Adverse Event|0|||
94287155|NCT00763321|322840606|FG002|Double-blind Period|Withdrawal by Subject|3|||
94287156|NCT00763321|322840604|FG000|Double-blind Period|Other|0|||
94287157|NCT00763321|322840605|FG001|Double-blind Period|Other|2|||
94287158|NCT00763321|322840606|FG002|Double-blind Period|Other|3|||
94287159|NCT03175549|322840607|FG000|Overall Study|Lost to Follow-up|2|||
94219588|NCT01136733|322596450|FG002|Phase 2|Adverse Event|0|||
94219589|NCT01136733|322596451|FG003|Phase 2|Adverse Event|0|||
94219590|NCT01136733|322596452|FG004|Phase 2|Adverse Event|11|||
94219591|NCT01136733|322596453|FG005|Phase 2|Adverse Event|13|||
94219592|NCT01136733|322596454|FG006|Phase 2|Adverse Event|5|||
94219593|NCT01136733|322596448|FG000|Phase 2|Participant Choice|0|||
94287160|NCT03175549|322840608|FG001|Overall Study|Lost to Follow-up|2|||
94287161|NCT03175549|322840607|FG000|Overall Study|Medication non-compliance|2|||
94219594|NCT01136733|322596449|FG001|Phase 2|Participant Choice|0|||
94219595|NCT01136733|322596450|FG002|Phase 2|Participant Choice|0|||
94219596|NCT01136733|322596451|FG003|Phase 2|Participant Choice|0|||
94219597|NCT01136733|322596452|FG004|Phase 2|Participant Choice|3|||
94219598|NCT01136733|322596453|FG005|Phase 2|Participant Choice|0|||
94219599|NCT01136733|322596454|FG006|Phase 2|Participant Choice|1|||
94219600|NCT01136733|322596448|FG000|Phase 2|Administrative-Withdrew Consent|0|||
94219601|NCT01136733|322596449|FG001|Phase 2|Administrative-Withdrew Consent|0|||
94219602|NCT01136733|322596450|FG002|Phase 2|Administrative-Withdrew Consent|0|||
94219603|NCT01136733|322596451|FG003|Phase 2|Administrative-Withdrew Consent|0|||
94219604|NCT01136733|322596452|FG004|Phase 2|Administrative-Withdrew Consent|1|||
94219605|NCT01136733|322596453|FG005|Phase 2|Administrative-Withdrew Consent|0|||
94287162|NCT03175549|322840608|FG001|Overall Study|Medication non-compliance|2|||
94287163|NCT02793232|322840609|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
94219606|NCT01136733|322596454|FG006|Phase 2|Administrative-Withdrew Consent|0|||
94219607|NCT01136733|322596448|FG000|Phase 2|Other|0|||
94219608|NCT01136733|322596449|FG001|Phase 2|Other|0|||
94219609|NCT01136733|322596450|FG002|Phase 2|Other|0|||
94219610|NCT01136733|322596451|FG003|Phase 2|Other|0|||
94219611|NCT01136733|322596452|FG004|Phase 2|Other|6|||
94219612|NCT01136733|322596453|FG005|Phase 2|Other|7|||
94219613|NCT01136733|322596454|FG006|Phase 2|Other|6|||
94219614|NCT01358175|322596457|FG000|Overall Study|Death|1|||
94219615|NCT01358175|322596458|FG001|Overall Study|Death|0|||
94219616|NCT01358175|322596459|FG002|Overall Study|Death|1|||
94219617|NCT01358175|322596457|FG000|Overall Study|Withdrawal by Subject|9|||
94219618|NCT01358175|322596458|FG001|Overall Study|Withdrawal by Subject|5|||
94219619|NCT01358175|322596459|FG002|Overall Study|Withdrawal by Subject|10|||
94219620|NCT01358175|322596457|FG000|Overall Study|Technical issues|0|||
94219621|NCT01358175|322596458|FG001|Overall Study|Technical issues|1|||
94219622|NCT01358175|322596459|FG002|Overall Study|Technical issues|0|||
94219623|NCT01358175|322596457|FG000|Overall Study|Pregnancy|0|||
94219624|NCT01358175|322596458|FG001|Overall Study|Pregnancy|1|||
94219625|NCT01358175|322596459|FG002|Overall Study|Pregnancy|0|||
94219626|NCT01358175|322596457|FG000|Overall Study|Physician Decision|1|||
94219627|NCT01358175|322596458|FG001|Overall Study|Physician Decision|0|||
94219628|NCT01358175|322596459|FG002|Overall Study|Physician Decision|0|||
94219629|NCT01358175|322596457|FG000|Overall Study|Non Compliance with Study Treatment|0|||
94219630|NCT01358175|322596458|FG001|Overall Study|Non Compliance with Study Treatment|1|||
94219631|NCT01358175|322596459|FG002|Overall Study|Non Compliance with Study Treatment|1|||
94219632|NCT01358175|322596457|FG000|Overall Study|Lost to Follow-up|1|||
94219633|NCT01358175|322596458|FG001|Overall Study|Lost to Follow-up|1|||
94219634|NCT01358175|322596459|FG002|Overall Study|Lost to Follow-up|3|||
94219635|NCT01358175|322596457|FG000|Overall Study|Lack of Efficacy|3|||
94219636|NCT01358175|322596458|FG001|Overall Study|Lack of Efficacy|8|||
94219637|NCT01358175|322596459|FG002|Overall Study|Lack of Efficacy|6|||
94219638|NCT01358175|322596457|FG000|Overall Study|Adverse Event|6|||
94219639|NCT01358175|322596458|FG001|Overall Study|Adverse Event|11|||
94219640|NCT01358175|322596459|FG002|Overall Study|Adverse Event|11|||
94219641|NCT01106586|322596460|FG000|Overall Study|Adverse Event|9|||
94219642|NCT01106586|322596461|FG001|Overall Study|Adverse Event|15|||
94219643|NCT01106586|322596460|FG000|Overall Study|Death|1|||
94219644|NCT01106586|322596461|FG001|Overall Study|Death|3|||
94219645|NCT01106586|322596460|FG000|Overall Study|Pregnancy|2|||
94219646|NCT01106586|322596461|FG001|Overall Study|Pregnancy|2|||
94219647|NCT01106586|322596460|FG000|Overall Study|Lack of Efficacy|1|||
94219648|NCT01106586|322596461|FG001|Overall Study|Lack of Efficacy|0|||
94219649|NCT01106586|322596460|FG000|Overall Study|Investigator's Discretion|5|||
94219650|NCT01106586|322596461|FG001|Overall Study|Investigator's Discretion|8|||
94219651|NCT01106586|322596460|FG000|Overall Study|Withdrew Consent|18|||
94219652|NCT01106586|322596461|FG001|Overall Study|Withdrew Consent|30|||
94219653|NCT01106586|322596460|FG000|Overall Study|Lost to Follow-up|24|||
94219654|NCT01106586|322596461|FG001|Overall Study|Lost to Follow-up|20|||
94219655|NCT01106586|322596460|FG000|Overall Study|Participant Noncompliance|12|||
94219656|NCT01106586|322596461|FG001|Overall Study|Participant Noncompliance|10|||
94219657|NCT01106586|322596460|FG000|Overall Study|Protocol Violation|1|||
94219658|NCT01106586|322596461|FG001|Overall Study|Protocol Violation|0|||
94219659|NCT01106586|322596460|FG000|Overall Study|Participant Transferred to Another Study|212|||
94219660|NCT01106586|322596461|FG001|Overall Study|Participant Transferred to Another Study|197|||
94219661|NCT03647709|322596468|FG000|Overall Study|Lost to Follow-up|5|||
94219662|NCT03647709|322596468|FG000|Overall Study|Physician Decision|6|||
94219663|NCT03647709|322596468|FG000|Overall Study|Withdrawal by Subject|3|||
94219664|NCT01721109|322596471|FG000|Overall Study|Lack of Efficacy|1|||
94219665|NCT01721109|322596471|FG000|Overall Study|Non- Compliance with Study Drug|3|||
94219666|NCT01721109|322596471|FG000|Overall Study|Withdrew Consent|1|||
94219667|NCT01721109|322596471|FG000|Overall Study|Lost to Follow-up|2|||
94219668|NCT05008224|322596472|FG000|Overall Study|Death|3|||
94219669|NCT05008224|322596472|FG000|Overall Study|Lost to Follow-up|2|||
94219670|NCT05008224|322596472|FG000|Overall Study|Did Not Continue on Extension Study|39|||
94219671|NCT05008224|322596472|FG000|Overall Study|Transferred to Extension Study|100|||
94219672|NCT05008224|322596472|FG000|Overall Study|Withdrawal by Subject|2|||
94219673|NCT03504397|322596473|FG000|Overall Study|Progressive Disease|151|||
94219674|NCT03504397|322596474|FG001|Overall Study|Progressive Disease|199|||
94219675|NCT03504397|322596473|FG000|Overall Study|Withdrawal by Subject|29|||
94219676|NCT03504397|322596474|FG001|Overall Study|Withdrawal by Subject|17|||
94219677|NCT03504397|322596473|FG000|Overall Study|Lost to Follow-up|1|||
94219678|NCT03504397|322596474|FG001|Overall Study|Lost to Follow-up|0|||
94219679|NCT03504397|322596473|FG000|Overall Study|Death|14|||
94219680|NCT03504397|322596474|FG001|Overall Study|Death|16|||
94219681|NCT03504397|322596473|FG000|Overall Study|Adverse Event|40|||
94219682|NCT03504397|322596474|FG001|Overall Study|Adverse Event|14|||
94219683|NCT03504397|322596473|FG000|Overall Study|miscellaneous|17|||
94219684|NCT03504397|322596474|FG001|Overall Study|miscellaneous|15|||
94219685|NCT03504397|322596473|FG000|Overall Study|Protocol deviation|1|||
94219686|NCT03504397|322596474|FG001|Overall Study|Protocol deviation|0|||
94219687|NCT03504397|322596473|FG000|Overall Study|Participants who did not take the study drug|4|||
94219688|NCT03504397|322596474|FG001|Overall Study|Participants who did not take the study drug|4|||
94219689|NCT05234632|322596475|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
94219690|NCT05234632|322596476|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
94219691|NCT05234632|322596475|FG000|Overall Study|Withdrawal by Subject|2|||
94219692|NCT05234632|322596476|FG001|Overall Study|Withdrawal by Subject|0|||
94219693|NCT05234632|322596475|FG000|Overall Study|Adverse Event|0|||
94219694|NCT05234632|322596476|FG001|Overall Study|Adverse Event|4|||
94219695|NCT05234632|322596475|FG000|Overall Study|Physician Decision|1|||
94219696|NCT05234632|322596476|FG001|Overall Study|Physician Decision|1|||
94219697|NCT05234632|322596475|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
94219698|NCT05234632|322596476|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
94219699|NCT05234632|322596475|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
94219700|NCT05234632|322596476|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
94219701|NCT01699178|322596479|FG000|Overall Study|Adverse Event|1|||
94219702|NCT01699178|322596480|FG001|Overall Study|Adverse Event|5|||
94219703|NCT01699178|322596479|FG000|Overall Study|Lost to Follow-up|1|||
94219704|NCT01699178|322596480|FG001|Overall Study|Lost to Follow-up|6|||
94219705|NCT01699178|322596479|FG000|Overall Study|Non-compliance with Study Drug|3|||
94219706|NCT01699178|322596480|FG001|Overall Study|Non-compliance with Study Drug|1|||
94219707|NCT01699178|322596479|FG000|Overall Study|Physician Decision|1|||
94219708|NCT01699178|322596480|FG001|Overall Study|Physician Decision|0|||
94219709|NCT01699178|322596479|FG000|Overall Study|Withdrawal by Subject|4|||
94219710|NCT01699178|322596480|FG001|Overall Study|Withdrawal by Subject|12|||
94219711|NCT01699178|322596479|FG000|Overall Study|Hematocrit >54%|1|||
94219712|NCT01699178|322596480|FG001|Overall Study|Hematocrit >54%|1|||
94219713|NCT01699178|322596479|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
94219714|NCT01699178|322596480|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
94219715|NCT01699178|322596479|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
94219716|NCT01699178|322596480|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
94219717|NCT03305458|322596482|FG000|Overall Study|Withdrawal by Subject|50|||
94219718|NCT03305458|322596483|FG001|Overall Study|Withdrawal by Subject|46|||
94219719|NCT03305458|322596484|FG002|Overall Study|Withdrawal by Subject|93|||
94219720|NCT03305458|322596482|FG000|Overall Study|Lost to Follow-up|85|||
94219721|NCT03305458|322596483|FG001|Overall Study|Lost to Follow-up|85|||
94219722|NCT03305458|322596484|FG002|Overall Study|Lost to Follow-up|35|||
94219723|NCT02332824|322596487|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
94219724|NCT02332824|322596488|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
94219725|NCT02332824|322596489|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
94219726|NCT02332824|322596490|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
94219727|NCT02332824|322596491|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
94219728|NCT02332824|322596492|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
94219729|NCT02332824|322596487|FG000|Overall Study|Voluntary Withdrawal|1|||
94219730|NCT02332824|322596488|FG001|Overall Study|Voluntary Withdrawal|0|||
94219731|NCT02332824|322596489|FG002|Overall Study|Voluntary Withdrawal|0|||
94219732|NCT02332824|322596490|FG003|Overall Study|Voluntary Withdrawal|0|||
94219733|NCT02332824|322596491|FG004|Overall Study|Voluntary Withdrawal|0|||
94219734|NCT02332824|322596492|FG005|Overall Study|Voluntary Withdrawal|0|||
94219735|NCT02332824|322596487|FG000|Overall Study|Inconvenient schedule|1|||
94219736|NCT02332824|322596488|FG001|Overall Study|Inconvenient schedule|1|||
94219737|NCT02332824|322596489|FG002|Overall Study|Inconvenient schedule|0|||
94219738|NCT02332824|322596490|FG003|Overall Study|Inconvenient schedule|0|||
94219739|NCT02332824|322596491|FG004|Overall Study|Inconvenient schedule|0|||
94219740|NCT02332824|322596492|FG005|Overall Study|Inconvenient schedule|0|||
94219741|NCT02332824|322596487|FG000|Overall Study|Transfer|0|||
94219742|NCT02332824|322596488|FG001|Overall Study|Transfer|0|||
94219743|NCT02332824|322596489|FG002|Overall Study|Transfer|1|||
94219744|NCT02332824|322596490|FG003|Overall Study|Transfer|1|||
94219745|NCT02332824|322596491|FG004|Overall Study|Transfer|0|||
94219746|NCT02332824|322596492|FG005|Overall Study|Transfer|0|||
94219747|NCT00440037|322596493|FG000|Overall Study|Withdrawal by Subject|6|||
94219748|NCT00440037|322596493|FG000|Overall Study|Administrative decision|3|||
94219749|NCT03928821|322596494|FG000|Overall Study|Death|0|||
94219750|NCT03928821|322596495|FG001|Overall Study|Death|1|||
94219751|NCT03928821|322596496|FG002|Overall Study|Death|0|||
94219752|NCT03928821|322596497|FG003|Overall Study|Death|0|||
94219753|NCT03928821|322596494|FG000|Overall Study|Lost to Follow-up|0|||
94219754|NCT03928821|322596495|FG001|Overall Study|Lost to Follow-up|2|||
94219755|NCT03928821|322596496|FG002|Overall Study|Lost to Follow-up|3|||
94219756|NCT03928821|322596497|FG003|Overall Study|Lost to Follow-up|0|||
94219757|NCT03928821|322596494|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
94219758|NCT03928821|322596495|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
94219759|NCT03928821|322596496|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
94219760|NCT03928821|322596497|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
94219761|NCT00321672|322596500|FG000|Overall Study|Withdrawal by Subject|5|||
94219762|NCT00321672|322596501|FG001|Overall Study|Withdrawal by Subject|1|||
94219763|NCT00321672|322596502|FG002|Overall Study|Withdrawal by Subject|2|||
94219764|NCT00321672|322596503|FG003|Overall Study|Withdrawal by Subject|0|||
94219765|NCT00321672|322596500|FG000|Overall Study|Noncompliance|1|||
94219766|NCT00321672|322596501|FG001|Overall Study|Noncompliance|2|||
94219767|NCT00321672|322596502|FG002|Overall Study|Noncompliance|1|||
94219768|NCT00321672|322596503|FG003|Overall Study|Noncompliance|0|||
94219769|NCT00321672|322596500|FG000|Overall Study|Adverse Event|1|||
94219770|NCT00321672|322596501|FG001|Overall Study|Adverse Event|1|||
94219771|NCT00321672|322596502|FG002|Overall Study|Adverse Event|0|||
94219772|NCT00321672|322596503|FG003|Overall Study|Adverse Event|0|||
94219773|NCT00321672|322596500|FG000|Overall Study|Lack of Efficacy|1|||
94219774|NCT00321672|322596501|FG001|Overall Study|Lack of Efficacy|1|||
94219775|NCT00321672|322596502|FG002|Overall Study|Lack of Efficacy|0|||
94219776|NCT00321672|322596503|FG003|Overall Study|Lack of Efficacy|0|||
94219777|NCT00321672|322596500|FG000|Overall Study|Lost to Follow-up|2|||
94219778|NCT00321672|322596501|FG001|Overall Study|Lost to Follow-up|0|||
94219779|NCT00321672|322596502|FG002|Overall Study|Lost to Follow-up|4|||
94219780|NCT00321672|322596503|FG003|Overall Study|Lost to Follow-up|2|||
94219781|NCT00321672|322596500|FG000|Overall Study|Death|1|||
94219782|NCT00321672|322596501|FG001|Overall Study|Death|0|||
94219783|NCT00321672|322596502|FG002|Overall Study|Death|0|||
94219784|NCT00321672|322596503|FG003|Overall Study|Death|0|||
94219785|NCT00321672|322596500|FG000|Overall Study|Too far to travel for visits|1|||
94219786|NCT00321672|322596501|FG001|Overall Study|Too far to travel for visits|0|||
94219787|NCT00321672|322596502|FG002|Overall Study|Too far to travel for visits|0|||
94219788|NCT00321672|322596503|FG003|Overall Study|Too far to travel for visits|0|||
94219789|NCT00321672|322596500|FG000|Overall Study|Incarcerated|0|||
94219790|NCT00321672|322596501|FG001|Overall Study|Incarcerated|0|||
94219791|NCT00321672|322596502|FG002|Overall Study|Incarcerated|2|||
94219792|NCT00321672|322596503|FG003|Overall Study|Incarcerated|0|||
94219793|NCT00321672|322596500|FG000|Overall Study|Moved out of state|0|||
94219794|NCT00321672|322596501|FG001|Overall Study|Moved out of state|1|||
94219795|NCT00321672|322596502|FG002|Overall Study|Moved out of state|1|||
94219796|NCT00321672|322596503|FG003|Overall Study|Moved out of state|0|||
94219797|NCT00321672|322596500|FG000|Overall Study|Protocol Violation|0|||
94219798|NCT00321672|322596501|FG001|Overall Study|Protocol Violation|0|||
94219799|NCT00321672|322596502|FG002|Overall Study|Protocol Violation|1|||
94219800|NCT00321672|322596503|FG003|Overall Study|Protocol Violation|0|||
94219801|NCT00321672|322596500|FG000|Overall Study|Diagnosis of testicular cancer|0|||
94219802|NCT00321672|322596501|FG001|Overall Study|Diagnosis of testicular cancer|1|||
94219803|NCT00321672|322596502|FG002|Overall Study|Diagnosis of testicular cancer|0|||
94219804|NCT00321672|322596503|FG003|Overall Study|Diagnosis of testicular cancer|0|||
94219805|NCT00321672|322596500|FG000|Overall Study|Extensive travel required for new job|0|||
94219806|NCT00321672|322596501|FG001|Overall Study|Extensive travel required for new job|1|||
94219807|NCT00321672|322596502|FG002|Overall Study|Extensive travel required for new job|0|||
94219808|NCT00321672|322596503|FG003|Overall Study|Extensive travel required for new job|0|||
94219809|NCT00448344|322596504|FG000|Overall Study|Lost to Follow-up|20|||
94219810|NCT00448344|322596505|FG001|Overall Study|Lost to Follow-up|22|||
94219811|NCT00448344|322596504|FG000|Overall Study|Withdrawal by Subject|6|||
94219812|NCT00448344|322596505|FG001|Overall Study|Withdrawal by Subject|8|||
94219813|NCT00448344|322596504|FG000|Overall Study|Death|3|||
94219814|NCT00448344|322596505|FG001|Overall Study|Death|4|||
94287164|NCT02793232|322840610|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
94287165|NCT02793232|322840611|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
94287166|NCT02793232|322840612|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
94287167|NCT02793232|322840613|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
94287168|NCT02793232|322840614|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
94287169|NCT02793232|322840615|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
94287170|NCT02793232|322840616|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
94219815|NCT00448344|322596504|FG000|Overall Study|Physician Decision|1|||
94219816|NCT00448344|322596505|FG001|Overall Study|Physician Decision|2|||
94219817|NCT00525915|322596506|FG000|Overall Study|Non-Compliance|0|||
94219818|NCT00525915|322596507|FG001|Overall Study|Non-Compliance|1|||
94219819|NCT00525915|322596506|FG000|Overall Study|Disease Progression|5|||
94219820|NCT00525915|322596507|FG001|Overall Study|Disease Progression|6|||
94287171|NCT02793232|322840617|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
94372487|NCT01964105|323150270|FG000|Overall Study|Lost to Follow-up|2|||
94219821|NCT00525915|322596506|FG000|Overall Study|Withdrawal by Subject|1|||
94219822|NCT00525915|322596507|FG001|Overall Study|Withdrawal by Subject|0|||
94219823|NCT00525915|322596506|FG000|Overall Study|Refused Surgery|1|||
94372488|NCT01964105|323150271|FG001|Overall Study|Lost to Follow-up|13|||
94219824|NCT00525915|322596507|FG001|Overall Study|Refused Surgery|2|||
94219825|NCT00525915|322596506|FG000|Overall Study|Unrelated illness|1|||
94219826|NCT00525915|322596507|FG001|Overall Study|Unrelated illness|0|||
94219827|NCT02577315|322596508|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
94372489|NCT01964105|323150272|FG002|Overall Study|Lost to Follow-up|0|||
94219828|NCT02577315|322596509|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
94219829|NCT01945086|322596514|FG000|Overall Study|Withdrawal by Subject|1|||
94219830|NCT01945086|322596515|FG001|Overall Study|Withdrawal by Subject|0|||
94219831|NCT01945086|322596516|FG002|Overall Study|Withdrawal by Subject|1|||
94219832|NCT01945086|322596514|FG000|Overall Study|Adverse Event|0|||
94219833|NCT01945086|322596515|FG001|Overall Study|Adverse Event|0|||
94219834|NCT01945086|322596516|FG002|Overall Study|Adverse Event|1|||
94219835|NCT04212299|322596517|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
94219836|NCT04341584|322596520|FG000|Overall Study|Withdrew consent|0|||
94219837|NCT04341584|322596521|FG001|Overall Study|Withdrew consent|2|||
94219838|NCT04341584|322596522|FG002|Overall Study|Withdrew consent|2|||
94219839|NCT04341584|322596523|FG003|Overall Study|Withdrew consent|1|||
94219840|NCT04523571|322597500|FG000|Received 2 Doses|Withdrawal by Subject|0|||
94219841|NCT04523571|322597501|FG001|Received 2 Doses|Withdrawal by Subject|0|||
94219842|NCT04523571|322597502|FG002|Received 2 Doses|Withdrawal by Subject|0|||
94219843|NCT04523571|322597503|FG003|Received 2 Doses|Withdrawal by Subject|1|||
94219844|NCT04523571|322597504|FG004|Received 2 Doses|Withdrawal by Subject|1|||
94219845|NCT04523571|322597505|FG005|Received 2 Doses|Withdrawal by Subject|0|||
94219846|NCT04523571|322597500|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
94219847|NCT04523571|322597501|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
94219848|NCT04523571|322597502|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
94219849|NCT04523571|322597503|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
94219850|NCT04523571|322597504|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
94219851|NCT04523571|322597505|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
94219852|NCT04523571|322597500|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
94219853|NCT04523571|322597501|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
94219854|NCT04523571|322597502|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
94219855|NCT04523571|322597503|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
94219856|NCT04523571|322597504|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
94219857|NCT04523571|322597505|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
94219858|NCT04523571|322597500|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
94219859|NCT04523571|322597501|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
94219860|NCT04523571|322597502|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
94219861|NCT04523571|322597503|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
94219862|NCT04523571|322597504|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
94219863|NCT04523571|322597505|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
94219864|NCT03602053|322597509|FG000|Overall Study|Withdrawal by Subject|7|||
94219865|NCT03602053|322597510|FG001|Overall Study|Withdrawal by Subject|9|||
94219866|NCT03602053|322597511|FG002|Overall Study|Withdrawal by Subject|7|||
94219867|NCT03602053|322597509|FG000|Overall Study|Lost to Follow-up|5|||
94219868|NCT03602053|322597510|FG001|Overall Study|Lost to Follow-up|6|||
94219869|NCT03602053|322597511|FG002|Overall Study|Lost to Follow-up|0|||
94219870|NCT03602053|322597509|FG000|Overall Study|Protocol Violation|3|||
94219871|NCT03602053|322597510|FG001|Overall Study|Protocol Violation|0|||
94219872|NCT03602053|322597511|FG002|Overall Study|Protocol Violation|4|||
94219873|NCT03602053|322597509|FG000|Overall Study|Physician Decision|1|||
94219874|NCT03602053|322597510|FG001|Overall Study|Physician Decision|0|||
94219875|NCT03602053|322597511|FG002|Overall Study|Physician Decision|0|||
94219876|NCT03602053|322597509|FG000|Overall Study|migration|2|||
94219877|NCT03602053|322597510|FG001|Overall Study|migration|3|||
94219878|NCT03602053|322597511|FG002|Overall Study|migration|0|||
94219879|NCT03602053|322597509|FG000|Overall Study|Other|1|||
94219880|NCT03602053|322597510|FG001|Overall Study|Other|0|||
94219881|NCT03602053|322597511|FG002|Overall Study|Other|0|||
94287172|NCT04673786|322840618|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
94287173|NCT04673786|322840619|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
94287174|NCT04673786|322840620|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
94287175|NCT04673786|322840618|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
94287176|NCT04673786|322840619|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
94287177|NCT04673786|322840620|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
94287178|NCT04673786|322840618|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
94287179|NCT04673786|322840619|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
94287180|NCT04673786|322840620|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
94219882|NCT01807234|322597512|FG000|Overall Study|Lost to Follow-up|2|||
94219883|NCT01807234|322597513|FG001|Overall Study|Lost to Follow-up|5|||
94219884|NCT01807234|322597514|FG002|Overall Study|Lost to Follow-up|1|||
94287181|NCT04673786|322840618|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
94219885|NCT01807234|322597515|FG003|Overall Study|Lost to Follow-up|1|||
94219886|NCT01807234|322597516|FG004|Overall Study|Lost to Follow-up|1|||
94219887|NCT01807234|322597517|FG005|Overall Study|Lost to Follow-up|2|||
94287182|NCT04673786|322840619|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
94219888|NCT01807234|322597512|FG000|Overall Study|Withdrawal by Subject|3|||
94219889|NCT01807234|322597513|FG001|Overall Study|Withdrawal by Subject|1|||
94219890|NCT01807234|322597514|FG002|Overall Study|Withdrawal by Subject|1|||
94219891|NCT01807234|322597515|FG003|Overall Study|Withdrawal by Subject|1|||
94219892|NCT01807234|322597516|FG004|Overall Study|Withdrawal by Subject|2|||
94219893|NCT01807234|322597517|FG005|Overall Study|Withdrawal by Subject|1|||
94219894|NCT01807234|322597512|FG000|Overall Study|Lack of Efficacy|0|||
94219895|NCT01807234|322597513|FG001|Overall Study|Lack of Efficacy|0|||
94219896|NCT01807234|322597514|FG002|Overall Study|Lack of Efficacy|0|||
94219897|NCT01807234|322597515|FG003|Overall Study|Lack of Efficacy|0|||
94219898|NCT01807234|322597516|FG004|Overall Study|Lack of Efficacy|1|||
94219899|NCT01807234|322597517|FG005|Overall Study|Lack of Efficacy|1|||
94219900|NCT01090076|322597523|FG000|Overall Study|Death|1|||
94219901|NCT01090076|322597524|FG001|Overall Study|Death|1|||
94219902|NCT01090076|322597523|FG000|Overall Study|Withdrawal by Subject|0|||
94219903|NCT01090076|322597524|FG001|Overall Study|Withdrawal by Subject|1|||
94219904|NCT01636258|322597529|FG000|Overall Study|Lost to Follow-up|1|||
94219905|NCT01636258|322597530|FG001|Overall Study|Lost to Follow-up|0|||
94219906|NCT01469819|322597554|FG000|Overall Study|Withdrawal by Subject|1|||
94219907|NCT01469819|322597554|FG000|Overall Study|Did not meet inclusionary criteria|2|||
94219908|NCT01469819|322597554|FG000|Overall Study|Could not swallow SmartPill|2|||
94219909|NCT01469819|322597554|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
94219910|NCT03481725|322597555|FG000|Overall Study|Withdrawal by Subject|1|||
94219911|NCT03481725|322597556|FG001|Overall Study|Withdrawal by Subject|0|||
94219912|NCT05072795|322597559|FG000|Overall Study|Lost to Follow-up|5|||
94219913|NCT05274906|322597568|FG000|Overall Study|Withdrawal by Subject|2|||
94219914|NCT05274906|322597569|FG001|Overall Study|Withdrawal by Subject|1|||
94219915|NCT04474691|322597570|FG000|Overall Study|Withdrawal by Subject|9|||
94219916|NCT00850993|322597571|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
94219917|NCT00850993|322597572|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
94219918|NCT00850993|322597573|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
94219919|NCT00850993|322597574|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
94219920|NCT04799587|322597575|FG000|Overall Study|Withdrawal by Subject|0|||
94219921|NCT04799587|322597576|FG001|Overall Study|Withdrawal by Subject|1|||
94219922|NCT04736472|322597577|FG000|Overall Study|Lost to Follow-up|1|||
94219923|NCT04736472|322597578|FG001|Overall Study|Lost to Follow-up|0|||
94219924|NCT04736472|322597579|FG002|Overall Study|Lost to Follow-up|0|||
94219925|NCT04736472|322597577|FG000|Overall Study|Withdrawal by Subject|2|||
94219926|NCT04736472|322597578|FG001|Overall Study|Withdrawal by Subject|0|||
94219927|NCT04736472|322597579|FG002|Overall Study|Withdrawal by Subject|0|||
94219928|NCT04736472|322597577|FG000|Overall Study|Protocol Violation|48|||
94219929|NCT04736472|322597578|FG001|Overall Study|Protocol Violation|0|||
94219930|NCT04736472|322597579|FG002|Overall Study|Protocol Violation|6|||
94219931|NCT03003962|322597580|FG000|Overall Study|Withdrawal by Subject|5|||
94219932|NCT03003962|322597581|FG001|Overall Study|Withdrawal by Subject|17|||
94219933|NCT03003962|322597580|FG000|Overall Study|Death|274|||
94219934|NCT03003962|322597581|FG001|Overall Study|Death|277|||
94219935|NCT03003962|322597580|FG000|Overall Study|Participants ongoing at DCO|55|||
94219936|NCT03003962|322597581|FG001|Overall Study|Participants ongoing at DCO|40|||
94219937|NCT02252172|322597582|FG000|Overall Study|Lost to Follow-up|3|||
94219938|NCT02252172|322597583|FG001|Overall Study|Lost to Follow-up|1|||
94219939|NCT02252172|322597582|FG000|Overall Study|Ongoing|276|||
94219940|NCT02252172|322597583|FG001|Overall Study|Ongoing|298|||
94219941|NCT05061693|322597584|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
94219942|NCT05061693|322597585|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
94219943|NCT05061693|322597586|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
94219944|NCT05061693|322597587|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
94219945|NCT05061693|322597588|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
94219946|NCT05061693|322597589|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
94219947|NCT05061693|322597590|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
94219948|NCT05061693|322597591|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
94219949|NCT05061693|322597592|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
94219950|NCT05061693|322597593|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
94219951|NCT05061693|322597594|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
94219952|NCT05061693|322597595|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
94219953|NCT05061693|322597584|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
94219954|NCT05061693|322597585|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
94219955|NCT05061693|322597586|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
94219956|NCT05061693|322597587|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
94219957|NCT05061693|322597588|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
94219958|NCT05061693|322597589|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
94219959|NCT05061693|322597590|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
94219960|NCT05061693|322597591|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
94219961|NCT05061693|322597592|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
94219962|NCT05061693|322597593|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
94219963|NCT05061693|322597594|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
94219964|NCT05061693|322597595|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
94219965|NCT05061693|322597584|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
94219966|NCT05061693|322597585|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
94219967|NCT05061693|322597586|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
94219968|NCT05061693|322597587|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
94219969|NCT05061693|322597588|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
94219970|NCT05061693|322597589|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
94219971|NCT05061693|322597590|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
94219972|NCT05061693|322597591|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
94219973|NCT05061693|322597592|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
94219974|NCT05061693|322597593|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
94219975|NCT05061693|322597594|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
94219976|NCT05061693|322597595|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
94219977|NCT05061693|322597584|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
94219978|NCT05061693|322597585|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
94219979|NCT05061693|322597586|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
94219980|NCT05061693|322597587|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
94219981|NCT05061693|322597588|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
94219982|NCT05061693|322597589|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
94219983|NCT05061693|322597590|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
94219984|NCT05061693|322597591|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
94219985|NCT05061693|322597592|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
94219986|NCT05061693|322597593|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
94219987|NCT05061693|322597594|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
94219988|NCT05061693|322597595|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
94219989|NCT05061693|322597584|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
94219990|NCT05061693|322597585|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
94219991|NCT05061693|322597586|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
94219992|NCT05061693|322597587|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
94219993|NCT05061693|322597588|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
94219994|NCT05061693|322597589|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
94219995|NCT05061693|322597590|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
94219996|NCT05061693|322597591|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
94219997|NCT05061693|322597592|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
94219998|NCT05061693|322597593|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
94219999|NCT05061693|322597594|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
94220000|NCT05061693|322597595|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
94220001|NCT05061693|322597584|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
94220002|NCT05061693|322597585|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
94220003|NCT05061693|322597586|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
94220004|NCT05061693|322597587|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
94220005|NCT05061693|322597588|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
94220006|NCT05061693|322597589|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
94220007|NCT05061693|322597590|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
94220008|NCT05061693|322597591|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
94220009|NCT05061693|322597592|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
94220010|NCT05061693|322597593|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
94220011|NCT05061693|322597594|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
94220012|NCT05061693|322597595|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
94220013|NCT05061693|322597584|FG000|24-week Extension Period|Adverse Event|0|||
94220014|NCT05061693|322597585|FG001|24-week Extension Period|Adverse Event|0|||
94220015|NCT05061693|322597586|FG002|24-week Extension Period|Adverse Event|0|||
94220016|NCT05061693|322597587|FG003|24-week Extension Period|Adverse Event|0|||
94220017|NCT05061693|322597588|FG004|24-week Extension Period|Adverse Event|0|||
94220018|NCT05061693|322597589|FG005|24-week Extension Period|Adverse Event|0|||
94220019|NCT05061693|322597590|FG006|24-week Extension Period|Adverse Event|0|||
94220020|NCT05061693|322597591|FG007|24-week Extension Period|Adverse Event|2|||
94220021|NCT05061693|322597592|FG008|24-week Extension Period|Adverse Event|2|||
94220022|NCT05061693|322597593|FG009|24-week Extension Period|Adverse Event|0|||
94220023|NCT05061693|322597594|FG010|24-week Extension Period|Adverse Event|1|||
94220024|NCT05061693|322597595|FG011|24-week Extension Period|Adverse Event|3|||
94220025|NCT05061693|322597584|FG000|24-week Extension Period|Lack of Efficacy|0|||
94220026|NCT05061693|322597585|FG001|24-week Extension Period|Lack of Efficacy|0|||
94220027|NCT05061693|322597586|FG002|24-week Extension Period|Lack of Efficacy|0|||
94372490|NCT02746705|323150273|FG000|Overall Study|Physician Decision|1|||
94287183|NCT04673786|322840620|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
94220028|NCT05061693|322597587|FG003|24-week Extension Period|Lack of Efficacy|0|||
94220029|NCT05061693|322597588|FG004|24-week Extension Period|Lack of Efficacy|0|||
94220030|NCT05061693|322597589|FG005|24-week Extension Period|Lack of Efficacy|0|||
94220031|NCT05061693|322597590|FG006|24-week Extension Period|Lack of Efficacy|0|||
94220032|NCT05061693|322597591|FG007|24-week Extension Period|Lack of Efficacy|0|||
94220033|NCT05061693|322597592|FG008|24-week Extension Period|Lack of Efficacy|0|||
94220034|NCT05061693|322597593|FG009|24-week Extension Period|Lack of Efficacy|0|||
94220035|NCT05061693|322597594|FG010|24-week Extension Period|Lack of Efficacy|2|||
94220036|NCT05061693|322597595|FG011|24-week Extension Period|Lack of Efficacy|0|||
94220037|NCT05061693|322597584|FG000|24-week Extension Period|Lost to Follow-up|0|||
94220038|NCT05061693|322597585|FG001|24-week Extension Period|Lost to Follow-up|0|||
94220039|NCT05061693|322597586|FG002|24-week Extension Period|Lost to Follow-up|0|||
94220040|NCT05061693|322597587|FG003|24-week Extension Period|Lost to Follow-up|0|||
94220041|NCT05061693|322597588|FG004|24-week Extension Period|Lost to Follow-up|0|||
94220042|NCT05061693|322597589|FG005|24-week Extension Period|Lost to Follow-up|0|||
94220043|NCT05061693|322597590|FG006|24-week Extension Period|Lost to Follow-up|1|||
94220044|NCT05061693|322597591|FG007|24-week Extension Period|Lost to Follow-up|0|||
94220045|NCT05061693|322597592|FG008|24-week Extension Period|Lost to Follow-up|1|||
94220046|NCT05061693|322597593|FG009|24-week Extension Period|Lost to Follow-up|1|||
94220047|NCT05061693|322597594|FG010|24-week Extension Period|Lost to Follow-up|0|||
94220048|NCT05061693|322597595|FG011|24-week Extension Period|Lost to Follow-up|0|||
94220049|NCT05061693|322597584|FG000|24-week Extension Period|Withdrawal by Subject|0|||
94220050|NCT05061693|322597585|FG001|24-week Extension Period|Withdrawal by Subject|0|||
94220051|NCT05061693|322597586|FG002|24-week Extension Period|Withdrawal by Subject|0|||
94220052|NCT05061693|322597587|FG003|24-week Extension Period|Withdrawal by Subject|0|||
94220053|NCT05061693|322597588|FG004|24-week Extension Period|Withdrawal by Subject|0|||
94220054|NCT05061693|322597589|FG005|24-week Extension Period|Withdrawal by Subject|0|||
94220055|NCT05061693|322597590|FG006|24-week Extension Period|Withdrawal by Subject|0|||
94220056|NCT05061693|322597591|FG007|24-week Extension Period|Withdrawal by Subject|0|||
94220057|NCT05061693|322597592|FG008|24-week Extension Period|Withdrawal by Subject|1|||
94220058|NCT05061693|322597593|FG009|24-week Extension Period|Withdrawal by Subject|2|||
94220059|NCT05061693|322597594|FG010|24-week Extension Period|Withdrawal by Subject|2|||
94220060|NCT05061693|322597595|FG011|24-week Extension Period|Withdrawal by Subject|1|||
94220061|NCT05061693|322597584|FG000|24-week Extension Period|Sponsor Decision|0|||
94220062|NCT05061693|322597585|FG001|24-week Extension Period|Sponsor Decision|0|||
94220063|NCT05061693|322597586|FG002|24-week Extension Period|Sponsor Decision|0|||
94220064|NCT05061693|322597587|FG003|24-week Extension Period|Sponsor Decision|0|||
94220065|NCT05061693|322597588|FG004|24-week Extension Period|Sponsor Decision|0|||
94220066|NCT05061693|322597589|FG005|24-week Extension Period|Sponsor Decision|0|||
94220067|NCT05061693|322597590|FG006|24-week Extension Period|Sponsor Decision|0|||
94220068|NCT05061693|322597591|FG007|24-week Extension Period|Sponsor Decision|1|||
94220069|NCT05061693|322597592|FG008|24-week Extension Period|Sponsor Decision|0|||
94220070|NCT05061693|322597593|FG009|24-week Extension Period|Sponsor Decision|0|||
94220071|NCT05061693|322597594|FG010|24-week Extension Period|Sponsor Decision|0|||
94220072|NCT05061693|322597595|FG011|24-week Extension Period|Sponsor Decision|0|||
94220073|NCT05061693|322597584|FG000|24-week Extension Period|Site Closure|0|||
94220074|NCT05061693|322597585|FG001|24-week Extension Period|Site Closure|0|||
94220075|NCT05061693|322597586|FG002|24-week Extension Period|Site Closure|0|||
94220076|NCT05061693|322597587|FG003|24-week Extension Period|Site Closure|0|||
94220077|NCT05061693|322597588|FG004|24-week Extension Period|Site Closure|0|||
94220078|NCT05061693|322597589|FG005|24-week Extension Period|Site Closure|0|||
94220079|NCT05061693|322597590|FG006|24-week Extension Period|Site Closure|0|||
94220080|NCT05061693|322597591|FG007|24-week Extension Period|Site Closure|0|||
94220081|NCT05061693|322597592|FG008|24-week Extension Period|Site Closure|1|||
94220082|NCT05061693|322597593|FG009|24-week Extension Period|Site Closure|0|||
94287184|NCT04673786|322840618|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
94287185|NCT04673786|322840619|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
94287186|NCT04673786|322840620|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
94220083|NCT05061693|322597594|FG010|24-week Extension Period|Site Closure|0|||
94220084|NCT05061693|322597595|FG011|24-week Extension Period|Site Closure|1|||
94220085|NCT01075815|322597598|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
94220086|NCT01075815|322597599|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
94220087|NCT01075815|322597598|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
94220088|NCT01075815|322597599|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
94220089|NCT01075815|322597598|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
94220090|NCT01075815|322597599|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
94220091|NCT00732498|322597603|FG000|Overall Study|Ineligible|1|||
94220092|NCT00732498|322597603|FG000|Overall Study|Adverse Event|2|||
94220093|NCT00732498|322597603|FG000|Overall Study|Physician Decision|3|||
94220094|NCT03394508|322597606|FG000|Overall Study|Protocol Violation|0|||
94220095|NCT03394508|322597607|FG001|Overall Study|Protocol Violation|3|||
94372491|NCT02746705|323150274|FG001|Overall Study|Physician Decision|1|||
94220096|NCT03394508|322597606|FG000|Overall Study|Lost to Follow-up|1|||
94220097|NCT03394508|322597607|FG001|Overall Study|Lost to Follow-up|0|||
94220098|NCT04853394|322597610|FG000|Follow-up Interviews|Lost to Follow-up|22|||
94220099|NCT04853394|322597611|FG001|Follow-up Interviews|Lost to Follow-up|15|||
94220100|NCT02785900|322597615|FG000|Overall Study|Study Termination by Sponsor|64|||
94220101|NCT02785900|322597616|FG001|Overall Study|Study Termination by Sponsor|81|||
94220102|NCT02785900|322597615|FG000|Overall Study|Death|46|||
94220103|NCT02785900|322597616|FG001|Overall Study|Death|32|||
94220104|NCT02785900|322597615|FG000|Overall Study|Withdrawal by Subject|4|||
94220105|NCT02785900|322597616|FG001|Overall Study|Withdrawal by Subject|8|||
94220106|NCT02785900|322597615|FG000|Overall Study|Physician Decision|3|||
94220107|NCT02785900|322597616|FG001|Overall Study|Physician Decision|2|||
94220108|NCT00711555|322599229|FG000|Overall Study|Adverse Event|3|||
94220109|NCT00961298|322599230|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
94220110|NCT00961298|322599230|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
94220111|NCT00961298|322599230|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
94220112|NCT03050372|322599233|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
94220113|NCT03050372|322599234|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
94220114|NCT03050372|322599233|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
94220115|NCT03050372|322599234|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
94220116|NCT00678899|322599235|FG000|Overall Study|Adverse Event|1|||
94220117|NCT01375777|322599238|FG000|Overall Study|Withdrawal by Subject|0|||
94220118|NCT01375777|322599239|FG001|Overall Study|Withdrawal by Subject|2|||
94220119|NCT01375777|322599240|FG002|Overall Study|Withdrawal by Subject|1|||
94287187|NCT04673786|322840618|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
94287188|NCT04673786|322840619|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
94287189|NCT04673786|322840620|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
94287190|NCT00087646|322840623|FG000|Overall Study|Adverse Event|37|||
94287191|NCT00087646|322840624|FG001|Overall Study|Adverse Event|6|||
94287192|NCT00087646|322840625|FG002|Overall Study|Adverse Event|18|||
94287193|NCT00087646|322840626|FG003|Overall Study|Adverse Event|20|||
94287194|NCT00087646|322840623|FG000|Overall Study|Death|0|||
94287195|NCT00087646|322840624|FG001|Overall Study|Death|1|||
94287196|NCT00087646|322840625|FG002|Overall Study|Death|0|||
94287197|NCT00087646|322840626|FG003|Overall Study|Death|0|||
94287198|NCT00087646|322840623|FG000|Overall Study|Withdrawal by Subject|6|||
94287199|NCT00087646|322840624|FG001|Overall Study|Withdrawal by Subject|1|||
94287200|NCT00087646|322840625|FG002|Overall Study|Withdrawal by Subject|2|||
94287201|NCT00087646|322840626|FG003|Overall Study|Withdrawal by Subject|2|||
94287202|NCT00087646|322840623|FG000|Overall Study|Insufficient therapeutic response|64|||
94287203|NCT00087646|322840624|FG001|Overall Study|Insufficient therapeutic response|24|||
94287204|NCT00087646|322840625|FG002|Overall Study|Insufficient therapeutic response|38|||
94287205|NCT00087646|322840626|FG003|Overall Study|Insufficient therapeutic response|51|||
94220120|NCT01375777|322599241|FG003|Overall Study|Withdrawal by Subject|0|||
94220121|NCT01375777|322599242|FG004|Overall Study|Withdrawal by Subject|1|||
94220122|NCT01375777|322599243|FG005|Overall Study|Withdrawal by Subject|1|||
94220123|NCT01375777|322599244|FG006|Overall Study|Withdrawal by Subject|1|||
94220124|NCT01375777|322599245|FG007|Overall Study|Withdrawal by Subject|2|||
94220125|NCT01375777|322599246|FG008|Overall Study|Withdrawal by Subject|1|||
94220126|NCT01375777|322599238|FG000|Overall Study|Lost to Follow-up|1|||
94220127|NCT01375777|322599239|FG001|Overall Study|Lost to Follow-up|0|||
94220128|NCT01375777|322599240|FG002|Overall Study|Lost to Follow-up|0|||
94220129|NCT01375777|322599241|FG003|Overall Study|Lost to Follow-up|0|||
94220130|NCT01375777|322599242|FG004|Overall Study|Lost to Follow-up|0|||
94220131|NCT01375777|322599243|FG005|Overall Study|Lost to Follow-up|0|||
94220132|NCT01375777|322599244|FG006|Overall Study|Lost to Follow-up|1|||
94220133|NCT01375777|322599245|FG007|Overall Study|Lost to Follow-up|0|||
94220134|NCT01375777|322599246|FG008|Overall Study|Lost to Follow-up|0|||
94220135|NCT01375777|322599238|FG000|Overall Study|Other|1|||
94220136|NCT01375777|322599239|FG001|Overall Study|Other|1|||
94220137|NCT01375777|322599240|FG002|Overall Study|Other|0|||
94220138|NCT01375777|322599241|FG003|Overall Study|Other|0|||
94220139|NCT01375777|322599242|FG004|Overall Study|Other|0|||
94220140|NCT01375777|322599243|FG005|Overall Study|Other|0|||
94220141|NCT01375777|322599244|FG006|Overall Study|Other|0|||
94287206|NCT00087646|322840623|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
94220142|NCT01375777|322599245|FG007|Overall Study|Other|0|||
94220143|NCT01375777|322599246|FG008|Overall Study|Other|1|||
94220144|NCT02409732|322599250|FG000|Overall Study|Withdrawal by Subject|4|||
94287207|NCT00087646|322840624|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
94372492|NCT02746705|323150273|FG000|Overall Study|Lost to Follow-up|1|||
94220145|NCT02409732|322599250|FG000|Overall Study|Lost to Follow-up|2|||
94220146|NCT00473512|322599251|FG000|Period 1 (Phase 1)|Adverse Event|0|||
94220147|NCT00473512|322599252|FG001|Period 1 (Phase 1)|Adverse Event|0|||
94220148|NCT00473512|322599253|FG002|Period 1 (Phase 1)|Adverse Event|0|||
94220149|NCT00473512|322599254|FG003|Period 1 (Phase 1)|Adverse Event|5|||
94220150|NCT00473512|322599255|FG004|Period 1 (Phase 1)|Adverse Event|0|||
94220151|NCT00473512|322599251|FG000|Period 1 (Phase 1)|Death|0|||
94220152|NCT00473512|322599252|FG001|Period 1 (Phase 1)|Death|0|||
94220153|NCT00473512|322599253|FG002|Period 1 (Phase 1)|Death|0|||
94220154|NCT00473512|322599254|FG003|Period 1 (Phase 1)|Death|1|||
94220155|NCT00473512|322599255|FG004|Period 1 (Phase 1)|Death|0|||
94220156|NCT00473512|322599251|FG000|Period 1 (Phase 1)|Disease Progression|1|||
94220157|NCT00473512|322599252|FG001|Period 1 (Phase 1)|Disease Progression|1|||
94220158|NCT00473512|322599253|FG002|Period 1 (Phase 1)|Disease Progression|0|||
94220159|NCT00473512|322599254|FG003|Period 1 (Phase 1)|Disease Progression|10|||
94220160|NCT00473512|322599255|FG004|Period 1 (Phase 1)|Disease Progression|1|||
94220161|NCT00473512|322599251|FG000|Period 1 (Phase 1)|Other|0|||
94220162|NCT00473512|322599252|FG001|Period 1 (Phase 1)|Other|0|||
94220163|NCT00473512|322599253|FG002|Period 1 (Phase 1)|Other|0|||
94220164|NCT00473512|322599254|FG003|Period 1 (Phase 1)|Other|1|||
94220165|NCT00473512|322599255|FG004|Period 1 (Phase 1)|Other|0|||
94220166|NCT00473512|322599251|FG000|Period 2 (Phase 2)|Adverse Event|0|||
94220167|NCT00473512|322599252|FG001|Period 2 (Phase 2)|Adverse Event|0|||
94220168|NCT00473512|322599253|FG002|Period 2 (Phase 2)|Adverse Event|0|||
94220169|NCT00473512|322599254|FG003|Period 2 (Phase 2)|Adverse Event|1|||
94220170|NCT00473512|322599255|FG004|Period 2 (Phase 2)|Adverse Event|0|||
94220171|NCT00473512|322599251|FG000|Period 2 (Phase 2)|Death|0|||
94220172|NCT00473512|322599252|FG001|Period 2 (Phase 2)|Death|0|||
94220173|NCT00473512|322599253|FG002|Period 2 (Phase 2)|Death|0|||
94220174|NCT00473512|322599254|FG003|Period 2 (Phase 2)|Death|1|||
94220175|NCT00473512|322599255|FG004|Period 2 (Phase 2)|Death|1|||
94220176|NCT00473512|322599251|FG000|Period 2 (Phase 2)|Disease Progression|0|||
94220177|NCT00473512|322599252|FG001|Period 2 (Phase 2)|Disease Progression|2|||
94220178|NCT00473512|322599253|FG002|Period 2 (Phase 2)|Disease Progression|2|||
94220179|NCT00473512|322599254|FG003|Period 2 (Phase 2)|Disease Progression|17|||
94220180|NCT00473512|322599255|FG004|Period 2 (Phase 2)|Disease Progression|1|||
94220181|NCT00473512|322599251|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
94220182|NCT00473512|322599252|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
94220183|NCT00473512|322599253|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
94220184|NCT00473512|322599254|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
94220185|NCT00473512|322599255|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
94220186|NCT00473512|322599251|FG000|Period 2 (Phase 2)|Other|1|||
94220187|NCT00473512|322599252|FG001|Period 2 (Phase 2)|Other|0|||
94220188|NCT00473512|322599253|FG002|Period 2 (Phase 2)|Other|0|||
94220189|NCT00473512|322599254|FG003|Period 2 (Phase 2)|Other|3|||
94220190|NCT00473512|322599255|FG004|Period 2 (Phase 2)|Other|0|||
94220191|NCT01107353|322599256|FG000|Overall Study|Positive Drug Screen|1|||
94220192|NCT01107353|322599257|FG001|Overall Study|Positive Drug Screen|0|||
94220193|NCT04879823|322599260|FG000|Overall Study|Physician Decision|3|||
94220194|NCT04879823|322599261|FG001|Overall Study|Physician Decision|1|||
94220195|NCT04879823|322599260|FG000|Overall Study|Protocol Violation|2|||
94220196|NCT04879823|322599261|FG001|Overall Study|Protocol Violation|3|||
94220197|NCT04879823|322599260|FG000|Overall Study|Lost to Follow-up|43|||
94287208|NCT00087646|322840625|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
94287209|NCT00087646|322840626|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
94287210|NCT00087646|322840623|FG000|Overall Study|Failure to Return|5|||
94287211|NCT00087646|322840624|FG001|Overall Study|Failure to Return|2|||
94287212|NCT00087646|322840625|FG002|Overall Study|Failure to Return|2|||
94287213|NCT00087646|322840626|FG003|Overall Study|Failure to Return|3|||
94287214|NCT00087646|322840623|FG000|Overall Study|Administrative/Other|6|||
94287215|NCT00087646|322840624|FG001|Overall Study|Administrative/Other|1|||
94287216|NCT00087646|322840625|FG002|Overall Study|Administrative/Other|1|||
94287217|NCT00087646|322840626|FG003|Overall Study|Administrative/Other|2|||
94287218|NCT00087646|322840623|FG000|Overall Study|Other Protocol Violation|3|||
94220198|NCT04879823|322599261|FG001|Overall Study|Lost to Follow-up|35|||
94287219|NCT00087646|322840624|FG001|Overall Study|Other Protocol Violation|1|||
94287220|NCT00087646|322840625|FG002|Overall Study|Other Protocol Violation|0|||
94287221|NCT00087646|322840626|FG003|Overall Study|Other Protocol Violation|0|||
94287222|NCT00087646|322840623|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
94287223|NCT00087646|322840624|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
94287224|NCT00087646|322840625|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
94220199|NCT04468633|322599262|FG000|Overall Study|Withdrawal by Subject|4|||
94220200|NCT04468633|322599263|FG001|Overall Study|Withdrawal by Subject|0|||
94220201|NCT01498445|322599264|FG000|Overall Study|Lack of Efficacy|0|||
94287225|NCT00087646|322840626|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
94287226|NCT03543410|322840627|FG000|Overall Study|Adverse Event|10|||
94287227|NCT03543410|322840628|FG001|Overall Study|Adverse Event|8|||
94287228|NCT03543410|322840629|FG002|Overall Study|Adverse Event|2|||
94287229|NCT03543410|322840627|FG000|Overall Study|Lack of Efficacy|0|||
94372493|NCT02746705|323150274|FG001|Overall Study|Lost to Follow-up|0|||
94220202|NCT01498445|322599265|FG001|Overall Study|Lack of Efficacy|0|||
94220203|NCT01498445|322599266|FG002|Overall Study|Lack of Efficacy|1|||
94220204|NCT01498445|322599267|FG003|Overall Study|Lack of Efficacy|2|||
94220205|NCT01498445|322599268|FG004|Overall Study|Lack of Efficacy|0|||
94220206|NCT01498445|322599269|FG005|Overall Study|Lack of Efficacy|0|||
94220207|NCT01498445|322599264|FG000|Overall Study|Screen Failure|0|||
94287230|NCT03543410|322840628|FG001|Overall Study|Lack of Efficacy|1|||
94287231|NCT03543410|322840629|FG002|Overall Study|Lack of Efficacy|0|||
94287232|NCT03543410|322840627|FG000|Overall Study|Lost to Follow-up|0|||
94287233|NCT03543410|322840628|FG001|Overall Study|Lost to Follow-up|1|||
94287234|NCT03543410|322840629|FG002|Overall Study|Lost to Follow-up|0|||
94287235|NCT03543410|322840627|FG000|Overall Study|Withdrawal by Subject|5|||
94287236|NCT03543410|322840628|FG001|Overall Study|Withdrawal by Subject|2|||
94287237|NCT03543410|322840629|FG002|Overall Study|Withdrawal by Subject|8|||
94287238|NCT03543410|322840627|FG000|Overall Study|Protocol Violation|0|||
94287239|NCT03543410|322840628|FG001|Overall Study|Protocol Violation|1|||
94287240|NCT03543410|322840629|FG002|Overall Study|Protocol Violation|0|||
94287241|NCT03543410|322840627|FG000|Overall Study|Due to COVID-19|4|||
94287242|NCT03543410|322840628|FG001|Overall Study|Due to COVID-19|0|||
94287243|NCT03543410|322840629|FG002|Overall Study|Due to COVID-19|2|||
94287244|NCT03543410|322840627|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
94287245|NCT03543410|322840628|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
94287246|NCT03543410|322840629|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
94287247|NCT03543410|322840627|FG000|Overall Study|Not Due to COVID-19|2|||
94220208|NCT01498445|322599265|FG001|Overall Study|Screen Failure|0|||
94220209|NCT01498445|322599266|FG002|Overall Study|Screen Failure|0|||
94220210|NCT01498445|322599267|FG003|Overall Study|Screen Failure|0|||
94220211|NCT01498445|322599268|FG004|Overall Study|Screen Failure|1|||
94220212|NCT01498445|322599269|FG005|Overall Study|Screen Failure|1|||
94220213|NCT02722278|322599272|FG000|Overall Study|Withdrawal by Subject|5|||
94220214|NCT02722278|322599273|FG001|Overall Study|Withdrawal by Subject|3|||
94220215|NCT02722278|322599272|FG000|Overall Study|Adverse Event|4|||
94220216|NCT02722278|322599273|FG001|Overall Study|Adverse Event|1|||
94220217|NCT02722278|322599272|FG000|Overall Study|Lost to Follow-up|2|||
94220218|NCT02722278|322599273|FG001|Overall Study|Lost to Follow-up|0|||
94220219|NCT02722278|322599272|FG000|Overall Study|Protocol Violation|1|||
94287248|NCT03543410|322840628|FG001|Overall Study|Not Due to COVID-19|0|||
94287249|NCT03543410|322840629|FG002|Overall Study|Not Due to COVID-19|1|||
94220220|NCT02722278|322599273|FG001|Overall Study|Protocol Violation|0|||
94220221|NCT02722278|322599272|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
94220222|NCT02722278|322599273|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
94220223|NCT02722278|322599272|FG000|Overall Study|Subject declined after tx assignment|0|||
94220224|NCT02722278|322599273|FG001|Overall Study|Subject declined after tx assignment|1|||
94220225|NCT02722278|322599272|FG000|Overall Study|Site closure not study related|0|||
94220226|NCT02722278|322599273|FG001|Overall Study|Site closure not study related|1|||
94220227|NCT02465866|322599274|FG000|Period 3|Withdrawal by Subject|0|||
94220228|NCT02465866|322599275|FG001|Period 3|Withdrawal by Subject|1|||
94220229|NCT02465866|322599276|FG002|Period 3|Withdrawal by Subject|0|||
94220230|NCT02465866|322599277|FG003|Period 3|Withdrawal by Subject|0|||
94220231|NCT00248794|322599280|FG000|Overall Study|Lost to Follow-up|6|||
94220232|NCT00248794|322599281|FG001|Overall Study|Lost to Follow-up|8|||
94220233|NCT00248794|322599282|FG002|Overall Study|Lost to Follow-up|3|||
94220234|NCT02023099|322599283|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
94220235|NCT02023099|322599284|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
94220236|NCT02023099|322599285|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
94220237|NCT02023099|322599283|FG000|Overall Study|Withdrawn Consent|3|||
94220238|NCT02023099|322599284|FG001|Overall Study|Withdrawn Consent|0|||
94220239|NCT02023099|322599285|FG002|Overall Study|Withdrawn Consent|1|||
94220240|NCT02023099|322599283|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
94220241|NCT02023099|322599284|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
94220242|NCT02023099|322599285|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
94220243|NCT00203502|322599286|FG000|Overall Study|Death|1|||
94220244|NCT01951105|322599287|FG000|Overall Study|Adverse Event|0|||
94220245|NCT01951105|322599288|FG001|Overall Study|Adverse Event|5|||
94220246|NCT01951105|322599289|FG002|Overall Study|Adverse Event|0|||
94287250|NCT02902120|322840630|FG000|Overall Study|Lack of Efficacy|1|||
94287251|NCT02883244|322840631|FG000|Overall Study|Lost to Follow-up|0|||
94287252|NCT02883244|322840632|FG001|Overall Study|Lost to Follow-up|1|||
94287253|NCT01486199|322840638|FG000|Two Year Period Between Study Days|Physician Decision|1|||
94287254|NCT01486199|322840639|FG001|Two Year Period Between Study Days|Physician Decision|0|||
94287255|NCT01162421|322840642|FG000|Overall Study|Did not receive study drug|2|||
94220247|NCT01951105|322599287|FG000|Overall Study|Lost to Follow-up|0|||
94220248|NCT01951105|322599288|FG001|Overall Study|Lost to Follow-up|1|||
94220249|NCT01951105|322599289|FG002|Overall Study|Lost to Follow-up|0|||
94220250|NCT01951105|322599287|FG000|Overall Study|Protocol Violation|1|||
94220251|NCT01951105|322599288|FG001|Overall Study|Protocol Violation|1|||
94220252|NCT01951105|322599289|FG002|Overall Study|Protocol Violation|1|||
94220253|NCT01951105|322599287|FG000|Overall Study|Withdrawal by Subject|0|||
94220254|NCT01951105|322599288|FG001|Overall Study|Withdrawal by Subject|3|||
94220255|NCT01951105|322599289|FG002|Overall Study|Withdrawal by Subject|1|||
94220256|NCT02632747|322599290|FG000|Wash-out Period|Adverse Event|1|||
94287256|NCT01162421|322840643|FG001|Overall Study|Did not receive study drug|1|||
94287257|NCT01162421|322840642|FG000|Overall Study|Adverse Event|2|||
94220257|NCT02632747|322599291|FG001|Wash-out Period|Adverse Event|0|||
94220258|NCT04175392|322599292|FG000|Overall Study|Withdrawal by Subject|3|||
94220259|NCT04175392|322599293|FG001|Overall Study|Withdrawal by Subject|2|||
94220260|NCT03449979|322599294|FG000|Overall Study|Technical difficulty|0|||
94220261|NCT03449979|322599295|FG001|Overall Study|Technical difficulty|0|||
94220262|NCT03449979|322599296|FG002|Overall Study|Technical difficulty|0|||
94220263|NCT03449979|322599297|FG003|Overall Study|Technical difficulty|1|||
94220264|NCT02592434|322599300|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
94220265|NCT02592434|322599301|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
94220266|NCT02592434|322599302|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
94220267|NCT02592434|322599300|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
94220268|NCT02592434|322599301|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
94220269|NCT02592434|322599302|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
94220270|NCT02592434|322599300|FG000|Open-Label Phase (18 Weeks)|Other|3|||
94220271|NCT02592434|322599301|FG001|Open-Label Phase (18 Weeks)|Other|0|||
94220272|NCT02592434|322599302|FG002|Open-Label Phase (18 Weeks)|Other|0|||
94220273|NCT02592434|322599300|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
94220274|NCT02592434|322599301|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
94220275|NCT02592434|322599302|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
94220276|NCT02592434|322599300|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
94220277|NCT02592434|322599301|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
94220278|NCT02592434|322599302|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
94220279|NCT02592434|322599300|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
94220280|NCT02592434|322599301|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
94220281|NCT02592434|322599302|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
94220282|NCT02592434|322599300|FG000|Double Blind Phase (26 Weeks)|Other|0|||
94220283|NCT02592434|322599301|FG001|Double Blind Phase (26 Weeks)|Other|1|||
94220284|NCT02592434|322599302|FG002|Double Blind Phase (26 Weeks)|Other|0|||
94220285|NCT02592434|322599300|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
94220286|NCT02592434|322599301|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
94220287|NCT02592434|322599302|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
94220288|NCT02592434|322599300|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
94220289|NCT02592434|322599301|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
94220290|NCT02592434|322599302|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
94220291|NCT02592434|322599300|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
94220292|NCT02592434|322599301|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
94220293|NCT02592434|322599302|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
94220294|NCT02727998|322599303|FG000|Overall Study|Lost to Follow-up|3|||
94220295|NCT02727998|322599304|FG001|Overall Study|Lost to Follow-up|3|||
94220296|NCT02727998|322599303|FG000|Overall Study|Withdrawal by Subject|0|||
94220297|NCT02727998|322599304|FG001|Overall Study|Withdrawal by Subject|1|||
94220298|NCT03209492|322599305|FG000|Overall Study|Case Report Forms Uncollected|5|||
94220299|NCT02105688|322599306|FG000|Part A: Double-Blind|Adverse Event|1|||
94220300|NCT02105688|322599307|FG001|Part A: Double-Blind|Adverse Event|0|||
94220301|NCT02105688|322599306|FG000|Part A: Double-Blind|Death|0|||
94220302|NCT02105688|322599307|FG001|Part A: Double-Blind|Death|1|||
94220303|NCT02105688|322599306|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
94220304|NCT02105688|322599307|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
94220305|NCT02105688|322599306|FG000|Part A: Double-Blind|Physician Decision|0|||
94220306|NCT02105688|322599307|FG001|Part A: Double-Blind|Physician Decision|1|||
94220307|NCT02105688|322599306|FG000|Part A: Double-Blind|Status Unknown|0|||
94220308|NCT02105688|322599307|FG001|Part A: Double-Blind|Status Unknown|2|||
94220309|NCT02105688|322599306|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
94220310|NCT02105688|322599307|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
94220311|NCT02105688|322599306|FG000|Part B: Observational Follow-up|Death|2|||
94220312|NCT02105688|322599307|FG001|Part B: Observational Follow-up|Death|1|||
94220313|NCT02105688|322599306|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
94220314|NCT02105688|322599307|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
94220315|NCT02105688|322599306|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
94220316|NCT02105688|322599307|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
94220317|NCT02105688|322599306|FG000|Part B: Observational Follow-up|Physician Decision|3|||
94220318|NCT02105688|322599307|FG001|Part B: Observational Follow-up|Physician Decision|1|||
94220319|NCT01103141|322599308|FG000|Overall Study|Death|0|||
94220320|NCT01103141|322599309|FG001|Overall Study|Death|1|||
94220321|NCT01103141|322599308|FG000|Overall Study|Lost to Follow-up|2|||
94220322|NCT01103141|322599309|FG001|Overall Study|Lost to Follow-up|1|||
94220323|NCT01525875|322599310|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
94220324|NCT01525875|322599311|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
94220325|NCT01525875|322599310|FG000|Open-label Period|Lost to Follow-up|0|||
94220326|NCT01525875|322599311|FG001|Open-label Period|Lost to Follow-up|2|||
94220327|NCT01762345|322599312|FG000|Overall Study|Adverse Event|5|||
94220328|NCT01762345|322599312|FG000|Overall Study|Protocol Violation|2|||
94220329|NCT01403805|322599313|FG000|Overall Study|Withdrawal by Subject|0|||
94220330|NCT01403805|322599314|FG001|Overall Study|Withdrawal by Subject|4|||
94220331|NCT01403805|322599313|FG000|Overall Study|Lost to Follow-up|0|||
94220332|NCT01403805|322599314|FG001|Overall Study|Lost to Follow-up|2|||
94220333|NCT01403805|322599313|FG000|Overall Study|Death|0|||
94220334|NCT01403805|322599314|FG001|Overall Study|Death|1|||
94220335|NCT01695993|322599315|FG000|Overall Study|Lost to Follow-up|2|||
94220336|NCT01695993|322599316|FG001|Overall Study|Lost to Follow-up|1|||
94220337|NCT01695993|322599317|FG002|Overall Study|Lost to Follow-up|3|||
94220338|NCT01695993|322599315|FG000|Overall Study|Withdrawal by Subject|2|||
94220339|NCT01695993|322599316|FG001|Overall Study|Withdrawal by Subject|2|||
94220340|NCT01695993|322599317|FG002|Overall Study|Withdrawal by Subject|2|||
94220341|NCT01695993|322599315|FG000|Overall Study|To ill to continue|1|||
94220342|NCT01695993|322599316|FG001|Overall Study|To ill to continue|2|||
94220343|NCT01695993|322599317|FG002|Overall Study|To ill to continue|0|||
94220344|NCT01695993|322599315|FG000|Overall Study|Changed Medical Facility|0|||
94220345|NCT01695993|322599316|FG001|Overall Study|Changed Medical Facility|0|||
94220346|NCT01695993|322599317|FG002|Overall Study|Changed Medical Facility|1|||
94220347|NCT00147745|322599349|FG000|Overall Study|Withdrawal by Subject|1|||
94220348|NCT00147745|322599350|FG001|Overall Study|Withdrawal by Subject|0|||
94220349|NCT00147745|322599351|FG002|Overall Study|Withdrawal by Subject|0|||
94220350|NCT01124916|322599352|FG000|Overall Study|Lost to Follow-up|3|||
94220351|NCT01124916|322599353|FG001|Overall Study|Lost to Follow-up|2|||
94220352|NCT01757171|322599356|FG000|Overall Study|Adverse Event|5|||
94220353|NCT01757171|322599357|FG001|Overall Study|Adverse Event|1|||
94220354|NCT01757171|322599356|FG000|Overall Study|Disease Progression|1|||
94220355|NCT01757171|322599357|FG001|Overall Study|Disease Progression|0|||
94220356|NCT01757171|322599356|FG000|Overall Study|Hospitalization|1|||
94220357|NCT01757171|322599357|FG001|Overall Study|Hospitalization|0|||
94220358|NCT01757171|322599356|FG000|Overall Study|ECOG decline|1|||
94220359|NCT01757171|322599357|FG001|Overall Study|ECOG decline|0|||
94220360|NCT02305797|322599359|FG000|Overall Study|Adverse Event|11|||
94220361|NCT02305797|322599360|FG001|Overall Study|Adverse Event|2|||
94220362|NCT02305797|322599359|FG000|Overall Study|Withdrawal by Subject|9|||
94220363|NCT02305797|322599360|FG001|Overall Study|Withdrawal by Subject|10|||
94220364|NCT02305797|322599359|FG000|Overall Study|Lack of Efficacy|6|||
94220365|NCT02305797|322599360|FG001|Overall Study|Lack of Efficacy|0|||
94220366|NCT02305797|322599359|FG000|Overall Study|Lost to Follow-up|5|||
94220367|NCT02305797|322599360|FG001|Overall Study|Lost to Follow-up|11|||
94220368|NCT02305797|322599359|FG000|Overall Study|Pregnancy|0|||
94220369|NCT02305797|322599360|FG001|Overall Study|Pregnancy|2|||
94220370|NCT02305797|322599359|FG000|Overall Study|Noncompliance|14|||
94220371|NCT02305797|322599360|FG001|Overall Study|Noncompliance|12|||
94220372|NCT02305797|322599359|FG000|Overall Study|Reason not collected|0|||
94220373|NCT02305797|322599360|FG001|Overall Study|Reason not collected|1|||
94220374|NCT00422162|322599361|FG000|Overall Study|Adverse Event|11|||
94220375|NCT00422162|322599362|FG001|Overall Study|Adverse Event|9|||
94220376|NCT00422162|322599361|FG000|Overall Study|Lack of Efficacy|4|||
94220377|NCT00422162|322599362|FG001|Overall Study|Lack of Efficacy|10|||
94220378|NCT00422162|322599361|FG000|Overall Study|Withdrawal by Subject|7|||
94220379|NCT00422162|322599362|FG001|Overall Study|Withdrawal by Subject|6|||
94220380|NCT00422162|322599361|FG000|Overall Study|Lost to Follow-up|1|||
94220381|NCT00422162|322599362|FG001|Overall Study|Lost to Follow-up|2|||
94220382|NCT00422162|322599361|FG000|Overall Study|Non-Compliant with Protocol|1|||
94220383|NCT00422162|322599362|FG001|Overall Study|Non-Compliant with Protocol|1|||
94220384|NCT00422162|322599361|FG000|Overall Study|Other|0|||
94220385|NCT00422162|322599362|FG001|Overall Study|Other|1|||
94220386|NCT00422162|322599361|FG000|Overall Study|Didn't Receive Treatment|0|||
94220387|NCT00422162|322599362|FG001|Overall Study|Didn't Receive Treatment|1|||
94287258|NCT01162421|322840643|FG001|Overall Study|Adverse Event|5|||
94220388|NCT03508830|322599363|FG000|Overall Study|Withdrawal by Subject|3|||
94220389|NCT03508830|322599364|FG001|Overall Study|Withdrawal by Subject|4|||
94220390|NCT03508830|322599363|FG000|Overall Study|Physician Decision|2|||
94220391|NCT03508830|322599364|FG001|Overall Study|Physician Decision|2|||
94220392|NCT00296504|322599365|FG000|Interim Analysis|Withdrawal by Subject|8|||
94220393|NCT00296504|322599366|FG001|Interim Analysis|Withdrawal by Subject|0|||
94220394|NCT00296504|322599367|FG002|Interim Analysis|Withdrawal by Subject|12|||
94220395|NCT00296504|322599368|FG003|Interim Analysis|Withdrawal by Subject|0|||
94220396|NCT00296504|322599369|FG004|Interim Analysis|Withdrawal by Subject|5|||
94220397|NCT00296504|322599370|FG005|Interim Analysis|Withdrawal by Subject|5|||
94220398|NCT00296504|322599371|FG006|Interim Analysis|Withdrawal by Subject|9|||
94220399|NCT00296504|322599372|FG007|Interim Analysis|Withdrawal by Subject|3|||
94220400|NCT00296504|322599373|FG008|Interim Analysis|Withdrawal by Subject|0|||
94220401|NCT00296504|322599365|FG000|Interim Analysis|Lost to Follow-up|13|||
94220402|NCT00296504|322599366|FG001|Interim Analysis|Lost to Follow-up|3|||
94220403|NCT00296504|322599367|FG002|Interim Analysis|Lost to Follow-up|26|||
94220404|NCT00296504|322599368|FG003|Interim Analysis|Lost to Follow-up|8|||
94220405|NCT00296504|322599369|FG004|Interim Analysis|Lost to Follow-up|14|||
94220406|NCT00296504|322599370|FG005|Interim Analysis|Lost to Follow-up|4|||
94220407|NCT00296504|322599371|FG006|Interim Analysis|Lost to Follow-up|11|||
94220408|NCT00296504|322599372|FG007|Interim Analysis|Lost to Follow-up|4|||
94220409|NCT00296504|322599373|FG008|Interim Analysis|Lost to Follow-up|0|||
94220410|NCT00296504|322599365|FG000|Interim Analysis|Clinical Progression|1|||
94220411|NCT00296504|322599366|FG001|Interim Analysis|Clinical Progression|0|||
94220412|NCT00296504|322599367|FG002|Interim Analysis|Clinical Progression|1|||
94220413|NCT00296504|322599368|FG003|Interim Analysis|Clinical Progression|1|||
94220414|NCT00296504|322599369|FG004|Interim Analysis|Clinical Progression|0|||
94220415|NCT00296504|322599370|FG005|Interim Analysis|Clinical Progression|2|||
94220416|NCT00296504|322599371|FG006|Interim Analysis|Clinical Progression|1|||
94220417|NCT00296504|322599372|FG007|Interim Analysis|Clinical Progression|2|||
94220418|NCT00296504|322599373|FG008|Interim Analysis|Clinical Progression|0|||
94220419|NCT00296504|322599365|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
94220420|NCT00296504|322599366|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
94220421|NCT00296504|322599367|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
94220422|NCT00296504|322599368|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
94220423|NCT00296504|322599369|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
94220424|NCT00296504|322599370|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
94220425|NCT00296504|322599371|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
94220426|NCT00296504|322599372|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
94220427|NCT00296504|322599373|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
94220428|NCT00296504|322599365|FG000|Interim Analysis|Adverse Event|0|||
94220429|NCT00296504|322599366|FG001|Interim Analysis|Adverse Event|0|||
94220430|NCT00296504|322599367|FG002|Interim Analysis|Adverse Event|13|||
94220431|NCT00296504|322599368|FG003|Interim Analysis|Adverse Event|4|||
94220432|NCT00296504|322599369|FG004|Interim Analysis|Adverse Event|6|||
94220433|NCT00296504|322599370|FG005|Interim Analysis|Adverse Event|3|||
94220434|NCT00296504|322599371|FG006|Interim Analysis|Adverse Event|4|||
94220435|NCT00296504|322599372|FG007|Interim Analysis|Adverse Event|5|||
94220436|NCT00296504|322599373|FG008|Interim Analysis|Adverse Event|0|||
94220437|NCT00296504|322599365|FG000|Interim Analysis|Protocol Violation|0|||
94220438|NCT00296504|322599366|FG001|Interim Analysis|Protocol Violation|0|||
94220439|NCT00296504|322599367|FG002|Interim Analysis|Protocol Violation|2|||
94220440|NCT00296504|322599368|FG003|Interim Analysis|Protocol Violation|0|||
94220441|NCT00296504|322599369|FG004|Interim Analysis|Protocol Violation|1|||
94220442|NCT00296504|322599370|FG005|Interim Analysis|Protocol Violation|0|||
94220443|NCT00296504|322599371|FG006|Interim Analysis|Protocol Violation|0|||
94220444|NCT00296504|322599372|FG007|Interim Analysis|Protocol Violation|1|||
94220445|NCT00296504|322599373|FG008|Interim Analysis|Protocol Violation|0|||
94220446|NCT00296504|322599365|FG000|Interim Analysis|Insufficient CD4 Response|0|||
94220447|NCT00296504|322599366|FG001|Interim Analysis|Insufficient CD4 Response|0|||
94220448|NCT00296504|322599367|FG002|Interim Analysis|Insufficient CD4 Response|0|||
94220449|NCT00296504|322599368|FG003|Interim Analysis|Insufficient CD4 Response|0|||
94220450|NCT00296504|322599369|FG004|Interim Analysis|Insufficient CD4 Response|1|||
94220451|NCT00296504|322599370|FG005|Interim Analysis|Insufficient CD4 Response|1|||
94220452|NCT00296504|322599371|FG006|Interim Analysis|Insufficient CD4 Response|0|||
94220453|NCT00296504|322599372|FG007|Interim Analysis|Insufficient CD4 Response|0|||
94220454|NCT00296504|322599373|FG008|Interim Analysis|Insufficient CD4 Response|0|||
94220455|NCT00296504|322599365|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
94220456|NCT00296504|322599366|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
94220457|NCT00296504|322599367|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
94220458|NCT00296504|322599368|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
94220459|NCT00296504|322599369|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
94287259|NCT01162421|322840642|FG000|Overall Study|Lost to Follow-up|0|||
94220460|NCT00296504|322599370|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
94220461|NCT00296504|322599371|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
94220462|NCT00296504|322599372|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
94220463|NCT00296504|322599373|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
94220464|NCT00296504|322599365|FG000|Interim Analysis|Pregnancy|4|||
94220465|NCT00296504|322599366|FG001|Interim Analysis|Pregnancy|1|||
94220466|NCT00296504|322599367|FG002|Interim Analysis|Pregnancy|4|||
94220467|NCT00296504|322599368|FG003|Interim Analysis|Pregnancy|2|||
94220468|NCT00296504|322599369|FG004|Interim Analysis|Pregnancy|0|||
94220469|NCT00296504|322599370|FG005|Interim Analysis|Pregnancy|1|||
94220470|NCT00296504|322599371|FG006|Interim Analysis|Pregnancy|1|||
94220471|NCT00296504|322599372|FG007|Interim Analysis|Pregnancy|1|||
94220472|NCT00296504|322599373|FG008|Interim Analysis|Pregnancy|0|||
94220473|NCT00296504|322599365|FG000|Interim Analysis|Death|1|||
94220474|NCT00296504|322599366|FG001|Interim Analysis|Death|0|||
94220475|NCT00296504|322599367|FG002|Interim Analysis|Death|3|||
94220476|NCT00296504|322599368|FG003|Interim Analysis|Death|0|||
94220477|NCT00296504|322599369|FG004|Interim Analysis|Death|0|||
94220478|NCT00296504|322599370|FG005|Interim Analysis|Death|0|||
94220479|NCT00296504|322599371|FG006|Interim Analysis|Death|0|||
94220480|NCT00296504|322599372|FG007|Interim Analysis|Death|0|||
94220481|NCT00296504|322599373|FG008|Interim Analysis|Death|0|||
94220482|NCT00296504|322599365|FG000|Interim Analysis|Participant Non-compliant|0|||
94220483|NCT00296504|322599366|FG001|Interim Analysis|Participant Non-compliant|1|||
94220484|NCT00296504|322599367|FG002|Interim Analysis|Participant Non-compliant|2|||
94220485|NCT00296504|322599368|FG003|Interim Analysis|Participant Non-compliant|1|||
94220486|NCT00296504|322599369|FG004|Interim Analysis|Participant Non-compliant|1|||
94220487|NCT00296504|322599370|FG005|Interim Analysis|Participant Non-compliant|3|||
94220488|NCT00296504|322599371|FG006|Interim Analysis|Participant Non-compliant|6|||
94220489|NCT00296504|322599372|FG007|Interim Analysis|Participant Non-compliant|2|||
94220490|NCT00296504|322599373|FG008|Interim Analysis|Participant Non-compliant|0|||
94220491|NCT00296504|322599365|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
94220492|NCT00296504|322599366|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
94220493|NCT00296504|322599367|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
94220494|NCT00296504|322599368|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
94220495|NCT00296504|322599369|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
94220496|NCT00296504|322599370|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
94220497|NCT00296504|322599371|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
94220498|NCT00296504|322599372|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
94220499|NCT00296504|322599373|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
94220500|NCT00296504|322599365|FG000|Interim Analysis|To Simplify Treatment|0|||
94220501|NCT00296504|322599366|FG001|Interim Analysis|To Simplify Treatment|0|||
94220502|NCT00296504|322599367|FG002|Interim Analysis|To Simplify Treatment|1|||
94287260|NCT01162421|322840643|FG001|Overall Study|Lost to Follow-up|2|||
94287261|NCT01162421|322840642|FG000|Overall Study|Lack of Efficacy|2|||
94287262|NCT01162421|322840643|FG001|Overall Study|Lack of Efficacy|2|||
94287263|NCT01162421|322840642|FG000|Overall Study|Other|2|||
94287264|NCT01162421|322840643|FG001|Overall Study|Other|3|||
94287265|NCT02551159|322840646|FG000|Overall Study|Death|352|||
94287266|NCT02551159|322840647|FG001|Overall Study|Death|174|||
94287267|NCT02551159|322840648|FG002|Overall Study|Death|161|||
94287268|NCT02551159|322840646|FG000|Overall Study|Withdrawal by Subject|8|||
94287269|NCT02551159|322840647|FG001|Overall Study|Withdrawal by Subject|5|||
94287270|NCT02551159|322840648|FG002|Overall Study|Withdrawal by Subject|16|||
94287271|NCT02551159|322840646|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
94287272|NCT02551159|322840647|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
94287273|NCT02551159|322840648|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
94287274|NCT04506294|322840649|FG000|Overall Study|Lost to Follow-up|70|||
94287275|NCT04506294|322840650|FG001|Overall Study|Lost to Follow-up|20|||
94287276|NCT04506294|322840649|FG000|Overall Study|Withdrawal by Subject|16|||
94287277|NCT04506294|322840650|FG001|Overall Study|Withdrawal by Subject|2|||
94287278|NCT00573794|322840659|FG000|Overall Study|Adverse Event|81|||
94287279|NCT00573794|322840659|FG000|Overall Study|Withdrew Consent|90|||
94287280|NCT00573794|322840659|FG000|Overall Study|Lost to Follow-up|13|||
94287281|NCT00573794|322840659|FG000|Overall Study|Protocol Violation|6|||
94287282|NCT00573794|322840659|FG000|Overall Study|Lack of Efficacy|94|||
94287283|NCT00573794|322840659|FG000|Overall Study|Other|46|||
94287284|NCT02474329|322840663|FG000|Overall Study|Withdraw or did not contribute data.|13|||
94287285|NCT00695565|322840664|FG000|Overall Study|Lost to Follow-up|4|||
94287286|NCT00695565|322840665|FG001|Overall Study|Lost to Follow-up|4|||
94287287|NCT00695565|322840664|FG000|Overall Study|Adverse Event|3|||
94287288|NCT00695565|322840665|FG001|Overall Study|Adverse Event|1|||
94287289|NCT00695565|322840664|FG000|Overall Study|Protocol Violation|3|||
94287290|NCT00695565|322840665|FG001|Overall Study|Protocol Violation|1|||
94287291|NCT00695565|322840664|FG000|Overall Study|Withdrawal by Subject|1|||
94287292|NCT00695565|322840665|FG001|Overall Study|Withdrawal by Subject|1|||
94287293|NCT00695565|322840664|FG000|Overall Study|Lack of Efficacy|1|||
94287294|NCT00695565|322840665|FG001|Overall Study|Lack of Efficacy|1|||
94287295|NCT00695565|322840664|FG000|Overall Study|Subject did not follow instructions|1|||
94287296|NCT00695565|322840665|FG001|Overall Study|Subject did not follow instructions|1|||
94287297|NCT00500682|322840666|FG000|Overall Study|Adverse Event|37|||
94287298|NCT00500682|322840667|FG001|Overall Study|Adverse Event|29|||
94287299|NCT00500682|322840666|FG000|Overall Study|Death|25|||
94287300|NCT00500682|322840667|FG001|Overall Study|Death|16|||
94287301|NCT00500682|322840666|FG000|Overall Study|Lost to Follow-up|11|||
94220503|NCT00296504|322599368|FG003|Interim Analysis|To Simplify Treatment|0|||
94220504|NCT00296504|322599369|FG004|Interim Analysis|To Simplify Treatment|0|||
94220505|NCT00296504|322599370|FG005|Interim Analysis|To Simplify Treatment|0|||
94220506|NCT00296504|322599371|FG006|Interim Analysis|To Simplify Treatment|2|||
94220507|NCT00296504|322599372|FG007|Interim Analysis|To Simplify Treatment|0|||
94220508|NCT00296504|322599373|FG008|Interim Analysis|To Simplify Treatment|0|||
94287302|NCT00500682|322840667|FG001|Overall Study|Lost to Follow-up|11|||
94287303|NCT00500682|322840666|FG000|Overall Study|Physician Decision|6|||
94287304|NCT00500682|322840667|FG001|Overall Study|Physician Decision|10|||
94220509|NCT00296504|322599365|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
94287305|NCT00500682|322840666|FG000|Overall Study|Pregnancy|2|||
94287306|NCT00500682|322840667|FG001|Overall Study|Pregnancy|0|||
94220510|NCT00296504|322599366|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
94220511|NCT00296504|322599367|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
94220512|NCT00296504|322599368|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
94220513|NCT00296504|322599369|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
94220514|NCT00296504|322599370|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
94220515|NCT00296504|322599371|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
94220516|NCT00296504|322599372|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
94220517|NCT00296504|322599373|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
94220518|NCT00296504|322599365|FG000|Interim Analysis|Participant Moved|1|||
94220519|NCT00296504|322599366|FG001|Interim Analysis|Participant Moved|0|||
94220520|NCT00296504|322599367|FG002|Interim Analysis|Participant Moved|1|||
94220521|NCT00296504|322599368|FG003|Interim Analysis|Participant Moved|0|||
94220522|NCT00296504|322599369|FG004|Interim Analysis|Participant Moved|0|||
94220523|NCT00296504|322599370|FG005|Interim Analysis|Participant Moved|1|||
94220524|NCT00296504|322599371|FG006|Interim Analysis|Participant Moved|1|||
94220525|NCT00296504|322599372|FG007|Interim Analysis|Participant Moved|0|||
94220526|NCT00296504|322599373|FG008|Interim Analysis|Participant Moved|0|||
94220527|NCT00296504|322599365|FG000|Interim Analysis|Participant Was Incarcerated|2|||
94220528|NCT00296504|322599366|FG001|Interim Analysis|Participant Was Incarcerated|0|||
94220529|NCT00296504|322599367|FG002|Interim Analysis|Participant Was Incarcerated|1|||
94220530|NCT00296504|322599368|FG003|Interim Analysis|Participant Was Incarcerated|0|||
94220531|NCT00296504|322599369|FG004|Interim Analysis|Participant Was Incarcerated|0|||
94220532|NCT00296504|322599370|FG005|Interim Analysis|Participant Was Incarcerated|0|||
94220533|NCT00296504|322599371|FG006|Interim Analysis|Participant Was Incarcerated|0|||
94220534|NCT00296504|322599372|FG007|Interim Analysis|Participant Was Incarcerated|0|||
94220535|NCT00296504|322599373|FG008|Interim Analysis|Participant Was Incarcerated|0|||
94220536|NCT00296504|322599365|FG000|Interim Analysis|Resistance to FPV|0|||
94220537|NCT00296504|322599366|FG001|Interim Analysis|Resistance to FPV|0|||
94220538|NCT00296504|322599367|FG002|Interim Analysis|Resistance to FPV|1|||
94220539|NCT00296504|322599368|FG003|Interim Analysis|Resistance to FPV|0|||
94220540|NCT00296504|322599369|FG004|Interim Analysis|Resistance to FPV|0|||
94220541|NCT00296504|322599370|FG005|Interim Analysis|Resistance to FPV|0|||
94220542|NCT00296504|322599371|FG006|Interim Analysis|Resistance to FPV|0|||
94220543|NCT00296504|322599372|FG007|Interim Analysis|Resistance to FPV|0|||
94220544|NCT00296504|322599373|FG008|Interim Analysis|Resistance to FPV|0|||
94220545|NCT00296504|322599365|FG000|Interim Analysis|Physician Decision|0|||
94220546|NCT00296504|322599366|FG001|Interim Analysis|Physician Decision|0|||
94220547|NCT00296504|322599367|FG002|Interim Analysis|Physician Decision|1|||
94287307|NCT00500682|322840666|FG000|Overall Study|Protocol Violation|1|||
94287308|NCT00500682|322840667|FG001|Overall Study|Protocol Violation|3|||
94287309|NCT00500682|322840666|FG000|Overall Study|Withdrawal by Subject|80|||
94287310|NCT00500682|322840667|FG001|Overall Study|Withdrawal by Subject|74|||
94287311|NCT00500682|322840666|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
94287312|NCT00500682|322840667|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
94287313|NCT01182428|322840674|FG000|Overall Study|Physician Decision|1|||
94287314|NCT01182428|322840675|FG001|Overall Study|Physician Decision|0|||
94287315|NCT01182428|322840674|FG000|Overall Study|Lost to Follow-up|9|||
94287316|NCT01182428|322840675|FG001|Overall Study|Lost to Follow-up|1|||
94287317|NCT01182428|322840674|FG000|Overall Study|Withdrawal by Subject|1|||
94287318|NCT01182428|322840675|FG001|Overall Study|Withdrawal by Subject|0|||
94287319|NCT00865020|322840678|FG000|Overall Study|Withdrawal by Subject|22|||
94287320|NCT00865020|322840679|FG001|Overall Study|Withdrawal by Subject|16|||
94287321|NCT00865020|322840678|FG000|Overall Study|Adverse Event|9|||
94287322|NCT00865020|322840679|FG001|Overall Study|Adverse Event|14|||
94287323|NCT00865020|322840678|FG000|Overall Study|Abnormal test procedure result(s)|6|||
94287324|NCT00865020|322840679|FG001|Overall Study|Abnormal test procedure result(s)|8|||
94287325|NCT00865020|322840678|FG000|Overall Study|Lost to Follow-up|6|||
94287326|NCT00865020|322840679|FG001|Overall Study|Lost to Follow-up|4|||
94287327|NCT00865020|322840678|FG000|Overall Study|Protocol deviation|4|||
94287328|NCT00865020|322840679|FG001|Overall Study|Protocol deviation|1|||
94372494|NCT02746705|323150273|FG000|Overall Study|outlier scores deemed not valid|0|||
94220548|NCT00296504|322599368|FG003|Interim Analysis|Physician Decision|0|||
94220549|NCT00296504|322599369|FG004|Interim Analysis|Physician Decision|0|||
94220550|NCT00296504|322599370|FG005|Interim Analysis|Physician Decision|0|||
94220551|NCT00296504|322599371|FG006|Interim Analysis|Physician Decision|0|||
94220552|NCT00296504|322599372|FG007|Interim Analysis|Physician Decision|0|||
94220553|NCT00296504|322599373|FG008|Interim Analysis|Physician Decision|0|||
94287329|NCT00865020|322840678|FG000|Overall Study|Administrative problems|0|||
94287330|NCT00865020|322840679|FG001|Overall Study|Administrative problems|2|||
94372495|NCT02746705|323150274|FG001|Overall Study|outlier scores deemed not valid|1|||
94372496|NCT00479401|323150276|FG000|Overall Study|Adverse Event|24|||
94287331|NCT00865020|322840678|FG000|Overall Study|Abnormal laboratory value(s)|0|||
94220554|NCT00296504|322599365|FG000|Interim Analysis|Principle Investigator Discretion|2|||
94220555|NCT00296504|322599366|FG001|Interim Analysis|Principle Investigator Discretion|0|||
94220556|NCT00296504|322599367|FG002|Interim Analysis|Principle Investigator Discretion|1|||
94220557|NCT00296504|322599368|FG003|Interim Analysis|Principle Investigator Discretion|1|||
94220558|NCT00296504|322599369|FG004|Interim Analysis|Principle Investigator Discretion|0|||
94220559|NCT00296504|322599370|FG005|Interim Analysis|Principle Investigator Discretion|0|||
94220560|NCT00296504|322599371|FG006|Interim Analysis|Principle Investigator Discretion|0|||
94220561|NCT00296504|322599372|FG007|Interim Analysis|Principle Investigator Discretion|0|||
94220562|NCT00296504|322599373|FG008|Interim Analysis|Principle Investigator Discretion|0|||
94220563|NCT00296504|322599365|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
94220564|NCT00296504|322599366|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
94220565|NCT00296504|322599367|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
94220566|NCT00296504|322599368|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
94220567|NCT00296504|322599369|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
94220568|NCT00296504|322599370|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
94220569|NCT00296504|322599371|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
94220570|NCT00296504|322599372|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
94220571|NCT00296504|322599373|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
94220572|NCT00296504|322599365|FG000|Interim Analysis|Non-adherence|2|||
94220573|NCT00296504|322599366|FG001|Interim Analysis|Non-adherence|0|||
94220574|NCT00296504|322599367|FG002|Interim Analysis|Non-adherence|0|||
94220575|NCT00296504|322599368|FG003|Interim Analysis|Non-adherence|0|||
94220576|NCT00296504|322599369|FG004|Interim Analysis|Non-adherence|1|||
94220577|NCT00296504|322599370|FG005|Interim Analysis|Non-adherence|0|||
94220578|NCT00296504|322599371|FG006|Interim Analysis|Non-adherence|0|||
94220579|NCT00296504|322599372|FG007|Interim Analysis|Non-adherence|1|||
94220580|NCT00296504|322599373|FG008|Interim Analysis|Non-adherence|0|||
94220581|NCT00296504|322599365|FG000|Interim Analysis|Site Closing|1|||
94220582|NCT00296504|322599366|FG001|Interim Analysis|Site Closing|0|||
94220583|NCT00296504|322599367|FG002|Interim Analysis|Site Closing|0|||
94220584|NCT00296504|322599368|FG003|Interim Analysis|Site Closing|0|||
94220585|NCT00296504|322599369|FG004|Interim Analysis|Site Closing|0|||
94220586|NCT00296504|322599370|FG005|Interim Analysis|Site Closing|1|||
94220587|NCT00296504|322599371|FG006|Interim Analysis|Site Closing|2|||
94220588|NCT00296504|322599372|FG007|Interim Analysis|Site Closing|0|||
94220589|NCT00296504|322599373|FG008|Interim Analysis|Site Closing|0|||
94220590|NCT00296504|322599365|FG000|Interim Analysis|Lack of Personnel at Site|1|||
94220591|NCT00296504|322599366|FG001|Interim Analysis|Lack of Personnel at Site|0|||
94287332|NCT00865020|322840679|FG001|Overall Study|Abnormal laboratory value(s)|1|||
94287333|NCT00865020|322840678|FG000|Overall Study|Death|0|||
94287334|NCT00865020|322840679|FG001|Overall Study|Death|1|||
94287335|NCT00865020|322840678|FG000|Overall Study|Randomized but discontinued|2|||
94287336|NCT00865020|322840679|FG001|Overall Study|Randomized but discontinued|4|||
94287337|NCT03641560|322840680|FG000|Overall Study|Withdrawal by Subject|6|||
94287338|NCT03641560|322840680|FG000|Overall Study|Progressive disease|40|||
94287339|NCT03641560|322840680|FG000|Overall Study|Death|6|||
94287340|NCT00768898|322842247|FG000|Overall Study|Unrelated injury|1|||
94287341|NCT00768898|322842247|FG000|Overall Study|Headache|1|||
94287342|NCT00403260|322842249|FG000|Overall Study|Adverse Event|5|||
94287343|NCT00403260|322842250|FG001|Overall Study|Adverse Event|4|||
94287344|NCT00403260|322842249|FG000|Overall Study|Withdrawal by Subject|5|||
94287345|NCT00403260|322842250|FG001|Overall Study|Withdrawal by Subject|6|||
94287346|NCT00403260|322842249|FG000|Overall Study|Lost to Follow-up|49|||
94287347|NCT00403260|322842250|FG001|Overall Study|Lost to Follow-up|25|||
94287348|NCT00403260|322842249|FG000|Overall Study|Re-appearance of P. falciparum|34|||
94287349|NCT00403260|322842250|FG001|Overall Study|Re-appearance of P. falciparum|25|||
94287350|NCT00403260|322842249|FG000|Overall Study|P. vivax infection|26|||
94287351|NCT00403260|322842250|FG001|Overall Study|P. vivax infection|4|||
94287352|NCT00403260|322842249|FG000|Overall Study|Mixed infection with P. vivax|2|||
94287353|NCT00403260|322842250|FG001|Overall Study|Mixed infection with P. vivax|0|||
94287354|NCT00403260|322842249|FG000|Overall Study|Mixed infection with P. falciparum|1|||
94287355|NCT00403260|322842250|FG001|Overall Study|Mixed infection with P. falciparum|0|||
94287356|NCT00403260|322842249|FG000|Overall Study|P. vivax infection at screening|1|||
94287357|NCT00403260|322842250|FG001|Overall Study|P. vivax infection at screening|0|||
94220592|NCT00296504|322599367|FG002|Interim Analysis|Lack of Personnel at Site|0|||
94220593|NCT00296504|322599368|FG003|Interim Analysis|Lack of Personnel at Site|0|||
94287358|NCT00403260|322842249|FG000|Overall Study|P. ovale infection|1|||
94287359|NCT00403260|322842250|FG001|Overall Study|P. ovale infection|0|||
94287360|NCT00403260|322842249|FG000|Overall Study|Gametocyte re-appearance|1|||
94287361|NCT00403260|322842250|FG001|Overall Study|Gametocyte re-appearance|1|||
94287362|NCT00403260|322842249|FG000|Overall Study|Withdrawn from study accidentally|0|||
94287363|NCT00403260|322842250|FG001|Overall Study|Withdrawn from study accidentally|1|||
94220594|NCT00296504|322599369|FG004|Interim Analysis|Lack of Personnel at Site|0|||
94220595|NCT00296504|322599370|FG005|Interim Analysis|Lack of Personnel at Site|0|||
94220596|NCT00296504|322599371|FG006|Interim Analysis|Lack of Personnel at Site|0|||
94220597|NCT00296504|322599372|FG007|Interim Analysis|Lack of Personnel at Site|0|||
94220598|NCT00296504|322599373|FG008|Interim Analysis|Lack of Personnel at Site|0|||
94220599|NCT00296504|322599365|FG000|Interim Analysis|Missed Schedule Date|1|||
94220600|NCT00296504|322599366|FG001|Interim Analysis|Missed Schedule Date|0|||
94220601|NCT00296504|322599367|FG002|Interim Analysis|Missed Schedule Date|0|||
94220602|NCT00296504|322599368|FG003|Interim Analysis|Missed Schedule Date|0|||
94220603|NCT00296504|322599369|FG004|Interim Analysis|Missed Schedule Date|0|||
94220604|NCT00296504|322599370|FG005|Interim Analysis|Missed Schedule Date|0|||
94220605|NCT00296504|322599371|FG006|Interim Analysis|Missed Schedule Date|0|||
94220606|NCT00296504|322599372|FG007|Interim Analysis|Missed Schedule Date|0|||
94220607|NCT00296504|322599373|FG008|Interim Analysis|Missed Schedule Date|0|||
94220608|NCT00296504|322599365|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
94220609|NCT00296504|322599366|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
94220610|NCT00296504|322599367|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
94220611|NCT00296504|322599368|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
94220612|NCT00296504|322599369|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
94220613|NCT00296504|322599370|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
94220614|NCT00296504|322599371|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
94220615|NCT00296504|322599372|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
94220616|NCT00296504|322599373|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
94220617|NCT00296504|322599365|FG000|Interim Analysis|Participant Stopped|0|||
94220618|NCT00296504|322599366|FG001|Interim Analysis|Participant Stopped|0|||
94220619|NCT00296504|322599367|FG002|Interim Analysis|Participant Stopped|0|||
94220620|NCT00296504|322599368|FG003|Interim Analysis|Participant Stopped|0|||
94220621|NCT00296504|322599369|FG004|Interim Analysis|Participant Stopped|1|||
94220622|NCT00296504|322599370|FG005|Interim Analysis|Participant Stopped|0|||
94220623|NCT00296504|322599371|FG006|Interim Analysis|Participant Stopped|0|||
94220624|NCT00296504|322599372|FG007|Interim Analysis|Participant Stopped|0|||
94220625|NCT00296504|322599373|FG008|Interim Analysis|Participant Stopped|0|||
94220626|NCT00296504|322599365|FG000|Interim Analysis|Physician and Participant Decision|0|||
94220627|NCT00296504|322599366|FG001|Interim Analysis|Physician and Participant Decision|0|||
94220628|NCT00296504|322599367|FG002|Interim Analysis|Physician and Participant Decision|0|||
94220629|NCT00296504|322599368|FG003|Interim Analysis|Physician and Participant Decision|0|||
94220630|NCT00296504|322599369|FG004|Interim Analysis|Physician and Participant Decision|0|||
94220631|NCT00296504|322599370|FG005|Interim Analysis|Physician and Participant Decision|1|||
94220632|NCT00296504|322599371|FG006|Interim Analysis|Physician and Participant Decision|0|||
94220633|NCT00296504|322599372|FG007|Interim Analysis|Physician and Participant Decision|0|||
94220634|NCT00296504|322599373|FG008|Interim Analysis|Physician and Participant Decision|0|||
94220635|NCT00296504|322599365|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
94220636|NCT00296504|322599366|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
94220637|NCT00296504|322599367|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
94220638|NCT00296504|322599368|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
94220639|NCT00296504|322599369|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
94220640|NCT00296504|322599370|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
94220641|NCT00296504|322599371|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
94220642|NCT00296504|322599372|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
94220643|NCT00296504|322599373|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
94220644|NCT00296504|322599365|FG000|Interim Analysis|Study Ended|0|||
94287364|NCT02894840|322842253|FG000|Overall Study|Lost to Follow-up|1|||
94287365|NCT02894840|322842254|FG001|Overall Study|Lost to Follow-up|0|||
94287366|NCT02894840|322842255|FG002|Overall Study|Lost to Follow-up|3|||
94287367|NCT02894840|322842256|FG003|Overall Study|Lost to Follow-up|0|||
94287368|NCT00805740|322842261|FG000|Overall Study|Death|7|||
94287369|NCT00805740|322842262|FG001|Overall Study|Death|4|||
94287370|NCT00805740|322842261|FG000|Overall Study|Withdrawal by Subject|1|||
94287371|NCT00805740|322842262|FG001|Overall Study|Withdrawal by Subject|0|||
94220645|NCT00296504|322599366|FG001|Interim Analysis|Study Ended|0|||
94220646|NCT00296504|322599367|FG002|Interim Analysis|Study Ended|0|||
94220647|NCT00296504|322599368|FG003|Interim Analysis|Study Ended|0|||
94220648|NCT00296504|322599369|FG004|Interim Analysis|Study Ended|0|||
94220649|NCT00296504|322599370|FG005|Interim Analysis|Study Ended|0|||
94220650|NCT00296504|322599371|FG006|Interim Analysis|Study Ended|1|||
94220651|NCT00296504|322599372|FG007|Interim Analysis|Study Ended|0|||
94220652|NCT00296504|322599373|FG008|Interim Analysis|Study Ended|0|||
94220653|NCT00296504|322599365|FG000|Interim Analysis|Participant Needed Interferon|0|||
94220654|NCT00296504|322599366|FG001|Interim Analysis|Participant Needed Interferon|0|||
94220655|NCT00296504|322599367|FG002|Interim Analysis|Participant Needed Interferon|0|||
94220656|NCT00296504|322599368|FG003|Interim Analysis|Participant Needed Interferon|0|||
94220657|NCT00296504|322599369|FG004|Interim Analysis|Participant Needed Interferon|0|||
94220658|NCT00296504|322599370|FG005|Interim Analysis|Participant Needed Interferon|0|||
94220659|NCT00296504|322599371|FG006|Interim Analysis|Participant Needed Interferon|0|||
94220660|NCT00296504|322599372|FG007|Interim Analysis|Participant Needed Interferon|1|||
94220661|NCT00296504|322599373|FG008|Interim Analysis|Participant Needed Interferon|0|||
94220662|NCT00296504|322599365|FG000|Interim Analysis|Ongoing|32|||
94220663|NCT00296504|322599366|FG001|Interim Analysis|Ongoing|12|||
94220664|NCT00296504|322599367|FG002|Interim Analysis|Ongoing|16|||
94220665|NCT00296504|322599368|FG003|Interim Analysis|Ongoing|22|||
94220666|NCT00296504|322599369|FG004|Interim Analysis|Ongoing|0|||
94220667|NCT00296504|322599370|FG005|Interim Analysis|Ongoing|0|||
94220668|NCT00296504|322599371|FG006|Interim Analysis|Ongoing|30|||
94220669|NCT00296504|322599372|FG007|Interim Analysis|Ongoing|1|||
94220670|NCT00296504|322599373|FG008|Interim Analysis|Ongoing|0|||
94220671|NCT00296504|322599365|FG000|Final Analysis|Withdrawal by Subject|0|||
94220672|NCT00296504|322599366|FG001|Final Analysis|Withdrawal by Subject|0|||
94220673|NCT00296504|322599367|FG002|Final Analysis|Withdrawal by Subject|0|||
94220674|NCT00296504|322599368|FG003|Final Analysis|Withdrawal by Subject|0|||
94220675|NCT00296504|322599369|FG004|Final Analysis|Withdrawal by Subject|0|||
94220676|NCT00296504|322599370|FG005|Final Analysis|Withdrawal by Subject|0|||
94220677|NCT00296504|322599371|FG006|Final Analysis|Withdrawal by Subject|0|||
94220678|NCT00296504|322599372|FG007|Final Analysis|Withdrawal by Subject|0|||
94220679|NCT00296504|322599373|FG008|Final Analysis|Withdrawal by Subject|1|||
94220680|NCT00296504|322599365|FG000|Final Analysis|Lost to Follow-up|0|||
94220681|NCT00296504|322599366|FG001|Final Analysis|Lost to Follow-up|0|||
94220682|NCT00296504|322599367|FG002|Final Analysis|Lost to Follow-up|0|||
94220683|NCT00296504|322599368|FG003|Final Analysis|Lost to Follow-up|0|||
94220684|NCT00296504|322599369|FG004|Final Analysis|Lost to Follow-up|0|||
94220685|NCT00296504|322599370|FG005|Final Analysis|Lost to Follow-up|0|||
94220686|NCT00296504|322599371|FG006|Final Analysis|Lost to Follow-up|0|||
94220687|NCT00296504|322599372|FG007|Final Analysis|Lost to Follow-up|0|||
94220688|NCT00296504|322599373|FG008|Final Analysis|Lost to Follow-up|5|||
94220689|NCT00296504|322599365|FG000|Final Analysis|Insufficient Viral Load Response|0|||
94220690|NCT00296504|322599366|FG001|Final Analysis|Insufficient Viral Load Response|0|||
94220691|NCT00296504|322599367|FG002|Final Analysis|Insufficient Viral Load Response|0|||
94220692|NCT00296504|322599368|FG003|Final Analysis|Insufficient Viral Load Response|0|||
94220693|NCT00296504|322599369|FG004|Final Analysis|Insufficient Viral Load Response|0|||
94220694|NCT00296504|322599370|FG005|Final Analysis|Insufficient Viral Load Response|0|||
94220695|NCT00296504|322599371|FG006|Final Analysis|Insufficient Viral Load Response|0|||
94220696|NCT00296504|322599372|FG007|Final Analysis|Insufficient Viral Load Response|0|||
94220697|NCT00296504|322599373|FG008|Final Analysis|Insufficient Viral Load Response|6|||
94220698|NCT00296504|322599365|FG000|Final Analysis|Adverse Event|0|||
94220699|NCT00296504|322599366|FG001|Final Analysis|Adverse Event|0|||
94220700|NCT00296504|322599367|FG002|Final Analysis|Adverse Event|0|||
94220701|NCT00296504|322599368|FG003|Final Analysis|Adverse Event|0|||
94220702|NCT00296504|322599369|FG004|Final Analysis|Adverse Event|0|||
94220703|NCT00296504|322599370|FG005|Final Analysis|Adverse Event|0|||
94220704|NCT00296504|322599371|FG006|Final Analysis|Adverse Event|0|||
94220705|NCT00296504|322599372|FG007|Final Analysis|Adverse Event|0|||
94220706|NCT00296504|322599373|FG008|Final Analysis|Adverse Event|2|||
94220707|NCT00296504|322599365|FG000|Final Analysis|Pregnancy|0|||
94220708|NCT00296504|322599366|FG001|Final Analysis|Pregnancy|0|||
94220709|NCT00296504|322599367|FG002|Final Analysis|Pregnancy|0|||
94220710|NCT00296504|322599368|FG003|Final Analysis|Pregnancy|0|||
94220711|NCT00296504|322599369|FG004|Final Analysis|Pregnancy|0|||
94220712|NCT00296504|322599370|FG005|Final Analysis|Pregnancy|0|||
94220713|NCT00296504|322599371|FG006|Final Analysis|Pregnancy|0|||
94220714|NCT00296504|322599372|FG007|Final Analysis|Pregnancy|0|||
94220715|NCT00296504|322599373|FG008|Final Analysis|Pregnancy|4|||
94220716|NCT00296504|322599365|FG000|Final Analysis|Tuberculosis|0|||
94220717|NCT00296504|322599366|FG001|Final Analysis|Tuberculosis|0|||
94287372|NCT00805740|322842261|FG000|Overall Study|Lost to Follow-up|1|||
94287373|NCT00805740|322842262|FG001|Overall Study|Lost to Follow-up|0|||
94287374|NCT00805740|322842261|FG000|Overall Study|Randomized, but not treated|2|||
94220718|NCT00296504|322599367|FG002|Final Analysis|Tuberculosis|0|||
94220719|NCT00296504|322599368|FG003|Final Analysis|Tuberculosis|0|||
94220720|NCT00296504|322599369|FG004|Final Analysis|Tuberculosis|0|||
94220721|NCT00296504|322599370|FG005|Final Analysis|Tuberculosis|0|||
94220722|NCT00296504|322599371|FG006|Final Analysis|Tuberculosis|0|||
94220723|NCT00296504|322599372|FG007|Final Analysis|Tuberculosis|0|||
94220724|NCT00296504|322599373|FG008|Final Analysis|Tuberculosis|1|||
94220725|NCT00296504|322599365|FG000|Final Analysis|Participant Moved to Another Country|0|||
94220726|NCT00296504|322599366|FG001|Final Analysis|Participant Moved to Another Country|0|||
94220727|NCT00296504|322599367|FG002|Final Analysis|Participant Moved to Another Country|0|||
94220728|NCT00296504|322599368|FG003|Final Analysis|Participant Moved to Another Country|0|||
94220729|NCT00296504|322599369|FG004|Final Analysis|Participant Moved to Another Country|0|||
94220730|NCT00296504|322599370|FG005|Final Analysis|Participant Moved to Another Country|0|||
94220731|NCT00296504|322599371|FG006|Final Analysis|Participant Moved to Another Country|0|||
94220732|NCT00296504|322599372|FG007|Final Analysis|Participant Moved to Another Country|0|||
94220733|NCT00296504|322599373|FG008|Final Analysis|Participant Moved to Another Country|1|||
94220734|NCT00296504|322599365|FG000|Final Analysis|Poor Adherence|0|||
94220735|NCT00296504|322599366|FG001|Final Analysis|Poor Adherence|0|||
94220736|NCT00296504|322599367|FG002|Final Analysis|Poor Adherence|0|||
94220737|NCT00296504|322599368|FG003|Final Analysis|Poor Adherence|0|||
94220738|NCT00296504|322599369|FG004|Final Analysis|Poor Adherence|0|||
94220739|NCT00296504|322599370|FG005|Final Analysis|Poor Adherence|0|||
94220740|NCT00296504|322599371|FG006|Final Analysis|Poor Adherence|0|||
94220741|NCT00296504|322599372|FG007|Final Analysis|Poor Adherence|0|||
94220742|NCT00296504|322599373|FG008|Final Analysis|Poor Adherence|1|||
94220743|NCT04393779|322599374|FG000|Overall Study|Death|1|||
94220744|NCT04393779|322599374|FG000|Overall Study|Device reintervention or explant|4|||
94220745|NCT02038803|322599375|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
94220746|NCT02038803|322599375|FG000|Overall Study|Lost to Follow-up|1|||
94220747|NCT03517969|322599376|FG000|Overall Study|Never started protocol treatment|3|||
94220748|NCT03517969|322599377|FG001|Overall Study|Never started protocol treatment|5|||
94220749|NCT03517969|322599376|FG000|Overall Study|Disease progression|11|||
94220750|NCT03517969|322599377|FG001|Overall Study|Disease progression|16|||
94220751|NCT03517969|322599376|FG000|Overall Study|PSA progression|8|||
94220752|NCT03517969|322599377|FG001|Overall Study|PSA progression|1|||
94220753|NCT03517969|322599376|FG000|Overall Study|Clinical progression|4|||
94220754|NCT03517969|322599377|FG001|Overall Study|Clinical progression|2|||
94220755|NCT03517969|322599376|FG000|Overall Study|Adverse Event|5|||
94220756|NCT03517969|322599377|FG001|Overall Study|Adverse Event|4|||
94220757|NCT03517969|322599376|FG000|Overall Study|Intercurrent illness|1|||
94220758|NCT03517969|322599377|FG001|Overall Study|Intercurrent illness|2|||
94220759|NCT03517969|322599376|FG000|Overall Study|Death|1|||
94220760|NCT03517969|322599377|FG001|Overall Study|Death|1|||
94220761|NCT03517969|322599376|FG000|Overall Study|Withdrawal by Subject|1|||
94220762|NCT03517969|322599377|FG001|Overall Study|Withdrawal by Subject|2|||
94220763|NCT03517969|322599376|FG000|Overall Study|Physician Decision|1|||
94220764|NCT03517969|322599377|FG001|Overall Study|Physician Decision|1|||
94220765|NCT03517969|322599376|FG000|Overall Study|No clinical benefit|1|||
94220766|NCT03517969|322599377|FG001|Overall Study|No clinical benefit|0|||
94220767|NCT03517969|322599376|FG000|Overall Study|Delayed treatment for dental treatment|1|||
94220768|NCT03517969|322599377|FG001|Overall Study|Delayed treatment for dental treatment|0|||
94220769|NCT03517969|322599376|FG000|Overall Study|Difficult to maintain appointment|0|||
94220770|NCT03517969|322599377|FG001|Overall Study|Difficult to maintain appointment|1|||
94220771|NCT03517969|322599376|FG000|Overall Study|Protocol Violation|0|||
94220772|NCT03517969|322599377|FG001|Overall Study|Protocol Violation|1|||
94220773|NCT05740371|322599378|FG000|Overall Study|Death|1|||
94220774|NCT03849300|322599379|FG000|Overall Study|move out to different area|1|||
94220775|NCT03849300|322599380|FG001|Overall Study|move out to different area|3|||
94220776|NCT03849300|322599381|FG002|Overall Study|move out to different area|1|||
94220777|NCT03849300|322599382|FG003|Overall Study|move out to different area|4|||
94220778|NCT03849300|322599379|FG000|Overall Study|scheduling/transportation conflict|4|||
94220779|NCT03849300|322599380|FG001|Overall Study|scheduling/transportation conflict|4|||
94220780|NCT03849300|322599381|FG002|Overall Study|scheduling/transportation conflict|3|||
94220781|NCT03849300|322599382|FG003|Overall Study|scheduling/transportation conflict|2|||
94220782|NCT00464737|322599384|FG000|Overall Study|Adverse Event|12|||
94220783|NCT00464737|322599385|FG001|Overall Study|Adverse Event|17|||
94220784|NCT00464737|322599386|FG002|Overall Study|Adverse Event|33|||
94220785|NCT00464737|322599384|FG000|Overall Study|Lack of Efficacy|7|||
94220786|NCT00464737|322599385|FG001|Overall Study|Lack of Efficacy|7|||
94220787|NCT00464737|322599386|FG002|Overall Study|Lack of Efficacy|4|||
94220788|NCT00464737|322599384|FG000|Overall Study|Withdrawal by Subject|5|||
94220789|NCT00464737|322599385|FG001|Overall Study|Withdrawal by Subject|3|||
94220790|NCT00464737|322599386|FG002|Overall Study|Withdrawal by Subject|5|||
94220791|NCT00464737|322599384|FG000|Overall Study|Protocol Violation|1|||
94220792|NCT00464737|322599385|FG001|Overall Study|Protocol Violation|1|||
94220793|NCT00464737|322599386|FG002|Overall Study|Protocol Violation|5|||
94220794|NCT00464737|322599384|FG000|Overall Study|Non-compliance|0|||
94220795|NCT00464737|322599385|FG001|Overall Study|Non-compliance|1|||
94220796|NCT00464737|322599386|FG002|Overall Study|Non-compliance|1|||
94220797|NCT00464737|322599384|FG000|Overall Study|Lost to Follow-up|5|||
94220798|NCT00464737|322599385|FG001|Overall Study|Lost to Follow-up|2|||
94220799|NCT00464737|322599386|FG002|Overall Study|Lost to Follow-up|5|||
94220800|NCT00464737|322599384|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
94220801|NCT00464737|322599385|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
94220802|NCT00464737|322599386|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
94220803|NCT00464737|322599384|FG000|Overall Study|Other: Subject left town; family illness|1|||
94220804|NCT00464737|322599385|FG001|Overall Study|Other: Subject left town; family illness|0|||
94220805|NCT00464737|322599386|FG002|Overall Study|Other: Subject left town; family illness|0|||
94220806|NCT00464737|322599384|FG000|Overall Study|Other: Study demands too great|0|||
94220807|NCT00464737|322599385|FG001|Overall Study|Other: Study demands too great|1|||
94220808|NCT00464737|322599386|FG002|Overall Study|Other: Study demands too great|0|||
94220809|NCT00464737|322599384|FG000|Overall Study|Other: Personal family reasons|0|||
94220810|NCT00464737|322599385|FG001|Overall Study|Other: Personal family reasons|0|||
94220811|NCT00464737|322599386|FG002|Overall Study|Other: Personal family reasons|1|||
94220812|NCT00464737|322599384|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
94220813|NCT00464737|322599385|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
94220814|NCT00464737|322599386|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
94220815|NCT04374253|322599387|FG000|Overall Study|Adverse Event|0|||
94220816|NCT04374253|322599388|FG001|Overall Study|Adverse Event|26|||
94220817|NCT04374253|322599389|FG002|Overall Study|Adverse Event|2|||
94220818|NCT04374253|322599390|FG003|Overall Study|Adverse Event|12|||
94220819|NCT04374253|322599387|FG000|Overall Study|Study terminated by sponsor|13|||
94220820|NCT04374253|322599388|FG001|Overall Study|Study terminated by sponsor|593|||
94220821|NCT04374253|322599389|FG002|Overall Study|Study terminated by sponsor|21|||
94220822|NCT04374253|322599390|FG003|Overall Study|Study terminated by sponsor|567|||
94220823|NCT04374253|322599387|FG000|Overall Study|Withdrawal by Subject|0|||
94220824|NCT04374253|322599388|FG001|Overall Study|Withdrawal by Subject|55|||
94220825|NCT04374253|322599389|FG002|Overall Study|Withdrawal by Subject|3|||
94220826|NCT04374253|322599390|FG003|Overall Study|Withdrawal by Subject|40|||
94220827|NCT04374253|322599387|FG000|Overall Study|Physician Decision|1|||
94220828|NCT04374253|322599388|FG001|Overall Study|Physician Decision|10|||
94220829|NCT04374253|322599389|FG002|Overall Study|Physician Decision|1|||
94220830|NCT04374253|322599390|FG003|Overall Study|Physician Decision|10|||
94220831|NCT04374253|322599387|FG000|Overall Study|Protocol Violation|0|||
94220832|NCT04374253|322599388|FG001|Overall Study|Protocol Violation|0|||
94220833|NCT04374253|322599389|FG002|Overall Study|Protocol Violation|0|||
94220834|NCT04374253|322599390|FG003|Overall Study|Protocol Violation|2|||
94220835|NCT04374253|322599387|FG000|Overall Study|Death|0|||
94220836|NCT04374253|322599388|FG001|Overall Study|Death|3|||
94220837|NCT04374253|322599389|FG002|Overall Study|Death|1|||
94220838|NCT04374253|322599390|FG003|Overall Study|Death|1|||
94220839|NCT04374253|322599387|FG000|Overall Study|Lack of Efficacy|0|||
94220840|NCT04374253|322599388|FG001|Overall Study|Lack of Efficacy|0|||
94220841|NCT04374253|322599389|FG002|Overall Study|Lack of Efficacy|0|||
94220842|NCT04374253|322599390|FG003|Overall Study|Lack of Efficacy|1|||
94220843|NCT04374253|322599387|FG000|Overall Study|Lost to Follow-up|1|||
94220844|NCT04374253|322599388|FG001|Overall Study|Lost to Follow-up|1|||
94220845|NCT04374253|322599389|FG002|Overall Study|Lost to Follow-up|0|||
94220846|NCT04374253|322599390|FG003|Overall Study|Lost to Follow-up|2|||
94220847|NCT04374253|322599387|FG000|Overall Study|Reason Not Specified|0|||
94220848|NCT04374253|322599388|FG001|Overall Study|Reason Not Specified|8|||
94220849|NCT04374253|322599389|FG002|Overall Study|Reason Not Specified|0|||
94220850|NCT04374253|322599390|FG003|Overall Study|Reason Not Specified|8|||
94220851|NCT00145496|322599391|FG000|Overall Study|Adverse Event|42|||
94220852|NCT00145496|322599392|FG001|Overall Study|Adverse Event|30|||
94220853|NCT00145496|322599391|FG000|Overall Study|Lack of Efficacy|12|||
94220854|NCT00145496|322599392|FG001|Overall Study|Lack of Efficacy|7|||
94220855|NCT00145496|322599391|FG000|Overall Study|Withdrawal by Subject|32|||
94220856|NCT00145496|322599392|FG001|Overall Study|Withdrawal by Subject|26|||
94220857|NCT00145496|322599391|FG000|Overall Study|Lost to Follow-up|12|||
94220858|NCT00145496|322599392|FG001|Overall Study|Lost to Follow-up|5|||
94220859|NCT00145496|322599391|FG000|Overall Study|Other|25|||
94220860|NCT00145496|322599392|FG001|Overall Study|Other|13|||
94220861|NCT02676778|322599395|FG000|Overall Study|Disease Progression|7|||
94372497|NCT00479401|323150277|FG001|Overall Study|Adverse Event|20|||
94220862|NCT02676778|322599396|FG001|Overall Study|Disease Progression|3|||
94220863|NCT02676778|322599397|FG002|Overall Study|Disease Progression|1|||
94220864|NCT02676778|322599395|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
94220865|NCT02676778|322599396|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
94220866|NCT02676778|322599397|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
94220867|NCT02676778|322599395|FG000|Overall Study|Withdrawal by Subject|3|||
94220868|NCT02676778|322599396|FG001|Overall Study|Withdrawal by Subject|2|||
94220869|NCT02676778|322599397|FG002|Overall Study|Withdrawal by Subject|0|||
94220870|NCT02676778|322599395|FG000|Overall Study|Other|4|||
94220871|NCT02676778|322599396|FG001|Overall Study|Other|3|||
94220872|NCT02676778|322599397|FG002|Overall Study|Other|0|||
94220873|NCT02676778|322599395|FG000|Overall Study|Adverse Event|2|||
94220874|NCT02676778|322599396|FG001|Overall Study|Adverse Event|3|||
94220875|NCT02676778|322599397|FG002|Overall Study|Adverse Event|0|||
94220876|NCT03214198|322599401|FG000|Overall Study|Case Report Forms Uncollected|18|||
94220877|NCT03214198|322599401|FG000|Overall Study|Protocol Deviation|18|||
94220878|NCT00267865|322599402|FG000|Induction Treatment|Died before completing.|2|||
94220879|NCT00267865|322599402|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
94220880|NCT00760877|322601398|FG000|Overall Study|Protocol Violation|1|||
94220881|NCT00760877|322601399|FG001|Overall Study|Protocol Violation|0|||
94220882|NCT00760877|322601398|FG000|Overall Study|Non-compliance with protocol treatment|2|||
94220883|NCT00760877|322601399|FG001|Overall Study|Non-compliance with protocol treatment|1|||
94220884|NCT00760877|322601398|FG000|Overall Study|Pregnancy|1|||
94220885|NCT00760877|322601399|FG001|Overall Study|Pregnancy|4|||
94220886|NCT00760877|322601398|FG000|Overall Study|Death|2|||
94220887|NCT00760877|322601399|FG001|Overall Study|Death|1|||
94220888|NCT00760877|322601398|FG000|Overall Study|Withdrawal by Subject|7|||
94372498|NCT00479401|323150278|FG002|Overall Study|Adverse Event|4|||
94372499|NCT00479401|323150276|FG000|Overall Study|Lack of Efficacy|2|||
94220889|NCT00760877|322601399|FG001|Overall Study|Withdrawal by Subject|3|||
94220890|NCT00760877|322601398|FG000|Overall Study|Adverse Event|19|||
94220891|NCT00760877|322601399|FG001|Overall Study|Adverse Event|12|||
94220892|NCT00760877|322601398|FG000|Overall Study|Participant diagnosed with AML|0|||
94220893|NCT00760877|322601399|FG001|Overall Study|Participant diagnosed with AML|1|||
94220894|NCT00760877|322601398|FG000|Overall Study|Participant not eligible to cross-over|0|||
94220895|NCT00760877|322601399|FG001|Overall Study|Participant not eligible to cross-over|1|||
94220896|NCT00760877|322601398|FG000|Overall Study|Physician Decision|1|||
94220897|NCT00760877|322601399|FG001|Overall Study|Physician Decision|2|||
94220898|NCT00760877|322601398|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
94220899|NCT00760877|322601399|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
94220900|NCT00760877|322601398|FG000|Overall Study|Treatment failure|1|||
94220901|NCT00760877|322601399|FG001|Overall Study|Treatment failure|0|||
94220902|NCT01730118|322601402|FG000|Dose Escalation|Death on study|5|||
94220903|NCT01730118|322601403|FG001|Dose Escalation|Death on study|7|||
94220904|NCT01730118|322601404|FG002|Dose Escalation|Death on study|2|||
94220905|NCT01730118|322601405|FG003|Dose Escalation|Death on study|6|||
94220906|NCT01730118|322601406|FG004|Dose Escalation|Death on study|0|||
94220907|NCT01730118|322601407|FG005|Dose Escalation|Death on study|0|||
94220908|NCT01730118|322601408|FG006|Dose Escalation|Death on study|0|||
94220909|NCT01730118|322601402|FG000|Dose Escalation|Died before treatment|0|||
94220910|NCT01730118|322601403|FG001|Dose Escalation|Died before treatment|0|||
94220911|NCT01730118|322601404|FG002|Dose Escalation|Died before treatment|0|||
94220912|NCT01730118|322601405|FG003|Dose Escalation|Died before treatment|0|||
94220913|NCT01730118|322601406|FG004|Dose Escalation|Died before treatment|0|||
94220914|NCT01730118|322601407|FG005|Dose Escalation|Died before treatment|0|||
94220915|NCT01730118|322601408|FG006|Dose Escalation|Died before treatment|1|||
94220916|NCT01730118|322601402|FG000|Dose Escalation|Chose to start a different treatment|1|||
94220917|NCT01730118|322601403|FG001|Dose Escalation|Chose to start a different treatment|0|||
94220918|NCT01730118|322601404|FG002|Dose Escalation|Chose to start a different treatment|0|||
94220919|NCT01730118|322601405|FG003|Dose Escalation|Chose to start a different treatment|0|||
94220920|NCT01730118|322601406|FG004|Dose Escalation|Chose to start a different treatment|0|||
94220921|NCT01730118|322601407|FG005|Dose Escalation|Chose to start a different treatment|0|||
94220922|NCT01730118|322601408|FG006|Dose Escalation|Chose to start a different treatment|0|||
94220923|NCT01730118|322601402|FG000|Dose Escalation|Withdrawal by Subject|0|||
94220924|NCT01730118|322601403|FG001|Dose Escalation|Withdrawal by Subject|0|||
94220925|NCT01730118|322601404|FG002|Dose Escalation|Withdrawal by Subject|1|||
94220926|NCT01730118|322601405|FG003|Dose Escalation|Withdrawal by Subject|0|||
94220927|NCT01730118|322601406|FG004|Dose Escalation|Withdrawal by Subject|0|||
94220928|NCT01730118|322601407|FG005|Dose Escalation|Withdrawal by Subject|0|||
94220929|NCT01730118|322601408|FG006|Dose Escalation|Withdrawal by Subject|0|||
94220930|NCT01730118|322601402|FG000|Dose Escalation|Disease progression prior to treatment|0|||
94220931|NCT01730118|322601403|FG001|Dose Escalation|Disease progression prior to treatment|0|||
94220932|NCT01730118|322601404|FG002|Dose Escalation|Disease progression prior to treatment|0|||
94220933|NCT01730118|322601405|FG003|Dose Escalation|Disease progression prior to treatment|0|||
94220934|NCT01730118|322601406|FG004|Dose Escalation|Disease progression prior to treatment|0|||
94220935|NCT01730118|322601407|FG005|Dose Escalation|Disease progression prior to treatment|0|||
94220936|NCT01730118|322601408|FG006|Dose Escalation|Disease progression prior to treatment|1|||
94220937|NCT01730118|322601402|FG000|Dose Expansion|Death|0|||
94220938|NCT01730118|322601403|FG001|Dose Expansion|Death|0|||
94220939|NCT01730118|322601404|FG002|Dose Expansion|Death|0|||
94220940|NCT01730118|322601405|FG003|Dose Expansion|Death|0|||
94220941|NCT01730118|322601406|FG004|Dose Expansion|Death|1|||
94220942|NCT01730118|322601407|FG005|Dose Expansion|Death|0|||
94220943|NCT01730118|322601408|FG006|Dose Expansion|Death|0|||
94220944|NCT01730118|322601402|FG000|Dose Expansion|Other medical condition|0|||
94220945|NCT01730118|322601403|FG001|Dose Expansion|Other medical condition|0|||
94220946|NCT01730118|322601404|FG002|Dose Expansion|Other medical condition|0|||
94220947|NCT01730118|322601405|FG003|Dose Expansion|Other medical condition|0|||
94287375|NCT00805740|322842262|FG001|Overall Study|Randomized, but not treated|0|||
94287376|NCT03068325|322842263|FG000|Overall Study|Lost to Follow-up|5|||
94287377|NCT00700180|322842264|FG000|Overall Study|Death|99|||
94287378|NCT00700180|322842265|FG001|Overall Study|Death|114|||
94220948|NCT01730118|322601406|FG004|Dose Expansion|Other medical condition|1|||
94220949|NCT01730118|322601407|FG005|Dose Expansion|Other medical condition|0|||
94220950|NCT01730118|322601408|FG006|Dose Expansion|Other medical condition|0|||
94220951|NCT01730118|322601402|FG000|Dose Expansion|Withdrawal by Subject|0|||
94220952|NCT01730118|322601403|FG001|Dose Expansion|Withdrawal by Subject|0|||
94220953|NCT01730118|322601404|FG002|Dose Expansion|Withdrawal by Subject|0|||
94220954|NCT01730118|322601405|FG003|Dose Expansion|Withdrawal by Subject|0|||
94220955|NCT01730118|322601406|FG004|Dose Expansion|Withdrawal by Subject|1|||
94220956|NCT01730118|322601407|FG005|Dose Expansion|Withdrawal by Subject|0|||
94220957|NCT01730118|322601408|FG006|Dose Expansion|Withdrawal by Subject|0|||
94287379|NCT00700180|322842264|FG000|Overall Study|Alive on treatment|5|||
94287380|NCT00700180|322842265|FG001|Overall Study|Alive on treatment|3|||
94220958|NCT01730118|322601402|FG000|Dose Expansion|Disease progression|0|||
94220959|NCT01730118|322601403|FG001|Dose Expansion|Disease progression|0|||
94220960|NCT01730118|322601404|FG002|Dose Expansion|Disease progression|0|||
94220961|NCT01730118|322601405|FG003|Dose Expansion|Disease progression|0|||
94220962|NCT01730118|322601406|FG004|Dose Expansion|Disease progression|0|||
94220963|NCT01730118|322601407|FG005|Dose Expansion|Disease progression|1|||
94220964|NCT01730118|322601408|FG006|Dose Expansion|Disease progression|0|||
94220965|NCT01730118|322601402|FG000|Dose Expansion|Inability to return|0|||
94220966|NCT01730118|322601403|FG001|Dose Expansion|Inability to return|0|||
94220967|NCT01730118|322601404|FG002|Dose Expansion|Inability to return|0|||
94220968|NCT01730118|322601405|FG003|Dose Expansion|Inability to return|0|||
94220969|NCT01730118|322601406|FG004|Dose Expansion|Inability to return|0|||
94220970|NCT01730118|322601407|FG005|Dose Expansion|Inability to return|1|||
94220971|NCT01730118|322601408|FG006|Dose Expansion|Inability to return|0|||
94220972|NCT01730118|322601402|FG000|Dose Expansion|Physician Decision|0|||
94220973|NCT01730118|322601403|FG001|Dose Expansion|Physician Decision|0|||
94220974|NCT01730118|322601404|FG002|Dose Expansion|Physician Decision|0|||
94220975|NCT01730118|322601405|FG003|Dose Expansion|Physician Decision|0|||
94220976|NCT01730118|322601406|FG004|Dose Expansion|Physician Decision|0|||
94220977|NCT01730118|322601407|FG005|Dose Expansion|Physician Decision|1|||
94220978|NCT01730118|322601408|FG006|Dose Expansion|Physician Decision|0|||
94220979|NCT00489489|322601412|FG000|Overall Study|Not treated due to protocol violation|0|||
94220980|NCT00489489|322601413|FG001|Overall Study|Not treated due to protocol violation|1|||
94220981|NCT00489489|322601414|FG002|Overall Study|Not treated due to protocol violation|1|||
94220982|NCT00489489|322601412|FG000|Overall Study|Adverse Event|1|||
94220983|NCT00489489|322601413|FG001|Overall Study|Adverse Event|1|||
94220984|NCT00489489|322601414|FG002|Overall Study|Adverse Event|1|||
94220985|NCT00489489|322601412|FG000|Overall Study|Protocol Violation|1|||
94220986|NCT00489489|322601413|FG001|Overall Study|Protocol Violation|0|||
94220987|NCT00489489|322601414|FG002|Overall Study|Protocol Violation|1|||
94220988|NCT00489489|322601412|FG000|Overall Study|Progressive disease|0|||
94220989|NCT00489489|322601413|FG001|Overall Study|Progressive disease|1|||
94220990|NCT00489489|322601414|FG002|Overall Study|Progressive disease|0|||
94220991|NCT00489489|322601412|FG000|Overall Study|Participant did not wish to continue|1|||
94220992|NCT00489489|322601413|FG001|Overall Study|Participant did not wish to continue|1|||
94220993|NCT00489489|322601414|FG002|Overall Study|Participant did not wish to continue|0|||
94220994|NCT00489489|322601412|FG000|Overall Study|Other than above|0|||
94287381|NCT00700180|322842264|FG000|Overall Study|Alive in follow-up|46|||
94287382|NCT00700180|322842265|FG001|Overall Study|Alive in follow-up|27|||
94287383|NCT00700180|322842264|FG000|Overall Study|Lost to Follow-up|4|||
94287384|NCT00700180|322842265|FG001|Overall Study|Lost to Follow-up|5|||
94287385|NCT01613326|322842268|FG000|Overall Study|Adverse Event|7|||
94287386|NCT01613326|322842269|FG001|Overall Study|Adverse Event|5|||
94287387|NCT01613326|322842268|FG000|Overall Study|Withdrawal by Subject|3|||
94287388|NCT01613326|322842269|FG001|Overall Study|Withdrawal by Subject|4|||
94287389|NCT01613326|322842268|FG000|Overall Study|Abnormal test procedure result(s)|2|||
94287390|NCT01613326|322842269|FG001|Overall Study|Abnormal test procedure result(s)|0|||
94287391|NCT01613326|322842268|FG000|Overall Study|inability to use device|1|||
94287392|NCT01613326|322842269|FG001|Overall Study|inability to use device|0|||
94287393|NCT01613326|322842268|FG000|Overall Study|Lack of Efficacy|0|||
94287394|NCT01613326|322842269|FG001|Overall Study|Lack of Efficacy|1|||
94287395|NCT01613326|322842268|FG000|Overall Study|Lost to Follow-up|0|||
94287396|NCT01613326|322842269|FG001|Overall Study|Lost to Follow-up|1|||
94287397|NCT01613326|322842268|FG000|Overall Study|Administrative|0|||
94287398|NCT01613326|322842269|FG001|Overall Study|Administrative|2|||
94287399|NCT01613326|322842268|FG000|Overall Study|Protocol Violation|0|||
94287400|NCT01613326|322842269|FG001|Overall Study|Protocol Violation|1|||
94287401|NCT03588741|322842272|FG000|Overall Study|Withdrawal by Subject|1|||
94287402|NCT00420511|322842273|FG000|Overall Study|Adverse Event|1|||
94287403|NCT00420511|322842274|FG001|Overall Study|Adverse Event|1|||
94287404|NCT00420511|322842273|FG000|Overall Study|Lost to Follow-up|1|||
94287405|NCT00420511|322842274|FG001|Overall Study|Lost to Follow-up|0|||
94287406|NCT01467492|322842275|FG000|Overall Study|Withdrawal by Subject|6|||
94287407|NCT01467492|322842276|FG001|Overall Study|Withdrawal by Subject|4|||
94287408|NCT01467492|322842275|FG000|Overall Study|Study Terminated by Sponsor|6|||
94287409|NCT01467492|322842276|FG001|Overall Study|Study Terminated by Sponsor|4|||
94220995|NCT00489489|322601413|FG001|Overall Study|Other than above|1|||
94220996|NCT00489489|322601414|FG002|Overall Study|Other than above|0|||
94220997|NCT04620733|322601416|FG000|Overall Study|Adverse Event|4|||
94220998|NCT04620733|322601417|FG001|Overall Study|Adverse Event|3|||
94287410|NCT01467492|322842275|FG000|Overall Study|Adverse Event|4|||
94287411|NCT01467492|322842276|FG001|Overall Study|Adverse Event|3|||
94220999|NCT04620733|322601416|FG000|Overall Study|Withdrawal by Subject|2|||
94287412|NCT01467492|322842275|FG000|Overall Study|Lost to Follow-up|3|||
94221000|NCT04620733|322601417|FG001|Overall Study|Withdrawal by Subject|5|||
94221001|NCT04620733|322601416|FG000|Overall Study|Lost to Follow-up|1|||
94221002|NCT04620733|322601417|FG001|Overall Study|Lost to Follow-up|1|||
94221003|NCT04620733|322601416|FG000|Overall Study|Protocol Deviation|1|||
94221004|NCT04620733|322601417|FG001|Overall Study|Protocol Deviation|1|||
94221005|NCT04620733|322601416|FG000|Overall Study|Reason Not Specified|0|||
94221006|NCT04620733|322601417|FG001|Overall Study|Reason Not Specified|1|||
94221007|NCT01503515|322601420|FG000|Overall Study|Adverse Event|4|||
94221008|NCT01503515|322601421|FG001|Overall Study|Adverse Event|5|||
94221009|NCT01503515|322601420|FG000|Overall Study|Death|0|||
94221010|NCT01503515|322601421|FG001|Overall Study|Death|1|||
94221011|NCT01503515|322601420|FG000|Overall Study|Physician Decision|14|||
94221012|NCT01503515|322601421|FG001|Overall Study|Physician Decision|23|||
94221013|NCT01503515|322601420|FG000|Overall Study|Withdrawal by Subject|0|||
94221014|NCT01503515|322601421|FG001|Overall Study|Withdrawal by Subject|1|||
94221015|NCT01503515|322601420|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
94221016|NCT01503515|322601421|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
94221017|NCT01503515|322601420|FG000|Overall Study|Ineligible|1|||
94221018|NCT01503515|322601421|FG001|Overall Study|Ineligible|1|||
94221019|NCT04050722|322601422|FG000|Overall Study|Withdrawal by Subject|1|||
94221020|NCT04050722|322601423|FG001|Overall Study|Withdrawal by Subject|0|||
94221021|NCT02762500|322601424|FG000|Overall Study|Lack of Efficacy|1|||
94221022|NCT02762500|322601425|FG001|Overall Study|Lack of Efficacy|0|||
94221023|NCT02762500|322601424|FG000|Overall Study|Withdrawal by Subject|1|||
94221024|NCT02762500|322601425|FG001|Overall Study|Withdrawal by Subject|1|||
94221025|NCT02762500|322601424|FG000|Overall Study|Adverse Event|0|||
94221026|NCT02762500|322601425|FG001|Overall Study|Adverse Event|2|||
94221027|NCT01350102|322601426|FG000|Overall Study|Adverse Event|0|||
94221028|NCT01350102|322601427|FG001|Overall Study|Adverse Event|0|||
94221029|NCT01350102|322601428|FG002|Overall Study|Adverse Event|1|||
94221030|NCT01350102|322601429|FG003|Overall Study|Adverse Event|0|||
94221031|NCT05066230|322601431|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
94221032|NCT05066230|322601432|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
94221033|NCT05066230|322601431|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
94221034|NCT05066230|322601432|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
94221035|NCT05066230|322601431|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
94221036|NCT05066230|322601432|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
94221037|NCT05066230|322601431|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
94221038|NCT05066230|322601432|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
94221039|NCT05066230|322601431|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
94221040|NCT05066230|322601432|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
94221041|NCT05066230|322601431|FG000|After Week 48|Adverse Event|1|||
94221042|NCT05066230|322601432|FG001|After Week 48|Adverse Event|0|||
94221043|NCT05066230|322601431|FG000|After Week 48|Non-compliance with study schedule|1|||
94221044|NCT05066230|322601432|FG001|After Week 48|Non-compliance with study schedule|0|||
94221045|NCT05066230|322601431|FG000|After Week 48|Withdrawal by Subject|0|||
94221046|NCT05066230|322601432|FG001|After Week 48|Withdrawal by Subject|1|||
94221047|NCT05066230|322601431|FG000|After Week 48|Lost to Follow-up|3|||
94221048|NCT05066230|322601432|FG001|After Week 48|Lost to Follow-up|3|||
94221049|NCT05066230|322601431|FG000|After Week 48|Sponsor Request|115|||
94221050|NCT05066230|322601432|FG001|After Week 48|Sponsor Request|111|||
94221051|NCT01863368|322601433|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
94221052|NCT01863368|322601434|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
94221053|NCT01863368|322601433|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
94221054|NCT01863368|322601434|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
94221055|NCT01863368|322601433|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
94221056|NCT01863368|322601434|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
94221057|NCT01863368|322601433|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
94221058|NCT01863368|322601434|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
94221059|NCT01863368|322601433|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
94221060|NCT01863368|322601434|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
94221061|NCT01863368|322601433|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
94221062|NCT01863368|322601434|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
94221063|NCT00515112|322601435|FG000|Overall Study|Death|0|||
94221064|NCT00515112|322601436|FG001|Overall Study|Death|1|||
94221065|NCT00515112|322601435|FG000|Overall Study|The study was terminated|3|||
94221066|NCT00515112|322601436|FG001|Overall Study|The study was terminated|2|||
94221067|NCT01020487|322601437|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
94221068|NCT01020487|322601438|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
94221069|NCT01020487|322601439|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
94221070|NCT01020487|322601437|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
94221071|NCT01020487|322601438|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
94221072|NCT01020487|322601439|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
94221073|NCT01020487|322601437|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
94221074|NCT01020487|322601438|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
94221075|NCT01020487|322601439|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
94221076|NCT01020487|322601437|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
94221077|NCT01020487|322601438|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
94221078|NCT01020487|322601439|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
94221079|NCT01020487|322601437|FG000|Part 2 Open-label Period|Adverse Event|0|||
94221080|NCT01020487|322601438|FG001|Part 2 Open-label Period|Adverse Event|4|||
94221081|NCT01020487|322601439|FG002|Part 2 Open-label Period|Adverse Event|1|||
94221082|NCT01825785|322601440|FG000|Overall Study|Adverse Event|0|||
94221083|NCT01825785|322601441|FG001|Overall Study|Adverse Event|0|||
94221084|NCT01825785|322601442|FG002|Overall Study|Adverse Event|0|||
94221085|NCT01825785|322601443|FG003|Overall Study|Adverse Event|0|||
94221086|NCT01825785|322601444|FG004|Overall Study|Adverse Event|1|||
94221087|NCT01825785|322601445|FG005|Overall Study|Adverse Event|0|||
94221088|NCT01825785|322601446|FG006|Overall Study|Adverse Event|0|||
94221089|NCT01825785|322601440|FG000|Overall Study|Withdrawal by Subject|0|||
94221090|NCT01825785|322601441|FG001|Overall Study|Withdrawal by Subject|0|||
94221091|NCT01825785|322601442|FG002|Overall Study|Withdrawal by Subject|0|||
94221092|NCT01825785|322601443|FG003|Overall Study|Withdrawal by Subject|0|||
94221093|NCT01825785|322601444|FG004|Overall Study|Withdrawal by Subject|1|||
94221094|NCT01825785|322601445|FG005|Overall Study|Withdrawal by Subject|1|||
94221095|NCT01825785|322601446|FG006|Overall Study|Withdrawal by Subject|0|||
94221096|NCT00946088|322601447|FG000|Overall Study|Withdrawal by Subject|0|||
94221097|NCT00946088|322601448|FG001|Overall Study|Withdrawal by Subject|1|||
94221098|NCT02368691|322601451|FG000|Overall Study|Death|13|||
94221099|NCT02368691|322601451|FG000|Overall Study|Lack of Efficacy|15|||
94221100|NCT02368691|322601451|FG000|Overall Study|Physician Decision|4|||
94221101|NCT02660034|322601452|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
94221102|NCT02660034|322601453|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
94221103|NCT02660034|322601454|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
94221104|NCT02660034|322601455|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
94221105|NCT02660034|322601456|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
94221106|NCT02660034|322601457|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
94221107|NCT02660034|322601458|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
94221108|NCT02660034|322601459|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
94221109|NCT02660034|322601460|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
94221110|NCT02660034|322601461|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
94221111|NCT02660034|322601462|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
94221112|NCT02660034|322601463|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
94221113|NCT02660034|322601464|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
94221114|NCT02660034|322601465|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
94221115|NCT02660034|322601452|FG000|Overall Study|Progressive Disease (Clinical)|7|||
94221116|NCT02660034|322601453|FG001|Overall Study|Progressive Disease (Clinical)|8|||
94221117|NCT02660034|322601454|FG002|Overall Study|Progressive Disease (Clinical)|3|||
94221118|NCT02660034|322601455|FG003|Overall Study|Progressive Disease (Clinical)|9|||
94221119|NCT02660034|322601456|FG004|Overall Study|Progressive Disease (Clinical)|3|||
94221120|NCT02660034|322601457|FG005|Overall Study|Progressive Disease (Clinical)|0|||
94221121|NCT02660034|322601458|FG006|Overall Study|Progressive Disease (Clinical)|0|||
94221122|NCT02660034|322601459|FG007|Overall Study|Progressive Disease (Clinical)|0|||
94221123|NCT02660034|322601460|FG008|Overall Study|Progressive Disease (Clinical)|0|||
94221124|NCT02660034|322601461|FG009|Overall Study|Progressive Disease (Clinical)|0|||
94221125|NCT02660034|322601462|FG010|Overall Study|Progressive Disease (Clinical)|0|||
94221126|NCT02660034|322601463|FG011|Overall Study|Progressive Disease (Clinical)|0|||
94221127|NCT02660034|322601464|FG012|Overall Study|Progressive Disease (Clinical)|0|||
94221128|NCT02660034|322601465|FG013|Overall Study|Progressive Disease (Clinical)|0|||
94221129|NCT02660034|322601452|FG000|Overall Study|Lost to Follow-up|0|||
94221130|NCT02660034|322601453|FG001|Overall Study|Lost to Follow-up|0|||
94221131|NCT02660034|322601454|FG002|Overall Study|Lost to Follow-up|1|||
94221132|NCT02660034|322601455|FG003|Overall Study|Lost to Follow-up|1|||
94221133|NCT02660034|322601456|FG004|Overall Study|Lost to Follow-up|0|||
94221134|NCT02660034|322601457|FG005|Overall Study|Lost to Follow-up|0|||
94221135|NCT02660034|322601458|FG006|Overall Study|Lost to Follow-up|0|||
94287413|NCT01467492|322842276|FG001|Overall Study|Lost to Follow-up|2|||
94287414|NCT01467492|322842275|FG000|Overall Study|Undefined|2|||
94221136|NCT02660034|322601459|FG007|Overall Study|Lost to Follow-up|0|||
94221137|NCT02660034|322601460|FG008|Overall Study|Lost to Follow-up|0|||
94221138|NCT02660034|322601461|FG009|Overall Study|Lost to Follow-up|1|||
94221139|NCT02660034|322601462|FG010|Overall Study|Lost to Follow-up|1|||
94221140|NCT02660034|322601463|FG011|Overall Study|Lost to Follow-up|1|||
94221141|NCT02660034|322601464|FG012|Overall Study|Lost to Follow-up|0|||
94221142|NCT02660034|322601465|FG013|Overall Study|Lost to Follow-up|0|||
94221143|NCT02660034|322601452|FG000|Overall Study|Participant moved into special access scheme|1|||
94221144|NCT02660034|322601453|FG001|Overall Study|Participant moved into special access scheme|2|||
94221145|NCT02660034|322601454|FG002|Overall Study|Participant moved into special access scheme|0|||
94287415|NCT01467492|322842276|FG001|Overall Study|Undefined|0|||
94287416|NCT01467492|322842275|FG000|Overall Study|Enrolled But Not Treated|1|||
94221146|NCT02660034|322601455|FG003|Overall Study|Participant moved into special access scheme|0|||
94221147|NCT02660034|322601456|FG004|Overall Study|Participant moved into special access scheme|0|||
94221148|NCT02660034|322601457|FG005|Overall Study|Participant moved into special access scheme|0|||
94221149|NCT02660034|322601458|FG006|Overall Study|Participant moved into special access scheme|0|||
94221150|NCT02660034|322601459|FG007|Overall Study|Participant moved into special access scheme|0|||
94221151|NCT02660034|322601460|FG008|Overall Study|Participant moved into special access scheme|0|||
94221152|NCT02660034|322601461|FG009|Overall Study|Participant moved into special access scheme|0|||
94221153|NCT02660034|322601462|FG010|Overall Study|Participant moved into special access scheme|0|||
94221154|NCT02660034|322601463|FG011|Overall Study|Participant moved into special access scheme|0|||
94221155|NCT02660034|322601464|FG012|Overall Study|Participant moved into special access scheme|0|||
94221156|NCT02660034|322601465|FG013|Overall Study|Participant moved into special access scheme|0|||
94221157|NCT02660034|322601452|FG000|Overall Study|Adverse Event|1|||
94221158|NCT02660034|322601453|FG001|Overall Study|Adverse Event|0|||
94221159|NCT02660034|322601454|FG002|Overall Study|Adverse Event|0|||
94221160|NCT02660034|322601455|FG003|Overall Study|Adverse Event|0|||
94221161|NCT02660034|322601456|FG004|Overall Study|Adverse Event|0|||
94221162|NCT02660034|322601457|FG005|Overall Study|Adverse Event|0|||
94221163|NCT02660034|322601458|FG006|Overall Study|Adverse Event|0|||
94221164|NCT02660034|322601459|FG007|Overall Study|Adverse Event|0|||
94221165|NCT02660034|322601460|FG008|Overall Study|Adverse Event|0|||
94221166|NCT02660034|322601461|FG009|Overall Study|Adverse Event|0|||
94221167|NCT02660034|322601462|FG010|Overall Study|Adverse Event|0|||
94221168|NCT02660034|322601463|FG011|Overall Study|Adverse Event|0|||
94221169|NCT02660034|322601464|FG012|Overall Study|Adverse Event|0|||
94221170|NCT02660034|322601465|FG013|Overall Study|Adverse Event|0|||
94221171|NCT02660034|322601452|FG000|Overall Study|Sponsor Decision|0|||
94221172|NCT02660034|322601453|FG001|Overall Study|Sponsor Decision|1|||
94221173|NCT02660034|322601454|FG002|Overall Study|Sponsor Decision|2|||
94221174|NCT02660034|322601455|FG003|Overall Study|Sponsor Decision|2|||
94221175|NCT02660034|322601456|FG004|Overall Study|Sponsor Decision|3|||
94221176|NCT02660034|322601457|FG005|Overall Study|Sponsor Decision|0|||
94221177|NCT02660034|322601458|FG006|Overall Study|Sponsor Decision|0|||
94221178|NCT02660034|322601459|FG007|Overall Study|Sponsor Decision|0|||
94221179|NCT02660034|322601460|FG008|Overall Study|Sponsor Decision|0|||
94221180|NCT02660034|322601461|FG009|Overall Study|Sponsor Decision|0|||
94221181|NCT02660034|322601462|FG010|Overall Study|Sponsor Decision|0|||
94221182|NCT02660034|322601463|FG011|Overall Study|Sponsor Decision|0|||
94221183|NCT02660034|322601464|FG012|Overall Study|Sponsor Decision|0|||
94221184|NCT02660034|322601465|FG013|Overall Study|Sponsor Decision|1|||
94221185|NCT02660034|322601452|FG000|Overall Study|Withdrawal by Subject|0|||
94221186|NCT02660034|322601453|FG001|Overall Study|Withdrawal by Subject|0|||
94221187|NCT02660034|322601454|FG002|Overall Study|Withdrawal by Subject|0|||
94221188|NCT02660034|322601455|FG003|Overall Study|Withdrawal by Subject|0|||
94221189|NCT02660034|322601456|FG004|Overall Study|Withdrawal by Subject|0|||
94221190|NCT02660034|322601457|FG005|Overall Study|Withdrawal by Subject|0|||
94221191|NCT02660034|322601458|FG006|Overall Study|Withdrawal by Subject|1|||
94221192|NCT02660034|322601459|FG007|Overall Study|Withdrawal by Subject|1|||
94221193|NCT02660034|322601460|FG008|Overall Study|Withdrawal by Subject|1|||
94221194|NCT02660034|322601461|FG009|Overall Study|Withdrawal by Subject|0|||
94221195|NCT02660034|322601462|FG010|Overall Study|Withdrawal by Subject|0|||
94221196|NCT02660034|322601463|FG011|Overall Study|Withdrawal by Subject|1|||
94221197|NCT02660034|322601464|FG012|Overall Study|Withdrawal by Subject|2|||
94221198|NCT02660034|322601465|FG013|Overall Study|Withdrawal by Subject|0|||
94221199|NCT02660034|322601452|FG000|Overall Study|Death|0|||
94221200|NCT02660034|322601453|FG001|Overall Study|Death|0|||
94221201|NCT02660034|322601454|FG002|Overall Study|Death|0|||
94221202|NCT02660034|322601455|FG003|Overall Study|Death|0|||
94221203|NCT02660034|322601456|FG004|Overall Study|Death|0|||
94221204|NCT02660034|322601457|FG005|Overall Study|Death|13|||
94221205|NCT02660034|322601458|FG006|Overall Study|Death|14|||
94221206|NCT02660034|322601459|FG007|Overall Study|Death|10|||
94221207|NCT02660034|322601460|FG008|Overall Study|Death|9|||
94221208|NCT02660034|322601461|FG009|Overall Study|Death|21|||
94221209|NCT02660034|322601462|FG010|Overall Study|Death|17|||
94287417|NCT01467492|322842276|FG001|Overall Study|Enrolled But Not Treated|0|||
94287418|NCT00168831|322842280|FG000|Overall Study|Adverse Event|36|||
94221210|NCT02660034|322601463|FG011|Overall Study|Death|15|||
94221211|NCT02660034|322601464|FG012|Overall Study|Death|18|||
94221212|NCT02660034|322601465|FG013|Overall Study|Death|7|||
94221213|NCT02660034|322601452|FG000|Overall Study|Physician Decision|0|||
94221214|NCT02660034|322601453|FG001|Overall Study|Physician Decision|0|||
94221215|NCT02660034|322601454|FG002|Overall Study|Physician Decision|0|||
94221216|NCT02660034|322601455|FG003|Overall Study|Physician Decision|0|||
94221217|NCT02660034|322601456|FG004|Overall Study|Physician Decision|0|||
94221218|NCT02660034|322601457|FG005|Overall Study|Physician Decision|0|||
94221219|NCT02660034|322601458|FG006|Overall Study|Physician Decision|0|||
94221220|NCT02660034|322601459|FG007|Overall Study|Physician Decision|0|||
94287419|NCT00168831|322842281|FG001|Overall Study|Adverse Event|47|||
94221221|NCT02660034|322601460|FG008|Overall Study|Physician Decision|0|||
94221222|NCT02660034|322601461|FG009|Overall Study|Physician Decision|0|||
94221223|NCT02660034|322601462|FG010|Overall Study|Physician Decision|0|||
94221224|NCT02660034|322601463|FG011|Overall Study|Physician Decision|0|||
94221225|NCT02660034|322601464|FG012|Overall Study|Physician Decision|0|||
94221226|NCT02660034|322601465|FG013|Overall Study|Physician Decision|1|||
94221227|NCT02660034|322601452|FG000|Overall Study|Participants transferred to LTE|0|||
94221228|NCT02660034|322601453|FG001|Overall Study|Participants transferred to LTE|0|||
94221229|NCT02660034|322601454|FG002|Overall Study|Participants transferred to LTE|0|||
94221230|NCT02660034|322601455|FG003|Overall Study|Participants transferred to LTE|0|||
94221231|NCT02660034|322601456|FG004|Overall Study|Participants transferred to LTE|0|||
94221232|NCT02660034|322601457|FG005|Overall Study|Participants transferred to LTE|10|||
94221233|NCT02660034|322601458|FG006|Overall Study|Participants transferred to LTE|8|||
94221234|NCT02660034|322601459|FG007|Overall Study|Participants transferred to LTE|8|||
94221235|NCT02660034|322601460|FG008|Overall Study|Participants transferred to LTE|10|||
94221236|NCT02660034|322601461|FG009|Overall Study|Participants transferred to LTE|1|||
94221237|NCT02660034|322601462|FG010|Overall Study|Participants transferred to LTE|2|||
94221238|NCT02660034|322601463|FG011|Overall Study|Participants transferred to LTE|4|||
94221239|NCT02660034|322601464|FG012|Overall Study|Participants transferred to LTE|1|||
94221240|NCT02660034|322601465|FG013|Overall Study|Participants transferred to LTE|1|||
94221241|NCT01838447|322601466|FG000|Overall Study|Change in surgical plan|1|||
94221242|NCT01838447|322601467|FG001|Overall Study|Change in surgical plan|2|||
94221243|NCT01838447|322601466|FG000|Overall Study|Withdrawal by Subject|1|||
94221244|NCT01838447|322601467|FG001|Overall Study|Withdrawal by Subject|1|||
94221245|NCT01114217|322601469|FG000|Overall Study|Adverse Event|5|||
94221246|NCT01114217|322601470|FG001|Overall Study|Adverse Event|3|||
94221247|NCT01114217|322601469|FG000|Overall Study|Lost to Follow-up|17|||
94221248|NCT01114217|322601470|FG001|Overall Study|Lost to Follow-up|33|||
94221249|NCT01114217|322601469|FG000|Overall Study|Withdrawal by Subject|21|||
94221250|NCT01114217|322601470|FG001|Overall Study|Withdrawal by Subject|28|||
94221251|NCT01114217|322601469|FG000|Overall Study|Other-Clerical Error|3|||
94221252|NCT01114217|322601470|FG001|Overall Study|Other-Clerical Error|0|||
94221253|NCT01114217|322601469|FG000|Overall Study|Other-Early termination|6|||
94221254|NCT01114217|322601470|FG001|Overall Study|Other-Early termination|10|||
94221255|NCT01114217|322601469|FG000|Overall Study|Other-Procedure|1|||
94221256|NCT01114217|322601470|FG001|Overall Study|Other-Procedure|1|||
94221257|NCT01114217|322601469|FG000|Overall Study|Other-Pregnancy|2|||
94221258|NCT01114217|322601470|FG001|Overall Study|Other-Pregnancy|4|||
94221259|NCT01114217|322601469|FG000|Overall Study|Other-Protocol Violation|1|||
94221260|NCT01114217|322601470|FG001|Overall Study|Other-Protocol Violation|3|||
94221261|NCT01114217|322601469|FG000|Overall Study|Other-Lack of Efficacy|1|||
94221262|NCT01114217|322601470|FG001|Overall Study|Other-Lack of Efficacy|0|||
94221263|NCT01114217|322601469|FG000|Overall Study|Other-Non Compliance|2|||
94221264|NCT01114217|322601470|FG001|Overall Study|Other-Non Compliance|0|||
94221265|NCT01114217|322601469|FG000|Overall Study|Other-Physician Decision|1|||
94221266|NCT01114217|322601470|FG001|Overall Study|Other-Physician Decision|1|||
94221267|NCT01114217|322601469|FG000|Overall Study|Other-Sponsor Decision|10|||
94221268|NCT01114217|322601470|FG001|Overall Study|Other-Sponsor Decision|12|||
94221269|NCT01114217|322601469|FG000|Overall Study|Other-Study Termination|0|||
94221270|NCT01114217|322601470|FG001|Overall Study|Other-Study Termination|1|||
94221271|NCT01114217|322601469|FG000|Overall Study|Other-Study Withdrawn|1|||
94221272|NCT01114217|322601470|FG001|Overall Study|Other-Study Withdrawn|1|||
94221273|NCT01114217|322601469|FG000|Overall Study|Other-Site Stopped Communicating|2|||
94221274|NCT01114217|322601470|FG001|Overall Study|Other-Site Stopped Communicating|0|||
94221275|NCT01114217|322601469|FG000|Overall Study|Other-Lost to Follow-up|1|||
94221276|NCT01114217|322601470|FG001|Overall Study|Other-Lost to Follow-up|0|||
94221277|NCT01114217|322601469|FG000|Overall Study|Other-Withdrawal by Subject|1|||
94221278|NCT01114217|322601470|FG001|Overall Study|Other-Withdrawal by Subject|1|||
94221279|NCT01703988|322601471|FG000|Overall Study|Investigator Judgment|0|||
94221280|NCT01703988|322601472|FG001|Overall Study|Investigator Judgment|0|||
94221281|NCT01703988|322601473|FG002|Overall Study|Investigator Judgment|0|||
94221282|NCT01703988|322601474|FG003|Overall Study|Investigator Judgment|1|||
94221283|NCT02475733|322601477|FG000|Overall Study|Withdrawal by Subject|1|||
94221284|NCT02475733|322601478|FG001|Overall Study|Withdrawal by Subject|0|||
94221285|NCT02475733|322601477|FG000|Overall Study|Physician Decision|1|||
94221286|NCT02475733|322601478|FG001|Overall Study|Physician Decision|0|||
94221287|NCT00157209|322601481|FG000|Overall Study|Ongoing at data cut-off|10|||
94221288|NCT00157209|322601482|FG001|Overall Study|Ongoing at data cut-off|0|||
94221289|NCT03751280|322601483|FG000|Overall Study|Adverse Event|0|||
94221290|NCT03751280|322601484|FG001|Overall Study|Adverse Event|1|||
94221291|NCT03751280|322601483|FG000|Overall Study|Lost to Follow-up|3|||
94372500|NCT00479401|323150277|FG001|Overall Study|Lack of Efficacy|2|||
94221292|NCT03751280|322601484|FG001|Overall Study|Lost to Follow-up|5|||
94221293|NCT03751280|322601483|FG000|Overall Study|Physician Decision|0|||
94221294|NCT03751280|322601484|FG001|Overall Study|Physician Decision|2|||
94221295|NCT03751280|322601483|FG000|Overall Study|Protocol Violation|0|||
94221296|NCT03751280|322601484|FG001|Overall Study|Protocol Violation|2|||
94221297|NCT03751280|322601483|FG000|Overall Study|Withdrawal by Subject|5|||
94221298|NCT03751280|322601484|FG001|Overall Study|Withdrawal by Subject|2|||
94221299|NCT01047306|322601488|FG000|Overall Study|Withdrawal by Subject|2|||
94221300|NCT01047306|322601489|FG001|Overall Study|Withdrawal by Subject|0|||
94221301|NCT01047306|322601488|FG000|Overall Study|Lost to Follow-up|1|||
94221302|NCT01047306|322601489|FG001|Overall Study|Lost to Follow-up|0|||
94221303|NCT01878253|322601490|FG000|Overall Study|Death|1|||
94221304|NCT01878253|322601490|FG000|Overall Study|SIdus System Removal|3|||
94221305|NCT01878253|322601490|FG000|Overall Study|Withdrawal by Subject|1|||
94221306|NCT01878253|322601490|FG000|Overall Study|Lost to Follow-up|2|||
94221307|NCT01878253|322601490|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
94221308|NCT02809677|322601505|FG000|Overall Study|Withdrawal by Subject|8|||
94221309|NCT04362176|322601506|FG000|Overall Study|Lost to Follow-up|5|||
94221310|NCT04362176|322601507|FG001|Overall Study|Lost to Follow-up|8|||
94221311|NCT04362176|322601506|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
94221312|NCT04362176|322601507|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
94221313|NCT01648699|322601512|FG000|Overall Study|Death|1|||
94221314|NCT01648699|322601512|FG000|Overall Study|Lost to Follow-up|2|||
94221315|NCT01648699|322601512|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
94221316|NCT03861078|322601513|FG000|Overall Study|COVID-19 shut down|4|||
94221317|NCT03861078|322601513|FG000|Overall Study|Lost to Follow-up|1|||
94287420|NCT00168831|322842282|FG002|Overall Study|Adverse Event|74|||
94287421|NCT00168831|322842280|FG000|Overall Study|Lost to Follow-up|5|||
94287422|NCT00168831|322842281|FG001|Overall Study|Lost to Follow-up|6|||
94221318|NCT03861078|322601513|FG000|Overall Study|Protocol Violation|2|||
94221319|NCT03861078|322601513|FG000|Overall Study|lack of venous access|1|||
94221320|NCT02971683|322601514|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
94221321|NCT02971683|322601515|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
94221322|NCT02971683|322601514|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
94221323|NCT02971683|322601515|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
94221324|NCT02971683|322601514|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
94221325|NCT02971683|322601515|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
94221326|NCT02971683|322601514|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
94221327|NCT02971683|322601515|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
94287423|NCT00168831|322842282|FG002|Overall Study|Lost to Follow-up|4|||
94287424|NCT00168831|322842280|FG000|Overall Study|Withdrawal by Subject|7|||
94287425|NCT00168831|322842281|FG001|Overall Study|Withdrawal by Subject|14|||
94287426|NCT00168831|322842282|FG002|Overall Study|Withdrawal by Subject|19|||
94287427|NCT00168831|322842280|FG000|Overall Study|Protocol Violation|6|||
94287428|NCT00168831|322842281|FG001|Overall Study|Protocol Violation|11|||
94287429|NCT00168831|322842282|FG002|Overall Study|Protocol Violation|11|||
94287430|NCT00168831|322842280|FG000|Overall Study|Other|6|||
94287431|NCT00168831|322842281|FG001|Overall Study|Other|3|||
94287432|NCT00168831|322842282|FG002|Overall Study|Other|6|||
94287433|NCT01622569|322842283|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
94287434|NCT01622569|322842284|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
94287435|NCT01622569|322842285|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
94287436|NCT01622569|322842286|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
94287437|NCT01622569|322842283|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
94287438|NCT01622569|322842284|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
94287439|NCT01622569|322842285|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
94287440|NCT01622569|322842286|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
94287441|NCT01622569|322842283|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
94287442|NCT01622569|322842284|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
94287443|NCT01622569|322842285|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
94287444|NCT01622569|322842286|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
94287445|NCT01622569|322842283|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
94287446|NCT01622569|322842284|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
94221328|NCT02971683|322601514|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
94221329|NCT02971683|322601515|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
94221330|NCT02971683|322601514|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
94221331|NCT02971683|322601515|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
94221332|NCT02971683|322601514|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
94287447|NCT01622569|322842285|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
94287448|NCT01622569|322842286|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
94287449|NCT01622569|322842283|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
94467893|NCT00404924|323502433|FG001|Overall Study|Adverse Event|16|||
94221333|NCT02971683|322601515|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
94221334|NCT02971683|322601514|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
94221335|NCT02971683|322601515|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
94287450|NCT01622569|322842284|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
94221336|NCT02971683|322601514|FG000|Open-Label|Lost to Follow-up|1|||
94221337|NCT02971683|322601515|FG001|Open-Label|Lost to Follow-up|0|||
94221338|NCT02971683|322601514|FG000|Open-Label|Participants withdrew consent|0|||
94221339|NCT02971683|322601515|FG001|Open-Label|Participants withdrew consent|2|||
94221340|NCT02971683|322601514|FG000|Open-Label|Participant request to discontinue study treatment|1|||
94221341|NCT02971683|322601515|FG001|Open-Label|Participant request to discontinue study treatment|0|||
94221342|NCT02971683|322601514|FG000|Open-Label|Lack of Efficacy|2|||
94221343|NCT02971683|322601515|FG001|Open-Label|Lack of Efficacy|0|||
94221344|NCT02971683|322601514|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
94221345|NCT02971683|322601515|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
94221346|NCT02971683|322601514|FG000|Long-Term Open Label|Participant withdrew consent|1|||
94221347|NCT02971683|322601515|FG001|Long-Term Open Label|Participant withdrew consent|0|||
94221348|NCT02971683|322601514|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
94221349|NCT02971683|322601515|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
94221350|NCT02971683|322601514|FG000|Long-Term Open Label|Adverse Event|1|||
94221351|NCT02971683|322601515|FG001|Long-Term Open Label|Adverse Event|2|||
94221352|NCT02971683|322601514|FG000|Long-Term Open Label|Lack of Efficacy|1|||
94221353|NCT02971683|322601515|FG001|Long-Term Open Label|Lack of Efficacy|1|||
94221354|NCT00596960|322601517|FG000|Overall Study|Death|1|||
94221355|NCT00596960|322601518|FG001|Overall Study|Death|2|||
94221356|NCT00596960|322601517|FG000|Overall Study|Lost to Follow-up|6|||
94221357|NCT00596960|322601518|FG001|Overall Study|Lost to Follow-up|5|||
94221358|NCT00596960|322601517|FG000|Overall Study|Withdrawal by Subject|1|||
94221359|NCT00596960|322601518|FG001|Overall Study|Withdrawal by Subject|0|||
94221360|NCT00596960|322601517|FG000|Overall Study|Incarcerated|2|||
94221361|NCT00596960|322601518|FG001|Overall Study|Incarcerated|0|||
94221362|NCT00596960|322601517|FG000|Overall Study|Physician Decision|1|||
94221363|NCT00596960|322601518|FG001|Overall Study|Physician Decision|0|||
94221364|NCT00596960|322601517|FG000|Overall Study|Protocol Violation|0|||
94221365|NCT00596960|322601518|FG001|Overall Study|Protocol Violation|1|||
94221366|NCT00596960|322601517|FG000|Overall Study|No alcohol use data|0|||
94221367|NCT00596960|322601518|FG001|Overall Study|No alcohol use data|1|||
94221368|NCT02066389|322601522|FG000|Overall Study|Adverse Event|1|||
94221369|NCT02066389|322601523|FG001|Overall Study|Adverse Event|1|||
94221370|NCT02066389|322601524|FG002|Overall Study|Adverse Event|1|||
94221371|NCT02066389|322601525|FG003|Overall Study|Adverse Event|1|||
94221372|NCT02066389|322601526|FG004|Overall Study|Adverse Event|5|||
94221373|NCT02066389|322601527|FG005|Overall Study|Adverse Event|1|||
94221374|NCT02066389|322601522|FG000|Overall Study|Withdrawal by Subject|4|||
94221375|NCT02066389|322601523|FG001|Overall Study|Withdrawal by Subject|0|||
94221376|NCT02066389|322601524|FG002|Overall Study|Withdrawal by Subject|5|||
94221377|NCT02066389|322601525|FG003|Overall Study|Withdrawal by Subject|1|||
94221378|NCT02066389|322601526|FG004|Overall Study|Withdrawal by Subject|1|||
94221379|NCT02066389|322601527|FG005|Overall Study|Withdrawal by Subject|2|||
94221380|NCT02066389|322601522|FG000|Overall Study|Lost to Follow-up|0|||
94287451|NCT01622569|322842285|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
94287452|NCT01622569|322842286|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
94287453|NCT01622569|322842283|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
94287454|NCT01622569|322842284|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
94287455|NCT01622569|322842285|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
94287456|NCT01622569|322842286|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
94287457|NCT01622569|322842283|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
94287458|NCT01622569|322842284|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
94287459|NCT01622569|322842285|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
94287460|NCT01622569|322842286|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
94287461|NCT01622569|322842283|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
94287462|NCT01622569|322842284|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
94287463|NCT01622569|322842285|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
94287464|NCT01622569|322842286|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
94287465|NCT02009878|322842287|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
94287466|NCT02009878|322842288|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
94287467|NCT02009878|322842289|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
94287468|NCT00584233|322842292|FG000|Overall Study|Withdrawal by Subject|5|||
94287469|NCT00584233|322842292|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
94287470|NCT02222714|322842294|FG000|Overall Study|Death|0|||
94221381|NCT02066389|322601523|FG001|Overall Study|Lost to Follow-up|0|||
94221382|NCT02066389|322601524|FG002|Overall Study|Lost to Follow-up|0|||
94221383|NCT02066389|322601525|FG003|Overall Study|Lost to Follow-up|1|||
94221384|NCT02066389|322601526|FG004|Overall Study|Lost to Follow-up|1|||
94221385|NCT02066389|322601527|FG005|Overall Study|Lost to Follow-up|1|||
94221386|NCT02066389|322601522|FG000|Overall Study|Randomized in Error|0|||
94221387|NCT02066389|322601523|FG001|Overall Study|Randomized in Error|0|||
94221388|NCT02066389|322601524|FG002|Overall Study|Randomized in Error|0|||
94287471|NCT02222714|322842295|FG001|Overall Study|Death|2|||
94287472|NCT02222714|322842296|FG002|Overall Study|Death|3|||
94287473|NCT02222714|322842297|FG003|Overall Study|Death|4|||
94287474|NCT02222714|322842298|FG004|Overall Study|Death|6|||
94287475|NCT02222714|322842294|FG000|Overall Study|Withdrawal by Subject|0|||
94287476|NCT02222714|322842295|FG001|Overall Study|Withdrawal by Subject|0|||
94287477|NCT02222714|322842296|FG002|Overall Study|Withdrawal by Subject|1|||
94287478|NCT02222714|322842297|FG003|Overall Study|Withdrawal by Subject|0|||
94287479|NCT02222714|322842298|FG004|Overall Study|Withdrawal by Subject|1|||
94287480|NCT01940484|322842299|FG000|Overall Study|Withdrawal by Subject|3|||
94287481|NCT01940484|322842299|FG000|Overall Study|Underwent transplantation|4|||
94287482|NCT01940484|322842299|FG000|Overall Study|Death|2|||
94287483|NCT01940484|322842299|FG000|Overall Study|Adverse Event|1|||
94287484|NCT02658448|322842300|FG000|Overall Study|Lost to Follow-up|1|||
94287485|NCT01491178|322842303|FG000|Overall Study|Adverse Event|1016|||
94221389|NCT02066389|322601525|FG003|Overall Study|Randomized in Error|0|||
94221390|NCT02066389|322601526|FG004|Overall Study|Randomized in Error|0|||
94221391|NCT02066389|322601527|FG005|Overall Study|Randomized in Error|1|||
94221392|NCT02374476|322601530|FG000|VT Induced Ablation|Screening Failures|36|||
94221393|NCT02374476|322601531|FG001|VT Induced Ablation|Screening Failures|0|||
94221394|NCT02374476|322601532|FG002|VT Induced Ablation|Screening Failures|0|||
94221395|NCT02374476|322601530|FG000|Arm Assignment|Withdrawal by Subject|0|||
94221396|NCT02374476|322601531|FG001|Arm Assignment|Withdrawal by Subject|0|||
94221397|NCT02374476|322601532|FG002|Arm Assignment|Withdrawal by Subject|1|||
94221398|NCT00498797|322601533|FG000|Overall Study|Withdrawal by Subject|4|||
94221399|NCT00498797|322601534|FG001|Overall Study|Withdrawal by Subject|2|||
94221400|NCT00498797|322601533|FG000|Overall Study|Adverse Event|12|||
94221401|NCT00498797|322601534|FG001|Overall Study|Adverse Event|5|||
94221402|NCT00498797|322601533|FG000|Overall Study|Condition under investigation worsened|19|||
94221403|NCT00498797|322601534|FG001|Overall Study|Condition under investigation worsened|21|||
94221404|NCT00498797|322601533|FG000|Overall Study|Other|3|||
94221405|NCT00498797|322601534|FG001|Overall Study|Other|1|||
94221406|NCT00985621|322601535|FG000|Overall Study|Adverse Event|2|||
94221407|NCT00985621|322601536|FG001|Overall Study|Adverse Event|3|||
94221408|NCT00985621|322601537|FG002|Overall Study|Adverse Event|4|||
94221409|NCT00985621|322601538|FG003|Overall Study|Adverse Event|16|||
94221410|NCT00985621|322601535|FG000|Overall Study|Lack of Efficacy|10|||
94221411|NCT00985621|322601536|FG001|Overall Study|Lack of Efficacy|6|||
94221412|NCT00985621|322601537|FG002|Overall Study|Lack of Efficacy|5|||
94221413|NCT00985621|322601538|FG003|Overall Study|Lack of Efficacy|12|||
94221414|NCT00985621|322601535|FG000|Overall Study|Lost to Follow-up|2|||
94221415|NCT00985621|322601536|FG001|Overall Study|Lost to Follow-up|3|||
94221416|NCT00985621|322601537|FG002|Overall Study|Lost to Follow-up|4|||
94221417|NCT00985621|322601538|FG003|Overall Study|Lost to Follow-up|4|||
94221418|NCT00985621|322601535|FG000|Overall Study|Study Terminated by Sponsor|89|||
94221419|NCT00985621|322601536|FG001|Overall Study|Study Terminated by Sponsor|108|||
94221420|NCT00985621|322601537|FG002|Overall Study|Study Terminated by Sponsor|99|||
94221421|NCT00985621|322601538|FG003|Overall Study|Study Terminated by Sponsor|92|||
94221422|NCT00985621|322601535|FG000|Overall Study|Protocol Violation|1|||
94221423|NCT00985621|322601536|FG001|Overall Study|Protocol Violation|1|||
94221424|NCT00985621|322601537|FG002|Overall Study|Protocol Violation|1|||
94221425|NCT00985621|322601538|FG003|Overall Study|Protocol Violation|0|||
94221426|NCT00985621|322601535|FG000|Overall Study|Withdrawal by Subject|8|||
94221427|NCT00985621|322601536|FG001|Overall Study|Withdrawal by Subject|10|||
94221428|NCT00985621|322601537|FG002|Overall Study|Withdrawal by Subject|8|||
94221429|NCT00985621|322601538|FG003|Overall Study|Withdrawal by Subject|12|||
94221430|NCT00985621|322601535|FG000|Overall Study|Other|1|||
94221431|NCT00985621|322601536|FG001|Overall Study|Other|0|||
94221432|NCT00985621|322601537|FG002|Overall Study|Other|0|||
94221433|NCT00985621|322601538|FG003|Overall Study|Other|0|||
94287486|NCT01491178|322842303|FG000|Overall Study|Improvement of NVAF|210|||
94287487|NCT01491178|322842303|FG000|Overall Study|To conduct invasive treatment|59|||
94287488|NCT01491178|322842303|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
94287489|NCT01491178|322842303|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
94287490|NCT01491178|322842303|FG000|Overall Study|To take a contraindication|20|||
94287491|NCT01491178|322842303|FG000|Overall Study|Other than specified above|657|||
94287492|NCT03106779|322842304|FG000|Overall Study|Lack of Efficacy|33|||
94287493|NCT03106779|322842305|FG001|Overall Study|Lack of Efficacy|24|||
94287494|NCT03106779|322842304|FG000|Overall Study|Adverse Event|8|||
94287495|NCT03106779|322842305|FG001|Overall Study|Adverse Event|16|||
94287496|NCT03106779|322842304|FG000|Overall Study|Physician Decision|10|||
94287497|NCT03106779|322842305|FG001|Overall Study|Physician Decision|6|||
94287498|NCT03106779|322842304|FG000|Overall Study|Patient/guardian decision|4|||
94287499|NCT03106779|322842305|FG001|Overall Study|Patient/guardian decision|3|||
94287500|NCT03106779|322842304|FG000|Overall Study|Progressive disease|1|||
94287501|NCT03106779|322842305|FG001|Overall Study|Progressive disease|3|||
94467894|NCT00404924|323502432|FG000|Overall Study|Condition under investigation worsened|475|||
94467895|NCT00404924|323502433|FG001|Overall Study|Condition under investigation worsened|264|||
94221434|NCT00985621|322601535|FG000|Overall Study|Randomized but not Treated|1|||
94221435|NCT00985621|322601536|FG001|Overall Study|Randomized but not Treated|0|||
94221436|NCT00985621|322601537|FG002|Overall Study|Randomized but not Treated|2|||
94221437|NCT00985621|322601538|FG003|Overall Study|Randomized but not Treated|1|||
94221438|NCT00595764|322601539|FG000|Overall Study|Protocol Violation|24|||
94221439|NCT00595764|322601540|FG001|Overall Study|Protocol Violation|19|||
94287502|NCT03106779|322842304|FG000|Overall Study|Lost to Follow-up|1|||
94221440|NCT00595764|322601539|FG000|Overall Study|Missed Medication >1 week|10|||
94221441|NCT00595764|322601540|FG001|Overall Study|Missed Medication >1 week|17|||
94221442|NCT00595764|322601539|FG000|Overall Study|Missed 3 PM visits|1|||
94221443|NCT00595764|322601540|FG001|Overall Study|Missed 3 PM visits|7|||
94221444|NCT00595764|322601539|FG000|Overall Study|Withdrawal by Subject|4|||
94287503|NCT03106779|322842305|FG001|Overall Study|Lost to Follow-up|2|||
94221445|NCT00595764|322601540|FG001|Overall Study|Withdrawal by Subject|0|||
94221446|NCT04222088|322601541|FG000|Overall Study|Lost to Follow-up|5|||
94221447|NCT04222088|322601542|FG001|Overall Study|Lost to Follow-up|1|||
94221448|NCT04222088|322601541|FG000|Overall Study|Withdrawal by Subject|4|||
94221449|NCT04222088|322601542|FG001|Overall Study|Withdrawal by Subject|0|||
94221450|NCT00905255|322601543|FG000|Overall Study|Adverse Event|7|||
94221451|NCT00905255|322601544|FG001|Overall Study|Adverse Event|5|||
94221452|NCT00905255|322601543|FG000|Overall Study|Withdrawal by Subject|5|||
94221453|NCT00905255|322601544|FG001|Overall Study|Withdrawal by Subject|4|||
94221454|NCT00905255|322601543|FG000|Overall Study|Familial and Personal Reasons|1|||
94221455|NCT00905255|322601544|FG001|Overall Study|Familial and Personal Reasons|0|||
94221456|NCT02389894|322601547|FG000|Overall Study|Death|4|||
94221457|NCT02389894|322601548|FG001|Overall Study|Death|5|||
94221458|NCT02389894|322601549|FG002|Overall Study|Death|3|||
94221459|NCT02389894|322601547|FG000|Overall Study|Withdrawal by Subject|2|||
94221460|NCT02389894|322601548|FG001|Overall Study|Withdrawal by Subject|4|||
94221461|NCT02389894|322601549|FG002|Overall Study|Withdrawal by Subject|5|||
94221462|NCT02389894|322601547|FG000|Overall Study|Lost to Follow-up|2|||
94221463|NCT02389894|322601548|FG001|Overall Study|Lost to Follow-up|1|||
94221464|NCT02389894|322601549|FG002|Overall Study|Lost to Follow-up|1|||
94221465|NCT01207453|322601550|FG000|First Intervention|Adverse Event|2|||
94221466|NCT01207453|322601551|FG001|First Intervention|Adverse Event|1|||
94221467|NCT01207453|322601550|FG000|Washout|Adverse Event|1|||
94221468|NCT01207453|322601551|FG001|Washout|Adverse Event|0|||
94221469|NCT01207453|322601550|FG000|Washout|Lost to Follow-up|1|||
94221470|NCT01207453|322601551|FG001|Washout|Lost to Follow-up|0|||
94221471|NCT01207453|322601550|FG000|2nd Intervention|Adverse Event|1|||
94221472|NCT01207453|322601551|FG001|2nd Intervention|Adverse Event|2|||
94221473|NCT01207453|322601550|FG000|2nd Intervention|Lost to Follow-up|1|||
94221474|NCT01207453|322601551|FG001|2nd Intervention|Lost to Follow-up|0|||
94221475|NCT02133131|322601556|FG000|Overall Study|Adverse Event|0|||
94221476|NCT02133131|322601557|FG001|Overall Study|Adverse Event|0|||
94221477|NCT02133131|322601558|FG002|Overall Study|Adverse Event|0|||
94221478|NCT02133131|322601559|FG003|Overall Study|Adverse Event|1|||
94221479|NCT02133131|322601560|FG004|Overall Study|Adverse Event|0|||
94221480|NCT02133131|322601561|FG005|Overall Study|Adverse Event|0|||
94221481|NCT02133131|322601562|FG006|Overall Study|Adverse Event|0|||
94221482|NCT02133131|322601556|FG000|Overall Study|Lost to Follow-up|1|||
94221483|NCT02133131|322601557|FG001|Overall Study|Lost to Follow-up|0|||
94221484|NCT02133131|322601558|FG002|Overall Study|Lost to Follow-up|0|||
94221485|NCT02133131|322601559|FG003|Overall Study|Lost to Follow-up|1|||
94221486|NCT02133131|322601560|FG004|Overall Study|Lost to Follow-up|0|||
94221487|NCT02133131|322601561|FG005|Overall Study|Lost to Follow-up|0|||
94221488|NCT02133131|322601562|FG006|Overall Study|Lost to Follow-up|0|||
94221489|NCT02133131|322601556|FG000|Overall Study|Status not recorded|4|||
94221490|NCT02133131|322601557|FG001|Overall Study|Status not recorded|5|||
94221491|NCT02133131|322601558|FG002|Overall Study|Status not recorded|1|||
94221492|NCT02133131|322601559|FG003|Overall Study|Status not recorded|4|||
94221493|NCT02133131|322601560|FG004|Overall Study|Status not recorded|0|||
94221494|NCT02133131|322601561|FG005|Overall Study|Status not recorded|0|||
94221495|NCT02133131|322601562|FG006|Overall Study|Status not recorded|0|||
94221496|NCT02133131|322601556|FG000|Overall Study|Ongoing in study|0|||
94221497|NCT02133131|322601557|FG001|Overall Study|Ongoing in study|0|||
94221498|NCT02133131|322601558|FG002|Overall Study|Ongoing in study|0|||
94221499|NCT02133131|322601559|FG003|Overall Study|Ongoing in study|0|||
94221500|NCT02133131|322601560|FG004|Overall Study|Ongoing in study|15|||
94287504|NCT03106779|322842304|FG000|Overall Study|Death|1|||
94287505|NCT03106779|322842305|FG001|Overall Study|Death|0|||
94287506|NCT03106779|322842304|FG000|Overall Study|Protocol Violation|1|||
94287507|NCT03106779|322842305|FG001|Overall Study|Protocol Violation|0|||
94287508|NCT03106779|322842304|FG000|Overall Study|Not treated|1|||
94221501|NCT02133131|322601561|FG005|Overall Study|Ongoing in study|14|||
94221502|NCT02133131|322601562|FG006|Overall Study|Ongoing in study|11|||
94221503|NCT02133131|322601556|FG000|Overall Study|Protocol Violation|0|||
94221504|NCT02133131|322601557|FG001|Overall Study|Protocol Violation|0|||
94221505|NCT02133131|322601558|FG002|Overall Study|Protocol Violation|0|||
94221506|NCT02133131|322601559|FG003|Overall Study|Protocol Violation|0|||
94221507|NCT02133131|322601560|FG004|Overall Study|Protocol Violation|0|||
94221508|NCT02133131|322601561|FG005|Overall Study|Protocol Violation|0|||
94221509|NCT02133131|322601562|FG006|Overall Study|Protocol Violation|1|||
94221510|NCT00443755|322603404|FG000|Overall Study|Withdrawal by Subject|2|||
94287509|NCT03106779|322842305|FG001|Overall Study|Not treated|0|||
94287510|NCT01604512|322842306|FG000|Overall Study|Withdrawal by Subject|3|||
94221511|NCT00443755|322603405|FG001|Overall Study|Withdrawal by Subject|1|||
94221512|NCT04203199|322603413|FG000|First Intervention Period|Lost to Follow-up|0|||
94221513|NCT04203199|322603414|FG001|First Intervention Period|Lost to Follow-up|1|||
94221514|NCT04203199|322603413|FG000|Second Intervention Period|Medication change|1|||
94221515|NCT04203199|322603414|FG001|Second Intervention Period|Medication change|0|||
94221516|NCT03320941|322603415|FG000|Overall Study|subject/guardian decision|0|||
94221517|NCT03320941|322603416|FG001|Overall Study|subject/guardian decision|0|||
94221518|NCT03320941|322603417|FG002|Overall Study|subject/guardian decision|0|||
94221519|NCT03320941|322603418|FG003|Overall Study|subject/guardian decision|1|||
94221520|NCT03320941|322603419|FG004|Overall Study|subject/guardian decision|0|||
94221521|NCT01753323|322603420|FG000|Overall Study|Lack of Efficacy|0|||
94221522|NCT01753323|322603421|FG001|Overall Study|Lack of Efficacy|0|||
94221523|NCT01753323|322603422|FG002|Overall Study|Lack of Efficacy|8|||
94221524|NCT01753323|322603420|FG000|Overall Study|Protocol deviation|1|||
94221525|NCT01753323|322603421|FG001|Overall Study|Protocol deviation|0|||
94221526|NCT01753323|322603422|FG002|Overall Study|Protocol deviation|0|||
94221527|NCT01753323|322603420|FG000|Overall Study|Adverse Event|0|||
94221528|NCT01753323|322603421|FG001|Overall Study|Adverse Event|0|||
94221529|NCT01753323|322603422|FG002|Overall Study|Adverse Event|1|||
94221530|NCT01745380|322603425|FG000|Overall Study|Lost to Follow-up|1|||
94221531|NCT01745380|322603426|FG001|Overall Study|Lost to Follow-up|0|||
94221532|NCT01745380|322603425|FG000|Overall Study|Lack of Efficacy|0|||
94221533|NCT01745380|322603426|FG001|Overall Study|Lack of Efficacy|1|||
94221534|NCT02498418|322603433|FG000|Overall Study|Lack of Efficacy|0|||
94221535|NCT02498418|322603434|FG001|Overall Study|Lack of Efficacy|0|||
94221536|NCT02498418|322603435|FG002|Overall Study|Lack of Efficacy|1|||
94221537|NCT02498418|322603433|FG000|Overall Study|Withdrawal by Subject|2|||
94221538|NCT02498418|322603434|FG001|Overall Study|Withdrawal by Subject|0|||
94221539|NCT02498418|322603435|FG002|Overall Study|Withdrawal by Subject|3|||
94221540|NCT02498418|322603433|FG000|Overall Study|Lost to Follow-up|0|||
94221541|NCT02498418|322603434|FG001|Overall Study|Lost to Follow-up|1|||
94221542|NCT02498418|322603435|FG002|Overall Study|Lost to Follow-up|1|||
94221543|NCT02498418|322603433|FG000|Overall Study|Participant taken prohibited medication|0|||
94221544|NCT02498418|322603434|FG001|Overall Study|Participant taken prohibited medication|1|||
94221545|NCT02498418|322603435|FG002|Overall Study|Participant taken prohibited medication|1|||
94221546|NCT00510783|322603438|FG000|Overall Study|Lost to Follow-up|29|||
94221547|NCT00510783|322603439|FG001|Overall Study|Lost to Follow-up|25|||
94221548|NCT00510783|322603438|FG000|Overall Study|Withdrawal by Subject|2|||
94221549|NCT00510783|322603439|FG001|Overall Study|Withdrawal by Subject|3|||
94221550|NCT00510783|322603438|FG000|Overall Study|Protocol Violation|0|||
94221551|NCT00510783|322603439|FG001|Overall Study|Protocol Violation|1|||
94221552|NCT01348763|322603446|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
94221553|NCT01348763|322603446|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
94221554|NCT02213458|322603452|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
94221555|NCT02213458|322603453|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
94221556|NCT02213458|322603452|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
94221557|NCT02213458|322603453|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
94221558|NCT02213458|322603452|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
94221559|NCT02213458|322603453|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
94221560|NCT02213458|322603452|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
94221561|NCT02213458|322603453|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
94221562|NCT02213458|322603452|FG000|Overall Study|Refused re-consent|6|||
94221563|NCT02213458|322603453|FG001|Overall Study|Refused re-consent|0|||
94221564|NCT02213458|322603452|FG000|Overall Study|Lost to Follow-up|2|||
94221565|NCT02213458|322603453|FG001|Overall Study|Lost to Follow-up|2|||
94221566|NCT02213458|322603452|FG000|Overall Study|Withdrawal by Subject|26|||
94221567|NCT02213458|322603453|FG001|Overall Study|Withdrawal by Subject|8|||
94221568|NCT00449033|322603455|FG000|Treatment Period|Adverse Event|117|||
94221569|NCT00449033|322603456|FG001|Treatment Period|Adverse Event|83|||
94221570|NCT00449033|322603455|FG000|Treatment Period|Death|21|||
94221571|NCT00449033|322603456|FG001|Treatment Period|Death|12|||
94221572|NCT00449033|322603455|FG000|Treatment Period|Lost to Follow-up|0|||
94221573|NCT00449033|322603456|FG001|Treatment Period|Lost to Follow-up|2|||
94221574|NCT00449033|322603455|FG000|Treatment Period|Physician Decision|4|||
94221575|NCT00449033|322603456|FG001|Treatment Period|Physician Decision|5|||
94221576|NCT00449033|322603455|FG000|Treatment Period|Protocol Violation|8|||
94221577|NCT00449033|322603456|FG001|Treatment Period|Protocol Violation|7|||
94221578|NCT00449033|322603455|FG000|Treatment Period|Disease Progression|231|||
94221579|NCT00449033|322603456|FG001|Treatment Period|Disease Progression|288|||
94221580|NCT00449033|322603455|FG000|Treatment Period|Consent Withdrawn|36|||
94221581|NCT00449033|322603456|FG001|Treatment Period|Consent Withdrawn|20|||
94221582|NCT00449033|322603455|FG000|Treatment Period|Amended Protocol Criteria|22|||
94221583|NCT00449033|322603456|FG001|Treatment Period|Amended Protocol Criteria|18|||
94221584|NCT00449033|322603455|FG000|Treatment Period|Non-compliance|7|||
94221585|NCT00449033|322603456|FG001|Treatment Period|Non-compliance|8|||
94221586|NCT00449033|322603455|FG000|Treatment Period|Second Malignancy|0|||
94221587|NCT00449033|322603456|FG001|Treatment Period|Second Malignancy|1|||
94221588|NCT00449033|322603455|FG000|Treatment Period|Reason Missing|0|||
94221589|NCT00449033|322603456|FG001|Treatment Period|Reason Missing|4|||
94221590|NCT00449033|322603455|FG000|Treatment Period|Treatment Ongoing|6|||
94221591|NCT00449033|322603456|FG001|Treatment Period|Treatment Ongoing|4|||
94221592|NCT00449033|322603455|FG000|Follow-up Period|Death|299|||
94221593|NCT00449033|322603456|FG001|Follow-up Period|Death|311|||
94221594|NCT00449033|322603455|FG000|Follow-up Period|Lost to Follow-up|6|||
94221595|NCT00449033|322603456|FG001|Follow-up Period|Lost to Follow-up|10|||
94221596|NCT00449033|322603455|FG000|Follow-up Period|Reason Missing|120|||
94221597|NCT00449033|322603456|FG001|Follow-up Period|Reason Missing|113|||
94221598|NCT00794573|322603474|FG000|Overall Study|Death|3|||
94221599|NCT00794573|322603475|FG001|Overall Study|Death|0|||
94221600|NCT00794573|322603474|FG000|Overall Study|Withdrawal by Subject|9|||
94221601|NCT00794573|322603475|FG001|Overall Study|Withdrawal by Subject|12|||
94221602|NCT00794573|322603474|FG000|Overall Study|Lost to Follow-up|26|||
94221603|NCT00794573|322603475|FG001|Overall Study|Lost to Follow-up|33|||
94372501|NCT00479401|323150278|FG002|Overall Study|Lack of Efficacy|4|||
94221604|NCT03562117|322603476|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
94221605|NCT03562117|322603477|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
94221606|NCT03562117|322603478|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
94221607|NCT02784535|322603479|FG000|Overall Study|Adverse Event|1|||
94221608|NCT02784535|322603480|FG001|Overall Study|Adverse Event|0|||
94221609|NCT02784535|322603479|FG000|Overall Study|Withdrawal by Subject|0|||
94221610|NCT02784535|322603480|FG001|Overall Study|Withdrawal by Subject|1|||
94221611|NCT02784535|322603479|FG000|Overall Study|Physician Decision|0|||
94221612|NCT02784535|322603480|FG001|Overall Study|Physician Decision|1|||
94221613|NCT00914732|322603485|FG000|Overall Study|Lost to Follow-up|6|||
94221614|NCT00914732|322603486|FG001|Overall Study|Lost to Follow-up|7|||
94221615|NCT00914732|322603487|FG002|Overall Study|Lost to Follow-up|9|||
94221616|NCT00914732|322603485|FG000|Overall Study|Withdrawal by Subject|3|||
94221617|NCT00914732|322603486|FG001|Overall Study|Withdrawal by Subject|0|||
94221618|NCT00914732|322603487|FG002|Overall Study|Withdrawal by Subject|2|||
94221619|NCT00914732|322603485|FG000|Overall Study|Adverse Event|1|||
94221620|NCT00914732|322603486|FG001|Overall Study|Adverse Event|0|||
94221621|NCT00914732|322603487|FG002|Overall Study|Adverse Event|0|||
94221622|NCT01911819|322603488|FG000|Overall Study|Adverse Event|0|||
94221623|NCT01911819|322603489|FG001|Overall Study|Adverse Event|1|||
94221624|NCT01911819|322603490|FG002|Overall Study|Adverse Event|0|||
94221625|NCT01911819|322603488|FG000|Overall Study|Withdrawal by Subject|1|||
94221626|NCT01911819|322603489|FG001|Overall Study|Withdrawal by Subject|1|||
94221627|NCT01911819|322603490|FG002|Overall Study|Withdrawal by Subject|0|||
94221628|NCT00257556|322603491|FG000|Overall Study|Adverse Event|1|||
94221629|NCT00257556|322603492|FG001|Overall Study|Adverse Event|4|||
94221630|NCT00257556|322603491|FG000|Overall Study|Physician Decision|6|||
94221631|NCT00257556|322603492|FG001|Overall Study|Physician Decision|0|||
94221632|NCT00257556|322603491|FG000|Overall Study|Did not meet hCG criterion|3|||
94221633|NCT00257556|322603492|FG001|Overall Study|Did not meet hCG criterion|0|||
94221634|NCT00257556|322603491|FG000|Overall Study|other reason|4|||
94221635|NCT00257556|322603492|FG001|Overall Study|other reason|6|||
94221636|NCT03873038|322603493|FG000|Part 2|Withdrawal by Subject|0|||
94221637|NCT03873038|322603494|FG001|Part 2|Withdrawal by Subject|0|||
94221638|NCT03873038|322603495|FG002|Part 2|Withdrawal by Subject|0|||
94221639|NCT03873038|322603496|FG003|Part 2|Withdrawal by Subject|0|||
94221640|NCT03873038|322603497|FG004|Part 2|Withdrawal by Subject|0|||
94221641|NCT03873038|322603498|FG005|Part 2|Withdrawal by Subject|1|||
94221642|NCT03873038|322603493|FG000|Part 2|Unknon|0|||
94221643|NCT03873038|322603494|FG001|Part 2|Unknon|0|||
94221644|NCT03873038|322603495|FG002|Part 2|Unknon|0|||
94221645|NCT03873038|322603496|FG003|Part 2|Unknon|0|||
94221646|NCT03873038|322603497|FG004|Part 2|Unknon|1|||
94221647|NCT03873038|322603498|FG005|Part 2|Unknon|0|||
94221648|NCT00603278|322603499|FG000|Overall Study|Lack of Efficacy|35|||
94221649|NCT00603278|322603500|FG001|Overall Study|Lack of Efficacy|10|||
94221650|NCT00603278|322603501|FG002|Overall Study|Lack of Efficacy|11|||
94221651|NCT00603278|322603502|FG003|Overall Study|Lack of Efficacy|8|||
94221652|NCT00603278|322603503|FG004|Overall Study|Lack of Efficacy|7|||
94221653|NCT00603278|322603504|FG005|Overall Study|Lack of Efficacy|14|||
94221654|NCT00603278|322603499|FG000|Overall Study|Adverse Event|0|||
94221655|NCT00603278|322603500|FG001|Overall Study|Adverse Event|3|||
94221656|NCT00603278|322603501|FG002|Overall Study|Adverse Event|1|||
94221657|NCT00603278|322603502|FG003|Overall Study|Adverse Event|0|||
94221658|NCT00603278|322603503|FG004|Overall Study|Adverse Event|2|||
94221659|NCT00603278|322603504|FG005|Overall Study|Adverse Event|1|||
94221660|NCT00603278|322603499|FG000|Overall Study|Withdrawal by Subject|2|||
94221661|NCT00603278|322603500|FG001|Overall Study|Withdrawal by Subject|3|||
94372502|NCT00479401|323150276|FG000|Overall Study|Protocol Violation|2|||
94221662|NCT00603278|322603501|FG002|Overall Study|Withdrawal by Subject|1|||
94221663|NCT00603278|322603502|FG003|Overall Study|Withdrawal by Subject|2|||
94221664|NCT00603278|322603503|FG004|Overall Study|Withdrawal by Subject|1|||
94221665|NCT00603278|322603504|FG005|Overall Study|Withdrawal by Subject|2|||
94221666|NCT00603278|322603499|FG000|Overall Study|Protocol Violation|3|||
94221667|NCT00603278|322603500|FG001|Overall Study|Protocol Violation|0|||
94221668|NCT00603278|322603501|FG002|Overall Study|Protocol Violation|1|||
94221669|NCT00603278|322603502|FG003|Overall Study|Protocol Violation|1|||
94221670|NCT00603278|322603503|FG004|Overall Study|Protocol Violation|0|||
94221671|NCT00603278|322603504|FG005|Overall Study|Protocol Violation|1|||
94221672|NCT00603278|322603499|FG000|Overall Study|Physician Decision|0|||
94221673|NCT00603278|322603500|FG001|Overall Study|Physician Decision|1|||
94221674|NCT00603278|322603501|FG002|Overall Study|Physician Decision|0|||
94221675|NCT00603278|322603502|FG003|Overall Study|Physician Decision|0|||
94221676|NCT00603278|322603503|FG004|Overall Study|Physician Decision|2|||
94221677|NCT00603278|322603504|FG005|Overall Study|Physician Decision|1|||
94221678|NCT00603278|322603499|FG000|Overall Study|Lost to Follow-up|1|||
94221679|NCT00603278|322603500|FG001|Overall Study|Lost to Follow-up|0|||
94221680|NCT00603278|322603501|FG002|Overall Study|Lost to Follow-up|0|||
94221681|NCT00603278|322603502|FG003|Overall Study|Lost to Follow-up|0|||
94221682|NCT00603278|322603503|FG004|Overall Study|Lost to Follow-up|1|||
94287511|NCT01604512|322842306|FG000|Overall Study|Not treated|4|||
94287512|NCT05030311|322842307|FG000|Overall Study|Technical problems|0|||
94287513|NCT05030311|322842308|FG001|Overall Study|Technical problems|1|||
94287514|NCT05030311|322842307|FG000|Overall Study|Withdrawal by Subject|31|||
94287515|NCT05030311|322842308|FG001|Overall Study|Withdrawal by Subject|17|||
94287516|NCT05030311|322842307|FG000|Overall Study|Adverse Event|13|||
94287517|NCT05030311|322842308|FG001|Overall Study|Adverse Event|5|||
94287518|NCT05030311|322842307|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
94287519|NCT05030311|322842308|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
94287520|NCT05030311|322842307|FG000|Overall Study|Physician Decision|5|||
94287521|NCT05030311|322842308|FG001|Overall Study|Physician Decision|2|||
94287522|NCT05030311|322842307|FG000|Overall Study|Lost to Follow-up|5|||
94287523|NCT05030311|322842308|FG001|Overall Study|Lost to Follow-up|1|||
94287524|NCT05030311|322842307|FG000|Overall Study|Protocol Violation|4|||
94287525|NCT05030311|322842308|FG001|Overall Study|Protocol Violation|4|||
94287526|NCT02288247|322842309|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
94287527|NCT02288247|322842310|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
94287528|NCT02288247|322842309|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
94287529|NCT02288247|322842310|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
94287530|NCT02288247|322842309|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
94287531|NCT02288247|322842310|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
94287532|NCT02288247|322842309|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
94287533|NCT02288247|322842310|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
94287534|NCT02288247|322842309|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
94287535|NCT02288247|322842310|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
94287536|NCT02288247|322842309|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
94287537|NCT02288247|322842310|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
94287538|NCT02288247|322842309|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
94287539|NCT02288247|322842310|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
94287540|NCT02288247|322842309|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
94287541|NCT02288247|322842310|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
94287542|NCT02288247|322842309|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
94287543|NCT02288247|322842310|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
94287544|NCT02288247|322842309|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
94287545|NCT02288247|322842310|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
94287546|NCT02288247|322842309|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
94287547|NCT02288247|322842310|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
94287548|NCT02288247|322842309|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
94287549|NCT02288247|322842310|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
94287550|NCT02288247|322842309|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
94287551|NCT02288247|322842310|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
94287552|NCT02288247|322842309|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
94287553|NCT02288247|322842310|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
94287554|NCT02288247|322842309|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
94287555|NCT02288247|322842310|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
94287556|NCT02288247|322842309|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
94287557|NCT02288247|322842310|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
94287558|NCT04652804|322842311|FG000|Overall Study|Ineligible post randomization|1|||
94287559|NCT04652804|322842312|FG001|Overall Study|Ineligible post randomization|0|||
94287560|NCT04652804|322842313|FG002|Overall Study|Ineligible post randomization|1|||
94221683|NCT00603278|322603504|FG005|Overall Study|Lost to Follow-up|0|||
94287561|NCT04652804|322842314|FG003|Overall Study|Ineligible post randomization|0|||
94287562|NCT04652804|322842315|FG004|Overall Study|Ineligible post randomization|1|||
94287563|NCT04652804|322842316|FG005|Overall Study|Ineligible post randomization|1|||
94372503|NCT00479401|323150277|FG001|Overall Study|Protocol Violation|1|||
94287564|NCT04652804|322842311|FG000|Overall Study|Missing SVR lab results|2|||
94287565|NCT04652804|322842312|FG001|Overall Study|Missing SVR lab results|0|||
94287566|NCT04652804|322842313|FG002|Overall Study|Missing SVR lab results|0|||
94287567|NCT04652804|322842314|FG003|Overall Study|Missing SVR lab results|0|||
94287568|NCT04652804|322842315|FG004|Overall Study|Missing SVR lab results|0|||
94372504|NCT00479401|323150278|FG002|Overall Study|Protocol Violation|1|||
94221684|NCT00676663|322603505|FG000|Overall Study|Death|43|||
94221685|NCT00676663|322603506|FG001|Overall Study|Death|27|||
94221686|NCT00676663|322603505|FG000|Overall Study|Withdrew Consent|1|||
94221687|NCT00676663|322603506|FG001|Overall Study|Withdrew Consent|8|||
94221688|NCT00676663|322603505|FG000|Overall Study|Lost to Follow-up|1|||
94221689|NCT00676663|322603506|FG001|Overall Study|Lost to Follow-up|3|||
94221690|NCT03640754|322603508|FG000|Overall Study|Withdrawal by Subject|1|||
94221691|NCT03640754|322603509|FG001|Overall Study|Withdrawal by Subject|0|||
94221692|NCT03640754|322603508|FG000|Overall Study|Lost to Follow-up|0|||
94221693|NCT03640754|322603509|FG001|Overall Study|Lost to Follow-up|1|||
94221694|NCT04382053|322603510|FG000|Overall Study|Death|6|||
94221695|NCT04382053|322603511|FG001|Overall Study|Death|8|||
94221696|NCT04382053|322603510|FG000|Overall Study|Lost to Follow-up|0|||
94221697|NCT04382053|322603511|FG001|Overall Study|Lost to Follow-up|2|||
94221698|NCT04382053|322603510|FG000|Overall Study|Protocol Deviation|1|||
94221699|NCT04382053|322603511|FG001|Overall Study|Protocol Deviation|2|||
94221700|NCT04382053|322603510|FG000|Overall Study|Withdrawal by Subject|2|||
94221701|NCT04382053|322603511|FG001|Overall Study|Withdrawal by Subject|1|||
94221702|NCT03689452|322603514|FG000|Overall Study|Lost to Follow-up|1|||
94221703|NCT03689452|322603515|FG001|Overall Study|Lost to Follow-up|1|||
94221704|NCT01288729|322603516|FG000|Overall Study|Withdrawal by Subject|1|||
94221705|NCT01288729|322603517|FG001|Overall Study|Withdrawal by Subject|0|||
94221706|NCT00417989|322603520|FG000|Overall Study|Withdrawal by Subject|13|||
94221707|NCT00417989|322603521|FG001|Overall Study|Withdrawal by Subject|13|||
94221708|NCT00417989|322603520|FG000|Overall Study|Lost to Follow-up|1|||
94221709|NCT00417989|322603521|FG001|Overall Study|Lost to Follow-up|6|||
94221710|NCT00417989|322603520|FG000|Overall Study|Protocol Violation|1|||
94221711|NCT00417989|322603521|FG001|Overall Study|Protocol Violation|0|||
94221712|NCT00417989|322603520|FG000|Overall Study|Death|0|||
94221713|NCT00417989|322603521|FG001|Overall Study|Death|1|||
94221714|NCT00417989|322603520|FG000|Overall Study|Physician Decision|5|||
94221715|NCT00417989|322603521|FG001|Overall Study|Physician Decision|2|||
94221716|NCT01636778|322603522|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
94221717|NCT01636778|322603523|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
94221718|NCT01636778|322603524|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
94221719|NCT01636778|322603522|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
94221720|NCT01636778|322603523|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
94221721|NCT01636778|322603524|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
94221722|NCT01636778|322603522|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
94221723|NCT01636778|322603523|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
94221724|NCT01636778|322603524|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
94221725|NCT01636778|322603522|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
94221726|NCT01636778|322603523|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
94221727|NCT01636778|322603524|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
94221728|NCT01636778|322603522|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
94221729|NCT01636778|322603523|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
94221730|NCT01636778|322603524|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
94221731|NCT01636778|322603522|FG000|Follow-up Period After Part 2|Other|0|||
94221732|NCT01636778|322603523|FG001|Follow-up Period After Part 2|Other|0|||
94221733|NCT01636778|322603524|FG002|Follow-up Period After Part 2|Other|1|||
94221734|NCT01636778|322603522|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
94221735|NCT01636778|322603523|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
94221736|NCT01636778|322603524|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
94221737|NCT01636778|322603522|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
94221738|NCT01636778|322603523|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
94221739|NCT01636778|322603524|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
94221740|NCT03169530|322603527|FG000|Overall Study|Study ended by NIH|15|||
94221741|NCT03169530|322603528|FG001|Overall Study|Study ended by NIH|17|||
94221742|NCT00990821|322603538|FG000|Overall Study|Withdrawal by Subject|0|||
94221743|NCT00990821|322603539|FG001|Overall Study|Withdrawal by Subject|2|||
94221744|NCT00990821|322603540|FG002|Overall Study|Withdrawal by Subject|0|||
94221745|NCT00990821|322603541|FG003|Overall Study|Withdrawal by Subject|0|||
94221746|NCT00990821|322603542|FG004|Overall Study|Withdrawal by Subject|3|||
94221747|NCT00990821|322603543|FG005|Overall Study|Withdrawal by Subject|3|||
94221748|NCT00990821|322603544|FG006|Overall Study|Withdrawal by Subject|1|||
94221749|NCT00990821|322603545|FG007|Overall Study|Withdrawal by Subject|0|||
94221750|NCT00990821|322603546|FG008|Overall Study|Withdrawal by Subject|0|||
94221751|NCT00990821|322603547|FG009|Overall Study|Withdrawal by Subject|1|||
94221752|NCT00990821|322603548|FG010|Overall Study|Withdrawal by Subject|3|||
94221753|NCT00990821|322603549|FG011|Overall Study|Withdrawal by Subject|5|||
94221754|NCT00990821|322603550|FG012|Overall Study|Withdrawal by Subject|2|||
94221755|NCT00990821|322603551|FG013|Overall Study|Withdrawal by Subject|1|||
94221756|NCT03530345|322603552|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
94221757|NCT03530345|322603553|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
94221758|NCT03530345|322603552|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
94221759|NCT03530345|322603553|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
94221760|NCT03530345|322603552|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
94221761|NCT03530345|322603553|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
94221762|NCT03530345|322603552|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
94221763|NCT03530345|322603553|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
94221764|NCT00500539|322603554|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
94221765|NCT00500539|322603554|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
94221766|NCT00500539|322603554|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
94221767|NCT00500539|322603554|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
94221768|NCT00500539|322603554|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
94221769|NCT00500539|322603554|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
94221770|NCT00500539|322603554|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
94221771|NCT00500539|322603554|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
94221772|NCT00500539|322603554|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
94221773|NCT00500539|322603554|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
94221774|NCT00500539|322603554|FG000|Follow-up Period (16 Weeks)|Death|1|||
94221775|NCT00500539|322603554|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
94221776|NCT00500539|322603554|FG000|Follow-up Period (16 Weeks)|Missing|3|||
94221777|NCT00308113|322603557|FG000|Overall Study|Protocol closure|0|||
94221778|NCT00308113|322603558|FG001|Overall Study|Protocol closure|0|||
94221779|NCT00308113|322603559|FG002|Overall Study|Protocol closure|0|||
94221780|NCT00308113|322603560|FG003|Overall Study|Protocol closure|1|||
94221781|NCT02316171|322603565|FG000|Overall Study|difficulties with urinary catheter|1|||
94221782|NCT02316171|322603566|FG001|Overall Study|difficulties with urinary catheter|0|||
94221783|NCT02316171|322603567|FG002|Overall Study|difficulties with urinary catheter|0|||
94221784|NCT02316171|322603568|FG003|Overall Study|difficulties with urinary catheter|0|||
94221785|NCT04267393|322603576|FG000|Randomization|Adverse Event|1|||
94221786|NCT04267393|322603577|FG001|Randomization|Adverse Event|0|||
94221787|NCT04267393|322603578|FG002|Randomization|Adverse Event|0|||
94221788|NCT04267393|322603576|FG000|Randomization|Administrative Reasons by Sponsor|0|||
94221789|NCT04267393|322603577|FG001|Randomization|Administrative Reasons by Sponsor|1|||
94221790|NCT04267393|322603578|FG002|Randomization|Administrative Reasons by Sponsor|0|||
94221791|NCT04267393|322603576|FG000|Treatment Period|Adverse Event|0|||
94221792|NCT04267393|322603577|FG001|Treatment Period|Adverse Event|2|||
94221793|NCT04267393|322603578|FG002|Treatment Period|Adverse Event|3|||
94221794|NCT04267393|322603576|FG000|Treatment Period|Participant Withdrew Consent|0|||
94221795|NCT04267393|322603577|FG001|Treatment Period|Participant Withdrew Consent|0|||
94221796|NCT04267393|322603578|FG002|Treatment Period|Participant Withdrew Consent|1|||
94221797|NCT04267393|322603576|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
94221798|NCT04267393|322603577|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
94221799|NCT04267393|322603578|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
94221800|NCT04413149|322605019|FG000|Overall Study|Death|10|||
94221801|NCT04413149|322605020|FG001|Overall Study|Death|5|||
94221802|NCT04413149|322605019|FG000|Overall Study|Lung transplantation|1|||
94221803|NCT04413149|322605020|FG001|Overall Study|Lung transplantation|0|||
94221804|NCT02878590|322605021|FG000|Overall Study|Withdrawal by Subject|2|||
94221805|NCT03322514|322605022|FG000|Overall Study|Withdrawal by Subject|1|||
94221806|NCT03322514|322605023|FG001|Overall Study|Withdrawal by Subject|1|||
94221807|NCT00946998|322605027|FG000|Overall Study|Exited prior to first outcome assessment|5|||
94221808|NCT00946998|322605028|FG001|Overall Study|Exited prior to first outcome assessment|3|||
94221809|NCT02081196|322605029|FG000|Overall Study|Lost to Follow-up|1|||
94221810|NCT01904019|322605030|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
94221811|NCT01904019|322605030|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
94221812|NCT01904019|322605030|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
94221813|NCT01904019|322605030|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
94221814|NCT01904019|322605030|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
94221815|NCT01904019|322605030|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
94221816|NCT00507429|322605031|FG000|Treatment Phase|Disease Progression|12|||
94221817|NCT00507429|322605032|FG001|Treatment Phase|Disease Progression|5|||
94221818|NCT00507429|322605031|FG000|Treatment Phase|Adverse Event|12|||
94221819|NCT00507429|322605032|FG001|Treatment Phase|Adverse Event|5|||
94221820|NCT00507429|322605031|FG000|Treatment Phase|Withdrawal by Subject|3|||
94221821|NCT00507429|322605032|FG001|Treatment Phase|Withdrawal by Subject|3|||
94221822|NCT00507429|322605031|FG000|Treatment Phase|Physician Decision|4|||
94221823|NCT00507429|322605032|FG001|Treatment Phase|Physician Decision|2|||
94221824|NCT00507429|322605031|FG000|Treatment Phase|Other|6|||
94221825|NCT00507429|322605032|FG001|Treatment Phase|Other|3|||
94221826|NCT00507429|322605031|FG000|Maintenance Phase|Progressive Disease|14|||
94221827|NCT00507429|322605032|FG001|Maintenance Phase|Progressive Disease|0|||
94221828|NCT00839306|322605033|FG000|Overall Study|Adverse Event|3|||
94221829|NCT00839306|322605034|FG001|Overall Study|Adverse Event|5|||
94221830|NCT00839306|322605033|FG000|Overall Study|Lost to Follow-up|6|||
94221831|NCT00839306|322605034|FG001|Overall Study|Lost to Follow-up|9|||
94221832|NCT00839306|322605033|FG000|Overall Study|Withdrawal by Subject|5|||
94221833|NCT00839306|322605034|FG001|Overall Study|Withdrawal by Subject|7|||
94221834|NCT00839306|322605033|FG000|Overall Study|Lack of Efficacy|5|||
94221835|NCT00839306|322605034|FG001|Overall Study|Lack of Efficacy|4|||
94221836|NCT00839306|322605033|FG000|Overall Study|Other|6|||
94221837|NCT00839306|322605034|FG001|Overall Study|Other|18|||
94221838|NCT01038128|322605035|FG000|Overall Study|Lack of Efficacy|1|||
94221839|NCT01038128|322605035|FG000|Overall Study|Lost to Follow-up|1|||
94221840|NCT01038128|322605035|FG000|Overall Study|Withdrawal by Subject|2|||
94221841|NCT00331799|322605040|FG000|Overall Study|Withdrawal by Subject|2|||
94221842|NCT00331799|322605040|FG000|Overall Study|Sedation|1|||
94221843|NCT02068352|322605043|FG000|Overall Study|Lost to Follow-up|0|||
94221844|NCT02068352|322605044|FG001|Overall Study|Lost to Follow-up|2|||
94221845|NCT02068352|322605045|FG002|Overall Study|Lost to Follow-up|0|||
94221846|NCT02068352|322605043|FG000|Overall Study|Adverse Event|4|||
94221847|NCT02068352|322605044|FG001|Overall Study|Adverse Event|2|||
94221848|NCT02068352|322605045|FG002|Overall Study|Adverse Event|7|||
94221849|NCT02068352|322605043|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
94221850|NCT02068352|322605044|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
94221851|NCT02068352|322605045|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
94221852|NCT02068352|322605043|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
94221853|NCT02068352|322605044|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
94221854|NCT02068352|322605045|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
94221855|NCT02068352|322605043|FG000|Overall Study|Protocol Deviation|0|||
94221856|NCT02068352|322605044|FG001|Overall Study|Protocol Deviation|0|||
94221857|NCT02068352|322605045|FG002|Overall Study|Protocol Deviation|1|||
94221858|NCT01838499|322605047|FG000|Overall Study|Protocol Violation|0|||
94221859|NCT01838499|322605048|FG001|Overall Study|Protocol Violation|1|||
94221860|NCT01838499|322605047|FG000|Overall Study|Lost to Follow-up|2|||
94221861|NCT01838499|322605048|FG001|Overall Study|Lost to Follow-up|4|||
94221862|NCT01838499|322605047|FG000|Overall Study|Lack of Efficacy|1|||
94221863|NCT01838499|322605048|FG001|Overall Study|Lack of Efficacy|2|||
94221864|NCT01838499|322605047|FG000|Overall Study|Adverse Event|2|||
94221865|NCT01838499|322605048|FG001|Overall Study|Adverse Event|1|||
94221866|NCT01838499|322605047|FG000|Overall Study|Withdrawal by Subject|19|||
94221867|NCT01838499|322605048|FG001|Overall Study|Withdrawal by Subject|9|||
94221868|NCT00809783|322605053|FG000|Overall Study|Death|1|||
94221869|NCT00809783|322605054|FG001|Overall Study|Death|0|||
94221870|NCT00809783|322605055|FG002|Overall Study|Death|0|||
94221871|NCT00809783|322605053|FG000|Overall Study|Adverse Event|34|||
94221872|NCT00809783|322605054|FG001|Overall Study|Adverse Event|52|||
94221873|NCT00809783|322605055|FG002|Overall Study|Adverse Event|71|||
94221874|NCT00809783|322605053|FG000|Overall Study|Lack of Efficacy|39|||
94221875|NCT00809783|322605054|FG001|Overall Study|Lack of Efficacy|52|||
94221876|NCT00809783|322605055|FG002|Overall Study|Lack of Efficacy|63|||
94221877|NCT00809783|322605053|FG000|Overall Study|Lost to Follow-up|0|||
94221878|NCT00809783|322605054|FG001|Overall Study|Lost to Follow-up|3|||
94221879|NCT00809783|322605055|FG002|Overall Study|Lost to Follow-up|4|||
94221880|NCT00809783|322605053|FG000|Overall Study|Withdrawal by Subject|47|||
94221881|NCT00809783|322605054|FG001|Overall Study|Withdrawal by Subject|72|||
94221882|NCT00809783|322605055|FG002|Overall Study|Withdrawal by Subject|64|||
94221883|NCT00809783|322605053|FG000|Overall Study|Protocol Violation|2|||
94221884|NCT00809783|322605054|FG001|Overall Study|Protocol Violation|6|||
94221885|NCT00809783|322605055|FG002|Overall Study|Protocol Violation|5|||
94221886|NCT00809783|322605053|FG000|Overall Study|Randomized, but not treated|3|||
94221887|NCT00809783|322605054|FG001|Overall Study|Randomized, but not treated|0|||
94221888|NCT00809783|322605055|FG002|Overall Study|Randomized, but not treated|2|||
94221889|NCT00809783|322605053|FG000|Overall Study|Study Terminated by Sponsor|378|||
94221890|NCT00809783|322605054|FG001|Overall Study|Study Terminated by Sponsor|626|||
94221891|NCT00809783|322605055|FG002|Overall Study|Study Terminated by Sponsor|565|||
94221892|NCT00809783|322605053|FG000|Overall Study|Other|21|||
94221893|NCT00809783|322605054|FG001|Overall Study|Other|21|||
94221894|NCT00809783|322605055|FG002|Overall Study|Other|16|||
94221895|NCT00126555|322605056|FG000|Overall Study|Withdrawal by Subject|1|||
94372505|NCT00479401|323150276|FG000|Overall Study|Lost to Follow-up|1|||
94221896|NCT00126555|322605056|FG000|Overall Study|Adverse Event|2|||
94221897|NCT00126555|322605056|FG000|Overall Study|Progressive Disease|3|||
94221898|NCT03314233|322605060|FG000|Overall Study|No longer eligible at time of delivery|1|||
94221899|NCT02567227|322605061|FG000|9 Weeks|Adverse Event|5|||
94221900|NCT02567227|322605062|FG001|9 Weeks|Adverse Event|5|||
94221901|NCT02567227|322605061|FG000|9 Weeks|Withdrawal by Subject|18|||
94221902|NCT02567227|322605062|FG001|9 Weeks|Withdrawal by Subject|8|||
94221903|NCT02567227|322605061|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
94221904|NCT02567227|322605062|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
94221905|NCT02567227|322605061|FG000|6 Month|Death|2|||
94221906|NCT02567227|322605062|FG001|6 Month|Death|0|||
94221907|NCT02567227|322605061|FG000|6 Month|Lost to Follow-up|43|||
94221908|NCT02567227|322605062|FG001|6 Month|Lost to Follow-up|40|||
94287569|NCT04652804|322842316|FG005|Overall Study|Missing SVR lab results|0|||
94287570|NCT04093531|322842317|FG000|Overall Study|failed screening|4|||
94287571|NCT03634800|322842318|FG000|Overall Study|Adverse Event|1|||
94467896|NCT00404924|323502432|FG000|Overall Study|Lost to Follow-up|1|||
94467897|NCT00404924|323502433|FG001|Overall Study|Lost to Follow-up|1|||
94287572|NCT03634800|322842318|FG000|Overall Study|Disease Progression|4|||
94287573|NCT03634800|322842318|FG000|Overall Study|Withdrawal by Subject|1|||
94287574|NCT02217566|322842320|FG000|Overall Study|Lost to Follow-up|2|||
94287575|NCT02217566|322842320|FG000|Overall Study|Death|3|||
94287576|NCT02217566|322842320|FG000|Overall Study|Early study termination|6|||
94287577|NCT00257010|322842321|FG000|Overall Study|Lack of Efficacy|11|||
94287578|NCT00257010|322842321|FG000|Overall Study|Lost to Follow-up|53|||
94287579|NCT00257010|322842321|FG000|Overall Study|Withdrawal by Subject|34|||
94287580|NCT00257010|322842321|FG000|Overall Study|Adverse Event|10|||
94287581|NCT00257010|322842321|FG000|Overall Study|various|11|||
94287582|NCT00257010|322842321|FG000|Overall Study|no headache reported|9|||
94287583|NCT00094757|322842323|FG000|Overall Study|Adverse Event|11|||
94287584|NCT00094757|322842324|FG001|Overall Study|Adverse Event|9|||
94287585|NCT00094757|322842325|FG002|Overall Study|Adverse Event|6|||
94287586|NCT00094757|322842323|FG000|Overall Study|Lack of Efficacy|11|||
94287587|NCT00094757|322842324|FG001|Overall Study|Lack of Efficacy|15|||
94287588|NCT00094757|322842325|FG002|Overall Study|Lack of Efficacy|8|||
94287589|NCT00094757|322842323|FG000|Overall Study|Lost to Follow-up|3|||
94287590|NCT00094757|322842324|FG001|Overall Study|Lost to Follow-up|5|||
94287591|NCT00094757|322842325|FG002|Overall Study|Lost to Follow-up|6|||
94287592|NCT00094757|322842323|FG000|Overall Study|Patient Moved|2|||
94287593|NCT00094757|322842324|FG001|Overall Study|Patient Moved|1|||
94287594|NCT00094757|322842325|FG002|Overall Study|Patient Moved|1|||
94287595|NCT00094757|322842323|FG000|Overall Study|Protocol Violation|8|||
94287596|NCT00094757|322842324|FG001|Overall Study|Protocol Violation|5|||
94287597|NCT00094757|322842325|FG002|Overall Study|Protocol Violation|3|||
94287598|NCT00094757|322842323|FG000|Overall Study|Withdrawal by Subject|14|||
94287599|NCT00094757|322842324|FG001|Overall Study|Withdrawal by Subject|21|||
94287600|NCT00094757|322842325|FG002|Overall Study|Withdrawal by Subject|5|||
94287601|NCT00094757|322842323|FG000|Overall Study|Other|3|||
94287602|NCT00094757|322842324|FG001|Overall Study|Other|3|||
94287603|NCT00094757|322842325|FG002|Overall Study|Other|1|||
94287604|NCT00094757|322842323|FG000|Overall Study|Protocol specified discontinuation|1|||
94287605|NCT00094757|322842324|FG001|Overall Study|Protocol specified discontinuation|3|||
94287606|NCT00094757|322842325|FG002|Overall Study|Protocol specified discontinuation|0|||
94287607|NCT01700192|322842331|FG000|Overall Study|Adverse Event|73|||
94287608|NCT01700192|322842332|FG001|Overall Study|Adverse Event|18|||
94287609|NCT01700192|322842331|FG000|Overall Study|Lack of Efficacy|1|||
94287610|NCT01700192|322842332|FG001|Overall Study|Lack of Efficacy|0|||
94287611|NCT01700192|322842331|FG000|Overall Study|Lost to Follow-up|42|||
94287612|NCT01700192|322842332|FG001|Overall Study|Lost to Follow-up|29|||
94287613|NCT01700192|322842331|FG000|Overall Study|Noncompliance with study drug|0|||
94287614|NCT01700192|322842332|FG001|Overall Study|Noncompliance with study drug|5|||
94287615|NCT01700192|322842331|FG000|Overall Study|Physician Decision|2|||
94467898|NCT00404924|323502432|FG000|Overall Study|Withdrawal by Subject|26|||
94467899|NCT00404924|323502433|FG001|Overall Study|Withdrawal by Subject|13|||
94467900|NCT00404924|323502432|FG000|Overall Study|Other|25|||
94467901|NCT00404924|323502433|FG001|Overall Study|Other|11|||
94287616|NCT01700192|322842332|FG001|Overall Study|Physician Decision|3|||
94287617|NCT01700192|322842331|FG000|Overall Study|Pregnancy|1|||
94287618|NCT01700192|322842332|FG001|Overall Study|Pregnancy|4|||
94287619|NCT01700192|322842331|FG000|Overall Study|Progressive disease|1|||
94287620|NCT01700192|322842332|FG001|Overall Study|Progressive disease|0|||
94287621|NCT01700192|322842331|FG000|Overall Study|Protocol Violation|3|||
94287622|NCT01700192|322842332|FG001|Overall Study|Protocol Violation|4|||
94287623|NCT01700192|322842331|FG000|Overall Study|Technical problems|0|||
94287624|NCT01700192|322842332|FG001|Overall Study|Technical problems|1|||
94287625|NCT01700192|322842331|FG000|Overall Study|Withdrawal by Subject|56|||
94221909|NCT02567227|322605061|FG000|12 Months|Lost to Follow-up|31|||
94221910|NCT02567227|322605062|FG001|12 Months|Lost to Follow-up|32|||
94221911|NCT02567227|322605061|FG000|12 Months|Death|0|||
94221912|NCT02567227|322605062|FG001|12 Months|Death|2|||
94221913|NCT00005908|322605064|FG000|Overall Study|Withdrawal by Subject|1|||
94221914|NCT00005908|322605065|FG001|Overall Study|Withdrawal by Subject|0|||
94221915|NCT04736602|322605066|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
94221916|NCT04736602|322605066|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
94221917|NCT01379521|322605067|FG000|Overall Study -Treatment Period|Adverse Event|3|||
94221918|NCT01379521|322605068|FG001|Overall Study -Treatment Period|Adverse Event|0|||
94221919|NCT01379521|322605067|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
94221920|NCT01379521|322605068|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
94221921|NCT01379521|322605067|FG000|Overall Study -Treatment Period|Disease Progression|23|||
94221922|NCT01379521|322605068|FG001|Overall Study -Treatment Period|Disease Progression|22|||
94221923|NCT01379521|322605067|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
94221924|NCT01379521|322605068|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
94221925|NCT01379521|322605067|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
94221926|NCT01379521|322605068|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
94221927|NCT01379521|322605067|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
94221928|NCT01379521|322605068|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
94221929|NCT01379521|322605067|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
94221930|NCT01379521|322605068|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
94221931|NCT01379521|322605067|FG000|Overall Study -Treatment Period|Death|2|||
94221932|NCT01379521|322605068|FG001|Overall Study -Treatment Period|Death|1|||
94221933|NCT01379521|322605067|FG000|Post-Treatment Evaluations|Disease Progression|22|||
94221934|NCT01379521|322605068|FG001|Post-Treatment Evaluations|Disease Progression|20|||
94221935|NCT01379521|322605067|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
94221936|NCT01379521|322605068|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
94221937|NCT01379521|322605067|FG000|Post-Treatment Evaluations|Death|1|||
94221938|NCT01379521|322605068|FG001|Post-Treatment Evaluations|Death|0|||
94221939|NCT01026103|322605069|FG000|Overall Study|Physician Decision|1|||
94221940|NCT01026103|322605069|FG000|Overall Study|did not receive study device bc of error|1|||
94221941|NCT02205476|322605070|FG000|Overall Study|Study termination by Sponsor|7|||
94221942|NCT02205476|322605071|FG001|Overall Study|Study termination by Sponsor|3|||
94221943|NCT02097056|322605079|FG000|Overall Study|Protocol Violation|2|||
94221944|NCT02097056|322605079|FG000|Overall Study|Withdrawal by Subject|15|||
94221945|NCT02097056|322605079|FG000|Overall Study|Lost to Follow-up|2|||
94221946|NCT02097056|322605079|FG000|Overall Study|Adverse Event|37|||
94221947|NCT02097056|322605079|FG000|Overall Study|Other|2|||
94221948|NCT03906240|322605082|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
94221949|NCT03906240|322605083|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
94221950|NCT03906240|322605082|FG000|Overall Study|Lost to Follow-up|1|||
94221951|NCT03906240|322605083|FG001|Overall Study|Lost to Follow-up|0|||
94221952|NCT03906240|322605082|FG000|Overall Study|Withdrawal by Subject|0|||
94221953|NCT03906240|322605083|FG001|Overall Study|Withdrawal by Subject|1|||
94221954|NCT01446042|322605084|FG000|Overall Study|Withdrawal by Subject|12|||
94221955|NCT01446042|322605085|FG001|Overall Study|Withdrawal by Subject|2|||
94221956|NCT01446042|322605086|FG002|Overall Study|Withdrawal by Subject|4|||
94221957|NCT01446042|322605084|FG000|Overall Study|Adverse Event|1|||
94221958|NCT01446042|322605085|FG001|Overall Study|Adverse Event|0|||
94221959|NCT01446042|322605086|FG002|Overall Study|Adverse Event|4|||
94221960|NCT01446042|322605084|FG000|Overall Study|Lost to Follow-up|5|||
94221961|NCT01446042|322605085|FG001|Overall Study|Lost to Follow-up|0|||
94221962|NCT01446042|322605086|FG002|Overall Study|Lost to Follow-up|0|||
94221963|NCT01446042|322605084|FG000|Overall Study|Other reasons|2|||
94221964|NCT01446042|322605085|FG001|Overall Study|Other reasons|1|||
94221965|NCT01446042|322605086|FG002|Overall Study|Other reasons|1|||
94221966|NCT00460577|322605087|FG000|Overall Study|Protocol Violation|2|||
94221967|NCT00460577|322605088|FG001|Overall Study|Protocol Violation|6|||
94221968|NCT02625922|322605094|FG000|Overall Study|Non-availability of IMP|1|||
94221969|NCT02625922|322605095|FG001|Overall Study|Non-availability of IMP|1|||
94221970|NCT02625922|322605094|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
94221971|NCT02625922|322605095|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
94287626|NCT01700192|322842332|FG001|Overall Study|Withdrawal by Subject|64|||
94221972|NCT01078571|322605096|FG000|Overall Study|Adverse Event|36|||
94221973|NCT01078571|322605096|FG000|Overall Study|Lack of effectiveness|36|||
94221974|NCT01078571|322605096|FG000|Overall Study|Reason not reported|21|||
94221975|NCT01078571|322605096|FG000|Overall Study|Withdrawal by Subject|12|||
94287627|NCT01700192|322842331|FG000|Overall Study|Never received study drug|1|||
94287628|NCT01700192|322842332|FG001|Overall Study|Never received study drug|0|||
94221976|NCT01078571|322605096|FG000|Overall Study|Lost to Follow-up|8|||
94221977|NCT01078571|322605096|FG000|Overall Study|Protocol Violation|2|||
94221978|NCT03839355|322605108|FG000|Overall Study|Withdrawal by Subject|1|||
94287629|NCT03403192|322842333|FG000|Overall Study|Lost to Follow-up|1|||
94221979|NCT03839355|322605109|FG001|Overall Study|Withdrawal by Subject|0|||
94221980|NCT03802513|322605110|FG000|Overall Study|Lost to Follow-up|1|||
94221981|NCT01023022|322605111|FG000|Overall Study|Death|5|||
94221982|NCT01023022|322605111|FG000|Overall Study|Lost to Follow-up|7|||
94221983|NCT01023022|322605111|FG000|Overall Study|due to technical issues|2|||
94221984|NCT01622088|322605112|FG000|Overall Study|Adverse Event|20|||
94221985|NCT01622088|322605112|FG000|Overall Study|Lost to Follow-up|1|||
94221986|NCT01622088|322605112|FG000|Overall Study|Withdrawal by Subject|20|||
94221987|NCT01622088|322605112|FG000|Overall Study|Investigator Decision|1|||
94221988|NCT01622088|322605112|FG000|Overall Study|Death|53|||
94221989|NCT01622088|322605112|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
94221990|NCT05287178|322605121|FG000|Overall Study|Lost to Follow-up|2|||
94221991|NCT03023878|322605122|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
94221992|NCT03023878|322605122|FG000|Pre-Study Run-In Period|Death|1|||
94221993|NCT03023878|322605122|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
94221994|NCT03023878|322605122|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
94221995|NCT03023878|322605122|FG000|Treatment Period|Disease Progression|1|||
94221996|NCT03023878|322605122|FG000|Treatment Period|Withdrawal by Subject|1|||
94221997|NCT03023878|322605122|FG000|Treatment Period|Adverse Event|1|||
94221998|NCT03023878|322605122|FG000|Long Term Follow-Up Period|Death|2|||
94221999|NCT00728884|322605127|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
94222000|NCT00728884|322605127|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
94222001|NCT02588027|322605132|FG000|Overall Study|Withdrawal by Subject|1|||
94222002|NCT02588027|322605133|FG001|Overall Study|Withdrawal by Subject|3|||
94222003|NCT02588027|322605132|FG000|Overall Study|Protocol Violation|4|||
94222004|NCT02588027|322605133|FG001|Overall Study|Protocol Violation|1|||
94222005|NCT02116582|322605134|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
94222006|NCT02116582|322605134|FG000|Overall Study|Adverse Event|22|||
94222007|NCT02116582|322605134|FG000|Overall Study|Death|9|||
94222008|NCT02116582|322605134|FG000|Overall Study|Progressive Disease|148|||
94222009|NCT02116582|322605134|FG000|Overall Study|Protocol Violation|3|||
94222010|NCT02116582|322605134|FG000|Overall Study|Withdrawal by Subject|8|||
94222011|NCT02116582|322605134|FG000|Overall Study|Other: Miscellaneous|11|||
94222012|NCT02116582|322605134|FG000|Overall Study|Lost to Follow-up|1|||
94222013|NCT02116582|322605134|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
94222014|NCT01261793|322605135|FG000|Overall Study|Lack of Efficacy|44|||
94222015|NCT01261793|322605136|FG001|Overall Study|Lack of Efficacy|37|||
94222016|NCT01261793|322605137|FG002|Overall Study|Lack of Efficacy|32|||
94222017|NCT01261793|322605135|FG000|Overall Study|Protocol Violation|3|||
94222018|NCT01261793|322605136|FG001|Overall Study|Protocol Violation|5|||
94222019|NCT01261793|322605137|FG002|Overall Study|Protocol Violation|6|||
94222020|NCT01261793|322605135|FG000|Overall Study|Lost to Follow-up|10|||
94222021|NCT01261793|322605136|FG001|Overall Study|Lost to Follow-up|3|||
94222022|NCT01261793|322605137|FG002|Overall Study|Lost to Follow-up|7|||
94222023|NCT01261793|322605135|FG000|Overall Study|Withdrawal by Subject|12|||
94222024|NCT01261793|322605136|FG001|Overall Study|Withdrawal by Subject|14|||
94222025|NCT01261793|322605137|FG002|Overall Study|Withdrawal by Subject|14|||
94222026|NCT01261793|322605135|FG000|Overall Study|Death|3|||
94222027|NCT01261793|322605136|FG001|Overall Study|Death|1|||
94222028|NCT01261793|322605137|FG002|Overall Study|Death|0|||
94222029|NCT01261793|322605135|FG000|Overall Study|Adverse Event|9|||
94222030|NCT01261793|322605136|FG001|Overall Study|Adverse Event|24|||
94222031|NCT01261793|322605137|FG002|Overall Study|Adverse Event|19|||
94222032|NCT01261793|322605135|FG000|Overall Study|Patient non-availability|1|||
94222033|NCT01261793|322605136|FG001|Overall Study|Patient non-availability|1|||
94222034|NCT01261793|322605137|FG002|Overall Study|Patient non-availability|1|||
94222035|NCT01261793|322605135|FG000|Overall Study|Suspected pregnancy|1|||
94222036|NCT01261793|322605136|FG001|Overall Study|Suspected pregnancy|1|||
94222037|NCT01261793|322605137|FG002|Overall Study|Suspected pregnancy|0|||
94222038|NCT01261793|322605135|FG000|Overall Study|Patient non-compliance|1|||
94222039|NCT01261793|322605136|FG001|Overall Study|Patient non-compliance|0|||
94222040|NCT01261793|322605137|FG002|Overall Study|Patient non-compliance|1|||
94222041|NCT01261793|322605135|FG000|Overall Study|Patient pregnant|1|||
94222042|NCT01261793|322605136|FG001|Overall Study|Patient pregnant|0|||
94222043|NCT01261793|322605137|FG002|Overall Study|Patient pregnant|0|||
94222044|NCT01261793|322605135|FG000|Overall Study|Outside the study area|0|||
94222045|NCT01261793|322605136|FG001|Overall Study|Outside the study area|2|||
94222046|NCT01261793|322605137|FG002|Overall Study|Outside the study area|1|||
94222047|NCT01261793|322605135|FG000|Overall Study|Lack of efficacy & patient not available|0|||
94222048|NCT01261793|322605136|FG001|Overall Study|Lack of efficacy & patient not available|1|||
94222049|NCT01261793|322605137|FG002|Overall Study|Lack of efficacy & patient not available|0|||
94222050|NCT01261793|322605135|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
94222051|NCT01261793|322605136|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
94222052|NCT01261793|322605137|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
94222053|NCT01261793|322605135|FG000|Overall Study|Randomization error|0|||
94222054|NCT01261793|322605136|FG001|Overall Study|Randomization error|1|||
94222055|NCT01261793|322605137|FG002|Overall Study|Randomization error|0|||
94222056|NCT01261793|322605135|FG000|Overall Study|Patient unable to start IV line|0|||
94222057|NCT01261793|322605136|FG001|Overall Study|Patient unable to start IV line|0|||
94222058|NCT01261793|322605137|FG002|Overall Study|Patient unable to start IV line|1|||
94222059|NCT00577096|322605138|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
94222060|NCT00577096|322605139|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
94222061|NCT00577096|322605138|FG000|Short Term Participation|Withdrawal by Subject|3|||
94222062|NCT00577096|322605139|FG001|Short Term Participation|Withdrawal by Subject|5|||
94222063|NCT00577096|322605138|FG000|Short Term Participation|Death|1|||
94222064|NCT00577096|322605139|FG001|Short Term Participation|Death|1|||
94222065|NCT00734851|322605140|FG000|Overall Study|Withdrawal by Subject|2|||
94287630|NCT03403192|322842334|FG001|Overall Study|Lost to Follow-up|2|||
94287631|NCT03403192|322842335|FG002|Overall Study|Lost to Follow-up|0|||
94287632|NCT03403192|322842336|FG003|Overall Study|Lost to Follow-up|0|||
94287633|NCT03403192|322842333|FG000|Overall Study|Unable to respond|0|||
94287634|NCT03403192|322842334|FG001|Overall Study|Unable to respond|1|||
94287635|NCT03403192|322842335|FG002|Overall Study|Unable to respond|0|||
94287636|NCT03403192|322842336|FG003|Overall Study|Unable to respond|0|||
94287637|NCT03403192|322842333|FG000|Overall Study|Incomplete|3|||
94287638|NCT03403192|322842334|FG001|Overall Study|Incomplete|1|||
94287639|NCT03403192|322842335|FG002|Overall Study|Incomplete|3|||
94287640|NCT03403192|322842336|FG003|Overall Study|Incomplete|6|||
94287641|NCT02435914|322842337|FG000|Overall Study|Ocular Adverse Event|1|||
94287642|NCT02435914|322842338|FG001|Overall Study|Ocular Adverse Event|0|||
94287643|NCT02435914|322842339|FG002|Overall Study|Ocular Adverse Event|0|||
94287644|NCT02435914|322842340|FG003|Overall Study|Ocular Adverse Event|0|||
94287645|NCT02435914|322842337|FG000|Overall Study|Withdrawal by Subject|0|||
94287646|NCT02435914|322842338|FG001|Overall Study|Withdrawal by Subject|1|||
94287647|NCT02435914|322842339|FG002|Overall Study|Withdrawal by Subject|0|||
94287648|NCT02435914|322842340|FG003|Overall Study|Withdrawal by Subject|0|||
94287649|NCT02435914|322842337|FG000|Overall Study|Other Miscellaneous Reason|0|||
94287650|NCT02435914|322842338|FG001|Overall Study|Other Miscellaneous Reason|0|||
94287651|NCT02435914|322842339|FG002|Overall Study|Other Miscellaneous Reason|1|||
94287652|NCT02435914|322842340|FG003|Overall Study|Other Miscellaneous Reason|0|||
94287653|NCT01960855|322842341|FG000|Overall Study|Subject noncompliant|1|||
94287654|NCT01960855|322842342|FG001|Overall Study|Subject noncompliant|0|||
94287655|NCT01960855|322842343|FG002|Overall Study|Subject noncompliant|0|||
94287656|NCT01960855|322842344|FG003|Overall Study|Subject noncompliant|0|||
94287657|NCT01960855|322842345|FG004|Overall Study|Subject noncompliant|0|||
94287658|NCT01960855|322842341|FG000|Overall Study|Adverse Event|2|||
94287659|NCT01960855|322842342|FG001|Overall Study|Adverse Event|0|||
94287660|NCT01960855|322842343|FG002|Overall Study|Adverse Event|6|||
94287661|NCT01960855|322842344|FG003|Overall Study|Adverse Event|2|||
94287662|NCT01960855|322842345|FG004|Overall Study|Adverse Event|2|||
94287663|NCT01960855|322842341|FG000|Overall Study|Lack of Efficacy|1|||
94287664|NCT01960855|322842342|FG001|Overall Study|Lack of Efficacy|1|||
94287665|NCT01960855|322842343|FG002|Overall Study|Lack of Efficacy|0|||
94287666|NCT01960855|322842344|FG003|Overall Study|Lack of Efficacy|0|||
94287667|NCT01960855|322842345|FG004|Overall Study|Lack of Efficacy|0|||
94287668|NCT01960855|322842341|FG000|Overall Study|Other|2|||
94287669|NCT01960855|322842342|FG001|Overall Study|Other|1|||
94287670|NCT01960855|322842343|FG002|Overall Study|Other|1|||
94287671|NCT01960855|322842344|FG003|Overall Study|Other|1|||
94222066|NCT00734851|322605140|FG000|Overall Study|Lost to Follow-up|1|||
94222067|NCT00734851|322605140|FG000|Overall Study|Physician Decision|18|||
94287672|NCT01960855|322842345|FG004|Overall Study|Other|0|||
94287673|NCT01960855|322842341|FG000|Overall Study|Consent withdrawn by subject|3|||
94287674|NCT01960855|322842342|FG001|Overall Study|Consent withdrawn by subject|1|||
94287675|NCT01960855|322842343|FG002|Overall Study|Consent withdrawn by subject|2|||
94287676|NCT01960855|322842344|FG003|Overall Study|Consent withdrawn by subject|1|||
94287677|NCT01960855|322842345|FG004|Overall Study|Consent withdrawn by subject|1|||
94287678|NCT01960855|322842341|FG000|Overall Study|Lost to Follow-up|2|||
94287679|NCT01960855|322842342|FG001|Overall Study|Lost to Follow-up|1|||
94287680|NCT01960855|322842343|FG002|Overall Study|Lost to Follow-up|0|||
94287681|NCT01960855|322842344|FG003|Overall Study|Lost to Follow-up|0|||
94287682|NCT01960855|322842345|FG004|Overall Study|Lost to Follow-up|2|||
94372506|NCT00479401|323150277|FG001|Overall Study|Lost to Follow-up|1|||
94222068|NCT00818519|322605141|FG000|Overall Study|Adverse Event|2|||
94287683|NCT00820755|322842346|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
94287684|NCT00820755|322842347|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
94287685|NCT00820755|322842348|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
94287686|NCT00820755|322842346|FG000|Period 1: Combination Therapy Phase|Death|28|||
94287687|NCT00820755|322842347|FG001|Period 1: Combination Therapy Phase|Death|0|||
94287688|NCT00820755|322842348|FG002|Period 1: Combination Therapy Phase|Death|0|||
94287689|NCT00820755|322842346|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
94287690|NCT00820755|322842347|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
94287691|NCT00820755|322842348|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
94287692|NCT00820755|322842346|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
94287693|NCT00820755|322842347|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
94287694|NCT00820755|322842348|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
94287695|NCT00820755|322842346|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
94287696|NCT00820755|322842347|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
94287697|NCT00820755|322842348|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
94287698|NCT00820755|322842346|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
94287699|NCT00820755|322842347|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
94287700|NCT00820755|322842348|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
94287701|NCT00820755|322842346|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
94287702|NCT00820755|322842347|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
94287703|NCT00820755|322842348|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
94287704|NCT00820755|322842346|FG000|Period 1: Combination Therapy Phase|Other|11|||
94287705|NCT00820755|322842347|FG001|Period 1: Combination Therapy Phase|Other|0|||
94287706|NCT00820755|322842348|FG002|Period 1: Combination Therapy Phase|Other|0|||
94287707|NCT00820755|322842346|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
94287708|NCT00820755|322842347|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
94287709|NCT00820755|322842348|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
94287710|NCT01405053|322842353|FG000|Overall Study|Adverse Event|3|||
94287711|NCT01405053|322842354|FG001|Overall Study|Adverse Event|0|||
94287712|NCT01405053|322842353|FG000|Overall Study|Lost to Follow-up|0|||
94287713|NCT01405053|322842354|FG001|Overall Study|Lost to Follow-up|1|||
94287714|NCT01405053|322842353|FG000|Overall Study|Participant choice|2|||
94287715|NCT01405053|322842354|FG001|Overall Study|Participant choice|1|||
94287716|NCT01405053|322842353|FG000|Overall Study|Inadequate therapeutic effect|2|||
94287717|NCT01405053|322842354|FG001|Overall Study|Inadequate therapeutic effect|1|||
94287718|NCT01405053|322842353|FG000|Overall Study|Withdrawal by Subject|3|||
94287719|NCT01405053|322842354|FG001|Overall Study|Withdrawal by Subject|4|||
94287720|NCT01405053|322842353|FG000|Overall Study|Other|0|||
94287721|NCT01405053|322842354|FG001|Overall Study|Other|1|||
94287722|NCT00130286|322842357|FG000|Overall Study|Withdrawal by Subject|0|||
94287723|NCT00130286|322842358|FG001|Overall Study|Withdrawal by Subject|1|||
94287724|NCT00130286|322842359|FG002|Overall Study|Withdrawal by Subject|2|||
94287725|NCT00130286|322842360|FG003|Overall Study|Withdrawal by Subject|2|||
94287726|NCT00130286|322842357|FG000|Overall Study|Adverse Event|0|||
94287727|NCT00130286|322842358|FG001|Overall Study|Adverse Event|0|||
94287728|NCT00130286|322842359|FG002|Overall Study|Adverse Event|2|||
94287729|NCT00130286|322842360|FG003|Overall Study|Adverse Event|0|||
94287730|NCT00130286|322842357|FG000|Overall Study|Missing lab specimens|0|||
94287731|NCT00130286|322842358|FG001|Overall Study|Missing lab specimens|2|||
94287732|NCT00130286|322842359|FG002|Overall Study|Missing lab specimens|0|||
94287733|NCT00130286|322842360|FG003|Overall Study|Missing lab specimens|0|||
94287734|NCT02154425|322842361|FG000|Screening Period|Adverse Event|1|||
94287735|NCT04178772|322842368|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
94287736|NCT04178772|322842368|FG000|Overall Study|study terminated early due to COVID-19|7|||
94287737|NCT00713219|322842372|FG000|Overall Study|Death|1|||
94287738|NCT00713219|322842372|FG000|Overall Study|Protocol Violation|1|||
94287739|NCT01557166|322842380|FG000|Overall Study|Adverse Event|20|||
94287740|NCT01557166|322842381|FG001|Overall Study|Adverse Event|6|||
94287741|NCT01557166|322842380|FG000|Overall Study|Lack of Efficacy|2|||
94287742|NCT01557166|322842381|FG001|Overall Study|Lack of Efficacy|1|||
94287743|NCT01557166|322842380|FG000|Overall Study|Protocol Violation|8|||
94287744|NCT01557166|322842381|FG001|Overall Study|Protocol Violation|5|||
94287745|NCT01557166|322842380|FG000|Overall Study|Withdrawn consent|12|||
94287746|NCT01557166|322842381|FG001|Overall Study|Withdrawn consent|20|||
94372507|NCT00479401|323150278|FG002|Overall Study|Lost to Follow-up|1|||
94372508|NCT00479401|323150276|FG000|Overall Study|Withdrawal by Subject|16|||
94287747|NCT01557166|322842380|FG000|Overall Study|Target dose not tolerated|1|||
94287748|NCT01557166|322842381|FG001|Overall Study|Target dose not tolerated|0|||
94287749|NCT01557166|322842380|FG000|Overall Study|Psychiatric disorder|1|||
94287750|NCT01557166|322842381|FG001|Overall Study|Psychiatric disorder|0|||
94287751|NCT01557166|322842380|FG000|Overall Study|Unclassified|2|||
94287752|NCT01557166|322842381|FG001|Overall Study|Unclassified|5|||
94287753|NCT00911989|322842382|FG000|Overall Study|Adverse Event|1|||
94287754|NCT04811716|322842392|FG000|Overall Study|Withdrawal by Subject|2|||
94372509|NCT00479401|323150277|FG001|Overall Study|Withdrawal by Subject|10|||
94372510|NCT00479401|323150278|FG002|Overall Study|Withdrawal by Subject|2|||
94287755|NCT04811716|322842393|FG001|Overall Study|Withdrawal by Subject|0|||
94287756|NCT02320487|322842396|FG000|Overall Study|Reason not Specified|1|||
94287757|NCT02320487|322842396|FG000|Overall Study|Physician Decision|5|||
94287758|NCT02320487|322842396|FG000|Overall Study|Withdrawal by Subject|1|||
94287759|NCT02320487|322842396|FG000|Overall Study|Death|3|||
94287760|NCT02320487|322842396|FG000|Overall Study|Adverse Event|11|||
94287761|NCT03344003|322842397|FG000|Overall Study|Switched to alternative treatment|1|||
94287762|NCT03344003|322842398|FG001|Overall Study|Switched to alternative treatment|0|||
94222069|NCT00818519|322605142|FG001|Overall Study|Adverse Event|2|||
94222070|NCT00818519|322605141|FG000|Overall Study|Lost to Follow-up|4|||
94222071|NCT00818519|322605142|FG001|Overall Study|Lost to Follow-up|6|||
94222072|NCT00818519|322605141|FG000|Overall Study|Protocol Violation|2|||
94222073|NCT00818519|322605142|FG001|Overall Study|Protocol Violation|1|||
94222074|NCT00818519|322605141|FG000|Overall Study|Pregnancy|0|||
94222075|NCT00818519|322605142|FG001|Overall Study|Pregnancy|1|||
94222076|NCT00818519|322605141|FG000|Overall Study|Withdrawal by Subject|4|||
94222077|NCT00818519|322605142|FG001|Overall Study|Withdrawal by Subject|9|||
94222078|NCT00818519|322605141|FG000|Overall Study|participant recovered completely|1|||
94222079|NCT00818519|322605142|FG001|Overall Study|participant recovered completely|0|||
94222080|NCT00818519|322605141|FG000|Overall Study|participant will leave for long tme|1|||
94222081|NCT00818519|322605142|FG001|Overall Study|participant will leave for long tme|0|||
94222082|NCT00832650|322605143|FG000|Overall Study|Randomized but not treated|0|||
94222083|NCT00832650|322605144|FG001|Overall Study|Randomized but not treated|0|||
94222084|NCT00832650|322605145|FG002|Overall Study|Randomized but not treated|1|||
94222085|NCT03219216|322605146|FG000|Overall Study|Lost to Follow-up|0|||
94222086|NCT03219216|322605147|FG001|Overall Study|Lost to Follow-up|1|||
94222087|NCT05431543|322605150|FG000|Overall Study|Medical History|1|||
94222088|NCT05431543|322605151|FG001|Overall Study|Medical History|0|||
94222089|NCT05431543|322605152|FG002|Overall Study|Medical History|0|||
94222090|NCT03030599|322605153|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
94222091|NCT03030599|322605154|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
94287763|NCT03344003|322842397|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
94287764|NCT03344003|322842398|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
94287765|NCT01602341|322844087|FG000|Overall Study|Adverse Event|0|||
94287766|NCT01602341|322844088|FG001|Overall Study|Adverse Event|1|||
94287767|NCT03786432|322844090|FG000|Overall Study|Screen Failure after consent|1|||
94287768|NCT03786432|322844090|FG000|Overall Study|Lost to Follow-up|4|||
94287769|NCT03786432|322844090|FG000|Overall Study|did not complete 12 month CT scan|1|||
94287770|NCT03160560|322844091|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
94287771|NCT03160560|322844092|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
94287772|NCT03160560|322844093|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
94287773|NCT03160560|322844094|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
94287774|NCT03160560|322844091|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
94287775|NCT03160560|322844092|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
94287776|NCT03160560|322844093|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
94287777|NCT03160560|322844094|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
94287778|NCT00544869|322844097|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
94287779|NCT00544869|322844098|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
94287780|NCT00544869|322844099|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
94287781|NCT00544869|322844097|FG000|Overall Study|Adverse Event|6|||
94287782|NCT00544869|322844098|FG001|Overall Study|Adverse Event|1|||
94287783|NCT00544869|322844099|FG002|Overall Study|Adverse Event|0|||
94287784|NCT00544869|322844097|FG000|Overall Study|Lack of Efficacy|1|||
94287785|NCT00544869|322844098|FG001|Overall Study|Lack of Efficacy|1|||
94287786|NCT00544869|322844099|FG002|Overall Study|Lack of Efficacy|0|||
94287787|NCT00544869|322844097|FG000|Overall Study|Physician Decision|2|||
94287788|NCT00544869|322844098|FG001|Overall Study|Physician Decision|0|||
94287789|NCT00544869|322844099|FG002|Overall Study|Physician Decision|0|||
94287790|NCT02002975|322844100|FG000|Overall Study|Case Report Forms Uncollected|135|||
94287791|NCT02002975|322844100|FG000|Overall Study|Protocol Deviation|437|||
94287792|NCT00772629|322844104|FG000|Overall Study|Subject was not vaccinated|1|||
94287793|NCT00772629|322844105|FG001|Overall Study|Subject was not vaccinated|0|||
94287794|NCT05162066|322844106|FG000|Overall Study|Adverse Event|1|||
94287795|NCT05162066|322844107|FG001|Overall Study|Adverse Event|0|||
94287796|NCT05162066|322844108|FG002|Overall Study|Adverse Event|0|||
94287797|NCT05162066|322844106|FG000|Overall Study|Perceived lack of efficacy|1|||
94287798|NCT05162066|322844107|FG001|Overall Study|Perceived lack of efficacy|0|||
94287799|NCT05162066|322844108|FG002|Overall Study|Perceived lack of efficacy|0|||
94287800|NCT01072344|322844109|FG000|Overall Study|Relasped-reached end point|7|||
94222092|NCT03030599|322605155|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
94222093|NCT03030599|322605153|FG000|Open Label Treatment and Titration|Other|1|||
94222094|NCT03030599|322605154|FG001|Open Label Treatment and Titration|Other|0|||
94222095|NCT03030599|322605155|FG002|Open Label Treatment and Titration|Other|0|||
94222096|NCT03030599|322605153|FG000|Open Label Treatment and Titration|Physician Decision|3|||
94222097|NCT03030599|322605154|FG001|Open Label Treatment and Titration|Physician Decision|0|||
94222098|NCT03030599|322605155|FG002|Open Label Treatment and Titration|Physician Decision|0|||
94287801|NCT01072344|322844110|FG001|Overall Study|Relasped-reached end point|12|||
94287802|NCT01072344|322844109|FG000|Overall Study|Protocol Violation|1|||
94287803|NCT01072344|322844110|FG001|Overall Study|Protocol Violation|2|||
94287804|NCT01072344|322844109|FG000|Overall Study|Lost to Follow-up|3|||
94287805|NCT01072344|322844110|FG001|Overall Study|Lost to Follow-up|4|||
94287806|NCT03969875|322844111|FG000|Overall Study|did not receive allocated intervention|3|||
94222099|NCT03030599|322605153|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
94222100|NCT03030599|322605154|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
94222101|NCT03030599|322605155|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
94222102|NCT03030599|322605153|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
94222103|NCT03030599|322605154|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
94222104|NCT03030599|322605155|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
94222105|NCT03030599|322605153|FG000|Open Label Treatment and Titration|Adverse Event|18|||
94222106|NCT03030599|322605154|FG001|Open Label Treatment and Titration|Adverse Event|0|||
94222107|NCT03030599|322605155|FG002|Open Label Treatment and Titration|Adverse Event|0|||
94222108|NCT03030599|322605153|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
94222109|NCT03030599|322605154|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
94222110|NCT03030599|322605155|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
94222111|NCT03030599|322605153|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
94222112|NCT03030599|322605154|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
94222113|NCT03030599|322605155|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
94222114|NCT03030599|322605153|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
94222115|NCT03030599|322605154|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
94222116|NCT03030599|322605155|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
94222117|NCT03030599|322605153|FG000|Stable Dose|Protocol deviation|3|||
94222118|NCT03030599|322605154|FG001|Stable Dose|Protocol deviation|0|||
94222119|NCT03030599|322605155|FG002|Stable Dose|Protocol deviation|0|||
94222120|NCT03030599|322605153|FG000|Stable Dose|Adverse Event|1|||
94222121|NCT03030599|322605154|FG001|Stable Dose|Adverse Event|0|||
94222122|NCT03030599|322605155|FG002|Stable Dose|Adverse Event|0|||
94222123|NCT03030599|322605153|FG000|Stable Dose|Lost to Follow-up|1|||
94222124|NCT03030599|322605154|FG001|Stable Dose|Lost to Follow-up|0|||
94222125|NCT03030599|322605155|FG002|Stable Dose|Lost to Follow-up|0|||
94222126|NCT03030599|322605153|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
94222127|NCT03030599|322605154|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
94222128|NCT03030599|322605155|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
94222129|NCT03030599|322605153|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
94222130|NCT03030599|322605154|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
94222131|NCT03030599|322605155|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
94222132|NCT03030599|322605153|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
94222133|NCT03030599|322605154|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
94222134|NCT03030599|322605155|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
94222135|NCT03030599|322605153|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
94222136|NCT03030599|322605154|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
94222137|NCT03030599|322605155|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
94222138|NCT03030599|322605153|FG000|Open-label Extension|Adverse Event|3|||
94222139|NCT03030599|322605154|FG001|Open-label Extension|Adverse Event|0|||
94222140|NCT03030599|322605155|FG002|Open-label Extension|Adverse Event|0|||
94222141|NCT03030599|322605153|FG000|Open-label Extension|Lost to Follow-up|2|||
94222142|NCT03030599|322605154|FG001|Open-label Extension|Lost to Follow-up|0|||
94222143|NCT03030599|322605155|FG002|Open-label Extension|Lost to Follow-up|0|||
94222144|NCT03030599|322605153|FG000|Open-label Extension|Lack of Efficacy|1|||
94222145|NCT03030599|322605154|FG001|Open-label Extension|Lack of Efficacy|0|||
94222146|NCT03030599|322605155|FG002|Open-label Extension|Lack of Efficacy|0|||
94222147|NCT03030599|322605153|FG000|Open-label Extension|Other Reason|1|||
94222148|NCT03030599|322605154|FG001|Open-label Extension|Other Reason|0|||
94222149|NCT03030599|322605155|FG002|Open-label Extension|Other Reason|0|||
94222150|NCT04839289|322605156|FG000|Overall Study|Withdrawal by Subject|1|||
94222151|NCT04839289|322605157|FG001|Overall Study|Withdrawal by Subject|0|||
94222152|NCT02273180|322605164|FG000|Overall Study|Adverse Event|2|||
94222153|NCT02273180|322605165|FG001|Overall Study|Adverse Event|2|||
94222154|NCT02273180|322605164|FG000|Overall Study|Lack of Efficacy|1|||
94222155|NCT02273180|322605165|FG001|Overall Study|Lack of Efficacy|0|||
94222156|NCT02273180|322605164|FG000|Overall Study|Protocol Violation|1|||
94222157|NCT02273180|322605165|FG001|Overall Study|Protocol Violation|7|||
94222158|NCT02273180|322605164|FG000|Overall Study|Randomized but not treated|1|||
94222159|NCT02273180|322605165|FG001|Overall Study|Randomized but not treated|0|||
94222160|NCT02273180|322605164|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
94222161|NCT02273180|322605165|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
94222162|NCT02273180|322605164|FG000|Overall Study|Other than specified above|21|||
94222163|NCT02273180|322605165|FG001|Overall Study|Other than specified above|10|||
94222164|NCT01804140|322605166|FG000|Overall Study|No sampling or biopsy procedures done|114|||
94222165|NCT01524887|322605167|FG000|Overall Study|Withdrawal by Subject|6|||
94222166|NCT01524887|322605168|FG001|Overall Study|Withdrawal by Subject|2|||
94222167|NCT01524887|322605169|FG002|Overall Study|Withdrawal by Subject|3|||
94222168|NCT01524887|322605167|FG000|Overall Study|Adverse Event|5|||
94222169|NCT01524887|322605168|FG001|Overall Study|Adverse Event|1|||
94467902|NCT00404924|323502432|FG000|Overall Study|Randomised but not received treatment|1|||
94467903|NCT00404924|323502433|FG001|Overall Study|Randomised but not received treatment|1|||
94467904|NCT04490018|323502440|FG000|Overall Study|Protocol Violation|0|||
94467905|NCT04490018|323502441|FG001|Overall Study|Protocol Violation|2|||
94467906|NCT04490018|323502442|FG002|Overall Study|Protocol Violation|1|||
94222170|NCT01524887|322605169|FG002|Overall Study|Adverse Event|1|||
94222171|NCT01524887|322605167|FG000|Overall Study|Protocol Violation|0|||
94222172|NCT01524887|322605168|FG001|Overall Study|Protocol Violation|0|||
94222173|NCT01524887|322605169|FG002|Overall Study|Protocol Violation|1|||
94222174|NCT01524887|322605167|FG000|Overall Study|Study termination|73|||
94222175|NCT01524887|322605168|FG001|Overall Study|Study termination|87|||
94222176|NCT01524887|322605169|FG002|Overall Study|Study termination|79|||
94222177|NCT01524887|322605167|FG000|Overall Study|Withdrawal by Caregiver|0|||
94222178|NCT01524887|322605168|FG001|Overall Study|Withdrawal by Caregiver|0|||
94222179|NCT01524887|322605169|FG002|Overall Study|Withdrawal by Caregiver|2|||
94222180|NCT01524887|322605167|FG000|Overall Study|Use of prohibited medication|1|||
94222181|NCT01524887|322605168|FG001|Overall Study|Use of prohibited medication|0|||
94222182|NCT01524887|322605169|FG002|Overall Study|Use of prohibited medication|0|||
94222183|NCT00547300|322605170|FG000|Overall Study|Study was Administratively Terminated|25|||
94222184|NCT00547300|322605171|FG001|Overall Study|Study was Administratively Terminated|24|||
94222185|NCT00547300|322605170|FG000|Overall Study|Did not Meet Entry Criteria|0|||
94222186|NCT00547300|322605171|FG001|Overall Study|Did not Meet Entry Criteria|2|||
94222187|NCT00170950|322605172|FG000|Overall Study|Death|236|||
94222188|NCT00170950|322605173|FG001|Overall Study|Death|274|||
94222189|NCT00170950|322605172|FG000|Overall Study|Withdrawal by Subject|496|||
94222190|NCT00170950|322605173|FG001|Overall Study|Withdrawal by Subject|498|||
94222191|NCT00170950|322605172|FG000|Overall Study|Lost to Follow-up|134|||
94222192|NCT00170950|322605173|FG001|Overall Study|Lost to Follow-up|115|||
94222193|NCT00170950|322605172|FG000|Overall Study|Missing|2|||
94222194|NCT00170950|322605173|FG001|Overall Study|Missing|1|||
94222195|NCT00170950|322605172|FG000|Overall Study|Termination Data Not Recorded|17|||
94222196|NCT00170950|322605173|FG001|Overall Study|Termination Data Not Recorded|22|||
94222197|NCT00748098|322605174|FG000|First Treatment Intervention Period|Adverse Event|1|||
94222198|NCT00748098|322605175|FG001|First Treatment Intervention Period|Adverse Event|1|||
94222199|NCT00748098|322605174|FG000|First Treatment Intervention Period|Protocol Violation|1|||
94222200|NCT00748098|322605175|FG001|First Treatment Intervention Period|Protocol Violation|0|||
94222201|NCT00748098|322605174|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
94222202|NCT00748098|322605175|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
94222203|NCT00748098|322605174|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
94222204|NCT00748098|322605175|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
94222205|NCT00748098|322605174|FG000|First Taper Period|Protocol Violation|1|||
94222206|NCT00748098|322605175|FG001|First Taper Period|Protocol Violation|0|||
94222207|NCT00748098|322605174|FG000|First Taper Period|Withdrawal by Subject|2|||
94222208|NCT00748098|322605175|FG001|First Taper Period|Withdrawal by Subject|0|||
94222209|NCT00748098|322605174|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
94222210|NCT00748098|322605175|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
94222211|NCT00748098|322605174|FG000|1-Week Washout Period|Adverse Event|0|||
94222212|NCT00748098|322605175|FG001|1-Week Washout Period|Adverse Event|1|||
94222213|NCT00748098|322605174|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
94222214|NCT00748098|322605175|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
94222215|NCT00748098|322605174|FG000|Second Treatment Intervention Period|Adverse Event|4|||
94222216|NCT00748098|322605175|FG001|Second Treatment Intervention Period|Adverse Event|1|||
94222217|NCT00748098|322605174|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
94222218|NCT00748098|322605175|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
94222219|NCT00748098|322605174|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
94222220|NCT00748098|322605175|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
94222221|NCT00230971|322605176|FG000|Randomization|No study drug administered|3|||
94222222|NCT00230971|322605177|FG001|Randomization|No study drug administered|3|||
94222223|NCT00230971|322605176|FG000|Baseline Participants|Lost to Follow-up|5|||
94222224|NCT00230971|322605177|FG001|Baseline Participants|Lost to Follow-up|12|||
94222225|NCT00230971|322605176|FG000|Baseline Participants|Death|6|||
94222226|NCT00230971|322605177|FG001|Baseline Participants|Death|5|||
94222227|NCT00230971|322605176|FG000|Baseline Participants|Withdrawal by Subject|7|||
94222228|NCT00230971|322605177|FG001|Baseline Participants|Withdrawal by Subject|1|||
94222229|NCT00230971|322605176|FG000|Baseline Participants|Adverse Event|1|||
94222230|NCT00230971|322605177|FG001|Baseline Participants|Adverse Event|0|||
94222231|NCT00230971|322605176|FG000|Baseline Participants|No bacteria observed|1|||
94222232|NCT00230971|322605177|FG001|Baseline Participants|No bacteria observed|0|||
94222233|NCT00230971|322605176|FG000|Baseline Participants|Failure to return|1|||
94222234|NCT00230971|322605177|FG001|Baseline Participants|Failure to return|1|||
94222235|NCT00230971|322605176|FG000|Baseline Participants|Reintervention|1|||
94222236|NCT00230971|322605177|FG001|Baseline Participants|Reintervention|0|||
94222237|NCT04380688|322605178|FG000|Overall Study|Death|2|||
94222238|NCT04380688|322605179|FG001|Overall Study|Death|2|||
94467907|NCT04490018|323502440|FG000|Overall Study|Lost to Follow-up|2|||
94222239|NCT04380688|322605178|FG000|Overall Study|Lost to Follow-up|2|||
94222240|NCT04380688|322605179|FG001|Overall Study|Lost to Follow-up|4|||
94222241|NCT04380688|322605178|FG000|Overall Study|Withdrawal by Subject|3|||
94222242|NCT04380688|322605179|FG001|Overall Study|Withdrawal by Subject|3|||
94287807|NCT03969875|322844112|FG001|Overall Study|did not receive allocated intervention|3|||
94287808|NCT03969875|322844113|FG002|Overall Study|did not receive allocated intervention|4|||
94287809|NCT03969875|322844111|FG000|Overall Study|Protocol Violation|4|||
94287810|NCT03969875|322844112|FG001|Overall Study|Protocol Violation|2|||
94287811|NCT03969875|322844113|FG002|Overall Study|Protocol Violation|2|||
94287812|NCT01871090|322844120|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
94287813|NCT01871090|322844121|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
94287814|NCT01871090|322844120|FG000|Overall Study|Interrogation not completed correctly|1|||
94287815|NCT01871090|322844121|FG001|Overall Study|Interrogation not completed correctly|0|||
94287816|NCT01871090|322844120|FG000|Overall Study|Subject Non-Compliance|0|||
94287817|NCT01871090|322844121|FG001|Overall Study|Subject Non-Compliance|1|||
94287818|NCT01307033|322844125|FG000|8-week Double-blind Period|Adverse Event|2|||
94287819|NCT01307033|322844126|FG001|8-week Double-blind Period|Adverse Event|0|||
94287820|NCT01307033|322844127|FG002|8-week Double-blind Period|Adverse Event|0|||
94287821|NCT01307033|322844128|FG003|8-week Double-blind Period|Adverse Event|0|||
94287822|NCT01307033|322844125|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
94287823|NCT01307033|322844126|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
94287824|NCT01307033|322844127|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
94287825|NCT01307033|322844128|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
94287826|NCT01307033|322844125|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
94287827|NCT01307033|322844126|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
94287828|NCT01307033|322844127|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
94287829|NCT01307033|322844128|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
94287830|NCT01307033|322844125|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
94287831|NCT01307033|322844126|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
94287832|NCT01307033|322844127|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
94287833|NCT01307033|322844128|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
94287834|NCT01307033|322844125|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
94287835|NCT01307033|322844126|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
94287836|NCT01307033|322844127|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
94287837|NCT01307033|322844128|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
94287838|NCT01307033|322844125|FG000|44-week Open-label Extension|Adverse Event|0|||
94287839|NCT01307033|322844126|FG001|44-week Open-label Extension|Adverse Event|0|||
94287840|NCT01307033|322844127|FG002|44-week Open-label Extension|Adverse Event|2|||
94287841|NCT01307033|322844128|FG003|44-week Open-label Extension|Adverse Event|1|||
94287842|NCT01307033|322844125|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
94287843|NCT01307033|322844126|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
94287844|NCT01307033|322844127|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
94287845|NCT01307033|322844128|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
94287846|NCT01307033|322844125|FG000|44-week Open-label Extension|Physician Decision|0|||
94287847|NCT01307033|322844126|FG001|44-week Open-label Extension|Physician Decision|0|||
94287848|NCT01307033|322844127|FG002|44-week Open-label Extension|Physician Decision|1|||
94287849|NCT01307033|322844128|FG003|44-week Open-label Extension|Physician Decision|0|||
94287850|NCT01307033|322844125|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
94287851|NCT01307033|322844126|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
94287852|NCT01307033|322844127|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
94287853|NCT01307033|322844128|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
94287854|NCT01307033|322844125|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
94287855|NCT01307033|322844126|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
94287856|NCT01307033|322844127|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
94287857|NCT01307033|322844128|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
94287858|NCT01307033|322844125|FG000|44-week Open-label Extension|Death|0|||
94287859|NCT01307033|322844126|FG001|44-week Open-label Extension|Death|0|||
94287860|NCT01307033|322844127|FG002|44-week Open-label Extension|Death|0|||
94287861|NCT01307033|322844128|FG003|44-week Open-label Extension|Death|1|||
94287862|NCT01461044|322844131|FG000|Overall Study|Death|58|||
94287863|NCT01461044|322844132|FG001|Overall Study|Death|35|||
94287864|NCT01461044|322844131|FG000|Overall Study|Lost to Follow-up|12|||
94287865|NCT01461044|322844132|FG001|Overall Study|Lost to Follow-up|5|||
94287866|NCT01268293|322844133|FG000|Overall Study|Disease progression|7|||
94287867|NCT01268293|322844133|FG000|Overall Study|Adverse Event|1|||
94287868|NCT01268293|322844133|FG000|Overall Study|Subject choice|1|||
94287869|NCT00716976|322844134|FG000|Overall Study|Adverse Event|2|||
94287870|NCT00716976|322844135|FG001|Overall Study|Adverse Event|0|||
94287871|NCT00716976|322844134|FG000|Overall Study|Death|1|||
94287872|NCT00716976|322844135|FG001|Overall Study|Death|0|||
94287873|NCT00716976|322844134|FG000|Overall Study|Physician Decision|2|||
94287874|NCT00716976|322844135|FG001|Overall Study|Physician Decision|2|||
94287875|NCT00716976|322844134|FG000|Overall Study|Withdrawal by Subject|5|||
94287876|NCT00716976|322844135|FG001|Overall Study|Withdrawal by Subject|1|||
94287877|NCT00716976|322844134|FG000|Overall Study|Premature discontinuation cisplatin|5|||
94287878|NCT00716976|322844135|FG001|Overall Study|Premature discontinuation cisplatin|4|||
94287879|NCT00716976|322844134|FG000|Overall Study|Radiation during protocol|1|||
94287880|NCT00716976|322844135|FG001|Overall Study|Radiation during protocol|0|||
94287881|NCT00716976|322844134|FG000|Overall Study|Ineligibles|4|||
94287882|NCT00716976|322844135|FG001|Overall Study|Ineligibles|2|||
94287883|NCT02804763|322844136|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
94287884|NCT02804763|322844137|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
94287885|NCT02804763|322844138|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
94287886|NCT02804763|322844139|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
94287887|NCT02804763|322844136|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
94287888|NCT02804763|322844137|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
94287889|NCT02804763|322844138|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
94287890|NCT02804763|322844139|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
94287891|NCT02804763|322844136|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
94287892|NCT02804763|322844137|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
94287893|NCT02804763|322844138|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
94287894|NCT02804763|322844139|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
94287895|NCT02804763|322844136|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
94287896|NCT02804763|322844137|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
94287897|NCT02804763|322844138|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
94287898|NCT02804763|322844139|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
94287899|NCT02804763|322844136|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
94287900|NCT02804763|322844137|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
94287901|NCT02804763|322844138|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
94287902|NCT02804763|322844139|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
94287903|NCT02804763|322844136|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
94287904|NCT02804763|322844137|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
94287905|NCT02804763|322844138|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
94287906|NCT02804763|322844139|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
94287907|NCT02597855|322844147|FG000|Overall Study|Lost to Follow-up|2|||
94287908|NCT02597855|322844148|FG001|Overall Study|Lost to Follow-up|1|||
94287909|NCT02971202|322844167|FG000|Overall Study|Pregnancy|1|||
94287910|NCT02971202|322844168|FG001|Overall Study|Pregnancy|0|||
94287911|NCT02971202|322844169|FG002|Overall Study|Pregnancy|0|||
94287912|NCT02971202|322844167|FG000|Overall Study|screen fail after consent|1|||
94287913|NCT02971202|322844168|FG001|Overall Study|screen fail after consent|0|||
94287914|NCT02971202|322844169|FG002|Overall Study|screen fail after consent|1|||
94287915|NCT03980938|322844171|FG000|Treatment Period 1|Study Terminated|1|||
94287916|NCT03980938|322844172|FG001|Treatment Period 1|Study Terminated|1|||
94287917|NCT03980938|322844171|FG000|Treatment Period 2|Study Terminated|2|||
94287918|NCT03980938|322844172|FG001|Treatment Period 2|Study Terminated|2|||
94287919|NCT02723201|322844173|FG000|Second Intervention Period|Protocol Violation|1|||
94287920|NCT02723201|322844174|FG001|Second Intervention Period|Protocol Violation|0|||
94287921|NCT02723201|322844175|FG002|Second Intervention Period|Protocol Violation|0|||
94287922|NCT02723201|322844173|FG000|Second Intervention Period|Adverse Event|1|||
94287923|NCT02723201|322844174|FG001|Second Intervention Period|Adverse Event|0|||
94287924|NCT02723201|322844175|FG002|Second Intervention Period|Adverse Event|0|||
94287925|NCT02908880|322844176|FG000|Overall Study|Lost to Follow-up|4|||
94287926|NCT02908880|322844176|FG000|Overall Study|Explantation of the device|1|||
94287927|NCT02908880|322844176|FG000|Overall Study|Withdrawal by Subject|17|||
94287928|NCT02908880|322844176|FG000|Overall Study|Death|5|||
94287929|NCT02421887|322844177|FG000|Overall Study|Lost to Follow-up|5|||
94287930|NCT02421887|322844178|FG001|Overall Study|Lost to Follow-up|0|||
94287931|NCT02421887|322844177|FG000|Overall Study|Withdrawal by Subject|8|||
94287932|NCT02421887|322844178|FG001|Overall Study|Withdrawal by Subject|5|||
94287933|NCT02421887|322844177|FG000|Overall Study|Physician Decision|2|||
94287934|NCT02421887|322844178|FG001|Overall Study|Physician Decision|4|||
94287935|NCT02421887|322844177|FG000|Overall Study|Adverse Event|2|||
94287936|NCT02421887|322844178|FG001|Overall Study|Adverse Event|0|||
94287937|NCT00469612|322844182|FG000|Overall Study|Study terminated before data collected|2|||
94287938|NCT00469612|322844183|FG001|Overall Study|Study terminated before data collected|0|||
94287939|NCT04557384|322844184|FG000|Overall Study|Study Terminated by Sponsor|1|||
94287940|NCT04557384|322844184|FG000|Overall Study|Death|1|||
94287941|NCT02397473|322844185|FG000|Treatment Phase|Adverse Event|1|||
94287942|NCT02397473|322844186|FG001|Treatment Phase|Adverse Event|2|||
94372511|NCT00479401|323150276|FG000|Overall Study|Exclusion criteria, relocation|4|||
94287943|NCT02397473|322844185|FG000|Treatment Phase|Lack of Efficacy|8|||
94287944|NCT02397473|322844186|FG001|Treatment Phase|Lack of Efficacy|1|||
94287945|NCT02397473|322844185|FG000|Treatment Phase|Lost to Follow-up|1|||
94287946|NCT02397473|322844186|FG001|Treatment Phase|Lost to Follow-up|0|||
94287947|NCT02397473|322844185|FG000|Treatment Phase|Withdrawal by Subject|2|||
94287948|NCT02397473|322844186|FG001|Treatment Phase|Withdrawal by Subject|1|||
94287949|NCT02397473|322844185|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
94287950|NCT02397473|322844186|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
94287951|NCT02397473|322844185|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
94287952|NCT02397473|322844186|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
94287953|NCT02397473|322844185|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
94287954|NCT02397473|322844186|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
94287955|NCT02397473|322844185|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
94287956|NCT02397473|322844186|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
94287957|NCT02397473|322844185|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
94287958|NCT02397473|322844186|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
94287959|NCT02631538|322844187|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
94287960|NCT02631538|322844188|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
94287961|NCT02631538|322844189|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
94287962|NCT02631538|322844190|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
94287963|NCT02631538|322844187|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
94287964|NCT02631538|322844188|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
94287965|NCT02631538|322844189|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
94287966|NCT02631538|322844190|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
94287967|NCT02631538|322844187|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
94287968|NCT02631538|322844188|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
94287969|NCT02631538|322844189|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
94287970|NCT02631538|322844190|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
94287971|NCT02631538|322844187|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
94287972|NCT02631538|322844188|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
94287973|NCT02631538|322844189|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
94287974|NCT02631538|322844190|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
94287975|NCT02631538|322844187|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
94287976|NCT02631538|322844188|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
94287977|NCT02631538|322844189|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
94287978|NCT02631538|322844190|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
94287979|NCT02631538|322844187|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
94287980|NCT02631538|322844188|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
94287981|NCT02631538|322844189|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
94287982|NCT02631538|322844190|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
94287983|NCT00643994|322844193|FG000|Overall Study|Death|24|||
94287984|NCT00643994|322844193|FG000|Overall Study|Lost to Follow-up|72|||
94287985|NCT00927368|322844194|FG000|Overall Study|enrollment in another study|1|||
94287986|NCT00927368|322844195|FG001|Overall Study|enrollment in another study|1|||
94287987|NCT00927368|322844196|FG002|Overall Study|enrollment in another study|2|||
94287988|NCT00927368|322844194|FG000|Overall Study|Lost to Follow-up|4|||
94287989|NCT00927368|322844195|FG001|Overall Study|Lost to Follow-up|0|||
94287990|NCT00927368|322844196|FG002|Overall Study|Lost to Follow-up|0|||
94287991|NCT00927368|322844194|FG000|Overall Study|equipment failure|1|||
94287992|NCT00927368|322844195|FG001|Overall Study|equipment failure|0|||
94287993|NCT00927368|322844196|FG002|Overall Study|equipment failure|0|||
94287994|NCT00927368|322844194|FG000|Overall Study|ineligible post randomization|0|||
94287995|NCT00927368|322844195|FG001|Overall Study|ineligible post randomization|3|||
94287996|NCT00927368|322844196|FG002|Overall Study|ineligible post randomization|1|||
94287997|NCT00927368|322844194|FG000|Overall Study|cancellation of surgery|0|||
94287998|NCT00927368|322844195|FG001|Overall Study|cancellation of surgery|1|||
94287999|NCT00927368|322844196|FG002|Overall Study|cancellation of surgery|2|||
94288000|NCT00343512|322844199|FG000|Overall Study|Withdrawal by Subject|2|||
94288001|NCT00440726|322844203|FG000|Phase 1|Dose-Limiting Toxicity|0|||
94288002|NCT00440726|322844204|FG001|Phase 1|Dose-Limiting Toxicity|1|||
94288003|NCT00440726|322844205|FG002|Phase 1|Dose-Limiting Toxicity|0|||
94288004|NCT00440726|322844203|FG000|Phase 1|Physician Decision|1|||
94288005|NCT00440726|322844204|FG001|Phase 1|Physician Decision|0|||
94288006|NCT00440726|322844205|FG002|Phase 1|Physician Decision|0|||
94288007|NCT00440726|322844203|FG000|Phase 2|Death|0|||
94288008|NCT00440726|322844204|FG001|Phase 2|Death|0|||
94288009|NCT00440726|322844205|FG002|Phase 2|Death|1|||
94467908|NCT04490018|323502441|FG001|Overall Study|Lost to Follow-up|2|||
94288010|NCT00440726|322844203|FG000|Phase 2|Adverse Event|0|||
94288011|NCT00440726|322844204|FG001|Phase 2|Adverse Event|0|||
94288012|NCT00440726|322844205|FG002|Phase 2|Adverse Event|1|||
94288013|NCT01163786|322844206|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
94288014|NCT01163786|322844206|FG000|Treatment With Bortezomib|Adverse Event|2|||
94288015|NCT01163786|322844206|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
94288016|NCT00234039|322844207|FG000|Overall Study|Adverse Event|2|||
94288017|NCT00234039|322844207|FG000|Overall Study|Progression/relapse|34|||
94288018|NCT00234039|322844207|FG000|Overall Study|Other - Not Protocol Specified|3|||
94288019|NCT00234039|322844207|FG000|Overall Study|Ineligible|9|||
94288020|NCT00234039|322844207|FG000|Overall Study|No Protocol Treatment Received|2|||
94288021|NCT01808612|322844208|FG000|Treatment Period|Adverse Event|8|||
94288022|NCT01808612|322844209|FG001|Treatment Period|Adverse Event|4|||
94288023|NCT01808612|322844210|FG002|Treatment Period|Adverse Event|3|||
94288024|NCT01808612|322844208|FG000|Treatment Period|Lost to Follow-up|2|||
94288025|NCT01808612|322844209|FG001|Treatment Period|Lost to Follow-up|2|||
94288026|NCT01808612|322844210|FG002|Treatment Period|Lost to Follow-up|1|||
94288027|NCT01808612|322844208|FG000|Treatment Period|Protocol Violation|1|||
94288028|NCT01808612|322844209|FG001|Treatment Period|Protocol Violation|0|||
94288029|NCT01808612|322844210|FG002|Treatment Period|Protocol Violation|0|||
94288030|NCT01808612|322844208|FG000|Treatment Period|Withdrawal by Subject|1|||
94288031|NCT01808612|322844209|FG001|Treatment Period|Withdrawal by Subject|0|||
94288032|NCT01808612|322844210|FG002|Treatment Period|Withdrawal by Subject|4|||
94288033|NCT01808612|322844208|FG000|Treatment Period|Physician Decision|1|||
94288034|NCT01808612|322844209|FG001|Treatment Period|Physician Decision|0|||
94288035|NCT01808612|322844210|FG002|Treatment Period|Physician Decision|4|||
94288036|NCT01808612|322844208|FG000|Treatment Period|Sponsor Decision|1|||
94288037|NCT01808612|322844209|FG001|Treatment Period|Sponsor Decision|0|||
94288038|NCT01808612|322844210|FG002|Treatment Period|Sponsor Decision|0|||
94288039|NCT01808612|322844208|FG000|Treatment Period|Lack of Efficacy|1|||
94288040|NCT01808612|322844209|FG001|Treatment Period|Lack of Efficacy|1|||
94288041|NCT01808612|322844210|FG002|Treatment Period|Lack of Efficacy|2|||
94288042|NCT01808612|322844208|FG000|Discontinuation Period|Adverse Event|1|||
94288043|NCT01808612|322844209|FG001|Discontinuation Period|Adverse Event|0|||
94288044|NCT01808612|322844210|FG002|Discontinuation Period|Adverse Event|0|||
94288045|NCT01808612|322844208|FG000|Discontinuation Period|Physician Decision|1|||
94288046|NCT01808612|322844209|FG001|Discontinuation Period|Physician Decision|0|||
94288047|NCT01808612|322844210|FG002|Discontinuation Period|Physician Decision|0|||
94288048|NCT01808612|322844208|FG000|Discontinuation Period|Lost to Follow-up|0|||
94288049|NCT01808612|322844209|FG001|Discontinuation Period|Lost to Follow-up|1|||
94288050|NCT01808612|322844210|FG002|Discontinuation Period|Lost to Follow-up|0|||
94288051|NCT00090545|322844211|FG000|Overall Study|Disease progression on study|21|||
94288052|NCT00090545|322844212|FG001|Overall Study|Disease progression on study|17|||
94288053|NCT00090545|322844211|FG000|Overall Study|Refused further treatment|1|||
94288054|NCT00090545|322844212|FG001|Overall Study|Refused further treatment|4|||
94288055|NCT00090545|322844211|FG000|Overall Study|Death|0|||
94288056|NCT00090545|322844212|FG001|Overall Study|Death|1|||
94288057|NCT00090545|322844211|FG000|Overall Study|Adverse Event|0|||
94288058|NCT00090545|322844212|FG001|Overall Study|Adverse Event|2|||
94288059|NCT03683394|322844213|FG000|Overall Study|Withdrawal by Subject|4|||
94288060|NCT03683394|322844214|FG001|Overall Study|Withdrawal by Subject|8|||
94288061|NCT03683394|322844213|FG000|Overall Study|Lost to Follow-up|7|||
94288062|NCT03683394|322844214|FG001|Overall Study|Lost to Follow-up|0|||
94288063|NCT03683394|322844213|FG000|Overall Study|Death|3|||
94288064|NCT03683394|322844214|FG001|Overall Study|Death|1|||
94288065|NCT00441545|322844215|FG000|First Intervention|Adverse Event|6|||
94288066|NCT00441545|322844216|FG001|First Intervention|Adverse Event|5|||
94288067|NCT00441545|322844215|FG000|First Intervention|Protocol Violation|2|||
94288068|NCT00441545|322844216|FG001|First Intervention|Protocol Violation|2|||
94288069|NCT00441545|322844215|FG000|First Intervention|Withdrawal by Subject|3|||
94288070|NCT00441545|322844216|FG001|First Intervention|Withdrawal by Subject|3|||
94288071|NCT00441545|322844215|FG000|First Intervention|Kidney transplant|1|||
94288072|NCT00441545|322844216|FG001|First Intervention|Kidney transplant|1|||
94372512|NCT00479401|323150277|FG001|Overall Study|Exclusion criteria, relocation|3|||
94288073|NCT00441545|322844215|FG000|First Intervention|Lack of Efficacy|2|||
94288074|NCT00441545|322844216|FG001|First Intervention|Lack of Efficacy|0|||
94288075|NCT00441545|322844215|FG000|First Intervention|Subject exceeded safety criteria|0|||
94288076|NCT00441545|322844216|FG001|First Intervention|Subject exceeded safety criteria|1|||
94288077|NCT00441545|322844215|FG000|First Intervention|Subject met an exclusionary criteria|1|||
94288078|NCT00441545|322844216|FG001|First Intervention|Subject met an exclusionary criteria|0|||
94288079|NCT00441545|322844215|FG000|First Intervention|Extended hospitalization|1|||
94288080|NCT00441545|322844216|FG001|First Intervention|Extended hospitalization|0|||
94288081|NCT00441545|322844215|FG000|First Intervention|Site error|1|||
94288082|NCT00441545|322844216|FG001|First Intervention|Site error|0|||
94288083|NCT00441545|322844215|FG000|First Intervention|Sponsor's request|1|||
94288084|NCT00441545|322844216|FG001|First Intervention|Sponsor's request|0|||
94288085|NCT00441545|322844215|FG000|Second Intervention|Adverse Event|5|||
94288086|NCT00441545|322844216|FG001|Second Intervention|Adverse Event|2|||
94288087|NCT00441545|322844215|FG000|Second Intervention|Protocol Violation|4|||
94288088|NCT00441545|322844216|FG001|Second Intervention|Protocol Violation|1|||
94288089|NCT00441545|322844215|FG000|Second Intervention|Withdrawal by Subject|1|||
94467909|NCT04490018|323502442|FG002|Overall Study|Lost to Follow-up|0|||
94467910|NCT04490018|323502440|FG000|Overall Study|Withdrawal by Subject|2|||
94467911|NCT04490018|323502441|FG001|Overall Study|Withdrawal by Subject|1|||
94467912|NCT04490018|323502442|FG002|Overall Study|Withdrawal by Subject|0|||
94467913|NCT04490018|323502440|FG000|Overall Study|Withdrawal by parent/guardian|2|||
94467914|NCT04490018|323502441|FG001|Overall Study|Withdrawal by parent/guardian|3|||
94467915|NCT04490018|323502442|FG002|Overall Study|Withdrawal by parent/guardian|0|||
94467916|NCT03313310|323502443|FG000|Phase 2|Lost to Follow-up|4|||
94467917|NCT03313310|323502444|FG001|Phase 2|Lost to Follow-up|0|||
94467918|NCT03313310|323502443|FG000|Phase 3|Lost to Follow-up|0|||
94467919|NCT03313310|323502444|FG001|Phase 3|Lost to Follow-up|1|||
94467920|NCT01281956|323502445|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
94467921|NCT01281956|323502446|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
94467922|NCT00575510|323502447|FG000|Overall Study|Lost to Follow-up|4|||
94467923|NCT00575510|323502448|FG001|Overall Study|Lost to Follow-up|6|||
94467924|NCT00575510|323502449|FG002|Overall Study|Lost to Follow-up|9|||
94467925|NCT00575510|323502447|FG000|Overall Study|Withdrawal by Subject|1|||
94467926|NCT00575510|323502448|FG001|Overall Study|Withdrawal by Subject|0|||
94467927|NCT00575510|323502449|FG002|Overall Study|Withdrawal by Subject|0|||
94467928|NCT00575510|323502447|FG000|Overall Study|Clinic Called Patient|7|||
94467929|NCT00575510|323502448|FG001|Overall Study|Clinic Called Patient|7|||
94467930|NCT00575510|323502449|FG002|Overall Study|Clinic Called Patient|7|||
94467931|NCT00575510|323502447|FG000|Overall Study|Pregnancy|0|||
94467932|NCT00575510|323502448|FG001|Overall Study|Pregnancy|0|||
94467933|NCT00575510|323502449|FG002|Overall Study|Pregnancy|1|||
94467934|NCT01593254|323502450|FG000|Overall Study|Disease progression|2|||
94467935|NCT01593254|323502451|FG001|Overall Study|Disease progression|7|||
94467936|NCT01593254|323502450|FG000|Overall Study|Study drug toxicity|6|||
94467937|NCT01593254|323502451|FG001|Overall Study|Study drug toxicity|20|||
94467938|NCT01593254|323502450|FG000|Overall Study|Death|3|||
94467939|NCT01593254|323502451|FG001|Overall Study|Death|3|||
94467940|NCT01593254|323502450|FG000|Overall Study|AE unrelated to study drug|0|||
94467941|NCT01593254|323502451|FG001|Overall Study|AE unrelated to study drug|1|||
94467942|NCT01593254|323502450|FG000|Overall Study|participant request to discontinue study treatment|1|||
94467943|NCT01593254|323502451|FG001|Overall Study|participant request to discontinue study treatment|3|||
94467944|NCT01593254|323502450|FG000|Overall Study|participant withdrew consent|0|||
94467945|NCT01593254|323502451|FG001|Overall Study|participant withdrew consent|9|||
94467946|NCT01593254|323502450|FG000|Overall Study|lost to follow up|1|||
94467947|NCT01593254|323502451|FG001|Overall Study|lost to follow up|6|||
94467948|NCT01593254|323502450|FG000|Overall Study|maximum clinical benefit|1|||
94467949|NCT01593254|323502451|FG001|Overall Study|maximum clinical benefit|2|||
94467950|NCT01593254|323502450|FG000|Overall Study|Poor/non compliance|1|||
94467951|NCT01593254|323502451|FG001|Overall Study|Poor/non compliance|1|||
94467952|NCT01593254|323502450|FG000|Overall Study|Pregnancy|0|||
94467953|NCT01593254|323502451|FG001|Overall Study|Pregnancy|3|||
94467954|NCT01593254|323502450|FG000|Overall Study|participant no longer meets study criteria|1|||
94467955|NCT01593254|323502451|FG001|Overall Study|participant no longer meets study criteria|1|||
94467956|NCT01593254|323502450|FG000|Overall Study|Admin reason by sponsor|7|||
94467957|NCT01593254|323502451|FG001|Overall Study|Admin reason by sponsor|3|||
94467958|NCT01593254|323502450|FG000|Overall Study|Imatinib treatment failure|2|||
94467959|NCT01593254|323502451|FG001|Overall Study|Imatinib treatment failure|0|||
94467960|NCT01593254|323502450|FG000|Overall Study|Other Reasons|61|||
94467961|NCT01593254|323502451|FG001|Overall Study|Other Reasons|115|||
94467962|NCT00926536|323502454|FG000|Overall Study|Physician Decision|1|||
94467963|NCT00926536|323502455|FG001|Overall Study|Physician Decision|2|||
94288090|NCT00441545|322844216|FG001|Second Intervention|Withdrawal by Subject|1|||
94288091|NCT00441545|322844215|FG000|Second Intervention|Kidney Transplant|1|||
94288092|NCT00441545|322844216|FG001|Second Intervention|Kidney Transplant|1|||
94288093|NCT00441545|322844215|FG000|Second Intervention|Lack of Efficacy|0|||
94288094|NCT00441545|322844216|FG001|Second Intervention|Lack of Efficacy|1|||
94288095|NCT00441545|322844215|FG000|Second Intervention|Subject exceeded safety criteria|1|||
94288096|NCT00441545|322844216|FG001|Second Intervention|Subject exceeded safety criteria|0|||
94288097|NCT00441545|322844215|FG000|Second Intervention|Subject moved|0|||
94288098|NCT00441545|322844216|FG001|Second Intervention|Subject moved|1|||
94288099|NCT01046695|322844217|FG000|Overall Study|Subject had a pacemaker|0|||
94288100|NCT01046695|322844218|FG001|Overall Study|Subject had a pacemaker|1|||
94288101|NCT01046695|322844217|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
94288102|NCT01046695|322844218|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
94288103|NCT04303000|322844219|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
94288104|NCT04303000|322844220|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
94288105|NCT04303000|322844221|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
94288106|NCT03653390|322844225|FG000|Overall Study|Lost to Follow-up|12|||
94288107|NCT03653390|322844226|FG001|Overall Study|Lost to Follow-up|8|||
94288108|NCT03653390|322844227|FG002|Overall Study|Lost to Follow-up|7|||
94288109|NCT03653390|322844225|FG000|Overall Study|Withdrawal by Subject|6|||
94288110|NCT03653390|322844226|FG001|Overall Study|Withdrawal by Subject|1|||
94288111|NCT03653390|322844227|FG002|Overall Study|Withdrawal by Subject|1|||
94288112|NCT03653390|322844225|FG000|Overall Study|Death|1|||
94288113|NCT03653390|322844226|FG001|Overall Study|Death|0|||
94288114|NCT03653390|322844227|FG002|Overall Study|Death|0|||
94288115|NCT03653390|322844225|FG000|Overall Study|Paper Survey Lost|1|||
94288116|NCT03653390|322844226|FG001|Overall Study|Paper Survey Lost|0|||
94288117|NCT03653390|322844227|FG002|Overall Study|Paper Survey Lost|0|||
94288118|NCT00939692|322844228|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
94288119|NCT00939692|322844229|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
94288120|NCT00939692|322844228|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
94288121|NCT00939692|322844229|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
94288122|NCT05099640|322844232|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
94288123|NCT05099640|322844233|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
94288124|NCT05099640|322844234|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
94288125|NCT05099640|322844232|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
94288126|NCT05099640|322844233|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
94288127|NCT05099640|322844234|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
94288128|NCT05099640|322844232|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
94288129|NCT05099640|322844233|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
94288130|NCT05099640|322844234|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
94288131|NCT05099640|322844232|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
94288132|NCT05099640|322844233|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
94288133|NCT05099640|322844234|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
94288134|NCT05099640|322844232|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
94288135|NCT05099640|322844233|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
94288136|NCT05099640|322844234|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
94288137|NCT05099640|322844232|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
94288138|NCT05099640|322844233|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
94288139|NCT05099640|322844234|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
94288140|NCT02690194|322844235|FG000|Overall Study|Withdrawal by Subject|1|||
94288141|NCT02690194|322844236|FG001|Overall Study|Withdrawal by Subject|4|||
94288142|NCT02690194|322844237|FG002|Overall Study|Withdrawal by Subject|0|||
94288143|NCT01987908|322844238|FG000|Placebo Lead-in Period|Adverse Event|2|||
94288144|NCT01987908|322844239|FG001|Placebo Lead-in Period|Adverse Event|0|||
94288145|NCT01987908|322844240|FG002|Placebo Lead-in Period|Adverse Event|0|||
94288146|NCT01987908|322844238|FG000|Placebo Lead-in Period|Physician Decision|2|||
94288147|NCT01987908|322844239|FG001|Placebo Lead-in Period|Physician Decision|0|||
94288148|NCT01987908|322844240|FG002|Placebo Lead-in Period|Physician Decision|0|||
94467964|NCT03013985|323502456|FG000|Overall Study|Protocol Violation|2|||
94467965|NCT03013985|323502457|FG001|Overall Study|Protocol Violation|2|||
94288149|NCT01987908|322844238|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
94288150|NCT01987908|322844239|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
94288151|NCT01987908|322844240|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
94288152|NCT01987908|322844238|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
94288153|NCT01987908|322844239|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
94288154|NCT01987908|322844240|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
94288155|NCT01987908|322844238|FG000|Treatment Period|Adverse Event|0|||
94288156|NCT01987908|322844239|FG001|Treatment Period|Adverse Event|1|||
94288157|NCT01987908|322844240|FG002|Treatment Period|Adverse Event|1|||
94288158|NCT01987908|322844238|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
94288159|NCT01987908|322844239|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
94288160|NCT01987908|322844240|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
94288161|NCT01987908|322844238|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
94288162|NCT01987908|322844239|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
94288163|NCT01987908|322844240|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
94288164|NCT01528787|322844241|FG000|Overall Study|Withdrawal by Subject|0|||
94288165|NCT01528787|322844242|FG001|Overall Study|Withdrawal by Subject|0|||
94288166|NCT01528787|322844243|FG002|Overall Study|Withdrawal by Subject|0|||
94288167|NCT01528787|322844244|FG003|Overall Study|Withdrawal by Subject|1|||
94288168|NCT01528787|322844241|FG000|Overall Study|Family Emergency|0|||
94288169|NCT01528787|322844242|FG001|Overall Study|Family Emergency|0|||
94288170|NCT01528787|322844243|FG002|Overall Study|Family Emergency|1|||
94288171|NCT01528787|322844244|FG003|Overall Study|Family Emergency|0|||
94288172|NCT01262625|322844245|FG000|Overall Study|Administrative Error|1|||
94288173|NCT01262625|322844246|FG001|Overall Study|Administrative Error|1|||
94288174|NCT01262625|322844245|FG000|Overall Study|Site Closed|1|||
94288175|NCT01262625|322844246|FG001|Overall Study|Site Closed|0|||
94288176|NCT02058147|322844248|FG000|Overall Study|Randomized but not treated|0|||
94288177|NCT02058147|322844249|FG001|Overall Study|Randomized but not treated|0|||
94288178|NCT02058147|322844250|FG002|Overall Study|Randomized but not treated|1|||
94288179|NCT02058147|322844248|FG000|Overall Study|Adverse Event|12|||
94288180|NCT02058147|322844249|FG001|Overall Study|Adverse Event|9|||
94288181|NCT02058147|322844250|FG002|Overall Study|Adverse Event|21|||
94288182|NCT02058147|322844248|FG000|Overall Study|Lack of Efficacy|1|||
94288183|NCT02058147|322844249|FG001|Overall Study|Lack of Efficacy|0|||
94288184|NCT02058147|322844250|FG002|Overall Study|Lack of Efficacy|3|||
94288185|NCT02058147|322844248|FG000|Overall Study|Poor compliance to protocol|8|||
94288186|NCT02058147|322844249|FG001|Overall Study|Poor compliance to protocol|9|||
94288187|NCT02058147|322844250|FG002|Overall Study|Poor compliance to protocol|4|||
94288188|NCT02058147|322844248|FG000|Overall Study|Other than specified|8|||
94288189|NCT02058147|322844249|FG001|Overall Study|Other than specified|9|||
94288190|NCT02058147|322844250|FG002|Overall Study|Other than specified|0|||
94288191|NCT02817087|322844254|FG000|Overall Study|Withdrawal by Subject|2|||
94288192|NCT02817087|322844255|FG001|Overall Study|Withdrawal by Subject|0|||
94288193|NCT01890421|322844256|FG000|Overall Study|Adverse Event|1|||
94288194|NCT01890421|322844256|FG000|Overall Study|Other reason|10|||
94288195|NCT02317562|322844259|FG000|Overall Study|Physician Decision|1|||
94288196|NCT02317562|322844259|FG000|Overall Study|early termination of the study|8|||
94288197|NCT02317562|322844259|FG000|Overall Study|Lack of Efficacy|4|||
94288198|NCT02317562|322844259|FG000|Overall Study|Withdrawal by Subject|1|||
94288199|NCT02445586|322844260|FG000|Overall Study|Death|14|||
94288200|NCT02445586|322844260|FG000|Overall Study|Withdrawal by Subject|13|||
94288201|NCT02445586|322844260|FG000|Overall Study|Disease Progression|10|||
94288202|NCT02445586|322844260|FG000|Overall Study|Protocol Violation|1|||
94288203|NCT02445586|322844260|FG000|Overall Study|Medical Condition|1|||
94288204|NCT00428597|322844265|FG000|Overall Study|Randomized but not treated|3|||
94288205|NCT00428597|322844266|FG001|Overall Study|Randomized but not treated|3|||
94288206|NCT00428597|322844265|FG000|Overall Study|Objective Progression or Relapse|19|||
94288207|NCT00428597|322844266|FG001|Overall Study|Objective Progression or Relapse|47|||
94288208|NCT00428597|322844265|FG000|Overall Study|Study Terminated by Sponsor|41|||
94288209|NCT00428597|322844266|FG001|Overall Study|Study Terminated by Sponsor|16|||
94288210|NCT00428597|322844265|FG000|Overall Study|Adverse Event|15|||
94288211|NCT00428597|322844266|FG001|Overall Study|Adverse Event|7|||
94288212|NCT00428597|322844265|FG000|Overall Study|Global Deterioration of Health Status|1|||
94288213|NCT00428597|322844266|FG001|Overall Study|Global Deterioration of Health Status|5|||
94288214|NCT00428597|322844265|FG000|Overall Study|Protocol Violation|2|||
94288215|NCT00428597|322844266|FG001|Overall Study|Protocol Violation|1|||
94288216|NCT00428597|322844265|FG000|Overall Study|Withdrawal by Subject|2|||
94288217|NCT00428597|322844266|FG001|Overall Study|Withdrawal by Subject|1|||
94288218|NCT00428597|322844265|FG000|Overall Study|Other|1|||
94288219|NCT00428597|322844266|FG001|Overall Study|Other|1|||
94288220|NCT00428597|322844265|FG000|Overall Study|Lost to Follow-up|0|||
94288221|NCT00428597|322844266|FG001|Overall Study|Lost to Follow-up|1|||
94288222|NCT00428597|322844265|FG000|Overall Study|Pregnancy|1|||
94288223|NCT00428597|322844266|FG001|Overall Study|Pregnancy|0|||
94288224|NCT00428597|322844265|FG000|Overall Study|Death|1|||
94288225|NCT00428597|322844266|FG001|Overall Study|Death|3|||
94288226|NCT01299766|322845977|FG000|Overall Study|Death|5|||
94288227|NCT01299766|322845978|FG001|Overall Study|Death|4|||
94288228|NCT01299766|322845977|FG000|Overall Study|Withdrawal by Subject|29|||
94288229|NCT01299766|322845978|FG001|Overall Study|Withdrawal by Subject|19|||
94288230|NCT04002310|322845979|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
94288231|NCT04002310|322845980|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
94288232|NCT04002310|322845981|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
94288233|NCT04002310|322845982|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
94288234|NCT04002310|322845983|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
94288235|NCT00542997|322845984|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
94288236|NCT00542997|322845984|FG000|Wash in / Wash Out Period|Adverse Event|3|||
94288237|NCT00542997|322845984|FG000|Efficacy Period|Adverse Event|3|||
94288238|NCT02949128|322845985|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
94288239|NCT02949128|322845985|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
94288240|NCT02949128|322845985|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
94288241|NCT02949128|322845985|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
94288242|NCT02949128|322845985|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
94288243|NCT02949128|322845985|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
94288244|NCT02949128|322845985|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
94288245|NCT02949128|322845985|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
94288246|NCT02949128|322845985|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
94288247|NCT02949128|322845985|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
94288248|NCT03064763|322845986|FG000|Overall Study|Lost to Follow-up|1|||
94288249|NCT03064763|322845986|FG000|Overall Study|Death|8|||
94288250|NCT02090855|322845987|FG000|Overall Study|no evaluable Standard of Truth results|2|||
94288251|NCT03038308|322845988|FG000|Overall Study|Surgical resection|1|||
94288252|NCT03038308|322845988|FG000|Overall Study|Withdrawal by Subject|2|||
94288253|NCT03038308|322845988|FG000|Overall Study|Lost to Follow-up|1|||
94288254|NCT01354028|322845989|FG000|Overall Study|Physician Decision|0|||
94288255|NCT01354028|322845990|FG001|Overall Study|Physician Decision|2|||
94288256|NCT01354028|322845989|FG000|Overall Study|Discharged before study start|2|||
94288257|NCT01354028|322845990|FG001|Overall Study|Discharged before study start|2|||
94288258|NCT01354028|322845989|FG000|Overall Study|No quiet alert state|0|||
94288259|NCT01354028|322845990|FG001|Overall Study|No quiet alert state|1|||
94288260|NCT03968419|322845993|FG000|Treatment Period|Adverse Event|0|||
94288261|NCT03968419|322845994|FG001|Treatment Period|Adverse Event|0|||
94288262|NCT03968419|322845995|FG002|Treatment Period|Adverse Event|1|||
94288263|NCT03968419|322845993|FG000|Safety Follow-up Period|Death|3|||
94288264|NCT03968419|322845994|FG001|Safety Follow-up Period|Death|2|||
94288265|NCT03968419|322845995|FG002|Safety Follow-up Period|Death|1|||
94288266|NCT03968419|322845993|FG000|Safety Follow-up Period|Subject Decision|2|||
94288267|NCT03968419|322845994|FG001|Safety Follow-up Period|Subject Decision|1|||
94288268|NCT03968419|322845995|FG002|Safety Follow-up Period|Subject Decision|0|||
94288269|NCT00935883|322845996|FG000|Treatment Period|Physician Decision|1|||
94288270|NCT00935883|322845997|FG001|Treatment Period|Physician Decision|0|||
94288271|NCT00935883|322845996|FG000|Treatment Period|Withdrawal by Subject|0|||
94288272|NCT00935883|322845997|FG001|Treatment Period|Withdrawal by Subject|2|||
94288273|NCT00793793|322846007|FG000|Overall Study|Adverse Event|0|||
94288274|NCT00793793|322846008|FG001|Overall Study|Adverse Event|0|||
94288275|NCT00793793|322846009|FG002|Overall Study|Adverse Event|1|||
94288276|NCT00793793|322846010|FG003|Overall Study|Adverse Event|1|||
94288277|NCT00793793|322846011|FG004|Overall Study|Adverse Event|0|||
94288278|NCT00793793|322846012|FG005|Overall Study|Adverse Event|1|||
94288279|NCT00793793|322846013|FG006|Overall Study|Adverse Event|2|||
94288280|NCT00793793|322846014|FG007|Overall Study|Adverse Event|0|||
94288281|NCT00793793|322846015|FG008|Overall Study|Adverse Event|0|||
94288282|NCT00793793|322846016|FG009|Overall Study|Adverse Event|0|||
94288283|NCT00793793|322846017|FG010|Overall Study|Adverse Event|0|||
94288284|NCT00793793|322846018|FG011|Overall Study|Adverse Event|2|||
94288285|NCT00793793|322846007|FG000|Overall Study|Protocol Violation|0|||
94288286|NCT00793793|322846008|FG001|Overall Study|Protocol Violation|0|||
94288287|NCT00793793|322846009|FG002|Overall Study|Protocol Violation|0|||
94288288|NCT00793793|322846010|FG003|Overall Study|Protocol Violation|1|||
94288289|NCT00793793|322846011|FG004|Overall Study|Protocol Violation|0|||
94288290|NCT00793793|322846012|FG005|Overall Study|Protocol Violation|0|||
94288291|NCT00793793|322846013|FG006|Overall Study|Protocol Violation|0|||
94288292|NCT00793793|322846014|FG007|Overall Study|Protocol Violation|0|||
94288293|NCT00793793|322846015|FG008|Overall Study|Protocol Violation|0|||
94288294|NCT00793793|322846016|FG009|Overall Study|Protocol Violation|0|||
94288295|NCT00793793|322846017|FG010|Overall Study|Protocol Violation|0|||
94288296|NCT00793793|322846018|FG011|Overall Study|Protocol Violation|0|||
94288297|NCT00793793|322846007|FG000|Overall Study|Lost to Follow-up|0|||
94288298|NCT00793793|322846008|FG001|Overall Study|Lost to Follow-up|0|||
94288299|NCT00793793|322846009|FG002|Overall Study|Lost to Follow-up|1|||
94288300|NCT00793793|322846010|FG003|Overall Study|Lost to Follow-up|0|||
94288301|NCT00793793|322846011|FG004|Overall Study|Lost to Follow-up|0|||
94288302|NCT00793793|322846012|FG005|Overall Study|Lost to Follow-up|0|||
94288303|NCT00793793|322846013|FG006|Overall Study|Lost to Follow-up|0|||
94288304|NCT00793793|322846014|FG007|Overall Study|Lost to Follow-up|0|||
94288305|NCT00793793|322846015|FG008|Overall Study|Lost to Follow-up|1|||
94288306|NCT00793793|322846016|FG009|Overall Study|Lost to Follow-up|3|||
94288307|NCT00793793|322846017|FG010|Overall Study|Lost to Follow-up|1|||
94288308|NCT00793793|322846018|FG011|Overall Study|Lost to Follow-up|0|||
94288309|NCT00793793|322846007|FG000|Overall Study|Withdrawal by Subject|0|||
94288310|NCT00793793|322846008|FG001|Overall Study|Withdrawal by Subject|0|||
94288311|NCT00793793|322846009|FG002|Overall Study|Withdrawal by Subject|0|||
94288312|NCT00793793|322846010|FG003|Overall Study|Withdrawal by Subject|0|||
94288313|NCT00793793|322846011|FG004|Overall Study|Withdrawal by Subject|1|||
94288314|NCT00793793|322846012|FG005|Overall Study|Withdrawal by Subject|0|||
94288315|NCT00793793|322846013|FG006|Overall Study|Withdrawal by Subject|0|||
94288316|NCT00793793|322846014|FG007|Overall Study|Withdrawal by Subject|0|||
94288317|NCT00793793|322846015|FG008|Overall Study|Withdrawal by Subject|1|||
94288318|NCT00793793|322846016|FG009|Overall Study|Withdrawal by Subject|0|||
94288319|NCT00793793|322846017|FG010|Overall Study|Withdrawal by Subject|0|||
94288320|NCT00793793|322846018|FG011|Overall Study|Withdrawal by Subject|0|||
94288321|NCT00793793|322846007|FG000|Overall Study|reason not specified|0|||
94288322|NCT00793793|322846008|FG001|Overall Study|reason not specified|1|||
94288323|NCT00793793|322846009|FG002|Overall Study|reason not specified|0|||
94288324|NCT00793793|322846010|FG003|Overall Study|reason not specified|1|||
94288325|NCT00793793|322846011|FG004|Overall Study|reason not specified|1|||
94288326|NCT00793793|322846012|FG005|Overall Study|reason not specified|1|||
94288327|NCT00793793|322846013|FG006|Overall Study|reason not specified|2|||
94288328|NCT00793793|322846014|FG007|Overall Study|reason not specified|0|||
94288329|NCT00793793|322846015|FG008|Overall Study|reason not specified|7|||
94288330|NCT00793793|322846016|FG009|Overall Study|reason not specified|6|||
94288331|NCT00793793|322846017|FG010|Overall Study|reason not specified|2|||
94288332|NCT00793793|322846018|FG011|Overall Study|reason not specified|4|||
94288333|NCT00840827|322846019|FG000|Overall Study|Adverse Event|1|||
94288334|NCT00840827|322846019|FG000|Overall Study|Lack of Efficacy|4|||
94288335|NCT00840827|322846019|FG000|Overall Study|Physician Decision|1|||
94288336|NCT01445535|322846020|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
94288337|NCT01445535|322846021|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
94288338|NCT01445535|322846022|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
94288339|NCT01445535|322846023|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
94288340|NCT01445535|322846020|FG000|Overall Study|Disease progression|1|||
94288341|NCT01445535|322846021|FG001|Overall Study|Disease progression|0|||
94288342|NCT01445535|322846022|FG002|Overall Study|Disease progression|1|||
94288343|NCT01445535|322846023|FG003|Overall Study|Disease progression|0|||
94288344|NCT01445535|322846020|FG000|Overall Study|PI discretion|0|||
94288345|NCT01445535|322846021|FG001|Overall Study|PI discretion|0|||
94288346|NCT01445535|322846022|FG002|Overall Study|PI discretion|0|||
94288347|NCT01445535|322846023|FG003|Overall Study|PI discretion|1|||
94288348|NCT02487108|322846024|FG000|Overall Study|Adverse Event|1|||
94288349|NCT02487108|322846025|FG001|Overall Study|Adverse Event|6|||
94288350|NCT02487108|322846026|FG002|Overall Study|Adverse Event|12|||
94288351|NCT02487108|322846027|FG003|Overall Study|Adverse Event|6|||
94288352|NCT02487108|322846024|FG000|Overall Study|Withdrawal by Subject|8|||
94288353|NCT02487108|322846025|FG001|Overall Study|Withdrawal by Subject|5|||
94288354|NCT02487108|322846026|FG002|Overall Study|Withdrawal by Subject|5|||
94288355|NCT02487108|322846027|FG003|Overall Study|Withdrawal by Subject|0|||
94288356|NCT02487108|322846024|FG000|Overall Study|Non-compliance to study medication|3|||
94288357|NCT02487108|322846025|FG001|Overall Study|Non-compliance to study medication|2|||
94288358|NCT02487108|322846026|FG002|Overall Study|Non-compliance to study medication|5|||
94288359|NCT02487108|322846027|FG003|Overall Study|Non-compliance to study medication|4|||
94288360|NCT02487108|322846024|FG000|Overall Study|Protocol Violation|1|||
94288361|NCT02487108|322846025|FG001|Overall Study|Protocol Violation|1|||
94288362|NCT02487108|322846026|FG002|Overall Study|Protocol Violation|2|||
94288363|NCT02487108|322846027|FG003|Overall Study|Protocol Violation|0|||
94372513|NCT00479401|323150278|FG002|Overall Study|Exclusion criteria, relocation|0|||
94288364|NCT02487108|322846024|FG000|Overall Study|Non-compliance to study procedures|0|||
94288365|NCT02487108|322846025|FG001|Overall Study|Non-compliance to study procedures|0|||
94288366|NCT02487108|322846026|FG002|Overall Study|Non-compliance to study procedures|0|||
94288367|NCT02487108|322846027|FG003|Overall Study|Non-compliance to study procedures|1|||
94288368|NCT02487108|322846024|FG000|Overall Study|Other than specified|3|||
94288369|NCT02487108|322846025|FG001|Overall Study|Other than specified|2|||
94288370|NCT02487108|322846026|FG002|Overall Study|Other than specified|2|||
94288371|NCT02487108|322846027|FG003|Overall Study|Other than specified|0|||
94288372|NCT02720757|322846028|FG000|Overall Study|Other reason|5|||
94288373|NCT02720757|322846028|FG000|Overall Study|Loss of contact|4|||
94288374|NCT02720757|322846028|FG000|Overall Study|Informed consent withdrawal|1|||
94288375|NCT02720757|322846028|FG000|Overall Study|Patients wish to withdraw|2|||
94288376|NCT02720757|322846028|FG000|Overall Study|Missing|3|||
94288377|NCT02720757|322846028|FG000|Overall Study|General exclusion|3|||
94288378|NCT02415712|322846029|FG000|Overall Study|Protocol Violation|16|||
94288379|NCT01668654|322846030|FG000|Overall Study|Study Closed/Terminated|3|||
94288380|NCT01668654|322846030|FG000|Overall Study|Withdrawal by Subject|1|||
94288381|NCT01084551|322846031|FG000|Overall Study|Adverse Event|2|||
94288382|NCT01084551|322846032|FG001|Overall Study|Adverse Event|9|||
94288383|NCT01084551|322846033|FG002|Overall Study|Adverse Event|4|||
94288384|NCT01084551|322846031|FG000|Overall Study|Lack of Efficacy|2|||
94288385|NCT01084551|322846032|FG001|Overall Study|Lack of Efficacy|0|||
94288386|NCT01084551|322846033|FG002|Overall Study|Lack of Efficacy|1|||
94288387|NCT01084551|322846031|FG000|Overall Study|Withdrawal by Subject|2|||
94288388|NCT01084551|322846032|FG001|Overall Study|Withdrawal by Subject|1|||
94288389|NCT01084551|322846033|FG002|Overall Study|Withdrawal by Subject|0|||
94288390|NCT01084551|322846031|FG000|Overall Study|Protocol Violation|2|||
94288391|NCT01084551|322846032|FG001|Overall Study|Protocol Violation|4|||
94288392|NCT01084551|322846033|FG002|Overall Study|Protocol Violation|0|||
94288393|NCT01084551|322846031|FG000|Overall Study|Lost to Follow-up|0|||
94288394|NCT01084551|322846032|FG001|Overall Study|Lost to Follow-up|0|||
94288395|NCT01084551|322846033|FG002|Overall Study|Lost to Follow-up|3|||
94288396|NCT01084551|322846031|FG000|Overall Study|Physician Decision|1|||
94288397|NCT01084551|322846032|FG001|Overall Study|Physician Decision|0|||
94288398|NCT01084551|322846033|FG002|Overall Study|Physician Decision|0|||
94288399|NCT00454779|322846037|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
94288400|NCT00454779|322846038|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
94288401|NCT00454779|322846037|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
94288402|NCT00454779|322846038|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
94288403|NCT00454779|322846037|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
94288404|NCT00454779|322846038|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
94288405|NCT00454779|322846037|FG000|First-line Treatment Phase|Protocol Violation|0|||
94288406|NCT00454779|322846038|FG001|First-line Treatment Phase|Protocol Violation|1|||
94288407|NCT00454779|322846037|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
94288408|NCT00454779|322846038|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
94288409|NCT00454779|322846037|FG000|First-line Treatment Phase|Ongoing|1|||
94288410|NCT00454779|322846038|FG001|First-line Treatment Phase|Ongoing|0|||
94288411|NCT00454779|322846037|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
94288412|NCT00454779|322846038|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
94288413|NCT00454779|322846037|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
94288414|NCT00454779|322846038|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
94288415|NCT00454779|322846037|FG000|Second-line Treatment Phase|Ongoing|0|||
94288416|NCT00454779|322846038|FG001|Second-line Treatment Phase|Ongoing|1|||
94288417|NCT01337973|322846039|FG000|Overall Study|Lost to Follow-up|2|||
94288418|NCT01337973|322846040|FG001|Overall Study|Lost to Follow-up|4|||
94288419|NCT01337973|322846041|FG002|Overall Study|Lost to Follow-up|3|||
94288420|NCT01337973|322846039|FG000|Overall Study|Death|1|||
94288421|NCT01337973|322846040|FG001|Overall Study|Death|2|||
94288422|NCT01337973|322846041|FG002|Overall Study|Death|1|||
94288423|NCT01337973|322846039|FG000|Overall Study|Withdrawal by Subject|10|||
94288424|NCT01337973|322846040|FG001|Overall Study|Withdrawal by Subject|8|||
94288425|NCT01337973|322846041|FG002|Overall Study|Withdrawal by Subject|4|||
94288426|NCT01337973|322846039|FG000|Overall Study|missing data on primary outcome|3|||
94288427|NCT01337973|322846040|FG001|Overall Study|missing data on primary outcome|1|||
94288428|NCT01337973|322846041|FG002|Overall Study|missing data on primary outcome|3|||
94288429|NCT05425563|322846042|FG000|Overall Study|Withdrawal by Subject|17|||
94288430|NCT03823391|322846044|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
94288431|NCT03823391|322846045|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
94288432|NCT03823391|322846044|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
94288433|NCT03823391|322846045|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
94288434|NCT04173741|322846047|FG000|Overall Study|IVC measurement cannot be done|1|||
94288435|NCT04173741|322846048|FG001|Overall Study|IVC measurement cannot be done|1|||
94288436|NCT00289913|322846049|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
94288437|NCT00289913|322846050|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
94288438|NCT00289913|322846051|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
94288439|NCT00289913|322846052|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
94288440|NCT00289913|322846053|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
94288441|NCT00289913|322846049|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
94288442|NCT00289913|322846050|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
94288443|NCT00289913|322846051|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
94288444|NCT00289913|322846052|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
94372514|NCT01571635|323150279|FG000|Overall Study|Adverse Event|3|||
94288445|NCT00289913|322846053|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
94288446|NCT00289913|322846049|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
94288447|NCT00289913|322846050|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
94288448|NCT00289913|322846051|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
94288449|NCT00289913|322846052|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
94288450|NCT00289913|322846053|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
94288451|NCT00289913|322846049|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
94288452|NCT00289913|322846050|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
94288453|NCT00289913|322846051|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
94288454|NCT00289913|322846052|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
94288455|NCT00289913|322846053|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
94288456|NCT00289913|322846049|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
94288457|NCT00289913|322846050|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
94288458|NCT00289913|322846051|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
94288459|NCT00289913|322846052|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
94288460|NCT00289913|322846053|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
94288461|NCT00289913|322846049|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
94288462|NCT00289913|322846050|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
94288463|NCT00289913|322846051|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
94288464|NCT00289913|322846052|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
94288465|NCT00289913|322846053|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
94288466|NCT00289913|322846049|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
94288467|NCT00289913|322846050|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
94288468|NCT00289913|322846051|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
94288469|NCT00289913|322846052|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
94288470|NCT00289913|322846053|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
94288471|NCT00289913|322846049|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
94288472|NCT00289913|322846050|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
94288473|NCT00289913|322846051|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
94288474|NCT00289913|322846052|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
94288475|NCT00289913|322846053|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
94288476|NCT00289913|322846049|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
94288477|NCT00289913|322846050|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
94288478|NCT00289913|322846051|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
94288479|NCT00289913|322846052|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
94288480|NCT00289913|322846053|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
94288481|NCT00289913|322846049|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
94288482|NCT00289913|322846050|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
94288483|NCT00289913|322846051|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
94288484|NCT00289913|322846052|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
94288485|NCT00289913|322846053|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
94288486|NCT00289913|322846049|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
94288487|NCT00289913|322846050|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
94288488|NCT00289913|322846051|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
94288489|NCT00289913|322846052|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
94288490|NCT00289913|322846053|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
94288491|NCT00289913|322846049|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
94288492|NCT00289913|322846050|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
94288493|NCT00289913|322846051|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
94288494|NCT00289913|322846052|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
94288495|NCT00289913|322846053|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
94288496|NCT00289913|322846049|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
94288497|NCT00289913|322846050|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
94288498|NCT00289913|322846051|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
94288499|NCT00289913|322846052|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
94288500|NCT00289913|322846053|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
94288501|NCT00289913|322846049|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
94288502|NCT00289913|322846050|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
94288503|NCT00289913|322846051|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
94288504|NCT00289913|322846052|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
94288505|NCT00289913|322846053|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
94372515|NCT01571635|323150280|FG001|Overall Study|Adverse Event|0|||
94372516|NCT01571635|323150281|FG002|Overall Study|Adverse Event|2|||
94372517|NCT01571635|323150282|FG003|Overall Study|Adverse Event|3|||
94372518|NCT01571635|323150283|FG004|Overall Study|Adverse Event|5|||
94288506|NCT00289913|322846049|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
94288507|NCT00289913|322846050|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
94288508|NCT00289913|322846051|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
94288509|NCT00289913|322846052|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
94288510|NCT00289913|322846053|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
94288511|NCT00289913|322846049|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
94288512|NCT00289913|322846050|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
94288513|NCT00289913|322846051|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
94288514|NCT00289913|322846052|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
94288515|NCT00289913|322846053|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
94288516|NCT00289913|322846049|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
94288517|NCT00289913|322846050|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
94288518|NCT00289913|322846051|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
94288519|NCT00289913|322846052|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
94288520|NCT00289913|322846053|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
94288521|NCT00289913|322846049|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
94288522|NCT00289913|322846050|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
94288523|NCT00289913|322846051|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
94288524|NCT00289913|322846052|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
94288525|NCT00289913|322846053|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
94288526|NCT00289913|322846049|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
94288527|NCT00289913|322846050|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
94288528|NCT00289913|322846051|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
94288529|NCT00289913|322846052|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
94288530|NCT00289913|322846053|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
94288531|NCT00289913|322846049|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
94288532|NCT00289913|322846050|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
94288533|NCT00289913|322846051|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
94288534|NCT00289913|322846052|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
94288535|NCT00289913|322846053|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
94288536|NCT00289913|322846049|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
94288537|NCT00289913|322846050|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
94288538|NCT00289913|322846051|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
94288539|NCT00289913|322846052|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
94288540|NCT00289913|322846053|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
94288541|NCT00289913|322846049|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
94288542|NCT00289913|322846050|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
94288543|NCT00289913|322846051|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
94288544|NCT00289913|322846052|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
94288545|NCT00289913|322846053|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
94288546|NCT00289913|322846049|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
94288547|NCT00289913|322846050|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
94288548|NCT00289913|322846051|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
94288549|NCT00289913|322846052|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
94288550|NCT00289913|322846053|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
94288551|NCT00289913|322846049|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
94288552|NCT00289913|322846050|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
94288553|NCT00289913|322846051|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
94288554|NCT00289913|322846052|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
94288555|NCT00289913|322846053|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
94288556|NCT00289913|322846049|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
94288557|NCT00289913|322846050|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
94288558|NCT00289913|322846051|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
94288559|NCT00289913|322846052|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
94288560|NCT00289913|322846053|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
94288561|NCT00289913|322846049|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
94288562|NCT00289913|322846050|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
94288563|NCT00289913|322846051|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
94288564|NCT00289913|322846052|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
94288565|NCT00289913|322846053|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
94288566|NCT00289913|322846049|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
94288567|NCT00289913|322846050|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
94288568|NCT00289913|322846051|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
94288569|NCT00289913|322846052|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
94288570|NCT00289913|322846053|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
94288571|NCT00289913|322846049|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
94288572|NCT00289913|322846050|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
94288573|NCT00289913|322846051|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
94288574|NCT00289913|322846052|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
94288575|NCT00289913|322846053|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
94288576|NCT00289913|322846049|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
94288577|NCT00289913|322846050|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
94288578|NCT00289913|322846051|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
94288579|NCT00289913|322846052|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
94288580|NCT00289913|322846053|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
94288581|NCT00289913|322846049|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
94288582|NCT00289913|322846050|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
94288583|NCT00289913|322846051|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
94288584|NCT00289913|322846052|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
94288585|NCT00289913|322846053|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
94288586|NCT00289913|322846049|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
94288587|NCT00289913|322846050|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
94288588|NCT00289913|322846051|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
94288589|NCT00289913|322846052|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
94288590|NCT00289913|322846053|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
94288591|NCT02522767|322846056|FG000|Double-blind|Withdrawal by Subject|8|||
94288592|NCT02522767|322846057|FG001|Double-blind|Withdrawal by Subject|11|||
94288593|NCT02522767|322846056|FG000|Double-blind|Lost to Follow-up|1|||
94288594|NCT02522767|322846057|FG001|Double-blind|Lost to Follow-up|0|||
94288595|NCT02522767|322846056|FG000|Double-blind|Adverse Event|1|||
94288596|NCT02522767|322846057|FG001|Double-blind|Adverse Event|10|||
94288597|NCT02522767|322846056|FG000|Double-blind|Protocol Violation|0|||
94288598|NCT02522767|322846057|FG001|Double-blind|Protocol Violation|1|||
94288599|NCT02522767|322846056|FG000|Double-blind|Lack of Efficacy|0|||
94288600|NCT02522767|322846057|FG001|Double-blind|Lack of Efficacy|2|||
94288601|NCT02522767|322846056|FG000|Double-blind|Protocol Deviation|1|||
94288602|NCT02522767|322846057|FG001|Double-blind|Protocol Deviation|0|||
94288603|NCT02522767|322846056|FG000|Open-label|Withdrawal by Subject|2|||
94288604|NCT02522767|322846057|FG001|Open-label|Withdrawal by Subject|3|||
94288605|NCT02522767|322846056|FG000|Open-label|Lost to Follow-up|0|||
94288606|NCT02522767|322846057|FG001|Open-label|Lost to Follow-up|1|||
94288607|NCT02522767|322846056|FG000|Open-label|Adverse Event|2|||
94288608|NCT02522767|322846057|FG001|Open-label|Adverse Event|1|||
94288609|NCT02522767|322846056|FG000|Open-label|Lack of Efficacy|1|||
94288610|NCT02522767|322846057|FG001|Open-label|Lack of Efficacy|1|||
94288611|NCT02522767|322846056|FG000|Open-label|Protocol Violation|0|||
94288612|NCT02522767|322846057|FG001|Open-label|Protocol Violation|1|||
94288613|NCT04269395|322846058|FG000|Overall Study|Lost to Follow-up|1|||
94288614|NCT04269395|322846059|FG001|Overall Study|Lost to Follow-up|0|||
94288615|NCT04269395|322846058|FG000|Overall Study|Study terminated by Sponsor|13|||
94288616|NCT04269395|322846059|FG001|Overall Study|Study terminated by Sponsor|10|||
94288617|NCT02494596|322846060|FG000|Overall Study|Insufficient Therapeutic Response|3|||
94288618|NCT02494596|322846061|FG001|Overall Study|Insufficient Therapeutic Response|3|||
94288619|NCT02494596|322846062|FG002|Overall Study|Insufficient Therapeutic Response|1|||
94288620|NCT02494596|322846060|FG000|Overall Study|Adverse Event|0|||
94288621|NCT02494596|322846061|FG001|Overall Study|Adverse Event|1|||
94288622|NCT02494596|322846062|FG002|Overall Study|Adverse Event|0|||
94288623|NCT02494596|322846060|FG000|Overall Study|Refused Treatment|0|||
94288624|NCT02494596|322846061|FG001|Overall Study|Refused Treatment|1|||
94288625|NCT02494596|322846062|FG002|Overall Study|Refused Treatment|0|||
94288626|NCT00254566|322846063|FG000|Overall Study|Death|1|||
94288627|NCT00254566|322846064|FG001|Overall Study|Death|0|||
94288628|NCT00254566|322846063|FG000|Overall Study|Adverse Event|5|||
94288629|NCT00254566|322846064|FG001|Overall Study|Adverse Event|4|||
94288630|NCT00254566|322846063|FG000|Overall Study|Lack of Efficacy|12|||
94288631|NCT00254566|322846064|FG001|Overall Study|Lack of Efficacy|9|||
94288632|NCT00254566|322846063|FG000|Overall Study|Other|1|||
94288633|NCT00254566|322846064|FG001|Overall Study|Other|5|||
94288634|NCT00254566|322846063|FG000|Overall Study|Withdrawal by Subject|5|||
94288635|NCT00254566|322846064|FG001|Overall Study|Withdrawal by Subject|6|||
94288636|NCT00254566|322846063|FG000|Overall Study|Lost to Follow-up|7|||
94288637|NCT00254566|322846064|FG001|Overall Study|Lost to Follow-up|2|||
94288638|NCT00059202|322846065|FG000|Overall Study|Withdrawal by Subject|5|||
94288639|NCT00059202|322846066|FG001|Overall Study|Withdrawal by Subject|9|||
94288640|NCT00059202|322846065|FG000|Overall Study|Protocol Violation|1|||
94288641|NCT00059202|322846066|FG001|Overall Study|Protocol Violation|3|||
94372519|NCT01571635|323150279|FG000|Overall Study|Other reasons|2|||
94288642|NCT00059202|322846065|FG000|Overall Study|drug toxicity|0|||
94288643|NCT00059202|322846066|FG001|Overall Study|drug toxicity|3|||
94288644|NCT04276207|322846067|FG000|Period 1|Withdrawal by Subject|0|||
94288645|NCT04276207|322846068|FG001|Period 1|Withdrawal by Subject|1|||
94288646|NCT03882424|322846069|FG000|Overall Study|Lost to Follow-up|3|||
94288647|NCT03882424|322846070|FG001|Overall Study|Lost to Follow-up|0|||
94288648|NCT03882424|322846071|FG002|Overall Study|Lost to Follow-up|0|||
94288649|NCT03882424|322846069|FG000|Overall Study|schedule conflict|1|||
94288650|NCT03882424|322846070|FG001|Overall Study|schedule conflict|0|||
94288651|NCT03882424|322846071|FG002|Overall Study|schedule conflict|0|||
94288652|NCT02400255|322846072|FG000|Overall Study|Relapse|4|||
94288653|NCT02400255|322846073|FG001|Overall Study|Relapse|1|||
94288654|NCT02400255|322846074|FG002|Overall Study|Relapse|1|||
94288655|NCT02400255|322846075|FG003|Overall Study|Relapse|2|||
94288656|NCT02400255|322846072|FG000|Overall Study|Adverse Event|6|||
94288657|NCT02400255|322846073|FG001|Overall Study|Adverse Event|3|||
94288658|NCT02400255|322846074|FG002|Overall Study|Adverse Event|0|||
94288659|NCT02400255|322846075|FG003|Overall Study|Adverse Event|0|||
94288660|NCT02400255|322846072|FG000|Overall Study|Physician Decision|6|||
94288661|NCT02400255|322846073|FG001|Overall Study|Physician Decision|0|||
94288662|NCT02400255|322846074|FG002|Overall Study|Physician Decision|0|||
94288663|NCT02400255|322846075|FG003|Overall Study|Physician Decision|0|||
94288664|NCT02400255|322846072|FG000|Overall Study|Loss of insurance|1|||
94288665|NCT02400255|322846073|FG001|Overall Study|Loss of insurance|0|||
94288666|NCT02400255|322846074|FG002|Overall Study|Loss of insurance|0|||
94288667|NCT02400255|322846075|FG003|Overall Study|Loss of insurance|0|||
94288668|NCT01961544|322846076|FG000|Overall Study|Protocol Violation|1|||
94288669|NCT01961544|322846076|FG000|Overall Study|Withdrawal by Subject|7|||
94288670|NCT01961544|322846076|FG000|Overall Study|Adverse Event|1|||
94288671|NCT01961544|322846076|FG000|Overall Study|Physician Decision|2|||
94288672|NCT01961544|322846076|FG000|Overall Study|Poor Tolerance|1|||
94288673|NCT01961544|322846076|FG000|Overall Study|Aggravation of Steral Pain|1|||
94288674|NCT01500057|322846079|FG000|Overall Study|Lost to Follow-up|6|||
94288675|NCT01500057|322846080|FG001|Overall Study|Lost to Follow-up|4|||
94288676|NCT00354601|322846081|FG000|Overall Study|Protocol Violation|1|||
94288677|NCT00354601|322846081|FG000|Overall Study|progression|1|||
94288678|NCT01014585|322846086|FG000|Overall Study|Adverse Event|0|||
94288679|NCT01014585|322846087|FG001|Overall Study|Adverse Event|2|||
94288680|NCT01014585|322846088|FG002|Overall Study|Adverse Event|0|||
94288681|NCT01014585|322846089|FG003|Overall Study|Adverse Event|3|||
94288682|NCT01014585|322846086|FG000|Overall Study|Withdrawal by Subject|2|||
94288683|NCT01014585|322846087|FG001|Overall Study|Withdrawal by Subject|0|||
94288684|NCT01014585|322846088|FG002|Overall Study|Withdrawal by Subject|1|||
94288685|NCT01014585|322846089|FG003|Overall Study|Withdrawal by Subject|3|||
94288686|NCT01014585|322846086|FG000|Overall Study|Lost to Follow-up|0|||
94288687|NCT01014585|322846087|FG001|Overall Study|Lost to Follow-up|0|||
94288688|NCT01014585|322846088|FG002|Overall Study|Lost to Follow-up|0|||
94288689|NCT01014585|322846089|FG003|Overall Study|Lost to Follow-up|2|||
94288690|NCT01014585|322846086|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
94288691|NCT01014585|322846087|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
94288692|NCT01014585|322846088|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
94288693|NCT01014585|322846089|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
94288694|NCT00880256|322846092|FG000|Overall Study|Lost to Follow-up|28|||
94288695|NCT00330187|322846095|FG000|Overall Study|Lost to Follow-up|12|||
94288696|NCT00330187|322846096|FG001|Overall Study|Lost to Follow-up|13|||
94288697|NCT00330187|322846097|FG002|Overall Study|Lost to Follow-up|14|||
94288698|NCT00330187|322846098|FG003|Overall Study|Lost to Follow-up|10|||
94288699|NCT00330187|322846095|FG000|Overall Study|Withdrawal by Subject|8|||
94288700|NCT00330187|322846096|FG001|Overall Study|Withdrawal by Subject|5|||
94288701|NCT00330187|322846097|FG002|Overall Study|Withdrawal by Subject|4|||
94288702|NCT00330187|322846098|FG003|Overall Study|Withdrawal by Subject|4|||
94288703|NCT01225562|322846099|FG000|Overall Study|Withdrawal by Subject|52|||
94288704|NCT01225562|322846100|FG001|Overall Study|Withdrawal by Subject|50|||
94288705|NCT01225562|322846101|FG002|Overall Study|Withdrawal by Subject|52|||
94288706|NCT01225562|322846099|FG000|Overall Study|Lost to Follow-up|3|||
94288707|NCT01225562|322846100|FG001|Overall Study|Lost to Follow-up|6|||
94288708|NCT01225562|322846101|FG002|Overall Study|Lost to Follow-up|1|||
94288709|NCT00364182|322846108|FG000|First Intervention|Secondary prophylaxis|1|||
94288710|NCT00364182|322846109|FG001|First Intervention|Secondary prophylaxis|0|||
94288711|NCT00364182|322846110|FG002|First Intervention|Secondary prophylaxis|0|||
94288712|NCT00364182|322846108|FG000|First Intervention|Withdrawal by Subject|2|||
94288713|NCT00364182|322846109|FG001|First Intervention|Withdrawal by Subject|0|||
94288714|NCT00364182|322846110|FG002|First Intervention|Withdrawal by Subject|0|||
94288715|NCT00364182|322846108|FG000|Second Intervention|non-compliance|0|||
94288716|NCT00364182|322846109|FG001|Second Intervention|non-compliance|1|||
94288717|NCT00364182|322846110|FG002|Second Intervention|non-compliance|1|||
94288718|NCT00364182|322846108|FG000|Second Intervention|Protocol Violation|0|||
94288719|NCT00364182|322846109|FG001|Second Intervention|Protocol Violation|1|||
94288720|NCT00364182|322846110|FG002|Second Intervention|Protocol Violation|0|||
94288721|NCT00364182|322846108|FG000|Second Intervention|Adverse Event|0|||
94288722|NCT00364182|322846109|FG001|Second Intervention|Adverse Event|0|||
94288723|NCT00364182|322846110|FG002|Second Intervention|Adverse Event|1|||
94288724|NCT00364182|322846108|FG000|Third Intervention|non-compliance|0|||
94288725|NCT00364182|322846109|FG001|Third Intervention|non-compliance|1|||
94288726|NCT00364182|322846110|FG002|Third Intervention|non-compliance|0|||
94288727|NCT00364182|322846108|FG000|Third Intervention|Lost to Follow-up|0|||
94288728|NCT00364182|322846109|FG001|Third Intervention|Lost to Follow-up|0|||
94288729|NCT00364182|322846110|FG002|Third Intervention|Lost to Follow-up|1|||
94288730|NCT00705263|322846127|FG000|Overall Study|Withdrawal by Subject|2|||
94288731|NCT02899156|322846128|FG000|Overall Study|Death|1|||
94288732|NCT02899156|322846129|FG001|Overall Study|Death|0|||
94288733|NCT02899156|322846128|FG000|Overall Study|Physician Decision|0|||
94288734|NCT02899156|322846129|FG001|Overall Study|Physician Decision|1|||
94288735|NCT00787787|322846135|FG000|Overall Study|Lack of Efficacy|4|||
94288736|NCT00787787|322846135|FG000|Overall Study|Adverse Event|3|||
94288737|NCT03828487|322846136|FG000|Overall Study|Physician Decision|1|||
94288738|NCT04722991|322846137|FG000|Overall Study|Adverse Event|12|||
94288739|NCT04722991|322846138|FG001|Overall Study|Adverse Event|4|||
94288740|NCT04722991|322846137|FG000|Overall Study|Death|2|||
94288741|NCT04722991|322846138|FG001|Overall Study|Death|0|||
94288742|NCT04722991|322846137|FG000|Overall Study|Lost to Follow-up|1|||
94288743|NCT04722991|322846138|FG001|Overall Study|Lost to Follow-up|1|||
94288744|NCT04722991|322846137|FG000|Overall Study|Withdrawal cirterion met|2|||
94288745|NCT04722991|322846138|FG001|Overall Study|Withdrawal cirterion met|2|||
94288746|NCT04722991|322846137|FG000|Overall Study|Other|1|||
94288747|NCT04722991|322846138|FG001|Overall Study|Other|0|||
94288748|NCT04722991|322846137|FG000|Overall Study|Non-compliance|0|||
94288749|NCT04722991|322846138|FG001|Overall Study|Non-compliance|1|||
94288750|NCT04722991|322846137|FG000|Overall Study|Withdrawal by Subject|0|||
94288751|NCT04722991|322846138|FG001|Overall Study|Withdrawal by Subject|1|||
94288752|NCT01986062|322846144|FG000|Overall Study|Lost to Follow-up|1|||
94288753|NCT01986062|322846145|FG001|Overall Study|Lost to Follow-up|0|||
94288754|NCT01986062|322846144|FG000|Overall Study|Withdrawal by Subject|0|||
94288755|NCT01986062|322846145|FG001|Overall Study|Withdrawal by Subject|1|||
94288756|NCT02425098|322846147|FG000|Overall Study|Lost to Follow-up|7|||
94288757|NCT02425098|322846148|FG001|Overall Study|Lost to Follow-up|7|||
94288758|NCT02425098|322846147|FG000|Overall Study|Withdrawal by Subject|4|||
94288759|NCT02425098|322846148|FG001|Overall Study|Withdrawal by Subject|8|||
94288760|NCT02425098|322846147|FG000|Overall Study|Pregnancy|2|||
94288761|NCT02425098|322846148|FG001|Overall Study|Pregnancy|0|||
94288762|NCT02425098|322846147|FG000|Overall Study|Reason not Specified|0|||
94288763|NCT02425098|322846148|FG001|Overall Study|Reason not Specified|1|||
94288764|NCT04698629|322846149|FG000|Overall Study|Adverse Event|1|||
94288765|NCT02286089|322846152|FG000|Overall Study|Ongoing in Study|1|||
94288766|NCT02286089|322846153|FG001|Overall Study|Ongoing in Study|1|||
94288767|NCT02286089|322846154|FG002|Overall Study|Ongoing in Study|4|||
94288768|NCT02286089|322846155|FG003|Overall Study|Ongoing in Study|10|||
94288769|NCT02286089|322846152|FG000|Overall Study|Withdrawal by Subject|0|||
94288770|NCT02286089|322846153|FG001|Overall Study|Withdrawal by Subject|0|||
94288771|NCT02286089|322846154|FG002|Overall Study|Withdrawal by Subject|2|||
94288772|NCT02286089|322846155|FG003|Overall Study|Withdrawal by Subject|2|||
94288773|NCT02527707|322847846|FG000|Overall Study|Adverse Event|1|||
94288774|NCT02527707|322847846|FG000|Overall Study|Adverse Event|1|||
94288775|NCT01231555|322847852|FG000|Overall Study|Study terminated|8|||
94288776|NCT01231555|322847853|FG001|Overall Study|Study terminated|5|||
94288777|NCT01231555|322847854|FG002|Overall Study|Study terminated|8|||
94288778|NCT01231555|322847852|FG000|Overall Study|Withdrawal by Subject|0|||
94288779|NCT01231555|322847853|FG001|Overall Study|Withdrawal by Subject|2|||
94288780|NCT01231555|322847854|FG002|Overall Study|Withdrawal by Subject|0|||
94288781|NCT00947531|322847855|FG000|Overall Study|Withdrawal by Subject|10|||
94288782|NCT00947531|322847856|FG001|Overall Study|Withdrawal by Subject|7|||
94288783|NCT00947531|322847855|FG000|Overall Study|Administrative Reason|0|||
94288784|NCT00947531|322847856|FG001|Overall Study|Administrative Reason|1|||
94288785|NCT00947531|322847855|FG000|Overall Study|Adverse Event|2|||
94288786|NCT00947531|322847856|FG001|Overall Study|Adverse Event|2|||
94288787|NCT00947531|322847855|FG000|Overall Study|Lack of Efficacy|1|||
94288788|NCT00947531|322847856|FG001|Overall Study|Lack of Efficacy|0|||
94288789|NCT00947531|322847855|FG000|Overall Study|Other|1|||
94288790|NCT00947531|322847856|FG001|Overall Study|Other|1|||
94288791|NCT00808444|322847859|FG000|Overall Study|Withdrawal by Subject|1|||
94288792|NCT00808444|322847860|FG001|Overall Study|Withdrawal by Subject|0|||
94288793|NCT00808444|322847859|FG000|Overall Study|Lost to Follow-up|0|||
94288794|NCT00808444|322847860|FG001|Overall Study|Lost to Follow-up|1|||
94288795|NCT00688909|322847861|FG000|Overall Study|Adverse Event|28|||
94288796|NCT00688909|322847861|FG000|Overall Study|Patient withdrew consent|2|||
94288797|NCT00688909|322847861|FG000|Overall Study|Administrative problems|1|||
94288798|NCT00688909|322847861|FG000|Overall Study|Protocol Violation|2|||
94288799|NCT00699348|322847864|FG000|Overall Study|Death|6|||
94288800|NCT00699348|322847864|FG000|Overall Study|Adverse Event|15|||
94288801|NCT00699348|322847864|FG000|Overall Study|Withdrawal by Subject|11|||
94288802|NCT00699348|322847864|FG000|Overall Study|Protocol Violation|10|||
94288803|NCT00699348|322847864|FG000|Overall Study|Lack of Efficacy|8|||
94288804|NCT00699348|322847864|FG000|Overall Study|Failure to return|1|||
94288805|NCT00699348|322847864|FG000|Overall Study|Blood transfusion|24|||
94288806|NCT00699348|322847864|FG000|Overall Study|Renal transplantation|10|||
94288807|NCT00699348|322847864|FG000|Overall Study|Other|5|||
94288808|NCT00463476|322847868|FG000|Overall Study|Withdrawal by Subject|1|||
94288809|NCT00463476|322847869|FG001|Overall Study|Withdrawal by Subject|2|||
94288810|NCT00463476|322847868|FG000|Overall Study|Lost to Follow-up|1|||
94288811|NCT00463476|322847869|FG001|Overall Study|Lost to Follow-up|1|||
94288812|NCT00988247|322847871|FG000|Overall Study|Adverse Event|17|||
94288813|NCT00988247|322847872|FG001|Overall Study|Adverse Event|3|||
94288814|NCT00988247|322847871|FG000|Overall Study|Withdrawal by Subject|44|||
94288815|NCT00988247|322847872|FG001|Overall Study|Withdrawal by Subject|13|||
94288816|NCT00988247|322847871|FG000|Overall Study|Pregnancy|1|||
94288817|NCT00988247|322847872|FG001|Overall Study|Pregnancy|2|||
94288818|NCT00988247|322847871|FG000|Overall Study|Lost to Follow-up|11|||
94288819|NCT00988247|322847872|FG001|Overall Study|Lost to Follow-up|2|||
94288820|NCT00988247|322847871|FG000|Overall Study|Protocol Violation|4|||
94288821|NCT00988247|322847872|FG001|Overall Study|Protocol Violation|5|||
94288822|NCT00988247|322847871|FG000|Overall Study|Sponsor requested withdrawal|3|||
94288823|NCT00988247|322847872|FG001|Overall Study|Sponsor requested withdrawal|1|||
94288824|NCT00988247|322847871|FG000|Overall Study|Other|3|||
94288825|NCT00988247|322847872|FG001|Overall Study|Other|0|||
94288826|NCT02661594|322847873|FG000|Overall Study|Protocol Violation|1|||
94288827|NCT02661594|322847874|FG001|Overall Study|Protocol Violation|0|||
94288828|NCT02661594|322847875|FG002|Overall Study|Protocol Violation|1|||
94288829|NCT02661594|322847876|FG003|Overall Study|Protocol Violation|0|||
94288830|NCT02471716|322847883|FG000|Overall Study|Withdrawal by Subject|0|||
94288831|NCT02471716|322847884|FG001|Overall Study|Withdrawal by Subject|1|||
94288832|NCT02471716|322847885|FG002|Overall Study|Withdrawal by Subject|0|||
94288833|NCT02471716|322847886|FG003|Overall Study|Withdrawal by Subject|2|||
94288834|NCT02471716|322847887|FG004|Overall Study|Withdrawal by Subject|5|||
94288835|NCT02471716|322847883|FG000|Overall Study|Study Terminiated by sponsor|0|||
94288836|NCT02471716|322847884|FG001|Overall Study|Study Terminiated by sponsor|0|||
94288837|NCT02471716|322847885|FG002|Overall Study|Study Terminiated by sponsor|0|||
94288838|NCT02471716|322847886|FG003|Overall Study|Study Terminiated by sponsor|1|||
94288839|NCT02471716|322847887|FG004|Overall Study|Study Terminiated by sponsor|0|||
94288840|NCT02471716|322847883|FG000|Overall Study|Lost to Follow-up|0|||
94288841|NCT02471716|322847884|FG001|Overall Study|Lost to Follow-up|0|||
94288842|NCT02471716|322847885|FG002|Overall Study|Lost to Follow-up|0|||
94288843|NCT02471716|322847886|FG003|Overall Study|Lost to Follow-up|3|||
94288844|NCT02471716|322847887|FG004|Overall Study|Lost to Follow-up|2|||
94288845|NCT02471716|322847883|FG000|Overall Study|Death|0|||
94288846|NCT02471716|322847884|FG001|Overall Study|Death|0|||
94288847|NCT02471716|322847885|FG002|Overall Study|Death|0|||
94288848|NCT02471716|322847886|FG003|Overall Study|Death|1|||
94288849|NCT02471716|322847887|FG004|Overall Study|Death|0|||
94288850|NCT02471716|322847883|FG000|Overall Study|Other|0|||
94288851|NCT02471716|322847884|FG001|Overall Study|Other|0|||
94288852|NCT02471716|322847885|FG002|Overall Study|Other|0|||
94288853|NCT02471716|322847886|FG003|Overall Study|Other|8|||
94288854|NCT02471716|322847887|FG004|Overall Study|Other|9|||
94288855|NCT03604445|322847888|FG000|Overall Study|Death|0|||
94288856|NCT03604445|322847889|FG001|Overall Study|Death|0|||
94288857|NCT03604445|322847890|FG002|Overall Study|Death|0|||
94288858|NCT03604445|322847891|FG003|Overall Study|Death|0|||
94288859|NCT03604445|322847892|FG004|Overall Study|Death|0|||
94288860|NCT03604445|322847893|FG005|Overall Study|Death|0|||
94288861|NCT03604445|322847894|FG006|Overall Study|Death|0|||
94288862|NCT03604445|322847895|FG007|Overall Study|Death|0|||
94288863|NCT03604445|322847896|FG008|Overall Study|Death|1|||
94288864|NCT03604445|322847888|FG000|Overall Study|Withdrawal by Subject|0|||
94288865|NCT03604445|322847889|FG001|Overall Study|Withdrawal by Subject|0|||
94288866|NCT03604445|322847890|FG002|Overall Study|Withdrawal by Subject|0|||
94288867|NCT03604445|322847891|FG003|Overall Study|Withdrawal by Subject|0|||
94288868|NCT03604445|322847892|FG004|Overall Study|Withdrawal by Subject|0|||
94288869|NCT03604445|322847893|FG005|Overall Study|Withdrawal by Subject|0|||
94288870|NCT03604445|322847894|FG006|Overall Study|Withdrawal by Subject|1|||
94288871|NCT03604445|322847895|FG007|Overall Study|Withdrawal by Subject|0|||
94288872|NCT03604445|322847896|FG008|Overall Study|Withdrawal by Subject|0|||
94288873|NCT03604445|322847888|FG000|Overall Study|Missing visit|0|||
94288874|NCT03604445|322847889|FG001|Overall Study|Missing visit|0|||
94288875|NCT03604445|322847890|FG002|Overall Study|Missing visit|0|||
94288876|NCT03604445|322847891|FG003|Overall Study|Missing visit|0|||
94288877|NCT03604445|322847892|FG004|Overall Study|Missing visit|0|||
94288878|NCT03604445|322847893|FG005|Overall Study|Missing visit|1|||
94288879|NCT03604445|322847894|FG006|Overall Study|Missing visit|0|||
94288880|NCT03604445|322847895|FG007|Overall Study|Missing visit|1|||
94288881|NCT03604445|322847896|FG008|Overall Study|Missing visit|0|||
94288882|NCT03604445|322847888|FG000|Overall Study|Adverse Event|0|||
94288883|NCT03604445|322847889|FG001|Overall Study|Adverse Event|0|||
94288884|NCT03604445|322847890|FG002|Overall Study|Adverse Event|0|||
94288885|NCT03604445|322847891|FG003|Overall Study|Adverse Event|1|||
94288886|NCT03604445|322847892|FG004|Overall Study|Adverse Event|0|||
94288887|NCT03604445|322847893|FG005|Overall Study|Adverse Event|0|||
94288888|NCT03604445|322847894|FG006|Overall Study|Adverse Event|0|||
94288889|NCT03604445|322847895|FG007|Overall Study|Adverse Event|0|||
94288890|NCT03604445|322847896|FG008|Overall Study|Adverse Event|1|||
94288891|NCT03183128|322847903|FG000|Overall Study|Adverse Event|1|||
94288892|NCT03183128|322847904|FG001|Overall Study|Adverse Event|2|||
94288893|NCT03183128|322847903|FG000|Overall Study|Withdrawal by Subject|1|||
94288894|NCT03183128|322847904|FG001|Overall Study|Withdrawal by Subject|8|||
94288895|NCT03183128|322847903|FG000|Overall Study|Protocol Violation|2|||
94288896|NCT03183128|322847904|FG001|Overall Study|Protocol Violation|0|||
94288897|NCT03183128|322847903|FG000|Overall Study|Lack of Efficacy|4|||
94288898|NCT03183128|322847904|FG001|Overall Study|Lack of Efficacy|27|||
94288899|NCT03183128|322847903|FG000|Overall Study|Lost to Follow-up|1|||
94288900|NCT03183128|322847904|FG001|Overall Study|Lost to Follow-up|0|||
94288901|NCT03183128|322847903|FG000|Overall Study|Death|2|||
94288902|NCT03183128|322847904|FG001|Overall Study|Death|0|||
94288903|NCT03183128|322847903|FG000|Overall Study|Physician Decision|1|||
94288904|NCT03183128|322847904|FG001|Overall Study|Physician Decision|0|||
94288905|NCT02601573|322847907|FG000|Overall Study|Lost to Follow-up|0|||
94288906|NCT02601573|322847908|FG001|Overall Study|Lost to Follow-up|3|||
94288907|NCT02601573|322847909|FG002|Overall Study|Lost to Follow-up|1|||
94288908|NCT02601573|322847910|FG003|Overall Study|Lost to Follow-up|0|||
94288909|NCT02601573|322847911|FG004|Overall Study|Lost to Follow-up|2|||
94288910|NCT02601573|322847907|FG000|Overall Study|Withdrawal by Subject|0|||
94288911|NCT02601573|322847908|FG001|Overall Study|Withdrawal by Subject|1|||
94288912|NCT02601573|322847909|FG002|Overall Study|Withdrawal by Subject|0|||
94288913|NCT02601573|322847910|FG003|Overall Study|Withdrawal by Subject|1|||
94288914|NCT02601573|322847911|FG004|Overall Study|Withdrawal by Subject|0|||
94288915|NCT01384292|322847912|FG000|Part B|Severe non-compliance to protocol|1|||
94288916|NCT01384292|322847913|FG001|Part B|Severe non-compliance to protocol|0|||
94288917|NCT01384292|322847914|FG002|Part B|Severe non-compliance to protocol|0|||
94288918|NCT03310970|322847915|FG000|Overall Study|Withdrawal by Subject|0|||
94288919|NCT03310970|322847916|FG001|Overall Study|Withdrawal by Subject|1|||
94288920|NCT01133171|322847917|FG000|Overall Study|Withdrawal by Subject|1|||
94288921|NCT01133171|322847918|FG001|Overall Study|Withdrawal by Subject|2|||
94288922|NCT01133171|322847919|FG002|Overall Study|Withdrawal by Subject|0|||
94288923|NCT03969888|322847920|FG000|Overall Study|Never Received Study Drug|0|||
94288924|NCT03969888|322847921|FG001|Overall Study|Never Received Study Drug|0|||
94288925|NCT03969888|322847922|FG002|Overall Study|Never Received Study Drug|1|||
94288926|NCT03969888|322847923|FG003|Overall Study|Never Received Study Drug|0|||
94288927|NCT03969888|322847924|FG004|Overall Study|Never Received Study Drug|0|||
94288928|NCT03969888|322847925|FG005|Overall Study|Never Received Study Drug|0|||
94288929|NCT03969888|322847926|FG006|Overall Study|Never Received Study Drug|1|||
94288930|NCT03969888|322847927|FG007|Overall Study|Never Received Study Drug|0|||
94288931|NCT03969888|322847920|FG000|Overall Study|Reason Not Specified|0|||
94288932|NCT03969888|322847921|FG001|Overall Study|Reason Not Specified|0|||
94288933|NCT03969888|322847922|FG002|Overall Study|Reason Not Specified|0|||
94288934|NCT03969888|322847923|FG003|Overall Study|Reason Not Specified|0|||
94288935|NCT03969888|322847924|FG004|Overall Study|Reason Not Specified|0|||
94288936|NCT03969888|322847925|FG005|Overall Study|Reason Not Specified|0|||
94288937|NCT03969888|322847926|FG006|Overall Study|Reason Not Specified|0|||
94288938|NCT03969888|322847927|FG007|Overall Study|Reason Not Specified|1|||
94288939|NCT00291551|322847928|FG000|Overall Study|Death|7|||
94288940|NCT00291551|322847928|FG000|Overall Study|Withdrawal by Subject|6|||
94288941|NCT01375764|322847929|FG000|Overall Study|Lost to Follow-up|0|||
94288942|NCT01375764|322847930|FG001|Overall Study|Lost to Follow-up|1|||
94288943|NCT01375764|322847931|FG002|Overall Study|Lost to Follow-up|0|||
94288944|NCT01375764|322847932|FG003|Overall Study|Lost to Follow-up|0|||
94288945|NCT01375764|322847933|FG004|Overall Study|Lost to Follow-up|0|||
94288946|NCT01375764|322847929|FG000|Overall Study|Withdrawal by Subject|2|||
94288947|NCT01375764|322847930|FG001|Overall Study|Withdrawal by Subject|0|||
94288948|NCT01375764|322847931|FG002|Overall Study|Withdrawal by Subject|0|||
94288949|NCT01375764|322847932|FG003|Overall Study|Withdrawal by Subject|0|||
94288950|NCT01375764|322847933|FG004|Overall Study|Withdrawal by Subject|1|||
94288951|NCT01375764|322847929|FG000|Overall Study|Other|0|||
94288952|NCT01375764|322847930|FG001|Overall Study|Other|0|||
94288953|NCT01375764|322847931|FG002|Overall Study|Other|0|||
94288954|NCT01375764|322847932|FG003|Overall Study|Other|1|||
94288955|NCT01375764|322847933|FG004|Overall Study|Other|0|||
94288956|NCT01465659|322847934|FG000|Completed 1 Cycle of Treatment|Death|0|||
94288957|NCT01465659|322847935|FG001|Completed 1 Cycle of Treatment|Death|1|||
94288958|NCT01465659|322847936|FG002|Completed 1 Cycle of Treatment|Death|0|||
94288959|NCT01465659|322847937|FG003|Completed 1 Cycle of Treatment|Death|0|||
94288960|NCT01465659|322847934|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
94288961|NCT01465659|322847935|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
94288962|NCT01465659|322847936|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
94288963|NCT01465659|322847937|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
94288964|NCT01465659|322847934|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
94288965|NCT01465659|322847935|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
94288966|NCT01465659|322847936|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
94288967|NCT01465659|322847937|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
94288968|NCT01465659|322847934|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
94288969|NCT01465659|322847935|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
94288970|NCT01465659|322847936|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
94288971|NCT01465659|322847937|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
94288972|NCT01465659|322847934|FG000|Completed Follow for 1 Year|Death|6|||
94288973|NCT01465659|322847935|FG001|Completed Follow for 1 Year|Death|3|||
94288974|NCT01465659|322847936|FG002|Completed Follow for 1 Year|Death|2|||
94288975|NCT01465659|322847937|FG003|Completed Follow for 1 Year|Death|4|||
94288976|NCT02658812|322847938|FG000|Overall Study|Disease Progression|7|||
94288977|NCT02658812|322847938|FG000|Overall Study|Unrelated to study treatment|1|||
94288978|NCT02658812|322847938|FG000|Overall Study|Adverse Event|1|||
94288979|NCT01818297|322847939|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
94288980|NCT01818297|322847940|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
94288981|NCT01818297|322847939|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
94288982|NCT01818297|322847940|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
94288983|NCT01818297|322847939|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
94288984|NCT01818297|322847940|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
94288985|NCT01791855|322847942|FG000|Overall Study|Adverse Event|0|||
94288986|NCT01791855|322847943|FG001|Overall Study|Adverse Event|0|||
94288987|NCT01791855|322847944|FG002|Overall Study|Adverse Event|0|||
94288988|NCT01791855|322847945|FG003|Overall Study|Adverse Event|1|||
94288989|NCT01791855|322847942|FG000|Overall Study|Randomized, not treated|0|||
94288990|NCT01791855|322847943|FG001|Overall Study|Randomized, not treated|1|||
94288991|NCT01791855|322847944|FG002|Overall Study|Randomized, not treated|0|||
94288992|NCT01791855|322847945|FG003|Overall Study|Randomized, not treated|0|||
94288993|NCT03686969|322847946|FG000|Overall Study|Study terminated|1|||
94288994|NCT03686969|322847947|FG001|Overall Study|Study terminated|0|||
94288995|NCT01988090|322847951|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
94288996|NCT01988090|322847952|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
94288997|NCT01988090|322847951|FG000|Start Treament After Randomization|Protocol Violation|0|||
94288998|NCT01988090|322847952|FG001|Start Treament After Randomization|Protocol Violation|1|||
94288999|NCT01988090|322847951|FG000|Complete Study After Start|Withdrawal by Subject|2|||
94289000|NCT01988090|322847952|FG001|Complete Study After Start|Withdrawal by Subject|0|||
94289001|NCT01988090|322847951|FG000|Complete Study After Start|Protocol Violation|1|||
94289002|NCT01988090|322847952|FG001|Complete Study After Start|Protocol Violation|1|||
94289003|NCT01957137|322847953|FG000|Randomized Portion|Adverse Event|1|||
94289004|NCT01957137|322847953|FG000|Randomized Portion|Withdrawal by Subject|1|||
94289005|NCT00578643|322847954|FG000|Overall Study|Death|1|||
94289006|NCT00578643|322847954|FG000|Overall Study|Lost to Follow-up|1|||
94289007|NCT02440581|322847955|FG000|Overall Study|Death|0|||
94289008|NCT02440581|322847956|FG001|Overall Study|Death|0|||
94289009|NCT02440581|322847957|FG002|Overall Study|Death|7|||
94289010|NCT02440581|322847958|FG003|Overall Study|Death|5|||
94289011|NCT02440581|322847955|FG000|Overall Study|Transplanted|1|||
94289012|NCT02440581|322847956|FG001|Overall Study|Transplanted|0|||
94289013|NCT02440581|322847957|FG002|Overall Study|Transplanted|3|||
94289014|NCT02440581|322847958|FG003|Overall Study|Transplanted|2|||
94289015|NCT02440581|322847955|FG000|Overall Study|Withdrawal by Subject|4|||
94289016|NCT02440581|322847956|FG001|Overall Study|Withdrawal by Subject|11|||
94289017|NCT02440581|322847957|FG002|Overall Study|Withdrawal by Subject|3|||
94289018|NCT02440581|322847958|FG003|Overall Study|Withdrawal by Subject|7|||
94289019|NCT03430986|322847959|FG000|24-week Control Period|Adverse Event|1|||
94289020|NCT03430986|322847960|FG001|24-week Control Period|Adverse Event|0|||
94289021|NCT03430986|322847959|FG000|24-week Control Period|Lost to Follow-up|2|||
94289022|NCT03430986|322847960|FG001|24-week Control Period|Lost to Follow-up|2|||
94289023|NCT03430986|322847959|FG000|24-week Control Period|Withdrawal by Participant|5|||
94289024|NCT03430986|322847960|FG001|24-week Control Period|Withdrawal by Participant|0|||
94289025|NCT03430986|322847959|FG000|24-week Control Period|Protocol Deviation|0|||
94289026|NCT03430986|322847960|FG001|24-week Control Period|Protocol Deviation|2|||
94289027|NCT03430986|322847959|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
94289028|NCT03430986|322847960|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
94289029|NCT03430986|322847959|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
94289030|NCT03430986|322847960|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
94289031|NCT02116621|322847963|FG000|Baseline|Withdrawal by Subject|0|||
94372520|NCT01571635|323150280|FG001|Overall Study|Other reasons|1|||
94372521|NCT01571635|323150281|FG002|Overall Study|Other reasons|2|||
94289032|NCT02116621|322847964|FG001|Baseline|Withdrawal by Subject|4|||
94289033|NCT02116621|322847963|FG000|Three Month Follow-up|Death|1|||
94289034|NCT02116621|322847964|FG001|Three Month Follow-up|Death|1|||
94289035|NCT02116621|322847963|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
94289036|NCT02116621|322847964|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
94289037|NCT02116621|322847963|FG000|Three Month Follow-up|Lost to Follow-up|0|||
94289038|NCT02116621|322847964|FG001|Three Month Follow-up|Lost to Follow-up|1|||
94289039|NCT02116621|322847963|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
94289040|NCT02116621|322847964|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
94289041|NCT02116621|322847963|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
94289042|NCT02116621|322847964|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
94289043|NCT02116621|322847963|FG000|Six Month Follow-up|Lost to Follow-up|2|||
94289044|NCT02116621|322847964|FG001|Six Month Follow-up|Lost to Follow-up|1|||
94289045|NCT02116621|322847963|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
94289046|NCT02116621|322847964|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
94289047|NCT02116621|322847963|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
94289048|NCT02116621|322847964|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
94289049|NCT02116621|322847963|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
94289050|NCT02116621|322847964|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
94289051|NCT02116621|322847963|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
94289052|NCT02116621|322847964|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
94289053|NCT02116621|322847963|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
94289054|NCT02116621|322847964|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
94289055|NCT02901431|322847965|FG000|PK Part|Adverse Event|0|||
94289056|NCT02901431|322847966|FG001|PK Part|Adverse Event|1|||
94289057|NCT02901431|322847967|FG002|PK Part|Adverse Event|0|||
94289058|NCT02901431|322847968|FG003|PK Part|Adverse Event|0|||
94289059|NCT02901431|322847969|FG004|PK Part|Adverse Event|0|||
94289060|NCT02901431|322847970|FG005|PK Part|Adverse Event|0|||
94289061|NCT02901431|322847971|FG006|PK Part|Adverse Event|0|||
94289062|NCT02901431|322847972|FG007|PK Part|Adverse Event|0|||
94289063|NCT02901431|322847973|FG008|PK Part|Adverse Event|0|||
94289064|NCT02901431|322847974|FG009|PK Part|Adverse Event|0|||
94289065|NCT02901431|322847975|FG010|PK Part|Adverse Event|0|||
94289066|NCT02901431|322847976|FG011|PK Part|Adverse Event|0|||
94289067|NCT02901431|322847977|FG012|PK Part|Adverse Event|0|||
94289068|NCT02901431|322847965|FG000|PK Part|Lost to Follow-up|0|||
94289069|NCT02901431|322847966|FG001|PK Part|Lost to Follow-up|0|||
94289070|NCT02901431|322847967|FG002|PK Part|Lost to Follow-up|1|||
94289071|NCT02901431|322847968|FG003|PK Part|Lost to Follow-up|0|||
94289072|NCT02901431|322847969|FG004|PK Part|Lost to Follow-up|0|||
94289073|NCT02901431|322847970|FG005|PK Part|Lost to Follow-up|0|||
94289074|NCT02901431|322847971|FG006|PK Part|Lost to Follow-up|0|||
94289075|NCT02901431|322847972|FG007|PK Part|Lost to Follow-up|0|||
94289076|NCT02901431|322847973|FG008|PK Part|Lost to Follow-up|0|||
94289077|NCT02901431|322847974|FG009|PK Part|Lost to Follow-up|0|||
94289078|NCT02901431|322847975|FG010|PK Part|Lost to Follow-up|0|||
94289079|NCT02901431|322847976|FG011|PK Part|Lost to Follow-up|0|||
94289080|NCT02901431|322847977|FG012|PK Part|Lost to Follow-up|0|||
94289081|NCT02901431|322847965|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
94289082|NCT02901431|322847966|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
94289083|NCT02901431|322847967|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
94289084|NCT02901431|322847968|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
94289085|NCT02901431|322847969|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
94289086|NCT02901431|322847970|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
94289087|NCT02901431|322847971|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
94289088|NCT02901431|322847972|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
94289089|NCT02901431|322847973|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
94289090|NCT02901431|322847974|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
94289091|NCT02901431|322847975|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
94289092|NCT02901431|322847976|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
94289093|NCT02901431|322847977|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
94289094|NCT02901431|322847965|FG000|PK Part|Pending dose confirmation|0|||
94289095|NCT02901431|322847966|FG001|PK Part|Pending dose confirmation|1|||
94289096|NCT02901431|322847967|FG002|PK Part|Pending dose confirmation|0|||
94289097|NCT02901431|322847968|FG003|PK Part|Pending dose confirmation|0|||
94289098|NCT02901431|322847969|FG004|PK Part|Pending dose confirmation|0|||
94289099|NCT02901431|322847970|FG005|PK Part|Pending dose confirmation|0|||
94289100|NCT02901431|322847971|FG006|PK Part|Pending dose confirmation|0|||
94289101|NCT02901431|322847972|FG007|PK Part|Pending dose confirmation|0|||
94289102|NCT02901431|322847973|FG008|PK Part|Pending dose confirmation|0|||
94289103|NCT02901431|322847974|FG009|PK Part|Pending dose confirmation|0|||
94289104|NCT02901431|322847975|FG010|PK Part|Pending dose confirmation|0|||
94289105|NCT02901431|322847976|FG011|PK Part|Pending dose confirmation|0|||
94289106|NCT02901431|322847977|FG012|PK Part|Pending dose confirmation|0|||
94289107|NCT02901431|322847965|FG000|PK Part|8 weeks of treatment ran out|2|||
94372522|NCT01571635|323150282|FG003|Overall Study|Other reasons|2|||
94372523|NCT01571635|323150283|FG004|Overall Study|Other reasons|1|||
94372524|NCT01571635|323150279|FG000|Overall Study|Study terminated by sponsor|0|||
94289108|NCT02901431|322847966|FG001|PK Part|8 weeks of treatment ran out|0|||
94289109|NCT02901431|322847967|FG002|PK Part|8 weeks of treatment ran out|0|||
94289110|NCT02901431|322847968|FG003|PK Part|8 weeks of treatment ran out|0|||
94289111|NCT02901431|322847969|FG004|PK Part|8 weeks of treatment ran out|0|||
94289112|NCT02901431|322847970|FG005|PK Part|8 weeks of treatment ran out|0|||
94289113|NCT02901431|322847971|FG006|PK Part|8 weeks of treatment ran out|0|||
94289114|NCT02901431|322847972|FG007|PK Part|8 weeks of treatment ran out|0|||
94289115|NCT02901431|322847973|FG008|PK Part|8 weeks of treatment ran out|0|||
94289116|NCT02901431|322847974|FG009|PK Part|8 weeks of treatment ran out|0|||
94289117|NCT02901431|322847975|FG010|PK Part|8 weeks of treatment ran out|0|||
94289118|NCT02901431|322847976|FG011|PK Part|8 weeks of treatment ran out|0|||
94289119|NCT02901431|322847977|FG012|PK Part|8 weeks of treatment ran out|0|||
94289120|NCT02901431|322847965|FG000|PK Part|Stopped treatment after 8 weeks|1|||
94289121|NCT02901431|322847966|FG001|PK Part|Stopped treatment after 8 weeks|0|||
94289122|NCT02901431|322847967|FG002|PK Part|Stopped treatment after 8 weeks|1|||
94289123|NCT02901431|322847968|FG003|PK Part|Stopped treatment after 8 weeks|0|||
94289124|NCT02901431|322847969|FG004|PK Part|Stopped treatment after 8 weeks|0|||
94289125|NCT02901431|322847970|FG005|PK Part|Stopped treatment after 8 weeks|0|||
94289126|NCT02901431|322847971|FG006|PK Part|Stopped treatment after 8 weeks|0|||
94289127|NCT02901431|322847972|FG007|PK Part|Stopped treatment after 8 weeks|0|||
94289128|NCT02901431|322847973|FG008|PK Part|Stopped treatment after 8 weeks|0|||
94289129|NCT02901431|322847974|FG009|PK Part|Stopped treatment after 8 weeks|0|||
94289130|NCT02901431|322847975|FG010|PK Part|Stopped treatment after 8 weeks|0|||
94289131|NCT02901431|322847976|FG011|PK Part|Stopped treatment after 8 weeks|0|||
94289132|NCT02901431|322847977|FG012|PK Part|Stopped treatment after 8 weeks|0|||
94289133|NCT02901431|322847965|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
94289134|NCT02901431|322847966|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
94289135|NCT02901431|322847967|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
94289136|NCT02901431|322847968|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
94289137|NCT02901431|322847969|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
94289138|NCT02901431|322847970|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
94289139|NCT02901431|322847971|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
94289140|NCT02901431|322847972|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
94289141|NCT02901431|322847973|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
94289142|NCT02901431|322847974|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
94289143|NCT02901431|322847975|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
94289144|NCT02901431|322847976|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
94289145|NCT02901431|322847977|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
94289146|NCT02901431|322847965|FG000|PK Part|Discontinued per Sponsor|0|||
94289147|NCT02901431|322847966|FG001|PK Part|Discontinued per Sponsor|3|||
94289148|NCT02901431|322847967|FG002|PK Part|Discontinued per Sponsor|0|||
94289149|NCT02901431|322847968|FG003|PK Part|Discontinued per Sponsor|0|||
94289150|NCT02901431|322847969|FG004|PK Part|Discontinued per Sponsor|0|||
94289151|NCT02901431|322847970|FG005|PK Part|Discontinued per Sponsor|0|||
94289152|NCT02901431|322847971|FG006|PK Part|Discontinued per Sponsor|0|||
94289153|NCT02901431|322847972|FG007|PK Part|Discontinued per Sponsor|0|||
94289154|NCT02901431|322847973|FG008|PK Part|Discontinued per Sponsor|0|||
94289155|NCT02901431|322847974|FG009|PK Part|Discontinued per Sponsor|0|||
94289156|NCT02901431|322847975|FG010|PK Part|Discontinued per Sponsor|0|||
94289157|NCT02901431|322847976|FG011|PK Part|Discontinued per Sponsor|0|||
94289158|NCT02901431|322847977|FG012|PK Part|Discontinued per Sponsor|0|||
94289159|NCT02901431|322847965|FG000|PK Part|Withdrawal by Subject|1|||
94289160|NCT02901431|322847966|FG001|PK Part|Withdrawal by Subject|1|||
94289161|NCT02901431|322847967|FG002|PK Part|Withdrawal by Subject|3|||
94289162|NCT02901431|322847968|FG003|PK Part|Withdrawal by Subject|0|||
94289163|NCT02901431|322847969|FG004|PK Part|Withdrawal by Subject|0|||
94289164|NCT02901431|322847970|FG005|PK Part|Withdrawal by Subject|0|||
94289165|NCT02901431|322847971|FG006|PK Part|Withdrawal by Subject|0|||
94289166|NCT02901431|322847972|FG007|PK Part|Withdrawal by Subject|0|||
94289167|NCT02901431|322847973|FG008|PK Part|Withdrawal by Subject|0|||
94289168|NCT02901431|322847974|FG009|PK Part|Withdrawal by Subject|0|||
94289169|NCT02901431|322847975|FG010|PK Part|Withdrawal by Subject|0|||
94289170|NCT02901431|322847976|FG011|PK Part|Withdrawal by Subject|0|||
94289171|NCT02901431|322847977|FG012|PK Part|Withdrawal by Subject|0|||
94289172|NCT02901431|322847965|FG000|Main Treatment Part|Adverse Event|0|||
94289173|NCT02901431|322847966|FG001|Main Treatment Part|Adverse Event|0|||
94289174|NCT02901431|322847967|FG002|Main Treatment Part|Adverse Event|0|||
94289175|NCT02901431|322847968|FG003|Main Treatment Part|Adverse Event|3|||
94289176|NCT02901431|322847969|FG004|Main Treatment Part|Adverse Event|3|||
94289177|NCT02901431|322847970|FG005|Main Treatment Part|Adverse Event|4|||
94289178|NCT02901431|322847971|FG006|Main Treatment Part|Adverse Event|1|||
94289179|NCT02901431|322847972|FG007|Main Treatment Part|Adverse Event|0|||
94289180|NCT02901431|322847973|FG008|Main Treatment Part|Adverse Event|0|||
94289181|NCT02901431|322847974|FG009|Main Treatment Part|Adverse Event|0|||
94289182|NCT02901431|322847975|FG010|Main Treatment Part|Adverse Event|0|||
94289183|NCT02901431|322847976|FG011|Main Treatment Part|Adverse Event|0|||
94289184|NCT02901431|322847977|FG012|Main Treatment Part|Adverse Event|0|||
94289185|NCT02901431|322847965|FG000|Main Treatment Part|Lack of Efficacy|0|||
94289186|NCT02901431|322847966|FG001|Main Treatment Part|Lack of Efficacy|0|||
94289187|NCT02901431|322847967|FG002|Main Treatment Part|Lack of Efficacy|0|||
94289188|NCT02901431|322847968|FG003|Main Treatment Part|Lack of Efficacy|1|||
94289189|NCT02901431|322847969|FG004|Main Treatment Part|Lack of Efficacy|0|||
94289190|NCT02901431|322847970|FG005|Main Treatment Part|Lack of Efficacy|0|||
94289191|NCT02901431|322847971|FG006|Main Treatment Part|Lack of Efficacy|0|||
94289192|NCT02901431|322847972|FG007|Main Treatment Part|Lack of Efficacy|0|||
94289193|NCT02901431|322847973|FG008|Main Treatment Part|Lack of Efficacy|0|||
94289194|NCT02901431|322847974|FG009|Main Treatment Part|Lack of Efficacy|0|||
94289195|NCT02901431|322847975|FG010|Main Treatment Part|Lack of Efficacy|0|||
94289196|NCT02901431|322847976|FG011|Main Treatment Part|Lack of Efficacy|0|||
94289197|NCT02901431|322847977|FG012|Main Treatment Part|Lack of Efficacy|0|||
94289198|NCT02901431|322847965|FG000|Main Treatment Part|Lost to Follow-up|0|||
94289199|NCT02901431|322847966|FG001|Main Treatment Part|Lost to Follow-up|0|||
94289200|NCT02901431|322847967|FG002|Main Treatment Part|Lost to Follow-up|0|||
94289201|NCT02901431|322847968|FG003|Main Treatment Part|Lost to Follow-up|3|||
94289202|NCT02901431|322847969|FG004|Main Treatment Part|Lost to Follow-up|1|||
94289203|NCT02901431|322847970|FG005|Main Treatment Part|Lost to Follow-up|2|||
94289204|NCT02901431|322847971|FG006|Main Treatment Part|Lost to Follow-up|3|||
94289205|NCT02901431|322847972|FG007|Main Treatment Part|Lost to Follow-up|0|||
94289206|NCT02901431|322847973|FG008|Main Treatment Part|Lost to Follow-up|0|||
94289207|NCT02901431|322847974|FG009|Main Treatment Part|Lost to Follow-up|0|||
94289208|NCT02901431|322847975|FG010|Main Treatment Part|Lost to Follow-up|0|||
94289209|NCT02901431|322847976|FG011|Main Treatment Part|Lost to Follow-up|0|||
94289210|NCT02901431|322847977|FG012|Main Treatment Part|Lost to Follow-up|0|||
94289211|NCT02901431|322847965|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
94289212|NCT02901431|322847966|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
94289213|NCT02901431|322847967|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
94289214|NCT02901431|322847968|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
94289215|NCT02901431|322847969|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
94289216|NCT02901431|322847970|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
94289217|NCT02901431|322847971|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
94289218|NCT02901431|322847972|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
94289219|NCT02901431|322847973|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
94289220|NCT02901431|322847974|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
94289221|NCT02901431|322847975|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
94289222|NCT02901431|322847976|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
94289223|NCT02901431|322847977|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
94289224|NCT02901431|322847965|FG000|Main Treatment Part|Physician Decision|0|||
94289225|NCT02901431|322847966|FG001|Main Treatment Part|Physician Decision|0|||
94289226|NCT02901431|322847967|FG002|Main Treatment Part|Physician Decision|0|||
94289227|NCT02901431|322847968|FG003|Main Treatment Part|Physician Decision|1|||
94289228|NCT02901431|322847969|FG004|Main Treatment Part|Physician Decision|0|||
94289229|NCT02901431|322847970|FG005|Main Treatment Part|Physician Decision|0|||
94289230|NCT02901431|322847971|FG006|Main Treatment Part|Physician Decision|1|||
94289231|NCT02901431|322847972|FG007|Main Treatment Part|Physician Decision|0|||
94289232|NCT02901431|322847973|FG008|Main Treatment Part|Physician Decision|0|||
94289233|NCT02901431|322847974|FG009|Main Treatment Part|Physician Decision|0|||
94289234|NCT02901431|322847975|FG010|Main Treatment Part|Physician Decision|0|||
94289235|NCT02901431|322847976|FG011|Main Treatment Part|Physician Decision|0|||
94289236|NCT02901431|322847977|FG012|Main Treatment Part|Physician Decision|0|||
94289237|NCT02901431|322847965|FG000|Main Treatment Part|Withdrawal by Subject|0|||
94289238|NCT02901431|322847966|FG001|Main Treatment Part|Withdrawal by Subject|0|||
94289239|NCT02901431|322847967|FG002|Main Treatment Part|Withdrawal by Subject|0|||
94289240|NCT02901431|322847968|FG003|Main Treatment Part|Withdrawal by Subject|18|||
94289241|NCT02901431|322847969|FG004|Main Treatment Part|Withdrawal by Subject|3|||
94289242|NCT02901431|322847970|FG005|Main Treatment Part|Withdrawal by Subject|5|||
94289243|NCT02901431|322847971|FG006|Main Treatment Part|Withdrawal by Subject|6|||
94289244|NCT02901431|322847972|FG007|Main Treatment Part|Withdrawal by Subject|0|||
94289245|NCT02901431|322847973|FG008|Main Treatment Part|Withdrawal by Subject|0|||
94289246|NCT02901431|322847974|FG009|Main Treatment Part|Withdrawal by Subject|0|||
94289247|NCT02901431|322847975|FG010|Main Treatment Part|Withdrawal by Subject|0|||
94289248|NCT02901431|322847976|FG011|Main Treatment Part|Withdrawal by Subject|0|||
94289249|NCT02901431|322847977|FG012|Main Treatment Part|Withdrawal by Subject|0|||
94289250|NCT02901431|322847965|FG000|Open Label Part|Adverse Event|0|||
94289251|NCT02901431|322847966|FG001|Open Label Part|Adverse Event|0|||
94372525|NCT01571635|323150280|FG001|Overall Study|Study terminated by sponsor|4|||
94289252|NCT02901431|322847967|FG002|Open Label Part|Adverse Event|0|||
94289253|NCT02901431|322847968|FG003|Open Label Part|Adverse Event|0|||
94289254|NCT02901431|322847969|FG004|Open Label Part|Adverse Event|0|||
94289255|NCT02901431|322847970|FG005|Open Label Part|Adverse Event|0|||
94289256|NCT02901431|322847971|FG006|Open Label Part|Adverse Event|0|||
94289257|NCT02901431|322847972|FG007|Open Label Part|Adverse Event|0|||
94289258|NCT02901431|322847973|FG008|Open Label Part|Adverse Event|4|||
94289259|NCT02901431|322847974|FG009|Open Label Part|Adverse Event|4|||
94289260|NCT02901431|322847975|FG010|Open Label Part|Adverse Event|0|||
94289261|NCT02901431|322847976|FG011|Open Label Part|Adverse Event|4|||
94289262|NCT02901431|322847977|FG012|Open Label Part|Adverse Event|1|||
94289263|NCT02901431|322847965|FG000|Open Label Part|Lost to Follow-up|0|||
94289264|NCT02901431|322847966|FG001|Open Label Part|Lost to Follow-up|0|||
94289265|NCT02901431|322847967|FG002|Open Label Part|Lost to Follow-up|0|||
94289266|NCT02901431|322847968|FG003|Open Label Part|Lost to Follow-up|0|||
94289267|NCT02901431|322847969|FG004|Open Label Part|Lost to Follow-up|0|||
94289268|NCT02901431|322847970|FG005|Open Label Part|Lost to Follow-up|0|||
94289269|NCT02901431|322847971|FG006|Open Label Part|Lost to Follow-up|0|||
94289270|NCT02901431|322847972|FG007|Open Label Part|Lost to Follow-up|0|||
94289271|NCT02901431|322847973|FG008|Open Label Part|Lost to Follow-up|2|||
94289272|NCT02901431|322847974|FG009|Open Label Part|Lost to Follow-up|2|||
94289273|NCT02901431|322847975|FG010|Open Label Part|Lost to Follow-up|1|||
94289274|NCT02901431|322847976|FG011|Open Label Part|Lost to Follow-up|1|||
94289275|NCT02901431|322847977|FG012|Open Label Part|Lost to Follow-up|1|||
94289276|NCT02901431|322847965|FG000|Open Label Part|Physician Decision|0|||
94289277|NCT02901431|322847966|FG001|Open Label Part|Physician Decision|0|||
94289278|NCT02901431|322847967|FG002|Open Label Part|Physician Decision|0|||
94289279|NCT02901431|322847968|FG003|Open Label Part|Physician Decision|0|||
94289280|NCT02901431|322847969|FG004|Open Label Part|Physician Decision|0|||
94289281|NCT02901431|322847970|FG005|Open Label Part|Physician Decision|0|||
94289282|NCT02901431|322847971|FG006|Open Label Part|Physician Decision|0|||
94289283|NCT02901431|322847972|FG007|Open Label Part|Physician Decision|0|||
94289284|NCT02901431|322847973|FG008|Open Label Part|Physician Decision|1|||
94289285|NCT02901431|322847974|FG009|Open Label Part|Physician Decision|1|||
94289286|NCT02901431|322847975|FG010|Open Label Part|Physician Decision|0|||
94289287|NCT02901431|322847976|FG011|Open Label Part|Physician Decision|0|||
94289288|NCT02901431|322847977|FG012|Open Label Part|Physician Decision|0|||
94289289|NCT02901431|322847965|FG000|Open Label Part|Study Terminated By Sponsor|0|||
94289290|NCT02901431|322847966|FG001|Open Label Part|Study Terminated By Sponsor|0|||
94289291|NCT02901431|322847967|FG002|Open Label Part|Study Terminated By Sponsor|0|||
94289292|NCT02901431|322847968|FG003|Open Label Part|Study Terminated By Sponsor|0|||
94289293|NCT02901431|322847969|FG004|Open Label Part|Study Terminated By Sponsor|0|||
94289294|NCT02901431|322847970|FG005|Open Label Part|Study Terminated By Sponsor|0|||
94289295|NCT02901431|322847971|FG006|Open Label Part|Study Terminated By Sponsor|0|||
94289296|NCT02901431|322847972|FG007|Open Label Part|Study Terminated By Sponsor|0|||
94289297|NCT02901431|322847973|FG008|Open Label Part|Study Terminated By Sponsor|35|||
94289298|NCT02901431|322847974|FG009|Open Label Part|Study Terminated By Sponsor|12|||
94289299|NCT02901431|322847975|FG010|Open Label Part|Study Terminated By Sponsor|21|||
94289300|NCT02901431|322847976|FG011|Open Label Part|Study Terminated By Sponsor|31|||
94289301|NCT02901431|322847977|FG012|Open Label Part|Study Terminated By Sponsor|0|||
94289302|NCT02901431|322847965|FG000|Open Label Part|Withdrawal by Subject|0|||
94289303|NCT02901431|322847966|FG001|Open Label Part|Withdrawal by Subject|0|||
94289304|NCT02901431|322847967|FG002|Open Label Part|Withdrawal by Subject|0|||
94289305|NCT02901431|322847968|FG003|Open Label Part|Withdrawal by Subject|0|||
94289306|NCT02901431|322847969|FG004|Open Label Part|Withdrawal by Subject|0|||
94289307|NCT02901431|322847970|FG005|Open Label Part|Withdrawal by Subject|0|||
94289308|NCT02901431|322847971|FG006|Open Label Part|Withdrawal by Subject|0|||
94289309|NCT02901431|322847972|FG007|Open Label Part|Withdrawal by Subject|0|||
94289310|NCT02901431|322847973|FG008|Open Label Part|Withdrawal by Subject|6|||
94289311|NCT02901431|322847974|FG009|Open Label Part|Withdrawal by Subject|5|||
94289312|NCT02901431|322847975|FG010|Open Label Part|Withdrawal by Subject|7|||
94289313|NCT02901431|322847976|FG011|Open Label Part|Withdrawal by Subject|3|||
94289314|NCT02901431|322847977|FG012|Open Label Part|Withdrawal by Subject|1|||
94289315|NCT01412957|322847978|FG000|Overall Study|Withdrawal by Subject|6|||
94289316|NCT01412957|322847979|FG001|Overall Study|Withdrawal by Subject|22|||
94289317|NCT01412957|322847978|FG000|Overall Study|Lost to Follow-up|7|||
94289318|NCT01412957|322847979|FG001|Overall Study|Lost to Follow-up|2|||
94289319|NCT01412957|322847978|FG000|Overall Study|Death|136|||
94289320|NCT01412957|322847979|FG001|Overall Study|Death|133|||
94289321|NCT00413959|322847980|FG000|Overall Study|Pt had only one cycle.|1|||
94289322|NCT04035486|322847981|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
94289323|NCT04035486|322847982|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
94289324|NCT04035486|322847983|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
94289325|NCT04035486|322847984|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
94289326|NCT04035486|322847981|FG000|Overall Study|Death|6|||
94289327|NCT04035486|322847982|FG001|Overall Study|Death|3|||
94289328|NCT04035486|322847983|FG002|Overall Study|Death|70|||
94289329|NCT04035486|322847984|FG003|Overall Study|Death|77|||
94289330|NCT04035486|322847981|FG000|Overall Study|Screen Failure|0|||
94289331|NCT04035486|322847982|FG001|Overall Study|Screen Failure|0|||
94372526|NCT01571635|323150281|FG002|Overall Study|Study terminated by sponsor|1|||
94467966|NCT03013985|323502456|FG000|Overall Study|Withdrawal by Subject|14|||
94289332|NCT04035486|322847983|FG002|Overall Study|Screen Failure|1|||
94289333|NCT04035486|322847984|FG003|Overall Study|Screen Failure|1|||
94289334|NCT04035486|322847981|FG000|Overall Study|Withdrawal by Subject|1|||
94289335|NCT04035486|322847982|FG001|Overall Study|Withdrawal by Subject|1|||
94289336|NCT04035486|322847983|FG002|Overall Study|Withdrawal by Subject|11|||
94289337|NCT04035486|322847984|FG003|Overall Study|Withdrawal by Subject|9|||
94289338|NCT00630331|322847989|FG000|Overall Study|Death|2|||
94289339|NCT00630331|322847990|FG001|Overall Study|Death|1|||
94289340|NCT00630331|322847991|FG002|Overall Study|Death|1|||
94289341|NCT00630331|322847989|FG000|Overall Study|Adverse Event|1|||
94289342|NCT00630331|322847990|FG001|Overall Study|Adverse Event|0|||
94289343|NCT00630331|322847991|FG002|Overall Study|Adverse Event|0|||
94289344|NCT00630331|322847989|FG000|Overall Study|Withdrawal by Subject|12|||
94289345|NCT00630331|322847990|FG001|Overall Study|Withdrawal by Subject|7|||
94289346|NCT00630331|322847991|FG002|Overall Study|Withdrawal by Subject|5|||
94289347|NCT00630331|322847989|FG000|Overall Study|Lost to Follow-up|175|||
94289348|NCT00630331|322847990|FG001|Overall Study|Lost to Follow-up|143|||
94289349|NCT00630331|322847991|FG002|Overall Study|Lost to Follow-up|170|||
94289350|NCT00630331|322847989|FG000|Overall Study|Inappropriate enrollment|3|||
94289351|NCT00630331|322847990|FG001|Overall Study|Inappropriate enrollment|6|||
94289352|NCT00630331|322847991|FG002|Overall Study|Inappropriate enrollment|3|||
94289353|NCT00630331|322847989|FG000|Overall Study|Unable to classify|9|||
94289354|NCT00630331|322847990|FG001|Overall Study|Unable to classify|4|||
94289355|NCT00630331|322847991|FG002|Overall Study|Unable to classify|3|||
94289356|NCT00630331|322847989|FG000|Overall Study|Protocol Violation|4|||
94289357|NCT00630331|322847990|FG001|Overall Study|Protocol Violation|5|||
94289358|NCT00630331|322847991|FG002|Overall Study|Protocol Violation|6|||
94289359|NCT01827384|322847992|FG000|Overall Study|Switched to alternative treatment|0|||
94289360|NCT01827384|322847993|FG001|Overall Study|Switched to alternative treatment|0|||
94289361|NCT01827384|322847994|FG002|Overall Study|Switched to alternative treatment|0|||
94289362|NCT01827384|322847995|FG003|Overall Study|Switched to alternative treatment|0|||
94289363|NCT01827384|322847996|FG004|Overall Study|Switched to alternative treatment|0|||
94289364|NCT01827384|322847997|FG005|Overall Study|Switched to alternative treatment|0|||
94289365|NCT01827384|322847998|FG006|Overall Study|Switched to alternative treatment|0|||
94289366|NCT01827384|322847999|FG007|Overall Study|Switched to alternative treatment|0|||
94289367|NCT01827384|322848000|FG008|Overall Study|Switched to alternative treatment|0|||
94289368|NCT01827384|322848001|FG009|Overall Study|Switched to alternative treatment|0|||
94289369|NCT01827384|322848002|FG010|Overall Study|Switched to alternative treatment|0|||
94289370|NCT01827384|322848003|FG011|Overall Study|Switched to alternative treatment|0|||
94289371|NCT01827384|322848004|FG012|Overall Study|Switched to alternative treatment|0|||
94289372|NCT01827384|322848005|FG013|Overall Study|Switched to alternative treatment|2|||
94289373|NCT01827384|322847992|FG000|Overall Study|Disease progression before treatment|0|||
94289374|NCT01827384|322847993|FG001|Overall Study|Disease progression before treatment|0|||
94289375|NCT01827384|322847994|FG002|Overall Study|Disease progression before treatment|0|||
94289376|NCT01827384|322847995|FG003|Overall Study|Disease progression before treatment|0|||
94289377|NCT01827384|322847996|FG004|Overall Study|Disease progression before treatment|0|||
94289378|NCT01827384|322847997|FG005|Overall Study|Disease progression before treatment|0|||
94289379|NCT01827384|322847998|FG006|Overall Study|Disease progression before treatment|0|||
94289380|NCT01827384|322847999|FG007|Overall Study|Disease progression before treatment|0|||
94289381|NCT01827384|322848000|FG008|Overall Study|Disease progression before treatment|0|||
94289382|NCT01827384|322848001|FG009|Overall Study|Disease progression before treatment|0|||
94289383|NCT01827384|322848002|FG010|Overall Study|Disease progression before treatment|0|||
94289384|NCT01827384|322848003|FG011|Overall Study|Disease progression before treatment|0|||
94289385|NCT01827384|322848004|FG012|Overall Study|Disease progression before treatment|0|||
94289386|NCT01827384|322848005|FG013|Overall Study|Disease progression before treatment|4|||
94289387|NCT01827384|322847992|FG000|Overall Study|Ineligible|0|||
94289388|NCT01827384|322847993|FG001|Overall Study|Ineligible|0|||
94289389|NCT01827384|322847994|FG002|Overall Study|Ineligible|0|||
94289390|NCT01827384|322847995|FG003|Overall Study|Ineligible|0|||
94289391|NCT01827384|322847996|FG004|Overall Study|Ineligible|0|||
94289392|NCT01827384|322847997|FG005|Overall Study|Ineligible|0|||
94289393|NCT01827384|322847998|FG006|Overall Study|Ineligible|0|||
94289394|NCT01827384|322847999|FG007|Overall Study|Ineligible|0|||
94289395|NCT01827384|322848000|FG008|Overall Study|Ineligible|0|||
94289396|NCT01827384|322848001|FG009|Overall Study|Ineligible|0|||
94289397|NCT01827384|322848002|FG010|Overall Study|Ineligible|0|||
94289398|NCT01827384|322848003|FG011|Overall Study|Ineligible|0|||
94289399|NCT01827384|322848004|FG012|Overall Study|Ineligible|0|||
94289400|NCT01827384|322848005|FG013|Overall Study|Ineligible|19|||
94289401|NCT01827384|322847992|FG000|Overall Study|Participant died before treatment|0|||
94289402|NCT01827384|322847993|FG001|Overall Study|Participant died before treatment|0|||
94289403|NCT01827384|322847994|FG002|Overall Study|Participant died before treatment|0|||
94289404|NCT01827384|322847995|FG003|Overall Study|Participant died before treatment|0|||
94289405|NCT01827384|322847996|FG004|Overall Study|Participant died before treatment|0|||
94289406|NCT01827384|322847997|FG005|Overall Study|Participant died before treatment|0|||
94289407|NCT01827384|322847998|FG006|Overall Study|Participant died before treatment|0|||
94289408|NCT01827384|322847999|FG007|Overall Study|Participant died before treatment|0|||
94289409|NCT01827384|322848000|FG008|Overall Study|Participant died before treatment|0|||
94289410|NCT01827384|322848001|FG009|Overall Study|Participant died before treatment|0|||
94289411|NCT01827384|322848002|FG010|Overall Study|Participant died before treatment|0|||
94289412|NCT01827384|322848003|FG011|Overall Study|Participant died before treatment|0|||
94289413|NCT01827384|322848004|FG012|Overall Study|Participant died before treatment|0|||
94289414|NCT01827384|322848005|FG013|Overall Study|Participant died before treatment|5|||
94289415|NCT01827384|322847992|FG000|Overall Study|Insufficient tumor cells|0|||
94289416|NCT01827384|322847993|FG001|Overall Study|Insufficient tumor cells|0|||
94289417|NCT01827384|322847994|FG002|Overall Study|Insufficient tumor cells|0|||
94289418|NCT01827384|322847995|FG003|Overall Study|Insufficient tumor cells|0|||
94289419|NCT01827384|322847996|FG004|Overall Study|Insufficient tumor cells|0|||
94289420|NCT01827384|322847997|FG005|Overall Study|Insufficient tumor cells|0|||
94289421|NCT01827384|322847998|FG006|Overall Study|Insufficient tumor cells|0|||
94289422|NCT01827384|322847999|FG007|Overall Study|Insufficient tumor cells|0|||
94289423|NCT01827384|322848000|FG008|Overall Study|Insufficient tumor cells|0|||
94289424|NCT01827384|322848001|FG009|Overall Study|Insufficient tumor cells|0|||
94289425|NCT01827384|322848002|FG010|Overall Study|Insufficient tumor cells|0|||
94289426|NCT01827384|322848003|FG011|Overall Study|Insufficient tumor cells|0|||
94289427|NCT01827384|322848004|FG012|Overall Study|Insufficient tumor cells|0|||
94289428|NCT01827384|322848005|FG013|Overall Study|Insufficient tumor cells|13|||
94289429|NCT01827384|322847992|FG000|Overall Study|No actionable mutation|0|||
94289430|NCT01827384|322847993|FG001|Overall Study|No actionable mutation|0|||
94289431|NCT01827384|322847994|FG002|Overall Study|No actionable mutation|0|||
94289432|NCT01827384|322847995|FG003|Overall Study|No actionable mutation|0|||
94289433|NCT01827384|322847996|FG004|Overall Study|No actionable mutation|0|||
94289434|NCT01827384|322847997|FG005|Overall Study|No actionable mutation|0|||
94289435|NCT01827384|322847998|FG006|Overall Study|No actionable mutation|0|||
94289436|NCT01827384|322847999|FG007|Overall Study|No actionable mutation|0|||
94289437|NCT01827384|322848000|FG008|Overall Study|No actionable mutation|0|||
94289438|NCT01827384|322848001|FG009|Overall Study|No actionable mutation|0|||
94289439|NCT01827384|322848002|FG010|Overall Study|No actionable mutation|0|||
94289440|NCT01827384|322848003|FG011|Overall Study|No actionable mutation|0|||
94289441|NCT01827384|322848004|FG012|Overall Study|No actionable mutation|0|||
94289442|NCT01827384|322848005|FG013|Overall Study|No actionable mutation|73|||
94289443|NCT01827384|322847992|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
94289444|NCT01827384|322847993|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
94289445|NCT01827384|322847994|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
94289446|NCT01827384|322847995|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
94289447|NCT01827384|322847996|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
94289448|NCT01827384|322847997|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
94289449|NCT01827384|322847998|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
94289450|NCT01827384|322847999|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
94289451|NCT01827384|322848000|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
94289452|NCT01827384|322848001|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
94289453|NCT01827384|322848002|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
94289454|NCT01827384|322848003|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
94289455|NCT01827384|322848004|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
94289456|NCT01827384|322848005|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
94289457|NCT00821678|322848006|FG000|Overall Study|Withdrawal by Subject|8|||
94289458|NCT00821678|322848007|FG001|Overall Study|Withdrawal by Subject|0|||
94289459|NCT00821678|322848006|FG000|Overall Study|Lost to Follow-up|13|||
94289460|NCT00821678|322848007|FG001|Overall Study|Lost to Follow-up|12|||
94289461|NCT00821678|322848006|FG000|Overall Study|Death|0|||
94289462|NCT00821678|322848007|FG001|Overall Study|Death|2|||
94289463|NCT02292771|322848011|FG000|Overall Study|Withdrawal by Subject|2|||
94289464|NCT02292771|322848012|FG001|Overall Study|Withdrawal by Subject|1|||
94289465|NCT02292771|322848011|FG000|Overall Study|Lost to Follow-up|2|||
94289466|NCT02292771|322848012|FG001|Overall Study|Lost to Follow-up|1|||
94289467|NCT05888103|322850472|FG000|Overall Study|Participant decision|3|||
94289468|NCT05888103|322850473|FG001|Overall Study|Participant decision|3|||
94289469|NCT04660643|322850474|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
94289470|NCT04660643|322850475|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
94289471|NCT04660643|322850476|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
94289472|NCT04660643|322850474|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
94289473|NCT04660643|322850475|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
94289474|NCT04660643|322850476|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
94289475|NCT04660643|322850474|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
94289476|NCT04660643|322850475|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
94289477|NCT04660643|322850476|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
94289478|NCT04660643|322850474|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
94289479|NCT04660643|322850475|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
94289480|NCT04660643|322850476|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
94289481|NCT04660643|322850474|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
94289482|NCT04660643|322850475|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
94289483|NCT04660643|322850476|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
94289484|NCT04660643|322850474|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
94289485|NCT04660643|322850475|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
94289486|NCT04660643|322850476|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
94289487|NCT04660643|322850474|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
94289488|NCT04660643|322850475|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
94289489|NCT04660643|322850476|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
94289490|NCT04660643|322850474|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
94289491|NCT04660643|322850475|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
94289492|NCT04660643|322850476|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
94289493|NCT04660643|322850474|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
94289494|NCT04660643|322850475|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
94289495|NCT04660643|322850476|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
94289496|NCT04660643|322850474|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
94289497|NCT04660643|322850475|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
94289498|NCT04660643|322850476|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
94289499|NCT04660643|322850474|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
94289500|NCT04660643|322850475|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
94289501|NCT04660643|322850476|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
94289502|NCT04660643|322850474|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
94289503|NCT04660643|322850475|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
94289504|NCT04660643|322850476|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
94289505|NCT04660643|322850474|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
94289506|NCT04660643|322850475|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
94289507|NCT04660643|322850476|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
94289508|NCT04660643|322850474|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
94289509|NCT04660643|322850475|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
94289510|NCT04660643|322850476|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
94289511|NCT04660643|322850474|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
94289512|NCT04660643|322850475|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
94289513|NCT04660643|322850476|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
94289514|NCT04660643|322850474|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
94289515|NCT04660643|322850475|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
94289516|NCT04660643|322850476|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
94289517|NCT00804687|322850479|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
94289518|NCT00804687|322850480|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
94289519|NCT00804687|322850481|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
94289520|NCT00804687|322850482|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
94289521|NCT00804687|322850483|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
94289522|NCT00804687|322850484|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
94289523|NCT00804687|322850479|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
94289524|NCT00804687|322850480|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
94289525|NCT00804687|322850481|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
94289526|NCT00804687|322850482|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
94289527|NCT00804687|322850483|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
94289528|NCT00804687|322850484|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
94289529|NCT00804687|322850479|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
94289530|NCT00804687|322850480|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
94289531|NCT00804687|322850481|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
94289532|NCT00804687|322850482|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
94289533|NCT00804687|322850483|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
94289534|NCT00804687|322850484|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
94289535|NCT00804687|322850479|FG000|Period 5: Treatment Period|Positive drug test|1|||
94289536|NCT00804687|322850480|FG001|Period 5: Treatment Period|Positive drug test|0|||
94289537|NCT00804687|322850481|FG002|Period 5: Treatment Period|Positive drug test|0|||
94289538|NCT00804687|322850482|FG003|Period 5: Treatment Period|Positive drug test|0|||
94289539|NCT00804687|322850483|FG004|Period 5: Treatment Period|Positive drug test|0|||
94289540|NCT00804687|322850484|FG005|Period 5: Treatment Period|Positive drug test|0|||
94289541|NCT02327260|322850486|FG000|Overall Study|Lost to Follow-up|2|||
94289542|NCT02327260|322850487|FG001|Overall Study|Lost to Follow-up|3|||
94289543|NCT02327260|322850488|FG002|Overall Study|Lost to Follow-up|2|||
94289544|NCT02327260|322850486|FG000|Overall Study|invalid phone number|1|||
94289545|NCT02327260|322850487|FG001|Overall Study|invalid phone number|1|||
94289546|NCT02327260|322850488|FG002|Overall Study|invalid phone number|0|||
94289547|NCT02327260|322850486|FG000|Overall Study|non-adherence to protocol|2|||
94289548|NCT02327260|322850487|FG001|Overall Study|non-adherence to protocol|0|||
94289549|NCT02327260|322850488|FG002|Overall Study|non-adherence to protocol|0|||
94289550|NCT02327260|322850486|FG000|Overall Study|cognitive concerns|1|||
94289551|NCT02327260|322850487|FG001|Overall Study|cognitive concerns|0|||
94289552|NCT02327260|322850488|FG002|Overall Study|cognitive concerns|0|||
94289553|NCT03502330|322850489|FG000|Overall Study|Adverse Event|2|||
94289554|NCT03502330|322850490|FG001|Overall Study|Adverse Event|1|||
94289555|NCT03502330|322850491|FG002|Overall Study|Adverse Event|0|||
94289556|NCT03502330|322850492|FG003|Overall Study|Adverse Event|0|||
94289557|NCT03502330|322850493|FG004|Overall Study|Adverse Event|1|||
94289558|NCT03502330|322850494|FG005|Overall Study|Adverse Event|0|||
94289559|NCT03502330|322850495|FG006|Overall Study|Adverse Event|1|||
94289560|NCT03502330|322850496|FG007|Overall Study|Adverse Event|1|||
94289561|NCT03502330|322850497|FG008|Overall Study|Adverse Event|0|||
94289562|NCT03502330|322850489|FG000|Overall Study|Lack of Efficacy|1|||
94289563|NCT03502330|322850490|FG001|Overall Study|Lack of Efficacy|5|||
94289564|NCT03502330|322850491|FG002|Overall Study|Lack of Efficacy|3|||
94289565|NCT03502330|322850492|FG003|Overall Study|Lack of Efficacy|5|||
94289566|NCT03502330|322850493|FG004|Overall Study|Lack of Efficacy|1|||
94289567|NCT03502330|322850494|FG005|Overall Study|Lack of Efficacy|5|||
94289568|NCT03502330|322850495|FG006|Overall Study|Lack of Efficacy|5|||
94289569|NCT03502330|322850496|FG007|Overall Study|Lack of Efficacy|6|||
94289570|NCT03502330|322850497|FG008|Overall Study|Lack of Efficacy|0|||
94289571|NCT03502330|322850489|FG000|Overall Study|Physician Decision|0|||
94289572|NCT03502330|322850490|FG001|Overall Study|Physician Decision|0|||
94289573|NCT03502330|322850491|FG002|Overall Study|Physician Decision|0|||
94289574|NCT03502330|322850492|FG003|Overall Study|Physician Decision|0|||
94289575|NCT03502330|322850493|FG004|Overall Study|Physician Decision|1|||
94289576|NCT03502330|322850494|FG005|Overall Study|Physician Decision|0|||
94289577|NCT03502330|322850495|FG006|Overall Study|Physician Decision|0|||
94289578|NCT03502330|322850496|FG007|Overall Study|Physician Decision|0|||
94289579|NCT03502330|322850497|FG008|Overall Study|Physician Decision|0|||
94289580|NCT03502330|322850489|FG000|Overall Study|Withdrawal by Subject|0|||
94289581|NCT03502330|322850490|FG001|Overall Study|Withdrawal by Subject|0|||
94289582|NCT03502330|322850491|FG002|Overall Study|Withdrawal by Subject|0|||
94289583|NCT03502330|322850492|FG003|Overall Study|Withdrawal by Subject|0|||
94289584|NCT03502330|322850493|FG004|Overall Study|Withdrawal by Subject|0|||
94289585|NCT03502330|322850494|FG005|Overall Study|Withdrawal by Subject|1|||
94289586|NCT03502330|322850495|FG006|Overall Study|Withdrawal by Subject|0|||
94289587|NCT03502330|322850496|FG007|Overall Study|Withdrawal by Subject|1|||
94289588|NCT03502330|322850497|FG008|Overall Study|Withdrawal by Subject|0|||
94289589|NCT03502330|322850489|FG000|Overall Study|Death|0|||
94289590|NCT03502330|322850490|FG001|Overall Study|Death|0|||
94289591|NCT03502330|322850491|FG002|Overall Study|Death|0|||
94289592|NCT03502330|322850492|FG003|Overall Study|Death|0|||
94289593|NCT03502330|322850493|FG004|Overall Study|Death|0|||
94289594|NCT03502330|322850494|FG005|Overall Study|Death|0|||
94289595|NCT03502330|322850495|FG006|Overall Study|Death|2|||
94289596|NCT03502330|322850496|FG007|Overall Study|Death|0|||
94289597|NCT03502330|322850497|FG008|Overall Study|Death|0|||
94289598|NCT03896503|322850498|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
94289599|NCT03896503|322850499|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
94289600|NCT03896503|322850500|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
94289601|NCT03896503|322850501|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
94289602|NCT03896503|322850502|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
94289603|NCT03896503|322850503|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
94289604|NCT03896503|322850504|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
94289605|NCT03896503|322850505|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
94289606|NCT03896503|322850498|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
94289607|NCT03896503|322850499|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
94289608|NCT03896503|322850500|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
94289609|NCT03896503|322850501|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
94289610|NCT03896503|322850502|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
94289611|NCT03896503|322850503|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
94289612|NCT03896503|322850504|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
94289613|NCT03896503|322850505|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
94289614|NCT03896503|322850498|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
94289615|NCT03896503|322850499|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
94289616|NCT03896503|322850500|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
94289617|NCT03896503|322850501|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
94289618|NCT03896503|322850502|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
94289619|NCT03896503|322850503|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
94289620|NCT03896503|322850504|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
94289621|NCT03896503|322850505|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
94289622|NCT03896503|322850498|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
94289623|NCT03896503|322850499|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
94289624|NCT03896503|322850500|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
94289625|NCT03896503|322850501|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
94289626|NCT03896503|322850502|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
94289627|NCT03896503|322850503|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
94289628|NCT03896503|322850504|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
94289629|NCT03896503|322850505|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
94289630|NCT03896503|322850498|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
94289631|NCT03896503|322850499|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
94289632|NCT03896503|322850500|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
94289633|NCT03896503|322850501|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
94289634|NCT03896503|322850502|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
94289635|NCT03896503|322850503|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
94289636|NCT03896503|322850504|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
94289637|NCT03896503|322850505|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
94289638|NCT03896503|322850498|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
94289639|NCT03896503|322850499|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
94289640|NCT03896503|322850500|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
94289641|NCT03896503|322850501|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
94289642|NCT03896503|322850502|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
94289643|NCT03896503|322850503|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
94289644|NCT03896503|322850504|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
94289645|NCT03896503|322850505|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
94289646|NCT03896503|322850498|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
94289647|NCT03896503|322850499|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
94289648|NCT03896503|322850500|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
94289649|NCT03896503|322850501|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
94289650|NCT03896503|322850502|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
94289651|NCT03896503|322850503|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
94289652|NCT03896503|322850504|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
94289653|NCT03896503|322850505|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
94289654|NCT03896503|322850498|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
94289655|NCT03896503|322850499|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
94289656|NCT03896503|322850500|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
94289657|NCT03896503|322850501|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
94289658|NCT03896503|322850502|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
94289659|NCT03896503|322850503|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
94289660|NCT03896503|322850504|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
94289661|NCT03896503|322850505|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
94289662|NCT03896503|322850498|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
94289663|NCT03896503|322850499|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
94289664|NCT03896503|322850500|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
94289665|NCT03896503|322850501|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
94289666|NCT03896503|322850502|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
94289667|NCT03896503|322850503|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
94289668|NCT03896503|322850504|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
94289669|NCT03896503|322850505|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
94289670|NCT03896503|322850498|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
94289671|NCT03896503|322850499|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
94289672|NCT03896503|322850500|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
94289673|NCT03896503|322850501|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
94289674|NCT03896503|322850502|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
94289675|NCT03896503|322850503|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
94289676|NCT03896503|322850504|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
94289677|NCT03896503|322850505|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
94289678|NCT03896503|322850498|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
94289679|NCT03896503|322850499|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
94289680|NCT03896503|322850500|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
94289681|NCT03896503|322850501|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
94289682|NCT03896503|322850502|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
94289683|NCT03896503|322850503|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
94289684|NCT03896503|322850504|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
94289685|NCT03896503|322850505|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
94289686|NCT02939131|322850506|FG000|Overall Study|Unable to get to clinic|6|||
94289687|NCT02939131|322850507|FG001|Overall Study|Unable to get to clinic|4|||
94289688|NCT02939131|322850506|FG000|Overall Study|Lost to Follow-up|2|||
94289689|NCT02939131|322850507|FG001|Overall Study|Lost to Follow-up|4|||
94289690|NCT02939131|322850506|FG000|Overall Study|severe debilitation|1|||
94289691|NCT02939131|322850507|FG001|Overall Study|severe debilitation|0|||
94289692|NCT02939131|322850506|FG000|Overall Study|Other|0|||
94289693|NCT02939131|322850507|FG001|Overall Study|Other|1|||
94289694|NCT02939131|322850506|FG000|Overall Study|not willing to adhere to protocol|2|||
94289695|NCT02939131|322850507|FG001|Overall Study|not willing to adhere to protocol|0|||
94289696|NCT03706365|322850508|FG000|Overall Study|Lost to Follow-up|7|||
94289697|NCT03706365|322850509|FG001|Overall Study|Lost to Follow-up|0|||
94289698|NCT03706365|322850508|FG000|Overall Study|Withdrawal by Subject|17|||
94289699|NCT03706365|322850509|FG001|Overall Study|Withdrawal by Subject|15|||
94289700|NCT03706365|322850508|FG000|Overall Study|On Study Treatment|51|||
94289701|NCT03706365|322850509|FG001|Overall Study|On Study Treatment|51|||
94289702|NCT03806127|322850510|FG000|Overall Study|Withdrawal by Subject|4|||
94289703|NCT03806127|322850511|FG001|Overall Study|Withdrawal by Subject|5|||
94289704|NCT03806127|322850510|FG000|Overall Study|Protocol Violation|3|||
94289705|NCT03806127|322850511|FG001|Overall Study|Protocol Violation|1|||
94289706|NCT03806127|322850510|FG000|Overall Study|Adverse Event|3|||
94289707|NCT03806127|322850511|FG001|Overall Study|Adverse Event|0|||
94289708|NCT03806127|322850510|FG000|Overall Study|Unable to Complete Procedures|0|||
94289709|NCT03806127|322850511|FG001|Overall Study|Unable to Complete Procedures|1|||
94289710|NCT03806127|322850510|FG000|Overall Study|Pregnancy|0|||
94289711|NCT03806127|322850511|FG001|Overall Study|Pregnancy|1|||
94289712|NCT03806127|322850510|FG000|Overall Study|Lost to Follow-up|5|||
94289713|NCT03806127|322850511|FG001|Overall Study|Lost to Follow-up|1|||
94289714|NCT03806127|322850510|FG000|Overall Study|Physician Decision|1|||
94289715|NCT03806127|322850511|FG001|Overall Study|Physician Decision|1|||
94289716|NCT03806127|322850510|FG000|Overall Study|Could Not Come Due to Covid|1|||
94289717|NCT03806127|322850511|FG001|Overall Study|Could Not Come Due to Covid|0|||
94289718|NCT03806127|322850510|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
94289719|NCT03806127|322850511|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
94289720|NCT03806127|322850510|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
94289721|NCT03806127|322850511|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
94289722|NCT03806127|322850510|FG000|Overall Study|Covid 19 Restrictions|2|||
94289723|NCT03806127|322850511|FG001|Overall Study|Covid 19 Restrictions|0|||
94289724|NCT03806127|322850510|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
94289725|NCT03806127|322850511|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
94289726|NCT03806127|322850510|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
94289727|NCT03806127|322850511|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
94289728|NCT01505894|322850512|FG000|Overall Study|Adverse Event|1|||
94289729|NCT01505894|322850513|FG001|Overall Study|Adverse Event|0|||
94289730|NCT01505894|322850514|FG002|Overall Study|Adverse Event|0|||
94289731|NCT01505894|322850515|FG003|Overall Study|Adverse Event|0|||
94289732|NCT01505894|322850516|FG004|Overall Study|Adverse Event|0|||
94289733|NCT01505894|322850517|FG005|Overall Study|Adverse Event|0|||
94289734|NCT01505894|322850518|FG006|Overall Study|Adverse Event|0|||
94289735|NCT01505894|322850519|FG007|Overall Study|Adverse Event|0|||
94289736|NCT01505894|322850520|FG008|Overall Study|Adverse Event|0|||
94289737|NCT01505894|322850512|FG000|Overall Study|Other than specified|0|||
94289738|NCT01505894|322850513|FG001|Overall Study|Other than specified|0|||
94289739|NCT01505894|322850514|FG002|Overall Study|Other than specified|0|||
94289740|NCT01505894|322850515|FG003|Overall Study|Other than specified|0|||
94289741|NCT01505894|322850516|FG004|Overall Study|Other than specified|1|||
94289742|NCT01505894|322850517|FG005|Overall Study|Other than specified|0|||
94289743|NCT01505894|322850518|FG006|Overall Study|Other than specified|0|||
94289744|NCT01505894|322850519|FG007|Overall Study|Other than specified|0|||
94289745|NCT01505894|322850520|FG008|Overall Study|Other than specified|0|||
94289746|NCT01001702|322850521|FG000|Overall Study|Lost to Follow-up|7|||
94289747|NCT01001702|322850521|FG000|Overall Study|Adverse Event|7|||
94289748|NCT01001702|322850521|FG000|Overall Study|Sponsor Discontinued Study|4|||
94289749|NCT01001702|322850521|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
94289750|NCT01001702|322850521|FG000|Overall Study|Investigator withdrew Subject|10|||
94289751|NCT01001702|322850521|FG000|Overall Study|Withdrawal by Subject|19|||
94289752|NCT01001702|322850521|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
94289753|NCT00548548|322850524|FG000|Overall Study|Death|345|||
94289754|NCT00548548|322850525|FG001|Overall Study|Death|348|||
94289755|NCT00548548|322850524|FG000|Overall Study|Lost to Follow-up|17|||
94289756|NCT00548548|322850525|FG001|Overall Study|Lost to Follow-up|18|||
94289757|NCT01279057|322850526|FG000|Overall Study|Adverse Event|1|||
94289758|NCT01279057|322850527|FG001|Overall Study|Adverse Event|0|||
94289759|NCT01279057|322850528|FG002|Overall Study|Adverse Event|1|||
94289760|NCT01279057|322850526|FG000|Overall Study|Insufficient therapeutic response|0|||
94289761|NCT01279057|322850527|FG001|Overall Study|Insufficient therapeutic response|0|||
94289762|NCT01279057|322850528|FG002|Overall Study|Insufficient therapeutic response|1|||
94289763|NCT01279057|322850526|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
94289764|NCT01279057|322850527|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
94289765|NCT01279057|322850528|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
94289766|NCT01279057|322850526|FG000|Overall Study|Withdrew consent|2|||
94289767|NCT01279057|322850527|FG001|Overall Study|Withdrew consent|0|||
94289768|NCT01279057|322850528|FG002|Overall Study|Withdrew consent|1|||
94289769|NCT01279057|322850526|FG000|Overall Study|Pregnancy|0|||
94289770|NCT01279057|322850527|FG001|Overall Study|Pregnancy|1|||
94289771|NCT01279057|322850528|FG002|Overall Study|Pregnancy|0|||
94289772|NCT01279057|322850526|FG000|Overall Study|Other|3|||
94289773|NCT01279057|322850527|FG001|Overall Study|Other|3|||
94289774|NCT01279057|322850528|FG002|Overall Study|Other|0|||
94289775|NCT03502187|322850532|FG000|Overall Study|Withdrawal by Subject|4|||
94289776|NCT03502187|322850533|FG001|Overall Study|Withdrawal by Subject|3|||
94289777|NCT03502187|322850534|FG002|Overall Study|Withdrawal by Subject|3|||
94289778|NCT03502187|322850532|FG000|Overall Study|Lost to Follow-up|5|||
94289779|NCT03502187|322850533|FG001|Overall Study|Lost to Follow-up|4|||
94289780|NCT03502187|322850534|FG002|Overall Study|Lost to Follow-up|5|||
94289781|NCT00214461|322850535|FG000|Overall Study|Adverse Event|0|||
94289782|NCT00214461|322850536|FG001|Overall Study|Adverse Event|0|||
94289783|NCT00214461|322850537|FG002|Overall Study|Adverse Event|1|||
94289784|NCT00214461|322850538|FG003|Overall Study|Adverse Event|1|||
94289785|NCT00214461|322850535|FG000|Overall Study|Withdrawal by Subject|0|||
94289786|NCT00214461|322850536|FG001|Overall Study|Withdrawal by Subject|0|||
94289787|NCT00214461|322850537|FG002|Overall Study|Withdrawal by Subject|1|||
94289788|NCT00214461|322850538|FG003|Overall Study|Withdrawal by Subject|0|||
94289789|NCT01061008|322850539|FG000|Overall Study|Badiocephalic fistula failed|3|||
94289790|NCT01061008|322850540|FG001|Overall Study|Badiocephalic fistula failed|2|||
94289791|NCT01061008|322850539|FG000|Overall Study|Death|1|||
94289792|NCT01061008|322850540|FG001|Overall Study|Death|0|||
94289793|NCT01061008|322850539|FG000|Overall Study|Withdrawal by Subject|1|||
94289794|NCT01061008|322850540|FG001|Overall Study|Withdrawal by Subject|3|||
94289795|NCT01061008|322850539|FG000|Overall Study|Unable to exercise following surgery|1|||
94289796|NCT01061008|322850540|FG001|Overall Study|Unable to exercise following surgery|0|||
94289797|NCT01061008|322850539|FG000|Overall Study|Adverse Event|0|||
94289798|NCT01061008|322850540|FG001|Overall Study|Adverse Event|1|||
94289799|NCT02908100|322850541|FG000|Overall Study|Adverse Event|7|||
94289800|NCT02908100|322850542|FG001|Overall Study|Adverse Event|6|||
94289801|NCT02908100|322850543|FG002|Overall Study|Adverse Event|9|||
94289802|NCT02908100|322850541|FG000|Overall Study|Death|2|||
94289803|NCT02908100|322850542|FG001|Overall Study|Death|0|||
94289804|NCT02908100|322850543|FG002|Overall Study|Death|0|||
94289805|NCT02908100|322850541|FG000|Overall Study|Lack of Efficacy|2|||
94289806|NCT02908100|322850542|FG001|Overall Study|Lack of Efficacy|3|||
94289807|NCT02908100|322850543|FG002|Overall Study|Lack of Efficacy|3|||
94289808|NCT02908100|322850541|FG000|Overall Study|Lost to Follow-up|0|||
94289809|NCT02908100|322850542|FG001|Overall Study|Lost to Follow-up|1|||
94289810|NCT02908100|322850543|FG002|Overall Study|Lost to Follow-up|2|||
94289811|NCT02908100|322850541|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94289812|NCT02908100|322850542|FG001|Overall Study|Non-Compliance With Study Drug|1|||
94289813|NCT02908100|322850543|FG002|Overall Study|Non-Compliance With Study Drug|2|||
94289814|NCT02908100|322850541|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
94289815|NCT02908100|322850542|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
94289816|NCT02908100|322850543|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
94289817|NCT02908100|322850541|FG000|Overall Study|Physician Decision|0|||
94289818|NCT02908100|322850542|FG001|Overall Study|Physician Decision|1|||
94289819|NCT02908100|322850543|FG002|Overall Study|Physician Decision|0|||
94289820|NCT02908100|322850541|FG000|Overall Study|Pregnancy|1|||
94289821|NCT02908100|322850542|FG001|Overall Study|Pregnancy|2|||
94289822|NCT02908100|322850543|FG002|Overall Study|Pregnancy|0|||
94289823|NCT02908100|322850541|FG000|Overall Study|Withdrawal by Subject|8|||
94289824|NCT02908100|322850542|FG001|Overall Study|Withdrawal by Subject|7|||
94289825|NCT02908100|322850543|FG002|Overall Study|Withdrawal by Subject|5|||
94289826|NCT02908100|322850541|FG000|Overall Study|Randomised in Error|1|||
94289827|NCT02908100|322850542|FG001|Overall Study|Randomised in Error|0|||
94289828|NCT02908100|322850543|FG002|Overall Study|Randomised in Error|0|||
94289829|NCT02024971|322850544|FG000|Overall Study|Data Not Available|30|||
94289830|NCT02024971|322850544|FG000|Overall Study|Lost to Follow-up|6|||
94289831|NCT00648167|322850547|FG000|Overall Study|Adverse Event|6|||
94289832|NCT00648167|322850547|FG000|Overall Study|unable to swallow tablets|1|||
94289833|NCT01688050|322850548|FG000|Overall Study|Death|7|||
94289834|NCT01688050|322850548|FG000|Overall Study|Conversion to open repair|1|||
94289835|NCT01688050|322850548|FG000|Overall Study|Lost to Follow-up|13|||
94289836|NCT01688050|322850548|FG000|Overall Study|Withdrawal by Subject|10|||
94289837|NCT02624492|322850549|FG000|Overall Study|Adverse Event|2|||
94289838|NCT02624492|322850550|FG001|Overall Study|Adverse Event|2|||
94289839|NCT02624492|322850551|FG002|Overall Study|Adverse Event|2|||
94289840|NCT02624492|322850549|FG000|Overall Study|Progressive disease|0|||
94289841|NCT02624492|322850550|FG001|Overall Study|Progressive disease|2|||
94289842|NCT02624492|322850551|FG002|Overall Study|Progressive disease|3|||
94289843|NCT00364689|322850552|FG000|Overall Study|Lost to Follow-up|1|||
94289844|NCT02167945|322850560|FG000|Overall Study|Adverse Event|16|||
94289845|NCT02167945|322850560|FG000|Overall Study|Withdrew Consent|42|||
94289846|NCT02167945|322850560|FG000|Overall Study|Lost to Follow-up|122|||
94289847|NCT02167945|322850560|FG000|Overall Study|COVID-19 logistical restrictions|6|||
94289848|NCT02167945|322850560|FG000|Overall Study|Other, not specified|63|||
94289849|NCT01554579|322850561|FG000|Overall Study|Adverse Event|6|||
94289850|NCT01554579|322850562|FG001|Overall Study|Adverse Event|25|||
94289851|NCT01554579|322850561|FG000|Overall Study|Lack of Efficacy|2|||
94289852|NCT01554579|322850562|FG001|Overall Study|Lack of Efficacy|1|||
94289853|NCT01554579|322850561|FG000|Overall Study|Withdrawal by Subject|2|||
94289854|NCT01554579|322850562|FG001|Overall Study|Withdrawal by Subject|1|||
94289855|NCT01192347|322850563|FG000|Overall Study|Death|3|||
94289856|NCT01192347|322850563|FG000|Overall Study|Lost to Follow-up|3|||
94289857|NCT01192347|322850563|FG000|Overall Study|Withdrawal by Subject|1|||
94289858|NCT01192347|322850563|FG000|Overall Study|Adverse Event|1|||
94289859|NCT01192347|322850563|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
94289860|NCT01192347|322850563|FG000|Overall Study|Patient seen in different hospital|1|||
94289861|NCT01192347|322850563|FG000|Overall Study|Patient not visiting hospital regularly|1|||
94289862|NCT01192347|322850563|FG000|Overall Study|Patient did not show up for visits|1|||
94289863|NCT03072160|322850564|FG000|Overall Study|Adverse Event|3|||
94289864|NCT03072160|322850565|FG001|Overall Study|Adverse Event|1|||
94289865|NCT03072160|322850564|FG000|Overall Study|Refused further treatment|6|||
94289866|NCT03072160|322850565|FG001|Overall Study|Refused further treatment|1|||
94289867|NCT03072160|322850564|FG000|Overall Study|Physician Decision|1|||
94289868|NCT03072160|322850565|FG001|Overall Study|Physician Decision|0|||
94289869|NCT03072160|322850564|FG000|Overall Study|Disease progression on study|1|||
94289870|NCT03072160|322850565|FG001|Overall Study|Disease progression on study|1|||
94289871|NCT03072160|322850564|FG000|Overall Study|No contact|0|||
94289872|NCT03072160|322850565|FG001|Overall Study|No contact|1|||
94289873|NCT00395967|322850567|FG000|Treatment Period|Failed Mobilization|1|||
94289874|NCT00395967|322850567|FG000|Follow-up Period|Death|1|||
94289875|NCT00395967|322850567|FG000|Follow-up Period|Lost to Follow-up|1|||
94289876|NCT03118947|322850568|FG000|Overall Study|Adverse Event|7|||
94289877|NCT03118947|322850568|FG000|Overall Study|Death|3|||
94289878|NCT03118947|322850568|FG000|Overall Study|Lack of Efficacy|4|||
94289879|NCT03118947|322850568|FG000|Overall Study|Non-compliance with study drug|1|||
94289880|NCT03118947|322850568|FG000|Overall Study|Protocol Violation|2|||
94289881|NCT03118947|322850568|FG000|Overall Study|Withdrawal by Subject|3|||
94289882|NCT03118947|322850568|FG000|Overall Study|Withdrawal by caregiver|3|||
94289883|NCT03118947|322850568|FG000|Overall Study|Change in patient's living situation|4|||
94289884|NCT03118947|322850568|FG000|Overall Study|Lost to Follow-up|2|||
94289885|NCT00179959|322850569|FG000|Overall Study|Lost to Follow-up|3|||
94289886|NCT00179959|322850570|FG001|Overall Study|Lost to Follow-up|1|||
94289887|NCT00179959|322850569|FG000|Overall Study|Withdrawal by Subject|3|||
94289888|NCT00179959|322850570|FG001|Overall Study|Withdrawal by Subject|2|||
94289889|NCT01262976|322850571|FG000|Up to Month 2|Serious Adverse Event|0|||
94289890|NCT01262976|322850572|FG001|Up to Month 2|Serious Adverse Event|0|||
94289891|NCT01262976|322850573|FG002|Up to Month 2|Serious Adverse Event|1|||
94289892|NCT01262976|322850574|FG003|Up to Month 2|Serious Adverse Event|0|||
94289893|NCT01262976|322850575|FG004|Up to Month 2|Serious Adverse Event|0|||
94289894|NCT01262976|322850576|FG005|Up to Month 2|Serious Adverse Event|0|||
94289895|NCT01262976|322850571|FG000|Up to Month 2|Withdrawal by Subject|1|||
94289896|NCT01262976|322850572|FG001|Up to Month 2|Withdrawal by Subject|0|||
94289897|NCT01262976|322850573|FG002|Up to Month 2|Withdrawal by Subject|0|||
94289898|NCT01262976|322850574|FG003|Up to Month 2|Withdrawal by Subject|0|||
94289899|NCT01262976|322850575|FG004|Up to Month 2|Withdrawal by Subject|0|||
94289900|NCT01262976|322850576|FG005|Up to Month 2|Withdrawal by Subject|0|||
94289901|NCT01262976|322850571|FG000|Up to Month 2|Migrated/moved from study area|0|||
94289902|NCT01262976|322850572|FG001|Up to Month 2|Migrated/moved from study area|1|||
94289903|NCT01262976|322850573|FG002|Up to Month 2|Migrated/moved from study area|0|||
94289904|NCT01262976|322850574|FG003|Up to Month 2|Migrated/moved from study area|0|||
94289905|NCT01262976|322850575|FG004|Up to Month 2|Migrated/moved from study area|1|||
94289906|NCT01262976|322850576|FG005|Up to Month 2|Migrated/moved from study area|1|||
94289907|NCT01262976|322850571|FG000|Up to Month 2|Lost to Follow-up|1|||
94289908|NCT01262976|322850572|FG001|Up to Month 2|Lost to Follow-up|0|||
94289909|NCT01262976|322850573|FG002|Up to Month 2|Lost to Follow-up|0|||
94289910|NCT01262976|322850574|FG003|Up to Month 2|Lost to Follow-up|1|||
94289911|NCT01262976|322850575|FG004|Up to Month 2|Lost to Follow-up|1|||
94289912|NCT01262976|322850576|FG005|Up to Month 2|Lost to Follow-up|1|||
94289913|NCT01262976|322850571|FG000|Up to Month 2|Other|1|||
94289914|NCT01262976|322850572|FG001|Up to Month 2|Other|0|||
94289915|NCT01262976|322850573|FG002|Up to Month 2|Other|0|||
94289916|NCT01262976|322850574|FG003|Up to Month 2|Other|1|||
94289917|NCT01262976|322850575|FG004|Up to Month 2|Other|0|||
94289918|NCT01262976|322850576|FG005|Up to Month 2|Other|2|||
94289919|NCT01262976|322850571|FG000|Up to Month 7|Serious Adverse Event|0|||
94289920|NCT01262976|322850572|FG001|Up to Month 7|Serious Adverse Event|0|||
94289921|NCT01262976|322850573|FG002|Up to Month 7|Serious Adverse Event|2|||
94289922|NCT01262976|322850574|FG003|Up to Month 7|Serious Adverse Event|0|||
94289923|NCT01262976|322850575|FG004|Up to Month 7|Serious Adverse Event|0|||
94289924|NCT01262976|322850576|FG005|Up to Month 7|Serious Adverse Event|0|||
94289925|NCT01262976|322850571|FG000|Up to Month 7|Withdrawal by Subject|1|||
94289926|NCT01262976|322850572|FG001|Up to Month 7|Withdrawal by Subject|0|||
94289927|NCT01262976|322850573|FG002|Up to Month 7|Withdrawal by Subject|0|||
94289928|NCT01262976|322850574|FG003|Up to Month 7|Withdrawal by Subject|0|||
94289929|NCT01262976|322850575|FG004|Up to Month 7|Withdrawal by Subject|0|||
94289930|NCT01262976|322850576|FG005|Up to Month 7|Withdrawal by Subject|0|||
94289931|NCT01262976|322850571|FG000|Up to Month 7|Migrated/moved from study area|0|||
94289932|NCT01262976|322850572|FG001|Up to Month 7|Migrated/moved from study area|0|||
94289933|NCT01262976|322850573|FG002|Up to Month 7|Migrated/moved from study area|1|||
94289934|NCT01262976|322850574|FG003|Up to Month 7|Migrated/moved from study area|3|||
94289935|NCT01262976|322850575|FG004|Up to Month 7|Migrated/moved from study area|1|||
94289936|NCT01262976|322850576|FG005|Up to Month 7|Migrated/moved from study area|1|||
94289937|NCT01262976|322850571|FG000|Up to Month 7|Lost to Follow-up|1|||
94289938|NCT01262976|322850572|FG001|Up to Month 7|Lost to Follow-up|0|||
94289939|NCT01262976|322850573|FG002|Up to Month 7|Lost to Follow-up|1|||
94289940|NCT01262976|322850574|FG003|Up to Month 7|Lost to Follow-up|3|||
94289941|NCT01262976|322850575|FG004|Up to Month 7|Lost to Follow-up|1|||
94289942|NCT01262976|322850576|FG005|Up to Month 7|Lost to Follow-up|3|||
94289943|NCT01262976|322850571|FG000|Up to Month 7|Other|3|||
94289944|NCT01262976|322850572|FG001|Up to Month 7|Other|0|||
94289945|NCT01262976|322850573|FG002|Up to Month 7|Other|2|||
94289946|NCT01262976|322850574|FG003|Up to Month 7|Other|0|||
94289947|NCT01262976|322850575|FG004|Up to Month 7|Other|0|||
94289948|NCT01262976|322850576|FG005|Up to Month 7|Other|0|||
94289949|NCT01262976|322850571|FG000|Up to Year 1|Serious Adverse Event|0|||
94289950|NCT01262976|322850572|FG001|Up to Year 1|Serious Adverse Event|0|||
94289951|NCT01262976|322850573|FG002|Up to Year 1|Serious Adverse Event|2|||
94289952|NCT01262976|322850574|FG003|Up to Year 1|Serious Adverse Event|0|||
94289953|NCT01262976|322850575|FG004|Up to Year 1|Serious Adverse Event|0|||
94289954|NCT01262976|322850576|FG005|Up to Year 1|Serious Adverse Event|0|||
94289955|NCT01262976|322850571|FG000|Up to Year 1|Withdrawal by Subject|1|||
94289956|NCT01262976|322850572|FG001|Up to Year 1|Withdrawal by Subject|0|||
94289957|NCT01262976|322850573|FG002|Up to Year 1|Withdrawal by Subject|0|||
94289958|NCT01262976|322850574|FG003|Up to Year 1|Withdrawal by Subject|0|||
94289959|NCT01262976|322850575|FG004|Up to Year 1|Withdrawal by Subject|0|||
94289960|NCT01262976|322850576|FG005|Up to Year 1|Withdrawal by Subject|0|||
94289961|NCT01262976|322850571|FG000|Up to Year 1|Migrated/moved from study area|1|||
94289962|NCT01262976|322850572|FG001|Up to Year 1|Migrated/moved from study area|0|||
94289963|NCT01262976|322850573|FG002|Up to Year 1|Migrated/moved from study area|0|||
94289964|NCT01262976|322850574|FG003|Up to Year 1|Migrated/moved from study area|3|||
94289965|NCT01262976|322850575|FG004|Up to Year 1|Migrated/moved from study area|3|||
94289966|NCT01262976|322850576|FG005|Up to Year 1|Migrated/moved from study area|2|||
94289967|NCT01262976|322850571|FG000|Up to Year 1|Lost to Follow-up|4|||
94289968|NCT01262976|322850572|FG001|Up to Year 1|Lost to Follow-up|0|||
94289969|NCT01262976|322850573|FG002|Up to Year 1|Lost to Follow-up|0|||
94289970|NCT01262976|322850574|FG003|Up to Year 1|Lost to Follow-up|1|||
94289971|NCT01262976|322850575|FG004|Up to Year 1|Lost to Follow-up|6|||
94289972|NCT01262976|322850576|FG005|Up to Year 1|Lost to Follow-up|5|||
94289973|NCT01262976|322850571|FG000|Up to Year 1|Other|3|||
94289974|NCT01262976|322850572|FG001|Up to Year 1|Other|1|||
94289975|NCT01262976|322850573|FG002|Up to Year 1|Other|0|||
94289976|NCT01262976|322850574|FG003|Up to Year 1|Other|0|||
94289977|NCT01262976|322850575|FG004|Up to Year 1|Other|2|||
94289978|NCT01262976|322850576|FG005|Up to Year 1|Other|1|||
94289979|NCT01262976|322850571|FG000|Up to Year 1|Subjects with unknown completion status|0|||
94289980|NCT01262976|322850572|FG001|Up to Year 1|Subjects with unknown completion status|0|||
94289981|NCT01262976|322850573|FG002|Up to Year 1|Subjects with unknown completion status|1|||
94289982|NCT01262976|322850574|FG003|Up to Year 1|Subjects with unknown completion status|0|||
94289983|NCT01262976|322850575|FG004|Up to Year 1|Subjects with unknown completion status|0|||
94289984|NCT01262976|322850576|FG005|Up to Year 1|Subjects with unknown completion status|1|||
94289985|NCT01262976|322850571|FG000|Up to Year 2|Serious Adverse Event|0|||
94289986|NCT01262976|322850572|FG001|Up to Year 2|Serious Adverse Event|0|||
94289987|NCT01262976|322850573|FG002|Up to Year 2|Serious Adverse Event|2|||
94289988|NCT01262976|322850574|FG003|Up to Year 2|Serious Adverse Event|0|||
94289989|NCT01262976|322850575|FG004|Up to Year 2|Serious Adverse Event|0|||
94289990|NCT01262976|322850576|FG005|Up to Year 2|Serious Adverse Event|0|||
94289991|NCT01262976|322850571|FG000|Up to Year 2|Withdrawal by Subject|1|||
94289992|NCT01262976|322850572|FG001|Up to Year 2|Withdrawal by Subject|0|||
94289993|NCT01262976|322850573|FG002|Up to Year 2|Withdrawal by Subject|0|||
94289994|NCT01262976|322850574|FG003|Up to Year 2|Withdrawal by Subject|0|||
94289995|NCT01262976|322850575|FG004|Up to Year 2|Withdrawal by Subject|0|||
94289996|NCT01262976|322850576|FG005|Up to Year 2|Withdrawal by Subject|0|||
94289997|NCT01262976|322850571|FG000|Up to Year 2|Migrated/moved from study area|0|||
94289998|NCT01262976|322850572|FG001|Up to Year 2|Migrated/moved from study area|0|||
94289999|NCT01262976|322850573|FG002|Up to Year 2|Migrated/moved from study area|0|||
94290000|NCT01262976|322850574|FG003|Up to Year 2|Migrated/moved from study area|2|||
94290001|NCT01262976|322850575|FG004|Up to Year 2|Migrated/moved from study area|1|||
94290002|NCT01262976|322850576|FG005|Up to Year 2|Migrated/moved from study area|2|||
94290003|NCT01262976|322850571|FG000|Up to Year 2|Lost to Follow-up|1|||
94290004|NCT01262976|322850572|FG001|Up to Year 2|Lost to Follow-up|1|||
94290005|NCT01262976|322850573|FG002|Up to Year 2|Lost to Follow-up|2|||
94290006|NCT01262976|322850574|FG003|Up to Year 2|Lost to Follow-up|2|||
94290007|NCT01262976|322850575|FG004|Up to Year 2|Lost to Follow-up|3|||
94290008|NCT01262976|322850576|FG005|Up to Year 2|Lost to Follow-up|3|||
94290009|NCT01262976|322850571|FG000|Up to Year 2|Subjects with unknown completion status|0|||
94290010|NCT01262976|322850572|FG001|Up to Year 2|Subjects with unknown completion status|0|||
94290011|NCT01262976|322850573|FG002|Up to Year 2|Subjects with unknown completion status|1|||
94290012|NCT01262976|322850574|FG003|Up to Year 2|Subjects with unknown completion status|0|||
94290013|NCT01262976|322850575|FG004|Up to Year 2|Subjects with unknown completion status|0|||
94290014|NCT01262976|322850576|FG005|Up to Year 2|Subjects with unknown completion status|0|||
94290015|NCT01262976|322850571|FG000|Up to Year 2|Other|3|||
94290016|NCT01262976|322850572|FG001|Up to Year 2|Other|0|||
94290017|NCT01262976|322850573|FG002|Up to Year 2|Other|0|||
94290018|NCT01262976|322850574|FG003|Up to Year 2|Other|0|||
94290019|NCT01262976|322850575|FG004|Up to Year 2|Other|0|||
94290020|NCT01262976|322850576|FG005|Up to Year 2|Other|0|||
94290021|NCT01262976|322850571|FG000|Up to Year 3|Serious Adverse Event|0|||
94290022|NCT01262976|322850572|FG001|Up to Year 3|Serious Adverse Event|0|||
94290023|NCT01262976|322850573|FG002|Up to Year 3|Serious Adverse Event|2|||
94290024|NCT01262976|322850574|FG003|Up to Year 3|Serious Adverse Event|0|||
94290025|NCT01262976|322850575|FG004|Up to Year 3|Serious Adverse Event|0|||
94290026|NCT01262976|322850576|FG005|Up to Year 3|Serious Adverse Event|0|||
94290027|NCT01262976|322850571|FG000|Up to Year 3|Withdrawal by Subject|1|||
94290028|NCT01262976|322850572|FG001|Up to Year 3|Withdrawal by Subject|0|||
94290029|NCT01262976|322850573|FG002|Up to Year 3|Withdrawal by Subject|0|||
94290030|NCT01262976|322850574|FG003|Up to Year 3|Withdrawal by Subject|0|||
94290031|NCT01262976|322850575|FG004|Up to Year 3|Withdrawal by Subject|0|||
94290032|NCT01262976|322850576|FG005|Up to Year 3|Withdrawal by Subject|0|||
94290033|NCT01262976|322850571|FG000|Up to Year 3|Migrated/moved from study area|0|||
94372527|NCT01571635|323150282|FG003|Overall Study|Study terminated by sponsor|3|||
94290034|NCT01262976|322850572|FG001|Up to Year 3|Migrated/moved from study area|0|||
94290035|NCT01262976|322850573|FG002|Up to Year 3|Migrated/moved from study area|0|||
94290036|NCT01262976|322850574|FG003|Up to Year 3|Migrated/moved from study area|2|||
94290037|NCT01262976|322850575|FG004|Up to Year 3|Migrated/moved from study area|1|||
94290038|NCT01262976|322850576|FG005|Up to Year 3|Migrated/moved from study area|1|||
94290039|NCT01262976|322850571|FG000|Up to Year 3|Lost to Follow-up|2|||
94290040|NCT01262976|322850572|FG001|Up to Year 3|Lost to Follow-up|2|||
94290041|NCT01262976|322850573|FG002|Up to Year 3|Lost to Follow-up|4|||
94290042|NCT01262976|322850574|FG003|Up to Year 3|Lost to Follow-up|3|||
94290043|NCT01262976|322850575|FG004|Up to Year 3|Lost to Follow-up|1|||
94290044|NCT01262976|322850576|FG005|Up to Year 3|Lost to Follow-up|3|||
94290045|NCT01262976|322850571|FG000|Up to Year 3|Subjects with unknown completion status|0|||
94290046|NCT01262976|322850572|FG001|Up to Year 3|Subjects with unknown completion status|0|||
94290047|NCT01262976|322850573|FG002|Up to Year 3|Subjects with unknown completion status|1|||
94290048|NCT01262976|322850574|FG003|Up to Year 3|Subjects with unknown completion status|0|||
94290049|NCT01262976|322850575|FG004|Up to Year 3|Subjects with unknown completion status|0|||
94290050|NCT01262976|322850576|FG005|Up to Year 3|Subjects with unknown completion status|0|||
94290051|NCT01262976|322850571|FG000|Up to Year 3|Other|3|||
94290052|NCT01262976|322850572|FG001|Up to Year 3|Other|0|||
94290053|NCT01262976|322850573|FG002|Up to Year 3|Other|0|||
94290054|NCT01262976|322850574|FG003|Up to Year 3|Other|0|||
94290055|NCT01262976|322850575|FG004|Up to Year 3|Other|0|||
94290056|NCT01262976|322850576|FG005|Up to Year 3|Other|0|||
94290057|NCT00189462|322850586|FG000|Overall Study|Lack of Efficacy|5|||
94290058|NCT00189462|322850587|FG001|Overall Study|Lack of Efficacy|1|||
94290059|NCT00189462|322850586|FG000|Overall Study|Lost to Follow-up|18|||
94290060|NCT00189462|322850587|FG001|Overall Study|Lost to Follow-up|20|||
94290061|NCT01869348|322850588|FG000|Overall Study|Withdrawal by Subject|1|||
94290062|NCT01869348|322850589|FG001|Overall Study|Withdrawal by Subject|1|||
94290063|NCT02789657|322850590|FG000|Overall Study|Withdrawal by Subject|2|||
94290064|NCT02789657|322850591|FG001|Overall Study|Withdrawal by Subject|0|||
94290065|NCT02789657|322850592|FG002|Overall Study|Withdrawal by Subject|0|||
94290066|NCT02789657|322850593|FG003|Overall Study|Withdrawal by Subject|0|||
94290067|NCT03075163|322850594|FG000|Overall Study|not eligible for treatment limb|138|||
94290068|NCT03075163|322850595|FG001|Overall Study|not eligible for treatment limb|138|||
94290069|NCT00236080|322850596|FG000|Overall Study|Adverse Event|0|||
94290070|NCT00236080|322850597|FG001|Overall Study|Adverse Event|0|||
94290071|NCT00236080|322850598|FG002|Overall Study|Adverse Event|3|||
94290072|NCT00236080|322850599|FG003|Overall Study|Adverse Event|1|||
94290073|NCT00236080|322850600|FG004|Overall Study|Adverse Event|0|||
94290074|NCT00236080|322850596|FG000|Overall Study|Lost to Follow-up|0|||
94290075|NCT00236080|322850597|FG001|Overall Study|Lost to Follow-up|1|||
94290076|NCT00236080|322850598|FG002|Overall Study|Lost to Follow-up|0|||
94290077|NCT00236080|322850599|FG003|Overall Study|Lost to Follow-up|0|||
94290078|NCT00236080|322850600|FG004|Overall Study|Lost to Follow-up|0|||
94290079|NCT00236080|322850596|FG000|Overall Study|Physician Decision|1|||
94290080|NCT00236080|322850597|FG001|Overall Study|Physician Decision|0|||
94290081|NCT00236080|322850598|FG002|Overall Study|Physician Decision|1|||
94290082|NCT00236080|322850599|FG003|Overall Study|Physician Decision|1|||
94290083|NCT00236080|322850600|FG004|Overall Study|Physician Decision|1|||
94290084|NCT00236080|322850596|FG000|Overall Study|Withdrawal by Subject|1|||
94290085|NCT00236080|322850597|FG001|Overall Study|Withdrawal by Subject|0|||
94290086|NCT00236080|322850598|FG002|Overall Study|Withdrawal by Subject|0|||
94290087|NCT00236080|322850599|FG003|Overall Study|Withdrawal by Subject|0|||
94290088|NCT00236080|322850600|FG004|Overall Study|Withdrawal by Subject|0|||
94290089|NCT00236080|322850596|FG000|Overall Study|Miscellaneous|0|||
94290090|NCT00236080|322850597|FG001|Overall Study|Miscellaneous|0|||
94290091|NCT00236080|322850598|FG002|Overall Study|Miscellaneous|1|||
94290092|NCT00236080|322850599|FG003|Overall Study|Miscellaneous|0|||
94290093|NCT00236080|322850600|FG004|Overall Study|Miscellaneous|0|||
94290094|NCT01214044|322850601|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
94290095|NCT01214044|322850601|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
94290096|NCT01214044|322850601|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
94290097|NCT01214044|322850601|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
94290098|NCT01214044|322850601|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
94290099|NCT01214044|322850601|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
94290100|NCT00944034|322850602|FG000|Overall Study|Inappropriate enrollment|0|||
94290101|NCT00944034|322850603|FG001|Overall Study|Inappropriate enrollment|1|||
94290102|NCT00944034|322850604|FG002|Overall Study|Inappropriate enrollment|0|||
94290103|NCT00944034|322850605|FG003|Overall Study|Inappropriate enrollment|1|||
94290104|NCT00944034|322850606|FG004|Overall Study|Inappropriate enrollment|2|||
94290105|NCT00944034|322850607|FG005|Overall Study|Inappropriate enrollment|1|||
94290106|NCT00944034|322850608|FG006|Overall Study|Inappropriate enrollment|0|||
94290107|NCT00944034|322850609|FG007|Overall Study|Inappropriate enrollment|0|||
94290108|NCT00944034|322850610|FG008|Overall Study|Inappropriate enrollment|1|||
94290109|NCT00944034|322850611|FG009|Overall Study|Inappropriate enrollment|1|||
94290110|NCT00944034|322850612|FG010|Overall Study|Inappropriate enrollment|0|||
94290111|NCT00944034|322850613|FG011|Overall Study|Inappropriate enrollment|0|||
94290112|NCT00944034|322850602|FG000|Overall Study|Withdrawal by Subject|3|||
94290113|NCT00944034|322850603|FG001|Overall Study|Withdrawal by Subject|2|||
94290114|NCT00944034|322850604|FG002|Overall Study|Withdrawal by Subject|6|||
94290115|NCT00944034|322850605|FG003|Overall Study|Withdrawal by Subject|2|||
94290116|NCT00944034|322850606|FG004|Overall Study|Withdrawal by Subject|5|||
94290117|NCT00944034|322850607|FG005|Overall Study|Withdrawal by Subject|8|||
94290118|NCT00944034|322850608|FG006|Overall Study|Withdrawal by Subject|2|||
94290119|NCT00944034|322850609|FG007|Overall Study|Withdrawal by Subject|2|||
94290120|NCT00944034|322850610|FG008|Overall Study|Withdrawal by Subject|3|||
94290121|NCT00944034|322850611|FG009|Overall Study|Withdrawal by Subject|4|||
94290122|NCT00944034|322850612|FG010|Overall Study|Withdrawal by Subject|0|||
94290123|NCT00944034|322850613|FG011|Overall Study|Withdrawal by Subject|4|||
94290124|NCT00944034|322850602|FG000|Overall Study|Lost to Follow-up|0|||
94290125|NCT00944034|322850603|FG001|Overall Study|Lost to Follow-up|4|||
94290126|NCT00944034|322850604|FG002|Overall Study|Lost to Follow-up|2|||
94290127|NCT00944034|322850605|FG003|Overall Study|Lost to Follow-up|0|||
94290128|NCT00944034|322850606|FG004|Overall Study|Lost to Follow-up|5|||
94290129|NCT00944034|322850607|FG005|Overall Study|Lost to Follow-up|7|||
94290130|NCT00944034|322850608|FG006|Overall Study|Lost to Follow-up|0|||
94290131|NCT00944034|322850609|FG007|Overall Study|Lost to Follow-up|1|||
94290132|NCT00944034|322850610|FG008|Overall Study|Lost to Follow-up|5|||
94290133|NCT00944034|322850611|FG009|Overall Study|Lost to Follow-up|1|||
94290134|NCT00944034|322850612|FG010|Overall Study|Lost to Follow-up|1|||
94290135|NCT00944034|322850613|FG011|Overall Study|Lost to Follow-up|0|||
94290136|NCT00944034|322850602|FG000|Overall Study|Death|0|||
94290137|NCT00944034|322850603|FG001|Overall Study|Death|0|||
94290138|NCT00944034|322850604|FG002|Overall Study|Death|1|||
94290139|NCT00944034|322850605|FG003|Overall Study|Death|0|||
94290140|NCT00944034|322850606|FG004|Overall Study|Death|0|||
94290141|NCT00944034|322850607|FG005|Overall Study|Death|0|||
94290142|NCT00944034|322850608|FG006|Overall Study|Death|0|||
94290143|NCT00944034|322850609|FG007|Overall Study|Death|0|||
94290144|NCT00944034|322850610|FG008|Overall Study|Death|0|||
94290145|NCT00944034|322850611|FG009|Overall Study|Death|0|||
94290146|NCT00944034|322850612|FG010|Overall Study|Death|0|||
94290147|NCT00944034|322850613|FG011|Overall Study|Death|0|||
94290148|NCT00944034|322850602|FG000|Overall Study|Protocol Violation|2|||
94290149|NCT00944034|322850603|FG001|Overall Study|Protocol Violation|0|||
94290150|NCT00944034|322850604|FG002|Overall Study|Protocol Violation|0|||
94290151|NCT00944034|322850605|FG003|Overall Study|Protocol Violation|1|||
94290152|NCT00944034|322850606|FG004|Overall Study|Protocol Violation|2|||
94290153|NCT00944034|322850607|FG005|Overall Study|Protocol Violation|3|||
94290154|NCT00944034|322850608|FG006|Overall Study|Protocol Violation|0|||
94290155|NCT00944034|322850609|FG007|Overall Study|Protocol Violation|1|||
94290156|NCT00944034|322850610|FG008|Overall Study|Protocol Violation|1|||
94290157|NCT00944034|322850611|FG009|Overall Study|Protocol Violation|4|||
94290158|NCT00944034|322850612|FG010|Overall Study|Protocol Violation|0|||
94290159|NCT00944034|322850613|FG011|Overall Study|Protocol Violation|0|||
94290160|NCT00944034|322850602|FG000|Overall Study|Unable to classify|0|||
94290161|NCT00944034|322850603|FG001|Overall Study|Unable to classify|0|||
94290162|NCT00944034|322850604|FG002|Overall Study|Unable to classify|0|||
94290163|NCT00944034|322850605|FG003|Overall Study|Unable to classify|0|||
94290164|NCT00944034|322850606|FG004|Overall Study|Unable to classify|0|||
94290165|NCT00944034|322850607|FG005|Overall Study|Unable to classify|1|||
94290166|NCT00944034|322850608|FG006|Overall Study|Unable to classify|1|||
94290167|NCT00944034|322850609|FG007|Overall Study|Unable to classify|1|||
94290168|NCT00944034|322850610|FG008|Overall Study|Unable to classify|0|||
94290169|NCT00944034|322850611|FG009|Overall Study|Unable to classify|0|||
94290170|NCT00944034|322850612|FG010|Overall Study|Unable to classify|0|||
94290171|NCT00944034|322850613|FG011|Overall Study|Unable to classify|0|||
94290172|NCT00944034|322850602|FG000|Overall Study|Administrative reason|0|||
94290173|NCT00944034|322850603|FG001|Overall Study|Administrative reason|0|||
94290174|NCT00944034|322850604|FG002|Overall Study|Administrative reason|0|||
94290175|NCT00944034|322850605|FG003|Overall Study|Administrative reason|0|||
94290176|NCT00944034|322850606|FG004|Overall Study|Administrative reason|0|||
94290177|NCT00944034|322850607|FG005|Overall Study|Administrative reason|0|||
94290178|NCT00944034|322850608|FG006|Overall Study|Administrative reason|1|||
94290179|NCT00944034|322850609|FG007|Overall Study|Administrative reason|0|||
94290180|NCT00944034|322850610|FG008|Overall Study|Administrative reason|0|||
94290181|NCT00944034|322850611|FG009|Overall Study|Administrative reason|0|||
94290182|NCT00944034|322850612|FG010|Overall Study|Administrative reason|0|||
94290183|NCT00944034|322850613|FG011|Overall Study|Administrative reason|0|||
94290184|NCT02388295|322850621|FG000|Dose Escalation Week 1|Adverse Event|1|||
94290185|NCT02388295|322850622|FG001|Dose Escalation Week 1|Adverse Event|2|||
94290186|NCT02388295|322850623|FG002|Dose Escalation Week 1|Adverse Event|1|||
94290187|NCT02388295|322850621|FG000|Dose Escalation Week 1|Determined not eligible|1|||
94290188|NCT02388295|322850622|FG001|Dose Escalation Week 1|Determined not eligible|1|||
94290189|NCT02388295|322850623|FG002|Dose Escalation Week 1|Determined not eligible|1|||
94290190|NCT02388295|322850621|FG000|Dose Escalation Week 2|Protocol Violation|0|||
94290191|NCT02388295|322850622|FG001|Dose Escalation Week 2|Protocol Violation|1|||
94290192|NCT02388295|322850623|FG002|Dose Escalation Week 2|Protocol Violation|0|||
94290193|NCT02388295|322850621|FG000|Dose Escalation Week 2|Determined not eligible|1|||
94290194|NCT02388295|322850622|FG001|Dose Escalation Week 2|Determined not eligible|1|||
94290195|NCT02388295|322850623|FG002|Dose Escalation Week 2|Determined not eligible|1|||
94290196|NCT02388295|322850621|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
94290197|NCT02388295|322850622|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
94290198|NCT02388295|322850623|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
94290199|NCT03603652|322850627|FG000|Overall Study|Death|2|||
94290200|NCT03213366|322850632|FG000|Overall Study|Lost to Follow-up|9|||
94290201|NCT03213366|322850633|FG001|Overall Study|Lost to Follow-up|4|||
94290202|NCT04134494|322850634|FG000|Overall Study|Lost to Follow-up|2|||
94290203|NCT00666926|322850635|FG000|Overall Study|Adverse Event|0|||
94290204|NCT00666926|322850636|FG001|Overall Study|Adverse Event|0|||
94290205|NCT00666926|322850637|FG002|Overall Study|Adverse Event|0|||
94290206|NCT00666926|322850638|FG003|Overall Study|Adverse Event|0|||
94290207|NCT00666926|322850639|FG004|Overall Study|Adverse Event|0|||
94290208|NCT00666926|322850640|FG005|Overall Study|Adverse Event|0|||
94290209|NCT00666926|322850641|FG006|Overall Study|Adverse Event|0|||
94290210|NCT00666926|322850642|FG007|Overall Study|Adverse Event|0|||
94290211|NCT00666926|322850643|FG008|Overall Study|Adverse Event|0|||
94290212|NCT00666926|322850644|FG009|Overall Study|Adverse Event|2|||
94290213|NCT00666926|322850645|FG010|Overall Study|Adverse Event|2|||
94290214|NCT00666926|322850646|FG011|Overall Study|Adverse Event|2|||
94290215|NCT00666926|322850647|FG012|Overall Study|Adverse Event|0|||
94290216|NCT00666926|322850648|FG013|Overall Study|Adverse Event|1|||
94290217|NCT00666926|322850649|FG014|Overall Study|Adverse Event|0|||
94290218|NCT00666926|322850650|FG015|Overall Study|Adverse Event|0|||
94290219|NCT00666926|322850635|FG000|Overall Study|Laboratory abnormality|0|||
94290220|NCT00666926|322850636|FG001|Overall Study|Laboratory abnormality|0|||
94290221|NCT00666926|322850637|FG002|Overall Study|Laboratory abnormality|0|||
94290222|NCT00666926|322850638|FG003|Overall Study|Laboratory abnormality|0|||
94290223|NCT00666926|322850639|FG004|Overall Study|Laboratory abnormality|0|||
94290224|NCT00666926|322850640|FG005|Overall Study|Laboratory abnormality|0|||
94290225|NCT00666926|322850641|FG006|Overall Study|Laboratory abnormality|0|||
94290226|NCT00666926|322850642|FG007|Overall Study|Laboratory abnormality|0|||
94290227|NCT00666926|322850643|FG008|Overall Study|Laboratory abnormality|0|||
94290228|NCT00666926|322850644|FG009|Overall Study|Laboratory abnormality|0|||
94290229|NCT00666926|322850645|FG010|Overall Study|Laboratory abnormality|1|||
94290230|NCT00666926|322850646|FG011|Overall Study|Laboratory abnormality|0|||
94290231|NCT00666926|322850647|FG012|Overall Study|Laboratory abnormality|0|||
94290232|NCT00666926|322850648|FG013|Overall Study|Laboratory abnormality|0|||
94290233|NCT00666926|322850649|FG014|Overall Study|Laboratory abnormality|0|||
94290234|NCT00666926|322850650|FG015|Overall Study|Laboratory abnormality|1|||
94290235|NCT00666926|322850635|FG000|Overall Study|Lack of Efficacy|0|||
94290236|NCT00666926|322850636|FG001|Overall Study|Lack of Efficacy|0|||
94290237|NCT00666926|322850637|FG002|Overall Study|Lack of Efficacy|0|||
94290238|NCT00666926|322850638|FG003|Overall Study|Lack of Efficacy|0|||
94290239|NCT00666926|322850639|FG004|Overall Study|Lack of Efficacy|0|||
94290240|NCT00666926|322850640|FG005|Overall Study|Lack of Efficacy|1|||
94290241|NCT00666926|322850641|FG006|Overall Study|Lack of Efficacy|0|||
94290242|NCT00666926|322850642|FG007|Overall Study|Lack of Efficacy|0|||
94290243|NCT00666926|322850643|FG008|Overall Study|Lack of Efficacy|0|||
94290244|NCT00666926|322850644|FG009|Overall Study|Lack of Efficacy|0|||
94290245|NCT00666926|322850645|FG010|Overall Study|Lack of Efficacy|0|||
94290246|NCT00666926|322850646|FG011|Overall Study|Lack of Efficacy|1|||
94290247|NCT00666926|322850647|FG012|Overall Study|Lack of Efficacy|0|||
94290248|NCT00666926|322850648|FG013|Overall Study|Lack of Efficacy|0|||
94290249|NCT00666926|322850649|FG014|Overall Study|Lack of Efficacy|0|||
94290250|NCT00666926|322850650|FG015|Overall Study|Lack of Efficacy|0|||
94290251|NCT00666926|322850635|FG000|Overall Study|Lost to Follow-up|0|||
94290252|NCT00666926|322850636|FG001|Overall Study|Lost to Follow-up|0|||
94290253|NCT00666926|322850637|FG002|Overall Study|Lost to Follow-up|0|||
94290254|NCT00666926|322850638|FG003|Overall Study|Lost to Follow-up|1|||
94290255|NCT00666926|322850639|FG004|Overall Study|Lost to Follow-up|0|||
94290256|NCT00666926|322850640|FG005|Overall Study|Lost to Follow-up|0|||
94290257|NCT00666926|322850641|FG006|Overall Study|Lost to Follow-up|0|||
94290258|NCT00666926|322850642|FG007|Overall Study|Lost to Follow-up|0|||
94290259|NCT00666926|322850643|FG008|Overall Study|Lost to Follow-up|0|||
94290260|NCT00666926|322850644|FG009|Overall Study|Lost to Follow-up|0|||
94290261|NCT00666926|322850645|FG010|Overall Study|Lost to Follow-up|0|||
94290262|NCT00666926|322850646|FG011|Overall Study|Lost to Follow-up|0|||
94290263|NCT00666926|322850647|FG012|Overall Study|Lost to Follow-up|0|||
94290264|NCT00666926|322850648|FG013|Overall Study|Lost to Follow-up|0|||
94290265|NCT00666926|322850649|FG014|Overall Study|Lost to Follow-up|0|||
94290266|NCT00666926|322850650|FG015|Overall Study|Lost to Follow-up|0|||
94290267|NCT00666926|322850635|FG000|Overall Study|Other|2|||
94290268|NCT00666926|322850636|FG001|Overall Study|Other|4|||
94290269|NCT00666926|322850637|FG002|Overall Study|Other|3|||
94290270|NCT00666926|322850638|FG003|Overall Study|Other|3|||
94290271|NCT00666926|322850639|FG004|Overall Study|Other|3|||
94290272|NCT00666926|322850640|FG005|Overall Study|Other|3|||
94290273|NCT00666926|322850641|FG006|Overall Study|Other|4|||
94290274|NCT00666926|322850642|FG007|Overall Study|Other|0|||
94290275|NCT00666926|322850643|FG008|Overall Study|Other|3|||
94290276|NCT00666926|322850644|FG009|Overall Study|Other|5|||
94290277|NCT00666926|322850645|FG010|Overall Study|Other|3|||
94290278|NCT00666926|322850646|FG011|Overall Study|Other|26|||
94290279|NCT00666926|322850647|FG012|Overall Study|Other|3|||
94290280|NCT00666926|322850648|FG013|Overall Study|Other|2|||
94290281|NCT00666926|322850649|FG014|Overall Study|Other|4|||
94290282|NCT00666926|322850650|FG015|Overall Study|Other|4|||
94290283|NCT00666926|322850635|FG000|Overall Study|Withdrawal by Subject|0|||
94290284|NCT00666926|322850636|FG001|Overall Study|Withdrawal by Subject|0|||
94290285|NCT00666926|322850637|FG002|Overall Study|Withdrawal by Subject|0|||
94290286|NCT00666926|322850638|FG003|Overall Study|Withdrawal by Subject|0|||
94290287|NCT00666926|322850639|FG004|Overall Study|Withdrawal by Subject|0|||
94290288|NCT00666926|322850640|FG005|Overall Study|Withdrawal by Subject|0|||
94290289|NCT00666926|322850641|FG006|Overall Study|Withdrawal by Subject|0|||
94290290|NCT00666926|322850642|FG007|Overall Study|Withdrawal by Subject|1|||
94290291|NCT00666926|322850643|FG008|Overall Study|Withdrawal by Subject|0|||
94290292|NCT00666926|322850644|FG009|Overall Study|Withdrawal by Subject|3|||
94290293|NCT00666926|322850645|FG010|Overall Study|Withdrawal by Subject|0|||
94290294|NCT00666926|322850646|FG011|Overall Study|Withdrawal by Subject|3|||
94290295|NCT00666926|322850647|FG012|Overall Study|Withdrawal by Subject|0|||
94290296|NCT00666926|322850648|FG013|Overall Study|Withdrawal by Subject|1|||
94290297|NCT00666926|322850649|FG014|Overall Study|Withdrawal by Subject|3|||
94290298|NCT00666926|322850650|FG015|Overall Study|Withdrawal by Subject|3|||
94290299|NCT00666926|322850635|FG000|Overall Study|Death|0|||
94290300|NCT00666926|322850636|FG001|Overall Study|Death|0|||
94290301|NCT00666926|322850637|FG002|Overall Study|Death|0|||
94290302|NCT00666926|322850638|FG003|Overall Study|Death|0|||
94290303|NCT00666926|322850639|FG004|Overall Study|Death|0|||
94290304|NCT00666926|322850640|FG005|Overall Study|Death|0|||
94290305|NCT00666926|322850641|FG006|Overall Study|Death|0|||
94290306|NCT00666926|322850642|FG007|Overall Study|Death|0|||
94290307|NCT00666926|322850643|FG008|Overall Study|Death|0|||
94290308|NCT00666926|322850644|FG009|Overall Study|Death|0|||
94290309|NCT00666926|322850645|FG010|Overall Study|Death|0|||
94290310|NCT00666926|322850646|FG011|Overall Study|Death|1|||
94290311|NCT00666926|322850647|FG012|Overall Study|Death|0|||
94290312|NCT00666926|322850648|FG013|Overall Study|Death|0|||
94290313|NCT00666926|322850649|FG014|Overall Study|Death|0|||
94290314|NCT00666926|322850650|FG015|Overall Study|Death|0|||
94290315|NCT01727258|322850651|FG000|Overall Study|Adverse Event|0|||
94290316|NCT01727258|322850652|FG001|Overall Study|Adverse Event|2|||
94290317|NCT01727258|322850653|FG002|Overall Study|Adverse Event|0|||
94290318|NCT01727258|322850651|FG000|Overall Study|Noncompliance with Study Drug|0|||
94290319|NCT01727258|322850652|FG001|Overall Study|Noncompliance with Study Drug|0|||
94290320|NCT01727258|322850653|FG002|Overall Study|Noncompliance with Study Drug|1|||
94290321|NCT01727258|322850651|FG000|Overall Study|Withdrawal by Subject|1|||
94290322|NCT01727258|322850652|FG001|Overall Study|Withdrawal by Subject|1|||
94290323|NCT01727258|322850653|FG002|Overall Study|Withdrawal by Subject|0|||
94290324|NCT01727258|322850651|FG000|Overall Study|Lost to Follow-up|1|||
94290325|NCT01727258|322850652|FG001|Overall Study|Lost to Follow-up|0|||
94290326|NCT01727258|322850653|FG002|Overall Study|Lost to Follow-up|0|||
94290327|NCT01900002|322850656|FG000|Overall Study|Withdrawal by Subject|2|||
94290328|NCT01900002|322850656|FG000|Overall Study|ineligible for Y-90|4|||
94290329|NCT01573910|322850659|FG000|Overall Study|Adverse Event|4|||
94290330|NCT01573910|322850660|FG001|Overall Study|Adverse Event|4|||
94290331|NCT01573910|322850659|FG000|Overall Study|Lost to Follow-up|2|||
94290332|NCT01573910|322850660|FG001|Overall Study|Lost to Follow-up|1|||
94290333|NCT01573910|322850659|FG000|Overall Study|Withdrawal by Subject|0|||
94290334|NCT01573910|322850660|FG001|Overall Study|Withdrawal by Subject|1|||
94290335|NCT01573910|322850659|FG000|Overall Study|Protocol Violation|3|||
94290336|NCT01573910|322850660|FG001|Overall Study|Protocol Violation|0|||
94290337|NCT01573910|322850659|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
94290338|NCT01573910|322850660|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
94290339|NCT01818726|322850663|FG000|Overall Study|Administrative reasons|5|||
94290340|NCT01818726|322850664|FG001|Overall Study|Administrative reasons|1|||
94290341|NCT01818726|322850663|FG000|Overall Study|Withdrawal by Subject|0|||
94290342|NCT01818726|322850664|FG001|Overall Study|Withdrawal by Subject|1|||
94290343|NCT01818726|322850663|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
94290344|NCT01818726|322850664|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
94290345|NCT01948830|322850670|FG000|Overall Study|Physician Decision|1|||
94290346|NCT01948830|322850671|FG001|Overall Study|Physician Decision|3|||
94290347|NCT01948830|322850670|FG000|Overall Study|Protocol deviation|1|||
94290348|NCT01948830|322850671|FG001|Overall Study|Protocol deviation|2|||
94290349|NCT01948830|322850670|FG000|Overall Study|Lost to Follow-up|5|||
94290350|NCT01948830|322850671|FG001|Overall Study|Lost to Follow-up|4|||
94290351|NCT01948830|322850670|FG000|Overall Study|Withdrawal by Subject|14|||
94290352|NCT01948830|322850671|FG001|Overall Study|Withdrawal by Subject|17|||
94290353|NCT01948830|322850670|FG000|Overall Study|Adverse Event|9|||
94290354|NCT01948830|322850671|FG001|Overall Study|Adverse Event|2|||
94290355|NCT01948830|322850670|FG000|Overall Study|Death|3|||
94290356|NCT01948830|322850671|FG001|Overall Study|Death|4|||
94290357|NCT00712348|322850672|FG000|Overall Study|Withdrawal by Subject|1|||
94290358|NCT00854828|322850676|FG000|Overall Study|Death|1|||
94290359|NCT00854828|322850677|FG001|Overall Study|Death|0|||
94290360|NCT00854828|322850678|FG002|Overall Study|Death|0|||
94290361|NCT00854828|322850679|FG003|Overall Study|Death|0|||
94290362|NCT00854828|322850676|FG000|Overall Study|Withdrawal by Subject|1|||
94290363|NCT00854828|322850677|FG001|Overall Study|Withdrawal by Subject|1|||
94290364|NCT00854828|322850678|FG002|Overall Study|Withdrawal by Subject|0|||
94290365|NCT00854828|322850679|FG003|Overall Study|Withdrawal by Subject|9|||
94290366|NCT00854828|322850676|FG000|Overall Study|Missed 24mo visit|1|||
94290367|NCT00854828|322850677|FG001|Overall Study|Missed 24mo visit|1|||
94290368|NCT00854828|322850678|FG002|Overall Study|Missed 24mo visit|8|||
94290369|NCT00854828|322850679|FG003|Overall Study|Missed 24mo visit|8|||
94290370|NCT03682120|322850680|FG000|Overall Study|Lost to Follow-up|11|||
94290371|NCT03682120|322850681|FG001|Overall Study|Lost to Follow-up|4|||
94290372|NCT03682120|322850682|FG002|Overall Study|Lost to Follow-up|5|||
94290373|NCT03682120|322850683|FG003|Overall Study|Lost to Follow-up|2|||
94290374|NCT03682120|322850680|FG000|Overall Study|Physician Decision|1|||
94290375|NCT03682120|322850681|FG001|Overall Study|Physician Decision|0|||
94290376|NCT03682120|322850682|FG002|Overall Study|Physician Decision|0|||
94290377|NCT03682120|322850683|FG003|Overall Study|Physician Decision|0|||
94290378|NCT03682120|322850680|FG000|Overall Study|Withdrawal by Subject|1|||
94290379|NCT03682120|322850681|FG001|Overall Study|Withdrawal by Subject|2|||
94290380|NCT03682120|322850682|FG002|Overall Study|Withdrawal by Subject|3|||
94290381|NCT03682120|322850683|FG003|Overall Study|Withdrawal by Subject|0|||
94290382|NCT03682120|322850680|FG000|Overall Study|Death|0|||
94290383|NCT03682120|322850681|FG001|Overall Study|Death|1|||
94290384|NCT03682120|322850682|FG002|Overall Study|Death|0|||
94290385|NCT03682120|322850683|FG003|Overall Study|Death|0|||
94290386|NCT03682120|322850680|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
94290387|NCT03682120|322850681|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
94290388|NCT03682120|322850682|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
94290389|NCT03682120|322850683|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
94290390|NCT03308188|322850684|FG000|Overall Study|Withdrawal by Subject|0|||
94290391|NCT03308188|322850685|FG001|Overall Study|Withdrawal by Subject|3|||
94290392|NCT03308188|322850684|FG000|Overall Study|Death|0|||
94290393|NCT03308188|322850685|FG001|Overall Study|Death|1|||
94290394|NCT03887130|322850689|FG000|Overall Study|Progressive disease|23|||
94290395|NCT03887130|322850690|FG001|Overall Study|Progressive disease|14|||
94290396|NCT03887130|322850691|FG002|Overall Study|Progressive disease|7|||
94290397|NCT03887130|322850689|FG000|Overall Study|Protocol Violation|3|||
94290398|NCT03887130|322850690|FG001|Overall Study|Protocol Violation|1|||
94290399|NCT03887130|322850691|FG002|Overall Study|Protocol Violation|2|||
94290400|NCT03887130|322850689|FG000|Overall Study|Drug related toxicity|7|||
94290401|NCT03887130|322850690|FG001|Overall Study|Drug related toxicity|7|||
94290402|NCT03887130|322850691|FG002|Overall Study|Drug related toxicity|13|||
94290403|NCT03887130|322850689|FG000|Overall Study|Non drug related toxicity|3|||
94290404|NCT03887130|322850690|FG001|Overall Study|Non drug related toxicity|0|||
94290405|NCT03887130|322850691|FG002|Overall Study|Non drug related toxicity|0|||
94290406|NCT03887130|322850689|FG000|Overall Study|Death|2|||
94290407|NCT03887130|322850690|FG001|Overall Study|Death|2|||
94290408|NCT03887130|322850691|FG002|Overall Study|Death|1|||
94290409|NCT03887130|322850689|FG000|Overall Study|Withdrawal by Subject|7|||
94290410|NCT03887130|322850690|FG001|Overall Study|Withdrawal by Subject|6|||
94290411|NCT03887130|322850691|FG002|Overall Study|Withdrawal by Subject|11|||
94290412|NCT03887130|322850689|FG000|Overall Study|other reason|6|||
94290413|NCT03887130|322850690|FG001|Overall Study|other reason|20|||
94290414|NCT03887130|322850691|FG002|Overall Study|other reason|17|||
94290415|NCT04082663|322850692|FG000|Overall Study|Adverse Event|6|||
94290416|NCT04082663|322850692|FG000|Overall Study|Lost to Follow-up|1|||
94290417|NCT01583374|322850695|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
94290418|NCT01583374|322850696|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
94290419|NCT01583374|322850697|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
94290420|NCT01583374|322850698|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
94290421|NCT01583374|322850699|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
94290422|NCT01583374|322850700|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
94290423|NCT01583374|322850701|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
94290424|NCT01583374|322850702|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
94290425|NCT01583374|322850703|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
94290426|NCT01583374|322850695|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
94290427|NCT01583374|322850696|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
94290428|NCT01583374|322850697|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
94290429|NCT01583374|322850698|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
94290430|NCT01583374|322850699|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
94290431|NCT01583374|322850700|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
94290432|NCT01583374|322850701|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
94290433|NCT01583374|322850702|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
94290434|NCT01583374|322850703|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
94290435|NCT01583374|322850695|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
94290436|NCT01583374|322850696|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
94290437|NCT01583374|322850697|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
94290438|NCT01583374|322850698|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
94290439|NCT01583374|322850699|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
94290440|NCT01583374|322850700|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
94290441|NCT01583374|322850701|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
94290442|NCT01583374|322850702|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
94290443|NCT01583374|322850703|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
94290444|NCT01583374|322850695|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
94290445|NCT01583374|322850696|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
94290446|NCT01583374|322850697|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
94290447|NCT01583374|322850698|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
94290448|NCT01583374|322850699|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
94290449|NCT01583374|322850700|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
94290450|NCT01583374|322850701|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
94290451|NCT01583374|322850702|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
94290452|NCT01583374|322850703|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
94290453|NCT01583374|322850695|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
94290454|NCT01583374|322850696|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
94290455|NCT01583374|322850697|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
94290456|NCT01583374|322850698|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
94290457|NCT01583374|322850699|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
94290458|NCT01583374|322850700|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
94290459|NCT01583374|322850701|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
94290460|NCT01583374|322850702|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
94290461|NCT01583374|322850703|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
94290462|NCT01583374|322850695|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
94290463|NCT01583374|322850696|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
94290464|NCT01583374|322850697|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
94290465|NCT01583374|322850698|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
94290466|NCT01583374|322850699|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
94290467|NCT01583374|322850700|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
94290468|NCT01583374|322850701|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
94290469|NCT01583374|322850702|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
94290470|NCT01583374|322850703|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
94290471|NCT01583374|322850695|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
94290472|NCT01583374|322850696|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
94290473|NCT01583374|322850697|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
94290474|NCT01583374|322850698|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
94290475|NCT01583374|322850699|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
94290476|NCT01583374|322850700|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
94290477|NCT01583374|322850701|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
94290478|NCT01583374|322850702|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
94290479|NCT01583374|322850703|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
94290480|NCT01583374|322850695|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
94290481|NCT01583374|322850696|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
94290482|NCT01583374|322850697|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
94290483|NCT01583374|322850698|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
94290484|NCT01583374|322850699|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
94290485|NCT01583374|322850700|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
94290486|NCT01583374|322850701|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
94290487|NCT01583374|322850702|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
94290488|NCT01583374|322850703|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
94290489|NCT01583374|322850695|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
94290490|NCT01583374|322850696|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
94290491|NCT01583374|322850697|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
94290492|NCT01583374|322850698|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
94290493|NCT01583374|322850699|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
94290494|NCT01583374|322850700|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
94290495|NCT01583374|322850701|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
94290496|NCT01583374|322850702|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
94290497|NCT01583374|322850703|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
94290498|NCT01583374|322850695|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
94290499|NCT01583374|322850696|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
94290500|NCT01583374|322850697|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
94290501|NCT01583374|322850698|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
94290502|NCT01583374|322850699|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
94290503|NCT01583374|322850700|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
94290504|NCT01583374|322850701|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
94290505|NCT01583374|322850702|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
94290506|NCT01583374|322850703|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
94290507|NCT01583374|322850695|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
94290508|NCT01583374|322850696|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
94290509|NCT01583374|322850697|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
94290510|NCT01583374|322850698|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
94290511|NCT01583374|322850699|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
94290512|NCT01583374|322850700|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
94290513|NCT01583374|322850701|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
94290514|NCT01583374|322850702|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
94290515|NCT01583374|322850703|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
94290516|NCT01583374|322850695|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
94290517|NCT01583374|322850696|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
94290518|NCT01583374|322850697|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
94290519|NCT01583374|322850698|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
94290520|NCT01583374|322850699|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
94290521|NCT01583374|322850700|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
94290522|NCT01583374|322850701|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
94290523|NCT01583374|322850702|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
94290524|NCT01583374|322850703|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
94290525|NCT01583374|322850695|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
94290526|NCT01583374|322850696|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
94290527|NCT01583374|322850697|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
94290528|NCT01583374|322850698|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
94290529|NCT01583374|322850699|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
94290530|NCT01583374|322850700|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
94290531|NCT01583374|322850701|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
94290532|NCT01583374|322850702|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
94290533|NCT01583374|322850703|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
94290534|NCT01583374|322850695|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
94290535|NCT01583374|322850696|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
94290536|NCT01583374|322850697|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
94290537|NCT01583374|322850698|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
94290538|NCT01583374|322850699|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
94290539|NCT01583374|322850700|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
94290540|NCT01583374|322850701|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
94290541|NCT01583374|322850702|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
94290542|NCT01583374|322850703|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
94290543|NCT01583374|322850695|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
94290544|NCT01583374|322850696|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
94290545|NCT01583374|322850697|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
94290546|NCT01583374|322850698|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
94290547|NCT01583374|322850699|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
94290548|NCT01583374|322850700|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
94290549|NCT01583374|322850701|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
94290550|NCT01583374|322850702|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
94372528|NCT01571635|323150283|FG004|Overall Study|Study terminated by sponsor|1|||
94372529|NCT01571635|323150279|FG000|Overall Study|Withdrew consent|1|||
94290551|NCT01583374|322850703|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
94290552|NCT01583374|322850695|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
94372530|NCT01571635|323150280|FG001|Overall Study|Withdrew consent|1|||
94372531|NCT01571635|323150281|FG002|Overall Study|Withdrew consent|2|||
94290553|NCT01583374|322850696|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
94290554|NCT01583374|322850697|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
94290555|NCT01583374|322850698|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
94290556|NCT01583374|322850699|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
94290557|NCT01583374|322850700|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
94290558|NCT01583374|322850701|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
94290559|NCT01583374|322850702|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
94290560|NCT01583374|322850703|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
94290561|NCT01583374|322850695|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
94290562|NCT01583374|322850696|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
94290563|NCT01583374|322850697|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
94290564|NCT01583374|322850698|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
94290565|NCT01583374|322850699|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
94290566|NCT01583374|322850700|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
94290567|NCT01583374|322850701|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
94290568|NCT01583374|322850702|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
94290569|NCT01583374|322850703|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
94290570|NCT01583374|322850695|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
94290571|NCT01583374|322850696|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
94290572|NCT01583374|322850697|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
94290573|NCT01583374|322850698|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
94290574|NCT01583374|322850699|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
94290575|NCT01583374|322850700|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
94290576|NCT01583374|322850701|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
94290577|NCT01583374|322850702|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
94290578|NCT01583374|322850703|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
94290579|NCT01583374|322850695|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
94290580|NCT01583374|322850696|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
94290581|NCT01583374|322850697|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
94290582|NCT01583374|322850698|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
94290583|NCT01583374|322850699|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
94290584|NCT01583374|322850700|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
94290585|NCT01583374|322850701|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
94290586|NCT01583374|322850702|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
94290587|NCT01583374|322850703|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
94290588|NCT01292057|322850704|FG000|Overall Study|Protocol Violation|1|||
94290589|NCT01292057|322850705|FG001|Overall Study|Protocol Violation|1|||
94290590|NCT01292057|322850704|FG000|Overall Study|Lost to Follow-up|1|||
94290591|NCT01292057|322850705|FG001|Overall Study|Lost to Follow-up|1|||
94290592|NCT01386385|322852491|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
94290593|NCT01386385|322852492|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
94290594|NCT01386385|322852493|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
94290595|NCT01386385|322852494|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
94290596|NCT01386385|322852495|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
94290597|NCT01386385|322852496|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
94290598|NCT01386385|322852497|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
94290599|NCT01386385|322852498|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
94290600|NCT01386385|322852491|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
94290601|NCT01386385|322852492|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
94290602|NCT01386385|322852493|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
94290603|NCT01386385|322852494|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
94290604|NCT01386385|322852495|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
94290605|NCT01386385|322852496|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
94290606|NCT01386385|322852497|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
94290607|NCT01386385|322852498|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
94290608|NCT01386385|322852491|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
94290609|NCT01386385|322852492|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
94290610|NCT01386385|322852493|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
94290611|NCT01386385|322852494|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
94290612|NCT01386385|322852495|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
94290613|NCT01386385|322852496|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
94372532|NCT01571635|323150282|FG003|Overall Study|Withdrew consent|3|||
94290614|NCT01386385|322852497|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
94290615|NCT01386385|322852498|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
94290616|NCT01386385|322852491|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
94290617|NCT01386385|322852492|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
94290618|NCT01386385|322852493|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
94290619|NCT01386385|322852494|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
94290620|NCT01386385|322852495|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
94290621|NCT01386385|322852496|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
94290622|NCT01386385|322852497|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
94290623|NCT01386385|322852498|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
94290624|NCT01386385|322852491|FG000|Phase II Concurrent CRT|Adverse Event|0|||
94290625|NCT01386385|322852492|FG001|Phase II Concurrent CRT|Adverse Event|0|||
94290626|NCT01386385|322852493|FG002|Phase II Concurrent CRT|Adverse Event|0|||
94290627|NCT01386385|322852494|FG003|Phase II Concurrent CRT|Adverse Event|0|||
94290628|NCT01386385|322852495|FG004|Phase II Concurrent CRT|Adverse Event|0|||
94290629|NCT01386385|322852496|FG005|Phase II Concurrent CRT|Adverse Event|0|||
94290630|NCT01386385|322852497|FG006|Phase II Concurrent CRT|Adverse Event|3|||
94290631|NCT01386385|322852498|FG007|Phase II Concurrent CRT|Adverse Event|3|||
94290632|NCT01386385|322852491|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
94290633|NCT01386385|322852492|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
94290634|NCT01386385|322852493|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
94290635|NCT01386385|322852494|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
94290636|NCT01386385|322852495|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
94290637|NCT01386385|322852496|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
94290638|NCT01386385|322852497|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
94290639|NCT01386385|322852498|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
94290640|NCT01386385|322852491|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
94290641|NCT01386385|322852492|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
94290642|NCT01386385|322852493|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
94290643|NCT01386385|322852494|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
94290644|NCT01386385|322852495|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
94290645|NCT01386385|322852496|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
94290646|NCT01386385|322852497|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
94290647|NCT01386385|322852498|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
94290648|NCT01386385|322852491|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
94290649|NCT01386385|322852492|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
94290650|NCT01386385|322852493|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
94290651|NCT01386385|322852494|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
94290652|NCT01386385|322852495|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
94290653|NCT01386385|322852496|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
94290654|NCT01386385|322852497|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
94290655|NCT01386385|322852498|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
94290656|NCT01386385|322852491|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
94290657|NCT01386385|322852492|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
94290658|NCT01386385|322852493|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
94290659|NCT01386385|322852494|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
94290660|NCT01386385|322852495|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
94290661|NCT01386385|322852496|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
94290662|NCT01386385|322852497|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
94290663|NCT01386385|322852498|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
94290664|NCT05847686|322852499|FG000|Overall Study|Withdrawal by Subject|3|||
94290665|NCT04484285|322852500|FG000|Overall Study|Unable to operate stimulator|3|||
94290666|NCT04484285|322852501|FG001|Overall Study|Unable to operate stimulator|0|||
94290667|NCT02775851|322852502|FG000|Overall Study|Adverse Event|1|||
94290668|NCT02775851|322852503|FG001|Overall Study|Adverse Event|10|||
94290669|NCT02775851|322852502|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
94290670|NCT02775851|322852503|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
94290671|NCT02775851|322852502|FG000|Overall Study|Progression/Relapse|0|||
94290672|NCT02775851|322852503|FG001|Overall Study|Progression/Relapse|4|||
94290673|NCT02775851|322852502|FG000|Overall Study|Other - Not Protocol Specified|0|||
94290674|NCT02775851|322852503|FG001|Overall Study|Other - Not Protocol Specified|7|||
94290675|NCT02775851|322852502|FG000|Overall Study|Withdrawal by Subject|1|||
94290676|NCT02775851|322852503|FG001|Overall Study|Withdrawal by Subject|0|||
94290677|NCT04439175|322852505|FG000|Overall Study|Never started treatment|4|||
94290678|NCT04439175|322852505|FG000|Overall Study|Ineligible|5|||
94290679|NCT04439175|322852505|FG000|Overall Study|Adverse Event|6|||
94290680|NCT04439175|322852505|FG000|Overall Study|Death|4|||
94290681|NCT04439175|322852505|FG000|Overall Study|Disease progression|44|||
94290682|NCT04439175|322852505|FG000|Overall Study|Withdrawal by Subject|4|||
94290683|NCT04439175|322852505|FG000|Overall Study|Alternative Therapy|1|||
94290684|NCT04439175|322852505|FG000|Overall Study|Other|2|||
94290685|NCT05280756|322852506|FG000|Overall Study|Lost to Follow-up|1|||
94290686|NCT05280756|322852507|FG001|Overall Study|Lost to Follow-up|1|||
94290687|NCT02152345|322852508|FG000|Overall Study|Case Cancellations|2|||
94290688|NCT02152345|322852509|FG001|Overall Study|Case Cancellations|4|||
94290689|NCT02152345|322852508|FG000|Overall Study|Withdrawal by Subject|2|||
94290690|NCT02152345|322852509|FG001|Overall Study|Withdrawal by Subject|1|||
94290691|NCT02554929|322852510|FG000|Overall Study|Lost to Follow-up|4|||
94290692|NCT02554929|322852511|FG001|Overall Study|Lost to Follow-up|4|||
94290693|NCT02554929|322852510|FG000|Overall Study|Withdrawal by Subject|2|||
94290694|NCT02554929|322852511|FG001|Overall Study|Withdrawal by Subject|8|||
94290695|NCT01916980|322852514|FG000|Overall Study|Adverse Event|4|||
94290696|NCT01916980|322852515|FG001|Overall Study|Adverse Event|2|||
94290697|NCT01916980|322852514|FG000|Overall Study|Lack of Efficacy|2|||
94290698|NCT01916980|322852515|FG001|Overall Study|Lack of Efficacy|2|||
94290699|NCT01916980|322852514|FG000|Overall Study|Withdrawal by Subject|1|||
94290700|NCT01916980|322852515|FG001|Overall Study|Withdrawal by Subject|0|||
94290701|NCT02324270|322852516|FG000|Overall Study|Withdrawal by Subject|0|||
94290702|NCT02324270|322852517|FG001|Overall Study|Withdrawal by Subject|1|||
94290703|NCT02324270|322852518|FG002|Overall Study|Withdrawal by Subject|0|||
94290704|NCT02324270|322852516|FG000|Overall Study|Lost to Follow-up|4|||
94290705|NCT02324270|322852517|FG001|Overall Study|Lost to Follow-up|3|||
94290706|NCT02324270|322852518|FG002|Overall Study|Lost to Follow-up|4|||
94290707|NCT02324270|322852516|FG000|Overall Study|Protocol Violation|0|||
94290708|NCT02324270|322852517|FG001|Overall Study|Protocol Violation|1|||
94290709|NCT02324270|322852518|FG002|Overall Study|Protocol Violation|1|||
94290710|NCT02324270|322852516|FG000|Overall Study|Non Compliance with Study Drug|1|||
94290711|NCT02324270|322852517|FG001|Overall Study|Non Compliance with Study Drug|2|||
94290712|NCT02324270|322852518|FG002|Overall Study|Non Compliance with Study Drug|0|||
94290713|NCT00546364|322852519|FG000|Overall Study|Disease progression|5|||
94290714|NCT00546364|322852520|FG001|Overall Study|Disease progression|11|||
94290715|NCT00546364|322852521|FG002|Overall Study|Disease progression|8|||
94290716|NCT00546364|322852519|FG000|Overall Study|Completed and off treatment|1|||
94290717|NCT00546364|322852520|FG001|Overall Study|Completed and off treatment|0|||
94290718|NCT00546364|322852521|FG002|Overall Study|Completed and off treatment|2|||
94290719|NCT00546364|322852519|FG000|Overall Study|Administrative reason by sponsor|1|||
94290720|NCT00546364|322852520|FG001|Overall Study|Administrative reason by sponsor|0|||
94290721|NCT00546364|322852521|FG002|Overall Study|Administrative reason by sponsor|0|||
94290722|NCT00546364|322852519|FG000|Overall Study|Poor compliance/noncompliance|0|||
94290723|NCT00546364|322852520|FG001|Overall Study|Poor compliance/noncompliance|0|||
94290724|NCT00546364|322852521|FG002|Overall Study|Poor compliance/noncompliance|1|||
94290725|NCT00546364|322852519|FG000|Overall Study|No longer meets study criteria|1|||
94290726|NCT00546364|322852520|FG001|Overall Study|No longer meets study criteria|1|||
94290727|NCT00546364|322852521|FG002|Overall Study|No longer meets study criteria|0|||
94290728|NCT00546364|322852519|FG000|Overall Study|Withdrawal by Subject|5|||
94290729|NCT00546364|322852520|FG001|Overall Study|Withdrawal by Subject|6|||
94290730|NCT00546364|322852521|FG002|Overall Study|Withdrawal by Subject|3|||
94290731|NCT00546364|322852519|FG000|Overall Study|Prior taxotere|1|||
94290732|NCT00546364|322852520|FG001|Overall Study|Prior taxotere|0|||
94290733|NCT00546364|322852521|FG002|Overall Study|Prior taxotere|0|||
94290734|NCT00546364|322852519|FG000|Overall Study|Mixed response|1|||
94290735|NCT00546364|322852520|FG001|Overall Study|Mixed response|0|||
94290736|NCT00546364|322852521|FG002|Overall Study|Mixed response|0|||
94290737|NCT00546364|322852519|FG000|Overall Study|Palliative treatment|1|||
94290738|NCT00546364|322852520|FG001|Overall Study|Palliative treatment|0|||
94290739|NCT00546364|322852521|FG002|Overall Study|Palliative treatment|1|||
94290740|NCT00546364|322852519|FG000|Overall Study|Target lesions resected|1|||
94290741|NCT00546364|322852520|FG001|Overall Study|Target lesions resected|0|||
94290742|NCT00546364|322852521|FG002|Overall Study|Target lesions resected|0|||
94290743|NCT00546364|322852519|FG000|Overall Study|Physician Decision|0|||
94290744|NCT00546364|322852520|FG001|Overall Study|Physician Decision|0|||
94290745|NCT00546364|322852521|FG002|Overall Study|Physician Decision|1|||
94290746|NCT00546364|322852519|FG000|Overall Study|Sponsor decision|0|||
94290747|NCT00546364|322852520|FG001|Overall Study|Sponsor decision|0|||
94290748|NCT00546364|322852521|FG002|Overall Study|Sponsor decision|1|||
94290749|NCT03521791|322852522|FG000|Overall Study|Protocol Violation|7|||
94290750|NCT03521791|322852523|FG001|Overall Study|Protocol Violation|17|||
94290751|NCT00680836|322852524|FG000|Overall Study|Withdrawal by Subject|3|||
94290752|NCT00680836|322852525|FG001|Overall Study|Withdrawal by Subject|0|||
94290753|NCT00680836|322852524|FG000|Overall Study|Lost to Follow-up|3|||
94467967|NCT03013985|323502457|FG001|Overall Study|Withdrawal by Subject|17|||
94467968|NCT01887678|323502459|FG000|Overall Study|Adverse Event|4|||
94290754|NCT00680836|322852525|FG001|Overall Study|Lost to Follow-up|1|||
94290755|NCT00680836|322852524|FG000|Overall Study|Physician Decision|2|||
94290756|NCT00680836|322852525|FG001|Overall Study|Physician Decision|1|||
94290757|NCT00388947|322852526|FG000|Overall Study|Protocol Violation|47|||
94290758|NCT04187092|322852529|FG000|Overall Study|Lost to Follow-up|1|||
94290759|NCT04187092|322852530|FG001|Overall Study|Lost to Follow-up|1|||
94290760|NCT04187092|322852529|FG000|Overall Study|Withdrawal by Subject|1|||
94290761|NCT04187092|322852530|FG001|Overall Study|Withdrawal by Subject|1|||
94290762|NCT04187092|322852529|FG000|Overall Study|Adverse Event|0|||
94290763|NCT04187092|322852530|FG001|Overall Study|Adverse Event|1|||
94290764|NCT00619502|322852533|FG000|Overall Study|Lost to Follow-up|8|||
94290765|NCT00619502|322852534|FG001|Overall Study|Lost to Follow-up|10|||
94290766|NCT01777763|322852545|FG000|Overall Study|Adverse Event|2|||
94290767|NCT01777763|322852546|FG001|Overall Study|Adverse Event|32|||
94290768|NCT01777763|322852545|FG000|Overall Study|Protocol Violation|1|||
94290769|NCT01777763|322852546|FG001|Overall Study|Protocol Violation|7|||
94290770|NCT01777763|322852545|FG000|Overall Study|Withdrawal by Subject|0|||
94290771|NCT01777763|322852546|FG001|Overall Study|Withdrawal by Subject|2|||
94290772|NCT01777763|322852545|FG000|Overall Study|Treatment Failure|1|||
94290773|NCT01777763|322852546|FG001|Overall Study|Treatment Failure|6|||
94290774|NCT00771472|322852547|FG000|Overall Study|Physician Decision|2|||
94290775|NCT00771472|322852548|FG001|Overall Study|Physician Decision|3|||
94290776|NCT00771472|322852547|FG000|Overall Study|Progressive Disease|3|||
94290777|NCT00771472|322852548|FG001|Overall Study|Progressive Disease|1|||
94290778|NCT00771472|322852547|FG000|Overall Study|Protocol Violation|1|||
94290779|NCT00771472|322852548|FG001|Overall Study|Protocol Violation|0|||
94290780|NCT00667576|322852556|FG000|Overall Study|Withdrawal by Subject|1|||
94290781|NCT00667576|322852557|FG001|Overall Study|Withdrawal by Subject|0|||
94290782|NCT00667576|322852558|FG002|Overall Study|Withdrawal by Subject|1|||
94290783|NCT00667576|322852559|FG003|Overall Study|Withdrawal by Subject|1|||
94290784|NCT00667576|322852560|FG004|Overall Study|Withdrawal by Subject|1|||
94290785|NCT00667576|322852556|FG000|Overall Study|Adverse Event|1|||
94290786|NCT00667576|322852557|FG001|Overall Study|Adverse Event|1|||
94290787|NCT00667576|322852558|FG002|Overall Study|Adverse Event|0|||
94290788|NCT00667576|322852559|FG003|Overall Study|Adverse Event|0|||
94290789|NCT00667576|322852560|FG004|Overall Study|Adverse Event|0|||
94290790|NCT00667576|322852556|FG000|Overall Study|Lost to Follow-up|0|||
94290791|NCT00667576|322852557|FG001|Overall Study|Lost to Follow-up|0|||
94290792|NCT00667576|322852558|FG002|Overall Study|Lost to Follow-up|1|||
94290793|NCT00667576|322852559|FG003|Overall Study|Lost to Follow-up|0|||
94290794|NCT00667576|322852560|FG004|Overall Study|Lost to Follow-up|0|||
94290795|NCT00667576|322852556|FG000|Overall Study|Protocol Violation|0|||
94290796|NCT00667576|322852557|FG001|Overall Study|Protocol Violation|0|||
94290797|NCT00667576|322852558|FG002|Overall Study|Protocol Violation|0|||
94290798|NCT00667576|322852559|FG003|Overall Study|Protocol Violation|1|||
94290799|NCT00667576|322852560|FG004|Overall Study|Protocol Violation|0|||
94290800|NCT00667576|322852556|FG000|Overall Study|Physician Decision|0|||
94290801|NCT00667576|322852557|FG001|Overall Study|Physician Decision|0|||
94290802|NCT00667576|322852558|FG002|Overall Study|Physician Decision|0|||
94290803|NCT00667576|322852559|FG003|Overall Study|Physician Decision|1|||
94290804|NCT00667576|322852560|FG004|Overall Study|Physician Decision|0|||
94290805|NCT00667576|322852556|FG000|Overall Study|Missed Visit|0|||
94290806|NCT00667576|322852557|FG001|Overall Study|Missed Visit|0|||
94290807|NCT00667576|322852558|FG002|Overall Study|Missed Visit|0|||
94290808|NCT00667576|322852559|FG003|Overall Study|Missed Visit|1|||
94290809|NCT00667576|322852560|FG004|Overall Study|Missed Visit|0|||
94290810|NCT00483327|322852561|FG000|Overall Study|Adverse Event|1|||
94290811|NCT00483327|322852561|FG000|Overall Study|Withdrawal by Subject|3|||
94290812|NCT00483327|322852561|FG000|Overall Study|Lost to Follow-up|4|||
94290813|NCT00483327|322852561|FG000|Overall Study|Patient Non Compliance|2|||
94290814|NCT01891643|322852562|FG000|Overall Study|Adverse event unrelated to study drug|2|||
94290815|NCT01891643|322852563|FG001|Overall Study|Adverse event unrelated to study drug|5|||
94290816|NCT01891643|322852562|FG000|Overall Study|Disease Progression|4|||
94290817|NCT01891643|322852563|FG001|Overall Study|Disease Progression|3|||
94290818|NCT01891643|322852562|FG000|Overall Study|Study Drug Toxicity|3|||
94290819|NCT01891643|322852563|FG001|Overall Study|Study Drug Toxicity|0|||
94290820|NCT01891643|322852562|FG000|Overall Study|Maximum Clinical Benefit|0|||
94290821|NCT01891643|322852563|FG001|Overall Study|Maximum Clinical Benefit|1|||
94290822|NCT01891643|322852562|FG000|Overall Study|Poor/Non-compliance|0|||
94290823|NCT01891643|322852563|FG001|Overall Study|Poor/Non-compliance|1|||
94290824|NCT01891643|322852562|FG000|Overall Study|Participant request to discontinue|1|||
94290825|NCT01891643|322852563|FG001|Overall Study|Participant request to discontinue|0|||
94290826|NCT01583179|322852566|FG000|Overall Study|Screen failure|1|||
94290827|NCT01583179|322852567|FG001|Overall Study|Screen failure|2|||
94290828|NCT01246206|322852568|FG000|Overall Study|Patient did not receive study regiments.|1|||
94290829|NCT03523351|322852569|FG000|Overall Study|Death|13|||
94290830|NCT03523351|322852570|FG001|Overall Study|Death|11|||
94290831|NCT03523351|322852569|FG000|Overall Study|Lost to Follow-up|2|||
94290832|NCT03523351|322852570|FG001|Overall Study|Lost to Follow-up|3|||
94290833|NCT03523351|322852569|FG000|Overall Study|Withdrawal by Subject|4|||
94290834|NCT03523351|322852570|FG001|Overall Study|Withdrawal by Subject|0|||
94290835|NCT03523351|322852569|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
94290836|NCT03523351|322852570|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
94290837|NCT02663895|322852571|FG000|Overall Study|Adverse Event|3|||
94290838|NCT02663895|322852571|FG000|Overall Study|Physician Decision|2|||
94290839|NCT02663895|322852571|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
94290840|NCT02663895|322852571|FG000|Overall Study|Withdrawal by Subject|1|||
94290841|NCT00559273|322852575|FG000|Correction Period (20 Weeks)|Death|3|||
94290842|NCT00559273|322852576|FG001|Correction Period (20 Weeks)|Death|4|||
94290843|NCT00559273|322852575|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
94290844|NCT00559273|322852576|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
94290845|NCT00559273|322852575|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
94290846|NCT00559273|322852576|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
94290847|NCT00559273|322852575|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
94290848|NCT00559273|322852576|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
94290849|NCT00559273|322852575|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
94290850|NCT00559273|322852576|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
94290851|NCT00559273|322852575|FG000|Evaluation Period (8 Weeks)|Death|1|||
94290852|NCT00559273|322852576|FG001|Evaluation Period (8 Weeks)|Death|3|||
94290853|NCT00559273|322852575|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
94290854|NCT00559273|322852576|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
94290855|NCT00559273|322852575|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
94290856|NCT00559273|322852576|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
94290857|NCT00559273|322852575|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
94290858|NCT00559273|322852576|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
94290859|NCT00849667|322852579|FG000|Overall Study|Withdrawal by Subject|16|||
94290860|NCT00849667|322852580|FG001|Overall Study|Withdrawal by Subject|33|||
94290861|NCT00849667|322852581|FG002|Overall Study|Withdrawal by Subject|35|||
94290862|NCT00849667|322852579|FG000|Overall Study|Lost to Follow-up|8|||
94290863|NCT00849667|322852580|FG001|Overall Study|Lost to Follow-up|8|||
94290864|NCT00849667|322852581|FG002|Overall Study|Lost to Follow-up|8|||
94290865|NCT00849667|322852579|FG000|Overall Study|Adverse Event|1|||
94290866|NCT00849667|322852580|FG001|Overall Study|Adverse Event|2|||
94290867|NCT00849667|322852581|FG002|Overall Study|Adverse Event|0|||
94290868|NCT00849667|322852579|FG000|Overall Study|Other|18|||
94290869|NCT00849667|322852580|FG001|Overall Study|Other|19|||
94290870|NCT00849667|322852581|FG002|Overall Study|Other|18|||
94290871|NCT00849667|322852579|FG000|Overall Study|Progressive disease|119|||
94290872|NCT00849667|322852580|FG001|Overall Study|Progressive disease|100|||
94290873|NCT00849667|322852581|FG002|Overall Study|Progressive disease|112|||
94290874|NCT00849667|322852579|FG000|Overall Study|Sponsor decision|208|||
94290875|NCT00849667|322852580|FG001|Overall Study|Sponsor decision|204|||
94290876|NCT00849667|322852581|FG002|Overall Study|Sponsor decision|190|||
94290877|NCT00849667|322852579|FG000|Overall Study|Investigator discretion|0|||
94290878|NCT00849667|322852580|FG001|Overall Study|Investigator discretion|0|||
94290879|NCT00849667|322852581|FG002|Overall Study|Investigator discretion|1|||
94290880|NCT01728779|322852582|FG000|Overall Study|Withdrawal by Subject|1|||
94290881|NCT00624520|322852583|FG000|Overall Study|Withdrawal by Subject|12|||
94290882|NCT00624520|322852584|FG001|Overall Study|Withdrawal by Subject|7|||
94290883|NCT00624520|322852583|FG000|Overall Study|Death|0|||
94290884|NCT00624520|322852584|FG001|Overall Study|Death|1|||
94290885|NCT02796755|322852585|FG000|Overall Study|Adverse Event|2|||
94290886|NCT02796755|322852586|FG001|Overall Study|Adverse Event|0|||
94290887|NCT00675025|322852587|FG000|Overall Study|Study Terminated by Sponsor|38|||
94290888|NCT00675025|322852588|FG001|Overall Study|Study Terminated by Sponsor|42|||
94290889|NCT00675025|322852587|FG000|Overall Study|Adverse Event|6|||
94290890|NCT00675025|322852588|FG001|Overall Study|Adverse Event|11|||
94290891|NCT00675025|322852587|FG000|Overall Study|Lost to Follow-up|6|||
94290892|NCT00675025|322852588|FG001|Overall Study|Lost to Follow-up|4|||
94290893|NCT00675025|322852587|FG000|Overall Study|Withdrawal by Subject|4|||
94290894|NCT00675025|322852588|FG001|Overall Study|Withdrawal by Subject|6|||
94290895|NCT03433781|322852589|FG000|Overall Study|Progression of Disease|1|||
94290896|NCT03433781|322852590|FG001|Overall Study|Progression of Disease|0|||
94290897|NCT03433781|322852591|FG002|Overall Study|Progression of Disease|0|||
94290898|NCT03433781|322852589|FG000|Overall Study|Physician Decision|0|||
94290899|NCT03433781|322852590|FG001|Overall Study|Physician Decision|1|||
94290900|NCT03433781|322852591|FG002|Overall Study|Physician Decision|0|||
94290901|NCT00556426|322852592|FG000|Overall Study|Withdrawal by Subject|3|||
94290902|NCT00556426|322852592|FG000|Overall Study|Death|6|||
94290903|NCT01731678|322852600|FG000|Overall Study|Withdrawal by Subject|3|||
94290904|NCT01731678|322852600|FG000|Overall Study|Did not meet inclusion criteria|1|||
94290905|NCT01731678|322852600|FG000|Overall Study|RMT too high, making TMS difficult|3|||
94290906|NCT00792298|322852601|FG000|Treatment Period 1|Adverse Event|0|||
94290907|NCT00792298|322852602|FG001|Treatment Period 1|Adverse Event|1|||
94290908|NCT00792298|322852603|FG002|Treatment Period 1|Adverse Event|0|||
94290909|NCT00792298|322852604|FG003|Treatment Period 1|Adverse Event|1|||
94290910|NCT00792298|322852605|FG004|Treatment Period 1|Adverse Event|0|||
94290911|NCT00792298|322852606|FG005|Treatment Period 1|Adverse Event|1|||
94290912|NCT00792298|322852607|FG006|Treatment Period 1|Adverse Event|1|||
94290913|NCT00792298|322852608|FG007|Treatment Period 1|Adverse Event|0|||
94290914|NCT00792298|322852601|FG000|Treatment Period 1|Lack of Efficacy|0|||
94290915|NCT00792298|322852602|FG001|Treatment Period 1|Lack of Efficacy|0|||
94290916|NCT00792298|322852603|FG002|Treatment Period 1|Lack of Efficacy|1|||
94290917|NCT00792298|322852604|FG003|Treatment Period 1|Lack of Efficacy|0|||
94290918|NCT00792298|322852605|FG004|Treatment Period 1|Lack of Efficacy|0|||
94290919|NCT00792298|322852606|FG005|Treatment Period 1|Lack of Efficacy|0|||
94290920|NCT00792298|322852607|FG006|Treatment Period 1|Lack of Efficacy|0|||
94290921|NCT00792298|322852608|FG007|Treatment Period 1|Lack of Efficacy|0|||
94290922|NCT00792298|322852601|FG000|Treatment Period 1|Withdrawal by Subject|1|||
94290923|NCT00792298|322852602|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94290924|NCT00792298|322852603|FG002|Treatment Period 1|Withdrawal by Subject|1|||
94290925|NCT00792298|322852604|FG003|Treatment Period 1|Withdrawal by Subject|2|||
94467969|NCT01887678|323502460|FG001|Overall Study|Adverse Event|6|||
94467970|NCT01887678|323502459|FG000|Overall Study|Exceeded rescue medication dosage|4|||
94290926|NCT00792298|322852605|FG004|Treatment Period 1|Withdrawal by Subject|0|||
94290927|NCT00792298|322852606|FG005|Treatment Period 1|Withdrawal by Subject|2|||
94290928|NCT00792298|322852607|FG006|Treatment Period 1|Withdrawal by Subject|1|||
94290929|NCT00792298|322852608|FG007|Treatment Period 1|Withdrawal by Subject|0|||
94290930|NCT00792298|322852601|FG000|Treatment Period 1|Lost to Follow-up|0|||
94290931|NCT00792298|322852602|FG001|Treatment Period 1|Lost to Follow-up|0|||
94290932|NCT00792298|322852603|FG002|Treatment Period 1|Lost to Follow-up|0|||
94290933|NCT00792298|322852604|FG003|Treatment Period 1|Lost to Follow-up|0|||
94290934|NCT00792298|322852605|FG004|Treatment Period 1|Lost to Follow-up|0|||
94290935|NCT00792298|322852606|FG005|Treatment Period 1|Lost to Follow-up|0|||
94290936|NCT00792298|322852607|FG006|Treatment Period 1|Lost to Follow-up|1|||
94290937|NCT00792298|322852608|FG007|Treatment Period 1|Lost to Follow-up|0|||
94290938|NCT00792298|322852601|FG000|Treatment Period 1|Physician Decision|0|||
94290939|NCT00792298|322852602|FG001|Treatment Period 1|Physician Decision|0|||
94290940|NCT00792298|322852603|FG002|Treatment Period 1|Physician Decision|0|||
94290941|NCT00792298|322852604|FG003|Treatment Period 1|Physician Decision|1|||
94290942|NCT00792298|322852605|FG004|Treatment Period 1|Physician Decision|0|||
94290943|NCT00792298|322852606|FG005|Treatment Period 1|Physician Decision|0|||
94290944|NCT00792298|322852607|FG006|Treatment Period 1|Physician Decision|1|||
94290945|NCT00792298|322852608|FG007|Treatment Period 1|Physician Decision|0|||
94290946|NCT00792298|322852601|FG000|Treatment Period 1|Protocol Violation|0|||
94290947|NCT00792298|322852602|FG001|Treatment Period 1|Protocol Violation|0|||
94290948|NCT00792298|322852603|FG002|Treatment Period 1|Protocol Violation|0|||
94290949|NCT00792298|322852604|FG003|Treatment Period 1|Protocol Violation|0|||
94290950|NCT00792298|322852605|FG004|Treatment Period 1|Protocol Violation|0|||
94290951|NCT00792298|322852606|FG005|Treatment Period 1|Protocol Violation|0|||
94290952|NCT00792298|322852607|FG006|Treatment Period 1|Protocol Violation|0|||
94290953|NCT00792298|322852608|FG007|Treatment Period 1|Protocol Violation|1|||
94290954|NCT00792298|322852601|FG000|Washout|Adverse Event|0|||
94290955|NCT00792298|322852602|FG001|Washout|Adverse Event|0|||
94290956|NCT00792298|322852603|FG002|Washout|Adverse Event|0|||
94290957|NCT00792298|322852604|FG003|Washout|Adverse Event|0|||
94290958|NCT00792298|322852605|FG004|Washout|Adverse Event|0|||
94290959|NCT00792298|322852606|FG005|Washout|Adverse Event|1|||
94290960|NCT00792298|322852607|FG006|Washout|Adverse Event|0|||
94290961|NCT00792298|322852608|FG007|Washout|Adverse Event|0|||
94290962|NCT00792298|322852601|FG000|Washout|Withdrawal by Subject|0|||
94290963|NCT00792298|322852602|FG001|Washout|Withdrawal by Subject|0|||
94290964|NCT00792298|322852603|FG002|Washout|Withdrawal by Subject|1|||
94290965|NCT00792298|322852604|FG003|Washout|Withdrawal by Subject|0|||
94290966|NCT00792298|322852605|FG004|Washout|Withdrawal by Subject|0|||
94290967|NCT00792298|322852606|FG005|Washout|Withdrawal by Subject|1|||
94290968|NCT00792298|322852607|FG006|Washout|Withdrawal by Subject|0|||
94290969|NCT00792298|322852608|FG007|Washout|Withdrawal by Subject|0|||
94290970|NCT00792298|322852601|FG000|Treatment Period 2|Lack of Efficacy|0|||
94290971|NCT00792298|322852602|FG001|Treatment Period 2|Lack of Efficacy|0|||
94290972|NCT00792298|322852603|FG002|Treatment Period 2|Lack of Efficacy|0|||
94290973|NCT00792298|322852604|FG003|Treatment Period 2|Lack of Efficacy|0|||
94290974|NCT00792298|322852605|FG004|Treatment Period 2|Lack of Efficacy|1|||
94290975|NCT00792298|322852606|FG005|Treatment Period 2|Lack of Efficacy|0|||
94290976|NCT00792298|322852607|FG006|Treatment Period 2|Lack of Efficacy|0|||
94290977|NCT00792298|322852608|FG007|Treatment Period 2|Lack of Efficacy|0|||
94290978|NCT00792298|322852601|FG000|Treatment Period 2|Physician Decision|0|||
94290979|NCT00792298|322852602|FG001|Treatment Period 2|Physician Decision|0|||
94290980|NCT00792298|322852603|FG002|Treatment Period 2|Physician Decision|0|||
94290981|NCT00792298|322852604|FG003|Treatment Period 2|Physician Decision|0|||
94290982|NCT00792298|322852605|FG004|Treatment Period 2|Physician Decision|0|||
94290983|NCT00792298|322852606|FG005|Treatment Period 2|Physician Decision|0|||
94290984|NCT00792298|322852607|FG006|Treatment Period 2|Physician Decision|1|||
94290985|NCT00792298|322852608|FG007|Treatment Period 2|Physician Decision|0|||
94290986|NCT00792298|322852601|FG000|Treatment Period 2|Pregnancy|0|||
94290987|NCT00792298|322852602|FG001|Treatment Period 2|Pregnancy|0|||
94290988|NCT00792298|322852603|FG002|Treatment Period 2|Pregnancy|1|||
94290989|NCT00792298|322852604|FG003|Treatment Period 2|Pregnancy|0|||
94290990|NCT00792298|322852605|FG004|Treatment Period 2|Pregnancy|0|||
94290991|NCT00792298|322852606|FG005|Treatment Period 2|Pregnancy|0|||
94290992|NCT00792298|322852607|FG006|Treatment Period 2|Pregnancy|0|||
94290993|NCT00792298|322852608|FG007|Treatment Period 2|Pregnancy|0|||
94290994|NCT00792298|322852601|FG000|Treatment Period 2|Withdrawal by Subject|1|||
94290995|NCT00792298|322852602|FG001|Treatment Period 2|Withdrawal by Subject|1|||
94290996|NCT00792298|322852603|FG002|Treatment Period 2|Withdrawal by Subject|0|||
94290997|NCT00792298|322852604|FG003|Treatment Period 2|Withdrawal by Subject|2|||
94290998|NCT00792298|322852605|FG004|Treatment Period 2|Withdrawal by Subject|1|||
94290999|NCT00792298|322852606|FG005|Treatment Period 2|Withdrawal by Subject|0|||
94291000|NCT00792298|322852607|FG006|Treatment Period 2|Withdrawal by Subject|0|||
94291001|NCT00792298|322852608|FG007|Treatment Period 2|Withdrawal by Subject|2|||
94291002|NCT03093155|322852610|FG000|Overall Study|Not Eligible|1|||
94291003|NCT03093155|322852611|FG001|Overall Study|Not Eligible|0|||
94291004|NCT03093155|322852610|FG000|Overall Study|Withdrawal by Subject|0|||
94291005|NCT03093155|322852611|FG001|Overall Study|Withdrawal by Subject|1|||
94291006|NCT02429856|322852612|FG000|Overall Study|Death|12|||
94291007|NCT02429856|322852613|FG001|Overall Study|Death|13|||
94291008|NCT02429856|322852612|FG000|Overall Study|Lost to Follow-up|6|||
94291009|NCT02429856|322852613|FG001|Overall Study|Lost to Follow-up|5|||
94291010|NCT02429856|322852612|FG000|Overall Study|Withdrawal by Subject|1|||
94291011|NCT02429856|322852613|FG001|Overall Study|Withdrawal by Subject|1|||
94291012|NCT02041962|322852614|FG000|Overall Study|Lost Aetna Coverage|43|||
94291013|NCT02041962|322852615|FG001|Overall Study|Lost Aetna Coverage|40|||
94291014|NCT02041962|322852614|FG000|Overall Study|Death|1|||
94291015|NCT02041962|322852615|FG001|Overall Study|Death|1|||
94291016|NCT02041962|322852614|FG000|Overall Study|Lost to Follow-up|37|||
94291017|NCT02041962|322852615|FG001|Overall Study|Lost to Follow-up|32|||
94291018|NCT02041962|322852614|FG000|Overall Study|Withdrawal by Subject|0|||
94291019|NCT02041962|322852615|FG001|Overall Study|Withdrawal by Subject|11|||
94291020|NCT01481896|322852616|FG000|Overall Study|Lost to Follow-up|12|||
94291021|NCT02266433|322852619|FG000|Overall Study|Lost to Follow-up|54|||
94291022|NCT02266433|322852620|FG001|Overall Study|Lost to Follow-up|46|||
94291023|NCT02266433|322852619|FG000|Overall Study|Withdrawal by Subject|5|||
94291024|NCT02266433|322852620|FG001|Overall Study|Withdrawal by Subject|7|||
94291025|NCT00243659|322852621|FG000|Overall Study|Withdrawal by Subject|1|||
94291026|NCT00243659|322852622|FG001|Overall Study|Withdrawal by Subject|1|||
94291027|NCT00243659|322852621|FG000|Overall Study|Protocol Violation|1|||
94291028|NCT00243659|322852622|FG001|Overall Study|Protocol Violation|2|||
94291029|NCT02867761|322852629|FG000|Overall Study|Participant withdrawn by investigator|0|||
94291030|NCT02867761|322852630|FG001|Overall Study|Participant withdrawn by investigator|1|||
94291031|NCT02867761|322852629|FG000|Overall Study|Lost to Follow-up|25|||
94291032|NCT02867761|322852630|FG001|Overall Study|Lost to Follow-up|18|||
94291033|NCT02867761|322852629|FG000|Overall Study|Unable to complete protocol|3|||
94291034|NCT02867761|322852630|FG001|Overall Study|Unable to complete protocol|7|||
94291035|NCT03595280|322852631|FG000|Overall Study|Lost to Follow-up|6|||
94291036|NCT03595280|322852632|FG001|Overall Study|Lost to Follow-up|9|||
94291037|NCT03595280|322852633|FG002|Overall Study|Lost to Follow-up|15|||
94291038|NCT01931059|322852636|FG000|Day 1|Pregnancy|0|||
94291039|NCT01931059|322852637|FG001|Day 1|Pregnancy|1|||
94291040|NCT01931059|322852636|FG000|Day3|Lost to Follow-up|1|||
94291041|NCT01931059|322852637|FG001|Day3|Lost to Follow-up|0|||
94291042|NCT04957290|322852646|FG000|Overall Study|Progressive disease|3|||
94291043|NCT04957290|322852647|FG001|Overall Study|Progressive disease|3|||
94291044|NCT04957290|322852648|FG002|Overall Study|Progressive disease|2|||
94291045|NCT04957290|322852649|FG003|Overall Study|Progressive disease|0|||
94291046|NCT04957290|322852650|FG004|Overall Study|Progressive disease|0|||
94291047|NCT04957290|322852651|FG005|Overall Study|Progressive disease|0|||
94291048|NCT04957290|322852646|FG000|Overall Study|Withdrawal by Subject|1|||
94291049|NCT04957290|322852647|FG001|Overall Study|Withdrawal by Subject|0|||
94291050|NCT04957290|322852648|FG002|Overall Study|Withdrawal by Subject|1|||
94291051|NCT04957290|322852649|FG003|Overall Study|Withdrawal by Subject|0|||
94291052|NCT04957290|322852650|FG004|Overall Study|Withdrawal by Subject|0|||
94291053|NCT04957290|322852651|FG005|Overall Study|Withdrawal by Subject|0|||
94291054|NCT04957290|322852646|FG000|Overall Study|Death|0|||
94291055|NCT04957290|322852647|FG001|Overall Study|Death|2|||
94291056|NCT04957290|322852648|FG002|Overall Study|Death|1|||
94291057|NCT04957290|322852649|FG003|Overall Study|Death|0|||
94291058|NCT04957290|322852650|FG004|Overall Study|Death|0|||
94291059|NCT04957290|322852651|FG005|Overall Study|Death|0|||
94291060|NCT04957290|322852646|FG000|Overall Study|non compliance with study drug|0|||
94291061|NCT04957290|322852647|FG001|Overall Study|non compliance with study drug|1|||
94291062|NCT04957290|322852648|FG002|Overall Study|non compliance with study drug|0|||
94291063|NCT04957290|322852649|FG003|Overall Study|non compliance with study drug|0|||
94291064|NCT04957290|322852650|FG004|Overall Study|non compliance with study drug|0|||
94291065|NCT04957290|322852651|FG005|Overall Study|non compliance with study drug|0|||
94291066|NCT04957290|322852646|FG000|Overall Study|none specified.|0|||
94291067|NCT04957290|322852647|FG001|Overall Study|none specified.|1|||
94291068|NCT04957290|322852648|FG002|Overall Study|none specified.|2|||
94291069|NCT04957290|322852649|FG003|Overall Study|none specified.|0|||
94291070|NCT04957290|322852650|FG004|Overall Study|none specified.|0|||
94291071|NCT04957290|322852651|FG005|Overall Study|none specified.|0|||
94291072|NCT04957290|322852646|FG000|Overall Study|unacceptable toxicity|0|||
94291073|NCT04957290|322852647|FG001|Overall Study|unacceptable toxicity|0|||
94291074|NCT04957290|322852648|FG002|Overall Study|unacceptable toxicity|1|||
94291075|NCT04957290|322852649|FG003|Overall Study|unacceptable toxicity|0|||
94291076|NCT04957290|322852650|FG004|Overall Study|unacceptable toxicity|0|||
94291077|NCT04957290|322852651|FG005|Overall Study|unacceptable toxicity|0|||
94291078|NCT04957290|322852646|FG000|Overall Study|Adverse Event|0|||
94291079|NCT04957290|322852647|FG001|Overall Study|Adverse Event|0|||
94291080|NCT04957290|322852648|FG002|Overall Study|Adverse Event|1|||
94291081|NCT04957290|322852649|FG003|Overall Study|Adverse Event|0|||
94291082|NCT04957290|322852650|FG004|Overall Study|Adverse Event|0|||
94291083|NCT04957290|322852651|FG005|Overall Study|Adverse Event|0|||
94291084|NCT04957290|322852646|FG000|Overall Study|study terminated by sponsor|0|||
94291085|NCT04957290|322852647|FG001|Overall Study|study terminated by sponsor|0|||
94291086|NCT04957290|322852648|FG002|Overall Study|study terminated by sponsor|2|||
94291087|NCT04957290|322852649|FG003|Overall Study|study terminated by sponsor|0|||
94291088|NCT04957290|322852650|FG004|Overall Study|study terminated by sponsor|0|||
94291089|NCT04957290|322852651|FG005|Overall Study|study terminated by sponsor|0|||
94291090|NCT02149810|322852652|FG000|Overall Study|Physician Decision|1|||
94291091|NCT02149810|322852653|FG001|Overall Study|Physician Decision|2|||
94291092|NCT02149810|322852652|FG000|Overall Study|Lost to Follow-up|2|||
94291093|NCT02149810|322852653|FG001|Overall Study|Lost to Follow-up|1|||
94291094|NCT02149810|322852652|FG000|Overall Study|Withdrawal by Subject|5|||
94291095|NCT02149810|322852653|FG001|Overall Study|Withdrawal by Subject|1|||
94291096|NCT03158220|322852654|FG000|Overall Study|Screen Failure|0|||
94291097|NCT03158220|322852655|FG001|Overall Study|Screen Failure|1|||
94291098|NCT03158220|322852654|FG000|Overall Study|Withdrawal by Subject|8|||
94291099|NCT03158220|322852655|FG001|Overall Study|Withdrawal by Subject|9|||
94291100|NCT03158220|322852654|FG000|Overall Study|Status unknown|0|||
94291101|NCT03158220|322852655|FG001|Overall Study|Status unknown|1|||
94291102|NCT03158220|322852654|FG000|Overall Study|Lost to Follow-up|8|||
94291103|NCT03158220|322852655|FG001|Overall Study|Lost to Follow-up|5|||
94291104|NCT03158220|322852654|FG000|Overall Study|Physician Decision|1|||
94291105|NCT03158220|322852655|FG001|Overall Study|Physician Decision|0|||
94291106|NCT01469000|322852656|FG000|Overall Study|Withdrawal by Subject|16|||
94291107|NCT01469000|322852657|FG001|Overall Study|Withdrawal by Subject|3|||
94291108|NCT01469000|322852656|FG000|Overall Study|Sponsor Decision|4|||
94291109|NCT01469000|322852657|FG001|Overall Study|Sponsor Decision|1|||
94291110|NCT01671280|322852659|FG000|Overall Study|Withdrawal by Subject|2|||
94467971|NCT01887678|323502460|FG001|Overall Study|Exceeded rescue medication dosage|5|||
94467972|NCT01887678|323502459|FG000|Overall Study|Withdrawal of consent|3|||
94291111|NCT01959165|322852660|FG000|Overall Study|Adverse Event|0|||
94291112|NCT01959165|322852661|FG001|Overall Study|Adverse Event|0|||
94291113|NCT01959165|322852662|FG002|Overall Study|Adverse Event|0|||
94291114|NCT01959165|322852663|FG003|Overall Study|Adverse Event|1|||
94291115|NCT01959165|322852660|FG000|Overall Study|Lack of Efficacy|1|||
94291116|NCT01959165|322852661|FG001|Overall Study|Lack of Efficacy|0|||
94291117|NCT01959165|322852662|FG002|Overall Study|Lack of Efficacy|0|||
94291118|NCT01959165|322852663|FG003|Overall Study|Lack of Efficacy|0|||
94291119|NCT01959165|322852660|FG000|Overall Study|overdose|0|||
94291120|NCT01959165|322852661|FG001|Overall Study|overdose|0|||
94291121|NCT01959165|322852662|FG002|Overall Study|overdose|0|||
94291122|NCT01959165|322852663|FG003|Overall Study|overdose|1|||
94291123|NCT01959165|322852660|FG000|Overall Study|Welfare recipient|0|||
94291124|NCT01959165|322852661|FG001|Overall Study|Welfare recipient|1|||
94291125|NCT01959165|322852662|FG002|Overall Study|Welfare recipient|0|||
94291126|NCT01959165|322852663|FG003|Overall Study|Welfare recipient|0|||
94291127|NCT00848120|322852664|FG000|Overall Study|Adverse Event|1|||
94291128|NCT00560755|322852665|FG000|Overall Study|Protocol Violation|15|||
94291129|NCT00560755|322852665|FG000|Overall Study|Withdrawal by Subject|26|||
94291130|NCT00560755|322852665|FG000|Overall Study|Lost to Follow-up|9|||
94291131|NCT00560755|322852665|FG000|Overall Study|Adverse Event|8|||
94291132|NCT00560755|322852665|FG000|Overall Study|Physician Decision|2|||
94291133|NCT00769119|322852669|FG000|Overall Study|Voluntary discontinuation|0|||
94291134|NCT00769119|322852670|FG001|Overall Study|Voluntary discontinuation|2|||
94291135|NCT00769119|322852669|FG000|Overall Study|Adverse Event|1|||
94291136|NCT00769119|322852670|FG001|Overall Study|Adverse Event|1|||
94291137|NCT00769119|322852669|FG000|Overall Study|Disallowed medication|1|||
94291138|NCT00769119|322852670|FG001|Overall Study|Disallowed medication|0|||
94291139|NCT00686647|322852678|FG000|Overall Study|Lost to Follow-up|1|||
94291140|NCT00686647|322852678|FG000|Overall Study|Death|1|||
94291141|NCT03094195|322852679|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
94291142|NCT03094195|322852680|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
94291143|NCT03094195|322852681|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
94291144|NCT03094195|322852682|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
94291145|NCT03094195|322852683|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
94291146|NCT03094195|322852684|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
94291147|NCT03094195|322852685|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
94291148|NCT03094195|322852686|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
94291149|NCT03094195|322852679|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
94291150|NCT03094195|322852680|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
94291151|NCT03094195|322852681|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
94291152|NCT03094195|322852682|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
94291153|NCT03094195|322852683|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
94291154|NCT03094195|322852684|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
94291155|NCT03094195|322852685|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
94291156|NCT03094195|322852686|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
94291157|NCT03094195|322852679|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
94291158|NCT03094195|322852680|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
94291159|NCT03094195|322852681|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
94291160|NCT03094195|322852682|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
94291161|NCT03094195|322852683|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
94291162|NCT03094195|322852684|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
94291163|NCT03094195|322852685|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
94291164|NCT03094195|322852686|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
94291165|NCT03094195|322852679|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
94291166|NCT03094195|322852680|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
94291167|NCT03094195|322852681|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
94291168|NCT03094195|322852682|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
94291169|NCT03094195|322852683|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
94291170|NCT03094195|322852684|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
94291171|NCT03094195|322852685|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
94291172|NCT03094195|322852686|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
94291173|NCT01961115|322852687|FG000|Overall Study|Disease Progression|1|||
94291174|NCT01961115|322852688|FG001|Overall Study|Disease Progression|0|||
94291175|NCT01961115|322852689|FG002|Overall Study|Disease Progression|3|||
94291176|NCT01961115|322852687|FG000|Overall Study|Adverse Event|1|||
94291177|NCT01961115|322852688|FG001|Overall Study|Adverse Event|0|||
94291178|NCT01961115|322852689|FG002|Overall Study|Adverse Event|1|||
94291179|NCT02497001|322852690|FG000|Overall Study|Lost to Follow-up|10|||
94291180|NCT02497001|322852691|FG001|Overall Study|Lost to Follow-up|2|||
94291181|NCT02497001|322852692|FG002|Overall Study|Lost to Follow-up|0|||
94291182|NCT02497001|322852693|FG003|Overall Study|Lost to Follow-up|2|||
94291183|NCT02497001|322852690|FG000|Overall Study|Adverse Event|28|||
94291184|NCT02497001|322852691|FG001|Overall Study|Adverse Event|30|||
94291185|NCT02497001|322852692|FG002|Overall Study|Adverse Event|11|||
94291186|NCT02497001|322852693|FG003|Overall Study|Adverse Event|11|||
94467973|NCT01887678|323502460|FG001|Overall Study|Withdrawal of consent|4|||
94291187|NCT02497001|322852690|FG000|Overall Study|Withdrawal by Subject|14|||
94291188|NCT02497001|322852691|FG001|Overall Study|Withdrawal by Subject|37|||
94291189|NCT02497001|322852692|FG002|Overall Study|Withdrawal by Subject|19|||
94291190|NCT02497001|322852693|FG003|Overall Study|Withdrawal by Subject|15|||
94291191|NCT02497001|322852690|FG000|Overall Study|Physician Decision|5|||
94291192|NCT02497001|322852691|FG001|Overall Study|Physician Decision|11|||
94291193|NCT02497001|322852692|FG002|Overall Study|Physician Decision|5|||
94291194|NCT02497001|322852693|FG003|Overall Study|Physician Decision|1|||
94291195|NCT02497001|322852690|FG000|Overall Study|subjects that were not treated|1|||
94291196|NCT02497001|322852691|FG001|Overall Study|subjects that were not treated|2|||
94291197|NCT02497001|322852692|FG002|Overall Study|subjects that were not treated|2|||
94291198|NCT02497001|322852693|FG003|Overall Study|subjects that were not treated|1|||
94291199|NCT02497001|322852690|FG000|Overall Study|Major Protocol Deviation|3|||
94291200|NCT02497001|322852691|FG001|Overall Study|Major Protocol Deviation|4|||
94291201|NCT02497001|322852692|FG002|Overall Study|Major Protocol Deviation|4|||
94291202|NCT02497001|322852693|FG003|Overall Study|Major Protocol Deviation|4|||
94291203|NCT02497001|322852690|FG000|Overall Study|Lack of Efficacy|10|||
94291204|NCT02497001|322852691|FG001|Overall Study|Lack of Efficacy|16|||
94291205|NCT02497001|322852692|FG002|Overall Study|Lack of Efficacy|6|||
94291206|NCT02497001|322852693|FG003|Overall Study|Lack of Efficacy|6|||
94291207|NCT02497001|322852690|FG000|Overall Study|Protocol Violation|3|||
94291208|NCT02497001|322852691|FG001|Overall Study|Protocol Violation|1|||
94291209|NCT02497001|322852692|FG002|Overall Study|Protocol Violation|3|||
94291210|NCT02497001|322852693|FG003|Overall Study|Protocol Violation|1|||
94291211|NCT01752023|322852694|FG000|Overall Study|Physician Decision|2|||
94291212|NCT01752023|322852695|FG001|Overall Study|Physician Decision|1|||
94291213|NCT01275222|322852696|FG000|Phase l by Treatment|Adverse Event|1|||
94291214|NCT01275222|322852697|FG001|Phase l by Treatment|Adverse Event|4|||
94291215|NCT01275222|322852698|FG002|Phase l by Treatment|Adverse Event|2|||
94291216|NCT01275222|322852699|FG003|Phase l by Treatment|Adverse Event|3|||
94291217|NCT01275222|322852700|FG004|Phase l by Treatment|Adverse Event|0|||
94291218|NCT01275222|322852701|FG005|Phase l by Treatment|Adverse Event|0|||
94291219|NCT01275222|322852696|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
94291220|NCT01275222|322852697|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
94291221|NCT01275222|322852698|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
94291222|NCT01275222|322852699|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
94291223|NCT01275222|322852700|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
94291224|NCT01275222|322852701|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
94291225|NCT01275222|322852696|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
94291226|NCT01275222|322852697|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
94291227|NCT01275222|322852698|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
94291228|NCT01275222|322852699|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
94291229|NCT01275222|322852700|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
94291230|NCT01275222|322852701|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
94291231|NCT01275222|322852696|FG000|Phase l by Treatment|Disease progression|12|||
94291232|NCT01275222|322852697|FG001|Phase l by Treatment|Disease progression|8|||
94291233|NCT01275222|322852698|FG002|Phase l by Treatment|Disease progression|2|||
94291234|NCT01275222|322852699|FG003|Phase l by Treatment|Disease progression|5|||
94291235|NCT01275222|322852700|FG004|Phase l by Treatment|Disease progression|0|||
94291236|NCT01275222|322852701|FG005|Phase l by Treatment|Disease progression|0|||
94291237|NCT01275222|322852696|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
94291238|NCT01275222|322852697|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
94291239|NCT01275222|322852698|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
94291240|NCT01275222|322852699|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
94291241|NCT01275222|322852700|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
94291242|NCT01275222|322852701|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
94291243|NCT01275222|322852696|FG000|Phase l by Treatment|Death|0|||
94291244|NCT01275222|322852697|FG001|Phase l by Treatment|Death|1|||
94291245|NCT01275222|322852698|FG002|Phase l by Treatment|Death|0|||
94291246|NCT01275222|322852699|FG003|Phase l by Treatment|Death|1|||
94291247|NCT01275222|322852700|FG004|Phase l by Treatment|Death|0|||
94291248|NCT01275222|322852701|FG005|Phase l by Treatment|Death|0|||
94291249|NCT01275222|322852696|FG000|Phase ll by Stratum|Adverse Event|0|||
94291250|NCT01275222|322852697|FG001|Phase ll by Stratum|Adverse Event|0|||
94291251|NCT01275222|322852698|FG002|Phase ll by Stratum|Adverse Event|0|||
94291252|NCT01275222|322852699|FG003|Phase ll by Stratum|Adverse Event|0|||
94291253|NCT01275222|322852700|FG004|Phase ll by Stratum|Adverse Event|2|||
94291254|NCT01275222|322852701|FG005|Phase ll by Stratum|Adverse Event|10|||
94291255|NCT01275222|322852696|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
94291256|NCT01275222|322852697|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
94291257|NCT01275222|322852698|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
94291258|NCT01275222|322852699|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
94291259|NCT01275222|322852700|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
94291260|NCT01275222|322852701|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
94291261|NCT01275222|322852696|FG000|Phase ll by Stratum|Disease progression|0|||
94291262|NCT01275222|322852697|FG001|Phase ll by Stratum|Disease progression|0|||
94291263|NCT01275222|322852698|FG002|Phase ll by Stratum|Disease progression|0|||
94291264|NCT01275222|322852699|FG003|Phase ll by Stratum|Disease progression|0|||
94291265|NCT01275222|322852700|FG004|Phase ll by Stratum|Disease progression|23|||
94291266|NCT01275222|322852701|FG005|Phase ll by Stratum|Disease progression|31|||
94291267|NCT01275222|322852696|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
94291268|NCT01275222|322852697|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
94291269|NCT01275222|322852698|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
94291270|NCT01275222|322852699|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
94291271|NCT01275222|322852700|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
94291272|NCT01275222|322852701|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
94291273|NCT01275222|322852696|FG000|Phase ll by Stratum|Death|0|||
94291274|NCT01275222|322852697|FG001|Phase ll by Stratum|Death|0|||
94291275|NCT01275222|322852698|FG002|Phase ll by Stratum|Death|0|||
94291276|NCT01275222|322852699|FG003|Phase ll by Stratum|Death|0|||
94291277|NCT01275222|322852700|FG004|Phase ll by Stratum|Death|1|||
94291278|NCT01275222|322852701|FG005|Phase ll by Stratum|Death|1|||
94291279|NCT01661790|322852703|FG000|Overall Study|Lost to Follow-up|0|||
94291280|NCT01661790|322852704|FG001|Overall Study|Lost to Follow-up|2|||
94291281|NCT01990261|322852705|FG000|Overall Study|Death Before Treatment Start|2|||
94291282|NCT01990261|322852705|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
94291283|NCT01990261|322852705|FG000|Overall Study|Death From other Causes|1|||
94291284|NCT01990261|322852705|FG000|Overall Study|Disease Progression (PD)|8|||
94291285|NCT01990261|322852705|FG000|Overall Study|PD Before Treatment Start|1|||
94291286|NCT01990261|322852705|FG000|Overall Study|Dossier not Approved|1|||
94291287|NCT01990261|322852705|FG000|Overall Study|Lost to Follow-up|2|||
94291288|NCT00925600|322854532|FG000|Overall Study|Withdrawal by Subject|16|||
94291289|NCT00925600|322854533|FG001|Overall Study|Withdrawal by Subject|14|||
94291290|NCT00925600|322854532|FG000|Overall Study|Death|4|||
94291291|NCT00925600|322854533|FG001|Overall Study|Death|3|||
94291292|NCT00925600|322854532|FG000|Overall Study|Lost to Follow-up|2|||
94291293|NCT00925600|322854533|FG001|Overall Study|Lost to Follow-up|2|||
94291294|NCT00925600|322854532|FG000|Overall Study|Disease Progression|1|||
94291295|NCT00925600|322854533|FG001|Overall Study|Disease Progression|3|||
94291296|NCT00925600|322854532|FG000|Overall Study|Administrative Decision|1|||
94291297|NCT00925600|322854533|FG001|Overall Study|Administrative Decision|1|||
94291298|NCT00925600|322854532|FG000|Overall Study|Noncompliance|2|||
94291299|NCT00925600|322854533|FG001|Overall Study|Noncompliance|0|||
94291300|NCT00925600|322854532|FG000|Overall Study|Ineligibility Determined|2|||
94291301|NCT00925600|322854533|FG001|Overall Study|Ineligibility Determined|0|||
94291302|NCT00925600|322854532|FG000|Overall Study|Protocol Deviation|0|||
94291303|NCT00925600|322854533|FG001|Overall Study|Protocol Deviation|1|||
94291304|NCT00925600|322854532|FG000|Overall Study|Requirement for Alternative Therapy|0|||
94291305|NCT00925600|322854533|FG001|Overall Study|Requirement for Alternative Therapy|1|||
94291306|NCT00925600|322854532|FG000|Overall Study|Other|3|||
94291307|NCT00925600|322854533|FG001|Overall Study|Other|1|||
94291308|NCT00925600|322854532|FG000|Overall Study|Adverse Event|1|||
94291309|NCT00925600|322854533|FG001|Overall Study|Adverse Event|2|||
94291310|NCT03593915|322854534|FG000|Overall Study|Adverse Event|0|||
94291311|NCT03593915|322854535|FG001|Overall Study|Adverse Event|0|||
94291312|NCT03593915|322854536|FG002|Overall Study|Adverse Event|0|||
94291313|NCT03593915|322854537|FG003|Overall Study|Adverse Event|1|||
94291314|NCT03593915|322854538|FG004|Overall Study|Adverse Event|0|||
94291315|NCT03593915|322854539|FG005|Overall Study|Adverse Event|0|||
94291316|NCT03593915|322854534|FG000|Overall Study|Physician Decision|0|||
94291317|NCT03593915|322854535|FG001|Overall Study|Physician Decision|0|||
94291318|NCT03593915|322854536|FG002|Overall Study|Physician Decision|0|||
94291319|NCT03593915|322854537|FG003|Overall Study|Physician Decision|0|||
94291320|NCT03593915|322854538|FG004|Overall Study|Physician Decision|0|||
94291321|NCT03593915|322854539|FG005|Overall Study|Physician Decision|1|||
94291322|NCT04188197|322854540|FG000|Overall Study|Lost to Follow-up|4|||
94291323|NCT04188197|322854541|FG001|Overall Study|Lost to Follow-up|1|||
94291324|NCT04188197|322854540|FG000|Overall Study|Withdrawal by Subject|1|||
94291325|NCT04188197|322854541|FG001|Overall Study|Withdrawal by Subject|1|||
94291326|NCT04188197|322854540|FG000|Overall Study|Pregnancy|0|||
94291327|NCT04188197|322854541|FG001|Overall Study|Pregnancy|1|||
94291328|NCT00132041|322854544|FG000|Baseline|Ineligible|6|||
94291329|NCT00132041|322854544|FG000|3 Months Post Ablation|Transplant|1|||
94291330|NCT00132041|322854544|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
94291331|NCT00132041|322854544|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
94291332|NCT00132041|322854544|FG000|6 Months Post Ablation|Death|2|||
94291333|NCT00132041|322854544|FG000|6 Months Post Ablation|Transplant|6|||
94291334|NCT00132041|322854544|FG000|9 Months Post Ablation|Death|1|||
94291335|NCT00132041|322854544|FG000|9 Months Post Ablation|Transplant|1|||
94291336|NCT00132041|322854544|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
94291337|NCT00132041|322854544|FG000|12 Months Post Ablation|Death|1|||
94291338|NCT00132041|322854544|FG000|12 Months Post Ablation|Transplant|1|||
94291339|NCT00132041|322854544|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
94291340|NCT00132041|322854544|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
94291341|NCT00132041|322854544|FG000|15 Months Post Ablation|Death|1|||
94291342|NCT00132041|322854544|FG000|15 Months Post Ablation|Transplant|5|||
94291343|NCT00132041|322854544|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
94291344|NCT00132041|322854544|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
94291345|NCT00132041|322854544|FG000|18 Months Post Ablation|Transplant|1|||
94291346|NCT00132041|322854544|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
94291347|NCT00132041|322854544|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
94291348|NCT00167245|322854545|FG000|Overall Study|Lost to Follow-up|20|||
94291349|NCT00167245|322854546|FG001|Overall Study|Lost to Follow-up|31|||
94291350|NCT00167245|322854545|FG000|Overall Study|Withdrawal by Subject|5|||
94291351|NCT00167245|322854546|FG001|Overall Study|Withdrawal by Subject|8|||
94291352|NCT00167245|322854545|FG000|Overall Study|Incarcerated|3|||
94291353|NCT00167245|322854546|FG001|Overall Study|Incarcerated|2|||
94291354|NCT00167245|322854545|FG000|Overall Study|Drowsy|1|||
94291355|NCT00167245|322854546|FG001|Overall Study|Drowsy|0|||
94291356|NCT01773421|322854547|FG000|Treatment Phase|Other|0|||
94291357|NCT01773421|322854548|FG001|Treatment Phase|Other|0|||
94291358|NCT01773421|322854549|FG002|Treatment Phase|Other|2|||
94291359|NCT01773421|322854550|FG003|Treatment Phase|Other|0|||
94291360|NCT01773421|322854551|FG004|Treatment Phase|Other|0|||
94291361|NCT01773421|322854552|FG005|Treatment Phase|Other|0|||
94291362|NCT01773421|322854553|FG006|Treatment Phase|Other|0|||
94291363|NCT01773421|322854547|FG000|Treatment Phase|Adverse Event|0|||
94291364|NCT01773421|322854548|FG001|Treatment Phase|Adverse Event|0|||
94291365|NCT01773421|322854549|FG002|Treatment Phase|Adverse Event|3|||
94291366|NCT01773421|322854550|FG003|Treatment Phase|Adverse Event|1|||
94291367|NCT01773421|322854551|FG004|Treatment Phase|Adverse Event|0|||
94291368|NCT01773421|322854552|FG005|Treatment Phase|Adverse Event|0|||
94291369|NCT01773421|322854553|FG006|Treatment Phase|Adverse Event|0|||
94291370|NCT01773421|322854547|FG000|Treatment Phase|Withdrawal by Subject|0|||
94291371|NCT01773421|322854548|FG001|Treatment Phase|Withdrawal by Subject|0|||
94291372|NCT01773421|322854549|FG002|Treatment Phase|Withdrawal by Subject|1|||
94291373|NCT01773421|322854550|FG003|Treatment Phase|Withdrawal by Subject|1|||
94291374|NCT01773421|322854551|FG004|Treatment Phase|Withdrawal by Subject|0|||
94291375|NCT01773421|322854552|FG005|Treatment Phase|Withdrawal by Subject|0|||
94291376|NCT01773421|322854553|FG006|Treatment Phase|Withdrawal by Subject|0|||
94291377|NCT01773421|322854547|FG000|Extension Phase|Other|0|||
94291378|NCT01773421|322854548|FG001|Extension Phase|Other|0|||
94291379|NCT01773421|322854549|FG002|Extension Phase|Other|0|||
94291380|NCT01773421|322854550|FG003|Extension Phase|Other|0|||
94291381|NCT01773421|322854551|FG004|Extension Phase|Other|1|||
94291382|NCT01773421|322854552|FG005|Extension Phase|Other|2|||
94291383|NCT01773421|322854553|FG006|Extension Phase|Other|0|||
94291384|NCT01773421|322854547|FG000|Extension Phase|Adverse Event|0|||
94291385|NCT01773421|322854548|FG001|Extension Phase|Adverse Event|0|||
94291386|NCT01773421|322854549|FG002|Extension Phase|Adverse Event|0|||
94291387|NCT01773421|322854550|FG003|Extension Phase|Adverse Event|0|||
94291388|NCT01773421|322854551|FG004|Extension Phase|Adverse Event|2|||
94291389|NCT01773421|322854552|FG005|Extension Phase|Adverse Event|0|||
94291390|NCT01773421|322854553|FG006|Extension Phase|Adverse Event|0|||
94291391|NCT01220414|322854554|FG000|Overall Study|Withdrawal by Subject|1|||
94291392|NCT01220414|322854555|FG001|Overall Study|Withdrawal by Subject|0|||
94291393|NCT01220414|322854556|FG002|Overall Study|Withdrawal by Subject|0|||
94291394|NCT01220414|322854557|FG003|Overall Study|Withdrawal by Subject|1|||
94291395|NCT02472847|322854559|FG000|Overall Study|Withdrawal by Subject|1|||
94291396|NCT02472847|322854560|FG001|Overall Study|Withdrawal by Subject|5|||
94291397|NCT04656990|322854561|FG000|Baseline|pandemic|20|||
94291398|NCT04656990|322854562|FG001|Baseline|pandemic|24|||
94291399|NCT04656990|322854561|FG000|Follow Up Period|Lost to Follow-up|61|||
94291400|NCT04656990|322854562|FG001|Follow Up Period|Lost to Follow-up|73|||
94291401|NCT00008385|322854563|FG000|Overall Study|Off treatment reasons not reported|79|||
94291402|NCT00008385|322854564|FG001|Overall Study|Off treatment reasons not reported|70|||
94291403|NCT00008385|322854563|FG000|Overall Study|Progressive disease|52|||
94291404|NCT00008385|322854564|FG001|Overall Study|Progressive disease|117|||
94291405|NCT00008385|322854563|FG000|Overall Study|Adverse Event|8|||
94291406|NCT00008385|322854564|FG001|Overall Study|Adverse Event|20|||
94291407|NCT00008385|322854563|FG000|Overall Study|Death|12|||
94291408|NCT00008385|322854564|FG001|Overall Study|Death|18|||
94291409|NCT00008385|322854563|FG000|Overall Study|Withdrawal by Subject|67|||
94291410|NCT00008385|322854564|FG001|Overall Study|Withdrawal by Subject|157|||
94291411|NCT00008385|322854563|FG000|Overall Study|Start non-protocol therapy|3|||
94291412|NCT00008385|322854564|FG001|Overall Study|Start non-protocol therapy|1|||
94291413|NCT00008385|322854563|FG000|Overall Study|Other complicating disease|17|||
94291414|NCT00008385|322854564|FG001|Overall Study|Other complicating disease|30|||
94291415|NCT00008385|322854563|FG000|Overall Study|Maximum dose reached|0|||
94291416|NCT00008385|322854564|FG001|Overall Study|Maximum dose reached|2|||
94291417|NCT00008385|322854563|FG000|Overall Study|Other|105|||
94291418|NCT00008385|322854564|FG001|Overall Study|Other|212|||
94291419|NCT00008385|322854563|FG000|Overall Study|Not start protocol therapy|44|||
94291420|NCT00008385|322854564|FG001|Overall Study|Not start protocol therapy|175|||
94291421|NCT05148884|322854565|FG000|Overall Study|Withdrawal by Subject|3|||
94291422|NCT05148884|322854566|FG001|Overall Study|Withdrawal by Subject|0|||
94291423|NCT05148884|322854565|FG000|Overall Study|Deep brain stimulation operation|0|||
94291424|NCT05148884|322854566|FG001|Overall Study|Deep brain stimulation operation|1|||
94291425|NCT01993888|322854567|FG000|Overall Study|Death|1|||
94291426|NCT01993888|322854568|FG001|Overall Study|Death|1|||
94291427|NCT01993888|322854567|FG000|Overall Study|Lost to Follow-up|1|||
94291428|NCT01993888|322854568|FG001|Overall Study|Lost to Follow-up|1|||
94291429|NCT01993888|322854567|FG000|Overall Study|Withdrawal by Subject|0|||
94291430|NCT01993888|322854568|FG001|Overall Study|Withdrawal by Subject|1|||
94291431|NCT01341457|322854569|FG000|Overall Study|Adverse Event|2|||
94291432|NCT01341457|322854570|FG001|Overall Study|Adverse Event|0|||
94291433|NCT02000622|322854571|FG000|Overall Study|Withdrawal by Subject|5|||
94291434|NCT02000622|322854572|FG001|Overall Study|Withdrawal by Subject|7|||
94291435|NCT02000622|322854571|FG000|Overall Study|Lost to Follow-up|4|||
94291436|NCT02000622|322854572|FG001|Overall Study|Lost to Follow-up|0|||
94291437|NCT02000622|322854571|FG000|Overall Study|Death|159|||
94291438|NCT02000622|322854572|FG001|Overall Study|Death|73|||
94291439|NCT02000622|322854571|FG000|Overall Study|Withdrawn due to site closure|1|||
94291440|NCT02000622|322854572|FG001|Overall Study|Withdrawn due to site closure|0|||
94291441|NCT00605267|322854573|FG000|Overall Study|Adverse Event|0|||
94291442|NCT00605267|322854574|FG001|Overall Study|Adverse Event|1|||
94291443|NCT00605267|322854573|FG000|Overall Study|Lack of Efficacy|1|||
94291444|NCT00605267|322854574|FG001|Overall Study|Lack of Efficacy|5|||
94291445|NCT00605267|322854573|FG000|Overall Study|Withdrawal by Subject|2|||
94291446|NCT00605267|322854574|FG001|Overall Study|Withdrawal by Subject|3|||
94291447|NCT02162862|322854575|FG000|Overall Study|Lost to Follow-up|0|||
94291448|NCT02162862|322854576|FG001|Overall Study|Lost to Follow-up|11|||
94291449|NCT02162862|322854577|FG002|Overall Study|Lost to Follow-up|0|||
94291450|NCT02162862|322854575|FG000|Overall Study|Subject did not feel the med was needed|0|||
94291451|NCT02162862|322854576|FG001|Overall Study|Subject did not feel the med was needed|0|||
94291452|NCT02162862|322854577|FG002|Overall Study|Subject did not feel the med was needed|4|||
94291453|NCT04684420|322854579|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94291454|NCT04684420|322854580|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94291455|NCT04684420|322854581|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
94291456|NCT04684420|322854582|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
94291457|NCT04684420|322854579|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
94291458|NCT04684420|322854580|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
94291459|NCT04684420|322854581|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
94291460|NCT04684420|322854582|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
94291461|NCT01169779|322854584|FG000|Overall Study|Adverse Event|3|||
94291462|NCT01169779|322854585|FG001|Overall Study|Adverse Event|11|||
94291463|NCT01169779|322854584|FG000|Overall Study|Lack of Efficacy|1|||
94291464|NCT01169779|322854585|FG001|Overall Study|Lack of Efficacy|0|||
94291465|NCT01169779|322854584|FG000|Overall Study|Protocol Violation|1|||
94291466|NCT01169779|322854585|FG001|Overall Study|Protocol Violation|1|||
94291467|NCT01169779|322854584|FG000|Overall Study|Withdrawal by Subject|3|||
94291468|NCT01169779|322854585|FG001|Overall Study|Withdrawal by Subject|2|||
94291469|NCT01169779|322854584|FG000|Overall Study|Familial and personal reasons|3|||
94291470|NCT01169779|322854585|FG001|Overall Study|Familial and personal reasons|3|||
94291471|NCT00841763|322854587|FG000|Overall Study|Withdrawal by Subject|60|||
94291472|NCT00841763|322854588|FG001|Overall Study|Withdrawal by Subject|17|||
94291473|NCT00841763|322854589|FG002|Overall Study|Withdrawal by Subject|4|||
94291474|NCT00841763|322854590|FG003|Overall Study|Withdrawal by Subject|1|||
94291475|NCT00841763|322854587|FG000|Overall Study|Adverse Event|9|||
94291476|NCT00841763|322854588|FG001|Overall Study|Adverse Event|10|||
94291477|NCT00841763|322854589|FG002|Overall Study|Adverse Event|3|||
94291478|NCT00841763|322854590|FG003|Overall Study|Adverse Event|2|||
94291479|NCT00841763|322854587|FG000|Overall Study|Lost to Follow-up|63|||
94291480|NCT00841763|322854588|FG001|Overall Study|Lost to Follow-up|25|||
94291481|NCT00841763|322854589|FG002|Overall Study|Lost to Follow-up|0|||
94291482|NCT00841763|322854590|FG003|Overall Study|Lost to Follow-up|0|||
94291483|NCT00841763|322854587|FG000|Overall Study|Protocol Violation|20|||
94291484|NCT00841763|322854588|FG001|Overall Study|Protocol Violation|3|||
94291485|NCT00841763|322854589|FG002|Overall Study|Protocol Violation|1|||
94291486|NCT00841763|322854590|FG003|Overall Study|Protocol Violation|0|||
94291487|NCT00841763|322854587|FG000|Overall Study|Administrative Reasons|3|||
94291488|NCT00841763|322854588|FG001|Overall Study|Administrative Reasons|1|||
94291489|NCT00841763|322854589|FG002|Overall Study|Administrative Reasons|0|||
94291490|NCT00841763|322854590|FG003|Overall Study|Administrative Reasons|0|||
94291491|NCT00841763|322854587|FG000|Overall Study|Unable to Classify|7|||
94291492|NCT00841763|322854588|FG001|Overall Study|Unable to Classify|1|||
94291493|NCT00841763|322854589|FG002|Overall Study|Unable to Classify|0|||
94291494|NCT00841763|322854590|FG003|Overall Study|Unable to Classify|0|||
94291495|NCT01482910|322854591|FG000|Overall Study|Adverse Event|6|||
94291496|NCT01482910|322854592|FG001|Overall Study|Adverse Event|5|||
94291497|NCT01482910|322854591|FG000|Overall Study|Lost to Follow-up|0|||
94291498|NCT01482910|322854592|FG001|Overall Study|Lost to Follow-up|1|||
94291499|NCT01482910|322854591|FG000|Overall Study|Protocol Violation|1|||
94291500|NCT01482910|322854592|FG001|Overall Study|Protocol Violation|1|||
94291501|NCT01482910|322854591|FG000|Overall Study|Withdrawal by Subject|7|||
94291502|NCT01482910|322854592|FG001|Overall Study|Withdrawal by Subject|2|||
94291503|NCT01482910|322854591|FG000|Overall Study|Death|1|||
94291504|NCT01482910|322854592|FG001|Overall Study|Death|0|||
94291505|NCT03624946|322854595|FG000|Overall Study|Lost to Follow-up|0|||
94291506|NCT03624946|322854596|FG001|Overall Study|Lost to Follow-up|1|||
94291507|NCT00553462|322854600|FG000|Overall Study|Adverse Event|4|||
94291508|NCT00553462|322854600|FG000|Overall Study|Progression|4|||
94291509|NCT00553462|322854600|FG000|Overall Study|Withdrawal by Subject|5|||
94291510|NCT00553462|322854600|FG000|Overall Study|Physician Decision|1|||
94291511|NCT01925209|322854602|FG000|Treatment Epoch|Physician Decision|1|||
94291512|NCT01925209|322854603|FG001|Treatment Epoch|Physician Decision|0|||
94291513|NCT01925209|322854604|FG002|Treatment Epoch|Physician Decision|0|||
94291514|NCT01925209|322854605|FG003|Treatment Epoch|Physician Decision|0|||
94291515|NCT01925209|322854602|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
94291516|NCT01925209|322854603|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
94291517|NCT01925209|322854604|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
94291518|NCT01925209|322854605|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
94291519|NCT01925209|322854602|FG000|Treatment Epoch|Death|1|||
94291520|NCT01925209|322854603|FG001|Treatment Epoch|Death|0|||
94291521|NCT01925209|322854604|FG002|Treatment Epoch|Death|0|||
94291522|NCT01925209|322854605|FG003|Treatment Epoch|Death|0|||
94291523|NCT01925209|322854602|FG000|Treatment Epoch|Protocol deviation|0|||
94291524|NCT01925209|322854603|FG001|Treatment Epoch|Protocol deviation|0|||
94291525|NCT01925209|322854604|FG002|Treatment Epoch|Protocol deviation|1|||
94291526|NCT01925209|322854605|FG003|Treatment Epoch|Protocol deviation|1|||
94291527|NCT01925209|322854602|FG000|Treatment Epoch|Withdrawal by Subject|4|||
94291528|NCT01925209|322854603|FG001|Treatment Epoch|Withdrawal by Subject|3|||
94291529|NCT01925209|322854604|FG002|Treatment Epoch|Withdrawal by Subject|3|||
94291530|NCT01925209|322854605|FG003|Treatment Epoch|Withdrawal by Subject|2|||
94291531|NCT01925209|322854602|FG000|Treatment Epoch|Adverse Event|3|||
94291532|NCT01925209|322854603|FG001|Treatment Epoch|Adverse Event|5|||
94291533|NCT01925209|322854604|FG002|Treatment Epoch|Adverse Event|3|||
94291534|NCT01925209|322854605|FG003|Treatment Epoch|Adverse Event|1|||
94291535|NCT01925209|322854602|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
94291536|NCT01925209|322854603|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
94291537|NCT01925209|322854604|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
94291538|NCT01925209|322854605|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
94291539|NCT01925209|322854602|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
94291540|NCT01925209|322854603|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
94291541|NCT01925209|322854604|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
94291542|NCT01925209|322854605|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
94291543|NCT01925209|322854602|FG000|Follow-up|Adverse Event|1|||
94291544|NCT01925209|322854603|FG001|Follow-up|Adverse Event|4|||
94291545|NCT01925209|322854604|FG002|Follow-up|Adverse Event|0|||
94291546|NCT01925209|322854605|FG003|Follow-up|Adverse Event|1|||
94291547|NCT01925209|322854602|FG000|Follow-up|Physician Decision|0|||
94291548|NCT01925209|322854603|FG001|Follow-up|Physician Decision|0|||
94291549|NCT01925209|322854604|FG002|Follow-up|Physician Decision|1|||
94291550|NCT01925209|322854605|FG003|Follow-up|Physician Decision|0|||
94291551|NCT01925209|322854602|FG000|Follow-up|Non-compliance with study treatment|0|||
94291552|NCT01925209|322854603|FG001|Follow-up|Non-compliance with study treatment|0|||
94291553|NCT01925209|322854604|FG002|Follow-up|Non-compliance with study treatment|0|||
94291554|NCT01925209|322854605|FG003|Follow-up|Non-compliance with study treatment|1|||
94291555|NCT01925209|322854602|FG000|Follow-up|Withdrawal by Subject|0|||
94291556|NCT01925209|322854603|FG001|Follow-up|Withdrawal by Subject|2|||
94291557|NCT01925209|322854604|FG002|Follow-up|Withdrawal by Subject|0|||
94291558|NCT01925209|322854605|FG003|Follow-up|Withdrawal by Subject|2|||
94291559|NCT00110994|322854606|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
94291560|NCT00110994|322854607|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
94291561|NCT00110994|322854606|FG000|Double-blind (DB) Treatment|Death|1|||
94291562|NCT00110994|322854607|FG001|Double-blind (DB) Treatment|Death|0|||
94291563|NCT00110994|322854606|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
94291564|NCT00110994|322854607|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
94291565|NCT00110994|322854606|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
94291566|NCT00110994|322854607|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
94291567|NCT00110994|322854606|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
94291568|NCT00110994|322854607|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
94291569|NCT00110994|322854606|FG000|Double-blind (DB) Treatment|other reasons|2|||
94291570|NCT00110994|322854607|FG001|Double-blind (DB) Treatment|other reasons|3|||
94291571|NCT00110994|322854606|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
94291572|NCT00110994|322854607|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
94291573|NCT00110994|322854606|FG000|Active Follow-up|Other reasons|0|||
94291574|NCT00110994|322854607|FG001|Active Follow-up|Other reasons|2|||
94291575|NCT00110994|322854606|FG000|Long Term Follow-up|Death|19|||
94291576|NCT00110994|322854607|FG001|Long Term Follow-up|Death|17|||
94291577|NCT00888355|322854614|FG000|Overall Study|Adverse Event|10|||
94291578|NCT00888355|322854615|FG001|Overall Study|Adverse Event|0|||
94291579|NCT00888355|322854616|FG002|Overall Study|Adverse Event|3|||
94291580|NCT00888355|322854617|FG003|Overall Study|Adverse Event|3|||
94291581|NCT00888355|322854614|FG000|Overall Study|Lack of Efficacy|9|||
94291582|NCT00888355|322854615|FG001|Overall Study|Lack of Efficacy|2|||
94291583|NCT00888355|322854616|FG002|Overall Study|Lack of Efficacy|5|||
94291584|NCT00888355|322854617|FG003|Overall Study|Lack of Efficacy|2|||
94291585|NCT00888355|322854614|FG000|Overall Study|Lost to Follow-up|0|||
94291586|NCT00888355|322854615|FG001|Overall Study|Lost to Follow-up|2|||
94291587|NCT00888355|322854616|FG002|Overall Study|Lost to Follow-up|2|||
94291588|NCT00888355|322854617|FG003|Overall Study|Lost to Follow-up|0|||
94291589|NCT00888355|322854614|FG000|Overall Study|Protocol Violation|3|||
94291590|NCT00888355|322854615|FG001|Overall Study|Protocol Violation|2|||
94291591|NCT00888355|322854616|FG002|Overall Study|Protocol Violation|1|||
94291592|NCT00888355|322854617|FG003|Overall Study|Protocol Violation|2|||
94291593|NCT00888355|322854614|FG000|Overall Study|Withdrawal by Subject|0|||
94291594|NCT00888355|322854615|FG001|Overall Study|Withdrawal by Subject|3|||
94291595|NCT00888355|322854616|FG002|Overall Study|Withdrawal by Subject|1|||
94291596|NCT00888355|322854617|FG003|Overall Study|Withdrawal by Subject|3|||
94291597|NCT01879410|322854618|FG000|Overall Study|Adverse Event|9|||
94291598|NCT01879410|322854619|FG001|Overall Study|Adverse Event|14|||
94291599|NCT01879410|322854618|FG000|Overall Study|Lack of Efficacy|4|||
94291600|NCT01879410|322854619|FG001|Overall Study|Lack of Efficacy|6|||
94291601|NCT01879410|322854618|FG000|Overall Study|Protocol Violation|1|||
94291602|NCT01879410|322854619|FG001|Overall Study|Protocol Violation|7|||
94291603|NCT01879410|322854618|FG000|Overall Study|Lost to Follow-up|2|||
94291604|NCT01879410|322854619|FG001|Overall Study|Lost to Follow-up|1|||
94291605|NCT01879410|322854618|FG000|Overall Study|Withdrawal by Subject|7|||
94291606|NCT01879410|322854619|FG001|Overall Study|Withdrawal by Subject|8|||
94291607|NCT01879410|322854618|FG000|Overall Study|Randomised in Error|1|||
94291608|NCT01879410|322854619|FG001|Overall Study|Randomised in Error|2|||
94291609|NCT01670994|322854620|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
94291610|NCT01670994|322854621|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
94291611|NCT01670994|322854620|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
94291612|NCT01670994|322854621|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
94291613|NCT01670994|322854620|FG000|Overall Study|Patient experienced DLT|0|||
94291614|NCT01670994|322854621|FG001|Overall Study|Patient experienced DLT|1|||
94291615|NCT01318122|322854622|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
94291616|NCT01318122|322854623|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
94291617|NCT01318122|322854624|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
94291618|NCT01318122|322854625|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
94291619|NCT01318122|322854622|FG000|Enrolled - Long-Term Extension Study|Other|1|||
94291620|NCT01318122|322854623|FG001|Enrolled - Long-Term Extension Study|Other|0|||
94291621|NCT01318122|322854624|FG002|Enrolled - Long-Term Extension Study|Other|0|||
94291622|NCT01318122|322854625|FG003|Enrolled - Long-Term Extension Study|Other|0|||
94291623|NCT01318122|322854622|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
94291624|NCT01318122|322854623|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
94291625|NCT01318122|322854624|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
94372533|NCT01571635|323150283|FG004|Overall Study|Withdrew consent|0|||
94291626|NCT01318122|322854625|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
94291627|NCT01318122|322854622|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
94291628|NCT01318122|322854623|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
94291629|NCT01318122|322854624|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
94291630|NCT01318122|322854625|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
94291631|NCT01318122|322854622|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
94291632|NCT01318122|322854623|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
94291633|NCT01318122|322854624|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
94291634|NCT01318122|322854625|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
94291635|NCT01318122|322854622|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
94291636|NCT01318122|322854623|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
94291637|NCT01318122|322854624|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
94291638|NCT01318122|322854625|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
94291639|NCT04897867|322854631|FG000|Overall Study|Withdrawal of Consent|1|||
94291640|NCT04897867|322854631|FG000|Overall Study|Pregnancy|1|||
94291641|NCT04897867|322854631|FG000|Overall Study|Lost to Follow-up|7|||
94291642|NCT04897867|322854631|FG000|Overall Study|Reason not Specified|2|||
94291643|NCT00802360|322854635|FG000|Overall Study|Stimulation failure|4|||
94291644|NCT00802360|322854636|FG001|Overall Study|Stimulation failure|0|||
94291645|NCT00802360|322854637|FG002|Overall Study|Stimulation failure|3|||
94291646|NCT00802360|322854638|FG003|Overall Study|Stimulation failure|3|||
94291647|NCT00802360|322854635|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
94291648|NCT00802360|322854636|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
94291649|NCT00802360|322854637|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
94291650|NCT00802360|322854638|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
94291651|NCT00802360|322854635|FG000|Overall Study|Cycle cancelled|0|||
94291652|NCT00802360|322854636|FG001|Overall Study|Cycle cancelled|1|||
94291653|NCT00802360|322854637|FG002|Overall Study|Cycle cancelled|1|||
94291654|NCT00802360|322854638|FG003|Overall Study|Cycle cancelled|1|||
94291655|NCT00802360|322854635|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
94291656|NCT00802360|322854636|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
94291657|NCT00802360|322854637|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
94291658|NCT00802360|322854638|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
94291659|NCT00802360|322854635|FG000|Overall Study|No positive serum pregnancy|17|||
94291660|NCT00802360|322854636|FG001|Overall Study|No positive serum pregnancy|20|||
94291661|NCT00802360|322854637|FG002|Overall Study|No positive serum pregnancy|14|||
94291662|NCT00802360|322854638|FG003|Overall Study|No positive serum pregnancy|10|||
94291663|NCT00802360|322854635|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
94291664|NCT00802360|322854636|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
94291665|NCT00802360|322854637|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
94291666|NCT00802360|322854638|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
94291667|NCT00802360|322854635|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
94291668|NCT00802360|322854636|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
94291669|NCT00802360|322854637|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
94291670|NCT00802360|322854638|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
94291671|NCT00802360|322854635|FG000|Overall Study|Other|2|||
94291672|NCT00802360|322854636|FG001|Overall Study|Other|3|||
94291673|NCT00802360|322854637|FG002|Overall Study|Other|6|||
94291674|NCT00802360|322854638|FG003|Overall Study|Other|3|||
94291675|NCT02908516|322854645|FG000|Overall Study|Study Terminated|3|||
94291676|NCT02908516|322854646|FG001|Overall Study|Study Terminated|3|||
94291677|NCT00888238|322854647|FG000|Washout Period After Period 2|Adverse Event|0|||
94291678|NCT00888238|322854648|FG001|Washout Period After Period 2|Adverse Event|0|||
94291679|NCT00888238|322854649|FG002|Washout Period After Period 2|Adverse Event|1|||
94291680|NCT02251912|322854652|FG000|Overall Study|Withdrawal by Subject|2|||
94291681|NCT02251912|322854653|FG001|Overall Study|Withdrawal by Subject|3|||
94291682|NCT02251912|322854652|FG000|Overall Study|Adverse Event|0|||
94291683|NCT02251912|322854653|FG001|Overall Study|Adverse Event|2|||
94291684|NCT05172544|322854654|FG000|Overall Study|Withdrawal by Subject|1|||
94291685|NCT05172544|322854655|FG001|Overall Study|Withdrawal by Subject|0|||
94291686|NCT05172544|322854656|FG002|Overall Study|Withdrawal by Subject|0|||
94291687|NCT05172544|322854654|FG000|Overall Study|Physician Decision|0|||
94291688|NCT05172544|322854655|FG001|Overall Study|Physician Decision|0|||
94291689|NCT05172544|322854656|FG002|Overall Study|Physician Decision|1|||
94291690|NCT03336502|322854660|FG000|Overall Study|Physician Decision|0|||
94291691|NCT03336502|322854661|FG001|Overall Study|Physician Decision|1|||
94291692|NCT03336502|322854660|FG000|Overall Study|Prohibited Drugs|1|||
94291693|NCT03336502|322854661|FG001|Overall Study|Prohibited Drugs|1|||
94291694|NCT03336502|322854660|FG000|Overall Study|Death|1|||
94291695|NCT03336502|322854661|FG001|Overall Study|Death|2|||
94467974|NCT01887678|323502459|FG000|Overall Study|Lost to Follow-up|4|||
94291696|NCT03336502|322854660|FG000|Overall Study|Adverse Event|2|||
94291697|NCT03336502|322854661|FG001|Overall Study|Adverse Event|5|||
94467975|NCT01887678|323502460|FG001|Overall Study|Lost to Follow-up|2|||
94291698|NCT02921425|322854666|FG000|Overall Study|Protocol Violation|9|||
94291699|NCT00611247|322854667|FG000|Overall Study|Death|1|||
94291700|NCT00611247|322854668|FG001|Overall Study|Death|5|||
94291701|NCT00611247|322854667|FG000|Overall Study|Lack of Efficacy|1|||
94291702|NCT00611247|322854668|FG001|Overall Study|Lack of Efficacy|16|||
94291703|NCT01285349|322854670|FG000|Overall Study|Lost to Follow-up|27|||
94291704|NCT01285349|322854671|FG001|Overall Study|Lost to Follow-up|20|||
94291705|NCT01285349|322854672|FG002|Overall Study|Lost to Follow-up|27|||
94291706|NCT04666038|322854673|FG000|Overall Study|Progressive Disease|2|||
94291707|NCT04666038|322854674|FG001|Overall Study|Progressive Disease|0|||
94372534|NCT01571635|323150279|FG000|Overall Study|Lack of Efficacy|0|||
94372535|NCT01571635|323150280|FG001|Overall Study|Lack of Efficacy|2|||
94372536|NCT01571635|323150281|FG002|Overall Study|Lack of Efficacy|0|||
94372537|NCT01571635|323150282|FG003|Overall Study|Lack of Efficacy|1|||
94291708|NCT04666038|322854673|FG000|Overall Study|Death|38|||
94291709|NCT04666038|322854674|FG001|Overall Study|Death|32|||
94291710|NCT04666038|322854673|FG000|Overall Study|Withdrawal by Subject|10|||
94291711|NCT04666038|322854674|FG001|Overall Study|Withdrawal by Subject|19|||
94291712|NCT04666038|322854673|FG000|Overall Study|Lost to Follow-up|0|||
94291713|NCT04666038|322854674|FG001|Overall Study|Lost to Follow-up|2|||
94291714|NCT04666038|322854673|FG000|Overall Study|On Study Treatment|46|||
94291715|NCT04666038|322854674|FG001|Overall Study|On Study Treatment|5|||
94291716|NCT04666038|322854673|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
94291717|NCT04666038|322854674|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
94291718|NCT00584870|322854677|FG000|Overall Study|Adverse Event|4|||
94291719|NCT00584870|322854678|FG001|Overall Study|Adverse Event|3|||
94291720|NCT00584870|322854679|FG002|Overall Study|Adverse Event|2|||
94291721|NCT00584870|322854677|FG000|Overall Study|Lost to Follow-up|4|||
94291722|NCT00584870|322854678|FG001|Overall Study|Lost to Follow-up|1|||
94291723|NCT00584870|322854679|FG002|Overall Study|Lost to Follow-up|1|||
94291724|NCT00584870|322854677|FG000|Overall Study|Lack of Efficacy|7|||
94291725|NCT00584870|322854678|FG001|Overall Study|Lack of Efficacy|14|||
94291726|NCT00584870|322854679|FG002|Overall Study|Lack of Efficacy|8|||
94291727|NCT00584870|322854677|FG000|Overall Study|Withdrawal by Subject|10|||
94291728|NCT00584870|322854678|FG001|Overall Study|Withdrawal by Subject|5|||
94291729|NCT00584870|322854679|FG002|Overall Study|Withdrawal by Subject|3|||
94291730|NCT00584870|322854677|FG000|Overall Study|Protocol Violation|1|||
94291731|NCT00584870|322854678|FG001|Overall Study|Protocol Violation|1|||
94291732|NCT00584870|322854679|FG002|Overall Study|Protocol Violation|2|||
94291733|NCT00584870|322854677|FG000|Overall Study|Did not met entrance criteria|1|||
94291734|NCT00584870|322854678|FG001|Overall Study|Did not met entrance criteria|0|||
94291735|NCT00584870|322854679|FG002|Overall Study|Did not met entrance criteria|0|||
94291736|NCT00584870|322854677|FG000|Overall Study|Other|2|||
94291737|NCT00584870|322854678|FG001|Overall Study|Other|0|||
94291738|NCT00584870|322854679|FG002|Overall Study|Other|0|||
94291739|NCT00584870|322854677|FG000|Overall Study|Randomized but not treated|0|||
94291740|NCT00584870|322854678|FG001|Overall Study|Randomized but not treated|1|||
94291741|NCT00584870|322854679|FG002|Overall Study|Randomized but not treated|2|||
94291742|NCT01194440|322854680|FG000|Baseline (First Dose)|Reason not specified|4|||
94291743|NCT01194440|322854680|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
94291744|NCT01194440|322854680|FG000|Baseline (First Dose)|Change in therapy|1|||
94291745|NCT01194440|322854680|FG000|Baseline (First Dose)|Adverse Event|1|||
94291746|NCT01194440|322854680|FG000|6-months (2nd Dose)|Change in therapy|4|||
94291747|NCT00772447|322854681|FG000|Overall Study|Withdrawal by Subject|9|||
94291748|NCT00772447|322854682|FG001|Overall Study|Withdrawal by Subject|5|||
94291749|NCT00772447|322854681|FG000|Overall Study|Physician Decision|4|||
94291750|NCT00772447|322854682|FG001|Overall Study|Physician Decision|8|||
94291751|NCT00772447|322854681|FG000|Overall Study|Lost to Follow-up|2|||
94291752|NCT00772447|322854682|FG001|Overall Study|Lost to Follow-up|4|||
94291753|NCT00772447|322854681|FG000|Overall Study|incorrect enrolment|3|||
94291754|NCT00772447|322854682|FG001|Overall Study|incorrect enrolment|4|||
94291755|NCT00772447|322854681|FG000|Overall Study|Protocol Violation|0|||
94291756|NCT00772447|322854682|FG001|Overall Study|Protocol Violation|1|||
94291757|NCT00772447|322854681|FG000|Overall Study|all others|2|||
94291758|NCT00772447|322854682|FG001|Overall Study|all others|2|||
94291759|NCT01439945|322854692|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
94372538|NCT01571635|323150283|FG004|Overall Study|Lack of Efficacy|2|||
94291760|NCT01439945|322854693|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
94291761|NCT01439945|322854694|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
94291762|NCT01439945|322854695|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
94291763|NCT01439945|322854692|FG000|Double-Blind Treatment Phase|Ineligible|1|||
94291764|NCT01439945|322854693|FG001|Double-Blind Treatment Phase|Ineligible|2|||
94291765|NCT01439945|322854694|FG002|Double-Blind Treatment Phase|Ineligible|0|||
94291766|NCT01439945|322854695|FG003|Double-Blind Treatment Phase|Ineligible|1|||
94291767|NCT00927563|322854696|FG000|Overall Study|Lost to Follow-up|1|||
94291768|NCT00927563|322854696|FG000|Overall Study|Withdrawal by Subject|1|||
94291769|NCT01497262|322854697|FG000|Overall Study|Abnormal Lab Values|4|||
94372539|NCT00591253|323150286|FG000|Overall Study|Adverse Event|3|||
94467976|NCT01887678|323502459|FG000|Overall Study|Deterioration of clinical condition|0|||
94467977|NCT01887678|323502460|FG001|Overall Study|Deterioration of clinical condition|4|||
94467978|NCT01887678|323502459|FG000|Overall Study|Lack of Efficacy|1|||
94291770|NCT01497262|322854697|FG000|Overall Study|Abnormal Test Procedure Result|1|||
94291771|NCT01497262|322854697|FG000|Overall Study|Physician Decision|1|||
94291772|NCT01497262|322854697|FG000|Overall Study|Withdrawal by Subject|2|||
94291773|NCT01497262|322854697|FG000|Overall Study|Adverse Event|2|||
94291774|NCT01497262|322854697|FG000|Overall Study|Protocol Violation|1|||
94291775|NCT00054132|322854702|FG000|Overall Study|Not Treated|1|||
94291776|NCT01468987|322854703|FG000|Overall Study|Adverse Event|12|||
94291777|NCT01468987|322854704|FG001|Overall Study|Adverse Event|9|||
94291778|NCT01468987|322854703|FG000|Overall Study|Death|4|||
94291779|NCT01468987|322854704|FG001|Overall Study|Death|1|||
94291780|NCT01468987|322854703|FG000|Overall Study|Lost to Follow-up|10|||
94291781|NCT01468987|322854704|FG001|Overall Study|Lost to Follow-up|5|||
94291782|NCT01468987|322854703|FG000|Overall Study|Protocol Violation|8|||
94291783|NCT01468987|322854704|FG001|Overall Study|Protocol Violation|2|||
94291784|NCT01468987|322854703|FG000|Overall Study|Withdrawal by Subject|28|||
94291785|NCT01468987|322854704|FG001|Overall Study|Withdrawal by Subject|28|||
94291786|NCT01468987|322854703|FG000|Overall Study|Physician Decision|8|||
94291787|NCT01468987|322854704|FG001|Overall Study|Physician Decision|15|||
94291788|NCT01468987|322854703|FG000|Overall Study|Sponsor Decision|1|||
94291789|NCT01468987|322854704|FG001|Overall Study|Sponsor Decision|0|||
94291790|NCT01795547|322854705|FG000|Overall Study|Adverse Event|16|||
94291791|NCT01795547|322854706|FG001|Overall Study|Adverse Event|27|||
94291792|NCT01795547|322854705|FG000|Overall Study|Lack of Efficacy|8|||
94291793|NCT01795547|322854706|FG001|Overall Study|Lack of Efficacy|3|||
94291794|NCT01795547|322854705|FG000|Overall Study|Protocol Violation|6|||
94291795|NCT01795547|322854706|FG001|Overall Study|Protocol Violation|4|||
94291796|NCT01795547|322854705|FG000|Overall Study|Lost to Follow-up|2|||
94291797|NCT01795547|322854706|FG001|Overall Study|Lost to Follow-up|5|||
94291798|NCT01795547|322854705|FG000|Overall Study|Withdrawal of consent|7|||
94291799|NCT01795547|322854706|FG001|Overall Study|Withdrawal of consent|12|||
94291800|NCT01795547|322854705|FG000|Overall Study|Not Treated|4|||
94291801|NCT01795547|322854706|FG001|Overall Study|Not Treated|10|||
94291802|NCT01795547|322854705|FG000|Overall Study|Non-compliance with IMP|1|||
94291803|NCT01795547|322854706|FG001|Overall Study|Non-compliance with IMP|1|||
94291804|NCT01795547|322854705|FG000|Overall Study|Others|4|||
94291805|NCT01795547|322854706|FG001|Overall Study|Others|1|||
94291806|NCT01795547|322854705|FG000|Overall Study|Not stated|0|||
94291807|NCT01795547|322854706|FG001|Overall Study|Not stated|1|||
94291808|NCT05032950|322854708|FG000|Overall Study|Adverse Event|0|||
94291809|NCT05032950|322854709|FG001|Overall Study|Adverse Event|0|||
94291810|NCT05032950|322854710|FG002|Overall Study|Adverse Event|1|||
94291811|NCT05032950|322854711|FG003|Overall Study|Adverse Event|1|||
94291812|NCT05032950|322854712|FG004|Overall Study|Adverse Event|0|||
94291813|NCT05032950|322854713|FG005|Overall Study|Adverse Event|0|||
94291814|NCT04223609|322854716|FG000|Overall Study|Adverse Event|0|||
94291815|NCT04223609|322854717|FG001|Overall Study|Adverse Event|1|||
94291816|NCT04223609|322854716|FG000|Overall Study|Missed last visit|0|||
94291817|NCT04223609|322854717|FG001|Overall Study|Missed last visit|1|||
94291818|NCT03437447|322854718|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94291819|NCT03437447|322854719|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94291820|NCT03437447|322854720|FG002|Treatment Period 1|Withdrawal by Subject|1|||
94291821|NCT02764541|322854721|FG000|Overall Study|Withdrawal by Subject|0|||
94291822|NCT02764541|322854722|FG001|Overall Study|Withdrawal by Subject|0|||
94291823|NCT02764541|322854723|FG002|Overall Study|Withdrawal by Subject|0|||
94291824|NCT02764541|322854724|FG003|Overall Study|Withdrawal by Subject|0|||
94291825|NCT02764541|322854725|FG004|Overall Study|Withdrawal by Subject|1|||
94291826|NCT02764541|322854726|FG005|Overall Study|Withdrawal by Subject|1|||
94291827|NCT02764541|322854727|FG006|Overall Study|Withdrawal by Subject|0|||
94291828|NCT02764541|322854728|FG007|Overall Study|Withdrawal by Subject|1|||
94291829|NCT02764541|322854721|FG000|Overall Study|Adverse Event|1|||
94291830|NCT02764541|322854722|FG001|Overall Study|Adverse Event|0|||
94291831|NCT02764541|322854723|FG002|Overall Study|Adverse Event|0|||
94291832|NCT02764541|322854724|FG003|Overall Study|Adverse Event|0|||
94291833|NCT02764541|322854725|FG004|Overall Study|Adverse Event|0|||
94291834|NCT02764541|322854726|FG005|Overall Study|Adverse Event|0|||
94291835|NCT02764541|322854727|FG006|Overall Study|Adverse Event|1|||
94291836|NCT02764541|322854728|FG007|Overall Study|Adverse Event|0|||
94291837|NCT02764541|322854721|FG000|Overall Study|Metastasis|1|||
94291838|NCT02764541|322854722|FG001|Overall Study|Metastasis|0|||
94291839|NCT02764541|322854723|FG002|Overall Study|Metastasis|0|||
94291840|NCT02764541|322854724|FG003|Overall Study|Metastasis|0|||
94291841|NCT02764541|322854725|FG004|Overall Study|Metastasis|0|||
94291842|NCT02764541|322854726|FG005|Overall Study|Metastasis|0|||
94291843|NCT02764541|322854727|FG006|Overall Study|Metastasis|0|||
94291844|NCT02764541|322854728|FG007|Overall Study|Metastasis|0|||
94291845|NCT02764541|322854721|FG000|Overall Study|Disease progression|1|||
94291846|NCT02764541|322854722|FG001|Overall Study|Disease progression|1|||
94291847|NCT02764541|322854723|FG002|Overall Study|Disease progression|0|||
94291848|NCT02764541|322854724|FG003|Overall Study|Disease progression|0|||
94291849|NCT02764541|322854725|FG004|Overall Study|Disease progression|0|||
94291850|NCT02764541|322854726|FG005|Overall Study|Disease progression|0|||
94291851|NCT02764541|322854727|FG006|Overall Study|Disease progression|0|||
94291852|NCT02764541|322854728|FG007|Overall Study|Disease progression|1|||
94291853|NCT02764541|322854721|FG000|Overall Study|Protocol Violation|0|||
94291854|NCT02764541|322854722|FG001|Overall Study|Protocol Violation|0|||
94291855|NCT02764541|322854723|FG002|Overall Study|Protocol Violation|0|||
94291856|NCT02764541|322854724|FG003|Overall Study|Protocol Violation|1|||
94291857|NCT02764541|322854725|FG004|Overall Study|Protocol Violation|0|||
94291858|NCT02764541|322854726|FG005|Overall Study|Protocol Violation|1|||
94291859|NCT02764541|322854727|FG006|Overall Study|Protocol Violation|0|||
94291860|NCT02764541|322854728|FG007|Overall Study|Protocol Violation|0|||
94291861|NCT02764541|322854721|FG000|Overall Study|Physician Decision|0|||
94291862|NCT02764541|322854722|FG001|Overall Study|Physician Decision|0|||
94291863|NCT02764541|322854723|FG002|Overall Study|Physician Decision|0|||
94291864|NCT02764541|322854724|FG003|Overall Study|Physician Decision|1|||
94291865|NCT02764541|322854725|FG004|Overall Study|Physician Decision|0|||
94291866|NCT02764541|322854726|FG005|Overall Study|Physician Decision|0|||
94291867|NCT02764541|322854727|FG006|Overall Study|Physician Decision|0|||
94291868|NCT02764541|322854728|FG007|Overall Study|Physician Decision|1|||
94291869|NCT02764541|322854721|FG000|Overall Study|Three Cycles completed before surgery|0|||
94291870|NCT02764541|322854722|FG001|Overall Study|Three Cycles completed before surgery|0|||
94291871|NCT02764541|322854723|FG002|Overall Study|Three Cycles completed before surgery|0|||
94291872|NCT02764541|322854724|FG003|Overall Study|Three Cycles completed before surgery|1|||
94291873|NCT02764541|322854725|FG004|Overall Study|Three Cycles completed before surgery|0|||
94291874|NCT02764541|322854726|FG005|Overall Study|Three Cycles completed before surgery|0|||
94291875|NCT02764541|322854727|FG006|Overall Study|Three Cycles completed before surgery|0|||
94291876|NCT02764541|322854728|FG007|Overall Study|Three Cycles completed before surgery|0|||
94291877|NCT02764541|322854721|FG000|Overall Study|Patient Compliance|0|||
94291878|NCT02764541|322854722|FG001|Overall Study|Patient Compliance|0|||
94291879|NCT02764541|322854723|FG002|Overall Study|Patient Compliance|1|||
94291880|NCT02764541|322854724|FG003|Overall Study|Patient Compliance|0|||
94291881|NCT02764541|322854725|FG004|Overall Study|Patient Compliance|0|||
94291882|NCT02764541|322854726|FG005|Overall Study|Patient Compliance|0|||
94291883|NCT02764541|322854727|FG006|Overall Study|Patient Compliance|0|||
94291884|NCT02764541|322854728|FG007|Overall Study|Patient Compliance|0|||
94291885|NCT02764541|322854721|FG000|Overall Study|Death|0|||
94291886|NCT02764541|322854722|FG001|Overall Study|Death|0|||
94291887|NCT02764541|322854723|FG002|Overall Study|Death|0|||
94291888|NCT02764541|322854724|FG003|Overall Study|Death|0|||
94291889|NCT02764541|322854725|FG004|Overall Study|Death|0|||
94291890|NCT02764541|322854726|FG005|Overall Study|Death|0|||
94291891|NCT02764541|322854727|FG006|Overall Study|Death|1|||
94291892|NCT02764541|322854728|FG007|Overall Study|Death|0|||
94291893|NCT02764541|322854721|FG000|Overall Study|Insurance reasons|0|||
94291894|NCT02764541|322854722|FG001|Overall Study|Insurance reasons|0|||
94291895|NCT02764541|322854723|FG002|Overall Study|Insurance reasons|0|||
94291896|NCT02764541|322854724|FG003|Overall Study|Insurance reasons|0|||
94291897|NCT02764541|322854725|FG004|Overall Study|Insurance reasons|0|||
94291898|NCT02764541|322854726|FG005|Overall Study|Insurance reasons|0|||
94291899|NCT02764541|322854727|FG006|Overall Study|Insurance reasons|1|||
94291900|NCT02764541|322854728|FG007|Overall Study|Insurance reasons|0|||
94291901|NCT00355121|322854729|FG000|Overall Study|Did not receive study vaccine|1|||
94291902|NCT00355121|322854730|FG001|Overall Study|Did not receive study vaccine|0|||
94291903|NCT00355121|322854731|FG002|Overall Study|Did not receive study vaccine|1|||
94291904|NCT00355121|322854729|FG000|Overall Study|Adverse Event|0|||
94291905|NCT00355121|322854730|FG001|Overall Study|Adverse Event|1|||
94291906|NCT00355121|322854731|FG002|Overall Study|Adverse Event|0|||
94291907|NCT00355121|322854729|FG000|Overall Study|Protocol Violation|7|||
94291908|NCT00355121|322854730|FG001|Overall Study|Protocol Violation|9|||
94291909|NCT00355121|322854731|FG002|Overall Study|Protocol Violation|1|||
94291910|NCT00355121|322854729|FG000|Overall Study|Lost to Follow-up|4|||
94291911|NCT00355121|322854730|FG001|Overall Study|Lost to Follow-up|7|||
94291912|NCT00355121|322854731|FG002|Overall Study|Lost to Follow-up|1|||
94291913|NCT00355121|322854729|FG000|Overall Study|Withdrawal by Subject|9|||
94291914|NCT00355121|322854730|FG001|Overall Study|Withdrawal by Subject|10|||
94291915|NCT00355121|322854731|FG002|Overall Study|Withdrawal by Subject|2|||
94291916|NCT00355121|322854729|FG000|Overall Study|Serious adverse events|0|||
94291917|NCT00355121|322854730|FG001|Overall Study|Serious adverse events|2|||
94291918|NCT00355121|322854731|FG002|Overall Study|Serious adverse events|0|||
94291919|NCT03186989|322854733|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
94291920|NCT03186989|322854734|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
94291921|NCT03186989|322854735|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
94291922|NCT03186989|322854736|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
94291923|NCT03186989|322854737|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
94291924|NCT03186989|322854738|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
94291925|NCT03186989|322854739|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
94291926|NCT03186989|322854740|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
94291927|NCT03186989|322854741|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
94291928|NCT03186989|322854742|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
94372540|NCT00591253|323150287|FG001|Overall Study|Adverse Event|3|||
94372541|NCT00591253|323150288|FG002|Overall Study|Adverse Event|1|||
94372542|NCT00591253|323150286|FG000|Overall Study|Protocol Violation|2|||
94372543|NCT00591253|323150287|FG001|Overall Study|Protocol Violation|2|||
94291929|NCT03186989|322854743|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
94291930|NCT03186989|322854733|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
94291931|NCT03186989|322854734|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
94291932|NCT03186989|322854735|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
94291933|NCT03186989|322854736|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
94291934|NCT03186989|322854737|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
94291935|NCT03186989|322854738|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
94291936|NCT03186989|322854739|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
94291937|NCT03186989|322854740|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
94291938|NCT03186989|322854741|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
94291939|NCT03186989|322854742|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
94291940|NCT03186989|322854743|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
94291941|NCT03186989|322854733|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
94291942|NCT03186989|322854734|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
94291943|NCT03186989|322854735|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
94291944|NCT03186989|322854736|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
94291945|NCT03186989|322854737|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
94291946|NCT03186989|322854738|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
94291947|NCT03186989|322854739|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
94291948|NCT03186989|322854740|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
94291949|NCT03186989|322854741|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
94291950|NCT03186989|322854742|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
94291951|NCT03186989|322854743|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
94291952|NCT03186989|322854733|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
94291953|NCT03186989|322854734|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
94291954|NCT03186989|322854735|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
94291955|NCT03186989|322854736|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
94291956|NCT03186989|322854737|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
94291957|NCT03186989|322854738|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
94291958|NCT03186989|322854739|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
94291959|NCT03186989|322854740|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
94291960|NCT03186989|322854741|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
94291961|NCT03186989|322854742|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
94291962|NCT03186989|322854743|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
94291963|NCT06272370|322856921|FG000|Overall Study|Lost to Follow-up|0|||
94291964|NCT06272370|322856922|FG001|Overall Study|Lost to Follow-up|3|||
94291965|NCT06272370|322856923|FG002|Overall Study|Lost to Follow-up|1|||
94291966|NCT06272370|322856924|FG003|Overall Study|Lost to Follow-up|1|||
94291967|NCT02363478|322856925|FG000|Overall Study|Lost to Follow-up|4|||
94291968|NCT02363478|322856925|FG000|Overall Study|Adverse Event|4|||
94291969|NCT00670007|322856926|FG000|Overall Study|Drug abuse|1|||
94291970|NCT00670007|322856926|FG000|Overall Study|Lung transplant|1|||
94291971|NCT00670007|322856926|FG000|Overall Study|Travel/Vacation|1|||
94291972|NCT00670007|322856926|FG000|Overall Study|Adverse event, serious fatal|1|||
94291973|NCT00670007|322856926|FG000|Overall Study|Adverse Event|1|||
94291974|NCT00670007|322856926|FG000|Overall Study|Withdrawal by Subject|4|||
94291975|NCT01390389|322856929|FG000|Overall Study|Withdrawal by Subject|2|||
94291976|NCT01390389|322856930|FG001|Overall Study|Withdrawal by Subject|0|||
94291977|NCT01390389|322856929|FG000|Overall Study|Screen Fail|2|||
94291978|NCT01390389|322856930|FG001|Overall Study|Screen Fail|1|||
94291979|NCT01974817|322856931|FG000|Overall Study|Death|4|||
94291980|NCT01974817|322856931|FG000|Overall Study|Lost to Follow-up|2|||
94291981|NCT01974817|322856931|FG000|Overall Study|Protocol Violation|2|||
94291982|NCT05512949|322856932|FG000|Overall Study|Lost to Follow-up|4|||
94291983|NCT05512949|322856933|FG001|Overall Study|Lost to Follow-up|6|||
94291984|NCT05512949|322856934|FG002|Overall Study|Lost to Follow-up|2|||
94291985|NCT05512949|322856932|FG000|Overall Study|Protocol Violation|0|||
94291986|NCT05512949|322856933|FG001|Overall Study|Protocol Violation|0|||
94291987|NCT05512949|322856934|FG002|Overall Study|Protocol Violation|1|||
94291988|NCT05512949|322856932|FG000|Overall Study|Withdrawal by Subject|1|||
94291989|NCT05512949|322856933|FG001|Overall Study|Withdrawal by Subject|1|||
94291990|NCT05512949|322856934|FG002|Overall Study|Withdrawal by Subject|2|||
94291991|NCT05512949|322856932|FG000|Overall Study|Completion status unknown|1|||
94291992|NCT05512949|322856933|FG001|Overall Study|Completion status unknown|3|||
94291993|NCT05512949|322856934|FG002|Overall Study|Completion status unknown|0|||
94291994|NCT02107703|322856935|FG000|Overall Study|Withdrawal by Subject|46|||
94291995|NCT02107703|322856936|FG001|Overall Study|Withdrawal by Subject|21|||
94291996|NCT02107703|322856935|FG000|Overall Study|Lost to Follow-up|20|||
94291997|NCT02107703|322856936|FG001|Overall Study|Lost to Follow-up|9|||
94291998|NCT02107703|322856935|FG000|Overall Study|On study treatment/follow up|48|||
94291999|NCT02107703|322856936|FG001|Overall Study|On study treatment/follow up|5|||
94292000|NCT01097629|322856939|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
94292001|NCT01097629|322856940|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
94292002|NCT01097629|322856941|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
94292003|NCT01097629|322856942|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
94292004|NCT01097629|322856943|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
94292005|NCT01097629|322856944|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
94292006|NCT01097629|322856945|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
94292007|NCT01097629|322856946|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
94292008|NCT01097629|322856939|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
94292009|NCT01097629|322856940|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
94292010|NCT01097629|322856941|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
94292011|NCT01097629|322856942|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
94292012|NCT01097629|322856943|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
94292013|NCT01097629|322856944|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
94292014|NCT01097629|322856945|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
94292015|NCT01097629|322856946|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
94292016|NCT01097629|322856939|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
94292017|NCT01097629|322856940|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
94292018|NCT01097629|322856941|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
94292019|NCT01097629|322856942|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
94292020|NCT01097629|322856943|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
94292021|NCT01097629|322856944|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
94292022|NCT01097629|322856945|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
94292023|NCT01097629|322856946|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
94292024|NCT01097629|322856939|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
94292025|NCT01097629|322856940|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
94292026|NCT01097629|322856941|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
94292027|NCT01097629|322856942|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
94292028|NCT01097629|322856943|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
94292029|NCT01097629|322856944|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
94292030|NCT01097629|322856945|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
94292031|NCT01097629|322856946|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
94292032|NCT01097629|322856939|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
94292033|NCT01097629|322856940|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
94292034|NCT01097629|322856941|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
94292035|NCT01097629|322856942|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
94292036|NCT01097629|322856943|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
94292037|NCT01097629|322856944|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
94292038|NCT01097629|322856945|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
94292039|NCT01097629|322856946|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
94292040|NCT01097629|322856939|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
94292041|NCT01097629|322856940|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
94292042|NCT01097629|322856941|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
94292043|NCT01097629|322856942|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
94292044|NCT01097629|322856943|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
94292045|NCT01097629|322856944|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
94292046|NCT01097629|322856945|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
94292047|NCT01097629|322856946|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
94292048|NCT01097629|322856939|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
94292049|NCT01097629|322856940|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
94292050|NCT01097629|322856941|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
94292051|NCT01097629|322856942|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
94292052|NCT01097629|322856943|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
94292053|NCT01097629|322856944|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
94292054|NCT01097629|322856945|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
94292055|NCT01097629|322856946|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
94292056|NCT01097629|322856939|FG000|DB RO Phase|Withdrawal by Subject|0|||
94292057|NCT01097629|322856940|FG001|DB RO Phase|Withdrawal by Subject|0|||
94292058|NCT01097629|322856941|FG002|DB RO Phase|Withdrawal by Subject|0|||
94467979|NCT01887678|323502460|FG001|Overall Study|Lack of Efficacy|2|||
94467980|NCT01887678|323502459|FG000|Overall Study|Non-compliance|0|||
94467981|NCT01887678|323502460|FG001|Overall Study|Non-compliance|3|||
94467982|NCT01887678|323502459|FG000|Overall Study|Specified|1|||
94467983|NCT01887678|323502460|FG001|Overall Study|Specified|2|||
94292059|NCT01097629|322856942|FG003|DB RO Phase|Withdrawal by Subject|0|||
94292060|NCT01097629|322856943|FG004|DB RO Phase|Withdrawal by Subject|0|||
94292061|NCT01097629|322856944|FG005|DB RO Phase|Withdrawal by Subject|0|||
94292062|NCT01097629|322856945|FG006|DB RO Phase|Withdrawal by Subject|0|||
94292063|NCT01097629|322856946|FG007|DB RO Phase|Withdrawal by Subject|1|||
94292064|NCT01097629|322856939|FG000|DB RO Phase|Protocol Violation|0|||
94292065|NCT01097629|322856940|FG001|DB RO Phase|Protocol Violation|0|||
94292066|NCT01097629|322856941|FG002|DB RO Phase|Protocol Violation|0|||
94292067|NCT01097629|322856942|FG003|DB RO Phase|Protocol Violation|1|||
94292068|NCT01097629|322856943|FG004|DB RO Phase|Protocol Violation|0|||
94292069|NCT01097629|322856944|FG005|DB RO Phase|Protocol Violation|1|||
94292070|NCT01097629|322856945|FG006|DB RO Phase|Protocol Violation|1|||
94292071|NCT01097629|322856946|FG007|DB RO Phase|Protocol Violation|0|||
94292072|NCT01097629|322856939|FG000|DB RO Phase|Lost to Follow-up|0|||
94292073|NCT01097629|322856940|FG001|DB RO Phase|Lost to Follow-up|0|||
94292074|NCT01097629|322856941|FG002|DB RO Phase|Lost to Follow-up|0|||
94292075|NCT01097629|322856942|FG003|DB RO Phase|Lost to Follow-up|0|||
94292076|NCT01097629|322856943|FG004|DB RO Phase|Lost to Follow-up|0|||
94292077|NCT01097629|322856944|FG005|DB RO Phase|Lost to Follow-up|0|||
94292078|NCT01097629|322856945|FG006|DB RO Phase|Lost to Follow-up|2|||
94292079|NCT01097629|322856946|FG007|DB RO Phase|Lost to Follow-up|0|||
94292080|NCT01171820|322856947|FG000|Overall Study|Death|3|||
94292081|NCT01171820|322856948|FG001|Overall Study|Death|3|||
94292082|NCT01171820|322856947|FG000|Overall Study|Lost to Follow-up|0|||
94292083|NCT01171820|322856948|FG001|Overall Study|Lost to Follow-up|1|||
94292084|NCT01171820|322856947|FG000|Overall Study|Withdrawal by Subject|2|||
94292085|NCT01171820|322856948|FG001|Overall Study|Withdrawal by Subject|0|||
94292086|NCT01171820|322856947|FG000|Overall Study|Physician Decision|0|||
94292087|NCT01171820|322856948|FG001|Overall Study|Physician Decision|1|||
94292088|NCT01171820|322856947|FG000|Overall Study|1-Year Missed Visit|1|||
94292089|NCT01171820|322856948|FG001|Overall Study|1-Year Missed Visit|1|||
94292090|NCT01805180|322856949|FG000|Lead-in Donor Phase|screen failure|1|||
94292091|NCT01805180|322856950|FG001|Lead-in Donor Phase|screen failure|0|||
94292092|NCT01805180|322856951|FG002|Lead-in Donor Phase|screen failure|0|||
94292093|NCT06441877|322856953|FG000|Overall Study|Withdrawal by Subject|0|||
94292094|NCT06441877|322856954|FG001|Overall Study|Withdrawal by Subject|2|||
94292095|NCT06441877|322856955|FG002|Overall Study|Withdrawal by Subject|0|||
94292096|NCT06441877|322856956|FG003|Overall Study|Withdrawal by Subject|0|||
94292097|NCT01705691|322856962|FG000|Overall Study|Death|1|||
94292098|NCT01705691|322856963|FG001|Overall Study|Death|2|||
94292099|NCT01705691|322856962|FG000|Overall Study|Withdrawal by Subject|1|||
94292100|NCT01705691|322856963|FG001|Overall Study|Withdrawal by Subject|2|||
94292101|NCT01705691|322856962|FG000|Overall Study|Lost to Follow-up|1|||
94292102|NCT01705691|322856963|FG001|Overall Study|Lost to Follow-up|1|||
94292103|NCT01705691|322856962|FG000|Overall Study|Other|0|||
94292104|NCT01705691|322856963|FG001|Overall Study|Other|1|||
94292105|NCT02763566|322856964|FG000|Overall Study|Lost to Follow-up|1|||
94292106|NCT02763566|322856965|FG001|Overall Study|Lost to Follow-up|4|||
94292107|NCT02763566|322856966|FG002|Overall Study|Lost to Follow-up|0|||
94292108|NCT02763566|322856967|FG003|Overall Study|Lost to Follow-up|1|||
94292109|NCT02763566|322856964|FG000|Overall Study|On study treatment at study conclusion|114|||
94292110|NCT02763566|322856965|FG001|Overall Study|On study treatment at study conclusion|34|||
94292111|NCT02763566|322856966|FG002|Overall Study|On study treatment at study conclusion|54|||
94292112|NCT02763566|322856967|FG003|Overall Study|On study treatment at study conclusion|13|||
94292113|NCT02763566|322856964|FG000|Overall Study|Withdrawal by Subject|3|||
94292114|NCT02763566|322856965|FG001|Overall Study|Withdrawal by Subject|1|||
94292115|NCT02763566|322856966|FG002|Overall Study|Withdrawal by Subject|0|||
94292116|NCT02763566|322856967|FG003|Overall Study|Withdrawal by Subject|0|||
94292117|NCT04088409|322856968|FG000|Part A|Withdrawal by Subject|2|||
94292118|NCT04088409|322856969|FG001|Part A|Withdrawal by Subject|1|||
94292119|NCT04088409|322856968|FG000|Part A|Did Not Meet Randomization Criteria|2|||
94292120|NCT04088409|322856969|FG001|Part A|Did Not Meet Randomization Criteria|0|||
94292121|NCT04088409|322856968|FG000|Part A|Lack of Efficacy|9|||
94292122|NCT04088409|322856969|FG001|Part A|Lack of Efficacy|0|||
94292123|NCT04088409|322856968|FG000|Part A|Lost to Follow-up|1|||
94292124|NCT04088409|322856969|FG001|Part A|Lost to Follow-up|0|||
94292125|NCT04088409|322856968|FG000|Part A|Adverse Event|1|||
94292126|NCT04088409|322856969|FG001|Part A|Adverse Event|0|||
94292127|NCT04088409|322856968|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
94292128|NCT04088409|322856969|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
94292129|NCT04088409|322856968|FG000|Part B|Ongoing Treatment|10|||
94292130|NCT04088409|322856969|FG001|Part B|Ongoing Treatment|0|||
94292131|NCT02411448|322856970|FG000|Overall Study|Withdrawal by Subject|1|||
94292132|NCT02411448|322856971|FG001|Overall Study|Withdrawal by Subject|14|||
94292133|NCT02411448|322856972|FG002|Overall Study|Withdrawal by Subject|9|||
94292134|NCT02411448|322856970|FG000|Overall Study|Other|0|||
94292135|NCT02411448|322856971|FG001|Overall Study|Other|2|||
94292136|NCT02411448|322856972|FG002|Overall Study|Other|0|||
94292137|NCT02411448|322856970|FG000|Overall Study|Did not receive study treatment|0|||
94292138|NCT02411448|322856971|FG001|Overall Study|Did not receive study treatment|3|||
94292139|NCT02411448|322856972|FG002|Overall Study|Did not receive study treatment|0|||
94292140|NCT02411448|322856970|FG000|Overall Study|Alive on study treatment|3|||
94292141|NCT02411448|322856971|FG001|Overall Study|Alive on study treatment|64|||
94292142|NCT02411448|322856972|FG002|Overall Study|Alive on study treatment|43|||
94292143|NCT03370770|322856979|FG000|Overall Study|Patient was followed in another hospital center|1|||
94292144|NCT03370770|322856979|FG000|Overall Study|Progressive Disease|98|||
94292145|NCT03370770|322856979|FG000|Overall Study|Adverse Event|2|||
94292146|NCT03370770|322856979|FG000|Overall Study|Death|5|||
94292147|NCT04067518|322856980|FG000|Overall Study|Adverse Event|1|||
94292148|NCT04067518|322856981|FG001|Overall Study|Adverse Event|3|||
94292149|NCT04067518|322856980|FG000|Overall Study|Screen failures|0|||
94292150|NCT04067518|322856981|FG001|Overall Study|Screen failures|1|||
94292151|NCT04067518|322856980|FG000|Overall Study|Enrolled but not treated|0|||
94292152|NCT04067518|322856981|FG001|Overall Study|Enrolled but not treated|1|||
94292153|NCT02771522|322856982|FG000|Overall Study|Lost to Follow-up|3|||
94292154|NCT02771522|322856982|FG000|Overall Study|Withdrawal by Subject|2|||
94292155|NCT02771522|322856982|FG000|Overall Study|No white spot lesions|3|||
94292156|NCT00110019|322856983|FG000|Overall Study|Lack of Efficacy|253|||
94292157|NCT00110019|322856984|FG001|Overall Study|Lack of Efficacy|285|||
94292158|NCT00110019|322856983|FG000|Overall Study|Adverse Event|61|||
94292159|NCT00110019|322856984|FG001|Overall Study|Adverse Event|40|||
94292160|NCT00110019|322856983|FG000|Overall Study|Death|13|||
94292161|NCT00110019|322856984|FG001|Overall Study|Death|15|||
94292162|NCT00110019|322856983|FG000|Overall Study|Withdrawal by Subject|21|||
94292163|NCT00110019|322856984|FG001|Overall Study|Withdrawal by Subject|9|||
94292164|NCT00110019|322856983|FG000|Overall Study|alternative therapy|5|||
94292165|NCT00110019|322856984|FG001|Overall Study|alternative therapy|1|||
94292166|NCT00110019|322856983|FG000|Overall Study|complicating disease|1|||
94292167|NCT00110019|322856984|FG001|Overall Study|complicating disease|1|||
94292168|NCT00110019|322856983|FG000|Overall Study|symptom deterioration|13|||
94292169|NCT00110019|322856984|FG001|Overall Study|symptom deterioration|16|||
94292170|NCT00110019|322856983|FG000|Overall Study|Not start protocol therapy|17|||
94292171|NCT00110019|322856984|FG001|Overall Study|Not start protocol therapy|16|||
94292172|NCT00110019|322856983|FG000|Overall Study|other reasons|22|||
94292173|NCT00110019|322856984|FG001|Overall Study|other reasons|30|||
94292174|NCT04426695|322856987|FG000|Overall Study|Death|2|||
94292175|NCT04426695|322856988|FG001|Overall Study|Death|0|||
94292176|NCT04426695|322856989|FG002|Overall Study|Death|1|||
94292177|NCT04426695|322856990|FG003|Overall Study|Death|27|||
94292178|NCT04426695|322856991|FG004|Overall Study|Death|25|||
94292179|NCT04426695|322856992|FG005|Overall Study|Death|21|||
94292180|NCT04426695|322856993|FG006|Overall Study|Death|42|||
94292181|NCT04426695|322856994|FG007|Overall Study|Death|23|||
94292182|NCT04426695|322856995|FG008|Overall Study|Death|37|||
94292183|NCT04426695|322856996|FG009|Overall Study|Death|14|||
94292184|NCT04426695|322856997|FG010|Overall Study|Death|8|||
94292185|NCT04426695|322856998|FG011|Overall Study|Death|7|||
94292186|NCT04426695|322856999|FG012|Overall Study|Death|13|||
94292187|NCT04426695|322857000|FG013|Overall Study|Death|25|||
94292188|NCT04426695|322857001|FG014|Overall Study|Death|19|||
94292189|NCT04426695|322857002|FG015|Overall Study|Death|7|||
94292190|NCT04426695|322857003|FG016|Overall Study|Death|8|||
94292191|NCT04426695|322857004|FG017|Overall Study|Death|4|||
94292192|NCT04426695|322856987|FG000|Overall Study|Lost to Follow-up|2|||
94292193|NCT04426695|322856988|FG001|Overall Study|Lost to Follow-up|4|||
94292194|NCT04426695|322856989|FG002|Overall Study|Lost to Follow-up|1|||
94292195|NCT04426695|322856990|FG003|Overall Study|Lost to Follow-up|19|||
94292196|NCT04426695|322856991|FG004|Overall Study|Lost to Follow-up|10|||
94292197|NCT04426695|322856992|FG005|Overall Study|Lost to Follow-up|14|||
94292198|NCT04426695|322856993|FG006|Overall Study|Lost to Follow-up|5|||
94292199|NCT04426695|322856994|FG007|Overall Study|Lost to Follow-up|14|||
94292200|NCT04426695|322856995|FG008|Overall Study|Lost to Follow-up|10|||
94292201|NCT04426695|322856996|FG009|Overall Study|Lost to Follow-up|11|||
94292202|NCT04426695|322856997|FG010|Overall Study|Lost to Follow-up|12|||
94292203|NCT04426695|322856998|FG011|Overall Study|Lost to Follow-up|6|||
94292204|NCT04426695|322856999|FG012|Overall Study|Lost to Follow-up|2|||
94292205|NCT04426695|322857000|FG013|Overall Study|Lost to Follow-up|2|||
94292206|NCT04426695|322857001|FG014|Overall Study|Lost to Follow-up|2|||
94292207|NCT04426695|322857002|FG015|Overall Study|Lost to Follow-up|0|||
94292208|NCT04426695|322857003|FG016|Overall Study|Lost to Follow-up|0|||
94292209|NCT04426695|322857004|FG017|Overall Study|Lost to Follow-up|0|||
94292210|NCT04426695|322856987|FG000|Overall Study|Participant Decision|1|||
94292211|NCT04426695|322856988|FG001|Overall Study|Participant Decision|2|||
94372544|NCT00591253|323150288|FG002|Overall Study|Protocol Violation|2|||
94372545|NCT00591253|323150286|FG000|Overall Study|Lost to Follow-up|2|||
94292212|NCT04426695|322856989|FG002|Overall Study|Participant Decision|2|||
94292213|NCT04426695|322856990|FG003|Overall Study|Participant Decision|12|||
94292214|NCT04426695|322856991|FG004|Overall Study|Participant Decision|18|||
94292215|NCT04426695|322856992|FG005|Overall Study|Participant Decision|22|||
94372546|NCT00591253|323150287|FG001|Overall Study|Lost to Follow-up|4|||
94292216|NCT04426695|322856993|FG006|Overall Study|Participant Decision|13|||
94292217|NCT04426695|322856994|FG007|Overall Study|Participant Decision|13|||
94292218|NCT04426695|322856995|FG008|Overall Study|Participant Decision|10|||
94292219|NCT04426695|322856996|FG009|Overall Study|Participant Decision|15|||
94292220|NCT04426695|322856997|FG010|Overall Study|Participant Decision|16|||
94292221|NCT04426695|322856998|FG011|Overall Study|Participant Decision|17|||
94292222|NCT04426695|322856999|FG012|Overall Study|Participant Decision|2|||
94292223|NCT04426695|322857000|FG013|Overall Study|Participant Decision|1|||
94292224|NCT04426695|322857001|FG014|Overall Study|Participant Decision|2|||
94292225|NCT04426695|322857002|FG015|Overall Study|Participant Decision|0|||
94292226|NCT04426695|322857003|FG016|Overall Study|Participant Decision|0|||
94292227|NCT04426695|322857004|FG017|Overall Study|Participant Decision|0|||
94292228|NCT04426695|322856987|FG000|Overall Study|Adverse Event|0|||
94292229|NCT04426695|322856988|FG001|Overall Study|Adverse Event|0|||
94292230|NCT04426695|322856989|FG002|Overall Study|Adverse Event|0|||
94292231|NCT04426695|322856990|FG003|Overall Study|Adverse Event|0|||
94292232|NCT04426695|322856991|FG004|Overall Study|Adverse Event|0|||
94292233|NCT04426695|322856992|FG005|Overall Study|Adverse Event|0|||
94292234|NCT04426695|322856993|FG006|Overall Study|Adverse Event|0|||
94292235|NCT04426695|322856994|FG007|Overall Study|Adverse Event|1|||
94292236|NCT04426695|322856995|FG008|Overall Study|Adverse Event|0|||
94292237|NCT04426695|322856996|FG009|Overall Study|Adverse Event|0|||
94292238|NCT04426695|322856997|FG010|Overall Study|Adverse Event|1|||
94292239|NCT04426695|322856998|FG011|Overall Study|Adverse Event|1|||
94292240|NCT04426695|322856999|FG012|Overall Study|Adverse Event|0|||
94292241|NCT04426695|322857000|FG013|Overall Study|Adverse Event|0|||
94292242|NCT04426695|322857001|FG014|Overall Study|Adverse Event|0|||
94292243|NCT04426695|322857002|FG015|Overall Study|Adverse Event|0|||
94292244|NCT04426695|322857003|FG016|Overall Study|Adverse Event|0|||
94292245|NCT04426695|322857004|FG017|Overall Study|Adverse Event|0|||
94292246|NCT04426695|322856987|FG000|Overall Study|Sponsor Request|0|||
94292247|NCT04426695|322856988|FG001|Overall Study|Sponsor Request|0|||
94292248|NCT04426695|322856989|FG002|Overall Study|Sponsor Request|0|||
94292249|NCT04426695|322856990|FG003|Overall Study|Sponsor Request|0|||
94292250|NCT04426695|322856991|FG004|Overall Study|Sponsor Request|0|||
94292251|NCT04426695|322856992|FG005|Overall Study|Sponsor Request|0|||
94292252|NCT04426695|322856993|FG006|Overall Study|Sponsor Request|1|||
94292253|NCT04426695|322856994|FG007|Overall Study|Sponsor Request|0|||
94292254|NCT04426695|322856995|FG008|Overall Study|Sponsor Request|0|||
94292255|NCT04426695|322856996|FG009|Overall Study|Sponsor Request|0|||
94292256|NCT04426695|322856997|FG010|Overall Study|Sponsor Request|0|||
94292257|NCT04426695|322856998|FG011|Overall Study|Sponsor Request|0|||
94292258|NCT04426695|322856999|FG012|Overall Study|Sponsor Request|0|||
94292259|NCT04426695|322857000|FG013|Overall Study|Sponsor Request|0|||
94292260|NCT04426695|322857001|FG014|Overall Study|Sponsor Request|0|||
94292261|NCT04426695|322857002|FG015|Overall Study|Sponsor Request|0|||
94292262|NCT04426695|322857003|FG016|Overall Study|Sponsor Request|0|||
94292263|NCT04426695|322857004|FG017|Overall Study|Sponsor Request|0|||
94292264|NCT04426695|322856987|FG000|Overall Study|Physician Decision|0|||
94292265|NCT04426695|322856988|FG001|Overall Study|Physician Decision|0|||
94292266|NCT04426695|322856989|FG002|Overall Study|Physician Decision|0|||
94292267|NCT04426695|322856990|FG003|Overall Study|Physician Decision|0|||
94292268|NCT04426695|322856991|FG004|Overall Study|Physician Decision|0|||
94292269|NCT04426695|322856992|FG005|Overall Study|Physician Decision|0|||
94292270|NCT04426695|322856993|FG006|Overall Study|Physician Decision|0|||
94292271|NCT04426695|322856994|FG007|Overall Study|Physician Decision|0|||
94292272|NCT04426695|322856995|FG008|Overall Study|Physician Decision|0|||
94292273|NCT04426695|322856996|FG009|Overall Study|Physician Decision|1|||
94292274|NCT04426695|322856997|FG010|Overall Study|Physician Decision|0|||
94292275|NCT04426695|322856998|FG011|Overall Study|Physician Decision|0|||
94292276|NCT04426695|322856999|FG012|Overall Study|Physician Decision|1|||
94292277|NCT04426695|322857000|FG013|Overall Study|Physician Decision|0|||
94292278|NCT04426695|322857001|FG014|Overall Study|Physician Decision|0|||
94292279|NCT04426695|322857002|FG015|Overall Study|Physician Decision|0|||
94292280|NCT04426695|322857003|FG016|Overall Study|Physician Decision|0|||
94292281|NCT04426695|322857004|FG017|Overall Study|Physician Decision|0|||
94292282|NCT04426695|322856987|FG000|Overall Study|Randomized but Never Treated|3|||
94292283|NCT04426695|322856988|FG001|Overall Study|Randomized but Never Treated|1|||
94292284|NCT04426695|322856989|FG002|Overall Study|Randomized but Never Treated|0|||
94292285|NCT04426695|322856990|FG003|Overall Study|Randomized but Never Treated|4|||
94292286|NCT04426695|322856991|FG004|Overall Study|Randomized but Never Treated|5|||
94292287|NCT04426695|322856992|FG005|Overall Study|Randomized but Never Treated|5|||
94292288|NCT04426695|322856993|FG006|Overall Study|Randomized but Never Treated|4|||
94292289|NCT04426695|322856994|FG007|Overall Study|Randomized but Never Treated|6|||
94292290|NCT04426695|322856995|FG008|Overall Study|Randomized but Never Treated|6|||
94372547|NCT00591253|323150288|FG002|Overall Study|Lost to Follow-up|0|||
94292291|NCT04426695|322856996|FG009|Overall Study|Randomized but Never Treated|3|||
94292292|NCT04426695|322856997|FG010|Overall Study|Randomized but Never Treated|3|||
94292293|NCT04426695|322856998|FG011|Overall Study|Randomized but Never Treated|6|||
94292294|NCT04426695|322856999|FG012|Overall Study|Randomized but Never Treated|1|||
94292295|NCT04426695|322857000|FG013|Overall Study|Randomized but Never Treated|2|||
94292296|NCT04426695|322857001|FG014|Overall Study|Randomized but Never Treated|0|||
94292297|NCT04426695|322857002|FG015|Overall Study|Randomized but Never Treated|0|||
94292298|NCT04426695|322857003|FG016|Overall Study|Randomized but Never Treated|0|||
94292299|NCT04426695|322857004|FG017|Overall Study|Randomized but Never Treated|0|||
94292300|NCT05655377|322857005|FG000|Overall Study|Withdrawal by Subject|2|||
94292301|NCT01109940|322857007|FG000|Overall Study|Administrative problems|2|||
94292302|NCT01109940|322857008|FG001|Overall Study|Administrative problems|0|||
94292303|NCT01109940|322857009|FG002|Overall Study|Administrative problems|0|||
94292304|NCT01109940|322857010|FG003|Overall Study|Administrative problems|0|||
94292305|NCT01109940|322857007|FG000|Overall Study|Serious Adverse Event|2|||
94292306|NCT01109940|322857008|FG001|Overall Study|Serious Adverse Event|1|||
94292307|NCT01109940|322857009|FG002|Overall Study|Serious Adverse Event|0|||
94292308|NCT01109940|322857010|FG003|Overall Study|Serious Adverse Event|0|||
94292309|NCT01109940|322857007|FG000|Overall Study|Lost to Follow-up|1|||
94292310|NCT01109940|322857008|FG001|Overall Study|Lost to Follow-up|0|||
94292311|NCT01109940|322857009|FG002|Overall Study|Lost to Follow-up|0|||
94292312|NCT01109940|322857010|FG003|Overall Study|Lost to Follow-up|0|||
94292313|NCT01109940|322857007|FG000|Overall Study|Patient withdrew consent|1|||
94292314|NCT01109940|322857008|FG001|Overall Study|Patient withdrew consent|1|||
94292315|NCT01109940|322857009|FG002|Overall Study|Patient withdrew consent|0|||
94292316|NCT01109940|322857010|FG003|Overall Study|Patient withdrew consent|0|||
94292317|NCT01109940|322857007|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
94292318|NCT01109940|322857008|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94292319|NCT01109940|322857009|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
94292320|NCT01109940|322857010|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
94292321|NCT01552681|322857011|FG000|Overall Study|Withdrawal by Subject|4|||
94292322|NCT01552681|322857012|FG001|Overall Study|Withdrawal by Subject|0|||
94292323|NCT01552681|322857011|FG000|Overall Study|Physician Decision|1|||
94292324|NCT01552681|322857012|FG001|Overall Study|Physician Decision|0|||
94292325|NCT01552681|322857011|FG000|Overall Study|Subject moved away|0|||
94292326|NCT01552681|322857012|FG001|Overall Study|Subject moved away|1|||
94292327|NCT04698525|322857016|FG000|Overall Study|Lost to Follow-up|1|||
94292328|NCT04698525|322857017|FG001|Overall Study|Lost to Follow-up|2|||
94292329|NCT04698525|322857016|FG000|Overall Study|Three suffered of Covid-19|2|||
94292330|NCT04698525|322857017|FG001|Overall Study|Three suffered of Covid-19|1|||
94292331|NCT00510276|322857019|FG000|Acute Double-Blind Phase|Adverse Event|21|||
94292332|NCT00510276|322857020|FG001|Acute Double-Blind Phase|Adverse Event|6|||
94292333|NCT00510276|322857019|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
94292334|NCT00510276|322857020|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
94292335|NCT00510276|322857019|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
94292336|NCT00510276|322857020|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
94292337|NCT00510276|322857019|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
94292338|NCT00510276|322857020|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
94292339|NCT00510276|322857019|FG000|Acute Double-Blind Phase|Physician Decision|0|||
94292340|NCT00510276|322857020|FG001|Acute Double-Blind Phase|Physician Decision|3|||
94292341|NCT00510276|322857019|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
94292342|NCT00510276|322857020|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
94292343|NCT00510276|322857019|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
94292344|NCT00510276|322857020|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
94292345|NCT00510276|322857019|FG000|Acute Double-Blind Phase|Subject Decision|26|||
94292346|NCT00510276|322857020|FG001|Acute Double-Blind Phase|Subject Decision|28|||
94292347|NCT00510276|322857019|FG000|Extension Open-Label Phase|Adverse Event|9|||
94292348|NCT00510276|322857020|FG001|Extension Open-Label Phase|Adverse Event|18|||
94292349|NCT00510276|322857019|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
94292350|NCT00510276|322857020|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
94292351|NCT00510276|322857019|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
94292352|NCT00510276|322857020|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
94292353|NCT00510276|322857019|FG000|Extension Open-Label Phase|Physician Decision|2|||
94292354|NCT00510276|322857020|FG001|Extension Open-Label Phase|Physician Decision|3|||
94292355|NCT00510276|322857019|FG000|Extension Open-Label Phase|Protocol Violation|0|||
94292356|NCT00510276|322857020|FG001|Extension Open-Label Phase|Protocol Violation|1|||
94292357|NCT00510276|322857019|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
94292358|NCT00510276|322857020|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
94292359|NCT00510276|322857019|FG000|Extension Open-Label Phase|Subject Decision|7|||
94292360|NCT00510276|322857020|FG001|Extension Open-Label Phase|Subject Decision|9|||
94292361|NCT02076165|322857024|FG000|Overall Study|Lost to Follow-up|7|||
94292362|NCT02076165|322857025|FG001|Overall Study|Lost to Follow-up|5|||
94292363|NCT02076165|322857024|FG000|Overall Study|Refused follow-up assessment|1|||
94467984|NCT00803205|323502463|FG000|Overall Study|Adverse Event|7|||
94292364|NCT02076165|322857025|FG001|Overall Study|Refused follow-up assessment|1|||
94292365|NCT01551693|322857029|FG000|Overall Study|Disease Progression|1|||
94292366|NCT01551693|322857030|FG001|Overall Study|Disease Progression|0|||
94292367|NCT01551693|322857029|FG000|Overall Study|Adverse Event|0|||
94292368|NCT01551693|322857030|FG001|Overall Study|Adverse Event|1|||
94292369|NCT01551693|322857029|FG000|Overall Study|Withdrawal by Subject|0|||
94292370|NCT01551693|322857030|FG001|Overall Study|Withdrawal by Subject|1|||
94292371|NCT03157531|322857031|FG000|Overall Study|Death|2|||
94292372|NCT03157531|322857031|FG000|Overall Study|Lost to Follow-up|4|||
94292373|NCT00331006|322857032|FG000|Screening Phase|Withdrawal by Subject|1|||
94292374|NCT00331006|322857032|FG000|Screening Phase|enrollment halted|1|||
94292375|NCT00331006|322857032|FG000|Screening Phase|Lost to Follow-up|1|||
94292376|NCT00331006|322857032|FG000|Screening Phase|Ineligible for treatment phase|4|||
94292377|NCT00331006|322857032|FG000|Treatment Phase|Withdrawal by Subject|1|||
94292378|NCT00331006|322857032|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
94292379|NCT00331006|322857032|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
94292380|NCT03804684|322857033|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
94292381|NCT03804684|322857034|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
94292382|NCT01756456|322857038|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
94292383|NCT01756456|322857039|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
94292384|NCT01756456|322857040|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
94292385|NCT01756456|322857041|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
94292386|NCT01756456|322857042|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
94292387|NCT01756456|322857043|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
94292388|NCT01756456|322857038|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
94292389|NCT01756456|322857039|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
94292390|NCT01756456|322857040|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
94292391|NCT01756456|322857041|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
94292392|NCT01756456|322857042|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
94292393|NCT01756456|322857043|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
94292394|NCT01756456|322857038|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
94292395|NCT01756456|322857039|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
94292396|NCT01756456|322857040|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
94292397|NCT01756456|322857041|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
94292398|NCT01756456|322857042|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
94292399|NCT01756456|322857043|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
94292400|NCT01756456|322857038|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
94292401|NCT01756456|322857039|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
94292402|NCT01756456|322857040|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
94292403|NCT01756456|322857041|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
94292404|NCT01756456|322857042|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
94292405|NCT01756456|322857043|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
94292406|NCT01756456|322857038|FG000|Treatment Period: Phase I/II|Other causes|0|||
94292407|NCT01756456|322857039|FG001|Treatment Period: Phase I/II|Other causes|0|||
94292408|NCT01756456|322857040|FG002|Treatment Period: Phase I/II|Other causes|0|||
94292409|NCT01756456|322857041|FG003|Treatment Period: Phase I/II|Other causes|1|||
94292410|NCT01756456|322857042|FG004|Treatment Period: Phase I/II|Other causes|2|||
94292411|NCT01756456|322857043|FG005|Treatment Period: Phase I/II|Other causes|2|||
94292412|NCT01756456|322857038|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
94292413|NCT01756456|322857039|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
94292414|NCT01756456|322857040|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
94292415|NCT01756456|322857041|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
94292416|NCT01756456|322857042|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
94292417|NCT01756456|322857043|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
94292418|NCT01756456|322857038|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
94292419|NCT01756456|322857039|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
94292420|NCT01756456|322857040|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
94292421|NCT01756456|322857041|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
94292422|NCT01756456|322857042|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
94292423|NCT01756456|322857043|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
94292424|NCT01756456|322857038|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
94292425|NCT01756456|322857039|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
94292426|NCT01756456|322857040|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
94292427|NCT01756456|322857041|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
94292428|NCT01756456|322857042|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
94292429|NCT01756456|322857043|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
94292430|NCT01756456|322857038|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
94292431|NCT01756456|322857039|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
94292432|NCT01756456|322857040|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
94292433|NCT01756456|322857041|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
94292434|NCT01756456|322857042|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
94292435|NCT01756456|322857043|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
94292436|NCT01756456|322857038|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
94292437|NCT01756456|322857039|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
94292438|NCT01756456|322857040|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
94292439|NCT01756456|322857041|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
94292440|NCT01756456|322857042|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
94292441|NCT01756456|322857043|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
94467985|NCT00803205|323502464|FG001|Overall Study|Adverse Event|2|||
94467986|NCT00803205|323502463|FG000|Overall Study|Lost to Follow-up|1|||
94292442|NCT01756456|322857038|FG000|Follow Up Period Phase I/II|Other causes|0|||
94292443|NCT01756456|322857039|FG001|Follow Up Period Phase I/II|Other causes|0|||
94292444|NCT01756456|322857040|FG002|Follow Up Period Phase I/II|Other causes|0|||
94292445|NCT01756456|322857041|FG003|Follow Up Period Phase I/II|Other causes|1|||
94292446|NCT01756456|322857042|FG004|Follow Up Period Phase I/II|Other causes|3|||
94292447|NCT01756456|322857043|FG005|Follow Up Period Phase I/II|Other causes|5|||
94292448|NCT01273064|322857046|FG000|Overall Study|Adverse Event|5|||
94292449|NCT01273064|322857047|FG001|Overall Study|Adverse Event|1|||
94292450|NCT01273064|322857048|FG002|Overall Study|Adverse Event|3|||
94292451|NCT01273064|322857049|FG003|Overall Study|Adverse Event|2|||
94292452|NCT01273064|322857050|FG004|Overall Study|Adverse Event|1|||
94292453|NCT01273064|322857046|FG000|Overall Study|Withdrawal by Subject|4|||
94292454|NCT01273064|322857047|FG001|Overall Study|Withdrawal by Subject|2|||
94292455|NCT01273064|322857048|FG002|Overall Study|Withdrawal by Subject|2|||
94292456|NCT01273064|322857049|FG003|Overall Study|Withdrawal by Subject|2|||
94292457|NCT01273064|322857050|FG004|Overall Study|Withdrawal by Subject|0|||
94292458|NCT01273064|322857046|FG000|Overall Study|Study Termination|13|||
94292459|NCT01273064|322857047|FG001|Overall Study|Study Termination|27|||
94292460|NCT01273064|322857048|FG002|Overall Study|Study Termination|26|||
94292461|NCT01273064|322857049|FG003|Overall Study|Study Termination|16|||
94292462|NCT01273064|322857050|FG004|Overall Study|Study Termination|8|||
94292463|NCT01273064|322857046|FG000|Overall Study|Lost to Follow-up|1|||
94292464|NCT01273064|322857047|FG001|Overall Study|Lost to Follow-up|0|||
94292465|NCT01273064|322857048|FG002|Overall Study|Lost to Follow-up|0|||
94292466|NCT01273064|322857049|FG003|Overall Study|Lost to Follow-up|0|||
94292467|NCT01273064|322857050|FG004|Overall Study|Lost to Follow-up|0|||
94292468|NCT01273064|322857046|FG000|Overall Study|Physician Decision|0|||
94292469|NCT01273064|322857047|FG001|Overall Study|Physician Decision|0|||
94292470|NCT01273064|322857048|FG002|Overall Study|Physician Decision|0|||
94292471|NCT01273064|322857049|FG003|Overall Study|Physician Decision|0|||
94292472|NCT01273064|322857050|FG004|Overall Study|Physician Decision|1|||
94292473|NCT00996203|322857051|FG000|Overall Study|Adverse Event|3|||
94292474|NCT00996203|322857051|FG000|Overall Study|Lost to Follow-up|1|||
94292475|NCT00996203|322857051|FG000|Overall Study|Lack of Efficacy|1|||
94292476|NCT00996203|322857051|FG000|Overall Study|Protocol Violation|2|||
94292477|NCT00481065|322857052|FG000|Overall Study|Adverse event or death|1|||
94292478|NCT00481065|322857053|FG001|Overall Study|Adverse event or death|1|||
94292479|NCT00481065|322857054|FG002|Overall Study|Adverse event or death|3|||
94292480|NCT00481065|322857055|FG003|Overall Study|Adverse event or death|0|||
94292481|NCT00481065|322857056|FG004|Overall Study|Adverse event or death|2|||
94292482|NCT00481065|322857057|FG005|Overall Study|Adverse event or death|0|||
94292483|NCT00481065|322857058|FG006|Overall Study|Adverse event or death|1|||
94292484|NCT00481065|322857059|FG007|Overall Study|Adverse event or death|1|||
94292485|NCT00481065|322857052|FG000|Overall Study|Withdrawal by Subject|11|||
94292486|NCT00481065|322857053|FG001|Overall Study|Withdrawal by Subject|12|||
94292487|NCT00481065|322857054|FG002|Overall Study|Withdrawal by Subject|7|||
94292488|NCT00481065|322857055|FG003|Overall Study|Withdrawal by Subject|11|||
94292489|NCT00481065|322857056|FG004|Overall Study|Withdrawal by Subject|13|||
94292490|NCT00481065|322857057|FG005|Overall Study|Withdrawal by Subject|12|||
94292491|NCT00481065|322857058|FG006|Overall Study|Withdrawal by Subject|9|||
94292492|NCT00481065|322857059|FG007|Overall Study|Withdrawal by Subject|10|||
94292493|NCT00481065|322857052|FG000|Overall Study|Lost to Follow-up|4|||
94292494|NCT00481065|322857053|FG001|Overall Study|Lost to Follow-up|2|||
94292495|NCT00481065|322857054|FG002|Overall Study|Lost to Follow-up|4|||
94292496|NCT00481065|322857055|FG003|Overall Study|Lost to Follow-up|3|||
94292497|NCT00481065|322857056|FG004|Overall Study|Lost to Follow-up|3|||
94292498|NCT00481065|322857057|FG005|Overall Study|Lost to Follow-up|3|||
94292499|NCT00481065|322857058|FG006|Overall Study|Lost to Follow-up|2|||
94292500|NCT00481065|322857059|FG007|Overall Study|Lost to Follow-up|5|||
94292501|NCT00481065|322857052|FG000|Overall Study|Inappropriate enrollment|4|||
94292502|NCT00481065|322857053|FG001|Overall Study|Inappropriate enrollment|0|||
94292503|NCT00481065|322857054|FG002|Overall Study|Inappropriate enrollment|2|||
94292504|NCT00481065|322857055|FG003|Overall Study|Inappropriate enrollment|0|||
94292505|NCT00481065|322857056|FG004|Overall Study|Inappropriate enrollment|2|||
94292506|NCT00481065|322857057|FG005|Overall Study|Inappropriate enrollment|1|||
94292507|NCT00481065|322857058|FG006|Overall Study|Inappropriate enrollment|0|||
94292508|NCT00481065|322857059|FG007|Overall Study|Inappropriate enrollment|1|||
94292509|NCT00481065|322857052|FG000|Overall Study|Administrative reason|0|||
94292510|NCT00481065|322857053|FG001|Overall Study|Administrative reason|0|||
94292511|NCT00481065|322857054|FG002|Overall Study|Administrative reason|0|||
94292512|NCT00481065|322857055|FG003|Overall Study|Administrative reason|0|||
94292513|NCT00481065|322857056|FG004|Overall Study|Administrative reason|0|||
94292514|NCT00481065|322857057|FG005|Overall Study|Administrative reason|2|||
94292515|NCT00481065|322857058|FG006|Overall Study|Administrative reason|1|||
94292516|NCT00481065|322857059|FG007|Overall Study|Administrative reason|0|||
94292517|NCT00481065|322857052|FG000|Overall Study|Protocol Violation|2|||
94292518|NCT00481065|322857053|FG001|Overall Study|Protocol Violation|1|||
94292519|NCT00481065|322857054|FG002|Overall Study|Protocol Violation|1|||
94292520|NCT00481065|322857055|FG003|Overall Study|Protocol Violation|1|||
94292521|NCT00481065|322857056|FG004|Overall Study|Protocol Violation|2|||
94292522|NCT00481065|322857057|FG005|Overall Study|Protocol Violation|6|||
94292523|NCT00481065|322857058|FG006|Overall Study|Protocol Violation|3|||
94292524|NCT00481065|322857059|FG007|Overall Study|Protocol Violation|2|||
94292525|NCT00481065|322857052|FG000|Overall Study|Unable to classify|0|||
94292526|NCT00481065|322857053|FG001|Overall Study|Unable to classify|1|||
94292527|NCT00481065|322857054|FG002|Overall Study|Unable to classify|2|||
94292528|NCT00481065|322857055|FG003|Overall Study|Unable to classify|0|||
94292529|NCT00481065|322857056|FG004|Overall Study|Unable to classify|1|||
94292530|NCT00481065|322857057|FG005|Overall Study|Unable to classify|0|||
94292531|NCT00481065|322857058|FG006|Overall Study|Unable to classify|0|||
94292532|NCT00481065|322857059|FG007|Overall Study|Unable to classify|0|||
94292533|NCT02330419|322857070|FG000|Overall Study|Lost to Follow-up|3|||
94292534|NCT02330419|322857071|FG001|Overall Study|Lost to Follow-up|7|||
94292535|NCT01870739|322857072|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
94292536|NCT01870739|322857073|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
94292537|NCT01870739|322857072|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
94292538|NCT01870739|322857073|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
94292539|NCT01870739|322857072|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
94292540|NCT01870739|322857073|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
94292541|NCT01870739|322857072|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
94292542|NCT01870739|322857073|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
94292543|NCT01870739|322857072|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
94292544|NCT01870739|322857073|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
94292545|NCT01870739|322857072|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
94292546|NCT01870739|322857073|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
94292547|NCT01870739|322857072|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
94292548|NCT01870739|322857073|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
94292549|NCT01459614|322857074|FG000|Overall Study|Adverse Event|1|||
94292550|NCT01459614|322857075|FG001|Overall Study|Adverse Event|0|||
94292551|NCT01506882|322857076|FG000|Overall Study|Lack of Efficacy|4|||
94292552|NCT01506882|322857077|FG001|Overall Study|Lack of Efficacy|3|||
94292553|NCT01506882|322857076|FG000|Overall Study|Lost to Follow-up|1|||
94292554|NCT01506882|322857077|FG001|Overall Study|Lost to Follow-up|0|||
94292555|NCT01506882|322857076|FG000|Overall Study|Withdrawal by Subject|9|||
94292556|NCT01506882|322857077|FG001|Overall Study|Withdrawal by Subject|3|||
94292557|NCT01506882|322857076|FG000|Overall Study|SAE, non-fatal|2|||
94292558|NCT01506882|322857077|FG001|Overall Study|SAE, non-fatal|0|||
94292559|NCT01506882|322857076|FG000|Overall Study|AE, non-serious non-fatal|3|||
94292560|NCT01506882|322857077|FG001|Overall Study|AE, non-serious non-fatal|1|||
94292561|NCT01506882|322857076|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
94292562|NCT01506882|322857077|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
94292563|NCT01506882|322857076|FG000|Overall Study|Other Reason|2|||
94292564|NCT01506882|322857077|FG001|Overall Study|Other Reason|0|||
94292565|NCT04640766|322857078|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
94292566|NCT01671345|322857091|FG000|Overall Study|Lost to Follow-up|10|||
94292567|NCT01671345|322857092|FG001|Overall Study|Lost to Follow-up|6|||
94292568|NCT01671345|322857091|FG000|Overall Study|visit with non-participating physician|3|||
94292569|NCT01671345|322857092|FG001|Overall Study|visit with non-participating physician|3|||
94292570|NCT01291017|322857095|FG000|Overall Study|Lost to Follow-up|2|||
94292571|NCT01291017|322857095|FG000|Overall Study|Withdrawal by Subject|3|||
94292572|NCT02847598|322857096|FG000|Overall Study|Adverse Event|0|||
94292573|NCT02847598|322857097|FG001|Overall Study|Adverse Event|0|||
94292574|NCT02847598|322857098|FG002|Overall Study|Adverse Event|0|||
94292575|NCT02847598|322857099|FG003|Overall Study|Adverse Event|0|||
94292576|NCT02847598|322857100|FG004|Overall Study|Adverse Event|0|||
94292577|NCT02847598|322857101|FG005|Overall Study|Adverse Event|0|||
94292578|NCT02847598|322857102|FG006|Overall Study|Adverse Event|0|||
94292579|NCT02847598|322857103|FG007|Overall Study|Adverse Event|1|||
94292580|NCT02847598|322857096|FG000|Overall Study|Consent withdrawn|2|||
94292581|NCT02847598|322857097|FG001|Overall Study|Consent withdrawn|0|||
94292582|NCT02847598|322857098|FG002|Overall Study|Consent withdrawn|0|||
94292583|NCT02847598|322857099|FG003|Overall Study|Consent withdrawn|4|||
94292584|NCT02847598|322857100|FG004|Overall Study|Consent withdrawn|3|||
94372548|NCT00591253|323150286|FG000|Overall Study|Withdrawal by Subject|1|||
94292585|NCT02847598|322857101|FG005|Overall Study|Consent withdrawn|2|||
94292586|NCT02847598|322857102|FG006|Overall Study|Consent withdrawn|1|||
94292587|NCT02847598|322857103|FG007|Overall Study|Consent withdrawn|3|||
94292588|NCT02847598|322857096|FG000|Overall Study|Death|3|||
94292589|NCT02847598|322857097|FG001|Overall Study|Death|0|||
94292590|NCT02847598|322857098|FG002|Overall Study|Death|0|||
94292591|NCT02847598|322857099|FG003|Overall Study|Death|0|||
94292592|NCT02847598|322857100|FG004|Overall Study|Death|0|||
94372549|NCT00591253|323150287|FG001|Overall Study|Withdrawal by Subject|7|||
94292593|NCT02847598|322857101|FG005|Overall Study|Death|0|||
94292594|NCT02847598|322857102|FG006|Overall Study|Death|0|||
94292595|NCT02847598|322857103|FG007|Overall Study|Death|0|||
94292596|NCT02847598|322857096|FG000|Overall Study|Lost to Follow-up|0|||
94292597|NCT02847598|322857097|FG001|Overall Study|Lost to Follow-up|0|||
94292598|NCT02847598|322857098|FG002|Overall Study|Lost to Follow-up|0|||
94292599|NCT02847598|322857099|FG003|Overall Study|Lost to Follow-up|0|||
94292600|NCT02847598|322857100|FG004|Overall Study|Lost to Follow-up|0|||
94292601|NCT02847598|322857101|FG005|Overall Study|Lost to Follow-up|1|||
94292602|NCT02847598|322857102|FG006|Overall Study|Lost to Follow-up|1|||
94292603|NCT02847598|322857103|FG007|Overall Study|Lost to Follow-up|0|||
94292604|NCT03690869|322857105|FG000|Overall Study|Adverse Event|0|||
94292605|NCT03690869|322857106|FG001|Overall Study|Adverse Event|0|||
94292606|NCT03690869|322857107|FG002|Overall Study|Adverse Event|0|||
94292607|NCT03690869|322857108|FG003|Overall Study|Adverse Event|1|||
94292608|NCT03690869|322857109|FG004|Overall Study|Adverse Event|0|||
94292609|NCT03690869|322857110|FG005|Overall Study|Adverse Event|0|||
94292610|NCT03690869|322857111|FG006|Overall Study|Adverse Event|0|||
94292611|NCT03690869|322857112|FG007|Overall Study|Adverse Event|1|||
94292612|NCT03690869|322857113|FG008|Overall Study|Adverse Event|0|||
94292613|NCT03690869|322857114|FG009|Overall Study|Adverse Event|1|||
94292614|NCT03690869|322857105|FG000|Overall Study|Death|1|||
94292615|NCT03690869|322857106|FG001|Overall Study|Death|1|||
94292616|NCT03690869|322857107|FG002|Overall Study|Death|1|||
94292617|NCT03690869|322857108|FG003|Overall Study|Death|4|||
94292618|NCT03690869|322857109|FG004|Overall Study|Death|2|||
94292619|NCT03690869|322857110|FG005|Overall Study|Death|5|||
94292620|NCT03690869|322857111|FG006|Overall Study|Death|3|||
94292621|NCT03690869|322857112|FG007|Overall Study|Death|2|||
94292622|NCT03690869|322857113|FG008|Overall Study|Death|0|||
94292623|NCT03690869|322857114|FG009|Overall Study|Death|3|||
94292624|NCT03690869|322857105|FG000|Overall Study|Lost to Follow-up|0|||
94292625|NCT03690869|322857106|FG001|Overall Study|Lost to Follow-up|0|||
94292626|NCT03690869|322857107|FG002|Overall Study|Lost to Follow-up|1|||
94292627|NCT03690869|322857108|FG003|Overall Study|Lost to Follow-up|0|||
94292628|NCT03690869|322857109|FG004|Overall Study|Lost to Follow-up|0|||
94292629|NCT03690869|322857110|FG005|Overall Study|Lost to Follow-up|0|||
94292630|NCT03690869|322857111|FG006|Overall Study|Lost to Follow-up|0|||
94292631|NCT03690869|322857112|FG007|Overall Study|Lost to Follow-up|0|||
94292632|NCT03690869|322857113|FG008|Overall Study|Lost to Follow-up|0|||
94292633|NCT03690869|322857114|FG009|Overall Study|Lost to Follow-up|0|||
94292634|NCT03690869|322857105|FG000|Overall Study|Other Treatment|1|||
94292635|NCT03690869|322857106|FG001|Overall Study|Other Treatment|1|||
94292636|NCT03690869|322857107|FG002|Overall Study|Other Treatment|1|||
94292637|NCT03690869|322857108|FG003|Overall Study|Other Treatment|2|||
94292638|NCT03690869|322857109|FG004|Overall Study|Other Treatment|3|||
94292639|NCT03690869|322857110|FG005|Overall Study|Other Treatment|1|||
94292640|NCT03690869|322857111|FG006|Overall Study|Other Treatment|2|||
94292641|NCT03690869|322857112|FG007|Overall Study|Other Treatment|7|||
94292642|NCT03690869|322857113|FG008|Overall Study|Other Treatment|0|||
94292643|NCT03690869|322857114|FG009|Overall Study|Other Treatment|3|||
94292644|NCT03690869|322857105|FG000|Overall Study|Physician Decision|0|||
94292645|NCT03690869|322857106|FG001|Overall Study|Physician Decision|1|||
94292646|NCT03690869|322857107|FG002|Overall Study|Physician Decision|0|||
94292647|NCT03690869|322857108|FG003|Overall Study|Physician Decision|0|||
94292648|NCT03690869|322857109|FG004|Overall Study|Physician Decision|0|||
94292649|NCT03690869|322857110|FG005|Overall Study|Physician Decision|0|||
94292650|NCT03690869|322857111|FG006|Overall Study|Physician Decision|0|||
94292651|NCT03690869|322857112|FG007|Overall Study|Physician Decision|0|||
94292652|NCT03690869|322857113|FG008|Overall Study|Physician Decision|0|||
94292653|NCT03690869|322857114|FG009|Overall Study|Physician Decision|0|||
94292654|NCT03690869|322857105|FG000|Overall Study|Progressive Disease|1|||
94292655|NCT03690869|322857106|FG001|Overall Study|Progressive Disease|2|||
94292656|NCT03690869|322857107|FG002|Overall Study|Progressive Disease|0|||
94292657|NCT03690869|322857108|FG003|Overall Study|Progressive Disease|1|||
94292658|NCT03690869|322857109|FG004|Overall Study|Progressive Disease|0|||
94292659|NCT03690869|322857110|FG005|Overall Study|Progressive Disease|0|||
94292660|NCT03690869|322857111|FG006|Overall Study|Progressive Disease|0|||
94292661|NCT03690869|322857112|FG007|Overall Study|Progressive Disease|0|||
94292662|NCT03690869|322857113|FG008|Overall Study|Progressive Disease|1|||
94292663|NCT03690869|322857114|FG009|Overall Study|Progressive Disease|1|||
94292664|NCT03690869|322857105|FG000|Overall Study|Subject Decision|0|||
94292665|NCT03690869|322857106|FG001|Overall Study|Subject Decision|0|||
94292666|NCT03690869|322857107|FG002|Overall Study|Subject Decision|0|||
94292667|NCT03690869|322857108|FG003|Overall Study|Subject Decision|1|||
94292668|NCT03690869|322857109|FG004|Overall Study|Subject Decision|0|||
94292669|NCT03690869|322857110|FG005|Overall Study|Subject Decision|0|||
94292670|NCT03690869|322857111|FG006|Overall Study|Subject Decision|0|||
94292671|NCT03690869|322857112|FG007|Overall Study|Subject Decision|1|||
94292672|NCT03690869|322857113|FG008|Overall Study|Subject Decision|0|||
94292673|NCT03690869|322857114|FG009|Overall Study|Subject Decision|0|||
94292674|NCT00352534|322859277|FG000|Initial Staging|Ineligible|8|||
94292675|NCT00352534|322859278|FG001|Initial Staging|Ineligible|9|||
94292676|NCT00352534|322859279|FG002|Initial Staging|Ineligible|0|||
94292677|NCT00352534|322859280|FG003|Initial Staging|Ineligible|0|||
94292678|NCT00352534|322859281|FG004|Initial Staging|Ineligible|0|||
94292679|NCT00352534|322859282|FG005|Initial Staging|Ineligible|0|||
94292680|NCT00352534|322859283|FG006|Initial Staging|Ineligible|0|||
94292681|NCT00352534|322859277|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
94292682|NCT00352534|322859278|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
94292683|NCT00352534|322859279|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
94292684|NCT00352534|322859280|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
94292685|NCT00352534|322859281|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
94292686|NCT00352534|322859282|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
94292687|NCT00352534|322859283|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
94292688|NCT00352534|322859277|FG000|Final Risk Group Assignment|Physician Decision|0|||
94292689|NCT00352534|322859278|FG001|Final Risk Group Assignment|Physician Decision|0|||
94292690|NCT00352534|322859279|FG002|Final Risk Group Assignment|Physician Decision|0|||
94292691|NCT00352534|322859280|FG003|Final Risk Group Assignment|Physician Decision|0|||
94292692|NCT00352534|322859281|FG004|Final Risk Group Assignment|Physician Decision|0|||
94292693|NCT00352534|322859282|FG005|Final Risk Group Assignment|Physician Decision|8|||
94292694|NCT00352534|322859283|FG006|Final Risk Group Assignment|Physician Decision|0|||
94292695|NCT00352534|322859277|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
94292696|NCT00352534|322859278|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
94292697|NCT00352534|322859279|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
94292698|NCT00352534|322859280|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
94292699|NCT00352534|322859281|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
94292700|NCT00352534|322859282|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
94292701|NCT00352534|322859283|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
94292702|NCT00352534|322859277|FG000|Final Risk Group Assignment|Ineligible|0|||
94292703|NCT00352534|322859278|FG001|Final Risk Group Assignment|Ineligible|0|||
94292704|NCT00352534|322859279|FG002|Final Risk Group Assignment|Ineligible|3|||
94292705|NCT00352534|322859280|FG003|Final Risk Group Assignment|Ineligible|1|||
94292706|NCT00352534|322859281|FG004|Final Risk Group Assignment|Ineligible|0|||
94292707|NCT00352534|322859282|FG005|Final Risk Group Assignment|Ineligible|13|||
94292708|NCT00352534|322859283|FG006|Final Risk Group Assignment|Ineligible|0|||
94292709|NCT00352534|322859277|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
94292710|NCT00352534|322859278|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
94292711|NCT00352534|322859279|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
94292712|NCT00352534|322859280|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
94292713|NCT00352534|322859281|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
94292714|NCT00352534|322859282|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
94292715|NCT00352534|322859283|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
94292716|NCT00352534|322859277|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
94292717|NCT00352534|322859278|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
94292718|NCT00352534|322859279|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
94292719|NCT00352534|322859280|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
94292720|NCT00352534|322859281|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
94292721|NCT00352534|322859282|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
94292722|NCT00352534|322859283|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
94292723|NCT00352534|322859277|FG000|Final Risk Group Assignment|Death|0|||
94292724|NCT00352534|322859278|FG001|Final Risk Group Assignment|Death|0|||
94292725|NCT00352534|322859279|FG002|Final Risk Group Assignment|Death|0|||
94292726|NCT00352534|322859280|FG003|Final Risk Group Assignment|Death|0|||
94292727|NCT00352534|322859281|FG004|Final Risk Group Assignment|Death|0|||
94292728|NCT00352534|322859282|FG005|Final Risk Group Assignment|Death|2|||
94292729|NCT00352534|322859283|FG006|Final Risk Group Assignment|Death|0|||
94292730|NCT04439279|322859284|FG000|Overall Study|Adverse Event|7|||
94292731|NCT04439279|322859284|FG000|Overall Study|Death|4|||
94292732|NCT04439279|322859284|FG000|Overall Study|Disease progression|17|||
94292733|NCT04439279|322859284|FG000|Overall Study|Complicating disease|3|||
94292734|NCT04439279|322859284|FG000|Overall Study|Withdrawal by Subject|2|||
94292735|NCT04439279|322859284|FG000|Overall Study|Ineligible|1|||
94292736|NCT04439279|322859284|FG000|Overall Study|Treatment still ongoing|1|||
94292737|NCT00880750|322859285|FG000|First Intervention|Adverse Event|1|||
94292738|NCT00880750|322859286|FG001|First Intervention|Adverse Event|0|||
94292739|NCT00880750|322859285|FG000|First Intervention|Unable to collect urine|4|||
94292740|NCT00880750|322859286|FG001|First Intervention|Unable to collect urine|0|||
94292741|NCT00880750|322859285|FG000|First Intervention|Non-compliance with meals|0|||
94292742|NCT00880750|322859286|FG001|First Intervention|Non-compliance with meals|1|||
94292743|NCT00880750|322859285|FG000|First Intervention|Withdrawal by Subject|2|||
94292744|NCT00880750|322859286|FG001|First Intervention|Withdrawal by Subject|0|||
94292745|NCT00880750|322859285|FG000|First Intervention|Lost to Follow-up|2|||
94292746|NCT00880750|322859286|FG001|First Intervention|Lost to Follow-up|0|||
94372550|NCT00591253|323150288|FG002|Overall Study|Withdrawal by Subject|6|||
94372551|NCT00591253|323150286|FG000|Overall Study|Lack of Efficacy|1|||
94292747|NCT00880750|322859285|FG000|Second Intervention|Withdrawal by Subject|2|||
94292748|NCT00880750|322859286|FG001|Second Intervention|Withdrawal by Subject|2|||
94292749|NCT00880750|322859285|FG000|Second Intervention|Protocol Violation|1|||
94292750|NCT00880750|322859286|FG001|Second Intervention|Protocol Violation|0|||
94292751|NCT00880750|322859285|FG000|Second Intervention|Unable to collect urine|1|||
94292752|NCT00880750|322859286|FG001|Second Intervention|Unable to collect urine|0|||
94292753|NCT02965716|322859291|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
94292754|NCT02965716|322859292|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
94292755|NCT02965716|322859291|FG000|Overall Study|Progression/Relapse|8|||
94292756|NCT02965716|322859292|FG001|Overall Study|Progression/Relapse|16|||
94292757|NCT02965716|322859291|FG000|Overall Study|Death|1|||
94292758|NCT02965716|322859292|FG001|Overall Study|Death|0|||
94292759|NCT02965716|322859291|FG000|Overall Study|Not Protocol Specified|1|||
94292760|NCT02965716|322859292|FG001|Overall Study|Not Protocol Specified|3|||
94292761|NCT04047797|322859293|FG000|Overall Study|Progressive Disease|1|||
94292762|NCT03609619|322859296|FG000|Overall Study|Adverse Event|1|||
94292763|NCT03609619|322859297|FG001|Overall Study|Adverse Event|0|||
94292764|NCT03609619|322859296|FG000|Overall Study|Lack of Efficacy|1|||
94292765|NCT03609619|322859297|FG001|Overall Study|Lack of Efficacy|2|||
94292766|NCT03609619|322859296|FG000|Overall Study|Protocol Violation|5|||
94292767|NCT03609619|322859297|FG001|Overall Study|Protocol Violation|0|||
94292768|NCT03609619|322859296|FG000|Overall Study|Withdrawal by Subject|2|||
94292769|NCT03609619|322859297|FG001|Overall Study|Withdrawal by Subject|3|||
94292770|NCT03609619|322859296|FG000|Overall Study|Lost to Follow-up|1|||
94292771|NCT03609619|322859297|FG001|Overall Study|Lost to Follow-up|1|||
94292772|NCT00956943|322859298|FG000|Overall Study|Lost to Follow-up|9|||
94292773|NCT00956943|322859299|FG001|Overall Study|Lost to Follow-up|10|||
94292774|NCT02613208|322859300|FG000|Overall Study|Withdrawal by Subject|1|||
94292775|NCT02613208|322859300|FG000|Overall Study|Change of address|2|||
94292776|NCT02613208|322859300|FG000|Overall Study|Physician Decision|2|||
94292777|NCT02613208|322859300|FG000|Overall Study|Lost to Follow-up|5|||
94292778|NCT02613208|322859300|FG000|Overall Study|Death|37|||
94292779|NCT01524991|322859301|FG000|Overall Study|Adverse Event|12|||
94292780|NCT01524991|322859301|FG000|Overall Study|Death|1|||
94292781|NCT01524991|322859301|FG000|Overall Study|Disease ProgressionDu|17|||
94292782|NCT01524991|322859301|FG000|Overall Study|Other complicating disease|1|||
94292783|NCT01524991|322859301|FG000|Overall Study|Withdrawal by Subject|2|||
94292784|NCT01524991|322859301|FG000|Overall Study|Symptomatic Deterioration|1|||
94292785|NCT00365989|322859304|FG000|Overall Study|Withdrawal by Subject|1|||
94292786|NCT00365989|322859304|FG000|Overall Study|Non-compliance|1|||
94292787|NCT01276821|322859308|FG000|Overall Study|Protocol Violation|0|||
94292788|NCT01276821|322859309|FG001|Overall Study|Protocol Violation|1|||
94292789|NCT00317044|322859310|FG000|Overall Study|Protocol Violation|28|||
94292790|NCT00317044|322859311|FG001|Overall Study|Protocol Violation|22|||
94292791|NCT00317044|322859312|FG002|Overall Study|Protocol Violation|20|||
94292792|NCT00317044|322859310|FG000|Overall Study|Adverse Event|4|||
94292793|NCT00317044|322859311|FG001|Overall Study|Adverse Event|7|||
94292794|NCT00317044|322859312|FG002|Overall Study|Adverse Event|4|||
94292795|NCT00317044|322859310|FG000|Overall Study|Withdrawal by Subject|10|||
94292796|NCT00317044|322859311|FG001|Overall Study|Withdrawal by Subject|7|||
94292797|NCT00317044|322859312|FG002|Overall Study|Withdrawal by Subject|12|||
94292798|NCT00317044|322859310|FG000|Overall Study|Lost to Follow-up|0|||
94292799|NCT00317044|322859311|FG001|Overall Study|Lost to Follow-up|2|||
94292800|NCT00317044|322859312|FG002|Overall Study|Lost to Follow-up|3|||
94292801|NCT00317044|322859310|FG000|Overall Study|Multiple Reasons|6|||
94292802|NCT00317044|322859311|FG001|Overall Study|Multiple Reasons|2|||
94292803|NCT00317044|322859312|FG002|Overall Study|Multiple Reasons|6|||
94292804|NCT00950170|322859313|FG000|Overall Study|Parent/Legal Guardian Request|1|||
94292805|NCT00950170|322859313|FG000|Overall Study|Adverse Event|2|||
94292806|NCT00950170|322859313|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
94292807|NCT02367521|322859316|FG000|Overall Study|severe headache after intervention|2|||
94292808|NCT02367521|322859317|FG001|Overall Study|severe headache after intervention|0|||
94292809|NCT02367521|322859316|FG000|Overall Study|unable to find transportation|2|||
94292810|NCT02367521|322859317|FG001|Overall Study|unable to find transportation|0|||
94292811|NCT00430755|322859320|FG000|Overall Study|Withdrawal by Subject|53|||
94292812|NCT03575104|322859321|FG000|Overall Study|Adverse Event|4|||
94292813|NCT03575104|322859322|FG001|Overall Study|Adverse Event|3|||
94292814|NCT03575104|322859323|FG002|Overall Study|Adverse Event|4|||
94292815|NCT03575104|322859321|FG000|Overall Study|Withdrawal by Subject|13|||
94292816|NCT03575104|322859322|FG001|Overall Study|Withdrawal by Subject|16|||
94292817|NCT03575104|322859323|FG002|Overall Study|Withdrawal by Subject|11|||
94292818|NCT03575104|322859321|FG000|Overall Study|Other reasons|6|||
94292819|NCT03575104|322859322|FG001|Overall Study|Other reasons|8|||
94292820|NCT03575104|322859323|FG002|Overall Study|Other reasons|6|||
94292821|NCT03575104|322859321|FG000|Overall Study|Lost to Follow-up|1|||
94292822|NCT03575104|322859322|FG001|Overall Study|Lost to Follow-up|2|||
94292823|NCT03575104|322859323|FG002|Overall Study|Lost to Follow-up|1|||
94292824|NCT03480802|322859324|FG000|Overall Study|Lost to Follow-up|5|||
94292825|NCT03480802|322859325|FG001|Overall Study|Lost to Follow-up|1|||
94292826|NCT03480802|322859324|FG000|Overall Study|Withdrawal by Subject|2|||
94292827|NCT03480802|322859325|FG001|Overall Study|Withdrawal by Subject|1|||
94292828|NCT03480802|322859324|FG000|Overall Study|Relocated|0|||
94292829|NCT03480802|322859325|FG001|Overall Study|Relocated|1|||
94292830|NCT01703000|322859326|FG000|Overall Study|Death|1|||
94292831|NCT00434967|322859327|FG000|Overall Study|Adverse Event|2|||
94292832|NCT00434967|322859328|FG001|Overall Study|Adverse Event|4|||
94292833|NCT00434967|322859329|FG002|Overall Study|Adverse Event|3|||
94292834|NCT00434967|322859330|FG003|Overall Study|Adverse Event|3|||
94292835|NCT00434967|322859327|FG000|Overall Study|Lost to Follow-up|0|||
94292836|NCT00434967|322859328|FG001|Overall Study|Lost to Follow-up|0|||
94292837|NCT00434967|322859329|FG002|Overall Study|Lost to Follow-up|1|||
94292838|NCT00434967|322859330|FG003|Overall Study|Lost to Follow-up|0|||
94292839|NCT00434967|322859327|FG000|Overall Study|Withdrawal by Subject|2|||
94292840|NCT00434967|322859328|FG001|Overall Study|Withdrawal by Subject|2|||
94292841|NCT00434967|322859329|FG002|Overall Study|Withdrawal by Subject|4|||
94292842|NCT00434967|322859330|FG003|Overall Study|Withdrawal by Subject|6|||
94292843|NCT00434967|322859327|FG000|Overall Study|Randomized in error|0|||
94292844|NCT00434967|322859328|FG001|Overall Study|Randomized in error|0|||
94292845|NCT00434967|322859329|FG002|Overall Study|Randomized in error|0|||
94292846|NCT00434967|322859330|FG003|Overall Study|Randomized in error|1|||
94292847|NCT00434967|322859327|FG000|Overall Study|Protocol Violation|0|||
94292848|NCT00434967|322859328|FG001|Overall Study|Protocol Violation|1|||
94292849|NCT00434967|322859329|FG002|Overall Study|Protocol Violation|0|||
94292850|NCT00434967|322859330|FG003|Overall Study|Protocol Violation|1|||
94292851|NCT00434967|322859327|FG000|Overall Study|Physician Decision|1|||
94292852|NCT00434967|322859328|FG001|Overall Study|Physician Decision|1|||
94292853|NCT00434967|322859329|FG002|Overall Study|Physician Decision|1|||
94292854|NCT00434967|322859330|FG003|Overall Study|Physician Decision|0|||
94292855|NCT00434967|322859327|FG000|Overall Study|Patient Disposition Challenges|2|||
94292856|NCT00434967|322859328|FG001|Overall Study|Patient Disposition Challenges|0|||
94292857|NCT00434967|322859329|FG002|Overall Study|Patient Disposition Challenges|0|||
94292858|NCT00434967|322859330|FG003|Overall Study|Patient Disposition Challenges|3|||
94292859|NCT01427309|322859332|FG000|Overall Study|Lost to Follow-up|130|||
94292860|NCT01427309|322859333|FG001|Overall Study|Lost to Follow-up|145|||
94292861|NCT01427309|322859334|FG002|Overall Study|Lost to Follow-up|122|||
94292862|NCT01427309|322859335|FG003|Overall Study|Lost to Follow-up|135|||
94292863|NCT01427309|322859332|FG000|Overall Study|Protocol Violation|42|||
94292864|NCT01427309|322859333|FG001|Overall Study|Protocol Violation|69|||
94292865|NCT01427309|322859334|FG002|Overall Study|Protocol Violation|125|||
94292866|NCT01427309|322859335|FG003|Overall Study|Protocol Violation|124|||
94292867|NCT01427309|322859332|FG000|Overall Study|Adverse Event|0|||
94292868|NCT01427309|322859333|FG001|Overall Study|Adverse Event|0|||
94292869|NCT01427309|322859334|FG002|Overall Study|Adverse Event|3|||
94292870|NCT01427309|322859335|FG003|Overall Study|Adverse Event|1|||
94292871|NCT01427309|322859332|FG000|Overall Study|Serious adverse event|52|||
94292872|NCT01427309|322859333|FG001|Overall Study|Serious adverse event|45|||
94292873|NCT01427309|322859334|FG002|Overall Study|Serious adverse event|50|||
94292874|NCT01427309|322859335|FG003|Overall Study|Serious adverse event|61|||
94292875|NCT01427309|322859332|FG000|Overall Study|Withdrawal by Subject|148|||
94292876|NCT01427309|322859333|FG001|Overall Study|Withdrawal by Subject|148|||
94292877|NCT01427309|322859334|FG002|Overall Study|Withdrawal by Subject|61|||
94292878|NCT01427309|322859335|FG003|Overall Study|Withdrawal by Subject|55|||
94292879|NCT01354132|322859336|FG000|Randomization|Physician Decision|1|||
94292880|NCT01354132|322859337|FG001|Randomization|Physician Decision|0|||
94292881|NCT01354132|322859336|FG000|Randomization|Withdrawal by Subject|0|||
94292882|NCT01354132|322859337|FG001|Randomization|Withdrawal by Subject|1|||
94292883|NCT01354132|322859336|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
94292884|NCT01354132|322859337|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
94292885|NCT01354132|322859336|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
94292886|NCT01354132|322859337|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
94292887|NCT01354132|322859336|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
94372552|NCT00591253|323150287|FG001|Overall Study|Lack of Efficacy|0|||
94292888|NCT01354132|322859337|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
94292889|NCT00849017|322859338|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
94372553|NCT00591253|323150288|FG002|Overall Study|Lack of Efficacy|3|||
94372554|NCT00591253|323150286|FG000|Overall Study|Other|5|||
94292890|NCT00849017|322859339|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
94292891|NCT00849017|322859340|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
94292892|NCT00849017|322859338|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
94292893|NCT00849017|322859339|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
94292894|NCT00849017|322859340|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
94292895|NCT00849017|322859338|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
94292896|NCT00849017|322859339|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
94292897|NCT00849017|322859340|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
94292898|NCT00849017|322859338|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
94292899|NCT00849017|322859339|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
94292900|NCT00849017|322859340|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
94292901|NCT00849017|322859338|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
94292902|NCT00849017|322859339|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
94292903|NCT00849017|322859340|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
94292904|NCT00849017|322859338|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
94292905|NCT00849017|322859339|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
94292906|NCT00849017|322859340|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
94292907|NCT00849017|322859338|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
94292908|NCT00849017|322859339|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
94292909|NCT00849017|322859340|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
94292910|NCT00849017|322859338|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
94292911|NCT00849017|322859339|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
94292912|NCT00849017|322859340|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
94292913|NCT00849017|322859338|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
94292914|NCT00849017|322859339|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
94292915|NCT00849017|322859340|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
94292916|NCT00849017|322859338|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
94292917|NCT00849017|322859339|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
94292918|NCT00849017|322859340|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
94292919|NCT00849017|322859338|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
94292920|NCT00849017|322859339|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
94292921|NCT00849017|322859340|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
94292922|NCT00849017|322859338|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
94292923|NCT00849017|322859339|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
94292924|NCT00849017|322859340|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
94292925|NCT00849017|322859338|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
94292926|NCT00849017|322859339|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
94292927|NCT00849017|322859340|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
94292928|NCT00849017|322859338|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
94292929|NCT00849017|322859339|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
94292930|NCT00849017|322859340|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
94292931|NCT00849017|322859338|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
94292932|NCT00849017|322859339|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
94292933|NCT00849017|322859340|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
94292934|NCT00849017|322859338|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
94292935|NCT00849017|322859339|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
94292936|NCT00849017|322859340|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
94292937|NCT00849017|322859338|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
94292938|NCT00849017|322859339|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
94292939|NCT00849017|322859340|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
94292940|NCT00849017|322859338|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
94292941|NCT00849017|322859339|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
94292942|NCT00849017|322859340|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
94292943|NCT00849017|322859338|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
94292944|NCT00849017|322859339|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
94292945|NCT00849017|322859340|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
94292946|NCT00400400|322859344|FG000|Overall Study|Adverse Event|9|||
94292947|NCT00400400|322859345|FG001|Overall Study|Adverse Event|8|||
94292948|NCT00400400|322859344|FG000|Overall Study|Protocol Violation|2|||
94292949|NCT00400400|322859345|FG001|Overall Study|Protocol Violation|0|||
94292950|NCT00400400|322859344|FG000|Overall Study|Withdrawal by Subject|1|||
94292951|NCT00400400|322859345|FG001|Overall Study|Withdrawal by Subject|3|||
94292952|NCT00400400|322859344|FG000|Overall Study|Administrative Problem|1|||
94292953|NCT00400400|322859345|FG001|Overall Study|Administrative Problem|0|||
94292954|NCT00400400|322859344|FG000|Overall Study|Lost to Follow-up|0|||
94292955|NCT00400400|322859345|FG001|Overall Study|Lost to Follow-up|1|||
94292956|NCT00400400|322859344|FG000|Overall Study|Did not receive study drug|1|||
94292957|NCT00400400|322859345|FG001|Overall Study|Did not receive study drug|3|||
94292958|NCT03041311|322859346|FG000|Overall Study|Death|39|||
94292959|NCT03041311|322859347|FG001|Overall Study|Death|42|||
94292960|NCT03041311|322859346|FG000|Overall Study|Lost to Follow-up|0|||
94292961|NCT03041311|322859347|FG001|Overall Study|Lost to Follow-up|1|||
94292962|NCT03041311|322859346|FG000|Overall Study|Withdrawal by Subject|8|||
94292963|NCT03041311|322859347|FG001|Overall Study|Withdrawal by Subject|5|||
94292964|NCT03041311|322859346|FG000|Overall Study|Sponsor Terminated Study|2|||
94292965|NCT03041311|322859347|FG001|Overall Study|Sponsor Terminated Study|4|||
94292966|NCT03041311|322859346|FG000|Overall Study|Disease Progression|3|||
94292967|NCT03041311|322859347|FG001|Overall Study|Disease Progression|1|||
94292968|NCT03041311|322859346|FG000|Overall Study|Randomized in error, did not receive drug|2|||
94292969|NCT03041311|322859347|FG001|Overall Study|Randomized in error, did not receive drug|0|||
94292970|NCT01299727|322859348|FG000|Overall Study|Withdrawal by Subject|1|||
94292971|NCT01299727|322859349|FG001|Overall Study|Withdrawal by Subject|0|||
94372555|NCT00591253|323150287|FG001|Overall Study|Other|5|||
94292972|NCT01299727|322859350|FG002|Overall Study|Withdrawal by Subject|0|||
94372556|NCT00591253|323150288|FG002|Overall Study|Other|3|||
94292973|NCT01299727|322859348|FG000|Overall Study|Adverse Event|0|||
94292974|NCT01299727|322859349|FG001|Overall Study|Adverse Event|0|||
94292975|NCT01299727|322859350|FG002|Overall Study|Adverse Event|1|||
94292976|NCT01299727|322859348|FG000|Overall Study|Completed the Treatment Period|3|||
94292977|NCT01299727|322859349|FG001|Overall Study|Completed the Treatment Period|4|||
94292978|NCT01299727|322859350|FG002|Overall Study|Completed the Treatment Period|3|||
94292979|NCT02772757|322859354|FG000|Overall Study|Withdrawal by Subject|1|||
94292980|NCT02772757|322859355|FG001|Overall Study|Withdrawal by Subject|0|||
94292981|NCT02772757|322859356|FG002|Overall Study|Withdrawal by Subject|1|||
94292982|NCT02772757|322859354|FG000|Overall Study|Protocol Violation|0|||
94292983|NCT02772757|322859355|FG001|Overall Study|Protocol Violation|0|||
94292984|NCT02772757|322859356|FG002|Overall Study|Protocol Violation|1|||
94292985|NCT02772757|322859354|FG000|Overall Study|Physician Decision|0|||
94292986|NCT02772757|322859355|FG001|Overall Study|Physician Decision|3|||
94292987|NCT02772757|322859356|FG002|Overall Study|Physician Decision|3|||
94292988|NCT01570244|322859357|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
94292989|NCT00531960|322859361|FG000|Overall Study|Adverse Event|5|||
94292990|NCT00531960|322859362|FG001|Overall Study|Adverse Event|4|||
94292991|NCT00531960|322859361|FG000|Overall Study|Death|3|||
94292992|NCT00531960|322859362|FG001|Overall Study|Death|2|||
94292993|NCT00531960|322859361|FG000|Overall Study|Lack of Efficacy|42|||
94292994|NCT00531960|322859362|FG001|Overall Study|Lack of Efficacy|41|||
94292995|NCT00531960|322859361|FG000|Overall Study|Violation of Selection Criteria|2|||
94292996|NCT00531960|322859362|FG001|Overall Study|Violation of Selection Criteria|0|||
94292997|NCT00531960|322859361|FG000|Overall Study|Refused Treatment|5|||
94292998|NCT00531960|322859362|FG001|Overall Study|Refused Treatment|6|||
94292999|NCT00531960|322859361|FG000|Overall Study|Other|4|||
94293000|NCT00531960|322859362|FG001|Overall Study|Other|10|||
94293001|NCT00441792|322859363|FG000|Overall Study|Lost to Follow-up|0|||
94293002|NCT00441792|322859364|FG001|Overall Study|Lost to Follow-up|2|||
94293003|NCT02649634|322859369|FG000|Overall Study|Withdrawal by Subject|3|||
94293004|NCT02649634|322859370|FG001|Overall Study|Withdrawal by Subject|5|||
94293005|NCT02649634|322859369|FG000|Overall Study|Lost to Follow-up|0|||
94293006|NCT02649634|322859370|FG001|Overall Study|Lost to Follow-up|1|||
94293007|NCT01360645|322859372|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
94293008|NCT01360645|322859373|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
94293009|NCT01360645|322859374|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
94293010|NCT01360645|322859375|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
94293011|NCT01360645|322859372|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
94293012|NCT01360645|322859373|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
94293013|NCT01360645|322859374|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
94293014|NCT01360645|322859375|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
94293015|NCT01360645|322859372|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
94293016|NCT01360645|322859373|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
94293017|NCT01360645|322859374|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
94293018|NCT01360645|322859375|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
94293019|NCT01360645|322859372|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
94293020|NCT01360645|322859373|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
94293021|NCT01360645|322859374|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
94293022|NCT01360645|322859375|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
94293023|NCT01360645|322859372|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
94293024|NCT01360645|322859373|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
94293025|NCT01360645|322859374|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
94293026|NCT01360645|322859375|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
94293027|NCT01360645|322859372|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
94293028|NCT01360645|322859373|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
94293029|NCT01360645|322859374|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
94293030|NCT01360645|322859375|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
94293031|NCT01360645|322859372|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
94293032|NCT01360645|322859373|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
94293033|NCT01360645|322859374|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
94293034|NCT01360645|322859375|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
94293035|NCT01360645|322859372|FG000|Phase B (6 Weeks)|Adverse Event|0|||
94293036|NCT01360645|322859373|FG001|Phase B (6 Weeks)|Adverse Event|6|||
94293037|NCT01360645|322859374|FG002|Phase B (6 Weeks)|Adverse Event|0|||
94293038|NCT01360645|322859375|FG003|Phase B (6 Weeks)|Adverse Event|0|||
94293039|NCT01360645|322859372|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
94293040|NCT01360645|322859373|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
94293041|NCT01360645|322859374|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
94293042|NCT01360645|322859375|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
94293043|NCT01360645|322859372|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
94293044|NCT01360645|322859373|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
94293045|NCT01360645|322859374|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
94293046|NCT01360645|322859375|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
94293047|NCT01360645|322859372|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
94293048|NCT01360645|322859373|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
94293049|NCT01360645|322859374|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
94293050|NCT01360645|322859375|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
94293051|NCT01360645|322859372|FG000|Phase A+|Lost to Follow-up|0|||
94293052|NCT01360645|322859373|FG001|Phase A+|Lost to Follow-up|0|||
94293053|NCT01360645|322859374|FG002|Phase A+|Lost to Follow-up|0|||
94293054|NCT01360645|322859375|FG003|Phase A+|Lost to Follow-up|7|||
94293055|NCT01360645|322859372|FG000|Phase A+|Adverse Event|0|||
94293056|NCT01360645|322859373|FG001|Phase A+|Adverse Event|0|||
94293057|NCT01360645|322859374|FG002|Phase A+|Adverse Event|0|||
94293058|NCT01360645|322859375|FG003|Phase A+|Adverse Event|2|||
94293059|NCT01360645|322859372|FG000|Phase A+|Met Withdrawal Criteria|0|||
94293060|NCT01360645|322859373|FG001|Phase A+|Met Withdrawal Criteria|0|||
94293061|NCT01360645|322859374|FG002|Phase A+|Met Withdrawal Criteria|0|||
94293062|NCT01360645|322859375|FG003|Phase A+|Met Withdrawal Criteria|4|||
94293063|NCT01360645|322859372|FG000|Phase A+|Physician Decision|0|||
94293064|NCT01360645|322859373|FG001|Phase A+|Physician Decision|0|||
94293065|NCT01360645|322859374|FG002|Phase A+|Physician Decision|0|||
94293066|NCT01360645|322859375|FG003|Phase A+|Physician Decision|2|||
94293067|NCT01360645|322859372|FG000|Phase A+|Withdrawal by Subject|0|||
94293068|NCT01360645|322859373|FG001|Phase A+|Withdrawal by Subject|0|||
94293069|NCT01360645|322859374|FG002|Phase A+|Withdrawal by Subject|0|||
94293070|NCT01360645|322859375|FG003|Phase A+|Withdrawal by Subject|5|||
94293071|NCT01360645|322859372|FG000|Phase A+|Protocol Deviation|0|||
94293072|NCT01360645|322859373|FG001|Phase A+|Protocol Deviation|0|||
94293073|NCT01360645|322859374|FG002|Phase A+|Protocol Deviation|0|||
94293074|NCT01360645|322859375|FG003|Phase A+|Protocol Deviation|4|||
94293075|NCT00885365|322859376|FG000|4 Weeks ON Treatment|Adverse Event|2|||
94293076|NCT00885365|322859377|FG001|4 Weeks ON Treatment|Adverse Event|4|||
94293077|NCT00885365|322859376|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
94293078|NCT00885365|322859377|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
94293079|NCT00885365|322859376|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
94293080|NCT00885365|322859377|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
94293081|NCT00773279|322859378|FG000|Period 1|Adverse Event|2|||
94293082|NCT00773279|322859379|FG001|Period 1|Adverse Event|1|||
94293083|NCT00773279|322859378|FG000|Period 1|Lack of Efficacy|0|||
94293084|NCT00773279|322859379|FG001|Period 1|Lack of Efficacy|2|||
94293085|NCT00773279|322859378|FG000|Period 1|Unclassified|5|||
94293086|NCT00773279|322859379|FG001|Period 1|Unclassified|1|||
94293087|NCT00773279|322859378|FG000|Period 2|Adverse Event|0|||
94293088|NCT00773279|322859379|FG001|Period 2|Adverse Event|1|||
94293089|NCT00773279|322859378|FG000|Period 2|Lack of Efficacy|1|||
94293090|NCT00773279|322859379|FG001|Period 2|Lack of Efficacy|0|||
94293091|NCT00773279|322859378|FG000|Period 2|Protocol Violation|0|||
94293092|NCT00773279|322859379|FG001|Period 2|Protocol Violation|3|||
94293093|NCT00773279|322859378|FG000|Period 2|Unclassified|2|||
94293094|NCT00773279|322859379|FG001|Period 2|Unclassified|2|||
94293095|NCT01737931|322859380|FG000|Overall Study|Withdrawal by Subject|0|||
94293096|NCT01737931|322859381|FG001|Overall Study|Withdrawal by Subject|1|||
94293097|NCT01737931|322859382|FG002|Overall Study|Withdrawal by Subject|1|||
94293098|NCT01737931|322859380|FG000|Overall Study|Physician Decision|0|||
94293099|NCT01737931|322859381|FG001|Overall Study|Physician Decision|1|||
94293100|NCT01737931|322859382|FG002|Overall Study|Physician Decision|0|||
94293101|NCT04336163|322859383|FG000|Overall Study|Lost to Follow-up|55|||
94293102|NCT04336163|322859384|FG001|Overall Study|Lost to Follow-up|0|||
94293103|NCT01227967|322859385|FG000|Overall Study|Protocol Violation|3|||
94293104|NCT01227967|322859386|FG001|Overall Study|Protocol Violation|1|||
94293105|NCT01227967|322859385|FG000|Overall Study|Death|0|||
94293106|NCT01227967|322859386|FG001|Overall Study|Death|1|||
94293107|NCT01227967|322859385|FG000|Overall Study|Lost to Follow-up|8|||
94467987|NCT00803205|323502464|FG001|Overall Study|Lost to Follow-up|0|||
94293108|NCT01227967|322859386|FG001|Overall Study|Lost to Follow-up|3|||
94293109|NCT01227967|322859385|FG000|Overall Study|Withdrawal by Subject|4|||
94293110|NCT01227967|322859386|FG001|Overall Study|Withdrawal by Subject|3|||
94293111|NCT01227967|322859385|FG000|Overall Study|Physician Decision|0|||
94293112|NCT01227967|322859386|FG001|Overall Study|Physician Decision|1|||
94293113|NCT01227967|322859385|FG000|Overall Study|Never Started Treatment|0|||
94293114|NCT01227967|322859386|FG001|Overall Study|Never Started Treatment|4|||
94293115|NCT01227967|322859385|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
94293116|NCT01227967|322859386|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
94293117|NCT01512264|322859388|FG000|Overall Study|Lost to Follow-up|0|||
94293118|NCT01512264|322859389|FG001|Overall Study|Lost to Follow-up|0|||
94293119|NCT01512264|322859390|FG002|Overall Study|Lost to Follow-up|0|||
94293120|NCT01512264|322859391|FG003|Overall Study|Lost to Follow-up|1|||
94293121|NCT02040142|322859392|FG000|Overall Study|Lost to Follow-up|5|||
94293122|NCT02040142|322859392|FG000|Overall Study|Death|17|||
94467988|NCT00803205|323502463|FG000|Overall Study|Withdrawal by Subject|9|||
94293123|NCT02040142|322859392|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
94293124|NCT03538743|322859393|FG000|Overall Study|Adverse Event|0|||
94293125|NCT03538743|322859394|FG001|Overall Study|Adverse Event|0|||
94293126|NCT03538743|322859395|FG002|Overall Study|Adverse Event|1|||
94293127|NCT03538743|322859396|FG003|Overall Study|Adverse Event|1|||
94293128|NCT03538743|322859397|FG004|Overall Study|Adverse Event|0|||
94293129|NCT03538743|322859398|FG005|Overall Study|Adverse Event|0|||
94293130|NCT03538743|322859399|FG006|Overall Study|Adverse Event|0|||
94293131|NCT03538743|322859400|FG007|Overall Study|Adverse Event|0|||
94293132|NCT03538743|322859401|FG008|Overall Study|Adverse Event|0|||
94293133|NCT03538743|322859393|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
94293134|NCT03538743|322859394|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
94293135|NCT03538743|322859395|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
94293136|NCT03538743|322859396|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
94293137|NCT03538743|322859397|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
94293138|NCT03538743|322859398|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
94293139|NCT03538743|322859399|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
94293140|NCT03538743|322859400|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
94293141|NCT03538743|322859401|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
94293142|NCT03538743|322859393|FG000|Overall Study|Withdrawal by Subject|0|||
94293143|NCT03538743|322859394|FG001|Overall Study|Withdrawal by Subject|0|||
94293144|NCT03538743|322859395|FG002|Overall Study|Withdrawal by Subject|0|||
94293145|NCT03538743|322859396|FG003|Overall Study|Withdrawal by Subject|1|||
94293146|NCT03538743|322859397|FG004|Overall Study|Withdrawal by Subject|0|||
94293147|NCT03538743|322859398|FG005|Overall Study|Withdrawal by Subject|0|||
94293148|NCT03538743|322859399|FG006|Overall Study|Withdrawal by Subject|0|||
94293149|NCT03538743|322859400|FG007|Overall Study|Withdrawal by Subject|0|||
94293150|NCT03538743|322859401|FG008|Overall Study|Withdrawal by Subject|0|||
94293151|NCT03136107|322859408|FG000|Overall Study|Other (Not specified)|1|||
94293152|NCT01955707|322859410|FG000|Overall Study|Adverse Event|1|||
94293153|NCT01955707|322859411|FG001|Overall Study|Adverse Event|2|||
94293154|NCT01955707|322859410|FG000|Overall Study|Lost to Follow-up|2|||
94293155|NCT01955707|322859411|FG001|Overall Study|Lost to Follow-up|1|||
94293156|NCT01955707|322859410|FG000|Overall Study|Withdrawal by Subject|0|||
94293157|NCT01955707|322859411|FG001|Overall Study|Withdrawal by Subject|3|||
94293158|NCT01955707|322859410|FG000|Overall Study|Death|13|||
94293159|NCT01955707|322859411|FG001|Overall Study|Death|14|||
94293160|NCT01955707|322859410|FG000|Overall Study|Other|4|||
94293161|NCT01955707|322859411|FG001|Overall Study|Other|2|||
94293162|NCT01817790|322859412|FG000|Overall Study|Adverse Event|0|||
94293163|NCT01817790|322859413|FG001|Overall Study|Adverse Event|2|||
94293164|NCT01817790|322859412|FG000|Overall Study|Lost to Follow-up|0|||
94293165|NCT01817790|322859413|FG001|Overall Study|Lost to Follow-up|1|||
94293166|NCT01817790|322859412|FG000|Overall Study|Protocol Violation|2|||
94293167|NCT01817790|322859413|FG001|Overall Study|Protocol Violation|1|||
94293168|NCT01817790|322859412|FG000|Overall Study|Withdrawal by Subject|1|||
94293169|NCT01817790|322859413|FG001|Overall Study|Withdrawal by Subject|3|||
94293170|NCT01817790|322859412|FG000|Overall Study|Other: Could not attend appointment|1|||
94293171|NCT01817790|322859413|FG001|Overall Study|Other: Could not attend appointment|1|||
94293172|NCT01707992|322859414|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
94293173|NCT01707992|322859415|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
94293174|NCT01707992|322859416|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
94293175|NCT01707992|322859417|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
94293176|NCT01707992|322859418|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
94293177|NCT01707992|322859419|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
94293178|NCT01707992|322859414|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
94293179|NCT01707992|322859415|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
94293180|NCT01707992|322859416|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
94293181|NCT01707992|322859417|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
94293182|NCT01707992|322859418|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
94293183|NCT01707992|322859419|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
94293184|NCT01707992|322859414|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
94293185|NCT01707992|322859415|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
94293186|NCT01707992|322859416|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
94293187|NCT01707992|322859417|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
94293188|NCT01707992|322859418|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
94293189|NCT01707992|322859419|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
94293190|NCT01707992|322859414|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
94293191|NCT01707992|322859415|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
94293192|NCT01707992|322859416|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
94293193|NCT01707992|322859417|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
94293194|NCT01707992|322859418|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
94372557|NCT00446654|323150289|FG000|Overall Study|Withdrawal by Subject|1|||
94372558|NCT00446654|323150290|FG001|Overall Study|Withdrawal by Subject|0|||
94293195|NCT01707992|322859419|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
94293196|NCT01707992|322859414|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
94293197|NCT01707992|322859415|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
94293198|NCT01707992|322859416|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
94293199|NCT01707992|322859417|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
94293200|NCT01707992|322859418|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
94293201|NCT01707992|322859419|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
94293202|NCT01707992|322859414|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
94293203|NCT01707992|322859415|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
94293204|NCT01707992|322859416|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
94293205|NCT01707992|322859417|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
94293206|NCT01707992|322859418|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
94293207|NCT01707992|322859419|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
94293208|NCT01707992|322859414|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
94293209|NCT01707992|322859415|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
94293210|NCT01707992|322859416|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
94293211|NCT01707992|322859417|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
94293212|NCT01707992|322859418|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
94293213|NCT01707992|322859419|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
94293214|NCT01707992|322859414|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
94293215|NCT01707992|322859415|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
94293216|NCT01707992|322859416|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
94293217|NCT01707992|322859417|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
94293218|NCT01707992|322859418|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
94293219|NCT01707992|322859419|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
94293220|NCT01707992|322859414|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
94293221|NCT01707992|322859415|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
94293222|NCT01707992|322859416|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
94293223|NCT01707992|322859417|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
94293224|NCT01707992|322859418|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
94293225|NCT01707992|322859419|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
94293226|NCT01707992|322859414|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
94293227|NCT01707992|322859415|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
94293228|NCT01707992|322859416|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
94293229|NCT01707992|322859417|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
94293230|NCT01707992|322859418|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
94293231|NCT01707992|322859419|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
94293232|NCT01707992|322859414|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
94293233|NCT01707992|322859415|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
94293234|NCT01707992|322859416|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
94293235|NCT01707992|322859417|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
94293236|NCT01707992|322859418|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
94293237|NCT01707992|322859419|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
94293238|NCT01707992|322859414|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
94293239|NCT01707992|322859415|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
94293240|NCT01707992|322859416|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
94293241|NCT01707992|322859417|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
94293242|NCT01707992|322859418|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
94293243|NCT01707992|322859419|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
94293244|NCT01707992|322859414|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
94293245|NCT01707992|322859415|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
94293246|NCT01707992|322859416|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
94293247|NCT01707992|322859417|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
94293248|NCT01707992|322859418|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
94293249|NCT01707992|322859419|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
94293250|NCT01707992|322859414|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
94293251|NCT01707992|322859415|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
94293252|NCT01707992|322859416|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
94293253|NCT01707992|322859417|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
94293254|NCT01707992|322859418|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
94293255|NCT01707992|322859419|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
94293256|NCT01707992|322859414|FG000|Active Treatment Phase (24 Months)|Death|0|||
94372559|NCT00446654|323150289|FG000|Overall Study|Adverse Event|1|||
94372560|NCT00446654|323150290|FG001|Overall Study|Adverse Event|0|||
94372561|NCT01783730|323150296|FG000|Overall Study|Failed to meet inclusion criteria|6|||
94293257|NCT01707992|322859415|FG001|Active Treatment Phase (24 Months)|Death|0|||
94293258|NCT01707992|322859416|FG002|Active Treatment Phase (24 Months)|Death|0|||
94293259|NCT01707992|322859417|FG003|Active Treatment Phase (24 Months)|Death|2|||
94293260|NCT01707992|322859418|FG004|Active Treatment Phase (24 Months)|Death|0|||
94293261|NCT01707992|322859419|FG005|Active Treatment Phase (24 Months)|Death|0|||
94293262|NCT01707992|322859414|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
94293263|NCT01707992|322859415|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
94293264|NCT01707992|322859416|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
94293265|NCT01707992|322859417|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
94293266|NCT01707992|322859418|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
94293267|NCT01707992|322859419|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
94293268|NCT01707992|322859414|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
94293269|NCT01707992|322859415|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
94293270|NCT01707992|322859416|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
94293271|NCT01707992|322859417|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
94293272|NCT01707992|322859418|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
94293273|NCT01707992|322859419|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
94293274|NCT01707992|322859414|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
94293275|NCT01707992|322859415|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
94293276|NCT01707992|322859416|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
94293277|NCT01707992|322859417|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
94293278|NCT01707992|322859418|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
94293279|NCT01707992|322859419|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
94293280|NCT01707992|322859414|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
94293281|NCT01707992|322859415|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
94293282|NCT01707992|322859416|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
94293283|NCT01707992|322859417|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
94293284|NCT01707992|322859418|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
94293285|NCT01707992|322859419|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
94293286|NCT01976806|322859420|FG000|Overall Study|Lost to Follow-up|1|||
94293287|NCT01976806|322859421|FG001|Overall Study|Lost to Follow-up|4|||
94293288|NCT01976806|322859420|FG000|Overall Study|Adverse Event|1|||
94293289|NCT01976806|322859421|FG001|Overall Study|Adverse Event|1|||
94293290|NCT01976806|322859420|FG000|Overall Study|Withdrawal by Subject|1|||
94293291|NCT01976806|322859421|FG001|Overall Study|Withdrawal by Subject|1|||
94293292|NCT02654002|322859422|FG000|Overall Study|Adverse Event|0|||
94293293|NCT02654002|322859423|FG001|Overall Study|Adverse Event|0|||
94293294|NCT02654002|322859424|FG002|Overall Study|Adverse Event|0|||
94293295|NCT02654002|322859425|FG003|Overall Study|Adverse Event|0|||
94293296|NCT02654002|322859426|FG004|Overall Study|Adverse Event|0|||
94293297|NCT02654002|322859427|FG005|Overall Study|Adverse Event|0|||
94293298|NCT02654002|322859428|FG006|Overall Study|Adverse Event|1|||
94293299|NCT02654002|322859429|FG007|Overall Study|Adverse Event|0|||
94293300|NCT02654002|322859430|FG008|Overall Study|Adverse Event|0|||
94293301|NCT02654002|322859422|FG000|Overall Study|Withdrew Consent|0|||
94293302|NCT02654002|322859423|FG001|Overall Study|Withdrew Consent|0|||
94293303|NCT02654002|322859424|FG002|Overall Study|Withdrew Consent|0|||
94293304|NCT02654002|322859425|FG003|Overall Study|Withdrew Consent|0|||
94293305|NCT02654002|322859426|FG004|Overall Study|Withdrew Consent|0|||
94293306|NCT02654002|322859427|FG005|Overall Study|Withdrew Consent|1|||
94293307|NCT02654002|322859428|FG006|Overall Study|Withdrew Consent|0|||
94293308|NCT02654002|322859429|FG007|Overall Study|Withdrew Consent|1|||
94293309|NCT02654002|322859430|FG008|Overall Study|Withdrew Consent|0|||
94293310|NCT03313050|322859435|FG000|Stage 2: 12 Months|Adverse Event|0|||
94293311|NCT03313050|322859436|FG001|Stage 2: 12 Months|Adverse Event|0|||
94293312|NCT03313050|322859437|FG002|Stage 2: 12 Months|Adverse Event|0|||
94293313|NCT03313050|322859438|FG003|Stage 2: 12 Months|Adverse Event|1|||
94293314|NCT03313050|322859435|FG000|Stage 2: 12 Months|Death|0|||
94293315|NCT03313050|322859436|FG001|Stage 2: 12 Months|Death|0|||
94293316|NCT03313050|322859437|FG002|Stage 2: 12 Months|Death|3|||
94293317|NCT03313050|322859438|FG003|Stage 2: 12 Months|Death|0|||
94293318|NCT03313050|322859435|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
94293319|NCT03313050|322859436|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
94293320|NCT03313050|322859437|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
94293321|NCT03313050|322859438|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
94293322|NCT03313050|322859435|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
94293323|NCT03313050|322859436|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
94293324|NCT03313050|322859437|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
94293325|NCT03313050|322859438|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
94293326|NCT03313050|322859435|FG000|Stage 2: 12 Months|Protocol deviation|0|||
94293327|NCT03313050|322859436|FG001|Stage 2: 12 Months|Protocol deviation|0|||
94293328|NCT03313050|322859437|FG002|Stage 2: 12 Months|Protocol deviation|7|||
94293329|NCT03313050|322859438|FG003|Stage 2: 12 Months|Protocol deviation|7|||
94293330|NCT03313050|322859435|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
94293331|NCT03313050|322859436|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
94293332|NCT03313050|322859437|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
94293333|NCT03313050|322859438|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
94293334|NCT03313050|322859435|FG000|Stage 2: 12 Months|Other|0|||
94293335|NCT03313050|322859436|FG001|Stage 2: 12 Months|Other|0|||
94293336|NCT03313050|322859437|FG002|Stage 2: 12 Months|Other|0|||
94293337|NCT03313050|322859438|FG003|Stage 2: 12 Months|Other|1|||
94293338|NCT02848833|322859441|FG000|Overall Study|subject who are duplicated|1|||
94293339|NCT02848833|322859441|FG000|Overall Study|have not taken the study drug|11|||
94293340|NCT02848833|322859441|FG000|Overall Study|follow-up failure|6|||
94293341|NCT02848833|322859441|FG000|Overall Study|Protocol Violation|119|||
94293342|NCT04980391|322859442|FG000|Overall Study|Death|0|||
94293343|NCT04980391|322859443|FG001|Overall Study|Death|0|||
94293344|NCT04980391|322859444|FG002|Overall Study|Death|1|||
94293345|NCT04980391|322859445|FG003|Overall Study|Death|1|||
94293346|NCT04980391|322859442|FG000|Overall Study|Lost to Follow-up|3|||
94293347|NCT04980391|322859443|FG001|Overall Study|Lost to Follow-up|3|||
94293348|NCT04980391|322859444|FG002|Overall Study|Lost to Follow-up|2|||
94293349|NCT04980391|322859445|FG003|Overall Study|Lost to Follow-up|3|||
94293350|NCT04980391|322859442|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
94293351|NCT04980391|322859443|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
94293352|NCT04980391|322859444|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
94293353|NCT04980391|322859445|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
94293354|NCT04980391|322859442|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
94293355|NCT04980391|322859443|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
94293356|NCT04980391|322859444|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
94293357|NCT04980391|322859445|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
94293358|NCT04980391|322859442|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
94293359|NCT04980391|322859443|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
94293360|NCT04980391|322859444|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
94293361|NCT04980391|322859445|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
94293362|NCT04167345|322859448|FG000|Overall Study|Other|1|||
94293363|NCT04167345|322859449|FG001|Overall Study|Other|1|||
94293364|NCT04167345|322859450|FG002|Overall Study|Other|0|||
94293365|NCT04167345|322859451|FG003|Overall Study|Other|0|||
94293366|NCT04167345|322859452|FG004|Overall Study|Other|0|||
94293367|NCT00977574|322859453|FG000|Overall Study|Never Treated|4|||
94293368|NCT00977574|322859454|FG001|Overall Study|Never Treated|2|||
94293369|NCT00977574|322859455|FG002|Overall Study|Never Treated|4|||
94293370|NCT04280081|322859456|FG000|Overall Study|Adverse Event|4|||
94293371|NCT04280081|322859456|FG000|Overall Study|Death|2|||
94293372|NCT04280081|322859456|FG000|Overall Study|Progressive Disease|6|||
94293373|NCT06119191|322859457|FG000|Overall Study|Adverse Event|0|||
94293374|NCT06119191|322859458|FG001|Overall Study|Adverse Event|1|||
94293375|NCT06119191|322859457|FG000|Overall Study|Protocol Violation|1|||
94293376|NCT06119191|322859458|FG001|Overall Study|Protocol Violation|0|||
94293377|NCT05900115|322861571|FG000|Overall Study|Lost to Follow-up|129|||
94293378|NCT05900115|322861572|FG001|Overall Study|Lost to Follow-up|98|||
94293379|NCT01400932|322861573|FG000|Overall Study|Adverse Event|10|||
94293380|NCT01400932|322861574|FG001|Overall Study|Adverse Event|5|||
94293381|NCT01400932|322861573|FG000|Overall Study|Lack of Efficacy|0|||
94293382|NCT01400932|322861574|FG001|Overall Study|Lack of Efficacy|3|||
94293383|NCT01400932|322861573|FG000|Overall Study|Withdrawal by Subject|2|||
94293384|NCT01400932|322861574|FG001|Overall Study|Withdrawal by Subject|6|||
94293385|NCT01400932|322861573|FG000|Overall Study|Lost to Follow-up|1|||
94293386|NCT01400932|322861574|FG001|Overall Study|Lost to Follow-up|0|||
94293387|NCT01400932|322861573|FG000|Overall Study|Protocol Deviation|0|||
94293388|NCT01400932|322861574|FG001|Overall Study|Protocol Deviation|1|||
94293389|NCT01400932|322861573|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
94293390|NCT01400932|322861574|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
94293391|NCT04574999|322861575|FG000|Overall Study|Adverse Event|1|||
94293392|NCT04574999|322861576|FG001|Overall Study|Adverse Event|0|||
94293393|NCT04574999|322861575|FG000|Overall Study|Lack of Efficacy|2|||
94293394|NCT04574999|322861576|FG001|Overall Study|Lack of Efficacy|3|||
94293395|NCT04574999|322861575|FG000|Overall Study|Protocol Violation|1|||
94293396|NCT04574999|322861576|FG001|Overall Study|Protocol Violation|0|||
94293397|NCT04574999|322861575|FG000|Overall Study|Withdrawal by Subject|2|||
94293398|NCT04574999|322861576|FG001|Overall Study|Withdrawal by Subject|2|||
94293399|NCT04574999|322861575|FG000|Overall Study|Lost to Follow-up|1|||
94293400|NCT04574999|322861576|FG001|Overall Study|Lost to Follow-up|0|||
94293401|NCT04574999|322861575|FG000|Overall Study|Personal problems|1|||
94293402|NCT04574999|322861576|FG001|Overall Study|Personal problems|0|||
94293403|NCT04574999|322861575|FG000|Overall Study|Previous planned surgery|1|||
94293404|NCT04574999|322861576|FG001|Overall Study|Previous planned surgery|0|||
94293405|NCT03244059|322861579|FG000|Specific Aim 1|Physician Decision|1|||
94293406|NCT03244059|322861580|FG001|Specific Aim 1|Physician Decision|0|||
94293407|NCT03244059|322861579|FG000|Specific Aim 2|Physician Decision|1|||
94293408|NCT03244059|322861580|FG001|Specific Aim 2|Physician Decision|0|||
94293409|NCT00582556|322861581|FG000|Overall Study|Withdrawal by Subject|0|||
94293410|NCT00582556|322861582|FG001|Overall Study|Withdrawal by Subject|1|||
94293411|NCT00582556|322861583|FG002|Overall Study|Withdrawal by Subject|1|||
94293412|NCT00582556|322861581|FG000|Overall Study|Physician Decision|0|||
94293413|NCT00582556|322861582|FG001|Overall Study|Physician Decision|0|||
94293414|NCT00582556|322861583|FG002|Overall Study|Physician Decision|1|||
94293415|NCT00623831|322861588|FG000|Overall Study|Withdrawal by Subject|1|||
94293416|NCT00623831|322861589|FG001|Overall Study|Withdrawal by Subject|0|||
94293417|NCT00623831|322861588|FG000|Overall Study|Progressive Disease|0|||
94293418|NCT00623831|322861589|FG001|Overall Study|Progressive Disease|1|||
94293419|NCT00832819|322861590|FG000|Overall Study|Adverse Event|0|||
94293420|NCT00832819|322861591|FG001|Overall Study|Adverse Event|1|||
94293421|NCT00832819|322861592|FG002|Overall Study|Adverse Event|0|||
94293422|NCT00832819|322861590|FG000|Overall Study|Protocol Violation|0|||
94293423|NCT00832819|322861591|FG001|Overall Study|Protocol Violation|0|||
94293424|NCT00832819|322861592|FG002|Overall Study|Protocol Violation|1|||
94293425|NCT03124459|322861593|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
94293426|NCT03124459|322861594|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
94293427|NCT03124459|322861595|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
94293428|NCT03124459|322861596|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
94293429|NCT03124459|322861597|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
94293430|NCT03124459|322861598|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
94293431|NCT03124459|322861593|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
94293432|NCT03124459|322861594|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
94293433|NCT03124459|322861595|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
94293434|NCT03124459|322861596|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
94293435|NCT03124459|322861597|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
94293436|NCT03124459|322861598|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
94293437|NCT03124459|322861593|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
94293438|NCT03124459|322861594|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
94293439|NCT03124459|322861595|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
94293440|NCT03124459|322861596|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
94293441|NCT03124459|322861597|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
94293442|NCT03124459|322861598|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
94293443|NCT03124459|322861593|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
94293444|NCT03124459|322861594|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
94293445|NCT03124459|322861595|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
94293446|NCT03124459|322861596|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
94293447|NCT03124459|322861597|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
94293448|NCT03124459|322861598|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
94293449|NCT03124459|322861593|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
94293450|NCT03124459|322861594|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
94293451|NCT03124459|322861595|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
94293452|NCT03124459|322861596|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
94293453|NCT03124459|322861597|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
94293454|NCT03124459|322861598|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
94293455|NCT03124459|322861593|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
94293456|NCT03124459|322861594|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
94293457|NCT03124459|322861595|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
94293458|NCT03124459|322861596|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
94293459|NCT03124459|322861597|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
94293460|NCT03124459|322861598|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
94293461|NCT01070329|322861601|FG000|Overall Study|Adverse Event|13|||
94293462|NCT01070329|322861602|FG001|Overall Study|Adverse Event|10|||
94293463|NCT01070329|322861601|FG000|Overall Study|Lost to Follow-up|22|||
94293464|NCT01070329|322861602|FG001|Overall Study|Lost to Follow-up|12|||
94293465|NCT01070329|322861601|FG000|Overall Study|Withdrawal by Subject|9|||
94293466|NCT01070329|322861602|FG001|Overall Study|Withdrawal by Subject|11|||
94293467|NCT01070329|322861601|FG000|Overall Study|Protocol Violation|3|||
94293468|NCT01070329|322861602|FG001|Overall Study|Protocol Violation|8|||
94293469|NCT01070329|322861601|FG000|Overall Study|Lack of Efficacy|2|||
94293470|NCT01070329|322861602|FG001|Overall Study|Lack of Efficacy|6|||
94293471|NCT01070329|322861601|FG000|Overall Study|Physician Decision|2|||
94293472|NCT01070329|322861602|FG001|Overall Study|Physician Decision|1|||
94293473|NCT01070329|322861601|FG000|Overall Study|Entry Criteria Not Met|1|||
94293474|NCT01070329|322861602|FG001|Overall Study|Entry Criteria Not Met|0|||
94293475|NCT01070329|322861601|FG000|Overall Study|Sponsor Decision|0|||
94293476|NCT01070329|322861602|FG001|Overall Study|Sponsor Decision|1|||
94293477|NCT01748071|322861603|FG000|Overall Study|Adverse Event|2|||
94293478|NCT01748071|322861604|FG001|Overall Study|Adverse Event|2|||
94293479|NCT01748071|322861605|FG002|Overall Study|Adverse Event|0|||
94293480|NCT02863848|322861606|FG000|Overall Study|Lost to Follow-up|1|||
94293481|NCT02863848|322861607|FG001|Overall Study|Lost to Follow-up|1|||
94293482|NCT02863848|322861606|FG000|Overall Study|Protocol Violation|1|||
94293483|NCT02863848|322861607|FG001|Overall Study|Protocol Violation|2|||
94293484|NCT02318095|322861608|FG000|Overall Study|Adverse Event|1|||
94293485|NCT00686127|322861609|FG000|Overall Study|Withdrawal by Subject|14|||
94293486|NCT00686127|322861610|FG001|Overall Study|Withdrawal by Subject|6|||
94293487|NCT00066690|322861611|FG000|Overall Study|Adverse Event|145|||
94293488|NCT00066690|322861612|FG001|Overall Study|Adverse Event|58|||
94293489|NCT00066690|322861613|FG002|Overall Study|Adverse Event|126|||
94293490|NCT00066690|322861611|FG000|Overall Study|Death|3|||
94293491|NCT00066690|322861612|FG001|Overall Study|Death|0|||
94293492|NCT00066690|322861613|FG002|Overall Study|Death|2|||
94293493|NCT00066690|322861611|FG000|Overall Study|Lack of Efficacy|114|||
94293494|NCT00066690|322861612|FG001|Overall Study|Lack of Efficacy|110|||
94293495|NCT00066690|322861613|FG002|Overall Study|Lack of Efficacy|76|||
94293496|NCT00066690|322861611|FG000|Overall Study|Lost to Follow-up|40|||
94293497|NCT00066690|322861612|FG001|Overall Study|Lost to Follow-up|21|||
94293498|NCT00066690|322861613|FG002|Overall Study|Lost to Follow-up|29|||
94293499|NCT00066690|322861611|FG000|Overall Study|Withdrawal by Subject|50|||
94293500|NCT00066690|322861612|FG001|Overall Study|Withdrawal by Subject|55|||
94293501|NCT00066690|322861613|FG002|Overall Study|Withdrawal by Subject|49|||
94293502|NCT00066690|322861611|FG000|Overall Study|Treatment Ongoing|246|||
94293503|NCT00066690|322861612|FG001|Overall Study|Treatment Ongoing|278|||
94293504|NCT00066690|322861613|FG002|Overall Study|Treatment Ongoing|282|||
94293505|NCT05742984|322861614|FG000|Overall Study|Adverse Event|0|||
94293506|NCT05742984|322861615|FG001|Overall Study|Adverse Event|0|||
94293507|NCT05742984|322861616|FG002|Overall Study|Adverse Event|1|||
94293508|NCT05742984|322861617|FG003|Overall Study|Adverse Event|0|||
94293509|NCT05742984|322861618|FG004|Overall Study|Adverse Event|1|||
94293510|NCT05742984|322861619|FG005|Overall Study|Adverse Event|1|||
94293511|NCT05742984|322861614|FG000|Overall Study|Withdrawal by Subject|0|||
94293512|NCT05742984|322861615|FG001|Overall Study|Withdrawal by Subject|1|||
94293513|NCT05742984|322861616|FG002|Overall Study|Withdrawal by Subject|0|||
94293514|NCT05742984|322861617|FG003|Overall Study|Withdrawal by Subject|0|||
94293515|NCT05742984|322861618|FG004|Overall Study|Withdrawal by Subject|0|||
94293516|NCT05742984|322861619|FG005|Overall Study|Withdrawal by Subject|2|||
94293517|NCT00379340|322861622|FG000|Overall Study|Death|0|||
94293518|NCT00379340|322861623|FG001|Overall Study|Death|0|||
94293519|NCT00379340|322861624|FG002|Overall Study|Death|0|||
94293520|NCT00379340|322861625|FG003|Overall Study|Death|2|||
94293521|NCT00379340|322861626|FG004|Overall Study|Death|0|||
94293522|NCT00379340|322861622|FG000|Overall Study|Lack of Efficacy|6|||
94293523|NCT00379340|322861623|FG001|Overall Study|Lack of Efficacy|1|||
94293524|NCT00379340|322861624|FG002|Overall Study|Lack of Efficacy|0|||
94293525|NCT00379340|322861625|FG003|Overall Study|Lack of Efficacy|4|||
94293526|NCT00379340|322861626|FG004|Overall Study|Lack of Efficacy|3|||
94293527|NCT00379340|322861622|FG000|Overall Study|Physician Decision|6|||
94293528|NCT00379340|322861623|FG001|Overall Study|Physician Decision|2|||
94293529|NCT00379340|322861624|FG002|Overall Study|Physician Decision|1|||
94293530|NCT00379340|322861625|FG003|Overall Study|Physician Decision|2|||
94293531|NCT00379340|322861626|FG004|Overall Study|Physician Decision|3|||
94293532|NCT00379340|322861622|FG000|Overall Study|Withdrawal by Subject|0|||
94293533|NCT00379340|322861623|FG001|Overall Study|Withdrawal by Subject|0|||
94293534|NCT00379340|322861624|FG002|Overall Study|Withdrawal by Subject|0|||
94293535|NCT00379340|322861625|FG003|Overall Study|Withdrawal by Subject|1|||
94293536|NCT00379340|322861626|FG004|Overall Study|Withdrawal by Subject|0|||
94293537|NCT00379340|322861622|FG000|Overall Study|Refusal of further protocol therapy|1|||
94293538|NCT00379340|322861623|FG001|Overall Study|Refusal of further protocol therapy|0|||
94293539|NCT00379340|322861624|FG002|Overall Study|Refusal of further protocol therapy|1|||
94293540|NCT00379340|322861625|FG003|Overall Study|Refusal of further protocol therapy|1|||
94293541|NCT00379340|322861626|FG004|Overall Study|Refusal of further protocol therapy|7|||
94293542|NCT00379340|322861622|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
94293543|NCT00379340|322861623|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
94293544|NCT00379340|322861624|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
94293545|NCT00379340|322861625|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
94293546|NCT00379340|322861626|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
94293547|NCT00379340|322861622|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
94293548|NCT00379340|322861623|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
94372562|NCT01254045|323150297|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
94293549|NCT00379340|322861624|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
94293550|NCT00379340|322861625|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
94293551|NCT00379340|322861626|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
94293552|NCT02159807|322861629|FG000|Overall Study|Adverse Event|0|||
94293553|NCT02159807|322861630|FG001|Overall Study|Adverse Event|0|||
94293554|NCT02159807|322861631|FG002|Overall Study|Adverse Event|1|||
94293555|NCT02159807|322861629|FG000|Overall Study|No CSF|1|||
94293556|NCT02159807|322861630|FG001|Overall Study|No CSF|1|||
94293557|NCT02159807|322861631|FG002|Overall Study|No CSF|1|||
94293558|NCT02159807|322861629|FG000|Overall Study|elevated blood pressure|0|||
94293559|NCT02159807|322861630|FG001|Overall Study|elevated blood pressure|0|||
94293560|NCT02159807|322861631|FG002|Overall Study|elevated blood pressure|1|||
94293561|NCT05195528|322861632|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
94293562|NCT05195528|322861633|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
94293563|NCT05195528|322861634|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
94293564|NCT05195528|322861635|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
94293565|NCT05195528|322861636|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
94293566|NCT05195528|322861632|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
94293567|NCT05195528|322861633|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
94293568|NCT05195528|322861634|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
94293569|NCT05195528|322861635|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
94293570|NCT05195528|322861636|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
94293571|NCT05195528|322861632|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
94293572|NCT05195528|322861633|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
94293573|NCT05195528|322861634|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
94293574|NCT05195528|322861635|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
94293575|NCT05195528|322861636|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
94293576|NCT05195528|322861632|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
94293577|NCT05195528|322861633|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
94293578|NCT05195528|322861634|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
94293579|NCT05195528|322861635|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
94293580|NCT05195528|322861636|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
94293581|NCT05195528|322861632|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
94293582|NCT05195528|322861633|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
94293583|NCT05195528|322861634|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
94293584|NCT05195528|322861635|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
94293585|NCT05195528|322861636|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
94293586|NCT05195528|322861632|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
94293587|NCT05195528|322861633|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
94293588|NCT05195528|322861634|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
94293589|NCT05195528|322861635|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
94293590|NCT05195528|322861636|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
94293591|NCT05195528|322861632|FG000|Placebo-controlled Treatment Period|Other|0|||
94293592|NCT05195528|322861633|FG001|Placebo-controlled Treatment Period|Other|0|||
94293593|NCT05195528|322861634|FG002|Placebo-controlled Treatment Period|Other|1|||
94293594|NCT05195528|322861635|FG003|Placebo-controlled Treatment Period|Other|0|||
94293595|NCT05195528|322861636|FG004|Placebo-controlled Treatment Period|Other|0|||
94293596|NCT05195528|322861632|FG000|Extension Period|PTE or AE or SAE|0|||
94293597|NCT05195528|322861633|FG001|Extension Period|PTE or AE or SAE|4|||
94293598|NCT05195528|322861634|FG002|Extension Period|PTE or AE or SAE|5|||
94293599|NCT05195528|322861635|FG003|Extension Period|PTE or AE or SAE|4|||
94293600|NCT05195528|322861636|FG004|Extension Period|PTE or AE or SAE|4|||
94293601|NCT05195528|322861632|FG000|Extension Period|Protocol Violation|0|||
94293602|NCT05195528|322861633|FG001|Extension Period|Protocol Violation|2|||
94293603|NCT05195528|322861634|FG002|Extension Period|Protocol Violation|1|||
94293604|NCT05195528|322861635|FG003|Extension Period|Protocol Violation|0|||
94293605|NCT05195528|322861636|FG004|Extension Period|Protocol Violation|1|||
94293606|NCT05195528|322861632|FG000|Extension Period|Lost to Follow-up|0|||
94293607|NCT05195528|322861633|FG001|Extension Period|Lost to Follow-up|6|||
94293608|NCT05195528|322861634|FG002|Extension Period|Lost to Follow-up|13|||
94293609|NCT05195528|322861635|FG003|Extension Period|Lost to Follow-up|3|||
94293610|NCT05195528|322861636|FG004|Extension Period|Lost to Follow-up|7|||
94293611|NCT05195528|322861632|FG000|Extension Period|Withdrawal by Subject|0|||
94293612|NCT05195528|322861633|FG001|Extension Period|Withdrawal by Subject|12|||
94293613|NCT05195528|322861634|FG002|Extension Period|Withdrawal by Subject|9|||
94293614|NCT05195528|322861635|FG003|Extension Period|Withdrawal by Subject|6|||
94293615|NCT05195528|322861636|FG004|Extension Period|Withdrawal by Subject|5|||
94293616|NCT05195528|322861632|FG000|Extension Period|Lack of Efficacy|0|||
94293617|NCT05195528|322861633|FG001|Extension Period|Lack of Efficacy|3|||
94293618|NCT05195528|322861634|FG002|Extension Period|Lack of Efficacy|0|||
94293619|NCT05195528|322861635|FG003|Extension Period|Lack of Efficacy|0|||
94293620|NCT05195528|322861636|FG004|Extension Period|Lack of Efficacy|2|||
94293621|NCT05195528|322861632|FG000|Extension Period|Not Treated|0|||
94293622|NCT05195528|322861633|FG001|Extension Period|Not Treated|0|||
94293623|NCT05195528|322861634|FG002|Extension Period|Not Treated|2|||
94293624|NCT05195528|322861635|FG003|Extension Period|Not Treated|3|||
94293625|NCT05195528|322861636|FG004|Extension Period|Not Treated|0|||
94293626|NCT05195528|322861632|FG000|Extension Period|Other|0|||
94293627|NCT05195528|322861633|FG001|Extension Period|Other|1|||
94293628|NCT05195528|322861634|FG002|Extension Period|Other|1|||
94293629|NCT05195528|322861635|FG003|Extension Period|Other|0|||
94293630|NCT05195528|322861636|FG004|Extension Period|Other|0|||
94293631|NCT00542191|322861639|FG000|Overall Study|Death|3|||
94293632|NCT02913313|322861642|FG000|Overall Study|DISEASE PROGRESSION|1|||
94293633|NCT02913313|322861643|FG001|Overall Study|DISEASE PROGRESSION|2|||
94293634|NCT02913313|322861644|FG002|Overall Study|DISEASE PROGRESSION|2|||
94293635|NCT02913313|322861645|FG003|Overall Study|DISEASE PROGRESSION|4|||
94293636|NCT02913313|322861646|FG004|Overall Study|DISEASE PROGRESSION|6|||
94293637|NCT02913313|322861647|FG005|Overall Study|DISEASE PROGRESSION|4|||
94293638|NCT02913313|322861648|FG006|Overall Study|DISEASE PROGRESSION|19|||
94293639|NCT02913313|322861649|FG007|Overall Study|DISEASE PROGRESSION|3|||
94293640|NCT02913313|322861650|FG008|Overall Study|DISEASE PROGRESSION|4|||
94293641|NCT02913313|322861651|FG009|Overall Study|DISEASE PROGRESSION|4|||
94293642|NCT02913313|322861652|FG010|Overall Study|DISEASE PROGRESSION|11|||
94293643|NCT02913313|322861653|FG011|Overall Study|DISEASE PROGRESSION|5|||
94293644|NCT02913313|322861654|FG012|Overall Study|DISEASE PROGRESSION|14|||
94293645|NCT02913313|322861655|FG013|Overall Study|DISEASE PROGRESSION|3|||
94293646|NCT02913313|322861642|FG000|Overall Study|Not Reported|0|||
94293647|NCT02913313|322861643|FG001|Overall Study|Not Reported|0|||
94293648|NCT02913313|322861644|FG002|Overall Study|Not Reported|0|||
94293649|NCT02913313|322861645|FG003|Overall Study|Not Reported|0|||
94293650|NCT02913313|322861646|FG004|Overall Study|Not Reported|1|||
94293651|NCT02913313|322861647|FG005|Overall Study|Not Reported|0|||
94293652|NCT02913313|322861648|FG006|Overall Study|Not Reported|0|||
94293653|NCT02913313|322861649|FG007|Overall Study|Not Reported|0|||
94293654|NCT02913313|322861650|FG008|Overall Study|Not Reported|0|||
94293655|NCT02913313|322861651|FG009|Overall Study|Not Reported|0|||
94293656|NCT02913313|322861652|FG010|Overall Study|Not Reported|4|||
94293657|NCT02913313|322861653|FG011|Overall Study|Not Reported|0|||
94293658|NCT02913313|322861654|FG012|Overall Study|Not Reported|0|||
94293659|NCT02913313|322861655|FG013|Overall Study|Not Reported|0|||
94293660|NCT02913313|322861642|FG000|Overall Study|Other reasons|0|||
94293661|NCT02913313|322861643|FG001|Overall Study|Other reasons|0|||
94293662|NCT02913313|322861644|FG002|Overall Study|Other reasons|0|||
94293663|NCT02913313|322861645|FG003|Overall Study|Other reasons|0|||
94293664|NCT02913313|322861646|FG004|Overall Study|Other reasons|1|||
94293665|NCT02913313|322861647|FG005|Overall Study|Other reasons|0|||
94293666|NCT02913313|322861648|FG006|Overall Study|Other reasons|0|||
94293667|NCT02913313|322861649|FG007|Overall Study|Other reasons|0|||
94293668|NCT02913313|322861650|FG008|Overall Study|Other reasons|0|||
94293669|NCT02913313|322861651|FG009|Overall Study|Other reasons|0|||
94293670|NCT02913313|322861652|FG010|Overall Study|Other reasons|1|||
94293671|NCT02913313|322861653|FG011|Overall Study|Other reasons|0|||
94293672|NCT02913313|322861654|FG012|Overall Study|Other reasons|0|||
94293673|NCT02913313|322861655|FG013|Overall Study|Other reasons|0|||
94293674|NCT02913313|322861642|FG000|Overall Study|Withdrawal by Subject|0|||
94293675|NCT02913313|322861643|FG001|Overall Study|Withdrawal by Subject|0|||
94293676|NCT02913313|322861644|FG002|Overall Study|Withdrawal by Subject|1|||
94293677|NCT02913313|322861645|FG003|Overall Study|Withdrawal by Subject|0|||
94293678|NCT02913313|322861646|FG004|Overall Study|Withdrawal by Subject|0|||
94293679|NCT02913313|322861647|FG005|Overall Study|Withdrawal by Subject|0|||
94293680|NCT02913313|322861648|FG006|Overall Study|Withdrawal by Subject|1|||
94293681|NCT02913313|322861649|FG007|Overall Study|Withdrawal by Subject|1|||
94293682|NCT02913313|322861650|FG008|Overall Study|Withdrawal by Subject|0|||
94293683|NCT02913313|322861651|FG009|Overall Study|Withdrawal by Subject|0|||
94293684|NCT02913313|322861652|FG010|Overall Study|Withdrawal by Subject|1|||
94293685|NCT02913313|322861653|FG011|Overall Study|Withdrawal by Subject|0|||
94293686|NCT02913313|322861654|FG012|Overall Study|Withdrawal by Subject|0|||
94293687|NCT02913313|322861655|FG013|Overall Study|Withdrawal by Subject|0|||
94293688|NCT02913313|322861642|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
94293689|NCT02913313|322861643|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
94293690|NCT02913313|322861644|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
94293691|NCT02913313|322861645|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
94293692|NCT02913313|322861646|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
94293693|NCT02913313|322861647|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
94293694|NCT02913313|322861648|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
94293695|NCT02913313|322861649|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
94293696|NCT02913313|322861650|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
94293697|NCT02913313|322861651|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
94293698|NCT02913313|322861652|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
94293699|NCT02913313|322861653|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
94293700|NCT02913313|322861654|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
94293701|NCT02913313|322861655|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
94293702|NCT02913313|322861642|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
94293703|NCT02913313|322861643|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
94293704|NCT02913313|322861644|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
94293705|NCT02913313|322861645|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
94293706|NCT02913313|322861646|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
94293707|NCT02913313|322861647|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
94293708|NCT02913313|322861648|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
94293709|NCT02913313|322861649|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
94293710|NCT02913313|322861650|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
94293711|NCT02913313|322861651|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
94293712|NCT02913313|322861652|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
94293713|NCT02913313|322861653|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
94293714|NCT02913313|322861654|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
94293715|NCT02913313|322861655|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
94293716|NCT01596257|322861659|FG000|Overall Study|Inadequate Collection|23|||
94293717|NCT01596257|322861660|FG001|Overall Study|Inadequate Collection|19|||
94293718|NCT04007159|322861671|FG000|Induction Phase|(missed study visits)|16|||
94293719|NCT04007159|322861671|FG000|Induction Phase|Withdrawal by Subject|4|||
94293720|NCT04007159|322861671|FG000|Induction Phase|Adverse Event|2|||
94293721|NCT04007159|322861671|FG000|Challenge Phase|missed study visits|3|||
94293722|NCT04258579|322861672|FG000|Overall Study|Withdrawal by Subject|7|||
94293723|NCT04258579|322861672|FG000|Overall Study|Lost to Follow-up|3|||
94293724|NCT04258579|322861672|FG000|Overall Study|Protocol Violation|2|||
94293725|NCT04258579|322861672|FG000|Overall Study|Adverse Event|1|||
94293726|NCT01950819|322861673|FG000|Overall Study|Graft Loss|35|||
94293727|NCT01950819|322861674|FG001|Overall Study|Graft Loss|30|||
94293728|NCT01950819|322861673|FG000|Overall Study|Death|29|||
94293729|NCT01950819|322861674|FG001|Overall Study|Death|34|||
94293730|NCT01950819|322861673|FG000|Overall Study|Subject / Gardian decision|54|||
94293731|NCT01950819|322861674|FG001|Overall Study|Subject / Gardian decision|51|||
94293732|NCT01950819|322861673|FG000|Overall Study|technical problems|2|||
94293733|NCT01950819|322861674|FG001|Overall Study|technical problems|0|||
94293734|NCT01950819|322861673|FG000|Overall Study|Pregnancy|0|||
94293735|NCT01950819|322861674|FG001|Overall Study|Pregnancy|2|||
94293736|NCT01950819|322861673|FG000|Overall Study|Lost to Follow-up|9|||
94293737|NCT01950819|322861674|FG001|Overall Study|Lost to Follow-up|17|||
94293738|NCT01756274|322861675|FG000|Overall Study|Protocol Violation|2|||
94293739|NCT01756274|322861675|FG000|Overall Study|Laboratory error|1|||
94293740|NCT01147926|322861676|FG000|Overall Study|Subject Withdrew Consent|9|||
94293741|NCT01147926|322861677|FG001|Overall Study|Subject Withdrew Consent|10|||
94293742|NCT01147926|322861676|FG000|Overall Study|Adverse Event|7|||
94293743|NCT01147926|322861677|FG001|Overall Study|Adverse Event|6|||
94293744|NCT01147926|322861676|FG000|Overall Study|Subject Non-Compliant|5|||
94293745|NCT01147926|322861677|FG001|Overall Study|Subject Non-Compliant|4|||
94293746|NCT01147926|322861676|FG000|Overall Study|Principal investigator left hospital|1|||
94293747|NCT01147926|322861677|FG001|Overall Study|Principal investigator left hospital|3|||
94293748|NCT01147926|322861676|FG000|Overall Study|Selection criteria not met|3|||
94293749|NCT01147926|322861677|FG001|Overall Study|Selection criteria not met|1|||
94293750|NCT01147926|322861676|FG000|Overall Study|Lost to Follow-up|0|||
94293751|NCT01147926|322861677|FG001|Overall Study|Lost to Follow-up|2|||
94293752|NCT01147926|322861676|FG000|Overall Study|Sponsor's Decision|0|||
94293753|NCT01147926|322861677|FG001|Overall Study|Sponsor's Decision|1|||
94293754|NCT01147926|322861676|FG000|Overall Study|Lack of Efficacy|1|||
94293755|NCT01147926|322861677|FG001|Overall Study|Lack of Efficacy|0|||
94293756|NCT01147926|322861676|FG000|Overall Study|Too busy, no time for study|1|||
94293757|NCT01147926|322861677|FG001|Overall Study|Too busy, no time for study|0|||
94293758|NCT01147926|322861676|FG000|Overall Study|Went on holiday|0|||
94293759|NCT01147926|322861677|FG001|Overall Study|Went on holiday|1|||
94293760|NCT01147926|322861676|FG000|Overall Study|Colonoscopy result|0|||
94293761|NCT01147926|322861677|FG001|Overall Study|Colonoscopy result|1|||
94293762|NCT01824979|322861679|FG000|Overall Study|Withdrawal by Subject|5|||
94293763|NCT01824979|322861680|FG001|Overall Study|Withdrawal by Subject|0|||
94293764|NCT01824979|322861679|FG000|Overall Study|Physician Decision|2|||
94293765|NCT01824979|322861680|FG001|Overall Study|Physician Decision|0|||
94293766|NCT01824979|322861679|FG000|Overall Study|Protocol Violation|6|||
94293767|NCT01824979|322861680|FG001|Overall Study|Protocol Violation|13|||
94293768|NCT02211261|322861684|FG000|Overall Study|Withdrawal by Subject|0|||
94293769|NCT02211261|322861685|FG001|Overall Study|Withdrawal by Subject|0|||
94293770|NCT02211261|322861686|FG002|Overall Study|Withdrawal by Subject|1|||
94293771|NCT02211261|322861687|FG003|Overall Study|Withdrawal by Subject|0|||
94293772|NCT02211261|322861688|FG004|Overall Study|Withdrawal by Subject|2|||
94293773|NCT02211261|322861689|FG005|Overall Study|Withdrawal by Subject|0|||
94293774|NCT02211261|322861690|FG006|Overall Study|Withdrawal by Subject|0|||
94293775|NCT02211261|322861691|FG007|Overall Study|Withdrawal by Subject|0|||
94293776|NCT02211261|322861692|FG008|Overall Study|Withdrawal by Subject|0|||
94293777|NCT02211261|322861693|FG009|Overall Study|Withdrawal by Subject|0|||
94293778|NCT02211261|322861694|FG010|Overall Study|Withdrawal by Subject|0|||
94293779|NCT02211261|322861684|FG000|Overall Study|Other|0|||
94293780|NCT02211261|322861685|FG001|Overall Study|Other|0|||
94293781|NCT02211261|322861686|FG002|Overall Study|Other|0|||
94293782|NCT02211261|322861687|FG003|Overall Study|Other|0|||
94293783|NCT02211261|322861688|FG004|Overall Study|Other|0|||
94293784|NCT02211261|322861689|FG005|Overall Study|Other|1|||
94293785|NCT02211261|322861690|FG006|Overall Study|Other|0|||
94293786|NCT02211261|322861691|FG007|Overall Study|Other|0|||
94293787|NCT02211261|322861692|FG008|Overall Study|Other|0|||
94293788|NCT02211261|322861693|FG009|Overall Study|Other|2|||
94293789|NCT02211261|322861694|FG010|Overall Study|Other|0|||
94293790|NCT02211261|322861684|FG000|Overall Study|Lost to Follow-up|0|||
94293791|NCT02211261|322861685|FG001|Overall Study|Lost to Follow-up|0|||
94293792|NCT02211261|322861686|FG002|Overall Study|Lost to Follow-up|0|||
94293793|NCT02211261|322861687|FG003|Overall Study|Lost to Follow-up|0|||
94293794|NCT02211261|322861688|FG004|Overall Study|Lost to Follow-up|0|||
94293795|NCT02211261|322861689|FG005|Overall Study|Lost to Follow-up|0|||
94293796|NCT02211261|322861690|FG006|Overall Study|Lost to Follow-up|0|||
94293797|NCT02211261|322861691|FG007|Overall Study|Lost to Follow-up|1|||
94293798|NCT02211261|322861692|FG008|Overall Study|Lost to Follow-up|0|||
94293799|NCT02211261|322861693|FG009|Overall Study|Lost to Follow-up|0|||
94293800|NCT02211261|322861694|FG010|Overall Study|Lost to Follow-up|0|||
94293801|NCT01451645|322861695|FG000|Overall Study|Protocol Violation|1|||
94293802|NCT01451645|322861696|FG001|Overall Study|Protocol Violation|0|||
94293803|NCT01451645|322861695|FG000|Overall Study|Adverse Event|0|||
94293804|NCT01451645|322861696|FG001|Overall Study|Adverse Event|3|||
94293805|NCT01451645|322861695|FG000|Overall Study|Withdrawal by Subject|4|||
94293806|NCT01451645|322861696|FG001|Overall Study|Withdrawal by Subject|2|||
94293807|NCT01451645|322861695|FG000|Overall Study|Lost to Follow-up|4|||
94293808|NCT01451645|322861696|FG001|Overall Study|Lost to Follow-up|3|||
94293809|NCT03838484|322861702|FG000|Overall Study|Lost to Follow-up|0|||
94293810|NCT03838484|322861703|FG001|Overall Study|Lost to Follow-up|1|||
94293811|NCT03838484|322861704|FG002|Overall Study|Lost to Follow-up|0|||
94293812|NCT03838484|322861705|FG003|Overall Study|Lost to Follow-up|0|||
94293813|NCT03258814|322861706|FG000|Overall Study|Early Termination|4|||
94293814|NCT03258814|322861707|FG001|Overall Study|Early Termination|3|||
94293815|NCT03258814|322861708|FG002|Overall Study|Early Termination|10|||
94293816|NCT00473876|322861717|FG000|Overall Study|Lost to Follow-up|3|||
94293817|NCT00473876|322861718|FG001|Overall Study|Lost to Follow-up|1|||
94293818|NCT03371355|322861721|FG000|Overall Study|Investigator judgment|0|||
94293819|NCT03371355|322861722|FG001|Overall Study|Investigator judgment|0|||
94293820|NCT03371355|322861723|FG002|Overall Study|Investigator judgment|1|||
94293821|NCT03371355|322861724|FG003|Overall Study|Investigator judgment|1|||
94293822|NCT03371355|322861721|FG000|Overall Study|Voluntary withdrawal|1|||
94293823|NCT03371355|322861722|FG001|Overall Study|Voluntary withdrawal|0|||
94293824|NCT03371355|322861723|FG002|Overall Study|Voluntary withdrawal|1|||
94293825|NCT03371355|322861724|FG003|Overall Study|Voluntary withdrawal|2|||
94293826|NCT03371355|322861721|FG000|Overall Study|Adverse Event|0|||
94293827|NCT03371355|322861722|FG001|Overall Study|Adverse Event|1|||
94293828|NCT03371355|322861723|FG002|Overall Study|Adverse Event|2|||
94293829|NCT03371355|322861724|FG003|Overall Study|Adverse Event|3|||
94293830|NCT03371355|322861721|FG000|Overall Study|Reason not Specified|0|||
94293831|NCT03371355|322861722|FG001|Overall Study|Reason not Specified|1|||
94293832|NCT03371355|322861723|FG002|Overall Study|Reason not Specified|0|||
94293833|NCT03371355|322861724|FG003|Overall Study|Reason not Specified|1|||
94293834|NCT01662648|322861725|FG000|Overall Study|Death|1|||
94293835|NCT01662648|322861726|FG001|Overall Study|Death|3|||
94293836|NCT01662648|322861725|FG000|Overall Study|Adverse Event|40|||
94293837|NCT01662648|322861726|FG001|Overall Study|Adverse Event|37|||
94293838|NCT01662648|322861725|FG000|Overall Study|Lack of Efficacy|17|||
94293839|NCT01662648|322861726|FG001|Overall Study|Lack of Efficacy|16|||
94293840|NCT01662648|322861725|FG000|Overall Study|Participant ineligible to continue trial|1|||
94293841|NCT01662648|322861726|FG001|Overall Study|Participant ineligible to continue trial|1|||
94293842|NCT01662648|322861725|FG000|Overall Study|Lost to Follow-up|24|||
94293843|NCT01662648|322861726|FG001|Overall Study|Lost to Follow-up|36|||
94293844|NCT01662648|322861725|FG000|Overall Study|Withdrawal by Subject|36|||
94293845|NCT01662648|322861726|FG001|Overall Study|Withdrawal by Subject|53|||
94293846|NCT01662648|322861725|FG000|Overall Study|Participant non-compliant|16|||
94293847|NCT01662648|322861726|FG001|Overall Study|Participant non-compliant|20|||
94293848|NCT01662648|322861725|FG000|Overall Study|Other|8|||
94293849|NCT01662648|322861726|FG001|Overall Study|Other|11|||
94293850|NCT01662648|322861725|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
94293851|NCT01662648|322861726|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
94293852|NCT01662648|322861725|FG000|Overall Study|LOE and other reason unspecified|1|||
94293853|NCT01662648|322861726|FG001|Overall Study|LOE and other reason unspecified|0|||
94293854|NCT01662648|322861725|FG000|Overall Study|LOE and Participant non-compliant|0|||
94293855|NCT01662648|322861726|FG001|Overall Study|LOE and Participant non-compliant|1|||
94293856|NCT03751111|322861727|FG000|Overall Study|Lack of Efficacy|9|||
94293857|NCT03751111|322861728|FG001|Overall Study|Lack of Efficacy|30|||
94293858|NCT03751111|322861727|FG000|Overall Study|Adverse Event|3|||
94293859|NCT03751111|322861728|FG001|Overall Study|Adverse Event|2|||
94293860|NCT00974220|322861729|FG000|Treatment Period 1|Adverse Event|2|||
94293861|NCT00974220|322861730|FG001|Treatment Period 1|Adverse Event|1|||
94293862|NCT00974220|322861729|FG000|Treatment Period 1|noncompliant subjects|0|||
94293863|NCT00974220|322861730|FG001|Treatment Period 1|noncompliant subjects|1|||
94293864|NCT00480857|322861731|FG000|Overall Study|Lack of Efficacy|2|||
94293865|NCT01264939|322861741|FG000|Overall Study|Adverse Event|1|||
94293866|NCT01264939|322861742|FG001|Overall Study|Adverse Event|3|||
94293867|NCT01264939|322861741|FG000|Overall Study|Lost to Follow-up|0|||
94293868|NCT01264939|322861742|FG001|Overall Study|Lost to Follow-up|3|||
94293869|NCT01264939|322861741|FG000|Overall Study|Physician Decision|1|||
94293870|NCT01264939|322861742|FG001|Overall Study|Physician Decision|1|||
94293871|NCT01264939|322861741|FG000|Overall Study|Patient/Guardian Decision|8|||
94293872|NCT01264939|322861742|FG001|Overall Study|Patient/Guardian Decision|10|||
94293873|NCT01264939|322861741|FG000|Overall Study|Disease Progression|8|||
94293874|NCT01264939|322861742|FG001|Overall Study|Disease Progression|11|||
94293875|NCT00977470|322861743|FG000|Overall Study|Lack of Efficacy|32|||
94293876|NCT00977470|322861744|FG001|Overall Study|Lack of Efficacy|30|||
94293877|NCT00977470|322861743|FG000|Overall Study|Physician Decision|2|||
94293878|NCT00977470|322861744|FG001|Overall Study|Physician Decision|0|||
94293879|NCT00977470|322861743|FG000|Overall Study|Adverse Event|1|||
94293880|NCT00977470|322861744|FG001|Overall Study|Adverse Event|2|||
94293881|NCT00977470|322861743|FG000|Overall Study|Protocol Violation|1|||
94293882|NCT00977470|322861744|FG001|Overall Study|Protocol Violation|0|||
94293883|NCT00977470|322861743|FG000|Overall Study|Withdrawal by Subject|0|||
94293884|NCT00977470|322861744|FG001|Overall Study|Withdrawal by Subject|2|||
94293885|NCT00977470|322861743|FG000|Overall Study|Death|0|||
94293886|NCT00977470|322861744|FG001|Overall Study|Death|2|||
94293887|NCT00977470|322861743|FG000|Overall Study|clinical decline|0|||
94293888|NCT00977470|322861744|FG001|Overall Study|clinical decline|1|||
94293889|NCT00977470|322861743|FG000|Overall Study|prolonged recovery post-surgery|0|||
94293890|NCT00977470|322861744|FG001|Overall Study|prolonged recovery post-surgery|1|||
94293891|NCT00977470|322861743|FG000|Overall Study|Still on-study|2|||
94293892|NCT00977470|322861744|FG001|Overall Study|Still on-study|0|||
94293893|NCT02452762|322861747|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
94293894|NCT02452762|322861748|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
94293895|NCT02452762|322861747|FG000|Overall Study|Withdrawal by Subject|1|||
94293896|NCT02452762|322861748|FG001|Overall Study|Withdrawal by Subject|0|||
94293897|NCT02675075|322861749|FG000|Overall Study|Lost to Follow-up|3|||
94293898|NCT02675075|322861750|FG001|Overall Study|Lost to Follow-up|0|||
94293899|NCT00896532|322861751|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293900|NCT00896532|322861752|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293901|NCT00896532|322861753|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293902|NCT00896532|322861754|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
94293903|NCT00896532|322861755|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293904|NCT00896532|322861756|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
94293905|NCT00896532|322861757|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293906|NCT00896532|322861758|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293907|NCT00896532|322861759|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293908|NCT00896532|322861760|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293909|NCT00896532|322861761|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293910|NCT00896532|322861762|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293911|NCT00896532|322861763|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293912|NCT00896532|322861764|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293913|NCT00896532|322861765|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293914|NCT00896532|322861766|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293915|NCT00896532|322861767|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293916|NCT00896532|322861768|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293917|NCT00896532|322861769|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94372563|NCT01254045|323150298|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
94293918|NCT00896532|322861770|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293919|NCT00896532|322861771|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293920|NCT00896532|322861772|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293921|NCT00896532|322861773|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
94293922|NCT00896532|322861751|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
94293923|NCT00896532|322861752|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
94293924|NCT00896532|322861753|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
94372564|NCT01254045|323150299|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
94372565|NCT01254045|323150300|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
94293925|NCT00896532|322861754|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
94293926|NCT00896532|322861755|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
94293927|NCT00896532|322861756|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
94293928|NCT00896532|322861757|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
94293929|NCT00896532|322861758|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
94293930|NCT00896532|322861759|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
94293931|NCT00896532|322861760|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
94293932|NCT00896532|322861761|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
94293933|NCT00896532|322861762|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
94293934|NCT00896532|322861763|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
94293935|NCT00896532|322861764|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
94293936|NCT00896532|322861765|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
94293937|NCT00896532|322861766|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
94293938|NCT00896532|322861767|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
94293939|NCT00896532|322861768|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
94293940|NCT00896532|322861769|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
94293941|NCT00896532|322861770|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
94293942|NCT00896532|322861771|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
94293943|NCT00896532|322861772|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
94293944|NCT00896532|322861773|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
94293945|NCT00896532|322861751|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
94293946|NCT00896532|322861752|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
94293947|NCT00896532|322861753|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
94293948|NCT00896532|322861754|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
94293949|NCT00896532|322861755|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
94293950|NCT00896532|322861756|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
94293951|NCT00896532|322861757|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
94293952|NCT00896532|322861758|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
94293953|NCT00896532|322861759|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
94293954|NCT00896532|322861760|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
94293955|NCT00896532|322861761|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
94293956|NCT00896532|322861762|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
94293957|NCT00896532|322861763|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
94293958|NCT00896532|322861764|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
94293959|NCT00896532|322861765|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
94293960|NCT00896532|322861766|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
94293961|NCT00896532|322861767|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
94293962|NCT00896532|322861768|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
94293963|NCT00896532|322861769|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
94293964|NCT00896532|322861770|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
94293965|NCT00896532|322861771|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
94293966|NCT00896532|322861772|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
94293967|NCT00896532|322861773|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
94293968|NCT00896532|322861751|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293969|NCT00896532|322861752|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293970|NCT00896532|322861753|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
94293971|NCT00896532|322861754|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293972|NCT00896532|322861755|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
94293973|NCT00896532|322861756|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293974|NCT00896532|322861757|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293975|NCT00896532|322861758|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293976|NCT00896532|322861759|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293977|NCT00896532|322861760|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293978|NCT00896532|322861761|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293979|NCT00896532|322861762|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293980|NCT00896532|322861763|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293981|NCT00896532|322861764|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293982|NCT00896532|322861765|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293983|NCT00896532|322861766|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293984|NCT00896532|322861767|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293985|NCT00896532|322861768|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293986|NCT00896532|322861769|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293987|NCT00896532|322861770|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293988|NCT00896532|322861771|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293989|NCT00896532|322861772|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293990|NCT00896532|322861773|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
94293991|NCT00896532|322861751|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
94293992|NCT00896532|322861752|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94293993|NCT00896532|322861753|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94293994|NCT00896532|322861754|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
94293995|NCT00896532|322861755|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94293996|NCT00896532|322861756|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94293997|NCT00896532|322861757|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94293998|NCT00896532|322861758|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94293999|NCT00896532|322861759|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94294000|NCT00896532|322861760|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94294001|NCT00896532|322861761|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94294002|NCT00896532|322861762|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94294003|NCT00896532|322861763|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94294004|NCT00896532|322861764|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94294005|NCT00896532|322861765|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94294006|NCT00896532|322861766|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94294007|NCT00896532|322861767|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94294008|NCT00896532|322861768|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94294009|NCT00896532|322861769|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94294010|NCT00896532|322861770|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94294011|NCT00896532|322861771|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94294012|NCT00896532|322861772|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94294013|NCT00896532|322861773|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
94294014|NCT00896532|322861751|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294015|NCT00896532|322861752|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294016|NCT00896532|322861753|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
94294017|NCT00896532|322861754|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294018|NCT00896532|322861755|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294019|NCT00896532|322861756|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294020|NCT00896532|322861757|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294021|NCT00896532|322861758|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294022|NCT00896532|322861759|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294023|NCT00896532|322861760|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294024|NCT00896532|322861761|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294025|NCT00896532|322861762|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294026|NCT00896532|322861763|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294027|NCT00896532|322861764|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294028|NCT00896532|322861765|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294029|NCT00896532|322861766|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294030|NCT00896532|322861767|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294031|NCT00896532|322861768|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294032|NCT00896532|322861769|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294033|NCT00896532|322861770|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294034|NCT00896532|322861771|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294035|NCT00896532|322861772|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294036|NCT00896532|322861773|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
94294037|NCT00896532|322861751|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294038|NCT00896532|322861752|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294039|NCT00896532|322861753|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
94294040|NCT00896532|322861754|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294041|NCT00896532|322861755|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294042|NCT00896532|322861756|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294043|NCT00896532|322861757|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294044|NCT00896532|322861758|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294045|NCT00896532|322861759|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294046|NCT00896532|322861760|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294047|NCT00896532|322861761|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294048|NCT00896532|322861762|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294049|NCT00896532|322861763|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294050|NCT00896532|322861764|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294051|NCT00896532|322861765|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294052|NCT00896532|322861766|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294053|NCT00896532|322861767|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294054|NCT00896532|322861768|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294055|NCT00896532|322861769|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294056|NCT00896532|322861770|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294057|NCT00896532|322861771|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294058|NCT00896532|322861772|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294059|NCT00896532|322861773|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
94294060|NCT00896532|322861751|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294061|NCT00896532|322861752|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294062|NCT00896532|322861753|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294063|NCT00896532|322861754|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
94294064|NCT00896532|322861755|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294065|NCT00896532|322861756|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294066|NCT00896532|322861757|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294067|NCT00896532|322861758|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294068|NCT00896532|322861759|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294069|NCT00896532|322861760|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294070|NCT00896532|322861761|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294071|NCT00896532|322861762|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294072|NCT00896532|322861763|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294073|NCT00896532|322861764|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294074|NCT00896532|322861765|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294075|NCT00896532|322861766|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294076|NCT00896532|322861767|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294077|NCT00896532|322861768|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294078|NCT00896532|322861769|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294079|NCT00896532|322861770|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294080|NCT00896532|322861771|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294081|NCT00896532|322861772|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294082|NCT00896532|322861773|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
94294083|NCT00896532|322861751|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294084|NCT00896532|322861752|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
94294085|NCT00896532|322861753|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294086|NCT00896532|322861754|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
94294087|NCT00896532|322861755|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
94294088|NCT00896532|322861756|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294089|NCT00896532|322861757|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294090|NCT00896532|322861758|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294091|NCT00896532|322861759|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294092|NCT00896532|322861760|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294093|NCT00896532|322861761|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294094|NCT00896532|322861762|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294095|NCT00896532|322861763|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294096|NCT00896532|322861764|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294097|NCT00896532|322861765|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294098|NCT00896532|322861766|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294099|NCT00896532|322861767|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294100|NCT00896532|322861768|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294101|NCT00896532|322861769|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294102|NCT00896532|322861770|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294103|NCT00896532|322861771|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294104|NCT00896532|322861772|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294105|NCT00896532|322861773|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
94294106|NCT00896532|322861751|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294107|NCT00896532|322861752|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294108|NCT00896532|322861753|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294109|NCT00896532|322861754|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294110|NCT00896532|322861755|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294111|NCT00896532|322861756|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294112|NCT00896532|322861757|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294113|NCT00896532|322861758|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294114|NCT00896532|322861759|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
94294115|NCT00896532|322861760|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294116|NCT00896532|322861761|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294117|NCT00896532|322861762|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294118|NCT00896532|322861763|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294119|NCT00896532|322861764|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294120|NCT00896532|322861765|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294121|NCT00896532|322861766|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294122|NCT00896532|322861767|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294123|NCT00896532|322861768|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294124|NCT00896532|322861769|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294125|NCT00896532|322861770|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294126|NCT00896532|322861771|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294127|NCT00896532|322861772|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294128|NCT00896532|322861773|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
94294129|NCT00896532|322861751|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294130|NCT00896532|322861752|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294131|NCT00896532|322861753|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294132|NCT00896532|322861754|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294133|NCT00896532|322861755|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294134|NCT00896532|322861756|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294135|NCT00896532|322861757|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294136|NCT00896532|322861758|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294137|NCT00896532|322861759|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294138|NCT00896532|322861760|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294139|NCT00896532|322861761|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294140|NCT00896532|322861762|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294141|NCT00896532|322861763|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
94294142|NCT00896532|322861764|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294143|NCT00896532|322861765|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294144|NCT00896532|322861766|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294145|NCT00896532|322861767|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294146|NCT00896532|322861768|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294147|NCT00896532|322861769|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294148|NCT00896532|322861770|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294149|NCT00896532|322861771|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294150|NCT00896532|322861772|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294151|NCT00896532|322861773|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
94294152|NCT00896532|322861751|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294153|NCT00896532|322861752|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294154|NCT00896532|322861753|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294155|NCT00896532|322861754|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294156|NCT00896532|322861755|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294157|NCT00896532|322861756|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294158|NCT00896532|322861757|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294159|NCT00896532|322861758|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294160|NCT00896532|322861759|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294161|NCT00896532|322861760|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294162|NCT00896532|322861761|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
94294163|NCT00896532|322861762|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294164|NCT00896532|322861763|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
94294165|NCT00896532|322861764|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294166|NCT00896532|322861765|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294167|NCT00896532|322861766|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294168|NCT00896532|322861767|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294169|NCT00896532|322861768|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294170|NCT00896532|322861769|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294171|NCT00896532|322861770|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294172|NCT00896532|322861771|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294173|NCT00896532|322861772|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294174|NCT00896532|322861773|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
94294175|NCT00896532|322861751|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294176|NCT00896532|322861752|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294177|NCT00896532|322861753|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294178|NCT00896532|322861754|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294179|NCT00896532|322861755|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294180|NCT00896532|322861756|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94372566|NCT01254045|323150301|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
94372567|NCT01254045|323150302|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
94372568|NCT00597207|323150303|FG000|Overall Study|Lost to Follow-up|5|||
94372569|NCT00597207|323150304|FG001|Overall Study|Lost to Follow-up|7|||
94372570|NCT00252187|323150307|FG000|Overall Study|Adverse Event|3|||
94372571|NCT00252187|323150308|FG001|Overall Study|Adverse Event|1|||
94294181|NCT00896532|322861757|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294182|NCT00896532|322861758|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294183|NCT00896532|322861759|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294184|NCT00896532|322861760|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294185|NCT00896532|322861761|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294186|NCT00896532|322861762|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294187|NCT00896532|322861763|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
94294188|NCT00896532|322861764|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
94294189|NCT00896532|322861765|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294190|NCT00896532|322861766|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294191|NCT00896532|322861767|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294192|NCT00896532|322861768|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294193|NCT00896532|322861769|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294194|NCT00896532|322861770|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294195|NCT00896532|322861771|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294196|NCT00896532|322861772|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294197|NCT00896532|322861773|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
94294198|NCT00896532|322861751|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
94294199|NCT00896532|322861752|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
94294200|NCT00896532|322861753|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
94294201|NCT00896532|322861754|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
94294202|NCT00896532|322861755|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
94294203|NCT00896532|322861756|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
94294204|NCT00896532|322861757|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
94294205|NCT00896532|322861758|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
94294206|NCT00896532|322861759|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
94294207|NCT00896532|322861760|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
94294208|NCT00896532|322861761|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
94294209|NCT00896532|322861762|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
94294210|NCT00896532|322861763|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
94294211|NCT00896532|322861764|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
94294212|NCT00896532|322861765|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
94294213|NCT00896532|322861766|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
94294214|NCT00896532|322861767|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
94294215|NCT00896532|322861768|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
94294216|NCT00896532|322861769|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
94294217|NCT00896532|322861770|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
94294218|NCT00896532|322861771|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
94294219|NCT00896532|322861772|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
94294220|NCT00896532|322861773|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
94294221|NCT00896532|322861751|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294222|NCT00896532|322861752|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294223|NCT00896532|322861753|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294224|NCT00896532|322861754|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294225|NCT00896532|322861755|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294226|NCT00896532|322861756|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294227|NCT00896532|322861757|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94372572|NCT00252187|323150307|FG000|Overall Study|Withdrawal by Subject|1|||
94372573|NCT00252187|323150308|FG001|Overall Study|Withdrawal by Subject|0|||
94294228|NCT00896532|322861758|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294229|NCT00896532|322861759|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294230|NCT00896532|322861760|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294231|NCT00896532|322861761|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294232|NCT00896532|322861762|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294233|NCT00896532|322861763|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294234|NCT00896532|322861764|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294235|NCT00896532|322861765|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294236|NCT00896532|322861766|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
94294237|NCT00896532|322861767|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
94372574|NCT01328054|323150311|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
94294238|NCT00896532|322861768|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294239|NCT00896532|322861769|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294240|NCT00896532|322861770|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294241|NCT00896532|322861771|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294242|NCT00896532|322861772|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294243|NCT00896532|322861773|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
94294244|NCT00896532|322861751|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294245|NCT00896532|322861752|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294246|NCT00896532|322861753|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294247|NCT00896532|322861754|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294248|NCT00896532|322861755|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294249|NCT00896532|322861756|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294250|NCT00896532|322861757|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294251|NCT00896532|322861758|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294252|NCT00896532|322861759|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294253|NCT00896532|322861760|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294254|NCT00896532|322861761|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294255|NCT00896532|322861762|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294256|NCT00896532|322861763|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294257|NCT00896532|322861764|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294258|NCT00896532|322861765|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294259|NCT00896532|322861766|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
94294260|NCT00896532|322861767|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
94294261|NCT00896532|322861768|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
94294262|NCT00896532|322861769|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294263|NCT00896532|322861770|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294264|NCT00896532|322861771|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294265|NCT00896532|322861772|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294266|NCT00896532|322861773|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
94294267|NCT00896532|322861751|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294268|NCT00896532|322861752|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294269|NCT00896532|322861753|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294270|NCT00896532|322861754|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294271|NCT00896532|322861755|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294272|NCT00896532|322861756|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294273|NCT00896532|322861757|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294274|NCT00896532|322861758|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294275|NCT00896532|322861759|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294276|NCT00896532|322861760|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294277|NCT00896532|322861761|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294278|NCT00896532|322861762|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294279|NCT00896532|322861763|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294280|NCT00896532|322861764|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294281|NCT00896532|322861765|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294282|NCT00896532|322861766|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294283|NCT00896532|322861767|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
94294284|NCT00896532|322861768|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294285|NCT00896532|322861769|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294286|NCT00896532|322861770|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294287|NCT00896532|322861771|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294288|NCT00896532|322861772|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294289|NCT00896532|322861773|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
94294290|NCT00896532|322861751|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
94294291|NCT00896532|322861752|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
94294292|NCT00896532|322861753|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
94294293|NCT00896532|322861754|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
94294294|NCT00896532|322861755|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
94294295|NCT00896532|322861756|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
94294296|NCT00896532|322861757|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
94294297|NCT00896532|322861758|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
94294298|NCT00896532|322861759|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
94294299|NCT00896532|322861760|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
94294300|NCT00896532|322861761|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
94294301|NCT00896532|322861762|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
94294302|NCT00896532|322861763|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
94294303|NCT00896532|322861764|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
94294304|NCT00896532|322861765|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
94294305|NCT00896532|322861766|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
94294306|NCT00896532|322861767|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
94294307|NCT00896532|322861768|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
94294308|NCT00896532|322861769|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
94294309|NCT00896532|322861770|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
94294310|NCT00896532|322861771|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
94294311|NCT00896532|322861772|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
94294312|NCT00896532|322861773|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
94294313|NCT00896532|322861751|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294314|NCT00896532|322861752|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294315|NCT00896532|322861753|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294316|NCT00896532|322861754|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294317|NCT00896532|322861755|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294318|NCT00896532|322861756|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294319|NCT00896532|322861757|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294320|NCT00896532|322861758|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294321|NCT00896532|322861759|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294322|NCT00896532|322861760|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294323|NCT00896532|322861761|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294324|NCT00896532|322861762|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294325|NCT00896532|322861763|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294326|NCT00896532|322861764|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294327|NCT00896532|322861765|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294328|NCT00896532|322861766|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294329|NCT00896532|322861767|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
94294330|NCT00896532|322861768|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294331|NCT00896532|322861769|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294332|NCT00896532|322861770|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294333|NCT00896532|322861771|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294334|NCT00896532|322861772|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294335|NCT00896532|322861773|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
94294336|NCT00896532|322861751|FG000|Months 48-72: Follow-on Phase|Death|0|||
94294337|NCT00896532|322861752|FG001|Months 48-72: Follow-on Phase|Death|0|||
94294338|NCT00896532|322861753|FG002|Months 48-72: Follow-on Phase|Death|0|||
94294339|NCT00896532|322861754|FG003|Months 48-72: Follow-on Phase|Death|0|||
94294340|NCT00896532|322861755|FG004|Months 48-72: Follow-on Phase|Death|0|||
94294341|NCT00896532|322861756|FG005|Months 48-72: Follow-on Phase|Death|0|||
94294342|NCT00896532|322861757|FG006|Months 48-72: Follow-on Phase|Death|0|||
94294343|NCT00896532|322861758|FG007|Months 48-72: Follow-on Phase|Death|0|||
94294344|NCT00896532|322861759|FG008|Months 48-72: Follow-on Phase|Death|0|||
94294345|NCT00896532|322861760|FG009|Months 48-72: Follow-on Phase|Death|0|||
94294346|NCT00896532|322861761|FG010|Months 48-72: Follow-on Phase|Death|0|||
94294347|NCT00896532|322861762|FG011|Months 48-72: Follow-on Phase|Death|0|||
94294348|NCT00896532|322861763|FG012|Months 48-72: Follow-on Phase|Death|0|||
94294349|NCT00896532|322861764|FG013|Months 48-72: Follow-on Phase|Death|0|||
94294350|NCT00896532|322861765|FG014|Months 48-72: Follow-on Phase|Death|0|||
94294351|NCT00896532|322861766|FG015|Months 48-72: Follow-on Phase|Death|0|||
94294352|NCT00896532|322861767|FG016|Months 48-72: Follow-on Phase|Death|0|||
94294353|NCT00896532|322861768|FG017|Months 48-72: Follow-on Phase|Death|0|||
94294354|NCT00896532|322861769|FG018|Months 48-72: Follow-on Phase|Death|1|||
94294355|NCT00896532|322861770|FG019|Months 48-72: Follow-on Phase|Death|0|||
94294356|NCT00896532|322861771|FG020|Months 48-72: Follow-on Phase|Death|0|||
94294357|NCT00896532|322861772|FG021|Months 48-72: Follow-on Phase|Death|0|||
94294358|NCT00896532|322861773|FG022|Months 48-72: Follow-on Phase|Death|0|||
94294359|NCT00896532|322861751|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294360|NCT00896532|322861752|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294361|NCT00896532|322861753|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294362|NCT00896532|322861754|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294363|NCT00896532|322861755|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294364|NCT00896532|322861756|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294365|NCT00896532|322861757|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294366|NCT00896532|322861758|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294367|NCT00896532|322861759|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294368|NCT00896532|322861760|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294369|NCT00896532|322861761|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294370|NCT00896532|322861762|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294371|NCT00896532|322861763|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294372|NCT00896532|322861764|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294373|NCT00896532|322861765|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294374|NCT00896532|322861766|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294375|NCT00896532|322861767|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294376|NCT00896532|322861768|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294377|NCT00896532|322861769|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294378|NCT00896532|322861770|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294379|NCT00896532|322861771|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294380|NCT00896532|322861772|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
94294381|NCT00896532|322861773|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
94294382|NCT00896532|322861751|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294383|NCT00896532|322861752|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294384|NCT00896532|322861753|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294385|NCT00896532|322861754|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294386|NCT00896532|322861755|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294387|NCT00896532|322861756|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294388|NCT00896532|322861757|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294389|NCT00896532|322861758|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294390|NCT00896532|322861759|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294391|NCT00896532|322861760|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294392|NCT00896532|322861761|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294393|NCT00896532|322861762|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294394|NCT00896532|322861763|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294395|NCT00896532|322861764|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294396|NCT00896532|322861765|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294397|NCT00896532|322861766|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294398|NCT00896532|322861767|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294399|NCT00896532|322861768|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294400|NCT00896532|322861769|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294401|NCT00896532|322861770|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294402|NCT00896532|322861771|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294403|NCT00896532|322861772|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
94294404|NCT00896532|322861773|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
94294405|NCT02411747|322861774|FG000|Overall Study|Withdrawal by Subject|1|||
94294406|NCT02411747|322861775|FG001|Overall Study|Withdrawal by Subject|0|||
94294407|NCT02411747|322861774|FG000|Overall Study|Protocol Violation|2|||
94294408|NCT02411747|322861775|FG001|Overall Study|Protocol Violation|4|||
94294409|NCT01245673|322861776|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
94294410|NCT01237951|322861777|FG000|Overall Study|Death|1|||
94294411|NCT03946449|322861778|FG000|Treatment Extension II|Rolled over to another study|0|||
94294412|NCT03946449|322861779|FG001|Treatment Extension II|Rolled over to another study|0|||
94294413|NCT03946449|322861780|FG002|Treatment Extension II|Rolled over to another study|2|||
94294414|NCT03946449|322861778|FG000|Treatment Extension II|Withdrawal by Subject|0|||
94294415|NCT03946449|322861779|FG001|Treatment Extension II|Withdrawal by Subject|0|||
94294416|NCT03946449|322861780|FG002|Treatment Extension II|Withdrawal by Subject|1|||
94294417|NCT04025632|322863604|FG000|Overall Study|Adverse Event|1|||
94294418|NCT04025632|322863605|FG001|Overall Study|Adverse Event|1|||
94294419|NCT04025632|322863604|FG000|Overall Study|Withdrawal by Subject|1|||
94294420|NCT04025632|322863605|FG001|Overall Study|Withdrawal by Subject|1|||
94294421|NCT04025632|322863604|FG000|Overall Study|Study Terminated by Sponsor|10|||
94294422|NCT04025632|322863605|FG001|Overall Study|Study Terminated by Sponsor|9|||
94294423|NCT04025632|322863604|FG000|Overall Study|Physician Decision|3|||
94294424|NCT04025632|322863605|FG001|Overall Study|Physician Decision|1|||
94294425|NCT00200057|322863608|FG000|Overall Study|Lack of Efficacy|3|||
94294426|NCT00200057|322863608|FG000|Overall Study|Exited due to terminal illness of PI|2|||
94294427|NCT00200057|322863608|FG000|Overall Study|Withdrawal by Subject|1|||
94294428|NCT00200057|322863608|FG000|Overall Study|Change in medical condition|1|||
94294429|NCT00200057|322863608|FG000|Overall Study|Infection|1|||
94294430|NCT00200057|322863608|FG000|Overall Study|Death|1|||
94294431|NCT01059448|322863610|FG000|Overall Study|Adverse Event|1|||
94294432|NCT01059448|322863611|FG001|Overall Study|Adverse Event|3|||
94294433|NCT01059448|322863612|FG002|Overall Study|Adverse Event|0|||
94294434|NCT01059448|322863613|FG003|Overall Study|Adverse Event|1|||
94294435|NCT01059448|322863610|FG000|Overall Study|Withdrawal by Subject|2|||
94294436|NCT01059448|322863611|FG001|Overall Study|Withdrawal by Subject|0|||
94294437|NCT01059448|322863612|FG002|Overall Study|Withdrawal by Subject|2|||
94294438|NCT01059448|322863613|FG003|Overall Study|Withdrawal by Subject|4|||
94294439|NCT01059448|322863610|FG000|Overall Study|Disease Progression|2|||
94294440|NCT01059448|322863611|FG001|Overall Study|Disease Progression|1|||
94294441|NCT01059448|322863612|FG002|Overall Study|Disease Progression|4|||
94294442|NCT01059448|322863613|FG003|Overall Study|Disease Progression|2|||
94294443|NCT01059448|322863610|FG000|Overall Study|Administrative Decision|43|||
94294444|NCT01059448|322863611|FG001|Overall Study|Administrative Decision|49|||
94294445|NCT01059448|322863612|FG002|Overall Study|Administrative Decision|45|||
94294446|NCT01059448|322863613|FG003|Overall Study|Administrative Decision|46|||
94294447|NCT01059448|322863610|FG000|Overall Study|Lost to Follow-up|0|||
94294448|NCT01059448|322863611|FG001|Overall Study|Lost to Follow-up|0|||
94294449|NCT01059448|322863612|FG002|Overall Study|Lost to Follow-up|2|||
94294450|NCT01059448|322863613|FG003|Overall Study|Lost to Follow-up|0|||
94294451|NCT01059448|322863610|FG000|Overall Study|Death|0|||
94294452|NCT01059448|322863611|FG001|Overall Study|Death|1|||
94294453|NCT01059448|322863612|FG002|Overall Study|Death|0|||
94294454|NCT01059448|322863613|FG003|Overall Study|Death|0|||
94294455|NCT01059448|322863610|FG000|Overall Study|Other|1|||
94294456|NCT01059448|322863611|FG001|Overall Study|Other|1|||
94294457|NCT01059448|322863612|FG002|Overall Study|Other|0|||
94294458|NCT01059448|322863613|FG003|Overall Study|Other|1|||
94294459|NCT00778830|322863614|FG000|Overall Study|Ongoing at data cut-off|0|||
94294460|NCT00778830|322863615|FG001|Overall Study|Ongoing at data cut-off|1|||
94294461|NCT02338843|322863616|FG000|Overall Study|Adverse Event|2|||
94294462|NCT02338843|322863617|FG001|Overall Study|Adverse Event|1|||
94294463|NCT02338843|322863616|FG000|Overall Study|Death|40|||
94294464|NCT02338843|322863617|FG001|Overall Study|Death|53|||
94294465|NCT02338843|322863616|FG000|Overall Study|Physician Decision|1|||
94294466|NCT02338843|322863617|FG001|Overall Study|Physician Decision|0|||
94294467|NCT02338843|322863616|FG000|Overall Study|Withdrawal by Subject|0|||
94294468|NCT02338843|322863617|FG001|Overall Study|Withdrawal by Subject|2|||
94294469|NCT02338843|322863616|FG000|Overall Study|Subject Recovered|0|||
94294470|NCT02338843|322863617|FG001|Overall Study|Subject Recovered|2|||
94294471|NCT02338843|322863616|FG000|Overall Study|Discontinued prior to randomizat|1|||
94294472|NCT02338843|322863617|FG001|Overall Study|Discontinued prior to randomizat|0|||
94294473|NCT02591615|322863618|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
94294474|NCT02591615|322863619|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
94294475|NCT02591615|322863620|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
94294476|NCT02591615|322863621|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
94294477|NCT02591615|322863618|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
94294478|NCT02591615|322863619|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
94294479|NCT02591615|322863620|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
94294480|NCT02591615|322863621|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
94294481|NCT02591615|322863618|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
94294482|NCT02591615|322863619|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
94294483|NCT02591615|322863620|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
94294484|NCT02591615|322863621|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
94294485|NCT02591615|322863618|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
94294486|NCT02591615|322863619|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
94294487|NCT02591615|322863620|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
94294488|NCT02591615|322863621|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
94294489|NCT02591615|322863618|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
94294490|NCT02591615|322863619|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
94294491|NCT02591615|322863620|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
94294492|NCT02591615|322863621|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
94294493|NCT02591615|322863618|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
94294494|NCT02591615|322863619|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
94294495|NCT02591615|322863620|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
94294496|NCT02591615|322863621|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
94294497|NCT02591615|322863618|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
94294498|NCT02591615|322863619|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
94294499|NCT02591615|322863620|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
94294500|NCT02591615|322863621|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
94294501|NCT02591615|322863618|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
94294502|NCT02591615|322863619|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
94294503|NCT02591615|322863620|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
94294504|NCT02591615|322863621|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
94294505|NCT02591615|322863618|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
94294506|NCT02591615|322863619|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
94294507|NCT02591615|322863620|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
94294508|NCT02591615|322863621|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
94294509|NCT02591615|322863618|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
94294510|NCT02591615|322863619|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
94294511|NCT02591615|322863620|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
94294512|NCT02591615|322863621|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
94294513|NCT02591615|322863618|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
94294514|NCT02591615|322863619|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
94294515|NCT02591615|322863620|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
94294516|NCT02591615|322863621|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
94294517|NCT02591615|322863618|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
94294518|NCT02591615|322863619|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
94294519|NCT02591615|322863620|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
94294520|NCT02591615|322863621|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
94294521|NCT02591615|322863618|FG000|Maintenance MK-3475|Adverse Event|0|||
94294522|NCT02591615|322863619|FG001|Maintenance MK-3475|Adverse Event|3|||
94294523|NCT02591615|322863620|FG002|Maintenance MK-3475|Adverse Event|1|||
94294524|NCT02591615|322863621|FG003|Maintenance MK-3475|Adverse Event|2|||
94294525|NCT02591615|322863618|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
94294526|NCT02591615|322863619|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
94294527|NCT02591615|322863620|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
94294528|NCT02591615|322863621|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
94294529|NCT02591615|322863618|FG000|Maintenance MK-3475|Death|0|||
94294530|NCT02591615|322863619|FG001|Maintenance MK-3475|Death|1|||
94294531|NCT02591615|322863620|FG002|Maintenance MK-3475|Death|1|||
94294532|NCT02591615|322863621|FG003|Maintenance MK-3475|Death|0|||
94294533|NCT02591615|322863618|FG000|Maintenance MK-3475|Physician discretion|0|||
94294534|NCT02591615|322863619|FG001|Maintenance MK-3475|Physician discretion|0|||
94294535|NCT02591615|322863620|FG002|Maintenance MK-3475|Physician discretion|1|||
94294536|NCT02591615|322863621|FG003|Maintenance MK-3475|Physician discretion|0|||
94294537|NCT02591615|322863618|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
94294538|NCT02591615|322863619|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
94294539|NCT02591615|322863620|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
94294540|NCT02591615|322863621|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
94294541|NCT02591615|322863618|FG000|Maintenance MK-3475|In active treatment|2|||
94294542|NCT02591615|322863619|FG001|Maintenance MK-3475|In active treatment|0|||
94294543|NCT02591615|322863620|FG002|Maintenance MK-3475|In active treatment|0|||
94294544|NCT02591615|322863621|FG003|Maintenance MK-3475|In active treatment|1|||
94294545|NCT02911688|322863624|FG000|Washout|Lost to Follow-up|1|||
94294546|NCT02911688|322863625|FG001|Washout|Lost to Follow-up|1|||
94294547|NCT02911688|322863624|FG000|Washout|Withdrawal by Subject|0|||
94294548|NCT02911688|322863625|FG001|Washout|Withdrawal by Subject|1|||
94294549|NCT00809328|322863628|FG000|Overall Study|Lack of Efficacy|18|||
94294550|NCT00809328|322863628|FG000|Overall Study|Adverse Event|6|||
94294551|NCT00809328|322863628|FG000|Overall Study|Protocol Violation|3|||
94294552|NCT00809328|322863628|FG000|Overall Study|Withdrawal by Subject|2|||
94294553|NCT00282243|322863633|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
94294554|NCT00282243|322863633|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
94294555|NCT00282243|322863633|FG000|Extension Treatment Period|Adverse Event|15|||
94294556|NCT00282243|322863633|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
94294557|NCT00282243|322863633|FG000|Extension Treatment Period|Non-compliance|2|||
94294558|NCT00282243|322863633|FG000|Extension Treatment Period|Physician Decision|1|||
94294559|NCT00851903|322863634|FG000|Overall Study|Withdrawal by Subject|2|||
94294560|NCT00270894|322863635|FG000|Overall Study|Adverse Event|1|||
94294561|NCT00270894|322863635|FG000|Overall Study|Withdrawal by Subject|1|||
94294562|NCT03116113|322863646|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
94294563|NCT03116113|322863647|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
94294564|NCT03116113|322863648|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
94294565|NCT03116113|322863649|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
94294566|NCT03116113|322863650|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
94294567|NCT03116113|322863651|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
94294568|NCT03116113|322863652|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
94294569|NCT03116113|322863653|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
94294570|NCT03116113|322863654|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
94294571|NCT01552902|322863655|FG000|Overall Study|Adverse Event|1|||
94294572|NCT01552902|322863656|FG001|Overall Study|Adverse Event|15|||
94294573|NCT01552902|322863657|FG002|Overall Study|Adverse Event|14|||
94294574|NCT01552902|322863655|FG000|Overall Study|Protocol Violation|3|||
94294575|NCT01552902|322863656|FG001|Overall Study|Protocol Violation|3|||
94294576|NCT01552902|322863657|FG002|Overall Study|Protocol Violation|3|||
94294577|NCT01552902|322863655|FG000|Overall Study|Lack of Efficacy|4|||
94294578|NCT01552902|322863656|FG001|Overall Study|Lack of Efficacy|3|||
94294579|NCT01552902|322863657|FG002|Overall Study|Lack of Efficacy|1|||
94294580|NCT01552902|322863655|FG000|Overall Study|Withdrawal by Subject|1|||
94294581|NCT01552902|322863656|FG001|Overall Study|Withdrawal by Subject|9|||
94294582|NCT01552902|322863657|FG002|Overall Study|Withdrawal by Subject|6|||
94294583|NCT01552902|322863655|FG000|Overall Study|Lost to Follow-up|1|||
94294584|NCT01552902|322863656|FG001|Overall Study|Lost to Follow-up|3|||
94294585|NCT01552902|322863657|FG002|Overall Study|Lost to Follow-up|6|||
94294586|NCT01552902|322863655|FG000|Overall Study|Other|3|||
94294587|NCT01552902|322863656|FG001|Overall Study|Other|4|||
94294588|NCT01552902|322863657|FG002|Overall Study|Other|3|||
94294589|NCT01254669|322863659|FG000|Overall Study|Withdrawal by Subject|0|||
94294590|NCT01254669|322863660|FG001|Overall Study|Withdrawal by Subject|1|||
94294591|NCT01254669|322863659|FG000|Overall Study|time constraint|2|||
94294592|NCT01254669|322863660|FG001|Overall Study|time constraint|2|||
94294593|NCT01254669|322863659|FG000|Overall Study|called to clinic during intervention|1|||
94294594|NCT01254669|322863660|FG001|Overall Study|called to clinic during intervention|1|||
94294595|NCT00600171|322863661|FG000|Overall Study|Adverse Event|0|||
94294596|NCT00600171|322863662|FG001|Overall Study|Adverse Event|1|||
94294597|NCT00600171|322863663|FG002|Overall Study|Adverse Event|0|||
94294598|NCT00600171|322863664|FG003|Overall Study|Adverse Event|0|||
94294599|NCT00600171|322863665|FG004|Overall Study|Adverse Event|1|||
94294600|NCT00600171|322863666|FG005|Overall Study|Adverse Event|0|||
94294601|NCT00600171|322863661|FG000|Overall Study|Lack of Efficacy|9|||
94294602|NCT00600171|322863662|FG001|Overall Study|Lack of Efficacy|12|||
94294603|NCT00600171|322863663|FG002|Overall Study|Lack of Efficacy|3|||
94294604|NCT00600171|322863664|FG003|Overall Study|Lack of Efficacy|5|||
94294605|NCT00600171|322863665|FG004|Overall Study|Lack of Efficacy|4|||
94294606|NCT00600171|322863666|FG005|Overall Study|Lack of Efficacy|0|||
94294607|NCT00600171|322863661|FG000|Overall Study|Protocol Violation|1|||
94294608|NCT00600171|322863662|FG001|Overall Study|Protocol Violation|2|||
94294609|NCT00600171|322863663|FG002|Overall Study|Protocol Violation|0|||
94294610|NCT00600171|322863664|FG003|Overall Study|Protocol Violation|1|||
94294611|NCT00600171|322863665|FG004|Overall Study|Protocol Violation|0|||
94294612|NCT00600171|322863666|FG005|Overall Study|Protocol Violation|0|||
94294613|NCT00600171|322863661|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
94294614|NCT00600171|322863662|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
94294615|NCT00600171|322863663|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
94294616|NCT00600171|322863664|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
94294617|NCT00600171|322863665|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
94294618|NCT00600171|322863666|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
94294619|NCT00600171|322863661|FG000|Overall Study|Withdrawal by Subject|3|||
94294620|NCT00600171|322863662|FG001|Overall Study|Withdrawal by Subject|0|||
94294621|NCT00600171|322863663|FG002|Overall Study|Withdrawal by Subject|0|||
94294622|NCT00600171|322863664|FG003|Overall Study|Withdrawal by Subject|1|||
94294623|NCT00600171|322863665|FG004|Overall Study|Withdrawal by Subject|1|||
94294624|NCT00600171|322863666|FG005|Overall Study|Withdrawal by Subject|1|||
94294625|NCT00600171|322863661|FG000|Overall Study|Physician Decision|0|||
94294626|NCT00600171|322863662|FG001|Overall Study|Physician Decision|1|||
94294627|NCT00600171|322863663|FG002|Overall Study|Physician Decision|0|||
94294628|NCT00600171|322863664|FG003|Overall Study|Physician Decision|1|||
94294629|NCT00600171|322863665|FG004|Overall Study|Physician Decision|0|||
94294630|NCT00600171|322863666|FG005|Overall Study|Physician Decision|2|||
94294631|NCT00600171|322863661|FG000|Overall Study|Lost to Follow-up|0|||
94294632|NCT00600171|322863662|FG001|Overall Study|Lost to Follow-up|0|||
94294633|NCT00600171|322863663|FG002|Overall Study|Lost to Follow-up|0|||
94294634|NCT00600171|322863664|FG003|Overall Study|Lost to Follow-up|1|||
94294635|NCT00600171|322863665|FG004|Overall Study|Lost to Follow-up|0|||
94294636|NCT00600171|322863666|FG005|Overall Study|Lost to Follow-up|0|||
94294637|NCT00393718|322863677|FG000|Overall Study|Adverse Event|20|||
94294638|NCT00393718|322863678|FG001|Overall Study|Adverse Event|8|||
94294639|NCT00393718|322863677|FG000|Overall Study|Protocol Violation|1|||
94294640|NCT00393718|322863678|FG001|Overall Study|Protocol Violation|2|||
94294641|NCT00393718|322863677|FG000|Overall Study|Lack of Efficacy|10|||
94294642|NCT00393718|322863678|FG001|Overall Study|Lack of Efficacy|9|||
94294643|NCT00393718|322863677|FG000|Overall Study|Hypoglycaemia|3|||
94294644|NCT00393718|322863678|FG001|Overall Study|Hypoglycaemia|2|||
94294645|NCT00393718|322863677|FG000|Overall Study|Subject decision|5|||
94294646|NCT00393718|322863678|FG001|Overall Study|Subject decision|0|||
94294647|NCT00393718|322863677|FG000|Overall Study|Withdrawal of consent|2|||
94294648|NCT00393718|322863678|FG001|Overall Study|Withdrawal of consent|1|||
94294649|NCT00393718|322863677|FG000|Overall Study|Missed measurement|1|||
94294650|NCT00393718|322863678|FG001|Overall Study|Missed measurement|0|||
94294651|NCT00393718|322863677|FG000|Overall Study|Move|1|||
94294652|NCT00393718|322863678|FG001|Overall Study|Move|0|||
94294653|NCT00883493|322863679|FG000|Overall Study|Adverse Event|11|||
94294654|NCT00883493|322863680|FG001|Overall Study|Adverse Event|12|||
94294655|NCT00883493|322863679|FG000|Overall Study|Lack of Efficacy|4|||
94294656|NCT00883493|322863680|FG001|Overall Study|Lack of Efficacy|3|||
94294657|NCT00883493|322863679|FG000|Overall Study|Lost to Follow-up|7|||
94294658|NCT00883493|322863680|FG001|Overall Study|Lost to Follow-up|6|||
94294659|NCT00883493|322863679|FG000|Overall Study|Withdrawal by Subject|11|||
94294660|NCT00883493|322863680|FG001|Overall Study|Withdrawal by Subject|20|||
94294661|NCT00883493|322863679|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
94294662|NCT00883493|322863680|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
94294663|NCT00883493|322863679|FG000|Overall Study|Study specific disc. criteria|2|||
94294664|NCT00883493|322863680|FG001|Overall Study|Study specific disc. criteria|0|||
94294665|NCT00883493|322863679|FG000|Overall Study|Other|5|||
94294666|NCT00883493|322863680|FG001|Overall Study|Other|3|||
94294667|NCT05019131|322863682|FG000|Overall Study|Lost to Follow-up|0|||
94294668|NCT05019131|322863683|FG001|Overall Study|Lost to Follow-up|3|||
94294669|NCT03902080|322863684|FG000|Overall Study|Adverse Event|17|||
94294670|NCT03902080|322863685|FG001|Overall Study|Adverse Event|15|||
94294671|NCT03902080|322863684|FG000|Overall Study|Withdrawal by Subject|28|||
94294672|NCT03902080|322863685|FG001|Overall Study|Withdrawal by Subject|35|||
94294673|NCT03902080|322863684|FG000|Overall Study|Lost to Follow-up|6|||
94294674|NCT03902080|322863685|FG001|Overall Study|Lost to Follow-up|7|||
94294675|NCT03902080|322863684|FG000|Overall Study|Other|3|||
94294676|NCT03902080|322863685|FG001|Overall Study|Other|5|||
94294677|NCT03902080|322863684|FG000|Overall Study|Non compliance|4|||
94294678|NCT03902080|322863685|FG001|Overall Study|Non compliance|3|||
94294679|NCT03902080|322863684|FG000|Overall Study|Physician Decision|5|||
94294680|NCT03902080|322863685|FG001|Overall Study|Physician Decision|1|||
94294681|NCT03902080|322863684|FG000|Overall Study|Protocol Violation|3|||
94294682|NCT03902080|322863685|FG001|Overall Study|Protocol Violation|3|||
94294683|NCT03902080|322863684|FG000|Overall Study|Lack of Efficacy|1|||
94294684|NCT03902080|322863685|FG001|Overall Study|Lack of Efficacy|3|||
94294685|NCT03902080|322863684|FG000|Overall Study|Withdrawn prior to dosing|0|||
94294686|NCT03902080|322863685|FG001|Overall Study|Withdrawn prior to dosing|1|||
94294687|NCT00603239|322863690|FG000|Overall Study|Adverse Event|4|||
94294688|NCT00603239|322863691|FG001|Overall Study|Adverse Event|1|||
94294689|NCT00603239|322863690|FG000|Overall Study|Entry criteria not met|0|||
94294690|NCT00603239|322863691|FG001|Overall Study|Entry criteria not met|1|||
94294691|NCT00603239|322863690|FG000|Overall Study|Loss of glucose control|3|||
94294692|NCT00603239|322863691|FG001|Overall Study|Loss of glucose control|0|||
94294693|NCT00603239|322863690|FG000|Overall Study|Lost to Follow-up|2|||
94294694|NCT00603239|322863691|FG001|Overall Study|Lost to Follow-up|1|||
94294695|NCT00603239|322863690|FG000|Overall Study|Physician Decision|2|||
94294696|NCT00603239|322863691|FG001|Overall Study|Physician Decision|0|||
94294697|NCT00603239|322863690|FG000|Overall Study|Protocol Violation|2|||
94294698|NCT00603239|322863691|FG001|Overall Study|Protocol Violation|0|||
94294699|NCT00603239|322863690|FG000|Overall Study|Subject decision|2|||
94294700|NCT00603239|322863691|FG001|Overall Study|Subject decision|1|||
94294701|NCT02357420|322863694|FG000|Overall Study|Adverse Event|3|||
94294702|NCT02357420|322863695|FG001|Overall Study|Adverse Event|3|||
94294703|NCT02357420|322863696|FG002|Overall Study|Adverse Event|8|||
94294704|NCT02357420|322863697|FG003|Overall Study|Adverse Event|9|||
94294705|NCT02357420|322863694|FG000|Overall Study|Investigator Decision|1|||
94294706|NCT02357420|322863695|FG001|Overall Study|Investigator Decision|0|||
94294707|NCT02357420|322863696|FG002|Overall Study|Investigator Decision|0|||
94294708|NCT02357420|322863697|FG003|Overall Study|Investigator Decision|0|||
94294709|NCT02357420|322863694|FG000|Overall Study|Prohibited Medication|1|||
94294710|NCT02357420|322863695|FG001|Overall Study|Prohibited Medication|1|||
94294711|NCT02357420|322863696|FG002|Overall Study|Prohibited Medication|0|||
94294712|NCT02357420|322863697|FG003|Overall Study|Prohibited Medication|0|||
94294713|NCT02357420|322863694|FG000|Overall Study|Protocol Non-compliance|0|||
94294714|NCT02357420|322863695|FG001|Overall Study|Protocol Non-compliance|0|||
94294715|NCT02357420|322863696|FG002|Overall Study|Protocol Non-compliance|0|||
94294716|NCT02357420|322863697|FG003|Overall Study|Protocol Non-compliance|1|||
94294717|NCT02357420|322863694|FG000|Overall Study|Withdrawn Consent|4|||
94294718|NCT02357420|322863695|FG001|Overall Study|Withdrawn Consent|8|||
94294719|NCT02357420|322863696|FG002|Overall Study|Withdrawn Consent|6|||
94294720|NCT02357420|322863697|FG003|Overall Study|Withdrawn Consent|6|||
94294721|NCT02357420|322863694|FG000|Overall Study|Lost to Follow-up|3|||
94294722|NCT02357420|322863695|FG001|Overall Study|Lost to Follow-up|0|||
94294723|NCT02357420|322863696|FG002|Overall Study|Lost to Follow-up|2|||
94294724|NCT02357420|322863697|FG003|Overall Study|Lost to Follow-up|3|||
94294725|NCT01874353|322863698|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
94294726|NCT01874353|322863699|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
94294727|NCT01874353|322863700|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
94294728|NCT01874353|322863701|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
94294729|NCT01874353|322863698|FG000|Overall Study|Lost to Follow-up|2|||
94294730|NCT01874353|322863699|FG001|Overall Study|Lost to Follow-up|2|||
94294731|NCT01874353|322863700|FG002|Overall Study|Lost to Follow-up|2|||
94294732|NCT01874353|322863701|FG003|Overall Study|Lost to Follow-up|0|||
94294733|NCT01874353|322863698|FG000|Overall Study|Death|110|||
94294734|NCT01874353|322863699|FG001|Overall Study|Death|60|||
94294735|NCT01874353|322863700|FG002|Overall Study|Death|13|||
94294736|NCT01874353|322863701|FG003|Overall Study|Death|7|||
94294737|NCT01874353|322863698|FG000|Overall Study|Withdrawal by Subject|13|||
94294738|NCT01874353|322863699|FG001|Overall Study|Withdrawal by Subject|11|||
94294739|NCT01874353|322863700|FG002|Overall Study|Withdrawal by Subject|0|||
94294740|NCT01874353|322863701|FG003|Overall Study|Withdrawal by Subject|0|||
94294741|NCT00862251|322863702|FG000|Overall Study|Adverse Event|8|||
94294742|NCT00862251|322863703|FG001|Overall Study|Adverse Event|3|||
94294743|NCT00862251|322863704|FG002|Overall Study|Adverse Event|1|||
94294744|NCT00862251|322863702|FG000|Overall Study|Lost to Follow-up|0|||
94294745|NCT00862251|322863703|FG001|Overall Study|Lost to Follow-up|0|||
94294746|NCT00862251|322863704|FG002|Overall Study|Lost to Follow-up|1|||
94294747|NCT00862251|322863702|FG000|Overall Study|Protocol Violation|2|||
94294748|NCT00862251|322863703|FG001|Overall Study|Protocol Violation|0|||
94294749|NCT00862251|322863704|FG002|Overall Study|Protocol Violation|1|||
94294750|NCT00862251|322863702|FG000|Overall Study|Withdrawal by Subject|9|||
94294751|NCT00862251|322863703|FG001|Overall Study|Withdrawal by Subject|2|||
94294752|NCT00862251|322863704|FG002|Overall Study|Withdrawal by Subject|6|||
94294753|NCT03486392|322863705|FG000|Overall Study|Lost to Follow-up|0|||
94294754|NCT03486392|322863706|FG001|Overall Study|Lost to Follow-up|0|||
94294755|NCT03486392|322863707|FG002|Overall Study|Lost to Follow-up|8|||
94294756|NCT03486392|322863708|FG003|Overall Study|Lost to Follow-up|5|||
94294757|NCT03486392|322863709|FG004|Overall Study|Lost to Follow-up|2|||
94294758|NCT03486392|322863705|FG000|Overall Study|Withdrawal by Subject|3|||
94294759|NCT03486392|322863706|FG001|Overall Study|Withdrawal by Subject|0|||
94294760|NCT03486392|322863707|FG002|Overall Study|Withdrawal by Subject|6|||
94294761|NCT03486392|322863708|FG003|Overall Study|Withdrawal by Subject|4|||
94294762|NCT03486392|322863709|FG004|Overall Study|Withdrawal by Subject|1|||
94294763|NCT03486392|322863705|FG000|Overall Study|Death|0|||
94294764|NCT03486392|322863706|FG001|Overall Study|Death|0|||
94294765|NCT03486392|322863707|FG002|Overall Study|Death|0|||
94294766|NCT03486392|322863708|FG003|Overall Study|Death|0|||
94294767|NCT03486392|322863709|FG004|Overall Study|Death|1|||
94294768|NCT02347631|322863710|FG000|First Intervention (2 Months)|Adverse Event|1|||
94294769|NCT02347631|322863711|FG001|First Intervention (2 Months)|Adverse Event|1|||
94294770|NCT02347631|322863710|FG000|First Intervention (2 Months)|Pregnancy|1|||
94294771|NCT02347631|322863711|FG001|First Intervention (2 Months)|Pregnancy|0|||
94294772|NCT02347631|322863710|FG000|First Intervention (2 Months)|Moved out of area|0|||
94294773|NCT02347631|322863711|FG001|First Intervention (2 Months)|Moved out of area|2|||
94294774|NCT02347631|322863710|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
94294775|NCT02347631|322863711|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
94294776|NCT02347631|322863710|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
94294777|NCT02347631|322863711|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
94294778|NCT02347631|322863710|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
94294779|NCT02347631|322863711|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
94294780|NCT02347631|322863710|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
94294781|NCT02347631|322863711|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
94294782|NCT02347631|322863710|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
94294783|NCT02347631|322863711|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
94294784|NCT00934102|322863712|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
94294785|NCT00934102|322863713|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
94294786|NCT00934102|322863714|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
94294787|NCT02304926|322863715|FG000|Overall Study|Lost to Follow-up|2|||
94294788|NCT02304926|322863716|FG001|Overall Study|Lost to Follow-up|1|||
94294789|NCT01015833|322863719|FG000|Overall Study|Death|1|||
94294790|NCT01015833|322863720|FG001|Overall Study|Death|0|||
94294791|NCT01015833|322863719|FG000|Overall Study|Withdrawal by Subject|3|||
94294792|NCT01015833|322863720|FG001|Overall Study|Withdrawal by Subject|2|||
94294793|NCT01015833|322863719|FG000|Overall Study|Adverse Event|0|||
94294794|NCT01015833|322863720|FG001|Overall Study|Adverse Event|1|||
94294795|NCT01015833|322863719|FG000|Overall Study|Physician Decision|2|||
94294796|NCT01015833|322863720|FG001|Overall Study|Physician Decision|0|||
94294797|NCT01015833|322863719|FG000|Overall Study|Symptomatic deterioration|0|||
94294798|NCT01015833|322863720|FG001|Overall Study|Symptomatic deterioration|1|||
94294799|NCT01015833|322863719|FG000|Overall Study|Other|5|||
94294800|NCT01015833|322863720|FG001|Overall Study|Other|1|||
94294801|NCT01015833|322863719|FG000|Overall Study|Motor Vehicle Accidents|1|||
94294802|NCT01015833|322863720|FG001|Overall Study|Motor Vehicle Accidents|0|||
94294803|NCT01015833|322863719|FG000|Overall Study|Did not start treatment|1|||
94294804|NCT01015833|322863720|FG001|Overall Study|Did not start treatment|0|||
94294805|NCT01709331|322863722|FG000|Overall Study|Adverse Event|1|||
94294806|NCT02959814|322863725|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
94294807|NCT02959814|322863725|FG000|Overall Study|Excluded based on anatomical criteria|2|||
94294808|NCT02959814|322863725|FG000|Overall Study|Protocol Violation|7|||
94294809|NCT02959814|322863725|FG000|Overall Study|FFR not measured|2|||
94294810|NCT02959814|322863725|FG000|Overall Study|In-procedure QFR not computed|6|||
94294811|NCT02959814|322863725|FG000|Overall Study|Excluded by FFR core-lab|24|||
94294812|NCT02495948|322863728|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
94294813|NCT02495948|322863729|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
94294814|NCT02495948|322863728|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
94294815|NCT02495948|322863729|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
94294816|NCT01444300|322863731|FG000|Overall Study|Adverse Event|4|||
94294817|NCT01444300|322863732|FG001|Overall Study|Adverse Event|0|||
94294818|NCT00490542|322863733|FG000|Overall Study|Lost to Follow-up|3|||
94294819|NCT00490542|322863734|FG001|Overall Study|Lost to Follow-up|0|||
94294820|NCT00490542|322863733|FG000|Overall Study|Adverse Event|3|||
94294821|NCT00490542|322863734|FG001|Overall Study|Adverse Event|3|||
94294822|NCT00490542|322863733|FG000|Overall Study|Lack of Efficacy|1|||
94294823|NCT00490542|322863734|FG001|Overall Study|Lack of Efficacy|1|||
94294824|NCT04696861|322863735|FG000|Overall Study|Death|1|||
94294825|NCT04696861|322863736|FG001|Overall Study|Death|0|||
94294826|NCT04696861|322863735|FG000|Overall Study|Lost to Follow-up|3|||
94294827|NCT04696861|322863736|FG001|Overall Study|Lost to Follow-up|0|||
94294828|NCT03952559|322863737|FG000|Double Blind Treatment Period|Adverse Event|0|||
94294829|NCT03952559|322863738|FG001|Double Blind Treatment Period|Adverse Event|2|||
94294830|NCT03952559|322863739|FG002|Double Blind Treatment Period|Adverse Event|1|||
94294831|NCT03952559|322863740|FG003|Double Blind Treatment Period|Adverse Event|0|||
94294832|NCT03952559|322863741|FG004|Double Blind Treatment Period|Adverse Event|1|||
94294833|NCT03952559|322863737|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
94294834|NCT03952559|322863738|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
94294835|NCT03952559|322863739|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
94294836|NCT03952559|322863740|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
94294837|NCT03952559|322863741|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
94294838|NCT03952559|322863737|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
94294839|NCT03952559|322863738|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
94294840|NCT03952559|322863739|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
94294841|NCT03952559|322863740|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
94294842|NCT03952559|322863741|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
94294843|NCT03952559|322863737|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
94294844|NCT03952559|322863738|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
94294845|NCT03952559|322863739|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
94294846|NCT03952559|322863740|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
94294847|NCT03952559|322863741|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
94294848|NCT01565980|322863744|FG000|Overall Study|Death|1|||
94294849|NCT01565980|322863745|FG001|Overall Study|Death|0|||
94294850|NCT01565980|322863744|FG000|Overall Study|Lost to Follow-up|1|||
94294851|NCT01565980|322863745|FG001|Overall Study|Lost to Follow-up|0|||
94294852|NCT01565980|322863744|FG000|Overall Study|health complications|1|||
94294853|NCT01565980|322863745|FG001|Overall Study|health complications|1|||
94294854|NCT01565980|322863744|FG000|Overall Study|stopped medical treatment|1|||
94294855|NCT01565980|322863745|FG001|Overall Study|stopped medical treatment|0|||
94294856|NCT01565980|322863744|FG000|Overall Study|Withdrawal by Subject|0|||
94294857|NCT01565980|322863745|FG001|Overall Study|Withdrawal by Subject|3|||
94294858|NCT01929135|322863746|FG000|Overall Study|Lost to Follow-up|1|||
94294859|NCT01929135|322863747|FG001|Overall Study|Lost to Follow-up|1|||
94294860|NCT02382133|322863752|FG000|Overall Study|Death|22|||
94294861|NCT02382133|322863752|FG000|Overall Study|transfer out of ICU|4|||
94294862|NCT02382133|322863752|FG000|Overall Study|Physician Decision|2|||
94294863|NCT02382133|322863752|FG000|Overall Study|arterial catheter loss|4|||
94294864|NCT02382133|322863752|FG000|Overall Study|pressure injury both sites|1|||
94294865|NCT00655928|322863753|FG000|Overall Study|Withdrawal by Subject|2|||
94294866|NCT00655928|322863754|FG001|Overall Study|Withdrawal by Subject|1|||
94294867|NCT00655928|322863753|FG000|Overall Study|Physician Decision|1|||
94294868|NCT00655928|322863754|FG001|Overall Study|Physician Decision|1|||
94294869|NCT03636906|322863755|FG000|Overall Study|Adverse Event|0|||
94294870|NCT03636906|322863756|FG001|Overall Study|Adverse Event|0|||
94294871|NCT03636906|322863757|FG002|Overall Study|Adverse Event|1|||
94294872|NCT03636906|322863755|FG000|Overall Study|Lost to Follow-up|1|||
94294873|NCT03636906|322863756|FG001|Overall Study|Lost to Follow-up|0|||
94294874|NCT03636906|322863757|FG002|Overall Study|Lost to Follow-up|0|||
94294875|NCT03636906|322863755|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
94294876|NCT03636906|322863756|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
94294877|NCT03636906|322863757|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
94294878|NCT03636906|322863755|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
94294879|NCT03636906|322863756|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
94294880|NCT03636906|322863757|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
94294881|NCT03636906|322863755|FG000|Overall Study|Other|0|||
94294882|NCT03636906|322863756|FG001|Overall Study|Other|0|||
94294883|NCT03636906|322863757|FG002|Overall Study|Other|1|||
94294884|NCT00684177|322863759|FG000|Overall Study|Adverse Event|4|||
94294885|NCT00684177|322863760|FG001|Overall Study|Adverse Event|3|||
94294886|NCT00684177|322863759|FG000|Overall Study|Lack of Efficacy|10|||
94294887|NCT00684177|322863760|FG001|Overall Study|Lack of Efficacy|15|||
94294888|NCT00684177|322863759|FG000|Overall Study|Protocol Violation|1|||
94294889|NCT00684177|322863760|FG001|Overall Study|Protocol Violation|0|||
94294890|NCT00684177|322863759|FG000|Overall Study|Lost to Follow-up|2|||
94294891|NCT00684177|322863760|FG001|Overall Study|Lost to Follow-up|1|||
94294892|NCT00684177|322863759|FG000|Overall Study|Physician Decision|2|||
94294893|NCT00684177|322863760|FG001|Overall Study|Physician Decision|0|||
94294894|NCT00684177|322863759|FG000|Overall Study|Withdrawal by Subject|1|||
94294895|NCT00684177|322863760|FG001|Overall Study|Withdrawal by Subject|2|||
94294896|NCT00684177|322863759|FG000|Overall Study|Other|1|||
94294897|NCT00684177|322863760|FG001|Overall Study|Other|2|||
94294898|NCT01371981|322863761|FG000|Overall Study|Adverse Event|12|||
94294899|NCT01371981|322863762|FG001|Overall Study|Adverse Event|17|||
94294900|NCT01371981|322863763|FG002|Overall Study|Adverse Event|0|||
94294901|NCT01371981|322863764|FG003|Overall Study|Adverse Event|4|||
94294902|NCT01371981|322863765|FG004|Overall Study|Adverse Event|1|||
94294903|NCT01371981|322863766|FG005|Overall Study|Adverse Event|0|||
94294904|NCT01371981|322863761|FG000|Overall Study|Death|22|||
94294905|NCT01371981|322863762|FG001|Overall Study|Death|16|||
94294906|NCT01371981|322863763|FG002|Overall Study|Death|0|||
94294907|NCT01371981|322863764|FG003|Overall Study|Death|0|||
94294908|NCT01371981|322863765|FG004|Overall Study|Death|2|||
94294909|NCT01371981|322863766|FG005|Overall Study|Death|2|||
94294910|NCT01371981|322863761|FG000|Overall Study|Lack of Efficacy|69|||
94294911|NCT01371981|322863762|FG001|Overall Study|Lack of Efficacy|61|||
94294912|NCT01371981|322863763|FG002|Overall Study|Lack of Efficacy|4|||
94294913|NCT01371981|322863764|FG003|Overall Study|Lack of Efficacy|8|||
94294914|NCT01371981|322863765|FG004|Overall Study|Lack of Efficacy|5|||
94294915|NCT01371981|322863766|FG005|Overall Study|Lack of Efficacy|0|||
94294916|NCT01371981|322863761|FG000|Overall Study|Physician Decision|48|||
94294917|NCT01371981|322863762|FG001|Overall Study|Physician Decision|63|||
94294918|NCT01371981|322863763|FG002|Overall Study|Physician Decision|1|||
94294919|NCT01371981|322863764|FG003|Overall Study|Physician Decision|7|||
94294920|NCT01371981|322863765|FG004|Overall Study|Physician Decision|14|||
94294921|NCT01371981|322863766|FG005|Overall Study|Physician Decision|3|||
94294922|NCT01371981|322863761|FG000|Overall Study|Withdrawal by Subject|12|||
94294923|NCT01371981|322863762|FG001|Overall Study|Withdrawal by Subject|19|||
94294924|NCT01371981|322863763|FG002|Overall Study|Withdrawal by Subject|1|||
94294925|NCT01371981|322863764|FG003|Overall Study|Withdrawal by Subject|2|||
94294926|NCT01371981|322863765|FG004|Overall Study|Withdrawal by Subject|10|||
94294927|NCT01371981|322863766|FG005|Overall Study|Withdrawal by Subject|3|||
94294928|NCT01371981|322863761|FG000|Overall Study|Ineligible|19|||
94294929|NCT01371981|322863762|FG001|Overall Study|Ineligible|13|||
94294930|NCT01371981|322863763|FG002|Overall Study|Ineligible|0|||
94294931|NCT01371981|322863764|FG003|Overall Study|Ineligible|0|||
94294932|NCT01371981|322863765|FG004|Overall Study|Ineligible|0|||
94294933|NCT01371981|322863766|FG005|Overall Study|Ineligible|4|||
94294934|NCT01371981|322863761|FG000|Overall Study|Did not start treatment|2|||
94294935|NCT01371981|322863762|FG001|Overall Study|Did not start treatment|3|||
94294936|NCT01371981|322863763|FG002|Overall Study|Did not start treatment|0|||
94294937|NCT01371981|322863764|FG003|Overall Study|Did not start treatment|0|||
94294938|NCT01371981|322863765|FG004|Overall Study|Did not start treatment|0|||
94294939|NCT01371981|322863766|FG005|Overall Study|Did not start treatment|2|||
94294940|NCT00376961|322865575|FG000|Initial Registration|Adverse Event|1|||
94294941|NCT00376961|322865576|FG001|Initial Registration|Adverse Event|0|||
94294942|NCT00376961|322865575|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
94294943|NCT00376961|322865576|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
94294944|NCT00376961|322865575|FG000|Initial Registration|Progression/relapse|1|||
94294945|NCT00376961|322865576|FG001|Initial Registration|Progression/relapse|0|||
94294946|NCT00376961|322865575|FG000|Initial Registration|Ineligible|3|||
94294947|NCT00376961|322865576|FG001|Initial Registration|Ineligible|0|||
94294948|NCT00376961|322865575|FG000|Maintenance|Adverse Event|0|||
94294949|NCT00376961|322865576|FG001|Maintenance|Adverse Event|1|||
94294950|NCT00376961|322865575|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
94294951|NCT00376961|322865576|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
94372575|NCT01328054|323150312|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
94372576|NCT01328054|323150311|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
94372577|NCT01328054|323150312|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
94372578|NCT01328054|323150311|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
94294952|NCT00376961|322865575|FG000|Maintenance|Progression/relapse|0|||
94294953|NCT00376961|322865576|FG001|Maintenance|Progression/relapse|18|||
94294954|NCT00376961|322865575|FG000|Maintenance|Ineligible|0|||
94294955|NCT00376961|322865576|FG001|Maintenance|Ineligible|3|||
94294956|NCT00618722|322865577|FG000|Overall Study|Refusal of Treatment|0|||
94294957|NCT00618722|322865578|FG001|Overall Study|Refusal of Treatment|0|||
94294958|NCT00618722|322865579|FG002|Overall Study|Refusal of Treatment|1|||
94294959|NCT00618722|322865580|FG003|Overall Study|Refusal of Treatment|0|||
94294960|NCT00618722|322865577|FG000|Overall Study|Patient Request|1|||
94294961|NCT00618722|322865578|FG001|Overall Study|Patient Request|1|||
94294962|NCT00618722|322865579|FG002|Overall Study|Patient Request|1|||
94294963|NCT00618722|322865580|FG003|Overall Study|Patient Request|1|||
94294964|NCT00618722|322865577|FG000|Overall Study|Inability to Complete Study Procedure|0|||
94294965|NCT00618722|322865578|FG001|Overall Study|Inability to Complete Study Procedure|1|||
94294966|NCT00618722|322865579|FG002|Overall Study|Inability to Complete Study Procedure|0|||
94294967|NCT00618722|322865580|FG003|Overall Study|Inability to Complete Study Procedure|0|||
94294968|NCT00618722|322865577|FG000|Overall Study|Lost to Follow-up|2|||
94294969|NCT00618722|322865578|FG001|Overall Study|Lost to Follow-up|0|||
94294970|NCT00618722|322865579|FG002|Overall Study|Lost to Follow-up|0|||
94294971|NCT00618722|322865580|FG003|Overall Study|Lost to Follow-up|2|||
94294972|NCT00618722|322865577|FG000|Overall Study|Miscellaneous Reasons|0|||
94294973|NCT00618722|322865578|FG001|Overall Study|Miscellaneous Reasons|0|||
94294974|NCT00618722|322865579|FG002|Overall Study|Miscellaneous Reasons|1|||
94294975|NCT00618722|322865580|FG003|Overall Study|Miscellaneous Reasons|1|||
94294976|NCT00398112|322865581|FG000|Overall Study|Adverse Event|4|||
94294977|NCT00398112|322865581|FG000|Overall Study|Disease progression|9|||
94294978|NCT00398112|322865581|FG000|Overall Study|Alternative treatment|1|||
94294979|NCT00398112|322865581|FG000|Overall Study|Withdrawal by Subject|3|||
94294980|NCT00398112|322865581|FG000|Overall Study|Death|1|||
94294981|NCT00103012|322865585|FG000|Overall Study|Withdrawal by Subject|2|||
94294982|NCT00103012|322865586|FG001|Overall Study|Withdrawal by Subject|1|||
94294983|NCT00103012|322865587|FG002|Overall Study|Withdrawal by Subject|2|||
94294984|NCT00103012|322865585|FG000|Overall Study|Pregnancy|1|||
94294985|NCT00103012|322865586|FG001|Overall Study|Pregnancy|0|||
94294986|NCT00103012|322865587|FG002|Overall Study|Pregnancy|0|||
94294987|NCT00103012|322865585|FG000|Overall Study|Adverse Event|0|||
94294988|NCT00103012|322865586|FG001|Overall Study|Adverse Event|0|||
94294989|NCT00103012|322865587|FG002|Overall Study|Adverse Event|1|||
94294990|NCT00103012|322865585|FG000|Overall Study|Subject non-compliant with medications|0|||
94294991|NCT00103012|322865586|FG001|Overall Study|Subject non-compliant with medications|0|||
94294992|NCT00103012|322865587|FG002|Overall Study|Subject non-compliant with medications|1|||
94294993|NCT05211336|322865590|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
94294994|NCT05211336|322865591|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
94294995|NCT05211336|322865590|FG000|Overall Study|Progressive disease|0|||
94294996|NCT05211336|322865591|FG001|Overall Study|Progressive disease|4|||
94294997|NCT05211336|322865590|FG000|Overall Study|Death due to myocardial infarction|0|||
94294998|NCT05211336|322865591|FG001|Overall Study|Death due to myocardial infarction|1|||
94294999|NCT05211336|322865590|FG000|Overall Study|Death due to unknown cause|0|||
94295000|NCT05211336|322865591|FG001|Overall Study|Death due to unknown cause|1|||
94295001|NCT05211336|322865590|FG000|Overall Study|Worsening kidney function and quality of response|0|||
94295002|NCT05211336|322865591|FG001|Overall Study|Worsening kidney function and quality of response|1|||
94295003|NCT00332709|322865592|FG000|Overall Study|Adverse Event|11|||
94295004|NCT00332709|322865593|FG001|Overall Study|Adverse Event|14|||
94295005|NCT00332709|322865592|FG000|Overall Study|Withdrawal by Subject|2|||
94295006|NCT00332709|322865593|FG001|Overall Study|Withdrawal by Subject|3|||
94295007|NCT00332709|322865592|FG000|Overall Study|Lost to Follow-up|2|||
94295008|NCT00332709|322865593|FG001|Overall Study|Lost to Follow-up|0|||
94295009|NCT00332709|322865592|FG000|Overall Study|Administrative Problems|0|||
94295010|NCT00332709|322865593|FG001|Overall Study|Administrative Problems|3|||
94295011|NCT00332709|322865592|FG000|Overall Study|Abnormal test procedure result|1|||
94295012|NCT00332709|322865593|FG001|Overall Study|Abnormal test procedure result|0|||
94295013|NCT01409928|322865596|FG000|Overall Study|Physician Decision|12|||
94295014|NCT03822884|322865597|FG000|Overall Study|Withdrawal by Subject|0|||
94295015|NCT03822884|322865598|FG001|Overall Study|Withdrawal by Subject|0|||
94295016|NCT03822884|322865599|FG002|Overall Study|Withdrawal by Subject|0|||
94295017|NCT03822884|322865600|FG003|Overall Study|Withdrawal by Subject|0|||
94295018|NCT03822884|322865601|FG004|Overall Study|Withdrawal by Subject|1|||
94295019|NCT03822884|322865602|FG005|Overall Study|Withdrawal by Subject|0|||
94295020|NCT00432237|322865603|FG000|Overall Study|Adverse Event|0|||
94295021|NCT00432237|322865604|FG001|Overall Study|Adverse Event|0|||
94295022|NCT00432237|322865605|FG002|Overall Study|Adverse Event|0|||
94295023|NCT00432237|322865606|FG003|Overall Study|Adverse Event|1|||
94295024|NCT00432237|322865603|FG000|Overall Study|Lack of Efficacy|0|||
94295025|NCT00432237|322865604|FG001|Overall Study|Lack of Efficacy|0|||
94295026|NCT00432237|322865605|FG002|Overall Study|Lack of Efficacy|0|||
94295027|NCT00432237|322865606|FG003|Overall Study|Lack of Efficacy|1|||
94295028|NCT00432237|322865603|FG000|Overall Study|Lost to Follow-up|10|||
94295029|NCT00432237|322865604|FG001|Overall Study|Lost to Follow-up|10|||
94295030|NCT00432237|322865605|FG002|Overall Study|Lost to Follow-up|18|||
94295031|NCT00432237|322865606|FG003|Overall Study|Lost to Follow-up|18|||
94295032|NCT00432237|322865603|FG000|Overall Study|Physician Decision|1|||
94295033|NCT00432237|322865604|FG001|Overall Study|Physician Decision|3|||
94295034|NCT00432237|322865605|FG002|Overall Study|Physician Decision|2|||
94295035|NCT00432237|322865606|FG003|Overall Study|Physician Decision|1|||
94295036|NCT00432237|322865603|FG000|Overall Study|Pregnancy|0|||
94295037|NCT00432237|322865604|FG001|Overall Study|Pregnancy|1|||
94295038|NCT00432237|322865605|FG002|Overall Study|Pregnancy|0|||
94295039|NCT00432237|322865606|FG003|Overall Study|Pregnancy|0|||
94295040|NCT00432237|322865603|FG000|Overall Study|Protocol Violation|13|||
94295041|NCT00432237|322865604|FG001|Overall Study|Protocol Violation|10|||
94295042|NCT00432237|322865605|FG002|Overall Study|Protocol Violation|11|||
94295043|NCT00432237|322865606|FG003|Overall Study|Protocol Violation|8|||
94295044|NCT00432237|322865603|FG000|Overall Study|Withdrawal by Subject|5|||
94295045|NCT00432237|322865604|FG001|Overall Study|Withdrawal by Subject|6|||
94295046|NCT00432237|322865605|FG002|Overall Study|Withdrawal by Subject|9|||
94295047|NCT00432237|322865606|FG003|Overall Study|Withdrawal by Subject|11|||
94295048|NCT00432237|322865603|FG000|Overall Study|Lack of Qualifying Event|38|||
94295049|NCT00432237|322865604|FG001|Overall Study|Lack of Qualifying Event|71|||
94295050|NCT00432237|322865605|FG002|Overall Study|Lack of Qualifying Event|69|||
94295051|NCT00432237|322865606|FG003|Overall Study|Lack of Qualifying Event|84|||
94295052|NCT03617705|322865607|FG000|Overall Study|Withdrawal by Subject|2|||
94295053|NCT03617705|322865607|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
94295054|NCT03617705|322865607|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
94295055|NCT00928070|322865610|FG000|Overall Study|Lost to Follow-up|1|||
94295056|NCT00928070|322865611|FG001|Overall Study|Lost to Follow-up|2|||
94295057|NCT00928070|322865610|FG000|Overall Study|Withdrawal by Subject|10|||
94295058|NCT00928070|322865611|FG001|Overall Study|Withdrawal by Subject|3|||
94295059|NCT00928070|322865610|FG000|Overall Study|Adverse Event|14|||
94295060|NCT00928070|322865611|FG001|Overall Study|Adverse Event|26|||
94295061|NCT00928070|322865610|FG000|Overall Study|Lack of Efficacy|9|||
94295062|NCT00928070|322865611|FG001|Overall Study|Lack of Efficacy|5|||
94295063|NCT00928070|322865610|FG000|Overall Study|Did not meet entrance criteria|16|||
94295064|NCT00928070|322865611|FG001|Overall Study|Did not meet entrance criteria|9|||
94295065|NCT00928070|322865610|FG000|Overall Study|Protocol Violation|6|||
94295066|NCT00928070|322865611|FG001|Overall Study|Protocol Violation|5|||
94295067|NCT00928070|322865610|FG000|Overall Study|Randomized but not treated|2|||
94295068|NCT00928070|322865611|FG001|Overall Study|Randomized but not treated|2|||
94295069|NCT00928070|322865610|FG000|Overall Study|Other|5|||
94295070|NCT00928070|322865611|FG001|Overall Study|Other|5|||
94295071|NCT00191854|322865612|FG000|Overall Study|Death|26|||
94295072|NCT00191854|322865613|FG001|Overall Study|Death|23|||
94295073|NCT00191854|322865614|FG002|Overall Study|Death|29|||
94295074|NCT00191854|322865612|FG000|Overall Study|Lost to Follow-up|7|||
94295075|NCT00191854|322865613|FG001|Overall Study|Lost to Follow-up|5|||
94295076|NCT00191854|322865614|FG002|Overall Study|Lost to Follow-up|5|||
94295077|NCT00191854|322865612|FG000|Overall Study|Withdrawal by Subject|4|||
94295078|NCT00191854|322865613|FG001|Overall Study|Withdrawal by Subject|2|||
94295079|NCT00191854|322865614|FG002|Overall Study|Withdrawal by Subject|3|||
94295080|NCT00191854|322865612|FG000|Overall Study|Sponsor Decision|0|||
94295081|NCT00191854|322865613|FG001|Overall Study|Sponsor Decision|0|||
94295082|NCT00191854|322865614|FG002|Overall Study|Sponsor Decision|1|||
94295083|NCT00191854|322865612|FG000|Overall Study|Screen Failure|0|||
94295084|NCT00191854|322865613|FG001|Overall Study|Screen Failure|0|||
94295085|NCT00191854|322865614|FG002|Overall Study|Screen Failure|1|||
94295086|NCT03293654|322865616|FG000|Overall Study|Lost to Follow-up|0|||
94295087|NCT03293654|322865617|FG001|Overall Study|Lost to Follow-up|1|||
94295088|NCT03293654|322865618|FG002|Overall Study|Lost to Follow-up|0|||
94295089|NCT04437511|322865622|FG000|Overall Study|Adverse Event|50|||
94295090|NCT04437511|322865623|FG001|Overall Study|Adverse Event|21|||
94295091|NCT04437511|322865622|FG000|Overall Study|Death|15|||
94295092|NCT04437511|322865623|FG001|Overall Study|Death|10|||
94295093|NCT04437511|322865622|FG000|Overall Study|Lost to Follow-up|11|||
94295094|NCT04437511|322865623|FG001|Overall Study|Lost to Follow-up|11|||
94295095|NCT04437511|322865622|FG000|Overall Study|Physician Decision|19|||
94295096|NCT04437511|322865623|FG001|Overall Study|Physician Decision|10|||
94295097|NCT04437511|322865622|FG000|Overall Study|Progressive Disease|4|||
94295098|NCT04437511|322865623|FG001|Overall Study|Progressive Disease|7|||
94295099|NCT04437511|322865622|FG000|Overall Study|Withdrawal by Subject|111|||
94295100|NCT04437511|322865623|FG001|Overall Study|Withdrawal by Subject|94|||
94295101|NCT04437511|322865622|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
94295102|NCT04437511|322865623|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
94295103|NCT04437511|322865622|FG000|Overall Study|Continuing Study|7|||
94295104|NCT04437511|322865623|FG001|Overall Study|Continuing Study|5|||
94295105|NCT06118385|322865626|FG000|Overall Study|Protocol Violation|0|||
94295106|NCT06118385|322865627|FG001|Overall Study|Protocol Violation|0|||
94295107|NCT06118385|322865628|FG002|Overall Study|Protocol Violation|0|||
94295108|NCT06118385|322865629|FG003|Overall Study|Protocol Violation|0|||
94295109|NCT06118385|322865630|FG004|Overall Study|Protocol Violation|0|||
94295110|NCT06118385|322865631|FG005|Overall Study|Protocol Violation|0|||
94295111|NCT06118385|322865632|FG006|Overall Study|Protocol Violation|0|||
94295112|NCT06118385|322865633|FG007|Overall Study|Protocol Violation|0|||
94295113|NCT06118385|322865634|FG008|Overall Study|Protocol Violation|1|||
94295114|NCT06118385|322865635|FG009|Overall Study|Protocol Violation|0|||
94295115|NCT06118385|322865636|FG010|Overall Study|Protocol Violation|0|||
94295116|NCT06118385|322865637|FG011|Overall Study|Protocol Violation|0|||
94295117|NCT06118385|322865626|FG000|Overall Study|Out-of-range blood tests|0|||
94295118|NCT06118385|322865627|FG001|Overall Study|Out-of-range blood tests|0|||
94295119|NCT06118385|322865628|FG002|Overall Study|Out-of-range blood tests|0|||
94295120|NCT06118385|322865629|FG003|Overall Study|Out-of-range blood tests|0|||
94295121|NCT06118385|322865630|FG004|Overall Study|Out-of-range blood tests|0|||
94295122|NCT06118385|322865631|FG005|Overall Study|Out-of-range blood tests|0|||
94295123|NCT06118385|322865632|FG006|Overall Study|Out-of-range blood tests|0|||
94295124|NCT06118385|322865633|FG007|Overall Study|Out-of-range blood tests|0|||
94295125|NCT06118385|322865634|FG008|Overall Study|Out-of-range blood tests|1|||
94295126|NCT06118385|322865635|FG009|Overall Study|Out-of-range blood tests|0|||
94295127|NCT06118385|322865636|FG010|Overall Study|Out-of-range blood tests|0|||
94295128|NCT06118385|322865637|FG011|Overall Study|Out-of-range blood tests|0|||
94295129|NCT04233229|322865638|FG000|Overall Study|Withdrawal by Subject|0|||
94295130|NCT04233229|322865639|FG001|Overall Study|Withdrawal by Subject|1|||
94295131|NCT04233229|322865638|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
94295132|NCT04233229|322865639|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
94295133|NCT04233229|322865638|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
94295134|NCT04233229|322865639|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
94295135|NCT01355289|322865642|FG000|Core Study|Adverse Event, Non-Fatal|1|||
94295136|NCT01355289|322865643|FG001|Core Study|Adverse Event, Non-Fatal|0|||
94295137|NCT01355289|322865644|FG002|Core Study|Adverse Event, Non-Fatal|0|||
94295138|NCT01355289|322865645|FG003|Core Study|Adverse Event, Non-Fatal|0|||
94295139|NCT01355289|322865646|FG004|Core Study|Adverse Event, Non-Fatal|0|||
94295140|NCT01355289|322865642|FG000|Core Study|Inadequate Therapeutic Effect|0|||
94295141|NCT01355289|322865643|FG001|Core Study|Inadequate Therapeutic Effect|0|||
94295142|NCT01355289|322865644|FG002|Core Study|Inadequate Therapeutic Effect|0|||
94295143|NCT01355289|322865645|FG003|Core Study|Inadequate Therapeutic Effect|1|||
94295144|NCT01355289|322865646|FG004|Core Study|Inadequate Therapeutic Effect|0|||
94295145|NCT01355289|322865642|FG000|Core Study|Other|0|||
94295146|NCT01355289|322865643|FG001|Core Study|Other|0|||
94295147|NCT01355289|322865644|FG002|Core Study|Other|0|||
94295148|NCT01355289|322865645|FG003|Core Study|Other|1|||
94295149|NCT01355289|322865646|FG004|Core Study|Other|0|||
94295150|NCT01355289|322865642|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
94295151|NCT01355289|322865643|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
94295152|NCT01355289|322865644|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
94295153|NCT01355289|322865645|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
94295154|NCT01355289|322865646|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
94295155|NCT01355289|322865642|FG000|Open Label Extension|Lost to Follow-up|0|||
94295156|NCT01355289|322865643|FG001|Open Label Extension|Lost to Follow-up|0|||
94295157|NCT01355289|322865644|FG002|Open Label Extension|Lost to Follow-up|0|||
94295158|NCT01355289|322865645|FG003|Open Label Extension|Lost to Follow-up|0|||
94295159|NCT01355289|322865646|FG004|Open Label Extension|Lost to Follow-up|1|||
94295160|NCT01355289|322865642|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
94295161|NCT01355289|322865643|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
94295162|NCT01355289|322865644|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
94372579|NCT01328054|323150312|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
94372580|NCT03264066|323150313|FG000|Overall Study|Adverse Event|1|||
94372581|NCT03264066|323150314|FG001|Overall Study|Adverse Event|1|||
94295163|NCT01355289|322865645|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
94295164|NCT01355289|322865646|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
94295165|NCT01355289|322865642|FG000|Open Label Extension|Other|0|||
94295166|NCT01355289|322865643|FG001|Open Label Extension|Other|0|||
94295167|NCT01355289|322865644|FG002|Open Label Extension|Other|0|||
94295168|NCT01355289|322865645|FG003|Open Label Extension|Other|0|||
94295169|NCT01355289|322865646|FG004|Open Label Extension|Other|3|||
94295170|NCT00348140|322865648|FG000|Overall Study|Adverse Event|46|||
94295171|NCT00348140|322865649|FG001|Overall Study|Adverse Event|49|||
94295172|NCT00348140|322865650|FG002|Overall Study|Adverse Event|78|||
94295173|NCT00348140|322865648|FG000|Overall Study|Lost to Follow-up|4|||
94295174|NCT00348140|322865649|FG001|Overall Study|Lost to Follow-up|4|||
94295175|NCT00348140|322865650|FG002|Overall Study|Lost to Follow-up|4|||
94295176|NCT00348140|322865648|FG000|Overall Study|Protocol Violation|12|||
94295177|NCT00348140|322865649|FG001|Overall Study|Protocol Violation|13|||
94295178|NCT00348140|322865650|FG002|Overall Study|Protocol Violation|14|||
94295179|NCT00348140|322865648|FG000|Overall Study|Withdrawal by Subject|32|||
94295180|NCT00348140|322865649|FG001|Overall Study|Withdrawal by Subject|40|||
94295181|NCT00348140|322865650|FG002|Overall Study|Withdrawal by Subject|40|||
94295182|NCT00348140|322865648|FG000|Overall Study|Non-compliance|8|||
94295183|NCT00348140|322865649|FG001|Overall Study|Non-compliance|13|||
94295184|NCT00348140|322865650|FG002|Overall Study|Non-compliance|5|||
94295185|NCT00348140|322865648|FG000|Overall Study|Participant at risk due to study drug|2|||
94295186|NCT00348140|322865649|FG001|Overall Study|Participant at risk due to study drug|0|||
94295187|NCT00348140|322865650|FG002|Overall Study|Participant at risk due to study drug|0|||
94295188|NCT00348140|322865648|FG000|Overall Study|Conditional medication increased dose|1|||
94295189|NCT00348140|322865649|FG001|Overall Study|Conditional medication increased dose|0|||
94295190|NCT00348140|322865650|FG002|Overall Study|Conditional medication increased dose|0|||
94295191|NCT00348140|322865648|FG000|Overall Study|Caregiver related|4|||
94295192|NCT00348140|322865649|FG001|Overall Study|Caregiver related|7|||
94295193|NCT00348140|322865650|FG002|Overall Study|Caregiver related|3|||
94295194|NCT00348140|322865648|FG000|Overall Study|Participant hospitalised|3|||
94295195|NCT00348140|322865649|FG001|Overall Study|Participant hospitalised|0|||
94295196|NCT00348140|322865650|FG002|Overall Study|Participant hospitalised|0|||
94295197|NCT00348140|322865648|FG000|Overall Study|Efficacy related|1|||
94295198|NCT00348140|322865649|FG001|Overall Study|Efficacy related|1|||
94295199|NCT00348140|322865650|FG002|Overall Study|Efficacy related|0|||
94295200|NCT00348140|322865648|FG000|Overall Study|Administration related|3|||
94295201|NCT00348140|322865649|FG001|Overall Study|Administration related|1|||
94295202|NCT00348140|322865650|FG002|Overall Study|Administration related|1|||
94295203|NCT00348140|322865648|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
94295204|NCT00348140|322865649|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
94295205|NCT00348140|322865650|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
94295206|NCT00348140|322865648|FG000|Overall Study|Participant unwell|1|||
94295207|NCT00348140|322865649|FG001|Overall Study|Participant unwell|0|||
94295208|NCT00348140|322865650|FG002|Overall Study|Participant unwell|0|||
94295209|NCT00348140|322865648|FG000|Overall Study|Screen failure|1|||
94295210|NCT00348140|322865649|FG001|Overall Study|Screen failure|0|||
94295211|NCT00348140|322865650|FG002|Overall Study|Screen failure|0|||
94295212|NCT00348140|322865648|FG000|Overall Study|Investigator decided to discontinue|4|||
94295213|NCT00348140|322865649|FG001|Overall Study|Investigator decided to discontinue|1|||
94295214|NCT00348140|322865650|FG002|Overall Study|Investigator decided to discontinue|4|||
94295215|NCT00348140|322865648|FG000|Overall Study|Decided to discontinue on their own|1|||
94295216|NCT00348140|322865649|FG001|Overall Study|Decided to discontinue on their own|4|||
94295217|NCT00348140|322865650|FG002|Overall Study|Decided to discontinue on their own|1|||
94295218|NCT00348140|322865648|FG000|Overall Study|Use of prohibited drug|1|||
94295219|NCT00348140|322865649|FG001|Overall Study|Use of prohibited drug|0|||
94295220|NCT00348140|322865650|FG002|Overall Study|Use of prohibited drug|2|||
94295221|NCT00348140|322865648|FG000|Overall Study|Disease progression|1|||
94295222|NCT00348140|322865649|FG001|Overall Study|Disease progression|2|||
94295223|NCT00348140|322865650|FG002|Overall Study|Disease progression|5|||
94295224|NCT00348140|322865648|FG000|Overall Study|Increased risk of cardiac infarction|0|||
94295225|NCT00348140|322865649|FG001|Overall Study|Increased risk of cardiac infarction|1|||
94295226|NCT00348140|322865650|FG002|Overall Study|Increased risk of cardiac infarction|0|||
94295227|NCT00348140|322865648|FG000|Overall Study|Serious adverse event|0|||
94295228|NCT00348140|322865649|FG001|Overall Study|Serious adverse event|1|||
94295229|NCT00348140|322865650|FG002|Overall Study|Serious adverse event|0|||
94295230|NCT00348140|322865648|FG000|Overall Study|Abnormal ECG|0|||
94295231|NCT00348140|322865649|FG001|Overall Study|Abnormal ECG|1|||
94295232|NCT00348140|322865650|FG002|Overall Study|Abnormal ECG|3|||
94295233|NCT00348140|322865648|FG000|Overall Study|Participant died|0|||
94295234|NCT00348140|322865649|FG001|Overall Study|Participant died|1|||
94295235|NCT00348140|322865650|FG002|Overall Study|Participant died|0|||
94295236|NCT00348140|322865648|FG000|Overall Study|Exclusion criteria met|0|||
94295237|NCT00348140|322865649|FG001|Overall Study|Exclusion criteria met|0|||
94295238|NCT00348140|322865650|FG002|Overall Study|Exclusion criteria met|1|||
94295239|NCT00348140|322865648|FG000|Overall Study|Memory declined|0|||
94295240|NCT00348140|322865649|FG001|Overall Study|Memory declined|0|||
94295241|NCT00348140|322865650|FG002|Overall Study|Memory declined|1|||
94295242|NCT01107444|322865652|FG000|Overall Study|Withdrawal by Subject|8|||
94295243|NCT01107444|322865653|FG001|Overall Study|Withdrawal by Subject|12|||
94295244|NCT01107444|322865652|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
94295245|NCT01107444|322865653|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
94295246|NCT01171612|322865654|FG000|Overall Study|Lost to Follow-up|51|||
94295247|NCT02292212|322865660|FG000|ViE Phase|Withdrawal by Subject|1|||
94295248|NCT02292212|322865660|FG000|ViE Phase|Protocol Violation|2|||
94295249|NCT01176916|322865661|FG000|Overall Study|Adverse Event|61|||
94295250|NCT01176916|322865661|FG000|Overall Study|Death|1|||
94295251|NCT01176916|322865661|FG000|Overall Study|Lost to Follow-up|15|||
94295252|NCT01176916|322865661|FG000|Overall Study|Objective progression or relapse|17|||
94295253|NCT01176916|322865661|FG000|Overall Study|Protocol Violation|24|||
94295254|NCT01176916|322865661|FG000|Overall Study|Withdrawal by Subject|37|||
94295255|NCT01176916|322865661|FG000|Overall Study|Other|6|||
94295256|NCT01176916|322865661|FG000|Overall Study|Withdrawal prior to Treatment|6|||
94295257|NCT00631137|322865662|FG000|Overall Study|Withdrawal by Subject|1|||
94295258|NCT00631137|322865663|FG001|Overall Study|Withdrawal by Subject|0|||
94295259|NCT05681715|322865664|FG000|Training Period (6-weeks)|Adverse Event|3|||
94295260|NCT05681715|322865665|FG001|Training Period (6-weeks)|Adverse Event|0|||
94295261|NCT05681715|322865666|FG002|Training Period (6-weeks)|Adverse Event|0|||
94295262|NCT05681715|322865664|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
94295263|NCT05681715|322865665|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
94295264|NCT05681715|322865666|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
94295265|NCT05681715|322865664|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
94295266|NCT05681715|322865665|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
94295267|NCT05681715|322865666|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
94295268|NCT05681715|322865664|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
94295269|NCT05681715|322865665|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
94295270|NCT05681715|322865666|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
94295271|NCT05681715|322865664|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
94295272|NCT05681715|322865665|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
94295273|NCT05681715|322865666|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
94372582|NCT03264066|323150315|FG002|Overall Study|Adverse Event|0|||
94372583|NCT03264066|323150316|FG003|Overall Study|Adverse Event|0|||
94295274|NCT05681715|322865664|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
94295275|NCT05681715|322865665|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
94295276|NCT05681715|322865666|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
94295277|NCT05681715|322865664|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
94295278|NCT05681715|322865665|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
94295279|NCT05681715|322865666|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
94295280|NCT05681715|322865664|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
94295281|NCT05681715|322865665|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
94295282|NCT05681715|322865666|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
94295283|NCT03896295|322865674|FG000|Overall Study|Adverse Event|0|||
94295284|NCT03896295|322865675|FG001|Overall Study|Adverse Event|1|||
94295285|NCT03896295|322865674|FG000|Overall Study|COVID-19|7|||
94295286|NCT03896295|322865675|FG001|Overall Study|COVID-19|29|||
94295287|NCT03529409|322865676|FG000|Randomized|Lost to Follow-up|0|||
94295288|NCT03529409|322865677|FG001|Randomized|Lost to Follow-up|0|||
94295289|NCT03529409|322865678|FG002|Randomized|Lost to Follow-up|4|||
94295290|NCT03529409|322865676|FG000|Randomized|Excluded|0|||
94295291|NCT03529409|322865677|FG001|Randomized|Excluded|0|||
94295292|NCT03529409|322865678|FG002|Randomized|Excluded|1|||
94295293|NCT03529409|322865676|FG000|Post-treatment Assessment|Death|1|||
94295294|NCT03529409|322865677|FG001|Post-treatment Assessment|Death|0|||
94295295|NCT03529409|322865678|FG002|Post-treatment Assessment|Death|0|||
94295296|NCT03529409|322865676|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
94295297|NCT03529409|322865677|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
94295298|NCT03529409|322865678|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
94295299|NCT03529409|322865676|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
94295300|NCT03529409|322865677|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
94295301|NCT03529409|322865678|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
94295302|NCT03529409|322865676|FG000|Follow-up Assessment|Death|1|||
94295303|NCT03529409|322865677|FG001|Follow-up Assessment|Death|0|||
94295304|NCT03529409|322865678|FG002|Follow-up Assessment|Death|0|||
94295305|NCT03529409|322865676|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
94295306|NCT03529409|322865677|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
94295307|NCT03529409|322865678|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
94295308|NCT03898063|322865679|FG000|Overall Study|Withdrawal by Subject|10|||
94295309|NCT03898063|322865680|FG001|Overall Study|Withdrawal by Subject|8|||
94295310|NCT01651780|322865681|FG000|Overall Study|Physician decision: No 30-day visit|2|||
94295311|NCT01651780|322865682|FG001|Overall Study|Physician decision: No 30-day visit|1|||
94295312|NCT01651780|322865681|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
94295313|NCT01651780|322865682|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
94295314|NCT01651780|322865681|FG000|Overall Study|Withdrawal by Subject|2|||
94295315|NCT01651780|322865682|FG001|Overall Study|Withdrawal by Subject|0|||
94295316|NCT01651780|322865681|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
94295317|NCT01651780|322865682|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
94295318|NCT01651780|322865681|FG000|Overall Study|Lost to Follow-up|1|||
94295319|NCT01651780|322865682|FG001|Overall Study|Lost to Follow-up|2|||
94295320|NCT01651780|322865681|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
94295321|NCT01651780|322865682|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
94295322|NCT02949830|322865683|FG000|Overall Study|Adverse Event|1|||
94295323|NCT02949830|322865683|FG000|Overall Study|Withdrawal by Subject|1|||
94295324|NCT02305563|322865684|FG000|Treatment Period|Disease progression|0|||
94295325|NCT02305563|322865685|FG001|Treatment Period|Disease progression|0|||
94295326|NCT02305563|322865686|FG002|Treatment Period|Disease progression|15|||
94295327|NCT02305563|322865687|FG003|Treatment Period|Disease progression|6|||
94295328|NCT02305563|322865688|FG004|Treatment Period|Disease progression|6|||
94295329|NCT02305563|322865684|FG000|Treatment Period|Study drug toxicity|0|||
94295330|NCT02305563|322865685|FG001|Treatment Period|Study drug toxicity|0|||
94295331|NCT02305563|322865686|FG002|Treatment Period|Study drug toxicity|0|||
94295332|NCT02305563|322865687|FG003|Treatment Period|Study drug toxicity|1|||
94295333|NCT02305563|322865688|FG004|Treatment Period|Study drug toxicity|2|||
94295334|NCT02305563|322865684|FG000|Treatment Period|Death|0|||
94295335|NCT02305563|322865685|FG001|Treatment Period|Death|0|||
94295336|NCT02305563|322865686|FG002|Treatment Period|Death|1|||
94295337|NCT02305563|322865687|FG003|Treatment Period|Death|2|||
94295338|NCT02305563|322865688|FG004|Treatment Period|Death|1|||
94295339|NCT02305563|322865684|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
94295340|NCT02305563|322865685|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
94295341|NCT02305563|322865686|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
94295342|NCT02305563|322865687|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
94295343|NCT02305563|322865688|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
94295344|NCT02305563|322865684|FG000|Treatment Period|Participant request to stop therapy|0|||
94295345|NCT02305563|322865685|FG001|Treatment Period|Participant request to stop therapy|2|||
94295346|NCT02305563|322865686|FG002|Treatment Period|Participant request to stop therapy|0|||
94295347|NCT02305563|322865687|FG003|Treatment Period|Participant request to stop therapy|1|||
94295348|NCT02305563|322865688|FG004|Treatment Period|Participant request to stop therapy|0|||
94295349|NCT02305563|322865684|FG000|Treatment Period|Participant withdrew consent|0|||
94295350|NCT02305563|322865685|FG001|Treatment Period|Participant withdrew consent|0|||
94295351|NCT02305563|322865686|FG002|Treatment Period|Participant withdrew consent|1|||
94295352|NCT02305563|322865687|FG003|Treatment Period|Participant withdrew consent|1|||
94295353|NCT02305563|322865688|FG004|Treatment Period|Participant withdrew consent|1|||
94295354|NCT02305563|322865684|FG000|Treatment Period|Maximum clinical benefit|0|||
94372584|NCT03264066|323150317|FG004|Overall Study|Adverse Event|0|||
94295355|NCT02305563|322865685|FG001|Treatment Period|Maximum clinical benefit|0|||
94295356|NCT02305563|322865686|FG002|Treatment Period|Maximum clinical benefit|0|||
94295357|NCT02305563|322865687|FG003|Treatment Period|Maximum clinical benefit|0|||
94295358|NCT02305563|322865688|FG004|Treatment Period|Maximum clinical benefit|1|||
94295359|NCT02305563|322865684|FG000|Treatment Period|Poor/non-compliance|0|||
94295360|NCT02305563|322865685|FG001|Treatment Period|Poor/non-compliance|0|||
94295361|NCT02305563|322865686|FG002|Treatment Period|Poor/non-compliance|0|||
94295362|NCT02305563|322865687|FG003|Treatment Period|Poor/non-compliance|0|||
94295363|NCT02305563|322865688|FG004|Treatment Period|Poor/non-compliance|1|||
94295364|NCT02305563|322865684|FG000|Treatment Period|Administrative reason by Sponsor|0|||
94295365|NCT02305563|322865685|FG001|Treatment Period|Administrative reason by Sponsor|0|||
94295366|NCT02305563|322865686|FG002|Treatment Period|Administrative reason by Sponsor|0|||
94295367|NCT02305563|322865687|FG003|Treatment Period|Administrative reason by Sponsor|0|||
94295368|NCT02305563|322865688|FG004|Treatment Period|Administrative reason by Sponsor|1|||
94295369|NCT02305563|322865684|FG000|Treatment Period|other reason|2|||
94295370|NCT02305563|322865685|FG001|Treatment Period|other reason|0|||
94295371|NCT02305563|322865686|FG002|Treatment Period|other reason|2|||
94295372|NCT02305563|322865687|FG003|Treatment Period|other reason|2|||
94295373|NCT02305563|322865688|FG004|Treatment Period|other reason|1|||
94295374|NCT02305563|322865684|FG000|Treatment Period|Randomized but not treated|0|||
94295375|NCT02305563|322865685|FG001|Treatment Period|Randomized but not treated|0|||
94295376|NCT02305563|322865686|FG002|Treatment Period|Randomized but not treated|0|||
94295377|NCT02305563|322865687|FG003|Treatment Period|Randomized but not treated|0|||
94295378|NCT02305563|322865688|FG004|Treatment Period|Randomized but not treated|2|||
94295379|NCT02305563|322865684|FG000|Treatment Period|added ULO, then disease progression|0|||
94295380|NCT02305563|322865685|FG001|Treatment Period|added ULO, then disease progression|0|||
94295381|NCT02305563|322865686|FG002|Treatment Period|added ULO, then disease progression|0|||
94295382|NCT02305563|322865687|FG003|Treatment Period|added ULO, then disease progression|0|||
94295383|NCT02305563|322865688|FG004|Treatment Period|added ULO, then disease progression|4|||
94295384|NCT02305563|322865684|FG000|Treatment Period|added ULO; then other reason|0|||
94295385|NCT02305563|322865685|FG001|Treatment Period|added ULO; then other reason|0|||
94295386|NCT02305563|322865686|FG002|Treatment Period|added ULO; then other reason|0|||
94295387|NCT02305563|322865687|FG003|Treatment Period|added ULO; then other reason|0|||
94295388|NCT02305563|322865688|FG004|Treatment Period|added ULO; then other reason|1|||
94295389|NCT02305563|322865684|FG000|Treatment Period|added ULO, then request to stop|0|||
94295390|NCT02305563|322865685|FG001|Treatment Period|added ULO, then request to stop|0|||
94295391|NCT02305563|322865686|FG002|Treatment Period|added ULO, then request to stop|0|||
94295392|NCT02305563|322865687|FG003|Treatment Period|added ULO, then request to stop|0|||
94295393|NCT02305563|322865688|FG004|Treatment Period|added ULO, then request to stop|1|||
94295394|NCT02305563|322865684|FG000|Follow-up Period|Death|0|||
94295395|NCT02305563|322865685|FG001|Follow-up Period|Death|0|||
94295396|NCT02305563|322865686|FG002|Follow-up Period|Death|5|||
94295397|NCT02305563|322865687|FG003|Follow-up Period|Death|4|||
94295398|NCT02305563|322865688|FG004|Follow-up Period|Death|7|||
94295399|NCT02305563|322865684|FG000|Follow-up Period|Participant withdrew consent|0|||
94295400|NCT02305563|322865685|FG001|Follow-up Period|Participant withdrew consent|0|||
94295401|NCT02305563|322865686|FG002|Follow-up Period|Participant withdrew consent|2|||
94295402|NCT02305563|322865687|FG003|Follow-up Period|Participant withdrew consent|1|||
94295403|NCT02305563|322865688|FG004|Follow-up Period|Participant withdrew consent|0|||
94295404|NCT02305563|322865684|FG000|Follow-up Period|other reason|0|||
94295405|NCT02305563|322865685|FG001|Follow-up Period|other reason|0|||
94295406|NCT02305563|322865686|FG002|Follow-up Period|other reason|0|||
94295407|NCT02305563|322865687|FG003|Follow-up Period|other reason|0|||
94295408|NCT02305563|322865688|FG004|Follow-up Period|other reason|1|||
94295409|NCT02305563|322865684|FG000|Follow-up Period|Followup no longer required per protocol|3|||
94295410|NCT02305563|322865685|FG001|Follow-up Period|Followup no longer required per protocol|3|||
94372585|NCT03264066|323150318|FG005|Overall Study|Adverse Event|0|||
94372586|NCT03264066|323150313|FG000|Overall Study|Death|12|||
94295411|NCT02305563|322865686|FG002|Follow-up Period|Followup no longer required per protocol|4|||
94295412|NCT02305563|322865687|FG003|Follow-up Period|Followup no longer required per protocol|1|||
94295413|NCT02305563|322865688|FG004|Follow-up Period|Followup no longer required per protocol|4|||
94295414|NCT01290887|322865689|FG000|Overall Study|Adverse Event|6|||
94295415|NCT01290887|322865690|FG001|Overall Study|Adverse Event|11|||
94295416|NCT01290887|322865689|FG000|Overall Study|Lack of Efficacy|4|||
94295417|NCT01290887|322865690|FG001|Overall Study|Lack of Efficacy|5|||
94295418|NCT01290887|322865689|FG000|Overall Study|Withdrawal by Subject|26|||
94295419|NCT01290887|322865690|FG001|Overall Study|Withdrawal by Subject|32|||
94295420|NCT01290887|322865689|FG000|Overall Study|Protocol Violation|2|||
94295421|NCT01290887|322865690|FG001|Overall Study|Protocol Violation|1|||
94295422|NCT01290887|322865689|FG000|Overall Study|Lost to Follow-up|4|||
94295423|NCT01290887|322865690|FG001|Overall Study|Lost to Follow-up|4|||
94295424|NCT01290887|322865689|FG000|Overall Study|Non-compliance to study procedures|0|||
94295425|NCT01290887|322865690|FG001|Overall Study|Non-compliance to study procedures|1|||
94295426|NCT01290887|322865689|FG000|Overall Study|Non-compliance to study medications|1|||
94295427|NCT01290887|322865690|FG001|Overall Study|Non-compliance to study medications|0|||
94295428|NCT01290887|322865689|FG000|Overall Study|Sponsor closure of study|420|||
94295429|NCT01290887|322865690|FG001|Overall Study|Sponsor closure of study|476|||
94295430|NCT01290887|322865689|FG000|Overall Study|Other|3|||
94295431|NCT01290887|322865690|FG001|Overall Study|Other|6|||
94295432|NCT04373460|322865691|FG000|Overall Study|Did not receive tranfusion|18|||
94295433|NCT04373460|322865692|FG001|Overall Study|Did not receive tranfusion|26|||
94295434|NCT00700804|322865696|FG000|Overall Study|Withdrawal by Subject|1|||
94295435|NCT00700804|322865697|FG001|Overall Study|Withdrawal by Subject|2|||
94295436|NCT00700804|322865696|FG000|Overall Study|Protocol Violation|1|||
94295437|NCT00700804|322865697|FG001|Overall Study|Protocol Violation|1|||
94295438|NCT00700804|322865696|FG000|Overall Study|Loose Stools|1|||
94295439|NCT00700804|322865697|FG001|Overall Study|Loose Stools|1|||
94295440|NCT00591734|322865700|FG000|Overall Study|Lack of Efficacy|35|||
94295441|NCT00591734|322865700|FG000|Overall Study|Adverse Event|5|||
94295442|NCT00591734|322865700|FG000|Overall Study|Physician Decision|5|||
94295443|NCT00591734|322865700|FG000|Overall Study|Intercurrent Illness|8|||
94295444|NCT01511445|322865701|FG000|Overall Study|Lost to Follow-up|3|||
94295445|NCT01511445|322865702|FG001|Overall Study|Lost to Follow-up|1|||
94295446|NCT01511445|322865701|FG000|Overall Study|Protocol Violation|1|||
94295447|NCT01511445|322865702|FG001|Overall Study|Protocol Violation|3|||
94295448|NCT01511445|322865701|FG000|Overall Study|Protocol Violation|1|||
94295449|NCT01511445|322865702|FG001|Overall Study|Protocol Violation|0|||
94295450|NCT00332202|322865703|FG000|Overall Study|Adverse Event|72|||
94295451|NCT00332202|322865704|FG001|Overall Study|Adverse Event|28|||
94295452|NCT00332202|322865703|FG000|Overall Study|Lost to Follow-up|2|||
94295453|NCT00332202|322865704|FG001|Overall Study|Lost to Follow-up|1|||
94295454|NCT00332202|322865703|FG000|Overall Study|Physician Decision|6|||
94295455|NCT00332202|322865704|FG001|Overall Study|Physician Decision|8|||
94295456|NCT00332202|322865703|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
94295457|NCT00332202|322865704|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
94295458|NCT00332202|322865703|FG000|Overall Study|Protocol Violation|7|||
94295459|NCT00332202|322865704|FG001|Overall Study|Protocol Violation|2|||
94295460|NCT00332202|322865703|FG000|Overall Study|Sponsor Decision|1|||
94295461|NCT00332202|322865704|FG001|Overall Study|Sponsor Decision|2|||
94295462|NCT00332202|322865703|FG000|Overall Study|Withdrawal by Subject|36|||
94295463|NCT00332202|322865704|FG001|Overall Study|Withdrawal by Subject|17|||
94295464|NCT00332202|322865703|FG000|Overall Study|Progressive Disease|106|||
94295465|NCT00332202|322865704|FG001|Overall Study|Progressive Disease|60|||
94295466|NCT00332202|322865703|FG000|Overall Study|Death|5|||
94295467|NCT00332202|322865704|FG001|Overall Study|Death|2|||
94295468|NCT04752384|322865705|FG000|Overall Study|Withdrawal by Subject|1|||
94295469|NCT04752384|322865705|FG000|Overall Study|Death|1|||
94295470|NCT01813890|322865706|FG000|Overall Study|Adverse Event|0|||
94295471|NCT01813890|322865707|FG001|Overall Study|Adverse Event|3|||
94295472|NCT01813890|322865708|FG002|Overall Study|Adverse Event|4|||
94295473|NCT01813890|322865706|FG000|Overall Study|Lack of Efficacy|9|||
94295474|NCT01813890|322865707|FG001|Overall Study|Lack of Efficacy|1|||
94295475|NCT01813890|322865708|FG002|Overall Study|Lack of Efficacy|2|||
94295476|NCT04439123|322865709|FG000|Overall Study|Adverse Event|11|||
94295477|NCT04439123|322865709|FG000|Overall Study|Death|1|||
94295478|NCT04439123|322865709|FG000|Overall Study|Disease progression|19|||
94295479|NCT04439123|322865709|FG000|Overall Study|Withdrawal by Subject|2|||
94295480|NCT04439123|322865709|FG000|Overall Study|Still on treatment|2|||
94295481|NCT04906707|322865710|FG000|Overall Study|Withdrawal by Subject|2|||
94295482|NCT04906707|322865711|FG001|Overall Study|Withdrawal by Subject|0|||
94295483|NCT04906707|322865710|FG000|Overall Study|Withdrawal due to PI decision|1|||
94295484|NCT04906707|322865711|FG001|Overall Study|Withdrawal due to PI decision|0|||
94295485|NCT04906707|322865710|FG000|Overall Study|Lost to Follow-up|0|||
94295486|NCT04906707|322865711|FG001|Overall Study|Lost to Follow-up|1|||
94295487|NCT00275561|322865713|FG000|Overall Study|Withdrawal by Subject|0|||
94295488|NCT00275561|322865714|FG001|Overall Study|Withdrawal by Subject|1|||
94295489|NCT00275561|322865713|FG000|Overall Study|Travel|1|||
94295490|NCT00275561|322865714|FG001|Overall Study|Travel|1|||
94295491|NCT00275561|322865713|FG000|Overall Study|Scheduling|1|||
94295492|NCT00275561|322865714|FG001|Overall Study|Scheduling|2|||
94295493|NCT00275561|322865713|FG000|Overall Study|Family Issues|0|||
94295494|NCT00275561|322865714|FG001|Overall Study|Family Issues|2|||
94295495|NCT03665038|322865715|FG000|Overall Study|Lost to Follow-up|0|||
94295496|NCT03665038|322865716|FG001|Overall Study|Lost to Follow-up|0|||
94295497|NCT03665038|322865717|FG002|Overall Study|Lost to Follow-up|1|||
94295498|NCT04211337|322865718|FG000|Overall Study|On Treatment|175|||
94295499|NCT04211337|322865719|FG001|Overall Study|On Treatment|40|||
94295500|NCT04211337|322865718|FG000|Overall Study|Withdrawal by Subject|0|||
94295501|NCT04211337|322865719|FG001|Overall Study|Withdrawal by Subject|2|||
94295502|NCT00045032|322865720|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
94295503|NCT00045032|322865721|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
94295504|NCT00045032|322865722|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
94295505|NCT00045032|322865720|FG000|Overall Study|Death|22|||
94295506|NCT00045032|322865721|FG001|Overall Study|Death|24|||
94295507|NCT00045032|322865722|FG002|Overall Study|Death|17|||
94295508|NCT00045032|322865720|FG000|Overall Study|Insufficient Therapeutic Response|542|||
94295509|NCT00045032|322865721|FG001|Overall Study|Insufficient Therapeutic Response|437|||
94295510|NCT00045032|322865722|FG002|Overall Study|Insufficient Therapeutic Response|445|||
94295511|NCT00045032|322865720|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
94295512|NCT00045032|322865721|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
94295513|NCT00045032|322865722|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
94295514|NCT00045032|322865720|FG000|Overall Study|Other Protocol Violation|2|||
94295515|NCT00045032|322865721|FG001|Overall Study|Other Protocol Violation|0|||
94295516|NCT00045032|322865722|FG002|Overall Study|Other Protocol Violation|1|||
94295517|NCT00045032|322865720|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
94295518|NCT00045032|322865721|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
94295519|NCT00045032|322865722|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
94295520|NCT00045032|322865720|FG000|Overall Study|Failure to Return|57|||
94295521|NCT00045032|322865721|FG001|Overall Study|Failure to Return|62|||
94295522|NCT00045032|322865722|FG002|Overall Study|Failure to Return|61|||
94295523|NCT00045032|322865720|FG000|Overall Study|Other|93|||
94295524|NCT00045032|322865721|FG001|Overall Study|Other|84|||
94295525|NCT00045032|322865722|FG002|Overall Study|Other|105|||
94295526|NCT04284787|322867879|FG000|Overall Study|Disease Progression|9|||
94295527|NCT04284787|322867880|FG001|Overall Study|Disease Progression|12|||
94295528|NCT04284787|322867879|FG000|Overall Study|Physician Decision|12|||
94295529|NCT04284787|322867880|FG001|Overall Study|Physician Decision|7|||
94295530|NCT04284787|322867879|FG000|Overall Study|Transplant|5|||
94295531|NCT04284787|322867880|FG001|Overall Study|Transplant|4|||
94295532|NCT04284787|322867879|FG000|Overall Study|Death|1|||
94295533|NCT04284787|322867880|FG001|Overall Study|Death|2|||
94295534|NCT04284787|322867879|FG000|Overall Study|Adverse Event|0|||
94295535|NCT04284787|322867880|FG001|Overall Study|Adverse Event|4|||
94295536|NCT04284787|322867879|FG000|Overall Study|Non-adherence|2|||
94295537|NCT04284787|322867880|FG001|Overall Study|Non-adherence|0|||
94295538|NCT04284787|322867879|FG000|Overall Study|Lack of Efficacy|2|||
94295539|NCT04284787|322867880|FG001|Overall Study|Lack of Efficacy|0|||
94295540|NCT00408005|322867887|FG000|Induction|Adverse Event|19|||
94295541|NCT00408005|322867888|FG001|Induction|Adverse Event|3|||
94295542|NCT00408005|322867889|FG002|Induction|Adverse Event|0|||
94295543|NCT00408005|322867890|FG003|Induction|Adverse Event|0|||
94295544|NCT00408005|322867891|FG004|Induction|Adverse Event|0|||
94295545|NCT00408005|322867892|FG005|Induction|Adverse Event|0|||
94295546|NCT00408005|322867893|FG006|Induction|Adverse Event|0|||
94295547|NCT00408005|322867894|FG007|Induction|Adverse Event|0|||
94295548|NCT00408005|322867887|FG000|Induction|Death|6|||
94295549|NCT00408005|322867888|FG001|Induction|Death|0|||
94295550|NCT00408005|322867889|FG002|Induction|Death|0|||
94295551|NCT00408005|322867890|FG003|Induction|Death|0|||
94295552|NCT00408005|322867891|FG004|Induction|Death|0|||
94295553|NCT00408005|322867892|FG005|Induction|Death|0|||
94295554|NCT00408005|322867893|FG006|Induction|Death|0|||
94295555|NCT00408005|322867894|FG007|Induction|Death|0|||
94295556|NCT00408005|322867887|FG000|Induction|Physician Decision|83|||
94295557|NCT00408005|322867888|FG001|Induction|Physician Decision|9|||
94295558|NCT00408005|322867889|FG002|Induction|Physician Decision|0|||
94372587|NCT03264066|323150314|FG001|Overall Study|Death|12|||
94372588|NCT03264066|323150315|FG002|Overall Study|Death|8|||
94372589|NCT03264066|323150316|FG003|Overall Study|Death|10|||
94372590|NCT03264066|323150317|FG004|Overall Study|Death|6|||
94372591|NCT03264066|323150318|FG005|Overall Study|Death|1|||
94295559|NCT00408005|322867890|FG003|Induction|Physician Decision|0|||
94295560|NCT00408005|322867891|FG004|Induction|Physician Decision|0|||
94295561|NCT00408005|322867892|FG005|Induction|Physician Decision|0|||
94295562|NCT00408005|322867893|FG006|Induction|Physician Decision|0|||
94295563|NCT00408005|322867894|FG007|Induction|Physician Decision|0|||
94295564|NCT00408005|322867887|FG000|Induction|Withdrawal by Subject|2|||
94295565|NCT00408005|322867888|FG001|Induction|Withdrawal by Subject|4|||
94295566|NCT00408005|322867889|FG002|Induction|Withdrawal by Subject|0|||
94295567|NCT00408005|322867890|FG003|Induction|Withdrawal by Subject|0|||
94295568|NCT00408005|322867891|FG004|Induction|Withdrawal by Subject|0|||
94295569|NCT00408005|322867892|FG005|Induction|Withdrawal by Subject|0|||
94372592|NCT03264066|323150313|FG000|Overall Study|Lost to Follow-up|1|||
94295570|NCT00408005|322867893|FG006|Induction|Withdrawal by Subject|0|||
94295571|NCT00408005|322867894|FG007|Induction|Withdrawal by Subject|0|||
94295572|NCT00408005|322867887|FG000|Induction|Ineligible|33|||
94295573|NCT00408005|322867888|FG001|Induction|Ineligible|14|||
94295574|NCT00408005|322867889|FG002|Induction|Ineligible|0|||
94295575|NCT00408005|322867890|FG003|Induction|Ineligible|0|||
94295576|NCT00408005|322867891|FG004|Induction|Ineligible|0|||
94295577|NCT00408005|322867892|FG005|Induction|Ineligible|0|||
94295578|NCT00408005|322867893|FG006|Induction|Ineligible|0|||
94295579|NCT00408005|322867894|FG007|Induction|Ineligible|0|||
94295580|NCT00408005|322867887|FG000|Induction|Refusal of Further Protocol Therapy|225|||
94295581|NCT00408005|322867888|FG001|Induction|Refusal of Further Protocol Therapy|44|||
94295582|NCT00408005|322867889|FG002|Induction|Refusal of Further Protocol Therapy|0|||
94295583|NCT00408005|322867890|FG003|Induction|Refusal of Further Protocol Therapy|0|||
94295584|NCT00408005|322867891|FG004|Induction|Refusal of Further Protocol Therapy|0|||
94295585|NCT00408005|322867892|FG005|Induction|Refusal of Further Protocol Therapy|0|||
94295586|NCT00408005|322867893|FG006|Induction|Refusal of Further Protocol Therapy|0|||
94295587|NCT00408005|322867894|FG007|Induction|Refusal of Further Protocol Therapy|0|||
94295588|NCT00408005|322867887|FG000|Induction|Entered another COG therapeutic protocol|4|||
94295589|NCT00408005|322867888|FG001|Induction|Entered another COG therapeutic protocol|0|||
94295590|NCT00408005|322867889|FG002|Induction|Entered another COG therapeutic protocol|0|||
94295591|NCT00408005|322867890|FG003|Induction|Entered another COG therapeutic protocol|0|||
94295592|NCT00408005|322867891|FG004|Induction|Entered another COG therapeutic protocol|0|||
94295593|NCT00408005|322867892|FG005|Induction|Entered another COG therapeutic protocol|0|||
94295594|NCT00408005|322867893|FG006|Induction|Entered another COG therapeutic protocol|0|||
94295595|NCT00408005|322867894|FG007|Induction|Entered another COG therapeutic protocol|0|||
94295596|NCT00408005|322867887|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
94295597|NCT00408005|322867888|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
94295598|NCT00408005|322867889|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
94295599|NCT00408005|322867890|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
94295600|NCT00408005|322867891|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
94295601|NCT00408005|322867892|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
94295602|NCT00408005|322867893|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
94295603|NCT00408005|322867894|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
94295604|NCT00408005|322867887|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
94295605|NCT00408005|322867888|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
94295606|NCT00408005|322867889|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
94295607|NCT00408005|322867890|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
94295608|NCT00408005|322867891|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
94295609|NCT00408005|322867892|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
94295610|NCT00408005|322867893|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
94295611|NCT00408005|322867894|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
94295612|NCT00408005|322867887|FG000|Induction|Progressive Disease|0|||
94295613|NCT00408005|322867888|FG001|Induction|Progressive Disease|1|||
94295614|NCT00408005|322867889|FG002|Induction|Progressive Disease|0|||
94295615|NCT00408005|322867890|FG003|Induction|Progressive Disease|0|||
94295616|NCT00408005|322867891|FG004|Induction|Progressive Disease|0|||
94295617|NCT00408005|322867892|FG005|Induction|Progressive Disease|0|||
94295618|NCT00408005|322867893|FG006|Induction|Progressive Disease|0|||
94295619|NCT00408005|322867894|FG007|Induction|Progressive Disease|0|||
94295620|NCT00408005|322867887|FG000|Induction|Inevaluable|18|||
94295621|NCT00408005|322867888|FG001|Induction|Inevaluable|14|||
94295622|NCT00408005|322867889|FG002|Induction|Inevaluable|0|||
94295623|NCT00408005|322867890|FG003|Induction|Inevaluable|0|||
94295624|NCT00408005|322867891|FG004|Induction|Inevaluable|0|||
94295625|NCT00408005|322867892|FG005|Induction|Inevaluable|0|||
94295626|NCT00408005|322867893|FG006|Induction|Inevaluable|0|||
94295627|NCT00408005|322867894|FG007|Induction|Inevaluable|0|||
94295628|NCT00408005|322867887|FG000|Induction|Failed to Complete Randomization|3|||
94295629|NCT00408005|322867888|FG001|Induction|Failed to Complete Randomization|2|||
94295630|NCT00408005|322867889|FG002|Induction|Failed to Complete Randomization|0|||
94295631|NCT00408005|322867890|FG003|Induction|Failed to Complete Randomization|0|||
94295632|NCT00408005|322867891|FG004|Induction|Failed to Complete Randomization|0|||
94295633|NCT00408005|322867892|FG005|Induction|Failed to Complete Randomization|0|||
94295634|NCT00408005|322867893|FG006|Induction|Failed to Complete Randomization|0|||
94295635|NCT00408005|322867894|FG007|Induction|Failed to Complete Randomization|0|||
94295636|NCT00408005|322867887|FG000|Induction|Protocol Deviation|3|||
94295637|NCT00408005|322867888|FG001|Induction|Protocol Deviation|1|||
94295638|NCT00408005|322867889|FG002|Induction|Protocol Deviation|0|||
94295639|NCT00408005|322867890|FG003|Induction|Protocol Deviation|0|||
94295640|NCT00408005|322867891|FG004|Induction|Protocol Deviation|0|||
94295641|NCT00408005|322867892|FG005|Induction|Protocol Deviation|0|||
94295642|NCT00408005|322867893|FG006|Induction|Protocol Deviation|0|||
94372593|NCT03264066|323150314|FG001|Overall Study|Lost to Follow-up|0|||
94372594|NCT03264066|323150315|FG002|Overall Study|Lost to Follow-up|0|||
94295643|NCT00408005|322867894|FG007|Induction|Protocol Deviation|0|||
94295644|NCT00408005|322867887|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
94295645|NCT00408005|322867888|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
94295646|NCT00408005|322867889|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
94295647|NCT00408005|322867890|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
94295648|NCT00408005|322867891|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
94295649|NCT00408005|322867892|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
94295650|NCT00408005|322867893|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
94295651|NCT00408005|322867894|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
94295652|NCT00408005|322867887|FG000|Induction|Recurrent leukemia|1|||
94295653|NCT00408005|322867888|FG001|Induction|Recurrent leukemia|0|||
94295654|NCT00408005|322867889|FG002|Induction|Recurrent leukemia|0|||
94295655|NCT00408005|322867890|FG003|Induction|Recurrent leukemia|0|||
94295656|NCT00408005|322867891|FG004|Induction|Recurrent leukemia|0|||
94295657|NCT00408005|322867892|FG005|Induction|Recurrent leukemia|0|||
94295658|NCT00408005|322867893|FG006|Induction|Recurrent leukemia|0|||
94295659|NCT00408005|322867894|FG007|Induction|Recurrent leukemia|0|||
94295660|NCT00408005|322867887|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
94295661|NCT00408005|322867888|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
94295662|NCT00408005|322867889|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
94295663|NCT00408005|322867890|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
94295664|NCT00408005|322867891|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
94295665|NCT00408005|322867892|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
94295666|NCT00408005|322867893|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
94295667|NCT00408005|322867894|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
94295668|NCT00408005|322867887|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
94295669|NCT00408005|322867888|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
94295670|NCT00408005|322867889|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
94295671|NCT00408005|322867890|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
94295672|NCT00408005|322867891|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
94295673|NCT00408005|322867892|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
94295674|NCT00408005|322867893|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
94295675|NCT00408005|322867894|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
94295676|NCT00408005|322867887|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
94295677|NCT00408005|322867888|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
94295678|NCT00408005|322867889|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
94295679|NCT00408005|322867890|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
94295680|NCT00408005|322867891|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
94295681|NCT00408005|322867892|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
94295682|NCT00408005|322867893|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
94295683|NCT00408005|322867894|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
94295684|NCT00408005|322867887|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
94295685|NCT00408005|322867888|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
94295686|NCT00408005|322867889|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
94295687|NCT00408005|322867890|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
94295688|NCT00408005|322867891|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
94295689|NCT00408005|322867892|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
94295690|NCT00408005|322867893|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
94295691|NCT00408005|322867894|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
94295692|NCT00408005|322867887|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
94295693|NCT00408005|322867888|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
94295694|NCT00408005|322867889|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
94295695|NCT00408005|322867890|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
94295696|NCT00408005|322867891|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
94295697|NCT00408005|322867892|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
94295698|NCT00408005|322867893|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
94295699|NCT00408005|322867894|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
94295700|NCT00408005|322867887|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
94295701|NCT00408005|322867888|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
94295702|NCT00408005|322867889|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
94295703|NCT00408005|322867890|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
94295704|NCT00408005|322867891|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
94295705|NCT00408005|322867892|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
94295706|NCT00408005|322867893|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
94295707|NCT00408005|322867894|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
94330897|NCT00118911|322991755|FG000|Overall Study|Withdrawal by Subject|2|||
94295708|NCT00408005|322867887|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
94295709|NCT00408005|322867888|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
94295710|NCT00408005|322867889|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
94295711|NCT00408005|322867890|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
94295712|NCT00408005|322867891|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
94295713|NCT00408005|322867892|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
94295714|NCT00408005|322867893|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
94295715|NCT00408005|322867894|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
94295716|NCT00408005|322867887|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
94295717|NCT00408005|322867888|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
94295718|NCT00408005|322867889|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
94295719|NCT00408005|322867890|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
94295720|NCT00408005|322867891|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
94295721|NCT00408005|322867892|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
94295722|NCT00408005|322867893|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
94295723|NCT00408005|322867894|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
94295724|NCT00408005|322867887|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
94295725|NCT00408005|322867888|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
94295726|NCT00408005|322867889|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
94295727|NCT00408005|322867890|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
94295728|NCT00408005|322867891|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
94295729|NCT00408005|322867892|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
94295730|NCT00408005|322867893|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
94295731|NCT00408005|322867894|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
94295732|NCT00408005|322867887|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
94295733|NCT00408005|322867888|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
94295734|NCT00408005|322867889|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
94295735|NCT00408005|322867890|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
94295736|NCT00408005|322867891|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
94295737|NCT00408005|322867892|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
94295738|NCT00408005|322867893|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
94295739|NCT00408005|322867894|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
94295740|NCT00408005|322867887|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
94295741|NCT00408005|322867888|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
94295742|NCT00408005|322867889|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
94295743|NCT00408005|322867890|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
94295744|NCT00408005|322867891|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
94295745|NCT00408005|322867892|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
94295746|NCT00408005|322867893|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
94295747|NCT00408005|322867894|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
94295748|NCT00408005|322867887|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
94295749|NCT00408005|322867888|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
94295750|NCT00408005|322867889|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
94295751|NCT00408005|322867890|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
94295752|NCT00408005|322867891|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
94295753|NCT00408005|322867892|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
94295754|NCT00408005|322867893|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
94295755|NCT00408005|322867894|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
94295756|NCT00408005|322867887|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
94295757|NCT00408005|322867888|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
94295758|NCT00408005|322867889|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
94295759|NCT00408005|322867890|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
94295760|NCT00408005|322867891|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
94295761|NCT00408005|322867892|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
94295762|NCT00408005|322867893|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
94372595|NCT03264066|323150316|FG003|Overall Study|Lost to Follow-up|0|||
94372596|NCT03264066|323150317|FG004|Overall Study|Lost to Follow-up|0|||
94372597|NCT03264066|323150318|FG005|Overall Study|Lost to Follow-up|0|||
94372598|NCT03264066|323150313|FG000|Overall Study|Progressive Disease|0|||
94295763|NCT00408005|322867894|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
94295764|NCT00408005|322867887|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
94295765|NCT00408005|322867888|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
94295766|NCT00408005|322867889|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
94295767|NCT00408005|322867890|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
94295768|NCT00408005|322867891|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
94295769|NCT00408005|322867892|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
94295770|NCT00408005|322867893|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
94295771|NCT00408005|322867894|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
94295772|NCT04889209|322867895|FG000|All Cohorts Except 15E|Adverse Event|0|||
94295773|NCT04889209|322867896|FG001|All Cohorts Except 15E|Adverse Event|0|||
94295774|NCT04889209|322867897|FG002|All Cohorts Except 15E|Adverse Event|0|||
94295775|NCT04889209|322867898|FG003|All Cohorts Except 15E|Adverse Event|0|||
94295776|NCT04889209|322867899|FG004|All Cohorts Except 15E|Adverse Event|0|||
94295777|NCT04889209|322867900|FG005|All Cohorts Except 15E|Adverse Event|0|||
94295778|NCT04889209|322867901|FG006|All Cohorts Except 15E|Adverse Event|1|||
94295779|NCT04889209|322867902|FG007|All Cohorts Except 15E|Adverse Event|0|||
94295780|NCT04889209|322867903|FG008|All Cohorts Except 15E|Adverse Event|0|||
94295781|NCT04889209|322867904|FG009|All Cohorts Except 15E|Adverse Event|0|||
94295782|NCT04889209|322867905|FG010|All Cohorts Except 15E|Adverse Event|0|||
94295783|NCT04889209|322867906|FG011|All Cohorts Except 15E|Adverse Event|0|||
94295784|NCT04889209|322867907|FG012|All Cohorts Except 15E|Adverse Event|0|||
94295785|NCT04889209|322867908|FG013|All Cohorts Except 15E|Adverse Event|0|||
94295786|NCT04889209|322867909|FG014|All Cohorts Except 15E|Adverse Event|0|||
94295787|NCT04889209|322867910|FG015|All Cohorts Except 15E|Adverse Event|0|||
94295788|NCT04889209|322867911|FG016|All Cohorts Except 15E|Adverse Event|0|||
94295789|NCT04889209|322867912|FG017|All Cohorts Except 15E|Adverse Event|0|||
94295790|NCT04889209|322867895|FG000|All Cohorts Except 15E|Death|0|||
94295791|NCT04889209|322867896|FG001|All Cohorts Except 15E|Death|1|||
94295792|NCT04889209|322867897|FG002|All Cohorts Except 15E|Death|0|||
94295793|NCT04889209|322867898|FG003|All Cohorts Except 15E|Death|0|||
94295794|NCT04889209|322867899|FG004|All Cohorts Except 15E|Death|0|||
94295795|NCT04889209|322867900|FG005|All Cohorts Except 15E|Death|0|||
94295796|NCT04889209|322867901|FG006|All Cohorts Except 15E|Death|0|||
94295797|NCT04889209|322867902|FG007|All Cohorts Except 15E|Death|0|||
94295798|NCT04889209|322867903|FG008|All Cohorts Except 15E|Death|0|||
94295799|NCT04889209|322867904|FG009|All Cohorts Except 15E|Death|0|||
94295800|NCT04889209|322867905|FG010|All Cohorts Except 15E|Death|0|||
94295801|NCT04889209|322867906|FG011|All Cohorts Except 15E|Death|0|||
94295802|NCT04889209|322867907|FG012|All Cohorts Except 15E|Death|0|||
94295803|NCT04889209|322867908|FG013|All Cohorts Except 15E|Death|0|||
94295804|NCT04889209|322867909|FG014|All Cohorts Except 15E|Death|0|||
94295805|NCT04889209|322867910|FG015|All Cohorts Except 15E|Death|0|||
94295806|NCT04889209|322867911|FG016|All Cohorts Except 15E|Death|0|||
94295807|NCT04889209|322867912|FG017|All Cohorts Except 15E|Death|0|||
94295808|NCT04889209|322867895|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
94295809|NCT04889209|322867896|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
94295810|NCT04889209|322867897|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
94295811|NCT04889209|322867898|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
94295812|NCT04889209|322867899|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
94295813|NCT04889209|322867900|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
94295814|NCT04889209|322867901|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
94295815|NCT04889209|322867902|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
94295816|NCT04889209|322867903|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
94295817|NCT04889209|322867904|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
94295818|NCT04889209|322867905|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
94295819|NCT04889209|322867906|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
94295820|NCT04889209|322867907|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
94295821|NCT04889209|322867908|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
94295822|NCT04889209|322867909|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
94295823|NCT04889209|322867910|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
94295824|NCT04889209|322867911|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
94295825|NCT04889209|322867912|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
94295826|NCT04889209|322867895|FG000|All Cohorts Except 15E|Physician Decision|0|||
94295827|NCT04889209|322867896|FG001|All Cohorts Except 15E|Physician Decision|0|||
94295828|NCT04889209|322867897|FG002|All Cohorts Except 15E|Physician Decision|0|||
94295829|NCT04889209|322867898|FG003|All Cohorts Except 15E|Physician Decision|0|||
94295830|NCT04889209|322867899|FG004|All Cohorts Except 15E|Physician Decision|1|||
94295831|NCT04889209|322867900|FG005|All Cohorts Except 15E|Physician Decision|0|||
94295832|NCT04889209|322867901|FG006|All Cohorts Except 15E|Physician Decision|0|||
94295833|NCT04889209|322867902|FG007|All Cohorts Except 15E|Physician Decision|1|||
94295834|NCT04889209|322867903|FG008|All Cohorts Except 15E|Physician Decision|0|||
94295835|NCT04889209|322867904|FG009|All Cohorts Except 15E|Physician Decision|1|||
94295836|NCT04889209|322867905|FG010|All Cohorts Except 15E|Physician Decision|0|||
94372599|NCT03264066|323150314|FG001|Overall Study|Progressive Disease|2|||
94372600|NCT03264066|323150315|FG002|Overall Study|Progressive Disease|1|||
94295837|NCT04889209|322867906|FG011|All Cohorts Except 15E|Physician Decision|1|||
94295838|NCT04889209|322867907|FG012|All Cohorts Except 15E|Physician Decision|1|||
94295839|NCT04889209|322867908|FG013|All Cohorts Except 15E|Physician Decision|0|||
94295840|NCT04889209|322867909|FG014|All Cohorts Except 15E|Physician Decision|0|||
94295841|NCT04889209|322867910|FG015|All Cohorts Except 15E|Physician Decision|0|||
94295842|NCT04889209|322867911|FG016|All Cohorts Except 15E|Physician Decision|0|||
94295843|NCT04889209|322867912|FG017|All Cohorts Except 15E|Physician Decision|0|||
94295844|NCT04889209|322867895|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
94295845|NCT04889209|322867896|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
94295846|NCT04889209|322867897|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
94295847|NCT04889209|322867898|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
94295848|NCT04889209|322867899|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
94295849|NCT04889209|322867900|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
94295850|NCT04889209|322867901|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
94295851|NCT04889209|322867902|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
94295852|NCT04889209|322867903|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
94372601|NCT03264066|323150316|FG003|Overall Study|Progressive Disease|0|||
94372602|NCT03264066|323150317|FG004|Overall Study|Progressive Disease|0|||
94372603|NCT03264066|323150318|FG005|Overall Study|Progressive Disease|0|||
94295853|NCT04889209|322867904|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
94295854|NCT04889209|322867905|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
94295855|NCT04889209|322867906|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
94295856|NCT04889209|322867907|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
94295857|NCT04889209|322867908|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
94295858|NCT04889209|322867909|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
94295859|NCT04889209|322867910|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
94295860|NCT04889209|322867911|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
94295861|NCT04889209|322867912|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
94295862|NCT04889209|322867895|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
94295863|NCT04889209|322867896|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
94295864|NCT04889209|322867897|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
94295865|NCT04889209|322867898|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
94295866|NCT04889209|322867899|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
94295867|NCT04889209|322867900|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
94295868|NCT04889209|322867901|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
94295869|NCT04889209|322867902|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
94295870|NCT04889209|322867903|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
94295871|NCT04889209|322867904|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
94295872|NCT04889209|322867905|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
94295873|NCT04889209|322867906|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
94295874|NCT04889209|322867907|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
94295875|NCT04889209|322867908|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
94295876|NCT04889209|322867909|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
94295877|NCT04889209|322867910|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
94295878|NCT04889209|322867911|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
94295879|NCT04889209|322867912|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
94295880|NCT04889209|322867895|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
94295881|NCT04889209|322867896|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
94295882|NCT04889209|322867897|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
94295883|NCT04889209|322867898|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
94295884|NCT04889209|322867899|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
94295885|NCT04889209|322867900|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
94295886|NCT04889209|322867901|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
94295887|NCT04889209|322867902|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
94295888|NCT04889209|322867903|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
94295889|NCT04889209|322867904|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
94295890|NCT04889209|322867905|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
94295891|NCT04889209|322867906|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
94295892|NCT04889209|322867907|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
94295893|NCT04889209|322867908|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
94295894|NCT04889209|322867909|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
94295895|NCT04889209|322867910|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
94295896|NCT04889209|322867911|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
94295897|NCT04889209|322867912|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
94295898|NCT04889209|322867895|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
94295899|NCT04889209|322867896|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
94295900|NCT04889209|322867897|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
94295901|NCT04889209|322867898|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
94295902|NCT04889209|322867899|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
94295903|NCT04889209|322867900|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
94295904|NCT04889209|322867901|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
94295905|NCT04889209|322867902|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
94295906|NCT04889209|322867903|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
94372604|NCT03264066|323150313|FG000|Overall Study|Study Terminated by Sponsor|5|||
94372605|NCT03264066|323150314|FG001|Overall Study|Study Terminated by Sponsor|5|||
94372606|NCT03264066|323150315|FG002|Overall Study|Study Terminated by Sponsor|8|||
94372607|NCT03264066|323150316|FG003|Overall Study|Study Terminated by Sponsor|5|||
94372608|NCT03264066|323150317|FG004|Overall Study|Study Terminated by Sponsor|1|||
94372609|NCT03264066|323150318|FG005|Overall Study|Study Terminated by Sponsor|2|||
94372610|NCT03264066|323150313|FG000|Overall Study|Withdrawal by Subject|1|||
94372611|NCT03264066|323150314|FG001|Overall Study|Withdrawal by Subject|0|||
94372612|NCT03264066|323150315|FG002|Overall Study|Withdrawal by Subject|0|||
94372613|NCT03264066|323150316|FG003|Overall Study|Withdrawal by Subject|5|||
94372614|NCT03264066|323150317|FG004|Overall Study|Withdrawal by Subject|0|||
94372615|NCT03264066|323150318|FG005|Overall Study|Withdrawal by Subject|0|||
94372616|NCT04304950|323150319|FG000|Overall Study|Lost to Follow-up|1|||
94372617|NCT04304950|323150320|FG001|Overall Study|Lost to Follow-up|1|||
94372618|NCT03077828|323150321|FG000|Treatment Cycles|Death|1|||
94372619|NCT03077828|323150321|FG000|Treatment Cycles|Withdrawal by Subject|1|||
94372620|NCT03077828|323150321|FG000|Treatment Cycles|Screen Fail|2|||
94372621|NCT03077828|323150321|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
94372622|NCT03077828|323150321|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
94372623|NCT03077828|323150321|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
94372624|NCT03077828|323150321|FG000|Follow-up|Patients still in follow-up|15|||
94372625|NCT03493698|323150322|FG000|Treatment Period C|Adverse Event|1|||
94372626|NCT03493698|323150322|FG000|Treatment Period C|Withdrawal by Subject|1|||
94372627|NCT00871728|323150323|FG000|Overall Study|Adverse Event|1|||
94372628|NCT00871728|323150323|FG000|Overall Study|Protocol Violation|7|||
94372629|NCT00871728|323150323|FG000|Overall Study|Lost to Follow-up|2|||
94372630|NCT00871728|323150323|FG000|Overall Study|Failed to Visit Hospital|4|||
94372631|NCT00871728|323150323|FG000|Overall Study|Participant Non-compliance|1|||
94372632|NCT00871728|323150323|FG000|Overall Study|Withdrawal of Informed Consent|5|||
94295907|NCT04889209|322867904|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
94295908|NCT04889209|322867905|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
94295909|NCT04889209|322867906|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
94295910|NCT04889209|322867907|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
94295911|NCT04889209|322867908|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
94295912|NCT04889209|322867909|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
94295913|NCT04889209|322867910|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
94295914|NCT04889209|322867911|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
94295915|NCT04889209|322867912|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
94295916|NCT04889209|322867895|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
94295917|NCT04889209|322867896|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
94295918|NCT04889209|322867897|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
94295919|NCT04889209|322867898|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
94295920|NCT04889209|322867899|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
94295921|NCT04889209|322867900|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
94295922|NCT04889209|322867901|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
94295923|NCT04889209|322867902|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
94295924|NCT04889209|322867903|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
94295925|NCT04889209|322867904|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
94295926|NCT04889209|322867905|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
94295927|NCT04889209|322867906|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
94295928|NCT04889209|322867907|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
94295929|NCT04889209|322867908|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
94295930|NCT04889209|322867909|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
94295931|NCT04889209|322867910|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
94295932|NCT04889209|322867911|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
94295933|NCT04889209|322867912|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
94295934|NCT04889209|322867895|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
94295935|NCT04889209|322867896|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
94295936|NCT04889209|322867897|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
94295937|NCT04889209|322867898|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
94295938|NCT04889209|322867899|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
94295939|NCT04889209|322867900|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
94295940|NCT04889209|322867901|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
94295941|NCT04889209|322867902|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
94295942|NCT04889209|322867903|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
94295943|NCT04889209|322867904|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
94295944|NCT04889209|322867905|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
94295945|NCT04889209|322867906|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
94372633|NCT02418910|323150324|FG000|Overall Study|Lost to Follow-up|3|||
94372634|NCT02418910|323150324|FG000|Overall Study|Withdrawal by Subject|4|||
94372635|NCT02472977|323150326|FG000|Overall Study|Disease progression|4|||
94372636|NCT02472977|323150327|FG001|Overall Study|Disease progression|25|||
94372637|NCT02472977|323150328|FG002|Overall Study|Disease progression|6|||
94372638|NCT02472977|323150326|FG000|Overall Study|Withdrawal by Subject|0|||
94372639|NCT02472977|323150327|FG001|Overall Study|Withdrawal by Subject|1|||
94295946|NCT04889209|322867907|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
94295947|NCT04889209|322867908|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
94295948|NCT04889209|322867909|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
94295949|NCT04889209|322867910|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
94295950|NCT04889209|322867911|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
94295951|NCT04889209|322867912|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
94295952|NCT04889209|322867895|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
94295953|NCT04889209|322867896|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
94295954|NCT04889209|322867897|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
94295955|NCT04889209|322867898|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
94295956|NCT04889209|322867899|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
94295957|NCT04889209|322867900|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
94295958|NCT04889209|322867901|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
94295959|NCT04889209|322867902|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
94295960|NCT04889209|322867903|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
94295961|NCT04889209|322867904|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
94295962|NCT04889209|322867905|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
94295963|NCT04889209|322867906|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
94295964|NCT04889209|322867907|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
94295965|NCT04889209|322867908|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
94295966|NCT04889209|322867909|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
94295967|NCT04889209|322867910|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
94295968|NCT04889209|322867911|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
94295969|NCT04889209|322867912|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
94295970|NCT05254418|322867913|FG000|Overall Study|Adverse Event|2|||
94295971|NCT01323478|322867915|FG000|Overall Study|Adverse Event|7|||
94295972|NCT01323478|322867915|FG000|Overall Study|Lack of Efficacy|4|||
94295973|NCT01323478|322867915|FG000|Overall Study|Non-compliance With Study Product|3|||
94295974|NCT01323478|322867915|FG000|Overall Study|Protocol Violation|1|||
94295975|NCT01323478|322867915|FG000|Overall Study|Withdrawal of Consent|1|||
94295976|NCT01323478|322867915|FG000|Overall Study|Administrative or Other Reasons|8|||
94295977|NCT03155997|322867916|FG000|Overall Study|Withdrawal by Subject|119|||
94295978|NCT03155997|322867917|FG001|Overall Study|Withdrawal by Subject|134|||
94295979|NCT03155997|322867916|FG000|Overall Study|Lost to Follow-up|12|||
94295980|NCT03155997|322867917|FG001|Overall Study|Lost to Follow-up|13|||
94295981|NCT03155997|322867916|FG000|Overall Study|Missing disposition data|0|||
94295982|NCT03155997|322867917|FG001|Overall Study|Missing disposition data|1|||
94295983|NCT03155997|322867916|FG000|Overall Study|On study treatment|2027|||
94295984|NCT03155997|322867917|FG001|Overall Study|On study treatment|2074|||
94295985|NCT01848145|322867918|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
94295986|NCT01848145|322867918|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
94295987|NCT01848145|322867918|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
94295988|NCT01848145|322867918|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
94295989|NCT01848145|322867918|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
94295990|NCT01848145|322867918|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
94295991|NCT01848145|322867918|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
94295992|NCT01256177|322867921|FG000|Overall Study|Withdrawal by Subject|23|||
94295993|NCT01256177|322867922|FG001|Overall Study|Withdrawal by Subject|22|||
94295994|NCT01256177|322867921|FG000|Overall Study|Lost to Follow-up|2|||
94295995|NCT01256177|322867922|FG001|Overall Study|Lost to Follow-up|2|||
94295996|NCT01256177|322867921|FG000|Overall Study|Adverse Event|8|||
94295997|NCT01256177|322867922|FG001|Overall Study|Adverse Event|9|||
94295998|NCT01256177|322867921|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
94295999|NCT01256177|322867922|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
94296000|NCT01256177|322867921|FG000|Overall Study|Condition under Investigation Worsened|1|||
94296001|NCT01256177|322867922|FG001|Overall Study|Condition under Investigation Worsened|0|||
94296002|NCT01256177|322867921|FG000|Overall Study|Lack of Efficacy|11|||
94296003|NCT01256177|322867922|FG001|Overall Study|Lack of Efficacy|2|||
94296004|NCT01256177|322867921|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
94296005|NCT01256177|322867922|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
94296006|NCT04398732|322867923|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
94296007|NCT03093402|322867925|FG000|Overall Study|Lost to Follow-up|1|||
94296008|NCT03093402|322867926|FG001|Overall Study|Lost to Follow-up|0|||
94296009|NCT03093402|322867927|FG002|Overall Study|Lost to Follow-up|0|||
94296010|NCT03093402|322867928|FG003|Overall Study|Lost to Follow-up|0|||
94296011|NCT03093402|322867925|FG000|Overall Study|Withdrawal by Subject|3|||
94296012|NCT03093402|322867926|FG001|Overall Study|Withdrawal by Subject|3|||
94296013|NCT03093402|322867927|FG002|Overall Study|Withdrawal by Subject|0|||
94372640|NCT02472977|323150328|FG002|Overall Study|Withdrawal by Subject|0|||
94372641|NCT02472977|323150326|FG000|Overall Study|Study drug toxicity|2|||
94296014|NCT03093402|322867928|FG003|Overall Study|Withdrawal by Subject|1|||
94296015|NCT03093402|322867925|FG000|Overall Study|Withdrew prior to dosing|2|||
94296016|NCT03093402|322867926|FG001|Overall Study|Withdrew prior to dosing|1|||
94296017|NCT03093402|322867927|FG002|Overall Study|Withdrew prior to dosing|2|||
94296018|NCT03093402|322867928|FG003|Overall Study|Withdrew prior to dosing|3|||
94296019|NCT03093402|322867925|FG000|Overall Study|Ineligible for study|1|||
94296020|NCT03093402|322867926|FG001|Overall Study|Ineligible for study|0|||
94296021|NCT03093402|322867927|FG002|Overall Study|Ineligible for study|0|||
94296022|NCT03093402|322867928|FG003|Overall Study|Ineligible for study|0|||
94296023|NCT03093402|322867925|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
94296024|NCT03093402|322867926|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
94296025|NCT03093402|322867927|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
94296026|NCT03093402|322867928|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
94296027|NCT02886702|322867929|FG000|Overall Study|Other|4|||
94296028|NCT02886702|322867930|FG001|Overall Study|Other|3|||
94296029|NCT02886702|322867931|FG002|Overall Study|Other|9|||
94296030|NCT02886702|322867929|FG000|Overall Study|Withdrawal by Subject|24|||
94296031|NCT02886702|322867930|FG001|Overall Study|Withdrawal by Subject|18|||
94296032|NCT02886702|322867931|FG002|Overall Study|Withdrawal by Subject|22|||
94296033|NCT02886702|322867929|FG000|Overall Study|Significant Worsening of Condition|0|||
94296034|NCT02886702|322867930|FG001|Overall Study|Significant Worsening of Condition|1|||
94296035|NCT02886702|322867931|FG002|Overall Study|Significant Worsening of Condition|0|||
94296036|NCT02886702|322867929|FG000|Overall Study|Protocol Violation|2|||
94296037|NCT02886702|322867930|FG001|Overall Study|Protocol Violation|2|||
94296038|NCT02886702|322867931|FG002|Overall Study|Protocol Violation|1|||
94296039|NCT02886702|322867929|FG000|Overall Study|Non-Compliance With Study Drug|0|||
94296040|NCT02886702|322867930|FG001|Overall Study|Non-Compliance With Study Drug|1|||
94296041|NCT02886702|322867931|FG002|Overall Study|Non-Compliance With Study Drug|4|||
94296042|NCT02886702|322867929|FG000|Overall Study|Lost to Follow-up|11|||
94296043|NCT02886702|322867930|FG001|Overall Study|Lost to Follow-up|13|||
94296044|NCT02886702|322867931|FG002|Overall Study|Lost to Follow-up|8|||
94296045|NCT02886702|322867929|FG000|Overall Study|Lack of Efficacy|3|||
94296046|NCT02886702|322867930|FG001|Overall Study|Lack of Efficacy|4|||
94296047|NCT02886702|322867931|FG002|Overall Study|Lack of Efficacy|5|||
94296048|NCT02886702|322867929|FG000|Overall Study|Adverse Event|4|||
94296049|NCT02886702|322867930|FG001|Overall Study|Adverse Event|9|||
94296050|NCT02886702|322867931|FG002|Overall Study|Adverse Event|3|||
94296051|NCT02886702|322867929|FG000|Overall Study|Administrative Reasons|0|||
94296052|NCT02886702|322867930|FG001|Overall Study|Administrative Reasons|0|||
94296053|NCT02886702|322867931|FG002|Overall Study|Administrative Reasons|1|||
94296054|NCT00474240|322867935|FG000|Overall Study|Withdrawal by Subject|1|||
94296055|NCT00474240|322867936|FG001|Overall Study|Withdrawal by Subject|1|||
94296056|NCT00474240|322867937|FG002|Overall Study|Withdrawal by Subject|0|||
94296057|NCT00474240|322867938|FG003|Overall Study|Withdrawal by Subject|2|||
94296058|NCT00474240|322867939|FG004|Overall Study|Withdrawal by Subject|3|||
94296059|NCT00474240|322867940|FG005|Overall Study|Withdrawal by Subject|1|||
94296060|NCT00474240|322867935|FG000|Overall Study|Adverse Event|0|||
94296061|NCT00474240|322867936|FG001|Overall Study|Adverse Event|0|||
94296062|NCT00474240|322867937|FG002|Overall Study|Adverse Event|9|||
94296063|NCT00474240|322867938|FG003|Overall Study|Adverse Event|14|||
94296064|NCT00474240|322867939|FG004|Overall Study|Adverse Event|5|||
94296065|NCT00474240|322867940|FG005|Overall Study|Adverse Event|16|||
94296066|NCT00474240|322867935|FG000|Overall Study|Removed due to lab value|0|||
94296067|NCT00474240|322867936|FG001|Overall Study|Removed due to lab value|0|||
94296068|NCT00474240|322867937|FG002|Overall Study|Removed due to lab value|0|||
94296069|NCT00474240|322867938|FG003|Overall Study|Removed due to lab value|0|||
94296070|NCT00474240|322867939|FG004|Overall Study|Removed due to lab value|0|||
94296071|NCT00474240|322867940|FG005|Overall Study|Removed due to lab value|1|||
94296072|NCT02054702|322867941|FG000|Overall Study|Lost to Follow-up|3|||
94296073|NCT02054702|322867942|FG001|Overall Study|Lost to Follow-up|5|||
94296074|NCT02054702|322867941|FG000|Overall Study|Adverse Event|3|||
94296075|NCT02054702|322867942|FG001|Overall Study|Adverse Event|1|||
94296076|NCT02054702|322867941|FG000|Overall Study|Met Withdrawal Criteria|4|||
94296077|NCT02054702|322867942|FG001|Overall Study|Met Withdrawal Criteria|1|||
94296078|NCT02054702|322867941|FG000|Overall Study|Physician Decision|0|||
94296079|NCT02054702|322867942|FG001|Overall Study|Physician Decision|1|||
94296080|NCT02054702|322867941|FG000|Overall Study|Withdrawal by Subject|14|||
94296081|NCT02054702|322867942|FG001|Overall Study|Withdrawal by Subject|4|||
94296082|NCT02318784|322867947|FG000|Overall Study|Adverse Event|13|||
94296083|NCT02318784|322867947|FG000|Overall Study|Death|2|||
94296084|NCT02318784|322867947|FG000|Overall Study|Progressive Disease|37|||
94296085|NCT02318784|322867947|FG000|Overall Study|Withdrawal by Subject|10|||
94296086|NCT01700829|322867953|FG000|Overall Study|Withdrawal by Subject|1|||
94296087|NCT01700829|322867954|FG001|Overall Study|Withdrawal by Subject|1|||
94296088|NCT00486603|322867960|FG000|Overall Study|Withdrawal by Subject|1|||
94296089|NCT00486603|322867961|FG001|Overall Study|Withdrawal by Subject|0|||
94296090|NCT00486603|322867962|FG002|Overall Study|Withdrawal by Subject|0|||
94296091|NCT00486603|322867963|FG003|Overall Study|Withdrawal by Subject|0|||
94296092|NCT00486603|322867964|FG004|Overall Study|Withdrawal by Subject|0|||
94296093|NCT00486603|322867960|FG000|Overall Study|Physician Decision|0|||
94296094|NCT00486603|322867961|FG001|Overall Study|Physician Decision|1|||
94296095|NCT00486603|322867962|FG002|Overall Study|Physician Decision|0|||
94296096|NCT00486603|322867963|FG003|Overall Study|Physician Decision|0|||
94296097|NCT00486603|322867964|FG004|Overall Study|Physician Decision|0|||
94296098|NCT02786901|322867965|FG000|Overall Study|Adverse Event|1|||
94296099|NCT02786901|322867966|FG001|Overall Study|Adverse Event|1|||
94296100|NCT02786901|322867967|FG002|Overall Study|Adverse Event|2|||
94296101|NCT02786901|322867965|FG000|Overall Study|Physician Decision|1|||
94296102|NCT02786901|322867966|FG001|Overall Study|Physician Decision|0|||
94296103|NCT02786901|322867967|FG002|Overall Study|Physician Decision|0|||
94296104|NCT02786901|322867965|FG000|Overall Study|Rescue Therapy Use|71|||
94296105|NCT02786901|322867966|FG001|Overall Study|Rescue Therapy Use|49|||
94296106|NCT02786901|322867967|FG002|Overall Study|Rescue Therapy Use|33|||
94296107|NCT02786901|322867965|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
94296108|NCT02786901|322867966|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
94296109|NCT02786901|322867967|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
94296110|NCT02786901|322867965|FG000|Overall Study|Disallowed medication|1|||
94296111|NCT02786901|322867966|FG001|Overall Study|Disallowed medication|1|||
94296112|NCT02786901|322867967|FG002|Overall Study|Disallowed medication|0|||
94296113|NCT02786901|322867965|FG000|Overall Study|Randomized in error|2|||
94296114|NCT02786901|322867966|FG001|Overall Study|Randomized in error|0|||
94296115|NCT02786901|322867967|FG002|Overall Study|Randomized in error|1|||
94296116|NCT03367871|322867968|FG000|Overall Study|Lost to Follow-up|1|||
94296117|NCT01075178|322867969|FG000|Subject Matching|eligible but not matched|130|||
94296118|NCT01075178|322867970|FG001|Subject Matching|eligible but not matched|403|||
94296119|NCT01075178|322867969|FG000|Subject Chart Review|died before chart review period|0|||
94296120|NCT01075178|322867970|FG001|Subject Chart Review|died before chart review period|2|||
94296121|NCT01075178|322867969|FG000|Subject Chart Review|no data collected due to site closure|3|||
94296122|NCT01075178|322867970|FG001|Subject Chart Review|no data collected due to site closure|4|||
94296123|NCT01075178|322867969|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
94296124|NCT01075178|322867970|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
94296125|NCT00763009|322867971|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
94296126|NCT01111604|322867972|FG000|Overall Study|Lost to Follow-up|0|||
94296127|NCT01111604|322867973|FG001|Overall Study|Lost to Follow-up|0|||
94296128|NCT01111604|322867974|FG002|Overall Study|Lost to Follow-up|1|||
94296129|NCT01111604|322867972|FG000|Overall Study|Withdrew Consent|3|||
94296130|NCT01111604|322867973|FG001|Overall Study|Withdrew Consent|0|||
94296131|NCT01111604|322867974|FG002|Overall Study|Withdrew Consent|2|||
94296132|NCT01111604|322867972|FG000|Overall Study|Withdrawal by Subject|2|||
94296133|NCT01111604|322867973|FG001|Overall Study|Withdrawal by Subject|0|||
94296134|NCT01111604|322867974|FG002|Overall Study|Withdrawal by Subject|0|||
94296135|NCT01111604|322867972|FG000|Overall Study|Death|1|||
94296136|NCT01111604|322867973|FG001|Overall Study|Death|0|||
94296137|NCT01111604|322867974|FG002|Overall Study|Death|0|||
94296138|NCT01111604|322867972|FG000|Overall Study|Met Exclusion Criteria|2|||
94296139|NCT01111604|322867973|FG001|Overall Study|Met Exclusion Criteria|0|||
94296140|NCT01111604|322867974|FG002|Overall Study|Met Exclusion Criteria|0|||
94296141|NCT00607048|322867975|FG000|Overall Study|Adverse Event|0|||
94296142|NCT00607048|322867976|FG001|Overall Study|Adverse Event|1|||
94296143|NCT00607048|322867977|FG002|Overall Study|Adverse Event|0|||
94296144|NCT00607048|322867978|FG003|Overall Study|Adverse Event|0|||
94296145|NCT00607048|322867979|FG004|Overall Study|Adverse Event|4|||
94296146|NCT00607048|322867980|FG005|Overall Study|Adverse Event|0|||
94296147|NCT00607048|322867975|FG000|Overall Study|Global deterioration of health|1|||
94296148|NCT00607048|322867976|FG001|Overall Study|Global deterioration of health|0|||
94296149|NCT00607048|322867977|FG002|Overall Study|Global deterioration of health|0|||
94296150|NCT00607048|322867978|FG003|Overall Study|Global deterioration of health|0|||
94296151|NCT00607048|322867979|FG004|Overall Study|Global deterioration of health|0|||
94296152|NCT00607048|322867980|FG005|Overall Study|Global deterioration of health|0|||
94296153|NCT00607048|322867975|FG000|Overall Study|Objective disease progression - relapse|1|||
94296154|NCT00607048|322867976|FG001|Overall Study|Objective disease progression - relapse|2|||
94296155|NCT00607048|322867977|FG002|Overall Study|Objective disease progression - relapse|4|||
94296156|NCT00607048|322867978|FG003|Overall Study|Objective disease progression - relapse|2|||
94296157|NCT00607048|322867979|FG004|Overall Study|Objective disease progression - relapse|2|||
94296158|NCT00607048|322867980|FG005|Overall Study|Objective disease progression - relapse|2|||
94296159|NCT00607048|322867975|FG000|Overall Study|Withdrawal by Subject|0|||
94296160|NCT00607048|322867976|FG001|Overall Study|Withdrawal by Subject|0|||
94296161|NCT00607048|322867977|FG002|Overall Study|Withdrawal by Subject|0|||
94296162|NCT00607048|322867978|FG003|Overall Study|Withdrawal by Subject|1|||
94296163|NCT00607048|322867979|FG004|Overall Study|Withdrawal by Subject|0|||
94296164|NCT00607048|322867980|FG005|Overall Study|Withdrawal by Subject|2|||
94296165|NCT00607048|322867975|FG000|Overall Study|Other|1|||
94296166|NCT00607048|322867976|FG001|Overall Study|Other|1|||
94296167|NCT00607048|322867977|FG002|Overall Study|Other|0|||
94296168|NCT00607048|322867978|FG003|Overall Study|Other|0|||
94296169|NCT00607048|322867979|FG004|Overall Study|Other|0|||
94296170|NCT00607048|322867980|FG005|Overall Study|Other|1|||
94296171|NCT02013544|322867981|FG000|Overall Study|Adverse Event|5|||
94296172|NCT02013544|322867982|FG001|Overall Study|Adverse Event|5|||
94296173|NCT02013544|322867981|FG000|Overall Study|Lost to Follow-up|2|||
94296174|NCT02013544|322867982|FG001|Overall Study|Lost to Follow-up|3|||
94296175|NCT02013544|322867981|FG000|Overall Study|Withdrawal by Subject|2|||
94296176|NCT02013544|322867982|FG001|Overall Study|Withdrawal by Subject|8|||
94296177|NCT02013544|322867981|FG000|Overall Study|Physician Decision|0|||
94296178|NCT02013544|322867982|FG001|Overall Study|Physician Decision|1|||
94296179|NCT02013544|322867981|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
94296180|NCT02013544|322867982|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
94296181|NCT00238264|322867983|FG000|Overall Study|Death|7|||
94296182|NCT00238264|322867983|FG000|Overall Study|Lost to Follow-up|18|||
94296183|NCT00238264|322867983|FG000|Overall Study|Withdrawal by Subject|4|||
94296184|NCT00238264|322867983|FG000|Overall Study|Ineligible|7|||
94296185|NCT03514914|322867984|FG000|Overall Study|Death|3|||
94296186|NCT03514914|322867985|FG001|Overall Study|Death|3|||
94296187|NCT03514914|322867984|FG000|Overall Study|Lost to Follow-up|117|||
94296188|NCT03514914|322867985|FG001|Overall Study|Lost to Follow-up|89|||
94296189|NCT01085682|322867986|FG000|Overall Study|Withdrawal by Subject|25|||
94296190|NCT01085682|322867987|FG001|Overall Study|Withdrawal by Subject|25|||
94296191|NCT03926143|322867989|FG000|Overall Study|Physician Decision|3|||
94296192|NCT03926143|322867989|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
94296193|NCT03926143|322867989|FG000|Overall Study|Adverse Event|2|||
94296194|NCT03926143|322867989|FG000|Overall Study|Progressive disease|3|||
94296195|NCT00706628|322867990|FG000|Overall Study|Other Adverse Event|16|||
94296196|NCT00706628|322867991|FG001|Overall Study|Other Adverse Event|5|||
94296197|NCT00706628|322867992|FG002|Overall Study|Other Adverse Event|5|||
94296198|NCT00706628|322867993|FG003|Overall Study|Other Adverse Event|2|||
94296199|NCT00706628|322867990|FG000|Overall Study|Non compliant with protocol|0|||
94296200|NCT00706628|322867991|FG001|Overall Study|Non compliant with protocol|1|||
94296201|NCT00706628|322867992|FG002|Overall Study|Non compliant with protocol|0|||
94296202|NCT00706628|322867993|FG003|Overall Study|Non compliant with protocol|0|||
94296203|NCT00706628|322867990|FG000|Overall Study|Consent withdrawn|6|||
94296204|NCT00706628|322867991|FG001|Overall Study|Consent withdrawn|1|||
94296205|NCT00706628|322867992|FG002|Overall Study|Consent withdrawn|3|||
94296206|NCT00706628|322867993|FG003|Overall Study|Consent withdrawn|0|||
94296207|NCT00706628|322867990|FG000|Overall Study|Progressive disease|20|||
94296208|NCT00706628|322867991|FG001|Overall Study|Progressive disease|13|||
94296209|NCT00706628|322867992|FG002|Overall Study|Progressive disease|8|||
94296210|NCT00706628|322867993|FG003|Overall Study|Progressive disease|1|||
94296211|NCT00706628|322867990|FG000|Overall Study|Other than those stated above|4|||
94296212|NCT00706628|322867991|FG001|Overall Study|Other than those stated above|0|||
94296213|NCT00706628|322867992|FG002|Overall Study|Other than those stated above|0|||
94296214|NCT00706628|322867993|FG003|Overall Study|Other than those stated above|0|||
94296215|NCT00706628|322867990|FG000|Overall Study|Not treated|1|||
94296216|NCT00706628|322867991|FG001|Overall Study|Not treated|1|||
94296217|NCT00706628|322867992|FG002|Overall Study|Not treated|0|||
94296218|NCT00706628|322867993|FG003|Overall Study|Not treated|0|||
94296219|NCT00868790|322867994|FG000|Period 1|Adverse Event|1|||
94296220|NCT00868790|322867995|FG001|Period 1|Adverse Event|0|||
94296221|NCT00868790|322867996|FG002|Period 1|Adverse Event|0|||
94296222|NCT00868790|322867997|FG003|Period 1|Adverse Event|0|||
94296223|NCT00868790|322867998|FG004|Period 1|Adverse Event|0|||
94296224|NCT00868790|322867999|FG005|Period 1|Adverse Event|0|||
94296225|NCT00868790|322868000|FG006|Period 1|Adverse Event|0|||
94296226|NCT00868790|322868001|FG007|Period 1|Adverse Event|3|||
94296227|NCT00868790|322868002|FG008|Period 1|Adverse Event|1|||
94296228|NCT00868790|322868003|FG009|Period 1|Adverse Event|0|||
94296229|NCT00868790|322868004|FG010|Period 1|Adverse Event|0|||
94296230|NCT00868790|322868005|FG011|Period 1|Adverse Event|0|||
94296231|NCT00868790|322868006|FG012|Period 1|Adverse Event|0|||
94296232|NCT00868790|322868007|FG013|Period 1|Adverse Event|1|||
94296233|NCT00868790|322867994|FG000|Period 1|Protocol Violation|1|||
94296234|NCT00868790|322867995|FG001|Period 1|Protocol Violation|0|||
94296235|NCT00868790|322867996|FG002|Period 1|Protocol Violation|0|||
94296236|NCT00868790|322867997|FG003|Period 1|Protocol Violation|0|||
94296237|NCT00868790|322867998|FG004|Period 1|Protocol Violation|0|||
94296238|NCT00868790|322867999|FG005|Period 1|Protocol Violation|0|||
94296239|NCT00868790|322868000|FG006|Period 1|Protocol Violation|0|||
94296240|NCT00868790|322868001|FG007|Period 1|Protocol Violation|0|||
94296241|NCT00868790|322868002|FG008|Period 1|Protocol Violation|0|||
94296242|NCT00868790|322868003|FG009|Period 1|Protocol Violation|0|||
94296243|NCT00868790|322868004|FG010|Period 1|Protocol Violation|0|||
94296244|NCT00868790|322868005|FG011|Period 1|Protocol Violation|0|||
94296245|NCT00868790|322868006|FG012|Period 1|Protocol Violation|0|||
94467989|NCT00803205|323502464|FG001|Overall Study|Withdrawal by Subject|9|||
94296246|NCT00868790|322868007|FG013|Period 1|Protocol Violation|0|||
94296247|NCT00868790|322867994|FG000|Period 1|Withdrawal by Subject|0|||
94296248|NCT00868790|322867995|FG001|Period 1|Withdrawal by Subject|1|||
94296249|NCT00868790|322867996|FG002|Period 1|Withdrawal by Subject|0|||
94296250|NCT00868790|322867997|FG003|Period 1|Withdrawal by Subject|0|||
94296251|NCT00868790|322867998|FG004|Period 1|Withdrawal by Subject|0|||
94296252|NCT00868790|322867999|FG005|Period 1|Withdrawal by Subject|0|||
94296253|NCT00868790|322868000|FG006|Period 1|Withdrawal by Subject|0|||
94296254|NCT00868790|322868001|FG007|Period 1|Withdrawal by Subject|0|||
94296255|NCT00868790|322868002|FG008|Period 1|Withdrawal by Subject|0|||
94296256|NCT00868790|322868003|FG009|Period 1|Withdrawal by Subject|0|||
94296257|NCT00868790|322868004|FG010|Period 1|Withdrawal by Subject|0|||
94296258|NCT00868790|322868005|FG011|Period 1|Withdrawal by Subject|0|||
94296259|NCT00868790|322868006|FG012|Period 1|Withdrawal by Subject|0|||
94296260|NCT00868790|322868007|FG013|Period 1|Withdrawal by Subject|1|||
94296261|NCT00868790|322867994|FG000|Period 1|Abnormal Triglycerides|0|||
94296262|NCT00868790|322867995|FG001|Period 1|Abnormal Triglycerides|0|||
94296263|NCT00868790|322867996|FG002|Period 1|Abnormal Triglycerides|0|||
94296264|NCT00868790|322867997|FG003|Period 1|Abnormal Triglycerides|0|||
94296265|NCT00868790|322867998|FG004|Period 1|Abnormal Triglycerides|1|||
94296266|NCT00868790|322867999|FG005|Period 1|Abnormal Triglycerides|0|||
94296267|NCT00868790|322868000|FG006|Period 1|Abnormal Triglycerides|0|||
94296268|NCT00868790|322868001|FG007|Period 1|Abnormal Triglycerides|0|||
94296269|NCT00868790|322868002|FG008|Period 1|Abnormal Triglycerides|0|||
94296270|NCT00868790|322868003|FG009|Period 1|Abnormal Triglycerides|0|||
94296271|NCT00868790|322868004|FG010|Period 1|Abnormal Triglycerides|0|||
94296272|NCT00868790|322868005|FG011|Period 1|Abnormal Triglycerides|0|||
94296273|NCT00868790|322868006|FG012|Period 1|Abnormal Triglycerides|0|||
94296274|NCT00868790|322868007|FG013|Period 1|Abnormal Triglycerides|0|||
94296275|NCT00868790|322867994|FG000|Period 1|Lost to Follow-up|0|||
94296276|NCT00868790|322867995|FG001|Period 1|Lost to Follow-up|0|||
94296277|NCT00868790|322867996|FG002|Period 1|Lost to Follow-up|0|||
94296278|NCT00868790|322867997|FG003|Period 1|Lost to Follow-up|0|||
94296279|NCT00868790|322867998|FG004|Period 1|Lost to Follow-up|0|||
94296280|NCT00868790|322867999|FG005|Period 1|Lost to Follow-up|1|||
94296281|NCT00868790|322868000|FG006|Period 1|Lost to Follow-up|0|||
94296282|NCT00868790|322868001|FG007|Period 1|Lost to Follow-up|0|||
94296283|NCT00868790|322868002|FG008|Period 1|Lost to Follow-up|0|||
94296284|NCT00868790|322868003|FG009|Period 1|Lost to Follow-up|0|||
94296285|NCT00868790|322868004|FG010|Period 1|Lost to Follow-up|0|||
94296286|NCT00868790|322868005|FG011|Period 1|Lost to Follow-up|0|||
94296287|NCT00868790|322868006|FG012|Period 1|Lost to Follow-up|0|||
94296288|NCT00868790|322868007|FG013|Period 1|Lost to Follow-up|0|||
94296289|NCT00868790|322867994|FG000|Period 2|Adverse Event|0|||
94296290|NCT00868790|322867995|FG001|Period 2|Adverse Event|0|||
94296291|NCT00868790|322867996|FG002|Period 2|Adverse Event|0|||
94296292|NCT00868790|322867997|FG003|Period 2|Adverse Event|0|||
94296293|NCT00868790|322867998|FG004|Period 2|Adverse Event|0|||
94296294|NCT00868790|322867999|FG005|Period 2|Adverse Event|0|||
94296295|NCT00868790|322868000|FG006|Period 2|Adverse Event|0|||
94296296|NCT00868790|322868001|FG007|Period 2|Adverse Event|0|||
94296297|NCT00868790|322868002|FG008|Period 2|Adverse Event|1|||
94296298|NCT00868790|322868003|FG009|Period 2|Adverse Event|0|||
94296299|NCT00868790|322868004|FG010|Period 2|Adverse Event|0|||
94296300|NCT00868790|322868005|FG011|Period 2|Adverse Event|0|||
94296301|NCT00868790|322868006|FG012|Period 2|Adverse Event|0|||
94296302|NCT00868790|322868007|FG013|Period 2|Adverse Event|0|||
94296303|NCT00868790|322867994|FG000|Period 2|Lost to Follow-up|0|||
94296304|NCT00868790|322867995|FG001|Period 2|Lost to Follow-up|1|||
94296305|NCT00868790|322867996|FG002|Period 2|Lost to Follow-up|0|||
94296306|NCT00868790|322867997|FG003|Period 2|Lost to Follow-up|0|||
94296307|NCT00868790|322867998|FG004|Period 2|Lost to Follow-up|0|||
94296308|NCT00868790|322867999|FG005|Period 2|Lost to Follow-up|1|||
94296309|NCT00868790|322868000|FG006|Period 2|Lost to Follow-up|0|||
94296310|NCT00868790|322868001|FG007|Period 2|Lost to Follow-up|0|||
94296311|NCT00868790|322868002|FG008|Period 2|Lost to Follow-up|0|||
94296312|NCT00868790|322868003|FG009|Period 2|Lost to Follow-up|0|||
94296313|NCT00868790|322868004|FG010|Period 2|Lost to Follow-up|0|||
94296314|NCT00868790|322868005|FG011|Period 2|Lost to Follow-up|0|||
94296315|NCT00868790|322868006|FG012|Period 2|Lost to Follow-up|0|||
94296316|NCT00868790|322868007|FG013|Period 2|Lost to Follow-up|0|||
94296317|NCT00868790|322867994|FG000|Period 2|Withdrawal by Subject|0|||
94296318|NCT00868790|322867995|FG001|Period 2|Withdrawal by Subject|0|||
94296319|NCT00868790|322867996|FG002|Period 2|Withdrawal by Subject|0|||
94296320|NCT00868790|322867997|FG003|Period 2|Withdrawal by Subject|0|||
94296321|NCT00868790|322867998|FG004|Period 2|Withdrawal by Subject|0|||
94296322|NCT00868790|322867999|FG005|Period 2|Withdrawal by Subject|0|||
94296323|NCT00868790|322868000|FG006|Period 2|Withdrawal by Subject|0|||
94296324|NCT00868790|322868001|FG007|Period 2|Withdrawal by Subject|0|||
94296325|NCT00868790|322868002|FG008|Period 2|Withdrawal by Subject|1|||
94296326|NCT00868790|322868003|FG009|Period 2|Withdrawal by Subject|0|||
94296327|NCT00868790|322868004|FG010|Period 2|Withdrawal by Subject|0|||
94296328|NCT00868790|322868005|FG011|Period 2|Withdrawal by Subject|0|||
94296329|NCT00868790|322868006|FG012|Period 2|Withdrawal by Subject|0|||
94296330|NCT00868790|322868007|FG013|Period 2|Withdrawal by Subject|1|||
94296331|NCT00868790|322867994|FG000|Period 3|Adverse Event|0|||
94296332|NCT00868790|322867995|FG001|Period 3|Adverse Event|0|||
94296333|NCT00868790|322867996|FG002|Period 3|Adverse Event|0|||
94296334|NCT00868790|322867997|FG003|Period 3|Adverse Event|0|||
94296335|NCT00868790|322867998|FG004|Period 3|Adverse Event|0|||
94296336|NCT00868790|322867999|FG005|Period 3|Adverse Event|0|||
94296337|NCT00868790|322868000|FG006|Period 3|Adverse Event|0|||
94296338|NCT00868790|322868001|FG007|Period 3|Adverse Event|0|||
94296339|NCT00868790|322868002|FG008|Period 3|Adverse Event|0|||
94296340|NCT00868790|322868003|FG009|Period 3|Adverse Event|1|||
94296341|NCT00868790|322868004|FG010|Period 3|Adverse Event|0|||
94296342|NCT00868790|322868005|FG011|Period 3|Adverse Event|0|||
94296343|NCT00868790|322868006|FG012|Period 3|Adverse Event|0|||
94372642|NCT02472977|323150327|FG001|Overall Study|Study drug toxicity|0|||
94372643|NCT02472977|323150328|FG002|Overall Study|Study drug toxicity|2|||
94372644|NCT02472977|323150326|FG000|Overall Study|Subject request to discontinue treatment|0|||
94372645|NCT02472977|323150327|FG001|Overall Study|Subject request to discontinue treatment|1|||
94372646|NCT02472977|323150328|FG002|Overall Study|Subject request to discontinue treatment|0|||
94372647|NCT01199601|323150331|FG000|Overall Study|Lost to Follow-up|47|||
94372648|NCT01199601|323150332|FG001|Overall Study|Lost to Follow-up|66|||
94372649|NCT01199601|323150331|FG000|Overall Study|Withdrawal by Subject|15|||
94372650|NCT01199601|323150332|FG001|Overall Study|Withdrawal by Subject|3|||
94372651|NCT01199601|323150331|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
94372652|NCT01199601|323150332|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
94296344|NCT00868790|322868007|FG013|Period 3|Adverse Event|0|||
94296345|NCT00868790|322867994|FG000|Period 3|Protocol Violation|0|||
94296346|NCT00868790|322867995|FG001|Period 3|Protocol Violation|0|||
94296347|NCT00868790|322867996|FG002|Period 3|Protocol Violation|0|||
94296348|NCT00868790|322867997|FG003|Period 3|Protocol Violation|0|||
94296349|NCT00868790|322867998|FG004|Period 3|Protocol Violation|0|||
94296350|NCT00868790|322867999|FG005|Period 3|Protocol Violation|0|||
94296351|NCT00868790|322868000|FG006|Period 3|Protocol Violation|0|||
94372653|NCT00345683|323150333|FG000|Overall Study|Lost to Follow-up|19|||
94296352|NCT00868790|322868001|FG007|Period 3|Protocol Violation|0|||
94296353|NCT00868790|322868002|FG008|Period 3|Protocol Violation|0|||
94296354|NCT00868790|322868003|FG009|Period 3|Protocol Violation|0|||
94296355|NCT00868790|322868004|FG010|Period 3|Protocol Violation|1|||
94296356|NCT00868790|322868005|FG011|Period 3|Protocol Violation|0|||
94296357|NCT00868790|322868006|FG012|Period 3|Protocol Violation|0|||
94296358|NCT00868790|322868007|FG013|Period 3|Protocol Violation|0|||
94296359|NCT00868790|322867994|FG000|Period 3|Study Terminated by Sponsor|0|||
94296360|NCT00868790|322867995|FG001|Period 3|Study Terminated by Sponsor|0|||
94296361|NCT00868790|322867996|FG002|Period 3|Study Terminated by Sponsor|0|||
94296362|NCT00868790|322867997|FG003|Period 3|Study Terminated by Sponsor|1|||
94296363|NCT00868790|322867998|FG004|Period 3|Study Terminated by Sponsor|0|||
94296364|NCT00868790|322867999|FG005|Period 3|Study Terminated by Sponsor|0|||
94296365|NCT00868790|322868000|FG006|Period 3|Study Terminated by Sponsor|0|||
94296366|NCT00868790|322868001|FG007|Period 3|Study Terminated by Sponsor|0|||
94296367|NCT00868790|322868002|FG008|Period 3|Study Terminated by Sponsor|0|||
94296368|NCT00868790|322868003|FG009|Period 3|Study Terminated by Sponsor|0|||
94296369|NCT00868790|322868004|FG010|Period 3|Study Terminated by Sponsor|0|||
94296370|NCT00868790|322868005|FG011|Period 3|Study Terminated by Sponsor|0|||
94296371|NCT00868790|322868006|FG012|Period 3|Study Terminated by Sponsor|0|||
94296372|NCT00868790|322868007|FG013|Period 3|Study Terminated by Sponsor|0|||
94296373|NCT00868790|322867994|FG000|Period 4|Adverse Event|0|||
94296374|NCT00868790|322867995|FG001|Period 4|Adverse Event|0|||
94296375|NCT00868790|322867996|FG002|Period 4|Adverse Event|0|||
94296376|NCT00868790|322867997|FG003|Period 4|Adverse Event|0|||
94296377|NCT00868790|322867998|FG004|Period 4|Adverse Event|0|||
94296378|NCT00868790|322867999|FG005|Period 4|Adverse Event|0|||
94296379|NCT00868790|322868000|FG006|Period 4|Adverse Event|0|||
94296380|NCT00868790|322868001|FG007|Period 4|Adverse Event|1|||
94296381|NCT00868790|322868002|FG008|Period 4|Adverse Event|0|||
94296382|NCT00868790|322868003|FG009|Period 4|Adverse Event|0|||
94296383|NCT00868790|322868004|FG010|Period 4|Adverse Event|1|||
94296384|NCT00868790|322868005|FG011|Period 4|Adverse Event|0|||
94296385|NCT00868790|322868006|FG012|Period 4|Adverse Event|1|||
94296386|NCT00868790|322868007|FG013|Period 4|Adverse Event|0|||
94296387|NCT00868790|322867994|FG000|Period 4|Lost to Follow-up|0|||
94296388|NCT00868790|322867995|FG001|Period 4|Lost to Follow-up|0|||
94296389|NCT00868790|322867996|FG002|Period 4|Lost to Follow-up|0|||
94296390|NCT00868790|322867997|FG003|Period 4|Lost to Follow-up|0|||
94296391|NCT00868790|322867998|FG004|Period 4|Lost to Follow-up|0|||
94296392|NCT00868790|322867999|FG005|Period 4|Lost to Follow-up|0|||
94296393|NCT00868790|322868000|FG006|Period 4|Lost to Follow-up|0|||
94296394|NCT00868790|322868001|FG007|Period 4|Lost to Follow-up|1|||
94296395|NCT00868790|322868002|FG008|Period 4|Lost to Follow-up|0|||
94296396|NCT00868790|322868003|FG009|Period 4|Lost to Follow-up|0|||
94296397|NCT00868790|322868004|FG010|Period 4|Lost to Follow-up|0|||
94296398|NCT00868790|322868005|FG011|Period 4|Lost to Follow-up|0|||
94296399|NCT00868790|322868006|FG012|Period 4|Lost to Follow-up|0|||
94296400|NCT00868790|322868007|FG013|Period 4|Lost to Follow-up|0|||
94296401|NCT00868790|322867994|FG000|Period 4|Study Terminated by Sponsor|2|||
94296402|NCT00868790|322867995|FG001|Period 4|Study Terminated by Sponsor|0|||
94296403|NCT00868790|322867996|FG002|Period 4|Study Terminated by Sponsor|0|||
94296404|NCT00868790|322867997|FG003|Period 4|Study Terminated by Sponsor|0|||
94296405|NCT00868790|322867998|FG004|Period 4|Study Terminated by Sponsor|0|||
94296406|NCT00868790|322867999|FG005|Period 4|Study Terminated by Sponsor|0|||
94296407|NCT00868790|322868000|FG006|Period 4|Study Terminated by Sponsor|0|||
94296408|NCT00868790|322868001|FG007|Period 4|Study Terminated by Sponsor|1|||
94296409|NCT00868790|322868002|FG008|Period 4|Study Terminated by Sponsor|2|||
94296410|NCT00868790|322868003|FG009|Period 4|Study Terminated by Sponsor|0|||
94296411|NCT00868790|322868004|FG010|Period 4|Study Terminated by Sponsor|2|||
94296412|NCT00868790|322868005|FG011|Period 4|Study Terminated by Sponsor|1|||
94296413|NCT00868790|322868006|FG012|Period 4|Study Terminated by Sponsor|0|||
94296414|NCT00868790|322868007|FG013|Period 4|Study Terminated by Sponsor|1|||
94296415|NCT00868790|322867994|FG000|Period 4|Abnormal ALT/AST|0|||
94296416|NCT00868790|322867995|FG001|Period 4|Abnormal ALT/AST|0|||
94296417|NCT00868790|322867996|FG002|Period 4|Abnormal ALT/AST|1|||
94296418|NCT00868790|322867997|FG003|Period 4|Abnormal ALT/AST|0|||
94296419|NCT00868790|322867998|FG004|Period 4|Abnormal ALT/AST|0|||
94296420|NCT00868790|322867999|FG005|Period 4|Abnormal ALT/AST|0|||
94296421|NCT00868790|322868000|FG006|Period 4|Abnormal ALT/AST|0|||
94296422|NCT00868790|322868001|FG007|Period 4|Abnormal ALT/AST|0|||
94296423|NCT00868790|322868002|FG008|Period 4|Abnormal ALT/AST|0|||
94372654|NCT00345683|323150334|FG001|Overall Study|Lost to Follow-up|7|||
94372655|NCT00345683|323150333|FG000|Overall Study|Other|6|||
94372656|NCT00345683|323150334|FG001|Overall Study|Other|2|||
94372657|NCT03443869|323150335|FG000|Overall Study|Death|3|||
94296424|NCT00868790|322868003|FG009|Period 4|Abnormal ALT/AST|0|||
94296425|NCT00868790|322868004|FG010|Period 4|Abnormal ALT/AST|0|||
94372658|NCT03443869|323150336|FG001|Overall Study|Death|3|||
94296426|NCT00868790|322868005|FG011|Period 4|Abnormal ALT/AST|0|||
94296427|NCT00868790|322868006|FG012|Period 4|Abnormal ALT/AST|0|||
94296428|NCT00868790|322868007|FG013|Period 4|Abnormal ALT/AST|0|||
94296429|NCT00868790|322867994|FG000|Post-study|Withdrawal by Subject|0|||
94296430|NCT00868790|322867995|FG001|Post-study|Withdrawal by Subject|0|||
94296431|NCT00868790|322867996|FG002|Post-study|Withdrawal by Subject|0|||
94296432|NCT00868790|322867997|FG003|Post-study|Withdrawal by Subject|0|||
94296433|NCT00868790|322867998|FG004|Post-study|Withdrawal by Subject|1|||
94296434|NCT00868790|322867999|FG005|Post-study|Withdrawal by Subject|0|||
94296435|NCT00868790|322868000|FG006|Post-study|Withdrawal by Subject|0|||
94372659|NCT03443869|323150335|FG000|Overall Study|Withdrawal by Subject|34|||
94296436|NCT00868790|322868001|FG007|Post-study|Withdrawal by Subject|0|||
94296437|NCT00868790|322868002|FG008|Post-study|Withdrawal by Subject|0|||
94296438|NCT00868790|322868003|FG009|Post-study|Withdrawal by Subject|0|||
94296439|NCT00868790|322868004|FG010|Post-study|Withdrawal by Subject|0|||
94296440|NCT00868790|322868005|FG011|Post-study|Withdrawal by Subject|0|||
94296441|NCT00868790|322868006|FG012|Post-study|Withdrawal by Subject|0|||
94296442|NCT00868790|322868007|FG013|Post-study|Withdrawal by Subject|0|||
94296443|NCT00868790|322867994|FG000|Post-study|Excluded Medication|0|||
94296444|NCT00868790|322867995|FG001|Post-study|Excluded Medication|0|||
94296445|NCT00868790|322867996|FG002|Post-study|Excluded Medication|0|||
94296446|NCT00868790|322867997|FG003|Post-study|Excluded Medication|0|||
94296447|NCT00868790|322867998|FG004|Post-study|Excluded Medication|0|||
94296448|NCT00868790|322867999|FG005|Post-study|Excluded Medication|0|||
94296449|NCT00868790|322868000|FG006|Post-study|Excluded Medication|0|||
94296450|NCT00868790|322868001|FG007|Post-study|Excluded Medication|2|||
94296451|NCT00868790|322868002|FG008|Post-study|Excluded Medication|0|||
94296452|NCT00868790|322868003|FG009|Post-study|Excluded Medication|1|||
94296453|NCT00868790|322868004|FG010|Post-study|Excluded Medication|0|||
94296454|NCT00868790|322868005|FG011|Post-study|Excluded Medication|0|||
94296455|NCT00868790|322868006|FG012|Post-study|Excluded Medication|0|||
94296456|NCT00868790|322868007|FG013|Post-study|Excluded Medication|0|||
94296457|NCT03068715|322868008|FG000|Overall Study|No longer met inclusion criteria|1|||
94296458|NCT03068715|322868009|FG001|Overall Study|No longer met inclusion criteria|0|||
94296459|NCT03403400|322868015|FG000|Overall Study|Lost to Follow-up|1|||
94296460|NCT03403400|322868016|FG001|Overall Study|Lost to Follow-up|0|||
94296461|NCT03403400|322868017|FG002|Overall Study|Lost to Follow-up|1|||
94296462|NCT03403400|322868015|FG000|Overall Study|Hospitalization|1|||
94296463|NCT03403400|322868016|FG001|Overall Study|Hospitalization|0|||
94296464|NCT03403400|322868017|FG002|Overall Study|Hospitalization|0|||
94296465|NCT03403400|322868015|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
94296466|NCT03403400|322868016|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
94296467|NCT03403400|322868017|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
94296468|NCT03168867|322868018|FG000|Overall Study|Withdrawal by Subject|1|||
94296469|NCT03168867|322868019|FG001|Overall Study|Withdrawal by Subject|5|||
94296470|NCT04348851|322868020|FG000|Post-Test 1|Withdrawal by Subject|0|||
94296471|NCT04348851|322868021|FG001|Post-Test 1|Withdrawal by Subject|1|||
94467990|NCT00803205|323502463|FG000|Overall Study|Physician Decision|1|||
94296472|NCT04348851|322868022|FG002|Post-Test 1|Withdrawal by Subject|0|||
94296473|NCT04348851|322868023|FG003|Post-Test 1|Withdrawal by Subject|0|||
94296474|NCT04348851|322868020|FG000|Post-Test 1|Lost to Follow-up|0|||
94296475|NCT04348851|322868021|FG001|Post-Test 1|Lost to Follow-up|1|||
94296476|NCT04348851|322868022|FG002|Post-Test 1|Lost to Follow-up|0|||
94296477|NCT04348851|322868023|FG003|Post-Test 1|Lost to Follow-up|0|||
94296478|NCT04348851|322868020|FG000|Post-Test 2|Stroke survivor death|0|||
94296479|NCT04348851|322868021|FG001|Post-Test 2|Stroke survivor death|1|||
94296480|NCT04348851|322868022|FG002|Post-Test 2|Stroke survivor death|0|||
94296481|NCT04348851|322868023|FG003|Post-Test 2|Stroke survivor death|1|||
94296482|NCT01454076|322868024|FG000|Overall Study|Other|2|||
94296483|NCT01454076|322868025|FG001|Overall Study|Other|0|||
94296484|NCT01454076|322868026|FG002|Overall Study|Other|0|||
94296485|NCT01454076|322868027|FG003|Overall Study|Other|1|||
94296486|NCT01454076|322868028|FG004|Overall Study|Other|2|||
94296487|NCT01454076|322868024|FG000|Overall Study|Withdrawal by Subject|3|||
94296488|NCT01454076|322868025|FG001|Overall Study|Withdrawal by Subject|4|||
94296489|NCT01454076|322868026|FG002|Overall Study|Withdrawal by Subject|2|||
94296490|NCT01454076|322868027|FG003|Overall Study|Withdrawal by Subject|1|||
94296491|NCT01454076|322868028|FG004|Overall Study|Withdrawal by Subject|2|||
94296492|NCT01454076|322868024|FG000|Overall Study|Adverse Event|8|||
94296493|NCT01454076|322868025|FG001|Overall Study|Adverse Event|2|||
94296494|NCT01454076|322868026|FG002|Overall Study|Adverse Event|7|||
94296495|NCT01454076|322868027|FG003|Overall Study|Adverse Event|0|||
94296496|NCT01454076|322868028|FG004|Overall Study|Adverse Event|2|||
94296497|NCT02965378|322868029|FG000|Overall Study|Progression|16|||
94296498|NCT02965378|322868030|FG001|Overall Study|Progression|4|||
94296499|NCT02965378|322868029|FG000|Overall Study|Adverse Event|5|||
94467991|NCT00803205|323502464|FG001|Overall Study|Physician Decision|0|||
94467992|NCT00803205|323502463|FG000|Overall Study|Protocol Violation|1|||
94296500|NCT02965378|322868030|FG001|Overall Study|Adverse Event|2|||
94296501|NCT02965378|322868029|FG000|Overall Study|Death|2|||
94296502|NCT02965378|322868030|FG001|Overall Study|Death|0|||
94296503|NCT02965378|322868029|FG000|Overall Study|Refusal|2|||
94296504|NCT02965378|322868030|FG001|Overall Study|Refusal|1|||
94296505|NCT02965378|322868029|FG000|Overall Study|Not protocol specified|0|||
94467993|NCT00803205|323502464|FG001|Overall Study|Protocol Violation|1|||
94296506|NCT02965378|322868030|FG001|Overall Study|Not protocol specified|2|||
94296507|NCT00737529|322868038|FG000|Overall Study|Disease Progression|95|||
94296508|NCT00737529|322868038|FG000|Overall Study|Adverse Event|24|||
94296509|NCT00737529|322868038|FG000|Overall Study|Withdrawal by Subject|5|||
94296510|NCT00737529|322868038|FG000|Overall Study|Death|4|||
94296511|NCT00737529|322868038|FG000|Overall Study|Protocol Violation|1|||
94296512|NCT00737529|322868038|FG000|Overall Study|Other|4|||
94296513|NCT01145560|322868039|FG000|Overall Study|Withdrawal by Subject|2|||
94296514|NCT01145560|322868040|FG001|Overall Study|Withdrawal by Subject|1|||
94296515|NCT01145560|322868041|FG002|Overall Study|Withdrawal by Subject|0|||
94296516|NCT01145560|322868039|FG000|Overall Study|Lost to Follow-up|1|||
94296517|NCT01145560|322868040|FG001|Overall Study|Lost to Follow-up|1|||
94296518|NCT01145560|322868041|FG002|Overall Study|Lost to Follow-up|1|||
94296519|NCT01145560|322868039|FG000|Overall Study|No study drug by 24h after organ failure|1|||
94296520|NCT01145560|322868040|FG001|Overall Study|No study drug by 24h after organ failure|0|||
94296521|NCT01145560|322868041|FG002|Overall Study|No study drug by 24h after organ failure|0|||
94296522|NCT01145560|322868039|FG000|Overall Study|Accidental unblinding of study treatment|0|||
94296523|NCT01145560|322868040|FG001|Overall Study|Accidental unblinding of study treatment|1|||
94296524|NCT01145560|322868041|FG002|Overall Study|Accidental unblinding of study treatment|0|||
94296525|NCT01145560|322868039|FG000|Overall Study|False insurance information|0|||
94296526|NCT01145560|322868040|FG001|Overall Study|False insurance information|1|||
94296527|NCT01145560|322868041|FG002|Overall Study|False insurance information|0|||
94296528|NCT01145560|322868039|FG000|Overall Study|Withdrawal of therapy|0|||
94296529|NCT01145560|322868040|FG001|Overall Study|Withdrawal of therapy|0|||
94296530|NCT01145560|322868041|FG002|Overall Study|Withdrawal of therapy|1|||
94296531|NCT04062214|322868049|FG000|Week 12|Death|1|||
94296532|NCT04062214|322868050|FG001|Week 12|Death|1|||
94296533|NCT04062214|322868049|FG000|Week 12|Withdrawal by Subject|14|||
94296534|NCT04062214|322868050|FG001|Week 12|Withdrawal by Subject|13|||
94296535|NCT04062214|322868049|FG000|Week 12|Lost to Follow-up|55|||
94296536|NCT04062214|322868050|FG001|Week 12|Lost to Follow-up|68|||
94296537|NCT04062214|322868049|FG000|Week 12|Intermittent missing|31|||
94296538|NCT04062214|322868050|FG001|Week 12|Intermittent missing|29|||
94296539|NCT04062214|322868049|FG000|Week 36|Withdrawal by Subject|4|||
94296540|NCT04062214|322868050|FG001|Week 36|Withdrawal by Subject|5|||
94296541|NCT04062214|322868049|FG000|Week 36|Lost to Follow-up|50|||
94296542|NCT04062214|322868050|FG001|Week 36|Lost to Follow-up|46|||
94296543|NCT04062214|322868049|FG000|Week 36|Death|0|||
94296544|NCT04062214|322868050|FG001|Week 36|Death|1|||
94296545|NCT01412229|322868051|FG000|Overall Study|Physician Decision|1|||
94296546|NCT02246621|322868055|FG000|Overall Study|Withdrawal by Subject|28|||
94296547|NCT02246621|322868056|FG001|Overall Study|Withdrawal by Subject|16|||
94296548|NCT02246621|322868055|FG000|Overall Study|Lost to Follow-up|1|||
94296549|NCT02246621|322868056|FG001|Overall Study|Lost to Follow-up|0|||
94296550|NCT02246621|322868055|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
94296551|NCT02246621|322868056|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
94296552|NCT02875223|322868057|FG000|Overall Study|Other reasons|0|||
94296553|NCT02875223|322868058|FG001|Overall Study|Other reasons|0|||
94296554|NCT02875223|322868059|FG002|Overall Study|Other reasons|1|||
94296555|NCT02875223|322868060|FG003|Overall Study|Other reasons|0|||
94296556|NCT02875223|322868061|FG004|Overall Study|Other reasons|1|||
94296557|NCT02875223|322868062|FG005|Overall Study|Other reasons|2|||
94296558|NCT02875223|322868063|FG006|Overall Study|Other reasons|0|||
94296559|NCT02875223|322868064|FG007|Overall Study|Other reasons|2|||
94296560|NCT02875223|322868065|FG008|Overall Study|Other reasons|0|||
94296561|NCT02875223|322868066|FG009|Overall Study|Other reasons|0|||
94296562|NCT02875223|322868067|FG010|Overall Study|Other reasons|0|||
94296563|NCT02875223|322868068|FG011|Overall Study|Other reasons|0|||
94296564|NCT02875223|322868069|FG012|Overall Study|Other reasons|0|||
94296565|NCT02875223|322868057|FG000|Overall Study|Withdrawal by Subject|0|||
94296566|NCT02875223|322868058|FG001|Overall Study|Withdrawal by Subject|0|||
94296567|NCT02875223|322868059|FG002|Overall Study|Withdrawal by Subject|0|||
94296568|NCT02875223|322868060|FG003|Overall Study|Withdrawal by Subject|0|||
94296569|NCT02875223|322868061|FG004|Overall Study|Withdrawal by Subject|1|||
94296570|NCT02875223|322868062|FG005|Overall Study|Withdrawal by Subject|1|||
94296571|NCT02875223|322868063|FG006|Overall Study|Withdrawal by Subject|0|||
94296572|NCT02875223|322868064|FG007|Overall Study|Withdrawal by Subject|0|||
94296573|NCT02875223|322868065|FG008|Overall Study|Withdrawal by Subject|1|||
94296574|NCT02875223|322868066|FG009|Overall Study|Withdrawal by Subject|0|||
94296575|NCT02875223|322868067|FG010|Overall Study|Withdrawal by Subject|0|||
94296576|NCT02875223|322868068|FG011|Overall Study|Withdrawal by Subject|0|||
94296577|NCT02875223|322868069|FG012|Overall Study|Withdrawal by Subject|0|||
94296578|NCT02875223|322868057|FG000|Overall Study|Progressive disease|0|||
94296579|NCT02875223|322868058|FG001|Overall Study|Progressive disease|0|||
94296580|NCT02875223|322868059|FG002|Overall Study|Progressive disease|1|||
94296581|NCT02875223|322868060|FG003|Overall Study|Progressive disease|0|||
94296582|NCT02875223|322868061|FG004|Overall Study|Progressive disease|0|||
94296583|NCT02875223|322868062|FG005|Overall Study|Progressive disease|0|||
94296584|NCT02875223|322868063|FG006|Overall Study|Progressive disease|0|||
94296585|NCT02875223|322868064|FG007|Overall Study|Progressive disease|0|||
94296586|NCT02875223|322868065|FG008|Overall Study|Progressive disease|0|||
94296587|NCT02875223|322868066|FG009|Overall Study|Progressive disease|12|||
94296588|NCT02875223|322868067|FG010|Overall Study|Progressive disease|2|||
94296589|NCT02875223|322868068|FG011|Overall Study|Progressive disease|3|||
94296590|NCT02875223|322868069|FG012|Overall Study|Progressive disease|6|||
94296591|NCT02875223|322868057|FG000|Overall Study|Death|4|||
94296592|NCT02875223|322868058|FG001|Overall Study|Death|4|||
94296593|NCT02875223|322868059|FG002|Overall Study|Death|3|||
94296594|NCT02875223|322868060|FG003|Overall Study|Death|4|||
94296595|NCT02875223|322868061|FG004|Overall Study|Death|2|||
94296596|NCT02875223|322868062|FG005|Overall Study|Death|3|||
94296597|NCT02875223|322868063|FG006|Overall Study|Death|5|||
94372660|NCT03443869|323150336|FG001|Overall Study|Withdrawal by Subject|22|||
94372661|NCT03443869|323150335|FG000|Overall Study|Lost to Follow-up|1|||
94372662|NCT03443869|323150336|FG001|Overall Study|Lost to Follow-up|2|||
94372663|NCT03443869|323150335|FG000|Overall Study|Physician Decision|3|||
94372664|NCT03443869|323150336|FG001|Overall Study|Physician Decision|3|||
94372665|NCT03443869|323150335|FG000|Overall Study|Other|4|||
94372666|NCT03443869|323150336|FG001|Overall Study|Other|4|||
94372667|NCT00096486|323150338|FG000|Overall Study|Withdrawal by Subject|0|||
94372668|NCT00096486|323150339|FG001|Overall Study|Withdrawal by Subject|0|||
94372669|NCT00096486|323150340|FG002|Overall Study|Withdrawal by Subject|1|||
94372670|NCT00096486|323150341|FG003|Overall Study|Withdrawal by Subject|1|||
94372671|NCT00096486|323150338|FG000|Overall Study|Not Treated|0|||
94372672|NCT00096486|323150339|FG001|Overall Study|Not Treated|0|||
94296598|NCT02875223|322868064|FG007|Overall Study|Death|7|||
94296599|NCT02875223|322868065|FG008|Overall Study|Death|3|||
94296600|NCT02875223|322868066|FG009|Overall Study|Death|2|||
94296601|NCT02875223|322868067|FG010|Overall Study|Death|0|||
94296602|NCT02875223|322868068|FG011|Overall Study|Death|0|||
94296603|NCT02875223|322868069|FG012|Overall Study|Death|0|||
94296604|NCT02875223|322868057|FG000|Overall Study|Lost to Follow-up|0|||
94296605|NCT02875223|322868058|FG001|Overall Study|Lost to Follow-up|1|||
94296606|NCT02875223|322868059|FG002|Overall Study|Lost to Follow-up|1|||
94296607|NCT02875223|322868060|FG003|Overall Study|Lost to Follow-up|0|||
94296608|NCT02875223|322868061|FG004|Overall Study|Lost to Follow-up|1|||
94296609|NCT02875223|322868062|FG005|Overall Study|Lost to Follow-up|0|||
94296610|NCT02875223|322868063|FG006|Overall Study|Lost to Follow-up|1|||
94296611|NCT02875223|322868064|FG007|Overall Study|Lost to Follow-up|1|||
94296612|NCT02875223|322868065|FG008|Overall Study|Lost to Follow-up|0|||
94296613|NCT02875223|322868066|FG009|Overall Study|Lost to Follow-up|0|||
94296614|NCT02875223|322868067|FG010|Overall Study|Lost to Follow-up|0|||
94296615|NCT02875223|322868068|FG011|Overall Study|Lost to Follow-up|0|||
94296616|NCT02875223|322868069|FG012|Overall Study|Lost to Follow-up|0|||
94296617|NCT02078219|322868072|FG000|Overall Study|Other|2|||
94296618|NCT02078219|322868073|FG001|Overall Study|Other|2|||
94296619|NCT02078219|322868074|FG002|Overall Study|Other|3|||
94296620|NCT02078219|322868075|FG003|Overall Study|Other|0|||
94296621|NCT02078219|322868076|FG004|Overall Study|Other|1|||
94296622|NCT02078219|322868072|FG000|Overall Study|Withdrawal by Subject|0|||
94296623|NCT02078219|322868073|FG001|Overall Study|Withdrawal by Subject|1|||
94296624|NCT02078219|322868074|FG002|Overall Study|Withdrawal by Subject|0|||
94296625|NCT02078219|322868075|FG003|Overall Study|Withdrawal by Subject|1|||
94296626|NCT02078219|322868076|FG004|Overall Study|Withdrawal by Subject|1|||
94296627|NCT02078219|322868072|FG000|Overall Study|Protocol Violation|0|||
94296628|NCT02078219|322868073|FG001|Overall Study|Protocol Violation|0|||
94296629|NCT02078219|322868074|FG002|Overall Study|Protocol Violation|0|||
94296630|NCT02078219|322868075|FG003|Overall Study|Protocol Violation|1|||
94296631|NCT02078219|322868076|FG004|Overall Study|Protocol Violation|0|||
94296632|NCT02078219|322868072|FG000|Overall Study|Death|0|||
94296633|NCT02078219|322868073|FG001|Overall Study|Death|0|||
94296634|NCT02078219|322868074|FG002|Overall Study|Death|0|||
94296635|NCT02078219|322868075|FG003|Overall Study|Death|1|||
94296636|NCT02078219|322868076|FG004|Overall Study|Death|0|||
94296637|NCT02078219|322868072|FG000|Overall Study|Adverse Event|1|||
94296638|NCT02078219|322868073|FG001|Overall Study|Adverse Event|1|||
94296639|NCT02078219|322868074|FG002|Overall Study|Adverse Event|3|||
94296640|NCT02078219|322868075|FG003|Overall Study|Adverse Event|1|||
94296641|NCT02078219|322868076|FG004|Overall Study|Adverse Event|0|||
94372673|NCT00096486|323150340|FG002|Overall Study|Not Treated|1|||
94296642|NCT01468311|322868077|FG000|Overall Study|mobilization failure|1|||
94372674|NCT00096486|323150341|FG003|Overall Study|Not Treated|1|||
94372675|NCT00529568|323150342|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
94372676|NCT00529568|323150343|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
94296643|NCT01468311|322868077|FG000|Overall Study|Withdrawal by Subject|1|||
94296644|NCT03283085|322868078|FG000|Overall Study|Adverse Event|18|||
94296645|NCT03283085|322868079|FG001|Overall Study|Adverse Event|3|||
94296646|NCT03283085|322868080|FG002|Overall Study|Adverse Event|13|||
94296647|NCT03283085|322868081|FG003|Overall Study|Adverse Event|0|||
94296648|NCT03283085|322868082|FG004|Overall Study|Adverse Event|0|||
94372677|NCT00529568|323150344|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
94296649|NCT03283085|322868083|FG005|Overall Study|Adverse Event|5|||
94296650|NCT03283085|322868078|FG000|Overall Study|Death|0|||
94296651|NCT03283085|322868079|FG001|Overall Study|Death|0|||
94296652|NCT03283085|322868080|FG002|Overall Study|Death|3|||
94296653|NCT03283085|322868081|FG003|Overall Study|Death|1|||
94296654|NCT03283085|322868082|FG004|Overall Study|Death|0|||
94296655|NCT03283085|322868083|FG005|Overall Study|Death|0|||
94296656|NCT03283085|322868078|FG000|Overall Study|Withdrawal by Subject|42|||
94296657|NCT03283085|322868079|FG001|Overall Study|Withdrawal by Subject|21|||
94296658|NCT03283085|322868080|FG002|Overall Study|Withdrawal by Subject|66|||
94296659|NCT03283085|322868081|FG003|Overall Study|Withdrawal by Subject|3|||
94296660|NCT03283085|322868082|FG004|Overall Study|Withdrawal by Subject|3|||
94296661|NCT03283085|322868083|FG005|Overall Study|Withdrawal by Subject|5|||
94296662|NCT03283085|322868078|FG000|Overall Study|Physician Decision|14|||
94296663|NCT03283085|322868079|FG001|Overall Study|Physician Decision|8|||
94296664|NCT03283085|322868080|FG002|Overall Study|Physician Decision|19|||
94296665|NCT03283085|322868081|FG003|Overall Study|Physician Decision|0|||
94296666|NCT03283085|322868082|FG004|Overall Study|Physician Decision|0|||
94296667|NCT03283085|322868083|FG005|Overall Study|Physician Decision|2|||
94296668|NCT03283085|322868078|FG000|Overall Study|Site Terminated by Sponsor|1|||
94296669|NCT03283085|322868079|FG001|Overall Study|Site Terminated by Sponsor|0|||
94296670|NCT03283085|322868080|FG002|Overall Study|Site Terminated by Sponsor|3|||
94296671|NCT03283085|322868081|FG003|Overall Study|Site Terminated by Sponsor|0|||
94296672|NCT03283085|322868082|FG004|Overall Study|Site Terminated by Sponsor|0|||
94296673|NCT03283085|322868083|FG005|Overall Study|Site Terminated by Sponsor|0|||
94296674|NCT03283085|322868078|FG000|Overall Study|Lost to Follow-up|2|||
94296675|NCT03283085|322868079|FG001|Overall Study|Lost to Follow-up|0|||
94296676|NCT03283085|322868080|FG002|Overall Study|Lost to Follow-up|2|||
94296677|NCT03283085|322868081|FG003|Overall Study|Lost to Follow-up|0|||
94296678|NCT03283085|322868082|FG004|Overall Study|Lost to Follow-up|0|||
94296679|NCT03283085|322868083|FG005|Overall Study|Lost to Follow-up|1|||
94296680|NCT03283085|322868078|FG000|Overall Study|Pregnancy|0|||
94296681|NCT03283085|322868079|FG001|Overall Study|Pregnancy|0|||
94296682|NCT03283085|322868080|FG002|Overall Study|Pregnancy|1|||
94296683|NCT03283085|322868081|FG003|Overall Study|Pregnancy|0|||
94296684|NCT03283085|322868082|FG004|Overall Study|Pregnancy|0|||
94296685|NCT03283085|322868083|FG005|Overall Study|Pregnancy|0|||
94296686|NCT03283085|322868078|FG000|Overall Study|Lack of Efficacy|12|||
94296687|NCT03283085|322868079|FG001|Overall Study|Lack of Efficacy|6|||
94296688|NCT03283085|322868080|FG002|Overall Study|Lack of Efficacy|24|||
94296689|NCT03283085|322868081|FG003|Overall Study|Lack of Efficacy|1|||
94296690|NCT03283085|322868082|FG004|Overall Study|Lack of Efficacy|1|||
94296691|NCT03283085|322868083|FG005|Overall Study|Lack of Efficacy|0|||
94296692|NCT03283085|322868078|FG000|Overall Study|Reason not Specified|0|||
94296693|NCT03283085|322868079|FG001|Overall Study|Reason not Specified|4|||
94296694|NCT03283085|322868080|FG002|Overall Study|Reason not Specified|8|||
94296695|NCT03283085|322868081|FG003|Overall Study|Reason not Specified|0|||
94296696|NCT03283085|322868082|FG004|Overall Study|Reason not Specified|0|||
94296697|NCT03283085|322868083|FG005|Overall Study|Reason not Specified|1|||
94296698|NCT00924703|322868086|FG000|Overall Study|Withdrawal by Subject|11|||
94296699|NCT00924703|322868086|FG000|Overall Study|Physician Decision|5|||
94296700|NCT00924703|322868086|FG000|Overall Study|Lost to Follow-up|3|||
94296701|NCT00924703|322868086|FG000|Overall Study|Adverse Event|2|||
94296702|NCT00924703|322868086|FG000|Overall Study|Withdrawal by Sponsor|1|||
94296703|NCT00666562|322868087|FG000|Overall Study|Withdrawal by Subject|0|||
94296704|NCT00666562|322868088|FG001|Overall Study|Withdrawal by Subject|1|||
94296705|NCT00666562|322868089|FG002|Overall Study|Withdrawal by Subject|0|||
94296706|NCT00666562|322868087|FG000|Overall Study|Concomitant Medication|0|||
94296707|NCT00666562|322868088|FG001|Overall Study|Concomitant Medication|1|||
94296708|NCT00666562|322868089|FG002|Overall Study|Concomitant Medication|0|||
94296709|NCT04840667|322870207|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
94296710|NCT00162773|322870208|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
94296711|NCT03417440|322870209|FG000|Overall Study|Lost to Follow-up|0|||
94296712|NCT03417440|322870210|FG001|Overall Study|Lost to Follow-up|1|||
94296713|NCT03417440|322870211|FG002|Overall Study|Lost to Follow-up|0|||
94296714|NCT03417440|322870212|FG003|Overall Study|Lost to Follow-up|0|||
94296715|NCT03417440|322870213|FG004|Overall Study|Lost to Follow-up|1|||
94296716|NCT03417440|322870214|FG005|Overall Study|Lost to Follow-up|0|||
94296717|NCT03417440|322870215|FG006|Overall Study|Lost to Follow-up|0|||
94296718|NCT03417440|322870216|FG007|Overall Study|Lost to Follow-up|0|||
94296719|NCT03417440|322870209|FG000|Overall Study|Withdrawal by Subject|2|||
94296720|NCT03417440|322870210|FG001|Overall Study|Withdrawal by Subject|0|||
94296721|NCT03417440|322870211|FG002|Overall Study|Withdrawal by Subject|2|||
94296722|NCT03417440|322870212|FG003|Overall Study|Withdrawal by Subject|1|||
94296723|NCT03417440|322870213|FG004|Overall Study|Withdrawal by Subject|1|||
94296724|NCT03417440|322870214|FG005|Overall Study|Withdrawal by Subject|0|||
94296725|NCT03417440|322870215|FG006|Overall Study|Withdrawal by Subject|0|||
94296726|NCT03417440|322870216|FG007|Overall Study|Withdrawal by Subject|1|||
94296727|NCT00781365|322870217|FG000|Overall Study|Withdrawal by Subject|13|||
94296728|NCT00781365|322870218|FG001|Overall Study|Withdrawal by Subject|8|||
94296729|NCT00781365|322870217|FG000|Overall Study|Did Not Attend Visit|20|||
94296730|NCT00781365|322870218|FG001|Overall Study|Did Not Attend Visit|28|||
94296731|NCT00781365|322870217|FG000|Overall Study|Language barrier|1|||
94296732|NCT00781365|322870218|FG001|Overall Study|Language barrier|0|||
94296733|NCT03304522|322870219|FG000|Overall Study|Adverse Event|0|||
94296734|NCT03304522|322870220|FG001|Overall Study|Adverse Event|4|||
94296735|NCT03304522|322870219|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
94296736|NCT03304522|322870220|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
94296737|NCT03304522|322870219|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
94296738|NCT03304522|322870220|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
94296739|NCT03304522|322870219|FG000|Overall Study|Other|0|||
94296740|NCT03304522|322870220|FG001|Overall Study|Other|1|||
94296741|NCT00316264|322870221|FG000|Overall Study|Lost to Follow-up|0|||
94296742|NCT00316264|322870222|FG001|Overall Study|Lost to Follow-up|1|||
94296743|NCT00316264|322870223|FG002|Overall Study|Lost to Follow-up|0|||
94296744|NCT00316264|322870221|FG000|Overall Study|Withdrawal of Consent|3|||
94296745|NCT00316264|322870222|FG001|Overall Study|Withdrawal of Consent|5|||
94296746|NCT00316264|322870223|FG002|Overall Study|Withdrawal of Consent|6|||
94296747|NCT00316264|322870221|FG000|Overall Study|Death|2|||
94296748|NCT00316264|322870222|FG001|Overall Study|Death|0|||
94296749|NCT00316264|322870223|FG002|Overall Study|Death|0|||
94296750|NCT00316264|322870221|FG000|Overall Study|Other|1|||
94296751|NCT00316264|322870222|FG001|Overall Study|Other|1|||
94296752|NCT00316264|322870223|FG002|Overall Study|Other|0|||
94296753|NCT01157117|322870224|FG000|Overall Study|Dosing Symptoms|0|||
94296754|NCT01157117|322870225|FG001|Overall Study|Dosing Symptoms|4|||
94296755|NCT01157117|322870226|FG002|Overall Study|Dosing Symptoms|0|||
94296756|NCT01157117|322870224|FG000|Overall Study|Withdrawal by Subject|4|||
94296757|NCT01157117|322870225|FG001|Overall Study|Withdrawal by Subject|1|||
94296758|NCT01157117|322870226|FG002|Overall Study|Withdrawal by Subject|1|||
94296759|NCT01157117|322870224|FG000|Overall Study|Lack of Efficacy|1|||
94296760|NCT01157117|322870225|FG001|Overall Study|Lack of Efficacy|1|||
94296761|NCT01157117|322870226|FG002|Overall Study|Lack of Efficacy|0|||
94296762|NCT01157117|322870224|FG000|Overall Study|Lost to Follow-up|0|||
94296763|NCT01157117|322870225|FG001|Overall Study|Lost to Follow-up|0|||
94296764|NCT01157117|322870226|FG002|Overall Study|Lost to Follow-up|1|||
94296765|NCT01157117|322870224|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
94296766|NCT01157117|322870225|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
94296767|NCT01157117|322870226|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
94296768|NCT00826514|322870229|FG000|Overall Study|Adverse Event|1|||
94296769|NCT00826514|322870230|FG001|Overall Study|Adverse Event|1|||
94296770|NCT00826514|322870229|FG000|Overall Study|Lack of Efficacy|0|||
94296771|NCT00826514|322870230|FG001|Overall Study|Lack of Efficacy|1|||
94296772|NCT00826514|322870229|FG000|Overall Study|Withdrawal by Subject|2|||
94296773|NCT00826514|322870230|FG001|Overall Study|Withdrawal by Subject|3|||
94296774|NCT01686568|322870233|FG000|Main Study|Withdrawal by Subject|1|||
94296775|NCT01686568|322870234|FG001|Main Study|Withdrawal by Subject|3|||
94296776|NCT01686568|322870233|FG000|Main Study|Noncompliance with protocol|0|||
94296777|NCT01686568|322870234|FG001|Main Study|Noncompliance with protocol|1|||
94296778|NCT01686568|322870233|FG000|Main Study|Liver enzymes above range of exclusion|1|||
94296779|NCT01686568|322870234|FG001|Main Study|Liver enzymes above range of exclusion|0|||
94296780|NCT01686568|322870233|FG000|Sub-Study|Not consented for sub-study|2|||
94296781|NCT01686568|322870234|FG001|Sub-Study|Not consented for sub-study|2|||
94296782|NCT02706938|322870235|FG000|First Period, 6 Weeks|Adverse Event|8|||
94296783|NCT02706938|322870236|FG001|First Period, 6 Weeks|Adverse Event|0|||
94296784|NCT02706938|322870235|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
94296785|NCT02706938|322870236|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
94296786|NCT02706938|322870235|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
94296787|NCT02706938|322870236|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
94296788|NCT02706938|322870235|FG000|Second Period, 6 Weeks|Adverse Event|0|||
94296789|NCT02706938|322870236|FG001|Second Period, 6 Weeks|Adverse Event|7|||
94296790|NCT02706938|322870235|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
94296791|NCT02706938|322870236|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
94296792|NCT01838044|322870241|FG000|Overall Study|Adverse Event|4|||
94296793|NCT01838044|322870242|FG001|Overall Study|Adverse Event|6|||
94296794|NCT01838044|322870241|FG000|Overall Study|Protocol Violation|3|||
94296795|NCT01838044|322870242|FG001|Overall Study|Protocol Violation|3|||
94296796|NCT01838044|322870241|FG000|Overall Study|Withdrawal by Subject|0|||
94296797|NCT01838044|322870242|FG001|Overall Study|Withdrawal by Subject|2|||
94296798|NCT01838044|322870241|FG000|Overall Study|Insufficient clinical response|1|||
94296799|NCT01838044|322870242|FG001|Overall Study|Insufficient clinical response|2|||
94296800|NCT01838044|322870241|FG000|Overall Study|Medication error without associated AE|0|||
94296801|NCT01838044|322870242|FG001|Overall Study|Medication error without associated AE|1|||
94296802|NCT01838044|322870241|FG000|Overall Study|Lost to Follow-up|0|||
94296803|NCT01838044|322870242|FG001|Overall Study|Lost to Follow-up|2|||
94296804|NCT01413958|322870244|FG000|Overall Study|Lost to Follow-up|0|||
94296805|NCT01413958|322870245|FG001|Overall Study|Lost to Follow-up|1|||
94296806|NCT02507349|322870246|FG000|Overall Study|Death|12|||
94296807|NCT02507349|322870247|FG001|Overall Study|Death|16|||
94296808|NCT02507349|322870246|FG000|Overall Study|Withdrawal by Subject|1|||
94296809|NCT02507349|322870247|FG001|Overall Study|Withdrawal by Subject|1|||
94296810|NCT02507349|322870246|FG000|Overall Study|Lost to Follow-up|174|||
94296811|NCT02507349|322870247|FG001|Overall Study|Lost to Follow-up|144|||
94296812|NCT01614964|322870248|FG000|Overall Study|Withdrawal by Subject|2|||
94296813|NCT01614964|322870249|FG001|Overall Study|Withdrawal by Subject|0|||
94296814|NCT01614964|322870248|FG000|Overall Study|Lost to Follow-up|3|||
94296815|NCT01614964|322870249|FG001|Overall Study|Lost to Follow-up|0|||
94296816|NCT00158184|322870260|FG000|Overall Study|personal issues|3|||
94296817|NCT00158184|322870261|FG001|Overall Study|personal issues|1|||
94296818|NCT00158184|322870260|FG000|Overall Study|failed for follow unit/study rules|2|||
94296819|NCT00158184|322870261|FG001|Overall Study|failed for follow unit/study rules|0|||
94296820|NCT00158184|322870260|FG000|Overall Study|Adverse Event|1|||
94296821|NCT00158184|322870261|FG001|Overall Study|Adverse Event|1|||
94296822|NCT02700984|322870262|FG000|Overall Study|Death|2|||
94296823|NCT02700984|322870263|FG001|Overall Study|Death|1|||
94296824|NCT02700984|322870262|FG000|Overall Study|Lost to Follow-up|2|||
94296825|NCT02700984|322870263|FG001|Overall Study|Lost to Follow-up|1|||
94296826|NCT02700984|322870262|FG000|Overall Study|Physician Decision|0|||
94296827|NCT02700984|322870263|FG001|Overall Study|Physician Decision|1|||
94296828|NCT02700984|322870262|FG000|Overall Study|Withdrawal by Subject|8|||
94296829|NCT02700984|322870263|FG001|Overall Study|Withdrawal by Subject|9|||
94296830|NCT02700984|322870262|FG000|Overall Study|Reason not specified|3|||
94296831|NCT02700984|322870263|FG001|Overall Study|Reason not specified|2|||
94296832|NCT05340504|322870264|FG000|Overall Study|Withdrawal by Subject|1|||
94296833|NCT05340504|322870265|FG001|Overall Study|Withdrawal by Subject|0|||
94296834|NCT01032629|322870267|FG000|Overall Study|Closed Site|21|||
94296835|NCT01032629|322870268|FG001|Overall Study|Closed Site|18|||
94296836|NCT01032629|322870269|FG002|Overall Study|Closed Site|16|||
94296837|NCT01032629|322870267|FG000|Overall Study|Withdrawal by Subject|50|||
94296838|NCT01032629|322870268|FG001|Overall Study|Withdrawal by Subject|36|||
94296839|NCT01032629|322870269|FG002|Overall Study|Withdrawal by Subject|35|||
94296840|NCT01032629|322870267|FG000|Overall Study|Lost to Follow-up|74|||
94296841|NCT01032629|322870268|FG001|Overall Study|Lost to Follow-up|47|||
94296842|NCT01032629|322870269|FG002|Overall Study|Lost to Follow-up|37|||
94296843|NCT02393209|322870275|FG000|Overall Study|Study Terminated by Sponsor|1|||
94296844|NCT02393209|322870276|FG001|Overall Study|Study Terminated by Sponsor|1|||
94296845|NCT02393209|322870277|FG002|Overall Study|Study Terminated by Sponsor|0|||
94296846|NCT02393209|322870278|FG003|Overall Study|Study Terminated by Sponsor|0|||
94296847|NCT02393209|322870275|FG000|Overall Study|Withdrawal by Patient|1|||
94296848|NCT02393209|322870276|FG001|Overall Study|Withdrawal by Patient|0|||
94296849|NCT02393209|322870277|FG002|Overall Study|Withdrawal by Patient|0|||
94296850|NCT02393209|322870278|FG003|Overall Study|Withdrawal by Patient|0|||
94296851|NCT02393209|322870275|FG000|Overall Study|Death|2|||
94296852|NCT02393209|322870276|FG001|Overall Study|Death|2|||
94296853|NCT02393209|322870277|FG002|Overall Study|Death|0|||
94296854|NCT02393209|322870278|FG003|Overall Study|Death|0|||
94296855|NCT02393209|322870275|FG000|Overall Study|Death due to Disease Progression|2|||
94296856|NCT02393209|322870276|FG001|Overall Study|Death due to Disease Progression|2|||
94296857|NCT02393209|322870277|FG002|Overall Study|Death due to Disease Progression|0|||
94296858|NCT02393209|322870278|FG003|Overall Study|Death due to Disease Progression|0|||
94296859|NCT02393209|322870275|FG000|Overall Study|Death from Legionella Infection|0|||
94296860|NCT02393209|322870276|FG001|Overall Study|Death from Legionella Infection|1|||
94296861|NCT02393209|322870277|FG002|Overall Study|Death from Legionella Infection|0|||
94296862|NCT02393209|322870278|FG003|Overall Study|Death from Legionella Infection|0|||
94296863|NCT02393209|322870275|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
94296864|NCT02393209|322870276|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
94296865|NCT02393209|322870277|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
94296866|NCT02393209|322870278|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
94296867|NCT02393209|322870275|FG000|Overall Study|Lost to Follow-up|0|||
94296868|NCT02393209|322870276|FG001|Overall Study|Lost to Follow-up|1|||
94296869|NCT02393209|322870277|FG002|Overall Study|Lost to Follow-up|0|||
94296870|NCT02393209|322870278|FG003|Overall Study|Lost to Follow-up|0|||
94296871|NCT00619957|322870279|FG000|Month 24 Double-Blind|Adverse Event|9|||
94296872|NCT00619957|322870280|FG001|Month 24 Double-Blind|Adverse Event|7|||
94296873|NCT00619957|322870279|FG000|Month 24 Double-Blind|Protocol Violation|1|||
94296874|NCT00619957|322870280|FG001|Month 24 Double-Blind|Protocol Violation|0|||
94296875|NCT00619957|322870279|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
94296876|NCT00619957|322870280|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
94296877|NCT00619957|322870279|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
94296878|NCT00619957|322870280|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
94296879|NCT00619957|322870279|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
94296880|NCT00619957|322870280|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
94296881|NCT00619957|322870279|FG000|Month 48 Open-Label|Adverse Event|4|||
94296882|NCT00619957|322870280|FG001|Month 48 Open-Label|Adverse Event|4|||
94296883|NCT00619957|322870279|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
94296884|NCT00619957|322870280|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
94296885|NCT00619957|322870279|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
94296886|NCT00619957|322870280|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
94372678|NCT00529568|323150342|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
94372679|NCT00529568|323150343|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
94372680|NCT00529568|323150344|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
94372681|NCT00529568|323150342|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
94372682|NCT00529568|323150343|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
94372683|NCT00529568|323150344|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
94372684|NCT00529568|323150342|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
94372685|NCT00529568|323150343|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
94372686|NCT00529568|323150344|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
94372687|NCT00529568|323150342|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
94372688|NCT00529568|323150343|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
94372689|NCT00529568|323150344|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
94296887|NCT00727402|322870281|FG000|Overall Study|Physician Decision|116|||
94296888|NCT03545282|322870282|FG000|Overall Study|Lost to Follow-up|15|||
94296889|NCT03545282|322870283|FG001|Overall Study|Lost to Follow-up|10|||
94296890|NCT03545282|322870282|FG000|Overall Study|Withdrawal by Subject|2|||
94296891|NCT03545282|322870283|FG001|Overall Study|Withdrawal by Subject|2|||
94296892|NCT00723957|322870284|FG000|Overall Study|Adverse event unrelated to study drug|1|||
94296893|NCT00723957|322870285|FG001|Overall Study|Adverse event unrelated to study drug|4|||
94296894|NCT00723957|322870284|FG000|Overall Study|Death|3|||
94296895|NCT00723957|322870285|FG001|Overall Study|Death|4|||
94296896|NCT00723957|322870284|FG000|Overall Study|Disease progression|27|||
94296897|NCT00723957|322870285|FG001|Overall Study|Disease progression|25|||
94296898|NCT00723957|322870284|FG000|Overall Study|Maximum clinical benefit|4|||
94296899|NCT00723957|322870285|FG001|Overall Study|Maximum clinical benefit|5|||
94296900|NCT00723957|322870284|FG000|Overall Study|Investigator decision|1|||
94296901|NCT00723957|322870285|FG001|Overall Study|Investigator decision|1|||
94296902|NCT00723957|322870284|FG000|Overall Study|Study drug toxicity|4|||
94296903|NCT00723957|322870285|FG001|Overall Study|Study drug toxicity|6|||
94296904|NCT00723957|322870284|FG000|Overall Study|Withdrawal by Subject|7|||
94296905|NCT00723957|322870285|FG001|Overall Study|Withdrawal by Subject|5|||
94296906|NCT00723957|322870284|FG000|Overall Study|Reason not analyzed|1|||
94296907|NCT00723957|322870285|FG001|Overall Study|Reason not analyzed|0|||
94296908|NCT00723957|322870284|FG000|Overall Study|Never received treatment|3|||
94296909|NCT00723957|322870285|FG001|Overall Study|Never received treatment|3|||
94296910|NCT00755079|322870286|FG000|Overall Study|Lost to Follow-up|1|||
94296911|NCT00755079|322870287|FG001|Overall Study|Lost to Follow-up|3|||
94296912|NCT00755079|322870286|FG000|Overall Study|Adverse Event|0|||
94296913|NCT00755079|322870287|FG001|Overall Study|Adverse Event|1|||
94296914|NCT00755079|322870286|FG000|Overall Study|Withdrawal by Subject|0|||
94296915|NCT00755079|322870287|FG001|Overall Study|Withdrawal by Subject|2|||
94296916|NCT01850615|322870289|FG000|Overall Study|Protocol Violation|4|||
94296917|NCT01850615|322870290|FG001|Overall Study|Protocol Violation|1|||
94296918|NCT01850615|322870289|FG000|Overall Study|Adverse Event|2|||
94296919|NCT01850615|322870290|FG001|Overall Study|Adverse Event|1|||
94296920|NCT01850615|322870289|FG000|Overall Study|Withdrawal by Subject|3|||
94296921|NCT01850615|322870290|FG001|Overall Study|Withdrawal by Subject|1|||
94296922|NCT01850615|322870289|FG000|Overall Study|Lost to Follow-up|0|||
94296923|NCT01850615|322870290|FG001|Overall Study|Lost to Follow-up|1|||
94296924|NCT01850615|322870289|FG000|Overall Study|Unclassified|0|||
94296925|NCT01850615|322870290|FG001|Overall Study|Unclassified|1|||
94296926|NCT01763164|322870291|FG000|Treatment Phase|Participant/Guardian decision|26|||
94296927|NCT01763164|322870292|FG001|Treatment Phase|Participant/Guardian decision|14|||
94296928|NCT01763164|322870291|FG000|Treatment Phase|Protocol Violation|1|||
94296929|NCT01763164|322870292|FG001|Treatment Phase|Protocol Violation|1|||
94296930|NCT01763164|322870291|FG000|Treatment Phase|Progressive Disease|142|||
94296931|NCT01763164|322870292|FG001|Treatment Phase|Progressive Disease|76|||
94296932|NCT01763164|322870291|FG000|Treatment Phase|Physician Decision|24|||
94296933|NCT01763164|322870292|FG001|Treatment Phase|Physician Decision|13|||
94296934|NCT01763164|322870291|FG000|Treatment Phase|Death|10|||
94296935|NCT01763164|322870292|FG001|Treatment Phase|Death|1|||
94372690|NCT00529568|323150342|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
94372691|NCT00529568|323150343|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
94296936|NCT01763164|322870291|FG000|Treatment Phase|Adverse Event|66|||
94296937|NCT01763164|322870292|FG001|Treatment Phase|Adverse Event|8|||
94296938|NCT01763164|322870291|FG000|Treatment Phase|Randomized but not Treated|0|||
94296939|NCT01763164|322870292|FG001|Treatment Phase|Randomized but not Treated|19|||
94296940|NCT01763164|322870291|FG000|Treatment Phase|Other|0|||
94296941|NCT01763164|322870292|FG001|Treatment Phase|Other|1|||
94296942|NCT01763164|322870291|FG000|Follow up Phase|New therapy for study indication|12|||
94296943|NCT01763164|322870292|FG001|Follow up Phase|New therapy for study indication|3|||
94296944|NCT01763164|322870291|FG000|Follow up Phase|Death|21|||
94296945|NCT01763164|322870292|FG001|Follow up Phase|Death|4|||
94296946|NCT01763164|322870291|FG000|Follow up Phase|Subject/guardian decision|9|||
94296947|NCT01763164|322870292|FG001|Follow up Phase|Subject/guardian decision|2|||
94296948|NCT01763164|322870291|FG000|Follow up Phase|Progressive disease|127|||
94296949|NCT01763164|322870292|FG001|Follow up Phase|Progressive disease|62|||
94296950|NCT01763164|322870291|FG000|Follow up Phase|Physician Decision|10|||
94296951|NCT01763164|322870292|FG001|Follow up Phase|Physician Decision|3|||
94296952|NCT01763164|322870291|FG000|Follow up Phase|Lost to Follow-up|1|||
94296953|NCT01763164|322870292|FG001|Follow up Phase|Lost to Follow-up|0|||
94296954|NCT01763164|322870291|FG000|Follow up Phase|Adverse Event|17|||
94296955|NCT01763164|322870292|FG001|Follow up Phase|Adverse Event|1|||
94296956|NCT03377634|322870294|FG000|Study Period|Adverse Event|1|||
94296957|NCT03377634|322870295|FG001|Study Period|Adverse Event|0|||
94296958|NCT03377634|322870294|FG000|Study Period|Withdrawal by Subject|1|||
94296959|NCT03377634|322870295|FG001|Study Period|Withdrawal by Subject|0|||
94296960|NCT00675597|322870297|FG000|Overall Study|Withdrawal by Subject|3|||
94296961|NCT04439344|322870300|FG000|Overall Study|Never started threapy|3|||
94296962|NCT04439344|322870300|FG000|Overall Study|Ineligible|3|||
94296963|NCT04439344|322870300|FG000|Overall Study|Adverse Event|13|||
94296964|NCT04439344|322870300|FG000|Overall Study|Death|2|||
94296965|NCT04439344|322870300|FG000|Overall Study|Disease progression|29|||
94296966|NCT04439344|322870300|FG000|Overall Study|Withdrawal by Subject|2|||
94296967|NCT04439344|322870300|FG000|Overall Study|Alternative therapy|1|||
94296968|NCT01628926|322870304|FG000|Overall Study|Adverse Event|13|||
94296969|NCT01628926|322870305|FG001|Overall Study|Adverse Event|11|||
94296970|NCT01628926|322870306|FG002|Overall Study|Adverse Event|9|||
94296971|NCT01628926|322870304|FG000|Overall Study|Lack of Efficacy|2|||
94296972|NCT01628926|322870305|FG001|Overall Study|Lack of Efficacy|1|||
94296973|NCT01628926|322870306|FG002|Overall Study|Lack of Efficacy|5|||
94296974|NCT01628926|322870304|FG000|Overall Study|Withdrawal by Subject|6|||
94296975|NCT01628926|322870305|FG001|Overall Study|Withdrawal by Subject|4|||
94296976|NCT01628926|322870306|FG002|Overall Study|Withdrawal by Subject|2|||
94296977|NCT01628926|322870304|FG000|Overall Study|Protocol Violation|0|||
94296978|NCT01628926|322870305|FG001|Overall Study|Protocol Violation|1|||
94296979|NCT01628926|322870306|FG002|Overall Study|Protocol Violation|0|||
94296980|NCT01628926|322870304|FG000|Overall Study|Discontinuation criteria|3|||
94296981|NCT01628926|322870305|FG001|Overall Study|Discontinuation criteria|4|||
94296982|NCT01628926|322870306|FG002|Overall Study|Discontinuation criteria|0|||
94296983|NCT01628926|322870304|FG000|Overall Study|Physician Decision|2|||
94296984|NCT01628926|322870305|FG001|Overall Study|Physician Decision|2|||
94296985|NCT01628926|322870306|FG002|Overall Study|Physician Decision|1|||
94296986|NCT03029832|322870307|FG000|Overall Study|Safety Follow-Up Completed|2|||
94296987|NCT03029832|322870308|FG001|Overall Study|Safety Follow-Up Completed|0|||
94296988|NCT03029832|322870307|FG000|Overall Study|Death due to Disease Progression|1|||
94296989|NCT03029832|322870308|FG001|Overall Study|Death due to Disease Progression|0|||
94296990|NCT03029832|322870307|FG000|Overall Study|Study Terminated By Sponsor|1|||
94296991|NCT03029832|322870308|FG001|Overall Study|Study Terminated By Sponsor|1|||
94296992|NCT02700451|322870309|FG000|Overall Study|Protocol Violation|2|||
94296993|NCT02700451|322870310|FG001|Overall Study|Protocol Violation|2|||
94296994|NCT02700451|322870311|FG002|Overall Study|Protocol Violation|3|||
94296995|NCT02700451|322870309|FG000|Overall Study|Discontinued intervention|14|||
94296996|NCT02700451|322870310|FG001|Overall Study|Discontinued intervention|15|||
94296997|NCT02700451|322870311|FG002|Overall Study|Discontinued intervention|14|||
94296998|NCT00454207|322870312|FG000|Overall Study|Adverse Event|3|||
94296999|NCT00454207|322870313|FG001|Overall Study|Adverse Event|1|||
94297000|NCT00454207|322870312|FG000|Overall Study|Lack of Efficacy|1|||
94297001|NCT00454207|322870313|FG001|Overall Study|Lack of Efficacy|0|||
94297002|NCT00454207|322870312|FG000|Overall Study|Protocol Violation|0|||
94297003|NCT00454207|322870313|FG001|Overall Study|Protocol Violation|1|||
94297004|NCT00642642|322870321|FG000|Treatment & Follow Up|Adverse Event|2|||
94297005|NCT00642642|322870321|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
94297006|NCT00642642|322870321|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
94297007|NCT00151892|322870323|FG000|Overall Study|Lack of Efficacy|50|||
94297008|NCT00151892|322870324|FG001|Overall Study|Lack of Efficacy|57|||
94297009|NCT00151892|322870323|FG000|Overall Study|Patient request|10|||
94372692|NCT00529568|323150344|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
94372693|NCT00529568|323150342|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
94297010|NCT00151892|322870324|FG001|Overall Study|Patient request|7|||
94297011|NCT00151892|322870323|FG000|Overall Study|Lost to Follow-up|5|||
94297012|NCT00151892|322870324|FG001|Overall Study|Lost to Follow-up|10|||
94297013|NCT00151892|322870323|FG000|Overall Study|Adverse Event|6|||
94297014|NCT00151892|322870324|FG001|Overall Study|Adverse Event|3|||
94297015|NCT00151892|322870323|FG000|Overall Study|Protocol Violation|3|||
94372694|NCT00529568|323150343|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
94297016|NCT00151892|322870324|FG001|Overall Study|Protocol Violation|3|||
94297017|NCT00151892|322870323|FG000|Overall Study|Non-compliance|0|||
94297018|NCT00151892|322870324|FG001|Overall Study|Non-compliance|1|||
94297019|NCT00151892|322870323|FG000|Overall Study|Pregnancy|0|||
94297020|NCT00151892|322870324|FG001|Overall Study|Pregnancy|1|||
94297021|NCT00151892|322870323|FG000|Overall Study|Did not return for a visit|1|||
94297022|NCT00151892|322870324|FG001|Overall Study|Did not return for a visit|0|||
94297023|NCT00151892|322870323|FG000|Overall Study|Used prohibited corticosteroids|1|||
94297024|NCT00151892|322870324|FG001|Overall Study|Used prohibited corticosteroids|0|||
94297025|NCT00151892|322870323|FG000|Overall Study|Lack of study medication at center|0|||
94297026|NCT00151892|322870324|FG001|Overall Study|Lack of study medication at center|1|||
94297027|NCT01889602|322870325|FG000|First Intervention|Adverse Event|1|||
94297028|NCT01889602|322870326|FG001|First Intervention|Adverse Event|1|||
94297029|NCT01889602|322870327|FG002|First Intervention|Adverse Event|1|||
94297030|NCT01889602|322870325|FG000|First Intervention|Protocol Violation|0|||
94297031|NCT01889602|322870326|FG001|First Intervention|Protocol Violation|1|||
94297032|NCT01889602|322870327|FG002|First Intervention|Protocol Violation|1|||
94297033|NCT01889602|322870325|FG000|First Intervention|Study ending|0|||
94297034|NCT01889602|322870326|FG001|First Intervention|Study ending|1|||
94297035|NCT01889602|322870327|FG002|First Intervention|Study ending|0|||
94297036|NCT01889602|322870325|FG000|Second Intervention|Adverse Event|0|||
94297037|NCT01889602|322870326|FG001|Second Intervention|Adverse Event|0|||
94297038|NCT01889602|322870327|FG002|Second Intervention|Adverse Event|1|||
94297039|NCT01889602|322870325|FG000|Second Intervention|Study ending|1|||
94297040|NCT01889602|322870326|FG001|Second Intervention|Study ending|0|||
94297041|NCT01889602|322870327|FG002|Second Intervention|Study ending|0|||
94297042|NCT01889602|322870325|FG000|Second Intervention|Withdrawal by Subject|0|||
94297043|NCT01889602|322870326|FG001|Second Intervention|Withdrawal by Subject|0|||
94297044|NCT01889602|322870327|FG002|Second Intervention|Withdrawal by Subject|1|||
94297045|NCT01889602|322870325|FG000|Third Intervention|Protocol Violation|1|||
94297046|NCT01889602|322870326|FG001|Third Intervention|Protocol Violation|0|||
94297047|NCT01889602|322870327|FG002|Third Intervention|Protocol Violation|0|||
94297048|NCT01889602|322870325|FG000|Third Intervention|Withdrawal by Subject|2|||
94297049|NCT01889602|322870326|FG001|Third Intervention|Withdrawal by Subject|2|||
94297050|NCT01889602|322870327|FG002|Third Intervention|Withdrawal by Subject|0|||
94297051|NCT00961961|322870328|FG000|Phase I|Withdrawal by Subject|7|||
94297052|NCT00961961|322870329|FG001|Phase I|Withdrawal by Subject|0|||
94297053|NCT00961961|322870330|FG002|Phase I|Withdrawal by Subject|0|||
94297054|NCT00961961|322870331|FG003|Phase I|Withdrawal by Subject|0|||
94297055|NCT00961961|322870328|FG000|Phase I|Lost to Follow-up|10|||
94297056|NCT00961961|322870329|FG001|Phase I|Lost to Follow-up|0|||
94297057|NCT00961961|322870330|FG002|Phase I|Lost to Follow-up|0|||
94297058|NCT00961961|322870331|FG003|Phase I|Lost to Follow-up|0|||
94297059|NCT00961961|322870328|FG000|Phase I|Lack of Efficacy|94|||
94297060|NCT00961961|322870329|FG001|Phase I|Lack of Efficacy|0|||
94297061|NCT00961961|322870330|FG002|Phase I|Lack of Efficacy|0|||
94297062|NCT00961961|322870331|FG003|Phase I|Lack of Efficacy|0|||
94297063|NCT00961961|322870328|FG000|Phase I|Adverse Event|7|||
94297064|NCT00961961|322870329|FG001|Phase I|Adverse Event|0|||
94297065|NCT00961961|322870330|FG002|Phase I|Adverse Event|0|||
94297066|NCT00961961|322870331|FG003|Phase I|Adverse Event|0|||
94297067|NCT00961961|322870328|FG000|Phase I|Physician Decision|8|||
94297068|NCT00961961|322870329|FG001|Phase I|Physician Decision|0|||
94297069|NCT00961961|322870330|FG002|Phase I|Physician Decision|0|||
94297070|NCT00961961|322870331|FG003|Phase I|Physician Decision|0|||
94297071|NCT00961961|322870328|FG000|Phase II|Lost to Follow-up|0|||
94297072|NCT00961961|322870329|FG001|Phase II|Lost to Follow-up|0|||
94297073|NCT00961961|322870330|FG002|Phase II|Lost to Follow-up|10|||
94297074|NCT00961961|322870331|FG003|Phase II|Lost to Follow-up|7|||
94297075|NCT00961961|322870328|FG000|Phase II|Adverse Event|0|||
94297076|NCT00961961|322870329|FG001|Phase II|Adverse Event|0|||
94297077|NCT00961961|322870330|FG002|Phase II|Adverse Event|0|||
94297078|NCT00961961|322870331|FG003|Phase II|Adverse Event|1|||
94297079|NCT00961961|322870328|FG000|Phase II|Physician Decision|0|||
94297080|NCT00961961|322870329|FG001|Phase II|Physician Decision|0|||
94297081|NCT00961961|322870330|FG002|Phase II|Physician Decision|1|||
94297082|NCT00961961|322870331|FG003|Phase II|Physician Decision|0|||
94297083|NCT00961961|322870328|FG000|Phase II|Withdrawal by Subject|0|||
94297084|NCT00961961|322870329|FG001|Phase II|Withdrawal by Subject|0|||
94297085|NCT00961961|322870330|FG002|Phase II|Withdrawal by Subject|1|||
94297086|NCT00961961|322870331|FG003|Phase II|Withdrawal by Subject|0|||
94297087|NCT00404092|322870332|FG000|Overall Study|Death|1|||
94297088|NCT00404092|322870333|FG001|Overall Study|Death|0|||
94297089|NCT00404092|322870334|FG002|Overall Study|Death|0|||
94297090|NCT00404092|322870335|FG003|Overall Study|Death|0|||
94297091|NCT00404092|322870332|FG000|Overall Study|Adverse Event|0|||
94297092|NCT00404092|322870333|FG001|Overall Study|Adverse Event|0|||
94297093|NCT00404092|322870334|FG002|Overall Study|Adverse Event|1|||
94297094|NCT00404092|322870335|FG003|Overall Study|Adverse Event|0|||
94297095|NCT00484315|322870338|FG000|12-Month Clinical Follow-up|Death|6|||
94297096|NCT00484315|322870339|FG001|12-Month Clinical Follow-up|Death|2|||
94297097|NCT00484315|322870338|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
94297098|NCT00484315|322870339|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
94297099|NCT00484315|322870338|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
94297100|NCT00484315|322870339|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
94297101|NCT00484315|322870338|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
94297102|NCT00484315|322870339|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
94297103|NCT00484315|322870338|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
94297104|NCT00484315|322870339|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
94297105|NCT00484315|322870338|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
94297106|NCT00484315|322870339|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
94297107|NCT00484315|322870338|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
94297108|NCT00484315|322870339|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
94297109|NCT02344576|322870340|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
94297110|NCT02344576|322870341|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
94297111|NCT02344576|322870342|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
94297112|NCT02344576|322870343|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
94297113|NCT02344576|322870340|FG000|1-Month Follow-Up|Death|13|||
94297114|NCT02344576|322870341|FG001|1-Month Follow-Up|Death|8|||
94297115|NCT02344576|322870342|FG002|1-Month Follow-Up|Death|0|||
94467994|NCT00803205|323502463|FG000|Overall Study|Medical Monitor Decision|1|||
94467995|NCT00803205|323502464|FG001|Overall Study|Medical Monitor Decision|0|||
94467996|NCT00803205|323502463|FG000|Overall Study|Acquired a Lung Infection|0|||
94467997|NCT00803205|323502464|FG001|Overall Study|Acquired a Lung Infection|1|||
94467998|NCT00803205|323502463|FG000|Overall Study|Sponsor Decision|0|||
94467999|NCT00803205|323502464|FG001|Overall Study|Sponsor Decision|1|||
94297116|NCT02344576|322870343|FG003|1-Month Follow-Up|Death|0|||
94297117|NCT02344576|322870340|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
94297118|NCT02344576|322870341|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
94297119|NCT02344576|322870342|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
94297120|NCT02344576|322870343|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
94297121|NCT02344576|322870340|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
94297122|NCT02344576|322870341|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
94297123|NCT02344576|322870342|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
94297124|NCT02344576|322870343|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
94297125|NCT02344576|322870340|FG000|6-Month Follow-Up|Death|14|||
94297126|NCT02344576|322870341|FG001|6-Month Follow-Up|Death|14|||
94297127|NCT02344576|322870342|FG002|6-Month Follow-Up|Death|0|||
94297128|NCT02344576|322870343|FG003|6-Month Follow-Up|Death|0|||
94297129|NCT02344576|322870340|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
94297130|NCT02344576|322870341|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
94297131|NCT02344576|322870342|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
94297132|NCT02344576|322870343|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
94297133|NCT02344576|322870340|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
94297134|NCT02344576|322870341|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
94297135|NCT02344576|322870342|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
94297136|NCT02344576|322870343|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
94297137|NCT00943683|322870344|FG000|Overall Study|Adverse Event|3|||
94297138|NCT00943683|322870345|FG001|Overall Study|Adverse Event|3|||
94297139|NCT00943683|322870344|FG000|Overall Study|Lost to Follow-up|1|||
94297140|NCT00943683|322870345|FG001|Overall Study|Lost to Follow-up|1|||
94297141|NCT00943683|322870344|FG000|Overall Study|Protocol Violation|1|||
94297142|NCT00943683|322870345|FG001|Overall Study|Protocol Violation|2|||
94297143|NCT00943683|322870344|FG000|Overall Study|Withdrawal by Subject|1|||
94297144|NCT00943683|322870345|FG001|Overall Study|Withdrawal by Subject|0|||
94297145|NCT00943683|322870344|FG000|Overall Study|Patient Moved|1|||
94297146|NCT00943683|322870345|FG001|Overall Study|Patient Moved|0|||
94297147|NCT02500537|322870346|FG000|Overall Study|Death|2|||
94297148|NCT02500537|322870347|FG001|Overall Study|Death|0|||
94297149|NCT02500537|322870346|FG000|Overall Study|Lost to Follow-up|0|||
94297150|NCT02500537|322870347|FG001|Overall Study|Lost to Follow-up|1|||
94297151|NCT02500537|322870346|FG000|Overall Study|Withdrawal by Subject|1|||
94297152|NCT02500537|322870347|FG001|Overall Study|Withdrawal by Subject|0|||
94297153|NCT04672083|322870348|FG000|Overall Study|Lost to Follow-up|1|||
94297154|NCT04672083|322870349|FG001|Overall Study|Lost to Follow-up|0|||
94297155|NCT04672083|322870350|FG002|Overall Study|Lost to Follow-up|0|||
94297156|NCT04672083|322870351|FG003|Overall Study|Lost to Follow-up|0|||
94297157|NCT04672083|322870352|FG004|Overall Study|Lost to Follow-up|0|||
94297158|NCT01551745|322870353|FG000|Overall Study|Withdrawal by Subject|1|||
94297159|NCT01551745|322870353|FG000|Overall Study|Disease Progression|2|||
94297160|NCT00749190|322870356|FG000|Overall Study|Adverse Event|0|||
94468000|NCT01857102|323502465|FG000|Period 1|No longer meets Eligibility Criteria|0|||
94297161|NCT00749190|322870357|FG001|Overall Study|Adverse Event|2|||
94297162|NCT00749190|322870358|FG002|Overall Study|Adverse Event|0|||
94297163|NCT00749190|322870359|FG003|Overall Study|Adverse Event|4|||
94297164|NCT00749190|322870360|FG004|Overall Study|Adverse Event|0|||
94297165|NCT00749190|322870361|FG005|Overall Study|Adverse Event|3|||
94297166|NCT00749190|322870362|FG006|Overall Study|Adverse Event|0|||
94297167|NCT00749190|322870356|FG000|Overall Study|Lack of Efficacy|3|||
94297168|NCT00749190|322870357|FG001|Overall Study|Lack of Efficacy|1|||
94297169|NCT00749190|322870358|FG002|Overall Study|Lack of Efficacy|1|||
94297170|NCT00749190|322870359|FG003|Overall Study|Lack of Efficacy|0|||
94297171|NCT00749190|322870360|FG004|Overall Study|Lack of Efficacy|0|||
94297172|NCT00749190|322870361|FG005|Overall Study|Lack of Efficacy|1|||
94297173|NCT00749190|322870362|FG006|Overall Study|Lack of Efficacy|0|||
94297174|NCT00749190|322870356|FG000|Overall Study|Withdrawal by Subject|2|||
94297175|NCT00749190|322870357|FG001|Overall Study|Withdrawal by Subject|1|||
94297176|NCT00749190|322870358|FG002|Overall Study|Withdrawal by Subject|0|||
94297177|NCT00749190|322870359|FG003|Overall Study|Withdrawal by Subject|0|||
94297178|NCT00749190|322870360|FG004|Overall Study|Withdrawal by Subject|0|||
94297179|NCT00749190|322870361|FG005|Overall Study|Withdrawal by Subject|1|||
94297180|NCT00749190|322870362|FG006|Overall Study|Withdrawal by Subject|0|||
94297181|NCT00749190|322870356|FG000|Overall Study|Protocol Violation|0|||
94297182|NCT00749190|322870357|FG001|Overall Study|Protocol Violation|1|||
94297183|NCT00749190|322870358|FG002|Overall Study|Protocol Violation|0|||
94297184|NCT00749190|322870359|FG003|Overall Study|Protocol Violation|0|||
94297185|NCT00749190|322870360|FG004|Overall Study|Protocol Violation|0|||
94297186|NCT00749190|322870361|FG005|Overall Study|Protocol Violation|0|||
94297187|NCT00749190|322870362|FG006|Overall Study|Protocol Violation|1|||
94297188|NCT00749190|322870356|FG000|Overall Study|Other reason not defined above|0|||
94297189|NCT00749190|322870357|FG001|Overall Study|Other reason not defined above|0|||
94297190|NCT00749190|322870358|FG002|Overall Study|Other reason not defined above|0|||
94297191|NCT00749190|322870359|FG003|Overall Study|Other reason not defined above|1|||
94297192|NCT00749190|322870360|FG004|Overall Study|Other reason not defined above|0|||
94297193|NCT00749190|322870361|FG005|Overall Study|Other reason not defined above|0|||
94297194|NCT00749190|322870362|FG006|Overall Study|Other reason not defined above|0|||
94297195|NCT02337387|322870365|FG000|Overall Study|Adverse Event|0|||
94297196|NCT02337387|322870366|FG001|Overall Study|Adverse Event|1|||
94297197|NCT02337387|322870367|FG002|Overall Study|Adverse Event|0|||
94297198|NCT02337387|322870368|FG003|Overall Study|Adverse Event|0|||
94297199|NCT02337387|322870365|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
94297200|NCT02337387|322870366|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
94297201|NCT02337387|322870367|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
94297202|NCT02337387|322870368|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
94297203|NCT02853760|322870369|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
94297204|NCT02853760|322870370|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
94297205|NCT02853760|322870371|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
94372695|NCT00529568|323150344|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
94372696|NCT00529568|323150342|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
94372697|NCT00529568|323150343|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
94372698|NCT00529568|323150344|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
94372699|NCT00529568|323150342|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
94372700|NCT00529568|323150343|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
94372701|NCT00529568|323150344|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
94372702|NCT00529568|323150342|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
94372703|NCT00529568|323150343|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
94372704|NCT00529568|323150344|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
94372705|NCT00529568|323150342|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
94372706|NCT00529568|323150343|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
94372707|NCT00529568|323150344|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
94372708|NCT00931385|323150345|FG000|Overall Study|Adverse Event|2|||
94372709|NCT00931385|323150346|FG001|Overall Study|Adverse Event|1|||
94372710|NCT00931385|323150347|FG002|Overall Study|Adverse Event|0|||
94372711|NCT00931385|323150348|FG003|Overall Study|Adverse Event|3|||
94372712|NCT00931385|323150345|FG000|Overall Study|Protocol Violation|0|||
94372713|NCT00931385|323150346|FG001|Overall Study|Protocol Violation|0|||
94372714|NCT00931385|323150347|FG002|Overall Study|Protocol Violation|1|||
94372715|NCT00931385|323150348|FG003|Overall Study|Protocol Violation|0|||
94372716|NCT00931385|323150345|FG000|Overall Study|Withdrawal by Subject|0|||
94372717|NCT00931385|323150346|FG001|Overall Study|Withdrawal by Subject|1|||
94372718|NCT00931385|323150347|FG002|Overall Study|Withdrawal by Subject|0|||
94372719|NCT00931385|323150348|FG003|Overall Study|Withdrawal by Subject|1|||
94372720|NCT00931385|323150345|FG000|Overall Study|Lost to Follow-up|0|||
94297206|NCT02853760|322870372|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
94297207|NCT02853760|322870373|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
94297208|NCT02853760|322870374|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
94297209|NCT00981526|322870380|FG000|Overall Study|Withdrawal by Subject|0|||
94297210|NCT00981526|322870381|FG001|Overall Study|Withdrawal by Subject|2|||
94297211|NCT00981526|322870380|FG000|Overall Study|Physician Decision|4|||
94297212|NCT00981526|322870381|FG001|Overall Study|Physician Decision|4|||
94297213|NCT02272790|322870382|FG000|Overall Study|Physician Decision|0|||
94372721|NCT00931385|323150346|FG001|Overall Study|Lost to Follow-up|0|||
94372722|NCT00931385|323150347|FG002|Overall Study|Lost to Follow-up|0|||
94297214|NCT02272790|322870383|FG001|Overall Study|Physician Decision|1|||
94297215|NCT02272790|322870384|FG002|Overall Study|Physician Decision|0|||
94297216|NCT02272790|322870385|FG003|Overall Study|Physician Decision|0|||
94297217|NCT02272790|322870386|FG004|Overall Study|Physician Decision|0|||
94297218|NCT02272790|322870387|FG005|Overall Study|Physician Decision|0|||
94297219|NCT03871491|322870388|FG000|Overall Study|Withdrawal by Subject|14|||
94297220|NCT03871491|322870389|FG001|Overall Study|Withdrawal by Subject|14|||
94297221|NCT03871491|322870390|FG002|Overall Study|Withdrawal by Subject|14|||
94297222|NCT03871491|322870391|FG003|Overall Study|Withdrawal by Subject|14|||
94297223|NCT03871491|322870388|FG000|Overall Study|Physician Decision|0|||
94297224|NCT03871491|322870389|FG001|Overall Study|Physician Decision|0|||
94297225|NCT03871491|322870390|FG002|Overall Study|Physician Decision|1|||
94297226|NCT03871491|322870391|FG003|Overall Study|Physician Decision|1|||
94297227|NCT03871491|322870388|FG000|Overall Study|Lost to Follow-up|50|||
94297228|NCT03871491|322870389|FG001|Overall Study|Lost to Follow-up|15|||
94297229|NCT03871491|322870390|FG002|Overall Study|Lost to Follow-up|36|||
94297230|NCT03871491|322870391|FG003|Overall Study|Lost to Follow-up|11|||
94297231|NCT02747004|322870392|FG000|Overall Study|Withdrawal by Subject|8|||
94297232|NCT02747004|322870393|FG001|Overall Study|Withdrawal by Subject|5|||
94297233|NCT02747004|322870394|FG002|Overall Study|Withdrawal by Subject|4|||
94297234|NCT02747004|322870392|FG000|Overall Study|Lost to Follow-up|1|||
94297235|NCT02747004|322870393|FG001|Overall Study|Lost to Follow-up|2|||
94297236|NCT02747004|322870394|FG002|Overall Study|Lost to Follow-up|2|||
94297237|NCT02747004|322870392|FG000|Overall Study|on study treatment/follow-up|48|||
94297238|NCT02747004|322870393|FG001|Overall Study|on study treatment/follow-up|42|||
94297239|NCT02747004|322870394|FG002|Overall Study|on study treatment/follow-up|41|||
94297240|NCT05087030|322870395|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
94297241|NCT05087030|322870396|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
94297242|NCT05087030|322870397|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
94297243|NCT05087030|322870398|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
94297244|NCT05087030|322870399|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
94297245|NCT05087030|322870395|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
94297246|NCT05087030|322870396|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
94297247|NCT05087030|322870397|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
94297248|NCT05087030|322870398|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
94297249|NCT05087030|322870399|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
94297250|NCT05087030|322870395|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
94297251|NCT05087030|322870396|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
94297252|NCT05087030|322870397|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
94297253|NCT05087030|322870398|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
94297254|NCT05087030|322870399|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
94297255|NCT05087030|322870395|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
94297256|NCT05087030|322870396|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
94297257|NCT05087030|322870397|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
94297258|NCT05087030|322870398|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
94297259|NCT05087030|322870399|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
94297260|NCT05087030|322870395|FG000|Main Period (Week 0 to Week 52)|Death|0|||
94297261|NCT05087030|322870396|FG001|Main Period (Week 0 to Week 52)|Death|1|||
94297262|NCT05087030|322870397|FG002|Main Period (Week 0 to Week 52)|Death|0|||
94297263|NCT05087030|322870398|FG003|Main Period (Week 0 to Week 52)|Death|0|||
94297264|NCT05087030|322870399|FG004|Main Period (Week 0 to Week 52)|Death|0|||
94297265|NCT05087030|322870395|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
94297266|NCT05087030|322870396|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
94297267|NCT05087030|322870397|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
94297268|NCT05087030|322870398|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
94297269|NCT05087030|322870399|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
94297270|NCT05087030|322870395|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
94297271|NCT05087030|322870396|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
94297272|NCT05087030|322870397|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
94297273|NCT05087030|322870398|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
94297274|NCT05087030|322870399|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
94297275|NCT05087030|322870395|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
94297276|NCT05087030|322870396|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
94297277|NCT05087030|322870397|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
94297278|NCT05087030|322870398|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
94297279|NCT05087030|322870399|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
94297280|NCT05087030|322870395|FG000|Main Period (Week 0 to Week 52)|Other|1|||
94297281|NCT05087030|322870396|FG001|Main Period (Week 0 to Week 52)|Other|2|||
94297282|NCT05087030|322870397|FG002|Main Period (Week 0 to Week 52)|Other|0|||
94297283|NCT05087030|322870398|FG003|Main Period (Week 0 to Week 52)|Other|0|||
94297284|NCT05087030|322870399|FG004|Main Period (Week 0 to Week 52)|Other|0|||
94297285|NCT05087030|322870395|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
94297286|NCT05087030|322870396|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
94297287|NCT05087030|322870397|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
94297288|NCT05087030|322870398|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
94297289|NCT05087030|322870399|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
94297290|NCT04343651|322870400|FG000|Overall Study|Physician Decision|2|||
94297291|NCT04343651|322870401|FG001|Overall Study|Physician Decision|1|||
94297292|NCT04343651|322870400|FG000|Overall Study|Lost to Follow-up|2|||
94297293|NCT04343651|322870401|FG001|Overall Study|Lost to Follow-up|1|||
94297294|NCT04343651|322870400|FG000|Overall Study|Protocol Violation|4|||
94297295|NCT04343651|322870401|FG001|Overall Study|Protocol Violation|6|||
94297296|NCT04343651|322870400|FG000|Overall Study|Missing|3|||
94297297|NCT04343651|322870401|FG001|Overall Study|Missing|9|||
94297298|NCT04343651|322870400|FG000|Overall Study|Withdrawal by Subject|0|||
94297299|NCT04343651|322870401|FG001|Overall Study|Withdrawal by Subject|4|||
94297300|NCT04343651|322870400|FG000|Overall Study|Death|0|||
94297301|NCT04343651|322870401|FG001|Overall Study|Death|1|||
94297302|NCT04343651|322870400|FG000|Overall Study|Did not start treatment|1|||
94297303|NCT04343651|322870401|FG001|Overall Study|Did not start treatment|1|||
94297304|NCT04343651|322870400|FG000|Overall Study|Patient did not complete visits 3-6|0|||
94297305|NCT04343651|322870401|FG001|Overall Study|Patient did not complete visits 3-6|1|||
94297306|NCT00023322|322871809|FG000|Overall Study|Lost to Follow-up|1|||
94297307|NCT02185521|322871814|FG000|Overall Study|Withdrawal by Subject|1|||
94297308|NCT02185521|322871814|FG000|Overall Study|Protocol Violation|1|||
94297309|NCT01028352|322871817|FG000|Overall Study|Ineligible due to baseline average pain|5|||
94297310|NCT01028352|322871817|FG000|Overall Study|Withdrawal by Subject|1|||
94297311|NCT01903876|322871818|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
94297312|NCT01903876|322871819|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
94297313|NCT01903876|322871818|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
94297314|NCT01903876|322871819|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
94297315|NCT00496366|322871820|FG000|Overall Study|Death|1|||
94297316|NCT02612909|322871821|FG000|Phase 2|Withdrawal by Subject|2|||
94297317|NCT02612909|322871822|FG001|Phase 2|Withdrawal by Subject|5|||
94297318|NCT02612909|322871823|FG002|Phase 2|Withdrawal by Subject|0|||
94297319|NCT02612909|322871824|FG003|Phase 2|Withdrawal by Subject|0|||
94297320|NCT02612909|322871825|FG004|Phase 2|Withdrawal by Subject|0|||
94297321|NCT02612909|322871821|FG000|Phase 2|Pregnancy|0|||
94297322|NCT02612909|322871822|FG001|Phase 2|Pregnancy|0|||
94297323|NCT02612909|322871823|FG002|Phase 2|Pregnancy|1|||
94297324|NCT02612909|322871824|FG003|Phase 2|Pregnancy|0|||
94297325|NCT02612909|322871825|FG004|Phase 2|Pregnancy|0|||
94297326|NCT02612909|322871821|FG000|Phase 3|Withdrawal by Subject|0|||
94297327|NCT02612909|322871822|FG001|Phase 3|Withdrawal by Subject|0|||
94297328|NCT02612909|322871823|FG002|Phase 3|Withdrawal by Subject|0|||
94297329|NCT02612909|322871824|FG003|Phase 3|Withdrawal by Subject|1|||
94297330|NCT02612909|322871825|FG004|Phase 3|Withdrawal by Subject|0|||
94297331|NCT01717638|322871826|FG000|Overall Study|Lost to Follow-up|0|||
94297332|NCT01717638|322871827|FG001|Overall Study|Lost to Follow-up|0|||
94297333|NCT01717638|322871828|FG002|Overall Study|Lost to Follow-up|0|||
94297334|NCT01717638|322871829|FG003|Overall Study|Lost to Follow-up|0|||
94297335|NCT01717638|322871830|FG004|Overall Study|Lost to Follow-up|0|||
94297336|NCT01717638|322871831|FG005|Overall Study|Lost to Follow-up|1|||
94297337|NCT01717638|322871832|FG006|Overall Study|Lost to Follow-up|0|||
94297338|NCT01717638|322871833|FG007|Overall Study|Lost to Follow-up|0|||
94297339|NCT01717638|322871834|FG008|Overall Study|Lost to Follow-up|0|||
94297340|NCT01717638|322871835|FG009|Overall Study|Lost to Follow-up|0|||
94297341|NCT01717638|322871836|FG010|Overall Study|Lost to Follow-up|0|||
94297342|NCT01717638|322871837|FG011|Overall Study|Lost to Follow-up|0|||
94297343|NCT01717638|322871838|FG012|Overall Study|Lost to Follow-up|0|||
94297344|NCT01717638|322871826|FG000|Overall Study|Father in hospital|0|||
94297345|NCT01717638|322871827|FG001|Overall Study|Father in hospital|0|||
94297346|NCT01717638|322871828|FG002|Overall Study|Father in hospital|0|||
94297347|NCT01717638|322871829|FG003|Overall Study|Father in hospital|0|||
94372723|NCT00931385|323150348|FG003|Overall Study|Lost to Follow-up|1|||
94297348|NCT01717638|322871830|FG004|Overall Study|Father in hospital|0|||
94297349|NCT01717638|322871831|FG005|Overall Study|Father in hospital|0|||
94297350|NCT01717638|322871832|FG006|Overall Study|Father in hospital|0|||
94297351|NCT01717638|322871833|FG007|Overall Study|Father in hospital|0|||
94297352|NCT01717638|322871834|FG008|Overall Study|Father in hospital|0|||
94297353|NCT01717638|322871835|FG009|Overall Study|Father in hospital|0|||
94297354|NCT01717638|322871836|FG010|Overall Study|Father in hospital|0|||
94297355|NCT01717638|322871837|FG011|Overall Study|Father in hospital|0|||
94297356|NCT01717638|322871838|FG012|Overall Study|Father in hospital|1|||
94372724|NCT02230085|323150352|FG000|Overall Study|Physician Decision|1|||
94297357|NCT01717638|322871826|FG000|Overall Study|Withdrawal by Subject|0|||
94297358|NCT01717638|322871827|FG001|Overall Study|Withdrawal by Subject|1|||
94297359|NCT01717638|322871828|FG002|Overall Study|Withdrawal by Subject|1|||
94372725|NCT02230085|323150352|FG000|Overall Study|Withdrawal by Subject|3|||
94297360|NCT01717638|322871829|FG003|Overall Study|Withdrawal by Subject|0|||
94297361|NCT01717638|322871830|FG004|Overall Study|Withdrawal by Subject|1|||
94297362|NCT01717638|322871831|FG005|Overall Study|Withdrawal by Subject|0|||
94297363|NCT01717638|322871832|FG006|Overall Study|Withdrawal by Subject|2|||
94297364|NCT01717638|322871833|FG007|Overall Study|Withdrawal by Subject|1|||
94297365|NCT01717638|322871834|FG008|Overall Study|Withdrawal by Subject|2|||
94297366|NCT01717638|322871835|FG009|Overall Study|Withdrawal by Subject|1|||
94297367|NCT01717638|322871836|FG010|Overall Study|Withdrawal by Subject|0|||
94297368|NCT01717638|322871837|FG011|Overall Study|Withdrawal by Subject|0|||
94297369|NCT01717638|322871838|FG012|Overall Study|Withdrawal by Subject|18|||
94297370|NCT03539432|322871839|FG000|Overall Study|Lost to Follow-up|0|||
94297371|NCT03539432|322871840|FG001|Overall Study|Lost to Follow-up|1|||
94297372|NCT00501228|322871843|FG000|Overall Study|Withdrawal by Subject|1|||
94297373|NCT02731742|322871846|FG000|Overall Study|Death|1|||
94297374|NCT02731742|322871847|FG001|Overall Study|Death|2|||
94297375|NCT02731742|322871848|FG002|Overall Study|Death|5|||
94297376|NCT02731742|322871849|FG003|Overall Study|Death|0|||
94297377|NCT02731742|322871846|FG000|Overall Study|Physician Decision|0|||
94297378|NCT02731742|322871847|FG001|Overall Study|Physician Decision|0|||
94297379|NCT02731742|322871848|FG002|Overall Study|Physician Decision|0|||
94297380|NCT02731742|322871849|FG003|Overall Study|Physician Decision|1|||
94297381|NCT02731742|322871846|FG000|Overall Study|Study Terminated by Sponsor|2|||
94297382|NCT02731742|322871847|FG001|Overall Study|Study Terminated by Sponsor|1|||
94297383|NCT02731742|322871848|FG002|Overall Study|Study Terminated by Sponsor|1|||
94297384|NCT02731742|322871849|FG003|Overall Study|Study Terminated by Sponsor|1|||
94297385|NCT00502840|322871852|FG000|Overall Study|Adverse Event|5|||
94297386|NCT00502840|322871852|FG000|Overall Study|Additional or changed therapy|48|||
94297387|NCT00502840|322871852|FG000|Overall Study|Lack of Efficacy|11|||
94297388|NCT00502840|322871852|FG000|Overall Study|Protocol Violation|4|||
94297389|NCT00502840|322871852|FG000|Overall Study|Withdrawal by Subject|5|||
94297390|NCT00502840|322871852|FG000|Overall Study|Lost to Follow-up|6|||
94297391|NCT00502840|322871852|FG000|Overall Study|Administrative problems|1|||
94297392|NCT00502840|322871852|FG000|Overall Study|Other|20|||
94297393|NCT01295125|322871860|FG000|Overall Study|Study stopped prematurely|9|||
94297394|NCT00891735|322871861|FG000|Overall Study|Adverse Event|2|||
94297395|NCT00891735|322871862|FG001|Overall Study|Adverse Event|0|||
94297396|NCT00891735|322871863|FG002|Overall Study|Adverse Event|2|||
94297397|NCT00891735|322871864|FG003|Overall Study|Adverse Event|0|||
94297398|NCT00891735|322871861|FG000|Overall Study|Death|8|||
94297399|NCT00891735|322871862|FG001|Overall Study|Death|5|||
94297400|NCT00891735|322871863|FG002|Overall Study|Death|4|||
94297401|NCT00891735|322871864|FG003|Overall Study|Death|5|||
94297402|NCT00891735|322871861|FG000|Overall Study|Lost to Follow-up|2|||
94297403|NCT00891735|322871862|FG001|Overall Study|Lost to Follow-up|2|||
94297404|NCT00891735|322871863|FG002|Overall Study|Lost to Follow-up|2|||
94297405|NCT00891735|322871864|FG003|Overall Study|Lost to Follow-up|2|||
94297406|NCT00891735|322871861|FG000|Overall Study|Physician's decision to withdraw patient|1|||
94297407|NCT00891735|322871862|FG001|Overall Study|Physician's decision to withdraw patient|0|||
94297408|NCT00891735|322871863|FG002|Overall Study|Physician's decision to withdraw patient|0|||
94297409|NCT00891735|322871864|FG003|Overall Study|Physician's decision to withdraw patient|0|||
94297410|NCT00891735|322871861|FG000|Overall Study|Patient's decision to withdraw|4|||
94297411|NCT00891735|322871862|FG001|Overall Study|Patient's decision to withdraw|9|||
94297412|NCT00891735|322871863|FG002|Overall Study|Patient's decision to withdraw|4|||
94297413|NCT00891735|322871864|FG003|Overall Study|Patient's decision to withdraw|8|||
94297414|NCT03663166|322871871|FG000|Overall Study|Withdrawal by Subject|1|||
94297415|NCT02978222|322871873|FG000|Overall Study|Withdrawal by Subject|2|||
94297416|NCT02978222|322871874|FG001|Overall Study|Withdrawal by Subject|2|||
94297417|NCT02978222|322871873|FG000|Overall Study|Physician Decision|2|||
94297418|NCT02978222|322871874|FG001|Overall Study|Physician Decision|0|||
94297419|NCT02978222|322871873|FG000|Overall Study|Adverse Event|0|||
94297420|NCT02978222|322871874|FG001|Overall Study|Adverse Event|1|||
94297421|NCT02978222|322871873|FG000|Overall Study|Death|1|||
94297422|NCT02978222|322871874|FG001|Overall Study|Death|0|||
94297423|NCT02978222|322871873|FG000|Overall Study|Disease Progression|32|||
94297424|NCT02978222|322871874|FG001|Overall Study|Disease Progression|32|||
94297425|NCT02978222|322871873|FG000|Overall Study|Early Study Termination|24|||
94297426|NCT02978222|322871874|FG001|Overall Study|Early Study Termination|21|||
94297427|NCT01071070|322871876|FG000|Overall Study|Adverse Event|0|||
94297428|NCT01071070|322871877|FG001|Overall Study|Adverse Event|3|||
94297429|NCT01071070|322871876|FG000|Overall Study|Withdrawal by Subject|1|||
94297430|NCT01071070|322871877|FG001|Overall Study|Withdrawal by Subject|0|||
94297431|NCT01071070|322871876|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
94297432|NCT01071070|322871877|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
94297433|NCT01071070|322871876|FG000|Overall Study|Hypercalcemia|1|||
94297434|NCT01071070|322871877|FG001|Overall Study|Hypercalcemia|0|||
94297435|NCT02620020|322871879|FG000|Overall Study|Adverse Event|8|||
94297436|NCT02620020|322871880|FG001|Overall Study|Adverse Event|4|||
94297437|NCT02620020|322871881|FG002|Overall Study|Adverse Event|3|||
94297438|NCT02620020|322871882|FG003|Overall Study|Adverse Event|5|||
94297439|NCT02620020|322871879|FG000|Overall Study|Lost to Follow-up|4|||
94297440|NCT02620020|322871880|FG001|Overall Study|Lost to Follow-up|8|||
94297441|NCT02620020|322871881|FG002|Overall Study|Lost to Follow-up|1|||
94297442|NCT02620020|322871882|FG003|Overall Study|Lost to Follow-up|4|||
94297443|NCT02620020|322871879|FG000|Overall Study|Physician Decision|7|||
94297444|NCT02620020|322871880|FG001|Overall Study|Physician Decision|4|||
94297445|NCT02620020|322871881|FG002|Overall Study|Physician Decision|3|||
94297446|NCT02620020|322871882|FG003|Overall Study|Physician Decision|4|||
94297447|NCT02620020|322871879|FG000|Overall Study|Protocol Violation|5|||
94297448|NCT02620020|322871880|FG001|Overall Study|Protocol Violation|2|||
94297449|NCT02620020|322871881|FG002|Overall Study|Protocol Violation|1|||
94297450|NCT02620020|322871882|FG003|Overall Study|Protocol Violation|1|||
94297451|NCT02620020|322871879|FG000|Overall Study|Withdrawal by Subject|20|||
94297452|NCT02620020|322871880|FG001|Overall Study|Withdrawal by Subject|16|||
94297453|NCT02620020|322871881|FG002|Overall Study|Withdrawal by Subject|17|||
94297454|NCT02620020|322871882|FG003|Overall Study|Withdrawal by Subject|12|||
94297455|NCT02620020|322871879|FG000|Overall Study|Death|0|||
94297456|NCT02620020|322871880|FG001|Overall Study|Death|1|||
94297457|NCT02620020|322871881|FG002|Overall Study|Death|0|||
94297458|NCT02620020|322871882|FG003|Overall Study|Death|0|||
94297459|NCT02928952|322871884|FG000|Overall Study|Lost to Follow-up|5|||
94297460|NCT02928952|322871885|FG001|Overall Study|Lost to Follow-up|5|||
94297461|NCT02928952|322871884|FG000|Overall Study|Withdrawal by Subject|5|||
94297462|NCT02928952|322871885|FG001|Overall Study|Withdrawal by Subject|1|||
94297463|NCT02928952|322871884|FG000|Overall Study|Physician Decision|0|||
94297464|NCT02928952|322871885|FG001|Overall Study|Physician Decision|1|||
94297465|NCT00432809|322871889|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
94297466|NCT00432809|322871890|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
94297467|NCT00432809|322871891|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
94297468|NCT00432809|322871889|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
94297469|NCT00432809|322871890|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
94297470|NCT00432809|322871891|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
94297471|NCT01243268|322871892|FG000|Overall Study|Lost to Follow-up|4|||
94297472|NCT01243268|322871892|FG000|Overall Study|Protocol Violation|51|||
94297473|NCT01243268|322871892|FG000|Overall Study|Deviation with contract date|7|||
94297474|NCT01243268|322871892|FG000|Overall Study|Duplicate subject|2|||
94297475|NCT05202808|322871893|FG000|Overall Study|Lost to Follow-up|3|||
94297476|NCT05202808|322871894|FG001|Overall Study|Lost to Follow-up|1|||
94297477|NCT00947349|322871903|FG000|Triple Treatment Combination Period|Adverse Event|0|||
94297478|NCT00947349|322871904|FG001|Triple Treatment Combination Period|Adverse Event|1|||
94297479|NCT00947349|322871905|FG002|Triple Treatment Combination Period|Adverse Event|0|||
94297480|NCT00947349|322871906|FG003|Triple Treatment Combination Period|Adverse Event|0|||
94297481|NCT00947349|322871903|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
94297482|NCT00947349|322871904|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
94297483|NCT00947349|322871905|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
94297484|NCT00947349|322871906|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
94297485|NCT00947349|322871903|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
94297486|NCT00947349|322871904|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
94297487|NCT00947349|322871905|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
94297488|NCT00947349|322871906|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
94297489|NCT00947349|322871903|FG000|Overall Study Standard of Care|Other|0|||
94297490|NCT00947349|322871904|FG001|Overall Study Standard of Care|Other|0|||
94297491|NCT00947349|322871905|FG002|Overall Study Standard of Care|Other|0|||
94297492|NCT00947349|322871906|FG003|Overall Study Standard of Care|Other|1|||
94297493|NCT00538681|322871907|FG000|Overall Study|Progressive Disease|7|||
94297494|NCT00538681|322871908|FG001|Overall Study|Progressive Disease|0|||
94297495|NCT00538681|322871909|FG002|Overall Study|Progressive Disease|1|||
94297496|NCT00538681|322871910|FG003|Overall Study|Progressive Disease|0|||
94297497|NCT00538681|322871907|FG000|Overall Study|Sponsor Decision|1|||
94297498|NCT00538681|322871908|FG001|Overall Study|Sponsor Decision|3|||
94297499|NCT00538681|322871909|FG002|Overall Study|Sponsor Decision|8|||
94297500|NCT00538681|322871910|FG003|Overall Study|Sponsor Decision|9|||
94297501|NCT00538681|322871907|FG000|Overall Study|Adverse Event|1|||
94297502|NCT00538681|322871908|FG001|Overall Study|Adverse Event|1|||
94297503|NCT00538681|322871909|FG002|Overall Study|Adverse Event|1|||
94297504|NCT00538681|322871910|FG003|Overall Study|Adverse Event|0|||
94297505|NCT00538681|322871907|FG000|Overall Study|Death|0|||
94297506|NCT00538681|322871908|FG001|Overall Study|Death|0|||
94297507|NCT00538681|322871909|FG002|Overall Study|Death|1|||
94297508|NCT00538681|322871910|FG003|Overall Study|Death|1|||
94297509|NCT00538681|322871907|FG000|Overall Study|Investigator Decision|0|||
94372726|NCT01360632|323150356|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
94297510|NCT00538681|322871908|FG001|Overall Study|Investigator Decision|0|||
94297511|NCT00538681|322871909|FG002|Overall Study|Investigator Decision|0|||
94297512|NCT00538681|322871910|FG003|Overall Study|Investigator Decision|1|||
94297513|NCT02582658|322871918|FG000|Overall Study|Failure to Return|10|||
94468001|NCT01857102|323502466|FG001|Period 1|No longer meets Eligibility Criteria|2|||
94468002|NCT01857102|323502465|FG000|Period 1|Lost to Follow-up|0|||
94468003|NCT01857102|323502466|FG001|Period 1|Lost to Follow-up|3|||
94468004|NCT01857102|323502465|FG000|Period 1|Unsatisfactory Lens Fit|1|||
94468005|NCT01857102|323502466|FG001|Period 1|Unsatisfactory Lens Fit|0|||
94468006|NCT01857102|323502465|FG000|Period 1|Unsatisfactory Visual Response|1|||
94468007|NCT01857102|323502466|FG001|Period 1|Unsatisfactory Visual Response|0|||
94468008|NCT01857102|323502465|FG000|Period 1|Physician Decision|1|||
94468009|NCT01857102|323502466|FG001|Period 1|Physician Decision|0|||
94468010|NCT01857102|323502465|FG000|Period 2|Lens Discomfort|1|||
94468011|NCT01857102|323502466|FG001|Period 2|Lens Discomfort|0|||
94297514|NCT02582658|322871918|FG000|Overall Study|Insufficient Virological Response|2|||
94297515|NCT02582658|322871918|FG000|Overall Study|Withdrawn Consent|1|||
94297516|NCT02582658|322871918|FG000|Overall Study|Death|1|||
94297517|NCT02582658|322871918|FG000|Overall Study|Not further specified|11|||
94297518|NCT00891202|322871919|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
94297519|NCT00891202|322871920|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
94297520|NCT00891202|322871921|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
94297521|NCT00891202|322871922|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
94297522|NCT00891202|322871919|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
94297523|NCT00891202|322871920|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
94297524|NCT00891202|322871921|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
94297525|NCT00891202|322871922|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
94297526|NCT00891202|322871919|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
94297527|NCT00891202|322871920|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
94297528|NCT00891202|322871921|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
94297529|NCT00891202|322871922|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
94297530|NCT00891202|322871919|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
94297531|NCT00891202|322871920|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
94297532|NCT00891202|322871921|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
94297533|NCT00891202|322871922|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
94297534|NCT04429022|322871923|FG000|Overall Study|Protocol Violation|18|||
94297535|NCT04429022|322871924|FG001|Overall Study|Protocol Violation|1|||
94297536|NCT01769105|322871925|FG000|First Intervention|Protocol Violation|2|||
94297537|NCT01769105|322871926|FG001|First Intervention|Protocol Violation|2|||
94297538|NCT01769105|322871925|FG000|Cross-over|Lost to Follow-up|5|||
94297539|NCT01769105|322871926|FG001|Cross-over|Lost to Follow-up|0|||
94297540|NCT00998738|322871927|FG000|Overall Study|Uknown|1|||
94297541|NCT04194944|322871928|FG000|Overall Study|Lost to Follow-up|3|||
94297542|NCT04194944|322871929|FG001|Overall Study|Lost to Follow-up|0|||
94297543|NCT04194944|322871928|FG000|Overall Study|Withdrawal by Subject|2|||
94297544|NCT04194944|322871929|FG001|Overall Study|Withdrawal by Subject|2|||
94297545|NCT04194944|322871928|FG000|Overall Study|On Treatment|93|||
94297546|NCT04194944|322871929|FG001|Overall Study|On Treatment|30|||
94297547|NCT02711553|322871930|FG000|Overall Study|Withdrawal by Subject|2|||
94297548|NCT02711553|322871931|FG001|Overall Study|Withdrawal by Subject|1|||
94297549|NCT02711553|322871932|FG002|Overall Study|Withdrawal by Subject|1|||
94297550|NCT02711553|322871933|FG003|Overall Study|Withdrawal by Subject|0|||
94372727|NCT01360632|323150357|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
94372728|NCT01360632|323150358|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
94372729|NCT01360632|323150359|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
94372730|NCT01360632|323150360|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
94372731|NCT01360632|323150356|FG000|Phase A (8 Weeks)|Adverse Event|60|||
94372732|NCT01360632|323150357|FG001|Phase A (8 Weeks)|Adverse Event|0|||
94372733|NCT01360632|323150358|FG002|Phase A (8 Weeks)|Adverse Event|0|||
94372734|NCT01360632|323150359|FG003|Phase A (8 Weeks)|Adverse Event|0|||
94372735|NCT01360632|323150360|FG004|Phase A (8 Weeks)|Adverse Event|0|||
94372736|NCT01360632|323150356|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
94372737|NCT01360632|323150357|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
94372738|NCT01360632|323150358|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
94372739|NCT01360632|323150359|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
94372740|NCT01360632|323150360|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
94468012|NCT01857102|323502465|FG000|Period 2|Unsatisfactory Lens Fit|1|||
94468013|NCT01857102|323502466|FG001|Period 2|Unsatisfactory Lens Fit|0|||
94468014|NCT02603562|323502474|FG000|Overall Study|Lost to Follow-up|1|||
94297551|NCT02711553|322871930|FG000|Overall Study|Lost to Follow-up|3|||
94468015|NCT00379808|323502475|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
94468016|NCT00379808|323502476|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
94297552|NCT02711553|322871931|FG001|Overall Study|Lost to Follow-up|3|||
94297553|NCT02711553|322871932|FG002|Overall Study|Lost to Follow-up|6|||
94297554|NCT02711553|322871933|FG003|Overall Study|Lost to Follow-up|3|||
94297555|NCT02711553|322871930|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
94372741|NCT01360632|323150356|FG000|Phase A (8 Weeks)|Physician Decision|10|||
94372742|NCT01360632|323150357|FG001|Phase A (8 Weeks)|Physician Decision|0|||
94468017|NCT02279745|323502477|FG000|Overall Study|Adverse Event|7|||
94297556|NCT02711553|322871931|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
94297557|NCT02711553|322871932|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
94297558|NCT02711553|322871933|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
94297559|NCT00127127|322873742|FG000|Overall Study|Adverse Event|0|||
94297560|NCT00127127|322873743|FG001|Overall Study|Adverse Event|2|||
94297561|NCT00127127|322873744|FG002|Overall Study|Adverse Event|0|||
94297562|NCT00127127|322873745|FG003|Overall Study|Adverse Event|1|||
94297563|NCT00127127|322873742|FG000|Overall Study|Lack of Efficacy|1|||
94297564|NCT00127127|322873743|FG001|Overall Study|Lack of Efficacy|3|||
94297565|NCT00127127|322873744|FG002|Overall Study|Lack of Efficacy|0|||
94297566|NCT00127127|322873745|FG003|Overall Study|Lack of Efficacy|2|||
94297567|NCT01412879|322873746|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
94297568|NCT01412879|322873747|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
94297569|NCT01412879|322873748|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
94297570|NCT01412879|322873746|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
94297571|NCT01412879|322873747|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
94297572|NCT01412879|322873748|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
94297573|NCT01412879|322873746|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
94297574|NCT01412879|322873747|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
94297575|NCT01412879|322873748|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
94297576|NCT01412879|322873746|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
94297577|NCT01412879|322873747|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
94297578|NCT01412879|322873748|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
94297579|NCT01412879|322873746|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
94297580|NCT01412879|322873747|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
94297581|NCT01412879|322873748|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
94297582|NCT02091440|322873751|FG000|Overall Study|Death|2|||
94297583|NCT03323749|322873754|FG000|Double-blind Period|Lost to Follow-up|4|||
94297584|NCT03323749|322873755|FG001|Double-blind Period|Lost to Follow-up|5|||
94297585|NCT03323749|322873754|FG000|Double-blind Period|Adverse Event|3|||
94297586|NCT03323749|322873755|FG001|Double-blind Period|Adverse Event|1|||
94297587|NCT03323749|322873754|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
94297588|NCT03323749|322873755|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
94297589|NCT03323749|322873754|FG000|Open-Label Period|Adverse Event|3|||
94297590|NCT03323749|322873755|FG001|Open-Label Period|Adverse Event|10|||
94297591|NCT03323749|322873754|FG000|Open-Label Period|Withdrawal by Subject|7|||
94297592|NCT03323749|322873755|FG001|Open-Label Period|Withdrawal by Subject|5|||
94297593|NCT03312218|322873756|FG000|Overall Study|Never signed in to access the app|54|||
94297594|NCT03312218|322873757|FG001|Overall Study|Never signed in to access the app|58|||
94297595|NCT01389245|322873762|FG000|Overall Study|Protocol Violation|10|||
94297596|NCT01389245|322873762|FG000|Overall Study|Lost to Follow-up|3|||
94297597|NCT01389245|322873762|FG000|Overall Study|Withdrawal by Subject|2|||
94297598|NCT01485614|322873763|FG000|Randomization|Not Treated|1|||
94297599|NCT01485614|322873764|FG001|Randomization|Not Treated|0|||
94297600|NCT01485614|322873765|FG002|Randomization|Not Treated|0|||
94297601|NCT01485614|322873766|FG003|Randomization|Not Treated|0|||
94297602|NCT01485614|322873763|FG000|Weeks 0-20|Lost to Follow-up|2|||
94297603|NCT01485614|322873764|FG001|Weeks 0-20|Lost to Follow-up|0|||
94297604|NCT01485614|322873765|FG002|Weeks 0-20|Lost to Follow-up|0|||
94297605|NCT01485614|322873766|FG003|Weeks 0-20|Lost to Follow-up|0|||
94297606|NCT01485614|322873763|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
94297607|NCT01485614|322873764|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
94297608|NCT01485614|322873765|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
94297609|NCT01485614|322873766|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
94297610|NCT01485614|322873763|FG000|Weeks 0-20|Withdrawal by Subject|3|||
94297611|NCT01485614|322873764|FG001|Weeks 0-20|Withdrawal by Subject|2|||
94297612|NCT01485614|322873765|FG002|Weeks 0-20|Withdrawal by Subject|1|||
94297613|NCT01485614|322873766|FG003|Weeks 0-20|Withdrawal by Subject|0|||
94297614|NCT01485614|322873763|FG000|Weeks 20-54|Lost to Follow-up|4|||
94297615|NCT01485614|322873764|FG001|Weeks 20-54|Lost to Follow-up|3|||
94297616|NCT01485614|322873765|FG002|Weeks 20-54|Lost to Follow-up|1|||
94297617|NCT01485614|322873766|FG003|Weeks 20-54|Lost to Follow-up|0|||
94297618|NCT01485614|322873763|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
94297619|NCT01485614|322873764|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
94297620|NCT01485614|322873765|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
94297621|NCT01485614|322873766|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
94297622|NCT01485614|322873763|FG000|Weeks 20-54|Withdrawal by Subject|5|||
94297623|NCT01485614|322873764|FG001|Weeks 20-54|Withdrawal by Subject|3|||
94297624|NCT01485614|322873765|FG002|Weeks 20-54|Withdrawal by Subject|0|||
94297625|NCT01485614|322873766|FG003|Weeks 20-54|Withdrawal by Subject|0|||
94297626|NCT04125680|322873768|FG000|Overall Study|Lost to Follow-up|15|||
94297627|NCT02582515|322873773|FG000|Overall Study|Withdrawal by Subject|0|||
94297628|NCT02582515|322873774|FG001|Overall Study|Withdrawal by Subject|1|||
94297629|NCT00363415|322873775|FG000|Overall Study|Progressive Disease|196|||
94297630|NCT00363415|322873776|FG001|Overall Study|Progressive Disease|107|||
94297631|NCT00363415|322873775|FG000|Overall Study|Sponsor Decision|67|||
94297632|NCT00363415|322873776|FG001|Overall Study|Sponsor Decision|31|||
94297633|NCT00363415|322873775|FG000|Overall Study|Death|32|||
94297634|NCT00363415|322873776|FG001|Overall Study|Death|29|||
94297635|NCT00363415|322873775|FG000|Overall Study|Adverse Event|24|||
94297636|NCT00363415|322873776|FG001|Overall Study|Adverse Event|15|||
94297637|NCT00363415|322873775|FG000|Overall Study|Physician Decision|18|||
94297638|NCT00363415|322873776|FG001|Overall Study|Physician Decision|35|||
94297639|NCT00363415|322873775|FG000|Overall Study|Entry Criteria Not Met|11|||
94297640|NCT00363415|322873776|FG001|Overall Study|Entry Criteria Not Met|10|||
94297641|NCT00363415|322873775|FG000|Overall Study|Withdrawal by Subject|9|||
94297642|NCT00363415|322873776|FG001|Overall Study|Withdrawal by Subject|15|||
94297643|NCT00363415|322873775|FG000|Overall Study|Lost to Follow-up|3|||
94297644|NCT00363415|322873776|FG001|Overall Study|Lost to Follow-up|3|||
94297645|NCT00363415|322873775|FG000|Overall Study|Protocol Violation|1|||
94297646|NCT00363415|322873776|FG001|Overall Study|Protocol Violation|4|||
94297647|NCT04439266|322873787|FG000|Overall Study|Ineligible|1|||
94297648|NCT04439266|322873787|FG000|Overall Study|Adverse Event|1|||
94297649|NCT04439266|322873787|FG000|Overall Study|Death|1|||
94297650|NCT04439266|322873787|FG000|Overall Study|Disease progression|1|||
94297651|NCT04439266|322873787|FG000|Overall Study|Still on treatment|1|||
94297652|NCT05817045|322873789|FG000|Overall Study|Protocol Violation|0|||
94297653|NCT05817045|322873790|FG001|Overall Study|Protocol Violation|3|||
94297654|NCT05817045|322873789|FG000|Overall Study|Withdrawal by Subject|10|||
94297655|NCT05817045|322873790|FG001|Overall Study|Withdrawal by Subject|7|||
94297656|NCT05817045|322873789|FG000|Overall Study|Physician Decision|3|||
94297657|NCT05817045|322873790|FG001|Overall Study|Physician Decision|0|||
94297658|NCT05817045|322873789|FG000|Overall Study|Lost to Follow-up|0|||
94297659|NCT05817045|322873790|FG001|Overall Study|Lost to Follow-up|1|||
94297660|NCT05817045|322873789|FG000|Overall Study|Device Deficiency|1|||
94297661|NCT05817045|322873790|FG001|Overall Study|Device Deficiency|0|||
94297662|NCT05817045|322873789|FG000|Overall Study|System Error|1|||
94297663|NCT05817045|322873790|FG001|Overall Study|System Error|0|||
94297664|NCT01701258|322873793|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
94297665|NCT01701258|322873794|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
94297666|NCT01701258|322873795|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
94297667|NCT01701258|322873796|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
94297668|NCT01701258|322873797|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
94297669|NCT01701258|322873798|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
94297670|NCT01701258|322873799|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
94297671|NCT01701258|322873800|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
94297672|NCT01701258|322873801|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
94297673|NCT01701258|322873802|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
94297674|NCT01701258|322873803|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
94297675|NCT01701258|322873804|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
94297676|NCT01701258|322873805|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
94297677|NCT01701258|322873793|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
94297678|NCT01701258|322873794|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
94297679|NCT01701258|322873795|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
94372743|NCT01360632|323150358|FG002|Phase A (8 Weeks)|Physician Decision|0|||
94372744|NCT01360632|323150359|FG003|Phase A (8 Weeks)|Physician Decision|0|||
94372745|NCT01360632|323150360|FG004|Phase A (8 Weeks)|Physician Decision|0|||
94372746|NCT01360632|323150356|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
94372747|NCT01360632|323150357|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
94372748|NCT01360632|323150358|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
94372749|NCT01360632|323150359|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
94372750|NCT01360632|323150360|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
94372751|NCT01360632|323150356|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
94372752|NCT01360632|323150357|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
94372753|NCT01360632|323150358|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
94372754|NCT01360632|323150359|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
94372755|NCT01360632|323150360|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
94372756|NCT01360632|323150356|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
94372757|NCT01360632|323150357|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
94297680|NCT01701258|322873796|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
94297681|NCT01701258|322873797|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
94297682|NCT01701258|322873798|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
94297683|NCT01701258|322873799|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
94297684|NCT01701258|322873800|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
94297685|NCT01701258|322873801|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
94297686|NCT01701258|322873802|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
94297687|NCT01701258|322873803|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
94372758|NCT01360632|323150358|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
94372759|NCT01360632|323150359|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
94297688|NCT01701258|322873804|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
94297689|NCT01701258|322873805|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
94297690|NCT01701258|322873793|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
94297691|NCT01701258|322873794|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
94297692|NCT01701258|322873795|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
94297693|NCT01701258|322873796|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
94297694|NCT01701258|322873797|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
94297695|NCT01701258|322873798|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
94297696|NCT01701258|322873799|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
94297697|NCT01701258|322873800|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
94297698|NCT01701258|322873801|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
94297699|NCT01701258|322873802|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
94297700|NCT01701258|322873803|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
94297701|NCT01701258|322873804|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
94297702|NCT01701258|322873805|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
94297703|NCT01701258|322873793|FG000|Assessment and Scheduling|Investigator Terminated|2|||
94297704|NCT01701258|322873794|FG001|Assessment and Scheduling|Investigator Terminated|0|||
94297705|NCT01701258|322873795|FG002|Assessment and Scheduling|Investigator Terminated|0|||
94297706|NCT01701258|322873796|FG003|Assessment and Scheduling|Investigator Terminated|0|||
94297707|NCT01701258|322873797|FG004|Assessment and Scheduling|Investigator Terminated|0|||
94297708|NCT01701258|322873798|FG005|Assessment and Scheduling|Investigator Terminated|0|||
94297709|NCT01701258|322873799|FG006|Assessment and Scheduling|Investigator Terminated|0|||
94297710|NCT01701258|322873800|FG007|Assessment and Scheduling|Investigator Terminated|0|||
94297711|NCT01701258|322873801|FG008|Assessment and Scheduling|Investigator Terminated|0|||
94297712|NCT01701258|322873802|FG009|Assessment and Scheduling|Investigator Terminated|0|||
94297713|NCT01701258|322873803|FG010|Assessment and Scheduling|Investigator Terminated|0|||
94297714|NCT01701258|322873804|FG011|Assessment and Scheduling|Investigator Terminated|0|||
94297715|NCT01701258|322873805|FG012|Assessment and Scheduling|Investigator Terminated|0|||
94297716|NCT01147497|322873812|FG000|Overall Study|failed insertion|2|||
94297717|NCT01147497|322873813|FG001|Overall Study|failed insertion|0|||
94297718|NCT02983604|322873816|FG000|Overall Study|Enrolled but not Treated|0|||
94297719|NCT02983604|322873817|FG001|Overall Study|Enrolled but not Treated|0|||
94297720|NCT02983604|322873818|FG002|Overall Study|Enrolled but not Treated|1|||
94297721|NCT02983604|322873819|FG003|Overall Study|Enrolled but not Treated|0|||
94297722|NCT00813995|322873820|FG000|Overall Study|Clinical adverse event|9|||
94297723|NCT00813995|322873821|FG001|Overall Study|Clinical adverse event|3|||
94297724|NCT00813995|322873820|FG000|Overall Study|Laboratory adverse event|0|||
94297725|NCT00813995|322873821|FG001|Overall Study|Laboratory adverse event|2|||
94297726|NCT00813995|322873820|FG000|Overall Study|Lack of Efficacy|1|||
94297727|NCT00813995|322873821|FG001|Overall Study|Lack of Efficacy|0|||
94297728|NCT00813995|322873820|FG000|Overall Study|Lost to Follow-up|4|||
94297729|NCT00813995|322873821|FG001|Overall Study|Lost to Follow-up|2|||
94372760|NCT01360632|323150360|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
94372761|NCT01360632|323150356|FG000|Phase B (6 Weeks)|Adverse Event|0|||
94372762|NCT01360632|323150357|FG001|Phase B (6 Weeks)|Adverse Event|3|||
94372763|NCT01360632|323150358|FG002|Phase B (6 Weeks)|Adverse Event|9|||
94372764|NCT01360632|323150359|FG003|Phase B (6 Weeks)|Adverse Event|3|||
94372765|NCT01360632|323150360|FG004|Phase B (6 Weeks)|Adverse Event|0|||
94297730|NCT00813995|322873820|FG000|Overall Study|Other reason|2|||
94297731|NCT00813995|322873821|FG001|Overall Study|Other reason|2|||
94297732|NCT00813995|322873820|FG000|Overall Study|Protocol Violation|3|||
94297733|NCT00813995|322873821|FG001|Overall Study|Protocol Violation|2|||
94297734|NCT00813995|322873820|FG000|Overall Study|Subject moved|4|||
94297735|NCT00813995|322873821|FG001|Overall Study|Subject moved|0|||
94297736|NCT00813995|322873820|FG000|Overall Study|Withdrawal by Subject|0|||
94372766|NCT01360632|323150356|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
94372767|NCT01360632|323150357|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
94372768|NCT01360632|323150358|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
94372769|NCT01360632|323150359|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
94372770|NCT01360632|323150360|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
94372771|NCT01360632|323150356|FG000|Phase B (6 Weeks)|Physician Decision|0|||
94372772|NCT01360632|323150357|FG001|Phase B (6 Weeks)|Physician Decision|0|||
94372773|NCT01360632|323150358|FG002|Phase B (6 Weeks)|Physician Decision|0|||
94372774|NCT01360632|323150359|FG003|Phase B (6 Weeks)|Physician Decision|1|||
94372775|NCT01360632|323150360|FG004|Phase B (6 Weeks)|Physician Decision|0|||
94372776|NCT01360632|323150356|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
94372777|NCT01360632|323150357|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
94372778|NCT01360632|323150358|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
94372779|NCT01360632|323150359|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
94372780|NCT01360632|323150360|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
94372781|NCT01360632|323150356|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
94372782|NCT01360632|323150357|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
94372783|NCT01360632|323150358|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
94372784|NCT01360632|323150359|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
94372785|NCT01360632|323150360|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
94372786|NCT01360632|323150356|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
94372787|NCT01360632|323150357|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
94372788|NCT01360632|323150358|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
94372789|NCT01360632|323150359|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
94372790|NCT01360632|323150360|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
94372791|NCT01360632|323150356|FG000|Phase A+|Lost to Follow-up|0|||
94372792|NCT01360632|323150357|FG001|Phase A+|Lost to Follow-up|0|||
94297737|NCT00813995|322873821|FG001|Overall Study|Withdrawal by Subject|5|||
94297738|NCT02868892|322873822|FG000|Overall Study|Investigator left site and no follow-up|6|||
94297739|NCT01025635|322873823|FG000|Overall Study|Withdrawal by Subject|6|||
94297740|NCT01025635|322873824|FG001|Overall Study|Withdrawal by Subject|7|||
94297741|NCT01025635|322873823|FG000|Overall Study|Protocol Violation|4|||
94297742|NCT01025635|322873824|FG001|Overall Study|Protocol Violation|2|||
94297743|NCT01025635|322873823|FG000|Overall Study|Lack of Efficacy|0|||
94297744|NCT01025635|322873824|FG001|Overall Study|Lack of Efficacy|1|||
94297745|NCT01025635|322873823|FG000|Overall Study|Lost to Follow-up|9|||
94297746|NCT01025635|322873824|FG001|Overall Study|Lost to Follow-up|13|||
94297747|NCT01025635|322873823|FG000|Overall Study|Reason not known|4|||
94297748|NCT01025635|322873824|FG001|Overall Study|Reason not known|2|||
94297749|NCT02582671|322873825|FG000|Overall Study|Failure to return|1|||
94297750|NCT02582671|322873825|FG000|Overall Study|Other, not specified|1|||
94297751|NCT01287104|322873830|FG000|Overall Study|Patient developed progressive disease|1|||
94297752|NCT01287104|322873831|FG001|Overall Study|Patient developed progressive disease|1|||
94297753|NCT01287104|322873832|FG002|Overall Study|Patient developed progressive disease|3|||
94297754|NCT01287104|322873833|FG003|Overall Study|Patient developed progressive disease|2|||
94297755|NCT01287104|322873830|FG000|Overall Study|Donor anaphylaxis|0|||
94297756|NCT01287104|322873831|FG001|Overall Study|Donor anaphylaxis|1|||
94297757|NCT01287104|322873832|FG002|Overall Study|Donor anaphylaxis|0|||
94297758|NCT01287104|322873833|FG003|Overall Study|Donor anaphylaxis|1|||
94297759|NCT01287104|322873830|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
94297760|NCT01287104|322873831|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
94297761|NCT01287104|322873832|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
94297762|NCT01287104|322873833|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
94297763|NCT01287104|322873830|FG000|Overall Study|Low donor chimerism|0|||
94297764|NCT01287104|322873831|FG001|Overall Study|Low donor chimerism|1|||
94297765|NCT01287104|322873832|FG002|Overall Study|Low donor chimerism|0|||
94297766|NCT01287104|322873833|FG003|Overall Study|Low donor chimerism|0|||
94297767|NCT01287104|322873830|FG000|Overall Study|NK cells did not meet release criteria|0|||
94297768|NCT01287104|322873831|FG001|Overall Study|NK cells did not meet release criteria|1|||
94297769|NCT01287104|322873832|FG002|Overall Study|NK cells did not meet release criteria|0|||
94297770|NCT01287104|322873833|FG003|Overall Study|NK cells did not meet release criteria|0|||
94297771|NCT00098787|322873834|FG000|Overall Study|Never started treatment|3|||
94297772|NCT00098787|322873835|FG001|Overall Study|Never started treatment|2|||
94297773|NCT00098787|322873836|FG002|Overall Study|Never started treatment|1|||
94297774|NCT00098787|322873834|FG000|Overall Study|Ineligible|9|||
94297775|NCT00098787|322873835|FG001|Overall Study|Ineligible|7|||
94297776|NCT00098787|322873836|FG002|Overall Study|Ineligible|3|||
94297777|NCT00098787|322873834|FG000|Overall Study|Disease progression|28|||
94297778|NCT00098787|322873835|FG001|Overall Study|Disease progression|17|||
94297779|NCT00098787|322873836|FG002|Overall Study|Disease progression|23|||
94297780|NCT00098787|322873834|FG000|Overall Study|Adverse Event|8|||
94297781|NCT00098787|322873835|FG001|Overall Study|Adverse Event|17|||
94297782|NCT00098787|322873836|FG002|Overall Study|Adverse Event|8|||
94297783|NCT00098787|322873834|FG000|Overall Study|Death|6|||
94297784|NCT00098787|322873835|FG001|Overall Study|Death|1|||
94297785|NCT00098787|322873836|FG002|Overall Study|Death|0|||
94297786|NCT00098787|322873834|FG000|Overall Study|Withdrawal by Subject|4|||
94297787|NCT00098787|322873835|FG001|Overall Study|Withdrawal by Subject|12|||
94297788|NCT00098787|322873836|FG002|Overall Study|Withdrawal by Subject|6|||
94297789|NCT00098787|322873834|FG000|Overall Study|Alternative therapy|8|||
94297790|NCT00098787|322873835|FG001|Overall Study|Alternative therapy|13|||
94297791|NCT00098787|322873836|FG002|Overall Study|Alternative therapy|13|||
94297792|NCT00098787|322873834|FG000|Overall Study|Other|7|||
94297793|NCT00098787|322873835|FG001|Overall Study|Other|6|||
94468018|NCT02279745|323502477|FG000|Overall Study|Death|6|||
94297794|NCT00098787|322873836|FG002|Overall Study|Other|9|||
94297795|NCT02203149|322873837|FG000|Part 1|Adverse Event|0|||
94297796|NCT02203149|322873838|FG001|Part 1|Adverse Event|1|||
94297797|NCT02203149|322873839|FG002|Part 1|Adverse Event|0|||
94297798|NCT02203149|322873840|FG003|Part 1|Adverse Event|0|||
94297799|NCT02203149|322873841|FG004|Part 1|Adverse Event|0|||
94297800|NCT02203149|322873837|FG000|Part 2|Death|0|||
94297801|NCT02203149|322873838|FG001|Part 2|Death|0|||
94297802|NCT02203149|322873839|FG002|Part 2|Death|1|||
94297803|NCT02203149|322873840|FG003|Part 2|Death|1|||
94297804|NCT02203149|322873841|FG004|Part 2|Death|0|||
94372793|NCT01360632|323150358|FG002|Phase A+|Lost to Follow-up|0|||
94372794|NCT01360632|323150359|FG003|Phase A+|Lost to Follow-up|0|||
94468019|NCT02279745|323502477|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
94297805|NCT02203149|322873837|FG000|Part 2|Withdrawal by Subject|0|||
94297806|NCT02203149|322873838|FG001|Part 2|Withdrawal by Subject|0|||
94297807|NCT02203149|322873839|FG002|Part 2|Withdrawal by Subject|0|||
94297808|NCT02203149|322873840|FG003|Part 2|Withdrawal by Subject|1|||
94297809|NCT02203149|322873841|FG004|Part 2|Withdrawal by Subject|0|||
94297810|NCT02203149|322873837|FG000|Part 2|Adverse Event|0|||
94297811|NCT02203149|322873838|FG001|Part 2|Adverse Event|0|||
94297812|NCT02203149|322873839|FG002|Part 2|Adverse Event|0|||
94297813|NCT02203149|322873840|FG003|Part 2|Adverse Event|1|||
94297814|NCT02203149|322873841|FG004|Part 2|Adverse Event|1|||
94297815|NCT01360996|322873842|FG000|Overall Study|Withdrawal by Subject|4|||
94297816|NCT01360996|322873843|FG001|Overall Study|Withdrawal by Subject|3|||
94297817|NCT01360996|322873844|FG002|Overall Study|Withdrawal by Subject|2|||
94468020|NCT02279745|323502477|FG000|Overall Study|Withdrawal by Subject|2|||
94468021|NCT02279745|323502477|FG000|Overall Study|Pregnancy|1|||
94468022|NCT02279745|323502477|FG000|Overall Study|Study Non-compliance|1|||
94468023|NCT02279745|323502477|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
94468024|NCT01810783|323502486|FG000|Overall Study|Adverse Event|32|||
94468025|NCT01810783|323502486|FG000|Overall Study|Withdrawal by Subject|22|||
94297818|NCT01360996|322873842|FG000|Overall Study|Noncompliant|2|||
94297819|NCT01360996|322873843|FG001|Overall Study|Noncompliant|0|||
94297820|NCT01360996|322873844|FG002|Overall Study|Noncompliant|0|||
94297821|NCT01193686|322873850|FG000|Overall Study|Withdrawal by Subject|4|||
94297822|NCT01193686|322873851|FG001|Overall Study|Withdrawal by Subject|1|||
94297823|NCT01193686|322873850|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
94297824|NCT01193686|322873851|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
94297825|NCT01147809|322873852|FG000|Phase I (168 Days)|Adverse Event|0|||
94297826|NCT01147809|322873853|FG001|Phase I (168 Days)|Adverse Event|0|||
94297827|NCT01147809|322873854|FG002|Phase I (168 Days)|Adverse Event|0|||
94297828|NCT01147809|322873855|FG003|Phase I (168 Days)|Adverse Event|1|||
94297829|NCT01147809|322873856|FG004|Phase I (168 Days)|Adverse Event|0|||
94297830|NCT01147809|322873857|FG005|Phase I (168 Days)|Adverse Event|0|||
94297831|NCT01147809|322873852|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
94297832|NCT01147809|322873853|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
94297833|NCT01147809|322873854|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
94297834|NCT01147809|322873855|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
94297835|NCT01147809|322873856|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
94297836|NCT01147809|322873857|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
94297837|NCT01147809|322873852|FG000|Phase I (168 Days)|Physician Decision|0|||
94297838|NCT01147809|322873853|FG001|Phase I (168 Days)|Physician Decision|1|||
94297839|NCT01147809|322873854|FG002|Phase I (168 Days)|Physician Decision|2|||
94297840|NCT01147809|322873855|FG003|Phase I (168 Days)|Physician Decision|0|||
94297841|NCT01147809|322873856|FG004|Phase I (168 Days)|Physician Decision|0|||
94297842|NCT01147809|322873857|FG005|Phase I (168 Days)|Physician Decision|0|||
94297843|NCT01147809|322873852|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
94297844|NCT01147809|322873853|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
94297845|NCT01147809|322873854|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
94297846|NCT01147809|322873855|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
94297847|NCT01147809|322873856|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
94297848|NCT01147809|322873857|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
94297849|NCT01147809|322873852|FG000|Phase II (168 Days)|Adverse Event|0|||
94297850|NCT01147809|322873853|FG001|Phase II (168 Days)|Adverse Event|0|||
94297851|NCT01147809|322873854|FG002|Phase II (168 Days)|Adverse Event|0|||
94297852|NCT01147809|322873855|FG003|Phase II (168 Days)|Adverse Event|0|||
94297853|NCT01147809|322873856|FG004|Phase II (168 Days)|Adverse Event|3|||
94297854|NCT01147809|322873857|FG005|Phase II (168 Days)|Adverse Event|6|||
94297855|NCT01147809|322873852|FG000|Phase II (168 Days)|Protocol Violation|0|||
94297856|NCT01147809|322873853|FG001|Phase II (168 Days)|Protocol Violation|0|||
94297857|NCT01147809|322873854|FG002|Phase II (168 Days)|Protocol Violation|0|||
94297858|NCT01147809|322873855|FG003|Phase II (168 Days)|Protocol Violation|0|||
94297859|NCT01147809|322873856|FG004|Phase II (168 Days)|Protocol Violation|0|||
94297860|NCT01147809|322873857|FG005|Phase II (168 Days)|Protocol Violation|1|||
94297861|NCT01147809|322873852|FG000|Phase II (168 Days)|Physician Decision|0|||
94297862|NCT01147809|322873853|FG001|Phase II (168 Days)|Physician Decision|0|||
94297863|NCT01147809|322873854|FG002|Phase II (168 Days)|Physician Decision|0|||
94297864|NCT01147809|322873855|FG003|Phase II (168 Days)|Physician Decision|0|||
94297865|NCT01147809|322873856|FG004|Phase II (168 Days)|Physician Decision|5|||
94297866|NCT01147809|322873857|FG005|Phase II (168 Days)|Physician Decision|11|||
94297867|NCT01147809|322873852|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
94468026|NCT01810783|323502486|FG000|Overall Study|Lack of Efficacy|12|||
94297868|NCT01147809|322873853|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
94297869|NCT01147809|322873854|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
94297870|NCT01147809|322873855|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
94297871|NCT01147809|322873856|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
94297872|NCT01147809|322873857|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
94297873|NCT01147809|322873852|FG000|Phase II (168 Days)|Ongoing|0|||
94297874|NCT01147809|322873853|FG001|Phase II (168 Days)|Ongoing|0|||
94297875|NCT01147809|322873854|FG002|Phase II (168 Days)|Ongoing|0|||
94297876|NCT01147809|322873855|FG003|Phase II (168 Days)|Ongoing|0|||
94297877|NCT01147809|322873856|FG004|Phase II (168 Days)|Ongoing|1|||
94297878|NCT01147809|322873857|FG005|Phase II (168 Days)|Ongoing|0|||
94297879|NCT03040024|322873858|FG000|Overall Study|Adverse Event|0|||
94297880|NCT03040024|322873859|FG001|Overall Study|Adverse Event|1|||
94297881|NCT03040024|322873860|FG002|Overall Study|Adverse Event|0|||
94297882|NCT03040024|322873858|FG000|Overall Study|Death|0|||
94297883|NCT03040024|322873859|FG001|Overall Study|Death|1|||
94297884|NCT03040024|322873860|FG002|Overall Study|Death|0|||
94297885|NCT03040024|322873858|FG000|Overall Study|Physician Decision|0|||
94297886|NCT03040024|322873859|FG001|Overall Study|Physician Decision|0|||
94297887|NCT03040024|322873860|FG002|Overall Study|Physician Decision|1|||
94297888|NCT01499290|322873861|FG000|Overall Study|Withdrawal by Subject|22|||
94297889|NCT01499290|322873862|FG001|Overall Study|Withdrawal by Subject|15|||
94297890|NCT01499290|322873861|FG000|Overall Study|Not specified in study report|11|||
94297891|NCT01499290|322873862|FG001|Overall Study|Not specified in study report|5|||
94297892|NCT01499290|322873861|FG000|Overall Study|Condition improved/subject recovered|1|||
94297893|NCT01499290|322873862|FG001|Overall Study|Condition improved/subject recovered|0|||
94297894|NCT01499290|322873861|FG000|Overall Study|Lack of Efficacy|7|||
94297895|NCT01499290|322873862|FG001|Overall Study|Lack of Efficacy|8|||
94297896|NCT01499290|322873861|FG000|Overall Study|Adverse Event|14|||
94297897|NCT01499290|322873862|FG001|Overall Study|Adverse Event|7|||
94297898|NCT02371629|322873863|FG000|Overall Study|Patient decision|14|||
94297899|NCT02371629|322873864|FG001|Overall Study|Patient decision|10|||
94297900|NCT02371629|322873863|FG000|Overall Study|Adverse Event|8|||
94297901|NCT02371629|322873864|FG001|Overall Study|Adverse Event|8|||
94297902|NCT02371629|322873863|FG000|Overall Study|Physician Decision|2|||
94297903|NCT02371629|322873864|FG001|Overall Study|Physician Decision|3|||
94297904|NCT02371629|322873863|FG000|Overall Study|Death|1|||
94297905|NCT02371629|322873864|FG001|Overall Study|Death|1|||
94297906|NCT02371629|322873863|FG000|Overall Study|Noncompliance with study treatment|1|||
94297907|NCT02371629|322873864|FG001|Overall Study|Noncompliance with study treatment|0|||
94297908|NCT02371629|322873863|FG000|Overall Study|Lack of Efficacy|0|||
94297909|NCT02371629|322873864|FG001|Overall Study|Lack of Efficacy|2|||
94297910|NCT02371629|322873863|FG000|Overall Study|Protocol deviation|0|||
94297911|NCT02371629|322873864|FG001|Overall Study|Protocol deviation|1|||
94297912|NCT02209766|322873865|FG000|Overall Study|Withdrawal by Subject|0|||
94297913|NCT02209766|322873866|FG001|Overall Study|Withdrawal by Subject|0|||
94297914|NCT02209766|322873867|FG002|Overall Study|Withdrawal by Subject|0|||
94297915|NCT02209766|322873868|FG003|Overall Study|Withdrawal by Subject|1|||
94297916|NCT02209766|322873869|FG004|Overall Study|Withdrawal by Subject|0|||
94297917|NCT02690701|322873870|FG000|Treatment Period 1|Adverse Event|2|||
94297918|NCT02690701|322873871|FG001|Treatment Period 1|Adverse Event|2|||
94297919|NCT02690701|322873870|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94297920|NCT02690701|322873871|FG001|Treatment Period 1|Withdrawal by Subject|1|||
94297921|NCT02690701|322873870|FG000|Treatment Period 2|Adverse Event|2|||
94297922|NCT02690701|322873871|FG001|Treatment Period 2|Adverse Event|0|||
94297923|NCT02690701|322873870|FG000|Treatment Period 2|Lack of Efficacy|1|||
94297924|NCT02690701|322873871|FG001|Treatment Period 2|Lack of Efficacy|0|||
94297925|NCT02690701|322873870|FG000|Treatment Period 2|Lost to Follow-up|0|||
94297926|NCT02690701|322873871|FG001|Treatment Period 2|Lost to Follow-up|2|||
94297927|NCT02690701|322873870|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94297928|NCT02690701|322873871|FG001|Treatment Period 2|Withdrawal by Subject|2|||
94297929|NCT02690701|322873870|FG000|Treatment Period 2|Protocol Violation|0|||
94297930|NCT02690701|322873871|FG001|Treatment Period 2|Protocol Violation|1|||
94297931|NCT01442181|322873872|FG000|Overall Study|patient refused surgery|1|||
94297932|NCT01442181|322873873|FG001|Overall Study|patient refused surgery|0|||
94297933|NCT01442181|322873872|FG000|Overall Study|no insurance for surgery|1|||
94297934|NCT01442181|322873873|FG001|Overall Study|no insurance for surgery|0|||
94297935|NCT01442181|322873872|FG000|Overall Study|low ejection factor|0|||
94297936|NCT01442181|322873873|FG001|Overall Study|low ejection factor|1|||
94297937|NCT01442181|322873872|FG000|Overall Study|Lost to Follow-up|1|||
94297938|NCT01442181|322873873|FG001|Overall Study|Lost to Follow-up|1|||
94297939|NCT01442181|322873872|FG000|Overall Study|patient in an additional study|1|||
94297940|NCT01442181|322873873|FG001|Overall Study|patient in an additional study|0|||
94297941|NCT01442181|322873872|FG000|Overall Study|atrial fibrillation not noted|0|||
94297942|NCT01442181|322873873|FG001|Overall Study|atrial fibrillation not noted|1|||
94297943|NCT01658514|322873874|FG000|Overall Study|Protocol Violation|1|||
94297944|NCT01658514|322873875|FG001|Overall Study|Protocol Violation|0|||
94297945|NCT01658514|322873876|FG002|Overall Study|Protocol Violation|2|||
94297946|NCT03440944|322873877|FG000|Overall Study|Physician Decision|1|||
94297947|NCT03440944|322873878|FG001|Overall Study|Physician Decision|0|||
94297948|NCT03440944|322873877|FG000|Overall Study|No Acceptable Vasculature|0|||
94297949|NCT03440944|322873878|FG001|Overall Study|No Acceptable Vasculature|1|||
94297950|NCT03832387|322873892|FG000|Overall Study|Protocol Violation|2|||
94297951|NCT03832387|322873893|FG001|Overall Study|Protocol Violation|6|||
94297952|NCT03832387|322873892|FG000|Overall Study|EXCLUSION CRITERIA|3|||
94297953|NCT03832387|322873893|FG001|Overall Study|EXCLUSION CRITERIA|1|||
94297954|NCT01587989|322873898|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
94297955|NCT01587989|322873899|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
94297956|NCT01587989|322873900|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
94297957|NCT01587989|322873898|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
94372795|NCT01360632|323150360|FG004|Phase A+|Lost to Follow-up|2|||
94372796|NCT01360632|323150356|FG000|Phase A+|Adverse Event|0|||
94297958|NCT01587989|322873899|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
94297959|NCT01587989|322873900|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
94297960|NCT01587989|322873898|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
94297961|NCT01587989|322873899|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
94297962|NCT01587989|322873900|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
94297963|NCT01587989|322873898|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
94297964|NCT01587989|322873899|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
94297965|NCT01587989|322873900|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
94297966|NCT01587989|322873898|FG000|Randomized Study Treatment|Screening failure|0|||
94297967|NCT01587989|322873899|FG001|Randomized Study Treatment|Screening failure|1|||
94297968|NCT01587989|322873900|FG002|Randomized Study Treatment|Screening failure|0|||
94297969|NCT01587989|322873898|FG000|Randomized Study Treatment|Physician Decision|0|||
94297970|NCT01587989|322873899|FG001|Randomized Study Treatment|Physician Decision|0|||
94297971|NCT01587989|322873900|FG002|Randomized Study Treatment|Physician Decision|1|||
94297972|NCT02581995|322873901|FG000|Overall Study|Unspecified other|3|||
94297973|NCT02581995|322873901|FG000|Overall Study|Adverse Event|6|||
94297974|NCT02581995|322873901|FG000|Overall Study|Lost to Follow-up|5|||
94297975|NCT02581995|322873901|FG000|Overall Study|Withdrawal by participant|12|||
94297976|NCT02581995|322873901|FG000|Overall Study|Physician Decision|1|||
94297977|NCT02581995|322873901|FG000|Overall Study|Death|4|||
94297978|NCT03263806|322876041|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
94297979|NCT03263806|322876042|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
94297980|NCT03263806|322876041|FG000|Overall Study|Withdrawal by Subject|0|||
94297981|NCT03263806|322876042|FG001|Overall Study|Withdrawal by Subject|1|||
94297982|NCT03263806|322876041|FG000|Overall Study|Study Termination|5|||
94297983|NCT03263806|322876042|FG001|Overall Study|Study Termination|6|||
94297984|NCT03195894|322876043|FG000|Overall Study|"An example is Started other treatment."|4|||
94297985|NCT03195894|322876044|FG001|Overall Study|"An example is Started other treatment."|5|||
94297986|NCT03195894|322876043|FG000|Overall Study|Withdrawal by Subject|15|||
94297987|NCT03195894|322876044|FG001|Overall Study|Withdrawal by Subject|4|||
94297988|NCT03195894|322876043|FG000|Overall Study|Lost to Follow-up|14|||
94297989|NCT03195894|322876044|FG001|Overall Study|Lost to Follow-up|19|||
94297990|NCT05047523|322876053|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
94297991|NCT05047523|322876054|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
94297992|NCT05047523|322876055|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
94297993|NCT05047523|322876056|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
94297994|NCT05047523|322876057|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
94297995|NCT05047523|322876058|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
94297996|NCT05047523|322876053|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
94297997|NCT05047523|322876054|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
94297998|NCT05047523|322876055|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
94297999|NCT05047523|322876056|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
94298000|NCT05047523|322876057|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
94298001|NCT05047523|322876058|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
94298002|NCT05047523|322876053|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
94298003|NCT05047523|322876054|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
94298004|NCT05047523|322876055|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
94298005|NCT05047523|322876056|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
94298006|NCT05047523|322876057|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
94298007|NCT05047523|322876058|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
94298008|NCT05047523|322876053|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
94298009|NCT05047523|322876054|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
94298010|NCT05047523|322876055|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
94298011|NCT05047523|322876056|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
94298012|NCT05047523|322876057|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
94298013|NCT05047523|322876058|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
94298014|NCT05047523|322876053|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
94298015|NCT05047523|322876054|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
94298016|NCT05047523|322876055|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
94372797|NCT01360632|323150357|FG001|Phase A+|Adverse Event|0|||
94372798|NCT01360632|323150358|FG002|Phase A+|Adverse Event|0|||
94298017|NCT05047523|322876056|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
94298018|NCT05047523|322876057|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
94298019|NCT05047523|322876058|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
94298020|NCT05047523|322876053|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
94298021|NCT05047523|322876054|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
94298022|NCT05047523|322876055|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
94298023|NCT05047523|322876056|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
94298024|NCT05047523|322876057|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
94298025|NCT05047523|322876058|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
94298026|NCT04317690|322876060|FG000|Overall Study|did not have complete information for primary outcome|0|||
94298027|NCT04317690|322876061|FG001|Overall Study|did not have complete information for primary outcome|4|||
94298028|NCT04317690|322876062|FG002|Overall Study|did not have complete information for primary outcome|0|||
94298029|NCT04317690|322876063|FG003|Overall Study|did not have complete information for primary outcome|2|||
94298030|NCT04317690|322876064|FG004|Overall Study|did not have complete information for primary outcome|0|||
94298031|NCT02207907|322876082|FG000|Overall Study|Lost to Follow-up|3|||
94298032|NCT02207907|322876083|FG001|Overall Study|Lost to Follow-up|1|||
94298033|NCT02207907|322876082|FG000|Overall Study|Withdrawal by Subject|5|||
94298034|NCT02207907|322876083|FG001|Overall Study|Withdrawal by Subject|6|||
94298035|NCT02207907|322876082|FG000|Overall Study|Did not meet study criteria|3|||
94298036|NCT02207907|322876083|FG001|Overall Study|Did not meet study criteria|0|||
94298037|NCT02207907|322876082|FG000|Overall Study|Pregnancy|0|||
94298038|NCT02207907|322876083|FG001|Overall Study|Pregnancy|1|||
94298039|NCT05292755|322876089|FG000|Overall Study|Lost to Follow-up|5|||
94298040|NCT05292755|322876090|FG001|Overall Study|Lost to Follow-up|9|||
94298041|NCT04525703|322876091|FG000|Overall Study|Lost to Follow-up|6|||
94298042|NCT04525703|322876092|FG001|Overall Study|Lost to Follow-up|15|||
94298043|NCT04525703|322876093|FG002|Overall Study|Lost to Follow-up|8|||
94298044|NCT01478958|322876094|FG000|Overall Study|Withdrawal by Subject|1|||
94298045|NCT01478958|322876095|FG001|Overall Study|Withdrawal by Subject|1|||
94298046|NCT01478958|322876096|FG002|Overall Study|Withdrawal by Subject|1|||
94298047|NCT01478958|322876094|FG000|Overall Study|Weight loss|1|||
94298048|NCT01478958|322876095|FG001|Overall Study|Weight loss|0|||
94298049|NCT01478958|322876096|FG002|Overall Study|Weight loss|0|||
94298050|NCT01478958|322876094|FG000|Overall Study|Re-located|0|||
94298051|NCT01478958|322876095|FG001|Overall Study|Re-located|1|||
94298052|NCT01478958|322876096|FG002|Overall Study|Re-located|0|||
94298053|NCT01478958|322876094|FG000|Overall Study|Unable to comply|0|||
94298054|NCT01478958|322876095|FG001|Overall Study|Unable to comply|0|||
94298055|NCT01478958|322876096|FG002|Overall Study|Unable to comply|2|||
94298056|NCT01051739|322876097|FG000|Overall Study|Death|3|||
94298057|NCT01051739|322876098|FG001|Overall Study|Death|3|||
94298058|NCT01051739|322876097|FG000|Overall Study|Withdrawal by Subject|25|||
94298059|NCT01051739|322876098|FG001|Overall Study|Withdrawal by Subject|10|||
94298060|NCT00190775|322876099|FG000|Overall Study|Adverse Event|57|||
94298061|NCT00190775|322876100|FG001|Overall Study|Adverse Event|22|||
94298062|NCT00190775|322876099|FG000|Overall Study|Satisfactory Response|1|||
94298063|NCT00190775|322876100|FG001|Overall Study|Satisfactory Response|0|||
94298064|NCT00190775|322876099|FG000|Overall Study|Lack of Efficacy|28|||
94298065|NCT00190775|322876100|FG001|Overall Study|Lack of Efficacy|32|||
94298066|NCT00190775|322876099|FG000|Overall Study|Lost to Follow-up|31|||
94298067|NCT00190775|322876100|FG001|Overall Study|Lost to Follow-up|23|||
94298068|NCT00190775|322876099|FG000|Overall Study|Participant Moved|0|||
94298069|NCT00190775|322876100|FG001|Overall Study|Participant Moved|1|||
94298070|NCT00190775|322876099|FG000|Overall Study|Withdrawal by Subject|24|||
94298071|NCT00190775|322876100|FG001|Overall Study|Withdrawal by Subject|13|||
94298072|NCT00190775|322876099|FG000|Overall Study|Sponsor Decision|1|||
94298073|NCT00190775|322876100|FG001|Overall Study|Sponsor Decision|0|||
94298074|NCT00190775|322876099|FG000|Overall Study|Physician Decision|3|||
94298075|NCT00190775|322876100|FG001|Overall Study|Physician Decision|0|||
94298076|NCT00190775|322876099|FG000|Overall Study|Noncompliance|3|||
94298077|NCT00190775|322876100|FG001|Overall Study|Noncompliance|5|||
94298078|NCT00190775|322876099|FG000|Overall Study|Protocol Violation|0|||
94298079|NCT00190775|322876100|FG001|Overall Study|Protocol Violation|1|||
94298080|NCT00190775|322876099|FG000|Overall Study|Exclusion Criteria Met|1|||
94298081|NCT00190775|322876100|FG001|Overall Study|Exclusion Criteria Met|3|||
94298082|NCT01526148|322876101|FG000|Overall Study|Adverse Event|6|||
94298083|NCT01526148|322876102|FG001|Overall Study|Adverse Event|5|||
94298084|NCT01526148|322876101|FG000|Overall Study|Lost to Follow-up|3|||
94298085|NCT01526148|322876102|FG001|Overall Study|Lost to Follow-up|6|||
94298086|NCT01526148|322876101|FG000|Overall Study|Withdrawal by Subject|2|||
94298087|NCT01526148|322876102|FG001|Overall Study|Withdrawal by Subject|0|||
94298088|NCT01526148|322876101|FG000|Overall Study|Unstable Medical Condition|1|||
94298089|NCT01526148|322876102|FG001|Overall Study|Unstable Medical Condition|0|||
94298090|NCT01526148|322876101|FG000|Overall Study|Unable to discontinue concomitant med|1|||
94298091|NCT01526148|322876102|FG001|Overall Study|Unable to discontinue concomitant med|0|||
94298092|NCT01526148|322876101|FG000|Overall Study|Moved out of state|1|||
94298093|NCT01526148|322876102|FG001|Overall Study|Moved out of state|0|||
94298094|NCT01526148|322876101|FG000|Overall Study|Incarcerated|0|||
94298095|NCT01526148|322876102|FG001|Overall Study|Incarcerated|2|||
94298096|NCT00519077|322876103|FG000|Overall Study|Death|6|||
94298097|NCT00519077|322876103|FG000|Overall Study|Other|2|||
94298098|NCT01967225|322876105|FG000|Overall Study|Adverse Event|3|||
94298099|NCT01967225|322876106|FG001|Overall Study|Adverse Event|1|||
94298100|NCT01967225|322876105|FG000|Overall Study|Withdrawal by Subject|2|||
94298101|NCT01967225|322876106|FG001|Overall Study|Withdrawal by Subject|1|||
94298102|NCT01967225|322876105|FG000|Overall Study|Lack of Efficacy|1|||
94298103|NCT01967225|322876106|FG001|Overall Study|Lack of Efficacy|1|||
94298104|NCT01967225|322876105|FG000|Overall Study|Switching to other therapy|2|||
94298105|NCT01967225|322876106|FG001|Overall Study|Switching to other therapy|0|||
94298106|NCT01967225|322876105|FG000|Overall Study|Protocol driven decision point|1|||
94298107|NCT01967225|322876106|FG001|Overall Study|Protocol driven decision point|0|||
94298108|NCT01967225|322876105|FG000|Overall Study|Logistical difficulties|1|||
94298109|NCT01967225|322876106|FG001|Overall Study|Logistical difficulties|0|||
94298110|NCT01967225|322876105|FG000|Overall Study|Protocol Violation|2|||
94298111|NCT01967225|322876106|FG001|Overall Study|Protocol Violation|0|||
94298112|NCT01672957|322876112|FG000|Overall Study|Protocol Violation|48|||
94298113|NCT01672957|322876112|FG000|Overall Study|Death|2|||
94298114|NCT01672957|322876112|FG000|Overall Study|ICF Signed After Transplantation|5|||
94298115|NCT00709202|322876119|FG000|Overall Study|Withdrawal by Subject|6|||
94298116|NCT00709202|322876120|FG001|Overall Study|Withdrawal by Subject|6|||
94298117|NCT02048904|322876123|FG000|Overall Study|Withdrawal by Subject|7|||
94298118|NCT02048904|322876123|FG000|Overall Study|Physician Decision|70|||
94298119|NCT04325503|322876124|FG000|Overall Study|Withdrawal by Subject|1|||
94298120|NCT04325503|322876124|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
94298121|NCT01856114|322876126|FG000|Overall Study|Withdrawal by Subject|1|||
94298122|NCT01856114|322876127|FG001|Overall Study|Withdrawal by Subject|0|||
94298123|NCT01856114|322876126|FG000|Overall Study|Adverse Event|1|||
94298124|NCT01856114|322876127|FG001|Overall Study|Adverse Event|0|||
94298125|NCT01642212|322876129|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
94298126|NCT01642212|322876130|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
94298127|NCT01642212|322876131|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
94298128|NCT01642212|322876132|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
94298129|NCT01642212|322876133|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
94298130|NCT01642212|322876129|FG000|Double-blind Treatment|Other|0|||
94298131|NCT01642212|322876130|FG001|Double-blind Treatment|Other|2|||
94298132|NCT01642212|322876131|FG002|Double-blind Treatment|Other|1|||
94298133|NCT01642212|322876132|FG003|Double-blind Treatment|Other|0|||
94298134|NCT01642212|322876133|FG004|Double-blind Treatment|Other|0|||
94298135|NCT01642212|322876129|FG000|Double-blind Treatment|Non-compliance|0|||
94298136|NCT01642212|322876130|FG001|Double-blind Treatment|Non-compliance|1|||
94298137|NCT01642212|322876131|FG002|Double-blind Treatment|Non-compliance|0|||
94298138|NCT01642212|322876132|FG003|Double-blind Treatment|Non-compliance|0|||
94298139|NCT01642212|322876133|FG004|Double-blind Treatment|Non-compliance|0|||
94298140|NCT01642212|322876129|FG000|Double-blind Treatment|Adverse Event|0|||
94298141|NCT01642212|322876130|FG001|Double-blind Treatment|Adverse Event|0|||
94298142|NCT01642212|322876131|FG002|Double-blind Treatment|Adverse Event|1|||
94298143|NCT01642212|322876132|FG003|Double-blind Treatment|Adverse Event|0|||
94298144|NCT01642212|322876133|FG004|Double-blind Treatment|Adverse Event|0|||
94298145|NCT01642212|322876129|FG000|Open-label Extension|Adverse Event|0|||
94298146|NCT01642212|322876130|FG001|Open-label Extension|Adverse Event|0|||
94298147|NCT01642212|322876131|FG002|Open-label Extension|Adverse Event|0|||
94298148|NCT01642212|322876132|FG003|Open-label Extension|Adverse Event|3|||
94298149|NCT01642212|322876133|FG004|Open-label Extension|Adverse Event|0|||
94298150|NCT01642212|322876129|FG000|Open-label Extension|Sponsor Decision|0|||
94298151|NCT01642212|322876130|FG001|Open-label Extension|Sponsor Decision|0|||
94298152|NCT01642212|322876131|FG002|Open-label Extension|Sponsor Decision|0|||
94298153|NCT01642212|322876132|FG003|Open-label Extension|Sponsor Decision|7|||
94298154|NCT01642212|322876133|FG004|Open-label Extension|Sponsor Decision|4|||
94298155|NCT01642212|322876129|FG000|Open-label Extension|Consent Withdrawn|0|||
94298156|NCT01642212|322876130|FG001|Open-label Extension|Consent Withdrawn|0|||
94298157|NCT01642212|322876131|FG002|Open-label Extension|Consent Withdrawn|0|||
94298158|NCT01642212|322876132|FG003|Open-label Extension|Consent Withdrawn|0|||
94298159|NCT01642212|322876133|FG004|Open-label Extension|Consent Withdrawn|2|||
94298160|NCT01642212|322876129|FG000|Open-label Extension|Lost to Follow-up|0|||
94298161|NCT01642212|322876130|FG001|Open-label Extension|Lost to Follow-up|0|||
94298162|NCT01642212|322876131|FG002|Open-label Extension|Lost to Follow-up|0|||
94298163|NCT01642212|322876132|FG003|Open-label Extension|Lost to Follow-up|0|||
94298164|NCT01642212|322876133|FG004|Open-label Extension|Lost to Follow-up|1|||
94298165|NCT01642212|322876129|FG000|Open-label Extension|Other|0|||
94298166|NCT01642212|322876130|FG001|Open-label Extension|Other|0|||
94298167|NCT01642212|322876131|FG002|Open-label Extension|Other|0|||
94298168|NCT01642212|322876132|FG003|Open-label Extension|Other|0|||
94298169|NCT01642212|322876133|FG004|Open-label Extension|Other|1|||
94298170|NCT00144170|322876134|FG000|Overall Study|Adverse Event|84|||
94298171|NCT00144170|322876135|FG001|Overall Study|Adverse Event|41|||
94298172|NCT00144170|322876134|FG000|Overall Study|Protocol Violation|23|||
94298173|NCT00144170|322876135|FG001|Overall Study|Protocol Violation|16|||
94298174|NCT00144170|322876134|FG000|Overall Study|Lost to Follow-up|5|||
94298175|NCT00144170|322876135|FG001|Overall Study|Lost to Follow-up|10|||
94298176|NCT00144170|322876134|FG000|Overall Study|Withdrawal by Subject|29|||
94298177|NCT00144170|322876135|FG001|Overall Study|Withdrawal by Subject|13|||
94298178|NCT00144170|322876134|FG000|Overall Study|Other reason not defined above|211|||
94298179|NCT00144170|322876135|FG001|Overall Study|Other reason not defined above|316|||
94298180|NCT01564784|322876136|FG000|Overall Study|Other|1|||
94298181|NCT01564784|322876137|FG001|Overall Study|Other|0|||
94298182|NCT01564784|322876136|FG000|Overall Study|Subject refused further follow-up|1|||
94298183|NCT01564784|322876137|FG001|Overall Study|Subject refused further follow-up|6|||
94298184|NCT01564784|322876136|FG000|Overall Study|Lost to Follow-up|1|||
94298185|NCT01564784|322876137|FG001|Overall Study|Lost to Follow-up|1|||
94298186|NCT01564784|322876136|FG000|Overall Study|Death|131|||
94298187|NCT01564784|322876137|FG001|Overall Study|Death|126|||
94298188|NCT01299025|322876138|FG000|Overall Study|Withdrawal by Subject|2|||
94298189|NCT01299025|322876139|FG001|Overall Study|Withdrawal by Subject|1|||
94298190|NCT01299025|322876138|FG000|Overall Study|Lost to Follow-up|1|||
94298191|NCT01299025|322876139|FG001|Overall Study|Lost to Follow-up|0|||
94298192|NCT00702143|322876140|FG000|Overall Study|Lost to Follow-up|0|||
94298193|NCT00702143|322876141|FG001|Overall Study|Lost to Follow-up|0|||
94298194|NCT00702143|322876142|FG002|Overall Study|Lost to Follow-up|1|||
94298195|NCT04439331|322876143|FG000|Overall Study|Never Start Protocol Therapy|2|||
94298196|NCT04439331|322876143|FG000|Overall Study|Ineligible|2|||
94298197|NCT04439331|322876143|FG000|Overall Study|Mutation Status Not Confirmed|1|||
94298198|NCT04439331|322876143|FG000|Overall Study|Adverse Event|1|||
94298199|NCT04439331|322876143|FG000|Overall Study|Death|1|||
94298200|NCT04439331|322876143|FG000|Overall Study|Disease Progression|20|||
94298201|NCT04439331|322876143|FG000|Overall Study|Withdrawal by Subject|6|||
94298202|NCT04439331|322876143|FG000|Overall Study|Physician Decision|1|||
94298203|NCT04439331|322876143|FG000|Overall Study|Other Complicating Disease|1|||
94298204|NCT04091217|322876144|FG000|Overall Study|Lost to Follow-up|2|||
94298205|NCT00100048|322876147|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
94298206|NCT00100048|322876148|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
94298207|NCT00100048|322876149|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
94298208|NCT00100048|322876150|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
94298209|NCT00100048|322876151|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
94298210|NCT00100048|322876152|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
94298211|NCT00100048|322876147|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
94298212|NCT00100048|322876148|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
94298213|NCT00100048|322876149|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
94298214|NCT00100048|322876150|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
94298215|NCT00100048|322876151|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
94298216|NCT00100048|322876152|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
94298217|NCT00100048|322876147|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
94298218|NCT00100048|322876148|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
94298219|NCT00100048|322876149|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
94298220|NCT00100048|322876150|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
94298221|NCT00100048|322876151|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
94298222|NCT00100048|322876152|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
94298223|NCT00100048|322876147|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
94298224|NCT00100048|322876148|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
94298225|NCT00100048|322876149|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
94298226|NCT00100048|322876150|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
94298227|NCT00100048|322876151|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
94298228|NCT00100048|322876152|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
94298229|NCT00100048|322876147|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
94298230|NCT00100048|322876148|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
94298231|NCT00100048|322876149|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
94298232|NCT00100048|322876150|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
94298233|NCT00100048|322876151|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
94298234|NCT00100048|322876152|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
94298235|NCT00100048|322876147|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
94298236|NCT00100048|322876148|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
94298237|NCT00100048|322876149|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
94298238|NCT00100048|322876150|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
94298239|NCT00100048|322876151|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
94298240|NCT00100048|322876152|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
94298241|NCT00100048|322876147|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
94298242|NCT00100048|322876148|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
94298243|NCT00100048|322876149|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
94298244|NCT00100048|322876150|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
94298245|NCT00100048|322876151|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
94298246|NCT00100048|322876152|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
94298247|NCT00100048|322876147|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
94372799|NCT01360632|323150359|FG003|Phase A+|Adverse Event|0|||
94372800|NCT01360632|323150360|FG004|Phase A+|Adverse Event|2|||
94372801|NCT01360632|323150356|FG000|Phase A+|Met Withdrawal Criteria|0|||
94298248|NCT00100048|322876148|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
94298249|NCT00100048|322876149|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
94298250|NCT00100048|322876150|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
94298251|NCT00100048|322876151|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
94298252|NCT00100048|322876152|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
94298253|NCT01624142|322876153|FG000|Overall Study|Withdrawal by Subject|14|||
94298254|NCT01624142|322876154|FG001|Overall Study|Withdrawal by Subject|4|||
94298255|NCT01624142|322876153|FG000|Overall Study|Death|3|||
94298256|NCT01624142|322876154|FG001|Overall Study|Death|6|||
94298257|NCT01624142|322876153|FG000|Overall Study|Study Closure|12|||
94298258|NCT01624142|322876154|FG001|Overall Study|Study Closure|6|||
94298259|NCT01624142|322876153|FG000|Overall Study|Lost to Follow-up|2|||
94298260|NCT01624142|322876154|FG001|Overall Study|Lost to Follow-up|0|||
94298261|NCT01624142|322876153|FG000|Overall Study|Other|1|||
94298262|NCT01624142|322876154|FG001|Overall Study|Other|0|||
94298263|NCT01822561|322876155|FG000|Overall Study|Withdrawal by Subject|2|||
94298264|NCT01926626|322876162|FG000|Overall Study|Withdrawal by Subject|15|||
94298265|NCT01926626|322876162|FG000|Overall Study|Lost to Follow-up|7|||
94298266|NCT01708057|322876168|FG000|Overall Study|Withdrawal due to study termination.|1|||
94298267|NCT01708057|322876169|FG001|Overall Study|Withdrawal due to study termination.|1|||
94298268|NCT01708057|322876170|FG002|Overall Study|Withdrawal due to study termination.|1|||
94298269|NCT00628355|322876172|FG000|Overall Study|Withdrawal by Subject|1|||
94298270|NCT00628355|322876173|FG001|Overall Study|Withdrawal by Subject|1|||
94298271|NCT01523873|322876183|FG000|Overall Study|Protocol Violation|422|||
94298272|NCT01392183|322876189|FG000|First Drug Administration|Adverse Event|3|||
94298273|NCT01392183|322876190|FG001|First Drug Administration|Adverse Event|2|||
94298274|NCT01392183|322876189|FG000|First Drug Administration|Death|1|||
94298275|NCT01392183|322876190|FG001|First Drug Administration|Death|0|||
94298276|NCT01392183|322876189|FG000|First Drug Administration|Withdrawal by Subject|10|||
94298277|NCT01392183|322876190|FG001|First Drug Administration|Withdrawal by Subject|17|||
94298278|NCT04321343|322876193|FG000|Overall Study|Adverse Event|0|||
94298279|NCT04321343|322876194|FG001|Overall Study|Adverse Event|0|||
94298280|NCT04321343|322876195|FG002|Overall Study|Adverse Event|1|||
94298281|NCT04321343|322876196|FG003|Overall Study|Adverse Event|0|||
94298282|NCT04321343|322876193|FG000|Overall Study|Death|0|||
94298283|NCT04321343|322876194|FG001|Overall Study|Death|0|||
94298284|NCT04321343|322876195|FG002|Overall Study|Death|0|||
94298285|NCT04321343|322876196|FG003|Overall Study|Death|1|||
94298286|NCT04321343|322876193|FG000|Overall Study|Pregnancy|1|||
94298287|NCT04321343|322876194|FG001|Overall Study|Pregnancy|0|||
94298288|NCT04321343|322876195|FG002|Overall Study|Pregnancy|0|||
94298289|NCT04321343|322876196|FG003|Overall Study|Pregnancy|0|||
94298290|NCT04321343|322876193|FG000|Overall Study|Protocol Violation|1|||
94298291|NCT04321343|322876194|FG001|Overall Study|Protocol Violation|1|||
94298292|NCT04321343|322876195|FG002|Overall Study|Protocol Violation|1|||
94298293|NCT04321343|322876196|FG003|Overall Study|Protocol Violation|1|||
94298294|NCT04321343|322876193|FG000|Overall Study|Withdrawal by Subject|0|||
94298295|NCT04321343|322876194|FG001|Overall Study|Withdrawal by Subject|6|||
94298296|NCT04321343|322876195|FG002|Overall Study|Withdrawal by Subject|0|||
94298297|NCT04321343|322876196|FG003|Overall Study|Withdrawal by Subject|2|||
94298298|NCT04321343|322876193|FG000|Overall Study|Lost to Follow-up|2|||
94298299|NCT04321343|322876194|FG001|Overall Study|Lost to Follow-up|2|||
94298300|NCT04321343|322876195|FG002|Overall Study|Lost to Follow-up|1|||
94298301|NCT04321343|322876196|FG003|Overall Study|Lost to Follow-up|3|||
94298302|NCT00963807|322876197|FG000|Overall Study|Physician Decision|2|||
94298303|NCT00963807|322876197|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
94298304|NCT00963807|322876197|FG000|Overall Study|Disease progression|15|||
94298305|NCT03430310|322876198|FG000|Overall Study|Protocol Violation|2|||
94298306|NCT03430310|322876199|FG001|Overall Study|Protocol Violation|0|||
94298307|NCT03430310|322876198|FG000|Overall Study|Withdrawal by Subject|3|||
94298308|NCT03430310|322876199|FG001|Overall Study|Withdrawal by Subject|2|||
94298309|NCT03430310|322876198|FG000|Overall Study|COVID shutdown March 2020|0|||
94298310|NCT03430310|322876199|FG001|Overall Study|COVID shutdown March 2020|1|||
94298311|NCT02234622|322876200|FG000|Overall Study|Withdrawal by Subject|16|||
94298312|NCT02234622|322876201|FG001|Overall Study|Withdrawal by Subject|22|||
94298313|NCT02234622|322876200|FG000|Overall Study|Lost to Follow-up|27|||
94298314|NCT02234622|322876201|FG001|Overall Study|Lost to Follow-up|14|||
94298315|NCT03476239|322876204|FG000|Overall Study|Withdrawal by Subject|10|||
94298316|NCT03476239|322876204|FG000|Overall Study|Death|80|||
94298317|NCT03476239|322876204|FG000|Overall Study|Lost to Follow-up|8|||
94298318|NCT01446809|322876208|FG000|Overall Study|Adverse Event|0|||
94298319|NCT01446809|322876209|FG001|Overall Study|Adverse Event|0|||
94298320|NCT01446809|322876210|FG002|Overall Study|Adverse Event|1|||
94298321|NCT01446809|322876208|FG000|Overall Study|Failure to complete study procedures|0|||
94298322|NCT01446809|322876209|FG001|Overall Study|Failure to complete study procedures|0|||
94298323|NCT01446809|322876210|FG002|Overall Study|Failure to complete study procedures|1|||
94298324|NCT01097044|322876211|FG000|Overall Study|Withdrawal by Subject|4|||
94298325|NCT01097044|322876212|FG001|Overall Study|Withdrawal by Subject|4|||
94298326|NCT01097044|322876211|FG000|Overall Study|Lost to Follow-up|1|||
94298327|NCT01097044|322876212|FG001|Overall Study|Lost to Follow-up|0|||
94298328|NCT01097044|322876211|FG000|Overall Study|Withdrawal by Sponsor|0|||
94298329|NCT01097044|322876212|FG001|Overall Study|Withdrawal by Sponsor|1|||
94298330|NCT01331161|322876213|FG000|Overall Study|Physician Decision|1|||
94298331|NCT01331161|322876214|FG001|Overall Study|Physician Decision|0|||
94298332|NCT01331161|322876213|FG000|Overall Study|Lost to Follow-up|0|||
94298333|NCT01331161|322876214|FG001|Overall Study|Lost to Follow-up|1|||
94298334|NCT01331161|322876213|FG000|Overall Study|Pregnancy|0|||
94298335|NCT01331161|322876214|FG001|Overall Study|Pregnancy|1|||
94298336|NCT01682044|322876217|FG000|Overall Study|Death|1|||
94298337|NCT01682044|322876217|FG000|Overall Study|Progression|3|||
94298338|NCT03219164|322878290|FG000|Overall Study|Study Terminated by Sponsor|16|||
94298339|NCT03219164|322878291|FG001|Overall Study|Study Terminated by Sponsor|12|||
94298340|NCT03219164|322878290|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
94298341|NCT03219164|322878291|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
94298342|NCT03219164|322878290|FG000|Overall Study|Lost to Follow-up|1|||
94298343|NCT03219164|322878291|FG001|Overall Study|Lost to Follow-up|1|||
94298344|NCT03219164|322878290|FG000|Overall Study|Adverse Event|1|||
94298345|NCT03219164|322878291|FG001|Overall Study|Adverse Event|0|||
94298346|NCT03219164|322878290|FG000|Overall Study|Non-Compliance with Study Drug|1|||
94298347|NCT03219164|322878291|FG001|Overall Study|Non-Compliance with Study Drug|0|||
94298348|NCT03219164|322878290|FG000|Overall Study|Protocol Violation|0|||
94298349|NCT03219164|322878291|FG001|Overall Study|Protocol Violation|1|||
94298350|NCT03219164|322878290|FG000|Overall Study|Withdrew Assent|1|||
94298351|NCT03219164|322878291|FG001|Overall Study|Withdrew Assent|0|||
94298352|NCT00960076|322878292|FG000|Overall Study|Adverse Event|1|||
94298353|NCT00960076|322878293|FG001|Overall Study|Adverse Event|7|||
94298354|NCT00960076|322878292|FG000|Overall Study|No longer met study criteria|1|||
94298355|NCT00960076|322878293|FG001|Overall Study|No longer met study criteria|5|||
94298356|NCT00960076|322878292|FG000|Overall Study|Withdrawal by Subject|1|||
94298357|NCT00960076|322878293|FG001|Overall Study|Withdrawal by Subject|2|||
94298358|NCT00960076|322878292|FG000|Overall Study|Lost to Follow-up|3|||
94298359|NCT00960076|322878293|FG001|Overall Study|Lost to Follow-up|3|||
94298360|NCT00960076|322878292|FG000|Overall Study|Severe non-compliance to protocol|1|||
94298361|NCT00960076|322878293|FG001|Overall Study|Severe non-compliance to protocol|2|||
94298362|NCT00960076|322878292|FG000|Overall Study|Hyperglycemia|1|||
94298363|NCT00960076|322878293|FG001|Overall Study|Hyperglycemia|5|||
94298364|NCT00960076|322878292|FG000|Overall Study|Did not attend the termination visit|0|||
94298365|NCT00960076|322878293|FG001|Overall Study|Did not attend the termination visit|1|||
94298366|NCT00500266|322878294|FG000|Overall Study|Death|3|||
94298367|NCT00500266|322878294|FG000|Overall Study|Lost to Follow-up|3|||
94298368|NCT00500266|322878294|FG000|Overall Study|Withdrawal by Subject|3|||
94298369|NCT00500266|322878294|FG000|Overall Study|Assigned, not treated|4|||
94468027|NCT01810783|323502486|FG000|Overall Study|Lost to Follow-up|10|||
94298370|NCT02689492|322878295|FG000|Overall Study|Lost to Follow-up|61|||
94298371|NCT02689492|322878295|FG000|Overall Study|Withdrawal by Subject|11|||
94298372|NCT02689492|322878295|FG000|Overall Study|Death|9|||
94298373|NCT02689492|322878295|FG000|Overall Study|Physician Decision|2|||
94298374|NCT02689492|322878295|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
94298375|NCT02689492|322878295|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
94298376|NCT02689492|322878295|FG000|Overall Study|Other than listed|1|||
94298377|NCT01431287|322878296|FG000|Overall Study|not treated|0|||
94298378|NCT01431287|322878297|FG001|Overall Study|not treated|0|||
94298379|NCT01431287|322878298|FG002|Overall Study|not treated|1|||
94298380|NCT01431287|322878299|FG003|Overall Study|not treated|0|||
94298381|NCT01431287|322878300|FG004|Overall Study|not treated|0|||
94298382|NCT01431287|322878296|FG000|Overall Study|Adverse Event|59|||
94298383|NCT01431287|322878297|FG001|Overall Study|Adverse Event|57|||
94298384|NCT01431287|322878298|FG002|Overall Study|Adverse Event|53|||
94298385|NCT01431287|322878299|FG003|Overall Study|Adverse Event|33|||
94298386|NCT01431287|322878300|FG004|Overall Study|Adverse Event|41|||
94468028|NCT01810783|323502486|FG000|Overall Study|Protocol Violation|5|||
94298387|NCT01431287|322878296|FG000|Overall Study|Non compliant with protocol|6|||
94298388|NCT01431287|322878297|FG001|Overall Study|Non compliant with protocol|6|||
94298389|NCT01431287|322878298|FG002|Overall Study|Non compliant with protocol|5|||
94298390|NCT01431287|322878299|FG003|Overall Study|Non compliant with protocol|6|||
94298391|NCT01431287|322878300|FG004|Overall Study|Non compliant with protocol|5|||
94298392|NCT01431287|322878296|FG000|Overall Study|Lost to Follow-up|0|||
94298393|NCT01431287|322878297|FG001|Overall Study|Lost to Follow-up|3|||
94298394|NCT01431287|322878298|FG002|Overall Study|Lost to Follow-up|2|||
94298395|NCT01431287|322878299|FG003|Overall Study|Lost to Follow-up|3|||
94298396|NCT01431287|322878300|FG004|Overall Study|Lost to Follow-up|1|||
94298397|NCT01431287|322878296|FG000|Overall Study|Consent withdrawn not due to AE|29|||
94298398|NCT01431287|322878297|FG001|Overall Study|Consent withdrawn not due to AE|30|||
94298399|NCT01431287|322878298|FG002|Overall Study|Consent withdrawn not due to AE|34|||
94298400|NCT01431287|322878299|FG003|Overall Study|Consent withdrawn not due to AE|19|||
94298401|NCT01431287|322878300|FG004|Overall Study|Consent withdrawn not due to AE|29|||
94298402|NCT01431287|322878296|FG000|Overall Study|not stated above|4|||
94298403|NCT01431287|322878297|FG001|Overall Study|not stated above|2|||
94298404|NCT01431287|322878298|FG002|Overall Study|not stated above|2|||
94298405|NCT01431287|322878299|FG003|Overall Study|not stated above|2|||
94298406|NCT01431287|322878300|FG004|Overall Study|not stated above|1|||
94298407|NCT02029976|322878301|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
94298408|NCT02029976|322878302|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
94298409|NCT02029976|322878301|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
94298410|NCT02029976|322878302|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
94298411|NCT02029976|322878301|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
94298412|NCT02029976|322878302|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
94298413|NCT02029976|322878301|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
94298414|NCT02029976|322878302|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
94298415|NCT01475734|322878303|FG000|Overall Study|Withdrawal by Subject|1|||
94298416|NCT01475734|322878304|FG001|Overall Study|Withdrawal by Subject|0|||
94298417|NCT01475734|322878303|FG000|Overall Study|Protocol Violation|1|||
94298418|NCT01475734|322878304|FG001|Overall Study|Protocol Violation|0|||
94298419|NCT01475734|322878303|FG000|Overall Study|Physician Decision|0|||
94298420|NCT01475734|322878304|FG001|Overall Study|Physician Decision|1|||
94298421|NCT00110305|322878313|FG000|Overall Study|Adverse Event|46|||
94298422|NCT00110305|322878314|FG001|Overall Study|Adverse Event|13|||
94298423|NCT00110305|322878313|FG000|Overall Study|Sponsors Decision|1|||
94298424|NCT00110305|322878314|FG001|Overall Study|Sponsors Decision|0|||
94298425|NCT00110305|322878313|FG000|Overall Study|Subject Non-Compliant|9|||
94298426|NCT00110305|322878314|FG001|Overall Study|Subject Non-Compliant|2|||
94298427|NCT00110305|322878313|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
94298428|NCT00110305|322878314|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
94298429|NCT00110305|322878313|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
94298430|NCT00110305|322878314|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
94298431|NCT00110305|322878313|FG000|Overall Study|Protocol Violation|0|||
94298432|NCT00110305|322878314|FG001|Overall Study|Protocol Violation|1|||
94298433|NCT00110305|322878313|FG000|Overall Study|Withdrawal by Subject|7|||
94298434|NCT00110305|322878314|FG001|Overall Study|Withdrawal by Subject|7|||
94298435|NCT00110305|322878313|FG000|Overall Study|Lost to Follow-up|20|||
94298436|NCT00110305|322878314|FG001|Overall Study|Lost to Follow-up|3|||
94298437|NCT00110305|322878313|FG000|Overall Study|Other|8|||
94298438|NCT00110305|322878314|FG001|Overall Study|Other|2|||
94298439|NCT03658889|322878319|FG000|Overall Study|Protocol Violation|2|||
94298440|NCT03658889|322878320|FG001|Overall Study|Protocol Violation|0|||
94298441|NCT00768222|322878327|FG000|Overall Study|Lost to Follow-up|1|||
94298442|NCT00768222|322878328|FG001|Overall Study|Lost to Follow-up|1|||
94372802|NCT01360632|323150357|FG001|Phase A+|Met Withdrawal Criteria|0|||
94372803|NCT01360632|323150358|FG002|Phase A+|Met Withdrawal Criteria|0|||
94372804|NCT01360632|323150359|FG003|Phase A+|Met Withdrawal Criteria|0|||
94372805|NCT01360632|323150360|FG004|Phase A+|Met Withdrawal Criteria|7|||
94372806|NCT01360632|323150356|FG000|Phase A+|Physician Decision|0|||
94372807|NCT01360632|323150357|FG001|Phase A+|Physician Decision|0|||
94372808|NCT01360632|323150358|FG002|Phase A+|Physician Decision|0|||
94372809|NCT01360632|323150359|FG003|Phase A+|Physician Decision|0|||
94372810|NCT01360632|323150360|FG004|Phase A+|Physician Decision|3|||
94372811|NCT01360632|323150356|FG000|Phase A+|Withdrawal by Subject|0|||
94372812|NCT01360632|323150357|FG001|Phase A+|Withdrawal by Subject|0|||
94372813|NCT01360632|323150358|FG002|Phase A+|Withdrawal by Subject|0|||
94372814|NCT01360632|323150359|FG003|Phase A+|Withdrawal by Subject|0|||
94372815|NCT01360632|323150360|FG004|Phase A+|Withdrawal by Subject|8|||
94372816|NCT01360632|323150356|FG000|Phase A+|Protocol Deviation|0|||
94372817|NCT01360632|323150357|FG001|Phase A+|Protocol Deviation|0|||
94372818|NCT01360632|323150358|FG002|Phase A+|Protocol Deviation|0|||
94372819|NCT01360632|323150359|FG003|Phase A+|Protocol Deviation|0|||
94372820|NCT01360632|323150360|FG004|Phase A+|Protocol Deviation|3|||
94372821|NCT04079842|323150363|FG000|Overall Study|Request of subject|2|||
94372822|NCT04079842|323150363|FG000|Overall Study|Unable to draw Arterial samples|1|||
94298443|NCT00768222|322878327|FG000|Overall Study|Withdrawal by Subject|3|||
94298444|NCT00768222|322878328|FG001|Overall Study|Withdrawal by Subject|1|||
94298445|NCT00768222|322878327|FG000|Overall Study|Protocol Violation|0|||
94298446|NCT00768222|322878328|FG001|Overall Study|Protocol Violation|2|||
94298447|NCT00278629|322878329|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
94298448|NCT03263091|322878330|FG000|OL Component|Withdrawal by Subject|1|||
94298449|NCT03263091|322878331|FG001|OL Component|Withdrawal by Subject|1|||
94298450|NCT03263091|322878332|FG002|OL Component|Withdrawal by Subject|0|||
94298451|NCT03263091|322878333|FG003|OL Component|Withdrawal by Subject|0|||
94298452|NCT03263091|322878334|FG004|OL Component|Withdrawal by Subject|0|||
94298453|NCT03263091|322878335|FG005|OL Component|Withdrawal by Subject|0|||
94298454|NCT03263091|322878330|FG000|OL Component|Physician Decision|0|||
94298455|NCT03263091|322878331|FG001|OL Component|Physician Decision|1|||
94298456|NCT03263091|322878332|FG002|OL Component|Physician Decision|2|||
94298457|NCT03263091|322878333|FG003|OL Component|Physician Decision|0|||
94298458|NCT03263091|322878334|FG004|OL Component|Physician Decision|0|||
94298459|NCT03263091|322878335|FG005|OL Component|Physician Decision|0|||
94298460|NCT03263091|322878330|FG000|OL Component|Death|1|||
94298461|NCT03263091|322878331|FG001|OL Component|Death|0|||
94298462|NCT03263091|322878332|FG002|OL Component|Death|0|||
94298463|NCT03263091|322878333|FG003|OL Component|Death|0|||
94298464|NCT03263091|322878334|FG004|OL Component|Death|0|||
94298465|NCT03263091|322878335|FG005|OL Component|Death|0|||
94298466|NCT03263091|322878330|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
94298467|NCT03263091|322878331|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
94298468|NCT03263091|322878332|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
94298469|NCT03263091|322878333|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
94298470|NCT03263091|322878334|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
94298471|NCT03263091|322878335|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
94298472|NCT03263091|322878330|FG000|OL High-EPO Component|Physician Decision|0|||
94298473|NCT03263091|322878331|FG001|OL High-EPO Component|Physician Decision|0|||
94298474|NCT03263091|322878332|FG002|OL High-EPO Component|Physician Decision|0|||
94298475|NCT03263091|322878333|FG003|OL High-EPO Component|Physician Decision|1|||
94298476|NCT03263091|322878334|FG004|OL High-EPO Component|Physician Decision|0|||
94298477|NCT03263091|322878335|FG005|OL High-EPO Component|Physician Decision|0|||
94298478|NCT03263091|322878330|FG000|OL High-EPO Component|Death|0|||
94298479|NCT03263091|322878331|FG001|OL High-EPO Component|Death|0|||
94298480|NCT03263091|322878332|FG002|OL High-EPO Component|Death|0|||
94298481|NCT03263091|322878333|FG003|OL High-EPO Component|Death|3|||
94298482|NCT03263091|322878334|FG004|OL High-EPO Component|Death|0|||
94298483|NCT03263091|322878335|FG005|OL High-EPO Component|Death|0|||
94298484|NCT03263091|322878330|FG000|DB Component|Withdrawal by Subject|0|||
94298485|NCT03263091|322878331|FG001|DB Component|Withdrawal by Subject|0|||
94298486|NCT03263091|322878332|FG002|DB Component|Withdrawal by Subject|0|||
94298487|NCT03263091|322878333|FG003|DB Component|Withdrawal by Subject|0|||
94298488|NCT03263091|322878334|FG004|DB Component|Withdrawal by Subject|22|||
94298489|NCT03263091|322878335|FG005|DB Component|Withdrawal by Subject|8|||
94298490|NCT03263091|322878330|FG000|DB Component|Physician Decision|0|||
94298491|NCT03263091|322878331|FG001|DB Component|Physician Decision|0|||
94298492|NCT03263091|322878332|FG002|DB Component|Physician Decision|0|||
94298493|NCT03263091|322878333|FG003|DB Component|Physician Decision|0|||
94298494|NCT03263091|322878334|FG004|DB Component|Physician Decision|3|||
94298495|NCT03263091|322878335|FG005|DB Component|Physician Decision|1|||
94298496|NCT03263091|322878330|FG000|DB Component|Adverse Event|0|||
94298497|NCT03263091|322878331|FG001|DB Component|Adverse Event|0|||
94298498|NCT03263091|322878332|FG002|DB Component|Adverse Event|0|||
94298499|NCT03263091|322878333|FG003|DB Component|Adverse Event|0|||
94298500|NCT03263091|322878334|FG004|DB Component|Adverse Event|2|||
94298501|NCT03263091|322878335|FG005|DB Component|Adverse Event|1|||
94298502|NCT03263091|322878330|FG000|DB Component|Lost to Follow-up|0|||
94298503|NCT03263091|322878331|FG001|DB Component|Lost to Follow-up|0|||
94298504|NCT03263091|322878332|FG002|DB Component|Lost to Follow-up|0|||
94298505|NCT03263091|322878333|FG003|DB Component|Lost to Follow-up|0|||
94298506|NCT03263091|322878334|FG004|DB Component|Lost to Follow-up|2|||
94372823|NCT02904200|323150364|FG000|Overall Study|Withdrawal by Subject|1|||
94372824|NCT02904200|323150365|FG001|Overall Study|Withdrawal by Subject|0|||
94372825|NCT02133352|323150366|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
94298507|NCT03263091|322878335|FG005|DB Component|Lost to Follow-up|1|||
94298508|NCT03263091|322878330|FG000|DB Component|Death|0|||
94298509|NCT03263091|322878331|FG001|DB Component|Death|0|||
94298510|NCT03263091|322878332|FG002|DB Component|Death|0|||
94298511|NCT03263091|322878333|FG003|DB Component|Death|0|||
94298512|NCT03263091|322878334|FG004|DB Component|Death|7|||
94298513|NCT03263091|322878335|FG005|DB Component|Death|4|||
94298514|NCT03263091|322878330|FG000|DB Component|Other than specified|0|||
94298515|NCT03263091|322878331|FG001|DB Component|Other than specified|0|||
94298516|NCT03263091|322878332|FG002|DB Component|Other than specified|0|||
94298517|NCT03263091|322878333|FG003|DB Component|Other than specified|0|||
94298518|NCT03263091|322878334|FG004|DB Component|Other than specified|8|||
94298519|NCT03263091|322878335|FG005|DB Component|Other than specified|6|||
94298520|NCT02300129|322878336|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
94298521|NCT02300129|322878337|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
94298522|NCT02300129|322878338|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
94298523|NCT02300129|322878339|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
94298524|NCT02300129|322878336|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
94298525|NCT02300129|322878337|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
94298526|NCT02300129|322878338|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
94298527|NCT02300129|322878339|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
94298528|NCT02300129|322878336|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
94298529|NCT02300129|322878337|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
94298530|NCT02300129|322878338|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
94298531|NCT02300129|322878339|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
94298532|NCT01887912|322878340|FG000|Overall Study|Serious adverse event|400|||
94298533|NCT01887912|322878341|FG001|Overall Study|Serious adverse event|198|||
94298534|NCT01887912|322878340|FG000|Overall Study|Other Adverse Event|34|||
94298535|NCT01887912|322878341|FG001|Overall Study|Other Adverse Event|15|||
94298536|NCT01887912|322878340|FG000|Overall Study|Protocol Violation|67|||
94298537|NCT01887912|322878341|FG001|Overall Study|Protocol Violation|37|||
94298538|NCT01887912|322878340|FG000|Overall Study|Lost to Follow-up|163|||
94298539|NCT01887912|322878341|FG001|Overall Study|Lost to Follow-up|74|||
94298540|NCT01887912|322878340|FG000|Overall Study|Withdrawal by Subject|606|||
94298541|NCT01887912|322878341|FG001|Overall Study|Withdrawal by Subject|349|||
94298542|NCT01887912|322878340|FG000|Overall Study|Other|122|||
94298543|NCT01887912|322878341|FG001|Overall Study|Other|58|||
94298544|NCT02443402|322878344|FG000|Overall Study|Withdrawal by Subject|3|||
94298545|NCT02443402|322878345|FG001|Overall Study|Withdrawal by Subject|1|||
94298546|NCT02443402|322878344|FG000|Overall Study|Screen Failure|1|||
94298547|NCT02443402|322878345|FG001|Overall Study|Screen Failure|2|||
94298548|NCT01934504|322878346|FG000|Overall Study|Protocol Deviation|0|||
94298549|NCT01934504|322878347|FG001|Overall Study|Protocol Deviation|0|||
94298550|NCT01934504|322878348|FG002|Overall Study|Protocol Deviation|0|||
94298551|NCT01934504|322878349|FG003|Overall Study|Protocol Deviation|2|||
94298552|NCT01934504|322878346|FG000|Overall Study|Study Terminated by Sponsor|1|||
94298553|NCT01934504|322878347|FG001|Overall Study|Study Terminated by Sponsor|0|||
94298554|NCT01934504|322878348|FG002|Overall Study|Study Terminated by Sponsor|5|||
94298555|NCT01934504|322878349|FG003|Overall Study|Study Terminated by Sponsor|5|||
94298556|NCT00522392|322878350|FG000|Overall Study|Disease progression|0|||
94298557|NCT00522392|322878351|FG001|Overall Study|Disease progression|3|||
94298558|NCT00522392|322878350|FG000|Overall Study|Adverse Event|7|||
94298559|NCT00522392|322878351|FG001|Overall Study|Adverse Event|7|||
94298560|NCT00522392|322878350|FG000|Overall Study|Withdrawal by Subject|1|||
94298561|NCT00522392|322878351|FG001|Overall Study|Withdrawal by Subject|1|||
94298562|NCT00522392|322878350|FG000|Overall Study|Physician Decision|0|||
94298563|NCT00522392|322878351|FG001|Overall Study|Physician Decision|1|||
94298564|NCT00522392|322878350|FG000|Overall Study|Non-compliance|0|||
94298565|NCT00522392|322878351|FG001|Overall Study|Non-compliance|1|||
94298566|NCT00824564|322878352|FG000|Overall Study|Lost to Follow-up|5|||
94298567|NCT00824564|322878353|FG001|Overall Study|Lost to Follow-up|7|||
94298568|NCT00824564|322878352|FG000|Overall Study|Withdrawal by Subject|1|||
94298569|NCT00824564|322878353|FG001|Overall Study|Withdrawal by Subject|1|||
94298570|NCT00824564|322878352|FG000|Overall Study|Other|1|||
94298571|NCT00824564|322878353|FG001|Overall Study|Other|2|||
94298572|NCT00824564|322878352|FG000|Overall Study|Randomized, but not treated|1|||
94298573|NCT00824564|322878353|FG001|Overall Study|Randomized, but not treated|0|||
94298574|NCT00486902|322878354|FG000|Overall Study|Withdrawal by Subject|1|||
94298575|NCT00486902|322878355|FG001|Overall Study|Withdrawal by Subject|2|||
94298576|NCT00486902|322878354|FG000|Overall Study|decision for postpartum tubal ligation|3|||
94298577|NCT00486902|322878355|FG001|Overall Study|decision for postpartum tubal ligation|1|||
94298578|NCT00486902|322878354|FG000|Overall Study|spinal anesthetic protocal violation|1|||
94298579|NCT00486902|322878355|FG001|Overall Study|spinal anesthetic protocal violation|1|||
94298580|NCT00486902|322878354|FG000|Overall Study|Did not meet inclusion criteria|1|||
94372826|NCT03016078|323150367|FG000|Overall Study|Protocol Violation|1|||
94298581|NCT00486902|322878355|FG001|Overall Study|Did not meet inclusion criteria|0|||
94298582|NCT00486902|322878354|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
94298583|NCT00486902|322878355|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
94298584|NCT01552057|322878366|FG000|Overall Study|Adverse Event|14|||
94298585|NCT01552057|322878367|FG001|Overall Study|Adverse Event|15|||
94298586|NCT01552057|322878366|FG000|Overall Study|Lack of Efficacy|8|||
94298587|NCT01552057|322878367|FG001|Overall Study|Lack of Efficacy|23|||
94298588|NCT01552057|322878366|FG000|Overall Study|Withdrawal by Subject|5|||
94372827|NCT03016078|323150367|FG000|Overall Study|Protocol Violation|1|||
94298589|NCT01552057|322878367|FG001|Overall Study|Withdrawal by Subject|8|||
94298590|NCT01552057|322878366|FG000|Overall Study|Entry Criteria Not Met|2|||
94298591|NCT01552057|322878367|FG001|Overall Study|Entry Criteria Not Met|2|||
94298592|NCT01552057|322878366|FG000|Overall Study|Physician Decision|1|||
94298593|NCT01552057|322878367|FG001|Overall Study|Physician Decision|0|||
94298594|NCT00476086|322878368|FG000|Overall Study|Alternative therapy|1|||
94298595|NCT00476086|322878368|FG000|Overall Study|Progressive Disease|4|||
94298596|NCT04178590|322878369|FG000|Overall Study|Pregnancy|1|||
94298597|NCT04178590|322878369|FG000|Overall Study|Lost to Follow-up|1|||
94298598|NCT00996840|322878370|FG000|Overall Study|Adverse Event|0|||
94298599|NCT00996840|322878371|FG001|Overall Study|Adverse Event|1|||
94298600|NCT00996840|322878372|FG002|Overall Study|Adverse Event|0|||
94298601|NCT00996840|322878373|FG003|Overall Study|Adverse Event|0|||
94298602|NCT00996840|322878374|FG004|Overall Study|Adverse Event|0|||
94298603|NCT00996840|322878370|FG000|Overall Study|Physician Decision|0|||
94298604|NCT00996840|322878371|FG001|Overall Study|Physician Decision|0|||
94298605|NCT00996840|322878372|FG002|Overall Study|Physician Decision|1|||
94298606|NCT00996840|322878373|FG003|Overall Study|Physician Decision|1|||
94298607|NCT00996840|322878374|FG004|Overall Study|Physician Decision|2|||
94298608|NCT00996840|322878370|FG000|Overall Study|Withdrawal by Subject|1|||
94298609|NCT00996840|322878371|FG001|Overall Study|Withdrawal by Subject|1|||
94298610|NCT00996840|322878372|FG002|Overall Study|Withdrawal by Subject|0|||
94298611|NCT00996840|322878373|FG003|Overall Study|Withdrawal by Subject|0|||
94298612|NCT00996840|322878374|FG004|Overall Study|Withdrawal by Subject|0|||
94298613|NCT02292849|322878375|FG000|Overall Study|Lost to Follow-up|0|||
94298614|NCT02292849|322878376|FG001|Overall Study|Lost to Follow-up|2|||
94298615|NCT02292849|322878377|FG002|Overall Study|Lost to Follow-up|2|||
94298616|NCT02292849|322878375|FG000|Overall Study|Physician Decision|4|||
94298617|NCT02292849|322878376|FG001|Overall Study|Physician Decision|0|||
94298618|NCT02292849|322878377|FG002|Overall Study|Physician Decision|0|||
94298619|NCT00733902|322878378|FG000|Overall Study|Death|0|||
94298620|NCT00733902|322878379|FG001|Overall Study|Death|0|||
94298621|NCT00733902|322878380|FG002|Overall Study|Death|0|||
94298622|NCT00733902|322878381|FG003|Overall Study|Death|1|||
94298623|NCT00733902|322878378|FG000|Overall Study|Adverse Event|3|||
94298624|NCT00733902|322878379|FG001|Overall Study|Adverse Event|4|||
94298625|NCT00733902|322878380|FG002|Overall Study|Adverse Event|7|||
94298626|NCT00733902|322878381|FG003|Overall Study|Adverse Event|11|||
94298627|NCT00733902|322878378|FG000|Overall Study|Lack of Efficacy|56|||
94298628|NCT00733902|322878379|FG001|Overall Study|Lack of Efficacy|21|||
94298629|NCT00733902|322878380|FG002|Overall Study|Lack of Efficacy|34|||
94298630|NCT00733902|322878381|FG003|Overall Study|Lack of Efficacy|23|||
94298631|NCT00733902|322878378|FG000|Overall Study|Protocol Violation|4|||
94298632|NCT00733902|322878379|FG001|Overall Study|Protocol Violation|6|||
94298633|NCT00733902|322878380|FG002|Overall Study|Protocol Violation|3|||
94298634|NCT00733902|322878381|FG003|Overall Study|Protocol Violation|3|||
94298635|NCT00733902|322878378|FG000|Overall Study|Withdrawal by Subject|10|||
94298636|NCT00733902|322878379|FG001|Overall Study|Withdrawal by Subject|5|||
94298637|NCT00733902|322878380|FG002|Overall Study|Withdrawal by Subject|4|||
94298638|NCT00733902|322878381|FG003|Overall Study|Withdrawal by Subject|16|||
94298639|NCT00733902|322878378|FG000|Overall Study|Entered extension study|89|||
94298640|NCT00733902|322878379|FG001|Overall Study|Entered extension study|124|||
94298641|NCT00733902|322878380|FG002|Overall Study|Entered extension study|111|||
94298642|NCT00733902|322878381|FG003|Overall Study|Entered extension study|109|||
94298643|NCT00733902|322878378|FG000|Overall Study|Randomized but not treated|2|||
94298644|NCT00733902|322878379|FG001|Overall Study|Randomized but not treated|2|||
94298645|NCT00733902|322878380|FG002|Overall Study|Randomized but not treated|2|||
94298646|NCT00733902|322878381|FG003|Overall Study|Randomized but not treated|1|||
94298647|NCT01562028|322878382|FG000|Overall Study|Withdrawal by Subject|1|||
94298648|NCT01562028|322878383|FG001|Overall Study|Withdrawal by Subject|1|||
94298649|NCT01562028|322878382|FG000|Overall Study|Lost to Follow-up|2|||
94298650|NCT01562028|322878383|FG001|Overall Study|Lost to Follow-up|1|||
94298651|NCT00828464|322878386|FG000|Overall Study|Withdrawal by Subject|1|||
94298652|NCT02542267|322878387|FG000|Overall Study|Withdrawal by Subject|10|||
94298653|NCT02542267|322878387|FG000|Overall Study|Physician Decision|6|||
94298654|NCT02542267|322878387|FG000|Overall Study|Lost to Follow-up|4|||
94298655|NCT02542267|322878387|FG000|Overall Study|Death|13|||
94298656|NCT02542267|322878387|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
94372828|NCT02196506|323150368|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
94372829|NCT02196506|323150369|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
94372830|NCT02196506|323150370|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
94372831|NCT02196506|323150371|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
94372832|NCT02196506|323150368|FG000|Phase A|Withdrawal by Subject|34|||
94372833|NCT02196506|323150369|FG001|Phase A|Withdrawal by Subject|0|||
94372834|NCT02196506|323150370|FG002|Phase A|Withdrawal by Subject|0|||
94372835|NCT02196506|323150371|FG003|Phase A|Withdrawal by Subject|0|||
94372836|NCT02196506|323150368|FG000|Phase A|Adverse Event|22|||
94372837|NCT02196506|323150369|FG001|Phase A|Adverse Event|0|||
94298657|NCT02542267|322878387|FG000|Overall Study|Other|9|||
94298658|NCT03049449|322878388|FG000|Overall Study|Did not receive treatment.|0|||
94298659|NCT03049449|322878389|FG001|Overall Study|Did not receive treatment.|0|||
94298660|NCT03049449|322878390|FG002|Overall Study|Did not receive treatment.|0|||
94298661|NCT03049449|322878391|FG003|Overall Study|Did not receive treatment.|0|||
94298662|NCT03049449|322878392|FG004|Overall Study|Did not receive treatment.|0|||
94298663|NCT03049449|322878393|FG005|Overall Study|Did not receive treatment.|0|||
94298664|NCT03049449|322878394|FG006|Overall Study|Did not receive treatment.|0|||
94298665|NCT03049449|322878395|FG007|Overall Study|Did not receive treatment.|0|||
94298666|NCT03049449|322878396|FG008|Overall Study|Did not receive treatment.|1|||
94298667|NCT03049449|322878397|FG009|Overall Study|Did not receive treatment.|0|||
94298668|NCT03049449|322878388|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
94298669|NCT03049449|322878389|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
94298670|NCT03049449|322878390|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
94298671|NCT03049449|322878391|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
94298672|NCT03049449|322878392|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
94298673|NCT03049449|322878393|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
94298674|NCT03049449|322878394|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
94298675|NCT03049449|322878395|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
94298676|NCT03049449|322878396|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
94298677|NCT03049449|322878397|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
94298678|NCT03049449|322878388|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
94298679|NCT03049449|322878389|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
94298680|NCT03049449|322878390|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
94298681|NCT03049449|322878391|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
94298682|NCT03049449|322878392|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
94298683|NCT03049449|322878393|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
94298684|NCT03049449|322878394|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
94298685|NCT03049449|322878395|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
94298686|NCT03049449|322878396|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
94298687|NCT03049449|322878397|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
94298688|NCT00355264|322878398|FG000|Extension (Variable Duration)|Adverse Event|1|||
94298689|NCT00355264|322878398|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
94298690|NCT04964258|322878399|FG000|Overall Study|Lost to Follow-up|1|||
94298691|NCT04964258|322878400|FG001|Overall Study|Lost to Follow-up|0|||
94298692|NCT04964258|322878401|FG002|Overall Study|Lost to Follow-up|0|||
94298693|NCT04964258|322878402|FG003|Overall Study|Lost to Follow-up|0|||
94298694|NCT04964258|322878403|FG004|Overall Study|Lost to Follow-up|0|||
94298695|NCT04964258|322878404|FG005|Overall Study|Lost to Follow-up|1|||
94298696|NCT04964258|322878405|FG006|Overall Study|Lost to Follow-up|0|||
94298697|NCT04964258|322878406|FG007|Overall Study|Lost to Follow-up|0|||
94298698|NCT04964258|322878407|FG008|Overall Study|Lost to Follow-up|0|||
94298699|NCT04964258|322878408|FG009|Overall Study|Lost to Follow-up|0|||
94298700|NCT04964258|322878409|FG010|Overall Study|Lost to Follow-up|0|||
94298701|NCT02909153|322878410|FG000|Overall Study|Withdrawal by Subject|0|||
94298702|NCT02909153|322878411|FG001|Overall Study|Withdrawal by Subject|1|||
94298703|NCT02909153|322878412|FG002|Overall Study|Withdrawal by Subject|0|||
94298704|NCT02909153|322878413|FG003|Overall Study|Withdrawal by Subject|0|||
94298705|NCT02909153|322878414|FG004|Overall Study|Withdrawal by Subject|0|||
94298706|NCT03401749|322878415|FG000|Overall Study|Lost to Follow-up|20|||
94298707|NCT03401749|322878416|FG001|Overall Study|Lost to Follow-up|16|||
94298708|NCT03401749|322878417|FG002|Overall Study|Lost to Follow-up|26|||
94298709|NCT04052139|322878421|FG000|Overall Study|Lost to Follow-up|2|||
94298710|NCT04052139|322878422|FG001|Overall Study|Lost to Follow-up|0|||
94298711|NCT04052139|322878423|FG002|Overall Study|Lost to Follow-up|0|||
94298712|NCT04052139|322878421|FG000|Overall Study|Withdrawal by Subject|1|||
94298713|NCT04052139|322878422|FG001|Overall Study|Withdrawal by Subject|0|||
94298714|NCT04052139|322878423|FG002|Overall Study|Withdrawal by Subject|0|||
94298715|NCT04433117|322878424|FG000|Overall Study|Withdrawal by Subject|1|||
94298716|NCT04433117|322878425|FG001|Overall Study|Withdrawal by Subject|0|||
94298717|NCT02286102|322878426|FG000|Overall Study|Screen Failure|1|||
94298718|NCT02286102|322878427|FG001|Overall Study|Screen Failure|1|||
94298719|NCT00818259|322878428|FG000|Part I|Withdrawal by Subject|1|||
94298720|NCT00818259|322878429|FG001|Part I|Withdrawal by Subject|0|||
94298721|NCT00818259|322878430|FG002|Part I|Withdrawal by Subject|0|||
94298722|NCT00818259|322878431|FG003|Part I|Withdrawal by Subject|0|||
94298723|NCT00818259|322878432|FG004|Part I|Withdrawal by Subject|0|||
94298724|NCT00818259|322878433|FG005|Part I|Withdrawal by Subject|0|||
94298725|NCT00818259|322878434|FG006|Part I|Withdrawal by Subject|0|||
94468029|NCT01810783|323502486|FG000|Overall Study|Non-compliance with IMP|4|||
94468030|NCT01810783|323502486|FG000|Overall Study|Adminstrative or other reason(s)|23|||
94298726|NCT00818259|322878435|FG007|Part I|Withdrawal by Subject|0|||
94468031|NCT01810783|323502486|FG000|Overall Study|Enrolled, not treated|1|||
94372838|NCT02196506|323150370|FG002|Phase A|Adverse Event|0|||
94372839|NCT02196506|323150371|FG003|Phase A|Adverse Event|0|||
94372840|NCT02196506|323150368|FG000|Phase A|Lost to Follow-up|9|||
94372841|NCT02196506|323150369|FG001|Phase A|Lost to Follow-up|0|||
94372842|NCT02196506|323150370|FG002|Phase A|Lost to Follow-up|0|||
94372843|NCT02196506|323150371|FG003|Phase A|Lost to Follow-up|0|||
94372844|NCT02196506|323150368|FG000|Phase A|Protocol deviation|12|||
94372845|NCT02196506|323150369|FG001|Phase A|Protocol deviation|0|||
94372846|NCT02196506|323150370|FG002|Phase A|Protocol deviation|0|||
94298727|NCT00818259|322878436|FG008|Part I|Withdrawal by Subject|0|||
94298728|NCT00818259|322878428|FG000|Part II|Physician Decision|0|||
94298729|NCT00818259|322878429|FG001|Part II|Physician Decision|0|||
94298730|NCT00818259|322878430|FG002|Part II|Physician Decision|1|||
94298731|NCT00818259|322878431|FG003|Part II|Physician Decision|0|||
94298732|NCT00818259|322878432|FG004|Part II|Physician Decision|0|||
94298733|NCT00818259|322878433|FG005|Part II|Physician Decision|0|||
94298734|NCT00818259|322878434|FG006|Part II|Physician Decision|0|||
94298735|NCT00818259|322878435|FG007|Part II|Physician Decision|0|||
94298736|NCT00818259|322878436|FG008|Part II|Physician Decision|0|||
94298737|NCT00818259|322878428|FG000|Part II|Lack of Efficacy|0|||
94298738|NCT00818259|322878429|FG001|Part II|Lack of Efficacy|0|||
94298739|NCT00818259|322878430|FG002|Part II|Lack of Efficacy|0|||
94298740|NCT00818259|322878431|FG003|Part II|Lack of Efficacy|1|||
94298741|NCT00818259|322878432|FG004|Part II|Lack of Efficacy|0|||
94298742|NCT00818259|322878433|FG005|Part II|Lack of Efficacy|0|||
94298743|NCT00818259|322878434|FG006|Part II|Lack of Efficacy|0|||
94298744|NCT00818259|322878435|FG007|Part II|Lack of Efficacy|0|||
94298745|NCT00818259|322878436|FG008|Part II|Lack of Efficacy|0|||
94298746|NCT00818259|322878428|FG000|Part II|Not Treated|0|||
94298747|NCT00818259|322878429|FG001|Part II|Not Treated|0|||
94298748|NCT00818259|322878430|FG002|Part II|Not Treated|0|||
94298749|NCT00818259|322878431|FG003|Part II|Not Treated|1|||
94298750|NCT00818259|322878432|FG004|Part II|Not Treated|0|||
94298751|NCT00818259|322878433|FG005|Part II|Not Treated|0|||
94298752|NCT00818259|322878434|FG006|Part II|Not Treated|0|||
94298753|NCT00818259|322878435|FG007|Part II|Not Treated|0|||
94298754|NCT00818259|322878436|FG008|Part II|Not Treated|0|||
94298755|NCT00818259|322878428|FG000|Part IV|Physician Decision|0|||
94298756|NCT00818259|322878429|FG001|Part IV|Physician Decision|0|||
94298757|NCT00818259|322878430|FG002|Part IV|Physician Decision|0|||
94298758|NCT00818259|322878431|FG003|Part IV|Physician Decision|0|||
94298759|NCT00818259|322878432|FG004|Part IV|Physician Decision|0|||
94298760|NCT00818259|322878433|FG005|Part IV|Physician Decision|1|||
94298761|NCT00818259|322878434|FG006|Part IV|Physician Decision|0|||
94298762|NCT00818259|322878435|FG007|Part IV|Physician Decision|0|||
94298763|NCT00818259|322878436|FG008|Part IV|Physician Decision|0|||
94298764|NCT00818259|322878428|FG000|Part V|Adverse Event|0|||
94298765|NCT00818259|322878429|FG001|Part V|Adverse Event|0|||
94298766|NCT00818259|322878430|FG002|Part V|Adverse Event|0|||
94298767|NCT00818259|322878431|FG003|Part V|Adverse Event|0|||
94298768|NCT00818259|322878432|FG004|Part V|Adverse Event|0|||
94298769|NCT00818259|322878433|FG005|Part V|Adverse Event|0|||
94298770|NCT00818259|322878434|FG006|Part V|Adverse Event|0|||
94298771|NCT00818259|322878435|FG007|Part V|Adverse Event|1|||
94298772|NCT00818259|322878436|FG008|Part V|Adverse Event|0|||
94298773|NCT00256295|322878437|FG000|Overall Study|Withdrawal by Subject|3|||
94298774|NCT00256295|322878437|FG000|Overall Study|Death|1|||
94298775|NCT02117687|322878438|FG000|Overall Study|Lost to Follow-up|0|||
94298776|NCT02117687|322878439|FG001|Overall Study|Lost to Follow-up|1|||
94298777|NCT02117687|322878438|FG000|Overall Study|Adverse Event|0|||
94298778|NCT02117687|322878439|FG001|Overall Study|Adverse Event|2|||
94298779|NCT02117687|322878438|FG000|Overall Study|Other Reasons|1|||
94298780|NCT02117687|322878439|FG001|Overall Study|Other Reasons|1|||
94372847|NCT02196506|323150371|FG003|Phase A|Protocol deviation|0|||
94372848|NCT02196506|323150368|FG000|Phase A|Participant withdrawn by investigator|10|||
94372849|NCT02196506|323150369|FG001|Phase A|Participant withdrawn by investigator|0|||
94372850|NCT02196506|323150370|FG002|Phase A|Participant withdrawn by investigator|0|||
94298781|NCT01126580|322878440|FG000|Overall Study|Adverse Event|14|||
94298782|NCT01126580|322878441|FG001|Overall Study|Adverse Event|8|||
94298783|NCT01126580|322878442|FG002|Overall Study|Adverse Event|12|||
94298784|NCT01126580|322878440|FG000|Overall Study|Withdrawal by Subject|11|||
94372851|NCT02196506|323150371|FG003|Phase A|Participant withdrawn by investigator|0|||
94298785|NCT01126580|322878441|FG001|Overall Study|Withdrawal by Subject|19|||
94298786|NCT01126580|322878442|FG002|Overall Study|Withdrawal by Subject|14|||
94298787|NCT01126580|322878440|FG000|Overall Study|Sponsor Decision|5|||
94298788|NCT01126580|322878441|FG001|Overall Study|Sponsor Decision|4|||
94298789|NCT01126580|322878442|FG002|Overall Study|Sponsor Decision|7|||
94298790|NCT01126580|322878440|FG000|Overall Study|Physician Decision|1|||
94298791|NCT01126580|322878441|FG001|Overall Study|Physician Decision|1|||
94298792|NCT01126580|322878442|FG002|Overall Study|Physician Decision|2|||
94298793|NCT01126580|322878440|FG000|Overall Study|Entry Criteria Not Met|1|||
94298794|NCT01126580|322878441|FG001|Overall Study|Entry Criteria Not Met|1|||
94298795|NCT01126580|322878442|FG002|Overall Study|Entry Criteria Not Met|2|||
94298796|NCT01126580|322878440|FG000|Overall Study|Lack of Efficacy|2|||
94298797|NCT01126580|322878441|FG001|Overall Study|Lack of Efficacy|3|||
94298798|NCT01126580|322878442|FG002|Overall Study|Lack of Efficacy|4|||
94298799|NCT01126580|322878440|FG000|Overall Study|Protocol Violation|0|||
94298800|NCT01126580|322878441|FG001|Overall Study|Protocol Violation|1|||
94298801|NCT01126580|322878442|FG002|Overall Study|Protocol Violation|2|||
94298802|NCT01126580|322878440|FG000|Overall Study|Lost to Follow-up|15|||
94298803|NCT01126580|322878441|FG001|Overall Study|Lost to Follow-up|13|||
94298804|NCT01126580|322878442|FG002|Overall Study|Lost to Follow-up|9|||
94298805|NCT01126580|322878440|FG000|Overall Study|Treatment Non-compliance|0|||
94298806|NCT01126580|322878441|FG001|Overall Study|Treatment Non-compliance|2|||
94298807|NCT01126580|322878442|FG002|Overall Study|Treatment Non-compliance|3|||
94298808|NCT01731002|322878452|FG000|Overall Study|Adverse Event|0|||
94298809|NCT01731002|322878453|FG001|Overall Study|Adverse Event|2|||
94298810|NCT01731002|322878454|FG002|Overall Study|Adverse Event|2|||
94298811|NCT01731002|322878452|FG000|Overall Study|Non-Compliant|0|||
94298812|NCT01731002|322878453|FG001|Overall Study|Non-Compliant|1|||
94298813|NCT01731002|322878454|FG002|Overall Study|Non-Compliant|0|||
94298814|NCT01731002|322878452|FG000|Overall Study|Lost to Follow-up|1|||
94372852|NCT02196506|323150368|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
94372853|NCT02196506|323150369|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
94372854|NCT02196506|323150370|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
94372855|NCT02196506|323150371|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
94372856|NCT02196506|323150368|FG000|Phase B|Lack of Efficacy|0|||
94372857|NCT02196506|323150369|FG001|Phase B|Lack of Efficacy|1|||
94372858|NCT02196506|323150370|FG002|Phase B|Lack of Efficacy|2|||
94372859|NCT02196506|323150371|FG003|Phase B|Lack of Efficacy|0|||
94372860|NCT02196506|323150368|FG000|Phase B|Withdrawal by Participant|0|||
94372861|NCT02196506|323150369|FG001|Phase B|Withdrawal by Participant|8|||
94372862|NCT02196506|323150370|FG002|Phase B|Withdrawal by Participant|1|||
94372863|NCT02196506|323150371|FG003|Phase B|Withdrawal by Participant|0|||
94372864|NCT02196506|323150368|FG000|Phase B|Adverse Event|0|||
94372865|NCT02196506|323150369|FG001|Phase B|Adverse Event|4|||
94372866|NCT02196506|323150370|FG002|Phase B|Adverse Event|1|||
94372867|NCT02196506|323150371|FG003|Phase B|Adverse Event|0|||
94372868|NCT02196506|323150368|FG000|Phase B|Lost to Follow-up|0|||
94372869|NCT02196506|323150369|FG001|Phase B|Lost to Follow-up|2|||
94372870|NCT02196506|323150370|FG002|Phase B|Lost to Follow-up|1|||
94372871|NCT02196506|323150371|FG003|Phase B|Lost to Follow-up|0|||
94372872|NCT02196506|323150368|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
94372873|NCT02196506|323150369|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
94372874|NCT02196506|323150370|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
94372875|NCT02196506|323150371|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
94372876|NCT02196506|323150368|FG000|Phase A+|Withdrawal by Participant|0|||
94372877|NCT02196506|323150369|FG001|Phase A+|Withdrawal by Participant|0|||
94372878|NCT02196506|323150370|FG002|Phase A+|Withdrawal by Participant|0|||
94372879|NCT02196506|323150371|FG003|Phase A+|Withdrawal by Participant|5|||
94372880|NCT02196506|323150368|FG000|Phase A+|Adverse Event|0|||
94372881|NCT02196506|323150369|FG001|Phase A+|Adverse Event|0|||
94372882|NCT02196506|323150370|FG002|Phase A+|Adverse Event|0|||
94372883|NCT02196506|323150371|FG003|Phase A+|Adverse Event|1|||
94372884|NCT02196506|323150368|FG000|Phase A+|Lost to Follow-up|0|||
94372885|NCT02196506|323150369|FG001|Phase A+|Lost to Follow-up|0|||
94372886|NCT02196506|323150370|FG002|Phase A+|Lost to Follow-up|0|||
94372887|NCT02196506|323150371|FG003|Phase A+|Lost to Follow-up|6|||
94372888|NCT02196506|323150368|FG000|Phase A+|Participant withdrawn by investigator|0|||
94372889|NCT02196506|323150369|FG001|Phase A+|Participant withdrawn by investigator|0|||
94372890|NCT02196506|323150370|FG002|Phase A+|Participant withdrawn by investigator|0|||
94372891|NCT02196506|323150371|FG003|Phase A+|Participant withdrawn by investigator|1|||
94298815|NCT01731002|322878453|FG001|Overall Study|Lost to Follow-up|0|||
94372892|NCT00185211|323150372|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
94372893|NCT00185211|323150373|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
94372894|NCT00185211|323150372|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
94372895|NCT00185211|323150373|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
94372896|NCT00185211|323150372|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
94372897|NCT00185211|323150373|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
94372898|NCT00185211|323150372|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
94372899|NCT00185211|323150373|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
94372900|NCT00185211|323150372|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
94298816|NCT01731002|322878454|FG002|Overall Study|Lost to Follow-up|0|||
94372901|NCT00185211|323150373|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
94372902|NCT00185211|323150372|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
94298817|NCT01731002|322878452|FG000|Overall Study|Test Agent Discontinuation|0|||
94298818|NCT01731002|322878453|FG001|Overall Study|Test Agent Discontinuation|1|||
94298819|NCT01731002|322878454|FG002|Overall Study|Test Agent Discontinuation|0|||
94298820|NCT01731002|322878452|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
94298821|NCT01731002|322878453|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
94298822|NCT01731002|322878454|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
94298823|NCT01731002|322878452|FG000|Overall Study|Elevated IOP|1|||
94298824|NCT01731002|322878453|FG001|Overall Study|Elevated IOP|0|||
94298825|NCT01731002|322878454|FG002|Overall Study|Elevated IOP|0|||
94298826|NCT01731002|322878452|FG000|Overall Study|Inappropriate use of study medications|0|||
94298827|NCT01731002|322878453|FG001|Overall Study|Inappropriate use of study medications|0|||
94298828|NCT01731002|322878454|FG002|Overall Study|Inappropriate use of study medications|1|||
94298829|NCT00609622|322878455|FG000|Overall Study|Adverse Event|14|||
94298830|NCT00609622|322878456|FG001|Overall Study|Adverse Event|10|||
94298831|NCT00609622|322878455|FG000|Overall Study|Withdrawal by Subject|4|||
94372903|NCT00185211|323150373|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
94372904|NCT00185211|323150372|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
94372905|NCT00185211|323150373|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
94372906|NCT00185211|323150372|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
94372907|NCT00185211|323150373|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
94372908|NCT00185211|323150372|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
94372909|NCT00185211|323150373|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
94372910|NCT00185211|323150372|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
94372911|NCT00185211|323150373|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
94372912|NCT00185211|323150372|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
94372913|NCT00185211|323150373|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
94372914|NCT00185211|323150372|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
94372915|NCT00185211|323150373|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
94298832|NCT00609622|322878456|FG001|Overall Study|Withdrawal by Subject|20|||
94298833|NCT00609622|322878455|FG000|Overall Study|Death|1|||
94298834|NCT00609622|322878456|FG001|Overall Study|Death|4|||
94298835|NCT00609622|322878455|FG000|Overall Study|Protocol Violation|1|||
94298836|NCT00609622|322878456|FG001|Overall Study|Protocol Violation|1|||
94298837|NCT00609622|322878455|FG000|Overall Study|Objective progression or relapse|47|||
94298838|NCT00609622|322878456|FG001|Overall Study|Objective progression or relapse|41|||
94298839|NCT00609622|322878455|FG000|Overall Study|Study terminated by sponsor|16|||
94298840|NCT00609622|322878456|FG001|Overall Study|Study terminated by sponsor|3|||
94298841|NCT00609622|322878455|FG000|Overall Study|Other|7|||
94298842|NCT00609622|322878456|FG001|Overall Study|Other|14|||
94298843|NCT00609622|322878455|FG000|Overall Study|Global deterioration of health status|6|||
94298844|NCT00609622|322878456|FG001|Overall Study|Global deterioration of health status|2|||
94298845|NCT00686543|322878457|FG000|Overall Study|Adverse Event|9|||
94298846|NCT00686543|322878458|FG001|Overall Study|Adverse Event|1|||
94298847|NCT00686543|322878459|FG002|Overall Study|Adverse Event|3|||
94298848|NCT00686543|322878460|FG003|Overall Study|Adverse Event|2|||
94298849|NCT00686543|322878457|FG000|Overall Study|Withdrawal by Subject|2|||
94298850|NCT00686543|322878458|FG001|Overall Study|Withdrawal by Subject|0|||
94298851|NCT00686543|322878459|FG002|Overall Study|Withdrawal by Subject|0|||
94298852|NCT00686543|322878460|FG003|Overall Study|Withdrawal by Subject|0|||
94298853|NCT00686543|322878457|FG000|Overall Study|Protocol Violation|3|||
94298854|NCT00686543|322878458|FG001|Overall Study|Protocol Violation|0|||
94298855|NCT00686543|322878459|FG002|Overall Study|Protocol Violation|2|||
94298856|NCT00686543|322878460|FG003|Overall Study|Protocol Violation|1|||
94298857|NCT02370121|322878463|FG000|Overall Study|Lost to Follow-up|1|||
94298858|NCT02370121|322878464|FG001|Overall Study|Lost to Follow-up|1|||
94298859|NCT03542682|322878465|FG000|Overall Study|COVID-19 Protocol|0|||
94298860|NCT03542682|322878466|FG001|Overall Study|COVID-19 Protocol|1|||
94298861|NCT00785577|322878468|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
94298862|NCT00785577|322878469|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
94298863|NCT00785577|322878470|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
94298864|NCT00785577|322878471|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
94298865|NCT00785577|322878472|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
94298866|NCT00785577|322878468|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
94298867|NCT00785577|322878469|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
94298868|NCT00785577|322878470|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
94298869|NCT00785577|322878471|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
94298870|NCT00785577|322878472|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
94372916|NCT01070394|323150375|FG000|Overall Study|Adverse Event|6|||
94298871|NCT00785577|322878468|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
94298872|NCT00785577|322878469|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
94298873|NCT00785577|322878470|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
94298874|NCT00785577|322878471|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
94298875|NCT00785577|322878472|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
94298876|NCT00785577|322878468|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
94298877|NCT00785577|322878469|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
94298878|NCT00785577|322878470|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
94298879|NCT00785577|322878471|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
94298880|NCT00785577|322878472|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
94298881|NCT00785577|322878468|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
94298882|NCT00785577|322878469|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
94298883|NCT00785577|322878470|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
94298884|NCT00785577|322878471|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
94298885|NCT00785577|322878472|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
94298886|NCT00785577|322878468|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
94298887|NCT00785577|322878469|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
94298888|NCT00785577|322878470|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
94298889|NCT00785577|322878471|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
94298890|NCT00785577|322878472|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
94298891|NCT00785577|322878468|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
94298892|NCT00785577|322878469|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
94298893|NCT00785577|322878470|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
94298894|NCT00785577|322878471|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
94298895|NCT00785577|322878472|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
94298896|NCT00785577|322878468|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
94298897|NCT00785577|322878469|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
94298898|NCT00785577|322878470|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
94298899|NCT00785577|322878471|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
94298900|NCT00785577|322878472|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
94298901|NCT00785577|322878468|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
94298902|NCT00785577|322878469|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
94298903|NCT00785577|322878470|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
94298904|NCT00785577|322878471|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
94298905|NCT00785577|322878472|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
94298906|NCT00785577|322878468|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
94298907|NCT00785577|322878469|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
94298908|NCT00785577|322878470|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
94298909|NCT00785577|322878471|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
94298910|NCT00785577|322878472|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
94298911|NCT02770807|322878478|FG000|Overall Study|Adverse Event|3|||
94298912|NCT02770807|322878479|FG001|Overall Study|Adverse Event|3|||
94298913|NCT02770807|322878480|FG002|Overall Study|Adverse Event|1|||
94298914|NCT02770807|322878478|FG000|Overall Study|Withdrawal by Subject|7|||
94298915|NCT02770807|322878479|FG001|Overall Study|Withdrawal by Subject|3|||
94298916|NCT02770807|322878480|FG002|Overall Study|Withdrawal by Subject|4|||
94298917|NCT02770807|322878478|FG000|Overall Study|Other|0|||
94298918|NCT02770807|322878479|FG001|Overall Study|Other|1|||
94298919|NCT02770807|322878480|FG002|Overall Study|Other|0|||
94298920|NCT02770807|322878478|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
94298921|NCT02770807|322878479|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
94298922|NCT02770807|322878480|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
94298923|NCT02770807|322878478|FG000|Overall Study|Physician Decision|0|||
94298924|NCT02770807|322878479|FG001|Overall Study|Physician Decision|0|||
94298925|NCT02770807|322878480|FG002|Overall Study|Physician Decision|1|||
94298926|NCT03277196|322878481|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
94298927|NCT03277196|322878481|FG000|Overall Study|Lost to Follow-up|3|||
94298928|NCT03277196|322878481|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
94298929|NCT03277196|322878481|FG000|Overall Study|Other|2|||
94298930|NCT00260208|322879826|FG000|Overall Study|Subject withdrew consent|11|||
94298931|NCT00260208|322879827|FG001|Overall Study|Subject withdrew consent|7|||
94298932|NCT00260208|322879826|FG000|Overall Study|Lost to Follow-up|6|||
94298933|NCT00260208|322879827|FG001|Overall Study|Lost to Follow-up|1|||
94298934|NCT00260208|322879826|FG000|Overall Study|Death|12|||
94298935|NCT00260208|322879827|FG001|Overall Study|Death|10|||
94298936|NCT00260208|322879826|FG000|Overall Study|Missing|18|||
94298937|NCT00260208|322879827|FG001|Overall Study|Missing|16|||
94298938|NCT02468193|322879828|FG000|Overall Study|Adverse Event|4|||
94298939|NCT02468193|322879828|FG000|Overall Study|Subject/ Guardian decision|2|||
94298940|NCT00742781|322879830|FG000|Overall Study|Withdrawal by Subject|3|||
94298941|NCT01719757|322879831|FG000|Overall Study|Adverse Event|38|||
94298942|NCT01719757|322879831|FG000|Overall Study|Withdrawal by Subject|15|||
94298943|NCT01719757|322879831|FG000|Overall Study|Lost to Follow-up|20|||
94298944|NCT01719757|322879831|FG000|Overall Study|Protocol Violation|1|||
94298945|NCT01719757|322879831|FG000|Overall Study|well controlled pain|27|||
94298946|NCT00826748|322879832|FG000|Overall Study|Withdrawal by Subject|0|||
94298947|NCT00826748|322879833|FG001|Overall Study|Withdrawal by Subject|0|||
94298948|NCT00826748|322879834|FG002|Overall Study|Withdrawal by Subject|2|||
94298949|NCT00826748|322879832|FG000|Overall Study|Physician Decision|0|||
94298950|NCT00826748|322879833|FG001|Overall Study|Physician Decision|0|||
94298951|NCT00826748|322879834|FG002|Overall Study|Physician Decision|1|||
94468032|NCT01447927|323502487|FG000|Overall Study|Adverse Event|4|||
94298952|NCT00826748|322879832|FG000|Overall Study|Samples Did Not pass QC|0|||
94298953|NCT00826748|322879833|FG001|Overall Study|Samples Did Not pass QC|0|||
94298954|NCT00826748|322879834|FG002|Overall Study|Samples Did Not pass QC|1|||
94298955|NCT02698410|322879840|FG000|Overall Study|Adverse Event|2|||
94298956|NCT02698410|322879840|FG000|Overall Study|Withdrawal by Subject|1|||
94298957|NCT02698410|322879840|FG000|Overall Study|Other|1|||
94298958|NCT01901224|322879841|FG000|Overall Study|study was not funded and terminated|2|||
94298959|NCT00450580|322879842|FG000|Overall Study|Adverse Event|5|||
94298960|NCT00450580|322879843|FG001|Overall Study|Adverse Event|7|||
94298961|NCT00450580|322879842|FG000|Overall Study|Lost to Follow-up|4|||
94298962|NCT00450580|322879843|FG001|Overall Study|Lost to Follow-up|5|||
94298963|NCT00450580|322879842|FG000|Overall Study|Withdrawal by Subject|2|||
94298964|NCT00450580|322879843|FG001|Overall Study|Withdrawal by Subject|2|||
94298965|NCT00450580|322879842|FG000|Overall Study|Protocol Violation|1|||
94298966|NCT00450580|322879843|FG001|Overall Study|Protocol Violation|1|||
94298967|NCT00450580|322879842|FG000|Overall Study|Protocol-defined virologic failure|1|||
94298968|NCT00450580|322879843|FG001|Overall Study|Protocol-defined virologic failure|0|||
94298969|NCT00450580|322879842|FG000|Overall Study|Could not comply with scheduled visits|1|||
94298970|NCT00450580|322879843|FG001|Overall Study|Could not comply with scheduled visits|0|||
94298971|NCT00450580|322879842|FG000|Overall Study|Patient went to Brazil|1|||
94298972|NCT00450580|322879843|FG001|Overall Study|Patient went to Brazil|0|||
94298973|NCT00450580|322879842|FG000|Overall Study|Patient could not swallow Norvir|1|||
94298974|NCT00450580|322879843|FG001|Overall Study|Patient could not swallow Norvir|0|||
94298975|NCT00450580|322879842|FG000|Overall Study|Withdrawal due to pregnancy|0|||
94298976|NCT00450580|322879843|FG001|Overall Study|Withdrawal due to pregnancy|1|||
94298977|NCT03615222|322879845|FG000|Overall Study|Ineligible|26|||
94298978|NCT03615222|322879845|FG000|Overall Study|Withdrawal by Subject|7|||
94298979|NCT03615222|322879845|FG000|Overall Study|Death|1|||
94298980|NCT02210780|322879846|FG000|Overall Study|Adverse Event|0|||
94298981|NCT02210780|322879847|FG001|Overall Study|Adverse Event|5|||
94298982|NCT02210780|322879846|FG000|Overall Study|Lost to Follow-up|2|||
94298983|NCT02210780|322879847|FG001|Overall Study|Lost to Follow-up|1|||
94298984|NCT02210780|322879846|FG000|Overall Study|Withdrawal by Subject|1|||
94298985|NCT02210780|322879847|FG001|Overall Study|Withdrawal by Subject|1|||
94298986|NCT02210780|322879846|FG000|Overall Study|Physician Decision|1|||
94298987|NCT02210780|322879847|FG001|Overall Study|Physician Decision|0|||
94298988|NCT02210780|322879846|FG000|Overall Study|Protocol Violation|1|||
94298989|NCT02210780|322879847|FG001|Overall Study|Protocol Violation|0|||
94298990|NCT02210780|322879846|FG000|Overall Study|Other than specified above|0|||
94298991|NCT02210780|322879847|FG001|Overall Study|Other than specified above|1|||
94298992|NCT02360098|322879848|FG000|Overall Study|Physician Decision|7|||
94298993|NCT04938648|322879849|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
94298994|NCT04938648|322879850|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
94298995|NCT04938648|322879849|FG000|Overall Study|Patient too ill|0|||
94298996|NCT04938648|322879850|FG001|Overall Study|Patient too ill|1|||
94298997|NCT04938648|322879849|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
94298998|NCT04938648|322879850|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
94298999|NCT04938648|322879849|FG000|Overall Study|Patient did not have memory problems|1|||
94299000|NCT04938648|322879850|FG001|Overall Study|Patient did not have memory problems|1|||
94299001|NCT04938648|322879849|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
94299002|NCT04938648|322879850|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
94299003|NCT04938648|322879849|FG000|Overall Study|Care partner could not be reached|0|||
94299004|NCT04938648|322879850|FG001|Overall Study|Care partner could not be reached|1|||
94299005|NCT04938648|322879849|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
94299006|NCT04938648|322879850|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
94299007|NCT04938648|322879849|FG000|Overall Study|Withdrawal by Subject|2|||
94299008|NCT04938648|322879850|FG001|Overall Study|Withdrawal by Subject|1|||
94299009|NCT00364793|322879851|FG000|Overall Study|Adverse Event|2|||
94299010|NCT00364793|322879852|FG001|Overall Study|Adverse Event|0|||
94299011|NCT00364793|322879853|FG002|Overall Study|Adverse Event|0|||
94299012|NCT00364793|322879854|FG003|Overall Study|Adverse Event|0|||
94299013|NCT00364793|322879851|FG000|Overall Study|Death|1|||
94299014|NCT00364793|322879852|FG001|Overall Study|Death|0|||
94299015|NCT00364793|322879853|FG002|Overall Study|Death|1|||
94372917|NCT01070394|323150375|FG000|Overall Study|Withdrawal by Subject|1|||
94299016|NCT00364793|322879854|FG003|Overall Study|Death|0|||
94299017|NCT00364793|322879851|FG000|Overall Study|Lack of Efficacy|3|||
94299018|NCT00364793|322879852|FG001|Overall Study|Lack of Efficacy|3|||
94299019|NCT00364793|322879853|FG002|Overall Study|Lack of Efficacy|1|||
94299020|NCT00364793|322879854|FG003|Overall Study|Lack of Efficacy|1|||
94299021|NCT00364793|322879851|FG000|Overall Study|Lost to Follow-up|1|||
94299022|NCT00364793|322879852|FG001|Overall Study|Lost to Follow-up|0|||
94372918|NCT01098240|323150376|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
94299023|NCT00364793|322879853|FG002|Overall Study|Lost to Follow-up|2|||
94299024|NCT00364793|322879854|FG003|Overall Study|Lost to Follow-up|0|||
94468033|NCT01447927|323502488|FG001|Overall Study|Adverse Event|3|||
94299025|NCT00364793|322879851|FG000|Overall Study|Poor or non-compliance|1|||
94299026|NCT00364793|322879852|FG001|Overall Study|Poor or non-compliance|1|||
94299027|NCT00364793|322879853|FG002|Overall Study|Poor or non-compliance|0|||
94299028|NCT00364793|322879854|FG003|Overall Study|Poor or non-compliance|1|||
94299029|NCT00364793|322879851|FG000|Overall Study|No longer meets criteria|0|||
94299030|NCT00364793|322879852|FG001|Overall Study|No longer meets criteria|0|||
94299031|NCT00364793|322879853|FG002|Overall Study|No longer meets criteria|0|||
94299032|NCT00364793|322879854|FG003|Overall Study|No longer meets criteria|1|||
94299033|NCT00364793|322879851|FG000|Overall Study|Withdrawal by Subject|0|||
94299034|NCT00364793|322879852|FG001|Overall Study|Withdrawal by Subject|1|||
94299035|NCT00364793|322879853|FG002|Overall Study|Withdrawal by Subject|0|||
94299036|NCT00364793|322879854|FG003|Overall Study|Withdrawal by Subject|0|||
94299037|NCT02966314|322879855|FG000|Overall Study|Lost to Follow-up|1|||
94299038|NCT02966314|322879856|FG001|Overall Study|Lost to Follow-up|0|||
94299039|NCT00391976|322879857|FG000|Overall Study|Adverse Event|0|||
94299040|NCT00391976|322879858|FG001|Overall Study|Adverse Event|0|||
94299041|NCT00391976|322879859|FG002|Overall Study|Adverse Event|1|||
94299042|NCT00391976|322879857|FG000|Overall Study|Withdrawal of consent|0|||
94299043|NCT00391976|322879858|FG001|Overall Study|Withdrawal of consent|1|||
94299044|NCT00391976|322879859|FG002|Overall Study|Withdrawal of consent|1|||
94299045|NCT00391976|322879857|FG000|Overall Study|Lost to Follow-up|1|||
94299046|NCT00391976|322879858|FG001|Overall Study|Lost to Follow-up|2|||
94299047|NCT00391976|322879859|FG002|Overall Study|Lost to Follow-up|0|||
94299048|NCT00391976|322879857|FG000|Overall Study|Inappropriate enrollment|1|||
94299049|NCT00391976|322879858|FG001|Overall Study|Inappropriate enrollment|1|||
94299050|NCT00391976|322879859|FG002|Overall Study|Inappropriate enrollment|0|||
94299051|NCT00391976|322879857|FG000|Overall Study|Protocol deviation/violation|4|||
94299052|NCT00391976|322879858|FG001|Overall Study|Protocol deviation/violation|2|||
94299053|NCT00391976|322879859|FG002|Overall Study|Protocol deviation/violation|1|||
94299054|NCT00391976|322879857|FG000|Overall Study|Recurrence/no eradication of infection|21|||
94299055|NCT00391976|322879858|FG001|Overall Study|Recurrence/no eradication of infection|19|||
94299056|NCT00391976|322879859|FG002|Overall Study|Recurrence/no eradication of infection|0|||
94299057|NCT00391976|322879857|FG000|Overall Study|Unable to classify|0|||
94299058|NCT00391976|322879858|FG001|Overall Study|Unable to classify|0|||
94299059|NCT00391976|322879859|FG002|Overall Study|Unable to classify|1|||
94299060|NCT00391976|322879857|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
94299061|NCT00391976|322879858|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
94299062|NCT00391976|322879859|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
94299063|NCT00049127|322879860|FG000|Overall Study|Withdrawal by Subject|0|||
94299064|NCT00049127|322879861|FG001|Overall Study|Withdrawal by Subject|0|||
94299065|NCT00049127|322879862|FG002|Overall Study|Withdrawal by Subject|1|||
94299066|NCT00049127|322879863|FG003|Overall Study|Withdrawal by Subject|0|||
94299067|NCT00049127|322879864|FG004|Overall Study|Withdrawal by Subject|0|||
94299068|NCT01919307|322879865|FG000|Overall Study|Withdrawal by Subject|9|||
94299069|NCT00775021|322879869|FG000|First Intervention|Lost to Follow-up|1|||
94299070|NCT00775021|322879870|FG001|First Intervention|Lost to Follow-up|0|||
94299071|NCT00775021|322879869|FG000|Second Intervention|Adverse Event|0|||
94299072|NCT00775021|322879870|FG001|Second Intervention|Adverse Event|1|||
94299073|NCT01725165|322879873|FG000|Overall Study|Death|11|||
94299074|NCT01725165|322879874|FG001|Overall Study|Death|18|||
94299075|NCT02725788|322879875|FG000|Overall Study|Lost to Follow-up|1|||
94299076|NCT02725788|322879876|FG001|Overall Study|Lost to Follow-up|1|||
94299077|NCT02725788|322879875|FG000|Overall Study|Protocol Violation|0|||
94299078|NCT02725788|322879876|FG001|Overall Study|Protocol Violation|1|||
94299079|NCT02688647|322879879|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
94299080|NCT02688647|322879880|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
94299081|NCT02688647|322879879|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
94299082|NCT02688647|322879880|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
94299083|NCT02688647|322879879|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
94299084|NCT02688647|322879880|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
94299085|NCT02688647|322879879|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
94299086|NCT02688647|322879880|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
94299087|NCT02688647|322879879|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
94299088|NCT02688647|322879880|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
94299089|NCT02688647|322879879|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
94299090|NCT02688647|322879880|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
94299091|NCT02688647|322879879|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
94299092|NCT02688647|322879880|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
94299093|NCT00382967|322879881|FG000|Overall Study|Protocol Violation|1|||
94299094|NCT00382967|322879882|FG001|Overall Study|Protocol Violation|1|||
94299095|NCT02197377|322879883|FG000|Overall Study|Insertion Failure|0|||
94468034|NCT01447927|323502487|FG000|Overall Study|Withdrawal by Subject|1|||
94299096|NCT02197377|322879884|FG001|Overall Study|Insertion Failure|3|||
94299097|NCT00195650|322879885|FG000|Overall Study|Adverse Event|194|||
94299098|NCT00195650|322879885|FG000|Overall Study|Lack of Efficacy|99|||
94299099|NCT00195650|322879885|FG000|Overall Study|Withdrawal by Subject|67|||
94299100|NCT00195650|322879885|FG000|Overall Study|Lost to Follow-up|44|||
94299101|NCT00195650|322879885|FG000|Overall Study|Death|23|||
94299102|NCT00195650|322879885|FG000|Overall Study|Protocol Violation|15|||
94299103|NCT00195650|322879885|FG000|Overall Study|Administrative reasons|83|||
94299104|NCT01120626|322879886|FG000|Overall Study|Withdrawal by Subject|1|||
94299105|NCT01120626|322879887|FG001|Overall Study|Withdrawal by Subject|0|||
94299106|NCT02635204|322879888|FG000|Overall Study|Adverse Event|1|||
94299107|NCT02635204|322879889|FG001|Overall Study|Adverse Event|0|||
94299108|NCT02635204|322879888|FG000|Overall Study|Lost to Follow-up|1|||
94299109|NCT02635204|322879889|FG001|Overall Study|Lost to Follow-up|1|||
94299110|NCT03075839|322879891|FG000|Overall Study|Lost to Follow-up|4|||
94299111|NCT03830281|322879893|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
94299112|NCT03830281|322879894|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
94299113|NCT03830281|322879893|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
94299114|NCT03830281|322879894|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
94299115|NCT03830281|322879893|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
94299116|NCT03830281|322879894|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
94299117|NCT03830281|322879893|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
94299118|NCT03830281|322879894|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
94299119|NCT03830281|322879893|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
94299120|NCT03830281|322879894|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
94299121|NCT03830281|322879893|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
94299122|NCT03830281|322879894|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
94299123|NCT03830281|322879893|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
94299124|NCT03830281|322879894|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
94299125|NCT03830281|322879893|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
94299126|NCT03830281|322879894|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
94299127|NCT03830281|322879893|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
94299128|NCT03830281|322879894|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
94299129|NCT00201851|322879895|FG000|Overall Study|Lost to Follow-up|2|||
94299130|NCT00201851|322879896|FG001|Overall Study|Lost to Follow-up|1|||
94299131|NCT00201851|322879897|FG002|Overall Study|Lost to Follow-up|0|||
94299132|NCT00201851|322879895|FG000|Overall Study|Ineligible post enrollment|6|||
94299133|NCT00201851|322879896|FG001|Overall Study|Ineligible post enrollment|1|||
94299134|NCT00201851|322879897|FG002|Overall Study|Ineligible post enrollment|1|||
94299135|NCT02469246|322879898|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
94299136|NCT02469246|322879899|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
94299137|NCT02469246|322879898|FG000|Double-Blind Phase|Adverse Event|12|||
94299138|NCT02469246|322879899|FG001|Double-Blind Phase|Adverse Event|9|||
94299139|NCT02469246|322879898|FG000|Double-Blind Phase|Death|2|||
94299140|NCT02469246|322879899|FG001|Double-Blind Phase|Death|0|||
94299141|NCT02469246|322879898|FG000|Double-Blind Phase|Lack of Efficacy|2|||
94299142|NCT02469246|322879899|FG001|Double-Blind Phase|Lack of Efficacy|1|||
94299143|NCT02469246|322879898|FG000|Double-Blind Phase|Investigator's Discretion|8|||
94299144|NCT02469246|322879899|FG001|Double-Blind Phase|Investigator's Discretion|8|||
94299145|NCT02469246|322879898|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
94299146|NCT02469246|322879899|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
94299147|NCT02469246|322879898|FG000|Double-Blind Phase|Protocol Violation|1|||
94299148|NCT02469246|322879899|FG001|Double-Blind Phase|Protocol Violation|1|||
94299149|NCT02469246|322879898|FG000|Double-Blind Phase|Withdrew Consent|25|||
94299150|NCT02469246|322879899|FG001|Double-Blind Phase|Withdrew Consent|25|||
94299151|NCT02469246|322879898|FG000|Double-Blind Phase|Lost to Follow-up|9|||
94372919|NCT01098240|323150377|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
94372920|NCT01098240|323150378|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
94372921|NCT01098240|323150376|FG000|Open-Label Phase|Protocol Violation|4|||
94372922|NCT01098240|323150377|FG001|Open-Label Phase|Protocol Violation|0|||
94372923|NCT01098240|323150378|FG002|Open-Label Phase|Protocol Violation|0|||
94372924|NCT01098240|323150376|FG000|Open-Label Phase|Lost to Follow-up|13|||
94372925|NCT01098240|323150377|FG001|Open-Label Phase|Lost to Follow-up|0|||
94372926|NCT01098240|323150378|FG002|Open-Label Phase|Lost to Follow-up|0|||
94372927|NCT01098240|323150376|FG000|Open-Label Phase|Other|19|||
94372928|NCT01098240|323150377|FG001|Open-Label Phase|Other|0|||
94372929|NCT01098240|323150378|FG002|Open-Label Phase|Other|0|||
94372930|NCT01098240|323150376|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
94372931|NCT01098240|323150377|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
94372932|NCT01098240|323150378|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
94372933|NCT01098240|323150376|FG000|Open-Label Phase|Pregnancy|1|||
94299152|NCT02469246|322879899|FG001|Double-Blind Phase|Lost to Follow-up|5|||
94372934|NCT01098240|323150377|FG001|Open-Label Phase|Pregnancy|0|||
94299153|NCT01491945|322879900|FG000|Overall Study|Death|30|||
94299154|NCT01491945|322879900|FG000|Overall Study|Withdrwan/LTF|16|||
94299155|NCT01491945|322879900|FG000|Overall Study|Conversion|4|||
94372935|NCT01098240|323150378|FG002|Open-Label Phase|Pregnancy|0|||
94299156|NCT01491945|322879900|FG000|Overall Study|Missed Visit|1|||
94299157|NCT00074958|322879901|FG000|Overall Study|Adverse Event|1|||
94299158|NCT03770403|322879902|FG000|Overall Study|Adverse Event|8|||
94299159|NCT03770403|322879902|FG000|Overall Study|Death|5|||
94299160|NCT03770403|322879902|FG000|Overall Study|Physician Decision|1|||
94299161|NCT03770403|322879902|FG000|Overall Study|Sponsor decision|1|||
94299162|NCT03770403|322879902|FG000|Overall Study|Study terminated by Sponsor|1|||
94299163|NCT03770403|322879902|FG000|Overall Study|Withdrawal by Subject|13|||
94299164|NCT03770403|322879902|FG000|Overall Study|Other|88|||
94299165|NCT02115308|322879921|FG000|Overall Study|Safety Screening|2|||
94299166|NCT02115308|322879922|FG001|Overall Study|Safety Screening|2|||
94299167|NCT00613626|322879928|FG000|Overall Study|Ineligible|0|||
94299168|NCT00613626|322879929|FG001|Overall Study|Ineligible|1|||
94299169|NCT00613626|322879930|FG002|Overall Study|Ineligible|0|||
94299170|NCT00784758|322879931|FG000|Overall Study|Withdrawal by Subject|3|||
94299171|NCT00784758|322879932|FG001|Overall Study|Withdrawal by Subject|0|||
94299172|NCT00784758|322879931|FG000|Overall Study|Adverse Event|1|||
94299173|NCT00784758|322879932|FG001|Overall Study|Adverse Event|0|||
94299174|NCT02597062|322879934|FG000|Overall Study|Ineligible|1|||
94299175|NCT00741819|322879935|FG000|Overall Study|Adverse Event|3|||
94299176|NCT00741819|322879935|FG000|Overall Study|Withdrawal by Subject|3|||
94299177|NCT00741819|322879935|FG000|Overall Study|Death|1|||
94299178|NCT00741819|322879935|FG000|Overall Study|Disease progression|1|||
94299179|NCT01053429|322879938|FG000|Overall Study|Adverse Event|64|||
94299180|NCT01053429|322879938|FG000|Overall Study|Other|309|||
94299181|NCT00752986|322879941|FG000|Overall Study|Withdrawal by Subject|2|||
94299182|NCT00752986|322879942|FG001|Overall Study|Withdrawal by Subject|1|||
94299183|NCT00752986|322879943|FG002|Overall Study|Withdrawal by Subject|2|||
94299184|NCT00752986|322879941|FG000|Overall Study|Protocol Violation|3|||
94299185|NCT00752986|322879942|FG001|Overall Study|Protocol Violation|0|||
94299186|NCT00752986|322879943|FG002|Overall Study|Protocol Violation|0|||
94299187|NCT02970929|322879946|FG000|Overall Study|Adverse Event|18|||
94299188|NCT02970929|322879946|FG000|Overall Study|Lack of Efficacy|8|||
94299189|NCT02970929|322879946|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
94299190|NCT02970929|322879946|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
94299191|NCT02970929|322879946|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
94299192|NCT02970929|322879946|FG000|Overall Study|LOST TO FOLLOWUP|6|||
94299193|NCT02970929|322879946|FG000|Overall Study|MOVED OUT OF STATE|1|||
94299194|NCT02970929|322879946|FG000|Overall Study|Withdrawal by Subject|16|||
94299195|NCT05369806|322879947|FG000|Overall Study|Lost to Follow-up|1|||
94299196|NCT00140855|322879948|FG000|Overall Study|Progressive disease|2|||
94299197|NCT02732951|322881906|FG000|Overall Study|Other than listed|1|||
94299198|NCT02732951|322881907|FG001|Overall Study|Other than listed|0|||
94299199|NCT02732951|322881906|FG000|Overall Study|Lost to Follow-up|0|||
94299200|NCT02732951|322881907|FG001|Overall Study|Lost to Follow-up|1|||
94299201|NCT02732951|322881906|FG000|Overall Study|Adverse Event|4|||
94299202|NCT02732951|322881907|FG001|Overall Study|Adverse Event|4|||
94299203|NCT02732951|322881906|FG000|Overall Study|Protocol Violation|0|||
94299204|NCT02732951|322881907|FG001|Overall Study|Protocol Violation|1|||
94299205|NCT01750918|322881908|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
94299206|NCT01750918|322881909|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
94299207|NCT01750918|322881910|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
94299208|NCT01750918|322881911|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
94299209|NCT01750918|322881912|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
94299210|NCT01750918|322881913|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
94299211|NCT01750918|322881914|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
94299212|NCT01750918|322881915|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
94299213|NCT01750918|322881908|FG000|Overall Study|Lost to Follow-up|0|||
94299214|NCT01750918|322881909|FG001|Overall Study|Lost to Follow-up|0|||
94299215|NCT01750918|322881910|FG002|Overall Study|Lost to Follow-up|2|||
94299216|NCT01750918|322881911|FG003|Overall Study|Lost to Follow-up|2|||
94299217|NCT01750918|322881912|FG004|Overall Study|Lost to Follow-up|0|||
94299218|NCT01750918|322881913|FG005|Overall Study|Lost to Follow-up|0|||
94299219|NCT01750918|322881914|FG006|Overall Study|Lost to Follow-up|0|||
94299220|NCT01750918|322881915|FG007|Overall Study|Lost to Follow-up|1|||
94299221|NCT01750918|322881908|FG000|Overall Study|Withdrawal by Subject|0|||
94299222|NCT01750918|322881909|FG001|Overall Study|Withdrawal by Subject|0|||
94299223|NCT01750918|322881910|FG002|Overall Study|Withdrawal by Subject|1|||
94299224|NCT01750918|322881911|FG003|Overall Study|Withdrawal by Subject|2|||
94299225|NCT01750918|322881912|FG004|Overall Study|Withdrawal by Subject|1|||
94299226|NCT01750918|322881913|FG005|Overall Study|Withdrawal by Subject|1|||
94299227|NCT01750918|322881914|FG006|Overall Study|Withdrawal by Subject|2|||
94299228|NCT01750918|322881915|FG007|Overall Study|Withdrawal by Subject|2|||
94299229|NCT00075881|322881917|FG000|Overall Study|Lack of Efficacy|18|||
94299230|NCT00075881|322881917|FG000|Overall Study|Adverse Event|7|||
94299231|NCT00075881|322881917|FG000|Overall Study|Death|1|||
94299232|NCT00075881|322881917|FG000|Overall Study|Withdrawal by Subject|2|||
94299233|NCT00075881|322881917|FG000|Overall Study|Protocol Violation|4|||
94299234|NCT00075881|322881917|FG000|Overall Study|other complicating disease|3|||
94299235|NCT00075881|322881917|FG000|Overall Study|other|4|||
94299236|NCT00075881|322881917|FG000|Overall Study|missing data|2|||
94299237|NCT00075881|322881917|FG000|Overall Study|Ineligible|1|||
94299238|NCT00075881|322881917|FG000|Overall Study|never start protocol therapy|1|||
94299239|NCT00206726|322881919|FG000|Overall Study|Delayed recovery of blood counts|1|||
94299240|NCT00206726|322881919|FG000|Overall Study|Progressive disease or relapsed disease|18|||
94299241|NCT00206726|322881919|FG000|Overall Study|Placed on new protocol|1|||
94299242|NCT00206726|322881919|FG000|Overall Study|Bone marrow transplant|1|||
94299243|NCT00206726|322881919|FG000|Overall Study|Adverse Event|17|||
94299244|NCT00206726|322881919|FG000|Overall Study|Death|4|||
94299245|NCT00206726|322881919|FG000|Overall Study|Protocol Violation|1|||
94299246|NCT00206726|322881919|FG000|Overall Study|Withdrawal by Subject|8|||
94299247|NCT02626338|322881922|FG000|Overall Study|Lack of Efficacy|3|||
94299248|NCT02626338|322881923|FG001|Overall Study|Lack of Efficacy|2|||
94299249|NCT02626338|322881924|FG002|Overall Study|Lack of Efficacy|0|||
94299250|NCT01896232|322881927|FG000|Overall Study|Death|6|||
94299251|NCT01896232|322881928|FG001|Overall Study|Death|10|||
94299252|NCT01896232|322881927|FG000|Overall Study|Withdrawal by Subject|32|||
94299253|NCT01896232|322881928|FG001|Overall Study|Withdrawal by Subject|31|||
94299254|NCT01896232|322881927|FG000|Overall Study|Sponsor Decision|2|||
94299255|NCT01896232|322881928|FG001|Overall Study|Sponsor Decision|0|||
94299256|NCT01896232|322881927|FG000|Overall Study|Lost to Follow-up|9|||
94299257|NCT01896232|322881928|FG001|Overall Study|Lost to Follow-up|12|||
94299258|NCT02665689|322881929|FG000|Overall Study|Adverse Event|1|||
94299259|NCT02665689|322881930|FG001|Overall Study|Adverse Event|0|||
94299260|NCT02665689|322881929|FG000|Overall Study|Trial termination|1|||
94299261|NCT02665689|322881930|FG001|Overall Study|Trial termination|1|||
94299262|NCT02665689|322881929|FG000|Overall Study|Lost to Follow-up|0|||
94299263|NCT02665689|322881930|FG001|Overall Study|Lost to Follow-up|1|||
94299264|NCT00331760|322881933|FG000|Overall Study|Ineligible / no protocol treatment|15|||
94299265|NCT00331760|322881934|FG001|Overall Study|Ineligible / no protocol treatment|8|||
94299266|NCT02561156|322881936|FG000|Part 2|Adverse Event|0|||
94299267|NCT02561156|322881937|FG001|Part 2|Adverse Event|0|||
94299268|NCT02561156|322881938|FG002|Part 2|Adverse Event|0|||
94299269|NCT02561156|322881939|FG003|Part 2|Adverse Event|0|||
94299270|NCT02561156|322881940|FG004|Part 2|Adverse Event|0|||
94299271|NCT02561156|322881941|FG005|Part 2|Adverse Event|0|||
94299272|NCT02561156|322881942|FG006|Part 2|Adverse Event|0|||
94299273|NCT02561156|322881943|FG007|Part 2|Adverse Event|0|||
94299274|NCT02561156|322881944|FG008|Part 2|Adverse Event|0|||
94299275|NCT02561156|322881945|FG009|Part 2|Adverse Event|0|||
94299276|NCT02561156|322881946|FG010|Part 2|Adverse Event|0|||
94299277|NCT02561156|322881947|FG011|Part 2|Adverse Event|1|||
94299278|NCT02561156|322881948|FG012|Part 2|Adverse Event|0|||
94299279|NCT04927312|322881949|FG000|Overall Study|Adverse Event|1|||
94299280|NCT04927312|322881949|FG000|Overall Study|Death|1|||
94299281|NCT04927312|322881949|FG000|Overall Study|Withdrawal by Subject|1|||
94299282|NCT04927312|322881949|FG000|Overall Study|Other|1|||
94299283|NCT00860470|322881957|FG000|Overall Study|Death|6|||
94299284|NCT00860470|322881958|FG001|Overall Study|Death|10|||
94299285|NCT00860470|322881957|FG000|Overall Study|Moved away|8|||
94299286|NCT00860470|322881958|FG001|Overall Study|Moved away|10|||
94299287|NCT00860470|322881957|FG000|Overall Study|Lost to Follow-up|34|||
94299288|NCT00860470|322881958|FG001|Overall Study|Lost to Follow-up|39|||
94299289|NCT01122927|322881968|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
94299290|NCT01122927|322881969|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
94299291|NCT01122927|322881968|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
94299292|NCT01122927|322881969|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
94299293|NCT01122927|322881968|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
94299294|NCT01122927|322881969|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
94468035|NCT01447927|323502488|FG001|Overall Study|Withdrawal by Subject|0|||
94299295|NCT01122927|322881968|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
94299296|NCT01122927|322881969|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
94299297|NCT01122927|322881968|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
94299298|NCT01122927|322881969|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
94299299|NCT01122927|322881968|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
94299300|NCT01122927|322881969|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
94299301|NCT01122927|322881968|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
94299302|NCT01122927|322881969|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
94299303|NCT01122927|322881968|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
94299304|NCT01122927|322881969|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
94299305|NCT01122927|322881968|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
94299306|NCT01122927|322881969|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
94299307|NCT01122927|322881968|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
94299308|NCT01122927|322881969|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
94299309|NCT01122927|322881968|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
94299310|NCT01122927|322881969|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
94299311|NCT01122927|322881968|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
94299312|NCT01122927|322881969|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
94299313|NCT00929240|322881970|FG000|Initial Treatment Phase|Adverse Event|31|||
94299314|NCT00929240|322881971|FG001|Initial Treatment Phase|Adverse Event|0|||
94299315|NCT00929240|322881972|FG002|Initial Treatment Phase|Adverse Event|0|||
94299316|NCT00929240|322881970|FG000|Initial Treatment Phase|Disease progression|41|||
94372936|NCT01098240|323150376|FG000|Open-Label Phase|Withdrawal by Subject|9|||
94372937|NCT01098240|323150377|FG001|Open-Label Phase|Withdrawal by Subject|0|||
94372938|NCT01098240|323150378|FG002|Open-Label Phase|Withdrawal by Subject|0|||
94372939|NCT01098240|323150376|FG000|Open-Label Phase|Adverse Event|12|||
94372940|NCT01098240|323150377|FG001|Open-Label Phase|Adverse Event|0|||
94372941|NCT01098240|323150378|FG002|Open-Label Phase|Adverse Event|0|||
94372942|NCT01098240|323150376|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
94372943|NCT01098240|323150377|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
94372944|NCT01098240|323150378|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
94372945|NCT01098240|323150376|FG000|Double-Blind Phase|Protocol Violation|0|||
94372946|NCT01098240|323150377|FG001|Double-Blind Phase|Protocol Violation|2|||
94372947|NCT01098240|323150378|FG002|Double-Blind Phase|Protocol Violation|4|||
94372948|NCT01098240|323150376|FG000|Double-Blind Phase|Lost to Follow-up|0|||
94372949|NCT01098240|323150377|FG001|Double-Blind Phase|Lost to Follow-up|2|||
94372950|NCT01098240|323150378|FG002|Double-Blind Phase|Lost to Follow-up|0|||
94372951|NCT01098240|323150376|FG000|Double-Blind Phase|Other|0|||
94372952|NCT01098240|323150377|FG001|Double-Blind Phase|Other|2|||
94372953|NCT01098240|323150378|FG002|Double-Blind Phase|Other|2|||
94372954|NCT01098240|323150376|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
94372955|NCT01098240|323150377|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
94372956|NCT01098240|323150378|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
94372957|NCT01098240|323150376|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
94372958|NCT01098240|323150377|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
94372959|NCT01098240|323150378|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
94372960|NCT01098240|323150376|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
94372961|NCT01098240|323150377|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
94372962|NCT01098240|323150378|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
94372963|NCT01098240|323150376|FG000|Double-Blind Phase|Adverse Event|0|||
94372964|NCT01098240|323150377|FG001|Double-Blind Phase|Adverse Event|3|||
94372965|NCT01098240|323150378|FG002|Double-Blind Phase|Adverse Event|3|||
94372966|NCT02094937|323150379|FG000|8 Weeks in Period 1|Adverse Event|9|||
94372967|NCT02094937|323150380|FG001|8 Weeks in Period 1|Adverse Event|0|||
94372968|NCT02094937|323150381|FG002|8 Weeks in Period 1|Adverse Event|0|||
94372969|NCT02094937|323150382|FG003|8 Weeks in Period 1|Adverse Event|0|||
94372970|NCT02094937|323150379|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
94372971|NCT02094937|323150380|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
94372972|NCT02094937|323150381|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
94372973|NCT02094937|323150382|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
94372974|NCT02094937|323150379|FG000|8 Weeks in Period 1|Protocol Violation|2|||
94372975|NCT02094937|323150380|FG001|8 Weeks in Period 1|Protocol Violation|0|||
94372976|NCT02094937|323150381|FG002|8 Weeks in Period 1|Protocol Violation|0|||
94372977|NCT02094937|323150382|FG003|8 Weeks in Period 1|Protocol Violation|0|||
94372978|NCT02094937|323150379|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
94372979|NCT02094937|323150380|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
94372980|NCT02094937|323150381|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
94372981|NCT02094937|323150382|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
94372982|NCT02094937|323150379|FG000|8 Weeks in Period 1|Physician Decision|1|||
94372983|NCT02094937|323150380|FG001|8 Weeks in Period 1|Physician Decision|0|||
94372984|NCT02094937|323150381|FG002|8 Weeks in Period 1|Physician Decision|0|||
94372985|NCT02094937|323150382|FG003|8 Weeks in Period 1|Physician Decision|0|||
94299317|NCT00929240|322881971|FG001|Initial Treatment Phase|Disease progression|0|||
94372986|NCT02094937|323150379|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
94372987|NCT02094937|323150380|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
94372988|NCT02094937|323150381|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
94372989|NCT02094937|323150382|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
94372990|NCT02094937|323150379|FG000|12 Weeks in Period 2|Adverse Event|0|||
94372991|NCT02094937|323150380|FG001|12 Weeks in Period 2|Adverse Event|2|||
94372992|NCT02094937|323150381|FG002|12 Weeks in Period 2|Adverse Event|4|||
94372993|NCT02094937|323150382|FG003|12 Weeks in Period 2|Adverse Event|1|||
94299318|NCT00929240|322881972|FG002|Initial Treatment Phase|Disease progression|0|||
94372994|NCT02094937|323150379|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
94372995|NCT02094937|323150380|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
94372996|NCT02094937|323150381|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
94372997|NCT02094937|323150382|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
94372998|NCT02094937|323150379|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
94299319|NCT00929240|322881970|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
94299320|NCT00929240|322881971|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
94299321|NCT00929240|322881972|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
94299322|NCT00929240|322881970|FG000|Initial Treatment Phase|Protocol Violation|5|||
94299323|NCT00929240|322881971|FG001|Initial Treatment Phase|Protocol Violation|0|||
94299324|NCT00929240|322881972|FG002|Initial Treatment Phase|Protocol Violation|0|||
94299325|NCT00929240|322881970|FG000|Initial Treatment Phase|Death|2|||
94299326|NCT00929240|322881971|FG001|Initial Treatment Phase|Death|0|||
94299327|NCT00929240|322881972|FG002|Initial Treatment Phase|Death|0|||
94299328|NCT00929240|322881970|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
94299329|NCT00929240|322881971|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
94299330|NCT00929240|322881972|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
94299331|NCT00929240|322881970|FG000|Initial Treatment Phase|Physician Decision|4|||
94299332|NCT00929240|322881971|FG001|Initial Treatment Phase|Physician Decision|0|||
94299333|NCT00929240|322881972|FG002|Initial Treatment Phase|Physician Decision|0|||
94299334|NCT00929240|322881970|FG000|Maintenance Phase|Disease progression|0|||
94299335|NCT00929240|322881971|FG001|Maintenance Phase|Disease progression|73|||
94299336|NCT00929240|322881972|FG002|Maintenance Phase|Disease progression|60|||
94299337|NCT00929240|322881970|FG000|Maintenance Phase|Adverse Event|0|||
94299338|NCT00929240|322881971|FG001|Maintenance Phase|Adverse Event|9|||
94299339|NCT00929240|322881972|FG002|Maintenance Phase|Adverse Event|12|||
94299340|NCT00929240|322881970|FG000|Maintenance Phase|Withdrawal by Subject|0|||
94299341|NCT00929240|322881971|FG001|Maintenance Phase|Withdrawal by Subject|2|||
94299342|NCT00929240|322881972|FG002|Maintenance Phase|Withdrawal by Subject|6|||
94299343|NCT00929240|322881970|FG000|Maintenance Phase|Protocol Violation|0|||
94299344|NCT00929240|322881971|FG001|Maintenance Phase|Protocol Violation|1|||
94299345|NCT00929240|322881972|FG002|Maintenance Phase|Protocol Violation|0|||
94299346|NCT00929240|322881970|FG000|Maintenance Phase|Health authority/Study termination|0|||
94299347|NCT00929240|322881971|FG001|Maintenance Phase|Health authority/Study termination|1|||
94299348|NCT00929240|322881972|FG002|Maintenance Phase|Health authority/Study termination|2|||
94299349|NCT00929240|322881970|FG000|Maintenance Phase|Physician Decision|0|||
94299350|NCT00929240|322881971|FG001|Maintenance Phase|Physician Decision|2|||
94299351|NCT00929240|322881972|FG002|Maintenance Phase|Physician Decision|1|||
94468036|NCT02073565|323502489|FG000|Cohort A|Withdrawal by Subject|1|||
94468037|NCT02073565|323502490|FG001|Cohort A|Withdrawal by Subject|0|||
94468038|NCT02073565|323502489|FG000|Cohort B|Withdrawal by Subject|1|||
94468039|NCT02073565|323502490|FG001|Cohort B|Withdrawal by Subject|2|||
94468040|NCT02073565|323502489|FG000|Cohort C|Withdrawal by Subject|0|||
94299352|NCT00929240|322881970|FG000|Maintenance Phase|Change of treatment|0|||
94299353|NCT00929240|322881971|FG001|Maintenance Phase|Change of treatment|4|||
94299354|NCT00929240|322881972|FG002|Maintenance Phase|Change of treatment|0|||
94299355|NCT00929240|322881970|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
94299356|NCT00929240|322881971|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
94299357|NCT00929240|322881972|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
94299358|NCT00929240|322881970|FG000|Maintenance Phase|Participant not treated|0|||
94299359|NCT00929240|322881971|FG001|Maintenance Phase|Participant not treated|2|||
94299360|NCT00929240|322881972|FG002|Maintenance Phase|Participant not treated|0|||
94299361|NCT00684814|322881975|FG000|Washout Period of 7 Days|Adverse Event|1|||
94299362|NCT00684814|322881976|FG001|Washout Period of 7 Days|Adverse Event|2|||
94299363|NCT00684814|322881975|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
94299364|NCT00684814|322881976|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
94299365|NCT00684814|322881975|FG000|Second Intervention|Adverse Event|1|||
94299366|NCT00684814|322881976|FG001|Second Intervention|Adverse Event|0|||
94372999|NCT02094937|323150380|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
94373000|NCT02094937|323150381|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
94373001|NCT02094937|323150382|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
94373002|NCT02094937|323150379|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
94373003|NCT02094937|323150380|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
94373004|NCT02094937|323150381|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
94373005|NCT02094937|323150382|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
94373006|NCT02094937|323150379|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
94373007|NCT02094937|323150380|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
94373008|NCT02094937|323150381|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
94373009|NCT02094937|323150382|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
94299367|NCT01276288|322881977|FG000|Overall Study|Adverse Event|1|||
94373010|NCT01715415|323150383|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
94468041|NCT02073565|323502490|FG001|Cohort C|Withdrawal by Subject|2|||
94299368|NCT01276288|322881978|FG001|Overall Study|Adverse Event|1|||
94299369|NCT01276288|322881979|FG002|Overall Study|Adverse Event|0|||
94299370|NCT01276288|322881980|FG003|Overall Study|Adverse Event|0|||
94299371|NCT01276288|322881977|FG000|Overall Study|not treated|1|||
94299372|NCT01276288|322881978|FG001|Overall Study|not treated|0|||
94299373|NCT01276288|322881979|FG002|Overall Study|not treated|0|||
94299374|NCT01276288|322881980|FG003|Overall Study|not treated|0|||
94299375|NCT02537678|322881981|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
94299376|NCT02537678|322881982|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
94299377|NCT02537678|322881981|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
94299378|NCT02537678|322881982|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
94299379|NCT02537678|322881981|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
94299380|NCT02537678|322881982|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
94299381|NCT02537678|322881981|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
94299382|NCT02537678|322881982|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
94299383|NCT02537678|322881981|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
94299384|NCT02537678|322881982|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
94299385|NCT02537678|322881981|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
94299386|NCT02537678|322881982|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
94299387|NCT02537678|322881981|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
94299388|NCT02537678|322881982|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
94299389|NCT02886715|322881983|FG000|Overall Study|Non-Compliance With Study Drug|0|||
94299390|NCT02886715|322881984|FG001|Overall Study|Non-Compliance With Study Drug|2|||
94299391|NCT02886715|322881985|FG002|Overall Study|Non-Compliance With Study Drug|0|||
94299392|NCT02886715|322881983|FG000|Overall Study|Adverse Event|4|||
94299393|NCT02886715|322881984|FG001|Overall Study|Adverse Event|2|||
94468042|NCT02073565|323502489|FG000|Cohort C|Lost to Follow-up|0|||
94468043|NCT02073565|323502490|FG001|Cohort C|Lost to Follow-up|2|||
94468044|NCT02429310|323502491|FG000|Overall Study|Lost to Follow-up|1|||
94468045|NCT02429310|323502492|FG001|Overall Study|Lost to Follow-up|2|||
94468046|NCT02429310|323502491|FG000|Overall Study|Protocol Violation|1|||
94468047|NCT02429310|323502492|FG001|Overall Study|Protocol Violation|1|||
94468048|NCT00394433|323502493|FG000|Overall Study|Adverse Event|2|||
94468049|NCT00394433|323502493|FG000|Overall Study|Alternative Therapy|1|||
94468050|NCT01764997|323502496|FG000|Run-in Period|Adverse Event|15|||
94468051|NCT01764997|323502497|FG001|Run-in Period|Adverse Event|0|||
94468052|NCT01764997|323502498|FG002|Run-in Period|Adverse Event|0|||
94468053|NCT01764997|323502499|FG003|Run-in Period|Adverse Event|0|||
94468054|NCT01764997|323502500|FG004|Run-in Period|Adverse Event|0|||
94468055|NCT01764997|323502496|FG000|Run-in Period|Lack of Efficacy|5|||
94299394|NCT02886715|322881985|FG002|Overall Study|Adverse Event|0|||
94299395|NCT02886715|322881983|FG000|Overall Study|Lack of Efficacy|0|||
94299396|NCT02886715|322881984|FG001|Overall Study|Lack of Efficacy|2|||
94299397|NCT02886715|322881985|FG002|Overall Study|Lack of Efficacy|1|||
94299398|NCT02886715|322881983|FG000|Overall Study|Lost to Follow-up|29|||
94299399|NCT02886715|322881984|FG001|Overall Study|Lost to Follow-up|26|||
94299400|NCT02886715|322881985|FG002|Overall Study|Lost to Follow-up|10|||
94299401|NCT02886715|322881983|FG000|Overall Study|Pregnancy|1|||
94299402|NCT02886715|322881984|FG001|Overall Study|Pregnancy|1|||
94299403|NCT02886715|322881985|FG002|Overall Study|Pregnancy|1|||
94299404|NCT02886715|322881983|FG000|Overall Study|Protocol Violation|3|||
94299405|NCT02886715|322881984|FG001|Overall Study|Protocol Violation|2|||
94299406|NCT02886715|322881985|FG002|Overall Study|Protocol Violation|1|||
94299407|NCT02886715|322881983|FG000|Overall Study|Withdrawal by Subject|20|||
94299408|NCT02886715|322881984|FG001|Overall Study|Withdrawal by Subject|18|||
94299409|NCT02886715|322881985|FG002|Overall Study|Withdrawal by Subject|5|||
94299410|NCT02886715|322881983|FG000|Overall Study|missing|7|||
94299411|NCT02886715|322881984|FG001|Overall Study|missing|2|||
94299412|NCT02886715|322881985|FG002|Overall Study|missing|2|||
94299413|NCT00222105|322881986|FG000|Overall Study|Removed due to wrong diagnosis|1|||
94299414|NCT00222105|322881986|FG000|Overall Study|Withdrawal by Subject|1|||
94299415|NCT00222105|322881986|FG000|Overall Study|Adverse Event|8|||
94299416|NCT00222105|322881986|FG000|Overall Study|Treatment delays|2|||
94299417|NCT00222105|322881986|FG000|Overall Study|Death|2|||
94299418|NCT00503399|322881987|FG000|Overall Study|Death|2|||
94299419|NCT00503399|322881988|FG001|Overall Study|Death|1|||
94299420|NCT00503399|322881987|FG000|Overall Study|Protocol Violation|1|||
94299421|NCT00503399|322881988|FG001|Overall Study|Protocol Violation|0|||
94299422|NCT00503399|322881987|FG000|Overall Study|Withdrawal by Subject|4|||
94299423|NCT00503399|322881988|FG001|Overall Study|Withdrawal by Subject|2|||
94468056|NCT01764997|323502497|FG001|Run-in Period|Lack of Efficacy|0|||
94299424|NCT00503399|322881987|FG000|Overall Study|Adverse Event|0|||
94299425|NCT00503399|322881988|FG001|Overall Study|Adverse Event|3|||
94299426|NCT00503399|322881987|FG000|Overall Study|Lost to Follow-up|0|||
94299427|NCT00503399|322881988|FG001|Overall Study|Lost to Follow-up|2|||
94299428|NCT01676961|322881989|FG000|Overall Study|Death|3|||
94299429|NCT01676961|322881989|FG000|Overall Study|Lost to Follow-up|1|||
94299430|NCT01676961|322881989|FG000|Overall Study|Withdrawal by Subject|1|||
94299431|NCT00768560|322881992|FG000|Intervention Set 1|Adverse Event|0|||
94468057|NCT01764997|323502498|FG002|Run-in Period|Lack of Efficacy|0|||
94468058|NCT01764997|323502499|FG003|Run-in Period|Lack of Efficacy|0|||
94468059|NCT01764997|323502500|FG004|Run-in Period|Lack of Efficacy|0|||
94299432|NCT00768560|322881993|FG001|Intervention Set 1|Adverse Event|1|||
94299433|NCT00768560|322881994|FG002|Intervention Set 1|Adverse Event|0|||
94299434|NCT00768560|322881995|FG003|Intervention Set 1|Adverse Event|0|||
94299435|NCT00768560|322881996|FG004|Intervention Set 1|Adverse Event|0|||
94299436|NCT00768560|322881997|FG005|Intervention Set 1|Adverse Event|0|||
94299437|NCT01128387|322881998|FG000|Overall Study|Physician Decision|0|||
94299438|NCT01128387|322881999|FG001|Overall Study|Physician Decision|1|||
94299439|NCT03427073|322882000|FG000|Overall Study|Disease Progression|1|||
94299440|NCT03427073|322882001|FG001|Overall Study|Disease Progression|1|||
94299441|NCT03427073|322882002|FG002|Overall Study|Disease Progression|1|||
94299442|NCT03427073|322882003|FG003|Overall Study|Disease Progression|3|||
94299443|NCT03427073|322882004|FG004|Overall Study|Disease Progression|3|||
94299444|NCT03427073|322882005|FG005|Overall Study|Disease Progression|4|||
94299445|NCT03427073|322882006|FG006|Overall Study|Disease Progression|2|||
94299446|NCT03427073|322882007|FG007|Overall Study|Disease Progression|3|||
94299447|NCT03427073|322882000|FG000|Overall Study|Physician Decision|0|||
94299448|NCT03427073|322882001|FG001|Overall Study|Physician Decision|0|||
94299449|NCT03427073|322882002|FG002|Overall Study|Physician Decision|0|||
94299450|NCT03427073|322882003|FG003|Overall Study|Physician Decision|0|||
94299451|NCT03427073|322882004|FG004|Overall Study|Physician Decision|0|||
94299452|NCT03427073|322882005|FG005|Overall Study|Physician Decision|0|||
94299453|NCT03427073|322882006|FG006|Overall Study|Physician Decision|1|||
94299454|NCT03427073|322882007|FG007|Overall Study|Physician Decision|1|||
94299455|NCT01535235|322882008|FG000|Overall Study|Adverse Event|1|||
94299456|NCT01535235|322882009|FG001|Overall Study|Adverse Event|0|||
94299457|NCT01244737|322882011|FG000|Overall Study|Physician Decision|2|||
94299458|NCT01244737|322882012|FG001|Overall Study|Physician Decision|18|||
94299459|NCT01244737|322882013|FG002|Overall Study|Physician Decision|5|||
94299460|NCT01244737|322882011|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
94299461|NCT01244737|322882012|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
94299462|NCT01244737|322882013|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
94299463|NCT01244737|322882011|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
94299464|NCT01244737|322882012|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
94299465|NCT01244737|322882013|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
94299466|NCT01244737|322882011|FG000|Overall Study|MIB immunopathology results not available|3|||
94299467|NCT01244737|322882012|FG001|Overall Study|MIB immunopathology results not available|2|||
94299468|NCT01244737|322882013|FG002|Overall Study|MIB immunopathology results not available|0|||
94299469|NCT01244737|322882011|FG000|Overall Study|PET data failure|0|||
94299470|NCT01244737|322882012|FG001|Overall Study|PET data failure|1|||
94299471|NCT01244737|322882013|FG002|Overall Study|PET data failure|0|||
94299472|NCT01244737|322882011|FG000|Overall Study|Withdrawal by Subject|0|||
94299473|NCT01244737|322882012|FG001|Overall Study|Withdrawal by Subject|0|||
94299474|NCT01244737|322882013|FG002|Overall Study|Withdrawal by Subject|1|||
94299475|NCT00389207|322882018|FG000|Overall Study|Adverse Event|26|||
94299476|NCT00389207|322882019|FG001|Overall Study|Adverse Event|32|||
94299477|NCT00389207|322882020|FG002|Overall Study|Adverse Event|10|||
94299478|NCT00389207|322882018|FG000|Overall Study|Protocol Violation|3|||
94299479|NCT00389207|322882019|FG001|Overall Study|Protocol Violation|1|||
94299480|NCT00389207|322882020|FG002|Overall Study|Protocol Violation|4|||
94299481|NCT00389207|322882018|FG000|Overall Study|Lost to Follow-up|12|||
94299482|NCT00389207|322882019|FG001|Overall Study|Lost to Follow-up|9|||
94299483|NCT00389207|322882020|FG002|Overall Study|Lost to Follow-up|7|||
94299484|NCT00389207|322882018|FG000|Overall Study|Withdrawal by Subject|5|||
94299485|NCT00389207|322882019|FG001|Overall Study|Withdrawal by Subject|7|||
94299486|NCT00389207|322882020|FG002|Overall Study|Withdrawal by Subject|11|||
94299487|NCT00389207|322882018|FG000|Overall Study|Other|17|||
94299488|NCT00389207|322882019|FG001|Overall Study|Other|23|||
94299489|NCT00389207|322882020|FG002|Overall Study|Other|9|||
94299490|NCT02835495|322882022|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
94299491|NCT02835495|322882023|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
94299492|NCT02835495|322882022|FG000|Overall Study|Declined in-person follow-up visit|4|||
94299493|NCT02835495|322882023|FG001|Overall Study|Declined in-person follow-up visit|2|||
94299494|NCT00629083|322882024|FG000|Overall Study|Adverse Event|0|||
94299495|NCT00629083|322882025|FG001|Overall Study|Adverse Event|2|||
94299496|NCT00629083|322882024|FG000|Overall Study|Lack of Efficacy|3|||
94299497|NCT00629083|322882025|FG001|Overall Study|Lack of Efficacy|1|||
94299498|NCT00629083|322882024|FG000|Overall Study|Withdrawal by Subject|10|||
94299499|NCT00629083|322882025|FG001|Overall Study|Withdrawal by Subject|2|||
94299500|NCT00629083|322882024|FG000|Overall Study|Lost to Follow-up|12|||
94299501|NCT00629083|322882025|FG001|Overall Study|Lost to Follow-up|8|||
94299502|NCT00629083|322882024|FG000|Overall Study|Moved out of country/state|2|||
94299503|NCT00629083|322882025|FG001|Overall Study|Moved out of country/state|1|||
94299504|NCT00629083|322882024|FG000|Overall Study|Refused to return for 12 month visit|1|||
94299505|NCT00629083|322882025|FG001|Overall Study|Refused to return for 12 month visit|0|||
94299506|NCT02318602|322882027|FG000|Overall Study|Adverse Event|0|||
94299507|NCT02318602|322882028|FG001|Overall Study|Adverse Event|1|||
94299508|NCT02318602|322882029|FG002|Overall Study|Adverse Event|1|||
94299509|NCT02318602|322882027|FG000|Overall Study|Withdrawal by Subject|0|||
94299510|NCT02318602|322882028|FG001|Overall Study|Withdrawal by Subject|3|||
94299511|NCT02318602|322882029|FG002|Overall Study|Withdrawal by Subject|0|||
94299512|NCT02318602|322882027|FG000|Overall Study|Death|1|||
94299513|NCT02318602|322882028|FG001|Overall Study|Death|0|||
94299514|NCT02318602|322882029|FG002|Overall Study|Death|0|||
94299515|NCT02318602|322882027|FG000|Overall Study|Guardian decision to withdraw|0|||
94299516|NCT02318602|322882028|FG001|Overall Study|Guardian decision to withdraw|0|||
94299517|NCT02318602|322882029|FG002|Overall Study|Guardian decision to withdraw|1|||
94299518|NCT00693706|322882032|FG000|Overall Study|Protocol Violation|0|||
94299519|NCT00693706|322882033|FG001|Overall Study|Protocol Violation|1|||
94299520|NCT00488631|322882039|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
94299521|NCT00488631|322882040|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
94299522|NCT00488631|322882041|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
94299523|NCT00488631|322882042|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
94299524|NCT00488631|322882043|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
94299525|NCT00488631|322882044|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
94299526|NCT00488631|322882045|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
94299527|NCT00488631|322882046|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
94299528|NCT00488631|322882047|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
94299529|NCT00488631|322882048|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
94299530|NCT00488631|322882039|FG000|Double Blind Period (Week 0-54)|Death|0|||
94299531|NCT00488631|322882040|FG001|Double Blind Period (Week 0-54)|Death|0|||
94299532|NCT00488631|322882041|FG002|Double Blind Period (Week 0-54)|Death|0|||
94299533|NCT00488631|322882042|FG003|Double Blind Period (Week 0-54)|Death|0|||
94299534|NCT00488631|322882043|FG004|Double Blind Period (Week 0-54)|Death|0|||
94299535|NCT00488631|322882044|FG005|Double Blind Period (Week 0-54)|Death|1|||
94299536|NCT00488631|322882045|FG006|Double Blind Period (Week 0-54)|Death|0|||
94299537|NCT00488631|322882046|FG007|Double Blind Period (Week 0-54)|Death|0|||
94299538|NCT00488631|322882047|FG008|Double Blind Period (Week 0-54)|Death|0|||
94299539|NCT00488631|322882048|FG009|Double Blind Period (Week 0-54)|Death|0|||
94299540|NCT00488631|322882039|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
94299541|NCT00488631|322882040|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
94299542|NCT00488631|322882041|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
94299543|NCT00488631|322882042|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
94299544|NCT00488631|322882043|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
94299545|NCT00488631|322882044|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
94299546|NCT00488631|322882045|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
94299547|NCT00488631|322882046|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
94299548|NCT00488631|322882047|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
94299549|NCT00488631|322882048|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
94299550|NCT00488631|322882039|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
94299551|NCT00488631|322882040|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
94299552|NCT00488631|322882041|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
94299553|NCT00488631|322882042|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
94299554|NCT00488631|322882043|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
94299555|NCT00488631|322882044|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
94299556|NCT00488631|322882045|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
94299557|NCT00488631|322882046|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
94299558|NCT00488631|322882047|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
94299559|NCT00488631|322882048|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
94299560|NCT00488631|322882039|FG000|Double Blind Period (Week 0-54)|Other|6|||
94299561|NCT00488631|322882040|FG001|Double Blind Period (Week 0-54)|Other|12|||
94299562|NCT00488631|322882041|FG002|Double Blind Period (Week 0-54)|Other|10|||
94299563|NCT00488631|322882042|FG003|Double Blind Period (Week 0-54)|Other|11|||
94299564|NCT00488631|322882043|FG004|Double Blind Period (Week 0-54)|Other|14|||
94299565|NCT00488631|322882044|FG005|Double Blind Period (Week 0-54)|Other|34|||
94299566|NCT00488631|322882045|FG006|Double Blind Period (Week 0-54)|Other|0|||
94299567|NCT00488631|322882046|FG007|Double Blind Period (Week 0-54)|Other|0|||
94299568|NCT00488631|322882047|FG008|Double Blind Period (Week 0-54)|Other|0|||
94299569|NCT00488631|322882048|FG009|Double Blind Period (Week 0-54)|Other|0|||
94299570|NCT00488631|322882039|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
94468060|NCT01764997|323502496|FG000|Run-in Period|Poor compliance to protocol|1|||
94468061|NCT01764997|323502497|FG001|Run-in Period|Poor compliance to protocol|0|||
94468062|NCT01764997|323502498|FG002|Run-in Period|Poor compliance to protocol|0|||
94299571|NCT00488631|322882040|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
94299572|NCT00488631|322882041|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
94299573|NCT00488631|322882042|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
94468063|NCT01764997|323502499|FG003|Run-in Period|Poor compliance to protocol|0|||
94299574|NCT00488631|322882043|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
94299575|NCT00488631|322882044|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
94299576|NCT00488631|322882045|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
94299577|NCT00488631|322882046|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
94299578|NCT00488631|322882047|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
94299579|NCT00488631|322882048|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
94299580|NCT00488631|322882039|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
94299581|NCT00488631|322882040|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
94299582|NCT00488631|322882041|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
94299583|NCT00488631|322882042|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
94299584|NCT00488631|322882043|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
94299585|NCT00488631|322882044|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
94299586|NCT00488631|322882045|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
94299587|NCT00488631|322882046|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
94299588|NCT00488631|322882047|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
94299589|NCT00488631|322882048|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
94299590|NCT00488631|322882039|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
94299591|NCT00488631|322882040|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
94299592|NCT00488631|322882041|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
94299593|NCT00488631|322882042|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
94299594|NCT00488631|322882043|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
94299595|NCT00488631|322882044|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
94299596|NCT00488631|322882045|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
94299597|NCT00488631|322882046|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
94299598|NCT00488631|322882047|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
94299599|NCT00488631|322882048|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
94299600|NCT00488631|322882039|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
94299601|NCT00488631|322882040|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
94299602|NCT00488631|322882041|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
94299603|NCT00488631|322882042|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
94299604|NCT00488631|322882043|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
94299605|NCT00488631|322882044|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
94299606|NCT00488631|322882045|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
94299607|NCT00488631|322882046|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
94299608|NCT00488631|322882047|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
94299609|NCT00488631|322882048|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
94299610|NCT00488631|322882039|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
94299611|NCT00488631|322882040|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
94299612|NCT00488631|322882041|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
94299613|NCT00488631|322882042|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
94299614|NCT00488631|322882043|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
94299615|NCT00488631|322882044|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
94299616|NCT00488631|322882045|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
94299617|NCT00488631|322882046|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
94299618|NCT00488631|322882047|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
94299619|NCT00488631|322882048|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
94299620|NCT03406962|322882049|FG000|Overall Study|Death|2|||
94299621|NCT03406962|322882049|FG000|Overall Study|Adverse Event|1|||
94299622|NCT00707577|322882050|FG000|Overall Study|Withdrawal by Subject|3|||
94299623|NCT00707577|322882051|FG001|Overall Study|Withdrawal by Subject|2|||
94299624|NCT00707577|322882050|FG000|Overall Study|Lost to Follow-up|34|||
94299625|NCT00707577|322882051|FG001|Overall Study|Lost to Follow-up|25|||
94299626|NCT00707577|322882050|FG000|Overall Study|Left employment|13|||
94299627|NCT00707577|322882051|FG001|Overall Study|Left employment|10|||
94299628|NCT00707577|322882050|FG000|Overall Study|Pregnancy|4|||
94299629|NCT00707577|322882051|FG001|Overall Study|Pregnancy|1|||
94299630|NCT03853694|322882052|FG000|Overall Study|Protocol Violation|3|||
94299631|NCT03853694|322882053|FG001|Overall Study|Protocol Violation|5|||
94299632|NCT03853694|322882054|FG002|Overall Study|Protocol Violation|3|||
94299633|NCT03853694|322882052|FG000|Overall Study|Delivered early|0|||
94299634|NCT03853694|322882053|FG001|Overall Study|Delivered early|1|||
94299635|NCT03853694|322882054|FG002|Overall Study|Delivered early|0|||
94299636|NCT03853694|322882052|FG000|Overall Study|not suitable to proceed|0|||
94299637|NCT03853694|322882053|FG001|Overall Study|not suitable to proceed|1|||
94299638|NCT03853694|322882054|FG002|Overall Study|not suitable to proceed|0|||
94299639|NCT03853694|322882052|FG000|Overall Study|difficult surgery|0|||
94299640|NCT03853694|322882053|FG001|Overall Study|difficult surgery|0|||
94373011|NCT01715415|323150384|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
94373012|NCT01715415|323150383|FG000|Double-blind Treatment|Adverse Event|3|||
94373013|NCT01715415|323150384|FG001|Double-blind Treatment|Adverse Event|0|||
94373014|NCT01715415|323150383|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
94299641|NCT03853694|322882054|FG002|Overall Study|difficult surgery|1|||
94299642|NCT03853694|322882052|FG000|Overall Study|Lost to Follow-up|0|||
94299643|NCT03853694|322882053|FG001|Overall Study|Lost to Follow-up|1|||
94299644|NCT03853694|322882054|FG002|Overall Study|Lost to Follow-up|0|||
94299645|NCT03853694|322882052|FG000|Overall Study|Withdrawal by Subject|0|||
94299646|NCT03853694|322882053|FG001|Overall Study|Withdrawal by Subject|1|||
94299647|NCT03853694|322882054|FG002|Overall Study|Withdrawal by Subject|0|||
94299648|NCT01794780|322882056|FG000|Overall Study|Adverse Event|0|||
94299649|NCT01794780|322882057|FG001|Overall Study|Adverse Event|1|||
94299650|NCT01794780|322882058|FG002|Overall Study|Adverse Event|2|||
94299651|NCT01794780|322882059|FG003|Overall Study|Adverse Event|0|||
94299652|NCT01794780|322882060|FG004|Overall Study|Adverse Event|0|||
94299653|NCT01794780|322882061|FG005|Overall Study|Adverse Event|0|||
94299654|NCT01794780|322882062|FG006|Overall Study|Adverse Event|0|||
94299655|NCT01794780|322882063|FG007|Overall Study|Adverse Event|0|||
94299656|NCT01794780|322882056|FG000|Overall Study|Death|0|||
94299657|NCT01794780|322882057|FG001|Overall Study|Death|2|||
94299658|NCT01794780|322882058|FG002|Overall Study|Death|14|||
94299659|NCT01794780|322882059|FG003|Overall Study|Death|1|||
94299660|NCT01794780|322882060|FG004|Overall Study|Death|0|||
94299661|NCT01794780|322882061|FG005|Overall Study|Death|9|||
94299662|NCT01794780|322882062|FG006|Overall Study|Death|4|||
94299663|NCT01794780|322882063|FG007|Overall Study|Death|0|||
94299664|NCT01794780|322882056|FG000|Overall Study|Lost to Follow-up|10|||
94299665|NCT01794780|322882057|FG001|Overall Study|Lost to Follow-up|64|||
94299666|NCT01794780|322882058|FG002|Overall Study|Lost to Follow-up|165|||
94299667|NCT01794780|322882059|FG003|Overall Study|Lost to Follow-up|53|||
94299668|NCT01794780|322882060|FG004|Overall Study|Lost to Follow-up|2|||
94299669|NCT01794780|322882061|FG005|Overall Study|Lost to Follow-up|99|||
94299670|NCT01794780|322882062|FG006|Overall Study|Lost to Follow-up|30|||
94299671|NCT01794780|322882063|FG007|Overall Study|Lost to Follow-up|5|||
94299672|NCT01794780|322882056|FG000|Overall Study|Withdrew informed consent|7|||
94299673|NCT01794780|322882057|FG001|Overall Study|Withdrew informed consent|17|||
94299674|NCT01794780|322882058|FG002|Overall Study|Withdrew informed consent|36|||
94299675|NCT01794780|322882059|FG003|Overall Study|Withdrew informed consent|9|||
94299676|NCT01794780|322882060|FG004|Overall Study|Withdrew informed consent|0|||
94299677|NCT01794780|322882061|FG005|Overall Study|Withdrew informed consent|48|||
94299678|NCT01794780|322882062|FG006|Overall Study|Withdrew informed consent|4|||
94299679|NCT01794780|322882063|FG007|Overall Study|Withdrew informed consent|3|||
94299680|NCT01794780|322882056|FG000|Overall Study|Other|0|||
94299681|NCT01794780|322882057|FG001|Overall Study|Other|12|||
94299682|NCT01794780|322882058|FG002|Overall Study|Other|25|||
94299683|NCT01794780|322882059|FG003|Overall Study|Other|20|||
94299684|NCT01794780|322882060|FG004|Overall Study|Other|1|||
94299685|NCT01794780|322882061|FG005|Overall Study|Other|24|||
94299686|NCT01794780|322882062|FG006|Overall Study|Other|4|||
94299687|NCT01794780|322882063|FG007|Overall Study|Other|1|||
94299688|NCT00824421|322882064|FG000|Overall Study|Adverse Event|6|||
94299689|NCT00824421|322882065|FG001|Overall Study|Adverse Event|6|||
94299690|NCT00824421|322882066|FG002|Overall Study|Adverse Event|6|||
94299691|NCT00824421|322882064|FG000|Overall Study|Death|0|||
94299692|NCT00824421|322882065|FG001|Overall Study|Death|1|||
94299693|NCT00824421|322882066|FG002|Overall Study|Death|0|||
94299694|NCT00824421|322882064|FG000|Overall Study|Lack of Efficacy|5|||
94299695|NCT00824421|322882065|FG001|Overall Study|Lack of Efficacy|7|||
94299696|NCT00824421|322882066|FG002|Overall Study|Lack of Efficacy|4|||
94299697|NCT00824421|322882064|FG000|Overall Study|Lost to Follow-up|2|||
94299698|NCT00824421|322882065|FG001|Overall Study|Lost to Follow-up|3|||
94373015|NCT01715415|323150384|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
94373016|NCT01715415|323150383|FG000|Double-blind Treatment|Other|1|||
94299699|NCT00824421|322882066|FG002|Overall Study|Lost to Follow-up|0|||
94299700|NCT00824421|322882064|FG000|Overall Study|Pregnancy|1|||
94299701|NCT00824421|322882065|FG001|Overall Study|Pregnancy|0|||
94299702|NCT00824421|322882066|FG002|Overall Study|Pregnancy|1|||
94299703|NCT00824421|322882064|FG000|Overall Study|Withdrawal by Subject|2|||
94299704|NCT00824421|322882065|FG001|Overall Study|Withdrawal by Subject|3|||
94299705|NCT00824421|322882066|FG002|Overall Study|Withdrawal by Subject|3|||
94299706|NCT00824421|322882064|FG000|Overall Study|Randomized but not Treated|1|||
94373017|NCT01715415|323150384|FG001|Double-blind Treatment|Other|0|||
94299707|NCT00824421|322882065|FG001|Overall Study|Randomized but not Treated|1|||
94299708|NCT00824421|322882066|FG002|Overall Study|Randomized but not Treated|0|||
94299709|NCT00824421|322882064|FG000|Overall Study|Other|0|||
94299710|NCT00824421|322882065|FG001|Overall Study|Other|1|||
94299711|NCT00824421|322882066|FG002|Overall Study|Other|0|||
94299712|NCT02499952|322882067|FG000|Overall Study|Lost to Follow-up|1|||
94299713|NCT02499952|322882067|FG000|Overall Study|Death|9|||
94299714|NCT05089708|322882068|FG000|Overall Study|Lost to Follow-up|9|||
94373018|NCT01715415|323150383|FG000|Open-label Treatment|Adverse Event|0|||
94373019|NCT01715415|323150384|FG001|Open-label Treatment|Adverse Event|1|||
94373020|NCT01715415|323150383|FG000|Open-label Treatment|Subject Noncompliant|0|||
94373021|NCT01715415|323150384|FG001|Open-label Treatment|Subject Noncompliant|1|||
94373022|NCT03836729|323152353|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
94373023|NCT00948025|323152354|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
94373024|NCT00948025|323152355|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
94373025|NCT00948025|323152354|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
94373026|NCT00948025|323152355|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
94373027|NCT00948025|323152354|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
94373028|NCT00948025|323152355|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
94373029|NCT03208933|323152359|FG000|Overall Study|Death|3|||
94373030|NCT03208933|323152359|FG000|Overall Study|Withdrawal by Subject|3|||
94373031|NCT03208933|323152359|FG000|Overall Study|Adverse Event|1|||
94373032|NCT03208933|323152359|FG000|Overall Study|Lost to Follow-up|2|||
94373033|NCT03208933|323152359|FG000|Overall Study|Physician Decision|3|||
94373034|NCT03208933|323152359|FG000|Overall Study|Protocol Violation|1|||
94373035|NCT01792284|323152362|FG000|Lead-in Period|Adverse Event|15|||
94373036|NCT01792284|323152363|FG001|Lead-in Period|Adverse Event|0|||
94373037|NCT01792284|323152364|FG002|Lead-in Period|Adverse Event|0|||
94373038|NCT01792284|323152362|FG000|Lead-in Period|Lost to Follow-up|2|||
94373039|NCT01792284|323152363|FG001|Lead-in Period|Lost to Follow-up|0|||
94373040|NCT01792284|323152364|FG002|Lead-in Period|Lost to Follow-up|0|||
94373041|NCT01792284|323152362|FG000|Lead-in Period|Protocol Violation|1|||
94373042|NCT01792284|323152363|FG001|Lead-in Period|Protocol Violation|0|||
94373043|NCT01792284|323152364|FG002|Lead-in Period|Protocol Violation|0|||
94373044|NCT01792284|323152362|FG000|Lead-in Period|Withdrawal by Subject|10|||
94373045|NCT01792284|323152363|FG001|Lead-in Period|Withdrawal by Subject|0|||
94373046|NCT01792284|323152364|FG002|Lead-in Period|Withdrawal by Subject|0|||
94373047|NCT01792284|323152362|FG000|Lead-in Period|Physician Decision|1|||
94373048|NCT01792284|323152363|FG001|Lead-in Period|Physician Decision|0|||
94373049|NCT01792284|323152364|FG002|Lead-in Period|Physician Decision|0|||
94373050|NCT01792284|323152362|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
94373051|NCT01792284|323152363|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
94373052|NCT01792284|323152364|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
94373053|NCT01792284|323152362|FG000|Randomization Period 1|Withdrawal by Subject|0|||
94373054|NCT01792284|323152363|FG001|Randomization Period 1|Withdrawal by Subject|1|||
94373055|NCT01792284|323152364|FG002|Randomization Period 1|Withdrawal by Subject|1|||
94373056|NCT01792284|323152362|FG000|Randomization Period 1|Physician Decision|0|||
94373057|NCT01792284|323152363|FG001|Randomization Period 1|Physician Decision|1|||
94373058|NCT01792284|323152364|FG002|Randomization Period 1|Physician Decision|1|||
94373059|NCT01792284|323152362|FG000|Randomization Period 1|Adverse Event|0|||
94373060|NCT01792284|323152363|FG001|Randomization Period 1|Adverse Event|0|||
94373061|NCT01792284|323152364|FG002|Randomization Period 1|Adverse Event|2|||
94373062|NCT01792284|323152362|FG000|Randomization Period 1|Lost to Follow-up|0|||
94373063|NCT01792284|323152363|FG001|Randomization Period 1|Lost to Follow-up|0|||
94373064|NCT01792284|323152364|FG002|Randomization Period 1|Lost to Follow-up|1|||
94373065|NCT01792284|323152362|FG000|Randomization Period 2|Protocol Violation|0|||
94373066|NCT01792284|323152363|FG001|Randomization Period 2|Protocol Violation|1|||
94373067|NCT01792284|323152364|FG002|Randomization Period 2|Protocol Violation|0|||
94373068|NCT01792284|323152362|FG000|Randomization Period 2|Withdrawal by Subject|0|||
94373069|NCT01792284|323152363|FG001|Randomization Period 2|Withdrawal by Subject|2|||
94373070|NCT01792284|323152364|FG002|Randomization Period 2|Withdrawal by Subject|0|||
94373071|NCT02257632|323152365|FG000|Overall Study|Withdrawal by Subject|0|||
94373072|NCT02257632|323152366|FG001|Overall Study|Withdrawal by Subject|1|||
94373073|NCT02257632|323152365|FG000|Overall Study|Adverse Event|1|||
94373074|NCT02257632|323152366|FG001|Overall Study|Adverse Event|2|||
94373075|NCT01605461|323152367|FG000|Overall Study|Lost to Follow-up|3|||
94373076|NCT01605461|323152367|FG000|Overall Study|Withdrawal by Subject|1|||
94373077|NCT01169649|323152368|FG000|Overall Study|Patient Not Treated|3|||
94373078|NCT00525031|323152374|FG000|Overall Study|Disease Progression|1|||
94373079|NCT00525031|323152375|FG001|Overall Study|Disease Progression|1|||
94373080|NCT02454972|323152378|FG000|Overall Study|Progressive disease|17|||
94373081|NCT02454972|323152379|FG001|Overall Study|Progressive disease|16|||
94373082|NCT02454972|323152380|FG002|Overall Study|Progressive disease|59|||
94468064|NCT01764997|323502500|FG004|Run-in Period|Poor compliance to protocol|0|||
94468065|NCT01764997|323502496|FG000|Run-in Period|Other than specified above|17|||
94468066|NCT01764997|323502497|FG001|Run-in Period|Other than specified above|0|||
94468067|NCT01764997|323502498|FG002|Run-in Period|Other than specified above|0|||
94373083|NCT02454972|323152381|FG003|Overall Study|Progressive disease|23|||
94373084|NCT02454972|323152382|FG004|Overall Study|Progressive disease|16|||
94373085|NCT02454972|323152383|FG005|Overall Study|Progressive disease|12|||
94373086|NCT02454972|323152384|FG006|Overall Study|Progressive disease|19|||
94373087|NCT02454972|323152385|FG007|Overall Study|Progressive disease|27|||
94373088|NCT02454972|323152386|FG008|Overall Study|Progressive disease|0|||
94373089|NCT02454972|323152378|FG000|Overall Study|Death|0|||
94468068|NCT01764997|323502499|FG003|Run-in Period|Other than specified above|0|||
94373090|NCT02454972|323152379|FG001|Overall Study|Death|0|||
94373091|NCT02454972|323152380|FG002|Overall Study|Death|5|||
94373092|NCT02454972|323152381|FG003|Overall Study|Death|1|||
94373093|NCT02454972|323152382|FG004|Overall Study|Death|0|||
94373094|NCT02454972|323152383|FG005|Overall Study|Death|0|||
94373095|NCT02454972|323152384|FG006|Overall Study|Death|0|||
94299715|NCT05089708|322882069|FG001|Overall Study|Lost to Follow-up|7|||
94299716|NCT05089708|322882068|FG000|Overall Study|Withdrawal by Subject|3|||
94299717|NCT05089708|322882069|FG001|Overall Study|Withdrawal by Subject|1|||
94299718|NCT05089708|322882068|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
94299719|NCT05089708|322882069|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
94299720|NCT05089708|322882068|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
94299721|NCT05089708|322882069|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
94299722|NCT01173653|322882070|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
94299723|NCT01173653|322882071|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
94299724|NCT00064701|322882072|FG000|One Year Post-transplant|Did not receive study drug|7|||
94299725|NCT00064701|322882073|FG001|One Year Post-transplant|Did not receive study drug|12|||
94299726|NCT00064701|322882074|FG002|One Year Post-transplant|Did not receive study drug|11|||
94299727|NCT00064701|322882072|FG000|One Year Post-transplant|Adverse Event|23|||
94299728|NCT00064701|322882073|FG001|One Year Post-transplant|Adverse Event|19|||
94299729|NCT00064701|322882074|FG002|One Year Post-transplant|Adverse Event|37|||
94299730|NCT00064701|322882072|FG000|One Year Post-transplant|Rejection|0|||
94299731|NCT00064701|322882073|FG001|One Year Post-transplant|Rejection|1|||
94299732|NCT00064701|322882074|FG002|One Year Post-transplant|Rejection|16|||
94299733|NCT00064701|322882072|FG000|One Year Post-transplant|Non-compliance|4|||
94299734|NCT00064701|322882073|FG001|One Year Post-transplant|Non-compliance|2|||
94299735|NCT00064701|322882074|FG002|One Year Post-transplant|Non-compliance|5|||
94299736|NCT00064701|322882072|FG000|One Year Post-transplant|Graft Failure|3|||
94299737|NCT00064701|322882073|FG001|One Year Post-transplant|Graft Failure|2|||
94299738|NCT00064701|322882074|FG002|One Year Post-transplant|Graft Failure|1|||
94299739|NCT00064701|322882072|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
94299740|NCT00064701|322882073|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
94299741|NCT00064701|322882074|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
94299742|NCT00064701|322882072|FG000|One Year Post-transplant|Lost to Follow-up|1|||
94299743|NCT00064701|322882073|FG001|One Year Post-transplant|Lost to Follow-up|0|||
94299744|NCT00064701|322882074|FG002|One Year Post-transplant|Lost to Follow-up|0|||
94299745|NCT00064701|322882072|FG000|One Year Post-transplant|Converted to rapamycin|1|||
94299746|NCT00064701|322882073|FG001|One Year Post-transplant|Converted to rapamycin|0|||
94299747|NCT00064701|322882074|FG002|One Year Post-transplant|Converted to rapamycin|0|||
94299748|NCT00064701|322882072|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
94299749|NCT00064701|322882073|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
94299750|NCT00064701|322882074|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
94299751|NCT00064701|322882072|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
94299752|NCT00064701|322882073|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
94299753|NCT00064701|322882074|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
94299754|NCT00064701|322882072|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
94299755|NCT00064701|322882073|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
94299756|NCT00064701|322882074|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
94299757|NCT00064701|322882072|FG000|One Year Post-transplant|Poor absorption|0|||
94299758|NCT00064701|322882073|FG001|One Year Post-transplant|Poor absorption|1|||
94299759|NCT00064701|322882074|FG002|One Year Post-transplant|Poor absorption|0|||
94299760|NCT00064701|322882072|FG000|One Year Post-transplant|Pancreas transplant|0|||
94299761|NCT00064701|322882073|FG001|One Year Post-transplant|Pancreas transplant|0|||
94299762|NCT00064701|322882074|FG002|One Year Post-transplant|Pancreas transplant|1|||
94299763|NCT00064701|322882072|FG000|Clinical Continuation Phase|Adverse Event|12|||
94299764|NCT00064701|322882073|FG001|Clinical Continuation Phase|Adverse Event|21|||
94299765|NCT00064701|322882074|FG002|Clinical Continuation Phase|Adverse Event|14|||
94299766|NCT00064701|322882072|FG000|Clinical Continuation Phase|Non-compliance|8|||
94299767|NCT00064701|322882073|FG001|Clinical Continuation Phase|Non-compliance|6|||
94299768|NCT00064701|322882074|FG002|Clinical Continuation Phase|Non-compliance|7|||
94299769|NCT00064701|322882072|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
94299770|NCT00064701|322882073|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
94299771|NCT00064701|322882074|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
94299772|NCT00064701|322882072|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
94299773|NCT00064701|322882073|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
94373096|NCT02454972|323152385|FG007|Overall Study|Death|0|||
94299774|NCT00064701|322882074|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
94299775|NCT00064701|322882072|FG000|Clinical Continuation Phase|Graft Failure|5|||
94299776|NCT00064701|322882073|FG001|Clinical Continuation Phase|Graft Failure|5|||
94373097|NCT02454972|323152386|FG008|Overall Study|Death|95|||
94373098|NCT02454972|323152378|FG000|Overall Study|Physician Decision|0|||
94373099|NCT02454972|323152379|FG001|Overall Study|Physician Decision|1|||
94373100|NCT02454972|323152380|FG002|Overall Study|Physician Decision|2|||
94373101|NCT02454972|323152381|FG003|Overall Study|Physician Decision|1|||
94373102|NCT02454972|323152382|FG004|Overall Study|Physician Decision|2|||
94373103|NCT02454972|323152383|FG005|Overall Study|Physician Decision|0|||
94373104|NCT02454972|323152384|FG006|Overall Study|Physician Decision|0|||
94373105|NCT02454972|323152385|FG007|Overall Study|Physician Decision|1|||
94373106|NCT02454972|323152386|FG008|Overall Study|Physician Decision|0|||
94373107|NCT02454972|323152378|FG000|Overall Study|Non treatment-related adverse event|2|||
94373108|NCT02454972|323152379|FG001|Overall Study|Non treatment-related adverse event|0|||
94373109|NCT02454972|323152380|FG002|Overall Study|Non treatment-related adverse event|1|||
94373110|NCT02454972|323152381|FG003|Overall Study|Non treatment-related adverse event|0|||
94373111|NCT02454972|323152382|FG004|Overall Study|Non treatment-related adverse event|0|||
94373112|NCT02454972|323152383|FG005|Overall Study|Non treatment-related adverse event|1|||
94373113|NCT02454972|323152384|FG006|Overall Study|Non treatment-related adverse event|0|||
94373114|NCT02454972|323152385|FG007|Overall Study|Non treatment-related adverse event|1|||
94373115|NCT02454972|323152386|FG008|Overall Study|Non treatment-related adverse event|0|||
94373116|NCT02454972|323152378|FG000|Overall Study|Treatment-related adverse events|0|||
94373117|NCT02454972|323152379|FG001|Overall Study|Treatment-related adverse events|1|||
94373118|NCT02454972|323152380|FG002|Overall Study|Treatment-related adverse events|1|||
94373119|NCT02454972|323152381|FG003|Overall Study|Treatment-related adverse events|0|||
94373120|NCT02454972|323152382|FG004|Overall Study|Treatment-related adverse events|2|||
94373121|NCT02454972|323152383|FG005|Overall Study|Treatment-related adverse events|0|||
94373122|NCT02454972|323152384|FG006|Overall Study|Treatment-related adverse events|0|||
94373123|NCT02454972|323152385|FG007|Overall Study|Treatment-related adverse events|2|||
94373124|NCT02454972|323152386|FG008|Overall Study|Treatment-related adverse events|0|||
94373125|NCT02454972|323152378|FG000|Overall Study|Patient moves to compassionate use|0|||
94373126|NCT02454972|323152379|FG001|Overall Study|Patient moves to compassionate use|0|||
94373127|NCT02454972|323152380|FG002|Overall Study|Patient moves to compassionate use|0|||
94373128|NCT02454972|323152381|FG003|Overall Study|Patient moves to compassionate use|0|||
94373129|NCT02454972|323152382|FG004|Overall Study|Patient moves to compassionate use|0|||
94373130|NCT02454972|323152383|FG005|Overall Study|Patient moves to compassionate use|0|||
94373131|NCT02454972|323152384|FG006|Overall Study|Patient moves to compassionate use|2|||
94373132|NCT02454972|323152385|FG007|Overall Study|Patient moves to compassionate use|0|||
94373133|NCT02454972|323152386|FG008|Overall Study|Patient moves to compassionate use|0|||
94373134|NCT02454972|323152378|FG000|Overall Study|Withdrawal by Subject|0|||
94373135|NCT02454972|323152379|FG001|Overall Study|Withdrawal by Subject|1|||
94373136|NCT02454972|323152380|FG002|Overall Study|Withdrawal by Subject|5|||
94373137|NCT02454972|323152381|FG003|Overall Study|Withdrawal by Subject|2|||
94373138|NCT02454972|323152382|FG004|Overall Study|Withdrawal by Subject|3|||
94373139|NCT02454972|323152383|FG005|Overall Study|Withdrawal by Subject|2|||
94373140|NCT02454972|323152384|FG006|Overall Study|Withdrawal by Subject|0|||
94373141|NCT02454972|323152385|FG007|Overall Study|Withdrawal by Subject|1|||
94373142|NCT02454972|323152386|FG008|Overall Study|Withdrawal by Subject|2|||
94373143|NCT02454972|323152378|FG000|Overall Study|Multiple delay/holds on treatment|0|||
94373144|NCT02454972|323152379|FG001|Overall Study|Multiple delay/holds on treatment|0|||
94373145|NCT02454972|323152380|FG002|Overall Study|Multiple delay/holds on treatment|0|||
94373146|NCT02454972|323152381|FG003|Overall Study|Multiple delay/holds on treatment|1|||
94373147|NCT02454972|323152382|FG004|Overall Study|Multiple delay/holds on treatment|0|||
94373148|NCT02454972|323152383|FG005|Overall Study|Multiple delay/holds on treatment|0|||
94373149|NCT02454972|323152384|FG006|Overall Study|Multiple delay/holds on treatment|0|||
94373150|NCT02454972|323152385|FG007|Overall Study|Multiple delay/holds on treatment|0|||
94299777|NCT00064701|322882074|FG002|Clinical Continuation Phase|Graft Failure|2|||
94299778|NCT00064701|322882072|FG000|Clinical Continuation Phase|Rejection|1|||
94299779|NCT00064701|322882073|FG001|Clinical Continuation Phase|Rejection|2|||
94299780|NCT00064701|322882074|FG002|Clinical Continuation Phase|Rejection|2|||
94299781|NCT00064701|322882072|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
94299782|NCT00064701|322882073|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
94299783|NCT00064701|322882074|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
94299784|NCT00064701|322882072|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
94299785|NCT00064701|322882073|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
94299786|NCT00064701|322882074|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
94299787|NCT00064701|322882072|FG000|Clinical Continuation Phase|Physician Decision|1|||
94299788|NCT00064701|322882073|FG001|Clinical Continuation Phase|Physician Decision|3|||
94299789|NCT00064701|322882074|FG002|Clinical Continuation Phase|Physician Decision|0|||
94299790|NCT00064701|322882072|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
94299791|NCT00064701|322882073|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
94373151|NCT02454972|323152386|FG008|Overall Study|Multiple delay/holds on treatment|0|||
94373152|NCT02454972|323152378|FG000|Overall Study|Never treated|0|||
94373153|NCT02454972|323152379|FG001|Overall Study|Never treated|0|||
94373154|NCT02454972|323152380|FG002|Overall Study|Never treated|3|||
94299792|NCT00064701|322882074|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
94299793|NCT00064701|322882072|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
94299794|NCT00064701|322882073|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
94299795|NCT00064701|322882074|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
94299796|NCT00064701|322882072|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
94299797|NCT00064701|322882073|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
94299798|NCT00064701|322882074|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
94299799|NCT00064701|322882072|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
94299800|NCT00064701|322882073|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
94299801|NCT00064701|322882074|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
94299802|NCT00064701|322882072|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
94299803|NCT00064701|322882073|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
94299804|NCT00064701|322882074|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
94373155|NCT02454972|323152381|FG003|Overall Study|Never treated|1|||
94373156|NCT02454972|323152382|FG004|Overall Study|Never treated|1|||
94299805|NCT00064701|322882072|FG000|Clinical Continuation Phase|Patient opted out|0|||
94299806|NCT00064701|322882073|FG001|Clinical Continuation Phase|Patient opted out|0|||
94299807|NCT00064701|322882074|FG002|Clinical Continuation Phase|Patient opted out|1|||
94299808|NCT00749203|322882082|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
94299809|NCT00749203|322882083|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
94299810|NCT00749203|322882082|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
94299811|NCT00749203|322882083|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
94299812|NCT00749203|322882082|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
94299813|NCT00749203|322882083|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
94299814|NCT00749203|322882082|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
94299815|NCT00749203|322882083|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
94299816|NCT00749203|322882082|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
94299817|NCT00749203|322882083|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
94299818|NCT00749203|322882082|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
94299819|NCT00749203|322882083|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
94299820|NCT02722044|322882084|FG000|Overall Study|Adverse Event|2|||
94299821|NCT02722044|322882084|FG000|Overall Study|Physician Decision|1|||
94299822|NCT02722044|322882084|FG000|Overall Study|Withdrawal by Subject|1|||
94299823|NCT02722044|322882084|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
94299824|NCT04826900|322882085|FG000|Overall Study|Family factor|1|||
94299825|NCT04826900|322882086|FG001|Overall Study|Family factor|1|||
94299826|NCT03372941|322882087|FG000|Overall Study|Lost to Follow-up|2|||
94299827|NCT03372941|322882088|FG001|Overall Study|Lost to Follow-up|4|||
94299828|NCT02328014|322883709|FG000|Overall Study|Adverse Event|1|||
94299829|NCT02328014|322883710|FG001|Overall Study|Adverse Event|0|||
94299830|NCT02328014|322883711|FG002|Overall Study|Adverse Event|0|||
94299831|NCT02328014|322883712|FG003|Overall Study|Adverse Event|1|||
94299832|NCT02328014|322883709|FG000|Overall Study|Death|0|||
94299833|NCT02328014|322883710|FG001|Overall Study|Death|0|||
94299834|NCT02328014|322883711|FG002|Overall Study|Death|0|||
94299835|NCT02328014|322883712|FG003|Overall Study|Death|4|||
94299836|NCT02328014|322883709|FG000|Overall Study|Physician Decision|0|||
94299837|NCT02328014|322883710|FG001|Overall Study|Physician Decision|0|||
94299838|NCT02328014|322883711|FG002|Overall Study|Physician Decision|0|||
94299839|NCT02328014|322883712|FG003|Overall Study|Physician Decision|1|||
94299840|NCT02328014|322883709|FG000|Overall Study|Disease Progression|1|||
94299841|NCT02328014|322883710|FG001|Overall Study|Disease Progression|0|||
94299842|NCT02328014|322883711|FG002|Overall Study|Disease Progression|1|||
94299843|NCT02328014|322883712|FG003|Overall Study|Disease Progression|3|||
94299844|NCT02328014|322883709|FG000|Overall Study|Study Terminated by Sponsor|4|||
94299845|NCT02328014|322883710|FG001|Overall Study|Study Terminated by Sponsor|1|||
94299846|NCT02328014|322883711|FG002|Overall Study|Study Terminated by Sponsor|1|||
94299847|NCT02328014|322883712|FG003|Overall Study|Study Terminated by Sponsor|0|||
94299848|NCT02328014|322883709|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
94299849|NCT02328014|322883710|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
94299850|NCT02328014|322883711|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
94299851|NCT02328014|322883712|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
94299852|NCT02328014|322883709|FG000|Overall Study|Withdrawal by Subject|0|||
94299853|NCT02328014|322883710|FG001|Overall Study|Withdrawal by Subject|0|||
94299854|NCT02328014|322883711|FG002|Overall Study|Withdrawal by Subject|0|||
94299855|NCT02328014|322883712|FG003|Overall Study|Withdrawal by Subject|1|||
94299856|NCT04770753|322883713|FG000|Overall Study|Randomized, never treated|1|||
94299857|NCT04770753|322883714|FG001|Overall Study|Randomized, never treated|1|||
94299858|NCT04770753|322883713|FG000|Overall Study|Withdrawal by Subject|3|||
94299859|NCT04770753|322883714|FG001|Overall Study|Withdrawal by Subject|1|||
94299860|NCT04770753|322883713|FG000|Overall Study|Adverse Event|2|||
94299861|NCT04770753|322883714|FG001|Overall Study|Adverse Event|0|||
94299862|NCT04770753|322883713|FG000|Overall Study|Pregnancy|1|||
94299863|NCT04770753|322883714|FG001|Overall Study|Pregnancy|0|||
94299864|NCT04770753|322883713|FG000|Overall Study|Other un-specified|1|||
94299865|NCT04770753|322883714|FG001|Overall Study|Other un-specified|0|||
94299866|NCT03945773|322883715|FG000|Overall Study|Consent Withdrawn|1|||
94299867|NCT03945773|322883716|FG001|Overall Study|Consent Withdrawn|1|||
94299868|NCT03945773|322883715|FG000|Overall Study|Lost to Follow-up|1|||
94299869|NCT03945773|322883716|FG001|Overall Study|Lost to Follow-up|0|||
94299870|NCT03945773|322883715|FG000|Overall Study|Death|46|||
94299871|NCT03945773|322883716|FG001|Overall Study|Death|22|||
94299872|NCT03945773|322883715|FG000|Overall Study|Physician Decision|1|||
94299873|NCT03945773|322883716|FG001|Overall Study|Physician Decision|0|||
94299874|NCT03945773|322883715|FG000|Overall Study|Other|1|||
94299875|NCT03945773|322883716|FG001|Overall Study|Other|0|||
94299876|NCT03945773|322883715|FG000|Overall Study|Ongoing at the time of DCO|4|||
94299877|NCT03945773|322883716|FG001|Overall Study|Ongoing at the time of DCO|3|||
94299878|NCT03896581|322883719|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
94299879|NCT03896581|322883720|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
94299880|NCT03896581|322883719|FG000|Overall Study|Withdrawal by Subject|4|||
94299881|NCT03896581|322883720|FG001|Overall Study|Withdrawal by Subject|1|||
94299882|NCT03896581|322883719|FG000|Overall Study|Lost to Follow-up|1|||
94299883|NCT03896581|322883720|FG001|Overall Study|Lost to Follow-up|0|||
94299884|NCT03896581|322883719|FG000|Overall Study|Lack of Efficacy|2|||
94299885|NCT03896581|322883720|FG001|Overall Study|Lack of Efficacy|1|||
94299886|NCT03896581|322883719|FG000|Overall Study|Adverse event, non-fatal|0|||
94299887|NCT03896581|322883720|FG001|Overall Study|Adverse event, non-fatal|2|||
94299888|NCT05630846|322883721|FG000|Overall Study|Death|1|||
94299889|NCT05630846|322883722|FG001|Overall Study|Death|0|||
94299890|NCT05630846|322883723|FG002|Overall Study|Death|0|||
94299891|NCT05630846|322883724|FG003|Overall Study|Death|0|||
94299892|NCT05630846|322883721|FG000|Overall Study|Withdrawal by Subject|3|||
94299893|NCT05630846|322883722|FG001|Overall Study|Withdrawal by Subject|3|||
94299894|NCT05630846|322883723|FG002|Overall Study|Withdrawal by Subject|4|||
94299895|NCT05630846|322883724|FG003|Overall Study|Withdrawal by Subject|1|||
94299896|NCT05630846|322883721|FG000|Overall Study|Lost to Follow-up|6|||
94299897|NCT05630846|322883722|FG001|Overall Study|Lost to Follow-up|5|||
94299898|NCT05630846|322883723|FG002|Overall Study|Lost to Follow-up|2|||
94299899|NCT05630846|322883724|FG003|Overall Study|Lost to Follow-up|5|||
94299900|NCT05630846|322883721|FG000|Overall Study|Other|1|||
94299901|NCT05630846|322883722|FG001|Overall Study|Other|0|||
94299902|NCT05630846|322883723|FG002|Overall Study|Other|0|||
94299903|NCT05630846|322883724|FG003|Overall Study|Other|0|||
94299904|NCT04242446|322883726|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
94299905|NCT04242446|322883727|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
94299906|NCT04242446|322883728|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
94299907|NCT04242446|322883729|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
94299908|NCT04242446|322883730|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
94299909|NCT04242446|322883731|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
94299910|NCT04242446|322883732|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
94299911|NCT04242446|322883726|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
94299912|NCT04242446|322883727|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
94299913|NCT04242446|322883728|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
94299914|NCT04242446|322883729|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
94299915|NCT04242446|322883730|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
94299916|NCT04242446|322883731|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
94299917|NCT04242446|322883732|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
94299918|NCT04242446|322883726|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
94299919|NCT04242446|322883727|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
94299920|NCT04242446|322883728|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
94299921|NCT04242446|322883729|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
94299922|NCT04242446|322883730|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
94299923|NCT04242446|322883731|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
94299924|NCT04242446|322883732|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
94299925|NCT04242446|322883726|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
94299926|NCT04242446|322883727|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
94299927|NCT04242446|322883728|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
94299928|NCT04242446|322883729|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
94299929|NCT04242446|322883730|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
94299930|NCT04242446|322883731|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
94299931|NCT04242446|322883732|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
94299932|NCT04242446|322883726|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
94299933|NCT04242446|322883727|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
94299934|NCT04242446|322883728|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
94299935|NCT04242446|322883729|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
94299936|NCT04242446|322883730|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
94299937|NCT04242446|322883731|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
94299938|NCT04242446|322883732|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
94299939|NCT04242446|322883726|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
94299940|NCT04242446|322883727|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
94299941|NCT04242446|322883728|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
94299942|NCT04242446|322883729|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
94299943|NCT04242446|322883730|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
94299944|NCT04242446|322883731|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
94299945|NCT04242446|322883732|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
94299946|NCT04242446|322883726|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
94299947|NCT04242446|322883727|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
94299948|NCT04242446|322883728|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
94299949|NCT04242446|322883729|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
94299950|NCT04242446|322883730|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
94299951|NCT04242446|322883731|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
94299952|NCT04242446|322883732|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
94299953|NCT04242446|322883726|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
94299954|NCT04242446|322883727|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
94299955|NCT04242446|322883728|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
94299956|NCT04242446|322883729|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
94299957|NCT04242446|322883730|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
94299958|NCT04242446|322883731|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
94299959|NCT04242446|322883732|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
94299960|NCT04242446|322883726|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
94299961|NCT04242446|322883727|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
94299962|NCT04242446|322883728|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
94299963|NCT04242446|322883729|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
94299964|NCT04242446|322883730|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
94299965|NCT04242446|322883731|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
94299966|NCT04242446|322883732|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
94299967|NCT04242446|322883726|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
94299968|NCT04242446|322883727|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
94299969|NCT04242446|322883728|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
94299970|NCT04242446|322883729|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
94299971|NCT04242446|322883730|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
94299972|NCT04242446|322883731|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
94299973|NCT04242446|322883732|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
94299974|NCT04242446|322883726|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
94299975|NCT04242446|322883727|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
94299976|NCT04242446|322883728|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
94299977|NCT04242446|322883729|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
94299978|NCT04242446|322883730|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
94299979|NCT04242446|322883731|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
94299980|NCT04242446|322883732|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
94299981|NCT04242446|322883726|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
94299982|NCT04242446|322883727|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
94373157|NCT02454972|323152383|FG005|Overall Study|Never treated|0|||
94373158|NCT02454972|323152384|FG006|Overall Study|Never treated|0|||
94373159|NCT02454972|323152385|FG007|Overall Study|Never treated|0|||
94373160|NCT02454972|323152386|FG008|Overall Study|Never treated|5|||
94373161|NCT02454972|323152378|FG000|Overall Study|Lost to Follow-up|0|||
94373162|NCT02454972|323152379|FG001|Overall Study|Lost to Follow-up|0|||
94373163|NCT02454972|323152380|FG002|Overall Study|Lost to Follow-up|0|||
94373164|NCT02454972|323152381|FG003|Overall Study|Lost to Follow-up|0|||
94373165|NCT02454972|323152382|FG004|Overall Study|Lost to Follow-up|0|||
94373166|NCT02454972|323152383|FG005|Overall Study|Lost to Follow-up|0|||
94373167|NCT02454972|323152384|FG006|Overall Study|Lost to Follow-up|0|||
94373168|NCT02454972|323152385|FG007|Overall Study|Lost to Follow-up|0|||
94373169|NCT02454972|323152386|FG008|Overall Study|Lost to Follow-up|2|||
94373170|NCT02454972|323152378|FG000|Overall Study|Study termination|0|||
94373171|NCT02454972|323152379|FG001|Overall Study|Study termination|0|||
94373172|NCT02454972|323152380|FG002|Overall Study|Study termination|0|||
94373173|NCT02454972|323152381|FG003|Overall Study|Study termination|0|||
94373174|NCT02454972|323152382|FG004|Overall Study|Study termination|0|||
94299983|NCT04242446|322883728|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
94299984|NCT04242446|322883729|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
94299985|NCT04242446|322883730|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
94299986|NCT04242446|322883731|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
94299987|NCT04242446|322883732|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
94299988|NCT04242446|322883726|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
94299989|NCT04242446|322883727|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
94299990|NCT04242446|322883728|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
94299991|NCT04242446|322883729|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
94299992|NCT04242446|322883730|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
94299993|NCT04242446|322883731|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
94299994|NCT04242446|322883732|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
94299995|NCT04242446|322883726|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
94299996|NCT04242446|322883727|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
94299997|NCT04242446|322883728|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
94299998|NCT04242446|322883729|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
94299999|NCT04242446|322883730|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
94300000|NCT04242446|322883731|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
94300001|NCT04242446|322883732|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
94300002|NCT04242446|322883726|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
94300003|NCT04242446|322883727|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
94300004|NCT04242446|322883728|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
94300005|NCT04242446|322883729|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
94300006|NCT04242446|322883730|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
94300007|NCT04242446|322883731|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
94300008|NCT04242446|322883732|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
94300009|NCT04242446|322883726|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
94300010|NCT04242446|322883727|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
94300011|NCT04242446|322883728|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
94300012|NCT04242446|322883729|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
94300013|NCT04242446|322883730|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
94300014|NCT04242446|322883731|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
94300015|NCT04242446|322883732|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
94300016|NCT04242446|322883726|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
94300017|NCT04242446|322883727|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
94300018|NCT04242446|322883728|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
94300019|NCT04242446|322883729|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
94300020|NCT04242446|322883730|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
94300021|NCT04242446|322883731|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
94300022|NCT04242446|322883732|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
94300023|NCT04242446|322883726|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
94300024|NCT04242446|322883727|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
94300025|NCT04242446|322883728|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
94300026|NCT04242446|322883729|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
94300027|NCT04242446|322883730|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
94300028|NCT04242446|322883731|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
94300029|NCT04242446|322883732|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
94300030|NCT04242446|322883726|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
94300031|NCT04242446|322883727|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
94300032|NCT04242446|322883728|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
94300033|NCT04242446|322883729|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
94300034|NCT04242446|322883730|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
94300035|NCT04242446|322883731|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
94300036|NCT04242446|322883732|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
94300037|NCT04242446|322883726|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
94300038|NCT04242446|322883727|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
94300039|NCT04242446|322883728|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
94300040|NCT04242446|322883729|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
94300041|NCT04242446|322883730|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
94300042|NCT04242446|322883731|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
94300043|NCT04242446|322883732|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
94300044|NCT04242446|322883726|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
94300045|NCT04242446|322883727|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
94300046|NCT04242446|322883728|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
94300047|NCT04242446|322883729|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
94300048|NCT04242446|322883730|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
94300049|NCT04242446|322883731|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
94300050|NCT04242446|322883732|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
94300051|NCT04242446|322883726|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
94300052|NCT04242446|322883727|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
94300053|NCT04242446|322883728|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
94300054|NCT04242446|322883729|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
94300055|NCT04242446|322883730|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
94300056|NCT04242446|322883731|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
94300057|NCT04242446|322883732|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
94300058|NCT04242446|322883726|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
94300059|NCT04242446|322883727|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
94300060|NCT04242446|322883728|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
94300061|NCT04242446|322883729|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
94300062|NCT04242446|322883730|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
94300063|NCT04242446|322883731|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
94300064|NCT04242446|322883732|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
94300065|NCT04242446|322883726|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
94300066|NCT04242446|322883727|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
94300067|NCT04242446|322883728|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
94300068|NCT04242446|322883729|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
94300069|NCT04242446|322883730|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
94300070|NCT04242446|322883731|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
94300071|NCT04242446|322883732|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
94300072|NCT02031679|322883733|FG000|Overall Study|Protocol Violation|0|||
94300073|NCT02031679|322883734|FG001|Overall Study|Protocol Violation|1|||
94300074|NCT02031679|322883733|FG000|Overall Study|Lack of Efficacy|0|||
94300075|NCT02031679|322883734|FG001|Overall Study|Lack of Efficacy|1|||
94300076|NCT02224664|322883735|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
94300077|NCT02224664|322883736|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
94300078|NCT02224664|322883737|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
94300079|NCT02224664|322883738|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
94300080|NCT02224664|322883739|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
94300081|NCT02224664|322883735|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
94300082|NCT02224664|322883736|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
94300083|NCT02224664|322883737|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
94300084|NCT02224664|322883738|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
94300085|NCT02224664|322883739|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
94300086|NCT02224664|322883735|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
94300087|NCT02224664|322883736|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
94300088|NCT02224664|322883737|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
94300089|NCT02224664|322883738|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
94300090|NCT02224664|322883739|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
94300091|NCT01024244|322883749|FG000|Overall Study|Adverse Event|1|||
94300092|NCT01024244|322883750|FG001|Overall Study|Adverse Event|2|||
94300093|NCT01024244|322883751|FG002|Overall Study|Adverse Event|0|||
94300094|NCT01024244|322883752|FG003|Overall Study|Adverse Event|1|||
94300095|NCT01024244|322883753|FG004|Overall Study|Adverse Event|2|||
94300096|NCT01024244|322883749|FG000|Overall Study|Entry Criteria Not Met|0|||
94300097|NCT01024244|322883750|FG001|Overall Study|Entry Criteria Not Met|1|||
94300098|NCT01024244|322883751|FG002|Overall Study|Entry Criteria Not Met|0|||
94300099|NCT01024244|322883752|FG003|Overall Study|Entry Criteria Not Met|0|||
94300100|NCT01024244|322883753|FG004|Overall Study|Entry Criteria Not Met|0|||
94468069|NCT01764997|323502500|FG004|Run-in Period|Other than specified above|0|||
94468070|NCT01764997|323502496|FG000|Study Drug Treatment Period|Adverse Event|0|||
94468071|NCT01764997|323502497|FG001|Study Drug Treatment Period|Adverse Event|1|||
94468072|NCT01764997|323502498|FG002|Study Drug Treatment Period|Adverse Event|0|||
94468073|NCT01764997|323502499|FG003|Study Drug Treatment Period|Adverse Event|0|||
94468074|NCT01764997|323502500|FG004|Study Drug Treatment Period|Adverse Event|24|||
94468075|NCT01764997|323502496|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
94468076|NCT01764997|323502497|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
94468077|NCT01764997|323502498|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
94468078|NCT01764997|323502499|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
94468079|NCT01764997|323502500|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
94468080|NCT01764997|323502496|FG000|Study Drug Treatment Period|Other than specified above|0|||
94468081|NCT01764997|323502497|FG001|Study Drug Treatment Period|Other than specified above|0|||
94300101|NCT01024244|322883749|FG000|Overall Study|Lack of Efficacy|1|||
94300102|NCT01024244|322883750|FG001|Overall Study|Lack of Efficacy|0|||
94300103|NCT01024244|322883751|FG002|Overall Study|Lack of Efficacy|0|||
94300104|NCT01024244|322883752|FG003|Overall Study|Lack of Efficacy|0|||
94300105|NCT01024244|322883753|FG004|Overall Study|Lack of Efficacy|0|||
94300106|NCT01024244|322883749|FG000|Overall Study|Protocol Violation|1|||
94300107|NCT01024244|322883750|FG001|Overall Study|Protocol Violation|0|||
94300108|NCT01024244|322883751|FG002|Overall Study|Protocol Violation|0|||
94300109|NCT01024244|322883752|FG003|Overall Study|Protocol Violation|0|||
94300110|NCT01024244|322883753|FG004|Overall Study|Protocol Violation|2|||
94300111|NCT01024244|322883749|FG000|Overall Study|Sponsor Decision|14|||
94300112|NCT01024244|322883750|FG001|Overall Study|Sponsor Decision|7|||
94300113|NCT01024244|322883751|FG002|Overall Study|Sponsor Decision|14|||
94300114|NCT01024244|322883752|FG003|Overall Study|Sponsor Decision|12|||
94300115|NCT01024244|322883753|FG004|Overall Study|Sponsor Decision|10|||
94300116|NCT01024244|322883749|FG000|Overall Study|Withdrawal by Subject|0|||
94300117|NCT01024244|322883750|FG001|Overall Study|Withdrawal by Subject|1|||
94300118|NCT01024244|322883751|FG002|Overall Study|Withdrawal by Subject|0|||
94300119|NCT01024244|322883752|FG003|Overall Study|Withdrawal by Subject|0|||
94373175|NCT02454972|323152383|FG005|Overall Study|Study termination|0|||
94373176|NCT02454972|323152384|FG006|Overall Study|Study termination|0|||
94373177|NCT02454972|323152385|FG007|Overall Study|Study termination|0|||
94373178|NCT02454972|323152386|FG008|Overall Study|Study termination|6|||
94373179|NCT02323295|323152387|FG000|Overall Study|Adverse Event|0|||
94373180|NCT02323295|323152388|FG001|Overall Study|Adverse Event|1|||
94373181|NCT02323295|323152387|FG000|Overall Study|Withdrawal by Subject|0|||
94373182|NCT02323295|323152388|FG001|Overall Study|Withdrawal by Subject|1|||
94373183|NCT02323295|323152387|FG000|Overall Study|Patient did not have surgery as planned.|0|||
94373184|NCT02323295|323152388|FG001|Overall Study|Patient did not have surgery as planned.|1|||
94373185|NCT00830063|323152389|FG000|Overall Study|Adverse Event|7|||
94373186|NCT00830063|323152390|FG001|Overall Study|Adverse Event|13|||
94373187|NCT00830063|323152391|FG002|Overall Study|Adverse Event|16|||
94373188|NCT00830063|323152392|FG003|Overall Study|Adverse Event|13|||
94373189|NCT00830063|323152389|FG000|Overall Study|Death|1|||
94373190|NCT00830063|323152390|FG001|Overall Study|Death|0|||
94373191|NCT00830063|323152391|FG002|Overall Study|Death|0|||
94373192|NCT00830063|323152392|FG003|Overall Study|Death|0|||
94373193|NCT00830063|323152389|FG000|Overall Study|Lost to Follow-up|0|||
94373194|NCT00830063|323152390|FG001|Overall Study|Lost to Follow-up|0|||
94373195|NCT00830063|323152391|FG002|Overall Study|Lost to Follow-up|3|||
94373196|NCT00830063|323152392|FG003|Overall Study|Lost to Follow-up|1|||
94373197|NCT00830063|323152389|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
94373198|NCT00830063|323152390|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
94373199|NCT00830063|323152391|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
94373200|NCT00830063|323152392|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
94373201|NCT00830063|323152389|FG000|Overall Study|Lack of Efficacy|51|||
94373202|NCT00830063|323152390|FG001|Overall Study|Lack of Efficacy|23|||
94300120|NCT01024244|322883753|FG004|Overall Study|Withdrawal by Subject|0|||
94300121|NCT02489318|322883756|FG000|Randomized|Withdrawal by Subject|0|||
94373203|NCT00830063|323152391|FG002|Overall Study|Lack of Efficacy|25|||
94373204|NCT00830063|323152392|FG003|Overall Study|Lack of Efficacy|32|||
94373205|NCT00830063|323152389|FG000|Overall Study|Other|5|||
94373206|NCT00830063|323152390|FG001|Overall Study|Other|5|||
94300122|NCT02489318|322883757|FG001|Randomized|Withdrawal by Subject|1|||
94300123|NCT02489318|322883756|FG000|Treated|Adverse Event|19|||
94300124|NCT02489318|322883757|FG001|Treated|Adverse Event|62|||
94300125|NCT02489318|322883756|FG000|Treated|Death|13|||
94300126|NCT02489318|322883757|FG001|Treated|Death|11|||
94373207|NCT00830063|323152391|FG002|Overall Study|Other|8|||
94468082|NCT01764997|323502498|FG002|Study Drug Treatment Period|Other than specified above|0|||
94468083|NCT01764997|323502499|FG003|Study Drug Treatment Period|Other than specified above|0|||
94468084|NCT01764997|323502500|FG004|Study Drug Treatment Period|Other than specified above|10|||
94373208|NCT00830063|323152392|FG003|Overall Study|Other|6|||
94373209|NCT00830063|323152389|FG000|Overall Study|Withdrawal by Subject|16|||
94373210|NCT00830063|323152390|FG001|Overall Study|Withdrawal by Subject|10|||
94373211|NCT00830063|323152391|FG002|Overall Study|Withdrawal by Subject|16|||
94373212|NCT00830063|323152392|FG003|Overall Study|Withdrawal by Subject|13|||
94373213|NCT00830063|323152389|FG000|Overall Study|Protocol Violation|1|||
94373214|NCT00830063|323152390|FG001|Overall Study|Protocol Violation|0|||
94373215|NCT00830063|323152391|FG002|Overall Study|Protocol Violation|3|||
94373216|NCT00830063|323152392|FG003|Overall Study|Protocol Violation|2|||
94373217|NCT00830063|323152389|FG000|Overall Study|Randomized But Not Treated|0|||
94373218|NCT00830063|323152390|FG001|Overall Study|Randomized But Not Treated|2|||
94373219|NCT00830063|323152391|FG002|Overall Study|Randomized But Not Treated|0|||
94373220|NCT00830063|323152392|FG003|Overall Study|Randomized But Not Treated|2|||
94373221|NCT00775983|323152398|FG000|Overall Study|Protocol Violation|1|||
94373222|NCT00775983|323152399|FG001|Overall Study|Protocol Violation|2|||
94373223|NCT03763331|323152400|FG000|Overall Study|Lost to Follow-up|1|||
94373224|NCT03763331|323152401|FG001|Overall Study|Lost to Follow-up|0|||
94373225|NCT03763331|323152400|FG000|Overall Study|Withdrawal by Subject|1|||
94373226|NCT03763331|323152401|FG001|Overall Study|Withdrawal by Subject|0|||
94373227|NCT03763331|323152400|FG000|Overall Study|Non-compliance|0|||
94373228|NCT03763331|323152401|FG001|Overall Study|Non-compliance|3|||
94373229|NCT01312779|323152402|FG000|Overall Study|Withdrawal by Subject|2|||
94373230|NCT01312779|323152402|FG000|Overall Study|Death|3|||
94373231|NCT01312779|323152402|FG000|Overall Study|Not Implanted with Device|27|||
94373232|NCT00597584|323152403|FG000|Overall Study|Adverse Event|4|||
94373233|NCT00597584|323152404|FG001|Overall Study|Adverse Event|2|||
94373234|NCT00597584|323152403|FG000|Overall Study|Death|53|||
94373235|NCT00597584|323152404|FG001|Overall Study|Death|30|||
94373236|NCT00597584|323152403|FG000|Overall Study|Lack of Efficacy|1|||
94373237|NCT00597584|323152404|FG001|Overall Study|Lack of Efficacy|0|||
94373238|NCT00597584|323152403|FG000|Overall Study|Lost to Follow-up|2|||
94373239|NCT00597584|323152404|FG001|Overall Study|Lost to Follow-up|4|||
94373240|NCT00597584|323152403|FG000|Overall Study|Physician Decision|3|||
94373241|NCT00597584|323152404|FG001|Overall Study|Physician Decision|0|||
94373242|NCT00597584|323152403|FG000|Overall Study|Pregnancy|2|||
94373243|NCT00597584|323152404|FG001|Overall Study|Pregnancy|0|||
94373244|NCT00597584|323152403|FG000|Overall Study|Withdrawal by Subject|44|||
94373245|NCT00597584|323152404|FG001|Overall Study|Withdrawal by Subject|12|||
94373246|NCT00597584|323152403|FG000|Overall Study|Discontinued Dialysis|0|||
94373247|NCT00597584|323152404|FG001|Overall Study|Discontinued Dialysis|1|||
94373248|NCT00597584|323152403|FG000|Overall Study|Lost ability to consent|1|||
94373249|NCT00597584|323152404|FG001|Overall Study|Lost ability to consent|1|||
94373250|NCT00597584|323152403|FG000|Overall Study|Never dosed|1|||
94468085|NCT03646305|323502501|FG000|Overall Study|Lost to Follow-up|4|||
94300127|NCT02489318|322883756|FG000|Treated|Physician Decision|4|||
94300128|NCT02489318|322883757|FG001|Treated|Physician Decision|6|||
94300129|NCT02489318|322883756|FG000|Treated|Protocol Violation|1|||
94300130|NCT02489318|322883757|FG001|Treated|Protocol Violation|2|||
94300131|NCT02489318|322883756|FG000|Treated|Withdrawal by Subject|37|||
94300132|NCT02489318|322883757|FG001|Treated|Withdrawal by Subject|36|||
94300133|NCT02489318|322883756|FG000|Treated|Other: Progressive Disease|245|||
94300134|NCT02489318|322883757|FG001|Treated|Other: Progressive Disease|138|||
94300135|NCT02489318|322883756|FG000|Treated|Other|0|||
94300136|NCT02489318|322883757|FG001|Treated|Other|2|||
94300137|NCT02489318|322883756|FG000|Treated|Ongoing|0|||
94300138|NCT02489318|322883757|FG001|Treated|Ongoing|267|||
94300139|NCT01793792|322883758|FG000|Overall Study|Death|5|||
94300140|NCT01793792|322883758|FG000|Overall Study|Lost to Follow-up|5|||
94300141|NCT01793792|322883758|FG000|Overall Study|Withdrawal by Subject|1|||
94300142|NCT01793792|322883758|FG000|Overall Study|Device Not Implanted|1|||
94300143|NCT05224258|322883761|FG000|Overall Study|Withdrawal by Subject|1|||
94300144|NCT05224258|322883762|FG001|Overall Study|Withdrawal by Subject|1|||
94300145|NCT05224258|322883761|FG000|Overall Study|Physician Decision|1|||
94300146|NCT05224258|322883762|FG001|Overall Study|Physician Decision|1|||
94373251|NCT00597584|323152404|FG001|Overall Study|Never dosed|0|||
94373252|NCT00597584|323152403|FG000|Overall Study|Relocation|8|||
94373253|NCT00597584|323152404|FG001|Overall Study|Relocation|6|||
94373254|NCT00597584|323152403|FG000|Overall Study|Renal transplant|9|||
94373255|NCT00597584|323152404|FG001|Overall Study|Renal transplant|7|||
94373256|NCT00881959|323152407|FG000|Overall Study|Lost to Follow-up|2|||
94373257|NCT00881959|323152408|FG001|Overall Study|Lost to Follow-up|4|||
94300147|NCT05224258|322883761|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
94300148|NCT05224258|322883762|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94300149|NCT05224258|322883761|FG000|Overall Study|Study Product No Longer in Use|1|||
94300150|NCT05224258|322883762|FG001|Overall Study|Study Product No Longer in Use|0|||
94373258|NCT02791659|323152409|FG000|Overall Study|Protocol Violation|0|||
94373259|NCT02791659|323152410|FG001|Overall Study|Protocol Violation|1|||
94373260|NCT02762565|323152413|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
94373261|NCT02143947|323152414|FG000|Overall Study|Lost to Follow-up|4|||
94373262|NCT02143947|323152415|FG001|Overall Study|Lost to Follow-up|2|||
94373263|NCT04228302|323152418|FG000|Overall Study|Adverse Event|0|||
94373264|NCT04228302|323152419|FG001|Overall Study|Adverse Event|0|||
94373265|NCT04228302|323152420|FG002|Overall Study|Adverse Event|0|||
94373266|NCT04228302|323152421|FG003|Overall Study|Adverse Event|0|||
94373267|NCT04228302|323152422|FG004|Overall Study|Adverse Event|1|||
94373268|NCT04228302|323152423|FG005|Overall Study|Adverse Event|0|||
94373269|NCT01967888|323152424|FG000|Overall Study|Lost to Follow-up|6|||
94373270|NCT01967888|323152425|FG001|Overall Study|Lost to Follow-up|4|||
94373271|NCT01967888|323152424|FG000|Overall Study|Withdrawal by Subject|1|||
94373272|NCT01967888|323152425|FG001|Overall Study|Withdrawal by Subject|1|||
94373273|NCT01967888|323152424|FG000|Overall Study|Did Not Have Transplant|1|||
94373274|NCT01967888|323152425|FG001|Overall Study|Did Not Have Transplant|0|||
94373275|NCT01967888|323152424|FG000|Overall Study|Research visit not done, data recorded|1|||
94373276|NCT01967888|323152425|FG001|Overall Study|Research visit not done, data recorded|0|||
94373277|NCT01967888|323152424|FG000|Overall Study|Subject excluded after randomization|1|||
94373278|NCT01967888|323152425|FG001|Overall Study|Subject excluded after randomization|0|||
94373279|NCT01967888|323152424|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
94373280|NCT01967888|323152425|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
94373281|NCT01967888|323152424|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
94373282|NCT01967888|323152425|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
94373283|NCT00267007|323152433|FG000|Overall Study|Withdrawal by Subject|6|||
94373284|NCT00267007|323152434|FG001|Overall Study|Withdrawal by Subject|0|||
94373285|NCT00267007|323152433|FG000|Overall Study|Lost to Follow-up|1|||
94373286|NCT00267007|323152434|FG001|Overall Study|Lost to Follow-up|0|||
94373287|NCT00267007|323152433|FG000|Overall Study|Non-compliance|0|||
94373288|NCT00267007|323152434|FG001|Overall Study|Non-compliance|1|||
94373289|NCT00267007|323152433|FG000|Overall Study|Adverse Event|1|||
94373290|NCT00267007|323152434|FG001|Overall Study|Adverse Event|0|||
94373291|NCT00849524|323152435|FG000|Overall Study|Lack of Efficacy|3|||
94373292|NCT01418352|323152436|FG000|Overall Study|Lost to Follow-up|2|||
94373293|NCT01418352|323152437|FG001|Overall Study|Lost to Follow-up|0|||
94373294|NCT01418352|323152438|FG002|Overall Study|Lost to Follow-up|0|||
94373295|NCT01418352|323152439|FG003|Overall Study|Lost to Follow-up|0|||
94373296|NCT01418352|323152436|FG000|Overall Study|Adverse Event|0|||
94373297|NCT01418352|323152437|FG001|Overall Study|Adverse Event|1|||
94373298|NCT01418352|323152438|FG002|Overall Study|Adverse Event|0|||
94373299|NCT01418352|323152439|FG003|Overall Study|Adverse Event|0|||
94373300|NCT01418352|323152436|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
94373301|NCT01418352|323152437|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
94373302|NCT01418352|323152438|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
94373303|NCT01418352|323152439|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
94373304|NCT01418352|323152436|FG000|Overall Study|Subject Withdrew Consent|0|||
94373305|NCT01418352|323152437|FG001|Overall Study|Subject Withdrew Consent|1|||
94373306|NCT01418352|323152438|FG002|Overall Study|Subject Withdrew Consent|2|||
94373307|NCT01418352|323152439|FG003|Overall Study|Subject Withdrew Consent|1|||
94373308|NCT01418352|323152436|FG000|Overall Study|Protocol Deviation|0|||
94373309|NCT01418352|323152437|FG001|Overall Study|Protocol Deviation|0|||
94373310|NCT01418352|323152438|FG002|Overall Study|Protocol Deviation|1|||
94373311|NCT01418352|323152439|FG003|Overall Study|Protocol Deviation|0|||
94373312|NCT01418352|323152436|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
94373313|NCT01418352|323152437|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
94373314|NCT01418352|323152438|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
94373315|NCT01418352|323152439|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
94373316|NCT03840135|323152442|FG000|Overall Study|Protocol Violation|6|||
94373317|NCT03840135|323152443|FG001|Overall Study|Protocol Violation|1|||
94373318|NCT03840135|323152442|FG000|Overall Study|Withdrawal by Subject|1|||
94373319|NCT03840135|323152443|FG001|Overall Study|Withdrawal by Subject|0|||
94373320|NCT00475852|323152445|FG000|Overall Study|Death|444|||
94373321|NCT00475852|323152446|FG001|Overall Study|Death|456|||
94373322|NCT00475852|323152445|FG000|Overall Study|Withdrawal by Subject|19|||
94373323|NCT00475852|323152446|FG001|Overall Study|Withdrawal by Subject|24|||
94373324|NCT00475852|323152445|FG000|Overall Study|Lost to Follow-up|54|||
94373325|NCT00475852|323152446|FG001|Overall Study|Lost to Follow-up|68|||
94300151|NCT05224258|322883761|FG000|Overall Study|Adverse Event|0|||
94300152|NCT05224258|322883762|FG001|Overall Study|Adverse Event|1|||
94300153|NCT05224258|322883761|FG000|Overall Study|Protocol Deviation|0|||
94300154|NCT05224258|322883762|FG001|Overall Study|Protocol Deviation|1|||
94300155|NCT04988295|322883763|FG000|Overall Study|Withdrawal by Subject|9|||
94300156|NCT04988295|322883764|FG001|Overall Study|Withdrawal by Subject|29|||
94300157|NCT04988295|322883765|FG002|Overall Study|Withdrawal by Subject|6|||
94300158|NCT04988295|322883766|FG003|Overall Study|Withdrawal by Subject|0|||
94300159|NCT04988295|322883763|FG000|Overall Study|Lost to Follow-up|1|||
94300160|NCT04988295|322883764|FG001|Overall Study|Lost to Follow-up|0|||
94300161|NCT04988295|322883765|FG002|Overall Study|Lost to Follow-up|0|||
94300162|NCT04988295|322883766|FG003|Overall Study|Lost to Follow-up|0|||
94300163|NCT04988295|322883763|FG000|Overall Study|Study participation ongoing|186|||
94300164|NCT04988295|322883764|FG001|Overall Study|Study participation ongoing|169|||
94300165|NCT04988295|322883765|FG002|Overall Study|Study participation ongoing|99|||
94300166|NCT04988295|322883766|FG003|Overall Study|Study participation ongoing|119|||
94300167|NCT04083976|322883767|FG000|Overall Study|Lost to Follow-up|3|||
94300168|NCT04083976|322883768|FG001|Overall Study|Lost to Follow-up|0|||
94300169|NCT04083976|322883769|FG002|Overall Study|Lost to Follow-up|0|||
94300170|NCT04083976|322883770|FG003|Overall Study|Lost to Follow-up|1|||
94300171|NCT04083976|322883767|FG000|Overall Study|Withdrawal by Subject|16|||
94300172|NCT04083976|322883768|FG001|Overall Study|Withdrawal by Subject|1|||
94300173|NCT04083976|322883769|FG002|Overall Study|Withdrawal by Subject|9|||
94300174|NCT04083976|322883770|FG003|Overall Study|Withdrawal by Subject|0|||
94300175|NCT04083976|322883767|FG000|Overall Study|Sponsor Decision|14|||
94300176|NCT04083976|322883768|FG001|Overall Study|Sponsor Decision|0|||
94300177|NCT04083976|322883769|FG002|Overall Study|Sponsor Decision|0|||
94300178|NCT04083976|322883770|FG003|Overall Study|Sponsor Decision|7|||
94300179|NCT04083976|322883767|FG000|Overall Study|Other|1|||
94300180|NCT04083976|322883768|FG001|Overall Study|Other|0|||
94300181|NCT04083976|322883769|FG002|Overall Study|Other|1|||
94300182|NCT04083976|322883770|FG003|Overall Study|Other|0|||
94300183|NCT04462536|322883771|FG000|Overall Study|Withdrawal by Subject|3|||
94300184|NCT04462536|322883772|FG001|Overall Study|Withdrawal by Subject|9|||
94300185|NCT04462536|322883771|FG000|Overall Study|Lost to Follow-up|2|||
94300186|NCT04462536|322883772|FG001|Overall Study|Lost to Follow-up|4|||
94300187|NCT03895203|322883775|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
94300188|NCT03895203|322883776|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
94300189|NCT03895203|322883777|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
94300190|NCT03895203|322883778|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
94300191|NCT03895203|322883779|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
94300192|NCT03895203|322883780|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
94300193|NCT03895203|322883775|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
94300194|NCT03895203|322883776|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
94300195|NCT03895203|322883777|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
94300196|NCT03895203|322883778|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
94300197|NCT03895203|322883779|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
94300198|NCT03895203|322883780|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
94300199|NCT03895203|322883775|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
94300200|NCT03895203|322883776|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
94300201|NCT03895203|322883777|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
94300202|NCT03895203|322883778|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
94300203|NCT03895203|322883779|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
94300204|NCT03895203|322883780|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
94300205|NCT03895203|322883775|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
94300206|NCT03895203|322883776|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
94300207|NCT03895203|322883777|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
94300208|NCT03895203|322883778|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
94300209|NCT03895203|322883779|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
94300210|NCT03895203|322883780|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
94300211|NCT03895203|322883775|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
94300212|NCT03895203|322883776|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
94300213|NCT03895203|322883777|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
94300214|NCT03895203|322883778|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
94300215|NCT03895203|322883779|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
94300216|NCT03895203|322883780|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
94300217|NCT03895203|322883775|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
94300218|NCT03895203|322883776|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
94300219|NCT03895203|322883777|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
94373326|NCT00272961|323152447|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
94373327|NCT00272961|323152448|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
94373328|NCT00272961|323152449|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
94373329|NCT00272961|323152450|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
94373330|NCT00272961|323152451|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
94373331|NCT00272961|323152447|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
94373332|NCT00272961|323152448|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
94373333|NCT00272961|323152449|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
94373334|NCT00272961|323152450|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
94373335|NCT00272961|323152451|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
94468086|NCT03646305|323502502|FG001|Overall Study|Lost to Follow-up|2|||
94468087|NCT03646305|323502503|FG002|Overall Study|Lost to Follow-up|2|||
94373336|NCT00272961|323152447|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
94373337|NCT00272961|323152448|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
94373338|NCT00272961|323152449|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
94373339|NCT00272961|323152450|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
94373340|NCT00272961|323152451|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
94373341|NCT00272961|323152447|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
94373342|NCT00272961|323152448|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
94373343|NCT00272961|323152449|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
94373344|NCT00272961|323152450|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
94373345|NCT00272961|323152451|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
94373346|NCT00272961|323152447|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
94373347|NCT00272961|323152448|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
94373348|NCT00272961|323152449|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
94373349|NCT00272961|323152450|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
94373350|NCT00272961|323152451|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
94373351|NCT00272961|323152447|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
94373352|NCT00272961|323152448|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
94373353|NCT00272961|323152449|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
94373354|NCT00272961|323152450|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
94373355|NCT00272961|323152451|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
94373356|NCT00272961|323152447|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
94373357|NCT00272961|323152448|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
94373358|NCT00272961|323152449|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
94373359|NCT00272961|323152450|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
94373360|NCT00272961|323152451|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
94373361|NCT00272961|323152447|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
94373362|NCT00272961|323152448|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
94373363|NCT00272961|323152449|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
94373364|NCT00272961|323152450|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
94373365|NCT00272961|323152451|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
94373366|NCT01361607|323152452|FG000|Overall Study|Adverse Event|38|||
94373367|NCT01361607|323152453|FG001|Overall Study|Adverse Event|29|||
94373368|NCT01361607|323152452|FG000|Overall Study|Withdrawal by Subject|19|||
94373369|NCT01361607|323152453|FG001|Overall Study|Withdrawal by Subject|8|||
94373370|NCT01361607|323152452|FG000|Overall Study|Withdrawal by Investigator|5|||
94373371|NCT01361607|323152453|FG001|Overall Study|Withdrawal by Investigator|3|||
94373372|NCT01361607|323152452|FG000|Overall Study|Lost to Follow-up|1|||
94373373|NCT01361607|323152453|FG001|Overall Study|Lost to Follow-up|0|||
94373374|NCT01361607|323152452|FG000|Overall Study|Met Withdrawal Criteria|1|||
94373375|NCT01361607|323152453|FG001|Overall Study|Met Withdrawal Criteria|1|||
94373376|NCT01401478|323152454|FG000|Overall Study|Study drug not available|6|||
94373377|NCT01401478|323152454|FG000|Overall Study|Adverse Event|5|||
94373378|NCT01401478|323152454|FG000|Overall Study|Hyperphosphatemia|5|||
94373379|NCT01401478|323152454|FG000|Overall Study|Lost to Follow-up|5|||
94373380|NCT01401478|323152454|FG000|Overall Study|Kidney transplantation|3|||
94373381|NCT01401478|323152454|FG000|Overall Study|Withdrawal by Subject|3|||
94373382|NCT01401478|323152454|FG000|Overall Study|Blood samples not available|1|||
94373383|NCT01401478|323152454|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
94373384|NCT01401478|323152454|FG000|Overall Study|Low intact parathyroid hormone|1|||
94373385|NCT01401478|323152454|FG000|Overall Study|Serious adverse event|1|||
94373386|NCT01809314|323152455|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
94373387|NCT01809314|323152455|FG000|Overall Study|Adverse Event|6|||
94373388|NCT01809314|323152455|FG000|Overall Study|Insufficient Therapeutic Response|14|||
94373389|NCT01809314|323152455|FG000|Overall Study|Lost to Follow-up|724|||
94373390|NCT03196791|323152456|FG000|Overall Study|Protocol Violation|7|||
94373391|NCT03196791|323152457|FG001|Overall Study|Protocol Violation|3|||
94373392|NCT03196791|323152456|FG000|Overall Study|Withdrawal by Subject|3|||
94468088|NCT03646305|323502504|FG003|Overall Study|Lost to Follow-up|1|||
94373393|NCT03196791|323152457|FG001|Overall Study|Withdrawal by Subject|2|||
94373394|NCT00219557|323152459|FG000|Phase 1|Lack of Efficacy|3|||
94373395|NCT00219557|323152460|FG001|Phase 1|Lack of Efficacy|0|||
94373396|NCT00219557|323152461|FG002|Phase 1|Lack of Efficacy|0|||
94373397|NCT00219557|323152459|FG000|Phase 1|Adverse Event|2|||
94373398|NCT00219557|323152460|FG001|Phase 1|Adverse Event|0|||
94373399|NCT00219557|323152461|FG002|Phase 1|Adverse Event|0|||
94373400|NCT00219557|323152459|FG000|Phase 1|Withdrawal by Subject|1|||
94373401|NCT00219557|323152460|FG001|Phase 1|Withdrawal by Subject|0|||
94373402|NCT00219557|323152461|FG002|Phase 1|Withdrawal by Subject|0|||
94373403|NCT00219557|323152459|FG000|Phase 1|Started chemotherapy at other institute|1|||
94373404|NCT00219557|323152460|FG001|Phase 1|Started chemotherapy at other institute|0|||
94373405|NCT00219557|323152461|FG002|Phase 1|Started chemotherapy at other institute|0|||
94373406|NCT00219557|323152459|FG000|Phase 2|Lack of Efficacy|0|||
94373407|NCT00219557|323152460|FG001|Phase 2|Lack of Efficacy|21|||
94373408|NCT00219557|323152461|FG002|Phase 2|Lack of Efficacy|15|||
94373409|NCT00219557|323152459|FG000|Phase 2|Adverse Event|0|||
94373410|NCT00219557|323152460|FG001|Phase 2|Adverse Event|22|||
94373411|NCT00219557|323152461|FG002|Phase 2|Adverse Event|2|||
94373412|NCT00219557|323152459|FG000|Phase 2|Death|0|||
94373413|NCT00219557|323152460|FG001|Phase 2|Death|8|||
94373414|NCT00219557|323152461|FG002|Phase 2|Death|2|||
94373415|NCT00219557|323152459|FG000|Phase 2|Other|0|||
94373416|NCT00219557|323152460|FG001|Phase 2|Other|8|||
94373417|NCT00219557|323152461|FG002|Phase 2|Other|6|||
94373418|NCT00219557|323152459|FG000|Phase 2|Withdrawal by Subject|0|||
94373419|NCT00219557|323152460|FG001|Phase 2|Withdrawal by Subject|9|||
94373420|NCT00219557|323152461|FG002|Phase 2|Withdrawal by Subject|5|||
94373421|NCT00219557|323152459|FG000|Phase 2|Treatment not received|0|||
94373422|NCT00219557|323152460|FG001|Phase 2|Treatment not received|1|||
94373423|NCT00219557|323152461|FG002|Phase 2|Treatment not received|3|||
94373424|NCT01427803|323152464|FG000|Overall Study|Lost to Follow-up|32|||
94373425|NCT01427803|323152465|FG001|Overall Study|Lost to Follow-up|26|||
94373426|NCT01427803|323152464|FG000|Overall Study|Withdrawal by Subject|20|||
94373427|NCT01427803|323152465|FG001|Overall Study|Withdrawal by Subject|0|||
94373428|NCT01427803|323152464|FG000|Overall Study|Unable to complete full treatment period|6|||
94373429|NCT01427803|323152465|FG001|Overall Study|Unable to complete full treatment period|0|||
94373430|NCT01427803|323152464|FG000|Overall Study|Protocol Violation|1|||
94373431|NCT01427803|323152465|FG001|Overall Study|Protocol Violation|0|||
94373432|NCT01427803|323152464|FG000|Overall Study|Physician Decision|3|||
94373433|NCT01427803|323152465|FG001|Overall Study|Physician Decision|0|||
94373434|NCT01427803|323152464|FG000|Overall Study|did not take product|1|||
94373435|NCT01427803|323152465|FG001|Overall Study|did not take product|0|||
94373436|NCT00415532|323152471|FG000|Treatment Period|Adverse Event|2|||
94373437|NCT00415532|323152472|FG001|Treatment Period|Adverse Event|3|||
94373438|NCT00415532|323152471|FG000|Treatment Period|Death|2|||
94373439|NCT00415532|323152472|FG001|Treatment Period|Death|1|||
94373440|NCT00415532|323152471|FG000|Treatment Period|Lost to Follow-up|1|||
94373441|NCT00415532|323152472|FG001|Treatment Period|Lost to Follow-up|1|||
94373442|NCT00415532|323152471|FG000|Treatment Period|Protocol Violation|1|||
94373443|NCT00415532|323152472|FG001|Treatment Period|Protocol Violation|0|||
94373444|NCT00415532|323152471|FG000|Treatment Period|Withdrawal by Subject|6|||
94373445|NCT00415532|323152472|FG001|Treatment Period|Withdrawal by Subject|6|||
94373446|NCT00415532|323152471|FG000|Treatment Period|Other|2|||
94373447|NCT00415532|323152472|FG001|Treatment Period|Other|2|||
94373448|NCT00415532|323152471|FG000|Treatment Period|Ineligibility determined|1|||
94373449|NCT00415532|323152472|FG001|Treatment Period|Ineligibility determined|1|||
94373450|NCT00415532|323152471|FG000|Treatment Period|Noncompliance|1|||
94373451|NCT00415532|323152472|FG001|Treatment Period|Noncompliance|1|||
94373452|NCT00415532|323152471|FG000|Treatment Period|Requirement for alternative therapy|1|||
94373453|NCT00415532|323152472|FG001|Treatment Period|Requirement for alternative therapy|0|||
94373454|NCT00415532|323152471|FG000|Safety Follow Up Period|Adverse Event|1|||
94373455|NCT00415532|323152472|FG001|Safety Follow Up Period|Adverse Event|3|||
94373456|NCT00415532|323152471|FG000|Safety Follow Up Period|Death|3|||
94373457|NCT00415532|323152472|FG001|Safety Follow Up Period|Death|0|||
94373458|NCT00415532|323152471|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
94373459|NCT00415532|323152472|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
94373460|NCT00415532|323152471|FG000|Safety Follow Up Period|Other|1|||
94373461|NCT00415532|323152472|FG001|Safety Follow Up Period|Other|4|||
94373462|NCT00415532|323152471|FG000|Safety Follow Up Period|Ineligibility determined|1|||
94373463|NCT00415532|323152472|FG001|Safety Follow Up Period|Ineligibility determined|1|||
94373464|NCT00415532|323152471|FG000|Safety Follow Up Period|Noncompliance|1|||
94373465|NCT00415532|323152472|FG001|Safety Follow Up Period|Noncompliance|0|||
94373466|NCT00415532|323152471|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
94373467|NCT00415532|323152472|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
94373468|NCT03063632|323152473|FG000|Overall Study|Death|4|||
94373469|NCT03063632|323152474|FG001|Overall Study|Death|6|||
94373470|NCT03063632|323152473|FG000|Overall Study|Lost to Follow-up|0|||
94373471|NCT03063632|323152474|FG001|Overall Study|Lost to Follow-up|1|||
94300220|NCT03895203|322883778|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
94300221|NCT03895203|322883779|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
94300222|NCT03895203|322883780|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
94300223|NCT03895203|322883775|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
94300224|NCT03895203|322883776|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
94300225|NCT03895203|322883777|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
94300226|NCT03895203|322883778|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
94300227|NCT03895203|322883779|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
94300228|NCT03895203|322883780|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
94300229|NCT03895203|322883775|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
94300230|NCT03895203|322883776|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
94300231|NCT03895203|322883777|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
94300232|NCT03895203|322883778|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
94300233|NCT03895203|322883779|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
94300234|NCT03895203|322883780|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
94300235|NCT03895203|322883775|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
94300236|NCT03895203|322883776|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
94300237|NCT03895203|322883777|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
94300238|NCT03895203|322883778|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
94300239|NCT03895203|322883779|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
94300240|NCT03895203|322883780|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
94300241|NCT03895203|322883775|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
94300242|NCT03895203|322883776|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
94300243|NCT03895203|322883777|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
94300244|NCT03895203|322883778|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
94300245|NCT03895203|322883779|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
94300246|NCT03895203|322883780|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
94300247|NCT03895203|322883775|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
94300248|NCT03895203|322883776|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
94300249|NCT03895203|322883777|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
94300250|NCT03895203|322883778|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
94300251|NCT03895203|322883779|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
94300252|NCT03895203|322883780|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
94300253|NCT03895203|322883775|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
94300254|NCT03895203|322883776|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
94300255|NCT03895203|322883777|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
94300256|NCT03895203|322883778|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
94300257|NCT03895203|322883779|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
94300258|NCT03895203|322883780|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
94300259|NCT03895203|322883775|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
94300260|NCT03895203|322883776|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
94300261|NCT03895203|322883777|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
94300262|NCT03895203|322883778|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
94300263|NCT03895203|322883779|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
94300264|NCT03895203|322883780|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
94300265|NCT03895203|322883775|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
94300266|NCT03895203|322883776|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
94300267|NCT03895203|322883777|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
94300268|NCT03895203|322883778|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
94300269|NCT03895203|322883779|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
94300270|NCT03895203|322883780|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
94300271|NCT02362035|322883781|FG000|Overall Study|Death|67|||
94300272|NCT02362035|322883781|FG000|Overall Study|Lost to Follow-up|3|||
94300273|NCT02362035|322883781|FG000|Overall Study|Adverse Event|1|||
94300274|NCT02362035|322883781|FG000|Overall Study|Physician Decision|1|||
94300275|NCT02362035|322883781|FG000|Overall Study|Subject started another cancer therapy|10|||
94300276|NCT02362035|322883781|FG000|Overall Study|Study terminated by sponsor|45|||
94300277|NCT02362035|322883781|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
94300278|NCT02362035|322883781|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
94300279|NCT02362035|322883781|FG000|Overall Study|Disease progression|11|||
94300280|NCT02362035|322883781|FG000|Overall Study|Withdrawal by Subject|20|||
94300281|NCT03801902|322883782|FG000|Overall Study|Did not receive protocol treatment.|1|||
94300282|NCT03801902|322883783|FG001|Overall Study|Did not receive protocol treatment.|0|||
94373472|NCT03063632|323152473|FG000|Overall Study|Withdrawal by Subject|0|||
94373473|NCT03063632|323152474|FG001|Overall Study|Withdrawal by Subject|2|||
94373474|NCT03063632|323152473|FG000|Overall Study|Physician Decision|2|||
94373475|NCT03063632|323152474|FG001|Overall Study|Physician Decision|0|||
94373476|NCT03063632|323152473|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
94373477|NCT03063632|323152474|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
94373478|NCT02570165|323152475|FG000|Overall Study|Adverse Event|1|||
94373479|NCT02570165|323152476|FG001|Overall Study|Adverse Event|0|||
94373480|NCT02570165|323152477|FG002|Overall Study|Adverse Event|2|||
94373481|NCT02570165|323152478|FG003|Overall Study|Adverse Event|0|||
94373482|NCT02570165|323152479|FG004|Overall Study|Adverse Event|0|||
94373483|NCT02570165|323152480|FG005|Overall Study|Adverse Event|0|||
94373484|NCT02570165|323152481|FG006|Overall Study|Adverse Event|0|||
94373485|NCT02570165|323152475|FG000|Overall Study|Lack of Efficacy|0|||
94373486|NCT02570165|323152476|FG001|Overall Study|Lack of Efficacy|1|||
94373487|NCT02570165|323152477|FG002|Overall Study|Lack of Efficacy|0|||
94373488|NCT02570165|323152478|FG003|Overall Study|Lack of Efficacy|0|||
94373489|NCT02570165|323152479|FG004|Overall Study|Lack of Efficacy|4|||
94373490|NCT02570165|323152480|FG005|Overall Study|Lack of Efficacy|0|||
94373491|NCT02570165|323152481|FG006|Overall Study|Lack of Efficacy|0|||
94373492|NCT02570165|323152475|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
94373493|NCT02570165|323152476|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
94373494|NCT02570165|323152477|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
94373495|NCT02570165|323152478|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
94373496|NCT02570165|323152479|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
94373497|NCT02570165|323152480|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
94373498|NCT02570165|323152481|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
94373499|NCT02570165|323152475|FG000|Overall Study|Lost to Follow-up|0|||
94373500|NCT02570165|323152476|FG001|Overall Study|Lost to Follow-up|0|||
94373501|NCT02570165|323152477|FG002|Overall Study|Lost to Follow-up|1|||
94373502|NCT02570165|323152478|FG003|Overall Study|Lost to Follow-up|1|||
94373503|NCT02570165|323152479|FG004|Overall Study|Lost to Follow-up|0|||
94373504|NCT02570165|323152480|FG005|Overall Study|Lost to Follow-up|0|||
94373505|NCT02570165|323152481|FG006|Overall Study|Lost to Follow-up|0|||
94373506|NCT02570165|323152475|FG000|Overall Study|Physician Decision|0|||
94373507|NCT02570165|323152476|FG001|Overall Study|Physician Decision|1|||
94373508|NCT02570165|323152477|FG002|Overall Study|Physician Decision|0|||
94373509|NCT02570165|323152478|FG003|Overall Study|Physician Decision|0|||
94373510|NCT02570165|323152479|FG004|Overall Study|Physician Decision|0|||
94373511|NCT02570165|323152480|FG005|Overall Study|Physician Decision|0|||
94373512|NCT02570165|323152481|FG006|Overall Study|Physician Decision|0|||
94373513|NCT02570165|323152475|FG000|Overall Study|Withdrawal by Subject|0|||
94373514|NCT02570165|323152476|FG001|Overall Study|Withdrawal by Subject|0|||
94373515|NCT02570165|323152477|FG002|Overall Study|Withdrawal by Subject|0|||
94373516|NCT02570165|323152478|FG003|Overall Study|Withdrawal by Subject|2|||
94373517|NCT02570165|323152479|FG004|Overall Study|Withdrawal by Subject|1|||
94373518|NCT02570165|323152480|FG005|Overall Study|Withdrawal by Subject|0|||
94373519|NCT02570165|323152481|FG006|Overall Study|Withdrawal by Subject|0|||
94373520|NCT02570165|323152475|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
94300283|NCT03801902|322883784|FG002|Overall Study|Did not receive protocol treatment.|0|||
94300284|NCT03801902|322883785|FG003|Overall Study|Did not receive protocol treatment.|0|||
94300285|NCT05027802|322883786|FG000|Overall Study|Adverse Event|2|||
94300286|NCT05027802|322883786|FG000|Overall Study|Withdrawal by Subject|18|||
94300287|NCT05027802|322883786|FG000|Overall Study|Death|2|||
94300288|NCT05027802|322883786|FG000|Overall Study|Other|1|||
94300289|NCT05040971|322883787|FG000|Overall Study|Withdrawal by Subject|0|||
94300290|NCT05040971|322883788|FG001|Overall Study|Withdrawal by Subject|2|||
94300291|NCT05040971|322883787|FG000|Overall Study|Lost to Follow-up|8|||
94300292|NCT05040971|322883788|FG001|Overall Study|Lost to Follow-up|3|||
94300293|NCT05040971|322883787|FG000|Overall Study|Death|2|||
94300294|NCT05040971|322883788|FG001|Overall Study|Death|0|||
94300295|NCT06161012|322883789|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
94300296|NCT06161012|322883790|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
94300297|NCT02601950|322883791|FG000|Overall Study|Participant enrolled in rollover study|0|||
94300298|NCT02601950|322883792|FG001|Overall Study|Participant enrolled in rollover study|0|||
94300299|NCT02601950|322883793|FG002|Overall Study|Participant enrolled in rollover study|1|||
94300300|NCT02601950|322883794|FG003|Overall Study|Participant enrolled in rollover study|0|||
94300301|NCT02601950|322883795|FG004|Overall Study|Participant enrolled in rollover study|1|||
94373521|NCT02570165|323152476|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
94373522|NCT02570165|323152477|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
94373523|NCT02570165|323152478|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
94373524|NCT02570165|323152479|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
94373525|NCT02570165|323152480|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
94300302|NCT02601950|322883796|FG005|Overall Study|Participant enrolled in rollover study|1|||
94300303|NCT02601950|322883797|FG006|Overall Study|Participant enrolled in rollover study|1|||
94373526|NCT02570165|323152481|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
94373527|NCT02570165|323152475|FG000|Overall Study|Withdrawal Request by GSK|0|||
94373528|NCT02570165|323152476|FG001|Overall Study|Withdrawal Request by GSK|0|||
94373529|NCT02570165|323152477|FG002|Overall Study|Withdrawal Request by GSK|2|||
94373530|NCT02570165|323152478|FG003|Overall Study|Withdrawal Request by GSK|0|||
94373531|NCT02570165|323152479|FG004|Overall Study|Withdrawal Request by GSK|0|||
94373532|NCT02570165|323152480|FG005|Overall Study|Withdrawal Request by GSK|0|||
94373533|NCT02570165|323152481|FG006|Overall Study|Withdrawal Request by GSK|0|||
94373534|NCT01783496|323152482|FG000|Overall Study|Lost to Follow-up|0|||
94373535|NCT01783496|323152483|FG001|Overall Study|Lost to Follow-up|0|||
94373536|NCT01783496|323152484|FG002|Overall Study|Lost to Follow-up|0|||
94373537|NCT01783496|323152485|FG003|Overall Study|Lost to Follow-up|2|||
94373538|NCT01783496|323152486|FG004|Overall Study|Lost to Follow-up|0|||
94373539|NCT01783496|323152487|FG005|Overall Study|Lost to Follow-up|1|||
94373540|NCT01783496|323152482|FG000|Overall Study|Withdrawal by Subject|1|||
94373541|NCT01783496|323152483|FG001|Overall Study|Withdrawal by Subject|0|||
94373542|NCT01783496|323152484|FG002|Overall Study|Withdrawal by Subject|0|||
94373543|NCT01783496|323152485|FG003|Overall Study|Withdrawal by Subject|0|||
94373544|NCT01783496|323152486|FG004|Overall Study|Withdrawal by Subject|0|||
94373545|NCT01783496|323152487|FG005|Overall Study|Withdrawal by Subject|0|||
94373546|NCT01280981|323152490|FG000|Overall Study|Withdrawal by Subject|11|||
94300304|NCT02601950|322883798|FG007|Overall Study|Participant enrolled in rollover study|0|||
94300305|NCT02601950|322883791|FG000|Overall Study|Disease progression - radiological|21|||
94300306|NCT02601950|322883792|FG001|Overall Study|Disease progression - radiological|26|||
94300307|NCT02601950|322883793|FG002|Overall Study|Disease progression - radiological|22|||
94300308|NCT02601950|322883794|FG003|Overall Study|Disease progression - radiological|11|||
94300309|NCT02601950|322883795|FG004|Overall Study|Disease progression - radiological|46|||
94300310|NCT02601950|322883796|FG005|Overall Study|Disease progression - radiological|52|||
94300311|NCT02601950|322883797|FG006|Overall Study|Disease progression - radiological|7|||
94300312|NCT02601950|322883798|FG007|Overall Study|Disease progression - radiological|5|||
94300313|NCT02601950|322883791|FG000|Overall Study|Disease progression - clinical|3|||
94300314|NCT02601950|322883792|FG001|Overall Study|Disease progression - clinical|5|||
94300315|NCT02601950|322883793|FG002|Overall Study|Disease progression - clinical|4|||
94300316|NCT02601950|322883794|FG003|Overall Study|Disease progression - clinical|2|||
94300317|NCT02601950|322883795|FG004|Overall Study|Disease progression - clinical|6|||
94300318|NCT02601950|322883796|FG005|Overall Study|Disease progression - clinical|6|||
94300319|NCT02601950|322883797|FG006|Overall Study|Disease progression - clinical|5|||
94300320|NCT02601950|322883798|FG007|Overall Study|Disease progression - clinical|1|||
94300321|NCT02601950|322883791|FG000|Overall Study|Death|6|||
94300322|NCT02601950|322883792|FG001|Overall Study|Death|0|||
94300323|NCT02601950|322883793|FG002|Overall Study|Death|3|||
94300324|NCT02601950|322883794|FG003|Overall Study|Death|1|||
94300325|NCT02601950|322883795|FG004|Overall Study|Death|4|||
94300326|NCT02601950|322883796|FG005|Overall Study|Death|1|||
94300327|NCT02601950|322883797|FG006|Overall Study|Death|0|||
94300328|NCT02601950|322883798|FG007|Overall Study|Death|0|||
94300329|NCT02601950|322883791|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
94300330|NCT02601950|322883792|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
94300331|NCT02601950|322883793|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
94300332|NCT02601950|322883794|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
94300333|NCT02601950|322883795|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
94300334|NCT02601950|322883796|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
94300335|NCT02601950|322883797|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
94300336|NCT02601950|322883798|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
94300337|NCT02601950|322883791|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
94300338|NCT02601950|322883792|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
94300339|NCT02601950|322883793|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
94300340|NCT02601950|322883794|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
94300341|NCT02601950|322883795|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
94300342|NCT02601950|322883796|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
94300343|NCT02601950|322883797|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
94300344|NCT02601950|322883798|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
94300345|NCT02601950|322883791|FG000|Overall Study|Non-compliance|0|||
94300346|NCT02601950|322883792|FG001|Overall Study|Non-compliance|1|||
94300347|NCT02601950|322883793|FG002|Overall Study|Non-compliance|0|||
94300348|NCT02601950|322883794|FG003|Overall Study|Non-compliance|0|||
94300349|NCT02601950|322883795|FG004|Overall Study|Non-compliance|0|||
94373547|NCT01280981|323152490|FG000|Overall Study|Protocol Violation|2|||
94373548|NCT01280981|323152490|FG000|Overall Study|Lack of Efficacy|13|||
94373549|NCT01280981|323152490|FG000|Overall Study|Lost to Follow-up|3|||
94373550|NCT01280981|323152490|FG000|Overall Study|Adverse Event|6|||
94373551|NCT01280981|323152490|FG000|Overall Study|Irregular or discontinued menses|3|||
94373552|NCT01280981|323152490|FG000|Overall Study|Failed to return|45|||
94373553|NCT01280981|323152490|FG000|Overall Study|Non-compliance with protocol|3|||
94373554|NCT01280981|323152490|FG000|Overall Study|Withdrawal of consent|3|||
94373555|NCT01280981|323152490|FG000|Overall Study|Elective surgery|2|||
94373556|NCT01280981|323152490|FG000|Overall Study|Study site closure|1|||
94373557|NCT01138150|323152493|FG000|Overall Study|blood unable to be processed|0|||
94373558|NCT01138150|323152494|FG001|Overall Study|blood unable to be processed|1|||
94373559|NCT01138150|323152493|FG000|Overall Study|Physician Decision|1|||
94373560|NCT01138150|323152494|FG001|Overall Study|Physician Decision|0|||
94373561|NCT00545233|323152495|FG000|Overall Study|Adverse Event|10|||
94373562|NCT00545233|323152496|FG001|Overall Study|Adverse Event|5|||
94373563|NCT00545233|323152495|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
94373564|NCT00545233|323152496|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
94373565|NCT00545233|323152495|FG000|Overall Study|Protocol Violation|2|||
94373566|NCT00545233|323152496|FG001|Overall Study|Protocol Violation|0|||
94373567|NCT00545233|323152495|FG000|Overall Study|Refused Treatment|9|||
94373568|NCT00545233|323152496|FG001|Overall Study|Refused Treatment|7|||
94373569|NCT00545233|323152495|FG000|Overall Study|Failure to Return|4|||
94373570|NCT00545233|323152496|FG001|Overall Study|Failure to Return|6|||
94373571|NCT00545233|323152495|FG000|Overall Study|Insufficient response|14|||
94373572|NCT00545233|323152496|FG001|Overall Study|Insufficient response|15|||
94373573|NCT00545233|323152495|FG000|Overall Study|Physician Decision|2|||
94373574|NCT00545233|323152496|FG001|Overall Study|Physician Decision|1|||
94373575|NCT00520351|323152497|FG000|First Intervention|Withdrawal by Subject|1|||
94373576|NCT00520351|323152498|FG001|First Intervention|Withdrawal by Subject|1|||
94373577|NCT02280356|323152499|FG000|Overall Study|Not Treated|2|||
94373578|NCT02280356|323152499|FG000|Overall Study|Withdrawal by Subject|1|||
94373579|NCT02280356|323152499|FG000|Overall Study|Not evaluable|2|||
94373580|NCT03469271|323152502|FG000|Overall Study|Withdrawal by Subject|2|||
94373581|NCT03469271|323152503|FG001|Overall Study|Withdrawal by Subject|0|||
94373582|NCT03469271|323152504|FG002|Overall Study|Withdrawal by Subject|0|||
94373583|NCT03469271|323152505|FG003|Overall Study|Withdrawal by Subject|1|||
94373584|NCT00146770|323152506|FG000|Overall Study|Adverse Event|2|||
94373585|NCT00146770|323152507|FG001|Overall Study|Adverse Event|0|||
94373586|NCT00146770|323152506|FG000|Overall Study|Pregnancy|1|||
94373587|NCT00146770|323152507|FG001|Overall Study|Pregnancy|0|||
94373588|NCT00146770|323152506|FG000|Overall Study|Withdrawal by Subject|2|||
94373589|NCT00146770|323152507|FG001|Overall Study|Withdrawal by Subject|0|||
94373590|NCT02629965|323152510|FG000|Period 1|Adverse Event|1|||
94373591|NCT02629965|323152511|FG001|Period 1|Adverse Event|0|||
94373592|NCT02629965|323152510|FG000|Period 1|Unexpected worsening of disease|2|||
94373593|NCT02629965|323152511|FG001|Period 1|Unexpected worsening of disease|0|||
94373594|NCT02629965|323152510|FG000|Period 1|Other than listed above|1|||
94373595|NCT02629965|323152511|FG001|Period 1|Other than listed above|2|||
94373596|NCT02629965|323152510|FG000|Period 2|Adverse Event|1|||
94373597|NCT02629965|323152511|FG001|Period 2|Adverse Event|0|||
94373598|NCT02826603|323152518|FG000|Overall Study|Adverse Event|17|||
94373599|NCT02826603|323152519|FG001|Overall Study|Adverse Event|9|||
94373600|NCT02826603|323152518|FG000|Overall Study|Lack of Efficacy|4|||
94373601|NCT02826603|323152519|FG001|Overall Study|Lack of Efficacy|9|||
94373602|NCT02826603|323152518|FG000|Overall Study|Lost to Follow-up|13|||
94373603|NCT02826603|323152519|FG001|Overall Study|Lost to Follow-up|12|||
94373604|NCT02826603|323152518|FG000|Overall Study|Noncompliance with treatment|0|||
94373605|NCT02826603|323152519|FG001|Overall Study|Noncompliance with treatment|2|||
94373606|NCT02826603|323152518|FG000|Overall Study|Physician Decision|1|||
94373607|NCT02826603|323152519|FG001|Overall Study|Physician Decision|7|||
94373608|NCT02826603|323152518|FG000|Overall Study|Pregnancy|1|||
94373609|NCT02826603|323152519|FG001|Overall Study|Pregnancy|2|||
94373610|NCT02826603|323152518|FG000|Overall Study|Protocol Violation|3|||
94373611|NCT02826603|323152519|FG001|Overall Study|Protocol Violation|3|||
94373612|NCT02826603|323152518|FG000|Overall Study|Withdrawal by Subject|20|||
94373613|NCT02826603|323152519|FG001|Overall Study|Withdrawal by Subject|19|||
94373614|NCT02826603|323152518|FG000|Overall Study|Death|2|||
94373615|NCT02826603|323152519|FG001|Overall Study|Death|0|||
94373616|NCT02826603|323152518|FG000|Overall Study|New therapy for study indication|0|||
94373617|NCT02826603|323152519|FG001|Overall Study|New therapy for study indication|1|||
94373618|NCT01337050|323152522|FG000|Overall Study|Death|0|||
94373619|NCT01337050|323152523|FG001|Overall Study|Death|0|||
94373620|NCT01337050|323152524|FG002|Overall Study|Death|4|||
94373621|NCT01337050|323152522|FG000|Overall Study|Other|4|||
94373622|NCT01337050|323152523|FG001|Overall Study|Other|6|||
94373623|NCT01337050|323152524|FG002|Overall Study|Other|8|||
94373624|NCT01337050|323152522|FG000|Overall Study|Participants refused further follow-up|0|||
94373625|NCT01337050|323152523|FG001|Overall Study|Participants refused further follow-up|7|||
94373626|NCT01337050|323152524|FG002|Overall Study|Participants refused further follow-up|7|||
94373627|NCT00583596|323152525|FG000|Overall Study|Lost to Follow-up|110|||
94373628|NCT00583596|323152525|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
94300350|NCT02601950|322883796|FG005|Overall Study|Non-compliance|1|||
94300351|NCT02601950|322883797|FG006|Overall Study|Non-compliance|1|||
94300352|NCT02601950|322883798|FG007|Overall Study|Non-compliance|0|||
94300353|NCT02601950|322883791|FG000|Overall Study|Participant refused further study treatment|0|||
94300354|NCT02601950|322883792|FG001|Overall Study|Participant refused further study treatment|1|||
94300355|NCT02601950|322883793|FG002|Overall Study|Participant refused further study treatment|1|||
94300356|NCT02601950|322883794|FG003|Overall Study|Participant refused further study treatment|0|||
94300357|NCT02601950|322883795|FG004|Overall Study|Participant refused further study treatment|2|||
94300358|NCT02601950|322883796|FG005|Overall Study|Participant refused further study treatment|2|||
94300359|NCT02601950|322883797|FG006|Overall Study|Participant refused further study treatment|2|||
94300360|NCT02601950|322883798|FG007|Overall Study|Participant refused further study treatment|1|||
94300361|NCT02601950|322883791|FG000|Overall Study|Investigator discretion|1|||
94300362|NCT02601950|322883792|FG001|Overall Study|Investigator discretion|0|||
94300363|NCT02601950|322883793|FG002|Overall Study|Investigator discretion|1|||
94300364|NCT02601950|322883794|FG003|Overall Study|Investigator discretion|0|||
94300365|NCT02601950|322883795|FG004|Overall Study|Investigator discretion|1|||
94300366|NCT02601950|322883796|FG005|Overall Study|Investigator discretion|1|||
94300367|NCT02601950|322883797|FG006|Overall Study|Investigator discretion|1|||
94300368|NCT02601950|322883798|FG007|Overall Study|Investigator discretion|0|||
94300369|NCT02601950|322883791|FG000|Overall Study|Other|0|||
94300370|NCT02601950|322883792|FG001|Overall Study|Other|0|||
94300371|NCT02601950|322883793|FG002|Overall Study|Other|0|||
94300372|NCT02601950|322883794|FG003|Overall Study|Other|0|||
94300373|NCT02601950|322883795|FG004|Overall Study|Other|2|||
94300374|NCT02601950|322883796|FG005|Overall Study|Other|2|||
94300375|NCT02601950|322883797|FG006|Overall Study|Other|1|||
94300376|NCT02601950|322883798|FG007|Overall Study|Other|0|||
94300377|NCT02365597|322883799|FG000|Overall Study|Lost to Follow-up|0|||
94300378|NCT02365597|322883800|FG001|Overall Study|Lost to Follow-up|1|||
94300379|NCT02365597|322883801|FG002|Overall Study|Lost to Follow-up|0|||
94300380|NCT02365597|322883802|FG003|Overall Study|Lost to Follow-up|1|||
94300381|NCT02365597|322883799|FG000|Overall Study|Withdrawal by Subject|1|||
94300382|NCT02365597|322883800|FG001|Overall Study|Withdrawal by Subject|8|||
94300383|NCT02365597|322883801|FG002|Overall Study|Withdrawal by Subject|5|||
94300384|NCT02365597|322883802|FG003|Overall Study|Withdrawal by Subject|1|||
94300385|NCT02365597|322883799|FG000|Overall Study|Sponsor's decision|1|||
94300386|NCT02365597|322883800|FG001|Overall Study|Sponsor's decision|3|||
94300387|NCT02365597|322883801|FG002|Overall Study|Sponsor's decision|13|||
94300388|NCT02365597|322883802|FG003|Overall Study|Sponsor's decision|0|||
94300389|NCT02365597|322883799|FG000|Overall Study|Other|0|||
94300390|NCT02365597|322883800|FG001|Overall Study|Other|4|||
94300391|NCT02365597|322883801|FG002|Overall Study|Other|0|||
94300392|NCT02365597|322883802|FG003|Overall Study|Other|0|||
94300393|NCT02365597|322883799|FG000|Overall Study|Enrolled but not treated|0|||
94300394|NCT02365597|322883800|FG001|Overall Study|Enrolled but not treated|1|||
94300395|NCT02365597|322883801|FG002|Overall Study|Enrolled but not treated|1|||
94300396|NCT02365597|322883802|FG003|Overall Study|Enrolled but not treated|0|||
94300397|NCT02365597|322883799|FG000|Overall Study|Ongoing|0|||
94300398|NCT02365597|322883800|FG001|Overall Study|Ongoing|0|||
94300399|NCT02365597|322883801|FG002|Overall Study|Ongoing|0|||
94300400|NCT02365597|322883802|FG003|Overall Study|Ongoing|17|||
94300401|NCT03698019|322883807|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
94300402|NCT03698019|322883808|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
94300403|NCT03698019|322883807|FG000|Step 1: Registration|Withdrawal by Subject|7|||
94300404|NCT03698019|322883808|FG001|Step 1: Registration|Withdrawal by Subject|2|||
94300405|NCT03698019|322883807|FG000|Step 1: Registration|Toxicity|0|||
94300406|NCT03698019|322883808|FG001|Step 1: Registration|Toxicity|1|||
94300407|NCT03698019|322883807|FG000|Step 1: Registration|Disease Progression|0|||
94300408|NCT03698019|322883808|FG001|Step 1: Registration|Disease Progression|12|||
94300409|NCT03698019|322883807|FG000|Step 1: Registration|Co-morbidities|0|||
94300410|NCT03698019|322883808|FG001|Step 1: Registration|Co-morbidities|1|||
94300411|NCT03698019|322883807|FG000|Step 1: Registration|Scheduling Issues|1|||
94300412|NCT03698019|322883808|FG001|Step 1: Registration|Scheduling Issues|0|||
94300413|NCT03698019|322883807|FG000|Step 1: Registration|Participant Refusal|0|||
94300414|NCT03698019|322883808|FG001|Step 1: Registration|Participant Refusal|1|||
94300415|NCT03698019|322883807|FG000|Step 2: Surgery|Participant Refusal|2|||
94300416|NCT03698019|322883808|FG001|Step 2: Surgery|Participant Refusal|1|||
94300417|NCT03698019|322883807|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
94300418|NCT03698019|322883808|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
94300419|NCT03698019|322883807|FG000|Step 2: Surgery|Metastatic Disease|16|||
94300420|NCT03698019|322883808|FG001|Step 2: Surgery|Metastatic Disease|9|||
94300421|NCT03698019|322883807|FG000|Step 2: Surgery|Residual Disease|2|||
94300422|NCT03698019|322883808|FG001|Step 2: Surgery|Residual Disease|1|||
94300423|NCT03698019|322883807|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
94300424|NCT03698019|322883808|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
94300425|NCT03698019|322883807|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
94300426|NCT03698019|322883808|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
94373629|NCT00583596|323152525|FG000|Overall Study|Death|2|||
94373630|NCT00583596|323152525|FG000|Overall Study|Withdrawal by Subject|6|||
94373631|NCT00583596|323152525|FG000|Overall Study|Lost to Follow-up|94|||
94373632|NCT00583596|323152525|FG000|Overall Study|Data not complete|1|||
94373633|NCT00583596|323152525|FG000|Overall Study|Not consented|15|||
94373634|NCT00583596|323152525|FG000|Overall Study|Outside f-up window|26|||
94373635|NCT00616928|323152530|FG000|Overall Study|Adverse Event|6|||
94373636|NCT00616928|323152531|FG001|Overall Study|Adverse Event|3|||
94373637|NCT00616928|323152532|FG002|Overall Study|Adverse Event|2|||
94373638|NCT00616928|323152533|FG003|Overall Study|Adverse Event|2|||
94373639|NCT00616928|323152530|FG000|Overall Study|Other|51|||
94373640|NCT00616928|323152531|FG001|Overall Study|Other|8|||
94373641|NCT00616928|323152532|FG002|Overall Study|Other|15|||
94373642|NCT00616928|323152533|FG003|Overall Study|Other|5|||
94373643|NCT00616928|323152530|FG000|Overall Study|Lost to Follow-up|5|||
94373644|NCT00616928|323152531|FG001|Overall Study|Lost to Follow-up|7|||
94373645|NCT00616928|323152532|FG002|Overall Study|Lost to Follow-up|0|||
94373646|NCT00616928|323152533|FG003|Overall Study|Lost to Follow-up|0|||
94373647|NCT01133392|323152543|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
94373648|NCT01133392|323152544|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
94373649|NCT01133392|323152543|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
94373650|NCT01133392|323152544|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
94373651|NCT01759537|323152545|FG000|Overall Study|Death|1|||
94373652|NCT01759537|323152546|FG001|Overall Study|Death|1|||
94373653|NCT01759537|323152545|FG000|Overall Study|Pregnancy|1|||
94373654|NCT01759537|323152546|FG001|Overall Study|Pregnancy|1|||
94373655|NCT01759537|323152545|FG000|Overall Study|Lost to Follow-up|9|||
94373656|NCT01759537|323152546|FG001|Overall Study|Lost to Follow-up|9|||
94373657|NCT01759537|323152545|FG000|Overall Study|Accident involving jaw fracture|1|||
94373658|NCT01759537|323152546|FG001|Overall Study|Accident involving jaw fracture|1|||
94373659|NCT01759537|323152545|FG000|Overall Study|Subcrestal implant too coronal|1|||
94373660|NCT01759537|323152546|FG001|Overall Study|Subcrestal implant too coronal|1|||
94373661|NCT01015612|323152556|FG000|Overall Study|Death|113|||
94373662|NCT01015612|323152556|FG000|Overall Study|Withdrawal by Subject|40|||
94373663|NCT00066807|323152557|FG000|Overall Study|Study was terminated early|14|||
94373664|NCT00066807|323152558|FG001|Overall Study|Study was terminated early|15|||
94373665|NCT00207714|323154084|FG000|Overall Study|Adverse Event|6|||
94373666|NCT00207714|323154085|FG001|Overall Study|Adverse Event|2|||
94373667|NCT00207714|323154086|FG002|Overall Study|Adverse Event|4|||
94373668|NCT00207714|323154087|FG003|Overall Study|Adverse Event|3|||
94373669|NCT00207714|323154088|FG004|Overall Study|Adverse Event|1|||
94373670|NCT00207714|323154084|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
94373671|NCT00207714|323154085|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
94373672|NCT00207714|323154086|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
94373673|NCT00207714|323154087|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
94373674|NCT00207714|323154088|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
94373675|NCT00207714|323154084|FG000|Overall Study|Other|3|||
94373676|NCT00207714|323154085|FG001|Overall Study|Other|2|||
94373677|NCT00207714|323154086|FG002|Overall Study|Other|5|||
94373678|NCT00207714|323154087|FG003|Overall Study|Other|1|||
94373679|NCT00207714|323154088|FG004|Overall Study|Other|0|||
94373680|NCT01165242|323154089|FG000|Overall Study|Unreachable Subjects|1|||
94373681|NCT01165242|323154090|FG001|Overall Study|Unreachable Subjects|0|||
94373682|NCT01165242|323154091|FG002|Overall Study|Unreachable Subjects|0|||
94373683|NCT01165242|323154089|FG000|Overall Study|Incarcerated Subjects|0|||
94373684|NCT01165242|323154090|FG001|Overall Study|Incarcerated Subjects|1|||
94373685|NCT01165242|323154091|FG002|Overall Study|Incarcerated Subjects|0|||
94373686|NCT01165242|323154089|FG000|Overall Study|Visit 2 Declined by Subject|0|||
94373687|NCT01165242|323154090|FG001|Overall Study|Visit 2 Declined by Subject|0|||
94373688|NCT01165242|323154091|FG002|Overall Study|Visit 2 Declined by Subject|1|||
94373689|NCT01165242|323154089|FG000|Overall Study|Withdrawal by Subject|0|||
94373690|NCT01165242|323154090|FG001|Overall Study|Withdrawal by Subject|2|||
94373691|NCT01165242|323154091|FG002|Overall Study|Withdrawal by Subject|2|||
94373692|NCT01165242|323154089|FG000|Overall Study|Extended Holiday|0|||
94373693|NCT01165242|323154090|FG001|Overall Study|Extended Holiday|0|||
94373694|NCT01165242|323154091|FG002|Overall Study|Extended Holiday|1|||
94373695|NCT01165242|323154089|FG000|Overall Study|Lost to Follow-up|9|||
94373696|NCT01165242|323154090|FG001|Overall Study|Lost to Follow-up|7|||
94373697|NCT01165242|323154091|FG002|Overall Study|Lost to Follow-up|10|||
94373698|NCT03877237|323154092|FG000|Overall Study|Adverse Event|1|||
94373699|NCT03877237|323154093|FG001|Overall Study|Adverse Event|2|||
94373700|NCT03877237|323154092|FG000|Overall Study|Death|3|||
94373701|NCT03877237|323154093|FG001|Overall Study|Death|2|||
94373702|NCT03877237|323154092|FG000|Overall Study|Physician Decision|1|||
94373703|NCT03877237|323154093|FG001|Overall Study|Physician Decision|0|||
94373704|NCT03877237|323154092|FG000|Overall Study|Withdrawal by Subject|0|||
94373705|NCT03877237|323154093|FG001|Overall Study|Withdrawal by Subject|2|||
94373706|NCT02614703|323154094|FG000|Overall Study|Withdrawal by Subject|7|||
94373707|NCT02614703|323154095|FG001|Overall Study|Withdrawal by Subject|1|||
94300427|NCT03698019|322883807|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
94300428|NCT03698019|322883808|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
94300429|NCT03698019|322883807|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
94300430|NCT03698019|322883808|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
94300431|NCT03698019|322883807|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
94300432|NCT03698019|322883808|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
94300433|NCT03698019|322883807|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
94300434|NCT03698019|322883808|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
94300435|NCT03698019|322883807|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
94300436|NCT03698019|322883808|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
94300437|NCT03698019|322883807|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
94300438|NCT03698019|322883808|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
94300439|NCT01238120|322883809|FG000|Overall Study|Withdrawal by Subject|4|||
94300440|NCT01238120|322883810|FG001|Overall Study|Withdrawal by Subject|1|||
94300441|NCT01238120|322883811|FG002|Overall Study|Withdrawal by Subject|2|||
94300442|NCT01238120|322883812|FG003|Overall Study|Withdrawal by Subject|5|||
94300443|NCT01238120|322883809|FG000|Overall Study|Lost to Follow-up|2|||
94300444|NCT01238120|322883810|FG001|Overall Study|Lost to Follow-up|0|||
94300445|NCT01238120|322883811|FG002|Overall Study|Lost to Follow-up|1|||
94300446|NCT01238120|322883812|FG003|Overall Study|Lost to Follow-up|1|||
94300447|NCT01238120|322883809|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
94300448|NCT01238120|322883810|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
94300449|NCT01238120|322883811|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
94300450|NCT01238120|322883812|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
94300451|NCT02209506|322883813|FG000|Overall Study|Withdrawal by Subject|0|||
94300452|NCT02209506|322883814|FG001|Overall Study|Withdrawal by Subject|0|||
94300453|NCT02209506|322883815|FG002|Overall Study|Withdrawal by Subject|0|||
94300454|NCT02209506|322883816|FG003|Overall Study|Withdrawal by Subject|0|||
94300455|NCT02209506|322883817|FG004|Overall Study|Withdrawal by Subject|1|||
94300456|NCT01307423|322883821|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
94300457|NCT01307423|322883822|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
94300458|NCT01307423|322883823|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
94300459|NCT01307423|322883824|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
94300460|NCT01307423|322883825|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
94300461|NCT01307423|322883826|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
94300462|NCT01307423|322883827|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
94300463|NCT01307423|322883828|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
94300464|NCT01307423|322883829|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
94300465|NCT01307423|322883821|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
94300466|NCT01307423|322883822|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
94300467|NCT01307423|322883823|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
94300468|NCT01307423|322883824|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
94300469|NCT01307423|322883825|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
94300470|NCT01307423|322883826|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
94300471|NCT01307423|322883827|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
94300472|NCT01307423|322883828|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
94373708|NCT02280421|323154096|FG000|Washout (2 Weeks)|Adverse Event|0|||
94373709|NCT02280421|323154097|FG001|Washout (2 Weeks)|Adverse Event|1|||
94373710|NCT02280421|323154096|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
94373711|NCT02280421|323154097|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
94373712|NCT01020305|323154101|FG000|Overall Study|Adverse Event|2|||
94373713|NCT01456052|323154102|FG000|Overall Study|Adverse Event|1|||
94373714|NCT01456052|323154103|FG001|Overall Study|Adverse Event|1|||
94373715|NCT01456052|323154104|FG002|Overall Study|Adverse Event|2|||
94373716|NCT01456052|323154102|FG000|Overall Study|Consent withdrawn|0|||
94373717|NCT01456052|323154103|FG001|Overall Study|Consent withdrawn|2|||
94373718|NCT01456052|323154104|FG002|Overall Study|Consent withdrawn|1|||
94373719|NCT01456052|323154102|FG000|Overall Study|Protocol Violation|0|||
94373720|NCT01456052|323154103|FG001|Overall Study|Protocol Violation|1|||
94373721|NCT01456052|323154104|FG002|Overall Study|Protocol Violation|0|||
94373722|NCT01456052|323154102|FG000|Overall Study|Physician Decision|1|||
94373723|NCT01456052|323154103|FG001|Overall Study|Physician Decision|0|||
94300473|NCT01307423|322883829|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
94300474|NCT01307423|322883821|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
94300475|NCT01307423|322883822|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
94300476|NCT01307423|322883823|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
94373724|NCT01456052|323154104|FG002|Overall Study|Physician Decision|1|||
94373725|NCT01456052|323154102|FG000|Overall Study|Treatment Failure|0|||
94373726|NCT01456052|323154103|FG001|Overall Study|Treatment Failure|1|||
94373727|NCT01456052|323154104|FG002|Overall Study|Treatment Failure|1|||
94373728|NCT01625845|323154105|FG000|Overall Study|Adverse Event|1|||
94373729|NCT01625845|323154106|FG001|Overall Study|Adverse Event|2|||
94373730|NCT01625845|323154105|FG000|Overall Study|Lost to Follow-up|2|||
94373731|NCT01625845|323154106|FG001|Overall Study|Lost to Follow-up|1|||
94373732|NCT01625845|323154105|FG000|Overall Study|Withdrawal by Subject|2|||
94373733|NCT01625845|323154106|FG001|Overall Study|Withdrawal by Subject|0|||
94373734|NCT00686374|323154107|FG000|Overall Study|Lack of Efficacy|10|||
94373735|NCT00686374|323154107|FG000|Overall Study|Adverse Event|8|||
94373736|NCT00686374|323154107|FG000|Overall Study|Withdrew consent|5|||
94373737|NCT00686374|323154107|FG000|Overall Study|Lost to Follow-up|1|||
94373738|NCT00686374|323154107|FG000|Overall Study|Missing reason|33|||
94373739|NCT00686374|323154107|FG000|Overall Study|Other, not specified|4|||
94373740|NCT02853929|323154108|FG000|Overall Study|Lost to Follow-up|3|||
94373741|NCT02853929|323154109|FG001|Overall Study|Lost to Follow-up|0|||
94373742|NCT02853929|323154108|FG000|Overall Study|Withdrawal by Subject|1|||
94373743|NCT02853929|323154109|FG001|Overall Study|Withdrawal by Subject|0|||
94373744|NCT02853929|323154108|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
94373745|NCT02853929|323154109|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
94373746|NCT01070966|323154110|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
94373747|NCT01070966|323154110|FG000|Participants for Safety Evaluation|Off-label use|9|||
94373748|NCT01070966|323154110|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
94373749|NCT01070966|323154110|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
94373750|NCT01070966|323154110|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
94373751|NCT01070966|323154110|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
94373752|NCT01070966|323154110|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
94373753|NCT01070966|323154110|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
94373754|NCT02770716|323154111|FG000|Overall Study|Death|101|||
94373755|NCT02770716|323154112|FG001|Overall Study|Death|45|||
94373756|NCT02770716|323154111|FG000|Overall Study|Withdrawal by Subject|4|||
94373757|NCT02770716|323154112|FG001|Overall Study|Withdrawal by Subject|2|||
94373758|NCT02770716|323154111|FG000|Overall Study|Lost to Follow-up|1|||
94373759|NCT02770716|323154112|FG001|Overall Study|Lost to Follow-up|0|||
94373760|NCT02770716|323154111|FG000|Overall Study|Various reasons|6|||
94373761|NCT02770716|323154112|FG001|Overall Study|Various reasons|2|||
94373762|NCT01078623|323154113|FG000|Treatment Period 1|Adverse Event|1|||
94373763|NCT01078623|323154114|FG001|Treatment Period 1|Adverse Event|1|||
94373764|NCT01078623|323154115|FG002|Treatment Period 1|Adverse Event|1|||
94373765|NCT01078623|323154116|FG003|Treatment Period 1|Adverse Event|0|||
94373766|NCT01078623|323154117|FG004|Treatment Period 1|Adverse Event|0|||
94373767|NCT01078623|323154118|FG005|Treatment Period 1|Adverse Event|0|||
94373768|NCT01078623|323154119|FG006|Treatment Period 1|Adverse Event|1|||
94373769|NCT01078623|323154120|FG007|Treatment Period 1|Adverse Event|0|||
94373770|NCT01078623|323154121|FG008|Treatment Period 1|Adverse Event|1|||
94373771|NCT01078623|323154122|FG009|Treatment Period 1|Adverse Event|1|||
94373772|NCT01078623|323154123|FG010|Treatment Period 1|Adverse Event|0|||
94373773|NCT01078623|323154124|FG011|Treatment Period 1|Adverse Event|0|||
94373774|NCT01078623|323154125|FG012|Treatment Period 1|Adverse Event|0|||
94373775|NCT01078623|323154126|FG013|Treatment Period 1|Adverse Event|0|||
94373776|NCT01078623|323154127|FG014|Treatment Period 1|Adverse Event|0|||
94373777|NCT01078623|323154128|FG015|Treatment Period 1|Adverse Event|0|||
94373778|NCT01078623|323154129|FG016|Treatment Period 1|Adverse Event|0|||
94373779|NCT01078623|323154130|FG017|Treatment Period 1|Adverse Event|0|||
94373780|NCT01078623|323154131|FG018|Treatment Period 1|Adverse Event|0|||
94373781|NCT01078623|323154132|FG019|Treatment Period 1|Adverse Event|0|||
94373782|NCT01078623|323154113|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94373783|NCT01078623|323154114|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94373784|NCT01078623|323154115|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94373785|NCT01078623|323154116|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94373786|NCT01078623|323154117|FG004|Treatment Period 1|Withdrawal by Subject|0|||
94373787|NCT01078623|323154118|FG005|Treatment Period 1|Withdrawal by Subject|0|||
94373788|NCT01078623|323154119|FG006|Treatment Period 1|Withdrawal by Subject|0|||
94373789|NCT01078623|323154120|FG007|Treatment Period 1|Withdrawal by Subject|1|||
94373790|NCT01078623|323154121|FG008|Treatment Period 1|Withdrawal by Subject|0|||
94373791|NCT01078623|323154122|FG009|Treatment Period 1|Withdrawal by Subject|0|||
94373792|NCT01078623|323154123|FG010|Treatment Period 1|Withdrawal by Subject|1|||
94373793|NCT01078623|323154124|FG011|Treatment Period 1|Withdrawal by Subject|0|||
94373794|NCT01078623|323154125|FG012|Treatment Period 1|Withdrawal by Subject|0|||
94373795|NCT01078623|323154126|FG013|Treatment Period 1|Withdrawal by Subject|0|||
94373796|NCT01078623|323154127|FG014|Treatment Period 1|Withdrawal by Subject|0|||
94373797|NCT01078623|323154128|FG015|Treatment Period 1|Withdrawal by Subject|0|||
94373798|NCT01078623|323154129|FG016|Treatment Period 1|Withdrawal by Subject|0|||
94373799|NCT01078623|323154130|FG017|Treatment Period 1|Withdrawal by Subject|0|||
94373800|NCT01078623|323154131|FG018|Treatment Period 1|Withdrawal by Subject|0|||
94373801|NCT01078623|323154132|FG019|Treatment Period 1|Withdrawal by Subject|0|||
94373802|NCT01078623|323154113|FG000|Treatment Period 1|Protocol Violation|0|||
94373803|NCT01078623|323154114|FG001|Treatment Period 1|Protocol Violation|0|||
94373804|NCT01078623|323154115|FG002|Treatment Period 1|Protocol Violation|0|||
94373805|NCT01078623|323154116|FG003|Treatment Period 1|Protocol Violation|0|||
94373806|NCT01078623|323154117|FG004|Treatment Period 1|Protocol Violation|0|||
94373807|NCT01078623|323154118|FG005|Treatment Period 1|Protocol Violation|1|||
94373808|NCT01078623|323154119|FG006|Treatment Period 1|Protocol Violation|0|||
94373809|NCT01078623|323154120|FG007|Treatment Period 1|Protocol Violation|0|||
94373810|NCT01078623|323154121|FG008|Treatment Period 1|Protocol Violation|0|||
94373811|NCT01078623|323154122|FG009|Treatment Period 1|Protocol Violation|0|||
94373812|NCT01078623|323154123|FG010|Treatment Period 1|Protocol Violation|0|||
94373813|NCT01078623|323154124|FG011|Treatment Period 1|Protocol Violation|0|||
94373814|NCT01078623|323154125|FG012|Treatment Period 1|Protocol Violation|0|||
94373815|NCT01078623|323154126|FG013|Treatment Period 1|Protocol Violation|0|||
94468089|NCT03646305|323502501|FG000|Overall Study|Withdrawal by Subject|1|||
94468090|NCT03646305|323502502|FG001|Overall Study|Withdrawal by Subject|0|||
94300477|NCT01307423|322883824|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
94300478|NCT01307423|322883825|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
94300479|NCT01307423|322883826|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
94300480|NCT01307423|322883827|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
94300481|NCT01307423|322883828|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
94300482|NCT01307423|322883829|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
94300483|NCT01307423|322883821|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
94300484|NCT01307423|322883822|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
94300485|NCT01307423|322883823|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
94300486|NCT01307423|322883824|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
94300487|NCT01307423|322883825|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
94300488|NCT01307423|322883826|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
94300489|NCT01307423|322883827|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
94300490|NCT01307423|322883828|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
94300491|NCT01307423|322883829|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
94300492|NCT01307423|322883821|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
94300493|NCT01307423|322883822|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
94300494|NCT01307423|322883823|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
94300495|NCT01307423|322883824|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94300496|NCT01307423|322883825|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94300497|NCT01307423|322883826|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94300498|NCT01307423|322883827|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94300499|NCT01307423|322883828|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94300500|NCT01307423|322883829|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94300501|NCT01307423|322883821|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
94300502|NCT01307423|322883822|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94300503|NCT01307423|322883823|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94300504|NCT01307423|322883824|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94300505|NCT01307423|322883825|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94300506|NCT01307423|322883826|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94300507|NCT01307423|322883827|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94300508|NCT01307423|322883828|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94300509|NCT01307423|322883829|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
94300510|NCT01307423|322883821|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
94300511|NCT01307423|322883822|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
94300512|NCT01307423|322883823|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
94300513|NCT01307423|322883824|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
94300514|NCT01307423|322883825|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
94300515|NCT01307423|322883826|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
94300516|NCT01307423|322883827|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
94300517|NCT01307423|322883828|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
94300518|NCT01307423|322883829|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
94300519|NCT01307423|322883821|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
94300520|NCT01307423|322883822|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
94300521|NCT01307423|322883823|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
94300522|NCT01307423|322883824|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
94300523|NCT01307423|322883825|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
94300524|NCT01307423|322883826|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
94300525|NCT01307423|322883827|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
94468091|NCT03646305|323502503|FG002|Overall Study|Withdrawal by Subject|0|||
94468092|NCT03646305|323502504|FG003|Overall Study|Withdrawal by Subject|1|||
94468093|NCT01554176|323502505|FG000|Treatment Phase|Protocol Violation|1|||
94468094|NCT01554176|323502506|FG001|Treatment Phase|Protocol Violation|2|||
94373816|NCT01078623|323154127|FG014|Treatment Period 1|Protocol Violation|0|||
94373817|NCT01078623|323154128|FG015|Treatment Period 1|Protocol Violation|0|||
94373818|NCT01078623|323154129|FG016|Treatment Period 1|Protocol Violation|0|||
94373819|NCT01078623|323154130|FG017|Treatment Period 1|Protocol Violation|0|||
94373820|NCT01078623|323154131|FG018|Treatment Period 1|Protocol Violation|0|||
94373821|NCT01078623|323154132|FG019|Treatment Period 1|Protocol Violation|0|||
94373822|NCT01078623|323154113|FG000|Treatment Period 2|Adverse Event|0|||
94373823|NCT01078623|323154114|FG001|Treatment Period 2|Adverse Event|0|||
94373824|NCT01078623|323154115|FG002|Treatment Period 2|Adverse Event|0|||
94373825|NCT01078623|323154116|FG003|Treatment Period 2|Adverse Event|0|||
94373826|NCT01078623|323154117|FG004|Treatment Period 2|Adverse Event|0|||
94373827|NCT01078623|323154118|FG005|Treatment Period 2|Adverse Event|0|||
94373828|NCT01078623|323154119|FG006|Treatment Period 2|Adverse Event|1|||
94373829|NCT01078623|323154120|FG007|Treatment Period 2|Adverse Event|0|||
94373830|NCT01078623|323154121|FG008|Treatment Period 2|Adverse Event|0|||
94373831|NCT01078623|323154122|FG009|Treatment Period 2|Adverse Event|0|||
94373832|NCT01078623|323154123|FG010|Treatment Period 2|Adverse Event|0|||
94373833|NCT01078623|323154124|FG011|Treatment Period 2|Adverse Event|0|||
94373834|NCT01078623|323154125|FG012|Treatment Period 2|Adverse Event|0|||
94373835|NCT01078623|323154126|FG013|Treatment Period 2|Adverse Event|0|||
94373836|NCT01078623|323154127|FG014|Treatment Period 2|Adverse Event|0|||
94373837|NCT01078623|323154128|FG015|Treatment Period 2|Adverse Event|0|||
94373838|NCT01078623|323154129|FG016|Treatment Period 2|Adverse Event|0|||
94373839|NCT01078623|323154130|FG017|Treatment Period 2|Adverse Event|0|||
94373840|NCT01078623|323154131|FG018|Treatment Period 2|Adverse Event|1|||
94373841|NCT01078623|323154132|FG019|Treatment Period 2|Adverse Event|0|||
94373842|NCT01078623|323154113|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94373843|NCT01078623|323154114|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94373844|NCT01078623|323154115|FG002|Treatment Period 2|Withdrawal by Subject|0|||
94373845|NCT01078623|323154116|FG003|Treatment Period 2|Withdrawal by Subject|0|||
94373846|NCT01078623|323154117|FG004|Treatment Period 2|Withdrawal by Subject|0|||
94373847|NCT01078623|323154118|FG005|Treatment Period 2|Withdrawal by Subject|1|||
94373848|NCT01078623|323154119|FG006|Treatment Period 2|Withdrawal by Subject|0|||
94373849|NCT01078623|323154120|FG007|Treatment Period 2|Withdrawal by Subject|0|||
94373850|NCT01078623|323154121|FG008|Treatment Period 2|Withdrawal by Subject|0|||
94373851|NCT01078623|323154122|FG009|Treatment Period 2|Withdrawal by Subject|0|||
94373852|NCT01078623|323154123|FG010|Treatment Period 2|Withdrawal by Subject|0|||
94373853|NCT01078623|323154124|FG011|Treatment Period 2|Withdrawal by Subject|0|||
94373854|NCT01078623|323154125|FG012|Treatment Period 2|Withdrawal by Subject|0|||
94373855|NCT01078623|323154126|FG013|Treatment Period 2|Withdrawal by Subject|0|||
94373856|NCT01078623|323154127|FG014|Treatment Period 2|Withdrawal by Subject|0|||
94373857|NCT01078623|323154128|FG015|Treatment Period 2|Withdrawal by Subject|0|||
94373858|NCT01078623|323154129|FG016|Treatment Period 2|Withdrawal by Subject|0|||
94373859|NCT01078623|323154130|FG017|Treatment Period 2|Withdrawal by Subject|0|||
94373860|NCT01078623|323154131|FG018|Treatment Period 2|Withdrawal by Subject|0|||
94373861|NCT01078623|323154132|FG019|Treatment Period 2|Withdrawal by Subject|0|||
94373862|NCT01078623|323154113|FG000|Treatment Period 3|Adverse Event|0|||
94373863|NCT01078623|323154114|FG001|Treatment Period 3|Adverse Event|0|||
94373864|NCT01078623|323154115|FG002|Treatment Period 3|Adverse Event|0|||
94373865|NCT01078623|323154116|FG003|Treatment Period 3|Adverse Event|0|||
94373866|NCT01078623|323154117|FG004|Treatment Period 3|Adverse Event|1|||
94373867|NCT01078623|323154118|FG005|Treatment Period 3|Adverse Event|0|||
94373868|NCT01078623|323154119|FG006|Treatment Period 3|Adverse Event|0|||
94373869|NCT01078623|323154120|FG007|Treatment Period 3|Adverse Event|0|||
94373870|NCT01078623|323154121|FG008|Treatment Period 3|Adverse Event|0|||
94373871|NCT01078623|323154122|FG009|Treatment Period 3|Adverse Event|0|||
94373872|NCT01078623|323154123|FG010|Treatment Period 3|Adverse Event|0|||
94373873|NCT01078623|323154124|FG011|Treatment Period 3|Adverse Event|0|||
94373874|NCT01078623|323154125|FG012|Treatment Period 3|Adverse Event|0|||
94373875|NCT01078623|323154126|FG013|Treatment Period 3|Adverse Event|1|||
94373876|NCT01078623|323154127|FG014|Treatment Period 3|Adverse Event|0|||
94373877|NCT01078623|323154128|FG015|Treatment Period 3|Adverse Event|0|||
94373878|NCT01078623|323154129|FG016|Treatment Period 3|Adverse Event|0|||
94373879|NCT01078623|323154130|FG017|Treatment Period 3|Adverse Event|0|||
94373880|NCT01078623|323154131|FG018|Treatment Period 3|Adverse Event|0|||
94373881|NCT01078623|323154132|FG019|Treatment Period 3|Adverse Event|0|||
94373882|NCT01078623|323154113|FG000|Treatment Period 4|Adverse Event|0|||
94373883|NCT01078623|323154114|FG001|Treatment Period 4|Adverse Event|0|||
94373884|NCT01078623|323154115|FG002|Treatment Period 4|Adverse Event|1|||
94373885|NCT01078623|323154116|FG003|Treatment Period 4|Adverse Event|0|||
94373886|NCT01078623|323154117|FG004|Treatment Period 4|Adverse Event|0|||
94373887|NCT01078623|323154118|FG005|Treatment Period 4|Adverse Event|0|||
94373888|NCT01078623|323154119|FG006|Treatment Period 4|Adverse Event|0|||
94373889|NCT01078623|323154120|FG007|Treatment Period 4|Adverse Event|0|||
94373890|NCT01078623|323154121|FG008|Treatment Period 4|Adverse Event|0|||
94373891|NCT01078623|323154122|FG009|Treatment Period 4|Adverse Event|0|||
94373892|NCT01078623|323154123|FG010|Treatment Period 4|Adverse Event|0|||
94373893|NCT01078623|323154124|FG011|Treatment Period 4|Adverse Event|0|||
94373894|NCT01078623|323154125|FG012|Treatment Period 4|Adverse Event|0|||
94300526|NCT01307423|322883828|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
94300527|NCT01307423|322883829|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
94300528|NCT01307423|322883821|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
94300529|NCT01307423|322883822|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
94300530|NCT01307423|322883823|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
94300531|NCT01307423|322883824|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
94300532|NCT01307423|322883825|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
94300533|NCT01307423|322883826|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
94300534|NCT01307423|322883827|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
94300535|NCT01307423|322883828|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
94300536|NCT01307423|322883829|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
94300537|NCT01307423|322883821|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
94300538|NCT01307423|322883822|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
94300539|NCT01307423|322883823|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
94300540|NCT01307423|322883824|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
94300541|NCT01307423|322883825|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
94300542|NCT01307423|322883826|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
94300543|NCT01307423|322883827|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
94300544|NCT01307423|322883828|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
94300545|NCT01307423|322883829|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
94300546|NCT01307423|322883821|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
94300547|NCT01307423|322883822|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
94300548|NCT01307423|322883823|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
94300549|NCT01307423|322883824|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
94300550|NCT01307423|322883825|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
94300551|NCT01307423|322883826|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
94300552|NCT01307423|322883827|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
94300553|NCT01307423|322883828|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
94300554|NCT01307423|322883829|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
94300555|NCT01307423|322883821|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
94300556|NCT01307423|322883822|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
94300557|NCT01307423|322883823|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
94300558|NCT01307423|322883824|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
94300559|NCT01307423|322883825|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
94300560|NCT01307423|322883826|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
94300561|NCT01307423|322883827|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
94300562|NCT01307423|322883828|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
94300563|NCT01307423|322883829|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
94300564|NCT01307423|322883821|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
94300565|NCT01307423|322883822|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
94300566|NCT01307423|322883823|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
94300567|NCT01307423|322883824|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
94300568|NCT01307423|322883825|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
94300569|NCT01307423|322883826|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
94300570|NCT01307423|322883827|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
94300571|NCT01307423|322883828|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
94300572|NCT01307423|322883829|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
94300573|NCT01307423|322883821|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
94300574|NCT01307423|322883822|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
94300575|NCT01307423|322883823|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
94300576|NCT01307423|322883824|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
94300577|NCT01307423|322883825|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
94300578|NCT01307423|322883826|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
94300579|NCT01307423|322883827|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
94300580|NCT01307423|322883828|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
94300581|NCT01307423|322883829|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
94300582|NCT01307423|322883821|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
94300583|NCT01307423|322883822|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
94300584|NCT01307423|322883823|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
94300585|NCT01307423|322883824|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
94300586|NCT01307423|322883825|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
94300587|NCT01307423|322883826|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
94300588|NCT01307423|322883827|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
94300589|NCT01307423|322883828|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
94300590|NCT01307423|322883829|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
94300591|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
94300592|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
94300593|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
94300594|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
94300595|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
94300596|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
94300597|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
94300598|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
94300599|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
94300600|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
94300601|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
94300602|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
94300603|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
94300604|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
94300605|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
94300606|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
94300607|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
94300608|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
94300609|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
94300610|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
94300611|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
94300612|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
94300613|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
94300614|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
94300615|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
94300616|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
94300617|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
94300618|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
94300619|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
94300620|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
94300621|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
94300622|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
94300623|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
94300624|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
94300625|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
94300626|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
94300627|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
94300628|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
94300629|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
94300630|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
94300631|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
94300632|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
94300633|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
94300634|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
94300635|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
94300636|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
94300637|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
94300638|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
94300639|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
94300640|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
94300641|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
94300642|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
94300643|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
94300644|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
94300645|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
94300646|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
94300647|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
94300648|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
94300649|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
94300650|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
94300651|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
94300652|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
94300653|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
94300654|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
94300655|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
94300656|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
94300657|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
94300658|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
94373895|NCT01078623|323154126|FG013|Treatment Period 4|Adverse Event|0|||
94373896|NCT01078623|323154127|FG014|Treatment Period 4|Adverse Event|0|||
94300659|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
94300660|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
94300661|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
94300662|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
94300663|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
94300664|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
94300665|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
94300666|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
94300667|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
94300668|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
94300669|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
94300670|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
94300671|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
94300672|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
94300673|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
94300674|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
94300675|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
94300676|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
94300677|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
94300678|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
94300679|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
94300680|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
94300681|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
94300682|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
94300683|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
94300684|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
94300685|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
94300686|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
94300687|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
94300688|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
94300689|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
94300690|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
94300691|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
94300692|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
94300693|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
94300694|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
94300695|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
94300696|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
94300697|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
94300698|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
94300699|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
94300700|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
94300701|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
94300702|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
94300703|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
94300704|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
94300705|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
94300706|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
94300707|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
94300708|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
94300709|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
94300710|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
94300711|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
94300712|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
94300713|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
94300714|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
94300715|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
94300716|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
94300717|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
94300718|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
94373897|NCT01078623|323154128|FG015|Treatment Period 4|Adverse Event|0|||
94373898|NCT01078623|323154129|FG016|Treatment Period 4|Adverse Event|0|||
94373899|NCT01078623|323154130|FG017|Treatment Period 4|Adverse Event|0|||
94300719|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
94300720|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
94300721|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
94300722|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
94373900|NCT01078623|323154131|FG018|Treatment Period 4|Adverse Event|0|||
94300723|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
94300724|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
94300725|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
94300726|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
94300727|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
94300728|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
94300729|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
94300730|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
94300731|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
94300732|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
94300733|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
94300734|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
94300735|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
94300736|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
94300737|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
94300738|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
94300739|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
94300740|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
94300741|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
94300742|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
94300743|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
94300744|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
94300745|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
94300746|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
94300747|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
94300748|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
94300749|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
94300750|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
94300751|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
94300752|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
94300753|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
94300754|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
94300755|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
94300756|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
94300757|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
94300758|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
94300759|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
94300760|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
94300761|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
94300762|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
94300763|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
94300764|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
94300765|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
94300766|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
94300767|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
94300768|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
94300769|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
94300770|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
94300771|NCT01307423|322883821|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
94300772|NCT01307423|322883822|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
94300773|NCT01307423|322883823|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
94300774|NCT01307423|322883824|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
94300775|NCT01307423|322883825|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
94300776|NCT01307423|322883826|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
94300777|NCT01307423|322883827|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
94300778|NCT01307423|322883828|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
94300779|NCT01307423|322883829|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
94300780|NCT01946204|322883830|FG000|Overall Study|Death|38|||
94300781|NCT01946204|322883831|FG001|Overall Study|Death|59|||
94300782|NCT01946204|322883830|FG000|Overall Study|Withdrawal by Subject|37|||
94300783|NCT01946204|322883831|FG001|Overall Study|Withdrawal by Subject|50|||
94300784|NCT01946204|322883830|FG000|Overall Study|Lost to Follow-up|3|||
94300785|NCT01946204|322883831|FG001|Overall Study|Lost to Follow-up|7|||
94300786|NCT01946204|322883830|FG000|Overall Study|Ongoing|316|||
94300787|NCT01946204|322883831|FG001|Overall Study|Ongoing|687|||
94300788|NCT01946204|322883830|FG000|Overall Study|Other|7|||
94300789|NCT01946204|322883831|FG001|Overall Study|Other|3|||
94300790|NCT03466411|322883832|FG000|Overall Study|Lost to Follow-up|0|||
94300791|NCT03466411|322883833|FG001|Overall Study|Lost to Follow-up|1|||
94300792|NCT03466411|322883834|FG002|Overall Study|Lost to Follow-up|1|||
94300793|NCT03466411|322883835|FG003|Overall Study|Lost to Follow-up|0|||
94300794|NCT03466411|322883836|FG004|Overall Study|Lost to Follow-up|0|||
94300795|NCT03466411|322883837|FG005|Overall Study|Lost to Follow-up|0|||
94300796|NCT03466411|322883838|FG006|Overall Study|Lost to Follow-up|1|||
94300797|NCT03466411|322883839|FG007|Overall Study|Lost to Follow-up|1|||
94300798|NCT03466411|322883840|FG008|Overall Study|Lost to Follow-up|0|||
94300799|NCT03466411|322883841|FG009|Overall Study|Lost to Follow-up|1|||
94300800|NCT03466411|322883842|FG010|Overall Study|Lost to Follow-up|1|||
94300801|NCT03466411|322883843|FG011|Overall Study|Lost to Follow-up|1|||
94300802|NCT03466411|322883844|FG012|Overall Study|Lost to Follow-up|0|||
94300803|NCT03466411|322883832|FG000|Overall Study|Withdrawal by Subject|14|||
94300804|NCT03466411|322883833|FG001|Overall Study|Withdrawal by Subject|7|||
94300805|NCT03466411|322883834|FG002|Overall Study|Withdrawal by Subject|8|||
94300806|NCT03466411|322883835|FG003|Overall Study|Withdrawal by Subject|4|||
94300807|NCT03466411|322883836|FG004|Overall Study|Withdrawal by Subject|6|||
94300808|NCT03466411|322883837|FG005|Overall Study|Withdrawal by Subject|3|||
94300809|NCT03466411|322883838|FG006|Overall Study|Withdrawal by Subject|6|||
94300810|NCT03466411|322883839|FG007|Overall Study|Withdrawal by Subject|9|||
94300811|NCT03466411|322883840|FG008|Overall Study|Withdrawal by Subject|6|||
94300812|NCT03466411|322883841|FG009|Overall Study|Withdrawal by Subject|11|||
94300813|NCT03466411|322883842|FG010|Overall Study|Withdrawal by Subject|14|||
94300814|NCT03466411|322883843|FG011|Overall Study|Withdrawal by Subject|12|||
94300815|NCT03466411|322883844|FG012|Overall Study|Withdrawal by Subject|7|||
94300816|NCT03466411|322883832|FG000|Overall Study|Other|1|||
94300817|NCT03466411|322883833|FG001|Overall Study|Other|1|||
94300818|NCT03466411|322883834|FG002|Overall Study|Other|0|||
94300819|NCT03466411|322883835|FG003|Overall Study|Other|1|||
94300820|NCT03466411|322883836|FG004|Overall Study|Other|2|||
94300821|NCT03466411|322883837|FG005|Overall Study|Other|0|||
94300822|NCT03466411|322883838|FG006|Overall Study|Other|0|||
94300823|NCT03466411|322883839|FG007|Overall Study|Other|0|||
94300824|NCT03466411|322883840|FG008|Overall Study|Other|0|||
94300825|NCT03466411|322883841|FG009|Overall Study|Other|1|||
94300826|NCT03466411|322883842|FG010|Overall Study|Other|2|||
94300827|NCT03466411|322883843|FG011|Overall Study|Other|0|||
94300828|NCT03466411|322883844|FG012|Overall Study|Other|0|||
94300829|NCT03466411|322883832|FG000|Overall Study|Randomized but not Treated|0|||
94300830|NCT03466411|322883833|FG001|Overall Study|Randomized but not Treated|0|||
94300831|NCT03466411|322883834|FG002|Overall Study|Randomized but not Treated|0|||
94300832|NCT03466411|322883835|FG003|Overall Study|Randomized but not Treated|0|||
94300833|NCT03466411|322883836|FG004|Overall Study|Randomized but not Treated|0|||
94300834|NCT03466411|322883837|FG005|Overall Study|Randomized but not Treated|0|||
94300835|NCT03466411|322883838|FG006|Overall Study|Randomized but not Treated|1|||
94300836|NCT03466411|322883839|FG007|Overall Study|Randomized but not Treated|0|||
94300837|NCT03466411|322883840|FG008|Overall Study|Randomized but not Treated|0|||
94300838|NCT03466411|322883841|FG009|Overall Study|Randomized but not Treated|0|||
94300839|NCT03466411|322883842|FG010|Overall Study|Randomized but not Treated|0|||
94300840|NCT03466411|322883843|FG011|Overall Study|Randomized but not Treated|0|||
94300841|NCT03466411|322883844|FG012|Overall Study|Randomized but not Treated|0|||
94300842|NCT05564052|322883845|FG000|Overall Study|Withdrawal by Subject|0|||
94300843|NCT05564052|322883846|FG001|Overall Study|Withdrawal by Subject|0|||
94300844|NCT05564052|322883847|FG002|Overall Study|Withdrawal by Subject|0|||
94300845|NCT05564052|322883848|FG003|Overall Study|Withdrawal by Subject|1|||
94300846|NCT05564052|322883845|FG000|Overall Study|Ongoing|8|||
94300847|NCT05564052|322883846|FG001|Overall Study|Ongoing|5|||
94300848|NCT05564052|322883847|FG002|Overall Study|Ongoing|4|||
94300849|NCT05564052|322883848|FG003|Overall Study|Ongoing|1|||
94300850|NCT04233424|322883849|FG000|Overall Study|Death|15|||
94300851|NCT04233424|322883850|FG001|Overall Study|Death|16|||
94300852|NCT04233424|322883849|FG000|Overall Study|Withdrawal by Subject|2|||
94300853|NCT04233424|322883850|FG001|Overall Study|Withdrawal by Subject|8|||
94300854|NCT04233424|322883849|FG000|Overall Study|Physician Decision|1|||
94300855|NCT04233424|322883850|FG001|Overall Study|Physician Decision|3|||
94300856|NCT04233424|322883849|FG000|Overall Study|Protocol Violation|3|||
94300857|NCT04233424|322883850|FG001|Overall Study|Protocol Violation|1|||
94300858|NCT04233424|322883849|FG000|Overall Study|Lost to Follow-up|1|||
94300859|NCT04233424|322883850|FG001|Overall Study|Lost to Follow-up|3|||
94300860|NCT04233424|322883849|FG000|Overall Study|subject refuse to visit site|2|||
94300861|NCT04233424|322883850|FG001|Overall Study|subject refuse to visit site|0|||
94300862|NCT04538664|322883851|FG000|Overall Study|Withdrawal by Subject|5|||
94300863|NCT04538664|322883852|FG001|Overall Study|Withdrawal by Subject|9|||
94300864|NCT04538664|322883851|FG000|Overall Study|Lost to Follow-up|2|||
94300865|NCT04538664|322883852|FG001|Overall Study|Lost to Follow-up|1|||
94300866|NCT04538664|322883851|FG000|Overall Study|Ongoing|106|||
94300867|NCT04538664|322883852|FG001|Overall Study|Ongoing|115|||
94300868|NCT04770779|322883853|FG000|Overall Study|Randomized, never treated|0|||
94300869|NCT04770779|322883854|FG001|Overall Study|Randomized, never treated|1|||
94300870|NCT04770779|322883853|FG000|Overall Study|Adverse Event|9|||
94300871|NCT04770779|322883854|FG001|Overall Study|Adverse Event|1|||
94300872|NCT04770779|322883853|FG000|Overall Study|Withdrawal by Subject|7|||
94300873|NCT04770779|322883854|FG001|Overall Study|Withdrawal by Subject|1|||
94300874|NCT04770779|322883853|FG000|Overall Study|Pregnancy|0|||
94373901|NCT01078623|323154132|FG019|Treatment Period 4|Adverse Event|0|||
94373902|NCT01078623|323154113|FG000|Treatment Period 4|Withdrawal by Subject|0|||
94373903|NCT01078623|323154114|FG001|Treatment Period 4|Withdrawal by Subject|0|||
94373904|NCT01078623|323154115|FG002|Treatment Period 4|Withdrawal by Subject|0|||
94373905|NCT01078623|323154116|FG003|Treatment Period 4|Withdrawal by Subject|0|||
94373906|NCT01078623|323154117|FG004|Treatment Period 4|Withdrawal by Subject|0|||
94373907|NCT01078623|323154118|FG005|Treatment Period 4|Withdrawal by Subject|0|||
94373908|NCT01078623|323154119|FG006|Treatment Period 4|Withdrawal by Subject|0|||
94373909|NCT01078623|323154120|FG007|Treatment Period 4|Withdrawal by Subject|0|||
94373910|NCT01078623|323154121|FG008|Treatment Period 4|Withdrawal by Subject|0|||
94373911|NCT01078623|323154122|FG009|Treatment Period 4|Withdrawal by Subject|0|||
94373912|NCT01078623|323154123|FG010|Treatment Period 4|Withdrawal by Subject|0|||
94373913|NCT01078623|323154124|FG011|Treatment Period 4|Withdrawal by Subject|0|||
94373914|NCT01078623|323154125|FG012|Treatment Period 4|Withdrawal by Subject|0|||
94373915|NCT01078623|323154126|FG013|Treatment Period 4|Withdrawal by Subject|0|||
94373916|NCT01078623|323154127|FG014|Treatment Period 4|Withdrawal by Subject|0|||
94373917|NCT01078623|323154128|FG015|Treatment Period 4|Withdrawal by Subject|1|||
94373918|NCT01078623|323154129|FG016|Treatment Period 4|Withdrawal by Subject|0|||
94373919|NCT01078623|323154130|FG017|Treatment Period 4|Withdrawal by Subject|0|||
94373920|NCT01078623|323154131|FG018|Treatment Period 4|Withdrawal by Subject|0|||
94373921|NCT01078623|323154132|FG019|Treatment Period 4|Withdrawal by Subject|0|||
94373922|NCT00326885|323154135|FG000|Overall Study|Adverse Event|1|||
94373923|NCT00326885|323154135|FG000|Overall Study|Withdrawal by Subject|3|||
94373924|NCT00326885|323154135|FG000|Overall Study|Physician Decision|1|||
94373925|NCT00326885|323154135|FG000|Overall Study|Hospice withdrew consent|2|||
94373926|NCT02499354|323154136|FG000|Overall Study|Withdrawal by Subject|1|||
94373927|NCT02499354|323154137|FG001|Overall Study|Withdrawal by Subject|0|||
94373928|NCT02424565|323154139|FG000|Period 1 (D0)|Protocol Violation|0|||
94373929|NCT02424565|323154140|FG001|Period 1 (D0)|Protocol Violation|1|||
94373930|NCT01415921|323154142|FG000|Overall Study|Adverse Event|0|||
94373931|NCT01415921|323154143|FG001|Overall Study|Adverse Event|1|||
94373932|NCT01415921|323154142|FG000|Overall Study|Physician Decision|1|||
94373933|NCT01415921|323154143|FG001|Overall Study|Physician Decision|1|||
94373934|NCT01415921|323154142|FG000|Overall Study|Withdrawal by Subject|0|||
94373935|NCT01415921|323154143|FG001|Overall Study|Withdrawal by Subject|1|||
94373936|NCT01415921|323154142|FG000|Overall Study|Other|2|||
94373937|NCT01415921|323154143|FG001|Overall Study|Other|0|||
94373938|NCT03568500|323154144|FG000|Overall Study|Lost to Follow-up|1|||
94373939|NCT03568500|323154145|FG001|Overall Study|Lost to Follow-up|1|||
94373940|NCT03568500|323154146|FG002|Overall Study|Lost to Follow-up|2|||
94373941|NCT03568500|323154144|FG000|Overall Study|Adverse Event|1|||
94373942|NCT03568500|323154145|FG001|Overall Study|Adverse Event|1|||
94373943|NCT03568500|323154146|FG002|Overall Study|Adverse Event|2|||
94373944|NCT03568500|323154144|FG000|Overall Study|Physician Decision|1|||
94373945|NCT03568500|323154145|FG001|Overall Study|Physician Decision|0|||
94373946|NCT03568500|323154146|FG002|Overall Study|Physician Decision|0|||
94373947|NCT03568500|323154144|FG000|Overall Study|Withdrawal by Subject|4|||
94373948|NCT03568500|323154145|FG001|Overall Study|Withdrawal by Subject|2|||
94300875|NCT04770779|322883854|FG001|Overall Study|Pregnancy|1|||
94300876|NCT03692052|322883855|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
94300877|NCT03692052|322883855|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
94300878|NCT03692052|322883855|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
94300879|NCT03692052|322883855|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
94300880|NCT02257736|322883856|FG000|Overall Study|Progressive disease|365|||
94300881|NCT02257736|322883857|FG001|Overall Study|Progressive disease|327|||
94300882|NCT02257736|322883856|FG000|Overall Study|Adverse Event|45|||
94300883|NCT02257736|322883857|FG001|Overall Study|Adverse Event|56|||
94300884|NCT02257736|322883856|FG000|Overall Study|Withdrawal by Subject|21|||
94300885|NCT02257736|322883857|FG001|Overall Study|Withdrawal by Subject|38|||
94300886|NCT02257736|322883856|FG000|Overall Study|Death|11|||
94300887|NCT02257736|322883857|FG001|Overall Study|Death|6|||
94373949|NCT03568500|323154146|FG002|Overall Study|Withdrawal by Subject|0|||
94373950|NCT03568500|323154144|FG000|Overall Study|Technical Problems|2|||
94373951|NCT03568500|323154145|FG001|Overall Study|Technical Problems|1|||
94373952|NCT03568500|323154146|FG002|Overall Study|Technical Problems|0|||
94373953|NCT03568500|323154144|FG000|Overall Study|Participant Noncompliance|1|||
94373954|NCT03568500|323154145|FG001|Overall Study|Participant Noncompliance|1|||
94300888|NCT02257736|322883856|FG000|Overall Study|Physician Decision|5|||
94300889|NCT02257736|322883857|FG001|Overall Study|Physician Decision|9|||
94300890|NCT02257736|322883856|FG000|Overall Study|Non-Compliance with study drug|1|||
94373955|NCT03568500|323154146|FG002|Overall Study|Participant Noncompliance|0|||
94373956|NCT01759381|323154153|FG000|Overall Study|Death|1|||
94373957|NCT01759381|323154154|FG001|Overall Study|Death|0|||
94373958|NCT01244815|323154157|FG000|Overall Study|Not Treated|0|||
94373959|NCT01244815|323154158|FG001|Overall Study|Not Treated|1|||
94373960|NCT01244815|323154159|FG002|Overall Study|Not Treated|0|||
94373961|NCT01244815|323154160|FG003|Overall Study|Not Treated|0|||
94373962|NCT01244815|323154157|FG000|Overall Study|Adverse Event|4|||
94373963|NCT01244815|323154158|FG001|Overall Study|Adverse Event|7|||
94373964|NCT01244815|323154159|FG002|Overall Study|Adverse Event|5|||
94373965|NCT01244815|323154160|FG003|Overall Study|Adverse Event|5|||
94373966|NCT01244815|323154157|FG000|Overall Study|Treatment Failure|0|||
94373967|NCT01244815|323154158|FG001|Overall Study|Treatment Failure|0|||
94373968|NCT01244815|323154159|FG002|Overall Study|Treatment Failure|0|||
94373969|NCT01244815|323154160|FG003|Overall Study|Treatment Failure|1|||
94373970|NCT01244815|323154157|FG000|Overall Study|Lost to Follow-up|3|||
94373971|NCT01244815|323154158|FG001|Overall Study|Lost to Follow-up|2|||
94373972|NCT01244815|323154159|FG002|Overall Study|Lost to Follow-up|3|||
94373973|NCT01244815|323154160|FG003|Overall Study|Lost to Follow-up|2|||
94373974|NCT01244815|323154157|FG000|Overall Study|Withdrawal by Subject|0|||
94373975|NCT01244815|323154158|FG001|Overall Study|Withdrawal by Subject|2|||
94373976|NCT01244815|323154159|FG002|Overall Study|Withdrawal by Subject|0|||
94373977|NCT01244815|323154160|FG003|Overall Study|Withdrawal by Subject|3|||
94373978|NCT01244815|323154157|FG000|Overall Study|Protocol Violation|7|||
94373979|NCT01244815|323154158|FG001|Overall Study|Protocol Violation|4|||
94373980|NCT01244815|323154159|FG002|Overall Study|Protocol Violation|3|||
94373981|NCT01244815|323154160|FG003|Overall Study|Protocol Violation|1|||
94373982|NCT01244815|323154157|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
94373983|NCT01244815|323154158|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
94373984|NCT01244815|323154159|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
94468095|NCT01554176|323502507|FG002|Treatment Phase|Protocol Violation|0|||
94468096|NCT01554176|323502508|FG003|Treatment Phase|Protocol Violation|0|||
94468097|NCT01554176|323502509|FG004|Treatment Phase|Protocol Violation|0|||
94468098|NCT01554176|323502505|FG000|Treatment Phase|Physician Decision|1|||
94468099|NCT01554176|323502506|FG001|Treatment Phase|Physician Decision|1|||
94468100|NCT01554176|323502507|FG002|Treatment Phase|Physician Decision|0|||
94468101|NCT01554176|323502508|FG003|Treatment Phase|Physician Decision|0|||
94468102|NCT01554176|323502509|FG004|Treatment Phase|Physician Decision|0|||
94300891|NCT02257736|322883857|FG001|Overall Study|Non-Compliance with study drug|2|||
94300892|NCT02257736|322883856|FG000|Overall Study|Protocol Violation|1|||
94300893|NCT02257736|322883857|FG001|Overall Study|Protocol Violation|0|||
94300894|NCT02257736|322883856|FG000|Overall Study|Other|1|||
94300895|NCT02257736|322883857|FG001|Overall Study|Other|7|||
94300896|NCT02257736|322883856|FG000|Overall Study|Randomized, not treated|1|||
94300897|NCT02257736|322883857|FG001|Overall Study|Randomized, not treated|2|||
94300898|NCT04242498|322883858|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
94300899|NCT04242498|322883859|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
94300900|NCT04242498|322883860|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
94300901|NCT04242498|322883861|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
94300902|NCT04242498|322883862|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
94300903|NCT04242498|322883863|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
94300904|NCT04242498|322883864|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
94300905|NCT04242498|322883858|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
94300906|NCT04242498|322883859|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
94300907|NCT04242498|322883860|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
94300908|NCT04242498|322883861|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
94300909|NCT04242498|322883862|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
94300910|NCT04242498|322883863|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
94300911|NCT04242498|322883864|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
94300912|NCT04242498|322883858|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
94300913|NCT04242498|322883859|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
94300914|NCT04242498|322883860|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
94300915|NCT04242498|322883861|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
94300916|NCT04242498|322883862|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
94300917|NCT04242498|322883863|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
94300918|NCT04242498|322883864|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
94300919|NCT04242498|322883858|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
94300920|NCT04242498|322883859|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
94300921|NCT04242498|322883860|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
94373985|NCT01244815|323154160|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
94468103|NCT01554176|323502505|FG000|Treatment Phase|Lack of Efficacy|0|||
94300922|NCT04242498|322883861|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
94373986|NCT01808209|323154163|FG000|Overall Study|Lost to Follow-up|0|||
94300923|NCT04242498|322883862|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
94373987|NCT01808209|323154164|FG001|Overall Study|Lost to Follow-up|1|||
94373988|NCT01830920|323154166|FG000|Overall Study|Adverse Event|1|||
94373989|NCT01830920|323154167|FG001|Overall Study|Adverse Event|0|||
94468104|NCT01554176|323502506|FG001|Treatment Phase|Lack of Efficacy|1|||
94373990|NCT01830920|323154168|FG002|Overall Study|Adverse Event|1|||
94373991|NCT01830920|323154169|FG003|Overall Study|Adverse Event|0|||
94373992|NCT01830920|323154170|FG004|Overall Study|Adverse Event|0|||
94373993|NCT01830920|323154166|FG000|Overall Study|Withdrawal by Subject|2|||
94373994|NCT01830920|323154167|FG001|Overall Study|Withdrawal by Subject|2|||
94373995|NCT01830920|323154168|FG002|Overall Study|Withdrawal by Subject|1|||
94373996|NCT01830920|323154169|FG003|Overall Study|Withdrawal by Subject|7|||
94373997|NCT01830920|323154170|FG004|Overall Study|Withdrawal by Subject|1|||
94373998|NCT01830920|323154166|FG000|Overall Study|Death|3|||
94373999|NCT01830920|323154167|FG001|Overall Study|Death|3|||
94374000|NCT01830920|323154168|FG002|Overall Study|Death|5|||
94374001|NCT01830920|323154169|FG003|Overall Study|Death|4|||
94374002|NCT01830920|323154170|FG004|Overall Study|Death|4|||
94374003|NCT01830920|323154166|FG000|Overall Study|Other|15|||
94374004|NCT01830920|323154167|FG001|Overall Study|Other|1|||
94374005|NCT01830920|323154168|FG002|Overall Study|Other|1|||
94374006|NCT01830920|323154169|FG003|Overall Study|Other|5|||
94374007|NCT01830920|323154170|FG004|Overall Study|Other|3|||
94374008|NCT01703741|323154177|FG000|Overall Study|Withdrawal by Subject|6|||
94374009|NCT01703741|323154177|FG000|Overall Study|Adverse Event|2|||
94374010|NCT01703741|323154177|FG000|Overall Study|Physician Decision|2|||
94374011|NCT01703741|323154177|FG000|Overall Study|Protocol Violation|1|||
94374012|NCT01703741|323154177|FG000|Overall Study|Lost to Follow-up|3|||
94374013|NCT01703741|323154177|FG000|Overall Study|Subject did not want to continue|2|||
94374014|NCT01703741|323154177|FG000|Overall Study|Subject cannot comply with study visits|1|||
94374015|NCT01703741|323154177|FG000|Overall Study|Subject started testosterone injections|1|||
94374016|NCT00697112|323154178|FG000|Overall Study|Adverse Event|8|||
94374017|NCT00697112|323154178|FG000|Overall Study|Lost to Follow-up|1|||
94374018|NCT00697112|323154178|FG000|Overall Study|Did not meet inclusion criteria|1|||
94374019|NCT01170364|323154179|FG000|Overall Study|Protocol Violation|4|||
94374020|NCT01170364|323154180|FG001|Overall Study|Protocol Violation|1|||
94374021|NCT00368537|323154181|FG000|Randomization|No study drug dosed|13|||
94374022|NCT00368537|323154182|FG001|Randomization|No study drug dosed|6|||
94374023|NCT00368537|323154181|FG000|Baseline Participants|Lost to Follow-up|16|||
94374024|NCT00368537|323154182|FG001|Baseline Participants|Lost to Follow-up|17|||
94374025|NCT00368537|323154181|FG000|Baseline Participants|Withdrawal by Subject|6|||
94374026|NCT00368537|323154182|FG001|Baseline Participants|Withdrawal by Subject|4|||
94374027|NCT00368537|323154181|FG000|Baseline Participants|Death|1|||
94374028|NCT00368537|323154182|FG001|Baseline Participants|Death|2|||
94374029|NCT00368537|323154181|FG000|Baseline Participants|No susceptibility|1|||
94374030|NCT00368537|323154182|FG001|Baseline Participants|No susceptibility|0|||
94374031|NCT00368537|323154181|FG000|Baseline Participants|Patient uncompliant|0|||
94374032|NCT00368537|323154182|FG001|Baseline Participants|Patient uncompliant|1|||
94374033|NCT01427920|323154183|FG000|Overall Study|Adverse Event|1|||
94374034|NCT01427920|323154184|FG001|Overall Study|Adverse Event|2|||
94374035|NCT01427920|323154183|FG000|Overall Study|Lack of Efficacy|1|||
94374036|NCT01427920|323154184|FG001|Overall Study|Lack of Efficacy|0|||
94374037|NCT01427920|323154183|FG000|Overall Study|Protocol Violation|1|||
94374038|NCT01427920|323154184|FG001|Overall Study|Protocol Violation|3|||
94374039|NCT01427920|323154183|FG000|Overall Study|Withdrawal Criteria|4|||
94374040|NCT01427920|323154184|FG001|Overall Study|Withdrawal Criteria|4|||
94374041|NCT01427920|323154183|FG000|Overall Study|Unclassified|2|||
94374042|NCT01427920|323154184|FG001|Overall Study|Unclassified|8|||
94374043|NCT02041494|323154185|FG000|Overall Study|Death|1|||
94374044|NCT02041494|323154186|FG001|Overall Study|Death|3|||
94374045|NCT02041494|323154185|FG000|Overall Study|Lost to Follow-up|2|||
94374046|NCT02041494|323154186|FG001|Overall Study|Lost to Follow-up|6|||
94374047|NCT02041494|323154185|FG000|Overall Study|study terminated|16|||
94374048|NCT02041494|323154186|FG001|Overall Study|study terminated|11|||
94374049|NCT01717456|323154188|FG000|End of Treatment|Physician Decision|0|||
94374050|NCT01717456|323154189|FG001|End of Treatment|Physician Decision|1|||
94374051|NCT01717456|323154188|FG000|End of Treatment|Lost to Follow-up|0|||
94374052|NCT01717456|323154189|FG001|End of Treatment|Lost to Follow-up|1|||
94374053|NCT01717456|323154188|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
94374054|NCT01717456|323154189|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
94374055|NCT01489956|323154197|FG000|Overall Study|Lost to Follow-up|1|||
94374056|NCT01489956|323154198|FG001|Overall Study|Lost to Follow-up|0|||
94374057|NCT01489956|323154199|FG002|Overall Study|Lost to Follow-up|0|||
94374058|NCT01489956|323154197|FG000|Overall Study|Withdrawal by Subject|0|||
94374059|NCT01489956|323154198|FG001|Overall Study|Withdrawal by Subject|0|||
94374060|NCT01489956|323154199|FG002|Overall Study|Withdrawal by Subject|1|||
94374061|NCT00667719|323154202|FG000|Overall Study|Adverse Event|39|||
94374062|NCT00667719|323154202|FG000|Overall Study|Abnormal Test Procedure|1|||
94374063|NCT00667719|323154202|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
94374064|NCT00667719|323154202|FG000|Overall Study|Protocol Violation|3|||
94374065|NCT00667719|323154202|FG000|Overall Study|Withdrawal by Subject|17|||
94374066|NCT00667719|323154202|FG000|Overall Study|Lost to Follow-up|8|||
94374067|NCT01827371|323154203|FG000|Overall Study|Adverse Event|0|||
94374068|NCT01827371|323154204|FG001|Overall Study|Adverse Event|0|||
94300924|NCT04242498|322883863|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
94300925|NCT04242498|322883864|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
94300926|NCT04242498|322883858|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
94300927|NCT04242498|322883859|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
94300928|NCT04242498|322883860|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
94300929|NCT04242498|322883861|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
94300930|NCT04242498|322883862|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
94300931|NCT04242498|322883863|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
94300932|NCT04242498|322883864|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
94300933|NCT04242498|322883858|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
94300934|NCT04242498|322883859|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
94300935|NCT04242498|322883860|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
94300936|NCT04242498|322883861|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
94300937|NCT04242498|322883862|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
94300938|NCT04242498|322883863|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
94300939|NCT04242498|322883864|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
94300940|NCT04242498|322883858|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
94300941|NCT04242498|322883859|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
94300942|NCT04242498|322883860|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
94300943|NCT04242498|322883861|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
94300944|NCT04242498|322883862|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
94300945|NCT04242498|322883863|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
94300946|NCT04242498|322883864|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
94300947|NCT04242498|322883858|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
94300948|NCT04242498|322883859|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
94300949|NCT04242498|322883860|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
94300950|NCT04242498|322883861|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
94300951|NCT04242498|322883862|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
94300952|NCT04242498|322883863|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
94300953|NCT04242498|322883864|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
94300954|NCT04242498|322883858|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
94300955|NCT04242498|322883859|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
94300956|NCT04242498|322883860|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
94300957|NCT04242498|322883861|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
94300958|NCT04242498|322883862|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
94300959|NCT04242498|322883863|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
94300960|NCT04242498|322883864|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
94300961|NCT04242498|322883858|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
94300962|NCT04242498|322883859|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
94300963|NCT04242498|322883860|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
94300964|NCT04242498|322883861|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
94300965|NCT04242498|322883862|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
94300966|NCT04242498|322883863|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
94300967|NCT04242498|322883864|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
94300968|NCT04242498|322883858|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
94300969|NCT04242498|322883859|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
94300970|NCT04242498|322883860|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
94300971|NCT04242498|322883861|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
94300972|NCT04242498|322883862|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
94300973|NCT04242498|322883863|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
94300974|NCT04242498|322883864|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
94300975|NCT04242498|322883858|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
94300976|NCT04242498|322883859|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
94374069|NCT01827371|323154205|FG002|Overall Study|Adverse Event|4|||
94374070|NCT01827371|323154206|FG003|Overall Study|Adverse Event|2|||
94374071|NCT01827371|323154203|FG000|Overall Study|Lost to Follow-up|0|||
94374072|NCT01827371|323154204|FG001|Overall Study|Lost to Follow-up|2|||
94374073|NCT01827371|323154205|FG002|Overall Study|Lost to Follow-up|0|||
94374074|NCT01827371|323154206|FG003|Overall Study|Lost to Follow-up|4|||
94374075|NCT01827371|323154203|FG000|Overall Study|Protocol Violation|1|||
94374076|NCT01827371|323154204|FG001|Overall Study|Protocol Violation|0|||
94374077|NCT01827371|323154205|FG002|Overall Study|Protocol Violation|0|||
94300977|NCT04242498|322883860|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
94300978|NCT04242498|322883861|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
94300979|NCT04242498|322883862|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
94300980|NCT04242498|322883863|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
94300981|NCT04242498|322883864|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
94300982|NCT04242498|322883858|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
94300983|NCT04242498|322883859|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
94300984|NCT04242498|322883860|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
94300985|NCT04242498|322883861|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
94300986|NCT04242498|322883862|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
94300987|NCT04242498|322883863|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
94300988|NCT04242498|322883864|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
94300989|NCT04242498|322883858|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
94300990|NCT04242498|322883859|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
94300991|NCT04242498|322883860|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
94300992|NCT04242498|322883861|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
94300993|NCT04242498|322883862|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
94300994|NCT04242498|322883863|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
94300995|NCT04242498|322883864|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
94300996|NCT04242498|322883858|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
94300997|NCT04242498|322883859|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
94300998|NCT04242498|322883860|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
94300999|NCT04242498|322883861|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
94301000|NCT04242498|322883862|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
94301001|NCT04242498|322883863|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
94374078|NCT01827371|323154206|FG003|Overall Study|Protocol Violation|0|||
94301002|NCT04242498|322883864|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
94301003|NCT04242498|322883858|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
94301004|NCT04242498|322883859|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
94301005|NCT04242498|322883860|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
94301006|NCT04242498|322883861|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
94301007|NCT04242498|322883862|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
94301008|NCT04242498|322883863|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
94301009|NCT04242498|322883864|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
94301010|NCT03248128|322883865|FG000|Overall Study|Lost to Follow-up|1|||
94301011|NCT03248128|322883866|FG001|Overall Study|Lost to Follow-up|0|||
94301012|NCT03248128|322883865|FG000|Overall Study|Withdrawal by Subject|16|||
94301013|NCT03248128|322883866|FG001|Overall Study|Withdrawal by Subject|14|||
94301014|NCT03248128|322883865|FG000|Overall Study|Site Closed|4|||
94301015|NCT03248128|322883866|FG001|Overall Study|Site Closed|3|||
94301016|NCT03248128|322883865|FG000|Overall Study|Randomized, but did not receive treatment|1|||
94301017|NCT03248128|322883866|FG001|Overall Study|Randomized, but did not receive treatment|3|||
94301018|NCT02017444|322884523|FG000|Overall Study|Physician Decision|1|||
94301019|NCT02017444|322884524|FG001|Overall Study|Physician Decision|0|||
94301020|NCT02017444|322884523|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
94301021|NCT02017444|322884524|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
94301022|NCT00215150|322884526|FG000|Open Label Phase|Lost to Follow-up|7|||
94301023|NCT00215150|322884526|FG000|Open Label Phase|Withdrawal by Subject|1|||
94301024|NCT00215150|322884526|FG000|Open Label Phase|Did not complete a post base visit|13|||
94301025|NCT00215150|322884526|FG000|Open Label Phase|Did not meet randomization criteria|9|||
94301026|NCT00215150|322884526|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
94301027|NCT00215150|322884526|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
94301028|NCT00215150|322884526|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
94301029|NCT02251743|322884527|FG000|Overall Study|Withdrawal by Subject|1|||
94301030|NCT02251743|322884528|FG001|Overall Study|Withdrawal by Subject|1|||
94374079|NCT01827371|323154203|FG000|Overall Study|Withdrawal by Subject|1|||
94374080|NCT01827371|323154204|FG001|Overall Study|Withdrawal by Subject|2|||
94374081|NCT01827371|323154205|FG002|Overall Study|Withdrawal by Subject|2|||
94374082|NCT01827371|323154206|FG003|Overall Study|Withdrawal by Subject|3|||
94374083|NCT01827371|323154203|FG000|Overall Study|Physician Decision|0|||
94374084|NCT01827371|323154204|FG001|Overall Study|Physician Decision|1|||
94374085|NCT01827371|323154205|FG002|Overall Study|Physician Decision|0|||
94374086|NCT01827371|323154206|FG003|Overall Study|Physician Decision|1|||
94374087|NCT01827371|323154203|FG000|Overall Study|Temporary study halt to vaccinations|11|||
94374088|NCT01827371|323154204|FG001|Overall Study|Temporary study halt to vaccinations|2|||
94374089|NCT01827371|323154205|FG002|Overall Study|Temporary study halt to vaccinations|5|||
94374090|NCT01827371|323154206|FG003|Overall Study|Temporary study halt to vaccinations|13|||
94374091|NCT03255031|323154208|FG000|Overall Study|Adverse Event|5|||
94374092|NCT03255031|323154209|FG001|Overall Study|Adverse Event|3|||
94374093|NCT03255031|323154208|FG000|Overall Study|Physician Decision|2|||
94374094|NCT03255031|323154209|FG001|Overall Study|Physician Decision|1|||
94374095|NCT03255031|323154208|FG000|Overall Study|Withdrawal by Subject|9|||
94374096|NCT03255031|323154209|FG001|Overall Study|Withdrawal by Subject|3|||
94374097|NCT00297479|323154210|FG000|Overall Study|Lost to Follow-up|37|||
94374098|NCT00297479|323154211|FG001|Overall Study|Lost to Follow-up|54|||
94374099|NCT00297479|323154212|FG002|Overall Study|Lost to Follow-up|51|||
94374100|NCT00863057|323154214|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
94374101|NCT00863057|323154215|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
94374102|NCT00863057|323154216|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
94374103|NCT00863057|323154217|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
94374104|NCT00863057|323154214|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
94374105|NCT00863057|323154215|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
94374106|NCT00863057|323154216|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
94374107|NCT00863057|323154217|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
94374108|NCT00863057|323154214|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
94374109|NCT00863057|323154215|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
94374110|NCT00863057|323154216|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
94374111|NCT00863057|323154217|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
94374112|NCT00863057|323154214|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
94374113|NCT00863057|323154215|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
94374114|NCT00863057|323154216|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
94374115|NCT00863057|323154217|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
94374116|NCT00373685|323154220|FG000|Overall Study|Death|2|||
94374117|NCT00373685|323154221|FG001|Overall Study|Death|1|||
94374118|NCT00373685|323154220|FG000|Overall Study|Adverse Event|278|||
94374119|NCT00373685|323154221|FG001|Overall Study|Adverse Event|253|||
94374120|NCT00373685|323154220|FG000|Overall Study|Insufficient clinical response|169|||
94374121|NCT00373685|323154221|FG001|Overall Study|Insufficient clinical response|119|||
94374122|NCT00373685|323154220|FG000|Overall Study|Did not meet entrance criteria|167|||
94374123|NCT00373685|323154221|FG001|Overall Study|Did not meet entrance criteria|184|||
94374124|NCT00373685|323154220|FG000|Overall Study|Lost to follow up|83|||
94374125|NCT00373685|323154221|FG001|Overall Study|Lost to follow up|103|||
94374126|NCT00373685|323154220|FG000|Overall Study|No longer willing to participate|337|||
94374127|NCT00373685|323154221|FG001|Overall Study|No longer willing to participate|352|||
94374128|NCT00373685|323154220|FG000|Overall Study|Other|149|||
94374129|NCT00373685|323154221|FG001|Overall Study|Other|146|||
94374130|NCT00373685|323154220|FG000|Overall Study|Protocol Violation|191|||
94374131|NCT00373685|323154221|FG001|Overall Study|Protocol Violation|182|||
94374132|NCT00373685|323154220|FG000|Overall Study|Final Status Unknown|12|||
94374133|NCT00373685|323154221|FG001|Overall Study|Final Status Unknown|4|||
94374134|NCT00373685|323154220|FG000|Overall Study|Randomized, not treated|51|||
94374135|NCT00373685|323154221|FG001|Overall Study|Randomized, not treated|77|||
94374136|NCT01612156|323154222|FG000|Overall Study|Protocol Violation|2|||
94374137|NCT01612156|323154223|FG001|Overall Study|Protocol Violation|0|||
94374138|NCT01698320|323154224|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
94374139|NCT01698320|323154225|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
94374140|NCT01698320|323154226|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
94374141|NCT01698320|323154224|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
94374142|NCT01698320|323154225|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
94374143|NCT01698320|323154226|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
94374144|NCT01698320|323154224|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
94374145|NCT01698320|323154225|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
94374146|NCT01698320|323154226|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
94374147|NCT01698320|323154224|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
94374148|NCT01698320|323154225|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
94468105|NCT01554176|323502507|FG002|Treatment Phase|Lack of Efficacy|0|||
94374149|NCT01698320|323154226|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
94374150|NCT01698320|323154224|FG000|12-Week Double-Blind Period|Adverse Event|0|||
94374151|NCT01698320|323154225|FG001|12-Week Double-Blind Period|Adverse Event|1|||
94374152|NCT01698320|323154226|FG002|12-Week Double-Blind Period|Adverse Event|1|||
94374153|NCT01698320|323154224|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
94374154|NCT01698320|323154225|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
94374155|NCT01698320|323154226|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
94468106|NCT01554176|323502508|FG003|Treatment Phase|Lack of Efficacy|0|||
94374156|NCT01698320|323154224|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
94374157|NCT01698320|323154225|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
94374158|NCT01698320|323154226|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
94374159|NCT01698320|323154224|FG000|12-Week Double-Blind Period|Pregnancy|0|||
94374160|NCT01698320|323154225|FG001|12-Week Double-Blind Period|Pregnancy|1|||
94374161|NCT01698320|323154226|FG002|12-Week Double-Blind Period|Pregnancy|1|||
94374162|NCT01698320|323154224|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
94374163|NCT01698320|323154225|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
94374164|NCT01698320|323154226|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
94374165|NCT01698320|323154224|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
94374166|NCT01698320|323154225|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
94374167|NCT01698320|323154226|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
94374168|NCT01698320|323154224|FG000|40-Week Open-Label Period|Adverse Event|0|||
94374169|NCT01698320|323154225|FG001|40-Week Open-Label Period|Adverse Event|3|||
94374170|NCT01698320|323154226|FG002|40-Week Open-Label Period|Adverse Event|2|||
94374171|NCT01698320|323154224|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
94374172|NCT01698320|323154225|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
94374173|NCT01698320|323154226|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
94374174|NCT01698320|323154224|FG000|40-Week Open-Label Period|Pregnancy|0|||
94374175|NCT01698320|323154225|FG001|40-Week Open-Label Period|Pregnancy|2|||
94374176|NCT01698320|323154226|FG002|40-Week Open-Label Period|Pregnancy|1|||
94374177|NCT01698320|323154224|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
94374178|NCT01698320|323154225|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
94374179|NCT01698320|323154226|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
94374180|NCT01698320|323154224|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
94374181|NCT01698320|323154225|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
94374182|NCT01698320|323154226|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
94374183|NCT01023269|323154227|FG000|Overall Study|early termination of the study|2|||
94374184|NCT01023269|323154228|FG001|Overall Study|early termination of the study|0|||
94374185|NCT01953783|323154229|FG000|Overall Study|Progressive disease|2|||
94374186|NCT00686920|323154233|FG000|Overall Study|Death|45|||
94374187|NCT00686920|323154234|FG001|Overall Study|Death|14|||
94374188|NCT00686920|323154233|FG000|Overall Study|Liver Transplant|23|||
94374189|NCT00686920|323154234|FG001|Overall Study|Liver Transplant|8|||
94374190|NCT00686920|323154233|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
94374191|NCT00686920|323154234|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
94374192|NCT00686920|323154233|FG000|Overall Study|Withdrawal by Subject|23|||
94374193|NCT00686920|323154234|FG001|Overall Study|Withdrawal by Subject|5|||
94374194|NCT00686920|323154233|FG000|Overall Study|Protocol Violation|2|||
94374195|NCT00686920|323154234|FG001|Overall Study|Protocol Violation|1|||
94374196|NCT00686920|323154233|FG000|Overall Study|Adverse Event|10|||
94374197|NCT00686920|323154234|FG001|Overall Study|Adverse Event|2|||
94374198|NCT00686920|323154233|FG000|Overall Study|Personal Reason|0|||
94374199|NCT00686920|323154234|FG001|Overall Study|Personal Reason|1|||
94374200|NCT00686920|323154233|FG000|Overall Study|Lost to Follow-up|15|||
94374201|NCT00686920|323154234|FG001|Overall Study|Lost to Follow-up|3|||
94374202|NCT00686920|323154233|FG000|Overall Study|Moved to Another State|1|||
94374203|NCT00686920|323154234|FG001|Overall Study|Moved to Another State|0|||
94374204|NCT00686920|323154233|FG000|Overall Study|Transferred to Nursing Home|1|||
94374205|NCT00686920|323154234|FG001|Overall Study|Transferred to Nursing Home|0|||
94374206|NCT00686920|323154233|FG000|Overall Study|Noncompliance|9|||
94374207|NCT00686920|323154234|FG001|Overall Study|Noncompliance|0|||
94374208|NCT00686920|323154233|FG000|Overall Study|Principal Investigator Decision|2|||
94374209|NCT00686920|323154234|FG001|Overall Study|Principal Investigator Decision|0|||
94374210|NCT00947011|323154237|FG000|Overall Study|Study was terminated,PI left institution|12|||
94374211|NCT02971605|323154244|FG000|Overall Study|Withdrawal by Subject|1|||
94374212|NCT02110706|323154247|FG000|Overall Study|Adverse Event|2|||
94374213|NCT02110706|323154248|FG001|Overall Study|Adverse Event|3|||
94374214|NCT02110706|323154247|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
94374215|NCT02110706|323154248|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
94374216|NCT00395083|323154253|FG000|Overall Study|Withdrawal by Subject|6|||
94374217|NCT00395083|323154254|FG001|Overall Study|Withdrawal by Subject|5|||
94374218|NCT00395083|323154253|FG000|Overall Study|Developed another disease|4|||
94374219|NCT00395083|323154254|FG001|Overall Study|Developed another disease|3|||
94374220|NCT03586830|323154256|FG000|Overall Study|Site terminated by Sponsor|1|||
94374221|NCT03586830|323154257|FG001|Overall Study|Site terminated by Sponsor|4|||
94374222|NCT03586830|323154258|FG002|Overall Study|Site terminated by Sponsor|3|||
94374223|NCT03586830|323154259|FG003|Overall Study|Site terminated by Sponsor|3|||
94374224|NCT03586830|323154256|FG000|Overall Study|Lost to Follow-up|0|||
94374225|NCT03586830|323154257|FG001|Overall Study|Lost to Follow-up|2|||
94374226|NCT03586830|323154258|FG002|Overall Study|Lost to Follow-up|2|||
94374227|NCT03586830|323154259|FG003|Overall Study|Lost to Follow-up|1|||
94374228|NCT03586830|323154256|FG000|Overall Study|Withdrawal by Subject|1|||
94374229|NCT03586830|323154257|FG001|Overall Study|Withdrawal by Subject|0|||
94301031|NCT00001337|322884534|FG000|Overall Study|Switched to alternate treatment|2|||
94301032|NCT00001337|322884535|FG001|Overall Study|Switched to alternate treatment|2|||
94301033|NCT00001337|322884536|FG002|Overall Study|Switched to alternate treatment|0|||
94301034|NCT00001337|322884534|FG000|Overall Study|Refused further treatment|2|||
94301035|NCT00001337|322884535|FG001|Overall Study|Refused further treatment|1|||
94301036|NCT00001337|322884536|FG002|Overall Study|Refused further treatment|0|||
94301037|NCT00001337|322884534|FG000|Overall Study|Began other Tx|1|||
94301038|NCT00001337|322884535|FG001|Overall Study|Began other Tx|0|||
94301039|NCT00001337|322884536|FG002|Overall Study|Began other Tx|0|||
94301040|NCT00001337|322884534|FG000|Overall Study|Physician Decision|3|||
94301041|NCT00001337|322884535|FG001|Overall Study|Physician Decision|1|||
94301042|NCT00001337|322884536|FG002|Overall Study|Physician Decision|0|||
94301043|NCT00001337|322884534|FG000|Overall Study|Doesn't have NHL|0|||
94301044|NCT00001337|322884535|FG001|Overall Study|Doesn't have NHL|1|||
94301045|NCT00001337|322884536|FG002|Overall Study|Doesn't have NHL|0|||
94301046|NCT00001337|322884534|FG000|Overall Study|Non protocol tx needed|3|||
94301047|NCT00001337|322884535|FG001|Overall Study|Non protocol tx needed|1|||
94301048|NCT00001337|322884536|FG002|Overall Study|Non protocol tx needed|0|||
94301049|NCT00001337|322884534|FG000|Overall Study|Protocol change|1|||
94301050|NCT00001337|322884535|FG001|Overall Study|Protocol change|0|||
94301051|NCT00001337|322884536|FG002|Overall Study|Protocol change|0|||
94301052|NCT00001337|322884534|FG000|Overall Study|2nd primary disease|0|||
94301053|NCT00001337|322884535|FG001|Overall Study|2nd primary disease|0|||
94301054|NCT00001337|322884536|FG002|Overall Study|2nd primary disease|1|||
94301055|NCT00001337|322884534|FG000|Overall Study|Death during follow up period|9|||
94301056|NCT00001337|322884535|FG001|Overall Study|Death during follow up period|4|||
94301057|NCT00001337|322884536|FG002|Overall Study|Death during follow up period|0|||
94301058|NCT00001337|322884534|FG000|Overall Study|Death on study|19|||
94301059|NCT00001337|322884535|FG001|Overall Study|Death on study|9|||
94301060|NCT00001337|322884536|FG002|Overall Study|Death on study|0|||
94301061|NCT00001337|322884534|FG000|Overall Study|Disease progression during follow-up period|3|||
94301062|NCT00001337|322884535|FG001|Overall Study|Disease progression during follow-up period|1|||
94301063|NCT00001337|322884536|FG002|Overall Study|Disease progression during follow-up period|0|||
94301064|NCT00001337|322884534|FG000|Overall Study|Disease progression on study|33|||
94301065|NCT00001337|322884535|FG001|Overall Study|Disease progression on study|41|||
94301066|NCT00001337|322884536|FG002|Overall Study|Disease progression on study|0|||
94301067|NCT00001337|322884534|FG000|Overall Study|Lost to further follow-up|10|||
94301068|NCT00001337|322884535|FG001|Overall Study|Lost to further follow-up|6|||
94301069|NCT00001337|322884536|FG002|Overall Study|Lost to further follow-up|0|||
94301070|NCT00001337|322884534|FG000|Overall Study|2nd malignancy|1|||
94301071|NCT00001337|322884535|FG001|Overall Study|2nd malignancy|0|||
94301072|NCT00001337|322884536|FG002|Overall Study|2nd malignancy|0|||
94301073|NCT00001337|322884534|FG000|Overall Study|Treatment for second lymphoma|0|||
94301074|NCT00001337|322884535|FG001|Overall Study|Treatment for second lymphoma|1|||
94301075|NCT00001337|322884536|FG002|Overall Study|Treatment for second lymphoma|0|||
94301076|NCT00001337|322884534|FG000|Overall Study|Transfer to transplant|0|||
94301077|NCT00001337|322884535|FG001|Overall Study|Transfer to transplant|1|||
94301078|NCT00001337|322884536|FG002|Overall Study|Transfer to transplant|0|||
94301079|NCT03459040|322884537|FG000|Overall Study|Death|8|||
94301080|NCT03459040|322884537|FG000|Overall Study|Withdrawal by Subject|1|||
94301081|NCT03815175|322884540|FG000|Overall Study|Subject Lost to Follow-up|6|||
94301082|NCT03815175|322884540|FG000|Overall Study|Subject Withdrew Consent|48|||
94301083|NCT03815175|322884540|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
94301084|NCT03815175|322884540|FG000|Overall Study|Death|86|||
94301085|NCT03815175|322884540|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
94301086|NCT03815175|322884540|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
94301087|NCT03815175|322884540|FG000|Overall Study|Other Status Change Reason|1|||
94301088|NCT03815175|322884540|FG000|Overall Study|Missed Visit|12|||
94301089|NCT02493751|322884545|FG000|Overall Study|Withdrawal by Subject|2|||
94301090|NCT02493751|322884546|FG001|Overall Study|Withdrawal by Subject|8|||
94301091|NCT02493751|322884545|FG000|Overall Study|Death|6|||
94374230|NCT03586830|323154258|FG002|Overall Study|Withdrawal by Subject|3|||
94374231|NCT03586830|323154259|FG003|Overall Study|Withdrawal by Subject|1|||
94301092|NCT02493751|322884546|FG001|Overall Study|Death|13|||
94301093|NCT02493751|322884545|FG000|Overall Study|Lost to Follow-up|2|||
94301094|NCT02493751|322884546|FG001|Overall Study|Lost to Follow-up|3|||
94301095|NCT02493751|322884545|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
94301096|NCT02493751|322884546|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
94301097|NCT03822468|322884547|FG000|Treatment Period|Progressive disease|98|||
94301098|NCT03822468|322884548|FG001|Treatment Period|Progressive disease|94|||
94301099|NCT03822468|322884547|FG000|Treatment Period|Adverse Event|21|||
94301100|NCT03822468|322884548|FG001|Treatment Period|Adverse Event|24|||
94301101|NCT03822468|322884547|FG000|Treatment Period|Withdrawal by Subject|9|||
94301102|NCT03822468|322884548|FG001|Treatment Period|Withdrawal by Subject|5|||
94301103|NCT03822468|322884547|FG000|Treatment Period|Physician Decision|9|||
94301104|NCT03822468|322884548|FG001|Treatment Period|Physician Decision|7|||
94301105|NCT03822468|322884547|FG000|Treatment Period|Protocol Violation|2|||
94301106|NCT03822468|322884548|FG001|Treatment Period|Protocol Violation|1|||
94301107|NCT03822468|322884547|FG000|Treatment Period|Death|2|||
94301108|NCT03822468|322884548|FG001|Treatment Period|Death|3|||
94301109|NCT03822468|322884547|FG000|Treatment Period|Lost to Follow-up|1|||
94301110|NCT03822468|322884548|FG001|Treatment Period|Lost to Follow-up|1|||
94301111|NCT03822468|322884547|FG000|Treatment Period|Sponsor decision|46|||
94301112|NCT03822468|322884548|FG001|Treatment Period|Sponsor decision|53|||
94301113|NCT03822468|322884547|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
94301114|NCT03822468|322884548|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
94301115|NCT03822468|322884547|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
94301116|NCT03822468|322884548|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
94301117|NCT03822468|322884547|FG000|Post-treatment Efficacy Follow-up|Death|1|||
94301118|NCT03822468|322884548|FG001|Post-treatment Efficacy Follow-up|Death|0|||
94301119|NCT03822468|322884547|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
94301120|NCT03822468|322884548|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
94301121|NCT03822468|322884547|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
94301122|NCT03822468|322884548|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
94301123|NCT03822468|322884547|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
94301124|NCT03822468|322884548|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
94301125|NCT03822468|322884547|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
94301126|NCT03822468|322884548|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
94301127|NCT05121103|322884549|FG000|Overall Study|Progressive disease|2|||
94301128|NCT05121103|322884550|FG001|Overall Study|Progressive disease|1|||
94301129|NCT05121103|322884551|FG002|Overall Study|Progressive disease|6|||
94301130|NCT05121103|322884549|FG000|Overall Study|Physician Decision|2|||
94301131|NCT05121103|322884550|FG001|Overall Study|Physician Decision|1|||
94301132|NCT05121103|322884551|FG002|Overall Study|Physician Decision|0|||
94301133|NCT05121103|322884549|FG000|Overall Study|Withdrawal by Subject|0|||
94301134|NCT05121103|322884550|FG001|Overall Study|Withdrawal by Subject|1|||
94301135|NCT05121103|322884551|FG002|Overall Study|Withdrawal by Subject|0|||
94301136|NCT04885257|322884552|FG000|Overall Study|Withdrawal by Subject|1|||
94301137|NCT04885257|322884553|FG001|Overall Study|Withdrawal by Subject|0|||
94301138|NCT03390504|322884554|FG000|Overall Study|Lost to Follow-up|2|||
94301139|NCT03390504|322884555|FG001|Overall Study|Lost to Follow-up|4|||
94301140|NCT03390504|322884556|FG002|Overall Study|Lost to Follow-up|0|||
94301141|NCT03390504|322884557|FG003|Overall Study|Lost to Follow-up|1|||
94301142|NCT03390504|322884554|FG000|Overall Study|Withdrawal by Subject|3|||
94301143|NCT03390504|322884555|FG001|Overall Study|Withdrawal by Subject|15|||
94301144|NCT03390504|322884556|FG002|Overall Study|Withdrawal by Subject|5|||
94301145|NCT03390504|322884557|FG003|Overall Study|Withdrawal by Subject|2|||
94301146|NCT03390504|322884554|FG000|Overall Study|Other|1|||
94301147|NCT03390504|322884555|FG001|Overall Study|Other|2|||
94301148|NCT03390504|322884556|FG002|Overall Study|Other|2|||
94301149|NCT03390504|322884557|FG003|Overall Study|Other|6|||
94301150|NCT04576455|322884558|FG000|Overall Study|Ongoing in the Study|48|||
94301151|NCT04576455|322884559|FG001|Overall Study|Ongoing in the Study|58|||
94301152|NCT04576455|322884558|FG000|Overall Study|Death|83|||
94301153|NCT04576455|322884559|FG001|Overall Study|Death|77|||
94301154|NCT04576455|322884558|FG000|Overall Study|Lost to Follow-up|4|||
94301155|NCT04576455|322884559|FG001|Overall Study|Lost to Follow-up|5|||
94301156|NCT04576455|322884558|FG000|Overall Study|Withdrawal by Subject|16|||
94301157|NCT04576455|322884559|FG001|Overall Study|Withdrawal by Subject|12|||
94301158|NCT03878446|322884560|FG000|Overall Study|Withdrawn by parent or guardian|1|||
94301159|NCT03878446|322884561|FG001|Overall Study|Withdrawn by parent or guardian|0|||
94301160|NCT03878446|322884562|FG002|Overall Study|Withdrawn by parent or guardian|0|||
94301161|NCT03878446|322884563|FG003|Overall Study|Withdrawn by parent or guardian|0|||
94301162|NCT03878446|322884564|FG004|Overall Study|Withdrawn by parent or guardian|0|||
94301163|NCT04458857|322884566|FG000|Overall Study|Adverse Event|0|||
94301164|NCT04458857|322884567|FG001|Overall Study|Adverse Event|1|||
94301165|NCT04458857|322884568|FG002|Overall Study|Adverse Event|0|||
94301166|NCT04458857|322884566|FG000|Overall Study|Withdrawal by Subject|2|||
94301167|NCT04458857|322884567|FG001|Overall Study|Withdrawal by Subject|0|||
94301168|NCT04458857|322884568|FG002|Overall Study|Withdrawal by Subject|0|||
94301169|NCT04458857|322884566|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94301170|NCT04458857|322884567|FG001|Overall Study|Withdrawal by parent/guardian|0|||
94301171|NCT04458857|322884568|FG002|Overall Study|Withdrawal by parent/guardian|1|||
94301172|NCT04458857|322884566|FG000|Overall Study|Non-compliance with study drug|0|||
94301173|NCT04458857|322884567|FG001|Overall Study|Non-compliance with study drug|1|||
94301174|NCT04458857|322884568|FG002|Overall Study|Non-compliance with study drug|0|||
94301175|NCT04458857|322884566|FG000|Overall Study|Lost to Follow-up|4|||
94301176|NCT04458857|322884567|FG001|Overall Study|Lost to Follow-up|1|||
94301177|NCT04458857|322884568|FG002|Overall Study|Lost to Follow-up|0|||
94301178|NCT01937117|322884569|FG000|Overall Study|Disease Progression|7|||
94301179|NCT01937117|322884569|FG000|Overall Study|Physician Decision|4|||
94374232|NCT03558997|323154261|FG000|Overall Study|Adverse Event|0|||
94374233|NCT03558997|323154262|FG001|Overall Study|Adverse Event|2|||
94374234|NCT03558997|323154263|FG002|Overall Study|Adverse Event|5|||
94374235|NCT03558997|323154264|FG003|Overall Study|Adverse Event|1|||
94374236|NCT03558997|323154261|FG000|Overall Study|Physician Decision|0|||
94374237|NCT03558997|323154262|FG001|Overall Study|Physician Decision|0|||
94374238|NCT03558997|323154263|FG002|Overall Study|Physician Decision|1|||
94374239|NCT03558997|323154264|FG003|Overall Study|Physician Decision|0|||
94374240|NCT03558997|323154261|FG000|Overall Study|Withdrawal by Subject|1|||
94374241|NCT03558997|323154262|FG001|Overall Study|Withdrawal by Subject|0|||
94374242|NCT03558997|323154263|FG002|Overall Study|Withdrawal by Subject|1|||
94374243|NCT03558997|323154264|FG003|Overall Study|Withdrawal by Subject|1|||
94374244|NCT03558997|323154261|FG000|Overall Study|Lost to Follow-up|0|||
94374245|NCT03558997|323154262|FG001|Overall Study|Lost to Follow-up|0|||
94374246|NCT03558997|323154263|FG002|Overall Study|Lost to Follow-up|1|||
94374247|NCT03558997|323154264|FG003|Overall Study|Lost to Follow-up|0|||
94374248|NCT03740100|323154265|FG000|Overall Study|Adverse Event|1|||
94374249|NCT03740100|323154265|FG000|Overall Study|Death|1|||
94374250|NCT05028751|323154266|FG000|Overall Study|Study Terminated by Sponsor|3|||
94374251|NCT05028751|323154267|FG001|Overall Study|Study Terminated by Sponsor|0|||
94374252|NCT05028751|323154268|FG002|Overall Study|Study Terminated by Sponsor|0|||
94374253|NCT05028751|323154269|FG003|Overall Study|Study Terminated by Sponsor|0|||
94374254|NCT05028751|323154266|FG000|Overall Study|Death|9|||
94374255|NCT05028751|323154267|FG001|Overall Study|Death|3|||
94374256|NCT05028751|323154268|FG002|Overall Study|Death|2|||
94374257|NCT05028751|323154269|FG003|Overall Study|Death|4|||
94374258|NCT05028751|323154266|FG000|Overall Study|Withdrawal by Subject|0|||
94374259|NCT05028751|323154267|FG001|Overall Study|Withdrawal by Subject|0|||
94374260|NCT05028751|323154268|FG002|Overall Study|Withdrawal by Subject|1|||
94374261|NCT05028751|323154269|FG003|Overall Study|Withdrawal by Subject|0|||
94374262|NCT05028751|323154266|FG000|Overall Study|Miscellaneous|2|||
94374263|NCT05028751|323154267|FG001|Overall Study|Miscellaneous|0|||
94374264|NCT05028751|323154268|FG002|Overall Study|Miscellaneous|0|||
94374265|NCT05028751|323154269|FG003|Overall Study|Miscellaneous|0|||
94374266|NCT00972153|323154270|FG000|Overall Study|Equipment malfunction during case|0|||
94374267|NCT00972153|323154271|FG001|Overall Study|Equipment malfunction during case|1|||
94374268|NCT00972153|323154272|FG002|Overall Study|Equipment malfunction during case|0|||
94374269|NCT01375010|323156614|FG000|Overall Study|Lost to Follow-up|8|||
94374270|NCT01375010|323156615|FG001|Overall Study|Lost to Follow-up|2|||
94374271|NCT01375010|323156614|FG000|Overall Study|Withdrawal by Subject|4|||
94374272|NCT01375010|323156615|FG001|Overall Study|Withdrawal by Subject|2|||
94374273|NCT02082912|323156616|FG000|Overall Study|Physician Decision|0|||
94374274|NCT02082912|323156617|FG001|Overall Study|Physician Decision|1|||
94374275|NCT02266706|323156618|FG000|Overall Study|Withdrawal by Subject|0|||
94374276|NCT02266706|323156619|FG001|Overall Study|Withdrawal by Subject|1|||
94374277|NCT02266706|323156620|FG002|Overall Study|Withdrawal by Subject|1|||
94374278|NCT02266706|323156621|FG003|Overall Study|Withdrawal by Subject|0|||
94374279|NCT02266706|323156622|FG004|Overall Study|Withdrawal by Subject|0|||
94374280|NCT02266706|323156623|FG005|Overall Study|Withdrawal by Subject|1|||
94374281|NCT02266706|323156624|FG006|Overall Study|Withdrawal by Subject|0|||
94374282|NCT02266706|323156625|FG007|Overall Study|Withdrawal by Subject|0|||
94374283|NCT02266706|323156626|FG008|Overall Study|Withdrawal by Subject|0|||
94374284|NCT02266706|323156618|FG000|Overall Study|Screen failure|0|||
94374285|NCT02266706|323156619|FG001|Overall Study|Screen failure|0|||
94374286|NCT02266706|323156620|FG002|Overall Study|Screen failure|0|||
94374287|NCT02266706|323156621|FG003|Overall Study|Screen failure|0|||
94374288|NCT02266706|323156622|FG004|Overall Study|Screen failure|0|||
94374289|NCT02266706|323156623|FG005|Overall Study|Screen failure|1|||
94374290|NCT02266706|323156624|FG006|Overall Study|Screen failure|1|||
94374291|NCT02266706|323156625|FG007|Overall Study|Screen failure|0|||
94374292|NCT02266706|323156626|FG008|Overall Study|Screen failure|0|||
94374293|NCT02266706|323156618|FG000|Overall Study|Enrollment in another study|0|||
94374294|NCT02266706|323156619|FG001|Overall Study|Enrollment in another study|0|||
94374295|NCT02266706|323156620|FG002|Overall Study|Enrollment in another study|0|||
94374296|NCT02266706|323156621|FG003|Overall Study|Enrollment in another study|1|||
94374297|NCT02266706|323156622|FG004|Overall Study|Enrollment in another study|0|||
94374298|NCT02266706|323156623|FG005|Overall Study|Enrollment in another study|0|||
94374299|NCT02266706|323156624|FG006|Overall Study|Enrollment in another study|0|||
94374300|NCT02266706|323156625|FG007|Overall Study|Enrollment in another study|0|||
94374301|NCT02266706|323156626|FG008|Overall Study|Enrollment in another study|0|||
94374302|NCT01977352|323156627|FG000|Overall Study|Lost to Follow-up|1|||
94374303|NCT01977352|323156628|FG001|Overall Study|Lost to Follow-up|2|||
94374304|NCT01835132|323156629|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
94374305|NCT00856778|323156630|FG000|Overall Study|Adverse Event|7|||
94374306|NCT00856778|323156630|FG000|Overall Study|Withdrawal by Subject|10|||
94374307|NCT00856778|323156630|FG000|Overall Study|Study deviation|2|||
94374308|NCT00856778|323156630|FG000|Overall Study|Lost to Follow-up|5|||
94374309|NCT01681771|323156631|FG000|Overall Study|Lost to Follow-up|4|||
94374310|NCT01681771|323156632|FG001|Overall Study|Lost to Follow-up|2|||
94374311|NCT02092961|323156633|FG000|Overall Study|Not reported|1|||
94374312|NCT02092961|323156634|FG001|Overall Study|Not reported|0|||
94374313|NCT02092961|323156635|FG002|Overall Study|Not reported|1|||
94301180|NCT01937117|322884569|FG000|Overall Study|Adverse Event|2|||
94301181|NCT00224016|322886353|FG000|Titration Period|Withdrawal by Subject|0|||
94301182|NCT00224016|322886354|FG001|Titration Period|Withdrawal by Subject|1|||
94301183|NCT00224016|322886353|FG000|Titration Period|Lost to Follow-up|1|||
94301184|NCT00224016|322886354|FG001|Titration Period|Lost to Follow-up|0|||
94301185|NCT00224016|322886353|FG000|Maintenance Period|Withdrawal by Subject|2|||
94301186|NCT00224016|322886354|FG001|Maintenance Period|Withdrawal by Subject|0|||
94301187|NCT00224016|322886353|FG000|Maintenance Period|Lost to Follow-up|0|||
94301188|NCT00224016|322886354|FG001|Maintenance Period|Lost to Follow-up|1|||
94301189|NCT01252966|322886355|FG000|Overall Study|Lost to Follow-up|16|||
94301190|NCT01252966|322886356|FG001|Overall Study|Lost to Follow-up|10|||
94301191|NCT01252966|322886355|FG000|Overall Study|Withdrawal by Subject|7|||
94301192|NCT01252966|322886356|FG001|Overall Study|Withdrawal by Subject|3|||
94301193|NCT03311126|322886357|FG000|Induction|Death|1|||
94301194|NCT03311126|322886357|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
94301195|NCT00886938|322886359|FG000|Overall Study|Adverse Event|1|||
94301196|NCT00886938|322886359|FG000|Overall Study|Withdrawal by Subject|1|||
94301197|NCT00097539|322886362|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
94301198|NCT00097539|322886363|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
94301199|NCT00097539|322886364|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
94301200|NCT00097539|322886365|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
94301201|NCT00097539|322886366|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
94301202|NCT00097539|322886367|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
94301203|NCT00097539|322886368|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
94301204|NCT00097539|322886362|FG000|Overall Study|Withdrawal by Subject|925|||
94301205|NCT00097539|322886363|FG001|Overall Study|Withdrawal by Subject|323|||
94301206|NCT00097539|322886364|FG002|Overall Study|Withdrawal by Subject|346|||
94301207|NCT00097539|322886365|FG003|Overall Study|Withdrawal by Subject|217|||
94301208|NCT00097539|322886366|FG004|Overall Study|Withdrawal by Subject|68|||
94301209|NCT00097539|322886367|FG005|Overall Study|Withdrawal by Subject|229|||
94301210|NCT00097539|322886368|FG006|Overall Study|Withdrawal by Subject|3|||
94301211|NCT00097539|322886362|FG000|Overall Study|Participant Non-compliant|2140|||
94301212|NCT00097539|322886363|FG001|Overall Study|Participant Non-compliant|567|||
94301213|NCT00097539|322886364|FG002|Overall Study|Participant Non-compliant|1067|||
94301214|NCT00097539|322886365|FG003|Overall Study|Participant Non-compliant|353|||
94301215|NCT00097539|322886366|FG004|Overall Study|Participant Non-compliant|136|||
94301216|NCT00097539|322886367|FG005|Overall Study|Participant Non-compliant|543|||
94301217|NCT00097539|322886368|FG006|Overall Study|Participant Non-compliant|18|||
94301218|NCT00097539|322886362|FG000|Overall Study|Lack of Efficacy|249|||
94301219|NCT00097539|322886363|FG001|Overall Study|Lack of Efficacy|122|||
94301220|NCT00097539|322886364|FG002|Overall Study|Lack of Efficacy|202|||
94301221|NCT00097539|322886365|FG003|Overall Study|Lack of Efficacy|105|||
94301222|NCT00097539|322886366|FG004|Overall Study|Lack of Efficacy|45|||
94301223|NCT00097539|322886367|FG005|Overall Study|Lack of Efficacy|228|||
94301224|NCT00097539|322886368|FG006|Overall Study|Lack of Efficacy|5|||
94301225|NCT00097539|322886362|FG000|Overall Study|Adverse Event|78|||
94301226|NCT00097539|322886363|FG001|Overall Study|Adverse Event|133|||
94301227|NCT00097539|322886364|FG002|Overall Study|Adverse Event|37|||
94301228|NCT00097539|322886365|FG003|Overall Study|Adverse Event|27|||
94301229|NCT00097539|322886366|FG004|Overall Study|Adverse Event|30|||
94301230|NCT00097539|322886367|FG005|Overall Study|Adverse Event|59|||
94301231|NCT00097539|322886368|FG006|Overall Study|Adverse Event|1|||
94301232|NCT00097539|322886362|FG000|Overall Study|Death|2|||
94301233|NCT00097539|322886363|FG001|Overall Study|Death|7|||
94301234|NCT00097539|322886364|FG002|Overall Study|Death|0|||
94301235|NCT00097539|322886365|FG003|Overall Study|Death|0|||
94301236|NCT00097539|322886366|FG004|Overall Study|Death|1|||
94301237|NCT00097539|322886367|FG005|Overall Study|Death|3|||
94301238|NCT00097539|322886368|FG006|Overall Study|Death|0|||
94301239|NCT00097539|322886362|FG000|Overall Study|Reasons Other Than Above|3602|||
94301240|NCT00097539|322886363|FG001|Overall Study|Reasons Other Than Above|1382|||
94301241|NCT00097539|322886364|FG002|Overall Study|Reasons Other Than Above|1757|||
94301242|NCT00097539|322886365|FG003|Overall Study|Reasons Other Than Above|692|||
94301243|NCT00097539|322886366|FG004|Overall Study|Reasons Other Than Above|361|||
94301244|NCT00097539|322886367|FG005|Overall Study|Reasons Other Than Above|1244|||
94301245|NCT00097539|322886368|FG006|Overall Study|Reasons Other Than Above|34|||
94301246|NCT00097539|322886362|FG000|Overall Study|Reason not Specified|111|||
94301247|NCT00097539|322886363|FG001|Overall Study|Reason not Specified|49|||
94301248|NCT00097539|322886364|FG002|Overall Study|Reason not Specified|53|||
94301249|NCT00097539|322886365|FG003|Overall Study|Reason not Specified|21|||
94301250|NCT00097539|322886366|FG004|Overall Study|Reason not Specified|11|||
94374314|NCT02092961|323156633|FG000|Overall Study|Study stopped|13|||
94374315|NCT02092961|323156634|FG001|Overall Study|Study stopped|9|||
94374316|NCT02092961|323156635|FG002|Overall Study|Study stopped|12|||
94374317|NCT02092961|323156633|FG000|Overall Study|Lack of therapeutic response|2|||
94374318|NCT02092961|323156634|FG001|Overall Study|Lack of therapeutic response|1|||
94374319|NCT02092961|323156635|FG002|Overall Study|Lack of therapeutic response|3|||
94374320|NCT02092961|323156633|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
94374321|NCT02092961|323156634|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
94374322|NCT02092961|323156635|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
94374323|NCT02092961|323156633|FG000|Overall Study|Adverse Event|2|||
94468107|NCT01554176|323502509|FG004|Treatment Phase|Lack of Efficacy|0|||
94468108|NCT01554176|323502505|FG000|Treatment Phase|Adverse event, non-fatal|1|||
94468109|NCT01554176|323502506|FG001|Treatment Phase|Adverse event, non-fatal|1|||
94468110|NCT01554176|323502507|FG002|Treatment Phase|Adverse event, non-fatal|0|||
94468111|NCT01554176|323502508|FG003|Treatment Phase|Adverse event, non-fatal|0|||
94468112|NCT01554176|323502509|FG004|Treatment Phase|Adverse event, non-fatal|0|||
94468113|NCT01554176|323502505|FG000|Treatment Phase|Non-compliance with study drug|1|||
94468114|NCT01554176|323502506|FG001|Treatment Phase|Non-compliance with study drug|0|||
94468115|NCT01554176|323502507|FG002|Treatment Phase|Non-compliance with study drug|0|||
94468116|NCT01554176|323502508|FG003|Treatment Phase|Non-compliance with study drug|0|||
94468117|NCT01554176|323502509|FG004|Treatment Phase|Non-compliance with study drug|0|||
94468118|NCT01554176|323502505|FG000|Treatment Phase|Withdrawal by Subject|1|||
94468119|NCT01554176|323502506|FG001|Treatment Phase|Withdrawal by Subject|0|||
94468120|NCT01554176|323502507|FG002|Treatment Phase|Withdrawal by Subject|0|||
94468121|NCT01554176|323502508|FG003|Treatment Phase|Withdrawal by Subject|0|||
94468122|NCT01554176|323502509|FG004|Treatment Phase|Withdrawal by Subject|0|||
94468123|NCT01554176|323502505|FG000|Treatment Phase|Lost to Follow-up|3|||
94468124|NCT01554176|323502506|FG001|Treatment Phase|Lost to Follow-up|0|||
94468125|NCT01554176|323502507|FG002|Treatment Phase|Lost to Follow-up|0|||
94468126|NCT01554176|323502508|FG003|Treatment Phase|Lost to Follow-up|0|||
94468127|NCT01554176|323502509|FG004|Treatment Phase|Lost to Follow-up|0|||
94468128|NCT01554176|323502505|FG000|Run-out Phase|Protocol Violation|0|||
94468129|NCT01554176|323502506|FG001|Run-out Phase|Protocol Violation|0|||
94468130|NCT01554176|323502507|FG002|Run-out Phase|Protocol Violation|0|||
94468131|NCT01554176|323502508|FG003|Run-out Phase|Protocol Violation|1|||
94468132|NCT01554176|323502509|FG004|Run-out Phase|Protocol Violation|0|||
94468133|NCT02240069|323502510|FG000|Overall Study|Withdrawal by Subject|5|||
94468134|NCT02240069|323502511|FG001|Overall Study|Withdrawal by Subject|5|||
94468135|NCT02240069|323502512|FG002|Overall Study|Withdrawal by Subject|2|||
94468136|NCT03417024|323502513|FG000|Overall Study|Study Termination prior to follow-up|11|||
94468137|NCT03417024|323502513|FG000|Overall Study|Physician Decision|2|||
94512806|NCT00725985|323676428|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
94512807|NCT00725985|323676429|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
94512808|NCT00725985|323676430|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
94512809|NCT00725985|323676431|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
94512810|NCT00725985|323676420|FG000|OLMP (Up to 96 Weeks)|Other|0|||
94512811|NCT00725985|323676421|FG001|OLMP (Up to 96 Weeks)|Other|0|||
94512812|NCT00725985|323676422|FG002|OLMP (Up to 96 Weeks)|Other|0|||
94512813|NCT00725985|323676423|FG003|OLMP (Up to 96 Weeks)|Other|15|||
94512814|NCT00725985|323676424|FG004|OLMP (Up to 96 Weeks)|Other|20|||
94512815|NCT00725985|323676425|FG005|OLMP (Up to 96 Weeks)|Other|44|||
94512816|NCT00725985|323676426|FG006|OLMP (Up to 96 Weeks)|Other|0|||
94512817|NCT00725985|323676427|FG007|OLMP (Up to 96 Weeks)|Other|0|||
94512818|NCT00725985|323676428|FG008|OLMP (Up to 96 Weeks)|Other|0|||
94512819|NCT00725985|323676429|FG009|OLMP (Up to 96 Weeks)|Other|0|||
94512820|NCT00725985|323676430|FG010|OLMP (Up to 96 Weeks)|Other|0|||
94512821|NCT00725985|323676431|FG011|OLMP (Up to 96 Weeks)|Other|0|||
94301251|NCT00097539|322886367|FG005|Overall Study|Reason not Specified|40|||
94301252|NCT00097539|322886368|FG006|Overall Study|Reason not Specified|2|||
94301253|NCT05127486|322886369|FG000|Overall Study|Adverse Event|2|||
94301254|NCT05127486|322886370|FG001|Overall Study|Adverse Event|4|||
94301255|NCT05127486|322886369|FG000|Overall Study|Lack of Efficacy|1|||
94301256|NCT05127486|322886370|FG001|Overall Study|Lack of Efficacy|0|||
94301257|NCT05127486|322886369|FG000|Overall Study|Pregnancy|0|||
94301258|NCT05127486|322886370|FG001|Overall Study|Pregnancy|1|||
94301259|NCT05127486|322886369|FG000|Overall Study|Physician Decision|4|||
94374324|NCT02092961|323156634|FG001|Overall Study|Adverse Event|4|||
94512822|NCT00725985|323676420|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
94512823|NCT00725985|323676421|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
94512824|NCT00725985|323676422|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
94301260|NCT05127486|322886370|FG001|Overall Study|Physician Decision|1|||
94374325|NCT02092961|323156635|FG002|Overall Study|Adverse Event|0|||
94512825|NCT00725985|323676423|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
94512826|NCT00725985|323676424|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
94512827|NCT00725985|323676425|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
94512828|NCT00725985|323676426|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
94512829|NCT00725985|323676427|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
94468138|NCT00224406|323503874|FG000|Overall Study|Re-transplant|0|||
94468139|NCT00224406|323503875|FG001|Overall Study|Re-transplant|2|||
94468140|NCT00224406|323503874|FG000|Overall Study|Death|0|||
94468141|NCT00224406|323503875|FG001|Overall Study|Death|1|||
94468142|NCT00224406|323503874|FG000|Overall Study|Transplant cancelled|0|||
94468143|NCT00224406|323503875|FG001|Overall Study|Transplant cancelled|4|||
94468144|NCT00224406|323503874|FG000|Overall Study|Drug not delivered|2|||
94468145|NCT00224406|323503875|FG001|Overall Study|Drug not delivered|0|||
94468146|NCT00224406|323503874|FG000|Overall Study|Other|4|||
94468147|NCT00224406|323503875|FG001|Overall Study|Other|0|||
94468148|NCT00224406|323503874|FG000|Overall Study|Transplant cancelled|3|||
94468149|NCT00224406|323503875|FG001|Overall Study|Transplant cancelled|0|||
94468150|NCT03774394|323503876|FG000|Overall Study|Withdrawal by Subject|2|||
94468151|NCT03774394|323503877|FG001|Overall Study|Withdrawal by Subject|0|||
94468152|NCT02864316|323503878|FG000|Overall Study|Progressive Disease|2|||
94468153|NCT02864316|323503879|FG001|Overall Study|Progressive Disease|1|||
94468154|NCT02864316|323503878|FG000|Overall Study|Adverse Event|0|||
94468155|NCT02864316|323503879|FG001|Overall Study|Adverse Event|1|||
94468156|NCT02570750|323503881|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
94468157|NCT02570750|323503882|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
94468158|NCT02570750|323503881|FG000|Overall Study|Protocol deviation|4|||
94468159|NCT02570750|323503882|FG001|Overall Study|Protocol deviation|2|||
94468160|NCT02570750|323503881|FG000|Overall Study|Withdrawal by Subject|5|||
94468161|NCT02570750|323503882|FG001|Overall Study|Withdrawal by Subject|0|||
94468162|NCT02570750|323503881|FG000|Overall Study|Lost to Follow-up|2|||
94468163|NCT02570750|323503882|FG001|Overall Study|Lost to Follow-up|2|||
94468164|NCT02570750|323503881|FG000|Overall Study|Adverse Event|2|||
94468165|NCT02570750|323503882|FG001|Overall Study|Adverse Event|1|||
94468166|NCT01636947|323503894|FG000|Overall Study|Not Treated|2|||
94468167|NCT01636947|323503895|FG001|Overall Study|Not Treated|2|||
94468168|NCT01636947|323503894|FG000|Overall Study|Lost to Follow-up|4|||
94468169|NCT01636947|323503895|FG001|Overall Study|Lost to Follow-up|0|||
94468170|NCT01636947|323503894|FG000|Overall Study|Protocol Violation|1|||
94468171|NCT01636947|323503895|FG001|Overall Study|Protocol Violation|1|||
94468172|NCT01636947|323503894|FG000|Overall Study|Withdrawal by Subject|3|||
94468173|NCT01636947|323503895|FG001|Overall Study|Withdrawal by Subject|3|||
94468174|NCT01636947|323503894|FG000|Overall Study|Adverse Event|1|||
94468175|NCT01636947|323503895|FG001|Overall Study|Adverse Event|1|||
94468176|NCT01636947|323503894|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
94301261|NCT05127486|322886369|FG000|Overall Study|Withdrawal by Subject|14|||
94301262|NCT05127486|322886370|FG001|Overall Study|Withdrawal by Subject|13|||
94301263|NCT05127486|322886369|FG000|Overall Study|Lost to Follow-up|5|||
94301264|NCT05127486|322886370|FG001|Overall Study|Lost to Follow-up|8|||
94301265|NCT01021007|322886371|FG000|Overall Study|Lost to Follow-up|1|||
94301266|NCT01021007|322886372|FG001|Overall Study|Lost to Follow-up|1|||
94301267|NCT01021007|322886371|FG000|Overall Study|Adverse Event|1|||
94301268|NCT01021007|322886372|FG001|Overall Study|Adverse Event|3|||
94301269|NCT01287754|322886373|FG000|Overall Study|Death|2|||
94301270|NCT01287754|322886374|FG001|Overall Study|Death|12|||
94301271|NCT01287754|322886373|FG000|Overall Study|Lost to Follow-up|1|||
94301272|NCT01287754|322886374|FG001|Overall Study|Lost to Follow-up|6|||
94301273|NCT01287754|322886373|FG000|Overall Study|Protocol Violation|0|||
94301274|NCT01287754|322886374|FG001|Overall Study|Protocol Violation|3|||
94301275|NCT05113940|322886375|FG000|Part A (18 Days)|Adverse Event|0|||
94301276|NCT05113940|322886376|FG001|Part A (18 Days)|Adverse Event|0|||
94301277|NCT05113940|322886377|FG002|Part A (18 Days)|Adverse Event|1|||
94301278|NCT05113940|322886378|FG003|Part A (18 Days)|Adverse Event|1|||
94301279|NCT05113940|322886379|FG004|Part A (18 Days)|Adverse Event|1|||
94301280|NCT05113940|322886380|FG005|Part A (18 Days)|Adverse Event|0|||
94301281|NCT05113940|322886381|FG006|Part A (18 Days)|Adverse Event|0|||
94301282|NCT05113940|322886382|FG007|Part A (18 Days)|Adverse Event|0|||
94301283|NCT05113940|322886383|FG008|Part A (18 Days)|Adverse Event|0|||
94301284|NCT05113940|322886384|FG009|Part A (18 Days)|Adverse Event|0|||
94301285|NCT05113940|322886385|FG010|Part A (18 Days)|Adverse Event|0|||
94301286|NCT05113940|322886386|FG011|Part A (18 Days)|Adverse Event|2|||
94301287|NCT05113940|322886387|FG012|Part A (18 Days)|Adverse Event|0|||
94301288|NCT05113940|322886388|FG013|Part A (18 Days)|Adverse Event|0|||
94301289|NCT05113940|322886389|FG014|Part A (18 Days)|Adverse Event|0|||
94468177|NCT01636947|323503895|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
94468178|NCT00957424|323503896|FG000|Overall Study|Lost to Follow-up|19|||
94468179|NCT00957424|323503896|FG000|Overall Study|Protocol Violation|3|||
94301290|NCT05113940|322886375|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
94301291|NCT05113940|322886376|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
94301292|NCT05113940|322886377|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
94301293|NCT05113940|322886378|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
94468180|NCT00957424|323503896|FG000|Overall Study|Withdrawal by Subject|1|||
94468181|NCT01038752|323503900|FG000|Overall Study|Tumor Progression|2|||
94468182|NCT01038752|323503901|FG001|Overall Study|Tumor Progression|2|||
94468183|NCT01038752|323503900|FG000|Overall Study|Lost to Follow-up|3|||
94468184|NCT01038752|323503901|FG001|Overall Study|Lost to Follow-up|3|||
94374326|NCT02270983|323156636|FG000|Overall Study|Adverse Event|3|||
94374327|NCT02270983|323156637|FG001|Overall Study|Adverse Event|2|||
94374328|NCT02270983|323156638|FG002|Overall Study|Adverse Event|6|||
94374329|NCT02270983|323156636|FG000|Overall Study|Lack of Efficacy|2|||
94374330|NCT02270983|323156637|FG001|Overall Study|Lack of Efficacy|1|||
94374331|NCT02270983|323156638|FG002|Overall Study|Lack of Efficacy|1|||
94374332|NCT02270983|323156636|FG000|Overall Study|Withdrawal by Subject|1|||
94374333|NCT02270983|323156637|FG001|Overall Study|Withdrawal by Subject|0|||
94374334|NCT02270983|323156638|FG002|Overall Study|Withdrawal by Subject|2|||
94374335|NCT02270983|323156636|FG000|Overall Study|Lost to Follow-up|1|||
94374336|NCT02270983|323156637|FG001|Overall Study|Lost to Follow-up|1|||
94374337|NCT02270983|323156638|FG002|Overall Study|Lost to Follow-up|2|||
94374338|NCT02270983|323156636|FG000|Overall Study|Protocol Violation|1|||
94374339|NCT02270983|323156637|FG001|Overall Study|Protocol Violation|1|||
94374340|NCT02270983|323156638|FG002|Overall Study|Protocol Violation|1|||
94374341|NCT02270983|323156636|FG000|Overall Study|family emergency|0|||
94374342|NCT02270983|323156637|FG001|Overall Study|family emergency|1|||
94374343|NCT02270983|323156638|FG002|Overall Study|family emergency|0|||
94374344|NCT02270983|323156636|FG000|Overall Study|study procedure non-compliance|1|||
94374345|NCT02270983|323156637|FG001|Overall Study|study procedure non-compliance|0|||
94374346|NCT02270983|323156638|FG002|Overall Study|study procedure non-compliance|0|||
94374347|NCT02270983|323156636|FG000|Overall Study|moved away from study site|0|||
94468185|NCT00316914|323503923|FG000|Overall Study|Withdrawal by Subject|5|||
94468186|NCT00316914|323503924|FG001|Overall Study|Withdrawal by Subject|3|||
94468187|NCT00316914|323503923|FG000|Overall Study|Adverse Event|8|||
94468188|NCT00316914|323503924|FG001|Overall Study|Adverse Event|7|||
94301294|NCT05113940|322886379|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
94301295|NCT05113940|322886380|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
94301296|NCT05113940|322886381|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
94301297|NCT05113940|322886382|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
94301298|NCT05113940|322886383|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
94301299|NCT05113940|322886384|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
94301300|NCT05113940|322886385|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
94301301|NCT05113940|322886386|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
94301302|NCT05113940|322886387|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
94301303|NCT05113940|322886388|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
94301304|NCT05113940|322886389|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
94301305|NCT01262898|322886390|FG000|Overall Study|Protocol Violation|1|||
94301306|NCT01262898|322886391|FG001|Overall Study|Protocol Violation|1|||
94301307|NCT01262898|322886392|FG002|Overall Study|Protocol Violation|0|||
94301308|NCT01262898|322886393|FG003|Overall Study|Protocol Violation|0|||
94301309|NCT01262898|322886390|FG000|Overall Study|Lost to Follow-up|1|||
94301310|NCT01262898|322886391|FG001|Overall Study|Lost to Follow-up|0|||
94301311|NCT01262898|322886392|FG002|Overall Study|Lost to Follow-up|0|||
94301312|NCT01262898|322886393|FG003|Overall Study|Lost to Follow-up|0|||
94301313|NCT01262898|322886390|FG000|Overall Study|Withdrawal by Subject|1|||
94301314|NCT01262898|322886391|FG001|Overall Study|Withdrawal by Subject|1|||
94301315|NCT01262898|322886392|FG002|Overall Study|Withdrawal by Subject|0|||
94301316|NCT01262898|322886393|FG003|Overall Study|Withdrawal by Subject|0|||
94301317|NCT02599402|322886394|FG000|Overall Study|Disease progression|153|||
94301318|NCT02599402|322886394|FG000|Overall Study|Study drug toxicity|201|||
94301319|NCT02599402|322886394|FG000|Overall Study|Death|26|||
94301320|NCT02599402|322886394|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
94301321|NCT02599402|322886394|FG000|Overall Study|Participant request to discontinue study treatment|13|||
94301322|NCT02599402|322886394|FG000|Overall Study|Participant withdrew consent|5|||
94301323|NCT02599402|322886394|FG000|Overall Study|Lost to Follow-up|1|||
94301324|NCT02599402|322886394|FG000|Overall Study|Maximum Clinical Benefit|7|||
94301325|NCT02599402|322886394|FG000|Overall Study|Poor/non-compliance|1|||
94301326|NCT02599402|322886394|FG000|Overall Study|Pregnancy|1|||
94374348|NCT02270983|323156637|FG001|Overall Study|moved away from study site|1|||
94301327|NCT02599402|322886394|FG000|Overall Study|Participant no longer met study criteria|7|||
94301328|NCT02599402|322886394|FG000|Overall Study|Other Reasons|95|||
94301329|NCT01974323|322886395|FG000|Overall Study|Other Reasons|25|||
94374349|NCT02270983|323156638|FG002|Overall Study|moved away from study site|0|||
94301330|NCT01974323|322886396|FG001|Overall Study|Other Reasons|28|||
94301331|NCT01974323|322886395|FG000|Overall Study|Protocol Violation|2|||
94374350|NCT00854620|323156639|FG000|Overall Study|Adverse Event|1|||
94374351|NCT01623830|323156642|FG000|Overall Study|Withdrawal by Subject|6|||
94374352|NCT01623830|323156643|FG001|Overall Study|Withdrawal by Subject|7|||
94374353|NCT01623830|323156642|FG000|Overall Study|Exclusion from Study|1|||
94301332|NCT01974323|322886396|FG001|Overall Study|Protocol Violation|2|||
94301333|NCT01974323|322886395|FG000|Overall Study|Personal Reasons|15|||
94301334|NCT01974323|322886396|FG001|Overall Study|Personal Reasons|19|||
94374354|NCT01623830|323156643|FG001|Overall Study|Exclusion from Study|2|||
94374355|NCT04242186|323156644|FG000|Overall Study|Death|5|||
94374356|NCT03769181|323156645|FG000|Overall Study|Adverse Event|1|||
94374357|NCT03769181|323156646|FG001|Overall Study|Adverse Event|0|||
94468189|NCT00316914|323503923|FG000|Overall Study|Other Problems|6|||
94301335|NCT01974323|322886395|FG000|Overall Study|Lost to Follow-up|45|||
94301336|NCT01974323|322886396|FG001|Overall Study|Lost to Follow-up|40|||
94301337|NCT01974323|322886395|FG000|Overall Study|Pregnancy|2|||
94301338|NCT01974323|322886396|FG001|Overall Study|Pregnancy|1|||
94301339|NCT01974323|322886395|FG000|Overall Study|Lack of Efficacy|1|||
94301340|NCT01974323|322886396|FG001|Overall Study|Lack of Efficacy|1|||
94301341|NCT01974323|322886395|FG000|Overall Study|Adverse Event|2|||
94301342|NCT01974323|322886396|FG001|Overall Study|Adverse Event|2|||
94301343|NCT00461175|322886397|FG000|Overall Study|Protocol Violation|522|||
94301344|NCT00461175|322886398|FG001|Overall Study|Protocol Violation|365|||
94301345|NCT00833092|322886399|FG000|Overall Study|Withdrawal by Subject|2|||
94301346|NCT00833092|322886400|FG001|Overall Study|Withdrawal by Subject|3|||
94301347|NCT00833092|322886399|FG000|Overall Study|Protocol Violation|2|||
94301348|NCT00833092|322886400|FG001|Overall Study|Protocol Violation|1|||
94301349|NCT00833092|322886399|FG000|Overall Study|Diarrhea|0|||
94301350|NCT00833092|322886400|FG001|Overall Study|Diarrhea|2|||
94301351|NCT00833092|322886399|FG000|Overall Study|constipation|0|||
94301352|NCT00833092|322886400|FG001|Overall Study|constipation|1|||
94301353|NCT00619229|322886401|FG000|Overall Study|Withdrawal by Subject|1|||
94301354|NCT00619229|322886402|FG001|Overall Study|Withdrawal by Subject|1|||
94301355|NCT00619229|322886401|FG000|Overall Study|Lost to Follow-up|1|||
94301356|NCT00619229|322886402|FG001|Overall Study|Lost to Follow-up|0|||
94301357|NCT00619229|322886401|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
94301358|NCT00619229|322886402|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
94301359|NCT00619229|322886401|FG000|Overall Study|Investigator planned Cataract Operation|1|||
94301360|NCT00619229|322886402|FG001|Overall Study|Investigator planned Cataract Operation|0|||
94301361|NCT02586805|322886405|FG000|Overall Study|Withdrawal by Subject|3|||
94301362|NCT02586805|322886406|FG001|Overall Study|Withdrawal by Subject|1|||
94301363|NCT02586805|322886407|FG002|Overall Study|Withdrawal by Subject|1|||
94301364|NCT02586805|322886408|FG003|Overall Study|Withdrawal by Subject|2|||
94301365|NCT02586805|322886405|FG000|Overall Study|Adverse Event|2|||
94301366|NCT02586805|322886406|FG001|Overall Study|Adverse Event|0|||
94301367|NCT02586805|322886407|FG002|Overall Study|Adverse Event|1|||
94301368|NCT02586805|322886408|FG003|Overall Study|Adverse Event|0|||
94301369|NCT02586805|322886405|FG000|Overall Study|Lost to Follow-up|0|||
94301370|NCT02586805|322886406|FG001|Overall Study|Lost to Follow-up|0|||
94301371|NCT02586805|322886407|FG002|Overall Study|Lost to Follow-up|1|||
94301372|NCT02586805|322886408|FG003|Overall Study|Lost to Follow-up|0|||
94301373|NCT02586805|322886405|FG000|Overall Study|Physician Decision|1|||
94301374|NCT02586805|322886406|FG001|Overall Study|Physician Decision|0|||
94301375|NCT02586805|322886407|FG002|Overall Study|Physician Decision|0|||
94301376|NCT02586805|322886408|FG003|Overall Study|Physician Decision|0|||
94301377|NCT00087438|322886409|FG000|Overall Study|Ineligible / No protocol treatment|4|||
94301378|NCT00466505|322886410|FG000|Overall Study|disease progression|13|||
94301379|NCT00466505|322886410|FG000|Overall Study|Adverse Event|4|||
94301380|NCT00699192|322886411|FG000|Overall Study|Missing|1|||
94301381|NCT00699192|322886412|FG001|Overall Study|Missing|1|||
94301382|NCT00699192|322886413|FG002|Overall Study|Missing|1|||
94301383|NCT00699192|322886411|FG000|Overall Study|Adverse Event|9|||
94301384|NCT00699192|322886412|FG001|Overall Study|Adverse Event|4|||
94301385|NCT00699192|322886413|FG002|Overall Study|Adverse Event|3|||
94301386|NCT00699192|322886411|FG000|Overall Study|Abnormal test procedure result(s)|0|||
94301387|NCT00699192|322886412|FG001|Overall Study|Abnormal test procedure result(s)|0|||
94301388|NCT00699192|322886413|FG002|Overall Study|Abnormal test procedure result(s)|1|||
94301389|NCT00699192|322886411|FG000|Overall Study|Lack of Efficacy|0|||
94301390|NCT00699192|322886412|FG001|Overall Study|Lack of Efficacy|0|||
94301391|NCT00699192|322886413|FG002|Overall Study|Lack of Efficacy|1|||
94301392|NCT00699192|322886411|FG000|Overall Study|Withdrawal by Subject|3|||
94301393|NCT00699192|322886412|FG001|Overall Study|Withdrawal by Subject|2|||
94301394|NCT00699192|322886413|FG002|Overall Study|Withdrawal by Subject|4|||
94301395|NCT00699192|322886411|FG000|Overall Study|Administrative problems|1|||
94301396|NCT00699192|322886412|FG001|Overall Study|Administrative problems|3|||
94301397|NCT00699192|322886413|FG002|Overall Study|Administrative problems|1|||
94301398|NCT00699192|322886411|FG000|Overall Study|Protocol Violation|2|||
94301399|NCT00699192|322886412|FG001|Overall Study|Protocol Violation|2|||
94301400|NCT00699192|322886413|FG002|Overall Study|Protocol Violation|0|||
94301401|NCT01773473|322886414|FG000|Overall Study|Adverse Event|3|||
94301402|NCT01773473|322886415|FG001|Overall Study|Adverse Event|2|||
94301403|NCT01773473|322886414|FG000|Overall Study|Protocol Violation|0|||
94301404|NCT01773473|322886415|FG001|Overall Study|Protocol Violation|4|||
94301405|NCT01773473|322886414|FG000|Overall Study|Physician Decision|3|||
94301406|NCT01773473|322886415|FG001|Overall Study|Physician Decision|5|||
94301407|NCT01773473|322886414|FG000|Overall Study|Sponsor Decision|2|||
94301408|NCT01773473|322886415|FG001|Overall Study|Sponsor Decision|0|||
94301409|NCT01773473|322886414|FG000|Overall Study|Lack of Efficacy|0|||
94301410|NCT01773473|322886415|FG001|Overall Study|Lack of Efficacy|1|||
94301411|NCT01773473|322886414|FG000|Overall Study|Non-Compliance with study drug|1|||
94301412|NCT01773473|322886415|FG001|Overall Study|Non-Compliance with study drug|4|||
94301413|NCT01773473|322886414|FG000|Overall Study|Withdrawal by Subject|5|||
94468190|NCT00316914|323503924|FG001|Overall Study|Other Problems|11|||
94468191|NCT00316914|323503923|FG000|Overall Study|Missing end of treatment documentation|14|||
94468192|NCT00316914|323503924|FG001|Overall Study|Missing end of treatment documentation|15|||
94468193|NCT01398410|323503930|FG000|Overall Study|Adverse Event|12|||
94468194|NCT01398410|323503931|FG001|Overall Study|Adverse Event|16|||
94468195|NCT01398410|323503930|FG000|Overall Study|Participants Choice|8|||
94468196|NCT01398410|323503931|FG001|Overall Study|Participants Choice|11|||
94468197|NCT01398410|323503930|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
94468198|NCT01398410|323503931|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
94468199|NCT01398410|323503930|FG000|Overall Study|Other|36|||
94468200|NCT01398410|323503931|FG001|Overall Study|Other|29|||
94468201|NCT03436199|323503932|FG000|Overall Study|Adverse Event|15|||
94468202|NCT03436199|323503933|FG001|Overall Study|Adverse Event|40|||
94468203|NCT03436199|323503934|FG002|Overall Study|Adverse Event|7|||
94468204|NCT03436199|323503932|FG000|Overall Study|Withdrawal by Subject|4|||
94468205|NCT03436199|323503933|FG001|Overall Study|Withdrawal by Subject|10|||
94468206|NCT03436199|323503934|FG002|Overall Study|Withdrawal by Subject|3|||
94468207|NCT03436199|323503932|FG000|Overall Study|Lost to Follow-up|1|||
94468208|NCT03436199|323503933|FG001|Overall Study|Lost to Follow-up|0|||
94301414|NCT01773473|322886415|FG001|Overall Study|Withdrawal by Subject|3|||
94301415|NCT01773473|322886414|FG000|Overall Study|Lost to Follow-up|2|||
94301416|NCT01773473|322886415|FG001|Overall Study|Lost to Follow-up|0|||
94301417|NCT01931865|322886416|FG000|Overall Study|Lost to Follow-up|2|||
94301418|NCT01931865|322886416|FG000|Overall Study|Withdrawal by Subject|2|||
94301419|NCT00283387|322886417|FG000|First Intervention|Subject non-compliant|1|||
94301420|NCT00283387|322886418|FG001|First Intervention|Subject non-compliant|1|||
94301421|NCT00283387|322886417|FG000|First Intervention|Withdrawal by Subject|0|||
94301422|NCT00283387|322886418|FG001|First Intervention|Withdrawal by Subject|1|||
94301423|NCT00504257|322886419|FG000|Overall Study|Withdrawal by Subject|2|||
94301424|NCT00504257|322886419|FG000|Overall Study|ineligible histology|2|||
94301425|NCT04919564|322886429|FG000|Overall Study|Lost to Follow-up|1|||
94301426|NCT04919564|322886430|FG001|Overall Study|Lost to Follow-up|0|||
94301427|NCT04919564|322886429|FG000|Overall Study|Physician Decision|1|||
94301428|NCT04919564|322886430|FG001|Overall Study|Physician Decision|1|||
94301429|NCT01241786|322886432|FG000|Overall Study|Lack of Efficacy|5|||
94301430|NCT03812510|322886433|FG000|Overall Study|Lost to Follow-up|39|||
94301431|NCT03812510|322886433|FG000|Overall Study|Withdrawal by Subject|42|||
94301432|NCT03812510|322886433|FG000|Overall Study|Physician Decision|2|||
94301433|NCT03812510|322886433|FG000|Overall Study|Study Terminated by Sponsor|9|||
94301434|NCT03812510|322886433|FG000|Overall Study|Did Not Start Study Medication|55|||
94301435|NCT03812510|322886433|FG000|Overall Study|Adverse Event|5|||
94301436|NCT00805207|322886437|FG000|Overall Study|Protocol Violation|0|||
94301437|NCT00805207|322886438|FG001|Overall Study|Protocol Violation|0|||
94301438|NCT00805207|322886439|FG002|Overall Study|Protocol Violation|1|||
94301439|NCT00805207|322886440|FG003|Overall Study|Protocol Violation|0|||
94301440|NCT00805207|322886441|FG004|Overall Study|Protocol Violation|0|||
94301441|NCT00805207|322886442|FG005|Overall Study|Protocol Violation|0|||
94301442|NCT00805207|322886443|FG006|Overall Study|Protocol Violation|0|||
94301443|NCT00805207|322886444|FG007|Overall Study|Protocol Violation|0|||
94301444|NCT00805207|322886445|FG008|Overall Study|Protocol Violation|0|||
94301445|NCT00805207|322886437|FG000|Overall Study|Physician Decision|0|||
94301446|NCT00805207|322886438|FG001|Overall Study|Physician Decision|1|||
94301447|NCT00805207|322886439|FG002|Overall Study|Physician Decision|0|||
94301448|NCT00805207|322886440|FG003|Overall Study|Physician Decision|0|||
94301449|NCT00805207|322886441|FG004|Overall Study|Physician Decision|0|||
94301450|NCT00805207|322886442|FG005|Overall Study|Physician Decision|1|||
94301451|NCT00805207|322886443|FG006|Overall Study|Physician Decision|0|||
94301452|NCT00805207|322886444|FG007|Overall Study|Physician Decision|0|||
94301453|NCT00805207|322886445|FG008|Overall Study|Physician Decision|0|||
94301454|NCT00805207|322886437|FG000|Overall Study|Withdrawal by Subject|0|||
94301455|NCT00805207|322886438|FG001|Overall Study|Withdrawal by Subject|1|||
94301456|NCT00805207|322886439|FG002|Overall Study|Withdrawal by Subject|0|||
94301457|NCT00805207|322886440|FG003|Overall Study|Withdrawal by Subject|0|||
94301458|NCT00805207|322886441|FG004|Overall Study|Withdrawal by Subject|1|||
94301459|NCT00805207|322886442|FG005|Overall Study|Withdrawal by Subject|2|||
94301460|NCT00805207|322886443|FG006|Overall Study|Withdrawal by Subject|0|||
94301461|NCT00805207|322886444|FG007|Overall Study|Withdrawal by Subject|0|||
94468209|NCT03436199|323503934|FG002|Overall Study|Lost to Follow-up|2|||
94301462|NCT00805207|322886445|FG008|Overall Study|Withdrawal by Subject|0|||
94301463|NCT01985321|322886446|FG000|Overall Study|Protocol Violation|4|||
94301464|NCT01985321|322886447|FG001|Overall Study|Protocol Violation|3|||
94301465|NCT01985321|322886446|FG000|Overall Study|Withdrawal by Subject|1|||
94301466|NCT01985321|322886447|FG001|Overall Study|Withdrawal by Subject|0|||
94301467|NCT01985321|322886446|FG000|Overall Study|Lost to Follow-up|5|||
94301468|NCT01985321|322886447|FG001|Overall Study|Lost to Follow-up|2|||
94301469|NCT01985321|322886446|FG000|Overall Study|Subject treated wrong type of sore|1|||
94301470|NCT01985321|322886447|FG001|Overall Study|Subject treated wrong type of sore|0|||
94468210|NCT03436199|323503932|FG000|Overall Study|Protocol Violation|1|||
94374358|NCT03769181|323156647|FG002|Overall Study|Adverse Event|2|||
94374359|NCT03769181|323156648|FG003|Overall Study|Adverse Event|4|||
94374360|NCT03769181|323156645|FG000|Overall Study|Withdrawal by Subject|1|||
94374361|NCT03769181|323156646|FG001|Overall Study|Withdrawal by Subject|0|||
94374362|NCT03769181|323156647|FG002|Overall Study|Withdrawal by Subject|2|||
94374363|NCT03769181|323156648|FG003|Overall Study|Withdrawal by Subject|1|||
94374364|NCT03769181|323156645|FG000|Overall Study|Progressive disease|9|||
94374365|NCT03769181|323156646|FG001|Overall Study|Progressive disease|7|||
94374366|NCT03769181|323156647|FG002|Overall Study|Progressive disease|13|||
94374367|NCT03769181|323156648|FG003|Overall Study|Progressive disease|6|||
94374368|NCT03769181|323156645|FG000|Overall Study|Other - Unspecified|2|||
94374369|NCT03769181|323156646|FG001|Overall Study|Other - Unspecified|1|||
94374370|NCT03769181|323156647|FG002|Overall Study|Other - Unspecified|0|||
94374371|NCT03769181|323156648|FG003|Overall Study|Other - Unspecified|0|||
94374372|NCT01847313|323156653|FG000|Overall Study|Death|0|||
94374373|NCT01847313|323156654|FG001|Overall Study|Death|1|||
94374374|NCT01847313|323156653|FG000|Overall Study|Withdrawal by Subject|0|||
94374375|NCT01847313|323156654|FG001|Overall Study|Withdrawal by Subject|1|||
94374376|NCT01663714|323156655|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
94374377|NCT01663714|323156655|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
94374378|NCT01663714|323156655|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
94374379|NCT01663714|323156655|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
94374380|NCT01663714|323156655|FG000|Long-Term Follow-Up|Death|4|||
94374381|NCT01663714|323156655|FG000|Long-Term Follow-Up|Non-compliance|1|||
94374382|NCT02764489|323156659|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
94374383|NCT02764489|323156660|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
94374384|NCT02764489|323156659|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
94374385|NCT02764489|323156660|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
94374386|NCT02764489|323156659|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
94374387|NCT02764489|323156660|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
94374388|NCT02764489|323156659|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
94374389|NCT02764489|323156660|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
94374390|NCT00660790|323156661|FG000|Baseline to 3 Months|Death|1|||
94374391|NCT00660790|323156661|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
94374392|NCT00660790|323156661|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
94374393|NCT01294592|323156663|FG000|Overall Study|Adverse Event|28|||
94374394|NCT01294592|323156664|FG001|Overall Study|Adverse Event|13|||
94374395|NCT01294592|323156663|FG000|Overall Study|Lack of Efficacy|7|||
94374396|NCT01294592|323156664|FG001|Overall Study|Lack of Efficacy|5|||
94374397|NCT01294592|323156663|FG000|Overall Study|Protocol Violation|1|||
94374398|NCT01294592|323156664|FG001|Overall Study|Protocol Violation|7|||
94374399|NCT01294592|323156663|FG000|Overall Study|Lost to Follow-up|7|||
94374400|NCT01294592|323156664|FG001|Overall Study|Lost to Follow-up|9|||
94374401|NCT01294592|323156663|FG000|Overall Study|Physician Decision|6|||
94374402|NCT01294592|323156664|FG001|Overall Study|Physician Decision|11|||
94374403|NCT01294592|323156663|FG000|Overall Study|Withdrawal by Subject|28|||
94374404|NCT01294592|323156664|FG001|Overall Study|Withdrawal by Subject|28|||
94374405|NCT03549130|323156665|FG000|Overall Study|Adverse Event|0|||
94374406|NCT03549130|323156666|FG001|Overall Study|Adverse Event|1|||
94374407|NCT03549130|323156665|FG000|Overall Study|Lost to Follow-up|0|||
94374408|NCT03549130|323156666|FG001|Overall Study|Lost to Follow-up|1|||
94374409|NCT00549198|323156667|FG000|Overall Study|Adverse Event|28|||
94374410|NCT00549198|323156668|FG001|Overall Study|Adverse Event|26|||
94374411|NCT00549198|323156667|FG000|Overall Study|Insufficient Viral Load Response|4|||
94374412|NCT00549198|323156668|FG001|Overall Study|Insufficient Viral Load Response|2|||
94374413|NCT00549198|323156667|FG000|Overall Study|Protocol-defined Virological Failure|7|||
94374414|NCT00549198|323156668|FG001|Overall Study|Protocol-defined Virological Failure|0|||
94374415|NCT00549198|323156667|FG000|Overall Study|Non-compliance|2|||
94374416|NCT00549198|323156668|FG001|Overall Study|Non-compliance|4|||
94374417|NCT00549198|323156667|FG000|Overall Study|Lost to Follow-up|7|||
94374418|NCT00549198|323156668|FG001|Overall Study|Lost to Follow-up|8|||
94374419|NCT00549198|323156667|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
94374420|NCT00549198|323156668|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
94374421|NCT00549198|323156667|FG000|Overall Study|Protocol Violation|7|||
94374422|NCT00549198|323156668|FG001|Overall Study|Protocol Violation|2|||
94374423|NCT00549198|323156667|FG000|Overall Study|Investigator Decision|4|||
94374424|NCT00549198|323156668|FG001|Overall Study|Investigator Decision|3|||
94374425|NCT00549198|323156667|FG000|Overall Study|Withdrawal by Subject|7|||
94374426|NCT00549198|323156668|FG001|Overall Study|Withdrawal by Subject|7|||
94374427|NCT00549198|323156667|FG000|Overall Study|Disease Progression|1|||
94374428|NCT00549198|323156668|FG001|Overall Study|Disease Progression|0|||
94374429|NCT00549198|323156667|FG000|Overall Study|Participant Moved|2|||
94374430|NCT00549198|323156668|FG001|Overall Study|Participant Moved|0|||
94374431|NCT00549198|323156667|FG000|Overall Study|Participant not able to perform Week 96|1|||
94374432|NCT00549198|323156668|FG001|Overall Study|Participant not able to perform Week 96|0|||
94374433|NCT00549198|323156667|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
94374434|NCT00549198|323156668|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
94374435|NCT00549198|323156667|FG000|Overall Study|Prohibited Medication|1|||
94374436|NCT00549198|323156668|FG001|Overall Study|Prohibited Medication|2|||
94374437|NCT00549198|323156667|FG000|Overall Study|Participant planning pregnancy|1|||
94374438|NCT00549198|323156668|FG001|Overall Study|Participant planning pregnancy|0|||
94374439|NCT00549198|323156667|FG000|Overall Study|Participant overweight, no scan possible|1|||
94374440|NCT00549198|323156668|FG001|Overall Study|Participant overweight, no scan possible|0|||
94374441|NCT00549198|323156667|FG000|Overall Study|No scan facilities|0|||
94374442|NCT00549198|323156668|FG001|Overall Study|No scan facilities|2|||
94374443|NCT00549198|323156667|FG000|Overall Study|Pregnancy|0|||
94374444|NCT00549198|323156668|FG001|Overall Study|Pregnancy|3|||
94374445|NCT00549198|323156667|FG000|Overall Study|Not Exposed to Study Drug|3|||
94374446|NCT00549198|323156668|FG001|Overall Study|Not Exposed to Study Drug|4|||
94374447|NCT04356573|323156670|FG000|Overall Study|Didn't Qualify|1|||
94374448|NCT04356573|323156671|FG001|Overall Study|Didn't Qualify|0|||
94374449|NCT01473758|323156676|FG000|Cycle 1|Adverse Event|10|||
94374450|NCT01473758|323156677|FG001|Cycle 1|Adverse Event|2|||
94374451|NCT01473758|323156678|FG002|Cycle 1|Adverse Event|0|||
94374452|NCT01473758|323156679|FG003|Cycle 1|Adverse Event|0|||
94374453|NCT01473758|323156676|FG000|Cycle 1|Withdrawal by Subject|1|||
94374454|NCT01473758|323156677|FG001|Cycle 1|Withdrawal by Subject|1|||
94374455|NCT01473758|323156678|FG002|Cycle 1|Withdrawal by Subject|0|||
94374456|NCT01473758|323156679|FG003|Cycle 1|Withdrawal by Subject|0|||
94374457|NCT01473758|323156676|FG000|Cycle 2|Adverse Event|0|||
94374458|NCT01473758|323156677|FG001|Cycle 2|Adverse Event|0|||
94374459|NCT01473758|323156678|FG002|Cycle 2|Adverse Event|5|||
94374460|NCT01473758|323156679|FG003|Cycle 2|Adverse Event|0|||
94374461|NCT02480010|323156680|FG000|Overall Study|Adverse Event|3|||
94374462|NCT02480010|323156681|FG001|Overall Study|Adverse Event|1|||
94374463|NCT02480010|323156680|FG000|Overall Study|Death|1|||
94374464|NCT02480010|323156681|FG001|Overall Study|Death|0|||
94374465|NCT02480010|323156680|FG000|Overall Study|Insufficient therapeutic response|31|||
94374466|NCT02480010|323156681|FG001|Overall Study|Insufficient therapeutic response|29|||
94374467|NCT02480010|323156680|FG000|Overall Study|Refused Treatment|0|||
94374468|NCT02480010|323156681|FG001|Overall Study|Refused Treatment|3|||
94374469|NCT02763579|323156691|FG000|Global Period|Death|167|||
94374470|NCT02763579|323156692|FG001|Global Period|Death|151|||
94374471|NCT02763579|323156693|FG002|Global Period|Death|0|||
94374472|NCT02763579|323156694|FG003|Global Period|Death|0|||
94374473|NCT02763579|323156691|FG000|Global Period|Lost to Follow-up|2|||
94374474|NCT02763579|323156692|FG001|Global Period|Lost to Follow-up|4|||
94374475|NCT02763579|323156693|FG002|Global Period|Lost to Follow-up|0|||
94374476|NCT02763579|323156694|FG003|Global Period|Lost to Follow-up|0|||
94374477|NCT02763579|323156691|FG000|Global Period|Physician Decision|0|||
94374478|NCT02763579|323156692|FG001|Global Period|Physician Decision|2|||
94374479|NCT02763579|323156693|FG002|Global Period|Physician Decision|0|||
94374480|NCT02763579|323156694|FG003|Global Period|Physician Decision|0|||
94374481|NCT02763579|323156691|FG000|Global Period|Study Terminated By Sponsor|21|||
94374482|NCT02763579|323156692|FG001|Global Period|Study Terminated By Sponsor|26|||
94374483|NCT02763579|323156693|FG002|Global Period|Study Terminated By Sponsor|0|||
94374484|NCT02763579|323156694|FG003|Global Period|Study Terminated By Sponsor|0|||
94374485|NCT02763579|323156691|FG000|Global Period|Withdrawal by Subject|12|||
94374486|NCT02763579|323156692|FG001|Global Period|Withdrawal by Subject|18|||
94374487|NCT02763579|323156693|FG002|Global Period|Withdrawal by Subject|0|||
94374488|NCT02763579|323156694|FG003|Global Period|Withdrawal by Subject|0|||
94374489|NCT02763579|323156691|FG000|China Period|Death|0|||
94374490|NCT02763579|323156692|FG001|China Period|Death|0|||
94374491|NCT02763579|323156693|FG002|China Period|Death|46|||
94374492|NCT02763579|323156694|FG003|China Period|Death|48|||
94374493|NCT02763579|323156691|FG000|China Period|Lost to Follow-up|0|||
94374494|NCT02763579|323156692|FG001|China Period|Lost to Follow-up|0|||
94374495|NCT02763579|323156693|FG002|China Period|Lost to Follow-up|1|||
94374496|NCT02763579|323156694|FG003|China Period|Lost to Follow-up|1|||
94374497|NCT02763579|323156691|FG000|China Period|Physician Decision|0|||
94374498|NCT02763579|323156692|FG001|China Period|Physician Decision|0|||
94374499|NCT02763579|323156693|FG002|China Period|Physician Decision|0|||
94374500|NCT02763579|323156694|FG003|China Period|Physician Decision|1|||
94374501|NCT02763579|323156691|FG000|China Period|Study Terminated By Sponsor|0|||
94374502|NCT02763579|323156692|FG001|China Period|Study Terminated By Sponsor|0|||
94374503|NCT02763579|323156693|FG002|China Period|Study Terminated By Sponsor|3|||
94374504|NCT02763579|323156694|FG003|China Period|Study Terminated By Sponsor|4|||
94374505|NCT02763579|323156691|FG000|China Period|Withdrawal by Subject|0|||
94374506|NCT02763579|323156692|FG001|China Period|Withdrawal by Subject|0|||
94374507|NCT02763579|323156693|FG002|China Period|Withdrawal by Subject|3|||
94374508|NCT02763579|323156694|FG003|China Period|Withdrawal by Subject|3|||
94374509|NCT01034137|323156700|FG000|Overall Study|Adverse Event|9|||
94374510|NCT01034137|323156701|FG001|Overall Study|Adverse Event|10|||
94374511|NCT01034137|323156702|FG002|Overall Study|Adverse Event|8|||
94374512|NCT01034137|323156700|FG000|Overall Study|Withdrawal by Subject|4|||
94374513|NCT01034137|323156701|FG001|Overall Study|Withdrawal by Subject|3|||
94374514|NCT01034137|323156702|FG002|Overall Study|Withdrawal by Subject|3|||
94374515|NCT01034137|323156700|FG000|Overall Study|Lack of Efficacy|9|||
94374516|NCT01034137|323156701|FG001|Overall Study|Lack of Efficacy|4|||
94374517|NCT01034137|323156702|FG002|Overall Study|Lack of Efficacy|13|||
94374518|NCT01034137|323156700|FG000|Overall Study|Protocol Violation|2|||
94301471|NCT02388776|322886448|FG000|Overall Study|Death|1|||
94301472|NCT02388776|322886448|FG000|Overall Study|Lost to Follow-up|1|||
94301473|NCT03293680|322886454|FG000|Overall Study|Death|1|||
94301474|NCT03293680|322886454|FG000|Overall Study|Did not meet inclusion criteria|8|||
94301475|NCT02201940|322886455|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
94301476|NCT02201940|322886456|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
94301477|NCT02201940|322886455|FG000|Overall Study|Lack of Efficacy|2|||
94301478|NCT02201940|322886456|FG001|Overall Study|Lack of Efficacy|113|||
94301479|NCT02201940|322886455|FG000|Overall Study|Lost to Follow-up|5|||
94301480|NCT02201940|322886456|FG001|Overall Study|Lost to Follow-up|0|||
94301481|NCT02201940|322886455|FG000|Overall Study|Withdrew Consent|2|||
94301482|NCT02201940|322886456|FG001|Overall Study|Withdrew Consent|1|||
94301483|NCT02201940|322886455|FG000|Overall Study|Investigator's Discretion|1|||
94301484|NCT02201940|322886456|FG001|Overall Study|Investigator's Discretion|1|||
94301485|NCT02201940|322886455|FG000|Overall Study|Death|1|||
94301486|NCT02201940|322886456|FG001|Overall Study|Death|0|||
94301487|NCT02201940|322886455|FG000|Overall Study|Adverse Event|0|||
94301488|NCT02201940|322886456|FG001|Overall Study|Adverse Event|1|||
94301489|NCT00636818|322886457|FG000|Overall Study|Adverse Event|1|||
94301490|NCT00636818|322886457|FG000|Overall Study|Lost to Follow-up|2|||
94301491|NCT00636818|322886457|FG000|Overall Study|Entry Criteria Exclusion|3|||
94301492|NCT00636818|322886457|FG000|Overall Study|Protocol Violation|1|||
94301493|NCT00636818|322886457|FG000|Overall Study|Withdrawal by Subject|4|||
94301494|NCT01309737|322886462|FG000|Week 0 to 16|Death|1|||
94301495|NCT01309737|322886463|FG001|Week 0 to 16|Death|0|||
94301496|NCT01309737|322886464|FG002|Week 0 to 16|Death|1|||
94301497|NCT01309737|322886465|FG003|Week 0 to 16|Death|0|||
94301498|NCT01309737|322886466|FG004|Week 0 to 16|Death|0|||
94301499|NCT01309737|322886462|FG000|Week 0 to 16|Adverse Event|11|||
94301500|NCT01309737|322886463|FG001|Week 0 to 16|Adverse Event|10|||
94301501|NCT01309737|322886464|FG002|Week 0 to 16|Adverse Event|5|||
94301502|NCT01309737|322886465|FG003|Week 0 to 16|Adverse Event|0|||
94301503|NCT01309737|322886466|FG004|Week 0 to 16|Adverse Event|0|||
94301504|NCT01309737|322886462|FG000|Week 0 to 16|Lack of Efficacy|15|||
94301505|NCT01309737|322886463|FG001|Week 0 to 16|Lack of Efficacy|2|||
94301506|NCT01309737|322886464|FG002|Week 0 to 16|Lack of Efficacy|24|||
94301507|NCT01309737|322886465|FG003|Week 0 to 16|Lack of Efficacy|0|||
94301508|NCT01309737|322886466|FG004|Week 0 to 16|Lack of Efficacy|0|||
94301509|NCT01309737|322886462|FG000|Week 0 to 16|Lost to Follow-up|7|||
94301510|NCT01309737|322886463|FG001|Week 0 to 16|Lost to Follow-up|8|||
94301511|NCT01309737|322886464|FG002|Week 0 to 16|Lost to Follow-up|3|||
94301512|NCT01309737|322886465|FG003|Week 0 to 16|Lost to Follow-up|0|||
94301513|NCT01309737|322886466|FG004|Week 0 to 16|Lost to Follow-up|0|||
94301514|NCT01309737|322886462|FG000|Week 0 to 16|Withdrawal by Subject|7|||
94301515|NCT01309737|322886463|FG001|Week 0 to 16|Withdrawal by Subject|6|||
94301516|NCT01309737|322886464|FG002|Week 0 to 16|Withdrawal by Subject|7|||
94301517|NCT01309737|322886465|FG003|Week 0 to 16|Withdrawal by Subject|0|||
94301518|NCT01309737|322886466|FG004|Week 0 to 16|Withdrawal by Subject|0|||
94301519|NCT01309737|322886462|FG000|Week 0 to 16|Other|10|||
94301520|NCT01309737|322886463|FG001|Week 0 to 16|Other|14|||
94301521|NCT01309737|322886464|FG002|Week 0 to 16|Other|4|||
94301522|NCT01309737|322886465|FG003|Week 0 to 16|Other|0|||
94301523|NCT01309737|322886466|FG004|Week 0 to 16|Other|0|||
94301524|NCT01309737|322886462|FG000|Week 0 to 16|Randomized, but not treated|1|||
94301525|NCT01309737|322886463|FG001|Week 0 to 16|Randomized, but not treated|0|||
94301526|NCT01309737|322886464|FG002|Week 0 to 16|Randomized, but not treated|0|||
94301527|NCT01309737|322886465|FG003|Week 0 to 16|Randomized, but not treated|0|||
94301528|NCT01309737|322886466|FG004|Week 0 to 16|Randomized, but not treated|0|||
94301529|NCT01309737|322886462|FG000|Week 16 to 52|Death|0|||
94301530|NCT01309737|322886463|FG001|Week 16 to 52|Death|0|||
94301531|NCT01309737|322886464|FG002|Week 16 to 52|Death|0|||
94301532|NCT01309737|322886465|FG003|Week 16 to 52|Death|0|||
94301533|NCT01309737|322886466|FG004|Week 16 to 52|Death|1|||
94301534|NCT01309737|322886462|FG000|Week 16 to 52|Adverse Event|7|||
94301535|NCT01309737|322886463|FG001|Week 16 to 52|Adverse Event|7|||
94301536|NCT01309737|322886464|FG002|Week 16 to 52|Adverse Event|0|||
94301537|NCT01309737|322886465|FG003|Week 16 to 52|Adverse Event|6|||
94301538|NCT01309737|322886466|FG004|Week 16 to 52|Adverse Event|5|||
94301539|NCT01309737|322886462|FG000|Week 16 to 52|Lack of Efficacy|107|||
94301540|NCT01309737|322886463|FG001|Week 16 to 52|Lack of Efficacy|76|||
94468211|NCT03436199|323503933|FG001|Overall Study|Protocol Violation|1|||
94301541|NCT01309737|322886464|FG002|Week 16 to 52|Lack of Efficacy|0|||
94301542|NCT01309737|322886465|FG003|Week 16 to 52|Lack of Efficacy|25|||
94301543|NCT01309737|322886466|FG004|Week 16 to 52|Lack of Efficacy|21|||
94301544|NCT01309737|322886462|FG000|Week 16 to 52|Lost to Follow-up|4|||
94301545|NCT01309737|322886463|FG001|Week 16 to 52|Lost to Follow-up|2|||
94301546|NCT01309737|322886464|FG002|Week 16 to 52|Lost to Follow-up|0|||
94301547|NCT01309737|322886465|FG003|Week 16 to 52|Lost to Follow-up|1|||
94301548|NCT01309737|322886466|FG004|Week 16 to 52|Lost to Follow-up|4|||
94301549|NCT01309737|322886462|FG000|Week 16 to 52|Withdrawal by Subject|5|||
94301550|NCT01309737|322886463|FG001|Week 16 to 52|Withdrawal by Subject|6|||
94301551|NCT01309737|322886464|FG002|Week 16 to 52|Withdrawal by Subject|0|||
94301552|NCT01309737|322886465|FG003|Week 16 to 52|Withdrawal by Subject|0|||
94301553|NCT01309737|322886466|FG004|Week 16 to 52|Withdrawal by Subject|2|||
94301554|NCT01309737|322886462|FG000|Week 16 to 52|Other|10|||
94301555|NCT01309737|322886463|FG001|Week 16 to 52|Other|12|||
94301556|NCT01309737|322886464|FG002|Week 16 to 52|Other|0|||
94301557|NCT01309737|322886465|FG003|Week 16 to 52|Other|2|||
94301558|NCT01309737|322886466|FG004|Week 16 to 52|Other|0|||
94301559|NCT02502864|322886467|FG000|Overall Study|Withdrawal by Subject|1|||
94301560|NCT03772327|322886468|FG000|Overall Study|Lost to Follow-up|3|||
94301561|NCT03772327|322886469|FG001|Overall Study|Lost to Follow-up|4|||
94301562|NCT03772327|322886468|FG000|Overall Study|Withdrawal by Subject|2|||
94301563|NCT03772327|322886469|FG001|Overall Study|Withdrawal by Subject|3|||
94301564|NCT00957853|322886471|FG000|Overall Study|Withdrawal by Subject|1|||
94301565|NCT00957853|322886472|FG001|Overall Study|Withdrawal by Subject|0|||
94301566|NCT00957853|322886473|FG002|Overall Study|Withdrawal by Subject|0|||
94301567|NCT00816036|322886474|FG000|Overall Study|Death|47|||
94301568|NCT00816036|322886475|FG001|Overall Study|Death|28|||
94301569|NCT00816036|322886474|FG000|Overall Study|Lost to Follow-up|75|||
94301570|NCT00816036|322886475|FG001|Overall Study|Lost to Follow-up|57|||
94301571|NCT00816036|322886474|FG000|Overall Study|Withdrawal by Subject|54|||
94301572|NCT00816036|322886475|FG001|Overall Study|Withdrawal by Subject|23|||
94301573|NCT00004980|322886476|FG000|Overall Study|Withdrawal by Subject|1|||
94301574|NCT00004980|322886477|FG001|Overall Study|Withdrawal by Subject|0|||
94301575|NCT00004980|322886476|FG000|Overall Study|memory difficulties|1|||
94301576|NCT00004980|322886477|FG001|Overall Study|memory difficulties|1|||
94301577|NCT00004980|322886476|FG000|Overall Study|Physician Decision|0|||
94301578|NCT00004980|322886477|FG001|Overall Study|Physician Decision|1|||
94301579|NCT01624194|322886478|FG000|Overall Study|Lost to Follow-up|1|||
94301580|NCT01624194|322886479|FG001|Overall Study|Lost to Follow-up|0|||
94301581|NCT01624194|322886478|FG000|Overall Study|Withdrawal by Subject|1|||
94301582|NCT01624194|322886479|FG001|Overall Study|Withdrawal by Subject|0|||
94301583|NCT03212261|322886480|FG000|Overall Study|Became ineligible d/t tech|2|||
94301584|NCT03212261|322886480|FG000|Overall Study|Tech Trouble- No first study visit|1|||
94301585|NCT03212261|322886480|FG000|Overall Study|Lost to Follow-up|7|||
94301586|NCT03212261|322886480|FG000|Overall Study|Family Emergency|1|||
94301587|NCT03212261|322886480|FG000|Overall Study|Too busy/ No time|5|||
94301588|NCT05480514|322886481|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
94301589|NCT05480514|322886482|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
94301590|NCT05480514|322886481|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
94301591|NCT05480514|322886482|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
94301592|NCT05480514|322886481|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
94301593|NCT05480514|322886482|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
94301594|NCT05480514|322886481|FG000|Period 1|Covid-19 Related|1|||
94301595|NCT05480514|322886482|FG001|Period 1|Covid-19 Related|0|||
94301596|NCT05480514|322886481|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
94301597|NCT05480514|322886482|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
94301598|NCT03577990|322886483|FG000|Overall Study|Lost to Follow-up|4|||
94301599|NCT03577990|322886484|FG001|Overall Study|Lost to Follow-up|6|||
94301600|NCT03577990|322886483|FG000|Overall Study|Withdrawal by Subject|4|||
94301601|NCT03577990|322886484|FG001|Overall Study|Withdrawal by Subject|7|||
94301602|NCT05300087|322886485|FG000|Overall Study|Withdrawal by Subject|0|||
94301603|NCT05300087|322886486|FG001|Overall Study|Withdrawal by Subject|1|||
94301604|NCT04488822|322886487|FG000|Overall Study|Adverse Event|8|||
94301605|NCT04488822|322886487|FG000|Overall Study|Withdrawal by Subject|1|||
94301606|NCT01914679|322886489|FG000|Overall Study|Lack of Efficacy|1|||
94301607|NCT01914679|322886489|FG000|Overall Study|Sponsor terminated study|4|||
94301608|NCT03875235|322886493|FG000|Overall Study|Ongoing study treatment|63|||
94301609|NCT03875235|322886494|FG001|Overall Study|Ongoing study treatment|20|||
94301610|NCT03875235|322886493|FG000|Overall Study|Off treatment|77|||
94468212|NCT03436199|323503934|FG002|Overall Study|Protocol Violation|0|||
94301611|NCT03875235|322886494|FG001|Overall Study|Off treatment|91|||
94301612|NCT03875235|322886493|FG000|Overall Study|Withdrawal by Subject|3|||
94301613|NCT03875235|322886494|FG001|Overall Study|Withdrawal by Subject|10|||
94301614|NCT03875235|322886493|FG000|Overall Study|Death|198|||
94301615|NCT03875235|322886494|FG001|Overall Study|Death|223|||
94301616|NCT04526665|322886495|FG000|Overall Study|Withdrawal by Subject|6|||
94374519|NCT01034137|323156701|FG001|Overall Study|Protocol Violation|2|||
94374520|NCT01034137|323156702|FG002|Overall Study|Protocol Violation|1|||
94374521|NCT01034137|323156700|FG000|Overall Study|Refused treatment or did not cooperate|2|||
94374522|NCT01034137|323156701|FG001|Overall Study|Refused treatment or did not cooperate|0|||
94374523|NCT01034137|323156702|FG002|Overall Study|Refused treatment or did not cooperate|1|||
94374524|NCT01034137|323156700|FG000|Overall Study|Administrative or other|2|||
94374525|NCT01034137|323156701|FG001|Overall Study|Administrative or other|3|||
94374526|NCT01034137|323156702|FG002|Overall Study|Administrative or other|4|||
94374527|NCT03705351|323156703|FG000|Overall Study|Study termination|3|||
94374528|NCT03705351|323156703|FG000|Overall Study|Death|1|||
94374529|NCT03705351|323156703|FG000|Overall Study|Lack of Efficacy|2|||
94374530|NCT03705351|323156703|FG000|Overall Study|Withdrawal by Subject|1|||
94374531|NCT03572933|323156704|FG000|Overall Study|Adverse Event|4|||
94374532|NCT03572933|323156705|FG001|Overall Study|Adverse Event|1|||
94374533|NCT03572933|323156704|FG000|Overall Study|Withdrawal by Subject|0|||
94374534|NCT03572933|323156705|FG001|Overall Study|Withdrawal by Subject|1|||
94374535|NCT01764854|323156709|FG000|Overall Study|Adverse Event|0|||
94374536|NCT01764854|323156710|FG001|Overall Study|Adverse Event|0|||
94374537|NCT01764854|323156711|FG002|Overall Study|Adverse Event|2|||
94374538|NCT01764854|323156712|FG003|Overall Study|Adverse Event|0|||
94374539|NCT01764854|323156709|FG000|Overall Study|Withdrawal by Subject|0|||
94374540|NCT01764854|323156710|FG001|Overall Study|Withdrawal by Subject|0|||
94374541|NCT01764854|323156711|FG002|Overall Study|Withdrawal by Subject|1|||
94374542|NCT01764854|323156712|FG003|Overall Study|Withdrawal by Subject|0|||
94374543|NCT01764854|323156709|FG000|Overall Study|relocation|0|||
94374544|NCT01764854|323156710|FG001|Overall Study|relocation|0|||
94374545|NCT01764854|323156711|FG002|Overall Study|relocation|2|||
94374546|NCT01764854|323156712|FG003|Overall Study|relocation|0|||
94374547|NCT01764854|323156709|FG000|Overall Study|Protocol Violation|0|||
94374548|NCT01764854|323156710|FG001|Overall Study|Protocol Violation|0|||
94374549|NCT01764854|323156711|FG002|Overall Study|Protocol Violation|1|||
94374550|NCT01764854|323156712|FG003|Overall Study|Protocol Violation|2|||
94374551|NCT02049359|323156713|FG000|Overall Study|Lost to Follow-up|26|||
94374552|NCT02049359|323156714|FG001|Overall Study|Lost to Follow-up|19|||
94374553|NCT01907087|323156715|FG000|Overall Study|Withdrawal by Subject|1|||
94374554|NCT03273387|323156716|FG000|Overall Study|Death|2|||
94374555|NCT03273387|323156717|FG001|Overall Study|Death|2|||
94374556|NCT03273387|323156716|FG000|Overall Study|Withdrawal by Subject|1|||
94374557|NCT03273387|323156717|FG001|Overall Study|Withdrawal by Subject|1|||
94374558|NCT03377556|323156718|FG000|Overall Study|Adverse Event|5|||
94374559|NCT03377556|323156718|FG000|Overall Study|Refusal unrelated to adverse events|1|||
94374560|NCT03377556|323156718|FG000|Overall Study|Progression/relapse|38|||
94374561|NCT03377556|323156718|FG000|Overall Study|Death|3|||
94374562|NCT00472446|323156719|FG000|Overall Study|Protocol Violation|0|||
94374563|NCT00472446|323156720|FG001|Overall Study|Protocol Violation|0|||
94374564|NCT00472446|323156721|FG002|Overall Study|Protocol Violation|0|||
94374565|NCT00472446|323156722|FG003|Overall Study|Protocol Violation|1|||
94374566|NCT00472446|323156719|FG000|Overall Study|Reintervention|0|||
94374567|NCT00472446|323156720|FG001|Overall Study|Reintervention|0|||
94374568|NCT00472446|323156721|FG002|Overall Study|Reintervention|1|||
94374569|NCT00472446|323156722|FG003|Overall Study|Reintervention|1|||
94374570|NCT00472446|323156719|FG000|Overall Study|Questionnaires not returned|5|||
94374571|NCT00472446|323156720|FG001|Overall Study|Questionnaires not returned|6|||
94374572|NCT00472446|323156721|FG002|Overall Study|Questionnaires not returned|6|||
94374573|NCT00472446|323156722|FG003|Overall Study|Questionnaires not returned|4|||
94468213|NCT03436199|323503932|FG000|Overall Study|Physician Decision|0|||
94468214|NCT03436199|323503933|FG001|Overall Study|Physician Decision|1|||
94468215|NCT03436199|323503934|FG002|Overall Study|Physician Decision|0|||
94468216|NCT03436199|323503932|FG000|Overall Study|Could not return to clinic|1|||
94468217|NCT03436199|323503933|FG001|Overall Study|Could not return to clinic|0|||
94468218|NCT03436199|323503934|FG002|Overall Study|Could not return to clinic|0|||
94374574|NCT04132232|323156723|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
94374575|NCT04132232|323156724|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
94468219|NCT03436199|323503932|FG000|Overall Study|Withdrawn per physician|0|||
94468220|NCT03436199|323503933|FG001|Overall Study|Withdrawn per physician|1|||
94374576|NCT04132232|323156723|FG000|Overall Study|Lost to Follow-up|6|||
94374577|NCT04132232|323156724|FG001|Overall Study|Lost to Follow-up|7|||
94374578|NCT00619619|323156732|FG000|Overall Study|Physician Decision|0|||
94374579|NCT00619619|323156733|FG001|Overall Study|Physician Decision|0|||
94374580|NCT00619619|323156734|FG002|Overall Study|Physician Decision|1|||
94374581|NCT00619619|323156735|FG003|Overall Study|Physician Decision|0|||
94374582|NCT00619619|323156736|FG004|Overall Study|Physician Decision|0|||
94374583|NCT00619619|323156737|FG005|Overall Study|Physician Decision|0|||
94374584|NCT00619619|323156738|FG006|Overall Study|Physician Decision|0|||
94374585|NCT00619619|323156739|FG007|Overall Study|Physician Decision|0|||
94374586|NCT00619619|323156732|FG000|Overall Study|Protocol Violation|0|||
94468221|NCT03436199|323503934|FG002|Overall Study|Withdrawn per physician|0|||
94301617|NCT04526665|322886496|FG001|Overall Study|Withdrawal by Subject|3|||
94301618|NCT04526665|322886495|FG000|Overall Study|Adverse Event|4|||
94301619|NCT04526665|322886496|FG001|Overall Study|Adverse Event|1|||
94301620|NCT04526665|322886495|FG000|Overall Study|Physician Decision|2|||
94301621|NCT04526665|322886496|FG001|Overall Study|Physician Decision|2|||
94301622|NCT04526665|322886495|FG000|Overall Study|Death|2|||
94301623|NCT04526665|322886496|FG001|Overall Study|Death|0|||
94301624|NCT04526665|322886495|FG000|Overall Study|Other|0|||
94301625|NCT04526665|322886496|FG001|Overall Study|Other|1|||
94301626|NCT03232073|322886497|FG000|Overall Study|Death|1|||
94301627|NCT03232073|322886498|FG001|Overall Study|Death|0|||
94301628|NCT03232073|322886497|FG000|Overall Study|Adverse Event|7|||
94301629|NCT03232073|322886498|FG001|Overall Study|Adverse Event|12|||
94301630|NCT03232073|322886497|FG000|Overall Study|Lost to Follow-up|6|||
94301631|NCT03232073|322886498|FG001|Overall Study|Lost to Follow-up|6|||
94301632|NCT03232073|322886497|FG000|Overall Study|Lack of Efficacy|10|||
94301633|NCT03232073|322886498|FG001|Overall Study|Lack of Efficacy|8|||
94301634|NCT03232073|322886497|FG000|Overall Study|Physician Decision|9|||
94301635|NCT03232073|322886498|FG001|Overall Study|Physician Decision|2|||
94301636|NCT03232073|322886497|FG000|Overall Study|Withdrawal by Subject|54|||
94301637|NCT03232073|322886498|FG001|Overall Study|Withdrawal by Subject|39|||
94301638|NCT01826214|322888159|FG000|Overall Study|Adverse Event|7|||
94301639|NCT01826214|322888160|FG001|Overall Study|Adverse Event|6|||
94301640|NCT01826214|322888159|FG000|Overall Study|Death|3|||
94301641|NCT01826214|322888160|FG001|Overall Study|Death|1|||
94301642|NCT01826214|322888159|FG000|Overall Study|Lost to Follow-up|1|||
94301643|NCT01826214|322888160|FG001|Overall Study|Lost to Follow-up|0|||
94301644|NCT01826214|322888159|FG000|Overall Study|Physician Decision|0|||
94301645|NCT01826214|322888160|FG001|Overall Study|Physician Decision|2|||
94301646|NCT01826214|322888159|FG000|Overall Study|Progressive disease|22|||
94301647|NCT01826214|322888160|FG001|Overall Study|Progressive disease|21|||
94301648|NCT01826214|322888159|FG000|Overall Study|Study terminated by Sponsor|0|||
94301649|NCT01826214|322888160|FG001|Overall Study|Study terminated by Sponsor|1|||
94301650|NCT01826214|322888159|FG000|Overall Study|Subject/guardian decision|2|||
94301651|NCT01826214|322888160|FG001|Overall Study|Subject/guardian decision|3|||
94301652|NCT04030195|322888161|FG000|Overall Study|Withdrawal by Subject|2|||
94301653|NCT04030195|322888162|FG001|Overall Study|Withdrawal by Subject|0|||
94374587|NCT00619619|323156733|FG001|Overall Study|Protocol Violation|0|||
94374588|NCT00619619|323156734|FG002|Overall Study|Protocol Violation|0|||
94374589|NCT00619619|323156735|FG003|Overall Study|Protocol Violation|1|||
94374590|NCT00619619|323156736|FG004|Overall Study|Protocol Violation|0|||
94374591|NCT00619619|323156737|FG005|Overall Study|Protocol Violation|0|||
94374592|NCT00619619|323156738|FG006|Overall Study|Protocol Violation|1|||
94374593|NCT00619619|323156739|FG007|Overall Study|Protocol Violation|1|||
94374594|NCT00619619|323156732|FG000|Overall Study|Adverse Event|0|||
94374595|NCT00619619|323156733|FG001|Overall Study|Adverse Event|0|||
94374596|NCT00619619|323156734|FG002|Overall Study|Adverse Event|0|||
94374597|NCT00619619|323156735|FG003|Overall Study|Adverse Event|0|||
94374598|NCT00619619|323156736|FG004|Overall Study|Adverse Event|2|||
94374599|NCT00619619|323156737|FG005|Overall Study|Adverse Event|0|||
94374600|NCT00619619|323156738|FG006|Overall Study|Adverse Event|0|||
94374601|NCT00619619|323156739|FG007|Overall Study|Adverse Event|2|||
94374602|NCT00078819|323156740|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
94374603|NCT00078819|323156741|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
94468222|NCT04150068|323503938|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
94468223|NCT04150068|323503939|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
94468224|NCT04150068|323503940|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
94301654|NCT04030195|322888163|FG002|Overall Study|Withdrawal by Subject|0|||
94301655|NCT02109029|322888164|FG000|Part B|Adverse Event|0|||
94301656|NCT02109029|322888165|FG001|Part B|Adverse Event|0|||
94301657|NCT02109029|322888166|FG002|Part B|Adverse Event|0|||
94301658|NCT02109029|322888167|FG003|Part B|Adverse Event|0|||
94301659|NCT02109029|322888168|FG004|Part B|Adverse Event|1|||
94301660|NCT02109029|322888169|FG005|Part B|Adverse Event|1|||
94301661|NCT02128490|322888175|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
94301662|NCT02128490|322888176|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
94301663|NCT02128490|322888177|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
94374604|NCT00078819|323156742|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
94374605|NCT00078819|323156743|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
94301664|NCT02128490|322888178|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
94301665|NCT02128490|322888179|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
94301666|NCT02128490|322888175|FG000|Overall Study|Major Protocol Deviation|1|||
94301667|NCT02128490|322888176|FG001|Overall Study|Major Protocol Deviation|2|||
94301668|NCT02128490|322888177|FG002|Overall Study|Major Protocol Deviation|0|||
94301669|NCT02128490|322888178|FG003|Overall Study|Major Protocol Deviation|2|||
94374606|NCT00078819|323156740|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
94374607|NCT00078819|323156741|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
94374608|NCT00078819|323156742|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
94301670|NCT02128490|322888179|FG004|Overall Study|Major Protocol Deviation|2|||
94301671|NCT02128490|322888175|FG000|Overall Study|Lost to Follow-up|0|||
94301672|NCT02128490|322888176|FG001|Overall Study|Lost to Follow-up|0|||
94301673|NCT02128490|322888177|FG002|Overall Study|Lost to Follow-up|1|||
94301674|NCT02128490|322888178|FG003|Overall Study|Lost to Follow-up|1|||
94301675|NCT02128490|322888179|FG004|Overall Study|Lost to Follow-up|1|||
94301676|NCT02128490|322888175|FG000|Overall Study|Voluntary Withdrawal|3|||
94301677|NCT02128490|322888176|FG001|Overall Study|Voluntary Withdrawal|3|||
94301678|NCT02128490|322888177|FG002|Overall Study|Voluntary Withdrawal|1|||
94301679|NCT02128490|322888178|FG003|Overall Study|Voluntary Withdrawal|1|||
94301680|NCT02128490|322888179|FG004|Overall Study|Voluntary Withdrawal|2|||
94301681|NCT02128490|322888175|FG000|Overall Study|Lack of Efficacy|0|||
94301682|NCT02128490|322888176|FG001|Overall Study|Lack of Efficacy|1|||
94301683|NCT02128490|322888177|FG002|Overall Study|Lack of Efficacy|0|||
94301684|NCT02128490|322888178|FG003|Overall Study|Lack of Efficacy|0|||
94301685|NCT02128490|322888179|FG004|Overall Study|Lack of Efficacy|0|||
94301686|NCT02128490|322888175|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
94301687|NCT02128490|322888176|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
94301688|NCT02128490|322888177|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
94301689|NCT02128490|322888178|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
94301690|NCT02128490|322888179|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
94301691|NCT02128490|322888175|FG000|Overall Study|Other Miscellaneous Reasons|0|||
94301692|NCT02128490|322888176|FG001|Overall Study|Other Miscellaneous Reasons|0|||
94301693|NCT02128490|322888177|FG002|Overall Study|Other Miscellaneous Reasons|2|||
94301694|NCT02128490|322888178|FG003|Overall Study|Other Miscellaneous Reasons|1|||
94301695|NCT02128490|322888179|FG004|Overall Study|Other Miscellaneous Reasons|1|||
94301696|NCT01609933|322888180|FG000|Overall Study|Adverse Event|1|||
94301697|NCT01609933|322888180|FG000|Overall Study|Withdrawal by Subject|3|||
94301698|NCT00377962|322888181|FG000|Core Study: 0-12 Months|Adverse Event|18|||
94301699|NCT00377962|322888182|FG001|Core Study: 0-12 Months|Adverse Event|2|||
94301700|NCT00377962|322888181|FG000|Core Study: 0-12 Months|Death|3|||
94301701|NCT00377962|322888182|FG001|Core Study: 0-12 Months|Death|0|||
94301702|NCT00377962|322888181|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
94301703|NCT00377962|322888182|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
94301704|NCT00377962|322888181|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
94301705|NCT00377962|322888182|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
94301706|NCT00377962|322888181|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
94301707|NCT00377962|322888182|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
94301708|NCT00377962|322888181|FG000|Extension Study: 12-24 Months|Death|1|||
94374609|NCT00078819|323156743|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
94374610|NCT00078819|323156740|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
94374611|NCT00078819|323156741|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
94374612|NCT00078819|323156742|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
94374613|NCT00078819|323156743|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
94374614|NCT00078819|323156740|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
94374615|NCT00078819|323156741|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
94374616|NCT00078819|323156742|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
94374617|NCT00078819|323156743|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
94374618|NCT00078819|323156740|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
94374619|NCT00078819|323156741|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
94374620|NCT00078819|323156742|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
94374621|NCT00078819|323156743|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
94374622|NCT00078819|323156740|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
94374623|NCT00078819|323156741|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
94374624|NCT00078819|323156742|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
94374625|NCT00078819|323156743|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
94374626|NCT00078819|323156740|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
94374627|NCT00078819|323156741|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
94374628|NCT00078819|323156742|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
94374629|NCT00078819|323156743|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
94374630|NCT00078819|323156740|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
94301709|NCT00377962|322888182|FG001|Extension Study: 12-24 Months|Death|1|||
94301710|NCT00377962|322888181|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
94301711|NCT00377962|322888182|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
94301712|NCT00377962|322888181|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
94301713|NCT00377962|322888182|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
94301714|NCT00377962|322888181|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
94301715|NCT00377962|322888182|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
94301716|NCT00942162|322888185|FG000|Overall Study|Death|45|||
94301717|NCT00942162|322888186|FG001|Overall Study|Death|35|||
94301718|NCT00942162|322888187|FG002|Overall Study|Death|0|||
94301719|NCT00942162|322888185|FG000|Overall Study|Withdrawal by Subject|7|||
94301720|NCT00942162|322888186|FG001|Overall Study|Withdrawal by Subject|2|||
94301721|NCT00942162|322888187|FG002|Overall Study|Withdrawal by Subject|0|||
94301722|NCT00942162|322888185|FG000|Overall Study|Lost to Follow-up|4|||
94301723|NCT00942162|322888186|FG001|Overall Study|Lost to Follow-up|0|||
94301724|NCT00942162|322888187|FG002|Overall Study|Lost to Follow-up|0|||
94301725|NCT00942162|322888185|FG000|Overall Study|Other|14|||
94301726|NCT00942162|322888186|FG001|Overall Study|Other|13|||
94301727|NCT00942162|322888187|FG002|Overall Study|Other|2|||
94301728|NCT02799381|322888190|FG000|Overall Study|Withdrew consent|3|||
94301729|NCT02799381|322888191|FG001|Overall Study|Withdrew consent|2|||
94301730|NCT02799381|322888190|FG000|Overall Study|Adverse Event|0|||
94301731|NCT02799381|322888191|FG001|Overall Study|Adverse Event|1|||
94301732|NCT02799381|322888190|FG000|Overall Study|Participant did not take any study drug|1|||
94301733|NCT02799381|322888191|FG001|Overall Study|Participant did not take any study drug|0|||
94301734|NCT00783289|322888194|FG000|Overall Study|Protocol Violation|0|||
94301735|NCT00783289|322888195|FG001|Overall Study|Protocol Violation|1|||
94301736|NCT00783289|322888196|FG002|Overall Study|Protocol Violation|0|||
94301737|NCT00783289|322888197|FG003|Overall Study|Protocol Violation|0|||
94301738|NCT03368859|322888198|FG000|Overall Study|Withdrew Consent|5|||
94301739|NCT03368859|322888199|FG001|Overall Study|Withdrew Consent|4|||
94301740|NCT03368859|322888198|FG000|Overall Study|Death|12|||
94301741|NCT03368859|322888199|FG001|Overall Study|Death|6|||
94301742|NCT03368859|322888198|FG000|Overall Study|Study terminated by Sponsor|18|||
94301743|NCT03368859|322888199|FG001|Overall Study|Study terminated by Sponsor|23|||
94301744|NCT03368859|322888198|FG000|Overall Study|Other|1|||
94301745|NCT03368859|322888199|FG001|Overall Study|Other|1|||
94301746|NCT03952130|322888200|FG000|Overall Study|Adverse Event|0|||
94301747|NCT03952130|322888201|FG001|Overall Study|Adverse Event|1|||
94301748|NCT03952130|322888200|FG000|Overall Study|Lost to Follow-up|1|||
94301749|NCT03952130|322888201|FG001|Overall Study|Lost to Follow-up|0|||
94301750|NCT03952130|322888200|FG000|Overall Study|Withdrawal by Subject|1|||
94301751|NCT03952130|322888201|FG001|Overall Study|Withdrawal by Subject|5|||
94301752|NCT00506389|322888203|FG000|In-treatment Period|Other|3|||
94301753|NCT00506389|322888204|FG001|In-treatment Period|Other|3|||
94301754|NCT00506389|322888205|FG002|In-treatment Period|Other|4|||
94301755|NCT00506389|322888203|FG000|In-treatment Period|Lost to Follow-up|0|||
94301756|NCT00506389|322888204|FG001|In-treatment Period|Lost to Follow-up|0|||
94301757|NCT00506389|322888205|FG002|In-treatment Period|Lost to Follow-up|1|||
94301758|NCT00506389|322888203|FG000|In-treatment Period|Lack of compliance|1|||
94301759|NCT00506389|322888204|FG001|In-treatment Period|Lack of compliance|0|||
94301760|NCT00506389|322888205|FG002|In-treatment Period|Lack of compliance|0|||
94301761|NCT00506389|322888203|FG000|In-treatment Period|Reasons not related to trial|4|||
94301762|NCT00506389|322888204|FG001|In-treatment Period|Reasons not related to trial|1|||
94301763|NCT00506389|322888205|FG002|In-treatment Period|Reasons not related to trial|0|||
94301764|NCT00506389|322888203|FG000|In-treatment Period|Withdrawal by Subject|3|||
94301765|NCT00506389|322888204|FG001|In-treatment Period|Withdrawal by Subject|3|||
94301766|NCT00506389|322888205|FG002|In-treatment Period|Withdrawal by Subject|4|||
94301767|NCT00506389|322888203|FG000|In-treatment Period|Lack of Efficacy|0|||
94301768|NCT00506389|322888204|FG001|In-treatment Period|Lack of Efficacy|2|||
94301769|NCT00506389|322888205|FG002|In-treatment Period|Lack of Efficacy|0|||
94301770|NCT00506389|322888203|FG000|In-treatment Period|Adverse Event|11|||
94301771|NCT00506389|322888204|FG001|In-treatment Period|Adverse Event|5|||
94301772|NCT00506389|322888205|FG002|In-treatment Period|Adverse Event|2|||
94301773|NCT00506389|322888203|FG000|In-treatment Period|Randomized but not treated|4|||
94301774|NCT00506389|322888204|FG001|In-treatment Period|Randomized but not treated|1|||
94301775|NCT00506389|322888205|FG002|In-treatment Period|Randomized but not treated|1|||
94301776|NCT01324830|322888207|FG000|Overall Study|Progressive Disease|3|||
94301777|NCT01324830|322888208|FG001|Overall Study|Progressive Disease|2|||
94301778|NCT01324830|322888209|FG002|Overall Study|Progressive Disease|3|||
94301779|NCT01324830|322888210|FG003|Overall Study|Progressive Disease|3|||
94301780|NCT01324830|322888211|FG004|Overall Study|Progressive Disease|6|||
94301781|NCT01324830|322888212|FG005|Overall Study|Progressive Disease|6|||
94301782|NCT01324830|322888213|FG006|Overall Study|Progressive Disease|3|||
94301783|NCT01324830|322888214|FG007|Overall Study|Progressive Disease|3|||
94301784|NCT01324830|322888215|FG008|Overall Study|Progressive Disease|3|||
94301785|NCT01324830|322888216|FG009|Overall Study|Progressive Disease|6|||
94301786|NCT01324830|322888217|FG010|Overall Study|Progressive Disease|2|||
94301787|NCT01324830|322888218|FG011|Overall Study|Progressive Disease|1|||
94301788|NCT01324830|322888219|FG012|Overall Study|Progressive Disease|1|||
94301789|NCT01324830|322888220|FG013|Overall Study|Progressive Disease|1|||
94301790|NCT01324830|322888221|FG014|Overall Study|Progressive Disease|1|||
94301791|NCT01324830|322888222|FG015|Overall Study|Progressive Disease|3|||
94301792|NCT01324830|322888223|FG016|Overall Study|Progressive Disease|2|||
94301793|NCT01324830|322888224|FG017|Overall Study|Progressive Disease|3|||
94301794|NCT01324830|322888225|FG018|Overall Study|Progressive Disease|4|||
94301795|NCT01324830|322888207|FG000|Overall Study|Dose limiting toxicity|0|||
94301796|NCT01324830|322888208|FG001|Overall Study|Dose limiting toxicity|0|||
94301797|NCT01324830|322888209|FG002|Overall Study|Dose limiting toxicity|0|||
94301798|NCT01324830|322888210|FG003|Overall Study|Dose limiting toxicity|0|||
94301799|NCT01324830|322888211|FG004|Overall Study|Dose limiting toxicity|1|||
94301800|NCT01324830|322888212|FG005|Overall Study|Dose limiting toxicity|0|||
94301801|NCT01324830|322888213|FG006|Overall Study|Dose limiting toxicity|0|||
94301802|NCT01324830|322888214|FG007|Overall Study|Dose limiting toxicity|0|||
94301803|NCT01324830|322888215|FG008|Overall Study|Dose limiting toxicity|0|||
94301804|NCT01324830|322888216|FG009|Overall Study|Dose limiting toxicity|0|||
94301805|NCT01324830|322888217|FG010|Overall Study|Dose limiting toxicity|0|||
94301806|NCT01324830|322888218|FG011|Overall Study|Dose limiting toxicity|0|||
94301807|NCT01324830|322888219|FG012|Overall Study|Dose limiting toxicity|0|||
94301808|NCT01324830|322888220|FG013|Overall Study|Dose limiting toxicity|0|||
94301809|NCT01324830|322888221|FG014|Overall Study|Dose limiting toxicity|0|||
94301810|NCT01324830|322888222|FG015|Overall Study|Dose limiting toxicity|0|||
94301811|NCT01324830|322888223|FG016|Overall Study|Dose limiting toxicity|1|||
94301812|NCT01324830|322888224|FG017|Overall Study|Dose limiting toxicity|1|||
94301813|NCT01324830|322888225|FG018|Overall Study|Dose limiting toxicity|1|||
94301814|NCT01324830|322888207|FG000|Overall Study|Reason not mentioned above|0|||
94301815|NCT01324830|322888208|FG001|Overall Study|Reason not mentioned above|0|||
94301816|NCT01324830|322888209|FG002|Overall Study|Reason not mentioned above|0|||
94301817|NCT01324830|322888210|FG003|Overall Study|Reason not mentioned above|0|||
94301818|NCT01324830|322888211|FG004|Overall Study|Reason not mentioned above|0|||
94301819|NCT01324830|322888212|FG005|Overall Study|Reason not mentioned above|0|||
94301820|NCT01324830|322888213|FG006|Overall Study|Reason not mentioned above|0|||
94301821|NCT01324830|322888214|FG007|Overall Study|Reason not mentioned above|0|||
94301822|NCT01324830|322888215|FG008|Overall Study|Reason not mentioned above|0|||
94301823|NCT01324830|322888216|FG009|Overall Study|Reason not mentioned above|0|||
94301824|NCT01324830|322888217|FG010|Overall Study|Reason not mentioned above|0|||
94301825|NCT01324830|322888218|FG011|Overall Study|Reason not mentioned above|0|||
94301826|NCT01324830|322888219|FG012|Overall Study|Reason not mentioned above|0|||
94301827|NCT01324830|322888220|FG013|Overall Study|Reason not mentioned above|0|||
94301828|NCT01324830|322888221|FG014|Overall Study|Reason not mentioned above|0|||
94301829|NCT01324830|322888222|FG015|Overall Study|Reason not mentioned above|0|||
94301830|NCT01324830|322888223|FG016|Overall Study|Reason not mentioned above|0|||
94301831|NCT01324830|322888224|FG017|Overall Study|Reason not mentioned above|1|||
94301832|NCT01324830|322888225|FG018|Overall Study|Reason not mentioned above|0|||
94301833|NCT01324830|322888207|FG000|Overall Study|Adverse Event, serious fatal|0|||
94301834|NCT01324830|322888208|FG001|Overall Study|Adverse Event, serious fatal|1|||
94301835|NCT01324830|322888209|FG002|Overall Study|Adverse Event, serious fatal|0|||
94301836|NCT01324830|322888210|FG003|Overall Study|Adverse Event, serious fatal|0|||
94301837|NCT01324830|322888211|FG004|Overall Study|Adverse Event, serious fatal|0|||
94301838|NCT01324830|322888212|FG005|Overall Study|Adverse Event, serious fatal|0|||
94301839|NCT01324830|322888213|FG006|Overall Study|Adverse Event, serious fatal|0|||
94301840|NCT01324830|322888214|FG007|Overall Study|Adverse Event, serious fatal|0|||
94301841|NCT01324830|322888215|FG008|Overall Study|Adverse Event, serious fatal|0|||
94301842|NCT01324830|322888216|FG009|Overall Study|Adverse Event, serious fatal|0|||
94301843|NCT01324830|322888217|FG010|Overall Study|Adverse Event, serious fatal|0|||
94301844|NCT01324830|322888218|FG011|Overall Study|Adverse Event, serious fatal|0|||
94301845|NCT01324830|322888219|FG012|Overall Study|Adverse Event, serious fatal|0|||
94301846|NCT01324830|322888220|FG013|Overall Study|Adverse Event, serious fatal|0|||
94301847|NCT01324830|322888221|FG014|Overall Study|Adverse Event, serious fatal|0|||
94301848|NCT01324830|322888222|FG015|Overall Study|Adverse Event, serious fatal|0|||
94301849|NCT01324830|322888223|FG016|Overall Study|Adverse Event, serious fatal|0|||
94468225|NCT04150068|323503938|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
94301850|NCT01324830|322888224|FG017|Overall Study|Adverse Event, serious fatal|0|||
94301851|NCT01324830|322888225|FG018|Overall Study|Adverse Event, serious fatal|0|||
94301852|NCT01324830|322888207|FG000|Overall Study|Adverse Event, non-fatal|0|||
94301853|NCT01324830|322888208|FG001|Overall Study|Adverse Event, non-fatal|0|||
94301854|NCT01324830|322888209|FG002|Overall Study|Adverse Event, non-fatal|0|||
94301855|NCT01324830|322888210|FG003|Overall Study|Adverse Event, non-fatal|0|||
94301856|NCT01324830|322888211|FG004|Overall Study|Adverse Event, non-fatal|0|||
94301857|NCT01324830|322888212|FG005|Overall Study|Adverse Event, non-fatal|0|||
94301858|NCT01324830|322888213|FG006|Overall Study|Adverse Event, non-fatal|0|||
94301859|NCT01324830|322888214|FG007|Overall Study|Adverse Event, non-fatal|0|||
94301860|NCT01324830|322888215|FG008|Overall Study|Adverse Event, non-fatal|2|||
94301861|NCT01324830|322888216|FG009|Overall Study|Adverse Event, non-fatal|0|||
94301862|NCT01324830|322888217|FG010|Overall Study|Adverse Event, non-fatal|1|||
94301863|NCT01324830|322888218|FG011|Overall Study|Adverse Event, non-fatal|0|||
94301864|NCT01324830|322888219|FG012|Overall Study|Adverse Event, non-fatal|0|||
94301865|NCT01324830|322888220|FG013|Overall Study|Adverse Event, non-fatal|0|||
94301866|NCT01324830|322888221|FG014|Overall Study|Adverse Event, non-fatal|0|||
94301867|NCT01324830|322888222|FG015|Overall Study|Adverse Event, non-fatal|0|||
94301868|NCT01324830|322888223|FG016|Overall Study|Adverse Event, non-fatal|0|||
94301869|NCT01324830|322888224|FG017|Overall Study|Adverse Event, non-fatal|1|||
94301870|NCT01324830|322888225|FG018|Overall Study|Adverse Event, non-fatal|0|||
94301871|NCT01324830|322888207|FG000|Overall Study|Withdrawal by Subject|0|||
94301872|NCT01324830|322888208|FG001|Overall Study|Withdrawal by Subject|0|||
94301873|NCT01324830|322888209|FG002|Overall Study|Withdrawal by Subject|0|||
94301874|NCT01324830|322888210|FG003|Overall Study|Withdrawal by Subject|0|||
94301875|NCT01324830|322888211|FG004|Overall Study|Withdrawal by Subject|0|||
94301876|NCT01324830|322888212|FG005|Overall Study|Withdrawal by Subject|1|||
94301877|NCT01324830|322888213|FG006|Overall Study|Withdrawal by Subject|0|||
94301878|NCT01324830|322888214|FG007|Overall Study|Withdrawal by Subject|0|||
94301879|NCT01324830|322888215|FG008|Overall Study|Withdrawal by Subject|0|||
94301880|NCT01324830|322888216|FG009|Overall Study|Withdrawal by Subject|0|||
94301881|NCT01324830|322888217|FG010|Overall Study|Withdrawal by Subject|1|||
94301882|NCT01324830|322888218|FG011|Overall Study|Withdrawal by Subject|0|||
94301883|NCT01324830|322888219|FG012|Overall Study|Withdrawal by Subject|0|||
94301884|NCT01324830|322888220|FG013|Overall Study|Withdrawal by Subject|0|||
94301885|NCT01324830|322888221|FG014|Overall Study|Withdrawal by Subject|0|||
94301886|NCT01324830|322888222|FG015|Overall Study|Withdrawal by Subject|0|||
94301887|NCT01324830|322888223|FG016|Overall Study|Withdrawal by Subject|0|||
94301888|NCT01324830|322888224|FG017|Overall Study|Withdrawal by Subject|0|||
94301889|NCT01324830|322888225|FG018|Overall Study|Withdrawal by Subject|1|||
94301890|NCT00942409|322888226|FG000|Overall Study|Lack of Efficacy|1|||
94301891|NCT00942409|322888226|FG000|Overall Study|study drug unavailable|2|||
94301892|NCT00817414|322888229|FG000|Overall Study|Adverse Event|1|||
94301893|NCT00817414|322888230|FG001|Overall Study|Adverse Event|1|||
94301894|NCT00817414|322888231|FG002|Overall Study|Adverse Event|1|||
94301895|NCT00817414|322888232|FG003|Overall Study|Adverse Event|0|||
94301896|NCT00817414|322888233|FG004|Overall Study|Adverse Event|0|||
94301897|NCT00817414|322888229|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
94301898|NCT00817414|322888230|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
94301899|NCT00817414|322888231|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
94301900|NCT00817414|322888232|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
94301901|NCT00817414|322888233|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
94301902|NCT00817414|322888229|FG000|Overall Study|Withdrawal by Subject|1|||
94301903|NCT00817414|322888230|FG001|Overall Study|Withdrawal by Subject|1|||
94374631|NCT00078819|323156741|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
94374632|NCT00078819|323156742|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
94374633|NCT00078819|323156743|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
94374634|NCT01159769|323156744|FG000|Overall Study|Adverse Event|1|||
94374635|NCT00323609|323156745|FG000|Overall Study|Death|16|||
94374636|NCT00323609|323156746|FG001|Overall Study|Death|21|||
94374637|NCT00323609|323156747|FG002|Overall Study|Death|0|||
94374638|NCT00323609|323156748|FG003|Overall Study|Death|0|||
94374639|NCT00323609|323156745|FG000|Overall Study|Lost to Follow-up|9|||
94374640|NCT00323609|323156746|FG001|Overall Study|Lost to Follow-up|10|||
94374641|NCT00323609|323156747|FG002|Overall Study|Lost to Follow-up|0|||
94374642|NCT00323609|323156748|FG003|Overall Study|Lost to Follow-up|0|||
94374643|NCT00323609|323156745|FG000|Overall Study|Physician Decision|2|||
94374644|NCT00323609|323156746|FG001|Overall Study|Physician Decision|0|||
94374645|NCT00323609|323156747|FG002|Overall Study|Physician Decision|0|||
94374646|NCT00323609|323156748|FG003|Overall Study|Physician Decision|1|||
94301904|NCT00817414|322888231|FG002|Overall Study|Withdrawal by Subject|0|||
94374647|NCT00323609|323156745|FG000|Overall Study|Withdrawal by Subject|11|||
94374648|NCT00323609|323156746|FG001|Overall Study|Withdrawal by Subject|23|||
94374649|NCT00323609|323156747|FG002|Overall Study|Withdrawal by Subject|4|||
94374650|NCT00323609|323156748|FG003|Overall Study|Withdrawal by Subject|4|||
94301905|NCT00817414|322888232|FG003|Overall Study|Withdrawal by Subject|0|||
94301906|NCT00817414|322888233|FG004|Overall Study|Withdrawal by Subject|0|||
94301907|NCT00817414|322888229|FG000|Overall Study|Lost to Follow-up|0|||
94301908|NCT00817414|322888230|FG001|Overall Study|Lost to Follow-up|0|||
94301909|NCT00817414|322888231|FG002|Overall Study|Lost to Follow-up|1|||
94301910|NCT00817414|322888232|FG003|Overall Study|Lost to Follow-up|1|||
94301911|NCT00817414|322888233|FG004|Overall Study|Lost to Follow-up|1|||
94301912|NCT00817414|322888229|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
94301913|NCT00817414|322888230|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
94301914|NCT00817414|322888231|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
94301915|NCT00817414|322888232|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
94301916|NCT00817414|322888233|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
94301917|NCT00817414|322888229|FG000|Overall Study|Protocol Violation|0|||
94301918|NCT00817414|322888230|FG001|Overall Study|Protocol Violation|0|||
94301919|NCT00817414|322888231|FG002|Overall Study|Protocol Violation|0|||
94301920|NCT00817414|322888232|FG003|Overall Study|Protocol Violation|0|||
94301921|NCT00817414|322888233|FG004|Overall Study|Protocol Violation|1|||
94301922|NCT00870688|322888234|FG000|Overall Study|Lost to Follow-up|2|||
94301923|NCT00870688|322888234|FG000|Overall Study|Death, Unrelated|1|||
94301924|NCT00870688|322888234|FG000|Overall Study|Granules in the Stools|1|||
94301925|NCT04026568|322888235|FG000|Overall Study|study terminated|0|||
94301926|NCT04026568|322888236|FG001|Overall Study|study terminated|1|||
94301927|NCT00809133|322888237|FG000|Overall Study|Progressive disease|2|||
94301928|NCT00809133|322888238|FG001|Overall Study|Progressive disease|5|||
94301929|NCT00809133|322888239|FG002|Overall Study|Progressive disease|5|||
94301930|NCT00809133|322888240|FG003|Overall Study|Progressive disease|3|||
94301931|NCT00809133|322888241|FG004|Overall Study|Progressive disease|4|||
94301932|NCT00809133|322888242|FG005|Overall Study|Progressive disease|1|||
94301933|NCT00809133|322888243|FG006|Overall Study|Progressive disease|3|||
94301934|NCT00809133|322888244|FG007|Overall Study|Progressive disease|3|||
94301935|NCT00809133|322888245|FG008|Overall Study|Progressive disease|3|||
94301936|NCT00809133|322888246|FG009|Overall Study|Progressive disease|9|||
94301937|NCT00809133|322888247|FG010|Overall Study|Progressive disease|5|||
94301938|NCT00809133|322888248|FG011|Overall Study|Progressive disease|7|||
94301939|NCT00809133|322888249|FG012|Overall Study|Progressive disease|5|||
94301940|NCT00809133|322888250|FG013|Overall Study|Progressive disease|4|||
94301941|NCT00809133|322888237|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94301942|NCT00809133|322888238|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94301943|NCT00809133|322888239|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94301944|NCT00809133|322888240|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94301945|NCT00809133|322888241|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94301946|NCT00809133|322888242|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
94301947|NCT00809133|322888243|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
94301948|NCT00809133|322888244|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
94301949|NCT00809133|322888245|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94301950|NCT00809133|322888246|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94301951|NCT00809133|322888247|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94301952|NCT00809133|322888248|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94301953|NCT00809133|322888249|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94301954|NCT00809133|322888250|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
94301955|NCT00809133|322888237|FG000|Overall Study|Other adverse event|1|||
94301956|NCT00809133|322888238|FG001|Overall Study|Other adverse event|1|||
94301957|NCT00809133|322888239|FG002|Overall Study|Other adverse event|1|||
94301958|NCT00809133|322888240|FG003|Overall Study|Other adverse event|0|||
94301959|NCT00809133|322888241|FG004|Overall Study|Other adverse event|0|||
94301960|NCT00809133|322888242|FG005|Overall Study|Other adverse event|3|||
94301961|NCT00809133|322888243|FG006|Overall Study|Other adverse event|2|||
94301962|NCT00809133|322888244|FG007|Overall Study|Other adverse event|4|||
94301963|NCT00809133|322888245|FG008|Overall Study|Other adverse event|0|||
94301964|NCT00809133|322888246|FG009|Overall Study|Other adverse event|0|||
94301965|NCT00809133|322888247|FG010|Overall Study|Other adverse event|1|||
94301966|NCT00809133|322888248|FG011|Overall Study|Other adverse event|1|||
94301967|NCT00809133|322888249|FG012|Overall Study|Other adverse event|0|||
94301968|NCT00809133|322888250|FG013|Overall Study|Other adverse event|1|||
94301969|NCT00809133|322888237|FG000|Overall Study|Lost to Follow-up|0|||
94301970|NCT00809133|322888238|FG001|Overall Study|Lost to Follow-up|0|||
94301971|NCT00809133|322888239|FG002|Overall Study|Lost to Follow-up|0|||
94301972|NCT00809133|322888240|FG003|Overall Study|Lost to Follow-up|0|||
94301973|NCT00809133|322888241|FG004|Overall Study|Lost to Follow-up|0|||
94301974|NCT00809133|322888242|FG005|Overall Study|Lost to Follow-up|1|||
94301975|NCT00809133|322888243|FG006|Overall Study|Lost to Follow-up|0|||
94301976|NCT00809133|322888244|FG007|Overall Study|Lost to Follow-up|0|||
94301977|NCT00809133|322888245|FG008|Overall Study|Lost to Follow-up|0|||
94301978|NCT00809133|322888246|FG009|Overall Study|Lost to Follow-up|0|||
94301979|NCT00809133|322888247|FG010|Overall Study|Lost to Follow-up|0|||
94301980|NCT00809133|322888248|FG011|Overall Study|Lost to Follow-up|0|||
94301981|NCT00809133|322888249|FG012|Overall Study|Lost to Follow-up|0|||
94374651|NCT00323609|323156745|FG000|Overall Study|Other non-VCF-related medical condition|3|||
94374652|NCT00323609|323156746|FG001|Overall Study|Other non-VCF-related medical condition|2|||
94374653|NCT00323609|323156747|FG002|Overall Study|Other non-VCF-related medical condition|0|||
94374654|NCT00323609|323156748|FG003|Overall Study|Other non-VCF-related medical condition|0|||
94374655|NCT00323609|323156745|FG000|Overall Study|Sponsor discontinued trial|29|||
94374656|NCT00323609|323156746|FG001|Overall Study|Sponsor discontinued trial|29|||
94374657|NCT00323609|323156747|FG002|Overall Study|Sponsor discontinued trial|0|||
94374658|NCT00323609|323156748|FG003|Overall Study|Sponsor discontinued trial|0|||
94374659|NCT00323609|323156745|FG000|Overall Study|Unrelenting or severe back pain|1|||
94374660|NCT00323609|323156746|FG001|Overall Study|Unrelenting or severe back pain|1|||
94374661|NCT00323609|323156747|FG002|Overall Study|Unrelenting or severe back pain|0|||
94374662|NCT00323609|323156748|FG003|Overall Study|Unrelenting or severe back pain|0|||
94374663|NCT00323609|323156745|FG000|Overall Study|Logistical withdrawal|9|||
94374664|NCT00323609|323156746|FG001|Overall Study|Logistical withdrawal|5|||
94374665|NCT00323609|323156747|FG002|Overall Study|Logistical withdrawal|0|||
94374666|NCT00323609|323156748|FG003|Overall Study|Logistical withdrawal|1|||
94374667|NCT00323609|323156745|FG000|Overall Study|Other reason|11|||
94374668|NCT00323609|323156746|FG001|Overall Study|Other reason|8|||
94374669|NCT00323609|323156747|FG002|Overall Study|Other reason|4|||
94374670|NCT00323609|323156748|FG003|Overall Study|Other reason|9|||
94374671|NCT01684722|323156753|FG000|Overall Study|Lost to Follow-up|78|||
94374672|NCT01684722|323156754|FG001|Overall Study|Lost to Follow-up|56|||
94374673|NCT01684722|323156755|FG002|Overall Study|Lost to Follow-up|75|||
94374674|NCT01684722|323156756|FG003|Overall Study|Lost to Follow-up|89|||
94374675|NCT01684722|323156753|FG000|Overall Study|Death|19|||
94374676|NCT01684722|323156754|FG001|Overall Study|Death|21|||
94374677|NCT01684722|323156755|FG002|Overall Study|Death|19|||
94374678|NCT01684722|323156756|FG003|Overall Study|Death|21|||
94374679|NCT05085964|323156762|FG000|Overall Study|Premature termination of study|21|||
94374680|NCT05085964|323156763|FG001|Overall Study|Premature termination of study|0|||
94374681|NCT00320593|323156764|FG000|Overall Study|Lost to Follow-up|3|||
94374682|NCT00320593|323156765|FG001|Overall Study|Lost to Follow-up|0|||
94374683|NCT00320593|323156764|FG000|Overall Study|Moved to another state|1|||
94374684|NCT00320593|323156765|FG001|Overall Study|Moved to another state|0|||
94374685|NCT00320593|323156764|FG000|Overall Study|Withdrawal by Subject|2|||
94468226|NCT04150068|323503939|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
94468227|NCT04150068|323503940|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
94468228|NCT00821015|323503946|FG000|Overall Study|Lost to Follow-up|12|||
94301982|NCT00809133|322888250|FG013|Overall Study|Lost to Follow-up|0|||
94301983|NCT00809133|322888237|FG000|Overall Study|Consent withdrawn|0|||
94301984|NCT00809133|322888238|FG001|Overall Study|Consent withdrawn|0|||
94301985|NCT00809133|322888239|FG002|Overall Study|Consent withdrawn|0|||
94301986|NCT00809133|322888240|FG003|Overall Study|Consent withdrawn|0|||
94301987|NCT00809133|322888241|FG004|Overall Study|Consent withdrawn|1|||
94301988|NCT00809133|322888242|FG005|Overall Study|Consent withdrawn|0|||
94301989|NCT00809133|322888243|FG006|Overall Study|Consent withdrawn|0|||
94301990|NCT00809133|322888244|FG007|Overall Study|Consent withdrawn|0|||
94301991|NCT00809133|322888245|FG008|Overall Study|Consent withdrawn|0|||
94301992|NCT00809133|322888246|FG009|Overall Study|Consent withdrawn|0|||
94301993|NCT00809133|322888247|FG010|Overall Study|Consent withdrawn|0|||
94301994|NCT00809133|322888248|FG011|Overall Study|Consent withdrawn|0|||
94301995|NCT00809133|322888249|FG012|Overall Study|Consent withdrawn|0|||
94301996|NCT00809133|322888250|FG013|Overall Study|Consent withdrawn|0|||
94301997|NCT00809133|322888237|FG000|Overall Study|Other not mentioned above|0|||
94301998|NCT00809133|322888238|FG001|Overall Study|Other not mentioned above|1|||
94301999|NCT00809133|322888239|FG002|Overall Study|Other not mentioned above|0|||
94302000|NCT00809133|322888240|FG003|Overall Study|Other not mentioned above|0|||
94302001|NCT00809133|322888241|FG004|Overall Study|Other not mentioned above|0|||
94302002|NCT00809133|322888242|FG005|Overall Study|Other not mentioned above|1|||
94302003|NCT00809133|322888243|FG006|Overall Study|Other not mentioned above|0|||
94302004|NCT00809133|322888244|FG007|Overall Study|Other not mentioned above|0|||
94302005|NCT00809133|322888245|FG008|Overall Study|Other not mentioned above|0|||
94302006|NCT00809133|322888246|FG009|Overall Study|Other not mentioned above|0|||
94374686|NCT00320593|323156765|FG001|Overall Study|Withdrawal by Subject|1|||
94374687|NCT00320593|323156764|FG000|Overall Study|Withdrawal by clinical center|1|||
94374688|NCT00320593|323156765|FG001|Overall Study|Withdrawal by clinical center|0|||
94374689|NCT05288673|323156766|FG000|Overall Study|Consent withdrawn by subject|0|||
94468229|NCT03170609|323503947|FG000|Overall Study|Death|0|||
94302007|NCT00809133|322888247|FG010|Overall Study|Other not mentioned above|0|||
94302008|NCT00809133|322888248|FG011|Overall Study|Other not mentioned above|0|||
94302009|NCT00809133|322888249|FG012|Overall Study|Other not mentioned above|0|||
94302010|NCT00809133|322888250|FG013|Overall Study|Other not mentioned above|0|||
94374690|NCT05288673|323156767|FG001|Overall Study|Consent withdrawn by subject|0|||
94374691|NCT05288673|323156768|FG002|Overall Study|Consent withdrawn by subject|1|||
94374692|NCT02868281|323156770|FG000|Overall Study|Adverse Event|2|||
94374693|NCT02868281|323156771|FG001|Overall Study|Adverse Event|2|||
94468230|NCT03170609|323503948|FG001|Overall Study|Death|0|||
94302011|NCT02317510|322888251|FG000|Overall Study|Adverse Event|0|||
94302012|NCT02317510|322888252|FG001|Overall Study|Adverse Event|1|||
94302013|NCT00472303|322888253|FG000|Titration Phase|Adverse Event|22|||
94302014|NCT00472303|322888254|FG001|Titration Phase|Adverse Event|12|||
94302015|NCT00472303|322888255|FG002|Titration Phase|Adverse Event|0|||
94302016|NCT00472303|322888253|FG000|Titration Phase|Death|4|||
94302017|NCT00472303|322888254|FG001|Titration Phase|Death|2|||
94302018|NCT00472303|322888255|FG002|Titration Phase|Death|0|||
94302019|NCT00472303|322888253|FG000|Titration Phase|Lack of Efficacy|10|||
94302020|NCT00472303|322888254|FG001|Titration Phase|Lack of Efficacy|0|||
94374694|NCT02868281|323156770|FG000|Overall Study|Protocol Violation|13|||
94302021|NCT00472303|322888255|FG002|Titration Phase|Lack of Efficacy|0|||
94302022|NCT00472303|322888253|FG000|Titration Phase|Withdrawal by Subject|16|||
94302023|NCT00472303|322888254|FG001|Titration Phase|Withdrawal by Subject|13|||
94302024|NCT00472303|322888255|FG002|Titration Phase|Withdrawal by Subject|0|||
94302025|NCT00472303|322888253|FG000|Titration Phase|Trial Medication non-compliant|4|||
94302026|NCT00472303|322888254|FG001|Titration Phase|Trial Medication non-compliant|1|||
94374695|NCT02868281|323156771|FG001|Overall Study|Protocol Violation|10|||
94374696|NCT02868281|323156770|FG000|Overall Study|Lost to Follow-up|3|||
94374697|NCT02868281|323156771|FG001|Overall Study|Lost to Follow-up|6|||
94374698|NCT02868281|323156770|FG000|Overall Study|Withdrawal by Subject|11|||
94374699|NCT02868281|323156771|FG001|Overall Study|Withdrawal by Subject|15|||
94374700|NCT02868281|323156770|FG000|Overall Study|Physician Decision|2|||
94374701|NCT02868281|323156771|FG001|Overall Study|Physician Decision|0|||
94374702|NCT02868281|323156770|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
94374703|NCT02868281|323156771|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
94374704|NCT02868281|323156770|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
94374705|NCT02868281|323156771|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
94374706|NCT02868281|323156770|FG000|Overall Study|Long journey/moving away|1|||
94374707|NCT02868281|323156771|FG001|Overall Study|Long journey/moving away|1|||
94374708|NCT01335464|323156772|FG000|Overall Study|Adverse Event|15|||
94374709|NCT01335464|323156773|FG001|Overall Study|Adverse Event|25|||
94374710|NCT01335464|323156772|FG000|Overall Study|Non compliant with protocol|2|||
94374711|NCT01335464|323156773|FG001|Overall Study|Non compliant with protocol|0|||
94374712|NCT01335464|323156772|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
94374713|NCT01335464|323156773|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
94374714|NCT01335464|323156772|FG000|Overall Study|Not treated|2|||
94374715|NCT01335464|323156773|FG001|Overall Study|Not treated|0|||
94374716|NCT01335464|323156772|FG000|Overall Study|Reason other than those stated above|1|||
94374717|NCT01335464|323156773|FG001|Overall Study|Reason other than those stated above|1|||
94374718|NCT03156270|323156774|FG000|Overall Study|Failed pre-treatment screening|1|||
94374719|NCT03156270|323156774|FG000|Overall Study|Lost to Follow-up|1|||
94374720|NCT00481247|323156775|FG000|Overall Study|Death|0|||
94374721|NCT00481247|323156776|FG001|Overall Study|Death|1|||
94302027|NCT00472303|322888255|FG002|Titration Phase|Trial Medication non-compliant|0|||
94302028|NCT00472303|322888253|FG000|Titration Phase|Other|3|||
94302029|NCT00472303|322888254|FG001|Titration Phase|Other|1|||
94302030|NCT00472303|322888255|FG002|Titration Phase|Other|0|||
94302031|NCT00472303|322888253|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
94374722|NCT00481247|323156775|FG000|Overall Study|Disease progression|18|||
94374723|NCT00481247|323156776|FG001|Overall Study|Disease progression|22|||
94374724|NCT00481247|323156775|FG000|Overall Study|Intolerance|42|||
94468231|NCT03170609|323503949|FG002|Overall Study|Death|1|||
94468232|NCT03170609|323503950|FG003|Overall Study|Death|0|||
94468233|NCT03170609|323503951|FG004|Overall Study|Death|0|||
94468234|NCT03170609|323503952|FG005|Overall Study|Death|0|||
94468235|NCT03170609|323503953|FG006|Overall Study|Death|0|||
94468236|NCT03170609|323503947|FG000|Overall Study|Withdrawal by Subject|1|||
94468237|NCT03170609|323503948|FG001|Overall Study|Withdrawal by Subject|2|||
94468238|NCT03170609|323503949|FG002|Overall Study|Withdrawal by Subject|0|||
94468239|NCT03170609|323503950|FG003|Overall Study|Withdrawal by Subject|0|||
94468240|NCT03170609|323503951|FG004|Overall Study|Withdrawal by Subject|0|||
94468241|NCT03170609|323503952|FG005|Overall Study|Withdrawal by Subject|0|||
94468242|NCT03170609|323503953|FG006|Overall Study|Withdrawal by Subject|1|||
94374725|NCT00481247|323156776|FG001|Overall Study|Intolerance|17|||
94374726|NCT00481247|323156775|FG000|Overall Study|Treatment failure|10|||
94374727|NCT00481247|323156776|FG001|Overall Study|Treatment failure|14|||
94374728|NCT00481247|323156775|FG000|Overall Study|AE unrelated to study drug|13|||
94374729|NCT00481247|323156776|FG001|Overall Study|AE unrelated to study drug|4|||
94374730|NCT00481247|323156775|FG000|Overall Study|Withdrawal by Subject|8|||
94374731|NCT00481247|323156776|FG001|Overall Study|Withdrawal by Subject|13|||
94374732|NCT00481247|323156775|FG000|Overall Study|Pregnancy|2|||
94374733|NCT00481247|323156776|FG001|Overall Study|Pregnancy|1|||
94374734|NCT00481247|323156775|FG000|Overall Study|Lost to Follow-up|1|||
94374735|NCT00481247|323156776|FG001|Overall Study|Lost to Follow-up|2|||
94374736|NCT00481247|323156775|FG000|Overall Study|Poor compliance/noncompliance|1|||
94374737|NCT00481247|323156776|FG001|Overall Study|Poor compliance/noncompliance|7|||
94374738|NCT00481247|323156775|FG000|Overall Study|Administrative reason by sponsor|157|||
94374739|NCT00481247|323156776|FG001|Overall Study|Administrative reason by sponsor|162|||
94374740|NCT00481247|323156775|FG000|Overall Study|Varied|6|||
94374741|NCT00481247|323156776|FG001|Overall Study|Varied|15|||
94374742|NCT00481247|323156775|FG000|Overall Study|Did not receive treatment|1|||
94374743|NCT00481247|323156776|FG001|Overall Study|Did not receive treatment|2|||
94374744|NCT00124449|323156777|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
94374745|NCT00124449|323156778|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
94374746|NCT00124449|323156777|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
94374747|NCT00124449|323156778|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
94374748|NCT00124449|323156777|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
94374749|NCT00124449|323156778|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
94374750|NCT00124449|323156777|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
94374751|NCT00124449|323156778|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
94374752|NCT00124449|323156777|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
94374753|NCT00124449|323156778|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
94374754|NCT00124449|323156777|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
94374755|NCT00124449|323156778|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
94374756|NCT00124449|323156777|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
94374757|NCT00124449|323156778|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
94374758|NCT00124449|323156777|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
94374759|NCT00124449|323156778|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
94374760|NCT00124449|323156777|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
94374761|NCT00124449|323156778|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
94374762|NCT00124449|323156777|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
94374763|NCT00124449|323156778|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
94374764|NCT00124449|323156777|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
94374765|NCT00124449|323156778|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
94374766|NCT00124449|323156777|FG000|18-Month Untreated Observation Period|Relocated|1|||
94468243|NCT03170609|323503947|FG000|Overall Study|Lost to Follow-up|1|||
94302032|NCT00472303|322888254|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
94374767|NCT00124449|323156778|FG001|18-Month Untreated Observation Period|Relocated|0|||
94374768|NCT01504867|323156782|FG000|Overall Study|Inclusion criteria not met|2|||
94468244|NCT03170609|323503948|FG001|Overall Study|Lost to Follow-up|0|||
94468245|NCT03170609|323503949|FG002|Overall Study|Lost to Follow-up|5|||
94468246|NCT03170609|323503950|FG003|Overall Study|Lost to Follow-up|2|||
94302033|NCT00472303|322888255|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
94302034|NCT00472303|322888253|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
94302035|NCT00472303|322888254|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
94468247|NCT03170609|323503951|FG004|Overall Study|Lost to Follow-up|1|||
94468248|NCT03170609|323503952|FG005|Overall Study|Lost to Follow-up|1|||
94468249|NCT03170609|323503953|FG006|Overall Study|Lost to Follow-up|0|||
94468250|NCT03170609|323503947|FG000|Overall Study|Other|1|||
94468251|NCT03170609|323503948|FG001|Overall Study|Other|0|||
94468252|NCT03170609|323503949|FG002|Overall Study|Other|0|||
94468253|NCT03170609|323503950|FG003|Overall Study|Other|0|||
94468254|NCT03170609|323503951|FG004|Overall Study|Other|0|||
94468255|NCT03170609|323503952|FG005|Overall Study|Other|1|||
94302036|NCT00472303|322888255|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
94302037|NCT00472303|322888253|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
94302038|NCT00472303|322888254|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
94302039|NCT00472303|322888255|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
94302040|NCT00472303|322888253|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
94302041|NCT00472303|322888254|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
94302042|NCT00472303|322888255|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
94302043|NCT00472303|322888253|FG000|Discontinuations After Titration Phase|Other|5|||
94302044|NCT00472303|322888254|FG001|Discontinuations After Titration Phase|Other|0|||
94302045|NCT00472303|322888255|FG002|Discontinuations After Titration Phase|Other|0|||
94302046|NCT00472303|322888253|FG000|Maintenance Phase|Adverse Event|5|||
94302047|NCT00472303|322888254|FG001|Maintenance Phase|Adverse Event|6|||
94302048|NCT00472303|322888255|FG002|Maintenance Phase|Adverse Event|6|||
94302049|NCT00472303|322888253|FG000|Maintenance Phase|Death|3|||
94302050|NCT00472303|322888254|FG001|Maintenance Phase|Death|0|||
94302051|NCT00472303|322888255|FG002|Maintenance Phase|Death|2|||
94302052|NCT00472303|322888253|FG000|Maintenance Phase|Lack of Efficacy|2|||
94302053|NCT00472303|322888254|FG001|Maintenance Phase|Lack of Efficacy|2|||
94302054|NCT00472303|322888255|FG002|Maintenance Phase|Lack of Efficacy|4|||
94302055|NCT00472303|322888253|FG000|Maintenance Phase|Withdrawal by Subject|6|||
94302056|NCT00472303|322888254|FG001|Maintenance Phase|Withdrawal by Subject|7|||
94302057|NCT00472303|322888255|FG002|Maintenance Phase|Withdrawal by Subject|3|||
94302058|NCT00472303|322888253|FG000|Maintenance Phase|Trial medication non-compliant|0|||
94302059|NCT00472303|322888254|FG001|Maintenance Phase|Trial medication non-compliant|0|||
94302060|NCT00472303|322888255|FG002|Maintenance Phase|Trial medication non-compliant|1|||
94302061|NCT00472303|322888253|FG000|Maintenance Phase|Resolution of pain|0|||
94302062|NCT00472303|322888254|FG001|Maintenance Phase|Resolution of pain|0|||
94302063|NCT00472303|322888255|FG002|Maintenance Phase|Resolution of pain|1|||
94468256|NCT03170609|323503953|FG006|Overall Study|Other|0|||
94468257|NCT03411902|323503956|FG000|Overall Study|Lost to Follow-up|3|||
94302064|NCT00472303|322888253|FG000|Maintenance Phase|Other|1|||
94302065|NCT00472303|322888254|FG001|Maintenance Phase|Other|1|||
94302066|NCT00472303|322888255|FG002|Maintenance Phase|Other|0|||
94302067|NCT03182738|322888256|FG000|Overall Study|Lost to Follow-up|9|||
94302068|NCT03182738|322888257|FG001|Overall Study|Lost to Follow-up|3|||
94302069|NCT03182738|322888256|FG000|Overall Study|Pregnancy|0|||
94302070|NCT03182738|322888257|FG001|Overall Study|Pregnancy|1|||
94302071|NCT03182738|322888256|FG000|Overall Study|Withdrawal by Subject|0|||
94302072|NCT03182738|322888257|FG001|Overall Study|Withdrawal by Subject|1|||
94302073|NCT00858832|322888258|FG000|Overall Study|became ineligible: delivered vaginally|1|||
94302074|NCT00858832|322888259|FG001|Overall Study|became ineligible: delivered vaginally|0|||
94302075|NCT00858832|322888258|FG000|Overall Study|Adverse Event|0|||
94302076|NCT00858832|322888259|FG001|Overall Study|Adverse Event|1|||
94302077|NCT00927485|322888265|FG000|Overall Study|Adverse Event|4|||
94302078|NCT00927485|322888266|FG001|Overall Study|Adverse Event|2|||
94302079|NCT00927485|322888265|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
94302080|NCT00927485|322888266|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
94302081|NCT00730236|322888267|FG000|Overall Study|Adverse Event|4|||
94302082|NCT00730236|322888267|FG000|Overall Study|Withdrawal by Subject|1|||
94302083|NCT00730236|322888267|FG000|Overall Study|Non-compliance|1|||
94302084|NCT01772134|322888268|FG000|Overall Study|Adverse Event|6|||
94302085|NCT01772134|322888269|FG001|Overall Study|Adverse Event|5|||
94302086|NCT01772134|322888270|FG002|Overall Study|Adverse Event|10|||
94302087|NCT01772134|322888268|FG000|Overall Study|Withdrew Consent|3|||
94302088|NCT01772134|322888269|FG001|Overall Study|Withdrew Consent|1|||
94302089|NCT01772134|322888270|FG002|Overall Study|Withdrew Consent|5|||
94302090|NCT01772134|322888268|FG000|Overall Study|Lost to Follow-up|2|||
94302091|NCT01772134|322888269|FG001|Overall Study|Lost to Follow-up|0|||
94302092|NCT01772134|322888270|FG002|Overall Study|Lost to Follow-up|0|||
94302093|NCT01772134|322888268|FG000|Overall Study|Protocol Deviation|4|||
94302094|NCT01772134|322888269|FG001|Overall Study|Protocol Deviation|3|||
94302095|NCT01772134|322888270|FG002|Overall Study|Protocol Deviation|3|||
94302096|NCT01772134|322888268|FG000|Overall Study|Lack of Efficacy|11|||
94302097|NCT01772134|322888269|FG001|Overall Study|Lack of Efficacy|5|||
94302098|NCT01772134|322888270|FG002|Overall Study|Lack of Efficacy|3|||
94302099|NCT01772134|322888268|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
94302100|NCT01772134|322888269|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
94302101|NCT01772134|322888270|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
94302102|NCT01772134|322888268|FG000|Overall Study|Randomized Study Medication Not Received|2|||
94302103|NCT01772134|322888269|FG001|Overall Study|Randomized Study Medication Not Received|0|||
94302104|NCT01772134|322888270|FG002|Overall Study|Randomized Study Medication Not Received|1|||
94302105|NCT03486314|322888275|FG000|Part A|Adverse Event|1|||
94302106|NCT03486314|322888276|FG001|Part A|Adverse Event|0|||
94302107|NCT03486314|322888277|FG002|Part A|Adverse Event|0|||
94302108|NCT03486314|322888275|FG000|Part A|Symptomatic Deterioration|2|||
94302109|NCT03486314|322888276|FG001|Part A|Symptomatic Deterioration|0|||
94302110|NCT03486314|322888277|FG002|Part A|Symptomatic Deterioration|0|||
94302111|NCT00327444|322888278|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
94302112|NCT00327444|322888279|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
94302113|NCT00327444|322888278|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
94302114|NCT00327444|322888279|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
94302115|NCT00327444|322888278|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
94302116|NCT00327444|322888279|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
94302117|NCT00327444|322888278|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
94302118|NCT00327444|322888279|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
94302119|NCT00327444|322888278|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
94302120|NCT00327444|322888279|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
94302121|NCT00327444|322888278|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
94302122|NCT00327444|322888279|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
94302123|NCT00327444|322888278|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
94302124|NCT00327444|322888279|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
94302125|NCT00327444|322888278|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
94302126|NCT00327444|322888279|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
94302127|NCT01440101|322888280|FG000|Overall Study|Adverse Event|2|||
94302128|NCT01440101|322888281|FG001|Overall Study|Adverse Event|0|||
94302129|NCT01440101|322888282|FG002|Overall Study|Adverse Event|0|||
94302130|NCT01440101|322888280|FG000|Overall Study|Withdrawal by Subject|0|||
94302131|NCT01440101|322888281|FG001|Overall Study|Withdrawal by Subject|3|||
94374769|NCT01504867|323156783|FG001|Overall Study|Inclusion criteria not met|2|||
94374770|NCT01504867|323156782|FG000|Overall Study|Consent revoked|5|||
94374771|NCT01504867|323156783|FG001|Overall Study|Consent revoked|1|||
94374772|NCT00571922|323156784|FG000|Overall Study|Completion unknown|36|||
94374773|NCT00571922|323156785|FG001|Overall Study|Completion unknown|36|||
94374774|NCT01841359|323156787|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
94374775|NCT01841359|323156787|FG000|Overall Study|Concommitant medical issues|2|||
94374776|NCT01841359|323156787|FG000|Overall Study|Adverse Event|3|||
94374777|NCT01841359|323156787|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
94374778|NCT02533999|323156788|FG000|Overall Study|Lost to Follow-up|3|||
94374779|NCT02533999|323156789|FG001|Overall Study|Lost to Follow-up|5|||
94374780|NCT02533999|323156788|FG000|Overall Study|Protocol Violation|3|||
94374781|NCT02533999|323156789|FG001|Overall Study|Protocol Violation|0|||
94374782|NCT02533999|323156788|FG000|Overall Study|Adverse Event|0|||
94374783|NCT02533999|323156789|FG001|Overall Study|Adverse Event|1|||
94374784|NCT02533999|323156788|FG000|Overall Study|Randomized but intervention not received|0|||
94374785|NCT02533999|323156789|FG001|Overall Study|Randomized but intervention not received|1|||
94374786|NCT00254397|323156792|FG000|Overall Study|Disease Progression|4|||
94374787|NCT00254397|323156793|FG001|Overall Study|Disease Progression|1|||
94374788|NCT00254397|323156794|FG002|Overall Study|Disease Progression|16|||
94374789|NCT00254397|323156795|FG003|Overall Study|Disease Progression|23|||
94374790|NCT00254397|323156792|FG000|Overall Study|Non-Compliant|0|||
94374791|NCT00254397|323156793|FG001|Overall Study|Non-Compliant|0|||
94374792|NCT00254397|323156794|FG002|Overall Study|Non-Compliant|0|||
94374793|NCT00254397|323156795|FG003|Overall Study|Non-Compliant|1|||
94374794|NCT00254397|323156792|FG000|Overall Study|Adverse Event|2|||
94374795|NCT00254397|323156793|FG001|Overall Study|Adverse Event|0|||
94374796|NCT00254397|323156794|FG002|Overall Study|Adverse Event|3|||
94374797|NCT00254397|323156795|FG003|Overall Study|Adverse Event|1|||
94374798|NCT01588106|323156797|FG000|Overall Study|Withdrawal by Subject|5|||
94374799|NCT01588106|323156798|FG001|Overall Study|Withdrawal by Subject|4|||
94374800|NCT03083132|323156799|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
94374801|NCT03083132|323156800|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
94374802|NCT03083132|323156799|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
94374803|NCT03083132|323156800|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
94374804|NCT03083132|323156799|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
94374805|NCT03083132|323156800|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
94374806|NCT04317053|323156803|FG000|Overall Study|Withdrawn (screen failure)|4|||
94374807|NCT04317053|323156804|FG001|Overall Study|Withdrawn (screen failure)|2|||
94374808|NCT01077713|323156805|FG000|Overall Study|Withdrawal by Subject|1|||
94374809|NCT01077713|323156806|FG001|Overall Study|Withdrawal by Subject|2|||
94374810|NCT01077713|323156805|FG000|Overall Study|Progressive Disease (PD)|0|||
94374811|NCT01077713|323156806|FG001|Overall Study|Progressive Disease (PD)|1|||
94374812|NCT01077713|323156805|FG000|Overall Study|Death|28|||
94374813|NCT01077713|323156806|FG001|Overall Study|Death|29|||
94374814|NCT01077713|323156805|FG000|Overall Study|Lost to Follow-up|1|||
94374815|NCT01077713|323156806|FG001|Overall Study|Lost to Follow-up|1|||
94374816|NCT01077713|323156805|FG000|Overall Study|Adverse Event|2|||
94374817|NCT01077713|323156806|FG001|Overall Study|Adverse Event|1|||
94374818|NCT01077713|323156805|FG000|Overall Study|Other|4|||
94374819|NCT01077713|323156806|FG001|Overall Study|Other|2|||
94374820|NCT03372083|323158645|FG000|Overall Study|Adverse Event|3|||
94374821|NCT03372083|323158645|FG000|Overall Study|Physician Decision|1|||
94374822|NCT03372083|323158645|FG000|Overall Study|Withdrawal by Subject|1|||
94374823|NCT01677910|323158646|FG000|Double-Blind Treatment Period|Adverse Event|6|||
94374824|NCT01677910|323158647|FG001|Double-Blind Treatment Period|Adverse Event|2|||
94374825|NCT01677910|323158648|FG002|Double-Blind Treatment Period|Adverse Event|3|||
94374826|NCT01677910|323158649|FG003|Double-Blind Treatment Period|Adverse Event|0|||
94374827|NCT01677910|323158646|FG000|Double-Blind Treatment Period|Physician Decision|0|||
94374828|NCT01677910|323158647|FG001|Double-Blind Treatment Period|Physician Decision|0|||
94374829|NCT01677910|323158648|FG002|Double-Blind Treatment Period|Physician Decision|1|||
94374830|NCT01677910|323158649|FG003|Double-Blind Treatment Period|Physician Decision|0|||
94374831|NCT01677910|323158646|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
94374832|NCT01677910|323158647|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
94374833|NCT01677910|323158648|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
94374834|NCT01677910|323158649|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
94374835|NCT01677910|323158646|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
94374836|NCT01677910|323158647|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
94374837|NCT01677910|323158648|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
94374838|NCT01677910|323158649|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
94374839|NCT01677910|323158646|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
94374840|NCT01677910|323158647|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
94374841|NCT01677910|323158648|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
94374842|NCT01677910|323158649|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
94374843|NCT01677910|323158646|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
94374844|NCT01677910|323158647|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
94468258|NCT03411902|323503957|FG001|Overall Study|Lost to Follow-up|0|||
94302132|NCT01440101|322888282|FG002|Overall Study|Withdrawal by Subject|1|||
94302133|NCT01440101|322888280|FG000|Overall Study|Other|0|||
94302134|NCT01440101|322888281|FG001|Overall Study|Other|1|||
94302135|NCT01440101|322888282|FG002|Overall Study|Other|0|||
94302136|NCT03826914|322888284|FG000|Overall Study|Withdrawal by Subject|1|||
94302137|NCT03826914|322888285|FG001|Overall Study|Withdrawal by Subject|1|||
94302138|NCT03228186|322888288|FG000|Overall Study|Patient never started treatment|1|||
94302139|NCT04246047|322888290|FG000|Overall Study|Death|50|||
94302140|NCT04246047|322888291|FG001|Overall Study|Death|77|||
94302141|NCT04246047|322888290|FG000|Overall Study|Lost to Follow-up|1|||
94302142|NCT04246047|322888291|FG001|Overall Study|Lost to Follow-up|3|||
94302143|NCT04246047|322888290|FG000|Overall Study|Physician Decision|4|||
94302144|NCT04246047|322888291|FG001|Overall Study|Physician Decision|10|||
94302145|NCT04246047|322888290|FG000|Overall Study|Withdrawal by Subject|19|||
94302146|NCT04246047|322888291|FG001|Overall Study|Withdrawal by Subject|26|||
94302147|NCT04246047|322888290|FG000|Overall Study|Ongoing|169|||
94302148|NCT04246047|322888291|FG001|Overall Study|Ongoing|135|||
94302149|NCT02604264|322888292|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
94302150|NCT02604264|322888293|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
94302151|NCT00552110|322888294|FG000|Overall Study|Serious or Life-Threatening AE|0|||
94302152|NCT00552110|322888295|FG001|Overall Study|Serious or Life-Threatening AE|0|||
94302153|NCT00552110|322888296|FG002|Overall Study|Serious or Life-Threatening AE|1|||
94302154|NCT00552110|322888297|FG003|Overall Study|Serious or Life-Threatening AE|0|||
94302155|NCT00552110|322888298|FG004|Overall Study|Serious or Life-Threatening AE|0|||
94302156|NCT00552110|322888294|FG000|Overall Study|Lack of Efficacy|1|||
94302157|NCT00552110|322888295|FG001|Overall Study|Lack of Efficacy|0|||
94302158|NCT00552110|322888296|FG002|Overall Study|Lack of Efficacy|0|||
94302159|NCT00552110|322888297|FG003|Overall Study|Lack of Efficacy|1|||
94302160|NCT00552110|322888298|FG004|Overall Study|Lack of Efficacy|4|||
94302161|NCT00552110|322888294|FG000|Overall Study|Withdrawal by Subject|0|||
94302162|NCT00552110|322888295|FG001|Overall Study|Withdrawal by Subject|2|||
94302163|NCT00552110|322888296|FG002|Overall Study|Withdrawal by Subject|0|||
94302164|NCT00552110|322888297|FG003|Overall Study|Withdrawal by Subject|3|||
94302165|NCT00552110|322888298|FG004|Overall Study|Withdrawal by Subject|2|||
94302166|NCT00552110|322888294|FG000|Overall Study|Lost to Follow-up|0|||
94302167|NCT00552110|322888295|FG001|Overall Study|Lost to Follow-up|0|||
94302168|NCT00552110|322888296|FG002|Overall Study|Lost to Follow-up|0|||
94302169|NCT00552110|322888297|FG003|Overall Study|Lost to Follow-up|1|||
94302170|NCT00552110|322888298|FG004|Overall Study|Lost to Follow-up|1|||
94302171|NCT00552110|322888294|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
94302172|NCT00552110|322888295|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
94302173|NCT00552110|322888296|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
94302174|NCT00552110|322888297|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
94302175|NCT00552110|322888298|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
94302176|NCT00552110|322888294|FG000|Overall Study|Withdrawn per Sponsor|0|||
94302177|NCT00552110|322888295|FG001|Overall Study|Withdrawn per Sponsor|1|||
94302178|NCT00552110|322888296|FG002|Overall Study|Withdrawn per Sponsor|0|||
94302179|NCT00552110|322888297|FG003|Overall Study|Withdrawn per Sponsor|0|||
94302180|NCT00552110|322888298|FG004|Overall Study|Withdrawn per Sponsor|1|||
94302181|NCT00552110|322888294|FG000|Overall Study|Use of Prohibited Medication|1|||
94302182|NCT00552110|322888295|FG001|Overall Study|Use of Prohibited Medication|1|||
94302183|NCT00552110|322888296|FG002|Overall Study|Use of Prohibited Medication|0|||
94302184|NCT00552110|322888297|FG003|Overall Study|Use of Prohibited Medication|0|||
94302185|NCT00552110|322888298|FG004|Overall Study|Use of Prohibited Medication|0|||
94302186|NCT00552110|322888294|FG000|Overall Study|Delay of Study due to Relabeling|0|||
94302187|NCT00552110|322888295|FG001|Overall Study|Delay of Study due to Relabeling|0|||
94302188|NCT00552110|322888296|FG002|Overall Study|Delay of Study due to Relabeling|0|||
94302189|NCT00552110|322888297|FG003|Overall Study|Delay of Study due to Relabeling|1|||
94302190|NCT00552110|322888298|FG004|Overall Study|Delay of Study due to Relabeling|0|||
94302191|NCT00552110|322888294|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
94302192|NCT00552110|322888295|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
94302193|NCT00552110|322888296|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
94302194|NCT00552110|322888297|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
94302195|NCT00552110|322888298|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
94302196|NCT00552110|322888294|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
94302197|NCT00552110|322888295|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
94302198|NCT00552110|322888296|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
94302199|NCT00552110|322888297|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
94302200|NCT00552110|322888298|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
94302201|NCT05139030|322888299|FG000|Overall Study|Withdrawal by Subject|1|||
94302202|NCT05139030|322888300|FG001|Overall Study|Withdrawal by Subject|3|||
94302203|NCT05139030|322888299|FG000|Overall Study|Adverse Event|0|||
94302204|NCT05139030|322888300|FG001|Overall Study|Adverse Event|1|||
94302205|NCT05139030|322888299|FG000|Overall Study|Failure to meet continuation criteria|0|||
94302206|NCT05139030|322888300|FG001|Overall Study|Failure to meet continuation criteria|1|||
94302207|NCT04003610|322888301|FG000|Overall Study|Lost to Follow-up|0|||
94302208|NCT04003610|322888302|FG001|Overall Study|Lost to Follow-up|1|||
94302209|NCT04003610|322888303|FG002|Overall Study|Lost to Follow-up|0|||
94302210|NCT04003610|322888301|FG000|Overall Study|Death|0|||
94302211|NCT04003610|322888302|FG001|Overall Study|Death|0|||
94302212|NCT04003610|322888303|FG002|Overall Study|Death|3|||
94302213|NCT04003610|322888301|FG000|Overall Study|Study Terminated by Sponsor|0|||
94302214|NCT04003610|322888302|FG001|Overall Study|Study Terminated by Sponsor|0|||
94302215|NCT04003610|322888303|FG002|Overall Study|Study Terminated by Sponsor|3|||
94302216|NCT01023789|322888304|FG000|3 - Year Visit|Death|29|||
94302217|NCT01023789|322888304|FG000|3 - Year Visit|Withdrawal of consent|1|||
94302218|NCT01023789|322888304|FG000|3 - Year Visit|Lost to Follow-up|13|||
94302219|NCT02034123|322888310|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
94302220|NCT02034123|322888311|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
94302221|NCT02034123|322888312|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
94302222|NCT02034123|322888313|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
94302223|NCT02034123|322888314|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
94302224|NCT02034123|322888315|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
94302225|NCT02034123|322888316|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
94302226|NCT02034123|322888317|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
94302227|NCT02034123|322888318|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
94302228|NCT02034123|322888319|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
94302229|NCT02034123|322888320|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
94302230|NCT02034123|322888321|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
94302231|NCT02034123|322888322|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
94302232|NCT02034123|322888323|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
94302233|NCT02034123|322888324|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
94302234|NCT02034123|322888325|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
94302235|NCT02034123|322888326|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
94302236|NCT02034123|322888327|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
94302237|NCT02034123|322888310|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
94302238|NCT02034123|322888311|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
94302239|NCT02034123|322888312|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
94302240|NCT02034123|322888313|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
94302241|NCT02034123|322888314|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
94302242|NCT02034123|322888315|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
94302243|NCT02034123|322888316|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
94302244|NCT02034123|322888317|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
94302245|NCT02034123|322888318|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
94302246|NCT02034123|322888319|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
94302247|NCT02034123|322888320|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
94302248|NCT02034123|322888321|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
94302249|NCT02034123|322888322|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
94302250|NCT02034123|322888323|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
94302251|NCT02034123|322888324|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
94302252|NCT02034123|322888325|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
94302253|NCT02034123|322888326|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
94302254|NCT02034123|322888327|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
94302255|NCT02034123|322888310|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
94302256|NCT02034123|322888311|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
94302257|NCT02034123|322888312|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
94302258|NCT02034123|322888313|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
94302259|NCT02034123|322888314|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
94302260|NCT02034123|322888315|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
94302261|NCT02034123|322888316|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
94302262|NCT02034123|322888317|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
94302263|NCT02034123|322888318|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
94302264|NCT02034123|322888319|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
94302265|NCT02034123|322888320|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
94302266|NCT02034123|322888321|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
94302267|NCT02034123|322888322|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
94302268|NCT02034123|322888323|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
94302269|NCT02034123|322888324|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
94302270|NCT02034123|322888325|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
94302271|NCT02034123|322888326|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
94374845|NCT01677910|323158648|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
94374846|NCT01677910|323158649|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
94374847|NCT01677910|323158646|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
94374848|NCT01677910|323158647|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
94374849|NCT01677910|323158648|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
94374850|NCT01677910|323158649|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
94374851|NCT01677910|323158646|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
94374852|NCT01677910|323158647|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
94374853|NCT01677910|323158648|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
94374854|NCT01677910|323158649|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
94374855|NCT01677910|323158646|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
94374856|NCT01677910|323158647|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
94374857|NCT01677910|323158648|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
94374858|NCT01677910|323158649|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
94374859|NCT01677910|323158646|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
94374860|NCT01677910|323158647|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
94374861|NCT01677910|323158648|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
94374862|NCT01677910|323158649|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
94374863|NCT00606684|323158650|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
94374864|NCT00606684|323158651|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
94374865|NCT00606684|323158652|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
94374866|NCT00606684|323158653|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
94374867|NCT00606684|323158654|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
94374868|NCT00606684|323158655|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
94374869|NCT00606684|323158656|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
94374870|NCT00606684|323158650|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
94374871|NCT00606684|323158651|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
94374872|NCT00606684|323158652|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
94374873|NCT00606684|323158653|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
94374874|NCT00606684|323158654|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
94374875|NCT00606684|323158655|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
94374876|NCT00606684|323158656|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
94374877|NCT00606684|323158650|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
94374878|NCT00606684|323158651|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
94374879|NCT00606684|323158652|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
94374880|NCT00606684|323158653|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
94374881|NCT00606684|323158654|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
94374882|NCT00606684|323158655|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
94374883|NCT00606684|323158656|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
94374884|NCT00606684|323158650|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
94374885|NCT00606684|323158651|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
94374886|NCT00606684|323158652|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
94374887|NCT00606684|323158653|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
94374888|NCT00606684|323158654|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
94374889|NCT00606684|323158655|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
94374890|NCT00606684|323158656|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
94374891|NCT00606684|323158650|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
94374892|NCT00606684|323158651|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
94374893|NCT00606684|323158652|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
94374894|NCT00606684|323158653|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
94374895|NCT00606684|323158654|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
94374896|NCT00606684|323158655|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
94374897|NCT00606684|323158656|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
94374898|NCT00606684|323158650|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
94374899|NCT00606684|323158651|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
94374900|NCT00606684|323158652|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
94374901|NCT00606684|323158653|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
94374902|NCT00606684|323158654|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
94374903|NCT00606684|323158655|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
94374904|NCT00606684|323158656|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
94374905|NCT00606684|323158650|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
94374906|NCT00606684|323158651|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
94302272|NCT02034123|322888327|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
94302273|NCT02034123|322888310|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
94302274|NCT02034123|322888311|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
94302275|NCT02034123|322888312|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
94302276|NCT02034123|322888313|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
94302277|NCT02034123|322888314|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
94302278|NCT02034123|322888315|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
94302279|NCT02034123|322888316|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
94302280|NCT02034123|322888317|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
94302281|NCT02034123|322888318|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
94302282|NCT02034123|322888319|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
94302283|NCT02034123|322888320|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
94302284|NCT02034123|322888321|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
94302285|NCT02034123|322888322|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
94302286|NCT02034123|322888323|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
94302287|NCT02034123|322888324|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
94302288|NCT02034123|322888325|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
94302289|NCT02034123|322888326|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
94302290|NCT02034123|322888327|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
94302291|NCT03517436|322888328|FG000|Overall Study|Death|3|||
94302292|NCT03517436|322888328|FG000|Overall Study|Withdrawal by Subject|4|||
94302293|NCT03517436|322888328|FG000|Overall Study|Did not receive study valve.|1|||
94302294|NCT02698189|322888329|FG000|Overall Study|Physician Decision|3|||
94302295|NCT02698189|322888330|FG001|Overall Study|Physician Decision|0|||
94302296|NCT02698189|322888329|FG000|Overall Study|Progressive disease|0|||
94302297|NCT02698189|322888330|FG001|Overall Study|Progressive disease|5|||
94302298|NCT02698189|322888329|FG000|Overall Study|Study terminated by sponsor|0|||
94302299|NCT02698189|322888330|FG001|Overall Study|Study terminated by sponsor|1|||
94302300|NCT05502289|322888333|FG000|Period 1|Out Of Window|1|||
94302301|NCT05502289|322888334|FG001|Period 1|Out Of Window|0|||
94302302|NCT02333227|322888335|FG000|Overall Study|Lost to Follow-up|137|||
94302303|NCT02333227|322888336|FG001|Overall Study|Lost to Follow-up|106|||
94302304|NCT02333227|322888335|FG000|Overall Study|Pregnancy Interrupted|42|||
94302305|NCT02333227|322888336|FG001|Overall Study|Pregnancy Interrupted|89|||
94302306|NCT02333227|322888335|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
94302307|NCT02333227|322888336|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
94302308|NCT01076179|322888337|FG000|Overall Study|Withdrawal by Subject|1|||
94302309|NCT01650805|322888341|FG000|Overall Study|Withdrawal by Subject|1|||
94302310|NCT01650805|322888342|FG001|Overall Study|Withdrawal by Subject|0|||
94302311|NCT03019549|322890278|FG000|Washout|DId not meet genotype criteria|11|||
94302312|NCT03019549|322890278|FG000|Period 2|Adverse Event|2|||
94302313|NCT03019549|322890278|FG000|Period 2|Physician Decision|2|||
94302314|NCT03019549|322890278|FG000|Period 2|Withdrawal by Subject|1|||
94302315|NCT03528681|322890291|FG000|Open-Label Phase|Physician Decision|2|||
94302316|NCT03528681|322890292|FG001|Open-Label Phase|Physician Decision|0|||
94302317|NCT03528681|322890293|FG002|Open-Label Phase|Physician Decision|0|||
94302318|NCT03528681|322890294|FG003|Open-Label Phase|Physician Decision|0|||
94302319|NCT03528681|322890291|FG000|Open-Label Phase|Withdrawal by Subject|8|||
94302320|NCT03528681|322890292|FG001|Open-Label Phase|Withdrawal by Subject|0|||
94302321|NCT03528681|322890293|FG002|Open-Label Phase|Withdrawal by Subject|0|||
94302322|NCT03528681|322890294|FG003|Open-Label Phase|Withdrawal by Subject|0|||
94302323|NCT03528681|322890291|FG000|Open-Label Phase|(Not collected)|4|||
94302324|NCT03528681|322890292|FG001|Open-Label Phase|(Not collected)|0|||
94302325|NCT03528681|322890293|FG002|Open-Label Phase|(Not collected)|0|||
94302326|NCT03528681|322890294|FG003|Open-Label Phase|(Not collected)|0|||
94302327|NCT03528681|322890291|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
94302328|NCT03528681|322890292|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
94302329|NCT03528681|322890293|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
94302330|NCT03528681|322890294|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
94302331|NCT03528681|322890291|FG000|Randomized Treatment Phase|Physician Decision|0|||
94302332|NCT03528681|322890292|FG001|Randomized Treatment Phase|Physician Decision|5|||
94302333|NCT03528681|322890293|FG002|Randomized Treatment Phase|Physician Decision|1|||
94302334|NCT03528681|322890294|FG003|Randomized Treatment Phase|Physician Decision|2|||
94302335|NCT03528681|322890291|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
94302336|NCT03528681|322890292|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
94302337|NCT03528681|322890293|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
94302338|NCT03528681|322890294|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
94302339|NCT03528681|322890291|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
94302340|NCT03528681|322890292|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
94302341|NCT03528681|322890293|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
94302342|NCT03528681|322890294|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
94302343|NCT03528681|322890291|FG000|Randomized Treatment Phase|(Not collected)|0|||
94302344|NCT03528681|322890292|FG001|Randomized Treatment Phase|(Not collected)|4|||
94302345|NCT03528681|322890293|FG002|Randomized Treatment Phase|(Not collected)|6|||
94302346|NCT03528681|322890294|FG003|Randomized Treatment Phase|(Not collected)|5|||
94302347|NCT02243176|322890295|FG000|Overall Study|Other reason|1|||
94302348|NCT02243176|322890296|FG001|Overall Study|Other reason|2|||
94302349|NCT02243176|322890295|FG000|Overall Study|protocol specified withdrawal critera|1|||
94302350|NCT02243176|322890296|FG001|Overall Study|protocol specified withdrawal critera|3|||
94302351|NCT02243176|322890295|FG000|Overall Study|Protocol Violation|2|||
94302352|NCT02243176|322890296|FG001|Overall Study|Protocol Violation|1|||
94302353|NCT02243176|322890295|FG000|Overall Study|Withdrawal by Subject|8|||
94374907|NCT00606684|323158652|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
94374908|NCT00606684|323158653|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
94374909|NCT00606684|323158654|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
94374910|NCT00606684|323158655|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
94374911|NCT00606684|323158656|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
94374912|NCT00606684|323158650|FG000|Double-Blind Treatment Period|Adverse Event|0|||
94374913|NCT00606684|323158651|FG001|Double-Blind Treatment Period|Adverse Event|3|||
94374914|NCT00606684|323158652|FG002|Double-Blind Treatment Period|Adverse Event|2|||
94374915|NCT00606684|323158653|FG003|Double-Blind Treatment Period|Adverse Event|4|||
94374916|NCT00606684|323158654|FG004|Double-Blind Treatment Period|Adverse Event|2|||
94374917|NCT00606684|323158655|FG005|Double-Blind Treatment Period|Adverse Event|0|||
94374918|NCT00606684|323158656|FG006|Double-Blind Treatment Period|Adverse Event|1|||
94374919|NCT00606684|323158650|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
94374920|NCT00606684|323158651|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
94374921|NCT00606684|323158652|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
94374922|NCT00606684|323158653|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
94374923|NCT00606684|323158654|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
94374924|NCT00606684|323158655|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
94374925|NCT00606684|323158656|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
94374926|NCT00606684|323158650|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
94374927|NCT00606684|323158651|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
94374928|NCT00606684|323158652|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
94374929|NCT00606684|323158653|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
94374930|NCT00606684|323158654|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
94374931|NCT00606684|323158655|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
94374932|NCT00606684|323158656|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
94374933|NCT00606684|323158650|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
94374934|NCT00606684|323158651|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
94374935|NCT00606684|323158652|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
94374936|NCT00606684|323158653|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
94374937|NCT00606684|323158654|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
94374938|NCT00606684|323158655|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
94374939|NCT00606684|323158656|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
94374940|NCT00606684|323158650|FG000|Double-Blind Treatment Period|Physician Decision|0|||
94374941|NCT00606684|323158651|FG001|Double-Blind Treatment Period|Physician Decision|5|||
94374942|NCT00606684|323158652|FG002|Double-Blind Treatment Period|Physician Decision|1|||
94374943|NCT00606684|323158653|FG003|Double-Blind Treatment Period|Physician Decision|0|||
94374944|NCT00606684|323158654|FG004|Double-Blind Treatment Period|Physician Decision|3|||
94374945|NCT00606684|323158655|FG005|Double-Blind Treatment Period|Physician Decision|1|||
94374946|NCT00606684|323158656|FG006|Double-Blind Treatment Period|Physician Decision|2|||
94374947|NCT00606684|323158650|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
94374948|NCT00606684|323158651|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
94374949|NCT00606684|323158652|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
94374950|NCT00606684|323158653|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
94374951|NCT00606684|323158654|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
94374952|NCT00606684|323158655|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
94374953|NCT00606684|323158656|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
94374954|NCT01368276|323158668|FG000|Overall Study|Death|1|||
94374955|NCT01368276|323158669|FG001|Overall Study|Death|10|||
94302354|NCT02243176|322890296|FG001|Overall Study|Withdrawal by Subject|7|||
94302355|NCT02243176|322890295|FG000|Overall Study|Adverse Event|2|||
94374956|NCT00685919|323158670|FG000|Overall Study|Withdrawal by Subject|0|||
94374957|NCT00685919|323158671|FG001|Overall Study|Withdrawal by Subject|0|||
94302356|NCT02243176|322890296|FG001|Overall Study|Adverse Event|2|||
94302357|NCT00886821|322890297|FG000|Stage 2|Adverse Event|0|||
94302358|NCT00886821|322890298|FG001|Stage 2|Adverse Event|0|||
94302359|NCT00886821|322890299|FG002|Stage 2|Adverse Event|0|||
94302360|NCT00886821|322890300|FG003|Stage 2|Adverse Event|0|||
94302361|NCT00886821|322890301|FG004|Stage 2|Adverse Event|0|||
94302362|NCT00886821|322890302|FG005|Stage 2|Adverse Event|0|||
94302363|NCT00886821|322890303|FG006|Stage 2|Adverse Event|0|||
94302364|NCT00886821|322890304|FG007|Stage 2|Adverse Event|0|||
94302365|NCT00886821|322890305|FG008|Stage 2|Adverse Event|0|||
94302366|NCT00886821|322890306|FG009|Stage 2|Adverse Event|0|||
94302367|NCT00886821|322890307|FG010|Stage 2|Adverse Event|0|||
94302368|NCT00886821|322890308|FG011|Stage 2|Adverse Event|1|||
94302369|NCT00886821|322890309|FG012|Stage 2|Adverse Event|3|||
94302370|NCT00886821|322890310|FG013|Stage 2|Adverse Event|0|||
94302371|NCT00886821|322890297|FG000|Stage 2|Lost to Follow-up|0|||
94302372|NCT00886821|322890298|FG001|Stage 2|Lost to Follow-up|0|||
94302373|NCT00886821|322890299|FG002|Stage 2|Lost to Follow-up|0|||
94302374|NCT00886821|322890300|FG003|Stage 2|Lost to Follow-up|0|||
94302375|NCT00886821|322890301|FG004|Stage 2|Lost to Follow-up|0|||
94302376|NCT00886821|322890302|FG005|Stage 2|Lost to Follow-up|0|||
94302377|NCT00886821|322890303|FG006|Stage 2|Lost to Follow-up|0|||
94302378|NCT00886821|322890304|FG007|Stage 2|Lost to Follow-up|0|||
94302379|NCT00886821|322890305|FG008|Stage 2|Lost to Follow-up|0|||
94302380|NCT00886821|322890306|FG009|Stage 2|Lost to Follow-up|0|||
94302381|NCT00886821|322890307|FG010|Stage 2|Lost to Follow-up|0|||
94302382|NCT00886821|322890308|FG011|Stage 2|Lost to Follow-up|0|||
94302383|NCT00886821|322890309|FG012|Stage 2|Lost to Follow-up|2|||
94302384|NCT00886821|322890310|FG013|Stage 2|Lost to Follow-up|1|||
94302385|NCT02660580|322890311|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
94302386|NCT02660580|322890312|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
94302387|NCT02660580|322890313|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
94302388|NCT02660580|322890314|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
94302389|NCT02660580|322890315|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
94302390|NCT02660580|322890311|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
94302391|NCT02660580|322890312|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
94302392|NCT02660580|322890313|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
94302393|NCT02660580|322890314|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
94302394|NCT02660580|322890315|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
94302395|NCT02660580|322890311|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
94302396|NCT02660580|322890312|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
94302397|NCT02660580|322890313|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
94302398|NCT02660580|322890314|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
94302399|NCT02660580|322890315|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
94302400|NCT02660580|322890311|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
94302401|NCT02660580|322890312|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
94302402|NCT02660580|322890313|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
94302403|NCT02660580|322890314|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
94302404|NCT02660580|322890315|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
94302405|NCT02660580|322890311|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
94302406|NCT02660580|322890312|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
94302407|NCT02660580|322890313|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
94302408|NCT02660580|322890314|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
94302409|NCT02660580|322890315|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
94302410|NCT02660580|322890311|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
94302411|NCT02660580|322890312|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
94302412|NCT02660580|322890313|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
94302413|NCT02660580|322890314|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
94302414|NCT02660580|322890315|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
94302415|NCT02660580|322890311|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
94302416|NCT02660580|322890312|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
94302417|NCT02660580|322890313|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
94302418|NCT02660580|322890314|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
94302419|NCT02660580|322890315|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
94302420|NCT02660580|322890311|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
94302421|NCT02660580|322890312|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
94302422|NCT02660580|322890313|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
94302423|NCT02660580|322890314|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
94302424|NCT02660580|322890315|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
94302425|NCT02660580|322890311|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
94302426|NCT02660580|322890312|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
94302427|NCT02660580|322890313|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
94302428|NCT02660580|322890314|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
94302429|NCT02660580|322890315|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
94302430|NCT02660580|322890311|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
94302431|NCT02660580|322890312|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
94302432|NCT02660580|322890313|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
94302433|NCT02660580|322890314|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
94302434|NCT02660580|322890315|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
94302435|NCT02660580|322890311|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
94302436|NCT02660580|322890312|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
94302437|NCT02660580|322890313|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
94302438|NCT02660580|322890314|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
94302439|NCT02660580|322890315|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
94302440|NCT02660580|322890311|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
94302441|NCT02660580|322890312|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
94302442|NCT02660580|322890313|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
94302443|NCT02660580|322890314|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
94302444|NCT02660580|322890315|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
94302445|NCT02660580|322890311|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
94302446|NCT02660580|322890312|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
94302447|NCT02660580|322890313|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
94302448|NCT02660580|322890314|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
94302449|NCT02660580|322890315|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
94302450|NCT00469079|322890317|FG000|Overall Study|Lack of Efficacy|3|||
94302451|NCT00469079|322890318|FG001|Overall Study|Lack of Efficacy|8|||
94302452|NCT00469079|322890319|FG002|Overall Study|Lack of Efficacy|5|||
94302453|NCT00469079|322890317|FG000|Overall Study|Adverse Event|1|||
94302454|NCT00469079|322890318|FG001|Overall Study|Adverse Event|3|||
94302455|NCT00469079|322890319|FG002|Overall Study|Adverse Event|2|||
94302456|NCT00469079|322890317|FG000|Overall Study|Lost to Follow-up|4|||
94302457|NCT00469079|322890318|FG001|Overall Study|Lost to Follow-up|8|||
94302458|NCT00469079|322890319|FG002|Overall Study|Lost to Follow-up|10|||
94302459|NCT00469079|322890317|FG000|Overall Study|Withdrawal by Subject|1|||
94302460|NCT00469079|322890318|FG001|Overall Study|Withdrawal by Subject|2|||
94302461|NCT00469079|322890319|FG002|Overall Study|Withdrawal by Subject|2|||
94302462|NCT00469079|322890317|FG000|Overall Study|Ineligible|0|||
94302463|NCT00469079|322890318|FG001|Overall Study|Ineligible|1|||
94302464|NCT00469079|322890319|FG002|Overall Study|Ineligible|0|||
94302465|NCT03874234|322890324|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
94302466|NCT03874234|322890325|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
94302467|NCT03874234|322890326|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
94302468|NCT03874234|322890327|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
94302469|NCT03874234|322890328|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
94302470|NCT03874234|322890329|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
94302471|NCT03874234|322890330|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
94302472|NCT03874234|322890331|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
94302473|NCT03874234|322890332|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
94302474|NCT03874234|322890333|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
94302475|NCT03874234|322890334|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
94302476|NCT03874234|322890335|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
94302477|NCT03874234|322890336|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
94302478|NCT03874234|322890324|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
94302479|NCT03874234|322890325|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
94302480|NCT03874234|322890326|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
94302481|NCT03874234|322890327|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
94302482|NCT03874234|322890328|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
94302483|NCT03874234|322890329|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
94302484|NCT03874234|322890330|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
94302485|NCT03874234|322890331|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
94302486|NCT03874234|322890332|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
94302487|NCT03874234|322890333|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
94302488|NCT03874234|322890334|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
94302489|NCT03874234|322890335|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
94302490|NCT03874234|322890336|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
94302491|NCT03874234|322890324|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
94302492|NCT03874234|322890325|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
94302493|NCT03874234|322890326|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
94302494|NCT03874234|322890327|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
94302495|NCT03874234|322890328|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
94302496|NCT03874234|322890329|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
94302497|NCT03874234|322890330|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
94302498|NCT03874234|322890331|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
94302499|NCT03874234|322890332|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
94302500|NCT03874234|322890333|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
94302501|NCT03874234|322890334|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
94302502|NCT03874234|322890335|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
94302503|NCT03874234|322890336|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
94302504|NCT03874234|322890324|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
94302505|NCT03874234|322890325|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
94302506|NCT03874234|322890326|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
94302507|NCT03874234|322890327|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
94302508|NCT03874234|322890328|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
94302509|NCT03874234|322890329|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
94302510|NCT03874234|322890330|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
94302511|NCT03874234|322890331|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
94302512|NCT03874234|322890332|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
94302513|NCT03874234|322890333|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
94302514|NCT03874234|322890334|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
94302515|NCT03874234|322890335|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
94302516|NCT03874234|322890336|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
94302517|NCT03874234|322890324|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
94302518|NCT03874234|322890325|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
94302519|NCT03874234|322890326|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
94302520|NCT03874234|322890327|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
94302521|NCT03874234|322890328|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
94302522|NCT03874234|322890329|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
94302523|NCT03874234|322890330|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
94302524|NCT03874234|322890331|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
94302525|NCT03874234|322890332|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
94302526|NCT03874234|322890333|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
94302527|NCT03874234|322890334|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
94302528|NCT03874234|322890335|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
94302529|NCT03874234|322890336|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
94302530|NCT03874234|322890324|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
94302531|NCT03874234|322890325|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
94302532|NCT03874234|322890326|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
94302533|NCT03874234|322890327|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
94302534|NCT03874234|322890328|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
94302535|NCT03874234|322890329|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
94302536|NCT03874234|322890330|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
94302537|NCT03874234|322890331|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
94302538|NCT03874234|322890332|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
94302539|NCT03874234|322890333|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
94302540|NCT03874234|322890334|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
94302541|NCT03874234|322890335|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
94302542|NCT03874234|322890336|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
94302543|NCT03874234|322890324|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
94302544|NCT03874234|322890325|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
94302545|NCT03874234|322890326|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
94302546|NCT03874234|322890327|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
94302547|NCT03874234|322890328|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
94302548|NCT03874234|322890329|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
94302549|NCT03874234|322890330|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
94302550|NCT03874234|322890331|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
94302551|NCT03874234|322890332|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
94302552|NCT03874234|322890333|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
94302553|NCT03874234|322890334|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
94302554|NCT03874234|322890335|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
94302555|NCT03874234|322890336|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
94302556|NCT03874234|322890324|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
94302557|NCT03874234|322890325|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
94302558|NCT03874234|322890326|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
94302559|NCT03874234|322890327|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
94302560|NCT03874234|322890328|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
94302561|NCT03874234|322890329|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
94302562|NCT03874234|322890330|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
94302563|NCT03874234|322890331|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
94302564|NCT03874234|322890332|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
94302565|NCT03874234|322890333|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
94302566|NCT03874234|322890334|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
94302567|NCT03874234|322890335|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
94302568|NCT03874234|322890336|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
94302569|NCT01756157|322890341|FG000|First Intervention Period|Withdrawal by Subject|1|||
94302570|NCT01756157|322890342|FG001|First Intervention Period|Withdrawal by Subject|0|||
94302571|NCT01756157|322890341|FG000|First Intervention Period|Lost to Follow-up|0|||
94302572|NCT01756157|322890342|FG001|First Intervention Period|Lost to Follow-up|2|||
94302573|NCT00541307|322890356|FG000|Overall Study|Death|5|||
94302574|NCT00541307|322890356|FG000|Overall Study|Physician Decision|3|||
94302575|NCT00541307|322890356|FG000|Overall Study|Withdrawal by Subject|6|||
94302576|NCT00541307|322890356|FG000|Overall Study|Lost to Follow-up|4|||
94302577|NCT00541307|322890356|FG000|Overall Study|Subject returned early (outside window)|1|||
94302578|NCT00541307|322890356|FG000|Overall Study|Surgical Bypass|5|||
94302579|NCT01154101|322890360|FG000|Overall Study|Adverse Event|0|||
94302580|NCT01154101|322890361|FG001|Overall Study|Adverse Event|2|||
94302581|NCT01154101|322890362|FG002|Overall Study|Adverse Event|1|||
94302582|NCT01154101|322890363|FG003|Overall Study|Adverse Event|1|||
94302583|NCT01154101|322890364|FG004|Overall Study|Adverse Event|0|||
94302584|NCT01154101|322890360|FG000|Overall Study|Lost to Follow-up|0|||
94302585|NCT01154101|322890361|FG001|Overall Study|Lost to Follow-up|1|||
94302586|NCT01154101|322890362|FG002|Overall Study|Lost to Follow-up|0|||
94302587|NCT01154101|322890363|FG003|Overall Study|Lost to Follow-up|1|||
94302588|NCT01154101|322890364|FG004|Overall Study|Lost to Follow-up|0|||
94302589|NCT01154101|322890360|FG000|Overall Study|Withdrawal by Subject|0|||
94302590|NCT01154101|322890361|FG001|Overall Study|Withdrawal by Subject|1|||
94302591|NCT01154101|322890362|FG002|Overall Study|Withdrawal by Subject|2|||
94302592|NCT01154101|322890363|FG003|Overall Study|Withdrawal by Subject|0|||
94302593|NCT01154101|322890364|FG004|Overall Study|Withdrawal by Subject|1|||
94302594|NCT00117312|322890365|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
94302595|NCT00117312|322890366|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
94302596|NCT00117312|322890367|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
94302597|NCT00117312|322890368|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
94302598|NCT00117312|322890365|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
94302599|NCT00117312|322890366|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
94302600|NCT00117312|322890367|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
94302601|NCT00117312|322890368|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
94302602|NCT00117312|322890365|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
94302603|NCT00117312|322890366|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
94302604|NCT00117312|322890367|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
94302605|NCT00117312|322890368|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
94302606|NCT00117312|322890365|FG000|Overall Study|Other|0|||
94468259|NCT01094782|323503963|FG000|Overall Study|Withdrawal by Subject|5|||
94468260|NCT01094782|323503964|FG001|Overall Study|Withdrawal by Subject|5|||
94468261|NCT01094782|323503965|FG002|Overall Study|Withdrawal by Subject|1|||
94468262|NCT01094782|323503966|FG003|Overall Study|Withdrawal by Subject|5|||
94468263|NCT01094782|323503967|FG004|Overall Study|Withdrawal by Subject|5|||
94468264|NCT01094782|323503968|FG005|Overall Study|Withdrawal by Subject|0|||
94468265|NCT01094782|323503963|FG000|Overall Study|Lost to Follow-up|1|||
94468266|NCT01094782|323503964|FG001|Overall Study|Lost to Follow-up|0|||
94302607|NCT00117312|322890366|FG001|Overall Study|Other|1|||
94302608|NCT00117312|322890367|FG002|Overall Study|Other|3|||
94302609|NCT00117312|322890368|FG003|Overall Study|Other|1|||
94302610|NCT00117312|322890365|FG000|Overall Study|Patient choice|0|||
94302611|NCT00117312|322890366|FG001|Overall Study|Patient choice|0|||
94302612|NCT00117312|322890367|FG002|Overall Study|Patient choice|2|||
94302613|NCT00117312|322890368|FG003|Overall Study|Patient choice|1|||
94302614|NCT00117312|322890365|FG000|Overall Study|Adverse Event|0|||
94468267|NCT01094782|323503965|FG002|Overall Study|Lost to Follow-up|0|||
94468268|NCT01094782|323503966|FG003|Overall Study|Lost to Follow-up|2|||
94468269|NCT01094782|323503967|FG004|Overall Study|Lost to Follow-up|1|||
94468270|NCT01094782|323503968|FG005|Overall Study|Lost to Follow-up|4|||
94302615|NCT00117312|322890366|FG001|Overall Study|Adverse Event|2|||
94302616|NCT00117312|322890367|FG002|Overall Study|Adverse Event|0|||
94302617|NCT00117312|322890368|FG003|Overall Study|Adverse Event|0|||
94302618|NCT00117312|322890365|FG000|Overall Study|Protocol Violation|0|||
94302619|NCT00117312|322890366|FG001|Overall Study|Protocol Violation|1|||
94302620|NCT00117312|322890367|FG002|Overall Study|Protocol Violation|3|||
94302621|NCT00117312|322890368|FG003|Overall Study|Protocol Violation|0|||
94302622|NCT00117312|322890365|FG000|Overall Study|PSA decrease <=50%|0|||
94302623|NCT00117312|322890366|FG001|Overall Study|PSA decrease <=50%|2|||
94302624|NCT00117312|322890367|FG002|Overall Study|PSA decrease <=50%|2|||
94302625|NCT00117312|322890368|FG003|Overall Study|PSA decrease <=50%|4|||
94302626|NCT00117312|322890365|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
94302627|NCT00117312|322890366|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
94302628|NCT00117312|322890367|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
94302629|NCT00117312|322890368|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
94302630|NCT00117312|322890365|FG000|Overall Study|Hepatic abnormality|0|||
94302631|NCT00117312|322890366|FG001|Overall Study|Hepatic abnormality|1|||
94302632|NCT00117312|322890367|FG002|Overall Study|Hepatic abnormality|0|||
94302633|NCT00117312|322890368|FG003|Overall Study|Hepatic abnormality|1|||
94302634|NCT00117312|322890365|FG000|Overall Study|Withdrawal by Subject|0|||
94302635|NCT00117312|322890366|FG001|Overall Study|Withdrawal by Subject|2|||
94302636|NCT00117312|322890367|FG002|Overall Study|Withdrawal by Subject|0|||
94302637|NCT00117312|322890368|FG003|Overall Study|Withdrawal by Subject|0|||
94302638|NCT00509106|322890370|FG000|Overall Study|Adverse Event|3|||
94302639|NCT00509106|322890371|FG001|Overall Study|Adverse Event|2|||
94302640|NCT00509106|322890370|FG000|Overall Study|Noncompliance|0|||
94302641|NCT00509106|322890371|FG001|Overall Study|Noncompliance|1|||
94302642|NCT00509106|322890370|FG000|Overall Study|At the request of sponsor/investigator|1|||
94302643|NCT00509106|322890371|FG001|Overall Study|At the request of sponsor/investigator|2|||
94302644|NCT00509106|322890370|FG000|Overall Study|Withdrew consent|4|||
94302645|NCT00509106|322890371|FG001|Overall Study|Withdrew consent|8|||
94302646|NCT00509106|322890370|FG000|Overall Study|Lost to Follow-up|16|||
94302647|NCT00509106|322890371|FG001|Overall Study|Lost to Follow-up|10|||
94302648|NCT00509106|322890370|FG000|Overall Study|Other|1|||
94302649|NCT00509106|322890371|FG001|Overall Study|Other|0|||
94302650|NCT00509106|322890370|FG000|Overall Study|Death|6|||
94302651|NCT00509106|322890371|FG001|Overall Study|Death|6|||
94302652|NCT03192904|322890377|FG000|Overall Study|Physician Decision|3|||
94302653|NCT03192904|322890378|FG001|Overall Study|Physician Decision|1|||
94302654|NCT03192904|322890377|FG000|Overall Study|Lost to Follow-up|0|||
94302655|NCT03192904|322890378|FG001|Overall Study|Lost to Follow-up|1|||
94302656|NCT00424398|322890379|FG000|Overall Study|Withdrawal by Subject|2|||
94302657|NCT00424398|322890380|FG001|Overall Study|Withdrawal by Subject|1|||
94302658|NCT00424398|322890381|FG002|Overall Study|Withdrawal by Subject|0|||
94302659|NCT00424398|322890379|FG000|Overall Study|Subject met exclusion criteria|1|||
94302660|NCT00424398|322890380|FG001|Overall Study|Subject met exclusion criteria|0|||
94302661|NCT00424398|322890381|FG002|Overall Study|Subject met exclusion criteria|0|||
94302662|NCT00246259|322890383|FG000|Overall Study|Other|3|||
94302663|NCT00246259|322890384|FG001|Overall Study|Other|3|||
94302664|NCT00246259|322890383|FG000|Overall Study|Not stable by Week 18|2|||
94302665|NCT00246259|322890384|FG001|Overall Study|Not stable by Week 18|1|||
94302666|NCT00246259|322890383|FG000|Overall Study|Participant non-compliant|4|||
94302667|NCT00246259|322890384|FG001|Overall Study|Participant non-compliant|9|||
94302668|NCT00246259|322890383|FG000|Overall Study|Lack of Efficacy|2|||
94302669|NCT00246259|322890384|FG001|Overall Study|Lack of Efficacy|2|||
94302670|NCT00246259|322890383|FG000|Overall Study|Investigator withdrew participant|2|||
94302671|NCT00246259|322890384|FG001|Overall Study|Investigator withdrew participant|0|||
94302672|NCT00246259|322890383|FG000|Overall Study|Adverse Event|5|||
94302673|NCT00246259|322890384|FG001|Overall Study|Adverse Event|0|||
94302674|NCT00246259|322890383|FG000|Overall Study|Lost to Follow-up|3|||
94302675|NCT00246259|322890384|FG001|Overall Study|Lost to Follow-up|4|||
94302676|NCT00246259|322890383|FG000|Overall Study|Withdrawal by Subject|5|||
94302677|NCT00246259|322890384|FG001|Overall Study|Withdrawal by Subject|1|||
94302678|NCT00246259|322890383|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
94302679|NCT00246259|322890384|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
94302680|NCT02240706|322890386|FG000|Overall Study|Lack of Efficacy|2|||
94302681|NCT02240706|322890387|FG001|Overall Study|Lack of Efficacy|2|||
94302682|NCT02240706|322890388|FG002|Overall Study|Lack of Efficacy|2|||
94302683|NCT02240706|322890389|FG003|Overall Study|Lack of Efficacy|2|||
94302684|NCT02240706|322890390|FG004|Overall Study|Lack of Efficacy|5|||
94302685|NCT02240706|322890391|FG005|Overall Study|Lack of Efficacy|0|||
94468271|NCT01094782|323503963|FG000|Overall Study|Positive Drug Screen|2|||
94468272|NCT01094782|323503964|FG001|Overall Study|Positive Drug Screen|2|||
94302686|NCT02240706|322890392|FG006|Overall Study|Lack of Efficacy|0|||
94302687|NCT02240706|322890386|FG000|Overall Study|Adverse Event|1|||
94302688|NCT02240706|322890387|FG001|Overall Study|Adverse Event|0|||
94302689|NCT02240706|322890388|FG002|Overall Study|Adverse Event|1|||
94302690|NCT02240706|322890389|FG003|Overall Study|Adverse Event|0|||
94302691|NCT02240706|322890390|FG004|Overall Study|Adverse Event|2|||
94302692|NCT02240706|322890391|FG005|Overall Study|Adverse Event|0|||
94302693|NCT02240706|322890392|FG006|Overall Study|Adverse Event|0|||
94302694|NCT02240706|322890386|FG000|Overall Study|Progressive disease|0|||
94302695|NCT02240706|322890387|FG001|Overall Study|Progressive disease|0|||
94302696|NCT02240706|322890388|FG002|Overall Study|Progressive disease|0|||
94302697|NCT02240706|322890389|FG003|Overall Study|Progressive disease|0|||
94302698|NCT02240706|322890390|FG004|Overall Study|Progressive disease|1|||
94302699|NCT02240706|322890391|FG005|Overall Study|Progressive disease|0|||
94302700|NCT02240706|322890392|FG006|Overall Study|Progressive disease|0|||
94302701|NCT02240706|322890386|FG000|Overall Study|Dose limiting toxicity|0|||
94302702|NCT02240706|322890387|FG001|Overall Study|Dose limiting toxicity|0|||
94302703|NCT02240706|322890388|FG002|Overall Study|Dose limiting toxicity|0|||
94302704|NCT02240706|322890389|FG003|Overall Study|Dose limiting toxicity|0|||
94302705|NCT02240706|322890390|FG004|Overall Study|Dose limiting toxicity|1|||
94302706|NCT02240706|322890391|FG005|Overall Study|Dose limiting toxicity|0|||
94302707|NCT02240706|322890392|FG006|Overall Study|Dose limiting toxicity|0|||
94302708|NCT02240706|322890386|FG000|Overall Study|Refused to continue taking medication|0|||
94302709|NCT02240706|322890387|FG001|Overall Study|Refused to continue taking medication|1|||
94302710|NCT02240706|322890388|FG002|Overall Study|Refused to continue taking medication|3|||
94302711|NCT02240706|322890389|FG003|Overall Study|Refused to continue taking medication|1|||
94302712|NCT02240706|322890390|FG004|Overall Study|Refused to continue taking medication|2|||
94302713|NCT02240706|322890391|FG005|Overall Study|Refused to continue taking medication|0|||
94302714|NCT02240706|322890392|FG006|Overall Study|Refused to continue taking medication|0|||
94302715|NCT02240706|322890386|FG000|Overall Study|Insurance billing concerns|0|||
94302716|NCT02240706|322890387|FG001|Overall Study|Insurance billing concerns|0|||
94302717|NCT02240706|322890388|FG002|Overall Study|Insurance billing concerns|0|||
94302718|NCT02240706|322890389|FG003|Overall Study|Insurance billing concerns|1|||
94302719|NCT02240706|322890390|FG004|Overall Study|Insurance billing concerns|0|||
94302720|NCT02240706|322890391|FG005|Overall Study|Insurance billing concerns|0|||
94302721|NCT02240706|322890392|FG006|Overall Study|Insurance billing concerns|0|||
94302722|NCT00855439|322890399|FG000|Overall Study|Withdrawal by Subject|2|||
94302723|NCT00855439|322890400|FG001|Overall Study|Withdrawal by Subject|0|||
94302724|NCT00855439|322890399|FG000|Overall Study|Pregnancy|1|||
94302725|NCT00855439|322890400|FG001|Overall Study|Pregnancy|0|||
94302726|NCT03022461|322890403|FG000|Overall Study|Death|3|||
94302727|NCT03633331|322890404|FG000|Overall Study|Withdrawal by Subject|1|||
94302728|NCT00587223|322890405|FG000|Overall Study|Adverse Event|1|||
94302729|NCT00104871|322890412|FG000|Overall Study|Not evaluable|1|||
94302730|NCT00814710|322890413|FG000|Overall Study|Adverse Event|1|||
94302731|NCT00814710|322890414|FG001|Overall Study|Adverse Event|0|||
94302732|NCT00814710|322890413|FG000|Overall Study|Lost to Follow-up|7|||
94302733|NCT00814710|322890414|FG001|Overall Study|Lost to Follow-up|3|||
94302734|NCT01591330|322890415|FG000|Period 1|Adverse Event|1|||
94302735|NCT01591330|322890416|FG001|Period 1|Adverse Event|0|||
94302736|NCT01591330|322890417|FG002|Period 1|Adverse Event|0|||
94302737|NCT01591330|322890418|FG003|Period 1|Adverse Event|0|||
94302738|NCT01591330|322890415|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
94302739|NCT01591330|322890416|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
94302740|NCT01591330|322890417|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
94302741|NCT01591330|322890418|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
94302742|NCT01591330|322890415|FG000|Period 2|Adverse Event|1|||
94302743|NCT01591330|322890416|FG001|Period 2|Adverse Event|0|||
94302744|NCT01591330|322890417|FG002|Period 2|Adverse Event|0|||
94302745|NCT01591330|322890418|FG003|Period 2|Adverse Event|0|||
94302746|NCT00002850|322890419|FG000|Overall Study|Death|4|||
94302747|NCT00002850|322890420|FG001|Overall Study|Death|1|||
94302748|NCT00002850|322890421|FG002|Overall Study|Death|3|||
94302749|NCT00002850|322890419|FG000|Overall Study|Protocol Violation|1|||
94302750|NCT00002850|322890420|FG001|Overall Study|Protocol Violation|0|||
94302751|NCT00002850|322890421|FG002|Overall Study|Protocol Violation|1|||
94302752|NCT00002850|322890419|FG000|Overall Study|Withdrawal by Subject|0|||
94302753|NCT00002850|322890420|FG001|Overall Study|Withdrawal by Subject|1|||
94302754|NCT00002850|322890421|FG002|Overall Study|Withdrawal by Subject|0|||
94302755|NCT01697345|322890422|FG000|Overall Study|Withdrawal by Subject|1|||
94302756|NCT04800315|322890423|FG000|Randomization|Did not receive study treatment|1|||
94302757|NCT04800315|322890424|FG001|Randomization|Did not receive study treatment|0|||
94302758|NCT04800315|322890425|FG002|Randomization|Did not receive study treatment|0|||
94302759|NCT04800315|322890426|FG003|Randomization|Did not receive study treatment|0|||
94468273|NCT01094782|323503965|FG002|Overall Study|Positive Drug Screen|1|||
94302760|NCT04800315|322890423|FG000|Treatment Period|Adverse Event|4|||
94302761|NCT04800315|322890424|FG001|Treatment Period|Adverse Event|2|||
94302762|NCT04800315|322890425|FG002|Treatment Period|Adverse Event|1|||
94302763|NCT04800315|322890426|FG003|Treatment Period|Adverse Event|2|||
94302764|NCT04800315|322890423|FG000|Treatment Period|Lack of Efficacy|1|||
94302765|NCT04800315|322890424|FG001|Treatment Period|Lack of Efficacy|0|||
94302766|NCT04800315|322890425|FG002|Treatment Period|Lack of Efficacy|0|||
94302767|NCT04800315|322890426|FG003|Treatment Period|Lack of Efficacy|3|||
94302768|NCT04800315|322890423|FG000|Treatment Period|Lost to Follow-up|0|||
94302769|NCT04800315|322890424|FG001|Treatment Period|Lost to Follow-up|1|||
94302770|NCT04800315|322890425|FG002|Treatment Period|Lost to Follow-up|2|||
94302771|NCT04800315|322890426|FG003|Treatment Period|Lost to Follow-up|2|||
94302772|NCT04800315|322890423|FG000|Treatment Period|Withdrawal by participant|0|||
94302773|NCT04800315|322890424|FG001|Treatment Period|Withdrawal by participant|0|||
94302774|NCT04800315|322890425|FG002|Treatment Period|Withdrawal by participant|0|||
94302775|NCT04800315|322890426|FG003|Treatment Period|Withdrawal by participant|4|||
94302776|NCT04800315|322890423|FG000|Treatment Period|Other Reasons|0|||
94302777|NCT04800315|322890424|FG001|Treatment Period|Other Reasons|2|||
94302778|NCT04800315|322890425|FG002|Treatment Period|Other Reasons|0|||
94302779|NCT04800315|322890426|FG003|Treatment Period|Other Reasons|1|||
94302780|NCT01662999|322890427|FG000|Period 3|Withdrawal by Subject|0|||
94302781|NCT01662999|322890428|FG001|Period 3|Withdrawal by Subject|1|||
94302782|NCT01662999|322890429|FG002|Period 3|Withdrawal by Subject|0|||
94302783|NCT01662999|322890430|FG003|Period 3|Withdrawal by Subject|0|||
94302784|NCT01662999|322890431|FG004|Period 3|Withdrawal by Subject|0|||
94302785|NCT01662999|322890432|FG005|Period 3|Withdrawal by Subject|0|||
94302786|NCT02932267|322890438|FG000|Overall Study|Withdrawal by Subject|3|||
94302787|NCT02932267|322890438|FG000|Overall Study|Lost to Follow-up|4|||
94302788|NCT02932267|322890438|FG000|Overall Study|Pregnancy|1|||
94302789|NCT00995371|322890442|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
94302790|NCT00995371|322890443|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
94302791|NCT04725682|322890447|FG000|Overall Study|Withdrawal by Subject|7|||
94302792|NCT04725682|322890448|FG001|Overall Study|Withdrawal by Subject|5|||
94302793|NCT04725682|322890447|FG000|Overall Study|Failed to comply with the requirements|2|||
94302794|NCT04725682|322890448|FG001|Overall Study|Failed to comply with the requirements|1|||
94302795|NCT04725682|322890447|FG000|Overall Study|Adverse Event|1|||
94302796|NCT04725682|322890448|FG001|Overall Study|Adverse Event|1|||
94302797|NCT04725682|322890447|FG000|Overall Study|Death|0|||
94302798|NCT04725682|322890448|FG001|Overall Study|Death|1|||
94302799|NCT00618956|322890451|FG000|Overall Study|Adverse Event|10|||
94302800|NCT00618956|322890452|FG001|Overall Study|Adverse Event|34|||
94302801|NCT00618956|322890451|FG000|Overall Study|Lack of Efficacy|2|||
94302802|NCT00618956|322890452|FG001|Overall Study|Lack of Efficacy|1|||
94302803|NCT00618956|322890451|FG000|Overall Study|Withdrawal by Subject|5|||
94302804|NCT00618956|322890452|FG001|Overall Study|Withdrawal by Subject|7|||
94302805|NCT00618956|322890451|FG000|Overall Study|Lost to Follow-up|4|||
94302806|NCT00618956|322890452|FG001|Overall Study|Lost to Follow-up|5|||
94302807|NCT00618956|322890451|FG000|Overall Study|Protocol Violation|2|||
94302808|NCT00618956|322890452|FG001|Overall Study|Protocol Violation|2|||
94302809|NCT00618956|322890451|FG000|Overall Study|did not meet criteria, non-compliance|2|||
94302810|NCT00618956|322890452|FG001|Overall Study|did not meet criteria, non-compliance|1|||
94302811|NCT03598777|322890453|FG000|Overall Study|Study Terminated by Sponsor|3|||
94302812|NCT03598777|322890454|FG001|Overall Study|Study Terminated by Sponsor|0|||
94302813|NCT03598777|322890455|FG002|Overall Study|Study Terminated by Sponsor|0|||
94374958|NCT00685919|323158672|FG002|Overall Study|Withdrawal by Subject|1|||
94374959|NCT00685919|323158673|FG003|Overall Study|Withdrawal by Subject|0|||
94374960|NCT00685919|323158670|FG000|Overall Study|Physician Decision|1|||
94374961|NCT00685919|323158671|FG001|Overall Study|Physician Decision|0|||
94374962|NCT00685919|323158672|FG002|Overall Study|Physician Decision|0|||
94374963|NCT00685919|323158673|FG003|Overall Study|Physician Decision|0|||
94374964|NCT00672620|323158699|FG000|Overall Study|Adverse Event|7|||
94374965|NCT00672620|323158700|FG001|Overall Study|Adverse Event|7|||
94374966|NCT00672620|323158701|FG002|Overall Study|Adverse Event|12|||
94374967|NCT00672620|323158702|FG003|Overall Study|Adverse Event|17|||
94374968|NCT00672620|323158699|FG000|Overall Study|Lack of Efficacy|1|||
94374969|NCT00672620|323158700|FG001|Overall Study|Lack of Efficacy|2|||
94374970|NCT00672620|323158701|FG002|Overall Study|Lack of Efficacy|2|||
94374971|NCT00672620|323158702|FG003|Overall Study|Lack of Efficacy|0|||
94374972|NCT00672620|323158699|FG000|Overall Study|Noncompliance with Study Drug|3|||
94374973|NCT00672620|323158700|FG001|Overall Study|Noncompliance with Study Drug|4|||
94374974|NCT00672620|323158701|FG002|Overall Study|Noncompliance with Study Drug|0|||
94374975|NCT00672620|323158702|FG003|Overall Study|Noncompliance with Study Drug|2|||
94374976|NCT00672620|323158699|FG000|Overall Study|Protocol Deviations|5|||
94374977|NCT00672620|323158700|FG001|Overall Study|Protocol Deviations|7|||
94374978|NCT00672620|323158701|FG002|Overall Study|Protocol Deviations|2|||
94374979|NCT00672620|323158702|FG003|Overall Study|Protocol Deviations|5|||
94374980|NCT00672620|323158699|FG000|Overall Study|Withdrawal of Consent|6|||
94374981|NCT00672620|323158700|FG001|Overall Study|Withdrawal of Consent|12|||
94468274|NCT01094782|323503966|FG003|Overall Study|Positive Drug Screen|1|||
94302814|NCT03598777|322890456|FG003|Overall Study|Study Terminated by Sponsor|0|||
94302815|NCT03598777|322890457|FG004|Overall Study|Study Terminated by Sponsor|15|||
94374982|NCT00672620|323158701|FG002|Overall Study|Withdrawal of Consent|5|||
94374983|NCT00672620|323158702|FG003|Overall Study|Withdrawal of Consent|6|||
94374984|NCT00672620|323158699|FG000|Overall Study|Lost to Follow-up|8|||
94468275|NCT01094782|323503967|FG004|Overall Study|Positive Drug Screen|3|||
94302816|NCT03598777|322890453|FG000|Overall Study|Withdrawal by Subject|1|||
94302817|NCT03598777|322890454|FG001|Overall Study|Withdrawal by Subject|1|||
94302818|NCT03598777|322890455|FG002|Overall Study|Withdrawal by Subject|0|||
94374985|NCT00672620|323158700|FG001|Overall Study|Lost to Follow-up|19|||
94302819|NCT03598777|322890456|FG003|Overall Study|Withdrawal by Subject|0|||
94302820|NCT03598777|322890457|FG004|Overall Study|Withdrawal by Subject|0|||
94302821|NCT03598777|322890453|FG000|Overall Study|Adverse Event|1|||
94302822|NCT03598777|322890454|FG001|Overall Study|Adverse Event|0|||
94302823|NCT03598777|322890455|FG002|Overall Study|Adverse Event|0|||
94302824|NCT03598777|322890456|FG003|Overall Study|Adverse Event|0|||
94302825|NCT03598777|322890457|FG004|Overall Study|Adverse Event|0|||
94302826|NCT03598777|322890453|FG000|Overall Study|Lost to Follow-up|1|||
94302827|NCT03598777|322890454|FG001|Overall Study|Lost to Follow-up|0|||
94302828|NCT03598777|322890455|FG002|Overall Study|Lost to Follow-up|0|||
94302829|NCT03598777|322890456|FG003|Overall Study|Lost to Follow-up|0|||
94302830|NCT03598777|322890457|FG004|Overall Study|Lost to Follow-up|0|||
94302831|NCT01445171|322891566|FG000|Overall Study|Lost to Follow-up|11|||
94302832|NCT01445171|322891566|FG000|Overall Study|Withdrawal by Subject|16|||
94302833|NCT01445171|322891566|FG000|Overall Study|Death|51|||
94302834|NCT01445171|322891566|FG000|Overall Study|Subjects declined to return for followup|9|||
94302835|NCT01445171|322891566|FG000|Overall Study|Consented but did not receive device|8|||
94302836|NCT04024228|322891575|FG000|Overall Study|Adverse Event|1|||
94302837|NCT04024228|322891576|FG001|Overall Study|Adverse Event|0|||
94302838|NCT04024228|322891575|FG000|Overall Study|Protocol Deviation|0|||
94302839|NCT04024228|322891576|FG001|Overall Study|Protocol Deviation|2|||
94302840|NCT04024228|322891575|FG000|Overall Study|Withdrawal by Subject|3|||
94302841|NCT04024228|322891576|FG001|Overall Study|Withdrawal by Subject|4|||
94302842|NCT03404960|322891579|FG000|Overall Study|Adverse Event|0|||
94302843|NCT03404960|322891580|FG001|Overall Study|Adverse Event|2|||
94302844|NCT03404960|322891579|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
94302845|NCT03404960|322891580|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
94302846|NCT03404960|322891579|FG000|Overall Study|Bowel obstruction|0|||
94302847|NCT03404960|322891580|FG001|Overall Study|Bowel obstruction|1|||
94302848|NCT03404960|322891579|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
94302849|NCT03404960|322891580|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
94302850|NCT02629393|322891581|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
94302851|NCT02629393|322891581|FG000|Overall Study|Physician Decision|1|||
94302852|NCT00374556|322891586|FG000|Overall Study|Lost to Follow-up|1|||
94302853|NCT00374556|322891587|FG001|Overall Study|Lost to Follow-up|0|||
94302854|NCT00374556|322891586|FG000|Overall Study|Removed at baseline due to medical cond|0|||
94302855|NCT00374556|322891587|FG001|Overall Study|Removed at baseline due to medical cond|1|||
94302856|NCT00473694|322891591|FG000|Overall Study|Adverse Event|0|||
94302857|NCT00473694|322891592|FG001|Overall Study|Adverse Event|1|||
94302858|NCT00473694|322891593|FG002|Overall Study|Adverse Event|0|||
94302859|NCT00473694|322891594|FG003|Overall Study|Adverse Event|0|||
94302860|NCT00473694|322891591|FG000|Overall Study|Participants did not receive treatment|11|||
94302861|NCT00473694|322891592|FG001|Overall Study|Participants did not receive treatment|3|||
94302862|NCT00473694|322891593|FG002|Overall Study|Participants did not receive treatment|5|||
94302863|NCT00473694|322891594|FG003|Overall Study|Participants did not receive treatment|6|||
94302864|NCT00473694|322891591|FG000|Overall Study|Lost to Follow-up|0|||
94302865|NCT00473694|322891592|FG001|Overall Study|Lost to Follow-up|0|||
94302866|NCT00473694|322891593|FG002|Overall Study|Lost to Follow-up|0|||
94302867|NCT00473694|322891594|FG003|Overall Study|Lost to Follow-up|1|||
94302868|NCT03716726|322891595|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
94302869|NCT03716726|322891596|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
94302870|NCT03716726|322891595|FG000|12 Months Followup|Lost to Follow-up|10|||
94302871|NCT03716726|322891596|FG001|12 Months Followup|Lost to Follow-up|17|||
94302872|NCT01821963|322891607|FG000|Overall Study|Adverse Event|1|||
94302873|NCT04331899|322891612|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
94302874|NCT04331899|322891613|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
94302875|NCT02432807|322891617|FG000|Overall Study|Adverse Event|0|||
94302876|NCT02432807|322891618|FG001|Overall Study|Adverse Event|2|||
94302877|NCT02432807|322891617|FG000|Overall Study|Lost to Follow-up|1|||
94302878|NCT02432807|322891618|FG001|Overall Study|Lost to Follow-up|0|||
94302879|NCT02432807|322891617|FG000|Overall Study|Withdrawal by Subject|1|||
94302880|NCT02432807|322891618|FG001|Overall Study|Withdrawal by Subject|1|||
94302881|NCT02432807|322891617|FG000|Overall Study|Other|1|||
94302882|NCT02432807|322891618|FG001|Overall Study|Other|1|||
94302883|NCT05408858|322891619|FG000|Overall Study|no longer met eligibility criteria|1|||
94302884|NCT01503021|322891622|FG000|Overall Study|Adverse Event|7|||
94302885|NCT01503021|322891623|FG001|Overall Study|Adverse Event|6|||
94302886|NCT01503021|322891622|FG000|Overall Study|Death|0|||
94302887|NCT01503021|322891623|FG001|Overall Study|Death|2|||
94302888|NCT01503021|322891622|FG000|Overall Study|Lost to Follow-up|2|||
94302889|NCT01503021|322891623|FG001|Overall Study|Lost to Follow-up|0|||
94302890|NCT01503021|322891622|FG000|Overall Study|Physician Decision|3|||
94302891|NCT01503021|322891623|FG001|Overall Study|Physician Decision|0|||
94302892|NCT01503021|322891622|FG000|Overall Study|Protocol Violation|1|||
94302893|NCT01503021|322891623|FG001|Overall Study|Protocol Violation|3|||
94302894|NCT01503021|322891622|FG000|Overall Study|Withdrawal by Subject|9|||
94302895|NCT01503021|322891623|FG001|Overall Study|Withdrawal by Subject|8|||
94302896|NCT01503021|322891622|FG000|Overall Study|Moved, received transplant, etc.|5|||
94302897|NCT01503021|322891623|FG001|Overall Study|Moved, received transplant, etc.|7|||
94302898|NCT03941548|322891624|FG000|Overall Study|Adverse Event|0|||
94302899|NCT03941548|322891625|FG001|Overall Study|Adverse Event|1|||
94302900|NCT03941548|322891624|FG000|Overall Study|Lost to Follow-up|0|||
94302901|NCT03941548|322891625|FG001|Overall Study|Lost to Follow-up|1|||
94302902|NCT03941548|322891624|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
94302903|NCT03941548|322891625|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
94302904|NCT01242111|322891629|FG000|Overall Study|Adverse Event|1|||
94302905|NCT01242111|322891629|FG000|Overall Study|Withdrawal by Subject|1|||
94302906|NCT01242111|322891629|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
94302907|NCT03619213|322891630|FG000|Overall Study|Lost to Follow-up|2|||
94302908|NCT03619213|322891631|FG001|Overall Study|Lost to Follow-up|1|||
94302909|NCT03619213|322891630|FG000|Overall Study|Withdrawal by Subject|8|||
94302910|NCT03619213|322891631|FG001|Overall Study|Withdrawal by Subject|10|||
94302911|NCT00442598|322891632|FG000|Overall Study|Adverse Event|1|||
94302912|NCT00442598|322891633|FG001|Overall Study|Adverse Event|0|||
94302913|NCT00442598|322891634|FG002|Overall Study|Adverse Event|0|||
94302914|NCT00442598|322891632|FG000|Overall Study|Tumor progression|3|||
94302915|NCT00442598|322891633|FG001|Overall Study|Tumor progression|4|||
94302916|NCT00442598|322891634|FG002|Overall Study|Tumor progression|0|||
94302917|NCT00442598|322891632|FG000|Overall Study|Clinical deterioration|1|||
94302918|NCT00442598|322891633|FG001|Overall Study|Clinical deterioration|2|||
94302919|NCT00442598|322891634|FG002|Overall Study|Clinical deterioration|0|||
94302920|NCT00442598|322891632|FG000|Overall Study|CA125 progression|0|||
94302921|NCT00442598|322891633|FG001|Overall Study|CA125 progression|1|||
94302922|NCT00442598|322891634|FG002|Overall Study|CA125 progression|0|||
94302923|NCT00442598|322891632|FG000|Overall Study|Reduced creatinine clearance|1|||
94302924|NCT00442598|322891633|FG001|Overall Study|Reduced creatinine clearance|0|||
94374986|NCT00672620|323158701|FG002|Overall Study|Lost to Follow-up|8|||
94374987|NCT00672620|323158702|FG003|Overall Study|Lost to Follow-up|11|||
94374988|NCT00672620|323158699|FG000|Overall Study|Reason not Specified|3|||
94374989|NCT00672620|323158700|FG001|Overall Study|Reason not Specified|3|||
94374990|NCT00672620|323158701|FG002|Overall Study|Reason not Specified|2|||
94374991|NCT00672620|323158702|FG003|Overall Study|Reason not Specified|1|||
94374992|NCT02965820|323158703|FG000|Period 2, Second 30 Days|Adverse Event|1|||
94374993|NCT02965820|323158704|FG001|Period 2, Second 30 Days|Adverse Event|1|||
94374994|NCT02114931|323158705|FG000|Overall Study|Withdrawal by Subject|15|||
94374995|NCT02114931|323158706|FG001|Overall Study|Withdrawal by Subject|18|||
94374996|NCT02114931|323158705|FG000|Overall Study|Adverse Event|4|||
94374997|NCT02114931|323158706|FG001|Overall Study|Adverse Event|6|||
94374998|NCT02114931|323158705|FG000|Overall Study|Lost to Follow-up|3|||
94374999|NCT02114931|323158706|FG001|Overall Study|Lost to Follow-up|3|||
94375000|NCT02114931|323158705|FG000|Overall Study|Physician Decision|1|||
94375001|NCT02114931|323158706|FG001|Overall Study|Physician Decision|2|||
94375002|NCT02114931|323158705|FG000|Overall Study|Other|2|||
94375003|NCT02114931|323158706|FG001|Overall Study|Other|1|||
94375004|NCT03412019|323158712|FG000|Overall Study|Withdrawal by Subject|1|||
94375005|NCT03412019|323158713|FG001|Overall Study|Withdrawal by Subject|1|||
94375006|NCT01141283|323158714|FG000|Overall Study|Adverse Event|56|||
94375007|NCT01141283|323158714|FG000|Overall Study|Lost to Follow-up|4|||
94375008|NCT01141283|323158714|FG000|Overall Study|Withdrawal by Subject|14|||
94375009|NCT01141283|323158714|FG000|Overall Study|Administrative|4|||
94375010|NCT01141283|323158714|FG000|Overall Study|Lack of Efficacy|10|||
94375011|NCT01620983|323158715|FG000|Overall Study|Lost to Follow-up|8|||
94375012|NCT01620983|323158716|FG001|Overall Study|Lost to Follow-up|4|||
94375013|NCT01620983|323158717|FG002|Overall Study|Lost to Follow-up|9|||
94375014|NCT01620983|323158715|FG000|Overall Study|Withdrawal by Subject|6|||
94375015|NCT01620983|323158716|FG001|Overall Study|Withdrawal by Subject|8|||
94375016|NCT01620983|323158717|FG002|Overall Study|Withdrawal by Subject|1|||
94375017|NCT01620983|323158715|FG000|Overall Study|Death|2|||
94375018|NCT01620983|323158716|FG001|Overall Study|Death|0|||
94375019|NCT01620983|323158717|FG002|Overall Study|Death|0|||
94375020|NCT01620983|323158715|FG000|Overall Study|Physician Decision|3|||
94375021|NCT01620983|323158716|FG001|Overall Study|Physician Decision|10|||
94375022|NCT01620983|323158717|FG002|Overall Study|Physician Decision|5|||
94375023|NCT01430104|323158727|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
94375024|NCT01076166|323158728|FG000|Overall Study|Adverse Event|3|||
94302925|NCT00442598|322891634|FG002|Overall Study|Reduced creatinine clearance|0|||
94302926|NCT00442598|322891632|FG000|Overall Study|Death|0|||
94302927|NCT00442598|322891633|FG001|Overall Study|Death|1|||
94302928|NCT00442598|322891634|FG002|Overall Study|Death|0|||
94302929|NCT01929083|322891635|FG000|Intervention 1|Lost to Follow-up|2|||
94302930|NCT01929083|322891636|FG001|Intervention 1|Lost to Follow-up|0|||
94302931|NCT01929083|322891635|FG000|Intervention 1|Nonadherent to study medications|1|||
94302932|NCT01929083|322891636|FG001|Intervention 1|Nonadherent to study medications|0|||
94302933|NCT01929083|322891635|FG000|Intervention 2|Adverse Event|0|||
94302934|NCT01929083|322891636|FG001|Intervention 2|Adverse Event|1|||
94302935|NCT02945657|322891637|FG000|Overall Study|Adverse Event|1|||
94302936|NCT02945657|322891637|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
94302937|NCT01859403|322891638|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
94302938|NCT01859403|322891639|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
94302939|NCT01859403|322891638|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
94302940|NCT01859403|322891639|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
94302941|NCT01859403|322891638|FG000|Primary Endpoint Measure|Physician Decision|0|||
94302942|NCT01859403|322891639|FG001|Primary Endpoint Measure|Physician Decision|1|||
94302943|NCT01859403|322891638|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
94302944|NCT01859403|322891639|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
94302945|NCT00813748|322891641|FG000|Skin Test Substudy|Physician Decision|0|||
94302946|NCT00813748|322891642|FG001|Skin Test Substudy|Physician Decision|1|||
94302947|NCT01829048|322891645|FG000|Overall Study|Withdrawal by Subject|0|||
94302948|NCT01829048|322891646|FG001|Overall Study|Withdrawal by Subject|0|||
94302949|NCT01829048|322891647|FG002|Overall Study|Withdrawal by Subject|0|||
94302950|NCT01829048|322891648|FG003|Overall Study|Withdrawal by Subject|2|||
94302951|NCT01829048|322891649|FG004|Overall Study|Withdrawal by Subject|0|||
94302952|NCT00892437|322891650|FG000|Randomized Phase|Randomized but not treated|6|||
94302953|NCT00892437|322891651|FG001|Randomized Phase|Randomized but not treated|0|||
94302954|NCT00892437|322891650|FG000|Randomized Phase|Adverse Event|2|||
94302955|NCT00892437|322891651|FG001|Randomized Phase|Adverse Event|2|||
94302956|NCT00892437|322891650|FG000|Randomized Phase|Lost to Follow-up|1|||
94302957|NCT00892437|322891651|FG001|Randomized Phase|Lost to Follow-up|3|||
94302958|NCT00892437|322891650|FG000|Randomized Phase|Investigator's Discretion|1|||
94302959|NCT00892437|322891651|FG001|Randomized Phase|Investigator's Discretion|0|||
94302960|NCT00892437|322891650|FG000|Randomized Phase|Withdrew Consent|1|||
94302961|NCT00892437|322891651|FG001|Randomized Phase|Withdrew Consent|0|||
94302962|NCT00892437|322891650|FG000|Open-Label Extension Phase|Adverse Event|4|||
94302963|NCT00892437|322891651|FG001|Open-Label Extension Phase|Adverse Event|2|||
94302964|NCT00892437|322891650|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
94302965|NCT00892437|322891651|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
94302966|NCT00892437|322891650|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
94302967|NCT00892437|322891651|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
94302968|NCT00892437|322891650|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
94302969|NCT00892437|322891651|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
94302970|NCT00892437|322891650|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
94302971|NCT00892437|322891651|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
94302972|NCT02750410|322891653|FG000|Double-Blind Treatment Period|Adverse Event|2|||
94302973|NCT02750410|322891654|FG001|Double-Blind Treatment Period|Adverse Event|2|||
94302974|NCT02750410|322891653|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
94302975|NCT02750410|322891654|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
94302976|NCT02750410|322891653|FG000|Open-Label Extension Period|Adverse Event|5|||
94302977|NCT02750410|322891654|FG001|Open-Label Extension Period|Adverse Event|3|||
94302978|NCT02750410|322891653|FG000|Open-Label Extension Period|Protocol Violation|0|||
94302979|NCT02750410|322891654|FG001|Open-Label Extension Period|Protocol Violation|1|||
94302980|NCT02750410|322891653|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
94302981|NCT02750410|322891654|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
94302982|NCT01531725|322891655|FG000|Overall Study|Protocol Violation|5|||
94302983|NCT01873950|322891656|FG000|Period 5|Withdrawal by Subject|0|||
94302984|NCT01873950|322891657|FG001|Period 5|Withdrawal by Subject|0|||
94302985|NCT01873950|322891658|FG002|Period 5|Withdrawal by Subject|0|||
94302986|NCT01873950|322891659|FG003|Period 5|Withdrawal by Subject|1|||
94302987|NCT01873950|322891660|FG004|Period 5|Withdrawal by Subject|0|||
94302988|NCT00624338|322891664|FG000|Overall Study|Adverse Event|14|||
94302989|NCT00624338|322891665|FG001|Overall Study|Adverse Event|14|||
94302990|NCT00624338|322891666|FG002|Overall Study|Adverse Event|18|||
94302991|NCT00624338|322891664|FG000|Overall Study|Lost to Follow-up|1|||
94302992|NCT00624338|322891665|FG001|Overall Study|Lost to Follow-up|0|||
94302993|NCT00624338|322891666|FG002|Overall Study|Lost to Follow-up|0|||
94302994|NCT00624338|322891664|FG000|Overall Study|Lack of Efficacy|11|||
94302995|NCT00624338|322891665|FG001|Overall Study|Lack of Efficacy|3|||
94302996|NCT00624338|322891666|FG002|Overall Study|Lack of Efficacy|14|||
94302997|NCT00624338|322891664|FG000|Overall Study|Protocol Violation|3|||
94302998|NCT00624338|322891665|FG001|Overall Study|Protocol Violation|3|||
94302999|NCT00624338|322891666|FG002|Overall Study|Protocol Violation|2|||
94303000|NCT00624338|322891664|FG000|Overall Study|Death|0|||
94303001|NCT00624338|322891665|FG001|Overall Study|Death|2|||
94303002|NCT00624338|322891666|FG002|Overall Study|Death|0|||
94303003|NCT00624338|322891664|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
94303004|NCT00624338|322891665|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
94303005|NCT00624338|322891666|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
94468276|NCT01094782|323503968|FG005|Overall Study|Positive Drug Screen|2|||
94468277|NCT01094782|323503963|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
94468278|NCT01094782|323503964|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
94468279|NCT01094782|323503965|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
94468280|NCT01094782|323503966|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
94468281|NCT01094782|323503967|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
94468282|NCT01094782|323503968|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
94468283|NCT01094782|323503963|FG000|Overall Study|Unable to Complete Questionnaires|0|||
94468284|NCT01094782|323503964|FG001|Overall Study|Unable to Complete Questionnaires|1|||
94468285|NCT01094782|323503965|FG002|Overall Study|Unable to Complete Questionnaires|0|||
94468286|NCT01094782|323503966|FG003|Overall Study|Unable to Complete Questionnaires|0|||
94468287|NCT01094782|323503967|FG004|Overall Study|Unable to Complete Questionnaires|0|||
94468288|NCT01094782|323503968|FG005|Overall Study|Unable to Complete Questionnaires|0|||
94468289|NCT01094782|323503963|FG000|Overall Study|Healthy Subject Had Pain|0|||
94468290|NCT01094782|323503964|FG001|Overall Study|Healthy Subject Had Pain|1|||
94468291|NCT01094782|323503965|FG002|Overall Study|Healthy Subject Had Pain|0|||
94468292|NCT01094782|323503966|FG003|Overall Study|Healthy Subject Had Pain|0|||
94468293|NCT01094782|323503967|FG004|Overall Study|Healthy Subject Had Pain|0|||
94468294|NCT01094782|323503968|FG005|Overall Study|Healthy Subject Had Pain|0|||
94468295|NCT01094782|323503963|FG000|Overall Study|Hypertension|0|||
94468296|NCT01094782|323503964|FG001|Overall Study|Hypertension|0|||
94468297|NCT01094782|323503965|FG002|Overall Study|Hypertension|1|||
94468298|NCT01094782|323503966|FG003|Overall Study|Hypertension|0|||
94468299|NCT01094782|323503967|FG004|Overall Study|Hypertension|0|||
94468300|NCT01094782|323503968|FG005|Overall Study|Hypertension|0|||
94468301|NCT01094782|323503963|FG000|Overall Study|Wrong Pain Condition|0|||
94468302|NCT01094782|323503964|FG001|Overall Study|Wrong Pain Condition|0|||
94468303|NCT01094782|323503965|FG002|Overall Study|Wrong Pain Condition|0|||
94468304|NCT01094782|323503966|FG003|Overall Study|Wrong Pain Condition|2|||
94468305|NCT01094782|323503967|FG004|Overall Study|Wrong Pain Condition|1|||
94468306|NCT01094782|323503968|FG005|Overall Study|Wrong Pain Condition|1|||
94468307|NCT01094782|323503963|FG000|Overall Study|Recent Interventional Injection|0|||
94468308|NCT01094782|323503964|FG001|Overall Study|Recent Interventional Injection|0|||
94468309|NCT01094782|323503965|FG002|Overall Study|Recent Interventional Injection|0|||
94468310|NCT01094782|323503966|FG003|Overall Study|Recent Interventional Injection|0|||
94468311|NCT01094782|323503967|FG004|Overall Study|Recent Interventional Injection|0|||
94468312|NCT01094782|323503968|FG005|Overall Study|Recent Interventional Injection|1|||
94468313|NCT01094782|323503963|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
94468314|NCT01094782|323503964|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
94303006|NCT00624338|322891664|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
94303007|NCT00624338|322891665|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
94303008|NCT00624338|322891666|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
94303009|NCT00624338|322891664|FG000|Overall Study|Other|15|||
94303010|NCT00624338|322891665|FG001|Overall Study|Other|5|||
94303011|NCT00624338|322891666|FG002|Overall Study|Other|9|||
94303012|NCT00624338|322891664|FG000|Overall Study|Randomized but not treated|2|||
94303013|NCT00624338|322891665|FG001|Overall Study|Randomized but not treated|1|||
94303014|NCT00624338|322891666|FG002|Overall Study|Randomized but not treated|3|||
94303015|NCT01548638|322891667|FG000|Overall Study|Protocol Violation|3|||
94303016|NCT01548638|322891667|FG000|Overall Study|Withdrawal by Subject|1|||
94303017|NCT03885284|322891668|FG000|Overall Study|Disease Progression|1|||
94303018|NCT03885284|322891669|FG001|Overall Study|Disease Progression|3|||
94303019|NCT03885284|322891668|FG000|Overall Study|Physician Decision|0|||
94303020|NCT03885284|322891669|FG001|Overall Study|Physician Decision|1|||
94303021|NCT01450137|322891675|FG000|Up to Week 12|Adverse Event|2|||
94303022|NCT01450137|322891676|FG001|Up to Week 12|Adverse Event|1|||
94303023|NCT01450137|322891675|FG000|Up to Week 12|Withdrawal by Subject|0|||
94303024|NCT01450137|322891676|FG001|Up to Week 12|Withdrawal by Subject|2|||
94303025|NCT01450137|322891675|FG000|Week 12 to Study End|Death|0|||
94303026|NCT01450137|322891676|FG001|Week 12 to Study End|Death|1|||
94303027|NCT01450137|322891675|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
94303028|NCT01450137|322891676|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
94303029|NCT01450540|322891678|FG000|Overall Study|Withdrawal by Subject|19|||
94303030|NCT01450540|322891679|FG001|Overall Study|Withdrawal by Subject|13|||
94303031|NCT01450540|322891678|FG000|Overall Study|protocol deviation|3|||
94303032|NCT01450540|322891679|FG001|Overall Study|protocol deviation|23|||
94303033|NCT02986373|322891680|FG000|Overall Study|Adverse Event|4|||
94468315|NCT01094782|323503965|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
94468316|NCT01094782|323503966|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
94303034|NCT02986373|322891680|FG000|Overall Study|Lost to Follow-up|1|||
94303035|NCT02986373|322891680|FG000|Overall Study|Withdrawal by Subject|10|||
94303036|NCT02986373|322891680|FG000|Overall Study|Other|24|||
94303037|NCT01687673|322891682|FG000|Overall Study|Physician Decision|1|||
94303038|NCT03851510|322891683|FG000|Overall Study|Screen Fail|1|||
94303039|NCT03851510|322891683|FG000|Overall Study|Adverse Event|1|||
94303040|NCT03851510|322891683|FG000|Overall Study|Withdrawal by Subject|1|||
94303041|NCT01713348|322893500|FG000|Overall Study|Withdrawal by Subject|3|||
94303042|NCT01713348|322893501|FG001|Overall Study|Withdrawal by Subject|2|||
94303043|NCT01713348|322893502|FG002|Overall Study|Withdrawal by Subject|2|||
94303044|NCT01713348|322893503|FG003|Overall Study|Withdrawal by Subject|0|||
94303045|NCT01713348|322893500|FG000|Overall Study|Lost to Follow-up|1|||
94303046|NCT01713348|322893501|FG001|Overall Study|Lost to Follow-up|0|||
94303047|NCT01713348|322893502|FG002|Overall Study|Lost to Follow-up|0|||
94303048|NCT01713348|322893503|FG003|Overall Study|Lost to Follow-up|0|||
94303049|NCT00621023|322893505|FG000|Overall Study|Death|5|||
94303050|NCT00621023|322893505|FG000|Overall Study|Follow up discontinued|1|||
94303051|NCT04430348|322893510|FG000|Overall Study|Death|3|||
94303052|NCT04430348|322893511|FG001|Overall Study|Death|2|||
94303053|NCT04430348|322893512|FG002|Overall Study|Death|2|||
94303054|NCT04430348|322893513|FG003|Overall Study|Death|2|||
94303055|NCT04430348|322893514|FG004|Overall Study|Death|2|||
94303056|NCT04430348|322893515|FG005|Overall Study|Death|3|||
94303057|NCT04430348|322893510|FG000|Overall Study|Lost to Follow-up|0|||
94303058|NCT04430348|322893511|FG001|Overall Study|Lost to Follow-up|0|||
94303059|NCT04430348|322893512|FG002|Overall Study|Lost to Follow-up|0|||
94303060|NCT04430348|322893513|FG003|Overall Study|Lost to Follow-up|1|||
94303061|NCT04430348|322893514|FG004|Overall Study|Lost to Follow-up|0|||
94303062|NCT04430348|322893515|FG005|Overall Study|Lost to Follow-up|0|||
94303063|NCT04430348|322893510|FG000|Overall Study|Adverse Event|0|||
94303064|NCT04430348|322893511|FG001|Overall Study|Adverse Event|0|||
94303065|NCT04430348|322893512|FG002|Overall Study|Adverse Event|0|||
94303066|NCT04430348|322893513|FG003|Overall Study|Adverse Event|0|||
94303067|NCT04430348|322893514|FG004|Overall Study|Adverse Event|0|||
94303068|NCT04430348|322893515|FG005|Overall Study|Adverse Event|1|||
94303069|NCT04430348|322893510|FG000|Overall Study|Withdrawal by Subject|0|||
94303070|NCT04430348|322893511|FG001|Overall Study|Withdrawal by Subject|1|||
94303071|NCT04430348|322893512|FG002|Overall Study|Withdrawal by Subject|0|||
94303072|NCT04430348|322893513|FG003|Overall Study|Withdrawal by Subject|0|||
94303073|NCT04430348|322893514|FG004|Overall Study|Withdrawal by Subject|0|||
94303074|NCT04430348|322893515|FG005|Overall Study|Withdrawal by Subject|1|||
94303075|NCT04430348|322893510|FG000|Overall Study|Study Terminated by Sponsor|0|||
94303076|NCT04430348|322893511|FG001|Overall Study|Study Terminated by Sponsor|0|||
94303077|NCT04430348|322893512|FG002|Overall Study|Study Terminated by Sponsor|2|||
94303078|NCT04430348|322893513|FG003|Overall Study|Study Terminated by Sponsor|0|||
94303079|NCT04430348|322893514|FG004|Overall Study|Study Terminated by Sponsor|1|||
94303080|NCT04430348|322893515|FG005|Overall Study|Study Terminated by Sponsor|1|||
94303081|NCT02559505|322893516|FG000|Overall Study|Lost to Follow-up|23|||
94303082|NCT02559505|322893517|FG001|Overall Study|Lost to Follow-up|20|||
94303083|NCT02559505|322893516|FG000|Overall Study|Withdrawal by Subject|4|||
94303084|NCT02559505|322893517|FG001|Overall Study|Withdrawal by Subject|2|||
94303085|NCT00686205|322893518|FG000|Overall Study|Protocol Violation|127|||
94303086|NCT00686205|322893519|FG001|Overall Study|Protocol Violation|0|||
94303087|NCT00686205|322893518|FG000|Overall Study|Withdrawal by Subject|2|||
94303088|NCT00686205|322893519|FG001|Overall Study|Withdrawal by Subject|0|||
94303089|NCT00686205|322893518|FG000|Overall Study|Specimen handling procedure altered|5878|||
94303090|NCT00686205|322893519|FG001|Overall Study|Specimen handling procedure altered|0|||
94303091|NCT00686205|322893518|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
94303092|NCT00686205|322893519|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
94303093|NCT00265941|322893520|FG000|Overall Study|Protocol Violation|22|||
94303094|NCT00265941|322893521|FG001|Overall Study|Protocol Violation|25|||
94303095|NCT00265941|322893520|FG000|Overall Study|Lost to Follow-up|1|||
94303096|NCT00265941|322893521|FG001|Overall Study|Lost to Follow-up|1|||
94303097|NCT01381094|322893524|FG000|Overall Study|Adverse Event|1|||
94303098|NCT01381094|322893525|FG001|Overall Study|Adverse Event|2|||
94303099|NCT01381094|322893526|FG002|Overall Study|Adverse Event|0|||
94303100|NCT01381094|322893527|FG003|Overall Study|Adverse Event|1|||
94303101|NCT01381094|322893528|FG004|Overall Study|Adverse Event|0|||
94303102|NCT01381094|322893524|FG000|Overall Study|Lost to Follow-up|0|||
94303103|NCT01381094|322893525|FG001|Overall Study|Lost to Follow-up|0|||
94303104|NCT01381094|322893526|FG002|Overall Study|Lost to Follow-up|0|||
94303105|NCT01381094|322893527|FG003|Overall Study|Lost to Follow-up|0|||
94303106|NCT01381094|322893528|FG004|Overall Study|Lost to Follow-up|1|||
94303107|NCT01381094|322893524|FG000|Overall Study|Withdrawal of informed consent|0|||
94303108|NCT01381094|322893525|FG001|Overall Study|Withdrawal of informed consent|1|||
94303109|NCT01381094|322893526|FG002|Overall Study|Withdrawal of informed consent|0|||
94303110|NCT01381094|322893527|FG003|Overall Study|Withdrawal of informed consent|0|||
94303111|NCT01381094|322893528|FG004|Overall Study|Withdrawal of informed consent|0|||
94303112|NCT01381094|322893524|FG000|Overall Study|Participant given Aranesp injection|1|||
94303113|NCT01381094|322893525|FG001|Overall Study|Participant given Aranesp injection|0|||
94303114|NCT01381094|322893526|FG002|Overall Study|Participant given Aranesp injection|0|||
94303115|NCT01381094|322893527|FG003|Overall Study|Participant given Aranesp injection|0|||
94303116|NCT01381094|322893528|FG004|Overall Study|Participant given Aranesp injection|0|||
94375025|NCT01076166|323158728|FG000|Overall Study|Symptoms improved/resolved|6|||
94375026|NCT00457665|323158729|FG000|12 Months|Drug allergy|1|||
94375027|NCT00457665|323158730|FG001|12 Months|Drug allergy|1|||
94375028|NCT00457665|323158729|FG000|12 Months|High HIV viral load|5|||
94375029|NCT00457665|323158730|FG001|12 Months|High HIV viral load|1|||
94375030|NCT00457665|323158729|FG000|12 Months|Lipodystrophy|2|||
94375031|NCT00457665|323158730|FG001|12 Months|Lipodystrophy|0|||
94375032|NCT00457665|323158729|FG000|12 Months|Withdrawal by Subject|0|||
94375033|NCT00457665|323158730|FG001|12 Months|Withdrawal by Subject|2|||
94375034|NCT00457665|323158729|FG000|12 Months|Abnormal Liver function tests|0|||
94375035|NCT00457665|323158730|FG001|12 Months|Abnormal Liver function tests|5|||
94375036|NCT00457665|323158729|FG000|24 Months|Withdrawal by Subject|3|||
94375037|NCT00457665|323158730|FG001|24 Months|Withdrawal by Subject|2|||
94375038|NCT00457665|323158729|FG000|24 Months|Lipodystrophy|1|||
94375039|NCT00457665|323158730|FG001|24 Months|Lipodystrophy|1|||
94375040|NCT00457665|323158729|FG000|24 Months|Abnormal liver function tests|1|||
94375041|NCT00457665|323158730|FG001|24 Months|Abnormal liver function tests|5|||
94375042|NCT01722266|323158731|FG000|Overall Study|Withdrawal by Subject|1|||
94375043|NCT01722266|323158732|FG001|Overall Study|Withdrawal by Subject|2|||
94375044|NCT01722266|323158733|FG002|Overall Study|Withdrawal by Subject|0|||
94375045|NCT01722266|323158734|FG003|Overall Study|Withdrawal by Subject|0|||
94375046|NCT01722266|323158731|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
94375047|NCT01722266|323158732|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
94375048|NCT01722266|323158733|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
94375049|NCT01722266|323158734|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
94375050|NCT01722266|323158731|FG000|Overall Study|Dropped out due to Nausea|0|||
94375051|NCT01722266|323158732|FG001|Overall Study|Dropped out due to Nausea|0|||
94375052|NCT01722266|323158733|FG002|Overall Study|Dropped out due to Nausea|2|||
94375053|NCT01722266|323158734|FG003|Overall Study|Dropped out due to Nausea|0|||
94375054|NCT02535000|323158736|FG000|Overall Study|Cancellation of surgery.|1|||
94375055|NCT02535000|323158737|FG001|Overall Study|Cancellation of surgery.|2|||
94375056|NCT04317781|323158738|FG000|Overall Study|Adverse Event|1|||
94375057|NCT04317781|323158738|FG000|Overall Study|Disease relapse|1|||
94375058|NCT04317781|323158738|FG000|Overall Study|Withdrawal by Subject|1|||
94375059|NCT03124381|323158740|FG000|Overall Study|Lost to Follow-up|1|||
94375060|NCT03124381|323158741|FG001|Overall Study|Lost to Follow-up|1|||
94375061|NCT03124381|323158740|FG000|Overall Study|Withdrawal by Subject|6|||
94375062|NCT03124381|323158741|FG001|Overall Study|Withdrawal by Subject|3|||
94375063|NCT03124381|323158740|FG000|Overall Study|Protocol Violation|0|||
94375064|NCT03124381|323158741|FG001|Overall Study|Protocol Violation|1|||
94375065|NCT03124381|323158740|FG000|Overall Study|Adverse Event|1|||
94375066|NCT03124381|323158741|FG001|Overall Study|Adverse Event|1|||
94375067|NCT03124381|323158740|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
94375068|NCT03124381|323158741|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
94375069|NCT02151461|323158761|FG000|Overall Study|Adverse Event|5|||
94375070|NCT02151461|323158762|FG001|Overall Study|Adverse Event|1|||
94375071|NCT02151461|323158763|FG002|Overall Study|Adverse Event|0|||
94375072|NCT02151461|323158764|FG003|Overall Study|Adverse Event|2|||
94375073|NCT02151461|323158761|FG000|Overall Study|Lost to Follow-up|0|||
94375074|NCT02151461|323158762|FG001|Overall Study|Lost to Follow-up|0|||
94303117|NCT00719810|322893534|FG000|Overall Study|Adverse Event|0|||
94303118|NCT00719810|322893535|FG001|Overall Study|Adverse Event|2|||
94303119|NCT00719810|322893536|FG002|Overall Study|Adverse Event|3|||
94303120|NCT00719810|322893534|FG000|Overall Study|Lost to Follow-up|2|||
94303121|NCT00719810|322893535|FG001|Overall Study|Lost to Follow-up|0|||
94303122|NCT00719810|322893536|FG002|Overall Study|Lost to Follow-up|3|||
94303123|NCT00719810|322893534|FG000|Overall Study|Physician Decision|0|||
94303124|NCT00719810|322893535|FG001|Overall Study|Physician Decision|1|||
94303125|NCT00719810|322893536|FG002|Overall Study|Physician Decision|0|||
94303126|NCT00719810|322893534|FG000|Overall Study|Withdrawal by Subject|1|||
94303127|NCT00719810|322893535|FG001|Overall Study|Withdrawal by Subject|1|||
94303128|NCT00719810|322893536|FG002|Overall Study|Withdrawal by Subject|2|||
94303129|NCT02900092|322893539|FG000|Overall Study|Adverse Event|1|||
94303130|NCT04723537|322893540|FG000|Overall Study|Withdrawal by Subject|3|||
94303131|NCT04723537|322893541|FG001|Overall Study|Withdrawal by Subject|0|||
94303132|NCT04723537|322893542|FG002|Overall Study|Withdrawal by Subject|0|||
94303133|NCT04723537|322893540|FG000|Overall Study|Physician Decision|0|||
94303134|NCT04723537|322893541|FG001|Overall Study|Physician Decision|0|||
94303135|NCT04723537|322893542|FG002|Overall Study|Physician Decision|1|||
94375075|NCT02151461|323158763|FG002|Overall Study|Lost to Follow-up|1|||
94375076|NCT02151461|323158764|FG003|Overall Study|Lost to Follow-up|1|||
94375077|NCT02151461|323158761|FG000|Overall Study|Withdrawal by Subject|1|||
94375078|NCT02151461|323158762|FG001|Overall Study|Withdrawal by Subject|0|||
94468317|NCT01094782|323503967|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
94303136|NCT04723537|322893540|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
94375079|NCT02151461|323158763|FG002|Overall Study|Withdrawal by Subject|1|||
94375080|NCT02151461|323158764|FG003|Overall Study|Withdrawal by Subject|1|||
94375081|NCT02151461|323158761|FG000|Overall Study|Treatment discontinuation|0|||
94303137|NCT04723537|322893541|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
94303138|NCT04723537|322893542|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
94303139|NCT01486264|322893551|FG000|Overall Study|Death|1|||
94303140|NCT01486264|322893552|FG001|Overall Study|Death|1|||
94303141|NCT01486264|322893551|FG000|Overall Study|Adverse Event|3|||
94303142|NCT01486264|322893552|FG001|Overall Study|Adverse Event|3|||
94303143|NCT01486264|322893551|FG000|Overall Study|Lack of Efficacy|6|||
94303144|NCT01486264|322893552|FG001|Overall Study|Lack of Efficacy|10|||
94303145|NCT01486264|322893551|FG000|Overall Study|Withdrawal by Subject|7|||
94303146|NCT01486264|322893552|FG001|Overall Study|Withdrawal by Subject|18|||
94303147|NCT01486264|322893551|FG000|Overall Study|Physician Decision|1|||
94303148|NCT01486264|322893552|FG001|Overall Study|Physician Decision|1|||
94303149|NCT01486264|322893551|FG000|Overall Study|Protocol Violation|3|||
94303150|NCT01486264|322893552|FG001|Overall Study|Protocol Violation|0|||
94303151|NCT01486264|322893551|FG000|Overall Study|Lost to Follow-up|3|||
94303152|NCT01486264|322893552|FG001|Overall Study|Lost to Follow-up|2|||
94303153|NCT01486264|322893551|FG000|Overall Study|Other|5|||
94303154|NCT01486264|322893552|FG001|Overall Study|Other|11|||
94303155|NCT01486264|322893551|FG000|Overall Study|Not treated|0|||
94303156|NCT01486264|322893552|FG001|Overall Study|Not treated|1|||
94303157|NCT03185130|322893554|FG000|Overall Study|Withdrawal by Subject|0|||
94303158|NCT03185130|322893555|FG001|Overall Study|Withdrawal by Subject|2|||
94303159|NCT02504541|322893556|FG000|Overall Study|Adverse Event|4|||
94303160|NCT02504541|322893556|FG000|Overall Study|Withdrawal by Subject|4|||
94303161|NCT02504541|322893556|FG000|Overall Study|Lost to Follow-up|1|||
94303162|NCT02504541|322893556|FG000|Overall Study|Met Stopping Criteria|1|||
94303163|NCT02504541|322893556|FG000|Overall Study|Protocol Violation|2|||
94303164|NCT02504541|322893556|FG000|Overall Study|Termination by Sponsor|1|||
94303165|NCT02504541|322893556|FG000|Overall Study|Other|2|||
94303166|NCT02504541|322893556|FG000|Overall Study|Multiple|5|||
94303167|NCT04112914|322893563|FG000|Overall Study|Lost to Follow-up|13|||
94303168|NCT04112914|322893564|FG001|Overall Study|Lost to Follow-up|9|||
94303169|NCT04112914|322893563|FG000|Overall Study|Withdrawal by Subject|1|||
94303170|NCT04112914|322893564|FG001|Overall Study|Withdrawal by Subject|0|||
94303171|NCT01486238|322893565|FG000|Overall Study|Death|0|||
94303172|NCT01486238|322893566|FG001|Overall Study|Death|2|||
94303173|NCT01486238|322893565|FG000|Overall Study|Withdrawal by Subject|2|||
94303174|NCT01486238|322893566|FG001|Overall Study|Withdrawal by Subject|1|||
94303175|NCT01486238|322893565|FG000|Overall Study|Lost to Follow-up|0|||
94303176|NCT01486238|322893566|FG001|Overall Study|Lost to Follow-up|3|||
94303177|NCT00356915|322893567|FG000|Overall Study|Non compliance|1|||
94303178|NCT00356915|322893568|FG001|Overall Study|Non compliance|2|||
94303179|NCT00356915|322893569|FG002|Overall Study|Non compliance|1|||
94303180|NCT00356915|322893567|FG000|Overall Study|Protocol Violation|2|||
94303181|NCT00356915|322893568|FG001|Overall Study|Protocol Violation|3|||
94303182|NCT00356915|322893569|FG002|Overall Study|Protocol Violation|2|||
94303183|NCT00356915|322893567|FG000|Overall Study|Withdrawal by Subject|14|||
94303184|NCT00356915|322893568|FG001|Overall Study|Withdrawal by Subject|14|||
94303185|NCT00356915|322893569|FG002|Overall Study|Withdrawal by Subject|10|||
94303186|NCT00356915|322893567|FG000|Overall Study|Lack of Efficacy|0|||
94303187|NCT00356915|322893568|FG001|Overall Study|Lack of Efficacy|0|||
94303188|NCT00356915|322893569|FG002|Overall Study|Lack of Efficacy|3|||
94303189|NCT00356915|322893567|FG000|Overall Study|Lost to Follow-up|27|||
94303190|NCT00356915|322893568|FG001|Overall Study|Lost to Follow-up|34|||
94303191|NCT00356915|322893569|FG002|Overall Study|Lost to Follow-up|14|||
94303192|NCT00356915|322893567|FG000|Overall Study|Administrative Decision|0|||
94303193|NCT00356915|322893568|FG001|Overall Study|Administrative Decision|0|||
94375082|NCT02151461|323158762|FG001|Overall Study|Treatment discontinuation|0|||
94375083|NCT02151461|323158763|FG002|Overall Study|Treatment discontinuation|1|||
94303194|NCT00356915|322893569|FG002|Overall Study|Administrative Decision|1|||
94303195|NCT00356915|322893567|FG000|Overall Study|Physician Decision|0|||
94303196|NCT00356915|322893568|FG001|Overall Study|Physician Decision|2|||
94303197|NCT00356915|322893569|FG002|Overall Study|Physician Decision|0|||
94303198|NCT00356915|322893567|FG000|Overall Study|Adverse Event|21|||
94303199|NCT00356915|322893568|FG001|Overall Study|Adverse Event|31|||
94303200|NCT00356915|322893569|FG002|Overall Study|Adverse Event|8|||
94303201|NCT00356915|322893567|FG000|Overall Study|Miscellaneous reasons|11|||
94375084|NCT02151461|323158764|FG003|Overall Study|Treatment discontinuation|0|||
94303202|NCT00356915|322893568|FG001|Overall Study|Miscellaneous reasons|8|||
94303203|NCT00356915|322893569|FG002|Overall Study|Miscellaneous reasons|3|||
94303204|NCT01073943|322893579|FG000|Overall Study|Withdrawal by Subject|8|||
94303205|NCT01073943|322893580|FG001|Overall Study|Withdrawal by Subject|2|||
94303206|NCT01073943|322893579|FG000|Overall Study|Protocol Violation|2|||
94303207|NCT01073943|322893580|FG001|Overall Study|Protocol Violation|1|||
94375085|NCT01620489|323158765|FG000|Overall Study|Adverse Event|17|||
94303208|NCT01073943|322893579|FG000|Overall Study|Adverse Event|1|||
94303209|NCT01073943|322893580|FG001|Overall Study|Adverse Event|1|||
94303210|NCT01073943|322893579|FG000|Overall Study|Lost to Follow-up|0|||
94303211|NCT01073943|322893580|FG001|Overall Study|Lost to Follow-up|2|||
94303212|NCT01073943|322893579|FG000|Overall Study|Power outage; colonoscopy not done|1|||
94303213|NCT01073943|322893580|FG001|Overall Study|Power outage; colonoscopy not done|0|||
94303214|NCT01073943|322893579|FG000|Overall Study|Subject forgot|0|||
94303215|NCT01073943|322893580|FG001|Overall Study|Subject forgot|1|||
94303216|NCT01073943|322893579|FG000|Overall Study|Unable to return for follow-up|0|||
94303217|NCT01073943|322893580|FG001|Overall Study|Unable to return for follow-up|1|||
94303218|NCT01073943|322893579|FG000|Overall Study|Could not tolerate prep|1|||
94303219|NCT01073943|322893580|FG001|Overall Study|Could not tolerate prep|0|||
94303220|NCT01193335|322893586|FG000|After Infant Series|Lost to Follow-up|1|||
94303221|NCT01193335|322893587|FG001|After Infant Series|Lost to Follow-up|2|||
94303222|NCT01193335|322893586|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
94303223|NCT01193335|322893587|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
94303224|NCT01193335|322893586|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
94303225|NCT01193335|322893587|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
94303226|NCT01193335|322893586|FG000|1-Year Follow-up|Lost to Follow-up|4|||
94303227|NCT01193335|322893587|FG001|1-Year Follow-up|Lost to Follow-up|0|||
94303228|NCT01193335|322893586|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
94303229|NCT01193335|322893587|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
94303230|NCT01193335|322893586|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
94303231|NCT01193335|322893587|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
94303232|NCT02500550|322893596|FG000|Overall Study|Death|7|||
94303233|NCT01364467|322893598|FG000|Overall Study|Lost to Follow-up|1|||
94303234|NCT01364467|322893599|FG001|Overall Study|Lost to Follow-up|2|||
94303235|NCT01634243|322893600|FG000|Overall Study|Adverse Event|5|||
94303236|NCT01634243|322893601|FG001|Overall Study|Adverse Event|5|||
94303237|NCT01634243|322893600|FG000|Overall Study|Lack of Efficacy|1|||
94303238|NCT01634243|322893601|FG001|Overall Study|Lack of Efficacy|0|||
94303239|NCT03133767|322893613|FG000|Overall Study|Lost to Follow-up|38|||
94303240|NCT03133767|322893614|FG001|Overall Study|Lost to Follow-up|24|||
94303241|NCT03133767|322893613|FG000|Overall Study|Protocol Violation|0|||
94303242|NCT03133767|322893614|FG001|Overall Study|Protocol Violation|1|||
94303243|NCT03301857|322893615|FG000|Overall Study|Death|0|||
94303244|NCT03301857|322893616|FG001|Overall Study|Death|2|||
94303245|NCT03301857|322893615|FG000|Overall Study|Lost to Follow-up|4|||
94303246|NCT03301857|322893616|FG001|Overall Study|Lost to Follow-up|2|||
94303247|NCT03301857|322893615|FG000|Overall Study|Decision by Sponsor|6|||
94303248|NCT03301857|322893616|FG001|Overall Study|Decision by Sponsor|0|||
94303249|NCT03301857|322893615|FG000|Overall Study|Withdrawal by Subject|12|||
94303250|NCT03301857|322893616|FG001|Overall Study|Withdrawal by Subject|4|||
94303251|NCT04375878|322893619|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
94303252|NCT04375878|322893620|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
94303253|NCT04375878|322893621|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
94303254|NCT04375878|322893622|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
94303255|NCT04375878|322893623|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
94303256|NCT04375878|322893624|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
94303257|NCT04375878|322893619|FG000|Crossover First and Second Interventions|Adverse Event|0|||
94303258|NCT04375878|322893620|FG001|Crossover First and Second Interventions|Adverse Event|0|||
94303259|NCT04375878|322893621|FG002|Crossover First and Second Interventions|Adverse Event|1|||
94303260|NCT04375878|322893622|FG003|Crossover First and Second Interventions|Adverse Event|0|||
94303261|NCT04375878|322893623|FG004|Crossover First and Second Interventions|Adverse Event|0|||
94303262|NCT04375878|322893624|FG005|Crossover First and Second Interventions|Adverse Event|0|||
94303263|NCT04375878|322893619|FG000|Extension Phase|Withdrawal by Subject|0|||
94303264|NCT04375878|322893620|FG001|Extension Phase|Withdrawal by Subject|0|||
94303265|NCT04375878|322893621|FG002|Extension Phase|Withdrawal by Subject|0|||
94303266|NCT04375878|322893622|FG003|Extension Phase|Withdrawal by Subject|0|||
94303267|NCT04375878|322893623|FG004|Extension Phase|Withdrawal by Subject|1|||
94303268|NCT04375878|322893624|FG005|Extension Phase|Withdrawal by Subject|0|||
94303269|NCT01254344|322893625|FG000|Overall Study|Adverse Event|2|||
94303270|NCT01254344|322893626|FG001|Overall Study|Adverse Event|5|||
94303271|NCT01254344|322893625|FG000|Overall Study|Physician Decision|7|||
94303272|NCT01254344|322893626|FG001|Overall Study|Physician Decision|4|||
94303273|NCT01254344|322893625|FG000|Overall Study|Protocol Violation|1|||
94303274|NCT01254344|322893626|FG001|Overall Study|Protocol Violation|4|||
94303275|NCT01254344|322893625|FG000|Overall Study|Withdrawal by Subject|3|||
94303276|NCT01254344|322893626|FG001|Overall Study|Withdrawal by Subject|6|||
94303277|NCT00754390|322893627|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
94303278|NCT00754390|322893627|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
94303279|NCT00754390|322893627|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
94303280|NCT00754390|322893627|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
94303281|NCT03240081|322893628|FG000|Overall Study|Withdrawal by Subject|0|||
94303282|NCT03240081|322893629|FG001|Overall Study|Withdrawal by Subject|2|||
94303283|NCT03240081|322893628|FG000|Overall Study|Lost to Follow-up|0|||
94303284|NCT03240081|322893629|FG001|Overall Study|Lost to Follow-up|1|||
94303285|NCT00883753|322893630|FG000|Overall Study|Adverse Event|37|||
94303286|NCT00883753|322893630|FG000|Overall Study|Death|2|||
94303287|NCT00883753|322893630|FG000|Overall Study|Insufficient therapeutic response|16|||
94303288|NCT00883753|322893630|FG000|Overall Study|Lost to Follow-up|4|||
94303289|NCT00883753|322893630|FG000|Overall Study|Violation of selection criteria at entry|7|||
94303290|NCT00883753|322893630|FG000|Overall Study|Protocol Violation|2|||
94303291|NCT00883753|322893630|FG000|Overall Study|Refused treatment|4|||
94303292|NCT00883753|322893630|FG000|Overall Study|Withdrew consent|10|||
94303293|NCT00883753|322893630|FG000|Overall Study|Investigator's decision|17|||
94303294|NCT00883753|322893630|FG000|Overall Study|Administrative/Other|8|||
94303295|NCT02485717|322893633|FG000|Overall Study|Lost to Follow-up|6|||
94303296|NCT02485717|322893634|FG001|Overall Study|Lost to Follow-up|0|||
94303297|NCT02485717|322893635|FG002|Overall Study|Lost to Follow-up|0|||
94303298|NCT02485717|322893633|FG000|Overall Study|Withdrawal by Subject|0|||
94303299|NCT02485717|322893634|FG001|Overall Study|Withdrawal by Subject|0|||
94303300|NCT02485717|322893635|FG002|Overall Study|Withdrawal by Subject|1|||
94303301|NCT02485717|322893633|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
94303302|NCT02485717|322893634|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
94303303|NCT02485717|322893635|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
94303304|NCT02485717|322893633|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
94303305|NCT02485717|322893634|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
94303306|NCT02485717|322893635|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
94303307|NCT00519532|322893636|FG000|Overall Study|Adverse Event|11|||
94303308|NCT00519532|322893636|FG000|Overall Study|Withdrawal by Subject|5|||
94303309|NCT00519532|322893636|FG000|Overall Study|Lost to Follow-up|2|||
94303310|NCT03138564|322893639|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
94303311|NCT03138564|322893640|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
94303312|NCT03138564|322893639|FG000|Overall Study|Lost to Follow-up|16|||
94303313|NCT03138564|322893640|FG001|Overall Study|Lost to Follow-up|2|||
94303314|NCT03138564|322893639|FG000|Overall Study|Withdrawal by Subject|48|||
94303315|NCT03138564|322893640|FG001|Overall Study|Withdrawal by Subject|4|||
94303316|NCT03138564|322893639|FG000|Overall Study|No longer met eligibility criteria|2|||
94303317|NCT03138564|322893640|FG001|Overall Study|No longer met eligibility criteria|0|||
94303318|NCT03138564|322893639|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
94303319|NCT03138564|322893640|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
94303320|NCT03138564|322893639|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
94303321|NCT03138564|322893640|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
94303322|NCT03138564|322893639|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
94303323|NCT03138564|322893640|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
94303324|NCT03138564|322893639|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
94303325|NCT03138564|322893640|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
94303326|NCT02111811|322893641|FG000|Treatment Phase|Lost to Follow-up|22|||
94303327|NCT02111811|322893642|FG001|Treatment Phase|Lost to Follow-up|18|||
94303328|NCT02111811|322893641|FG000|Treatment Phase|Death|2|||
94303329|NCT02111811|322893642|FG001|Treatment Phase|Death|0|||
94303330|NCT02111811|322893641|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
94303331|NCT02111811|322893642|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
94303332|NCT02111811|322893641|FG000|Follow up Period (Aim 2)|Death|2|||
94303333|NCT02111811|322893642|FG001|Follow up Period (Aim 2)|Death|0|||
94303334|NCT02006576|322893654|FG000|Overall Study|Withdrawal by Subject|4|||
94303335|NCT02006576|322893655|FG001|Overall Study|Withdrawal by Subject|6|||
94303336|NCT02006576|322893656|FG002|Overall Study|Withdrawal by Subject|2|||
94303337|NCT02006576|322893654|FG000|Overall Study|Death|0|||
94303338|NCT02006576|322893655|FG001|Overall Study|Death|0|||
94303339|NCT02006576|322893656|FG002|Overall Study|Death|1|||
94303340|NCT02006576|322893654|FG000|Overall Study|Lost to Follow-up|1|||
94303341|NCT02006576|322893655|FG001|Overall Study|Lost to Follow-up|0|||
94303342|NCT02006576|322893656|FG002|Overall Study|Lost to Follow-up|1|||
94303343|NCT02006576|322893654|FG000|Overall Study|Screen Failure, too sick, other|13|||
94303344|NCT02006576|322893655|FG001|Overall Study|Screen Failure, too sick, other|1|||
94303345|NCT02006576|322893656|FG002|Overall Study|Screen Failure, too sick, other|13|||
94303346|NCT01151137|322893657|FG000|Overall Study|Death|15|||
94303347|NCT01151137|322893658|FG001|Overall Study|Death|27|||
94303348|NCT01151137|322893657|FG000|Overall Study|Lost to Follow-up|1|||
94303349|NCT01151137|322893658|FG001|Overall Study|Lost to Follow-up|1|||
94303350|NCT04090164|322893659|FG000|Overall Study|incomplete data on file|245|||
94303351|NCT04090164|322893660|FG001|Overall Study|incomplete data on file|0|||
94303352|NCT02452359|322893665|FG000|Overall Study|Adverse Event|1|||
94303353|NCT02452359|322893665|FG000|Overall Study|Lost to Follow-up|15|||
94303354|NCT02452359|322893665|FG000|Overall Study|Pregnancy|1|||
94303355|NCT02452359|322893665|FG000|Overall Study|Withdrawal by Subject|4|||
94303356|NCT01901328|322893673|FG000|Overall Study|Lost to Follow-up|1|||
94303357|NCT01901328|322893674|FG001|Overall Study|Lost to Follow-up|0|||
94303358|NCT01901328|322893673|FG000|Overall Study|Physician Decision|0|||
94303359|NCT01901328|322893674|FG001|Overall Study|Physician Decision|1|||
94303360|NCT01901328|322893673|FG000|Overall Study|Protocol Violation|1|||
94303361|NCT01901328|322893674|FG001|Overall Study|Protocol Violation|1|||
94303362|NCT01901328|322893673|FG000|Overall Study|Study Terminated by Sponsor|19|||
94303363|NCT01901328|322893674|FG001|Overall Study|Study Terminated by Sponsor|16|||
94303364|NCT01901328|322893673|FG000|Overall Study|Withdrawal by Subject|1|||
94303365|NCT01901328|322893674|FG001|Overall Study|Withdrawal by Subject|2|||
94303366|NCT01901328|322893673|FG000|Overall Study|Lack of Efficacy|0|||
94303367|NCT01901328|322893674|FG001|Overall Study|Lack of Efficacy|1|||
94303368|NCT04358458|322893677|FG000|Overall Study|Death|1|||
94303369|NCT04358458|322893678|FG001|Overall Study|Death|1|||
94303370|NCT04358458|322893679|FG002|Overall Study|Death|3|||
94303371|NCT04358458|322893680|FG003|Overall Study|Death|8|||
94303372|NCT04358458|322893681|FG004|Overall Study|Death|1|||
94303373|NCT04358458|322893682|FG005|Overall Study|Death|6|||
94303374|NCT04358458|322893683|FG006|Overall Study|Death|2|||
94303375|NCT04358458|322893684|FG007|Overall Study|Death|3|||
94303376|NCT04358458|322893677|FG000|Overall Study|Lost to Follow-up|0|||
94303377|NCT04358458|322893678|FG001|Overall Study|Lost to Follow-up|0|||
94303378|NCT04358458|322893679|FG002|Overall Study|Lost to Follow-up|0|||
94303379|NCT04358458|322893680|FG003|Overall Study|Lost to Follow-up|0|||
94303380|NCT04358458|322893681|FG004|Overall Study|Lost to Follow-up|0|||
94303381|NCT04358458|322893682|FG005|Overall Study|Lost to Follow-up|0|||
94303382|NCT04358458|322893683|FG006|Overall Study|Lost to Follow-up|0|||
94303383|NCT04358458|322893684|FG007|Overall Study|Lost to Follow-up|1|||
94303384|NCT04358458|322893677|FG000|Overall Study|Site is closing study participation|0|||
94303385|NCT04358458|322893678|FG001|Overall Study|Site is closing study participation|0|||
94303386|NCT04358458|322893679|FG002|Overall Study|Site is closing study participation|0|||
94303387|NCT04358458|322893680|FG003|Overall Study|Site is closing study participation|1|||
94303388|NCT04358458|322893681|FG004|Overall Study|Site is closing study participation|0|||
94303389|NCT04358458|322893682|FG005|Overall Study|Site is closing study participation|0|||
94303390|NCT04358458|322893683|FG006|Overall Study|Site is closing study participation|0|||
94303391|NCT04358458|322893684|FG007|Overall Study|Site is closing study participation|0|||
94303392|NCT04358458|322893677|FG000|Overall Study|Sponsor request|2|||
94303393|NCT04358458|322893678|FG001|Overall Study|Sponsor request|3|||
94303394|NCT04358458|322893679|FG002|Overall Study|Sponsor request|3|||
94303395|NCT04358458|322893680|FG003|Overall Study|Sponsor request|0|||
94303396|NCT04358458|322893681|FG004|Overall Study|Sponsor request|2|||
94303397|NCT04358458|322893682|FG005|Overall Study|Sponsor request|3|||
94303398|NCT04358458|322893683|FG006|Overall Study|Sponsor request|1|||
94303399|NCT04358458|322893684|FG007|Overall Study|Sponsor request|1|||
94303400|NCT04358458|322893677|FG000|Overall Study|Withdrawal by Subject|0|||
94303401|NCT04358458|322893678|FG001|Overall Study|Withdrawal by Subject|0|||
94303402|NCT04358458|322893679|FG002|Overall Study|Withdrawal by Subject|1|||
94303403|NCT04358458|322893680|FG003|Overall Study|Withdrawal by Subject|1|||
94303404|NCT04358458|322893681|FG004|Overall Study|Withdrawal by Subject|0|||
94303405|NCT04358458|322893682|FG005|Overall Study|Withdrawal by Subject|1|||
94303406|NCT04358458|322893683|FG006|Overall Study|Withdrawal by Subject|0|||
94303407|NCT04358458|322893684|FG007|Overall Study|Withdrawal by Subject|1|||
94303408|NCT03191786|322893685|FG000|Overall Study|Death|236|||
94303409|NCT03191786|322893686|FG001|Overall Study|Death|127|||
94303410|NCT03191786|322893685|FG000|Overall Study|Lost to Follow-up|9|||
94303411|NCT03191786|322893686|FG001|Overall Study|Lost to Follow-up|3|||
94303412|NCT03191786|322893685|FG000|Overall Study|Physician Decision|1|||
94303413|NCT03191786|322893686|FG001|Overall Study|Physician Decision|0|||
94303414|NCT03191786|322893685|FG000|Overall Study|Moved to Post Trial Access Program|30|||
94303415|NCT03191786|322893686|FG001|Overall Study|Moved to Post Trial Access Program|5|||
94303416|NCT03191786|322893685|FG000|Overall Study|Withdrawal by Subject|26|||
94303417|NCT03191786|322893686|FG001|Overall Study|Withdrawal by Subject|16|||
94303418|NCT01672892|322895358|FG000|Overall Study|Protocol Violation|7|||
94303419|NCT01672892|322895359|FG001|Overall Study|Protocol Violation|3|||
94303420|NCT01056107|322895360|FG000|Overall Study|Withdrawal by Subject|0|||
94303421|NCT01056107|322895361|FG001|Overall Study|Withdrawal by Subject|1|||
94303422|NCT01056107|322895362|FG002|Overall Study|Withdrawal by Subject|3|||
94303423|NCT01056107|322895363|FG003|Overall Study|Withdrawal by Subject|0|||
94303424|NCT04426630|322895371|FG000|Overall Study|Death|4|||
94303425|NCT04426630|322895371|FG000|Overall Study|Lost to Follow-up|2|||
94303426|NCT02579603|322895377|FG000|Overall Study|Not treated|1|||
94303427|NCT02579603|322895378|FG001|Overall Study|Not treated|0|||
94303428|NCT02579603|322895377|FG000|Overall Study|Adverse Event|2|||
94303429|NCT02579603|322895378|FG001|Overall Study|Adverse Event|2|||
94303430|NCT02579603|322895377|FG000|Overall Study|Other than stated|1|||
94375086|NCT01620489|323158766|FG001|Overall Study|Adverse Event|4|||
94375087|NCT01620489|323158765|FG000|Overall Study|Protocol Violation|0|||
94375088|NCT01620489|323158766|FG001|Overall Study|Protocol Violation|3|||
94375089|NCT01620489|323158765|FG000|Overall Study|Withdrawal Criteria|17|||
94375090|NCT01620489|323158766|FG001|Overall Study|Withdrawal Criteria|25|||
94375091|NCT01620489|323158765|FG000|Overall Study|Unclassified|1|||
94375092|NCT01620489|323158766|FG001|Overall Study|Unclassified|2|||
94303431|NCT02579603|322895378|FG001|Overall Study|Other than stated|0|||
94303432|NCT00573131|322895383|FG000|Overall Study|Withdrawal by Subject|10|||
94303433|NCT00573131|322895384|FG001|Overall Study|Withdrawal by Subject|8|||
94303434|NCT03090191|322895385|FG000|Overall Study|Adverse Event|90|||
94303435|NCT03090191|322895386|FG001|Overall Study|Adverse Event|72|||
94303436|NCT03090191|322895385|FG000|Overall Study|Death|365|||
94303437|NCT03090191|322895386|FG001|Overall Study|Death|358|||
94303438|NCT03090191|322895385|FG000|Overall Study|Lost to Follow-up|382|||
94303439|NCT03090191|322895386|FG001|Overall Study|Lost to Follow-up|394|||
94303440|NCT03090191|322895385|FG000|Overall Study|Physician Decision|77|||
94303441|NCT03090191|322895386|FG001|Overall Study|Physician Decision|66|||
94303442|NCT03090191|322895385|FG000|Overall Study|Protocol Violation|43|||
94303443|NCT03090191|322895386|FG001|Overall Study|Protocol Violation|52|||
94303444|NCT03090191|322895385|FG000|Overall Study|Withdrawal by Subject|2160|||
94303445|NCT03090191|322895386|FG001|Overall Study|Withdrawal by Subject|2133|||
94303446|NCT03090191|322895385|FG000|Overall Study|Site terminated|7|||
94303447|NCT03090191|322895386|FG001|Overall Study|Site terminated|8|||
94303448|NCT03090191|322895385|FG000|Overall Study|Other|66|||
94303449|NCT03090191|322895386|FG001|Overall Study|Other|60|||
94303450|NCT03090191|322895385|FG000|Overall Study|Withdrawn before any study vaccination|43|||
94303451|NCT03090191|322895386|FG001|Overall Study|Withdrawn before any study vaccination|52|||
94303452|NCT02024464|322895388|FG000|Overall Study|Discontinued|5|||
94303453|NCT02024464|322895389|FG001|Overall Study|Discontinued|4|||
94303454|NCT02024464|322895388|FG000|Overall Study|Missed Visits|1|||
94303455|NCT02024464|322895389|FG001|Overall Study|Missed Visits|0|||
94303456|NCT02024464|322895388|FG000|Overall Study|Lost to Follow-up|4|||
94303457|NCT02024464|322895389|FG001|Overall Study|Lost to Follow-up|7|||
94303458|NCT04419506|322895390|FG000|Overall Study|Adverse Event|0|||
94303459|NCT04419506|322895391|FG001|Overall Study|Adverse Event|10|||
94303460|NCT04419506|322895392|FG002|Overall Study|Adverse Event|0|||
94303461|NCT04419506|322895393|FG003|Overall Study|Adverse Event|3|||
94303462|NCT04419506|322895390|FG000|Overall Study|Withdrawal by Subject|0|||
94303463|NCT04419506|322895391|FG001|Overall Study|Withdrawal by Subject|0|||
94303464|NCT04419506|322895392|FG002|Overall Study|Withdrawal by Subject|0|||
94303465|NCT04419506|322895393|FG003|Overall Study|Withdrawal by Subject|1|||
94303466|NCT04419506|322895390|FG000|Overall Study|poor-compliance|0|||
94303467|NCT04419506|322895391|FG001|Overall Study|poor-compliance|0|||
94303468|NCT04419506|322895392|FG002|Overall Study|poor-compliance|0|||
94303469|NCT04419506|322895393|FG003|Overall Study|poor-compliance|1|||
94303470|NCT00384956|322895394|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
94303471|NCT03717922|322895395|FG000|Overall Study|Lost to Follow-up|2|||
94303472|NCT03717922|322895396|FG001|Overall Study|Lost to Follow-up|2|||
94303473|NCT02015819|322895397|FG000|Overall Study|Rickham catheter was misaligned|0|||
94303474|NCT02015819|322895398|FG001|Overall Study|Rickham catheter was misaligned|0|||
94303475|NCT02015819|322895399|FG002|Overall Study|Rickham catheter was misaligned|0|||
94303476|NCT02015819|322895400|FG003|Overall Study|Rickham catheter was misaligned|1|||
94303477|NCT00900796|322895405|FG000|Phase 1|Lacked sufficient information|4|||
94303478|NCT00900796|322895405|FG000|Phase 1|Missing information at Week 16|7|||
94303479|NCT00900796|322895405|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
94303480|NCT00900796|322895405|FG000|Phase 2|Lost to Follow-up|5|||
94303481|NCT02120417|322895428|FG000|Overall Study|Death|5|||
94303482|NCT02120417|322895429|FG001|Overall Study|Death|1|||
94303483|NCT02120417|322895428|FG000|Overall Study|Adverse Event|3|||
94303484|NCT02120417|322895429|FG001|Overall Study|Adverse Event|9|||
94303485|NCT02120417|322895428|FG000|Overall Study|Participant decision|4|||
94303486|NCT02120417|322895429|FG001|Overall Study|Participant decision|4|||
94303487|NCT02120417|322895428|FG000|Overall Study|Disease progression|41|||
94303488|NCT02120417|322895429|FG001|Overall Study|Disease progression|45|||
94303489|NCT02120417|322895428|FG000|Overall Study|Noncompliance with study treatment|0|||
94303490|NCT02120417|322895429|FG001|Overall Study|Noncompliance with study treatment|2|||
94303491|NCT02120417|322895428|FG000|Overall Study|Physician Decision|2|||
94303492|NCT02120417|322895429|FG001|Overall Study|Physician Decision|3|||
94303493|NCT02120417|322895428|FG000|Overall Study|Other unspecified|5|||
94303494|NCT02120417|322895429|FG001|Overall Study|Other unspecified|4|||
94303495|NCT00849212|322895430|FG000|Overall Study|Lack of Efficacy|1|||
94303496|NCT00849212|322895430|FG000|Overall Study|Withdrawal by Subject|3|||
94303497|NCT00849212|322895430|FG000|Overall Study|Adverse Event|2|||
94303498|NCT00849212|322895430|FG000|Overall Study|Miscellaneous|1|||
94303499|NCT01982630|322895440|FG000|Overall Study|Adverse Event|2|||
94303500|NCT01982630|322895441|FG001|Overall Study|Adverse Event|0|||
94303501|NCT01982630|322895442|FG002|Overall Study|Adverse Event|1|||
94303502|NCT01982630|322895443|FG003|Overall Study|Adverse Event|0|||
94303503|NCT01982630|322895444|FG004|Overall Study|Adverse Event|1|||
94303504|NCT01982630|322895445|FG005|Overall Study|Adverse Event|2|||
94303505|NCT01982630|322895446|FG006|Overall Study|Adverse Event|1|||
94303506|NCT01982630|322895447|FG007|Overall Study|Adverse Event|0|||
94303507|NCT01982630|322895440|FG000|Overall Study|Physician Decision|1|||
94303508|NCT01982630|322895441|FG001|Overall Study|Physician Decision|0|||
94303509|NCT01982630|322895442|FG002|Overall Study|Physician Decision|2|||
94303510|NCT01982630|322895443|FG003|Overall Study|Physician Decision|1|||
94303511|NCT01982630|322895444|FG004|Overall Study|Physician Decision|2|||
94303512|NCT01982630|322895445|FG005|Overall Study|Physician Decision|0|||
94303513|NCT01982630|322895446|FG006|Overall Study|Physician Decision|0|||
94303514|NCT01982630|322895447|FG007|Overall Study|Physician Decision|0|||
94303515|NCT01982630|322895440|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
94303516|NCT01982630|322895441|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
94303517|NCT01982630|322895442|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
94303518|NCT01982630|322895443|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
94303519|NCT01982630|322895444|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
94303520|NCT01982630|322895445|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
94303521|NCT01982630|322895446|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
94303522|NCT01982630|322895447|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
94303523|NCT01982630|322895440|FG000|Overall Study|Withdrawal by Subject|0|||
94303524|NCT01982630|322895441|FG001|Overall Study|Withdrawal by Subject|0|||
94303525|NCT01982630|322895442|FG002|Overall Study|Withdrawal by Subject|0|||
94303526|NCT01982630|322895443|FG003|Overall Study|Withdrawal by Subject|0|||
94303527|NCT01982630|322895444|FG004|Overall Study|Withdrawal by Subject|0|||
94303528|NCT01982630|322895445|FG005|Overall Study|Withdrawal by Subject|1|||
94303529|NCT01982630|322895446|FG006|Overall Study|Withdrawal by Subject|0|||
94303530|NCT01982630|322895447|FG007|Overall Study|Withdrawal by Subject|0|||
94303531|NCT01009294|322895448|FG000|Overall Study|Study discontinued by Sponsor|6|||
94303532|NCT00986349|322895452|FG000|Overall Study|Unsuccessful implant procedure|3|||
94303533|NCT00986349|322895452|FG000|Overall Study|Adverse Event|2|||
94303534|NCT00986349|322895452|FG000|Overall Study|Physician Decision|1|||
94303535|NCT00986349|322895452|FG000|Overall Study|device migration|1|||
94303536|NCT00561353|322895453|FG000|Overall Study|Subject reached a virologic endpoint|2|||
94303537|NCT00561353|322895454|FG001|Overall Study|Subject reached a virologic endpoint|1|||
94303538|NCT00561353|322895455|FG002|Overall Study|Subject reached a virologic endpoint|1|||
94303539|NCT00561353|322895456|FG003|Overall Study|Subject reached a virologic endpoint|4|||
94303540|NCT00561353|322895457|FG004|Overall Study|Subject reached a virologic endpoint|1|||
94303541|NCT00561353|322895458|FG005|Overall Study|Subject reached a virologic endpoint|3|||
94303542|NCT00561353|322895459|FG006|Overall Study|Subject reached a virologic endpoint|4|||
94303543|NCT00561353|322895460|FG007|Overall Study|Subject reached a virologic endpoint|4|||
94303544|NCT00561353|322895461|FG008|Overall Study|Subject reached a virologic endpoint|5|||
94303545|NCT00561353|322895462|FG009|Overall Study|Subject reached a virologic endpoint|0|||
94303546|NCT00561353|322895453|FG000|Overall Study|Subject ineligible to continue the trial|0|||
94303547|NCT00561353|322895454|FG001|Overall Study|Subject ineligible to continue the trial|0|||
94303548|NCT00561353|322895455|FG002|Overall Study|Subject ineligible to continue the trial|0|||
94303549|NCT00561353|322895456|FG003|Overall Study|Subject ineligible to continue the trial|0|||
94303550|NCT00561353|322895457|FG004|Overall Study|Subject ineligible to continue the trial|0|||
94303551|NCT00561353|322895458|FG005|Overall Study|Subject ineligible to continue the trial|1|||
94303552|NCT00561353|322895459|FG006|Overall Study|Subject ineligible to continue the trial|1|||
94303553|NCT00561353|322895460|FG007|Overall Study|Subject ineligible to continue the trial|0|||
94303554|NCT00561353|322895461|FG008|Overall Study|Subject ineligible to continue the trial|2|||
94303555|NCT00561353|322895462|FG009|Overall Study|Subject ineligible to continue the trial|1|||
94303556|NCT00561353|322895453|FG000|Overall Study|Other|1|||
94303557|NCT00561353|322895454|FG001|Overall Study|Other|0|||
94303558|NCT00561353|322895455|FG002|Overall Study|Other|1|||
94303559|NCT00561353|322895456|FG003|Overall Study|Other|0|||
94303560|NCT00561353|322895457|FG004|Overall Study|Other|0|||
94303561|NCT00561353|322895458|FG005|Overall Study|Other|2|||
94303562|NCT00561353|322895459|FG006|Overall Study|Other|0|||
94303563|NCT00561353|322895460|FG007|Overall Study|Other|0|||
94303564|NCT00561353|322895461|FG008|Overall Study|Other|0|||
94303565|NCT00561353|322895462|FG009|Overall Study|Other|0|||
94303566|NCT00561353|322895453|FG000|Overall Study|Adverse Event|0|||
94303567|NCT00561353|322895454|FG001|Overall Study|Adverse Event|0|||
94303568|NCT00561353|322895455|FG002|Overall Study|Adverse Event|0|||
94303569|NCT00561353|322895456|FG003|Overall Study|Adverse Event|2|||
94303570|NCT00561353|322895457|FG004|Overall Study|Adverse Event|0|||
94303571|NCT00561353|322895458|FG005|Overall Study|Adverse Event|0|||
94303572|NCT00561353|322895459|FG006|Overall Study|Adverse Event|1|||
94303573|NCT00561353|322895460|FG007|Overall Study|Adverse Event|0|||
94303574|NCT00561353|322895461|FG008|Overall Study|Adverse Event|0|||
94303575|NCT00561353|322895462|FG009|Overall Study|Adverse Event|1|||
94303576|NCT00561353|322895453|FG000|Overall Study|Lost to Follow-up|2|||
94303577|NCT00561353|322895454|FG001|Overall Study|Lost to Follow-up|0|||
94303578|NCT00561353|322895455|FG002|Overall Study|Lost to Follow-up|1|||
94303579|NCT00561353|322895456|FG003|Overall Study|Lost to Follow-up|0|||
94303580|NCT00561353|322895457|FG004|Overall Study|Lost to Follow-up|0|||
94303581|NCT00561353|322895458|FG005|Overall Study|Lost to Follow-up|0|||
94303582|NCT00561353|322895459|FG006|Overall Study|Lost to Follow-up|0|||
94303583|NCT00561353|322895460|FG007|Overall Study|Lost to Follow-up|0|||
94468318|NCT01094782|323503968|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
94468319|NCT01094782|323503963|FG000|Overall Study|Noncompliance With Study Schedule|0|||
94468320|NCT01094782|323503964|FG001|Overall Study|Noncompliance With Study Schedule|0|||
94468321|NCT01094782|323503965|FG002|Overall Study|Noncompliance With Study Schedule|0|||
94468322|NCT01094782|323503966|FG003|Overall Study|Noncompliance With Study Schedule|1|||
94468323|NCT01094782|323503967|FG004|Overall Study|Noncompliance With Study Schedule|0|||
94468324|NCT01094782|323503968|FG005|Overall Study|Noncompliance With Study Schedule|0|||
94468325|NCT00957905|323503973|FG000|Part B|Not Treated|0|||
94468326|NCT00957905|323503974|FG001|Part B|Not Treated|1|||
94468327|NCT00957905|323503973|FG000|Part B|Physician Decision|0|||
94468328|NCT00957905|323503974|FG001|Part B|Physician Decision|1|||
94468329|NCT00957905|323503973|FG000|Part B|Death|0|||
94468330|NCT00957905|323503974|FG001|Part B|Death|1|||
94468331|NCT00957905|323503973|FG000|Part B|Protocol Violation|0|||
94468332|NCT00957905|323503974|FG001|Part B|Protocol Violation|1|||
94468333|NCT02073656|323503977|FG000|Primary Study|Lost to Follow-up|6|||
94468334|NCT02073656|323503977|FG000|Primary Study|Death|1|||
94468335|NCT02073656|323503977|FG000|Primary Study|Withdrew Consent|1|||
94468336|NCT01260584|323503981|FG000|Period 1|Protocol Violation|0|||
94303584|NCT00561353|322895461|FG008|Overall Study|Lost to Follow-up|0|||
94303585|NCT00561353|322895462|FG009|Overall Study|Lost to Follow-up|0|||
94303586|NCT00561353|322895453|FG000|Overall Study|Withdrawal by Subject|0|||
94303587|NCT00561353|322895454|FG001|Overall Study|Withdrawal by Subject|2|||
94303588|NCT00561353|322895455|FG002|Overall Study|Withdrawal by Subject|0|||
94303589|NCT00561353|322895456|FG003|Overall Study|Withdrawal by Subject|0|||
94303590|NCT00561353|322895457|FG004|Overall Study|Withdrawal by Subject|0|||
94303591|NCT00561353|322895458|FG005|Overall Study|Withdrawal by Subject|0|||
94303592|NCT00561353|322895459|FG006|Overall Study|Withdrawal by Subject|0|||
94303593|NCT00561353|322895460|FG007|Overall Study|Withdrawal by Subject|0|||
94303594|NCT00561353|322895461|FG008|Overall Study|Withdrawal by Subject|0|||
94303595|NCT00561353|322895462|FG009|Overall Study|Withdrawal by Subject|0|||
94303596|NCT01856673|322895463|FG000|Overall Study|Withdrawal by Subject|44|||
94303597|NCT01856673|322895464|FG001|Overall Study|Withdrawal by Subject|50|||
94303598|NCT01856673|322895465|FG002|Overall Study|Withdrawal by Subject|33|||
94303599|NCT01856673|322895463|FG000|Overall Study|Lost to Follow-up|31|||
94303600|NCT01856673|322895464|FG001|Overall Study|Lost to Follow-up|34|||
94303601|NCT01856673|322895465|FG002|Overall Study|Lost to Follow-up|0|||
94303602|NCT01856673|322895463|FG000|Overall Study|Unknown reasons|9|||
94303603|NCT01856673|322895464|FG001|Overall Study|Unknown reasons|0|||
94303604|NCT01856673|322895465|FG002|Overall Study|Unknown reasons|0|||
94303605|NCT01856673|322895463|FG000|Overall Study|Psychologist decision|1|||
94303606|NCT01856673|322895464|FG001|Overall Study|Psychologist decision|0|||
94303607|NCT01856673|322895465|FG002|Overall Study|Psychologist decision|0|||
94303608|NCT01856673|322895463|FG000|Overall Study|Paperwork errors|8|||
94303609|NCT01856673|322895464|FG001|Overall Study|Paperwork errors|0|||
94303610|NCT01856673|322895465|FG002|Overall Study|Paperwork errors|0|||
94303611|NCT01856673|322895463|FG000|Overall Study|Death|1|||
94303612|NCT01856673|322895464|FG001|Overall Study|Death|1|||
94303613|NCT01856673|322895465|FG002|Overall Study|Death|0|||
94303614|NCT01856673|322895463|FG000|Overall Study|Protocol Violation|1|||
94303615|NCT01856673|322895464|FG001|Overall Study|Protocol Violation|0|||
94303616|NCT01856673|322895465|FG002|Overall Study|Protocol Violation|1|||
94303617|NCT02111369|322895466|FG000|Overall Study|Lost to Follow-up|2|||
94303618|NCT02111369|322895466|FG000|Overall Study|Withdrawal by Subject|1|||
94303619|NCT01273818|322895467|FG000|Overall Study|Physician Decision|13|||
94303620|NCT01273818|322895468|FG001|Overall Study|Physician Decision|2|||
94303621|NCT01273818|322895469|FG002|Overall Study|Physician Decision|9|||
94303622|NCT00820040|322895473|FG000|Overall Study|Death|1|||
94303623|NCT00820040|322895473|FG000|Overall Study|Sponsor terminated study|1|||
94303624|NCT00820040|322895473|FG000|Overall Study|Screen failure|1|||
94303625|NCT04332419|322895474|FG000|Overall Study|Withdrawal by Subject|1|||
94303626|NCT00971321|322895475|FG000|Up to Month 7|Withdrawal by Subject|1|||
94303627|NCT00971321|322895476|FG001|Up to Month 7|Withdrawal by Subject|0|||
94303628|NCT00971321|322895475|FG000|Up to Month 7|Migrated/moved from study area|3|||
94303629|NCT00971321|322895476|FG001|Up to Month 7|Migrated/moved from study area|2|||
94303630|NCT00971321|322895475|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
94468337|NCT01260584|323503982|FG001|Period 1|Protocol Violation|0|||
94468338|NCT01260584|323503983|FG002|Period 1|Protocol Violation|1|||
94468339|NCT01260584|323503984|FG003|Period 1|Protocol Violation|1|||
94468340|NCT01260584|323503981|FG000|Period 1|Adverse Event|0|||
94303631|NCT00971321|322895476|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
94303632|NCT00971321|322895475|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
94303633|NCT00971321|322895476|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
94303634|NCT00971321|322895475|FG000|Up to Month 11-12|Lost to Follow-up|1|||
94303635|NCT00971321|322895476|FG001|Up to Month 11-12|Lost to Follow-up|0|||
94303636|NCT01259466|322895479|FG000|Overall Study|Withdrawal by Subject|1|||
94303637|NCT01259466|322895480|FG001|Overall Study|Withdrawal by Subject|9|||
94468341|NCT01260584|323503982|FG001|Period 1|Adverse Event|0|||
94468342|NCT01260584|323503983|FG002|Period 1|Adverse Event|1|||
94303638|NCT02436239|322895483|FG000|Open-Lable Treatment Period|Adverse Event|12|||
94303639|NCT02436239|322895484|FG001|Open-Lable Treatment Period|Adverse Event|3|||
94303640|NCT02436239|322895485|FG002|Open-Lable Treatment Period|Adverse Event|4|||
94375093|NCT00871169|323158768|FG000|Overall Study|Protocol Violation|1|||
94375094|NCT00871169|323158768|FG000|Overall Study|Patient did not receive study treatment|2|||
94375095|NCT02168270|323158769|FG000|Overall Study|Lack of Efficacy|4|||
94375096|NCT03210259|323158773|FG000|12-Week Run-in Period|Adverse Event|1|||
94375097|NCT03210259|323158774|FG001|12-Week Run-in Period|Adverse Event|0|||
94375098|NCT03210259|323158775|FG002|12-Week Run-in Period|Adverse Event|0|||
94375099|NCT03210259|323158773|FG000|12-Week Run-in Period|Death|1|||
94375100|NCT03210259|323158774|FG001|12-Week Run-in Period|Death|0|||
94375101|NCT03210259|323158775|FG002|12-Week Run-in Period|Death|0|||
94375102|NCT03210259|323158773|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
94375103|NCT03210259|323158774|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
94375104|NCT03210259|323158775|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
94375105|NCT03210259|323158773|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
94375106|NCT03210259|323158774|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
94375107|NCT03210259|323158775|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
94375108|NCT03210259|323158773|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
94375109|NCT03210259|323158774|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
94375110|NCT03210259|323158775|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
94375111|NCT03210259|323158773|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
94375112|NCT03210259|323158774|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
94375113|NCT03210259|323158775|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
94375114|NCT03210259|323158773|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
94375115|NCT03210259|323158774|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
94375116|NCT03210259|323158775|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
94375117|NCT03210259|323158773|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
94375118|NCT03210259|323158774|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
94303641|NCT02436239|322895486|FG003|Open-Lable Treatment Period|Adverse Event|2|||
94303642|NCT02436239|322895483|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
94303643|NCT02436239|322895484|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
94303644|NCT02436239|322895485|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
94303645|NCT02436239|322895486|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
94303646|NCT02436239|322895483|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
94303647|NCT02436239|322895484|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
94303648|NCT02436239|322895485|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
94303649|NCT02436239|322895486|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
94303650|NCT02436239|322895483|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
94303651|NCT02436239|322895484|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
94303652|NCT02436239|322895485|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
94303653|NCT02436239|322895486|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
94303654|NCT02436239|322895483|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
94303655|NCT02436239|322895484|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
94303656|NCT02436239|322895485|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
94303657|NCT02436239|322895486|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
94303658|NCT02436239|322895483|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
94303659|NCT02436239|322895484|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
94303660|NCT02436239|322895485|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
94303661|NCT02436239|322895486|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
94303662|NCT02436239|322895483|FG000|Open-Lable Treatment Period|Other Reason|1|||
94303663|NCT02436239|322895484|FG001|Open-Lable Treatment Period|Other Reason|1|||
94375119|NCT03210259|323158775|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
94375120|NCT03210259|323158773|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
94375121|NCT03210259|323158774|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
94375122|NCT03210259|323158775|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
94375123|NCT03210259|323158773|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
94375124|NCT03210259|323158774|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
94375125|NCT03210259|323158775|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
94375126|NCT03210259|323158773|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
94375127|NCT03210259|323158774|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
94375128|NCT03210259|323158775|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
94375129|NCT02087059|323158776|FG000|Overall Study|Disease Progression|1|||
94375130|NCT02087059|323158776|FG000|Overall Study|Adverse Event|5|||
94375131|NCT02087059|323158776|FG000|Overall Study|Lost to Follow-up|1|||
94468343|NCT01260584|323503984|FG003|Period 1|Adverse Event|0|||
94468344|NCT01260584|323503981|FG000|Period 2|Protocol Violation|0|||
94303664|NCT02436239|322895485|FG002|Open-Lable Treatment Period|Other Reason|0|||
94303665|NCT02436239|322895486|FG003|Open-Lable Treatment Period|Other Reason|0|||
94303666|NCT02436239|322895483|FG000|Down-Taper Period|Withdrawal by Subject|4|||
94303667|NCT02436239|322895484|FG001|Down-Taper Period|Withdrawal by Subject|4|||
94303668|NCT02436239|322895485|FG002|Down-Taper Period|Withdrawal by Subject|1|||
94375132|NCT04896385|323158779|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
94375133|NCT04896385|323158780|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
94375134|NCT04896385|323158781|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
94303669|NCT02436239|322895486|FG003|Down-Taper Period|Withdrawal by Subject|2|||
94303670|NCT01824602|322895490|FG000|Overall Study|Withdrawal by Subject|0|||
94303671|NCT01824602|322895491|FG001|Overall Study|Withdrawal by Subject|0|||
94303672|NCT01824602|322895492|FG002|Overall Study|Withdrawal by Subject|1|||
94303673|NCT01824602|322895493|FG003|Overall Study|Withdrawal by Subject|2|||
94303674|NCT01824602|322895490|FG000|Overall Study|Patient non-compliance|0|||
94303675|NCT01824602|322895491|FG001|Overall Study|Patient non-compliance|0|||
94303676|NCT01824602|322895492|FG002|Overall Study|Patient non-compliance|1|||
94303677|NCT01824602|322895493|FG003|Overall Study|Patient non-compliance|0|||
94303678|NCT01824602|322895490|FG000|Overall Study|Adverse Event|1|||
94303679|NCT01824602|322895491|FG001|Overall Study|Adverse Event|0|||
94303680|NCT01824602|322895492|FG002|Overall Study|Adverse Event|2|||
94303681|NCT01824602|322895493|FG003|Overall Study|Adverse Event|2|||
94303682|NCT01824602|322895490|FG000|Overall Study|Treatment failure|0|||
94303683|NCT01824602|322895491|FG001|Overall Study|Treatment failure|0|||
94303684|NCT01824602|322895492|FG002|Overall Study|Treatment failure|0|||
94303685|NCT01824602|322895493|FG003|Overall Study|Treatment failure|1|||
94303686|NCT02498821|322895496|FG000|Overall Study|Screen failure|3|||
94303687|NCT02498821|322895497|FG001|Overall Study|Screen failure|5|||
94375135|NCT04896385|323158782|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
94375136|NCT04896385|323158779|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
94375137|NCT04896385|323158780|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
94375138|NCT04896385|323158781|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
94375139|NCT04896385|323158782|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
94375140|NCT04896385|323158779|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
94375141|NCT04896385|323158780|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
94375142|NCT04896385|323158781|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
94375143|NCT04896385|323158782|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
94375144|NCT04896385|323158779|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
94375145|NCT04896385|323158780|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
94375146|NCT04896385|323158781|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
94375147|NCT04896385|323158782|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
94375148|NCT04896385|323158779|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
94375149|NCT04896385|323158780|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
94375150|NCT04896385|323158781|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
94375151|NCT04896385|323158782|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
94375152|NCT04896385|323158779|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
94375153|NCT04896385|323158780|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
94375154|NCT04896385|323158781|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
94375155|NCT04896385|323158782|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
94375156|NCT01875445|323158783|FG000|Overall Study|Lost to Follow-up|5|||
94375157|NCT01875445|323158784|FG001|Overall Study|Lost to Follow-up|0|||
94375158|NCT01875445|323158783|FG000|Overall Study|Withdrawal by Subject|2|||
94375159|NCT01875445|323158784|FG001|Overall Study|Withdrawal by Subject|0|||
94375160|NCT05017493|323158785|FG000|Overall Study|Withdrawal by Subject|26|||
94375161|NCT05017493|323158786|FG001|Overall Study|Withdrawal by Subject|0|||
94375162|NCT05017493|323158785|FG000|Overall Study|Physician Decision|15|||
94375163|NCT05017493|323158786|FG001|Overall Study|Physician Decision|0|||
94375164|NCT05017493|323158785|FG000|Overall Study|Protocol Violation|81|||
94375165|NCT05017493|323158786|FG001|Overall Study|Protocol Violation|0|||
94375166|NCT01851590|323158788|FG000|Overall Study|Withdrawal by Subject|0|||
94375167|NCT01851590|323158789|FG001|Overall Study|Withdrawal by Subject|0|||
94375168|NCT01851590|323158790|FG002|Overall Study|Withdrawal by Subject|1|||
94375169|NCT01851590|323158788|FG000|Overall Study|Adverse Event|0|||
94375170|NCT01851590|323158789|FG001|Overall Study|Adverse Event|0|||
94375171|NCT01851590|323158790|FG002|Overall Study|Adverse Event|2|||
94375172|NCT01851590|323158788|FG000|Overall Study|Lack of Efficacy|0|||
94303688|NCT00761215|322895498|FG000|Overall Study|Randomized but didn't receive drug|1|||
94303689|NCT00761215|322895499|FG001|Overall Study|Randomized but didn't receive drug|1|||
94303690|NCT00761215|322895500|FG002|Overall Study|Randomized but didn't receive drug|2|||
94303691|NCT00761215|322895498|FG000|Overall Study|Lost to Follow-up|6|||
94375173|NCT01851590|323158789|FG001|Overall Study|Lack of Efficacy|1|||
94375174|NCT01851590|323158790|FG002|Overall Study|Lack of Efficacy|0|||
94375175|NCT01306253|323158795|FG000|Overall Study|Lost to Follow-up|1|||
94375176|NCT01306253|323158796|FG001|Overall Study|Lost to Follow-up|1|||
94375177|NCT05476679|323158800|FG000|Overall Study|Withdrawal by Subject|0|||
94375178|NCT05476679|323158801|FG001|Overall Study|Withdrawal by Subject|0|||
94303692|NCT00761215|322895499|FG001|Overall Study|Lost to Follow-up|3|||
94303693|NCT00761215|322895500|FG002|Overall Study|Lost to Follow-up|6|||
94303694|NCT00761215|322895498|FG000|Overall Study|Withdrawal by Subject|1|||
94303695|NCT00761215|322895499|FG001|Overall Study|Withdrawal by Subject|0|||
94375179|NCT05476679|323158802|FG002|Overall Study|Withdrawal by Subject|0|||
94375180|NCT05476679|323158803|FG003|Overall Study|Withdrawal by Subject|1|||
94375181|NCT05476679|323158804|FG004|Overall Study|Withdrawal by Subject|0|||
94375182|NCT05476679|323158800|FG000|Overall Study|Lost to Follow-up|0|||
94375183|NCT05476679|323158801|FG001|Overall Study|Lost to Follow-up|0|||
94375184|NCT05476679|323158802|FG002|Overall Study|Lost to Follow-up|0|||
94375185|NCT05476679|323158803|FG003|Overall Study|Lost to Follow-up|1|||
94375186|NCT05476679|323158804|FG004|Overall Study|Lost to Follow-up|0|||
94375187|NCT01211769|323158805|FG000|Overall Study|Lost to Follow-up|7|||
94375188|NCT01211769|323158806|FG001|Overall Study|Lost to Follow-up|9|||
94375189|NCT01211769|323158807|FG002|Overall Study|Lost to Follow-up|5|||
94375190|NCT01211769|323158808|FG003|Overall Study|Lost to Follow-up|9|||
94375191|NCT01211769|323158805|FG000|Overall Study|Physician Decision|2|||
94303696|NCT00761215|322895500|FG002|Overall Study|Withdrawal by Subject|0|||
94303697|NCT00761215|322895498|FG000|Overall Study|Bacteremia|1|||
94303698|NCT00761215|322895499|FG001|Overall Study|Bacteremia|0|||
94303699|NCT00761215|322895500|FG002|Overall Study|Bacteremia|0|||
94303700|NCT01716169|322895502|FG000|Overall Study|Adverse Event|1|||
94303701|NCT01716169|322895502|FG000|Overall Study|Lost to Follow-up|1|||
94303702|NCT01716169|322895502|FG000|Overall Study|Withdrawal by Subject|1|||
94303703|NCT01716169|322895502|FG000|Overall Study|inconsistent dressing application|1|||
94303704|NCT00667277|322895503|FG000|Overall Study|Withdrawal by Subject|2|||
94303705|NCT03443024|322895509|FG000|Overall Study|Adverse Event|2|||
94303706|NCT03443024|322895510|FG001|Overall Study|Adverse Event|4|||
94303707|NCT03443024|322895511|FG002|Overall Study|Adverse Event|3|||
94303708|NCT03443024|322895512|FG003|Overall Study|Adverse Event|1|||
94303709|NCT03443024|322895509|FG000|Overall Study|Lost to Follow-up|9|||
94303710|NCT03443024|322895510|FG001|Overall Study|Lost to Follow-up|9|||
94303711|NCT03443024|322895511|FG002|Overall Study|Lost to Follow-up|7|||
94303712|NCT03443024|322895512|FG003|Overall Study|Lost to Follow-up|5|||
94303713|NCT03443024|322895509|FG000|Overall Study|Withdrawal by Subject|8|||
94303714|NCT03443024|322895510|FG001|Overall Study|Withdrawal by Subject|15|||
94303715|NCT03443024|322895511|FG002|Overall Study|Withdrawal by Subject|9|||
94303716|NCT03443024|322895512|FG003|Overall Study|Withdrawal by Subject|23|||
94303717|NCT03443024|322895509|FG000|Overall Study|Physician Decision|1|||
94303718|NCT03443024|322895510|FG001|Overall Study|Physician Decision|2|||
94303719|NCT03443024|322895511|FG002|Overall Study|Physician Decision|0|||
94303720|NCT03443024|322895512|FG003|Overall Study|Physician Decision|1|||
94303721|NCT03443024|322895509|FG000|Overall Study|Sponsor Decision|1|||
94303722|NCT03443024|322895510|FG001|Overall Study|Sponsor Decision|1|||
94303723|NCT03443024|322895511|FG002|Overall Study|Sponsor Decision|0|||
94303724|NCT03443024|322895512|FG003|Overall Study|Sponsor Decision|0|||
94303725|NCT03443024|322895509|FG000|Overall Study|Protocol Deviation|0|||
94303726|NCT03443024|322895510|FG001|Overall Study|Protocol Deviation|0|||
94303727|NCT03443024|322895511|FG002|Overall Study|Protocol Deviation|0|||
94303728|NCT03443024|322895512|FG003|Overall Study|Protocol Deviation|2|||
94303729|NCT01926886|322895517|FG000|Overall Study|Administrative/other|1|||
94303730|NCT01926886|322895518|FG001|Overall Study|Administrative/other|0|||
94303731|NCT01926886|322895517|FG000|Overall Study|Adverse event/intercurrent illness|4|||
94303732|NCT01926886|322895518|FG001|Overall Study|Adverse event/intercurrent illness|0|||
94303733|NCT01926886|322895517|FG000|Overall Study|Disease progression/recurrence|4|||
94303734|NCT01926886|322895518|FG001|Overall Study|Disease progression/recurrence|0|||
94303735|NCT01926886|322895517|FG000|Overall Study|Withdrawal by Subject|15|||
94303736|NCT01926886|322895518|FG001|Overall Study|Withdrawal by Subject|0|||
94303737|NCT01926886|322895517|FG000|Overall Study|Failure to return|3|||
94375192|NCT01211769|323158806|FG001|Overall Study|Physician Decision|0|||
94375193|NCT01211769|323158807|FG002|Overall Study|Physician Decision|2|||
94468345|NCT01260584|323503982|FG001|Period 2|Protocol Violation|2|||
94468346|NCT01260584|323503983|FG002|Period 2|Protocol Violation|3|||
94468347|NCT01260584|323503984|FG003|Period 2|Protocol Violation|1|||
94468348|NCT01260584|323503981|FG000|Period 2|Adverse Event|1|||
94303738|NCT01926886|322895518|FG001|Overall Study|Failure to return|0|||
94303739|NCT01926886|322895517|FG000|Overall Study|Recurrence of disease|1|||
94303740|NCT01926886|322895518|FG001|Overall Study|Recurrence of disease|0|||
94303741|NCT01926886|322895517|FG000|Overall Study|Progression of disease|2|||
94303742|NCT01926886|322895518|FG001|Overall Study|Progression of disease|0|||
94303743|NCT01926886|322895517|FG000|Overall Study|Death|1|||
94303744|NCT01926886|322895518|FG001|Overall Study|Death|0|||
94303745|NCT01926886|322895517|FG000|Overall Study|Did not cooperate|1|||
94375194|NCT01211769|323158808|FG003|Overall Study|Physician Decision|1|||
94375195|NCT01211769|323158805|FG000|Overall Study|Adverse Event|0|||
94303746|NCT01926886|322895518|FG001|Overall Study|Did not cooperate|0|||
94303747|NCT02609399|322895519|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
94375196|NCT01211769|323158806|FG001|Overall Study|Adverse Event|1|||
94468349|NCT01260584|323503982|FG001|Period 2|Adverse Event|0|||
94468350|NCT01260584|323503983|FG002|Period 2|Adverse Event|2|||
94303748|NCT02609399|322895520|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
94303749|NCT02609399|322895519|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
94303750|NCT02609399|322895520|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
94303751|NCT02609399|322895519|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
94303752|NCT02609399|322895520|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
94303753|NCT01877655|322895533|FG000|Overall Study|Death|57|||
94468351|NCT01260584|323503984|FG003|Period 2|Adverse Event|0|||
94468352|NCT01260584|323503981|FG000|Period 2|Withdrawal by Subject|0|||
94468353|NCT01260584|323503982|FG001|Period 2|Withdrawal by Subject|1|||
94468354|NCT01260584|323503983|FG002|Period 2|Withdrawal by Subject|0|||
94468355|NCT01260584|323503984|FG003|Period 2|Withdrawal by Subject|0|||
94468356|NCT00045734|323503985|FG000|Overall Study|Protocol Violation|1|||
94468357|NCT03423147|323503986|FG000|Overall Study|Lost to Follow-up|5|||
94303754|NCT01877655|322895534|FG001|Overall Study|Death|52|||
94303755|NCT01877655|322895533|FG000|Overall Study|Withdrawal by Subject|18|||
94303756|NCT01877655|322895534|FG001|Overall Study|Withdrawal by Subject|26|||
94303757|NCT01877655|322895533|FG000|Overall Study|Physician Decision|11|||
94303758|NCT01877655|322895534|FG001|Overall Study|Physician Decision|10|||
94303759|NCT01877655|322895533|FG000|Overall Study|Miscellaneous|4|||
94303760|NCT01877655|322895534|FG001|Overall Study|Miscellaneous|4|||
94303761|NCT01877655|322895533|FG000|Overall Study|Randomized but Never Received Drug|8|||
94303762|NCT01877655|322895534|FG001|Overall Study|Randomized but Never Received Drug|5|||
94330898|NCT00118911|322991756|FG001|Overall Study|Withdrawal by Subject|5|||
94330899|NCT03814005|322991763|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
94330900|NCT03814005|322991764|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
94330901|NCT03814005|322991765|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
94330902|NCT03814005|322991763|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
94330903|NCT03814005|322991764|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
94330904|NCT03814005|322991765|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
94330905|NCT03814005|322991763|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
94330906|NCT03814005|322991764|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
94330907|NCT03814005|322991765|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
94330908|NCT03814005|322991763|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
94330909|NCT03814005|322991764|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
94330910|NCT03814005|322991765|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
94330911|NCT03814005|322991763|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
94330912|NCT03814005|322991764|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
94330913|NCT03814005|322991765|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
94330914|NCT03814005|322991763|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
94330915|NCT03814005|322991764|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
94330916|NCT03814005|322991765|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
94330917|NCT00810810|322991766|FG000|Overall Study|Withdrawal by Subject|0|||
94330918|NCT00810810|322991767|FG001|Overall Study|Withdrawal by Subject|8|||
94330919|NCT00810810|322991768|FG002|Overall Study|Withdrawal by Subject|10|||
94330920|NCT00810810|322991769|FG003|Overall Study|Withdrawal by Subject|8|||
94330921|NCT00810810|322991766|FG000|Overall Study|Physician Decision|0|||
94330922|NCT00810810|322991767|FG001|Overall Study|Physician Decision|3|||
94330923|NCT00810810|322991768|FG002|Overall Study|Physician Decision|1|||
94375197|NCT01211769|323158807|FG002|Overall Study|Adverse Event|1|||
94375198|NCT01211769|323158808|FG003|Overall Study|Adverse Event|1|||
94375199|NCT01086215|323158809|FG000|Overall Study|Death|14|||
94375200|NCT01086215|323158810|FG001|Overall Study|Death|8|||
94375201|NCT01086215|323158811|FG002|Overall Study|Death|8|||
94375202|NCT01086215|323158812|FG003|Overall Study|Death|1|||
94375203|NCT01086215|323158809|FG000|Overall Study|Lost to Follow-up|22|||
94375204|NCT01086215|323158810|FG001|Overall Study|Lost to Follow-up|39|||
94375205|NCT01086215|323158811|FG002|Overall Study|Lost to Follow-up|18|||
94375206|NCT01086215|323158812|FG003|Overall Study|Lost to Follow-up|2|||
94375207|NCT01862328|323158815|FG000|Overall Study|Progressive Disease|3|||
94375208|NCT01862328|323158816|FG001|Overall Study|Progressive Disease|11|||
94375209|NCT01862328|323158817|FG002|Overall Study|Progressive Disease|5|||
94375210|NCT01862328|323158818|FG003|Overall Study|Progressive Disease|6|||
94375211|NCT01862328|323158819|FG004|Overall Study|Progressive Disease|7|||
94375212|NCT01862328|323158820|FG005|Overall Study|Progressive Disease|4|||
94375213|NCT01862328|323158821|FG006|Overall Study|Progressive Disease|3|||
94468358|NCT03423147|323503987|FG001|Overall Study|Lost to Follow-up|8|||
94468359|NCT03423147|323503986|FG000|Overall Study|Withdrawal by Subject|1|||
94468360|NCT03423147|323503987|FG001|Overall Study|Withdrawal by Subject|0|||
94330924|NCT00810810|322991769|FG003|Overall Study|Physician Decision|5|||
94330925|NCT01819506|322991770|FG000|Overall Study|Physician Decision|5|||
94375214|NCT01862328|323158815|FG000|Overall Study|Adverse Event|0|||
94375215|NCT01862328|323158816|FG001|Overall Study|Adverse Event|4|||
94375216|NCT01862328|323158817|FG002|Overall Study|Adverse Event|0|||
94375217|NCT01862328|323158818|FG003|Overall Study|Adverse Event|1|||
94330926|NCT01819506|322991771|FG001|Overall Study|Physician Decision|2|||
94330927|NCT01819506|322991770|FG000|Overall Study|Withdrawal by Subject|3|||
94330928|NCT01819506|322991771|FG001|Overall Study|Withdrawal by Subject|3|||
94375218|NCT01862328|323158819|FG004|Overall Study|Adverse Event|0|||
94375219|NCT01862328|323158820|FG005|Overall Study|Adverse Event|2|||
94375220|NCT01862328|323158821|FG006|Overall Study|Adverse Event|4|||
94375221|NCT01862328|323158815|FG000|Overall Study|Other|0|||
94375222|NCT01862328|323158816|FG001|Overall Study|Other|2|||
94375223|NCT01862328|323158817|FG002|Overall Study|Other|1|||
94375224|NCT01862328|323158818|FG003|Overall Study|Other|0|||
94375225|NCT01862328|323158819|FG004|Overall Study|Other|4|||
94375226|NCT01862328|323158820|FG005|Overall Study|Other|0|||
94375227|NCT01862328|323158821|FG006|Overall Study|Other|1|||
94375228|NCT01862328|323158815|FG000|Overall Study|Withdrawal by Subject|1|||
94303763|NCT03439345|322896908|FG000|Overall Study|Lost to Follow-up|0|||
94303764|NCT03439345|322896909|FG001|Overall Study|Lost to Follow-up|1|||
94303765|NCT03439345|322896908|FG000|Overall Study|Consent withdrawn|0|||
94303766|NCT03439345|322896909|FG001|Overall Study|Consent withdrawn|1|||
94303767|NCT04909463|322896913|FG000|Overall Study|Withdrawal by Subject|0|||
94303768|NCT04909463|322896914|FG001|Overall Study|Withdrawal by Subject|1|||
94303769|NCT04909463|322896915|FG002|Overall Study|Withdrawal by Subject|0|||
94303770|NCT04909463|322896916|FG003|Overall Study|Withdrawal by Subject|0|||
94303771|NCT04909463|322896913|FG000|Overall Study|Lost to Follow-up|2|||
94303772|NCT04909463|322896914|FG001|Overall Study|Lost to Follow-up|1|||
94303773|NCT04909463|322896915|FG002|Overall Study|Lost to Follow-up|1|||
94303774|NCT04909463|322896916|FG003|Overall Study|Lost to Follow-up|0|||
94303775|NCT05635838|322896917|FG000|16-Week DBVC Period|Adverse Event|2|||
94303776|NCT05635838|322896918|FG001|16-Week DBVC Period|Adverse Event|0|||
94303777|NCT05635838|322896919|FG002|16-Week DBVC Period|Adverse Event|0|||
94303778|NCT05635838|322896920|FG003|16-Week DBVC Period|Adverse Event|0|||
94303779|NCT05635838|322896917|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
94303780|NCT05635838|322896918|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
94303781|NCT05635838|322896919|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
94303782|NCT05635838|322896920|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
94303783|NCT05635838|322896917|FG000|16-Week DBVC Period|Physician Decision|0|||
94303784|NCT05635838|322896918|FG001|16-Week DBVC Period|Physician Decision|1|||
94303785|NCT05635838|322896919|FG002|16-Week DBVC Period|Physician Decision|0|||
94303786|NCT05635838|322896920|FG003|16-Week DBVC Period|Physician Decision|0|||
94303787|NCT05635838|322896917|FG000|16-Week DBVC Period|Protocol Violation|1|||
94303788|NCT05635838|322896918|FG001|16-Week DBVC Period|Protocol Violation|0|||
94303789|NCT05635838|322896919|FG002|16-Week DBVC Period|Protocol Violation|0|||
94303790|NCT05635838|322896920|FG003|16-Week DBVC Period|Protocol Violation|0|||
94303791|NCT05635838|322896917|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
94303792|NCT05635838|322896918|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
94303793|NCT05635838|322896919|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
94303794|NCT05635838|322896920|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
94303795|NCT05635838|322896917|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
94303796|NCT05635838|322896918|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
94303797|NCT05635838|322896919|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
94303798|NCT05635838|322896920|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
94303799|NCT05635838|322896917|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
94303800|NCT05635838|322896918|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
94303801|NCT05635838|322896919|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
94303802|NCT05635838|322896920|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
94303803|NCT05635838|322896917|FG000|16-Week OLE Period|Adverse Event|0|||
94303804|NCT05635838|322896918|FG001|16-Week OLE Period|Adverse Event|0|||
94303805|NCT05635838|322896919|FG002|16-Week OLE Period|Adverse Event|0|||
94303806|NCT05635838|322896920|FG003|16-Week OLE Period|Adverse Event|2|||
94303807|NCT05635838|322896917|FG000|16-Week OLE Period|Lost to Follow-up|0|||
94303808|NCT05635838|322896918|FG001|16-Week OLE Period|Lost to Follow-up|0|||
94303809|NCT05635838|322896919|FG002|16-Week OLE Period|Lost to Follow-up|1|||
94303810|NCT05635838|322896920|FG003|16-Week OLE Period|Lost to Follow-up|3|||
94303811|NCT05635838|322896917|FG000|16-Week OLE Period|Physician Decision|0|||
94303812|NCT05635838|322896918|FG001|16-Week OLE Period|Physician Decision|0|||
94303813|NCT05635838|322896919|FG002|16-Week OLE Period|Physician Decision|0|||
94303814|NCT05635838|322896920|FG003|16-Week OLE Period|Physician Decision|1|||
94375229|NCT01862328|323158816|FG001|Overall Study|Withdrawal by Subject|1|||
94303815|NCT05635838|322896917|FG000|16-Week OLE Period|Protocol Violation|0|||
94303816|NCT05635838|322896918|FG001|16-Week OLE Period|Protocol Violation|0|||
94303817|NCT05635838|322896919|FG002|16-Week OLE Period|Protocol Violation|1|||
94303818|NCT05635838|322896920|FG003|16-Week OLE Period|Protocol Violation|1|||
94303819|NCT05635838|322896917|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
94303820|NCT05635838|322896918|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
94303821|NCT05635838|322896919|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
94303822|NCT05635838|322896920|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
94303823|NCT05635838|322896917|FG000|16-Week OLE Period|Pregnancy|0|||
94303824|NCT05635838|322896918|FG001|16-Week OLE Period|Pregnancy|0|||
94303825|NCT05635838|322896919|FG002|16-Week OLE Period|Pregnancy|1|||
94375230|NCT01862328|323158817|FG002|Overall Study|Withdrawal by Subject|0|||
94375231|NCT01862328|323158818|FG003|Overall Study|Withdrawal by Subject|0|||
94375232|NCT01862328|323158819|FG004|Overall Study|Withdrawal by Subject|1|||
94375233|NCT01862328|323158820|FG005|Overall Study|Withdrawal by Subject|1|||
94303826|NCT05635838|322896920|FG003|16-Week OLE Period|Pregnancy|0|||
94303827|NCT02143414|322896921|FG000|Induction|Adverse Event|1|||
94303828|NCT02143414|322896922|FG001|Induction|Adverse Event|2|||
94303829|NCT02143414|322896921|FG000|Induction|Death|1|||
94303830|NCT02143414|322896922|FG001|Induction|Death|2|||
94303831|NCT02143414|322896921|FG000|Induction|Patient refusal|1|||
94303832|NCT02143414|322896922|FG001|Induction|Patient refusal|1|||
94303833|NCT02143414|322896921|FG000|Induction|Refractory|1|||
94303834|NCT02143414|322896922|FG001|Induction|Refractory|0|||
94303835|NCT02143414|322896921|FG000|Induction|Began alternative treatment|1|||
94303836|NCT02143414|322896922|FG001|Induction|Began alternative treatment|0|||
94303837|NCT02143414|322896921|FG000|Induction|Ineligible for postremission|5|||
94303838|NCT02143414|322896922|FG001|Induction|Ineligible for postremission|1|||
94303839|NCT02143414|322896921|FG000|Post-remission|Adverse Event|0|||
94303840|NCT02143414|322896922|FG001|Post-remission|Adverse Event|2|||
94303841|NCT02143414|322896921|FG000|Post-remission|Disease progression/relapse|5|||
94303842|NCT02143414|322896922|FG001|Post-remission|Disease progression/relapse|0|||
94303843|NCT02143414|322896921|FG000|Maintenance|Adverse Event|4|||
94303844|NCT02143414|322896922|FG001|Maintenance|Adverse Event|6|||
94303845|NCT02143414|322896921|FG000|Maintenance|Disease progression/relapse|3|||
94303846|NCT02143414|322896922|FG001|Maintenance|Disease progression/relapse|2|||
94303847|NCT02143414|322896921|FG000|Maintenance|Patient refusal|2|||
94303848|NCT02143414|322896922|FG001|Maintenance|Patient refusal|1|||
94303849|NCT02143414|322896921|FG000|Maintenance|Physician Decision|1|||
94303850|NCT02143414|322896922|FG001|Maintenance|Physician Decision|0|||
94303851|NCT02143414|322896921|FG000|Maintenance|Death|0|||
94303852|NCT02143414|322896922|FG001|Maintenance|Death|1|||
94303853|NCT02143414|322896921|FG000|Maintenance|On protocol treatment|0|||
94303854|NCT02143414|322896922|FG001|Maintenance|On protocol treatment|6|||
94303855|NCT02342171|322896928|FG000|Overall Study|Death|4|||
94303856|NCT02342171|322896929|FG001|Overall Study|Death|87|||
94303857|NCT02342171|322896928|FG000|Overall Study|Received favipiravir|10|||
94303858|NCT02342171|322896929|FG001|Overall Study|Received favipiravir|0|||
94303859|NCT02342171|322896928|FG000|Overall Study|Missing cycle treshold value|1|||
94303860|NCT02342171|322896929|FG001|Overall Study|Missing cycle treshold value|0|||
94303861|NCT02342171|322896928|FG000|Overall Study|Unknown outcome|0|||
94303862|NCT02342171|322896929|FG001|Overall Study|Unknown outcome|1|||
94303863|NCT02342171|322896928|FG000|Overall Study|Missing age data|0|||
94303864|NCT02342171|322896929|FG001|Overall Study|Missing age data|1|||
94303865|NCT03167619|322896930|FG000|Overall Study|Death|11|||
94303866|NCT03167619|322896931|FG001|Overall Study|Death|8|||
94303867|NCT03167619|322896930|FG000|Overall Study|Withdrawal by Subject|1|||
94303868|NCT03167619|322896931|FG001|Overall Study|Withdrawal by Subject|2|||
94303869|NCT03167619|322896930|FG000|Overall Study|Physician Decision|0|||
94303870|NCT03167619|322896931|FG001|Overall Study|Physician Decision|1|||
94303871|NCT01006356|322896932|FG000|Overall Study|Adverse Event|6|||
94303872|NCT01006356|322896932|FG000|Overall Study|Physician Decision|1|||
94303873|NCT01006356|322896932|FG000|Overall Study|Paticipants did not cooperate|6|||
94303874|NCT01006356|322896932|FG000|Overall Study|Withdrawal by Subject|1|||
94303875|NCT01006356|322896932|FG000|Overall Study|Choice by participants|2|||
94303876|NCT01006356|322896932|FG000|Overall Study|Protocol Violation|3|||
94303877|NCT01006356|322896932|FG000|Overall Study|Other|23|||
94303878|NCT03095703|322896933|FG000|Overall Study|Withdrawal by Subject|1|||
94303879|NCT00613314|322896936|FG000|Overall Study|Adverse Event|5|||
94303880|NCT00613314|322896936|FG000|Overall Study|Protocol Violation|14|||
94303881|NCT00613314|322896936|FG000|Overall Study|Lost to Follow-up|46|||
94303882|NCT00613314|322896936|FG000|Overall Study|Other reason not defined above|90|||
94303883|NCT01584024|322896937|FG000|Overall Study|Lost to Follow-up|10|||
94303884|NCT01584024|322896937|FG000|Overall Study|Withdrawal by Subject|3|||
94375234|NCT01862328|323158821|FG006|Overall Study|Withdrawal by Subject|1|||
94375235|NCT01862328|323158815|FG000|Overall Study|Symptomatic Deterioration|0|||
94303885|NCT01217606|322896940|FG000|Initial Treatment Phase|Other Reasons|0|||
94375236|NCT01862328|323158816|FG001|Overall Study|Symptomatic Deterioration|0|||
94303886|NCT01217606|322896941|FG001|Initial Treatment Phase|Other Reasons|2|||
94303887|NCT01217606|322896940|FG000|Initial Treatment Phase|Protocol Violation|3|||
94303888|NCT01217606|322896941|FG001|Initial Treatment Phase|Protocol Violation|2|||
94303889|NCT01217606|322896940|FG000|Initial Treatment Phase|Personal Reasons|0|||
94303890|NCT01217606|322896941|FG001|Initial Treatment Phase|Personal Reasons|2|||
94303891|NCT01217606|322896940|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
94303892|NCT01217606|322896941|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
94303893|NCT01217606|322896940|FG000|Initial Treatment Phase|Adverse Event|10|||
94303894|NCT01217606|322896941|FG001|Initial Treatment Phase|Adverse Event|6|||
94303895|NCT01217606|322896940|FG000|9-Month Masked Extension|Adverse Event|3|||
94303896|NCT01217606|322896941|FG001|9-Month Masked Extension|Adverse Event|6|||
94303897|NCT01217606|322896940|FG000|9-Month Masked Extension|Other Reasons|4|||
94303898|NCT01217606|322896941|FG001|9-Month Masked Extension|Other Reasons|4|||
94303899|NCT01217606|322896940|FG000|9-Month Masked Extension|Personal Reasons|2|||
94303900|NCT01217606|322896941|FG001|9-Month Masked Extension|Personal Reasons|1|||
94303901|NCT01217606|322896940|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
94303902|NCT01217606|322896941|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
94303903|NCT01217606|322896940|FG000|9-Month Masked Extension|Pregnancy|1|||
94303904|NCT01217606|322896941|FG001|9-Month Masked Extension|Pregnancy|0|||
94303905|NCT01217606|322896940|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
94303906|NCT01217606|322896941|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
94303907|NCT02424539|322896949|FG000|Overall Study|Adverse Event|0|||
94303908|NCT02424539|322896950|FG001|Overall Study|Adverse Event|0|||
94303909|NCT02424539|322896951|FG002|Overall Study|Adverse Event|1|||
94303910|NCT02424539|322896949|FG000|Overall Study|Physician Decision|0|||
94303911|NCT02424539|322896950|FG001|Overall Study|Physician Decision|0|||
94303912|NCT02424539|322896951|FG002|Overall Study|Physician Decision|1|||
94303913|NCT02424539|322896949|FG000|Overall Study|Withdrawal by Subject|3|||
94303914|NCT02424539|322896950|FG001|Overall Study|Withdrawal by Subject|1|||
94303915|NCT02424539|322896951|FG002|Overall Study|Withdrawal by Subject|0|||
94303916|NCT02424539|322896949|FG000|Overall Study|Other: Reached stopping criteria|11|||
94303917|NCT02424539|322896950|FG001|Overall Study|Other: Reached stopping criteria|7|||
94303918|NCT02424539|322896951|FG002|Overall Study|Other: Reached stopping criteria|6|||
94303919|NCT01697215|322896959|FG000|Overall Study|Physician Decision|5|||
94303920|NCT01697215|322896959|FG000|Overall Study|Malfunction|9|||
94303921|NCT01697215|322896959|FG000|Overall Study|CXR not available|9|||
94303922|NCT04899271|322896960|FG000|Overall Study|Lost to Follow-up|1|||
94303923|NCT04899271|322896961|FG001|Overall Study|Lost to Follow-up|0|||
94303924|NCT04899271|322896960|FG000|Overall Study|Subject request/consent withdrawal|2|||
94303925|NCT04899271|322896961|FG001|Overall Study|Subject request/consent withdrawal|0|||
94303926|NCT03584009|322896970|FG000|Overall Study|Death|25|||
94303927|NCT03584009|322896971|FG001|Overall Study|Death|18|||
94303928|NCT03584009|322896970|FG000|Overall Study|Lost to Follow-up|0|||
94303929|NCT03584009|322896971|FG001|Overall Study|Lost to Follow-up|1|||
94303930|NCT03584009|322896970|FG000|Overall Study|Physician Decision|1|||
94303931|NCT03584009|322896971|FG001|Overall Study|Physician Decision|1|||
94303932|NCT03584009|322896970|FG000|Overall Study|Study Terminated by Sponsor|22|||
94303933|NCT03584009|322896971|FG001|Overall Study|Study Terminated by Sponsor|30|||
94303934|NCT03584009|322896970|FG000|Overall Study|Withdrawal by Subject|3|||
94303935|NCT03584009|322896971|FG001|Overall Study|Withdrawal by Subject|2|||
94303936|NCT00446030|322896972|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
94303937|NCT00446030|322896973|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
94303938|NCT00446030|322896972|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
94303939|NCT00446030|322896973|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
94303940|NCT00446030|322896972|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
94303941|NCT00446030|322896973|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
94303942|NCT00446030|322896972|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
94303943|NCT00446030|322896973|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
94303944|NCT00446030|322896972|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
94303945|NCT00446030|322896973|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
94303946|NCT00446030|322896972|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
94303947|NCT00446030|322896973|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
94303948|NCT00446030|322896972|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
94303949|NCT00446030|322896973|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
94303950|NCT00446030|322896972|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
94303951|NCT00446030|322896973|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
94303952|NCT00446030|322896972|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
94303953|NCT00446030|322896973|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
94303954|NCT00446030|322896972|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
94303955|NCT00446030|322896973|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
94303956|NCT00446030|322896972|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
94303957|NCT00446030|322896973|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
94303958|NCT00446030|322896972|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
94375237|NCT01862328|323158817|FG002|Overall Study|Symptomatic Deterioration|0|||
94375238|NCT01862328|323158818|FG003|Overall Study|Symptomatic Deterioration|0|||
94375239|NCT01862328|323158819|FG004|Overall Study|Symptomatic Deterioration|0|||
94303959|NCT00446030|322896973|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
94303960|NCT00446030|322896972|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
94303961|NCT00446030|322896973|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
94303962|NCT00446030|322896972|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
94303963|NCT00446030|322896973|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
94303964|NCT00446030|322896972|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
94303965|NCT00446030|322896973|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
94303966|NCT00446030|322896972|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
94303967|NCT00446030|322896973|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
94303968|NCT00446030|322896972|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
94303969|NCT00446030|322896973|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
94375240|NCT01862328|323158820|FG005|Overall Study|Symptomatic Deterioration|0|||
94375241|NCT01862328|323158821|FG006|Overall Study|Symptomatic Deterioration|1|||
94303970|NCT00446030|322896972|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
94303971|NCT00446030|322896973|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
94303972|NCT00446030|322896972|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
94303973|NCT00446030|322896973|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
94303974|NCT03596164|322896974|FG000|Overall Study|Adverse Event|0|||
94303975|NCT03596164|322896975|FG001|Overall Study|Adverse Event|1|||
94303976|NCT03596164|322896974|FG000|Overall Study|Death|1|||
94303977|NCT03596164|322896975|FG001|Overall Study|Death|0|||
94303978|NCT00594399|322896976|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
94303979|NCT00594399|322896977|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
94303980|NCT00594399|322896978|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
94303981|NCT00594399|322896976|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
94303982|NCT00594399|322896977|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
94303983|NCT00594399|322896978|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
94303984|NCT00594399|322896976|FG000|Initial 3 Month Counseling|Personal issues|2|||
94303985|NCT00594399|322896977|FG001|Initial 3 Month Counseling|Personal issues|0|||
94303986|NCT00594399|322896978|FG002|Initial 3 Month Counseling|Personal issues|0|||
94303987|NCT00594399|322896976|FG000|Initial 3 Month Counseling|Too busy|7|||
94303988|NCT00594399|322896977|FG001|Initial 3 Month Counseling|Too busy|1|||
94303989|NCT00594399|322896978|FG002|Initial 3 Month Counseling|Too busy|0|||
94303990|NCT00594399|322896976|FG000|Initial 3 Month Counseling|Pain|2|||
94303991|NCT00594399|322896977|FG001|Initial 3 Month Counseling|Pain|0|||
94303992|NCT00594399|322896978|FG002|Initial 3 Month Counseling|Pain|0|||
94303993|NCT00594399|322896976|FG000|Initial 3 Month Counseling|Moved|1|||
94303994|NCT00594399|322896977|FG001|Initial 3 Month Counseling|Moved|0|||
94303995|NCT00594399|322896978|FG002|Initial 3 Month Counseling|Moved|0|||
94303996|NCT00594399|322896976|FG000|Initial 3 Month Counseling|Family illness|1|||
94303997|NCT00594399|322896977|FG001|Initial 3 Month Counseling|Family illness|0|||
94303998|NCT00594399|322896978|FG002|Initial 3 Month Counseling|Family illness|0|||
94303999|NCT00594399|322896976|FG000|Rerandomization Arm 1 Only|Death|2|||
94304000|NCT00594399|322896977|FG001|Rerandomization Arm 1 Only|Death|1|||
94304001|NCT00594399|322896978|FG002|Rerandomization Arm 1 Only|Death|0|||
94304002|NCT00594399|322896976|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
94304003|NCT00594399|322896977|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
94304004|NCT00594399|322896978|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
94304005|NCT00659438|322896979|FG000|Overall Study|Withdrawal by Subject|2|||
94304006|NCT00659438|322896980|FG001|Overall Study|Withdrawal by Subject|2|||
94304007|NCT00659438|322896979|FG000|Overall Study|Death|11|||
94304008|NCT00659438|322896980|FG001|Overall Study|Death|6|||
94304009|NCT00659438|322896979|FG000|Overall Study|Lost to Follow-up|1|||
94304010|NCT00659438|322896980|FG001|Overall Study|Lost to Follow-up|0|||
94304011|NCT00845429|322896983|FG000|Overall Study|Protocol Violation|5|||
94304012|NCT00845429|322896984|FG001|Overall Study|Protocol Violation|4|||
94304013|NCT00845429|322896985|FG002|Overall Study|Protocol Violation|7|||
94304014|NCT00845429|322896983|FG000|Overall Study|Lost to Follow-up|7|||
94304015|NCT00845429|322896984|FG001|Overall Study|Lost to Follow-up|9|||
94304016|NCT00845429|322896985|FG002|Overall Study|Lost to Follow-up|10|||
94304017|NCT00845429|322896983|FG000|Overall Study|Withdrawal by Subject|2|||
94304018|NCT00845429|322896984|FG001|Overall Study|Withdrawal by Subject|2|||
94304019|NCT00845429|322896985|FG002|Overall Study|Withdrawal by Subject|2|||
94304020|NCT00845429|322896983|FG000|Overall Study|Serious adverse event|0|||
94304021|NCT00845429|322896984|FG001|Overall Study|Serious adverse event|0|||
94304022|NCT00845429|322896985|FG002|Overall Study|Serious adverse event|1|||
94304023|NCT01480180|322896986|FG000|Main Phase|Withdrawal criteria|12|||
94304024|NCT01480180|322896987|FG001|Main Phase|Withdrawal criteria|1|||
94304025|NCT01480180|322896988|FG002|Main Phase|Withdrawal criteria|0|||
94304026|NCT01480180|322896989|FG003|Main Phase|Withdrawal criteria|0|||
94304027|NCT01480180|322896990|FG004|Main Phase|Withdrawal criteria|0|||
94304028|NCT01480180|322896991|FG005|Main Phase|Withdrawal criteria|0|||
94304029|NCT01480180|322896986|FG000|Main Phase|Lack of Efficacy|1|||
94304030|NCT01480180|322896987|FG001|Main Phase|Lack of Efficacy|0|||
94304031|NCT01480180|322896988|FG002|Main Phase|Lack of Efficacy|0|||
94304032|NCT01480180|322896989|FG003|Main Phase|Lack of Efficacy|0|||
94304033|NCT01480180|322896990|FG004|Main Phase|Lack of Efficacy|0|||
94304034|NCT01480180|322896991|FG005|Main Phase|Lack of Efficacy|0|||
94304035|NCT01480180|322896986|FG000|Main Phase|Non-compliance|3|||
94304036|NCT01480180|322896987|FG001|Main Phase|Non-compliance|0|||
94468361|NCT03423147|323503986|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
94304037|NCT01480180|322896988|FG002|Main Phase|Non-compliance|0|||
94304038|NCT01480180|322896989|FG003|Main Phase|Non-compliance|0|||
94304039|NCT01480180|322896990|FG004|Main Phase|Non-compliance|0|||
94304040|NCT01480180|322896991|FG005|Main Phase|Non-compliance|0|||
94304041|NCT01480180|322896986|FG000|Main Phase|Unclassified|3|||
94304042|NCT01480180|322896987|FG001|Main Phase|Unclassified|0|||
94304043|NCT01480180|322896988|FG002|Main Phase|Unclassified|0|||
94304044|NCT01480180|322896989|FG003|Main Phase|Unclassified|0|||
94304045|NCT01480180|322896990|FG004|Main Phase|Unclassified|0|||
94304046|NCT01480180|322896991|FG005|Main Phase|Unclassified|0|||
94304047|NCT01480180|322896986|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
94304048|NCT01480180|322896987|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
94304049|NCT01480180|322896988|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
94304050|NCT01480180|322896989|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
94304051|NCT01480180|322896990|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
94304052|NCT01480180|322896991|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
94304053|NCT01480180|322896986|FG000|Extension Phase, Part 1|Unclassified|0|||
94304054|NCT01480180|322896987|FG001|Extension Phase, Part 1|Unclassified|0|||
94304055|NCT01480180|322896988|FG002|Extension Phase, Part 1|Unclassified|1|||
94304056|NCT01480180|322896989|FG003|Extension Phase, Part 1|Unclassified|0|||
94304057|NCT01480180|322896990|FG004|Extension Phase, Part 1|Unclassified|0|||
94304058|NCT01480180|322896991|FG005|Extension Phase, Part 1|Unclassified|0|||
94304059|NCT01480180|322896986|FG000|Extension Phase, Part 1|Adverse Event|0|||
94304060|NCT01480180|322896987|FG001|Extension Phase, Part 1|Adverse Event|0|||
94304061|NCT01480180|322896988|FG002|Extension Phase, Part 1|Adverse Event|4|||
94304062|NCT01480180|322896989|FG003|Extension Phase, Part 1|Adverse Event|1|||
94304063|NCT01480180|322896990|FG004|Extension Phase, Part 1|Adverse Event|0|||
94304064|NCT01480180|322896991|FG005|Extension Phase, Part 1|Adverse Event|0|||
94304065|NCT01480180|322896986|FG000|Extension Phase, Part 1|Change of treatment|0|||
94304066|NCT01480180|322896987|FG001|Extension Phase, Part 1|Change of treatment|0|||
94304067|NCT01480180|322896988|FG002|Extension Phase, Part 1|Change of treatment|0|||
94304068|NCT01480180|322896989|FG003|Extension Phase, Part 1|Change of treatment|9|||
94304069|NCT01480180|322896990|FG004|Extension Phase, Part 1|Change of treatment|0|||
94304070|NCT01480180|322896991|FG005|Extension Phase, Part 1|Change of treatment|0|||
94304071|NCT01480180|322896986|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
94304072|NCT01480180|322896987|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
94304073|NCT01480180|322896988|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
94304074|NCT01480180|322896989|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
94304075|NCT01480180|322896990|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
94304076|NCT01480180|322896991|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
94304077|NCT01480180|322896986|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
94304078|NCT01480180|322896987|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
94304079|NCT01480180|322896988|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
94304080|NCT01480180|322896989|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
94304081|NCT01480180|322896990|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
94304082|NCT01480180|322896991|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
94304083|NCT01480180|322896986|FG000|Extension Phase, Part 2|Unclassified|0|||
94304084|NCT01480180|322896987|FG001|Extension Phase, Part 2|Unclassified|0|||
94304085|NCT01480180|322896988|FG002|Extension Phase, Part 2|Unclassified|3|||
94304086|NCT01480180|322896989|FG003|Extension Phase, Part 2|Unclassified|1|||
94304087|NCT01480180|322896990|FG004|Extension Phase, Part 2|Unclassified|1|||
94304088|NCT01480180|322896991|FG005|Extension Phase, Part 2|Unclassified|0|||
94304089|NCT00828451|322896992|FG000|Overall Study|Death|2|||
94304090|NCT00828451|322896992|FG000|Overall Study|Lack of intravenous line|7|||
94304091|NCT00828451|322896992|FG000|Overall Study|Withdrawal by Subject|1|||
94304092|NCT00828451|322896992|FG000|Overall Study|Deterioration in clinical status|1|||
94304093|NCT05593432|322896993|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
94304094|NCT05593432|322896994|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
94304095|NCT05593432|322896995|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
94304096|NCT05593432|322896996|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
94304097|NCT05593432|322896993|FG000|16-Week OLE Period|Lack of Efficacy|0|||
94304098|NCT05593432|322896994|FG001|16-Week OLE Period|Lack of Efficacy|0|||
94304099|NCT05593432|322896995|FG002|16-Week OLE Period|Lack of Efficacy|0|||
94375242|NCT01348542|323158822|FG000|Overall Study|Withdrawal by Subject|3|||
94375243|NCT01348542|323158823|FG001|Overall Study|Withdrawal by Subject|0|||
94375244|NCT01484028|323158824|FG000|Period 1|Lost to Follow-up|0|||
94375245|NCT01484028|323158825|FG001|Period 1|Lost to Follow-up|1|||
94375246|NCT01484028|323158826|FG002|Period 1|Lost to Follow-up|0|||
94375247|NCT01484028|323158827|FG003|Period 1|Lost to Follow-up|0|||
94375248|NCT01484028|323158824|FG000|Period 1|Non-Compliance to Protocol|0|||
94375249|NCT01484028|323158825|FG001|Period 1|Non-Compliance to Protocol|1|||
94375250|NCT01484028|323158826|FG002|Period 1|Non-Compliance to Protocol|0|||
94375251|NCT01484028|323158827|FG003|Period 1|Non-Compliance to Protocol|1|||
94375252|NCT01484028|323158824|FG000|Period 1|Lens Discomfort|0|||
94375253|NCT01484028|323158825|FG001|Period 1|Lens Discomfort|1|||
94375254|NCT01484028|323158826|FG002|Period 1|Lens Discomfort|0|||
94304100|NCT05593432|322896996|FG003|16-Week OLE Period|Lack of Efficacy|1|||
94304101|NCT05593432|322896993|FG000|16-Week OLE Period|Lost to Follow-up|0|||
94304102|NCT05593432|322896994|FG001|16-Week OLE Period|Lost to Follow-up|0|||
94304103|NCT05593432|322896995|FG002|16-Week OLE Period|Lost to Follow-up|1|||
94375255|NCT01484028|323158827|FG003|Period 1|Lens Discomfort|0|||
94375256|NCT00408876|323158828|FG000|Overall Study|Adverse Event|9|||
94375257|NCT00408876|323158829|FG001|Overall Study|Adverse Event|17|||
94375258|NCT00408876|323158830|FG002|Overall Study|Adverse Event|27|||
94304104|NCT05593432|322896996|FG003|16-Week OLE Period|Lost to Follow-up|2|||
94304105|NCT05593432|322896993|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
94304106|NCT05593432|322896994|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
94304107|NCT05593432|322896995|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
94304108|NCT05593432|322896996|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
94304109|NCT00753922|322897000|FG000|Overall Study|Lost to Follow-up|155|||
94304110|NCT00753922|322897001|FG001|Overall Study|Lost to Follow-up|24|||
94304111|NCT00753922|322897002|FG002|Overall Study|Lost to Follow-up|28|||
94304112|NCT00753922|322897003|FG003|Overall Study|Lost to Follow-up|5|||
94304113|NCT00753922|322897000|FG000|Overall Study|Withdrawal by Subject|9|||
94304114|NCT00753922|322897001|FG001|Overall Study|Withdrawal by Subject|11|||
94304115|NCT00753922|322897002|FG002|Overall Study|Withdrawal by Subject|4|||
94304116|NCT00753922|322897003|FG003|Overall Study|Withdrawal by Subject|2|||
94304117|NCT00753922|322897000|FG000|Overall Study|Patient Non-compliance|55|||
94304118|NCT00753922|322897001|FG001|Overall Study|Patient Non-compliance|22|||
94304119|NCT00753922|322897002|FG002|Overall Study|Patient Non-compliance|14|||
94304120|NCT00753922|322897003|FG003|Overall Study|Patient Non-compliance|11|||
94304121|NCT00753922|322897000|FG000|Overall Study|Patients Not Completing Visit|11|||
94304122|NCT00753922|322897001|FG001|Overall Study|Patients Not Completing Visit|0|||
94304123|NCT00753922|322897002|FG002|Overall Study|Patients Not Completing Visit|1|||
94304124|NCT00753922|322897003|FG003|Overall Study|Patients Not Completing Visit|0|||
94304125|NCT00753922|322897000|FG000|Overall Study|Death|2|||
94304126|NCT00753922|322897001|FG001|Overall Study|Death|23|||
94304127|NCT00753922|322897002|FG002|Overall Study|Death|2|||
94304128|NCT00753922|322897003|FG003|Overall Study|Death|1|||
94304129|NCT00753922|322897000|FG000|Overall Study|Discontinuation Due to Explantation|14|||
94304130|NCT00753922|322897001|FG001|Overall Study|Discontinuation Due to Explantation|14|||
94304131|NCT00753922|322897002|FG002|Overall Study|Discontinuation Due to Explantation|14|||
94304132|NCT00753922|322897003|FG003|Overall Study|Discontinuation Due to Explantation|4|||
94304133|NCT00586690|322897006|FG000|Overall Study|Death|2|||
94304134|NCT00586690|322897007|FG001|Overall Study|Death|0|||
94304135|NCT00586690|322897006|FG000|Overall Study|Disease Progression|10|||
94304136|NCT00586690|322897007|FG001|Overall Study|Disease Progression|0|||
94304137|NCT00586690|322897006|FG000|Overall Study|Adverse Event|1|||
94304138|NCT00586690|322897007|FG001|Overall Study|Adverse Event|0|||
94304139|NCT00586690|322897006|FG000|Overall Study|Lack of Efficacy|2|||
94304140|NCT00586690|322897007|FG001|Overall Study|Lack of Efficacy|0|||
94304141|NCT00586690|322897006|FG000|Overall Study|Lab can't accommodate|1|||
94304142|NCT00586690|322897007|FG001|Overall Study|Lab can't accommodate|0|||
94304143|NCT02453841|322897008|FG000|Overall Study|Protocol Violation|1|||
94304144|NCT02453841|322897008|FG000|Overall Study|Unable to obtain blood samples|2|||
94304145|NCT00144300|322897009|FG000|Overall Study|Adverse Event|18|||
94304146|NCT00144300|322897010|FG001|Overall Study|Adverse Event|16|||
94304147|NCT00144300|322897009|FG000|Overall Study|Protocol Violation|1|||
94304148|NCT00144300|322897010|FG001|Overall Study|Protocol Violation|3|||
94304149|NCT00144300|322897009|FG000|Overall Study|Lost to Follow-up|3|||
94304150|NCT00144300|322897010|FG001|Overall Study|Lost to Follow-up|0|||
94304151|NCT00144300|322897009|FG000|Overall Study|Withdrawal by Subject|6|||
94304152|NCT00144300|322897010|FG001|Overall Study|Withdrawal by Subject|6|||
94304153|NCT00144300|322897009|FG000|Overall Study|Other reason (not specified)|1|||
94304154|NCT00144300|322897010|FG001|Overall Study|Other reason (not specified)|3|||
94304155|NCT01933672|322897011|FG000|Metformin Run-in Period|Adverse Event|1|||
94304156|NCT01933672|322897012|FG001|Metformin Run-in Period|Adverse Event|0|||
94304157|NCT01933672|322897013|FG002|Metformin Run-in Period|Adverse Event|0|||
94304158|NCT01933672|322897014|FG003|Metformin Run-in Period|Adverse Event|0|||
94304159|NCT01933672|322897015|FG004|Metformin Run-in Period|Adverse Event|0|||
94304160|NCT01933672|322897016|FG005|Metformin Run-in Period|Adverse Event|0|||
94304161|NCT01933672|322897017|FG006|Metformin Run-in Period|Adverse Event|0|||
94304162|NCT01933672|322897011|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
94304163|NCT01933672|322897012|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
94304164|NCT01933672|322897013|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
94304165|NCT01933672|322897014|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
94304166|NCT01933672|322897015|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
94304167|NCT01933672|322897016|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
94304168|NCT01933672|322897017|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
94304169|NCT01933672|322897011|FG000|Metformin Run-in Period|Other|5|||
94304170|NCT01933672|322897012|FG001|Metformin Run-in Period|Other|0|||
94304171|NCT01933672|322897013|FG002|Metformin Run-in Period|Other|0|||
94304172|NCT01933672|322897014|FG003|Metformin Run-in Period|Other|0|||
94304173|NCT01933672|322897015|FG004|Metformin Run-in Period|Other|0|||
94304174|NCT01933672|322897016|FG005|Metformin Run-in Period|Other|0|||
94304175|NCT01933672|322897017|FG006|Metformin Run-in Period|Other|0|||
94304176|NCT01933672|322897011|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
94304177|NCT01933672|322897012|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
94304178|NCT01933672|322897013|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
94304179|NCT01933672|322897014|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
94304180|NCT01933672|322897015|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
94304181|NCT01933672|322897016|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
94304182|NCT01933672|322897017|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
94304183|NCT01933672|322897011|FG000|First Intervention Period (12-16 Days)|Other|0|||
94304184|NCT01933672|322897012|FG001|First Intervention Period (12-16 Days)|Other|0|||
94304185|NCT01933672|322897013|FG002|First Intervention Period (12-16 Days)|Other|1|||
94304186|NCT01933672|322897014|FG003|First Intervention Period (12-16 Days)|Other|0|||
94304187|NCT01933672|322897015|FG004|First Intervention Period (12-16 Days)|Other|0|||
94304188|NCT01933672|322897016|FG005|First Intervention Period (12-16 Days)|Other|1|||
94304189|NCT01933672|322897017|FG006|First Intervention Period (12-16 Days)|Other|0|||
94304190|NCT01933672|322897011|FG000|Second Intervention Period (12-16 Days)|Other|0|||
94304191|NCT01933672|322897012|FG001|Second Intervention Period (12-16 Days)|Other|1|||
94304192|NCT01933672|322897013|FG002|Second Intervention Period (12-16 Days)|Other|1|||
94304193|NCT01933672|322897014|FG003|Second Intervention Period (12-16 Days)|Other|0|||
94304194|NCT01933672|322897015|FG004|Second Intervention Period (12-16 Days)|Other|0|||
94304195|NCT01933672|322897016|FG005|Second Intervention Period (12-16 Days)|Other|0|||
94304196|NCT01933672|322897017|FG006|Second Intervention Period (12-16 Days)|Other|0|||
94304197|NCT01933672|322897011|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
94304198|NCT01933672|322897012|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
94304199|NCT01933672|322897013|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
94304200|NCT01933672|322897014|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
94304201|NCT01933672|322897015|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
94304202|NCT01933672|322897016|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
94304203|NCT01933672|322897017|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
94304204|NCT01933672|322897011|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
94304205|NCT01933672|322897012|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
94304206|NCT01933672|322897013|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
94304207|NCT01933672|322897014|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
94304208|NCT01933672|322897015|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
94304209|NCT01933672|322897016|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
94304210|NCT01933672|322897017|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
94304211|NCT00524303|322897018|FG000|Overall Study|Lost to Follow-up|6|||
94304212|NCT00524303|322897019|FG001|Overall Study|Lost to Follow-up|0|||
94304213|NCT00524303|322897020|FG002|Overall Study|Lost to Follow-up|3|||
94304214|NCT00524303|322897018|FG000|Overall Study|Protocol Violation|0|||
94304215|NCT00524303|322897019|FG001|Overall Study|Protocol Violation|1|||
94304216|NCT00524303|322897020|FG002|Overall Study|Protocol Violation|1|||
94304217|NCT00524303|322897018|FG000|Overall Study|Withdrawal by Subject|3|||
94304218|NCT00524303|322897019|FG001|Overall Study|Withdrawal by Subject|0|||
94304219|NCT00524303|322897020|FG002|Overall Study|Withdrawal by Subject|4|||
94304220|NCT00524303|322897018|FG000|Overall Study|Death|0|||
94304221|NCT00524303|322897019|FG001|Overall Study|Death|2|||
94304222|NCT00524303|322897020|FG002|Overall Study|Death|3|||
94304223|NCT00524303|322897018|FG000|Overall Study|Adverse Event|1|||
94304224|NCT00524303|322897019|FG001|Overall Study|Adverse Event|2|||
94304225|NCT00524303|322897020|FG002|Overall Study|Adverse Event|3|||
94304226|NCT00524303|322897018|FG000|Overall Study|Did not Complete Study Dosing|1|||
94304227|NCT00524303|322897019|FG001|Overall Study|Did not Complete Study Dosing|0|||
94304228|NCT00524303|322897020|FG002|Overall Study|Did not Complete Study Dosing|0|||
94304229|NCT00524303|322897018|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
94304230|NCT00524303|322897019|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
94304231|NCT00524303|322897020|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
94304232|NCT00524303|322897018|FG000|Overall Study|Disease Progression|0|||
94304233|NCT00524303|322897019|FG001|Overall Study|Disease Progression|4|||
94304234|NCT00524303|322897020|FG002|Overall Study|Disease Progression|1|||
94304235|NCT00524303|322897018|FG000|Overall Study|Disease Recurrence|0|||
94304236|NCT00524303|322897019|FG001|Overall Study|Disease Recurrence|1|||
94304237|NCT00524303|322897020|FG002|Overall Study|Disease Recurrence|0|||
94304238|NCT00524303|322897018|FG000|Overall Study|Sponsor Request|0|||
94304239|NCT00524303|322897019|FG001|Overall Study|Sponsor Request|0|||
94304240|NCT00524303|322897020|FG002|Overall Study|Sponsor Request|1|||
94304241|NCT00524303|322897018|FG000|Overall Study|Physician Decision|0|||
94304242|NCT00524303|322897019|FG001|Overall Study|Physician Decision|0|||
94304243|NCT00524303|322897020|FG002|Overall Study|Physician Decision|1|||
94304244|NCT00524303|322897018|FG000|Overall Study|Completed 5 years|0|||
94304245|NCT00524303|322897019|FG001|Overall Study|Completed 5 years|0|||
94304246|NCT00524303|322897020|FG002|Overall Study|Completed 5 years|1|||
94304247|NCT03414359|322897021|FG000|Overall Study|Lack of Efficacy|1|||
94304248|NCT03414359|322897022|FG001|Overall Study|Lack of Efficacy|1|||
94304249|NCT03414359|322897021|FG000|Overall Study|Protocol Violation|0|||
94304250|NCT03414359|322897022|FG001|Overall Study|Protocol Violation|1|||
94304251|NCT02032875|322897023|FG000|Treatment Period|Adverse Event|1|||
94304252|NCT02032875|322897024|FG001|Treatment Period|Adverse Event|0|||
94304253|NCT02032875|322897023|FG000|Treatment Period|Liver transplant, No extension needed|0|||
94304254|NCT02032875|322897024|FG001|Treatment Period|Liver transplant, No extension needed|1|||
94304255|NCT02032875|322897023|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
94304256|NCT02032875|322897024|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
94304257|NCT02032875|322897023|FG000|Follow-up Period|Death|0|||
94304258|NCT02032875|322897024|FG001|Follow-up Period|Death|1|||
94304259|NCT02032875|322897023|FG000|Follow-up Period|Virologic Relapse|3|||
94304260|NCT02032875|322897024|FG001|Follow-up Period|Virologic Relapse|10|||
94304261|NCT00907738|322897025|FG000|Overall Study|Adverse Event|2|||
94304262|NCT00907738|322897026|FG001|Overall Study|Adverse Event|0|||
94304263|NCT00907738|322897027|FG002|Overall Study|Adverse Event|1|||
94304264|NCT00907738|322897028|FG003|Overall Study|Adverse Event|0|||
94304265|NCT00907738|322897029|FG004|Overall Study|Adverse Event|0|||
94304266|NCT00907738|322897025|FG000|Overall Study|not specified or withdrew consent|3|||
94304267|NCT00907738|322897026|FG001|Overall Study|not specified or withdrew consent|0|||
94304268|NCT00907738|322897027|FG002|Overall Study|not specified or withdrew consent|0|||
94304269|NCT00907738|322897028|FG003|Overall Study|not specified or withdrew consent|0|||
94304270|NCT00907738|322897029|FG004|Overall Study|not specified or withdrew consent|0|||
94304271|NCT00907738|322897025|FG000|Overall Study|Disease progression|8|||
94304272|NCT00907738|322897026|FG001|Overall Study|Disease progression|1|||
94304273|NCT00907738|322897027|FG002|Overall Study|Disease progression|6|||
94304274|NCT00907738|322897028|FG003|Overall Study|Disease progression|4|||
94304275|NCT00907738|322897029|FG004|Overall Study|Disease progression|2|||
94304276|NCT01739595|322897032|FG000|Overall Study|Adverse Event|3|||
94304277|NCT01739595|322897033|FG001|Overall Study|Adverse Event|0|||
94304278|NCT01739595|322897034|FG002|Overall Study|Adverse Event|0|||
94304279|NCT01739595|322897032|FG000|Overall Study|Lost to Follow-up|2|||
94304280|NCT01739595|322897033|FG001|Overall Study|Lost to Follow-up|0|||
94304281|NCT01739595|322897034|FG002|Overall Study|Lost to Follow-up|0|||
94304282|NCT01739595|322897032|FG000|Overall Study|Withdrawal by Subject|2|||
94304283|NCT01739595|322897033|FG001|Overall Study|Withdrawal by Subject|1|||
94375259|NCT00408876|323158831|FG003|Overall Study|Adverse Event|10|||
94375260|NCT00408876|323158828|FG000|Overall Study|Withdrawal by Subject|3|||
94375261|NCT00408876|323158829|FG001|Overall Study|Withdrawal by Subject|6|||
94375262|NCT00408876|323158830|FG002|Overall Study|Withdrawal by Subject|6|||
94375263|NCT00408876|323158831|FG003|Overall Study|Withdrawal by Subject|14|||
94375264|NCT00408876|323158828|FG000|Overall Study|Lack of Efficacy|2|||
94375265|NCT00408876|323158829|FG001|Overall Study|Lack of Efficacy|4|||
94375266|NCT00408876|323158830|FG002|Overall Study|Lack of Efficacy|5|||
94375267|NCT00408876|323158831|FG003|Overall Study|Lack of Efficacy|6|||
94375268|NCT00408876|323158828|FG000|Overall Study|Lost to Follow-up|1|||
94375269|NCT00408876|323158829|FG001|Overall Study|Lost to Follow-up|6|||
94375270|NCT00408876|323158830|FG002|Overall Study|Lost to Follow-up|5|||
94375271|NCT00408876|323158831|FG003|Overall Study|Lost to Follow-up|2|||
94375272|NCT00408876|323158828|FG000|Overall Study|Protocol Violation|0|||
94304284|NCT01739595|322897034|FG002|Overall Study|Withdrawal by Subject|2|||
94375273|NCT00408876|323158829|FG001|Overall Study|Protocol Violation|3|||
94304285|NCT01739595|322897032|FG000|Overall Study|Eligibility issue|3|||
94304286|NCT01739595|322897033|FG001|Overall Study|Eligibility issue|0|||
94304287|NCT01739595|322897034|FG002|Overall Study|Eligibility issue|0|||
94304288|NCT01739595|322897032|FG000|Overall Study|Protocol Violation|1|||
94304289|NCT01739595|322897033|FG001|Overall Study|Protocol Violation|0|||
94304290|NCT01739595|322897034|FG002|Overall Study|Protocol Violation|0|||
94304291|NCT01739595|322897032|FG000|Overall Study|Lab assessment|1|||
94304292|NCT01739595|322897033|FG001|Overall Study|Lab assessment|0|||
94375274|NCT00408876|323158830|FG002|Overall Study|Protocol Violation|4|||
94375275|NCT00408876|323158831|FG003|Overall Study|Protocol Violation|3|||
94375276|NCT00408876|323158828|FG000|Overall Study|Physician Decision|1|||
94304293|NCT01739595|322897034|FG002|Overall Study|Lab assessment|0|||
94304294|NCT01739595|322897032|FG000|Overall Study|Drug discrepancy|1|||
94304295|NCT01739595|322897033|FG001|Overall Study|Drug discrepancy|0|||
94304296|NCT01739595|322897034|FG002|Overall Study|Drug discrepancy|0|||
94304297|NCT00630032|322897041|FG000|Overall Study|Death|55|||
94304298|NCT00630032|322897042|FG001|Overall Study|Death|49|||
94304299|NCT00630032|322897041|FG000|Overall Study|Withdrawal by Subject|3|||
94304300|NCT00630032|322897042|FG001|Overall Study|Withdrawal by Subject|2|||
94304301|NCT00630032|322897041|FG000|Overall Study|Lost to Follow-up|18|||
94304302|NCT00630032|322897042|FG001|Overall Study|Lost to Follow-up|31|||
94304303|NCT00630032|322897041|FG000|Overall Study|Protocol Violation|1|||
94304304|NCT00630032|322897042|FG001|Overall Study|Protocol Violation|0|||
94304305|NCT00630032|322897041|FG000|Overall Study|Patient has moved|1|||
94304306|NCT00630032|322897042|FG001|Overall Study|Patient has moved|1|||
94304307|NCT00630032|322897041|FG000|Overall Study|Disease progression|1|||
94304308|NCT00630032|322897042|FG001|Overall Study|Disease progression|1|||
94304309|NCT00630032|322897041|FG000|Overall Study|End of monitoring in US centers|11|||
94304310|NCT00630032|322897042|FG001|Overall Study|End of monitoring in US centers|11|||
94304311|NCT00538733|322897043|FG000|Overall Study|Adverse Event|8|||
94304312|NCT00538733|322897043|FG000|Overall Study|Death|1|||
94304313|NCT00538733|322897043|FG000|Overall Study|declined to participate|2|||
94304314|NCT00538733|322897043|FG000|Overall Study|still on therapy|1|||
94304315|NCT00778999|322897046|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
94304316|NCT00778999|322897047|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
94304317|NCT00778999|322897046|FG000|Overall Study|Did not receive recFSH|14|||
94304318|NCT00778999|322897047|FG001|Overall Study|Did not receive recFSH|20|||
94304319|NCT03091192|322897053|FG000|Overall Study|Study terminated by sponsor|21|||
94304320|NCT03091192|322897054|FG001|Overall Study|Study terminated by sponsor|14|||
94304321|NCT03091192|322897053|FG000|Overall Study|Death|9|||
94304322|NCT03091192|322897054|FG001|Overall Study|Death|13|||
94304323|NCT03091192|322897053|FG000|Overall Study|Withdrawal by Subject|2|||
94304324|NCT03091192|322897054|FG001|Overall Study|Withdrawal by Subject|0|||
94304325|NCT03091192|322897053|FG000|Overall Study|Lost to Follow-up|1|||
94304326|NCT03091192|322897054|FG001|Overall Study|Lost to Follow-up|0|||
94304327|NCT03497689|322897055|FG000|Overall Study|Adverse Event|2|||
94304328|NCT03497689|322897055|FG000|Overall Study|Death|1|||
94304329|NCT03497689|322897055|FG000|Overall Study|Physician Decision|1|||
94304330|NCT03497689|322897055|FG000|Overall Study|Withdrawal by Subject|1|||
94304331|NCT03497689|322897055|FG000|Overall Study|Protocol Violation|2|||
94304332|NCT03567187|322897056|FG000|Overall Study|Lost to Follow-up|18|||
94304333|NCT05847881|322897057|FG000|Overall Study|Principal Investigator Decision|8|||
94304334|NCT05847881|322897057|FG000|Overall Study|Withdrawal by Subject|2|||
94304335|NCT04513158|322897058|FG000|Overall Study|Screen Failure|1|||
94304336|NCT00853632|322899112|FG000|Overall Study|Death|88|||
94304337|NCT00853632|322899112|FG000|Overall Study|Withdrawal by Subject|45|||
94304338|NCT00853632|322899112|FG000|Overall Study|Lost to Follow-up|30|||
94304339|NCT00853632|322899112|FG000|Overall Study|Reoperation/Explant|17|||
94304340|NCT00853632|322899112|FG000|Overall Study|Exit with other reason|22|||
94304341|NCT01614457|322899121|FG000|Overall Study|Non-Compliance|1|||
94304342|NCT01614457|322899122|FG001|Overall Study|Non-Compliance|0|||
94304343|NCT01614457|322899121|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
94304344|NCT01614457|322899122|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
94304345|NCT00875420|322899130|FG000|Overall Study|Adverse Event|0|||
94304346|NCT00875420|322899131|FG001|Overall Study|Adverse Event|1|||
94304347|NCT00875420|322899132|FG002|Overall Study|Adverse Event|1|||
94304348|NCT00875420|322899133|FG003|Overall Study|Adverse Event|0|||
94304349|NCT00875420|322899134|FG004|Overall Study|Adverse Event|0|||
94304350|NCT00875420|322899130|FG000|Overall Study|Inability to complete study procedures|1|||
94304351|NCT00875420|322899131|FG001|Overall Study|Inability to complete study procedures|0|||
94375277|NCT00408876|323158829|FG001|Overall Study|Physician Decision|0|||
94304352|NCT00875420|322899132|FG002|Overall Study|Inability to complete study procedures|1|||
94304353|NCT00875420|322899133|FG003|Overall Study|Inability to complete study procedures|1|||
94304354|NCT00875420|322899134|FG004|Overall Study|Inability to complete study procedures|1|||
94304355|NCT00875420|322899130|FG000|Overall Study|Lost to Follow-up|1|||
94304356|NCT00875420|322899131|FG001|Overall Study|Lost to Follow-up|0|||
94304357|NCT00875420|322899132|FG002|Overall Study|Lost to Follow-up|0|||
94304358|NCT00875420|322899133|FG003|Overall Study|Lost to Follow-up|0|||
94304359|NCT00875420|322899134|FG004|Overall Study|Lost to Follow-up|0|||
94304360|NCT00875420|322899130|FG000|Overall Study|Personal reason|0|||
94304361|NCT00875420|322899131|FG001|Overall Study|Personal reason|0|||
94304362|NCT00875420|322899132|FG002|Overall Study|Personal reason|0|||
94304363|NCT00875420|322899133|FG003|Overall Study|Personal reason|0|||
94304364|NCT00875420|322899134|FG004|Overall Study|Personal reason|1|||
94304365|NCT00875420|322899130|FG000|Overall Study|Prohibited medication|0|||
94304366|NCT00875420|322899131|FG001|Overall Study|Prohibited medication|0|||
94304367|NCT00875420|322899132|FG002|Overall Study|Prohibited medication|0|||
94304368|NCT00875420|322899133|FG003|Overall Study|Prohibited medication|1|||
94375278|NCT00408876|323158830|FG002|Overall Study|Physician Decision|3|||
94304369|NCT00875420|322899134|FG004|Overall Study|Prohibited medication|0|||
94304370|NCT00875420|322899130|FG000|Overall Study|Sponsor decision|0|||
94304371|NCT00875420|322899131|FG001|Overall Study|Sponsor decision|1|||
94304372|NCT00875420|322899132|FG002|Overall Study|Sponsor decision|0|||
94304373|NCT00875420|322899133|FG003|Overall Study|Sponsor decision|0|||
94304374|NCT00875420|322899134|FG004|Overall Study|Sponsor decision|0|||
94304375|NCT00875420|322899130|FG000|Overall Study|Withdrawal by Subject|0|||
94304376|NCT00875420|322899131|FG001|Overall Study|Withdrawal by Subject|0|||
94304377|NCT00875420|322899132|FG002|Overall Study|Withdrawal by Subject|1|||
94304378|NCT00875420|322899133|FG003|Overall Study|Withdrawal by Subject|0|||
94304379|NCT00875420|322899134|FG004|Overall Study|Withdrawal by Subject|0|||
94304380|NCT01416181|322899135|FG000|Part 1|Other|10|||
94304381|NCT01416181|322899136|FG001|Part 1|Other|24|||
94304382|NCT01416181|322899135|FG000|Part 1|Death|0|||
94304383|NCT01416181|322899136|FG001|Part 1|Death|1|||
94304384|NCT01416181|322899135|FG000|Part 1|Investigator Decision|7|||
94304385|NCT01416181|322899136|FG001|Part 1|Investigator Decision|6|||
94304386|NCT01416181|322899135|FG000|Part 1|Withdrawal by Subject|74|||
94304387|NCT01416181|322899136|FG001|Part 1|Withdrawal by Subject|48|||
94304388|NCT01416181|322899135|FG000|Part 1|Lack of Efficacy|16|||
94304389|NCT01416181|322899136|FG001|Part 1|Lack of Efficacy|8|||
94304390|NCT01416181|322899135|FG000|Part 1|Lost to Follow-up|1|||
94304391|NCT01416181|322899136|FG001|Part 1|Lost to Follow-up|1|||
94304392|NCT01416181|322899135|FG000|Part 1|Adverse Event|15|||
94304393|NCT01416181|322899136|FG001|Part 1|Adverse Event|18|||
94304394|NCT01416181|322899135|FG000|Part 1|Ongoing in Follow-Up|14|||
94304395|NCT01416181|322899136|FG001|Part 1|Ongoing in Follow-Up|8|||
94304396|NCT01416181|322899135|FG000|Part 2|Adverse Event|11|||
94304397|NCT01416181|322899136|FG001|Part 2|Adverse Event|4|||
94304398|NCT01416181|322899135|FG000|Part 2|Other|234|||
94304399|NCT01416181|322899136|FG001|Part 2|Other|267|||
94304400|NCT01416181|322899135|FG000|Part 2|Investigator Decision|6|||
94304401|NCT01416181|322899136|FG001|Part 2|Investigator Decision|7|||
94304402|NCT01416181|322899135|FG000|Part 2|Withdrawal by Subject|14|||
94304403|NCT01416181|322899136|FG001|Part 2|Withdrawal by Subject|5|||
94304404|NCT01416181|322899135|FG000|Part 2|Lack of Efficacy|4|||
94304405|NCT01416181|322899136|FG001|Part 2|Lack of Efficacy|1|||
94304406|NCT01416181|322899135|FG000|Part 2|Lost to Follow-up|2|||
94304407|NCT01416181|322899136|FG001|Part 2|Lost to Follow-up|2|||
94304408|NCT02981472|322899137|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
94304409|NCT02981472|322899138|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
94304410|NCT02981472|322899137|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
94304411|NCT02981472|322899138|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94304412|NCT02981472|322899137|FG000|Treatment Period|Adverse Event|6|||
94304413|NCT02981472|322899138|FG001|Treatment Period|Adverse Event|1|||
94304414|NCT02981472|322899137|FG000|Treatment Period|Participant withdrew consent|1|||
94304415|NCT02981472|322899138|FG001|Treatment Period|Participant withdrew consent|0|||
94304416|NCT02981472|322899137|FG000|Treatment Period|Lost to Follow-up|0|||
94304417|NCT02981472|322899138|FG001|Treatment Period|Lost to Follow-up|1|||
94304418|NCT01157169|322899139|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
94304419|NCT01157169|322899140|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
94304420|NCT01157169|322899139|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
94304421|NCT01157169|322899140|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
94304422|NCT01123889|322899141|FG000|Overall Study|Lost to Follow-up|3|||
94304423|NCT01123889|322899142|FG001|Overall Study|Lost to Follow-up|1|||
94304424|NCT01981187|322899147|FG000|Overall Study|Participant/guardian decision|2|||
94304425|NCT01981187|322899147|FG000|Overall Study|Physician Decision|1|||
94304426|NCT01981187|322899147|FG000|Overall Study|Disease progression|2|||
94304427|NCT01981187|322899147|FG000|Overall Study|Adverse Event|7|||
94304428|NCT02638012|322899148|FG000|Overall Study|Lost to Follow-up|1|||
94304429|NCT03846947|322899149|FG000|Overall Study|technical issues with imaging sequence|2|||
94304430|NCT02082184|322899154|FG000|Overall Study|Adverse Event|1|||
94304431|NCT02082184|322899155|FG001|Overall Study|Adverse Event|0|||
94304432|NCT02082184|322899154|FG000|Overall Study|Medical diagnosis|1|||
94304433|NCT02082184|322899155|FG001|Overall Study|Medical diagnosis|2|||
94304434|NCT02082184|322899154|FG000|Overall Study|Device associated symptoms|5|||
94304435|NCT02082184|322899155|FG001|Overall Study|Device associated symptoms|0|||
94304436|NCT02082184|322899154|FG000|Overall Study|Withdrawal by Subject|3|||
94304437|NCT02082184|322899155|FG001|Overall Study|Withdrawal by Subject|2|||
94304438|NCT02082184|322899154|FG000|Overall Study|Protocol Violation|0|||
94304439|NCT02082184|322899155|FG001|Overall Study|Protocol Violation|6|||
94304440|NCT02082184|322899154|FG000|Overall Study|Lost to Follow-up|0|||
94304441|NCT02082184|322899155|FG001|Overall Study|Lost to Follow-up|2|||
94304442|NCT02082184|322899154|FG000|Overall Study|Subject non-compliance|0|||
94304443|NCT02082184|322899155|FG001|Overall Study|Subject non-compliance|1|||
94304444|NCT03715465|322899156|FG000|Overall Study|Withdrawal by Subject|1|||
94304445|NCT03715465|322899157|FG001|Overall Study|Withdrawal by Subject|2|||
94304446|NCT04893265|322899158|FG000|Overall Study|Withdrawal by Subject|2|||
94304447|NCT04893265|322899159|FG001|Overall Study|Withdrawal by Subject|5|||
94304448|NCT04893265|322899158|FG000|Overall Study|Lost to Follow-up|0|||
94304449|NCT04893265|322899159|FG001|Overall Study|Lost to Follow-up|4|||
94304450|NCT02337829|322899167|FG000|Overall Study|Death|0|||
94304451|NCT02337829|322899168|FG001|Overall Study|Death|1|||
94304452|NCT02337829|322899169|FG002|Overall Study|Death|0|||
94304453|NCT02337829|322899170|FG003|Overall Study|Death|0|||
94304454|NCT02337829|322899167|FG000|Overall Study|Study terminated by sponsor|12|||
94304455|NCT02337829|322899168|FG001|Overall Study|Study terminated by sponsor|10|||
94304456|NCT02337829|322899169|FG002|Overall Study|Study terminated by sponsor|5|||
94304457|NCT02337829|322899170|FG003|Overall Study|Study terminated by sponsor|6|||
94304458|NCT02337829|322899167|FG000|Overall Study|discontinued for other reasons|6|||
94304459|NCT02337829|322899168|FG001|Overall Study|discontinued for other reasons|3|||
94304460|NCT02337829|322899169|FG002|Overall Study|discontinued for other reasons|1|||
94304461|NCT02337829|322899170|FG003|Overall Study|discontinued for other reasons|4|||
94304462|NCT01845025|322899171|FG000|Overall Study|Adverse Event|6|||
94304463|NCT01845025|322899172|FG001|Overall Study|Adverse Event|3|||
94304464|NCT01845025|322899171|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
94304465|NCT01845025|322899172|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
94304466|NCT01845025|322899171|FG000|Overall Study|Withdrawal by Subject|48|||
94304467|NCT01845025|322899172|FG001|Overall Study|Withdrawal by Subject|44|||
94304468|NCT01845025|322899171|FG000|Overall Study|Lost to Follow-up|13|||
94304469|NCT01845025|322899172|FG001|Overall Study|Lost to Follow-up|13|||
94304470|NCT01845025|322899171|FG000|Overall Study|Administrative problems|8|||
94304471|NCT01845025|322899172|FG001|Overall Study|Administrative problems|8|||
94304472|NCT01845025|322899171|FG000|Overall Study|Death|2|||
94304473|NCT01845025|322899172|FG001|Overall Study|Death|0|||
94304474|NCT01845025|322899171|FG000|Overall Study|Protocol deviation|3|||
94304475|NCT01845025|322899172|FG001|Overall Study|Protocol deviation|6|||
94304476|NCT01845025|322899171|FG000|Overall Study|Missing|1|||
94304477|NCT01845025|322899172|FG001|Overall Study|Missing|1|||
94304478|NCT03976401|322899173|FG000|Overall Study|Adverse Event|2|||
94304479|NCT03976401|322899174|FG001|Overall Study|Adverse Event|0|||
94304480|NCT03976401|322899175|FG002|Overall Study|Adverse Event|4|||
94304481|NCT03976401|322899176|FG003|Overall Study|Adverse Event|1|||
94304482|NCT03976401|322899177|FG004|Overall Study|Adverse Event|1|||
94304483|NCT03976401|322899178|FG005|Overall Study|Adverse Event|0|||
94304484|NCT03976401|322899173|FG000|Overall Study|Withdrawal by Subject|0|||
94468362|NCT03423147|323503987|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
94468363|NCT03423147|323503986|FG000|Overall Study|Age < 18|1|||
94468364|NCT03423147|323503987|FG001|Overall Study|Age < 18|0|||
94468365|NCT03423147|323503986|FG000|Overall Study|No Trial of Labor|0|||
94468366|NCT03423147|323503987|FG001|Overall Study|No Trial of Labor|1|||
94468367|NCT00586898|323503988|FG000|Overall Study|Adverse Event|1|||
94468368|NCT00586898|323503988|FG000|Overall Study|Patiemt Non-compliance|1|||
94468369|NCT00586898|323503988|FG000|Overall Study|Evaluable for Toxicity Only|5|||
94468370|NCT02258334|323503991|FG000|Overall Study|Adverse Event|1|||
94468371|NCT02258334|323503992|FG001|Overall Study|Adverse Event|0|||
94468372|NCT02258334|323503993|FG002|Overall Study|Adverse Event|0|||
94468373|NCT02258334|323503994|FG003|Overall Study|Adverse Event|0|||
94468374|NCT01969084|323503995|FG000|Overall Study|Adverse Event|0|||
94468375|NCT01969084|323503996|FG001|Overall Study|Adverse Event|1|||
94468376|NCT01926197|323503997|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
94468377|NCT01926197|323503998|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
94468378|NCT01926197|323503997|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
94468379|NCT01926197|323503998|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
94468380|NCT00862459|323503999|FG000|Overall Study|Lost to Follow-up|1|||
94468381|NCT00862459|323504000|FG001|Overall Study|Lost to Follow-up|2|||
94468382|NCT00862459|323504001|FG002|Overall Study|Lost to Follow-up|2|||
94468383|NCT00862459|323503999|FG000|Overall Study|Protocol Violation|1|||
94468384|NCT00862459|323504000|FG001|Overall Study|Protocol Violation|0|||
94468385|NCT00862459|323504001|FG002|Overall Study|Protocol Violation|0|||
94468386|NCT00862459|323503999|FG000|Overall Study|Withdrawal by Subject|1|||
94468387|NCT00862459|323504000|FG001|Overall Study|Withdrawal by Subject|1|||
94468388|NCT00862459|323504001|FG002|Overall Study|Withdrawal by Subject|3|||
94468389|NCT00862459|323503999|FG000|Overall Study|Adverse Event|0|||
94468390|NCT00862459|323504000|FG001|Overall Study|Adverse Event|1|||
94468391|NCT00862459|323504001|FG002|Overall Study|Adverse Event|0|||
94468392|NCT00862459|323503999|FG000|Overall Study|Personal reasons|1|||
94468393|NCT00862459|323504000|FG001|Overall Study|Personal reasons|0|||
94468394|NCT00862459|323504001|FG002|Overall Study|Personal reasons|0|||
94468395|NCT00862459|323503999|FG000|Overall Study|Operation|1|||
94468396|NCT00862459|323504000|FG001|Overall Study|Operation|1|||
94304485|NCT03976401|322899174|FG001|Overall Study|Withdrawal by Subject|1|||
94304486|NCT03976401|322899175|FG002|Overall Study|Withdrawal by Subject|0|||
94304487|NCT03976401|322899176|FG003|Overall Study|Withdrawal by Subject|0|||
94304488|NCT03976401|322899177|FG004|Overall Study|Withdrawal by Subject|0|||
94468397|NCT00862459|323504001|FG002|Overall Study|Operation|0|||
94304489|NCT03976401|322899178|FG005|Overall Study|Withdrawal by Subject|1|||
94468398|NCT00862459|323503999|FG000|Overall Study|Intravenous (IV) site problems|1|||
94468399|NCT00862459|323504000|FG001|Overall Study|Intravenous (IV) site problems|0|||
94468400|NCT00862459|323504001|FG002|Overall Study|Intravenous (IV) site problems|1|||
94468401|NCT00862459|323503999|FG000|Overall Study|Unable to hold still for imaging|0|||
94468402|NCT00862459|323504000|FG001|Overall Study|Unable to hold still for imaging|1|||
94468403|NCT00862459|323504001|FG002|Overall Study|Unable to hold still for imaging|0|||
94468404|NCT00862459|323503999|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
94468405|NCT00862459|323504000|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
94468406|NCT00862459|323504001|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
94468407|NCT00862459|323503999|FG000|Overall Study|Administrative problems|0|||
94468408|NCT00862459|323504000|FG001|Overall Study|Administrative problems|1|||
94468409|NCT00862459|323504001|FG002|Overall Study|Administrative problems|0|||
94468410|NCT03168919|323504012|FG000|Overall Study|Withdrawal by Subject|2|||
94468411|NCT02678000|323504013|FG000|PART 2|Adverse Event|0|||
94468412|NCT02678000|323504014|FG001|PART 2|Adverse Event|0|||
94468413|NCT02678000|323504015|FG002|PART 2|Adverse Event|2|||
94468414|NCT02678000|323504016|FG003|PART 2|Adverse Event|1|||
94468415|NCT02678000|323504017|FG004|PART 2|Adverse Event|0|||
94468416|NCT02678000|323504013|FG000|PART 2|Withdrawal by Subject|0|||
94468417|NCT02678000|323504014|FG001|PART 2|Withdrawal by Subject|0|||
94468418|NCT02678000|323504015|FG002|PART 2|Withdrawal by Subject|1|||
94468419|NCT02678000|323504016|FG003|PART 2|Withdrawal by Subject|0|||
94468420|NCT02678000|323504017|FG004|PART 2|Withdrawal by Subject|0|||
94468421|NCT03611582|323504020|FG000|Overall Study|Adverse Event|26|||
94468422|NCT03611582|323504021|FG001|Overall Study|Adverse Event|6|||
94468423|NCT03611582|323504020|FG000|Overall Study|Protocol Violation|0|||
94468424|NCT03611582|323504021|FG001|Overall Study|Protocol Violation|1|||
94468425|NCT03611582|323504020|FG000|Overall Study|Pregnancy|1|||
94468426|NCT03611582|323504021|FG001|Overall Study|Pregnancy|2|||
94468427|NCT03611582|323504020|FG000|Overall Study|Lack of Efficacy|0|||
94468428|NCT03611582|323504021|FG001|Overall Study|Lack of Efficacy|1|||
94468429|NCT03611582|323504020|FG000|Overall Study|At the discretion of the investigator|1|||
94304490|NCT03976401|322899173|FG000|Overall Study|Physician Decision|0|||
94304491|NCT03976401|322899174|FG001|Overall Study|Physician Decision|0|||
94304492|NCT03976401|322899175|FG002|Overall Study|Physician Decision|1|||
94304493|NCT03976401|322899176|FG003|Overall Study|Physician Decision|0|||
94304494|NCT03976401|322899177|FG004|Overall Study|Physician Decision|0|||
94304495|NCT03976401|322899178|FG005|Overall Study|Physician Decision|0|||
94304496|NCT03976401|322899173|FG000|Overall Study|Lost to Follow-up|1|||
94304497|NCT03976401|322899174|FG001|Overall Study|Lost to Follow-up|2|||
94304498|NCT03976401|322899175|FG002|Overall Study|Lost to Follow-up|0|||
94304499|NCT03976401|322899176|FG003|Overall Study|Lost to Follow-up|0|||
94304500|NCT03976401|322899177|FG004|Overall Study|Lost to Follow-up|0|||
94304501|NCT03976401|322899178|FG005|Overall Study|Lost to Follow-up|0|||
94304502|NCT03976401|322899173|FG000|Overall Study|Protocol Violation|0|||
94304503|NCT03976401|322899174|FG001|Overall Study|Protocol Violation|1|||
94304504|NCT03976401|322899175|FG002|Overall Study|Protocol Violation|0|||
94304505|NCT03976401|322899176|FG003|Overall Study|Protocol Violation|0|||
94304506|NCT03976401|322899177|FG004|Overall Study|Protocol Violation|0|||
94304507|NCT03976401|322899178|FG005|Overall Study|Protocol Violation|0|||
94304508|NCT03976401|322899173|FG000|Overall Study|Withdrew Consent|0|||
94304509|NCT03976401|322899174|FG001|Overall Study|Withdrew Consent|0|||
94304510|NCT03976401|322899175|FG002|Overall Study|Withdrew Consent|0|||
94304511|NCT03976401|322899176|FG003|Overall Study|Withdrew Consent|1|||
94304512|NCT03976401|322899177|FG004|Overall Study|Withdrew Consent|0|||
94304513|NCT03976401|322899178|FG005|Overall Study|Withdrew Consent|0|||
94304514|NCT00345605|322899187|FG000|Arm 1|Adverse Event|0|||
94304515|NCT00345605|322899188|FG001|Arm 1|Adverse Event|1|||
94304516|NCT00345605|322899187|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
94304517|NCT00345605|322899188|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
94304518|NCT03230097|322899194|FG000|Overall Study|Adverse Event|2|||
94304519|NCT03230097|322899195|FG001|Overall Study|Adverse Event|1|||
94304520|NCT03230097|322899194|FG000|Overall Study|non-compliance|0|||
94304521|NCT03230097|322899195|FG001|Overall Study|non-compliance|1|||
94304522|NCT03230097|322899194|FG000|Overall Study|Lost to Follow-up|2|||
94304523|NCT03230097|322899195|FG001|Overall Study|Lost to Follow-up|4|||
94304524|NCT03230097|322899194|FG000|Overall Study|Withdrawal by Subject|7|||
94304525|NCT03230097|322899195|FG001|Overall Study|Withdrawal by Subject|3|||
94304526|NCT03230097|322899194|FG000|Overall Study|Trial termination|4|||
94304527|NCT03230097|322899195|FG001|Overall Study|Trial termination|5|||
94304528|NCT03230097|322899194|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
94304529|NCT03230097|322899195|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
94304530|NCT03230097|322899194|FG000|Overall Study|outcome event|0|||
94304531|NCT03230097|322899195|FG001|Overall Study|outcome event|1|||
94304532|NCT00811252|322899196|FG000|Overall Study|Adverse Event|6|||
94304533|NCT00811252|322899197|FG001|Overall Study|Adverse Event|10|||
94375279|NCT00408876|323158831|FG003|Overall Study|Physician Decision|0|||
94375280|NCT03760510|323158832|FG000|Overall Study|Not ventilated for 24 hours|105|||
94375281|NCT03760510|323158833|FG001|Overall Study|Not ventilated for 24 hours|97|||
94375282|NCT00299728|323158846|FG000|Overall Study|Lost to Follow-up|0|||
94375283|NCT00299728|323158847|FG001|Overall Study|Lost to Follow-up|1|||
94375284|NCT00299728|323158846|FG000|Overall Study|Withdrawal by Subject|0|||
94375285|NCT00299728|323158847|FG001|Overall Study|Withdrawal by Subject|1|||
94375286|NCT00299728|323158846|FG000|Overall Study|Progressive disease|0|||
94375287|NCT00299728|323158847|FG001|Overall Study|Progressive disease|1|||
94375288|NCT00003102|323158848|FG000|Overall Study|Physician Decision|1|||
94375289|NCT00003102|323158849|FG001|Overall Study|Physician Decision|1|||
94375290|NCT00003102|323158850|FG002|Overall Study|Physician Decision|0|||
94375291|NCT00003102|323158848|FG000|Overall Study|Progressive Disease|0|||
94375292|NCT00003102|323158849|FG001|Overall Study|Progressive Disease|1|||
94375293|NCT00003102|323158850|FG002|Overall Study|Progressive Disease|0|||
94375294|NCT00003102|323158848|FG000|Overall Study|Adverse Event|0|||
94375295|NCT00003102|323158849|FG001|Overall Study|Adverse Event|1|||
94375296|NCT00003102|323158850|FG002|Overall Study|Adverse Event|1|||
94375297|NCT00003102|323158848|FG000|Overall Study|Death|0|||
94375298|NCT00003102|323158849|FG001|Overall Study|Death|0|||
94375299|NCT00003102|323158850|FG002|Overall Study|Death|1|||
94375300|NCT00895583|323158851|FG000|Overall Study|Adverse Event|28|||
94375301|NCT00895583|323158852|FG001|Overall Study|Adverse Event|4|||
94375302|NCT00895583|323158851|FG000|Overall Study|Death|2|||
94375303|NCT00895583|323158852|FG001|Overall Study|Death|1|||
94375304|NCT00895583|323158851|FG000|Overall Study|Physician Decision|3|||
94375305|NCT00895583|323158852|FG001|Overall Study|Physician Decision|1|||
94375306|NCT00895583|323158851|FG000|Overall Study|Lost to Follow-up|1|||
94375307|NCT00895583|323158852|FG001|Overall Study|Lost to Follow-up|3|||
94375308|NCT00895583|323158851|FG000|Overall Study|Protocol Violation|1|||
94375309|NCT00895583|323158852|FG001|Overall Study|Protocol Violation|0|||
94375310|NCT00895583|323158851|FG000|Overall Study|Withdrawal by Subject|4|||
94375311|NCT00895583|323158852|FG001|Overall Study|Withdrawal by Subject|2|||
94375312|NCT00895583|323158851|FG000|Overall Study|Lack of Efficacy|5|||
94375313|NCT00895583|323158852|FG001|Overall Study|Lack of Efficacy|0|||
94375314|NCT00895583|323158851|FG000|Overall Study|Other|0|||
94375315|NCT00895583|323158852|FG001|Overall Study|Other|1|||
94375316|NCT04409002|323158853|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
94375317|NCT02123459|323158854|FG000|Washout Period (1 Day)|Adverse Event|1|||
94375318|NCT02123459|323158855|FG001|Washout Period (1 Day)|Adverse Event|0|||
94375319|NCT02995837|323158856|FG000|Overall Study|Lost to Follow-up|9|||
94375320|NCT02995837|323158857|FG001|Overall Study|Lost to Follow-up|8|||
94375321|NCT00928252|323160251|FG000|Overall Study|Physician Decision|3|||
94375322|NCT02919475|323160254|FG000|Overall Study|Adverse Event|3|||
94375323|NCT02919475|323160255|FG001|Overall Study|Adverse Event|3|||
94375324|NCT02919475|323160256|FG002|Overall Study|Adverse Event|3|||
94375325|NCT02919475|323160257|FG003|Overall Study|Adverse Event|9|||
94375326|NCT02919475|323160258|FG004|Overall Study|Adverse Event|2|||
94375327|NCT02919475|323160254|FG000|Overall Study|Death|0|||
94375328|NCT02919475|323160255|FG001|Overall Study|Death|1|||
94375329|NCT02919475|323160256|FG002|Overall Study|Death|0|||
94375330|NCT02919475|323160257|FG003|Overall Study|Death|0|||
94375331|NCT02919475|323160258|FG004|Overall Study|Death|0|||
94375332|NCT02919475|323160254|FG000|Overall Study|Lost to Follow-up|0|||
94375333|NCT02919475|323160255|FG001|Overall Study|Lost to Follow-up|0|||
94375334|NCT02919475|323160256|FG002|Overall Study|Lost to Follow-up|0|||
94375335|NCT02919475|323160257|FG003|Overall Study|Lost to Follow-up|1|||
94468430|NCT03611582|323504021|FG001|Overall Study|At the discretion of the investigator|0|||
94468431|NCT03611582|323504020|FG000|Overall Study|Safety concern as judged by the investigator|1|||
94468432|NCT03611582|323504021|FG001|Overall Study|Safety concern as judged by the investigator|2|||
94468433|NCT03611582|323504020|FG000|Overall Study|Withdrawal by Subject|4|||
94468434|NCT03611582|323504021|FG001|Overall Study|Withdrawal by Subject|3|||
94468435|NCT03611582|323504020|FG000|Overall Study|Lost to Follow-up|18|||
94468436|NCT03611582|323504021|FG001|Overall Study|Lost to Follow-up|7|||
94468437|NCT03611582|323504020|FG000|Overall Study|other|17|||
94468438|NCT03611582|323504021|FG001|Overall Study|other|16|||
94375336|NCT02919475|323160258|FG004|Overall Study|Lost to Follow-up|0|||
94375337|NCT02919475|323160254|FG000|Overall Study|Withdrawal by Subject|2|||
94375338|NCT02919475|323160255|FG001|Overall Study|Withdrawal by Subject|3|||
94375339|NCT02919475|323160256|FG002|Overall Study|Withdrawal by Subject|1|||
94375340|NCT02919475|323160257|FG003|Overall Study|Withdrawal by Subject|2|||
94375341|NCT02919475|323160258|FG004|Overall Study|Withdrawal by Subject|2|||
94375342|NCT02919475|323160254|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
94375343|NCT02919475|323160255|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
94375344|NCT02919475|323160256|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
94375345|NCT02919475|323160257|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
94375346|NCT02919475|323160258|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
94375347|NCT04014959|323160259|FG000|Baseline MRI and Assessments|Physician Decision|2|||
94304534|NCT00811252|322899198|FG002|Overall Study|Adverse Event|15|||
94304535|NCT00811252|322899196|FG000|Overall Study|Lack of Efficacy|7|||
94304536|NCT00811252|322899197|FG001|Overall Study|Lack of Efficacy|2|||
94304537|NCT00811252|322899198|FG002|Overall Study|Lack of Efficacy|0|||
94304538|NCT00811252|322899196|FG000|Overall Study|Protocol Violation|3|||
94304539|NCT00811252|322899197|FG001|Overall Study|Protocol Violation|3|||
94304540|NCT00811252|322899198|FG002|Overall Study|Protocol Violation|2|||
94304541|NCT00811252|322899196|FG000|Overall Study|Withdrawal of Consent|1|||
94304542|NCT00811252|322899197|FG001|Overall Study|Withdrawal of Consent|2|||
94304543|NCT00811252|322899198|FG002|Overall Study|Withdrawal of Consent|2|||
94304544|NCT00811252|322899196|FG000|Overall Study|Lost to Follow-up|0|||
94304545|NCT00811252|322899197|FG001|Overall Study|Lost to Follow-up|0|||
94304546|NCT00811252|322899198|FG002|Overall Study|Lost to Follow-up|2|||
94304547|NCT00811252|322899196|FG000|Overall Study|Administrative or Other Reasons|0|||
94304548|NCT00811252|322899197|FG001|Overall Study|Administrative or Other Reasons|3|||
94304549|NCT00811252|322899198|FG002|Overall Study|Administrative or Other Reasons|2|||
94304550|NCT03215277|322899200|FG000|Overall Study|Adverse Event|2|||
94304551|NCT03215277|322899201|FG001|Overall Study|Adverse Event|3|||
94304552|NCT03215277|322899200|FG000|Overall Study|Death|1|||
94304553|NCT03215277|322899201|FG001|Overall Study|Death|0|||
94304554|NCT03215277|322899200|FG000|Overall Study|Lost to Follow-up|0|||
94304555|NCT03215277|322899201|FG001|Overall Study|Lost to Follow-up|1|||
94304556|NCT03215277|322899200|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
94304557|NCT03215277|322899201|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
94304558|NCT00728416|322899202|FG000|Overall Study|Adverse Event|1|||
94304559|NCT00728416|322899203|FG001|Overall Study|Adverse Event|1|||
94304560|NCT00728416|322899202|FG000|Overall Study|Treatment Failure|0|||
94304561|NCT00728416|322899203|FG001|Overall Study|Treatment Failure|1|||
94304562|NCT00728416|322899202|FG000|Overall Study|Withdrawal by Subject|1|||
94304563|NCT00728416|322899203|FG001|Overall Study|Withdrawal by Subject|0|||
94304564|NCT02580058|322899204|FG000|Overall Study|Adverse Event|16|||
94304565|NCT02580058|322899205|FG001|Overall Study|Adverse Event|30|||
94304566|NCT02580058|322899206|FG002|Overall Study|Adverse Event|20|||
94304567|NCT02580058|322899204|FG000|Overall Study|Death|4|||
94304568|NCT02580058|322899205|FG001|Overall Study|Death|4|||
94304569|NCT02580058|322899206|FG002|Overall Study|Death|5|||
94304570|NCT02580058|322899204|FG000|Overall Study|Physician Decision|1|||
94304571|NCT02580058|322899205|FG001|Overall Study|Physician Decision|3|||
94304572|NCT02580058|322899206|FG002|Overall Study|Physician Decision|11|||
94304573|NCT02580058|322899204|FG000|Overall Study|Other|5|||
94304574|NCT02580058|322899205|FG001|Overall Study|Other|1|||
94304575|NCT02580058|322899206|FG002|Overall Study|Other|3|||
94304576|NCT02580058|322899204|FG000|Overall Study|Withdrawal by Subject|4|||
94304577|NCT02580058|322899205|FG001|Overall Study|Withdrawal by Subject|7|||
94304578|NCT02580058|322899206|FG002|Overall Study|Withdrawal by Subject|31|||
94304579|NCT02580058|322899204|FG000|Overall Study|Global Deterioration of Health Status|19|||
94304580|NCT02580058|322899205|FG001|Overall Study|Global Deterioration of Health Status|18|||
94304581|NCT02580058|322899206|FG002|Overall Study|Global Deterioration of Health Status|24|||
94304582|NCT02580058|322899204|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
94304583|NCT02580058|322899205|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
94304584|NCT02580058|322899206|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
94304585|NCT02580058|322899204|FG000|Overall Study|Progressive Disease|137|||
94304586|NCT02580058|322899205|FG001|Overall Study|Progressive Disease|125|||
94304587|NCT02580058|322899206|FG002|Overall Study|Progressive Disease|94|||
94304588|NCT02580058|322899204|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94304589|NCT02580058|322899205|FG001|Overall Study|Non-Compliance With Study Drug|0|||
94304590|NCT02580058|322899206|FG002|Overall Study|Non-Compliance With Study Drug|0|||
94304591|NCT01733329|322899207|FG000|Overall Study|Protocol Violation|1|||
94304592|NCT01733329|322899208|FG001|Overall Study|Protocol Violation|1|||
94304593|NCT01733329|322899207|FG000|Overall Study|Uterine artery injury|1|||
94304594|NCT01733329|322899208|FG001|Overall Study|Uterine artery injury|0|||
94304595|NCT04334148|322899210|FG000|Overall Study|positive nasal swab at baseline|0|||
94304596|NCT04334148|322899211|FG001|Overall Study|positive nasal swab at baseline|1|||
94304597|NCT04814823|322899212|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
94304598|NCT00542828|322899213|FG000|Overall Study|Physician Decision|1|||
94375348|NCT04014959|323160259|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
94375349|NCT04014959|323160259|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
94304599|NCT00542828|322899213|FG000|Overall Study|Need for Prohibited Treatment|3|||
94304600|NCT00542828|322899213|FG000|Overall Study|Study Prematurely Discontinued|7|||
94304601|NCT00542828|322899213|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
94304602|NCT01499576|322899214|FG000|Overall Study|Physician Decision|12|||
94304603|NCT01499576|322899214|FG000|Overall Study|Withdrawal by Subject|9|||
94304604|NCT03233048|322899222|FG000|Overall Study|Withdrawal by Subject|1|||
94468439|NCT04459598|323504022|FG000|Overall Study|Adverse Event|1|||
94468440|NCT04459598|323504023|FG001|Overall Study|Adverse Event|1|||
94468441|NCT01907217|323504024|FG000|Overall Study|Withdrawal by Subject|0|||
94468442|NCT01907217|323504025|FG001|Overall Study|Withdrawal by Subject|2|||
94468443|NCT00463840|323504027|FG000|Overall Study|Disease progression|7|||
94468444|NCT00463840|323504027|FG000|Overall Study|Withdrawal by Subject|2|||
94468445|NCT00463840|323504027|FG000|Overall Study|Adverse Event|3|||
94468446|NCT03338569|323504028|FG000|Overall Study|Physician Decision|8|||
94468447|NCT03338569|323504029|FG001|Overall Study|Physician Decision|3|||
94468448|NCT03338569|323504028|FG000|Overall Study|Withdrawal by Subject|0|||
94468449|NCT03338569|323504029|FG001|Overall Study|Withdrawal by Subject|1|||
94468450|NCT03338569|323504028|FG000|Overall Study|Lost to Follow-up|0|||
94468451|NCT03338569|323504029|FG001|Overall Study|Lost to Follow-up|1|||
94468452|NCT05025332|323505675|FG000|Screening|Screen failure|12|||
94468453|NCT05025332|323505675|FG000|Treatment & Follow Up|Protocol Violation|1|||
94468454|NCT05025332|323505675|FG000|Treatment & Follow Up|Adverse Event|4|||
94468455|NCT04591015|323505676|FG000|Overall Study|Death|6|||
94468456|NCT04591015|323505677|FG001|Overall Study|Death|4|||
94468457|NCT04591015|323505676|FG000|Overall Study|Withdrawal by Subject|6|||
94468458|NCT04591015|323505677|FG001|Overall Study|Withdrawal by Subject|3|||
94468459|NCT04591015|323505676|FG000|Overall Study|Lost to Follow-up|16|||
94468460|NCT04591015|323505677|FG001|Overall Study|Lost to Follow-up|11|||
94468461|NCT06439095|323505678|FG000|Overall Study|Lost to Follow-up|2|||
94468462|NCT04942210|323505681|FG000|Overall Study|Adverse Event|0|||
94375350|NCT02370784|323160260|FG000|Overall Study|Patient started prohibited medication|0|||
94375351|NCT02370784|323160261|FG001|Overall Study|Patient started prohibited medication|1|||
94375352|NCT01059071|323160262|FG000|Overall Study|Lack of Efficacy|1|||
94375353|NCT01059071|323160263|FG001|Overall Study|Lack of Efficacy|4|||
94375354|NCT01059071|323160264|FG002|Overall Study|Lack of Efficacy|2|||
94375355|NCT01059071|323160265|FG003|Overall Study|Lack of Efficacy|3|||
94375356|NCT01059071|323160262|FG000|Overall Study|Withdrawal by Subject|1|||
94375357|NCT01059071|323160263|FG001|Overall Study|Withdrawal by Subject|0|||
94375358|NCT01059071|323160264|FG002|Overall Study|Withdrawal by Subject|0|||
94375359|NCT01059071|323160265|FG003|Overall Study|Withdrawal by Subject|2|||
94375360|NCT01059071|323160262|FG000|Overall Study|Physician Decision|0|||
94375361|NCT01059071|323160263|FG001|Overall Study|Physician Decision|0|||
94375362|NCT01059071|323160264|FG002|Overall Study|Physician Decision|0|||
94375363|NCT01059071|323160265|FG003|Overall Study|Physician Decision|1|||
94375364|NCT02962882|323160266|FG000|Overall Study|Adverse Event|2|||
94375365|NCT02962882|323160266|FG000|Overall Study|Withdrawal by Subject|2|||
94375366|NCT02962882|323160266|FG000|Overall Study|Transfer from ICU|32|||
94375367|NCT00515073|323160275|FG000|Overall Study|Withdrawal by Subject|1|||
94375368|NCT00515073|323160275|FG000|Overall Study|Physician Decision|1|||
94375369|NCT00463866|323160276|FG000|Overall Study|Adverse Event|70|||
94375370|NCT00463866|323160277|FG001|Overall Study|Adverse Event|93|||
94468463|NCT04942210|323505682|FG001|Overall Study|Adverse Event|1|||
94468464|NCT04942210|323505681|FG000|Overall Study|Protocol Deviation|4|||
94468465|NCT04942210|323505682|FG001|Overall Study|Protocol Deviation|1|||
94468466|NCT04942210|323505681|FG000|Overall Study|Withdrawal by Subject|5|||
94468467|NCT04942210|323505682|FG001|Overall Study|Withdrawal by Subject|2|||
94468468|NCT04942210|323505681|FG000|Overall Study|Lost to Follow-up|16|||
94468469|NCT04942210|323505682|FG001|Overall Study|Lost to Follow-up|7|||
94468470|NCT04942210|323505681|FG000|Overall Study|Ongoing at the time of DBL date|60|||
94468471|NCT04942210|323505682|FG001|Overall Study|Ongoing at the time of DBL date|25|||
94468472|NCT04942210|323505681|FG000|Overall Study|Randomized but did not receive vaccination|3|||
94468473|NCT04942210|323505682|FG001|Overall Study|Randomized but did not receive vaccination|0|||
94468474|NCT05697627|323505685|FG000|Overall Study|Adverse Event|1|||
94468475|NCT02722746|323505689|FG000|Overall Study|Withdrawal by Subject|0|||
94468476|NCT02722746|323505690|FG001|Overall Study|Withdrawal by Subject|1|||
94468477|NCT02722746|323505691|FG002|Overall Study|Withdrawal by Subject|0|||
94468478|NCT02722746|323505689|FG000|Overall Study|Protocol Violation|8|||
94468479|NCT02722746|323505690|FG001|Overall Study|Protocol Violation|4|||
94468480|NCT02722746|323505691|FG002|Overall Study|Protocol Violation|6|||
94468481|NCT02636699|323505692|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
94468482|NCT02636699|323505693|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
94468483|NCT02636699|323505694|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
94468484|NCT02636699|323505692|FG000|Screening Period|Withdrawal by Subject|0|||
94468485|NCT02636699|323505693|FG001|Screening Period|Withdrawal by Subject|0|||
94468486|NCT02636699|323505694|FG002|Screening Period|Withdrawal by Subject|23|||
94468487|NCT02636699|323505692|FG000|Screening Period|Adverse Event|0|||
94468488|NCT02636699|323505693|FG001|Screening Period|Adverse Event|0|||
94468489|NCT02636699|323505694|FG002|Screening Period|Adverse Event|1|||
94468490|NCT02636699|323505692|FG000|Screening Period|Other not specified|0|||
94375371|NCT00463866|323160276|FG000|Overall Study|Withdrawal by Subject|81|||
94375372|NCT00463866|323160277|FG001|Overall Study|Withdrawal by Subject|79|||
94375373|NCT00463866|323160276|FG000|Overall Study|Lost to Follow-up|46|||
94375374|NCT00463866|323160277|FG001|Overall Study|Lost to Follow-up|55|||
94468491|NCT02636699|323505693|FG001|Screening Period|Other not specified|0|||
94468492|NCT02636699|323505694|FG002|Screening Period|Other not specified|3|||
94468493|NCT02636699|323505692|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
94468494|NCT02636699|323505693|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
94468495|NCT02636699|323505694|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
94468496|NCT02636699|323505692|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
94468497|NCT02636699|323505693|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
94468498|NCT02636699|323505694|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
94468499|NCT02636699|323505692|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
94468500|NCT02636699|323505693|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
94468501|NCT02636699|323505694|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
94468502|NCT02636699|323505692|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
94468503|NCT02636699|323505693|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
94468504|NCT02636699|323505694|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
94468505|NCT02636699|323505692|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
94468506|NCT02636699|323505693|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
94468507|NCT02636699|323505694|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
94468508|NCT02636699|323505692|FG000|Treatment and Follow-up Periods|Other|3|||
94468509|NCT02636699|323505693|FG001|Treatment and Follow-up Periods|Other|1|||
94468510|NCT02636699|323505694|FG002|Treatment and Follow-up Periods|Other|0|||
94468511|NCT04379700|323505695|FG000|Overall Study|Withdrawal by Subject|10|||
94468512|NCT04379700|323505695|FG000|Overall Study|Screen Fail|4|||
94468513|NCT04379700|323505695|FG000|Overall Study|Lost to Follow-up|3|||
94468514|NCT04411641|323505696|FG000|DB Period|Other|7|||
94468515|NCT04411641|323505697|FG001|DB Period|Other|27|||
94468516|NCT04411641|323505698|FG002|DB Period|Other|0|||
94468517|NCT04411641|323505699|FG003|DB Period|Other|0|||
94468518|NCT04411641|323505696|FG000|DB Period|Withdrawal by Subject|67|||
94468519|NCT04411641|323505697|FG001|DB Period|Withdrawal by Subject|122|||
94468520|NCT04411641|323505698|FG002|DB Period|Withdrawal by Subject|0|||
94468521|NCT04411641|323505699|FG003|DB Period|Withdrawal by Subject|0|||
94468522|NCT04411641|323505696|FG000|DB Period|Progressive disease|76|||
94468523|NCT04411641|323505697|FG001|DB Period|Progressive disease|116|||
94468524|NCT04411641|323505698|FG002|DB Period|Progressive disease|0|||
94468525|NCT04411641|323505699|FG003|DB Period|Progressive disease|0|||
94468526|NCT04411641|323505696|FG000|DB Period|Poor compliance to protocol|1|||
94468527|NCT04411641|323505697|FG001|DB Period|Poor compliance to protocol|5|||
94468528|NCT04411641|323505698|FG002|DB Period|Poor compliance to protocol|0|||
94468529|NCT04411641|323505699|FG003|DB Period|Poor compliance to protocol|0|||
94468530|NCT04411641|323505696|FG000|DB Period|Lack of Efficacy|19|||
94468531|NCT04411641|323505697|FG001|DB Period|Lack of Efficacy|19|||
94468532|NCT04411641|323505698|FG002|DB Period|Lack of Efficacy|0|||
94468533|NCT04411641|323505699|FG003|DB Period|Lack of Efficacy|0|||
94468534|NCT04411641|323505696|FG000|DB Period|Adverse Event|13|||
94468535|NCT04411641|323505697|FG001|DB Period|Adverse Event|29|||
94468536|NCT04411641|323505698|FG002|DB Period|Adverse Event|0|||
94468537|NCT04411641|323505699|FG003|DB Period|Adverse Event|0|||
94468538|NCT04411641|323505696|FG000|DB Period|Randomized and not treated|2|||
94468539|NCT04411641|323505697|FG001|DB Period|Randomized and not treated|2|||
94468540|NCT04411641|323505698|FG002|DB Period|Randomized and not treated|0|||
94468541|NCT04411641|323505699|FG003|DB Period|Randomized and not treated|0|||
94468542|NCT04411641|323505696|FG000|OL|Withdrawal by Subject|0|||
94468543|NCT04411641|323505697|FG001|OL|Withdrawal by Subject|0|||
94468544|NCT04411641|323505698|FG002|OL|Withdrawal by Subject|6|||
94468545|NCT04411641|323505699|FG003|OL|Withdrawal by Subject|17|||
94468546|NCT04411641|323505696|FG000|OL|Progressive disease|0|||
94468547|NCT04411641|323505697|FG001|OL|Progressive disease|0|||
94468548|NCT04411641|323505698|FG002|OL|Progressive disease|1|||
94468549|NCT04411641|323505699|FG003|OL|Progressive disease|2|||
94468550|NCT04411641|323505696|FG000|OL|Poor compliance to protocol|0|||
94468551|NCT04411641|323505697|FG001|OL|Poor compliance to protocol|0|||
94468552|NCT04411641|323505698|FG002|OL|Poor compliance to protocol|1|||
94468553|NCT04411641|323505699|FG003|OL|Poor compliance to protocol|0|||
94468554|NCT04411641|323505696|FG000|OL|Adverse Event|0|||
94468555|NCT04411641|323505697|FG001|OL|Adverse Event|0|||
94468556|NCT04411641|323505698|FG002|OL|Adverse Event|1|||
94468557|NCT04411641|323505699|FG003|OL|Adverse Event|0|||
94468558|NCT04411641|323505696|FG000|OL|Other|0|||
94468559|NCT04411641|323505697|FG001|OL|Other|0|||
94468560|NCT04411641|323505698|FG002|OL|Other|0|||
94468561|NCT04411641|323505699|FG003|OL|Other|6|||
94468562|NCT02309723|323505701|FG000|Overall Study|Withdrawal by Subject|24|||
94468563|NCT02309723|323505702|FG001|Overall Study|Withdrawal by Subject|23|||
94468564|NCT02309723|323505703|FG002|Overall Study|Withdrawal by Subject|24|||
94468565|NCT04410991|323505704|FG000|Overall Study|Poor compliance to protocol|5|||
94468566|NCT04410991|323505705|FG001|Overall Study|Poor compliance to protocol|4|||
94468567|NCT04410991|323505704|FG000|Overall Study|Withdrawal by Subject|59|||
94468568|NCT04410991|323505705|FG001|Overall Study|Withdrawal by Subject|55|||
94468569|NCT04410991|323505704|FG000|Overall Study|Other|10|||
94304605|NCT05897853|322899224|FG000|Overall Study|Lost to Follow-up|2|||
94304606|NCT05897853|322899225|FG001|Overall Study|Lost to Follow-up|0|||
94304607|NCT05897853|322899224|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
94304608|NCT05897853|322899225|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
94304609|NCT01476787|322899226|FG000|Treatment|Progression|64|||
94304610|NCT01476787|322899227|FG001|Treatment|Progression|71|||
94304611|NCT01476787|322899226|FG000|Treatment|Toxicity|44|||
94304612|NCT01476787|322899227|FG001|Treatment|Toxicity|16|||
94304613|NCT01476787|322899226|FG000|Treatment|Death|0|||
94304614|NCT01476787|322899227|FG001|Treatment|Death|1|||
94304615|NCT01476787|322899226|FG000|Treatment|Withdrawal by Subject|3|||
94304616|NCT01476787|322899227|FG001|Treatment|Withdrawal by Subject|14|||
94304617|NCT01476787|322899226|FG000|Treatment|Major protocol violation|1|||
94304618|NCT01476787|322899227|FG001|Treatment|Major protocol violation|6|||
94304619|NCT01476787|322899226|FG000|Treatment|Other reasons|10|||
94304620|NCT01476787|322899227|FG001|Treatment|Other reasons|22|||
94304621|NCT01476787|322899226|FG000|Treatment|Concurrent illness|12|||
94304622|NCT01476787|322899227|FG001|Treatment|Concurrent illness|9|||
94304623|NCT01476787|322899226|FG000|Treatment|Insufficient response|15|||
94304624|NCT01476787|322899227|FG001|Treatment|Insufficient response|3|||
94304625|NCT01476787|322899226|FG000|Treatment|Voluntary treatment discontinuation|8|||
94304626|NCT01476787|322899227|FG001|Treatment|Voluntary treatment discontinuation|4|||
94304627|NCT01607892|322899238|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
94304628|NCT01607892|322899239|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
94304629|NCT01607892|322899240|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
94304630|NCT01607892|322899241|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
94304631|NCT01607892|322899242|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
94304632|NCT01607892|322899238|FG000|Overall Study|Death|4|||
94304633|NCT01607892|322899239|FG001|Overall Study|Death|2|||
94304634|NCT01607892|322899240|FG002|Overall Study|Death|8|||
94304635|NCT01607892|322899241|FG003|Overall Study|Death|10|||
94304636|NCT01607892|322899242|FG004|Overall Study|Death|3|||
94304637|NCT01607892|322899238|FG000|Overall Study|Investigator discretion|2|||
94304638|NCT01607892|322899239|FG001|Overall Study|Investigator discretion|4|||
94304639|NCT01607892|322899240|FG002|Overall Study|Investigator discretion|4|||
94304640|NCT01607892|322899241|FG003|Overall Study|Investigator discretion|8|||
94304641|NCT01607892|322899242|FG004|Overall Study|Investigator discretion|0|||
94304642|NCT01607892|322899238|FG000|Overall Study|Other treatments became available|1|||
94304643|NCT01607892|322899239|FG001|Overall Study|Other treatments became available|1|||
94304644|NCT01607892|322899240|FG002|Overall Study|Other treatments became available|0|||
94304645|NCT01607892|322899241|FG003|Overall Study|Other treatments became available|0|||
94304646|NCT01607892|322899242|FG004|Overall Study|Other treatments became available|2|||
94304647|NCT01607892|322899238|FG000|Overall Study|Intercurrent illness|1|||
94304648|NCT01607892|322899239|FG001|Overall Study|Intercurrent illness|0|||
94304649|NCT01607892|322899240|FG002|Overall Study|Intercurrent illness|0|||
94304650|NCT01607892|322899241|FG003|Overall Study|Intercurrent illness|3|||
94304651|NCT01607892|322899242|FG004|Overall Study|Intercurrent illness|0|||
94304652|NCT01607892|322899238|FG000|Overall Study|Non-Compliance with study procedures|0|||
94304653|NCT01607892|322899239|FG001|Overall Study|Non-Compliance with study procedures|0|||
94304654|NCT01607892|322899240|FG002|Overall Study|Non-Compliance with study procedures|1|||
94304655|NCT01607892|322899241|FG003|Overall Study|Non-Compliance with study procedures|0|||
94304656|NCT01607892|322899242|FG004|Overall Study|Non-Compliance with study procedures|0|||
94304657|NCT01607892|322899238|FG000|Overall Study|Consent withdrawn by participant|9|||
94304658|NCT01607892|322899239|FG001|Overall Study|Consent withdrawn by participant|4|||
94304659|NCT01607892|322899240|FG002|Overall Study|Consent withdrawn by participant|24|||
94304660|NCT01607892|322899241|FG003|Overall Study|Consent withdrawn by participant|14|||
94304661|NCT01607892|322899242|FG004|Overall Study|Consent withdrawn by participant|4|||
94304662|NCT01607892|322899238|FG000|Overall Study|Disease progression|38|||
94304663|NCT01607892|322899239|FG001|Overall Study|Disease progression|13|||
94304664|NCT01607892|322899240|FG002|Overall Study|Disease progression|37|||
94304665|NCT01607892|322899241|FG003|Overall Study|Disease progression|57|||
94304666|NCT01607892|322899242|FG004|Overall Study|Disease progression|9|||
94304667|NCT01607892|322899238|FG000|Overall Study|Incidence or severity of Adverse events|3|||
94304668|NCT01607892|322899239|FG001|Overall Study|Incidence or severity of Adverse events|3|||
94304669|NCT01607892|322899240|FG002|Overall Study|Incidence or severity of Adverse events|7|||
94304670|NCT01607892|322899241|FG003|Overall Study|Incidence or severity of Adverse events|2|||
94304671|NCT01607892|322899242|FG004|Overall Study|Incidence or severity of Adverse events|6|||
94304672|NCT01887210|322899243|FG000|Overall Study|Withdrawal by Subject|1|||
94304673|NCT01887210|322899244|FG001|Overall Study|Withdrawal by Subject|3|||
94304674|NCT01887210|322899243|FG000|Overall Study|Lost to Follow-up|0|||
94304675|NCT01887210|322899244|FG001|Overall Study|Lost to Follow-up|1|||
94304676|NCT00840463|322899245|FG000|Overall Study|Adverse Event|1|||
94304677|NCT00840463|322899246|FG001|Overall Study|Adverse Event|0|||
94304678|NCT02273973|322899249|FG000|Overall Study|Adverse Event|4|||
94304679|NCT02273973|322899250|FG001|Overall Study|Adverse Event|0|||
94304680|NCT02273973|322899249|FG000|Overall Study|Withdrawal by Subject|2|||
94304681|NCT02273973|322899250|FG001|Overall Study|Withdrawal by Subject|3|||
94304682|NCT02273973|322899249|FG000|Overall Study|Death|1|||
94304683|NCT02273973|322899250|FG001|Overall Study|Death|0|||
94304684|NCT02273973|322899249|FG000|Overall Study|Non-compliance|1|||
94304685|NCT02273973|322899250|FG001|Overall Study|Non-compliance|0|||
94304686|NCT02273973|322899249|FG000|Overall Study|Protocol Violation|1|||
94304687|NCT02273973|322899250|FG001|Overall Study|Protocol Violation|0|||
94304688|NCT02273973|322899249|FG000|Overall Study|Progression of disease|0|||
94304689|NCT02273973|322899250|FG001|Overall Study|Progression of disease|2|||
94304690|NCT02273973|322899249|FG000|Overall Study|Lost to Follow-up|0|||
94304691|NCT02273973|322899250|FG001|Overall Study|Lost to Follow-up|1|||
94304692|NCT02273973|322899249|FG000|Overall Study|Physician Decision|0|||
94304693|NCT02273973|322899250|FG001|Overall Study|Physician Decision|1|||
94304694|NCT02273973|322899249|FG000|Overall Study|Reason not specified|0|||
94304695|NCT02273973|322899250|FG001|Overall Study|Reason not specified|1|||
94304696|NCT03750838|322899253|FG000|Overall Study|Lost to Follow-up|10|||
94304697|NCT03750838|322899254|FG001|Overall Study|Lost to Follow-up|6|||
94304698|NCT02704429|322899261|FG000|Part A: 24 Weeks|Adverse Event|3|||
94304699|NCT02704429|322899262|FG001|Part A: 24 Weeks|Adverse Event|0|||
94304700|NCT02704429|322899261|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
94304701|NCT02704429|322899262|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
94304702|NCT01287117|322899263|FG000|Overall Study|Adverse Event|2|||
94375375|NCT00463866|323160276|FG000|Overall Study|Incorrect Enrolment|64|||
94375376|NCT00463866|323160277|FG001|Overall Study|Incorrect Enrolment|66|||
94375377|NCT00463866|323160276|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
94375378|NCT00463866|323160277|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
94375379|NCT00463866|323160276|FG000|Overall Study|Safety Reason|1|||
94375380|NCT00463866|323160277|FG001|Overall Study|Safety Reason|3|||
94375381|NCT00463866|323160276|FG000|Overall Study|Mis-Randomization of subject|0|||
94375382|NCT00463866|323160277|FG001|Overall Study|Mis-Randomization of subject|1|||
94375383|NCT00463866|323160276|FG000|Overall Study|Other|22|||
94375384|NCT00463866|323160277|FG001|Overall Study|Other|22|||
94375385|NCT00693784|323160279|FG000|Overall Study|Lost to Follow-up|2|||
94375386|NCT00693784|323160279|FG000|Overall Study|Withdrawal by Subject|2|||
94375387|NCT02265952|323160280|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
94375388|NCT02265952|323160281|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
94375389|NCT02265952|323160280|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
94375390|NCT02265952|323160281|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
94375391|NCT01664052|323160282|FG000|Phase 1|No device placement|6|||
94375392|NCT01664052|323160283|FG001|Phase 1|No device placement|0|||
94375393|NCT01664052|323160282|FG000|Phase 1|No HSG 1 hr post placement|1|||
94375394|NCT01664052|323160283|FG001|Phase 1|No HSG 1 hr post placement|0|||
94375395|NCT01664052|323160282|FG000|Phase 2|No device placement|0|||
94375396|NCT01664052|323160283|FG001|Phase 2|No device placement|4|||
94375397|NCT01042977|323160285|FG000|Overall Study|Adverse Event|4|||
94375398|NCT01042977|323160286|FG001|Overall Study|Adverse Event|12|||
94375399|NCT01042977|323160285|FG000|Overall Study|Death|2|||
94375400|NCT01042977|323160286|FG001|Overall Study|Death|1|||
94375401|NCT01042977|323160285|FG000|Overall Study|Withdrawal by Subject|8|||
94375402|NCT01042977|323160286|FG001|Overall Study|Withdrawal by Subject|16|||
94375403|NCT01042977|323160285|FG000|Overall Study|Lost to Follow-up|0|||
94375404|NCT01042977|323160286|FG001|Overall Study|Lost to Follow-up|2|||
94375405|NCT01042977|323160285|FG000|Overall Study|Poor/non-compliance|3|||
94375406|NCT01042977|323160286|FG001|Overall Study|Poor/non-compliance|4|||
94375407|NCT01042977|323160285|FG000|Overall Study|Subject no longer meets study criteria|15|||
94375408|NCT01042977|323160286|FG001|Overall Study|Subject no longer meets study criteria|13|||
94375409|NCT01042977|323160285|FG000|Overall Study|Incorrect enrollment|6|||
94375410|NCT01042977|323160286|FG001|Overall Study|Incorrect enrollment|4|||
94375411|NCT01042977|323160285|FG000|Overall Study|Safety|0|||
94375412|NCT01042977|323160286|FG001|Overall Study|Safety|2|||
94375413|NCT01042977|323160285|FG000|Overall Study|Administrative reason by sponsor|0|||
94468570|NCT04410991|323505705|FG001|Overall Study|Other|4|||
94375414|NCT01042977|323160286|FG001|Overall Study|Administrative reason by sponsor|1|||
94375415|NCT01042977|323160285|FG000|Overall Study|Various|3|||
94375416|NCT01042977|323160286|FG001|Overall Study|Various|0|||
94375417|NCT04313283|323160287|FG000|Overall Study|did not complete intervention|4|||
94375418|NCT03650400|323160288|FG000|Overall Study|Study terminated by sponsor|0|||
94375419|NCT03650400|323160289|FG001|Overall Study|Study terminated by sponsor|5|||
94375420|NCT00827827|323160302|FG000|Overall Study|Lost to Follow-up|3|||
94375421|NCT00827827|323160303|FG001|Overall Study|Lost to Follow-up|0|||
94375422|NCT00827827|323160302|FG000|Overall Study|Fall at home- hospitalization|1|||
94375423|NCT00827827|323160303|FG001|Overall Study|Fall at home- hospitalization|0|||
94375424|NCT00827827|323160302|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
94375425|NCT00827827|323160303|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
94375426|NCT00827827|323160302|FG000|Overall Study|Gout|1|||
94375427|NCT00827827|323160303|FG001|Overall Study|Gout|0|||
94304703|NCT01287117|322899264|FG001|Overall Study|Adverse Event|1|||
94304704|NCT01287117|322899265|FG002|Overall Study|Adverse Event|1|||
94304705|NCT01287117|322899266|FG003|Overall Study|Adverse Event|1|||
94304706|NCT01287117|322899263|FG000|Overall Study|Lost to Follow-up|1|||
94304707|NCT01287117|322899264|FG001|Overall Study|Lost to Follow-up|1|||
94304708|NCT01287117|322899265|FG002|Overall Study|Lost to Follow-up|0|||
94304709|NCT01287117|322899266|FG003|Overall Study|Lost to Follow-up|0|||
94304710|NCT01287117|322899263|FG000|Overall Study|Physician Decision|0|||
94304711|NCT01287117|322899264|FG001|Overall Study|Physician Decision|1|||
94304712|NCT01287117|322899265|FG002|Overall Study|Physician Decision|1|||
94304713|NCT01287117|322899266|FG003|Overall Study|Physician Decision|1|||
94304714|NCT01287117|322899263|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
94304715|NCT01287117|322899264|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
94304716|NCT01287117|322899265|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
94304717|NCT01287117|322899266|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
94375428|NCT00827827|323160302|FG000|Overall Study|Transportation issues|1|||
94375429|NCT00827827|323160303|FG001|Overall Study|Transportation issues|0|||
94375430|NCT00827827|323160302|FG000|Overall Study|Burned with water at home|1|||
94375431|NCT00827827|323160303|FG001|Overall Study|Burned with water at home|0|||
94375432|NCT01381900|323160313|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
94375433|NCT01381900|323160314|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
94375434|NCT01381900|323160315|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
94375435|NCT01381900|323160313|FG000|Overall Study|Adverse Event|4|||
94375436|NCT01381900|323160314|FG001|Overall Study|Adverse Event|6|||
94375437|NCT01381900|323160315|FG002|Overall Study|Adverse Event|7|||
94375438|NCT01381900|323160313|FG000|Overall Study|Noncompliance with study drug|0|||
94375439|NCT01381900|323160314|FG001|Overall Study|Noncompliance with study drug|0|||
94375440|NCT01381900|323160315|FG002|Overall Study|Noncompliance with study drug|1|||
94375441|NCT01381900|323160313|FG000|Overall Study|Physician Decision|0|||
94375442|NCT01381900|323160314|FG001|Overall Study|Physician Decision|1|||
94375443|NCT01381900|323160315|FG002|Overall Study|Physician Decision|1|||
94375444|NCT01381900|323160313|FG000|Overall Study|Protocol Violation|0|||
94375445|NCT01381900|323160314|FG001|Overall Study|Protocol Violation|1|||
94304718|NCT01287117|322899263|FG000|Overall Study|Disease Progression|10|||
94304719|NCT01287117|322899264|FG001|Overall Study|Disease Progression|5|||
94304720|NCT01287117|322899265|FG002|Overall Study|Disease Progression|6|||
94304721|NCT01287117|322899266|FG003|Overall Study|Disease Progression|5|||
94304722|NCT02975349|322899267|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94304723|NCT02975349|322899268|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94304724|NCT02975349|322899269|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94304725|NCT02975349|322899270|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
94304726|NCT02975349|322899271|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
94304727|NCT02975349|322899272|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94304728|NCT02975349|322899273|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94304729|NCT02975349|322899267|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
94304730|NCT02975349|322899268|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94304731|NCT02975349|322899269|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94304732|NCT02975349|322899270|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94304733|NCT02975349|322899271|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94304734|NCT02975349|322899272|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94304735|NCT02975349|322899273|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94304736|NCT02975349|322899267|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
94304737|NCT02975349|322899268|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
94304738|NCT02975349|322899269|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
94304739|NCT02975349|322899270|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
94304740|NCT02975349|322899271|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
94304741|NCT02975349|322899272|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
94304742|NCT02975349|322899273|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
94304743|NCT02975349|322899267|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
94304744|NCT02975349|322899268|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
94375446|NCT01381900|323160315|FG002|Overall Study|Protocol Violation|1|||
94375447|NCT01381900|323160313|FG000|Overall Study|Withdrawal by Subject|0|||
94375448|NCT01381900|323160314|FG001|Overall Study|Withdrawal by Subject|0|||
94375449|NCT01381900|323160315|FG002|Overall Study|Withdrawal by Subject|1|||
94375450|NCT01381900|323160313|FG000|Overall Study|Early withdraw|3|||
94375451|NCT01381900|323160314|FG001|Overall Study|Early withdraw|1|||
94375452|NCT01381900|323160315|FG002|Overall Study|Early withdraw|1|||
94375453|NCT02410252|323160316|FG000|Overall Study|Withdrawal by Subject|4|||
94375454|NCT02410252|323160316|FG000|Overall Study|Physician Decision|2|||
94375455|NCT03341273|323160328|FG000|Overall Study|Lost to Follow-up|7|||
94375456|NCT03341273|323160329|FG001|Overall Study|Lost to Follow-up|7|||
94375457|NCT03341273|323160328|FG000|Overall Study|Withdrawal by Subject|4|||
94375458|NCT03341273|323160329|FG001|Overall Study|Withdrawal by Subject|2|||
94375459|NCT03341273|323160328|FG000|Overall Study|Physician Decision|1|||
94468571|NCT04410978|323505714|FG000|Overall Study|Poor compliance to protocol|2|||
94468572|NCT04410978|323505715|FG001|Overall Study|Poor compliance to protocol|4|||
94468573|NCT04410978|323505714|FG000|Overall Study|Withdrawal by Subject|64|||
94468574|NCT04410978|323505715|FG001|Overall Study|Withdrawal by Subject|66|||
94468575|NCT04410978|323505714|FG000|Overall Study|Other|6|||
94468576|NCT04410978|323505715|FG001|Overall Study|Other|7|||
94468577|NCT04410978|323505714|FG000|Overall Study|Missing study status|1|||
94468578|NCT04410978|323505715|FG001|Overall Study|Missing study status|0|||
94468579|NCT02273908|323505717|FG000|Overall Study|Adverse Event|16|||
94468580|NCT02273908|323505718|FG001|Overall Study|Adverse Event|0|||
94468581|NCT02273908|323505717|FG000|Overall Study|Lost to Follow-up|10|||
94468582|NCT02273908|323505718|FG001|Overall Study|Lost to Follow-up|1|||
94468583|NCT02273908|323505717|FG000|Overall Study|Did not meet entrance criteria|3|||
94468584|NCT02273908|323505718|FG001|Overall Study|Did not meet entrance criteria|2|||
94468585|NCT02273908|323505717|FG000|Overall Study|Withdrawal by Subject|4|||
94468586|NCT02273908|323505718|FG001|Overall Study|Withdrawal by Subject|2|||
94468587|NCT00791492|323505722|FG000|Overall Study|Withdrawal by Subject|1|||
94468588|NCT00791492|323505723|FG001|Overall Study|Withdrawal by Subject|2|||
94468589|NCT00791492|323505722|FG000|Overall Study|Liver transplantation|5|||
94468590|NCT00791492|323505723|FG001|Overall Study|Liver transplantation|1|||
94468591|NCT00419159|323505724|FG000|Overall Study|Adverse Event|7|||
94468592|NCT00419159|323505725|FG001|Overall Study|Adverse Event|15|||
94468593|NCT00419159|323505724|FG000|Overall Study|Abnormal laboratory value(s)|0|||
94468594|NCT00419159|323505725|FG001|Overall Study|Abnormal laboratory value(s)|2|||
94468595|NCT00419159|323505724|FG000|Overall Study|Subject's no longer requires study drug|0|||
94468596|NCT00419159|323505725|FG001|Overall Study|Subject's no longer requires study drug|1|||
94468597|NCT00419159|323505724|FG000|Overall Study|Protocol Violation|1|||
94468598|NCT00419159|323505725|FG001|Overall Study|Protocol Violation|0|||
94468599|NCT00419159|323505724|FG000|Overall Study|Withdrawal by Subject|10|||
94468600|NCT00419159|323505725|FG001|Overall Study|Withdrawal by Subject|3|||
94468601|NCT00419159|323505724|FG000|Overall Study|Lost to Follow-up|0|||
94468602|NCT00419159|323505725|FG001|Overall Study|Lost to Follow-up|1|||
94468603|NCT00419159|323505724|FG000|Overall Study|Death|2|||
94468604|NCT00419159|323505725|FG001|Overall Study|Death|2|||
94468605|NCT00419159|323505724|FG000|Overall Study|Disease progression|79|||
94468606|NCT00419159|323505725|FG001|Overall Study|Disease progression|76|||
94468607|NCT02638259|323505726|FG000|Treatment Period 1|Adverse Event|1|||
94468608|NCT02638259|323505727|FG001|Treatment Period 1|Adverse Event|5|||
94468609|NCT02638259|323505726|FG000|Treatment Period 1|Death|0|||
94468610|NCT02638259|323505727|FG001|Treatment Period 1|Death|1|||
94468611|NCT02638259|323505726|FG000|Treatment Period 1|Lack of Efficacy|0|||
94468612|NCT02638259|323505727|FG001|Treatment Period 1|Lack of Efficacy|1|||
94468613|NCT02638259|323505726|FG000|Treatment Period 1|Protocol Violation|0|||
94468614|NCT02638259|323505727|FG001|Treatment Period 1|Protocol Violation|3|||
94468615|NCT02638259|323505726|FG000|Treatment Period 1|Withdrawal by Subject|4|||
94468616|NCT02638259|323505727|FG001|Treatment Period 1|Withdrawal by Subject|6|||
94468617|NCT02638259|323505726|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
94468618|NCT02638259|323505727|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
94468619|NCT02638259|323505726|FG000|Treatment Period 2|Adverse Event|5|||
94468620|NCT02638259|323505727|FG001|Treatment Period 2|Adverse Event|4|||
94468621|NCT02638259|323505726|FG000|Treatment Period 2|Withdrawal by Subject|1|||
94468622|NCT02638259|323505727|FG001|Treatment Period 2|Withdrawal by Subject|7|||
94468623|NCT01606748|323505728|FG000|Overall Study|Adverse Event|1|||
94468624|NCT01606748|323505729|FG001|Overall Study|Adverse Event|0|||
94468625|NCT01606748|323505728|FG000|Overall Study|Progressive Disease|1|||
94468626|NCT01606748|323505729|FG001|Overall Study|Progressive Disease|0|||
94468627|NCT01606748|323505728|FG000|Overall Study|Withdrawal by Subject|1|||
94468628|NCT01606748|323505729|FG001|Overall Study|Withdrawal by Subject|0|||
94468629|NCT02839876|323505730|FG000|Overall Study|Protocol Violation|10|||
94468630|NCT02839876|323505731|FG001|Overall Study|Protocol Violation|11|||
94468631|NCT02195427|323505732|FG000|Overall Study|Did not consent to study extension|13|||
94468632|NCT02195427|323505733|FG001|Overall Study|Did not consent to study extension|9|||
94468633|NCT02195427|323505732|FG000|Overall Study|Withdrawal by Subject|4|||
94468634|NCT02195427|323505733|FG001|Overall Study|Withdrawal by Subject|2|||
94468635|NCT02195427|323505732|FG000|Overall Study|Lost to Follow-up|0|||
94468636|NCT02195427|323505733|FG001|Overall Study|Lost to Follow-up|1|||
94468637|NCT02195427|323505732|FG000|Overall Study|Protocol Violation|7|||
94468638|NCT02195427|323505733|FG001|Overall Study|Protocol Violation|14|||
94468639|NCT02195427|323505732|FG000|Overall Study|Conditional re-treatment at W52|2|||
94468640|NCT02195427|323505733|FG001|Overall Study|Conditional re-treatment at W52|1|||
94468641|NCT02620384|323505738|FG000|Overall Study|Adverse Event|2|||
94468642|NCT02620384|323505739|FG001|Overall Study|Adverse Event|1|||
94468643|NCT02620384|323505738|FG000|Overall Study|Discharged prior to 2nd dose|2|||
94468644|NCT02620384|323505739|FG001|Overall Study|Discharged prior to 2nd dose|5|||
94468645|NCT02620384|323505738|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
94468646|NCT02620384|323505739|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
94512830|NCT00725985|323676428|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
94304745|NCT02975349|322899269|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
94304746|NCT02975349|322899270|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
94304747|NCT02975349|322899271|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
94304748|NCT02975349|322899272|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
94304749|NCT02975349|322899273|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
94304750|NCT02975349|322899267|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
94304751|NCT02975349|322899268|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
94304752|NCT02975349|322899269|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
94304753|NCT02975349|322899270|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
94304754|NCT02975349|322899271|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
94304755|NCT02975349|322899272|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
94304756|NCT02975349|322899273|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
94304757|NCT02975349|322899267|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
94304758|NCT02975349|322899268|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
94304759|NCT02975349|322899269|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
94304760|NCT02975349|322899270|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
94304761|NCT02975349|322899271|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
94304762|NCT02975349|322899272|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
94304763|NCT02975349|322899273|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
94304764|NCT02975349|322899267|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
94304765|NCT02975349|322899268|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
94304766|NCT02975349|322899269|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
94375460|NCT03341273|323160329|FG001|Overall Study|Physician Decision|0|||
94375461|NCT03341273|323160328|FG000|Overall Study|Protocol Violation|0|||
94375462|NCT03341273|323160329|FG001|Overall Study|Protocol Violation|1|||
94375463|NCT03341273|323160328|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
94375464|NCT03341273|323160329|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
94375465|NCT03341273|323160328|FG000|Overall Study|Became ineligible after enrollment|1|||
94375466|NCT03341273|323160329|FG001|Overall Study|Became ineligible after enrollment|0|||
94375467|NCT03341273|323160328|FG000|Overall Study|Not Eligible at Enrollment|0|||
94375468|NCT03341273|323160329|FG001|Overall Study|Not Eligible at Enrollment|1|||
94375469|NCT03341273|323160328|FG000|Overall Study|Participant incarcerated|1|||
94375470|NCT03341273|323160329|FG001|Overall Study|Participant incarcerated|0|||
94375471|NCT01590433|323160332|FG000|Overall Study|Lost to Follow-up|20|||
94375472|NCT01590433|323160333|FG001|Overall Study|Lost to Follow-up|8|||
94375473|NCT01590433|323160332|FG000|Overall Study|Withdrawal by Subject|21|||
94375474|NCT01590433|323160333|FG001|Overall Study|Withdrawal by Subject|11|||
94375475|NCT01590433|323160332|FG000|Overall Study|Adverse Event|11|||
94375476|NCT01590433|323160333|FG001|Overall Study|Adverse Event|3|||
94375477|NCT01452529|323160340|FG000|Run-in Period|Adverse Event|96|||
94375478|NCT01452529|323160341|FG001|Run-in Period|Adverse Event|0|||
94375479|NCT01452529|323160342|FG002|Run-in Period|Adverse Event|0|||
94375480|NCT01452529|323160340|FG000|Run-in Period|Withdrawal by Subject|49|||
94375481|NCT01452529|323160341|FG001|Run-in Period|Withdrawal by Subject|0|||
94375482|NCT01452529|323160342|FG002|Run-in Period|Withdrawal by Subject|0|||
94375483|NCT01452529|323160340|FG000|Run-in Period|Lost to Follow-up|19|||
94375484|NCT01452529|323160341|FG001|Run-in Period|Lost to Follow-up|0|||
94375485|NCT01452529|323160342|FG002|Run-in Period|Lost to Follow-up|0|||
94375486|NCT01452529|323160340|FG000|Run-in Period|Lack of Efficacy|46|||
94375487|NCT01452529|323160341|FG001|Run-in Period|Lack of Efficacy|0|||
94375488|NCT01452529|323160342|FG002|Run-in Period|Lack of Efficacy|0|||
94375489|NCT01452529|323160340|FG000|Run-in Period|Confirmed or suspected diversion|23|||
94375490|NCT01452529|323160341|FG001|Run-in Period|Confirmed or suspected diversion|0|||
94375491|NCT01452529|323160342|FG002|Run-in Period|Confirmed or suspected diversion|0|||
94375492|NCT01452529|323160340|FG000|Run-in Period|Administrative|21|||
94375493|NCT01452529|323160341|FG001|Run-in Period|Administrative|0|||
94375494|NCT01452529|323160342|FG002|Run-in Period|Administrative|0|||
94375495|NCT01452529|323160340|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
94375496|NCT01452529|323160341|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
94375497|NCT01452529|323160342|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
94375498|NCT01452529|323160340|FG000|Double-blind (DB) Period|Adverse Event|0|||
94375499|NCT01452529|323160341|FG001|Double-blind (DB) Period|Adverse Event|18|||
94375500|NCT01452529|323160342|FG002|Double-blind (DB) Period|Adverse Event|11|||
94375501|NCT01452529|323160340|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
94375502|NCT01452529|323160341|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
94375503|NCT01452529|323160342|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
94375504|NCT01452529|323160340|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
94304767|NCT02975349|322899270|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
94304768|NCT02975349|322899271|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
94304769|NCT02975349|322899272|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
94375505|NCT01452529|323160341|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
94375506|NCT01452529|323160342|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
94304770|NCT02975349|322899273|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
94304771|NCT02975349|322899267|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
94304772|NCT02975349|322899268|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
94304773|NCT02975349|322899269|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
94304774|NCT02975349|322899270|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
94304775|NCT02975349|322899271|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
94304776|NCT02975349|322899272|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
94304777|NCT02975349|322899273|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
94304778|NCT02975349|322899267|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
94304779|NCT02975349|322899268|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
94304780|NCT02975349|322899269|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
94304781|NCT02975349|322899270|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
94304782|NCT02975349|322899271|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
94304783|NCT02975349|322899272|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
94304784|NCT02975349|322899273|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
94304785|NCT02975349|322899267|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
94304786|NCT02975349|322899268|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
94304787|NCT02975349|322899269|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
94304788|NCT02975349|322899270|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
94304789|NCT02975349|322899271|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
94304790|NCT02975349|322899272|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
94304791|NCT02975349|322899273|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
94304792|NCT02975349|322899267|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
94304793|NCT02975349|322899268|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
94304794|NCT02975349|322899269|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
94304795|NCT02975349|322899270|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
94304796|NCT02975349|322899271|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
94304797|NCT02975349|322899272|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
94304798|NCT02975349|322899273|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
94304799|NCT02975349|322899267|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
94304800|NCT02975349|322899268|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
94304801|NCT02975349|322899269|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
94304802|NCT02975349|322899270|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
94304803|NCT02975349|322899271|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
94304804|NCT02975349|322899272|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
94304805|NCT02975349|322899273|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
94304806|NCT02975349|322899267|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
94304807|NCT02975349|322899268|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
94304808|NCT02975349|322899269|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
94304809|NCT02975349|322899270|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
94304810|NCT02975349|322899271|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
94304811|NCT02975349|322899272|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
94304812|NCT02975349|322899273|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
94304813|NCT02975349|322899267|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
94304814|NCT02975349|322899268|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
94304815|NCT02975349|322899269|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
94304816|NCT02975349|322899270|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
94304817|NCT02975349|322899271|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
94304818|NCT02975349|322899272|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
94304819|NCT02975349|322899273|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
94304820|NCT02975349|322899267|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
94304821|NCT02975349|322899268|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
94304822|NCT02975349|322899269|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
94304823|NCT02975349|322899270|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
94304824|NCT02975349|322899271|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
94304825|NCT02975349|322899272|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
94304826|NCT02975349|322899273|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
94304827|NCT03518840|322901278|FG000|Overall Study|Lost to Follow-up|6|||
94304828|NCT03704051|322901282|FG000|Overall Study|Withdrawal by Subject|4|||
94304829|NCT03704051|322901283|FG001|Overall Study|Withdrawal by Subject|0|||
94304830|NCT00914628|322901284|FG000|Overall Study|Death|35|||
94304831|NCT00914628|322901285|FG001|Overall Study|Death|17|||
94304832|NCT00914628|322901284|FG000|Overall Study|Medical decision|4|||
94304833|NCT00914628|322901285|FG001|Overall Study|Medical decision|0|||
94304834|NCT00914628|322901284|FG000|Overall Study|Protocol Violation|1|||
94304835|NCT00914628|322901285|FG001|Overall Study|Protocol Violation|0|||
94304836|NCT00914628|322901284|FG000|Overall Study|Lack of Efficacy|1|||
94468647|NCT00094536|323505740|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
94468648|NCT00094536|323505740|FG000|Treatment and Follow-up|Adverse Event|4|||
94468649|NCT00094536|323505740|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
94468650|NCT00094536|323505740|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
94468651|NCT00094536|323505740|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
94468652|NCT00094536|323505740|FG000|Treatment and Follow-up|Subject non-compliance|9|||
94468653|NCT00094536|323505740|FG000|Treatment and Follow-up|Unable to attend visits|1|||
94468654|NCT02607306|323505742|FG000|Overall Study|Adverse Event|8|||
94375507|NCT01452529|323160340|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
94375508|NCT01452529|323160341|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
94375509|NCT01452529|323160342|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
94375510|NCT01452529|323160340|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
94375511|NCT01452529|323160341|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
94375512|NCT01452529|323160342|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
94375513|NCT01452529|323160340|FG000|Double-blind (DB) Period|Administrative|0|||
94375514|NCT01452529|323160341|FG001|Double-blind (DB) Period|Administrative|11|||
94375515|NCT01452529|323160342|FG002|Double-blind (DB) Period|Administrative|7|||
94375516|NCT03551730|323160343|FG000|Overall Study|Adverse Event|1|||
94375517|NCT03551730|323160344|FG001|Overall Study|Adverse Event|0|||
94375518|NCT03551730|323160345|FG002|Overall Study|Adverse Event|0|||
94375519|NCT03551730|323160346|FG003|Overall Study|Adverse Event|0|||
94375520|NCT04633837|323160347|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
94375521|NCT04633837|323160348|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
94375522|NCT00112489|323160349|FG000|Overall Study|Refused further treatment|8|||
94375523|NCT00112489|323160349|FG000|Overall Study|Adverse Event|12|||
94375524|NCT00112489|323160349|FG000|Overall Study|Death|2|||
94375525|NCT00112489|323160349|FG000|Overall Study|Other, Not Specified|9|||
94375526|NCT00112489|323160349|FG000|Overall Study|Patient never treated|2|||
94375527|NCT00112489|323160349|FG000|Overall Study|Ineligible|7|||
94375528|NCT02231710|323160369|FG000|Overall Study|Physician Decision|1|||
94375529|NCT03565211|323160370|FG000|Overall Study|Withdrawal by Subject|2|||
94375530|NCT03565211|323160370|FG000|Overall Study|Lost to Follow-up|1|||
94375531|NCT03565211|323160370|FG000|Overall Study|Adverse Event|44|||
94375532|NCT03565211|323160370|FG000|Overall Study|Personal issues|1|||
94375533|NCT01092702|323160371|FG000|Overall Study|Withdrawal by Subject|7|||
94375534|NCT01092702|323160371|FG000|Overall Study|Lost to Follow-up|2|||
94375535|NCT02741271|323160375|FG000|Overall Study|Lost to Follow-up|2|||
94375536|NCT02741271|323160376|FG001|Overall Study|Lost to Follow-up|0|||
94375537|NCT02741271|323160375|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94375538|NCT02741271|323160376|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
94375539|NCT03652961|323160377|FG000|Overall Study|Lost to Follow-up|3|||
94375540|NCT03652961|323160377|FG000|Overall Study|Screen Failure|1|||
94375541|NCT00410410|323160378|FG000|Induction Period (IP)|Death|1|||
94375542|NCT00410410|323160379|FG001|Induction Period (IP)|Death|0|||
94375543|NCT00410410|323160380|FG002|Induction Period (IP)|Death|0|||
94375544|NCT00410410|323160381|FG003|Induction Period (IP)|Death|0|||
94375545|NCT00410410|323160382|FG004|Induction Period (IP)|Death|0|||
94375546|NCT00410410|323160383|FG005|Induction Period (IP)|Death|0|||
94375547|NCT00410410|323160384|FG006|Induction Period (IP)|Death|0|||
94375548|NCT00410410|323160385|FG007|Induction Period (IP)|Death|0|||
94375549|NCT00410410|323160386|FG008|Induction Period (IP)|Death|0|||
94375550|NCT00410410|323160378|FG000|Induction Period (IP)|Adverse Event|3|||
94375551|NCT00410410|323160379|FG001|Induction Period (IP)|Adverse Event|4|||
94375552|NCT00410410|323160380|FG002|Induction Period (IP)|Adverse Event|2|||
94375553|NCT00410410|323160381|FG003|Induction Period (IP)|Adverse Event|4|||
94375554|NCT00410410|323160382|FG004|Induction Period (IP)|Adverse Event|1|||
94375555|NCT00410410|323160383|FG005|Induction Period (IP)|Adverse Event|0|||
94375556|NCT00410410|323160384|FG006|Induction Period (IP)|Adverse Event|0|||
94375557|NCT00410410|323160385|FG007|Induction Period (IP)|Adverse Event|0|||
94375558|NCT00410410|323160386|FG008|Induction Period (IP)|Adverse Event|0|||
94375559|NCT00410410|323160378|FG000|Induction Period (IP)|Lack of Efficacy|26|||
94375560|NCT00410410|323160379|FG001|Induction Period (IP)|Lack of Efficacy|24|||
94375561|NCT00410410|323160380|FG002|Induction Period (IP)|Lack of Efficacy|8|||
94375562|NCT00410410|323160381|FG003|Induction Period (IP)|Lack of Efficacy|8|||
94375563|NCT00410410|323160382|FG004|Induction Period (IP)|Lack of Efficacy|7|||
94375564|NCT00410410|323160383|FG005|Induction Period (IP)|Lack of Efficacy|7|||
94375565|NCT00410410|323160384|FG006|Induction Period (IP)|Lack of Efficacy|0|||
94375566|NCT00410410|323160385|FG007|Induction Period (IP)|Lack of Efficacy|0|||
94375567|NCT00410410|323160386|FG008|Induction Period (IP)|Lack of Efficacy|0|||
94375568|NCT00410410|323160378|FG000|Induction Period (IP)|Lost to Follow-up|2|||
94375569|NCT00410410|323160379|FG001|Induction Period (IP)|Lost to Follow-up|2|||
94375570|NCT00410410|323160380|FG002|Induction Period (IP)|Lost to Follow-up|2|||
94375571|NCT00410410|323160381|FG003|Induction Period (IP)|Lost to Follow-up|3|||
94375572|NCT00410410|323160382|FG004|Induction Period (IP)|Lost to Follow-up|0|||
94375573|NCT00410410|323160383|FG005|Induction Period (IP)|Lost to Follow-up|1|||
94375574|NCT00410410|323160384|FG006|Induction Period (IP)|Lost to Follow-up|0|||
94468655|NCT02607306|323505743|FG001|Overall Study|Adverse Event|6|||
94375575|NCT00410410|323160385|FG007|Induction Period (IP)|Lost to Follow-up|0|||
94375576|NCT00410410|323160386|FG008|Induction Period (IP)|Lost to Follow-up|0|||
94375577|NCT00410410|323160378|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
94375578|NCT00410410|323160379|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
94375579|NCT00410410|323160380|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
94375580|NCT00410410|323160381|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
94468656|NCT02607306|323505744|FG002|Overall Study|Adverse Event|6|||
94468657|NCT02607306|323505742|FG000|Overall Study|Unclassified|1|||
94468658|NCT02607306|323505743|FG001|Overall Study|Unclassified|4|||
94468659|NCT02607306|323505744|FG002|Overall Study|Unclassified|0|||
94468660|NCT02607306|323505742|FG000|Overall Study|Withdrawal by Subject|8|||
94468661|NCT02607306|323505743|FG001|Overall Study|Withdrawal by Subject|10|||
94468662|NCT02607306|323505744|FG002|Overall Study|Withdrawal by Subject|2|||
94468663|NCT02607306|323505742|FG000|Overall Study|Lack of Efficacy|0|||
94468664|NCT02607306|323505743|FG001|Overall Study|Lack of Efficacy|1|||
94468665|NCT02607306|323505744|FG002|Overall Study|Lack of Efficacy|1|||
94468666|NCT02607306|323505742|FG000|Overall Study|Protocol Violation|4|||
94468667|NCT02607306|323505743|FG001|Overall Study|Protocol Violation|2|||
94468668|NCT02607306|323505744|FG002|Overall Study|Protocol Violation|1|||
94468669|NCT00207727|323505745|FG000|Overall Study|Withdrawal by Subject|0|||
94468670|NCT00207727|323505746|FG001|Overall Study|Withdrawal by Subject|0|||
94468671|NCT00207727|323505747|FG002|Overall Study|Withdrawal by Subject|0|||
94468672|NCT00207727|323505748|FG003|Overall Study|Withdrawal by Subject|0|||
94468673|NCT00207727|323505749|FG004|Overall Study|Withdrawal by Subject|1|||
94468674|NCT00207727|323505745|FG000|Overall Study|Lost to Follow-up|0|||
94468675|NCT00207727|323505746|FG001|Overall Study|Lost to Follow-up|1|||
94468676|NCT00207727|323505747|FG002|Overall Study|Lost to Follow-up|0|||
94468677|NCT00207727|323505748|FG003|Overall Study|Lost to Follow-up|0|||
94468678|NCT00207727|323505749|FG004|Overall Study|Lost to Follow-up|0|||
94468679|NCT00207727|323505745|FG000|Overall Study|Other|38|||
94468680|NCT00207727|323505746|FG001|Overall Study|Other|41|||
94468681|NCT00207727|323505747|FG002|Overall Study|Other|41|||
94468682|NCT00207727|323505748|FG003|Overall Study|Other|37|||
94468683|NCT00207727|323505749|FG004|Overall Study|Other|33|||
94468684|NCT00597012|323505752|FG000|Overall Study|Death|1|||
94468685|NCT00597012|323505753|FG001|Overall Study|Death|1|||
94468686|NCT00597012|323505752|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
94468687|NCT00597012|323505753|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
94304837|NCT00914628|322901285|FG001|Overall Study|Lack of Efficacy|0|||
94304838|NCT00914628|322901284|FG000|Overall Study|non-randomized|1|||
94304839|NCT00914628|322901285|FG001|Overall Study|non-randomized|0|||
94304840|NCT00914628|322901284|FG000|Overall Study|Relapse|1|||
94304841|NCT00914628|322901285|FG001|Overall Study|Relapse|2|||
94304842|NCT00914628|322901284|FG000|Overall Study|Study terminated by Sponsor|14|||
94304843|NCT00914628|322901285|FG001|Overall Study|Study terminated by Sponsor|8|||
94304844|NCT00914628|322901284|FG000|Overall Study|Patients who did not receive a single dose|7|||
94304845|NCT00914628|322901285|FG001|Overall Study|Patients who did not receive a single dose|1|||
94304846|NCT03937986|322901288|FG000|Overall Study|COVID-19 Pandemic|1|||
94304847|NCT02413255|322901297|FG000|Overall Study|Voluntary Withdrawal|0|||
94304848|NCT02413255|322901298|FG001|Overall Study|Voluntary Withdrawal|0|||
94304849|NCT02413255|322901299|FG002|Overall Study|Voluntary Withdrawal|0|||
94304850|NCT02413255|322901300|FG003|Overall Study|Voluntary Withdrawal|0|||
94304851|NCT02413255|322901301|FG004|Overall Study|Voluntary Withdrawal|0|||
94304852|NCT02413255|322901302|FG005|Overall Study|Voluntary Withdrawal|0|||
94304853|NCT02413255|322901303|FG006|Overall Study|Voluntary Withdrawal|0|||
94304854|NCT02413255|322901304|FG007|Overall Study|Voluntary Withdrawal|0|||
94304855|NCT02413255|322901305|FG008|Overall Study|Voluntary Withdrawal|0|||
94304856|NCT02413255|322901306|FG009|Overall Study|Voluntary Withdrawal|0|||
94304857|NCT02413255|322901307|FG010|Overall Study|Voluntary Withdrawal|0|||
94304858|NCT02413255|322901308|FG011|Overall Study|Voluntary Withdrawal|0|||
94304859|NCT02413255|322901309|FG012|Overall Study|Voluntary Withdrawal|0|||
94304860|NCT02413255|322901310|FG013|Overall Study|Voluntary Withdrawal|0|||
94304861|NCT02413255|322901311|FG014|Overall Study|Voluntary Withdrawal|1|||
94304862|NCT02413255|322901312|FG015|Overall Study|Voluntary Withdrawal|0|||
94304863|NCT02413255|322901313|FG016|Overall Study|Voluntary Withdrawal|0|||
94468688|NCT00597012|323505752|FG000|Overall Study|Withdrawal by Subject|7|||
94468689|NCT00597012|323505753|FG001|Overall Study|Withdrawal by Subject|4|||
94468690|NCT00597012|323505752|FG000|Overall Study|Ineligible|2|||
94468691|NCT00597012|323505753|FG001|Overall Study|Ineligible|0|||
94468692|NCT00597012|323505752|FG000|Overall Study|Lost to Follow-up|0|||
94468693|NCT00597012|323505753|FG001|Overall Study|Lost to Follow-up|2|||
94468694|NCT03755518|323505754|FG000|Overall Study|Lack of Efficacy|10|||
94468695|NCT03755518|323505754|FG000|Overall Study|Adverse Event|7|||
94304864|NCT03199911|322901314|FG000|Overall Study|Lost to Follow-up|5|||
94304865|NCT03199911|322901315|FG001|Overall Study|Lost to Follow-up|5|||
94304866|NCT03199911|322901314|FG000|Overall Study|Did not proceed with surgery|2|||
94304867|NCT03199911|322901315|FG001|Overall Study|Did not proceed with surgery|1|||
94304868|NCT02333331|322901316|FG000|Overall Study|Adverse Event|1|||
94468696|NCT03755518|323505754|FG000|Overall Study|Study Terminated by Sponsor|5|||
94468697|NCT03755518|323505754|FG000|Overall Study|Death|1|||
94468698|NCT03755518|323505754|FG000|Overall Study|Withdrawal by Subject|3|||
94468699|NCT03755518|323505754|FG000|Overall Study|Progressive Disease|4|||
94468700|NCT03755518|323505754|FG000|Overall Study|Bone Marrow Transplant|4|||
94468701|NCT03755518|323505754|FG000|Overall Study|Physicians Decision|1|||
94468702|NCT03755518|323505754|FG000|Overall Study|Relapse|1|||
94468703|NCT03755518|323505754|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
94468704|NCT03755518|323505754|FG000|Overall Study|Withdrawal by PI|1|||
94468705|NCT00395642|323505755|FG000|Overall Study|Death|4|||
94468706|NCT00395642|323505755|FG000|Overall Study|Lost to Follow-up|1|||
94468707|NCT00395642|323505755|FG000|Overall Study|Physician Decision|7|||
94468708|NCT00395642|323505755|FG000|Overall Study|Withdrawal by Subject|1|||
94468709|NCT02012959|323505756|FG000|Treatment Phase A|Adverse Event|2|||
94468710|NCT02012959|323505757|FG001|Treatment Phase A|Adverse Event|0|||
94468711|NCT02012959|323505758|FG002|Treatment Phase A|Adverse Event|0|||
94468712|NCT02012959|323505759|FG003|Treatment Phase A|Adverse Event|0|||
94468713|NCT02012959|323505760|FG004|Treatment Phase A|Adverse Event|0|||
94468714|NCT00866333|323505773|FG000|Overall Study|Withdrawal of consent|0|||
94468715|NCT00866333|323505774|FG001|Overall Study|Withdrawal of consent|1|||
94468716|NCT00866333|323505775|FG002|Overall Study|Withdrawal of consent|2|||
94468717|NCT00866333|323505773|FG000|Overall Study|Reason not Specified|3|||
94468718|NCT00866333|323505774|FG001|Overall Study|Reason not Specified|1|||
94468719|NCT00866333|323505775|FG002|Overall Study|Reason not Specified|1|||
94468720|NCT00866333|323505773|FG000|Overall Study|Study Terminated by Sponsor|2|||
94468721|NCT00866333|323505774|FG001|Overall Study|Study Terminated by Sponsor|5|||
94468722|NCT00866333|323505775|FG002|Overall Study|Study Terminated by Sponsor|9|||
94468723|NCT01653327|323505776|FG000|Overall Study|Withdrawal by Subject|1|||
94304869|NCT02333331|322901317|FG001|Overall Study|Adverse Event|0|||
94304870|NCT02333331|322901318|FG002|Overall Study|Adverse Event|4|||
94304871|NCT02333331|322901319|FG003|Overall Study|Adverse Event|1|||
94304872|NCT02333331|322901316|FG000|Overall Study|Death|0|||
94304873|NCT02333331|322901317|FG001|Overall Study|Death|0|||
94304874|NCT02333331|322901318|FG002|Overall Study|Death|2|||
94304875|NCT02333331|322901319|FG003|Overall Study|Death|0|||
94304876|NCT02333331|322901316|FG000|Overall Study|Lost to Follow-up|0|||
94304877|NCT02333331|322901317|FG001|Overall Study|Lost to Follow-up|0|||
94304878|NCT02333331|322901318|FG002|Overall Study|Lost to Follow-up|1|||
94304879|NCT02333331|322901319|FG003|Overall Study|Lost to Follow-up|0|||
94375581|NCT00410410|323160382|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
94375582|NCT00410410|323160383|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
94375583|NCT00410410|323160384|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
94375584|NCT00410410|323160385|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
94375585|NCT00410410|323160386|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
94375586|NCT00410410|323160378|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
94375587|NCT00410410|323160379|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
94375588|NCT00410410|323160380|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
94375589|NCT00410410|323160381|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
94375590|NCT00410410|323160382|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
94375591|NCT00410410|323160383|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
94375592|NCT00410410|323160384|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
94375593|NCT00410410|323160385|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
94375594|NCT00410410|323160386|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
94375595|NCT00410410|323160378|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
94375596|NCT00410410|323160379|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
94375597|NCT00410410|323160380|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
94375598|NCT00410410|323160381|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
94375599|NCT00410410|323160382|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
94375600|NCT00410410|323160383|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
94375601|NCT00410410|323160384|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
94375602|NCT00410410|323160385|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
94375603|NCT00410410|323160386|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
94375604|NCT00410410|323160378|FG000|Induction Period (IP)|Other|0|||
94375605|NCT00410410|323160379|FG001|Induction Period (IP)|Other|0|||
94375606|NCT00410410|323160380|FG002|Induction Period (IP)|Other|1|||
94375607|NCT00410410|323160381|FG003|Induction Period (IP)|Other|0|||
94375608|NCT00410410|323160382|FG004|Induction Period (IP)|Other|0|||
94468724|NCT01180049|323505777|FG000|Overall Study|Other|9|||
94375609|NCT00410410|323160383|FG005|Induction Period (IP)|Other|0|||
94375610|NCT00410410|323160384|FG006|Induction Period (IP)|Other|0|||
94375611|NCT00410410|323160385|FG007|Induction Period (IP)|Other|0|||
94375612|NCT00410410|323160386|FG008|Induction Period (IP)|Other|0|||
94375613|NCT00410410|323160378|FG000|Maintenance Period (MP)|Death|0|||
94468725|NCT01180049|323505778|FG001|Overall Study|Other|7|||
94375614|NCT00410410|323160379|FG001|Maintenance Period (MP)|Death|0|||
94468726|NCT01180049|323505777|FG000|Overall Study|Lost to Follow-up|8|||
94468727|NCT01180049|323505778|FG001|Overall Study|Lost to Follow-up|6|||
94468728|NCT01180049|323505777|FG000|Overall Study|Death|36|||
94304880|NCT02333331|322901316|FG000|Overall Study|Physician Decision|0|||
94304881|NCT02333331|322901317|FG001|Overall Study|Physician Decision|1|||
94304882|NCT02333331|322901318|FG002|Overall Study|Physician Decision|0|||
94304883|NCT02333331|322901319|FG003|Overall Study|Physician Decision|0|||
94304884|NCT02333331|322901316|FG000|Overall Study|Protocol Deviation|0|||
94304885|NCT02333331|322901317|FG001|Overall Study|Protocol Deviation|3|||
94304886|NCT02333331|322901318|FG002|Overall Study|Protocol Deviation|2|||
94304887|NCT02333331|322901319|FG003|Overall Study|Protocol Deviation|1|||
94304888|NCT02333331|322901316|FG000|Overall Study|Patient/Guardian Decision|1|||
94304889|NCT02333331|322901317|FG001|Overall Study|Patient/Guardian Decision|2|||
94304890|NCT02333331|322901318|FG002|Overall Study|Patient/Guardian Decision|9|||
94375615|NCT00410410|323160380|FG002|Maintenance Period (MP)|Death|0|||
94375616|NCT00410410|323160381|FG003|Maintenance Period (MP)|Death|0|||
94375617|NCT00410410|323160382|FG004|Maintenance Period (MP)|Death|0|||
94375618|NCT00410410|323160383|FG005|Maintenance Period (MP)|Death|0|||
94375619|NCT00410410|323160384|FG006|Maintenance Period (MP)|Death|1|||
94375620|NCT00410410|323160385|FG007|Maintenance Period (MP)|Death|0|||
94375621|NCT00410410|323160386|FG008|Maintenance Period (MP)|Death|0|||
94375622|NCT00410410|323160378|FG000|Maintenance Period (MP)|Adverse Event|0|||
94375623|NCT00410410|323160379|FG001|Maintenance Period (MP)|Adverse Event|0|||
94375624|NCT00410410|323160380|FG002|Maintenance Period (MP)|Adverse Event|0|||
94375625|NCT00410410|323160381|FG003|Maintenance Period (MP)|Adverse Event|0|||
94375626|NCT00410410|323160382|FG004|Maintenance Period (MP)|Adverse Event|0|||
94375627|NCT00410410|323160383|FG005|Maintenance Period (MP)|Adverse Event|0|||
94375628|NCT00410410|323160384|FG006|Maintenance Period (MP)|Adverse Event|1|||
94375629|NCT00410410|323160385|FG007|Maintenance Period (MP)|Adverse Event|3|||
94375630|NCT00410410|323160386|FG008|Maintenance Period (MP)|Adverse Event|0|||
94375631|NCT00410410|323160378|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
94375632|NCT00410410|323160379|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
94375633|NCT00410410|323160380|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
94375634|NCT00410410|323160381|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
94375635|NCT00410410|323160382|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
94375636|NCT00410410|323160383|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
94375637|NCT00410410|323160384|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
94375638|NCT00410410|323160385|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
94375639|NCT00410410|323160386|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
94375640|NCT00410410|323160378|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
94375641|NCT00410410|323160379|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
94375642|NCT00410410|323160380|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
94375643|NCT00410410|323160381|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
94375644|NCT00410410|323160382|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
94375645|NCT00410410|323160383|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
94375646|NCT00410410|323160384|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
94375647|NCT00410410|323160385|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
94375648|NCT00410410|323160386|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
94375649|NCT00410410|323160378|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
94375650|NCT00410410|323160379|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
94375651|NCT00410410|323160380|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
94375652|NCT00410410|323160381|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
94375653|NCT00410410|323160382|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
94375654|NCT00410410|323160383|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
94375655|NCT00410410|323160384|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
94375656|NCT00410410|323160385|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
94375657|NCT00410410|323160386|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
94375658|NCT00410410|323160378|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
94375659|NCT00410410|323160379|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
94375660|NCT00410410|323160380|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
94375661|NCT00410410|323160381|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
94375662|NCT00410410|323160382|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
94375663|NCT00410410|323160383|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
94375664|NCT00410410|323160384|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
94375665|NCT00410410|323160385|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
94375666|NCT00410410|323160386|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
94375667|NCT00410410|323160378|FG000|Open-Label Period (OL)|Death|0|||
94375668|NCT00410410|323160379|FG001|Open-Label Period (OL)|Death|0|||
94375669|NCT00410410|323160380|FG002|Open-Label Period (OL)|Death|0|||
94375670|NCT00410410|323160381|FG003|Open-Label Period (OL)|Death|0|||
94375671|NCT00410410|323160382|FG004|Open-Label Period (OL)|Death|0|||
94375672|NCT00410410|323160383|FG005|Open-Label Period (OL)|Death|0|||
94375673|NCT00410410|323160384|FG006|Open-Label Period (OL)|Death|0|||
94375674|NCT00410410|323160385|FG007|Open-Label Period (OL)|Death|0|||
94375675|NCT00410410|323160386|FG008|Open-Label Period (OL)|Death|1|||
94375676|NCT00410410|323160378|FG000|Open-Label Period (OL)|Adverse Event|0|||
94375677|NCT00410410|323160379|FG001|Open-Label Period (OL)|Adverse Event|0|||
94304891|NCT02333331|322901319|FG003|Overall Study|Patient/Guardian Decision|1|||
94375678|NCT00410410|323160380|FG002|Open-Label Period (OL)|Adverse Event|0|||
94304892|NCT05882890|322901320|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
94304893|NCT02213926|322901321|FG000|Overall Study|Death|59|||
94304894|NCT02213926|322901321|FG000|Overall Study|Withdrawal by Subject|10|||
94304895|NCT02213926|322901321|FG000|Overall Study|study terminated by sponsor|51|||
94304896|NCT02213926|322901321|FG000|Overall Study|Lost to Follow-up|3|||
94304897|NCT02213926|322901321|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
94304898|NCT05309668|322901325|FG000|Overall Study|Ongoing at data cut-off|14|||
94304899|NCT05309668|322901326|FG001|Overall Study|Ongoing at data cut-off|17|||
94304900|NCT05309668|322901327|FG002|Overall Study|Ongoing at data cut-off|4|||
94304901|NCT02586207|322901331|FG000|Overall Study|Physician Decision|1|||
94304902|NCT02586207|322901331|FG000|Overall Study|Withdrawal by Subject|1|||
94304903|NCT02158533|322901341|FG000|Stage 1|Adverse Event|6|||
94304904|NCT02158533|322901342|FG001|Stage 1|Adverse Event|4|||
94304905|NCT02158533|322901343|FG002|Stage 1|Adverse Event|7|||
94304906|NCT02158533|322901344|FG003|Stage 1|Adverse Event|0|||
94304907|NCT02158533|322901345|FG004|Stage 1|Adverse Event|0|||
94304908|NCT02158533|322901346|FG005|Stage 1|Adverse Event|0|||
94304909|NCT02158533|322901341|FG000|Stage 1|Withdrawal by Subject|3|||
94304910|NCT02158533|322901342|FG001|Stage 1|Withdrawal by Subject|2|||
94304911|NCT02158533|322901343|FG002|Stage 1|Withdrawal by Subject|1|||
94304912|NCT02158533|322901344|FG003|Stage 1|Withdrawal by Subject|0|||
94304913|NCT02158533|322901345|FG004|Stage 1|Withdrawal by Subject|0|||
94304914|NCT02158533|322901346|FG005|Stage 1|Withdrawal by Subject|0|||
94304915|NCT02158533|322901341|FG000|Stage 1|Lack of Efficacy|1|||
94304916|NCT02158533|322901342|FG001|Stage 1|Lack of Efficacy|0|||
94304917|NCT02158533|322901343|FG002|Stage 1|Lack of Efficacy|0|||
94304918|NCT02158533|322901344|FG003|Stage 1|Lack of Efficacy|0|||
94304919|NCT02158533|322901345|FG004|Stage 1|Lack of Efficacy|0|||
94304920|NCT02158533|322901346|FG005|Stage 1|Lack of Efficacy|0|||
94304921|NCT02158533|322901341|FG000|Stage 1|Lost to Follow-up|3|||
94304922|NCT02158533|322901342|FG001|Stage 1|Lost to Follow-up|1|||
94304923|NCT02158533|322901343|FG002|Stage 1|Lost to Follow-up|0|||
94304924|NCT02158533|322901344|FG003|Stage 1|Lost to Follow-up|0|||
94304925|NCT02158533|322901345|FG004|Stage 1|Lost to Follow-up|0|||
94304926|NCT02158533|322901346|FG005|Stage 1|Lost to Follow-up|0|||
94304927|NCT02158533|322901341|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
94304928|NCT02158533|322901342|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
94304929|NCT02158533|322901343|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
94304930|NCT02158533|322901344|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
94304931|NCT02158533|322901345|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
94304932|NCT02158533|322901346|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
94304933|NCT02158533|322901341|FG000|Stage 1|Non-compliance with study visits|1|||
94304934|NCT02158533|322901342|FG001|Stage 1|Non-compliance with study visits|0|||
94304935|NCT02158533|322901343|FG002|Stage 1|Non-compliance with study visits|0|||
94304936|NCT02158533|322901344|FG003|Stage 1|Non-compliance with study visits|0|||
94304937|NCT02158533|322901345|FG004|Stage 1|Non-compliance with study visits|0|||
94304938|NCT02158533|322901346|FG005|Stage 1|Non-compliance with study visits|0|||
94304939|NCT02158533|322901341|FG000|Stage 2|Adverse Event|0|||
94304940|NCT02158533|322901342|FG001|Stage 2|Adverse Event|0|||
94304941|NCT02158533|322901343|FG002|Stage 2|Adverse Event|0|||
94304942|NCT02158533|322901344|FG003|Stage 2|Adverse Event|0|||
94304943|NCT02158533|322901345|FG004|Stage 2|Adverse Event|0|||
94304944|NCT02158533|322901346|FG005|Stage 2|Adverse Event|1|||
94304945|NCT02158533|322901341|FG000|Stage 2|Lack of Efficacy|0|||
94304946|NCT02158533|322901342|FG001|Stage 2|Lack of Efficacy|0|||
94304947|NCT02158533|322901343|FG002|Stage 2|Lack of Efficacy|0|||
94304948|NCT02158533|322901344|FG003|Stage 2|Lack of Efficacy|0|||
94304949|NCT02158533|322901345|FG004|Stage 2|Lack of Efficacy|1|||
94304950|NCT02158533|322901346|FG005|Stage 2|Lack of Efficacy|0|||
94304951|NCT02158533|322901341|FG000|Stage 2|Lost to Follow-up|0|||
94304952|NCT02158533|322901342|FG001|Stage 2|Lost to Follow-up|0|||
94304953|NCT02158533|322901343|FG002|Stage 2|Lost to Follow-up|0|||
94304954|NCT02158533|322901344|FG003|Stage 2|Lost to Follow-up|1|||
94304955|NCT02158533|322901345|FG004|Stage 2|Lost to Follow-up|1|||
94304956|NCT02158533|322901346|FG005|Stage 2|Lost to Follow-up|2|||
94304957|NCT02158533|322901341|FG000|Stage 2|Withdrawal by Subject|0|||
94304958|NCT02158533|322901342|FG001|Stage 2|Withdrawal by Subject|0|||
94304959|NCT02158533|322901343|FG002|Stage 2|Withdrawal by Subject|0|||
94304960|NCT02158533|322901344|FG003|Stage 2|Withdrawal by Subject|0|||
94304961|NCT02158533|322901345|FG004|Stage 2|Withdrawal by Subject|1|||
94304962|NCT02158533|322901346|FG005|Stage 2|Withdrawal by Subject|2|||
94304963|NCT02158533|322901341|FG000|Stage 2|Physician Decision|0|||
94304964|NCT02158533|322901342|FG001|Stage 2|Physician Decision|0|||
94304965|NCT02158533|322901343|FG002|Stage 2|Physician Decision|0|||
94304966|NCT02158533|322901344|FG003|Stage 2|Physician Decision|0|||
94304967|NCT02158533|322901345|FG004|Stage 2|Physician Decision|1|||
94304968|NCT02158533|322901346|FG005|Stage 2|Physician Decision|0|||
94304969|NCT02158533|322901341|FG000|Stage 2|Pregnancy|0|||
94304970|NCT02158533|322901342|FG001|Stage 2|Pregnancy|0|||
94375679|NCT00410410|323160381|FG003|Open-Label Period (OL)|Adverse Event|0|||
94375680|NCT00410410|323160382|FG004|Open-Label Period (OL)|Adverse Event|0|||
94375681|NCT00410410|323160383|FG005|Open-Label Period (OL)|Adverse Event|0|||
94375682|NCT00410410|323160384|FG006|Open-Label Period (OL)|Adverse Event|0|||
94375683|NCT00410410|323160385|FG007|Open-Label Period (OL)|Adverse Event|0|||
94375684|NCT00410410|323160386|FG008|Open-Label Period (OL)|Adverse Event|10|||
94375685|NCT00410410|323160378|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
94375686|NCT00410410|323160379|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
94375687|NCT00410410|323160380|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
94375688|NCT00410410|323160381|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
94375689|NCT00410410|323160382|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
94375690|NCT00410410|323160383|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
94375691|NCT00410410|323160384|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
94375692|NCT00410410|323160385|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
94375693|NCT00410410|323160386|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
94375694|NCT00410410|323160378|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
94375695|NCT00410410|323160379|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
94375696|NCT00410410|323160380|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
94375697|NCT00410410|323160381|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
94375698|NCT00410410|323160382|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
94375699|NCT00410410|323160383|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
94375700|NCT00410410|323160384|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
94375701|NCT00410410|323160385|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
94375702|NCT00410410|323160386|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
94375703|NCT00410410|323160378|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
94375704|NCT00410410|323160379|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
94375705|NCT00410410|323160380|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
94375706|NCT00410410|323160381|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
94375707|NCT00410410|323160382|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
94375708|NCT00410410|323160383|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
94375709|NCT00410410|323160384|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
94375710|NCT00410410|323160385|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
94375711|NCT00410410|323160386|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
94375712|NCT00410410|323160378|FG000|Open-Label Period (OL)|Pregnancy|0|||
94375713|NCT00410410|323160379|FG001|Open-Label Period (OL)|Pregnancy|0|||
94375714|NCT00410410|323160380|FG002|Open-Label Period (OL)|Pregnancy|0|||
94375715|NCT00410410|323160381|FG003|Open-Label Period (OL)|Pregnancy|0|||
94375716|NCT00410410|323160382|FG004|Open-Label Period (OL)|Pregnancy|0|||
94375717|NCT00410410|323160383|FG005|Open-Label Period (OL)|Pregnancy|0|||
94375718|NCT00410410|323160384|FG006|Open-Label Period (OL)|Pregnancy|0|||
94375719|NCT00410410|323160385|FG007|Open-Label Period (OL)|Pregnancy|0|||
94375720|NCT00410410|323160386|FG008|Open-Label Period (OL)|Pregnancy|1|||
94375721|NCT00410410|323160378|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
94375722|NCT00410410|323160379|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
94375723|NCT00410410|323160380|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
94375724|NCT00410410|323160381|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
94375725|NCT00410410|323160382|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
94375726|NCT00410410|323160383|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
94375727|NCT00410410|323160384|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
94375728|NCT00410410|323160385|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
94375729|NCT00410410|323160386|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
94375730|NCT00410410|323160378|FG000|Open-Label Period (OL)|Other|0|||
94375731|NCT00410410|323160379|FG001|Open-Label Period (OL)|Other|0|||
94375732|NCT00410410|323160380|FG002|Open-Label Period (OL)|Other|0|||
94375733|NCT00410410|323160381|FG003|Open-Label Period (OL)|Other|0|||
94375734|NCT00410410|323160382|FG004|Open-Label Period (OL)|Other|0|||
94375735|NCT00410410|323160383|FG005|Open-Label Period (OL)|Other|0|||
94375736|NCT00410410|323160384|FG006|Open-Label Period (OL)|Other|0|||
94375737|NCT00410410|323160385|FG007|Open-Label Period (OL)|Other|0|||
94375738|NCT00410410|323160386|FG008|Open-Label Period (OL)|Other|7|||
94375739|NCT00283686|323160387|FG000|Overall Study|Death|1|||
94375740|NCT00283686|323160388|FG001|Overall Study|Death|1|||
94375741|NCT00283686|323160389|FG002|Overall Study|Death|1|||
94375742|NCT00283686|323160390|FG003|Overall Study|Death|0|||
94375743|NCT00283686|323160387|FG000|Overall Study|Lost to Follow-up|21|||
94375744|NCT00283686|323160388|FG001|Overall Study|Lost to Follow-up|31|||
94375745|NCT00283686|323160389|FG002|Overall Study|Lost to Follow-up|26|||
94375746|NCT00283686|323160390|FG003|Overall Study|Lost to Follow-up|20|||
94375747|NCT00283686|323160387|FG000|Overall Study|Less than full participation|7|||
94375748|NCT00283686|323160388|FG001|Overall Study|Less than full participation|9|||
94375749|NCT00283686|323160389|FG002|Overall Study|Less than full participation|6|||
94375750|NCT00283686|323160390|FG003|Overall Study|Less than full participation|12|||
94375751|NCT00638157|323160391|FG000|Overall Study|Adverse Event|0|||
94375752|NCT00638157|323160392|FG001|Overall Study|Adverse Event|1|||
94375753|NCT00638157|323160391|FG000|Overall Study|Clinical (symptomatic) failure|1|||
94468729|NCT01180049|323505778|FG001|Overall Study|Death|35|||
94468730|NCT01764659|323505779|FG000|Overall Study|Death|1|||
94468731|NCT01764659|323505779|FG000|Overall Study|Physician Decision|1|||
94468732|NCT01210352|323505782|FG000|Overall Study|Adverse Event|0|||
94468733|NCT01210352|323505783|FG001|Overall Study|Adverse Event|0|||
94468734|NCT01210352|323505784|FG002|Overall Study|Adverse Event|0|||
94468735|NCT01210352|323505785|FG003|Overall Study|Adverse Event|0|||
94468736|NCT01210352|323505786|FG004|Overall Study|Adverse Event|0|||
94468737|NCT01210352|323505787|FG005|Overall Study|Adverse Event|0|||
94468738|NCT01210352|323505788|FG006|Overall Study|Adverse Event|0|||
94468739|NCT01210352|323505789|FG007|Overall Study|Adverse Event|2|||
94304971|NCT02158533|322901343|FG002|Stage 2|Pregnancy|0|||
94468740|NCT01210352|323505790|FG008|Overall Study|Adverse Event|1|||
94468741|NCT01210352|323505782|FG000|Overall Study|Lack of Efficacy|0|||
94468742|NCT01210352|323505783|FG001|Overall Study|Lack of Efficacy|0|||
94468743|NCT01210352|323505784|FG002|Overall Study|Lack of Efficacy|0|||
94468744|NCT01210352|323505785|FG003|Overall Study|Lack of Efficacy|0|||
94468745|NCT01210352|323505786|FG004|Overall Study|Lack of Efficacy|0|||
94468746|NCT01210352|323505787|FG005|Overall Study|Lack of Efficacy|0|||
94468747|NCT01210352|323505788|FG006|Overall Study|Lack of Efficacy|1|||
94468748|NCT01210352|323505789|FG007|Overall Study|Lack of Efficacy|0|||
94468749|NCT01210352|323505790|FG008|Overall Study|Lack of Efficacy|0|||
94468750|NCT01210352|323505782|FG000|Overall Study|Physician Decision|0|||
94468751|NCT01210352|323505783|FG001|Overall Study|Physician Decision|0|||
94468752|NCT01210352|323505784|FG002|Overall Study|Physician Decision|0|||
94468753|NCT01210352|323505785|FG003|Overall Study|Physician Decision|0|||
94468754|NCT01210352|323505786|FG004|Overall Study|Physician Decision|0|||
94468755|NCT01210352|323505787|FG005|Overall Study|Physician Decision|0|||
94468756|NCT01210352|323505788|FG006|Overall Study|Physician Decision|0|||
94468757|NCT01210352|323505789|FG007|Overall Study|Physician Decision|1|||
94304972|NCT02158533|322901344|FG003|Stage 2|Pregnancy|1|||
94304973|NCT02158533|322901345|FG004|Stage 2|Pregnancy|0|||
94304974|NCT02158533|322901346|FG005|Stage 2|Pregnancy|0|||
94304975|NCT02158533|322901341|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
94304976|NCT02158533|322901342|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
94304977|NCT02158533|322901343|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
94304978|NCT02158533|322901344|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
94304979|NCT02158533|322901345|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
94304980|NCT02158533|322901346|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
94304981|NCT02158533|322901341|FG000|Stage 2|Non-adherence with study visits|0|||
94304982|NCT02158533|322901342|FG001|Stage 2|Non-adherence with study visits|0|||
94304983|NCT02158533|322901343|FG002|Stage 2|Non-adherence with study visits|0|||
94304984|NCT02158533|322901344|FG003|Stage 2|Non-adherence with study visits|0|||
94304985|NCT02158533|322901345|FG004|Stage 2|Non-adherence with study visits|0|||
94304986|NCT02158533|322901346|FG005|Stage 2|Non-adherence with study visits|1|||
94304987|NCT02037919|322901347|FG000|Overall Study|Lost to Follow-up|30|||
94304988|NCT02037919|322901348|FG001|Overall Study|Lost to Follow-up|45|||
94304989|NCT01973283|322901349|FG000|Overall Study|Lost to Follow-up|4|||
94304990|NCT03487445|322901352|FG000|Randomization|Not treated for administrative reasons|1|||
94304991|NCT03487445|322901353|FG001|Randomization|Not treated for administrative reasons|0|||
94304992|NCT00917384|322901354|FG000|Overall Study|Lost to Follow-up|4|||
94304993|NCT00917384|322901355|FG001|Overall Study|Lost to Follow-up|2|||
94304994|NCT00917384|322901354|FG000|Overall Study|Withdrawal by Subject|10|||
94304995|NCT00917384|322901355|FG001|Overall Study|Withdrawal by Subject|2|||
94304996|NCT03180736|322901357|FG000|Overall Study|Adverse Event|3|||
94304997|NCT03180736|322901358|FG001|Overall Study|Adverse Event|4|||
94304998|NCT03180736|322901357|FG000|Overall Study|Death|10|||
94304999|NCT03180736|322901358|FG001|Overall Study|Death|7|||
94305000|NCT03180736|322901357|FG000|Overall Study|Withdrawal by Subject|5|||
94305001|NCT03180736|322901358|FG001|Overall Study|Withdrawal by Subject|12|||
94305002|NCT03180736|322901357|FG000|Overall Study|Lost to Follow-up|1|||
94305003|NCT03180736|322901358|FG001|Overall Study|Lost to Follow-up|0|||
94305004|NCT03180736|322901357|FG000|Overall Study|Lack of Efficacy|66|||
94305005|NCT03180736|322901358|FG001|Overall Study|Lack of Efficacy|87|||
94305006|NCT03180736|322901357|FG000|Overall Study|Physician Decision|4|||
94305007|NCT03180736|322901358|FG001|Overall Study|Physician Decision|7|||
94305008|NCT03180736|322901357|FG000|Overall Study|randomized but not treated|2|||
94305009|NCT03180736|322901358|FG001|Overall Study|randomized but not treated|3|||
94305010|NCT01389128|322901359|FG000|Overall Study|Fetal distress|1|||
94305011|NCT01389128|322901360|FG001|Overall Study|Fetal distress|0|||
94468758|NCT01210352|323505790|FG008|Overall Study|Physician Decision|2|||
94468759|NCT01210352|323505782|FG000|Overall Study|Withdrawal by Subject|0|||
94468760|NCT01210352|323505783|FG001|Overall Study|Withdrawal by Subject|0|||
94468761|NCT01210352|323505784|FG002|Overall Study|Withdrawal by Subject|1|||
94468762|NCT01210352|323505785|FG003|Overall Study|Withdrawal by Subject|0|||
94468763|NCT01210352|323505786|FG004|Overall Study|Withdrawal by Subject|0|||
94468764|NCT01210352|323505787|FG005|Overall Study|Withdrawal by Subject|0|||
94468765|NCT01210352|323505788|FG006|Overall Study|Withdrawal by Subject|1|||
94468766|NCT01210352|323505789|FG007|Overall Study|Withdrawal by Subject|0|||
94375754|NCT00638157|323160392|FG001|Overall Study|Clinical (symptomatic) failure|1|||
94375755|NCT00638157|323160391|FG000|Overall Study|Microbiological failure|1|||
94375756|NCT00638157|323160392|FG001|Overall Study|Microbiological failure|0|||
94375757|NCT00638157|323160391|FG000|Overall Study|Lost to Follow-up|1|||
94375758|NCT00638157|323160392|FG001|Overall Study|Lost to Follow-up|0|||
94375759|NCT00638157|323160391|FG000|Overall Study|Physician Decision|1|||
94375760|NCT00638157|323160392|FG001|Overall Study|Physician Decision|0|||
94375761|NCT00638157|323160391|FG000|Overall Study|Other|1|||
94375762|NCT00638157|323160392|FG001|Overall Study|Other|2|||
94375763|NCT00638157|323160391|FG000|Overall Study|Randomized, not treated|2|||
94375764|NCT00638157|323160392|FG001|Overall Study|Randomized, not treated|0|||
94375765|NCT01738581|323160397|FG000|Overall Study|Lost to Follow-up|1|||
94375766|NCT01738581|323160398|FG001|Overall Study|Lost to Follow-up|0|||
94375767|NCT00771901|323160400|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
94375768|NCT00771901|323160401|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
94375769|NCT00771901|323160402|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
94375770|NCT00926289|323160404|FG000|Overall Study|Adverse Event|9|||
94375771|NCT00926289|323160405|FG001|Overall Study|Adverse Event|11|||
94375772|NCT00926289|323160404|FG000|Overall Study|Protocol Violation|8|||
94375773|NCT00926289|323160405|FG001|Overall Study|Protocol Violation|12|||
94375774|NCT00926289|323160404|FG000|Overall Study|Lost to Follow-up|3|||
94375775|NCT00926289|323160405|FG001|Overall Study|Lost to Follow-up|6|||
94375776|NCT00926289|323160404|FG000|Overall Study|Withdrawal by Subject|4|||
94375777|NCT00926289|323160405|FG001|Overall Study|Withdrawal by Subject|4|||
94375778|NCT00926289|323160404|FG000|Overall Study|Other|1|||
94375779|NCT00926289|323160405|FG001|Overall Study|Other|3|||
94375780|NCT00669955|323160414|FG000|Overall Study|Adverse Event|3|||
94375781|NCT00669955|323160415|FG001|Overall Study|Adverse Event|5|||
94375782|NCT00669955|323160414|FG000|Overall Study|Death|0|||
94375783|NCT00669955|323160415|FG001|Overall Study|Death|1|||
94375784|NCT00669955|323160414|FG000|Overall Study|Withdrawal by Subject|2|||
94375785|NCT00669955|323160415|FG001|Overall Study|Withdrawal by Subject|3|||
94375786|NCT00669955|323160414|FG000|Overall Study|Lost to Follow-up|5|||
94375787|NCT00669955|323160415|FG001|Overall Study|Lost to Follow-up|7|||
94375788|NCT00669955|323160414|FG000|Overall Study|Protocol Violation|2|||
94375789|NCT00669955|323160415|FG001|Overall Study|Protocol Violation|7|||
94375790|NCT00669955|323160414|FG000|Overall Study|Investigator Sponsor Judgement|0|||
94375791|NCT00669955|323160415|FG001|Overall Study|Investigator Sponsor Judgement|1|||
94375792|NCT00669955|323160414|FG000|Overall Study|not compliant with study drug/visit|2|||
94375793|NCT00669955|323160415|FG001|Overall Study|not compliant with study drug/visit|3|||
94375794|NCT01859702|323160416|FG000|Overall Study|Protocol deviation|3|||
94375795|NCT01859702|323160416|FG000|Overall Study|Adverse Event|2|||
94375796|NCT02004847|323161625|FG000|Overall Study|Protocol Violation|1|||
94375797|NCT02004847|323161626|FG001|Overall Study|Protocol Violation|1|||
94375798|NCT00275028|323161629|FG000|Overall Study|Withdrew consent before treatment began|1|||
94375799|NCT00275028|323161629|FG000|Overall Study|Withdrawal by Subject|5|||
94375800|NCT00275028|323161629|FG000|Overall Study|Adverse Event|9|||
94375801|NCT00275028|323161629|FG000|Overall Study|Progressive Disease|30|||
94375802|NCT00275028|323161629|FG000|Overall Study|Physician Decision|2|||
94375803|NCT00331630|323161635|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
94375804|NCT00331630|323161635|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
94375805|NCT00331630|323161635|FG000|Follow up for 5 Years|Death|5|||
94375806|NCT00331630|323161635|FG000|Follow up for 5 Years|Data collection was stopped|24|||
94375807|NCT01806597|323161640|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
94375808|NCT01806597|323161641|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
94375809|NCT01806597|323161642|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
94375810|NCT01806597|323161643|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
94375811|NCT01806597|323161644|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
94375812|NCT01806597|323161645|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
94375813|NCT01806597|323161640|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
94375814|NCT01806597|323161641|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
94375815|NCT01806597|323161642|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
94375816|NCT01806597|323161643|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
94375817|NCT01806597|323161644|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
94375818|NCT01806597|323161645|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
94375819|NCT01806597|323161640|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
94375820|NCT01806597|323161641|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
94375821|NCT01806597|323161642|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
94375822|NCT01806597|323161643|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
94375823|NCT01806597|323161644|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
94375824|NCT01806597|323161645|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
94375825|NCT01806597|323161640|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
94375826|NCT01806597|323161641|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
94375827|NCT01806597|323161642|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
94375828|NCT01806597|323161643|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
94468767|NCT01210352|323505790|FG008|Overall Study|Withdrawal by Subject|1|||
94468768|NCT01210352|323505782|FG000|Overall Study|Patient Discharged Early|0|||
94468769|NCT01210352|323505783|FG001|Overall Study|Patient Discharged Early|0|||
94468770|NCT01210352|323505784|FG002|Overall Study|Patient Discharged Early|1|||
94468771|NCT01210352|323505785|FG003|Overall Study|Patient Discharged Early|0|||
94468772|NCT01210352|323505786|FG004|Overall Study|Patient Discharged Early|0|||
94468773|NCT01210352|323505787|FG005|Overall Study|Patient Discharged Early|0|||
94468774|NCT01210352|323505788|FG006|Overall Study|Patient Discharged Early|0|||
94468775|NCT01210352|323505789|FG007|Overall Study|Patient Discharged Early|0|||
94468776|NCT01210352|323505790|FG008|Overall Study|Patient Discharged Early|0|||
94468777|NCT00628927|323505791|FG000|Overall Study|Problems performing blood draw|6|||
94468778|NCT00628927|323505792|FG001|Overall Study|Problems performing blood draw|0|||
94468779|NCT00628927|323505791|FG000|Overall Study|Lost to Follow-up|1|||
94468780|NCT00628927|323505792|FG001|Overall Study|Lost to Follow-up|0|||
94468781|NCT00628927|323505791|FG000|Overall Study|Equipment failure|1|||
94375829|NCT01806597|323161644|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
94468782|NCT00628927|323505792|FG001|Overall Study|Equipment failure|0|||
94468783|NCT02440854|323505793|FG000|Overall Study|Relocation of patient|1|||
94468784|NCT02440854|323505793|FG000|Overall Study|Death|6|||
94468785|NCT02440854|323505793|FG000|Overall Study|Lost to Follow-up|10|||
94468786|NCT02440854|323505793|FG000|Overall Study|Afatinib discontinuation|46|||
94468787|NCT02440854|323505793|FG000|Overall Study|stopped study at earlier timepoint|14|||
94468788|NCT02440854|323505793|FG000|Overall Study|Study medication not received|1|||
94468789|NCT02440854|323505793|FG000|Overall Study|Violation of inclusion criteria|2|||
94468790|NCT04607980|323505794|FG000|Overall Study|Adverse Event|3|||
94468791|NCT04607980|323505795|FG001|Overall Study|Adverse Event|4|||
94468792|NCT04607980|323505794|FG000|Overall Study|Death|0|||
94468793|NCT04607980|323505795|FG001|Overall Study|Death|1|||
94468794|NCT04607980|323505794|FG000|Overall Study|Withdrawal by Subject|2|||
94468795|NCT04607980|323505795|FG001|Overall Study|Withdrawal by Subject|5|||
94468796|NCT04607980|323505794|FG000|Overall Study|Lost to Follow-up|4|||
94468797|NCT04607980|323505795|FG001|Overall Study|Lost to Follow-up|8|||
94468798|NCT04607980|323505794|FG000|Overall Study|Protocol Violation|0|||
94468799|NCT04607980|323505795|FG001|Overall Study|Protocol Violation|3|||
94375830|NCT01806597|323161645|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
94375831|NCT01806597|323161640|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
94375832|NCT01806597|323161641|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
94375833|NCT01806597|323161642|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
94375834|NCT01806597|323161643|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
94375835|NCT01806597|323161644|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
94375836|NCT01806597|323161645|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
94375837|NCT01806597|323161640|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
94375838|NCT01806597|323161641|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
94375839|NCT01806597|323161642|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
94468800|NCT04607980|323505794|FG000|Overall Study|Other|3|||
94468801|NCT04607980|323505795|FG001|Overall Study|Other|0|||
94468802|NCT01900899|323505796|FG000|Overall Study|Withdrawal by Subject|7|||
94468803|NCT01900899|323505797|FG001|Overall Study|Withdrawal by Subject|1|||
94305012|NCT01389128|322901359|FG000|Overall Study|Cervix dilation stop|1|||
94305013|NCT01389128|322901360|FG001|Overall Study|Cervix dilation stop|2|||
94305014|NCT01389128|322901359|FG000|Overall Study|Rapid labor evolution|3|||
94305015|NCT01389128|322901360|FG001|Overall Study|Rapid labor evolution|2|||
94305016|NCT01389128|322901359|FG000|Overall Study|Intolerance to procedure|0|||
94305017|NCT01389128|322901360|FG001|Overall Study|Intolerance to procedure|2|||
94305018|NCT00756002|322901361|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
94305019|NCT00756002|322901362|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
94305020|NCT00756002|322901361|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
94305021|NCT00756002|322901362|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
94305022|NCT00756002|322901361|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
94305023|NCT00756002|322901362|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
94305024|NCT00756002|322901361|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
94305025|NCT00756002|322901362|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
94305026|NCT00756002|322901361|FG000|Double-Blind Treatment Period|Other|2|||
94305027|NCT00756002|322901362|FG001|Double-Blind Treatment Period|Other|2|||
94305028|NCT01736683|322901363|FG000|Overall Study|Disease Relapse|0|||
94375840|NCT01806597|323161643|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
94375841|NCT01806597|323161644|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
94375842|NCT01806597|323161645|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
94375843|NCT01806597|323161640|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
94468804|NCT01900899|323505796|FG000|Overall Study|Migrated from study area|2|||
94468805|NCT01900899|323505797|FG001|Overall Study|Migrated from study area|0|||
94468806|NCT02427802|323505798|FG000|Overall Study|Adverse Event|11|||
94468807|NCT02427802|323505799|FG001|Overall Study|Adverse Event|3|||
94468808|NCT02427802|323505800|FG002|Overall Study|Adverse Event|7|||
94375844|NCT01806597|323161641|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
94468809|NCT02427802|323505798|FG000|Overall Study|Death|0|||
94468810|NCT02427802|323505799|FG001|Overall Study|Death|4|||
94468811|NCT02427802|323505800|FG002|Overall Study|Death|1|||
94468812|NCT02427802|323505798|FG000|Overall Study|Lost to Follow-up|13|||
94468813|NCT02427802|323505799|FG001|Overall Study|Lost to Follow-up|8|||
94468814|NCT02427802|323505800|FG002|Overall Study|Lost to Follow-up|8|||
94468815|NCT02427802|323505798|FG000|Overall Study|Physician Decision|4|||
94468816|NCT02427802|323505799|FG001|Overall Study|Physician Decision|2|||
94468817|NCT02427802|323505800|FG002|Overall Study|Physician Decision|4|||
94468818|NCT02427802|323505798|FG000|Overall Study|Withdrawal by Subject|10|||
94468819|NCT02427802|323505799|FG001|Overall Study|Withdrawal by Subject|5|||
94468820|NCT02427802|323505800|FG002|Overall Study|Withdrawal by Subject|11|||
94468821|NCT02427802|323505798|FG000|Overall Study|Protocol Violation|3|||
94468822|NCT02427802|323505799|FG001|Overall Study|Protocol Violation|1|||
94468823|NCT02427802|323505800|FG002|Overall Study|Protocol Violation|1|||
94468824|NCT02427802|323505798|FG000|Overall Study|protocol specific treatment unrelated|18|||
94468825|NCT02427802|323505799|FG001|Overall Study|protocol specific treatment unrelated|11|||
94468826|NCT02427802|323505800|FG002|Overall Study|protocol specific treatment unrelated|11|||
94468827|NCT02634983|323505801|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
94468828|NCT02634983|323505802|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
94468829|NCT02109445|323505805|FG000|Overall Study|Symptomatic deterioration|2|||
94468830|NCT02109445|323505805|FG000|Overall Study|Adverse Event|1|||
94468831|NCT00549601|323507462|FG000|Randomized|Protocol Violation|0|||
94468832|NCT00549601|323507463|FG001|Randomized|Protocol Violation|0|||
94468833|NCT00549601|323507464|FG002|Randomized|Protocol Violation|1|||
94468834|NCT00549601|323507462|FG000|Randomized|Withdrawal by Subject|0|||
94468835|NCT00549601|323507463|FG001|Randomized|Withdrawal by Subject|1|||
94468836|NCT00549601|323507464|FG002|Randomized|Withdrawal by Subject|1|||
94468837|NCT00549601|323507462|FG000|Received Study Drug|Adverse Event|2|||
94468838|NCT00549601|323507463|FG001|Received Study Drug|Adverse Event|5|||
94468839|NCT00549601|323507464|FG002|Received Study Drug|Adverse Event|1|||
94468840|NCT00549601|323507462|FG000|Received Study Drug|Death|0|||
94468841|NCT00549601|323507463|FG001|Received Study Drug|Death|1|||
94468842|NCT00549601|323507464|FG002|Received Study Drug|Death|0|||
94468843|NCT00549601|323507462|FG000|Received Study Drug|Lost to Follow-up|0|||
94375845|NCT01806597|323161642|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
94375846|NCT01806597|323161643|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
94375847|NCT01806597|323161644|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
94375848|NCT01806597|323161645|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
94375849|NCT01806597|323161640|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
94375850|NCT01806597|323161641|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
94375851|NCT01806597|323161642|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
94375852|NCT01806597|323161643|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
94375853|NCT01806597|323161644|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
94375854|NCT01806597|323161645|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
94375855|NCT01806597|323161640|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
94375856|NCT01806597|323161641|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
94375857|NCT01806597|323161642|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
94375858|NCT01806597|323161643|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
94375859|NCT01806597|323161644|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
94375860|NCT01806597|323161645|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
94375861|NCT01806597|323161640|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
94375862|NCT01806597|323161641|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
94375863|NCT01806597|323161642|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
94375864|NCT01806597|323161643|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
94468844|NCT00549601|323507463|FG001|Received Study Drug|Lost to Follow-up|1|||
94468845|NCT00549601|323507464|FG002|Received Study Drug|Lost to Follow-up|1|||
94468846|NCT00549601|323507462|FG000|Received Study Drug|Protocol Violation|3|||
94468847|NCT00549601|323507463|FG001|Received Study Drug|Protocol Violation|4|||
94468848|NCT00549601|323507464|FG002|Received Study Drug|Protocol Violation|1|||
94468849|NCT00549601|323507462|FG000|Received Study Drug|Withdrawal by Subject|2|||
94468850|NCT00549601|323507463|FG001|Received Study Drug|Withdrawal by Subject|0|||
94468851|NCT00549601|323507464|FG002|Received Study Drug|Withdrawal by Subject|1|||
94468852|NCT05243563|323507467|FG000|Overall Study|Withdrawal by Subject|1|||
94468853|NCT05243563|323507468|FG001|Overall Study|Withdrawal by Subject|0|||
94468854|NCT05243563|323507467|FG000|Overall Study|Physician Decision|1|||
94468855|NCT05243563|323507468|FG001|Overall Study|Physician Decision|0|||
94468856|NCT03341936|323507469|FG000|Overall Study|Ineligible|1|||
94468857|NCT03341936|323507469|FG000|Overall Study|Disease Progression|2|||
94468858|NCT03341936|323507469|FG000|Overall Study|Withdrew Consent|4|||
94468859|NCT03341936|323507469|FG000|Overall Study|Non-Compliance|1|||
94468860|NCT03341936|323507469|FG000|Overall Study|Physician Decision|1|||
94468861|NCT03341936|323507469|FG000|Overall Study|Withdrawal by Subject|1|||
94468862|NCT03341936|323507469|FG000|Overall Study|Other|1|||
94468863|NCT02368886|323507470|FG000|Overall Study|Cancel|1|||
94468864|NCT02368886|323507471|FG001|Overall Study|Cancel|1|||
94468865|NCT02368886|323507472|FG002|Overall Study|Cancel|1|||
94468866|NCT02368886|323507473|FG003|Overall Study|Cancel|3|||
94468867|NCT02368886|323507470|FG000|Overall Study|Ineligible|0|||
94468868|NCT02368886|323507471|FG001|Overall Study|Ineligible|0|||
94468869|NCT02368886|323507472|FG002|Overall Study|Ineligible|0|||
94468870|NCT02368886|323507473|FG003|Overall Study|Ineligible|1|||
94468871|NCT04849416|323507475|FG000|Overall Study|Ongoing Treatment|12|||
94468872|NCT04849416|323507476|FG001|Overall Study|Ongoing Treatment|5|||
94468873|NCT04849416|323507477|FG002|Overall Study|Ongoing Treatment|3|||
94468874|NCT04849416|323507475|FG000|Overall Study|On Post-Treatment Follow-up|8|||
94468875|NCT04849416|323507476|FG001|Overall Study|On Post-Treatment Follow-up|9|||
94468876|NCT04849416|323507477|FG002|Overall Study|On Post-Treatment Follow-up|10|||
94468877|NCT04849416|323507475|FG000|Overall Study|Withdrawal by Subject|0|||
94468878|NCT04849416|323507476|FG001|Overall Study|Withdrawal by Subject|0|||
94468879|NCT04849416|323507477|FG002|Overall Study|Withdrawal by Subject|1|||
94468880|NCT04849416|323507475|FG000|Overall Study|Lost to Follow-up|1|||
94468881|NCT04849416|323507476|FG001|Overall Study|Lost to Follow-up|0|||
94375865|NCT01806597|323161644|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
94375866|NCT01806597|323161645|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
94468882|NCT04849416|323507477|FG002|Overall Study|Lost to Follow-up|0|||
94468883|NCT04767529|323507486|FG000|Overall Study|Adverse Event|0|||
94375867|NCT01806597|323161640|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
94375868|NCT01806597|323161641|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
94375869|NCT01806597|323161642|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
94375870|NCT01806597|323161643|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
94468884|NCT04767529|323507487|FG001|Overall Study|Adverse Event|4|||
94468885|NCT04767529|323507488|FG002|Overall Study|Adverse Event|3|||
94468886|NCT04767529|323507486|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
94468887|NCT04767529|323507487|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
94468888|NCT04767529|323507488|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
94468889|NCT04767529|323507486|FG000|Overall Study|Required use of a prohibited medication|0|||
94468890|NCT04767529|323507487|FG001|Overall Study|Required use of a prohibited medication|1|||
94468891|NCT04767529|323507488|FG002|Overall Study|Required use of a prohibited medication|0|||
94468892|NCT04767529|323507486|FG000|Overall Study|Withdrawal by Subject|7|||
94468893|NCT04767529|323507487|FG001|Overall Study|Withdrawal by Subject|5|||
94468894|NCT04767529|323507488|FG002|Overall Study|Withdrawal by Subject|4|||
94468895|NCT04767529|323507486|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
94468896|NCT04767529|323507487|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
94468897|NCT04767529|323507488|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
94468898|NCT04767529|323507486|FG000|Overall Study|Lost to Follow-up|0|||
94468899|NCT04767529|323507487|FG001|Overall Study|Lost to Follow-up|2|||
94468900|NCT04767529|323507488|FG002|Overall Study|Lost to Follow-up|3|||
94468901|NCT04847232|323507489|FG000|Overall Study|Death|123|||
94468902|NCT04847232|323507490|FG001|Overall Study|Death|115|||
94468903|NCT04847232|323507489|FG000|Overall Study|Lost to Follow-up|3|||
94468904|NCT04847232|323507490|FG001|Overall Study|Lost to Follow-up|10|||
94468905|NCT04847232|323507489|FG000|Overall Study|Withdrawal by Subject|73|||
94468906|NCT04847232|323507490|FG001|Overall Study|Withdrawal by Subject|101|||
94468907|NCT04847232|323507489|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
94468908|NCT04847232|323507490|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
94375871|NCT01806597|323161644|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
94375872|NCT01806597|323161645|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
94468909|NCT03997383|323507491|FG000|Double-blind Treatment Period|Adverse Event|4|||
94468910|NCT03997383|323507492|FG001|Double-blind Treatment Period|Adverse Event|3|||
94468911|NCT03997383|323507491|FG000|Double-blind Treatment Period|Death|4|||
94468912|NCT03997383|323507492|FG001|Double-blind Treatment Period|Death|4|||
94468913|NCT03997383|323507491|FG000|Double-blind Treatment Period|Physician Decision|2|||
94468914|NCT03997383|323507492|FG001|Double-blind Treatment Period|Physician Decision|0|||
94468915|NCT03997383|323507491|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
94468916|NCT03997383|323507492|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
94468917|NCT03997383|323507491|FG000|Open-label Extension Period|Ongoing|148|||
94468918|NCT03997383|323507492|FG001|Open-label Extension Period|Ongoing|151|||
94468919|NCT03997383|323507491|FG000|Open-label Extension Period|Adverse Event|4|||
94468920|NCT03997383|323507492|FG001|Open-label Extension Period|Adverse Event|1|||
94468921|NCT03997383|323507491|FG000|Open-label Extension Period|Death|8|||
94468922|NCT03997383|323507492|FG001|Open-label Extension Period|Death|9|||
94468923|NCT03997383|323507491|FG000|Open-label Extension Period|Physician Decision|1|||
94468924|NCT03997383|323507492|FG001|Open-label Extension Period|Physician Decision|1|||
94375873|NCT01806597|323161640|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
94375874|NCT01806597|323161641|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
94375875|NCT01806597|323161642|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
94375876|NCT01806597|323161643|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
94375877|NCT01806597|323161644|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
94375878|NCT01806597|323161645|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
94375879|NCT01806597|323161640|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
94468925|NCT03997383|323507491|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
94468926|NCT03997383|323507492|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
94468927|NCT03997383|323507491|FG000|Open-label Extension Period|Reason Not Specified|2|||
94468928|NCT03997383|323507492|FG001|Open-label Extension Period|Reason Not Specified|0|||
94468929|NCT04348500|323507499|FG000|Overall Study|Death|2|||
94468930|NCT04348500|323507500|FG001|Overall Study|Death|2|||
94468931|NCT04348500|323507499|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
94468932|NCT04348500|323507500|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
94468933|NCT05916131|323507503|FG000|Overall Study|Lost to Follow-up|0|||
94468934|NCT05916131|323507504|FG001|Overall Study|Lost to Follow-up|0|||
94468935|NCT05916131|323507505|FG002|Overall Study|Lost to Follow-up|1|||
94468936|NCT05916131|323507506|FG003|Overall Study|Lost to Follow-up|0|||
94468937|NCT05619692|323507507|FG000|Overall Study|Adverse Event|2|||
94468938|NCT05619692|323507508|FG001|Overall Study|Adverse Event|2|||
94468939|NCT05619692|323507507|FG000|Overall Study|Withdrawal by Participant|3|||
94468940|NCT05619692|323507508|FG001|Overall Study|Withdrawal by Participant|4|||
94468941|NCT05619692|323507507|FG000|Overall Study|Lost to Follow-up|2|||
94468942|NCT05619692|323507508|FG001|Overall Study|Lost to Follow-up|1|||
94468943|NCT05619692|323507507|FG000|Overall Study|Randomized but not treated|1|||
94468944|NCT05619692|323507508|FG001|Overall Study|Randomized but not treated|3|||
94468945|NCT00369161|323507511|FG000|Overall Study|Adverse Event|15|||
94468946|NCT00369161|323507512|FG001|Overall Study|Adverse Event|13|||
94468947|NCT00369161|323507511|FG000|Overall Study|Abnormal laboratory value|0|||
94468948|NCT00369161|323507512|FG001|Overall Study|Abnormal laboratory value|1|||
94468949|NCT00369161|323507511|FG000|Overall Study|Lack of Efficacy|3|||
94468950|NCT00369161|323507512|FG001|Overall Study|Lack of Efficacy|1|||
94468951|NCT00369161|323507511|FG000|Overall Study|Protocol Violation|0|||
94468952|NCT00369161|323507512|FG001|Overall Study|Protocol Violation|2|||
94468953|NCT00369161|323507511|FG000|Overall Study|Withdrawal by Subject|2|||
94468954|NCT00369161|323507512|FG001|Overall Study|Withdrawal by Subject|3|||
94468955|NCT00369161|323507511|FG000|Overall Study|Death|1|||
94468956|NCT00369161|323507512|FG001|Overall Study|Death|2|||
94468957|NCT00369161|323507511|FG000|Overall Study|Graft loss|4|||
94468958|NCT00369161|323507512|FG001|Overall Study|Graft loss|0|||
94468959|NCT00369161|323507511|FG000|Overall Study|Administrative Problem|2|||
94468960|NCT00369161|323507512|FG001|Overall Study|Administrative Problem|2|||
94468961|NCT03760458|323507513|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
94468962|NCT03760458|323507514|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
94468963|NCT03760458|323507515|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
94468964|NCT03760458|323507516|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
94468965|NCT03760458|323507517|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
94468966|NCT03008278|323507518|FG000|Overall Study|Progressive Disease|0|||
94468967|NCT03008278|323507519|FG001|Overall Study|Progressive Disease|0|||
94468968|NCT03008278|323507520|FG002|Overall Study|Progressive Disease|32|||
94468969|NCT03008278|323507518|FG000|Overall Study|Adverse Event|0|||
94468970|NCT03008278|323507519|FG001|Overall Study|Adverse Event|0|||
94468971|NCT03008278|323507520|FG002|Overall Study|Adverse Event|4|||
94468972|NCT03008278|323507518|FG000|Overall Study|Withdrawal by Subject|0|||
94468973|NCT03008278|323507519|FG001|Overall Study|Withdrawal by Subject|0|||
94468974|NCT03008278|323507520|FG002|Overall Study|Withdrawal by Subject|3|||
94468975|NCT03008278|323507518|FG000|Overall Study|Physician Decision|0|||
94468976|NCT03008278|323507519|FG001|Overall Study|Physician Decision|2|||
94468977|NCT03008278|323507520|FG002|Overall Study|Physician Decision|0|||
94468978|NCT02943785|323507521|FG000|Overall Study|Adverse Event|112|||
94305029|NCT01736683|322901364|FG001|Overall Study|Disease Relapse|0|||
94305030|NCT01736683|322901365|FG002|Overall Study|Disease Relapse|2|||
94305031|NCT01736683|322901366|FG003|Overall Study|Disease Relapse|1|||
94305032|NCT01736683|322901367|FG004|Overall Study|Disease Relapse|0|||
94305033|NCT01736683|322901363|FG000|Overall Study|Adverse Event|0|||
94305034|NCT01736683|322901364|FG001|Overall Study|Adverse Event|2|||
94305035|NCT01736683|322901365|FG002|Overall Study|Adverse Event|2|||
94305036|NCT01736683|322901366|FG003|Overall Study|Adverse Event|3|||
94305037|NCT01736683|322901367|FG004|Overall Study|Adverse Event|2|||
94305038|NCT01736683|322901363|FG000|Overall Study|Withdrawal by Subject|0|||
94305039|NCT01736683|322901364|FG001|Overall Study|Withdrawal by Subject|0|||
94305040|NCT01736683|322901365|FG002|Overall Study|Withdrawal by Subject|3|||
94305041|NCT01736683|322901366|FG003|Overall Study|Withdrawal by Subject|1|||
94305042|NCT01736683|322901367|FG004|Overall Study|Withdrawal by Subject|1|||
94468979|NCT02943785|323507522|FG001|Overall Study|Adverse Event|97|||
94468980|NCT02943785|323507521|FG000|Overall Study|Withdrawal by Subject|63|||
94468981|NCT02943785|323507522|FG001|Overall Study|Withdrawal by Subject|126|||
94468982|NCT02943785|323507521|FG000|Overall Study|Physician Decision|23|||
94468983|NCT02943785|323507522|FG001|Overall Study|Physician Decision|47|||
94468984|NCT02943785|323507521|FG000|Overall Study|Death|46|||
94468985|NCT02943785|323507522|FG001|Overall Study|Death|46|||
94305043|NCT01736683|322901363|FG000|Overall Study|Lack of Therapeutic Effect|7|||
94305044|NCT01736683|322901364|FG001|Overall Study|Lack of Therapeutic Effect|4|||
94375880|NCT01806597|323161641|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
94375881|NCT01806597|323161642|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
94375882|NCT01806597|323161643|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
94375883|NCT01806597|323161644|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
94375884|NCT01806597|323161645|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
94375885|NCT01806597|323161640|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
94375886|NCT01806597|323161641|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
94375887|NCT01806597|323161642|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
94375888|NCT01806597|323161643|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
94375889|NCT01806597|323161644|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
94375890|NCT01806597|323161645|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
94375891|NCT01806597|323161640|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
94375892|NCT01806597|323161641|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
94375893|NCT01806597|323161642|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
94375894|NCT01806597|323161643|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
94375895|NCT01806597|323161644|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
94375896|NCT01806597|323161645|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
94375897|NCT01806597|323161640|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
94375898|NCT01806597|323161641|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
94375899|NCT01806597|323161642|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
94375900|NCT01806597|323161643|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
94375901|NCT01806597|323161644|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
94375902|NCT01806597|323161645|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
94375903|NCT01806597|323161640|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
94375904|NCT01806597|323161641|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
94375905|NCT01806597|323161642|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
94375906|NCT01806597|323161643|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
94375907|NCT01806597|323161644|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
94375908|NCT01806597|323161645|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
94375909|NCT01806597|323161640|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
94375910|NCT01806597|323161641|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
94375911|NCT01806597|323161642|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
94375912|NCT01806597|323161643|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
94375913|NCT01806597|323161644|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
94375914|NCT01806597|323161645|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
94375915|NCT01806597|323161640|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
94375916|NCT01806597|323161641|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
94375917|NCT01806597|323161642|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
94375918|NCT01806597|323161643|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
94375919|NCT01806597|323161644|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
94375920|NCT01806597|323161645|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
94375921|NCT02482805|323161648|FG000|Overall Study|Lost to Follow-up|4|||
94375922|NCT02482805|323161649|FG001|Overall Study|Lost to Follow-up|4|||
94375923|NCT02482805|323161650|FG002|Overall Study|Lost to Follow-up|0|||
94375924|NCT01073020|323161651|FG000|Overall Study|Withdrawal by Subject|6|||
94375925|NCT01073020|323161652|FG001|Overall Study|Withdrawal by Subject|4|||
94375926|NCT01073020|323161653|FG002|Overall Study|Withdrawal by Subject|1|||
94375927|NCT01073020|323161654|FG003|Overall Study|Withdrawal by Subject|2|||
94375928|NCT01073020|323161651|FG000|Overall Study|Physician Decision|1|||
94375929|NCT01073020|323161652|FG001|Overall Study|Physician Decision|0|||
94375930|NCT01073020|323161653|FG002|Overall Study|Physician Decision|2|||
94375931|NCT01073020|323161654|FG003|Overall Study|Physician Decision|0|||
94375932|NCT01073020|323161651|FG000|Overall Study|Death|0|||
94375933|NCT01073020|323161652|FG001|Overall Study|Death|1|||
94375934|NCT01073020|323161653|FG002|Overall Study|Death|0|||
94375935|NCT01073020|323161654|FG003|Overall Study|Death|0|||
94375936|NCT03840811|323161655|FG000|Overall Study|Lost to Follow-up|0|||
94375937|NCT03840811|323161656|FG001|Overall Study|Lost to Follow-up|0|||
94375938|NCT03840811|323161657|FG002|Overall Study|Lost to Follow-up|1|||
94375939|NCT01904383|323161658|FG000|Overall Study|CRF not collected|117|||
94375940|NCT01904383|323161658|FG000|Overall Study|Reason not listed|147|||
94375941|NCT01904383|323161658|FG000|Overall Study|Lost to Follow-up|674|||
94375942|NCT01904383|323161658|FG000|Overall Study|Lack of Efficacy|370|||
94375943|NCT01904383|323161658|FG000|Overall Study|Improvement|141|||
94375944|NCT01904383|323161658|FG000|Overall Study|Adverse Event|271|||
94375945|NCT01904383|323161658|FG000|Overall Study|No patient visit after entry|54|||
94375946|NCT02497391|323161659|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
94305045|NCT01736683|322901365|FG002|Overall Study|Lack of Therapeutic Effect|13|||
94305046|NCT01736683|322901366|FG003|Overall Study|Lack of Therapeutic Effect|20|||
94305047|NCT01736683|322901367|FG004|Overall Study|Lack of Therapeutic Effect|1|||
94305048|NCT01736683|322901363|FG000|Overall Study|Progressive Disease|0|||
94305049|NCT01736683|322901364|FG001|Overall Study|Progressive Disease|0|||
94305050|NCT01736683|322901365|FG002|Overall Study|Progressive Disease|0|||
94305051|NCT01736683|322901366|FG003|Overall Study|Progressive Disease|1|||
94305052|NCT01736683|322901367|FG004|Overall Study|Progressive Disease|0|||
94305053|NCT01736683|322901363|FG000|Overall Study|Other|0|||
94305054|NCT01736683|322901364|FG001|Overall Study|Other|0|||
94305055|NCT01736683|322901365|FG002|Overall Study|Other|1|||
94305056|NCT01736683|322901366|FG003|Overall Study|Other|9|||
94305057|NCT01736683|322901367|FG004|Overall Study|Other|1|||
94305058|NCT00174941|322901370|FG000|Overall Study|Adverse Event|1|||
94305059|NCT00174941|322901371|FG001|Overall Study|Adverse Event|10|||
94305060|NCT00174941|322901372|FG002|Overall Study|Adverse Event|2|||
94305061|NCT00174941|322901373|FG003|Overall Study|Adverse Event|13|||
94305062|NCT00174941|322901370|FG000|Overall Study|Protocol Violation|0|||
94305063|NCT00174941|322901371|FG001|Overall Study|Protocol Violation|1|||
94305064|NCT00174941|322901372|FG002|Overall Study|Protocol Violation|0|||
94305065|NCT00174941|322901373|FG003|Overall Study|Protocol Violation|1|||
94305066|NCT00174941|322901370|FG000|Overall Study|Lost to Follow-up|0|||
94305067|NCT00174941|322901371|FG001|Overall Study|Lost to Follow-up|3|||
94305068|NCT00174941|322901372|FG002|Overall Study|Lost to Follow-up|2|||
94305069|NCT00174941|322901373|FG003|Overall Study|Lost to Follow-up|5|||
94305070|NCT00174941|322901370|FG000|Overall Study|Personal Reason(s)|0|||
94305071|NCT00174941|322901371|FG001|Overall Study|Personal Reason(s)|14|||
94305072|NCT00174941|322901372|FG002|Overall Study|Personal Reason(s)|8|||
94305073|NCT00174941|322901373|FG003|Overall Study|Personal Reason(s)|22|||
94305074|NCT00174941|322901370|FG000|Overall Study|Gout Flare|0|||
94305075|NCT00174941|322901371|FG001|Overall Study|Gout Flare|4|||
94305076|NCT00174941|322901372|FG002|Overall Study|Gout Flare|4|||
94305077|NCT00174941|322901373|FG003|Overall Study|Gout Flare|8|||
94305078|NCT00174941|322901370|FG000|Overall Study|Reason Not Specified|1|||
94305079|NCT00174941|322901371|FG001|Overall Study|Reason Not Specified|6|||
94305080|NCT00174941|322901372|FG002|Overall Study|Reason Not Specified|2|||
94305081|NCT00174941|322901373|FG003|Overall Study|Reason Not Specified|9|||
94305082|NCT03351244|322901376|FG000|Overall Study|Adverse Event|7|||
94305083|NCT03351244|322901377|FG001|Overall Study|Adverse Event|11|||
94305084|NCT03351244|322901378|FG002|Overall Study|Adverse Event|12|||
94305085|NCT03351244|322901376|FG000|Overall Study|Investigator's decision|0|||
94305086|NCT03351244|322901377|FG001|Overall Study|Investigator's decision|0|||
94305087|NCT03351244|322901378|FG002|Overall Study|Investigator's decision|2|||
94305088|NCT03351244|322901376|FG000|Overall Study|System error|0|||
94305089|NCT03351244|322901377|FG001|Overall Study|System error|0|||
94305090|NCT03351244|322901378|FG002|Overall Study|System error|2|||
94305091|NCT03351244|322901376|FG000|Overall Study|COVID-19 restrictions|3|||
94305092|NCT03351244|322901377|FG001|Overall Study|COVID-19 restrictions|0|||
94305093|NCT03351244|322901378|FG002|Overall Study|COVID-19 restrictions|1|||
94305094|NCT03351244|322901376|FG000|Overall Study|Non-compliance|2|||
94305095|NCT03351244|322901377|FG001|Overall Study|Non-compliance|5|||
94305096|NCT03351244|322901378|FG002|Overall Study|Non-compliance|0|||
94305097|NCT03351244|322901376|FG000|Overall Study|Withdrawal by Subject|11|||
94305098|NCT03351244|322901377|FG001|Overall Study|Withdrawal by Subject|16|||
94305099|NCT03351244|322901378|FG002|Overall Study|Withdrawal by Subject|13|||
94305100|NCT03351244|322901376|FG000|Overall Study|Lost to Follow-up|2|||
94305101|NCT03351244|322901377|FG001|Overall Study|Lost to Follow-up|6|||
94305102|NCT03351244|322901378|FG002|Overall Study|Lost to Follow-up|4|||
94305103|NCT03351244|322901376|FG000|Overall Study|Protocol Violation|2|||
94305104|NCT03351244|322901377|FG001|Overall Study|Protocol Violation|2|||
94305105|NCT03351244|322901378|FG002|Overall Study|Protocol Violation|0|||
94305106|NCT01937312|322901380|FG000|Overall Study|Adverse Event|10|||
94305107|NCT01937312|322901381|FG001|Overall Study|Adverse Event|1|||
94305108|NCT01937312|322901380|FG000|Overall Study|Lack of Efficacy|0|||
94305109|NCT01937312|322901381|FG001|Overall Study|Lack of Efficacy|1|||
94305110|NCT01937312|322901380|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
94305111|NCT01937312|322901381|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
94305112|NCT03794986|322901382|FG000|Overall Study|0 Sessions Attended|34|||
94305113|NCT03794986|322901383|FG001|Overall Study|0 Sessions Attended|37|||
94305114|NCT03794986|322901382|FG000|Overall Study|Withdrawal by Subject|4|||
94305115|NCT03794986|322901383|FG001|Overall Study|Withdrawal by Subject|6|||
94305116|NCT03794986|322901382|FG000|Overall Study|Protocol Violation|1|||
94305117|NCT03794986|322901383|FG001|Overall Study|Protocol Violation|0|||
94305118|NCT00592683|322901386|FG000|Overall Study|Found ineligible|0|||
94305119|NCT00592683|322901387|FG001|Overall Study|Found ineligible|1|||
94305120|NCT00592683|322901386|FG000|Overall Study|Withdrawal by Subject|1|||
94305121|NCT00592683|322901387|FG001|Overall Study|Withdrawal by Subject|0|||
94305122|NCT00592683|322901386|FG000|Overall Study|Adverse Event|0|||
94305123|NCT00592683|322901387|FG001|Overall Study|Adverse Event|2|||
94305124|NCT00592683|322901386|FG000|Overall Study|Protocol Violation|1|||
94375947|NCT02497391|323161660|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
94375948|NCT02497391|323161661|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
94375949|NCT02497391|323161662|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
94375950|NCT02497391|323161663|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
94375951|NCT02497391|323161664|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
94375952|NCT02497391|323161659|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
94375953|NCT02497391|323161660|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
94375954|NCT02497391|323161661|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
94375955|NCT02497391|323161662|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
94375956|NCT02497391|323161663|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
94375957|NCT02497391|323161664|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
94375958|NCT02497391|323161659|FG000|Period 3 (14 Days)|Adverse Event|0|||
94375959|NCT02497391|323161660|FG001|Period 3 (14 Days)|Adverse Event|1|||
94375960|NCT02497391|323161661|FG002|Period 3 (14 Days)|Adverse Event|0|||
94375961|NCT02497391|323161662|FG003|Period 3 (14 Days)|Adverse Event|0|||
94375962|NCT02497391|323161663|FG004|Period 3 (14 Days)|Adverse Event|0|||
94375963|NCT02497391|323161664|FG005|Period 3 (14 Days)|Adverse Event|0|||
94375964|NCT02497391|323161659|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
94375965|NCT02497391|323161660|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
94375966|NCT02497391|323161661|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
94375967|NCT02497391|323161662|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
94375968|NCT02497391|323161663|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
94375969|NCT02497391|323161664|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
94375970|NCT02497391|323161659|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
94375971|NCT02497391|323161660|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
94375972|NCT02497391|323161661|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
94375973|NCT02497391|323161662|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
94375974|NCT02497391|323161663|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
94375975|NCT02497391|323161664|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
94375976|NCT01084005|323161668|FG000|Overall Study|Adverse Event|1|||
94375977|NCT01084005|323161669|FG001|Overall Study|Adverse Event|8|||
94375978|NCT01084005|323161668|FG000|Overall Study|Protocol Violation|3|||
94375979|NCT01084005|323161669|FG001|Overall Study|Protocol Violation|7|||
94375980|NCT01084005|323161668|FG000|Overall Study|Withdrawal by Subject|1|||
94305125|NCT00592683|322901387|FG001|Overall Study|Protocol Violation|0|||
94305126|NCT00592683|322901386|FG000|Overall Study|Study drug expired|1|||
94305127|NCT00592683|322901387|FG001|Overall Study|Study drug expired|0|||
94305128|NCT00592683|322901386|FG000|Overall Study|Other|1|||
94305129|NCT00592683|322901387|FG001|Overall Study|Other|0|||
94305130|NCT00592683|322901386|FG000|Overall Study|Lost to Follow-up|0|||
94305131|NCT00592683|322901387|FG001|Overall Study|Lost to Follow-up|1|||
94305132|NCT05309083|322901388|FG000|Overall Study|Withdrawal by Subject|2|||
94305133|NCT01165229|322901391|FG000|Overall Study|Serious Adverse Event|456|||
94305134|NCT01165229|322901392|FG001|Overall Study|Serious Adverse Event|487|||
94305135|NCT01165229|322901391|FG000|Overall Study|Non-Serious Adverse Event|47|||
94305136|NCT01165229|322901392|FG001|Overall Study|Non-Serious Adverse Event|15|||
94305137|NCT01165229|322901391|FG000|Overall Study|Protocol Violation|6|||
94305138|NCT01165229|322901392|FG001|Overall Study|Protocol Violation|8|||
94305139|NCT01165229|322901391|FG000|Overall Study|Withdrawal by Subject|387|||
94305140|NCT01165229|322901392|FG001|Overall Study|Withdrawal by Subject|396|||
94305141|NCT01165229|322901391|FG000|Overall Study|Migrated/moved from study area|51|||
94305142|NCT01165229|322901392|FG001|Overall Study|Migrated/moved from study area|46|||
94305143|NCT01165229|322901391|FG000|Overall Study|Lost to Follow-up|123|||
94305144|NCT01165229|322901392|FG001|Overall Study|Lost to Follow-up|133|||
94305145|NCT01165229|322901391|FG000|Overall Study|Suspected HZ Episode|2|||
94305146|NCT01165229|322901392|FG001|Overall Study|Suspected HZ Episode|2|||
94305147|NCT01165229|322901391|FG000|Overall Study|No reason from the subject|108|||
94305148|NCT01165229|322901392|FG001|Overall Study|No reason from the subject|102|||
94305149|NCT01165229|322901391|FG000|Overall Study|Unknown completion status|0|||
94305150|NCT01165229|322901392|FG001|Overall Study|Unknown completion status|1|||
94305151|NCT00095303|322901398|FG000|Main Study|Lost to Follow-up|91|||
94305152|NCT00095303|322901399|FG001|Main Study|Lost to Follow-up|87|||
94305153|NCT00095303|322901398|FG000|Follow Up Study|Lost to Follow-up|59|||
94305154|NCT00095303|322901399|FG001|Follow Up Study|Lost to Follow-up|58|||
94305155|NCT00467649|322901400|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
94305156|NCT00467649|322901401|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
94305157|NCT00467649|322901402|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
94305158|NCT00467649|322901403|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
94305159|NCT00467649|322901404|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
94305160|NCT00467649|322901405|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
94305161|NCT00467649|322901400|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
94305162|NCT00467649|322901401|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
94305163|NCT00467649|322901402|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
94305164|NCT00467649|322901403|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
94305165|NCT00467649|322901404|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
94305166|NCT00467649|322901405|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
94468986|NCT02943785|323507521|FG000|Overall Study|Lost to Follow-up|1|||
94468987|NCT02943785|323507522|FG001|Overall Study|Lost to Follow-up|0|||
94468988|NCT02943785|323507521|FG000|Overall Study|Other|16|||
94468989|NCT02943785|323507522|FG001|Overall Study|Other|19|||
94468990|NCT02943785|323507521|FG000|Overall Study|Did not receive any study medication|21|||
94468991|NCT02943785|323507522|FG001|Overall Study|Did not receive any study medication|28|||
94468992|NCT02603107|323507523|FG000|Randomized Phase|Withdrew consent|8|||
94468993|NCT02603107|323507524|FG001|Randomized Phase|Withdrew consent|15|||
94468994|NCT02603107|323507523|FG000|Randomized Phase|Lost to Follow-up|1|||
94468995|NCT02603107|323507524|FG001|Randomized Phase|Lost to Follow-up|3|||
94468996|NCT02603107|323507523|FG000|Randomized Phase|Adverse Event|2|||
94468997|NCT02603107|323507524|FG001|Randomized Phase|Adverse Event|0|||
94468998|NCT02603107|323507523|FG000|Randomized Phase|Death|1|||
94468999|NCT02603107|323507524|FG001|Randomized Phase|Death|1|||
94469000|NCT02603107|323507523|FG000|Randomized Phase|Non-compliance with study drug|1|||
94469001|NCT02603107|323507524|FG001|Randomized Phase|Non-compliance with study drug|1|||
94469002|NCT02603107|323507523|FG000|Randomized Phase|Investigator's discretion|0|||
94469003|NCT02603107|323507524|FG001|Randomized Phase|Investigator's discretion|1|||
94469004|NCT02603107|323507523|FG000|Randomized Phase|Lack of Efficacy|1|||
94469005|NCT02603107|323507524|FG001|Randomized Phase|Lack of Efficacy|0|||
94469006|NCT02603107|323507523|FG000|Randomized Phase|Protocol Violation|1|||
94469007|NCT02603107|323507524|FG001|Randomized Phase|Protocol Violation|0|||
94469008|NCT02603107|323507523|FG000|Optional Extension Phase|Lost to Follow-up|3|||
94469009|NCT02603107|323507524|FG001|Optional Extension Phase|Lost to Follow-up|3|||
94469010|NCT02603107|323507523|FG000|Optional Extension Phase|Withdrew consent|3|||
94469011|NCT02603107|323507524|FG001|Optional Extension Phase|Withdrew consent|2|||
94469012|NCT02603107|323507523|FG000|Optional Extension Phase|Investigator's discretion|2|||
94469013|NCT02603107|323507524|FG001|Optional Extension Phase|Investigator's discretion|2|||
94469014|NCT02603107|323507523|FG000|Optional Extension Phase|Pregnancy|0|||
94469015|NCT02603107|323507524|FG001|Optional Extension Phase|Pregnancy|3|||
94469016|NCT02603107|323507523|FG000|Optional Extension Phase|Adverse Event|0|||
94469017|NCT02603107|323507524|FG001|Optional Extension Phase|Adverse Event|2|||
94469018|NCT02603107|323507523|FG000|Optional Extension Phase|Not treated in extension phase|0|||
94469019|NCT02603107|323507524|FG001|Optional Extension Phase|Not treated in extension phase|1|||
94469020|NCT02603107|323507523|FG000|Optional Extension Phase|Protocol Violation|1|||
94469021|NCT02603107|323507524|FG001|Optional Extension Phase|Protocol Violation|0|||
94469022|NCT02735096|323507530|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
94469023|NCT03084315|323507531|FG000|Overall Study|Lost to Follow-up|8|||
94469024|NCT03084315|323507532|FG001|Overall Study|Lost to Follow-up|7|||
94469025|NCT03084315|323507531|FG000|Overall Study|Withdrawal by Subject|2|||
94469026|NCT03084315|323507532|FG001|Overall Study|Withdrawal by Subject|2|||
94469027|NCT02069093|323507533|FG000|Overall Study|Disease progression|14|||
94469028|NCT02069093|323507533|FG000|Overall Study|New cancer therapy|1|||
94469029|NCT02069093|323507533|FG000|Overall Study|Death|1|||
94469030|NCT02069093|323507533|FG000|Overall Study|Administrative problems|1|||
94469031|NCT02069093|323507533|FG000|Overall Study|Withdrawal by Subject|2|||
94469032|NCT02069093|323507533|FG000|Overall Study|Abnormal laboratory values|1|||
94375981|NCT01084005|323161669|FG001|Overall Study|Withdrawal by Subject|1|||
94375982|NCT00633152|323161671|FG000|Overall Study|Adverse Event|1|||
94375983|NCT00633152|323161672|FG001|Overall Study|Adverse Event|0|||
94375984|NCT00633152|323161671|FG000|Overall Study|Randomized, did not receive study drug|5|||
94375985|NCT00633152|323161672|FG001|Overall Study|Randomized, did not receive study drug|2|||
94375986|NCT00633152|323161671|FG000|Overall Study|Withdrawal by Subject|1|||
94375987|NCT00633152|323161672|FG001|Overall Study|Withdrawal by Subject|1|||
94375988|NCT00633152|323161671|FG000|Overall Study|Lost to Follow-up|4|||
94375989|NCT00633152|323161672|FG001|Overall Study|Lost to Follow-up|1|||
94375990|NCT00633152|323161671|FG000|Overall Study|Miscellaneous Other|3|||
94375991|NCT00633152|323161672|FG001|Overall Study|Miscellaneous Other|2|||
94375992|NCT05216978|323161674|FG000|Overall Study|Withdrawal by Subject|3|||
94375993|NCT05216978|323161674|FG000|Overall Study|Lost to Follow-up|5|||
94375994|NCT02180061|323161675|FG000|Overall Study|Adverse Event|4|||
94375995|NCT02180061|323161676|FG001|Overall Study|Adverse Event|2|||
94469033|NCT02069093|323507533|FG000|Overall Study|Adverse Event|10|||
94375996|NCT02180061|323161675|FG000|Overall Study|Clinical Progression|5|||
94375997|NCT02180061|323161676|FG001|Overall Study|Clinical Progression|1|||
94375998|NCT02180061|323161675|FG000|Overall Study|Progressive Disease|15|||
94375999|NCT02180061|323161676|FG001|Overall Study|Progressive Disease|5|||
94469034|NCT00586508|323507536|FG000|Overall Study|Progressive disease|52|||
94469035|NCT00586508|323507537|FG001|Overall Study|Progressive disease|8|||
94469036|NCT00586508|323507536|FG000|Overall Study|Death|0|||
94469037|NCT00586508|323507537|FG001|Overall Study|Death|1|||
94469038|NCT00586508|323507536|FG000|Overall Study|Adverse Event|12|||
94469039|NCT00586508|323507537|FG001|Overall Study|Adverse Event|4|||
94469040|NCT00586508|323507536|FG000|Overall Study|Withdrawal by Subject|4|||
94376000|NCT02180061|323161675|FG000|Overall Study|Physician Decision|1|||
94376001|NCT02180061|323161676|FG001|Overall Study|Physician Decision|0|||
94305167|NCT00467649|322901400|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
94305168|NCT00467649|322901401|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
94305169|NCT00467649|322901402|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
94305170|NCT00467649|322901403|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
94305171|NCT00467649|322901404|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
94305172|NCT00467649|322901405|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
94305173|NCT00467649|322901400|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
94305174|NCT00467649|322901401|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
94305175|NCT00467649|322901402|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
94305176|NCT00467649|322901403|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
94305177|NCT00467649|322901404|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
94305178|NCT00467649|322901405|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
94305179|NCT00467649|322901400|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
94305180|NCT00467649|322901401|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
94305181|NCT00467649|322901402|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
94305182|NCT00467649|322901403|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
94305183|NCT00467649|322901404|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
94305184|NCT00467649|322901405|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
94305185|NCT00467649|322901400|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
94305186|NCT00467649|322901401|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
94305187|NCT00467649|322901402|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
94305188|NCT00467649|322901403|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
94305189|NCT00467649|322901404|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
94305190|NCT00467649|322901405|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
94305191|NCT00467649|322901400|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
94305192|NCT00467649|322901401|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
94305193|NCT00467649|322901402|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
94305194|NCT00467649|322901403|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
94305195|NCT00467649|322901404|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
94305196|NCT00467649|322901405|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
94305197|NCT00847613|322901406|FG000|Overall Study|Ongoing at cut-off date|250|||
94305198|NCT00847613|322901407|FG001|Overall Study|Ongoing at cut-off date|265|||
94305199|NCT00847613|322901408|FG002|Overall Study|Ongoing at cut-off date|64|||
94305200|NCT00847613|322901409|FG003|Overall Study|Ongoing at cut-off date|64|||
94305201|NCT00847613|322901406|FG000|Overall Study|Death|1|||
94305202|NCT00847613|322901407|FG001|Overall Study|Death|1|||
94305203|NCT00847613|322901408|FG002|Overall Study|Death|0|||
94305204|NCT00847613|322901409|FG003|Overall Study|Death|0|||
94305205|NCT00847613|322901406|FG000|Overall Study|Adverse Event|36|||
94305206|NCT00847613|322901407|FG001|Overall Study|Adverse Event|26|||
94305207|NCT00847613|322901408|FG002|Overall Study|Adverse Event|5|||
94305208|NCT00847613|322901409|FG003|Overall Study|Adverse Event|6|||
94305209|NCT00847613|322901406|FG000|Overall Study|Lack of Efficacy|7|||
94305210|NCT00847613|322901407|FG001|Overall Study|Lack of Efficacy|3|||
94305211|NCT00847613|322901408|FG002|Overall Study|Lack of Efficacy|3|||
94305212|NCT00847613|322901409|FG003|Overall Study|Lack of Efficacy|1|||
94305213|NCT00847613|322901406|FG000|Overall Study|Study terminated by Sponsor|1|||
94305214|NCT00847613|322901407|FG001|Overall Study|Study terminated by Sponsor|0|||
94305215|NCT00847613|322901408|FG002|Overall Study|Study terminated by Sponsor|2|||
94305216|NCT00847613|322901409|FG003|Overall Study|Study terminated by Sponsor|1|||
94305217|NCT00847613|322901406|FG000|Overall Study|Lost to Follow-up|5|||
94305218|NCT00847613|322901407|FG001|Overall Study|Lost to Follow-up|0|||
94305219|NCT00847613|322901408|FG002|Overall Study|Lost to Follow-up|0|||
94305220|NCT00847613|322901409|FG003|Overall Study|Lost to Follow-up|3|||
94305221|NCT00847613|322901406|FG000|Overall Study|Protocol Violation|6|||
94305222|NCT00847613|322901407|FG001|Overall Study|Protocol Violation|6|||
94305223|NCT00847613|322901408|FG002|Overall Study|Protocol Violation|3|||
94305224|NCT00847613|322901409|FG003|Overall Study|Protocol Violation|1|||
94305225|NCT00847613|322901406|FG000|Overall Study|Pregnancy|1|||
94305226|NCT00847613|322901407|FG001|Overall Study|Pregnancy|1|||
94305227|NCT00847613|322901408|FG002|Overall Study|Pregnancy|0|||
94305228|NCT00847613|322901409|FG003|Overall Study|Pregnancy|0|||
94305229|NCT00847613|322901406|FG000|Overall Study|Site closure|1|||
94305230|NCT00847613|322901407|FG001|Overall Study|Site closure|0|||
94305231|NCT00847613|322901408|FG002|Overall Study|Site closure|0|||
94305232|NCT00847613|322901409|FG003|Overall Study|Site closure|1|||
94305233|NCT00847613|322901406|FG000|Overall Study|Withdrawal by Subject|8|||
94305234|NCT00847613|322901407|FG001|Overall Study|Withdrawal by Subject|11|||
94305235|NCT00847613|322901408|FG002|Overall Study|Withdrawal by Subject|2|||
94305236|NCT00847613|322901409|FG003|Overall Study|Withdrawal by Subject|2|||
94305237|NCT00847613|322901406|FG000|Overall Study|Participant moved|4|||
94305238|NCT00847613|322901407|FG001|Overall Study|Participant moved|1|||
94305239|NCT00847613|322901408|FG002|Overall Study|Participant moved|0|||
94305240|NCT00847613|322901409|FG003|Overall Study|Participant moved|0|||
94305241|NCT00847613|322901406|FG000|Overall Study|Sponsor request|0|||
94305242|NCT00847613|322901407|FG001|Overall Study|Sponsor request|1|||
94305243|NCT00847613|322901408|FG002|Overall Study|Sponsor request|0|||
94305244|NCT00847613|322901409|FG003|Overall Study|Sponsor request|0|||
94305245|NCT00847613|322901406|FG000|Overall Study|Randomized, but not treated|0|||
94305246|NCT00847613|322901407|FG001|Overall Study|Randomized, but not treated|3|||
94305247|NCT00847613|322901408|FG002|Overall Study|Randomized, but not treated|0|||
94305248|NCT00847613|322901409|FG003|Overall Study|Randomized, but not treated|0|||
94305249|NCT00847613|322901406|FG000|Overall Study|Other|1|||
94305250|NCT00847613|322901407|FG001|Overall Study|Other|1|||
94305251|NCT00847613|322901408|FG002|Overall Study|Other|2|||
94305252|NCT00847613|322901409|FG003|Overall Study|Other|0|||
94305253|NCT01633060|322901410|FG000|Randomization Phase|Protocol deviation|1|||
94305254|NCT01633060|322901411|FG001|Randomization Phase|Protocol deviation|2|||
94305255|NCT01633060|322901410|FG000|Randomization Phase|Technical problem|0|||
94305256|NCT01633060|322901411|FG001|Randomization Phase|Technical problem|1|||
94305257|NCT01633060|322901410|FG000|Treatment Phase|Adverse Event|24|||
94305258|NCT01633060|322901411|FG001|Treatment Phase|Adverse Event|3|||
94305259|NCT01633060|322901410|FG000|Treatment Phase|Lost to Follow-up|1|||
94305260|NCT01633060|322901411|FG001|Treatment Phase|Lost to Follow-up|0|||
94305261|NCT01633060|322901410|FG000|Treatment Phase|Physician Decision|16|||
94305262|NCT01633060|322901411|FG001|Treatment Phase|Physician Decision|7|||
94305263|NCT01633060|322901410|FG000|Treatment Phase|Progressive Disease|210|||
94305264|NCT01633060|322901411|FG001|Treatment Phase|Progressive Disease|120|||
94305265|NCT01633060|322901410|FG000|Treatment Phase|Protocol Deviation|1|||
94305266|NCT01633060|322901411|FG001|Treatment Phase|Protocol Deviation|0|||
94305267|NCT01633060|322901410|FG000|Treatment Phase|Study Terminated by sponsor|7|||
94305268|NCT01633060|322901411|FG001|Treatment Phase|Study Terminated by sponsor|3|||
94305269|NCT01633060|322901410|FG000|Treatment Phase|Subject/guardian decision|25|||
94305270|NCT01633060|322901411|FG001|Treatment Phase|Subject/guardian decision|4|||
94305271|NCT01633060|322901410|FG000|Treatment Phase|Death|4|||
94305272|NCT01633060|322901411|FG001|Treatment Phase|Death|3|||
94305273|NCT01633060|322901410|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
94305274|NCT01633060|322901411|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
94305275|NCT01633060|322901410|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
94305276|NCT01633060|322901411|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
94305277|NCT01633060|322901410|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
94305278|NCT01633060|322901411|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
94305279|NCT01633060|322901410|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
94305280|NCT01633060|322901411|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
94305281|NCT01633060|322901410|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
94305282|NCT01633060|322901411|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
94305283|NCT01633060|322901410|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
94305284|NCT01633060|322901411|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
94305285|NCT00195351|322901412|FG000|Overall Study|Lost to Follow-up|9|||
94305286|NCT00195351|322901413|FG001|Overall Study|Lost to Follow-up|9|||
94305287|NCT00195351|322901412|FG000|Overall Study|Withdrawal by Subject|6|||
94305288|NCT00195351|322901413|FG001|Overall Study|Withdrawal by Subject|3|||
94305289|NCT00195351|322901412|FG000|Overall Study|Protocol Deviation|3|||
94305290|NCT00195351|322901413|FG001|Overall Study|Protocol Deviation|2|||
94305291|NCT00195351|322901412|FG000|Overall Study|Death|3|||
94305292|NCT00195351|322901413|FG001|Overall Study|Death|1|||
94305293|NCT00195351|322901412|FG000|Overall Study|Lack of Efficacy|0|||
94305294|NCT00195351|322901413|FG001|Overall Study|Lack of Efficacy|1|||
94305295|NCT01444391|322901420|FG000|Overall Study|Death|1|||
94305296|NCT03459846|322901421|FG000|Overall Study|Death|52|||
94305297|NCT03459846|322901422|FG001|Overall Study|Death|46|||
94305298|NCT03459846|322901421|FG000|Overall Study|Study terminated by sponsor|24|||
94305299|NCT03459846|322901422|FG001|Overall Study|Study terminated by sponsor|28|||
94305300|NCT03459846|322901421|FG000|Overall Study|Withdrawal by Subject|2|||
94305301|NCT03459846|322901422|FG001|Overall Study|Withdrawal by Subject|2|||
94305302|NCT04329949|322902409|FG000|Overall Study|Death|36|||
94305303|NCT04329949|322902409|FG000|Overall Study|Withdrawal by Subject|4|||
94305304|NCT04329949|322902409|FG000|Overall Study|Termination of study by sponsor|3|||
94305305|NCT01335971|322902413|FG000|Overall Study|Withdrawal by Subject|1|||
94305306|NCT01335971|322902414|FG001|Overall Study|Withdrawal by Subject|0|||
94469041|NCT00586508|323507537|FG001|Overall Study|Withdrawal by Subject|0|||
94469042|NCT02791438|323507538|FG000|Treatment Period|Adverse Event|1|||
94469043|NCT02791438|323507539|FG001|Treatment Period|Adverse Event|0|||
94469044|NCT02791438|323507538|FG000|Treatment Period|Withdrawal by Subject|0|||
94469045|NCT02791438|323507539|FG001|Treatment Period|Withdrawal by Subject|1|||
94469046|NCT02791438|323507538|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
94469047|NCT02791438|323507539|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
94469048|NCT01156051|323507542|FG000|Overall Study|Lost to Follow-up|1|||
94469049|NCT01156051|323507543|FG001|Overall Study|Lost to Follow-up|0|||
94469050|NCT01156051|323507542|FG000|Overall Study|patient not compliant with protocol|0|||
94469051|NCT01156051|323507543|FG001|Overall Study|patient not compliant with protocol|1|||
94469052|NCT04266795|323507545|FG000|Overall Study|Adverse Event|10|||
94305307|NCT01335971|322902415|FG002|Overall Study|Withdrawal by Subject|0|||
94305308|NCT01335971|322902413|FG000|Overall Study|Did not complete bronchoscopy|1|||
94305309|NCT01335971|322902414|FG001|Overall Study|Did not complete bronchoscopy|1|||
94305310|NCT01335971|322902415|FG002|Overall Study|Did not complete bronchoscopy|1|||
94305311|NCT05299892|322902416|FG000|Overall Study|Withdrawal by Subject|2|||
94305312|NCT01059812|322902417|FG000|Overall Study|Adverse Event|9|||
94305313|NCT01059812|322902418|FG001|Overall Study|Adverse Event|5|||
94305314|NCT01059812|322902417|FG000|Overall Study|Lack of Efficacy|2|||
94305315|NCT01059812|322902418|FG001|Overall Study|Lack of Efficacy|2|||
94305316|NCT01059812|322902417|FG000|Overall Study|Protocol Violation|3|||
94305317|NCT01059812|322902418|FG001|Overall Study|Protocol Violation|1|||
94305318|NCT01059812|322902417|FG000|Overall Study|Withdrawal Criteria|9|||
94305319|NCT01059812|322902418|FG001|Overall Study|Withdrawal Criteria|4|||
94305320|NCT01059812|322902417|FG000|Overall Study|Unclassified|14|||
94305321|NCT01059812|322902418|FG001|Overall Study|Unclassified|4|||
94305322|NCT01451515|322902424|FG000|Overall Study|Death|0|||
94305323|NCT01451515|322902425|FG001|Overall Study|Death|1|||
94305324|NCT01451515|322902426|FG002|Overall Study|Death|0|||
94305325|NCT01451515|322902424|FG000|Overall Study|Withdrawal by Subject|0|||
94305326|NCT01451515|322902425|FG001|Overall Study|Withdrawal by Subject|1|||
94305327|NCT01451515|322902426|FG002|Overall Study|Withdrawal by Subject|0|||
94305328|NCT01451515|322902424|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
94305329|NCT01451515|322902425|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
94305330|NCT01451515|322902426|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
94305331|NCT01451515|322902424|FG000|Overall Study|Relapse (except CNS)|1|||
94305332|NCT01451515|322902425|FG001|Overall Study|Relapse (except CNS)|1|||
94305333|NCT01451515|322902426|FG002|Overall Study|Relapse (except CNS)|0|||
94305334|NCT02397655|322902427|FG000|Overall Study|data not completed|1301|||
94305335|NCT03126227|322902430|FG000|Overall Study|Adverse Event|43|||
94305336|NCT03126227|322902431|FG001|Overall Study|Adverse Event|4|||
94305337|NCT03126227|322902430|FG000|Overall Study|Death|0|||
94305338|NCT03126227|322902431|FG001|Overall Study|Death|1|||
94305339|NCT03126227|322902430|FG000|Overall Study|Lost to Follow-up|0|||
94305340|NCT03126227|322902431|FG001|Overall Study|Lost to Follow-up|1|||
94305341|NCT03126227|322902430|FG000|Overall Study|Physician Decision|2|||
94305342|NCT03126227|322902431|FG001|Overall Study|Physician Decision|0|||
94305343|NCT03126227|322902430|FG000|Overall Study|Protocol Violation|1|||
94305344|NCT03126227|322902431|FG001|Overall Study|Protocol Violation|0|||
94305345|NCT03126227|322902430|FG000|Overall Study|Withdrawal by Subject|19|||
94305346|NCT03126227|322902431|FG001|Overall Study|Withdrawal by Subject|3|||
94305347|NCT03126227|322902430|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
94305348|NCT03126227|322902431|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
94305349|NCT03126227|322902430|FG000|Overall Study|Lack of dosing compliance|2|||
94305350|NCT03126227|322902431|FG001|Overall Study|Lack of dosing compliance|0|||
94305351|NCT03126227|322902430|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
94305352|NCT03126227|322902431|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
94305353|NCT03126227|322902430|FG000|Overall Study|Scheduling conflict|1|||
94305354|NCT03126227|322902431|FG001|Overall Study|Scheduling conflict|0|||
94305355|NCT00609609|322902435|FG000|Overall Study|Withdrawal by Subject|2|||
94305356|NCT00609609|322902436|FG001|Overall Study|Withdrawal by Subject|0|||
94305357|NCT00609609|322902435|FG000|Overall Study|Progression|4|||
94305358|NCT00609609|322902436|FG001|Overall Study|Progression|2|||
94305359|NCT05421754|322902440|FG000|Overall Study|Technical issue with sensor|1|||
94305360|NCT03000452|322902442|FG000|Treatment Period|Death|1|||
94305361|NCT03000452|322902442|FG000|Treatment Period|Progressive Disease (PD)|14|||
94305362|NCT03000452|322902442|FG000|Treatment Period|Physician Decision|1|||
94305363|NCT03000452|322902442|FG000|Treatment Period|Miscellaneous|2|||
94305364|NCT03000452|322902442|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
94305365|NCT03000452|322902442|FG000|Follow-Up Period|Death|3|||
94305366|NCT03000452|322902442|FG000|Follow-Up Period|Withdrawal by Subject|3|||
94469053|NCT04266795|323507546|FG001|Overall Study|Adverse Event|19|||
94305367|NCT03455543|322902443|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
94305368|NCT03455543|322902444|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
94469054|NCT04266795|323507545|FG000|Overall Study|Death|7|||
94469055|NCT04266795|323507546|FG001|Overall Study|Death|8|||
94469056|NCT04266795|323507545|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
94469057|NCT04266795|323507546|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
94469058|NCT04266795|323507545|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
94469059|NCT04266795|323507546|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
94469060|NCT04266795|323507545|FG000|Overall Study|Progressive Disease|12|||
94469061|NCT04266795|323507546|FG001|Overall Study|Progressive Disease|9|||
94469062|NCT04266795|323507545|FG000|Overall Study|Withdrawal by Patient|5|||
94469063|NCT04266795|323507546|FG001|Overall Study|Withdrawal by Patient|6|||
94305369|NCT03455543|322902445|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
94305370|NCT03455543|322902443|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
94305371|NCT03455543|322902444|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
94376002|NCT02732561|323161679|FG000|Overall Study|Lost to Follow-up|1|||
94376003|NCT02732561|323161680|FG001|Overall Study|Lost to Follow-up|1|||
94376004|NCT02732561|323161679|FG000|Overall Study|Withdrawal by Subject|1|||
94376005|NCT02732561|323161680|FG001|Overall Study|Withdrawal by Subject|0|||
94376006|NCT01772368|323161681|FG000|Overall Study|Adverse Event|1|||
94376007|NCT01772368|323161681|FG000|Overall Study|Withdrawal by Subject|3|||
94376008|NCT01772368|323161681|FG000|Overall Study|Protocol Violation|2|||
94376009|NCT01772368|323161681|FG000|Overall Study|Other|1|||
94376010|NCT01165684|323161698|FG000|Overall Study|Adverse Event|1|||
94376011|NCT01165684|323161699|FG001|Overall Study|Adverse Event|1|||
94376012|NCT01165684|323161698|FG000|Overall Study|Lack of Efficacy|2|||
94376013|NCT01165684|323161699|FG001|Overall Study|Lack of Efficacy|1|||
94376014|NCT01165684|323161698|FG000|Overall Study|Protocol Violation|7|||
94376015|NCT01165684|323161699|FG001|Overall Study|Protocol Violation|15|||
94305372|NCT03455543|322902445|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
94305373|NCT03455543|322902443|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
94305374|NCT03455543|322902444|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
94305375|NCT03455543|322902445|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
94305376|NCT03455543|322902443|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
94305377|NCT03455543|322902444|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
94305378|NCT03455543|322902445|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
94305379|NCT03455543|322902443|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
94305380|NCT03455543|322902444|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
94305381|NCT03455543|322902445|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
94305382|NCT03455543|322902443|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
94305383|NCT03455543|322902444|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
94305384|NCT03455543|322902445|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
94305385|NCT03455543|322902443|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
94305386|NCT03455543|322902444|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
94376016|NCT01165684|323161698|FG000|Overall Study|Withdrawal Criteria|2|||
94376017|NCT01165684|323161699|FG001|Overall Study|Withdrawal Criteria|13|||
94376018|NCT01165684|323161698|FG000|Overall Study|Unclassified|16|||
94376019|NCT01165684|323161699|FG001|Overall Study|Unclassified|22|||
94376020|NCT03347695|323161700|FG000|Overall Study|Death|0|||
94376021|NCT03347695|323161701|FG001|Overall Study|Death|4|||
94376022|NCT03347695|323161700|FG000|Overall Study|Lost to Follow-up|0|||
94376023|NCT03347695|323161701|FG001|Overall Study|Lost to Follow-up|1|||
94376024|NCT00671879|323161706|FG000|Overall Study|Withdrawal by Subject|0|||
94469064|NCT04266795|323507545|FG000|Overall Study|Disease Relapse|3|||
94305387|NCT03455543|322902445|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
94305388|NCT03455543|322902443|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
94305389|NCT03455543|322902444|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
94305390|NCT03455543|322902445|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
94305391|NCT03455543|322902443|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
94305392|NCT03455543|322902444|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
94305393|NCT03455543|322902445|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
94305394|NCT00479466|322902448|FG000|Overall Study|Adverse Event|5|||
94305395|NCT00479466|322902449|FG001|Overall Study|Adverse Event|1|||
94305396|NCT00479466|322902450|FG002|Overall Study|Adverse Event|0|||
94305397|NCT00479466|322902451|FG003|Overall Study|Adverse Event|1|||
94376025|NCT00671879|323161707|FG001|Overall Study|Withdrawal by Subject|4|||
94376026|NCT00671879|323161708|FG002|Overall Study|Withdrawal by Subject|6|||
94376027|NCT01886300|323161712|FG000|Overall Study|Trial terminated by sponsor|16|||
94376028|NCT01797120|323161713|FG000|Overall Study|Disesae progression|37|||
94376029|NCT01797120|323161714|FG001|Overall Study|Disesae progression|49|||
94376030|NCT01797120|323161713|FG000|Overall Study|Adverse Event|13|||
94376031|NCT01797120|323161714|FG001|Overall Study|Adverse Event|5|||
94376032|NCT01797120|323161713|FG000|Overall Study|Withdrawal by Subject|6|||
94469065|NCT04266795|323507546|FG001|Overall Study|Disease Relapse|6|||
94305398|NCT00479466|322902452|FG004|Overall Study|Adverse Event|2|||
94305399|NCT00479466|322902453|FG005|Overall Study|Adverse Event|0|||
94305400|NCT00479466|322902448|FG000|Overall Study|Hyperglycemia|0|||
94305401|NCT00479466|322902449|FG001|Overall Study|Hyperglycemia|0|||
94305402|NCT00479466|322902450|FG002|Overall Study|Hyperglycemia|0|||
94305403|NCT00479466|322902451|FG003|Overall Study|Hyperglycemia|0|||
94305404|NCT00479466|322902452|FG004|Overall Study|Hyperglycemia|0|||
94305405|NCT00479466|322902453|FG005|Overall Study|Hyperglycemia|1|||
94376033|NCT01797120|323161714|FG001|Overall Study|Withdrawal by Subject|6|||
94376034|NCT01797120|323161713|FG000|Overall Study|Symptomatic progression|2|||
94376035|NCT01797120|323161714|FG001|Overall Study|Symptomatic progression|1|||
94376036|NCT01797120|323161713|FG000|Overall Study|Non-compliance|1|||
94376037|NCT01797120|323161714|FG001|Overall Study|Non-compliance|0|||
94376038|NCT01797120|323161713|FG000|Overall Study|Physician Decision|3|||
94376039|NCT01797120|323161714|FG001|Overall Study|Physician Decision|0|||
94376040|NCT01797120|323161713|FG000|Overall Study|still on treatment|2|||
94376041|NCT01797120|323161714|FG001|Overall Study|still on treatment|4|||
94376042|NCT01797120|323161713|FG000|Overall Study|never start protocol therapy|2|||
94376043|NCT01797120|323161714|FG001|Overall Study|never start protocol therapy|0|||
94376044|NCT01399723|323161715|FG000|Overall Study|Lost to Follow-up|0|||
94376045|NCT01399723|323161716|FG001|Overall Study|Lost to Follow-up|1|||
94376046|NCT00295854|323161719|FG000|Overall Study|Adverse Event|7|||
94376047|NCT00295854|323161720|FG001|Overall Study|Adverse Event|7|||
94376048|NCT00295854|323161721|FG002|Overall Study|Adverse Event|6|||
94376049|NCT00295854|323161719|FG000|Overall Study|Protocol Violation|1|||
94376050|NCT00295854|323161720|FG001|Overall Study|Protocol Violation|1|||
94376051|NCT00295854|323161721|FG002|Overall Study|Protocol Violation|1|||
94376052|NCT00295854|323161719|FG000|Overall Study|Lost to Follow-up|2|||
94376053|NCT00295854|323161720|FG001|Overall Study|Lost to Follow-up|0|||
94376054|NCT00295854|323161721|FG002|Overall Study|Lost to Follow-up|1|||
94376055|NCT00295854|323161719|FG000|Overall Study|Withdrawal by Subject|3|||
94376056|NCT00295854|323161720|FG001|Overall Study|Withdrawal by Subject|7|||
94376057|NCT00295854|323161721|FG002|Overall Study|Withdrawal by Subject|4|||
94376058|NCT00295854|323161719|FG000|Overall Study|did not continue to meet criteria|1|||
94376059|NCT00295854|323161720|FG001|Overall Study|did not continue to meet criteria|1|||
94376060|NCT00295854|323161721|FG002|Overall Study|did not continue to meet criteria|2|||
94376061|NCT00295854|323161719|FG000|Overall Study|required a prohibited medication|1|||
94376062|NCT00295854|323161720|FG001|Overall Study|required a prohibited medication|0|||
94376063|NCT00295854|323161721|FG002|Overall Study|required a prohibited medication|0|||
94376064|NCT00295854|323161719|FG000|Overall Study|Other|3|||
94376065|NCT00295854|323161720|FG001|Overall Study|Other|5|||
94376066|NCT00295854|323161721|FG002|Overall Study|Other|1|||
94376067|NCT00772577|323161722|FG000|Overall Study|Adverse Event|6|||
94376068|NCT00772577|323161723|FG001|Overall Study|Adverse Event|3|||
94376069|NCT00772577|323161722|FG000|Overall Study|Abnormal laboratory values|0|||
94376070|NCT00772577|323161723|FG001|Overall Study|Abnormal laboratory values|1|||
94376071|NCT00772577|323161722|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94376072|NCT00772577|323161723|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
94376073|NCT00772577|323161722|FG000|Overall Study|Patient withdrew consent|8|||
94376074|NCT00772577|323161723|FG001|Overall Study|Patient withdrew consent|5|||
94376075|NCT00772577|323161722|FG000|Overall Study|Lost to Follow-up|4|||
94376076|NCT00772577|323161723|FG001|Overall Study|Lost to Follow-up|3|||
94376077|NCT00772577|323161722|FG000|Overall Study|Administrative problems|2|||
94376078|NCT00772577|323161723|FG001|Overall Study|Administrative problems|1|||
94376079|NCT00772577|323161722|FG000|Overall Study|Protocol Deviation|3|||
94376080|NCT00772577|323161723|FG001|Overall Study|Protocol Deviation|2|||
94376081|NCT03211156|323161724|FG000|Overall Study|Withdrawal by Subject|0|||
94376082|NCT03211156|323161725|FG001|Overall Study|Withdrawal by Subject|2|||
94376083|NCT03211156|323161724|FG000|Overall Study|Lost to Follow-up|1|||
94376084|NCT03211156|323161725|FG001|Overall Study|Lost to Follow-up|1|||
94376085|NCT03211156|323161724|FG000|Overall Study|Adverse Event|1|||
94376086|NCT03211156|323161725|FG001|Overall Study|Adverse Event|0|||
94305406|NCT00479466|322902448|FG000|Overall Study|Lack of Efficacy|2|||
94305407|NCT00479466|322902449|FG001|Overall Study|Lack of Efficacy|0|||
94376087|NCT01567306|323161726|FG000|Overall Study|Protocol Violation|2|||
94376088|NCT01567306|323161727|FG001|Overall Study|Protocol Violation|2|||
94376089|NCT01567306|323161728|FG002|Overall Study|Protocol Violation|0|||
94376090|NCT01567306|323161729|FG003|Overall Study|Protocol Violation|3|||
94376091|NCT01567306|323161730|FG004|Overall Study|Protocol Violation|1|||
94376092|NCT01567306|323161731|FG005|Overall Study|Protocol Violation|1|||
94376093|NCT01567306|323161726|FG000|Overall Study|Change site living|1|||
94376094|NCT01567306|323161727|FG001|Overall Study|Change site living|0|||
94376095|NCT01567306|323161728|FG002|Overall Study|Change site living|0|||
94376096|NCT01567306|323161729|FG003|Overall Study|Change site living|0|||
94376097|NCT01567306|323161730|FG004|Overall Study|Change site living|0|||
94376098|NCT01567306|323161731|FG005|Overall Study|Change site living|0|||
94376099|NCT01567306|323161726|FG000|Overall Study|Adverse Event|0|||
94305408|NCT00479466|322902450|FG002|Overall Study|Lack of Efficacy|1|||
94305409|NCT00479466|322902451|FG003|Overall Study|Lack of Efficacy|0|||
94469066|NCT04266795|323507545|FG000|Overall Study|Reason not Specified|12|||
94469067|NCT04266795|323507546|FG001|Overall Study|Reason not Specified|10|||
94469068|NCT04266795|323507545|FG000|Overall Study|Participants Ongoing on Treatment|25|||
94469069|NCT04266795|323507546|FG001|Overall Study|Participants Ongoing on Treatment|23|||
94469070|NCT01210144|323507547|FG000|Overall Study|Lack of ovarian response|1|||
94469071|NCT01210144|323507548|FG001|Overall Study|Lack of ovarian response|0|||
94469072|NCT01210144|323507547|FG000|Overall Study|No fertilization|1|||
94469073|NCT01210144|323507548|FG001|Overall Study|No fertilization|0|||
94469074|NCT01210144|323507547|FG000|Overall Study|No transfer|1|||
94469075|NCT01210144|323507548|FG001|Overall Study|No transfer|0|||
94469076|NCT00386425|323507549|FG000|Overall Study|Physician Decision|3|||
94469077|NCT00386425|323507550|FG001|Overall Study|Physician Decision|0|||
94469078|NCT00386425|323507551|FG002|Overall Study|Physician Decision|0|||
94469079|NCT00386425|323507549|FG000|Overall Study|Withdrawal by Subject|0|||
94469080|NCT00386425|323507550|FG001|Overall Study|Withdrawal by Subject|1|||
94305410|NCT00479466|322902452|FG004|Overall Study|Lack of Efficacy|0|||
94305411|NCT00479466|322902453|FG005|Overall Study|Lack of Efficacy|0|||
94305412|NCT00479466|322902448|FG000|Overall Study|Lost to Follow-up|0|||
94305413|NCT00479466|322902449|FG001|Overall Study|Lost to Follow-up|1|||
94469081|NCT00386425|323507551|FG002|Overall Study|Withdrawal by Subject|0|||
94469082|NCT00630747|323507552|FG000|Overall Study|Death|1|||
94305414|NCT00479466|322902450|FG002|Overall Study|Lost to Follow-up|1|||
94305415|NCT00479466|322902451|FG003|Overall Study|Lost to Follow-up|0|||
94305416|NCT00479466|322902452|FG004|Overall Study|Lost to Follow-up|2|||
94305417|NCT00479466|322902453|FG005|Overall Study|Lost to Follow-up|2|||
94305418|NCT00479466|322902448|FG000|Overall Study|Physician Decision|2|||
94305419|NCT00479466|322902449|FG001|Overall Study|Physician Decision|1|||
94305420|NCT00479466|322902450|FG002|Overall Study|Physician Decision|1|||
94305421|NCT00479466|322902451|FG003|Overall Study|Physician Decision|0|||
94305422|NCT00479466|322902452|FG004|Overall Study|Physician Decision|0|||
94305423|NCT00479466|322902453|FG005|Overall Study|Physician Decision|0|||
94305424|NCT00479466|322902448|FG000|Overall Study|Pregnancy|0|||
94305425|NCT00479466|322902449|FG001|Overall Study|Pregnancy|0|||
94305426|NCT00479466|322902450|FG002|Overall Study|Pregnancy|0|||
94305427|NCT00479466|322902451|FG003|Overall Study|Pregnancy|0|||
94305428|NCT00479466|322902452|FG004|Overall Study|Pregnancy|1|||
94305429|NCT00479466|322902453|FG005|Overall Study|Pregnancy|0|||
94305430|NCT00479466|322902448|FG000|Overall Study|Protocol Violation|1|||
94305431|NCT00479466|322902449|FG001|Overall Study|Protocol Violation|0|||
94305432|NCT00479466|322902450|FG002|Overall Study|Protocol Violation|0|||
94305433|NCT00479466|322902451|FG003|Overall Study|Protocol Violation|0|||
94305434|NCT00479466|322902452|FG004|Overall Study|Protocol Violation|0|||
94305435|NCT00479466|322902453|FG005|Overall Study|Protocol Violation|0|||
94305436|NCT00479466|322902448|FG000|Overall Study|Withdrawal by Subject|3|||
94305437|NCT00479466|322902449|FG001|Overall Study|Withdrawal by Subject|5|||
94305438|NCT00479466|322902450|FG002|Overall Study|Withdrawal by Subject|0|||
94305439|NCT00479466|322902451|FG003|Overall Study|Withdrawal by Subject|2|||
94305440|NCT00479466|322902452|FG004|Overall Study|Withdrawal by Subject|3|||
94305441|NCT00479466|322902453|FG005|Overall Study|Withdrawal by Subject|1|||
94305442|NCT00465569|322902454|FG000|Overall Study|persistent eczema during dose escalation|1|||
94305443|NCT00465569|322902455|FG001|Overall Study|persistent eczema during dose escalation|0|||
94305444|NCT00482001|322902456|FG000|Overall Study|Protocol Violation|1|||
94305445|NCT00482001|322902457|FG001|Overall Study|Protocol Violation|1|||
94305446|NCT04786210|322902458|FG000|Overall Study|Lost to Follow-up|2|||
94305447|NCT04786210|322902458|FG000|Overall Study|Withdrawal by Subject|4|||
94305448|NCT05370157|322902463|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
94305449|NCT05370157|322902464|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
94305450|NCT05370157|322902463|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
94305451|NCT05370157|322902464|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
94305452|NCT00519623|322902477|FG000|Overall Study|Adverse Event|1|||
94305453|NCT04925570|322902478|FG000|Overall Study|Protocol Violation|24|||
94305454|NCT04925570|322902479|FG001|Overall Study|Protocol Violation|30|||
94305455|NCT04925570|322902478|FG000|Overall Study|Withdrawal by Subject|0|||
94305456|NCT04925570|322902479|FG001|Overall Study|Withdrawal by Subject|2|||
94305457|NCT02190591|322902480|FG000|Overall Study|Withdrawal by Subject|1|||
94305458|NCT02190591|322902481|FG001|Overall Study|Withdrawal by Subject|8|||
94305459|NCT02190591|322902480|FG000|Overall Study|Protocol Violation|1|||
94305460|NCT02190591|322902481|FG001|Overall Study|Protocol Violation|0|||
94305461|NCT02190591|322902480|FG000|Overall Study|did not use peanut ball as instructed|0|||
94305462|NCT02190591|322902481|FG001|Overall Study|did not use peanut ball as instructed|2|||
94469083|NCT00630747|323507552|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
94469084|NCT00630747|323507552|FG000|Overall Study|Returned to country of origin|1|||
94305463|NCT02190591|322902480|FG000|Overall Study|face presentation so she was ineligible|0|||
94305464|NCT02190591|322902481|FG001|Overall Study|face presentation so she was ineligible|1|||
94305465|NCT00857246|322902482|FG000|Induction Regimen|Adverse Event|1|||
94305466|NCT00857246|322902482|FG000|Induction Regimen|disease-related complications|1|||
94376100|NCT01567306|323161727|FG001|Overall Study|Adverse Event|0|||
94376101|NCT01567306|323161728|FG002|Overall Study|Adverse Event|0|||
94376102|NCT01567306|323161729|FG003|Overall Study|Adverse Event|2|||
94376103|NCT01567306|323161730|FG004|Overall Study|Adverse Event|4|||
94376104|NCT01567306|323161731|FG005|Overall Study|Adverse Event|1|||
94376105|NCT01567306|323161726|FG000|Overall Study|Lost to Follow-up|0|||
94376106|NCT01567306|323161727|FG001|Overall Study|Lost to Follow-up|0|||
94376107|NCT01567306|323161728|FG002|Overall Study|Lost to Follow-up|0|||
94376108|NCT01567306|323161729|FG003|Overall Study|Lost to Follow-up|0|||
94376109|NCT01567306|323161730|FG004|Overall Study|Lost to Follow-up|2|||
94376110|NCT01567306|323161731|FG005|Overall Study|Lost to Follow-up|0|||
94376111|NCT01567306|323161726|FG000|Overall Study|Withdrawal by Subject|0|||
94376112|NCT01567306|323161727|FG001|Overall Study|Withdrawal by Subject|0|||
94376113|NCT01567306|323161728|FG002|Overall Study|Withdrawal by Subject|0|||
94376114|NCT01567306|323161729|FG003|Overall Study|Withdrawal by Subject|0|||
94376115|NCT01567306|323161730|FG004|Overall Study|Withdrawal by Subject|0|||
94376116|NCT01567306|323161731|FG005|Overall Study|Withdrawal by Subject|1|||
94376117|NCT02385526|323161732|FG000|Overall Study|Withdrawal by Subject|0|||
94376118|NCT02385526|323161733|FG001|Overall Study|Withdrawal by Subject|2|||
94376119|NCT02385526|323161734|FG002|Overall Study|Withdrawal by Subject|0|||
94376120|NCT02385526|323161732|FG000|Overall Study|Lost to Follow-up|0|||
94376121|NCT02385526|323161733|FG001|Overall Study|Lost to Follow-up|1|||
94376122|NCT02385526|323161734|FG002|Overall Study|Lost to Follow-up|0|||
94376123|NCT02385526|323161732|FG000|Overall Study|Physician Decision|1|||
94376124|NCT02385526|323161733|FG001|Overall Study|Physician Decision|0|||
94376125|NCT02385526|323161734|FG002|Overall Study|Physician Decision|0|||
94376126|NCT02385526|323161732|FG000|Overall Study|Protocol Violation|1|||
94376127|NCT02385526|323161733|FG001|Overall Study|Protocol Violation|0|||
94376128|NCT02385526|323161734|FG002|Overall Study|Protocol Violation|0|||
94376129|NCT00441584|323161735|FG000|Overall Study|Lack of Efficacy|79|||
94376130|NCT00441584|323161735|FG000|Overall Study|Withdrawal by Subject|8|||
94376131|NCT00441584|323161735|FG000|Overall Study|Adverse Event|6|||
94376132|NCT00441584|323161735|FG000|Overall Study|Protocol Violation|5|||
94376133|NCT00441584|323161735|FG000|Overall Study|Lost to Follow-up|4|||
94376134|NCT00441584|323161735|FG000|Overall Study|Failure to meet eligibility criteria|3|||
94376135|NCT04133519|323161740|FG000|Overall Study|Withdrawal by Subject|5|||
94376136|NCT04133519|323161741|FG001|Overall Study|Withdrawal by Subject|4|||
94376137|NCT04133519|323161740|FG000|Overall Study|Protocol Violation|0|||
94376138|NCT04133519|323161741|FG001|Overall Study|Protocol Violation|1|||
94376139|NCT04133519|323161740|FG000|Overall Study|Never started treatment|1|||
94376140|NCT04133519|323161741|FG001|Overall Study|Never started treatment|1|||
94376141|NCT02555618|323161742|FG000|Overall Study|Sponsor's Circumstances|1|||
94376142|NCT02555618|323161743|FG001|Overall Study|Sponsor's Circumstances|0|||
94376143|NCT02063698|323161744|FG000|Overall Study|did not complete booklet for days 2-8|1|||
94376144|NCT02063698|323161745|FG001|Overall Study|did not complete booklet for days 2-8|2|||
94376145|NCT03263819|323161746|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
94376146|NCT03263819|323161747|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
94376147|NCT01689974|323161748|FG000|Overall Study|Termination of Study|5|||
94376148|NCT01689974|323161749|FG001|Overall Study|Termination of Study|5|||
94376149|NCT00770991|323161753|FG000|Overall Study|Physician Decision|2|||
94376150|NCT00770991|323161754|FG001|Overall Study|Physician Decision|0|||
94376151|NCT00770991|323161753|FG000|Overall Study|Withdrawal by Subject|1|||
94376152|NCT00770991|323161754|FG001|Overall Study|Withdrawal by Subject|0|||
94376153|NCT00770991|323161753|FG000|Overall Study|Adverse Event|1|||
94376154|NCT00770991|323161754|FG001|Overall Study|Adverse Event|5|||
94376155|NCT00770991|323161753|FG000|Overall Study|Pregnancy|1|||
94376156|NCT00770991|323161754|FG001|Overall Study|Pregnancy|0|||
94376157|NCT05266456|323161755|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
94376158|NCT05266456|323161756|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
94376159|NCT05266456|323161757|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
94376160|NCT05266456|323161758|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
94376161|NCT05266456|323161755|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
94469085|NCT01783821|323507554|FG000|Overall Study|Screen Failure|1|||
94376162|NCT05266456|323161756|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
94376163|NCT05266456|323161757|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
94376164|NCT05266456|323161758|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
94376165|NCT05266456|323161755|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
94376166|NCT05266456|323161756|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
94376167|NCT05266456|323161757|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
94376168|NCT05266456|323161758|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
94376169|NCT05266456|323161755|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
94376170|NCT05266456|323161756|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
94376171|NCT05266456|323161757|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
94469086|NCT01783821|323507555|FG001|Overall Study|Screen Failure|1|||
94469087|NCT01078298|323507556|FG000|Overall Study|Lost to Follow-up|12|||
94469088|NCT01078298|323507557|FG001|Overall Study|Lost to Follow-up|13|||
94469089|NCT01078298|323507556|FG000|Overall Study|Withdrawal by Subject|31|||
94469090|NCT01078298|323507557|FG001|Overall Study|Withdrawal by Subject|33|||
94469091|NCT01078298|323507556|FG000|Overall Study|Protocol Violation|6|||
94469092|NCT01078298|323507557|FG001|Overall Study|Protocol Violation|6|||
94469093|NCT01078298|323507556|FG000|Overall Study|Adverse Event|6|||
94469094|NCT01078298|323507557|FG001|Overall Study|Adverse Event|5|||
94469095|NCT01078298|323507556|FG000|Overall Study|Death|2|||
94469096|NCT01078298|323507557|FG001|Overall Study|Death|0|||
94469097|NCT01078298|323507556|FG000|Overall Study|Did not meet entrance criteria|0|||
94469098|NCT01078298|323507557|FG001|Overall Study|Did not meet entrance criteria|1|||
94469099|NCT01078298|323507556|FG000|Overall Study|Other|24|||
94469100|NCT01078298|323507557|FG001|Overall Study|Other|32|||
94469101|NCT03275389|323507558|FG000|Overall Study|Lost to Follow-up|10|||
94469102|NCT03275389|323507559|FG001|Overall Study|Lost to Follow-up|10|||
94469103|NCT03275389|323507560|FG002|Overall Study|Lost to Follow-up|19|||
94469104|NCT03275389|323507561|FG003|Overall Study|Lost to Follow-up|12|||
94469105|NCT03275389|323507562|FG004|Overall Study|Lost to Follow-up|11|||
94469106|NCT03275389|323507563|FG005|Overall Study|Lost to Follow-up|12|||
94469107|NCT03275389|323507564|FG006|Overall Study|Lost to Follow-up|21|||
94469108|NCT03275389|323507565|FG007|Overall Study|Lost to Follow-up|15|||
94469109|NCT03275389|323507566|FG008|Overall Study|Lost to Follow-up|12|||
94469110|NCT03275389|323507567|FG009|Overall Study|Lost to Follow-up|14|||
94469111|NCT03275389|323507558|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
94469112|NCT03275389|323507559|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
94469113|NCT03275389|323507560|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
94469114|NCT03275389|323507561|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
94469115|NCT03275389|323507562|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
94469116|NCT03275389|323507563|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
94469117|NCT03275389|323507564|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
94469118|NCT03275389|323507565|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
94469119|NCT03275389|323507566|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
94469120|NCT03275389|323507567|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
94469121|NCT03275389|323507558|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
94469122|NCT03275389|323507559|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
94469123|NCT03275389|323507560|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
94469124|NCT03275389|323507561|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
94469125|NCT03275389|323507562|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
94469126|NCT03275389|323507563|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
94469127|NCT03275389|323507564|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
94469128|NCT03275389|323507565|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
94469129|NCT03275389|323507566|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
94469130|NCT03275389|323507567|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
94469131|NCT03275389|323507558|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94469132|NCT03275389|323507559|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
94469133|NCT03275389|323507560|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94469134|NCT03275389|323507561|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
94305467|NCT00857246|322902482|FG000|Induction Regimen|Withdrawal by Subject|1|||
94305468|NCT00857246|322902482|FG000|Surgery (Curative)|disease progression|6|||
94305469|NCT00857246|322902482|FG000|ChemoRT|Withdrawal by Subject|1|||
94305470|NCT00857246|322902482|FG000|ChemoRT|Adverse Event|2|||
94305471|NCT00072189|322902483|FG000|Overall Study|Withdrawal by Subject|1|||
94469135|NCT03275389|323507562|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94469136|NCT03275389|323507563|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94305472|NCT01919411|322902484|FG000|Overall Study|Lost to Follow-up|2|||
94469137|NCT03275389|323507564|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
94469138|NCT03275389|323507565|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94469139|NCT03275389|323507566|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94469140|NCT03275389|323507567|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94469141|NCT03275389|323507558|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
94469142|NCT03275389|323507559|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
94469143|NCT03275389|323507560|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
94469144|NCT03275389|323507561|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
94469145|NCT03275389|323507562|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
94469146|NCT03275389|323507563|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
94469147|NCT03275389|323507564|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
94469148|NCT03275389|323507565|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
94469149|NCT03275389|323507566|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
94469150|NCT03275389|323507567|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
94469151|NCT03275389|323507558|FG000|Overall Study|Other|0|||
94469152|NCT03275389|323507559|FG001|Overall Study|Other|4|||
94469153|NCT03275389|323507560|FG002|Overall Study|Other|3|||
94469154|NCT03275389|323507561|FG003|Overall Study|Other|2|||
94469155|NCT03275389|323507562|FG004|Overall Study|Other|2|||
94469156|NCT03275389|323507563|FG005|Overall Study|Other|2|||
94469157|NCT03275389|323507564|FG006|Overall Study|Other|0|||
94469158|NCT03275389|323507565|FG007|Overall Study|Other|0|||
94469159|NCT03275389|323507566|FG008|Overall Study|Other|1|||
94469160|NCT03275389|323507567|FG009|Overall Study|Other|0|||
94469161|NCT00594386|323507568|FG000|Overall Study|Major protocol violation|2|||
94469162|NCT00594386|323507568|FG000|Overall Study|Lack of Efficacy|12|||
94469163|NCT00594386|323507568|FG000|Overall Study|Adverse Event|68|||
94469164|NCT00594386|323507568|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
94469165|NCT00594386|323507568|FG000|Overall Study|Subject withdrew consent|35|||
94469166|NCT00594386|323507568|FG000|Overall Study|Study ended per sponsor|115|||
94469167|NCT00594386|323507568|FG000|Overall Study|Lost to Follow-up|6|||
94469168|NCT00594386|323507568|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
94469169|NCT00594386|323507568|FG000|Overall Study|Other: Subject moved to Seattle|1|||
94305473|NCT01919411|322902485|FG001|Overall Study|Lost to Follow-up|4|||
94305474|NCT01919411|322902484|FG000|Overall Study|Physician Decision|1|||
94305475|NCT01919411|322902485|FG001|Overall Study|Physician Decision|0|||
94305476|NCT01919411|322902484|FG000|Overall Study|Protocol Violation|2|||
94305477|NCT01919411|322902485|FG001|Overall Study|Protocol Violation|1|||
94305478|NCT02426086|322902489|FG000|Overall Study|Death|33|||
94305479|NCT02426086|322902490|FG001|Overall Study|Death|36|||
94305480|NCT02426086|322902489|FG000|Overall Study|Lost to Follow-up|2|||
94305481|NCT02426086|322902490|FG001|Overall Study|Lost to Follow-up|0|||
94305482|NCT02426086|322902489|FG000|Overall Study|Study Terminated by Sponsor|5|||
94305483|NCT02426086|322902490|FG001|Overall Study|Study Terminated by Sponsor|14|||
94305484|NCT02426086|322902489|FG000|Overall Study|Withdrawal by Subject|8|||
94305485|NCT02426086|322902490|FG001|Overall Study|Withdrawal by Subject|9|||
94305486|NCT03478683|322902491|FG000|Overall Study|Adverse Event|5|||
94305487|NCT03478683|322902492|FG001|Overall Study|Adverse Event|3|||
94305488|NCT03478683|322902491|FG000|Overall Study|Lost to Follow-up|0|||
94305489|NCT03478683|322902492|FG001|Overall Study|Lost to Follow-up|5|||
94305490|NCT03478683|322902491|FG000|Overall Study|Physician Decision|1|||
94305491|NCT03478683|322902492|FG001|Overall Study|Physician Decision|3|||
94305492|NCT03478683|322902491|FG000|Overall Study|Withdrawal by Subject|7|||
94305493|NCT03478683|322902492|FG001|Overall Study|Withdrawal by Subject|7|||
94305494|NCT00231478|322902494|FG000|Overall Study|Protocol Violation|3|||
94305495|NCT00231478|322902495|FG001|Overall Study|Protocol Violation|2|||
94305496|NCT00231478|322902494|FG000|Overall Study|Refused Treatment|1|||
94305497|NCT00231478|322902495|FG001|Overall Study|Refused Treatment|1|||
94305498|NCT00231478|322902494|FG000|Overall Study|Withdrawal by Subject|1|||
94305499|NCT00231478|322902495|FG001|Overall Study|Withdrawal by Subject|0|||
94305500|NCT00231478|322902494|FG000|Overall Study|Adverse Event|0|||
94305501|NCT00231478|322902495|FG001|Overall Study|Adverse Event|1|||
94305502|NCT00231478|322902494|FG000|Overall Study|Administrative|3|||
94305503|NCT00231478|322902495|FG001|Overall Study|Administrative|2|||
94305504|NCT00853905|322902496|FG000|Overall Study|Lost to Follow-up|1|||
94305505|NCT00853905|322902497|FG001|Overall Study|Lost to Follow-up|3|||
94305506|NCT00853905|322902496|FG000|Overall Study|Withdrawal by Subject|0|||
94305507|NCT00853905|322902497|FG001|Overall Study|Withdrawal by Subject|1|||
94305508|NCT00853905|322902496|FG000|Overall Study|never had surgery|1|||
94305509|NCT00853905|322902497|FG001|Overall Study|never had surgery|0|||
94305510|NCT00393458|322902506|FG000|Overall Study|Adverse Event|35|||
94305511|NCT00393458|322902507|FG001|Overall Study|Adverse Event|24|||
94305512|NCT00393458|322902508|FG002|Overall Study|Adverse Event|40|||
94469170|NCT00594386|323507568|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
94469171|NCT00594386|323507568|FG000|Overall Study|Other: Study terminated per investigator|2|||
94469172|NCT00594386|323507568|FG000|Overall Study|Other: Sponsor closure of study|1|||
94305513|NCT00393458|322902509|FG003|Overall Study|Adverse Event|35|||
94305514|NCT00393458|322902506|FG000|Overall Study|Subject withdrew consent|27|||
94305515|NCT00393458|322902507|FG001|Overall Study|Subject withdrew consent|40|||
94305516|NCT00393458|322902508|FG002|Overall Study|Subject withdrew consent|33|||
94305517|NCT00393458|322902509|FG003|Overall Study|Subject withdrew consent|50|||
94305518|NCT00393458|322902506|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
94305519|NCT00393458|322902507|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
94305520|NCT00393458|322902508|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
94305521|NCT00393458|322902509|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
94305522|NCT00393458|322902506|FG000|Overall Study|Protocol deviation|11|||
94305523|NCT00393458|322902507|FG001|Overall Study|Protocol deviation|11|||
94305524|NCT00393458|322902508|FG002|Overall Study|Protocol deviation|11|||
94305525|NCT00393458|322902509|FG003|Overall Study|Protocol deviation|10|||
94305526|NCT00393458|322902506|FG000|Overall Study|Administrative problems|7|||
94305527|NCT00393458|322902507|FG001|Overall Study|Administrative problems|8|||
94305528|NCT00393458|322902508|FG002|Overall Study|Administrative problems|5|||
94305529|NCT00393458|322902509|FG003|Overall Study|Administrative problems|2|||
94305530|NCT00393458|322902506|FG000|Overall Study|Lost to Follow-up|5|||
94305531|NCT00393458|322902507|FG001|Overall Study|Lost to Follow-up|6|||
94305532|NCT00393458|322902508|FG002|Overall Study|Lost to Follow-up|5|||
94305533|NCT00393458|322902509|FG003|Overall Study|Lost to Follow-up|3|||
94305534|NCT00393458|322902506|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94305535|NCT00393458|322902507|FG001|Overall Study|Abnormal laboratory value(s)|1|||
94305536|NCT00393458|322902508|FG002|Overall Study|Abnormal laboratory value(s)|0|||
94305537|NCT00393458|322902509|FG003|Overall Study|Abnormal laboratory value(s)|0|||
94305538|NCT00393458|322902506|FG000|Overall Study|Death|1|||
94305539|NCT00393458|322902507|FG001|Overall Study|Death|1|||
94305540|NCT00393458|322902508|FG002|Overall Study|Death|5|||
94305541|NCT00393458|322902509|FG003|Overall Study|Death|5|||
94305542|NCT00393458|322902506|FG000|Overall Study|Abnormal test procedure result(s)|0|||
94305543|NCT00393458|322902507|FG001|Overall Study|Abnormal test procedure result(s)|1|||
94305544|NCT00393458|322902508|FG002|Overall Study|Abnormal test procedure result(s)|1|||
94305545|NCT00393458|322902509|FG003|Overall Study|Abnormal test procedure result(s)|2|||
94305546|NCT00393458|322902506|FG000|Overall Study|Subject no longer requires study drug|0|||
94305547|NCT00393458|322902507|FG001|Overall Study|Subject no longer requires study drug|1|||
94305548|NCT00393458|322902508|FG002|Overall Study|Subject no longer requires study drug|0|||
94305549|NCT00393458|322902509|FG003|Overall Study|Subject no longer requires study drug|0|||
94305550|NCT01524289|322902510|FG000|Overall Study|Lost to Follow-up|0|||
94305551|NCT01524289|322902511|FG001|Overall Study|Lost to Follow-up|1|||
94305552|NCT01524289|322902510|FG000|Overall Study|Physician Decision|1|||
94305553|NCT01524289|322902511|FG001|Overall Study|Physician Decision|0|||
94305554|NCT01524289|322902510|FG000|Overall Study|Protocol Violation|5|||
94305555|NCT01524289|322902511|FG001|Overall Study|Protocol Violation|1|||
94305556|NCT01524289|322902510|FG000|Overall Study|Withdrawal by Subject|11|||
94305557|NCT01524289|322902511|FG001|Overall Study|Withdrawal by Subject|7|||
94305558|NCT01524289|322902510|FG000|Overall Study|Adverse Event|12|||
94305559|NCT01524289|322902511|FG001|Overall Study|Adverse Event|5|||
94305560|NCT01524289|322902510|FG000|Overall Study|Did not take study medication|1|||
94305561|NCT01524289|322902511|FG001|Overall Study|Did not take study medication|0|||
94305562|NCT02104180|322902512|FG000|Overall Study|Protocol Violation|1|||
94305563|NCT02104180|322902513|FG001|Overall Study|Protocol Violation|0|||
94305564|NCT01821677|322902518|FG000|Overall Study|Adverse Event|4|||
94305565|NCT01821677|322902519|FG001|Overall Study|Adverse Event|6|||
94305566|NCT01821677|322902520|FG002|Overall Study|Adverse Event|5|||
94305567|NCT01821677|322902518|FG000|Overall Study|Physician Decision|1|||
94305568|NCT01821677|322902519|FG001|Overall Study|Physician Decision|4|||
94305569|NCT01821677|322902520|FG002|Overall Study|Physician Decision|1|||
94305570|NCT01821677|322902518|FG000|Overall Study|Non-compliance|0|||
94305571|NCT01821677|322902519|FG001|Overall Study|Non-compliance|1|||
94305572|NCT01821677|322902520|FG002|Overall Study|Non-compliance|2|||
94305573|NCT01821677|322902518|FG000|Overall Study|Lost to Follow-up|2|||
94305574|NCT01821677|322902519|FG001|Overall Study|Lost to Follow-up|1|||
94305575|NCT01821677|322902520|FG002|Overall Study|Lost to Follow-up|3|||
94305576|NCT01821677|322902518|FG000|Overall Study|Protocol Violation|0|||
94305577|NCT01821677|322902519|FG001|Overall Study|Protocol Violation|0|||
94305578|NCT01821677|322902520|FG002|Overall Study|Protocol Violation|2|||
94305579|NCT01821677|322902518|FG000|Overall Study|Withdrawal by Subject|7|||
94305580|NCT01821677|322902519|FG001|Overall Study|Withdrawal by Subject|3|||
94305581|NCT01821677|322902520|FG002|Overall Study|Withdrawal by Subject|2|||
94305582|NCT01821677|322902518|FG000|Overall Study|Other|9|||
94305583|NCT01821677|322902519|FG001|Overall Study|Other|0|||
94305584|NCT01821677|322902520|FG002|Overall Study|Other|0|||
94469173|NCT00594386|323507568|FG000|Overall Study|Other: Site terminated participation|1|||
94305585|NCT00035815|322902524|FG000|Overall Study|Withdrawal by Subject|17|||
94305586|NCT00035815|322902525|FG001|Overall Study|Withdrawal by Subject|11|||
94305587|NCT03067311|322902526|FG000|Overall Study|Lost to Follow-up|1|||
94305588|NCT03067311|322902527|FG001|Overall Study|Lost to Follow-up|1|||
94305589|NCT03067311|322902526|FG000|Overall Study|Moved away|1|||
94305590|NCT03067311|322902527|FG001|Overall Study|Moved away|1|||
94305591|NCT01507246|322902528|FG000|Overall Study|Required different surgical procedures|2|||
94305592|NCT01507246|322902529|FG001|Overall Study|Required different surgical procedures|1|||
94305593|NCT00969618|322902533|FG000|Overall Study|Adverse Event|29|||
94305594|NCT00969618|322902533|FG000|Overall Study|Entry Criteria Not Met|3|||
94305595|NCT00969618|322902533|FG000|Overall Study|Lack of Efficacy|2|||
94305596|NCT00969618|322902533|FG000|Overall Study|Lost to Follow-up|7|||
94305597|NCT00969618|322902533|FG000|Overall Study|Physician Decision|1|||
94305598|NCT00969618|322902533|FG000|Overall Study|Protocol Violation|9|||
94305599|NCT00969618|322902533|FG000|Overall Study|Withdrawal by Subject|27|||
94305600|NCT02031146|322903866|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
94305601|NCT02031146|322903867|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
94305602|NCT02031146|322903868|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
94305603|NCT02031146|322903869|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
94305604|NCT02031146|322903870|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
94305605|NCT02031146|322903871|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
94305606|NCT02031146|322903872|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
94305607|NCT05165394|322903873|FG000|Overall Study|Withdrawal by Subject|5|||
94305608|NCT05165394|322903874|FG001|Overall Study|Withdrawal by Subject|1|||
94305609|NCT05165394|322903873|FG000|Overall Study|Lost to Follow-up|1|||
94305610|NCT05165394|322903874|FG001|Overall Study|Lost to Follow-up|2|||
94305611|NCT05165394|322903873|FG000|Overall Study|Other Than Specified|0|||
94305612|NCT05165394|322903874|FG001|Overall Study|Other Than Specified|1|||
94305613|NCT00001259|322903877|FG000|Study 2|Adverse Event|0|||
94305614|NCT00001259|322903878|FG001|Study 2|Adverse Event|0|||
94305615|NCT00001259|322903879|FG002|Study 2|Adverse Event|0|||
94305616|NCT00001259|322903880|FG003|Study 2|Adverse Event|0|||
94305617|NCT00001259|322903881|FG004|Study 2|Adverse Event|2|||
94305618|NCT00001259|322903882|FG005|Study 2|Adverse Event|0|||
94305619|NCT00001259|322903883|FG006|Study 2|Adverse Event|0|||
94305620|NCT03705494|322903884|FG000|Overall Study|Lost to Follow-up|2|||
94305621|NCT03705494|322903885|FG001|Overall Study|Lost to Follow-up|1|||
94305622|NCT03705494|322903884|FG000|Overall Study|Withdrawal by Subject|5|||
94305623|NCT03705494|322903885|FG001|Overall Study|Withdrawal by Subject|2|||
94305624|NCT01266148|322903886|FG000|Overall Study|Adverse Event|2|||
94305625|NCT01266148|322903887|FG001|Overall Study|Adverse Event|0|||
94305626|NCT01266148|322903886|FG000|Overall Study|Ongoing rejection|1|||
94305627|NCT01266148|322903887|FG001|Overall Study|Ongoing rejection|0|||
94305628|NCT01266148|322903886|FG000|Overall Study|2 2R rejections|1|||
94305629|NCT01266148|322903887|FG001|Overall Study|2 2R rejections|0|||
94305630|NCT01266148|322903886|FG000|Overall Study|Death|2|||
94305631|NCT01266148|322903887|FG001|Overall Study|Death|3|||
94305632|NCT01266148|322903886|FG000|Overall Study|missing mGFR value + AE|1|||
94305633|NCT01266148|322903887|FG001|Overall Study|missing mGFR value + AE|0|||
94305634|NCT02786537|322903888|FG000|As Randomized|Adverse Event|0|||
94305635|NCT02786537|322903889|FG001|As Randomized|Adverse Event|11|||
94305636|NCT02786537|322903890|FG002|As Randomized|Adverse Event|0|||
94305637|NCT02786537|322903891|FG003|As Randomized|Adverse Event|4|||
94305638|NCT02786537|322903892|FG004|As Randomized|Adverse Event|6|||
94305639|NCT02786537|322903893|FG005|As Randomized|Adverse Event|2|||
94305640|NCT02786537|322903888|FG000|As Randomized|Lack of Efficacy|0|||
94305641|NCT02786537|322903889|FG001|As Randomized|Lack of Efficacy|0|||
94305642|NCT02786537|322903890|FG002|As Randomized|Lack of Efficacy|0|||
94305643|NCT02786537|322903891|FG003|As Randomized|Lack of Efficacy|1|||
94305644|NCT02786537|322903892|FG004|As Randomized|Lack of Efficacy|0|||
94305645|NCT02786537|322903893|FG005|As Randomized|Lack of Efficacy|0|||
94305646|NCT02786537|322903888|FG000|As Randomized|Withdrawal by Subject|1|||
94305647|NCT02786537|322903889|FG001|As Randomized|Withdrawal by Subject|2|||
94305648|NCT02786537|322903890|FG002|As Randomized|Withdrawal by Subject|0|||
94305649|NCT02786537|322903891|FG003|As Randomized|Withdrawal by Subject|1|||
94305650|NCT02786537|322903892|FG004|As Randomized|Withdrawal by Subject|1|||
94305651|NCT02786537|322903893|FG005|As Randomized|Withdrawal by Subject|0|||
94376172|NCT05266456|323161758|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
94305652|NCT02786537|322903888|FG000|As Randomized|Death|0|||
94305653|NCT02786537|322903889|FG001|As Randomized|Death|2|||
94305654|NCT02786537|322903890|FG002|As Randomized|Death|0|||
94305655|NCT02786537|322903891|FG003|As Randomized|Death|3|||
94305656|NCT02786537|322903892|FG004|As Randomized|Death|1|||
94305657|NCT02786537|322903893|FG005|As Randomized|Death|0|||
94376173|NCT05266456|323161755|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
94376174|NCT05266456|323161756|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
94305658|NCT02786537|322903888|FG000|As Randomized|Non-compliance with study drug|1|||
94305659|NCT02786537|322903889|FG001|As Randomized|Non-compliance with study drug|11|||
94305660|NCT02786537|322903890|FG002|As Randomized|Non-compliance with study drug|0|||
94305661|NCT02786537|322903891|FG003|As Randomized|Non-compliance with study drug|1|||
94305662|NCT02786537|322903892|FG004|As Randomized|Non-compliance with study drug|0|||
94305663|NCT02786537|322903893|FG005|As Randomized|Non-compliance with study drug|1|||
94305664|NCT02786537|322903888|FG000|As Randomized|Lost to treatment follow-up|4|||
94305665|NCT02786537|322903889|FG001|As Randomized|Lost to treatment follow-up|32|||
94305666|NCT02786537|322903890|FG002|As Randomized|Lost to treatment follow-up|0|||
94305667|NCT02786537|322903891|FG003|As Randomized|Lost to treatment follow-up|24|||
94305668|NCT02786537|322903892|FG004|As Randomized|Lost to treatment follow-up|4|||
94305669|NCT02786537|322903893|FG005|As Randomized|Lost to treatment follow-up|4|||
94305670|NCT02786537|322903888|FG000|As Randomized|Incarceration|0|||
94305671|NCT02786537|322903889|FG001|As Randomized|Incarceration|1|||
94305672|NCT02786537|322903890|FG002|As Randomized|Incarceration|0|||
94305673|NCT02786537|322903891|FG003|As Randomized|Incarceration|0|||
94305674|NCT02786537|322903892|FG004|As Randomized|Incarceration|0|||
94305675|NCT02786537|322903893|FG005|As Randomized|Incarceration|0|||
94305676|NCT02786537|322903888|FG000|As Randomized|Opiate Dependency Relapse|0|||
94305677|NCT02786537|322903889|FG001|As Randomized|Opiate Dependency Relapse|1|||
94305678|NCT02786537|322903890|FG002|As Randomized|Opiate Dependency Relapse|0|||
94305679|NCT02786537|322903891|FG003|As Randomized|Opiate Dependency Relapse|0|||
94305680|NCT02786537|322903892|FG004|As Randomized|Opiate Dependency Relapse|0|||
94305681|NCT02786537|322903893|FG005|As Randomized|Opiate Dependency Relapse|0|||
94305682|NCT02786537|322903888|FG000|As Randomized|HCV drugs stolen from pt|0|||
94305683|NCT02786537|322903889|FG001|As Randomized|HCV drugs stolen from pt|1|||
94305684|NCT02786537|322903890|FG002|As Randomized|HCV drugs stolen from pt|0|||
94305685|NCT02786537|322903891|FG003|As Randomized|HCV drugs stolen from pt|0|||
94305686|NCT02786537|322903892|FG004|As Randomized|HCV drugs stolen from pt|0|||
94305687|NCT02786537|322903893|FG005|As Randomized|HCV drugs stolen from pt|0|||
94305688|NCT02786537|322903888|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
94305689|NCT02786537|322903889|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
94305690|NCT02786537|322903890|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
94305691|NCT02786537|322903891|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
94305692|NCT02786537|322903892|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
94305693|NCT02786537|322903893|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
94305694|NCT02786537|322903888|FG000|As Randomized|Subject lost insurance|0|||
94305695|NCT02786537|322903889|FG001|As Randomized|Subject lost insurance|0|||
94305696|NCT02786537|322903890|FG002|As Randomized|Subject lost insurance|0|||
94305697|NCT02786537|322903891|FG003|As Randomized|Subject lost insurance|1|||
94305698|NCT02786537|322903892|FG004|As Randomized|Subject lost insurance|0|||
94305699|NCT02786537|322903893|FG005|As Randomized|Subject lost insurance|0|||
94305700|NCT02786537|322903888|FG000|As Treated|Adverse Event|0|||
94305701|NCT02786537|322903889|FG001|As Treated|Adverse Event|11|||
94305702|NCT02786537|322903890|FG002|As Treated|Adverse Event|0|||
94305703|NCT02786537|322903891|FG003|As Treated|Adverse Event|4|||
94305704|NCT02786537|322903892|FG004|As Treated|Adverse Event|6|||
94305705|NCT02786537|322903893|FG005|As Treated|Adverse Event|2|||
94305706|NCT02786537|322903888|FG000|As Treated|Death|0|||
94305707|NCT02786537|322903889|FG001|As Treated|Death|2|||
94305708|NCT02786537|322903890|FG002|As Treated|Death|0|||
94305709|NCT02786537|322903891|FG003|As Treated|Death|3|||
94305710|NCT02786537|322903892|FG004|As Treated|Death|1|||
94305711|NCT02786537|322903893|FG005|As Treated|Death|0|||
94305712|NCT02786537|322903888|FG000|As Treated|Lack of Efficacy|0|||
94305713|NCT02786537|322903889|FG001|As Treated|Lack of Efficacy|0|||
94305714|NCT02786537|322903890|FG002|As Treated|Lack of Efficacy|0|||
94305715|NCT02786537|322903891|FG003|As Treated|Lack of Efficacy|1|||
94305716|NCT02786537|322903892|FG004|As Treated|Lack of Efficacy|0|||
94305717|NCT02786537|322903893|FG005|As Treated|Lack of Efficacy|0|||
94305718|NCT02786537|322903888|FG000|As Treated|Lost to Follow-up|4|||
94305719|NCT02786537|322903889|FG001|As Treated|Lost to Follow-up|32|||
94305720|NCT02786537|322903890|FG002|As Treated|Lost to Follow-up|0|||
94305721|NCT02786537|322903891|FG003|As Treated|Lost to Follow-up|25|||
94305722|NCT02786537|322903892|FG004|As Treated|Lost to Follow-up|4|||
94305723|NCT02786537|322903893|FG005|As Treated|Lost to Follow-up|4|||
94305724|NCT02786537|322903888|FG000|As Treated|Non-compliance with study drug|1|||
94305725|NCT02786537|322903889|FG001|As Treated|Non-compliance with study drug|11|||
94305726|NCT02786537|322903890|FG002|As Treated|Non-compliance with study drug|0|||
94305727|NCT02786537|322903891|FG003|As Treated|Non-compliance with study drug|1|||
94305728|NCT02786537|322903892|FG004|As Treated|Non-compliance with study drug|0|||
94305729|NCT02786537|322903893|FG005|As Treated|Non-compliance with study drug|1|||
94305730|NCT02786537|322903888|FG000|As Treated|Lost insurance|0|||
94305731|NCT02786537|322903889|FG001|As Treated|Lost insurance|0|||
94305732|NCT02786537|322903890|FG002|As Treated|Lost insurance|0|||
94305733|NCT02786537|322903891|FG003|As Treated|Lost insurance|1|||
94305734|NCT02786537|322903892|FG004|As Treated|Lost insurance|0|||
94305735|NCT02786537|322903893|FG005|As Treated|Lost insurance|0|||
94305736|NCT02786537|322903888|FG000|As Treated|Withdrawal by Subject|1|||
94305737|NCT02786537|322903889|FG001|As Treated|Withdrawal by Subject|2|||
94305738|NCT02786537|322903890|FG002|As Treated|Withdrawal by Subject|0|||
94305739|NCT02786537|322903891|FG003|As Treated|Withdrawal by Subject|0|||
94305740|NCT02786537|322903892|FG004|As Treated|Withdrawal by Subject|1|||
94305741|NCT02786537|322903893|FG005|As Treated|Withdrawal by Subject|0|||
94469174|NCT00594386|323507568|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
94469175|NCT00594386|323507568|FG000|Overall Study|Other: Loss of drivers license|1|||
94469176|NCT04494425|323509359|FG000|Overall Study|Death|160|||
94469177|NCT04494425|323509360|FG001|Overall Study|Death|166|||
94469178|NCT04494425|323509359|FG000|Overall Study|Withdrawal by Subject|10|||
94469179|NCT04494425|323509360|FG001|Overall Study|Withdrawal by Subject|40|||
94469180|NCT04494425|323509359|FG000|Overall Study|Other|1|||
94469181|NCT04494425|323509360|FG001|Overall Study|Other|1|||
94469182|NCT04494425|323509359|FG000|Overall Study|Ongoing at the time of PCD|265|||
94469183|NCT04494425|323509360|FG001|Overall Study|Ongoing at the time of PCD|223|||
94469184|NCT01172808|323509361|FG000|Overall Study|Adverse Event|8|||
94469185|NCT01172808|323509362|FG001|Overall Study|Adverse Event|4|||
94469186|NCT01172808|323509363|FG002|Overall Study|Adverse Event|8|||
94469187|NCT01172808|323509364|FG003|Overall Study|Adverse Event|3|||
94469188|NCT01172808|323509361|FG000|Overall Study|Lack of Efficacy|1|||
94469189|NCT01172808|323509362|FG001|Overall Study|Lack of Efficacy|0|||
94469190|NCT01172808|323509363|FG002|Overall Study|Lack of Efficacy|0|||
94469191|NCT01172808|323509364|FG003|Overall Study|Lack of Efficacy|0|||
94469192|NCT01172808|323509361|FG000|Overall Study|Protocol Violation|2|||
94469193|NCT01172808|323509362|FG001|Overall Study|Protocol Violation|2|||
94469194|NCT01172808|323509363|FG002|Overall Study|Protocol Violation|2|||
94469195|NCT01172808|323509364|FG003|Overall Study|Protocol Violation|0|||
94469196|NCT01172808|323509361|FG000|Overall Study|Lost to Follow-up|0|||
94469197|NCT01172808|323509362|FG001|Overall Study|Lost to Follow-up|1|||
94469198|NCT01172808|323509363|FG002|Overall Study|Lost to Follow-up|1|||
94469199|NCT01172808|323509364|FG003|Overall Study|Lost to Follow-up|3|||
94469200|NCT01172808|323509361|FG000|Overall Study|Withdrawal by Subject|4|||
94469201|NCT01172808|323509362|FG001|Overall Study|Withdrawal by Subject|1|||
94469202|NCT01172808|323509363|FG002|Overall Study|Withdrawal by Subject|3|||
94469203|NCT01172808|323509364|FG003|Overall Study|Withdrawal by Subject|2|||
94469204|NCT01172808|323509361|FG000|Overall Study|Other|6|||
94469205|NCT01172808|323509362|FG001|Overall Study|Other|5|||
94469206|NCT01172808|323509363|FG002|Overall Study|Other|9|||
94469207|NCT01172808|323509364|FG003|Overall Study|Other|7|||
94469208|NCT01066793|323509367|FG000|Overall Study|Death|4|||
94469209|NCT01066793|323509368|FG001|Overall Study|Death|1|||
94469210|NCT01066793|323509369|FG002|Overall Study|Death|1|||
94469211|NCT01066793|323509370|FG003|Overall Study|Death|0|||
94469212|NCT01066793|323509371|FG004|Overall Study|Death|0|||
94469213|NCT01066793|323509372|FG005|Overall Study|Death|0|||
94469214|NCT01066793|323509367|FG000|Overall Study|Lack of Efficacy|2|||
94469215|NCT01066793|323509368|FG001|Overall Study|Lack of Efficacy|1|||
94469216|NCT01066793|323509369|FG002|Overall Study|Lack of Efficacy|0|||
94305742|NCT02786537|322903888|FG000|As Treated|Incarceration|0|||
94305743|NCT02786537|322903889|FG001|As Treated|Incarceration|1|||
94305744|NCT02786537|322903890|FG002|As Treated|Incarceration|0|||
94305745|NCT02786537|322903891|FG003|As Treated|Incarceration|0|||
94305746|NCT02786537|322903892|FG004|As Treated|Incarceration|0|||
94305747|NCT02786537|322903893|FG005|As Treated|Incarceration|0|||
94305748|NCT02786537|322903888|FG000|As Treated|Opiate dependency relapse|0|||
94305749|NCT02786537|322903889|FG001|As Treated|Opiate dependency relapse|1|||
94305750|NCT02786537|322903890|FG002|As Treated|Opiate dependency relapse|0|||
94305751|NCT02786537|322903891|FG003|As Treated|Opiate dependency relapse|0|||
94305752|NCT02786537|322903892|FG004|As Treated|Opiate dependency relapse|0|||
94305753|NCT02786537|322903893|FG005|As Treated|Opiate dependency relapse|0|||
94305754|NCT02786537|322903888|FG000|As Treated|Drugs stolen from patient|0|||
94305755|NCT02786537|322903889|FG001|As Treated|Drugs stolen from patient|1|||
94305756|NCT02786537|322903890|FG002|As Treated|Drugs stolen from patient|0|||
94305757|NCT02786537|322903891|FG003|As Treated|Drugs stolen from patient|0|||
94305758|NCT02786537|322903892|FG004|As Treated|Drugs stolen from patient|0|||
94305759|NCT02786537|322903893|FG005|As Treated|Drugs stolen from patient|0|||
94305760|NCT02786537|322903888|FG000|As Treated|Advised to stop tx after loss of meds|0|||
94305761|NCT02786537|322903889|FG001|As Treated|Advised to stop tx after loss of meds|1|||
94305762|NCT02786537|322903890|FG002|As Treated|Advised to stop tx after loss of meds|0|||
94305763|NCT02786537|322903891|FG003|As Treated|Advised to stop tx after loss of meds|0|||
94305764|NCT02786537|322903892|FG004|As Treated|Advised to stop tx after loss of meds|0|||
94305765|NCT02786537|322903893|FG005|As Treated|Advised to stop tx after loss of meds|0|||
94469217|NCT01066793|323509370|FG003|Overall Study|Lack of Efficacy|0|||
94469218|NCT01066793|323509371|FG004|Overall Study|Lack of Efficacy|0|||
94469219|NCT01066793|323509372|FG005|Overall Study|Lack of Efficacy|0|||
94469220|NCT01066793|323509367|FG000|Overall Study|Lost to Follow-up|180|||
94469221|NCT01066793|323509368|FG001|Overall Study|Lost to Follow-up|39|||
94469222|NCT01066793|323509369|FG002|Overall Study|Lost to Follow-up|82|||
94469223|NCT01066793|323509370|FG003|Overall Study|Lost to Follow-up|16|||
94469224|NCT01066793|323509371|FG004|Overall Study|Lost to Follow-up|0|||
94469225|NCT01066793|323509372|FG005|Overall Study|Lost to Follow-up|1|||
94469226|NCT01066793|323509367|FG000|Overall Study|Physician Decision|3|||
94469227|NCT01066793|323509368|FG001|Overall Study|Physician Decision|0|||
94469228|NCT01066793|323509369|FG002|Overall Study|Physician Decision|0|||
94469229|NCT01066793|323509370|FG003|Overall Study|Physician Decision|0|||
94376175|NCT05266456|323161757|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
94376176|NCT05266456|323161758|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
94376177|NCT01580020|323161760|FG000|Overall Study|Lack of Efficacy|0|||
94376178|NCT01580020|323161761|FG001|Overall Study|Lack of Efficacy|5|||
94376179|NCT01580020|323161762|FG002|Overall Study|Lack of Efficacy|0|||
94376180|NCT01580020|323161763|FG003|Overall Study|Lack of Efficacy|1|||
94376181|NCT01580020|323161760|FG000|Overall Study|Withdrawal by Subject|0|||
94376182|NCT01580020|323161761|FG001|Overall Study|Withdrawal by Subject|1|||
94376183|NCT01580020|323161762|FG002|Overall Study|Withdrawal by Subject|1|||
94376184|NCT01580020|323161763|FG003|Overall Study|Withdrawal by Subject|0|||
94376185|NCT01580020|323161760|FG000|Overall Study|Adverse Event|1|||
94376186|NCT01580020|323161761|FG001|Overall Study|Adverse Event|1|||
94376187|NCT01580020|323161762|FG002|Overall Study|Adverse Event|1|||
94376188|NCT01580020|323161763|FG003|Overall Study|Adverse Event|1|||
94376189|NCT01580020|323161760|FG000|Overall Study|Administrative Problems|0|||
94376190|NCT01580020|323161761|FG001|Overall Study|Administrative Problems|0|||
94376191|NCT01580020|323161762|FG002|Overall Study|Administrative Problems|1|||
94376192|NCT01580020|323161763|FG003|Overall Study|Administrative Problems|0|||
94376193|NCT01580020|323161760|FG000|Overall Study|Lost to Follow-up|0|||
94376194|NCT01580020|323161761|FG001|Overall Study|Lost to Follow-up|0|||
94376195|NCT01580020|323161762|FG002|Overall Study|Lost to Follow-up|1|||
94376196|NCT01580020|323161763|FG003|Overall Study|Lost to Follow-up|0|||
94376197|NCT01716754|323161764|FG000|Overall Study|Death|0|||
94376198|NCT01716754|323161765|FG001|Overall Study|Death|0|||
94376199|NCT01716754|323161766|FG002|Overall Study|Death|0|||
94376200|NCT01716754|323161767|FG003|Overall Study|Death|1|||
94376201|NCT01716754|323161764|FG000|Overall Study|Protocol deviation|0|||
94376202|NCT01716754|323161765|FG001|Overall Study|Protocol deviation|2|||
94376203|NCT01716754|323161766|FG002|Overall Study|Protocol deviation|7|||
94376204|NCT01716754|323161767|FG003|Overall Study|Protocol deviation|2|||
94376205|NCT01716754|323161764|FG000|Overall Study|Non-compliance with study treatment|0|||
94376206|NCT01716754|323161765|FG001|Overall Study|Non-compliance with study treatment|0|||
94376207|NCT01716754|323161766|FG002|Overall Study|Non-compliance with study treatment|1|||
94376208|NCT01716754|323161767|FG003|Overall Study|Non-compliance with study treatment|0|||
94376209|NCT01716754|323161764|FG000|Overall Study|Physician Decision|1|||
94376210|NCT01716754|323161765|FG001|Overall Study|Physician Decision|0|||
94376211|NCT01716754|323161766|FG002|Overall Study|Physician Decision|0|||
94376212|NCT01716754|323161767|FG003|Overall Study|Physician Decision|0|||
94376213|NCT01716754|323161764|FG000|Overall Study|Lost to Follow-up|1|||
94376214|NCT01716754|323161765|FG001|Overall Study|Lost to Follow-up|0|||
94376215|NCT01716754|323161766|FG002|Overall Study|Lost to Follow-up|0|||
94376216|NCT01716754|323161767|FG003|Overall Study|Lost to Follow-up|1|||
94376217|NCT01716754|323161764|FG000|Overall Study|Adverse Event|4|||
94376218|NCT01716754|323161765|FG001|Overall Study|Adverse Event|2|||
94376219|NCT01716754|323161766|FG002|Overall Study|Adverse Event|2|||
94376220|NCT01716754|323161767|FG003|Overall Study|Adverse Event|1|||
94376221|NCT01716754|323161764|FG000|Overall Study|Withdrawal by Subject|5|||
94376222|NCT01716754|323161765|FG001|Overall Study|Withdrawal by Subject|0|||
94376223|NCT01716754|323161766|FG002|Overall Study|Withdrawal by Subject|4|||
94376224|NCT01716754|323161767|FG003|Overall Study|Withdrawal by Subject|3|||
94376225|NCT03811249|323161768|FG000|Overall Study|Withdrawal by Subject|44|||
94376226|NCT03811249|323161768|FG000|Overall Study|Missed Visit|24|||
94376227|NCT01102777|323161769|FG000|Overall Study|Death|2|||
94376228|NCT01102777|323161770|FG001|Overall Study|Death|6|||
94376229|NCT01102777|323161769|FG000|Overall Study|Lost to Follow-up|7|||
94376230|NCT01102777|323161770|FG001|Overall Study|Lost to Follow-up|10|||
94376231|NCT00706706|323161771|FG000|Overall Study|Death|53|||
94376232|NCT00706706|323161771|FG000|Overall Study|Lost to Follow-up|7|||
94376233|NCT00706706|323161771|FG000|Overall Study|Study endpoint had reached|45|||
94376234|NCT00593333|323161772|FG000|Overall Study|Lost to Follow-up|10|||
94376235|NCT00593333|323161773|FG001|Overall Study|Lost to Follow-up|11|||
94376236|NCT00210626|323161775|FG000|Overall Study|Adverse Event|1|||
94376237|NCT00210626|323161776|FG001|Overall Study|Adverse Event|2|||
94469230|NCT01066793|323509371|FG004|Overall Study|Physician Decision|0|||
94376238|NCT00210626|323161775|FG000|Overall Study|Protocol Violation|1|||
94376239|NCT00210626|323161776|FG001|Overall Study|Protocol Violation|5|||
94376240|NCT00210626|323161775|FG000|Overall Study|Lost to Follow-up|11|||
94376241|NCT00210626|323161776|FG001|Overall Study|Lost to Follow-up|11|||
94376242|NCT00210626|323161775|FG000|Overall Study|Death|1|||
94376243|NCT00210626|323161776|FG001|Overall Study|Death|0|||
94376244|NCT00210626|323161775|FG000|Overall Study|Withdrawal by Subject|29|||
94376245|NCT00210626|323161776|FG001|Overall Study|Withdrawal by Subject|20|||
94376246|NCT00210626|323161775|FG000|Overall Study|Physician Decision|0|||
94376247|NCT00210626|323161776|FG001|Overall Study|Physician Decision|2|||
94376248|NCT00210626|323161775|FG000|Overall Study|Sponser Request|1|||
94376249|NCT00210626|323161776|FG001|Overall Study|Sponser Request|0|||
94376250|NCT00210626|323161775|FG000|Overall Study|Other|4|||
94376251|NCT00210626|323161776|FG001|Overall Study|Other|5|||
94376252|NCT00003782|323161777|FG000|Overall Study|No follow up data|30|||
94376253|NCT00003782|323161778|FG001|Overall Study|No follow up data|31|||
94305766|NCT03056287|322903903|FG000|Overall Study|Withdrawal by Subject|0|||
94305767|NCT03056287|322903904|FG001|Overall Study|Withdrawal by Subject|1|||
94305768|NCT03056287|322903905|FG002|Overall Study|Withdrawal by Subject|0|||
94305769|NCT03056287|322903906|FG003|Overall Study|Withdrawal by Subject|0|||
94305770|NCT03056287|322903903|FG000|Overall Study|move out of area|0|||
94305771|NCT03056287|322903904|FG001|Overall Study|move out of area|0|||
94305772|NCT03056287|322903905|FG002|Overall Study|move out of area|1|||
94305773|NCT03056287|322903906|FG003|Overall Study|move out of area|1|||
94305774|NCT02442349|322903913|FG000|Overall Study|Death|95|||
94305775|NCT02442349|322903913|FG000|Overall Study|Withdrawal by Subject|27|||
94305776|NCT02442349|322903913|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
94305777|NCT02442349|322903913|FG000|Overall Study|Lost to Follow-up|1|||
94305778|NCT01121406|322903920|FG000|Overall Study|Progressive disease RECIST|44|||
94305779|NCT01121406|322903921|FG001|Overall Study|Progressive disease RECIST|28|||
94305780|NCT01121406|322903920|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
94305781|NCT01121406|322903921|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
94305782|NCT01121406|322903920|FG000|Overall Study|Other AE|3|||
94305783|NCT01121406|322903921|FG001|Overall Study|Other AE|10|||
94305784|NCT01121406|322903920|FG000|Overall Study|Non-compliant with protocol|0|||
94305785|NCT01121406|322903921|FG001|Overall Study|Non-compliant with protocol|2|||
94305786|NCT01121406|322903920|FG000|Overall Study|Lost to Follow-up|0|||
94305787|NCT01121406|322903921|FG001|Overall Study|Lost to Follow-up|1|||
94305788|NCT01121406|322903920|FG000|Overall Study|Refused continuation of study med.|1|||
94305789|NCT01121406|322903921|FG001|Overall Study|Refused continuation of study med.|2|||
94305790|NCT01121406|322903920|FG000|Overall Study|Reason other than specified above|2|||
94305791|NCT01121406|322903921|FG001|Overall Study|Reason other than specified above|6|||
94305792|NCT01121406|322903920|FG000|Overall Study|Not treated|1|||
94305793|NCT01121406|322903921|FG001|Overall Study|Not treated|0|||
94305794|NCT00440401|322903929|FG000|Overall Study|Adverse Event|2|||
94305795|NCT00440401|322903930|FG001|Overall Study|Adverse Event|1|||
94376254|NCT00003782|323161779|FG002|Overall Study|No follow up data|26|||
94376255|NCT01890707|323161780|FG000|Overall Study|Lost to Follow-up|1|||
94376256|NCT01890707|323161781|FG001|Overall Study|Lost to Follow-up|1|||
94376257|NCT03322462|323163297|FG000|Overall Study|Technical difficulties|2|||
94376258|NCT03322462|323163297|FG000|Overall Study|Other|1|||
94376259|NCT02034799|323163301|FG000|Overall Study|Withdrawal by Subject|0|||
94376260|NCT02034799|323163302|FG001|Overall Study|Withdrawal by Subject|2|||
94376261|NCT02034799|323163301|FG000|Overall Study|Lost to Follow-up|0|||
94376262|NCT02034799|323163302|FG001|Overall Study|Lost to Follow-up|1|||
94376263|NCT02034799|323163301|FG000|Overall Study|Death|2|||
94376264|NCT02034799|323163302|FG001|Overall Study|Death|1|||
94376265|NCT00720798|323163303|FG000|Overall Study|Adverse Event|304|||
94376266|NCT00720798|323163303|FG000|Overall Study|Death|39|||
94376267|NCT00720798|323163303|FG000|Overall Study|Insufficient Therapeutic Response|129|||
94376268|NCT00720798|323163303|FG000|Overall Study|Protocol Violation|4|||
94376269|NCT00720798|323163303|FG000|Overall Study|Refused Treatment|151|||
94376270|NCT00720798|323163303|FG000|Overall Study|Failure to Return|46|||
94376271|NCT00720798|323163303|FG000|Overall Study|Reason not Specified|83|||
94376272|NCT03031899|323163304|FG000|Overall Study|Protocol Violation|1|||
94376273|NCT03031899|323163304|FG000|Overall Study|lesion disappeared after stopping habit|1|||
94376274|NCT01466686|323163318|FG000|Overall Study|Withdrawal by Subject|1|||
94376275|NCT00658320|323163321|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
94376276|NCT00658320|323163322|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
94376277|NCT00658320|323163321|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
94376278|NCT00658320|323163322|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
94376279|NCT00658320|323163321|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
94376280|NCT00658320|323163322|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
94376281|NCT00658320|323163321|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
94376282|NCT00658320|323163322|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
94376283|NCT01405950|323163323|FG000|Overall Study|Withdrawal by Subject|1|||
94376284|NCT01405950|323163324|FG001|Overall Study|Withdrawal by Subject|0|||
94376285|NCT01405950|323163325|FG002|Overall Study|Withdrawal by Subject|0|||
94376286|NCT01405950|323163326|FG003|Overall Study|Withdrawal by Subject|0|||
94376287|NCT01724359|323163328|FG000|Overall Study|Adverse Event|10|||
94376288|NCT01724359|323163328|FG000|Overall Study|Death|1|||
94376289|NCT01724359|323163328|FG000|Overall Study|Other|20|||
94376290|NCT01186978|323163338|FG000|Overall Study|Withdrawal by Subject|1|||
94376291|NCT00947856|323163339|FG000|Treatment Period|Progressive Disease|33|||
94376292|NCT00947856|323163340|FG001|Treatment Period|Progressive Disease|12|||
94376293|NCT00947856|323163339|FG000|Treatment Period|Adverse Event|15|||
94376294|NCT00947856|323163340|FG001|Treatment Period|Adverse Event|9|||
94376295|NCT00947856|323163339|FG000|Treatment Period|Physician Decision|14|||
94376296|NCT00947856|323163340|FG001|Treatment Period|Physician Decision|6|||
94305796|NCT00440401|322903929|FG000|Overall Study|Other|2|||
94305797|NCT00440401|322903930|FG001|Overall Study|Other|5|||
94305798|NCT02286960|322903931|FG000|Overall Study|Lost to Follow-up|3|||
94469231|NCT01066793|323509372|FG005|Overall Study|Physician Decision|0|||
94469232|NCT01066793|323509367|FG000|Overall Study|Protocol Violation|3|||
94469233|NCT01066793|323509368|FG001|Overall Study|Protocol Violation|2|||
94469234|NCT01066793|323509369|FG002|Overall Study|Protocol Violation|2|||
94469235|NCT01066793|323509370|FG003|Overall Study|Protocol Violation|0|||
94469236|NCT01066793|323509371|FG004|Overall Study|Protocol Violation|0|||
94469237|NCT01066793|323509372|FG005|Overall Study|Protocol Violation|0|||
94469238|NCT01066793|323509367|FG000|Overall Study|Withdrawal by Subject|7|||
94469239|NCT01066793|323509368|FG001|Overall Study|Withdrawal by Subject|4|||
94469240|NCT01066793|323509369|FG002|Overall Study|Withdrawal by Subject|1|||
94469241|NCT01066793|323509370|FG003|Overall Study|Withdrawal by Subject|0|||
94469242|NCT01066793|323509371|FG004|Overall Study|Withdrawal by Subject|0|||
94469243|NCT01066793|323509372|FG005|Overall Study|Withdrawal by Subject|0|||
94469244|NCT01066793|323509367|FG000|Overall Study|Early Termination|3|||
94469245|NCT01066793|323509368|FG001|Overall Study|Early Termination|0|||
94469246|NCT01066793|323509369|FG002|Overall Study|Early Termination|0|||
94469247|NCT01066793|323509370|FG003|Overall Study|Early Termination|0|||
94469248|NCT01066793|323509371|FG004|Overall Study|Early Termination|0|||
94469249|NCT01066793|323509372|FG005|Overall Study|Early Termination|0|||
94469250|NCT01066793|323509367|FG000|Overall Study|Lab test not done|7|||
94469251|NCT01066793|323509368|FG001|Overall Study|Lab test not done|0|||
94469252|NCT01066793|323509369|FG002|Overall Study|Lab test not done|0|||
94469253|NCT01066793|323509370|FG003|Overall Study|Lab test not done|1|||
94469254|NCT01066793|323509371|FG004|Overall Study|Lab test not done|0|||
94469255|NCT01066793|323509372|FG005|Overall Study|Lab test not done|0|||
94469256|NCT01066793|323509367|FG000|Overall Study|Miscellaneous|4|||
94469257|NCT01066793|323509368|FG001|Overall Study|Miscellaneous|5|||
94469258|NCT01066793|323509369|FG002|Overall Study|Miscellaneous|6|||
94469259|NCT01066793|323509370|FG003|Overall Study|Miscellaneous|0|||
94469260|NCT01066793|323509371|FG004|Overall Study|Miscellaneous|0|||
94469261|NCT01066793|323509372|FG005|Overall Study|Miscellaneous|0|||
94469262|NCT01066793|323509367|FG000|Overall Study|Non-responders|104|||
94469263|NCT01066793|323509368|FG001|Overall Study|Non-responders|5|||
94469264|NCT01066793|323509369|FG002|Overall Study|Non-responders|11|||
94469265|NCT01066793|323509370|FG003|Overall Study|Non-responders|25|||
94469266|NCT01066793|323509371|FG004|Overall Study|Non-responders|0|||
94469267|NCT01066793|323509372|FG005|Overall Study|Non-responders|0|||
94469268|NCT01066793|323509367|FG000|Overall Study|Other|15|||
94469269|NCT01066793|323509368|FG001|Overall Study|Other|5|||
94469270|NCT01066793|323509369|FG002|Overall Study|Other|6|||
94469271|NCT01066793|323509370|FG003|Overall Study|Other|2|||
94469272|NCT01066793|323509371|FG004|Overall Study|Other|0|||
94469273|NCT01066793|323509372|FG005|Overall Study|Other|0|||
94469274|NCT01066793|323509367|FG000|Overall Study|Relapse|20|||
94469275|NCT01066793|323509368|FG001|Overall Study|Relapse|8|||
94469276|NCT01066793|323509369|FG002|Overall Study|Relapse|2|||
94469277|NCT01066793|323509370|FG003|Overall Study|Relapse|3|||
94469278|NCT01066793|323509371|FG004|Overall Study|Relapse|0|||
94469279|NCT01066793|323509372|FG005|Overall Study|Relapse|0|||
94469280|NCT01066793|323509367|FG000|Overall Study|Result Not Available|1|||
94469281|NCT01066793|323509368|FG001|Overall Study|Result Not Available|0|||
94469282|NCT01066793|323509369|FG002|Overall Study|Result Not Available|0|||
94469283|NCT01066793|323509370|FG003|Overall Study|Result Not Available|0|||
94469284|NCT01066793|323509371|FG004|Overall Study|Result Not Available|0|||
94469285|NCT01066793|323509372|FG005|Overall Study|Result Not Available|0|||
94469286|NCT01066793|323509367|FG000|Overall Study|Treatment Interrupted|1|||
94469287|NCT01066793|323509368|FG001|Overall Study|Treatment Interrupted|1|||
94469288|NCT01066793|323509369|FG002|Overall Study|Treatment Interrupted|0|||
94305799|NCT02286960|322903932|FG001|Overall Study|Lost to Follow-up|3|||
94469289|NCT01066793|323509370|FG003|Overall Study|Treatment Interrupted|0|||
94469290|NCT01066793|323509371|FG004|Overall Study|Treatment Interrupted|0|||
94469291|NCT01066793|323509372|FG005|Overall Study|Treatment Interrupted|0|||
94469292|NCT01066793|323509367|FG000|Overall Study|Treatment Never Started|18|||
94469293|NCT01066793|323509368|FG001|Overall Study|Treatment Never Started|5|||
94469294|NCT01066793|323509369|FG002|Overall Study|Treatment Never Started|4|||
94469295|NCT01066793|323509370|FG003|Overall Study|Treatment Never Started|1|||
94305800|NCT01925703|322903933|FG000|Overall Study|Physician Decision|1|||
94305801|NCT01925703|322903933|FG000|Overall Study|Lost to Follow-up|2|||
94469296|NCT01066793|323509371|FG004|Overall Study|Treatment Never Started|0|||
94469297|NCT01066793|323509372|FG005|Overall Study|Treatment Never Started|0|||
94469298|NCT01066793|323509367|FG000|Overall Study|Treatment Stopped|2|||
94469299|NCT01066793|323509368|FG001|Overall Study|Treatment Stopped|1|||
94469300|NCT01066793|323509369|FG002|Overall Study|Treatment Stopped|0|||
94469301|NCT01066793|323509370|FG003|Overall Study|Treatment Stopped|1|||
94469302|NCT01066793|323509371|FG004|Overall Study|Treatment Stopped|0|||
94305802|NCT01925703|322903933|FG000|Overall Study|Discharge prior to full iron repletion|1|||
94469303|NCT01066793|323509372|FG005|Overall Study|Treatment Stopped|0|||
94469304|NCT01911793|323509373|FG000|Overall Study|Physician Decision|1|||
94469305|NCT01911793|323509374|FG001|Overall Study|Physician Decision|5|||
94469306|NCT01313221|323509375|FG000|Overall Study|Protocol Violation|0|||
94376297|NCT00947856|323163339|FG000|Treatment Period|Study Stopped by Sponsor|4|||
94376298|NCT00947856|323163340|FG001|Treatment Period|Study Stopped by Sponsor|4|||
94376299|NCT00947856|323163339|FG000|Treatment Period|Withdrawal by Subject|12|||
94376300|NCT00947856|323163340|FG001|Treatment Period|Withdrawal by Subject|1|||
94376301|NCT00947856|323163339|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
94376302|NCT00947856|323163340|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
94376303|NCT00947856|323163339|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
94376304|NCT00947856|323163340|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
94376305|NCT00947856|323163339|FG000|Follow-up Period|Lost to Follow-up|7|||
94376306|NCT00947856|323163340|FG001|Follow-up Period|Lost to Follow-up|0|||
94376307|NCT00947856|323163339|FG000|Follow-up Period|Patient unavailable for site visits|1|||
94376308|NCT00947856|323163340|FG001|Follow-up Period|Patient unavailable for site visits|0|||
94376309|NCT00947856|323163339|FG000|Follow-up Period|Withdrawal by Subject|1|||
94376310|NCT00947856|323163340|FG001|Follow-up Period|Withdrawal by Subject|0|||
94376311|NCT00543439|323163344|FG000|Period 1|Adverse Event|0|||
94376312|NCT00543439|323163345|FG001|Period 1|Adverse Event|2|||
94376313|NCT00543439|323163346|FG002|Period 1|Adverse Event|1|||
94376314|NCT00543439|323163344|FG000|Period 1|Withdrawal by Subject|1|||
94376315|NCT00543439|323163345|FG001|Period 1|Withdrawal by Subject|1|||
94376316|NCT00543439|323163346|FG002|Period 1|Withdrawal by Subject|0|||
94376317|NCT00543439|323163344|FG000|Period 1|Physician Decision|0|||
94376318|NCT00543439|323163345|FG001|Period 1|Physician Decision|0|||
94376319|NCT00543439|323163346|FG002|Period 1|Physician Decision|1|||
94376320|NCT00543439|323163344|FG000|Period 2|Protocol Violation|1|||
94376321|NCT00543439|323163345|FG001|Period 2|Protocol Violation|0|||
94376322|NCT00543439|323163346|FG002|Period 2|Protocol Violation|1|||
94376323|NCT00543439|323163344|FG000|Period 2|Adverse Event|0|||
94376324|NCT00543439|323163345|FG001|Period 2|Adverse Event|1|||
94376325|NCT00543439|323163346|FG002|Period 2|Adverse Event|1|||
94376326|NCT01214330|323163347|FG000|Overall Study|Withdrawal by Subject|2|||
94376327|NCT01214330|323163347|FG000|Overall Study|Withdrawal by Subject|2|||
94376328|NCT00467584|323163348|FG000|Overall Study|Withdrawal by Subject|4|||
94376329|NCT00467584|323163349|FG001|Overall Study|Withdrawal by Subject|5|||
94376330|NCT00467584|323163350|FG002|Overall Study|Withdrawal by Subject|1|||
94376331|NCT00566709|323163353|FG000|Overall Study|Protocol Violation|5|||
94376332|NCT00566709|323163354|FG001|Overall Study|Protocol Violation|0|||
94376333|NCT04000009|323163359|FG000|Overall Study|Adverse Event|13|||
94376334|NCT04000009|323163359|FG000|Overall Study|Lack of Efficacy|7|||
94376335|NCT04000009|323163359|FG000|Overall Study|Lost to Follow-up|8|||
94376336|NCT04000009|323163359|FG000|Overall Study|Noncompliance with study drug|4|||
94376337|NCT04000009|323163359|FG000|Overall Study|Physician Decision|1|||
94305803|NCT01938625|322903934|FG000|Overall Study|Withdrawal by Subject|0|||
94305804|NCT01938625|322903935|FG001|Overall Study|Withdrawal by Subject|1|||
94305805|NCT01938625|322903934|FG000|Overall Study|Adverse Event|0|||
94305806|NCT01938625|322903935|FG001|Overall Study|Adverse Event|1|||
94305807|NCT01966731|322903936|FG000|Overall Study|Death|2|||
94305808|NCT01966731|322903936|FG000|Overall Study|Lost to Follow-up|1|||
94376338|NCT04000009|323163359|FG000|Overall Study|Use of prohibited medication|3|||
94376339|NCT04000009|323163359|FG000|Overall Study|Pregnancy|1|||
94376340|NCT04000009|323163359|FG000|Overall Study|Withdrawal by Subject|22|||
94376341|NCT04000009|323163359|FG000|Overall Study|Study terminated by sponsor|98|||
94376342|NCT04000009|323163359|FG000|Overall Study|Not further specified|8|||
94376343|NCT02668302|323163368|FG000|Overall Study|Withdrawal by Subject|1|||
94376344|NCT02668302|323163369|FG001|Overall Study|Withdrawal by Subject|0|||
94376345|NCT01512979|323163376|FG000|Overall Study|Adverse Event|2|||
94376346|NCT01512979|323163377|FG001|Overall Study|Adverse Event|2|||
94376347|NCT01512979|323163376|FG000|Overall Study|Protocol Violation|1|||
94376348|NCT01512979|323163377|FG001|Overall Study|Protocol Violation|4|||
94376349|NCT01512979|323163376|FG000|Overall Study|Lost to Follow-up|2|||
94376350|NCT01512979|323163377|FG001|Overall Study|Lost to Follow-up|5|||
94376351|NCT01512979|323163376|FG000|Overall Study|Withdrawal by Subject|1|||
94376352|NCT01512979|323163377|FG001|Overall Study|Withdrawal by Subject|2|||
94305809|NCT01966731|322903936|FG000|Overall Study|Physician Decision|2|||
94305810|NCT01966731|322903936|FG000|Overall Study|Follow up is not complete|600|||
94305811|NCT01966731|322903936|FG000|Overall Study|Screening Failure|29|||
94376353|NCT01512979|323163376|FG000|Overall Study|Reason other than stated above|13|||
94376354|NCT01512979|323163377|FG001|Overall Study|Reason other than stated above|9|||
94376355|NCT01533428|323163382|FG000|Overall Study|Adverse Event|0|||
94376356|NCT01533428|323163383|FG001|Overall Study|Adverse Event|1|||
94376357|NCT01533428|323163382|FG000|Overall Study|Lost to Follow-up|2|||
94376358|NCT01533428|323163383|FG001|Overall Study|Lost to Follow-up|1|||
94376359|NCT01533428|323163382|FG000|Overall Study|Withdrawal by Subject|7|||
94376360|NCT01533428|323163383|FG001|Overall Study|Withdrawal by Subject|6|||
94376361|NCT01078090|323163386|FG000|Overall Study|Lost to Follow-up|2363|||
94376362|NCT01078090|323163386|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
94305812|NCT01966731|322903936|FG000|Overall Study|Found to be ineligible|1|||
94305813|NCT02088034|322903937|FG000|Overall Study|Lost to Follow-up|1|||
94376363|NCT01078090|323163386|FG000|Overall Study|Lack of Efficacy|1193|||
94376364|NCT01078090|323163386|FG000|Overall Study|ADR and lack of efficacy|61|||
94376365|NCT01078090|323163386|FG000|Overall Study|Other|523|||
94376366|NCT04535583|323163387|FG000|Overall Study|Lost to Follow-up|1|||
94376367|NCT04535583|323163387|FG000|Overall Study|Physician Decision|1|||
94376368|NCT04535583|323163387|FG000|Overall Study|Withdrawal by Subject|1|||
94376369|NCT00745251|323163388|FG000|Overall Study|Adverse Event|1|||
94376370|NCT00745251|323163389|FG001|Overall Study|Adverse Event|2|||
94376371|NCT00745251|323163388|FG000|Overall Study|Withdrawal by Subject|1|||
94376372|NCT00745251|323163389|FG001|Overall Study|Withdrawal by Subject|1|||
94376373|NCT02669264|323163390|FG000|Overall Study|Death|5|||
94376374|NCT02669264|323163391|FG001|Overall Study|Death|5|||
94376375|NCT02669264|323163392|FG002|Overall Study|Death|3|||
94376376|NCT02669264|323163393|FG003|Overall Study|Death|3|||
94376377|NCT02669264|323163394|FG004|Overall Study|Death|3|||
94376378|NCT02669264|323163395|FG005|Overall Study|Death|6|||
94376379|NCT02669264|323163396|FG006|Overall Study|Death|3|||
94376380|NCT02669264|323163390|FG000|Overall Study|Withdrawal by Subject|0|||
94376381|NCT02669264|323163391|FG001|Overall Study|Withdrawal by Subject|1|||
94376382|NCT02669264|323163392|FG002|Overall Study|Withdrawal by Subject|0|||
94376383|NCT02669264|323163393|FG003|Overall Study|Withdrawal by Subject|0|||
94376384|NCT02669264|323163394|FG004|Overall Study|Withdrawal by Subject|1|||
94376385|NCT02669264|323163395|FG005|Overall Study|Withdrawal by Subject|0|||
94376386|NCT02669264|323163396|FG006|Overall Study|Withdrawal by Subject|0|||
94376387|NCT02669264|323163390|FG000|Overall Study|Lost to Follow-up|0|||
94376388|NCT02669264|323163391|FG001|Overall Study|Lost to Follow-up|0|||
94376389|NCT02669264|323163392|FG002|Overall Study|Lost to Follow-up|0|||
94376390|NCT02669264|323163393|FG003|Overall Study|Lost to Follow-up|0|||
94376391|NCT02669264|323163394|FG004|Overall Study|Lost to Follow-up|1|||
94376392|NCT02669264|323163395|FG005|Overall Study|Lost to Follow-up|0|||
94376393|NCT02669264|323163396|FG006|Overall Study|Lost to Follow-up|0|||
94376394|NCT02669264|323163390|FG000|Overall Study|Miscellaneous|0|||
94376395|NCT02669264|323163391|FG001|Overall Study|Miscellaneous|0|||
94376396|NCT02669264|323163392|FG002|Overall Study|Miscellaneous|0|||
94376397|NCT02669264|323163393|FG003|Overall Study|Miscellaneous|0|||
94376398|NCT02669264|323163394|FG004|Overall Study|Miscellaneous|0|||
94376399|NCT02669264|323163395|FG005|Overall Study|Miscellaneous|0|||
94376400|NCT02669264|323163396|FG006|Overall Study|Miscellaneous|2|||
94376401|NCT04049552|323163397|FG000|Overall Study|Lost to Follow-up|1|||
94376402|NCT00526890|323163398|FG000|Overall Study|Adverse Event|2|||
94376403|NCT01688037|323163399|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
94376404|NCT01688037|323163400|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
94376405|NCT01688037|323163401|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
94376406|NCT01688037|323163399|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
94376407|NCT01688037|323163400|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
94376408|NCT01688037|323163401|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
94376409|NCT01688037|323163399|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
94376410|NCT01688037|323163400|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
94376411|NCT01688037|323163401|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
94376412|NCT01688037|323163399|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
94376413|NCT01688037|323163400|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
94376414|NCT01688037|323163401|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
94376415|NCT01688037|323163399|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
94376416|NCT01688037|323163400|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
94376417|NCT01688037|323163401|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
94376418|NCT01688037|323163399|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
94376419|NCT01688037|323163400|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
94376420|NCT01688037|323163401|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
94376421|NCT01688037|323163399|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
94376422|NCT01688037|323163400|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
94376423|NCT01688037|323163401|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
94376424|NCT01688037|323163399|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
94376425|NCT01688037|323163400|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
94376426|NCT01688037|323163401|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
94376427|NCT01688037|323163399|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
94376428|NCT01688037|323163400|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
94376429|NCT01688037|323163401|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
94376430|NCT01688037|323163399|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
94376431|NCT01688037|323163400|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
94376432|NCT01688037|323163401|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
94376433|NCT00859469|323163402|FG000|Overall Study|Adverse Event|2|||
94376434|NCT00859469|323163402|FG000|Overall Study|Lack of Efficacy|9|||
94376435|NCT00859469|323163402|FG000|Overall Study|Withdrawal by Subject|1|||
94376436|NCT00859469|323163402|FG000|Overall Study|Death|16|||
94376437|NCT03111147|323163403|FG000|Overall Study|Lost to Follow-up|2|||
94376438|NCT03111147|323163404|FG001|Overall Study|Lost to Follow-up|5|||
94305814|NCT02088034|322903938|FG001|Overall Study|Lost to Follow-up|1|||
94305815|NCT02088034|322903939|FG002|Overall Study|Lost to Follow-up|0|||
94305816|NCT02088034|322903937|FG000|Overall Study|Pregnancy|2|||
94305817|NCT02088034|322903938|FG001|Overall Study|Pregnancy|1|||
94305818|NCT02088034|322903939|FG002|Overall Study|Pregnancy|2|||
94305819|NCT04734873|322903947|FG000|Overall Study|Lost to Follow-up|1|||
94305820|NCT04734873|322903948|FG001|Overall Study|Lost to Follow-up|3|||
94305821|NCT04734873|322903949|FG002|Overall Study|Lost to Follow-up|2|||
94305822|NCT04734873|322903947|FG000|Overall Study|Randomized but not dosed|1|||
94305823|NCT04734873|322903948|FG001|Overall Study|Randomized but not dosed|0|||
94305824|NCT04734873|322903949|FG002|Overall Study|Randomized but not dosed|1|||
94305825|NCT02424149|322903951|FG000|Overall Study|surgery cancelled|2|||
94305826|NCT02424149|322903952|FG001|Overall Study|surgery cancelled|0|||
94305827|NCT02424149|322903951|FG000|Overall Study|Withdrawal by Subject|0|||
94305828|NCT02424149|322903952|FG001|Overall Study|Withdrawal by Subject|1|||
94376439|NCT03111147|323163403|FG000|Overall Study|Withdrawal by Subject|4|||
94376440|NCT03111147|323163404|FG001|Overall Study|Withdrawal by Subject|3|||
94376441|NCT03111147|323163403|FG000|Overall Study|Protocol Violation|2|||
94305829|NCT01025336|322903955|FG000|Overall Study|Protocol Violation|0|||
94305830|NCT01025336|322903956|FG001|Overall Study|Protocol Violation|0|||
94305831|NCT01025336|322903957|FG002|Overall Study|Protocol Violation|0|||
94305832|NCT01025336|322903958|FG003|Overall Study|Protocol Violation|2|||
94305833|NCT01025336|322903959|FG004|Overall Study|Protocol Violation|0|||
94305834|NCT00201201|322903960|FG000|Overall Study|Death|0|||
94305835|NCT00201201|322903961|FG001|Overall Study|Death|2|||
94305836|NCT00201201|322903960|FG000|Overall Study|Withdrawal by Subject|5|||
94305837|NCT00201201|322903961|FG001|Overall Study|Withdrawal by Subject|5|||
94305838|NCT00500071|322903966|FG000|Screening and Washout Phase|Protocol Violation|1|||
94305839|NCT00500071|322903966|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
94376442|NCT03111147|323163404|FG001|Overall Study|Protocol Violation|1|||
94376443|NCT03111147|323163403|FG000|Overall Study|Death|1|||
94376444|NCT03111147|323163404|FG001|Overall Study|Death|1|||
94376445|NCT00319449|323163421|FG000|Overall Study|Subject did not wish to continue|1|||
94376446|NCT00319449|323163422|FG001|Overall Study|Subject did not wish to continue|0|||
94376447|NCT00319449|323163421|FG000|Overall Study|Noncompliance with the protocol|1|||
94376448|NCT00319449|323163422|FG001|Overall Study|Noncompliance with the protocol|0|||
94376449|NCT00095199|323163423|FG000|Overall Study|Adverse Event|40|||
94376450|NCT00095199|323163424|FG001|Overall Study|Adverse Event|22|||
94376451|NCT00095199|323163425|FG002|Overall Study|Adverse Event|26|||
94376452|NCT00095199|323163426|FG003|Overall Study|Adverse Event|11|||
94376453|NCT00095199|323163423|FG000|Overall Study|Progressive disease|213|||
94376454|NCT00095199|323163424|FG001|Overall Study|Progressive disease|179|||
94376455|NCT00095199|323163425|FG002|Overall Study|Progressive disease|105|||
94376456|NCT00095199|323163426|FG003|Overall Study|Progressive disease|98|||
94376457|NCT00095199|323163423|FG000|Overall Study|Death|10|||
94376458|NCT00095199|323163424|FG001|Overall Study|Death|6|||
94376459|NCT00095199|323163425|FG002|Overall Study|Death|11|||
94376460|NCT00095199|323163426|FG003|Overall Study|Death|9|||
94376461|NCT00095199|323163423|FG000|Overall Study|Withdrawal by Subject|21|||
94376462|NCT00095199|323163424|FG001|Overall Study|Withdrawal by Subject|16|||
94376463|NCT00095199|323163425|FG002|Overall Study|Withdrawal by Subject|13|||
94376464|NCT00095199|323163426|FG003|Overall Study|Withdrawal by Subject|22|||
94376465|NCT00095199|323163423|FG000|Overall Study|Protocol Violation|4|||
94376466|NCT00095199|323163424|FG001|Overall Study|Protocol Violation|4|||
94376467|NCT00095199|323163425|FG002|Overall Study|Protocol Violation|2|||
94376468|NCT00095199|323163426|FG003|Overall Study|Protocol Violation|0|||
94376469|NCT00095199|323163423|FG000|Overall Study|Liver function test results elevated|0|||
94376470|NCT00095199|323163424|FG001|Overall Study|Liver function test results elevated|0|||
94376471|NCT00095199|323163425|FG002|Overall Study|Liver function test results elevated|1|||
94376472|NCT00095199|323163426|FG003|Overall Study|Liver function test results elevated|1|||
94376473|NCT00095199|323163423|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
94376474|NCT00095199|323163424|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
94376475|NCT00095199|323163425|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
94376476|NCT00095199|323163426|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
94376477|NCT00095199|323163423|FG000|Overall Study|Physician Decision|5|||
94376478|NCT00095199|323163424|FG001|Overall Study|Physician Decision|6|||
94376479|NCT00095199|323163425|FG002|Overall Study|Physician Decision|1|||
94469307|NCT01313221|323509376|FG001|Overall Study|Protocol Violation|1|||
94305840|NCT00500071|322903966|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
94305841|NCT00500071|322903966|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
94305842|NCT00500071|322903966|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
94376480|NCT00095199|323163426|FG003|Overall Study|Physician Decision|1|||
94376481|NCT00095199|323163423|FG000|Overall Study|Not eligible|1|||
94376482|NCT00095199|323163424|FG001|Overall Study|Not eligible|7|||
94376483|NCT00095199|323163425|FG002|Overall Study|Not eligible|0|||
94376484|NCT00095199|323163426|FG003|Overall Study|Not eligible|1|||
94376485|NCT00095199|323163423|FG000|Overall Study|Started Palliative Radiotherapy|1|||
94305843|NCT00500071|322903966|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
94305844|NCT00500071|322903966|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
94305845|NCT00474253|322903967|FG000|Overall Study|Withdrew consent|2|||
94305846|NCT00474253|322903968|FG001|Overall Study|Withdrew consent|0|||
94305847|NCT00474253|322903967|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
94305848|NCT00474253|322903968|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
94305849|NCT00474253|322903967|FG000|Overall Study|Lost to Follow-up|1|||
94305850|NCT00474253|322903968|FG001|Overall Study|Lost to Follow-up|0|||
94305851|NCT00474253|322903967|FG000|Overall Study|Discharged prior to study completion|0|||
94305852|NCT00474253|322903968|FG001|Overall Study|Discharged prior to study completion|1|||
94305853|NCT00881205|322903970|FG000|Overall Study|Adverse Event|8|||
94305854|NCT00881205|322903971|FG001|Overall Study|Adverse Event|3|||
94305855|NCT00881205|322903970|FG000|Overall Study|Withdrawal by Subject|1|||
94305856|NCT00881205|322903971|FG001|Overall Study|Withdrawal by Subject|2|||
94305857|NCT00881205|322903970|FG000|Overall Study|Lost to Follow-up|0|||
94305858|NCT00881205|322903971|FG001|Overall Study|Lost to Follow-up|1|||
94305859|NCT00881205|322903970|FG000|Overall Study|Administrative problems|1|||
94305860|NCT00881205|322903971|FG001|Overall Study|Administrative problems|1|||
94305861|NCT00881205|322903970|FG000|Overall Study|Condition no longer requires drug|1|||
94305862|NCT00881205|322903971|FG001|Overall Study|Condition no longer requires drug|0|||
94305863|NCT01357239|322903975|FG000|Stratum: All Patients|Adverse Event|0|||
94305864|NCT01357239|322903976|FG001|Stratum: All Patients|Adverse Event|0|||
94305865|NCT01357239|322903977|FG002|Stratum: All Patients|Adverse Event|1|||
94305866|NCT01357239|322903978|FG003|Stratum: All Patients|Adverse Event|1|||
94305867|NCT01357239|322903975|FG000|Stratum: All Patients|Subject withdrew consent|0|||
94305868|NCT01357239|322903976|FG001|Stratum: All Patients|Subject withdrew consent|0|||
94305869|NCT01357239|322903977|FG002|Stratum: All Patients|Subject withdrew consent|1|||
94305870|NCT01357239|322903978|FG003|Stratum: All Patients|Subject withdrew consent|1|||
94305871|NCT01357239|322903975|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
94305872|NCT01357239|322903976|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
94305873|NCT01357239|322903977|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
94305874|NCT01357239|322903978|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
94305875|NCT01357239|322903975|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
94305876|NCT01357239|322903976|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
94305877|NCT01357239|322903977|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
94305878|NCT01357239|322903978|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
94305879|NCT01357239|322903975|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
94305880|NCT01357239|322903976|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
94305881|NCT01357239|322903977|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
94305882|NCT01357239|322903978|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
94305883|NCT00550238|322903979|FG000|Overall Study|Adverse Event|88|||
94305884|NCT00550238|322903979|FG000|Overall Study|Death|34|||
94305885|NCT00550238|322903979|FG000|Overall Study|Disease progression|46|||
94305886|NCT00550238|322903979|FG000|Overall Study|Withdrawal by Subject|167|||
94305887|NCT00550238|322903979|FG000|Overall Study|Physician Decision|31|||
94305888|NCT00550238|322903979|FG000|Overall Study|Patient noncompliance|25|||
94305889|NCT00550238|322903979|FG000|Overall Study|Lost to Follow-up|13|||
94305890|NCT00550238|322903979|FG000|Overall Study|Sponsor decision|55|||
94305891|NCT00670111|322903989|FG000|Enrollment to One Month|Testing Failure|0|||
94305892|NCT00670111|322903990|FG001|Enrollment to One Month|Testing Failure|0|||
94305893|NCT00670111|322903991|FG002|Enrollment to One Month|Testing Failure|13|||
94305894|NCT00670111|322903989|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
94305895|NCT00670111|322903990|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
94305896|NCT00670111|322903991|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
94469308|NCT01313221|323509377|FG002|Overall Study|Protocol Violation|1|||
94305897|NCT00670111|322903989|FG000|Enrollment to One Month|Physician Decision|1|||
94469309|NCT01313221|323509375|FG000|Overall Study|Non-compliance|3|||
94469310|NCT01313221|323509376|FG001|Overall Study|Non-compliance|0|||
94469311|NCT01313221|323509377|FG002|Overall Study|Non-compliance|2|||
94305898|NCT00670111|322903990|FG001|Enrollment to One Month|Physician Decision|0|||
94305899|NCT00670111|322903991|FG002|Enrollment to One Month|Physician Decision|0|||
94305900|NCT01457339|322903994|FG000|Period 3 (100 mg)|Adverse Event|0|||
94305901|NCT01457339|322903995|FG001|Period 3 (100 mg)|Adverse Event|1|||
94305902|NCT01457339|322903994|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
94305903|NCT01457339|322903995|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
94305904|NCT01457339|322903994|FG000|Period 6 (250 mg)|Family Emergency|1|||
94305905|NCT01457339|322903995|FG001|Period 6 (250 mg)|Family Emergency|0|||
94305906|NCT01457339|322903994|FG000|Period 6 (250 mg)|Personal appointment|0|||
94305907|NCT01457339|322903995|FG001|Period 6 (250 mg)|Personal appointment|1|||
94305908|NCT03368404|322903999|FG000|Overall Study|Adverse Event|2|||
94305909|NCT03368404|322904000|FG001|Overall Study|Adverse Event|1|||
94305910|NCT03368404|322903999|FG000|Overall Study|Withdrawal by Subject|1|||
94469312|NCT01313221|323509375|FG000|Overall Study|Withdrawal by Subject|2|||
94469313|NCT01313221|323509376|FG001|Overall Study|Withdrawal by Subject|3|||
94469314|NCT01313221|323509377|FG002|Overall Study|Withdrawal by Subject|5|||
94469315|NCT01313221|323509375|FG000|Overall Study|Requirement for alternative therapy|0|||
94469316|NCT01313221|323509376|FG001|Overall Study|Requirement for alternative therapy|1|||
94469317|NCT01313221|323509377|FG002|Overall Study|Requirement for alternative therapy|1|||
94469318|NCT01313221|323509375|FG000|Overall Study|Lost to Follow-up|6|||
94469319|NCT01313221|323509376|FG001|Overall Study|Lost to Follow-up|3|||
94469320|NCT01313221|323509377|FG002|Overall Study|Lost to Follow-up|1|||
94469321|NCT01313221|323509375|FG000|Overall Study|Other|1|||
94469322|NCT01313221|323509376|FG001|Overall Study|Other|0|||
94469323|NCT01313221|323509377|FG002|Overall Study|Other|0|||
94469324|NCT01313221|323509375|FG000|Overall Study|Adverse Event|0|||
94469325|NCT01313221|323509376|FG001|Overall Study|Adverse Event|0|||
94469326|NCT01313221|323509377|FG002|Overall Study|Adverse Event|7|||
94469327|NCT01313221|323509375|FG000|Overall Study|Disease progression|0|||
94469328|NCT01313221|323509376|FG001|Overall Study|Disease progression|0|||
94469329|NCT01313221|323509377|FG002|Overall Study|Disease progression|2|||
94469330|NCT01313221|323509375|FG000|Overall Study|Physician Decision|0|||
94469331|NCT01313221|323509376|FG001|Overall Study|Physician Decision|0|||
94469332|NCT01313221|323509377|FG002|Overall Study|Physician Decision|2|||
94469333|NCT01313221|323509375|FG000|Overall Study|Pregnancy|0|||
94469334|NCT01313221|323509376|FG001|Overall Study|Pregnancy|0|||
94469335|NCT01313221|323509377|FG002|Overall Study|Pregnancy|2|||
94469336|NCT00298363|323509381|FG000|Overall Study|Lost to Follow-up|0|||
94469337|NCT00298363|323509382|FG001|Overall Study|Lost to Follow-up|0|||
94469338|NCT00298363|323509383|FG002|Overall Study|Lost to Follow-up|1|||
94469339|NCT00298363|323509381|FG000|Overall Study|Physician Decision|4|||
94469340|NCT00298363|323509382|FG001|Overall Study|Physician Decision|1|||
94469341|NCT00298363|323509383|FG002|Overall Study|Physician Decision|0|||
94469342|NCT00298363|323509381|FG000|Overall Study|Protocol Violation|1|||
94469343|NCT00298363|323509382|FG001|Overall Study|Protocol Violation|1|||
94469344|NCT00298363|323509383|FG002|Overall Study|Protocol Violation|0|||
94469345|NCT00298363|323509381|FG000|Overall Study|Withdrawal by Subject|5|||
94469346|NCT00298363|323509382|FG001|Overall Study|Withdrawal by Subject|1|||
94469347|NCT00298363|323509383|FG002|Overall Study|Withdrawal by Subject|3|||
94469348|NCT00298363|323509381|FG000|Overall Study|Adverse Event|5|||
94469349|NCT00298363|323509382|FG001|Overall Study|Adverse Event|2|||
94469350|NCT00298363|323509383|FG002|Overall Study|Adverse Event|2|||
94469351|NCT00298363|323509381|FG000|Overall Study|Lack of Efficacy|2|||
94305911|NCT03368404|322904000|FG001|Overall Study|Withdrawal by Subject|1|||
94305912|NCT01164501|322904001|FG000|Overall Study|Not treated|2|||
94305913|NCT01164501|322904002|FG001|Overall Study|Not treated|0|||
94305914|NCT01164501|322904003|FG002|Overall Study|Not treated|1|||
94305915|NCT01164501|322904001|FG000|Overall Study|Adverse Event|18|||
94305916|NCT01164501|322904002|FG001|Overall Study|Adverse Event|4|||
94305917|NCT01164501|322904003|FG002|Overall Study|Adverse Event|21|||
94305918|NCT01164501|322904001|FG000|Overall Study|Lack of Efficacy|0|||
94305919|NCT01164501|322904002|FG001|Overall Study|Lack of Efficacy|0|||
94305920|NCT01164501|322904003|FG002|Overall Study|Lack of Efficacy|1|||
94305921|NCT01164501|322904001|FG000|Overall Study|Non compliant with protocol|1|||
94305922|NCT01164501|322904002|FG001|Overall Study|Non compliant with protocol|1|||
94305923|NCT01164501|322904003|FG002|Overall Study|Non compliant with protocol|4|||
94305924|NCT01164501|322904001|FG000|Overall Study|Lost to Follow-up|3|||
94305925|NCT01164501|322904002|FG001|Overall Study|Lost to Follow-up|0|||
94305926|NCT01164501|322904003|FG002|Overall Study|Lost to Follow-up|3|||
94305927|NCT01164501|322904001|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
94305928|NCT01164501|322904002|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
94305929|NCT01164501|322904003|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
94305930|NCT01164501|322904001|FG000|Overall Study|Other reason not defined above|9|||
94305931|NCT01164501|322904002|FG001|Overall Study|Other reason not defined above|1|||
94305932|NCT01164501|322904003|FG002|Overall Study|Other reason not defined above|4|||
94305933|NCT00638846|322904006|FG000|Overall Study|Adverse Event|0|||
94305934|NCT00638846|322904007|FG001|Overall Study|Adverse Event|1|||
94469352|NCT00298363|323509382|FG001|Overall Study|Lack of Efficacy|3|||
94305935|NCT00638846|322904006|FG000|Overall Study|Lost to Follow-up|3|||
94469353|NCT00298363|323509383|FG002|Overall Study|Lack of Efficacy|0|||
94305936|NCT00638846|322904007|FG001|Overall Study|Lost to Follow-up|2|||
94469354|NCT00433017|323509384|FG000|Overall Study|Adverse Event|5|||
94305937|NCT00638846|322904006|FG000|Overall Study|lens issue|1|||
94469355|NCT00433017|323509385|FG001|Overall Study|Adverse Event|3|||
94469356|NCT00433017|323509384|FG000|Overall Study|Withdrawal by Subject|4|||
94469357|NCT00433017|323509385|FG001|Overall Study|Withdrawal by Subject|5|||
94469358|NCT00433017|323509384|FG000|Overall Study|Lost to Follow-up|3|||
94305938|NCT00638846|322904007|FG001|Overall Study|lens issue|3|||
94305939|NCT01084252|322905603|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
94469359|NCT00433017|323509385|FG001|Overall Study|Lost to Follow-up|4|||
94469360|NCT00433017|323509384|FG000|Overall Study|Administrative problems|80|||
94469361|NCT00433017|323509385|FG001|Overall Study|Administrative problems|86|||
94469362|NCT00433017|323509384|FG000|Overall Study|Protocol Violation|1|||
94469363|NCT00433017|323509385|FG001|Overall Study|Protocol Violation|0|||
94305940|NCT01084252|322905604|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
94305941|NCT01084252|322905605|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
94305942|NCT01084252|322905606|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
94305943|NCT01084252|322905607|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
94305944|NCT01084252|322905608|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
94305945|NCT01084252|322905609|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
94305946|NCT01084252|322905610|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
94305947|NCT01084252|322905611|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
94305948|NCT01084252|322905612|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
94305949|NCT01084252|322905613|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
94305950|NCT01084252|322905614|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
94305951|NCT01084252|322905615|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
94305952|NCT01084252|322905616|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
94305953|NCT04493619|322905617|FG000|Overall Study|Death|4|||
94305954|NCT04493619|322905618|FG001|Overall Study|Death|3|||
94305955|NCT04493619|322905619|FG002|Overall Study|Death|3|||
94305956|NCT04493619|322905620|FG003|Overall Study|Death|4|||
94305957|NCT04493619|322905617|FG000|Overall Study|Study discontinued early|10|||
94305958|NCT04493619|322905618|FG001|Overall Study|Study discontinued early|0|||
94305959|NCT04493619|322905619|FG002|Overall Study|Study discontinued early|4|||
94305960|NCT04493619|322905620|FG003|Overall Study|Study discontinued early|8|||
94305961|NCT04493619|322905617|FG000|Overall Study|Lost to Follow-up|0|||
94305962|NCT04493619|322905618|FG001|Overall Study|Lost to Follow-up|0|||
94305963|NCT04493619|322905619|FG002|Overall Study|Lost to Follow-up|0|||
94305964|NCT04493619|322905620|FG003|Overall Study|Lost to Follow-up|1|||
94305965|NCT00955110|322905622|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
94305966|NCT00955110|322905622|FG000|Treatment Phase|Adverse Event|2|||
94305967|NCT00955110|322905622|FG000|Treatment Phase|Administrative reasons|2|||
94305968|NCT00955110|322905622|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
94305969|NCT00955110|322905622|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
94376486|NCT00095199|323163424|FG001|Overall Study|Started Palliative Radiotherapy|0|||
94376487|NCT00095199|323163425|FG002|Overall Study|Started Palliative Radiotherapy|0|||
94376488|NCT00095199|323163426|FG003|Overall Study|Started Palliative Radiotherapy|0|||
94376489|NCT00095199|323163423|FG000|Overall Study|Started radiotherapy regimen|0|||
94376490|NCT00095199|323163424|FG001|Overall Study|Started radiotherapy regimen|1|||
94376491|NCT00095199|323163425|FG002|Overall Study|Started radiotherapy regimen|0|||
94376492|NCT00095199|323163426|FG003|Overall Study|Started radiotherapy regimen|0|||
94376493|NCT00095199|323163423|FG000|Overall Study|Primary tumor removed in other surgery|0|||
94376494|NCT00095199|323163424|FG001|Overall Study|Primary tumor removed in other surgery|1|||
94376495|NCT00095199|323163425|FG002|Overall Study|Primary tumor removed in other surgery|0|||
94376496|NCT00095199|323163426|FG003|Overall Study|Primary tumor removed in other surgery|0|||
94376497|NCT00095199|323163423|FG000|Overall Study|Data inadvertently lost by site|1|||
94376498|NCT00095199|323163424|FG001|Overall Study|Data inadvertently lost by site|0|||
94376499|NCT00095199|323163425|FG002|Overall Study|Data inadvertently lost by site|0|||
94376500|NCT00095199|323163426|FG003|Overall Study|Data inadvertently lost by site|0|||
94376501|NCT03896490|323163464|FG000|Overall Study|Withdrawal by Subject|1|||
94376502|NCT03896490|323163465|FG001|Overall Study|Withdrawal by Subject|1|||
94376503|NCT03387059|323163467|FG000|Overall Study|Study termination|5|||
94376504|NCT03387059|323163468|FG001|Overall Study|Study termination|4|||
94376505|NCT03280537|323163471|FG000|Overall Study|Withdrawal by Subject|2|||
94376506|NCT03280537|323163472|FG001|Overall Study|Withdrawal by Subject|4|||
94376507|NCT03118739|323163473|FG000|Overall Study|Physician Decision|0|||
94376508|NCT03118739|323163474|FG001|Overall Study|Physician Decision|1|||
94376509|NCT03118739|323163473|FG000|Overall Study|Withdrawal by Subject|5|||
94376510|NCT03118739|323163474|FG001|Overall Study|Withdrawal by Subject|3|||
94376511|NCT03118739|323163473|FG000|Overall Study|Lost to Follow-up|2|||
94376512|NCT03118739|323163474|FG001|Overall Study|Lost to Follow-up|0|||
94376513|NCT00409188|323165036|FG000|Overall Study|Ongoing at data cut-off|383|||
94376514|NCT00409188|323165037|FG001|Overall Study|Ongoing at data cut-off|175|||
94376515|NCT02468557|323165039|FG000|Overall Study|Adverse Event|1|||
94376516|NCT02468557|323165039|FG000|Overall Study|Death|1|||
94376517|NCT02468557|323165039|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
94376518|NCT02468557|323165039|FG000|Overall Study|All Enrolled but Never Dosed|4|||
94376519|NCT00982410|323165040|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
94376520|NCT00982410|323165041|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
94376521|NCT00982410|323165040|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
94376522|NCT00982410|323165041|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
94469364|NCT00433017|323509384|FG000|Overall Study|Death|2|||
94305970|NCT01853228|322905623|FG000|Phase 1|Lack of Efficacy|8|||
94305971|NCT01853228|322905624|FG001|Phase 1|Lack of Efficacy|0|||
94305972|NCT01853228|322905623|FG000|Phase 1|Other|1|||
94305973|NCT01853228|322905624|FG001|Phase 1|Other|0|||
94376523|NCT00982410|323165040|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
94376524|NCT00982410|323165041|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
94376525|NCT00982410|323165040|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
94376526|NCT00982410|323165041|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
94376527|NCT00982410|323165040|FG000|6-month Follow-up Assessment|participant no transportation|1|||
94376528|NCT00982410|323165041|FG001|6-month Follow-up Assessment|participant no transportation|0|||
94376529|NCT00982410|323165040|FG000|6-month Follow-up Assessment|incarceration|0|||
94376530|NCT00982410|323165041|FG001|6-month Follow-up Assessment|incarceration|2|||
94376531|NCT00982410|323165040|FG000|6-month Follow-up Assessment|patent surgery|0|||
94376532|NCT00982410|323165041|FG001|6-month Follow-up Assessment|patent surgery|1|||
94376533|NCT00982410|323165040|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
94376534|NCT00982410|323165041|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
94376535|NCT00982410|323165040|FG000|12-month Follow-up Assessment|Death|0|||
94376536|NCT00982410|323165041|FG001|12-month Follow-up Assessment|Death|2|||
94469365|NCT00433017|323509385|FG001|Overall Study|Death|2|||
94469366|NCT00433017|323509384|FG000|Overall Study|Subject no longer requires study drug|1|||
94469367|NCT00433017|323509385|FG001|Overall Study|Subject no longer requires study drug|1|||
94469368|NCT04710368|323509386|FG000|Overall Study|Withdrawal by Subject|9|||
94469369|NCT04710368|323509386|FG000|Overall Study|Lost to Follow-up|4|||
94469370|NCT04710368|323509386|FG000|Overall Study|Death|2|||
94469371|NCT04710368|323509386|FG000|Overall Study|Patient preference|11|||
94469372|NCT04710368|323509386|FG000|Overall Study|Treatment discontinuation|1|||
94469373|NCT04571385|323509391|FG000|Overall Study|Participant non-compliance|1|||
94469374|NCT04571385|323509392|FG001|Overall Study|Participant non-compliance|0|||
94469375|NCT04571385|323509393|FG002|Overall Study|Participant non-compliance|0|||
94469376|NCT04571385|323509391|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
94469377|NCT04571385|323509392|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
94469378|NCT04571385|323509393|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
94469379|NCT04571385|323509391|FG000|Overall Study|Screen failure|0|||
94469380|NCT04571385|323509392|FG001|Overall Study|Screen failure|0|||
94469381|NCT04571385|323509393|FG002|Overall Study|Screen failure|1|||
94469382|NCT00255840|323509394|FG000|Overall Study|Lost to Follow-up|10|||
94469383|NCT00255840|323509395|FG001|Overall Study|Lost to Follow-up|14|||
94469384|NCT00255840|323509394|FG000|Overall Study|Discontinued intervention|53|||
94469385|NCT00255840|323509395|FG001|Overall Study|Discontinued intervention|56|||
94469386|NCT02173379|323509396|FG000|Overall Study|Lost to Follow-up|89|||
94469387|NCT02173379|323509397|FG001|Overall Study|Lost to Follow-up|81|||
94469388|NCT02173379|323509396|FG000|Overall Study|Withdrawal by Subject|24|||
94469389|NCT02173379|323509397|FG001|Overall Study|Withdrawal by Subject|29|||
94469390|NCT02173379|323509396|FG000|Overall Study|Physician Decision|8|||
94469391|NCT02173379|323509397|FG001|Overall Study|Physician Decision|8|||
94469392|NCT02173379|323509396|FG000|Overall Study|Death|75|||
94469393|NCT02173379|323509397|FG001|Overall Study|Death|72|||
94469394|NCT02173379|323509396|FG000|Overall Study|Other Reason|1|||
94469395|NCT02173379|323509397|FG001|Overall Study|Other Reason|0|||
94469396|NCT05600036|323509399|FG000|Overall Study|Adverse Event|0|||
94469397|NCT05600036|323509400|FG001|Overall Study|Adverse Event|2|||
94469398|NCT05600036|323509401|FG002|Overall Study|Adverse Event|1|||
94469399|NCT05600036|323509402|FG003|Overall Study|Adverse Event|0|||
94469400|NCT05600036|323509403|FG004|Overall Study|Adverse Event|1|||
94469401|NCT05600036|323509404|FG005|Overall Study|Adverse Event|0|||
94376537|NCT00982410|323165040|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
94376538|NCT00982410|323165041|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
94376539|NCT00982410|323165040|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
94376540|NCT00982410|323165041|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
94376541|NCT00982410|323165040|FG000|12-month Follow-up Assessment|incarceration|2|||
94376542|NCT00982410|323165041|FG001|12-month Follow-up Assessment|incarceration|1|||
94469402|NCT05600036|323509399|FG000|Overall Study|Lost to Follow-up|0|||
94469403|NCT05600036|323509400|FG001|Overall Study|Lost to Follow-up|2|||
94469404|NCT05600036|323509401|FG002|Overall Study|Lost to Follow-up|1|||
94469405|NCT05600036|323509402|FG003|Overall Study|Lost to Follow-up|1|||
94469406|NCT05600036|323509403|FG004|Overall Study|Lost to Follow-up|0|||
94376543|NCT00982410|323165040|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
94469407|NCT05600036|323509404|FG005|Overall Study|Lost to Follow-up|0|||
94469408|NCT05600036|323509399|FG000|Overall Study|Protocol Violation|0|||
94469409|NCT05600036|323509400|FG001|Overall Study|Protocol Violation|0|||
94469410|NCT05600036|323509401|FG002|Overall Study|Protocol Violation|2|||
94469411|NCT05600036|323509402|FG003|Overall Study|Protocol Violation|0|||
94469412|NCT05600036|323509403|FG004|Overall Study|Protocol Violation|0|||
94469413|NCT05600036|323509404|FG005|Overall Study|Protocol Violation|0|||
94469414|NCT05600036|323509399|FG000|Overall Study|Withdrawal by Subject|0|||
94469415|NCT05600036|323509400|FG001|Overall Study|Withdrawal by Subject|1|||
94469416|NCT05600036|323509401|FG002|Overall Study|Withdrawal by Subject|2|||
94469417|NCT05600036|323509402|FG003|Overall Study|Withdrawal by Subject|0|||
94305974|NCT01853228|322905623|FG000|Phase 2|Physician Decision|0|||
94305975|NCT01853228|322905624|FG001|Phase 2|Physician Decision|1|||
94305976|NCT01853228|322905623|FG000|Phase 2|Proceed To Transplant|0|||
94305977|NCT01853228|322905624|FG001|Phase 2|Proceed To Transplant|3|||
94305978|NCT01853228|322905623|FG000|Phase 2|Lack of Efficacy|0|||
94305979|NCT01853228|322905624|FG001|Phase 2|Lack of Efficacy|4|||
94305980|NCT00698516|322905625|FG000|Overall Study|Study Termination|2|||
94305981|NCT00698516|322905625|FG000|Overall Study|Withdrawal by Subject|3|||
94305982|NCT02138110|322905639|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
94305983|NCT02138110|322905639|FG000|Overall Scaffold Implantation|Death|3|||
94305984|NCT00430781|322905641|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
94305985|NCT00430781|322905642|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
94305986|NCT00430781|322905643|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
94305987|NCT00430781|322905641|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
94305988|NCT00430781|322905642|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
94305989|NCT00430781|322905643|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
94305990|NCT00430781|322905641|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
94305991|NCT00430781|322905642|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
94305992|NCT00430781|322905643|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
94305993|NCT00430781|322905641|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
94305994|NCT00430781|322905642|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
94305995|NCT00430781|322905643|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
94305996|NCT00430781|322905641|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
94305997|NCT00430781|322905642|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
94305998|NCT00430781|322905643|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
94305999|NCT00430781|322905641|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
94306000|NCT00430781|322905642|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
94306001|NCT00430781|322905643|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
94306002|NCT00430781|322905641|FG000|Interim Analysis; 11 February 2008|Death|0|||
94306003|NCT00430781|322905642|FG001|Interim Analysis; 11 February 2008|Death|1|||
94306004|NCT00430781|322905643|FG002|Interim Analysis; 11 February 2008|Death|0|||
94306005|NCT00430781|322905641|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
94306006|NCT00430781|322905642|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
94306007|NCT00430781|322905643|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
94306008|NCT00430781|322905641|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
94306009|NCT00430781|322905642|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
94306010|NCT00430781|322905643|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
94306011|NCT00430781|322905641|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
94306012|NCT00430781|322905642|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
94306013|NCT00430781|322905643|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
94306014|NCT00430781|322905641|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
94306015|NCT00430781|322905642|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
94306016|NCT00430781|322905643|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
94306017|NCT00430781|322905641|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
94306018|NCT00430781|322905642|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
94306019|NCT00430781|322905643|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
94306020|NCT00430781|322905641|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
94306021|NCT00430781|322905642|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
94306022|NCT00430781|322905643|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
94306023|NCT00430781|322905641|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
94306024|NCT00430781|322905642|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
94306025|NCT00430781|322905643|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
94306026|NCT00430781|322905641|FG000|Final Analysis; 31 July 2008|Other|0|||
94306027|NCT00430781|322905642|FG001|Final Analysis; 31 July 2008|Other|1|||
94376544|NCT00982410|323165041|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
94376545|NCT01393990|323165045|FG000|Overall Study|Adverse Event|0|||
94376546|NCT01393990|323165046|FG001|Overall Study|Adverse Event|0|||
94376547|NCT01393990|323165047|FG002|Overall Study|Adverse Event|0|||
94376548|NCT01393990|323165048|FG003|Overall Study|Adverse Event|0|||
94376549|NCT01393990|323165049|FG004|Overall Study|Adverse Event|0|||
94376550|NCT01393990|323165050|FG005|Overall Study|Adverse Event|0|||
94376551|NCT01393990|323165051|FG006|Overall Study|Adverse Event|0|||
94376552|NCT01393990|323165052|FG007|Overall Study|Adverse Event|0|||
94376553|NCT01393990|323165053|FG008|Overall Study|Adverse Event|0|||
94376554|NCT01393990|323165054|FG009|Overall Study|Adverse Event|0|||
94376555|NCT01393990|323165055|FG010|Overall Study|Adverse Event|0|||
94376556|NCT01393990|323165056|FG011|Overall Study|Adverse Event|0|||
94376557|NCT01393990|323165057|FG012|Overall Study|Adverse Event|0|||
94376558|NCT01393990|323165058|FG013|Overall Study|Adverse Event|0|||
94376559|NCT01393990|323165059|FG014|Overall Study|Adverse Event|1|||
94376560|NCT01393990|323165060|FG015|Overall Study|Adverse Event|1|||
94376561|NCT01393990|323165061|FG016|Overall Study|Adverse Event|0|||
94376562|NCT01393990|323165062|FG017|Overall Study|Adverse Event|0|||
94376563|NCT01393990|323165045|FG000|Overall Study|Progressive Disease|1|||
94376564|NCT01393990|323165046|FG001|Overall Study|Progressive Disease|0|||
94376565|NCT01393990|323165047|FG002|Overall Study|Progressive Disease|0|||
94376566|NCT01393990|323165048|FG003|Overall Study|Progressive Disease|1|||
94376567|NCT01393990|323165049|FG004|Overall Study|Progressive Disease|1|||
94376568|NCT01393990|323165050|FG005|Overall Study|Progressive Disease|1|||
94376569|NCT01393990|323165051|FG006|Overall Study|Progressive Disease|1|||
94376570|NCT01393990|323165052|FG007|Overall Study|Progressive Disease|1|||
94376571|NCT01393990|323165053|FG008|Overall Study|Progressive Disease|3|||
94376572|NCT01393990|323165054|FG009|Overall Study|Progressive Disease|1|||
94376573|NCT01393990|323165055|FG010|Overall Study|Progressive Disease|0|||
94376574|NCT01393990|323165056|FG011|Overall Study|Progressive Disease|0|||
94376575|NCT01393990|323165057|FG012|Overall Study|Progressive Disease|0|||
94376576|NCT01393990|323165058|FG013|Overall Study|Progressive Disease|1|||
94376577|NCT01393990|323165059|FG014|Overall Study|Progressive Disease|6|||
94376578|NCT01393990|323165060|FG015|Overall Study|Progressive Disease|1|||
94376579|NCT01393990|323165061|FG016|Overall Study|Progressive Disease|0|||
94376580|NCT01393990|323165062|FG017|Overall Study|Progressive Disease|0|||
94376581|NCT01393990|323165045|FG000|Overall Study|Death|0|||
94376582|NCT01393990|323165046|FG001|Overall Study|Death|0|||
94376583|NCT01393990|323165047|FG002|Overall Study|Death|0|||
94376584|NCT01393990|323165048|FG003|Overall Study|Death|0|||
94376585|NCT01393990|323165049|FG004|Overall Study|Death|1|||
94376586|NCT01393990|323165050|FG005|Overall Study|Death|0|||
94376587|NCT01393990|323165051|FG006|Overall Study|Death|0|||
94376588|NCT01393990|323165052|FG007|Overall Study|Death|0|||
94376589|NCT01393990|323165053|FG008|Overall Study|Death|0|||
94376590|NCT01393990|323165054|FG009|Overall Study|Death|0|||
94376591|NCT01393990|323165055|FG010|Overall Study|Death|0|||
94376592|NCT01393990|323165056|FG011|Overall Study|Death|0|||
94376593|NCT01393990|323165057|FG012|Overall Study|Death|0|||
94376594|NCT01393990|323165058|FG013|Overall Study|Death|1|||
94376595|NCT01393990|323165059|FG014|Overall Study|Death|1|||
94376596|NCT01393990|323165060|FG015|Overall Study|Death|0|||
94376597|NCT01393990|323165061|FG016|Overall Study|Death|0|||
94376598|NCT01393990|323165062|FG017|Overall Study|Death|0|||
94376599|NCT01393990|323165045|FG000|Overall Study|Withdrawal by Subject|0|||
94376600|NCT01393990|323165046|FG001|Overall Study|Withdrawal by Subject|0|||
94376601|NCT01393990|323165047|FG002|Overall Study|Withdrawal by Subject|0|||
94376602|NCT01393990|323165048|FG003|Overall Study|Withdrawal by Subject|0|||
94376603|NCT01393990|323165049|FG004|Overall Study|Withdrawal by Subject|0|||
94376604|NCT01393990|323165050|FG005|Overall Study|Withdrawal by Subject|0|||
94376605|NCT01393990|323165051|FG006|Overall Study|Withdrawal by Subject|0|||
94376606|NCT01393990|323165052|FG007|Overall Study|Withdrawal by Subject|0|||
94376607|NCT01393990|323165053|FG008|Overall Study|Withdrawal by Subject|0|||
94376608|NCT01393990|323165054|FG009|Overall Study|Withdrawal by Subject|0|||
94376609|NCT01393990|323165055|FG010|Overall Study|Withdrawal by Subject|0|||
94376610|NCT01393990|323165056|FG011|Overall Study|Withdrawal by Subject|0|||
94376611|NCT01393990|323165057|FG012|Overall Study|Withdrawal by Subject|0|||
94376612|NCT01393990|323165058|FG013|Overall Study|Withdrawal by Subject|0|||
94376613|NCT01393990|323165059|FG014|Overall Study|Withdrawal by Subject|1|||
94376614|NCT01393990|323165060|FG015|Overall Study|Withdrawal by Subject|1|||
94376615|NCT01393990|323165061|FG016|Overall Study|Withdrawal by Subject|0|||
94376616|NCT01393990|323165062|FG017|Overall Study|Withdrawal by Subject|0|||
94376617|NCT01133821|323165067|FG000|Overall Study|Lost to Follow-up|8|||
94376618|NCT01133821|323165068|FG001|Overall Study|Lost to Follow-up|11|||
94376619|NCT01133821|323165067|FG000|Overall Study|Withdrawal by Subject|8|||
94376620|NCT01133821|323165068|FG001|Overall Study|Withdrawal by Subject|3|||
94376621|NCT01133821|323165067|FG000|Overall Study|preferred other treatment|1|||
94469418|NCT05600036|323509403|FG004|Overall Study|Withdrawal by Subject|3|||
94376622|NCT01133821|323165068|FG001|Overall Study|preferred other treatment|1|||
94376623|NCT01133821|323165067|FG000|Overall Study|Protocol Violation|0|||
94376624|NCT01133821|323165068|FG001|Overall Study|Protocol Violation|1|||
94376625|NCT01133821|323165067|FG000|Overall Study|Refused participation|1|||
94376626|NCT01133821|323165068|FG001|Overall Study|Refused participation|3|||
94376627|NCT03342898|323165069|FG000|Overall Study|Adverse Event|3|||
94376628|NCT03342898|323165070|FG001|Overall Study|Adverse Event|1|||
94376629|NCT03342898|323165071|FG002|Overall Study|Adverse Event|0|||
94376630|NCT03342898|323165069|FG000|Overall Study|Lost to Follow-up|44|||
94376631|NCT03342898|323165070|FG001|Overall Study|Lost to Follow-up|40|||
94469419|NCT05600036|323509404|FG005|Overall Study|Withdrawal by Subject|5|||
94306028|NCT00430781|322905643|FG002|Final Analysis; 31 July 2008|Other|0|||
94306029|NCT00430781|322905641|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
94306030|NCT00430781|322905642|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
94306031|NCT00430781|322905643|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
94306032|NCT00430781|322905641|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
94306033|NCT00430781|322905642|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
94306034|NCT00430781|322905643|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
94306035|NCT00430781|322905641|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
94306036|NCT00430781|322905642|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
94306037|NCT00430781|322905643|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
94306038|NCT00430781|322905641|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
94306039|NCT00430781|322905642|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
94306040|NCT00430781|322905643|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
94306041|NCT00430781|322905641|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
94306042|NCT00430781|322905642|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
94306043|NCT00430781|322905643|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
94306044|NCT00430781|322905641|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
94306045|NCT00430781|322905642|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
94306046|NCT00430781|322905643|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
94306047|NCT00430781|322905641|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
94306048|NCT00430781|322905642|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
94306049|NCT00430781|322905643|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
94306050|NCT00882713|322905644|FG000|Overall Study|Adverse Event|2|||
94306051|NCT00882713|322905644|FG000|Overall Study|Death|3|||
94306052|NCT00882713|322905644|FG000|Overall Study|Administrative reasons|4|||
94306053|NCT00882713|322905644|FG000|Overall Study|refused treatment/withdrew consent|4|||
94306054|NCT00882713|322905644|FG000|Overall Study|Blood transfusion|2|||
94306055|NCT00882713|322905644|FG000|Overall Study|Insufficient therapeutic response|3|||
94306056|NCT00882713|322905644|FG000|Overall Study|Failure to return|2|||
94306057|NCT00882713|322905644|FG000|Overall Study|Other - Reasons|2|||
94306058|NCT00893789|322905645|FG000|Overall Study|Withdrawal by Subject|3|||
94306059|NCT00893789|322905646|FG001|Overall Study|Withdrawal by Subject|1|||
94306060|NCT00893789|322905647|FG002|Overall Study|Withdrawal by Subject|3|||
94306061|NCT00893789|322905648|FG003|Overall Study|Withdrawal by Subject|1|||
94306062|NCT00893789|322905645|FG000|Overall Study|Noncompliance With Study Drug|1|||
94306063|NCT00893789|322905646|FG001|Overall Study|Noncompliance With Study Drug|0|||
94306064|NCT00893789|322905647|FG002|Overall Study|Noncompliance With Study Drug|1|||
94306065|NCT00893789|322905648|FG003|Overall Study|Noncompliance With Study Drug|2|||
94306066|NCT00893789|322905645|FG000|Overall Study|Noncompliance With Study Procedures|1|||
94306067|NCT00893789|322905646|FG001|Overall Study|Noncompliance With Study Procedures|0|||
94306068|NCT00893789|322905647|FG002|Overall Study|Noncompliance With Study Procedures|0|||
94306069|NCT00893789|322905648|FG003|Overall Study|Noncompliance With Study Procedures|0|||
94306070|NCT00893789|322905645|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
94306071|NCT00893789|322905646|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
94306072|NCT00893789|322905647|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
94306073|NCT00893789|322905648|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
94306074|NCT00893789|322905645|FG000|Overall Study|Adverse Event|0|||
94306075|NCT00893789|322905646|FG001|Overall Study|Adverse Event|2|||
94306076|NCT00893789|322905647|FG002|Overall Study|Adverse Event|1|||
94306077|NCT00893789|322905648|FG003|Overall Study|Adverse Event|5|||
94306078|NCT00893789|322905645|FG000|Overall Study|Protocol Violation|0|||
94306079|NCT00893789|322905646|FG001|Overall Study|Protocol Violation|1|||
94306080|NCT00893789|322905647|FG002|Overall Study|Protocol Violation|1|||
94306081|NCT00893789|322905648|FG003|Overall Study|Protocol Violation|4|||
94306082|NCT00893789|322905645|FG000|Overall Study|Lost to Follow-up|0|||
94306083|NCT00893789|322905646|FG001|Overall Study|Lost to Follow-up|0|||
94306084|NCT00893789|322905647|FG002|Overall Study|Lost to Follow-up|0|||
94306085|NCT00893789|322905648|FG003|Overall Study|Lost to Follow-up|1|||
94376632|NCT03342898|323165071|FG002|Overall Study|Lost to Follow-up|42|||
94376633|NCT03342898|323165069|FG000|Overall Study|Withdrawal of Consent|5|||
94376634|NCT03342898|323165070|FG001|Overall Study|Withdrawal of Consent|9|||
94376635|NCT03342898|323165071|FG002|Overall Study|Withdrawal of Consent|11|||
94376636|NCT03342898|323165069|FG000|Overall Study|Death|0|||
94376637|NCT03342898|323165070|FG001|Overall Study|Death|1|||
94306086|NCT00149214|322905654|FG000|Overall Study|Adverse Event|12|||
94306087|NCT00149214|322905655|FG001|Overall Study|Adverse Event|9|||
94306088|NCT00149214|322905654|FG000|Overall Study|Withdrawal by Subject|4|||
94306089|NCT00149214|322905655|FG001|Overall Study|Withdrawal by Subject|1|||
94306090|NCT00149214|322905654|FG000|Overall Study|Physician Decision|3|||
94306091|NCT00149214|322905655|FG001|Overall Study|Physician Decision|3|||
94306092|NCT00149214|322905654|FG000|Overall Study|Sponsor Decision|0|||
94306093|NCT00149214|322905655|FG001|Overall Study|Sponsor Decision|1|||
94306094|NCT00149214|322905654|FG000|Overall Study|Progressive Disease|7|||
94306095|NCT00149214|322905655|FG001|Overall Study|Progressive Disease|3|||
94469420|NCT05600036|323509399|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
94306096|NCT00090285|322905656|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
94306097|NCT00090285|322905657|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
94306098|NCT00090285|322905658|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
94306099|NCT00090285|322905659|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
94306100|NCT00090285|322905660|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
94306101|NCT00090285|322905661|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
94306102|NCT00090285|322905656|FG000|Base Study Vaccination Period|Adverse Event|2|||
94306103|NCT00090285|322905657|FG001|Base Study Vaccination Period|Adverse Event|4|||
94306104|NCT00090285|322905658|FG002|Base Study Vaccination Period|Adverse Event|0|||
94306105|NCT00090285|322905659|FG003|Base Study Vaccination Period|Adverse Event|0|||
94306106|NCT00090285|322905660|FG004|Base Study Vaccination Period|Adverse Event|0|||
94306107|NCT00090285|322905661|FG005|Base Study Vaccination Period|Adverse Event|0|||
94306108|NCT00090285|322905656|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
94306109|NCT00090285|322905657|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
94306110|NCT00090285|322905658|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
94306111|NCT00090285|322905659|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
94306112|NCT00090285|322905660|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
94306113|NCT00090285|322905661|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
94306114|NCT00090285|322905656|FG000|Base Study Vaccination Period|Protocol Violation|2|||
94306115|NCT00090285|322905657|FG001|Base Study Vaccination Period|Protocol Violation|3|||
94306116|NCT00090285|322905658|FG002|Base Study Vaccination Period|Protocol Violation|0|||
94306117|NCT00090285|322905659|FG003|Base Study Vaccination Period|Protocol Violation|0|||
94306118|NCT00090285|322905660|FG004|Base Study Vaccination Period|Protocol Violation|0|||
94306119|NCT00090285|322905661|FG005|Base Study Vaccination Period|Protocol Violation|0|||
94306120|NCT00090285|322905656|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
94306121|NCT00090285|322905657|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
94306122|NCT00090285|322905658|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
94306123|NCT00090285|322905659|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
94306124|NCT00090285|322905660|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
94306125|NCT00090285|322905661|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
94306126|NCT00090285|322905656|FG000|Base Study Vaccination Period|Uncooperative|2|||
94306127|NCT00090285|322905657|FG001|Base Study Vaccination Period|Uncooperative|2|||
94306128|NCT00090285|322905658|FG002|Base Study Vaccination Period|Uncooperative|0|||
94306129|NCT00090285|322905659|FG003|Base Study Vaccination Period|Uncooperative|0|||
94306130|NCT00090285|322905660|FG004|Base Study Vaccination Period|Uncooperative|0|||
94306131|NCT00090285|322905661|FG005|Base Study Vaccination Period|Uncooperative|0|||
94306132|NCT00090285|322905656|FG000|Base Study Vaccination Period|Moved|20|||
94306133|NCT00090285|322905657|FG001|Base Study Vaccination Period|Moved|21|||
94306134|NCT00090285|322905658|FG002|Base Study Vaccination Period|Moved|0|||
94306135|NCT00090285|322905659|FG003|Base Study Vaccination Period|Moved|0|||
94306136|NCT00090285|322905660|FG004|Base Study Vaccination Period|Moved|0|||
94306137|NCT00090285|322905661|FG005|Base Study Vaccination Period|Moved|0|||
94306138|NCT00090285|322905656|FG000|Base Study Vaccination Period|Site Terminated|1|||
94306139|NCT00090285|322905657|FG001|Base Study Vaccination Period|Site Terminated|0|||
94306140|NCT00090285|322905658|FG002|Base Study Vaccination Period|Site Terminated|0|||
94306141|NCT00090285|322905659|FG003|Base Study Vaccination Period|Site Terminated|0|||
94306142|NCT00090285|322905660|FG004|Base Study Vaccination Period|Site Terminated|0|||
94306143|NCT00090285|322905661|FG005|Base Study Vaccination Period|Site Terminated|0|||
94306144|NCT00090285|322905656|FG000|Base Study Vaccination Period|Other|2|||
94306145|NCT00090285|322905657|FG001|Base Study Vaccination Period|Other|2|||
94306146|NCT00090285|322905658|FG002|Base Study Vaccination Period|Other|0|||
94306147|NCT00090285|322905659|FG003|Base Study Vaccination Period|Other|0|||
94306148|NCT00090285|322905660|FG004|Base Study Vaccination Period|Other|0|||
94306149|NCT00090285|322905661|FG005|Base Study Vaccination Period|Other|0|||
94306150|NCT00090285|322905656|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
94306151|NCT00090285|322905657|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
94306152|NCT00090285|322905658|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
94306153|NCT00090285|322905659|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
94306154|NCT00090285|322905660|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
94306155|NCT00090285|322905661|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
94306156|NCT00090285|322905656|FG000|Base Study Vaccination Period|HIV positive|1|||
94306157|NCT00090285|322905657|FG001|Base Study Vaccination Period|HIV positive|1|||
94306158|NCT00090285|322905658|FG002|Base Study Vaccination Period|HIV positive|0|||
94306159|NCT00090285|322905659|FG003|Base Study Vaccination Period|HIV positive|0|||
94306160|NCT00090285|322905660|FG004|Base Study Vaccination Period|HIV positive|0|||
94306161|NCT00090285|322905661|FG005|Base Study Vaccination Period|HIV positive|0|||
94306162|NCT00090285|322905656|FG000|Base Study Follow-up Period|Adverse Event|3|||
94306163|NCT00090285|322905657|FG001|Base Study Follow-up Period|Adverse Event|10|||
94306164|NCT00090285|322905658|FG002|Base Study Follow-up Period|Adverse Event|0|||
94306165|NCT00090285|322905659|FG003|Base Study Follow-up Period|Adverse Event|0|||
94306166|NCT00090285|322905660|FG004|Base Study Follow-up Period|Adverse Event|0|||
94306167|NCT00090285|322905661|FG005|Base Study Follow-up Period|Adverse Event|0|||
94306168|NCT00090285|322905656|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
94306169|NCT00090285|322905657|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
94306170|NCT00090285|322905658|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
94306171|NCT00090285|322905659|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
94306172|NCT00090285|322905660|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
94306173|NCT00090285|322905661|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
94306174|NCT00090285|322905656|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
94306175|NCT00090285|322905657|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
94306176|NCT00090285|322905658|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
94306177|NCT00090285|322905659|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
94306178|NCT00090285|322905660|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
94306179|NCT00090285|322905661|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
94306180|NCT00090285|322905656|FG000|Base Study Follow-up Period|Moved|41|||
94306181|NCT00090285|322905657|FG001|Base Study Follow-up Period|Moved|36|||
94306182|NCT00090285|322905658|FG002|Base Study Follow-up Period|Moved|0|||
94306183|NCT00090285|322905659|FG003|Base Study Follow-up Period|Moved|0|||
94306184|NCT00090285|322905660|FG004|Base Study Follow-up Period|Moved|0|||
94306185|NCT00090285|322905661|FG005|Base Study Follow-up Period|Moved|0|||
94306186|NCT00090285|322905656|FG000|Base Study Follow-up Period|Other|2|||
94306187|NCT00090285|322905657|FG001|Base Study Follow-up Period|Other|0|||
94306188|NCT00090285|322905658|FG002|Base Study Follow-up Period|Other|0|||
94306189|NCT00090285|322905659|FG003|Base Study Follow-up Period|Other|0|||
94306190|NCT00090285|322905660|FG004|Base Study Follow-up Period|Other|0|||
94306191|NCT00090285|322905661|FG005|Base Study Follow-up Period|Other|0|||
94306192|NCT00090285|322905656|FG000|Base Study Follow-up Period|Protocol Violation|1|||
94306193|NCT00090285|322905657|FG001|Base Study Follow-up Period|Protocol Violation|0|||
94306194|NCT00090285|322905658|FG002|Base Study Follow-up Period|Protocol Violation|0|||
94306195|NCT00090285|322905659|FG003|Base Study Follow-up Period|Protocol Violation|0|||
94306196|NCT00090285|322905660|FG004|Base Study Follow-up Period|Protocol Violation|0|||
94306197|NCT00090285|322905661|FG005|Base Study Follow-up Period|Protocol Violation|0|||
94306198|NCT00090285|322905656|FG000|Base Study Follow-up Period|Uncooperative|3|||
94306199|NCT00090285|322905657|FG001|Base Study Follow-up Period|Uncooperative|4|||
94306200|NCT00090285|322905658|FG002|Base Study Follow-up Period|Uncooperative|0|||
94306201|NCT00090285|322905659|FG003|Base Study Follow-up Period|Uncooperative|0|||
94306202|NCT00090285|322905660|FG004|Base Study Follow-up Period|Uncooperative|0|||
94306203|NCT00090285|322905661|FG005|Base Study Follow-up Period|Uncooperative|0|||
94376638|NCT03342898|323165071|FG002|Overall Study|Death|1|||
94376639|NCT03342898|323165069|FG000|Overall Study|Reason not Specified|2|||
94376640|NCT03342898|323165070|FG001|Overall Study|Reason not Specified|2|||
94376641|NCT03342898|323165071|FG002|Overall Study|Reason not Specified|0|||
94376642|NCT01387282|323165072|FG000|Overall Study|Death|47|||
94376643|NCT01387282|323165073|FG001|Overall Study|Death|16|||
94376644|NCT01387282|323165072|FG000|Overall Study|Other|5|||
94306204|NCT00090285|322905656|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
94376645|NCT01387282|323165073|FG001|Overall Study|Other|1|||
94306205|NCT00090285|322905657|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
94306206|NCT00090285|322905658|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
94306207|NCT00090285|322905659|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
94469421|NCT05600036|323509400|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
94469422|NCT05600036|323509401|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
94469423|NCT05600036|323509402|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
94469424|NCT05600036|323509403|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
94469425|NCT05600036|323509404|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
94469426|NCT05600036|323509399|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
94469427|NCT05600036|323509400|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
94469428|NCT05600036|323509401|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
94469429|NCT05600036|323509402|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
94469430|NCT05600036|323509403|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
94469431|NCT05600036|323509404|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
94469432|NCT05600036|323509399|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
94469433|NCT05600036|323509400|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
94469434|NCT05600036|323509401|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
94469435|NCT05600036|323509402|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
94469436|NCT05600036|323509403|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
94469437|NCT05600036|323509404|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
94469438|NCT01006590|323509407|FG000|Overall Study|Adverse Event|2|||
94469439|NCT01006590|323509408|FG001|Overall Study|Adverse Event|3|||
94469440|NCT01006590|323509407|FG000|Overall Study|Death|1|||
94469441|NCT01006590|323509408|FG001|Overall Study|Death|1|||
94469442|NCT01006590|323509407|FG000|Overall Study|Lost to Follow-up|1|||
94469443|NCT01006590|323509408|FG001|Overall Study|Lost to Follow-up|1|||
94469444|NCT01006590|323509407|FG000|Overall Study|Protocol Violation|1|||
94469445|NCT01006590|323509408|FG001|Overall Study|Protocol Violation|0|||
94306208|NCT00090285|322905660|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
94376646|NCT01387282|323165072|FG000|Overall Study|Unrelated AE|6|||
94376647|NCT01387282|323165073|FG001|Overall Study|Unrelated AE|4|||
94376648|NCT01387282|323165072|FG000|Overall Study|Withdrawal by patient|33|||
94376649|NCT01387282|323165073|FG001|Overall Study|Withdrawal by patient|23|||
94376650|NCT01387282|323165072|FG000|Overall Study|Study drug-related AE|2|||
94376651|NCT01387282|323165073|FG001|Overall Study|Study drug-related AE|2|||
94376652|NCT01387282|323165072|FG000|Overall Study|Lost to Follow-up|4|||
94376653|NCT01387282|323165073|FG001|Overall Study|Lost to Follow-up|1|||
94376654|NCT02008721|323165081|FG000|Overall Study|Withdrawal by Subject|5|||
94376655|NCT02008721|323165082|FG001|Overall Study|Withdrawal by Subject|1|||
94376656|NCT02008721|323165081|FG000|Overall Study|Death|4|||
94376657|NCT02008721|323165082|FG001|Overall Study|Death|2|||
94376658|NCT02008721|323165081|FG000|Overall Study|Adverse Event|3|||
94376659|NCT02008721|323165082|FG001|Overall Study|Adverse Event|5|||
94376660|NCT02008721|323165081|FG000|Overall Study|Protocol Violation|3|||
94376661|NCT02008721|323165082|FG001|Overall Study|Protocol Violation|2|||
94376662|NCT02884206|323165083|FG000|Valsartan Run-in Period|Death|1|||
94376663|NCT02884206|323165084|FG001|Valsartan Run-in Period|Death|0|||
94376664|NCT02884206|323165085|FG002|Valsartan Run-in Period|Death|0|||
94376665|NCT02884206|323165083|FG000|Valsartan Run-in Period|Adverse Event|31|||
94376666|NCT02884206|323165084|FG001|Valsartan Run-in Period|Adverse Event|0|||
94376667|NCT02884206|323165085|FG002|Valsartan Run-in Period|Adverse Event|0|||
94376668|NCT02884206|323165083|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
94376669|NCT02884206|323165084|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
94376670|NCT02884206|323165085|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
94376671|NCT02884206|323165083|FG000|Valsartan Run-in Period|Protocol deviation|4|||
94376672|NCT02884206|323165084|FG001|Valsartan Run-in Period|Protocol deviation|0|||
94376673|NCT02884206|323165085|FG002|Valsartan Run-in Period|Protocol deviation|0|||
94376674|NCT02884206|323165083|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
94376675|NCT02884206|323165084|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
94376676|NCT02884206|323165085|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
94376677|NCT02884206|323165083|FG000|Valsartan Run-in Period|Physician Decision|1|||
94376678|NCT02884206|323165084|FG001|Valsartan Run-in Period|Physician Decision|0|||
94376679|NCT02884206|323165085|FG002|Valsartan Run-in Period|Physician Decision|0|||
94376680|NCT02884206|323165083|FG000|LCZ696 Run-in Period|Adverse Event|38|||
94376681|NCT02884206|323165084|FG001|LCZ696 Run-in Period|Adverse Event|0|||
94376682|NCT02884206|323165085|FG002|LCZ696 Run-in Period|Adverse Event|0|||
94376683|NCT02884206|323165083|FG000|LCZ696 Run-in Period|Death|2|||
94376684|NCT02884206|323165084|FG001|LCZ696 Run-in Period|Death|0|||
94376685|NCT02884206|323165085|FG002|LCZ696 Run-in Period|Death|0|||
94376686|NCT02884206|323165083|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
94376687|NCT02884206|323165084|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
94376688|NCT02884206|323165085|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
94376689|NCT02884206|323165083|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
94376690|NCT02884206|323165084|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
94376691|NCT02884206|323165085|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
94376692|NCT02884206|323165083|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
94376693|NCT02884206|323165084|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
94376694|NCT02884206|323165085|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
94376695|NCT02884206|323165083|FG000|LCZ696 Run-in Period|Physician Decision|1|||
94376696|NCT02884206|323165084|FG001|LCZ696 Run-in Period|Physician Decision|0|||
94376697|NCT02884206|323165085|FG002|LCZ696 Run-in Period|Physician Decision|0|||
94376698|NCT02884206|323165083|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
94376699|NCT02884206|323165084|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
94376700|NCT02884206|323165085|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
94376701|NCT02884206|323165083|FG000|Double-Blind Period|Death|0|||
94376702|NCT02884206|323165084|FG001|Double-Blind Period|Death|28|||
94376703|NCT02884206|323165085|FG002|Double-Blind Period|Death|39|||
94376704|NCT02884206|323165083|FG000|Double-Blind Period|Patient/guardian decision|0|||
94376705|NCT02884206|323165084|FG001|Double-Blind Period|Patient/guardian decision|10|||
94376706|NCT02884206|323165085|FG002|Double-Blind Period|Patient/guardian decision|13|||
94376707|NCT02884206|323165083|FG000|Double-Blind Period|Lost to Follow-up|0|||
94376708|NCT02884206|323165084|FG001|Double-Blind Period|Lost to Follow-up|4|||
94376709|NCT02884206|323165085|FG002|Double-Blind Period|Lost to Follow-up|4|||
94376710|NCT02884206|323165083|FG000|Double-Blind Period|Physician Decision|0|||
94376711|NCT02884206|323165084|FG001|Double-Blind Period|Physician Decision|2|||
94376712|NCT02884206|323165085|FG002|Double-Blind Period|Physician Decision|0|||
94376713|NCT02884206|323165083|FG000|Double-Blind Period|Adverse Event|0|||
94376714|NCT02884206|323165084|FG001|Double-Blind Period|Adverse Event|0|||
94376715|NCT02884206|323165085|FG002|Double-Blind Period|Adverse Event|3|||
94376716|NCT02884206|323165083|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
94376717|NCT02884206|323165084|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
94469446|NCT01006590|323509407|FG000|Overall Study|Withdrawal by Subject|4|||
94306209|NCT00090285|322905661|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
94306210|NCT00090285|322905656|FG000|Extension 1|Adverse Event|0|||
94306211|NCT00090285|322905657|FG001|Extension 1|Adverse Event|0|||
94306212|NCT00090285|322905658|FG002|Extension 1|Adverse Event|2|||
94306213|NCT00090285|322905659|FG003|Extension 1|Adverse Event|0|||
94306214|NCT00090285|322905660|FG004|Extension 1|Adverse Event|0|||
94306215|NCT00090285|322905661|FG005|Extension 1|Adverse Event|0|||
94306216|NCT00090285|322905656|FG000|Extension 1|Lost to Follow-up|0|||
94306217|NCT00090285|322905657|FG001|Extension 1|Lost to Follow-up|0|||
94306218|NCT00090285|322905658|FG002|Extension 1|Lost to Follow-up|35|||
94306219|NCT00090285|322905659|FG003|Extension 1|Lost to Follow-up|0|||
94306220|NCT00090285|322905660|FG004|Extension 1|Lost to Follow-up|0|||
94306221|NCT00090285|322905661|FG005|Extension 1|Lost to Follow-up|0|||
94306222|NCT00090285|322905656|FG000|Extension 1|Withdrawal by Subject|0|||
94306223|NCT00090285|322905657|FG001|Extension 1|Withdrawal by Subject|0|||
94306224|NCT00090285|322905658|FG002|Extension 1|Withdrawal by Subject|13|||
94306225|NCT00090285|322905659|FG003|Extension 1|Withdrawal by Subject|1|||
94306226|NCT00090285|322905660|FG004|Extension 1|Withdrawal by Subject|0|||
94306227|NCT00090285|322905661|FG005|Extension 1|Withdrawal by Subject|0|||
94306228|NCT00090285|322905656|FG000|Extension 1|Other|0|||
94306229|NCT00090285|322905657|FG001|Extension 1|Other|0|||
94306230|NCT00090285|322905658|FG002|Extension 1|Other|4|||
94469447|NCT01006590|323509408|FG001|Overall Study|Withdrawal by Subject|2|||
94469448|NCT01006590|323509407|FG000|Overall Study|Study specific discontinuation criteria|16|||
94469449|NCT01006590|323509408|FG001|Overall Study|Study specific discontinuation criteria|23|||
94469450|NCT01006590|323509407|FG000|Overall Study|Other|3|||
94469451|NCT01006590|323509408|FG001|Overall Study|Other|2|||
94469452|NCT01410240|323509409|FG000|Overall Study|Physician Decision|0|||
94469453|NCT01410240|323509410|FG001|Overall Study|Physician Decision|0|||
94469454|NCT01410240|323509411|FG002|Overall Study|Physician Decision|1|||
94469455|NCT01410240|323509409|FG000|Overall Study|Missed week 6 assessments|1|||
94469456|NCT01410240|323509410|FG001|Overall Study|Missed week 6 assessments|1|||
94469457|NCT01410240|323509411|FG002|Overall Study|Missed week 6 assessments|1|||
94469458|NCT00981058|323509412|FG000|Overall Study|Progressive Disease|38|||
94469459|NCT00981058|323509413|FG001|Overall Study|Progressive Disease|31|||
94469460|NCT00981058|323509412|FG000|Overall Study|Lost to Follow-up|3|||
94469461|NCT00981058|323509413|FG001|Overall Study|Lost to Follow-up|2|||
94469462|NCT00981058|323509412|FG000|Overall Study|Physician Decision|4|||
94469463|NCT00981058|323509413|FG001|Overall Study|Physician Decision|5|||
94469464|NCT00981058|323509412|FG000|Overall Study|Randomization Error|0|||
94469465|NCT00981058|323509413|FG001|Overall Study|Randomization Error|1|||
94469466|NCT00981058|323509412|FG000|Overall Study|Withdrawal by Subject|24|||
94469467|NCT00981058|323509413|FG001|Overall Study|Withdrawal by Subject|22|||
94469468|NCT03810235|323509414|FG000|Overall Study|Withdrawal by Subject|2|||
94469469|NCT03810235|323509415|FG001|Overall Study|Withdrawal by Subject|0|||
94469470|NCT01275677|323509416|FG000|Overall Study|Not at risk for recurrence.|1|||
94469471|NCT01275677|323509417|FG001|Overall Study|Not at risk for recurrence.|1|||
94469472|NCT01275677|323509416|FG000|Overall Study|No follow-up|26|||
94469473|NCT01275677|323509417|FG001|Overall Study|No follow-up|37|||
94469474|NCT01275677|323509416|FG000|Overall Study|No clinical follow up.|1|||
94469475|NCT01275677|323509417|FG001|Overall Study|No clinical follow up.|4|||
94469476|NCT05053035|323509418|FG000|Overall Study|Withdrawal by Subject|1|||
94469477|NCT05053035|323509419|FG001|Overall Study|Withdrawal by Subject|0|||
94469478|NCT05182606|323509420|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
94469479|NCT01618916|323509421|FG000|Overall Study|Adverse Event|1|||
94469480|NCT01618916|323509422|FG001|Overall Study|Adverse Event|0|||
94469481|NCT01618916|323509423|FG002|Overall Study|Adverse Event|0|||
94469482|NCT01618916|323509424|FG003|Overall Study|Adverse Event|0|||
94469483|NCT01618916|323509425|FG004|Overall Study|Adverse Event|0|||
94469484|NCT01618916|323509426|FG005|Overall Study|Adverse Event|0|||
94469485|NCT01618916|323509421|FG000|Overall Study|Withdrawal by Subject|0|||
94469486|NCT01618916|323509422|FG001|Overall Study|Withdrawal by Subject|1|||
94469487|NCT01618916|323509423|FG002|Overall Study|Withdrawal by Subject|1|||
94469488|NCT01618916|323509424|FG003|Overall Study|Withdrawal by Subject|0|||
94469489|NCT01618916|323509425|FG004|Overall Study|Withdrawal by Subject|1|||
94469490|NCT01618916|323509426|FG005|Overall Study|Withdrawal by Subject|0|||
94469491|NCT01618916|323509421|FG000|Overall Study|Lost to Follow-up|1|||
94469492|NCT01618916|323509422|FG001|Overall Study|Lost to Follow-up|0|||
94469493|NCT01618916|323509423|FG002|Overall Study|Lost to Follow-up|0|||
94469494|NCT01618916|323509424|FG003|Overall Study|Lost to Follow-up|2|||
94469495|NCT01618916|323509425|FG004|Overall Study|Lost to Follow-up|0|||
94469496|NCT01618916|323509426|FG005|Overall Study|Lost to Follow-up|0|||
94469497|NCT04521114|323509427|FG000|Overall Study|Lost to Follow-up|1|||
94469498|NCT04521114|323509428|FG001|Overall Study|Lost to Follow-up|2|||
94469499|NCT04521114|323509429|FG002|Overall Study|Lost to Follow-up|0|||
94469500|NCT04521114|323509427|FG000|Overall Study|Withdrawal by Subject|1|||
94469501|NCT04521114|323509428|FG001|Overall Study|Withdrawal by Subject|2|||
94469502|NCT04521114|323509429|FG002|Overall Study|Withdrawal by Subject|2|||
94469503|NCT04521114|323509427|FG000|Overall Study|Adverse Event|1|||
94469504|NCT04521114|323509428|FG001|Overall Study|Adverse Event|0|||
94469505|NCT04521114|323509429|FG002|Overall Study|Adverse Event|0|||
94469506|NCT04521114|323509427|FG000|Overall Study|Sponsor Wish|1|||
94306231|NCT00090285|322905659|FG003|Extension 1|Other|0|||
94306232|NCT00090285|322905660|FG004|Extension 1|Other|0|||
94306233|NCT00090285|322905661|FG005|Extension 1|Other|0|||
94306234|NCT00090285|322905656|FG000|Extension 1|Moved|0|||
94469507|NCT04521114|323509428|FG001|Overall Study|Sponsor Wish|0|||
94469508|NCT04521114|323509429|FG002|Overall Study|Sponsor Wish|0|||
94469509|NCT04521114|323509427|FG000|Overall Study|Withdrawal of Consent|2|||
94469510|NCT04521114|323509428|FG001|Overall Study|Withdrawal of Consent|2|||
94469511|NCT04521114|323509429|FG002|Overall Study|Withdrawal of Consent|0|||
94469512|NCT00553358|323509430|FG000|Overall Study|Randomized but did not receive treatment|3|||
94469513|NCT00553358|323509431|FG001|Overall Study|Randomized but did not receive treatment|3|||
94469514|NCT00553358|323509432|FG002|Overall Study|Randomized but did not receive treatment|1|||
94469515|NCT00553358|323509430|FG000|Overall Study|Lost to Follow-up|22|||
94469516|NCT00553358|323509431|FG001|Overall Study|Lost to Follow-up|26|||
94469517|NCT00553358|323509432|FG002|Overall Study|Lost to Follow-up|18|||
94306235|NCT00090285|322905657|FG001|Extension 1|Moved|0|||
94469518|NCT00553358|323509430|FG000|Overall Study|Withdrew completely|23|||
94469519|NCT00553358|323509431|FG001|Overall Study|Withdrew completely|33|||
94469520|NCT00553358|323509432|FG002|Overall Study|Withdrew completely|34|||
94469521|NCT00553358|323509430|FG000|Overall Study|Died during clinical follow-up|25|||
94469522|NCT00553358|323509431|FG001|Overall Study|Died during clinical follow-up|29|||
94469523|NCT00553358|323509432|FG002|Overall Study|Died during clinical follow-up|32|||
94469524|NCT00553358|323509430|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
94469525|NCT00553358|323509431|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
94469526|NCT00553358|323509432|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
94469527|NCT00553358|323509430|FG000|Overall Study|Died after clinical follow-up ended|1|||
94469528|NCT00553358|323509431|FG001|Overall Study|Died after clinical follow-up ended|2|||
94469529|NCT00553358|323509432|FG002|Overall Study|Died after clinical follow-up ended|0|||
94469530|NCT00553358|323509430|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
94469531|NCT00553358|323509431|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
94469532|NCT00553358|323509432|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
94469533|NCT01133288|323509435|FG000|Eligibility Assessment|met exclusion criteria|5|||
94469534|NCT01133288|323509435|FG000|Intervention Allocation|study terminated|2|||
94469535|NCT02005627|323509438|FG000|Overall Study|Lost to Follow-up|1|||
94469536|NCT02005627|323509439|FG001|Overall Study|Lost to Follow-up|2|||
94469537|NCT02005627|323509438|FG000|Overall Study|Withdrawal by Subject|1|||
94469538|NCT02005627|323509439|FG001|Overall Study|Withdrawal by Subject|2|||
94469539|NCT00269477|323509440|FG000|Overall Study|Protocol Violation|5|||
94469540|NCT00269477|323509441|FG001|Overall Study|Protocol Violation|5|||
94469541|NCT00269477|323509442|FG002|Overall Study|Protocol Violation|1|||
94469542|NCT00269477|323509443|FG003|Overall Study|Protocol Violation|0|||
94469543|NCT00269477|323509440|FG000|Overall Study|Missed post-vaccination blood draw|0|||
94469544|NCT00269477|323509441|FG001|Overall Study|Missed post-vaccination blood draw|1|||
94469545|NCT00269477|323509442|FG002|Overall Study|Missed post-vaccination blood draw|0|||
94469546|NCT00269477|323509443|FG003|Overall Study|Missed post-vaccination blood draw|0|||
94469547|NCT00431067|323509448|FG000|Overall Study|Other Adverse Event|9|||
94469548|NCT00431067|323509448|FG000|Overall Study|Progressive disease|30|||
94469549|NCT00431067|323509448|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
94469550|NCT01017601|323509450|FG000|Overall Study|Disease Progression|12|||
94469551|NCT01017601|323509451|FG001|Overall Study|Disease Progression|12|||
94469552|NCT01017601|323509450|FG000|Overall Study|Withdrawal by Subject|0|||
94469553|NCT01017601|323509451|FG001|Overall Study|Withdrawal by Subject|1|||
94469554|NCT03742258|323509452|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
94469555|NCT03742258|323509453|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
94469556|NCT03742258|323509454|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
94469557|NCT03742258|323509452|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
94469558|NCT03742258|323509453|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
94306236|NCT00090285|322905658|FG002|Extension 1|Moved|3|||
94306237|NCT00090285|322905659|FG003|Extension 1|Moved|0|||
94469559|NCT03742258|323509454|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
94469560|NCT03742258|323509452|FG000|Survival Follow-Up|Still in Follow-up|0|||
94469561|NCT03742258|323509453|FG001|Survival Follow-Up|Still in Follow-up|0|||
94469562|NCT03742258|323509454|FG002|Survival Follow-Up|Still in Follow-up|2|||
94469563|NCT02028169|323509457|FG000|Overall Study|Lost to Follow-up|21|||
94469564|NCT02028169|323509457|FG000|Overall Study|Lack of Efficacy|2|||
94469565|NCT02028169|323509457|FG000|Overall Study|Withdrawal by Subject|2|||
94469566|NCT02028169|323509457|FG000|Overall Study|Adverse Event|1|||
94469567|NCT02028169|323509457|FG000|Overall Study|Cessation of Drug|1|||
94469568|NCT02028169|323509457|FG000|Overall Study|Concomitant Medication Usage|1|||
94469569|NCT02732327|323509463|FG000|Overall Study|Protocol Violation|0|||
94469570|NCT02732327|323509464|FG001|Overall Study|Protocol Violation|1|||
94469571|NCT04503668|323509467|FG000|Overall Study|Incomplete data|4|||
94469572|NCT04503668|323509468|FG001|Overall Study|Incomplete data|3|||
94469573|NCT04503668|323509467|FG000|Overall Study|Withdrawal by Subject|1|||
94469574|NCT04503668|323509468|FG001|Overall Study|Withdrawal by Subject|1|||
94469575|NCT04503668|323509467|FG000|Overall Study|Adverse Event|2|||
94469576|NCT04503668|323509468|FG001|Overall Study|Adverse Event|0|||
94469577|NCT01994902|323509471|FG000|Test Period 1|Withdrawal by Subject|3|||
94469578|NCT01994902|323509472|FG001|Test Period 1|Withdrawal by Subject|0|||
94469579|NCT01994902|323509471|FG000|Test Period 1|device deficiency with adverse event|0|||
94376718|NCT02884206|323165085|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
94376719|NCT03907280|323165090|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
94376720|NCT03907280|323165091|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
94376721|NCT03907280|323165092|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
94376722|NCT00909727|323165093|FG000|Overall Study|Adverse Event|1|||
94376723|NCT00909727|323165094|FG001|Overall Study|Adverse Event|0|||
94376724|NCT00909727|323165093|FG000|Overall Study|Wrong Genotype|1|||
94376725|NCT00909727|323165094|FG001|Overall Study|Wrong Genotype|0|||
94376726|NCT00909727|323165093|FG000|Overall Study|Withdrawal of Consent|1|||
94376727|NCT00909727|323165094|FG001|Overall Study|Withdrawal of Consent|0|||
94376728|NCT00909727|323165093|FG000|Overall Study|Prohibited Medication|1|||
94376729|NCT00909727|323165094|FG001|Overall Study|Prohibited Medication|0|||
94376730|NCT01339910|323165095|FG000|Overall Study|Withdrawal by Subject|1|||
94376731|NCT01339910|323165096|FG001|Overall Study|Withdrawal by Subject|0|||
94376732|NCT01339910|323165095|FG000|Overall Study|Physician Decision|1|||
94376733|NCT01339910|323165096|FG001|Overall Study|Physician Decision|0|||
94376734|NCT01339910|323165095|FG000|Overall Study|Disease relapse|1|||
94376735|NCT01339910|323165096|FG001|Overall Study|Disease relapse|4|||
94376736|NCT04081337|323165098|FG000|Overall Study|Adverse Event|0|||
94376737|NCT04081337|323165099|FG001|Overall Study|Adverse Event|1|||
94376738|NCT04081337|323165098|FG000|Overall Study|Withdrawal by Subject|2|||
94376739|NCT04081337|323165099|FG001|Overall Study|Withdrawal by Subject|0|||
94376740|NCT04081337|323165098|FG000|Overall Study|Physician Decision|1|||
94376741|NCT04081337|323165099|FG001|Overall Study|Physician Decision|2|||
94376742|NCT04081337|323165098|FG000|Overall Study|Lost to Follow-up|1|||
94376743|NCT04081337|323165099|FG001|Overall Study|Lost to Follow-up|0|||
94376744|NCT02688400|323165109|FG000|Overall Study|Protocol Violation|2|||
94376745|NCT02688400|323165110|FG001|Overall Study|Protocol Violation|5|||
94376746|NCT02688400|323165109|FG000|Overall Study|Lack of Efficacy|7|||
94376747|NCT02688400|323165110|FG001|Overall Study|Lack of Efficacy|7|||
94376748|NCT02688400|323165109|FG000|Overall Study|Adverse Event|21|||
94376749|NCT02688400|323165110|FG001|Overall Study|Adverse Event|12|||
94376750|NCT02688400|323165109|FG000|Overall Study|Withdrawal by Subject|15|||
94376751|NCT02688400|323165110|FG001|Overall Study|Withdrawal by Subject|13|||
94469580|NCT01994902|323509472|FG001|Test Period 1|device deficiency with adverse event|1|||
94469581|NCT01994902|323509471|FG000|Test Period 1|Adverse Event|2|||
94469582|NCT01994902|323509472|FG001|Test Period 1|Adverse Event|1|||
94469583|NCT01994902|323509471|FG000|Test Period 1|Lack of Efficacy|0|||
94469584|NCT01994902|323509472|FG001|Test Period 1|Lack of Efficacy|1|||
94469585|NCT01994902|323509471|FG000|Test Period 1|bag too small|1|||
94469586|NCT01994902|323509472|FG001|Test Period 1|bag too small|0|||
94469587|NCT01994902|323509471|FG000|Test Period 2|Withdrawal by Subject|0|||
94469588|NCT01994902|323509472|FG001|Test Period 2|Withdrawal by Subject|2|||
94469589|NCT01994902|323509471|FG000|Test Period 2|Lack of Efficacy|0|||
94469590|NCT01994902|323509472|FG001|Test Period 2|Lack of Efficacy|1|||
94469591|NCT01994902|323509471|FG000|Test Period 2|Other|0|||
94469592|NCT01994902|323509472|FG001|Test Period 2|Other|3|||
94469593|NCT01554163|323509473|FG000|Overall Study|Adverse Event|3|||
94469594|NCT01554163|323509474|FG001|Overall Study|Adverse Event|0|||
94469595|NCT01554163|323509473|FG000|Overall Study|Lack of Efficacy|1|||
94469596|NCT01554163|323509474|FG001|Overall Study|Lack of Efficacy|0|||
94469597|NCT01554163|323509473|FG000|Overall Study|Lost to Follow-up|1|||
94469598|NCT01554163|323509474|FG001|Overall Study|Lost to Follow-up|0|||
94469599|NCT01554163|323509473|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94469600|NCT01554163|323509474|FG001|Overall Study|Non-Compliance With Study Drug|1|||
94469601|NCT01554163|323509473|FG000|Overall Study|Protocol Violation|0|||
94469602|NCT01554163|323509474|FG001|Overall Study|Protocol Violation|4|||
94469603|NCT01554163|323509473|FG000|Overall Study|Withdrawal by Subject|1|||
94469604|NCT01554163|323509474|FG001|Overall Study|Withdrawal by Subject|5|||
94469605|NCT01554163|323509473|FG000|Overall Study|Not Treated|1|||
94469606|NCT01554163|323509474|FG001|Overall Study|Not Treated|0|||
94469607|NCT00467558|323509477|FG000|Overall Study|Lost to Follow-up|2|||
94376752|NCT02688400|323165109|FG000|Overall Study|No study medication intake|1|||
94376753|NCT02688400|323165110|FG001|Overall Study|No study medication intake|4|||
94376754|NCT02688400|323165109|FG000|Overall Study|Lost to Follow-up|0|||
94376755|NCT02688400|323165110|FG001|Overall Study|Lost to Follow-up|3|||
94469608|NCT00467558|323509478|FG001|Overall Study|Lost to Follow-up|0|||
94469609|NCT05188729|323509479|FG000|Overall Study|Withdrawal by Subject|0|||
94469610|NCT05188729|323509480|FG001|Overall Study|Withdrawal by Subject|0|||
94376756|NCT00673361|323165111|FG000|Overall Study|Screen Failure|2|||
94376757|NCT01338636|323165114|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
94469611|NCT05188729|323509481|FG002|Overall Study|Withdrawal by Subject|0|||
94469612|NCT05188729|323509482|FG003|Overall Study|Withdrawal by Subject|0|||
94469613|NCT05188729|323509483|FG004|Overall Study|Withdrawal by Subject|0|||
94469614|NCT05188729|323509484|FG005|Overall Study|Withdrawal by Subject|0|||
94469615|NCT05188729|323509485|FG006|Overall Study|Withdrawal by Subject|0|||
94469616|NCT05188729|323509486|FG007|Overall Study|Withdrawal by Subject|0|||
94469617|NCT05188729|323509487|FG008|Overall Study|Withdrawal by Subject|0|||
94469618|NCT05188729|323509488|FG009|Overall Study|Withdrawal by Subject|1|||
94469619|NCT05188729|323509489|FG010|Overall Study|Withdrawal by Subject|0|||
94469620|NCT05188729|323509490|FG011|Overall Study|Withdrawal by Subject|0|||
94469621|NCT05188729|323509491|FG012|Overall Study|Withdrawal by Subject|0|||
94469622|NCT05188729|323509479|FG000|Overall Study|Lost to Follow-up|0|||
94469623|NCT05188729|323509480|FG001|Overall Study|Lost to Follow-up|0|||
94469624|NCT05188729|323509481|FG002|Overall Study|Lost to Follow-up|0|||
94469625|NCT05188729|323509482|FG003|Overall Study|Lost to Follow-up|0|||
94469626|NCT05188729|323509483|FG004|Overall Study|Lost to Follow-up|0|||
94469627|NCT05188729|323509484|FG005|Overall Study|Lost to Follow-up|0|||
94469628|NCT05188729|323509485|FG006|Overall Study|Lost to Follow-up|0|||
94469629|NCT05188729|323509486|FG007|Overall Study|Lost to Follow-up|0|||
94469630|NCT05188729|323509487|FG008|Overall Study|Lost to Follow-up|0|||
94469631|NCT05188729|323509488|FG009|Overall Study|Lost to Follow-up|0|||
94469632|NCT05188729|323509489|FG010|Overall Study|Lost to Follow-up|1|||
94469633|NCT05188729|323509490|FG011|Overall Study|Lost to Follow-up|1|||
94469634|NCT05188729|323509491|FG012|Overall Study|Lost to Follow-up|0|||
94469635|NCT02824562|323511253|FG000|Overall Study|Lost to Follow-up|3|||
94469636|NCT02824562|323511254|FG001|Overall Study|Lost to Follow-up|4|||
94469637|NCT02824562|323511253|FG000|Overall Study|Death|0|||
94469638|NCT02824562|323511254|FG001|Overall Study|Death|1|||
94469639|NCT00904917|323511255|FG000|Overall Study|Lost to Follow-up|2|||
94469640|NCT00904917|323511256|FG001|Overall Study|Lost to Follow-up|2|||
94469641|NCT00904917|323511257|FG002|Overall Study|Lost to Follow-up|2|||
94469642|NCT00904917|323511258|FG003|Overall Study|Lost to Follow-up|2|||
94469643|NCT04122625|323511260|FG000|Part A (up to 2.92 Years)|Death|2|||
94469644|NCT04122625|323511261|FG001|Part A (up to 2.92 Years)|Death|4|||
94469645|NCT04122625|323511262|FG002|Part A (up to 2.92 Years)|Death|0|||
94469646|NCT04122625|323511263|FG003|Part A (up to 2.92 Years)|Death|0|||
94469647|NCT04122625|323511264|FG004|Part A (up to 2.92 Years)|Death|0|||
94469648|NCT04122625|323511265|FG005|Part A (up to 2.92 Years)|Death|0|||
94469649|NCT04122625|323511260|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
94469650|NCT04122625|323511261|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
94469651|NCT04122625|323511262|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
94469652|NCT04122625|323511263|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
94469653|NCT04122625|323511264|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
94469654|NCT04122625|323511265|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
94469655|NCT04122625|323511260|FG000|Part B (up to 2.33 Years)|Death|0|||
94469656|NCT04122625|323511261|FG001|Part B (up to 2.33 Years)|Death|0|||
94469657|NCT04122625|323511262|FG002|Part B (up to 2.33 Years)|Death|5|||
94469658|NCT04122625|323511263|FG003|Part B (up to 2.33 Years)|Death|7|||
94469659|NCT04122625|323511264|FG004|Part B (up to 2.33 Years)|Death|6|||
94469660|NCT04122625|323511265|FG005|Part B (up to 2.33 Years)|Death|7|||
94469661|NCT03699540|323511266|FG000|Overall Study|Lost to Follow-up|1|||
94469662|NCT00004088|323511268|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
94469663|NCT00004088|323511268|FG000|Overall Study|Withdrawal by Subject|1|||
94469664|NCT00004088|323511268|FG000|Overall Study|Protocol Violation|3|||
94469665|NCT00004088|323511268|FG000|Overall Study|Physician Decision|1|||
94469666|NCT02667587|323511269|FG000|Pre-Treatment|Not reported|1|||
94306238|NCT00090285|322905660|FG004|Extension 1|Moved|0|||
94306239|NCT00090285|322905661|FG005|Extension 1|Moved|0|||
94306240|NCT00090285|322905656|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
94306241|NCT00090285|322905657|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
94306242|NCT00090285|322905658|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
94306243|NCT00090285|322905659|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
94306244|NCT00090285|322905660|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
94306245|NCT00090285|322905661|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
94306246|NCT00090285|322905656|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
94306247|NCT00090285|322905657|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
94306248|NCT00090285|322905658|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
94306249|NCT00090285|322905659|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
94306250|NCT00090285|322905660|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
94306251|NCT00090285|322905661|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
94306252|NCT00090285|322905656|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
94306253|NCT00090285|322905657|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
94469667|NCT02667587|323511270|FG001|Pre-Treatment|Not reported|0|||
94469668|NCT02667587|323511269|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
94469669|NCT02667587|323511270|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
94469670|NCT02667587|323511269|FG000|Pre-Treatment|Participant withdrew consent|0|||
94469671|NCT02667587|323511270|FG001|Pre-Treatment|Participant withdrew consent|1|||
94469672|NCT02667587|323511269|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
94376758|NCT01952574|323165117|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
94376759|NCT01952574|323165118|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
94376760|NCT01952574|323165119|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
94376761|NCT01952574|323165120|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
94376762|NCT01952574|323165121|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
94376763|NCT01952574|323165122|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
94376764|NCT01952574|323165123|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
94376765|NCT01952574|323165117|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
94376766|NCT01952574|323165118|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
94376767|NCT01952574|323165119|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
94376768|NCT01952574|323165120|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
94376769|NCT01952574|323165121|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
94376770|NCT01952574|323165122|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
94376771|NCT01952574|323165123|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
94376772|NCT01952574|323165117|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
94376773|NCT01952574|323165118|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
94376774|NCT01952574|323165119|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
94376775|NCT01952574|323165120|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
94376776|NCT01952574|323165121|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
94376777|NCT01952574|323165122|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
94376778|NCT01952574|323165123|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
94376779|NCT01952574|323165117|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
94376780|NCT01952574|323165118|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
94376781|NCT01952574|323165119|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
94376782|NCT01952574|323165120|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
94376783|NCT01952574|323165121|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
94376784|NCT01952574|323165122|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
94376785|NCT01952574|323165123|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
94376786|NCT01952574|323165117|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
94376787|NCT01952574|323165118|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
94376788|NCT01952574|323165119|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
94376789|NCT01952574|323165120|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
94376790|NCT01952574|323165121|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
94376791|NCT01952574|323165122|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
94376792|NCT01952574|323165123|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
94376793|NCT01952574|323165117|FG000|Open-label Treatment Phase|Missing|0|||
94376794|NCT01952574|323165118|FG001|Open-label Treatment Phase|Missing|0|||
94376795|NCT01952574|323165119|FG002|Open-label Treatment Phase|Missing|0|||
94376796|NCT01952574|323165120|FG003|Open-label Treatment Phase|Missing|0|||
94376797|NCT01952574|323165121|FG004|Open-label Treatment Phase|Missing|4|||
94376798|NCT01952574|323165122|FG005|Open-label Treatment Phase|Missing|0|||
94376799|NCT01952574|323165123|FG006|Open-label Treatment Phase|Missing|0|||
94376800|NCT01952574|323165117|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
94376801|NCT01952574|323165118|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
94376802|NCT01952574|323165119|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
94376803|NCT01952574|323165120|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
94376804|NCT01952574|323165121|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
94376805|NCT01952574|323165122|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
94376806|NCT01952574|323165123|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
94376807|NCT01952574|323165117|FG000|Open-label Treatment Phase|Death|0|||
94376808|NCT01952574|323165118|FG001|Open-label Treatment Phase|Death|0|||
94376809|NCT01952574|323165119|FG002|Open-label Treatment Phase|Death|0|||
94376810|NCT01952574|323165120|FG003|Open-label Treatment Phase|Death|0|||
94376811|NCT01952574|323165121|FG004|Open-label Treatment Phase|Death|1|||
94376812|NCT01952574|323165122|FG005|Open-label Treatment Phase|Death|0|||
94376813|NCT01952574|323165123|FG006|Open-label Treatment Phase|Death|0|||
94376814|NCT01952574|323165117|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
94376815|NCT01952574|323165118|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
94376816|NCT01952574|323165119|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
94376817|NCT01952574|323165120|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
94376818|NCT01952574|323165121|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
94376819|NCT01952574|323165122|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
94376820|NCT01952574|323165123|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
94376821|NCT01952574|323165117|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
94376822|NCT01952574|323165118|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
94376823|NCT01952574|323165119|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
94376824|NCT01952574|323165120|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
94376825|NCT01952574|323165121|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
94376826|NCT01952574|323165122|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
94376827|NCT01952574|323165123|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
94376828|NCT01992107|323165128|FG000|Overall Study|Administrative reasons|2|||
94376829|NCT01992107|323165129|FG001|Overall Study|Administrative reasons|0|||
94376830|NCT01992107|323165130|FG002|Overall Study|Administrative reasons|0|||
94376831|NCT01992107|323165128|FG000|Overall Study|Adverse Event|0|||
94376832|NCT01992107|323165129|FG001|Overall Study|Adverse Event|1|||
94376833|NCT01992107|323165130|FG002|Overall Study|Adverse Event|0|||
94376834|NCT01992107|323165128|FG000|Overall Study|Lost to Follow-up|46|||
94376835|NCT01992107|323165129|FG001|Overall Study|Lost to Follow-up|22|||
94376836|NCT01992107|323165130|FG002|Overall Study|Lost to Follow-up|26|||
94376837|NCT01992107|323165128|FG000|Overall Study|noncompliance and were unavailable|7|||
94376838|NCT01992107|323165129|FG001|Overall Study|noncompliance and were unavailable|3|||
94376839|NCT01992107|323165130|FG002|Overall Study|noncompliance and were unavailable|2|||
94376840|NCT01992107|323165128|FG000|Overall Study|Withdrawal by Subject|13|||
94376841|NCT01992107|323165129|FG001|Overall Study|Withdrawal by Subject|7|||
94376842|NCT01992107|323165130|FG002|Overall Study|Withdrawal by Subject|8|||
94376843|NCT01107535|323165131|FG000|Overall Study|Death|5|||
94376844|NCT00886483|323165132|FG000|Overall Study|Lost to Follow-up|0|||
94376845|NCT00886483|323165133|FG001|Overall Study|Lost to Follow-up|1|||
94376846|NCT00886483|323165132|FG000|Overall Study|Pursue medications|1|||
94376847|NCT00886483|323165133|FG001|Overall Study|Pursue medications|2|||
94376848|NCT00886483|323165132|FG000|Overall Study|Distance to center, poor grades|1|||
94376849|NCT00886483|323165133|FG001|Overall Study|Distance to center, poor grades|0|||
94376850|NCT00585351|323165134|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
94376851|NCT00585351|323165135|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
94376852|NCT00585351|323165136|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
94376853|NCT00585351|323165137|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
94376854|NCT00585351|323165138|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
94376855|NCT00585351|323165139|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
94376856|NCT00585351|323165140|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
94376857|NCT00585351|323165141|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
94376858|NCT00585351|323165134|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
94376859|NCT00585351|323165135|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
94376860|NCT00585351|323165136|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
94376861|NCT00585351|323165137|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
94376862|NCT00585351|323165138|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
94376863|NCT00585351|323165139|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
94376864|NCT00585351|323165140|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
94376865|NCT00585351|323165141|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
94376866|NCT00585351|323165134|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
94376867|NCT00585351|323165135|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
94376868|NCT00585351|323165136|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
94376869|NCT00585351|323165137|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
94376870|NCT00585351|323165138|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
94376871|NCT00585351|323165139|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
94376872|NCT00585351|323165140|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
94376873|NCT00585351|323165141|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
94376874|NCT00585351|323165134|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
94376875|NCT00585351|323165135|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
94469673|NCT02667587|323511270|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
94469674|NCT02667587|323511269|FG000|End of Treatment|Disease Progression|193|||
94469675|NCT02667587|323511270|FG001|End of Treatment|Disease Progression|226|||
94469676|NCT02667587|323511269|FG000|End of Treatment|Study Drug Toxicity|75|||
94469677|NCT02667587|323511270|FG001|End of Treatment|Study Drug Toxicity|19|||
94469678|NCT02667587|323511269|FG000|End of Treatment|Death|2|||
94469679|NCT02667587|323511270|FG001|End of Treatment|Death|1|||
94469680|NCT02667587|323511269|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
94469681|NCT02667587|323511270|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
94469682|NCT02667587|323511269|FG000|End of Treatment|participant request to discontinue treatment|33|||
94469683|NCT02667587|323511270|FG001|End of Treatment|participant request to discontinue treatment|35|||
94469684|NCT02667587|323511269|FG000|End of Treatment|participant withdrew consent|5|||
94469685|NCT02667587|323511270|FG001|End of Treatment|participant withdrew consent|6|||
94469686|NCT02667587|323511269|FG000|End of Treatment|Lost to Follow-up|1|||
94469687|NCT02667587|323511270|FG001|End of Treatment|Lost to Follow-up|2|||
94469688|NCT02667587|323511269|FG000|End of Treatment|maximum clinical benefit|4|||
94469689|NCT02667587|323511270|FG001|End of Treatment|maximum clinical benefit|4|||
94469690|NCT02667587|323511269|FG000|End of Treatment|poor or non compliant|0|||
94469691|NCT02667587|323511270|FG001|End of Treatment|poor or non compliant|1|||
94469692|NCT02667587|323511269|FG000|End of Treatment|participant no longer meets study criteria|1|||
94469693|NCT02667587|323511270|FG001|End of Treatment|participant no longer meets study criteria|1|||
94469694|NCT02667587|323511269|FG000|End of Treatment|administrative reason by sponsor|1|||
94469695|NCT02667587|323511270|FG001|End of Treatment|administrative reason by sponsor|29|||
94469696|NCT02667587|323511269|FG000|End of Treatment|other reasonse|21|||
94469697|NCT02667587|323511270|FG001|End of Treatment|other reasonse|10|||
94469698|NCT01134263|323511271|FG000|Overall Study|Serious adverse event|2|||
94469699|NCT01134263|323511272|FG001|Overall Study|Serious adverse event|1|||
94469700|NCT01134263|323511273|FG002|Overall Study|Serious adverse event|1|||
94469701|NCT01134263|323511274|FG003|Overall Study|Serious adverse event|1|||
94469702|NCT01134263|323511275|FG004|Overall Study|Serious adverse event|1|||
94469703|NCT01134263|323511271|FG000|Overall Study|Other adverse event|1|||
94469704|NCT01134263|323511272|FG001|Overall Study|Other adverse event|2|||
94469705|NCT01134263|323511273|FG002|Overall Study|Other adverse event|5|||
94469706|NCT01134263|323511274|FG003|Overall Study|Other adverse event|3|||
94469707|NCT01134263|323511275|FG004|Overall Study|Other adverse event|0|||
94469708|NCT01134263|323511271|FG000|Overall Study|Protocol Violation|8|||
94469709|NCT01134263|323511272|FG001|Overall Study|Protocol Violation|7|||
94469710|NCT01134263|323511273|FG002|Overall Study|Protocol Violation|2|||
94469711|NCT01134263|323511274|FG003|Overall Study|Protocol Violation|4|||
94469712|NCT01134263|323511275|FG004|Overall Study|Protocol Violation|2|||
94469713|NCT01134263|323511271|FG000|Overall Study|Lost to Follow-up|4|||
94469714|NCT01134263|323511272|FG001|Overall Study|Lost to Follow-up|3|||
94469715|NCT01134263|323511273|FG002|Overall Study|Lost to Follow-up|5|||
94469716|NCT01134263|323511274|FG003|Overall Study|Lost to Follow-up|3|||
94469717|NCT01134263|323511275|FG004|Overall Study|Lost to Follow-up|1|||
94469718|NCT01134263|323511271|FG000|Overall Study|Withdrawal by Subject|8|||
94469719|NCT01134263|323511272|FG001|Overall Study|Withdrawal by Subject|6|||
94469720|NCT01134263|323511273|FG002|Overall Study|Withdrawal by Subject|16|||
94469721|NCT01134263|323511274|FG003|Overall Study|Withdrawal by Subject|7|||
94469722|NCT01134263|323511275|FG004|Overall Study|Withdrawal by Subject|5|||
94469723|NCT01134263|323511271|FG000|Overall Study|Enrolled, but not treated|1|||
94469724|NCT01134263|323511272|FG001|Overall Study|Enrolled, but not treated|1|||
94469725|NCT01134263|323511273|FG002|Overall Study|Enrolled, but not treated|0|||
94469726|NCT01134263|323511274|FG003|Overall Study|Enrolled, but not treated|1|||
94469727|NCT01134263|323511275|FG004|Overall Study|Enrolled, but not treated|0|||
94469728|NCT02700698|323511280|FG000|Overall Study|Withdrawal by Subject|1|||
94469729|NCT02700698|323511281|FG001|Overall Study|Withdrawal by Subject|0|||
94469730|NCT00703118|323511282|FG000|Overall Study|Adverse Event|1|||
94469731|NCT00703118|323511283|FG001|Overall Study|Adverse Event|2|||
94469732|NCT00703118|323511284|FG002|Overall Study|Adverse Event|2|||
94469733|NCT00703118|323511282|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
94469734|NCT00703118|323511283|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
94469735|NCT00703118|323511284|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
94469736|NCT00703118|323511282|FG000|Overall Study|Lost to Follow-up|6|||
94469737|NCT00703118|323511283|FG001|Overall Study|Lost to Follow-up|4|||
94469738|NCT00703118|323511284|FG002|Overall Study|Lost to Follow-up|4|||
94469739|NCT00703118|323511282|FG000|Overall Study|Withdrawal by Subject|8|||
94469740|NCT00703118|323511283|FG001|Overall Study|Withdrawal by Subject|7|||
94469741|NCT00703118|323511284|FG002|Overall Study|Withdrawal by Subject|13|||
94469742|NCT00703118|323511282|FG000|Overall Study|Other|0|||
94469743|NCT00703118|323511283|FG001|Overall Study|Other|0|||
94469744|NCT00703118|323511284|FG002|Overall Study|Other|1|||
94469745|NCT04165135|323511285|FG000|Overall Study|Protocol Violation|10|||
94306254|NCT00090285|322905658|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
94306255|NCT00090285|322905659|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
94306256|NCT00090285|322905660|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
94306257|NCT00090285|322905661|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
94306258|NCT00090285|322905656|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
94376876|NCT00585351|323165136|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
94376877|NCT00585351|323165137|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
94376878|NCT00585351|323165138|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
94376879|NCT00585351|323165139|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
94376880|NCT00585351|323165140|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
94376881|NCT00585351|323165141|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
94376882|NCT00585351|323165134|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
94376883|NCT00585351|323165135|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
94376884|NCT00585351|323165136|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
94376885|NCT00585351|323165137|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
94376886|NCT00585351|323165138|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
94376887|NCT00585351|323165139|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
94376888|NCT00585351|323165140|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
94376889|NCT00585351|323165141|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
94376890|NCT00585351|323165134|FG000|Enrollment Period (Intervention)|Death|0|||
94376891|NCT00585351|323165135|FG001|Enrollment Period (Intervention)|Death|0|||
94376892|NCT00585351|323165136|FG002|Enrollment Period (Intervention)|Death|0|||
94306259|NCT00090285|322905657|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
94306260|NCT00090285|322905658|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
94306261|NCT00090285|322905659|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
94306262|NCT00090285|322905660|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
94306263|NCT00090285|322905661|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
94306264|NCT01458340|322905662|FG000|Overall Study|Adverse Event|5|||
94306265|NCT01458340|322905663|FG001|Overall Study|Adverse Event|4|||
94306266|NCT01458340|322905664|FG002|Overall Study|Adverse Event|2|||
94306267|NCT01458340|322905662|FG000|Overall Study|Lost to Follow-up|3|||
94306268|NCT01458340|322905663|FG001|Overall Study|Lost to Follow-up|3|||
94306269|NCT01458340|322905664|FG002|Overall Study|Lost to Follow-up|10|||
94306270|NCT01458340|322905662|FG000|Overall Study|Miscellaneous|0|||
94306271|NCT01458340|322905663|FG001|Overall Study|Miscellaneous|1|||
94306272|NCT01458340|322905664|FG002|Overall Study|Miscellaneous|0|||
94306273|NCT01458340|322905662|FG000|Overall Study|Physician Decision|1|||
94306274|NCT01458340|322905663|FG001|Overall Study|Physician Decision|1|||
94306275|NCT01458340|322905664|FG002|Overall Study|Physician Decision|2|||
94306276|NCT01458340|322905662|FG000|Overall Study|Protocol Violation|6|||
94306277|NCT01458340|322905663|FG001|Overall Study|Protocol Violation|6|||
94306278|NCT01458340|322905664|FG002|Overall Study|Protocol Violation|5|||
94306279|NCT01458340|322905662|FG000|Overall Study|Withdrawal by Subject|12|||
94306280|NCT01458340|322905663|FG001|Overall Study|Withdrawal by Subject|6|||
94306281|NCT01458340|322905664|FG002|Overall Study|Withdrawal by Subject|4|||
94306282|NCT00098345|322905665|FG000|Overall Study|Adverse Event|7|||
94306283|NCT00098345|322905665|FG000|Overall Study|Withdrawal by Subject|2|||
94306284|NCT00098345|322905665|FG000|Overall Study|progression|4|||
94306285|NCT03334214|322905666|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
94306286|NCT03334214|322905667|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
94306287|NCT03334214|322905666|FG000|Overall Study|Withdrawal by Subject|0|||
94306288|NCT03334214|322905667|FG001|Overall Study|Withdrawal by Subject|1|||
94306289|NCT03334214|322905666|FG000|Overall Study|Other|1|||
94306290|NCT03334214|322905667|FG001|Overall Study|Other|0|||
94306291|NCT02747043|322905668|FG000|Overall Study|Other|1|||
94306292|NCT02747043|322905669|FG001|Overall Study|Other|1|||
94306293|NCT02747043|322905668|FG000|Overall Study|Adverse Event|3|||
94306294|NCT02747043|322905669|FG001|Overall Study|Adverse Event|1|||
94306295|NCT02747043|322905668|FG000|Overall Study|Withdrawal by Subject|1|||
94306296|NCT02747043|322905669|FG001|Overall Study|Withdrawal by Subject|1|||
94306297|NCT02747043|322905668|FG000|Overall Study|Physician Decision|1|||
94306298|NCT02747043|322905669|FG001|Overall Study|Physician Decision|1|||
94306299|NCT02747043|322905668|FG000|Overall Study|Protocol Violation|0|||
94306300|NCT02747043|322905669|FG001|Overall Study|Protocol Violation|1|||
94306301|NCT02747043|322905668|FG000|Overall Study|Disease progression|4|||
94306302|NCT02747043|322905669|FG001|Overall Study|Disease progression|0|||
94306303|NCT03707977|322905670|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
94306304|NCT03707977|322905671|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
94306305|NCT03707977|322905672|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
94306306|NCT03707977|322905670|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
94306307|NCT03707977|322905671|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
94306308|NCT03707977|322905672|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
94376893|NCT00585351|323165137|FG003|Enrollment Period (Intervention)|Death|0|||
94376894|NCT00585351|323165138|FG004|Enrollment Period (Intervention)|Death|1|||
94376895|NCT00585351|323165139|FG005|Enrollment Period (Intervention)|Death|0|||
94376896|NCT00585351|323165140|FG006|Enrollment Period (Intervention)|Death|1|||
94376897|NCT00585351|323165141|FG007|Enrollment Period (Intervention)|Death|0|||
94376898|NCT00585351|323165134|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
94376899|NCT00585351|323165135|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
94376900|NCT00585351|323165136|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
94376901|NCT00585351|323165137|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
94376902|NCT00585351|323165138|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
94376903|NCT00585351|323165139|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
94376904|NCT00585351|323165140|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
94376905|NCT00585351|323165141|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
94376906|NCT01842958|323165142|FG000|Overall Study|Lost to Follow-up|1|||
94376907|NCT01842958|323165143|FG001|Overall Study|Lost to Follow-up|1|||
94376908|NCT01829477|323165144|FG000|Overall Study|Study Terminated by Sponsor|15|||
94376909|NCT01829477|323165145|FG001|Overall Study|Study Terminated by Sponsor|15|||
94376910|NCT01829477|323165144|FG000|Overall Study|Withdrawal by Subject|1|||
94376911|NCT01829477|323165145|FG001|Overall Study|Withdrawal by Subject|0|||
94376912|NCT02974114|323165146|FG000|Overall Study|Other (Not specified)|0|||
94376913|NCT02974114|323165147|FG001|Overall Study|Other (Not specified)|1|||
94376914|NCT02974114|323165148|FG002|Overall Study|Other (Not specified)|2|||
94376915|NCT00798889|323165149|FG000|Overall Study|Adverse Event|53|||
94376916|NCT00798889|323165149|FG000|Overall Study|Protocol Violation|2|||
94376917|NCT00798889|323165149|FG000|Overall Study|Withdrawal by Subject|31|||
94376918|NCT00798889|323165149|FG000|Overall Study|Lost to Follow-up|1|||
94376919|NCT00798889|323165149|FG000|Overall Study|Lack of Efficacy|213|||
94376920|NCT00798889|323165149|FG000|Overall Study|Decision of Sponsor|11|||
94376921|NCT00798889|323165149|FG000|Overall Study|Enrolled, Not treated|3|||
94376922|NCT01821625|323165152|FG000|Overall Study|Withdrawal by Subject|2|||
94376923|NCT01821625|323165152|FG000|Overall Study|Lack of Efficacy|2|||
94376924|NCT01821625|323165152|FG000|Overall Study|Adverse Event|1|||
94376925|NCT01821625|323165152|FG000|Overall Study|Medical contraindication|1|||
94376926|NCT01752920|323165153|FG000|Overall Study|Adverse Event|1|||
94306309|NCT03842709|322905673|FG000|Overall Study|Withdrawal by Subject|3|||
94306310|NCT03842709|322905674|FG001|Overall Study|Withdrawal by Subject|3|||
94306311|NCT03842709|322905673|FG000|Overall Study|Lost to Follow-up|1|||
94376927|NCT01752920|323165154|FG001|Overall Study|Adverse Event|0|||
94376928|NCT01752920|323165155|FG002|Overall Study|Adverse Event|5|||
94306312|NCT03842709|322905674|FG001|Overall Study|Lost to Follow-up|0|||
94306313|NCT00947154|322905675|FG000|Overall Study|Lost to Follow-up|1|||
94376929|NCT01752920|323165156|FG003|Overall Study|Adverse Event|10|||
94306314|NCT02296125|322905676|FG000|Overall Study|Withdrawal by Subject|18|||
94306315|NCT02296125|322905677|FG001|Overall Study|Withdrawal by Subject|8|||
94306316|NCT02296125|322905678|FG002|Overall Study|Withdrawal by Subject|6|||
94306317|NCT02296125|322905679|FG003|Overall Study|Withdrawal by Subject|2|||
94306318|NCT02296125|322905676|FG000|Overall Study|Adverse Event|41|||
94306319|NCT02296125|322905677|FG001|Overall Study|Adverse Event|52|||
94306320|NCT02296125|322905678|FG002|Overall Study|Adverse Event|9|||
94306321|NCT02296125|322905679|FG003|Overall Study|Adverse Event|4|||
94306322|NCT02296125|322905676|FG000|Overall Study|Severe non-compliance to protocol|0|||
94306323|NCT02296125|322905677|FG001|Overall Study|Severe non-compliance to protocol|1|||
94306324|NCT02296125|322905678|FG002|Overall Study|Severe non-compliance to protocol|0|||
94306325|NCT02296125|322905679|FG003|Overall Study|Severe non-compliance to protocol|0|||
94306326|NCT02296125|322905676|FG000|Overall Study|Condition under investigation worsened|153|||
94306327|NCT02296125|322905677|FG001|Overall Study|Condition under investigation worsened|199|||
94306328|NCT02296125|322905678|FG002|Overall Study|Condition under investigation worsened|39|||
94306329|NCT02296125|322905679|FG003|Overall Study|Condition under investigation worsened|56|||
94306330|NCT02296125|322905676|FG000|Overall Study|Any reason not specifically recorded|6|||
94376930|NCT01752920|323165153|FG000|Overall Study|Clinical Disease Progression|6|||
94376931|NCT01752920|323165154|FG001|Overall Study|Clinical Disease Progression|4|||
94376932|NCT01752920|323165155|FG002|Overall Study|Clinical Disease Progression|1|||
94376933|NCT01752920|323165156|FG003|Overall Study|Clinical Disease Progression|13|||
94376934|NCT01752920|323165153|FG000|Overall Study|Physician Decision|1|||
94376935|NCT01752920|323165154|FG001|Overall Study|Physician Decision|0|||
94376936|NCT01752920|323165155|FG002|Overall Study|Physician Decision|0|||
94376937|NCT01752920|323165156|FG003|Overall Study|Physician Decision|3|||
94376938|NCT01752920|323165153|FG000|Overall Study|Radiographic Disease Progression|20|||
94376939|NCT01752920|323165154|FG001|Overall Study|Radiographic Disease Progression|7|||
94376940|NCT01752920|323165155|FG002|Overall Study|Radiographic Disease Progression|12|||
94376941|NCT01752920|323165156|FG003|Overall Study|Radiographic Disease Progression|29|||
94376942|NCT01752920|323165153|FG000|Overall Study|Study Terminated by Sponsor|0|||
94376943|NCT01752920|323165154|FG001|Overall Study|Study Terminated by Sponsor|0|||
94376944|NCT01752920|323165155|FG002|Overall Study|Study Terminated by Sponsor|0|||
94376945|NCT01752920|323165156|FG003|Overall Study|Study Terminated by Sponsor|1|||
94376946|NCT01752920|323165153|FG000|Overall Study|Withdrawal by Subject|0|||
94306331|NCT02296125|322905677|FG001|Overall Study|Any reason not specifically recorded|4|||
94306332|NCT02296125|322905678|FG002|Overall Study|Any reason not specifically recorded|2|||
94306333|NCT02296125|322905679|FG003|Overall Study|Any reason not specifically recorded|0|||
94306334|NCT00637728|322905680|FG000|Double-blind Phase|Adverse Event|1|||
94306335|NCT00637728|322905681|FG001|Double-blind Phase|Adverse Event|0|||
94306336|NCT00637728|322905682|FG002|Double-blind Phase|Adverse Event|0|||
94306337|NCT00637728|322905680|FG000|Double-blind Phase|Non-compliance|2|||
94306338|NCT00637728|322905681|FG001|Double-blind Phase|Non-compliance|0|||
94306339|NCT00637728|322905682|FG002|Double-blind Phase|Non-compliance|0|||
94306340|NCT00637728|322905680|FG000|Double-blind Phase|Study Discontinued|1|||
94306341|NCT00637728|322905681|FG001|Double-blind Phase|Study Discontinued|1|||
94306342|NCT00637728|322905682|FG002|Double-blind Phase|Study Discontinued|0|||
94306343|NCT03065530|322905686|FG000|Overall Study|Lack of Efficacy|1|||
94306344|NCT03065530|322905687|FG001|Overall Study|Lack of Efficacy|1|||
94306345|NCT03065530|322905688|FG002|Overall Study|Lack of Efficacy|0|||
94306346|NCT03065530|322905689|FG003|Overall Study|Lack of Efficacy|1|||
94306347|NCT03065530|322905686|FG000|Overall Study|Protocol Violation|1|||
94306348|NCT03065530|322905687|FG001|Overall Study|Protocol Violation|0|||
94306349|NCT03065530|322905688|FG002|Overall Study|Protocol Violation|1|||
94306350|NCT03065530|322905689|FG003|Overall Study|Protocol Violation|1|||
94306351|NCT03047213|322905690|FG000|Overall Study|Withdrawal by Subject|2|||
94306352|NCT03047213|322905691|FG001|Overall Study|Withdrawal by Subject|0|||
94306353|NCT03047213|322905690|FG000|Overall Study|Adverse Event|2|||
94306354|NCT03047213|322905691|FG001|Overall Study|Adverse Event|0|||
94306355|NCT02299934|322905692|FG000|Overall Study|Termination of study|13|||
94306356|NCT00414440|322905697|FG000|Core Period|Withdrawal by Subject|70|||
94306357|NCT00414440|322905698|FG001|Core Period|Withdrawal by Subject|32|||
94306358|NCT00414440|322905697|FG000|Extension Period|Lost to Follow-up|44|||
94306359|NCT00414440|322905698|FG001|Extension Period|Lost to Follow-up|52|||
94306360|NCT00414440|322905697|FG000|Extension Period|Did not consent to continue follow up|61|||
94306361|NCT00414440|322905698|FG001|Extension Period|Did not consent to continue follow up|54|||
94306362|NCT00414440|322905697|FG000|Extension Period|Other|1|||
94306363|NCT00414440|322905698|FG001|Extension Period|Other|1|||
94306364|NCT00414440|322905697|FG000|Extension Period|Administrative|16|||
94306365|NCT00414440|322905698|FG001|Extension Period|Administrative|16|||
94376947|NCT01752920|323165154|FG001|Overall Study|Withdrawal by Subject|1|||
94376948|NCT01752920|323165155|FG002|Overall Study|Withdrawal by Subject|0|||
94306366|NCT00414440|322905697|FG000|Extension Period|Death|1|||
94306367|NCT00414440|322905698|FG001|Extension Period|Death|2|||
94306368|NCT00414440|322905697|FG000|Extension Period|Withdrawal by Subject|9|||
94306369|NCT00414440|322905698|FG001|Extension Period|Withdrawal by Subject|7|||
94376949|NCT01752920|323165156|FG003|Overall Study|Withdrawal by Subject|1|||
94376950|NCT01752920|323165153|FG000|Overall Study|Lack of clinical benefit|1|||
94306370|NCT00414440|322905697|FG000|Extension Period|Not included in follow up period|18|||
94306371|NCT00414440|322905698|FG001|Extension Period|Not included in follow up period|8|||
94306372|NCT00184054|322905699|FG000|Overall Study|Adverse Event|1|||
94306373|NCT02296840|322905700|FG000|Overall Study|Adverse Event|1|||
94306374|NCT02296840|322905701|FG001|Overall Study|Adverse Event|1|||
94306375|NCT02296840|322905700|FG000|Overall Study|Protocol Violation|2|||
94306376|NCT02296840|322905701|FG001|Overall Study|Protocol Violation|1|||
94306377|NCT02296840|322905700|FG000|Overall Study|Lost to Follow-up|6|||
94306378|NCT02296840|322905701|FG001|Overall Study|Lost to Follow-up|17|||
94306379|NCT01743027|322905702|FG000|Overall Study|Adverse Event|2|||
94306380|NCT01743027|322905703|FG001|Overall Study|Adverse Event|0|||
94306381|NCT01743027|322905704|FG002|Overall Study|Adverse Event|0|||
94306382|NCT01743027|322905705|FG003|Overall Study|Adverse Event|0|||
94306383|NCT01743027|322905702|FG000|Overall Study|Lost to Follow-up|0|||
94306384|NCT01743027|322905703|FG001|Overall Study|Lost to Follow-up|0|||
94306385|NCT01743027|322905704|FG002|Overall Study|Lost to Follow-up|2|||
94306386|NCT01743027|322905705|FG003|Overall Study|Lost to Follow-up|0|||
94306387|NCT01743027|322905702|FG000|Overall Study|Progressive Disease|1|||
94306388|NCT01743027|322905703|FG001|Overall Study|Progressive Disease|4|||
94306389|NCT01743027|322905704|FG002|Overall Study|Progressive Disease|3|||
94306390|NCT01743027|322905705|FG003|Overall Study|Progressive Disease|0|||
94306391|NCT01743027|322905702|FG000|Overall Study|Protocol Violation|1|||
94306392|NCT01743027|322905703|FG001|Overall Study|Protocol Violation|1|||
94306393|NCT01743027|322905704|FG002|Overall Study|Protocol Violation|1|||
94306394|NCT01743027|322905705|FG003|Overall Study|Protocol Violation|0|||
94306395|NCT01743027|322905702|FG000|Overall Study|Withdrawal by Subject|1|||
94306396|NCT01743027|322905703|FG001|Overall Study|Withdrawal by Subject|0|||
94306397|NCT01743027|322905704|FG002|Overall Study|Withdrawal by Subject|3|||
94306398|NCT01743027|322905705|FG003|Overall Study|Withdrawal by Subject|1|||
94306399|NCT02782715|322905708|FG000|Overall Study|Withdrawal by Subject|1|||
94306400|NCT00069121|322905709|FG000|Overall Study|Death|286|||
94306401|NCT00069121|322905710|FG001|Overall Study|Death|242|||
94306402|NCT00069121|322905709|FG000|Overall Study|Withdrawal by Subject|18|||
94306403|NCT00069121|322905710|FG001|Overall Study|Withdrawal by Subject|20|||
94306404|NCT00069121|322905709|FG000|Overall Study|Lost to Follow-up|63|||
94306405|NCT00069121|322905710|FG001|Overall Study|Lost to Follow-up|63|||
94306406|NCT01208181|322905711|FG000|Part 1|Withdrawal by Subject|11|||
94306407|NCT01208181|322905712|FG001|Part 1|Withdrawal by Subject|10|||
94306408|NCT01208181|322905713|FG002|Part 1|Withdrawal by Subject|0|||
94306409|NCT01208181|322905714|FG003|Part 1|Withdrawal by Subject|0|||
94306410|NCT01208181|322905715|FG004|Part 1|Withdrawal by Subject|0|||
94306411|NCT01208181|322905711|FG000|Part 1|Technical problem|5|||
94306412|NCT01208181|322905712|FG001|Part 1|Technical problem|0|||
94306413|NCT01208181|322905713|FG002|Part 1|Technical problem|0|||
94306414|NCT01208181|322905714|FG003|Part 1|Technical problem|0|||
94306415|NCT01208181|322905715|FG004|Part 1|Technical problem|0|||
94306416|NCT01208181|322905711|FG000|Part 1|Protocol Violation|10|||
94306417|NCT01208181|322905712|FG001|Part 1|Protocol Violation|5|||
94306418|NCT01208181|322905713|FG002|Part 1|Protocol Violation|0|||
94306419|NCT01208181|322905714|FG003|Part 1|Protocol Violation|0|||
94306420|NCT01208181|322905715|FG004|Part 1|Protocol Violation|0|||
94306421|NCT01208181|322905711|FG000|Part 1|Physician Decision|4|||
94306422|NCT01208181|322905712|FG001|Part 1|Physician Decision|0|||
94306423|NCT01208181|322905713|FG002|Part 1|Physician Decision|0|||
94306424|NCT01208181|322905714|FG003|Part 1|Physician Decision|0|||
94306425|NCT01208181|322905715|FG004|Part 1|Physician Decision|0|||
94306426|NCT01208181|322905711|FG000|Part 1|Non-compliance with study drug|1|||
94306427|NCT01208181|322905712|FG001|Part 1|Non-compliance with study drug|1|||
94306428|NCT01208181|322905713|FG002|Part 1|Non-compliance with study drug|0|||
94306429|NCT01208181|322905714|FG003|Part 1|Non-compliance with study drug|0|||
94306430|NCT01208181|322905715|FG004|Part 1|Non-compliance with study drug|0|||
94306431|NCT01208181|322905711|FG000|Part 1|Lost to Follow-up|5|||
94306432|NCT01208181|322905712|FG001|Part 1|Lost to Follow-up|3|||
94306433|NCT01208181|322905713|FG002|Part 1|Lost to Follow-up|0|||
94306434|NCT01208181|322905714|FG003|Part 1|Lost to Follow-up|0|||
94306435|NCT01208181|322905715|FG004|Part 1|Lost to Follow-up|1|||
94306436|NCT01208181|322905711|FG000|Part 1|Lack of Efficacy|37|||
94306437|NCT01208181|322905712|FG001|Part 1|Lack of Efficacy|12|||
94306438|NCT01208181|322905713|FG002|Part 1|Lack of Efficacy|0|||
94469746|NCT04165135|323511285|FG000|Overall Study|Participants withdrawal of consent|5|||
94306439|NCT01208181|322905714|FG003|Part 1|Lack of Efficacy|0|||
94306440|NCT01208181|322905715|FG004|Part 1|Lack of Efficacy|17|||
94306441|NCT01208181|322905711|FG000|Part 1|Adverse Event|26|||
94306442|NCT01208181|322905712|FG001|Part 1|Adverse Event|24|||
94306443|NCT01208181|322905713|FG002|Part 1|Adverse Event|0|||
94469747|NCT00530790|323511286|FG000|Overall Study|Adverse Event|2|||
94306444|NCT01208181|322905714|FG003|Part 1|Adverse Event|0|||
94306445|NCT01208181|322905715|FG004|Part 1|Adverse Event|4|||
94306446|NCT01208181|322905711|FG000|Part 2|Adverse Event|0|||
94306447|NCT01208181|322905712|FG001|Part 2|Adverse Event|0|||
94306448|NCT01208181|322905713|FG002|Part 2|Adverse Event|6|||
94306449|NCT01208181|322905714|FG003|Part 2|Adverse Event|7|||
94306450|NCT01208181|322905715|FG004|Part 2|Adverse Event|0|||
94376951|NCT01752920|323165154|FG001|Overall Study|Lack of clinical benefit|1|||
94376952|NCT01752920|323165155|FG002|Overall Study|Lack of clinical benefit|1|||
94376953|NCT01752920|323165156|FG003|Overall Study|Lack of clinical benefit|1|||
94376954|NCT01965652|323165159|FG000|Overall Study|Adverse Event|40|||
94376955|NCT01965652|323165160|FG001|Overall Study|Adverse Event|37|||
94376956|NCT01965652|323165159|FG000|Overall Study|Withdrawal by Subject|62|||
94376957|NCT01965652|323165160|FG001|Overall Study|Withdrawal by Subject|69|||
94376958|NCT01965652|323165159|FG000|Overall Study|Lost to Follow-up|53|||
94376959|NCT01965652|323165160|FG001|Overall Study|Lost to Follow-up|40|||
94376960|NCT01965652|323165159|FG000|Overall Study|Protocol Violation|34|||
94376961|NCT01965652|323165160|FG001|Overall Study|Protocol Violation|38|||
94376962|NCT01965652|323165159|FG000|Overall Study|Death|3|||
94376963|NCT01965652|323165160|FG001|Overall Study|Death|4|||
94376964|NCT01965652|323165159|FG000|Overall Study|Other - Miscellaneous|18|||
94376965|NCT01965652|323165160|FG001|Overall Study|Other - Miscellaneous|21|||
94376966|NCT01965652|323165159|FG000|Overall Study|Pregnancy|0|||
94376967|NCT01965652|323165160|FG001|Overall Study|Pregnancy|1|||
94376968|NCT01121900|323165161|FG000|First Intervention Period|Adverse Event|1|||
94376969|NCT01121900|323165162|FG001|First Intervention Period|Adverse Event|1|||
94376970|NCT01121900|323165161|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
94376971|NCT01121900|323165162|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
94376972|NCT04274192|323165163|FG000|Overall Study|Protocol Violation|1|||
94376973|NCT04274192|323165164|FG001|Overall Study|Protocol Violation|0|||
94376974|NCT03361956|323165165|FG000|Overall Study|Adverse Event|1|||
94376975|NCT03361956|323165166|FG001|Overall Study|Adverse Event|0|||
94376976|NCT03361956|323165167|FG002|Overall Study|Adverse Event|1|||
94376977|NCT03361956|323165168|FG003|Overall Study|Adverse Event|1|||
94376978|NCT03361956|323165169|FG004|Overall Study|Adverse Event|0|||
94376979|NCT03361956|323165165|FG000|Overall Study|Other|0|||
94376980|NCT03361956|323165166|FG001|Overall Study|Other|0|||
94376981|NCT03361956|323165167|FG002|Overall Study|Other|0|||
94376982|NCT03361956|323165168|FG003|Overall Study|Other|1|||
94376983|NCT03361956|323165169|FG004|Overall Study|Other|0|||
94376984|NCT03361956|323165165|FG000|Overall Study|Withdrawal by Subject|2|||
94376985|NCT03361956|323165166|FG001|Overall Study|Withdrawal by Subject|2|||
94376986|NCT03361956|323165167|FG002|Overall Study|Withdrawal by Subject|2|||
94376987|NCT03361956|323165168|FG003|Overall Study|Withdrawal by Subject|0|||
94376988|NCT03361956|323165169|FG004|Overall Study|Withdrawal by Subject|3|||
94376989|NCT03361956|323165165|FG000|Overall Study|Disease Relapse|0|||
94376990|NCT03361956|323165166|FG001|Overall Study|Disease Relapse|0|||
94376991|NCT03361956|323165167|FG002|Overall Study|Disease Relapse|1|||
94376992|NCT03361956|323165168|FG003|Overall Study|Disease Relapse|0|||
94376993|NCT03361956|323165169|FG004|Overall Study|Disease Relapse|0|||
94376994|NCT03361956|323165165|FG000|Overall Study|Physician Decision|0|||
94376995|NCT03361956|323165166|FG001|Overall Study|Physician Decision|2|||
94376996|NCT03361956|323165167|FG002|Overall Study|Physician Decision|0|||
94376997|NCT03361956|323165168|FG003|Overall Study|Physician Decision|1|||
94376998|NCT03361956|323165169|FG004|Overall Study|Physician Decision|0|||
94376999|NCT03361956|323165165|FG000|Overall Study|Lost to Follow-up|0|||
94377000|NCT03361956|323165166|FG001|Overall Study|Lost to Follow-up|0|||
94377001|NCT03361956|323165167|FG002|Overall Study|Lost to Follow-up|1|||
94377002|NCT03361956|323165168|FG003|Overall Study|Lost to Follow-up|1|||
94377003|NCT03361956|323165169|FG004|Overall Study|Lost to Follow-up|2|||
94377004|NCT04147715|323165170|FG000|Overall Study|Adverse Event|0|||
94377005|NCT04147715|323165171|FG001|Overall Study|Adverse Event|0|||
94377006|NCT04147715|323165172|FG002|Overall Study|Adverse Event|0|||
94377007|NCT04147715|323165173|FG003|Overall Study|Adverse Event|0|||
94377008|NCT04147715|323165174|FG004|Overall Study|Adverse Event|0|||
94377009|NCT04147715|323165175|FG005|Overall Study|Adverse Event|0|||
94377010|NCT04147715|323165176|FG006|Overall Study|Adverse Event|0|||
94377011|NCT04147715|323165177|FG007|Overall Study|Adverse Event|2|||
94377012|NCT04147715|323165178|FG008|Overall Study|Adverse Event|1|||
94377013|NCT04147715|323165179|FG009|Overall Study|Adverse Event|0|||
94377014|NCT04147715|323165180|FG010|Overall Study|Adverse Event|0|||
94377015|NCT04147715|323165181|FG011|Overall Study|Adverse Event|0|||
94377016|NCT02115256|323165182|FG000|Overall Study|Withdrawal by Subject|0|||
94377017|NCT02115256|323165183|FG001|Overall Study|Withdrawal by Subject|1|||
94377018|NCT02742181|323165195|FG000|Overall Study|Physician Decision|1|||
94377019|NCT02742181|323165196|FG001|Overall Study|Physician Decision|0|||
94377020|NCT01118728|323165197|FG000|Overall Study|Adverse Event|17|||
94377021|NCT01118728|323165197|FG000|Overall Study|Lack of Efficacy|27|||
94377022|NCT01118728|323165197|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
94377023|NCT01118728|323165197|FG000|Overall Study|Withdrawal by Subject|3|||
94377024|NCT01118728|323165197|FG000|Overall Study|Lost to Follow-up|4|||
94377025|NCT02192905|323166488|FG000|Overall Study|Lost to Follow-up|1|||
94377026|NCT04467697|323166489|FG000|Overall Study|Adverse Event|2|||
94377027|NCT04467697|323166489|FG000|Overall Study|Lost to Follow-up|6|||
94377028|NCT04467697|323166489|FG000|Overall Study|Withdrawal by Subject|9|||
94377029|NCT04467697|323166489|FG000|Overall Study|Protocol Violation|3|||
94377030|NCT05751629|323166490|FG000|Overall Study|Withdrawal by Subject|6|||
94306451|NCT01208181|322905711|FG000|Part 2|Withdrawal by Subject|0|||
94306452|NCT01208181|322905712|FG001|Part 2|Withdrawal by Subject|0|||
94306453|NCT01208181|322905713|FG002|Part 2|Withdrawal by Subject|1|||
94306454|NCT01208181|322905714|FG003|Part 2|Withdrawal by Subject|1|||
94306455|NCT01208181|322905715|FG004|Part 2|Withdrawal by Subject|0|||
94306456|NCT01208181|322905711|FG000|Part 2|Protocol Violation|0|||
94306457|NCT01208181|322905712|FG001|Part 2|Protocol Violation|0|||
94306458|NCT01208181|322905713|FG002|Part 2|Protocol Violation|1|||
94306459|NCT01208181|322905714|FG003|Part 2|Protocol Violation|0|||
94306460|NCT01208181|322905715|FG004|Part 2|Protocol Violation|0|||
94306461|NCT01208181|322905711|FG000|Part 2|Physician Decision|0|||
94306462|NCT01208181|322905712|FG001|Part 2|Physician Decision|0|||
94306463|NCT01208181|322905713|FG002|Part 2|Physician Decision|1|||
94306464|NCT01208181|322905714|FG003|Part 2|Physician Decision|2|||
94306465|NCT01208181|322905715|FG004|Part 2|Physician Decision|0|||
94306466|NCT01208181|322905711|FG000|Part 2|Non-compliance with study drug|0|||
94306467|NCT01208181|322905712|FG001|Part 2|Non-compliance with study drug|0|||
94306468|NCT01208181|322905713|FG002|Part 2|Non-compliance with study drug|1|||
94306469|NCT01208181|322905714|FG003|Part 2|Non-compliance with study drug|1|||
94306470|NCT01208181|322905715|FG004|Part 2|Non-compliance with study drug|0|||
94306471|NCT01208181|322905711|FG000|Part 2|Lost to Follow-up|0|||
94306472|NCT01208181|322905712|FG001|Part 2|Lost to Follow-up|0|||
94306473|NCT01208181|322905713|FG002|Part 2|Lost to Follow-up|1|||
94306474|NCT01208181|322905714|FG003|Part 2|Lost to Follow-up|2|||
94306475|NCT01208181|322905715|FG004|Part 2|Lost to Follow-up|0|||
94306476|NCT01208181|322905711|FG000|Part 2|Lack of Efficacy|0|||
94306477|NCT01208181|322905712|FG001|Part 2|Lack of Efficacy|0|||
94306478|NCT01208181|322905713|FG002|Part 2|Lack of Efficacy|5|||
94306479|NCT01208181|322905714|FG003|Part 2|Lack of Efficacy|7|||
94306480|NCT01208181|322905715|FG004|Part 2|Lack of Efficacy|0|||
94306481|NCT00408681|322905716|FG000|Overall Study|Lack of Efficacy|2|||
94306482|NCT00408681|322905716|FG000|Overall Study|Adverse Event|7|||
94306483|NCT01787591|322905720|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
94306484|NCT01787591|322905721|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
94306485|NCT01787591|322905722|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
94306486|NCT01787591|322905723|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
94306487|NCT02725177|322905725|FG000|Overall Study|Physician Decision|4|||
94306488|NCT02725177|322905725|FG000|Overall Study|Adverse Event|1|||
94306489|NCT00793585|322905727|FG000|Overall Study|Adverse Event|1|||
94306490|NCT00793585|322905728|FG001|Overall Study|Adverse Event|1|||
94306491|NCT00793585|322905727|FG000|Overall Study|Protocol Violation|1|||
94306492|NCT00793585|322905728|FG001|Overall Study|Protocol Violation|2|||
94306493|NCT02795156|322905729|FG000|Overall Study|Progressive Disease|22|||
94306494|NCT02795156|322905730|FG001|Overall Study|Progressive Disease|7|||
94306495|NCT02795156|322905731|FG002|Overall Study|Progressive Disease|34|||
94306496|NCT02795156|322905732|FG003|Overall Study|Progressive Disease|7|||
94306497|NCT02795156|322905729|FG000|Overall Study|Adverse Event|13|||
94306498|NCT02795156|322905730|FG001|Overall Study|Adverse Event|2|||
94306499|NCT02795156|322905731|FG002|Overall Study|Adverse Event|3|||
94306500|NCT02795156|322905732|FG003|Overall Study|Adverse Event|2|||
94306501|NCT02795156|322905729|FG000|Overall Study|Death|1|||
94306502|NCT02795156|322905730|FG001|Overall Study|Death|1|||
94306503|NCT02795156|322905731|FG002|Overall Study|Death|1|||
94306504|NCT02795156|322905732|FG003|Overall Study|Death|0|||
94306505|NCT02795156|322905729|FG000|Overall Study|Physician Decision|1|||
94306506|NCT02795156|322905730|FG001|Overall Study|Physician Decision|0|||
94306507|NCT02795156|322905731|FG002|Overall Study|Physician Decision|1|||
94306508|NCT02795156|322905732|FG003|Overall Study|Physician Decision|0|||
94306509|NCT02795156|322905729|FG000|Overall Study|Withdrawal by Subject|2|||
94306510|NCT02795156|322905730|FG001|Overall Study|Withdrawal by Subject|0|||
94306511|NCT02795156|322905731|FG002|Overall Study|Withdrawal by Subject|3|||
94306512|NCT02795156|322905732|FG003|Overall Study|Withdrawal by Subject|0|||
94306513|NCT02707757|322905733|FG000|Overall Study|Protocol Violation|3|||
94306514|NCT02707757|322905734|FG001|Overall Study|Protocol Violation|2|||
94306515|NCT02707757|322905733|FG000|Overall Study|Withdrawal by Subject|2|||
94306516|NCT02707757|322905734|FG001|Overall Study|Withdrawal by Subject|0|||
94306517|NCT02707757|322905733|FG000|Overall Study|Death|0|||
94306518|NCT02707757|322905734|FG001|Overall Study|Death|1|||
94306519|NCT02707757|322905733|FG000|Overall Study|Adverse Event|6|||
94306520|NCT02707757|322905734|FG001|Overall Study|Adverse Event|4|||
94306521|NCT02707757|322905733|FG000|Overall Study|Renal transplant/elective operation|1|||
94306522|NCT02707757|322905734|FG001|Overall Study|Renal transplant/elective operation|5|||
94306523|NCT02332915|322905737|FG000|Overall Study|Moved out of region|3|||
94306524|NCT02332915|322905738|FG001|Overall Study|Moved out of region|0|||
94306525|NCT02332915|322905737|FG000|Overall Study|Unrelated illness|1|||
94306526|NCT02332915|322905738|FG001|Overall Study|Unrelated illness|1|||
94306527|NCT02332915|322905737|FG000|Overall Study|Travel distance prohibitive|0|||
94306528|NCT02332915|322905738|FG001|Overall Study|Travel distance prohibitive|1|||
94306529|NCT02332915|322905737|FG000|Overall Study|did not meet inclusion criteria|2|||
94306530|NCT02332915|322905738|FG001|Overall Study|did not meet inclusion criteria|4|||
94306531|NCT05363293|322905741|FG000|Overall Study|Withdrawal by Subject|1|||
94306532|NCT05363293|322905742|FG001|Overall Study|Withdrawal by Subject|0|||
94306533|NCT05363293|322905743|FG002|Overall Study|Withdrawal by Subject|0|||
94306534|NCT05363293|322905744|FG003|Overall Study|Withdrawal by Subject|0|||
94306535|NCT05363293|322905745|FG004|Overall Study|Withdrawal by Subject|0|||
94306536|NCT05363293|322905746|FG005|Overall Study|Withdrawal by Subject|0|||
94306537|NCT05363293|322905747|FG006|Overall Study|Withdrawal by Subject|0|||
94306538|NCT05363293|322905748|FG007|Overall Study|Withdrawal by Subject|0|||
94306539|NCT05363293|322905749|FG008|Overall Study|Withdrawal by Subject|0|||
94306540|NCT05363293|322905750|FG009|Overall Study|Withdrawal by Subject|0|||
94306541|NCT01318902|322905751|FG000|Overall Study|Symptomatic Deterioration|0|||
94306542|NCT01318902|322905752|FG001|Overall Study|Symptomatic Deterioration|1|||
94306543|NCT01318902|322905753|FG002|Overall Study|Symptomatic Deterioration|1|||
94306544|NCT01318902|322905754|FG003|Overall Study|Symptomatic Deterioration|2|||
94306545|NCT01318902|322905751|FG000|Overall Study|Withdrawal by Patient|0|||
94306546|NCT01318902|322905752|FG001|Overall Study|Withdrawal by Patient|1|||
94306547|NCT01318902|322905753|FG002|Overall Study|Withdrawal by Patient|0|||
94306548|NCT01318902|322905754|FG003|Overall Study|Withdrawal by Patient|3|||
94306549|NCT01318902|322905751|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
94306550|NCT01318902|322905752|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
94306551|NCT01318902|322905753|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
94306552|NCT01318902|322905754|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
94306553|NCT01318902|322905751|FG000|Overall Study|Adverse Event|0|||
94306554|NCT01318902|322905752|FG001|Overall Study|Adverse Event|1|||
94306555|NCT01318902|322905753|FG002|Overall Study|Adverse Event|0|||
94306556|NCT01318902|322905754|FG003|Overall Study|Adverse Event|0|||
94306557|NCT01318902|322905751|FG000|Overall Study|Terminated by Sponsor|0|||
94306558|NCT01318902|322905752|FG001|Overall Study|Terminated by Sponsor|0|||
94306559|NCT01318902|322905753|FG002|Overall Study|Terminated by Sponsor|1|||
94306560|NCT01318902|322905754|FG003|Overall Study|Terminated by Sponsor|0|||
94306561|NCT01272180|322907990|FG000|Overall Study|Adverse Event|0|||
94306562|NCT01272180|322907991|FG001|Overall Study|Adverse Event|0|||
94306563|NCT01272180|322907992|FG002|Overall Study|Adverse Event|1|||
94306564|NCT01272180|322907993|FG003|Overall Study|Adverse Event|0|||
94306565|NCT01272180|322907990|FG000|Overall Study|Withdrawal by Subject|2|||
94306566|NCT01272180|322907991|FG001|Overall Study|Withdrawal by Subject|6|||
94306567|NCT01272180|322907992|FG002|Overall Study|Withdrawal by Subject|3|||
94306568|NCT01272180|322907993|FG003|Overall Study|Withdrawal by Subject|2|||
94306569|NCT01272180|322907990|FG000|Overall Study|Lost to Follow-up|15|||
94306570|NCT01272180|322907991|FG001|Overall Study|Lost to Follow-up|14|||
94306571|NCT01272180|322907992|FG002|Overall Study|Lost to Follow-up|8|||
94306572|NCT01272180|322907993|FG003|Overall Study|Lost to Follow-up|10|||
94306573|NCT01272180|322907990|FG000|Overall Study|Inappropriate enrollment|0|||
94306574|NCT01272180|322907991|FG001|Overall Study|Inappropriate enrollment|0|||
94306575|NCT01272180|322907992|FG002|Overall Study|Inappropriate enrollment|1|||
94306576|NCT01272180|322907993|FG003|Overall Study|Inappropriate enrollment|1|||
94306577|NCT01272180|322907990|FG000|Overall Study|Protocol Violation|0|||
94306578|NCT01272180|322907991|FG001|Overall Study|Protocol Violation|1|||
94306579|NCT01272180|322907992|FG002|Overall Study|Protocol Violation|0|||
94306580|NCT01272180|322907993|FG003|Overall Study|Protocol Violation|1|||
94306581|NCT01260181|322907996|FG000|Overall Study|Decision of Investigator|1|||
94306582|NCT00635102|322907999|FG000|Overall Study|Withdrawal by Subject|7|||
94306583|NCT00635102|322908000|FG001|Overall Study|Withdrawal by Subject|8|||
94306584|NCT01380093|322908001|FG000|Naloxone Challenge Phase|Screen failures|21|||
94306585|NCT01380093|322908002|FG001|Naloxone Challenge Phase|Screen failures|0|||
94306586|NCT01380093|322908003|FG002|Naloxone Challenge Phase|Screen failures|0|||
94306587|NCT01380093|322908004|FG003|Naloxone Challenge Phase|Screen failures|0|||
94306588|NCT01380093|322908005|FG004|Naloxone Challenge Phase|Screen failures|0|||
94306589|NCT01380093|322908006|FG005|Naloxone Challenge Phase|Screen failures|0|||
94306590|NCT01380093|322908007|FG006|Naloxone Challenge Phase|Screen failures|0|||
94306591|NCT01380093|322908008|FG007|Naloxone Challenge Phase|Screen failures|0|||
94306592|NCT01380093|322908009|FG008|Naloxone Challenge Phase|Screen failures|0|||
94306593|NCT01380093|322908001|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
94306594|NCT01380093|322908002|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
94306595|NCT01380093|322908003|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
94306596|NCT01380093|322908004|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
94306597|NCT01380093|322908005|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
94306598|NCT01380093|322908006|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
94306599|NCT01380093|322908007|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
94306600|NCT01380093|322908008|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
94306601|NCT01380093|322908009|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
94377031|NCT05751629|323166490|FG000|Overall Study|Death|25|||
94377032|NCT05751629|323166490|FG000|Overall Study|Study Site Closed|9|||
94377033|NCT05751629|323166490|FG000|Overall Study|Physician Decision|1|||
94377034|NCT00829413|323166491|FG000|Overall Study|No study drug admimnistered|13|||
94377035|NCT00829413|323166491|FG000|Overall Study|Training Patients|67|||
94377036|NCT00829413|323166491|FG000|Overall Study|No truth standard procedure available|9|||
94377037|NCT00829413|323166491|FG000|Overall Study|Technically inadequate truth standard|2|||
94377038|NCT00829413|323166491|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
94377039|NCT02295774|323166493|FG000|Overall Study|Physician Decision|1|||
94377040|NCT02295774|323166493|FG000|Overall Study|Withdrawal by Subject|2|||
94377041|NCT03487796|323166494|FG000|Overall Study|Lost to Follow-up|18|||
94377042|NCT03487796|323166495|FG001|Overall Study|Lost to Follow-up|6|||
94377043|NCT01075763|323166496|FG000|Overall Study|Lost to Follow-up|2|||
94377044|NCT01075763|323166497|FG001|Overall Study|Lost to Follow-up|1|||
94377045|NCT01075763|323166496|FG000|Overall Study|Lack of Efficacy|0|||
94377046|NCT01075763|323166497|FG001|Overall Study|Lack of Efficacy|1|||
94377047|NCT01075763|323166496|FG000|Overall Study|Withdrawal by Subject|2|||
94377048|NCT01075763|323166497|FG001|Overall Study|Withdrawal by Subject|2|||
94377049|NCT04272775|323166498|FG000|Overall Study|Study Terminated by Sponsor|1|||
94377050|NCT04272775|323166499|FG001|Overall Study|Study Terminated by Sponsor|0|||
94377051|NCT04272775|323166498|FG000|Overall Study|Protocol Violation|0|||
94377052|NCT04272775|323166499|FG001|Overall Study|Protocol Violation|1|||
94377053|NCT04272775|323166498|FG000|Overall Study|Symptomatic Deterioration|1|||
94377054|NCT04272775|323166499|FG001|Overall Study|Symptomatic Deterioration|1|||
94377055|NCT04272775|323166498|FG000|Overall Study|Withdrawal by Subject|1|||
94377056|NCT04272775|323166499|FG001|Overall Study|Withdrawal by Subject|2|||
94377057|NCT04272775|323166498|FG000|Overall Study|Adverse Event|1|||
94377058|NCT04272775|323166499|FG001|Overall Study|Adverse Event|2|||
94377059|NCT04272775|323166498|FG000|Overall Study|Progressive Disease|3|||
94377060|NCT04272775|323166499|FG001|Overall Study|Progressive Disease|1|||
94377061|NCT03882047|323166502|FG000|Overall Study|Adverse Event|0|||
94377062|NCT03882047|323166503|FG001|Overall Study|Adverse Event|2|||
94377063|NCT03882047|323166504|FG002|Overall Study|Adverse Event|2|||
94377064|NCT03882047|323166502|FG000|Overall Study|Treatment Failure|3|||
94377065|NCT03882047|323166503|FG001|Overall Study|Treatment Failure|3|||
94377066|NCT03882047|323166504|FG002|Overall Study|Treatment Failure|12|||
94377067|NCT03882047|323166502|FG000|Overall Study|Lost to Follow-up|0|||
94377068|NCT03882047|323166503|FG001|Overall Study|Lost to Follow-up|1|||
94377069|NCT03882047|323166504|FG002|Overall Study|Lost to Follow-up|0|||
94377070|NCT03882047|323166502|FG000|Overall Study|Did Not Wish to Continue|1|||
94377071|NCT03882047|323166503|FG001|Overall Study|Did Not Wish to Continue|4|||
94377072|NCT03882047|323166504|FG002|Overall Study|Did Not Wish to Continue|1|||
94377073|NCT03882047|323166502|FG000|Overall Study|Noncompliance With Protocol|2|||
94377074|NCT03882047|323166503|FG001|Overall Study|Noncompliance With Protocol|0|||
94377075|NCT03882047|323166504|FG002|Overall Study|Noncompliance With Protocol|0|||
94377076|NCT03882047|323166502|FG000|Overall Study|Did Not Meet Eligibility|0|||
94377077|NCT03882047|323166503|FG001|Overall Study|Did Not Meet Eligibility|0|||
94377078|NCT03882047|323166504|FG002|Overall Study|Did Not Meet Eligibility|1|||
94377079|NCT03870997|323166505|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
94377080|NCT03870997|323166506|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
94377081|NCT03870997|323166507|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
94377082|NCT03870997|323166508|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
94377083|NCT03870997|323166509|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
94377084|NCT03870997|323166510|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
94377085|NCT01894984|323166511|FG000|Overall Study|Other|314|||
94377086|NCT01894984|323166512|FG001|Overall Study|Other|175|||
94377087|NCT03532009|323166513|FG000|Overall Study|Other|1|||
94377088|NCT03532009|323166514|FG001|Overall Study|Other|1|||
94377089|NCT03532009|323166513|FG000|Overall Study|Death|1|||
94377090|NCT03532009|323166514|FG001|Overall Study|Death|1|||
94377091|NCT03532009|323166513|FG000|Overall Study|Withdrawal by Patient|0|||
94377092|NCT03532009|323166514|FG001|Overall Study|Withdrawal by Patient|2|||
94377093|NCT01798485|323166518|FG000|Overall Study|Adverse Event|32|||
94377094|NCT01798485|323166519|FG001|Overall Study|Adverse Event|40|||
94377095|NCT01798485|323166518|FG000|Overall Study|Withdrawal by Subject|27|||
94377096|NCT01798485|323166519|FG001|Overall Study|Withdrawal by Subject|31|||
94377097|NCT01798485|323166518|FG000|Overall Study|Lost to Follow-up|0|||
94377098|NCT01798485|323166519|FG001|Overall Study|Lost to Follow-up|3|||
94377099|NCT01798485|323166518|FG000|Overall Study|Physician Decision|14|||
94377100|NCT01798485|323166519|FG001|Overall Study|Physician Decision|10|||
94377101|NCT01798485|323166518|FG000|Overall Study|Objective Disease Progression|152|||
94377102|NCT01798485|323166519|FG001|Overall Study|Objective Disease Progression|106|||
94377103|NCT01798485|323166518|FG000|Overall Study|Death|25|||
94377104|NCT01798485|323166519|FG001|Overall Study|Death|22|||
94377105|NCT01798485|323166518|FG000|Overall Study|Sponsor Decision|61|||
94377106|NCT01798485|323166519|FG001|Overall Study|Sponsor Decision|54|||
94377107|NCT01798485|323166518|FG000|Overall Study|Clinical Progression|35|||
94377108|NCT01798485|323166519|FG001|Overall Study|Clinical Progression|24|||
94377109|NCT00681863|323166520|FG000|Overall Study|Adverse Event|1|||
94377110|NCT00681863|323166520|FG000|Overall Study|Lost to Follow-up|2|||
94377111|NCT00681863|323166520|FG000|Overall Study|Lack of Efficacy|2|||
94377112|NCT00681863|323166520|FG000|Overall Study|Other|18|||
94377113|NCT02649231|323166525|FG000|Overall Study|Adverse Event|0|||
94377114|NCT02649231|323166526|FG001|Overall Study|Adverse Event|0|||
94377115|NCT02649231|323166527|FG002|Overall Study|Adverse Event|0|||
94377116|NCT02649231|323166528|FG003|Overall Study|Adverse Event|1|||
94377117|NCT02649231|323166525|FG000|Overall Study|Lost to Follow-up|2|||
94377118|NCT02649231|323166526|FG001|Overall Study|Lost to Follow-up|1|||
94377119|NCT02649231|323166527|FG002|Overall Study|Lost to Follow-up|1|||
94377120|NCT02649231|323166528|FG003|Overall Study|Lost to Follow-up|0|||
94377121|NCT02649231|323166525|FG000|Overall Study|Withdrawal by Subject|0|||
94377122|NCT02649231|323166526|FG001|Overall Study|Withdrawal by Subject|1|||
94377123|NCT02649231|323166527|FG002|Overall Study|Withdrawal by Subject|0|||
94377124|NCT02649231|323166528|FG003|Overall Study|Withdrawal by Subject|1|||
94377125|NCT02649231|323166525|FG000|Overall Study|Protocol Violation|2|||
94377126|NCT02649231|323166526|FG001|Overall Study|Protocol Violation|1|||
94377127|NCT02649231|323166527|FG002|Overall Study|Protocol Violation|1|||
94377128|NCT02649231|323166528|FG003|Overall Study|Protocol Violation|0|||
94377129|NCT02970669|323166529|FG000|Double-blind Period|Adverse Event|4|||
94377130|NCT02970669|323166530|FG001|Double-blind Period|Adverse Event|0|||
94377131|NCT02970669|323166529|FG000|Double-blind Period|Death|1|||
94377132|NCT02970669|323166530|FG001|Double-blind Period|Death|0|||
94377133|NCT02970669|323166529|FG000|Double-blind Period|Study terminated by sponsor|1|||
94377134|NCT02970669|323166530|FG001|Double-blind Period|Study terminated by sponsor|2|||
94377135|NCT02970669|323166529|FG000|Double-blind Period|Physician Decision|0|||
94377136|NCT02970669|323166530|FG001|Double-blind Period|Physician Decision|2|||
94377137|NCT02970669|323166529|FG000|Double-blind Period|Withdrawal by Subject|2|||
94377138|NCT02970669|323166530|FG001|Double-blind Period|Withdrawal by Subject|2|||
94377139|NCT02970669|323166529|FG000|Open-label Period|Withdrawal by Subject|2|||
94377140|NCT02970669|323166530|FG001|Open-label Period|Withdrawal by Subject|2|||
94377141|NCT02970669|323166529|FG000|Open-label Period|Adverse Event|1|||
94377142|NCT02970669|323166530|FG001|Open-label Period|Adverse Event|0|||
94377143|NCT02970669|323166529|FG000|Open-label Period|Physician Decision|1|||
94377144|NCT02970669|323166530|FG001|Open-label Period|Physician Decision|0|||
94377145|NCT01154153|323166531|FG000|Overall Study|Poor compliance to protocol|2|||
94377146|NCT01154153|323166532|FG001|Overall Study|Poor compliance to protocol|0|||
94377147|NCT01154153|323166531|FG000|Overall Study|Unable to use labs|2|||
94377148|NCT01154153|323166532|FG001|Overall Study|Unable to use labs|3|||
94377149|NCT01154153|323166531|FG000|Overall Study|Withdrew consent|1|||
94377150|NCT01154153|323166532|FG001|Overall Study|Withdrew consent|0|||
94377151|NCT00696709|323166533|FG000|Overall Study|Withdrawal by Subject|1|||
94377152|NCT00696709|323166534|FG001|Overall Study|Withdrawal by Subject|2|||
94377153|NCT00696709|323166535|FG002|Overall Study|Withdrawal by Subject|1|||
94377154|NCT00696709|323166536|FG003|Overall Study|Withdrawal by Subject|4|||
94377155|NCT00696709|323166537|FG004|Overall Study|Withdrawal by Subject|3|||
94377156|NCT00696709|323166533|FG000|Overall Study|Protocol Violation|1|||
94377157|NCT00696709|323166534|FG001|Overall Study|Protocol Violation|0|||
94377158|NCT00696709|323166535|FG002|Overall Study|Protocol Violation|0|||
94377159|NCT00696709|323166536|FG003|Overall Study|Protocol Violation|0|||
94377160|NCT00696709|323166537|FG004|Overall Study|Protocol Violation|0|||
94377161|NCT00696709|323166533|FG000|Overall Study|Lost to Follow-up|1|||
94377162|NCT00696709|323166534|FG001|Overall Study|Lost to Follow-up|1|||
94377163|NCT00696709|323166535|FG002|Overall Study|Lost to Follow-up|0|||
94377164|NCT00696709|323166536|FG003|Overall Study|Lost to Follow-up|0|||
94377165|NCT00696709|323166537|FG004|Overall Study|Lost to Follow-up|0|||
94469748|NCT00530790|323511286|FG000|Overall Study|Withdrawal by Subject|2|||
94469749|NCT00530790|323511286|FG000|Overall Study|Physician Decision|1|||
94469750|NCT00548249|323511296|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
94469751|NCT00548249|323511297|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
94469752|NCT00548249|323511298|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
94469753|NCT00548249|323511299|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
94306602|NCT01380093|322908001|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
94306603|NCT01380093|322908002|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
94306604|NCT01380093|322908003|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
94306605|NCT01380093|322908004|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
94306606|NCT01380093|322908005|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
94306607|NCT01380093|322908006|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
94306608|NCT01380093|322908007|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
94377166|NCT00696709|323166533|FG000|Overall Study|Adverse Event|0|||
94377167|NCT00696709|323166534|FG001|Overall Study|Adverse Event|0|||
94377168|NCT00696709|323166535|FG002|Overall Study|Adverse Event|0|||
94377169|NCT00696709|323166536|FG003|Overall Study|Adverse Event|1|||
94377170|NCT00696709|323166537|FG004|Overall Study|Adverse Event|0|||
94377171|NCT02611752|323166538|FG000|Overall Study|Adverse Event|0|||
94377172|NCT02611752|323166539|FG001|Overall Study|Adverse Event|1|||
94377173|NCT00321711|323166540|FG000|Part A|Adverse Event|3|||
94377174|NCT00321711|323166541|FG001|Part A|Adverse Event|3|||
94377175|NCT00321711|323166542|FG002|Part A|Adverse Event|2|||
94377176|NCT00321711|323166543|FG003|Part A|Adverse Event|0|||
94377177|NCT00321711|323166544|FG004|Part A|Adverse Event|0|||
94377178|NCT00321711|323166540|FG000|Part A|Withdrawal by Subject|1|||
94377179|NCT00321711|323166541|FG001|Part A|Withdrawal by Subject|1|||
94377180|NCT00321711|323166542|FG002|Part A|Withdrawal by Subject|1|||
94377181|NCT00321711|323166543|FG003|Part A|Withdrawal by Subject|0|||
94377182|NCT00321711|323166544|FG004|Part A|Withdrawal by Subject|0|||
94377183|NCT00321711|323166540|FG000|Part A|Disease progression|0|||
94377184|NCT00321711|323166541|FG001|Part A|Disease progression|1|||
94377185|NCT00321711|323166542|FG002|Part A|Disease progression|0|||
94377186|NCT00321711|323166543|FG003|Part A|Disease progression|0|||
94377187|NCT00321711|323166544|FG004|Part A|Disease progression|0|||
94377188|NCT00321711|323166540|FG000|Part A|Requirement for alternative therapy|0|||
94377189|NCT00321711|323166541|FG001|Part A|Requirement for alternative therapy|2|||
94306609|NCT01380093|322908008|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
94306610|NCT01380093|322908009|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
94306611|NCT01380093|322908001|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
94306612|NCT01380093|322908002|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
94306613|NCT01380093|322908003|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
94306614|NCT01380093|322908004|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
94306615|NCT01380093|322908005|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
94306616|NCT01380093|322908006|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
94306617|NCT01380093|322908007|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
94306618|NCT01380093|322908008|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
94306619|NCT01380093|322908009|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
94306620|NCT01380093|322908001|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
94306621|NCT01380093|322908002|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
94306622|NCT01380093|322908003|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
94306623|NCT01380093|322908004|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
94306624|NCT01380093|322908005|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
94306625|NCT01380093|322908006|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
94306626|NCT01380093|322908007|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
94306627|NCT01380093|322908008|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
94306628|NCT01380093|322908009|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
94306629|NCT01380093|322908001|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
94306630|NCT01380093|322908002|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
94377190|NCT00321711|323166542|FG002|Part A|Requirement for alternative therapy|1|||
94377191|NCT00321711|323166543|FG003|Part A|Requirement for alternative therapy|0|||
94377192|NCT00321711|323166544|FG004|Part A|Requirement for alternative therapy|0|||
94377193|NCT00321711|323166540|FG000|Part A|Physician Decision|0|||
94377194|NCT00321711|323166541|FG001|Part A|Physician Decision|1|||
94306631|NCT01380093|322908003|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
94306632|NCT01380093|322908004|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
94306633|NCT01380093|322908005|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
94306634|NCT01380093|322908006|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
94306635|NCT01380093|322908007|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
94306636|NCT01380093|322908008|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
94306637|NCT01380093|322908009|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
94306638|NCT01380093|322908001|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
94306639|NCT01380093|322908002|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
94306640|NCT01380093|322908003|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
94306641|NCT01380093|322908004|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
94306642|NCT01380093|322908005|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
94306643|NCT01380093|322908006|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
94306644|NCT01380093|322908007|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
94306645|NCT01380093|322908008|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
94306646|NCT01380093|322908009|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
94306647|NCT01380093|322908001|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
94306648|NCT01380093|322908002|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
94306649|NCT01380093|322908003|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
94306650|NCT01380093|322908004|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
94306651|NCT01380093|322908005|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
94306652|NCT01380093|322908006|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
94306653|NCT01380093|322908007|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
94306654|NCT01380093|322908008|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
94306655|NCT01380093|322908009|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
94306656|NCT01380093|322908001|FG000|Treatment Phase: Second Intervention|Other|0|||
94306657|NCT01380093|322908002|FG001|Treatment Phase: Second Intervention|Other|0|||
94306658|NCT01380093|322908003|FG002|Treatment Phase: Second Intervention|Other|0|||
94306659|NCT01380093|322908004|FG003|Treatment Phase: Second Intervention|Other|1|||
94306660|NCT01380093|322908005|FG004|Treatment Phase: Second Intervention|Other|0|||
94306661|NCT01380093|322908006|FG005|Treatment Phase: Second Intervention|Other|0|||
94306662|NCT01380093|322908007|FG006|Treatment Phase: Second Intervention|Other|0|||
94306663|NCT01380093|322908008|FG007|Treatment Phase: Second Intervention|Other|0|||
94306664|NCT01380093|322908009|FG008|Treatment Phase: Second Intervention|Other|0|||
94306665|NCT01380093|322908001|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
94306666|NCT01380093|322908002|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
94306667|NCT01380093|322908003|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
94306668|NCT01380093|322908004|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
94306669|NCT01380093|322908005|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
94306670|NCT01380093|322908006|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
94306671|NCT01380093|322908007|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
94306672|NCT01380093|322908008|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
94306673|NCT01380093|322908009|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
94306674|NCT01380093|322908001|FG000|Treatment Phase: Third Intervention|Other|0|||
94306675|NCT01380093|322908002|FG001|Treatment Phase: Third Intervention|Other|0|||
94306676|NCT01380093|322908003|FG002|Treatment Phase: Third Intervention|Other|0|||
94306677|NCT01380093|322908004|FG003|Treatment Phase: Third Intervention|Other|0|||
94306678|NCT01380093|322908005|FG004|Treatment Phase: Third Intervention|Other|0|||
94306679|NCT01380093|322908006|FG005|Treatment Phase: Third Intervention|Other|0|||
94306680|NCT01380093|322908007|FG006|Treatment Phase: Third Intervention|Other|0|||
94306681|NCT01380093|322908008|FG007|Treatment Phase: Third Intervention|Other|0|||
94306682|NCT01380093|322908009|FG008|Treatment Phase: Third Intervention|Other|1|||
94306683|NCT00308620|322908010|FG000|Overall Study|Death|1|||
94306684|NCT00308620|322908011|FG001|Overall Study|Death|1|||
94306685|NCT00308620|322908012|FG002|Overall Study|Death|0|||
94306686|NCT00308620|322908010|FG000|Overall Study|Lost to Follow-up|0|||
94306687|NCT00308620|322908011|FG001|Overall Study|Lost to Follow-up|0|||
94306688|NCT00308620|322908012|FG002|Overall Study|Lost to Follow-up|1|||
94306689|NCT00091793|322908013|FG000|Overall Study|Adverse Event|1|||
94306690|NCT00091793|322908014|FG001|Overall Study|Adverse Event|2|||
94306691|NCT00091793|322908013|FG000|Overall Study|Withdrawal by Subject|10|||
94306692|NCT00091793|322908014|FG001|Overall Study|Withdrawal by Subject|15|||
94306693|NCT00091793|322908013|FG000|Overall Study|Ineligibility determined|2|||
94306694|NCT00091793|322908014|FG001|Overall Study|Ineligibility determined|0|||
94306695|NCT00091793|322908013|FG000|Overall Study|Lost to Follow-up|7|||
94306696|NCT00091793|322908014|FG001|Overall Study|Lost to Follow-up|5|||
94306697|NCT00091793|322908013|FG000|Overall Study|Noncompliance|2|||
94377195|NCT00321711|323166542|FG002|Part A|Physician Decision|3|||
94377196|NCT00321711|323166543|FG003|Part A|Physician Decision|0|||
94377197|NCT00321711|323166544|FG004|Part A|Physician Decision|0|||
94377198|NCT00321711|323166540|FG000|Part A|Other|1|||
94377199|NCT00321711|323166541|FG001|Part A|Other|2|||
94306698|NCT00091793|322908014|FG001|Overall Study|Noncompliance|0|||
94306699|NCT00091793|322908013|FG000|Overall Study|Other|2|||
94306700|NCT00091793|322908014|FG001|Overall Study|Other|0|||
94306701|NCT01325493|322908017|FG000|Overall Study|Protocol Violation|0|||
94306702|NCT01325493|322908018|FG001|Overall Study|Protocol Violation|1|||
94306703|NCT01325493|322908017|FG000|Overall Study|loss of neuromonitoring signals|0|||
94306704|NCT01325493|322908018|FG001|Overall Study|loss of neuromonitoring signals|2|||
94306705|NCT01325493|322908017|FG000|Overall Study|Allergy|1|||
94306706|NCT01325493|322908018|FG001|Overall Study|Allergy|0|||
94306707|NCT00537745|322908019|FG000|Overall Study|Did not meet eligibility criteria|2|||
94306708|NCT00537745|322908019|FG000|Overall Study|Withdrawal by Subject|2|||
94306709|NCT00537745|322908019|FG000|Overall Study|Subject unable to provide Interlock info|1|||
94306710|NCT01508676|322908020|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
94306711|NCT01508676|322908021|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
94306712|NCT01508676|322908020|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
94306713|NCT01508676|322908021|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
94306714|NCT01508676|322908020|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
94306715|NCT01508676|322908021|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
94306716|NCT01508676|322908020|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
94306717|NCT01508676|322908021|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
94306718|NCT01508676|322908020|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
94306719|NCT01508676|322908021|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
94306720|NCT02532543|322908022|FG000|Overall Study|Lost to Follow-up|0|||
94306721|NCT02532543|322908023|FG001|Overall Study|Lost to Follow-up|0|||
94306722|NCT02532543|322908024|FG002|Overall Study|Lost to Follow-up|1|||
94306723|NCT02532543|322908025|FG003|Overall Study|Lost to Follow-up|0|||
94306724|NCT01720667|322908027|FG000|Overall Study|Adverse Event|1|||
94306725|NCT01720667|322908028|FG001|Overall Study|Adverse Event|1|||
94306726|NCT01720667|322908027|FG000|Overall Study|Withdrawal by Subject|3|||
94306727|NCT01720667|322908028|FG001|Overall Study|Withdrawal by Subject|0|||
94306728|NCT02614794|322908033|FG000|Overall Study|Death|258|||
94306729|NCT02614794|322908034|FG001|Overall Study|Death|151|||
94306730|NCT02614794|322908033|FG000|Overall Study|Study closure by Sponsor|119|||
94306731|NCT02614794|322908034|FG001|Overall Study|Study closure by Sponsor|45|||
94306732|NCT02614794|322908033|FG000|Overall Study|Withdrawal by Subject|24|||
94306733|NCT02614794|322908034|FG001|Overall Study|Withdrawal by Subject|5|||
94306734|NCT02614794|322908033|FG000|Overall Study|Lost to Follow-up|7|||
94306735|NCT02614794|322908034|FG001|Overall Study|Lost to Follow-up|0|||
94306736|NCT02614794|322908033|FG000|Overall Study|Physician Decision|1|||
94306737|NCT02614794|322908034|FG001|Overall Study|Physician Decision|1|||
94306738|NCT02614794|322908033|FG000|Overall Study|Hospital closure|1|||
94306739|NCT02614794|322908034|FG001|Overall Study|Hospital closure|0|||
94377200|NCT00321711|323166542|FG002|Part A|Other|3|||
94377201|NCT00321711|323166543|FG003|Part A|Other|0|||
94306740|NCT04498910|322908035|FG000|Overall Study|Lost to Follow-up|0|||
94306741|NCT04498910|322908036|FG001|Overall Study|Lost to Follow-up|1|||
94306742|NCT04498910|322908035|FG000|Overall Study|Withdrawal by Subject|2|||
94306743|NCT04498910|322908036|FG001|Overall Study|Withdrawal by Subject|1|||
94306744|NCT04498910|322908035|FG000|Overall Study|Adverse Event|1|||
94306745|NCT04498910|322908036|FG001|Overall Study|Adverse Event|0|||
94306746|NCT01070303|322908037|FG000|Overall Study|Adverse Event|39|||
94306747|NCT01070303|322908037|FG000|Overall Study|Withdrawal by Subject|20|||
94306748|NCT01070303|322908037|FG000|Overall Study|Lost to Follow-up|9|||
94306749|NCT01070303|322908037|FG000|Overall Study|Protocol Violation|0|||
94377202|NCT00321711|323166544|FG004|Part A|Other|0|||
94377203|NCT00321711|323166540|FG000|Part A|Protocol deviation|0|||
94377204|NCT00321711|323166541|FG001|Part A|Protocol deviation|0|||
94377205|NCT00321711|323166542|FG002|Part A|Protocol deviation|1|||
94377206|NCT00321711|323166543|FG003|Part A|Protocol deviation|0|||
94377207|NCT00321711|323166544|FG004|Part A|Protocol deviation|0|||
94377208|NCT00321711|323166540|FG000|Part B|Noncompliance|0|||
94377209|NCT00321711|323166541|FG001|Part B|Noncompliance|0|||
94377210|NCT00321711|323166542|FG002|Part B|Noncompliance|0|||
94377211|NCT00321711|323166543|FG003|Part B|Noncompliance|0|||
94377212|NCT00321711|323166544|FG004|Part B|Noncompliance|1|||
94377213|NCT00321711|323166540|FG000|Part B|Adverse Event|0|||
94377214|NCT00321711|323166541|FG001|Part B|Adverse Event|0|||
94377215|NCT00321711|323166542|FG002|Part B|Adverse Event|0|||
94377216|NCT00321711|323166543|FG003|Part B|Adverse Event|2|||
94377217|NCT00321711|323166544|FG004|Part B|Adverse Event|1|||
94377218|NCT00321711|323166540|FG000|Part B|Disease progression|0|||
94377219|NCT00321711|323166541|FG001|Part B|Disease progression|0|||
94377220|NCT00321711|323166542|FG002|Part B|Disease progression|0|||
94377221|NCT00321711|323166543|FG003|Part B|Disease progression|1|||
94377222|NCT00321711|323166544|FG004|Part B|Disease progression|0|||
94377223|NCT00321711|323166540|FG000|Part B|Physician Decision|0|||
94377224|NCT00321711|323166541|FG001|Part B|Physician Decision|0|||
94377225|NCT00321711|323166542|FG002|Part B|Physician Decision|0|||
94377226|NCT00321711|323166543|FG003|Part B|Physician Decision|1|||
94377227|NCT00321711|323166544|FG004|Part B|Physician Decision|2|||
94377228|NCT00321711|323166540|FG000|Part B|Death|0|||
94377229|NCT00321711|323166541|FG001|Part B|Death|0|||
94377230|NCT00321711|323166542|FG002|Part B|Death|0|||
94377231|NCT00321711|323166543|FG003|Part B|Death|2|||
94377232|NCT00321711|323166544|FG004|Part B|Death|1|||
94377233|NCT02843074|323166545|FG000|Overall Study|Withdrawal by Subject|5|||
94377234|NCT02843074|323166545|FG000|Overall Study|Progressive disease|1|||
94377235|NCT02843074|323166545|FG000|Overall Study|Physician Decision|1|||
94377236|NCT02843074|323166545|FG000|Overall Study|Lost to Follow-up|1|||
94377237|NCT02843074|323166545|FG000|Overall Study|Death|9|||
94377238|NCT02473510|323166546|FG000|Overall Study|Lost to Follow-up|1|||
94377239|NCT02473510|323166547|FG001|Overall Study|Lost to Follow-up|2|||
94377240|NCT03402893|323166553|FG000|Overall Study|Withdrawal by Subject|1|||
94377241|NCT00686036|323166558|FG000|Overall Study|Adverse Event|3|||
94377242|NCT00686036|323166559|FG001|Overall Study|Adverse Event|0|||
94377243|NCT00686036|323166558|FG000|Overall Study|Withdrawal by Subject|3|||
94377244|NCT00686036|323166559|FG001|Overall Study|Withdrawal by Subject|1|||
94377245|NCT00686036|323166558|FG000|Overall Study|Study terminated by AstraZeneca|2|||
94377246|NCT00686036|323166559|FG001|Overall Study|Study terminated by AstraZeneca|1|||
94377247|NCT00686036|323166558|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
94377248|NCT00686036|323166559|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
94377249|NCT00686036|323166558|FG000|Overall Study|Other reasons not identified|0|||
94377250|NCT00686036|323166559|FG001|Overall Study|Other reasons not identified|4|||
94377251|NCT02482571|323166560|FG000|Overall Study|Adverse Event|1|||
94377252|NCT02482571|323166560|FG000|Overall Study|Scanner or Respiract failure|3|||
94377253|NCT02482571|323166560|FG000|Overall Study|Withdrawal by Subject|4|||
94377254|NCT02006147|323166563|FG000|Overall Study|Protocol Violation|1|||
94377255|NCT02006147|323166564|FG001|Overall Study|Protocol Violation|1|||
94377256|NCT02006147|323166565|FG002|Overall Study|Protocol Violation|0|||
94377257|NCT02006147|323166566|FG003|Overall Study|Protocol Violation|0|||
94377258|NCT02006147|323166563|FG000|Overall Study|Withdrawal by Subject|0|||
94377259|NCT02006147|323166564|FG001|Overall Study|Withdrawal by Subject|1|||
94377260|NCT02006147|323166565|FG002|Overall Study|Withdrawal by Subject|0|||
94377261|NCT02006147|323166566|FG003|Overall Study|Withdrawal by Subject|0|||
94377262|NCT02006147|323166563|FG000|Overall Study|Withdrawal by Sponsor|1|||
94377263|NCT02006147|323166564|FG001|Overall Study|Withdrawal by Sponsor|0|||
94377264|NCT02006147|323166565|FG002|Overall Study|Withdrawal by Sponsor|0|||
94377265|NCT02006147|323166566|FG003|Overall Study|Withdrawal by Sponsor|0|||
94377266|NCT03404206|323166569|FG000|Overall Study|Withdrawal by Subject|1|||
94377267|NCT03404206|323166570|FG001|Overall Study|Withdrawal by Subject|1|||
94377268|NCT03404206|323166571|FG002|Overall Study|Withdrawal by Subject|0|||
94377269|NCT03404206|323166569|FG000|Overall Study|Lost to Follow-up|3|||
94377270|NCT03404206|323166570|FG001|Overall Study|Lost to Follow-up|1|||
94377271|NCT03404206|323166571|FG002|Overall Study|Lost to Follow-up|0|||
94377272|NCT01193517|323166573|FG000|Overall Study|Early Progression|1|||
94377273|NCT01193517|323166574|FG001|Overall Study|Early Progression|0|||
94377274|NCT01193517|323166575|FG002|Overall Study|Early Progression|0|||
94377275|NCT00753714|323166576|FG000|Overall Study|Lack of Efficacy|21|||
94377276|NCT00753714|323166577|FG001|Overall Study|Lack of Efficacy|34|||
94377277|NCT00753714|323166576|FG000|Overall Study|Adverse Event|26|||
94377278|NCT00753714|323166577|FG001|Overall Study|Adverse Event|18|||
94377279|NCT00753714|323166576|FG000|Overall Study|Protocol Violation|1|||
94377280|NCT00753714|323166577|FG001|Overall Study|Protocol Violation|0|||
94377281|NCT00753714|323166576|FG000|Overall Study|Lost to Follow-up|0|||
94377282|NCT00753714|323166577|FG001|Overall Study|Lost to Follow-up|1|||
94377283|NCT00753714|323166576|FG000|Overall Study|Withdrawal by Subject|2|||
94306750|NCT01070303|322908037|FG000|Overall Study|Lack of Efficacy|2|||
94306751|NCT01070303|322908037|FG000|Overall Study|Administrative Reason|1|||
94306752|NCT01070303|322908037|FG000|Overall Study|Other|18|||
94306753|NCT03396471|322908043|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
94306754|NCT03396471|322908043|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
94306755|NCT03396471|322908043|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
94306756|NCT03396471|322908043|FG000|Study Treatment - Up to 22 Months|Death|2|||
94306757|NCT03396471|322908043|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
94306758|NCT03396471|322908043|FG000|Follow up - Up to 2 Years|Death|9|||
94306759|NCT03396471|322908043|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
94306760|NCT03396471|322908043|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
94306761|NCT03396471|322908043|FG000|Follow up - Up to 2 Years|study terminated|1|||
94306762|NCT03396471|322908043|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
94306763|NCT03396471|322908043|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
94306764|NCT00923091|322908044|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
94306765|NCT00923091|322908045|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
94306766|NCT00923091|322908046|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
94306767|NCT00923091|322908047|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
94306768|NCT00923091|322908048|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
94306769|NCT00923091|322908049|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
94306770|NCT00923091|322908050|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
94306771|NCT00923091|322908051|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
94306772|NCT00923091|322908052|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
94306773|NCT00923091|322908053|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
94306774|NCT00923091|322908054|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
94306775|NCT00923091|322908055|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
94306776|NCT00923091|322908056|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
94306777|NCT00923091|322908044|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
94306778|NCT00923091|322908045|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
94306779|NCT00923091|322908046|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
94306780|NCT00923091|322908047|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
94306781|NCT00923091|322908048|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
94306782|NCT00923091|322908049|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
94306783|NCT00923091|322908050|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
94306784|NCT00923091|322908051|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
94306785|NCT00923091|322908052|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
94306786|NCT00923091|322908053|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
94306787|NCT00923091|322908054|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
94306788|NCT00923091|322908055|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
94306789|NCT00923091|322908056|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
94306790|NCT00923091|322908044|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
94306791|NCT00923091|322908045|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
94306792|NCT00923091|322908046|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
94306793|NCT00923091|322908047|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
94306794|NCT00923091|322908048|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
94306795|NCT00923091|322908049|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
94306796|NCT00923091|322908050|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
94306797|NCT00923091|322908051|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
94306798|NCT00923091|322908052|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
94377284|NCT00753714|323166577|FG001|Overall Study|Withdrawal by Subject|1|||
94377285|NCT00753714|323166576|FG000|Overall Study|Death|3|||
94377286|NCT00753714|323166577|FG001|Overall Study|Death|3|||
94377287|NCT00753714|323166576|FG000|Overall Study|Other|7|||
94377288|NCT00753714|323166577|FG001|Overall Study|Other|5|||
94377289|NCT02607800|323166578|FG000|Overall Study|Lost to Follow-up|7|||
94377290|NCT02607800|323166579|FG001|Overall Study|Lost to Follow-up|10|||
94377291|NCT02607800|323166578|FG000|Overall Study|Withdrew Consent|2|||
94377292|NCT02607800|323166579|FG001|Overall Study|Withdrew Consent|0|||
94377293|NCT02607800|323166578|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
94377294|NCT02607800|323166579|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
94377295|NCT01185288|323166584|FG000|Overall Study|Adverse Event|7|||
94377296|NCT01185288|323166585|FG001|Overall Study|Adverse Event|6|||
94377297|NCT01185288|323166584|FG000|Overall Study|Withdrawal by Subject|6|||
94377298|NCT01185288|323166585|FG001|Overall Study|Withdrawal by Subject|4|||
94377299|NCT01185288|323166584|FG000|Overall Study|Lost to Follow-up|2|||
94377300|NCT01185288|323166585|FG001|Overall Study|Lost to Follow-up|5|||
94377301|NCT01185288|323166584|FG000|Overall Study|Lack of Efficacy|2|||
94377302|NCT01185288|323166585|FG001|Overall Study|Lack of Efficacy|0|||
94377303|NCT01185288|323166584|FG000|Overall Study|Investigator discretion|1|||
94377304|NCT01185288|323166585|FG001|Overall Study|Investigator discretion|0|||
94377305|NCT01185288|323166584|FG000|Overall Study|Did not meet inclusion criteria|1|||
94377306|NCT01185288|323166585|FG001|Overall Study|Did not meet inclusion criteria|0|||
94377307|NCT01185288|323166584|FG000|Overall Study|Noncompliance|0|||
94377308|NCT01185288|323166585|FG001|Overall Study|Noncompliance|1|||
94377309|NCT00278512|323166586|FG000|Overall Study|Death|1|||
94377310|NCT00278512|323166587|FG001|Overall Study|Death|0|||
94377311|NCT01626859|323166588|FG000|Overall Study|Adverse Event|1|||
94377312|NCT01626859|323166589|FG001|Overall Study|Adverse Event|3|||
94377313|NCT01626859|323166590|FG002|Overall Study|Adverse Event|2|||
94377314|NCT01626859|323166588|FG000|Overall Study|Physician Decision|0|||
94377315|NCT01626859|323166589|FG001|Overall Study|Physician Decision|1|||
94377316|NCT01626859|323166590|FG002|Overall Study|Physician Decision|0|||
94377317|NCT01626859|323166588|FG000|Overall Study|Withdrawal by Subject|1|||
94377318|NCT01626859|323166589|FG001|Overall Study|Withdrawal by Subject|4|||
94377319|NCT01626859|323166590|FG002|Overall Study|Withdrawal by Subject|2|||
94377320|NCT01202747|323166591|FG000|Overall Study|Withdrawal by Subject|1|||
94377321|NCT02521948|323166592|FG000|Overall Study|Adverse Event|2|||
94377322|NCT02521948|323166592|FG000|Overall Study|Death|4|||
94377323|NCT02521948|323166592|FG000|Overall Study|Lost to Follow-up|1|||
94377324|NCT02521948|323166592|FG000|Overall Study|Did not attend one or both follow-ups|6|||
94377325|NCT02330081|323166593|FG000|Overall Study|Adverse Event|1|||
94377326|NCT02330081|323166593|FG000|Overall Study|Donation did not meet criteria|1|||
94377327|NCT02330081|323166593|FG000|Overall Study|Protocol Violation|6|||
94377328|NCT02292238|323166594|FG000|Overall Study|Protocol Violation|1|||
94377329|NCT02292238|323166595|FG001|Overall Study|Protocol Violation|2|||
94377330|NCT02292238|323166594|FG000|Overall Study|Withdrawal by Subject|2|||
94377331|NCT02292238|323166595|FG001|Overall Study|Withdrawal by Subject|1|||
94377332|NCT02292238|323166594|FG000|Overall Study|Lost to Follow-up|1|||
94377333|NCT02292238|323166595|FG001|Overall Study|Lost to Follow-up|0|||
94377334|NCT02292238|323166594|FG000|Overall Study|Physician Decision|0|||
94377335|NCT02292238|323166595|FG001|Overall Study|Physician Decision|1|||
94377336|NCT00905489|323166596|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
94377337|NCT00905489|323166596|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
94377338|NCT00905489|323166596|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
94377339|NCT02789111|323166599|FG000|Overall Study|Withdrawal by Subject|1|||
94377340|NCT02789111|323166600|FG001|Overall Study|Withdrawal by Subject|4|||
94377341|NCT01488578|323166601|FG000|Overall Study|Protocol Violation|1836|||
94377342|NCT03271528|323166605|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
94377343|NCT03271528|323166606|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
94377344|NCT03271528|323166605|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
94377345|NCT03271528|323166606|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
94377346|NCT03271528|323166605|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
94377347|NCT03271528|323166606|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
94377348|NCT03271528|323166605|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
94377349|NCT03271528|323166606|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
94377350|NCT03271528|323166605|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
94377351|NCT03271528|323166606|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
94377352|NCT03271528|323166605|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
94377353|NCT03271528|323166606|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
94377354|NCT03271528|323166605|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
94377355|NCT03271528|323166606|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
94377356|NCT00717756|323166610|FG000|Overall Study|Withdrawal by Subject|1|||
94377357|NCT00673790|323166611|FG000|Overall Study|Adverse Event|23|||
94377358|NCT00673790|323166612|FG001|Overall Study|Adverse Event|14|||
94377359|NCT00673790|323166613|FG002|Overall Study|Adverse Event|2|||
94377360|NCT00673790|323166611|FG000|Overall Study|Lack of Efficacy|2|||
94377361|NCT00673790|323166612|FG001|Overall Study|Lack of Efficacy|2|||
94377362|NCT00673790|323166613|FG002|Overall Study|Lack of Efficacy|2|||
94377363|NCT00673790|323166611|FG000|Overall Study|Protocol Violation|6|||
94377364|NCT00673790|323166612|FG001|Overall Study|Protocol Violation|9|||
94377365|NCT00673790|323166613|FG002|Overall Study|Protocol Violation|1|||
94377366|NCT00673790|323166611|FG000|Overall Study|Withdrawal by Subject|7|||
94377367|NCT00673790|323166612|FG001|Overall Study|Withdrawal by Subject|4|||
94377368|NCT00673790|323166613|FG002|Overall Study|Withdrawal by Subject|1|||
94377369|NCT00673790|323166611|FG000|Overall Study|Lost to Follow-up|6|||
94377370|NCT00673790|323166612|FG001|Overall Study|Lost to Follow-up|6|||
94377371|NCT00673790|323166613|FG002|Overall Study|Lost to Follow-up|5|||
94377372|NCT00673790|323166611|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
94377373|NCT00673790|323166612|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
94377374|NCT00673790|323166613|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
94377375|NCT00673790|323166611|FG000|Overall Study|Poor compliance|1|||
94377376|NCT00673790|323166612|FG001|Overall Study|Poor compliance|0|||
94377377|NCT00673790|323166613|FG002|Overall Study|Poor compliance|0|||
94377378|NCT00673790|323166611|FG000|Overall Study|Participated in two Nebivolol studies|0|||
94377379|NCT00673790|323166612|FG001|Overall Study|Participated in two Nebivolol studies|0|||
94377380|NCT00673790|323166613|FG002|Overall Study|Participated in two Nebivolol studies|1|||
94377381|NCT00673790|323166611|FG000|Overall Study|Unconfirmed pregnancy|0|||
94377382|NCT00673790|323166612|FG001|Overall Study|Unconfirmed pregnancy|1|||
94377383|NCT00673790|323166613|FG002|Overall Study|Unconfirmed pregnancy|0|||
94377384|NCT00673790|323166611|FG000|Overall Study|Randomization criteria not met|0|||
94377385|NCT00673790|323166612|FG001|Overall Study|Randomization criteria not met|1|||
94377386|NCT00673790|323166613|FG002|Overall Study|Randomization criteria not met|0|||
94377387|NCT00306384|323166614|FG000|Overall Study|Adverse Event|103|||
94377388|NCT00306384|323166615|FG001|Overall Study|Adverse Event|87|||
94377389|NCT00306384|323166616|FG002|Overall Study|Adverse Event|40|||
94377390|NCT00306384|323166614|FG000|Overall Study|Major protocol deviation|43|||
94377391|NCT00306384|323166615|FG001|Overall Study|Major protocol deviation|51|||
94377392|NCT00306384|323166616|FG002|Overall Study|Major protocol deviation|18|||
94377393|NCT00306384|323166614|FG000|Overall Study|Lost to Follow-up|57|||
94377394|NCT00306384|323166615|FG001|Overall Study|Lost to Follow-up|41|||
94377395|NCT00306384|323166616|FG002|Overall Study|Lost to Follow-up|35|||
94377396|NCT00306384|323166614|FG000|Overall Study|Voluntary withdrawal|199|||
94377397|NCT00306384|323166615|FG001|Overall Study|Voluntary withdrawal|187|||
94377398|NCT00306384|323166616|FG002|Overall Study|Voluntary withdrawal|91|||
94377399|NCT00306384|323166614|FG000|Overall Study|Study termination|1|||
94377400|NCT00306384|323166615|FG001|Overall Study|Study termination|0|||
94377401|NCT00306384|323166616|FG002|Overall Study|Study termination|1|||
94377402|NCT00306384|323166614|FG000|Overall Study|Pregnancy|3|||
94377403|NCT00306384|323166615|FG001|Overall Study|Pregnancy|1|||
94377404|NCT00306384|323166616|FG002|Overall Study|Pregnancy|1|||
94377405|NCT00306384|323166614|FG000|Overall Study|Lack of Efficacy|26|||
94377406|NCT00306384|323166615|FG001|Overall Study|Lack of Efficacy|40|||
94377407|NCT00306384|323166616|FG002|Overall Study|Lack of Efficacy|38|||
94377408|NCT00306384|323166614|FG000|Overall Study|Investigator discretion|28|||
94377409|NCT00306384|323166615|FG001|Overall Study|Investigator discretion|31|||
94377410|NCT00306384|323166616|FG002|Overall Study|Investigator discretion|21|||
94377411|NCT00306384|323166614|FG000|Overall Study|Other|80|||
94377412|NCT00306384|323166615|FG001|Overall Study|Other|70|||
94377413|NCT00306384|323166616|FG002|Overall Study|Other|32|||
94377414|NCT00306384|323166614|FG000|Overall Study|Site closure|2|||
94377415|NCT00306384|323166615|FG001|Overall Study|Site closure|0|||
94377416|NCT00306384|323166616|FG002|Overall Study|Site closure|0|||
94377417|NCT03828461|323166617|FG000|Overall Study|Lost to Follow-up|1|||
94377418|NCT03828461|323166617|FG000|Overall Study|Withdrawal by Subject|3|||
94377419|NCT02102490|323166621|FG000|Overall Study|Death|6|||
94377420|NCT02102490|323166621|FG000|Overall Study|Lost to Follow-up|1|||
94377421|NCT00911859|323166622|FG000|Treatment Period|Adverse Event|3|||
94377422|NCT00911859|323166623|FG001|Treatment Period|Adverse Event|3|||
94377423|NCT00911859|323166624|FG002|Treatment Period|Adverse Event|7|||
94377424|NCT00911859|323166622|FG000|Treatment Period|Death|1|||
94377425|NCT00911859|323166623|FG001|Treatment Period|Death|3|||
94377426|NCT00911859|323166624|FG002|Treatment Period|Death|5|||
94377427|NCT00911859|323166622|FG000|Treatment Period|Lack of Efficacy|1|||
94377428|NCT00911859|323166623|FG001|Treatment Period|Lack of Efficacy|7|||
94377429|NCT00911859|323166624|FG002|Treatment Period|Lack of Efficacy|5|||
94377430|NCT00911859|323166622|FG000|Treatment Period|Physician Decision|3|||
94377431|NCT00911859|323166623|FG001|Treatment Period|Physician Decision|3|||
94377432|NCT00911859|323166624|FG002|Treatment Period|Physician Decision|3|||
94377433|NCT00911859|323166622|FG000|Treatment Period|Withdrawal by Subject|0|||
94377434|NCT00911859|323166623|FG001|Treatment Period|Withdrawal by Subject|4|||
94377435|NCT00911859|323166624|FG002|Treatment Period|Withdrawal by Subject|5|||
94377436|NCT00911859|323166622|FG000|Treatment Period|Did not receive study treatment|0|||
94377437|NCT00911859|323166623|FG001|Treatment Period|Did not receive study treatment|1|||
94377438|NCT00911859|323166624|FG002|Treatment Period|Did not receive study treatment|0|||
94377439|NCT00911859|323166622|FG000|Maintainance Period|Lack of Efficacy|0|||
94377440|NCT00911859|323166623|FG001|Maintainance Period|Lack of Efficacy|0|||
94377441|NCT00911859|323166624|FG002|Maintainance Period|Lack of Efficacy|9|||
94377442|NCT00911859|323166622|FG000|Maintainance Period|Physician Decision|0|||
94377443|NCT00911859|323166623|FG001|Maintainance Period|Physician Decision|0|||
94377444|NCT00911859|323166624|FG002|Maintainance Period|Physician Decision|9|||
94377445|NCT00911859|323166622|FG000|Maintainance Period|Withdrawal by Subject|0|||
94377446|NCT00911859|323166623|FG001|Maintainance Period|Withdrawal by Subject|0|||
94377447|NCT00911859|323166624|FG002|Maintainance Period|Withdrawal by Subject|3|||
94377448|NCT00911859|323166622|FG000|Follow-up Period|Death|5|||
94306799|NCT00923091|322908053|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
94306800|NCT00923091|322908054|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
94306801|NCT00923091|322908055|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
94306802|NCT00923091|322908056|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
94306803|NCT00923091|322908044|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
94306804|NCT00923091|322908045|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
94306805|NCT00923091|322908046|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
94306806|NCT00923091|322908047|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
94306807|NCT00923091|322908048|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
94306808|NCT00923091|322908049|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
94306809|NCT00923091|322908050|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
94306810|NCT00923091|322908051|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
94306811|NCT00923091|322908052|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
94306812|NCT00923091|322908053|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
94306813|NCT00923091|322908054|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
94306814|NCT00923091|322908055|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
94306815|NCT00923091|322908056|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
94306816|NCT00923091|322908044|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
94306817|NCT00923091|322908045|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
94306818|NCT00923091|322908046|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
94377449|NCT00911859|323166623|FG001|Follow-up Period|Death|8|||
94377450|NCT00911859|323166624|FG002|Follow-up Period|Death|10|||
94306819|NCT00923091|322908047|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
94306820|NCT00923091|322908048|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
94306821|NCT00923091|322908049|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
94306822|NCT00923091|322908050|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
94306823|NCT00923091|322908051|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
94306824|NCT00923091|322908052|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
94306825|NCT00923091|322908053|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
94306826|NCT00923091|322908054|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
94306827|NCT00923091|322908055|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
94306828|NCT00923091|322908056|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
94306829|NCT00923091|322908044|FG000|Period III (Single-Blind)|Adverse Event|5|||
94306830|NCT00923091|322908045|FG001|Period III (Single-Blind)|Adverse Event|0|||
94306831|NCT00923091|322908046|FG002|Period III (Single-Blind)|Adverse Event|0|||
94306832|NCT00923091|322908047|FG003|Period III (Single-Blind)|Adverse Event|0|||
94306833|NCT00923091|322908048|FG004|Period III (Single-Blind)|Adverse Event|0|||
94306834|NCT00923091|322908049|FG005|Period III (Single-Blind)|Adverse Event|0|||
94306835|NCT00923091|322908050|FG006|Period III (Single-Blind)|Adverse Event|0|||
94306836|NCT00923091|322908051|FG007|Period III (Single-Blind)|Adverse Event|0|||
94306837|NCT00923091|322908052|FG008|Period III (Single-Blind)|Adverse Event|0|||
94306838|NCT00923091|322908053|FG009|Period III (Single-Blind)|Adverse Event|0|||
94306839|NCT00923091|322908054|FG010|Period III (Single-Blind)|Adverse Event|0|||
94306840|NCT00923091|322908055|FG011|Period III (Single-Blind)|Adverse Event|0|||
94306841|NCT00923091|322908056|FG012|Period III (Single-Blind)|Adverse Event|0|||
94377451|NCT00911859|323166622|FG000|Follow-up Period|Lost to Follow-up|1|||
94377452|NCT00911859|323166623|FG001|Follow-up Period|Lost to Follow-up|1|||
94377453|NCT00911859|323166624|FG002|Follow-up Period|Lost to Follow-up|0|||
94377454|NCT00911859|323166622|FG000|Follow-up Period|Withdrawal by Subject|0|||
94377455|NCT00911859|323166623|FG001|Follow-up Period|Withdrawal by Subject|4|||
94377456|NCT00911859|323166624|FG002|Follow-up Period|Withdrawal by Subject|4|||
94377457|NCT00911859|323166622|FG000|Follow-up Period|Study terminated by sponsor|5|||
94377458|NCT00911859|323166623|FG001|Follow-up Period|Study terminated by sponsor|33|||
94377459|NCT00911859|323166624|FG002|Follow-up Period|Study terminated by sponsor|27|||
94377460|NCT02260492|323166625|FG000|Overall Study|Adverse Event|6|||
94377461|NCT02260492|323166626|FG001|Overall Study|Adverse Event|1|||
94377462|NCT02260492|323166627|FG002|Overall Study|Adverse Event|2|||
94377463|NCT02260492|323166625|FG000|Overall Study|Death|0|||
94306842|NCT00923091|322908044|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
94306843|NCT00923091|322908045|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
94306844|NCT00923091|322908046|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
94306845|NCT00923091|322908047|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
94306846|NCT00923091|322908048|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
94306847|NCT00923091|322908049|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
94306848|NCT00923091|322908050|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
94306849|NCT00923091|322908051|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
94306850|NCT00923091|322908052|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
94306851|NCT00923091|322908053|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
94306852|NCT00923091|322908054|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
94306853|NCT00923091|322908055|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
94306854|NCT00923091|322908056|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
94306855|NCT00923091|322908044|FG000|Period III (Single-Blind)|Protocol Violation|3|||
94306856|NCT00923091|322908045|FG001|Period III (Single-Blind)|Protocol Violation|0|||
94306857|NCT00923091|322908046|FG002|Period III (Single-Blind)|Protocol Violation|0|||
94306858|NCT00923091|322908047|FG003|Period III (Single-Blind)|Protocol Violation|0|||
94306859|NCT00923091|322908048|FG004|Period III (Single-Blind)|Protocol Violation|0|||
94306860|NCT00923091|322908049|FG005|Period III (Single-Blind)|Protocol Violation|0|||
94306861|NCT00923091|322908050|FG006|Period III (Single-Blind)|Protocol Violation|0|||
94306862|NCT00923091|322908051|FG007|Period III (Single-Blind)|Protocol Violation|0|||
94306863|NCT00923091|322908052|FG008|Period III (Single-Blind)|Protocol Violation|0|||
94306864|NCT00923091|322908053|FG009|Period III (Single-Blind)|Protocol Violation|0|||
94306865|NCT00923091|322908054|FG010|Period III (Single-Blind)|Protocol Violation|0|||
94306866|NCT00923091|322908055|FG011|Period III (Single-Blind)|Protocol Violation|0|||
94306867|NCT00923091|322908056|FG012|Period III (Single-Blind)|Protocol Violation|0|||
94306868|NCT00923091|322908044|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
94306869|NCT00923091|322908045|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
94306870|NCT00923091|322908046|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
94306871|NCT00923091|322908047|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
94306872|NCT00923091|322908048|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
94306873|NCT00923091|322908049|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
94306874|NCT00923091|322908050|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
94306875|NCT00923091|322908051|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
94306876|NCT00923091|322908052|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
94306877|NCT00923091|322908053|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
94306878|NCT00923091|322908054|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
94306879|NCT00923091|322908055|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
94306880|NCT00923091|322908056|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
94306881|NCT00923091|322908044|FG000|Period IV (Double-Blind)|Adverse Event|2|||
94306882|NCT00923091|322908045|FG001|Period IV (Double-Blind)|Adverse Event|0|||
94306883|NCT00923091|322908046|FG002|Period IV (Double-Blind)|Adverse Event|0|||
94306884|NCT00923091|322908047|FG003|Period IV (Double-Blind)|Adverse Event|0|||
94306885|NCT00923091|322908048|FG004|Period IV (Double-Blind)|Adverse Event|0|||
94306886|NCT00923091|322908049|FG005|Period IV (Double-Blind)|Adverse Event|0|||
94306887|NCT00923091|322908050|FG006|Period IV (Double-Blind)|Adverse Event|0|||
94306888|NCT00923091|322908051|FG007|Period IV (Double-Blind)|Adverse Event|0|||
94306889|NCT00923091|322908052|FG008|Period IV (Double-Blind)|Adverse Event|0|||
94306890|NCT00923091|322908053|FG009|Period IV (Double-Blind)|Adverse Event|0|||
94306891|NCT00923091|322908054|FG010|Period IV (Double-Blind)|Adverse Event|0|||
94306892|NCT00923091|322908055|FG011|Period IV (Double-Blind)|Adverse Event|0|||
94306893|NCT00923091|322908056|FG012|Period IV (Double-Blind)|Adverse Event|0|||
94306894|NCT00923091|322908044|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
94306895|NCT00923091|322908045|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
94306896|NCT00923091|322908046|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
94306897|NCT00923091|322908047|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
94306898|NCT00923091|322908048|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
94306899|NCT00923091|322908049|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
94306900|NCT00923091|322908050|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
94306901|NCT00923091|322908051|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
94306902|NCT00923091|322908052|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
94377464|NCT02260492|323166626|FG001|Overall Study|Death|1|||
94377465|NCT02260492|323166627|FG002|Overall Study|Death|0|||
94306903|NCT00923091|322908053|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
94377466|NCT02260492|323166625|FG000|Overall Study|Lost to Follow-up|12|||
94377467|NCT02260492|323166626|FG001|Overall Study|Lost to Follow-up|9|||
94306904|NCT00923091|322908054|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
94306905|NCT00923091|322908055|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
94306906|NCT00923091|322908056|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
94306907|NCT00923091|322908044|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
94377468|NCT02260492|323166627|FG002|Overall Study|Lost to Follow-up|0|||
94377469|NCT02260492|323166625|FG000|Overall Study|Physician Decision|2|||
94306908|NCT00923091|322908045|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
94306909|NCT00923091|322908046|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
94306910|NCT00923091|322908047|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
94306911|NCT00923091|322908048|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
94306912|NCT00923091|322908049|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
94306913|NCT00923091|322908050|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
94306914|NCT00923091|322908051|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
94306915|NCT00923091|322908052|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
94306916|NCT00923091|322908053|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
94306917|NCT00923091|322908054|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
94306918|NCT00923091|322908055|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
94306919|NCT00923091|322908056|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
94306920|NCT00923091|322908044|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
94306921|NCT00923091|322908045|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
94469754|NCT00548249|323511300|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
94306922|NCT00923091|322908046|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
94306923|NCT00923091|322908047|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
94306924|NCT00923091|322908048|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
94306925|NCT00923091|322908049|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
94306926|NCT00923091|322908050|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
94306927|NCT00923091|322908051|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
94306928|NCT00923091|322908052|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
94306929|NCT00923091|322908053|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
94306930|NCT00923091|322908054|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
94306931|NCT00923091|322908055|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
94306932|NCT00923091|322908056|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
94306933|NCT00923091|322908044|FG000|Period V (Double -Blind)|Protocol Violation|0|||
94306934|NCT00923091|322908045|FG001|Period V (Double -Blind)|Protocol Violation|0|||
94306935|NCT00923091|322908046|FG002|Period V (Double -Blind)|Protocol Violation|0|||
94306936|NCT00923091|322908047|FG003|Period V (Double -Blind)|Protocol Violation|0|||
94306937|NCT00923091|322908048|FG004|Period V (Double -Blind)|Protocol Violation|0|||
94306938|NCT00923091|322908049|FG005|Period V (Double -Blind)|Protocol Violation|0|||
94306939|NCT00923091|322908050|FG006|Period V (Double -Blind)|Protocol Violation|0|||
94306940|NCT00923091|322908051|FG007|Period V (Double -Blind)|Protocol Violation|0|||
94306941|NCT00923091|322908052|FG008|Period V (Double -Blind)|Protocol Violation|0|||
94306942|NCT00923091|322908053|FG009|Period V (Double -Blind)|Protocol Violation|0|||
94306943|NCT00923091|322908054|FG010|Period V (Double -Blind)|Protocol Violation|0|||
94306944|NCT00923091|322908055|FG011|Period V (Double -Blind)|Protocol Violation|0|||
94306945|NCT00923091|322908056|FG012|Period V (Double -Blind)|Protocol Violation|1|||
94306946|NCT00923091|322908044|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
94306947|NCT00923091|322908045|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
94306948|NCT00923091|322908046|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
94306949|NCT00923091|322908047|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
94306950|NCT00923091|322908048|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
94306951|NCT00923091|322908049|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
94306952|NCT00923091|322908050|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
94306953|NCT00923091|322908051|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
94306954|NCT00923091|322908052|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
94306955|NCT00923091|322908053|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
94306956|NCT00923091|322908054|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
94306957|NCT00923091|322908055|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
94306958|NCT00923091|322908056|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
94306959|NCT00923091|322908044|FG000|Period VI (Open-Label)|Adverse Event|17|||
94306960|NCT00923091|322908045|FG001|Period VI (Open-Label)|Adverse Event|0|||
94306961|NCT00923091|322908046|FG002|Period VI (Open-Label)|Adverse Event|4|||
94306962|NCT00923091|322908047|FG003|Period VI (Open-Label)|Adverse Event|1|||
94306963|NCT00923091|322908048|FG004|Period VI (Open-Label)|Adverse Event|1|||
94306964|NCT00923091|322908049|FG005|Period VI (Open-Label)|Adverse Event|0|||
94306965|NCT00923091|322908050|FG006|Period VI (Open-Label)|Adverse Event|0|||
94306966|NCT00923091|322908051|FG007|Period VI (Open-Label)|Adverse Event|0|||
94306967|NCT00923091|322908052|FG008|Period VI (Open-Label)|Adverse Event|0|||
94306968|NCT00923091|322908053|FG009|Period VI (Open-Label)|Adverse Event|0|||
94306969|NCT00923091|322908054|FG010|Period VI (Open-Label)|Adverse Event|0|||
94306970|NCT00923091|322908055|FG011|Period VI (Open-Label)|Adverse Event|0|||
94306971|NCT00923091|322908056|FG012|Period VI (Open-Label)|Adverse Event|0|||
94306972|NCT00923091|322908044|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
94306973|NCT00923091|322908045|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
94306974|NCT00923091|322908046|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
94306975|NCT00923091|322908047|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
94469755|NCT00548249|323511296|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
94469756|NCT00548249|323511297|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
94306976|NCT00923091|322908048|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
94306977|NCT00923091|322908049|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
94306978|NCT00923091|322908050|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
94306979|NCT00923091|322908051|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
94306980|NCT00923091|322908052|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
94306981|NCT00923091|322908053|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
94306982|NCT00923091|322908054|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
94306983|NCT00923091|322908055|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
94306984|NCT00923091|322908056|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
94306985|NCT00923091|322908044|FG000|Period VI (Open-Label)|Protocol Violation|6|||
94306986|NCT00923091|322908045|FG001|Period VI (Open-Label)|Protocol Violation|1|||
94306987|NCT00923091|322908046|FG002|Period VI (Open-Label)|Protocol Violation|3|||
94306988|NCT00923091|322908047|FG003|Period VI (Open-Label)|Protocol Violation|1|||
94306989|NCT00923091|322908048|FG004|Period VI (Open-Label)|Protocol Violation|4|||
94306990|NCT00923091|322908049|FG005|Period VI (Open-Label)|Protocol Violation|0|||
94306991|NCT00923091|322908050|FG006|Period VI (Open-Label)|Protocol Violation|0|||
94306992|NCT00923091|322908051|FG007|Period VI (Open-Label)|Protocol Violation|0|||
94306993|NCT00923091|322908052|FG008|Period VI (Open-Label)|Protocol Violation|0|||
94306994|NCT00923091|322908053|FG009|Period VI (Open-Label)|Protocol Violation|0|||
94306995|NCT00923091|322908054|FG010|Period VI (Open-Label)|Protocol Violation|0|||
94306996|NCT00923091|322908055|FG011|Period VI (Open-Label)|Protocol Violation|0|||
94306997|NCT00923091|322908056|FG012|Period VI (Open-Label)|Protocol Violation|0|||
94306998|NCT00923091|322908044|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
94306999|NCT00923091|322908045|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
94307000|NCT00923091|322908046|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
94307001|NCT00923091|322908047|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
94307002|NCT00923091|322908048|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
94307003|NCT00923091|322908049|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
94307004|NCT00923091|322908050|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
94307005|NCT00923091|322908051|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
94307006|NCT00923091|322908052|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
94307007|NCT00923091|322908053|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
94307008|NCT00923091|322908054|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
94307009|NCT00923091|322908055|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
94307010|NCT00923091|322908056|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
94307011|NCT00923091|322908044|FG000|Period VI (Open-Label)|Other Reason|0|||
94307012|NCT00923091|322908045|FG001|Period VI (Open-Label)|Other Reason|0|||
94307013|NCT00923091|322908046|FG002|Period VI (Open-Label)|Other Reason|0|||
94307014|NCT00923091|322908047|FG003|Period VI (Open-Label)|Other Reason|1|||
94307015|NCT00923091|322908048|FG004|Period VI (Open-Label)|Other Reason|1|||
94307016|NCT00923091|322908049|FG005|Period VI (Open-Label)|Other Reason|0|||
94307017|NCT00923091|322908050|FG006|Period VI (Open-Label)|Other Reason|0|||
94307018|NCT00923091|322908051|FG007|Period VI (Open-Label)|Other Reason|0|||
94307019|NCT00923091|322908052|FG008|Period VI (Open-Label)|Other Reason|0|||
94307020|NCT00923091|322908053|FG009|Period VI (Open-Label)|Other Reason|0|||
94307021|NCT00923091|322908054|FG010|Period VI (Open-Label)|Other Reason|0|||
94307022|NCT00923091|322908055|FG011|Period VI (Open-Label)|Other Reason|0|||
94307023|NCT00923091|322908056|FG012|Period VI (Open-Label)|Other Reason|0|||
94307024|NCT04283461|322908060|FG000|Overall Study|Enrolled in separate trial|0|||
94307025|NCT04283461|322908061|FG001|Overall Study|Enrolled in separate trial|0|||
94307026|NCT04283461|322908062|FG002|Overall Study|Enrolled in separate trial|8|||
94307027|NCT04283461|322908063|FG003|Overall Study|Enrolled in separate trial|13|||
94307028|NCT04283461|322908064|FG004|Overall Study|Enrolled in separate trial|12|||
94377470|NCT02260492|323166626|FG001|Overall Study|Physician Decision|0|||
94377471|NCT02260492|323166627|FG002|Overall Study|Physician Decision|1|||
94377472|NCT02260492|323166625|FG000|Overall Study|Withdrawal by Subject|3|||
94307029|NCT04283461|322908065|FG005|Overall Study|Enrolled in separate trial|0|||
94307030|NCT04283461|322908066|FG006|Overall Study|Enrolled in separate trial|0|||
94377473|NCT02260492|323166626|FG001|Overall Study|Withdrawal by Subject|2|||
94377474|NCT02260492|323166627|FG002|Overall Study|Withdrawal by Subject|2|||
94377475|NCT01497938|323166628|FG000|Overall Study|Adverse Event|0|||
94377476|NCT01497938|323166629|FG001|Overall Study|Adverse Event|1|||
94377477|NCT01497938|323166628|FG000|Overall Study|Physician Decision|0|||
94377478|NCT01497938|323166629|FG001|Overall Study|Physician Decision|1|||
94377479|NCT01497938|323166628|FG000|Overall Study|Withdrawal by Subject|4|||
94377480|NCT01497938|323166629|FG001|Overall Study|Withdrawal by Subject|0|||
94377481|NCT01497938|323166628|FG000|Overall Study|Device Violation|1|||
94377482|NCT01497938|323166629|FG001|Overall Study|Device Violation|0|||
94307031|NCT04283461|322908067|FG007|Overall Study|Enrolled in separate trial|8|||
94307032|NCT04283461|322908068|FG008|Overall Study|Enrolled in separate trial|0|||
94307033|NCT04283461|322908069|FG009|Overall Study|Enrolled in separate trial|0|||
94307034|NCT04283461|322908070|FG010|Overall Study|Enrolled in separate trial|0|||
94307035|NCT04283461|322908071|FG011|Overall Study|Enrolled in separate trial|7|||
94307036|NCT04283461|322908072|FG012|Overall Study|Enrolled in separate trial|0|||
94307037|NCT03237845|322908073|FG000|Overall Study|Adverse Event|0|||
94307038|NCT03237845|322908074|FG001|Overall Study|Adverse Event|1|||
94307039|NCT03237845|322908073|FG000|Overall Study|Lost to Follow-up|13|||
94307040|NCT03237845|322908074|FG001|Overall Study|Lost to Follow-up|10|||
94307041|NCT03237845|322908073|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
94307042|NCT03237845|322908074|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
94307043|NCT03237845|322908073|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
94307044|NCT03237845|322908074|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
94307045|NCT03237845|322908073|FG000|Overall Study|Physician Decision|1|||
94307046|NCT03237845|322908074|FG001|Overall Study|Physician Decision|2|||
94307047|NCT03237845|322908073|FG000|Overall Study|Pregnancy|1|||
94307048|NCT03237845|322908074|FG001|Overall Study|Pregnancy|0|||
94307049|NCT03237845|322908073|FG000|Overall Study|Protocol Deviation|0|||
94307050|NCT03237845|322908074|FG001|Overall Study|Protocol Deviation|1|||
94307051|NCT03237845|322908073|FG000|Overall Study|Technical Problems|8|||
94307052|NCT03237845|322908074|FG001|Overall Study|Technical Problems|1|||
94307053|NCT03237845|322908073|FG000|Overall Study|Withdrawal by Subject|3|||
94307054|NCT03237845|322908074|FG001|Overall Study|Withdrawal by Subject|3|||
94307055|NCT03237845|322908073|FG000|Overall Study|Other Reasons|4|||
94307056|NCT03237845|322908074|FG001|Overall Study|Other Reasons|0|||
94307057|NCT01749735|322908075|FG000|Overall Study|Withdrawal by Subject|1|||
94307058|NCT01749735|322908076|FG001|Overall Study|Withdrawal by Subject|0|||
94307059|NCT04983901|322908078|FG000|Overall Study|Death|1|||
94307060|NCT04983901|322908079|FG001|Overall Study|Death|4|||
94307061|NCT04983901|322908078|FG000|Overall Study|Lost to Follow-up|3|||
94307062|NCT04983901|322908079|FG001|Overall Study|Lost to Follow-up|0|||
94307063|NCT04983901|322908078|FG000|Overall Study|Protocol Violation|1|||
94307064|NCT04983901|322908079|FG001|Overall Study|Protocol Violation|0|||
94307065|NCT04983901|322908078|FG000|Overall Study|Withdrawal by Subject|1|||
94307066|NCT04983901|322908079|FG001|Overall Study|Withdrawal by Subject|2|||
94307067|NCT04651777|322908082|FG000|Overall Study|Adverse Event|1|||
94307068|NCT04651777|322908082|FG000|Overall Study|Withdrawal by Subject|2|||
94307069|NCT00949650|322908083|FG000|Overall Study|Progressive disease|188|||
94307070|NCT00949650|322908084|FG001|Overall Study|Progressive disease|19|||
94307071|NCT00949650|322908083|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
94307072|NCT00949650|322908084|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
94307073|NCT00949650|322908083|FG000|Overall Study|Other Adverse Event (AE)|28|||
94307074|NCT00949650|322908084|FG001|Overall Study|Other Adverse Event (AE)|17|||
94307075|NCT00949650|322908083|FG000|Overall Study|Protocol Violation|1|||
94307076|NCT00949650|322908084|FG001|Overall Study|Protocol Violation|4|||
94307077|NCT00949650|322908083|FG000|Overall Study|Refusal to continue medication|7|||
94307078|NCT00949650|322908084|FG001|Overall Study|Refusal to continue medication|11|||
94307079|NCT00949650|322908083|FG000|Overall Study|Not treated|1|||
94307080|NCT00949650|322908084|FG001|Overall Study|Not treated|4|||
94307081|NCT00949650|322908083|FG000|Overall Study|Other not specified above|5|||
94307082|NCT00949650|322908084|FG001|Overall Study|Other not specified above|0|||
94307083|NCT04222725|322908085|FG000|Overall Study|Adverse Event|0|||
94307084|NCT04222725|322908086|FG001|Overall Study|Adverse Event|1|||
94307085|NCT04222725|322908087|FG002|Overall Study|Adverse Event|0|||
94307086|NCT04222725|322908088|FG003|Overall Study|Adverse Event|0|||
94307087|NCT03503773|322908098|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
94307088|NCT03503773|322908099|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
94307089|NCT03503773|322908098|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
94307090|NCT03503773|322908099|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
94307091|NCT03503773|322908098|FG000|Overall Study|Not completing the primary ABPM|3|||
94307092|NCT03503773|322908099|FG001|Overall Study|Not completing the primary ABPM|1|||
94307093|NCT03503773|322908098|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
94377483|NCT04603937|323166630|FG000|Overall Study|Adverse Event|9|||
94377484|NCT04603937|323166631|FG001|Overall Study|Adverse Event|10|||
94377485|NCT04603937|323166630|FG000|Overall Study|Withdrawal by Subject|7|||
94377486|NCT04603937|323166631|FG001|Overall Study|Withdrawal by Subject|6|||
94377487|NCT04603937|323166630|FG000|Overall Study|Lost to Follow-up|5|||
94377488|NCT04603937|323166631|FG001|Overall Study|Lost to Follow-up|6|||
94377489|NCT04603937|323166630|FG000|Overall Study|Physician Decision|0|||
94377490|NCT04603937|323166631|FG001|Overall Study|Physician Decision|1|||
94377491|NCT04603937|323166630|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
94377492|NCT04603937|323166631|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
94377493|NCT00770315|323166632|FG000|Overall Study|Adverse Event|11|||
94377494|NCT00770315|323166633|FG001|Overall Study|Adverse Event|17|||
94377495|NCT00770315|323166634|FG002|Overall Study|Adverse Event|16|||
94377496|NCT00770315|323166635|FG003|Overall Study|Adverse Event|6|||
94377497|NCT00770315|323166632|FG000|Overall Study|Lost to Follow-up|9|||
94377498|NCT00770315|323166633|FG001|Overall Study|Lost to Follow-up|5|||
94377499|NCT00770315|323166634|FG002|Overall Study|Lost to Follow-up|10|||
94377500|NCT00770315|323166635|FG003|Overall Study|Lost to Follow-up|3|||
94377501|NCT00770315|323166632|FG000|Overall Study|Withdrawal by Subject|13|||
94377502|NCT00770315|323166633|FG001|Overall Study|Withdrawal by Subject|17|||
94377503|NCT00770315|323166634|FG002|Overall Study|Withdrawal by Subject|24|||
94377504|NCT00770315|323166635|FG003|Overall Study|Withdrawal by Subject|20|||
94377505|NCT00770315|323166632|FG000|Overall Study|Noncompliance with Protocol|7|||
94377506|NCT00770315|323166633|FG001|Overall Study|Noncompliance with Protocol|4|||
94377507|NCT00770315|323166634|FG002|Overall Study|Noncompliance with Protocol|7|||
94377508|NCT00770315|323166635|FG003|Overall Study|Noncompliance with Protocol|9|||
94377509|NCT00598559|323168934|FG000|Overall Study|Adverse Event|11|||
94377510|NCT00598559|323168935|FG001|Overall Study|Adverse Event|7|||
94377511|NCT00598559|323168936|FG002|Overall Study|Adverse Event|0|||
94377512|NCT00598559|323168934|FG000|Overall Study|Withdrawal by Subject|2|||
94377513|NCT00598559|323168935|FG001|Overall Study|Withdrawal by Subject|2|||
94377514|NCT00598559|323168936|FG002|Overall Study|Withdrawal by Subject|0|||
94377515|NCT00598559|323168934|FG000|Overall Study|Protocol Non-compliance|1|||
94377516|NCT00598559|323168935|FG001|Overall Study|Protocol Non-compliance|0|||
94377517|NCT00598559|323168936|FG002|Overall Study|Protocol Non-compliance|0|||
94377518|NCT00598559|323168934|FG000|Overall Study|Early discharge from hospital|9|||
94377519|NCT00598559|323168935|FG001|Overall Study|Early discharge from hospital|12|||
94377520|NCT00598559|323168936|FG002|Overall Study|Early discharge from hospital|3|||
94377521|NCT00598559|323168934|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
94377522|NCT00598559|323168935|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
94377523|NCT00598559|323168936|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
94377524|NCT02806232|323168937|FG000|Overall Study|Lost to Follow-up|1|||
94377525|NCT02806232|323168938|FG001|Overall Study|Lost to Follow-up|2|||
94377526|NCT02806232|323168939|FG002|Overall Study|Lost to Follow-up|1|||
94377527|NCT02806232|323168940|FG003|Overall Study|Lost to Follow-up|0|||
94377528|NCT02806232|323168941|FG004|Overall Study|Lost to Follow-up|0|||
94377529|NCT02806232|323168942|FG005|Overall Study|Lost to Follow-up|1|||
94377530|NCT02806232|323168943|FG006|Overall Study|Lost to Follow-up|0|||
94377531|NCT02806232|323168944|FG007|Overall Study|Lost to Follow-up|0|||
94377532|NCT02806232|323168945|FG008|Overall Study|Lost to Follow-up|0|||
94377533|NCT02806232|323168937|FG000|Overall Study|Withdrawal by Subject|0|||
94377534|NCT02806232|323168938|FG001|Overall Study|Withdrawal by Subject|2|||
94377535|NCT02806232|323168939|FG002|Overall Study|Withdrawal by Subject|0|||
94377536|NCT02806232|323168940|FG003|Overall Study|Withdrawal by Subject|0|||
94377537|NCT02806232|323168941|FG004|Overall Study|Withdrawal by Subject|2|||
94377538|NCT02806232|323168942|FG005|Overall Study|Withdrawal by Subject|1|||
94377539|NCT02806232|323168943|FG006|Overall Study|Withdrawal by Subject|0|||
94377540|NCT02806232|323168944|FG007|Overall Study|Withdrawal by Subject|0|||
94377541|NCT02806232|323168945|FG008|Overall Study|Withdrawal by Subject|0|||
94377542|NCT00759148|323168946|FG000|Overall Study|Adverse Event|1|||
94377543|NCT00759148|323168947|FG001|Overall Study|Adverse Event|6|||
94377544|NCT00759148|323168946|FG000|Overall Study|Withdrawal by Subject|3|||
94377545|NCT00759148|323168947|FG001|Overall Study|Withdrawal by Subject|7|||
94377546|NCT00759148|323168946|FG000|Overall Study|Lost to Follow-up|3|||
94377547|NCT00759148|323168947|FG001|Overall Study|Lost to Follow-up|9|||
94377548|NCT00759148|323168946|FG000|Overall Study|Treatment Failure|6|||
94377549|NCT00759148|323168947|FG001|Overall Study|Treatment Failure|10|||
94469757|NCT00548249|323511298|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
94377550|NCT00759148|323168946|FG000|Overall Study|Reason not given|1|||
94377551|NCT00759148|323168947|FG001|Overall Study|Reason not given|0|||
94377552|NCT00608205|323168950|FG000|Overall Study|Adverse Event|3|||
94377553|NCT00608205|323168951|FG001|Overall Study|Adverse Event|2|||
94377554|NCT00608205|323168950|FG000|Overall Study|Patient non-compliant|0|||
94377555|NCT00608205|323168951|FG001|Overall Study|Patient non-compliant|1|||
94377556|NCT01296932|323168952|FG000|Overall Study|Dose limiting toxicity|0|||
94469758|NCT00548249|323511299|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
94307094|NCT03503773|322908099|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
94307095|NCT01088412|322908101|FG000|Overall Study|Adverse Event|38|||
94307096|NCT01088412|322908102|FG001|Overall Study|Adverse Event|0|||
94307097|NCT01088412|322908103|FG002|Overall Study|Adverse Event|0|||
94307098|NCT01088412|322908101|FG000|Overall Study|Death|42|||
94307099|NCT01088412|322908102|FG001|Overall Study|Death|6|||
94307100|NCT01088412|322908103|FG002|Overall Study|Death|0|||
94307101|NCT01088412|322908101|FG000|Overall Study|Other Reason per Case Report Form|2089|||
94307102|NCT01088412|322908102|FG001|Overall Study|Other Reason per Case Report Form|103|||
94307103|NCT01088412|322908103|FG002|Overall Study|Other Reason per Case Report Form|9|||
94307104|NCT01088412|322908101|FG000|Overall Study|Withdrawal by Subject|1761|||
94307105|NCT01088412|322908102|FG001|Overall Study|Withdrawal by Subject|25|||
94307106|NCT01088412|322908103|FG002|Overall Study|Withdrawal by Subject|1|||
94307107|NCT01088412|322908101|FG000|Overall Study|Received Another GH Product|79|||
94307108|NCT01088412|322908102|FG001|Overall Study|Received Another GH Product|0|||
94307109|NCT01088412|322908103|FG002|Overall Study|Received Another GH Product|0|||
94307110|NCT01088412|322908101|FG000|Overall Study|Participant Moved|601|||
94307111|NCT01088412|322908102|FG001|Overall Study|Participant Moved|21|||
94307112|NCT01088412|322908103|FG002|Overall Study|Participant Moved|2|||
94307113|NCT01088412|322908101|FG000|Overall Study|Physician Decision|1041|||
94307114|NCT01088412|322908102|FG001|Overall Study|Physician Decision|8|||
94307115|NCT01088412|322908103|FG002|Overall Study|Physician Decision|4|||
94307116|NCT01088412|322908101|FG000|Overall Study|Sponsor Decision|4467|||
94307117|NCT01088412|322908102|FG001|Overall Study|Sponsor Decision|79|||
94307118|NCT01088412|322908103|FG002|Overall Study|Sponsor Decision|23|||
94307119|NCT01088412|322908101|FG000|Overall Study|Third Party Required to Change Brand|487|||
94307120|NCT01088412|322908102|FG001|Overall Study|Third Party Required to Change Brand|0|||
94307121|NCT01088412|322908103|FG002|Overall Study|Third Party Required to Change Brand|0|||
94307122|NCT01088412|322908101|FG000|Overall Study|Lost to Follow-up|3052|||
94307123|NCT01088412|322908102|FG001|Overall Study|Lost to Follow-up|130|||
94307124|NCT01088412|322908103|FG002|Overall Study|Lost to Follow-up|11|||
94307125|NCT01088412|322908101|FG000|Overall Study|Study Summary Not Completed|4360|||
94307126|NCT01088412|322908102|FG001|Overall Study|Study Summary Not Completed|64|||
94307127|NCT01088412|322908103|FG002|Overall Study|Study Summary Not Completed|22|||
94307128|NCT00942708|322908107|FG000|Overall Study|Withdrawal by Subject|1|||
94307129|NCT01426386|322908108|FG000|Overall Study|Adverse Event|0|||
94307130|NCT01426386|322908109|FG001|Overall Study|Adverse Event|1|||
94307131|NCT01426386|322908110|FG002|Overall Study|Adverse Event|0|||
94307132|NCT01426386|322908111|FG003|Overall Study|Adverse Event|0|||
94307133|NCT01426386|322908112|FG004|Overall Study|Adverse Event|0|||
94307134|NCT01426386|322908113|FG005|Overall Study|Adverse Event|0|||
94307135|NCT01426386|322908108|FG000|Overall Study|Did not attend scheduled visit|1|||
94307136|NCT01426386|322908109|FG001|Overall Study|Did not attend scheduled visit|4|||
94307137|NCT01426386|322908110|FG002|Overall Study|Did not attend scheduled visit|0|||
94307138|NCT01426386|322908111|FG003|Overall Study|Did not attend scheduled visit|0|||
94307139|NCT01426386|322908112|FG004|Overall Study|Did not attend scheduled visit|2|||
94307140|NCT01426386|322908113|FG005|Overall Study|Did not attend scheduled visit|1|||
94307141|NCT01426386|322908108|FG000|Overall Study|Poor response|2|||
94307142|NCT01426386|322908109|FG001|Overall Study|Poor response|1|||
94307143|NCT01426386|322908110|FG002|Overall Study|Poor response|2|||
94307144|NCT01426386|322908111|FG003|Overall Study|Poor response|0|||
94307145|NCT01426386|322908112|FG004|Overall Study|Poor response|1|||
94307146|NCT01426386|322908113|FG005|Overall Study|Poor response|0|||
94307147|NCT01426386|322908108|FG000|Overall Study|Personal reasons|0|||
94307148|NCT01426386|322908109|FG001|Overall Study|Personal reasons|0|||
94307149|NCT01426386|322908110|FG002|Overall Study|Personal reasons|0|||
94307150|NCT01426386|322908111|FG003|Overall Study|Personal reasons|0|||
94307151|NCT01426386|322908112|FG004|Overall Study|Personal reasons|1|||
94307152|NCT01426386|322908113|FG005|Overall Study|Personal reasons|0|||
94307153|NCT00196937|322908116|FG000|Overall Study|Serious Adverse Event|1|||
94307154|NCT00196937|322908117|FG001|Overall Study|Serious Adverse Event|0|||
94307155|NCT00196937|322908118|FG002|Overall Study|Serious Adverse Event|0|||
94307156|NCT00196937|322908116|FG000|Overall Study|Non-serious adverse event|1|||
94307157|NCT00196937|322908117|FG001|Overall Study|Non-serious adverse event|1|||
94307158|NCT00196937|322908118|FG002|Overall Study|Non-serious adverse event|1|||
94307159|NCT00196937|322908116|FG000|Overall Study|Withdrawal by Subject|0|||
94307160|NCT00196937|322908117|FG001|Overall Study|Withdrawal by Subject|0|||
94307161|NCT00196937|322908118|FG002|Overall Study|Withdrawal by Subject|2|||
94307162|NCT00196937|322908116|FG000|Overall Study|Lost to Follow-up|4|||
94307163|NCT00196937|322908117|FG001|Overall Study|Lost to Follow-up|3|||
94307164|NCT00196937|322908118|FG002|Overall Study|Lost to Follow-up|3|||
94307165|NCT00196937|322908116|FG000|Overall Study|Other|3|||
94307166|NCT00196937|322908117|FG001|Overall Study|Other|1|||
94307167|NCT00196937|322908118|FG002|Overall Study|Other|1|||
94307168|NCT00964795|322908119|FG000|Overall Study|Withdrawal by Subject|79|||
94307169|NCT00964795|322908119|FG000|Overall Study|Adverse Event|12|||
94307170|NCT00964795|322908119|FG000|Overall Study|Death|14|||
94307171|NCT00964795|322908119|FG000|Overall Study|Lost to Follow-up|7|||
94377557|NCT01296932|323168953|FG001|Overall Study|Dose limiting toxicity|0|||
94377558|NCT01296932|323168954|FG002|Overall Study|Dose limiting toxicity|0|||
94377559|NCT01296932|323168955|FG003|Overall Study|Dose limiting toxicity|0|||
94377560|NCT01296932|323168956|FG004|Overall Study|Dose limiting toxicity|0|||
94377561|NCT01296932|323168957|FG005|Overall Study|Dose limiting toxicity|0|||
94377562|NCT01296932|323168958|FG006|Overall Study|Dose limiting toxicity|1|||
94307172|NCT00964795|322908119|FG000|Overall Study|Termination of Study by Sponsor|169|||
94307173|NCT00964795|322908119|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
94307174|NCT00964795|322908119|FG000|Overall Study|Other|23|||
94307175|NCT03245814|322908120|FG000|Overall Study|Lost to Follow-up|5|||
94307176|NCT03245814|322908121|FG001|Overall Study|Lost to Follow-up|8|||
94307177|NCT03245814|322908120|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
94307178|NCT03245814|322908121|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
94307179|NCT01096667|322908123|FG000|Overall Study|Lost to Follow-up|1|||
94307180|NCT01096667|322908124|FG001|Overall Study|Lost to Follow-up|1|||
94307181|NCT01096667|322908125|FG002|Overall Study|Lost to Follow-up|1|||
94307182|NCT01096667|322908126|FG003|Overall Study|Lost to Follow-up|0|||
94307183|NCT01096667|322908127|FG004|Overall Study|Lost to Follow-up|0|||
94307184|NCT01096667|322908123|FG000|Overall Study|Withdrawal by Subject|1|||
94307185|NCT01096667|322908124|FG001|Overall Study|Withdrawal by Subject|0|||
94307186|NCT01096667|322908125|FG002|Overall Study|Withdrawal by Subject|0|||
94307187|NCT01096667|322908126|FG003|Overall Study|Withdrawal by Subject|1|||
94307188|NCT01096667|322908127|FG004|Overall Study|Withdrawal by Subject|0|||
94307189|NCT01096667|322908123|FG000|Overall Study|Reason not available|0|||
94307190|NCT01096667|322908124|FG001|Overall Study|Reason not available|1|||
94307191|NCT01096667|322908125|FG002|Overall Study|Reason not available|1|||
94307192|NCT01096667|322908126|FG003|Overall Study|Reason not available|1|||
94307193|NCT01096667|322908127|FG004|Overall Study|Reason not available|0|||
94307194|NCT01096667|322908123|FG000|Overall Study|Protocol Violation|0|||
94307195|NCT01096667|322908124|FG001|Overall Study|Protocol Violation|0|||
94307196|NCT01096667|322908125|FG002|Overall Study|Protocol Violation|0|||
94307197|NCT01096667|322908126|FG003|Overall Study|Protocol Violation|1|||
94307198|NCT01096667|322908127|FG004|Overall Study|Protocol Violation|0|||
94307199|NCT01096667|322908123|FG000|Overall Study|Not treated|1|||
94307200|NCT01096667|322908124|FG001|Overall Study|Not treated|0|||
94307201|NCT01096667|322908125|FG002|Overall Study|Not treated|0|||
94307202|NCT01096667|322908126|FG003|Overall Study|Not treated|0|||
94307203|NCT01096667|322908127|FG004|Overall Study|Not treated|0|||
94307204|NCT02522377|322908128|FG000|Overall Study|Withdrawal by Subject|1|||
94307205|NCT02522377|322908129|FG001|Overall Study|Withdrawal by Subject|0|||
94307206|NCT02522377|322908128|FG000|Overall Study|Remission Achieved|3|||
94307207|NCT02522377|322908129|FG001|Overall Study|Remission Achieved|0|||
94307208|NCT02489630|322908130|FG000|Overall Study|Oversedation|1|||
94307209|NCT02489630|322908131|FG001|Overall Study|Oversedation|1|||
94307210|NCT02489630|322908130|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
94307211|NCT02489630|322908131|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
94307212|NCT02053246|322908132|FG000|Overall Study|Withdrawal by Subject|3|||
94307213|NCT02053246|322908132|FG000|Overall Study|Physician Decision|1|||
94307214|NCT01056523|322908133|FG000|Overall Study|Death|1|||
94307215|NCT01056523|322908134|FG001|Overall Study|Death|0|||
94307216|NCT01056523|322908135|FG002|Overall Study|Death|2|||
94307217|NCT01056523|322908136|FG003|Overall Study|Death|3|||
94307218|NCT01056523|322908137|FG004|Overall Study|Death|0|||
94307219|NCT01056523|322908138|FG005|Overall Study|Death|0|||
94307220|NCT01056523|322908139|FG006|Overall Study|Death|1|||
94307221|NCT03429556|322908140|FG000|Overall Study|Lost to Follow-up|0|||
94307222|NCT03429556|322908141|FG001|Overall Study|Lost to Follow-up|1|||
94307223|NCT03429556|322908142|FG002|Overall Study|Lost to Follow-up|0|||
94307224|NCT03429556|322908143|FG003|Overall Study|Lost to Follow-up|0|||
94307225|NCT01769404|322908144|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
94307226|NCT01769404|322908145|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
94307227|NCT01769404|322908144|FG000|Treatment Period 1|Withdrawal by Subject|3|||
94307228|NCT01769404|322908145|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94307229|NCT01769404|322908144|FG000|Treatment Period 1|Sponsor decision|1|||
94307230|NCT01769404|322908145|FG001|Treatment Period 1|Sponsor decision|0|||
94307231|NCT01769404|322908144|FG000|Treatment Period 2|Sponsor decision|7|||
94307232|NCT01769404|322908145|FG001|Treatment Period 2|Sponsor decision|0|||
94377563|NCT01296932|323168959|FG007|Overall Study|Dose limiting toxicity|0|||
94377564|NCT01296932|323168960|FG008|Overall Study|Dose limiting toxicity|1|||
94377565|NCT01296932|323168952|FG000|Overall Study|Progressive disease|2|||
94307233|NCT00377299|322908146|FG000|Overall Study|Lost to Follow-up|14|||
94377566|NCT01296932|323168953|FG001|Overall Study|Progressive disease|0|||
94377567|NCT01296932|323168954|FG002|Overall Study|Progressive disease|1|||
94307234|NCT00377299|322908147|FG001|Overall Study|Lost to Follow-up|19|||
94307235|NCT00377299|322908146|FG000|Overall Study|Adverse Event|0|||
94307236|NCT00377299|322908147|FG001|Overall Study|Adverse Event|1|||
94307237|NCT00377299|322908146|FG000|Overall Study|Withdrawal by Subject|5|||
94307238|NCT00377299|322908147|FG001|Overall Study|Withdrawal by Subject|4|||
94377568|NCT01296932|323168955|FG003|Overall Study|Progressive disease|1|||
94377569|NCT01296932|323168956|FG004|Overall Study|Progressive disease|2|||
94377570|NCT01296932|323168957|FG005|Overall Study|Progressive disease|3|||
94377571|NCT01296932|323168958|FG006|Overall Study|Progressive disease|1|||
94377572|NCT01296932|323168959|FG007|Overall Study|Progressive disease|0|||
94377573|NCT01296932|323168960|FG008|Overall Study|Progressive disease|0|||
94377574|NCT01296932|323168952|FG000|Overall Study|Withdrawal by Subject|0|||
94377575|NCT01296932|323168953|FG001|Overall Study|Withdrawal by Subject|0|||
94377576|NCT01296932|323168954|FG002|Overall Study|Withdrawal by Subject|1|||
94377577|NCT01296932|323168955|FG003|Overall Study|Withdrawal by Subject|1|||
94377578|NCT01296932|323168956|FG004|Overall Study|Withdrawal by Subject|0|||
94377579|NCT01296932|323168957|FG005|Overall Study|Withdrawal by Subject|0|||
94377580|NCT01296932|323168958|FG006|Overall Study|Withdrawal by Subject|3|||
94377581|NCT01296932|323168959|FG007|Overall Study|Withdrawal by Subject|0|||
94377582|NCT01296932|323168960|FG008|Overall Study|Withdrawal by Subject|0|||
94377583|NCT01296932|323168952|FG000|Overall Study|Adverse Event|1|||
94377584|NCT01296932|323168953|FG001|Overall Study|Adverse Event|1|||
94377585|NCT01296932|323168954|FG002|Overall Study|Adverse Event|1|||
94377586|NCT01296932|323168955|FG003|Overall Study|Adverse Event|2|||
94377587|NCT01296932|323168956|FG004|Overall Study|Adverse Event|1|||
94377588|NCT01296932|323168957|FG005|Overall Study|Adverse Event|0|||
94377589|NCT01296932|323168958|FG006|Overall Study|Adverse Event|0|||
94377590|NCT01296932|323168959|FG007|Overall Study|Adverse Event|0|||
94377591|NCT01296932|323168960|FG008|Overall Study|Adverse Event|1|||
94377592|NCT01296932|323168952|FG000|Overall Study|Investigator decision|0|||
94377593|NCT01296932|323168953|FG001|Overall Study|Investigator decision|1|||
94377594|NCT01296932|323168954|FG002|Overall Study|Investigator decision|0|||
94377595|NCT01296932|323168955|FG003|Overall Study|Investigator decision|1|||
94377596|NCT01296932|323168956|FG004|Overall Study|Investigator decision|0|||
94377597|NCT01296932|323168957|FG005|Overall Study|Investigator decision|0|||
94377598|NCT01296932|323168958|FG006|Overall Study|Investigator decision|1|||
94377599|NCT01296932|323168959|FG007|Overall Study|Investigator decision|0|||
94377600|NCT01296932|323168960|FG008|Overall Study|Investigator decision|1|||
94377601|NCT01296932|323168952|FG000|Overall Study|No clinical benefit anymore|0|||
94377602|NCT01296932|323168953|FG001|Overall Study|No clinical benefit anymore|1|||
94377603|NCT01296932|323168954|FG002|Overall Study|No clinical benefit anymore|0|||
94377604|NCT01296932|323168955|FG003|Overall Study|No clinical benefit anymore|0|||
94377605|NCT01296932|323168956|FG004|Overall Study|No clinical benefit anymore|0|||
94377606|NCT01296932|323168957|FG005|Overall Study|No clinical benefit anymore|0|||
94377607|NCT01296932|323168958|FG006|Overall Study|No clinical benefit anymore|0|||
94377608|NCT01296932|323168959|FG007|Overall Study|No clinical benefit anymore|0|||
94377609|NCT01296932|323168960|FG008|Overall Study|No clinical benefit anymore|0|||
94377610|NCT01296932|323168952|FG000|Overall Study|Physician Decision|0|||
94377611|NCT01296932|323168953|FG001|Overall Study|Physician Decision|0|||
94377612|NCT01296932|323168954|FG002|Overall Study|Physician Decision|1|||
94377613|NCT01296932|323168955|FG003|Overall Study|Physician Decision|0|||
94377614|NCT01296932|323168956|FG004|Overall Study|Physician Decision|0|||
94377615|NCT01296932|323168957|FG005|Overall Study|Physician Decision|0|||
94377616|NCT01296932|323168958|FG006|Overall Study|Physician Decision|0|||
94377617|NCT01296932|323168959|FG007|Overall Study|Physician Decision|0|||
94377618|NCT01296932|323168960|FG008|Overall Study|Physician Decision|0|||
94377619|NCT01296932|323168952|FG000|Overall Study|IV problems, administration not possible|0|||
94377620|NCT01296932|323168953|FG001|Overall Study|IV problems, administration not possible|0|||
94377621|NCT01296932|323168954|FG002|Overall Study|IV problems, administration not possible|1|||
94377622|NCT01296932|323168955|FG003|Overall Study|IV problems, administration not possible|0|||
94377623|NCT01296932|323168956|FG004|Overall Study|IV problems, administration not possible|0|||
94377624|NCT01296932|323168957|FG005|Overall Study|IV problems, administration not possible|0|||
94377625|NCT01296932|323168958|FG006|Overall Study|IV problems, administration not possible|0|||
94377626|NCT01296932|323168959|FG007|Overall Study|IV problems, administration not possible|0|||
94377627|NCT01296932|323168960|FG008|Overall Study|IV problems, administration not possible|0|||
94377628|NCT01296932|323168952|FG000|Overall Study|per protocol|0|||
94377629|NCT01296932|323168953|FG001|Overall Study|per protocol|0|||
94377630|NCT01296932|323168954|FG002|Overall Study|per protocol|1|||
94377631|NCT01296932|323168955|FG003|Overall Study|per protocol|1|||
94377632|NCT01296932|323168956|FG004|Overall Study|per protocol|0|||
94377633|NCT01296932|323168957|FG005|Overall Study|per protocol|0|||
94377634|NCT01296932|323168958|FG006|Overall Study|per protocol|0|||
94377635|NCT01296932|323168959|FG007|Overall Study|per protocol|0|||
94377636|NCT01296932|323168960|FG008|Overall Study|per protocol|0|||
94377637|NCT01296932|323168952|FG000|Overall Study|Low benefit and too many side effects|0|||
94377638|NCT01296932|323168953|FG001|Overall Study|Low benefit and too many side effects|0|||
94307239|NCT00095121|322908148|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
94307240|NCT00095121|322908149|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
94307241|NCT00095121|322908148|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
94307242|NCT00095121|322908149|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
94307243|NCT01118143|322908150|FG000|Overall Study|Withdrawal by Subject|2|||
94307244|NCT01118143|322908151|FG001|Overall Study|Withdrawal by Subject|5|||
94307245|NCT02209597|322908154|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
94307246|NCT02209597|322908154|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
94307247|NCT02209597|322908154|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
94307248|NCT02209597|322908154|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
94307249|NCT00501852|322908156|FG000|Overall Study|Adverse Event|3|||
94307250|NCT00501852|322908156|FG000|Overall Study|Withdrawal by Subject|2|||
94307251|NCT00492921|322908160|FG000|Overall Study|Death|1|||
94307252|NCT00492921|322908161|FG001|Overall Study|Death|0|||
94307253|NCT00492921|322908162|FG002|Overall Study|Death|1|||
94307254|NCT01855789|322908163|FG000|1) Baseline up to Week 24|Adverse Event|37|||
94307255|NCT01855789|322908164|FG001|1) Baseline up to Week 24|Adverse Event|0|||
94307256|NCT01855789|322908165|FG002|1) Baseline up to Week 24|Adverse Event|0|||
94307257|NCT01855789|322908166|FG003|1) Baseline up to Week 24|Adverse Event|0|||
94307258|NCT01855789|322908163|FG000|1) Baseline up to Week 24|Death|2|||
94307259|NCT01855789|322908164|FG001|1) Baseline up to Week 24|Death|0|||
94307260|NCT01855789|322908165|FG002|1) Baseline up to Week 24|Death|0|||
94307261|NCT01855789|322908166|FG003|1) Baseline up to Week 24|Death|0|||
94307262|NCT01855789|322908163|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
94307263|NCT01855789|322908164|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
94307264|NCT01855789|322908165|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
94307265|NCT01855789|322908166|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
94307266|NCT01855789|322908163|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
94307267|NCT01855789|322908164|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
94307268|NCT01855789|322908165|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
94307269|NCT01855789|322908166|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
94307270|NCT01855789|322908163|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
94307271|NCT01855789|322908164|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
94307272|NCT01855789|322908165|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
94307273|NCT01855789|322908166|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
94307274|NCT01855789|322908163|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
94307275|NCT01855789|322908164|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
94307276|NCT01855789|322908165|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
94307277|NCT01855789|322908166|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
94307278|NCT01855789|322908163|FG000|1) Baseline up to Week 24|Physician Decision|4|||
94307279|NCT01855789|322908164|FG001|1) Baseline up to Week 24|Physician Decision|0|||
94307280|NCT01855789|322908165|FG002|1) Baseline up to Week 24|Physician Decision|0|||
94307281|NCT01855789|322908166|FG003|1) Baseline up to Week 24|Physician Decision|0|||
94307282|NCT01855789|322908163|FG000|1) Baseline up to Week 24|Pregnancy|1|||
94307283|NCT01855789|322908164|FG001|1) Baseline up to Week 24|Pregnancy|0|||
94307284|NCT01855789|322908165|FG002|1) Baseline up to Week 24|Pregnancy|0|||
94307285|NCT01855789|322908166|FG003|1) Baseline up to Week 24|Pregnancy|0|||
94307286|NCT01855789|322908163|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
94307287|NCT01855789|322908164|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
94307288|NCT01855789|322908165|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
94307289|NCT01855789|322908166|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
94307290|NCT01855789|322908163|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
94307291|NCT01855789|322908164|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
94307292|NCT01855789|322908165|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
94307293|NCT01855789|322908166|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
94307294|NCT01855789|322908163|FG000|1) Baseline up to Week 24|Other|4|||
94307295|NCT01855789|322908164|FG001|1) Baseline up to Week 24|Other|0|||
94307296|NCT01855789|322908165|FG002|1) Baseline up to Week 24|Other|0|||
94307297|NCT01855789|322908166|FG003|1) Baseline up to Week 24|Other|0|||
94307298|NCT01855789|322908163|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
94307299|NCT01855789|322908164|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
94307300|NCT01855789|322908165|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
94307301|NCT01855789|322908166|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
94307302|NCT01855789|322908163|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
94307303|NCT01855789|322908164|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
94307304|NCT01855789|322908165|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
94307305|NCT01855789|322908166|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
94307306|NCT01855789|322908163|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
94307307|NCT01855789|322908164|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
94307308|NCT01855789|322908165|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
94377639|NCT01296932|323168954|FG002|Overall Study|Low benefit and too many side effects|0|||
94377640|NCT01296932|323168955|FG003|Overall Study|Low benefit and too many side effects|0|||
94377641|NCT01296932|323168956|FG004|Overall Study|Low benefit and too many side effects|0|||
94377642|NCT01296932|323168957|FG005|Overall Study|Low benefit and too many side effects|0|||
94377643|NCT01296932|323168958|FG006|Overall Study|Low benefit and too many side effects|0|||
94377644|NCT01296932|323168959|FG007|Overall Study|Low benefit and too many side effects|1|||
94377645|NCT01296932|323168960|FG008|Overall Study|Low benefit and too many side effects|0|||
94377646|NCT01296932|323168952|FG000|Overall Study|No adequate treatment response|0|||
94469759|NCT00548249|323511300|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
94469760|NCT00548249|323511296|FG000|Overall Study|Protocol Violation|1|||
94469761|NCT00548249|323511297|FG001|Overall Study|Protocol Violation|1|||
94469762|NCT00548249|323511298|FG002|Overall Study|Protocol Violation|4|||
94469763|NCT00548249|323511299|FG003|Overall Study|Protocol Violation|0|||
94469764|NCT00548249|323511300|FG004|Overall Study|Protocol Violation|3|||
94469765|NCT00548249|323511296|FG000|Overall Study|Miscellaneous|2|||
94469766|NCT00548249|323511297|FG001|Overall Study|Miscellaneous|3|||
94469767|NCT00548249|323511298|FG002|Overall Study|Miscellaneous|2|||
94469768|NCT00548249|323511299|FG003|Overall Study|Miscellaneous|0|||
94469769|NCT00548249|323511300|FG004|Overall Study|Miscellaneous|2|||
94469770|NCT00548249|323511296|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
94469771|NCT00548249|323511297|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
94469772|NCT00548249|323511298|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
94469773|NCT00548249|323511299|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
94469774|NCT00548249|323511300|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
94469775|NCT00548249|323511296|FG000|Overall Study|Adverse Event|2|||
94469776|NCT00548249|323511297|FG001|Overall Study|Adverse Event|2|||
94469777|NCT00548249|323511298|FG002|Overall Study|Adverse Event|0|||
94469778|NCT00548249|323511299|FG003|Overall Study|Adverse Event|1|||
94469779|NCT00548249|323511300|FG004|Overall Study|Adverse Event|1|||
94469780|NCT00548249|323511296|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
94469781|NCT00548249|323511297|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
94469782|NCT00548249|323511298|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
94469783|NCT00548249|323511299|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
94469784|NCT00548249|323511300|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
94469785|NCT00548249|323511296|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
94469786|NCT00548249|323511297|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
94469787|NCT00548249|323511298|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
94469788|NCT00548249|323511299|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
94469789|NCT00548249|323511300|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
94469790|NCT00548249|323511296|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
94469791|NCT00548249|323511297|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
94469792|NCT00548249|323511298|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
94469793|NCT00548249|323511299|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
94469794|NCT00548249|323511300|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
94469795|NCT00548249|323511296|FG000|Overall Study|Prolonged hospitalization|0|||
94469796|NCT00548249|323511297|FG001|Overall Study|Prolonged hospitalization|0|||
94469797|NCT00548249|323511298|FG002|Overall Study|Prolonged hospitalization|2|||
94469798|NCT00548249|323511299|FG003|Overall Study|Prolonged hospitalization|1|||
94469799|NCT00548249|323511300|FG004|Overall Study|Prolonged hospitalization|0|||
94469800|NCT00548249|323511296|FG000|Overall Study|Withdrawal by Subject|2|||
94469801|NCT00548249|323511297|FG001|Overall Study|Withdrawal by Subject|0|||
94469802|NCT00548249|323511298|FG002|Overall Study|Withdrawal by Subject|0|||
94469803|NCT00548249|323511299|FG003|Overall Study|Withdrawal by Subject|0|||
94469804|NCT00548249|323511300|FG004|Overall Study|Withdrawal by Subject|0|||
94469805|NCT00548249|323511296|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
94469806|NCT00548249|323511297|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
94469807|NCT00548249|323511298|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
94469808|NCT00548249|323511299|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
94469809|NCT00548249|323511300|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
94469810|NCT00548249|323511296|FG000|Overall Study|Sponsor's request|0|||
94469811|NCT00548249|323511297|FG001|Overall Study|Sponsor's request|0|||
94469812|NCT00548249|323511298|FG002|Overall Study|Sponsor's request|0|||
94377647|NCT01296932|323168953|FG001|Overall Study|No adequate treatment response|0|||
94377648|NCT01296932|323168954|FG002|Overall Study|No adequate treatment response|0|||
94469813|NCT00548249|323511299|FG003|Overall Study|Sponsor's request|1|||
94469814|NCT00548249|323511300|FG004|Overall Study|Sponsor's request|0|||
94469815|NCT03003000|323511301|FG000|Overall Study|Adverse Event|1|||
94469816|NCT03003000|323511302|FG001|Overall Study|Adverse Event|2|||
94469817|NCT03003000|323511303|FG002|Overall Study|Adverse Event|3|||
94469818|NCT03003000|323511301|FG000|Overall Study|Lack of Efficacy|1|||
94469819|NCT03003000|323511302|FG001|Overall Study|Lack of Efficacy|0|||
94307309|NCT01855789|322908166|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
94307310|NCT01855789|322908163|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
94307311|NCT01855789|322908164|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
94307312|NCT01855789|322908165|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
94307313|NCT01855789|322908166|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
94307314|NCT01855789|322908163|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
94307315|NCT01855789|322908164|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
94307316|NCT01855789|322908165|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
94307317|NCT01855789|322908166|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
94307318|NCT01855789|322908163|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
94307319|NCT01855789|322908164|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
94307320|NCT01855789|322908165|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
94307321|NCT01855789|322908166|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
94307322|NCT01855789|322908163|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
94307323|NCT01855789|322908164|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
94307324|NCT01855789|322908165|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
94307325|NCT01855789|322908166|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
94307326|NCT01855789|322908163|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
94307327|NCT01855789|322908164|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
94307328|NCT01855789|322908165|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
94307329|NCT01855789|322908166|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
94307330|NCT01855789|322908163|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
94307331|NCT01855789|322908164|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
94307332|NCT01855789|322908165|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
94307333|NCT01855789|322908166|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
94307334|NCT01855789|322908163|FG000|2) Week 24 up to End of Study|Other|0|||
94307335|NCT01855789|322908164|FG001|2) Week 24 up to End of Study|Other|0|||
94307336|NCT01855789|322908165|FG002|2) Week 24 up to End of Study|Other|0|||
94307337|NCT01855789|322908166|FG003|2) Week 24 up to End of Study|Other|1|||
94307338|NCT02369510|322908168|FG000|Overall Study|Spilled Medication|1|||
94307339|NCT02369510|322908169|FG001|Overall Study|Spilled Medication|2|||
94307340|NCT02369510|322908170|FG002|Overall Study|Spilled Medication|1|||
94307341|NCT02369510|322908168|FG000|Overall Study|Epidural Activation|1|||
94307342|NCT02369510|322908169|FG001|Overall Study|Epidural Activation|1|||
94307343|NCT02369510|322908170|FG002|Overall Study|Epidural Activation|5|||
94307344|NCT04285723|322908171|FG000|Overall Study|Subject decision|1|||
94307345|NCT04285723|322908172|FG001|Overall Study|Subject decision|2|||
94307346|NCT04285723|322908171|FG000|Overall Study|Physician Decision|1|||
94307347|NCT04285723|322908172|FG001|Overall Study|Physician Decision|0|||
94469820|NCT03003000|323511303|FG002|Overall Study|Lack of Efficacy|0|||
94307348|NCT04285723|322908171|FG000|Overall Study|No efficiency|1|||
94307349|NCT04285723|322908172|FG001|Overall Study|No efficiency|0|||
94307350|NCT02032524|322908173|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
94307351|NCT02032524|322908174|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
94307352|NCT02032524|322908175|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
94307353|NCT02032524|322908176|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
94307354|NCT02032524|322908177|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
94307355|NCT02032524|322908178|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
94307356|NCT02032524|322908173|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
94307357|NCT02032524|322908174|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
94307358|NCT02032524|322908175|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
94307359|NCT02032524|322908176|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
94307360|NCT02032524|322908177|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
94307361|NCT02032524|322908178|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
94307362|NCT02032524|322908173|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
94307363|NCT02032524|322908174|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
94307364|NCT02032524|322908175|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
94307365|NCT02032524|322908176|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
94307366|NCT02032524|322908177|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
94307367|NCT02032524|322908178|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
94307368|NCT02032524|322908173|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
94307369|NCT02032524|322908174|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
94307370|NCT02032524|322908175|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
94307371|NCT02032524|322908176|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
94307372|NCT02032524|322908177|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
94307373|NCT02032524|322908178|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
94307374|NCT02032524|322908173|FG000|Period 2: LTS13769 Study|Other|0|||
94307375|NCT02032524|322908174|FG001|Period 2: LTS13769 Study|Other|0|||
94307376|NCT02032524|322908175|FG002|Period 2: LTS13769 Study|Other|0|||
94307377|NCT02032524|322908176|FG003|Period 2: LTS13769 Study|Other|0|||
94307378|NCT02032524|322908177|FG004|Period 2: LTS13769 Study|Other|0|||
94307379|NCT02032524|322908178|FG005|Period 2: LTS13769 Study|Other|1|||
94307380|NCT02903511|322908181|FG000|Overall Study|Withdrawal by Subject|1|||
94307381|NCT02903511|322908182|FG001|Overall Study|Withdrawal by Subject|0|||
94307382|NCT02903511|322908181|FG000|Overall Study|Lost to Follow-up|3|||
94307383|NCT02903511|322908182|FG001|Overall Study|Lost to Follow-up|2|||
94307384|NCT02495077|322909698|FG000|Overall Study|Adverse Event|0|||
94307385|NCT02495077|322909699|FG001|Overall Study|Adverse Event|1|||
94307386|NCT02495077|322909700|FG002|Overall Study|Adverse Event|1|||
94307387|NCT02495077|322909701|FG003|Overall Study|Adverse Event|0|||
94307388|NCT02495077|322909698|FG000|Overall Study|Death|3|||
94307389|NCT02495077|322909699|FG001|Overall Study|Death|5|||
94307390|NCT02495077|322909700|FG002|Overall Study|Death|0|||
94307391|NCT02495077|322909701|FG003|Overall Study|Death|0|||
94307392|NCT02495077|322909698|FG000|Overall Study|Lost to Follow-up|6|||
94307393|NCT02495077|322909699|FG001|Overall Study|Lost to Follow-up|4|||
94307394|NCT02495077|322909700|FG002|Overall Study|Lost to Follow-up|0|||
94307395|NCT02495077|322909701|FG003|Overall Study|Lost to Follow-up|0|||
94307396|NCT02495077|322909698|FG000|Overall Study|Physician Decision|2|||
94307397|NCT02495077|322909699|FG001|Overall Study|Physician Decision|1|||
94307398|NCT02495077|322909700|FG002|Overall Study|Physician Decision|4|||
94307399|NCT02495077|322909701|FG003|Overall Study|Physician Decision|0|||
94307400|NCT02495077|322909698|FG000|Overall Study|Protocol Violation|0|||
94307401|NCT02495077|322909699|FG001|Overall Study|Protocol Violation|1|||
94307402|NCT02495077|322909700|FG002|Overall Study|Protocol Violation|0|||
94307403|NCT02495077|322909701|FG003|Overall Study|Protocol Violation|0|||
94307404|NCT02495077|322909698|FG000|Overall Study|Screen Failure|0|||
94307405|NCT02495077|322909699|FG001|Overall Study|Screen Failure|0|||
94307406|NCT02495077|322909700|FG002|Overall Study|Screen Failure|0|||
94307407|NCT02495077|322909701|FG003|Overall Study|Screen Failure|48|||
94307408|NCT02495077|322909698|FG000|Overall Study|Withdrawal by Subject|7|||
94307409|NCT02495077|322909699|FG001|Overall Study|Withdrawal by Subject|7|||
94307410|NCT02495077|322909700|FG002|Overall Study|Withdrawal by Subject|7|||
94307411|NCT02495077|322909701|FG003|Overall Study|Withdrawal by Subject|0|||
94307412|NCT02495077|322909698|FG000|Overall Study|Covid-19 research restrictions|1|||
94307413|NCT02495077|322909699|FG001|Overall Study|Covid-19 research restrictions|0|||
94307414|NCT02495077|322909700|FG002|Overall Study|Covid-19 research restrictions|0|||
94307415|NCT02495077|322909701|FG003|Overall Study|Covid-19 research restrictions|0|||
94307416|NCT02495077|322909698|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
94307417|NCT02495077|322909699|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
94307418|NCT02495077|322909700|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
94307419|NCT02495077|322909701|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
94307420|NCT02495077|322909698|FG000|Overall Study|Incarcerated|0|||
94307421|NCT02495077|322909699|FG001|Overall Study|Incarcerated|1|||
94307422|NCT02495077|322909700|FG002|Overall Study|Incarcerated|0|||
94307423|NCT02495077|322909701|FG003|Overall Study|Incarcerated|0|||
94307424|NCT02495077|322909698|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
94307425|NCT02495077|322909699|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
94307426|NCT02495077|322909700|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
94307427|NCT02495077|322909701|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
94307428|NCT02495077|322909698|FG000|Overall Study|Timing of transplant and randomization|0|||
94307429|NCT02495077|322909699|FG001|Overall Study|Timing of transplant and randomization|0|||
94307430|NCT02495077|322909700|FG002|Overall Study|Timing of transplant and randomization|5|||
94307431|NCT02495077|322909701|FG003|Overall Study|Timing of transplant and randomization|0|||
94307432|NCT00128206|322909702|FG000|Overall Study|Lost to Follow-up|137|||
94307433|NCT00128206|322909703|FG001|Overall Study|Lost to Follow-up|118|||
94307434|NCT00128206|322909702|FG000|Overall Study|Adverse Event|0|||
94307435|NCT00128206|322909703|FG001|Overall Study|Adverse Event|2|||
94307436|NCT03270085|322909704|FG000|Overall Study|Withdrawal by Subject|1|||
94307437|NCT03270085|322909705|FG001|Overall Study|Withdrawal by Subject|0|||
94307438|NCT02400346|322909711|FG000|Overall Study|Adverse Event|24|||
94307439|NCT02400346|322909711|FG000|Overall Study|Lack of Efficacy|9|||
94307440|NCT02400346|322909711|FG000|Overall Study|Non-compliance with IMP|1|||
94307441|NCT02400346|322909711|FG000|Overall Study|Withdrawal by Subject|7|||
94307442|NCT02400346|322909711|FG000|Overall Study|Administrative or other reason(s)|2|||
94307443|NCT02400346|322909711|FG000|Overall Study|Lost to Follow-up|1|||
94307444|NCT01269125|322909713|FG000|Overall Study|Adverse Event|3|||
94307445|NCT01269125|322909714|FG001|Overall Study|Adverse Event|5|||
94307446|NCT01269125|322909715|FG002|Overall Study|Adverse Event|0|||
94307447|NCT01269125|322909713|FG000|Overall Study|Lost to Follow-up|4|||
94307448|NCT01269125|322909714|FG001|Overall Study|Lost to Follow-up|0|||
94307449|NCT01269125|322909715|FG002|Overall Study|Lost to Follow-up|0|||
94307450|NCT01348919|322909717|FG000|Overall Study|Adverse Event|3|||
94307451|NCT01348919|322909718|FG001|Overall Study|Adverse Event|1|||
94307452|NCT01348919|322909719|FG002|Overall Study|Adverse Event|0|||
94307453|NCT01348919|322909717|FG000|Overall Study|Withdrawal by Subject|0|||
94307454|NCT01348919|322909718|FG001|Overall Study|Withdrawal by Subject|1|||
94307455|NCT01348919|322909719|FG002|Overall Study|Withdrawal by Subject|0|||
94307456|NCT01348919|322909717|FG000|Overall Study|Disease progression|0|||
94307457|NCT01348919|322909718|FG001|Overall Study|Disease progression|1|||
94307458|NCT01348919|322909719|FG002|Overall Study|Disease progression|1|||
94307459|NCT01518699|322909720|FG000|Period 2|Protocol Violation|1|||
94307460|NCT01518699|322909721|FG001|Period 2|Protocol Violation|1|||
94307461|NCT01518699|322909722|FG002|Period 2|Protocol Violation|0|||
94307462|NCT01518699|322909723|FG003|Period 2|Protocol Violation|0|||
94307463|NCT01518699|322909724|FG004|Period 2|Protocol Violation|0|||
94307464|NCT01518699|322909725|FG005|Period 2|Protocol Violation|0|||
94307465|NCT01518699|322909720|FG000|Period 2|Lost to Follow-up|0|||
94307466|NCT01518699|322909721|FG001|Period 2|Lost to Follow-up|1|||
94469821|NCT03003000|323511301|FG000|Overall Study|Non-compliant with protocol|0|||
94469822|NCT03003000|323511302|FG001|Overall Study|Non-compliant with protocol|1|||
94469823|NCT03003000|323511303|FG002|Overall Study|Non-compliant with protocol|1|||
94469824|NCT03003000|323511301|FG000|Overall Study|Refused to continue medication|2|||
94469825|NCT03003000|323511302|FG001|Overall Study|Refused to continue medication|0|||
94469826|NCT03003000|323511303|FG002|Overall Study|Refused to continue medication|0|||
94469827|NCT03003000|323511301|FG000|Overall Study|Other than listed|1|||
94469828|NCT03003000|323511302|FG001|Overall Study|Other than listed|1|||
94469829|NCT03003000|323511303|FG002|Overall Study|Other than listed|1|||
94469830|NCT00750919|323511308|FG000|Overall Study|Adverse Event|9|||
94469831|NCT00750919|323511308|FG000|Overall Study|Withdrawal by Subject|1|||
94469832|NCT00750919|323511308|FG000|Overall Study|Lack of Efficacy|8|||
94469833|NCT00750919|323511308|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
94469834|NCT00750919|323511308|FG000|Overall Study|Other|36|||
94469835|NCT02147067|323511309|FG000|Overall Study|Withdrawal by Subject|2|||
94469836|NCT02147067|323511310|FG001|Overall Study|Withdrawal by Subject|2|||
94469837|NCT00048997|323511316|FG000|Overall Study|Protocol Violation|7|||
94469838|NCT00048997|323511317|FG001|Overall Study|Protocol Violation|2|||
94469839|NCT00048997|323511316|FG000|Overall Study|Withdrawal by Subject|6|||
94469840|NCT00048997|323511317|FG001|Overall Study|Withdrawal by Subject|1|||
94469841|NCT01404949|323511325|FG000|Overall Study|Not Treated|1|||
94469842|NCT02886884|323511329|FG000|Follow-up|Withdrawal by Subject|0|||
94469843|NCT02886884|323511330|FG001|Follow-up|Withdrawal by Subject|0|||
94469844|NCT02886884|323511331|FG002|Follow-up|Withdrawal by Subject|0|||
94469845|NCT02886884|323511332|FG003|Follow-up|Withdrawal by Subject|1|||
94469846|NCT00621517|323511336|FG000|Overall Study|Lost to Follow-up|3|||
94469847|NCT00621517|323511337|FG001|Overall Study|Lost to Follow-up|3|||
94469848|NCT00621517|323511336|FG000|Overall Study|Withdrawal by Subject|3|||
94469849|NCT00621517|323511337|FG001|Overall Study|Withdrawal by Subject|4|||
94469850|NCT00621517|323511336|FG000|Overall Study|Adverse Event|1|||
94469851|NCT00621517|323511337|FG001|Overall Study|Adverse Event|0|||
94469852|NCT03469999|323511338|FG000|Overall Study|Lost to Follow-up|2|||
94469853|NCT00073008|323511339|FG000|Overall Study|Missing|6|||
94469854|NCT00073008|323511340|FG001|Overall Study|Missing|6|||
94469855|NCT00073008|323511339|FG000|Overall Study|Withdrawal by Subject|2|||
94469856|NCT00073008|323511340|FG001|Overall Study|Withdrawal by Subject|2|||
94469857|NCT00073008|323511339|FG000|Overall Study|Lost to Follow-up|1|||
94469858|NCT00073008|323511340|FG001|Overall Study|Lost to Follow-up|3|||
94469859|NCT00073008|323511339|FG000|Overall Study|Death|46|||
94469860|NCT00073008|323511340|FG001|Overall Study|Death|47|||
94469861|NCT00073008|323511339|FG000|Overall Study|"Other selected on Case Report Form"|7|||
94469862|NCT00073008|323511340|FG001|Overall Study|"Other selected on Case Report Form"|5|||
94469863|NCT02669667|323511341|FG000|Overall Study|Lost to Follow-up|0|||
94469864|NCT02669667|323511342|FG001|Overall Study|Lost to Follow-up|0|||
94469865|NCT02669667|323511343|FG002|Overall Study|Lost to Follow-up|0|||
94469866|NCT02669667|323511344|FG003|Overall Study|Lost to Follow-up|0|||
94469867|NCT02669667|323511345|FG004|Overall Study|Lost to Follow-up|0|||
94469868|NCT02669667|323511346|FG005|Overall Study|Lost to Follow-up|1|||
94469869|NCT02669667|323511347|FG006|Overall Study|Lost to Follow-up|0|||
94469870|NCT00334295|323511348|FG000|Overall Study|Patients received fewer than 3 injection|5|||
94469871|NCT00394771|323511353|FG000|Overall Study|Did not meet protocol requirements|1|||
94469872|NCT00394771|323511354|FG001|Overall Study|Did not meet protocol requirements|0|||
94469873|NCT00394771|323511355|FG002|Overall Study|Did not meet protocol requirements|2|||
94469874|NCT00394771|323511356|FG003|Overall Study|Did not meet protocol requirements|0|||
94469875|NCT00394771|323511353|FG000|Overall Study|Protocol Violation|2|||
94469876|NCT00394771|323511354|FG001|Overall Study|Protocol Violation|4|||
94469877|NCT00394771|323511355|FG002|Overall Study|Protocol Violation|9|||
94469878|NCT00394771|323511356|FG003|Overall Study|Protocol Violation|7|||
94469879|NCT00394771|323511353|FG000|Overall Study|Withdrawal by Subject|10|||
94469880|NCT00394771|323511354|FG001|Overall Study|Withdrawal by Subject|6|||
94469881|NCT00394771|323511355|FG002|Overall Study|Withdrawal by Subject|8|||
94469882|NCT00394771|323511356|FG003|Overall Study|Withdrawal by Subject|12|||
94469883|NCT00394771|323511353|FG000|Overall Study|Adverse Event|10|||
94469884|NCT00394771|323511354|FG001|Overall Study|Adverse Event|5|||
94469885|NCT00394771|323511355|FG002|Overall Study|Adverse Event|12|||
94469886|NCT00394771|323511356|FG003|Overall Study|Adverse Event|8|||
94469887|NCT00394771|323511353|FG000|Overall Study|Participant pregnant|0|||
94469888|NCT00394771|323511354|FG001|Overall Study|Participant pregnant|1|||
94469889|NCT00394771|323511355|FG002|Overall Study|Participant pregnant|2|||
94469890|NCT00394771|323511356|FG003|Overall Study|Participant pregnant|2|||
94469891|NCT00394771|323511353|FG000|Overall Study|Lost to Follow-up|15|||
94469892|NCT00394771|323511354|FG001|Overall Study|Lost to Follow-up|15|||
94469893|NCT00394771|323511355|FG002|Overall Study|Lost to Follow-up|13|||
94469894|NCT00394771|323511356|FG003|Overall Study|Lost to Follow-up|10|||
94469895|NCT00394771|323511353|FG000|Overall Study|Other|3|||
94377649|NCT01296932|323168955|FG003|Overall Study|No adequate treatment response|0|||
94377650|NCT01296932|323168956|FG004|Overall Study|No adequate treatment response|0|||
94377651|NCT01296932|323168957|FG005|Overall Study|No adequate treatment response|0|||
94377652|NCT01296932|323168958|FG006|Overall Study|No adequate treatment response|0|||
94377653|NCT01296932|323168959|FG007|Overall Study|No adequate treatment response|1|||
94377654|NCT01296932|323168960|FG008|Overall Study|No adequate treatment response|0|||
94377655|NCT01296932|323168952|FG000|Overall Study|Dosage already reduced, AE still present|0|||
94377656|NCT01296932|323168953|FG001|Overall Study|Dosage already reduced, AE still present|0|||
94377657|NCT01296932|323168954|FG002|Overall Study|Dosage already reduced, AE still present|0|||
94377658|NCT01296932|323168955|FG003|Overall Study|Dosage already reduced, AE still present|0|||
94377659|NCT01296932|323168956|FG004|Overall Study|Dosage already reduced, AE still present|0|||
94377660|NCT01296932|323168957|FG005|Overall Study|Dosage already reduced, AE still present|0|||
94377661|NCT01296932|323168958|FG006|Overall Study|Dosage already reduced, AE still present|0|||
94377662|NCT01296932|323168959|FG007|Overall Study|Dosage already reduced, AE still present|0|||
94377663|NCT01296932|323168960|FG008|Overall Study|Dosage already reduced, AE still present|1|||
94377664|NCT01464827|323168965|FG000|Overall Study|Adverse Event|0|||
94377665|NCT01464827|323168966|FG001|Overall Study|Adverse Event|0|||
94377666|NCT01464827|323168967|FG002|Overall Study|Adverse Event|0|||
94377667|NCT01464827|323168968|FG003|Overall Study|Adverse Event|0|||
94377668|NCT01464827|323168969|FG004|Overall Study|Adverse Event|0|||
94377669|NCT01464827|323168970|FG005|Overall Study|Adverse Event|0|||
94377670|NCT01464827|323168971|FG006|Overall Study|Adverse Event|0|||
94377671|NCT01464827|323168972|FG007|Overall Study|Adverse Event|0|||
94377672|NCT01464827|323168973|FG008|Overall Study|Adverse Event|0|||
94377673|NCT01464827|323168974|FG009|Overall Study|Adverse Event|0|||
94377674|NCT01464827|323168975|FG010|Overall Study|Adverse Event|0|||
94377675|NCT01464827|323168976|FG011|Overall Study|Adverse Event|0|||
94377676|NCT01464827|323168977|FG012|Overall Study|Adverse Event|1|||
94377677|NCT01464827|323168978|FG013|Overall Study|Adverse Event|0|||
94377678|NCT01464827|323168965|FG000|Overall Study|Withdrawal by Subject|1|||
94377679|NCT01464827|323168966|FG001|Overall Study|Withdrawal by Subject|0|||
94377680|NCT01464827|323168967|FG002|Overall Study|Withdrawal by Subject|0|||
94377681|NCT01464827|323168968|FG003|Overall Study|Withdrawal by Subject|0|||
94377682|NCT01464827|323168969|FG004|Overall Study|Withdrawal by Subject|1|||
94377683|NCT01464827|323168970|FG005|Overall Study|Withdrawal by Subject|0|||
94377684|NCT01464827|323168971|FG006|Overall Study|Withdrawal by Subject|0|||
94377685|NCT01464827|323168972|FG007|Overall Study|Withdrawal by Subject|1|||
94377686|NCT01464827|323168973|FG008|Overall Study|Withdrawal by Subject|0|||
94377687|NCT01464827|323168974|FG009|Overall Study|Withdrawal by Subject|0|||
94377688|NCT01464827|323168975|FG010|Overall Study|Withdrawal by Subject|0|||
94377689|NCT01464827|323168976|FG011|Overall Study|Withdrawal by Subject|0|||
94377690|NCT01464827|323168977|FG012|Overall Study|Withdrawal by Subject|0|||
94377691|NCT01464827|323168978|FG013|Overall Study|Withdrawal by Subject|0|||
94377692|NCT01464827|323168965|FG000|Overall Study|Lost to Follow-up|0|||
94377693|NCT01464827|323168966|FG001|Overall Study|Lost to Follow-up|2|||
94377694|NCT01464827|323168967|FG002|Overall Study|Lost to Follow-up|0|||
94377695|NCT01464827|323168968|FG003|Overall Study|Lost to Follow-up|2|||
94377696|NCT01464827|323168969|FG004|Overall Study|Lost to Follow-up|3|||
94377697|NCT01464827|323168970|FG005|Overall Study|Lost to Follow-up|1|||
94377698|NCT01464827|323168971|FG006|Overall Study|Lost to Follow-up|2|||
94377699|NCT01464827|323168972|FG007|Overall Study|Lost to Follow-up|2|||
94377700|NCT01464827|323168973|FG008|Overall Study|Lost to Follow-up|0|||
94377701|NCT01464827|323168974|FG009|Overall Study|Lost to Follow-up|0|||
94377702|NCT01464827|323168975|FG010|Overall Study|Lost to Follow-up|0|||
94377703|NCT01464827|323168976|FG011|Overall Study|Lost to Follow-up|1|||
94377704|NCT01464827|323168977|FG012|Overall Study|Lost to Follow-up|0|||
94377705|NCT01464827|323168978|FG013|Overall Study|Lost to Follow-up|1|||
94377706|NCT01464827|323168965|FG000|Overall Study|Other|2|||
94377707|NCT01464827|323168966|FG001|Overall Study|Other|3|||
94377708|NCT01464827|323168967|FG002|Overall Study|Other|0|||
94377709|NCT01464827|323168968|FG003|Overall Study|Other|2|||
94377710|NCT01464827|323168969|FG004|Overall Study|Other|3|||
94377711|NCT01464827|323168970|FG005|Overall Study|Other|0|||
94377712|NCT01464827|323168971|FG006|Overall Study|Other|1|||
94377713|NCT01464827|323168972|FG007|Overall Study|Other|0|||
94377714|NCT01464827|323168973|FG008|Overall Study|Other|3|||
94377715|NCT01464827|323168974|FG009|Overall Study|Other|1|||
94377716|NCT01464827|323168975|FG010|Overall Study|Other|2|||
94377717|NCT01464827|323168976|FG011|Overall Study|Other|0|||
94377718|NCT01464827|323168977|FG012|Overall Study|Other|1|||
94377719|NCT01464827|323168978|FG013|Overall Study|Other|0|||
94377720|NCT01464827|323168965|FG000|Overall Study|Not Treated|0|||
94377721|NCT01464827|323168966|FG001|Overall Study|Not Treated|2|||
94377722|NCT01464827|323168967|FG002|Overall Study|Not Treated|0|||
94377723|NCT01464827|323168968|FG003|Overall Study|Not Treated|0|||
94377724|NCT01464827|323168969|FG004|Overall Study|Not Treated|1|||
94377725|NCT01464827|323168970|FG005|Overall Study|Not Treated|0|||
94377726|NCT01464827|323168971|FG006|Overall Study|Not Treated|1|||
94377727|NCT01464827|323168972|FG007|Overall Study|Not Treated|0|||
94307467|NCT01518699|322909722|FG002|Period 2|Lost to Follow-up|0|||
94307468|NCT01518699|322909723|FG003|Period 2|Lost to Follow-up|0|||
94307469|NCT01518699|322909724|FG004|Period 2|Lost to Follow-up|0|||
94307470|NCT01518699|322909725|FG005|Period 2|Lost to Follow-up|0|||
94307471|NCT01518699|322909720|FG000|Period 2|Adverse Event|1|||
94307472|NCT01518699|322909721|FG001|Period 2|Adverse Event|0|||
94307473|NCT01518699|322909722|FG002|Period 2|Adverse Event|0|||
94307474|NCT01518699|322909723|FG003|Period 2|Adverse Event|0|||
94307475|NCT01518699|322909724|FG004|Period 2|Adverse Event|0|||
94307476|NCT01518699|322909725|FG005|Period 2|Adverse Event|0|||
94307477|NCT02839746|322909727|FG000|Overall Study|Not met selection criteria|12|||
94307478|NCT02517515|322909728|FG000|Overall Study|Adverse Event|0|||
94307479|NCT02517515|322909729|FG001|Overall Study|Adverse Event|1|||
94307480|NCT02517515|322909728|FG000|Overall Study|Withdrew Consent|0|||
94307481|NCT02517515|322909729|FG001|Overall Study|Withdrew Consent|1|||
94307482|NCT02517515|322909728|FG000|Overall Study|Lost to Follow-up|1|||
94307483|NCT02517515|322909729|FG001|Overall Study|Lost to Follow-up|0|||
94307484|NCT02517515|322909728|FG000|Overall Study|Other|1|||
94307485|NCT02517515|322909729|FG001|Overall Study|Other|0|||
94307486|NCT00151411|322909730|FG000|Overall Study|Lost to Follow-up|15|||
94307487|NCT00151411|322909731|FG001|Overall Study|Lost to Follow-up|19|||
94307488|NCT00151411|322909730|FG000|Overall Study|Withdrawal by Subject|12|||
94307489|NCT00151411|322909731|FG001|Overall Study|Withdrawal by Subject|20|||
94307490|NCT00151411|322909730|FG000|Overall Study|Adverse Event|6|||
94307491|NCT00151411|322909731|FG001|Overall Study|Adverse Event|0|||
94307492|NCT00151411|322909730|FG000|Overall Study|Pregnancy|0|||
94307493|NCT00151411|322909731|FG001|Overall Study|Pregnancy|4|||
94307494|NCT00443560|322909732|FG000|Overall Study|No intrathecal dose|58|||
94307495|NCT00443560|322909733|FG001|Overall Study|No intrathecal dose|26|||
94307496|NCT00443560|322909732|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
94307497|NCT00443560|322909733|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
94307498|NCT00092547|322909738|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
94307499|NCT00092547|322909739|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
94307500|NCT00092547|322909740|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
94307501|NCT00092547|322909738|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
94307502|NCT00092547|322909739|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
94307503|NCT00092547|322909740|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
94307504|NCT00092547|322909738|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
94307505|NCT00092547|322909739|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
94307506|NCT00092547|322909740|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
94307507|NCT00092547|322909738|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
94307508|NCT00092547|322909739|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
94307509|NCT00092547|322909740|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
94307510|NCT00092547|322909738|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
94307511|NCT00092547|322909739|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
94307512|NCT00092547|322909740|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
94307513|NCT00092547|322909738|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
94307514|NCT00092547|322909739|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
94307515|NCT00092547|322909740|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
94307516|NCT00092547|322909738|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
94307517|NCT00092547|322909739|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
94307518|NCT00092547|322909740|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
94307519|NCT00092547|322909738|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
94307520|NCT00092547|322909739|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
94307521|NCT00092547|322909740|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
94307522|NCT00092547|322909738|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
94307523|NCT00092547|322909739|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
94307524|NCT00092547|322909740|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
94307525|NCT00092547|322909738|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
94307526|NCT00092547|322909739|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
94469896|NCT00394771|323511354|FG001|Overall Study|Other|3|||
94377728|NCT01464827|323168973|FG008|Overall Study|Not Treated|0|||
94377729|NCT01464827|323168974|FG009|Overall Study|Not Treated|2|||
94377730|NCT01464827|323168975|FG010|Overall Study|Not Treated|0|||
94377731|NCT01464827|323168976|FG011|Overall Study|Not Treated|1|||
94377732|NCT01464827|323168977|FG012|Overall Study|Not Treated|0|||
94377733|NCT01464827|323168978|FG013|Overall Study|Not Treated|2|||
94377734|NCT00738673|323168979|FG000|Overall Study|Adverse Event|1|||
94377735|NCT00738673|323168980|FG001|Overall Study|Adverse Event|0|||
94377736|NCT00738673|323168979|FG000|Overall Study|Lack of Efficacy|19|||
94377737|NCT00738673|323168980|FG001|Overall Study|Lack of Efficacy|8|||
94377738|NCT00738673|323168979|FG000|Overall Study|Protocol Violation|1|||
94377739|NCT00738673|323168980|FG001|Overall Study|Protocol Violation|2|||
94377740|NCT00738673|323168979|FG000|Overall Study|Withdrawal by Subject|3|||
94377741|NCT00738673|323168980|FG001|Overall Study|Withdrawal by Subject|1|||
94377742|NCT01799590|323168981|FG000|Overall Study|Adverse Event|13|||
94377743|NCT01799590|323168982|FG001|Overall Study|Adverse Event|7|||
94377744|NCT01799590|323168983|FG002|Overall Study|Adverse Event|5|||
94377745|NCT01799590|323168981|FG000|Overall Study|Pregnancy|2|||
94377746|NCT01799590|323168982|FG001|Overall Study|Pregnancy|0|||
94377747|NCT01799590|323168983|FG002|Overall Study|Pregnancy|0|||
94377748|NCT01799590|323168981|FG000|Overall Study|Lack of Efficacy|3|||
94377749|NCT01799590|323168982|FG001|Overall Study|Lack of Efficacy|1|||
94377750|NCT01799590|323168983|FG002|Overall Study|Lack of Efficacy|3|||
94377751|NCT01799590|323168981|FG000|Overall Study|Participants convenience|4|||
94377752|NCT01799590|323168982|FG001|Overall Study|Participants convenience|4|||
94377753|NCT01799590|323168983|FG002|Overall Study|Participants convenience|2|||
94377754|NCT01799590|323168981|FG000|Overall Study|Aggravation of complications|0|||
94377755|NCT01799590|323168982|FG001|Overall Study|Aggravation of complications|1|||
94377756|NCT01799590|323168983|FG002|Overall Study|Aggravation of complications|1|||
94377757|NCT01799590|323168981|FG000|Overall Study|Using drugs with restricted days of use|0|||
94377758|NCT01799590|323168982|FG001|Overall Study|Using drugs with restricted days of use|3|||
94377759|NCT01799590|323168983|FG002|Overall Study|Using drugs with restricted days of use|2|||
94377760|NCT01799590|323168981|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
94377761|NCT01799590|323168982|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
94377762|NCT01799590|323168983|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
94377763|NCT01799590|323168981|FG000|Overall Study|Other|3|||
94377764|NCT01799590|323168982|FG001|Overall Study|Other|0|||
94377765|NCT01799590|323168983|FG002|Overall Study|Other|1|||
94377766|NCT01751412|323168984|FG000|Overall Study|Disease Progression Before Treatment|1|||
94377767|NCT00294723|323168987|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
94377768|NCT00294723|323168988|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
94377769|NCT00294723|323168989|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
94377770|NCT00294723|323168987|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
94377771|NCT00294723|323168988|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
94377772|NCT00294723|323168989|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
94377773|NCT00294723|323168987|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
94377774|NCT00294723|323168988|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
94377775|NCT00294723|323168989|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
94377776|NCT00294723|323168987|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
94377777|NCT00294723|323168988|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
94377778|NCT00294723|323168989|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
94377779|NCT00294723|323168987|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
94377780|NCT00294723|323168988|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
94377781|NCT00294723|323168989|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
94377782|NCT00294723|323168987|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
94377783|NCT00294723|323168988|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
94377784|NCT00294723|323168989|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
94377785|NCT00294723|323168987|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
94377786|NCT00294723|323168988|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
94377787|NCT00294723|323168989|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
94377788|NCT00294723|323168987|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
94377789|NCT00294723|323168988|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
94377790|NCT00294723|323168989|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
94377791|NCT00294723|323168987|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
94377792|NCT00294723|323168988|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
94377793|NCT00294723|323168989|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
94377794|NCT00294723|323168987|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
94377795|NCT00294723|323168988|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
94377796|NCT00294723|323168989|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
94377797|NCT00294723|323168987|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
94377798|NCT00294723|323168988|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
94377799|NCT00294723|323168989|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
94377800|NCT00294723|323168987|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
94377801|NCT00294723|323168988|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
94377802|NCT00294723|323168989|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
94377803|NCT00891774|323168993|FG000|Overall Study|Lost to Follow-up|5|||
94377804|NCT00891774|323168993|FG000|Overall Study|Illness (Self/Mother)|3|||
94377805|NCT00891774|323168993|FG000|Overall Study|Withdrawal by Subject|2|||
94377806|NCT00891774|323168993|FG000|Overall Study|Protocol Violation|4|||
94377807|NCT03175120|323168994|FG000|Overall Study|Adverse Event|2|||
94377808|NCT03175120|323168995|FG001|Overall Study|Adverse Event|2|||
94377809|NCT03175120|323168994|FG000|Overall Study|Protocol Violation|5|||
94377810|NCT03175120|323168995|FG001|Overall Study|Protocol Violation|2|||
94377811|NCT03175120|323168994|FG000|Overall Study|Lost to Follow-up|1|||
94377812|NCT03175120|323168995|FG001|Overall Study|Lost to Follow-up|0|||
94377813|NCT03175120|323168994|FG000|Overall Study|Withdrawal by Subject|2|||
94377814|NCT03175120|323168995|FG001|Overall Study|Withdrawal by Subject|5|||
94377815|NCT03175120|323168994|FG000|Overall Study|Other|2|||
94377816|NCT03175120|323168995|FG001|Overall Study|Other|3|||
94377817|NCT04120194|323168996|FG000|Overall Study|Lost to Follow-up|11|||
94377818|NCT04120194|323168997|FG001|Overall Study|Lost to Follow-up|8|||
94377819|NCT04120194|323168996|FG000|Overall Study|Adverse Event|4|||
94377820|NCT04120194|323168997|FG001|Overall Study|Adverse Event|5|||
94377821|NCT04120194|323168996|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
94377822|NCT04120194|323168997|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
94377823|NCT04120194|323168996|FG000|Overall Study|Miscellaneous|4|||
94377824|NCT04120194|323168997|FG001|Overall Study|Miscellaneous|5|||
94377825|NCT01958281|323168998|FG000|Overall Study|Lack of Efficacy|5|||
94377826|NCT01958281|323168999|FG001|Overall Study|Lack of Efficacy|2|||
94377827|NCT01958281|323169000|FG002|Overall Study|Lack of Efficacy|0|||
94377828|NCT01958281|323168998|FG000|Overall Study|Adverse Event|0|||
94377829|NCT01958281|323168999|FG001|Overall Study|Adverse Event|2|||
94377830|NCT01958281|323169000|FG002|Overall Study|Adverse Event|0|||
94377831|NCT01958281|323168998|FG000|Overall Study|Withdrew Consent|1|||
94377832|NCT01958281|323168999|FG001|Overall Study|Withdrew Consent|0|||
94377833|NCT01958281|323169000|FG002|Overall Study|Withdrew Consent|0|||
94377834|NCT03341507|323169003|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
94377835|NCT00989261|323169005|FG000|Overall Study|Still in follow up|12|||
94377836|NCT00989261|323169006|FG001|Overall Study|Still in follow up|21|||
94377837|NCT00989261|323169005|FG000|Overall Study|Withdrawal by Subject|0|||
94377838|NCT00989261|323169006|FG001|Overall Study|Withdrawal by Subject|1|||
94377839|NCT00989261|323169005|FG000|Overall Study|Lost to Follow-up|3|||
94377840|NCT00989261|323169006|FG001|Overall Study|Lost to Follow-up|0|||
94377841|NCT00576901|323169007|FG000|Overall Study|Withdrawal by Subject|1|||
94377842|NCT00576901|323169007|FG000|Overall Study|Disease course|1|||
94377843|NCT00576901|323169007|FG000|Overall Study|Protocol Violation|1|||
94377844|NCT00553540|323169008|FG000|Overall Study|discharged after first visit|2|||
94377845|NCT00553540|323169009|FG001|Overall Study|discharged after first visit|5|||
94377846|NCT01405820|323169012|FG000|Randomized Treatment Period|Adverse Event|3|||
94377847|NCT01405820|323169013|FG001|Randomized Treatment Period|Adverse Event|3|||
94377848|NCT01405820|323169014|FG002|Randomized Treatment Period|Adverse Event|3|||
94377849|NCT01405820|323169015|FG003|Randomized Treatment Period|Adverse Event|0|||
94377850|NCT01405820|323169016|FG004|Randomized Treatment Period|Adverse Event|2|||
94377851|NCT01405820|323169017|FG005|Randomized Treatment Period|Adverse Event|1|||
94377852|NCT01405820|323169012|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
94377853|NCT01405820|323169013|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
94377854|NCT01405820|323169014|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
94377855|NCT01405820|323169015|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
94377856|NCT01405820|323169016|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
94377857|NCT01405820|323169017|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
94469897|NCT00394771|323511355|FG002|Overall Study|Other|1|||
94469898|NCT00394771|323511356|FG003|Overall Study|Other|0|||
94377858|NCT01405820|323169012|FG000|Randomized Treatment Period|Other|2|||
94377859|NCT01405820|323169013|FG001|Randomized Treatment Period|Other|2|||
94377860|NCT01405820|323169014|FG002|Randomized Treatment Period|Other|1|||
94377861|NCT01405820|323169015|FG003|Randomized Treatment Period|Other|1|||
94377862|NCT01405820|323169016|FG004|Randomized Treatment Period|Other|0|||
94377863|NCT01405820|323169017|FG005|Randomized Treatment Period|Other|0|||
94377864|NCT01405820|323169012|FG000|Randomized Treatment Period|Physician Decision|0|||
94377865|NCT01405820|323169013|FG001|Randomized Treatment Period|Physician Decision|2|||
94377866|NCT01405820|323169014|FG002|Randomized Treatment Period|Physician Decision|1|||
94377867|NCT01405820|323169015|FG003|Randomized Treatment Period|Physician Decision|0|||
94377868|NCT01405820|323169016|FG004|Randomized Treatment Period|Physician Decision|0|||
94469899|NCT01952080|323511357|FG000|Overall Study|Withdrawal by Subject|0|||
94377869|NCT01405820|323169017|FG005|Randomized Treatment Period|Physician Decision|0|||
94377870|NCT01405820|323169012|FG000|Randomized Treatment Period|Rescue|0|||
94377871|NCT01405820|323169013|FG001|Randomized Treatment Period|Rescue|1|||
94377872|NCT01405820|323169014|FG002|Randomized Treatment Period|Rescue|13|||
94377873|NCT01405820|323169015|FG003|Randomized Treatment Period|Rescue|10|||
94377874|NCT01405820|323169016|FG004|Randomized Treatment Period|Rescue|8|||
94377875|NCT01405820|323169017|FG005|Randomized Treatment Period|Rescue|8|||
94377876|NCT01405820|323169012|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
94377877|NCT01405820|323169013|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
94377878|NCT01405820|323169014|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
94377879|NCT01405820|323169015|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
94377880|NCT01405820|323169016|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
94377881|NCT01405820|323169017|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
94377882|NCT01405820|323169012|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
94377883|NCT01405820|323169013|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
94377884|NCT01405820|323169014|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
94377885|NCT01405820|323169015|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
94377886|NCT01405820|323169016|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
94377887|NCT01405820|323169017|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
94377888|NCT01405820|323169012|FG000|Randomized Treatment Period|Death|0|||
94377889|NCT01405820|323169013|FG001|Randomized Treatment Period|Death|0|||
94377890|NCT01405820|323169014|FG002|Randomized Treatment Period|Death|0|||
94377891|NCT01405820|323169015|FG003|Randomized Treatment Period|Death|1|||
94377892|NCT01405820|323169016|FG004|Randomized Treatment Period|Death|0|||
94377893|NCT01405820|323169017|FG005|Randomized Treatment Period|Death|0|||
94469900|NCT01952080|323511358|FG001|Overall Study|Withdrawal by Subject|0|||
94469901|NCT01952080|323511359|FG002|Overall Study|Withdrawal by Subject|0|||
94377894|NCT01405820|323169012|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
94377895|NCT01405820|323169013|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
94377896|NCT01405820|323169014|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
94377897|NCT01405820|323169015|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
94469902|NCT01952080|323511360|FG003|Overall Study|Withdrawal by Subject|1|||
94377898|NCT01405820|323169016|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
94377899|NCT01405820|323169017|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
94377900|NCT01405820|323169012|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
94377901|NCT01405820|323169013|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
94377902|NCT01405820|323169014|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
94377903|NCT01405820|323169015|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
94377904|NCT01405820|323169016|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
94377905|NCT01405820|323169017|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
94377906|NCT01405820|323169012|FG000|Open-Label Treatment Period|Other|1|||
94377907|NCT01405820|323169013|FG001|Open-Label Treatment Period|Other|1|||
94377908|NCT01405820|323169014|FG002|Open-Label Treatment Period|Other|1|||
94377909|NCT01405820|323169015|FG003|Open-Label Treatment Period|Other|1|||
94377910|NCT01405820|323169016|FG004|Open-Label Treatment Period|Other|1|||
94377911|NCT01405820|323169017|FG005|Open-Label Treatment Period|Other|1|||
94377912|NCT01405820|323169012|FG000|Open-Label Treatment Period|Physician Decision|0|||
94377913|NCT01405820|323169013|FG001|Open-Label Treatment Period|Physician Decision|0|||
94377914|NCT01405820|323169014|FG002|Open-Label Treatment Period|Physician Decision|1|||
94377915|NCT01405820|323169015|FG003|Open-Label Treatment Period|Physician Decision|2|||
94377916|NCT01405820|323169016|FG004|Open-Label Treatment Period|Physician Decision|1|||
94377917|NCT01405820|323169017|FG005|Open-Label Treatment Period|Physician Decision|0|||
94377918|NCT01405820|323169012|FG000|Open-Label Treatment Period|Adverse Event|0|||
94377919|NCT01405820|323169013|FG001|Open-Label Treatment Period|Adverse Event|0|||
94377920|NCT01405820|323169014|FG002|Open-Label Treatment Period|Adverse Event|0|||
94377921|NCT01405820|323169015|FG003|Open-Label Treatment Period|Adverse Event|1|||
94377922|NCT01405820|323169016|FG004|Open-Label Treatment Period|Adverse Event|0|||
94377923|NCT01405820|323169017|FG005|Open-Label Treatment Period|Adverse Event|0|||
94377924|NCT00419926|323169020|FG000|Overall Study|Withdrawal by Subject|7|||
94377925|NCT00419926|323169021|FG001|Overall Study|Withdrawal by Subject|3|||
94377926|NCT00419926|323169020|FG000|Overall Study|Administrative Problem|4|||
94377927|NCT00419926|323169021|FG001|Overall Study|Administrative Problem|4|||
94377928|NCT00419926|323169020|FG000|Overall Study|Lost to Follow-up|1|||
94377929|NCT00419926|323169021|FG001|Overall Study|Lost to Follow-up|2|||
94377930|NCT00419926|323169020|FG000|Overall Study|Death|2|||
94377931|NCT00419926|323169021|FG001|Overall Study|Death|1|||
94377932|NCT01388647|323169040|FG000|Overall Study|Adverse Event|1|||
94377933|NCT01388647|323169041|FG001|Overall Study|Adverse Event|2|||
94377934|NCT03567057|323169043|FG000|Overall Study|Adverse Event|56|||
94377935|NCT03567057|323169044|FG001|Overall Study|Adverse Event|53|||
94377936|NCT03567057|323169045|FG002|Overall Study|Adverse Event|28|||
94377937|NCT03567057|323169043|FG000|Overall Study|Withdrawal by Subject|22|||
94377938|NCT03567057|323169044|FG001|Overall Study|Withdrawal by Subject|24|||
94377939|NCT03567057|323169045|FG002|Overall Study|Withdrawal by Subject|13|||
94377940|NCT03567057|323169043|FG000|Overall Study|Lost to Follow-up|3|||
94377941|NCT03567057|323169044|FG001|Overall Study|Lost to Follow-up|5|||
94377942|NCT03567057|323169045|FG002|Overall Study|Lost to Follow-up|2|||
94377943|NCT03567057|323169043|FG000|Overall Study|COVID-19 pandemic|4|||
94377944|NCT03567057|323169044|FG001|Overall Study|COVID-19 pandemic|3|||
94377945|NCT03567057|323169045|FG002|Overall Study|COVID-19 pandemic|0|||
94377946|NCT03567057|323169043|FG000|Overall Study|Non-compliance with study drug|4|||
94377947|NCT03567057|323169044|FG001|Overall Study|Non-compliance with study drug|2|||
94377948|NCT03567057|323169045|FG002|Overall Study|Non-compliance with study drug|0|||
94377949|NCT03567057|323169043|FG000|Overall Study|Lack of Efficacy|3|||
94377950|NCT03567057|323169044|FG001|Overall Study|Lack of Efficacy|0|||
94377951|NCT03567057|323169045|FG002|Overall Study|Lack of Efficacy|1|||
94377952|NCT03567057|323169043|FG000|Overall Study|Death|1|||
94377953|NCT03567057|323169044|FG001|Overall Study|Death|0|||
94377954|NCT03567057|323169045|FG002|Overall Study|Death|0|||
94377955|NCT03567057|323169043|FG000|Overall Study|Physician Decision|1|||
94377956|NCT03567057|323169044|FG001|Overall Study|Physician Decision|0|||
94377957|NCT03567057|323169045|FG002|Overall Study|Physician Decision|0|||
94377958|NCT03567057|323169043|FG000|Overall Study|Unstable medical condition|1|||
94377959|NCT03567057|323169044|FG001|Overall Study|Unstable medical condition|0|||
94377960|NCT03567057|323169045|FG002|Overall Study|Unstable medical condition|0|||
94377961|NCT03567057|323169043|FG000|Overall Study|Medical history event|0|||
94377962|NCT03567057|323169044|FG001|Overall Study|Medical history event|0|||
94377963|NCT03567057|323169045|FG002|Overall Study|Medical history event|1|||
94377964|NCT03567057|323169043|FG000|Overall Study|Other|0|||
94377965|NCT03567057|323169044|FG001|Overall Study|Other|0|||
94377966|NCT03567057|323169045|FG002|Overall Study|Other|1|||
94377967|NCT01006707|323169046|FG000|Study Session 1|Lost to Follow-up|2|||
94377968|NCT01006707|323169047|FG001|Study Session 1|Lost to Follow-up|0|||
94377969|NCT01006707|323169048|FG002|Study Session 1|Lost to Follow-up|0|||
94377970|NCT01006707|323169046|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
94377971|NCT01006707|323169047|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
94377972|NCT01006707|323169048|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
94377973|NCT01507896|323169049|FG000|Overall Study|Withdrawal by Subject|1|||
94377974|NCT01507896|323169049|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
94377975|NCT00490061|323169050|FG000|Overall Study|Physician Decision|1|||
94377976|NCT01155583|323169051|FG000|Phase I|Screen failure - did not start treatment|0|||
94377977|NCT01155583|323169052|FG001|Phase I|Screen failure - did not start treatment|0|||
94377978|NCT01155583|323169053|FG002|Phase I|Screen failure - did not start treatment|0|||
94377979|NCT01155583|323169054|FG003|Phase I|Screen failure - did not start treatment|0|||
94377980|NCT01155583|323169055|FG004|Phase I|Screen failure - did not start treatment|1|||
94377981|NCT01155583|323169056|FG005|Phase I|Screen failure - did not start treatment|0|||
94377982|NCT01155583|323169057|FG006|Phase I|Screen failure - did not start treatment|0|||
94377983|NCT01155583|323169058|FG007|Phase I|Screen failure - did not start treatment|2|||
94377984|NCT01155583|323169059|FG008|Phase I|Screen failure - did not start treatment|0|||
94377985|NCT01155583|323169051|FG000|Phase I|Withdrawal by Subject|0|||
94377986|NCT01155583|323169052|FG001|Phase I|Withdrawal by Subject|0|||
94377987|NCT01155583|323169053|FG002|Phase I|Withdrawal by Subject|0|||
94377988|NCT01155583|323169054|FG003|Phase I|Withdrawal by Subject|0|||
94377989|NCT01155583|323169055|FG004|Phase I|Withdrawal by Subject|0|||
94377990|NCT01155583|323169056|FG005|Phase I|Withdrawal by Subject|0|||
94377991|NCT01155583|323169057|FG006|Phase I|Withdrawal by Subject|0|||
94377992|NCT01155583|323169058|FG007|Phase I|Withdrawal by Subject|1|||
94377993|NCT01155583|323169059|FG008|Phase I|Withdrawal by Subject|0|||
94377994|NCT00952484|323169060|FG000|Overall Study|Withdrawal by Subject|0|||
94377995|NCT00952484|323169061|FG001|Overall Study|Withdrawal by Subject|1|||
94377996|NCT00952484|323169062|FG002|Overall Study|Withdrawal by Subject|0|||
94377997|NCT00192296|323169070|FG000|Overall Study|Withdrawal by Subject|0|||
94377998|NCT00192296|323169071|FG001|Overall Study|Withdrawal by Subject|1|||
94377999|NCT00192296|323169072|FG002|Overall Study|Withdrawal by Subject|0|||
94378000|NCT00192296|323169073|FG003|Overall Study|Withdrawal by Subject|0|||
94378001|NCT01001169|323169076|FG000|Overall Study|Withdrawal by Subject|2|||
94378002|NCT01001169|323169077|FG001|Overall Study|Withdrawal by Subject|1|||
94378003|NCT02536378|323169078|FG000|Overall Study|Physician Decision|0|||
94378004|NCT02536378|323169079|FG001|Overall Study|Physician Decision|2|||
94378005|NCT02536378|323169078|FG000|Overall Study|Withdrawal by Subject|0|||
94378006|NCT02536378|323169079|FG001|Overall Study|Withdrawal by Subject|1|||
94378007|NCT02536378|323169078|FG000|Overall Study|Death|1|||
94378008|NCT02536378|323169079|FG001|Overall Study|Death|2|||
94378009|NCT02536378|323169078|FG000|Overall Study|Patient refused further follow up|6|||
94378010|NCT02536378|323169079|FG001|Overall Study|Patient refused further follow up|2|||
94378011|NCT00617461|323169080|FG000|First Treatment Intervention Period|Adverse Event|2|||
94378012|NCT00617461|323169081|FG001|First Treatment Intervention Period|Adverse Event|0|||
94378013|NCT00617461|323169080|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
94378014|NCT00617461|323169081|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
94378015|NCT00617461|323169080|FG000|First Treatment Intervention Period|Protocol Violation|2|||
94378016|NCT00617461|323169081|FG001|First Treatment Intervention Period|Protocol Violation|1|||
94378017|NCT00617461|323169080|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
94378018|NCT00617461|323169081|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
94378019|NCT00617461|323169080|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
94378020|NCT00617461|323169081|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
94307527|NCT00092547|322909740|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
94307528|NCT00092547|322909738|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
94307529|NCT00092547|322909739|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
94307530|NCT00092547|322909740|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
94307531|NCT00092547|322909738|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
94307532|NCT00092547|322909739|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
94307533|NCT00092547|322909740|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
94307534|NCT00092547|322909738|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
94307535|NCT00092547|322909739|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
94307536|NCT00092547|322909740|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
94307537|NCT00092547|322909738|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
94307538|NCT00092547|322909739|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
94307539|NCT00092547|322909740|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
94307540|NCT00092547|322909738|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
94307541|NCT00092547|322909739|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
94307542|NCT00092547|322909740|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
94307543|NCT00092547|322909738|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
94307544|NCT00092547|322909739|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
94307545|NCT00092547|322909740|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
94307546|NCT00092547|322909738|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
94378021|NCT00617461|323169080|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
94378022|NCT00617461|323169081|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
94378023|NCT00617461|323169080|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
94378024|NCT00617461|323169081|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
94378025|NCT00617461|323169080|FG000|Second Treatment Intervention Period|Adverse Event|0|||
94378026|NCT00617461|323169081|FG001|Second Treatment Intervention Period|Adverse Event|1|||
94378027|NCT00617461|323169080|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
94378028|NCT00617461|323169081|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
94378029|NCT00617461|323169080|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
94378030|NCT00617461|323169081|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
94378031|NCT00617461|323169080|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
94378032|NCT00617461|323169081|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
94378033|NCT00358826|323169082|FG000|Core Study|Adverse Event|1|||
94378034|NCT00358826|323169083|FG001|Core Study|Adverse Event|3|||
94378035|NCT00358826|323169084|FG002|Core Study|Adverse Event|1|||
94378036|NCT00358826|323169085|FG003|Core Study|Adverse Event|1|||
94378037|NCT00358826|323169086|FG004|Core Study|Adverse Event|0|||
94378038|NCT00358826|323169087|FG005|Core Study|Adverse Event|0|||
94378039|NCT00358826|323169088|FG006|Core Study|Adverse Event|0|||
94378040|NCT00358826|323169089|FG007|Core Study|Adverse Event|0|||
94378041|NCT00358826|323169082|FG000|Core Study|Withdrawal by Subject|2|||
94378042|NCT00358826|323169083|FG001|Core Study|Withdrawal by Subject|2|||
94378043|NCT00358826|323169084|FG002|Core Study|Withdrawal by Subject|0|||
94378044|NCT00358826|323169085|FG003|Core Study|Withdrawal by Subject|0|||
94378045|NCT00358826|323169086|FG004|Core Study|Withdrawal by Subject|0|||
94378046|NCT00358826|323169087|FG005|Core Study|Withdrawal by Subject|0|||
94378047|NCT00358826|323169088|FG006|Core Study|Withdrawal by Subject|0|||
94378048|NCT00358826|323169089|FG007|Core Study|Withdrawal by Subject|0|||
94378049|NCT00358826|323169082|FG000|Core Study|Lost to Follow-up|0|||
94378050|NCT00358826|323169083|FG001|Core Study|Lost to Follow-up|0|||
94378051|NCT00358826|323169084|FG002|Core Study|Lost to Follow-up|0|||
94378052|NCT00358826|323169085|FG003|Core Study|Lost to Follow-up|1|||
94378053|NCT00358826|323169086|FG004|Core Study|Lost to Follow-up|0|||
94378054|NCT00358826|323169087|FG005|Core Study|Lost to Follow-up|0|||
94378055|NCT00358826|323169088|FG006|Core Study|Lost to Follow-up|0|||
94378056|NCT00358826|323169089|FG007|Core Study|Lost to Follow-up|0|||
94378057|NCT00358826|323169082|FG000|Core Study|Physician Decision|0|||
94378058|NCT00358826|323169083|FG001|Core Study|Physician Decision|0|||
94378059|NCT00358826|323169084|FG002|Core Study|Physician Decision|1|||
94378060|NCT00358826|323169085|FG003|Core Study|Physician Decision|0|||
94378061|NCT00358826|323169086|FG004|Core Study|Physician Decision|0|||
94378062|NCT00358826|323169087|FG005|Core Study|Physician Decision|0|||
94378063|NCT00358826|323169088|FG006|Core Study|Physician Decision|0|||
94378064|NCT00358826|323169089|FG007|Core Study|Physician Decision|0|||
94378065|NCT00358826|323169082|FG000|MDCT Substudy|Adverse Event|0|||
94378066|NCT00358826|323169083|FG001|MDCT Substudy|Adverse Event|0|||
94378067|NCT00358826|323169084|FG002|MDCT Substudy|Adverse Event|0|||
94378068|NCT00358826|323169085|FG003|MDCT Substudy|Adverse Event|0|||
94378069|NCT00358826|323169086|FG004|MDCT Substudy|Adverse Event|1|||
94378070|NCT00358826|323169087|FG005|MDCT Substudy|Adverse Event|0|||
94378071|NCT00358826|323169088|FG006|MDCT Substudy|Adverse Event|0|||
94378072|NCT00358826|323169089|FG007|MDCT Substudy|Adverse Event|0|||
94378073|NCT00358826|323169082|FG000|MDCT Substudy|Lost to Follow-up|0|||
94378074|NCT00358826|323169083|FG001|MDCT Substudy|Lost to Follow-up|0|||
94378075|NCT00358826|323169084|FG002|MDCT Substudy|Lost to Follow-up|0|||
94378076|NCT00358826|323169085|FG003|MDCT Substudy|Lost to Follow-up|0|||
94378077|NCT00358826|323169086|FG004|MDCT Substudy|Lost to Follow-up|0|||
94378078|NCT00358826|323169087|FG005|MDCT Substudy|Lost to Follow-up|1|||
94378079|NCT00358826|323169088|FG006|MDCT Substudy|Lost to Follow-up|0|||
94378080|NCT00358826|323169089|FG007|MDCT Substudy|Lost to Follow-up|0|||
94378081|NCT00358826|323169082|FG000|MDCT Substudy|Withdrawal by Subject|0|||
94378082|NCT00358826|323169083|FG001|MDCT Substudy|Withdrawal by Subject|0|||
94378083|NCT00358826|323169084|FG002|MDCT Substudy|Withdrawal by Subject|0|||
94378084|NCT00358826|323169085|FG003|MDCT Substudy|Withdrawal by Subject|0|||
94378085|NCT00358826|323169086|FG004|MDCT Substudy|Withdrawal by Subject|0|||
94378086|NCT00358826|323169087|FG005|MDCT Substudy|Withdrawal by Subject|1|||
94378087|NCT00358826|323169088|FG006|MDCT Substudy|Withdrawal by Subject|0|||
94378088|NCT00358826|323169089|FG007|MDCT Substudy|Withdrawal by Subject|0|||
94378089|NCT02175966|323169098|FG000|Follow-up Period|Lack of Efficacy|10|||
94378090|NCT02175966|323169099|FG001|Follow-up Period|Lack of Efficacy|6|||
94378091|NCT00310856|323169104|FG000|Overall Study|Withdrawal by Subject|2|||
94378092|NCT00310856|323169105|FG001|Overall Study|Withdrawal by Subject|2|||
94378093|NCT00310856|323169106|FG002|Overall Study|Withdrawal by Subject|2|||
94378094|NCT00310856|323169104|FG000|Overall Study|Lost to Follow-up|1|||
94378095|NCT00310856|323169105|FG001|Overall Study|Lost to Follow-up|2|||
94378096|NCT00310856|323169106|FG002|Overall Study|Lost to Follow-up|6|||
94378097|NCT00310856|323169104|FG000|Overall Study|Inappropriate enrollment|1|||
94378098|NCT00310856|323169105|FG001|Overall Study|Inappropriate enrollment|1|||
94378099|NCT00310856|323169106|FG002|Overall Study|Inappropriate enrollment|0|||
94378100|NCT00310856|323169104|FG000|Overall Study|Unable to classify|1|||
94378101|NCT00310856|323169105|FG001|Overall Study|Unable to classify|0|||
94378102|NCT00310856|323169106|FG002|Overall Study|Unable to classify|0|||
94378103|NCT01227668|323169107|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
94378104|NCT01227668|323169108|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
94378105|NCT01227668|323169107|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
94378106|NCT01227668|323169108|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
94378107|NCT01227668|323169107|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
94378108|NCT01227668|323169108|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
94378109|NCT01227668|323169107|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
94378110|NCT01227668|323169108|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
94378111|NCT01227668|323169107|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
94378112|NCT01227668|323169108|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
94378113|NCT01227668|323169107|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
94378114|NCT01227668|323169108|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
94378115|NCT01227668|323169107|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
94378116|NCT01227668|323169108|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
94378117|NCT01227668|323169107|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
94378118|NCT01227668|323169108|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
94378119|NCT01227668|323169107|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
94378120|NCT01227668|323169108|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
94378121|NCT01227668|323169107|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
94378122|NCT01227668|323169108|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
94469903|NCT01952080|323511357|FG000|Overall Study|Protocol Non-compliance|0|||
94469904|NCT01952080|323511358|FG001|Overall Study|Protocol Non-compliance|1|||
94307547|NCT00092547|322909739|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
94307548|NCT00092547|322909740|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
94307549|NCT00092547|322909738|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
94307550|NCT00092547|322909739|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
94307551|NCT00092547|322909740|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
94307552|NCT00092547|322909738|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
94307553|NCT00092547|322909739|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
94307554|NCT00092547|322909740|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
94307555|NCT00092547|322909738|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
94307556|NCT00092547|322909739|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
94307557|NCT00092547|322909740|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
94307558|NCT00092547|322909738|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
94307559|NCT00092547|322909739|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
94307560|NCT00092547|322909740|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
94307561|NCT00849693|322909743|FG000|Acute Treatment Phase|Adverse Event|12|||
94307562|NCT00849693|322909744|FG001|Acute Treatment Phase|Adverse Event|7|||
94307563|NCT00849693|322909745|FG002|Acute Treatment Phase|Adverse Event|6|||
94307564|NCT00849693|322909746|FG003|Acute Treatment Phase|Adverse Event|4|||
94307565|NCT00849693|322909743|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
94307566|NCT00849693|322909744|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
94307567|NCT00849693|322909745|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
94307568|NCT00849693|322909746|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
94307569|NCT00849693|322909743|FG000|Acute Treatment Phase|Protocol Violation|1|||
94307570|NCT00849693|322909744|FG001|Acute Treatment Phase|Protocol Violation|5|||
94307571|NCT00849693|322909745|FG002|Acute Treatment Phase|Protocol Violation|2|||
94307572|NCT00849693|322909746|FG003|Acute Treatment Phase|Protocol Violation|6|||
94307573|NCT00849693|322909743|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
94307574|NCT00849693|322909744|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
94307575|NCT00849693|322909745|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
94307576|NCT00849693|322909746|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
94307577|NCT00849693|322909743|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
94307578|NCT00849693|322909744|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
94307579|NCT00849693|322909745|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
94307580|NCT00849693|322909746|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
94307581|NCT00849693|322909743|FG000|Acute Treatment Phase|Physician Decision|2|||
94307582|NCT00849693|322909744|FG001|Acute Treatment Phase|Physician Decision|1|||
94307583|NCT00849693|322909745|FG002|Acute Treatment Phase|Physician Decision|2|||
94307584|NCT00849693|322909746|FG003|Acute Treatment Phase|Physician Decision|1|||
94307585|NCT00849693|322909743|FG000|Acute Treatment Phase|Sponsor decision|0|||
94307586|NCT00849693|322909744|FG001|Acute Treatment Phase|Sponsor decision|0|||
94307587|NCT00849693|322909745|FG002|Acute Treatment Phase|Sponsor decision|1|||
94307588|NCT00849693|322909746|FG003|Acute Treatment Phase|Sponsor decision|0|||
94307589|NCT00849693|322909743|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
94307590|NCT00849693|322909744|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
94307591|NCT00849693|322909745|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
94307592|NCT00849693|322909746|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
94307593|NCT00849693|322909743|FG000|Extension Phase|Adverse Event|4|||
94307594|NCT00849693|322909744|FG001|Extension Phase|Adverse Event|6|||
94307595|NCT00849693|322909745|FG002|Extension Phase|Adverse Event|3|||
94307596|NCT00849693|322909746|FG003|Extension Phase|Adverse Event|7|||
94307597|NCT00849693|322909743|FG000|Extension Phase|Lost to Follow-up|7|||
94307598|NCT00849693|322909744|FG001|Extension Phase|Lost to Follow-up|5|||
94307599|NCT00849693|322909745|FG002|Extension Phase|Lost to Follow-up|6|||
94307600|NCT00849693|322909746|FG003|Extension Phase|Lost to Follow-up|6|||
94307601|NCT00849693|322909743|FG000|Extension Phase|Protocol Violation|0|||
94307602|NCT00849693|322909744|FG001|Extension Phase|Protocol Violation|3|||
94307603|NCT00849693|322909745|FG002|Extension Phase|Protocol Violation|2|||
94307604|NCT00849693|322909746|FG003|Extension Phase|Protocol Violation|3|||
94307605|NCT00849693|322909743|FG000|Extension Phase|Withdrawal by Subject|6|||
94307606|NCT00849693|322909744|FG001|Extension Phase|Withdrawal by Subject|9|||
94307607|NCT00849693|322909745|FG002|Extension Phase|Withdrawal by Subject|10|||
94307608|NCT00849693|322909746|FG003|Extension Phase|Withdrawal by Subject|15|||
94307609|NCT00849693|322909743|FG000|Extension Phase|Parent or caregiver decision|9|||
94307610|NCT00849693|322909744|FG001|Extension Phase|Parent or caregiver decision|4|||
94307611|NCT00849693|322909745|FG002|Extension Phase|Parent or caregiver decision|10|||
94307612|NCT00849693|322909746|FG003|Extension Phase|Parent or caregiver decision|5|||
94307613|NCT00849693|322909743|FG000|Extension Phase|Physician Decision|1|||
94307614|NCT00849693|322909744|FG001|Extension Phase|Physician Decision|1|||
94307615|NCT00849693|322909745|FG002|Extension Phase|Physician Decision|2|||
94307616|NCT00849693|322909746|FG003|Extension Phase|Physician Decision|0|||
94307617|NCT00849693|322909743|FG000|Extension Phase|Sponsor decision|1|||
94307618|NCT00849693|322909744|FG001|Extension Phase|Sponsor decision|0|||
94307619|NCT00849693|322909745|FG002|Extension Phase|Sponsor decision|0|||
94307620|NCT00849693|322909746|FG003|Extension Phase|Sponsor decision|1|||
94307621|NCT00849693|322909743|FG000|Extension Phase|Lack of Efficacy|2|||
94307622|NCT00849693|322909744|FG001|Extension Phase|Lack of Efficacy|2|||
94307623|NCT00849693|322909745|FG002|Extension Phase|Lack of Efficacy|2|||
94307624|NCT00849693|322909746|FG003|Extension Phase|Lack of Efficacy|1|||
94307625|NCT00634543|322909747|FG000|Overall Study|Other|1|||
94307626|NCT00634543|322909748|FG001|Overall Study|Other|2|||
94307627|NCT00634543|322909747|FG000|Overall Study|Protocol Violation|3|||
94307628|NCT00634543|322909748|FG001|Overall Study|Protocol Violation|3|||
94307629|NCT00634543|322909747|FG000|Overall Study|Adverse Event|11|||
94307630|NCT00634543|322909748|FG001|Overall Study|Adverse Event|11|||
94307631|NCT00634543|322909747|FG000|Overall Study|Withdrawal by Subject|4|||
94307632|NCT00634543|322909748|FG001|Overall Study|Withdrawal by Subject|4|||
94307633|NCT00634543|322909747|FG000|Overall Study|Lost to Follow-up|0|||
94307634|NCT00634543|322909748|FG001|Overall Study|Lost to Follow-up|1|||
94307635|NCT02401256|322909749|FG000|Overall Study|Adverse Event|5|||
94307636|NCT02401256|322909749|FG000|Overall Study|Withdrawal by Subject|12|||
94307637|NCT01408537|322909750|FG000|Overall Study|Withdrawal by Subject|2|||
94307638|NCT01408537|322909750|FG000|Overall Study|Protocol Violation|3|||
94307639|NCT01408537|322909750|FG000|Overall Study|Lost to Follow-up|3|||
94307640|NCT03515538|322909751|FG000|Overall Study|Lack of Efficacy|2|||
94307641|NCT03515538|322909752|FG001|Overall Study|Lack of Efficacy|0|||
94307642|NCT03515538|322909753|FG002|Overall Study|Lack of Efficacy|2|||
94307643|NCT03515538|322909754|FG003|Overall Study|Lack of Efficacy|0|||
94307644|NCT03515538|322909751|FG000|Overall Study|Death|0|||
94307645|NCT03515538|322909752|FG001|Overall Study|Death|0|||
94307646|NCT03515538|322909753|FG002|Overall Study|Death|1|||
94307647|NCT03515538|322909754|FG003|Overall Study|Death|0|||
94307648|NCT03515538|322909751|FG000|Overall Study|Protocol Violation|0|||
94307649|NCT03515538|322909752|FG001|Overall Study|Protocol Violation|0|||
94307650|NCT03515538|322909753|FG002|Overall Study|Protocol Violation|0|||
94307651|NCT03515538|322909754|FG003|Overall Study|Protocol Violation|1|||
94307652|NCT03515538|322909751|FG000|Overall Study|Screen failure (baseline dropout)|0|||
94307653|NCT03515538|322909752|FG001|Overall Study|Screen failure (baseline dropout)|1|||
94307654|NCT03515538|322909753|FG002|Overall Study|Screen failure (baseline dropout)|0|||
94307655|NCT03515538|322909754|FG003|Overall Study|Screen failure (baseline dropout)|0|||
94307656|NCT03515538|322909751|FG000|Overall Study|Withdrawal by Subject|2|||
94307657|NCT03515538|322909752|FG001|Overall Study|Withdrawal by Subject|2|||
94307658|NCT03515538|322909753|FG002|Overall Study|Withdrawal by Subject|1|||
94307659|NCT03515538|322909754|FG003|Overall Study|Withdrawal by Subject|3|||
94307660|NCT03515538|322909751|FG000|Overall Study|Physician Decision|1|||
94307661|NCT03515538|322909752|FG001|Overall Study|Physician Decision|0|||
94307662|NCT03515538|322909753|FG002|Overall Study|Physician Decision|0|||
94307663|NCT03515538|322909754|FG003|Overall Study|Physician Decision|1|||
94307664|NCT02760602|322909755|FG000|Overall Study|Withdrawal by Subject|1|||
94307665|NCT02760602|322909756|FG001|Overall Study|Withdrawal by Subject|0|||
94307666|NCT02760602|322909755|FG000|Overall Study|Terminated by sponsor|12|||
94307667|NCT02760602|322909756|FG001|Overall Study|Terminated by sponsor|13|||
94307668|NCT04275310|322909758|FG000|Overall Study|Non-randomized due to running out of funding|4|||
94307669|NCT04275310|322909759|FG001|Overall Study|Non-randomized due to running out of funding|0|||
94307670|NCT00283712|322909766|FG000|Overall Study|Death|0|||
94307671|NCT00283712|322909767|FG001|Overall Study|Death|1|||
94307672|NCT04329923|322909768|FG000|Overall Study|Withdrawal by Subject|1|||
94307673|NCT04329923|322909769|FG001|Overall Study|Withdrawal by Subject|4|||
94307674|NCT04329923|322909770|FG002|Overall Study|Withdrawal by Subject|1|||
94307675|NCT04329923|322909771|FG003|Overall Study|Withdrawal by Subject|1|||
94307676|NCT04329923|322909772|FG004|Overall Study|Withdrawal by Subject|1|||
94307677|NCT04329923|322909773|FG005|Overall Study|Withdrawal by Subject|1|||
94307678|NCT04329923|322909768|FG000|Overall Study|early termination of study|0|||
94307679|NCT04329923|322909769|FG001|Overall Study|early termination of study|0|||
94307680|NCT04329923|322909770|FG002|Overall Study|early termination of study|0|||
94307681|NCT04329923|322909771|FG003|Overall Study|early termination of study|0|||
94307682|NCT04329923|322909772|FG004|Overall Study|early termination of study|1|||
94307683|NCT04329923|322909773|FG005|Overall Study|early termination of study|2|||
94307684|NCT04329923|322909768|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
94307685|NCT04329923|322909769|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
94307686|NCT04329923|322909770|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
94307687|NCT04329923|322909771|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
94307688|NCT04329923|322909772|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
94307689|NCT04329923|322909773|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
94307690|NCT02046564|322909778|FG000|Overall Study|Adverse Event|6|||
94307691|NCT02046564|322909779|FG001|Overall Study|Adverse Event|3|||
94307692|NCT02046564|322909778|FG000|Overall Study|Physician Decision|0|||
94307693|NCT02046564|322909779|FG001|Overall Study|Physician Decision|1|||
94307694|NCT02046564|322909778|FG000|Overall Study|Protocol Violation|3|||
94378123|NCT01227668|323169107|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
94378124|NCT01227668|323169108|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
94378125|NCT01227668|323169107|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
94378126|NCT01227668|323169108|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
94378127|NCT00679783|323169109|FG000|Overall Study|Adverse Event|0|||
94378128|NCT00679783|323169110|FG001|Overall Study|Adverse Event|0|||
94378129|NCT00679783|323169111|FG002|Overall Study|Adverse Event|0|||
94378130|NCT00679783|323169112|FG003|Overall Study|Adverse Event|3|||
94378131|NCT00679783|323169113|FG004|Overall Study|Adverse Event|0|||
94378132|NCT00679783|323169114|FG005|Overall Study|Adverse Event|0|||
94378133|NCT00679783|323169115|FG006|Overall Study|Adverse Event|1|||
94378134|NCT00679783|323169109|FG000|Overall Study|Lack of Efficacy|0|||
94378135|NCT00679783|323169110|FG001|Overall Study|Lack of Efficacy|1|||
94378136|NCT00679783|323169111|FG002|Overall Study|Lack of Efficacy|0|||
94378137|NCT00679783|323169112|FG003|Overall Study|Lack of Efficacy|2|||
94378138|NCT00679783|323169113|FG004|Overall Study|Lack of Efficacy|0|||
94378139|NCT00679783|323169114|FG005|Overall Study|Lack of Efficacy|0|||
94378140|NCT00679783|323169115|FG006|Overall Study|Lack of Efficacy|0|||
94378141|NCT00679783|323169109|FG000|Overall Study|Withdrawal by Subject|0|||
94378142|NCT00679783|323169110|FG001|Overall Study|Withdrawal by Subject|0|||
94378143|NCT00679783|323169111|FG002|Overall Study|Withdrawal by Subject|1|||
94378144|NCT00679783|323169112|FG003|Overall Study|Withdrawal by Subject|1|||
94378145|NCT00679783|323169113|FG004|Overall Study|Withdrawal by Subject|0|||
94378146|NCT00679783|323169114|FG005|Overall Study|Withdrawal by Subject|0|||
94378147|NCT00679783|323169115|FG006|Overall Study|Withdrawal by Subject|0|||
94378148|NCT00679783|323169109|FG000|Overall Study|Not Captured|0|||
94378149|NCT00679783|323169110|FG001|Overall Study|Not Captured|0|||
94378150|NCT00679783|323169111|FG002|Overall Study|Not Captured|0|||
94378151|NCT00679783|323169112|FG003|Overall Study|Not Captured|5|||
94378152|NCT00679783|323169113|FG004|Overall Study|Not Captured|0|||
94378153|NCT00679783|323169114|FG005|Overall Study|Not Captured|0|||
94378154|NCT00679783|323169115|FG006|Overall Study|Not Captured|0|||
94378155|NCT00679783|323169109|FG000|Overall Study|Ongoing at data cut-off|2|||
94378156|NCT00679783|323169110|FG001|Overall Study|Ongoing at data cut-off|2|||
94378157|NCT00679783|323169111|FG002|Overall Study|Ongoing at data cut-off|0|||
94378158|NCT00679783|323169112|FG003|Overall Study|Ongoing at data cut-off|9|||
94378159|NCT00679783|323169113|FG004|Overall Study|Ongoing at data cut-off|1|||
94378160|NCT00679783|323169114|FG005|Overall Study|Ongoing at data cut-off|0|||
94378161|NCT00679783|323169115|FG006|Overall Study|Ongoing at data cut-off|0|||
94378162|NCT00814320|323169118|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
94378163|NCT00814320|323169119|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
94378164|NCT00814320|323169118|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
94378165|NCT00814320|323169119|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
94378166|NCT00814320|323169118|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
94378167|NCT00814320|323169119|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
94378168|NCT00814320|323169118|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
94378169|NCT00814320|323169119|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
94378170|NCT00814320|323169118|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
94378171|NCT00814320|323169119|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
94378172|NCT00814320|323169118|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
94378173|NCT00814320|323169119|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
94307695|NCT02046564|322909779|FG001|Overall Study|Protocol Violation|1|||
94307696|NCT02046564|322909778|FG000|Overall Study|Withdrawal by Subject|4|||
94307697|NCT02046564|322909779|FG001|Overall Study|Withdrawal by Subject|10|||
94307698|NCT02046564|322909778|FG000|Overall Study|Subject met withdrawal criteria|2|||
94307699|NCT02046564|322909779|FG001|Overall Study|Subject met withdrawal criteria|5|||
94307700|NCT02564120|322909780|FG000|Overall Study|Did not return release forms|160|||
94307701|NCT02564120|322909780|FG000|Overall Study|Death|58|||
94307702|NCT02564120|322909780|FG000|Overall Study|Withdrawal by Subject|204|||
94307703|NCT02564120|322909780|FG000|Overall Study|Other medical condition|24|||
94307704|NCT00791128|322909781|FG000|Overall Study|Adverse Event|4|||
94307705|NCT00791128|322909781|FG000|Overall Study|Device migration|2|||
94307706|NCT00791128|322909781|FG000|Overall Study|non-compliance by subject|2|||
94307707|NCT00791128|322909781|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
94378174|NCT00814320|323169118|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
94378175|NCT00814320|323169119|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
94378176|NCT00814320|323169118|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
94307708|NCT00546351|322909784|FG000|Overall Study|Adverse Event|76|||
94378177|NCT00814320|323169119|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
94378178|NCT00814320|323169118|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
94307709|NCT00546351|322909784|FG000|Overall Study|Lack of Efficacy|15|||
94307710|NCT00546351|322909784|FG000|Overall Study|Withdrawal by Subject|109|||
94307711|NCT00546351|322909784|FG000|Overall Study|Lost to Follow-up|9|||
94307712|NCT00546351|322909784|FG000|Overall Study|Protocol Deviation|1|||
94307713|NCT00546351|322909784|FG000|Overall Study|Unsatisfactory compliance|9|||
94307714|NCT00546351|322909784|FG000|Overall Study|Other reasons for premature termination|17|||
94307715|NCT03952650|322909785|FG000|Overall Study|TRAVEL|0|||
94307716|NCT03952650|322909786|FG001|Overall Study|TRAVEL|4|||
94307717|NCT03952650|322909787|FG002|Overall Study|TRAVEL|0|||
94307718|NCT03952650|322909788|FG003|Overall Study|TRAVEL|4|||
94307719|NCT03952650|322909789|FG004|Overall Study|TRAVEL|0|||
94307720|NCT03952650|322909790|FG005|Overall Study|TRAVEL|3|||
94307721|NCT03952650|322909791|FG006|Overall Study|TRAVEL|2|||
94307722|NCT03952650|322909785|FG000|Overall Study|Withdrawal by Subject|0|||
94307723|NCT03952650|322909786|FG001|Overall Study|Withdrawal by Subject|2|||
94307724|NCT03952650|322909787|FG002|Overall Study|Withdrawal by Subject|0|||
94307725|NCT03952650|322909788|FG003|Overall Study|Withdrawal by Subject|3|||
94307726|NCT03952650|322909789|FG004|Overall Study|Withdrawal by Subject|0|||
94307727|NCT03952650|322909790|FG005|Overall Study|Withdrawal by Subject|1|||
94307728|NCT03952650|322909791|FG006|Overall Study|Withdrawal by Subject|1|||
94307729|NCT03952650|322909785|FG000|Overall Study|Lost to Follow-up|0|||
94307730|NCT03952650|322909786|FG001|Overall Study|Lost to Follow-up|1|||
94307731|NCT03952650|322909787|FG002|Overall Study|Lost to Follow-up|0|||
94307732|NCT03952650|322909788|FG003|Overall Study|Lost to Follow-up|0|||
94307733|NCT03952650|322909789|FG004|Overall Study|Lost to Follow-up|0|||
94307734|NCT03952650|322909790|FG005|Overall Study|Lost to Follow-up|1|||
94307735|NCT03952650|322909791|FG006|Overall Study|Lost to Follow-up|1|||
94307736|NCT03952650|322909785|FG000|Overall Study|Received wrong vaccine and travelled|0|||
94307737|NCT03952650|322909786|FG001|Overall Study|Received wrong vaccine and travelled|0|||
94307738|NCT03952650|322909787|FG002|Overall Study|Received wrong vaccine and travelled|0|||
94307739|NCT03952650|322909788|FG003|Overall Study|Received wrong vaccine and travelled|0|||
94307740|NCT03952650|322909789|FG004|Overall Study|Received wrong vaccine and travelled|0|||
94307741|NCT03952650|322909790|FG005|Overall Study|Received wrong vaccine and travelled|1|||
94307742|NCT03952650|322909791|FG006|Overall Study|Received wrong vaccine and travelled|0|||
94307743|NCT03952650|322909785|FG000|Overall Study|Unable to make study visit|0|||
94307744|NCT03952650|322909786|FG001|Overall Study|Unable to make study visit|0|||
94307745|NCT03952650|322909787|FG002|Overall Study|Unable to make study visit|0|||
94307746|NCT03952650|322909788|FG003|Overall Study|Unable to make study visit|0|||
94307747|NCT03952650|322909789|FG004|Overall Study|Unable to make study visit|0|||
94307748|NCT03952650|322909790|FG005|Overall Study|Unable to make study visit|1|||
94307749|NCT03952650|322909791|FG006|Overall Study|Unable to make study visit|0|||
94307750|NCT02723630|322909792|FG000|Intervention Period 1|Adverse Event|1|||
94307751|NCT02723630|322909793|FG001|Intervention Period 1|Adverse Event|0|||
94307752|NCT02723630|322909794|FG002|Intervention Period 1|Adverse Event|0|||
94307753|NCT02723630|322909795|FG003|Intervention Period 1|Adverse Event|0|||
94307754|NCT02723630|322909796|FG004|Intervention Period 1|Adverse Event|0|||
94307755|NCT02723630|322909797|FG005|Intervention Period 1|Adverse Event|0|||
94307756|NCT02723630|322909792|FG000|Intervention Period 3|consumption of restricted item|0|||
94307757|NCT02723630|322909793|FG001|Intervention Period 3|consumption of restricted item|1|||
94307758|NCT02723630|322909794|FG002|Intervention Period 3|consumption of restricted item|0|||
94307759|NCT02723630|322909795|FG003|Intervention Period 3|consumption of restricted item|0|||
94307760|NCT02723630|322909796|FG004|Intervention Period 3|consumption of restricted item|0|||
94378179|NCT00814320|323169119|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
94378180|NCT00814320|323169118|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
94378181|NCT00814320|323169119|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
94378182|NCT03775681|323169124|FG000|Overall Study|Physician Decision|3|||
94378183|NCT01855126|323169125|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
94378184|NCT01855126|323169126|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
94378185|NCT01855126|323169125|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
94378186|NCT01855126|323169126|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
94378187|NCT01626885|323169127|FG000|Overall Study|Adverse Event|8|||
94378188|NCT01626885|323169127|FG000|Overall Study|Withdrawal by Subject|4|||
94378189|NCT02308111|323169128|FG000|Overall Study|Adverse Event|31|||
94378190|NCT02308111|323169129|FG001|Overall Study|Adverse Event|19|||
94378191|NCT02308111|323169128|FG000|Overall Study|Death|9|||
94378192|NCT02308111|323169129|FG001|Overall Study|Death|6|||
94378193|NCT02308111|323169128|FG000|Overall Study|Lost to Follow-up|2|||
94378194|NCT02308111|323169129|FG001|Overall Study|Lost to Follow-up|7|||
94378195|NCT02308111|323169128|FG000|Overall Study|Physician Decision|6|||
94378196|NCT02308111|323169129|FG001|Overall Study|Physician Decision|17|||
94378197|NCT02308111|323169128|FG000|Overall Study|Protocol Violation|0|||
94378198|NCT02308111|323169129|FG001|Overall Study|Protocol Violation|1|||
94378199|NCT02308111|323169128|FG000|Overall Study|Withdrawal by Subject|28|||
94378200|NCT02308111|323169129|FG001|Overall Study|Withdrawal by Subject|38|||
94378201|NCT02308111|323169128|FG000|Overall Study|Study Terminated by Sponsor|72|||
94307761|NCT02723630|322909797|FG005|Intervention Period 3|consumption of restricted item|0|||
94307762|NCT05372315|322909798|FG000|Overall Study|Withdrawal by Subject|1|||
94307763|NCT05372315|322909799|FG001|Overall Study|Withdrawal by Subject|0|||
94307764|NCT01512368|322909800|FG000|Overall Study|Protocol Violation|3|||
94307765|NCT00552305|322909801|FG000|Overall Study|Adverse Event|43|||
94307766|NCT00552305|322909801|FG000|Overall Study|Lack of Efficacy|120|||
94307767|NCT00552305|322909801|FG000|Overall Study|Lost to Follow-up|4|||
94307768|NCT00552305|322909801|FG000|Overall Study|Protocol Violation|3|||
94307769|NCT00552305|322909801|FG000|Overall Study|Withdrawal by Subject|44|||
94307770|NCT00552305|322909801|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
94307771|NCT00552305|322909801|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
94307772|NCT00552305|322909801|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
94307773|NCT00552305|322909801|FG000|Overall Study|Unsatisfactory compliance|11|||
94307774|NCT00552305|322909801|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
94307775|NCT00552305|322909801|FG000|Overall Study|AE/Other: prohibited drug required|1|||
94307776|NCT00552305|322909801|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
94307777|NCT00552305|322909801|FG000|Overall Study|Other: Site closed|4|||
94307778|NCT00552305|322909801|FG000|Overall Study|Other: Personal problems|1|||
94307779|NCT00552305|322909801|FG000|Overall Study|Other: Unable to attend visits|1|||
94307780|NCT00552305|322909801|FG000|Overall Study|Other: Subject underwent surgery|4|||
94307781|NCT00552305|322909801|FG000|Overall Study|Other: Subject became pregnant|1|||
94307782|NCT00552305|322909801|FG000|Overall Study|Other: Health problems, not drug related|1|||
94307783|NCT00552305|322909801|FG000|Overall Study|Other: Subject moved from area|2|||
94307784|NCT00552305|322909801|FG000|Overall Study|Other: Subject incarcerated|1|||
94307785|NCT00552305|322909801|FG000|Overall Study|Other: Subject went to rehab|1|||
94307786|NCT01873742|322909803|FG000|Overall Study|Lost to Follow-up|68|||
94307787|NCT01873742|322909804|FG001|Overall Study|Lost to Follow-up|76|||
94307788|NCT00790296|322909805|FG000|Overall Study|Did not meet study eligibility criteria|1|||
94307789|NCT00790296|322909806|FG001|Overall Study|Did not meet study eligibility criteria|1|||
94307790|NCT00790296|322909805|FG000|Overall Study|Adverse Event|0|||
94307791|NCT00790296|322909806|FG001|Overall Study|Adverse Event|1|||
94307792|NCT00553787|322909807|FG000|Overall Study|Adverse Event|34|||
94307793|NCT00553787|322909808|FG001|Overall Study|Adverse Event|21|||
94307794|NCT00553787|322909809|FG002|Overall Study|Adverse Event|67|||
94307795|NCT00553787|322909807|FG000|Overall Study|Lost to Follow-up|132|||
94307796|NCT00553787|322909808|FG001|Overall Study|Lost to Follow-up|44|||
94307797|NCT00553787|322909809|FG002|Overall Study|Lost to Follow-up|78|||
94307798|NCT00553787|322909807|FG000|Overall Study|Withdrawal by Subject|151|||
94307799|NCT00553787|322909808|FG001|Overall Study|Withdrawal by Subject|40|||
94307800|NCT00553787|322909809|FG002|Overall Study|Withdrawal by Subject|83|||
94307801|NCT00553787|322909807|FG000|Overall Study|Lack of Efficacy|31|||
94378202|NCT02308111|323169129|FG001|Overall Study|Study Terminated by Sponsor|61|||
94378203|NCT02308111|323169128|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
94307802|NCT00553787|322909808|FG001|Overall Study|Lack of Efficacy|1|||
94378204|NCT02308111|323169129|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
94307803|NCT00553787|322909809|FG002|Overall Study|Lack of Efficacy|3|||
94307804|NCT00553787|322909807|FG000|Overall Study|Pregnancy|0|||
94307805|NCT00553787|322909808|FG001|Overall Study|Pregnancy|1|||
94307806|NCT00553787|322909809|FG002|Overall Study|Pregnancy|2|||
94307807|NCT00553787|322909807|FG000|Overall Study|non compliance|4|||
94307808|NCT00553787|322909808|FG001|Overall Study|non compliance|0|||
94307809|NCT00553787|322909809|FG002|Overall Study|non compliance|11|||
94307810|NCT00553787|322909807|FG000|Overall Study|Requirement for restricted medication|8|||
94307811|NCT00553787|322909808|FG001|Overall Study|Requirement for restricted medication|7|||
94307812|NCT00553787|322909809|FG002|Overall Study|Requirement for restricted medication|5|||
94307813|NCT00553787|322909807|FG000|Overall Study|Other|18|||
94307814|NCT00553787|322909808|FG001|Overall Study|Other|10|||
94307815|NCT00553787|322909809|FG002|Overall Study|Other|13|||
94307816|NCT02285010|322909812|FG000|Overall Study|not abdominal hysterectomy|2|||
94307817|NCT02285010|322909813|FG001|Overall Study|not abdominal hysterectomy|0|||
94307818|NCT02285010|322909812|FG000|Overall Study|Not spinal anesthesia|3|||
94307819|NCT02285010|322909813|FG001|Overall Study|Not spinal anesthesia|1|||
94307820|NCT04538950|322909824|FG000|Overall Study|Pulmonary Issues|2|||
94307821|NCT04538950|322909824|FG000|Overall Study|illness|2|||
94307822|NCT03022422|322909825|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
94307823|NCT03022422|322909826|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
94307824|NCT03022422|322909827|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
94307825|NCT03022422|322909828|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
94307826|NCT03022422|322909829|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
94307827|NCT03022422|322909830|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
94307828|NCT02515669|322909831|FG000|228 Week Open-Label Phase|Other|0|||
94307829|NCT02515669|322909832|FG001|228 Week Open-Label Phase|Other|0|||
94307830|NCT02515669|322909833|FG002|228 Week Open-Label Phase|Other|1|||
94307831|NCT02515669|322909834|FG003|228 Week Open-Label Phase|Other|4|||
94307832|NCT02515669|322909831|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
94378205|NCT02308111|323169128|FG000|Overall Study|Site Closure|3|||
94378206|NCT02308111|323169129|FG001|Overall Study|Site Closure|3|||
94378207|NCT02308111|323169128|FG000|Overall Study|Non-compliance with Study Drug|3|||
94378208|NCT02308111|323169129|FG001|Overall Study|Non-compliance with Study Drug|1|||
94378209|NCT02308111|323169128|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
94378210|NCT02308111|323169129|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
94378211|NCT02308111|323169128|FG000|Overall Study|Liver Transplant|3|||
94378212|NCT02308111|323169129|FG001|Overall Study|Liver Transplant|3|||
94378213|NCT02308111|323169128|FG000|Overall Study|Liver Transplant Waitlist|2|||
94378214|NCT02308111|323169129|FG001|Overall Study|Liver Transplant Waitlist|2|||
94378215|NCT02308111|323169128|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
94378216|NCT02308111|323169129|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
94378217|NCT01200394|323169130|FG000|Overall Study|Adverse Event|0|||
94378218|NCT01200394|323169131|FG001|Overall Study|Adverse Event|14|||
94378219|NCT01200394|323169130|FG000|Overall Study|Death|1|||
94378220|NCT01200394|323169131|FG001|Overall Study|Death|0|||
94378221|NCT01200394|323169130|FG000|Overall Study|Lost to Follow-up|0|||
94378222|NCT01200394|323169131|FG001|Overall Study|Lost to Follow-up|1|||
94378223|NCT01200394|323169130|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
94378224|NCT01200394|323169131|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
94378225|NCT01200394|323169130|FG000|Overall Study|Protocol Violation|0|||
94378226|NCT01200394|323169131|FG001|Overall Study|Protocol Violation|3|||
94378227|NCT01200394|323169130|FG000|Overall Study|Withdrawal by Subject|0|||
94378228|NCT01200394|323169131|FG001|Overall Study|Withdrawal by Subject|5|||
94378229|NCT01200394|323169130|FG000|Overall Study|Other|0|||
94378230|NCT01200394|323169131|FG001|Overall Study|Other|1|||
94378231|NCT00576199|323169132|FG000|Overall Study|Adverse Event|12|||
94378232|NCT00576199|323169132|FG000|Overall Study|Insufficient Therapeutic Response|14|||
94378233|NCT00576199|323169132|FG000|Overall Study|Refused Treatment|2|||
94378234|NCT00576199|323169132|FG000|Overall Study|Reason Unspecified|2|||
94378235|NCT01309919|323169133|FG000|Overall Study|Did not receive a postpartum IUD|17|||
94378236|NCT01309919|323169134|FG001|Overall Study|Did not receive a postpartum IUD|48|||
94378237|NCT00455533|323169135|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
94378238|NCT00455533|323169136|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
94378239|NCT00455533|323169137|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
94378240|NCT00455533|323169135|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
94378241|NCT00455533|323169136|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
94378242|NCT00455533|323169137|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
94378243|NCT00455533|323169135|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
94378244|NCT00455533|323169136|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
94378245|NCT00455533|323169137|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
94378246|NCT00455533|323169135|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
94378247|NCT00455533|323169136|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
94378248|NCT00455533|323169137|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
94378249|NCT00455533|323169135|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
94378250|NCT00455533|323169136|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
94378251|NCT00455533|323169137|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
94378252|NCT00455533|323169135|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
94378253|NCT00455533|323169136|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
94378254|NCT00455533|323169137|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
94378255|NCT00455533|323169135|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
94378256|NCT00455533|323169136|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
94378257|NCT00455533|323169137|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
94378258|NCT00455533|323169135|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
94378259|NCT00455533|323169136|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
94378260|NCT00455533|323169137|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
94378261|NCT00455533|323169135|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
94378262|NCT00455533|323169136|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
94378263|NCT00455533|323169137|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
94378264|NCT00455533|323169135|FG000|Period Two: Randomized Period|Death|0|||
94378265|NCT00455533|323169136|FG001|Period Two: Randomized Period|Death|0|||
94378266|NCT00455533|323169137|FG002|Period Two: Randomized Period|Death|3|||
94378267|NCT00455533|323169135|FG000|Period Two: Randomized Period|Disease Progression|0|||
94378268|NCT00455533|323169136|FG001|Period Two: Randomized Period|Disease Progression|1|||
94378269|NCT00455533|323169137|FG002|Period Two: Randomized Period|Disease Progression|1|||
94378270|NCT00455533|323169135|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
94378271|NCT00455533|323169136|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
94378272|NCT00455533|323169137|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
94378273|NCT00455533|323169135|FG000|Period Two: Randomized Period|Other - need reasons|0|||
94378274|NCT00455533|323169136|FG001|Period Two: Randomized Period|Other - need reasons|1|||
94307833|NCT02515669|322909832|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
94307834|NCT02515669|322909833|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
94307835|NCT02515669|322909834|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
94307836|NCT02515669|322909831|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
94307837|NCT02515669|322909832|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
94307838|NCT02515669|322909833|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
94307839|NCT02515669|322909834|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
94378275|NCT00455533|323169137|FG002|Period Two: Randomized Period|Other - need reasons|0|||
94378276|NCT00455533|323169135|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
94378277|NCT00455533|323169136|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
94378278|NCT00455533|323169137|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
94378279|NCT00455533|323169135|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
94378280|NCT00455533|323169136|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
94378281|NCT00455533|323169137|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
94378282|NCT01048333|323169138|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
94378283|NCT01048333|323169139|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
94378284|NCT01048333|323169140|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
94378285|NCT01048333|323169141|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
94378286|NCT01048333|323169142|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
94378287|NCT01048333|323169143|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
94378288|NCT00752856|323169145|FG000|Overall Study|randomized but did not do viral kinetics|0|||
94378289|NCT00752856|323169146|FG001|Overall Study|randomized but did not do viral kinetics|1|||
94378290|NCT00433381|323170796|FG000|Overall Study|Ineligible / no protocol treatment|3|||
94378291|NCT00433381|323170797|FG001|Overall Study|Ineligible / no protocol treatment|3|||
94378292|NCT03381248|323170798|FG000|0-6 Months|Withdrawal by Subject|4|||
94378293|NCT03381248|323170799|FG001|0-6 Months|Withdrawal by Subject|1|||
94378294|NCT03381248|323170798|FG000|0-6 Months|Lost to Follow-up|3|||
94378295|NCT03381248|323170799|FG001|0-6 Months|Lost to Follow-up|2|||
94378296|NCT03381248|323170798|FG000|0-6 Months|Lack of Efficacy|1|||
94378297|NCT03381248|323170799|FG001|0-6 Months|Lack of Efficacy|0|||
94378298|NCT03381248|323170798|FG000|0-6 Months|Adverse Event|1|||
94378299|NCT03381248|323170799|FG001|0-6 Months|Adverse Event|0|||
94378300|NCT03381248|323170798|FG000|0-6 Months|Protocol Violation|2|||
94378301|NCT03381248|323170799|FG001|0-6 Months|Protocol Violation|1|||
94307840|NCT02515669|322909831|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
94307841|NCT02515669|322909832|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
94307842|NCT02515669|322909833|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
94378302|NCT03381248|323170798|FG000|0-6 Months|Physician Decision|1|||
94378303|NCT03381248|323170799|FG001|0-6 Months|Physician Decision|0|||
94378304|NCT03381248|323170798|FG000|0-6 Months|Planning another procedure|1|||
94378305|NCT03381248|323170799|FG001|0-6 Months|Planning another procedure|2|||
94378306|NCT03381248|323170798|FG000|6-12 Months|Withdrawal by Subject|1|||
94378307|NCT03381248|323170799|FG001|6-12 Months|Withdrawal by Subject|3|||
94469905|NCT01952080|323511359|FG002|Overall Study|Protocol Non-compliance|0|||
94469906|NCT01952080|323511360|FG003|Overall Study|Protocol Non-compliance|0|||
94469907|NCT02208050|323511365|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
94469908|NCT02208050|323511366|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
94469909|NCT00793546|323511367|FG000|Overall Study|Death|3|||
94469910|NCT00793546|323511368|FG001|Overall Study|Death|0|||
94469911|NCT00793546|323511367|FG000|Overall Study|Lost to Follow-up|1|||
94469912|NCT00793546|323511368|FG001|Overall Study|Lost to Follow-up|0|||
94469913|NCT00793546|323511367|FG000|Overall Study|Withdrawal by Subject|1|||
94469914|NCT00793546|323511368|FG001|Overall Study|Withdrawal by Subject|1|||
94469915|NCT00793546|323511367|FG000|Overall Study|Study Terminated by Sponsor|8|||
94378308|NCT03381248|323170798|FG000|6-12 Months|Lost to Follow-up|0|||
94378309|NCT03381248|323170799|FG001|6-12 Months|Lost to Follow-up|2|||
94378310|NCT03381248|323170798|FG000|6-12 Months|Protocol Violation|3|||
94378311|NCT03381248|323170799|FG001|6-12 Months|Protocol Violation|2|||
94378312|NCT03381248|323170798|FG000|6-12 Months|Planning another procedure|6|||
94378313|NCT03381248|323170799|FG001|6-12 Months|Planning another procedure|2|||
94378314|NCT03381248|323170798|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
94378315|NCT03381248|323170799|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
94378316|NCT03381248|323170798|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
94378317|NCT03381248|323170799|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
94378318|NCT03381248|323170798|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
94378319|NCT03381248|323170799|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
94378320|NCT01003886|323170806|FG000|Overall Study|Lack of Efficacy|5|||
94378321|NCT01003886|323170806|FG000|Overall Study|Lost to Follow-up|169|||
94378322|NCT01003886|323170806|FG000|Overall Study|Withdrawal by Subject|39|||
94378323|NCT01003886|323170806|FG000|Overall Study|Other|14|||
94378324|NCT01003886|323170806|FG000|Overall Study|Adverse Event|3|||
94378325|NCT02637076|323170810|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
94378326|NCT02637076|323170811|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
94378327|NCT02637076|323170810|FG000|Overall Study|Withdrawal by Subject|0|||
94378328|NCT02637076|323170811|FG001|Overall Study|Withdrawal by Subject|4|||
94378329|NCT02710071|323170814|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
94378330|NCT02710071|323170815|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
94378331|NCT02710071|323170814|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
94378332|NCT02710071|323170815|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
94378333|NCT04604184|323170816|FG000|Overall Study|Adverse Event|5|||
94378334|NCT04604184|323170817|FG001|Overall Study|Adverse Event|5|||
94378335|NCT04604184|323170816|FG000|Overall Study|Death|2|||
94378336|NCT04604184|323170817|FG001|Overall Study|Death|1|||
94378337|NCT04604184|323170816|FG000|Overall Study|Withdrawal by Subject|1|||
94378338|NCT04604184|323170817|FG001|Overall Study|Withdrawal by Subject|3|||
94378339|NCT04604184|323170816|FG000|Overall Study|Not treated|2|||
94378340|NCT04604184|323170817|FG001|Overall Study|Not treated|2|||
94378341|NCT04604184|323170816|FG000|Overall Study|Due to sponsor decision|9|||
94378342|NCT04604184|323170817|FG001|Overall Study|Due to sponsor decision|7|||
94378343|NCT04604184|323170816|FG000|Overall Study|Physician Decision|0|||
94378344|NCT04604184|323170817|FG001|Overall Study|Physician Decision|1|||
94378345|NCT04604184|323170816|FG000|Overall Study|Transfer to healthcare|1|||
94378346|NCT04604184|323170817|FG001|Overall Study|Transfer to healthcare|0|||
94378347|NCT02043366|323170822|FG000|Overall Study|Lost to Follow-up|2|||
94378348|NCT02043366|323170823|FG001|Overall Study|Lost to Follow-up|2|||
94378349|NCT02043366|323170824|FG002|Overall Study|Lost to Follow-up|2|||
94378350|NCT02043366|323170825|FG003|Overall Study|Lost to Follow-up|2|||
94378351|NCT02043366|323170826|FG004|Overall Study|Lost to Follow-up|2|||
94378352|NCT02043366|323170827|FG005|Overall Study|Lost to Follow-up|2|||
94378353|NCT02736227|323170828|FG000|Overall Study|Withdrawal by Subject|0|||
94378354|NCT02736227|323170829|FG001|Overall Study|Withdrawal by Subject|0|||
94378355|NCT02736227|323170830|FG002|Overall Study|Withdrawal by Subject|1|||
94469916|NCT00793546|323511368|FG001|Overall Study|Study Terminated by Sponsor|27|||
94469917|NCT00793546|323511367|FG000|Overall Study|Other|1|||
94469918|NCT00793546|323511368|FG001|Overall Study|Other|0|||
94469919|NCT02655419|323511369|FG000|Overall Study|Enrolled but not treated|1|||
94469920|NCT02655419|323511370|FG001|Overall Study|Enrolled but not treated|5|||
94378356|NCT02736227|323170828|FG000|Overall Study|Physician Decision|0|||
94378357|NCT02736227|323170829|FG001|Overall Study|Physician Decision|0|||
94378358|NCT02736227|323170830|FG002|Overall Study|Physician Decision|5|||
94378359|NCT02736227|323170828|FG000|Overall Study|Non Compliant|0|||
94378360|NCT02736227|323170829|FG001|Overall Study|Non Compliant|0|||
94469921|NCT02655419|323511369|FG000|Overall Study|Withdrawal by Subject|4|||
94469922|NCT02655419|323511370|FG001|Overall Study|Withdrawal by Subject|1|||
94378361|NCT02736227|323170830|FG002|Overall Study|Non Compliant|2|||
94378362|NCT00752791|323170831|FG000|Overall Study|Adverse Event|7|||
94469923|NCT02655419|323511369|FG000|Overall Study|Other|0|||
94469924|NCT02655419|323511370|FG001|Overall Study|Other|1|||
94469925|NCT03053427|323511371|FG000|Overall Study|Adverse Event|4|||
94378363|NCT00752791|323170831|FG000|Overall Study|Withdrawal by Subject|1|||
94378364|NCT00752791|323170831|FG000|Overall Study|Physician Decision|1|||
94378365|NCT00752791|323170831|FG000|Overall Study|Death|1|||
94378366|NCT00752791|323170831|FG000|Overall Study|Renal transplant|3|||
94378367|NCT00752791|323170831|FG000|Overall Study|Switched to hemodialysis|2|||
94378368|NCT00752791|323170831|FG000|Overall Study|Protocol deviation|1|||
94378369|NCT00678392|323170835|FG000|Overall Study|Adverse Event|0|||
94378370|NCT00678392|323170836|FG001|Overall Study|Adverse Event|6|||
94378371|NCT00678392|323170835|FG000|Overall Study|Death|280|||
94378372|NCT00678392|323170836|FG001|Overall Study|Death|269|||
94378373|NCT00678392|323170835|FG000|Overall Study|Lost to Follow-up|15|||
94378374|NCT00678392|323170836|FG001|Overall Study|Lost to Follow-up|13|||
94378375|NCT00678392|323170835|FG000|Overall Study|Objective Progression or Relapse|3|||
94378376|NCT00678392|323170836|FG001|Overall Study|Objective Progression or Relapse|8|||
94378377|NCT00678392|323170835|FG000|Overall Study|Sponsor's Decision|1|||
94378378|NCT00678392|323170836|FG001|Overall Study|Sponsor's Decision|2|||
94378379|NCT00678392|323170835|FG000|Overall Study|Withdrawal by Subject|4|||
94378380|NCT00678392|323170836|FG001|Overall Study|Withdrawal by Subject|4|||
94378381|NCT00678392|323170835|FG000|Overall Study|Randomized But Not Treated|2|||
94378382|NCT00678392|323170836|FG001|Overall Study|Randomized But Not Treated|7|||
94378383|NCT00678392|323170835|FG000|Overall Study|Other|56|||
94378384|NCT00678392|323170836|FG001|Overall Study|Other|53|||
94378385|NCT02784106|323170837|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
94378386|NCT02784106|323170838|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
94378387|NCT02784106|323170839|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
94378388|NCT02784106|323170840|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
94378389|NCT02784106|323170837|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
94378390|NCT02784106|323170838|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
94378391|NCT02784106|323170839|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
94378392|NCT02784106|323170840|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
94378393|NCT02784106|323170837|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
94378394|NCT02784106|323170838|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
94378395|NCT02784106|323170839|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
94378396|NCT02784106|323170840|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
94378397|NCT02784106|323170837|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
94378398|NCT02784106|323170838|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
94378399|NCT02784106|323170839|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
94378400|NCT02784106|323170840|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
94378401|NCT02784106|323170837|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
94378402|NCT02784106|323170838|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
94378403|NCT02784106|323170839|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
94378404|NCT02784106|323170840|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
94378405|NCT02784106|323170837|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
94378406|NCT02784106|323170838|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
94378407|NCT02784106|323170839|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
94378408|NCT02784106|323170840|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
94378409|NCT01612000|323170848|FG000|Overall Study|Lost to Follow-up|6|||
94378410|NCT01612000|323170849|FG001|Overall Study|Lost to Follow-up|4|||
94378411|NCT01612000|323170850|FG002|Overall Study|Lost to Follow-up|4|||
94378412|NCT01612000|323170851|FG003|Overall Study|Lost to Follow-up|8|||
94378413|NCT01612000|323170848|FG000|Overall Study|Physician Decision|0|||
94378414|NCT01612000|323170849|FG001|Overall Study|Physician Decision|0|||
94378415|NCT01612000|323170850|FG002|Overall Study|Physician Decision|1|||
94378416|NCT01612000|323170851|FG003|Overall Study|Physician Decision|0|||
94378417|NCT01612000|323170848|FG000|Overall Study|Withdrawal by Subject|3|||
94378418|NCT01612000|323170849|FG001|Overall Study|Withdrawal by Subject|1|||
94378419|NCT01612000|323170850|FG002|Overall Study|Withdrawal by Subject|2|||
94378420|NCT01612000|323170851|FG003|Overall Study|Withdrawal by Subject|2|||
94378421|NCT01333033|323170855|FG000|Overall Study|Ineligible|0|||
94378422|NCT01333033|323170856|FG001|Overall Study|Ineligible|0|||
94378423|NCT01333033|323170857|FG002|Overall Study|Ineligible|0|||
94378424|NCT01333033|323170858|FG003|Overall Study|Ineligible|0|||
94378425|NCT01333033|323170859|FG004|Overall Study|Ineligible|6|||
94378426|NCT01333033|323170860|FG005|Overall Study|Ineligible|8|||
94378427|NCT01333033|323170855|FG000|Overall Study|Withdrawal by Subject|0|||
94378428|NCT01333033|323170856|FG001|Overall Study|Withdrawal by Subject|0|||
94378429|NCT01333033|323170857|FG002|Overall Study|Withdrawal by Subject|0|||
94378430|NCT01333033|323170858|FG003|Overall Study|Withdrawal by Subject|0|||
94378431|NCT01333033|323170859|FG004|Overall Study|Withdrawal by Subject|4|||
94378432|NCT01333033|323170860|FG005|Overall Study|Withdrawal by Subject|2|||
94378433|NCT01333033|323170855|FG000|Overall Study|PET inevaluable|0|||
94378434|NCT01333033|323170856|FG001|Overall Study|PET inevaluable|0|||
94378435|NCT01333033|323170857|FG002|Overall Study|PET inevaluable|0|||
94378436|NCT01333033|323170858|FG003|Overall Study|PET inevaluable|0|||
94378437|NCT01333033|323170859|FG004|Overall Study|PET inevaluable|2|||
94378438|NCT01333033|323170860|FG005|Overall Study|PET inevaluable|4|||
94378439|NCT01333033|323170855|FG000|Overall Study|Adverse Event|0|||
94378440|NCT01333033|323170856|FG001|Overall Study|Adverse Event|0|||
94378441|NCT01333033|323170857|FG002|Overall Study|Adverse Event|0|||
94378442|NCT01333033|323170858|FG003|Overall Study|Adverse Event|0|||
94378443|NCT01333033|323170859|FG004|Overall Study|Adverse Event|2|||
94378444|NCT01333033|323170860|FG005|Overall Study|Adverse Event|1|||
94378445|NCT01333033|323170855|FG000|Overall Study|Progression|0|||
94378446|NCT01333033|323170856|FG001|Overall Study|Progression|0|||
94378447|NCT01333033|323170857|FG002|Overall Study|Progression|0|||
94378448|NCT01333033|323170858|FG003|Overall Study|Progression|0|||
94378449|NCT01333033|323170859|FG004|Overall Study|Progression|0|||
94378450|NCT01333033|323170860|FG005|Overall Study|Progression|1|||
94378451|NCT01333033|323170855|FG000|Overall Study|MD Decision|0|||
94378452|NCT01333033|323170856|FG001|Overall Study|MD Decision|0|||
94378453|NCT01333033|323170857|FG002|Overall Study|MD Decision|0|||
94378454|NCT01333033|323170858|FG003|Overall Study|MD Decision|0|||
94378455|NCT01333033|323170859|FG004|Overall Study|MD Decision|0|||
94378456|NCT01333033|323170860|FG005|Overall Study|MD Decision|2|||
94378457|NCT03687125|323170861|FG000|Overall Study|Progressive Disease|2|||
94378458|NCT03687125|323170862|FG001|Overall Study|Progressive Disease|1|||
94378459|NCT03687125|323170861|FG000|Overall Study|Protocol Violation|1|||
94378460|NCT03687125|323170862|FG001|Overall Study|Protocol Violation|0|||
94378461|NCT02087046|323170863|FG000|Overall Study|Adverse Event|4|||
94378462|NCT02087046|323170863|FG000|Overall Study|Death|1|||
94378463|NCT02087046|323170863|FG000|Overall Study|Lost to Follow-up|3|||
94378464|NCT02087046|323170863|FG000|Overall Study|Withdrawal by Subject|2|||
94378465|NCT02087046|323170863|FG000|Overall Study|Physician Decision|1|||
94378466|NCT01214603|323170864|FG000|Overall Study|Adverse Event|0|||
94378467|NCT01214603|323170865|FG001|Overall Study|Adverse Event|0|||
94378468|NCT01214603|323170866|FG002|Overall Study|Adverse Event|1|||
94378469|NCT01214603|323170864|FG000|Overall Study|Death|1|||
94378470|NCT01214603|323170865|FG001|Overall Study|Death|0|||
94378471|NCT01214603|323170866|FG002|Overall Study|Death|0|||
94378472|NCT01214603|323170864|FG000|Overall Study|Progressive Disease|4|||
94378473|NCT01214603|323170865|FG001|Overall Study|Progressive Disease|1|||
94378474|NCT01214603|323170866|FG002|Overall Study|Progressive Disease|3|||
94378475|NCT02444533|323170867|FG000|Overall Study|Not able to complete forms|0|||
94378476|NCT02444533|323170868|FG001|Overall Study|Not able to complete forms|2|||
94378477|NCT02444533|323170867|FG000|Overall Study|Only gave post-procedure complications|2|||
94378478|NCT02444533|323170868|FG001|Overall Study|Only gave post-procedure complications|2|||
94378479|NCT00290745|323170869|FG000|Overall Study|Withdrawal by Subject|4|||
94378480|NCT00290745|323170869|FG000|Overall Study|Physician Decision|2|||
94378481|NCT00290745|323170869|FG000|Overall Study|Surgery after 3 months for progression|3|||
94378482|NCT00290745|323170869|FG000|Overall Study|Baseline MRI not available|3|||
94378483|NCT03465891|323170872|FG000|Overall Study|Withdrawal by Subject|0|||
94378484|NCT03465891|323170873|FG001|Overall Study|Withdrawal by Subject|1|||
94378485|NCT03465891|323170872|FG000|Overall Study|Disease progression|1|||
94378486|NCT03465891|323170873|FG001|Overall Study|Disease progression|0|||
94378487|NCT02737306|323170874|FG000|Overall Study|Adverse Event|3|||
94378488|NCT02737306|323170875|FG001|Overall Study|Adverse Event|0|||
94378489|NCT02737306|323170874|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
94378490|NCT02737306|323170875|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
94378491|NCT00437281|323170884|FG000|Overall Study|Adverse Event|0|||
94378492|NCT00437281|323170885|FG001|Overall Study|Adverse Event|0|||
94378493|NCT00437281|323170886|FG002|Overall Study|Adverse Event|0|||
94378494|NCT00437281|323170887|FG003|Overall Study|Adverse Event|1|||
94378495|NCT00437281|323170888|FG004|Overall Study|Adverse Event|0|||
94378496|NCT00437281|323170889|FG005|Overall Study|Adverse Event|1|||
94378497|NCT00437281|323170890|FG006|Overall Study|Adverse Event|0|||
94378498|NCT00437281|323170891|FG007|Overall Study|Adverse Event|0|||
94378499|NCT00437281|323170892|FG008|Overall Study|Adverse Event|0|||
94378500|NCT00437281|323170893|FG009|Overall Study|Adverse Event|1|||
94378501|NCT00437281|323170894|FG010|Overall Study|Adverse Event|0|||
94378502|NCT00437281|323170895|FG011|Overall Study|Adverse Event|0|||
94378503|NCT00437281|323170896|FG012|Overall Study|Adverse Event|0|||
94378504|NCT00437281|323170897|FG013|Overall Study|Adverse Event|1|||
94378505|NCT00437281|323170898|FG014|Overall Study|Adverse Event|1|||
94378506|NCT00437281|323170899|FG015|Overall Study|Adverse Event|0|||
94378507|NCT00437281|323170900|FG016|Overall Study|Adverse Event|0|||
94378508|NCT00437281|323170901|FG017|Overall Study|Adverse Event|0|||
94378509|NCT00437281|323170902|FG018|Overall Study|Adverse Event|1|||
94378510|NCT00437281|323170903|FG019|Overall Study|Adverse Event|0|||
94378511|NCT00437281|323170884|FG000|Overall Study|Lost to Follow-up|0|||
94307843|NCT02515669|322909834|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
94307844|NCT02515669|322909831|FG000|228 Week Open-Label Phase|Missing|0|||
94307845|NCT02515669|322909832|FG001|228 Week Open-Label Phase|Missing|2|||
94307846|NCT02515669|322909833|FG002|228 Week Open-Label Phase|Missing|2|||
94307847|NCT02515669|322909834|FG003|228 Week Open-Label Phase|Missing|2|||
94307848|NCT01282814|322909835|FG000|First Intervention|Emesis During Dosing Interval|0|||
94307849|NCT01282814|322909836|FG001|First Intervention|Emesis During Dosing Interval|3|||
94307850|NCT01282814|322909835|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
94307851|NCT01282814|322909836|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
94307852|NCT01089725|322909837|FG000|Overall Study|Adverse Event|1|||
94307853|NCT01089725|322909838|FG001|Overall Study|Adverse Event|1|||
94307854|NCT01089725|322909839|FG002|Overall Study|Adverse Event|0|||
94307855|NCT01089725|322909840|FG003|Overall Study|Adverse Event|0|||
94307856|NCT01089725|322909841|FG004|Overall Study|Adverse Event|2|||
94307857|NCT01089725|322909837|FG000|Overall Study|Lack of Efficacy|4|||
94307858|NCT01089725|322909838|FG001|Overall Study|Lack of Efficacy|3|||
94307859|NCT01089725|322909839|FG002|Overall Study|Lack of Efficacy|1|||
94307860|NCT01089725|322909840|FG003|Overall Study|Lack of Efficacy|0|||
94307861|NCT01089725|322909841|FG004|Overall Study|Lack of Efficacy|4|||
94307862|NCT01089725|322909837|FG000|Overall Study|Lost to Follow-up|2|||
94307863|NCT01089725|322909838|FG001|Overall Study|Lost to Follow-up|2|||
94307864|NCT01089725|322909839|FG002|Overall Study|Lost to Follow-up|0|||
94307865|NCT01089725|322909840|FG003|Overall Study|Lost to Follow-up|3|||
94307866|NCT01089725|322909841|FG004|Overall Study|Lost to Follow-up|0|||
94307867|NCT01089725|322909837|FG000|Overall Study|Protocol Violation|0|||
94307868|NCT01089725|322909838|FG001|Overall Study|Protocol Violation|0|||
94307869|NCT01089725|322909839|FG002|Overall Study|Protocol Violation|1|||
94307870|NCT01089725|322909840|FG003|Overall Study|Protocol Violation|1|||
94307871|NCT01089725|322909841|FG004|Overall Study|Protocol Violation|0|||
94307872|NCT01089725|322909837|FG000|Overall Study|Withdrawal by Subject|5|||
94307873|NCT01089725|322909838|FG001|Overall Study|Withdrawal by Subject|5|||
94307874|NCT01089725|322909839|FG002|Overall Study|Withdrawal by Subject|4|||
94307875|NCT01089725|322909840|FG003|Overall Study|Withdrawal by Subject|5|||
94307876|NCT01089725|322909841|FG004|Overall Study|Withdrawal by Subject|4|||
94307877|NCT01089725|322909837|FG000|Overall Study|Study Terminated by Sponsor|51|||
94307878|NCT01089725|322909838|FG001|Overall Study|Study Terminated by Sponsor|56|||
94307879|NCT01089725|322909839|FG002|Overall Study|Study Terminated by Sponsor|53|||
94307880|NCT01089725|322909840|FG003|Overall Study|Study Terminated by Sponsor|68|||
94307881|NCT01089725|322909841|FG004|Overall Study|Study Terminated by Sponsor|68|||
94307882|NCT01089725|322909837|FG000|Overall Study|Randomized, but not treated|0|||
94307883|NCT01089725|322909838|FG001|Overall Study|Randomized, but not treated|1|||
94307884|NCT01089725|322909839|FG002|Overall Study|Randomized, but not treated|2|||
94307885|NCT01089725|322909840|FG003|Overall Study|Randomized, but not treated|1|||
94307886|NCT01089725|322909841|FG004|Overall Study|Randomized, but not treated|2|||
94307887|NCT01089725|322909837|FG000|Overall Study|Other|3|||
94307888|NCT01089725|322909838|FG001|Overall Study|Other|0|||
94307889|NCT01089725|322909839|FG002|Overall Study|Other|0|||
94307890|NCT01089725|322909840|FG003|Overall Study|Other|1|||
94307891|NCT01089725|322909841|FG004|Overall Study|Other|0|||
94307892|NCT02124798|322909843|FG000|Overall Study|Adverse Event|3|||
94307893|NCT02124798|322909843|FG000|Overall Study|Lost to Follow-up|1|||
94307894|NCT01589094|322909855|FG000|Overall Study|Did not receive treatment|2|||
94307895|NCT02112448|322909856|FG000|Overall Study|lab values precluding use of ketorolac|2|||
94307896|NCT02112448|322909857|FG001|Overall Study|lab values precluding use of ketorolac|2|||
94307897|NCT02112448|322909856|FG000|Overall Study|Protocol Violation|1|||
94307898|NCT02112448|322909857|FG001|Overall Study|Protocol Violation|2|||
94307899|NCT02112448|322909856|FG000|Overall Study|Physician Decision|4|||
94307900|NCT02112448|322909857|FG001|Overall Study|Physician Decision|6|||
94307901|NCT02112448|322909856|FG000|Overall Study|required heparin so could not use ketoro|1|||
94307902|NCT02112448|322909857|FG001|Overall Study|required heparin so could not use ketoro|0|||
94307903|NCT03635190|322911517|FG000|Overall Study|Lost to Follow-up|4|||
94307904|NCT03635190|322911517|FG000|Overall Study|Death|3|||
94307905|NCT03635190|322911517|FG000|Overall Study|Withdrawal by Subject|1|||
94307906|NCT03635190|322911517|FG000|Overall Study|Patient moved and did not return for follow up|1|||
94307907|NCT02767570|322911518|FG000|Overall Study|Lost to Follow-up|3|||
94378512|NCT00437281|323170885|FG001|Overall Study|Lost to Follow-up|0|||
94378513|NCT00437281|323170886|FG002|Overall Study|Lost to Follow-up|0|||
94378514|NCT00437281|323170887|FG003|Overall Study|Lost to Follow-up|0|||
94378515|NCT00437281|323170888|FG004|Overall Study|Lost to Follow-up|0|||
94378516|NCT00437281|323170889|FG005|Overall Study|Lost to Follow-up|0|||
94378517|NCT00437281|323170890|FG006|Overall Study|Lost to Follow-up|0|||
94378518|NCT00437281|323170891|FG007|Overall Study|Lost to Follow-up|0|||
94378519|NCT00437281|323170892|FG008|Overall Study|Lost to Follow-up|0|||
94378520|NCT00437281|323170893|FG009|Overall Study|Lost to Follow-up|0|||
94378521|NCT00437281|323170894|FG010|Overall Study|Lost to Follow-up|0|||
94378522|NCT00437281|323170895|FG011|Overall Study|Lost to Follow-up|0|||
94378523|NCT00437281|323170896|FG012|Overall Study|Lost to Follow-up|0|||
94378524|NCT00437281|323170897|FG013|Overall Study|Lost to Follow-up|0|||
94378525|NCT00437281|323170898|FG014|Overall Study|Lost to Follow-up|0|||
94378526|NCT00437281|323170899|FG015|Overall Study|Lost to Follow-up|0|||
94378527|NCT00437281|323170900|FG016|Overall Study|Lost to Follow-up|0|||
94378528|NCT00437281|323170901|FG017|Overall Study|Lost to Follow-up|0|||
94378529|NCT00437281|323170902|FG018|Overall Study|Lost to Follow-up|0|||
94378530|NCT00437281|323170903|FG019|Overall Study|Lost to Follow-up|1|||
94378531|NCT00491504|323170907|FG000|Overall Study|Adverse Event|0|||
94378532|NCT00491504|323170908|FG001|Overall Study|Adverse Event|1|||
94378533|NCT00491504|323170909|FG002|Overall Study|Adverse Event|0|||
94378534|NCT00491504|323170910|FG003|Overall Study|Adverse Event|0|||
94378535|NCT00491504|323170907|FG000|Overall Study|Withdrawal by Subject|0|||
94378536|NCT00491504|323170908|FG001|Overall Study|Withdrawal by Subject|0|||
94378537|NCT00491504|323170909|FG002|Overall Study|Withdrawal by Subject|1|||
94378538|NCT00491504|323170910|FG003|Overall Study|Withdrawal by Subject|2|||
94378539|NCT00491504|323170907|FG000|Overall Study|Protocol Violation|0|||
94378540|NCT00491504|323170908|FG001|Overall Study|Protocol Violation|0|||
94378541|NCT00491504|323170909|FG002|Overall Study|Protocol Violation|3|||
94378542|NCT00491504|323170910|FG003|Overall Study|Protocol Violation|2|||
94378543|NCT02153736|323170911|FG000|Overall Study|Lost to Follow-up|1|||
94378544|NCT02153736|323170912|FG001|Overall Study|Lost to Follow-up|0|||
94378545|NCT02153736|323170911|FG000|Overall Study|Medical status change made ineligible|1|||
94378546|NCT02153736|323170912|FG001|Overall Study|Medical status change made ineligible|0|||
94378547|NCT02153736|323170911|FG000|Overall Study|Death|0|||
94378548|NCT02153736|323170912|FG001|Overall Study|Death|1|||
94378549|NCT02153736|323170911|FG000|Overall Study|Withdrawal by Subject|0|||
94378550|NCT02153736|323170912|FG001|Overall Study|Withdrawal by Subject|1|||
94378551|NCT00203307|323170913|FG000|First Intervention|Adverse Event|2|||
94378552|NCT00203307|323170914|FG001|First Intervention|Adverse Event|0|||
94378553|NCT00969332|323170915|FG000|Overall Study|Physician Decision|8|||
94378554|NCT00969332|323170915|FG000|Overall Study|Withdrawal by Subject|3|||
94378555|NCT02666430|323170916|FG000|Period 1|Lost to Follow-up|1|||
94378556|NCT02666430|323170917|FG001|Period 1|Lost to Follow-up|0|||
94378557|NCT02666430|323170916|FG000|Period 1|Adverse Event|0|||
94378558|NCT02666430|323170917|FG001|Period 1|Adverse Event|1|||
94378559|NCT02666430|323170916|FG000|Period 2|Withdrawal by Subject|1|||
94378560|NCT02666430|323170917|FG001|Period 2|Withdrawal by Subject|4|||
94378561|NCT02666430|323170916|FG000|Period 3|Lost to Follow-up|1|||
94378562|NCT02666430|323170917|FG001|Period 3|Lost to Follow-up|0|||
94378563|NCT03035227|323170918|FG000|Overall Study|study stopped due to PI leaving institut|1|||
94378564|NCT03035227|323170919|FG001|Overall Study|study stopped due to PI leaving institut|1|||
94378565|NCT02100956|323170920|FG000|At Least One Week Between Injections|Adverse Event|0|||
94378566|NCT02100956|323170921|FG001|At Least One Week Between Injections|Adverse Event|1|||
94378567|NCT03529955|323170923|FG000|Overall Study|Adverse Event|1|||
94378568|NCT03529955|323170923|FG000|Overall Study|Lack of Efficacy|1|||
94378569|NCT02220907|323170924|FG000|Overall Study|Adverse Event|7|||
94378570|NCT02220907|323170924|FG000|Overall Study|Physician Decision|1|||
94378571|NCT02220907|323170924|FG000|Overall Study|Withdrawal by Subject|2|||
94378572|NCT02220907|323170924|FG000|Overall Study|Conflict with the stopping criteria|1|||
94378573|NCT02729896|323170925|FG000|Overall Study|Death|0|||
94378574|NCT02729896|323170926|FG001|Overall Study|Death|2|||
94378575|NCT02729896|323170927|FG002|Overall Study|Death|13|||
94378576|NCT02729896|323170925|FG000|Overall Study|Lost to Follow-up|0|||
94378577|NCT02729896|323170926|FG001|Overall Study|Lost to Follow-up|2|||
94378578|NCT02729896|323170927|FG002|Overall Study|Lost to Follow-up|3|||
94378579|NCT02729896|323170925|FG000|Overall Study|Other|0|||
94378580|NCT02729896|323170926|FG001|Overall Study|Other|2|||
94378581|NCT02729896|323170927|FG002|Overall Study|Other|0|||
94378582|NCT02729896|323170925|FG000|Overall Study|Physician Decision|1|||
94378583|NCT02729896|323170926|FG001|Overall Study|Physician Decision|2|||
94378584|NCT02729896|323170927|FG002|Overall Study|Physician Decision|3|||
94378585|NCT02729896|323170925|FG000|Overall Study|Progressive Disease|0|||
94378586|NCT02729896|323170926|FG001|Overall Study|Progressive Disease|1|||
94378587|NCT02729896|323170927|FG002|Overall Study|Progressive Disease|0|||
94378588|NCT02729896|323170925|FG000|Overall Study|Withdrawal by Subject|1|||
94378589|NCT02729896|323170926|FG001|Overall Study|Withdrawal by Subject|0|||
94378590|NCT02729896|323170927|FG002|Overall Study|Withdrawal by Subject|3|||
94378591|NCT01960816|323170928|FG000|Overall Study|Lost to Follow-up|1|||
94378592|NCT04345471|323170931|FG000|Overall Study|Adverse Event|8|||
94378593|NCT04345471|323170932|FG001|Overall Study|Adverse Event|5|||
94378594|NCT04345471|323170933|FG002|Overall Study|Adverse Event|6|||
94378595|NCT04345471|323170931|FG000|Overall Study|Lack of Efficacy|1|||
94378596|NCT04345471|323170932|FG001|Overall Study|Lack of Efficacy|1|||
94378597|NCT04345471|323170933|FG002|Overall Study|Lack of Efficacy|0|||
94378598|NCT04345471|323170931|FG000|Overall Study|Protocol Violation|0|||
94378599|NCT04345471|323170932|FG001|Overall Study|Protocol Violation|1|||
94378600|NCT04345471|323170933|FG002|Overall Study|Protocol Violation|2|||
94378601|NCT04345471|323170931|FG000|Overall Study|Withdrawal by Subject|10|||
94378602|NCT04345471|323170932|FG001|Overall Study|Withdrawal by Subject|5|||
94378603|NCT04345471|323170933|FG002|Overall Study|Withdrawal by Subject|10|||
94378604|NCT02415959|323170934|FG000|Overall Study|Adverse Event|0|||
94378605|NCT02415959|323170935|FG001|Overall Study|Adverse Event|1|||
94378606|NCT02415959|323170936|FG002|Overall Study|Adverse Event|0|||
94378607|NCT02415959|323170937|FG003|Overall Study|Adverse Event|0|||
94378608|NCT02415959|323170938|FG004|Overall Study|Adverse Event|0|||
94378609|NCT02415959|323170934|FG000|Overall Study|Protocol Violation|0|||
94378610|NCT02415959|323170935|FG001|Overall Study|Protocol Violation|0|||
94378611|NCT02415959|323170936|FG002|Overall Study|Protocol Violation|0|||
94378612|NCT02415959|323170937|FG003|Overall Study|Protocol Violation|1|||
94378613|NCT02415959|323170938|FG004|Overall Study|Protocol Violation|0|||
94378614|NCT03008460|323170941|FG000|Overall Study|Protocol deviation|0|||
94378615|NCT03008460|323170942|FG001|Overall Study|Protocol deviation|2|||
94378616|NCT03008460|323170941|FG000|Overall Study|Study drug not dispensed|0|||
94378617|NCT03008460|323170942|FG001|Overall Study|Study drug not dispensed|1|||
94378618|NCT03008460|323170941|FG000|Overall Study|Adverse Event|0|||
94378619|NCT03008460|323170942|FG001|Overall Study|Adverse Event|1|||
94378620|NCT03008460|323170941|FG000|Overall Study|Withdrawal by Subject|5|||
94378621|NCT03008460|323170942|FG001|Overall Study|Withdrawal by Subject|6|||
94378622|NCT03008460|323170941|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
94378623|NCT03008460|323170942|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
94378624|NCT03008460|323170941|FG000|Overall Study|End of study visit outside permitted time window|0|||
94378625|NCT03008460|323170942|FG001|Overall Study|End of study visit outside permitted time window|1|||
94378626|NCT03008460|323170941|FG000|Overall Study|Lost to Follow-up|1|||
94378627|NCT03008460|323170942|FG001|Overall Study|Lost to Follow-up|3|||
94378628|NCT00634179|323170947|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
94378629|NCT00434161|323172690|FG000|Overall Study|Adverse Event|5|||
94378630|NCT00434161|323172691|FG001|Overall Study|Adverse Event|1|||
94378631|NCT00434161|323172692|FG002|Overall Study|Adverse Event|4|||
94378632|NCT00434161|323172690|FG000|Overall Study|Lost to Follow-up|0|||
94378633|NCT00434161|323172691|FG001|Overall Study|Lost to Follow-up|1|||
94378634|NCT00434161|323172692|FG002|Overall Study|Lost to Follow-up|0|||
94378635|NCT00434161|323172690|FG000|Overall Study|Death|1|||
94378636|NCT00434161|323172691|FG001|Overall Study|Death|0|||
94378637|NCT00434161|323172692|FG002|Overall Study|Death|1|||
94378638|NCT00434161|323172690|FG000|Overall Study|Non-Compliance|1|||
94378639|NCT00434161|323172691|FG001|Overall Study|Non-Compliance|1|||
94378640|NCT00434161|323172692|FG002|Overall Study|Non-Compliance|0|||
94378641|NCT00434161|323172690|FG000|Overall Study|Withdrawal by Subject|2|||
94378642|NCT00434161|323172691|FG001|Overall Study|Withdrawal by Subject|0|||
94378643|NCT00434161|323172692|FG002|Overall Study|Withdrawal by Subject|3|||
94378644|NCT00434161|323172690|FG000|Overall Study|Logistical error study assessments|1|||
94378645|NCT00434161|323172691|FG001|Overall Study|Logistical error study assessments|0|||
94378646|NCT00434161|323172692|FG002|Overall Study|Logistical error study assessments|3|||
94378647|NCT03997448|323172697|FG000|Study Treatment|Disease Progression|1|||
94378648|NCT03997448|323172697|FG000|Study Treatment|Symptomatic Deterioration|1|||
94378649|NCT03997448|323172697|FG000|Follow up|Death|2|||
94378650|NCT03997448|323172697|FG000|Follow up|study terminated|1|||
94378651|NCT00125359|323172698|FG000|Overall Study|Death|4|||
94378652|NCT00125359|323172698|FG000|Overall Study|Adverse Event|5|||
94378653|NCT00125359|323172698|FG000|Overall Study|Physician Decision|14|||
94378654|NCT02451670|323172699|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
94378655|NCT02451670|323172700|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
94378656|NCT00461500|323172701|FG000|Overall Study|Adverse Event|1|||
94378657|NCT00461500|323172702|FG001|Overall Study|Adverse Event|0|||
94378658|NCT00461500|323172701|FG000|Overall Study|Lack of Efficacy|0|||
94378659|NCT00461500|323172702|FG001|Overall Study|Lack of Efficacy|1|||
94378660|NCT00461500|323172701|FG000|Overall Study|Expired Drug Treatment|1|||
94378661|NCT00461500|323172702|FG001|Overall Study|Expired Drug Treatment|1|||
94378662|NCT00461500|323172701|FG000|Overall Study|Study Stopped|1|||
94378663|NCT00461500|323172702|FG001|Overall Study|Study Stopped|2|||
94469926|NCT03053427|323511372|FG001|Overall Study|Adverse Event|4|||
94378664|NCT00461500|323172701|FG000|Overall Study|Drug Treatment Misuse|1|||
94469927|NCT03053427|323511371|FG000|Overall Study|Lack of Efficacy|1|||
94378665|NCT00461500|323172702|FG001|Overall Study|Drug Treatment Misuse|0|||
94378666|NCT00461500|323172701|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
94378667|NCT00461500|323172702|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
94378668|NCT00461500|323172701|FG000|Overall Study|Lost to Follow-up|2|||
94378669|NCT00461500|323172702|FG001|Overall Study|Lost to Follow-up|2|||
94378670|NCT00289458|323172707|FG000|Overall Study|Death|1|||
94378671|NCT00289458|323172708|FG001|Overall Study|Death|0|||
94378672|NCT00289458|323172709|FG002|Overall Study|Death|0|||
94378673|NCT00289458|323172707|FG000|Overall Study|Physician Decision|3|||
94378674|NCT00289458|323172708|FG001|Overall Study|Physician Decision|4|||
94378675|NCT00289458|323172709|FG002|Overall Study|Physician Decision|2|||
94378676|NCT00289458|323172707|FG000|Overall Study|Withdrawal by Subject|2|||
94378677|NCT00289458|323172708|FG001|Overall Study|Withdrawal by Subject|2|||
94378678|NCT00289458|323172709|FG002|Overall Study|Withdrawal by Subject|4|||
94378679|NCT01007916|323172713|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
94378680|NCT01007916|323172714|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
94378681|NCT01007916|323172713|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
94378682|NCT01007916|323172714|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
94378683|NCT00322556|323172717|FG000|Overall Study|Adverse Event|1|||
94378684|NCT00322556|323172717|FG000|Overall Study|Withdrawal by Subject|1|||
94378685|NCT00322556|323172717|FG000|Overall Study|Lost to Follow-up|3|||
94378686|NCT00322556|323172717|FG000|Overall Study|Other Reason|7|||
94378687|NCT01907737|323172718|FG000|Overall Study|Withdrawal by Subject|1|||
94378688|NCT02040428|323172719|FG000|Overall Study|Death|4|||
94378689|NCT02040428|323172720|FG001|Overall Study|Death|3|||
94378690|NCT02040428|323172719|FG000|Overall Study|Withdrawal by Subject|1|||
94378691|NCT02040428|323172720|FG001|Overall Study|Withdrawal by Subject|1|||
94378692|NCT02058628|323172721|FG000|Overall Study|Adverse Event|1|||
94378693|NCT02058628|323172722|FG001|Overall Study|Adverse Event|0|||
94378694|NCT02058628|323172721|FG000|Overall Study|Withdrawal by Subject|2|||
94378695|NCT02058628|323172722|FG001|Overall Study|Withdrawal by Subject|2|||
94378696|NCT02058628|323172721|FG000|Overall Study|Lost to Follow-up|2|||
94378697|NCT02058628|323172722|FG001|Overall Study|Lost to Follow-up|4|||
94378698|NCT02058628|323172721|FG000|Overall Study|Not in time schedule|0|||
94378699|NCT02058628|323172722|FG001|Overall Study|Not in time schedule|1|||
94378700|NCT02058628|323172721|FG000|Overall Study|The visit date was not in timeline|0|||
94378701|NCT02058628|323172722|FG001|Overall Study|The visit date was not in timeline|1|||
94378702|NCT02058628|323172721|FG000|Overall Study|A lot of time for study for participant|1|||
94378703|NCT02058628|323172722|FG001|Overall Study|A lot of time for study for participant|0|||
94378704|NCT02058628|323172721|FG000|Overall Study|Non compliance|1|||
94378705|NCT02058628|323172722|FG001|Overall Study|Non compliance|0|||
94378706|NCT04527471|323172724|FG000|Overall Study|Adverse Event|1|||
94378707|NCT04527471|323172725|FG001|Overall Study|Adverse Event|0|||
94378708|NCT04527471|323172724|FG000|Overall Study|Lost to Follow-up|1|||
94378709|NCT04527471|323172725|FG001|Overall Study|Lost to Follow-up|0|||
94378710|NCT02637557|323172729|FG000|Overall Study|Adverse Event|3|||
94378711|NCT02637557|323172730|FG001|Overall Study|Adverse Event|1|||
94378712|NCT02637557|323172731|FG002|Overall Study|Adverse Event|3|||
94378713|NCT02637557|323172732|FG003|Overall Study|Adverse Event|3|||
94378714|NCT02637557|323172729|FG000|Overall Study|Lost to Follow-up|1|||
94378715|NCT02637557|323172730|FG001|Overall Study|Lost to Follow-up|1|||
94378716|NCT02637557|323172731|FG002|Overall Study|Lost to Follow-up|0|||
94378717|NCT02637557|323172732|FG003|Overall Study|Lost to Follow-up|1|||
94378718|NCT02637557|323172729|FG000|Overall Study|Physician Decision|1|||
94378719|NCT02637557|323172730|FG001|Overall Study|Physician Decision|0|||
94378720|NCT02637557|323172731|FG002|Overall Study|Physician Decision|0|||
94378721|NCT02637557|323172732|FG003|Overall Study|Physician Decision|0|||
94378722|NCT02637557|323172729|FG000|Overall Study|Protocol Violation|2|||
94378723|NCT02637557|323172730|FG001|Overall Study|Protocol Violation|0|||
94378724|NCT02637557|323172731|FG002|Overall Study|Protocol Violation|2|||
94378725|NCT02637557|323172732|FG003|Overall Study|Protocol Violation|1|||
94378726|NCT02637557|323172729|FG000|Overall Study|Withdrawal by Subject|1|||
94378727|NCT02637557|323172730|FG001|Overall Study|Withdrawal by Subject|3|||
94378728|NCT02637557|323172731|FG002|Overall Study|Withdrawal by Subject|4|||
94378729|NCT02637557|323172732|FG003|Overall Study|Withdrawal by Subject|2|||
94378730|NCT02006706|323172740|FG000|Overall Study|Lost to Follow-up|1|||
94378731|NCT03734237|323172741|FG000|Overall Study|Lost to Follow-up|1|||
94378732|NCT03734237|323172742|FG001|Overall Study|Lost to Follow-up|3|||
94378733|NCT03734237|323172743|FG002|Overall Study|Lost to Follow-up|0|||
94378734|NCT03734237|323172741|FG000|Overall Study|Withdrawal by Subject|7|||
94469928|NCT03053427|323511372|FG001|Overall Study|Lack of Efficacy|3|||
94469929|NCT03053427|323511371|FG000|Overall Study|Lost to Follow-up|2|||
94469930|NCT03053427|323511372|FG001|Overall Study|Lost to Follow-up|2|||
94378735|NCT03734237|323172742|FG001|Overall Study|Withdrawal by Subject|9|||
94378736|NCT03734237|323172743|FG002|Overall Study|Withdrawal by Subject|10|||
94378737|NCT01673009|323172744|FG000|Overall Study|Physician Decision|5|||
94378738|NCT01673009|323172744|FG000|Overall Study|Withdrawal by Subject|8|||
94378739|NCT00449072|323172745|FG000|Overall Study|Adverse Event|3|||
94378740|NCT00449072|323172746|FG001|Overall Study|Adverse Event|1|||
94378741|NCT00449072|323172745|FG000|Overall Study|Protocol Violation|14|||
94378742|NCT00449072|323172746|FG001|Overall Study|Protocol Violation|12|||
94378743|NCT00449072|323172745|FG000|Overall Study|Lost to Follow-up|5|||
94378744|NCT00449072|323172746|FG001|Overall Study|Lost to Follow-up|7|||
94378745|NCT00449072|323172745|FG000|Overall Study|Withdrawal by Subject|11|||
94378746|NCT00449072|323172746|FG001|Overall Study|Withdrawal by Subject|8|||
94378747|NCT00449072|323172745|FG000|Overall Study|Lack of Efficacy|1|||
94378748|NCT00449072|323172746|FG001|Overall Study|Lack of Efficacy|1|||
94378749|NCT00449072|323172745|FG000|Overall Study|Physician Decision|1|||
94378750|NCT00449072|323172746|FG001|Overall Study|Physician Decision|0|||
94378751|NCT00449072|323172745|FG000|Overall Study|Not treated|0|||
94378752|NCT00449072|323172746|FG001|Overall Study|Not treated|1|||
94378753|NCT00449072|323172745|FG000|Overall Study|Excluded medication|0|||
94378754|NCT00449072|323172746|FG001|Overall Study|Excluded medication|2|||
94378755|NCT00449072|323172745|FG000|Overall Study|Non-compliance|2|||
94378756|NCT00449072|323172746|FG001|Overall Study|Non-compliance|5|||
94378757|NCT00449072|323172745|FG000|Overall Study|Sponsor decision|1|||
94378758|NCT00449072|323172746|FG001|Overall Study|Sponsor decision|3|||
94378759|NCT00449072|323172745|FG000|Overall Study|Relocation|3|||
94378760|NCT00449072|323172746|FG001|Overall Study|Relocation|2|||
94378761|NCT01977092|323172747|FG000|Overall Study|Death|3|||
94378762|NCT01977092|323172748|FG001|Overall Study|Death|4|||
94378763|NCT01977092|323172747|FG000|Overall Study|Lost to Follow-up|23|||
94378764|NCT01977092|323172748|FG001|Overall Study|Lost to Follow-up|14|||
94378765|NCT01977092|323172747|FG000|Overall Study|Withdrawal by Subject|2|||
94378766|NCT01977092|323172748|FG001|Overall Study|Withdrawal by Subject|1|||
94378767|NCT01977092|323172747|FG000|Overall Study|In prison|3|||
94378768|NCT01977092|323172748|FG001|Overall Study|In prison|11|||
94378769|NCT03038113|323172749|FG000|Overall Study|Withdrawal by Subject|0|||
94378770|NCT03038113|323172750|FG001|Overall Study|Withdrawal by Subject|0|||
94378771|NCT03038113|323172751|FG002|Overall Study|Withdrawal by Subject|1|||
94378772|NCT03038113|323172752|FG003|Overall Study|Withdrawal by Subject|0|||
94378773|NCT03038113|323172753|FG004|Overall Study|Withdrawal by Subject|0|||
94378774|NCT03038113|323172754|FG005|Overall Study|Withdrawal by Subject|0|||
94378775|NCT03038113|323172755|FG006|Overall Study|Withdrawal by Subject|0|||
94378776|NCT03038113|323172756|FG007|Overall Study|Withdrawal by Subject|0|||
94378777|NCT03038113|323172757|FG008|Overall Study|Withdrawal by Subject|0|||
94378778|NCT03038113|323172758|FG009|Overall Study|Withdrawal by Subject|0|||
94378779|NCT03038113|323172759|FG010|Overall Study|Withdrawal by Subject|0|||
94378780|NCT03038113|323172760|FG011|Overall Study|Withdrawal by Subject|0|||
94378781|NCT03038113|323172761|FG012|Overall Study|Withdrawal by Subject|0|||
94378782|NCT03038113|323172762|FG013|Overall Study|Withdrawal by Subject|1|||
94378783|NCT03038113|323172749|FG000|Overall Study|Lost to Follow-up|0|||
94378784|NCT03038113|323172750|FG001|Overall Study|Lost to Follow-up|0|||
94378785|NCT03038113|323172751|FG002|Overall Study|Lost to Follow-up|0|||
94378786|NCT03038113|323172752|FG003|Overall Study|Lost to Follow-up|0|||
94378787|NCT03038113|323172753|FG004|Overall Study|Lost to Follow-up|0|||
94378788|NCT03038113|323172754|FG005|Overall Study|Lost to Follow-up|0|||
94378789|NCT03038113|323172755|FG006|Overall Study|Lost to Follow-up|1|||
94378790|NCT03038113|323172756|FG007|Overall Study|Lost to Follow-up|0|||
94378791|NCT03038113|323172757|FG008|Overall Study|Lost to Follow-up|0|||
94378792|NCT03038113|323172758|FG009|Overall Study|Lost to Follow-up|0|||
94378793|NCT03038113|323172759|FG010|Overall Study|Lost to Follow-up|0|||
94378794|NCT03038113|323172760|FG011|Overall Study|Lost to Follow-up|0|||
94378795|NCT03038113|323172761|FG012|Overall Study|Lost to Follow-up|0|||
94378796|NCT03038113|323172762|FG013|Overall Study|Lost to Follow-up|0|||
94378797|NCT03209570|323172763|FG000|Overall Study|Death|1|||
94378798|NCT03209570|323172764|FG001|Overall Study|Death|0|||
94378799|NCT03209570|323172763|FG000|Overall Study|Incomplete Data|8|||
94378800|NCT03209570|323172764|FG001|Overall Study|Incomplete Data|10|||
94378801|NCT03209570|323172763|FG000|Overall Study|Protocol Violation|1|||
94378802|NCT03209570|323172764|FG001|Overall Study|Protocol Violation|0|||
94378803|NCT03209570|323172763|FG000|Overall Study|Withdrawal by Subject|0|||
94378804|NCT03209570|323172764|FG001|Overall Study|Withdrawal by Subject|3|||
94378805|NCT03222141|323172765|FG000|Overall Study|Death|15|||
94378806|NCT03222141|323172765|FG000|Overall Study|Lost to Follow-up|3|||
94378807|NCT02035137|323172768|FG000|Overall Study|Physician Decision|0|||
94378808|NCT02035137|323172769|FG001|Overall Study|Physician Decision|0|||
94378809|NCT02035137|323172770|FG002|Overall Study|Physician Decision|1|||
94378810|NCT02035137|323172768|FG000|Overall Study|Withdrawal by Subject|0|||
94378811|NCT02035137|323172769|FG001|Overall Study|Withdrawal by Subject|1|||
94378812|NCT02035137|323172770|FG002|Overall Study|Withdrawal by Subject|2|||
94378813|NCT02035137|323172768|FG000|Overall Study|Ineligible|0|||
94378814|NCT02035137|323172769|FG001|Overall Study|Ineligible|1|||
94378815|NCT02035137|323172770|FG002|Overall Study|Ineligible|2|||
94378816|NCT02035137|323172768|FG000|Overall Study|Disease progression prior to treatment start|2|||
94378817|NCT02035137|323172769|FG001|Overall Study|Disease progression prior to treatment start|0|||
94378818|NCT02035137|323172770|FG002|Overall Study|Disease progression prior to treatment start|0|||
94378819|NCT02022007|323172771|FG000|Overall Study|Withdrawal by Subject|1|||
94378820|NCT02022007|323172772|FG001|Overall Study|Withdrawal by Subject|1|||
94378821|NCT02022007|323172773|FG002|Overall Study|Withdrawal by Subject|1|||
94307908|NCT02767570|322911519|FG001|Overall Study|Lost to Follow-up|0|||
94307909|NCT02767570|322911518|FG000|Overall Study|COVID shutdown|2|||
94307910|NCT02767570|322911519|FG001|Overall Study|COVID shutdown|5|||
94307911|NCT02767570|322911518|FG000|Overall Study|Increased pain|2|||
94307912|NCT02767570|322911519|FG001|Overall Study|Increased pain|0|||
94307913|NCT02767570|322911518|FG000|Overall Study|Withdrawal by Subject|1|||
94307914|NCT02767570|322911519|FG001|Overall Study|Withdrawal by Subject|3|||
94307915|NCT02767570|322911518|FG000|Overall Study|Unrelated medical issue|1|||
94307916|NCT02767570|322911519|FG001|Overall Study|Unrelated medical issue|1|||
94307917|NCT02767570|322911518|FG000|Overall Study|Received intra-articular injection|0|||
94307918|NCT02767570|322911519|FG001|Overall Study|Received intra-articular injection|1|||
94307919|NCT03692910|322911520|FG000|Overall Study|Lost to Follow-up|4|||
94307920|NCT03692910|322911521|FG001|Overall Study|Lost to Follow-up|0|||
94307921|NCT03692910|322911522|FG002|Overall Study|Lost to Follow-up|0|||
94307922|NCT03692910|322911520|FG000|Overall Study|Withdrawal by Subject|2|||
94307923|NCT03692910|322911521|FG001|Overall Study|Withdrawal by Subject|0|||
94307924|NCT03692910|322911522|FG002|Overall Study|Withdrawal by Subject|0|||
94307925|NCT00663858|322911523|FG000|Overall Study|Adverse Event|9|||
94307926|NCT00663858|322911524|FG001|Overall Study|Adverse Event|1|||
94307927|NCT00663858|322911525|FG002|Overall Study|Adverse Event|6|||
94307928|NCT00663858|322911523|FG000|Overall Study|Lack of Efficacy|5|||
94307929|NCT00663858|322911524|FG001|Overall Study|Lack of Efficacy|1|||
94307930|NCT00663858|322911525|FG002|Overall Study|Lack of Efficacy|3|||
94378822|NCT02022007|323172771|FG000|Overall Study|Noncompliant|0|||
94378823|NCT02022007|323172772|FG001|Overall Study|Noncompliant|0|||
94378824|NCT02022007|323172773|FG002|Overall Study|Noncompliant|1|||
94378825|NCT00384033|323172774|FG000|Overall Study|Adverse Event|10|||
94378826|NCT00384033|323172775|FG001|Overall Study|Adverse Event|8|||
94378827|NCT00384033|323172776|FG002|Overall Study|Adverse Event|11|||
94378828|NCT00384033|323172777|FG003|Overall Study|Adverse Event|20|||
94378829|NCT00384033|323172774|FG000|Overall Study|Failed to return|1|||
94378830|NCT00384033|323172775|FG001|Overall Study|Failed to return|3|||
94378831|NCT00384033|323172776|FG002|Overall Study|Failed to return|2|||
94378832|NCT00384033|323172777|FG003|Overall Study|Failed to return|2|||
94378833|NCT00384033|323172774|FG000|Overall Study|Physician Decision|1|||
94378834|NCT00384033|323172775|FG001|Overall Study|Physician Decision|0|||
94378835|NCT00384033|323172776|FG002|Overall Study|Physician Decision|0|||
94378836|NCT00384033|323172777|FG003|Overall Study|Physician Decision|0|||
94378837|NCT00384033|323172774|FG000|Overall Study|Lost to Follow-up|6|||
94378838|NCT00384033|323172775|FG001|Overall Study|Lost to Follow-up|12|||
94378839|NCT00384033|323172776|FG002|Overall Study|Lost to Follow-up|7|||
94378840|NCT00384033|323172777|FG003|Overall Study|Lost to Follow-up|7|||
94378841|NCT00384033|323172774|FG000|Overall Study|Other|2|||
94378842|NCT00384033|323172775|FG001|Overall Study|Other|0|||
94378843|NCT00384033|323172776|FG002|Overall Study|Other|0|||
94378844|NCT00384033|323172777|FG003|Overall Study|Other|0|||
94378845|NCT00384033|323172774|FG000|Overall Study|Protocol Violation|5|||
94378846|NCT00384033|323172775|FG001|Overall Study|Protocol Violation|0|||
94378847|NCT00384033|323172776|FG002|Overall Study|Protocol Violation|5|||
94378848|NCT00384033|323172777|FG003|Overall Study|Protocol Violation|6|||
94378849|NCT00384033|323172774|FG000|Overall Study|Withdrawal by Subject|6|||
94378850|NCT00384033|323172775|FG001|Overall Study|Withdrawal by Subject|2|||
94378851|NCT00384033|323172776|FG002|Overall Study|Withdrawal by Subject|5|||
94378852|NCT00384033|323172777|FG003|Overall Study|Withdrawal by Subject|2|||
94378853|NCT00384033|323172774|FG000|Overall Study|Lack of Efficacy|7|||
94378854|NCT00384033|323172775|FG001|Overall Study|Lack of Efficacy|3|||
94378855|NCT00384033|323172776|FG002|Overall Study|Lack of Efficacy|3|||
94378856|NCT00384033|323172777|FG003|Overall Study|Lack of Efficacy|1|||
94378857|NCT00384033|323172774|FG000|Overall Study|Randomized but not treated|3|||
94378858|NCT00384033|323172775|FG001|Overall Study|Randomized but not treated|7|||
94378859|NCT00384033|323172776|FG002|Overall Study|Randomized but not treated|10|||
94378860|NCT00384033|323172777|FG003|Overall Study|Randomized but not treated|2|||
94378861|NCT02040766|323172778|FG000|Overall Study|Adverse Event|1|||
94378862|NCT02040766|323172779|FG001|Overall Study|Adverse Event|1|||
94378863|NCT02040766|323172780|FG002|Overall Study|Adverse Event|1|||
94378864|NCT02040766|323172781|FG003|Overall Study|Adverse Event|0|||
94469931|NCT03053427|323511371|FG000|Overall Study|Worsening of the target disease|0|||
94469932|NCT03053427|323511372|FG001|Overall Study|Worsening of the target disease|1|||
94378865|NCT02040766|323172782|FG004|Overall Study|Adverse Event|2|||
94378866|NCT02040766|323172778|FG000|Overall Study|Withdrawal by Subject|4|||
94378867|NCT02040766|323172779|FG001|Overall Study|Withdrawal by Subject|3|||
94378868|NCT02040766|323172780|FG002|Overall Study|Withdrawal by Subject|2|||
94378869|NCT02040766|323172781|FG003|Overall Study|Withdrawal by Subject|3|||
94378870|NCT02040766|323172782|FG004|Overall Study|Withdrawal by Subject|2|||
94307931|NCT00663858|322911523|FG000|Overall Study|Withdrawal by Subject|7|||
94307932|NCT00663858|322911524|FG001|Overall Study|Withdrawal by Subject|3|||
94307933|NCT00663858|322911525|FG002|Overall Study|Withdrawal by Subject|3|||
94307934|NCT00663858|322911523|FG000|Overall Study|Protocol Violation|5|||
94307935|NCT00663858|322911524|FG001|Overall Study|Protocol Violation|3|||
94307936|NCT00663858|322911525|FG002|Overall Study|Protocol Violation|4|||
94307937|NCT00663858|322911523|FG000|Overall Study|Other|8|||
94307938|NCT00663858|322911524|FG001|Overall Study|Other|2|||
94307939|NCT00663858|322911525|FG002|Overall Study|Other|4|||
94307940|NCT01362322|322911530|FG000|Overall Study|Withdrawal by Subject|3|||
94307941|NCT01362322|322911531|FG001|Overall Study|Withdrawal by Subject|1|||
94307942|NCT01362322|322911530|FG000|Overall Study|Lost to Follow-up|2|||
94307943|NCT01362322|322911531|FG001|Overall Study|Lost to Follow-up|6|||
94307944|NCT01943539|322911532|FG000|Overall Study|Non-compliance with at-home intervention|4|||
94307945|NCT01943539|322911533|FG001|Overall Study|Non-compliance with at-home intervention|0|||
94307946|NCT01009463|322911536|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
94307947|NCT01009463|322911537|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
94307948|NCT01009463|322911538|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
94307949|NCT01009463|322911539|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
94307950|NCT01009463|322911540|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
94307951|NCT01009463|322911536|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
94307952|NCT01009463|322911537|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
94307953|NCT01009463|322911538|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
94307954|NCT01009463|322911539|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
94307955|NCT01009463|322911540|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
94307956|NCT01009463|322911536|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
94307957|NCT01009463|322911537|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
94307958|NCT01009463|322911538|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
94307959|NCT01009463|322911539|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
94307960|NCT01009463|322911540|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
94307961|NCT01009463|322911536|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
94307962|NCT01009463|322911537|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
94307963|NCT01009463|322911538|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
94307964|NCT01009463|322911539|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
94307965|NCT01009463|322911540|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
94307966|NCT01009463|322911536|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
94307967|NCT01009463|322911537|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
94307968|NCT01009463|322911538|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
94307969|NCT01009463|322911539|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
94307970|NCT01009463|322911540|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
94307971|NCT01009463|322911536|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
94307972|NCT01009463|322911537|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
94307973|NCT01009463|322911538|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
94307974|NCT01009463|322911539|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
94307975|NCT01009463|322911540|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
94307976|NCT01009463|322911536|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
94307977|NCT01009463|322911537|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
94307978|NCT01009463|322911538|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
94307979|NCT01009463|322911539|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
94378871|NCT02040766|323172778|FG000|Overall Study|Non-compliance|0|||
94378872|NCT02040766|323172779|FG001|Overall Study|Non-compliance|1|||
94378873|NCT02040766|323172780|FG002|Overall Study|Non-compliance|0|||
94378874|NCT02040766|323172781|FG003|Overall Study|Non-compliance|0|||
94378875|NCT02040766|323172782|FG004|Overall Study|Non-compliance|0|||
94378876|NCT02040766|323172778|FG000|Overall Study|Protocol Violation|2|||
94378877|NCT02040766|323172779|FG001|Overall Study|Protocol Violation|1|||
94378878|NCT02040766|323172780|FG002|Overall Study|Protocol Violation|2|||
94378879|NCT02040766|323172781|FG003|Overall Study|Protocol Violation|3|||
94378880|NCT02040766|323172782|FG004|Overall Study|Protocol Violation|0|||
94378881|NCT02040766|323172778|FG000|Overall Study|Lost to Follow-up|4|||
94378882|NCT02040766|323172779|FG001|Overall Study|Lost to Follow-up|1|||
94378883|NCT02040766|323172780|FG002|Overall Study|Lost to Follow-up|3|||
94378884|NCT02040766|323172781|FG003|Overall Study|Lost to Follow-up|1|||
94378885|NCT02040766|323172782|FG004|Overall Study|Lost to Follow-up|4|||
94378886|NCT02040766|323172778|FG000|Overall Study|Not reported|1|||
94378887|NCT02040766|323172779|FG001|Overall Study|Not reported|0|||
94378888|NCT02040766|323172780|FG002|Overall Study|Not reported|0|||
94469933|NCT03053427|323511371|FG000|Overall Study|Protocol Deviation|3|||
94469934|NCT03053427|323511372|FG001|Overall Study|Protocol Deviation|3|||
94469935|NCT03053427|323511371|FG000|Overall Study|Withdrawal by Subject|3|||
94469936|NCT03053427|323511372|FG001|Overall Study|Withdrawal by Subject|2|||
94469937|NCT03053427|323511371|FG000|Overall Study|Miscellaneous|0|||
94469938|NCT03053427|323511372|FG001|Overall Study|Miscellaneous|1|||
94469939|NCT00603382|323511375|FG000|Overall Study|Adverse Event|0|||
94469940|NCT00603382|323511376|FG001|Overall Study|Adverse Event|1|||
94469941|NCT00603382|323511377|FG002|Overall Study|Adverse Event|1|||
94469942|NCT00603382|323511378|FG003|Overall Study|Adverse Event|2|||
94469943|NCT00603382|323511379|FG004|Overall Study|Adverse Event|1|||
94469944|NCT00603382|323511380|FG005|Overall Study|Adverse Event|2|||
94469945|NCT00603382|323511375|FG000|Overall Study|Lack of Efficacy|14|||
94469946|NCT00603382|323511376|FG001|Overall Study|Lack of Efficacy|9|||
94469947|NCT00603382|323511377|FG002|Overall Study|Lack of Efficacy|3|||
94469948|NCT00603382|323511378|FG003|Overall Study|Lack of Efficacy|6|||
94469949|NCT00603382|323511379|FG004|Overall Study|Lack of Efficacy|6|||
94469950|NCT00603382|323511380|FG005|Overall Study|Lack of Efficacy|11|||
94469951|NCT00603382|323511375|FG000|Overall Study|Protocol Violation|1|||
94469952|NCT00603382|323511376|FG001|Overall Study|Protocol Violation|0|||
94469953|NCT00603382|323511377|FG002|Overall Study|Protocol Violation|1|||
94469954|NCT00603382|323511378|FG003|Overall Study|Protocol Violation|2|||
94469955|NCT00603382|323511379|FG004|Overall Study|Protocol Violation|1|||
94469956|NCT00603382|323511380|FG005|Overall Study|Protocol Violation|0|||
94469957|NCT00603382|323511375|FG000|Overall Study|Lost to Follow-up|0|||
94469958|NCT00603382|323511376|FG001|Overall Study|Lost to Follow-up|1|||
94469959|NCT00603382|323511377|FG002|Overall Study|Lost to Follow-up|1|||
94469960|NCT00603382|323511378|FG003|Overall Study|Lost to Follow-up|1|||
94469961|NCT00603382|323511379|FG004|Overall Study|Lost to Follow-up|0|||
94469962|NCT00603382|323511380|FG005|Overall Study|Lost to Follow-up|1|||
94469963|NCT00603382|323511375|FG000|Overall Study|Physician Decision|0|||
94469964|NCT00603382|323511376|FG001|Overall Study|Physician Decision|0|||
94469965|NCT00603382|323511377|FG002|Overall Study|Physician Decision|2|||
94469966|NCT00603382|323511378|FG003|Overall Study|Physician Decision|0|||
94469967|NCT00603382|323511379|FG004|Overall Study|Physician Decision|1|||
94469968|NCT00603382|323511380|FG005|Overall Study|Physician Decision|3|||
94469969|NCT00603382|323511375|FG000|Overall Study|Withdrawal by Subject|3|||
94469970|NCT00603382|323511376|FG001|Overall Study|Withdrawal by Subject|3|||
94469971|NCT00603382|323511377|FG002|Overall Study|Withdrawal by Subject|1|||
94469972|NCT00603382|323511378|FG003|Overall Study|Withdrawal by Subject|1|||
94469973|NCT00603382|323511379|FG004|Overall Study|Withdrawal by Subject|0|||
94469974|NCT00603382|323511380|FG005|Overall Study|Withdrawal by Subject|1|||
94469975|NCT02333383|323511381|FG000|Overall Study|Adalimumab discontinuation|21|||
94469976|NCT02333383|323511381|FG000|Overall Study|Lost to Follow-up|15|||
94469977|NCT02333383|323511381|FG000|Overall Study|Withdrawal by Subject|3|||
94469978|NCT02333383|323511381|FG000|Overall Study|Transfer to another hospital|2|||
94469979|NCT02984267|323511384|FG000|Overall Study|Protocol Violation|1|||
94469980|NCT02984267|323511385|FG001|Overall Study|Protocol Violation|0|||
94469981|NCT02984267|323511384|FG000|Overall Study|Withdrawal by Subject|0|||
94469982|NCT02984267|323511385|FG001|Overall Study|Withdrawal by Subject|1|||
94469983|NCT02685072|323511386|FG000|Treatment Period|Lost to Follow-up|12|||
94469984|NCT02685072|323511387|FG001|Treatment Period|Lost to Follow-up|6|||
94469985|NCT02685072|323511386|FG000|Treatment Period|Withdrawal by Subject|1|||
94469986|NCT02685072|323511387|FG001|Treatment Period|Withdrawal by Subject|3|||
94469987|NCT02685072|323511386|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
94469988|NCT02685072|323511387|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
94469989|NCT03597139|323511388|FG000|Overall Study|Adverse Event|3|||
94469990|NCT03597139|323511389|FG001|Overall Study|Adverse Event|0|||
94469991|NCT03597139|323511388|FG000|Overall Study|Protocol Non-compliance|1|||
94469992|NCT03597139|323511389|FG001|Overall Study|Protocol Non-compliance|0|||
94469993|NCT02243046|323511390|FG000|Overall Study|Lost to Follow-up|1|||
94469994|NCT02243046|323511391|FG001|Overall Study|Lost to Follow-up|1|||
94469995|NCT02243046|323511392|FG002|Overall Study|Lost to Follow-up|4|||
94469996|NCT00248833|323511395|FG000|Overall Study|Adverse Event|2|||
94469997|NCT00248833|323511396|FG001|Overall Study|Adverse Event|0|||
94469998|NCT00248833|323511397|FG002|Overall Study|Adverse Event|0|||
94469999|NCT00248833|323511395|FG000|Overall Study|Withdrawal by Subject|0|||
94470000|NCT00248833|323511396|FG001|Overall Study|Withdrawal by Subject|1|||
94470001|NCT00248833|323511397|FG002|Overall Study|Withdrawal by Subject|1|||
94470002|NCT00248833|323511395|FG000|Overall Study|Lost to Follow-up|1|||
94470003|NCT00248833|323511396|FG001|Overall Study|Lost to Follow-up|1|||
94470004|NCT00248833|323511397|FG002|Overall Study|Lost to Follow-up|1|||
94470005|NCT00248833|323511395|FG000|Overall Study|Other|0|||
94470006|NCT00248833|323511396|FG001|Overall Study|Other|1|||
94307980|NCT01009463|322911540|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
94470007|NCT00248833|323511397|FG002|Overall Study|Other|0|||
94470008|NCT02772809|323511398|FG000|Overall Study|not completed some tasks|6|||
94307981|NCT01009463|322911536|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
94307982|NCT01009463|322911537|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
94307983|NCT01009463|322911538|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
94307984|NCT01009463|322911539|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
94307985|NCT01009463|322911540|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
94307986|NCT01009463|322911536|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
94307987|NCT01009463|322911537|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
94307988|NCT01009463|322911538|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
94307989|NCT01009463|322911539|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
94307990|NCT01009463|322911540|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
94307991|NCT01009463|322911536|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
94307992|NCT01009463|322911537|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
94307993|NCT01009463|322911538|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
94307994|NCT01009463|322911539|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
94307995|NCT01009463|322911540|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
94307996|NCT01009463|322911536|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
94307997|NCT01009463|322911537|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
94307998|NCT01009463|322911538|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
94307999|NCT01009463|322911539|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
94308000|NCT01009463|322911540|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
94308001|NCT01009463|322911536|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
94308002|NCT01009463|322911537|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
94308003|NCT01009463|322911538|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
94308004|NCT01009463|322911539|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
94308005|NCT01009463|322911540|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
94308006|NCT01009463|322911536|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
94308007|NCT01009463|322911537|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
94308008|NCT01009463|322911538|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
94308009|NCT01009463|322911539|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
94308010|NCT01009463|322911540|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
94308011|NCT03060577|322911541|FG000|Overall Study|Withdrawal by Subject|25|||
94308012|NCT03060577|322911542|FG001|Overall Study|Withdrawal by Subject|5|||
94308013|NCT03060577|322911541|FG000|Overall Study|Physician Decision|4|||
94308014|NCT03060577|322911542|FG001|Overall Study|Physician Decision|3|||
94308015|NCT03060577|322911541|FG000|Overall Study|Lost to Follow-up|3|||
94308016|NCT03060577|322911542|FG001|Overall Study|Lost to Follow-up|0|||
94308017|NCT03060577|322911541|FG000|Overall Study|Death|7|||
94308018|NCT03060577|322911542|FG001|Overall Study|Death|1|||
94308019|NCT03060577|322911541|FG000|Overall Study|Adverse Event|9|||
94308020|NCT03060577|322911542|FG001|Overall Study|Adverse Event|1|||
94308021|NCT03060577|322911541|FG000|Overall Study|Inclusion/Exclusion|1|||
94308022|NCT03060577|322911542|FG001|Overall Study|Inclusion/Exclusion|0|||
94308023|NCT03060577|322911541|FG000|Overall Study|Other|8|||
94308024|NCT03060577|322911542|FG001|Overall Study|Other|2|||
94308025|NCT02413398|322911545|FG000|Overall Study|Lost to Follow-up|2|||
94308026|NCT02413398|322911546|FG001|Overall Study|Lost to Follow-up|4|||
94308027|NCT02413398|322911545|FG000|Overall Study|Withdrawal by Subject|1|||
94308028|NCT02413398|322911546|FG001|Overall Study|Withdrawal by Subject|1|||
94308029|NCT02413398|322911545|FG000|Overall Study|Other Eligibility criteria|1|||
94308030|NCT02413398|322911546|FG001|Overall Study|Other Eligibility criteria|2|||
94308031|NCT01494038|322911547|FG000|Overall Study|Protocol Violation|1|||
94308032|NCT01494038|322911548|FG001|Overall Study|Protocol Violation|1|||
94308033|NCT01494038|322911547|FG000|Overall Study|Lost to Follow-up|18|||
94308034|NCT01494038|322911548|FG001|Overall Study|Lost to Follow-up|20|||
94308035|NCT01494038|322911547|FG000|Overall Study|Withdrawal by Subject|44|||
94308036|NCT01494038|322911548|FG001|Overall Study|Withdrawal by Subject|34|||
94308037|NCT01494038|322911547|FG000|Overall Study|Not able to get to clinic|21|||
94308038|NCT01494038|322911548|FG001|Overall Study|Not able to get to clinic|15|||
94308039|NCT01494038|322911547|FG000|Overall Study|Not willing to adhere to reqs|2|||
94308040|NCT01494038|322911548|FG001|Overall Study|Not willing to adhere to reqs|9|||
94308041|NCT01494038|322911547|FG000|Overall Study|Death|2|||
94378889|NCT02040766|323172781|FG003|Overall Study|Not reported|0|||
94378890|NCT02040766|323172782|FG004|Overall Study|Not reported|0|||
94378891|NCT02040766|323172778|FG000|Overall Study|Lack of Efficacy|6|||
94378892|NCT02040766|323172779|FG001|Overall Study|Lack of Efficacy|3|||
94378893|NCT02040766|323172780|FG002|Overall Study|Lack of Efficacy|4|||
94378894|NCT02040766|323172781|FG003|Overall Study|Lack of Efficacy|6|||
94378895|NCT02040766|323172782|FG004|Overall Study|Lack of Efficacy|5|||
94378896|NCT00936975|323172783|FG000|Overall Study|Withdrawal by Subject|1|||
94378897|NCT00936975|323172783|FG000|Overall Study|Disease progression|3|||
94378898|NCT00936975|323172783|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
94378899|NCT00423800|323172784|FG000|Overall Study|Protocol Violation|0|||
94378900|NCT00423800|323172785|FG001|Overall Study|Protocol Violation|1|||
94378901|NCT01873859|323172789|FG000|Overall Study|Withdrawal by Subject|0|||
94378902|NCT01873859|323172790|FG001|Overall Study|Withdrawal by Subject|4|||
94378903|NCT01364870|323172791|FG000|Overall Study|Withdrawal by Subject|13|||
94378904|NCT01364870|323172792|FG001|Overall Study|Withdrawal by Subject|24|||
94378905|NCT01364870|323172793|FG002|Overall Study|Withdrawal by Subject|10|||
94378906|NCT01364870|323172791|FG000|Overall Study|Adverse Event|8|||
94378907|NCT01364870|323172792|FG001|Overall Study|Adverse Event|6|||
94378908|NCT01364870|323172793|FG002|Overall Study|Adverse Event|4|||
94378909|NCT01364870|323172791|FG000|Overall Study|Protocol Violation|1|||
94378910|NCT01364870|323172792|FG001|Overall Study|Protocol Violation|0|||
94378911|NCT01364870|323172793|FG002|Overall Study|Protocol Violation|0|||
94378912|NCT00601484|323172794|FG000|Overall Study|Adverse Event|0|||
94378913|NCT00601484|323172795|FG001|Overall Study|Adverse Event|1|||
94378914|NCT00601484|323172794|FG000|Overall Study|Lost to Follow-up|4|||
94378915|NCT00601484|323172795|FG001|Overall Study|Lost to Follow-up|3|||
94378916|NCT00601484|323172794|FG000|Overall Study|Lack of Efficacy|0|||
94378917|NCT00601484|323172795|FG001|Overall Study|Lack of Efficacy|2|||
94378918|NCT00601484|323172794|FG000|Overall Study|Withdrawal by Subject|1|||
94378919|NCT00601484|323172795|FG001|Overall Study|Withdrawal by Subject|1|||
94378920|NCT00601484|323172794|FG000|Overall Study|Randomized, but not treated|0|||
94378921|NCT00601484|323172795|FG001|Overall Study|Randomized, but not treated|1|||
94378922|NCT03504852|323172796|FG000|Overall Study|Withdrawal of informed consent|2|||
94378923|NCT03504852|323172797|FG001|Overall Study|Withdrawal of informed consent|1|||
94378924|NCT03504852|323172798|FG002|Overall Study|Withdrawal of informed consent|0|||
94378925|NCT03504852|323172796|FG000|Overall Study|Withdrawal by Subject|5|||
94378926|NCT03504852|323172797|FG001|Overall Study|Withdrawal by Subject|5|||
94378927|NCT03504852|323172798|FG002|Overall Study|Withdrawal by Subject|1|||
94378928|NCT03504852|323172796|FG000|Overall Study|Lost to Follow-up|4|||
94378929|NCT03504852|323172797|FG001|Overall Study|Lost to Follow-up|1|||
94378930|NCT03504852|323172798|FG002|Overall Study|Lost to Follow-up|0|||
94378931|NCT03504852|323172796|FG000|Overall Study|New therapy for study indication|1|||
94378932|NCT03504852|323172797|FG001|Overall Study|New therapy for study indication|0|||
94378933|NCT03504852|323172798|FG002|Overall Study|New therapy for study indication|0|||
94378934|NCT03504852|323172796|FG000|Overall Study|Lack of Efficacy|1|||
94378935|NCT03504852|323172797|FG001|Overall Study|Lack of Efficacy|2|||
94378936|NCT03504852|323172798|FG002|Overall Study|Lack of Efficacy|0|||
94378937|NCT03504852|323172796|FG000|Overall Study|Death|0|||
94378938|NCT03504852|323172797|FG001|Overall Study|Death|1|||
94378939|NCT03504852|323172798|FG002|Overall Study|Death|0|||
94378940|NCT03504852|323172796|FG000|Overall Study|Adverse Event|4|||
94378941|NCT03504852|323172797|FG001|Overall Study|Adverse Event|8|||
94378942|NCT03504852|323172798|FG002|Overall Study|Adverse Event|2|||
94378943|NCT01748890|323172799|FG000|Overall Study|Insufficient recruitment for analysis|4|||
94378944|NCT03850509|323172800|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
94378945|NCT03850509|323172801|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
94378946|NCT01736553|323172806|FG000|Overall Study|Death|12|||
94378947|NCT01736553|323172807|FG001|Overall Study|Death|0|||
94378948|NCT01736553|323172806|FG000|Overall Study|Withdrawal by Subject|5|||
94378949|NCT01736553|323172807|FG001|Overall Study|Withdrawal by Subject|2|||
94378950|NCT01736553|323172806|FG000|Overall Study|Lost to Follow-up|2|||
94378951|NCT01736553|323172807|FG001|Overall Study|Lost to Follow-up|2|||
94378952|NCT01896297|323172808|FG000|Overall Study|Died in post treatment phase|1|||
94378953|NCT00767325|323172809|FG000|Overall Study|Lack of Efficacy|2|||
94378954|NCT00767325|323172809|FG000|Overall Study|Adverse Event|7|||
94378955|NCT00767325|323172809|FG000|Overall Study|Lost to Follow-up|3|||
94378956|NCT00767325|323172809|FG000|Overall Study|No longer met study criteria|2|||
94378957|NCT00767325|323172809|FG000|Overall Study|Missed visit due to family reasons|1|||
94378958|NCT03538756|323172810|FG000|Long-Term Follow-up|Adverse Event|0|||
94378959|NCT03538756|323172811|FG001|Long-Term Follow-up|Adverse Event|0|||
94378960|NCT03538756|323172812|FG002|Long-Term Follow-up|Adverse Event|6|||
94378961|NCT03538756|323172810|FG000|Long-Term Follow-up|Death|0|||
94378962|NCT03538756|323172811|FG001|Long-Term Follow-up|Death|0|||
94378963|NCT03538756|323172812|FG002|Long-Term Follow-up|Death|1|||
94378964|NCT03538756|323172810|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
94378965|NCT03538756|323172811|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
94378966|NCT03538756|323172812|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
94378967|NCT03538756|323172810|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
94378968|NCT03538756|323172811|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
94378969|NCT03538756|323172812|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
94378970|NCT03538756|323172810|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
94378971|NCT03538756|323172811|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
94378972|NCT03538756|323172812|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
94378973|NCT03131999|323172813|FG000|Overall Study|Withdrawal by Subject|0|||
94378974|NCT03131999|323172814|FG001|Overall Study|Withdrawal by Subject|1|||
94378975|NCT00385541|323172815|FG000|Overall Study|severe pain, clinician requested unblind|0|||
94378976|NCT00385541|323172816|FG001|Overall Study|severe pain, clinician requested unblind|1|||
94378977|NCT00996736|323172817|FG000|Overall Study|Death|1|||
94308042|NCT01494038|322911548|FG001|Overall Study|Death|4|||
94308043|NCT03088605|322911552|FG000|Overall Study|Withdrawal by Subject|1|||
94308044|NCT03088605|322911553|FG001|Overall Study|Withdrawal by Subject|0|||
94308045|NCT01183858|322911557|FG000|Overall Study|Death not related to Progressive Disease|5|||
94308046|NCT01183858|322911558|FG001|Overall Study|Death not related to Progressive Disease|6|||
94308047|NCT01183858|322911557|FG000|Overall Study|Adverse Event|14|||
94308048|NCT01183858|322911558|FG001|Overall Study|Adverse Event|11|||
94308049|NCT01183858|322911557|FG000|Overall Study|Investigator's Decision|0|||
94308050|NCT01183858|322911558|FG001|Overall Study|Investigator's Decision|3|||
94308051|NCT01183858|322911557|FG000|Overall Study|Insufficient Therapeutic Response|2|||
94308052|NCT01183858|322911558|FG001|Overall Study|Insufficient Therapeutic Response|0|||
94308053|NCT01183858|322911557|FG000|Overall Study|Refused Treatment|1|||
94308054|NCT01183858|322911558|FG001|Overall Study|Refused Treatment|4|||
94308055|NCT01183858|322911557|FG000|Overall Study|Withdrew Consent|4|||
94308056|NCT01183858|322911558|FG001|Overall Study|Withdrew Consent|4|||
94308057|NCT01183858|322911557|FG000|Overall Study|Discontinued Smoking|3|||
94308058|NCT01183858|322911558|FG001|Overall Study|Discontinued Smoking|1|||
94308059|NCT01183858|322911557|FG000|Overall Study|Protocol Violation|1|||
94308060|NCT01183858|322911558|FG001|Overall Study|Protocol Violation|0|||
94308061|NCT01183858|322911557|FG000|Overall Study|Administrative/Other|6|||
94308062|NCT01183858|322911558|FG001|Overall Study|Administrative/Other|6|||
94308063|NCT01183858|322911557|FG000|Overall Study|Progressive Disease|112|||
94308064|NCT01183858|322911558|FG001|Overall Study|Progressive Disease|115|||
94308065|NCT01183858|322911557|FG000|Overall Study|Death related to Progressive Disease|4|||
94308066|NCT01183858|322911558|FG001|Overall Study|Death related to Progressive Disease|5|||
94308067|NCT01183858|322911557|FG000|Overall Study|Lost to Follow-up|1|||
94308068|NCT01183858|322911558|FG001|Overall Study|Lost to Follow-up|1|||
94308069|NCT01126619|322911559|FG000|Overall Study|Not eligible for the study|2|||
94308070|NCT01126619|322911559|FG000|Overall Study|Investigator decision|4|||
94308071|NCT01126619|322911559|FG000|Overall Study|Serious adverse event|1|||
94308072|NCT01126619|322911559|FG000|Overall Study|Withdrawal by Subject|9|||
94308073|NCT01126619|322911559|FG000|Overall Study|Non-compliance|1|||
94308074|NCT00641147|322911562|FG000|Completed 4 Months.|Physician Decision|1|||
94308075|NCT00641147|322911563|FG001|Completed 4 Months.|Physician Decision|0|||
94308076|NCT00641147|322911562|FG000|Completed 4 Months.|Adverse Event|1|||
94308077|NCT00641147|322911563|FG001|Completed 4 Months.|Adverse Event|0|||
94308078|NCT00641147|322911562|FG000|Completed 8 Months.|Physician Decision|2|||
94470009|NCT02774005|323511403|FG000|Overall Study|Adverse Event|8|||
94470010|NCT02774005|323511403|FG000|Overall Study|Withdrawal by Subject|23|||
94470011|NCT02774005|323511403|FG000|Overall Study|Lost to Follow-up|7|||
94470012|NCT02774005|323511403|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
94470013|NCT02774005|323511403|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
94470014|NCT02774005|323511403|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
94470015|NCT02774005|323511403|FG000|Overall Study|Death|1|||
94470016|NCT02774005|323511403|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
94470017|NCT02774005|323511403|FG000|Overall Study|Lack of compliance with study medication|4|||
94470018|NCT02774005|323511403|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
94470019|NCT02774005|323511403|FG000|Overall Study|another study|1|||
94308079|NCT00641147|322911563|FG001|Completed 8 Months.|Physician Decision|1|||
94308080|NCT00641147|322911562|FG000|Completed 8 Months.|non compliance|1|||
94308081|NCT00641147|322911563|FG001|Completed 8 Months.|non compliance|0|||
94308082|NCT00641147|322911562|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
94308083|NCT00641147|322911563|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
94308084|NCT00641147|322911562|FG000|Completed 12 Months.|Physician Decision|1|||
94308085|NCT00641147|322911563|FG001|Completed 12 Months.|Physician Decision|1|||
94308086|NCT00641147|322911562|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
94308087|NCT00641147|322911563|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
94308088|NCT00641147|322911562|FG000|Completed 16 Months.|Physician Decision|1|||
94308089|NCT00641147|322911563|FG001|Completed 16 Months.|Physician Decision|0|||
94308090|NCT00641147|322911562|FG000|Completed 16 Months.|Lost to Follow-up|1|||
94308091|NCT00641147|322911563|FG001|Completed 16 Months.|Lost to Follow-up|0|||
94308092|NCT04655586|322911564|FG000|Overall Study|Physician Decision|1|||
94308093|NCT04655586|322911565|FG001|Overall Study|Physician Decision|3|||
94308094|NCT04655586|322911566|FG002|Overall Study|Physician Decision|4|||
94308095|NCT04655586|322911564|FG000|Overall Study|Withdrawal by Subject|1|||
94308096|NCT04655586|322911565|FG001|Overall Study|Withdrawal by Subject|3|||
94308097|NCT04655586|322911566|FG002|Overall Study|Withdrawal by Subject|1|||
94308098|NCT01588197|322911569|FG000|Overall Study|Lack of Efficacy|0|||
94308099|NCT01588197|322911570|FG001|Overall Study|Lack of Efficacy|1|||
94308100|NCT01588197|322911569|FG000|Overall Study|No MRI|1|||
94308101|NCT01588197|322911570|FG001|Overall Study|No MRI|0|||
94308102|NCT01844076|322911571|FG000|Overall Study|Adverse Event|1|||
94308103|NCT01844076|322911572|FG001|Overall Study|Adverse Event|0|||
94308104|NCT01844076|322911573|FG002|Overall Study|Adverse Event|0|||
94308105|NCT01844076|322911574|FG003|Overall Study|Adverse Event|0|||
94308106|NCT01844076|322911571|FG000|Overall Study|Withdrawal by Subject|1|||
94308107|NCT01844076|322911572|FG001|Overall Study|Withdrawal by Subject|0|||
94308108|NCT01844076|322911573|FG002|Overall Study|Withdrawal by Subject|0|||
94308109|NCT01844076|322911574|FG003|Overall Study|Withdrawal by Subject|0|||
94308110|NCT03133481|322911576|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
94308111|NCT03133481|322911577|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
94308112|NCT01050062|322911579|FG000|Overall Study|Adverse Event|75|||
94308113|NCT01050062|322911580|FG001|Overall Study|Adverse Event|22|||
94308114|NCT01050062|322911579|FG000|Overall Study|Lost to Follow-up|83|||
94308115|NCT01050062|322911580|FG001|Overall Study|Lost to Follow-up|35|||
94308116|NCT01050062|322911579|FG000|Overall Study|Lack of Efficacy|22|||
94308117|NCT01050062|322911580|FG001|Overall Study|Lack of Efficacy|35|||
94308118|NCT01050062|322911579|FG000|Overall Study|Physician Decision|74|||
94308119|NCT01050062|322911580|FG001|Overall Study|Physician Decision|9|||
94308120|NCT01050062|322911579|FG000|Overall Study|Others|17|||
94308121|NCT01050062|322911580|FG001|Overall Study|Others|11|||
94308122|NCT03988751|322911583|FG000|Overall Study|Withdrawal by Subject|1|||
94308123|NCT03988751|322911584|FG001|Overall Study|Withdrawal by Subject|0|||
94308124|NCT03988751|322911583|FG000|Overall Study|Protocol Violation|0|||
94308125|NCT03988751|322911584|FG001|Overall Study|Protocol Violation|1|||
94308126|NCT00844883|322911587|FG000|Overall Study|Bridged to liver transplant|3|||
94308127|NCT00844883|322911587|FG000|Overall Study|Bridged to resection|1|||
94308128|NCT02623361|322911588|FG000|Overall Study|Protocol Violation|0|||
94308129|NCT02623361|322911589|FG001|Overall Study|Protocol Violation|1|||
94308130|NCT02623361|322911588|FG000|Overall Study|Withdrawal by Subject|0|||
94308131|NCT02623361|322911589|FG001|Overall Study|Withdrawal by Subject|1|||
94308132|NCT03894540|322911590|FG000|Overall Study|Adverse Event|0|||
94308133|NCT03894540|322911591|FG001|Overall Study|Adverse Event|0|||
94308134|NCT03894540|322911592|FG002|Overall Study|Adverse Event|0|||
94308135|NCT03894540|322911593|FG003|Overall Study|Adverse Event|0|||
94308136|NCT03894540|322911594|FG004|Overall Study|Adverse Event|1|||
94308137|NCT03894540|322911595|FG005|Overall Study|Adverse Event|0|||
94308138|NCT03894540|322911590|FG000|Overall Study|Withdrawal by Subject|0|||
94308139|NCT03894540|322911591|FG001|Overall Study|Withdrawal by Subject|0|||
94308140|NCT03894540|322911592|FG002|Overall Study|Withdrawal by Subject|0|||
94308141|NCT03894540|322911593|FG003|Overall Study|Withdrawal by Subject|0|||
94308142|NCT03894540|322911594|FG004|Overall Study|Withdrawal by Subject|1|||
94470020|NCT02774005|323511403|FG000|Overall Study|cardiologist imposed travel restriction|1|||
94470021|NCT00534105|323511404|FG000|Overall Study|Lost to Follow-up|23|||
94470022|NCT00534105|323511405|FG001|Overall Study|Lost to Follow-up|39|||
94470023|NCT00723697|323511406|FG000|Overall Study|Physician questionnaires not received|2|||
94470024|NCT00723697|323511406|FG000|Overall Study|Missing Informed Consent Form|10|||
94470025|NCT00723697|323511406|FG000|Overall Study|Other exclusion criteria applied|6|||
94470026|NCT01289574|323511407|FG000|Overall Study|Lack of Efficacy|4|||
94470027|NCT01289574|323511408|FG001|Overall Study|Lack of Efficacy|0|||
94470028|NCT01289574|323511409|FG002|Overall Study|Lack of Efficacy|1|||
94470029|NCT01289574|323511407|FG000|Overall Study|Lost to Follow-up|2|||
94470030|NCT01289574|323511408|FG001|Overall Study|Lost to Follow-up|0|||
94470031|NCT01289574|323511409|FG002|Overall Study|Lost to Follow-up|1|||
94470032|NCT01289574|323511407|FG000|Overall Study|Withdrawal by Subject|1|||
94470033|NCT01289574|323511408|FG001|Overall Study|Withdrawal by Subject|1|||
94470034|NCT01289574|323511409|FG002|Overall Study|Withdrawal by Subject|1|||
94470035|NCT01289574|323511407|FG000|Overall Study|Adverse Event|0|||
94470036|NCT01289574|323511408|FG001|Overall Study|Adverse Event|1|||
94470037|NCT01289574|323511409|FG002|Overall Study|Adverse Event|0|||
94470038|NCT01289574|323511407|FG000|Overall Study|Subject wanted alternate treatment|0|||
94470039|NCT01289574|323511408|FG001|Overall Study|Subject wanted alternate treatment|1|||
94470040|NCT01289574|323511409|FG002|Overall Study|Subject wanted alternate treatment|0|||
94470041|NCT01483599|323511411|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
94470042|NCT01483599|323511412|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
94470043|NCT01483599|323511413|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
94470044|NCT01483599|323511414|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
94470045|NCT01483599|323511415|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
94470046|NCT01483599|323511416|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
94470047|NCT01483599|323511417|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
94470048|NCT01483599|323511418|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
94470049|NCT01483599|323511419|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
94470050|NCT01483599|323511420|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
94470051|NCT01483599|323511421|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
94470052|NCT01483599|323511422|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
94470053|NCT01483599|323511423|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
94470054|NCT01483599|323511424|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
94470055|NCT01483599|323511411|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
94470056|NCT01483599|323511412|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
94470057|NCT01483599|323511413|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
94470058|NCT01483599|323511414|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
94470059|NCT01483599|323511415|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
94470060|NCT01483599|323511416|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
94470061|NCT01483599|323511417|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
94470062|NCT01483599|323511418|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
94470063|NCT01483599|323511419|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
94470064|NCT01483599|323511420|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
94470065|NCT01483599|323511421|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
94470066|NCT01483599|323511422|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
94470067|NCT01483599|323511423|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
94470068|NCT01483599|323511424|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
94470069|NCT01483599|323511411|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
94470070|NCT01483599|323511412|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
94470071|NCT01483599|323511413|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
94470072|NCT01483599|323511414|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
94470073|NCT01483599|323511415|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
94470074|NCT01483599|323511416|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
94470075|NCT01483599|323511417|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
94470076|NCT01483599|323511418|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
94470077|NCT01483599|323511419|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
94470078|NCT01483599|323511420|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
94470079|NCT01483599|323511421|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
94470080|NCT01483599|323511422|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
94470081|NCT01483599|323511423|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
94470082|NCT01483599|323511424|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
94470083|NCT01483599|323511411|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
94470084|NCT01483599|323511412|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
94470085|NCT01483599|323511413|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
94470086|NCT01483599|323511414|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
94470087|NCT01483599|323511415|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
94470088|NCT01483599|323511416|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
94470089|NCT01483599|323511417|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
94470090|NCT01483599|323511418|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
94470091|NCT01483599|323511419|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
94470092|NCT01483599|323511420|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
94470093|NCT01483599|323511421|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
94470094|NCT01483599|323511422|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
94470095|NCT01483599|323511423|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
94470096|NCT01483599|323511424|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
94470097|NCT01483599|323511411|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
94470098|NCT01483599|323511412|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
94470099|NCT01483599|323511413|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
94470100|NCT01483599|323511414|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
94470101|NCT01483599|323511415|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
94470102|NCT01483599|323511416|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
94470103|NCT01483599|323511417|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
94470104|NCT01483599|323511418|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
94470105|NCT01483599|323511419|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
94470106|NCT01483599|323511420|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
94470107|NCT01483599|323511421|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
94470108|NCT01483599|323511422|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
94470109|NCT01483599|323511423|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
94470110|NCT01483599|323511424|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
94470111|NCT01483599|323511411|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
94470112|NCT01483599|323511412|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
94470113|NCT01483599|323511413|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
94470114|NCT01483599|323511414|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
94470115|NCT01483599|323511415|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
94470116|NCT01483599|323511416|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
94470117|NCT01483599|323511417|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
94470118|NCT01483599|323511418|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
94470119|NCT01483599|323511419|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
94470120|NCT01483599|323511420|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
94470121|NCT01483599|323511421|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
94470122|NCT01483599|323511422|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
94470123|NCT01483599|323511423|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
94470124|NCT01483599|323511424|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
94470125|NCT01483599|323511411|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
94470126|NCT01483599|323511412|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
94470127|NCT01483599|323511413|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
94470128|NCT01483599|323511414|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
94470129|NCT01483599|323511415|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
94470130|NCT01483599|323511416|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
94470131|NCT01483599|323511417|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
94470132|NCT01483599|323511418|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
94470133|NCT01483599|323511419|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
94470134|NCT01483599|323511420|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
94470135|NCT01483599|323511421|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
94470136|NCT01483599|323511422|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
94470137|NCT01483599|323511423|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
94470138|NCT01483599|323511424|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
94470139|NCT01483599|323511411|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
94470140|NCT01483599|323511412|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
94470141|NCT01483599|323511413|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
94470142|NCT01483599|323511414|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
94470143|NCT01483599|323511415|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
94470144|NCT01483599|323511416|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
94470145|NCT01483599|323511417|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
94470146|NCT01483599|323511418|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
94470147|NCT01483599|323511419|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
94470148|NCT01483599|323511420|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
94470149|NCT01483599|323511421|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
94470150|NCT01483599|323511422|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
94470151|NCT01483599|323511423|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
94470152|NCT01483599|323511424|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
94308143|NCT03894540|322911595|FG005|Overall Study|Withdrawal by Subject|0|||
94378978|NCT00996736|323172818|FG001|Overall Study|Death|1|||
94378979|NCT00996736|323172817|FG000|Overall Study|Lost to Follow-up|15|||
94378980|NCT00996736|323172818|FG001|Overall Study|Lost to Follow-up|14|||
94378981|NCT00996736|323172817|FG000|Overall Study|Visit not within 3-month window|5|||
94378982|NCT00996736|323172818|FG001|Overall Study|Visit not within 3-month window|3|||
94378983|NCT02688608|323172819|FG000|Overall Study|Lost to Follow-up|1|||
94378984|NCT02456909|323172820|FG000|Overall Study|Did not receive allocated intervention|24|||
94378985|NCT02456909|323172821|FG001|Overall Study|Did not receive allocated intervention|26|||
94378986|NCT02456909|323172820|FG000|Overall Study|Did not complete the primary outcome|0|||
94378987|NCT02456909|323172821|FG001|Overall Study|Did not complete the primary outcome|1|||
94378988|NCT04634409|323172822|FG000|Overall Study|Death|0|||
94378989|NCT04634409|323172823|FG001|Overall Study|Death|0|||
94378990|NCT04634409|323172824|FG002|Overall Study|Death|0|||
94378991|NCT04634409|323172825|FG003|Overall Study|Death|0|||
94378992|NCT04634409|323172826|FG004|Overall Study|Death|0|||
94378993|NCT04634409|323172827|FG005|Overall Study|Death|0|||
94378994|NCT04634409|323172828|FG006|Overall Study|Death|0|||
94378995|NCT04634409|323172829|FG007|Overall Study|Death|0|||
94378996|NCT04634409|323172830|FG008|Overall Study|Death|0|||
94378997|NCT04634409|323172831|FG009|Overall Study|Death|0|||
94378998|NCT04634409|323172832|FG010|Overall Study|Death|1|||
94378999|NCT04634409|323172833|FG011|Overall Study|Death|0|||
94379000|NCT04634409|323172834|FG012|Overall Study|Death|1|||
94379001|NCT04634409|323172835|FG013|Overall Study|Death|0|||
94379002|NCT04634409|323172836|FG014|Overall Study|Death|0|||
94379003|NCT04634409|323172837|FG015|Overall Study|Death|0|||
94379004|NCT04634409|323172838|FG016|Overall Study|Death|0|||
94379005|NCT04634409|323172839|FG017|Overall Study|Death|0|||
94379006|NCT04634409|323172840|FG018|Overall Study|Death|0|||
94379007|NCT04634409|323172841|FG019|Overall Study|Death|0|||
94379008|NCT04634409|323172842|FG020|Overall Study|Death|0|||
94379009|NCT04634409|323172843|FG021|Overall Study|Death|0|||
94379010|NCT04634409|323172844|FG022|Overall Study|Death|0|||
94379011|NCT04634409|323172845|FG023|Overall Study|Death|0|||
94379012|NCT04634409|323172846|FG024|Overall Study|Death|0|||
94379013|NCT04634409|323172847|FG025|Overall Study|Death|0|||
94379014|NCT04634409|323172848|FG026|Overall Study|Death|0|||
94379015|NCT04634409|323172822|FG000|Overall Study|Adverse Event|0|||
94379016|NCT04634409|323172823|FG001|Overall Study|Adverse Event|0|||
94379017|NCT04634409|323172824|FG002|Overall Study|Adverse Event|1|||
94379018|NCT04634409|323172825|FG003|Overall Study|Adverse Event|0|||
94379019|NCT04634409|323172826|FG004|Overall Study|Adverse Event|0|||
94379020|NCT04634409|323172827|FG005|Overall Study|Adverse Event|1|||
94379021|NCT04634409|323172828|FG006|Overall Study|Adverse Event|0|||
94379022|NCT04634409|323172829|FG007|Overall Study|Adverse Event|0|||
94379023|NCT04634409|323172830|FG008|Overall Study|Adverse Event|0|||
94379024|NCT04634409|323172831|FG009|Overall Study|Adverse Event|0|||
94379025|NCT04634409|323172832|FG010|Overall Study|Adverse Event|0|||
94379026|NCT04634409|323172833|FG011|Overall Study|Adverse Event|0|||
94379027|NCT04634409|323172834|FG012|Overall Study|Adverse Event|0|||
94379028|NCT04634409|323172835|FG013|Overall Study|Adverse Event|0|||
94379029|NCT04634409|323172836|FG014|Overall Study|Adverse Event|0|||
94379030|NCT04634409|323172837|FG015|Overall Study|Adverse Event|0|||
94379031|NCT04634409|323172838|FG016|Overall Study|Adverse Event|0|||
94379032|NCT04634409|323172839|FG017|Overall Study|Adverse Event|0|||
94379033|NCT04634409|323172840|FG018|Overall Study|Adverse Event|0|||
94379034|NCT04634409|323172841|FG019|Overall Study|Adverse Event|0|||
94379035|NCT04634409|323172842|FG020|Overall Study|Adverse Event|0|||
94379036|NCT04634409|323172843|FG021|Overall Study|Adverse Event|0|||
94379037|NCT04634409|323172844|FG022|Overall Study|Adverse Event|0|||
94379038|NCT04634409|323172845|FG023|Overall Study|Adverse Event|0|||
94379039|NCT04634409|323172846|FG024|Overall Study|Adverse Event|0|||
94379040|NCT04634409|323172847|FG025|Overall Study|Adverse Event|0|||
94379041|NCT04634409|323172848|FG026|Overall Study|Adverse Event|0|||
94379042|NCT04634409|323172822|FG000|Overall Study|Lost to Follow-up|3|||
94379043|NCT04634409|323172823|FG001|Overall Study|Lost to Follow-up|1|||
94379044|NCT04634409|323172824|FG002|Overall Study|Lost to Follow-up|1|||
94379045|NCT04634409|323172825|FG003|Overall Study|Lost to Follow-up|3|||
94379046|NCT04634409|323172826|FG004|Overall Study|Lost to Follow-up|1|||
94379047|NCT04634409|323172827|FG005|Overall Study|Lost to Follow-up|1|||
94379048|NCT04634409|323172828|FG006|Overall Study|Lost to Follow-up|1|||
94379049|NCT04634409|323172829|FG007|Overall Study|Lost to Follow-up|3|||
94379050|NCT04634409|323172830|FG008|Overall Study|Lost to Follow-up|3|||
94379051|NCT04634409|323172831|FG009|Overall Study|Lost to Follow-up|11|||
94379052|NCT04634409|323172832|FG010|Overall Study|Lost to Follow-up|8|||
94379053|NCT04634409|323172833|FG011|Overall Study|Lost to Follow-up|15|||
94379054|NCT04634409|323172834|FG012|Overall Study|Lost to Follow-up|3|||
94379055|NCT04634409|323172835|FG013|Overall Study|Lost to Follow-up|2|||
94379056|NCT04634409|323172836|FG014|Overall Study|Lost to Follow-up|7|||
94379057|NCT04634409|323172837|FG015|Overall Study|Lost to Follow-up|0|||
94379058|NCT04634409|323172838|FG016|Overall Study|Lost to Follow-up|0|||
94379059|NCT04634409|323172839|FG017|Overall Study|Lost to Follow-up|0|||
94379060|NCT04634409|323172840|FG018|Overall Study|Lost to Follow-up|0|||
94379061|NCT04634409|323172841|FG019|Overall Study|Lost to Follow-up|0|||
94379062|NCT04634409|323172842|FG020|Overall Study|Lost to Follow-up|0|||
94379063|NCT04634409|323172843|FG021|Overall Study|Lost to Follow-up|0|||
94379064|NCT04634409|323172844|FG022|Overall Study|Lost to Follow-up|0|||
94379065|NCT04634409|323172845|FG023|Overall Study|Lost to Follow-up|0|||
94379066|NCT04634409|323172846|FG024|Overall Study|Lost to Follow-up|0|||
94379067|NCT04634409|323172847|FG025|Overall Study|Lost to Follow-up|0|||
94379068|NCT04634409|323172848|FG026|Overall Study|Lost to Follow-up|0|||
94379069|NCT04634409|323172822|FG000|Overall Study|Withdrawal by Subject|3|||
94379070|NCT04634409|323172823|FG001|Overall Study|Withdrawal by Subject|1|||
94379071|NCT04634409|323172824|FG002|Overall Study|Withdrawal by Subject|6|||
94379072|NCT04634409|323172825|FG003|Overall Study|Withdrawal by Subject|4|||
94379073|NCT04634409|323172826|FG004|Overall Study|Withdrawal by Subject|2|||
94379074|NCT04634409|323172827|FG005|Overall Study|Withdrawal by Subject|0|||
94379075|NCT04634409|323172828|FG006|Overall Study|Withdrawal by Subject|0|||
94379076|NCT04634409|323172829|FG007|Overall Study|Withdrawal by Subject|2|||
94379077|NCT04634409|323172830|FG008|Overall Study|Withdrawal by Subject|3|||
94379078|NCT04634409|323172831|FG009|Overall Study|Withdrawal by Subject|2|||
94379079|NCT04634409|323172832|FG010|Overall Study|Withdrawal by Subject|3|||
94379080|NCT04634409|323172833|FG011|Overall Study|Withdrawal by Subject|2|||
94379081|NCT04634409|323172834|FG012|Overall Study|Withdrawal by Subject|2|||
94379082|NCT04634409|323172835|FG013|Overall Study|Withdrawal by Subject|1|||
94379083|NCT04634409|323172836|FG014|Overall Study|Withdrawal by Subject|5|||
94379084|NCT04634409|323172837|FG015|Overall Study|Withdrawal by Subject|0|||
94379085|NCT04634409|323172838|FG016|Overall Study|Withdrawal by Subject|0|||
94379086|NCT04634409|323172839|FG017|Overall Study|Withdrawal by Subject|1|||
94379087|NCT04634409|323172840|FG018|Overall Study|Withdrawal by Subject|0|||
94379088|NCT04634409|323172841|FG019|Overall Study|Withdrawal by Subject|0|||
94379089|NCT04634409|323172842|FG020|Overall Study|Withdrawal by Subject|0|||
94379090|NCT04634409|323172843|FG021|Overall Study|Withdrawal by Subject|0|||
94379091|NCT04634409|323172844|FG022|Overall Study|Withdrawal by Subject|0|||
94379092|NCT04634409|323172845|FG023|Overall Study|Withdrawal by Subject|1|||
94379093|NCT04634409|323172846|FG024|Overall Study|Withdrawal by Subject|0|||
94379094|NCT04634409|323172847|FG025|Overall Study|Withdrawal by Subject|0|||
94379095|NCT04634409|323172848|FG026|Overall Study|Withdrawal by Subject|0|||
94379096|NCT04634409|323172822|FG000|Overall Study|Other - As reported by Investigator|1|||
94379097|NCT04634409|323172823|FG001|Overall Study|Other - As reported by Investigator|0|||
94379098|NCT04634409|323172824|FG002|Overall Study|Other - As reported by Investigator|0|||
94379099|NCT04634409|323172825|FG003|Overall Study|Other - As reported by Investigator|0|||
94379100|NCT04634409|323172826|FG004|Overall Study|Other - As reported by Investigator|0|||
94379101|NCT04634409|323172827|FG005|Overall Study|Other - As reported by Investigator|0|||
94379102|NCT04634409|323172828|FG006|Overall Study|Other - As reported by Investigator|0|||
94379103|NCT04634409|323172829|FG007|Overall Study|Other - As reported by Investigator|6|||
94379104|NCT04634409|323172830|FG008|Overall Study|Other - As reported by Investigator|4|||
94379105|NCT04634409|323172831|FG009|Overall Study|Other - As reported by Investigator|0|||
94379106|NCT04634409|323172832|FG010|Overall Study|Other - As reported by Investigator|1|||
94379107|NCT04634409|323172833|FG011|Overall Study|Other - As reported by Investigator|2|||
94379108|NCT04634409|323172834|FG012|Overall Study|Other - As reported by Investigator|2|||
94379109|NCT04634409|323172835|FG013|Overall Study|Other - As reported by Investigator|1|||
94379110|NCT04634409|323172836|FG014|Overall Study|Other - As reported by Investigator|0|||
94379111|NCT04634409|323172837|FG015|Overall Study|Other - As reported by Investigator|0|||
94379112|NCT04634409|323172838|FG016|Overall Study|Other - As reported by Investigator|0|||
94379113|NCT04634409|323172839|FG017|Overall Study|Other - As reported by Investigator|0|||
94379114|NCT04634409|323172840|FG018|Overall Study|Other - As reported by Investigator|0|||
94379115|NCT04634409|323172841|FG019|Overall Study|Other - As reported by Investigator|0|||
94379116|NCT04634409|323172842|FG020|Overall Study|Other - As reported by Investigator|0|||
94379117|NCT04634409|323172843|FG021|Overall Study|Other - As reported by Investigator|0|||
94379118|NCT04634409|323172844|FG022|Overall Study|Other - As reported by Investigator|0|||
94379119|NCT04634409|323172845|FG023|Overall Study|Other - As reported by Investigator|0|||
94379120|NCT04634409|323172846|FG024|Overall Study|Other - As reported by Investigator|0|||
94379121|NCT04634409|323172847|FG025|Overall Study|Other - As reported by Investigator|0|||
94379122|NCT04634409|323172848|FG026|Overall Study|Other - As reported by Investigator|0|||
94379123|NCT01893138|323172849|FG000|Double-Blind Period|Withdrawal by Subject|1|||
94379124|NCT01893138|323172850|FG001|Double-Blind Period|Withdrawal by Subject|1|||
94379125|NCT01893138|323172849|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
94379126|NCT01893138|323172850|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
94379127|NCT01893138|323172849|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
94379128|NCT01893138|323172850|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
94379129|NCT01893138|323172849|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
94379130|NCT01893138|323172850|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
94379131|NCT01893138|323172849|FG000|Open Label - Unblinded Period|Adverse Event|1|||
94308144|NCT03894540|322911590|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
94308145|NCT03894540|322911591|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
94308146|NCT03894540|322911592|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
94308147|NCT03894540|322911593|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
94308148|NCT03894540|322911594|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
94308149|NCT03894540|322911595|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
94308150|NCT03894540|322911590|FG000|Overall Study|Progressive Disease Clinical|1|||
94308151|NCT03894540|322911591|FG001|Overall Study|Progressive Disease Clinical|1|||
94308152|NCT03894540|322911592|FG002|Overall Study|Progressive Disease Clinical|0|||
94308153|NCT03894540|322911593|FG003|Overall Study|Progressive Disease Clinical|1|||
94308154|NCT03894540|322911594|FG004|Overall Study|Progressive Disease Clinical|5|||
94308155|NCT03894540|322911595|FG005|Overall Study|Progressive Disease Clinical|1|||
94308156|NCT03894540|322911590|FG000|Overall Study|Study termination by sponsor|0|||
94308157|NCT03894540|322911591|FG001|Overall Study|Study termination by sponsor|0|||
94308158|NCT03894540|322911592|FG002|Overall Study|Study termination by sponsor|0|||
94308159|NCT03894540|322911593|FG003|Overall Study|Study termination by sponsor|0|||
94308160|NCT03894540|322911594|FG004|Overall Study|Study termination by sponsor|2|||
94308161|NCT03894540|322911595|FG005|Overall Study|Study termination by sponsor|0|||
94308162|NCT02441803|322911596|FG000|Overall Study|Physician Decision|0|||
94308163|NCT02441803|322911597|FG001|Overall Study|Physician Decision|2|||
94308164|NCT02441803|322911598|FG002|Overall Study|Physician Decision|2|||
94308165|NCT03043365|322911603|FG000|Weeks 0 to Week 8|Adverse Event|1|||
94308166|NCT03043365|322911604|FG001|Weeks 0 to Week 8|Adverse Event|3|||
94308167|NCT03043365|322911603|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
94308168|NCT03043365|322911604|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
94308169|NCT03043365|322911603|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
94308170|NCT03043365|322911604|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
94308171|NCT00593112|322911605|FG000|Overall Study|Scan Anxiety|3|||
94308172|NCT00593112|322911606|FG001|Overall Study|Scan Anxiety|0|||
94308173|NCT00593112|322911605|FG000|Overall Study|Abnormal Scan|1|||
94308174|NCT00593112|322911606|FG001|Overall Study|Abnormal Scan|0|||
94308175|NCT00593112|322911605|FG000|Overall Study|Unreadable Scan|1|||
94308176|NCT00593112|322911606|FG001|Overall Study|Unreadable Scan|0|||
94308177|NCT00593112|322911605|FG000|Overall Study|Withdrawal by Subject|5|||
94308178|NCT00593112|322911606|FG001|Overall Study|Withdrawal by Subject|0|||
94308179|NCT02498652|322911607|FG000|Overall Study|Protocol Violation|0|||
94308180|NCT02498652|322911608|FG001|Overall Study|Protocol Violation|1|||
94308181|NCT02873221|322911609|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
94308182|NCT02873221|322911610|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
94308183|NCT02873221|322911611|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
94308184|NCT02873221|322911609|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
94308185|NCT02873221|322911610|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
94308186|NCT02873221|322911611|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
94308187|NCT02873221|322911609|FG000|Treatment Period|Protocol Violation|2|||
94308188|NCT02873221|322911610|FG001|Treatment Period|Protocol Violation|5|||
94308189|NCT02873221|322911611|FG002|Treatment Period|Protocol Violation|8|||
94308190|NCT02873221|322911609|FG000|Treatment Period|Pregnancy|4|||
94308191|NCT02873221|322911610|FG001|Treatment Period|Pregnancy|6|||
94308192|NCT02873221|322911611|FG002|Treatment Period|Pregnancy|3|||
94308193|NCT02873221|322911609|FG000|Treatment Period|Lack of Qualifying Event|0|||
94308194|NCT02873221|322911610|FG001|Treatment Period|Lack of Qualifying Event|3|||
94308195|NCT02873221|322911611|FG002|Treatment Period|Lack of Qualifying Event|1|||
94308196|NCT02873221|322911609|FG000|Treatment Period|Withdrawal of Consent|52|||
94308197|NCT02873221|322911610|FG001|Treatment Period|Withdrawal of Consent|51|||
94308198|NCT02873221|322911611|FG002|Treatment Period|Withdrawal of Consent|41|||
94308199|NCT02873221|322911609|FG000|Treatment Period|Lack of Efficacy|0|||
94308200|NCT02873221|322911610|FG001|Treatment Period|Lack of Efficacy|17|||
94308201|NCT02873221|322911611|FG002|Treatment Period|Lack of Efficacy|12|||
94308202|NCT02873221|322911609|FG000|Treatment Period|Adverse Event|4|||
94308203|NCT02873221|322911610|FG001|Treatment Period|Adverse Event|9|||
94308204|NCT02873221|322911611|FG002|Treatment Period|Adverse Event|11|||
94379132|NCT01893138|323172850|FG001|Open Label - Unblinded Period|Adverse Event|0|||
94379133|NCT02154529|323172851|FG000|Overall Study|Death|1|||
94379134|NCT02154529|323172852|FG001|Overall Study|Death|1|||
94308205|NCT02873221|322911609|FG000|Treatment Period|Lost to Follow-up|26|||
94308206|NCT02873221|322911610|FG001|Treatment Period|Lost to Follow-up|30|||
94308207|NCT02873221|322911611|FG002|Treatment Period|Lost to Follow-up|26|||
94308208|NCT02873221|322911609|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
94308209|NCT02873221|322911610|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
94379135|NCT02154529|323172853|FG002|Overall Study|Death|5|||
94379136|NCT02154529|323172854|FG003|Overall Study|Death|1|||
94379137|NCT02154529|323172851|FG000|Overall Study|Termination of study by sponsor|2|||
94379138|NCT02154529|323172852|FG001|Overall Study|Termination of study by sponsor|2|||
94379139|NCT02154529|323172853|FG002|Overall Study|Termination of study by sponsor|3|||
94379140|NCT02154529|323172854|FG003|Overall Study|Termination of study by sponsor|1|||
94379141|NCT02154529|323172851|FG000|Overall Study|Lost to Follow-up|1|||
94379142|NCT02154529|323172852|FG001|Overall Study|Lost to Follow-up|0|||
94379143|NCT02154529|323172853|FG002|Overall Study|Lost to Follow-up|0|||
94379144|NCT02154529|323172854|FG003|Overall Study|Lost to Follow-up|0|||
94379145|NCT00365352|323172855|FG000|Overall Study|Adverse Event|6|||
94379146|NCT00365352|323172856|FG001|Overall Study|Adverse Event|7|||
94379147|NCT00365352|323172857|FG002|Overall Study|Adverse Event|8|||
94379148|NCT00365352|323172855|FG000|Overall Study|Participant Withdrew Consent|8|||
94379149|NCT00365352|323172856|FG001|Overall Study|Participant Withdrew Consent|3|||
94379150|NCT00365352|323172857|FG002|Overall Study|Participant Withdrew Consent|4|||
94379151|NCT00365352|323172855|FG000|Overall Study|Lack of Efficacy|3|||
94379152|NCT00365352|323172856|FG001|Overall Study|Lack of Efficacy|0|||
94379153|NCT00365352|323172857|FG002|Overall Study|Lack of Efficacy|0|||
94379154|NCT00365352|323172855|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
94379155|NCT00365352|323172856|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
94379156|NCT00365352|323172857|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
94379157|NCT00365352|323172855|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
94379158|NCT00365352|323172856|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
94379159|NCT00365352|323172857|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
94379160|NCT00365352|323172855|FG000|Overall Study|Lost to Follow-up|1|||
94379161|NCT00365352|323172856|FG001|Overall Study|Lost to Follow-up|1|||
94379162|NCT00365352|323172857|FG002|Overall Study|Lost to Follow-up|0|||
94379163|NCT00365352|323172855|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
94379164|NCT00365352|323172856|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
94379165|NCT00365352|323172857|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
94379166|NCT01326026|323172858|FG000|Overall Study|Adverse Event|4|||
94379167|NCT01326026|323172859|FG001|Overall Study|Adverse Event|3|||
94379168|NCT01326026|323172858|FG000|Overall Study|Withdrawal Criteria|5|||
94379169|NCT01326026|323172859|FG001|Overall Study|Withdrawal Criteria|7|||
94379170|NCT01326026|323172858|FG000|Overall Study|Other|3|||
94379171|NCT01326026|323172859|FG001|Overall Study|Other|3|||
94379172|NCT00409578|323172866|FG000|Overall Study|Adverse Event|27|||
94379173|NCT00409578|323172867|FG001|Overall Study|Adverse Event|37|||
94379174|NCT00409578|323172868|FG002|Overall Study|Adverse Event|25|||
94379175|NCT00409578|323172869|FG003|Overall Study|Adverse Event|33|||
94379176|NCT00409578|323172866|FG000|Overall Study|Abnormal laboratory value(s)|2|||
94379177|NCT00409578|323172867|FG001|Overall Study|Abnormal laboratory value(s)|2|||
94379178|NCT00409578|323172868|FG002|Overall Study|Abnormal laboratory value(s)|2|||
94379179|NCT00409578|323172869|FG003|Overall Study|Abnormal laboratory value(s)|4|||
94379180|NCT00409578|323172866|FG000|Overall Study|Lack of Efficacy|0|||
94379181|NCT00409578|323172867|FG001|Overall Study|Lack of Efficacy|0|||
94379182|NCT00409578|323172868|FG002|Overall Study|Lack of Efficacy|0|||
94379183|NCT00409578|323172869|FG003|Overall Study|Lack of Efficacy|2|||
94379184|NCT00409578|323172866|FG000|Overall Study|Subject no longer requires study drug|0|||
94379185|NCT00409578|323172867|FG001|Overall Study|Subject no longer requires study drug|0|||
94379186|NCT00409578|323172868|FG002|Overall Study|Subject no longer requires study drug|0|||
94379187|NCT00409578|323172869|FG003|Overall Study|Subject no longer requires study drug|1|||
94379188|NCT00409578|323172866|FG000|Overall Study|Withdrawal by Subject|8|||
94379189|NCT00409578|323172867|FG001|Overall Study|Withdrawal by Subject|15|||
94379190|NCT00409578|323172868|FG002|Overall Study|Withdrawal by Subject|16|||
94379191|NCT00409578|323172869|FG003|Overall Study|Withdrawal by Subject|17|||
94379192|NCT00409578|323172866|FG000|Overall Study|Lost to Follow-up|2|||
94379193|NCT00409578|323172867|FG001|Overall Study|Lost to Follow-up|0|||
94379194|NCT00409578|323172868|FG002|Overall Study|Lost to Follow-up|2|||
94379195|NCT00409578|323172869|FG003|Overall Study|Lost to Follow-up|2|||
94379196|NCT00409578|323172866|FG000|Overall Study|Administrative problems|8|||
94379197|NCT00409578|323172867|FG001|Overall Study|Administrative problems|9|||
94379198|NCT00409578|323172868|FG002|Overall Study|Administrative problems|2|||
94379199|NCT00409578|323172869|FG003|Overall Study|Administrative problems|4|||
94379200|NCT00409578|323172866|FG000|Overall Study|Death|2|||
94379201|NCT00409578|323172867|FG001|Overall Study|Death|4|||
94379202|NCT00409578|323172868|FG002|Overall Study|Death|4|||
94379203|NCT00409578|323172869|FG003|Overall Study|Death|2|||
94379204|NCT00409578|323172866|FG000|Overall Study|Protocol Violation|3|||
94379205|NCT00409578|323172867|FG001|Overall Study|Protocol Violation|2|||
94379206|NCT00409578|323172868|FG002|Overall Study|Protocol Violation|3|||
94379207|NCT00409578|323172869|FG003|Overall Study|Protocol Violation|1|||
94379208|NCT00409578|323172866|FG000|Overall Study|Missing|0|||
94379209|NCT00409578|323172867|FG001|Overall Study|Missing|1|||
94379210|NCT00409578|323172868|FG002|Overall Study|Missing|0|||
94379211|NCT00409578|323172869|FG003|Overall Study|Missing|1|||
94379212|NCT02683187|323172870|FG000|Overall Study|Failed IV access|3|||
94308210|NCT02873221|322911611|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
94308211|NCT02873221|322911609|FG000|Safety Follow-up Period|Protocol Violation|0|||
94308212|NCT02873221|322911610|FG001|Safety Follow-up Period|Protocol Violation|0|||
94308213|NCT02873221|322911611|FG002|Safety Follow-up Period|Protocol Violation|1|||
94308214|NCT02873221|322911609|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
94308215|NCT02873221|322911610|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
94308216|NCT02873221|322911611|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
94308217|NCT02873221|322911609|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
94308218|NCT02873221|322911610|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
94308219|NCT02873221|322911611|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
94308220|NCT00852930|322911612|FG000|Overall Study|Withdrawal by Subject|1|||
94308221|NCT00852930|322911613|FG001|Overall Study|Withdrawal by Subject|1|||
94308222|NCT00852930|322911614|FG002|Overall Study|Withdrawal by Subject|1|||
94308223|NCT00852930|322911612|FG000|Overall Study|Physician Decision|0|||
94308224|NCT00852930|322911613|FG001|Overall Study|Physician Decision|0|||
94308225|NCT00852930|322911614|FG002|Overall Study|Physician Decision|1|||
94308226|NCT00779038|322911615|FG000|Overall Study|Study Prematurely Terminated|13|||
94308227|NCT01570491|322911616|FG000|Overall Study|Lost to Follow-up|3|||
94308228|NCT01570491|322911617|FG001|Overall Study|Lost to Follow-up|1|||
94308229|NCT01570491|322911616|FG000|Overall Study|treatment: not given or discontinued|2|||
94308230|NCT01570491|322911617|FG001|Overall Study|treatment: not given or discontinued|0|||
94308231|NCT03700892|322911618|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
94308232|NCT03700892|322911619|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
94308233|NCT03700892|322911620|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
94308234|NCT00922935|322911621|FG000|Overall Study|Protocol Violation|0|||
94308235|NCT00922935|322911622|FG001|Overall Study|Protocol Violation|3|||
94308236|NCT00922935|322911623|FG002|Overall Study|Protocol Violation|0|||
94308237|NCT00922935|322911621|FG000|Overall Study|Physician Decision|1|||
94308238|NCT00922935|322911622|FG001|Overall Study|Physician Decision|1|||
94308239|NCT00922935|322911623|FG002|Overall Study|Physician Decision|0|||
94308240|NCT00922935|322911621|FG000|Overall Study|Lost to Follow-up|0|||
94308241|NCT00922935|322911622|FG001|Overall Study|Lost to Follow-up|1|||
94308242|NCT00922935|322911623|FG002|Overall Study|Lost to Follow-up|0|||
94308243|NCT00650585|322911624|FG000|Overall Study|Lost to Follow-up|505|||
94308244|NCT00650585|322911625|FG001|Overall Study|Lost to Follow-up|482|||
94308245|NCT00650585|322911624|FG000|Overall Study|No parental consent|935|||
94308246|NCT00650585|322911625|FG001|Overall Study|No parental consent|866|||
94308247|NCT00650585|322911624|FG000|Overall Study|Excluded/ruled ineligible|357|||
94308248|NCT00650585|322911625|FG001|Overall Study|Excluded/ruled ineligible|129|||
94308249|NCT04530825|322911626|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
94308250|NCT04530825|322911627|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
94308251|NCT04530825|322911628|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
94308252|NCT04530825|322911629|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
94308253|NCT04530825|322911626|FG000|Overall Study|Did not complete follow-up|3|||
94308254|NCT04530825|322911627|FG001|Overall Study|Did not complete follow-up|0|||
94308255|NCT04530825|322911628|FG002|Overall Study|Did not complete follow-up|0|||
94308256|NCT04530825|322911629|FG003|Overall Study|Did not complete follow-up|0|||
94308257|NCT04101422|322911631|FG000|Overall Study|Ineligible|1|||
94308258|NCT04101422|322911632|FG001|Overall Study|Ineligible|0|||
94308259|NCT04101422|322911633|FG002|Overall Study|Ineligible|9|||
94308260|NCT04101422|322911634|FG003|Overall Study|Ineligible|0|||
94308261|NCT04101422|322911631|FG000|Overall Study|Withdrawal by Subject|0|||
94308262|NCT04101422|322911632|FG001|Overall Study|Withdrawal by Subject|0|||
94308263|NCT04101422|322911633|FG002|Overall Study|Withdrawal by Subject|1|||
94308264|NCT04101422|322911634|FG003|Overall Study|Withdrawal by Subject|0|||
94308265|NCT04101422|322911631|FG000|Overall Study|Not attending to the stimuli|0|||
94308266|NCT04101422|322911632|FG001|Overall Study|Not attending to the stimuli|0|||
94308267|NCT04101422|322911633|FG002|Overall Study|Not attending to the stimuli|4|||
94308268|NCT04101422|322911634|FG003|Overall Study|Not attending to the stimuli|0|||
94308269|NCT04101422|322911631|FG000|Overall Study|Did not download app|0|||
94308270|NCT04101422|322911632|FG001|Overall Study|Did not download app|0|||
94308271|NCT04101422|322911633|FG002|Overall Study|Did not download app|0|||
94308272|NCT04101422|322911634|FG003|Overall Study|Did not download app|17|||
94308273|NCT04101422|322911631|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
94308274|NCT04101422|322911632|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
94308275|NCT04101422|322911633|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
94308276|NCT04101422|322911634|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
94308277|NCT04407507|322911635|FG000|Overall Study|Withdrawal by Subject|0|||
94308278|NCT04407507|322911636|FG001|Overall Study|Withdrawal by Subject|1|||
94308279|NCT00850499|322911637|FG000|Overall Study|Adverse Event|3|||
94308280|NCT00850499|322911638|FG001|Overall Study|Adverse Event|1|||
94308281|NCT00850499|322911637|FG000|Overall Study|Lack of Efficacy|0|||
94308282|NCT00850499|322911638|FG001|Overall Study|Lack of Efficacy|1|||
94308283|NCT00658333|322911641|FG000|Overall Study|Adverse Event|2|||
94308284|NCT00658333|322911642|FG001|Overall Study|Adverse Event|1|||
94308285|NCT01751646|322911645|FG000|Overall Study|Lost to Follow-up|5|||
94308286|NCT01751646|322911646|FG001|Overall Study|Lost to Follow-up|1|||
94308287|NCT01751646|322911645|FG000|Overall Study|Withdrawal by Subject|0|||
94308288|NCT01751646|322911646|FG001|Overall Study|Withdrawal by Subject|4|||
94379213|NCT02683187|323172870|FG000|Overall Study|Withdrawal by Subject|5|||
94379214|NCT02585258|323172871|FG000|Overall Study|Adverse Event|28|||
94308289|NCT01751646|322911645|FG000|Overall Study|Starting hormone therapy|1|||
94308290|NCT01751646|322911646|FG001|Overall Study|Starting hormone therapy|0|||
94308291|NCT01751646|322911645|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
94308292|NCT01751646|322911646|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
94308293|NCT01751646|322911645|FG000|Overall Study|Inadvertent enrollment|1|||
94308294|NCT01751646|322911646|FG001|Overall Study|Inadvertent enrollment|1|||
94379215|NCT02585258|323172872|FG001|Overall Study|Adverse Event|29|||
94379216|NCT02585258|323172871|FG000|Overall Study|Death|3|||
94379217|NCT02585258|323172872|FG001|Overall Study|Death|2|||
94379218|NCT02585258|323172871|FG000|Overall Study|Lack of Efficacy|7|||
94379219|NCT02585258|323172872|FG001|Overall Study|Lack of Efficacy|9|||
94379220|NCT02585258|323172871|FG000|Overall Study|includes covid-related access problems|42|||
94379221|NCT02585258|323172872|FG001|Overall Study|includes covid-related access problems|46|||
94379222|NCT02585258|323172871|FG000|Overall Study|Lost to Follow-up|5|||
94379223|NCT02585258|323172872|FG001|Overall Study|Lost to Follow-up|2|||
94379224|NCT00555009|323174694|FG000|Overall Study|Withdrawal by Subject|0|||
94379225|NCT00555009|323174695|FG001|Overall Study|Withdrawal by Subject|1|||
94379226|NCT00555009|323174694|FG000|Overall Study|Terminated by Sponsor|2|||
94379227|NCT00555009|323174695|FG001|Overall Study|Terminated by Sponsor|5|||
94379228|NCT02961920|323174696|FG000|Overall Study|did not achive stydy protocol schedule|1|||
94379229|NCT02961920|323174697|FG001|Overall Study|did not achive stydy protocol schedule|1|||
94379230|NCT01927757|323174702|FG000|Overall Study|Withdrawal by Subject|14|||
94379231|NCT01927757|323174702|FG000|Overall Study|Lost to Follow-up|2|||
94379232|NCT01927757|323174702|FG000|Overall Study|Decision by Sponsor|2|||
94379233|NCT01927757|323174702|FG000|Overall Study|Other|1|||
94379234|NCT01927757|323174702|FG000|Overall Study|Ethical Reasons|4|||
94379235|NCT01909466|323174703|FG000|Overall Study|Lost to Follow-up|5|||
94379236|NCT01909466|323174704|FG001|Overall Study|Lost to Follow-up|7|||
94379237|NCT01909466|323174703|FG000|Overall Study|Adverse Event|3|||
94379238|NCT01909466|323174704|FG001|Overall Study|Adverse Event|4|||
94379239|NCT01909466|323174703|FG000|Overall Study|Met Withdrawal Criteria|0|||
94379240|NCT01909466|323174704|FG001|Overall Study|Met Withdrawal Criteria|3|||
94379241|NCT01909466|323174703|FG000|Overall Study|Physician Decision|2|||
94379242|NCT01909466|323174704|FG001|Overall Study|Physician Decision|0|||
94379243|NCT01909466|323174703|FG000|Overall Study|Withdrawal by Subject|11|||
94379244|NCT01909466|323174704|FG001|Overall Study|Withdrawal by Subject|9|||
94379245|NCT01909466|323174703|FG000|Overall Study|Lack of Efficacy|1|||
94379246|NCT01909466|323174704|FG001|Overall Study|Lack of Efficacy|0|||
94379247|NCT04480463|323174705|FG000|Overall Study|Death|0|||
94379248|NCT04480463|323174706|FG001|Overall Study|Death|1|||
94379249|NCT04480463|323174705|FG000|Overall Study|Adverse Event|6|||
94379250|NCT04480463|323174706|FG001|Overall Study|Adverse Event|8|||
94379251|NCT04480463|323174705|FG000|Overall Study|Lost to Follow-up|3|||
94379252|NCT04480463|323174706|FG001|Overall Study|Lost to Follow-up|2|||
94379253|NCT04480463|323174705|FG000|Overall Study|Physician Decision|2|||
94379254|NCT04480463|323174706|FG001|Overall Study|Physician Decision|5|||
94379255|NCT04480463|323174705|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
94379256|NCT04480463|323174706|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
94379257|NCT04480463|323174705|FG000|Overall Study|Protocol Violation|2|||
94379258|NCT04480463|323174706|FG001|Overall Study|Protocol Violation|1|||
94379259|NCT04480463|323174705|FG000|Overall Study|Withdrawal by Subject|6|||
94379260|NCT04480463|323174706|FG001|Overall Study|Withdrawal by Subject|7|||
94379261|NCT04480463|323174705|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
94379262|NCT04480463|323174706|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
94379263|NCT04480463|323174705|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
94379264|NCT04480463|323174706|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
94379265|NCT04480463|323174705|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
94379266|NCT04480463|323174706|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
94379267|NCT04480463|323174705|FG000|Overall Study|Other|6|||
94379268|NCT04480463|323174706|FG001|Overall Study|Other|4|||
94379269|NCT01691859|323174708|FG000|Overall Study|Adverse Event|19|||
94379270|NCT01691859|323174708|FG000|Overall Study|Lack of Efficacy|11|||
94379271|NCT01691859|323174708|FG000|Overall Study|Protocol Violation|4|||
94379272|NCT01691859|323174708|FG000|Overall Study|Product commercially available|221|||
94379273|NCT01691859|323174708|FG000|Overall Study|Study closed/terminated|50|||
94379274|NCT01691859|323174708|FG000|Overall Study|Lost to Follow-up|5|||
94379275|NCT01691859|323174708|FG000|Overall Study|Physician Decision|6|||
94379276|NCT01691859|323174708|FG000|Overall Study|Withdrawal by Subject|31|||
94379277|NCT00124020|323174712|FG000|Overall Study|Death|67|||
94379278|NCT00124020|323174713|FG001|Overall Study|Death|71|||
94379279|NCT00124020|323174712|FG000|Overall Study|Withdrawal by Subject|13|||
94379280|NCT00124020|323174713|FG001|Overall Study|Withdrawal by Subject|11|||
94379281|NCT00124020|323174712|FG000|Overall Study|Lost to Follow-up|5|||
94379282|NCT00124020|323174713|FG001|Overall Study|Lost to Follow-up|8|||
94379283|NCT00124020|323174712|FG000|Overall Study|Other|1|||
94379284|NCT00124020|323174713|FG001|Overall Study|Other|1|||
94379285|NCT00124020|323174712|FG000|Overall Study|Transfer to another hospital|2|||
94470153|NCT01483599|323511411|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
94470154|NCT01483599|323511412|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
94470155|NCT01483599|323511413|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
94470156|NCT01483599|323511414|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
94470157|NCT01483599|323511415|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
94470158|NCT01483599|323511416|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
94470159|NCT01483599|323511417|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
94470160|NCT01483599|323511418|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
94470161|NCT01483599|323511419|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
94470162|NCT01483599|323511420|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
94470163|NCT01483599|323511421|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
94470164|NCT01483599|323511422|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
94470165|NCT01483599|323511423|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
94470166|NCT01483599|323511424|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
94379286|NCT00124020|323174713|FG001|Overall Study|Transfer to another hospital|0|||
94379287|NCT03731182|323174716|FG000|Overall Study|Lost to Follow-up|2|||
94379288|NCT03731182|323174717|FG001|Overall Study|Lost to Follow-up|0|||
94379289|NCT03731182|323174716|FG000|Overall Study|Physician Decision|1|||
94379290|NCT03731182|323174717|FG001|Overall Study|Physician Decision|0|||
94379291|NCT03731182|323174716|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
94379292|NCT03731182|323174717|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
94379293|NCT00268346|323174718|FG000|Overall Study|Adverse Event|0|||
94379294|NCT00268346|323174719|FG001|Overall Study|Adverse Event|1|||
94379295|NCT00268346|323174718|FG000|Overall Study|Death|0|||
94470167|NCT01483599|323511411|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
94470168|NCT01483599|323511412|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
94470169|NCT01483599|323511413|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
94470170|NCT01483599|323511414|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
94470171|NCT01483599|323511415|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
94470172|NCT01483599|323511416|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
94470173|NCT01483599|323511417|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
94470174|NCT01483599|323511418|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
94379296|NCT00268346|323174719|FG001|Overall Study|Death|1|||
94379297|NCT00268346|323174718|FG000|Overall Study|Withdrawal by Subject|0|||
94379298|NCT00268346|323174719|FG001|Overall Study|Withdrawal by Subject|1|||
94379299|NCT00613574|323174720|FG000|Overall Study|Adverse Event|3|||
94379300|NCT00613574|323174720|FG000|Overall Study|Lost to Follow-up|2|||
94379301|NCT00613574|323174720|FG000|Overall Study|Other|1|||
94379302|NCT00582036|323174722|FG000|Overall Study|Withdrawal by Subject|0|||
94379303|NCT00582036|323174723|FG001|Overall Study|Withdrawal by Subject|1|||
94379304|NCT02711956|323174724|FG000|Overall Study|Adverse Event|0|||
94379305|NCT02711956|323174725|FG001|Overall Study|Adverse Event|0|||
94379306|NCT02711956|323174726|FG002|Overall Study|Adverse Event|0|||
94379307|NCT02711956|323174727|FG003|Overall Study|Adverse Event|1|||
94379308|NCT02711956|323174728|FG004|Overall Study|Adverse Event|2|||
94379309|NCT02711956|323174729|FG005|Overall Study|Adverse Event|0|||
94379310|NCT02711956|323174730|FG006|Overall Study|Adverse Event|0|||
94379311|NCT02711956|323174731|FG007|Overall Study|Adverse Event|1|||
94379312|NCT02711956|323174732|FG008|Overall Study|Adverse Event|1|||
94379313|NCT02711956|323174733|FG009|Overall Study|Adverse Event|1|||
94379314|NCT02711956|323174734|FG010|Overall Study|Adverse Event|1|||
94379315|NCT02711956|323174735|FG011|Overall Study|Adverse Event|0|||
94379316|NCT02711956|323174736|FG012|Overall Study|Adverse Event|0|||
94379317|NCT02711956|323174737|FG013|Overall Study|Adverse Event|0|||
94379318|NCT02711956|323174738|FG014|Overall Study|Adverse Event|2|||
94379319|NCT02711956|323174724|FG000|Overall Study|Physician Decision|0|||
94470175|NCT01483599|323511419|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
94470176|NCT01483599|323511420|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
94470177|NCT01483599|323511421|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
94470178|NCT01483599|323511422|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
94379320|NCT02711956|323174725|FG001|Overall Study|Physician Decision|0|||
94470179|NCT01483599|323511423|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
94379321|NCT02711956|323174726|FG002|Overall Study|Physician Decision|0|||
94379322|NCT02711956|323174727|FG003|Overall Study|Physician Decision|2|||
94379323|NCT02711956|323174728|FG004|Overall Study|Physician Decision|0|||
94379324|NCT02711956|323174729|FG005|Overall Study|Physician Decision|0|||
94379325|NCT02711956|323174730|FG006|Overall Study|Physician Decision|0|||
94379326|NCT02711956|323174731|FG007|Overall Study|Physician Decision|0|||
94379327|NCT02711956|323174732|FG008|Overall Study|Physician Decision|0|||
94379328|NCT02711956|323174733|FG009|Overall Study|Physician Decision|0|||
94379329|NCT02711956|323174734|FG010|Overall Study|Physician Decision|0|||
94379330|NCT02711956|323174735|FG011|Overall Study|Physician Decision|0|||
94379331|NCT02711956|323174736|FG012|Overall Study|Physician Decision|0|||
94379332|NCT02711956|323174737|FG013|Overall Study|Physician Decision|0|||
94379333|NCT02711956|323174738|FG014|Overall Study|Physician Decision|0|||
94379334|NCT02711956|323174724|FG000|Overall Study|Withdrawal by Subject|0|||
94379335|NCT02711956|323174725|FG001|Overall Study|Withdrawal by Subject|0|||
94379336|NCT02711956|323174726|FG002|Overall Study|Withdrawal by Subject|0|||
94379337|NCT02711956|323174727|FG003|Overall Study|Withdrawal by Subject|0|||
94379338|NCT02711956|323174728|FG004|Overall Study|Withdrawal by Subject|0|||
94379339|NCT02711956|323174729|FG005|Overall Study|Withdrawal by Subject|0|||
94379340|NCT02711956|323174730|FG006|Overall Study|Withdrawal by Subject|1|||
94379341|NCT02711956|323174731|FG007|Overall Study|Withdrawal by Subject|0|||
94379342|NCT02711956|323174732|FG008|Overall Study|Withdrawal by Subject|0|||
94379343|NCT02711956|323174733|FG009|Overall Study|Withdrawal by Subject|0|||
94379344|NCT02711956|323174734|FG010|Overall Study|Withdrawal by Subject|0|||
94379345|NCT02711956|323174735|FG011|Overall Study|Withdrawal by Subject|1|||
94379346|NCT02711956|323174736|FG012|Overall Study|Withdrawal by Subject|6|||
94379347|NCT02711956|323174737|FG013|Overall Study|Withdrawal by Subject|0|||
94379348|NCT02711956|323174738|FG014|Overall Study|Withdrawal by Subject|1|||
94379349|NCT02711956|323174724|FG000|Overall Study|Clinical progression|1|||
94379350|NCT02711956|323174725|FG001|Overall Study|Clinical progression|0|||
94379351|NCT02711956|323174726|FG002|Overall Study|Clinical progression|0|||
94379352|NCT02711956|323174727|FG003|Overall Study|Clinical progression|0|||
94379353|NCT02711956|323174728|FG004|Overall Study|Clinical progression|0|||
94379354|NCT02711956|323174729|FG005|Overall Study|Clinical progression|0|||
94379355|NCT02711956|323174730|FG006|Overall Study|Clinical progression|1|||
94379356|NCT02711956|323174731|FG007|Overall Study|Clinical progression|0|||
94379357|NCT02711956|323174732|FG008|Overall Study|Clinical progression|1|||
94379358|NCT02711956|323174733|FG009|Overall Study|Clinical progression|0|||
94379359|NCT02711956|323174734|FG010|Overall Study|Clinical progression|0|||
94379360|NCT02711956|323174735|FG011|Overall Study|Clinical progression|2|||
94379361|NCT02711956|323174736|FG012|Overall Study|Clinical progression|4|||
94379362|NCT02711956|323174737|FG013|Overall Study|Clinical progression|1|||
94379363|NCT02711956|323174738|FG014|Overall Study|Clinical progression|1|||
94379364|NCT02711956|323174724|FG000|Overall Study|Radiographic progression|1|||
94379365|NCT02711956|323174725|FG001|Overall Study|Radiographic progression|1|||
94379366|NCT02711956|323174726|FG002|Overall Study|Radiographic progression|2|||
94379367|NCT02711956|323174727|FG003|Overall Study|Radiographic progression|0|||
94379368|NCT02711956|323174728|FG004|Overall Study|Radiographic progression|1|||
94379369|NCT02711956|323174729|FG005|Overall Study|Radiographic progression|0|||
94379370|NCT02711956|323174730|FG006|Overall Study|Radiographic progression|0|||
94308295|NCT01751646|322911645|FG000|Overall Study|Moved out of the area|1|||
94308296|NCT01751646|322911646|FG001|Overall Study|Moved out of the area|5|||
94308297|NCT01751646|322911645|FG000|Overall Study|Inability to attend required visits|0|||
94308298|NCT01751646|322911646|FG001|Overall Study|Inability to attend required visits|1|||
94308299|NCT01751646|322911645|FG000|Overall Study|Off study due to multiple obligations|0|||
94308300|NCT01751646|322911646|FG001|Overall Study|Off study due to multiple obligations|1|||
94308301|NCT01751646|322911645|FG000|Overall Study|Fails to comply with study requirements|0|||
94308302|NCT01751646|322911646|FG001|Overall Study|Fails to comply with study requirements|1|||
94379371|NCT02711956|323174731|FG007|Overall Study|Radiographic progression|0|||
94379372|NCT02711956|323174732|FG008|Overall Study|Radiographic progression|2|||
94379373|NCT02711956|323174733|FG009|Overall Study|Radiographic progression|1|||
94379374|NCT02711956|323174734|FG010|Overall Study|Radiographic progression|0|||
94379375|NCT02711956|323174735|FG011|Overall Study|Radiographic progression|5|||
94379376|NCT02711956|323174736|FG012|Overall Study|Radiographic progression|3|||
94379377|NCT02711956|323174737|FG013|Overall Study|Radiographic progression|0|||
94379378|NCT02711956|323174738|FG014|Overall Study|Radiographic progression|1|||
94379379|NCT02711956|323174724|FG000|Overall Study|PSA progression with clinical progression|0|||
94379380|NCT02711956|323174725|FG001|Overall Study|PSA progression with clinical progression|0|||
94379381|NCT02711956|323174726|FG002|Overall Study|PSA progression with clinical progression|0|||
94379382|NCT02711956|323174727|FG003|Overall Study|PSA progression with clinical progression|0|||
94379383|NCT02711956|323174728|FG004|Overall Study|PSA progression with clinical progression|1|||
94379384|NCT02711956|323174729|FG005|Overall Study|PSA progression with clinical progression|0|||
94379385|NCT02711956|323174730|FG006|Overall Study|PSA progression with clinical progression|0|||
94379386|NCT02711956|323174731|FG007|Overall Study|PSA progression with clinical progression|0|||
94308303|NCT01751646|322911645|FG000|Overall Study|Childcare issues|1|||
94308304|NCT01751646|322911646|FG001|Overall Study|Childcare issues|1|||
94308305|NCT00945191|322911647|FG000|Overall Study|Did not achieve a complete response|18|||
94308306|NCT00945191|322911647|FG000|Overall Study|Participant relocated to another state|1|||
94308307|NCT00945191|322911647|FG000|Overall Study|Disease progression|3|||
94308308|NCT00945191|322911647|FG000|Overall Study|Serious adverse event or adverse event|1|||
94308309|NCT00945191|322911647|FG000|Overall Study|Investigator's discretion|1|||
94308310|NCT00847561|322911650|FG000|Overall Study|Withdrawal by Subject|4|||
94308311|NCT00847561|322911651|FG001|Overall Study|Withdrawal by Subject|3|||
94308312|NCT00847561|322911650|FG000|Overall Study|Unable to schedule|9|||
94308313|NCT00847561|322911651|FG001|Overall Study|Unable to schedule|1|||
94308314|NCT05253807|322911655|FG000|Overall Study|Death|1|||
94308315|NCT05253807|322911656|FG001|Overall Study|Death|4|||
94308316|NCT05253807|322911655|FG000|Overall Study|Withdrawal by Subject|1|||
94308317|NCT05253807|322911656|FG001|Overall Study|Withdrawal by Subject|0|||
94308318|NCT05253807|322911655|FG000|Overall Study|Study Terminated by Sponsor|1|||
94308319|NCT05253807|322911656|FG001|Overall Study|Study Terminated by Sponsor|1|||
94308320|NCT01137435|322911661|FG000|Overall Study|Lost to Follow-up|24|||
94308321|NCT01137435|322911661|FG000|Overall Study|Off label usage|4|||
94308322|NCT00399802|322911664|FG000|Overall Study|Adverse Event|0|||
94308323|NCT00399802|322911665|FG001|Overall Study|Adverse Event|2|||
94308324|NCT00399802|322911664|FG000|Overall Study|Participant discontinued by mistake|0|||
94308325|NCT00399802|322911665|FG001|Overall Study|Participant discontinued by mistake|1|||
94308326|NCT00081289|322911669|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
94308327|NCT00081289|322911670|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
94308328|NCT00081289|322911669|FG000|Overall Study|Ineligible / no protocol treatment|3|||
94308329|NCT00081289|322911670|FG001|Overall Study|Ineligible / no protocol treatment|4|||
94308330|NCT02640612|322913258|FG000|Overall Study|Adverse Event|6|||
94308331|NCT02640612|322913259|FG001|Overall Study|Adverse Event|7|||
94308332|NCT02640612|322913260|FG002|Overall Study|Adverse Event|2|||
94308333|NCT02640612|322913258|FG000|Overall Study|Death|1|||
94308334|NCT02640612|322913259|FG001|Overall Study|Death|0|||
94308335|NCT02640612|322913260|FG002|Overall Study|Death|0|||
94308336|NCT02640612|322913258|FG000|Overall Study|Withdrawal by Subject|10|||
94308337|NCT02640612|322913259|FG001|Overall Study|Withdrawal by Subject|3|||
94308338|NCT02640612|322913260|FG002|Overall Study|Withdrawal by Subject|3|||
94308339|NCT02640612|322913258|FG000|Overall Study|Lost to Follow-up|4|||
94308340|NCT02640612|322913259|FG001|Overall Study|Lost to Follow-up|1|||
94470180|NCT01483599|323511424|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
94470181|NCT02494401|323511426|FG000|Overall Study|Lost to Follow-up|22|||
94308341|NCT02640612|322913260|FG002|Overall Study|Lost to Follow-up|1|||
94308342|NCT02640612|322913258|FG000|Overall Study|Protocol Violation|0|||
94308343|NCT02640612|322913259|FG001|Overall Study|Protocol Violation|2|||
94308344|NCT02640612|322913260|FG002|Overall Study|Protocol Violation|0|||
94308345|NCT02640612|322913258|FG000|Overall Study|Lack of Efficacy|1|||
94308346|NCT02640612|322913259|FG001|Overall Study|Lack of Efficacy|1|||
94308347|NCT02640612|322913260|FG002|Overall Study|Lack of Efficacy|0|||
94308348|NCT01849848|322913262|FG000|Overall Study|Physician Decision|1|||
94308349|NCT01849848|322913262|FG000|Overall Study|Progression of the primary disease|3|||
94308350|NCT01319929|322913269|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
94308351|NCT01319929|322913270|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
94308352|NCT01319929|322913269|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
94308353|NCT01319929|322913270|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
94308354|NCT01319929|322913269|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
94308355|NCT01319929|322913270|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
94308356|NCT01319929|322913269|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
94308357|NCT01319929|322913270|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
94308358|NCT01319929|322913269|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
94308359|NCT01319929|322913270|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
94308360|NCT00258154|322913274|FG000|Overall Study|Adverse Event|1|||
94308361|NCT00258154|322913275|FG001|Overall Study|Adverse Event|0|||
94308362|NCT00258154|322913274|FG000|Overall Study|Lost to Follow-up|0|||
94308363|NCT00258154|322913275|FG001|Overall Study|Lost to Follow-up|1|||
94308364|NCT00258154|322913274|FG000|Overall Study|Protocol Violation|2|||
94308365|NCT00258154|322913275|FG001|Overall Study|Protocol Violation|1|||
94308366|NCT00258154|322913274|FG000|Overall Study|Withdrawal by Subject|3|||
94308367|NCT00258154|322913275|FG001|Overall Study|Withdrawal by Subject|4|||
94308368|NCT00258154|322913274|FG000|Overall Study|Patient Moved|3|||
94308369|NCT00258154|322913275|FG001|Overall Study|Patient Moved|1|||
94308370|NCT02460822|322913280|FG000|Overall Study|Withdrawal by Subject|1|||
94308371|NCT03114969|322913283|FG000|Overall Study|Lost to Follow-up|0|||
94308372|NCT03114969|322913284|FG001|Overall Study|Lost to Follow-up|0|||
94308373|NCT03114969|322913285|FG002|Overall Study|Lost to Follow-up|3|||
94308374|NCT03114969|322913286|FG003|Overall Study|Lost to Follow-up|2|||
94308375|NCT03114969|322913287|FG004|Overall Study|Lost to Follow-up|0|||
94308376|NCT03114969|322913288|FG005|Overall Study|Lost to Follow-up|0|||
94308377|NCT03114969|322913289|FG006|Overall Study|Lost to Follow-up|0|||
94308378|NCT03114969|322913290|FG007|Overall Study|Lost to Follow-up|0|||
94308379|NCT03114969|322913291|FG008|Overall Study|Lost to Follow-up|0|||
94308380|NCT03114969|322913283|FG000|Overall Study|Adverse Event|0|||
94308381|NCT03114969|322913284|FG001|Overall Study|Adverse Event|0|||
94379387|NCT02711956|323174732|FG008|Overall Study|PSA progression with clinical progression|0|||
94379388|NCT02711956|323174733|FG009|Overall Study|PSA progression with clinical progression|0|||
94379389|NCT02711956|323174734|FG010|Overall Study|PSA progression with clinical progression|0|||
94379390|NCT02711956|323174735|FG011|Overall Study|PSA progression with clinical progression|0|||
94379391|NCT02711956|323174736|FG012|Overall Study|PSA progression with clinical progression|1|||
94308382|NCT03114969|322913285|FG002|Overall Study|Adverse Event|1|||
94308383|NCT03114969|322913286|FG003|Overall Study|Adverse Event|0|||
94308384|NCT03114969|322913287|FG004|Overall Study|Adverse Event|0|||
94308385|NCT03114969|322913288|FG005|Overall Study|Adverse Event|1|||
94308386|NCT03114969|322913289|FG006|Overall Study|Adverse Event|1|||
94308387|NCT03114969|322913290|FG007|Overall Study|Adverse Event|0|||
94308388|NCT03114969|322913291|FG008|Overall Study|Adverse Event|2|||
94470182|NCT02494401|323511427|FG001|Overall Study|Lost to Follow-up|25|||
94470183|NCT02494401|323511426|FG000|Overall Study|Withdrawal by Subject|3|||
94470184|NCT02494401|323511427|FG001|Overall Study|Withdrawal by Subject|2|||
94470185|NCT02000882|323513575|FG000|Overall Study|Adverse Event|3|||
94470186|NCT02000882|323513575|FG000|Overall Study|Physician Decision|2|||
94470187|NCT02000882|323513575|FG000|Overall Study|Withdrawal by Subject|1|||
94470188|NCT02227368|323513578|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
94470189|NCT02227368|323513579|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
94470190|NCT02227368|323513578|FG000|Overall Study|Lost to Follow-up|1|||
94470191|NCT02227368|323513579|FG001|Overall Study|Lost to Follow-up|0|||
94470192|NCT02227368|323513578|FG000|Overall Study|Adverse Event|1|||
94470193|NCT02227368|323513579|FG001|Overall Study|Adverse Event|0|||
94470194|NCT02510820|323513582|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
94470195|NCT02510820|323513583|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
94470196|NCT02510820|323513582|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
94470197|NCT02510820|323513583|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
94470198|NCT03089853|323513587|FG000|Overall Study|Lost to Follow-up|2|||
94470199|NCT03089853|323513588|FG001|Overall Study|Lost to Follow-up|1|||
94470200|NCT02913105|323513589|FG000|Overall Study|Adverse Event|11|||
94470201|NCT02913105|323513590|FG001|Overall Study|Adverse Event|0|||
94470202|NCT02913105|323513591|FG002|Overall Study|Adverse Event|4|||
94470203|NCT02913105|323513589|FG000|Overall Study|Non-Compliance With Study Drug|0|||
94470204|NCT02913105|323513590|FG001|Overall Study|Non-Compliance With Study Drug|0|||
94470205|NCT02913105|323513591|FG002|Overall Study|Non-Compliance With Study Drug|1|||
94470206|NCT02913105|323513589|FG000|Overall Study|Reason Not Specified|3|||
94470207|NCT02913105|323513590|FG001|Overall Study|Reason Not Specified|1|||
94470208|NCT02913105|323513591|FG002|Overall Study|Reason Not Specified|1|||
94470209|NCT02913105|323513589|FG000|Overall Study|Physician Decision|1|||
94470210|NCT02913105|323513590|FG001|Overall Study|Physician Decision|1|||
94470211|NCT02913105|323513591|FG002|Overall Study|Physician Decision|0|||
94470212|NCT02913105|323513589|FG000|Overall Study|Withdrawal by Subject|0|||
94470213|NCT02913105|323513590|FG001|Overall Study|Withdrawal by Subject|3|||
94470214|NCT02913105|323513591|FG002|Overall Study|Withdrawal by Subject|1|||
94470215|NCT02168777|323513592|FG000|Overall Study|Withdrawal by Subject|1|||
94470216|NCT02168777|323513593|FG001|Overall Study|Withdrawal by Subject|0|||
94308389|NCT04601272|322913292|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
94308390|NCT04601272|322913293|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
94308391|NCT04601272|322913294|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
94308392|NCT02168946|322913295|FG000|Overall Study|Adverse Event|8|||
94308393|NCT02168946|322913296|FG001|Overall Study|Adverse Event|5|||
94308394|NCT02168946|322913295|FG000|Overall Study|Lost to Follow-up|3|||
94308395|NCT02168946|322913296|FG001|Overall Study|Lost to Follow-up|0|||
94308396|NCT02168946|322913295|FG000|Overall Study|Subject unable to come back for visits|1|||
94308397|NCT02168946|322913296|FG001|Overall Study|Subject unable to come back for visits|0|||
94308398|NCT01541254|322913301|FG000|Overall Study|Withdrawal by Subject|1|||
94308399|NCT01541254|322913301|FG000|Overall Study|excluded - metal allergy|1|||
94308400|NCT01541254|322913301|FG000|Overall Study|enrolled after study closed|1|||
94308401|NCT01541254|322913301|FG000|Overall Study|GI bleed prior to procedure|1|||
94308402|NCT01541254|322913301|FG000|Overall Study|stent not required|1|||
94308403|NCT01541254|322913301|FG000|Overall Study|alternate stent used|1|||
94308404|NCT01753518|322913302|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
94308405|NCT01753518|322913303|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
94308406|NCT01753518|322913302|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
94308407|NCT01753518|322913303|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
94308408|NCT01753518|322913302|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
94308409|NCT01753518|322913303|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
94308410|NCT01753518|322913302|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
94308411|NCT01753518|322913303|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
94308412|NCT02075255|322913304|FG000|Overall Study|Study specific withdrawal criteria|0|||
94308413|NCT02075255|322913305|FG001|Overall Study|Study specific withdrawal criteria|1|||
94308414|NCT02075255|322913306|FG002|Overall Study|Study specific withdrawal criteria|1|||
94308415|NCT02075255|322913304|FG000|Overall Study|Withdrawal by Subject|4|||
94308416|NCT02075255|322913305|FG001|Overall Study|Withdrawal by Subject|1|||
94308417|NCT02075255|322913306|FG002|Overall Study|Withdrawal by Subject|0|||
94308418|NCT02075255|322913304|FG000|Overall Study|Lost to Follow-up|0|||
94308419|NCT02075255|322913305|FG001|Overall Study|Lost to Follow-up|0|||
94308420|NCT02075255|322913306|FG002|Overall Study|Lost to Follow-up|1|||
94308421|NCT02075255|322913304|FG000|Overall Study|Adverse Event|0|||
94308422|NCT02075255|322913305|FG001|Overall Study|Adverse Event|0|||
94308423|NCT02075255|322913306|FG002|Overall Study|Adverse Event|1|||
94470217|NCT02168777|323513594|FG002|Overall Study|Withdrawal by Subject|2|||
94470218|NCT02168777|323513592|FG000|Overall Study|Adverse Event|1|||
94308424|NCT02075255|322913304|FG000|Overall Study|Death|0|||
94308425|NCT02075255|322913305|FG001|Overall Study|Death|2|||
94470219|NCT02168777|323513593|FG001|Overall Study|Adverse Event|0|||
94470220|NCT02168777|323513594|FG002|Overall Study|Adverse Event|1|||
94470221|NCT02168777|323513592|FG000|Overall Study|Disease recurrence|0|||
94470222|NCT02168777|323513593|FG001|Overall Study|Disease recurrence|0|||
94470223|NCT02168777|323513594|FG002|Overall Study|Disease recurrence|1|||
94470224|NCT02168777|323513592|FG000|Overall Study|Radiological disease progression|0|||
94470225|NCT02168777|323513593|FG001|Overall Study|Radiological disease progression|5|||
94470226|NCT02168777|323513594|FG002|Overall Study|Radiological disease progression|5|||
94470227|NCT02168777|323513592|FG000|Overall Study|Clinical disease progression|0|||
94470228|NCT02168777|323513593|FG001|Overall Study|Clinical disease progression|1|||
94470229|NCT02168777|323513594|FG002|Overall Study|Clinical disease progression|2|||
94470230|NCT02168777|323513592|FG000|Overall Study|Other reason|0|||
94470231|NCT02168777|323513593|FG001|Overall Study|Other reason|1|||
94470232|NCT02168777|323513594|FG002|Overall Study|Other reason|0|||
94470233|NCT00441363|323513595|FG000|Overall Study|Adverse Event|4|||
94470234|NCT00441363|323513596|FG001|Overall Study|Adverse Event|2|||
94470235|NCT00441363|323513595|FG000|Overall Study|Withdrawal by Subject|3|||
94470236|NCT00441363|323513596|FG001|Overall Study|Withdrawal by Subject|4|||
94470237|NCT00441363|323513595|FG000|Overall Study|Physician Decision|6|||
94470238|NCT00441363|323513596|FG001|Overall Study|Physician Decision|7|||
94470239|NCT00441363|323513595|FG000|Overall Study|Lost to Follow-up|2|||
94308426|NCT02075255|322913306|FG002|Overall Study|Death|0|||
94308427|NCT00425438|322913307|FG000|Overall Study|Termination by Sponsor|25|||
94308428|NCT00425438|322913308|FG001|Overall Study|Termination by Sponsor|27|||
94308429|NCT00532259|322913311|FG000|Overall Study|Withdrawal by Subject|2|||
94308430|NCT00532259|322913311|FG000|Overall Study|Adverse Event|1|||
94308431|NCT00532259|322913311|FG000|Overall Study|Death|1|||
94308432|NCT00532259|322913311|FG000|Overall Study|Lack of Efficacy|21|||
94308433|NCT00532259|322913311|FG000|Overall Study|Lost to Follow-up|3|||
94308434|NCT00532259|322913311|FG000|Overall Study|Physician Decision|3|||
94308435|NCT00532259|322913311|FG000|Overall Study|Protocol Violation|1|||
94308436|NCT00793104|322913312|FG000|Overall Study|Lost to Follow-up|1|||
94308437|NCT00003641|322913315|FG000|Overall Study|Withdrawal by Subject|0|||
94308438|NCT00003641|322913316|FG001|Overall Study|Withdrawal by Subject|100|||
94308439|NCT00003641|322913315|FG000|Overall Study|Adverse Event|0|||
94308440|NCT00003641|322913316|FG001|Overall Study|Adverse Event|38|||
94308441|NCT00003641|322913315|FG000|Overall Study|Disease progression|0|||
94308442|NCT00003641|322913316|FG001|Overall Study|Disease progression|2|||
94308443|NCT00003641|322913315|FG000|Overall Study|Unknown/missing|0|||
94308444|NCT00003641|322913316|FG001|Overall Study|Unknown/missing|22|||
94308445|NCT00003641|322913315|FG000|Overall Study|Should not receive interferon therapy|2|||
94308446|NCT00003641|322913316|FG001|Overall Study|Should not receive interferon therapy|0|||
94308447|NCT00003641|322913315|FG000|Overall Study|Never started interferon|567|||
94308448|NCT00003641|322913316|FG001|Overall Study|Never started interferon|12|||
94308449|NCT03694522|322913320|FG000|Overall Study|Withdrawal by Subject|8|||
94308450|NCT03694522|322913321|FG001|Overall Study|Withdrawal by Subject|10|||
94308451|NCT03694522|322913320|FG000|Overall Study|Physician Decision|53|||
94308452|NCT03694522|322913321|FG001|Overall Study|Physician Decision|54|||
94308453|NCT03694522|322913320|FG000|Overall Study|Other|1|||
94308454|NCT03694522|322913321|FG001|Overall Study|Other|1|||
94308455|NCT03694522|322913320|FG000|Overall Study|Lost to Follow-up|0|||
94308456|NCT03694522|322913321|FG001|Overall Study|Lost to Follow-up|1|||
94308457|NCT02760407|322913322|FG000|Overall Study|Death|2|||
94308458|NCT02760407|322913323|FG001|Overall Study|Death|3|||
94308459|NCT02760407|322913324|FG002|Overall Study|Death|1|||
94308460|NCT02760407|322913325|FG003|Overall Study|Death|1|||
94308461|NCT02760407|322913322|FG000|Overall Study|Lost to Follow-up|1|||
94308462|NCT02760407|322913323|FG001|Overall Study|Lost to Follow-up|7|||
94308463|NCT02760407|322913324|FG002|Overall Study|Lost to Follow-up|4|||
94308464|NCT02760407|322913325|FG003|Overall Study|Lost to Follow-up|6|||
94470240|NCT00441363|323513596|FG001|Overall Study|Lost to Follow-up|2|||
94470241|NCT00441363|323513595|FG000|Overall Study|Other|2|||
94470242|NCT00441363|323513596|FG001|Overall Study|Other|0|||
94470243|NCT04114656|323513599|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
94470244|NCT04114656|323513600|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
94470245|NCT04114656|323513599|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
94470246|NCT04114656|323513600|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
94470247|NCT04114656|323513599|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
94470248|NCT04114656|323513600|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
94470249|NCT04114656|323513599|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
94470250|NCT04114656|323513600|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
94470251|NCT04114656|323513599|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
94470252|NCT04114656|323513600|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
94470253|NCT02661061|323513601|FG000|Overall Study|Lack of Efficacy|1|||
94470254|NCT02661061|323513602|FG001|Overall Study|Lack of Efficacy|1|||
94470255|NCT02661061|323513601|FG000|Overall Study|Withdrawal by Subject|1|||
94470256|NCT02661061|323513602|FG001|Overall Study|Withdrawal by Subject|1|||
94470257|NCT03041467|323513603|FG000|Overall Study|Death|46|||
94470258|NCT03041467|323513604|FG001|Overall Study|Death|39|||
94470259|NCT03041467|323513603|FG000|Overall Study|Withdrawal by Subject|36|||
94470260|NCT03041467|323513604|FG001|Overall Study|Withdrawal by Subject|37|||
94470261|NCT03041467|323513603|FG000|Overall Study|Lost to Follow-up|6|||
94470262|NCT03041467|323513604|FG001|Overall Study|Lost to Follow-up|8|||
94470263|NCT03041467|323513603|FG000|Overall Study|Declined consent for study extension|21|||
94470264|NCT03041467|323513604|FG001|Overall Study|Declined consent for study extension|33|||
94470265|NCT03041467|323513603|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
94470266|NCT03041467|323513604|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
94470267|NCT02732015|323513607|FG000|Overall Study|Lost to Follow-up|0|||
94470268|NCT02732015|323513608|FG001|Overall Study|Lost to Follow-up|1|||
94470269|NCT03052920|323513609|FG000|Overall Study|Withdrawal by Subject|1|||
94470270|NCT02578940|323513610|FG000|Overall Study|Screening failure|5|||
94470271|NCT02578940|323513610|FG000|Overall Study|Lost to Follow-up|1|||
94470272|NCT03334422|323513612|FG000|Overall Study|Adverse Event|1|||
94470273|NCT03334422|323513613|FG001|Overall Study|Adverse Event|3|||
94470274|NCT03334422|323513614|FG002|Overall Study|Adverse Event|2|||
94470275|NCT03334422|323513615|FG003|Overall Study|Adverse Event|2|||
94470276|NCT03334422|323513612|FG000|Overall Study|Lack of Efficacy|10|||
94470277|NCT03334422|323513613|FG001|Overall Study|Lack of Efficacy|2|||
94470278|NCT03334422|323513614|FG002|Overall Study|Lack of Efficacy|7|||
94470279|NCT03334422|323513615|FG003|Overall Study|Lack of Efficacy|3|||
94470280|NCT03334422|323513612|FG000|Overall Study|Withdrawal by Subject|8|||
94470281|NCT03334422|323513613|FG001|Overall Study|Withdrawal by Subject|3|||
94470282|NCT03334422|323513614|FG002|Overall Study|Withdrawal by Subject|1|||
94470283|NCT03334422|323513615|FG003|Overall Study|Withdrawal by Subject|0|||
94470284|NCT03334422|323513612|FG000|Overall Study|Lost to Follow-up|0|||
94470285|NCT03334422|323513613|FG001|Overall Study|Lost to Follow-up|0|||
94470286|NCT03334422|323513614|FG002|Overall Study|Lost to Follow-up|0|||
94470287|NCT03334422|323513615|FG003|Overall Study|Lost to Follow-up|1|||
94470288|NCT03334422|323513612|FG000|Overall Study|Inability to obtain laboratory samples|0|||
94470289|NCT03334422|323513613|FG001|Overall Study|Inability to obtain laboratory samples|1|||
94470290|NCT03334422|323513614|FG002|Overall Study|Inability to obtain laboratory samples|0|||
94470291|NCT03334422|323513615|FG003|Overall Study|Inability to obtain laboratory samples|0|||
94470292|NCT03334422|323513612|FG000|Overall Study|Pregnancy|0|||
94470293|NCT03334422|323513613|FG001|Overall Study|Pregnancy|1|||
94470294|NCT03334422|323513614|FG002|Overall Study|Pregnancy|0|||
94470295|NCT03334422|323513615|FG003|Overall Study|Pregnancy|0|||
94470296|NCT02697916|323513616|FG000|Overall Study|Death|357|||
94470297|NCT02697916|323513617|FG001|Overall Study|Death|315|||
94470298|NCT02697916|323513616|FG000|Overall Study|Withdrawal by Subject|221|||
94470299|NCT02697916|323513617|FG001|Overall Study|Withdrawal by Subject|393|||
94470300|NCT00994214|323513620|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
94470301|NCT00994214|323513621|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
94470302|NCT00994214|323513622|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
94470303|NCT00994214|323513623|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
94470304|NCT00994214|323513620|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
94470305|NCT00994214|323513621|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
94470306|NCT00994214|323513622|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
94470307|NCT00994214|323513623|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
94470308|NCT00994214|323513620|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
94470309|NCT00994214|323513621|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
94470310|NCT00994214|323513622|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
94470311|NCT00994214|323513623|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
94379392|NCT02711956|323174737|FG013|Overall Study|PSA progression with clinical progression|1|||
94379393|NCT02711956|323174738|FG014|Overall Study|PSA progression with clinical progression|0|||
94379394|NCT02711956|323174724|FG000|Overall Study|PSA progression with radiographic progression|0|||
94379395|NCT02711956|323174725|FG001|Overall Study|PSA progression with radiographic progression|1|||
94379396|NCT02711956|323174726|FG002|Overall Study|PSA progression with radiographic progression|0|||
94379397|NCT02711956|323174727|FG003|Overall Study|PSA progression with radiographic progression|0|||
94379398|NCT02711956|323174728|FG004|Overall Study|PSA progression with radiographic progression|0|||
94379399|NCT02711956|323174729|FG005|Overall Study|PSA progression with radiographic progression|2|||
94379400|NCT02711956|323174730|FG006|Overall Study|PSA progression with radiographic progression|2|||
94379401|NCT02711956|323174731|FG007|Overall Study|PSA progression with radiographic progression|1|||
94379402|NCT02711956|323174732|FG008|Overall Study|PSA progression with radiographic progression|0|||
94379403|NCT02711956|323174733|FG009|Overall Study|PSA progression with radiographic progression|1|||
94379404|NCT02711956|323174734|FG010|Overall Study|PSA progression with radiographic progression|0|||
94379405|NCT02711956|323174735|FG011|Overall Study|PSA progression with radiographic progression|1|||
94379406|NCT02711956|323174736|FG012|Overall Study|PSA progression with radiographic progression|2|||
94379407|NCT02711956|323174737|FG013|Overall Study|PSA progression with radiographic progression|3|||
94379408|NCT02711956|323174738|FG014|Overall Study|PSA progression with radiographic progression|3|||
94379409|NCT01844583|323174739|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
94379410|NCT01844583|323174740|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
94379411|NCT01625377|323174741|FG000|Overall Study|Death|1|||
94379412|NCT01625377|323174742|FG001|Overall Study|Death|1|||
94379413|NCT01625377|323174741|FG000|Overall Study|Administrative Problem|1|||
94379414|NCT01625377|323174742|FG001|Overall Study|Administrative Problem|1|||
94379415|NCT01625377|323174741|FG000|Overall Study|Protocol Violation|0|||
94379416|NCT01625377|323174742|FG001|Overall Study|Protocol Violation|3|||
94379417|NCT01625377|323174741|FG000|Overall Study|Adverse Event|3|||
94379418|NCT01625377|323174742|FG001|Overall Study|Adverse Event|16|||
94379419|NCT01625377|323174741|FG000|Overall Study|Graft loss|1|||
94379420|NCT01625377|323174742|FG001|Overall Study|Graft loss|0|||
94379421|NCT01625377|323174741|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94379422|NCT01625377|323174742|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
94379423|NCT01625377|323174741|FG000|Overall Study|Abnormal laboratory values|1|||
94379424|NCT01625377|323174742|FG001|Overall Study|Abnormal laboratory values|0|||
94379425|NCT04161144|323174743|FG000|Overall Study|Withdrawal by Subject|0|||
94379426|NCT04161144|323174744|FG001|Overall Study|Withdrawal by Subject|1|||
94379427|NCT04161144|323174743|FG000|Overall Study|Protocol Violation|1|||
94379428|NCT04161144|323174744|FG001|Overall Study|Protocol Violation|0|||
94379429|NCT01769378|323174745|FG000|Overall Study|Adverse Event|10|||
94379430|NCT01769378|323174746|FG001|Overall Study|Adverse Event|0|||
94379431|NCT01769378|323174745|FG000|Overall Study|Entry criteria not met|1|||
94379432|NCT01769378|323174746|FG001|Overall Study|Entry criteria not met|0|||
94379433|NCT01769378|323174745|FG000|Overall Study|Protocol Violation|1|||
94379434|NCT01769378|323174746|FG001|Overall Study|Protocol Violation|1|||
94379435|NCT01769378|323174745|FG000|Overall Study|Withdrawal by Subject|10|||
94379436|NCT01769378|323174746|FG001|Overall Study|Withdrawal by Subject|3|||
94379437|NCT01769378|323174745|FG000|Overall Study|Sponsor Decision|1|||
94379438|NCT01769378|323174746|FG001|Overall Study|Sponsor Decision|0|||
94379439|NCT01769378|323174745|FG000|Overall Study|Lost to Follow-up|2|||
94379440|NCT01769378|323174746|FG001|Overall Study|Lost to Follow-up|0|||
94379441|NCT02848599|323174747|FG000|Overall Study|Protocol Violation|7|||
94379442|NCT02848599|323174748|FG001|Overall Study|Protocol Violation|9|||
94379443|NCT01090765|323174749|FG000|Overall Study|Patient withdrew consent|0|||
94379444|NCT01090765|323174750|FG001|Overall Study|Patient withdrew consent|0|||
94379445|NCT01090765|323174751|FG002|Overall Study|Patient withdrew consent|0|||
94379446|NCT01090765|323174752|FG003|Overall Study|Patient withdrew consent|0|||
94379447|NCT01090765|323174753|FG004|Overall Study|Patient withdrew consent|1|||
94379448|NCT01090765|323174754|FG005|Overall Study|Patient withdrew consent|1|||
94379449|NCT01090765|323174749|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
94379450|NCT01090765|323174750|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
94379451|NCT01090765|323174751|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
94379452|NCT01090765|323174752|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
94379453|NCT01090765|323174753|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
94379454|NCT01090765|323174754|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
94470312|NCT00994214|323513620|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
94379455|NCT01090765|323174749|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
94470313|NCT00994214|323513621|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
94470314|NCT00994214|323513622|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
94379456|NCT01090765|323174750|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
94379457|NCT01090765|323174751|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
94379458|NCT01090765|323174752|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
94308465|NCT02760407|322913322|FG000|Overall Study|Withdrawal by Subject|25|||
94308466|NCT02760407|322913323|FG001|Overall Study|Withdrawal by Subject|31|||
94308467|NCT02760407|322913324|FG002|Overall Study|Withdrawal by Subject|37|||
94308468|NCT02760407|322913325|FG003|Overall Study|Withdrawal by Subject|25|||
94308469|NCT02760407|322913322|FG000|Overall Study|Violation of Eligibility criteria|0|||
94308470|NCT02760407|322913323|FG001|Overall Study|Violation of Eligibility criteria|0|||
94308471|NCT02760407|322913324|FG002|Overall Study|Violation of Eligibility criteria|1|||
94308472|NCT02760407|322913325|FG003|Overall Study|Violation of Eligibility criteria|1|||
94308473|NCT02760407|322913322|FG000|Overall Study|Personal reasons|0|||
94308474|NCT02760407|322913323|FG001|Overall Study|Personal reasons|0|||
94308475|NCT02760407|322913324|FG002|Overall Study|Personal reasons|0|||
94308476|NCT02760407|322913325|FG003|Overall Study|Personal reasons|1|||
94308477|NCT02760407|322913322|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
94308478|NCT02760407|322913323|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
94308479|NCT02760407|322913324|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
94308480|NCT02760407|322913325|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
94308481|NCT02760407|322913322|FG000|Overall Study|Use of prohibited Medication|0|||
94308482|NCT02760407|322913323|FG001|Overall Study|Use of prohibited Medication|0|||
94308483|NCT02760407|322913324|FG002|Overall Study|Use of prohibited Medication|1|||
94308484|NCT02760407|322913325|FG003|Overall Study|Use of prohibited Medication|0|||
94308485|NCT02760407|322913322|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
94308486|NCT02760407|322913323|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
94308487|NCT02760407|322913324|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
94308488|NCT02760407|322913325|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
94308489|NCT02760407|322913322|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
94308490|NCT02760407|322913323|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
94308491|NCT02760407|322913324|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
94308492|NCT02760407|322913325|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
94308493|NCT02760407|322913322|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
94308494|NCT02760407|322913323|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
94308495|NCT02760407|322913324|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
94308496|NCT02760407|322913325|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
94308497|NCT02760407|322913322|FG000|Overall Study|Inadequately Enrolled|0|||
94308498|NCT02760407|322913323|FG001|Overall Study|Inadequately Enrolled|0|||
94308499|NCT02760407|322913324|FG002|Overall Study|Inadequately Enrolled|0|||
94308500|NCT02760407|322913325|FG003|Overall Study|Inadequately Enrolled|1|||
94308501|NCT02760407|322913322|FG000|Overall Study|Withdrawal By PI's Decision|0|||
94308502|NCT02760407|322913323|FG001|Overall Study|Withdrawal By PI's Decision|1|||
94308503|NCT02760407|322913324|FG002|Overall Study|Withdrawal By PI's Decision|0|||
94308504|NCT02760407|322913325|FG003|Overall Study|Withdrawal By PI's Decision|0|||
94308505|NCT02760407|322913322|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
94308506|NCT02760407|322913323|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
94308507|NCT02760407|322913324|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
94308508|NCT02760407|322913325|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
94308509|NCT02760407|322913322|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
94308510|NCT02760407|322913323|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
94308511|NCT02760407|322913324|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
94308512|NCT02760407|322913325|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
94308513|NCT02760407|322913322|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
94308514|NCT02760407|322913323|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
94308515|NCT02760407|322913324|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
94308516|NCT02760407|322913325|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
94308517|NCT02760407|322913322|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
94308518|NCT02760407|322913323|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
94308519|NCT02760407|322913324|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
94308520|NCT02760407|322913325|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
94308521|NCT02760407|322913322|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
94308522|NCT02760407|322913323|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
94308523|NCT02760407|322913324|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
94308524|NCT02760407|322913325|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
94308525|NCT02760407|322913322|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
94308526|NCT02760407|322913323|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
94308527|NCT02760407|322913324|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
94308528|NCT02760407|322913325|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
94308529|NCT02760407|322913322|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
94308530|NCT02760407|322913323|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
94308531|NCT02760407|322913324|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
94308532|NCT02760407|322913325|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
94308533|NCT02760407|322913322|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
94308534|NCT02760407|322913323|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
94308535|NCT02760407|322913324|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
94308536|NCT02760407|322913325|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
94308537|NCT02760407|322913322|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
94308538|NCT02760407|322913323|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
94308539|NCT02760407|322913324|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
94308540|NCT02760407|322913325|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
94308541|NCT01645930|322913326|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
94308542|NCT01645930|322913326|FG000|Overall Study|Progressive Disease|12|||
94308543|NCT01645930|322913326|FG000|Overall Study|Adverse Event|4|||
94308544|NCT01645930|322913326|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
94308545|NCT01645930|322913326|FG000|Overall Study|Withdrawal by Participant|2|||
94308546|NCT01645930|322913326|FG000|Overall Study|Reason not Defined|1|||
94308547|NCT01748760|322913327|FG000|Overall Study|Withdrawal by Subject|1|||
94308548|NCT01748760|322913328|FG001|Overall Study|Withdrawal by Subject|1|||
94308549|NCT01748760|322913327|FG000|Overall Study|Lost to Follow-up|5|||
94308550|NCT01748760|322913328|FG001|Overall Study|Lost to Follow-up|1|||
94308551|NCT00306891|322913329|FG000|Part A|Withdrawal by Subject|1|||
94308552|NCT00306891|322913330|FG001|Part A|Withdrawal by Subject|1|||
94308553|NCT00306891|322913331|FG002|Part A|Withdrawal by Subject|0|||
94308554|NCT00306891|322913332|FG003|Part A|Withdrawal by Subject|0|||
94308555|NCT00306891|322913329|FG000|Part A|Condition under investigation worsened|2|||
94308556|NCT00306891|322913330|FG001|Part A|Condition under investigation worsened|2|||
94308557|NCT00306891|322913331|FG002|Part A|Condition under investigation worsened|0|||
94308558|NCT00306891|322913332|FG003|Part A|Condition under investigation worsened|0|||
94308559|NCT00306891|322913329|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
94308560|NCT00306891|322913330|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
94308561|NCT00306891|322913331|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
94308562|NCT00306891|322913332|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
94308563|NCT00306891|322913329|FG000|Part A|Partial bowel obstruction|1|||
94308564|NCT00306891|322913330|FG001|Part A|Partial bowel obstruction|0|||
94308565|NCT00306891|322913331|FG002|Part A|Partial bowel obstruction|0|||
94308566|NCT00306891|322913332|FG003|Part A|Partial bowel obstruction|0|||
94308567|NCT00306891|322913329|FG000|Part A|Reaccumul. of ascites following drainage|0|||
94308568|NCT00306891|322913330|FG001|Part A|Reaccumul. of ascites following drainage|1|||
94308569|NCT00306891|322913331|FG002|Part A|Reaccumul. of ascites following drainage|0|||
94308570|NCT00306891|322913332|FG003|Part A|Reaccumul. of ascites following drainage|0|||
94308571|NCT00306891|322913329|FG000|Part A|Suspicion of second malignancy|0|||
94308572|NCT00306891|322913330|FG001|Part A|Suspicion of second malignancy|1|||
94308573|NCT00306891|322913331|FG002|Part A|Suspicion of second malignancy|0|||
94308574|NCT00306891|322913332|FG003|Part A|Suspicion of second malignancy|0|||
94308575|NCT00306891|322913329|FG000|Part A|QTC interval outwith elig. criteria|1|||
94308576|NCT00306891|322913330|FG001|Part A|QTC interval outwith elig. criteria|0|||
94308577|NCT00306891|322913331|FG002|Part A|QTC interval outwith elig. criteria|0|||
94308578|NCT00306891|322913332|FG003|Part A|QTC interval outwith elig. criteria|0|||
94308579|NCT00306891|322913329|FG000|Part B|Death|0|||
94308580|NCT00306891|322913330|FG001|Part B|Death|0|||
94308581|NCT00306891|322913331|FG002|Part B|Death|1|||
94308582|NCT00306891|322913332|FG003|Part B|Death|2|||
94308583|NCT00306891|322913329|FG000|Part B|Adverse Event|0|||
94308584|NCT00306891|322913330|FG001|Part B|Adverse Event|0|||
94308585|NCT00306891|322913331|FG002|Part B|Adverse Event|5|||
94308586|NCT00306891|322913332|FG003|Part B|Adverse Event|5|||
94308587|NCT00306891|322913329|FG000|Part B|Withdrawal by Subject|0|||
94308588|NCT00306891|322913330|FG001|Part B|Withdrawal by Subject|0|||
94308589|NCT00306891|322913331|FG002|Part B|Withdrawal by Subject|3|||
94379459|NCT01090765|323174753|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
94308590|NCT00306891|322913332|FG003|Part B|Withdrawal by Subject|1|||
94308591|NCT00306891|322913329|FG000|Part B|Condition under investigation worsened|0|||
94308592|NCT00306891|322913330|FG001|Part B|Condition under investigation worsened|0|||
94308593|NCT00306891|322913331|FG002|Part B|Condition under investigation worsened|2|||
94308594|NCT00306891|322913332|FG003|Part B|Condition under investigation worsened|8|||
94470315|NCT00994214|323513623|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
94470316|NCT00994214|323513620|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
94470317|NCT00994214|323513621|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
94470318|NCT00994214|323513622|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
94470319|NCT00994214|323513623|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
94470320|NCT00994214|323513620|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
94470321|NCT00994214|323513621|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
94470322|NCT00994214|323513622|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
94470323|NCT00994214|323513623|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
94470324|NCT05459558|323513628|FG000|Overall Study|Adverse Event|1|||
94470325|NCT05459558|323513629|FG001|Overall Study|Adverse Event|0|||
94470326|NCT05459558|323513630|FG002|Overall Study|Adverse Event|0|||
94470327|NCT05459558|323513628|FG000|Overall Study|Scheduling issue|0|||
94470328|NCT05459558|323513629|FG001|Overall Study|Scheduling issue|1|||
94470329|NCT05459558|323513630|FG002|Overall Study|Scheduling issue|3|||
94470330|NCT05459558|323513628|FG000|Overall Study|Withdrawal by Subject|0|||
94470331|NCT05459558|323513629|FG001|Overall Study|Withdrawal by Subject|0|||
94470332|NCT05459558|323513630|FG002|Overall Study|Withdrawal by Subject|2|||
94470333|NCT02263729|323513633|FG000|Overall Study|Lost to Follow-up|1|||
94470334|NCT02263729|323513634|FG001|Overall Study|Lost to Follow-up|1|||
94470335|NCT02509078|323513635|FG000|Overall Study|Protocol Violation|1|||
94470336|NCT02509078|323513636|FG001|Overall Study|Protocol Violation|1|||
94470337|NCT02686814|323513637|FG000|Overall Study|Physician Decision|14|||
94470338|NCT02686814|323513637|FG000|Overall Study|Withdrawal by Subject|4|||
94470339|NCT02686814|323513637|FG000|Overall Study|Death|1|||
94470340|NCT01026818|323513638|FG000|Screening Period|Entry Criteria Not Met|105|||
94470341|NCT01026818|323513639|FG001|Screening Period|Entry Criteria Not Met|0|||
94470342|NCT01026818|323513640|FG002|Screening Period|Entry Criteria Not Met|0|||
94470343|NCT01026818|323513641|FG003|Screening Period|Entry Criteria Not Met|0|||
94470344|NCT01026818|323513638|FG000|Screening Period|Withdrawal by Subject|49|||
94470345|NCT01026818|323513639|FG001|Screening Period|Withdrawal by Subject|0|||
94470346|NCT01026818|323513640|FG002|Screening Period|Withdrawal by Subject|0|||
94470347|NCT01026818|323513641|FG003|Screening Period|Withdrawal by Subject|0|||
94470348|NCT01026818|323513638|FG000|Screening Period|Protocol Deviation|3|||
94470349|NCT01026818|323513639|FG001|Screening Period|Protocol Deviation|0|||
94470350|NCT01026818|323513640|FG002|Screening Period|Protocol Deviation|0|||
94470351|NCT01026818|323513641|FG003|Screening Period|Protocol Deviation|0|||
94470352|NCT01026818|323513638|FG000|Screening Period|Adverse Event|2|||
94470353|NCT01026818|323513639|FG001|Screening Period|Adverse Event|0|||
94470354|NCT01026818|323513640|FG002|Screening Period|Adverse Event|0|||
94470355|NCT01026818|323513641|FG003|Screening Period|Adverse Event|0|||
94470356|NCT01026818|323513638|FG000|Screening Period|Physician Decision|1|||
94470357|NCT01026818|323513639|FG001|Screening Period|Physician Decision|0|||
94470358|NCT01026818|323513640|FG002|Screening Period|Physician Decision|0|||
94470359|NCT01026818|323513641|FG003|Screening Period|Physician Decision|0|||
94470360|NCT01026818|323513638|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
94470361|NCT01026818|323513639|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
94470362|NCT01026818|323513640|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
94470363|NCT01026818|323513641|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
94470364|NCT01026818|323513638|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
94470365|NCT01026818|323513639|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
94470366|NCT01026818|323513640|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
94470367|NCT01026818|323513641|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
94470368|NCT01026818|323513638|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
94470369|NCT01026818|323513639|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
94470370|NCT01026818|323513640|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
94470371|NCT01026818|323513641|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
94470372|NCT01026818|323513638|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
94470373|NCT01026818|323513639|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
94470374|NCT01026818|323513640|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
94470375|NCT01026818|323513641|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
94470376|NCT01026818|323513638|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
94470377|NCT01026818|323513639|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
94470378|NCT01026818|323513640|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
94308595|NCT00306891|322913329|FG000|Part B|Development of study specific disc crit.|0|||
94470379|NCT01026818|323513641|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
94470380|NCT01026818|323513638|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
94470381|NCT01026818|323513639|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
94470382|NCT01026818|323513640|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
94470383|NCT01026818|323513641|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
94379460|NCT01090765|323174754|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
94379461|NCT02927847|323174755|FG000|Overall Study|Lost to Follow-up|1|||
94379462|NCT02927847|323174756|FG001|Overall Study|Lost to Follow-up|0|||
94379463|NCT02927847|323174755|FG000|Overall Study|Withdrawal by Subject|4|||
94379464|NCT02927847|323174756|FG001|Overall Study|Withdrawal by Subject|2|||
94379465|NCT02927847|323174755|FG000|Overall Study|PI withdrawn due to missed visits|1|||
94379466|NCT02927847|323174756|FG001|Overall Study|PI withdrawn due to missed visits|1|||
94379467|NCT00782509|323174761|FG000|Overall Study|Adverse Event|20|||
94379468|NCT00782509|323174762|FG001|Overall Study|Adverse Event|10|||
94379469|NCT00782509|323174763|FG002|Overall Study|Adverse Event|20|||
94379470|NCT00782509|323174761|FG000|Overall Study|Lost to Follow-up|1|||
94379471|NCT00782509|323174762|FG001|Overall Study|Lost to Follow-up|2|||
94379472|NCT00782509|323174763|FG002|Overall Study|Lost to Follow-up|3|||
94379473|NCT00782509|323174761|FG000|Overall Study|Withdrawal by Subject|3|||
94379474|NCT00782509|323174762|FG001|Overall Study|Withdrawal by Subject|5|||
94379475|NCT00782509|323174763|FG002|Overall Study|Withdrawal by Subject|8|||
94379476|NCT00782509|323174761|FG000|Overall Study|Non compliance with protocol|2|||
94379477|NCT00782509|323174762|FG001|Overall Study|Non compliance with protocol|0|||
94379478|NCT00782509|323174763|FG002|Overall Study|Non compliance with protocol|0|||
94379479|NCT00782509|323174761|FG000|Overall Study|Other reasons not stated above|5|||
94379480|NCT00782509|323174762|FG001|Overall Study|Other reasons not stated above|2|||
94379481|NCT00782509|323174763|FG002|Overall Study|Other reasons not stated above|3|||
94379482|NCT00782509|323174761|FG000|Overall Study|Lack of Efficacy|10|||
94379483|NCT00782509|323174762|FG001|Overall Study|Lack of Efficacy|5|||
94379484|NCT00782509|323174763|FG002|Overall Study|Lack of Efficacy|2|||
94379485|NCT03349333|323174768|FG000|Overall Study|Progression of Disease|36|||
94379486|NCT03349333|323174768|FG000|Overall Study|Adverse Event|11|||
94379487|NCT03349333|323174768|FG000|Overall Study|Other|6|||
94379488|NCT03349333|323174768|FG000|Overall Study|Withdrawal by Subject|5|||
94379489|NCT03349333|323174768|FG000|Overall Study|Conditions interfere with participation|2|||
94379490|NCT03349333|323174768|FG000|Overall Study|Physician Decision|2|||
94379491|NCT03349333|323174768|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
94379492|NCT03349333|323174768|FG000|Overall Study|Patients in treatment less than 24 month|8|||
94379493|NCT02985151|323174769|FG000|Original Randomization|Withdrawal by Subject|0|||
94379494|NCT02985151|323174770|FG001|Original Randomization|Withdrawal by Subject|1|||
94379495|NCT00760383|323174771|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
94379496|NCT00760383|323174772|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
94379497|NCT03361423|323174774|FG000|Overall Study|Withdrawal by Subject|4|||
94379498|NCT03361423|323174775|FG001|Overall Study|Withdrawal by Subject|3|||
94379499|NCT03361423|323174774|FG000|Overall Study|Did not treat|19|||
94379500|NCT03361423|323174775|FG001|Overall Study|Did not treat|18|||
94379501|NCT03361423|323174774|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
94379502|NCT03361423|323174775|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
94379503|NCT03361423|323174774|FG000|Overall Study|Missing data|4|||
94379504|NCT03361423|323174775|FG001|Overall Study|Missing data|1|||
94379505|NCT03267264|323174776|FG000|Overall Study|Withdrawal by Subject|1|||
94379506|NCT03267264|323174777|FG001|Overall Study|Withdrawal by Subject|0|||
94379507|NCT03267264|323174778|FG002|Overall Study|Withdrawal by Subject|2|||
94379508|NCT03267264|323174779|FG003|Overall Study|Withdrawal by Subject|4|||
94379509|NCT05034731|323174780|FG000|Overall Study|Screen fail|1|||
94379510|NCT05034731|323174781|FG001|Overall Study|Screen fail|1|||
94379511|NCT00818623|323174786|FG000|Overall Study|Adverse Event|1|||
94379512|NCT00818623|323174787|FG001|Overall Study|Adverse Event|0|||
94379513|NCT00818623|323174788|FG002|Overall Study|Adverse Event|1|||
94379514|NCT00818623|323174789|FG003|Overall Study|Adverse Event|0|||
94379515|NCT00818623|323174790|FG004|Overall Study|Adverse Event|0|||
94379516|NCT00818623|323174791|FG005|Overall Study|Adverse Event|1|||
94379517|NCT00818623|323174792|FG006|Overall Study|Adverse Event|0|||
94379518|NCT00818623|323174793|FG007|Overall Study|Adverse Event|0|||
94379519|NCT00818623|323174786|FG000|Overall Study|Bad prostate specific antigen response|0|||
94379520|NCT00818623|323174787|FG001|Overall Study|Bad prostate specific antigen response|3|||
94379521|NCT00818623|323174788|FG002|Overall Study|Bad prostate specific antigen response|2|||
94379522|NCT00818623|323174789|FG003|Overall Study|Bad prostate specific antigen response|5|||
94379523|NCT00818623|323174790|FG004|Overall Study|Bad prostate specific antigen response|0|||
94379524|NCT00818623|323174791|FG005|Overall Study|Bad prostate specific antigen response|1|||
94379525|NCT00818623|323174792|FG006|Overall Study|Bad prostate specific antigen response|0|||
94379526|NCT00818623|323174793|FG007|Overall Study|Bad prostate specific antigen response|0|||
94379527|NCT00818623|323174786|FG000|Overall Study|Withdrawal by Subject|0|||
94379528|NCT00818623|323174787|FG001|Overall Study|Withdrawal by Subject|1|||
94379529|NCT00818623|323174788|FG002|Overall Study|Withdrawal by Subject|1|||
94379530|NCT00818623|323174789|FG003|Overall Study|Withdrawal by Subject|0|||
94379531|NCT00818623|323174790|FG004|Overall Study|Withdrawal by Subject|0|||
94379532|NCT00818623|323174791|FG005|Overall Study|Withdrawal by Subject|1|||
94379533|NCT00818623|323174792|FG006|Overall Study|Withdrawal by Subject|1|||
94379534|NCT00818623|323174793|FG007|Overall Study|Withdrawal by Subject|1|||
94379535|NCT00818623|323174786|FG000|Overall Study|Protocol Violation|1|||
94379536|NCT00818623|323174787|FG001|Overall Study|Protocol Violation|0|||
94379537|NCT00818623|323174788|FG002|Overall Study|Protocol Violation|0|||
94379538|NCT00818623|323174789|FG003|Overall Study|Protocol Violation|0|||
94379539|NCT00818623|323174790|FG004|Overall Study|Protocol Violation|1|||
94379540|NCT00818623|323174791|FG005|Overall Study|Protocol Violation|0|||
94379541|NCT00818623|323174792|FG006|Overall Study|Protocol Violation|1|||
94379542|NCT00818623|323174793|FG007|Overall Study|Protocol Violation|0|||
94379543|NCT00818623|323174786|FG000|Overall Study|Need of additional treatment|0|||
94379544|NCT00818623|323174787|FG001|Overall Study|Need of additional treatment|0|||
94379545|NCT00818623|323174788|FG002|Overall Study|Need of additional treatment|0|||
94379546|NCT00818623|323174789|FG003|Overall Study|Need of additional treatment|0|||
94379547|NCT00818623|323174790|FG004|Overall Study|Need of additional treatment|1|||
94379548|NCT00818623|323174791|FG005|Overall Study|Need of additional treatment|0|||
94379549|NCT00818623|323174792|FG006|Overall Study|Need of additional treatment|0|||
94379550|NCT00818623|323174793|FG007|Overall Study|Need of additional treatment|0|||
94379551|NCT00818623|323174786|FG000|Overall Study|Lack of trial drug at site|0|||
94379552|NCT00818623|323174787|FG001|Overall Study|Lack of trial drug at site|0|||
94379553|NCT00818623|323174788|FG002|Overall Study|Lack of trial drug at site|0|||
94379554|NCT00818623|323174789|FG003|Overall Study|Lack of trial drug at site|0|||
94379555|NCT00818623|323174790|FG004|Overall Study|Lack of trial drug at site|2|||
94379556|NCT00818623|323174791|FG005|Overall Study|Lack of trial drug at site|0|||
94379557|NCT00818623|323174792|FG006|Overall Study|Lack of trial drug at site|1|||
94379558|NCT00818623|323174793|FG007|Overall Study|Lack of trial drug at site|0|||
94379559|NCT00818623|323174786|FG000|Overall Study|Disease progression|0|||
94379560|NCT00818623|323174787|FG001|Overall Study|Disease progression|0|||
94379561|NCT00818623|323174788|FG002|Overall Study|Disease progression|0|||
94379562|NCT00818623|323174789|FG003|Overall Study|Disease progression|0|||
94379563|NCT00818623|323174790|FG004|Overall Study|Disease progression|0|||
94379564|NCT00818623|323174791|FG005|Overall Study|Disease progression|0|||
94379565|NCT00818623|323174792|FG006|Overall Study|Disease progression|1|||
94379566|NCT00818623|323174793|FG007|Overall Study|Disease progression|0|||
94379567|NCT02978326|323174794|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
94379568|NCT02978326|323174795|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
94379569|NCT02978326|323174796|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
94379570|NCT02978326|323174794|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
94379571|NCT02978326|323174795|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
94379572|NCT02978326|323174796|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
94379573|NCT02978326|323174794|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
94379574|NCT02978326|323174795|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
94379575|NCT02978326|323174796|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
94379576|NCT02978326|323174794|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
94379577|NCT02978326|323174795|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
94379578|NCT02978326|323174796|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
94379579|NCT02015793|323174797|FG000|Overall Study|Adverse Event|3|||
94379580|NCT02015793|323174798|FG001|Overall Study|Adverse Event|3|||
94379581|NCT02015793|323174797|FG000|Overall Study|Withdrawal by Subject|1|||
94379582|NCT02015793|323174798|FG001|Overall Study|Withdrawal by Subject|1|||
94379583|NCT03521999|323174800|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
94379584|NCT03521999|323174801|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
94379585|NCT03521999|323174800|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
94379586|NCT03521999|323174801|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
94379587|NCT03521999|323174800|FG000|Completed 3 Month Follow up|Death|0|||
94379588|NCT03521999|323174801|FG001|Completed 3 Month Follow up|Death|1|||
94379589|NCT03521999|323174800|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
94379590|NCT03521999|323174801|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
94379591|NCT01564758|323174802|FG000|Overall Study|Death|8|||
94379592|NCT01564758|323174802|FG000|Overall Study|Adverse Event|3|||
94379593|NCT01564758|323174802|FG000|Overall Study|Other|3|||
94379594|NCT00947427|323174805|FG000|Overall Study|Withdrawal by Subject|1|||
94379595|NCT00947427|323174806|FG001|Overall Study|Withdrawal by Subject|3|||
94379596|NCT00947427|323174805|FG000|Overall Study|Protocol Violation|0|||
94379597|NCT00947427|323174806|FG001|Overall Study|Protocol Violation|1|||
94379598|NCT00249821|323174807|FG000|Overall Study|Technical problem|0|||
94379599|NCT00249821|323174808|FG001|Overall Study|Technical problem|1|||
94379600|NCT00601354|323174811|FG000|Overall Study|Lost to Follow-up|4|||
94379601|NCT00601354|323174812|FG001|Overall Study|Lost to Follow-up|5|||
94379602|NCT01709383|323174815|FG000|Overall Study|Lost to Follow-up|1|||
94379603|NCT01709383|323174816|FG001|Overall Study|Lost to Follow-up|0|||
94379604|NCT01937364|323174817|FG000|Overall Study|Adverse Event|2|||
94379605|NCT01937364|323174818|FG001|Overall Study|Adverse Event|1|||
94308596|NCT00306891|322913330|FG001|Part B|Development of study specific disc crit.|0|||
94308597|NCT00306891|322913331|FG002|Part B|Development of study specific disc crit.|0|||
94308598|NCT00306891|322913332|FG003|Part B|Development of study specific disc crit.|1|||
94308599|NCT02263365|322913333|FG000|Overall Study|Physician Decision|22|||
94308600|NCT02263365|322913334|FG001|Overall Study|Physician Decision|18|||
94308601|NCT00206518|322913335|FG000|Overall Study|Lack of Efficacy|6|||
94308602|NCT00206518|322913336|FG001|Overall Study|Lack of Efficacy|4|||
94308603|NCT00206518|322913335|FG000|Overall Study|Adverse Event|2|||
94308604|NCT00206518|322913336|FG001|Overall Study|Adverse Event|1|||
94308605|NCT00206518|322913335|FG000|Overall Study|Physician Decision|1|||
94308606|NCT00206518|322913336|FG001|Overall Study|Physician Decision|0|||
94308607|NCT00206518|322913335|FG000|Overall Study|Protocol Violation|1|||
94308608|NCT00206518|322913336|FG001|Overall Study|Protocol Violation|1|||
94308609|NCT01845077|322913337|FG000|Washout Period|Lost to Follow-up|0|||
94308610|NCT01845077|322913338|FG001|Washout Period|Lost to Follow-up|1|||
94308611|NCT01845077|322913339|FG002|Washout Period|Lost to Follow-up|0|||
94308612|NCT01845077|322913340|FG003|Washout Period|Lost to Follow-up|1|||
94308613|NCT01845077|322913341|FG004|Washout Period|Lost to Follow-up|0|||
94308614|NCT01845077|322913342|FG005|Washout Period|Lost to Follow-up|1|||
94308615|NCT01845077|322913337|FG000|Washout Period|Adverse Event|1|||
94308616|NCT01845077|322913338|FG001|Washout Period|Adverse Event|0|||
94308617|NCT01845077|322913339|FG002|Washout Period|Adverse Event|0|||
94308618|NCT01845077|322913340|FG003|Washout Period|Adverse Event|0|||
94308619|NCT01845077|322913341|FG004|Washout Period|Adverse Event|0|||
94308620|NCT01845077|322913342|FG005|Washout Period|Adverse Event|0|||
94308621|NCT01845077|322913337|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
94308622|NCT01845077|322913338|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
94308623|NCT01845077|322913339|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
94308624|NCT01845077|322913340|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
94308625|NCT01845077|322913341|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
94308626|NCT01845077|322913342|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
94308627|NCT01845077|322913337|FG000|Washout Period|Protocol Violation|0|||
94308628|NCT01845077|322913338|FG001|Washout Period|Protocol Violation|0|||
94308629|NCT01845077|322913339|FG002|Washout Period|Protocol Violation|0|||
94308630|NCT01845077|322913340|FG003|Washout Period|Protocol Violation|1|||
94308631|NCT01845077|322913341|FG004|Washout Period|Protocol Violation|1|||
94308632|NCT01845077|322913342|FG005|Washout Period|Protocol Violation|0|||
94308633|NCT02973815|322913343|FG000|Post Intervention|Death|1|||
94308634|NCT02973815|322913344|FG001|Post Intervention|Death|0|||
94308635|NCT02973815|322913343|FG000|Post Intervention|Lost to Follow-up|7|||
94308636|NCT02973815|322913344|FG001|Post Intervention|Lost to Follow-up|24|||
94308637|NCT02973815|322913343|FG000|Follow-up|Lost to Follow-up|2|||
94308638|NCT02973815|322913344|FG001|Follow-up|Lost to Follow-up|0|||
94308639|NCT02613572|322913345|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
94308640|NCT02613572|322913346|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
94308641|NCT02613572|322913347|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
94308642|NCT02613572|322913345|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
94308643|NCT02613572|322913346|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
94308644|NCT02613572|322913347|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
94308645|NCT04542291|322913348|FG000|Overall Study|Adverse Event|1|||
94308646|NCT04542291|322913348|FG000|Overall Study|Physician Decision|2|||
94308647|NCT05258058|322913355|FG000|Overall Study|Withdrawal by Subject|2|||
94308648|NCT01001494|322913360|FG000|Overall Study|Adverse Event|8|||
94308649|NCT01001494|322913361|FG001|Overall Study|Adverse Event|4|||
94308650|NCT01001494|322913362|FG002|Overall Study|Adverse Event|6|||
94308651|NCT01001494|322913360|FG000|Overall Study|Protocol Violation|0|||
94308652|NCT01001494|322913361|FG001|Overall Study|Protocol Violation|1|||
94308653|NCT01001494|322913362|FG002|Overall Study|Protocol Violation|1|||
94308654|NCT01001494|322913360|FG000|Overall Study|Lost to Follow-up|2|||
94308655|NCT01001494|322913361|FG001|Overall Study|Lost to Follow-up|0|||
94308656|NCT01001494|322913362|FG002|Overall Study|Lost to Follow-up|1|||
94308657|NCT01001494|322913360|FG000|Overall Study|Withdrawal by Subject|9|||
94308658|NCT01001494|322913361|FG001|Overall Study|Withdrawal by Subject|7|||
94308659|NCT01001494|322913362|FG002|Overall Study|Withdrawal by Subject|17|||
94308660|NCT01001494|322913360|FG000|Overall Study|COPD exacerbation|3|||
94308661|NCT01001494|322913361|FG001|Overall Study|COPD exacerbation|4|||
94308662|NCT01001494|322913362|FG002|Overall Study|COPD exacerbation|5|||
94308663|NCT01001494|322913360|FG000|Overall Study|Lack of Efficacy|2|||
94379606|NCT00319956|323174819|FG000|Overall Study|Death|20|||
94308664|NCT01001494|322913361|FG001|Overall Study|Lack of Efficacy|0|||
94308665|NCT01001494|322913362|FG002|Overall Study|Lack of Efficacy|8|||
94308666|NCT01001494|322913360|FG000|Overall Study|Other|0|||
94308667|NCT01001494|322913361|FG001|Overall Study|Other|1|||
94308668|NCT01001494|322913362|FG002|Overall Study|Other|3|||
94308669|NCT04579393|322913363|FG000|Overall Study|Withdrawal by Subject|2|||
94308670|NCT04579393|322913364|FG001|Overall Study|Withdrawal by Subject|2|||
94308671|NCT04579393|322913363|FG000|Overall Study|Death|1|||
94308672|NCT04579393|322913364|FG001|Overall Study|Death|3|||
94379607|NCT00319956|323174820|FG001|Overall Study|Death|24|||
94379608|NCT01656889|323174821|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
94379609|NCT01656889|323174822|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
94379610|NCT01656889|323174821|FG000|Treatment Period, 12 Weeks|Death|0|||
94379611|NCT01656889|323174822|FG001|Treatment Period, 12 Weeks|Death|1|||
94379612|NCT01656889|323174821|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
94379613|NCT01656889|323174822|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
94379614|NCT01656889|323174821|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
94379615|NCT01656889|323174822|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
94379616|NCT01656889|323174821|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
94379617|NCT01656889|323174822|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
94379618|NCT01656889|323174821|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
94379619|NCT01656889|323174822|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
94379620|NCT01656889|323174821|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
94379621|NCT01656889|323174822|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
94379622|NCT01656889|323174821|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
94379623|NCT01656889|323174822|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
94379624|NCT01656889|323174821|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
94379625|NCT01656889|323174822|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
94379626|NCT01656889|323174821|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
94379627|NCT01656889|323174822|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
94379628|NCT00619385|323174823|FG000|Overall Study|Adverse Event|0|||
94379629|NCT00619385|323174824|FG001|Overall Study|Adverse Event|0|||
94379630|NCT00619385|323174825|FG002|Overall Study|Adverse Event|3|||
94379631|NCT00619385|323174823|FG000|Overall Study|Other|1|||
94379632|NCT00619385|323174824|FG001|Overall Study|Other|2|||
94379633|NCT00619385|323174825|FG002|Overall Study|Other|1|||
94379634|NCT02041702|323174832|FG000|Overall Study|Lost to Follow-up|1|||
94379635|NCT02041702|323174833|FG001|Overall Study|Lost to Follow-up|6|||
94379636|NCT02041702|323174832|FG000|Overall Study|Death|4|||
94379637|NCT02041702|323174833|FG001|Overall Study|Death|0|||
94379638|NCT02041702|323174832|FG000|Overall Study|Withdrawal by Subject|4|||
94379639|NCT02041702|323174833|FG001|Overall Study|Withdrawal by Subject|3|||
94379640|NCT02041702|323174832|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
94379641|NCT02041702|323174833|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
94379642|NCT02041702|323174832|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
94308673|NCT01333189|322913365|FG000|Overall Study|Time constraints|1|||
94308674|NCT01333189|322913366|FG001|Overall Study|Time constraints|0|||
94308675|NCT01333189|322913365|FG000|Overall Study|Adverse Event|1|||
94308676|NCT01333189|322913366|FG001|Overall Study|Adverse Event|0|||
94308677|NCT01333189|322913365|FG000|Overall Study|Transportation difficulties|0|||
94308678|NCT01333189|322913366|FG001|Overall Study|Transportation difficulties|1|||
94308679|NCT01333189|322913365|FG000|Overall Study|Moved from region|0|||
94308680|NCT01333189|322913366|FG001|Overall Study|Moved from region|1|||
94308681|NCT02403206|322913367|FG000|Overall Study|Lost to Follow-up|4|||
94308682|NCT02403206|322913368|FG001|Overall Study|Lost to Follow-up|3|||
94308683|NCT02403206|322913367|FG000|Overall Study|Physician Decision|2|||
94308684|NCT02403206|322913368|FG001|Overall Study|Physician Decision|0|||
94308685|NCT02403206|322913367|FG000|Overall Study|Withdrawal by Subject|3|||
94308686|NCT02403206|322913368|FG001|Overall Study|Withdrawal by Subject|3|||
94308687|NCT02403206|322913367|FG000|Overall Study|Reason not given|2|||
94308688|NCT02403206|322913368|FG001|Overall Study|Reason not given|4|||
94379643|NCT02041702|323174833|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
94379644|NCT01066052|323174840|FG000|Overall Study|Enrolled But Not Treated|3|||
94308689|NCT00957372|322913369|FG000|PART I|Lost to Follow-up|0|||
94308690|NCT00957372|322913370|FG001|PART I|Lost to Follow-up|0|||
94308691|NCT00957372|322913371|FG002|PART I|Lost to Follow-up|1|||
94308692|NCT00957372|322913372|FG003|PART I|Lost to Follow-up|0|||
94308693|NCT00957372|322913369|FG000|PART II|Withdrawal by Subject|0|||
94308694|NCT00957372|322913370|FG001|PART II|Withdrawal by Subject|0|||
94308695|NCT00957372|322913371|FG002|PART II|Withdrawal by Subject|0|||
94308696|NCT00957372|322913372|FG003|PART II|Withdrawal by Subject|8|||
94308697|NCT00957372|322913369|FG000|PART II|Physician Decision|0|||
94308698|NCT00957372|322913370|FG001|PART II|Physician Decision|0|||
94308699|NCT00957372|322913371|FG002|PART II|Physician Decision|0|||
94308700|NCT00957372|322913372|FG003|PART II|Physician Decision|1|||
94308701|NCT00957372|322913369|FG000|PART II|Pregnancy|0|||
94308702|NCT00957372|322913370|FG001|PART II|Pregnancy|0|||
94308703|NCT00957372|322913371|FG002|PART II|Pregnancy|0|||
94308704|NCT00957372|322913372|FG003|PART II|Pregnancy|1|||
94308705|NCT00957372|322913369|FG000|PART II|Not Know|0|||
94308706|NCT00957372|322913370|FG001|PART II|Not Know|0|||
94308707|NCT00957372|322913371|FG002|PART II|Not Know|0|||
94379645|NCT01066052|323174841|FG001|Overall Study|Enrolled But Not Treated|0|||
94379646|NCT00582309|323174842|FG000|Overall Study|Protocol Violation|0|||
94379647|NCT00582309|323174843|FG001|Overall Study|Protocol Violation|0|||
94379648|NCT00582309|323174844|FG002|Overall Study|Protocol Violation|2|||
94379649|NCT01463683|323174848|FG000|Overall Study|Adverse Event|2|||
94379650|NCT01463683|323174849|FG001|Overall Study|Adverse Event|0|||
94379651|NCT01463683|323174850|FG002|Overall Study|Adverse Event|0|||
94379652|NCT01463683|323174848|FG000|Overall Study|Lost to Follow-up|10|||
94379653|NCT01463683|323174849|FG001|Overall Study|Lost to Follow-up|9|||
94379654|NCT01463683|323174850|FG002|Overall Study|Lost to Follow-up|7|||
94379655|NCT01463683|323174848|FG000|Overall Study|Physician Decision|0|||
94379656|NCT01463683|323174849|FG001|Overall Study|Physician Decision|3|||
94308708|NCT00957372|322913372|FG003|PART II|Not Know|20|||
94308709|NCT00957372|322913369|FG000|PART II|Adverse Event|0|||
94308710|NCT00957372|322913370|FG001|PART II|Adverse Event|0|||
94308711|NCT00957372|322913371|FG002|PART II|Adverse Event|0|||
94308712|NCT00957372|322913372|FG003|PART II|Adverse Event|10|||
94308713|NCT00957372|322913369|FG000|PART II|Patient non-compliance|0|||
94379657|NCT01463683|323174850|FG002|Overall Study|Physician Decision|1|||
94379658|NCT01463683|323174848|FG000|Overall Study|Pregnancy|2|||
94379659|NCT01463683|323174849|FG001|Overall Study|Pregnancy|2|||
94379660|NCT01463683|323174850|FG002|Overall Study|Pregnancy|1|||
94379661|NCT01463683|323174848|FG000|Overall Study|Withdrawal by Subject|5|||
94308714|NCT00957372|322913370|FG001|PART II|Patient non-compliance|0|||
94308715|NCT00957372|322913371|FG002|PART II|Patient non-compliance|0|||
94308716|NCT00957372|322913372|FG003|PART II|Patient non-compliance|4|||
94308717|NCT02519231|322913376|FG000|Overall Study|Lost to Follow-up|2|||
94308718|NCT02519231|322913377|FG001|Overall Study|Lost to Follow-up|5|||
94308719|NCT02519231|322913376|FG000|Overall Study|Withdrawal by Subject|0|||
94308720|NCT02519231|322913377|FG001|Overall Study|Withdrawal by Subject|1|||
94308721|NCT00104104|322913378|FG000|Overall Study|Adverse Event|8|||
94308722|NCT00104104|322913379|FG001|Overall Study|Adverse Event|8|||
94308723|NCT00104104|322913378|FG000|Overall Study|Abnormal laboratory value(s)|20|||
94308724|NCT00104104|322913379|FG001|Overall Study|Abnormal laboratory value(s)|14|||
94308725|NCT00104104|322913378|FG000|Overall Study|Lack of Efficacy|0|||
94308726|NCT00104104|322913379|FG001|Overall Study|Lack of Efficacy|3|||
94308727|NCT00104104|322913378|FG000|Overall Study|Condition no longer requires study drug|7|||
94308728|NCT00104104|322913379|FG001|Overall Study|Condition no longer requires study drug|4|||
94308729|NCT00104104|322913378|FG000|Overall Study|Protocol Violation|5|||
94308730|NCT00104104|322913379|FG001|Overall Study|Protocol Violation|2|||
94308731|NCT00104104|322913378|FG000|Overall Study|Withdrawal by Subject|11|||
94308732|NCT00104104|322913379|FG001|Overall Study|Withdrawal by Subject|15|||
94308733|NCT00104104|322913378|FG000|Overall Study|Lost to Follow-up|3|||
94308734|NCT00104104|322913379|FG001|Overall Study|Lost to Follow-up|7|||
94308735|NCT00104104|322913378|FG000|Overall Study|Administrative problems|12|||
94308736|NCT00104104|322913379|FG001|Overall Study|Administrative problems|13|||
94308737|NCT00104104|322913378|FG000|Overall Study|Death|9|||
94308738|NCT00104104|322913379|FG001|Overall Study|Death|6|||
94308739|NCT01676116|322913380|FG000|Overall Study|Withdrawal criteria|2|||
94308740|NCT01676116|322913381|FG001|Overall Study|Withdrawal criteria|14|||
94308741|NCT01676116|322913380|FG000|Overall Study|Adverse Event|1|||
94308742|NCT01676116|322913381|FG001|Overall Study|Adverse Event|2|||
94308743|NCT01676116|322913380|FG000|Overall Study|Unclassified|4|||
94308744|NCT01676116|322913381|FG001|Overall Study|Unclassified|10|||
94308745|NCT01676116|322913380|FG000|Overall Study|Protocol Violation|9|||
94308746|NCT01676116|322913381|FG001|Overall Study|Protocol Violation|3|||
94308747|NCT00447421|322913382|FG000|Overall Study|Lack of Efficacy|1|||
94308748|NCT00447421|322913382|FG000|Overall Study|Adverse Event|3|||
94308749|NCT00447421|322913382|FG000|Overall Study|Sponsor Decision|2|||
94308750|NCT01707147|322913386|FG000|Overall Study|Administered Trajenta prior to contract|5|||
94308751|NCT01707147|322913386|FG000|Overall Study|Patients who have not taken Trajenta|1|||
94308752|NCT01707147|322913386|FG000|Overall Study|Follow-up failure|17|||
94308753|NCT01707147|322913386|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
94308754|NCT02792777|322913387|FG000|Overall Study|Withdrawal by Subject|2|||
94308755|NCT02792777|322913388|FG001|Overall Study|Withdrawal by Subject|0|||
94308756|NCT02792777|322913387|FG000|Overall Study|Recording malfunction|2|||
94308757|NCT02792777|322913388|FG001|Overall Study|Recording malfunction|0|||
94308758|NCT02792777|322913387|FG000|Overall Study|Later determined to be ineligible|2|||
94308759|NCT02792777|322913388|FG001|Overall Study|Later determined to be ineligible|0|||
94308760|NCT02792777|322913387|FG000|Overall Study|Participant interviewed twice|1|||
94308761|NCT02792777|322913388|FG001|Overall Study|Participant interviewed twice|0|||
94308762|NCT01326962|322913391|FG000|Overall Study|Adverse Event|1|||
94308763|NCT01326962|322913391|FG000|Overall Study|Withdrawal by Subject|1|||
94308764|NCT01326962|322913391|FG000|Overall Study|Lost to Follow-up|3|||
94308765|NCT01326962|322913391|FG000|Overall Study|Other|2|||
94308766|NCT00772967|322913392|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
94308767|NCT00772967|322913393|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
94308768|NCT00772967|322913394|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
94308769|NCT00772967|322913395|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
94308770|NCT00772967|322913396|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
94308771|NCT00772967|322913397|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
94308772|NCT00772967|322913392|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
94379662|NCT01463683|323174849|FG001|Overall Study|Withdrawal by Subject|17|||
94379663|NCT01463683|323174850|FG002|Overall Study|Withdrawal by Subject|2|||
94379664|NCT01618305|323174851|FG000|Overall Study|Death|0|||
94308773|NCT00772967|322913393|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
94308774|NCT00772967|322913394|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
94308775|NCT00772967|322913395|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
94379665|NCT01618305|323174852|FG001|Overall Study|Death|1|||
94308776|NCT00772967|322913396|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
94308777|NCT00772967|322913397|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
94308778|NCT00772967|322913392|FG000|Crossover Treatment 3|Adverse Event|0|||
94308779|NCT00772967|322913393|FG001|Crossover Treatment 3|Adverse Event|0|||
94308780|NCT00772967|322913394|FG002|Crossover Treatment 3|Adverse Event|0|||
94308781|NCT00772967|322913395|FG003|Crossover Treatment 3|Adverse Event|0|||
94308782|NCT00772967|322913396|FG004|Crossover Treatment 3|Adverse Event|1|||
94379666|NCT01618305|323174851|FG000|Overall Study|Lost to Follow-up|11|||
94470384|NCT01026818|323513638|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
94470385|NCT01026818|323513639|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
94470386|NCT01026818|323513640|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
94470387|NCT01026818|323513641|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
94470388|NCT01026818|323513638|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
94470389|NCT01026818|323513639|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
94470390|NCT01026818|323513640|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
94470391|NCT01026818|323513641|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
94470392|NCT01026818|323513638|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
94470393|NCT01026818|323513639|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
94470394|NCT01026818|323513640|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
94470395|NCT01026818|323513641|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
94470396|NCT01026818|323513638|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
94470397|NCT01026818|323513639|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
94470398|NCT01026818|323513640|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
94470399|NCT01026818|323513641|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
94470400|NCT01026818|323513638|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
94470401|NCT01026818|323513639|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
94470402|NCT01026818|323513640|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
94470403|NCT01026818|323513641|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
94470404|NCT01026818|323513638|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
94470405|NCT01026818|323513639|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
94470406|NCT01026818|323513640|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
94470407|NCT01026818|323513641|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
94470408|NCT01026818|323513638|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
94470409|NCT01026818|323513639|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
94470410|NCT01026818|323513640|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
94470411|NCT01026818|323513641|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
94470412|NCT01026818|323513638|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
94470413|NCT01026818|323513639|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
94470414|NCT01026818|323513640|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
94470415|NCT01026818|323513641|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
94470416|NCT01026818|323513638|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
94470417|NCT01026818|323513639|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
94470418|NCT01026818|323513640|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
94470419|NCT01026818|323513641|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
94470420|NCT01026818|323513638|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
94470421|NCT01026818|323513639|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
94470422|NCT01026818|323513640|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
94470423|NCT01026818|323513641|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
94470424|NCT01026818|323513638|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
94470425|NCT01026818|323513639|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
94470426|NCT01026818|323513640|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
94470427|NCT01026818|323513641|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
94470428|NCT01026818|323513638|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
94470429|NCT01026818|323513639|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
94470430|NCT01026818|323513640|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
94470431|NCT01026818|323513641|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
94470432|NCT01026818|323513638|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
94470433|NCT01026818|323513639|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
94470434|NCT01026818|323513640|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
94470435|NCT01026818|323513641|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
94470436|NCT04575584|323513642|FG000|Overall Study|Death|6|||
94470437|NCT04575584|323513643|FG001|Overall Study|Death|4|||
94470438|NCT04575584|323513644|FG002|Overall Study|Death|6|||
94470439|NCT04575584|323513645|FG003|Overall Study|Death|2|||
94470440|NCT04575584|323513646|FG004|Overall Study|Death|0|||
94470441|NCT04575584|323513647|FG005|Overall Study|Death|0|||
94470442|NCT04575584|323513642|FG000|Overall Study|Lost to Follow-up|1|||
94470443|NCT04575584|323513643|FG001|Overall Study|Lost to Follow-up|1|||
94470444|NCT04575584|323513644|FG002|Overall Study|Lost to Follow-up|1|||
94470445|NCT04575584|323513645|FG003|Overall Study|Lost to Follow-up|1|||
94470446|NCT04575584|323513646|FG004|Overall Study|Lost to Follow-up|0|||
94470447|NCT04575584|323513647|FG005|Overall Study|Lost to Follow-up|0|||
94470448|NCT04575584|323513642|FG000|Overall Study|Physician Decision|0|||
94470449|NCT04575584|323513643|FG001|Overall Study|Physician Decision|1|||
94470450|NCT04575584|323513644|FG002|Overall Study|Physician Decision|1|||
94470451|NCT04575584|323513645|FG003|Overall Study|Physician Decision|1|||
94470452|NCT04575584|323513646|FG004|Overall Study|Physician Decision|0|||
94470453|NCT04575584|323513647|FG005|Overall Study|Physician Decision|0|||
94308783|NCT00772967|322913397|FG005|Crossover Treatment 3|Adverse Event|0|||
94308784|NCT00815308|322913398|FG000|Overall Study|Adverse Event|4|||
94308785|NCT00815308|322913398|FG000|Overall Study|Withdrawal by Subject|0|||
94308786|NCT00815308|322913398|FG000|Overall Study|Protocol Violation|6|||
94308787|NCT00487279|322913405|FG000|Overall Study|Death|1|||
94308788|NCT00487279|322913406|FG001|Overall Study|Death|0|||
94308789|NCT00487279|322913405|FG000|Overall Study|Withdrawal by Subject|0|||
94308790|NCT00487279|322913406|FG001|Overall Study|Withdrawal by Subject|2|||
94308791|NCT02746679|322913407|FG000|Overall Study|Lost to Follow-up|4|||
94308792|NCT02746679|322913408|FG001|Overall Study|Lost to Follow-up|6|||
94308793|NCT03176966|322913409|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
94308794|NCT03176966|322913410|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
94308795|NCT03176966|322913409|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
94308796|NCT03176966|322913410|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
94308797|NCT03176966|322913409|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
94308798|NCT03176966|322913410|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
94308799|NCT03176966|322913409|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
94308800|NCT03176966|322913410|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
94308801|NCT03176966|322913409|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
94308802|NCT03176966|322913410|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
94308803|NCT03176966|322913409|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
94308804|NCT03176966|322913410|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
94308805|NCT03176966|322913409|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
94308806|NCT03176966|322913410|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
94308807|NCT02961764|322913411|FG000|Overall Study|Protocol Violation|0|||
94308808|NCT02961764|322913412|FG001|Overall Study|Protocol Violation|1|||
94308809|NCT02961764|322913411|FG000|Overall Study|Death|2|||
94308810|NCT02961764|322913412|FG001|Overall Study|Death|0|||
94308811|NCT02961764|322913411|FG000|Overall Study|Lost to Follow-up|35|||
94308812|NCT02961764|322913412|FG001|Overall Study|Lost to Follow-up|24|||
94308813|NCT02961764|322913411|FG000|Overall Study|Withdrawal by Subject|2|||
94308814|NCT02961764|322913412|FG001|Overall Study|Withdrawal by Subject|0|||
94308815|NCT00469014|322913413|FG000|Initial Phase Randomization|Disease Progression|0|||
94308816|NCT00469014|322913414|FG001|Initial Phase Randomization|Disease Progression|1|||
94308817|NCT00469014|322913415|FG002|Initial Phase Randomization|Disease Progression|1|||
94308818|NCT00469014|322913416|FG003|Initial Phase Randomization|Disease Progression|0|||
94308819|NCT00469014|322913413|FG000|Initial Phase Randomization|No Response|1|||
94308820|NCT00469014|322913414|FG001|Initial Phase Randomization|No Response|0|||
94308821|NCT00469014|322913415|FG002|Initial Phase Randomization|No Response|0|||
94308822|NCT00469014|322913416|FG003|Initial Phase Randomization|No Response|1|||
94308823|NCT00469014|322913413|FG000|Adaptive Randomization|Not Evaluable|1|||
94308824|NCT00469014|322913414|FG001|Adaptive Randomization|Not Evaluable|0|||
94308825|NCT00469014|322913415|FG002|Adaptive Randomization|Not Evaluable|0|||
94308826|NCT00469014|322913416|FG003|Adaptive Randomization|Not Evaluable|1|||
94308827|NCT00469014|322913413|FG000|Adaptive Randomization|No Response|0|||
94308828|NCT00469014|322913414|FG001|Adaptive Randomization|No Response|1|||
94308829|NCT00469014|322913415|FG002|Adaptive Randomization|No Response|0|||
94308830|NCT00469014|322913416|FG003|Adaptive Randomization|No Response|0|||
94308831|NCT00469014|322913413|FG000|Adaptive Randomization|Death|0|||
94308832|NCT00469014|322913414|FG001|Adaptive Randomization|Death|0|||
94308833|NCT00469014|322913415|FG002|Adaptive Randomization|Death|1|||
94308834|NCT00469014|322913416|FG003|Adaptive Randomization|Death|0|||
94308835|NCT01415440|322913419|FG000|Overall Study|Lost to Follow-up|0|||
94308836|NCT01415440|322913420|FG001|Overall Study|Lost to Follow-up|1|||
94308837|NCT01415440|322913421|FG002|Overall Study|Lost to Follow-up|2|||
94308838|NCT01415440|322913419|FG000|Overall Study|Physician Decision|3|||
94308839|NCT01415440|322913420|FG001|Overall Study|Physician Decision|0|||
94308840|NCT01415440|322913421|FG002|Overall Study|Physician Decision|0|||
94308841|NCT01415440|322913419|FG000|Overall Study|Withdrawal by Subject|1|||
94308842|NCT01415440|322913420|FG001|Overall Study|Withdrawal by Subject|0|||
94308843|NCT01415440|322913421|FG002|Overall Study|Withdrawal by Subject|0|||
94308844|NCT02269319|322913422|FG000|Overall Study|Lost to Follow-up|4|||
94308845|NCT02269319|322913423|FG001|Overall Study|Lost to Follow-up|3|||
94308846|NCT02269319|322913422|FG000|Overall Study|Adverse Event|0|||
94308847|NCT02269319|322913423|FG001|Overall Study|Adverse Event|1|||
94308848|NCT02269319|322913422|FG000|Overall Study|Instructions not followed|1|||
94308849|NCT02269319|322913423|FG001|Overall Study|Instructions not followed|0|||
94308850|NCT02522481|322913424|FG000|Overall Study|discontinued|1|||
94308851|NCT02522481|322913424|FG000|Overall Study|Not dosed|2|||
94308852|NCT00376688|322913425|FG000|Overall Study|Adverse Event|3|||
94308853|NCT00376688|322913425|FG000|Overall Study|Death|1|||
94308854|NCT01582282|322914902|FG000|Overall Study|Adverse Event|1|||
94308855|NCT01582282|322914903|FG001|Overall Study|Adverse Event|1|||
94308856|NCT01582282|322914904|FG002|Overall Study|Adverse Event|0|||
94308857|NCT01582282|322914902|FG000|Overall Study|Lost to Follow-up|1|||
94308858|NCT01582282|322914903|FG001|Overall Study|Lost to Follow-up|0|||
94470454|NCT04575584|323513642|FG000|Overall Study|Withdrawal by Subject|7|||
94470455|NCT04575584|323513643|FG001|Overall Study|Withdrawal by Subject|9|||
94470456|NCT04575584|323513644|FG002|Overall Study|Withdrawal by Subject|5|||
94470457|NCT04575584|323513645|FG003|Overall Study|Withdrawal by Subject|3|||
94470458|NCT04575584|323513646|FG004|Overall Study|Withdrawal by Subject|0|||
94470459|NCT04575584|323513647|FG005|Overall Study|Withdrawal by Subject|0|||
94470460|NCT04575584|323513642|FG000|Overall Study|Not recorded|0|||
94470461|NCT04575584|323513643|FG001|Overall Study|Not recorded|0|||
94470462|NCT04575584|323513644|FG002|Overall Study|Not recorded|0|||
94470463|NCT04575584|323513645|FG003|Overall Study|Not recorded|1|||
94470464|NCT04575584|323513646|FG004|Overall Study|Not recorded|0|||
94470465|NCT04575584|323513647|FG005|Overall Study|Not recorded|0|||
94470466|NCT02815267|323513648|FG000|Double-Blind Phase|Adverse Event|0|||
94470467|NCT02815267|323513649|FG001|Double-Blind Phase|Adverse Event|3|||
94470468|NCT02815267|323513648|FG000|Double-Blind Phase|Lost to Follow-up|17|||
94470469|NCT02815267|323513649|FG001|Double-Blind Phase|Lost to Follow-up|9|||
94470470|NCT02815267|323513648|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
94470471|NCT02815267|323513649|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
94470472|NCT02815267|323513648|FG000|Double-Blind Phase|Protocol Violation|3|||
94470473|NCT02815267|323513649|FG001|Double-Blind Phase|Protocol Violation|2|||
94470474|NCT02815267|323513648|FG000|Double-Blind Phase|Site withdrawal|1|||
94470475|NCT02815267|323513649|FG001|Double-Blind Phase|Site withdrawal|6|||
94379667|NCT01618305|323174852|FG001|Overall Study|Lost to Follow-up|7|||
94379668|NCT01618305|323174851|FG000|Overall Study|Protocol Violation|1|||
94379669|NCT01618305|323174852|FG001|Overall Study|Protocol Violation|0|||
94379670|NCT01618305|323174851|FG000|Overall Study|Withdrawal by Subject|3|||
94379671|NCT01618305|323174852|FG001|Overall Study|Withdrawal by Subject|2|||
94379672|NCT02708277|323174853|FG000|Overall Study|Lost to Follow-up|7|||
94379673|NCT02708277|323174854|FG001|Overall Study|Lost to Follow-up|4|||
94379674|NCT01346410|323174863|FG000|Overall Study|Death|1|||
94379675|NCT02576990|323174864|FG000|Overall Study|Death|29|||
94379676|NCT02576990|323174865|FG001|Overall Study|Death|18|||
94379677|NCT02576990|323174864|FG000|Overall Study|Physician Decision|1|||
94379678|NCT02576990|323174865|FG001|Overall Study|Physician Decision|0|||
94379679|NCT02576990|323174864|FG000|Overall Study|Screen failure|2|||
94379680|NCT02576990|323174865|FG001|Overall Study|Screen failure|0|||
94379681|NCT02576990|323174864|FG000|Overall Study|Sponsor's decision|24|||
94379682|NCT02576990|323174865|FG001|Overall Study|Sponsor's decision|4|||
94379683|NCT02576990|323174864|FG000|Overall Study|Withdrawal by Subject|0|||
94379684|NCT02576990|323174865|FG001|Overall Study|Withdrawal by Subject|2|||
94379685|NCT00979628|323174866|FG000|Overall Study|received regimen < 24 hours|7|||
94379686|NCT00979628|323174867|FG001|Overall Study|received regimen < 24 hours|6|||
94379687|NCT00979628|323174868|FG002|Overall Study|received regimen < 24 hours|5|||
94379688|NCT00979628|323174866|FG000|Overall Study|received steroids|1|||
94379689|NCT00979628|323174867|FG001|Overall Study|received steroids|1|||
94379690|NCT00979628|323174868|FG002|Overall Study|received steroids|0|||
94379691|NCT00979628|323174866|FG000|Overall Study|transferred to ICU|1|||
94379692|NCT00979628|323174867|FG001|Overall Study|transferred to ICU|2|||
94379693|NCT00979628|323174868|FG002|Overall Study|transferred to ICU|1|||
94379694|NCT02109133|323174873|FG000|Overall Study|Lost to Follow-up|1|||
94379695|NCT02109133|323174874|FG001|Overall Study|Lost to Follow-up|0|||
94379696|NCT01922349|323174877|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
94379697|NCT01922349|323174878|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
94379698|NCT01922349|323174879|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
94379699|NCT01922349|323174880|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
94379700|NCT00458302|323176794|FG000|Overall Study|Adverse Event|4|||
94379701|NCT00458302|323176795|FG001|Overall Study|Adverse Event|14|||
94379702|NCT00458302|323176794|FG000|Overall Study|Pregnancy|2|||
94379703|NCT00458302|323176795|FG001|Overall Study|Pregnancy|1|||
94379704|NCT00458302|323176794|FG000|Overall Study|Protocol Violation|0|||
94379705|NCT00458302|323176795|FG001|Overall Study|Protocol Violation|2|||
94379706|NCT00458302|323176794|FG000|Overall Study|Withdrawal by Subject|6|||
94379707|NCT00458302|323176795|FG001|Overall Study|Withdrawal by Subject|4|||
94379708|NCT00458302|323176794|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
94379709|NCT00458302|323176795|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
94379710|NCT00458302|323176794|FG000|Overall Study|Study Termination By Sponsor|1|||
94379711|NCT00458302|323176795|FG001|Overall Study|Study Termination By Sponsor|0|||
94379712|NCT00458302|323176794|FG000|Overall Study|Lost to Follow-up|2|||
94470476|NCT02815267|323513648|FG000|Double-Blind Phase|Received a disallowed medication|1|||
94470477|NCT02815267|323513649|FG001|Double-Blind Phase|Received a disallowed medication|1|||
94470478|NCT02815267|323513648|FG000|Open-Label Phase|Adverse Event|1|||
94470479|NCT02815267|323513649|FG001|Open-Label Phase|Adverse Event|1|||
94379713|NCT00458302|323176795|FG001|Overall Study|Lost to Follow-up|0|||
94379714|NCT00458302|323176794|FG000|Overall Study|Other|4|||
94379715|NCT00458302|323176795|FG001|Overall Study|Other|2|||
94379716|NCT04582266|323176796|FG000|Overall Study|Lost to Follow-up|7|||
94379717|NCT04582266|323176797|FG001|Overall Study|Lost to Follow-up|5|||
94379718|NCT04582266|323176796|FG000|Overall Study|Withdrawal by Subject|1|||
94470480|NCT02815267|323513648|FG000|Open-Label Phase|Lost to Follow-up|23|||
94470481|NCT02815267|323513649|FG001|Open-Label Phase|Lost to Follow-up|9|||
94470482|NCT02815267|323513648|FG000|Open-Label Phase|Withdrawal by Subject|24|||
94470483|NCT02815267|323513649|FG001|Open-Label Phase|Withdrawal by Subject|13|||
94470484|NCT02815267|323513648|FG000|Open-Label Phase|Protocol Violation|0|||
94470485|NCT02815267|323513649|FG001|Open-Label Phase|Protocol Violation|1|||
94470486|NCT02815267|323513648|FG000|Open-Label Phase|Administrative|21|||
94470487|NCT02815267|323513649|FG001|Open-Label Phase|Administrative|12|||
94470488|NCT02815267|323513648|FG000|Open-Label Phase|Other|2|||
94470489|NCT02815267|323513649|FG001|Open-Label Phase|Other|5|||
94470490|NCT00564278|323513651|FG000|Overall Study|Lost to Follow-up|35|||
94470491|NCT00564278|323513652|FG001|Overall Study|Lost to Follow-up|33|||
94470492|NCT00564278|323513651|FG000|Overall Study|Physician Decision|1|||
94470493|NCT00564278|323513652|FG001|Overall Study|Physician Decision|2|||
94470494|NCT00564278|323513651|FG000|Overall Study|Withdrawal by Subject|11|||
94470495|NCT00564278|323513652|FG001|Overall Study|Withdrawal by Subject|7|||
94470496|NCT02776670|323513660|FG000|Overall Study|Adverse Event|0|||
94470497|NCT02776670|323513661|FG001|Overall Study|Adverse Event|2|||
94470498|NCT02776670|323513660|FG000|Overall Study|Protocol Violation|0|||
94470499|NCT02776670|323513661|FG001|Overall Study|Protocol Violation|2|||
94470500|NCT02776670|323513660|FG000|Overall Study|Withdrawal by Subject|0|||
94470501|NCT02776670|323513661|FG001|Overall Study|Withdrawal by Subject|1|||
94470502|NCT02776670|323513660|FG000|Overall Study|Other - Reason not given|0|||
94470503|NCT02776670|323513661|FG001|Overall Study|Other - Reason not given|1|||
94470504|NCT00592592|323513662|FG000|Overall Study|Patient found ineligible upon chart review|1|||
94470505|NCT00938587|323513669|FG000|Overall Study|Adverse Event|2|||
94470506|NCT00938587|323513670|FG001|Overall Study|Adverse Event|0|||
94470507|NCT00938587|323513671|FG002|Overall Study|Adverse Event|0|||
94470508|NCT00938587|323513672|FG003|Overall Study|Adverse Event|2|||
94470509|NCT00938587|323513669|FG000|Overall Study|Did not meet entrance criteria|0|||
94470510|NCT00938587|323513670|FG001|Overall Study|Did not meet entrance criteria|0|||
94470511|NCT00938587|323513671|FG002|Overall Study|Did not meet entrance criteria|1|||
94470512|NCT00938587|323513672|FG003|Overall Study|Did not meet entrance criteria|0|||
94470513|NCT00938587|323513669|FG000|Overall Study|Withdrawal by Subject|1|||
94470514|NCT00938587|323513670|FG001|Overall Study|Withdrawal by Subject|1|||
94470515|NCT00938587|323513671|FG002|Overall Study|Withdrawal by Subject|0|||
94470516|NCT00938587|323513672|FG003|Overall Study|Withdrawal by Subject|0|||
94470517|NCT03304184|323513673|FG000|Overall Study|Withdrawal by Subject|1|||
94470518|NCT03304184|323513674|FG001|Overall Study|Withdrawal by Subject|2|||
94470519|NCT03970200|323513675|FG000|Overall Study|Death|2|||
94470520|NCT03970200|323513676|FG001|Overall Study|Death|2|||
94470521|NCT03970200|323513677|FG002|Overall Study|Death|1|||
94470522|NCT03970200|323513675|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
94470523|NCT03970200|323513676|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
94308859|NCT01582282|322914904|FG002|Overall Study|Lost to Follow-up|0|||
94308860|NCT01582282|322914902|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
94308861|NCT01582282|322914903|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
94308862|NCT01582282|322914904|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
94470524|NCT03970200|323513677|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
94470525|NCT00830518|323513680|FG000|Overall Study|Progressive Disease|18|||
94470526|NCT00830518|323513681|FG001|Overall Study|Progressive Disease|8|||
94470527|NCT00830518|323513680|FG000|Overall Study|Symptomatic Deterioration|4|||
94470528|NCT00830518|323513681|FG001|Overall Study|Symptomatic Deterioration|1|||
94470529|NCT00830518|323513680|FG000|Overall Study|Adverse Event|14|||
94470530|NCT00830518|323513681|FG001|Overall Study|Adverse Event|1|||
94470531|NCT00830518|323513680|FG000|Overall Study|Withdrawal by Patient|2|||
94470532|NCT00830518|323513681|FG001|Overall Study|Withdrawal by Patient|0|||
94470533|NCT00830518|323513680|FG000|Overall Study|Reason not Specified|8|||
94470534|NCT00830518|323513681|FG001|Overall Study|Reason not Specified|1|||
94470535|NCT00564395|323513689|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
94308863|NCT01486316|322914905|FG000|Overall Study|Device explanted with/without re-implant|3|||
94308864|NCT01486316|322914906|FG001|Overall Study|Device explanted with/without re-implant|2|||
94470536|NCT00564395|323513690|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
94470537|NCT00564395|323513689|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
94470538|NCT00564395|323513690|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
94470539|NCT01428115|323513691|FG000|Overall Study|Lack of Efficacy|3|||
94470540|NCT01428115|323513691|FG000|Overall Study|Lost to Follow-up|10|||
94470541|NCT01428115|323513691|FG000|Overall Study|Pregnancy|1|||
94470542|NCT01428115|323513691|FG000|Overall Study|Protocol Violation|3|||
94470543|NCT01428115|323513691|FG000|Overall Study|Withdrawal by Subject|4|||
94470544|NCT02179749|323513692|FG000|Overall Study|Adverse Event|0|||
94470545|NCT02179749|323513693|FG001|Overall Study|Adverse Event|0|||
94470546|NCT02179749|323513694|FG002|Overall Study|Adverse Event|1|||
94470547|NCT02179749|323513692|FG000|Overall Study|Withdrawal by Subject|0|||
94379719|NCT04582266|323176797|FG001|Overall Study|Withdrawal by Subject|0|||
94379720|NCT04582266|323176796|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
94379721|NCT04582266|323176797|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
94379722|NCT01341639|323176798|FG000|Infant Series|Protocol Violation|1|||
94379723|NCT01341639|323176799|FG001|Infant Series|Protocol Violation|0|||
94379724|NCT01341639|323176798|FG000|Infant Series|Not Vaccinated|0|||
94379725|NCT01341639|323176799|FG001|Infant Series|Not Vaccinated|1|||
94379726|NCT01341639|323176798|FG000|Infant Series|Adverse Event|0|||
94379727|NCT01341639|323176799|FG001|Infant Series|Adverse Event|5|||
94379728|NCT01341639|323176798|FG000|Infant Series|Withdrawal by Subject|11|||
94379729|NCT01341639|323176799|FG001|Infant Series|Withdrawal by Subject|8|||
94379730|NCT01341639|323176798|FG000|Infant Series|Lost to Follow-up|0|||
94379731|NCT01341639|323176799|FG001|Infant Series|Lost to Follow-up|2|||
94379732|NCT01341639|323176798|FG000|Infant Series|Site 0048 Participants|17|||
94379733|NCT01341639|323176799|FG001|Infant Series|Site 0048 Participants|16|||
94379734|NCT01341639|323176798|FG000|Interim Period|Withdrawal by Subject|6|||
94379735|NCT01341639|323176799|FG001|Interim Period|Withdrawal by Subject|7|||
94379736|NCT01341639|323176798|FG000|Interim Period|Lost to Follow-up|2|||
94379737|NCT01341639|323176799|FG001|Interim Period|Lost to Follow-up|0|||
94379738|NCT01341639|323176798|FG000|Interim Period|Physician Decision|0|||
94379739|NCT01341639|323176799|FG001|Interim Period|Physician Decision|1|||
94379740|NCT01341639|323176798|FG000|Interim Period|Protocol Violation|0|||
94379741|NCT01341639|323176799|FG001|Interim Period|Protocol Violation|1|||
94379742|NCT01341639|323176798|FG000|Post-Treatment|Withdrawal by Subject|0|||
94379743|NCT01341639|323176799|FG001|Post-Treatment|Withdrawal by Subject|1|||
94379744|NCT01341639|323176798|FG000|Post-Treatment|Adverse Event|0|||
94379745|NCT01341639|323176799|FG001|Post-Treatment|Adverse Event|2|||
94379746|NCT01621490|323176800|FG000|Overall Study|Subject no longer meets study criteria|0|||
94379747|NCT01621490|323176801|FG001|Overall Study|Subject no longer meets study criteria|0|||
94379748|NCT01621490|323176802|FG002|Overall Study|Subject no longer meets study criteria|0|||
94379749|NCT01621490|323176803|FG003|Overall Study|Subject no longer meets study criteria|0|||
94379750|NCT01621490|323176804|FG004|Overall Study|Subject no longer meets study criteria|1|||
94379751|NCT01621490|323176805|FG005|Overall Study|Subject no longer meets study criteria|0|||
94379752|NCT01621490|323176806|FG006|Overall Study|Subject no longer meets study criteria|0|||
94379753|NCT01621490|323176807|FG007|Overall Study|Subject no longer meets study criteria|0|||
94379754|NCT01621490|323176808|FG008|Overall Study|Subject no longer meets study criteria|0|||
94379755|NCT01621490|323176809|FG009|Overall Study|Subject no longer meets study criteria|0|||
94379756|NCT01621490|323176810|FG010|Overall Study|Subject no longer meets study criteria|0|||
94379757|NCT01621490|323176800|FG000|Overall Study|Maximum clinical benefit|3|||
94379758|NCT01621490|323176801|FG001|Overall Study|Maximum clinical benefit|2|||
94379759|NCT01621490|323176802|FG002|Overall Study|Maximum clinical benefit|0|||
94379760|NCT01621490|323176803|FG003|Overall Study|Maximum clinical benefit|0|||
94379761|NCT01621490|323176804|FG004|Overall Study|Maximum clinical benefit|0|||
94379762|NCT01621490|323176805|FG005|Overall Study|Maximum clinical benefit|0|||
94379763|NCT01621490|323176806|FG006|Overall Study|Maximum clinical benefit|1|||
94379764|NCT01621490|323176807|FG007|Overall Study|Maximum clinical benefit|2|||
94379765|NCT01621490|323176808|FG008|Overall Study|Maximum clinical benefit|2|||
94379766|NCT01621490|323176809|FG009|Overall Study|Maximum clinical benefit|0|||
94379767|NCT01621490|323176810|FG010|Overall Study|Maximum clinical benefit|0|||
94379768|NCT01621490|323176800|FG000|Overall Study|Withdrawal by Subject|1|||
94379769|NCT01621490|323176801|FG001|Overall Study|Withdrawal by Subject|0|||
94379770|NCT01621490|323176802|FG002|Overall Study|Withdrawal by Subject|0|||
94379771|NCT01621490|323176803|FG003|Overall Study|Withdrawal by Subject|0|||
94379772|NCT01621490|323176804|FG004|Overall Study|Withdrawal by Subject|0|||
94379773|NCT01621490|323176805|FG005|Overall Study|Withdrawal by Subject|1|||
94379774|NCT01621490|323176806|FG006|Overall Study|Withdrawal by Subject|0|||
94379775|NCT01621490|323176807|FG007|Overall Study|Withdrawal by Subject|0|||
94379776|NCT01621490|323176808|FG008|Overall Study|Withdrawal by Subject|0|||
94379777|NCT01621490|323176809|FG009|Overall Study|Withdrawal by Subject|0|||
94379778|NCT01621490|323176810|FG010|Overall Study|Withdrawal by Subject|0|||
94379779|NCT01621490|323176800|FG000|Overall Study|Subject request to discontinue study|1|||
94379780|NCT01621490|323176801|FG001|Overall Study|Subject request to discontinue study|3|||
94379781|NCT01621490|323176802|FG002|Overall Study|Subject request to discontinue study|1|||
94379782|NCT01621490|323176803|FG003|Overall Study|Subject request to discontinue study|1|||
94379783|NCT01621490|323176804|FG004|Overall Study|Subject request to discontinue study|0|||
94379784|NCT01621490|323176805|FG005|Overall Study|Subject request to discontinue study|2|||
94379785|NCT01621490|323176806|FG006|Overall Study|Subject request to discontinue study|1|||
94379786|NCT01621490|323176807|FG007|Overall Study|Subject request to discontinue study|0|||
94379787|NCT01621490|323176808|FG008|Overall Study|Subject request to discontinue study|1|||
94379788|NCT01621490|323176809|FG009|Overall Study|Subject request to discontinue study|0|||
94470548|NCT02179749|323513693|FG001|Overall Study|Withdrawal by Subject|0|||
94470549|NCT02179749|323513694|FG002|Overall Study|Withdrawal by Subject|1|||
94470550|NCT02071082|323513695|FG000|Overall Study|Enrolled and Never Treated|1|||
94470551|NCT02071082|323513696|FG001|Overall Study|Enrolled and Never Treated|1|||
94470552|NCT02071082|323513695|FG000|Overall Study|Adverse Event|0|||
94470553|NCT02071082|323513696|FG001|Overall Study|Adverse Event|1|||
94470554|NCT02071082|323513695|FG000|Overall Study|Withdrew Consent|0|||
94470555|NCT02071082|323513696|FG001|Overall Study|Withdrew Consent|4|||
94470556|NCT02071082|323513695|FG000|Overall Study|Lost to Follow-up|1|||
94470557|NCT02071082|323513696|FG001|Overall Study|Lost to Follow-up|1|||
94470558|NCT02101359|323513697|FG000|Overall Study|Not included|23|||
94470559|NCT02101359|323513698|FG001|Overall Study|Not included|13|||
94308865|NCT01486316|322914907|FG002|Overall Study|Device explanted with/without re-implant|0|||
94308866|NCT01486316|322914908|FG003|Overall Study|Device explanted with/without re-implant|2|||
94308867|NCT01486316|322914905|FG000|Overall Study|Not meeting eligibility criteria|0|||
94308868|NCT01486316|322914906|FG001|Overall Study|Not meeting eligibility criteria|0|||
94308869|NCT01486316|322914907|FG002|Overall Study|Not meeting eligibility criteria|1|||
94308870|NCT01486316|322914908|FG003|Overall Study|Not meeting eligibility criteria|0|||
94308871|NCT01486316|322914905|FG000|Overall Study|Withdrawal by Subject|1|||
94308872|NCT01486316|322914906|FG001|Overall Study|Withdrawal by Subject|0|||
94308873|NCT01486316|322914907|FG002|Overall Study|Withdrawal by Subject|3|||
94308874|NCT01486316|322914908|FG003|Overall Study|Withdrawal by Subject|0|||
94308875|NCT01486316|322914905|FG000|Overall Study|Physician Decision|0|||
94308876|NCT01486316|322914906|FG001|Overall Study|Physician Decision|0|||
94308877|NCT01486316|322914907|FG002|Overall Study|Physician Decision|1|||
94308878|NCT01486316|322914908|FG003|Overall Study|Physician Decision|0|||
94308879|NCT01486316|322914905|FG000|Overall Study|Death|0|||
94308880|NCT01486316|322914906|FG001|Overall Study|Death|1|||
94308881|NCT01486316|322914907|FG002|Overall Study|Death|0|||
94308882|NCT01486316|322914908|FG003|Overall Study|Death|0|||
94308883|NCT03191396|322914911|FG000|Overall Study|Lost to Follow-up|0|||
94308884|NCT03191396|322914912|FG001|Overall Study|Lost to Follow-up|3|||
94308885|NCT03191396|322914911|FG000|Overall Study|Withdrawal by Subject|3|||
94308886|NCT03191396|322914912|FG001|Overall Study|Withdrawal by Subject|2|||
94308887|NCT03825042|322914913|FG000|Overall Study|Adverse Event|1|||
94308888|NCT03825042|322914914|FG001|Overall Study|Adverse Event|0|||
94308889|NCT03825042|322914913|FG000|Overall Study|Withdrawal by Subject|1|||
94308890|NCT03825042|322914914|FG001|Overall Study|Withdrawal by Subject|0|||
94308891|NCT01712438|322914916|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
94308892|NCT01712438|322914916|FG000|Overall Study|Ongoing ITI treatment|6|||
94308893|NCT01712438|322914916|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
94308894|NCT01712438|322914916|FG000|Overall Study|Prematurely Discontinued|25|||
94308895|NCT01330381|322914917|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
94308896|NCT01330381|322914918|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
94308897|NCT01330381|322914919|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
94308898|NCT01330381|322914917|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
94308899|NCT01330381|322914918|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
94308900|NCT01330381|322914919|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
94308901|NCT01330381|322914917|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
94308902|NCT01330381|322914918|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
94308903|NCT01330381|322914919|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
94308904|NCT01330381|322914917|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
94308905|NCT01330381|322914918|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
94308906|NCT01330381|322914919|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
94308907|NCT01330381|322914917|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
94308908|NCT01330381|322914918|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
94308909|NCT01330381|322914919|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
94308910|NCT01330381|322914917|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
94308911|NCT01330381|322914918|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
94308912|NCT01330381|322914919|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
94308913|NCT01330381|322914917|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
94308914|NCT01330381|322914918|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
94308915|NCT01330381|322914919|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
94308916|NCT01330381|322914917|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
94308917|NCT01330381|322914918|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
94308918|NCT01330381|322914919|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
94308919|NCT01330381|322914917|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
94308920|NCT01330381|322914918|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
94470560|NCT02101359|323513697|FG000|Overall Study|Withdrawal by Subject|5|||
94379789|NCT01621490|323176810|FG010|Overall Study|Subject request to discontinue study|0|||
94379790|NCT01621490|323176800|FG000|Overall Study|Adverse event unrelated to study drug|1|||
94379791|NCT01621490|323176801|FG001|Overall Study|Adverse event unrelated to study drug|1|||
94379792|NCT01621490|323176802|FG002|Overall Study|Adverse event unrelated to study drug|0|||
94379793|NCT01621490|323176803|FG003|Overall Study|Adverse event unrelated to study drug|0|||
94379794|NCT01621490|323176804|FG004|Overall Study|Adverse event unrelated to study drug|0|||
94379795|NCT01621490|323176805|FG005|Overall Study|Adverse event unrelated to study drug|0|||
94379796|NCT01621490|323176806|FG006|Overall Study|Adverse event unrelated to study drug|0|||
94379797|NCT01621490|323176807|FG007|Overall Study|Adverse event unrelated to study drug|2|||
94379798|NCT01621490|323176808|FG008|Overall Study|Adverse event unrelated to study drug|0|||
94379799|NCT01621490|323176809|FG009|Overall Study|Adverse event unrelated to study drug|0|||
94379800|NCT01621490|323176810|FG010|Overall Study|Adverse event unrelated to study drug|0|||
94379801|NCT01621490|323176800|FG000|Overall Study|Disease progression|27|||
94379802|NCT01621490|323176801|FG001|Overall Study|Disease progression|28|||
94379803|NCT01621490|323176802|FG002|Overall Study|Disease progression|1|||
94379804|NCT01621490|323176803|FG003|Overall Study|Disease progression|5|||
94379805|NCT01621490|323176804|FG004|Overall Study|Disease progression|3|||
94379806|NCT01621490|323176805|FG005|Overall Study|Disease progression|8|||
94379807|NCT01621490|323176806|FG006|Overall Study|Disease progression|7|||
94379808|NCT01621490|323176807|FG007|Overall Study|Disease progression|1|||
94379809|NCT01621490|323176808|FG008|Overall Study|Disease progression|4|||
94379810|NCT01621490|323176809|FG009|Overall Study|Disease progression|1|||
94379811|NCT01621490|323176810|FG010|Overall Study|Disease progression|1|||
94379812|NCT01621490|323176800|FG000|Overall Study|Study drug toxicity|1|||
94379813|NCT01621490|323176801|FG001|Overall Study|Study drug toxicity|4|||
94379814|NCT01621490|323176802|FG002|Overall Study|Study drug toxicity|5|||
94379815|NCT01621490|323176803|FG003|Overall Study|Study drug toxicity|3|||
94379816|NCT01621490|323176804|FG004|Overall Study|Study drug toxicity|1|||
94379817|NCT01621490|323176805|FG005|Overall Study|Study drug toxicity|10|||
94379818|NCT01621490|323176806|FG006|Overall Study|Study drug toxicity|1|||
94379819|NCT01621490|323176807|FG007|Overall Study|Study drug toxicity|4|||
94379820|NCT01621490|323176808|FG008|Overall Study|Study drug toxicity|1|||
94379821|NCT01621490|323176809|FG009|Overall Study|Study drug toxicity|0|||
94379822|NCT01621490|323176810|FG010|Overall Study|Study drug toxicity|0|||
94379823|NCT01621490|323176800|FG000|Overall Study|Death|0|||
94379824|NCT01621490|323176801|FG001|Overall Study|Death|0|||
94379825|NCT01621490|323176802|FG002|Overall Study|Death|0|||
94379826|NCT01621490|323176803|FG003|Overall Study|Death|0|||
94379827|NCT01621490|323176804|FG004|Overall Study|Death|0|||
94379828|NCT01621490|323176805|FG005|Overall Study|Death|0|||
94379829|NCT01621490|323176806|FG006|Overall Study|Death|0|||
94379830|NCT01621490|323176807|FG007|Overall Study|Death|0|||
94379831|NCT01621490|323176808|FG008|Overall Study|Death|1|||
94379832|NCT01621490|323176809|FG009|Overall Study|Death|0|||
94379833|NCT01621490|323176810|FG010|Overall Study|Death|0|||
94379834|NCT01621490|323176800|FG000|Overall Study|Other reasons|7|||
94379835|NCT01621490|323176801|FG001|Overall Study|Other reasons|6|||
94379836|NCT01621490|323176802|FG002|Overall Study|Other reasons|4|||
94379837|NCT01621490|323176803|FG003|Overall Study|Other reasons|1|||
94379838|NCT01621490|323176804|FG004|Overall Study|Other reasons|1|||
94379839|NCT01621490|323176805|FG005|Overall Study|Other reasons|3|||
94379840|NCT01621490|323176806|FG006|Overall Study|Other reasons|1|||
94379841|NCT01621490|323176807|FG007|Overall Study|Other reasons|1|||
94379842|NCT01621490|323176808|FG008|Overall Study|Other reasons|1|||
94379843|NCT01621490|323176809|FG009|Overall Study|Other reasons|0|||
94379844|NCT01621490|323176810|FG010|Overall Study|Other reasons|0|||
94379845|NCT01267266|323176816|FG000|Enrollment Phase|Withdrawal by Subject|2|||
94379846|NCT01267266|323176817|FG001|Enrollment Phase|Withdrawal by Subject|0|||
94379847|NCT01267266|323176816|FG000|Lead-in Phase|Lack of Efficacy|20|||
94379848|NCT01267266|323176817|FG001|Lead-in Phase|Lack of Efficacy|0|||
94379849|NCT01267266|323176816|FG000|Lead-in Phase|Adverse Event|2|||
94379850|NCT01267266|323176817|FG001|Lead-in Phase|Adverse Event|0|||
94379851|NCT01267266|323176816|FG000|Lead-in Phase|Withdrawal by Subject|1|||
94379852|NCT01267266|323176817|FG001|Lead-in Phase|Withdrawal by Subject|0|||
94379853|NCT01335477|323176818|FG000|Overall Study|Adverse Event|30|||
94379854|NCT01335477|323176819|FG001|Overall Study|Adverse Event|42|||
94379855|NCT01335477|323176818|FG000|Overall Study|Non compliant with protocol|0|||
94379856|NCT01335477|323176819|FG001|Overall Study|Non compliant with protocol|2|||
94379857|NCT01335477|323176818|FG000|Overall Study|Lost to Follow-up|1|||
94379858|NCT01335477|323176819|FG001|Overall Study|Lost to Follow-up|2|||
94379859|NCT01335477|323176818|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
94379860|NCT01335477|323176819|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
94379861|NCT01335477|323176818|FG000|Overall Study|Not treated|1|||
94379862|NCT01335477|323176819|FG001|Overall Study|Not treated|2|||
94379863|NCT01335477|323176818|FG000|Overall Study|Reason other than those stated above|2|||
94379864|NCT01335477|323176819|FG001|Overall Study|Reason other than those stated above|2|||
94379865|NCT03740698|323176821|FG000|Overall Study|Physician Decision|0|||
94379866|NCT03740698|323176822|FG001|Overall Study|Physician Decision|1|||
94470561|NCT02101359|323513698|FG001|Overall Study|Withdrawal by Subject|4|||
94470562|NCT02101359|323513697|FG000|Overall Study|Lost to Follow-up|1|||
94470563|NCT02101359|323513698|FG001|Overall Study|Lost to Follow-up|0|||
94470564|NCT02101359|323513697|FG000|Overall Study|Protocol Violation|0|||
94470565|NCT02101359|323513698|FG001|Overall Study|Protocol Violation|2|||
94470566|NCT00494221|323513699|FG000|Overall Study|Death|15|||
94470567|NCT00494221|323513700|FG001|Overall Study|Death|9|||
94470568|NCT00494221|323513701|FG002|Overall Study|Death|14|||
94470569|NCT00494221|323513699|FG000|Overall Study|Withdrawal by Subject|1|||
94470570|NCT00494221|323513700|FG001|Overall Study|Withdrawal by Subject|2|||
94470571|NCT00494221|323513701|FG002|Overall Study|Withdrawal by Subject|0|||
94470572|NCT03782974|323513702|FG000|Overall Study|Withdrawal by Subject|7|||
94470573|NCT03782974|323513703|FG001|Overall Study|Withdrawal by Subject|7|||
94470574|NCT03782974|323513702|FG000|Overall Study|Pregnancy|1|||
94470575|NCT03782974|323513703|FG001|Overall Study|Pregnancy|0|||
94470576|NCT00659776|323513709|FG000|Overall Study|Withdrawal by Subject|12|||
94470577|NCT00659776|323513710|FG001|Overall Study|Withdrawal by Subject|2|||
94470578|NCT00659776|323513711|FG002|Overall Study|Withdrawal by Subject|0|||
94470579|NCT02634710|323513712|FG000|Overall Study|Death|4|||
94470580|NCT04811664|323513714|FG000|Overall Study|Lost to Follow-up|78|||
94470581|NCT04811664|323513715|FG001|Overall Study|Lost to Follow-up|125|||
94470582|NCT04811664|323513716|FG002|Overall Study|Lost to Follow-up|46|||
94470583|NCT04811664|323513714|FG000|Overall Study|Withdrawal by Subject|39|||
94470584|NCT04811664|323513715|FG001|Overall Study|Withdrawal by Subject|76|||
94470585|NCT04811664|323513716|FG002|Overall Study|Withdrawal by Subject|12|||
94470586|NCT04811664|323513714|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
94470587|NCT04811664|323513715|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
94470588|NCT04811664|323513716|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
94470589|NCT04811664|323513714|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
94470590|NCT04811664|323513715|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
94470591|NCT04811664|323513716|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
94470592|NCT04811664|323513714|FG000|Overall Study|Protocol Violation|0|||
94470593|NCT04811664|323513715|FG001|Overall Study|Protocol Violation|5|||
94470594|NCT04811664|323513716|FG002|Overall Study|Protocol Violation|11|||
94470595|NCT04811664|323513714|FG000|Overall Study|Study Terminated by Sponsor|4|||
94470596|NCT04811664|323513715|FG001|Overall Study|Study Terminated by Sponsor|3|||
94470597|NCT04811664|323513716|FG002|Overall Study|Study Terminated by Sponsor|34|||
94470598|NCT04811664|323513714|FG000|Overall Study|Early Study Closure|3|||
94470599|NCT04811664|323513715|FG001|Overall Study|Early Study Closure|7|||
94470600|NCT04811664|323513716|FG002|Overall Study|Early Study Closure|79|||
94470601|NCT04811664|323513714|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
94470602|NCT04811664|323513715|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
94470603|NCT04811664|323513716|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
94470604|NCT00382109|323513717|FG000|Overall Study|Adverse Event|3|||
94470605|NCT00382109|323513718|FG001|Overall Study|Adverse Event|0|||
94470606|NCT00382109|323513717|FG000|Overall Study|Physician Decision|6|||
94470607|NCT00382109|323513718|FG001|Overall Study|Physician Decision|1|||
94470608|NCT00382109|323513717|FG000|Overall Study|Withdrawal by Subject|1|||
94470609|NCT00382109|323513718|FG001|Overall Study|Withdrawal by Subject|0|||
94470610|NCT00382109|323513717|FG000|Overall Study|ineligible|2|||
94470611|NCT00382109|323513718|FG001|Overall Study|ineligible|0|||
94470612|NCT00382109|323513717|FG000|Overall Study|Other|0|||
94470613|NCT00382109|323513718|FG001|Overall Study|Other|2|||
94470614|NCT00382109|323513717|FG000|Overall Study|consent withdrawal|0|||
94470615|NCT00382109|323513718|FG001|Overall Study|consent withdrawal|1|||
94470616|NCT02717442|323513719|FG000|Overall Study|Study Terminated by Sponsor|31|||
94470617|NCT02717442|323513720|FG001|Overall Study|Study Terminated by Sponsor|29|||
94470618|NCT02717442|323513719|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
94470619|NCT02717442|323513720|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
94470620|NCT02717442|323513719|FG000|Overall Study|Other - Not Specified|2|||
94470621|NCT02717442|323513720|FG001|Overall Study|Other - Not Specified|0|||
94470622|NCT01249833|323513721|FG000|Overall Study|Lost to Follow-up|0|||
94470623|NCT01249833|323513722|FG001|Overall Study|Lost to Follow-up|1|||
94470624|NCT00350779|323513723|FG000|Overall Study|Adverse Event|4|||
94308921|NCT01330381|322914919|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
94470625|NCT00350779|323513724|FG001|Overall Study|Adverse Event|2|||
94470626|NCT00350779|323513723|FG000|Overall Study|Lack of Efficacy|0|||
94470627|NCT00350779|323513724|FG001|Overall Study|Lack of Efficacy|4|||
94308922|NCT01330381|322914917|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
94470628|NCT00350779|323513723|FG000|Overall Study|Lost to Follow-up|2|||
94470629|NCT00350779|323513724|FG001|Overall Study|Lost to Follow-up|0|||
94470630|NCT00350779|323513723|FG000|Overall Study|Physician Decision|2|||
94470631|NCT00350779|323513724|FG001|Overall Study|Physician Decision|4|||
94470632|NCT00350779|323513723|FG000|Overall Study|Protocol Violation|3|||
94470633|NCT00350779|323513724|FG001|Overall Study|Protocol Violation|1|||
94470634|NCT00350779|323513723|FG000|Overall Study|Withdrawal by Subject|9|||
94470635|NCT00350779|323513724|FG001|Overall Study|Withdrawal by Subject|8|||
94470636|NCT00350779|323513723|FG000|Overall Study|Patient Moved|2|||
94470637|NCT00350779|323513724|FG001|Overall Study|Patient Moved|1|||
94470638|NCT00350779|323513723|FG000|Overall Study|Non-compliance with study procedures|0|||
94470639|NCT00350779|323513724|FG001|Overall Study|Non-compliance with study procedures|1|||
94470640|NCT03796676|323513725|FG000|Overall Study|Adverse Event|2|||
94470641|NCT03796676|323513726|FG001|Overall Study|Adverse Event|1|||
94470642|NCT03796676|323513727|FG002|Overall Study|Adverse Event|2|||
94470643|NCT03796676|323513725|FG000|Overall Study|Lost to Follow-up|2|||
94470644|NCT03796676|323513726|FG001|Overall Study|Lost to Follow-up|1|||
94470645|NCT03796676|323513727|FG002|Overall Study|Lost to Follow-up|0|||
94470646|NCT03796676|323513725|FG000|Overall Study|Protocol Violation|0|||
94470647|NCT03796676|323513726|FG001|Overall Study|Protocol Violation|0|||
94470648|NCT03796676|323513727|FG002|Overall Study|Protocol Violation|1|||
94470649|NCT03796676|323513725|FG000|Overall Study|Withdrawal by Subject|1|||
94470650|NCT03796676|323513726|FG001|Overall Study|Withdrawal by Subject|1|||
94470651|NCT03796676|323513727|FG002|Overall Study|Withdrawal by Subject|0|||
94470652|NCT03796676|323513725|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
94470653|NCT03796676|323513726|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
94470654|NCT03796676|323513727|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
94470655|NCT00448812|323513730|FG000|Year 2|Missed visit but remained in study|4|||
94470656|NCT00448812|323513731|FG001|Year 2|Missed visit but remained in study|1|||
94470657|NCT00448812|323513730|FG000|Year 3|Withdrawal by Subject|1|||
94470658|NCT00448812|323513731|FG001|Year 3|Withdrawal by Subject|3|||
94470659|NCT00448812|323513730|FG000|Year 3|Lost to Follow-up|1|||
94470660|NCT00448812|323513731|FG001|Year 3|Lost to Follow-up|0|||
94470661|NCT00448812|323513730|FG000|Year 3|Missed visit but remained in study|2|||
94470662|NCT00448812|323513731|FG001|Year 3|Missed visit but remained in study|0|||
94470663|NCT00448812|323513730|FG000|Year 5|Missed visit but remained in study|1|||
94470664|NCT00448812|323513731|FG001|Year 5|Missed visit but remained in study|0|||
94470665|NCT03749109|323513732|FG000|Overall Study|Adverse Event|2|||
94470666|NCT03749109|323513733|FG001|Overall Study|Adverse Event|0|||
94470667|NCT01905592|323513734|FG000|Overall Study|Disease Progression|51|||
94470668|NCT01905592|323513735|FG001|Overall Study|Disease Progression|110|||
94470669|NCT01905592|323513734|FG000|Overall Study|Toxicity|1|||
94470670|NCT01905592|323513735|FG001|Overall Study|Toxicity|16|||
94470671|NCT01905592|323513734|FG000|Overall Study|Physician Decision|0|||
94470672|NCT01905592|323513735|FG001|Overall Study|Physician Decision|2|||
94470673|NCT01905592|323513734|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
94470674|NCT01905592|323513735|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
94470675|NCT01905592|323513734|FG000|Overall Study|Protocol Violation|0|||
94470676|NCT01905592|323513735|FG001|Overall Study|Protocol Violation|1|||
94470677|NCT01905592|323513734|FG000|Overall Study|Sponsor's decision|1|||
94470678|NCT01905592|323513735|FG001|Overall Study|Sponsor's decision|1|||
94470679|NCT01905592|323513734|FG000|Overall Study|Not treated|7|||
94470680|NCT01905592|323513735|FG001|Overall Study|Not treated|3|||
94470681|NCT01905592|323513734|FG000|Overall Study|Withdrawal by Subject|10|||
94470682|NCT01905592|323513735|FG001|Overall Study|Withdrawal by Subject|2|||
94470683|NCT00966355|323513736|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
94470684|NCT00966355|323513737|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
94470685|NCT00966355|323513738|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
94470686|NCT00966355|323513736|FG000|Overall Study|newly diagnosed advanced HCC|11|||
94470687|NCT00966355|323513737|FG001|Overall Study|newly diagnosed advanced HCC|12|||
94470688|NCT00966355|323513738|FG002|Overall Study|newly diagnosed advanced HCC|10|||
94470689|NCT00966355|323513736|FG000|Overall Study|Lost to Follow-up|5|||
94470690|NCT00966355|323513737|FG001|Overall Study|Lost to Follow-up|4|||
94470691|NCT00966355|323513738|FG002|Overall Study|Lost to Follow-up|3|||
94470692|NCT03046056|323515084|FG000|Overall Study|Non-responder at Week 10|6|||
94470693|NCT03046056|323515085|FG001|Overall Study|Non-responder at Week 10|6|||
94470694|NCT03046056|323515086|FG002|Overall Study|Non-responder at Week 10|4|||
94470695|NCT03046056|323515084|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
94470696|NCT03046056|323515085|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
94470697|NCT03046056|323515086|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
94470698|NCT03046056|323515084|FG000|Overall Study|Adverse Event|1|||
94470699|NCT03046056|323515085|FG001|Overall Study|Adverse Event|5|||
94470700|NCT03046056|323515086|FG002|Overall Study|Adverse Event|0|||
94470701|NCT03046056|323515084|FG000|Overall Study|Non-compliance With Study Drug|0|||
94470702|NCT03046056|323515085|FG001|Overall Study|Non-compliance With Study Drug|0|||
94470703|NCT03046056|323515086|FG002|Overall Study|Non-compliance With Study Drug|2|||
94470704|NCT03046056|323515084|FG000|Overall Study|Protocol Violation|1|||
94470705|NCT03046056|323515085|FG001|Overall Study|Protocol Violation|1|||
94470706|NCT03046056|323515086|FG002|Overall Study|Protocol Violation|0|||
94470707|NCT03046056|323515084|FG000|Overall Study|Investigator's Discretion|0|||
94470708|NCT03046056|323515085|FG001|Overall Study|Investigator's Discretion|1|||
94470709|NCT03046056|323515086|FG002|Overall Study|Investigator's Discretion|0|||
94308923|NCT01330381|322914918|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
94379867|NCT03740698|323176823|FG002|Overall Study|Physician Decision|1|||
94379868|NCT03433001|323176831|FG000|Overall Study|Lack of Efficacy|109|||
94308924|NCT01330381|322914919|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
94308925|NCT01539837|322914920|FG000|Overall Study|reduce neutrophil level|0|||
94308926|NCT01539837|322914921|FG001|Overall Study|reduce neutrophil level|1|||
94308927|NCT01539837|322914922|FG002|Overall Study|reduce neutrophil level|1|||
94308928|NCT01539837|322914920|FG000|Overall Study|bad compliance|0|||
94308929|NCT01539837|322914921|FG001|Overall Study|bad compliance|0|||
94308930|NCT01539837|322914922|FG002|Overall Study|bad compliance|1|||
94308931|NCT01062399|322914924|FG000|Overall Study|Protocol Violation|0|||
94308932|NCT01062399|322914925|FG001|Overall Study|Protocol Violation|1|||
94308933|NCT01062399|322914926|FG002|Overall Study|Protocol Violation|0|||
94308934|NCT01062399|322914927|FG003|Overall Study|Protocol Violation|6|||
94308935|NCT01062399|322914928|FG004|Overall Study|Protocol Violation|4|||
94308936|NCT01978912|322914929|FG000|Overall Study|Adverse Event|0|||
94379869|NCT03433001|323176831|FG000|Overall Study|Adverse Event|69|||
94470710|NCT03046056|323515084|FG000|Overall Study|Withdrew Consent|1|||
94308937|NCT01978912|322914930|FG001|Overall Study|Adverse Event|1|||
94308938|NCT01978912|322914931|FG002|Overall Study|Adverse Event|0|||
94308939|NCT01978912|322914932|FG003|Overall Study|Adverse Event|0|||
94308940|NCT01978912|322914929|FG000|Overall Study|Lost to Follow-up|1|||
94379870|NCT03433001|323176831|FG000|Overall Study|Withdrawal by Subject|10|||
94379871|NCT03433001|323176831|FG000|Overall Study|Death|12|||
94379872|NCT03433001|323176831|FG000|Overall Study|Lost to Follow-up|4|||
94379873|NCT03433001|323176831|FG000|Overall Study|Other|25|||
94379874|NCT03507439|323176832|FG000|Overall Study|Other|2|||
94379875|NCT03507439|323176833|FG001|Overall Study|Other|1|||
94379876|NCT03507439|323176832|FG000|Overall Study|Withdrawal by Subject|1|||
94379877|NCT03507439|323176833|FG001|Overall Study|Withdrawal by Subject|0|||
94379878|NCT03507439|323176832|FG000|Overall Study|Death|1|||
94379879|NCT03507439|323176833|FG001|Overall Study|Death|1|||
94379880|NCT00387712|323176834|FG000|Overall Study|Physician Decision|6|||
94379881|NCT00387712|323176835|FG001|Overall Study|Physician Decision|4|||
94379882|NCT00387712|323176834|FG000|Overall Study|Lost to Follow-up|17|||
94379883|NCT00387712|323176835|FG001|Overall Study|Lost to Follow-up|20|||
94379884|NCT00387712|323176834|FG000|Overall Study|Withdrawal by Subject|6|||
94379885|NCT00387712|323176835|FG001|Overall Study|Withdrawal by Subject|12|||
94379886|NCT02742090|323176836|FG000|Overall Study|Adverse Event|10|||
94379887|NCT02742090|323176836|FG000|Overall Study|Death|3|||
94379888|NCT02742090|323176836|FG000|Overall Study|Disease Progression|25|||
94379889|NCT02742090|323176836|FG000|Overall Study|Investigator's Decision|1|||
94379890|NCT02742090|323176836|FG000|Overall Study|Lost to Follow-up|1|||
94379891|NCT02742090|323176836|FG000|Overall Study|Non-compliance with Study|1|||
94379892|NCT02742090|323176836|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
94379893|NCT02742090|323176836|FG000|Overall Study|Withdrawal by Subject|4|||
94379894|NCT02742090|323176836|FG000|Overall Study|Reason Not Specified|1|||
94379895|NCT01299038|323176837|FG000|Overall Study|Withdrawal by Subject|1|||
94379896|NCT01299038|323176838|FG001|Overall Study|Withdrawal by Subject|0|||
94379897|NCT01162499|323176843|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
94379898|NCT01162499|323176844|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
94379899|NCT00832078|323176845|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
94379900|NCT00832078|323176846|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
94379901|NCT00832078|323176845|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
94379902|NCT00832078|323176846|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
94379903|NCT01767597|323176847|FG000|Overall Study|Incomplete intervention|3|||
94379904|NCT01767597|323176848|FG001|Overall Study|Incomplete intervention|1|||
94379905|NCT01767597|323176847|FG000|Overall Study|Withdrawal by Subject|1|||
94379906|NCT01767597|323176848|FG001|Overall Study|Withdrawal by Subject|0|||
94379907|NCT01579474|323176850|FG000|Overall Study|Adverse Event|1|||
94379908|NCT01579474|323176851|FG001|Overall Study|Adverse Event|13|||
94379909|NCT01579474|323176852|FG002|Overall Study|Adverse Event|2|||
94379910|NCT01579474|323176853|FG003|Overall Study|Adverse Event|0|||
94379911|NCT01579474|323176854|FG004|Overall Study|Adverse Event|0|||
94379912|NCT01579474|323176855|FG005|Overall Study|Adverse Event|1|||
94379913|NCT01579474|323176850|FG000|Overall Study|Lack of Efficacy|1|||
94379914|NCT01579474|323176851|FG001|Overall Study|Lack of Efficacy|0|||
94379915|NCT01579474|323176852|FG002|Overall Study|Lack of Efficacy|0|||
94379916|NCT01579474|323176853|FG003|Overall Study|Lack of Efficacy|0|||
94379917|NCT01579474|323176854|FG004|Overall Study|Lack of Efficacy|1|||
94379918|NCT01579474|323176855|FG005|Overall Study|Lack of Efficacy|0|||
94379919|NCT01579474|323176850|FG000|Overall Study|Withdrawal by Subject|1|||
94379920|NCT01579474|323176851|FG001|Overall Study|Withdrawal by Subject|0|||
94379921|NCT01579474|323176852|FG002|Overall Study|Withdrawal by Subject|0|||
94379922|NCT01579474|323176853|FG003|Overall Study|Withdrawal by Subject|0|||
94379923|NCT01579474|323176854|FG004|Overall Study|Withdrawal by Subject|0|||
94379924|NCT01579474|323176855|FG005|Overall Study|Withdrawal by Subject|0|||
94379925|NCT00586521|323176856|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
94379926|NCT03083483|323176869|FG000|Overall Study|Adverse Event|1|||
94379927|NCT03083483|323176870|FG001|Overall Study|Adverse Event|1|||
94379928|NCT03083483|323176871|FG002|Overall Study|Adverse Event|1|||
94379929|NCT03083483|323176869|FG000|Overall Study|Lost to Follow-up|2|||
94379930|NCT03083483|323176870|FG001|Overall Study|Lost to Follow-up|1|||
94379931|NCT03083483|323176871|FG002|Overall Study|Lost to Follow-up|1|||
94379932|NCT03083483|323176869|FG000|Overall Study|technological issues|1|||
94379933|NCT03083483|323176870|FG001|Overall Study|technological issues|0|||
94379934|NCT03083483|323176871|FG002|Overall Study|technological issues|1|||
94379935|NCT05487456|323176876|FG000|Overall Study|Withdrawal by Subject|0|||
94379936|NCT05487456|323176877|FG001|Overall Study|Withdrawal by Subject|0|||
94379937|NCT05487456|323176878|FG002|Overall Study|Withdrawal by Subject|1|||
94379938|NCT05487456|323176879|FG003|Overall Study|Withdrawal by Subject|0|||
94379939|NCT03519256|323176885|FG000|Overall Study|Disease recurrence|4|||
94379940|NCT03519256|323176886|FG001|Overall Study|Disease recurrence|4|||
94379941|NCT03519256|323176887|FG002|Overall Study|Disease recurrence|5|||
94379942|NCT03519256|323176888|FG003|Overall Study|Disease recurrence|2|||
94379943|NCT03519256|323176885|FG000|Overall Study|Study drug toxicity|0|||
94379944|NCT03519256|323176886|FG001|Overall Study|Study drug toxicity|2|||
94379945|NCT03519256|323176887|FG002|Overall Study|Study drug toxicity|5|||
94379946|NCT03519256|323176888|FG003|Overall Study|Study drug toxicity|2|||
94379947|NCT03519256|323176885|FG000|Overall Study|Adverse event unrelated to study drug|0|||
94470711|NCT03046056|323515085|FG001|Overall Study|Withdrew Consent|0|||
94470712|NCT03046056|323515086|FG002|Overall Study|Withdrew Consent|0|||
94470713|NCT01744483|323515087|FG000|Overall Study|Death|9|||
94470714|NCT01744483|323515088|FG001|Overall Study|Death|4|||
94470715|NCT01744483|323515089|FG002|Overall Study|Death|11|||
94470716|NCT01744483|323515087|FG000|Overall Study|Lost to Follow-up|8|||
94470717|NCT01744483|323515088|FG001|Overall Study|Lost to Follow-up|9|||
94470718|NCT01744483|323515089|FG002|Overall Study|Lost to Follow-up|11|||
94470719|NCT01744483|323515087|FG000|Overall Study|Protocol Violation|1|||
94470720|NCT01744483|323515088|FG001|Overall Study|Protocol Violation|2|||
94470721|NCT01744483|323515089|FG002|Overall Study|Protocol Violation|1|||
94470722|NCT01744483|323515087|FG000|Overall Study|Withdrawal by Subject|4|||
94470723|NCT01744483|323515088|FG001|Overall Study|Withdrawal by Subject|6|||
94470724|NCT01744483|323515089|FG002|Overall Study|Withdrawal by Subject|2|||
94470725|NCT01744483|323515087|FG000|Overall Study|No ICU Admit|5|||
94470726|NCT01744483|323515088|FG001|Overall Study|No ICU Admit|1|||
94470727|NCT01744483|323515089|FG002|Overall Study|No ICU Admit|2|||
94470728|NCT01744483|323515087|FG000|Overall Study|Routed to OSH|2|||
94470729|NCT01744483|323515088|FG001|Overall Study|Routed to OSH|0|||
94470730|NCT01744483|323515089|FG002|Overall Study|Routed to OSH|1|||
94470731|NCT03015194|323515091|FG000|Overall Study|Death|10|||
94470732|NCT03015194|323515091|FG000|Overall Study|Withdrawal by Subject|2|||
94470733|NCT01698268|323515095|FG000|Overall Study|Physician Decision|2|||
94470734|NCT01698268|323515096|FG001|Overall Study|Physician Decision|1|||
94470735|NCT02469168|323515097|FG000|Overall Study|Trial closed|1|||
94470736|NCT02469168|323515098|FG001|Overall Study|Trial closed|0|||
94470737|NCT01533688|323515101|FG000|Overall Study|Withdrawal by Subject|5|||
94470738|NCT01533688|323515102|FG001|Overall Study|Withdrawal by Subject|4|||
94470739|NCT01533688|323515103|FG002|Overall Study|Withdrawal by Subject|3|||
94470740|NCT01533688|323515101|FG000|Overall Study|Medically unstable|1|||
94470741|NCT01533688|323515102|FG001|Overall Study|Medically unstable|3|||
94470742|NCT01533688|323515103|FG002|Overall Study|Medically unstable|3|||
94470743|NCT01533688|323515101|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
94470744|NCT01533688|323515102|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
94470745|NCT01533688|323515103|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
94470746|NCT01709409|323515104|FG000|Overall Study|Protocol Violation|1|||
94470747|NCT01709409|323515105|FG001|Overall Study|Protocol Violation|0|||
94470748|NCT02412878|323515106|FG000|Overall Study|Withdrawal by Subject|19|||
94470749|NCT02412878|323515107|FG001|Overall Study|Withdrawal by Subject|10|||
94470750|NCT02412878|323515106|FG000|Overall Study|Lost to Follow-up|2|||
94470751|NCT02412878|323515107|FG001|Overall Study|Lost to Follow-up|3|||
94470752|NCT01928199|323515108|FG000|Overall Study|Lost to Follow-up|2|||
94470753|NCT01928199|323515109|FG001|Overall Study|Lost to Follow-up|1|||
94470754|NCT01928199|323515108|FG000|Overall Study|Withdrawal by Subject|3|||
94470755|NCT01928199|323515109|FG001|Overall Study|Withdrawal by Subject|5|||
94470756|NCT01375374|323515110|FG000|Overall Study|Adverse Event|1|||
94470757|NCT01908582|323515111|FG000|Period 2|Physician Decision|1|||
94470758|NCT01908582|323515111|FG000|Period 2|Withdrawal by Subject|1|||
94470759|NCT00694356|323515112|FG000|Overall Study|Adverse Event|1|||
94470760|NCT00694356|323515113|FG001|Overall Study|Adverse Event|0|||
94470761|NCT00694356|323515114|FG002|Overall Study|Adverse Event|0|||
94470762|NCT00694356|323515112|FG000|Overall Study|Progressive Disease|2|||
94470763|NCT00694356|323515113|FG001|Overall Study|Progressive Disease|6|||
94470764|NCT00694356|323515114|FG002|Overall Study|Progressive Disease|6|||
94470765|NCT00253370|323515120|FG000|Overall Study|Adverse Event|18|||
94470766|NCT00253370|323515120|FG000|Overall Study|Disease progression|13|||
94470767|NCT00253370|323515120|FG000|Overall Study|Death|2|||
94470768|NCT00253370|323515120|FG000|Overall Study|Withdrawal by Subject|6|||
94470769|NCT00253370|323515120|FG000|Overall Study|Non-protocol therapy|1|||
94470770|NCT00253370|323515120|FG000|Overall Study|Physician Decision|1|||
94470771|NCT00253370|323515120|FG000|Overall Study|Protocol Violation|1|||
94470772|NCT00253370|323515120|FG000|Overall Study|Abdominal pain due to disease|1|||
94470773|NCT02697591|323515124|FG000|Overall Study|Lost to Follow-up|0|||
94470774|NCT02697591|323515125|FG001|Overall Study|Lost to Follow-up|0|||
94470775|NCT02697591|323515126|FG002|Overall Study|Lost to Follow-up|0|||
94470776|NCT02697591|323515127|FG003|Overall Study|Lost to Follow-up|0|||
94308941|NCT01978912|322914930|FG001|Overall Study|Lost to Follow-up|1|||
94308942|NCT01978912|322914931|FG002|Overall Study|Lost to Follow-up|0|||
94308943|NCT01978912|322914932|FG003|Overall Study|Lost to Follow-up|1|||
94308944|NCT01978912|322914929|FG000|Overall Study|Withdrawal by Subject|1|||
94470777|NCT02697591|323515128|FG004|Overall Study|Lost to Follow-up|0|||
94470778|NCT02697591|323515129|FG005|Overall Study|Lost to Follow-up|1|||
94470779|NCT02697591|323515130|FG006|Overall Study|Lost to Follow-up|1|||
94470780|NCT02697591|323515131|FG007|Overall Study|Lost to Follow-up|0|||
94308945|NCT01978912|322914930|FG001|Overall Study|Withdrawal by Subject|0|||
94470781|NCT02697591|323515132|FG008|Overall Study|Lost to Follow-up|0|||
94470782|NCT02697591|323515133|FG009|Overall Study|Lost to Follow-up|1|||
94470783|NCT02697591|323515124|FG000|Overall Study|Withdrawal by Subject|1|||
94470784|NCT02697591|323515125|FG001|Overall Study|Withdrawal by Subject|1|||
94470785|NCT02697591|323515126|FG002|Overall Study|Withdrawal by Subject|2|||
94308946|NCT01978912|322914931|FG002|Overall Study|Withdrawal by Subject|2|||
94308947|NCT01978912|322914932|FG003|Overall Study|Withdrawal by Subject|2|||
94308948|NCT01978912|322914929|FG000|Overall Study|Lumbar Surgery|1|||
94308949|NCT01978912|322914930|FG001|Overall Study|Lumbar Surgery|0|||
94308950|NCT01978912|322914931|FG002|Overall Study|Lumbar Surgery|1|||
94308951|NCT01978912|322914932|FG003|Overall Study|Lumbar Surgery|0|||
94308952|NCT01978912|322914929|FG000|Overall Study|Intradiscal Steroid Injection|0|||
94308953|NCT01978912|322914930|FG001|Overall Study|Intradiscal Steroid Injection|1|||
94308954|NCT01978912|322914931|FG002|Overall Study|Intradiscal Steroid Injection|0|||
94308955|NCT01978912|322914932|FG003|Overall Study|Intradiscal Steroid Injection|0|||
94308956|NCT02465034|322914935|FG000|Overall Study|Withdrawal by Subject|1|||
94308957|NCT02465034|322914936|FG001|Overall Study|Withdrawal by Subject|1|||
94308958|NCT02465034|322914935|FG000|Overall Study|Screen fail|2|||
94308959|NCT02465034|322914936|FG001|Overall Study|Screen fail|0|||
94308960|NCT02465034|322914935|FG000|Overall Study|Could not be scheduled for study visit|0|||
94308961|NCT02465034|322914936|FG001|Overall Study|Could not be scheduled for study visit|5|||
94308962|NCT01334125|322914937|FG000|Overall Study|Lost to Follow-up|3|||
94308963|NCT01334125|322914938|FG001|Overall Study|Lost to Follow-up|3|||
94308964|NCT02421120|322914940|FG000|Overall Study|Adverse Event|1|||
94308965|NCT00401973|322914941|FG000|Overall Study|Adverse Event|2|||
94308966|NCT00401973|322914942|FG001|Overall Study|Adverse Event|8|||
94308967|NCT00401973|322914943|FG002|Overall Study|Adverse Event|4|||
94308968|NCT00401973|322914941|FG000|Overall Study|Clinical Relapse|0|||
94308969|NCT00401973|322914942|FG001|Overall Study|Clinical Relapse|1|||
94308970|NCT00401973|322914943|FG002|Overall Study|Clinical Relapse|1|||
94308971|NCT00401973|322914941|FG000|Overall Study|Lack of Efficacy|0|||
94308972|NCT00401973|322914942|FG001|Overall Study|Lack of Efficacy|0|||
94308973|NCT00401973|322914943|FG002|Overall Study|Lack of Efficacy|3|||
94308974|NCT00401973|322914941|FG000|Overall Study|Lost to Follow-up|2|||
94308975|NCT00401973|322914942|FG001|Overall Study|Lost to Follow-up|2|||
94308976|NCT00401973|322914943|FG002|Overall Study|Lost to Follow-up|2|||
94308977|NCT00401973|322914941|FG000|Overall Study|Physician Decision|2|||
94308978|NCT00401973|322914942|FG001|Overall Study|Physician Decision|0|||
94308979|NCT00401973|322914943|FG002|Overall Study|Physician Decision|1|||
94308980|NCT00401973|322914941|FG000|Overall Study|Protocol Violation|1|||
94308981|NCT00401973|322914942|FG001|Overall Study|Protocol Violation|2|||
94308982|NCT00401973|322914943|FG002|Overall Study|Protocol Violation|3|||
94308983|NCT00401973|322914941|FG000|Overall Study|Sponsor Decision|0|||
94308984|NCT00401973|322914942|FG001|Overall Study|Sponsor Decision|1|||
94308985|NCT00401973|322914943|FG002|Overall Study|Sponsor Decision|0|||
94308986|NCT00401973|322914941|FG000|Overall Study|Withdrawal by Subject|4|||
94308987|NCT00401973|322914942|FG001|Overall Study|Withdrawal by Subject|12|||
94308988|NCT00401973|322914943|FG002|Overall Study|Withdrawal by Subject|9|||
94308989|NCT02584634|322914944|FG000|Overall Study|Adverse Event|3|||
94308990|NCT02584634|322914945|FG001|Overall Study|Adverse Event|5|||
94308991|NCT02584634|322914944|FG000|Overall Study|Death|0|||
94308992|NCT02584634|322914945|FG001|Overall Study|Death|1|||
94308993|NCT02584634|322914944|FG000|Overall Study|Lost to Follow-up|0|||
94308994|NCT02584634|322914945|FG001|Overall Study|Lost to Follow-up|1|||
94308995|NCT02584634|322914944|FG000|Overall Study|Physician Decision|1|||
94308996|NCT02584634|322914945|FG001|Overall Study|Physician Decision|2|||
94308997|NCT02584634|322914944|FG000|Overall Study|Progressive disease|7|||
94308998|NCT02584634|322914945|FG001|Overall Study|Progressive disease|15|||
94308999|NCT02584634|322914944|FG000|Overall Study|Withdrawal by Subject|1|||
94309000|NCT02584634|322914945|FG001|Overall Study|Withdrawal by Subject|1|||
94309001|NCT02584634|322914944|FG000|Overall Study|Other|0|||
94309002|NCT02584634|322914945|FG001|Overall Study|Other|6|||
94309003|NCT00984659|322914949|FG000|2-week Run-in Period|Adverse Event|8|||
94309004|NCT00984659|322914950|FG001|2-week Run-in Period|Adverse Event|0|||
94309005|NCT00984659|322914951|FG002|2-week Run-in Period|Adverse Event|0|||
94309006|NCT00984659|322914952|FG003|2-week Run-in Period|Adverse Event|0|||
94309007|NCT00984659|322914949|FG000|2-week Run-in Period|Protocol Violation|5|||
94379948|NCT03519256|323176886|FG001|Overall Study|Adverse event unrelated to study drug|1|||
94379949|NCT03519256|323176887|FG002|Overall Study|Adverse event unrelated to study drug|1|||
94379950|NCT03519256|323176888|FG003|Overall Study|Adverse event unrelated to study drug|0|||
94379951|NCT03519256|323176885|FG000|Overall Study|Participant request to discontinue study treatment|0|||
94379952|NCT03519256|323176886|FG001|Overall Study|Participant request to discontinue study treatment|0|||
94379953|NCT03519256|323176887|FG002|Overall Study|Participant request to discontinue study treatment|0|||
94379954|NCT03519256|323176888|FG003|Overall Study|Participant request to discontinue study treatment|2|||
94379955|NCT03519256|323176885|FG000|Overall Study|Other reasons|0|||
94379956|NCT03519256|323176886|FG001|Overall Study|Other reasons|0|||
94379957|NCT03519256|323176887|FG002|Overall Study|Other reasons|2|||
94379958|NCT03519256|323176888|FG003|Overall Study|Other reasons|0|||
94379959|NCT03519256|323176885|FG000|Overall Study|Disease progression|6|||
94379960|NCT03519256|323176886|FG001|Overall Study|Disease progression|3|||
94379961|NCT03519256|323176887|FG002|Overall Study|Disease progression|2|||
94379962|NCT03519256|323176888|FG003|Overall Study|Disease progression|1|||
94379963|NCT03519256|323176885|FG000|Overall Study|Lost to Follow-up|0|||
94379964|NCT03519256|323176886|FG001|Overall Study|Lost to Follow-up|1|||
94379965|NCT03519256|323176887|FG002|Overall Study|Lost to Follow-up|0|||
94379966|NCT03519256|323176888|FG003|Overall Study|Lost to Follow-up|0|||
94379967|NCT04828161|323176889|FG000|Overall Study|Withdrawal by Subject|0|||
94379968|NCT04828161|323176890|FG001|Overall Study|Withdrawal by Subject|3|||
94379969|NCT04828161|323176891|FG002|Overall Study|Withdrawal by Subject|3|||
94379970|NCT04828161|323176892|FG003|Overall Study|Withdrawal by Subject|4|||
94379971|NCT04828161|323176889|FG000|Overall Study|Lost to Follow-up|1|||
94379972|NCT04828161|323176890|FG001|Overall Study|Lost to Follow-up|4|||
94379973|NCT04828161|323176891|FG002|Overall Study|Lost to Follow-up|2|||
94379974|NCT04828161|323176892|FG003|Overall Study|Lost to Follow-up|2|||
94379975|NCT04828161|323176889|FG000|Overall Study|Other|2|||
94379976|NCT04828161|323176890|FG001|Overall Study|Other|0|||
94379977|NCT04828161|323176891|FG002|Overall Study|Other|2|||
94379978|NCT04828161|323176892|FG003|Overall Study|Other|0|||
94379979|NCT04828161|323176889|FG000|Overall Study|Death|0|||
94379980|NCT04828161|323176890|FG001|Overall Study|Death|0|||
94379981|NCT04828161|323176891|FG002|Overall Study|Death|0|||
94379982|NCT04828161|323176892|FG003|Overall Study|Death|2|||
94379983|NCT02352337|323176893|FG000|Overall Study|Patients never treated|4|||
94379984|NCT02352337|323176894|FG001|Overall Study|Patients never treated|1|||
94379985|NCT02352337|323176895|FG002|Overall Study|Patients never treated|2|||
94379986|NCT02398188|323176898|FG000|Overall Study|Adverse Event|2|||
94379987|NCT02398188|323176899|FG001|Overall Study|Adverse Event|3|||
94379988|NCT02398188|323176898|FG000|Overall Study|Lost to Follow-up|5|||
94379989|NCT02398188|323176899|FG001|Overall Study|Lost to Follow-up|0|||
94379990|NCT02398188|323176898|FG000|Overall Study|Non-compliance|4|||
94379991|NCT02398188|323176899|FG001|Overall Study|Non-compliance|4|||
94379992|NCT02398188|323176898|FG000|Overall Study|Protocol Violation|6|||
94379993|NCT02398188|323176899|FG001|Overall Study|Protocol Violation|10|||
94379994|NCT02398188|323176898|FG000|Overall Study|Sponsor Decision|2|||
94379995|NCT02398188|323176899|FG001|Overall Study|Sponsor Decision|1|||
94379996|NCT02398188|323176898|FG000|Overall Study|Pregnancy|1|||
94379997|NCT02398188|323176899|FG001|Overall Study|Pregnancy|0|||
94379998|NCT02398188|323176898|FG000|Overall Study|Withdrawal by Subject|7|||
94379999|NCT02398188|323176899|FG001|Overall Study|Withdrawal by Subject|16|||
94380000|NCT01259869|323176901|FG000|Overall Study|Duplicated registration|1|||
94380001|NCT00175019|323176902|FG000|Overall Study|Adverse Event|54|||
94380002|NCT00175019|323176903|FG001|Overall Study|Adverse Event|22|||
94380003|NCT00175019|323176904|FG002|Overall Study|Adverse Event|2|||
94380004|NCT00175019|323176902|FG000|Overall Study|Protocol Violation|6|||
94380005|NCT00175019|323176903|FG001|Overall Study|Protocol Violation|3|||
94380006|NCT00175019|323176904|FG002|Overall Study|Protocol Violation|3|||
94380007|NCT00175019|323176902|FG000|Overall Study|Lost to Follow-up|42|||
94380008|NCT00175019|323176903|FG001|Overall Study|Lost to Follow-up|39|||
94380009|NCT00175019|323176904|FG002|Overall Study|Lost to Follow-up|9|||
94380010|NCT00175019|323176902|FG000|Overall Study|Did not continue under Amendment 4|1|||
94470786|NCT02697591|323515127|FG003|Overall Study|Withdrawal by Subject|1|||
94470787|NCT02697591|323515128|FG004|Overall Study|Withdrawal by Subject|7|||
94470788|NCT02697591|323515129|FG005|Overall Study|Withdrawal by Subject|6|||
94470789|NCT02697591|323515130|FG006|Overall Study|Withdrawal by Subject|9|||
94470790|NCT02697591|323515131|FG007|Overall Study|Withdrawal by Subject|1|||
94470791|NCT02697591|323515132|FG008|Overall Study|Withdrawal by Subject|6|||
94470792|NCT02697591|323515133|FG009|Overall Study|Withdrawal by Subject|10|||
94470793|NCT02697591|323515124|FG000|Overall Study|Physician Decision|1|||
94470794|NCT02697591|323515125|FG001|Overall Study|Physician Decision|0|||
94470795|NCT02697591|323515126|FG002|Overall Study|Physician Decision|0|||
94470796|NCT02697591|323515127|FG003|Overall Study|Physician Decision|0|||
94470797|NCT02697591|323515128|FG004|Overall Study|Physician Decision|1|||
94470798|NCT02697591|323515129|FG005|Overall Study|Physician Decision|2|||
94470799|NCT02697591|323515130|FG006|Overall Study|Physician Decision|0|||
94470800|NCT02697591|323515131|FG007|Overall Study|Physician Decision|0|||
94470801|NCT02697591|323515132|FG008|Overall Study|Physician Decision|1|||
94470802|NCT02697591|323515133|FG009|Overall Study|Physician Decision|1|||
94470803|NCT02697591|323515124|FG000|Overall Study|Death|2|||
94470804|NCT02697591|323515125|FG001|Overall Study|Death|3|||
94470805|NCT02697591|323515126|FG002|Overall Study|Death|1|||
94470806|NCT02697591|323515127|FG003|Overall Study|Death|1|||
94470807|NCT02697591|323515128|FG004|Overall Study|Death|4|||
94470808|NCT02697591|323515129|FG005|Overall Study|Death|5|||
94470809|NCT02697591|323515130|FG006|Overall Study|Death|3|||
94470810|NCT02697591|323515131|FG007|Overall Study|Death|1|||
94470811|NCT02697591|323515132|FG008|Overall Study|Death|1|||
94470812|NCT02697591|323515133|FG009|Overall Study|Death|5|||
94470813|NCT02697591|323515124|FG000|Overall Study|Reason not Specified|0|||
94470814|NCT02697591|323515125|FG001|Overall Study|Reason not Specified|0|||
94470815|NCT02697591|323515126|FG002|Overall Study|Reason not Specified|0|||
94470816|NCT02697591|323515127|FG003|Overall Study|Reason not Specified|1|||
94470817|NCT02697591|323515128|FG004|Overall Study|Reason not Specified|1|||
94470818|NCT02697591|323515129|FG005|Overall Study|Reason not Specified|2|||
94470819|NCT02697591|323515130|FG006|Overall Study|Reason not Specified|3|||
94470820|NCT02697591|323515131|FG007|Overall Study|Reason not Specified|1|||
94470821|NCT02697591|323515132|FG008|Overall Study|Reason not Specified|1|||
94470822|NCT02697591|323515133|FG009|Overall Study|Reason not Specified|3|||
94470823|NCT01853696|323515140|FG000|Overall Study|Withdrawal by Subject|1|||
94470824|NCT01853696|323515141|FG001|Overall Study|Withdrawal by Subject|1|||
94470825|NCT01853696|323515140|FG000|Overall Study|Lost to Follow-up|5|||
94470826|NCT01853696|323515141|FG001|Overall Study|Lost to Follow-up|4|||
94470827|NCT00438256|323515142|FG000|Overall Study|Ineligible for Resection|2|||
94470828|NCT00438256|323515143|FG001|Overall Study|Ineligible for Resection|1|||
94470829|NCT00438256|323515144|FG002|Overall Study|Ineligible for Resection|1|||
94470830|NCT00438256|323515145|FG003|Overall Study|Ineligible for Resection|7|||
94470831|NCT00438256|323515142|FG000|Overall Study|Excluded final Diagnosis|0|||
94470832|NCT00438256|323515143|FG001|Overall Study|Excluded final Diagnosis|0|||
94470833|NCT00438256|323515144|FG002|Overall Study|Excluded final Diagnosis|0|||
94470834|NCT00438256|323515145|FG003|Overall Study|Excluded final Diagnosis|2|||
94470835|NCT03230838|323515148|FG000|Overall Study|Withdrawal by Subject|3|||
94470836|NCT03230838|323515149|FG001|Overall Study|Withdrawal by Subject|0|||
94470837|NCT03230838|323515148|FG000|Overall Study|Temperature excursion|1|||
94470838|NCT03230838|323515149|FG001|Overall Study|Temperature excursion|0|||
94470839|NCT01915771|323515150|FG000|Day 1|Withdrawal by Subject|1|||
94470840|NCT01915771|323515150|FG000|Day 15|Withdrawal by Subject|1|||
94470841|NCT01693185|323515153|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
94470842|NCT01693185|323515154|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
94470843|NCT00076999|323515155|FG000|Overall Study|Adverse Event|2|||
94470844|NCT00076999|323515156|FG001|Overall Study|Adverse Event|8|||
94470845|NCT00076999|323515157|FG002|Overall Study|Adverse Event|6|||
94470846|NCT00076999|323515158|FG003|Overall Study|Adverse Event|0|||
94470847|NCT00076999|323515159|FG004|Overall Study|Adverse Event|2|||
94470848|NCT00076999|323515155|FG000|Overall Study|Protocol Violation|0|||
94470849|NCT00076999|323515156|FG001|Overall Study|Protocol Violation|3|||
94470850|NCT00076999|323515157|FG002|Overall Study|Protocol Violation|4|||
94470851|NCT00076999|323515158|FG003|Overall Study|Protocol Violation|0|||
94470852|NCT00076999|323515159|FG004|Overall Study|Protocol Violation|9|||
94470853|NCT00076999|323515155|FG000|Overall Study|Lost to Follow-up|2|||
94470854|NCT00076999|323515156|FG001|Overall Study|Lost to Follow-up|1|||
94470855|NCT00076999|323515157|FG002|Overall Study|Lost to Follow-up|0|||
94470856|NCT00076999|323515158|FG003|Overall Study|Lost to Follow-up|0|||
94470857|NCT00076999|323515159|FG004|Overall Study|Lost to Follow-up|0|||
94470858|NCT00076999|323515155|FG000|Overall Study|Withdrawal by Subject|0|||
94470859|NCT00076999|323515156|FG001|Overall Study|Withdrawal by Subject|4|||
94470860|NCT00076999|323515157|FG002|Overall Study|Withdrawal by Subject|3|||
94470861|NCT00076999|323515158|FG003|Overall Study|Withdrawal by Subject|0|||
94470862|NCT00076999|323515159|FG004|Overall Study|Withdrawal by Subject|1|||
94470863|NCT00076999|323515155|FG000|Overall Study|Other reason (not specified)|8|||
94309008|NCT00984659|322914950|FG001|2-week Run-in Period|Protocol Violation|0|||
94309009|NCT00984659|322914951|FG002|2-week Run-in Period|Protocol Violation|0|||
94309010|NCT00984659|322914952|FG003|2-week Run-in Period|Protocol Violation|0|||
94309011|NCT00984659|322914949|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
94309012|NCT00984659|322914950|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
94309013|NCT00984659|322914951|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
94309014|NCT00984659|322914952|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
94309015|NCT00984659|322914949|FG000|2-week Run-in Period|Lost to Follow-up|3|||
94309016|NCT00984659|322914950|FG001|2-week Run-in Period|Lost to Follow-up|0|||
94309017|NCT00984659|322914951|FG002|2-week Run-in Period|Lost to Follow-up|0|||
94309018|NCT00984659|322914952|FG003|2-week Run-in Period|Lost to Follow-up|0|||
94309019|NCT00984659|322914949|FG000|2-week Run-in Period|Physician Decision|10|||
94309020|NCT00984659|322914950|FG001|2-week Run-in Period|Physician Decision|0|||
94380011|NCT00175019|323176903|FG001|Overall Study|Did not continue under Amendment 4|1|||
94380012|NCT00175019|323176904|FG002|Overall Study|Did not continue under Amendment 4|2|||
94380013|NCT00175019|323176902|FG000|Overall Study|Personal Reason(s)|39|||
94380014|NCT00175019|323176903|FG001|Overall Study|Personal Reason(s)|31|||
94380015|NCT00175019|323176904|FG002|Overall Study|Personal Reason(s)|8|||
94380016|NCT00175019|323176902|FG000|Overall Study|Therapeutic Failure|10|||
94380017|NCT00175019|323176903|FG001|Overall Study|Therapeutic Failure|38|||
94380018|NCT00175019|323176904|FG002|Overall Study|Therapeutic Failure|22|||
94380019|NCT00175019|323176902|FG000|Overall Study|Gout Flare|2|||
94380020|NCT00175019|323176903|FG001|Overall Study|Gout Flare|3|||
94380021|NCT00175019|323176904|FG002|Overall Study|Gout Flare|0|||
94380022|NCT00175019|323176902|FG000|Overall Study|Reason Not Specified|40|||
94380023|NCT00175019|323176903|FG001|Overall Study|Reason Not Specified|34|||
94380024|NCT00175019|323176904|FG002|Overall Study|Reason Not Specified|11|||
94380025|NCT00723554|323176912|FG000|Overall Study|Adverse Event|12|||
94380026|NCT00723554|323176912|FG000|Overall Study|Investigator's judgement|5|||
94380027|NCT00723554|323176912|FG000|Overall Study|Inhaled medication other than iloprost|4|||
94380028|NCT00723554|323176912|FG000|Overall Study|Withdrawal of consent|3|||
94380029|NCT00723554|323176912|FG000|Overall Study|Other|3|||
94380030|NCT00723554|323176912|FG000|Overall Study|Lost to Follow-up|1|||
94380031|NCT00723554|323176912|FG000|Overall Study|Non-compliance|1|||
94380032|NCT02173704|323176913|FG000|Overall Study|Adverse Event|1|||
94380033|NCT02173704|323176914|FG001|Overall Study|Adverse Event|0|||
94380034|NCT02173704|323176913|FG000|Overall Study|Lost to Follow-up|1|||
94380035|NCT02173704|323176914|FG001|Overall Study|Lost to Follow-up|0|||
94380036|NCT02173704|323176913|FG000|Overall Study|Other|1|||
94380037|NCT02173704|323176914|FG001|Overall Study|Other|0|||
94380038|NCT02173704|323176913|FG000|Overall Study|Protocol Violation|1|||
94380039|NCT02173704|323176914|FG001|Overall Study|Protocol Violation|0|||
94380040|NCT02173704|323176913|FG000|Overall Study|Withdrawal by Subject|9|||
94380041|NCT02173704|323176914|FG001|Overall Study|Withdrawal by Subject|4|||
94380042|NCT01957488|323176918|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
94380043|NCT01957488|323176919|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
94380044|NCT01957488|323176920|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
94380045|NCT01957488|323176921|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
94380046|NCT01957488|323176922|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
94380047|NCT01957488|323176923|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
94380048|NCT01957488|323176918|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
94380049|NCT01957488|323176919|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
94380050|NCT01957488|323176920|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
94380051|NCT01957488|323176921|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
94380052|NCT01957488|323176922|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
94380053|NCT01957488|323176923|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
94380054|NCT01957488|323176918|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
94380055|NCT01957488|323176919|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
94380056|NCT01957488|323176920|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
94380057|NCT01957488|323176921|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
94380058|NCT01957488|323176922|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
94470864|NCT00076999|323515156|FG001|Overall Study|Other reason (not specified)|8|||
94309021|NCT00984659|322914951|FG002|2-week Run-in Period|Physician Decision|0|||
94309022|NCT00984659|322914952|FG003|2-week Run-in Period|Physician Decision|0|||
94309023|NCT00984659|322914949|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
94309024|NCT00984659|322914950|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
94380059|NCT01957488|323176923|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
94380060|NCT01957488|323176918|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
94380061|NCT01957488|323176919|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
94380062|NCT01957488|323176920|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
94380063|NCT01957488|323176921|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
94380064|NCT01957488|323176922|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
94380065|NCT01957488|323176923|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
94380066|NCT01957488|323176918|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
94380067|NCT01957488|323176919|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
94470865|NCT00076999|323515157|FG002|Overall Study|Other reason (not specified)|4|||
94470866|NCT00076999|323515158|FG003|Overall Study|Other reason (not specified)|1|||
94470867|NCT00076999|323515159|FG004|Overall Study|Other reason (not specified)|13|||
94470868|NCT00380718|323515160|FG000|Overall Study|Adverse Event|1|||
94470869|NCT00380718|323515160|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
94470870|NCT02670382|323515161|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
94470871|NCT02670382|323515162|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
94470872|NCT03244618|323515163|FG000|Overall Study|Lost to Follow-up|3|||
94470873|NCT03244618|323515164|FG001|Overall Study|Lost to Follow-up|4|||
94470874|NCT03244618|323515163|FG000|Overall Study|Protocol Violation|4|||
94470875|NCT03244618|323515164|FG001|Overall Study|Protocol Violation|3|||
94470876|NCT03244618|323515163|FG000|Overall Study|Withdrawal by Subject|0|||
94470877|NCT03244618|323515164|FG001|Overall Study|Withdrawal by Subject|2|||
94470878|NCT01048099|323515167|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
94470879|NCT01048099|323515167|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
94470880|NCT01863732|323515169|FG000|Overall Study|Adverse Event|2|||
94470881|NCT01863732|323515170|FG001|Overall Study|Adverse Event|0|||
94470882|NCT01863732|323515171|FG002|Overall Study|Adverse Event|3|||
94470883|NCT01863732|323515172|FG003|Overall Study|Adverse Event|3|||
94470884|NCT01863732|323515169|FG000|Overall Study|Lack of Efficacy|1|||
94470885|NCT01863732|323515170|FG001|Overall Study|Lack of Efficacy|0|||
94470886|NCT01863732|323515171|FG002|Overall Study|Lack of Efficacy|2|||
94470887|NCT01863732|323515172|FG003|Overall Study|Lack of Efficacy|1|||
94470888|NCT01863732|323515169|FG000|Overall Study|Lost to Follow-up|2|||
94470889|NCT01863732|323515170|FG001|Overall Study|Lost to Follow-up|2|||
94470890|NCT01863732|323515171|FG002|Overall Study|Lost to Follow-up|1|||
94470891|NCT01863732|323515172|FG003|Overall Study|Lost to Follow-up|1|||
94470892|NCT01863732|323515169|FG000|Overall Study|Physician Decision|1|||
94470893|NCT01863732|323515170|FG001|Overall Study|Physician Decision|0|||
94470894|NCT01863732|323515171|FG002|Overall Study|Physician Decision|1|||
94470895|NCT01863732|323515172|FG003|Overall Study|Physician Decision|0|||
94470896|NCT01863732|323515169|FG000|Overall Study|Pregnancy|0|||
94470897|NCT01863732|323515170|FG001|Overall Study|Pregnancy|0|||
94470898|NCT01863732|323515171|FG002|Overall Study|Pregnancy|0|||
94470899|NCT01863732|323515172|FG003|Overall Study|Pregnancy|1|||
94470900|NCT01863732|323515169|FG000|Overall Study|Technical problems|0|||
94470901|NCT01863732|323515170|FG001|Overall Study|Technical problems|1|||
94470902|NCT01863732|323515171|FG002|Overall Study|Technical problems|1|||
94470903|NCT01863732|323515172|FG003|Overall Study|Technical problems|0|||
94470904|NCT01863732|323515169|FG000|Overall Study|Subject/guardian decision|6|||
94470905|NCT01863732|323515170|FG001|Overall Study|Subject/guardian decision|9|||
94470906|NCT01863732|323515171|FG002|Overall Study|Subject/guardian decision|3|||
94470907|NCT01863732|323515172|FG003|Overall Study|Subject/guardian decision|1|||
94470908|NCT01863732|323515169|FG000|Overall Study|Death|1|||
94470909|NCT01863732|323515170|FG001|Overall Study|Death|0|||
94470910|NCT01863732|323515171|FG002|Overall Study|Death|0|||
94470911|NCT01863732|323515172|FG003|Overall Study|Death|1|||
94470912|NCT00508157|323515173|FG000|Overall Study|Adverse Event|0|||
94309025|NCT00984659|322914951|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
94309026|NCT00984659|322914952|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
94309027|NCT00984659|322914949|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
94470913|NCT00508157|323515174|FG001|Overall Study|Adverse Event|1|||
94470914|NCT00508157|323515173|FG000|Overall Study|Subject Withdrew Consent|1|||
94470915|NCT00508157|323515174|FG001|Overall Study|Subject Withdrew Consent|0|||
94470916|NCT00508157|323515173|FG000|Overall Study|Lost to Follow-up|1|||
94470917|NCT00508157|323515174|FG001|Overall Study|Lost to Follow-up|0|||
94470918|NCT00508157|323515173|FG000|Overall Study|Subject no longer met study criteria|0|||
94470919|NCT00508157|323515174|FG001|Overall Study|Subject no longer met study criteria|1|||
94470920|NCT00508157|323515173|FG000|Overall Study|Other known cause|0|||
94470921|NCT00508157|323515174|FG001|Overall Study|Other known cause|1|||
94470922|NCT04399538|323515180|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
94470923|NCT04399538|323515181|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
94470924|NCT04399538|323515182|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
94470925|NCT04399538|323515183|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
94470926|NCT04399538|323515184|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
94470927|NCT04399538|323515180|FG000|Double-Blind Treatment|Adverse Event|0|||
94470928|NCT04399538|323515181|FG001|Double-Blind Treatment|Adverse Event|0|||
94470929|NCT04399538|323515182|FG002|Double-Blind Treatment|Adverse Event|0|||
94470930|NCT04399538|323515183|FG003|Double-Blind Treatment|Adverse Event|0|||
94470931|NCT04399538|323515184|FG004|Double-Blind Treatment|Adverse Event|1|||
94470932|NCT04399538|323515180|FG000|Follow-Up|Adverse Event|0|||
94470933|NCT04399538|323515181|FG001|Follow-Up|Adverse Event|0|||
94470934|NCT04399538|323515182|FG002|Follow-Up|Adverse Event|0|||
94470935|NCT04399538|323515183|FG003|Follow-Up|Adverse Event|0|||
94470936|NCT04399538|323515184|FG004|Follow-Up|Adverse Event|1|||
94470937|NCT04399538|323515180|FG000|Follow-Up|Withdrawal by Subject|0|||
94470938|NCT04399538|323515181|FG001|Follow-Up|Withdrawal by Subject|0|||
94470939|NCT04399538|323515182|FG002|Follow-Up|Withdrawal by Subject|0|||
94470940|NCT04399538|323515183|FG003|Follow-Up|Withdrawal by Subject|2|||
94470941|NCT04399538|323515184|FG004|Follow-Up|Withdrawal by Subject|0|||
94470942|NCT00742027|323515186|FG000|Overall Study|Disease Progression|76|||
94470943|NCT00742027|323515186|FG000|Overall Study|New Cancer Therapy|19|||
94470944|NCT00742027|323515186|FG000|Overall Study|Withdrawal by Subject|18|||
94470945|NCT00742027|323515186|FG000|Overall Study|Death|7|||
94470946|NCT00742027|323515186|FG000|Overall Study|Lost to Follow-up|4|||
94470947|NCT00742027|323515186|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
94470948|NCT00742027|323515186|FG000|Overall Study|Missing|2|||
94470949|NCT00742027|323515186|FG000|Overall Study|Administrative Problems|1|||
94470950|NCT02756364|323515192|FG000|Overall Study|Site Terminated by Sponsor|24|||
94470951|NCT02756364|323515193|FG001|Overall Study|Site Terminated by Sponsor|30|||
94470952|NCT02756364|323515194|FG002|Overall Study|Site Terminated by Sponsor|21|||
94470953|NCT02756364|323515192|FG000|Overall Study|Death|20|||
94470954|NCT02756364|323515193|FG001|Overall Study|Death|15|||
94470955|NCT02756364|323515194|FG002|Overall Study|Death|18|||
94470956|NCT02756364|323515192|FG000|Overall Study|Withdrawal by Patient|2|||
94470957|NCT02756364|323515193|FG001|Overall Study|Withdrawal by Patient|1|||
94470958|NCT02756364|323515194|FG002|Overall Study|Withdrawal by Patient|8|||
94470959|NCT02756364|323515192|FG000|Overall Study|Lost to Follow-up|0|||
94470960|NCT02756364|323515193|FG001|Overall Study|Lost to Follow-up|1|||
94470961|NCT02756364|323515194|FG002|Overall Study|Lost to Follow-up|1|||
94470962|NCT02432144|323515195|FG000|Overall Study|Participant Non-Compliance|1|||
94470963|NCT03035916|323515196|FG000|Overall Study|Puncture failed|0|||
94470964|NCT03035916|323515197|FG001|Overall Study|Puncture failed|2|||
94470965|NCT03035916|323515198|FG002|Overall Study|Puncture failed|0|||
94470966|NCT02452554|323515199|FG000|Overall Study|Death|2|||
94309028|NCT00984659|322914950|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
94309029|NCT00984659|322914951|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
94309030|NCT00984659|322914952|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
94309031|NCT00984659|322914949|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
94309032|NCT00984659|322914950|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
94309033|NCT00984659|322914951|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
94309034|NCT00984659|322914952|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
94309035|NCT00984659|322914949|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
94309036|NCT00984659|322914950|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
94309037|NCT00984659|322914951|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
94309038|NCT00984659|322914952|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
94309039|NCT00984659|322914949|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
94309040|NCT00984659|322914950|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
94309041|NCT00984659|322914951|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
94309042|NCT00984659|322914952|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
94309043|NCT00984659|322914949|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
94309044|NCT00984659|322914950|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
94309045|NCT00984659|322914951|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
94309046|NCT00984659|322914952|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
94309047|NCT00984659|322914949|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
94309048|NCT00984659|322914950|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
94309049|NCT00984659|322914951|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
94309050|NCT00984659|322914952|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
94309051|NCT01342640|322914953|FG000|Overall Study|Adverse Event|3|||
94309052|NCT01342640|322914953|FG000|Overall Study|Protocol Violation|16|||
94309053|NCT01342640|322914953|FG000|Overall Study|Lost to Follow-up|21|||
94309054|NCT01342640|322914953|FG000|Overall Study|Other|1|||
94309055|NCT00545818|322914954|FG000|Overall Study|Protocol Violation|1|||
94309056|NCT00545818|322914955|FG001|Overall Study|Protocol Violation|0|||
94309057|NCT00545818|322914954|FG000|Overall Study|Adverse Event|1|||
94309058|NCT00545818|322914955|FG001|Overall Study|Adverse Event|1|||
94309059|NCT00545818|322914954|FG000|Overall Study|Lost to Follow-up|1|||
94309060|NCT00545818|322914955|FG001|Overall Study|Lost to Follow-up|6|||
94309061|NCT00537823|322914958|FG000|Overall Study|Adverse Event|2|||
94309062|NCT00537823|322914959|FG001|Overall Study|Adverse Event|0|||
94309063|NCT02240628|322914960|FG000|Overall Study|Physician Decision|6|||
94309064|NCT02240628|322914961|FG001|Overall Study|Physician Decision|5|||
94309065|NCT02385123|322914965|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
94309066|NCT03472534|322914966|FG000|Overall Study|Withdrawal by Subject|9|||
94470967|NCT02452554|323515200|FG001|Overall Study|Death|1|||
94470968|NCT02452554|323515201|FG002|Overall Study|Death|0|||
94470969|NCT02452554|323515202|FG003|Overall Study|Death|0|||
94470970|NCT02452554|323515203|FG004|Overall Study|Death|0|||
94470971|NCT02452554|323515204|FG005|Overall Study|Death|0|||
94470972|NCT02452554|323515199|FG000|Overall Study|Lack of Efficacy|13|||
94380068|NCT01957488|323176920|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
94380069|NCT01957488|323176921|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
94380070|NCT01957488|323176922|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
94380071|NCT01957488|323176923|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
94380072|NCT01957488|323176918|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
94380073|NCT01957488|323176919|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
94380074|NCT01957488|323176920|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
94380075|NCT01957488|323176921|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
94380076|NCT01957488|323176922|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
94380077|NCT01957488|323176923|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
94380078|NCT01957488|323176918|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
94380079|NCT01957488|323176919|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
94380080|NCT01957488|323176920|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
94380081|NCT01957488|323176921|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
94380082|NCT01957488|323176922|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
94380083|NCT01957488|323176923|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
94380084|NCT01957488|323176918|FG000|Test Period 2 (2 Weeks)|Other|1|||
94380085|NCT01957488|323176919|FG001|Test Period 2 (2 Weeks)|Other|0|||
94380086|NCT01957488|323176920|FG002|Test Period 2 (2 Weeks)|Other|0|||
94380087|NCT01957488|323176921|FG003|Test Period 2 (2 Weeks)|Other|0|||
94380088|NCT01957488|323176922|FG004|Test Period 2 (2 Weeks)|Other|0|||
94380089|NCT01957488|323176923|FG005|Test Period 2 (2 Weeks)|Other|0|||
94380090|NCT01957488|323176918|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
94380091|NCT01957488|323176919|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
94380092|NCT01957488|323176920|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
94380093|NCT01957488|323176921|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
94380094|NCT01957488|323176922|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
94380095|NCT01957488|323176923|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
94380096|NCT01957488|323176918|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
94380097|NCT01957488|323176919|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
94380098|NCT01957488|323176920|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
94380099|NCT01957488|323176921|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
94380100|NCT01957488|323176922|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
94380101|NCT01957488|323176923|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
94380102|NCT01957488|323176918|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
94380103|NCT01957488|323176919|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
94380104|NCT01957488|323176920|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
94380105|NCT01957488|323176921|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
94380106|NCT01957488|323176922|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
94380107|NCT01957488|323176923|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
94380108|NCT01957488|323176918|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
94380109|NCT01957488|323176919|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
94380110|NCT01957488|323176920|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
94380111|NCT01957488|323176921|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
94380112|NCT01957488|323176922|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
94380113|NCT01957488|323176923|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
94380114|NCT01957488|323176918|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
94380115|NCT01957488|323176919|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
94380116|NCT01957488|323176920|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
94380117|NCT01957488|323176921|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
94380118|NCT01957488|323176922|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
94380119|NCT01957488|323176923|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
94380120|NCT02374918|323176924|FG000|Overall Study|Protocol Violation|2|||
94380121|NCT02374918|323176925|FG001|Overall Study|Protocol Violation|0|||
94380122|NCT02374918|323176926|FG002|Overall Study|Protocol Violation|2|||
94380123|NCT02374918|323176927|FG003|Overall Study|Protocol Violation|1|||
94380124|NCT02374918|323176924|FG000|Overall Study|Withdrawal by Subject|1|||
94380125|NCT02374918|323176925|FG001|Overall Study|Withdrawal by Subject|1|||
94380126|NCT02374918|323176926|FG002|Overall Study|Withdrawal by Subject|1|||
94380127|NCT02374918|323176927|FG003|Overall Study|Withdrawal by Subject|0|||
94380128|NCT02374918|323176924|FG000|Overall Study|Lack of Efficacy|0|||
94380129|NCT02374918|323176925|FG001|Overall Study|Lack of Efficacy|0|||
94380130|NCT02374918|323176926|FG002|Overall Study|Lack of Efficacy|1|||
94380131|NCT02374918|323176927|FG003|Overall Study|Lack of Efficacy|1|||
94380132|NCT04041570|323176928|FG000|Overall Study|Moved from Area|0|||
94380133|NCT04041570|323176929|FG001|Overall Study|Moved from Area|2|||
94380134|NCT02419313|323176930|FG000|First Intervention|Lost to Follow-up|2|||
94380135|NCT02419313|323176931|FG001|First Intervention|Lost to Follow-up|0|||
94380136|NCT02419313|323176930|FG000|Second Intervention|Lost to Follow-up|1|||
94380137|NCT02419313|323176931|FG001|Second Intervention|Lost to Follow-up|0|||
94470973|NCT02452554|323515200|FG001|Overall Study|Lack of Efficacy|14|||
94470974|NCT02452554|323515201|FG002|Overall Study|Lack of Efficacy|9|||
94470975|NCT02452554|323515202|FG003|Overall Study|Lack of Efficacy|1|||
94309067|NCT03472534|322914966|FG000|Overall Study|Adverse Event|2|||
94309068|NCT00718861|322914967|FG000|Overall Study|Withdrawal by Subject|15|||
94309069|NCT00718861|322914968|FG001|Overall Study|Withdrawal by Subject|10|||
94309070|NCT00718861|322914967|FG000|Overall Study|Adverse Event|2|||
94309071|NCT00718861|322914968|FG001|Overall Study|Adverse Event|1|||
94309072|NCT00718861|322914967|FG000|Overall Study|Lost to Follow-up|2|||
94309073|NCT00718861|322914968|FG001|Overall Study|Lost to Follow-up|1|||
94309074|NCT00718861|322914967|FG000|Overall Study|Administrative Problems|1|||
94309075|NCT00718861|322914968|FG001|Overall Study|Administrative Problems|1|||
94309076|NCT00718861|322914967|FG000|Overall Study|Death|1|||
94309077|NCT00718861|322914968|FG001|Overall Study|Death|5|||
94309078|NCT01221233|322914970|FG000|Overall Study|Withdrawal by Subject|3|||
94309079|NCT01221233|322914971|FG001|Overall Study|Withdrawal by Subject|1|||
94309080|NCT03865407|322914973|FG000|Overall Study|Adverse Event|1|||
94309081|NCT03865407|322914974|FG001|Overall Study|Adverse Event|0|||
94309082|NCT03865407|322914973|FG000|Overall Study|Withdrawal by Subject|1|||
94309083|NCT03865407|322914974|FG001|Overall Study|Withdrawal by Subject|0|||
94309084|NCT03865407|322914973|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
94309085|NCT03865407|322914974|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
94309086|NCT02117050|322914975|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
94309087|NCT00859898|322914976|FG000|Overall Study|Lack of Efficacy|0|||
94309088|NCT00859898|322914977|FG001|Overall Study|Lack of Efficacy|1|||
94309089|NCT00859898|322914978|FG002|Overall Study|Lack of Efficacy|1|||
94309090|NCT00859898|322914976|FG000|Overall Study|Adverse Event|4|||
94309091|NCT00859898|322914977|FG001|Overall Study|Adverse Event|9|||
94309092|NCT00859898|322914978|FG002|Overall Study|Adverse Event|8|||
94309093|NCT00859898|322914976|FG000|Overall Study|Withdrawal by Subject|11|||
94309094|NCT00859898|322914977|FG001|Overall Study|Withdrawal by Subject|8|||
94309095|NCT00859898|322914978|FG002|Overall Study|Withdrawal by Subject|11|||
94309096|NCT00859898|322914976|FG000|Overall Study|Death|0|||
94309097|NCT00859898|322914977|FG001|Overall Study|Death|0|||
94309098|NCT00859898|322914978|FG002|Overall Study|Death|1|||
94309099|NCT00859898|322914976|FG000|Overall Study|Lost to Follow-up|10|||
94309100|NCT00859898|322914977|FG001|Overall Study|Lost to Follow-up|11|||
94309101|NCT00859898|322914978|FG002|Overall Study|Lost to Follow-up|5|||
94309102|NCT00859898|322914976|FG000|Overall Study|poor/non-compliance|2|||
94309103|NCT00859898|322914977|FG001|Overall Study|poor/non-compliance|0|||
94380138|NCT02204371|323176932|FG000|Overall Study|Adverse Event|1|||
94380139|NCT00688064|323176933|FG000|Overall Study|Protocol Violation|0|||
94380140|NCT00688064|323176934|FG001|Overall Study|Protocol Violation|1|||
94380141|NCT00688064|323176933|FG000|Overall Study|Adverse Event|2|||
94380142|NCT00688064|323176934|FG001|Overall Study|Adverse Event|4|||
94380143|NCT00688064|323176933|FG000|Overall Study|Withdrawal by Subject|7|||
94380144|NCT00688064|323176934|FG001|Overall Study|Withdrawal by Subject|7|||
94380145|NCT00688064|323176933|FG000|Overall Study|Lost to Follow-up|10|||
94380146|NCT00688064|323176934|FG001|Overall Study|Lost to Follow-up|10|||
94380147|NCT00688064|323176933|FG000|Overall Study|Lack of Efficacy|0|||
94380148|NCT00688064|323176934|FG001|Overall Study|Lack of Efficacy|1|||
94380149|NCT00688064|323176933|FG000|Overall Study|Pregnancy|1|||
94380150|NCT00688064|323176934|FG001|Overall Study|Pregnancy|0|||
94380151|NCT00688064|323176933|FG000|Overall Study|Any other reasons|1|||
94380152|NCT00688064|323176934|FG001|Overall Study|Any other reasons|3|||
94380153|NCT00368966|323176935|FG000|Infant Series|Withdrawal by Subject|11|||
94380154|NCT00368966|323176936|FG001|Infant Series|Withdrawal by Subject|6|||
94380155|NCT00368966|323176935|FG000|Infant Series|Protocol Violation|2|||
94380156|NCT00368966|323176936|FG001|Infant Series|Protocol Violation|1|||
94380157|NCT00368966|323176935|FG000|Infant Series|Lost to Follow-up|2|||
94380158|NCT00368966|323176936|FG001|Infant Series|Lost to Follow-up|0|||
94380159|NCT00368966|323176935|FG000|Infant Series|Randomization error|0|||
94380160|NCT00368966|323176936|FG001|Infant Series|Randomization error|1|||
94380161|NCT00368966|323176935|FG000|Infant Series|Failed to meet eligibility criteria|0|||
94380162|NCT00368966|323176936|FG001|Infant Series|Failed to meet eligibility criteria|1|||
94380163|NCT00368966|323176935|FG000|Infant Series|Adverse Event|0|||
94380164|NCT00368966|323176936|FG001|Infant Series|Adverse Event|1|||
94380165|NCT00368966|323176935|FG000|Infant Series|Failed to return|1|||
94380166|NCT00368966|323176936|FG001|Infant Series|Failed to return|0|||
94380167|NCT00368966|323176935|FG000|After Infant|Failed to return|3|||
94380168|NCT00368966|323176936|FG001|After Infant|Failed to return|1|||
94380169|NCT00368966|323176935|FG000|After Infant|Adverse Event|1|||
94380170|NCT00368966|323176936|FG001|After Infant|Adverse Event|2|||
94380171|NCT00368966|323176935|FG000|After Infant|Withdrawal by Subject|1|||
94309104|NCT00859898|322914978|FG002|Overall Study|poor/non-compliance|0|||
94309105|NCT00859898|322914976|FG000|Overall Study|No longer meets criteria|0|||
94309106|NCT00859898|322914977|FG001|Overall Study|No longer meets criteria|1|||
94309107|NCT00859898|322914978|FG002|Overall Study|No longer meets criteria|0|||
94309108|NCT00859898|322914976|FG000|Overall Study|non-specified|1|||
94309109|NCT00859898|322914977|FG001|Overall Study|non-specified|1|||
94309110|NCT00859898|322914978|FG002|Overall Study|non-specified|1|||
94309111|NCT00546819|322914979|FG000|Overall Study|Adverse Event|2|||
94309112|NCT00546819|322914980|FG001|Overall Study|Adverse Event|3|||
94309113|NCT00546819|322914979|FG000|Overall Study|Lost to Follow-up|2|||
94309114|NCT00546819|322914980|FG001|Overall Study|Lost to Follow-up|1|||
94309115|NCT00546819|322914979|FG000|Overall Study|Withdrawal by Subject|4|||
94309116|NCT00546819|322914980|FG001|Overall Study|Withdrawal by Subject|2|||
94309117|NCT00858702|322914981|FG000|Overall Study|Lack of Efficacy|1|||
94309118|NCT00858702|322914982|FG001|Overall Study|Lack of Efficacy|0|||
94309119|NCT00858702|322914981|FG000|Overall Study|Protocol Violation|1|||
94309120|NCT00858702|322914982|FG001|Overall Study|Protocol Violation|1|||
94309121|NCT00858702|322914981|FG000|Overall Study|Other|2|||
94309122|NCT00858702|322914982|FG001|Overall Study|Other|1|||
94309123|NCT00858702|322914981|FG000|Overall Study|Withdrawal by Subject|1|||
94309124|NCT00858702|322914982|FG001|Overall Study|Withdrawal by Subject|0|||
94309125|NCT02859415|322914985|FG000|Overall Study|Physician Decision|1|||
94309126|NCT02859415|322914986|FG001|Overall Study|Physician Decision|0|||
94309127|NCT02859415|322914985|FG000|Overall Study|Off treatment due to cardiac event|0|||
94309128|NCT02859415|322914986|FG001|Overall Study|Off treatment due to cardiac event|1|||
94309129|NCT01396525|322914987|FG000|Overall Study|Withdrawal by Subject|8|||
94309130|NCT01396525|322914987|FG000|Overall Study|Death|14|||
94309131|NCT01396525|322914987|FG000|Overall Study|Lost to Follow-up|4|||
94309132|NCT01174784|322914988|FG000|Overall Study|Screen fails|4|||
94309133|NCT03671369|322914993|FG000|Overall Study|Other|1|||
94309134|NCT03671369|322914993|FG000|Overall Study|Withdrawal by Subject|289|||
94309135|NCT03671369|322914993|FG000|Overall Study|Not willing to be vaccinated|1|||
94309136|NCT02675517|322914995|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
94309137|NCT02675517|322914995|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
94309138|NCT02902809|322914996|FG000|Overall Study|Discontinuation of asthma program|28|||
94309139|NCT00611130|322914997|FG000|Overall Study|Lost to Follow-up|25|||
94309140|NCT00611130|322914998|FG001|Overall Study|Lost to Follow-up|29|||
94309141|NCT00611130|322914997|FG000|Overall Study|Protocol noncompliance|7|||
94309142|NCT00611130|322914998|FG001|Overall Study|Protocol noncompliance|6|||
94309143|NCT00611130|322914997|FG000|Overall Study|Withdrawal by Subject|6|||
94309144|NCT00611130|322914998|FG001|Overall Study|Withdrawal by Subject|5|||
94309145|NCT00611130|322914997|FG000|Overall Study|Other|5|||
94309146|NCT00611130|322914998|FG001|Overall Study|Other|4|||
94309147|NCT00611130|322914997|FG000|Overall Study|Incarceration|3|||
94309148|NCT00611130|322914998|FG001|Overall Study|Incarceration|2|||
94309149|NCT00611130|322914997|FG000|Overall Study|Administrative|1|||
94309150|NCT00611130|322914998|FG001|Overall Study|Administrative|1|||
94309151|NCT00611130|322914997|FG000|Overall Study|Adverse Event|1|||
94309152|NCT00611130|322914998|FG001|Overall Study|Adverse Event|0|||
94309153|NCT00611130|322914997|FG000|Overall Study|Death|1|||
94309154|NCT00611130|322914998|FG001|Overall Study|Death|0|||
94309155|NCT00514449|322914999|FG000|Overall Study|Withdrawal by Subject|1|||
94309156|NCT00514449|322915000|FG001|Overall Study|Withdrawal by Subject|2|||
94309157|NCT00514449|322914999|FG000|Overall Study|Protocol Violation|1|||
94309158|NCT00514449|322915000|FG001|Overall Study|Protocol Violation|2|||
94309159|NCT00514449|322914999|FG000|Overall Study|Lost to Follow-up|1|||
94309160|NCT00514449|322915000|FG001|Overall Study|Lost to Follow-up|0|||
94309161|NCT01478347|322915001|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
94309162|NCT01478347|322915001|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
94309163|NCT01478347|322915001|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
94309164|NCT02983292|322915002|FG000|Overall Study|Participant unwell & cannot travel|2|||
94309165|NCT02983292|322915002|FG000|Overall Study|Lost to Follow-up|3|||
94309166|NCT02983292|322915002|FG000|Overall Study|Participant withdrew consent|2|||
94309167|NCT02983292|322915002|FG000|Overall Study|Revision|7|||
94380172|NCT00368966|323176936|FG001|After Infant|Withdrawal by Subject|1|||
94380173|NCT00368966|323176935|FG000|After Infant|Death|1|||
94380174|NCT00368966|323176936|FG001|After Infant|Death|0|||
94309168|NCT02983292|322915002|FG000|Overall Study|Death|1|||
94309169|NCT02983292|322915002|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
94309170|NCT02983292|322915002|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
94309171|NCT02983292|322915002|FG000|Overall Study|Participant relocation|1|||
94309172|NCT01158950|322915003|FG000|1st Intervention (1 Day)|Physician Decision|1|||
94309173|NCT01158950|322915004|FG001|1st Intervention (1 Day)|Physician Decision|2|||
94309174|NCT00673673|322915005|FG000|Overall Study|Progressive disease|27|||
94309175|NCT00673673|322915005|FG000|Overall Study|Adverse Event|4|||
94309176|NCT00673673|322915005|FG000|Overall Study|Withdrawal by Subject|3|||
94309177|NCT00673673|322915005|FG000|Overall Study|Investigators' discretion|2|||
94309178|NCT02335450|322915012|FG000|Overall Study|Pregnancy|1|||
94309179|NCT00652093|322915013|FG000|Overall Study|Withdrawal by Subject|0|||
94309180|NCT00652093|322915014|FG001|Overall Study|Withdrawal by Subject|0|||
94309181|NCT00652093|322915015|FG002|Overall Study|Withdrawal by Subject|1|||
94309182|NCT00652093|322915016|FG003|Overall Study|Withdrawal by Subject|0|||
94309183|NCT00652093|322915017|FG004|Overall Study|Withdrawal by Subject|1|||
94309184|NCT00652093|322915018|FG005|Overall Study|Withdrawal by Subject|0|||
94380175|NCT00368966|323176935|FG000|After Infant|Lost to Follow-up|0|||
94380176|NCT00368966|323176936|FG001|After Infant|Lost to Follow-up|1|||
94380177|NCT00368966|323176935|FG000|Toddler Dose|Withdrawal by Subject|1|||
94380178|NCT00368966|323176936|FG001|Toddler Dose|Withdrawal by Subject|1|||
94380179|NCT00368966|323176935|FG000|Toddler Dose|Lost to Follow-up|0|||
94380180|NCT00368966|323176936|FG001|Toddler Dose|Lost to Follow-up|2|||
94380181|NCT02866175|323176937|FG000|Overall Study|Adverse Event|56|||
94380182|NCT02866175|323176938|FG001|Overall Study|Adverse Event|54|||
94380183|NCT02866175|323176937|FG000|Overall Study|Withdrawal by Subject|31|||
94380184|NCT02866175|323176938|FG001|Overall Study|Withdrawal by Subject|52|||
94380185|NCT02866175|323176937|FG000|Overall Study|Death|30|||
94380186|NCT02866175|323176938|FG001|Overall Study|Death|23|||
94380187|NCT02866175|323176937|FG000|Overall Study|Other|7|||
94380188|NCT02866175|323176938|FG001|Overall Study|Other|14|||
94380189|NCT02866175|323176937|FG000|Overall Study|Progressive disease|1|||
94380190|NCT02866175|323176938|FG001|Overall Study|Progressive disease|1|||
94380191|NCT02866175|323176937|FG000|Overall Study|Lost to Follow-up|2|||
94380192|NCT02866175|323176938|FG001|Overall Study|Lost to Follow-up|0|||
94380193|NCT02866175|323176937|FG000|Overall Study|Lack of Efficacy|0|||
94380194|NCT02866175|323176938|FG001|Overall Study|Lack of Efficacy|1|||
94380195|NCT02866175|323176937|FG000|Overall Study|Physician Decision|3|||
94380196|NCT02866175|323176938|FG001|Overall Study|Physician Decision|15|||
94380197|NCT02866175|323176937|FG000|Overall Study|Did not receive treatment|5|||
94380198|NCT02866175|323176938|FG001|Overall Study|Did not receive treatment|15|||
94380199|NCT01694485|323176939|FG000|Overall Study|Withdrawal by Subject|20|||
94380200|NCT01694485|323176940|FG001|Overall Study|Withdrawal by Subject|6|||
94380201|NCT01694485|323176941|FG002|Overall Study|Withdrawal by Subject|7|||
94380202|NCT01694485|323176942|FG003|Overall Study|Withdrawal by Subject|25|||
94380203|NCT01694485|323176943|FG004|Overall Study|Withdrawal by Subject|18|||
94380204|NCT01694485|323176939|FG000|Overall Study|Sponsor Decision|3|||
94380205|NCT01694485|323176940|FG001|Overall Study|Sponsor Decision|0|||
94380206|NCT01694485|323176941|FG002|Overall Study|Sponsor Decision|0|||
94380207|NCT01694485|323176942|FG003|Overall Study|Sponsor Decision|2|||
94380208|NCT01694485|323176943|FG004|Overall Study|Sponsor Decision|0|||
94380209|NCT01694485|323176939|FG000|Overall Study|Lost to Follow-up|9|||
94380210|NCT01694485|323176940|FG001|Overall Study|Lost to Follow-up|1|||
94380211|NCT01694485|323176941|FG002|Overall Study|Lost to Follow-up|6|||
94380212|NCT01694485|323176942|FG003|Overall Study|Lost to Follow-up|10|||
94380213|NCT01694485|323176943|FG004|Overall Study|Lost to Follow-up|7|||
94380214|NCT01694485|323176939|FG000|Overall Study|Death|1|||
94380215|NCT01694485|323176940|FG001|Overall Study|Death|0|||
94380216|NCT01694485|323176941|FG002|Overall Study|Death|0|||
94380217|NCT01694485|323176942|FG003|Overall Study|Death|1|||
94380218|NCT01694485|323176943|FG004|Overall Study|Death|0|||
94380219|NCT04956666|323176944|FG000|Overall Study|Adverse Event|18|||
94380220|NCT04956666|323176944|FG000|Overall Study|Physician Decision|5|||
94380221|NCT00729859|323176945|FG000|Overall Study|Adverse Event|0|||
94380222|NCT00729859|323176946|FG001|Overall Study|Adverse Event|1|||
94380223|NCT00729859|323176947|FG002|Overall Study|Adverse Event|0|||
94380224|NCT00729859|323176945|FG000|Overall Study|Withdrawal by Subject|0|||
94380225|NCT00729859|323176946|FG001|Overall Study|Withdrawal by Subject|1|||
94380226|NCT00729859|323176947|FG002|Overall Study|Withdrawal by Subject|0|||
94380227|NCT02750306|323176949|FG000|Overall Study|Withdrawal by Subject|5|||
94380228|NCT02750306|323176950|FG001|Overall Study|Withdrawal by Subject|2|||
94380229|NCT02750306|323176949|FG000|Overall Study|Protocol Violation|1|||
94380230|NCT02750306|323176950|FG001|Overall Study|Protocol Violation|0|||
94380231|NCT01966042|323176951|FG000|Overall Study|Death|2|||
94380232|NCT00113490|323176952|FG000|Overall Study|Withdrawal by Subject|1|||
94380233|NCT00113490|323176953|FG001|Overall Study|Withdrawal by Subject|3|||
94380234|NCT00113490|323176952|FG000|Overall Study|Lost to Follow-up|1|||
94380235|NCT00113490|323176953|FG001|Overall Study|Lost to Follow-up|0|||
94380236|NCT01254409|323176956|FG000|Overall Study|Adverse Event|0|||
94380237|NCT01254409|323176957|FG001|Overall Study|Adverse Event|1|||
94380238|NCT01254409|323176958|FG002|Overall Study|Adverse Event|0|||
94380239|NCT01254409|323176959|FG003|Overall Study|Adverse Event|0|||
94380240|NCT00876733|323176962|FG000|Overall Study|Adverse Event|34|||
94380241|NCT00876733|323176963|FG001|Overall Study|Adverse Event|20|||
94380242|NCT00876733|323176964|FG002|Overall Study|Adverse Event|10|||
94380243|NCT00876733|323176965|FG003|Overall Study|Adverse Event|3|||
94380244|NCT00876733|323176962|FG000|Overall Study|Lack of Efficacy|17|||
94380245|NCT00876733|323176963|FG001|Overall Study|Lack of Efficacy|9|||
94380246|NCT00876733|323176964|FG002|Overall Study|Lack of Efficacy|10|||
94380247|NCT00876733|323176965|FG003|Overall Study|Lack of Efficacy|1|||
94380248|NCT00876733|323176962|FG000|Overall Study|Lost to Follow-up|26|||
94380249|NCT00876733|323176963|FG001|Overall Study|Lost to Follow-up|10|||
94380250|NCT00876733|323176964|FG002|Overall Study|Lost to Follow-up|3|||
94380251|NCT00876733|323176965|FG003|Overall Study|Lost to Follow-up|2|||
94380252|NCT00876733|323176962|FG000|Overall Study|Data not available|14|||
94380253|NCT00876733|323176963|FG001|Overall Study|Data not available|3|||
94380254|NCT00876733|323176964|FG002|Overall Study|Data not available|7|||
94380255|NCT00876733|323176965|FG003|Overall Study|Data not available|1|||
94470976|NCT02452554|323515203|FG004|Overall Study|Lack of Efficacy|5|||
94470977|NCT02452554|323515204|FG005|Overall Study|Lack of Efficacy|8|||
94470978|NCT02452554|323515199|FG000|Overall Study|Physician Decision|0|||
94470979|NCT02452554|323515200|FG001|Overall Study|Physician Decision|1|||
94470980|NCT02452554|323515201|FG002|Overall Study|Physician Decision|0|||
94470981|NCT02452554|323515202|FG003|Overall Study|Physician Decision|0|||
94470982|NCT02452554|323515203|FG004|Overall Study|Physician Decision|0|||
94470983|NCT02452554|323515204|FG005|Overall Study|Physician Decision|0|||
94470984|NCT02452554|323515199|FG000|Overall Study|Withdrawal by Subject|1|||
94470985|NCT02452554|323515200|FG001|Overall Study|Withdrawal by Subject|0|||
94470986|NCT02452554|323515201|FG002|Overall Study|Withdrawal by Subject|2|||
94470987|NCT02452554|323515202|FG003|Overall Study|Withdrawal by Subject|0|||
94470988|NCT02452554|323515203|FG004|Overall Study|Withdrawal by Subject|0|||
94470989|NCT02452554|323515204|FG005|Overall Study|Withdrawal by Subject|1|||
94470990|NCT02452554|323515199|FG000|Overall Study|Ineligible|0|||
94470991|NCT02452554|323515200|FG001|Overall Study|Ineligible|1|||
94470992|NCT02452554|323515201|FG002|Overall Study|Ineligible|0|||
94470993|NCT02452554|323515202|FG003|Overall Study|Ineligible|0|||
94470994|NCT02452554|323515203|FG004|Overall Study|Ineligible|0|||
94470995|NCT02452554|323515204|FG005|Overall Study|Ineligible|0|||
94470996|NCT02452554|323515199|FG000|Overall Study|Never Received Treatment|1|||
94470997|NCT02452554|323515200|FG001|Overall Study|Never Received Treatment|0|||
94470998|NCT02452554|323515201|FG002|Overall Study|Never Received Treatment|0|||
94470999|NCT02452554|323515202|FG003|Overall Study|Never Received Treatment|0|||
94471000|NCT02452554|323515203|FG004|Overall Study|Never Received Treatment|0|||
94471001|NCT02452554|323515204|FG005|Overall Study|Never Received Treatment|0|||
94471002|NCT01402986|323515205|FG000|Overall Study|Withdrawal by Subject|7|||
94471003|NCT01402986|323515206|FG001|Overall Study|Withdrawal by Subject|10|||
94471004|NCT01402986|323515207|FG002|Overall Study|Withdrawal by Subject|7|||
94471005|NCT01402986|323515208|FG003|Overall Study|Withdrawal by Subject|13|||
94471006|NCT01402986|323515205|FG000|Overall Study|Death|0|||
94471007|NCT01402986|323515206|FG001|Overall Study|Death|0|||
94471008|NCT01402986|323515207|FG002|Overall Study|Death|0|||
94471009|NCT01402986|323515208|FG003|Overall Study|Death|2|||
94471010|NCT01402986|323515205|FG000|Overall Study|Lost to Follow-up|0|||
94471011|NCT01402986|323515206|FG001|Overall Study|Lost to Follow-up|0|||
94471012|NCT01402986|323515207|FG002|Overall Study|Lost to Follow-up|0|||
94471013|NCT01402986|323515208|FG003|Overall Study|Lost to Follow-up|1|||
94471014|NCT01402986|323515205|FG000|Overall Study|Other|2|||
94471015|NCT01402986|323515206|FG001|Overall Study|Other|5|||
94471016|NCT01402986|323515207|FG002|Overall Study|Other|1|||
94471017|NCT01402986|323515208|FG003|Overall Study|Other|6|||
94471018|NCT01085084|323515209|FG000|Overall Study|Withdrawal by Subject|1|||
94471019|NCT01085084|323515210|FG001|Overall Study|Withdrawal by Subject|0|||
94471020|NCT01085084|323515211|FG002|Overall Study|Withdrawal by Subject|0|||
94471021|NCT01085084|323515209|FG000|Overall Study|Lost to Follow-up|2|||
94471022|NCT01085084|323515210|FG001|Overall Study|Lost to Follow-up|1|||
94471023|NCT01085084|323515211|FG002|Overall Study|Lost to Follow-up|1|||
94471024|NCT01085084|323515209|FG000|Overall Study|Adverse Event|4|||
94471025|NCT01085084|323515210|FG001|Overall Study|Adverse Event|3|||
94471026|NCT01085084|323515211|FG002|Overall Study|Adverse Event|6|||
94471027|NCT01085084|323515209|FG000|Overall Study|Treatment Failure|0|||
94471028|NCT01085084|323515210|FG001|Overall Study|Treatment Failure|1|||
94471029|NCT01085084|323515211|FG002|Overall Study|Treatment Failure|2|||
94471030|NCT02749799|323515212|FG000|Overall Study|Adverse Event|2|||
94471031|NCT02749799|323515212|FG000|Overall Study|Lost to Follow-up|4|||
94471032|NCT02749799|323515212|FG000|Overall Study|Protocol Violation|1|||
94471033|NCT02749799|323515212|FG000|Overall Study|Withdrawal by Subject|1|||
94471034|NCT02636439|323515215|FG000|Overall Study|Adverse Event|2|||
94471035|NCT02636439|323515216|FG001|Overall Study|Adverse Event|2|||
94471036|NCT02636439|323515215|FG000|Overall Study|Lost to Follow-up|1|||
94471037|NCT02636439|323515216|FG001|Overall Study|Lost to Follow-up|0|||
94471038|NCT02636439|323515215|FG000|Overall Study|Non-compliance|1|||
94471039|NCT02636439|323515216|FG001|Overall Study|Non-compliance|1|||
94471040|NCT02636439|323515215|FG000|Overall Study|Personal reasons|2|||
94471041|NCT02636439|323515216|FG001|Overall Study|Personal reasons|0|||
94471042|NCT02552888|323515218|FG000|Overall Study|Lost to Follow-up|1|||
94471043|NCT02552888|323515219|FG001|Overall Study|Lost to Follow-up|1|||
94471044|NCT01153009|323516650|FG000|Overall Study|Adverse Event|4|||
94471045|NCT01153009|323516651|FG001|Overall Study|Adverse Event|14|||
94471046|NCT01153009|323516652|FG002|Overall Study|Adverse Event|14|||
94471047|NCT01153009|323516653|FG003|Overall Study|Adverse Event|10|||
94471048|NCT01153009|323516650|FG000|Overall Study|Lack of Efficacy|9|||
94471049|NCT01153009|323516651|FG001|Overall Study|Lack of Efficacy|0|||
94471050|NCT01153009|323516652|FG002|Overall Study|Lack of Efficacy|2|||
94471051|NCT01153009|323516653|FG003|Overall Study|Lack of Efficacy|1|||
94471052|NCT01153009|323516650|FG000|Overall Study|Noncompliance with Study Medication|1|||
94471053|NCT01153009|323516651|FG001|Overall Study|Noncompliance with Study Medication|3|||
94309185|NCT00652093|322915013|FG000|Overall Study|Physician Decision|0|||
94309186|NCT00652093|322915014|FG001|Overall Study|Physician Decision|0|||
94309187|NCT00652093|322915015|FG002|Overall Study|Physician Decision|0|||
94309188|NCT00652093|322915016|FG003|Overall Study|Physician Decision|0|||
94309189|NCT00652093|322915017|FG004|Overall Study|Physician Decision|1|||
94309190|NCT00652093|322915018|FG005|Overall Study|Physician Decision|0|||
94309191|NCT00542815|322915019|FG000|Overall Study|Adverse Event|19|||
94309192|NCT00542815|322915020|FG001|Overall Study|Adverse Event|6|||
94309193|NCT00542815|322915021|FG002|Overall Study|Adverse Event|9|||
94309194|NCT00542815|322915019|FG000|Overall Study|Death|10|||
94309195|NCT00542815|322915020|FG001|Overall Study|Death|7|||
94309196|NCT00542815|322915021|FG002|Overall Study|Death|3|||
94309197|NCT00542815|322915019|FG000|Overall Study|Lack of Efficacy|9|||
94309198|NCT00542815|322915020|FG001|Overall Study|Lack of Efficacy|2|||
94309199|NCT00542815|322915021|FG002|Overall Study|Lack of Efficacy|0|||
94309200|NCT00542815|322915019|FG000|Overall Study|Physician Decision|2|||
94309201|NCT00542815|322915020|FG001|Overall Study|Physician Decision|1|||
94309202|NCT00542815|322915021|FG002|Overall Study|Physician Decision|0|||
94309203|NCT00542815|322915019|FG000|Overall Study|Protocol Violation|1|||
94309204|NCT00542815|322915020|FG001|Overall Study|Protocol Violation|1|||
94309205|NCT00542815|322915021|FG002|Overall Study|Protocol Violation|2|||
94309206|NCT00542815|322915019|FG000|Overall Study|Withdrawal by Subject|41|||
94309207|NCT00542815|322915020|FG001|Overall Study|Withdrawal by Subject|5|||
94309208|NCT00542815|322915021|FG002|Overall Study|Withdrawal by Subject|8|||
94309209|NCT00542815|322915019|FG000|Overall Study|Other reasons|24|||
94309210|NCT00542815|322915020|FG001|Overall Study|Other reasons|10|||
94309211|NCT00542815|322915021|FG002|Overall Study|Other reasons|10|||
94309212|NCT00734929|322915022|FG000|Overall Study|Lost to Follow-up|1|||
94309213|NCT00734929|322915023|FG001|Overall Study|Lost to Follow-up|2|||
94309214|NCT00734929|322915022|FG000|Overall Study|No intervention/ screen fail|5|||
94309215|NCT00734929|322915023|FG001|Overall Study|No intervention/ screen fail|3|||
94309216|NCT01520922|322915027|FG000|Treatment Phase|Physician Decision|2|||
94309217|NCT01520922|322915028|FG001|Treatment Phase|Physician Decision|1|||
94309218|NCT01520922|322915027|FG000|Treatment Phase|Progression|0|||
94309219|NCT01520922|322915028|FG001|Treatment Phase|Progression|2|||
94309220|NCT01520922|322915027|FG000|Treatment Phase|Adverse Event|3|||
94309221|NCT01520922|322915028|FG001|Treatment Phase|Adverse Event|5|||
94309222|NCT01520922|322915027|FG000|Follow up|Lost to Follow-up|0|||
94309223|NCT01520922|322915028|FG001|Follow up|Lost to Follow-up|1|||
94309224|NCT01520922|322915027|FG000|Survival Follow-up|Withdrawal by Subject|1|||
94309225|NCT01520922|322915028|FG001|Survival Follow-up|Withdrawal by Subject|0|||
94309226|NCT01276847|322915032|FG000|Overall Study|Withdrawal by Subject|1|||
94309227|NCT01276847|322915033|FG001|Overall Study|Withdrawal by Subject|0|||
94309228|NCT01276847|322915034|FG002|Overall Study|Withdrawal by Subject|0|||
94309229|NCT01863758|322915035|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
94309230|NCT01863758|322915035|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
94309231|NCT00751881|322915036|FG000|Core Treatment Period|Not treated|1|||
94309232|NCT00751881|322915037|FG001|Core Treatment Period|Not treated|1|||
94309233|NCT00751881|322915038|FG002|Core Treatment Period|Not treated|2|||
94309234|NCT00751881|322915036|FG000|Core Treatment Period|Adverse Event|26|||
94309235|NCT00751881|322915037|FG001|Core Treatment Period|Adverse Event|54|||
94309236|NCT00751881|322915038|FG002|Core Treatment Period|Adverse Event|58|||
94309237|NCT00751881|322915036|FG000|Core Treatment Period|Lack of Efficacy|37|||
94309238|NCT00751881|322915037|FG001|Core Treatment Period|Lack of Efficacy|30|||
94309239|NCT00751881|322915038|FG002|Core Treatment Period|Lack of Efficacy|20|||
94309240|NCT00751881|322915036|FG000|Core Treatment Period|Poor compliance to protocol|15|||
94309241|NCT00751881|322915037|FG001|Core Treatment Period|Poor compliance to protocol|3|||
94309242|NCT00751881|322915038|FG002|Core Treatment Period|Poor compliance to protocol|4|||
94309243|NCT00751881|322915036|FG000|Core Treatment Period|Lost to Follow-up|6|||
94309244|NCT00751881|322915037|FG001|Core Treatment Period|Lost to Follow-up|4|||
94309245|NCT00751881|322915038|FG002|Core Treatment Period|Lost to Follow-up|3|||
94309246|NCT00751881|322915036|FG000|Core Treatment Period|Other: protocol deviation|3|||
94309247|NCT00751881|322915037|FG001|Core Treatment Period|Other: protocol deviation|3|||
94309248|NCT00751881|322915038|FG002|Core Treatment Period|Other: protocol deviation|7|||
94309249|NCT00751881|322915036|FG000|Core Treatment Period|Other: wish to parent|5|||
94309250|NCT00751881|322915037|FG001|Core Treatment Period|Other: wish to parent|7|||
94309251|NCT00751881|322915038|FG002|Core Treatment Period|Other: wish to parent|4|||
94471054|NCT01153009|323516652|FG002|Overall Study|Noncompliance with Study Medication|4|||
94309252|NCT00751881|322915036|FG000|Core Treatment Period|Other: personal/family constraints|6|||
94309253|NCT00751881|322915037|FG001|Core Treatment Period|Other: personal/family constraints|7|||
94309254|NCT00751881|322915038|FG002|Core Treatment Period|Other: personal/family constraints|10|||
94309255|NCT00751881|322915036|FG000|Core Treatment Period|Other: MS treatment change|6|||
94309256|NCT00751881|322915037|FG001|Core Treatment Period|Other: MS treatment change|4|||
94309257|NCT00751881|322915038|FG002|Core Treatment Period|Other: MS treatment change|4|||
94309258|NCT00751881|322915036|FG000|Core Treatment Period|Other: tolerability complaints|2|||
94309259|NCT00751881|322915037|FG001|Core Treatment Period|Other: tolerability complaints|0|||
94380256|NCT01498484|323176972|FG000|Overall Study|Death|6|||
94380257|NCT01498484|323176973|FG001|Overall Study|Death|3|||
94380258|NCT01498484|323176974|FG002|Overall Study|Death|1|||
94380259|NCT01498484|323176975|FG003|Overall Study|Death|1|||
94380260|NCT01498484|323176976|FG004|Overall Study|Death|0|||
94380261|NCT01498484|323176977|FG005|Overall Study|Death|0|||
94380262|NCT01498484|323176978|FG006|Overall Study|Death|10|||
94380263|NCT01498484|323176979|FG007|Overall Study|Death|1|||
94380264|NCT01498484|323176980|FG008|Overall Study|Death|0|||
94380265|NCT01498484|323176972|FG000|Overall Study|Physician Decision|3|||
94380266|NCT01498484|323176973|FG001|Overall Study|Physician Decision|2|||
94380267|NCT01498484|323176974|FG002|Overall Study|Physician Decision|1|||
94380268|NCT01498484|323176975|FG003|Overall Study|Physician Decision|1|||
94380269|NCT01498484|323176976|FG004|Overall Study|Physician Decision|0|||
94380270|NCT01498484|323176977|FG005|Overall Study|Physician Decision|0|||
94380271|NCT01498484|323176978|FG006|Overall Study|Physician Decision|8|||
94380272|NCT01498484|323176979|FG007|Overall Study|Physician Decision|13|||
94380273|NCT01498484|323176980|FG008|Overall Study|Physician Decision|1|||
94380274|NCT01498484|323176972|FG000|Overall Study|Adverse Event|0|||
94380275|NCT01498484|323176973|FG001|Overall Study|Adverse Event|0|||
94380276|NCT01498484|323176974|FG002|Overall Study|Adverse Event|0|||
94380277|NCT01498484|323176975|FG003|Overall Study|Adverse Event|0|||
94380278|NCT01498484|323176976|FG004|Overall Study|Adverse Event|0|||
94380279|NCT01498484|323176977|FG005|Overall Study|Adverse Event|1|||
94380280|NCT01498484|323176978|FG006|Overall Study|Adverse Event|0|||
94380281|NCT01498484|323176979|FG007|Overall Study|Adverse Event|0|||
94380282|NCT01498484|323176980|FG008|Overall Study|Adverse Event|0|||
94380283|NCT01498484|323176972|FG000|Overall Study|Withdrawal by Subject|0|||
94380284|NCT01498484|323176973|FG001|Overall Study|Withdrawal by Subject|0|||
94380285|NCT01498484|323176974|FG002|Overall Study|Withdrawal by Subject|0|||
94380286|NCT01498484|323176975|FG003|Overall Study|Withdrawal by Subject|1|||
94380287|NCT01498484|323176976|FG004|Overall Study|Withdrawal by Subject|0|||
94380288|NCT01498484|323176977|FG005|Overall Study|Withdrawal by Subject|0|||
94380289|NCT01498484|323176978|FG006|Overall Study|Withdrawal by Subject|1|||
94380290|NCT01498484|323176979|FG007|Overall Study|Withdrawal by Subject|0|||
94380291|NCT01498484|323176980|FG008|Overall Study|Withdrawal by Subject|0|||
94380292|NCT01498484|323176972|FG000|Overall Study|Other|5|||
94380293|NCT01498484|323176973|FG001|Overall Study|Other|2|||
94380294|NCT01498484|323176974|FG002|Overall Study|Other|0|||
94380295|NCT01498484|323176975|FG003|Overall Study|Other|0|||
94380296|NCT01498484|323176976|FG004|Overall Study|Other|1|||
94380297|NCT01498484|323176977|FG005|Overall Study|Other|0|||
94380298|NCT01498484|323176978|FG006|Overall Study|Other|3|||
94380299|NCT01498484|323176979|FG007|Overall Study|Other|0|||
94380300|NCT01498484|323176980|FG008|Overall Study|Other|1|||
94380301|NCT04104646|323176981|FG000|Overall Study|Withdrawal by Subject|1|||
94380302|NCT04104646|323176982|FG001|Overall Study|Withdrawal by Subject|1|||
94380303|NCT04104646|323176981|FG000|Overall Study|Lost to Follow-up|1|||
94380304|NCT04104646|323176982|FG001|Overall Study|Lost to Follow-up|0|||
94380305|NCT04104646|323176981|FG000|Overall Study|Physician Decision|2|||
94380306|NCT04104646|323176982|FG001|Overall Study|Physician Decision|0|||
94380307|NCT02486796|323176984|FG000|Overall Study|Withdrawal by Subject|1|||
94380308|NCT02486796|323176985|FG001|Overall Study|Withdrawal by Subject|1|||
94380309|NCT02486796|323176984|FG000|Overall Study|Physician Decision|1|||
94380310|NCT02486796|323176985|FG001|Overall Study|Physician Decision|0|||
94380311|NCT01446913|323176986|FG000|Overall Study|Significant illness|1|||
94380312|NCT01446913|323176987|FG001|Overall Study|Significant illness|1|||
94380313|NCT01446913|323176988|FG002|Overall Study|Significant illness|1|||
94380314|NCT01446913|323176986|FG000|Overall Study|Withdrawal by Subject|5|||
94380315|NCT01446913|323176987|FG001|Overall Study|Withdrawal by Subject|3|||
94380316|NCT01446913|323176988|FG002|Overall Study|Withdrawal by Subject|5|||
94380317|NCT01446913|323176986|FG000|Overall Study|Physician Decision|0|||
94380318|NCT01446913|323176987|FG001|Overall Study|Physician Decision|0|||
94380319|NCT01446913|323176988|FG002|Overall Study|Physician Decision|2|||
94380320|NCT01446913|323176986|FG000|Overall Study|Lost to Follow-up|3|||
94380321|NCT01446913|323176987|FG001|Overall Study|Lost to Follow-up|5|||
94380322|NCT01446913|323176988|FG002|Overall Study|Lost to Follow-up|3|||
94380323|NCT01789320|323176989|FG000|Overall Study|Re-enrolled into study|1|||
94380324|NCT01789320|323176989|FG000|Overall Study|Lost to Follow-up|1|||
94380325|NCT01754259|323176990|FG000|Overall Study|Withdrawal by Subject|2|||
94380326|NCT01754259|323176991|FG001|Overall Study|Withdrawal by Subject|4|||
94380327|NCT01754259|323176990|FG000|Overall Study|Adverse Event|3|||
94380328|NCT01754259|323176991|FG001|Overall Study|Adverse Event|1|||
94380329|NCT01754259|323176990|FG000|Overall Study|Lost to Follow-up|0|||
94380330|NCT01754259|323176991|FG001|Overall Study|Lost to Follow-up|1|||
94380331|NCT01144663|323179110|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
94380332|NCT01144663|323179111|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
94380333|NCT01144663|323179112|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
94380334|NCT01144663|323179113|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
94380335|NCT01144663|323179110|FG000|Primary Vaccination Phase|Adverse Event|1|||
94471055|NCT01153009|323516653|FG003|Overall Study|Noncompliance with Study Medication|1|||
94471056|NCT01153009|323516650|FG000|Overall Study|Protocol Deviations|4|||
94471057|NCT01153009|323516651|FG001|Overall Study|Protocol Deviations|3|||
94471058|NCT01153009|323516652|FG002|Overall Study|Protocol Deviations|3|||
94471059|NCT01153009|323516653|FG003|Overall Study|Protocol Deviations|2|||
94471060|NCT01153009|323516650|FG000|Overall Study|Withdrawal of Consent|5|||
94471061|NCT01153009|323516651|FG001|Overall Study|Withdrawal of Consent|5|||
94471062|NCT01153009|323516652|FG002|Overall Study|Withdrawal of Consent|4|||
94471063|NCT01153009|323516653|FG003|Overall Study|Withdrawal of Consent|6|||
94471064|NCT01153009|323516650|FG000|Overall Study|Lost to Follow-up|8|||
94471065|NCT01153009|323516651|FG001|Overall Study|Lost to Follow-up|8|||
94471066|NCT01153009|323516652|FG002|Overall Study|Lost to Follow-up|11|||
94471067|NCT01153009|323516653|FG003|Overall Study|Lost to Follow-up|15|||
94309260|NCT00751881|322915038|FG002|Core Treatment Period|Other: tolerability complaints|0|||
94309261|NCT00751881|322915036|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
94309262|NCT00751881|322915037|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
94309263|NCT00751881|322915038|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
94309264|NCT00751881|322915036|FG000|Extension Study Period|Adverse Event|18|||
94309265|NCT00751881|322915037|FG001|Extension Study Period|Adverse Event|20|||
94309266|NCT00751881|322915038|FG002|Extension Study Period|Adverse Event|21|||
94309267|NCT00751881|322915036|FG000|Extension Study Period|Lack of Efficacy|14|||
94309268|NCT00751881|322915037|FG001|Extension Study Period|Lack of Efficacy|10|||
94309269|NCT00751881|322915038|FG002|Extension Study Period|Lack of Efficacy|20|||
94309270|NCT00751881|322915036|FG000|Extension Study Period|Lost to Follow-up|4|||
94309271|NCT00751881|322915037|FG001|Extension Study Period|Lost to Follow-up|9|||
94309272|NCT00751881|322915038|FG002|Extension Study Period|Lost to Follow-up|6|||
94309273|NCT00751881|322915036|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
94309274|NCT00751881|322915037|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
94309275|NCT00751881|322915038|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
94309276|NCT00751881|322915036|FG000|Extension Study Period|Other than specified above|26|||
94309277|NCT00751881|322915037|FG001|Extension Study Period|Other than specified above|30|||
94309278|NCT00751881|322915038|FG002|Extension Study Period|Other than specified above|18|||
94309279|NCT04770155|322915039|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
94309280|NCT04770155|322915040|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
94309281|NCT04770155|322915041|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
94309282|NCT04770155|322915042|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
94309283|NCT04770155|322915043|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
94309284|NCT04770155|322915044|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
94309285|NCT04770155|322915045|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
94309286|NCT04770155|322915046|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
94309287|NCT01632878|322915047|FG000|Screening|Physician Decision|268|||
94309288|NCT01632878|322915047|FG000|Treatment|Lost to Follow-up|41|||
94309289|NCT01632878|322915047|FG000|Treatment|Withdrawal by Subject|36|||
94309290|NCT01632878|322915047|FG000|Treatment|Physician Decision|34|||
94309291|NCT01632878|322915047|FG000|Treatment|missing information|4|||
94309292|NCT01632878|322915047|FG000|Treatment|no information on study completion|43|||
94309293|NCT04773041|322915048|FG000|Overall Study|Unable to data match|1|||
94309294|NCT04773041|322915049|FG001|Overall Study|Unable to data match|0|||
94309295|NCT04773041|322915050|FG002|Overall Study|Unable to data match|0|||
94309296|NCT01894516|322916895|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
94309297|NCT01894516|322916896|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
94309298|NCT01894516|322916897|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
94309299|NCT01894516|322916898|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
94309300|NCT01894516|322916895|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
94309301|NCT01894516|322916896|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
94309302|NCT01894516|322916897|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
94309303|NCT01894516|322916898|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
94309304|NCT01894516|322916895|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
94309305|NCT01894516|322916896|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
94309306|NCT01894516|322916897|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
94309307|NCT01894516|322916898|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
94309308|NCT01894516|322916895|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
94309309|NCT01894516|322916896|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
94471068|NCT01153009|323516650|FG000|Overall Study|Other|1|||
94471069|NCT01153009|323516651|FG001|Overall Study|Other|1|||
94471070|NCT01153009|323516652|FG002|Overall Study|Other|3|||
94471071|NCT01153009|323516653|FG003|Overall Study|Other|2|||
94471072|NCT01663857|323516654|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
94471073|NCT01663857|323516655|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
94471074|NCT01663857|323516656|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
94471075|NCT01663857|323516657|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
94471076|NCT01663857|323516654|FG000|Overall Study|Lost to Follow-up|0|||
94471077|NCT01663857|323516655|FG001|Overall Study|Lost to Follow-up|0|||
94471078|NCT01663857|323516656|FG002|Overall Study|Lost to Follow-up|3|||
94471079|NCT01663857|323516657|FG003|Overall Study|Lost to Follow-up|1|||
94471080|NCT01421147|323516659|FG000|Treatment Period|Adverse Event|2|||
94471081|NCT01421147|323516660|FG001|Treatment Period|Adverse Event|3|||
94471082|NCT01421147|323516659|FG000|Treatment Period|Lost to Follow-up|2|||
94471083|NCT01421147|323516660|FG001|Treatment Period|Lost to Follow-up|1|||
94309310|NCT01894516|322916897|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
94309311|NCT01894516|322916898|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
94471084|NCT01421147|323516659|FG000|Treatment Period|Physician Decision|2|||
94471085|NCT01421147|323516660|FG001|Treatment Period|Physician Decision|2|||
94471086|NCT01421147|323516659|FG000|Treatment Period|Withdrawal by Subject|10|||
94471087|NCT01421147|323516660|FG001|Treatment Period|Withdrawal by Subject|5|||
94471088|NCT01421147|323516659|FG000|Extension Period|Adverse Event|0|||
94471089|NCT01421147|323516660|FG001|Extension Period|Adverse Event|2|||
94471090|NCT01421147|323516659|FG000|Extension Period|Death|0|||
94471091|NCT01421147|323516660|FG001|Extension Period|Death|1|||
94471092|NCT01421147|323516659|FG000|Extension Period|Lost to Follow-up|2|||
94471093|NCT01421147|323516660|FG001|Extension Period|Lost to Follow-up|5|||
94471094|NCT01421147|323516659|FG000|Extension Period|Physician Decision|1|||
94471095|NCT01421147|323516660|FG001|Extension Period|Physician Decision|0|||
94471096|NCT01421147|323516659|FG000|Extension Period|Withdrawal by Subject|5|||
94471097|NCT01421147|323516660|FG001|Extension Period|Withdrawal by Subject|3|||
94471098|NCT01270321|323516661|FG000|Overall Study|Death|3|||
94471099|NCT01270321|323516662|FG001|Overall Study|Death|1|||
94471100|NCT01270321|323516663|FG002|Overall Study|Death|4|||
94471101|NCT01270321|323516661|FG000|Overall Study|Adverse Event|7|||
94471102|NCT01270321|323516662|FG001|Overall Study|Adverse Event|9|||
94471103|NCT01270321|323516663|FG002|Overall Study|Adverse Event|5|||
94471104|NCT01393106|323516664|FG000|Overall Study|Adverse Event|3|||
94471105|NCT01393106|323516664|FG000|Overall Study|Withdrawal by Subject|1|||
94471106|NCT01393106|323516664|FG000|Overall Study|Lack of Efficacy|1|||
94471107|NCT01980628|323516665|FG000|Overall Study|Adverse Event|12|||
94471108|NCT01980628|323516665|FG000|Overall Study|Physician Decision|5|||
94471109|NCT01980628|323516665|FG000|Overall Study|Withdrawal by Subject|4|||
94471110|NCT01980628|323516665|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
94471111|NCT02474355|323516666|FG000|Overall Study|Other|43|||
94471112|NCT02474355|323516666|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
94471113|NCT02474355|323516666|FG000|Overall Study|Lost to Follow-up|98|||
94471114|NCT02474355|323516666|FG000|Overall Study|Withdrawal by Subject|124|||
94471115|NCT02474355|323516666|FG000|Overall Study|Death|1361|||
94471116|NCT01502956|323516668|FG000|Overall Study|Death|0|||
94471117|NCT01502956|323516669|FG001|Overall Study|Death|2|||
94471118|NCT01502956|323516668|FG000|Overall Study|Lost to Follow-up|14|||
94471119|NCT01502956|323516669|FG001|Overall Study|Lost to Follow-up|11|||
94471120|NCT01502956|323516668|FG000|Overall Study|Physician Decision|2|||
94471121|NCT01502956|323516669|FG001|Overall Study|Physician Decision|3|||
94471122|NCT01502956|323516668|FG000|Overall Study|Withdrawal by Subject|8|||
94471123|NCT01502956|323516669|FG001|Overall Study|Withdrawal by Subject|10|||
94471124|NCT03959488|323516670|FG000|Season 1|Other|6|||
94471125|NCT03959488|323516671|FG001|Season 1|Other|7|||
94471126|NCT03959488|323516672|FG002|Season 1|Other|0|||
94471127|NCT03959488|323516673|FG003|Season 1|Other|0|||
94471128|NCT03959488|323516674|FG004|Season 1|Other|0|||
94309312|NCT01894516|322916895|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
94309313|NCT01894516|322916896|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
94471129|NCT03959488|323516670|FG000|Season 1|Withdrawal by parent/guardian|43|||
94471130|NCT03959488|323516671|FG001|Season 1|Withdrawal by parent/guardian|28|||
94471131|NCT03959488|323516672|FG002|Season 1|Withdrawal by parent/guardian|0|||
94471132|NCT03959488|323516673|FG003|Season 1|Withdrawal by parent/guardian|0|||
94471133|NCT03959488|323516674|FG004|Season 1|Withdrawal by parent/guardian|0|||
94471134|NCT03959488|323516670|FG000|Season 1|Due to COVID-19 pandemic|2|||
94471135|NCT03959488|323516671|FG001|Season 1|Due to COVID-19 pandemic|3|||
94471136|NCT03959488|323516672|FG002|Season 1|Due to COVID-19 pandemic|0|||
94471137|NCT03959488|323516673|FG003|Season 1|Due to COVID-19 pandemic|0|||
94471138|NCT03959488|323516674|FG004|Season 1|Due to COVID-19 pandemic|0|||
94471139|NCT03959488|323516670|FG000|Season 1|Lost to Follow-up|17|||
94471140|NCT03959488|323516671|FG001|Season 1|Lost to Follow-up|7|||
94471141|NCT03959488|323516672|FG002|Season 1|Lost to Follow-up|0|||
94471142|NCT03959488|323516673|FG003|Season 1|Lost to Follow-up|0|||
94471143|NCT03959488|323516674|FG004|Season 1|Lost to Follow-up|0|||
94471144|NCT03959488|323516670|FG000|Season 1|Death|5|||
94471145|NCT03959488|323516671|FG001|Season 1|Death|1|||
94471146|NCT03959488|323516672|FG002|Season 1|Death|0|||
94471147|NCT03959488|323516673|FG003|Season 1|Death|0|||
94471148|NCT03959488|323516674|FG004|Season 1|Death|0|||
94471149|NCT03959488|323516670|FG000|Season 2|Other|0|||
94471150|NCT03959488|323516671|FG001|Season 2|Other|0|||
94471151|NCT03959488|323516672|FG002|Season 2|Other|2|||
94471152|NCT03959488|323516673|FG003|Season 2|Other|0|||
94471153|NCT03959488|323516674|FG004|Season 2|Other|0|||
94471154|NCT03959488|323516670|FG000|Season 2|Withdrawal by parent/guardian|0|||
94471155|NCT03959488|323516671|FG001|Season 2|Withdrawal by parent/guardian|0|||
94471156|NCT03959488|323516672|FG002|Season 2|Withdrawal by parent/guardian|3|||
94471157|NCT03959488|323516673|FG003|Season 2|Withdrawal by parent/guardian|1|||
94471158|NCT03959488|323516674|FG004|Season 2|Withdrawal by parent/guardian|1|||
94471159|NCT03959488|323516670|FG000|Season 2|Lost to Follow-up|0|||
94471160|NCT03959488|323516671|FG001|Season 2|Lost to Follow-up|0|||
94471161|NCT03959488|323516672|FG002|Season 2|Lost to Follow-up|1|||
94471162|NCT03959488|323516673|FG003|Season 2|Lost to Follow-up|0|||
94471163|NCT03959488|323516674|FG004|Season 2|Lost to Follow-up|1|||
94471164|NCT01760447|323516675|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
94471165|NCT01760447|323516676|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
94471166|NCT01760447|323516677|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
94471167|NCT01760447|323516678|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
94471168|NCT01760447|323516675|FG000|Weeks 0-20|Withdrawal by Subject|2|||
94471169|NCT01760447|323516676|FG001|Weeks 0-20|Withdrawal by Subject|0|||
94471170|NCT01760447|323516677|FG002|Weeks 0-20|Withdrawal by Subject|1|||
94471171|NCT01760447|323516678|FG003|Weeks 0-20|Withdrawal by Subject|0|||
94471172|NCT01760447|323516675|FG000|Weeks 0-20|Lost to Follow-up|1|||
94471173|NCT01760447|323516676|FG001|Weeks 0-20|Lost to Follow-up|0|||
94471174|NCT01760447|323516677|FG002|Weeks 0-20|Lost to Follow-up|1|||
94471175|NCT01760447|323516678|FG003|Weeks 0-20|Lost to Follow-up|1|||
94471176|NCT01760447|323516675|FG000|Weeks 0-20|Randomized but not treated|0|||
94471177|NCT01760447|323516676|FG001|Weeks 0-20|Randomized but not treated|0|||
94471178|NCT01760447|323516677|FG002|Weeks 0-20|Randomized but not treated|2|||
94471179|NCT01760447|323516678|FG003|Weeks 0-20|Randomized but not treated|0|||
94471180|NCT01760447|323516675|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
94471181|NCT01760447|323516676|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
94471182|NCT01760447|323516677|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
94471183|NCT01760447|323516678|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
94471184|NCT01760447|323516675|FG000|Weeks 20-54|Withdrawal by Subject|2|||
94471185|NCT01760447|323516676|FG001|Weeks 20-54|Withdrawal by Subject|1|||
94471186|NCT01760447|323516677|FG002|Weeks 20-54|Withdrawal by Subject|1|||
94471187|NCT01760447|323516678|FG003|Weeks 20-54|Withdrawal by Subject|2|||
94471188|NCT01760447|323516675|FG000|Weeks 20-54|Lost to Follow-up|0|||
94471189|NCT01760447|323516676|FG001|Weeks 20-54|Lost to Follow-up|0|||
94471190|NCT01760447|323516677|FG002|Weeks 20-54|Lost to Follow-up|1|||
94471191|NCT01760447|323516678|FG003|Weeks 20-54|Lost to Follow-up|2|||
94471192|NCT01641471|323516679|FG000|Overall Study|Withdrawal by Subject|19|||
94471193|NCT01641471|323516680|FG001|Overall Study|Withdrawal by Subject|19|||
94471194|NCT01641471|323516679|FG000|Overall Study|Lost to Follow-up|2|||
94471195|NCT01641471|323516680|FG001|Overall Study|Lost to Follow-up|4|||
94471196|NCT01641471|323516679|FG000|Overall Study|Protocol Violation|2|||
94471197|NCT01641471|323516680|FG001|Overall Study|Protocol Violation|4|||
94471198|NCT03488563|323516681|FG000|Overall Study|Lost to Follow-up|7|||
94471199|NCT03488563|323516682|FG001|Overall Study|Lost to Follow-up|6|||
94471200|NCT03488563|323516683|FG002|Overall Study|Lost to Follow-up|7|||
94471201|NCT03488563|323516681|FG000|Overall Study|Withdrawal by Subject|8|||
94471202|NCT03488563|323516682|FG001|Overall Study|Withdrawal by Subject|7|||
94471203|NCT03488563|323516683|FG002|Overall Study|Withdrawal by Subject|7|||
94471204|NCT03488563|323516681|FG000|Overall Study|Physician Decision|0|||
94471205|NCT03488563|323516682|FG001|Overall Study|Physician Decision|0|||
94471206|NCT03488563|323516683|FG002|Overall Study|Physician Decision|1|||
94471207|NCT03488563|323516681|FG000|Overall Study|Protocol Violation|3|||
94471208|NCT03488563|323516682|FG001|Overall Study|Protocol Violation|2|||
94471209|NCT03488563|323516683|FG002|Overall Study|Protocol Violation|6|||
94471210|NCT03488563|323516681|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
94471211|NCT03488563|323516682|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
94471212|NCT03488563|323516683|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
94471213|NCT03488563|323516681|FG000|Overall Study|Use of prohibited medication|2|||
94471214|NCT03488563|323516682|FG001|Overall Study|Use of prohibited medication|0|||
94471215|NCT03488563|323516683|FG002|Overall Study|Use of prohibited medication|0|||
94471216|NCT03488563|323516681|FG000|Overall Study|Adverse Event|1|||
94471217|NCT03488563|323516682|FG001|Overall Study|Adverse Event|0|||
94471218|NCT03488563|323516683|FG002|Overall Study|Adverse Event|1|||
94471219|NCT03488563|323516681|FG000|Overall Study|Subject returned for ET visit|0|||
94471220|NCT03488563|323516682|FG001|Overall Study|Subject returned for ET visit|1|||
94471221|NCT03488563|323516683|FG002|Overall Study|Subject returned for ET visit|0|||
94471222|NCT03488563|323516681|FG000|Overall Study|Sponsor's decision|0|||
94471223|NCT03488563|323516682|FG001|Overall Study|Sponsor's decision|0|||
94471224|NCT03488563|323516683|FG002|Overall Study|Sponsor's decision|1|||
94309314|NCT01894516|322916897|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
94309315|NCT01894516|322916898|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
94309316|NCT01894516|322916895|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
94309317|NCT01894516|322916896|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
94309318|NCT01894516|322916897|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
94309319|NCT01894516|322916898|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
94309320|NCT01894516|322916895|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
94309321|NCT01894516|322916896|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
94309322|NCT01894516|322916897|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
94309323|NCT01894516|322916898|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
94309324|NCT01894516|322916895|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
94309325|NCT01894516|322916896|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
94309326|NCT01894516|322916897|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
94309327|NCT01894516|322916898|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
94309328|NCT00893113|322916899|FG000|Overall Study|Lost to Follow-up|4|||
94309329|NCT00893113|322916900|FG001|Overall Study|Lost to Follow-up|8|||
94309330|NCT00893113|322916899|FG000|Overall Study|Early Termination|1|||
94309331|NCT00893113|322916900|FG001|Overall Study|Early Termination|1|||
94309332|NCT00893113|322916899|FG000|Overall Study|Withdrew Consent|8|||
94309333|NCT00893113|322916900|FG001|Overall Study|Withdrew Consent|7|||
94309334|NCT02114203|322916901|FG000|Overall Study|Adverse Event|0|||
94309335|NCT02114203|322916902|FG001|Overall Study|Adverse Event|1|||
94309336|NCT02114203|322916903|FG002|Overall Study|Adverse Event|0|||
94309337|NCT02114203|322916901|FG000|Overall Study|Withdrawal by Subject|0|||
94309338|NCT02114203|322916902|FG001|Overall Study|Withdrawal by Subject|1|||
94309339|NCT02114203|322916903|FG002|Overall Study|Withdrawal by Subject|0|||
94309340|NCT02089737|322916904|FG000|Overall Study|Survey form not completed|5|||
94309341|NCT02089737|322916904|FG000|Overall Study|Not treated|1|||
94309342|NCT00744055|322916905|FG000|Overall Study|Withdrawal by Subject|6|||
94309343|NCT00744055|322916906|FG001|Overall Study|Withdrawal by Subject|9|||
94309344|NCT00744055|322916905|FG000|Overall Study|Lack of Efficacy|0|||
94309345|NCT00744055|322916906|FG001|Overall Study|Lack of Efficacy|1|||
94309346|NCT00744055|322916905|FG000|Overall Study|Physician Decision|0|||
94380336|NCT01144663|323179111|FG001|Primary Vaccination Phase|Adverse Event|0|||
94380337|NCT01144663|323179112|FG002|Primary Vaccination Phase|Adverse Event|0|||
94380338|NCT01144663|323179113|FG003|Primary Vaccination Phase|Adverse Event|1|||
94380339|NCT01144663|323179110|FG000|Primary Vaccination Phase|Protocol Violation|2|||
94380340|NCT01144663|323179111|FG001|Primary Vaccination Phase|Protocol Violation|0|||
94380341|NCT01144663|323179112|FG002|Primary Vaccination Phase|Protocol Violation|1|||
94380342|NCT01144663|323179113|FG003|Primary Vaccination Phase|Protocol Violation|0|||
94380343|NCT01144663|323179110|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
94380344|NCT01144663|323179111|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
94380345|NCT01144663|323179112|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
94380346|NCT01144663|323179113|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
94380347|NCT01144663|323179110|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
94380348|NCT01144663|323179111|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
94380349|NCT01144663|323179112|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
94380350|NCT01144663|323179113|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
94380351|NCT01144663|323179110|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
94380352|NCT01144663|323179111|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
94380353|NCT01144663|323179112|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
94380354|NCT01144663|323179113|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
94380355|NCT01144663|323179110|FG000|Primary Vaccination Phase|Other|0|||
94380356|NCT01144663|323179111|FG001|Primary Vaccination Phase|Other|1|||
94380357|NCT01144663|323179112|FG002|Primary Vaccination Phase|Other|0|||
94380358|NCT01144663|323179113|FG003|Primary Vaccination Phase|Other|2|||
94380359|NCT01144663|323179110|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
94380360|NCT01144663|323179111|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
94380361|NCT01144663|323179112|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
94309347|NCT00744055|322916906|FG001|Overall Study|Physician Decision|2|||
94309348|NCT00744055|322916905|FG000|Overall Study|Protocol Violation|1|||
94309349|NCT00744055|322916906|FG001|Overall Study|Protocol Violation|1|||
94380362|NCT01144663|323179113|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
94380363|NCT01144663|323179110|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
94380364|NCT01144663|323179111|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
94380365|NCT01144663|323179112|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
94380366|NCT01144663|323179113|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
94309350|NCT00744055|322916905|FG000|Overall Study|Lost to Follow-up|0|||
94309351|NCT00744055|322916906|FG001|Overall Study|Lost to Follow-up|1|||
94309352|NCT03216265|322916916|FG000|Overall Study|Adverse Event|2|||
94309353|NCT03216265|322916917|FG001|Overall Study|Adverse Event|0|||
94309354|NCT03216265|322916918|FG002|Overall Study|Adverse Event|2|||
94309355|NCT03216265|322916916|FG000|Overall Study|Lost to Follow-up|0|||
94309356|NCT03216265|322916917|FG001|Overall Study|Lost to Follow-up|1|||
94309357|NCT03216265|322916918|FG002|Overall Study|Lost to Follow-up|0|||
94309358|NCT03216265|322916916|FG000|Overall Study|Withdrawal by Subject|0|||
94309359|NCT03216265|322916917|FG001|Overall Study|Withdrawal by Subject|0|||
94309360|NCT03216265|322916918|FG002|Overall Study|Withdrawal by Subject|1|||
94309361|NCT01277289|322916923|FG000|Overall Study|fragile vein|1|||
94309362|NCT01277289|322916924|FG001|Overall Study|fragile vein|0|||
94309363|NCT01277289|322916923|FG000|Overall Study|Physician Decision|1|||
94309364|NCT01277289|322916924|FG001|Overall Study|Physician Decision|0|||
94309365|NCT01277289|322916923|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
94309366|NCT01277289|322916924|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
94309367|NCT01277289|322916923|FG000|Overall Study|Protocol Violation|1|||
94309368|NCT01277289|322916924|FG001|Overall Study|Protocol Violation|1|||
94309369|NCT01277289|322916923|FG000|Overall Study|Adverse Event|2|||
94309370|NCT01277289|322916924|FG001|Overall Study|Adverse Event|1|||
94309371|NCT01277289|322916923|FG000|Overall Study|consent withdrawn|1|||
94309372|NCT01277289|322916924|FG001|Overall Study|consent withdrawn|1|||
94309373|NCT01277289|322916923|FG000|Overall Study|premature closure of the study|4|||
94309374|NCT01277289|322916924|FG001|Overall Study|premature closure of the study|2|||
94309375|NCT02874794|322916925|FG000|Overall Study|Physician Decision|3|||
94309376|NCT02874794|322916926|FG001|Overall Study|Physician Decision|2|||
94309377|NCT02874794|322916925|FG000|Overall Study|Withdrawal by Subject|2|||
94309378|NCT02874794|322916926|FG001|Overall Study|Withdrawal by Subject|8|||
94309379|NCT02874794|322916925|FG000|Overall Study|Death|2|||
94309380|NCT02874794|322916926|FG001|Overall Study|Death|1|||
94309381|NCT00537940|322916927|FG000|Overall Study|Adverse Event|20|||
94309382|NCT00537940|322916928|FG001|Overall Study|Adverse Event|19|||
94309383|NCT00537940|322916927|FG000|Overall Study|Lack of Efficacy|8|||
94309384|NCT00537940|322916928|FG001|Overall Study|Lack of Efficacy|16|||
94309385|NCT00537940|322916927|FG000|Overall Study|Lost to Follow-up|23|||
94309386|NCT00537940|322916928|FG001|Overall Study|Lost to Follow-up|29|||
94309387|NCT00537940|322916927|FG000|Overall Study|Withdrawal by Subject|113|||
94309388|NCT00537940|322916928|FG001|Overall Study|Withdrawal by Subject|95|||
94309389|NCT00537940|322916927|FG000|Overall Study|Protocol Violation|6|||
94309390|NCT00537940|322916928|FG001|Overall Study|Protocol Violation|4|||
94309391|NCT00537940|322916927|FG000|Overall Study|Pregnancy|1|||
94309392|NCT00537940|322916928|FG001|Overall Study|Pregnancy|1|||
94309393|NCT00537940|322916927|FG000|Overall Study|Study terminated by sponsor|2|||
94309394|NCT00537940|322916928|FG001|Overall Study|Study terminated by sponsor|3|||
94309395|NCT00537940|322916927|FG000|Overall Study|Other|10|||
94309396|NCT00537940|322916928|FG001|Overall Study|Other|12|||
94309397|NCT04328623|322916929|FG000|Overall Study|Protocol Violation|0|||
94309398|NCT04328623|322916930|FG001|Overall Study|Protocol Violation|1|||
94309399|NCT00224107|322916939|FG000|Overall Study|Adverse Event|20|||
94309400|NCT00224107|322916940|FG001|Overall Study|Adverse Event|6|||
94309401|NCT00224107|322916939|FG000|Overall Study|Protocol Violation|2|||
94309402|NCT00224107|322916940|FG001|Overall Study|Protocol Violation|3|||
94309403|NCT00224107|322916939|FG000|Overall Study|Withdrawal by Subject|1|||
94309404|NCT00224107|322916940|FG001|Overall Study|Withdrawal by Subject|4|||
94309405|NCT00224107|322916939|FG000|Overall Study|Lack of Efficacy|2|||
94309406|NCT00224107|322916940|FG001|Overall Study|Lack of Efficacy|0|||
94309407|NCT00224107|322916939|FG000|Overall Study|Lost to Follow-up|4|||
94309408|NCT00224107|322916940|FG001|Overall Study|Lost to Follow-up|0|||
94309409|NCT00224107|322916939|FG000|Overall Study|Physician Decision|1|||
94309410|NCT00224107|322916940|FG001|Overall Study|Physician Decision|0|||
94309411|NCT00224107|322916939|FG000|Overall Study|Other|1|||
94309412|NCT00224107|322916940|FG001|Overall Study|Other|1|||
94309413|NCT00685178|322916941|FG000|Overall Study|Adverse Event|1|||
94309414|NCT00685178|322916942|FG001|Overall Study|Adverse Event|5|||
94309415|NCT00685178|322916943|FG002|Overall Study|Adverse Event|2|||
94309416|NCT00685178|322916944|FG003|Overall Study|Adverse Event|4|||
94309417|NCT00685178|322916941|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
94309418|NCT00685178|322916942|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
94380367|NCT01144663|323179110|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
94380368|NCT01144663|323179111|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
94380369|NCT01144663|323179112|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
94309419|NCT00685178|322916943|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
94309420|NCT00685178|322916944|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
94309421|NCT00685178|322916941|FG000|Overall Study|voluntary study discharge|4|||
94309422|NCT00685178|322916942|FG001|Overall Study|voluntary study discharge|5|||
94309423|NCT00685178|322916943|FG002|Overall Study|voluntary study discharge|1|||
94309424|NCT00685178|322916944|FG003|Overall Study|voluntary study discharge|1|||
94309425|NCT00685178|322916941|FG000|Overall Study|incarcerated|1|||
94309426|NCT00685178|322916942|FG001|Overall Study|incarcerated|3|||
94309427|NCT00685178|322916943|FG002|Overall Study|incarcerated|7|||
94309428|NCT00685178|322916944|FG003|Overall Study|incarcerated|0|||
94309429|NCT00685178|322916941|FG000|Overall Study|administrative (disciplinary) discharge|0|||
94309430|NCT00685178|322916942|FG001|Overall Study|administrative (disciplinary) discharge|1|||
94471225|NCT01887288|323516693|FG000|Overall Study|The study was terminated and the PI has|16|||
94471226|NCT02164318|323516694|FG000|Overall Study|Withdrawal by Subject|0|||
94471227|NCT02164318|323516695|FG001|Overall Study|Withdrawal by Subject|1|||
94471228|NCT02164318|323516696|FG002|Overall Study|Withdrawal by Subject|0|||
94471229|NCT02164318|323516697|FG003|Overall Study|Withdrawal by Subject|1|||
94471230|NCT02335346|323516716|FG000|Overall Study|Adverse Event|11|||
94471231|NCT02335346|323516716|FG000|Overall Study|Withdrawal by Subject|1|||
94471232|NCT01548768|323516717|FG000|Overall Study|Withdrawal by Subject|0|||
94471233|NCT01548768|323516718|FG001|Overall Study|Withdrawal by Subject|2|||
94471234|NCT01548768|323516719|FG002|Overall Study|Withdrawal by Subject|1|||
94471235|NCT01548768|323516720|FG003|Overall Study|Withdrawal by Subject|0|||
94471236|NCT01548768|323516717|FG000|Overall Study|Physician Decision|1|||
94471237|NCT01548768|323516718|FG001|Overall Study|Physician Decision|0|||
94471238|NCT01548768|323516719|FG002|Overall Study|Physician Decision|0|||
94471239|NCT01548768|323516720|FG003|Overall Study|Physician Decision|0|||
94471240|NCT01548768|323516717|FG000|Overall Study|Adverse Event|0|||
94471241|NCT01548768|323516718|FG001|Overall Study|Adverse Event|0|||
94471242|NCT01548768|323516719|FG002|Overall Study|Adverse Event|0|||
94471243|NCT01548768|323516720|FG003|Overall Study|Adverse Event|1|||
94471244|NCT01548768|323516717|FG000|Overall Study|Non-Compliance|0|||
94471245|NCT01548768|323516718|FG001|Overall Study|Non-Compliance|0|||
94471246|NCT01548768|323516719|FG002|Overall Study|Non-Compliance|0|||
94471247|NCT01548768|323516720|FG003|Overall Study|Non-Compliance|3|||
94471248|NCT00290693|323516721|FG000|Overall Study|Withdrawal by Subject|2|||
94471249|NCT02769312|323516726|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
94471250|NCT02769312|323516727|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
94471251|NCT02769312|323516726|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
94471252|NCT02769312|323516727|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
94471253|NCT02769312|323516726|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
94471254|NCT02769312|323516727|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
94471255|NCT02769312|323516726|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
94471256|NCT02769312|323516727|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
94471257|NCT02769312|323516726|FG000|Follow-up|Lost to Follow-up|1|||
94471258|NCT02769312|323516727|FG001|Follow-up|Lost to Follow-up|1|||
94471259|NCT04126317|323516728|FG000|Overall Study|Adverse Event|0|||
94471260|NCT04126317|323516729|FG001|Overall Study|Adverse Event|1|||
94471261|NCT04126317|323516728|FG000|Overall Study|Withdrawal by Subject|4|||
94471262|NCT04126317|323516729|FG001|Overall Study|Withdrawal by Subject|1|||
94471263|NCT03326518|323516730|FG000|Overall Study|Protocol Violation|1|||
94471264|NCT03326518|323516731|FG001|Overall Study|Protocol Violation|0|||
94471265|NCT03326518|323516732|FG002|Overall Study|Protocol Violation|0|||
94471266|NCT03326518|323516730|FG000|Overall Study|Withdrawal by Subject|1|||
94471267|NCT03326518|323516731|FG001|Overall Study|Withdrawal by Subject|0|||
94471268|NCT03326518|323516732|FG002|Overall Study|Withdrawal by Subject|0|||
94471269|NCT03326518|323516730|FG000|Overall Study|Lost to Follow-up|1|||
94471270|NCT03326518|323516731|FG001|Overall Study|Lost to Follow-up|0|||
94471271|NCT03326518|323516732|FG002|Overall Study|Lost to Follow-up|1|||
94471272|NCT01796301|323516735|FG000|Overall Study|Withdrawal by Subject|15|||
94471273|NCT01796301|323516736|FG001|Overall Study|Withdrawal by Subject|15|||
94471274|NCT01796301|323516735|FG000|Overall Study|Lost to Follow-up|3|||
94471275|NCT01796301|323516736|FG001|Overall Study|Lost to Follow-up|3|||
94471276|NCT01796301|323516735|FG000|Overall Study|Death|0|||
94471277|NCT01796301|323516736|FG001|Overall Study|Death|1|||
94471278|NCT01796301|323516735|FG000|Overall Study|Decision by Sponsor|0|||
94471279|NCT01796301|323516736|FG001|Overall Study|Decision by Sponsor|1|||
94471280|NCT03077607|323516737|FG000|Period 1 (15 Days)|Adverse Event|1|||
94471281|NCT03077607|323516738|FG001|Period 1 (15 Days)|Adverse Event|0|||
94471282|NCT03077607|323516737|FG000|Period 1 (15 Days)|Death|1|||
94471283|NCT03077607|323516738|FG001|Period 1 (15 Days)|Death|0|||
94471284|NCT03077607|323516737|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
94380370|NCT01144663|323179113|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
94380371|NCT01144663|323179110|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
94380372|NCT01144663|323179111|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
94380373|NCT01144663|323179112|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
94380374|NCT01144663|323179113|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
94380375|NCT01144663|323179110|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
94380376|NCT01144663|323179111|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
94380377|NCT01144663|323179112|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
94471285|NCT03077607|323516738|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
94471286|NCT03077607|323516737|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
94471287|NCT03077607|323516738|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
94471288|NCT03484403|323516740|FG000|Overall Study|Withdrawal by Subject|6|||
94471289|NCT03484403|323516741|FG001|Overall Study|Withdrawal by Subject|4|||
94471290|NCT02131636|323516742|FG000|Overall Study|Personal Reasons|4|||
94471291|NCT02131636|323516743|FG001|Overall Study|Personal Reasons|4|||
94471292|NCT02131636|323516742|FG000|Overall Study|Lost to Follow-up|4|||
94309431|NCT00685178|322916943|FG002|Overall Study|administrative (disciplinary) discharge|0|||
94309432|NCT00685178|322916944|FG003|Overall Study|administrative (disciplinary) discharge|2|||
94309433|NCT00685178|322916941|FG000|Overall Study|Pregnancy|0|||
94309434|NCT00685178|322916942|FG001|Overall Study|Pregnancy|0|||
94309435|NCT00685178|322916943|FG002|Overall Study|Pregnancy|0|||
94309436|NCT00685178|322916944|FG003|Overall Study|Pregnancy|1|||
94309437|NCT01371838|322916950|FG000|Overall Study|Withdrawal by Subject|27|||
94309438|NCT01371838|322916951|FG001|Overall Study|Withdrawal by Subject|33|||
94309439|NCT01371838|322916950|FG000|Overall Study|Lost to Follow-up|10|||
94309440|NCT01371838|322916951|FG001|Overall Study|Lost to Follow-up|20|||
94309441|NCT01371838|322916950|FG000|Overall Study|Death|3|||
94309442|NCT01371838|322916951|FG001|Overall Study|Death|4|||
94309443|NCT01371838|322916950|FG000|Overall Study|Protocol Violation|3|||
94309444|NCT01371838|322916951|FG001|Overall Study|Protocol Violation|0|||
94309445|NCT01371838|322916950|FG000|Overall Study|Investigator Decision|3|||
94309446|NCT01371838|322916951|FG001|Overall Study|Investigator Decision|8|||
94309447|NCT01371838|322916950|FG000|Overall Study|Last follow-up visit not conducted|2|||
94309448|NCT01371838|322916951|FG001|Overall Study|Last follow-up visit not conducted|0|||
94309449|NCT01371838|322916950|FG000|Overall Study|Lack of therapeutic response|0|||
94309450|NCT01371838|322916951|FG001|Overall Study|Lack of therapeutic response|1|||
94309451|NCT01371838|322916950|FG000|Overall Study|Surgery|1|||
94309452|NCT01371838|322916951|FG001|Overall Study|Surgery|0|||
94309453|NCT00077623|322916952|FG000|Overall Study|Adverse Event|1|||
94309454|NCT00077623|322916953|FG001|Overall Study|Adverse Event|0|||
94309455|NCT00077623|322916954|FG002|Overall Study|Adverse Event|1|||
94309456|NCT00077623|322916952|FG000|Overall Study|Withdrawal by Subject|2|||
94309457|NCT00077623|322916953|FG001|Overall Study|Withdrawal by Subject|10|||
94309458|NCT00077623|322916954|FG002|Overall Study|Withdrawal by Subject|1|||
94309459|NCT00077623|322916952|FG000|Overall Study|Other-Non safety reason|18|||
94309460|NCT00077623|322916953|FG001|Overall Study|Other-Non safety reason|15|||
94309461|NCT00077623|322916954|FG002|Overall Study|Other-Non safety reason|19|||
94309462|NCT00077623|322916952|FG000|Overall Study|Insufficient therapeutic response|2|||
94309463|NCT00077623|322916953|FG001|Overall Study|Insufficient therapeutic response|0|||
94309464|NCT00077623|322916954|FG002|Overall Study|Insufficient therapeutic response|0|||
94309465|NCT00077623|322916952|FG000|Overall Study|Death|12|||
94309466|NCT00077623|322916953|FG001|Overall Study|Death|18|||
94309467|NCT00077623|322916954|FG002|Overall Study|Death|11|||
94309468|NCT00077623|322916952|FG000|Overall Study|Failure to return|1|||
94309469|NCT00077623|322916953|FG001|Overall Study|Failure to return|0|||
94309470|NCT00077623|322916954|FG002|Overall Study|Failure to return|0|||
94309471|NCT04220866|322916955|FG000|Overall Study|Death|4|||
94309472|NCT04220866|322916956|FG001|Overall Study|Death|5|||
94309473|NCT04220866|322916955|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
94309474|NCT04220866|322916956|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
94309475|NCT04220866|322916955|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
94309476|NCT04220866|322916956|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
94309477|NCT04220866|322916955|FG000|Overall Study|Withdrawal by Subject|0|||
94309478|NCT04220866|322916956|FG001|Overall Study|Withdrawal by Subject|1|||
94309479|NCT02345161|322916964|FG000|Overall Study|Withdrawal by Subject|25|||
94309480|NCT02345161|322916965|FG001|Overall Study|Withdrawal by Subject|33|||
94309481|NCT02345161|322916964|FG000|Overall Study|Adverse Event|16|||
94309482|NCT02345161|322916965|FG001|Overall Study|Adverse Event|19|||
94309483|NCT02345161|322916964|FG000|Overall Study|Physician Decision|4|||
94309484|NCT02345161|322916965|FG001|Overall Study|Physician Decision|4|||
94309485|NCT02345161|322916964|FG000|Overall Study|Lost to Follow-up|0|||
94309486|NCT02345161|322916965|FG001|Overall Study|Lost to Follow-up|1|||
94309487|NCT02225223|322916973|FG000|Overall Study|Death|10|||
94309488|NCT02225223|322916974|FG001|Overall Study|Death|1|||
94309489|NCT02225223|322916973|FG000|Overall Study|Lost to Follow-up|5|||
94309490|NCT02225223|322916974|FG001|Overall Study|Lost to Follow-up|0|||
94309491|NCT02225223|322916973|FG000|Overall Study|Other|1|||
94309492|NCT02225223|322916974|FG001|Overall Study|Other|2|||
94309493|NCT02225223|322916973|FG000|Overall Study|Physician Decision|1|||
94309494|NCT02225223|322916974|FG001|Overall Study|Physician Decision|0|||
94309495|NCT02225223|322916973|FG000|Overall Study|Withdrawal by Subject|2|||
94309496|NCT02225223|322916974|FG001|Overall Study|Withdrawal by Subject|2|||
94309497|NCT01650779|322916975|FG000|Overall Study|Withdrawal by Subject|1|||
94309498|NCT03666143|322916976|FG000|Overall Study|Death|158|||
94309499|NCT03666143|322916976|FG000|Overall Study|Sponsor Decision|31|||
94309500|NCT03666143|322916976|FG000|Overall Study|Withdrawal by Subject|11|||
94309501|NCT03666143|322916976|FG000|Overall Study|Lost to Follow-up|5|||
94309502|NCT03666143|322916976|FG000|Overall Study|Physician Decision|1|||
94309503|NCT03666143|322916976|FG000|Overall Study|Rolled into extension study|9|||
94309504|NCT03666143|322916976|FG000|Overall Study|Progressive Disease|1|||
94309505|NCT01936649|322916984|FG000|Overall Study|Withdrawal by Subject|4|||
94309506|NCT01936649|322916984|FG000|Overall Study|Physician Decision|2|||
94471293|NCT02131636|323516743|FG001|Overall Study|Lost to Follow-up|0|||
94471294|NCT02131636|323516742|FG000|Overall Study|Adverse Event|4|||
94471295|NCT02131636|323516743|FG001|Overall Study|Adverse Event|1|||
94471296|NCT03004924|323516744|FG000|Overall Study|Adverse Event|6|||
94471297|NCT03004924|323516745|FG001|Overall Study|Adverse Event|5|||
94471298|NCT03004924|323516746|FG002|Overall Study|Adverse Event|10|||
94471299|NCT03004924|323516744|FG000|Overall Study|Protocol Violation|4|||
94471300|NCT03004924|323516745|FG001|Overall Study|Protocol Violation|0|||
94471301|NCT03004924|323516746|FG002|Overall Study|Protocol Violation|1|||
94471302|NCT03004924|323516744|FG000|Overall Study|Withdrawal by Subject|5|||
94471303|NCT03004924|323516745|FG001|Overall Study|Withdrawal by Subject|3|||
94471304|NCT03004924|323516746|FG002|Overall Study|Withdrawal by Subject|5|||
94471305|NCT03004924|323516744|FG000|Overall Study|Lost to Follow-up|6|||
94471306|NCT03004924|323516745|FG001|Overall Study|Lost to Follow-up|1|||
94471307|NCT03004924|323516746|FG002|Overall Study|Lost to Follow-up|4|||
94471308|NCT03004924|323516744|FG000|Overall Study|Lack of Efficacy|2|||
94471309|NCT03004924|323516745|FG001|Overall Study|Lack of Efficacy|4|||
94471310|NCT03004924|323516746|FG002|Overall Study|Lack of Efficacy|2|||
94471311|NCT03004924|323516744|FG000|Overall Study|Physician Decision|1|||
94471312|NCT03004924|323516745|FG001|Overall Study|Physician Decision|0|||
94471313|NCT03004924|323516746|FG002|Overall Study|Physician Decision|1|||
94471314|NCT03004924|323516744|FG000|Overall Study|Withdrawal by parent/guardian|1|||
94471315|NCT03004924|323516745|FG001|Overall Study|Withdrawal by parent/guardian|0|||
94471316|NCT03004924|323516746|FG002|Overall Study|Withdrawal by parent/guardian|2|||
94471317|NCT03004924|323516744|FG000|Overall Study|Screen Failure|1|||
94471318|NCT03004924|323516745|FG001|Overall Study|Screen Failure|0|||
94471319|NCT03004924|323516746|FG002|Overall Study|Screen Failure|0|||
94471320|NCT03004924|323516744|FG000|Overall Study|Pregnancy|0|||
94471321|NCT03004924|323516745|FG001|Overall Study|Pregnancy|1|||
94471322|NCT03004924|323516746|FG002|Overall Study|Pregnancy|0|||
94471323|NCT03004924|323516744|FG000|Overall Study|Terminated by Sponsor|0|||
94471324|NCT03004924|323516745|FG001|Overall Study|Terminated by Sponsor|0|||
94471325|NCT03004924|323516746|FG002|Overall Study|Terminated by Sponsor|1|||
94380378|NCT01144663|323179113|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
94380379|NCT01144663|323179110|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
94380380|NCT01144663|323179111|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
94380381|NCT01144663|323179112|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
94380382|NCT01144663|323179113|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
94380383|NCT03355742|323179115|FG000|Overall Study|Lost to Follow-up|4|||
94380384|NCT03355742|323179115|FG000|Overall Study|Withdrawal by Subject|29|||
94380385|NCT03355742|323179115|FG000|Overall Study|Physician Decision|6|||
94380386|NCT03355742|323179115|FG000|Overall Study|Death|55|||
94380387|NCT03355742|323179115|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
94380388|NCT00901628|323179118|FG000|Overall Study|disconnection of catheter|4|||
94380389|NCT00901628|323179119|FG001|Overall Study|disconnection of catheter|8|||
94380390|NCT00901628|323179118|FG000|Overall Study|disconnection of drain|0|||
94380391|NCT00901628|323179119|FG001|Overall Study|disconnection of drain|1|||
94380392|NCT00901628|323179118|FG000|Overall Study|peroneal nerve palsy|0|||
94380393|NCT00901628|323179119|FG001|Overall Study|peroneal nerve palsy|1|||
94380394|NCT02668783|323179126|FG000|Overall Study|Pregnancy|0|||
94380395|NCT02668783|323179127|FG001|Overall Study|Pregnancy|1|||
94380396|NCT02668783|323179126|FG000|Overall Study|Protocol Violation|2|||
94380397|NCT02668783|323179127|FG001|Overall Study|Protocol Violation|1|||
94380398|NCT02668783|323179126|FG000|Overall Study|Study terminated by sponsor|9|||
94380399|NCT02668783|323179127|FG001|Overall Study|Study terminated by sponsor|10|||
94380400|NCT02668783|323179126|FG000|Overall Study|Subject moved|1|||
94380401|NCT02668783|323179127|FG001|Overall Study|Subject moved|0|||
94380402|NCT02668783|323179126|FG000|Overall Study|Withdrawal by Subject|1|||
94380403|NCT02668783|323179127|FG001|Overall Study|Withdrawal by Subject|0|||
94380404|NCT01628120|323179128|FG000|Overall Study|Withdrawal by Subject|7|||
94380405|NCT01628120|323179128|FG000|Overall Study|Adverse Event|12|||
94380406|NCT01628120|323179128|FG000|Overall Study|Lost to Follow-up|1|||
94380407|NCT01628120|323179128|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
94380408|NCT01628120|323179128|FG000|Overall Study|Non-compliant with Study Procedures|1|||
94380409|NCT01628120|323179128|FG000|Overall Study|Not Treated|3|||
94380410|NCT01628120|323179128|FG000|Overall Study|Sponsor Decision|5|||
94380411|NCT01628120|323179128|FG000|Overall Study|Switched Dialysis Method|2|||
94380412|NCT01628120|323179128|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
94471326|NCT03004924|323516744|FG000|Overall Study|Missed Study Visit|0|||
94471327|NCT03004924|323516745|FG001|Overall Study|Missed Study Visit|0|||
94471328|NCT03004924|323516746|FG002|Overall Study|Missed Study Visit|2|||
94471329|NCT03004924|323516744|FG000|Overall Study|HSV1 Positive|1|||
94471330|NCT03004924|323516745|FG001|Overall Study|HSV1 Positive|0|||
94471331|NCT03004924|323516746|FG002|Overall Study|HSV1 Positive|0|||
94471332|NCT01280682|323516747|FG000|Overall Study|Lost to Follow-up|0|||
94471333|NCT01280682|323516748|FG001|Overall Study|Lost to Follow-up|6|||
94471334|NCT01280682|323516747|FG000|Overall Study|Withdrawal by Subject|0|||
94471335|NCT01280682|323516748|FG001|Overall Study|Withdrawal by Subject|7|||
94471336|NCT02191046|323516749|FG000|Overall Study|low compliance|5|||
94471337|NCT02191046|323516750|FG001|Overall Study|low compliance|1|||
94471338|NCT02007278|323516754|FG000|Overall Study|Failure to comply with an eligibility|0|||
94471339|NCT02007278|323516755|FG001|Overall Study|Failure to comply with an eligibility|1|||
94471340|NCT02007278|323516754|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
94471341|NCT02007278|323516755|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
94471342|NCT02007278|323516754|FG000|Overall Study|Incorrect medication administration|1|||
94471343|NCT02007278|323516755|FG001|Overall Study|Incorrect medication administration|0|||
94471344|NCT02007278|323516754|FG000|Overall Study|Mis-randomization|1|||
94471345|NCT02007278|323516755|FG001|Overall Study|Mis-randomization|1|||
94471346|NCT02697734|323516763|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
94471347|NCT02697734|323516764|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
94471348|NCT02697734|323516763|FG000|Core Phase - up to Week 48|Adverse Event|1|||
94471349|NCT02697734|323516764|FG001|Core Phase - up to Week 48|Adverse Event|2|||
94471350|NCT02697734|323516763|FG000|Core Phase - up to Week 48|Physician Decision|1|||
94471351|NCT02697734|323516764|FG001|Core Phase - up to Week 48|Physician Decision|0|||
94471352|NCT02697734|323516763|FG000|Optional Extension Phase|Adverse Event|5|||
94471353|NCT02697734|323516764|FG001|Optional Extension Phase|Adverse Event|1|||
94471354|NCT02697734|323516763|FG000|Optional Extension Phase|Physician Decision|0|||
94471355|NCT02697734|323516764|FG001|Optional Extension Phase|Physician Decision|1|||
94471356|NCT02334384|323516766|FG000|Overall Study|Lost to Follow-up|1|||
94471357|NCT02334384|323516767|FG001|Overall Study|Lost to Follow-up|1|||
94471358|NCT02651688|323516768|FG000|Overall Study|Non-compliance|0|||
94471359|NCT02651688|323516769|FG001|Overall Study|Non-compliance|0|||
94471360|NCT02651688|323516770|FG002|Overall Study|Non-compliance|1|||
94471361|NCT02651688|323516768|FG000|Overall Study|Principal Investigator (PI) decision|0|||
94471362|NCT02651688|323516769|FG001|Overall Study|Principal Investigator (PI) decision|2|||
94471363|NCT02651688|323516770|FG002|Overall Study|Principal Investigator (PI) decision|0|||
94471364|NCT02651688|323516768|FG000|Overall Study|Lost to Follow-up|1|||
94471365|NCT02651688|323516769|FG001|Overall Study|Lost to Follow-up|3|||
94471366|NCT02651688|323516770|FG002|Overall Study|Lost to Follow-up|0|||
94471367|NCT02651688|323516768|FG000|Overall Study|Withdrawal by Subject|1|||
94471368|NCT02651688|323516769|FG001|Overall Study|Withdrawal by Subject|0|||
94471369|NCT02651688|323516770|FG002|Overall Study|Withdrawal by Subject|2|||
94471370|NCT00055497|323516773|FG000|Overall Study|Adverse Event|1|||
94471371|NCT00055497|323516774|FG001|Overall Study|Adverse Event|1|||
94471372|NCT00055497|323516775|FG002|Overall Study|Adverse Event|1|||
94471373|NCT00055497|323516776|FG003|Overall Study|Adverse Event|28|||
94471374|NCT00055497|323516773|FG000|Overall Study|Withdrawal by Subject|3|||
94471375|NCT00055497|323516774|FG001|Overall Study|Withdrawal by Subject|1|||
94471376|NCT00055497|323516775|FG002|Overall Study|Withdrawal by Subject|1|||
94471377|NCT00055497|323516776|FG003|Overall Study|Withdrawal by Subject|15|||
94471378|NCT00055497|323516773|FG000|Overall Study|Lost to Follow-up|0|||
94471379|NCT00055497|323516774|FG001|Overall Study|Lost to Follow-up|1|||
94471380|NCT00055497|323516775|FG002|Overall Study|Lost to Follow-up|0|||
94471381|NCT00055497|323516776|FG003|Overall Study|Lost to Follow-up|5|||
94471382|NCT00055497|323516773|FG000|Overall Study|Protocol Violation|0|||
94471383|NCT00055497|323516774|FG001|Overall Study|Protocol Violation|0|||
94471384|NCT00055497|323516775|FG002|Overall Study|Protocol Violation|0|||
94471385|NCT00055497|323516776|FG003|Overall Study|Protocol Violation|3|||
94471386|NCT00055497|323516773|FG000|Overall Study|Lack of Efficacy|1|||
94471387|NCT00055497|323516774|FG001|Overall Study|Lack of Efficacy|0|||
94471388|NCT00055497|323516775|FG002|Overall Study|Lack of Efficacy|0|||
94471389|NCT00055497|323516776|FG003|Overall Study|Lack of Efficacy|27|||
94471390|NCT00055497|323516773|FG000|Overall Study|Administrative Reasons|0|||
94471391|NCT00055497|323516774|FG001|Overall Study|Administrative Reasons|0|||
94471392|NCT00055497|323516775|FG002|Overall Study|Administrative Reasons|0|||
94471393|NCT00055497|323516776|FG003|Overall Study|Administrative Reasons|1|||
94471394|NCT00055497|323516773|FG000|Overall Study|Other|0|||
94471395|NCT00055497|323516774|FG001|Overall Study|Other|0|||
94471396|NCT00055497|323516775|FG002|Overall Study|Other|0|||
94471397|NCT00055497|323516776|FG003|Overall Study|Other|11|||
94471398|NCT01370616|323516778|FG000|Overall Study|Adverse Event|11|||
94471399|NCT01370616|323516779|FG001|Overall Study|Adverse Event|16|||
94471400|NCT01370616|323516778|FG000|Overall Study|Death|1|||
94471401|NCT01370616|323516779|FG001|Overall Study|Death|0|||
94471402|NCT01370616|323516778|FG000|Overall Study|Lack of Efficacy|6|||
94471403|NCT01370616|323516779|FG001|Overall Study|Lack of Efficacy|2|||
94471404|NCT01370616|323516778|FG000|Overall Study|Lost to Follow-up|0|||
94471405|NCT01370616|323516779|FG001|Overall Study|Lost to Follow-up|3|||
94471406|NCT01370616|323516778|FG000|Overall Study|Physician Decision|6|||
94471407|NCT01370616|323516779|FG001|Overall Study|Physician Decision|6|||
94471408|NCT01370616|323516778|FG000|Overall Study|Progressive Disease|0|||
94471409|NCT01370616|323516779|FG001|Overall Study|Progressive Disease|1|||
94471410|NCT01370616|323516778|FG000|Overall Study|Recovery|1|||
94471411|NCT01370616|323516779|FG001|Overall Study|Recovery|0|||
94471412|NCT01370616|323516778|FG000|Overall Study|Technical Problems|3|||
94309507|NCT01936649|322916984|FG000|Overall Study|Protocol Violation|2|||
94309508|NCT01936649|322916984|FG000|Overall Study|Other than specified above|5|||
94309509|NCT01295905|322916987|FG000|Overall Study|Did not meet inclusion criteria|1|||
94309510|NCT01295905|322916988|FG001|Overall Study|Did not meet inclusion criteria|0|||
94309511|NCT01295905|322916987|FG000|Overall Study|Met exclusion criteria|1|||
94309512|NCT01295905|322916988|FG001|Overall Study|Met exclusion criteria|0|||
94309513|NCT03268746|322916991|FG000|Overall Study|Withdrawal by Subject|1|||
94309514|NCT01184989|322916996|FG000|Overall Study|Adverse Event|11|||
94309515|NCT01184989|322916996|FG000|Overall Study|Withdrawal by Subject|1|||
94309516|NCT02927171|322916997|FG000|Overall Study|Lost to Follow-up|0|||
94309517|NCT02927171|322916998|FG001|Overall Study|Lost to Follow-up|1|||
94309518|NCT00328198|322916999|FG000|Treatment|Adverse Event|21|||
94380413|NCT01628120|323179128|FG000|Overall Study|Moved or Relocated|5|||
94380414|NCT01628120|323179128|FG000|Overall Study|Kidney Transplant|2|||
94380415|NCT01628120|323179128|FG000|Overall Study|Use of Standard of Care|1|||
94380416|NCT01165996|323179129|FG000|Overall Study|Death|1|||
94380417|NCT01165996|323179129|FG000|Overall Study|Physician Decision|1|||
94380418|NCT01506323|323179130|FG000|Overall Study|Lost to Follow-up|5|||
94380419|NCT01506323|323179131|FG001|Overall Study|Lost to Follow-up|4|||
94380420|NCT01506323|323179130|FG000|Overall Study|Withdrawal by Subject|4|||
94380421|NCT01506323|323179131|FG001|Overall Study|Withdrawal by Subject|4|||
94380422|NCT01506323|323179130|FG000|Overall Study|Lack of Efficacy|1|||
94380423|NCT01506323|323179131|FG001|Overall Study|Lack of Efficacy|3|||
94380424|NCT01506323|323179130|FG000|Overall Study|Moved out of area|5|||
94380425|NCT01506323|323179131|FG001|Overall Study|Moved out of area|2|||
94380426|NCT01506323|323179130|FG000|Overall Study|Schedule or Transportation conflict|8|||
94380427|NCT01506323|323179131|FG001|Overall Study|Schedule or Transportation conflict|0|||
94380428|NCT01506323|323179130|FG000|Overall Study|Started another treatment|1|||
94380429|NCT01506323|323179131|FG001|Overall Study|Started another treatment|0|||
94380430|NCT02891200|323179132|FG000|Overall Study|Lost to Follow-up|31|||
94380431|NCT02891200|323179133|FG001|Overall Study|Lost to Follow-up|36|||
94380432|NCT02891200|323179132|FG000|Overall Study|Death|10|||
94380433|NCT02891200|323179133|FG001|Overall Study|Death|9|||
94380434|NCT02891200|323179132|FG000|Overall Study|Withdrawal by Subject|1|||
94380435|NCT02891200|323179133|FG001|Overall Study|Withdrawal by Subject|4|||
94380436|NCT02232074|323179136|FG000|Overall Study|Withdrawal by Subject|5|||
94380437|NCT02232074|323179137|FG001|Overall Study|Withdrawal by Subject|3|||
94380438|NCT02232074|323179136|FG000|Overall Study|No legal concerns at baseline|36|||
94380439|NCT02232074|323179137|FG001|Overall Study|No legal concerns at baseline|41|||
94380440|NCT02232074|323179136|FG000|Overall Study|deemed ineligible|0|||
94380441|NCT02232074|323179137|FG001|Overall Study|deemed ineligible|1|||
94380442|NCT00444795|323179140|FG000|Overall Study|Not Treated|1|||
94380443|NCT00444795|323179140|FG000|Overall Study|Treated Prior to the Contract Date|2|||
94380444|NCT00988169|323179141|FG000|Overall Study|Withdrawal by Subject|1|||
94380445|NCT00704418|323179142|FG000|Overall Study|Withdrawal by Subject|2|||
94380446|NCT00704418|323179143|FG001|Overall Study|Withdrawal by Subject|0|||
94380447|NCT00704418|323179142|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
94380448|NCT00704418|323179143|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
94380449|NCT02322879|323179144|FG000|First Intervention|Physician Decision|1|||
94380450|NCT02322879|323179145|FG001|First Intervention|Physician Decision|0|||
94380451|NCT04583579|323179147|FG000|Overall Study|Lost to Follow-up|4|||
94380452|NCT04820842|323179148|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
94380453|NCT04820842|323179149|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
94380454|NCT04820842|323179150|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
94380455|NCT04820842|323179151|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
94380456|NCT04820842|323179152|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
94380457|NCT04820842|323179153|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
94380458|NCT04820842|323179154|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
94380459|NCT04820842|323179148|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
94380460|NCT04820842|323179149|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
94380461|NCT04820842|323179150|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
94380462|NCT04820842|323179151|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
94380463|NCT04820842|323179152|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
94380464|NCT04820842|323179153|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
94380465|NCT04820842|323179154|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
94380466|NCT04820842|323179148|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
94309519|NCT00328198|322916999|FG000|Treatment|Death|1|||
94309520|NCT00328198|322916999|FG000|Treatment|Physician Decision|5|||
94309521|NCT00328198|322916999|FG000|Treatment|Withdrawal by Subject|5|||
94380467|NCT04820842|323179149|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
94471413|NCT01370616|323516779|FG001|Overall Study|Technical Problems|5|||
94471414|NCT01370616|323516778|FG000|Overall Study|Withdrawal by Subject|34|||
94471415|NCT01370616|323516779|FG001|Overall Study|Withdrawal by Subject|34|||
94471416|NCT02112877|323516780|FG000|Overall Study|Withdrawal by Subject|1|||
94471417|NCT02112877|323516781|FG001|Overall Study|Withdrawal by Subject|7|||
94471418|NCT02112877|323516780|FG000|Overall Study|Visit Missed|1|||
94471419|NCT02112877|323516781|FG001|Overall Study|Visit Missed|6|||
94471420|NCT01084538|323516785|FG000|Overall Study|Drug not available|30|||
94471421|NCT01084538|323516785|FG000|Overall Study|Adverse Event|9|||
94471422|NCT01084538|323516785|FG000|Overall Study|Kidney transplant|6|||
94471423|NCT01084538|323516785|FG000|Overall Study|Serious Adverse Event|3|||
94471424|NCT01084538|323516785|FG000|Overall Study|Lack of effectiveness|2|||
94471425|NCT01084538|323516785|FG000|Overall Study|Patient noncompliance|2|||
94471426|NCT01084538|323516785|FG000|Overall Study|Hyperphosphatemia|2|||
94471427|NCT01084538|323516785|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
94471428|NCT01084538|323516785|FG000|Overall Study|Change of residence|2|||
94471429|NCT01084538|323516785|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
94471430|NCT01084538|323516785|FG000|Overall Study|Reason unknown|8|||
94471431|NCT01578499|323516790|FG000|Overall Study|Reason not Specified|0|||
94471432|NCT01578499|323516791|FG001|Overall Study|Reason not Specified|1|||
94471433|NCT01578499|323516790|FG000|Overall Study|Lost to Follow-up|2|||
94471434|NCT01578499|323516791|FG001|Overall Study|Lost to Follow-up|1|||
94471435|NCT01578499|323516790|FG000|Overall Study|Withdrawal by Subject|10|||
94471436|NCT01578499|323516791|FG001|Overall Study|Withdrawal by Subject|16|||
94471437|NCT01578499|323516790|FG000|Overall Study|Death|20|||
94471438|NCT01578499|323516791|FG001|Overall Study|Death|25|||
94471439|NCT01578499|323516790|FG000|Overall Study|Died and End of Study Page not Completed|2|||
94471440|NCT01578499|323516791|FG001|Overall Study|Died and End of Study Page not Completed|0|||
94471441|NCT02155322|323516792|FG000|Overall Study|Adverse Event|1|||
94471442|NCT02155322|323516792|FG000|Overall Study|Physician Decision|1|||
94471443|NCT02155322|323516792|FG000|Overall Study|Relapse/Recurrence|8|||
94471444|NCT02155322|323516792|FG000|Overall Study|Withdrawal by Subject|4|||
94471445|NCT01603394|323516798|FG000|Overall Study|Adverse Event|1|||
94471446|NCT00840034|323516800|FG000|Acute Treatment Phase|Adverse Event|6|||
94471447|NCT00840034|323516801|FG001|Acute Treatment Phase|Adverse Event|8|||
94471448|NCT00840034|323516800|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
94471449|NCT00840034|323516801|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
94471450|NCT00840034|323516800|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
94471451|NCT00840034|323516801|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
94471452|NCT00840034|323516800|FG000|Acute Treatment Phase|Physician Decision|0|||
94471453|NCT00840034|323516801|FG001|Acute Treatment Phase|Physician Decision|1|||
94471454|NCT00840034|323516800|FG000|Acute Treatment Phase|Protocol Violation|2|||
94471455|NCT00840034|323516801|FG001|Acute Treatment Phase|Protocol Violation|4|||
94471456|NCT00840034|323516800|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
94471457|NCT00840034|323516801|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
94471458|NCT00840034|323516800|FG000|Taper Phase|Adverse Event|1|||
94471459|NCT00840034|323516801|FG001|Taper Phase|Adverse Event|0|||
94471460|NCT00840034|323516800|FG000|Taper Phase|Lost to Follow-up|1|||
94471461|NCT00840034|323516801|FG001|Taper Phase|Lost to Follow-up|1|||
94471462|NCT00840034|323516800|FG000|Taper Phase|Withdrawal by Subject|1|||
94471463|NCT00840034|323516801|FG001|Taper Phase|Withdrawal by Subject|1|||
94471464|NCT01215435|323516802|FG000|Overall Study|Adverse Event|1|||
94471465|NCT01215435|323516803|FG001|Overall Study|Adverse Event|0|||
94471466|NCT01215435|323516802|FG000|Overall Study|Protocol Violation|2|||
94471467|NCT01215435|323516803|FG001|Overall Study|Protocol Violation|0|||
94471468|NCT01215435|323516802|FG000|Overall Study|Withdrawal Criteria|8|||
94471469|NCT01215435|323516803|FG001|Overall Study|Withdrawal Criteria|11|||
94471470|NCT01215435|323516802|FG000|Overall Study|Lost to Follow-up|3|||
94471471|NCT01215435|323516803|FG001|Overall Study|Lost to Follow-up|0|||
94471472|NCT01215435|323516802|FG000|Overall Study|Unclassified|5|||
94471473|NCT01215435|323516803|FG001|Overall Study|Unclassified|5|||
94471474|NCT00636961|323516806|FG000|Period 1|Administrative problems|1|||
94471475|NCT00636961|323516807|FG001|Period 1|Administrative problems|1|||
94471476|NCT00636961|323516806|FG000|Period 2|Adverse Event|1|||
94471477|NCT00636961|323516807|FG001|Period 2|Adverse Event|0|||
94471478|NCT00856843|323516808|FG000|Overall Study|Withdrawal by Subject|1|||
94471479|NCT00856843|323516809|FG001|Overall Study|Withdrawal by Subject|5|||
94471480|NCT00856843|323516808|FG000|Overall Study|Lack of Efficacy|1|||
94471481|NCT00856843|323516809|FG001|Overall Study|Lack of Efficacy|0|||
94471482|NCT03172364|323516810|FG000|Overall Study|Adverse Event|1|||
94471483|NCT03172364|323516811|FG001|Overall Study|Adverse Event|1|||
94471484|NCT03172364|323516810|FG000|Overall Study|Protocol Violation|1|||
94471485|NCT03172364|323516811|FG001|Overall Study|Protocol Violation|0|||
94471486|NCT01573754|323516813|FG000|Overall Study|Noncompliance or remission not achieved|3|||
94471487|NCT01573754|323516814|FG001|Overall Study|Noncompliance or remission not achieved|15|||
94471488|NCT00520767|323516817|FG000|Overall Study|Death|2|||
94471489|NCT00642954|323518345|FG000|Overall Study|Progressive Disease|3|||
94471490|NCT00642954|323518346|FG001|Overall Study|Progressive Disease|3|||
94471491|NCT00642954|323518347|FG002|Overall Study|Progressive Disease|3|||
94471492|NCT00642954|323518348|FG003|Overall Study|Progressive Disease|3|||
94471493|NCT00642954|323518349|FG004|Overall Study|Progressive Disease|9|||
94471494|NCT00642954|323518345|FG000|Overall Study|Withdrawal by Subject|0|||
94471495|NCT00642954|323518346|FG001|Overall Study|Withdrawal by Subject|0|||
94471496|NCT00642954|323518347|FG002|Overall Study|Withdrawal by Subject|0|||
94471497|NCT00642954|323518348|FG003|Overall Study|Withdrawal by Subject|0|||
94471498|NCT00642954|323518349|FG004|Overall Study|Withdrawal by Subject|1|||
94471499|NCT00642954|323518345|FG000|Overall Study|Adverse Event|1|||
94471500|NCT00642954|323518346|FG001|Overall Study|Adverse Event|1|||
94471501|NCT00642954|323518347|FG002|Overall Study|Adverse Event|0|||
94471502|NCT00642954|323518348|FG003|Overall Study|Adverse Event|0|||
94471503|NCT00642954|323518349|FG004|Overall Study|Adverse Event|6|||
94471504|NCT01709864|323518354|FG000|Overall Study|Physician Decision|0|||
94471505|NCT01709864|323518355|FG001|Overall Study|Physician Decision|1|||
94471506|NCT01709864|323518354|FG000|Overall Study|subject/guardian decision|5|||
94471507|NCT01709864|323518355|FG001|Overall Study|subject/guardian decision|6|||
94471508|NCT01709864|323518354|FG000|Overall Study|Lost to Follow-up|1|||
94471509|NCT01709864|323518355|FG001|Overall Study|Lost to Follow-up|0|||
94471510|NCT01709864|323518354|FG000|Overall Study|non-compliance with study treatment|1|||
94471511|NCT01709864|323518355|FG001|Overall Study|non-compliance with study treatment|1|||
94471512|NCT01709864|323518354|FG000|Overall Study|Adverse Event|0|||
94471513|NCT01709864|323518355|FG001|Overall Study|Adverse Event|2|||
94471514|NCT01709864|323518354|FG000|Overall Study|Death|0|||
94471515|NCT01709864|323518355|FG001|Overall Study|Death|1|||
94471516|NCT00703326|323518359|FG000|Overall Study|Lost to Follow-up|47|||
94471517|NCT00703326|323518360|FG001|Overall Study|Lost to Follow-up|18|||
94471518|NCT00703326|323518359|FG000|Overall Study|Withdrawal by Subject|54|||
94471519|NCT00703326|323518360|FG001|Overall Study|Withdrawal by Subject|20|||
94471520|NCT00703326|323518359|FG000|Overall Study|Adverse Event|1|||
94471521|NCT00703326|323518360|FG001|Overall Study|Adverse Event|0|||
94471522|NCT03307837|323518362|FG000|Overall Study|Withdrawal by Subject|0|||
94471523|NCT03307837|323518363|FG001|Overall Study|Withdrawal by Subject|0|||
94471524|NCT03307837|323518364|FG002|Overall Study|Withdrawal by Subject|1|||
94471525|NCT03307837|323518365|FG003|Overall Study|Withdrawal by Subject|0|||
94471526|NCT03307837|323518366|FG004|Overall Study|Withdrawal by Subject|0|||
94471527|NCT03307837|323518367|FG005|Overall Study|Withdrawal by Subject|1|||
94471528|NCT03307837|323518362|FG000|Overall Study|Lost to Follow-up|1|||
94471529|NCT03307837|323518363|FG001|Overall Study|Lost to Follow-up|1|||
94471530|NCT03307837|323518364|FG002|Overall Study|Lost to Follow-up|0|||
94471531|NCT03307837|323518365|FG003|Overall Study|Lost to Follow-up|0|||
94471532|NCT03307837|323518366|FG004|Overall Study|Lost to Follow-up|0|||
94471533|NCT03307837|323518367|FG005|Overall Study|Lost to Follow-up|1|||
94471534|NCT00135356|323518368|FG000|Overall Study|Adverse Event|6|||
94471535|NCT00135356|323518369|FG001|Overall Study|Adverse Event|2|||
94471536|NCT00135356|323518368|FG000|Overall Study|Lack of Efficacy|2|||
94471537|NCT00135356|323518369|FG001|Overall Study|Lack of Efficacy|0|||
94471538|NCT00135356|323518368|FG000|Overall Study|Lost to Follow-up|3|||
94471539|NCT00135356|323518369|FG001|Overall Study|Lost to Follow-up|1|||
94471540|NCT00135356|323518368|FG000|Overall Study|Surgery for abdominal fat|1|||
94471541|NCT00135356|323518369|FG001|Overall Study|Surgery for abdominal fat|0|||
94471542|NCT00135356|323518368|FG000|Overall Study|Change in antiviral regimen|0|||
94471543|NCT00135356|323518369|FG001|Overall Study|Change in antiviral regimen|1|||
94471544|NCT00135356|323518368|FG000|Overall Study|Poor/noncompliance|1|||
94471545|NCT00135356|323518369|FG001|Overall Study|Poor/noncompliance|1|||
94471546|NCT00135356|323518368|FG000|Overall Study|No longer meets study criteria|2|||
94471547|NCT00135356|323518369|FG001|Overall Study|No longer meets study criteria|0|||
94471548|NCT00135356|323518368|FG000|Overall Study|Withdrawal by Subject|2|||
94471549|NCT00135356|323518369|FG001|Overall Study|Withdrawal by Subject|4|||
94471550|NCT01212159|323518370|FG000|Overall Study|Withdrawal by Subject|12|||
94471551|NCT01212159|323518371|FG001|Overall Study|Withdrawal by Subject|12|||
94471552|NCT00582426|323518384|FG000|Overall Study|Lost to Follow-up|0|||
94471553|NCT00582426|323518385|FG001|Overall Study|Lost to Follow-up|2|||
94471554|NCT00582426|323518384|FG000|Overall Study|Adverse Event|4|||
94471555|NCT00582426|323518385|FG001|Overall Study|Adverse Event|2|||
94471556|NCT00582426|323518384|FG000|Overall Study|Protocol Violation|6|||
94471557|NCT00582426|323518385|FG001|Overall Study|Protocol Violation|2|||
94471558|NCT00582426|323518384|FG000|Overall Study|Death|4|||
94471559|NCT00582426|323518385|FG001|Overall Study|Death|3|||
94471560|NCT00582426|323518384|FG000|Overall Study|Withdrawal by Subject|3|||
94471561|NCT00582426|323518385|FG001|Overall Study|Withdrawal by Subject|2|||
94471562|NCT00582426|323518384|FG000|Overall Study|Disease Progression|2|||
94471563|NCT00582426|323518385|FG001|Overall Study|Disease Progression|2|||
94471564|NCT00582426|323518384|FG000|Overall Study|Use of illicit drugs|1|||
94471565|NCT00582426|323518385|FG001|Overall Study|Use of illicit drugs|0|||
94471566|NCT01108237|323518386|FG000|Overall Study|No alignment data|2|||
94471567|NCT01108237|323518387|FG001|Overall Study|No alignment data|15|||
94471568|NCT01108237|323518386|FG000|Overall Study|Did not meet criteria for analysis|7|||
94471569|NCT01108237|323518387|FG001|Overall Study|Did not meet criteria for analysis|0|||
94471570|NCT03594955|323518390|FG000|Overall Study|Adverse Event|1|||
94471571|NCT03594955|323518390|FG000|Overall Study|Progressive disease|5|||
94471572|NCT03594955|323518390|FG000|Overall Study|Sponsor's decision|1|||
94471573|NCT02065518|323518391|FG000|Overall Study|Lost to Follow-up|3|||
94471574|NCT02065518|323518392|FG001|Overall Study|Lost to Follow-up|4|||
94471575|NCT02065518|323518393|FG002|Overall Study|Lost to Follow-up|0|||
94471576|NCT02065518|323518394|FG003|Overall Study|Lost to Follow-up|3|||
94471577|NCT02065518|323518391|FG000|Overall Study|Withdrawal by Subject|3|||
94471578|NCT02065518|323518392|FG001|Overall Study|Withdrawal by Subject|4|||
94471579|NCT02065518|323518393|FG002|Overall Study|Withdrawal by Subject|9|||
94471580|NCT02065518|323518394|FG003|Overall Study|Withdrawal by Subject|2|||
94471581|NCT03042910|323518399|FG000|Overall Study|Adverse Event|1|||
94471582|NCT03042910|323518399|FG000|Overall Study|Disease Progression|2|||
94471583|NCT03042910|323518399|FG000|Overall Study|Withdrawal by Subject|3|||
94471584|NCT03042910|323518399|FG000|Overall Study|Enrolled but not treated|1|||
94471585|NCT02756819|323518400|FG000|Overall Study|Lost for observation|23|||
94471586|NCT02756819|323518400|FG000|Overall Study|Patient's unwillingness|16|||
94471587|NCT02756819|323518400|FG000|Overall Study|Insufficient efficacy|2|||
94471588|NCT02756819|323518400|FG000|Overall Study|Adverse Event|2|||
94471589|NCT02756819|323518400|FG000|Overall Study|Reason not Specified|9|||
94471590|NCT01090050|323518402|FG000|Overall Study|Lost to Follow-up|0|||
94471591|NCT01090050|323518403|FG001|Overall Study|Lost to Follow-up|1|||
94471592|NCT01090050|323518402|FG000|Overall Study|Lack of Efficacy|1|||
94471593|NCT01090050|323518403|FG001|Overall Study|Lack of Efficacy|5|||
94471594|NCT01090050|323518402|FG000|Overall Study|Physician Decision|0|||
94471595|NCT01090050|323518403|FG001|Overall Study|Physician Decision|1|||
94471596|NCT02496039|323518404|FG000|Overall Study|Adverse Event|3|||
94471597|NCT02496039|323518404|FG000|Overall Study|Protocol Violation|1|||
94471598|NCT00560703|323518405|FG000|Overall Study|Adverse Event|0|||
94471599|NCT00560703|323518406|FG001|Overall Study|Adverse Event|2|||
94471600|NCT00560703|323518405|FG000|Overall Study|Protocol Violation|0|||
94471601|NCT00560703|323518406|FG001|Overall Study|Protocol Violation|2|||
94471602|NCT00560703|323518405|FG000|Overall Study|Withdrawal by Subject|0|||
94309522|NCT00328198|322916999|FG000|Treatment|Evidence of disease progression|2|||
94309523|NCT00328198|322916999|FG000|Treatment|Non-compliance|1|||
94309524|NCT00328198|322916999|FG000|Treatment|Confirmed complete response, MRD -|3|||
94309525|NCT00328198|322916999|FG000|Follow-up|Lost to Follow-up|4|||
94471603|NCT00560703|323518406|FG001|Overall Study|Withdrawal by Subject|1|||
94471604|NCT00560703|323518405|FG000|Overall Study|non-compliance|0|||
94471605|NCT00560703|323518406|FG001|Overall Study|non-compliance|1|||
94471606|NCT00645671|323518407|FG000|Overall Study|Protocol Violation|1|||
94471607|NCT00645671|323518408|FG001|Overall Study|Protocol Violation|0|||
94471608|NCT00645671|323518407|FG000|Overall Study|Withdrawal by Subject|0|||
94471609|NCT00645671|323518408|FG001|Overall Study|Withdrawal by Subject|4|||
94471610|NCT00645671|323518407|FG000|Overall Study|Adverse Event|0|||
94471611|NCT00645671|323518408|FG001|Overall Study|Adverse Event|1|||
94471612|NCT00645671|323518407|FG000|Overall Study|Physician Decision|0|||
94471613|NCT00645671|323518408|FG001|Overall Study|Physician Decision|1|||
94471614|NCT00070564|323518409|FG000|Overall Study|Progression|2|||
94471615|NCT00070564|323518410|FG001|Overall Study|Progression|4|||
94471616|NCT00070564|323518411|FG002|Overall Study|Progression|7|||
94471617|NCT00070564|323518412|FG003|Overall Study|Progression|7|||
94471618|NCT00070564|323518413|FG004|Overall Study|Progression|1|||
94471619|NCT00070564|323518414|FG005|Overall Study|Progression|0|||
94471620|NCT00070564|323518409|FG000|Overall Study|Delinquent|1|||
94471621|NCT00070564|323518410|FG001|Overall Study|Delinquent|4|||
94309526|NCT00328198|322916999|FG000|Follow-up|Death|31|||
94309527|NCT02717546|322917002|FG000|Overall Study|Lost to Follow-up|12|||
94471622|NCT00070564|323518411|FG002|Overall Study|Delinquent|2|||
94471623|NCT00070564|323518412|FG003|Overall Study|Delinquent|0|||
94471624|NCT00070564|323518413|FG004|Overall Study|Delinquent|0|||
94471625|NCT00070564|323518414|FG005|Overall Study|Delinquent|0|||
94471626|NCT00070564|323518409|FG000|Overall Study|Adverse Event|150|||
94471627|NCT00070564|323518410|FG001|Overall Study|Adverse Event|142|||
94471628|NCT00070564|323518411|FG002|Overall Study|Adverse Event|120|||
94471629|NCT00070564|323518412|FG003|Overall Study|Adverse Event|108|||
94471630|NCT00070564|323518413|FG004|Overall Study|Adverse Event|63|||
94309528|NCT01645280|322917006|FG000|Overall Study|Death|0|||
94309529|NCT01645280|322917007|FG001|Overall Study|Death|1|||
94471631|NCT00070564|323518414|FG005|Overall Study|Adverse Event|36|||
94471632|NCT00070564|323518409|FG000|Overall Study|Death|4|||
94471633|NCT00070564|323518410|FG001|Overall Study|Death|1|||
94471634|NCT00070564|323518411|FG002|Overall Study|Death|5|||
94309530|NCT01645280|322917008|FG002|Overall Study|Death|0|||
94309531|NCT01645280|322917009|FG003|Overall Study|Death|0|||
94309532|NCT01645280|322917010|FG004|Overall Study|Death|0|||
94309533|NCT01645280|322917006|FG000|Overall Study|Withdrawal by Subject|4|||
94309534|NCT01645280|322917007|FG001|Overall Study|Withdrawal by Subject|0|||
94309535|NCT01645280|322917008|FG002|Overall Study|Withdrawal by Subject|2|||
94309536|NCT01645280|322917009|FG003|Overall Study|Withdrawal by Subject|4|||
94309537|NCT01645280|322917010|FG004|Overall Study|Withdrawal by Subject|5|||
94309538|NCT01645280|322917006|FG000|Overall Study|Lost to Follow-up|0|||
94309539|NCT01645280|322917007|FG001|Overall Study|Lost to Follow-up|0|||
94309540|NCT01645280|322917008|FG002|Overall Study|Lost to Follow-up|0|||
94309541|NCT01645280|322917009|FG003|Overall Study|Lost to Follow-up|2|||
94309542|NCT01645280|322917010|FG004|Overall Study|Lost to Follow-up|1|||
94309543|NCT01645280|322917006|FG000|Overall Study|Other|1|||
94309544|NCT01645280|322917007|FG001|Overall Study|Other|1|||
94309545|NCT01645280|322917008|FG002|Overall Study|Other|2|||
94309546|NCT01645280|322917009|FG003|Overall Study|Other|0|||
94309547|NCT01645280|322917010|FG004|Overall Study|Other|0|||
94309548|NCT01645280|322917006|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
94309549|NCT01645280|322917007|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
94309550|NCT01645280|322917008|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
94309551|NCT01645280|322917009|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
94309552|NCT01645280|322917010|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
94309553|NCT00234104|322917011|FG000|Overall Study|Adverse Event|4|||
94309554|NCT00234104|322917012|FG001|Overall Study|Adverse Event|0|||
94309555|NCT00234104|322917013|FG002|Overall Study|Adverse Event|3|||
94309556|NCT00234104|322917014|FG003|Overall Study|Adverse Event|5|||
94309557|NCT00234104|322917011|FG000|Overall Study|Protocol Violation|0|||
94309558|NCT00234104|322917012|FG001|Overall Study|Protocol Violation|0|||
94309559|NCT00234104|322917013|FG002|Overall Study|Protocol Violation|0|||
94309560|NCT00234104|322917014|FG003|Overall Study|Protocol Violation|1|||
94309561|NCT00234104|322917011|FG000|Overall Study|Physician Decision|0|||
94309562|NCT00234104|322917012|FG001|Overall Study|Physician Decision|1|||
94309563|NCT00234104|322917013|FG002|Overall Study|Physician Decision|2|||
94309564|NCT00234104|322917014|FG003|Overall Study|Physician Decision|2|||
94309565|NCT00491530|322917017|FG000|Overall Study|Adverse Event|6|||
94309566|NCT00491530|322917018|FG001|Overall Study|Adverse Event|1|||
94309567|NCT00491530|322917019|FG002|Overall Study|Adverse Event|2|||
94309568|NCT00491530|322917017|FG000|Overall Study|Withdrawal by Subject|3|||
94309569|NCT00491530|322917018|FG001|Overall Study|Withdrawal by Subject|0|||
94309570|NCT00491530|322917019|FG002|Overall Study|Withdrawal by Subject|0|||
94309571|NCT00491530|322917017|FG000|Overall Study|Lost to Follow-up|3|||
94309572|NCT00491530|322917018|FG001|Overall Study|Lost to Follow-up|2|||
94309573|NCT00491530|322917019|FG002|Overall Study|Lost to Follow-up|2|||
94309574|NCT00491530|322917017|FG000|Overall Study|Lack of Efficacy|0|||
94309575|NCT00491530|322917018|FG001|Overall Study|Lack of Efficacy|1|||
94309576|NCT00491530|322917019|FG002|Overall Study|Lack of Efficacy|0|||
94309577|NCT00491530|322917017|FG000|Overall Study|Investigator Discretion|0|||
94309578|NCT00491530|322917018|FG001|Overall Study|Investigator Discretion|1|||
94309579|NCT00491530|322917019|FG002|Overall Study|Investigator Discretion|0|||
94309580|NCT00491530|322917017|FG000|Overall Study|Patient Request|0|||
94309581|NCT00491530|322917018|FG001|Overall Study|Patient Request|1|||
94309582|NCT00491530|322917019|FG002|Overall Study|Patient Request|0|||
94309583|NCT00491530|322917017|FG000|Overall Study|Use of Prohibited Medication|0|||
94309584|NCT00491530|322917018|FG001|Overall Study|Use of Prohibited Medication|0|||
94309585|NCT00491530|322917019|FG002|Overall Study|Use of Prohibited Medication|1|||
94309586|NCT04382651|322917022|FG000|Overall Study|Death|26|||
94309587|NCT04382651|322917023|FG001|Overall Study|Death|23|||
94309588|NCT04382651|322917022|FG000|Overall Study|Lost to Follow-up|3|||
94309589|NCT04382651|322917023|FG001|Overall Study|Lost to Follow-up|4|||
94309590|NCT04382651|322917022|FG000|Overall Study|Withdrawal by Subject|2|||
94309591|NCT04382651|322917023|FG001|Overall Study|Withdrawal by Subject|0|||
94309592|NCT04382651|322917022|FG000|Overall Study|Physician Decision|0|||
94309593|NCT04382651|322917023|FG001|Overall Study|Physician Decision|1|||
94309594|NCT01507545|322917025|FG000|Overall Study|Withdrawal by Subject|6|||
94309595|NCT01507545|322917026|FG001|Overall Study|Withdrawal by Subject|2|||
94309596|NCT01507545|322917025|FG000|Overall Study|Lost to Follow-up|1|||
94309597|NCT01507545|322917026|FG001|Overall Study|Lost to Follow-up|0|||
94309598|NCT01507545|322917025|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
94309599|NCT01507545|322917026|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
94309600|NCT01507545|322917025|FG000|Overall Study|Progressive disease|60|||
94309601|NCT01507545|322917026|FG001|Overall Study|Progressive disease|27|||
94309602|NCT01507545|322917025|FG000|Overall Study|Other|6|||
94309603|NCT01507545|322917026|FG001|Overall Study|Other|4|||
94309604|NCT01188798|322917030|FG000|Overall Study|Death|0|||
94309605|NCT01188798|322917031|FG001|Overall Study|Death|1|||
94309606|NCT01188798|322917030|FG000|Overall Study|Required additional transplant|1|||
94309607|NCT01188798|322917031|FG001|Overall Study|Required additional transplant|1|||
94309608|NCT01188798|322917030|FG000|Overall Study|Protocol closure|1|||
94309609|NCT01188798|322917031|FG001|Overall Study|Protocol closure|1|||
94309610|NCT00465738|322917035|FG000|Overall Study|Lost to Follow-up|2|||
94471635|NCT00070564|323518412|FG003|Overall Study|Death|3|||
94471636|NCT00070564|323518413|FG004|Overall Study|Death|0|||
94471637|NCT00070564|323518414|FG005|Overall Study|Death|1|||
94471638|NCT00070564|323518409|FG000|Overall Study|Other, not protocol specified|17|||
94471639|NCT00070564|323518410|FG001|Overall Study|Other, not protocol specified|15|||
94471640|NCT00070564|323518411|FG002|Overall Study|Other, not protocol specified|14|||
94471641|NCT00070564|323518412|FG003|Overall Study|Other, not protocol specified|19|||
94471642|NCT00070564|323518413|FG004|Overall Study|Other, not protocol specified|6|||
94471643|NCT00070564|323518414|FG005|Overall Study|Other, not protocol specified|7|||
94471644|NCT00070564|323518409|FG000|Overall Study|Withdrawal by Subject|26|||
94471645|NCT00070564|323518410|FG001|Overall Study|Withdrawal by Subject|37|||
94471646|NCT00070564|323518411|FG002|Overall Study|Withdrawal by Subject|23|||
94471647|NCT00070564|323518412|FG003|Overall Study|Withdrawal by Subject|30|||
94471648|NCT00070564|323518413|FG004|Overall Study|Withdrawal by Subject|8|||
94471649|NCT00070564|323518414|FG005|Overall Study|Withdrawal by Subject|8|||
94471650|NCT00070564|323518409|FG000|Overall Study|Not reported|0|||
94471651|NCT00070564|323518410|FG001|Overall Study|Not reported|0|||
94471652|NCT00070564|323518411|FG002|Overall Study|Not reported|0|||
94471653|NCT00070564|323518412|FG003|Overall Study|Not reported|0|||
94471654|NCT00070564|323518413|FG004|Overall Study|Not reported|1|||
94471655|NCT00070564|323518414|FG005|Overall Study|Not reported|0|||
94471656|NCT02087943|323518416|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
94471657|NCT02087943|323518417|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
94471658|NCT02087943|323518418|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
94471659|NCT02087943|323518419|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
94471660|NCT02087943|323518420|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
94471661|NCT02087943|323518416|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
94471662|NCT02087943|323518417|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
94471663|NCT02087943|323518418|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
94471664|NCT02087943|323518419|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
94471665|NCT02087943|323518420|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
94471666|NCT02087943|323518416|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
94471667|NCT02087943|323518417|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
94471668|NCT02087943|323518418|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
94471669|NCT02087943|323518419|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
94471670|NCT02087943|323518420|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
94471671|NCT02087943|323518416|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
94471672|NCT02087943|323518417|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
94471673|NCT02087943|323518418|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
94471674|NCT02087943|323518419|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
94471675|NCT02087943|323518420|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
94471676|NCT02087943|323518416|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
94471677|NCT02087943|323518417|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
94471678|NCT02087943|323518418|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
94471679|NCT02087943|323518419|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
94471680|NCT02087943|323518420|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
94471681|NCT02087943|323518416|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
94471682|NCT02087943|323518417|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
94471683|NCT02087943|323518418|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
94471684|NCT02087943|323518419|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
94471685|NCT02087943|323518420|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
94471686|NCT02087943|323518416|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
94471687|NCT02087943|323518417|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
94471688|NCT02087943|323518418|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
94471689|NCT02087943|323518419|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
94471690|NCT02087943|323518420|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
94471691|NCT02087943|323518416|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
94471692|NCT02087943|323518417|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
94471693|NCT02087943|323518418|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
94471694|NCT02087943|323518419|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
94471695|NCT02087943|323518420|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
94471696|NCT02087943|323518416|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
94471697|NCT02087943|323518417|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
94471698|NCT02087943|323518418|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
94471699|NCT02087943|323518419|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
94471700|NCT02087943|323518420|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
94471701|NCT02087943|323518416|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
94471702|NCT02087943|323518417|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
94471703|NCT02087943|323518418|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
94471704|NCT02087943|323518419|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
94471705|NCT02087943|323518420|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
94471706|NCT01690299|323518421|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
94471707|NCT01690299|323518422|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
94471708|NCT01690299|323518423|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
94471709|NCT01690299|323518424|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
94471710|NCT01690299|323518425|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
94471711|NCT01690299|323518426|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
94471712|NCT01690299|323518421|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
94471713|NCT01690299|323518422|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
94471714|NCT01690299|323518423|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
94471715|NCT01690299|323518424|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
94471716|NCT01690299|323518425|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
94471717|NCT01690299|323518426|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
94471718|NCT01690299|323518421|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
94471719|NCT01690299|323518422|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
94471720|NCT01690299|323518423|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
94471721|NCT01690299|323518424|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
94471722|NCT01690299|323518425|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
94471723|NCT01690299|323518426|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
94471724|NCT01690299|323518421|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
94471725|NCT01690299|323518422|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
94471726|NCT01690299|323518423|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
94471727|NCT01690299|323518424|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
94471728|NCT01690299|323518425|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
94471729|NCT01690299|323518426|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
94471730|NCT01690299|323518421|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
94471731|NCT01690299|323518422|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
94471732|NCT01690299|323518423|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
94471733|NCT01690299|323518424|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
94471734|NCT01690299|323518425|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
94471735|NCT01690299|323518426|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
94471736|NCT01690299|323518421|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
94471737|NCT01690299|323518422|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
94471738|NCT01690299|323518423|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
94471739|NCT01690299|323518424|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
94471740|NCT01690299|323518425|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
94471741|NCT01690299|323518426|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
94471742|NCT01690299|323518421|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
94471743|NCT01690299|323518422|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
94471744|NCT01690299|323518423|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
94471745|NCT01690299|323518424|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
94471746|NCT01690299|323518425|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
94471747|NCT01690299|323518426|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
94471748|NCT01690299|323518421|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
94471749|NCT01690299|323518422|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
94471750|NCT01690299|323518423|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
94471751|NCT01690299|323518424|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
94471752|NCT01690299|323518425|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
94471753|NCT01690299|323518426|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
94471754|NCT01690299|323518421|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
94471755|NCT01690299|323518422|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
94471756|NCT01690299|323518423|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
94380468|NCT04820842|323179150|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
94380469|NCT04820842|323179151|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
94380470|NCT04820842|323179152|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
94380471|NCT04820842|323179153|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
94380472|NCT04820842|323179154|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
94380473|NCT04820842|323179148|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
94380474|NCT04820842|323179149|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
94380475|NCT04820842|323179150|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
94380476|NCT04820842|323179151|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
94380477|NCT04820842|323179152|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
94380478|NCT04820842|323179153|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
94380479|NCT04820842|323179154|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
94380480|NCT03294538|323179155|FG000|Overall Study|Adverse Event|0|||
94380481|NCT03294538|323179156|FG001|Overall Study|Adverse Event|1|||
94380482|NCT03294538|323179157|FG002|Overall Study|Adverse Event|1|||
94380483|NCT03294538|323179155|FG000|Overall Study|Lost to Follow-up|1|||
94380484|NCT03294538|323179156|FG001|Overall Study|Lost to Follow-up|0|||
94380485|NCT03294538|323179157|FG002|Overall Study|Lost to Follow-up|0|||
94380486|NCT03294538|323179155|FG000|Overall Study|Outside of Visit Window|4|||
94380487|NCT03294538|323179156|FG001|Overall Study|Outside of Visit Window|4|||
94380488|NCT03294538|323179157|FG002|Overall Study|Outside of Visit Window|1|||
94380489|NCT02207621|323179159|FG000|Overall Study|Adverse Event|71|||
94380490|NCT02207621|323179160|FG001|Overall Study|Adverse Event|15|||
94380491|NCT02207621|323179161|FG002|Overall Study|Adverse Event|132|||
94380492|NCT02207621|323179159|FG000|Overall Study|Withdrawal by Subject|9|||
94380493|NCT02207621|323179160|FG001|Overall Study|Withdrawal by Subject|9|||
94380494|NCT02207621|323179161|FG002|Overall Study|Withdrawal by Subject|13|||
94380495|NCT02207621|323179159|FG000|Overall Study|Non-Compliant|3|||
94380496|NCT02207621|323179160|FG001|Overall Study|Non-Compliant|3|||
94380497|NCT02207621|323179161|FG002|Overall Study|Non-Compliant|1|||
94380498|NCT02207621|323179159|FG000|Overall Study|Lost to Follow-up|1|||
94380499|NCT02207621|323179160|FG001|Overall Study|Lost to Follow-up|0|||
94380500|NCT02207621|323179161|FG002|Overall Study|Lost to Follow-up|3|||
94380501|NCT02207621|323179159|FG000|Overall Study|Lack of Efficacy|10|||
94380502|NCT02207621|323179160|FG001|Overall Study|Lack of Efficacy|2|||
94380503|NCT02207621|323179161|FG002|Overall Study|Lack of Efficacy|4|||
94380504|NCT02207621|323179159|FG000|Overall Study|Disallowed Concurrent Medication|2|||
94380505|NCT02207621|323179160|FG001|Overall Study|Disallowed Concurrent Medication|5|||
94380506|NCT02207621|323179161|FG002|Overall Study|Disallowed Concurrent Medication|2|||
94380507|NCT02207621|323179159|FG000|Overall Study|Physician Decision|1|||
94380508|NCT02207621|323179160|FG001|Overall Study|Physician Decision|2|||
94380509|NCT02207621|323179161|FG002|Overall Study|Physician Decision|2|||
94380510|NCT02207621|323179159|FG000|Overall Study|Protocol Violation|4|||
94380511|NCT02207621|323179160|FG001|Overall Study|Protocol Violation|10|||
94380512|NCT02207621|323179161|FG002|Overall Study|Protocol Violation|6|||
94380513|NCT02207621|323179159|FG000|Overall Study|Death|2|||
94380514|NCT02207621|323179160|FG001|Overall Study|Death|0|||
94380515|NCT02207621|323179161|FG002|Overall Study|Death|0|||
94380516|NCT02207621|323179159|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
94380517|NCT02207621|323179160|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
94380518|NCT02207621|323179161|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
94380519|NCT00718159|323179165|FG000|Overall Study|Progressive Disease|3|||
94471757|NCT01690299|323518424|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
94471758|NCT01690299|323518425|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
94380520|NCT00718159|323179166|FG001|Overall Study|Progressive Disease|3|||
94380521|NCT00718159|323179167|FG002|Overall Study|Progressive Disease|2|||
94380522|NCT00718159|323179168|FG003|Overall Study|Progressive Disease|0|||
94471759|NCT01690299|323518426|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
94380523|NCT00718159|323179169|FG004|Overall Study|Progressive Disease|6|||
94380524|NCT00718159|323179170|FG005|Overall Study|Progressive Disease|0|||
94380525|NCT00718159|323179171|FG006|Overall Study|Progressive Disease|0|||
94380526|NCT00718159|323179165|FG000|Overall Study|Death due to Adverse Event|0|||
94380527|NCT00718159|323179166|FG001|Overall Study|Death due to Adverse Event|0|||
94380528|NCT00718159|323179167|FG002|Overall Study|Death due to Adverse Event|0|||
94380529|NCT00718159|323179168|FG003|Overall Study|Death due to Adverse Event|2|||
94380530|NCT00718159|323179169|FG004|Overall Study|Death due to Adverse Event|2|||
94380531|NCT00718159|323179170|FG005|Overall Study|Death due to Adverse Event|0|||
94380532|NCT00718159|323179171|FG006|Overall Study|Death due to Adverse Event|0|||
94309611|NCT00465738|322917036|FG001|Overall Study|Lost to Follow-up|0|||
94309612|NCT00465738|322917035|FG000|Overall Study|Adverse Event|0|||
94309613|NCT00465738|322917036|FG001|Overall Study|Adverse Event|1|||
94309614|NCT00465738|322917035|FG000|Overall Study|Withdrawal by Subject|2|||
94309615|NCT00465738|322917036|FG001|Overall Study|Withdrawal by Subject|0|||
94309616|NCT00465738|322917035|FG000|Overall Study|Other|2|||
94309617|NCT00465738|322917036|FG001|Overall Study|Other|5|||
94309618|NCT01927562|322917037|FG000|Overall Study|Lost to Follow-up|30|||
94309619|NCT01927562|322917037|FG000|Overall Study|Withdrawal by Subject|3|||
94309620|NCT01927562|322917037|FG000|Overall Study|Physician Decision|5|||
94309621|NCT01696877|322917043|FG000|Overall Study|Adverse Event|0|||
94309622|NCT01696877|322917044|FG001|Overall Study|Adverse Event|1|||
94309623|NCT01899144|322917045|FG000|Treatment Period 2|Other|1|||
94309624|NCT01899144|322917045|FG000|Treatment Period 3|Other|2|||
94309625|NCT01899144|322917045|FG000|Treatment Period 5|Other|1|||
94309626|NCT00864227|322917048|FG000|Overall Study|Withdrawal by Subject|1|||
94309627|NCT00864227|322917048|FG000|Overall Study|Disease Relapse/Progression|3|||
94309628|NCT03321929|322917051|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
94309629|NCT00866294|322917052|FG000|Overall Study|Adverse Event|12|||
94309630|NCT00866294|322917053|FG001|Overall Study|Adverse Event|13|||
94309631|NCT00866294|322917054|FG002|Overall Study|Adverse Event|9|||
94309632|NCT00866294|322917052|FG000|Overall Study|Lack of Efficacy|7|||
94309633|NCT00866294|322917053|FG001|Overall Study|Lack of Efficacy|1|||
94309634|NCT00866294|322917054|FG002|Overall Study|Lack of Efficacy|0|||
94309635|NCT00866294|322917052|FG000|Overall Study|Protocol Violation|2|||
94309636|NCT00866294|322917053|FG001|Overall Study|Protocol Violation|0|||
94309637|NCT00866294|322917054|FG002|Overall Study|Protocol Violation|0|||
94309638|NCT00866294|322917052|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
94309639|NCT00866294|322917053|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
94309640|NCT00866294|322917054|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
94309641|NCT00866294|322917052|FG000|Overall Study|Lost to Follow-up|1|||
94309642|NCT00866294|322917053|FG001|Overall Study|Lost to Follow-up|3|||
94309643|NCT00866294|322917054|FG002|Overall Study|Lost to Follow-up|0|||
94309644|NCT00866294|322917052|FG000|Overall Study|Physician Decision|6|||
94309645|NCT00866294|322917053|FG001|Overall Study|Physician Decision|2|||
94309646|NCT00866294|322917054|FG002|Overall Study|Physician Decision|1|||
94309647|NCT04430582|322917059|FG000|Overall Study|Found to meet exclusionary criteria|1|||
94309648|NCT04430582|322917060|FG001|Overall Study|Found to meet exclusionary criteria|0|||
94309649|NCT04430582|322917059|FG000|Overall Study|Withdrawal by Subject|0|||
94309650|NCT04430582|322917060|FG001|Overall Study|Withdrawal by Subject|1|||
94309651|NCT03607682|322917061|FG000|Overall Study|Withdrawal by Subject|1|||
94309652|NCT03607682|322917061|FG000|Overall Study|Disease progression|1|||
94309653|NCT01770353|322917062|FG000|Overall Study|Progressive disease|2|||
94309654|NCT01770353|322917063|FG001|Overall Study|Progressive disease|1|||
94309655|NCT01770353|322917062|FG000|Overall Study|Adverse Event|0|||
94309656|NCT01770353|322917063|FG001|Overall Study|Adverse Event|1|||
94309657|NCT01770353|322917062|FG000|Overall Study|Protocol Violation|1|||
94309658|NCT01770353|322917063|FG001|Overall Study|Protocol Violation|0|||
94309659|NCT01770353|322917062|FG000|Overall Study|Physician Decision|0|||
94309660|NCT01770353|322917063|FG001|Overall Study|Physician Decision|3|||
94309661|NCT01770353|322917062|FG000|Overall Study|Clinical deterioration|3|||
94309662|NCT01770353|322917063|FG001|Overall Study|Clinical deterioration|6|||
94309663|NCT01770353|322917062|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
94309664|NCT01770353|322917063|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
94309665|NCT03575468|322917066|FG000|Overall Study|Withdrawal by Subject|3|||
94309666|NCT03575468|322917067|FG001|Overall Study|Withdrawal by Subject|0|||
94309667|NCT03575468|322917066|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
94309668|NCT03575468|322917067|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
94309669|NCT03575468|322917066|FG000|Overall Study|Lost to Follow-up|13|||
94309670|NCT03575468|322917067|FG001|Overall Study|Lost to Follow-up|17|||
94309671|NCT00404768|322917068|FG000|Part A and B|Withdrawn due to labor progression|1|||
94309672|NCT00404768|322917069|FG001|Part A and B|Withdrawn due to labor progression|0|||
94309673|NCT00404768|322917070|FG002|Part A and B|Withdrawn due to labor progression|0|||
94380533|NCT00718159|323179165|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
94380534|NCT00718159|323179166|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
94380535|NCT00718159|323179167|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
94471760|NCT01690299|323518421|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
94471761|NCT01690299|323518422|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
94471762|NCT01690299|323518423|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
94309674|NCT00404768|322917071|FG003|Part A and B|Withdrawn due to labor progression|0|||
94309675|NCT00404768|322917068|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
94309676|NCT00404768|322917069|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
94471763|NCT01690299|323518424|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
94471764|NCT01690299|323518425|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
94471765|NCT01690299|323518426|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
94471766|NCT06226649|323518427|FG000|Overall Study|Withdrawal by Subject|4|||
94471767|NCT06226649|323518428|FG001|Overall Study|Withdrawal by Subject|1|||
94471768|NCT04401202|323518429|FG000|Overall Study|Lost to Follow-up|2|||
94471769|NCT04401202|323518430|FG001|Overall Study|Lost to Follow-up|2|||
94471770|NCT04401202|323518429|FG000|Overall Study|Adverse Event|0|||
94471771|NCT04401202|323518430|FG001|Overall Study|Adverse Event|1|||
94471772|NCT04401202|323518429|FG000|Overall Study|Hospitalized|4|||
94471773|NCT04401202|323518430|FG001|Overall Study|Hospitalized|1|||
94471774|NCT00631163|323518431|FG000|Number of Participants in Year 1|Adverse Event|12|||
94471775|NCT00631163|323518431|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
94471776|NCT00631163|323518431|FG000|Number of Participants in Year 1|Death|6|||
94471777|NCT00631163|323518431|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
94471778|NCT00631163|323518431|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
94471779|NCT00631163|323518431|FG000|Number of Participants in Year 1|Administrative problems|6|||
94471780|NCT00631163|323518431|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
94471781|NCT00631163|323518431|FG000|Number of Participants in Year 2|Adverse Event|1|||
94471782|NCT00631163|323518431|FG000|Number of Participants in Year 2|Protocol Violation|1|||
94471783|NCT00631163|323518431|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
94471784|NCT00715520|323518433|FG000|Overall Study|Screen failure|8|||
94471785|NCT00715520|323518434|FG001|Overall Study|Screen failure|1|||
94471786|NCT00715520|323518435|FG002|Overall Study|Screen failure|1|||
94471787|NCT00715520|323518433|FG000|Overall Study|Withdrawal by Subject|2|||
94471788|NCT00715520|323518434|FG001|Overall Study|Withdrawal by Subject|0|||
94471789|NCT00715520|323518435|FG002|Overall Study|Withdrawal by Subject|1|||
94471790|NCT00329745|323518436|FG000|Overall Study|Protocol Violation|1|||
94471791|NCT00329745|323518437|FG001|Overall Study|Protocol Violation|0|||
94471792|NCT00329745|323518436|FG000|Overall Study|Withdrawal by Subject|0|||
94471793|NCT00329745|323518437|FG001|Overall Study|Withdrawal by Subject|1|||
94471794|NCT00329745|323518436|FG000|Overall Study|Lost to Follow-up|86|||
94471795|NCT00329745|323518437|FG001|Overall Study|Lost to Follow-up|101|||
94471796|NCT02290925|323518438|FG000|First Period of Three Months|Lost to Follow-up|2|||
94471797|NCT02290925|323518439|FG001|First Period of Three Months|Lost to Follow-up|1|||
94309677|NCT00404768|322917070|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
94309678|NCT00404768|322917071|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
94309679|NCT00404768|322917068|FG000|Part C|Adverse Event|0|||
94309680|NCT00404768|322917069|FG001|Part C|Adverse Event|0|||
94309681|NCT00404768|322917070|FG002|Part C|Adverse Event|0|||
94309682|NCT00404768|322917071|FG003|Part C|Adverse Event|3|||
94309683|NCT00404768|322917068|FG000|Part C|Lost to Follow-up|0|||
94309684|NCT00404768|322917069|FG001|Part C|Lost to Follow-up|0|||
94309685|NCT00404768|322917070|FG002|Part C|Lost to Follow-up|3|||
94309686|NCT00404768|322917071|FG003|Part C|Lost to Follow-up|1|||
94309687|NCT00404768|322917068|FG000|Part C|Withdrawal by Subject|0|||
94309688|NCT00404768|322917069|FG001|Part C|Withdrawal by Subject|0|||
94309689|NCT00404768|322917070|FG002|Part C|Withdrawal by Subject|2|||
94309690|NCT00404768|322917071|FG003|Part C|Withdrawal by Subject|1|||
94309691|NCT00404768|322917068|FG000|Part C|Early withdrawal from study medication|0|||
94309692|NCT00404768|322917069|FG001|Part C|Early withdrawal from study medication|0|||
94309693|NCT00404768|322917070|FG002|Part C|Early withdrawal from study medication|1|||
94309694|NCT00404768|322917071|FG003|Part C|Early withdrawal from study medication|0|||
94309695|NCT00404768|322917068|FG000|Part C|Participant did not respond to therapy|0|||
94309696|NCT00404768|322917069|FG001|Part C|Participant did not respond to therapy|0|||
94309697|NCT00404768|322917070|FG002|Part C|Participant did not respond to therapy|1|||
94309698|NCT00404768|322917071|FG003|Part C|Participant did not respond to therapy|1|||
94309699|NCT00404768|322917068|FG000|Part C|Physician withdrew the study medication|0|||
94309700|NCT00404768|322917069|FG001|Part C|Physician withdrew the study medication|0|||
94309701|NCT00404768|322917070|FG002|Part C|Physician withdrew the study medication|1|||
94309702|NCT00404768|322917071|FG003|Part C|Physician withdrew the study medication|0|||
94309703|NCT00404768|322917068|FG000|Part C|Participant delivered baby|0|||
94309704|NCT00404768|322917069|FG001|Part C|Participant delivered baby|0|||
94471798|NCT02290925|323518438|FG000|First Period of Three Months|Death|1|||
94471799|NCT02290925|323518439|FG001|First Period of Three Months|Death|0|||
94471800|NCT02290925|323518438|FG000|First Period of Three Months|Insulin Started|1|||
94471801|NCT02290925|323518439|FG001|First Period of Three Months|Insulin Started|1|||
94471802|NCT02290925|323518438|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
94471803|NCT02290925|323518439|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
94471804|NCT02290925|323518438|FG000|Second Period of 3 Months|insulin started|0|||
94471805|NCT02290925|323518439|FG001|Second Period of 3 Months|insulin started|1|||
94471806|NCT00496587|323518442|FG000|Overall Study|Adverse Event|2|||
94471807|NCT00496587|323518442|FG000|Overall Study|Progressive Disease|24|||
94471808|NCT00496587|323518442|FG000|Overall Study|Withdrawal by Subject|2|||
94471809|NCT00496587|323518442|FG000|Overall Study|Death|1|||
94471810|NCT00496587|323518442|FG000|Overall Study|Complications unrelated|2|||
94471811|NCT00624832|323518443|FG000|Overall Study|Adverse Event|0|||
94471812|NCT00624832|323518444|FG001|Overall Study|Adverse Event|1|||
94471813|NCT00624832|323518445|FG002|Overall Study|Adverse Event|0|||
94471814|NCT00624832|323518446|FG003|Overall Study|Adverse Event|1|||
94471815|NCT00624832|323518443|FG000|Overall Study|Abnormal Laboratory Value|2|||
94471816|NCT00624832|323518444|FG001|Overall Study|Abnormal Laboratory Value|0|||
94471817|NCT00624832|323518445|FG002|Overall Study|Abnormal Laboratory Value|0|||
94471818|NCT00624832|323518446|FG003|Overall Study|Abnormal Laboratory Value|0|||
94471819|NCT00482170|323518447|FG000|Overall Study|Adverse Event|5|||
94471820|NCT00482170|323518448|FG001|Overall Study|Adverse Event|14|||
94471821|NCT00482170|323518447|FG000|Overall Study|Withdrawal by Subject|6|||
94471822|NCT00482170|323518448|FG001|Overall Study|Withdrawal by Subject|1|||
94471823|NCT00482170|323518447|FG000|Overall Study|Protocol Violation|2|||
94471824|NCT00482170|323518448|FG001|Overall Study|Protocol Violation|3|||
94471825|NCT00482170|323518447|FG000|Overall Study|Lost to Follow-up|2|||
94471826|NCT00482170|323518448|FG001|Overall Study|Lost to Follow-up|0|||
94471827|NCT00482170|323518447|FG000|Overall Study|Unspecified reason|0|||
94471828|NCT00482170|323518448|FG001|Overall Study|Unspecified reason|2|||
94471829|NCT00162097|323518451|FG000|Overall Study|Participant no longer met study criteria|0|||
94471830|NCT00162097|323518452|FG001|Overall Study|Participant no longer met study criteria|0|||
94471831|NCT00162097|323518453|FG002|Overall Study|Participant no longer met study criteria|0|||
94471832|NCT00162097|323518454|FG003|Overall Study|Participant no longer met study criteria|1|||
94471833|NCT02937636|323518455|FG000|Overall Study|Other (Not specified)|3|||
94471834|NCT02937636|323518456|FG001|Overall Study|Other (Not specified)|2|||
94471835|NCT01204918|323518459|FG000|Overall Study|Withdrawal by Subject|4|||
94471836|NCT01204918|323518460|FG001|Overall Study|Withdrawal by Subject|10|||
94471837|NCT01204918|323518461|FG002|Overall Study|Withdrawal by Subject|5|||
94471838|NCT03585712|323518466|FG000|Treatment Period 1|Protocol Violation|1|||
94471839|NCT03585712|323518467|FG001|Treatment Period 1|Protocol Violation|0|||
94471840|NCT03585712|323518468|FG002|Treatment Period 1|Protocol Violation|0|||
94471841|NCT03585712|323518466|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
94471842|NCT03585712|323518467|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
94471843|NCT03585712|323518468|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
94471844|NCT03585712|323518466|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
94471845|NCT03585712|323518467|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
94471846|NCT03585712|323518468|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
94471847|NCT03585712|323518466|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
94471848|NCT03585712|323518467|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
94471849|NCT03585712|323518468|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
94471850|NCT01429441|323518473|FG000|Overall Study|Adverse Event|5|||
94471851|NCT01429441|323518474|FG001|Overall Study|Adverse Event|1|||
94471852|NCT01429441|323518473|FG000|Overall Study|Death|0|||
94471853|NCT01429441|323518474|FG001|Overall Study|Death|2|||
94471854|NCT01429441|323518473|FG000|Overall Study|Lost to Follow-up|5|||
94471855|NCT01429441|323518474|FG001|Overall Study|Lost to Follow-up|2|||
94471856|NCT01429441|323518473|FG000|Overall Study|Physician Decision|1|||
94471857|NCT01429441|323518474|FG001|Overall Study|Physician Decision|0|||
94471858|NCT01429441|323518473|FG000|Overall Study|Withdrawal by Subject|27|||
94471859|NCT01429441|323518474|FG001|Overall Study|Withdrawal by Subject|18|||
94471860|NCT02083653|323518478|FG000|Overall Study|Randomized but not Treated|0|||
94471861|NCT02083653|323518479|FG001|Overall Study|Randomized but not Treated|2|||
94471862|NCT02083653|323518480|FG002|Overall Study|Randomized but not Treated|7|||
94471863|NCT02083653|323518478|FG000|Overall Study|Adverse Event|12|||
94471864|NCT02083653|323518479|FG001|Overall Study|Adverse Event|5|||
94471865|NCT02083653|323518480|FG002|Overall Study|Adverse Event|4|||
94471866|NCT02083653|323518478|FG000|Overall Study|Lost to Follow-up|1|||
94471867|NCT02083653|323518479|FG001|Overall Study|Lost to Follow-up|0|||
94471868|NCT02083653|323518480|FG002|Overall Study|Lost to Follow-up|0|||
94471869|NCT02083653|323518478|FG000|Overall Study|Death|2|||
94471870|NCT02083653|323518479|FG001|Overall Study|Death|2|||
94471871|NCT02083653|323518480|FG002|Overall Study|Death|2|||
94471872|NCT02083653|323518478|FG000|Overall Study|Progressive Disease|65|||
94471873|NCT02083653|323518479|FG001|Overall Study|Progressive Disease|73|||
94471874|NCT02083653|323518480|FG002|Overall Study|Progressive Disease|63|||
94471875|NCT02083653|323518478|FG000|Overall Study|Withdrawal by Subject|2|||
94471876|NCT02083653|323518479|FG001|Overall Study|Withdrawal by Subject|1|||
94471877|NCT02083653|323518480|FG002|Overall Study|Withdrawal by Subject|2|||
94471878|NCT02083653|323518478|FG000|Overall Study|Other Events|0|||
94309705|NCT00404768|322917070|FG002|Part C|Participant delivered baby|0|||
94309706|NCT00404768|322917071|FG003|Part C|Participant delivered baby|1|||
94309707|NCT00404768|322917068|FG000|Part C|Unsatisfactory uterine response to IP|0|||
94309708|NCT00404768|322917069|FG001|Part C|Unsatisfactory uterine response to IP|0|||
94309709|NCT00404768|322917070|FG002|Part C|Unsatisfactory uterine response to IP|0|||
94309710|NCT00404768|322917071|FG003|Part C|Unsatisfactory uterine response to IP|1|||
94309711|NCT00404768|322917068|FG000|Part C|Active labor|0|||
94309712|NCT00404768|322917069|FG001|Part C|Active labor|0|||
94309713|NCT00404768|322917070|FG002|Part C|Active labor|0|||
94309714|NCT00404768|322917071|FG003|Part C|Active labor|1|||
94309715|NCT00404768|322917068|FG000|Part C|Lack of Efficacy|0|||
94380536|NCT00718159|323179168|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
94380537|NCT00718159|323179169|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
94380538|NCT00718159|323179170|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
94380539|NCT00718159|323179171|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
94380540|NCT00718159|323179165|FG000|Overall Study|Investigator Decision|0|||
94380541|NCT00718159|323179166|FG001|Overall Study|Investigator Decision|0|||
94380542|NCT00718159|323179167|FG002|Overall Study|Investigator Decision|0|||
94380543|NCT00718159|323179168|FG003|Overall Study|Investigator Decision|0|||
94380544|NCT00718159|323179169|FG004|Overall Study|Investigator Decision|0|||
94380545|NCT00718159|323179170|FG005|Overall Study|Investigator Decision|1|||
94380546|NCT00718159|323179171|FG006|Overall Study|Investigator Decision|1|||
94380547|NCT02270736|323179172|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
94380548|NCT02270736|323179173|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
94380549|NCT02270736|323179174|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
94380550|NCT02270736|323179175|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
94380551|NCT02270736|323179176|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
94380552|NCT02270736|323179172|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
94380553|NCT02270736|323179173|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
94380554|NCT02270736|323179174|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
94380555|NCT02270736|323179175|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
94380556|NCT02270736|323179176|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
94380557|NCT02270736|323179172|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
94380558|NCT02270736|323179173|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
94380559|NCT02270736|323179174|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
94380560|NCT02270736|323179175|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
94380561|NCT02270736|323179176|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
94380562|NCT02270736|323179172|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
94380563|NCT02270736|323179173|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
94380564|NCT02270736|323179174|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
94380565|NCT02270736|323179175|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
94380566|NCT02270736|323179176|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
94380567|NCT02270736|323179172|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
94380568|NCT02270736|323179173|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
94380569|NCT02270736|323179174|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
94380570|NCT02270736|323179175|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
94380571|NCT02270736|323179176|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
94380572|NCT02270736|323179172|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
94380573|NCT02270736|323179173|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
94380574|NCT02270736|323179174|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
94380575|NCT02270736|323179175|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
94380576|NCT02270736|323179176|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
94380577|NCT02270736|323179172|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
94380578|NCT02270736|323179173|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
94380579|NCT02270736|323179174|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
94380580|NCT02270736|323179175|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
94380581|NCT02270736|323179176|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
94380582|NCT02270736|323179172|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
94380583|NCT02270736|323179173|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
94380584|NCT02270736|323179174|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
94380585|NCT02270736|323179175|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
94380586|NCT02270736|323179176|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
94380587|NCT02270736|323179172|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
94309716|NCT00404768|322917069|FG001|Part C|Lack of Efficacy|0|||
94309717|NCT00404768|322917070|FG002|Part C|Lack of Efficacy|0|||
94309718|NCT00404768|322917071|FG003|Part C|Lack of Efficacy|2|||
94309719|NCT00404768|322917068|FG000|Part C|Treatment failure|0|||
94309720|NCT00404768|322917069|FG001|Part C|Treatment failure|0|||
94309721|NCT00404768|322917070|FG002|Part C|Treatment failure|0|||
94309722|NCT00404768|322917071|FG003|Part C|Treatment failure|1|||
94380588|NCT02270736|323179173|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
94380589|NCT02270736|323179174|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
94471879|NCT02083653|323518479|FG001|Overall Study|Other Events|2|||
94471880|NCT02083653|323518480|FG002|Overall Study|Other Events|2|||
94471881|NCT02083653|323518478|FG000|Overall Study|Reason Missing|0|||
94471882|NCT02083653|323518479|FG001|Overall Study|Reason Missing|0|||
94471883|NCT02083653|323518480|FG002|Overall Study|Reason Missing|4|||
94471884|NCT00460746|323518484|FG000|Overall Study|Adverse Event|1|||
94471885|NCT00460746|323518484|FG000|Overall Study|Lost to Follow-up|1|||
94471886|NCT00913770|323518489|FG000|Overall Study|Unable to contact|24|||
94471887|NCT00913770|323518490|FG001|Overall Study|Unable to contact|19|||
94471888|NCT00913770|323518491|FG002|Overall Study|Unable to contact|13|||
94471889|NCT00913770|323518489|FG000|Overall Study|Refused|11|||
94471890|NCT00913770|323518490|FG001|Overall Study|Refused|10|||
94471891|NCT00913770|323518491|FG002|Overall Study|Refused|8|||
94471892|NCT00978341|323518498|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
94471893|NCT00978341|323518499|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
94471894|NCT00262002|323518500|FG000|Overall Study|Adverse Event|2|||
94471895|NCT00262002|323518501|FG001|Overall Study|Adverse Event|1|||
94471896|NCT00262002|323518502|FG002|Overall Study|Adverse Event|0|||
94471897|NCT00262002|323518503|FG003|Overall Study|Adverse Event|0|||
94471898|NCT00262002|323518504|FG004|Overall Study|Adverse Event|0|||
94471899|NCT00262002|323518505|FG005|Overall Study|Adverse Event|1|||
94471900|NCT00262002|323518506|FG006|Overall Study|Adverse Event|0|||
94471901|NCT00262002|323518500|FG000|Overall Study|Withdrawal by Subject|4|||
94471902|NCT00262002|323518501|FG001|Overall Study|Withdrawal by Subject|2|||
94471903|NCT00262002|323518502|FG002|Overall Study|Withdrawal by Subject|0|||
94471904|NCT00262002|323518503|FG003|Overall Study|Withdrawal by Subject|1|||
94471905|NCT00262002|323518504|FG004|Overall Study|Withdrawal by Subject|2|||
94471906|NCT00262002|323518505|FG005|Overall Study|Withdrawal by Subject|2|||
94471907|NCT00262002|323518506|FG006|Overall Study|Withdrawal by Subject|2|||
94471908|NCT00262002|323518500|FG000|Overall Study|Lost to Follow-up|2|||
94471909|NCT00262002|323518501|FG001|Overall Study|Lost to Follow-up|0|||
94471910|NCT00262002|323518502|FG002|Overall Study|Lost to Follow-up|0|||
94471911|NCT00262002|323518503|FG003|Overall Study|Lost to Follow-up|2|||
94471912|NCT00262002|323518504|FG004|Overall Study|Lost to Follow-up|0|||
94471913|NCT00262002|323518505|FG005|Overall Study|Lost to Follow-up|1|||
94471914|NCT00262002|323518506|FG006|Overall Study|Lost to Follow-up|0|||
94471915|NCT00262002|323518500|FG000|Overall Study|Inapropriate enrollment|0|||
94471916|NCT00262002|323518501|FG001|Overall Study|Inapropriate enrollment|1|||
94471917|NCT00262002|323518502|FG002|Overall Study|Inapropriate enrollment|0|||
94471918|NCT00262002|323518503|FG003|Overall Study|Inapropriate enrollment|0|||
94471919|NCT00262002|323518504|FG004|Overall Study|Inapropriate enrollment|0|||
94471920|NCT00262002|323518505|FG005|Overall Study|Inapropriate enrollment|0|||
94471921|NCT00262002|323518506|FG006|Overall Study|Inapropriate enrollment|0|||
94471922|NCT00262002|323518500|FG000|Overall Study|Protocol Violation|3|||
94471923|NCT00262002|323518501|FG001|Overall Study|Protocol Violation|2|||
94471924|NCT00262002|323518502|FG002|Overall Study|Protocol Violation|0|||
94471925|NCT00262002|323518503|FG003|Overall Study|Protocol Violation|2|||
94471926|NCT00262002|323518504|FG004|Overall Study|Protocol Violation|5|||
94471927|NCT00262002|323518505|FG005|Overall Study|Protocol Violation|3|||
94471928|NCT00262002|323518506|FG006|Overall Study|Protocol Violation|2|||
94471929|NCT00262002|323518500|FG000|Overall Study|Unable to classify|0|||
94471930|NCT00262002|323518501|FG001|Overall Study|Unable to classify|0|||
94471931|NCT00262002|323518502|FG002|Overall Study|Unable to classify|0|||
94471932|NCT00262002|323518503|FG003|Overall Study|Unable to classify|0|||
94471933|NCT00262002|323518504|FG004|Overall Study|Unable to classify|0|||
94471934|NCT00262002|323518505|FG005|Overall Study|Unable to classify|0|||
94471935|NCT00262002|323518506|FG006|Overall Study|Unable to classify|2|||
94471936|NCT03885999|323518507|FG000|Overall Study|Adverse Event|1|||
94471937|NCT01451554|323518508|FG000|Overall Study|Withdrawal by Subject|14|||
94471938|NCT01451554|323518509|FG001|Overall Study|Withdrawal by Subject|9|||
94471939|NCT01790516|323518510|FG000|Overall Study|Physician Decision|1|||
94471940|NCT01790516|323518511|FG001|Overall Study|Physician Decision|0|||
94471941|NCT04003623|323520021|FG000|Overall Study|Withdrawal by Subject|1|||
94471942|NCT04003623|323520022|FG001|Overall Study|Withdrawal by Subject|0|||
94471943|NCT03246061|323520025|FG000|Overall Study|Still in follow-up|15|||
94471944|NCT03246061|323520026|FG001|Overall Study|Still in follow-up|21|||
94471945|NCT02232061|323520027|FG000|Overall Study|Administrative problems|1|||
94471946|NCT02232061|323520027|FG000|Overall Study|Withdrawal by Subject|1|||
94471947|NCT03297021|323520029|FG000|Overall Study|Incomplete/illegible data sheet|4|||
94471948|NCT03297021|323520030|FG001|Overall Study|Incomplete/illegible data sheet|2|||
94471949|NCT03297021|323520031|FG002|Overall Study|Incomplete/illegible data sheet|3|||
94471950|NCT03297021|323520029|FG000|Overall Study|Missing Post-Op Data|1|||
94471951|NCT03297021|323520030|FG001|Overall Study|Missing Post-Op Data|2|||
94471952|NCT03297021|323520031|FG002|Overall Study|Missing Post-Op Data|1|||
94471953|NCT00948922|323520032|FG000|Overall Study|Did not start study treatment|2|||
94471954|NCT00948922|323520033|FG001|Overall Study|Did not start study treatment|5|||
94471955|NCT00948922|323520034|FG002|Overall Study|Did not start study treatment|0|||
94471956|NCT00948922|323520032|FG000|Overall Study|Withdrawal by Subject|0|||
94309723|NCT00404768|322917068|FG000|Part C|Investigator discretion|0|||
94309724|NCT00404768|322917069|FG001|Part C|Investigator discretion|0|||
94380590|NCT02270736|323179175|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
94380591|NCT02270736|323179176|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
94380592|NCT01180244|323179179|FG000|Overall Study|Lack of Efficacy|0|||
94380593|NCT01180244|323179180|FG001|Overall Study|Lack of Efficacy|7|||
94380594|NCT01180244|323179179|FG000|Overall Study|Physician Decision|3|||
94380595|NCT01180244|323179180|FG001|Overall Study|Physician Decision|0|||
94380596|NCT01180244|323179179|FG000|Overall Study|Adverse Event|1|||
94380597|NCT01180244|323179180|FG001|Overall Study|Adverse Event|0|||
94380598|NCT01180244|323179179|FG000|Overall Study|Withdrawal by Subject|0|||
94380599|NCT01180244|323179180|FG001|Overall Study|Withdrawal by Subject|1|||
94380600|NCT01180244|323179179|FG000|Overall Study|Protocol Violation|1|||
94380601|NCT01180244|323179180|FG001|Overall Study|Protocol Violation|0|||
94380602|NCT01180244|323179179|FG000|Overall Study|Lost to Follow-up|1|||
94380603|NCT01180244|323179180|FG001|Overall Study|Lost to Follow-up|0|||
94380604|NCT01595009|323179185|FG000|Core|Patients completed per protocol|85|||
94380605|NCT01595009|323179186|FG001|Core|Patients completed per protocol|44|||
94380606|NCT01595009|323179187|FG002|Core|Patients completed per protocol|0|||
94380607|NCT01595009|323179188|FG003|Core|Patients completed per protocol|0|||
94380608|NCT01595009|323179185|FG000|Core|Adverse Event|19|||
94380609|NCT01595009|323179186|FG001|Core|Adverse Event|23|||
94380610|NCT01595009|323179187|FG002|Core|Adverse Event|0|||
94380611|NCT01595009|323179188|FG003|Core|Adverse Event|0|||
94380612|NCT01595009|323179185|FG000|Core|Disease progression|14|||
94380613|NCT01595009|323179186|FG001|Core|Disease progression|26|||
94380614|NCT01595009|323179187|FG002|Core|Disease progression|0|||
94380615|NCT01595009|323179188|FG003|Core|Disease progression|0|||
94380616|NCT01595009|323179185|FG000|Core|Withdrawal by Subject|4|||
94380617|NCT01595009|323179186|FG001|Core|Withdrawal by Subject|17|||
94380618|NCT01595009|323179187|FG002|Core|Withdrawal by Subject|0|||
94380619|NCT01595009|323179188|FG003|Core|Withdrawal by Subject|0|||
94380620|NCT01595009|323179185|FG000|Core|Death|3|||
94380621|NCT01595009|323179186|FG001|Core|Death|6|||
94380622|NCT01595009|323179187|FG002|Core|Death|0|||
94380623|NCT01595009|323179188|FG003|Core|Death|0|||
94380624|NCT01595009|323179185|FG000|Core|Lost to Follow-up|1|||
94380625|NCT01595009|323179186|FG001|Core|Lost to Follow-up|2|||
94380626|NCT01595009|323179187|FG002|Core|Lost to Follow-up|0|||
94380627|NCT01595009|323179188|FG003|Core|Lost to Follow-up|0|||
94380628|NCT01595009|323179185|FG000|Core|Protocol deviation|0|||
94380629|NCT01595009|323179186|FG001|Core|Protocol deviation|1|||
94380630|NCT01595009|323179187|FG002|Core|Protocol deviation|0|||
94380631|NCT01595009|323179188|FG003|Core|Protocol deviation|0|||
94380632|NCT01595009|323179185|FG000|Core|Administrative problems|0|||
94380633|NCT01595009|323179186|FG001|Core|Administrative problems|1|||
94380634|NCT01595009|323179187|FG002|Core|Administrative problems|0|||
94380635|NCT01595009|323179188|FG003|Core|Administrative problems|0|||
94380636|NCT01595009|323179185|FG000|Extension|Administrative problems|0|||
94380637|NCT01595009|323179186|FG001|Extension|Administrative problems|0|||
94380638|NCT01595009|323179187|FG002|Extension|Administrative problems|0|||
94309725|NCT00404768|322917070|FG002|Part C|Investigator discretion|0|||
94309726|NCT00404768|322917071|FG003|Part C|Investigator discretion|1|||
94309727|NCT00404768|322917068|FG000|Part C|Researcher suspended study medication|0|||
94309728|NCT00404768|322917069|FG001|Part C|Researcher suspended study medication|0|||
94309729|NCT00404768|322917070|FG002|Part C|Researcher suspended study medication|0|||
94309730|NCT00404768|322917071|FG003|Part C|Researcher suspended study medication|1|||
94309731|NCT02658656|322917074|FG000|Screening|Failed eligibility criteria|0|||
94309732|NCT02658656|322917075|FG001|Screening|Failed eligibility criteria|0|||
94309733|NCT02658656|322917076|FG002|Screening|Failed eligibility criteria|263|||
94309734|NCT02658656|322917074|FG000|Randomization|Withdrawal by Subject|8|||
94309735|NCT02658656|322917075|FG001|Randomization|Withdrawal by Subject|7|||
94309736|NCT02658656|322917076|FG002|Randomization|Withdrawal by Subject|0|||
94309737|NCT02658656|322917074|FG000|Randomization|Lost to Follow-up|1|||
94309738|NCT02658656|322917075|FG001|Randomization|Lost to Follow-up|3|||
94309739|NCT02658656|322917076|FG002|Randomization|Lost to Follow-up|0|||
94380639|NCT01595009|323179188|FG003|Extension|Administrative problems|1|||
94380640|NCT01595009|323179185|FG000|Extension|Patients completed per protocol|0|||
94380641|NCT01595009|323179186|FG001|Extension|Patients completed per protocol|0|||
94380642|NCT01595009|323179187|FG002|Extension|Patients completed per protocol|0|||
94380643|NCT01595009|323179188|FG003|Extension|Patients completed per protocol|2|||
94380644|NCT01595009|323179185|FG000|Extension|Disease progression|0|||
94309740|NCT02658656|322917074|FG000|Randomization|Adverse Event|4|||
94380645|NCT01595009|323179186|FG001|Extension|Disease progression|0|||
94380646|NCT01595009|323179187|FG002|Extension|Disease progression|4|||
94380647|NCT01595009|323179188|FG003|Extension|Disease progression|7|||
94380648|NCT01595009|323179185|FG000|Extension|Adverse Event|0|||
94380649|NCT01595009|323179186|FG001|Extension|Adverse Event|0|||
94380650|NCT01595009|323179187|FG002|Extension|Adverse Event|0|||
94380651|NCT01595009|323179188|FG003|Extension|Adverse Event|1|||
94380652|NCT02907203|323179189|FG000|Overall Study|Death|1|||
94309741|NCT02658656|322917075|FG001|Randomization|Adverse Event|0|||
94309742|NCT02658656|322917076|FG002|Randomization|Adverse Event|0|||
94309743|NCT02658656|322917074|FG000|Randomization|Administrative Termination|3|||
94309744|NCT02658656|322917075|FG001|Randomization|Administrative Termination|1|||
94309745|NCT02658656|322917076|FG002|Randomization|Administrative Termination|0|||
94309746|NCT02658656|322917074|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
94309747|NCT02658656|322917075|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
94309748|NCT02658656|322917076|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
94309749|NCT02658656|322917074|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
94330929|NCT01148693|322991774|FG000|Overall Study|Attempts for cannulation were failed|13|||
94330930|NCT01148693|322991775|FG001|Overall Study|Attempts for cannulation were failed|10|||
94330931|NCT01803711|322991776|FG000|Overall Study|Adverse Event|1|||
94330932|NCT01803711|322991777|FG001|Overall Study|Adverse Event|1|||
94330933|NCT01376245|322991780|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
94330934|NCT01376245|322991781|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
94330935|NCT01376245|322991782|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
94330936|NCT01376245|322991783|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
94330937|NCT01376245|322991784|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
94330938|NCT01376245|322991780|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
94330939|NCT01376245|322991781|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
94330940|NCT01376245|322991782|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
94330941|NCT01376245|322991783|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
94330942|NCT01376245|322991784|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
94330943|NCT01376245|322991780|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
94330944|NCT01376245|322991781|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
94330945|NCT01376245|322991782|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
94330946|NCT01376245|322991783|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
94330947|NCT01376245|322991784|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
94330948|NCT01376245|322991780|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
94330949|NCT01376245|322991781|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
94330950|NCT01376245|322991782|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
94330951|NCT01376245|322991783|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
94330952|NCT01376245|322991784|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
94330953|NCT01376245|322991780|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
94330954|NCT01376245|322991781|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
94330955|NCT01376245|322991782|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
94330956|NCT01376245|322991783|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
94330957|NCT01376245|322991784|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
94330958|NCT01376245|322991780|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
94330959|NCT01376245|322991781|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
94330960|NCT01376245|322991782|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
94330961|NCT01376245|322991783|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
94330962|NCT01376245|322991784|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
94330963|NCT01376245|322991780|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
94330964|NCT01376245|322991781|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
94330965|NCT01376245|322991782|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
94330966|NCT01376245|322991783|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
94330967|NCT01376245|322991784|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
94330968|NCT01376245|322991780|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
94330969|NCT01376245|322991781|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
94330970|NCT01376245|322991782|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
94330971|NCT01376245|322991783|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
94330972|NCT01376245|322991784|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
94330973|NCT01376245|322991780|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
94330974|NCT01376245|322991781|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
94330975|NCT01376245|322991782|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
94330976|NCT01376245|322991783|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
94330977|NCT01376245|322991784|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
94330978|NCT01376245|322991780|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
94330979|NCT01376245|322991781|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
94330980|NCT01376245|322991782|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
94471957|NCT00948922|323520033|FG001|Overall Study|Withdrawal by Subject|2|||
94471958|NCT00948922|323520034|FG002|Overall Study|Withdrawal by Subject|1|||
94471959|NCT00948922|323520032|FG000|Overall Study|Death|3|||
94471960|NCT00948922|323520033|FG001|Overall Study|Death|0|||
94471961|NCT00948922|323520034|FG002|Overall Study|Death|0|||
94471962|NCT00948922|323520032|FG000|Overall Study|Disease progression|0|||
94471963|NCT00948922|323520033|FG001|Overall Study|Disease progression|1|||
94471964|NCT00948922|323520034|FG002|Overall Study|Disease progression|0|||
94471965|NCT00948922|323520032|FG000|Overall Study|Insurance issues|1|||
94471966|NCT00948922|323520033|FG001|Overall Study|Insurance issues|0|||
94471967|NCT00948922|323520034|FG002|Overall Study|Insurance issues|0|||
94471968|NCT00948922|323520032|FG000|Overall Study|Transplant eligibility issues|2|||
94471969|NCT00948922|323520033|FG001|Overall Study|Transplant eligibility issues|3|||
94471970|NCT00948922|323520034|FG002|Overall Study|Transplant eligibility issues|0|||
94471971|NCT00948922|323520032|FG000|Overall Study|Not evaluable at time of analysis|0|||
94471972|NCT00948922|323520033|FG001|Overall Study|Not evaluable at time of analysis|3|||
94471973|NCT00948922|323520034|FG002|Overall Study|Not evaluable at time of analysis|0|||
94471974|NCT00217581|323520035|FG000|Overall Study|Withdrawal by Subject|1|||
94471975|NCT03836209|323520036|FG000|Overall Study|Adverse Event|5|||
94471976|NCT03836209|323520037|FG001|Overall Study|Adverse Event|2|||
94471977|NCT03836209|323520036|FG000|Overall Study|Death|4|||
94471978|NCT03836209|323520037|FG001|Overall Study|Death|1|||
94471979|NCT03836209|323520036|FG000|Overall Study|Lack of Efficacy|7|||
94471980|NCT03836209|323520037|FG001|Overall Study|Lack of Efficacy|10|||
94471981|NCT03836209|323520036|FG000|Overall Study|Physician Decision|7|||
94471982|NCT03836209|323520037|FG001|Overall Study|Physician Decision|11|||
94471983|NCT03836209|323520036|FG000|Overall Study|Protocol Violation|0|||
94471984|NCT03836209|323520037|FG001|Overall Study|Protocol Violation|3|||
94471985|NCT03836209|323520036|FG000|Overall Study|Withdrawal by Subject|2|||
94471986|NCT03836209|323520037|FG001|Overall Study|Withdrawal by Subject|10|||
94471987|NCT03836209|323520036|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
94471988|NCT03836209|323520037|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
94471989|NCT02714036|323520040|FG000|Overall Study|Adverse Event|9|||
94471990|NCT02714036|323520041|FG001|Overall Study|Adverse Event|2|||
94471991|NCT02714036|323520040|FG000|Overall Study|Withdrawal by Subject|3|||
94471992|NCT02714036|323520041|FG001|Overall Study|Withdrawal by Subject|2|||
94471993|NCT03332095|323520042|FG000|Overall Study|Lost to Follow-up|1|||
94471994|NCT03332095|323520043|FG001|Overall Study|Lost to Follow-up|0|||
94471995|NCT03332095|323520042|FG000|Overall Study|Pregnancy|0|||
94471996|NCT03332095|323520043|FG001|Overall Study|Pregnancy|1|||
94471997|NCT01597492|323520044|FG000|Overall Study|Withdrawal by Subject|1|||
94471998|NCT01597492|323520045|FG001|Overall Study|Withdrawal by Subject|2|||
94471999|NCT01597492|323520044|FG000|Overall Study|Adverse Event|3|||
94472000|NCT01597492|323520045|FG001|Overall Study|Adverse Event|0|||
94472001|NCT01597492|323520044|FG000|Overall Study|Lost to Follow-up|0|||
94472002|NCT01597492|323520045|FG001|Overall Study|Lost to Follow-up|2|||
94472003|NCT01597492|323520044|FG000|Overall Study|Other Reason|2|||
94472004|NCT01597492|323520045|FG001|Overall Study|Other Reason|0|||
94472005|NCT03517449|323520054|FG000|Overall Study|Death|184|||
94472006|NCT03517449|323520055|FG001|Overall Study|Death|236|||
94472007|NCT03517449|323520054|FG000|Overall Study|Lost to Follow-up|0|||
94472008|NCT03517449|323520055|FG001|Overall Study|Lost to Follow-up|2|||
94472009|NCT03517449|323520054|FG000|Overall Study|Withdrawal by Subject|7|||
94472010|NCT03517449|323520055|FG001|Overall Study|Withdrawal by Subject|26|||
94472011|NCT03517449|323520054|FG000|Overall Study|Participants Ongoing|220|||
94472012|NCT03517449|323520055|FG001|Overall Study|Participants Ongoing|152|||
94472013|NCT00359294|323520056|FG000|Overall Study|Progressive disease|1|||
94472014|NCT00359294|323520057|FG001|Overall Study|Progressive disease|1|||
94472015|NCT00359294|323520058|FG002|Overall Study|Progressive disease|2|||
94472016|NCT00359294|323520059|FG003|Overall Study|Progressive disease|3|||
94472017|NCT00359294|323520060|FG004|Overall Study|Progressive disease|2|||
94472018|NCT00359294|323520056|FG000|Overall Study|Withdrawal by Subject|0|||
94472019|NCT00359294|323520057|FG001|Overall Study|Withdrawal by Subject|0|||
94472020|NCT00359294|323520058|FG002|Overall Study|Withdrawal by Subject|0|||
94472021|NCT00359294|323520059|FG003|Overall Study|Withdrawal by Subject|0|||
94472022|NCT00359294|323520060|FG004|Overall Study|Withdrawal by Subject|1|||
94472023|NCT00359294|323520056|FG000|Overall Study|Not treated|0|||
94472024|NCT00359294|323520057|FG001|Overall Study|Not treated|0|||
94472025|NCT00359294|323520058|FG002|Overall Study|Not treated|0|||
94472026|NCT00359294|323520059|FG003|Overall Study|Not treated|1|||
94472027|NCT00359294|323520060|FG004|Overall Study|Not treated|0|||
94472028|NCT00359294|323520056|FG000|Overall Study|Physician Decision|0|||
94472029|NCT00359294|323520057|FG001|Overall Study|Physician Decision|0|||
94472030|NCT00359294|323520058|FG002|Overall Study|Physician Decision|1|||
94472031|NCT00359294|323520059|FG003|Overall Study|Physician Decision|0|||
94472032|NCT00359294|323520060|FG004|Overall Study|Physician Decision|0|||
94472033|NCT00099632|323520065|FG000|Overall Study|Lost to Follow-up|1|||
94472034|NCT00099632|323520066|FG001|Overall Study|Lost to Follow-up|0|||
94472035|NCT00099632|323520067|FG002|Overall Study|Lost to Follow-up|3|||
94472036|NCT00099632|323520068|FG003|Overall Study|Lost to Follow-up|1|||
94472037|NCT00099632|323520069|FG004|Overall Study|Lost to Follow-up|1|||
94472038|NCT00099632|323520070|FG005|Overall Study|Lost to Follow-up|0|||
94472039|NCT00099632|323520065|FG000|Overall Study|Withdrawal by Subject|0|||
94472040|NCT00099632|323520066|FG001|Overall Study|Withdrawal by Subject|1|||
94472041|NCT00099632|323520067|FG002|Overall Study|Withdrawal by Subject|0|||
94472042|NCT00099632|323520068|FG003|Overall Study|Withdrawal by Subject|0|||
94472043|NCT00099632|323520069|FG004|Overall Study|Withdrawal by Subject|0|||
94472044|NCT00099632|323520070|FG005|Overall Study|Withdrawal by Subject|1|||
94472045|NCT00099632|323520065|FG000|Overall Study|Protocol Violation|0|||
94472046|NCT00099632|323520066|FG001|Overall Study|Protocol Violation|0|||
94472047|NCT00099632|323520067|FG002|Overall Study|Protocol Violation|0|||
94472048|NCT00099632|323520068|FG003|Overall Study|Protocol Violation|0|||
94472049|NCT00099632|323520069|FG004|Overall Study|Protocol Violation|0|||
94472050|NCT00099632|323520070|FG005|Overall Study|Protocol Violation|1|||
94472051|NCT01964716|323520074|FG000|Overall Study|Withdrawal by Subject|2|||
94472052|NCT01964716|323520075|FG001|Overall Study|Withdrawal by Subject|3|||
94472053|NCT01964716|323520074|FG000|Overall Study|Lost to Follow-up|1|||
94472054|NCT01964716|323520075|FG001|Overall Study|Lost to Follow-up|2|||
94472055|NCT01964716|323520074|FG000|Overall Study|No longer met eligibility criteria|1|||
94472056|NCT01964716|323520075|FG001|Overall Study|No longer met eligibility criteria|1|||
94472057|NCT01964716|323520074|FG000|Overall Study|Death|1|||
94472058|NCT01964716|323520075|FG001|Overall Study|Death|0|||
94472059|NCT01464619|323520076|FG000|Overall Study|Lost to Follow-up|3|||
94472060|NCT01464619|323520077|FG001|Overall Study|Lost to Follow-up|4|||
94472061|NCT01658904|323520078|FG000|Overall Study|Principal Investigator discretion|2|||
94472062|NCT01658904|323520079|FG001|Overall Study|Principal Investigator discretion|0|||
94472063|NCT01658904|323520080|FG002|Overall Study|Principal Investigator discretion|0|||
94472064|NCT00080483|323520082|FG000|Overall Study|Lost to Follow-up|1|||
94472065|NCT00080483|323520083|FG001|Overall Study|Lost to Follow-up|1|||
94472066|NCT00080483|323520082|FG000|Overall Study|Physician Decision|1|||
94472067|NCT00080483|323520083|FG001|Overall Study|Physician Decision|1|||
94472068|NCT03124537|323520090|FG000|Overall Study|Lost to Follow-up|3|||
94472069|NCT03124537|323520091|FG001|Overall Study|Lost to Follow-up|5|||
94472070|NCT03124537|323520090|FG000|Overall Study|App Crash, Incomplete Data|7|||
94472071|NCT03124537|323520091|FG001|Overall Study|App Crash, Incomplete Data|8|||
94472072|NCT03420222|323520092|FG000|Overall Study|Withdrawal by Subject|5|||
94472073|NCT03420222|323520093|FG001|Overall Study|Withdrawal by Subject|0|||
94472074|NCT03420222|323520092|FG000|Overall Study|Physician Decision|0|||
94472075|NCT03420222|323520093|FG001|Overall Study|Physician Decision|1|||
94472076|NCT03681184|323520094|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
94472077|NCT03681184|323520095|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
94472078|NCT04527978|323520096|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
94472079|NCT04527978|323520097|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
94472080|NCT00731731|323520098|FG000|Overall Study|Protocol Violation|0|||
94472081|NCT00731731|323520099|FG001|Overall Study|Protocol Violation|0|||
94472082|NCT00731731|323520100|FG002|Overall Study|Protocol Violation|1|||
94472083|NCT00731731|323520098|FG000|Overall Study|Cancel prior to treatment|0|||
94472084|NCT00731731|323520099|FG001|Overall Study|Cancel prior to treatment|0|||
94472085|NCT00731731|323520100|FG002|Overall Study|Cancel prior to treatment|2|||
94472086|NCT02324699|323520101|FG000|Overall Study|study terminated|1|||
94472087|NCT01605825|323520102|FG000|Overall Study|Adverse Event|4|||
94472088|NCT01605825|323520103|FG001|Overall Study|Adverse Event|2|||
94472089|NCT01605825|323520102|FG000|Overall Study|Withdrawal by Subject|0|||
94472090|NCT01605825|323520103|FG001|Overall Study|Withdrawal by Subject|1|||
94472091|NCT01605825|323520102|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
94472092|NCT01605825|323520103|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
94472093|NCT01605825|323520102|FG000|Overall Study|Non-Compliance with Protocol|3|||
94472094|NCT01605825|323520103|FG001|Overall Study|Non-Compliance with Protocol|0|||
94472095|NCT00187278|323520106|FG000|Overall Study|Protocol Violation|10|||
94472096|NCT00187278|323520107|FG001|Overall Study|Protocol Violation|13|||
94472097|NCT03383692|323520112|FG000|Overall Study|Progressive disease as per RECIST|3|||
94472098|NCT03383692|323520113|FG001|Overall Study|Progressive disease as per RECIST|3|||
94472099|NCT03383692|323520112|FG000|Overall Study|Clinical progression|0|||
94472100|NCT03383692|323520113|FG001|Overall Study|Clinical progression|1|||
94472101|NCT03383692|323520112|FG000|Overall Study|Adverse Event|3|||
94472102|NCT03383692|323520113|FG001|Overall Study|Adverse Event|0|||
94472103|NCT00893971|323520114|FG000|Overall Study|Physician Decision|3|||
94472104|NCT03268005|323520116|FG000|Overall Study|Death|2|||
94472105|NCT03268005|323520117|FG001|Overall Study|Death|1|||
94472106|NCT03268005|323520116|FG000|Overall Study|Lost to Follow-up|2|||
94472107|NCT03268005|323520117|FG001|Overall Study|Lost to Follow-up|2|||
94472108|NCT03268005|323520116|FG000|Overall Study|Withdrawal by Subject|11|||
94472109|NCT03268005|323520117|FG001|Overall Study|Withdrawal by Subject|11|||
94472110|NCT03816007|323520118|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
94380653|NCT02907203|323179189|FG000|Overall Study|Lost to Follow-up|3|||
94380654|NCT02907203|323179189|FG000|Overall Study|Withdrawal by Subject|3|||
94380655|NCT02907203|323179189|FG000|Overall Study|Surgical bypass|1|||
94380656|NCT02623829|323179196|FG000|Overall Study|Lost to Follow-up|1|||
94380657|NCT02623829|323179197|FG001|Overall Study|Lost to Follow-up|1|||
94380658|NCT00662025|323179198|FG000|Overall Study|Objective progression or relapse|51|||
94380659|NCT00662025|323179198|FG000|Overall Study|Adverse Event|7|||
94380660|NCT00662025|323179198|FG000|Overall Study|Withdrawal by Subject|1|||
94380661|NCT00662025|323179198|FG000|Overall Study|Results of other clinical study|2|||
94380662|NCT00662025|323179198|FG000|Overall Study|Target lesion cannot be evaluated|1|||
94380663|NCT00662025|323179198|FG000|Overall Study|Domestic circumstances|1|||
94380664|NCT02166697|323179199|FG000|Overall Study|Protocol Violation|347|||
94380665|NCT00626925|323179206|FG000|Overall Study|Lost to Follow-up|1|||
94380666|NCT00626925|323179207|FG001|Overall Study|Lost to Follow-up|2|||
94380667|NCT00626925|323179206|FG000|Overall Study|relapse|1|||
94380668|NCT00626925|323179207|FG001|Overall Study|relapse|0|||
94380669|NCT00626925|323179206|FG000|Overall Study|Adverse effect|6|||
94380670|NCT00626925|323179207|FG001|Overall Study|Adverse effect|2|||
94380671|NCT00626925|323179206|FG000|Overall Study|Lack of Efficacy|1|||
94380672|NCT00626925|323179207|FG001|Overall Study|Lack of Efficacy|4|||
94380673|NCT00626925|323179206|FG000|Overall Study|Time constraints|3|||
94380674|NCT00626925|323179207|FG001|Overall Study|Time constraints|1|||
94380675|NCT01215942|323179214|FG000|Treatment Period|Adverse Event|15|||
94380676|NCT01215942|323179215|FG001|Treatment Period|Adverse Event|26|||
94380677|NCT01215942|323179214|FG000|Treatment Period|Death|2|||
94380678|NCT01215942|323179215|FG001|Treatment Period|Death|4|||
94380679|NCT01215942|323179214|FG000|Treatment Period|Lack of Efficacy|23|||
94380680|NCT01215942|323179215|FG001|Treatment Period|Lack of Efficacy|62|||
94380681|NCT01215942|323179214|FG000|Treatment Period|Lost to Follow-up|3|||
94380682|NCT01215942|323179215|FG001|Treatment Period|Lost to Follow-up|4|||
94380683|NCT01215942|323179214|FG000|Treatment Period|Withdrawal by Subject|17|||
94380684|NCT01215942|323179215|FG001|Treatment Period|Withdrawal by Subject|40|||
94380685|NCT01215942|323179214|FG000|Treatment Period|Physician Decision|5|||
94380686|NCT01215942|323179215|FG001|Treatment Period|Physician Decision|5|||
94380687|NCT01215942|323179214|FG000|Treatment Period|Protocol Violation|0|||
94380688|NCT01215942|323179215|FG001|Treatment Period|Protocol Violation|1|||
94380689|NCT01215942|323179214|FG000|Treatment Period|Sponsor Decision|349|||
94380690|NCT01215942|323179215|FG001|Treatment Period|Sponsor Decision|530|||
94380691|NCT01215942|323179214|FG000|Post-Treatment Follow-Up Period|Death|0|||
94380692|NCT01215942|323179215|FG001|Post-Treatment Follow-Up Period|Death|1|||
94380693|NCT01215942|323179214|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
94380694|NCT01215942|323179215|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
94380695|NCT01215942|323179214|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
94380696|NCT01215942|323179215|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
94380697|NCT01215942|323179214|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
94380698|NCT01215942|323179215|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
94380699|NCT01215942|323179214|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
94380700|NCT01215942|323179215|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
94380701|NCT02315898|323179216|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
94380702|NCT02315898|323179217|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
94380703|NCT02315898|323179218|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
94380704|NCT02315898|323179219|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
94380705|NCT01336894|323179220|FG000|Follow-up|Study terminated prematurely|2|||
94380706|NCT01336894|323179221|FG001|Follow-up|Study terminated prematurely|7|||
94380707|NCT02224391|323179222|FG000|Overall Study|Lost to Follow-up|26|||
94380708|NCT02224391|323179223|FG001|Overall Study|Lost to Follow-up|19|||
94380709|NCT02224391|323179222|FG000|Overall Study|Withdrawal by Subject|6|||
94380710|NCT02224391|323179223|FG001|Overall Study|Withdrawal by Subject|5|||
94380711|NCT03522948|323179224|FG000|Overall Study|Lost to Follow-up|1|||
94380712|NCT03937466|323179225|FG000|Overall Study|not eligbile after the 2-week diary|9|||
94380713|NCT03937466|323179225|FG000|Overall Study|never returned their diary|6|||
94380714|NCT03937466|323179225|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
94380715|NCT03937466|323179225|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
94380716|NCT03305055|323179226|FG000|Overall Study|Withdrawal by Subject|0|||
94380717|NCT03305055|323179227|FG001|Overall Study|Withdrawal by Subject|1|||
94380718|NCT03305055|323179226|FG000|Overall Study|Adverse Event|1|||
94380719|NCT03305055|323179227|FG001|Overall Study|Adverse Event|1|||
94380720|NCT00622908|323179229|FG000|Overall Study|Protocol Violation|1|||
94380721|NCT00622908|323179230|FG001|Overall Study|Protocol Violation|0|||
94380722|NCT00622908|323179229|FG000|Overall Study|Adverse Event|0|||
94380723|NCT00622908|323179230|FG001|Overall Study|Adverse Event|1|||
94380724|NCT00622908|323179229|FG000|Overall Study|Lack of Efficacy|1|||
94380725|NCT00622908|323179230|FG001|Overall Study|Lack of Efficacy|7|||
94380726|NCT00622908|323179229|FG000|Overall Study|Lost to Follow-up|1|||
94309750|NCT02658656|322917075|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
94309751|NCT02658656|322917076|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
94309752|NCT02658656|322917074|FG000|Randomization|Not eligible for Randomization|1|||
94309753|NCT02658656|322917075|FG001|Randomization|Not eligible for Randomization|0|||
94309754|NCT02658656|322917076|FG002|Randomization|Not eligible for Randomization|0|||
94309755|NCT02658656|322917074|FG000|Randomization|Protocol Violation|1|||
94309756|NCT02658656|322917075|FG001|Randomization|Protocol Violation|0|||
94309757|NCT02658656|322917076|FG002|Randomization|Protocol Violation|0|||
94309758|NCT01543490|322918855|FG000|Overall Study|Adverse Event|4|||
94309759|NCT01543490|322918856|FG001|Overall Study|Adverse Event|0|||
94309760|NCT01543490|322918855|FG000|Overall Study|Physician Decision|1|||
94309761|NCT01543490|322918856|FG001|Overall Study|Physician Decision|0|||
94309762|NCT01543490|322918855|FG000|Overall Study|Lack of Efficacy|3|||
94309763|NCT01543490|322918856|FG001|Overall Study|Lack of Efficacy|3|||
94309764|NCT01543490|322918855|FG000|Overall Study|Lost to Follow-up|5|||
94309765|NCT01543490|322918856|FG001|Overall Study|Lost to Follow-up|0|||
94309766|NCT01543490|322918855|FG000|Overall Study|Withdrawal by Subject|2|||
94309767|NCT01543490|322918856|FG001|Overall Study|Withdrawal by Subject|0|||
94309768|NCT01543490|322918855|FG000|Overall Study|Other-Various Administrative Reasons|1|||
94309769|NCT01543490|322918856|FG001|Overall Study|Other-Various Administrative Reasons|2|||
94309770|NCT02742649|322918857|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
94309771|NCT02742649|322918858|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
94309772|NCT02742649|322918859|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
94309773|NCT02742649|322918860|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
94309774|NCT02742649|322918861|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
94309775|NCT02742649|322918857|FG000|Double-Blind Treatment Period|Adverse Event|0|||
94309776|NCT02742649|322918858|FG001|Double-Blind Treatment Period|Adverse Event|1|||
94309777|NCT02742649|322918859|FG002|Double-Blind Treatment Period|Adverse Event|0|||
94309778|NCT02742649|322918860|FG003|Double-Blind Treatment Period|Adverse Event|0|||
94309779|NCT02742649|322918861|FG004|Double-Blind Treatment Period|Adverse Event|0|||
94309780|NCT02742649|322918857|FG000|Open-Label Period|Lost to Follow-up|0|||
94309781|NCT02742649|322918858|FG001|Open-Label Period|Lost to Follow-up|0|||
94309782|NCT02742649|322918859|FG002|Open-Label Period|Lost to Follow-up|0|||
94309783|NCT02742649|322918860|FG003|Open-Label Period|Lost to Follow-up|0|||
94309784|NCT02742649|322918861|FG004|Open-Label Period|Lost to Follow-up|1|||
94309785|NCT01981122|322918862|FG000|Overall Study|Withdrawal by Subject|0|||
94309786|NCT01981122|322918863|FG001|Overall Study|Withdrawal by Subject|2|||
94309787|NCT01981122|322918862|FG000|Overall Study|Protocol Violation|0|||
94380727|NCT00622908|323179230|FG001|Overall Study|Lost to Follow-up|0|||
94380728|NCT00622908|323179229|FG000|Overall Study|Refusal|0|||
94380729|NCT00622908|323179230|FG001|Overall Study|Refusal|1|||
94380730|NCT00622908|323179229|FG000|Overall Study|Termination by study sponser|0|||
94380731|NCT00622908|323179230|FG001|Overall Study|Termination by study sponser|1|||
94380732|NCT00819247|323179233|FG000|Overall Study|Adverse Event|0|||
94380733|NCT00819247|323179234|FG001|Overall Study|Adverse Event|5|||
94380734|NCT00819247|323179235|FG002|Overall Study|Adverse Event|3|||
94380735|NCT00819247|323179233|FG000|Overall Study|Insufficient testosterone response|5|||
94380736|NCT00819247|323179234|FG001|Overall Study|Insufficient testosterone response|8|||
94380737|NCT00819247|323179235|FG002|Overall Study|Insufficient testosterone response|10|||
94380738|NCT00819247|323179233|FG000|Overall Study|Withdrawal by Subject|1|||
94380739|NCT00819247|323179234|FG001|Overall Study|Withdrawal by Subject|0|||
94380740|NCT00819247|323179235|FG002|Overall Study|Withdrawal by Subject|0|||
94380741|NCT00819247|323179233|FG000|Overall Study|Protocol Violation|1|||
94380742|NCT00819247|323179234|FG001|Overall Study|Protocol Violation|0|||
94380743|NCT00819247|323179235|FG002|Overall Study|Protocol Violation|1|||
94380744|NCT00819247|323179233|FG000|Overall Study|Mistakenly withdrawn|0|||
94380745|NCT00819247|323179234|FG001|Overall Study|Mistakenly withdrawn|1|||
94380746|NCT00819247|323179235|FG002|Overall Study|Mistakenly withdrawn|0|||
94380747|NCT00819247|323179233|FG000|Overall Study|Bad prostate-specific antigen response|3|||
94380748|NCT00819247|323179234|FG001|Overall Study|Bad prostate-specific antigen response|2|||
94380749|NCT00819247|323179235|FG002|Overall Study|Bad prostate-specific antigen response|0|||
94380750|NCT00819247|323179233|FG000|Overall Study|Other|1|||
94380751|NCT00819247|323179234|FG001|Overall Study|Other|0|||
94380752|NCT00819247|323179235|FG002|Overall Study|Other|0|||
94380753|NCT01915732|323179236|FG000|Overall Study|Withdrawal by Subject|18|||
94380754|NCT01915732|323179237|FG001|Overall Study|Withdrawal by Subject|18|||
94380755|NCT01915732|323179236|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
94380756|NCT01915732|323179237|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
94380757|NCT01915732|323179236|FG000|Overall Study|Adverse Event|12|||
94380758|NCT01915732|323179237|FG001|Overall Study|Adverse Event|4|||
94380759|NCT01915732|323179236|FG000|Overall Study|Protocol Violation|5|||
94380760|NCT01915732|323179237|FG001|Overall Study|Protocol Violation|5|||
94380761|NCT01915732|323179236|FG000|Overall Study|Lack of Efficacy|6|||
94380762|NCT01915732|323179237|FG001|Overall Study|Lack of Efficacy|11|||
94309788|NCT01981122|322918863|FG001|Overall Study|Protocol Violation|1|||
94309789|NCT01981122|322918862|FG000|Overall Study|Lost to Follow-up|0|||
94309790|NCT01981122|322918863|FG001|Overall Study|Lost to Follow-up|1|||
94309791|NCT01981122|322918862|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
94309792|NCT01981122|322918863|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
94309793|NCT01981122|322918862|FG000|Overall Study|Death|14|||
94309794|NCT01981122|322918863|FG001|Overall Study|Death|15|||
94309795|NCT04003155|322918864|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
94380763|NCT01915732|323179236|FG000|Overall Study|Lost to Follow-up|22|||
94380764|NCT01915732|323179237|FG001|Overall Study|Lost to Follow-up|26|||
94380765|NCT01915732|323179236|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
94380766|NCT01915732|323179237|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
94380767|NCT01915732|323179236|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
94380768|NCT01915732|323179237|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
94380769|NCT01915732|323179236|FG000|Overall Study|Drug Release Error|1|||
94380770|NCT01915732|323179237|FG001|Overall Study|Drug Release Error|0|||
94380771|NCT01915732|323179236|FG000|Overall Study|Recovered|1|||
94380772|NCT01915732|323179237|FG001|Overall Study|Recovered|0|||
94380773|NCT01915732|323179236|FG000|Overall Study|Pregnancy|1|||
94380774|NCT01915732|323179237|FG001|Overall Study|Pregnancy|0|||
94380775|NCT01915732|323179236|FG000|Overall Study|Poor Perceived Efficacy|1|||
94380776|NCT01915732|323179237|FG001|Overall Study|Poor Perceived Efficacy|0|||
94380777|NCT01915732|323179236|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
94380778|NCT01915732|323179237|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
94380779|NCT01915732|323179236|FG000|Overall Study|Got Well|0|||
94380780|NCT01915732|323179237|FG001|Overall Study|Got Well|1|||
94380781|NCT01915732|323179236|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
94380782|NCT01915732|323179237|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
94380783|NCT01915732|323179236|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
94380784|NCT01915732|323179237|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
94380785|NCT01915732|323179236|FG000|Overall Study|Job Transfer|0|||
94380786|NCT01915732|323179237|FG001|Overall Study|Job Transfer|1|||
94380787|NCT01915732|323179236|FG000|Overall Study|Improper Facial Procedure|0|||
94380788|NCT01915732|323179237|FG001|Overall Study|Improper Facial Procedure|1|||
94380789|NCT01915732|323179236|FG000|Overall Study|Poor Conscious Effect|0|||
94380790|NCT01915732|323179237|FG001|Overall Study|Poor Conscious Effect|1|||
94380791|NCT00698685|323179238|FG000|Overall Study|Sister withdrew as donor|1|||
94380792|NCT00698685|323179238|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
94380793|NCT00602030|323179239|FG000|Lead-in Phase|Disease Progression|2|||
94380794|NCT00602030|323179240|FG001|Lead-in Phase|Disease Progression|3|||
94380795|NCT00602030|323179241|FG002|Lead-in Phase|Disease Progression|0|||
94380796|NCT00602030|323179242|FG003|Lead-in Phase|Disease Progression|0|||
94380797|NCT00602030|323179243|FG004|Lead-in Phase|Disease Progression|0|||
94380798|NCT00602030|323179239|FG000|Lead-in Phase|Adverse Event|0|||
94380799|NCT00602030|323179240|FG001|Lead-in Phase|Adverse Event|2|||
94380800|NCT00602030|323179241|FG002|Lead-in Phase|Adverse Event|0|||
94380801|NCT00602030|323179242|FG003|Lead-in Phase|Adverse Event|0|||
94380802|NCT00602030|323179243|FG004|Lead-in Phase|Adverse Event|0|||
94380803|NCT00602030|323179239|FG000|Double-blind Phase|Disease progression|0|||
94380804|NCT00602030|323179240|FG001|Double-blind Phase|Disease progression|0|||
94380805|NCT00602030|323179241|FG002|Double-blind Phase|Disease progression|33|||
94380806|NCT00602030|323179242|FG003|Double-blind Phase|Disease progression|30|||
94380807|NCT00602030|323179243|FG004|Double-blind Phase|Disease progression|0|||
94380808|NCT00602030|323179239|FG000|Double-blind Phase|Adverse Event|0|||
94380809|NCT00602030|323179240|FG001|Double-blind Phase|Adverse Event|0|||
94380810|NCT00602030|323179241|FG002|Double-blind Phase|Adverse Event|9|||
94380811|NCT00602030|323179242|FG003|Double-blind Phase|Adverse Event|18|||
94380812|NCT00602030|323179243|FG004|Double-blind Phase|Adverse Event|0|||
94380813|NCT00602030|323179239|FG000|Double-blind Phase|Consent withdrawal|0|||
94380814|NCT00602030|323179240|FG001|Double-blind Phase|Consent withdrawal|0|||
94380815|NCT00602030|323179241|FG002|Double-blind Phase|Consent withdrawal|4|||
94380816|NCT00602030|323179242|FG003|Double-blind Phase|Consent withdrawal|3|||
94309796|NCT04003155|322918865|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
94309797|NCT04003155|322918866|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
94309798|NCT04003155|322918867|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
94309799|NCT04003155|322918868|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
94309800|NCT04003155|322918864|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
94380817|NCT00602030|323179243|FG004|Double-blind Phase|Consent withdrawal|0|||
94380818|NCT00602030|323179239|FG000|Double-blind Phase|Death|0|||
94380819|NCT00602030|323179240|FG001|Double-blind Phase|Death|0|||
94380820|NCT00602030|323179241|FG002|Double-blind Phase|Death|3|||
94380821|NCT00602030|323179242|FG003|Double-blind Phase|Death|3|||
94380822|NCT00602030|323179243|FG004|Double-blind Phase|Death|0|||
94380823|NCT00602030|323179239|FG000|Double-blind Phase|Administrative decision|0|||
94380824|NCT00602030|323179240|FG001|Double-blind Phase|Administrative decision|0|||
94380825|NCT00602030|323179241|FG002|Double-blind Phase|Administrative decision|0|||
94380826|NCT00602030|323179242|FG003|Double-blind Phase|Administrative decision|2|||
94380827|NCT00602030|323179243|FG004|Double-blind Phase|Administrative decision|0|||
94380828|NCT00602030|323179239|FG000|Double-blind Phase|Ineligibility|0|||
94380829|NCT00602030|323179240|FG001|Double-blind Phase|Ineligibility|0|||
94380830|NCT00602030|323179241|FG002|Double-blind Phase|Ineligibility|0|||
94380831|NCT00602030|323179242|FG003|Double-blind Phase|Ineligibility|1|||
94380832|NCT00602030|323179243|FG004|Double-blind Phase|Ineligibility|0|||
94380833|NCT00602030|323179239|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
94380834|NCT00602030|323179240|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
94380835|NCT00602030|323179241|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
94380836|NCT00602030|323179242|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
94380837|NCT00602030|323179243|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
94380838|NCT00602030|323179239|FG000|Double-blind Phase|Reason not specified|0|||
94380839|NCT00602030|323179240|FG001|Double-blind Phase|Reason not specified|0|||
94380840|NCT00602030|323179241|FG002|Double-blind Phase|Reason not specified|4|||
94380841|NCT00602030|323179242|FG003|Double-blind Phase|Reason not specified|2|||
94380842|NCT00602030|323179243|FG004|Double-blind Phase|Reason not specified|0|||
94380843|NCT00602030|323179239|FG000|Crossover Phase|Disease Progression|0|||
94380844|NCT00602030|323179240|FG001|Crossover Phase|Disease Progression|0|||
94380845|NCT00602030|323179241|FG002|Crossover Phase|Disease Progression|0|||
94380846|NCT00602030|323179242|FG003|Crossover Phase|Disease Progression|0|||
94380847|NCT00602030|323179243|FG004|Crossover Phase|Disease Progression|11|||
94380848|NCT00602030|323179239|FG000|Crossover Phase|Adverse Event|0|||
94380849|NCT00602030|323179240|FG001|Crossover Phase|Adverse Event|0|||
94380850|NCT00602030|323179241|FG002|Crossover Phase|Adverse Event|0|||
94380851|NCT00602030|323179242|FG003|Crossover Phase|Adverse Event|0|||
94380852|NCT00602030|323179243|FG004|Crossover Phase|Adverse Event|3|||
94380853|NCT00602030|323179239|FG000|Crossover Phase|Consent withdrawal|0|||
94380854|NCT00602030|323179240|FG001|Crossover Phase|Consent withdrawal|0|||
94380855|NCT00602030|323179241|FG002|Crossover Phase|Consent withdrawal|0|||
94380856|NCT00602030|323179242|FG003|Crossover Phase|Consent withdrawal|0|||
94380857|NCT00602030|323179243|FG004|Crossover Phase|Consent withdrawal|2|||
94380858|NCT01984242|323179256|FG000|Overall Study|Death|52|||
94380859|NCT01984242|323179257|FG001|Overall Study|Death|50|||
94380860|NCT01984242|323179258|FG002|Overall Study|Death|52|||
94380861|NCT01984242|323179256|FG000|Overall Study|Withdrawal by Subject|5|||
94380862|NCT01984242|323179257|FG001|Overall Study|Withdrawal by Subject|3|||
94380863|NCT01984242|323179258|FG002|Overall Study|Withdrawal by Subject|10|||
94380864|NCT01984242|323179256|FG000|Overall Study|Physician Decision|0|||
94380865|NCT01984242|323179257|FG001|Overall Study|Physician Decision|0|||
94380866|NCT01984242|323179258|FG002|Overall Study|Physician Decision|1|||
94380867|NCT01984242|323179256|FG000|Overall Study|Lost to Follow-up|4|||
94380868|NCT01984242|323179257|FG001|Overall Study|Lost to Follow-up|0|||
94380869|NCT01984242|323179258|FG002|Overall Study|Lost to Follow-up|3|||
94380870|NCT01984242|323179256|FG000|Overall Study|Sponsor Decision|1|||
94380871|NCT01984242|323179257|FG001|Overall Study|Sponsor Decision|0|||
94380872|NCT01984242|323179258|FG002|Overall Study|Sponsor Decision|0|||
94380873|NCT01984242|323179256|FG000|Overall Study|Non-Compliance|1|||
94380874|NCT01984242|323179257|FG001|Overall Study|Non-Compliance|0|||
94380875|NCT01984242|323179258|FG002|Overall Study|Non-Compliance|0|||
94380876|NCT01984242|323179256|FG000|Overall Study|Study terminated by Sponsor|38|||
94380877|NCT01984242|323179257|FG001|Overall Study|Study terminated by Sponsor|50|||
94380878|NCT01984242|323179258|FG002|Overall Study|Study terminated by Sponsor|34|||
94380879|NCT01984242|323179256|FG000|Overall Study|Disease Progression|0|||
94380880|NCT01984242|323179257|FG001|Overall Study|Disease Progression|0|||
94380881|NCT01984242|323179258|FG002|Overall Study|Disease Progression|1|||
94380882|NCT04543136|323179259|FG000|Overall Study|Withdrawal by Subject|0|||
94380883|NCT04543136|323179260|FG001|Overall Study|Withdrawal by Subject|1|||
94380884|NCT04543136|323179261|FG002|Overall Study|Withdrawal by Subject|0|||
94380885|NCT04543136|323179262|FG003|Overall Study|Withdrawal by Subject|1|||
94380886|NCT04543136|323179263|FG004|Overall Study|Withdrawal by Subject|0|||
94380887|NCT04543136|323179264|FG005|Overall Study|Withdrawal by Subject|0|||
94380888|NCT00536575|323179265|FG000|Overall Study|Withdrawal by Subject|1|||
94380889|NCT00536575|323179265|FG000|Overall Study|Death|1|||
94380890|NCT00891293|323179268|FG000|Overall Study|Adverse Event|2|||
94472111|NCT03816007|323520119|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
94472112|NCT03816007|323520118|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
94380891|NCT00891293|323179268|FG000|Overall Study|Protocol Violation|2|||
94380892|NCT00891293|323179268|FG000|Overall Study|Laboratory abnormality|4|||
94472113|NCT03816007|323520119|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
94472114|NCT03816007|323520118|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
94380893|NCT00891293|323179268|FG000|Overall Study|Lost to Follow-up|7|||
94380894|NCT00891293|323179268|FG000|Overall Study|Subject withdrew consent|7|||
94380895|NCT00891293|323179268|FG000|Overall Study|Sponsor termination|62|||
94380896|NCT00865709|323179269|FG000|Treatment|Adverse Event|9|||
94380897|NCT00865709|323179270|FG001|Treatment|Adverse Event|6|||
94380898|NCT00865709|323179269|FG000|Treatment|Withdrawal by Subject|10|||
94380899|NCT00865709|323179270|FG001|Treatment|Withdrawal by Subject|7|||
94472115|NCT03816007|323520119|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
94472116|NCT00492232|323520122|FG000|Placebo Run-in|Adverse Event|0|||
94472117|NCT00492232|323520123|FG001|Placebo Run-in|Adverse Event|2|||
94472118|NCT00492232|323520122|FG000|Placebo Run-in|Protocol Violation|0|||
94472119|NCT00492232|323520123|FG001|Placebo Run-in|Protocol Violation|3|||
94472120|NCT00492232|323520122|FG000|Placebo Run-in|Lost to Follow-up|0|||
94472121|NCT00492232|323520123|FG001|Placebo Run-in|Lost to Follow-up|3|||
94472122|NCT00492232|323520122|FG000|Placebo Run-in|Withdrawal by Subject|0|||
94472123|NCT00492232|323520123|FG001|Placebo Run-in|Withdrawal by Subject|8|||
94472124|NCT00492232|323520122|FG000|Placebo Run-in|Pregnancy|0|||
94472125|NCT00492232|323520123|FG001|Placebo Run-in|Pregnancy|1|||
94472126|NCT00492232|323520122|FG000|Placebo Run-in|Entrance criteria not met|0|||
94309801|NCT04003155|322918865|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
94309802|NCT04003155|322918866|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
94309803|NCT04003155|322918867|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
94309804|NCT04003155|322918868|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
94309805|NCT04003155|322918864|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
94309806|NCT04003155|322918865|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
94309807|NCT04003155|322918866|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
94472127|NCT00492232|323520123|FG001|Placebo Run-in|Entrance criteria not met|45|||
94472128|NCT00492232|323520122|FG000|Placebo Run-in|Other|0|||
94472129|NCT00492232|323520123|FG001|Placebo Run-in|Other|6|||
94472130|NCT00492232|323520122|FG000|Placebo Run-in|Missing|0|||
94472131|NCT00492232|323520123|FG001|Placebo Run-in|Missing|2|||
94472132|NCT00492232|323520122|FG000|Double-Blind Treatment|Adverse Event|1|||
94472133|NCT00492232|323520123|FG001|Double-Blind Treatment|Adverse Event|2|||
94472134|NCT00492232|323520122|FG000|Double-Blind Treatment|Protocol Violation|3|||
94472135|NCT00492232|323520123|FG001|Double-Blind Treatment|Protocol Violation|7|||
94472136|NCT00492232|323520122|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
94472137|NCT00492232|323520123|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
94472138|NCT00492232|323520122|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
94472139|NCT00492232|323520123|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
94472140|NCT00492232|323520122|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
94472141|NCT00492232|323520123|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
94472142|NCT00492232|323520122|FG000|Double-Blind Treatment|Other|6|||
94472143|NCT00492232|323520123|FG001|Double-Blind Treatment|Other|5|||
94472144|NCT00492232|323520122|FG000|Double-Blind Treatment|Randomized not treated|1|||
94472145|NCT00492232|323520123|FG001|Double-Blind Treatment|Randomized not treated|0|||
94472146|NCT00492232|323520122|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
94472147|NCT00492232|323520123|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
94472148|NCT00845676|323520127|FG000|Overall Study|Virologic breakthrough at week 20|1|||
94472149|NCT00845676|323520127|FG000|Overall Study|Adverse Event|1|||
94472150|NCT02223364|323520128|FG000|Overall Study|Protocol Violation|3|||
94472151|NCT02223364|323520129|FG001|Overall Study|Protocol Violation|0|||
94472152|NCT02223364|323520130|FG002|Overall Study|Protocol Violation|3|||
94472153|NCT02223364|323520128|FG000|Overall Study|subject expired before surgery|1|||
94472154|NCT02223364|323520129|FG001|Overall Study|subject expired before surgery|0|||
94472155|NCT02223364|323520130|FG002|Overall Study|subject expired before surgery|0|||
94472156|NCT02223364|323520128|FG000|Overall Study|Physician Decision|1|||
94472157|NCT02223364|323520129|FG001|Overall Study|Physician Decision|0|||
94472158|NCT02223364|323520130|FG002|Overall Study|Physician Decision|0|||
94472159|NCT01841567|323520131|FG000|Overall Study|Adverse Event|3|||
94472160|NCT01366638|323520136|FG000|Overall Study|Withdrawal by Subject|0|||
94472161|NCT01366638|323520137|FG001|Overall Study|Withdrawal by Subject|0|||
94472162|NCT01366638|323520138|FG002|Overall Study|Withdrawal by Subject|6|||
94472163|NCT01366638|323520136|FG000|Overall Study|Other|1|||
94472164|NCT01366638|323520137|FG001|Overall Study|Other|0|||
94472165|NCT01366638|323520138|FG002|Overall Study|Other|0|||
94472166|NCT01237327|323520139|FG000|Overall Study|Protocol Violation: Core Study|1|||
94472167|NCT01237327|323520140|FG001|Overall Study|Protocol Violation: Core Study|0|||
94472168|NCT01237327|323520139|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
94472169|NCT01237327|323520140|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
94472170|NCT01237327|323520139|FG000|Overall Study|Progression of Disease: Core Study|18|||
94472171|NCT01237327|323520140|FG001|Overall Study|Progression of Disease: Core Study|22|||
94472172|NCT01237327|323520139|FG000|Overall Study|Progression of Disease: Extension Study|15|||
94472173|NCT01237327|323520140|FG001|Overall Study|Progression of Disease: Extension Study|13|||
94472174|NCT01237327|323520139|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
94472175|NCT01237327|323520140|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
94472176|NCT01237327|323520139|FG000|Overall Study|Withdrawal by Subject|1|||
94472177|NCT01237327|323520140|FG001|Overall Study|Withdrawal by Subject|3|||
94472178|NCT01237327|323520139|FG000|Overall Study|Lost to Follow-up|3|||
94472179|NCT01237327|323520140|FG001|Overall Study|Lost to Follow-up|0|||
94472180|NCT02483572|323520141|FG000|Overall Study|Withdrawal by Subject|1|||
94472181|NCT02483572|323520142|FG001|Overall Study|Withdrawal by Subject|0|||
94472182|NCT02483572|323520141|FG000|Overall Study|Lost to Follow-up|1|||
94472183|NCT02483572|323520142|FG001|Overall Study|Lost to Follow-up|0|||
94472184|NCT02483572|323520141|FG000|Overall Study|Physician Decision|0|||
94472185|NCT02483572|323520142|FG001|Overall Study|Physician Decision|1|||
94472186|NCT00528372|323520146|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
94472187|NCT00528372|323520147|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
94472188|NCT00528372|323520148|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
94472189|NCT00528372|323520149|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
94472190|NCT00528372|323520150|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
94472191|NCT00528372|323520151|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
94472192|NCT00528372|323520152|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
94472193|NCT00528372|323520153|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
94472194|NCT00528372|323520154|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
94472195|NCT00528372|323520146|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
94472196|NCT00528372|323520147|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
94472197|NCT00528372|323520148|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
94472198|NCT00528372|323520149|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
94472199|NCT00528372|323520150|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
94472200|NCT00528372|323520151|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
94472201|NCT00528372|323520152|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
94472202|NCT00528372|323520153|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
94472203|NCT00528372|323520154|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
94472204|NCT00528372|323520146|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
94472205|NCT00528372|323520147|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
94472206|NCT00528372|323520148|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
94472207|NCT00528372|323520149|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
94472208|NCT00528372|323520150|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
94472209|NCT00528372|323520151|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
94472210|NCT00528372|323520152|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
94472211|NCT00528372|323520153|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
94472212|NCT00528372|323520154|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
94472213|NCT00528372|323520146|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
94472214|NCT00528372|323520147|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
94472215|NCT00528372|323520148|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
94472216|NCT00528372|323520149|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
94472217|NCT00528372|323520150|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
94472218|NCT00528372|323520151|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
94472219|NCT00528372|323520152|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
94472220|NCT00528372|323520153|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
94472221|NCT00528372|323520154|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
94472222|NCT00528372|323520146|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
94472223|NCT00528372|323520147|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
94309808|NCT04003155|322918867|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
94309809|NCT04003155|322918868|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
94309810|NCT04003155|322918864|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
94309811|NCT04003155|322918865|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
94309812|NCT04003155|322918866|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
94309813|NCT04003155|322918867|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
94309814|NCT04003155|322918868|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
94309815|NCT04003155|322918864|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
94309816|NCT04003155|322918865|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
94309817|NCT04003155|322918866|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
94309818|NCT04003155|322918867|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
94309819|NCT04003155|322918868|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
94472224|NCT00528372|323520148|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
94472225|NCT00528372|323520149|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
94472226|NCT00528372|323520150|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
94472227|NCT00528372|323520151|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
94472228|NCT00528372|323520152|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
94472229|NCT00528372|323520153|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
94472230|NCT00528372|323520154|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
94309820|NCT04003155|322918864|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
94472231|NCT00528372|323520146|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
94472232|NCT00528372|323520147|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
94472233|NCT00528372|323520148|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
94472234|NCT00528372|323520149|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
94309821|NCT04003155|322918865|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
94309822|NCT04003155|322918866|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
94309823|NCT04003155|322918867|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
94309824|NCT04003155|322918868|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
94309825|NCT04003155|322918864|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
94309826|NCT04003155|322918865|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
94309827|NCT04003155|322918866|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
94309828|NCT04003155|322918867|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
94309829|NCT04003155|322918868|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
94309830|NCT04003155|322918864|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
94309831|NCT04003155|322918865|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
94309832|NCT04003155|322918866|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
94309833|NCT04003155|322918867|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
94309834|NCT04003155|322918868|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
94309835|NCT04003155|322918864|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
94309836|NCT04003155|322918865|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
94309837|NCT04003155|322918866|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
94309838|NCT04003155|322918867|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
94309839|NCT04003155|322918868|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
94309840|NCT01013883|322918875|FG000|Overall Study|Lost to Follow-up|2|||
94309841|NCT01013883|322918876|FG001|Overall Study|Lost to Follow-up|2|||
94309842|NCT00641043|322918879|FG000|Overall Study|Adverse Event|6|||
94309843|NCT00641043|322918880|FG001|Overall Study|Adverse Event|4|||
94309844|NCT00641043|322918879|FG000|Overall Study|Protocol Violation|2|||
94309845|NCT00641043|322918880|FG001|Overall Study|Protocol Violation|3|||
94309846|NCT00641043|322918879|FG000|Overall Study|Lost to Follow-up|3|||
94309847|NCT00641043|322918880|FG001|Overall Study|Lost to Follow-up|2|||
94309848|NCT00641043|322918879|FG000|Overall Study|Withdrawal by Subject|4|||
94309849|NCT00641043|322918880|FG001|Overall Study|Withdrawal by Subject|4|||
94309850|NCT00641043|322918879|FG000|Overall Study|Other incl. lack of efficacy|4|||
94309851|NCT00641043|322918880|FG001|Overall Study|Other incl. lack of efficacy|2|||
94309852|NCT05523362|322918881|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
94309853|NCT05523362|322918881|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
94309854|NCT05523362|322918881|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
94309855|NCT05523362|322918881|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
94309856|NCT00474630|322918882|FG000|Overall Study|Adverse Event|98|||
94309857|NCT00474630|322918883|FG001|Overall Study|Adverse Event|26|||
94309858|NCT00474630|322918882|FG000|Overall Study|Lost to Follow-up|22|||
94309859|NCT00474630|322918883|FG001|Overall Study|Lost to Follow-up|15|||
94309860|NCT00474630|322918882|FG000|Overall Study|Withdrawal by Subject|21|||
94309861|NCT00474630|322918883|FG001|Overall Study|Withdrawal by Subject|15|||
94309862|NCT00474630|322918882|FG000|Overall Study|Protocol Violation|3|||
94309863|NCT00474630|322918883|FG001|Overall Study|Protocol Violation|4|||
94309864|NCT00474630|322918882|FG000|Overall Study|Lack of Efficacy|5|||
94309865|NCT00474630|322918883|FG001|Overall Study|Lack of Efficacy|6|||
94309866|NCT00474630|322918882|FG000|Overall Study|Drug noncompliance, other|11|||
94309867|NCT00474630|322918883|FG001|Overall Study|Drug noncompliance, other|4|||
94309868|NCT04075604|322918884|FG000|Overall Study|Adverse Event|0|||
94309869|NCT04075604|322918885|FG001|Overall Study|Adverse Event|0|||
94309870|NCT04075604|322918886|FG002|Overall Study|Adverse Event|3|||
94309871|NCT04075604|322918884|FG000|Overall Study|Participant request to discontinue study treatment|0|||
94309872|NCT04075604|322918885|FG001|Overall Study|Participant request to discontinue study treatment|0|||
94309873|NCT04075604|322918886|FG002|Overall Study|Participant request to discontinue study treatment|1|||
94309874|NCT04075604|322918884|FG000|Overall Study|Participant withdrew consent|0|||
94309875|NCT04075604|322918885|FG001|Overall Study|Participant withdrew consent|0|||
94309876|NCT04075604|322918886|FG002|Overall Study|Participant withdrew consent|1|||
94309877|NCT04075604|322918884|FG000|Overall Study|Other reasons|1|||
94309878|NCT04075604|322918885|FG001|Overall Study|Other reasons|0|||
94309879|NCT04075604|322918886|FG002|Overall Study|Other reasons|0|||
94309880|NCT04075604|322918884|FG000|Overall Study|Disease progression|0|||
94309881|NCT04075604|322918885|FG001|Overall Study|Disease progression|1|||
94309882|NCT04075604|322918886|FG002|Overall Study|Disease progression|0|||
94309883|NCT04075604|322918884|FG000|Overall Study|Study drug toxicity|0|||
94309884|NCT04075604|322918885|FG001|Overall Study|Study drug toxicity|5|||
94309885|NCT04075604|322918886|FG002|Overall Study|Study drug toxicity|1|||
94380900|NCT00865709|323179269|FG000|Treatment|Physician Decision|3|||
94309886|NCT02606045|322918889|FG000|Overall Study|Study closed before treament could begin|1|||
94309887|NCT02606045|322918890|FG001|Overall Study|Study closed before treament could begin|2|||
94309888|NCT01629667|322918892|FG000|Overall Study|Lost to Follow-up|0|||
94309889|NCT01629667|322918893|FG001|Overall Study|Lost to Follow-up|1|||
94309890|NCT01629667|322918894|FG002|Overall Study|Lost to Follow-up|1|||
94309891|NCT01629667|322918892|FG000|Overall Study|Withdrawal by Subject|31|||
94309892|NCT01629667|322918893|FG001|Overall Study|Withdrawal by Subject|20|||
94472235|NCT00528372|323520150|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
94472236|NCT00528372|323520151|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
94380901|NCT00865709|323179270|FG001|Treatment|Physician Decision|2|||
94380902|NCT00865709|323179269|FG000|Treatment|Surgery|8|||
94380903|NCT00865709|323179270|FG001|Treatment|Surgery|3|||
94380904|NCT00906347|323179277|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
94380905|NCT00906347|323179278|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
94380906|NCT00906347|323179277|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
94380907|NCT00906347|323179278|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
94380908|NCT00906347|323179277|FG000|Received Study Drug|Refused study drug|1|||
94380909|NCT00906347|323179278|FG001|Received Study Drug|Refused study drug|0|||
94380910|NCT00906347|323179277|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
94380911|NCT00906347|323179278|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
94380912|NCT01485536|323179279|FG000|Overall Study|Withdrawal by Subject|3|||
94380913|NCT01485536|323179279|FG000|Overall Study|Adverse Event|1|||
94380914|NCT01058421|323179280|FG000|1 Month Outcomes|Death|10|||
94380915|NCT01058421|323179281|FG001|1 Month Outcomes|Death|6|||
94380916|NCT01058421|323179280|FG000|1 Month Outcomes|Lost to Follow-up|8|||
94380917|NCT01058421|323179281|FG001|1 Month Outcomes|Lost to Follow-up|7|||
94380918|NCT01058421|323179280|FG000|1 Month Outcomes|Remained in Hospital|5|||
94380919|NCT01058421|323179281|FG001|1 Month Outcomes|Remained in Hospital|12|||
94380920|NCT01058421|323179280|FG000|1 Month Outcomes|Remained in Other Facility|16|||
94380921|NCT01058421|323179281|FG001|1 Month Outcomes|Remained in Other Facility|17|||
94380922|NCT01058421|323179280|FG000|3 Month Outcomes|Death|3|||
94380923|NCT01058421|323179281|FG001|3 Month Outcomes|Death|5|||
94380924|NCT01058421|323179280|FG000|3 Month Outcomes|Lost to Follow-up|12|||
94380925|NCT01058421|323179281|FG001|3 Month Outcomes|Lost to Follow-up|11|||
94380926|NCT01058421|323179280|FG000|3 Month Outcomes|Remained in Hospital|0|||
94380927|NCT01058421|323179281|FG001|3 Month Outcomes|Remained in Hospital|2|||
94380928|NCT01058421|323179280|FG000|3 Month Outcomes|Remained in Other Facility|5|||
94380929|NCT01058421|323179281|FG001|3 Month Outcomes|Remained in Other Facility|8|||
94380930|NCT01058421|323179280|FG000|6 Month Outcomes|Death|2|||
94380931|NCT01058421|323179281|FG001|6 Month Outcomes|Death|2|||
94380932|NCT01058421|323179280|FG000|6 Month Outcomes|Lost to Follow-up|16|||
94380933|NCT01058421|323179281|FG001|6 Month Outcomes|Lost to Follow-up|21|||
94380934|NCT01058421|323179280|FG000|6 Month Outcomes|Remained in Other Facility|1|||
94380935|NCT01058421|323179281|FG001|6 Month Outcomes|Remained in Other Facility|3|||
94380936|NCT02984683|323179282|FG000|Overall Study|Adverse Event|3|||
94380937|NCT02984683|323179283|FG001|Overall Study|Adverse Event|3|||
94380938|NCT02984683|323179282|FG000|Overall Study|Withdrawal by Subject|1|||
94380939|NCT02984683|323179283|FG001|Overall Study|Withdrawal by Subject|0|||
94380940|NCT02984683|323179282|FG000|Overall Study|Disease progression|7|||
94380941|NCT02984683|323179283|FG001|Overall Study|Disease progression|9|||
94380942|NCT03495869|323179284|FG000|Overall Study|Lost to Follow-up|4|||
94380943|NCT03495869|323179285|FG001|Overall Study|Lost to Follow-up|17|||
94380944|NCT03495869|323179286|FG002|Overall Study|Lost to Follow-up|8|||
94380945|NCT03495869|323179287|FG003|Overall Study|Lost to Follow-up|14|||
94380946|NCT03495869|323179284|FG000|Overall Study|Withdrawal by Subject|0|||
94380947|NCT03495869|323179285|FG001|Overall Study|Withdrawal by Subject|3|||
94380948|NCT03495869|323179286|FG002|Overall Study|Withdrawal by Subject|0|||
94380949|NCT03495869|323179287|FG003|Overall Study|Withdrawal by Subject|3|||
94380950|NCT03495869|323179284|FG000|Overall Study|Dropped from study|0|||
94380951|NCT03495869|323179285|FG001|Overall Study|Dropped from study|7|||
94380952|NCT03495869|323179286|FG002|Overall Study|Dropped from study|2|||
94380953|NCT03495869|323179287|FG003|Overall Study|Dropped from study|4|||
94380954|NCT00836927|323181083|FG000|Overall Study|Progressive disease|2|||
94380955|NCT00836927|323181084|FG001|Overall Study|Progressive disease|0|||
94380956|NCT00836927|323181085|FG002|Overall Study|Progressive disease|0|||
94380957|NCT00836927|323181086|FG003|Overall Study|Progressive disease|1|||
94380958|NCT00836927|323181087|FG004|Overall Study|Progressive disease|1|||
94380959|NCT00836927|323181083|FG000|Overall Study|Withdrawal by Subject|1|||
94380960|NCT00836927|323181084|FG001|Overall Study|Withdrawal by Subject|0|||
94380961|NCT00836927|323181085|FG002|Overall Study|Withdrawal by Subject|0|||
94380962|NCT00836927|323181086|FG003|Overall Study|Withdrawal by Subject|0|||
94380963|NCT00836927|323181087|FG004|Overall Study|Withdrawal by Subject|0|||
94380964|NCT00614055|323181092|FG000|Overall Study|Adverse Event|1|||
94380965|NCT00614055|323181093|FG001|Overall Study|Adverse Event|0|||
94380966|NCT00614055|323181094|FG002|Overall Study|Adverse Event|0|||
94380967|NCT00614055|323181092|FG000|Overall Study|Protocol Violation|2|||
94380968|NCT00614055|323181093|FG001|Overall Study|Protocol Violation|2|||
94380969|NCT00614055|323181094|FG002|Overall Study|Protocol Violation|1|||
94380970|NCT00614055|323181092|FG000|Overall Study|Lack of Efficacy|0|||
94380971|NCT00614055|323181093|FG001|Overall Study|Lack of Efficacy|0|||
94380972|NCT00614055|323181094|FG002|Overall Study|Lack of Efficacy|2|||
94472237|NCT00528372|323520152|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
94472238|NCT00528372|323520153|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
94472239|NCT00528372|323520154|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
94472240|NCT00528372|323520146|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
94472241|NCT00528372|323520147|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
94472242|NCT00528372|323520148|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
94472243|NCT00528372|323520149|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
94472244|NCT00528372|323520150|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
94472245|NCT00528372|323520151|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
94472246|NCT00528372|323520152|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
94380973|NCT00614055|323181092|FG000|Overall Study|Unclassified|1|||
94380974|NCT00614055|323181093|FG001|Overall Study|Unclassified|4|||
94380975|NCT00614055|323181094|FG002|Overall Study|Unclassified|2|||
94380976|NCT01787825|323181103|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
94380977|NCT01787825|323181104|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
94380978|NCT01787825|323181103|FG000|Overall Study|Data Not Analyzable|5|||
94380979|NCT01787825|323181104|FG001|Overall Study|Data Not Analyzable|1|||
94380980|NCT00797108|323181105|FG000|Overall Study|Adverse Event|1|||
94380981|NCT00797108|323181106|FG001|Overall Study|Adverse Event|0|||
94380982|NCT00797108|323181107|FG002|Overall Study|Adverse Event|3|||
94380983|NCT00797108|323181105|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
94380984|NCT00797108|323181106|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
94380985|NCT00797108|323181107|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
94380986|NCT00797108|323181105|FG000|Overall Study|Global Deterioration of Health Status|0|||
94380987|NCT00797108|323181106|FG001|Overall Study|Global Deterioration of Health Status|1|||
94380988|NCT00797108|323181107|FG002|Overall Study|Global Deterioration of Health Status|0|||
94380989|NCT00797108|323181105|FG000|Overall Study|Lack of Efficacy|1|||
94380990|NCT00797108|323181106|FG001|Overall Study|Lack of Efficacy|0|||
94380991|NCT00797108|323181107|FG002|Overall Study|Lack of Efficacy|1|||
94380992|NCT00797108|323181105|FG000|Overall Study|Other|0|||
94380993|NCT00797108|323181106|FG001|Overall Study|Other|0|||
94380994|NCT00797108|323181107|FG002|Overall Study|Other|2|||
94380995|NCT00797108|323181105|FG000|Overall Study|Randomized but not Treated|2|||
94380996|NCT00797108|323181106|FG001|Overall Study|Randomized but not Treated|0|||
94380997|NCT00797108|323181107|FG002|Overall Study|Randomized but not Treated|0|||
94380998|NCT01031537|323181108|FG000|Overall Study|medical reasons not related to study|3|||
94380999|NCT01031537|323181108|FG000|Overall Study|Lack of Efficacy|1|||
94381000|NCT01031537|323181108|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
94381001|NCT01031537|323181108|FG000|Overall Study|moved, met exclusion criteria|10|||
94381002|NCT01031537|323181108|FG000|Overall Study|Withdrawal by Subject|5|||
94381003|NCT01031537|323181108|FG000|Overall Study|PI removal, no longer met eligibility|12|||
94381004|NCT01000337|323181114|FG000|Overall Study|Lost to Follow-up|4|||
94381005|NCT01000337|323181115|FG001|Overall Study|Lost to Follow-up|3|||
94381006|NCT01860976|323181116|FG000|Blinded Treatment|Adverse Event|1|||
94381007|NCT01860976|323181117|FG001|Blinded Treatment|Adverse Event|3|||
94381008|NCT01860976|323181116|FG000|Blinded Treatment|Lack of Efficacy|5|||
94381009|NCT01860976|323181117|FG001|Blinded Treatment|Lack of Efficacy|12|||
94381010|NCT01860976|323181116|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
94381011|NCT01860976|323181117|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
94381012|NCT01860976|323181116|FG000|Blinded Treatment|Withdrawal by Subject|3|||
94381013|NCT01860976|323181117|FG001|Blinded Treatment|Withdrawal by Subject|5|||
94381014|NCT01860976|323181116|FG000|Blinded Treatment|Subject no longer met criteria|1|||
94381015|NCT01860976|323181117|FG001|Blinded Treatment|Subject no longer met criteria|0|||
94381016|NCT01860976|323181116|FG000|Blinded Treatment|Entered Open-Label in error|0|||
94381017|NCT01860976|323181117|FG001|Blinded Treatment|Entered Open-Label in error|1|||
94381018|NCT01860976|323181116|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
94381019|NCT01860976|323181117|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
94381020|NCT01860976|323181116|FG000|Open-Label|Adverse Event|2|||
94381021|NCT01860976|323181117|FG001|Open-Label|Adverse Event|4|||
94381022|NCT01860976|323181116|FG000|Open-Label|Lack of Efficacy|16|||
94381023|NCT01860976|323181117|FG001|Open-Label|Lack of Efficacy|8|||
94381024|NCT01860976|323181116|FG000|Open-Label|Lost to Follow-up|1|||
94381025|NCT01860976|323181117|FG001|Open-Label|Lost to Follow-up|2|||
94381026|NCT01860976|323181116|FG000|Open-Label|Subject request discontinue treatment|4|||
94381027|NCT01860976|323181117|FG001|Open-Label|Subject request discontinue treatment|3|||
94381028|NCT01860976|323181116|FG000|Open-Label|Withdrawal by Subject|4|||
94381029|NCT01860976|323181117|FG001|Open-Label|Withdrawal by Subject|1|||
94381030|NCT01860976|323181116|FG000|Open-Label|Other Reasons|1|||
94381031|NCT01860976|323181117|FG001|Open-Label|Other Reasons|1|||
94381032|NCT01860976|323181116|FG000|Long Term Extension|Adverse Event|4|||
94381033|NCT01860976|323181117|FG001|Long Term Extension|Adverse Event|0|||
94472247|NCT00528372|323520153|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
94472248|NCT00528372|323520154|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
94472249|NCT00528372|323520146|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
94472250|NCT00528372|323520147|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
94472251|NCT00528372|323520148|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
94472252|NCT00528372|323520149|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
94472253|NCT00528372|323520150|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
94472254|NCT00528372|323520151|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
94472255|NCT00528372|323520152|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
94472256|NCT00528372|323520153|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
94472257|NCT00528372|323520154|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
94472258|NCT00528372|323520146|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
94472259|NCT00528372|323520147|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
94472260|NCT00528372|323520148|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
94472261|NCT00528372|323520149|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
94472262|NCT00528372|323520150|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
94472263|NCT00528372|323520151|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
94472264|NCT00528372|323520152|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
94472265|NCT00528372|323520153|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
94472266|NCT00528372|323520154|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
94472267|NCT00528372|323520146|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
94472268|NCT00528372|323520147|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
94472269|NCT00528372|323520148|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
94472270|NCT00528372|323520149|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
94472271|NCT00528372|323520150|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
94472272|NCT00528372|323520151|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
94472273|NCT00528372|323520152|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
94472274|NCT00528372|323520153|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
94472275|NCT00528372|323520154|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
94472276|NCT00528372|323520146|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
94472277|NCT00528372|323520147|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
94472278|NCT00528372|323520148|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
94472279|NCT00528372|323520149|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
94472280|NCT00528372|323520150|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
94472281|NCT00528372|323520151|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
94472282|NCT00528372|323520152|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
94472283|NCT00528372|323520153|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
94472284|NCT00528372|323520154|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
94472285|NCT00528372|323520146|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
94472286|NCT00528372|323520147|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
94472287|NCT00528372|323520148|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
94472288|NCT00528372|323520149|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
94472289|NCT00528372|323520150|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
94472290|NCT00528372|323520151|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
94472291|NCT00528372|323520152|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
94472292|NCT00528372|323520153|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
94472293|NCT00528372|323520154|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
94472294|NCT00528372|323520146|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
94472295|NCT00528372|323520147|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
94472296|NCT00528372|323520148|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
94472297|NCT00528372|323520149|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
94472298|NCT00528372|323520150|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
94472299|NCT00528372|323520151|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
94472300|NCT00528372|323520152|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
94472301|NCT00528372|323520153|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
94472302|NCT00528372|323520154|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
94472303|NCT00528372|323520146|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
94472304|NCT00528372|323520147|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
94472305|NCT00528372|323520148|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
94472306|NCT00528372|323520149|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
94472307|NCT00528372|323520150|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
94472308|NCT00528372|323520151|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
94309893|NCT01629667|322918894|FG002|Overall Study|Withdrawal by Subject|28|||
94309894|NCT01629667|322918892|FG000|Overall Study|Death|1|||
94309895|NCT01629667|322918893|FG001|Overall Study|Death|5|||
94309896|NCT01629667|322918894|FG002|Overall Study|Death|3|||
94309897|NCT01629667|322918892|FG000|Overall Study|Randomized, not treated|2|||
94309898|NCT01629667|322918893|FG001|Overall Study|Randomized, not treated|1|||
94309899|NCT01629667|322918894|FG002|Overall Study|Randomized, not treated|0|||
94309900|NCT01629667|322918892|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
94309901|NCT01629667|322918893|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
94309902|NCT01629667|322918894|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
94309903|NCT01629667|322918892|FG000|Overall Study|Requiring lung transplant|2|||
94309904|NCT01629667|322918893|FG001|Overall Study|Requiring lung transplant|1|||
94309905|NCT01629667|322918894|FG002|Overall Study|Requiring lung transplant|3|||
94309906|NCT01629667|322918892|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
94309907|NCT01629667|322918893|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
94309908|NCT01629667|322918894|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
94309909|NCT01629667|322918892|FG000|Overall Study|Started other medicine|1|||
94309910|NCT01629667|322918893|FG001|Overall Study|Started other medicine|0|||
94309911|NCT01629667|322918894|FG002|Overall Study|Started other medicine|1|||
94309912|NCT01629667|322918892|FG000|Overall Study|Site error in safety follow-up|0|||
94309913|NCT01629667|322918893|FG001|Overall Study|Site error in safety follow-up|0|||
94309914|NCT01629667|322918894|FG002|Overall Study|Site error in safety follow-up|1|||
94309915|NCT01629667|322918892|FG000|Overall Study|Enrolled in another clinical study|0|||
94309916|NCT01629667|322918893|FG001|Overall Study|Enrolled in another clinical study|1|||
94309917|NCT01629667|322918894|FG002|Overall Study|Enrolled in another clinical study|0|||
94309918|NCT01629667|322918892|FG000|Overall Study|Code break|1|||
94309919|NCT01629667|322918893|FG001|Overall Study|Code break|0|||
94309920|NCT01629667|322918894|FG002|Overall Study|Code break|0|||
94309921|NCT00891657|322918897|FG000|Overall Study|Withdrawal by Subject|1|||
94309922|NCT00891657|322918898|FG001|Overall Study|Withdrawal by Subject|1|||
94309923|NCT03849560|322918903|FG000|Overall Study|Withdrawal by Subject|1|||
94309924|NCT03849560|322918904|FG001|Overall Study|Withdrawal by Subject|0|||
94309925|NCT03849560|322918905|FG002|Overall Study|Withdrawal by Subject|0|||
94309926|NCT04045613|322918906|FG000|Overall Study|Adverse Event|2|||
94309927|NCT04045613|322918907|FG001|Overall Study|Adverse Event|2|||
94309928|NCT04045613|322918908|FG002|Overall Study|Adverse Event|1|||
94309929|NCT04045613|322918909|FG003|Overall Study|Adverse Event|1|||
94309930|NCT04045613|322918910|FG004|Overall Study|Adverse Event|0|||
94309931|NCT04045613|322918911|FG005|Overall Study|Adverse Event|0|||
94309932|NCT04045613|322918912|FG006|Overall Study|Adverse Event|1|||
94309933|NCT04045613|322918906|FG000|Overall Study|Withdrawal by Subject|0|||
94309934|NCT04045613|322918907|FG001|Overall Study|Withdrawal by Subject|5|||
94309935|NCT04045613|322918908|FG002|Overall Study|Withdrawal by Subject|0|||
94309936|NCT04045613|322918909|FG003|Overall Study|Withdrawal by Subject|0|||
94309937|NCT04045613|322918910|FG004|Overall Study|Withdrawal by Subject|0|||
94309938|NCT04045613|322918911|FG005|Overall Study|Withdrawal by Subject|1|||
94309939|NCT04045613|322918912|FG006|Overall Study|Withdrawal by Subject|0|||
94309940|NCT04045613|322918906|FG000|Overall Study|Physician Decision|2|||
94309941|NCT04045613|322918907|FG001|Overall Study|Physician Decision|0|||
94309942|NCT04045613|322918908|FG002|Overall Study|Physician Decision|0|||
94309943|NCT04045613|322918909|FG003|Overall Study|Physician Decision|0|||
94309944|NCT04045613|322918910|FG004|Overall Study|Physician Decision|1|||
94309945|NCT04045613|322918911|FG005|Overall Study|Physician Decision|0|||
94309946|NCT04045613|322918912|FG006|Overall Study|Physician Decision|0|||
94309947|NCT04045613|322918906|FG000|Overall Study|Death|3|||
94309948|NCT04045613|322918907|FG001|Overall Study|Death|0|||
94309949|NCT04045613|322918908|FG002|Overall Study|Death|0|||
94309950|NCT04045613|322918909|FG003|Overall Study|Death|0|||
94309951|NCT04045613|322918910|FG004|Overall Study|Death|0|||
94309952|NCT04045613|322918911|FG005|Overall Study|Death|0|||
94309953|NCT04045613|322918912|FG006|Overall Study|Death|1|||
94309954|NCT04045613|322918906|FG000|Overall Study|Other reasons|0|||
94309955|NCT04045613|322918907|FG001|Overall Study|Other reasons|1|||
94309956|NCT04045613|322918908|FG002|Overall Study|Other reasons|0|||
94309957|NCT04045613|322918909|FG003|Overall Study|Other reasons|0|||
94309958|NCT04045613|322918910|FG004|Overall Study|Other reasons|0|||
94309959|NCT04045613|322918911|FG005|Overall Study|Other reasons|0|||
94472309|NCT00528372|323520152|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
94309960|NCT04045613|322918912|FG006|Overall Study|Other reasons|1|||
94309961|NCT04045613|322918906|FG000|Overall Study|Progressive disease: Clinical progression|1|||
94309962|NCT04045613|322918907|FG001|Overall Study|Progressive disease: Clinical progression|0|||
94309963|NCT04045613|322918908|FG002|Overall Study|Progressive disease: Clinical progression|3|||
94309964|NCT04045613|322918909|FG003|Overall Study|Progressive disease: Clinical progression|1|||
94309965|NCT04045613|322918910|FG004|Overall Study|Progressive disease: Clinical progression|1|||
94309966|NCT04045613|322918911|FG005|Overall Study|Progressive disease: Clinical progression|3|||
94309967|NCT04045613|322918912|FG006|Overall Study|Progressive disease: Clinical progression|3|||
94472310|NCT00528372|323520153|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
94472311|NCT00528372|323520154|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
94472312|NCT00528372|323520146|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
94472313|NCT00528372|323520147|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
94472314|NCT00528372|323520148|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
94472315|NCT00528372|323520149|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
94472316|NCT00528372|323520150|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
94472317|NCT00528372|323520151|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
94472318|NCT00528372|323520152|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
94472319|NCT00528372|323520153|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
94472320|NCT00528372|323520154|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
94472321|NCT03178851|323520155|FG000|Overall Study|Death|48|||
94472322|NCT03178851|323520156|FG001|Overall Study|Death|2|||
94472323|NCT03178851|323520157|FG002|Overall Study|Death|25|||
94472324|NCT03178851|323520155|FG000|Overall Study|Withdrawal by Subject|8|||
94472325|NCT03178851|323520156|FG001|Overall Study|Withdrawal by Subject|0|||
94472326|NCT03178851|323520157|FG002|Overall Study|Withdrawal by Subject|0|||
94472327|NCT03178851|323520155|FG000|Overall Study|Lost to Follow-up|5|||
94472328|NCT03178851|323520156|FG001|Overall Study|Lost to Follow-up|2|||
94472329|NCT03178851|323520157|FG002|Overall Study|Lost to Follow-up|0|||
94472330|NCT03178851|323520155|FG000|Overall Study|Adverse Event|0|||
94472331|NCT03178851|323520156|FG001|Overall Study|Adverse Event|0|||
94472332|NCT03178851|323520157|FG002|Overall Study|Adverse Event|1|||
94472333|NCT03178851|323520155|FG000|Overall Study|Study Termination by Sponsor|31|||
94472334|NCT03178851|323520156|FG001|Overall Study|Study Termination by Sponsor|7|||
94472335|NCT03178851|323520157|FG002|Overall Study|Study Termination by Sponsor|26|||
94472336|NCT02226120|323520160|FG000|Overall Study|Adverse Event|60|||
94472337|NCT02226120|323520160|FG000|Overall Study|Death|172|||
94472338|NCT02226120|323520160|FG000|Overall Study|Study terminated by sponsor|1|||
94472339|NCT02226120|323520160|FG000|Overall Study|Technical problems|4|||
94472340|NCT02226120|323520160|FG000|Overall Study|Lost to Follow-up|13|||
94472341|NCT02226120|323520160|FG000|Overall Study|Physician Decision|21|||
94472342|NCT02226120|323520160|FG000|Overall Study|Withdrawal by parent/guardian|36|||
94472343|NCT02226120|323520160|FG000|Overall Study|Non-compliance with study drug|10|||
94472344|NCT02226120|323520160|FG000|Overall Study|Protocol deviation|1|||
94472345|NCT02226120|323520160|FG000|Overall Study|missing treatment disposition pages|2|||
94472346|NCT03034135|323520163|FG000|Overall Study|Withdrawal by Subject|2|||
94472347|NCT02669043|323520164|FG000|Overall Study|Didn't meet I/E criteria|4|||
94472348|NCT01687283|323521405|FG000|Overall Study|Adverse Event|11|||
94472349|NCT01687283|323521406|FG001|Overall Study|Adverse Event|4|||
94472350|NCT01687283|323521405|FG000|Overall Study|Lack of Efficacy|3|||
94472351|NCT01687283|323521406|FG001|Overall Study|Lack of Efficacy|1|||
94472352|NCT01687283|323521405|FG000|Overall Study|Protocol Violation|1|||
94472353|NCT01687283|323521406|FG001|Overall Study|Protocol Violation|3|||
94472354|NCT01687283|323521405|FG000|Overall Study|protocol defined stopping criteria|8|||
94472355|NCT01687283|323521406|FG001|Overall Study|protocol defined stopping criteria|10|||
94472356|NCT01687283|323521405|FG000|Overall Study|Lost to Follow-up|1|||
94472357|NCT01687283|323521406|FG001|Overall Study|Lost to Follow-up|1|||
94472358|NCT01687283|323521405|FG000|Overall Study|Investigator discretion|2|||
94472359|NCT01687283|323521406|FG001|Overall Study|Investigator discretion|0|||
94472360|NCT01687283|323521405|FG000|Overall Study|Withdrawal by Subject|9|||
94472361|NCT01687283|323521406|FG001|Overall Study|Withdrawal by Subject|8|||
94472362|NCT05437640|323521408|FG000|Washout (1 Week)|Adverse Event|1|||
94472363|NCT05437640|323521409|FG001|Washout (1 Week)|Adverse Event|0|||
94472364|NCT04228965|323521412|FG000|Overall Study|Lost to Follow-up|26|||
94472365|NCT04228965|323521413|FG001|Overall Study|Lost to Follow-up|11|||
94472366|NCT04228965|323521412|FG000|Overall Study|Withdrawal by Subject|18|||
94472367|NCT04228965|323521413|FG001|Overall Study|Withdrawal by Subject|5|||
94472368|NCT01754766|323521415|FG000|Overall Study|Personal reasons|1|||
94472369|NCT01754766|323521416|FG001|Overall Study|Personal reasons|1|||
94472370|NCT01754766|323521417|FG002|Overall Study|Personal reasons|0|||
94472371|NCT00314808|323521418|FG000|Overall Study|Disease Progression without AE|4|||
94472372|NCT00314808|323521418|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
94472373|NCT02187029|323521419|FG000|Overall Study|Adverse Event|0|||
94472374|NCT02187029|323521420|FG001|Overall Study|Adverse Event|1|||
94472375|NCT02187029|323521421|FG002|Overall Study|Adverse Event|1|||
94472376|NCT02187029|323521422|FG003|Overall Study|Adverse Event|0|||
94472377|NCT02187029|323521419|FG000|Overall Study|Study Terminated by Sponsor|0|||
94472378|NCT02187029|323521420|FG001|Overall Study|Study Terminated by Sponsor|0|||
94472379|NCT02187029|323521421|FG002|Overall Study|Study Terminated by Sponsor|10|||
94472380|NCT02187029|323521422|FG003|Overall Study|Study Terminated by Sponsor|3|||
94472381|NCT02187029|323521419|FG000|Overall Study|Withdrawal by Subject|1|||
94472382|NCT02187029|323521420|FG001|Overall Study|Withdrawal by Subject|0|||
94472383|NCT02187029|323521421|FG002|Overall Study|Withdrawal by Subject|0|||
94472384|NCT02187029|323521422|FG003|Overall Study|Withdrawal by Subject|0|||
94472385|NCT04105842|323521423|FG000|Overall Study|Withdrawal by Subject|2|||
94472386|NCT05161481|323521425|FG000|Overall Study|Withdrawal of consent|0|||
94472387|NCT05161481|323521426|FG001|Overall Study|Withdrawal of consent|1|||
94472388|NCT05161481|323521427|FG002|Overall Study|Withdrawal of consent|1|||
94472389|NCT05161481|323521425|FG000|Overall Study|Study terminated by sponsor|3|||
94472390|NCT05161481|323521426|FG001|Overall Study|Study terminated by sponsor|3|||
94472391|NCT05161481|323521427|FG002|Overall Study|Study terminated by sponsor|2|||
94472392|NCT05161481|323521425|FG000|Overall Study|Adverse Event|3|||
94472393|NCT05161481|323521426|FG001|Overall Study|Adverse Event|0|||
94472394|NCT05161481|323521427|FG002|Overall Study|Adverse Event|6|||
94472395|NCT05161481|323521425|FG000|Overall Study|Randomised in error and was not treated|1|||
94472396|NCT05161481|323521426|FG001|Overall Study|Randomised in error and was not treated|0|||
94472397|NCT05161481|323521427|FG002|Overall Study|Randomised in error and was not treated|0|||
94472398|NCT05161481|323521425|FG000|Overall Study|Subject decision|0|||
94472399|NCT05161481|323521426|FG001|Overall Study|Subject decision|0|||
94472400|NCT05161481|323521427|FG002|Overall Study|Subject decision|1|||
94472401|NCT03739710|323521428|FG000|Overall Study|Screen Failed|81|||
94472402|NCT01753115|323521429|FG000|Overall Study|Lost to Follow-up|3|||
94472403|NCT01753115|323521430|FG001|Overall Study|Lost to Follow-up|6|||
94472404|NCT01753115|323521431|FG002|Overall Study|Lost to Follow-up|8|||
94472405|NCT01753115|323521429|FG000|Overall Study|Withdrawal by Subject|6|||
94472406|NCT01753115|323521430|FG001|Overall Study|Withdrawal by Subject|5|||
94472407|NCT01753115|323521431|FG002|Overall Study|Withdrawal by Subject|6|||
94472408|NCT01753115|323521429|FG000|Overall Study|Subject non-compliant|3|||
94472409|NCT01753115|323521430|FG001|Overall Study|Subject non-compliant|3|||
94472410|NCT01753115|323521431|FG002|Overall Study|Subject non-compliant|0|||
94472411|NCT01753115|323521429|FG000|Overall Study|Used excluded drug|0|||
94472412|NCT01753115|323521430|FG001|Overall Study|Used excluded drug|1|||
94472413|NCT01753115|323521431|FG002|Overall Study|Used excluded drug|0|||
94472414|NCT01716520|323521435|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
94472415|NCT01716520|323521436|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
94472416|NCT01716520|323521437|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
94472417|NCT01716520|323521438|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
94472418|NCT01716520|323521439|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
94472419|NCT01716520|323521440|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
94472420|NCT01716520|323521435|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
94472421|NCT01716520|323521436|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
94472422|NCT01716520|323521437|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
94472423|NCT01716520|323521438|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
94472424|NCT01716520|323521439|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
94472425|NCT01716520|323521440|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
94472426|NCT01716520|323521435|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
94472427|NCT01716520|323521436|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
94472428|NCT01716520|323521437|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
94472429|NCT01716520|323521438|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
94472430|NCT01716520|323521439|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
94472431|NCT01716520|323521440|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
94472432|NCT01716520|323521435|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
94472433|NCT01716520|323521436|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
94472434|NCT01716520|323521437|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
94472435|NCT01716520|323521438|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
94472436|NCT01716520|323521439|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
94472437|NCT01716520|323521440|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
94472438|NCT01716520|323521435|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
94309968|NCT04045613|322918906|FG000|Overall Study|Progressive disease: Radiological progression|24|||
94309969|NCT04045613|322918907|FG001|Overall Study|Progressive disease: Radiological progression|6|||
94309970|NCT04045613|322918908|FG002|Overall Study|Progressive disease: Radiological progression|8|||
94309971|NCT04045613|322918909|FG003|Overall Study|Progressive disease: Radiological progression|0|||
94309972|NCT04045613|322918910|FG004|Overall Study|Progressive disease: Radiological progression|6|||
94472439|NCT01716520|323521436|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
94472440|NCT01716520|323521437|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
94472441|NCT01716520|323521438|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
94472442|NCT01716520|323521439|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
94472443|NCT01716520|323521440|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
94472444|NCT01716520|323521435|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
94309973|NCT04045613|322918911|FG005|Overall Study|Progressive disease: Radiological progression|6|||
94472445|NCT01716520|323521436|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
94472446|NCT01716520|323521437|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
94472447|NCT01716520|323521438|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
94472448|NCT01716520|323521439|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
94472449|NCT01716520|323521440|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
94472450|NCT01716520|323521435|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
94472451|NCT01716520|323521436|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
94472452|NCT01716520|323521437|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
94472453|NCT01716520|323521438|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
94472454|NCT01716520|323521439|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
94472455|NCT01716520|323521440|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
94472456|NCT01716520|323521435|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
94472457|NCT01716520|323521436|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
94472458|NCT01716520|323521437|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
94472459|NCT01716520|323521438|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
94472460|NCT01716520|323521439|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
94472461|NCT01716520|323521440|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
94472462|NCT01716520|323521435|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
94472463|NCT01716520|323521436|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
94472464|NCT01716520|323521437|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
94472465|NCT01716520|323521438|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
94472466|NCT01716520|323521439|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
94472467|NCT01716520|323521440|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
94472468|NCT01716520|323521435|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
94472469|NCT01716520|323521436|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
94472470|NCT01716520|323521437|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
94472471|NCT01716520|323521438|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
94472472|NCT01716520|323521439|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
94472473|NCT01716520|323521440|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
94472474|NCT01716520|323521435|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
94472475|NCT01716520|323521436|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
94472476|NCT01716520|323521437|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
94472477|NCT01716520|323521438|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
94472478|NCT01716520|323521439|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
94472479|NCT01716520|323521440|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
94472480|NCT01716520|323521435|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
94472481|NCT01716520|323521436|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
94472482|NCT01716520|323521437|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
94472483|NCT01716520|323521438|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
94472484|NCT01716520|323521439|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
94472485|NCT01716520|323521440|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
94472486|NCT01716520|323521435|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
94472487|NCT01716520|323521436|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
94472488|NCT01716520|323521437|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
94472489|NCT01716520|323521438|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
94472490|NCT01716520|323521439|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
94472491|NCT01716520|323521440|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
94472492|NCT01716520|323521435|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
94472493|NCT01716520|323521436|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
94472494|NCT01716520|323521437|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
94472495|NCT01716520|323521438|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
94472496|NCT01716520|323521439|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
94472497|NCT01716520|323521440|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
94472498|NCT01716520|323521435|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
94472499|NCT01716520|323521436|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
94472500|NCT01716520|323521437|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
94472501|NCT01716520|323521438|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
94472502|NCT01716520|323521439|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
94472503|NCT01716520|323521440|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
94472504|NCT00902746|323521441|FG000|Overall Study|Protocol Violation|7|||
94472505|NCT00902746|323521441|FG000|Overall Study|Withdrawal by Subject|16|||
94472506|NCT00902746|323521441|FG000|Overall Study|Adverse Event|8|||
94472507|NCT00902746|323521441|FG000|Overall Study|Lost to Follow-up|3|||
94472508|NCT00902746|323521441|FG000|Overall Study|Physician Decision|2|||
94472509|NCT03624569|323521446|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
94472510|NCT03624569|323521447|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
94472511|NCT03624569|323521446|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
94472512|NCT03624569|323521447|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
94472513|NCT01557517|323521448|FG000|Overall Study|Death|1|||
94472514|NCT01557517|323521449|FG001|Overall Study|Death|0|||
94472515|NCT01557517|323521448|FG000|Overall Study|Refused further treatment|0|||
94472516|NCT01557517|323521449|FG001|Overall Study|Refused further treatment|2|||
94472517|NCT01557517|323521448|FG000|Overall Study|Adverse Event|0|||
94472518|NCT01557517|323521449|FG001|Overall Study|Adverse Event|2|||
94472519|NCT01557517|323521448|FG000|Overall Study|Pt declined before treatment started|1|||
94472520|NCT01557517|323521449|FG001|Overall Study|Pt declined before treatment started|0|||
94472521|NCT00423813|323521454|FG000|Overall Study|Adverse Event|11|||
94472522|NCT00423813|323521455|FG001|Overall Study|Adverse Event|30|||
94472523|NCT00423813|323521456|FG002|Overall Study|Adverse Event|40|||
94472524|NCT00423813|323521454|FG000|Overall Study|Withdrawal by Subject|6|||
94472525|NCT00423813|323521455|FG001|Overall Study|Withdrawal by Subject|8|||
94472526|NCT00423813|323521456|FG002|Overall Study|Withdrawal by Subject|5|||
94472527|NCT00423813|323521454|FG000|Overall Study|Lost to Follow-up|5|||
94472528|NCT00423813|323521455|FG001|Overall Study|Lost to Follow-up|4|||
94472529|NCT00423813|323521456|FG002|Overall Study|Lost to Follow-up|4|||
94472530|NCT00423813|323521454|FG000|Overall Study|Lack of Efficacy|23|||
94472531|NCT00423813|323521455|FG001|Overall Study|Lack of Efficacy|18|||
94472532|NCT00423813|323521456|FG002|Overall Study|Lack of Efficacy|19|||
94472533|NCT00423813|323521454|FG000|Overall Study|Physician Decision|2|||
94472534|NCT00423813|323521455|FG001|Overall Study|Physician Decision|0|||
94472535|NCT00423813|323521456|FG002|Overall Study|Physician Decision|0|||
94472536|NCT00423813|323521454|FG000|Overall Study|Sponsor Decision|0|||
94472537|NCT00423813|323521455|FG001|Overall Study|Sponsor Decision|1|||
94472538|NCT00423813|323521456|FG002|Overall Study|Sponsor Decision|0|||
94472539|NCT00423813|323521454|FG000|Overall Study|Protocol Violation|9|||
94472540|NCT00423813|323521455|FG001|Overall Study|Protocol Violation|4|||
94472541|NCT00423813|323521456|FG002|Overall Study|Protocol Violation|4|||
94472542|NCT00423813|323521454|FG000|Overall Study|Pregnancy|0|||
94472543|NCT00423813|323521455|FG001|Overall Study|Pregnancy|0|||
94472544|NCT00423813|323521456|FG002|Overall Study|Pregnancy|1|||
94472545|NCT00423813|323521454|FG000|Overall Study|Subject started night shift work|1|||
94472546|NCT00423813|323521455|FG001|Overall Study|Subject started night shift work|0|||
94472547|NCT00423813|323521456|FG002|Overall Study|Subject started night shift work|0|||
94472548|NCT00423813|323521454|FG000|Overall Study|Will start exclusionary medications|0|||
94472549|NCT00423813|323521455|FG001|Overall Study|Will start exclusionary medications|1|||
94472550|NCT00423813|323521456|FG002|Overall Study|Will start exclusionary medications|0|||
94472551|NCT00423813|323521454|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
94472552|NCT00423813|323521455|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
94472553|NCT00423813|323521456|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
94472554|NCT02137226|323521462|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
94472555|NCT02137226|323521463|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
94472556|NCT02137226|323521464|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
94472557|NCT02137226|323521465|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
94472558|NCT02137226|323521466|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
94472559|NCT02137226|323521462|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
94472560|NCT02137226|323521463|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
94472561|NCT02137226|323521464|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
94309974|NCT04045613|322918912|FG006|Overall Study|Progressive disease: Radiological progression|11|||
94309975|NCT02732912|322918913|FG000|Overall Study|Discharged before night|2|||
94309976|NCT02732912|322918914|FG001|Overall Study|Discharged before night|6|||
94309977|NCT02732912|322918913|FG000|Overall Study|Incomplete completion of questionnaire|2|||
94309978|NCT02732912|322918914|FG001|Overall Study|Incomplete completion of questionnaire|3|||
94309979|NCT02732912|322918913|FG000|Overall Study|No outcome; discharged or refused|6|||
94309980|NCT02732912|322918914|FG001|Overall Study|No outcome; discharged or refused|9|||
94309981|NCT00450866|322918921|FG000|Overall Study|Adverse Event|0|||
94309982|NCT00450866|322918922|FG001|Overall Study|Adverse Event|1|||
94309983|NCT00450866|322918921|FG000|Overall Study|Withdrawal by Subject|5|||
94309984|NCT00450866|322918922|FG001|Overall Study|Withdrawal by Subject|2|||
94309985|NCT00450866|322918921|FG000|Overall Study|Death|1|||
94309986|NCT00450866|322918922|FG001|Overall Study|Death|0|||
94309987|NCT00450866|322918921|FG000|Overall Study|Physician Decision|1|||
94472562|NCT02137226|323521465|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
94472563|NCT02137226|323521466|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
94472564|NCT02137226|323521462|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
94472565|NCT02137226|323521463|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
94472566|NCT02137226|323521464|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
94472567|NCT02137226|323521465|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
94309988|NCT00450866|322918922|FG001|Overall Study|Physician Decision|0|||
94309989|NCT01022853|322918923|FG000|Overall Study|Progressive disease|2|||
94309990|NCT01022853|322918924|FG001|Overall Study|Progressive disease|3|||
94309991|NCT01022853|322918925|FG002|Overall Study|Progressive disease|11|||
94472568|NCT02137226|323521466|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
94472569|NCT02137226|323521462|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
94472570|NCT02137226|323521463|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
94472571|NCT02137226|323521464|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
94472572|NCT02137226|323521465|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
94472573|NCT02137226|323521466|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
94472574|NCT02137226|323521462|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
94472575|NCT02137226|323521463|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
94472576|NCT02137226|323521464|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
94472577|NCT02137226|323521465|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
94472578|NCT02137226|323521466|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
94472579|NCT02137226|323521462|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
94472580|NCT02137226|323521463|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
94472581|NCT02137226|323521464|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
94472582|NCT02137226|323521465|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
94472583|NCT02137226|323521466|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
94472584|NCT02137226|323521462|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
94472585|NCT02137226|323521463|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
94472586|NCT02137226|323521464|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
94472587|NCT02137226|323521465|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
94472588|NCT02137226|323521466|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
94472589|NCT02137226|323521462|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
94472590|NCT02137226|323521463|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
94472591|NCT02137226|323521464|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
94472592|NCT02137226|323521465|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
94472593|NCT02137226|323521466|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
94472594|NCT02137226|323521462|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
94472595|NCT02137226|323521463|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
94472596|NCT02137226|323521464|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
94472597|NCT02137226|323521465|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
94472598|NCT02137226|323521466|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
94472599|NCT02137226|323521462|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
94472600|NCT02137226|323521463|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
94472601|NCT02137226|323521464|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
94472602|NCT02137226|323521465|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
94472603|NCT02137226|323521466|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
94472604|NCT02137226|323521462|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
94472605|NCT02137226|323521463|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
94472606|NCT02137226|323521464|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
94472607|NCT02137226|323521465|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
94472608|NCT02137226|323521466|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
94472609|NCT02137226|323521462|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
94472610|NCT02137226|323521463|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
94472611|NCT02137226|323521464|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
94472612|NCT02137226|323521465|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
94472613|NCT02137226|323521466|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
94472614|NCT03762681|323521467|FG000|Part 1|Withdrawal by Subject|0|||
94472615|NCT03762681|323521468|FG001|Part 1|Withdrawal by Subject|0|||
94472616|NCT03762681|323521469|FG002|Part 1|Withdrawal by Subject|0|||
94472617|NCT03762681|323521470|FG003|Part 1|Withdrawal by Subject|1|||
94472618|NCT03762681|323521471|FG004|Part 1|Withdrawal by Subject|0|||
94472619|NCT03762681|323521472|FG005|Part 1|Withdrawal by Subject|0|||
94472620|NCT03762681|323521473|FG006|Part 1|Withdrawal by Subject|0|||
94472621|NCT03762681|323521474|FG007|Part 1|Withdrawal by Subject|0|||
94472622|NCT03762681|323521467|FG000|Part 2a|Pandemic Travel Restrictions|0|||
94472623|NCT03762681|323521468|FG001|Part 2a|Pandemic Travel Restrictions|0|||
94472624|NCT03762681|323521469|FG002|Part 2a|Pandemic Travel Restrictions|0|||
94472625|NCT03762681|323521470|FG003|Part 2a|Pandemic Travel Restrictions|0|||
94472626|NCT03762681|323521471|FG004|Part 2a|Pandemic Travel Restrictions|0|||
94309992|NCT01022853|322918926|FG003|Overall Study|Progressive disease|7|||
94309993|NCT01022853|322918927|FG004|Overall Study|Progressive disease|1|||
94309994|NCT01022853|322918923|FG000|Overall Study|Dose-limiting toxicity|0|||
94309995|NCT01022853|322918924|FG001|Overall Study|Dose-limiting toxicity|0|||
94472627|NCT03762681|323521472|FG005|Part 2a|Pandemic Travel Restrictions|0|||
94472628|NCT03762681|323521473|FG006|Part 2a|Pandemic Travel Restrictions|0|||
94309996|NCT01022853|322918925|FG002|Overall Study|Dose-limiting toxicity|0|||
94309997|NCT01022853|322918926|FG003|Overall Study|Dose-limiting toxicity|0|||
94472629|NCT03762681|323521474|FG007|Part 2a|Pandemic Travel Restrictions|1|||
94472630|NCT03333486|323521475|FG000|Overall Study|Withdrawal by Subject|1|||
94472631|NCT03333486|323521475|FG000|Overall Study|Lost to Follow-up|1|||
94472632|NCT01119846|323521476|FG000|Overall Study|Adverse Event|1|||
94472633|NCT01119846|323521477|FG001|Overall Study|Adverse Event|0|||
94472634|NCT01119846|323521478|FG002|Overall Study|Adverse Event|6|||
94472635|NCT01119846|323521476|FG000|Overall Study|Physician Decision|1|||
94472636|NCT01119846|323521477|FG001|Overall Study|Physician Decision|0|||
94472637|NCT01119846|323521478|FG002|Overall Study|Physician Decision|0|||
94472638|NCT01119846|323521476|FG000|Overall Study|Protocol Violation|0|||
94472639|NCT01119846|323521477|FG001|Overall Study|Protocol Violation|0|||
94472640|NCT01119846|323521478|FG002|Overall Study|Protocol Violation|1|||
94472641|NCT01119846|323521476|FG000|Overall Study|Withdrawal by Subject|0|||
94472642|NCT01119846|323521477|FG001|Overall Study|Withdrawal by Subject|0|||
94472643|NCT01119846|323521478|FG002|Overall Study|Withdrawal by Subject|4|||
94472644|NCT03148067|323521479|FG000|Overall Study|Lost to Follow-up|3|||
94472645|NCT03148067|323521479|FG000|Overall Study|Death|1|||
94472646|NCT02819440|323521482|FG000|Overall Study|Adverse Event|3|||
94472647|NCT02819440|323521483|FG001|Overall Study|Adverse Event|1|||
94472648|NCT02819440|323521482|FG000|Overall Study|Lost to Follow-up|1|||
94472649|NCT02819440|323521483|FG001|Overall Study|Lost to Follow-up|3|||
94472650|NCT02819440|323521482|FG000|Overall Study|Withdrawal by Subject|9|||
94472651|NCT02819440|323521483|FG001|Overall Study|Withdrawal by Subject|8|||
94472652|NCT00002525|323521487|FG000|Overall Study|Adverse Event|36|||
94472653|NCT00002525|323521488|FG001|Overall Study|Adverse Event|0|||
94472654|NCT00002525|323521487|FG000|Overall Study|Death|5|||
94472655|NCT00002525|323521488|FG001|Overall Study|Death|0|||
94472656|NCT00002525|323521487|FG000|Overall Study|Withdrawal by Subject|11|||
94472657|NCT00002525|323521488|FG001|Overall Study|Withdrawal by Subject|0|||
94472658|NCT00002525|323521487|FG000|Overall Study|Start non-protocol therapy|1|||
94472659|NCT00002525|323521488|FG001|Overall Study|Start non-protocol therapy|0|||
94472660|NCT00002525|323521487|FG000|Overall Study|Other complicating disease|1|||
94472661|NCT00002525|323521488|FG001|Overall Study|Other complicating disease|0|||
94472662|NCT00002525|323521487|FG000|Overall Study|Duke's A, B1, D disease|92|||
94472663|NCT00002525|323521488|FG001|Overall Study|Duke's A, B1, D disease|0|||
94472664|NCT00002525|323521487|FG000|Overall Study|Error|6|||
94472665|NCT00002525|323521488|FG001|Overall Study|Error|0|||
94472666|NCT00002525|323521487|FG000|Overall Study|Other|26|||
94472667|NCT00002525|323521488|FG001|Overall Study|Other|0|||
94472668|NCT00002525|323521487|FG000|Overall Study|Never start protocol therapy|8|||
94472669|NCT00002525|323521488|FG001|Overall Study|Never start protocol therapy|0|||
94472670|NCT00435188|323521491|FG000|Overall Study|Death|1|||
94472671|NCT00435188|323521492|FG001|Overall Study|Death|6|||
94472672|NCT00435188|323521491|FG000|Overall Study|Withdrawal by Subject|16|||
94472673|NCT00435188|323521492|FG001|Overall Study|Withdrawal by Subject|11|||
94472674|NCT00435188|323521491|FG000|Overall Study|Lost to Follow-up|5|||
94309998|NCT01022853|322918927|FG004|Overall Study|Dose-limiting toxicity|1|||
94309999|NCT01022853|322918923|FG000|Overall Study|Withdrawal by Subject|0|||
94310000|NCT01022853|322918924|FG001|Overall Study|Withdrawal by Subject|1|||
94310001|NCT01022853|322918925|FG002|Overall Study|Withdrawal by Subject|1|||
94310002|NCT01022853|322918926|FG003|Overall Study|Withdrawal by Subject|1|||
94310003|NCT01022853|322918927|FG004|Overall Study|Withdrawal by Subject|0|||
94310004|NCT01022853|322918923|FG000|Overall Study|Other not stated above|1|||
94310005|NCT01022853|322918924|FG001|Overall Study|Other not stated above|0|||
94310006|NCT01022853|322918925|FG002|Overall Study|Other not stated above|1|||
94310007|NCT01022853|322918926|FG003|Overall Study|Other not stated above|0|||
94310008|NCT01022853|322918927|FG004|Overall Study|Other not stated above|0|||
94310009|NCT01971476|322918928|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
94310010|NCT01971476|322918929|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
94310011|NCT01971476|322918930|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
94310012|NCT01971476|322918928|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
94310013|NCT01971476|322918929|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
94381034|NCT01860976|323181116|FG000|Long Term Extension|Lack of Efficacy|2|||
94381035|NCT01860976|323181117|FG001|Long Term Extension|Lack of Efficacy|0|||
94381036|NCT01860976|323181116|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
94381037|NCT01860976|323181117|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
94381038|NCT01860976|323181116|FG000|Long Term Extension|Lost to Follow-up|2|||
94381039|NCT01860976|323181117|FG001|Long Term Extension|Lost to Follow-up|0|||
94381040|NCT01860976|323181116|FG000|Long Term Extension|subject withdrew consent|7|||
94381041|NCT01860976|323181117|FG001|Long Term Extension|subject withdrew consent|0|||
94472675|NCT00435188|323521492|FG001|Overall Study|Lost to Follow-up|6|||
94472676|NCT01146561|323521493|FG000|Overall Study|Withdrawal by Subject|1|||
94472677|NCT01146561|323521493|FG000|Overall Study|Lost to Follow-up|1|||
94472678|NCT00396383|323521494|FG000|Overall Study|Death|2|||
94310014|NCT01971476|322918930|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
94381042|NCT00755326|323181118|FG000|Overall Study|Lost to Follow-up|2|||
94381043|NCT00755326|323181119|FG001|Overall Study|Lost to Follow-up|3|||
94472679|NCT00396383|323521494|FG000|Overall Study|Lost to Follow-up|1|||
94472680|NCT00048165|323521495|FG000|Completed 6 Months Study|Administration/Other|8|||
94472681|NCT00048165|323521496|FG001|Completed 6 Months Study|Administration/Other|8|||
94472682|NCT00048165|323521495|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
94472683|NCT00048165|323521496|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
94472684|NCT00048165|323521495|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
94472685|NCT00048165|323521496|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
94472686|NCT00048165|323521495|FG000|Completed 6 Months Study|Death|12|||
94472687|NCT00048165|323521496|FG001|Completed 6 Months Study|Death|6|||
94472688|NCT00048165|323521495|FG000|Completed 6 Months Study|Insufficient therapy|1|||
94472689|NCT00048165|323521496|FG001|Completed 6 Months Study|Insufficient therapy|4|||
94472690|NCT00048165|323521495|FG000|Completed 6 Months Study|Other violation|4|||
94472691|NCT00048165|323521496|FG001|Completed 6 Months Study|Other violation|6|||
94472692|NCT00048165|323521495|FG000|Completed 6 Months Study|Refused treatment|5|||
94472693|NCT00048165|323521496|FG001|Completed 6 Months Study|Refused treatment|5|||
94472694|NCT00048165|323521495|FG000|Completed 6 Months Study|Violation criteria|0|||
94472695|NCT00048165|323521496|FG001|Completed 6 Months Study|Violation criteria|2|||
94472696|NCT00048165|323521495|FG000|Completed 6 Months Study|Did not receive study drug|6|||
94310015|NCT01971476|322918928|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
94310016|NCT01971476|322918929|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
94310017|NCT01971476|322918930|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
94310018|NCT02795767|322918935|FG000|Overall Study|Received Commercial Emicizumab|1|||
94310019|NCT02795767|322918936|FG001|Overall Study|Received Commercial Emicizumab|0|||
94310020|NCT02795767|322918937|FG002|Overall Study|Received Commercial Emicizumab|0|||
94310021|NCT03662334|322918938|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
94310022|NCT03662334|322918939|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
94310023|NCT01302769|322918940|FG000|Overall Study|Lost to Follow-up|1|||
94310024|NCT01302769|322918941|FG001|Overall Study|Lost to Follow-up|1|||
94310025|NCT01097330|322918952|FG000|Overall Study|Study terminated early|7|||
94310026|NCT01097330|322918953|FG001|Overall Study|Study terminated early|5|||
94310027|NCT02619253|322918954|FG000|Overall Study|Adverse Event|0|||
94310028|NCT02619253|322918955|FG001|Overall Study|Adverse Event|0|||
94310029|NCT02619253|322918956|FG002|Overall Study|Adverse Event|1|||
94310030|NCT02619253|322918957|FG003|Overall Study|Adverse Event|1|||
94310031|NCT02619253|322918958|FG004|Overall Study|Adverse Event|3|||
94310032|NCT02619253|322918954|FG000|Overall Study|Alternative Therapy|0|||
94310033|NCT02619253|322918955|FG001|Overall Study|Alternative Therapy|0|||
94310034|NCT02619253|322918956|FG002|Overall Study|Alternative Therapy|1|||
94310035|NCT02619253|322918957|FG003|Overall Study|Alternative Therapy|0|||
94310036|NCT02619253|322918958|FG004|Overall Study|Alternative Therapy|0|||
94310037|NCT02619253|322918954|FG000|Overall Study|Death|0|||
94310038|NCT02619253|322918955|FG001|Overall Study|Death|0|||
94310039|NCT02619253|322918956|FG002|Overall Study|Death|0|||
94310040|NCT02619253|322918957|FG003|Overall Study|Death|1|||
94310041|NCT02619253|322918958|FG004|Overall Study|Death|0|||
94310042|NCT02619253|322918954|FG000|Overall Study|Disease Progression|4|||
94310043|NCT02619253|322918955|FG001|Overall Study|Disease Progression|2|||
94310044|NCT02619253|322918956|FG002|Overall Study|Disease Progression|8|||
94310045|NCT02619253|322918957|FG003|Overall Study|Disease Progression|9|||
94310046|NCT02619253|322918958|FG004|Overall Study|Disease Progression|10|||
94310047|NCT02619253|322918954|FG000|Overall Study|Needed a disqualifying therapy|0|||
94310048|NCT02619253|322918955|FG001|Overall Study|Needed a disqualifying therapy|0|||
94310049|NCT02619253|322918956|FG002|Overall Study|Needed a disqualifying therapy|1|||
94310050|NCT02619253|322918957|FG003|Overall Study|Needed a disqualifying therapy|0|||
94310051|NCT02619253|322918958|FG004|Overall Study|Needed a disqualifying therapy|0|||
94310052|NCT02619253|322918954|FG000|Overall Study|Transferred to hospice|0|||
94310053|NCT02619253|322918955|FG001|Overall Study|Transferred to hospice|0|||
94310054|NCT02619253|322918956|FG002|Overall Study|Transferred to hospice|1|||
94310055|NCT02619253|322918957|FG003|Overall Study|Transferred to hospice|0|||
94310056|NCT02619253|322918958|FG004|Overall Study|Transferred to hospice|0|||
94310057|NCT02619253|322918954|FG000|Overall Study|Physician Decision|0|||
94310058|NCT02619253|322918955|FG001|Overall Study|Physician Decision|1|||
94310059|NCT02619253|322918956|FG002|Overall Study|Physician Decision|2|||
94310060|NCT02619253|322918957|FG003|Overall Study|Physician Decision|3|||
94310061|NCT02619253|322918958|FG004|Overall Study|Physician Decision|0|||
94310062|NCT02619253|322918954|FG000|Overall Study|Withdrawal by Subject|0|||
94310063|NCT02619253|322918955|FG001|Overall Study|Withdrawal by Subject|1|||
94310064|NCT02619253|322918956|FG002|Overall Study|Withdrawal by Subject|0|||
94310065|NCT02619253|322918957|FG003|Overall Study|Withdrawal by Subject|0|||
94310066|NCT02619253|322918958|FG004|Overall Study|Withdrawal by Subject|2|||
94310067|NCT00149825|322918960|FG000|Overall Study|Intolerance to medication side effects|1|||
94310068|NCT00149825|322918961|FG001|Overall Study|Intolerance to medication side effects|2|||
94310069|NCT00149825|322918960|FG000|Overall Study|Time commitments|2|||
94310070|NCT00149825|322918961|FG001|Overall Study|Time commitments|1|||
94310071|NCT00149825|322918960|FG000|Overall Study|Not liking insomnia therapy|1|||
94310072|NCT00149825|322918961|FG001|Overall Study|Not liking insomnia therapy|0|||
94310073|NCT00149825|322918960|FG000|Overall Study|Other|1|||
94310074|NCT00149825|322918961|FG001|Overall Study|Other|0|||
94310075|NCT03303339|322918962|FG000|Overall Study|Death|2|||
94310076|NCT03303339|322918963|FG001|Overall Study|Death|2|||
94381044|NCT02354586|323181121|FG000|Overall Study|Death|230|||
94381045|NCT02354586|323181121|FG000|Overall Study|Withdrawal by Subject|59|||
94310077|NCT03303339|322918964|FG002|Overall Study|Death|2|||
94310078|NCT03303339|322918965|FG003|Overall Study|Death|1|||
94310079|NCT03303339|322918966|FG004|Overall Study|Death|4|||
94310080|NCT03303339|322918967|FG005|Overall Study|Death|2|||
94310081|NCT03303339|322918968|FG006|Overall Study|Death|2|||
94310082|NCT03303339|322918969|FG007|Overall Study|Death|2|||
94310083|NCT03303339|322918970|FG008|Overall Study|Death|3|||
94310084|NCT03303339|322918971|FG009|Overall Study|Death|3|||
94310085|NCT03303339|322918972|FG010|Overall Study|Death|4|||
94310086|NCT03303339|322918973|FG011|Overall Study|Death|24|||
94310087|NCT03303339|322918962|FG000|Overall Study|Study Terminated by Sponsor|0|||
94310088|NCT03303339|322918963|FG001|Overall Study|Study Terminated by Sponsor|0|||
94310089|NCT03303339|322918964|FG002|Overall Study|Study Terminated by Sponsor|0|||
94310090|NCT03303339|322918965|FG003|Overall Study|Study Terminated by Sponsor|0|||
94310091|NCT03303339|322918966|FG004|Overall Study|Study Terminated by Sponsor|0|||
94310092|NCT03303339|322918967|FG005|Overall Study|Study Terminated by Sponsor|0|||
94310093|NCT03303339|322918968|FG006|Overall Study|Study Terminated by Sponsor|0|||
94310094|NCT03303339|322918969|FG007|Overall Study|Study Terminated by Sponsor|0|||
94310095|NCT03303339|322918970|FG008|Overall Study|Study Terminated by Sponsor|1|||
94310096|NCT03303339|322918971|FG009|Overall Study|Study Terminated by Sponsor|0|||
94310097|NCT03303339|322918972|FG010|Overall Study|Study Terminated by Sponsor|1|||
94310098|NCT03303339|322918973|FG011|Overall Study|Study Terminated by Sponsor|1|||
94310099|NCT03303339|322918962|FG000|Overall Study|Withdrawal by Subject|1|||
94310100|NCT03303339|322918963|FG001|Overall Study|Withdrawal by Subject|0|||
94310101|NCT03303339|322918964|FG002|Overall Study|Withdrawal by Subject|0|||
94310102|NCT03303339|322918965|FG003|Overall Study|Withdrawal by Subject|0|||
94310103|NCT03303339|322918966|FG004|Overall Study|Withdrawal by Subject|0|||
94310104|NCT03303339|322918967|FG005|Overall Study|Withdrawal by Subject|1|||
94310105|NCT03303339|322918968|FG006|Overall Study|Withdrawal by Subject|1|||
94310106|NCT03303339|322918969|FG007|Overall Study|Withdrawal by Subject|0|||
94310107|NCT03303339|322918970|FG008|Overall Study|Withdrawal by Subject|0|||
94310108|NCT03303339|322918971|FG009|Overall Study|Withdrawal by Subject|0|||
94310109|NCT03303339|322918972|FG010|Overall Study|Withdrawal by Subject|0|||
94310110|NCT03303339|322918973|FG011|Overall Study|Withdrawal by Subject|2|||
94310111|NCT03303339|322918962|FG000|Overall Study|Physician Decision|0|||
94310112|NCT03303339|322918963|FG001|Overall Study|Physician Decision|0|||
94310113|NCT03303339|322918964|FG002|Overall Study|Physician Decision|0|||
94310114|NCT03303339|322918965|FG003|Overall Study|Physician Decision|0|||
94310115|NCT03303339|322918966|FG004|Overall Study|Physician Decision|1|||
94310116|NCT03303339|322918967|FG005|Overall Study|Physician Decision|0|||
94310117|NCT03303339|322918968|FG006|Overall Study|Physician Decision|0|||
94310118|NCT03303339|322918969|FG007|Overall Study|Physician Decision|0|||
94310119|NCT03303339|322918970|FG008|Overall Study|Physician Decision|0|||
94310120|NCT03303339|322918971|FG009|Overall Study|Physician Decision|0|||
94310121|NCT03303339|322918972|FG010|Overall Study|Physician Decision|0|||
94310122|NCT03303339|322918973|FG011|Overall Study|Physician Decision|0|||
94310123|NCT03303339|322918962|FG000|Overall Study|Safety/Non-compliance|0|||
94310124|NCT03303339|322918963|FG001|Overall Study|Safety/Non-compliance|0|||
94310125|NCT03303339|322918964|FG002|Overall Study|Safety/Non-compliance|0|||
94310126|NCT03303339|322918965|FG003|Overall Study|Safety/Non-compliance|0|||
94310127|NCT03303339|322918966|FG004|Overall Study|Safety/Non-compliance|0|||
94310128|NCT03303339|322918967|FG005|Overall Study|Safety/Non-compliance|0|||
94310129|NCT03303339|322918968|FG006|Overall Study|Safety/Non-compliance|0|||
94310130|NCT03303339|322918969|FG007|Overall Study|Safety/Non-compliance|0|||
94310131|NCT03303339|322918970|FG008|Overall Study|Safety/Non-compliance|0|||
94310132|NCT03303339|322918971|FG009|Overall Study|Safety/Non-compliance|0|||
94310133|NCT03303339|322918972|FG010|Overall Study|Safety/Non-compliance|0|||
94310134|NCT03303339|322918973|FG011|Overall Study|Safety/Non-compliance|1|||
94310135|NCT01359982|322918974|FG000|Overall Study|Adverse Event|2|||
94310136|NCT01359982|322918975|FG001|Overall Study|Adverse Event|0|||
94310137|NCT01359982|322918976|FG002|Overall Study|Adverse Event|0|||
94310138|NCT01359982|322918977|FG003|Overall Study|Adverse Event|1|||
94310139|NCT01359982|322918978|FG004|Overall Study|Adverse Event|0|||
94310140|NCT01359982|322918979|FG005|Overall Study|Adverse Event|0|||
94310141|NCT01359982|322918974|FG000|Overall Study|Death|1|||
94310142|NCT01359982|322918975|FG001|Overall Study|Death|0|||
94310143|NCT01359982|322918976|FG002|Overall Study|Death|0|||
94310144|NCT01359982|322918977|FG003|Overall Study|Death|0|||
94381046|NCT02354586|323181121|FG000|Overall Study|Lost to Follow-up|11|||
94381047|NCT02354586|323181121|FG000|Overall Study|Sponsor decision|51|||
94310145|NCT01359982|322918978|FG004|Overall Study|Death|0|||
94310146|NCT01359982|322918979|FG005|Overall Study|Death|0|||
94310147|NCT04156646|322918980|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
94310148|NCT04156646|322918981|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
94381048|NCT02354586|323181121|FG000|Overall Study|Site closure|2|||
94310149|NCT02179398|322918988|FG000|Overall Study|Lack of obligatory data|3|||
94310150|NCT02179398|322918989|FG001|Overall Study|Lack of obligatory data|3|||
94472697|NCT00048165|323521496|FG001|Completed 6 Months Study|Did not receive study drug|6|||
94472698|NCT00048165|323521495|FG000|Completed 12 Months Study|Administration/Other|0|||
94472699|NCT00048165|323521496|FG001|Completed 12 Months Study|Administration/Other|2|||
94472700|NCT00048165|323521495|FG000|Completed 12 Months Study|Death|2|||
94472701|NCT00048165|323521496|FG001|Completed 12 Months Study|Death|1|||
94472702|NCT00048165|323521495|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
94472703|NCT00048165|323521496|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
94472704|NCT04318132|323521501|FG000|Overall Study|Protocol Violation|0|||
94472705|NCT04318132|323521502|FG001|Overall Study|Protocol Violation|0|||
94472706|NCT04318132|323521503|FG002|Overall Study|Protocol Violation|3|||
94472707|NCT04318132|323521504|FG003|Overall Study|Protocol Violation|0|||
94472708|NCT00282152|323521505|FG000|Overall Study|Withdrawal by Subject|1|||
94472709|NCT00282152|323521506|FG001|Overall Study|Withdrawal by Subject|0|||
94472710|NCT00585325|323521507|FG000|Overall Study|Withdrawal by Subject|1|||
94472711|NCT00585325|323521508|FG001|Overall Study|Withdrawal by Subject|1|||
94472712|NCT03301831|323521509|FG000|Overall Study|Lost to Follow-up|5|||
94472713|NCT03301831|323521510|FG001|Overall Study|Lost to Follow-up|3|||
94472714|NCT03301831|323521509|FG000|Overall Study|Protocol Violation|4|||
94472715|NCT03301831|323521510|FG001|Overall Study|Protocol Violation|0|||
94472716|NCT03301831|323521509|FG000|Overall Study|Withdrawal by Subject|11|||
94472717|NCT03301831|323521510|FG001|Overall Study|Withdrawal by Subject|0|||
94472718|NCT04424914|323521511|FG000|Overall Study|Other|0|||
94472719|NCT04424914|323521512|FG001|Overall Study|Other|0|||
94472720|NCT04424914|323521513|FG002|Overall Study|Other|28|||
94472721|NCT04424914|323521511|FG000|Overall Study|Withdrawal by Subject|3|||
94472722|NCT04424914|323521512|FG001|Overall Study|Withdrawal by Subject|0|||
94472723|NCT04424914|323521513|FG002|Overall Study|Withdrawal by Subject|0|||
94472724|NCT04424914|323521511|FG000|Overall Study|Study terminated by sponsor|23|||
94472725|NCT04424914|323521512|FG001|Overall Study|Study terminated by sponsor|7|||
94472726|NCT04424914|323521513|FG002|Overall Study|Study terminated by sponsor|0|||
94472727|NCT04424914|323521511|FG000|Overall Study|Lost to Follow-up|0|||
94472728|NCT04424914|323521512|FG001|Overall Study|Lost to Follow-up|0|||
94472729|NCT04424914|323521513|FG002|Overall Study|Lost to Follow-up|1|||
94472730|NCT04424914|323521511|FG000|Overall Study|Death|3|||
94472731|NCT04424914|323521512|FG001|Overall Study|Death|1|||
94472732|NCT04424914|323521513|FG002|Overall Study|Death|0|||
94472733|NCT02362425|323523280|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
94472734|NCT02362425|323523281|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
94472735|NCT02362425|323523282|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
94472736|NCT02362425|323523283|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
94472737|NCT02362425|323523280|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
94472738|NCT02362425|323523281|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
94472739|NCT02362425|323523282|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
94472740|NCT02362425|323523283|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
94472741|NCT02362425|323523280|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
94472742|NCT02362425|323523281|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
94472743|NCT02362425|323523282|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
94472744|NCT02362425|323523283|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
94472745|NCT02362425|323523280|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
94472746|NCT02362425|323523281|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
94472747|NCT02362425|323523282|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
94472748|NCT02362425|323523283|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
94472749|NCT02362425|323523280|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
94472750|NCT02362425|323523281|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
94472751|NCT02362425|323523282|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
94472752|NCT02362425|323523283|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
94472753|NCT02362425|323523280|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
94472754|NCT02362425|323523281|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
94472755|NCT02362425|323523282|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
94472756|NCT02362425|323523283|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
94472757|NCT02362425|323523280|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
94472758|NCT02362425|323523281|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
94472759|NCT02362425|323523282|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
94472760|NCT02362425|323523283|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
94472761|NCT02362425|323523280|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
94472762|NCT02362425|323523281|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
94472763|NCT02362425|323523282|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
94472764|NCT02362425|323523283|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
94472765|NCT02688764|323523291|FG000|Overall Study|Adverse Event|3|||
94472766|NCT02688764|323523292|FG001|Overall Study|Adverse Event|3|||
94472767|NCT02688764|323523291|FG000|Overall Study|AE/Kidney transplant|1|||
94472768|NCT02688764|323523292|FG001|Overall Study|AE/Kidney transplant|0|||
94472769|NCT02688764|323523291|FG000|Overall Study|AE/Lack of efficacy|1|||
94472770|NCT02688764|323523292|FG001|Overall Study|AE/Lack of efficacy|0|||
94472771|NCT02688764|323523291|FG000|Overall Study|AE/Non-compl.|1|||
94472772|NCT02688764|323523292|FG001|Overall Study|AE/Non-compl.|0|||
94472773|NCT02688764|323523291|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
94472774|NCT02688764|323523292|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
94472775|NCT02688764|323523291|FG000|Overall Study|AE/Other|0|||
94472776|NCT02688764|323523292|FG001|Overall Study|AE/Other|1|||
94472777|NCT02688764|323523291|FG000|Overall Study|AE/Physician decision|1|||
94472778|NCT02688764|323523292|FG001|Overall Study|AE/Physician decision|0|||
94472779|NCT02688764|323523291|FG000|Overall Study|AE/Withd. parent|3|||
94472780|NCT02688764|323523292|FG001|Overall Study|AE/Withd. parent|0|||
94472781|NCT02688764|323523291|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
94472782|NCT02688764|323523292|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
94472783|NCT02688764|323523291|FG000|Overall Study|AE/Withd. subject|1|||
94472784|NCT02688764|323523292|FG001|Overall Study|AE/Withd. subject|0|||
94472785|NCT02688764|323523291|FG000|Overall Study|Kidney transplant|10|||
94472786|NCT02688764|323523292|FG001|Overall Study|Kidney transplant|4|||
94472787|NCT02688764|323523291|FG000|Overall Study|Lack of Efficacy|3|||
94472788|NCT02688764|323523292|FG001|Overall Study|Lack of Efficacy|2|||
94472789|NCT02688764|323523291|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
94472790|NCT02688764|323523292|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
94472791|NCT02688764|323523291|FG000|Overall Study|Non-compliance with study drug|4|||
94472792|NCT02688764|323523292|FG001|Overall Study|Non-compliance with study drug|0|||
94472793|NCT02688764|323523291|FG000|Overall Study|Non-compl./Physician decision|2|||
94472794|NCT02688764|323523292|FG001|Overall Study|Non-compl./Physician decision|0|||
94472795|NCT02688764|323523291|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
94472796|NCT02688764|323523292|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
94472797|NCT02688764|323523291|FG000|Overall Study|Non-compl./Withd. subject|0|||
94472798|NCT02688764|323523292|FG001|Overall Study|Non-compl./Withd. subject|2|||
94472799|NCT02688764|323523291|FG000|Overall Study|Phosphorus level outside safe range|0|||
94472800|NCT02688764|323523292|FG001|Overall Study|Phosphorus level outside safe range|1|||
94472801|NCT02688764|323523291|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
94472802|NCT02688764|323523292|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
94472803|NCT02688764|323523291|FG000|Overall Study|Study drug taste/Withd. parent|1|||
94472804|NCT02688764|323523292|FG001|Overall Study|Study drug taste/Withd. parent|0|||
94472805|NCT02688764|323523291|FG000|Overall Study|Subject moving out|2|||
94472806|NCT02688764|323523292|FG001|Overall Study|Subject moving out|0|||
94472807|NCT02688764|323523291|FG000|Overall Study|Subject taken off dialysis|1|||
94472808|NCT02688764|323523292|FG001|Overall Study|Subject taken off dialysis|0|||
94472809|NCT02688764|323523291|FG000|Overall Study|Withdrawal by parent|3|||
94472810|NCT02688764|323523292|FG001|Overall Study|Withdrawal by parent|0|||
94472811|NCT00885378|323523293|FG000|Overall Study|Lack of Efficacy|2|||
94472812|NCT00885378|323523294|FG001|Overall Study|Lack of Efficacy|2|||
94472813|NCT00885378|323523293|FG000|Overall Study|Withdrawal by Subject|1|||
94472814|NCT00885378|323523294|FG001|Overall Study|Withdrawal by Subject|2|||
94472815|NCT00885378|323523293|FG000|Overall Study|Lost to Follow-up|1|||
94472816|NCT00885378|323523294|FG001|Overall Study|Lost to Follow-up|2|||
94472817|NCT00885378|323523293|FG000|Overall Study|Poor/Noncompliance|2|||
94472818|NCT00885378|323523294|FG001|Overall Study|Poor/Noncompliance|2|||
94472819|NCT00885378|323523293|FG000|Overall Study|Protocol Violation|2|||
94472820|NCT00885378|323523294|FG001|Overall Study|Protocol Violation|0|||
94472821|NCT02190721|323523295|FG000|Overall Study|Patient was out of the city|0|||
94472822|NCT02190721|323523296|FG001|Overall Study|Patient was out of the city|1|||
94472823|NCT02190721|323523297|FG002|Overall Study|Patient was out of the city|0|||
94472824|NCT04676152|323523298|FG000|Overall Study|screen fail|9|||
94472825|NCT01306214|323523299|FG000|Overall Study|Death|0|||
94472826|NCT01306214|323523300|FG001|Overall Study|Death|0|||
94472827|NCT01306214|323523301|FG002|Overall Study|Death|1|||
94472828|NCT01306214|323523299|FG000|Overall Study|Lost to Follow-up|3|||
94472829|NCT01306214|323523300|FG001|Overall Study|Lost to Follow-up|5|||
94472830|NCT01306214|323523301|FG002|Overall Study|Lost to Follow-up|4|||
94472831|NCT01306214|323523299|FG000|Overall Study|Withdrawal by Subject|24|||
94472832|NCT01306214|323523300|FG001|Overall Study|Withdrawal by Subject|22|||
94472833|NCT01306214|323523301|FG002|Overall Study|Withdrawal by Subject|16|||
94472834|NCT01306214|323523299|FG000|Overall Study|Not treated|1|||
94472835|NCT01306214|323523300|FG001|Overall Study|Not treated|1|||
94472836|NCT01306214|323523301|FG002|Overall Study|Not treated|1|||
94472837|NCT04076319|323523302|FG000|Overall Study|Withdrawal by Subject|2|||
94472838|NCT04076319|323523303|FG001|Overall Study|Withdrawal by Subject|0|||
94472839|NCT04076319|323523302|FG000|Overall Study|Death|1|||
94472840|NCT04076319|323523303|FG001|Overall Study|Death|0|||
94472841|NCT01148459|323523311|FG000|Overall Study|Serious Adverse Event|5|||
94472842|NCT01148459|323523312|FG001|Overall Study|Serious Adverse Event|4|||
94472843|NCT01148459|323523311|FG000|Overall Study|Withdrawal by Subject|1|||
94472844|NCT01148459|323523312|FG001|Overall Study|Withdrawal by Subject|0|||
94472845|NCT01148459|323523311|FG000|Overall Study|Migrated/moved from study area|3|||
94472846|NCT01148459|323523312|FG001|Overall Study|Migrated/moved from study area|6|||
94472847|NCT01148459|323523311|FG000|Overall Study|Lost to Follow-up|2|||
94472848|NCT01148459|323523312|FG001|Overall Study|Lost to Follow-up|0|||
94472849|NCT01148459|323523311|FG000|Overall Study|Refusal|1|||
94472850|NCT01148459|323523312|FG001|Overall Study|Refusal|0|||
94472851|NCT01148459|323523311|FG000|Overall Study|Failure to comply with study procedures|0|||
94472852|NCT01148459|323523312|FG001|Overall Study|Failure to comply with study procedures|1|||
94472853|NCT01066663|323523320|FG000|Overall Study|Adverse Event|0|||
94472854|NCT01066663|323523321|FG001|Overall Study|Adverse Event|0|||
94472855|NCT01066663|323523322|FG002|Overall Study|Adverse Event|1|||
94472856|NCT02985021|323523323|FG000|Overall Study|Inability to comply with study procedures|1|||
94472857|NCT01491841|323523324|FG000|Overall Study|Screen Failure|10|||
94472858|NCT01491841|323523324|FG000|Overall Study|Withdrawal by Subject|1|||
94472859|NCT03374488|323523325|FG000|Overall Study|Death|13|||
94472860|NCT03374488|323523326|FG001|Overall Study|Death|13|||
94472861|NCT03374488|323523325|FG000|Overall Study|Withdrawal by Subject|3|||
94472862|NCT03374488|323523326|FG001|Overall Study|Withdrawal by Subject|1|||
94472863|NCT03374488|323523325|FG000|Overall Study|Physician Decision|3|||
94472864|NCT03374488|323523326|FG001|Overall Study|Physician Decision|0|||
94472865|NCT00339833|323523327|FG000|Overall Study|Withdrawal by Subject|1|||
94472866|NCT00339833|323523328|FG001|Overall Study|Withdrawal by Subject|2|||
94472867|NCT00339833|323523327|FG000|Overall Study|toothache|0|||
94472868|NCT00339833|323523328|FG001|Overall Study|toothache|1|||
94472869|NCT00339833|323523327|FG000|Overall Study|indigestion|0|||
94472870|NCT00339833|323523328|FG001|Overall Study|indigestion|1|||
94472871|NCT00339833|323523327|FG000|Overall Study|Chest pain|0|||
94472872|NCT00339833|323523328|FG001|Overall Study|Chest pain|1|||
94472873|NCT00339833|323523327|FG000|Overall Study|minor infection|0|||
94472874|NCT00339833|323523328|FG001|Overall Study|minor infection|1|||
94472875|NCT00339833|323523327|FG000|Overall Study|Poor venous access|2|||
94472876|NCT00339833|323523328|FG001|Overall Study|Poor venous access|2|||
94472877|NCT00339833|323523327|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
94472878|NCT00339833|323523328|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
94472879|NCT00339833|323523327|FG000|Overall Study|Error in data records|1|||
94472880|NCT00339833|323523328|FG001|Overall Study|Error in data records|0|||
94472881|NCT04399889|323523329|FG000|Overall Study|Death|5|||
94472882|NCT04399889|323523330|FG001|Overall Study|Death|1|||
94472883|NCT04399889|323523331|FG002|Overall Study|Death|1|||
94310151|NCT02179398|322918988|FG000|Overall Study|Lost to Follow-up|0|||
94310152|NCT02179398|322918989|FG001|Overall Study|Lost to Follow-up|1|||
94310153|NCT01416610|322918993|FG000|Overall Study|Adverse Event|4|||
94310154|NCT01416610|322918993|FG000|Overall Study|Adverse Event -Patient decision|3|||
94472884|NCT00707980|323523332|FG000|Overall Study|Adverse Event|49|||
94472885|NCT00707980|323523332|FG000|Overall Study|Lack of Efficacy|35|||
94472886|NCT00707980|323523332|FG000|Overall Study|Non-Compliance with Study Drug|28|||
94472887|NCT00707980|323523332|FG000|Overall Study|Protocol Deviations|19|||
94472888|NCT00707980|323523332|FG000|Overall Study|Withdrawal of Consent|81|||
94472889|NCT00707980|323523332|FG000|Overall Study|Lost to Follow-up|59|||
94472890|NCT00707980|323523332|FG000|Overall Study|Other|39|||
94472891|NCT01398358|323523338|FG000|Overall Study|Lost to Follow-up|11|||
94472892|NCT01398358|323523339|FG001|Overall Study|Lost to Follow-up|21|||
94472893|NCT01398358|323523340|FG002|Overall Study|Lost to Follow-up|18|||
94472894|NCT01398358|323523338|FG000|Overall Study|Withdrawal by Subject|3|||
94472895|NCT01398358|323523339|FG001|Overall Study|Withdrawal by Subject|2|||
94472896|NCT01398358|323523340|FG002|Overall Study|Withdrawal by Subject|2|||
94472897|NCT01398358|323523338|FG000|Overall Study|no longer eligible|1|||
94472898|NCT01398358|323523339|FG001|Overall Study|no longer eligible|0|||
94472899|NCT01398358|323523340|FG002|Overall Study|no longer eligible|1|||
94472900|NCT02559570|323523342|FG000|Overall Study|Adverse Event|0|||
94472901|NCT02559570|323523343|FG001|Overall Study|Adverse Event|2|||
94472902|NCT02559570|323523344|FG002|Overall Study|Adverse Event|0|||
94472903|NCT02559570|323523345|FG003|Overall Study|Adverse Event|1|||
94472904|NCT02559570|323523346|FG004|Overall Study|Adverse Event|0|||
94310155|NCT01416610|322918993|FG000|Overall Study|Lack of Efficacy|4|||
94310156|NCT01416610|322918993|FG000|Overall Study|No reason given|5|||
94310157|NCT01416610|322918993|FG000|Overall Study|Withdrawal by Subject|13|||
94310158|NCT01416610|322918993|FG000|Overall Study|Lost to Follow-up|7|||
94310159|NCT01416610|322918993|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
94472905|NCT02559570|323523342|FG000|Overall Study|Withdrawal of Consent|0|||
94472906|NCT02559570|323523343|FG001|Overall Study|Withdrawal of Consent|0|||
94472907|NCT02559570|323523344|FG002|Overall Study|Withdrawal of Consent|1|||
94472908|NCT02559570|323523345|FG003|Overall Study|Withdrawal of Consent|2|||
94472909|NCT02559570|323523346|FG004|Overall Study|Withdrawal of Consent|1|||
94310160|NCT01171521|322918994|FG000|Overall Study|Lost to Follow-up|5|||
94472910|NCT02559570|323523342|FG000|Overall Study|Lost to Follow-up|1|||
94472911|NCT02559570|323523343|FG001|Overall Study|Lost to Follow-up|0|||
94472912|NCT02559570|323523344|FG002|Overall Study|Lost to Follow-up|0|||
94472913|NCT02559570|323523345|FG003|Overall Study|Lost to Follow-up|0|||
94472914|NCT02559570|323523346|FG004|Overall Study|Lost to Follow-up|0|||
94472915|NCT02559570|323523342|FG000|Overall Study|Protocol Violation|1|||
94472916|NCT02559570|323523343|FG001|Overall Study|Protocol Violation|0|||
94472917|NCT02559570|323523344|FG002|Overall Study|Protocol Violation|0|||
94472918|NCT02559570|323523345|FG003|Overall Study|Protocol Violation|0|||
94472919|NCT02559570|323523346|FG004|Overall Study|Protocol Violation|1|||
94472920|NCT02559570|323523342|FG000|Overall Study|Other Miscellaneous Reasons|0|||
94472921|NCT02559570|323523343|FG001|Overall Study|Other Miscellaneous Reasons|0|||
94472922|NCT02559570|323523344|FG002|Overall Study|Other Miscellaneous Reasons|1|||
94472923|NCT02559570|323523345|FG003|Overall Study|Other Miscellaneous Reasons|0|||
94472924|NCT02559570|323523346|FG004|Overall Study|Other Miscellaneous Reasons|0|||
94472925|NCT00524680|323523353|FG000|Overall Study|progression|0|||
94472926|NCT00524680|323523354|FG001|Overall Study|progression|0|||
94472927|NCT00524680|323523355|FG002|Overall Study|progression|0|||
94472928|NCT00524680|323523356|FG003|Overall Study|progression|1|||
94472929|NCT00524680|323523353|FG000|Overall Study|Adverse Event|2|||
94472930|NCT00524680|323523354|FG001|Overall Study|Adverse Event|0|||
94472931|NCT00524680|323523355|FG002|Overall Study|Adverse Event|0|||
94472932|NCT00524680|323523356|FG003|Overall Study|Adverse Event|1|||
94472933|NCT00524680|323523353|FG000|Overall Study|Other|0|||
94472934|NCT00524680|323523354|FG001|Overall Study|Other|1|||
94472935|NCT00524680|323523355|FG002|Overall Study|Other|2|||
94472936|NCT00524680|323523356|FG003|Overall Study|Other|3|||
94472937|NCT00524680|323523353|FG000|Overall Study|Withdrawal by Subject|1|||
94472938|NCT00524680|323523354|FG001|Overall Study|Withdrawal by Subject|0|||
94472939|NCT00524680|323523355|FG002|Overall Study|Withdrawal by Subject|1|||
94472940|NCT00524680|323523356|FG003|Overall Study|Withdrawal by Subject|1|||
94472941|NCT03162328|323523358|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
94472942|NCT03162328|323523359|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
94472943|NCT03162328|323523360|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
94472944|NCT03162328|323523358|FG000|Screening Period|Withdrawal by Subject|1|||
94472945|NCT03162328|323523359|FG001|Screening Period|Withdrawal by Subject|0|||
94472946|NCT03162328|323523360|FG002|Screening Period|Withdrawal by Subject|0|||
94472947|NCT03162328|323523358|FG000|Study Period|Withdrawal by Subject|0|||
94472948|NCT03162328|323523359|FG001|Study Period|Withdrawal by Subject|0|||
94472949|NCT03162328|323523360|FG002|Study Period|Withdrawal by Subject|1|||
94472950|NCT03337048|323523362|FG000|Overall Study|Withdrawal by Subject|2|||
94472951|NCT03337048|323523363|FG001|Overall Study|Withdrawal by Subject|0|||
94472952|NCT03337048|323523364|FG002|Overall Study|Withdrawal by Subject|0|||
94472953|NCT03628716|323523376|FG000|Overall Study|Adverse Event|1|||
94472954|NCT03628716|323523377|FG001|Overall Study|Adverse Event|1|||
94472955|NCT03628716|323523376|FG000|Overall Study|Death|1|||
94472956|NCT03628716|323523377|FG001|Overall Study|Death|0|||
94472957|NCT03628716|323523376|FG000|Overall Study|Lack of Efficacy|15|||
94310161|NCT01171521|322918994|FG000|Overall Study|screen failure|1|||
94310162|NCT01161524|322918995|FG000|Core Study (23 Weeks)|Adverse Event|3|||
94310163|NCT01161524|322918996|FG001|Core Study (23 Weeks)|Adverse Event|0|||
94310164|NCT01161524|322918997|FG002|Core Study (23 Weeks)|Adverse Event|0|||
94310165|NCT01161524|322918995|FG000|Core Study (23 Weeks)|Other|1|||
94310166|NCT01161524|322918996|FG001|Core Study (23 Weeks)|Other|0|||
94310167|NCT01161524|322918997|FG002|Core Study (23 Weeks)|Other|0|||
94310168|NCT01161524|322918995|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
94310169|NCT01161524|322918996|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
94310170|NCT01161524|322918997|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
94310171|NCT01161524|322918995|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
94310172|NCT01161524|322918996|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
94310173|NCT01161524|322918997|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
94310174|NCT01161524|322918995|FG000|Core Study (23 Weeks)|Subject Choice|3|||
94310175|NCT01161524|322918996|FG001|Core Study (23 Weeks)|Subject Choice|2|||
94310176|NCT01161524|322918997|FG002|Core Study (23 Weeks)|Subject Choice|0|||
94472958|NCT03628716|323523377|FG001|Overall Study|Lack of Efficacy|20|||
94472959|NCT03628716|323523376|FG000|Overall Study|Withdrawal by Subject|1|||
94472960|NCT03628716|323523377|FG001|Overall Study|Withdrawal by Subject|2|||
94472961|NCT03628716|323523376|FG000|Overall Study|Study Terminated by Sponsor|1|||
94310177|NCT01161524|322918995|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
94310178|NCT01161524|322918996|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
94310179|NCT01161524|322918997|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
94310180|NCT01161524|322918995|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
94310181|NCT01161524|322918996|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
94310182|NCT01161524|322918997|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
94310183|NCT01161524|322918995|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
94472962|NCT03628716|323523377|FG001|Overall Study|Study Terminated by Sponsor|0|||
94310184|NCT01161524|322918996|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
94310185|NCT01161524|322918997|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
94472963|NCT00792116|323523378|FG000|Overall Study|Lost to Follow-up|0|||
94472964|NCT00792116|323523379|FG001|Overall Study|Lost to Follow-up|1|||
94472965|NCT00792116|323523378|FG000|Overall Study|Discontnued intervention|1|||
94472966|NCT00792116|323523379|FG001|Overall Study|Discontnued intervention|0|||
94472967|NCT00829829|323523380|FG000|Overall Study|Protocol Violation|0|||
94472968|NCT00829829|323523381|FG001|Overall Study|Protocol Violation|3|||
94472969|NCT00829829|323523382|FG002|Overall Study|Protocol Violation|0|||
94472970|NCT00829829|323523380|FG000|Overall Study|Adverse Event|4|||
94472971|NCT00829829|323523381|FG001|Overall Study|Adverse Event|4|||
94472972|NCT00829829|323523382|FG002|Overall Study|Adverse Event|3|||
94472973|NCT00829829|323523380|FG000|Overall Study|Withdrawal by Subject|8|||
94472974|NCT00829829|323523381|FG001|Overall Study|Withdrawal by Subject|4|||
94472975|NCT00829829|323523382|FG002|Overall Study|Withdrawal by Subject|2|||
94472976|NCT00829829|323523380|FG000|Overall Study|Decision by the Sponsor|1|||
94472977|NCT00829829|323523381|FG001|Overall Study|Decision by the Sponsor|0|||
94472978|NCT00829829|323523382|FG002|Overall Study|Decision by the Sponsor|2|||
94472979|NCT00829829|323523380|FG000|Overall Study|Lost to Follow-up|7|||
94472980|NCT00829829|323523381|FG001|Overall Study|Lost to Follow-up|3|||
94472981|NCT00829829|323523382|FG002|Overall Study|Lost to Follow-up|3|||
94472982|NCT00829829|323523380|FG000|Overall Study|Other than specified above|2|||
94472983|NCT00829829|323523381|FG001|Overall Study|Other than specified above|2|||
94472984|NCT00829829|323523382|FG002|Overall Study|Other than specified above|1|||
94472985|NCT00481767|323523383|FG000|Overall Study|Withdrawal by Subject|16|||
94472986|NCT00481767|323523384|FG001|Overall Study|Withdrawal by Subject|11|||
94472987|NCT00481767|323523383|FG000|Overall Study|Lost to Follow-up|16|||
94472988|NCT00481767|323523384|FG001|Overall Study|Lost to Follow-up|10|||
94472989|NCT00636636|323523385|FG000|Overall Study|Other reason|4|||
94472990|NCT00636636|323523386|FG001|Overall Study|Other reason|6|||
94472991|NCT00636636|323523385|FG000|Overall Study|Adverse Event|19|||
94472992|NCT00636636|323523386|FG001|Overall Study|Adverse Event|8|||
94472993|NCT00636636|323523385|FG000|Overall Study|Lack of Efficacy|7|||
94472994|NCT00636636|323523386|FG001|Overall Study|Lack of Efficacy|12|||
94472995|NCT00636636|323523385|FG000|Overall Study|Protocol Violation|2|||
94472996|NCT00636636|323523386|FG001|Overall Study|Protocol Violation|2|||
94472997|NCT00636636|323523385|FG000|Overall Study|Lost to Follow-up|0|||
94472998|NCT00636636|323523386|FG001|Overall Study|Lost to Follow-up|1|||
94472999|NCT00636636|323523385|FG000|Overall Study|Death|0|||
94473000|NCT00636636|323523386|FG001|Overall Study|Death|1|||
94473001|NCT00636636|323523385|FG000|Overall Study|Withdrawal by Subject|4|||
94473002|NCT00636636|323523386|FG001|Overall Study|Withdrawal by Subject|9|||
94473003|NCT00524173|323523387|FG000|Overall Study|Lost to Follow-up|0|||
94473004|NCT00524173|323523388|FG001|Overall Study|Lost to Follow-up|1|||
94473005|NCT00524173|323523387|FG000|Overall Study|Death|1|||
94473006|NCT00524173|323523388|FG001|Overall Study|Death|0|||
94473007|NCT00524173|323523387|FG000|Overall Study|Had not reached endpoint at study close|4|||
94473008|NCT00524173|323523388|FG001|Overall Study|Had not reached endpoint at study close|1|||
94473009|NCT05052697|323523389|FG000|Substudy A|Lost to Follow-up|0|||
94473010|NCT05052697|323523390|FG001|Substudy A|Lost to Follow-up|0|||
94473011|NCT05052697|323523391|FG002|Substudy A|Lost to Follow-up|0|||
94473012|NCT05052697|323523392|FG003|Substudy A|Lost to Follow-up|0|||
94473013|NCT05052697|323523393|FG004|Substudy A|Lost to Follow-up|0|||
94473014|NCT05052697|323523394|FG005|Substudy A|Lost to Follow-up|1|||
94473015|NCT05052697|323523395|FG006|Substudy A|Lost to Follow-up|0|||
94473016|NCT05052697|323523396|FG007|Substudy A|Lost to Follow-up|0|||
94473017|NCT05052697|323523397|FG008|Substudy A|Lost to Follow-up|0|||
94473018|NCT05052697|323523398|FG009|Substudy A|Lost to Follow-up|0|||
94473019|NCT05052697|323523399|FG010|Substudy A|Lost to Follow-up|0|||
94473020|NCT05052697|323523400|FG011|Substudy A|Lost to Follow-up|0|||
94473021|NCT05052697|323523401|FG012|Substudy A|Lost to Follow-up|0|||
94473022|NCT05052697|323523402|FG013|Substudy A|Lost to Follow-up|0|||
94473023|NCT05052697|323523403|FG014|Substudy A|Lost to Follow-up|0|||
94473024|NCT05052697|323523404|FG015|Substudy A|Lost to Follow-up|2|||
94473025|NCT05052697|323523405|FG016|Substudy A|Lost to Follow-up|0|||
94473026|NCT05052697|323523406|FG017|Substudy A|Lost to Follow-up|0|||
94473027|NCT05052697|323523407|FG018|Substudy A|Lost to Follow-up|0|||
94473028|NCT05052697|323523408|FG019|Substudy A|Lost to Follow-up|0|||
94473029|NCT05052697|323523409|FG020|Substudy A|Lost to Follow-up|0|||
94473030|NCT05052697|323523410|FG021|Substudy A|Lost to Follow-up|0|||
94473031|NCT05052697|323523411|FG022|Substudy A|Lost to Follow-up|0|||
94473032|NCT05052697|323523412|FG023|Substudy A|Lost to Follow-up|0|||
94473033|NCT05052697|323523413|FG024|Substudy A|Lost to Follow-up|0|||
94473034|NCT05052697|323523414|FG025|Substudy A|Lost to Follow-up|0|||
94473035|NCT05052697|323523415|FG026|Substudy A|Lost to Follow-up|0|||
94473036|NCT05052697|323523416|FG027|Substudy A|Lost to Follow-up|0|||
94473037|NCT05052697|323523417|FG028|Substudy A|Lost to Follow-up|0|||
94473038|NCT05052697|323523418|FG029|Substudy A|Lost to Follow-up|0|||
94473039|NCT05052697|323523419|FG030|Substudy A|Lost to Follow-up|0|||
94473040|NCT05052697|323523420|FG031|Substudy A|Lost to Follow-up|0|||
94473041|NCT05052697|323523421|FG032|Substudy A|Lost to Follow-up|0|||
94473042|NCT05052697|323523422|FG033|Substudy A|Lost to Follow-up|0|||
94473043|NCT05052697|323523389|FG000|Substudy A|No longer met eligibility criteria|0|||
94473044|NCT05052697|323523390|FG001|Substudy A|No longer met eligibility criteria|0|||
94310186|NCT01161524|322918995|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
94310187|NCT01161524|322918996|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
94310188|NCT01161524|322918997|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
94310189|NCT01161524|322918995|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
94310190|NCT01161524|322918996|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
94310191|NCT01161524|322918997|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
94310192|NCT00642616|322918998|FG000|Overall Study|Adverse Event|2|||
94310193|NCT00642616|322918999|FG001|Overall Study|Adverse Event|0|||
94310194|NCT00642616|322919000|FG002|Overall Study|Adverse Event|1|||
94381049|NCT02354586|323181121|FG000|Overall Study|Intercurrent illness|1|||
94381050|NCT02354586|323181121|FG000|Overall Study|Protocol Violation|3|||
94381051|NCT02354586|323181121|FG000|Overall Study|Physician Decision|13|||
94381052|NCT02354586|323181121|FG000|Overall Study|Lack of Efficacy|86|||
94381053|NCT02354586|323181121|FG000|Overall Study|Adverse Event|7|||
94381054|NCT03823300|323181122|FG000|Overall Study|Withdrawal by Subject|16|||
94381055|NCT03823300|323181123|FG001|Overall Study|Withdrawal by Subject|22|||
94381056|NCT03823300|323181122|FG000|Overall Study|Death|10|||
94381057|NCT03823300|323181123|FG001|Overall Study|Death|14|||
94381058|NCT03823300|323181122|FG000|Overall Study|Adverse Event|3|||
94381059|NCT03823300|323181123|FG001|Overall Study|Adverse Event|5|||
94381060|NCT03823300|323181122|FG000|Overall Study|Physician Decision|1|||
94381061|NCT03823300|323181123|FG001|Overall Study|Physician Decision|7|||
94381062|NCT03823300|323181122|FG000|Overall Study|Lost to Follow-up|1|||
94381063|NCT03823300|323181123|FG001|Overall Study|Lost to Follow-up|3|||
94381064|NCT03823300|323181122|FG000|Overall Study|Protocol Violation|1|||
94381065|NCT03823300|323181123|FG001|Overall Study|Protocol Violation|1|||
94310195|NCT00642616|322919001|FG003|Overall Study|Adverse Event|0|||
94310196|NCT00642616|322918998|FG000|Overall Study|Study Terminated by Sponsor|7|||
94310197|NCT00642616|322918999|FG001|Overall Study|Study Terminated by Sponsor|6|||
94310198|NCT00642616|322919000|FG002|Overall Study|Study Terminated by Sponsor|4|||
94310199|NCT00642616|322919001|FG003|Overall Study|Study Terminated by Sponsor|5|||
94310200|NCT00642616|322918998|FG000|Overall Study|Withdrawal by Subject|0|||
94310201|NCT00642616|322918999|FG001|Overall Study|Withdrawal by Subject|1|||
94310202|NCT00642616|322919000|FG002|Overall Study|Withdrawal by Subject|1|||
94310203|NCT00642616|322919001|FG003|Overall Study|Withdrawal by Subject|1|||
94310204|NCT00642616|322918998|FG000|Overall Study|Protocol Violation|0|||
94310205|NCT00642616|322918999|FG001|Overall Study|Protocol Violation|0|||
94310206|NCT00642616|322919000|FG002|Overall Study|Protocol Violation|2|||
94310207|NCT00642616|322919001|FG003|Overall Study|Protocol Violation|0|||
94310208|NCT00642616|322918998|FG000|Overall Study|Physician Decision|0|||
94310209|NCT00642616|322918999|FG001|Overall Study|Physician Decision|0|||
94310210|NCT00642616|322919000|FG002|Overall Study|Physician Decision|1|||
94310211|NCT00642616|322919001|FG003|Overall Study|Physician Decision|1|||
94310212|NCT02606877|322919002|FG000|Overall Study|Adverse Event|3|||
94310213|NCT02606877|322919003|FG001|Overall Study|Adverse Event|0|||
94310214|NCT02606877|322919002|FG000|Overall Study|Non-compliance with protocol|0|||
94310215|NCT02606877|322919003|FG001|Overall Study|Non-compliance with protocol|1|||
94310216|NCT02606877|322919002|FG000|Overall Study|Other than listed above|1|||
94310217|NCT02606877|322919003|FG001|Overall Study|Other than listed above|0|||
94310218|NCT00916721|322919004|FG000|Overall Study|Lost to Follow-up|0|||
94310219|NCT00916721|322919005|FG001|Overall Study|Lost to Follow-up|1|||
94310220|NCT00916721|322919004|FG000|Overall Study|Adverse Event|6|||
94310221|NCT00916721|322919005|FG001|Overall Study|Adverse Event|3|||
94310222|NCT00916721|322919004|FG000|Overall Study|Withdrawal by Subject|2|||
94310223|NCT00916721|322919005|FG001|Overall Study|Withdrawal by Subject|2|||
94381066|NCT03823300|323181122|FG000|Overall Study|Lack of Efficacy|1|||
94381067|NCT03823300|323181123|FG001|Overall Study|Lack of Efficacy|1|||
94381068|NCT03823300|323181122|FG000|Overall Study|Not Eligible|0|||
94381069|NCT03823300|323181123|FG001|Overall Study|Not Eligible|1|||
94381070|NCT03823300|323181122|FG000|Overall Study|Other|1|||
94381071|NCT03823300|323181123|FG001|Overall Study|Other|0|||
94381072|NCT00524459|323181124|FG000|Overall Study|Withdrawal by Subject|1|||
94381073|NCT00524459|323181124|FG000|Overall Study|Other|1|||
94381074|NCT00625807|323181125|FG000|Overall Study|schedule conflict|2|||
94381075|NCT00625807|323181126|FG001|Overall Study|schedule conflict|8|||
94381076|NCT00084084|323181127|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
94381077|NCT00084084|323181127|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
94381078|NCT01802879|323181128|FG000|Overall Study|Administrative problems|2|||
94381079|NCT01802879|323181128|FG000|Overall Study|Disease progression|6|||
94381080|NCT01193608|323181129|FG000|Overall Study|Other|0|||
94381081|NCT01193608|323181130|FG001|Overall Study|Other|1|||
94381082|NCT01193608|323181131|FG002|Overall Study|Other|0|||
94381083|NCT01193608|323181132|FG003|Overall Study|Other|0|||
94310224|NCT00916721|322919004|FG000|Overall Study|Protocol Violation|2|||
94310225|NCT00916721|322919005|FG001|Overall Study|Protocol Violation|4|||
94310226|NCT01903434|322919009|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
94310227|NCT01903434|322919010|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
94381084|NCT01193608|323181133|FG004|Overall Study|Other|0|||
94381085|NCT01193608|323181134|FG005|Overall Study|Other|0|||
94381086|NCT01193608|323181129|FG000|Overall Study|Withdrawal by Subject|0|||
94381087|NCT01193608|323181130|FG001|Overall Study|Withdrawal by Subject|1|||
94381088|NCT01193608|323181131|FG002|Overall Study|Withdrawal by Subject|2|||
94381089|NCT01193608|323181132|FG003|Overall Study|Withdrawal by Subject|3|||
94381090|NCT01193608|323181133|FG004|Overall Study|Withdrawal by Subject|3|||
94381091|NCT01193608|323181134|FG005|Overall Study|Withdrawal by Subject|0|||
94381092|NCT01193608|323181129|FG000|Overall Study|Lost to Follow-up|0|||
94381093|NCT01193608|323181130|FG001|Overall Study|Lost to Follow-up|0|||
94381094|NCT01193608|323181131|FG002|Overall Study|Lost to Follow-up|0|||
94381095|NCT01193608|323181132|FG003|Overall Study|Lost to Follow-up|0|||
94381096|NCT01193608|323181133|FG004|Overall Study|Lost to Follow-up|1|||
94381097|NCT01193608|323181134|FG005|Overall Study|Lost to Follow-up|2|||
94381098|NCT01193608|323181129|FG000|Overall Study|Adverse Event|0|||
94381099|NCT01193608|323181130|FG001|Overall Study|Adverse Event|0|||
94381100|NCT01193608|323181131|FG002|Overall Study|Adverse Event|0|||
94381101|NCT01193608|323181132|FG003|Overall Study|Adverse Event|0|||
94381102|NCT01193608|323181133|FG004|Overall Study|Adverse Event|1|||
94381103|NCT01193608|323181134|FG005|Overall Study|Adverse Event|0|||
94381104|NCT01047345|323181139|FG000|Base Study|Adverse Event|3|||
94381105|NCT01047345|323181140|FG001|Base Study|Adverse Event|0|||
94381106|NCT01047345|323181141|FG002|Base Study|Adverse Event|0|||
94381107|NCT01047345|323181139|FG000|Base Study|Lost to Follow-up|4|||
94381108|NCT01047345|323181140|FG001|Base Study|Lost to Follow-up|1|||
94381109|NCT01047345|323181141|FG002|Base Study|Lost to Follow-up|0|||
94381110|NCT01047345|323181139|FG000|Base Study|Protocol Violation|3|||
94381111|NCT01047345|323181140|FG001|Base Study|Protocol Violation|1|||
94381112|NCT01047345|323181141|FG002|Base Study|Protocol Violation|0|||
94381113|NCT01047345|323181139|FG000|Base Study|Withdrawal by Subject|12|||
94381114|NCT01047345|323181140|FG001|Base Study|Withdrawal by Subject|4|||
94381115|NCT01047345|323181141|FG002|Base Study|Withdrawal by Subject|0|||
94381116|NCT01047345|323181139|FG000|Extension|Withdrawal by Subject|0|||
94381117|NCT01047345|323181140|FG001|Extension|Withdrawal by Subject|0|||
94381118|NCT01047345|323181141|FG002|Extension|Withdrawal by Subject|1|||
94381119|NCT01047345|323181139|FG000|Extension|Lost to Follow-up|0|||
94381120|NCT01047345|323181140|FG001|Extension|Lost to Follow-up|0|||
94381121|NCT01047345|323181141|FG002|Extension|Lost to Follow-up|5|||
94381122|NCT02162758|323181142|FG000|Overall Study|Study termination|0|||
94381123|NCT02162758|323181143|FG001|Overall Study|Study termination|1|||
94381124|NCT04471935|323181144|FG000|Overall Study|Withdrawal by Subject|1|||
94381125|NCT04471935|323181144|FG000|Overall Study|Deemed ineligible to participate|1|||
94381126|NCT02187042|323181145|FG000|Overall Study|Death|1|||
94381127|NCT02187042|323181146|FG001|Overall Study|Death|1|||
94381128|NCT02187042|323181145|FG000|Overall Study|Toxicity|6|||
94381129|NCT02187042|323181146|FG001|Overall Study|Toxicity|5|||
94381130|NCT02187042|323181145|FG000|Overall Study|Participant choice|1|||
94381131|NCT02187042|323181146|FG001|Overall Study|Participant choice|0|||
94381132|NCT02187042|323181145|FG000|Overall Study|Doctor choice|1|||
94381133|NCT02187042|323181146|FG001|Overall Study|Doctor choice|0|||
94381134|NCT02187042|323181145|FG000|Overall Study|Progressive disease|4|||
94381135|NCT02187042|323181146|FG001|Overall Study|Progressive disease|8|||
94381136|NCT00108732|323181147|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
94381137|NCT00108732|323181147|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
94381138|NCT00108732|323181147|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
94381139|NCT00108732|323181147|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
94381140|NCT00108732|323181147|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
94381141|NCT00108732|323181147|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
94381142|NCT00108732|323181147|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
94381143|NCT01766921|323181149|FG000|Overall Study|Administrative Reason|5|||
94381144|NCT01766921|323181150|FG001|Overall Study|Administrative Reason|5|||
94381145|NCT01766921|323181149|FG000|Overall Study|Death|1|||
94381146|NCT01766921|323181150|FG001|Overall Study|Death|1|||
94381147|NCT01766921|323181149|FG000|Overall Study|Lost to Follow-up|1|||
94381148|NCT01766921|323181150|FG001|Overall Study|Lost to Follow-up|3|||
94381149|NCT01766921|323181149|FG000|Overall Study|Unclassified|2|||
94381150|NCT01766921|323181150|FG001|Overall Study|Unclassified|2|||
94473045|NCT05052697|323523391|FG002|Substudy A|No longer met eligibility criteria|0|||
94381151|NCT01766921|323181149|FG000|Overall Study|Protocol Violation|1|||
94381152|NCT01766921|323181150|FG001|Overall Study|Protocol Violation|1|||
94381153|NCT01766921|323181149|FG000|Overall Study|Withdrawal by Subject|14|||
94381154|NCT01766921|323181150|FG001|Overall Study|Withdrawal by Subject|5|||
94381155|NCT03213210|323181153|FG000|Overall Study|Lost to Follow-up|2|||
94381156|NCT03213210|323181153|FG000|Overall Study|Study termination|3|||
94381157|NCT01325207|323181161|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
94381158|NCT01325207|323181162|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
94381159|NCT01325207|323181163|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
94381160|NCT01325207|323181164|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
94473046|NCT05052697|323523392|FG003|Substudy A|No longer met eligibility criteria|0|||
94473047|NCT05052697|323523393|FG004|Substudy A|No longer met eligibility criteria|0|||
94473048|NCT05052697|323523394|FG005|Substudy A|No longer met eligibility criteria|0|||
94473049|NCT05052697|323523395|FG006|Substudy A|No longer met eligibility criteria|0|||
94473050|NCT05052697|323523396|FG007|Substudy A|No longer met eligibility criteria|0|||
94473051|NCT05052697|323523397|FG008|Substudy A|No longer met eligibility criteria|0|||
94473052|NCT05052697|323523398|FG009|Substudy A|No longer met eligibility criteria|0|||
94473053|NCT05052697|323523399|FG010|Substudy A|No longer met eligibility criteria|0|||
94473054|NCT05052697|323523400|FG011|Substudy A|No longer met eligibility criteria|0|||
94473055|NCT05052697|323523401|FG012|Substudy A|No longer met eligibility criteria|0|||
94473056|NCT05052697|323523402|FG013|Substudy A|No longer met eligibility criteria|1|||
94473057|NCT05052697|323523403|FG014|Substudy A|No longer met eligibility criteria|0|||
94473058|NCT05052697|323523404|FG015|Substudy A|No longer met eligibility criteria|0|||
94473059|NCT05052697|323523405|FG016|Substudy A|No longer met eligibility criteria|0|||
94473060|NCT05052697|323523406|FG017|Substudy A|No longer met eligibility criteria|0|||
94473061|NCT05052697|323523407|FG018|Substudy A|No longer met eligibility criteria|0|||
94473062|NCT05052697|323523408|FG019|Substudy A|No longer met eligibility criteria|0|||
94473063|NCT05052697|323523409|FG020|Substudy A|No longer met eligibility criteria|0|||
94473064|NCT05052697|323523410|FG021|Substudy A|No longer met eligibility criteria|0|||
94473065|NCT05052697|323523411|FG022|Substudy A|No longer met eligibility criteria|0|||
94473066|NCT05052697|323523412|FG023|Substudy A|No longer met eligibility criteria|0|||
94473067|NCT05052697|323523413|FG024|Substudy A|No longer met eligibility criteria|0|||
94473068|NCT05052697|323523414|FG025|Substudy A|No longer met eligibility criteria|0|||
94473069|NCT05052697|323523415|FG026|Substudy A|No longer met eligibility criteria|0|||
94473070|NCT05052697|323523416|FG027|Substudy A|No longer met eligibility criteria|0|||
94473071|NCT05052697|323523417|FG028|Substudy A|No longer met eligibility criteria|0|||
94473072|NCT05052697|323523418|FG029|Substudy A|No longer met eligibility criteria|0|||
94473073|NCT05052697|323523419|FG030|Substudy A|No longer met eligibility criteria|0|||
94473074|NCT05052697|323523420|FG031|Substudy A|No longer met eligibility criteria|0|||
94473075|NCT05052697|323523421|FG032|Substudy A|No longer met eligibility criteria|0|||
94473076|NCT05052697|323523422|FG033|Substudy A|No longer met eligibility criteria|0|||
94473077|NCT05052697|323523389|FG000|Substudy A|Not vaccinated|0|||
94473078|NCT05052697|323523390|FG001|Substudy A|Not vaccinated|0|||
94473079|NCT05052697|323523391|FG002|Substudy A|Not vaccinated|0|||
94473080|NCT05052697|323523392|FG003|Substudy A|Not vaccinated|1|||
94473081|NCT05052697|323523393|FG004|Substudy A|Not vaccinated|0|||
94473082|NCT05052697|323523394|FG005|Substudy A|Not vaccinated|0|||
94473083|NCT05052697|323523395|FG006|Substudy A|Not vaccinated|0|||
94473084|NCT05052697|323523396|FG007|Substudy A|Not vaccinated|0|||
94473085|NCT05052697|323523397|FG008|Substudy A|Not vaccinated|1|||
94473086|NCT05052697|323523398|FG009|Substudy A|Not vaccinated|0|||
94473087|NCT05052697|323523399|FG010|Substudy A|Not vaccinated|0|||
94473088|NCT05052697|323523400|FG011|Substudy A|Not vaccinated|0|||
94473089|NCT05052697|323523401|FG012|Substudy A|Not vaccinated|0|||
94473090|NCT05052697|323523402|FG013|Substudy A|Not vaccinated|0|||
94473091|NCT05052697|323523403|FG014|Substudy A|Not vaccinated|0|||
94473092|NCT05052697|323523404|FG015|Substudy A|Not vaccinated|0|||
94473093|NCT05052697|323523405|FG016|Substudy A|Not vaccinated|0|||
94473094|NCT05052697|323523406|FG017|Substudy A|Not vaccinated|0|||
94473095|NCT05052697|323523407|FG018|Substudy A|Not vaccinated|0|||
94473096|NCT05052697|323523408|FG019|Substudy A|Not vaccinated|0|||
94473097|NCT05052697|323523409|FG020|Substudy A|Not vaccinated|0|||
94473098|NCT05052697|323523410|FG021|Substudy A|Not vaccinated|0|||
94473099|NCT05052697|323523411|FG022|Substudy A|Not vaccinated|0|||
94473100|NCT05052697|323523412|FG023|Substudy A|Not vaccinated|0|||
94473101|NCT05052697|323523413|FG024|Substudy A|Not vaccinated|0|||
94381161|NCT01325207|323181165|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
94381162|NCT01325207|323181166|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
94381163|NCT01325207|323181161|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
94381164|NCT01325207|323181162|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
94381165|NCT01325207|323181163|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
94381166|NCT01325207|323181164|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
94381167|NCT01325207|323181165|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
94381168|NCT01325207|323181166|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
94381169|NCT01325207|323181161|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
94381170|NCT01325207|323181162|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
94473102|NCT05052697|323523414|FG025|Substudy A|Not vaccinated|0|||
94473103|NCT05052697|323523415|FG026|Substudy A|Not vaccinated|0|||
94473104|NCT05052697|323523416|FG027|Substudy A|Not vaccinated|0|||
94473105|NCT05052697|323523417|FG028|Substudy A|Not vaccinated|0|||
94473106|NCT05052697|323523418|FG029|Substudy A|Not vaccinated|0|||
94473107|NCT05052697|323523419|FG030|Substudy A|Not vaccinated|0|||
94473108|NCT05052697|323523420|FG031|Substudy A|Not vaccinated|0|||
94473109|NCT05052697|323523421|FG032|Substudy A|Not vaccinated|0|||
94473110|NCT05052697|323523422|FG033|Substudy A|Not vaccinated|0|||
94473111|NCT05052697|323523389|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473112|NCT05052697|323523390|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473113|NCT05052697|323523391|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473114|NCT05052697|323523392|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473115|NCT05052697|323523393|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473116|NCT05052697|323523394|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473117|NCT05052697|323523395|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473118|NCT05052697|323523396|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473119|NCT05052697|323523397|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473120|NCT05052697|323523398|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473121|NCT05052697|323523399|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473122|NCT05052697|323523400|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473123|NCT05052697|323523401|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473124|NCT05052697|323523402|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473125|NCT05052697|323523403|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473126|NCT05052697|323523404|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473127|NCT05052697|323523405|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473128|NCT05052697|323523406|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473129|NCT05052697|323523407|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
94473130|NCT05052697|323523408|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
94473131|NCT05052697|323523409|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473132|NCT05052697|323523410|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
94473133|NCT05052697|323523411|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
94473134|NCT05052697|323523412|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473135|NCT05052697|323523413|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473136|NCT05052697|323523414|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473137|NCT05052697|323523415|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473138|NCT05052697|323523416|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473139|NCT05052697|323523417|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473140|NCT05052697|323523418|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473141|NCT05052697|323523419|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473142|NCT05052697|323523420|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473143|NCT05052697|323523421|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473144|NCT05052697|323523422|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
94473145|NCT05052697|323523389|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473146|NCT05052697|323523390|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473147|NCT05052697|323523391|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473148|NCT05052697|323523392|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473149|NCT05052697|323523393|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473150|NCT05052697|323523394|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473151|NCT05052697|323523395|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473152|NCT05052697|323523396|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473153|NCT05052697|323523397|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473154|NCT05052697|323523398|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473155|NCT05052697|323523399|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473156|NCT05052697|323523400|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473157|NCT05052697|323523401|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473158|NCT05052697|323523402|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473159|NCT05052697|323523403|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473160|NCT05052697|323523404|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473161|NCT05052697|323523405|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473162|NCT05052697|323523406|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
94473163|NCT05052697|323523407|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473164|NCT05052697|323523408|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473165|NCT05052697|323523409|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473166|NCT05052697|323523410|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473167|NCT05052697|323523411|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473168|NCT05052697|323523412|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473169|NCT05052697|323523413|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473170|NCT05052697|323523414|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473171|NCT05052697|323523415|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473172|NCT05052697|323523416|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473173|NCT05052697|323523417|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473174|NCT05052697|323523418|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
94473175|NCT05052697|323523419|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
94310228|NCT01903434|322919009|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
94473176|NCT05052697|323523420|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
94310229|NCT01903434|322919010|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
94473177|NCT05052697|323523421|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
94310230|NCT01721369|322919015|FG000|Overall Study|Not initial etiological diagnosis|12|||
94310231|NCT02699515|322920408|FG000|Overall Study|Death|3|||
94310232|NCT02699515|322920409|FG001|Overall Study|Death|3|||
94310233|NCT02699515|322920410|FG002|Overall Study|Death|3|||
94310234|NCT02699515|322920411|FG003|Overall Study|Death|23|||
94310235|NCT02699515|322920412|FG004|Overall Study|Death|22|||
94310236|NCT02699515|322920413|FG005|Overall Study|Death|23|||
94310237|NCT02699515|322920414|FG006|Overall Study|Death|3|||
94310238|NCT02699515|322920415|FG007|Overall Study|Death|5|||
94310239|NCT02699515|322920408|FG000|Overall Study|Withdrawal by Subject|0|||
94310240|NCT02699515|322920409|FG001|Overall Study|Withdrawal by Subject|0|||
94310241|NCT02699515|322920410|FG002|Overall Study|Withdrawal by Subject|3|||
94310242|NCT02699515|322920411|FG003|Overall Study|Withdrawal by Subject|1|||
94310243|NCT02699515|322920412|FG004|Overall Study|Withdrawal by Subject|5|||
94310244|NCT02699515|322920413|FG005|Overall Study|Withdrawal by Subject|3|||
94310245|NCT02699515|322920414|FG006|Overall Study|Withdrawal by Subject|0|||
94310246|NCT02699515|322920415|FG007|Overall Study|Withdrawal by Subject|1|||
94310247|NCT02699515|322920408|FG000|Overall Study|Other|1|||
94310248|NCT02699515|322920409|FG001|Overall Study|Other|0|||
94310249|NCT02699515|322920410|FG002|Overall Study|Other|1|||
94310250|NCT02699515|322920411|FG003|Overall Study|Other|6|||
94310251|NCT02699515|322920412|FG004|Overall Study|Other|4|||
94310252|NCT02699515|322920413|FG005|Overall Study|Other|3|||
94310253|NCT02699515|322920414|FG006|Overall Study|Other|0|||
94310254|NCT02699515|322920415|FG007|Overall Study|Other|0|||
94310255|NCT05243550|322920416|FG000|Overall Study|Ongoing in the Study|171|||
94310256|NCT05243550|322920416|FG000|Overall Study|Withdrawal by Subject|10|||
94310257|NCT05243550|322920416|FG000|Overall Study|Lost to Follow-up|7|||
94310258|NCT05243550|322920416|FG000|Overall Study|Adverse Event|3|||
94310259|NCT05243550|322920416|FG000|Overall Study|Noncompliance|1|||
94310260|NCT05243550|322920416|FG000|Overall Study|Physician Decision|1|||
94310261|NCT05243550|322920416|FG000|Overall Study|Other Reason|4|||
94310262|NCT00375934|322920425|FG000|Overall Study|Adverse Event|1|||
94310263|NCT00375934|322920426|FG001|Overall Study|Adverse Event|1|||
94310264|NCT00375934|322920425|FG000|Overall Study|Withdrawal by Subject|2|||
94310265|NCT00375934|322920426|FG001|Overall Study|Withdrawal by Subject|2|||
94310266|NCT00375934|322920425|FG000|Overall Study|Lack of Efficacy|0|||
94310267|NCT00375934|322920426|FG001|Overall Study|Lack of Efficacy|2|||
94310268|NCT00375934|322920425|FG000|Overall Study|Physician Decision|0|||
94310269|NCT00375934|322920426|FG001|Overall Study|Physician Decision|1|||
94310270|NCT02452970|322920429|FG000|Overall Study|Adverse Event|1|||
94310271|NCT05094154|322920430|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
94310272|NCT05094154|322920431|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
94310273|NCT05094154|322920430|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
94310274|NCT05094154|322920431|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
94310275|NCT03953898|322920432|FG000|Overall Study|Lack of Efficacy|8|||
94310276|NCT03953898|322920432|FG000|Overall Study|Death|3|||
94310277|NCT03953898|322920432|FG000|Overall Study|Withdrawal by Subject|2|||
94310278|NCT03953898|322920432|FG000|Overall Study|Adverse Event|1|||
94310279|NCT01850563|322920433|FG000|Overall Study|Not eligible|3|||
94310280|NCT01850563|322920434|FG001|Overall Study|Not eligible|0|||
94310281|NCT02100657|322920435|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
94310282|NCT02100657|322920436|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
94310283|NCT02100657|322920437|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
94310284|NCT02100657|322920435|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
94310285|NCT02100657|322920436|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
94310286|NCT02100657|322920437|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
94310287|NCT02100657|322920435|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
94310288|NCT02100657|322920436|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
94310289|NCT02100657|322920437|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
94310290|NCT02100657|322920435|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
94310291|NCT02100657|322920436|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
94310292|NCT02100657|322920437|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
94310293|NCT02100657|322920435|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
94310294|NCT02100657|322920436|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
94310295|NCT02100657|322920437|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
94310296|NCT02100657|322920435|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
94310297|NCT02100657|322920436|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
94310298|NCT02100657|322920437|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
94310299|NCT02100657|322920435|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
94310300|NCT02100657|322920436|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
94310301|NCT02100657|322920437|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
94310302|NCT02100657|322920435|FG000|Cohort 3: Dose Level 3|Death|0|||
94310303|NCT02100657|322920436|FG001|Cohort 3: Dose Level 3|Death|0|||
94310304|NCT02100657|322920437|FG002|Cohort 3: Dose Level 3|Death|1|||
94310305|NCT02100657|322920435|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
94381171|NCT01325207|323181163|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
94381172|NCT01325207|323181164|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
94381173|NCT01325207|323181165|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
94381174|NCT01325207|323181166|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
94381175|NCT01325207|323181161|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
94381176|NCT01325207|323181162|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
94381177|NCT01325207|323181163|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
94381178|NCT01325207|323181164|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
94381179|NCT01325207|323181165|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
94381180|NCT01325207|323181166|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
94381181|NCT01325207|323181161|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
94381182|NCT01325207|323181162|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
94381183|NCT01325207|323181163|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
94381184|NCT01325207|323181164|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
94381185|NCT01325207|323181165|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
94381186|NCT01325207|323181166|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
94381187|NCT01325207|323181161|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
94381188|NCT01325207|323181162|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
94381189|NCT01325207|323181163|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
94381190|NCT01325207|323181164|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
94381191|NCT01325207|323181165|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
94381192|NCT01325207|323181166|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
94381193|NCT01325207|323181161|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
94381194|NCT01325207|323181162|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
94381195|NCT01325207|323181163|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
94381196|NCT01325207|323181164|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
94381197|NCT01325207|323181165|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
94381198|NCT01325207|323181166|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
94381199|NCT01166568|323181167|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
94381200|NCT01166568|323181168|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
94381201|NCT01166568|323181169|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
94381202|NCT01166568|323181167|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
94381203|NCT01166568|323181168|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
94381204|NCT01166568|323181169|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
94381205|NCT01166568|323181167|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
94381206|NCT01166568|323181168|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
94381207|NCT01166568|323181169|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
94381208|NCT03922477|323181172|FG000|Overall Study|Death|9|||
94381209|NCT03922477|323181172|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
94381210|NCT03922477|323181172|FG000|Overall Study|Physician Decision|1|||
94381211|NCT03922477|323181172|FG000|Overall Study|Withdrawal by Subject|2|||
94381212|NCT03387098|323181173|FG000|Overall Study|progressive disease|1|||
94381213|NCT03387098|323181173|FG000|Overall Study|Withdrawal by Subject|2|||
94381214|NCT03387098|323181173|FG000|Overall Study|study terminated by sponsor|1|||
94381215|NCT00662129|323181174|FG000|Overall Study|Protocol Violation|1|||
94381216|NCT00662129|323181174|FG000|Overall Study|Cancel prior to beginning treatment|1|||
94381217|NCT00662129|323181174|FG000|Overall Study|Ineligible|1|||
94381218|NCT02974153|323181175|FG000|Overall Study|Adverse Event|6|||
94381219|NCT02974153|323181176|FG001|Overall Study|Adverse Event|0|||
94381220|NCT02974153|323181177|FG002|Overall Study|Adverse Event|1|||
94381221|NCT02974153|323181175|FG000|Overall Study|Lack of Efficacy|6|||
94381222|NCT02974153|323181176|FG001|Overall Study|Lack of Efficacy|5|||
94381223|NCT02974153|323181177|FG002|Overall Study|Lack of Efficacy|10|||
94381224|NCT02974153|323181175|FG000|Overall Study|Lost to Follow-up|9|||
94381225|NCT02974153|323181176|FG001|Overall Study|Lost to Follow-up|10|||
94381226|NCT02974153|323181177|FG002|Overall Study|Lost to Follow-up|17|||
94381227|NCT02974153|323181175|FG000|Overall Study|Physician Decision|0|||
94381228|NCT02974153|323181176|FG001|Overall Study|Physician Decision|2|||
94381229|NCT02974153|323181177|FG002|Overall Study|Physician Decision|1|||
94381230|NCT02974153|323181175|FG000|Overall Study|Withdrawal by Subject|9|||
94381231|NCT02974153|323181176|FG001|Overall Study|Withdrawal by Subject|16|||
94381232|NCT02974153|323181177|FG002|Overall Study|Withdrawal by Subject|11|||
94381233|NCT02974153|323181175|FG000|Overall Study|Study Burden|8|||
94381234|NCT02974153|323181176|FG001|Overall Study|Study Burden|7|||
94381235|NCT02974153|323181177|FG002|Overall Study|Study Burden|3|||
94381236|NCT02974153|323181175|FG000|Overall Study|Other|14|||
94381237|NCT02974153|323181176|FG001|Overall Study|Other|8|||
94381238|NCT02974153|323181177|FG002|Overall Study|Other|7|||
94473178|NCT05052697|323523422|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
94310306|NCT02100657|322920436|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
94310307|NCT02100657|322920437|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
94310308|NCT02100657|322920435|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
94310309|NCT02100657|322920436|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
94310310|NCT02100657|322920437|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
94310311|NCT02100657|322920435|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
94310312|NCT02100657|322920436|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
94310313|NCT02100657|322920437|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
94310314|NCT02100657|322920435|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
94310315|NCT02100657|322920436|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
94310316|NCT02100657|322920437|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
94310317|NCT02100657|322920435|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
94310318|NCT02100657|322920436|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
94310319|NCT02100657|322920437|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
94310320|NCT04359823|322920438|FG000|Overall Study|Lost to Follow-up|0|||
94310321|NCT04359823|322920439|FG001|Overall Study|Lost to Follow-up|1|||
94310322|NCT04359823|322920438|FG000|Overall Study|Withdrawal by Subject|0|||
94381239|NCT01620177|323181180|FG000|Overall Study|Failure at Screening Visit|43|||
94381240|NCT01620177|323181180|FG000|Overall Study|Withdrawal by Subject|26|||
94381241|NCT01620177|323181180|FG000|Overall Study|Lost to Follow-up|7|||
94381242|NCT01620177|323181180|FG000|Overall Study|Physician Decision|2|||
94381243|NCT01620177|323181180|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
94381244|NCT02427607|323181184|FG000|Overall Study|Withdrawal by Subject|1|||
94381245|NCT02277769|323181185|FG000|Overall Study|Protocol Violation|3|||
94381246|NCT02277769|323181186|FG001|Overall Study|Protocol Violation|3|||
94381247|NCT02277769|323181187|FG002|Overall Study|Protocol Violation|5|||
94381248|NCT02277769|323181185|FG000|Overall Study|Lack of Efficacy|17|||
94381249|NCT02277769|323181186|FG001|Overall Study|Lack of Efficacy|0|||
94381250|NCT02277769|323181187|FG002|Overall Study|Lack of Efficacy|4|||
94381251|NCT02277769|323181185|FG000|Overall Study|Adverse Event|14|||
94381252|NCT02277769|323181186|FG001|Overall Study|Adverse Event|2|||
94381253|NCT02277769|323181187|FG002|Overall Study|Adverse Event|4|||
94381254|NCT02277769|323181185|FG000|Overall Study|Other than specified above|12|||
94381255|NCT02277769|323181186|FG001|Overall Study|Other than specified above|8|||
94381256|NCT02277769|323181187|FG002|Overall Study|Other than specified above|5|||
94381257|NCT00577460|323181189|FG000|Overall Study|Adverse Event|11|||
94381258|NCT00577460|323181190|FG001|Overall Study|Adverse Event|7|||
94381259|NCT00577460|323181191|FG002|Overall Study|Adverse Event|14|||
94381260|NCT00577460|323181189|FG000|Overall Study|Protocol Violation|0|||
94381261|NCT00577460|323181190|FG001|Overall Study|Protocol Violation|1|||
94381262|NCT00577460|323181191|FG002|Overall Study|Protocol Violation|1|||
94381263|NCT00577460|323181189|FG000|Overall Study|Lost to Follow-up|0|||
94381264|NCT00577460|323181190|FG001|Overall Study|Lost to Follow-up|3|||
94381265|NCT00577460|323181191|FG002|Overall Study|Lost to Follow-up|4|||
94381266|NCT00577460|323181189|FG000|Overall Study|Withdrawal by Subject|5|||
94381267|NCT00577460|323181190|FG001|Overall Study|Withdrawal by Subject|5|||
94381268|NCT00577460|323181191|FG002|Overall Study|Withdrawal by Subject|6|||
94381269|NCT00577460|323181189|FG000|Overall Study|Other|0|||
94381270|NCT00577460|323181190|FG001|Overall Study|Other|3|||
94381271|NCT00577460|323181191|FG002|Overall Study|Other|2|||
94381272|NCT01734772|323181192|FG000|Overall Study|Adverse Event|1|||
94381273|NCT01734772|323181193|FG001|Overall Study|Adverse Event|2|||
94381274|NCT01734772|323181192|FG000|Overall Study|Withdrawal by Subject|0|||
94381275|NCT01734772|323181193|FG001|Overall Study|Withdrawal by Subject|1|||
94381276|NCT03730103|323181194|FG000|Overall Study|Did not meet inclusion criteria|0|||
94381277|NCT03730103|323181195|FG001|Overall Study|Did not meet inclusion criteria|5|||
94381278|NCT00720122|323181200|FG000|Overall Study|Lost to Follow-up|1|||
94381279|NCT00720122|323181200|FG000|Overall Study|Physician Decision|1|||
94381280|NCT00720122|323181200|FG000|Overall Study|Withdrawal by Subject|7|||
94381281|NCT02275364|323181203|FG000|Period 1|Withdrawal by Subject|1|||
94381282|NCT02275364|323181204|FG001|Period 1|Withdrawal by Subject|0|||
94381283|NCT02275364|323181203|FG000|Period 1|Other reason|1|||
94381284|NCT02275364|323181204|FG001|Period 1|Other reason|0|||
94381285|NCT04591626|323181208|FG000|Overall Study|Adverse Event|4|||
94381286|NCT04591626|323181209|FG001|Overall Study|Adverse Event|0|||
94381287|NCT04591626|323181208|FG000|Overall Study|Withdrawal by Subject|5|||
94310323|NCT04359823|322920439|FG001|Overall Study|Withdrawal by Subject|1|||
94310324|NCT00909090|322920449|FG000|Overall Study|Lost to Follow-up|17|||
94310325|NCT00909090|322920450|FG001|Overall Study|Lost to Follow-up|17|||
94310326|NCT02345434|322920451|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
94381288|NCT04591626|323181209|FG001|Overall Study|Withdrawal by Subject|3|||
94381289|NCT04591626|323181208|FG000|Overall Study|Physician Decision|0|||
94381290|NCT04591626|323181209|FG001|Overall Study|Physician Decision|1|||
94381291|NCT04591626|323181208|FG000|Overall Study|Death|0|||
94381292|NCT04591626|323181209|FG001|Overall Study|Death|1|||
94381293|NCT04591626|323181208|FG000|Overall Study|Non-Compliance with Study Drug|1|||
94381294|NCT04591626|323181209|FG001|Overall Study|Non-Compliance with Study Drug|0|||
94310327|NCT02345434|322920452|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
94310328|NCT02612077|322920453|FG000|Overall Study|Adverse Event|3|||
94310329|NCT02612077|322920453|FG000|Overall Study|Withdrawal by Subject|9|||
94310330|NCT02612077|322920453|FG000|Overall Study|Protocol Violation|28|||
94310331|NCT02612077|322920453|FG000|Overall Study|Lost to Follow-up|20|||
94310332|NCT02612077|322920453|FG000|Overall Study|Death|377|||
94310333|NCT02612077|322920453|FG000|Overall Study|Moved or Changed Medical Team|23|||
94310334|NCT02612077|322920453|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
94310335|NCT02612077|322920453|FG000|Overall Study|Disease Progression|3|||
94310336|NCT02612077|322920453|FG000|Overall Study|Unknown reason|2|||
94310337|NCT01214434|322920456|FG000|Overall Study|Withdrawal by Subject|1|||
94310338|NCT01214434|322920457|FG001|Overall Study|Withdrawal by Subject|0|||
94310339|NCT01214434|322920456|FG000|Overall Study|Lost to Follow-up|2|||
94310340|NCT01214434|322920457|FG001|Overall Study|Lost to Follow-up|2|||
94310341|NCT01214434|322920456|FG000|Overall Study|Site error|1|||
94310342|NCT01214434|322920457|FG001|Overall Study|Site error|0|||
94310343|NCT03792750|322920459|FG000|Overall Study|Death|3|||
94310344|NCT00871858|322920460|FG000|Overall Study|Protocol Violation|3|||
94310345|NCT00871858|322920461|FG001|Overall Study|Protocol Violation|4|||
94310346|NCT00871858|322920460|FG000|Overall Study|Adverse Event|1|||
94310347|NCT00871858|322920461|FG001|Overall Study|Adverse Event|1|||
94310348|NCT00871858|322920460|FG000|Overall Study|Withdrawal by Subject|1|||
94310349|NCT00871858|322920461|FG001|Overall Study|Withdrawal by Subject|1|||
94310350|NCT00871858|322920460|FG000|Overall Study|Lost to Follow-up|0|||
94310351|NCT00871858|322920461|FG001|Overall Study|Lost to Follow-up|1|||
94310352|NCT00700752|322920471|FG000|First Intervention|Withdrawal by Subject|0|||
94310353|NCT00700752|322920472|FG001|First Intervention|Withdrawal by Subject|2|||
94310354|NCT03494725|322920474|FG000|Overall Study|Withdrawal by Subject|0|||
94310355|NCT03494725|322920475|FG001|Overall Study|Withdrawal by Subject|2|||
94310356|NCT03494725|322920474|FG000|Overall Study|Antibiotic use|1|||
94310357|NCT03494725|322920475|FG001|Overall Study|Antibiotic use|0|||
94310358|NCT00723840|322920476|FG000|Overall Study|Lost to Follow-up|2|||
94310359|NCT00723840|322920476|FG000|Overall Study|Failure to return|18|||
94310360|NCT00723840|322920476|FG000|Overall Study|Withdrawal by Subject|55|||
94310361|NCT00723840|322920476|FG000|Overall Study|Serious Adverse Events|3|||
94310362|NCT00723840|322920476|FG000|Overall Study|Other Medical Event|2|||
94310363|NCT00723840|322920476|FG000|Overall Study|Unspecified reason|2|||
94310364|NCT02853331|322920484|FG000|Overall Study|Death|59|||
94310365|NCT02853331|322920485|FG001|Overall Study|Death|95|||
94310366|NCT02853331|322920484|FG000|Overall Study|Withdrawal by Subject|5|||
94310367|NCT02853331|322920485|FG001|Overall Study|Withdrawal by Subject|9|||
94310368|NCT02853331|322920484|FG000|Overall Study|Ongoing in study|368|||
94310369|NCT02853331|322920485|FG001|Overall Study|Ongoing in study|325|||
94310370|NCT01004146|322920496|FG000|Overall Study|Withdrawal by Subject|4|||
94310371|NCT01004146|322920497|FG001|Overall Study|Withdrawal by Subject|5|||
94310372|NCT00970294|322920501|FG000|Overall Study|Physician Decision|4|||
94310373|NCT00970294|322920501|FG000|Overall Study|Withdrawal by Subject|1|||
94310374|NCT01797432|322920504|FG000|Overall Study|Lost to Follow-up|1|||
94310375|NCT01797432|322920504|FG000|Overall Study|Adverse Event|1|||
94310376|NCT01797432|322920504|FG000|Overall Study|Withdrawal by Subject|1|||
94310377|NCT01797432|322920504|FG000|Overall Study|lived too far from study site|1|||
94310378|NCT01595646|322920505|FG000|Overall Study|Withdrawal by Subject|1|||
94310379|NCT01595646|322920506|FG001|Overall Study|Withdrawal by Subject|0|||
94310380|NCT01595646|322920507|FG002|Overall Study|Withdrawal by Subject|0|||
94310381|NCT01618656|322920512|FG000|Overall Study|Withdrawal by Subject|7|||
94310382|NCT01618656|322920513|FG001|Overall Study|Withdrawal by Subject|3|||
94310383|NCT01618656|322920512|FG000|Overall Study|Physician Decision|1|||
94310384|NCT01618656|322920513|FG001|Overall Study|Physician Decision|1|||
94310385|NCT00231062|322920514|FG000|Overall Study|Physician Decision|6|||
94310386|NCT00803244|322920517|FG000|Overall Study|Adverse Event|1|||
94310387|NCT00803244|322920518|FG001|Overall Study|Adverse Event|2|||
94310388|NCT00803244|322920517|FG000|Overall Study|Withdrawal by Subject|2|||
94310389|NCT00803244|322920518|FG001|Overall Study|Withdrawal by Subject|3|||
94310390|NCT00803244|322920517|FG000|Overall Study|Any other reason not above-mentioned|4|||
94310391|NCT00803244|322920518|FG001|Overall Study|Any other reason not above-mentioned|10|||
94310392|NCT02119104|322920521|FG000|Overall Study|Protocol Violation|16|||
94310393|NCT01469052|322920524|FG000|Overall Study|Adverse Event|2|||
94310394|NCT01469052|322920525|FG001|Overall Study|Adverse Event|3|||
94310395|NCT01469052|322920526|FG002|Overall Study|Adverse Event|0|||
94310396|NCT01469052|322920527|FG003|Overall Study|Adverse Event|2|||
94310397|NCT01469052|322920528|FG004|Overall Study|Adverse Event|0|||
94310398|NCT01469052|322920529|FG005|Overall Study|Adverse Event|1|||
94310399|NCT01469052|322920524|FG000|Overall Study|Progressive disease|3|||
94310400|NCT01469052|322920525|FG001|Overall Study|Progressive disease|0|||
94310401|NCT01469052|322920526|FG002|Overall Study|Progressive disease|5|||
94310402|NCT01469052|322920527|FG003|Overall Study|Progressive disease|3|||
94310403|NCT01469052|322920528|FG004|Overall Study|Progressive disease|7|||
94310404|NCT01469052|322920529|FG005|Overall Study|Progressive disease|2|||
94310405|NCT01469052|322920524|FG000|Overall Study|Lack of Efficacy|0|||
94310406|NCT01469052|322920525|FG001|Overall Study|Lack of Efficacy|0|||
94310407|NCT01469052|322920526|FG002|Overall Study|Lack of Efficacy|0|||
94310408|NCT01469052|322920527|FG003|Overall Study|Lack of Efficacy|0|||
94310409|NCT01469052|322920528|FG004|Overall Study|Lack of Efficacy|0|||
94310410|NCT01469052|322920529|FG005|Overall Study|Lack of Efficacy|2|||
94310411|NCT01469052|322920524|FG000|Overall Study|Moved to rollover protocol|1|||
94310412|NCT01469052|322920525|FG001|Overall Study|Moved to rollover protocol|0|||
94310413|NCT01469052|322920526|FG002|Overall Study|Moved to rollover protocol|1|||
94310414|NCT01469052|322920527|FG003|Overall Study|Moved to rollover protocol|0|||
94310415|NCT01469052|322920528|FG004|Overall Study|Moved to rollover protocol|0|||
94310416|NCT01469052|322920529|FG005|Overall Study|Moved to rollover protocol|1|||
94310417|NCT01469052|322920524|FG000|Overall Study|Other|0|||
94310418|NCT01469052|322920525|FG001|Overall Study|Other|1|||
94310419|NCT01469052|322920526|FG002|Overall Study|Other|0|||
94310420|NCT01469052|322920527|FG003|Overall Study|Other|0|||
94310421|NCT01469052|322920528|FG004|Overall Study|Other|1|||
94310422|NCT01469052|322920529|FG005|Overall Study|Other|0|||
94310423|NCT01519427|322920530|FG000|Overall Study|disease progression|2|||
94310424|NCT00365976|322920537|FG000|Overall Study|Withdrawal by Subject|1|||
94310425|NCT00365976|322920538|FG001|Overall Study|Withdrawal by Subject|5|||
94310426|NCT01345786|322920539|FG000|Overall Study|Adverse Event|0|||
94310427|NCT01345786|322920540|FG001|Overall Study|Adverse Event|1|||
94310428|NCT01345786|322920541|FG002|Overall Study|Adverse Event|3|||
94310429|NCT01345786|322920542|FG003|Overall Study|Adverse Event|1|||
94310430|NCT01345786|322920539|FG000|Overall Study|Subject withdrew consent|2|||
94310431|NCT01345786|322920540|FG001|Overall Study|Subject withdrew consent|2|||
94310432|NCT01345786|322920541|FG002|Overall Study|Subject withdrew consent|1|||
94310433|NCT01345786|322920542|FG003|Overall Study|Subject withdrew consent|0|||
94310434|NCT01345786|322920539|FG000|Overall Study|Noncompliance with protocol|1|||
94310435|NCT01345786|322920540|FG001|Overall Study|Noncompliance with protocol|0|||
94310436|NCT01345786|322920541|FG002|Overall Study|Noncompliance with protocol|1|||
94310437|NCT01345786|322920542|FG003|Overall Study|Noncompliance with protocol|0|||
94310438|NCT01345786|322920539|FG000|Overall Study|Administrative|3|||
94310439|NCT01345786|322920540|FG001|Overall Study|Administrative|5|||
94310440|NCT01345786|322920541|FG002|Overall Study|Administrative|0|||
94310441|NCT01345786|322920542|FG003|Overall Study|Administrative|0|||
94310442|NCT01345786|322920539|FG000|Overall Study|Lost to Follow-up|0|||
94310443|NCT01345786|322920540|FG001|Overall Study|Lost to Follow-up|0|||
94310444|NCT01345786|322920541|FG002|Overall Study|Lost to Follow-up|0|||
94310445|NCT01345786|322920542|FG003|Overall Study|Lost to Follow-up|2|||
94310446|NCT02190435|322920543|FG000|Overall Study|First 12 patients were lead-ins|12|||
94310447|NCT02190435|322920544|FG001|Overall Study|First 12 patients were lead-ins|0|||
94310448|NCT02190435|322920543|FG000|Overall Study|3 consented screen fails|3|||
94310449|NCT02190435|322920544|FG001|Overall Study|3 consented screen fails|0|||
94310450|NCT01200511|322920552|FG000|Overall Study|Lost to Follow-up|3|||
94310451|NCT01200511|322920552|FG000|Overall Study|Withdrawal by Subject|1|||
94381295|NCT03066999|323181210|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
94381296|NCT03066999|323181211|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
94381297|NCT02928848|323181212|FG000|Arm 2|Withdrawal by Subject|1|||
94381298|NCT02928848|323181213|FG001|Arm 2|Withdrawal by Subject|0|||
94381299|NCT02994056|323181214|FG000|Overall Study|Death|8|||
94381300|NCT02994056|323181214|FG000|Overall Study|Withdrew Consent|1|||
94381301|NCT00182091|323181215|FG000|Overall Study|Withdrawal by Subject|1|||
94381302|NCT00182091|323181216|FG001|Overall Study|Withdrawal by Subject|0|||
94381303|NCT00182091|323181217|FG002|Overall Study|Withdrawal by Subject|0|||
94381304|NCT00182091|323181218|FG003|Overall Study|Withdrawal by Subject|0|||
94381305|NCT04094870|323181219|FG000|Overall Study|Lost to Follow-up|1|||
94381306|NCT04094870|323181220|FG001|Overall Study|Lost to Follow-up|1|||
94381307|NCT02739984|323181223|FG000|Overall Study|Sponsor Decision|1|||
94381308|NCT02739984|323181224|FG001|Overall Study|Sponsor Decision|0|||
94381309|NCT02739984|323181223|FG000|Overall Study|Withdrawal by Subject|1|||
94381310|NCT02739984|323181224|FG001|Overall Study|Withdrawal by Subject|1|||
94381311|NCT02739984|323181223|FG000|Overall Study|Death|0|||
94381312|NCT02739984|323181224|FG001|Overall Study|Death|1|||
94381313|NCT02739984|323181223|FG000|Overall Study|Lost to Follow-up|3|||
94381314|NCT02739984|323181224|FG001|Overall Study|Lost to Follow-up|0|||
94310452|NCT01200511|322920552|FG000|Overall Study|Adverse Event|1|||
94310453|NCT00336492|322920553|FG000|Overall Study|Adverse Event|4|||
94310454|NCT00336492|322920554|FG001|Overall Study|Adverse Event|3|||
94310455|NCT00336492|322920555|FG002|Overall Study|Adverse Event|6|||
94310456|NCT00336492|322920553|FG000|Overall Study|Lack of Efficacy|6|||
94310457|NCT00336492|322920554|FG001|Overall Study|Lack of Efficacy|1|||
94310458|NCT00336492|322920555|FG002|Overall Study|Lack of Efficacy|4|||
94310459|NCT00336492|322920553|FG000|Overall Study|Other|5|||
94473179|NCT05052697|323523389|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94310460|NCT00336492|322920554|FG001|Overall Study|Other|0|||
94310461|NCT00336492|322920555|FG002|Overall Study|Other|1|||
94310462|NCT02504892|322920556|FG000|Overall Study|Adverse event-pneumonitis|2|||
94381315|NCT05200858|323181228|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
94381316|NCT05200858|323181229|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
94381317|NCT05200858|323181230|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
94381318|NCT05200858|323181231|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
94381319|NCT01611090|323181232|FG000|Randomized Period|Lost to Follow-up|8|||
94381320|NCT01611090|323181233|FG001|Randomized Period|Lost to Follow-up|3|||
94381321|NCT01611090|323181234|FG002|Randomized Period|Lost to Follow-up|0|||
94381322|NCT01611090|323181232|FG000|Randomized Period|Withdrawal by Subject|22|||
94381323|NCT01611090|323181233|FG001|Randomized Period|Withdrawal by Subject|26|||
94381324|NCT01611090|323181234|FG002|Randomized Period|Withdrawal by Subject|0|||
94381325|NCT01611090|323181232|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
94381326|NCT01611090|323181233|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
94381327|NCT01611090|323181234|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
94381328|NCT01611090|323181232|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
94381329|NCT01611090|323181233|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
94381330|NCT01611090|323181234|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
94381331|NCT01469364|323183212|FG000|Overall Study|Adverse Event|1|||
94381332|NCT01469364|323183212|FG000|Overall Study|Withdrawal by Subject|1|||
94381333|NCT00278200|323183213|FG000|Overall Study|Death|1|||
94381334|NCT00278200|323183214|FG001|Overall Study|Death|3|||
94381335|NCT00278200|323183213|FG000|Overall Study|Physician Decision|0|||
94381336|NCT00278200|323183214|FG001|Overall Study|Physician Decision|1|||
94381337|NCT00130520|323183215|FG000|Overall Study|Adverse Event|11|||
94381338|NCT00130520|323183215|FG000|Overall Study|Death|1|||
94381339|NCT00130520|323183215|FG000|Overall Study|Physician Decision|1|||
94381340|NCT00130520|323183215|FG000|Overall Study|Withdrawal by Subject|1|||
94381341|NCT00130520|323183215|FG000|Overall Study|Disease Progression|23|||
94381342|NCT00130520|323183215|FG000|Overall Study|Protocol non-compliance|1|||
94381343|NCT00130520|323183215|FG000|Overall Study|Did not meet re-treatment criteria|1|||
94381344|NCT00958256|323183216|FG000|Overall Study|Adverse Event|3|||
94381345|NCT03036579|323183219|FG000|2 Years|Lost to Follow-up|1|||
94381346|NCT03036579|323183220|FG001|2 Years|Lost to Follow-up|0|||
94381347|NCT03036579|323183219|FG000|3 Years|Lost to Follow-up|0|||
94381348|NCT03036579|323183220|FG001|3 Years|Lost to Follow-up|1|||
94381349|NCT00421174|323183227|FG000|Overall Study|Withdrawal by Subject|0|||
94381350|NCT00421174|323183228|FG001|Overall Study|Withdrawal by Subject|1|||
94381351|NCT00421174|323183227|FG000|Overall Study|Ineligible due to infection|2|||
94381352|NCT00421174|323183228|FG001|Overall Study|Ineligible due to infection|0|||
94381353|NCT00992407|323183229|FG000|Overall Study|Protocol Violation|2|||
94381354|NCT00992407|323183230|FG001|Overall Study|Protocol Violation|1|||
94381355|NCT00992407|323183229|FG000|Overall Study|Lost to Follow-up|3|||
94381356|NCT00992407|323183230|FG001|Overall Study|Lost to Follow-up|3|||
94381357|NCT00992407|323183229|FG000|Overall Study|Adverse Event|3|||
94381358|NCT00992407|323183230|FG001|Overall Study|Adverse Event|2|||
94381359|NCT00992407|323183229|FG000|Overall Study|protocol Violation & Adverse events|2|||
94381360|NCT00992407|323183230|FG001|Overall Study|protocol Violation & Adverse events|4|||
94381361|NCT00992407|323183229|FG000|Overall Study|Other|2|||
94381362|NCT00992407|323183230|FG001|Overall Study|Other|0|||
94381363|NCT00992407|323183229|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
94381364|NCT00992407|323183230|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
94381365|NCT00992407|323183229|FG000|Overall Study|Study medication not administered|17|||
94381366|NCT00992407|323183230|FG001|Overall Study|Study medication not administered|13|||
94381367|NCT02336737|323183231|FG000|Overall Study|Withdrawal by Subject|5|||
94381368|NCT02336737|323183231|FG000|Overall Study|Physician Decision|8|||
94381369|NCT02228382|323183232|FG000|Overall Study|Death|5|||
94381370|NCT02228382|323183233|FG001|Overall Study|Death|7|||
94381371|NCT02228382|323183234|FG002|Overall Study|Death|5|||
94381372|NCT02228382|323183235|FG003|Overall Study|Death|0|||
94381373|NCT02228382|323183236|FG004|Overall Study|Death|2|||
94381374|NCT02228382|323183232|FG000|Overall Study|Participant refused further follow-up|0|||
94381375|NCT02228382|323183233|FG001|Overall Study|Participant refused further follow-up|0|||
94473180|NCT05052697|323523390|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94381376|NCT02228382|323183234|FG002|Overall Study|Participant refused further follow-up|1|||
94381377|NCT02228382|323183235|FG003|Overall Study|Participant refused further follow-up|0|||
94381378|NCT02228382|323183236|FG004|Overall Study|Participant refused further follow-up|0|||
94381379|NCT02228382|323183232|FG000|Overall Study|Study terminated by sponsor|3|||
94381380|NCT02228382|323183233|FG001|Overall Study|Study terminated by sponsor|5|||
94381381|NCT02228382|323183234|FG002|Overall Study|Study terminated by sponsor|7|||
94473181|NCT05052697|323523391|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473182|NCT05052697|323523392|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94381382|NCT02228382|323183235|FG003|Overall Study|Study terminated by sponsor|0|||
94381383|NCT02228382|323183236|FG004|Overall Study|Study terminated by sponsor|0|||
94381384|NCT02228382|323183232|FG000|Overall Study|Lost to Follow-up|0|||
94381385|NCT02228382|323183233|FG001|Overall Study|Lost to Follow-up|0|||
94381386|NCT02228382|323183234|FG002|Overall Study|Lost to Follow-up|3|||
94473183|NCT05052697|323523393|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473184|NCT05052697|323523394|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94310463|NCT01781026|322920557|FG000|Overall Study|Lack of Efficacy|2|||
94310464|NCT03090737|322920560|FG000|Overall Study|Other reasons|1|||
94310465|NCT03090737|322920560|FG000|Overall Study|Completed treatment as per protocol|17|||
94310466|NCT03090737|322920560|FG000|Overall Study|Maximum clinical benefit|2|||
94310467|NCT03090737|322920560|FG000|Overall Study|Adverse event unrelated to study drug|7|||
94310468|NCT03090737|322920560|FG000|Overall Study|Study drug toxicity|4|||
94310469|NCT03090737|322920560|FG000|Overall Study|Disease progression|98|||
94310470|NCT00227877|322920561|FG000|Pre-visit Assessment|Technical difficulties|7|||
94310471|NCT00227877|322920562|FG001|Pre-visit Assessment|Technical difficulties|3|||
94310472|NCT00227877|322920563|FG002|Pre-visit Assessment|Technical difficulties|0|||
94310473|NCT00227877|322920564|FG003|Pre-visit Assessment|Technical difficulties|0|||
94310474|NCT00227877|322920561|FG000|Post-visit Checklist|Lost to Follow-up|24|||
94310475|NCT00227877|322920562|FG001|Post-visit Checklist|Lost to Follow-up|13|||
94310476|NCT00227877|322920563|FG002|Post-visit Checklist|Lost to Follow-up|1|||
94310477|NCT00227877|322920564|FG003|Post-visit Checklist|Lost to Follow-up|0|||
94310478|NCT00227877|322920561|FG000|3-months Follow-up|Completed late|135|||
94310479|NCT00227877|322920562|FG001|3-months Follow-up|Completed late|128|||
94310480|NCT00227877|322920563|FG002|3-months Follow-up|Completed late|34|||
94310481|NCT00227877|322920564|FG003|3-months Follow-up|Completed late|8|||
94310482|NCT00227877|322920561|FG000|3-months Follow-up|Lost to Follow-up|178|||
94310483|NCT00227877|322920562|FG001|3-months Follow-up|Lost to Follow-up|139|||
94310484|NCT00227877|322920563|FG002|3-months Follow-up|Lost to Follow-up|18|||
94310485|NCT00227877|322920564|FG003|3-months Follow-up|Lost to Follow-up|13|||
94310486|NCT00227877|322920561|FG000|12-months Follow-up|Completed late|78|||
94310487|NCT00227877|322920562|FG001|12-months Follow-up|Completed late|74|||
94310488|NCT00227877|322920563|FG002|12-months Follow-up|Completed late|1|||
94310489|NCT00227877|322920564|FG003|12-months Follow-up|Completed late|0|||
94310490|NCT00227877|322920561|FG000|12-months Follow-up|Lost to Follow-up|232|||
94310491|NCT00227877|322920562|FG001|12-months Follow-up|Lost to Follow-up|189|||
94310492|NCT00227877|322920563|FG002|12-months Follow-up|Lost to Follow-up|30|||
94310493|NCT00227877|322920564|FG003|12-months Follow-up|Lost to Follow-up|26|||
94310494|NCT04083222|322920567|FG000|Overall Study|Voluntary Withdrawal|0|||
94310495|NCT04083222|322920568|FG001|Overall Study|Voluntary Withdrawal|1|||
94310496|NCT04083222|322920567|FG000|Overall Study|Reason not Specified|0|||
94310497|NCT04083222|322920568|FG001|Overall Study|Reason not Specified|1|||
94310498|NCT01040832|322921950|FG000|Overall Study|Adverse Event|4|||
94310499|NCT01040832|322921951|FG001|Overall Study|Adverse Event|5|||
94310500|NCT01040832|322921950|FG000|Overall Study|Death|4|||
94310501|NCT01040832|322921951|FG001|Overall Study|Death|6|||
94310502|NCT01040832|322921950|FG000|Overall Study|Withdrawal by Subject|2|||
94310503|NCT01040832|322921951|FG001|Overall Study|Withdrawal by Subject|3|||
94310504|NCT01040832|322921950|FG000|Overall Study|Progressive disease|32|||
94310505|NCT01040832|322921951|FG001|Overall Study|Progressive disease|17|||
94310506|NCT01040832|322921950|FG000|Overall Study|Symptomatic deterioration|2|||
94381387|NCT02228382|323183235|FG003|Overall Study|Lost to Follow-up|1|||
94381388|NCT02228382|323183236|FG004|Overall Study|Lost to Follow-up|0|||
94381389|NCT02228382|323183232|FG000|Overall Study|Withdrawal by Subject|0|||
94381390|NCT02228382|323183233|FG001|Overall Study|Withdrawal by Subject|3|||
94381391|NCT02228382|323183234|FG002|Overall Study|Withdrawal by Subject|2|||
94381392|NCT02228382|323183235|FG003|Overall Study|Withdrawal by Subject|1|||
94381393|NCT02228382|323183236|FG004|Overall Study|Withdrawal by Subject|0|||
94381394|NCT02228382|323183232|FG000|Overall Study|Other|2|||
94381395|NCT02228382|323183233|FG001|Overall Study|Other|3|||
94381396|NCT02228382|323183234|FG002|Overall Study|Other|3|||
94381397|NCT02228382|323183235|FG003|Overall Study|Other|0|||
94381398|NCT02228382|323183236|FG004|Overall Study|Other|0|||
94381399|NCT01238848|323183238|FG000|Overall Study|Physician Decision|13|||
94381400|NCT01238848|323183239|FG001|Overall Study|Physician Decision|5|||
94381401|NCT01755858|323183242|FG000|Overall Study|Adverse Event|1|||
94381402|NCT01755858|323183243|FG001|Overall Study|Adverse Event|1|||
94381403|NCT02396381|323183244|FG000|Overall Study|Adverse Event|3|||
94381404|NCT02396381|323183245|FG001|Overall Study|Adverse Event|2|||
94381405|NCT02396381|323183244|FG000|Overall Study|Withdrawal by Subject|33|||
94381406|NCT02396381|323183245|FG001|Overall Study|Withdrawal by Subject|24|||
94473185|NCT05052697|323523395|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473186|NCT05052697|323523396|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94310507|NCT01040832|322921951|FG001|Overall Study|Symptomatic deterioration|5|||
94310508|NCT01040832|322921950|FG000|Overall Study|Other|2|||
94310509|NCT01040832|322921951|FG001|Overall Study|Other|1|||
94381407|NCT02396381|323183244|FG000|Overall Study|Lost to Follow-up|49|||
94381408|NCT02396381|323183245|FG001|Overall Study|Lost to Follow-up|31|||
94381409|NCT02396381|323183244|FG000|Overall Study|Protocol Violation|1|||
94381410|NCT02396381|323183245|FG001|Overall Study|Protocol Violation|0|||
94381411|NCT02396381|323183244|FG000|Overall Study|Site terminated by sponsor|7|||
94381412|NCT02396381|323183245|FG001|Overall Study|Site terminated by sponsor|8|||
94381413|NCT02396381|323183244|FG000|Overall Study|Physician Decision|5|||
94381414|NCT02396381|323183245|FG001|Overall Study|Physician Decision|5|||
94310510|NCT01300286|322921952|FG000|Overall Study|did not get dosed|1|||
94310511|NCT00417612|322921953|FG000|Overall Study|Errant diagnosis|0|||
94310512|NCT00417612|322921954|FG001|Overall Study|Errant diagnosis|1|||
94310513|NCT00417612|322921953|FG000|Overall Study|Adverse Event|2|||
94310514|NCT00417612|322921954|FG001|Overall Study|Adverse Event|0|||
94310515|NCT00417612|322921953|FG000|Overall Study|Protocol Violation|0|||
94310516|NCT00417612|322921954|FG001|Overall Study|Protocol Violation|2|||
94310517|NCT00417612|322921953|FG000|Overall Study|Lost to Follow-up|1|||
94310518|NCT00417612|322921954|FG001|Overall Study|Lost to Follow-up|0|||
94310519|NCT00486226|322921957|FG000|Overall Study|Death|3|||
94310520|NCT00486226|322921957|FG000|Overall Study|Adverse Event|1|||
94310521|NCT00486226|322921957|FG000|Overall Study|Withdrawal by Subject|1|||
94310522|NCT00486226|322921957|FG000|Overall Study|Lost to Follow-up|8|||
94310523|NCT03242928|322921959|FG000|Overall Study|Adverse Event|2|||
94310524|NCT03242928|322921960|FG001|Overall Study|Adverse Event|1|||
94310525|NCT03242928|322921959|FG000|Overall Study|Lost to Follow-up|2|||
94310526|NCT03242928|322921960|FG001|Overall Study|Lost to Follow-up|0|||
94310527|NCT03242928|322921959|FG000|Overall Study|Physician Decision|0|||
94310528|NCT03242928|322921960|FG001|Overall Study|Physician Decision|1|||
94310529|NCT03242928|322921959|FG000|Overall Study|Withdrawal by Subject|5|||
94310530|NCT03242928|322921960|FG001|Overall Study|Withdrawal by Subject|3|||
94310531|NCT02207530|322921961|FG000|Overall Study|Worsening condition under investigation|78|||
94310532|NCT02207530|322921961|FG000|Overall Study|Patient decision to stop study treatment|5|||
94310533|NCT02207530|322921961|FG000|Overall Study|Adverse Event|8|||
94310534|NCT00536731|322921962|FG000|Overall Study|Adverse Event|3|||
94310535|NCT00536731|322921963|FG001|Overall Study|Adverse Event|2|||
94310536|NCT00536731|322921964|FG002|Overall Study|Adverse Event|3|||
94310537|NCT00536731|322921962|FG000|Overall Study|Withdrawal by Subject|0|||
94310538|NCT00536731|322921963|FG001|Overall Study|Withdrawal by Subject|2|||
94310539|NCT00536731|322921964|FG002|Overall Study|Withdrawal by Subject|0|||
94310540|NCT00536731|322921962|FG000|Overall Study|Intake of prohibited conc. medication|0|||
94310541|NCT00536731|322921963|FG001|Overall Study|Intake of prohibited conc. medication|0|||
94310542|NCT00536731|322921964|FG002|Overall Study|Intake of prohibited conc. medication|1|||
94310543|NCT00536731|322921962|FG000|Overall Study|Safety reasons|0|||
94310544|NCT00536731|322921963|FG001|Overall Study|Safety reasons|0|||
94310545|NCT00536731|322921964|FG002|Overall Study|Safety reasons|1|||
94310546|NCT00536731|322921962|FG000|Overall Study|Other|1|||
94310547|NCT00536731|322921963|FG001|Overall Study|Other|1|||
94310548|NCT00536731|322921964|FG002|Overall Study|Other|0|||
94310549|NCT01103349|322921967|FG000|Overall Study|Adverse Event|8|||
94310550|NCT01103349|322921968|FG001|Overall Study|Adverse Event|5|||
94310551|NCT01103349|322921969|FG002|Overall Study|Adverse Event|3|||
94310552|NCT01103349|322921967|FG000|Overall Study|Consent withdrawn|1|||
94310553|NCT01103349|322921968|FG001|Overall Study|Consent withdrawn|0|||
94310554|NCT01103349|322921969|FG002|Overall Study|Consent withdrawn|0|||
94310555|NCT01103349|322921967|FG000|Overall Study|Incorrectly included in the trial|1|||
94310556|NCT01103349|322921968|FG001|Overall Study|Incorrectly included in the trial|0|||
94310557|NCT01103349|322921969|FG002|Overall Study|Incorrectly included in the trial|0|||
94310558|NCT01103349|322921967|FG000|Overall Study|Withdrawal by Subject|1|||
94310559|NCT01103349|322921968|FG001|Overall Study|Withdrawal by Subject|1|||
94310560|NCT01103349|322921969|FG002|Overall Study|Withdrawal by Subject|0|||
94310561|NCT01103349|322921967|FG000|Overall Study|did not want to take trial medication|0|||
94310562|NCT01103349|322921968|FG001|Overall Study|did not want to take trial medication|1|||
94310563|NCT01103349|322921969|FG002|Overall Study|did not want to take trial medication|0|||
94310564|NCT01103349|322921967|FG000|Overall Study|forgot to take medication|0|||
94310565|NCT01103349|322921968|FG001|Overall Study|forgot to take medication|0|||
94310566|NCT01103349|322921969|FG002|Overall Study|forgot to take medication|1|||
94310567|NCT00958568|322921971|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
94310568|NCT00958568|322921972|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
94310569|NCT00958568|322921973|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
94310570|NCT00958568|322921974|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
94310571|NCT00958568|322921971|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
94310572|NCT00958568|322921972|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
94310573|NCT00958568|322921973|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
94310574|NCT00958568|322921974|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
94310575|NCT00958568|322921971|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
94310576|NCT00958568|322921972|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
94310577|NCT00958568|322921973|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
94310578|NCT00958568|322921974|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
94310579|NCT00958568|322921971|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
94310580|NCT00958568|322921972|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
94310581|NCT00958568|322921973|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
94381415|NCT02396381|323183244|FG000|Overall Study|Pregnancy|2|||
94381416|NCT02396381|323183245|FG001|Overall Study|Pregnancy|0|||
94381417|NCT02396381|323183244|FG000|Overall Study|Non-compliance with study procedures|1|||
94381418|NCT02396381|323183245|FG001|Overall Study|Non-compliance with study procedures|0|||
94381419|NCT02396381|323183244|FG000|Overall Study|Moved out of town/state|1|||
94381420|NCT02396381|323183245|FG001|Overall Study|Moved out of town/state|3|||
94381421|NCT02396381|323183244|FG000|Overall Study|Could not complete visit|1|||
94381422|NCT02396381|323183245|FG001|Overall Study|Could not complete visit|0|||
94381423|NCT02396381|323183244|FG000|Overall Study|Possible conflict of interest|1|||
94381424|NCT02396381|323183245|FG001|Overall Study|Possible conflict of interest|0|||
94381425|NCT02396381|323183244|FG000|Overall Study|Randomization/Screening Error|3|||
94381426|NCT02396381|323183245|FG001|Overall Study|Randomization/Screening Error|1|||
94381427|NCT02918162|323183247|FG000|Overall Study|Withdrawal by Subject|1|||
94381428|NCT02918162|323183247|FG000|Overall Study|Omental Disease|1|||
94381429|NCT00395226|323183248|FG000|Overall Study|Adverse Event|4|||
94381430|NCT00395226|323183249|FG001|Overall Study|Adverse Event|3|||
94381431|NCT00395226|323183248|FG000|Overall Study|Withdrawal by Subject|0|||
94381432|NCT00395226|323183249|FG001|Overall Study|Withdrawal by Subject|1|||
94381433|NCT00395226|323183248|FG000|Overall Study|Lost to Follow-up|0|||
94381434|NCT00395226|323183249|FG001|Overall Study|Lost to Follow-up|1|||
94381435|NCT02324465|323183253|FG000|Overall Study|device failure|0|||
94381436|NCT02324465|323183254|FG001|Overall Study|device failure|1|||
94381437|NCT00262600|323183255|FG000|Overall Study|Lost to Follow-up|17|||
94381438|NCT00262600|323183256|FG001|Overall Study|Lost to Follow-up|31|||
94381439|NCT00262600|323183257|FG002|Overall Study|Lost to Follow-up|41|||
94381440|NCT00262600|323183255|FG000|Overall Study|Withdrawal by Subject|128|||
94381441|NCT00262600|323183256|FG001|Overall Study|Withdrawal by Subject|145|||
94381442|NCT00262600|323183257|FG002|Overall Study|Withdrawal by Subject|139|||
94381443|NCT00262600|323183255|FG000|Overall Study|Not Treated|32|||
94381444|NCT00262600|323183256|FG001|Overall Study|Not Treated|17|||
94381445|NCT00262600|323183257|FG002|Overall Study|Not Treated|24|||
94381446|NCT00262600|323183255|FG000|Overall Study|Other|58|||
94381447|NCT00262600|323183256|FG001|Overall Study|Other|59|||
94381448|NCT00262600|323183257|FG002|Overall Study|Other|62|||
94381449|NCT04471207|323183258|FG000|Overall Study|Lost to Follow-up|4|||
94381450|NCT04471207|323183259|FG001|Overall Study|Lost to Follow-up|1|||
94381451|NCT04471207|323183258|FG000|Overall Study|Medication Contraindication|0|||
94381452|NCT04471207|323183259|FG001|Overall Study|Medication Contraindication|1|||
94381453|NCT04471207|323183258|FG000|Overall Study|Loss of Interest|2|||
94381454|NCT04471207|323183259|FG001|Overall Study|Loss of Interest|1|||
94381455|NCT04471207|323183258|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
94381456|NCT04471207|323183259|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
94381457|NCT04471207|323183258|FG000|Overall Study|Scheduling Conflicts|3|||
94381458|NCT04471207|323183259|FG001|Overall Study|Scheduling Conflicts|1|||
94381459|NCT04471207|323183258|FG000|Overall Study|Physician Decision|1|||
94381460|NCT04471207|323183259|FG001|Overall Study|Physician Decision|0|||
94381461|NCT04471207|323183258|FG000|Overall Study|Unwilling to Use System|0|||
94381462|NCT04471207|323183259|FG001|Overall Study|Unwilling to Use System|1|||
94381463|NCT02655237|323183260|FG000|Overall Study|Adverse Event|10|||
94381464|NCT02655237|323183261|FG001|Overall Study|Adverse Event|7|||
94381465|NCT02655237|323183260|FG000|Overall Study|Protocol Deviation|2|||
94381466|NCT02655237|323183261|FG001|Overall Study|Protocol Deviation|0|||
94381467|NCT02655237|323183260|FG000|Overall Study|Withdrawal by Participant|1|||
94381468|NCT02655237|323183261|FG001|Overall Study|Withdrawal by Participant|2|||
94381469|NCT02655237|323183260|FG000|Overall Study|Lack of Efficacy|0|||
94381470|NCT02655237|323183261|FG001|Overall Study|Lack of Efficacy|1|||
94381471|NCT02655237|323183260|FG000|Overall Study|Recovery Leading to Surgery|2|||
94381472|NCT02655237|323183261|FG001|Overall Study|Recovery Leading to Surgery|1|||
94381473|NCT02655237|323183260|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
94381474|NCT02655237|323183261|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
94381475|NCT02655237|323183260|FG000|Overall Study|Randomized but Not Treated|1|||
94381476|NCT02655237|323183261|FG001|Overall Study|Randomized but Not Treated|0|||
94381477|NCT02132247|323183271|FG000|Overall Study|Protocol Violation|1|||
94381478|NCT02132247|323183272|FG001|Overall Study|Protocol Violation|0|||
94381479|NCT03019965|323183276|FG000|Overall Study|Withdrawal by Subject|1|||
94473187|NCT05052697|323523397|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473188|NCT05052697|323523398|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473189|NCT05052697|323523399|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473190|NCT05052697|323523400|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473191|NCT05052697|323523401|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94381480|NCT03019965|323183277|FG001|Overall Study|Withdrawal by Subject|0|||
94381481|NCT03019965|323183276|FG000|Overall Study|Protocol Violation|1|||
94381482|NCT03019965|323183277|FG001|Overall Study|Protocol Violation|3|||
94381483|NCT03019965|323183276|FG000|Overall Study|viral or fungal infection|3|||
94381484|NCT03019965|323183277|FG001|Overall Study|viral or fungal infection|4|||
94381485|NCT03019965|323183276|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
94381486|NCT03019965|323183277|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
94381487|NCT03019965|323183276|FG000|Overall Study|Physician Decision|1|||
94381488|NCT03019965|323183277|FG001|Overall Study|Physician Decision|1|||
94310582|NCT00958568|322921974|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
94310583|NCT00958568|322921971|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
94310584|NCT00958568|322921972|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
94310585|NCT00958568|322921973|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
94310586|NCT00958568|322921974|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
94310587|NCT00958568|322921971|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
94310588|NCT00958568|322921972|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
94310589|NCT00958568|322921973|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
94310590|NCT00958568|322921974|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
94310591|NCT00958568|322921971|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
94310592|NCT00958568|322921972|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
94310593|NCT00958568|322921973|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
94310594|NCT00958568|322921974|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
94310595|NCT00958568|322921971|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
94310596|NCT00958568|322921972|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
94310597|NCT00958568|322921973|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
94310598|NCT00958568|322921974|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
94310599|NCT00958568|322921971|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
94310600|NCT00958568|322921972|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
94310601|NCT00958568|322921973|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
94310602|NCT00958568|322921974|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
94310603|NCT00958568|322921971|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
94310604|NCT00958568|322921972|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
94310605|NCT00958568|322921973|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
94310606|NCT00958568|322921974|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
94381489|NCT01659567|323183278|FG000|Overall Study|Lack of Efficacy|22|||
94381490|NCT01659567|323183278|FG000|Overall Study|Switched to Pegferon|6|||
94381491|NCT01659567|323183278|FG000|Overall Study|Adverse Event|12|||
94381492|NCT01659567|323183278|FG000|Overall Study|Good result at early stage of treatment|5|||
94381493|NCT01659567|323183278|FG000|Overall Study|Withdrawal by Subject|64|||
94381494|NCT01659567|323183278|FG000|Overall Study|Progression of the main disease|1|||
94381495|NCT01659567|323183278|FG000|Overall Study|Other|13|||
94381496|NCT01513148|323183279|FG000|Overall Study|Protocol Violation|2|||
94381497|NCT01513148|323183280|FG001|Overall Study|Protocol Violation|2|||
94381498|NCT03982433|323183281|FG000|Overall Study|Lost to Follow-up|1|||
94381499|NCT01411995|323183284|FG000|Overall Study|Failed IUD insertion|0|||
94381500|NCT01411995|323183285|FG001|Overall Study|Failed IUD insertion|1|||
94381501|NCT00368277|323183286|FG000|Overall Study|Adverse Event|33|||
94381502|NCT00368277|323183287|FG001|Overall Study|Adverse Event|49|||
94381503|NCT00368277|323183286|FG000|Overall Study|Death|2|||
94381504|NCT00368277|323183287|FG001|Overall Study|Death|1|||
94381505|NCT00368277|323183286|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
94381506|NCT00368277|323183287|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
94381507|NCT00368277|323183286|FG000|Overall Study|Protocol deviation|7|||
94381508|NCT00368277|323183287|FG001|Overall Study|Protocol deviation|0|||
94381509|NCT00368277|323183286|FG000|Overall Study|Patient withdrew consent|32|||
94381510|NCT00368277|323183287|FG001|Overall Study|Patient withdrew consent|28|||
94381511|NCT00368277|323183286|FG000|Overall Study|Lost to Follow-up|8|||
94381512|NCT00368277|323183287|FG001|Overall Study|Lost to Follow-up|6|||
94381513|NCT00788957|323183289|FG000|Part 1|Death|8|||
94381514|NCT00788957|323183290|FG001|Part 1|Death|0|||
94381515|NCT00788957|323183291|FG002|Part 1|Death|0|||
94381516|NCT00788957|323183292|FG003|Part 1|Death|0|||
94381517|NCT00788957|323183293|FG004|Part 1|Death|0|||
94381518|NCT00788957|323183294|FG005|Part 1|Death|0|||
94381519|NCT00788957|323183289|FG000|Part 1|Lost to Follow-up|1|||
94381520|NCT00788957|323183290|FG001|Part 1|Lost to Follow-up|0|||
94381521|NCT00788957|323183291|FG002|Part 1|Lost to Follow-up|0|||
94381522|NCT00788957|323183292|FG003|Part 1|Lost to Follow-up|0|||
94381523|NCT00788957|323183293|FG004|Part 1|Lost to Follow-up|0|||
94381524|NCT00788957|323183294|FG005|Part 1|Lost to Follow-up|0|||
94381525|NCT00788957|323183289|FG000|Part 2|Withdrawal by Subject|0|||
94381526|NCT00788957|323183290|FG001|Part 2|Withdrawal by Subject|9|||
94381527|NCT00788957|323183291|FG002|Part 2|Withdrawal by Subject|5|||
94381528|NCT00788957|323183292|FG003|Part 2|Withdrawal by Subject|3|||
94381529|NCT00788957|323183293|FG004|Part 2|Withdrawal by Subject|0|||
94381530|NCT00788957|323183294|FG005|Part 2|Withdrawal by Subject|0|||
94381531|NCT00788957|323183289|FG000|Part 2|Death|0|||
94381532|NCT00788957|323183290|FG001|Part 2|Death|32|||
94381533|NCT00788957|323183291|FG002|Part 2|Death|35|||
94381534|NCT00788957|323183292|FG003|Part 2|Death|37|||
94381535|NCT00788957|323183293|FG004|Part 2|Death|0|||
94381536|NCT00788957|323183294|FG005|Part 2|Death|0|||
94381537|NCT00788957|323183289|FG000|Part 2|Lost to Follow-up|0|||
94381538|NCT00788957|323183290|FG001|Part 2|Lost to Follow-up|0|||
94381539|NCT00788957|323183291|FG002|Part 2|Lost to Follow-up|3|||
94381540|NCT00788957|323183292|FG003|Part 2|Lost to Follow-up|0|||
94473192|NCT05052697|323523402|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473193|NCT05052697|323523403|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473194|NCT05052697|323523404|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473195|NCT05052697|323523405|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473196|NCT05052697|323523406|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473197|NCT05052697|323523407|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94310607|NCT00958568|322921971|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
94310608|NCT00958568|322921972|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
94310609|NCT00958568|322921973|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
94310610|NCT00958568|322921974|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
94310611|NCT00958568|322921971|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
94310612|NCT00958568|322921972|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
94310613|NCT00958568|322921973|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
94310614|NCT00958568|322921974|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
94310615|NCT00958568|322921971|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
94310616|NCT00958568|322921972|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
94310617|NCT00958568|322921973|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
94310618|NCT00958568|322921974|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
94310619|NCT00958568|322921971|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
94310620|NCT00958568|322921972|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
94310621|NCT00958568|322921973|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
94310622|NCT00958568|322921974|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
94310623|NCT00958568|322921971|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
94310624|NCT00958568|322921972|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
94310625|NCT00958568|322921973|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
94310626|NCT00958568|322921974|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
94310627|NCT00958568|322921971|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
94310628|NCT00958568|322921972|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
94310629|NCT00958568|322921973|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
94310630|NCT00958568|322921974|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
94310631|NCT00958568|322921971|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
94310632|NCT00958568|322921972|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
94310633|NCT00958568|322921973|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
94310634|NCT00958568|322921974|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
94310635|NCT00958568|322921971|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
94310636|NCT00958568|322921972|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
94310637|NCT00958568|322921973|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
94310638|NCT00958568|322921974|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
94310639|NCT00958568|322921971|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
94310640|NCT00958568|322921972|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
94310641|NCT00958568|322921973|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
94310642|NCT00958568|322921974|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
94310643|NCT00958568|322921971|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
94310644|NCT00958568|322921972|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
94310645|NCT00958568|322921973|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
94310646|NCT00958568|322921974|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
94310647|NCT00958568|322921971|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
94310648|NCT00958568|322921972|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
94310649|NCT00958568|322921973|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
94310650|NCT00958568|322921974|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
94310651|NCT00958568|322921971|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
94310652|NCT00958568|322921972|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
94310653|NCT00958568|322921973|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
94310654|NCT00958568|322921974|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
94310655|NCT00958568|322921971|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
94310656|NCT00958568|322921972|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
94310657|NCT00958568|322921973|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
94310658|NCT00958568|322921974|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
94310659|NCT00958568|322921971|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
94310660|NCT00958568|322921972|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
94310661|NCT00958568|322921973|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
94473198|NCT05052697|323523408|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
94473199|NCT05052697|323523409|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94310662|NCT00958568|322921974|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
94310663|NCT00958568|322921971|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
94310664|NCT00958568|322921972|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
94310665|NCT00958568|322921973|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
94310666|NCT00958568|322921974|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
94310667|NCT00958568|322921971|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
94310668|NCT00958568|322921972|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
94310669|NCT00958568|322921973|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
94310670|NCT00958568|322921974|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
94310671|NCT00958568|322921971|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
94310672|NCT00958568|322921972|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
94310673|NCT00958568|322921973|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
94310674|NCT00958568|322921974|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
94310675|NCT00958568|322921971|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
94310676|NCT00958568|322921972|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
94310677|NCT00958568|322921973|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
94310678|NCT00958568|322921974|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
94310679|NCT00958568|322921971|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
94310680|NCT00958568|322921972|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
94310681|NCT00958568|322921973|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
94310682|NCT00958568|322921974|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
94310683|NCT00915005|322921975|FG000|Overall Study|Withdrawal by Subject|4|||
94310684|NCT00915005|322921976|FG001|Overall Study|Withdrawal by Subject|4|||
94310685|NCT00915005|322921975|FG000|Overall Study|Patient preferred protons therapy|6|||
94310686|NCT00915005|322921976|FG001|Overall Study|Patient preferred protons therapy|0|||
94310687|NCT00915005|322921975|FG000|Overall Study|Insurance denial|3|||
94310688|NCT00915005|322921976|FG001|Overall Study|Insurance denial|15|||
94310689|NCT00907478|322921981|FG000|Overall Study|Ineligibility determined|0|||
94310690|NCT00907478|322921982|FG001|Overall Study|Ineligibility determined|0|||
94310691|NCT00907478|322921983|FG002|Overall Study|Ineligibility determined|1|||
94310692|NCT00907478|322921981|FG000|Overall Study|Noncompliance|0|||
94310693|NCT00907478|322921982|FG001|Overall Study|Noncompliance|0|||
94310694|NCT00907478|322921983|FG002|Overall Study|Noncompliance|1|||
94310695|NCT00907478|322921981|FG000|Overall Study|Adverse Event|3|||
94310696|NCT00907478|322921982|FG001|Overall Study|Adverse Event|1|||
94310697|NCT00907478|322921983|FG002|Overall Study|Adverse Event|2|||
94310698|NCT00907478|322921981|FG000|Overall Study|Withdrawal by Subject|8|||
94310699|NCT00907478|322921982|FG001|Overall Study|Withdrawal by Subject|9|||
94310700|NCT00907478|322921983|FG002|Overall Study|Withdrawal by Subject|6|||
94310701|NCT00907478|322921981|FG000|Overall Study|Requirement for alternative therapy|1|||
94310702|NCT00907478|322921982|FG001|Overall Study|Requirement for alternative therapy|2|||
94310703|NCT00907478|322921983|FG002|Overall Study|Requirement for alternative therapy|3|||
94310704|NCT00907478|322921981|FG000|Overall Study|Physician Decision|2|||
94310705|NCT00907478|322921982|FG001|Overall Study|Physician Decision|0|||
94310706|NCT00907478|322921983|FG002|Overall Study|Physician Decision|3|||
94310707|NCT00907478|322921981|FG000|Overall Study|Death|4|||
94310708|NCT00907478|322921982|FG001|Overall Study|Death|2|||
94310709|NCT00907478|322921983|FG002|Overall Study|Death|1|||
94310710|NCT00907478|322921981|FG000|Overall Study|Protocol-specified criteria|5|||
94310711|NCT00907478|322921982|FG001|Overall Study|Protocol-specified criteria|2|||
94310712|NCT00907478|322921983|FG002|Overall Study|Protocol-specified criteria|3|||
94381541|NCT00788957|323183293|FG004|Part 2|Lost to Follow-up|0|||
94381542|NCT00788957|323183294|FG005|Part 2|Lost to Follow-up|0|||
94381543|NCT00788957|323183289|FG000|Part 2|On-study at time of data cut-off|0|||
94381544|NCT00788957|323183290|FG001|Part 2|On-study at time of data cut-off|1|||
94381545|NCT00788957|323183291|FG002|Part 2|On-study at time of data cut-off|1|||
94381546|NCT00788957|323183292|FG003|Part 2|On-study at time of data cut-off|1|||
94381547|NCT00788957|323183293|FG004|Part 2|On-study at time of data cut-off|0|||
94381548|NCT00788957|323183294|FG005|Part 2|On-study at time of data cut-off|0|||
94381549|NCT00788957|323183289|FG000|Part 3|Withdrawal by Subject|0|||
94381550|NCT00788957|323183290|FG001|Part 3|Withdrawal by Subject|0|||
94381551|NCT00788957|323183291|FG002|Part 3|Withdrawal by Subject|0|||
94381552|NCT00788957|323183292|FG003|Part 3|Withdrawal by Subject|0|||
94381553|NCT00788957|323183293|FG004|Part 3|Withdrawal by Subject|0|||
94381554|NCT00788957|323183294|FG005|Part 3|Withdrawal by Subject|2|||
94381555|NCT00788957|323183289|FG000|Part 3|Death|0|||
94381556|NCT00788957|323183290|FG001|Part 3|Death|0|||
94381557|NCT00788957|323183291|FG002|Part 3|Death|0|||
94381558|NCT00788957|323183292|FG003|Part 3|Death|0|||
94381559|NCT00788957|323183293|FG004|Part 3|Death|8|||
94381560|NCT00788957|323183294|FG005|Part 3|Death|8|||
94381561|NCT00788957|323183289|FG000|Part 3|On-study at time of data cut-off|0|||
94381562|NCT00788957|323183290|FG001|Part 3|On-study at time of data cut-off|0|||
94381563|NCT00788957|323183291|FG002|Part 3|On-study at time of data cut-off|0|||
94381564|NCT00788957|323183292|FG003|Part 3|On-study at time of data cut-off|0|||
94310713|NCT00907478|322921981|FG000|Overall Study|Pregnancy|0|||
94310714|NCT00907478|322921982|FG001|Overall Study|Pregnancy|1|||
94310715|NCT00907478|322921983|FG002|Overall Study|Pregnancy|1|||
94310716|NCT00907478|322921981|FG000|Overall Study|Lost to Follow-up|1|||
94310717|NCT00907478|322921982|FG001|Overall Study|Lost to Follow-up|0|||
94310718|NCT00907478|322921983|FG002|Overall Study|Lost to Follow-up|0|||
94310719|NCT00907478|322921981|FG000|Overall Study|Other|3|||
94310720|NCT00907478|322921982|FG001|Overall Study|Other|0|||
94310721|NCT00907478|322921983|FG002|Overall Study|Other|1|||
94310722|NCT02869867|322921992|FG000|Overall Study|Protocol Violation|1|||
94310723|NCT02869867|322921993|FG001|Overall Study|Protocol Violation|0|||
94310724|NCT02869867|322921992|FG000|Overall Study|Lost to Follow-up|5|||
94310725|NCT02869867|322921993|FG001|Overall Study|Lost to Follow-up|5|||
94310726|NCT00305006|322921996|FG000|Overall Study|Withdrawal by Subject|1|||
94310727|NCT00305006|322921997|FG001|Overall Study|Withdrawal by Subject|0|||
94310728|NCT00305006|322921996|FG000|Overall Study|Failure to complete pretest|0|||
94310729|NCT00305006|322921997|FG001|Overall Study|Failure to complete pretest|1|||
94310730|NCT00631488|322921998|FG000|Overall Study|Adverse Event|1|||
94310731|NCT00631488|322921999|FG001|Overall Study|Adverse Event|0|||
94310732|NCT00631488|322922000|FG002|Overall Study|Adverse Event|0|||
94310733|NCT00631488|322921998|FG000|Overall Study|Lost to Follow-up|2|||
94310734|NCT00631488|322921999|FG001|Overall Study|Lost to Follow-up|2|||
94310735|NCT00631488|322922000|FG002|Overall Study|Lost to Follow-up|0|||
94310736|NCT00631488|322921998|FG000|Overall Study|Physician Decision|1|||
94310737|NCT00631488|322921999|FG001|Overall Study|Physician Decision|0|||
94310738|NCT00631488|322922000|FG002|Overall Study|Physician Decision|1|||
94310739|NCT00631488|322921998|FG000|Overall Study|Protocol Violation|0|||
94310740|NCT00631488|322921999|FG001|Overall Study|Protocol Violation|0|||
94310741|NCT00631488|322922000|FG002|Overall Study|Protocol Violation|1|||
94310742|NCT03648476|322922002|FG000|Overall Study|Withdrawal by Subject|2|||
94310743|NCT03648476|322922003|FG001|Overall Study|Withdrawal by Subject|1|||
94310744|NCT02639182|322922008|FG000|Overall Study|Disease Progression|50|||
94310745|NCT02639182|322922009|FG001|Overall Study|Disease Progression|49|||
94310746|NCT02639182|322922008|FG000|Overall Study|Adverse Event|7|||
94310747|NCT02639182|322922009|FG001|Overall Study|Adverse Event|5|||
94310748|NCT02639182|322922008|FG000|Overall Study|Physician Decision|3|||
94310749|NCT02639182|322922009|FG001|Overall Study|Physician Decision|3|||
94310750|NCT02639182|322922008|FG000|Overall Study|Withdrew Consent|5|||
94310751|NCT02639182|322922009|FG001|Overall Study|Withdrew Consent|4|||
94310752|NCT02639182|322922008|FG000|Overall Study|Lost to Follow-up|0|||
94310753|NCT02639182|322922009|FG001|Overall Study|Lost to Follow-up|1|||
94310754|NCT02639182|322922008|FG000|Overall Study|Study Closure|1|||
94310755|NCT02639182|322922009|FG001|Overall Study|Study Closure|2|||
94310756|NCT02639182|322922008|FG000|Overall Study|Sponsor Ended Study|0|||
94310757|NCT02639182|322922009|FG001|Overall Study|Sponsor Ended Study|1|||
94310758|NCT02639182|322922008|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
94381565|NCT00788957|323183293|FG004|Part 3|On-study at time of data cut-off|1|||
94381566|NCT00788957|323183294|FG005|Part 3|On-study at time of data cut-off|0|||
94381567|NCT02568384|323183299|FG000|Overall Study|Mobile devices incompatible with App|2|||
94381568|NCT03283709|323183310|FG000|Overall Study|trial terminated|0|||
94381569|NCT03283709|323183311|FG001|Overall Study|trial terminated|1|||
94381570|NCT00796510|323183312|FG000|Overall Study|Death|1|||
94381571|NCT00796510|323183313|FG001|Overall Study|Death|0|||
94381572|NCT00796510|323183312|FG000|Overall Study|Study Terminated|2|||
94381573|NCT00796510|323183313|FG001|Overall Study|Study Terminated|0|||
94381574|NCT02799602|323183314|FG000|Overall Study|Protocol Violation|1|||
94381575|NCT02799602|323183315|FG001|Overall Study|Protocol Violation|0|||
94381576|NCT02799602|323183314|FG000|Overall Study|Physician Decision|5|||
94381577|NCT02799602|323183315|FG001|Overall Study|Physician Decision|6|||
94381578|NCT02799602|323183314|FG000|Overall Study|Lost to Follow-up|4|||
94381579|NCT02799602|323183315|FG001|Overall Study|Lost to Follow-up|2|||
94381580|NCT02799602|323183314|FG000|Overall Study|Additional primary malignancy|11|||
94381581|NCT02799602|323183315|FG001|Overall Study|Additional primary malignancy|6|||
94381582|NCT02799602|323183314|FG000|Overall Study|Non-compliance with study drug|14|||
94381583|NCT02799602|323183315|FG001|Overall Study|Non-compliance with study drug|12|||
94381584|NCT02799602|323183314|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
94381585|NCT02799602|323183315|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
94381586|NCT02799602|323183314|FG000|Overall Study|Withdrawal by Subject|26|||
94381587|NCT02799602|323183315|FG001|Overall Study|Withdrawal by Subject|40|||
94381588|NCT02799602|323183314|FG000|Overall Study|Progressive disease - clinical progression|131|||
94381589|NCT02799602|323183315|FG001|Overall Study|Progressive disease - clinical progression|276|||
94381590|NCT02799602|323183314|FG000|Overall Study|Progressive disease - radiological progression|90|||
94381591|NCT02799602|323183315|FG001|Overall Study|Progressive disease - radiological progression|133|||
94310759|NCT02639182|322922009|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
94310760|NCT01671488|322922016|FG000|Overall Study|Withdrawal by Subject|1|||
94310761|NCT03123939|322922017|FG000|Overall Study|Lack of Efficacy|6|||
94310762|NCT03123939|322922017|FG000|Overall Study|Death|5|||
94310763|NCT03123939|322922017|FG000|Overall Study|Physician Decision|2|||
94310764|NCT03123939|322922017|FG000|Overall Study|Subject/guardian decision|2|||
94310765|NCT03123939|322922017|FG000|Overall Study|Lost to Follow-up|1|||
94310766|NCT03123939|322922017|FG000|Overall Study|New therapy for study indication|1|||
94310767|NCT03123939|322922017|FG000|Overall Study|Protocol deviation|1|||
94310768|NCT03123939|322922017|FG000|Overall Study|Progressive disease|18|||
94310769|NCT03123939|322922017|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
94310770|NCT03123939|322922017|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
94310771|NCT04983940|322922018|FG000|Overall Study|Lost to Follow-up|14|||
94310772|NCT04983940|322922018|FG000|Overall Study|Lack of Efficacy|2|||
94310773|NCT01734993|322922019|FG000|Overall Study|Adverse Event|1|||
94310774|NCT01734993|322922019|FG000|Overall Study|Lack of Efficacy|1|||
94310775|NCT00301067|322922020|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
94310776|NCT00301067|322922021|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
94310777|NCT00301067|322922022|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
94310778|NCT00301067|322922023|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
94310779|NCT00301067|322922020|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
94310780|NCT00301067|322922021|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
94310781|NCT00301067|322922022|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
94310782|NCT00301067|322922023|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
94310783|NCT00301067|322922020|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
94310784|NCT00301067|322922021|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
94310785|NCT00301067|322922022|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
94473200|NCT05052697|323523410|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94310786|NCT00301067|322922023|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
94310787|NCT00301067|322922020|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
94473201|NCT05052697|323523411|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473202|NCT05052697|323523412|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473203|NCT05052697|323523413|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473204|NCT05052697|323523414|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473205|NCT05052697|323523415|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473206|NCT05052697|323523416|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473207|NCT05052697|323523417|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473208|NCT05052697|323523418|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473209|NCT05052697|323523419|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473210|NCT05052697|323523420|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473211|NCT05052697|323523421|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473212|NCT05052697|323523422|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
94473213|NCT05052697|323523389|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473214|NCT05052697|323523390|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473215|NCT05052697|323523391|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473216|NCT05052697|323523392|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473217|NCT05052697|323523393|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473218|NCT05052697|323523394|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473219|NCT05052697|323523395|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473220|NCT05052697|323523396|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473221|NCT05052697|323523397|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473222|NCT05052697|323523398|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473223|NCT05052697|323523399|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473224|NCT05052697|323523400|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473225|NCT05052697|323523401|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473226|NCT05052697|323523402|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473227|NCT05052697|323523403|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473228|NCT05052697|323523404|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94310788|NCT00301067|322922021|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
94310789|NCT00301067|322922022|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
94310790|NCT00301067|322922023|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
94310791|NCT00301067|322922020|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
94310792|NCT00301067|322922021|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
94310793|NCT00301067|322922022|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
94310794|NCT00301067|322922023|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
94310795|NCT00301067|322922020|FG000|Follow up Until Death|Alive at last data cut point|1|||
94310796|NCT00301067|322922021|FG001|Follow up Until Death|Alive at last data cut point|0|||
94310797|NCT00301067|322922022|FG002|Follow up Until Death|Alive at last data cut point|0|||
94310798|NCT00301067|322922023|FG003|Follow up Until Death|Alive at last data cut point|1|||
94310799|NCT00510692|322922031|FG000|Overall Study|Adverse Event|1|||
94473229|NCT05052697|323523405|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473230|NCT05052697|323523406|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
94473231|NCT05052697|323523407|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94310800|NCT00510692|322922032|FG001|Overall Study|Adverse Event|3|||
94310801|NCT00510692|322922031|FG000|Overall Study|Withdrawal by Subject|1|||
94310802|NCT00510692|322922032|FG001|Overall Study|Withdrawal by Subject|0|||
94310803|NCT00872898|322922035|FG000|Part Two - Double Blind|Adverse Event|4|||
94310804|NCT00872898|322922036|FG001|Part Two - Double Blind|Adverse Event|3|||
94310805|NCT00872898|322922035|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
94310806|NCT00872898|322922036|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
94310807|NCT00872898|322922035|FG000|Part Two - Double Blind|Protocol Violation|1|||
94310808|NCT00872898|322922036|FG001|Part Two - Double Blind|Protocol Violation|0|||
94310809|NCT00872898|322922035|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
94310810|NCT00872898|322922036|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
94310811|NCT00872898|322922035|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
94310812|NCT00872898|322922036|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
94310813|NCT00872898|322922035|FG000|Part Two - Double Blind|Other reasons|2|||
94310814|NCT00872898|322922036|FG001|Part Two - Double Blind|Other reasons|0|||
94310815|NCT02955186|322922041|FG000|Overall Study|Withdrawal by Subject|6|||
94310816|NCT02955186|322922042|FG001|Overall Study|Withdrawal by Subject|2|||
94310817|NCT02955186|322922041|FG000|Overall Study|Protocol Violation|1|||
94310818|NCT02955186|322922042|FG001|Overall Study|Protocol Violation|0|||
94310819|NCT01422304|322922043|FG000|Overall Study|Adverse Event|0|||
94310820|NCT01422304|322922044|FG001|Overall Study|Adverse Event|1|||
94310821|NCT01422304|322922043|FG000|Overall Study|Lost to Follow-up|14|||
94310822|NCT01422304|322922044|FG001|Overall Study|Lost to Follow-up|20|||
94310823|NCT01422304|322922043|FG000|Overall Study|Never Entered Follow-up|2|||
94310824|NCT01422304|322922044|FG001|Overall Study|Never Entered Follow-up|1|||
94310825|NCT01422304|322922043|FG000|Overall Study|Protocol Violation|1|||
94310826|NCT01422304|322922044|FG001|Overall Study|Protocol Violation|0|||
94310827|NCT01422304|322922043|FG000|Overall Study|Withdrawal by Subject|4|||
94310828|NCT01422304|322922044|FG001|Overall Study|Withdrawal by Subject|2|||
94310829|NCT01422304|322922043|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
94310830|NCT01422304|322922044|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
94310831|NCT01422304|322922043|FG000|Overall Study|Not Treated|3|||
94310832|NCT01422304|322922044|FG001|Overall Study|Not Treated|11|||
94310833|NCT03634072|322922049|FG000|Overall Study|Early termination of overall study|1|||
94310834|NCT03634072|322922050|FG001|Overall Study|Early termination of overall study|0|||
94310835|NCT01765764|322922054|FG000|Treatment Period|Adverse Event|1|||
94310836|NCT01765764|322922055|FG001|Treatment Period|Adverse Event|2|||
94310837|NCT01765764|322922056|FG002|Treatment Period|Adverse Event|1|||
94310838|NCT01765764|322922054|FG000|Treatment Period|Lost to Follow-up|0|||
94310839|NCT01765764|322922055|FG001|Treatment Period|Lost to Follow-up|3|||
94310840|NCT01765764|322922056|FG002|Treatment Period|Lost to Follow-up|2|||
94310841|NCT01765764|322922054|FG000|Treatment Period|Personal Reasons|1|||
94310842|NCT01765764|322922055|FG001|Treatment Period|Personal Reasons|2|||
94310843|NCT01765764|322922056|FG002|Treatment Period|Personal Reasons|1|||
94310844|NCT01765764|322922054|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
94310845|NCT01765764|322922055|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
94310846|NCT01765764|322922056|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
94310847|NCT01558089|322922057|FG000|Overall Study|Adverse Event|1|||
94310848|NCT01558089|322922057|FG000|Overall Study|Lack of Efficacy|1|||
94310849|NCT01558089|322922057|FG000|Overall Study|Lost to Follow-up|5|||
94310850|NCT01558089|322922057|FG000|Overall Study|Withdrawal by Subject|6|||
94310851|NCT04952389|322922058|FG000|Overall Study|Withdrawal by Subject|8|||
94310852|NCT04952389|322922059|FG001|Overall Study|Withdrawal by Subject|4|||
94310853|NCT02050048|322922060|FG000|Overall Study|Lost to Follow-up|0|||
94310854|NCT02050048|322922061|FG001|Overall Study|Lost to Follow-up|1|||
94310855|NCT02050048|322922060|FG000|Overall Study|Death|1|||
94310856|NCT02050048|322922061|FG001|Overall Study|Death|0|||
94310857|NCT02050048|322922060|FG000|Overall Study|Ineligible after ERCP|4|||
94310858|NCT02050048|322922061|FG001|Overall Study|Ineligible after ERCP|1|||
94310859|NCT00839098|322922066|FG000|Overall Study|Withdrawal by Subject|2|||
94310860|NCT00839098|322922067|FG001|Overall Study|Withdrawal by Subject|1|||
94310861|NCT00839098|322922068|FG002|Overall Study|Withdrawal by Subject|7|||
94310862|NCT02807454|322922069|FG000|Overall Study|Adverse Event|1|||
94310863|NCT02807454|322922070|FG001|Overall Study|Adverse Event|0|||
94310864|NCT02807454|322922069|FG000|Overall Study|Withdrawal by Subject|0|||
94310865|NCT02807454|322922070|FG001|Overall Study|Withdrawal by Subject|1|||
94310866|NCT02807454|322922069|FG000|Overall Study|Progressive Disease|30|||
94310867|NCT02807454|322922070|FG001|Overall Study|Progressive Disease|3|||
94310868|NCT02807454|322922069|FG000|Overall Study|Other Reasons|1|||
94310869|NCT02807454|322922070|FG001|Overall Study|Other Reasons|1|||
94310870|NCT01165203|322922071|FG000|Active Phase|Serious Adverse Event|1|||
94310871|NCT01165203|322922072|FG001|Active Phase|Serious Adverse Event|0|||
94310872|NCT01165203|322922071|FG000|Active Phase|Withdrawal by Subject|2|||
94310873|NCT01165203|322922072|FG001|Active Phase|Withdrawal by Subject|1|||
94310874|NCT01165203|322922071|FG000|Active Phase|Migrated/moved from study area|0|||
94310875|NCT01165203|322922072|FG001|Active Phase|Migrated/moved from study area|1|||
94381592|NCT02799602|323183314|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
94381593|NCT02799602|323183315|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
94381594|NCT02799602|323183314|FG000|Overall Study|Death|9|||
94310876|NCT01165203|322922071|FG000|Active Phase|Lost to Follow-up|2|||
94310877|NCT01165203|322922072|FG001|Active Phase|Lost to Follow-up|0|||
94310878|NCT01165203|322922071|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
94310879|NCT01165203|322922072|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
94310880|NCT01165203|322922071|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
94310881|NCT01165203|322922072|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
94310882|NCT01165203|322922071|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
94310883|NCT01165203|322922072|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
94310884|NCT01165203|322922071|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
94310885|NCT01165203|322922072|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
94310886|NCT01165203|322922071|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
94310887|NCT01165203|322922072|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
94310888|NCT01108809|322922073|FG000|Overall Study|Adverse Event|3|||
94310889|NCT01108809|322922073|FG000|Overall Study|Lost to Follow-up|1|||
94310890|NCT03141307|322922079|FG000|In-Hospital|Withdrawal by Subject|0|||
94381595|NCT02799602|323183315|FG001|Overall Study|Death|5|||
94381596|NCT02799602|323183314|FG000|Overall Study|Other|287|||
94381597|NCT02799602|323183315|FG001|Overall Study|Other|118|||
94381598|NCT02799602|323183314|FG000|Overall Study|Study drug never administered|0|||
94381599|NCT02799602|323183315|FG001|Overall Study|Study drug never administered|3|||
94381600|NCT03072459|323183316|FG000|Overall Study|Device revised/removed|1|||
94381601|NCT03072459|323183316|FG000|Overall Study|Subject not able to return|1|||
94381602|NCT00329602|323183317|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
94381603|NCT00329602|323183318|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
94381604|NCT00329602|323183319|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
94381605|NCT00329602|323183317|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
94381606|NCT00329602|323183318|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
94381607|NCT00329602|323183319|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
94381608|NCT00329602|323183317|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
94381609|NCT00329602|323183318|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
94381610|NCT00329602|323183319|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
94381611|NCT00329602|323183317|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
94310891|NCT03141307|322922080|FG001|In-Hospital|Withdrawal by Subject|2|||
94310892|NCT03141307|322922079|FG000|In-Hospital|Protocol Violation|4|||
94310893|NCT03141307|322922080|FG001|In-Hospital|Protocol Violation|0|||
94310894|NCT03141307|322922079|FG000|Follow-Up|Lost to Follow-up|97|||
94310895|NCT03141307|322922080|FG001|Follow-Up|Lost to Follow-up|54|||
94310896|NCT00576693|322922081|FG000|Overall Study|Lost to Follow-up|7|||
94310897|NCT00576693|322922082|FG001|Overall Study|Lost to Follow-up|11|||
94310898|NCT00576693|322922081|FG000|Overall Study|Withdrawal by Subject|3|||
94310899|NCT00576693|322922082|FG001|Overall Study|Withdrawal by Subject|13|||
94310900|NCT03103750|322922083|FG000|Overall Study|Adverse Event|1|||
94310901|NCT03103750|322922084|FG001|Overall Study|Adverse Event|0|||
94310902|NCT03103750|322922083|FG000|Overall Study|Lost to Follow-up|1|||
94310903|NCT03103750|322922084|FG001|Overall Study|Lost to Follow-up|0|||
94310904|NCT03103750|322922083|FG000|Overall Study|PET Equipment Related|2|||
94310905|NCT03103750|322922084|FG001|Overall Study|PET Equipment Related|2|||
94310906|NCT02574312|322922085|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
94310907|NCT02574312|322922086|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
94310908|NCT01597622|322923407|FG000|Overall Study|Adverse Event|7|||
94310909|NCT01597622|322923407|FG000|Overall Study|Lack of Efficacy|3|||
94310910|NCT01597622|322923407|FG000|Overall Study|Protocol Violation|1|||
94310911|NCT01597622|322923407|FG000|Overall Study|Lost to Follow-up|1|||
94310912|NCT01597622|322923407|FG000|Overall Study|Investigator Discretion|5|||
94310913|NCT01597622|322923407|FG000|Overall Study|Withdrawal by Subject|20|||
94310914|NCT01597622|322923407|FG000|Overall Study|Death|1|||
94310915|NCT03132805|322923408|FG000|Overall Study|Lost to Follow-up|142|||
94310916|NCT03132805|322923409|FG001|Overall Study|Lost to Follow-up|141|||
94310917|NCT03132805|322923410|FG002|Overall Study|Lost to Follow-up|113|||
94310918|NCT02601001|322923416|FG000|Dosing Period 2|Adverse Event|0|||
94310919|NCT02601001|322923417|FG001|Dosing Period 2|Adverse Event|0|||
94310920|NCT02601001|322923418|FG002|Dosing Period 2|Adverse Event|0|||
94310921|NCT02601001|322923419|FG003|Dosing Period 2|Adverse Event|0|||
94310922|NCT02601001|322923420|FG004|Dosing Period 2|Adverse Event|0|||
94310923|NCT02601001|322923421|FG005|Dosing Period 2|Adverse Event|0|||
94310924|NCT02601001|322923422|FG006|Dosing Period 2|Adverse Event|1|||
94310925|NCT01259492|322923428|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
94310926|NCT01259492|322923429|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
94310927|NCT01259492|322923430|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
94310928|NCT01259492|322923431|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
94310929|NCT01259492|322923428|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
94310930|NCT01259492|322923429|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
94310931|NCT01259492|322923430|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
94310932|NCT01259492|322923431|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
94310933|NCT01259492|322923428|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
94310934|NCT01259492|322923429|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
94310935|NCT01259492|322923430|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
94310936|NCT01259492|322923431|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
94310937|NCT01259492|322923428|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
94310938|NCT01259492|322923429|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
94310939|NCT01259492|322923430|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
94310940|NCT01259492|322923431|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
94310941|NCT01259492|322923428|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
94310942|NCT01259492|322923429|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
94310943|NCT01259492|322923430|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
94310944|NCT01259492|322923431|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
94310945|NCT01259492|322923428|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
94310946|NCT01259492|322923429|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
94310947|NCT01259492|322923430|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
94310948|NCT01259492|322923431|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
94310949|NCT01259492|322923428|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
94310950|NCT01259492|322923429|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
94310951|NCT01259492|322923430|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
94310952|NCT01259492|322923431|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
94310953|NCT01259492|322923428|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
94310954|NCT01259492|322923429|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
94310955|NCT01259492|322923430|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
94310956|NCT01259492|322923431|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
94310957|NCT01259492|322923428|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
94310958|NCT01259492|322923429|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
94310959|NCT01259492|322923430|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
94310960|NCT01259492|322923431|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
94310961|NCT01259492|322923428|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
94310962|NCT01259492|322923429|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
94310963|NCT01259492|322923430|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
94310964|NCT01259492|322923431|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
94310965|NCT01259492|322923428|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
94310966|NCT01259492|322923429|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
94310967|NCT01259492|322923430|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
94310968|NCT01259492|322923431|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
94310969|NCT01259492|322923428|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
94310970|NCT01259492|322923429|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
94310971|NCT01259492|322923430|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
94310972|NCT01259492|322923431|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
94310973|NCT01259492|322923428|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
94310974|NCT01259492|322923429|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
94310975|NCT01259492|322923430|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
94310976|NCT01259492|322923431|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
94310977|NCT01259492|322923428|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
94310978|NCT01259492|322923429|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
94310979|NCT01259492|322923430|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
94310980|NCT01259492|322923431|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
94310981|NCT01259492|322923428|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
94310982|NCT01259492|322923429|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
94310983|NCT01259492|322923430|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
94310984|NCT01259492|322923431|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
94310985|NCT01259492|322923428|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
94310986|NCT01259492|322923429|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
94310987|NCT01259492|322923430|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
94310988|NCT01259492|322923431|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
94310989|NCT01259492|322923428|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
94310990|NCT01259492|322923429|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
94310991|NCT01259492|322923430|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
94310992|NCT01259492|322923431|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
94310993|NCT01259492|322923428|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
94310994|NCT01259492|322923429|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
94310995|NCT01259492|322923430|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
94310996|NCT01259492|322923431|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
94381612|NCT00329602|323183318|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
94381613|NCT00329602|323183319|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
94381614|NCT00329602|323183317|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
94381615|NCT00329602|323183318|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
94381616|NCT00329602|323183319|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
94381617|NCT00329602|323183317|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
94381618|NCT00329602|323183318|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
94381619|NCT00329602|323183319|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
94381620|NCT01867242|323183320|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
94381621|NCT01867242|323183321|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
94381622|NCT01867242|323183322|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
94381623|NCT02579096|323183323|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
94381624|NCT02579096|323183324|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
94381625|NCT02579096|323183323|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
94381626|NCT02579096|323183324|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
94381627|NCT02579096|323183323|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
94381628|NCT02579096|323183324|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
94381629|NCT02579096|323183323|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
94381630|NCT02579096|323183324|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
94381631|NCT02579096|323183323|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
94381632|NCT02579096|323183324|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
94381633|NCT02579096|323183323|FG000|Phase 2, Weeks 25 - 48|Death|2|||
94381634|NCT02579096|323183324|FG001|Phase 2, Weeks 25 - 48|Death|4|||
94381635|NCT02579096|323183323|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
94381636|NCT02579096|323183324|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
94381637|NCT02579096|323183323|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
94381638|NCT02579096|323183324|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
94381639|NCT02579096|323183323|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
94381640|NCT02579096|323183324|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
94381641|NCT02579096|323183323|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
94381642|NCT02579096|323183324|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
94381643|NCT02579096|323183323|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
94381644|NCT02579096|323183324|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
94381645|NCT02579096|323183323|FG000|Phase 3, Weeks 49 - 72|Death|3|||
94381646|NCT02579096|323183324|FG001|Phase 3, Weeks 49 - 72|Death|2|||
94381647|NCT02579096|323183323|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
94381648|NCT02579096|323183324|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
94381649|NCT02579096|323183323|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
94381650|NCT02579096|323183324|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
94381651|NCT02579096|323183323|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
94381652|NCT02579096|323183324|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
94381653|NCT02579096|323183323|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
94381654|NCT02579096|323183324|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
94381655|NCT02579096|323183323|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
94381656|NCT02579096|323183324|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
94381657|NCT02579096|323183323|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
94381658|NCT02579096|323183324|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
94381659|NCT02097121|323183328|FG000|Overall Study|Other, not specified|4|||
94381660|NCT02097121|323183329|FG001|Overall Study|Other, not specified|2|||
94381661|NCT02097121|323183330|FG002|Overall Study|Other, not specified|3|||
94381662|NCT02097121|323183328|FG000|Overall Study|Lack of Efficacy|2|||
94381663|NCT02097121|323183329|FG001|Overall Study|Lack of Efficacy|1|||
94381664|NCT02097121|323183330|FG002|Overall Study|Lack of Efficacy|3|||
94381665|NCT02097121|323183328|FG000|Overall Study|Withdrawal by Subject|0|||
94381666|NCT02097121|323183329|FG001|Overall Study|Withdrawal by Subject|1|||
94381667|NCT02097121|323183330|FG002|Overall Study|Withdrawal by Subject|2|||
94381668|NCT02097121|323183328|FG000|Overall Study|Adverse Event|0|||
94381669|NCT02097121|323183329|FG001|Overall Study|Adverse Event|1|||
94381670|NCT02097121|323183330|FG002|Overall Study|Adverse Event|0|||
94381671|NCT02097121|323183328|FG000|Overall Study|Lost to Follow-up|1|||
94381672|NCT02097121|323183329|FG001|Overall Study|Lost to Follow-up|1|||
94381673|NCT02097121|323183330|FG002|Overall Study|Lost to Follow-up|2|||
94381674|NCT00510510|323183331|FG000|Overall Study|Adverse Event|4|||
94381675|NCT00510510|323183332|FG001|Overall Study|Adverse Event|3|||
94381676|NCT00510510|323183333|FG002|Overall Study|Adverse Event|6|||
94381677|NCT00510510|323183331|FG000|Overall Study|Lack of Efficacy|0|||
94381678|NCT00510510|323183332|FG001|Overall Study|Lack of Efficacy|1|||
94381679|NCT00510510|323183333|FG002|Overall Study|Lack of Efficacy|1|||
94381680|NCT00510510|323183331|FG000|Overall Study|Subjects no longer requires study drug|0|||
94381681|NCT00510510|323183332|FG001|Overall Study|Subjects no longer requires study drug|0|||
94381682|NCT00510510|323183333|FG002|Overall Study|Subjects no longer requires study drug|2|||
94381683|NCT00510510|323183331|FG000|Overall Study|Withdrawal by Subject|1|||
94473232|NCT05052697|323523408|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473233|NCT05052697|323523409|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473234|NCT05052697|323523410|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473235|NCT05052697|323523411|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473236|NCT05052697|323523412|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473237|NCT05052697|323523413|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473238|NCT05052697|323523414|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
94473239|NCT05052697|323523415|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473240|NCT05052697|323523416|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
94473241|NCT05052697|323523417|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473242|NCT05052697|323523418|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473243|NCT05052697|323523419|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473244|NCT05052697|323523420|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94473245|NCT05052697|323523421|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94310997|NCT01259492|322923428|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
94310998|NCT01259492|322923429|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
94310999|NCT01259492|322923430|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
94311000|NCT01259492|322923431|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
94311001|NCT01259492|322923428|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
94311002|NCT01259492|322923429|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
94311003|NCT01259492|322923430|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
94311004|NCT01259492|322923431|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
94311005|NCT00084682|322923436|FG000|Overall Study|Withdrawal by Subject|1|||
94311006|NCT01166659|322923437|FG000|Overall Study|Subject Decision|8|||
94311007|NCT01166659|322923437|FG000|Overall Study|Investigator Decision|2|||
94311008|NCT01166659|322923437|FG000|Overall Study|Death|1|||
94311009|NCT01166659|322923437|FG000|Overall Study|Lost to Follow-up|1|||
94311010|NCT01166659|322923437|FG000|Overall Study|Study Closed at Site|1|||
94311011|NCT01372878|322923440|FG000|Overall Study|Withdrawal by Subject|63|||
94311012|NCT01372878|322923440|FG000|Overall Study|Protocol Violation|17|||
94311013|NCT01372878|322923440|FG000|Overall Study|incomplete study procedure|104|||
94311014|NCT01505491|322923446|FG000|Overall Study|Other reason not listed|1|||
94311015|NCT01505491|322923447|FG001|Overall Study|Other reason not listed|0|||
94311016|NCT01505491|322923448|FG002|Overall Study|Other reason not listed|0|||
94311017|NCT01505491|322923446|FG000|Overall Study|Withdrawal by Subject|1|||
94311018|NCT01505491|322923447|FG001|Overall Study|Withdrawal by Subject|1|||
94311019|NCT01505491|322923448|FG002|Overall Study|Withdrawal by Subject|4|||
94311020|NCT01505491|322923446|FG000|Overall Study|Lost to Follow-up|0|||
94311021|NCT01505491|322923447|FG001|Overall Study|Lost to Follow-up|0|||
94311022|NCT01505491|322923448|FG002|Overall Study|Lost to Follow-up|1|||
94311023|NCT02926573|322923450|FG000|Overall Study|Nausea|1|||
94311024|NCT02926573|322923451|FG001|Overall Study|Nausea|0|||
94311025|NCT02926573|322923450|FG000|Overall Study|Remain intubated|2|||
94311026|NCT02926573|322923451|FG001|Overall Study|Remain intubated|2|||
94311027|NCT02926573|322923450|FG000|Overall Study|Change in surgery plan|3|||
94311028|NCT02926573|322923451|FG001|Overall Study|Change in surgery plan|1|||
94311029|NCT02926573|322923450|FG000|Overall Study|Change to outpatient status|5|||
94311030|NCT02926573|322923451|FG001|Overall Study|Change to outpatient status|1|||
94311031|NCT02926573|322923450|FG000|Overall Study|Withdrawal by Subject|0|||
94311032|NCT02926573|322923451|FG001|Overall Study|Withdrawal by Subject|2|||
94311033|NCT02926573|322923450|FG000|Overall Study|Return to operating room|0|||
94311034|NCT02926573|322923451|FG001|Overall Study|Return to operating room|2|||
94311035|NCT02926573|322923450|FG000|Overall Study|Delirium|0|||
94311036|NCT02926573|322923451|FG001|Overall Study|Delirium|1|||
94311037|NCT02052960|322923453|FG000|Overall Study|Adverse Event|19|||
94311038|NCT02052960|322923454|FG001|Overall Study|Adverse Event|17|||
94311039|NCT02052960|322923453|FG000|Overall Study|Protocol Violation|4|||
94311040|NCT02052960|322923454|FG001|Overall Study|Protocol Violation|3|||
94311041|NCT02052960|322923453|FG000|Overall Study|Withdrawal by Subject|6|||
94311042|NCT02052960|322923454|FG001|Overall Study|Withdrawal by Subject|11|||
94311043|NCT02052960|322923453|FG000|Overall Study|Other|25|||
94311044|NCT02052960|322923454|FG001|Overall Study|Other|15|||
94311045|NCT01302041|322923457|FG000|Overall Study|Death|5|||
94311046|NCT01302041|322923457|FG000|Overall Study|Withdrawal by Subject|4|||
94311047|NCT01302041|322923457|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
94311048|NCT01302041|322923457|FG000|Overall Study|Other-Miscellaneous Reason|2|||
94311049|NCT00611455|322923458|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
94311050|NCT00611455|322923459|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
94311051|NCT00611455|322923460|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
94311052|NCT00611455|322923458|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
94311053|NCT00611455|322923459|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
94311054|NCT00611455|322923460|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
94311055|NCT00611455|322923458|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
94473246|NCT05052697|323523422|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
94311056|NCT00611455|322923459|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
94311057|NCT00611455|322923460|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
94311058|NCT00611455|322923458|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
94311059|NCT00611455|322923459|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
94311060|NCT00611455|322923460|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94311061|NCT00611455|322923458|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
94311062|NCT00611455|322923459|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
94311063|NCT00611455|322923460|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
94311064|NCT00611455|322923458|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
94311065|NCT00611455|322923459|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
94311066|NCT00611455|322923460|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
94311067|NCT00611455|322923458|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
94311068|NCT00611455|322923459|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
94311069|NCT00611455|322923460|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
94311070|NCT00611455|322923458|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
94311071|NCT00611455|322923459|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
94311072|NCT00611455|322923460|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
94311073|NCT00611455|322923458|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
94311074|NCT00611455|322923459|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
94311075|NCT00611455|322923460|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
94311076|NCT00611455|322923458|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
94311077|NCT00611455|322923459|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
94311078|NCT00611455|322923460|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
94311079|NCT00611455|322923458|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
94311080|NCT00611455|322923459|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
94311081|NCT00611455|322923460|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
94311082|NCT00611455|322923458|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
94311083|NCT00611455|322923459|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
94311084|NCT00611455|322923460|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
94311085|NCT00611455|322923458|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
94311086|NCT00611455|322923459|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
94311087|NCT00611455|322923460|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
94311088|NCT00611455|322923458|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
94311089|NCT00611455|322923459|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
94381684|NCT00510510|323183332|FG001|Overall Study|Withdrawal by Subject|2|||
94381685|NCT00510510|323183333|FG002|Overall Study|Withdrawal by Subject|3|||
94381686|NCT00510510|323183331|FG000|Overall Study|Lost to Follow-up|0|||
94381687|NCT00510510|323183332|FG001|Overall Study|Lost to Follow-up|0|||
94381688|NCT00510510|323183333|FG002|Overall Study|Lost to Follow-up|1|||
94381689|NCT00510510|323183331|FG000|Overall Study|Protocol Violation|0|||
94381690|NCT00510510|323183332|FG001|Overall Study|Protocol Violation|3|||
94381691|NCT00510510|323183333|FG002|Overall Study|Protocol Violation|4|||
94381692|NCT01361126|323183334|FG000|Overall Study|Sponsor decision|0|||
94381693|NCT01361126|323183335|FG001|Overall Study|Sponsor decision|2|||
94381694|NCT00264810|323183336|FG000|Baseline|Withdrawal by Subject|10|||
94381695|NCT00264810|323183337|FG001|Baseline|Withdrawal by Subject|10|||
94381696|NCT00264810|323183336|FG000|Baseline|Physician Decision|7|||
94381697|NCT00264810|323183337|FG001|Baseline|Physician Decision|8|||
94381698|NCT00264810|323183336|FG000|Baseline|Subject Compliance Failure|3|||
94381699|NCT00264810|323183337|FG001|Baseline|Subject Compliance Failure|3|||
94381700|NCT00264810|323183336|FG000|Baseline|Insufficient Seizure Frequency|2|||
94381701|NCT00264810|323183337|FG001|Baseline|Insufficient Seizure Frequency|2|||
94381702|NCT00264810|323183336|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
94381703|NCT00264810|323183337|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
94381704|NCT00264810|323183336|FG000|Baseline|Other|0|||
94381705|NCT00264810|323183337|FG001|Baseline|Other|1|||
94381706|NCT00264810|323183336|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
94381707|NCT00264810|323183337|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
94381708|NCT00264810|323183336|FG000|Stimulation Optimization Period|Death|0|||
94381709|NCT00264810|323183337|FG001|Stimulation Optimization Period|Death|1|||
94381710|NCT00264810|323183336|FG000|Blinded Evaluation Period|Explant due to infection|1|||
94381711|NCT00264810|323183337|FG001|Blinded Evaluation Period|Explant due to infection|1|||
94381712|NCT00264810|323183336|FG000|Open Label Evaluation Period|Explant due to infection|1|||
94381713|NCT00264810|323183337|FG001|Open Label Evaluation Period|Explant due to infection|1|||
94381714|NCT00264810|323183336|FG000|Open Label Evaluation Period|Death|3|||
94381715|NCT00264810|323183337|FG001|Open Label Evaluation Period|Death|2|||
94381716|NCT00264810|323183336|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
94381717|NCT00264810|323183337|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
94381718|NCT01868009|323183338|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
94381719|NCT01868009|323183339|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
94311090|NCT00611455|322923460|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
94311091|NCT00611455|322923458|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
94311092|NCT00611455|322923459|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
94311093|NCT00611455|322923460|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
94311094|NCT00611455|322923458|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
94311095|NCT00611455|322923459|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
94311096|NCT00611455|322923460|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
94311097|NCT00611455|322923458|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
94311098|NCT00611455|322923459|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
94311099|NCT00611455|322923460|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
94311100|NCT00611455|322923458|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
94311101|NCT00611455|322923459|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
94311102|NCT00611455|322923460|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
94311103|NCT00611455|322923458|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
94311104|NCT00611455|322923459|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
94311105|NCT00611455|322923460|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
94311106|NCT00611455|322923458|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
94311107|NCT00611455|322923459|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
94311108|NCT00611455|322923460|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
94311109|NCT00611455|322923458|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
94311110|NCT00611455|322923459|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
94311111|NCT00611455|322923460|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
94311112|NCT02416908|322923471|FG000|Dose Escalation Phase|Adverse Event|0|||
94311113|NCT02416908|322923472|FG001|Dose Escalation Phase|Adverse Event|0|||
94311114|NCT02416908|322923473|FG002|Dose Escalation Phase|Adverse Event|3|||
94311115|NCT02416908|322923474|FG003|Dose Escalation Phase|Adverse Event|0|||
94311116|NCT02416908|322923471|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
94311117|NCT02416908|322923472|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
94311118|NCT02416908|322923473|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
94311119|NCT02416908|322923474|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
94311120|NCT01797783|322923475|FG000|Overall Study|Adverse Event|1|||
94311121|NCT01797783|322923476|FG001|Overall Study|Adverse Event|1|||
94311122|NCT01797783|322923475|FG000|Overall Study|Withdrawal by Subject|1|||
94311123|NCT01797783|322923476|FG001|Overall Study|Withdrawal by Subject|0|||
94311124|NCT05232097|322923477|FG000|Overall Study|Physician Decision|1|||
94311125|NCT01327339|322923478|FG000|Overall Study|Protocol Violation|8|||
94311126|NCT01172288|322923479|FG000|Overall Study|Adverse Event|1|||
94311127|NCT01172288|322923480|FG001|Overall Study|Adverse Event|0|||
94311128|NCT01172288|322923479|FG000|Overall Study|Protocol Violation|0|||
94311129|NCT01172288|322923480|FG001|Overall Study|Protocol Violation|1|||
94311130|NCT03964415|322923483|FG000|Overall Study|Sponsor's decision|1563|||
94311131|NCT03964415|322923484|FG001|Overall Study|Sponsor's decision|1528|||
94311132|NCT03964415|322923483|FG000|Overall Study|Lost to Follow-up|139|||
94311133|NCT03964415|322923484|FG001|Overall Study|Lost to Follow-up|146|||
94311134|NCT03964415|322923483|FG000|Overall Study|Withdrawal by Subject|68|||
94311135|NCT03964415|322923484|FG001|Overall Study|Withdrawal by Subject|72|||
94311136|NCT03964415|322923483|FG000|Overall Study|Physician Decision|34|||
94311137|NCT03964415|322923484|FG001|Overall Study|Physician Decision|48|||
94311138|NCT03964415|322923483|FG000|Overall Study|Adverse Event|3|||
94311139|NCT03964415|322923484|FG001|Overall Study|Adverse Event|0|||
94311140|NCT03964415|322923483|FG000|Overall Study|Death|4|||
94311141|NCT03964415|322923484|FG001|Overall Study|Death|6|||
94311142|NCT03964415|322923483|FG000|Overall Study|Protocol Violation|1|||
94311143|NCT03964415|322923484|FG001|Overall Study|Protocol Violation|4|||
94311144|NCT03964415|322923483|FG000|Overall Study|Other|35|||
94311145|NCT03964415|322923484|FG001|Overall Study|Other|38|||
94311146|NCT03964415|322923483|FG000|Overall Study|Randomized but not treated|6|||
94311147|NCT03964415|322923484|FG001|Overall Study|Randomized but not treated|7|||
94311148|NCT02062151|322923492|FG000|Overall Study|screen failure|1|||
94311149|NCT00394914|322923493|FG000|Treatment Period|Adverse Event|0|||
94311150|NCT00394914|322923494|FG001|Treatment Period|Adverse Event|3|||
94311151|NCT00394914|322923495|FG002|Treatment Period|Adverse Event|1|||
94311152|NCT00394914|322923493|FG000|Treatment Period|Lost to Follow-up|0|||
94311153|NCT00394914|322923494|FG001|Treatment Period|Lost to Follow-up|1|||
94311154|NCT00394914|322923495|FG002|Treatment Period|Lost to Follow-up|0|||
94311155|NCT00394914|322923493|FG000|Treatment Period|Withdrawal by Subject|0|||
94311156|NCT00394914|322923494|FG001|Treatment Period|Withdrawal by Subject|2|||
94311157|NCT00394914|322923495|FG002|Treatment Period|Withdrawal by Subject|2|||
94311158|NCT00394914|322923493|FG000|Treatment Period|Noncompliance with protocol|0|||
94311159|NCT00394914|322923494|FG001|Treatment Period|Noncompliance with protocol|3|||
94311160|NCT00394914|322923495|FG002|Treatment Period|Noncompliance with protocol|2|||
94473247|NCT05052697|323523389|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473248|NCT05052697|323523390|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473249|NCT05052697|323523391|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473250|NCT05052697|323523392|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473251|NCT05052697|323523393|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473252|NCT05052697|323523394|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473253|NCT05052697|323523395|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473254|NCT05052697|323523396|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473255|NCT05052697|323523397|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473256|NCT05052697|323523398|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473257|NCT05052697|323523399|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94311161|NCT00394914|322923493|FG000|Treatment Period|Did not meet protocol eligibility|0|||
94311162|NCT00394914|322923494|FG001|Treatment Period|Did not meet protocol eligibility|1|||
94311163|NCT00394914|322923495|FG002|Treatment Period|Did not meet protocol eligibility|1|||
94311164|NCT02749721|322923500|FG000|Screening|Withdrawal by Subject|1|||
94311165|NCT02749721|322923500|FG000|Screening|Lost to Follow-up|2|||
94311166|NCT02749721|322923500|FG000|Screening|Protocol Violation|3|||
94311167|NCT02749721|322923500|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
94473258|NCT05052697|323523400|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473259|NCT05052697|323523401|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473260|NCT05052697|323523402|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473261|NCT05052697|323523403|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473262|NCT05052697|323523404|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473263|NCT05052697|323523405|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473264|NCT05052697|323523406|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473265|NCT05052697|323523407|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473266|NCT05052697|323523408|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473267|NCT05052697|323523409|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473268|NCT05052697|323523410|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473269|NCT05052697|323523411|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473270|NCT05052697|323523412|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473271|NCT05052697|323523413|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473272|NCT05052697|323523414|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473273|NCT05052697|323523415|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473274|NCT05052697|323523416|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473275|NCT05052697|323523417|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
94473276|NCT05052697|323523418|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473277|NCT05052697|323523419|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
94473278|NCT05052697|323523420|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
94473279|NCT05052697|323523421|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
94473280|NCT05052697|323523422|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
94473281|NCT05052697|323523389|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473282|NCT05052697|323523390|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473283|NCT05052697|323523391|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473284|NCT05052697|323523392|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94311168|NCT02749721|322923500|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
94311169|NCT02137772|322923501|FG000|Overall Study|Adverse Event|6|||
94311170|NCT02137772|322923502|FG001|Overall Study|Adverse Event|3|||
94311171|NCT02137772|322923501|FG000|Overall Study|Death|71|||
94311172|NCT02137772|322923502|FG001|Overall Study|Death|44|||
94311173|NCT02137772|322923501|FG000|Overall Study|Lost to Follow-up|8|||
94311174|NCT02137772|322923502|FG001|Overall Study|Lost to Follow-up|4|||
94473285|NCT05052697|323523393|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473286|NCT05052697|323523394|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473287|NCT05052697|323523395|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94311175|NCT02137772|322923501|FG000|Overall Study|Physician Decision|15|||
94311176|NCT02137772|322923502|FG001|Overall Study|Physician Decision|5|||
94311177|NCT02137772|322923501|FG000|Overall Study|Withdrawal by Subject|28|||
94311178|NCT02137772|322923502|FG001|Overall Study|Withdrawal by Subject|17|||
94311179|NCT02137772|322923501|FG000|Overall Study|Non-compliance with study drug|1|||
94311180|NCT02137772|322923502|FG001|Overall Study|Non-compliance with study drug|0|||
94311181|NCT02137772|322923501|FG000|Overall Study|Not treated|3|||
94311182|NCT02137772|322923502|FG001|Overall Study|Not treated|2|||
94311183|NCT00455858|322923503|FG000|Overall Study|Lost to Follow-up|2|||
94311184|NCT00455858|322923503|FG000|Overall Study|Protocol Violation|1|||
94311185|NCT00455858|322923503|FG000|Overall Study|Lack of Efficacy|1|||
94473288|NCT05052697|323523396|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473289|NCT05052697|323523397|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473290|NCT05052697|323523398|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473291|NCT05052697|323523399|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94311186|NCT00455858|322923503|FG000|Overall Study|Well controlled FPG without insulin|1|||
94381720|NCT01868009|323183338|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
94381721|NCT01868009|323183339|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
94381722|NCT01868009|323183338|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
94381723|NCT01868009|323183339|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
94381724|NCT00663871|323183345|FG000|Overall Study|Lost to Follow-up|5|||
94381725|NCT00663871|323183346|FG001|Overall Study|Lost to Follow-up|5|||
94311187|NCT00455858|322923503|FG000|Overall Study|Withdrawal|1|||
94311188|NCT02092389|322923506|FG000|Overall Study|Adverse Event|1|||
94311189|NCT02092389|322923506|FG000|Overall Study|Other|5|||
94311190|NCT00863928|322923507|FG000|Overall Study|Protocol Violation|26|||
94311191|NCT00863928|322923508|FG001|Overall Study|Protocol Violation|0|||
94311192|NCT00863928|322923507|FG000|Overall Study|Withdrawal by Subject|3|||
94311193|NCT00863928|322923508|FG001|Overall Study|Withdrawal by Subject|0|||
94311194|NCT00863928|322923507|FG000|Overall Study|surgery cancellation|4|||
94311195|NCT00863928|322923508|FG001|Overall Study|surgery cancellation|0|||
94311196|NCT00863928|322923507|FG000|Overall Study|medication allergy|3|||
94311197|NCT00863928|322923508|FG001|Overall Study|medication allergy|0|||
94311198|NCT03290300|322923509|FG000|Overall Study|Lost to Follow-up|3|||
94311199|NCT04172831|322923513|FG000|Overall Study|Adverse Event|21|||
94311200|NCT04172831|322923514|FG001|Overall Study|Adverse Event|9|||
94311201|NCT04172831|322923513|FG000|Overall Study|Lack of Efficacy|2|||
94311202|NCT04172831|322923514|FG001|Overall Study|Lack of Efficacy|8|||
94311203|NCT04172831|322923513|FG000|Overall Study|Physician Decision|0|||
94311204|NCT04172831|322923514|FG001|Overall Study|Physician Decision|1|||
94311205|NCT04172831|322923513|FG000|Overall Study|Withdrawal by Subject|12|||
94311206|NCT04172831|322923514|FG001|Overall Study|Withdrawal by Subject|11|||
94311207|NCT04172831|322923513|FG000|Overall Study|Lost to Follow-up|4|||
94311208|NCT04172831|322923514|FG001|Overall Study|Lost to Follow-up|9|||
94311209|NCT04172831|322923513|FG000|Overall Study|COVID-19 related crisis|3|||
94311210|NCT04172831|322923514|FG001|Overall Study|COVID-19 related crisis|3|||
94311211|NCT04172831|322923513|FG000|Overall Study|Subject non-compliance|1|||
94311212|NCT04172831|322923514|FG001|Overall Study|Subject non-compliance|1|||
94311213|NCT04172831|322923513|FG000|Overall Study|Family emergency|1|||
94311214|NCT04172831|322923514|FG001|Overall Study|Family emergency|0|||
94311215|NCT01041573|322923515|FG000|Overall Study|Withdrawal by Subject|2|||
94311216|NCT01041573|322923516|FG001|Overall Study|Withdrawal by Subject|5|||
94311217|NCT01041573|322923517|FG002|Overall Study|Withdrawal by Subject|2|||
94311218|NCT01041573|322923518|FG003|Overall Study|Withdrawal by Subject|0|||
94311219|NCT01041573|322923515|FG000|Overall Study|Death|1|||
94311220|NCT01041573|322923516|FG001|Overall Study|Death|0|||
94311221|NCT01041573|322923517|FG002|Overall Study|Death|0|||
94311222|NCT01041573|322923518|FG003|Overall Study|Death|0|||
94311223|NCT01041573|322923515|FG000|Overall Study|Lost to Follow-up|0|||
94311224|NCT01041573|322923516|FG001|Overall Study|Lost to Follow-up|1|||
94311225|NCT01041573|322923517|FG002|Overall Study|Lost to Follow-up|2|||
94311226|NCT01041573|322923518|FG003|Overall Study|Lost to Follow-up|1|||
94311227|NCT01041573|322923515|FG000|Overall Study|Adverse Event|0|||
94311228|NCT01041573|322923516|FG001|Overall Study|Adverse Event|2|||
94311229|NCT01041573|322923517|FG002|Overall Study|Adverse Event|0|||
94311230|NCT01041573|322923518|FG003|Overall Study|Adverse Event|0|||
94311231|NCT01041573|322923515|FG000|Overall Study|relocation|1|||
94311232|NCT01041573|322923516|FG001|Overall Study|relocation|4|||
94311233|NCT01041573|322923517|FG002|Overall Study|relocation|3|||
94311234|NCT01041573|322923518|FG003|Overall Study|relocation|1|||
94311235|NCT01041573|322923515|FG000|Overall Study|further blood extraction|0|||
94311236|NCT01041573|322923516|FG001|Overall Study|further blood extraction|1|||
94311237|NCT01041573|322923517|FG002|Overall Study|further blood extraction|0|||
94311238|NCT01041573|322923518|FG003|Overall Study|further blood extraction|0|||
94311239|NCT01041573|322923515|FG000|Overall Study|positive to anti-HCV|1|||
94311240|NCT01041573|322923516|FG001|Overall Study|positive to anti-HCV|0|||
94311241|NCT01041573|322923517|FG002|Overall Study|positive to anti-HCV|0|||
94311242|NCT01041573|322923518|FG003|Overall Study|positive to anti-HCV|0|||
94311243|NCT03461289|322923519|FG000|Overall Study|Death|1|||
94311244|NCT00616239|322923520|FG000|Overall Study|Withdrawal by Subject|2|||
94311245|NCT02873715|322923521|FG000|Overall Study|Lost to Follow-up|84|||
94311246|NCT02873715|322923522|FG001|Overall Study|Lost to Follow-up|94|||
94311247|NCT02873715|322923521|FG000|Overall Study|Withdrawal by Subject|7|||
94311248|NCT02873715|322923522|FG001|Overall Study|Withdrawal by Subject|26|||
94311249|NCT02021812|322923523|FG000|Overall Study|Death|8|||
94311250|NCT02021812|322923523|FG000|Overall Study|Withdrawal by Subject|3|||
94311251|NCT02021812|322923523|FG000|Overall Study|Lost to Follow-up|2|||
94311252|NCT02021812|322923523|FG000|Overall Study|Refuse to return, COVD 19|2|||
94311253|NCT03241173|322923524|FG000|Overall Study|Death|3|||
94311254|NCT03241173|322923525|FG001|Overall Study|Death|2|||
94311255|NCT03241173|322923526|FG002|Overall Study|Death|4|||
94311256|NCT03241173|322923527|FG003|Overall Study|Death|4|||
94311257|NCT03241173|322923528|FG004|Overall Study|Death|2|||
94311258|NCT03241173|322923529|FG005|Overall Study|Death|2|||
94311259|NCT03241173|322923530|FG006|Overall Study|Death|3|||
94311260|NCT03241173|322923531|FG007|Overall Study|Death|1|||
94311261|NCT03241173|322923532|FG008|Overall Study|Death|0|||
94311262|NCT03241173|322923533|FG009|Overall Study|Death|5|||
94311263|NCT03241173|322923534|FG010|Overall Study|Death|4|||
94311264|NCT03241173|322923535|FG011|Overall Study|Death|3|||
94311265|NCT03241173|322923536|FG012|Overall Study|Death|0|||
94311266|NCT03241173|322923537|FG013|Overall Study|Death|0|||
94311267|NCT03241173|322923538|FG014|Overall Study|Death|0|||
94311268|NCT03241173|322923524|FG000|Overall Study|Withdrawal by Subject|0|||
94311269|NCT03241173|322923525|FG001|Overall Study|Withdrawal by Subject|0|||
94311270|NCT03241173|322923526|FG002|Overall Study|Withdrawal by Subject|1|||
94311271|NCT03241173|322923527|FG003|Overall Study|Withdrawal by Subject|0|||
94311272|NCT03241173|322923528|FG004|Overall Study|Withdrawal by Subject|0|||
94311273|NCT03241173|322923529|FG005|Overall Study|Withdrawal by Subject|1|||
94311274|NCT03241173|322923530|FG006|Overall Study|Withdrawal by Subject|0|||
94311275|NCT03241173|322923531|FG007|Overall Study|Withdrawal by Subject|0|||
94311276|NCT03241173|322923532|FG008|Overall Study|Withdrawal by Subject|0|||
94311277|NCT03241173|322923533|FG009|Overall Study|Withdrawal by Subject|0|||
94311278|NCT03241173|322923534|FG010|Overall Study|Withdrawal by Subject|0|||
94311279|NCT03241173|322923535|FG011|Overall Study|Withdrawal by Subject|0|||
94311280|NCT03241173|322923536|FG012|Overall Study|Withdrawal by Subject|0|||
94311281|NCT03241173|322923537|FG013|Overall Study|Withdrawal by Subject|0|||
94311282|NCT03241173|322923538|FG014|Overall Study|Withdrawal by Subject|0|||
94311283|NCT03241173|322923524|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
94311284|NCT03241173|322923525|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
94311285|NCT03241173|322923526|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
94311286|NCT03241173|322923527|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
94311287|NCT03241173|322923528|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
94311288|NCT03241173|322923529|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
94311289|NCT03241173|322923530|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
94311290|NCT03241173|322923531|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
94311291|NCT03241173|322923532|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
94311292|NCT03241173|322923533|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
94311293|NCT03241173|322923534|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
94311294|NCT03241173|322923535|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
94311295|NCT03241173|322923536|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
94311296|NCT03241173|322923537|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
94311297|NCT03241173|322923538|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
94311298|NCT03241173|322923524|FG000|Overall Study|Lost to Follow-up|0|||
94311299|NCT03241173|322923525|FG001|Overall Study|Lost to Follow-up|0|||
94311300|NCT03241173|322923526|FG002|Overall Study|Lost to Follow-up|0|||
94311301|NCT03241173|322923527|FG003|Overall Study|Lost to Follow-up|0|||
94311302|NCT03241173|322923528|FG004|Overall Study|Lost to Follow-up|1|||
94311303|NCT03241173|322923529|FG005|Overall Study|Lost to Follow-up|0|||
94311304|NCT03241173|322923530|FG006|Overall Study|Lost to Follow-up|0|||
94311305|NCT03241173|322923531|FG007|Overall Study|Lost to Follow-up|0|||
94311306|NCT03241173|322923532|FG008|Overall Study|Lost to Follow-up|0|||
94311307|NCT03241173|322923533|FG009|Overall Study|Lost to Follow-up|1|||
94311308|NCT03241173|322923534|FG010|Overall Study|Lost to Follow-up|0|||
94311309|NCT03241173|322923535|FG011|Overall Study|Lost to Follow-up|0|||
94311310|NCT03241173|322923536|FG012|Overall Study|Lost to Follow-up|0|||
94311311|NCT03241173|322923537|FG013|Overall Study|Lost to Follow-up|0|||
94311312|NCT03241173|322923538|FG014|Overall Study|Lost to Follow-up|0|||
94311313|NCT00564629|322923539|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
94311314|NCT00564629|322923540|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
94311315|NCT02531035|322925203|FG000|Overall Study|Death|0|||
94311316|NCT02531035|322925204|FG001|Overall Study|Death|1|||
94311317|NCT02531035|322925203|FG000|Overall Study|Protocol Violation|1|||
94311318|NCT02531035|322925204|FG001|Overall Study|Protocol Violation|1|||
94311319|NCT02531035|322925203|FG000|Overall Study|Noncompliance with study drug|8|||
94311320|NCT02531035|322925204|FG001|Overall Study|Noncompliance with study drug|3|||
94311321|NCT02531035|322925203|FG000|Overall Study|Physician Decision|1|||
94311322|NCT02531035|322925204|FG001|Overall Study|Physician Decision|0|||
94311323|NCT02531035|322925203|FG000|Overall Study|Adverse Event|16|||
94311324|NCT02531035|322925204|FG001|Overall Study|Adverse Event|45|||
94311325|NCT02531035|322925203|FG000|Overall Study|Other|3|||
94311326|NCT02531035|322925204|FG001|Overall Study|Other|2|||
94311327|NCT02531035|322925203|FG000|Overall Study|Withdrawal by Subject|42|||
94311328|NCT02531035|322925204|FG001|Overall Study|Withdrawal by Subject|32|||
94311329|NCT02531035|322925203|FG000|Overall Study|Lost to Follow-up|8|||
94311330|NCT02531035|322925204|FG001|Overall Study|Lost to Follow-up|10|||
94311331|NCT02531035|322925203|FG000|Overall Study|Randomized, not treated|2|||
94311332|NCT02531035|322925204|FG001|Overall Study|Randomized, not treated|1|||
94311333|NCT04168645|322925210|FG000|Overall Study|Lost to Follow-up|23|||
94311334|NCT04168645|322925211|FG001|Overall Study|Lost to Follow-up|28|||
94311335|NCT04168645|322925212|FG002|Overall Study|Lost to Follow-up|15|||
94311336|NCT04168645|322925213|FG003|Overall Study|Lost to Follow-up|12|||
94311337|NCT04168645|322925210|FG000|Overall Study|Death|1|||
94311338|NCT04168645|322925211|FG001|Overall Study|Death|1|||
94311339|NCT04168645|322925212|FG002|Overall Study|Death|0|||
94311340|NCT04168645|322925213|FG003|Overall Study|Death|0|||
94311341|NCT04168645|322925210|FG000|Overall Study|Withdrawal by Subject|5|||
94311342|NCT04168645|322925211|FG001|Overall Study|Withdrawal by Subject|2|||
94311343|NCT04168645|322925212|FG002|Overall Study|Withdrawal by Subject|2|||
94311344|NCT04168645|322925213|FG003|Overall Study|Withdrawal by Subject|2|||
94311345|NCT04168645|322925210|FG000|Overall Study|Administrative Withdrawal|3|||
94311346|NCT04168645|322925211|FG001|Overall Study|Administrative Withdrawal|1|||
94311347|NCT04168645|322925212|FG002|Overall Study|Administrative Withdrawal|1|||
94311348|NCT04168645|322925213|FG003|Overall Study|Administrative Withdrawal|3|||
94311349|NCT03032068|322925219|FG000|Overall Study|Adverse Event|1|||
94311350|NCT00408421|322925222|FG000|Treatment Initial Randomization|Adverse Event|5|||
94311351|NCT00408421|322925223|FG001|Treatment Initial Randomization|Adverse Event|9|||
94311352|NCT00408421|322925224|FG002|Treatment Initial Randomization|Adverse Event|0|||
94311353|NCT00408421|322925222|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
94311354|NCT00408421|322925223|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
94311355|NCT00408421|322925224|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
94311356|NCT00408421|322925222|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
94311357|NCT00408421|322925223|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
94311358|NCT00408421|322925224|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
94311359|NCT00408421|322925222|FG000|Treatment Initial Randomization|Physician Decision|1|||
94311360|NCT00408421|322925223|FG001|Treatment Initial Randomization|Physician Decision|0|||
94311361|NCT00408421|322925224|FG002|Treatment Initial Randomization|Physician Decision|0|||
94311362|NCT00408421|322925222|FG000|Treatment Initial Randomization|Protocol Violation|0|||
94311363|NCT00408421|322925223|FG001|Treatment Initial Randomization|Protocol Violation|1|||
94311364|NCT00408421|322925224|FG002|Treatment Initial Randomization|Protocol Violation|0|||
94311365|NCT00408421|322925222|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
94311366|NCT00408421|322925223|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
94311367|NCT00408421|322925224|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
94311368|NCT00408421|322925222|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
94311369|NCT00408421|322925223|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
94311370|NCT00408421|322925224|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
94311371|NCT00408421|322925222|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
94311372|NCT00408421|322925223|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
94311373|NCT00408421|322925224|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
94311374|NCT00408421|322925222|FG000|Treatment Re-Randomization|Adverse Event|2|||
94311375|NCT00408421|322925223|FG001|Treatment Re-Randomization|Adverse Event|2|||
94311376|NCT00408421|322925224|FG002|Treatment Re-Randomization|Adverse Event|4|||
94311377|NCT00408421|322925222|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
94311378|NCT00408421|322925223|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
94311379|NCT00408421|322925224|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
94311380|NCT00408421|322925222|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
94311381|NCT00408421|322925223|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
94311382|NCT00408421|322925224|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
94311383|NCT00408421|322925222|FG000|Treatment Re-Randomization|Physician Decision|1|||
94381726|NCT00663871|323183345|FG000|Overall Study|Withdrawal by Subject|5|||
94381727|NCT00663871|323183346|FG001|Overall Study|Withdrawal by Subject|2|||
94381728|NCT01835145|323183347|FG000|Overall Study|Ineligible prior to treatment|1|||
94381729|NCT01835145|323183348|FG001|Overall Study|Ineligible prior to treatment|0|||
94381730|NCT01565083|323183349|FG000|Overall Study|Withdrawal by Subject|6|||
94381731|NCT01565083|323183350|FG001|Overall Study|Withdrawal by Subject|4|||
94381732|NCT01565083|323183349|FG000|Overall Study|Lost to Follow-up|2|||
94381733|NCT01565083|323183350|FG001|Overall Study|Lost to Follow-up|7|||
94381734|NCT01565083|323183349|FG000|Overall Study|Death|22|||
94381735|NCT01565083|323183350|FG001|Overall Study|Death|23|||
94381736|NCT01565083|323183349|FG000|Overall Study|Other|3|||
94381737|NCT01565083|323183350|FG001|Overall Study|Other|5|||
94381738|NCT01054599|323183351|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
94381739|NCT01054599|323183352|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
94381740|NCT01054599|323183351|FG000|Overall Study|Protocol Violation|1|||
94381741|NCT01054599|323183352|FG001|Overall Study|Protocol Violation|0|||
94381742|NCT01054599|323183351|FG000|Overall Study|Spells/seizure-like episodes|1|||
94381743|NCT01054599|323183352|FG001|Overall Study|Spells/seizure-like episodes|1|||
94381744|NCT01054599|323183351|FG000|Overall Study|Timing/scheduling difficulties|1|||
94381745|NCT01054599|323183352|FG001|Overall Study|Timing/scheduling difficulties|1|||
94381746|NCT01054599|323183351|FG000|Overall Study|Visual impairment, WTAR <80|0|||
94381747|NCT01054599|323183352|FG001|Overall Study|Visual impairment, WTAR <80|1|||
94381748|NCT01054599|323183351|FG000|Overall Study|Lost to Follow-up|0|||
94381749|NCT01054599|323183352|FG001|Overall Study|Lost to Follow-up|2|||
94381750|NCT01054599|323183351|FG000|Overall Study|Adverse Event|0|||
94381751|NCT01054599|323183352|FG001|Overall Study|Adverse Event|1|||
94381752|NCT01054599|323183351|FG000|Overall Study|Withdrawal by Subject|0|||
94381753|NCT01054599|323183352|FG001|Overall Study|Withdrawal by Subject|1|||
94381754|NCT04947579|323183353|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
94381755|NCT04947579|323183354|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
94381756|NCT04947579|323183355|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
94381757|NCT04947579|323183356|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
94381758|NCT04947579|323183357|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
94381759|NCT04947579|323183358|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
94381760|NCT04947579|323183353|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
94381761|NCT04947579|323183354|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
94311384|NCT00408421|322925223|FG001|Treatment Re-Randomization|Physician Decision|3|||
94311385|NCT00408421|322925224|FG002|Treatment Re-Randomization|Physician Decision|0|||
94311386|NCT00408421|322925222|FG000|Treatment Re-Randomization|Protocol Violation|1|||
94311387|NCT00408421|322925223|FG001|Treatment Re-Randomization|Protocol Violation|1|||
94311388|NCT00408421|322925224|FG002|Treatment Re-Randomization|Protocol Violation|0|||
94311389|NCT00408421|322925222|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
94311390|NCT00408421|322925223|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
94311391|NCT00408421|322925224|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
94311392|NCT03918642|322925225|FG000|Overall Study|Lost to Follow-up|12|||
94311393|NCT03918642|322925226|FG001|Overall Study|Lost to Follow-up|10|||
94311394|NCT01988012|322925235|FG000|Overall Study|Adverse Event|5|||
94311395|NCT01988012|322925235|FG000|Overall Study|Insufficient Therapeutic Response|3|||
94311396|NCT01988012|322925235|FG000|Overall Study|Patient Withdrawal of Consent|4|||
94311397|NCT01988012|322925235|FG000|Overall Study|Lost to Follow-up|1|||
94311398|NCT01988012|322925235|FG000|Overall Study|Physician Decision|1|||
94311399|NCT01988012|322925235|FG000|Overall Study|Protocol Violation|1|||
94311400|NCT01058369|322925236|FG000|Overall Study|Adverse Event|1|||
94311401|NCT01058369|322925236|FG000|Overall Study|Early termination study|1|||
94311402|NCT00089843|322925237|FG000|Overall Study|Withdrawal by Subject|1|||
94311403|NCT00089843|322925238|FG001|Overall Study|Withdrawal by Subject|4|||
94311404|NCT00089843|322925239|FG002|Overall Study|Withdrawal by Subject|5|||
94311405|NCT00089843|322925240|FG003|Overall Study|Withdrawal by Subject|6|||
94311406|NCT00089843|322925237|FG000|Overall Study|Physician Decision|1|||
94311407|NCT00089843|322925238|FG001|Overall Study|Physician Decision|0|||
94311408|NCT00089843|322925239|FG002|Overall Study|Physician Decision|0|||
94311409|NCT00089843|322925240|FG003|Overall Study|Physician Decision|1|||
94311410|NCT01912872|322925241|FG000|Overall Study|Lost to Follow-up|2|||
94311411|NCT01912872|322925242|FG001|Overall Study|Lost to Follow-up|3|||
94311412|NCT01912872|322925243|FG002|Overall Study|Lost to Follow-up|5|||
94311413|NCT01912872|322925244|FG003|Overall Study|Lost to Follow-up|5|||
94311414|NCT01912872|322925241|FG000|Overall Study|Other unspecified|3|||
94311415|NCT01912872|322925242|FG001|Overall Study|Other unspecified|1|||
94311416|NCT01912872|322925243|FG002|Overall Study|Other unspecified|3|||
94311417|NCT01912872|322925244|FG003|Overall Study|Other unspecified|0|||
94311418|NCT01912872|322925241|FG000|Overall Study|Informed consent withdrawn|0|||
94311419|NCT01912872|322925242|FG001|Overall Study|Informed consent withdrawn|0|||
94311420|NCT01912872|322925243|FG002|Overall Study|Informed consent withdrawn|1|||
94311421|NCT01912872|322925244|FG003|Overall Study|Informed consent withdrawn|1|||
94311422|NCT01912872|322925241|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
94311423|NCT01912872|322925242|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
94311424|NCT01912872|322925243|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
94311425|NCT01912872|322925244|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
94311426|NCT01912872|322925241|FG000|Overall Study|Protocol Violation|0|||
94311427|NCT01912872|322925242|FG001|Overall Study|Protocol Violation|0|||
94311428|NCT01912872|322925243|FG002|Overall Study|Protocol Violation|1|||
94311429|NCT01912872|322925244|FG003|Overall Study|Protocol Violation|0|||
94311430|NCT01912872|322925241|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94311431|NCT01912872|322925242|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94311432|NCT01912872|322925243|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
94311433|NCT01912872|322925244|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
94311434|NCT01912872|322925241|FG000|Overall Study|Withdrawal of study medication|0|||
94311435|NCT01912872|322925242|FG001|Overall Study|Withdrawal of study medication|0|||
94311436|NCT01912872|322925243|FG002|Overall Study|Withdrawal of study medication|0|||
94311437|NCT01912872|322925244|FG003|Overall Study|Withdrawal of study medication|2|||
94311438|NCT01912872|322925241|FG000|Overall Study|Missing|0|||
94311439|NCT01912872|322925242|FG001|Overall Study|Missing|0|||
94311440|NCT01912872|322925243|FG002|Overall Study|Missing|0|||
94311441|NCT01912872|322925244|FG003|Overall Study|Missing|1|||
94311442|NCT02940886|322925245|FG000|Overall Study|Adverse Event|7|||
94381762|NCT04947579|323183355|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
94473292|NCT05052697|323523400|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473293|NCT05052697|323523401|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473294|NCT05052697|323523402|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473295|NCT05052697|323523403|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473296|NCT05052697|323523404|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473297|NCT05052697|323523405|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473298|NCT05052697|323523406|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473299|NCT05052697|323523407|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473300|NCT05052697|323523408|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473301|NCT05052697|323523409|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473302|NCT05052697|323523410|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473303|NCT05052697|323523411|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473304|NCT05052697|323523412|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473305|NCT05052697|323523413|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473306|NCT05052697|323523414|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473307|NCT05052697|323523415|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473308|NCT05052697|323523416|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473309|NCT05052697|323523417|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
94473310|NCT05052697|323523418|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
94473311|NCT05052697|323523419|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
94473312|NCT05052697|323523420|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
94473313|NCT05052697|323523421|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
94473314|NCT05052697|323523422|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
94473315|NCT05052697|323523389|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473316|NCT05052697|323523390|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473317|NCT05052697|323523391|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473318|NCT05052697|323523392|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473319|NCT05052697|323523393|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473320|NCT05052697|323523394|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473321|NCT05052697|323523395|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473322|NCT05052697|323523396|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473323|NCT05052697|323523397|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473324|NCT05052697|323523398|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473325|NCT05052697|323523399|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473326|NCT05052697|323523400|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473327|NCT05052697|323523401|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473328|NCT05052697|323523402|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473329|NCT05052697|323523403|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473330|NCT05052697|323523404|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94311443|NCT02940886|322925246|FG001|Overall Study|Adverse Event|3|||
94311444|NCT02940886|322925245|FG000|Overall Study|Protocol Violation|0|||
94311445|NCT02940886|322925246|FG001|Overall Study|Protocol Violation|2|||
94311446|NCT02940886|322925245|FG000|Overall Study|Withdrawal by Subject|28|||
94311447|NCT02940886|322925246|FG001|Overall Study|Withdrawal by Subject|20|||
94311448|NCT02940886|322925245|FG000|Overall Study|Death|1|||
94311449|NCT02940886|322925246|FG001|Overall Study|Death|0|||
94311450|NCT02940886|322925245|FG000|Overall Study|Lack of Efficacy|1|||
94311451|NCT02940886|322925246|FG001|Overall Study|Lack of Efficacy|0|||
94311452|NCT02940886|322925245|FG000|Overall Study|Lost to Follow-up|49|||
94311453|NCT02940886|322925246|FG001|Overall Study|Lost to Follow-up|21|||
94311454|NCT02940886|322925245|FG000|Overall Study|Physician Decision|9|||
94311455|NCT02940886|322925246|FG001|Overall Study|Physician Decision|4|||
94311456|NCT02940886|322925245|FG000|Overall Study|Sponsor decision|0|||
94311457|NCT02940886|322925246|FG001|Overall Study|Sponsor decision|1|||
94311458|NCT02940886|322925245|FG000|Overall Study|No treatment|7|||
94311459|NCT02940886|322925246|FG001|Overall Study|No treatment|2|||
94311460|NCT02940886|322925245|FG000|Overall Study|Enrolment error|0|||
94311461|NCT02940886|322925246|FG001|Overall Study|Enrolment error|1|||
94311462|NCT03042611|322925247|FG000|Core Phase|Withdrawal by Subject|13|||
94311463|NCT03042611|322925248|FG001|Core Phase|Withdrawal by Subject|4|||
94311464|NCT03042611|322925249|FG002|Core Phase|Withdrawal by Subject|0|||
94311465|NCT03042611|322925250|FG003|Core Phase|Withdrawal by Subject|0|||
94311466|NCT03042611|322925247|FG000|Core Phase|Death|232|||
94311467|NCT03042611|322925248|FG001|Core Phase|Death|110|||
94311468|NCT03042611|322925249|FG002|Core Phase|Death|0|||
94311469|NCT03042611|322925250|FG003|Core Phase|Death|0|||
94311470|NCT03042611|322925247|FG000|Core Phase|Lost to Follow-up|4|||
94311471|NCT03042611|322925248|FG001|Core Phase|Lost to Follow-up|7|||
94311472|NCT03042611|322925249|FG002|Core Phase|Lost to Follow-up|0|||
94473331|NCT05052697|323523405|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473332|NCT05052697|323523406|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473333|NCT05052697|323523407|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473334|NCT05052697|323523408|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94381763|NCT04947579|323183356|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
94381764|NCT04947579|323183357|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
94381765|NCT04947579|323183358|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
94381766|NCT04947579|323183353|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
94381767|NCT04947579|323183354|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
94381768|NCT04947579|323183355|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
94381769|NCT04947579|323183356|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
94381770|NCT04947579|323183357|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
94381771|NCT04947579|323183358|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
94381772|NCT04947579|323183353|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
94381773|NCT04947579|323183354|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
94381774|NCT04947579|323183355|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
94381775|NCT04947579|323183356|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
94381776|NCT04947579|323183357|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
94381777|NCT04947579|323183358|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
94381778|NCT04947579|323183353|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
94381779|NCT04947579|323183354|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
94381780|NCT04947579|323183355|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
94381781|NCT04947579|323183356|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
94381782|NCT04947579|323183357|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
94381783|NCT04947579|323183358|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
94381784|NCT04947579|323183353|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
94381785|NCT04947579|323183354|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
94381786|NCT04947579|323183355|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
94381787|NCT04947579|323183356|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
94381788|NCT04947579|323183357|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
94381789|NCT04947579|323183358|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
94381790|NCT04947579|323183353|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
94381791|NCT04947579|323183354|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
94381792|NCT04947579|323183355|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
94381793|NCT04947579|323183356|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
94381794|NCT04947579|323183357|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
94381795|NCT04947579|323183358|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
94381796|NCT04947579|323183353|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
94381797|NCT04947579|323183354|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
94381798|NCT04947579|323183355|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
94381799|NCT04947579|323183356|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
94381800|NCT04947579|323183357|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
94381801|NCT04947579|323183358|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
94381802|NCT04947579|323183353|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
94311473|NCT03042611|322925250|FG003|Core Phase|Lost to Follow-up|0|||
94311474|NCT03042611|322925247|FG000|Core Phase|Physician Decision|7|||
94311475|NCT03042611|322925248|FG001|Core Phase|Physician Decision|2|||
94311476|NCT03042611|322925249|FG002|Core Phase|Physician Decision|0|||
94311477|NCT03042611|322925250|FG003|Core Phase|Physician Decision|0|||
94311478|NCT03042611|322925247|FG000|Core Phase|Study Closed|0|||
94311479|NCT03042611|322925248|FG001|Core Phase|Study Closed|1|||
94311480|NCT03042611|322925249|FG002|Core Phase|Study Closed|0|||
94311481|NCT03042611|322925250|FG003|Core Phase|Study Closed|0|||
94311482|NCT03042611|322925247|FG000|Extension Phase|Death|0|||
94311483|NCT03042611|322925248|FG001|Extension Phase|Death|0|||
94311484|NCT03042611|322925249|FG002|Extension Phase|Death|34|||
94311485|NCT03042611|322925250|FG003|Extension Phase|Death|16|||
94311486|NCT03042611|322925247|FG000|Extension Phase|Lost to Follow-up|0|||
94311487|NCT03042611|322925248|FG001|Extension Phase|Lost to Follow-up|0|||
94311488|NCT03042611|322925249|FG002|Extension Phase|Lost to Follow-up|1|||
94311489|NCT03042611|322925250|FG003|Extension Phase|Lost to Follow-up|1|||
94311490|NCT03042611|322925247|FG000|Extension Phase|Study Closed|0|||
94311491|NCT03042611|322925248|FG001|Extension Phase|Study Closed|0|||
94311492|NCT03042611|322925249|FG002|Extension Phase|Study Closed|17|||
94311493|NCT03042611|322925250|FG003|Extension Phase|Study Closed|11|||
94311494|NCT01306058|322925251|FG000|Overall Study|Death|1|||
94311495|NCT01306058|322925251|FG000|Overall Study|Enrolled but did not get treatment|1|||
94311496|NCT01666444|322925252|FG000|Overall Study|Did not initiate treatment|2|||
94311497|NCT01666444|322925253|FG001|Overall Study|Did not initiate treatment|1|||
94311498|NCT03074162|322925254|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
94311499|NCT03074162|322925255|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
94311500|NCT03074162|322925256|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
94311501|NCT03074162|322925257|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
94311502|NCT03074162|322925258|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
94473335|NCT05052697|323523409|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473336|NCT05052697|323523410|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473337|NCT05052697|323523411|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473338|NCT05052697|323523412|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473339|NCT05052697|323523413|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473340|NCT05052697|323523414|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473341|NCT05052697|323523415|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473342|NCT05052697|323523416|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473343|NCT05052697|323523417|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473344|NCT05052697|323523418|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473345|NCT05052697|323523419|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473346|NCT05052697|323523420|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473347|NCT05052697|323523421|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
94473348|NCT05052697|323523422|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
94473349|NCT05052697|323523389|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473350|NCT05052697|323523390|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473351|NCT05052697|323523391|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473352|NCT05052697|323523392|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473353|NCT05052697|323523393|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473354|NCT05052697|323523394|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473355|NCT05052697|323523395|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473356|NCT05052697|323523396|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473357|NCT05052697|323523397|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473358|NCT05052697|323523398|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473359|NCT05052697|323523399|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473360|NCT05052697|323523400|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473361|NCT05052697|323523401|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473362|NCT05052697|323523402|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473363|NCT05052697|323523403|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473364|NCT05052697|323523404|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473365|NCT05052697|323523405|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473366|NCT05052697|323523406|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473367|NCT05052697|323523407|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473368|NCT05052697|323523408|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473369|NCT05052697|323523409|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473370|NCT05052697|323523410|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473371|NCT05052697|323523411|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473372|NCT05052697|323523412|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473373|NCT05052697|323523413|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473374|NCT05052697|323523414|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473375|NCT05052697|323523415|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473376|NCT05052697|323523416|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473377|NCT05052697|323523417|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
94473378|NCT05052697|323523418|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
94473379|NCT05052697|323523419|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
94473380|NCT05052697|323523420|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473381|NCT05052697|323523421|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473382|NCT05052697|323523422|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
94473383|NCT01941537|323523423|FG000|Overall Study|Lack of Efficacy|1|||
94311503|NCT03074162|322925259|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
94311504|NCT03074162|322925254|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
94311505|NCT03074162|322925255|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
94311506|NCT03074162|322925256|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
94311507|NCT03074162|322925257|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
94311508|NCT03074162|322925258|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
94311509|NCT03074162|322925259|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
94311510|NCT03074162|322925254|FG000|Period 3|Withdrawal by Subject|1|||
94311511|NCT03074162|322925255|FG001|Period 3|Withdrawal by Subject|0|||
94311512|NCT03074162|322925256|FG002|Period 3|Withdrawal by Subject|0|||
94311513|NCT03074162|322925257|FG003|Period 3|Withdrawal by Subject|0|||
94311514|NCT03074162|322925258|FG004|Period 3|Withdrawal by Subject|1|||
94311515|NCT03074162|322925259|FG005|Period 3|Withdrawal by Subject|0|||
94311516|NCT01958671|322925260|FG000|Overall Study|Adverse Event|1|||
94311517|NCT01958671|322925261|FG001|Overall Study|Adverse Event|1|||
94473384|NCT01941537|323523424|FG001|Overall Study|Lack of Efficacy|2|||
94473385|NCT01941537|323523423|FG000|Overall Study|Lost to Follow-up|1|||
94473386|NCT01941537|323523424|FG001|Overall Study|Lost to Follow-up|0|||
94311518|NCT01958671|322925262|FG002|Overall Study|Adverse Event|5|||
94311519|NCT01958671|322925260|FG000|Overall Study|Death|1|||
94473387|NCT01941537|323523423|FG000|Overall Study|Pregnancy|1|||
94473388|NCT01941537|323523424|FG001|Overall Study|Pregnancy|0|||
94311520|NCT01958671|322925261|FG001|Overall Study|Death|0|||
94311521|NCT01958671|322925262|FG002|Overall Study|Death|0|||
94311522|NCT01958671|322925260|FG000|Overall Study|Excluded medication|0|||
94311523|NCT01958671|322925261|FG001|Overall Study|Excluded medication|0|||
94311524|NCT01958671|322925262|FG002|Overall Study|Excluded medication|1|||
94311525|NCT01958671|322925260|FG000|Overall Study|Hyperglycemia|0|||
94311526|NCT01958671|322925261|FG001|Overall Study|Hyperglycemia|0|||
94311527|NCT01958671|322925262|FG002|Overall Study|Hyperglycemia|2|||
94311528|NCT01958671|322925260|FG000|Overall Study|Lost to Follow-up|7|||
94311529|NCT01958671|322925261|FG001|Overall Study|Lost to Follow-up|11|||
94311530|NCT01958671|322925262|FG002|Overall Study|Lost to Follow-up|7|||
94311531|NCT01958671|322925260|FG000|Overall Study|Non-compliance with study drug|1|||
94311532|NCT01958671|322925261|FG001|Overall Study|Non-compliance with study drug|1|||
94311533|NCT01958671|322925262|FG002|Overall Study|Non-compliance with study drug|1|||
94311534|NCT01958671|322925260|FG000|Overall Study|Pregnancy|0|||
94311535|NCT01958671|322925261|FG001|Overall Study|Pregnancy|0|||
94311536|NCT01958671|322925262|FG002|Overall Study|Pregnancy|1|||
94311537|NCT01958671|322925260|FG000|Overall Study|Protocol Violation|0|||
94311538|NCT01958671|322925261|FG001|Overall Study|Protocol Violation|1|||
94311539|NCT01958671|322925262|FG002|Overall Study|Protocol Violation|0|||
94311540|NCT01958671|322925260|FG000|Overall Study|Study site terminated by sponsor|1|||
94311541|NCT01958671|322925261|FG001|Overall Study|Study site terminated by sponsor|0|||
94311542|NCT01958671|322925262|FG002|Overall Study|Study site terminated by sponsor|1|||
94311543|NCT01958671|322925260|FG000|Overall Study|Participant moved|0|||
94311544|NCT01958671|322925261|FG001|Overall Study|Participant moved|0|||
94311545|NCT01958671|322925262|FG002|Overall Study|Participant moved|1|||
94311546|NCT01958671|322925260|FG000|Overall Study|Withdrawal by Subject|8|||
94311547|NCT01958671|322925261|FG001|Overall Study|Withdrawal by Subject|10|||
94311548|NCT01958671|322925262|FG002|Overall Study|Withdrawal by Subject|13|||
94311549|NCT00950690|322925265|FG000|Overall Study|Death|4|||
94381803|NCT04947579|323183354|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
94381804|NCT04947579|323183355|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
94381805|NCT04947579|323183356|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
94381806|NCT04947579|323183357|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
94381807|NCT04947579|323183358|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
94381808|NCT04947579|323183353|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
94381809|NCT04947579|323183354|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
94381810|NCT04947579|323183355|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
94381811|NCT04947579|323183356|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
94381812|NCT04947579|323183357|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
94381813|NCT04947579|323183358|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
94381814|NCT04947579|323183353|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
94381815|NCT04947579|323183354|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
94381816|NCT04947579|323183355|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
94381817|NCT04947579|323183356|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
94381818|NCT04947579|323183357|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
94381819|NCT04947579|323183358|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
94381820|NCT00929708|323183359|FG000|Overall Study|Protocol Violation|2|||
94381821|NCT00929708|323183360|FG001|Overall Study|Protocol Violation|1|||
94381822|NCT00929708|323183361|FG002|Overall Study|Protocol Violation|1|||
94381823|NCT00929708|323183362|FG003|Overall Study|Protocol Violation|1|||
94381824|NCT00929708|323183363|FG004|Overall Study|Protocol Violation|1|||
94381825|NCT00929708|323183359|FG000|Overall Study|Withdrawal by Subject|2|||
94381826|NCT00929708|323183360|FG001|Overall Study|Withdrawal by Subject|0|||
94381827|NCT00929708|323183361|FG002|Overall Study|Withdrawal by Subject|0|||
94381828|NCT00929708|323183362|FG003|Overall Study|Withdrawal by Subject|2|||
94381829|NCT00929708|323183363|FG004|Overall Study|Withdrawal by Subject|1|||
94381830|NCT00929708|323183359|FG000|Overall Study|Adverse Event|0|||
94381831|NCT00929708|323183360|FG001|Overall Study|Adverse Event|0|||
94381832|NCT00929708|323183361|FG002|Overall Study|Adverse Event|0|||
94381833|NCT00929708|323183362|FG003|Overall Study|Adverse Event|0|||
94381834|NCT00929708|323183363|FG004|Overall Study|Adverse Event|3|||
94381835|NCT00929708|323183359|FG000|Overall Study|Physician Decision|0|||
94381836|NCT00929708|323183360|FG001|Overall Study|Physician Decision|2|||
94311550|NCT00950690|322925265|FG000|Overall Study|Adverse Event|15|||
94381837|NCT00929708|323183361|FG002|Overall Study|Physician Decision|2|||
94381838|NCT00929708|323183362|FG003|Overall Study|Physician Decision|2|||
94473389|NCT01941537|323523423|FG000|Overall Study|Adverse Event|1|||
94473390|NCT01941537|323523424|FG001|Overall Study|Adverse Event|0|||
94473391|NCT01941537|323523423|FG000|Overall Study|Withdrawal by Subject|0|||
94311551|NCT00950690|322925265|FG000|Overall Study|Lack of Efficacy|22|||
94311552|NCT00950690|322925265|FG000|Overall Study|Lost to Follow-up|40|||
94311553|NCT00950690|322925265|FG000|Overall Study|Other|163|||
94311554|NCT01713036|322925266|FG000|Overall Study|Death|1|||
94311555|NCT00592358|322925267|FG000|Overall Study|Withdrawal by Subject|2|||
94473392|NCT01941537|323523424|FG001|Overall Study|Withdrawal by Subject|1|||
94473393|NCT02070978|323523425|FG000|Overall Study|Adverse Event|6|||
94473394|NCT02070978|323523426|FG001|Overall Study|Adverse Event|2|||
94473395|NCT02070978|323523427|FG002|Overall Study|Adverse Event|0|||
94473396|NCT02070978|323523425|FG000|Overall Study|Lost to Follow-up|1|||
94473397|NCT02070978|323523426|FG001|Overall Study|Lost to Follow-up|3|||
94473398|NCT02070978|323523427|FG002|Overall Study|Lost to Follow-up|4|||
94473399|NCT02070978|323523425|FG000|Overall Study|Withdrawal by Subject|3|||
94473400|NCT02070978|323523426|FG001|Overall Study|Withdrawal by Subject|5|||
94473401|NCT02070978|323523427|FG002|Overall Study|Withdrawal by Subject|3|||
94473402|NCT02070978|323523425|FG000|Overall Study|Protocol Violation|1|||
94473403|NCT02070978|323523426|FG001|Overall Study|Protocol Violation|0|||
94473404|NCT02070978|323523427|FG002|Overall Study|Protocol Violation|3|||
94473405|NCT02070978|323523425|FG000|Overall Study|Lack of Efficacy|0|||
94473406|NCT02070978|323523426|FG001|Overall Study|Lack of Efficacy|1|||
94473407|NCT02070978|323523427|FG002|Overall Study|Lack of Efficacy|0|||
94473408|NCT02070978|323523425|FG000|Overall Study|Death|0|||
94473409|NCT02070978|323523426|FG001|Overall Study|Death|0|||
94311556|NCT00592358|322925267|FG000|Overall Study|Adverse Event|1|||
94311557|NCT00592358|322925267|FG000|Overall Study|Lack of Efficacy|2|||
94311558|NCT00592358|322925267|FG000|Overall Study|Inability to swallow pills|1|||
94311559|NCT02778867|322925268|FG000|Phase 1|Withdrawal by Subject|2|||
94311560|NCT02778867|322925269|FG001|Phase 1|Withdrawal by Subject|3|||
94311561|NCT02778867|322925270|FG002|Phase 1|Withdrawal by Subject|0|||
94311562|NCT02778867|322925271|FG003|Phase 1|Withdrawal by Subject|0|||
94311563|NCT02778867|322925268|FG000|Phase 2|Withdrawal by Subject|0|||
94311564|NCT02778867|322925269|FG001|Phase 2|Withdrawal by Subject|0|||
94311565|NCT02778867|322925270|FG002|Phase 2|Withdrawal by Subject|1|||
94381839|NCT00929708|323183363|FG004|Overall Study|Physician Decision|1|||
94381840|NCT00929708|323183359|FG000|Overall Study|Lost to Follow-up|0|||
94381841|NCT00929708|323183360|FG001|Overall Study|Lost to Follow-up|0|||
94381842|NCT00929708|323183361|FG002|Overall Study|Lost to Follow-up|0|||
94381843|NCT00929708|323183362|FG003|Overall Study|Lost to Follow-up|1|||
94381844|NCT00929708|323183363|FG004|Overall Study|Lost to Follow-up|0|||
94381845|NCT03481309|323183364|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
94381846|NCT03481309|323183365|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
94381847|NCT03481309|323183366|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
94381848|NCT03481309|323183367|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
94381849|NCT03481309|323183368|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
94381850|NCT03481309|323183369|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
94381851|NCT01575054|323183370|FG000|Overall Study|Other Reasons|5|||
94381852|NCT01575054|323183371|FG001|Overall Study|Other Reasons|3|||
94381853|NCT01575054|323183370|FG000|Overall Study|Protocol Violation|2|||
94381854|NCT01575054|323183371|FG001|Overall Study|Protocol Violation|1|||
94381855|NCT01575054|323183370|FG000|Overall Study|Personal Reasons|10|||
94381856|NCT01575054|323183371|FG001|Overall Study|Personal Reasons|11|||
94381857|NCT01575054|323183370|FG000|Overall Study|Lost to Follow-up|3|||
94381858|NCT01575054|323183371|FG001|Overall Study|Lost to Follow-up|3|||
94381859|NCT01575054|323183370|FG000|Overall Study|Adverse Event|9|||
94381860|NCT01575054|323183371|FG001|Overall Study|Adverse Event|8|||
94381861|NCT02070744|323183374|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
94381862|NCT02070744|323183375|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
94381863|NCT02070744|323183376|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
94381864|NCT02070744|323183377|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
94381865|NCT02070744|323183378|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
94381866|NCT02070744|323183374|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
94381867|NCT02070744|323183375|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
94381868|NCT02070744|323183376|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
94381869|NCT02070744|323183377|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
94381870|NCT02070744|323183378|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
94381871|NCT02070744|323183374|FG000|OLE Phase (48 Weeks)|Other|0|||
94381872|NCT02070744|323183375|FG001|OLE Phase (48 Weeks)|Other|0|||
94381873|NCT02070744|323183376|FG002|OLE Phase (48 Weeks)|Other|0|||
94381874|NCT02070744|323183377|FG003|OLE Phase (48 Weeks)|Other|0|||
94381875|NCT02070744|323183378|FG004|OLE Phase (48 Weeks)|Other|1|||
94381876|NCT02768298|323183379|FG000|Overall Study|Adverse Event|1|||
94381877|NCT02768298|323183380|FG001|Overall Study|Adverse Event|4|||
94381878|NCT02768298|323183379|FG000|Overall Study|Death|2|||
94381879|NCT02768298|323183380|FG001|Overall Study|Death|1|||
94381880|NCT02768298|323183379|FG000|Overall Study|Non-compliance with study treatment|0|||
94381881|NCT02768298|323183380|FG001|Overall Study|Non-compliance with study treatment|1|||
94381882|NCT02768298|323183379|FG000|Overall Study|Subject/guardian decision|1|||
94381883|NCT02768298|323183380|FG001|Overall Study|Subject/guardian decision|0|||
94381884|NCT02768298|323183379|FG000|Overall Study|Withdrawal of informed consent|0|||
94473410|NCT02070978|323523427|FG002|Overall Study|Death|2|||
94473411|NCT02070978|323523425|FG000|Overall Study|Un-specified|3|||
94473412|NCT02070978|323523426|FG001|Overall Study|Un-specified|2|||
94473413|NCT02070978|323523427|FG002|Overall Study|Un-specified|2|||
94311566|NCT02778867|322925271|FG003|Phase 2|Withdrawal by Subject|0|||
94311567|NCT02778867|322925268|FG000|Phase 2|Physician Decision|0|||
94311568|NCT02778867|322925269|FG001|Phase 2|Physician Decision|0|||
94311569|NCT02778867|322925270|FG002|Phase 2|Physician Decision|0|||
94311570|NCT02778867|322925271|FG003|Phase 2|Physician Decision|1|||
94311571|NCT02778867|322925268|FG000|Phase 2|Adverse Event|0|||
94311572|NCT02778867|322925269|FG001|Phase 2|Adverse Event|0|||
94311573|NCT02778867|322925270|FG002|Phase 2|Adverse Event|0|||
94311574|NCT02778867|322925271|FG003|Phase 2|Adverse Event|1|||
94311575|NCT01993329|322925272|FG000|Period 2|Adverse Event|0|||
94311576|NCT01993329|322925273|FG001|Period 2|Adverse Event|0|||
94311577|NCT01993329|322925274|FG002|Period 2|Adverse Event|0|||
94311578|NCT01993329|322925275|FG003|Period 2|Adverse Event|0|||
94311579|NCT01993329|322925276|FG004|Period 2|Adverse Event|0|||
94311580|NCT01993329|322925277|FG005|Period 2|Adverse Event|1|||
94311581|NCT01993329|322925272|FG000|Wash-out|Personal reasons|0|||
94311582|NCT01993329|322925273|FG001|Wash-out|Personal reasons|1|||
94311583|NCT01993329|322925274|FG002|Wash-out|Personal reasons|0|||
94311584|NCT01993329|322925275|FG003|Wash-out|Personal reasons|0|||
94311585|NCT01993329|322925276|FG004|Wash-out|Personal reasons|0|||
94311586|NCT01993329|322925277|FG005|Wash-out|Personal reasons|0|||
94311587|NCT04760314|322925278|FG000|Induction Period|Withdrawal by Subject|0|||
94311588|NCT04760314|322925279|FG001|Induction Period|Withdrawal by Subject|1|||
94311589|NCT04760314|322925280|FG002|Induction Period|Withdrawal by Subject|1|||
94311590|NCT04760314|322925281|FG003|Induction Period|Withdrawal by Subject|0|||
94311591|NCT04760314|322925282|FG004|Induction Period|Withdrawal by Subject|0|||
94311592|NCT04760314|322925283|FG005|Induction Period|Withdrawal by Subject|0|||
94311593|NCT04760314|322925284|FG006|Induction Period|Withdrawal by Subject|0|||
94311594|NCT04760314|322925285|FG007|Induction Period|Withdrawal by Subject|0|||
94311595|NCT04760314|322925286|FG008|Induction Period|Withdrawal by Subject|0|||
94311596|NCT04760314|322925287|FG009|Induction Period|Withdrawal by Subject|0|||
94311597|NCT04760314|322925288|FG010|Induction Period|Withdrawal by Subject|0|||
94311598|NCT04760314|322925278|FG000|Induction Period|Adverse Event|0|||
94311599|NCT04760314|322925279|FG001|Induction Period|Adverse Event|0|||
94311600|NCT04760314|322925280|FG002|Induction Period|Adverse Event|2|||
94311601|NCT04760314|322925281|FG003|Induction Period|Adverse Event|0|||
94311602|NCT04760314|322925282|FG004|Induction Period|Adverse Event|0|||
94311603|NCT04760314|322925283|FG005|Induction Period|Adverse Event|0|||
94311604|NCT04760314|322925284|FG006|Induction Period|Adverse Event|0|||
94311605|NCT04760314|322925285|FG007|Induction Period|Adverse Event|0|||
94311606|NCT04760314|322925286|FG008|Induction Period|Adverse Event|0|||
94311607|NCT04760314|322925287|FG009|Induction Period|Adverse Event|0|||
94311608|NCT04760314|322925288|FG010|Induction Period|Adverse Event|0|||
94311609|NCT04760314|322925278|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
94311610|NCT04760314|322925279|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
94311611|NCT04760314|322925280|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
94311612|NCT04760314|322925281|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
94311613|NCT04760314|322925282|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
94311614|NCT04760314|322925283|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
94311615|NCT04760314|322925284|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
94311616|NCT04760314|322925285|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
94311617|NCT04760314|322925286|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
94311618|NCT04760314|322925287|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
94311619|NCT04760314|322925288|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
94311620|NCT04760314|322925278|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
94381885|NCT02768298|323183380|FG001|Overall Study|Withdrawal of informed consent|1|||
94381886|NCT02346201|323183381|FG000|Overall Study|Adverse Event|3|||
94381887|NCT02346201|323183382|FG001|Overall Study|Adverse Event|2|||
94381888|NCT02346201|323183381|FG000|Overall Study|Lost to Follow-up|1|||
94311621|NCT04760314|322925279|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
94311622|NCT04760314|322925280|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
94311623|NCT04760314|322925281|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
94311624|NCT04760314|322925282|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
94311625|NCT04760314|322925283|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
94311626|NCT04760314|322925284|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
94311627|NCT04760314|322925285|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
94311628|NCT04760314|322925286|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
94311629|NCT04760314|322925287|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
94311630|NCT04760314|322925288|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
94311631|NCT04760314|322925278|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
94381889|NCT02346201|323183382|FG001|Overall Study|Lost to Follow-up|0|||
94381890|NCT02346201|323183381|FG000|Overall Study|Withdrawal by Subject|6|||
94311632|NCT04760314|322925279|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
94311633|NCT04760314|322925280|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
94311634|NCT04760314|322925281|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
94311635|NCT04760314|322925282|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
94381891|NCT02346201|323183382|FG001|Overall Study|Withdrawal by Subject|3|||
94311636|NCT04760314|322925283|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
94311637|NCT04760314|322925284|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
94311638|NCT04760314|322925285|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
94311639|NCT04760314|322925286|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
94311640|NCT04760314|322925287|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
94311641|NCT04760314|322925288|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
94311642|NCT04760314|322925278|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
94311643|NCT04760314|322925279|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
94311644|NCT04760314|322925280|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
94311645|NCT04760314|322925281|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
94311646|NCT04760314|322925282|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
94311647|NCT04760314|322925283|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
94311648|NCT04760314|322925284|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
94311649|NCT04760314|322925285|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
94311650|NCT04760314|322925286|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
94311651|NCT04760314|322925287|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
94311652|NCT04760314|322925288|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
94311653|NCT04760314|322925278|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94311654|NCT04760314|322925279|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94311655|NCT04760314|322925280|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94311656|NCT04760314|322925281|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94311657|NCT04760314|322925282|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94311658|NCT04760314|322925283|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94311659|NCT04760314|322925284|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94311660|NCT04760314|322925285|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
94311661|NCT04760314|322925286|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94311662|NCT04760314|322925287|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
94311663|NCT04760314|322925288|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
94311664|NCT04760314|322925278|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94311665|NCT04760314|322925279|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94311666|NCT04760314|322925280|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94311667|NCT04760314|322925281|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94311668|NCT04760314|322925282|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94311669|NCT04760314|322925283|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94311670|NCT04760314|322925284|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94311671|NCT04760314|322925285|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
94311672|NCT04760314|322925286|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
94311673|NCT04760314|322925287|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
94311674|NCT04760314|322925288|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94311675|NCT04760314|322925278|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94311676|NCT04760314|322925279|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94311677|NCT04760314|322925280|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94311678|NCT04760314|322925281|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94311679|NCT04760314|322925282|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94311680|NCT04760314|322925283|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94311681|NCT04760314|322925284|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94311682|NCT04760314|322925285|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
94311683|NCT04760314|322925286|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94311684|NCT04760314|322925287|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94311685|NCT04760314|322925288|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94311686|NCT04760314|322925278|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
94311687|NCT04760314|322925279|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
94311688|NCT04760314|322925280|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
94311689|NCT04760314|322925281|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
94311690|NCT04760314|322925282|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
94311691|NCT04760314|322925283|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
94311692|NCT04760314|322925284|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
94311693|NCT04760314|322925285|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
94311694|NCT04760314|322925286|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
94311695|NCT04760314|322925287|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
94311696|NCT04760314|322925288|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
94311697|NCT03238248|322925295|FG000|Overall Study|Death|5|||
94311698|NCT03238248|322925295|FG000|Overall Study|Withdrawal by Subject|7|||
94311699|NCT03238248|322925295|FG000|Overall Study|Participant proceeding to transplant|10|||
94311700|NCT03238248|322925295|FG000|Overall Study|Lack of Efficacy|4|||
94311701|NCT03238248|322925295|FG000|Overall Study|Physician Decision|3|||
94311702|NCT03238248|322925295|FG000|Overall Study|Transitioning to another study|1|||
94311703|NCT03238248|322925295|FG000|Overall Study|No longer benefiting|1|||
94311704|NCT03238248|322925295|FG000|Overall Study|Other complicating disease|1|||
94311705|NCT03238248|322925295|FG000|Overall Study|Adverse Event|5|||
94311706|NCT03238248|322925295|FG000|Overall Study|Disease progression|26|||
94311707|NCT03238248|322925295|FG000|Overall Study|N/A participant is still on treatment|1|||
94311708|NCT03238248|322925295|FG000|Overall Study|Decline in condition|1|||
94311709|NCT03238248|322925295|FG000|Overall Study|Alternative therapy|2|||
94311710|NCT00390780|322925296|FG000|Overall Study|Not completed|10|||
94311711|NCT00390780|322925297|FG001|Overall Study|Not completed|4|||
94311712|NCT00390780|322925296|FG000|Overall Study|Protocol Violation|6|||
94311713|NCT00390780|322925297|FG001|Overall Study|Protocol Violation|4|||
94381892|NCT02346201|323183381|FG000|Overall Study|Unavailable for future follow-up|0|||
94381893|NCT02346201|323183382|FG001|Overall Study|Unavailable for future follow-up|1|||
94381894|NCT02346201|323183381|FG000|Overall Study|Physician Decision|0|||
94381895|NCT02346201|323183382|FG001|Overall Study|Physician Decision|1|||
94381896|NCT02346201|323183381|FG000|Overall Study|Missed final visit|0|||
94381897|NCT02346201|323183382|FG001|Overall Study|Missed final visit|2|||
94381898|NCT02130466|323183383|FG000|Overall Study|Death|4|||
94381899|NCT02130466|323183384|FG001|Overall Study|Death|1|||
94381900|NCT02130466|323183385|FG002|Overall Study|Death|1|||
94381901|NCT02130466|323183386|FG003|Overall Study|Death|3|||
94381902|NCT02130466|323183387|FG004|Overall Study|Death|2|||
94381903|NCT02130466|323183388|FG005|Overall Study|Death|30|||
94381904|NCT02130466|323183389|FG006|Overall Study|Death|45|||
94381905|NCT02130466|323183390|FG007|Overall Study|Death|2|||
94381906|NCT02130466|323183391|FG008|Overall Study|Death|3|||
94381907|NCT02130466|323183392|FG009|Overall Study|Death|4|||
94381908|NCT02130466|323183393|FG010|Overall Study|Death|5|||
94381909|NCT02130466|323183394|FG011|Overall Study|Death|3|||
94381910|NCT02130466|323183395|FG012|Overall Study|Death|11|||
94381911|NCT02130466|323183396|FG013|Overall Study|Death|7|||
94381912|NCT02130466|323183383|FG000|Overall Study|Lost to Follow-up|1|||
94381913|NCT02130466|323183384|FG001|Overall Study|Lost to Follow-up|0|||
94381914|NCT02130466|323183385|FG002|Overall Study|Lost to Follow-up|0|||
94381915|NCT02130466|323183386|FG003|Overall Study|Lost to Follow-up|0|||
94381916|NCT02130466|323183387|FG004|Overall Study|Lost to Follow-up|0|||
94381917|NCT02130466|323183388|FG005|Overall Study|Lost to Follow-up|1|||
94381918|NCT02130466|323183389|FG006|Overall Study|Lost to Follow-up|0|||
94381919|NCT02130466|323183390|FG007|Overall Study|Lost to Follow-up|0|||
94381920|NCT02130466|323183391|FG008|Overall Study|Lost to Follow-up|0|||
94381921|NCT02130466|323183392|FG009|Overall Study|Lost to Follow-up|0|||
94381922|NCT02130466|323183393|FG010|Overall Study|Lost to Follow-up|0|||
94381923|NCT02130466|323183394|FG011|Overall Study|Lost to Follow-up|0|||
94381924|NCT02130466|323183395|FG012|Overall Study|Lost to Follow-up|1|||
94381925|NCT02130466|323183396|FG013|Overall Study|Lost to Follow-up|0|||
94381926|NCT02130466|323183383|FG000|Overall Study|Physician Decision|0|||
94381927|NCT02130466|323183384|FG001|Overall Study|Physician Decision|0|||
94381928|NCT02130466|323183385|FG002|Overall Study|Physician Decision|0|||
94381929|NCT02130466|323183386|FG003|Overall Study|Physician Decision|0|||
94381930|NCT02130466|323183387|FG004|Overall Study|Physician Decision|0|||
94381931|NCT02130466|323183388|FG005|Overall Study|Physician Decision|1|||
94381932|NCT02130466|323183389|FG006|Overall Study|Physician Decision|1|||
94381933|NCT02130466|323183390|FG007|Overall Study|Physician Decision|0|||
94381934|NCT02130466|323183391|FG008|Overall Study|Physician Decision|0|||
94381935|NCT02130466|323183392|FG009|Overall Study|Physician Decision|0|||
94311714|NCT00390780|322925296|FG000|Overall Study|Lost to Follow-up|3|||
94311715|NCT00390780|322925297|FG001|Overall Study|Lost to Follow-up|6|||
94311716|NCT00390780|322925296|FG000|Overall Study|Adverse Event|2|||
94311717|NCT00390780|322925297|FG001|Overall Study|Adverse Event|3|||
94311718|NCT00390780|322925296|FG000|Overall Study|Death|1|||
94311719|NCT00390780|322925297|FG001|Overall Study|Death|3|||
94311720|NCT00390780|322925296|FG000|Overall Study|Withdrawal by Subject|1|||
94311721|NCT00390780|322925297|FG001|Overall Study|Withdrawal by Subject|2|||
94311722|NCT00390780|322925296|FG000|Overall Study|Inclusion criteria not satisfied|0|||
94311723|NCT00390780|322925297|FG001|Overall Study|Inclusion criteria not satisfied|2|||
94311724|NCT00390780|322925296|FG000|Overall Study|Lost to follow up and other reasons|0|||
94311725|NCT00390780|322925297|FG001|Overall Study|Lost to follow up and other reasons|1|||
94311726|NCT00390780|322925296|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
94381936|NCT02130466|323183393|FG010|Overall Study|Physician Decision|0|||
94381937|NCT02130466|323183394|FG011|Overall Study|Physician Decision|0|||
94311727|NCT00390780|322925297|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
94381938|NCT02130466|323183395|FG012|Overall Study|Physician Decision|0|||
94381939|NCT02130466|323183396|FG013|Overall Study|Physician Decision|0|||
94381940|NCT02130466|323183383|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
94381941|NCT02130466|323183384|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
94381942|NCT02130466|323183385|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
94381943|NCT02130466|323183386|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
94381944|NCT02130466|323183387|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
94381945|NCT02130466|323183388|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
94311728|NCT00390780|322925296|FG000|Overall Study|SAE, death|0|||
94311729|NCT00390780|322925297|FG001|Overall Study|SAE, death|1|||
94311730|NCT02546856|322925306|FG000|4 Months Evaluation|Death|2|||
94311731|NCT02546856|322925307|FG001|4 Months Evaluation|Death|3|||
94381946|NCT02130466|323183389|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
94381947|NCT02130466|323183390|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
94381948|NCT02130466|323183391|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
94381949|NCT02130466|323183392|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
94381950|NCT02130466|323183393|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
94381951|NCT02130466|323183394|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
94381952|NCT02130466|323183395|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
94381953|NCT02130466|323183396|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
94381954|NCT02130466|323183383|FG000|Overall Study|Withdrawal by Subject|1|||
94381955|NCT02130466|323183384|FG001|Overall Study|Withdrawal by Subject|0|||
94381956|NCT02130466|323183385|FG002|Overall Study|Withdrawal by Subject|0|||
94381957|NCT02130466|323183386|FG003|Overall Study|Withdrawal by Subject|0|||
94381958|NCT02130466|323183387|FG004|Overall Study|Withdrawal by Subject|0|||
94381959|NCT02130466|323183388|FG005|Overall Study|Withdrawal by Subject|1|||
94381960|NCT02130466|323183389|FG006|Overall Study|Withdrawal by Subject|0|||
94381961|NCT02130466|323183390|FG007|Overall Study|Withdrawal by Subject|0|||
94381962|NCT02130466|323183391|FG008|Overall Study|Withdrawal by Subject|1|||
94381963|NCT02130466|323183392|FG009|Overall Study|Withdrawal by Subject|0|||
94381964|NCT02130466|323183393|FG010|Overall Study|Withdrawal by Subject|0|||
94381965|NCT02130466|323183394|FG011|Overall Study|Withdrawal by Subject|0|||
94381966|NCT02130466|323183395|FG012|Overall Study|Withdrawal by Subject|0|||
94381967|NCT02130466|323183396|FG013|Overall Study|Withdrawal by Subject|0|||
94311732|NCT02546856|322925306|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
94311733|NCT02546856|322925307|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
94311734|NCT02546856|322925306|FG000|4 Months Evaluation|Lost to Follow-up|3|||
94311735|NCT02546856|322925307|FG001|4 Months Evaluation|Lost to Follow-up|3|||
94311736|NCT02546856|322925306|FG000|4 Months Evaluation|Physician Decision|3|||
94311737|NCT02546856|322925307|FG001|4 Months Evaluation|Physician Decision|0|||
94311738|NCT02546856|322925306|FG000|4 Months Evaluation|Working or living abroad|5|||
94311739|NCT02546856|322925307|FG001|4 Months Evaluation|Working or living abroad|1|||
94311740|NCT02546856|322925306|FG000|4 Months Evaluation|reasons not due to titration|4|||
94311741|NCT02546856|322925307|FG001|4 Months Evaluation|reasons not due to titration|1|||
94311742|NCT02546856|322925306|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
94311743|NCT02546856|322925307|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
94311744|NCT02546856|322925306|FG000|6 Months Evaluation|Death|1|||
94311745|NCT02546856|322925307|FG001|6 Months Evaluation|Death|1|||
94311746|NCT02546856|322925306|FG000|6 Months Evaluation|Lost to Follow-up|1|||
94311747|NCT02546856|322925307|FG001|6 Months Evaluation|Lost to Follow-up|1|||
94311748|NCT02546856|322925306|FG000|6 Months Evaluation|Working or living abroad|6|||
94311749|NCT02546856|322925307|FG001|6 Months Evaluation|Working or living abroad|4|||
94311750|NCT02546856|322925306|FG000|6 Months Evaluation|reasons not due to titration|0|||
94311751|NCT02546856|322925307|FG001|6 Months Evaluation|reasons not due to titration|1|||
94311752|NCT01097616|322925308|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
94311753|NCT01097616|322925309|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
94311754|NCT01097616|322925310|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
94311755|NCT01097616|322925311|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
94311756|NCT01097616|322925312|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
94311757|NCT01097616|322925313|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
94311758|NCT01097616|322925314|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
94311759|NCT01097616|322925315|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
94311760|NCT01097616|322925308|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
94311761|NCT01097616|322925309|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
94311762|NCT01097616|322925310|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
94311763|NCT01097616|322925311|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
94311764|NCT01097616|322925312|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
94311765|NCT01097616|322925313|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
94311766|NCT01097616|322925314|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
94311767|NCT01097616|322925315|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
94311768|NCT01097616|322925308|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
94311769|NCT01097616|322925309|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
94311770|NCT01097616|322925310|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
94381968|NCT03708211|323183397|FG000|Overall Study|Progressive Disease|10|||
94311771|NCT01097616|322925311|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
94381969|NCT03708211|323183398|FG001|Overall Study|Progressive Disease|7|||
94381970|NCT03708211|323183397|FG000|Overall Study|Withdrawal by Subject|0|||
94381971|NCT03708211|323183398|FG001|Overall Study|Withdrawal by Subject|1|||
94311772|NCT01097616|322925312|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
94311773|NCT01097616|322925313|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
94311774|NCT01097616|322925314|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
94311775|NCT01097616|322925315|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
94311776|NCT01097616|322925308|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
94311777|NCT01097616|322925309|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
94311778|NCT01097616|322925310|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
94311779|NCT01097616|322925311|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
94311780|NCT01097616|322925312|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
94311781|NCT01097616|322925313|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
94311782|NCT01097616|322925314|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
94311783|NCT01097616|322925315|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
94311784|NCT01097616|322925308|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
94311785|NCT01097616|322925309|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
94311786|NCT01097616|322925310|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
94311787|NCT01097616|322925311|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
94311788|NCT01097616|322925312|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
94311789|NCT01097616|322925313|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
94311790|NCT01097616|322925314|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
94311791|NCT01097616|322925315|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
94311792|NCT01097616|322925308|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
94311793|NCT01097616|322925309|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
94311794|NCT01097616|322925310|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
94311795|NCT01097616|322925311|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
94311796|NCT01097616|322925312|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
94311797|NCT01097616|322925313|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
94311798|NCT01097616|322925314|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
94311799|NCT01097616|322925315|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
94311800|NCT01097616|322925308|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
94311801|NCT01097616|322925309|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
94311802|NCT01097616|322925310|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
94311803|NCT01097616|322925311|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
94311804|NCT01097616|322925312|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
94311805|NCT01097616|322925313|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
94311806|NCT01097616|322925314|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
94311807|NCT01097616|322925315|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
94311808|NCT01097616|322925308|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
94311809|NCT01097616|322925309|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
94311810|NCT01097616|322925310|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
94311811|NCT01097616|322925311|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
94311812|NCT01097616|322925312|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
94311813|NCT01097616|322925313|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
94311814|NCT01097616|322925314|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
94311815|NCT01097616|322925315|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
94311816|NCT01097616|322925308|FG000|Optional DB EXT Phase|Adverse Event|0|||
94311817|NCT01097616|322925309|FG001|Optional DB EXT Phase|Adverse Event|7|||
94311818|NCT01097616|322925310|FG002|Optional DB EXT Phase|Adverse Event|2|||
94311819|NCT01097616|322925311|FG003|Optional DB EXT Phase|Adverse Event|0|||
94311820|NCT01097616|322925312|FG004|Optional DB EXT Phase|Adverse Event|0|||
94311821|NCT01097616|322925313|FG005|Optional DB EXT Phase|Adverse Event|0|||
94311822|NCT01097616|322925314|FG006|Optional DB EXT Phase|Adverse Event|0|||
94311823|NCT01097616|322925315|FG007|Optional DB EXT Phase|Adverse Event|0|||
94311824|NCT01097616|322925308|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
94311825|NCT01097616|322925309|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
94311826|NCT01097616|322925310|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
94311827|NCT01097616|322925311|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
94311828|NCT01097616|322925312|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
94311829|NCT01097616|322925313|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
94311830|NCT01097616|322925314|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
94311831|NCT01097616|322925315|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
94311832|NCT01097616|322925308|FG000|Optional DB EXT Phase|Protocol Violation|0|||
94311833|NCT01097616|322925309|FG001|Optional DB EXT Phase|Protocol Violation|2|||
94311834|NCT01097616|322925310|FG002|Optional DB EXT Phase|Protocol Violation|3|||
94311835|NCT01097616|322925311|FG003|Optional DB EXT Phase|Protocol Violation|0|||
94311836|NCT01097616|322925312|FG004|Optional DB EXT Phase|Protocol Violation|0|||
94311837|NCT01097616|322925313|FG005|Optional DB EXT Phase|Protocol Violation|0|||
94381972|NCT03708211|323183397|FG000|Overall Study|Other|2|||
94381973|NCT03708211|323183398|FG001|Overall Study|Other|0|||
94311838|NCT01097616|322925314|FG006|Optional DB EXT Phase|Protocol Violation|0|||
94311839|NCT01097616|322925315|FG007|Optional DB EXT Phase|Protocol Violation|0|||
94311840|NCT01097616|322925308|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
94311841|NCT01097616|322925309|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
94311842|NCT01097616|322925310|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
94381974|NCT01411332|323183399|FG000|Enrollment|Protocol Violation|0|||
94381975|NCT01411332|323183400|FG001|Enrollment|Protocol Violation|1|||
94381976|NCT01411332|323183399|FG000|Enrollment|Withdrawal by Subject|0|||
94381977|NCT01411332|323183400|FG001|Enrollment|Withdrawal by Subject|1|||
94381978|NCT01411332|323183399|FG000|Treatment|Lost to Follow-up|1|||
94311843|NCT01097616|322925311|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
94381979|NCT01411332|323183400|FG001|Treatment|Lost to Follow-up|0|||
94381980|NCT02170688|323183401|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
94381981|NCT02170688|323183402|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
94311844|NCT01097616|322925312|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
94311845|NCT01097616|322925313|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
94311846|NCT01097616|322925314|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
94311847|NCT01097616|322925315|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
94311848|NCT01097616|322925308|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
94311849|NCT01097616|322925309|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
94311850|NCT01097616|322925310|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
94311851|NCT01097616|322925311|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
94311852|NCT01097616|322925312|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
94311853|NCT01097616|322925313|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
94311854|NCT01097616|322925314|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
94311855|NCT01097616|322925315|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
94311856|NCT01097616|322925308|FG000|Optional DB EXT Phase|Physician Decision|1|||
94311857|NCT01097616|322925309|FG001|Optional DB EXT Phase|Physician Decision|0|||
94311858|NCT01097616|322925310|FG002|Optional DB EXT Phase|Physician Decision|0|||
94311859|NCT01097616|322925311|FG003|Optional DB EXT Phase|Physician Decision|0|||
94311860|NCT01097616|322925312|FG004|Optional DB EXT Phase|Physician Decision|0|||
94311861|NCT01097616|322925313|FG005|Optional DB EXT Phase|Physician Decision|0|||
94311862|NCT01097616|322925314|FG006|Optional DB EXT Phase|Physician Decision|0|||
94311863|NCT01097616|322925315|FG007|Optional DB EXT Phase|Physician Decision|0|||
94311864|NCT01097616|322925308|FG000|DB RO Phase|Adverse Event|0|||
94311865|NCT01097616|322925309|FG001|DB RO Phase|Adverse Event|0|||
94311866|NCT01097616|322925310|FG002|DB RO Phase|Adverse Event|0|||
94311867|NCT01097616|322925311|FG003|DB RO Phase|Adverse Event|0|||
94311868|NCT01097616|322925312|FG004|DB RO Phase|Adverse Event|0|||
94311869|NCT01097616|322925313|FG005|DB RO Phase|Adverse Event|0|||
94311870|NCT01097616|322925314|FG006|DB RO Phase|Adverse Event|1|||
94311871|NCT01097616|322925315|FG007|DB RO Phase|Adverse Event|0|||
94311872|NCT01097616|322925308|FG000|DB RO Phase|Withdrawal by Subject|0|||
94311873|NCT01097616|322925309|FG001|DB RO Phase|Withdrawal by Subject|0|||
94311874|NCT01097616|322925310|FG002|DB RO Phase|Withdrawal by Subject|0|||
94311875|NCT01097616|322925311|FG003|DB RO Phase|Withdrawal by Subject|0|||
94311876|NCT01097616|322925312|FG004|DB RO Phase|Withdrawal by Subject|0|||
94311877|NCT01097616|322925313|FG005|DB RO Phase|Withdrawal by Subject|1|||
94311878|NCT01097616|322925314|FG006|DB RO Phase|Withdrawal by Subject|0|||
94311879|NCT01097616|322925315|FG007|DB RO Phase|Withdrawal by Subject|0|||
94311880|NCT01097616|322925308|FG000|DB RO Phase|Lost to Follow-up|0|||
94311881|NCT01097616|322925309|FG001|DB RO Phase|Lost to Follow-up|0|||
94311882|NCT01097616|322925310|FG002|DB RO Phase|Lost to Follow-up|0|||
94311883|NCT01097616|322925311|FG003|DB RO Phase|Lost to Follow-up|1|||
94311884|NCT01097616|322925312|FG004|DB RO Phase|Lost to Follow-up|1|||
94311885|NCT01097616|322925313|FG005|DB RO Phase|Lost to Follow-up|0|||
94311886|NCT01097616|322925314|FG006|DB RO Phase|Lost to Follow-up|0|||
94311887|NCT01097616|322925315|FG007|DB RO Phase|Lost to Follow-up|1|||
94311888|NCT01097616|322925308|FG000|DB RO Phase|Not Treated in RO|0|||
94311889|NCT01097616|322925309|FG001|DB RO Phase|Not Treated in RO|0|||
94311890|NCT01097616|322925310|FG002|DB RO Phase|Not Treated in RO|0|||
94311891|NCT01097616|322925311|FG003|DB RO Phase|Not Treated in RO|0|||
94311892|NCT01097616|322925312|FG004|DB RO Phase|Not Treated in RO|0|||
94311893|NCT01097616|322925313|FG005|DB RO Phase|Not Treated in RO|1|||
94311894|NCT01097616|322925314|FG006|DB RO Phase|Not Treated in RO|0|||
94311895|NCT01097616|322925315|FG007|DB RO Phase|Not Treated in RO|0|||
94311896|NCT01996319|322925316|FG000|Overall Study|Protocol Violation|1|||
94311897|NCT01996319|322925317|FG001|Overall Study|Protocol Violation|0|||
94311898|NCT01996319|322925316|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
94311899|NCT01996319|322925317|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
94311900|NCT01996319|322925316|FG000|Overall Study|Adverse Event|2|||
94311901|NCT01996319|322925317|FG001|Overall Study|Adverse Event|2|||
94311902|NCT03069690|322925318|FG000|Pregnancy Intervention|Pregnancy loss|9|||
94311903|NCT03069690|322925319|FG001|Pregnancy Intervention|Pregnancy loss|4|||
94311904|NCT03069690|322925320|FG002|Pregnancy Intervention|Pregnancy loss|0|||
94311905|NCT03069690|322925321|FG003|Pregnancy Intervention|Pregnancy loss|0|||
94311906|NCT03069690|322925322|FG004|Pregnancy Intervention|Pregnancy loss|0|||
94311907|NCT03069690|322925323|FG005|Pregnancy Intervention|Pregnancy loss|0|||
94311908|NCT03069690|322925318|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
94311909|NCT03069690|322925319|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
94311910|NCT03069690|322925320|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
94311911|NCT03069690|322925321|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
94381982|NCT02170688|323183403|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
94311912|NCT03069690|322925322|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
94311913|NCT03069690|322925323|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
94311914|NCT03069690|322925318|FG000|Postpartum Intervention|Lost to Follow-up|0|||
94311915|NCT03069690|322925319|FG001|Postpartum Intervention|Lost to Follow-up|0|||
94311916|NCT03069690|322925320|FG002|Postpartum Intervention|Lost to Follow-up|5|||
94381983|NCT02170688|323183404|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
94381984|NCT02170688|323183405|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
94381985|NCT02170688|323183401|FG000|Overall Study|Full dose not received|0|||
94381986|NCT02170688|323183402|FG001|Overall Study|Full dose not received|1|||
94381987|NCT02170688|323183403|FG002|Overall Study|Full dose not received|0|||
94381988|NCT02170688|323183404|FG003|Overall Study|Full dose not received|0|||
94381989|NCT02170688|323183405|FG004|Overall Study|Full dose not received|0|||
94381990|NCT02170688|323183401|FG000|Overall Study|Physician Decision|0|||
94381991|NCT02170688|323183402|FG001|Overall Study|Physician Decision|0|||
94381992|NCT02170688|323183403|FG002|Overall Study|Physician Decision|1|||
94381993|NCT02170688|323183404|FG003|Overall Study|Physician Decision|0|||
94381994|NCT02170688|323183405|FG004|Overall Study|Physician Decision|0|||
94381995|NCT01508936|323183411|FG000|Overall Study|Adverse Event|11|||
94381996|NCT01508936|323183412|FG001|Overall Study|Adverse Event|32|||
94381997|NCT01508936|323183411|FG000|Overall Study|Lack of Efficacy|0|||
94381998|NCT01508936|323183412|FG001|Overall Study|Lack of Efficacy|1|||
94381999|NCT01508936|323183411|FG000|Overall Study|Withdrawal by Subject|4|||
94382000|NCT01508936|323183412|FG001|Overall Study|Withdrawal by Subject|18|||
94382001|NCT01508936|323183411|FG000|Overall Study|Protocol Violation|2|||
94382002|NCT01508936|323183412|FG001|Overall Study|Protocol Violation|3|||
94382003|NCT01508936|323183411|FG000|Overall Study|Lost to Follow-up|2|||
94382004|NCT01508936|323183412|FG001|Overall Study|Lost to Follow-up|9|||
94382005|NCT01508936|323183411|FG000|Overall Study|Other|0|||
94382006|NCT01508936|323183412|FG001|Overall Study|Other|5|||
94382007|NCT01508936|323183411|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
94382008|NCT01508936|323183412|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
94382009|NCT00462982|323183415|FG000|Overall Study|Adverse Event|1|||
94382010|NCT00462982|323183415|FG000|Overall Study|Patient Not Treated|2|||
94382011|NCT02518685|323183417|FG000|Overall Study|Adverse Event|29|||
94382012|NCT02518685|323183418|FG001|Overall Study|Adverse Event|1|||
94382013|NCT02518685|323183417|FG000|Overall Study|Withdrawal by Subject|10|||
94382014|NCT02518685|323183418|FG001|Overall Study|Withdrawal by Subject|3|||
94382015|NCT02518685|323183417|FG000|Overall Study|relocation, study fatigue|7|||
94382016|NCT02518685|323183418|FG001|Overall Study|relocation, study fatigue|2|||
94382017|NCT02518685|323183417|FG000|Overall Study|Pregnancy|1|||
94382018|NCT02518685|323183418|FG001|Overall Study|Pregnancy|0|||
94382019|NCT02518685|323183417|FG000|Overall Study|Physician Decision|1|||
94382020|NCT02518685|323183418|FG001|Overall Study|Physician Decision|0|||
94382021|NCT02518685|323183417|FG000|Overall Study|Lost to Follow-up|1|||
94382022|NCT02518685|323183418|FG001|Overall Study|Lost to Follow-up|4|||
94382023|NCT00922779|323183419|FG000|Overall Study|Adverse Event|67|||
94382024|NCT00922779|323183419|FG000|Overall Study|Pregnancy|7|||
94382025|NCT00922779|323183419|FG000|Overall Study|Withdrawal by Subject|308|||
94382026|NCT00922779|323183419|FG000|Overall Study|Lost to Follow-up|44|||
94382027|NCT00922779|323183419|FG000|Overall Study|Other|27|||
94382028|NCT00922779|323183419|FG000|Overall Study|Missing|1874|||
94382029|NCT02507375|323183420|FG000|Overall Study|Progressive Disease|4|||
94382030|NCT02507375|323183421|FG001|Overall Study|Progressive Disease|5|||
94382031|NCT02507375|323183420|FG000|Overall Study|Death|0|||
94382032|NCT02507375|323183421|FG001|Overall Study|Death|1|||
94382033|NCT02507375|323183420|FG000|Overall Study|Refused treatment|0|||
94382034|NCT02507375|323183421|FG001|Overall Study|Refused treatment|1|||
94382035|NCT02507375|323183420|FG000|Overall Study|Adverse Event|0|||
94382036|NCT02507375|323183421|FG001|Overall Study|Adverse Event|1|||
94382037|NCT02448771|323183422|FG000|Overall Study|Disease Progression|30|||
94382038|NCT02448771|323183422|FG000|Overall Study|Unacceptable Toxicity|1|||
94382039|NCT02448771|323183422|FG000|Overall Study|Physician Decision|3|||
94382040|NCT02448771|323183422|FG000|Overall Study|Started new therapy|2|||
94382041|NCT02158936|323183423|FG000|Overall Study|Study closed/ terminated|57|||
94382042|NCT02158936|323183424|FG001|Overall Study|Study closed/ terminated|77|||
94382043|NCT02158936|323183423|FG000|Overall Study|Azacitidine tx discontinued|53|||
94382044|NCT02158936|323183424|FG001|Overall Study|Azacitidine tx discontinued|46|||
94382045|NCT02158936|323183423|FG000|Overall Study|Adverse Event|39|||
94382046|NCT02158936|323183424|FG001|Overall Study|Adverse Event|24|||
94382047|NCT02158936|323183423|FG000|Overall Study|Withdrawal by Subject|15|||
94382048|NCT02158936|323183424|FG001|Overall Study|Withdrawal by Subject|16|||
94382049|NCT02158936|323183423|FG000|Overall Study|Physician Decision|15|||
94382050|NCT02158936|323183424|FG001|Overall Study|Physician Decision|13|||
94382051|NCT02158936|323183423|FG000|Overall Study|Lost to Follow-up|0|||
94382052|NCT02158936|323183424|FG001|Overall Study|Lost to Follow-up|1|||
94382053|NCT00522457|323183425|FG000|Overall Study|Due to disease progression|16|||
94382054|NCT00522457|323183425|FG000|Overall Study|Adverse Event|2|||
94382055|NCT05188521|323185174|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
94382056|NCT05188521|323185175|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
94382057|NCT00506753|323185176|FG000|Overall Study|Lost to Follow-up|21|||
94382058|NCT00506753|323185177|FG001|Overall Study|Lost to Follow-up|15|||
94382059|NCT01513551|323185183|FG000|Overall Study|Death|0|||
94382060|NCT01513551|323185184|FG001|Overall Study|Death|1|||
94382061|NCT01513551|323185185|FG002|Overall Study|Death|0|||
94382062|NCT01513551|323185183|FG000|Overall Study|Lost to Follow-up|3|||
94382063|NCT01513551|323185184|FG001|Overall Study|Lost to Follow-up|5|||
94382064|NCT01513551|323185185|FG002|Overall Study|Lost to Follow-up|2|||
94382065|NCT01513551|323185183|FG000|Overall Study|Withdrawal by Subject|1|||
94382066|NCT01513551|323185184|FG001|Overall Study|Withdrawal by Subject|0|||
94382067|NCT01513551|323185185|FG002|Overall Study|Withdrawal by Subject|2|||
94382068|NCT01513551|323185183|FG000|Overall Study|Randomized but not vaccinated|0|||
94382069|NCT01513551|323185184|FG001|Overall Study|Randomized but not vaccinated|0|||
94382070|NCT01513551|323185185|FG002|Overall Study|Randomized but not vaccinated|1|||
94382071|NCT02178709|323185186|FG000|Overall Study|Adverse Event|5|||
94382072|NCT02178709|323185186|FG000|Overall Study|Death|2|||
94382073|NCT02178709|323185186|FG000|Overall Study|Withdrawal by Subject|2|||
94382074|NCT02178709|323185186|FG000|Overall Study|Physician Decision|2|||
94382075|NCT02178709|323185186|FG000|Overall Study|Disease Progression|5|||
94382076|NCT02224456|323185187|FG000|Overall Study|Lack of Efficacy|1|||
94382077|NCT02224456|323185187|FG000|Overall Study|Lost to Follow-up|15|||
94382078|NCT02224456|323185187|FG000|Overall Study|Withdrawal by Subject|9|||
94382079|NCT02224456|323185187|FG000|Overall Study|Physician Decision|3|||
94382080|NCT02224456|323185187|FG000|Overall Study|Death|2|||
94382081|NCT02224456|323185187|FG000|Overall Study|Pregnancy|4|||
94382082|NCT02224456|323185187|FG000|Overall Study|Protocol Violation|1|||
94382083|NCT02224456|323185187|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
94382084|NCT02946385|323185188|FG000|Overall Study|Lost to Follow-up|0|||
94382085|NCT02946385|323185189|FG001|Overall Study|Lost to Follow-up|0|||
94382086|NCT02946385|323185190|FG002|Overall Study|Lost to Follow-up|3|||
94382087|NCT02946385|323185191|FG003|Overall Study|Lost to Follow-up|0|||
94382088|NCT02946385|323185192|FG004|Overall Study|Lost to Follow-up|2|||
94382089|NCT02946385|323185193|FG005|Overall Study|Lost to Follow-up|1|||
94382090|NCT01241461|323185194|FG000|Overall Study|Progressive Disease|3|||
94382091|NCT01241461|323185195|FG001|Overall Study|Progressive Disease|6|||
94382092|NCT01379781|323185199|FG000|Overall Study|Lost to Follow-up|11|||
94382093|NCT01379781|323185200|FG001|Overall Study|Lost to Follow-up|8|||
94382094|NCT02247479|323185202|FG000|Overall Study|Adverse Event|8|||
94382095|NCT02247479|323185203|FG001|Overall Study|Adverse Event|9|||
94382096|NCT02247479|323185204|FG002|Overall Study|Adverse Event|8|||
94382097|NCT02247479|323185202|FG000|Overall Study|Death|5|||
94382098|NCT02247479|323185203|FG001|Overall Study|Death|4|||
94382099|NCT02247479|323185204|FG002|Overall Study|Death|6|||
94382100|NCT02247479|323185202|FG000|Overall Study|Lost to Follow-up|3|||
94382101|NCT02247479|323185203|FG001|Overall Study|Lost to Follow-up|3|||
94382102|NCT02247479|323185204|FG002|Overall Study|Lost to Follow-up|1|||
94382103|NCT02247479|323185202|FG000|Overall Study|Non-compliance|0|||
94382104|NCT02247479|323185203|FG001|Overall Study|Non-compliance|0|||
94382105|NCT02247479|323185204|FG002|Overall Study|Non-compliance|1|||
94382106|NCT02247479|323185202|FG000|Overall Study|Withdrawal by Subject|25|||
94382107|NCT02247479|323185203|FG001|Overall Study|Withdrawal by Subject|29|||
94382108|NCT02247479|323185204|FG002|Overall Study|Withdrawal by Subject|24|||
94382109|NCT02247479|323185202|FG000|Overall Study|Study Terminated by Sponsor|98|||
94382110|NCT02247479|323185203|FG001|Overall Study|Study Terminated by Sponsor|88|||
94382111|NCT02247479|323185204|FG002|Overall Study|Study Terminated by Sponsor|94|||
94382112|NCT02247479|323185202|FG000|Overall Study|Physician Decision|1|||
94382113|NCT02247479|323185203|FG001|Overall Study|Physician Decision|0|||
94382114|NCT02247479|323185204|FG002|Overall Study|Physician Decision|2|||
94382115|NCT02247479|323185202|FG000|Overall Study|Unspecified Reason|2|||
94382116|NCT02247479|323185203|FG001|Overall Study|Unspecified Reason|5|||
94382117|NCT02247479|323185204|FG002|Overall Study|Unspecified Reason|2|||
94382118|NCT01644890|323185205|FG000|Overall Study|Adverse Event|7|||
94382119|NCT01644890|323185206|FG001|Overall Study|Adverse Event|20|||
94382120|NCT01644890|323185205|FG000|Overall Study|Death|1|||
94382121|NCT01644890|323185206|FG001|Overall Study|Death|3|||
94382122|NCT01644890|323185205|FG000|Overall Study|Physician Decision|3|||
94382123|NCT01644890|323185206|FG001|Overall Study|Physician Decision|9|||
94382124|NCT01644890|323185205|FG000|Overall Study|Protocol Violation|6|||
94382125|NCT01644890|323185206|FG001|Overall Study|Protocol Violation|7|||
94382126|NCT01644890|323185205|FG000|Overall Study|Withdrawal by Subject|19|||
94382127|NCT01644890|323185206|FG001|Overall Study|Withdrawal by Subject|27|||
94382128|NCT01644890|323185205|FG000|Overall Study|Progression Disease|160|||
94382129|NCT01644890|323185206|FG001|Overall Study|Progression Disease|131|||
94382130|NCT01644890|323185205|FG000|Overall Study|Clinical Progression|6|||
94382131|NCT01644890|323185206|FG001|Overall Study|Clinical Progression|6|||
94382132|NCT01644890|323185205|FG000|Overall Study|> 28 days since last dose of study drug|6|||
94382133|NCT01644890|323185206|FG001|Overall Study|> 28 days since last dose of study drug|3|||
94382134|NCT01644890|323185205|FG000|Overall Study|Other|8|||
94382135|NCT01644890|323185206|FG001|Overall Study|Other|9|||
94382136|NCT01060670|323185208|FG000|Run In|screen failure|0|||
94382137|NCT01060670|323185209|FG001|Run In|screen failure|238|||
94382138|NCT01929109|323185210|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
94382139|NCT01929109|323185211|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
94382140|NCT01929109|323185212|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
94382141|NCT01929109|323185213|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
94311917|NCT03069690|322925321|FG003|Postpartum Intervention|Lost to Follow-up|5|||
94311918|NCT03069690|322925322|FG004|Postpartum Intervention|Lost to Follow-up|2|||
94311919|NCT03069690|322925323|FG005|Postpartum Intervention|Lost to Follow-up|4|||
94311920|NCT00130208|322925324|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
94311921|NCT00130208|322925325|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
94311922|NCT00130208|322925324|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
94311923|NCT00130208|322925325|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
94382142|NCT01929109|323185214|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
94382143|NCT00094302|323185215|FG000|Overall Study|Lost to Follow-up|43|||
94382144|NCT00094302|323185216|FG001|Overall Study|Lost to Follow-up|41|||
94382145|NCT00094302|323185215|FG000|Overall Study|Physician Decision|5|||
94382146|NCT00094302|323185216|FG001|Overall Study|Physician Decision|8|||
94382147|NCT00094302|323185215|FG000|Overall Study|Withdrawal by Subject|103|||
94382148|NCT00094302|323185216|FG001|Overall Study|Withdrawal by Subject|111|||
94382149|NCT00094302|323185215|FG000|Overall Study|Death|266|||
94382150|NCT00094302|323185216|FG001|Overall Study|Death|246|||
94382151|NCT02322047|323185221|FG000|Overall Study|Physician Decision|1|||
94382152|NCT02322047|323185222|FG001|Overall Study|Physician Decision|0|||
94382153|NCT02322047|323185223|FG002|Overall Study|Physician Decision|0|||
94382154|NCT02322047|323185224|FG003|Overall Study|Physician Decision|0|||
94382155|NCT02322047|323185221|FG000|Overall Study|Withdrawal by Subject|1|||
94382156|NCT02322047|323185222|FG001|Overall Study|Withdrawal by Subject|0|||
94382157|NCT02322047|323185223|FG002|Overall Study|Withdrawal by Subject|0|||
94382158|NCT02322047|323185224|FG003|Overall Study|Withdrawal by Subject|1|||
94382159|NCT02322047|323185221|FG000|Overall Study|Adverse Event|0|||
94382160|NCT02322047|323185222|FG001|Overall Study|Adverse Event|1|||
94382161|NCT02322047|323185223|FG002|Overall Study|Adverse Event|0|||
94382162|NCT02322047|323185224|FG003|Overall Study|Adverse Event|0|||
94382163|NCT02322047|323185221|FG000|Overall Study|Lost to Follow-up|0|||
94382164|NCT02322047|323185222|FG001|Overall Study|Lost to Follow-up|0|||
94382165|NCT02322047|323185223|FG002|Overall Study|Lost to Follow-up|1|||
94382166|NCT02322047|323185224|FG003|Overall Study|Lost to Follow-up|1|||
94382167|NCT00135707|323185233|FG000|Overall Study|Lost to Follow-up|94|||
94382168|NCT00135707|323185234|FG001|Overall Study|Lost to Follow-up|89|||
94382169|NCT00135707|323185233|FG000|Overall Study|Withdrawal by Subject|0|||
94382170|NCT00135707|323185234|FG001|Overall Study|Withdrawal by Subject|1|||
94382171|NCT00135707|323185233|FG000|Overall Study|Institutional review board request|1|||
94382172|NCT00135707|323185234|FG001|Overall Study|Institutional review board request|0|||
94382173|NCT01829464|323185235|FG000|Overall Study|Adverse Event|1|||
94382174|NCT01829464|323185236|FG001|Overall Study|Adverse Event|0|||
94382175|NCT01829464|323185237|FG002|Overall Study|Adverse Event|0|||
94382176|NCT01829464|323185235|FG000|Overall Study|Lost to Follow-up|0|||
94382177|NCT01829464|323185236|FG001|Overall Study|Lost to Follow-up|0|||
94382178|NCT01829464|323185237|FG002|Overall Study|Lost to Follow-up|1|||
94382179|NCT01829464|323185235|FG000|Overall Study|Withdrawal by Subject|2|||
94382180|NCT01829464|323185236|FG001|Overall Study|Withdrawal by Subject|0|||
94382181|NCT01829464|323185237|FG002|Overall Study|Withdrawal by Subject|0|||
94382182|NCT01829464|323185235|FG000|Overall Study|Study terminated by sponsor|25|||
94382183|NCT01829464|323185236|FG001|Overall Study|Study terminated by sponsor|28|||
94311924|NCT00130208|322925324|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
94311925|NCT00130208|322925325|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
94311926|NCT00130208|322925324|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
94311927|NCT00130208|322925325|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
94311928|NCT00130208|322925324|FG000|Maintenance Period (26 Weeks)|Other|1|||
94311929|NCT00130208|322925325|FG001|Maintenance Period (26 Weeks)|Other|1|||
94311930|NCT00130208|322925324|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
94311931|NCT00130208|322925325|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
94311932|NCT00130208|322925324|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
94311933|NCT00130208|322925325|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
94311934|NCT00130208|322925324|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
94311935|NCT00130208|322925325|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
94311936|NCT00130208|322925324|FG000|Washout Period (8 Weeks)|Other|1|||
94311937|NCT00130208|322925325|FG001|Washout Period (8 Weeks)|Other|1|||
94311938|NCT01671085|322925326|FG000|Overall Study|Withdrawal by Subject|1|||
94311939|NCT01671085|322925327|FG001|Overall Study|Withdrawal by Subject|0|||
94311940|NCT00589472|322925328|FG000|Overall Study|Adverse Event|1|||
94311941|NCT00570739|322925330|FG000|Overall Study|Adverse Event|8|||
94311942|NCT00570739|322925331|FG001|Overall Study|Adverse Event|6|||
94311943|NCT00570739|322925332|FG002|Overall Study|Adverse Event|2|||
94311944|NCT00570739|322925333|FG003|Overall Study|Adverse Event|2|||
94311945|NCT00570739|322925330|FG000|Overall Study|Lost to Follow-up|4|||
94311946|NCT00570739|322925331|FG001|Overall Study|Lost to Follow-up|5|||
94311947|NCT00570739|322925332|FG002|Overall Study|Lost to Follow-up|4|||
94311948|NCT00570739|322925333|FG003|Overall Study|Lost to Follow-up|1|||
94382184|NCT01829464|323185237|FG002|Overall Study|Study terminated by sponsor|25|||
94382185|NCT01829464|323185235|FG000|Overall Study|Lack of Efficacy|0|||
94311949|NCT00570739|322925330|FG000|Overall Study|Physician Decision|1|||
94382186|NCT01829464|323185236|FG001|Overall Study|Lack of Efficacy|1|||
94311950|NCT00570739|322925331|FG001|Overall Study|Physician Decision|1|||
94382187|NCT01829464|323185237|FG002|Overall Study|Lack of Efficacy|0|||
94382188|NCT03738332|323185240|FG000|Overall Study|Withdrawal by Subject|1|||
94382189|NCT02309099|323185246|FG000|Overall Study|Adverse Event|2|||
94382190|NCT02309099|323185247|FG001|Overall Study|Adverse Event|0|||
94382191|NCT00356200|323185248|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
94382192|NCT00356200|323185249|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
94311951|NCT00570739|322925332|FG002|Overall Study|Physician Decision|0|||
94311952|NCT00570739|322925333|FG003|Overall Study|Physician Decision|0|||
94311953|NCT00570739|322925330|FG000|Overall Study|Withdrawal by Subject|7|||
94311954|NCT00570739|322925331|FG001|Overall Study|Withdrawal by Subject|7|||
94311955|NCT00570739|322925332|FG002|Overall Study|Withdrawal by Subject|3|||
94311956|NCT00570739|322925333|FG003|Overall Study|Withdrawal by Subject|5|||
94311957|NCT00570739|322925330|FG000|Overall Study|Required restricted medication|0|||
94311958|NCT00570739|322925331|FG001|Overall Study|Required restricted medication|0|||
94311959|NCT00570739|322925332|FG002|Overall Study|Required restricted medication|1|||
94311960|NCT00570739|322925333|FG003|Overall Study|Required restricted medication|0|||
94311961|NCT00570739|322925330|FG000|Overall Study|Met discontinuation criteria|1|||
94311962|NCT00570739|322925331|FG001|Overall Study|Met discontinuation criteria|0|||
94311963|NCT00570739|322925332|FG002|Overall Study|Met discontinuation criteria|1|||
94311964|NCT00570739|322925333|FG003|Overall Study|Met discontinuation criteria|1|||
94311965|NCT00570739|322925330|FG000|Overall Study|Other|0|||
94311966|NCT00570739|322925331|FG001|Overall Study|Other|2|||
94311967|NCT00570739|322925332|FG002|Overall Study|Other|5|||
94311968|NCT00570739|322925333|FG003|Overall Study|Other|3|||
94311969|NCT00312377|322925334|FG000|Overall Study|Death|403|||
94311970|NCT00312377|322925335|FG001|Overall Study|Death|418|||
94311971|NCT00312377|322925334|FG000|Overall Study|Withdrawal by Subject|23|||
94311972|NCT00312377|322925335|FG001|Overall Study|Withdrawal by Subject|30|||
94311973|NCT00312377|322925334|FG000|Overall Study|Lost to Follow-up|9|||
94311974|NCT00312377|322925335|FG001|Overall Study|Lost to Follow-up|12|||
94311975|NCT00312377|322925334|FG000|Overall Study|Non-compliance|0|||
94311976|NCT00312377|322925335|FG001|Overall Study|Non-compliance|2|||
94311977|NCT00312377|322925334|FG000|Overall Study|Randomised but never received treatment|6|||
94311978|NCT00312377|322925335|FG001|Overall Study|Randomised but never received treatment|6|||
94311979|NCT00312377|322925334|FG000|Overall Study|Discontinue treatment survival follow up|202|||
94311980|NCT00312377|322925335|FG001|Overall Study|Discontinue treatment survival follow up|200|||
94311981|NCT00312377|322925334|FG000|Overall Study|Site ended participation in study|1|||
94311982|NCT00312377|322925335|FG001|Overall Study|Site ended participation in study|0|||
94311983|NCT01052012|322925337|FG000|Overall Study|Not treated|2|||
94311984|NCT01052012|322925338|FG001|Overall Study|Not treated|5|||
94311985|NCT01052012|322925339|FG002|Overall Study|Not treated|0|||
94311986|NCT01052012|322925340|FG003|Overall Study|Not treated|0|||
94311987|NCT01052012|322925341|FG004|Overall Study|Not treated|11|||
94311988|NCT01052012|322925342|FG005|Overall Study|Not treated|8|||
94311989|NCT01052012|322925337|FG000|Overall Study|Adverse Event|1|||
94311990|NCT01052012|322925338|FG001|Overall Study|Adverse Event|0|||
94311991|NCT01052012|322925339|FG002|Overall Study|Adverse Event|0|||
94311992|NCT01052012|322925340|FG003|Overall Study|Adverse Event|1|||
94311993|NCT01052012|322925341|FG004|Overall Study|Adverse Event|0|||
94311994|NCT01052012|322925342|FG005|Overall Study|Adverse Event|0|||
94311995|NCT01052012|322925337|FG000|Overall Study|Lost to Follow-up|0|||
94311996|NCT01052012|322925338|FG001|Overall Study|Lost to Follow-up|0|||
94311997|NCT01052012|322925339|FG002|Overall Study|Lost to Follow-up|0|||
94311998|NCT01052012|322925340|FG003|Overall Study|Lost to Follow-up|0|||
94311999|NCT01052012|322925341|FG004|Overall Study|Lost to Follow-up|1|||
94312000|NCT01052012|322925342|FG005|Overall Study|Lost to Follow-up|0|||
94312001|NCT01052012|322925337|FG000|Overall Study|Withdrawal by Subject|1|||
94312002|NCT01052012|322925338|FG001|Overall Study|Withdrawal by Subject|1|||
94312003|NCT01052012|322925339|FG002|Overall Study|Withdrawal by Subject|0|||
94312004|NCT01052012|322925340|FG003|Overall Study|Withdrawal by Subject|0|||
94312005|NCT01052012|322925341|FG004|Overall Study|Withdrawal by Subject|3|||
94312006|NCT01052012|322925342|FG005|Overall Study|Withdrawal by Subject|1|||
94312007|NCT01052012|322925337|FG000|Overall Study|Physician Decision|0|||
94312008|NCT01052012|322925338|FG001|Overall Study|Physician Decision|0|||
94312009|NCT01052012|322925339|FG002|Overall Study|Physician Decision|0|||
94312010|NCT01052012|322925340|FG003|Overall Study|Physician Decision|0|||
94312011|NCT01052012|322925341|FG004|Overall Study|Physician Decision|0|||
94312012|NCT01052012|322925342|FG005|Overall Study|Physician Decision|1|||
94312013|NCT01052012|322925337|FG000|Overall Study|Other|0|||
94312014|NCT01052012|322925338|FG001|Overall Study|Other|0|||
94312015|NCT01052012|322925339|FG002|Overall Study|Other|0|||
94312016|NCT01052012|322925340|FG003|Overall Study|Other|0|||
94312017|NCT01052012|322925341|FG004|Overall Study|Other|1|||
94312018|NCT01052012|322925342|FG005|Overall Study|Other|0|||
94312019|NCT04799782|322925345|FG000|Washout|Physician Decision|2|||
94312020|NCT04799782|322925346|FG001|Washout|Physician Decision|0|||
94312021|NCT04799782|322925345|FG000|Washout|Withdrawal by Subject|0|||
94312022|NCT04799782|322925346|FG001|Washout|Withdrawal by Subject|2|||
94312023|NCT04799782|322925345|FG000|Washout|Lost to Follow-up|0|||
94312024|NCT04799782|322925346|FG001|Washout|Lost to Follow-up|1|||
94312025|NCT00515463|322925347|FG000|Overall Study|Physician Decision|4|||
94312026|NCT00515463|322925348|FG001|Overall Study|Physician Decision|2|||
94312027|NCT00515463|322925347|FG000|Overall Study|Adverse Event|1|||
94312028|NCT00515463|322925348|FG001|Overall Study|Adverse Event|2|||
94312029|NCT00515463|322925347|FG000|Overall Study|Withdrawal by Subject|3|||
94312030|NCT00515463|322925348|FG001|Overall Study|Withdrawal by Subject|4|||
94312031|NCT00515463|322925347|FG000|Overall Study|Lost to Follow-up|6|||
94312032|NCT00515463|322925348|FG001|Overall Study|Lost to Follow-up|5|||
94312033|NCT00515463|322925347|FG000|Overall Study|Other|0|||
94382193|NCT00356200|323185248|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
94312034|NCT00515463|322925348|FG001|Overall Study|Other|1|||
94312035|NCT00530712|322925354|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
94312036|NCT00530712|322925354|FG000|30 Day Follow-up Visit|Missed Visit|5|||
94312037|NCT00530712|322925354|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
94312038|NCT00530712|322925354|FG000|6 Month Follow-up Visit|Missed Visit|3|||
94312039|NCT00530712|322925354|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
94312040|NCT00530712|322925354|FG000|6 Month Follow-up Visit|Death|2|||
94312041|NCT00530712|322925354|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
94312042|NCT00530712|322925354|FG000|12 Month Follow-up Visit|Missed Visit|3|||
94312043|NCT00530712|322925354|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
94312044|NCT00530712|322925354|FG000|12 Month Follow-up Visit|Death|9|||
94312045|NCT02749370|322925355|FG000|Overall Study|Withdrawal by Subject|11|||
94312046|NCT02749370|322925355|FG000|Overall Study|Lost to Follow-up|3|||
94312047|NCT02260193|322925359|FG000|Overall Study|Lack of Efficacy|0|||
94312048|NCT02260193|322925360|FG001|Overall Study|Lack of Efficacy|1|||
94312049|NCT02260193|322925361|FG002|Overall Study|Lack of Efficacy|6|||
94312050|NCT02260193|322925359|FG000|Overall Study|Adverse Event|3|||
94312051|NCT02260193|322925360|FG001|Overall Study|Adverse Event|4|||
94312052|NCT02260193|322925361|FG002|Overall Study|Adverse Event|1|||
94312053|NCT02260193|322925359|FG000|Overall Study|Protocol Violation|0|||
94312054|NCT02260193|322925360|FG001|Overall Study|Protocol Violation|4|||
94312055|NCT02260193|322925361|FG002|Overall Study|Protocol Violation|0|||
94312056|NCT02260193|322925359|FG000|Overall Study|Withdrawal by Subject|3|||
94312057|NCT02260193|322925360|FG001|Overall Study|Withdrawal by Subject|0|||
94312058|NCT02260193|322925361|FG002|Overall Study|Withdrawal by Subject|2|||
94312059|NCT02260193|322925359|FG000|Overall Study|Kidney Transplantation|0|||
94312060|NCT02260193|322925360|FG001|Overall Study|Kidney Transplantation|0|||
94312061|NCT02260193|322925361|FG002|Overall Study|Kidney Transplantation|1|||
94312062|NCT01522651|322925363|FG000|Overall Study|Adverse Event|3|||
94312063|NCT01522651|322925364|FG001|Overall Study|Adverse Event|4|||
94312064|NCT01522651|322925365|FG002|Overall Study|Adverse Event|4|||
94312065|NCT01522651|322925366|FG003|Overall Study|Adverse Event|5|||
94312066|NCT01522651|322925367|FG004|Overall Study|Adverse Event|4|||
94312067|NCT01522651|322925363|FG000|Overall Study|Cardioversion|1|||
94312068|NCT01522651|322925364|FG001|Overall Study|Cardioversion|0|||
94312069|NCT01522651|322925365|FG002|Overall Study|Cardioversion|0|||
94312070|NCT01522651|322925366|FG003|Overall Study|Cardioversion|0|||
94312071|NCT01522651|322925367|FG004|Overall Study|Cardioversion|0|||
94312072|NCT01522651|322925363|FG000|Overall Study|Device Malfunction|0|||
94312073|NCT01522651|322925364|FG001|Overall Study|Device Malfunction|1|||
94312074|NCT01522651|322925365|FG002|Overall Study|Device Malfunction|0|||
94312075|NCT01522651|322925366|FG003|Overall Study|Device Malfunction|0|||
94312076|NCT01522651|322925367|FG004|Overall Study|Device Malfunction|0|||
94312077|NCT01522651|322925363|FG000|Overall Study|Investigator's Discretion|0|||
94312078|NCT01522651|322925364|FG001|Overall Study|Investigator's Discretion|1|||
94312079|NCT01522651|322925365|FG002|Overall Study|Investigator's Discretion|0|||
94312080|NCT01522651|322925366|FG003|Overall Study|Investigator's Discretion|0|||
94312081|NCT01522651|322925367|FG004|Overall Study|Investigator's Discretion|0|||
94312082|NCT01522651|322925363|FG000|Overall Study|Protocol Violation|3|||
94312083|NCT01522651|322925364|FG001|Overall Study|Protocol Violation|0|||
94312084|NCT01522651|322925365|FG002|Overall Study|Protocol Violation|0|||
94312085|NCT01522651|322925366|FG003|Overall Study|Protocol Violation|0|||
94312086|NCT01522651|322925367|FG004|Overall Study|Protocol Violation|0|||
94312087|NCT01522651|322925363|FG000|Overall Study|Reason Not Specified|0|||
94312088|NCT01522651|322925364|FG001|Overall Study|Reason Not Specified|0|||
94312089|NCT01522651|322925365|FG002|Overall Study|Reason Not Specified|0|||
94312090|NCT01522651|322925366|FG003|Overall Study|Reason Not Specified|1|||
94312091|NCT01522651|322925367|FG004|Overall Study|Reason Not Specified|0|||
94312092|NCT01522651|322925363|FG000|Overall Study|Participant Non-Compliance|1|||
94312093|NCT01522651|322925364|FG001|Overall Study|Participant Non-Compliance|0|||
94312094|NCT01522651|322925365|FG002|Overall Study|Participant Non-Compliance|0|||
94312095|NCT01522651|322925366|FG003|Overall Study|Participant Non-Compliance|0|||
94312096|NCT01522651|322925367|FG004|Overall Study|Participant Non-Compliance|0|||
94312097|NCT01522651|322925363|FG000|Overall Study|Withdrew Consent|1|||
94312098|NCT01522651|322925364|FG001|Overall Study|Withdrew Consent|1|||
94312099|NCT01522651|322925365|FG002|Overall Study|Withdrew Consent|0|||
94312100|NCT01522651|322925366|FG003|Overall Study|Withdrew Consent|1|||
94312101|NCT01522651|322925367|FG004|Overall Study|Withdrew Consent|1|||
94312102|NCT01522651|322925363|FG000|Overall Study|Randomized but Never Treated|0|||
94312103|NCT01522651|322925364|FG001|Overall Study|Randomized but Never Treated|1|||
94312104|NCT01522651|322925365|FG002|Overall Study|Randomized but Never Treated|0|||
94312105|NCT01522651|322925366|FG003|Overall Study|Randomized but Never Treated|1|||
94312106|NCT01522651|322925367|FG004|Overall Study|Randomized but Never Treated|1|||
94312107|NCT00436215|322925368|FG000|Overall Study|Refused further treatment|3|||
94312108|NCT00436215|322925368|FG000|Overall Study|Small bowel obstruction|1|||
94312109|NCT00637273|322926819|FG000|Overall Study|Adverse Event|11|||
94312110|NCT00637273|322926820|FG001|Overall Study|Adverse Event|5|||
94312111|NCT00637273|322926821|FG002|Overall Study|Adverse Event|7|||
94312112|NCT00637273|322926819|FG000|Overall Study|Lost to Follow-up|8|||
94312113|NCT00637273|322926820|FG001|Overall Study|Lost to Follow-up|9|||
94312114|NCT00637273|322926821|FG002|Overall Study|Lost to Follow-up|13|||
94312115|NCT00637273|322926819|FG000|Overall Study|Protocol Violation|2|||
94312116|NCT00637273|322926820|FG001|Overall Study|Protocol Violation|4|||
94312117|NCT00637273|322926821|FG002|Overall Study|Protocol Violation|1|||
94382194|NCT00356200|323185249|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
94382195|NCT00635778|323185250|FG000|Overall Study|Adverse Event|1|||
94382196|NCT00635778|323185251|FG001|Overall Study|Adverse Event|0|||
94382197|NCT00635778|323185252|FG002|Overall Study|Adverse Event|0|||
94382198|NCT00635778|323185253|FG003|Overall Study|Adverse Event|3|||
94382199|NCT00635778|323185254|FG004|Overall Study|Adverse Event|3|||
94382200|NCT00635778|323185255|FG005|Overall Study|Adverse Event|6|||
94382201|NCT00635778|323185256|FG006|Overall Study|Adverse Event|1|||
94382202|NCT00635778|323185250|FG000|Overall Study|Withdrawal by Subject|0|||
94382203|NCT00635778|323185251|FG001|Overall Study|Withdrawal by Subject|0|||
94382204|NCT00635778|323185252|FG002|Overall Study|Withdrawal by Subject|0|||
94382205|NCT00635778|323185253|FG003|Overall Study|Withdrawal by Subject|1|||
94382206|NCT00635778|323185254|FG004|Overall Study|Withdrawal by Subject|0|||
94382207|NCT00635778|323185255|FG005|Overall Study|Withdrawal by Subject|1|||
94382208|NCT00635778|323185256|FG006|Overall Study|Withdrawal by Subject|1|||
94382209|NCT00635778|323185250|FG000|Overall Study|Progressive disease|0|||
94382210|NCT00635778|323185251|FG001|Overall Study|Progressive disease|3|||
94382211|NCT00635778|323185252|FG002|Overall Study|Progressive disease|3|||
94382212|NCT00635778|323185253|FG003|Overall Study|Progressive disease|4|||
94382213|NCT00635778|323185254|FG004|Overall Study|Progressive disease|5|||
94382214|NCT00635778|323185255|FG005|Overall Study|Progressive disease|14|||
94382215|NCT00635778|323185256|FG006|Overall Study|Progressive disease|4|||
94382216|NCT00812253|323185257|FG000|Overall Study|Withdrawal by Subject|3|||
94382217|NCT00812253|323185258|FG001|Overall Study|Withdrawal by Subject|2|||
94382218|NCT00812253|323185257|FG000|Overall Study|Protocol Violation|1|||
94382219|NCT00812253|323185258|FG001|Overall Study|Protocol Violation|1|||
94382220|NCT00812253|323185257|FG000|Overall Study|Lost to Follow-up|2|||
94382221|NCT00812253|323185258|FG001|Overall Study|Lost to Follow-up|0|||
94382222|NCT00576381|323185262|FG000|Overall Study|Reoperation|3|||
94382223|NCT00576381|323185262|FG000|Overall Study|Adverse Event|4|||
94382224|NCT01631864|323185266|FG000|Overall Study|Withdrawal by Subject|0|||
94382225|NCT01631864|323185267|FG001|Overall Study|Withdrawal by Subject|1|||
94382226|NCT01631864|323185266|FG000|Overall Study|Adverse Event|2|||
94382227|NCT01631864|323185267|FG001|Overall Study|Adverse Event|3|||
94382228|NCT01816477|323185274|FG000|Overall Study|Withdrawal by Subject|13|||
94382229|NCT01816477|323185275|FG001|Overall Study|Withdrawal by Subject|1|||
94382230|NCT01816477|323185274|FG000|Overall Study|Unable to tolerate catheter placement|3|||
94382231|NCT01816477|323185275|FG001|Overall Study|Unable to tolerate catheter placement|0|||
94382232|NCT02116803|323185276|FG000|Overall Study|Adverse Event|2|||
94382233|NCT02116803|323185277|FG001|Overall Study|Adverse Event|1|||
94382234|NCT02116803|323185276|FG000|Overall Study|Physician Decision|1|||
94382235|NCT02116803|323185277|FG001|Overall Study|Physician Decision|0|||
94382236|NCT02116803|323185276|FG000|Overall Study|Progressive disease|4|||
94382237|NCT02116803|323185277|FG001|Overall Study|Progressive disease|0|||
94382238|NCT02116803|323185276|FG000|Overall Study|Study terminated by sponsor|2|||
94382239|NCT02116803|323185277|FG001|Overall Study|Study terminated by sponsor|1|||
94382240|NCT02116803|323185276|FG000|Overall Study|Death|1|||
94382241|NCT02116803|323185277|FG001|Overall Study|Death|0|||
94382242|NCT00299156|323185280|FG000|Period 2 (Randomized)|Screen Failure|0|||
94382243|NCT00299156|323185281|FG001|Period 2 (Randomized)|Screen Failure|1|||
94382244|NCT00299156|323185282|FG002|Period 2 (Randomized)|Screen Failure|0|||
94382245|NCT01974895|323185283|FG000|Overall Study|Protocol Violation|1|||
94312118|NCT00637273|322926819|FG000|Overall Study|Withdrawal of Consent|18|||
94312119|NCT00637273|322926820|FG001|Overall Study|Withdrawal of Consent|6|||
94382246|NCT01974895|323185284|FG001|Overall Study|Protocol Violation|0|||
94382247|NCT01974895|323185283|FG000|Overall Study|Lost to Follow-up|4|||
94382248|NCT01974895|323185284|FG001|Overall Study|Lost to Follow-up|6|||
94382249|NCT01974895|323185283|FG000|Overall Study|Withdrawal by Subject|0|||
94382250|NCT01974895|323185284|FG001|Overall Study|Withdrawal by Subject|1|||
94382251|NCT01974895|323185283|FG000|Overall Study|Other (Missed Visit)|1|||
94382252|NCT01974895|323185284|FG001|Overall Study|Other (Missed Visit)|0|||
94382253|NCT01974895|323185283|FG000|Overall Study|Other (Reason unknown)|9|||
94382254|NCT01974895|323185284|FG001|Overall Study|Other (Reason unknown)|8|||
94382255|NCT00684671|323185285|FG000|Overall Study|Adverse Event|1|||
94382256|NCT00684671|323185286|FG001|Overall Study|Adverse Event|0|||
94382257|NCT00684671|323185287|FG002|Overall Study|Adverse Event|0|||
94382258|NCT00684671|323185285|FG000|Overall Study|Lost to Follow-up|1|||
94382259|NCT00684671|323185286|FG001|Overall Study|Lost to Follow-up|0|||
94382260|NCT00684671|323185287|FG002|Overall Study|Lost to Follow-up|0|||
94382261|NCT00684671|323185285|FG000|Overall Study|Alcoholic dependance|1|||
94382262|NCT00684671|323185286|FG001|Overall Study|Alcoholic dependance|0|||
94382263|NCT00684671|323185287|FG002|Overall Study|Alcoholic dependance|0|||
94382264|NCT04652453|323185292|FG000|Overall Study|Death|8|||
94382265|NCT04652453|323185293|FG001|Overall Study|Death|2|||
94382266|NCT04652453|323185294|FG002|Overall Study|Death|0|||
94382267|NCT04652453|323185292|FG000|Overall Study|Hospice|5|||
94382268|NCT04652453|323185293|FG001|Overall Study|Hospice|5|||
94382269|NCT04652453|323185294|FG002|Overall Study|Hospice|0|||
94382270|NCT04652453|323185292|FG000|Overall Study|Withdrawal by Subject|2|||
94382271|NCT04652453|323185293|FG001|Overall Study|Withdrawal by Subject|0|||
94382272|NCT04652453|323185294|FG002|Overall Study|Withdrawal by Subject|0|||
94382273|NCT01725451|323185296|FG000|Period 1|Withdrawal by Subject|1|||
94382274|NCT01725451|323185297|FG001|Period 1|Withdrawal by Subject|0|||
94382275|NCT01725451|323185298|FG002|Period 1|Withdrawal by Subject|0|||
94382276|NCT01725451|323185299|FG003|Period 1|Withdrawal by Subject|0|||
94382277|NCT01725451|323185296|FG000|Washout From Period 3|Protocol Violation|0|||
94382278|NCT01725451|323185297|FG001|Washout From Period 3|Protocol Violation|0|||
94382279|NCT01725451|323185298|FG002|Washout From Period 3|Protocol Violation|1|||
94382280|NCT01725451|323185299|FG003|Washout From Period 3|Protocol Violation|0|||
94382281|NCT01725451|323185296|FG000|Washout From Period 3|Adverse Event|0|||
94382282|NCT01725451|323185297|FG001|Washout From Period 3|Adverse Event|1|||
94382283|NCT01725451|323185298|FG002|Washout From Period 3|Adverse Event|0|||
94382284|NCT01725451|323185299|FG003|Washout From Period 3|Adverse Event|0|||
94382285|NCT01725451|323185296|FG000|Period 4|Adverse Event|0|||
94382286|NCT01725451|323185297|FG001|Period 4|Adverse Event|0|||
94382287|NCT01725451|323185298|FG002|Period 4|Adverse Event|1|||
94382288|NCT01725451|323185299|FG003|Period 4|Adverse Event|0|||
94382289|NCT01089647|323185300|FG000|Overall Study|Lost to Follow-up|2|||
94382290|NCT01089647|323185301|FG001|Overall Study|Lost to Follow-up|2|||
94382291|NCT01089647|323185300|FG000|Overall Study|Withdrawal by Subject|2|||
94382292|NCT01089647|323185301|FG001|Overall Study|Withdrawal by Subject|1|||
94382293|NCT01089647|323185300|FG000|Overall Study|Adverse Event|0|||
94382294|NCT01089647|323185301|FG001|Overall Study|Adverse Event|1|||
94382295|NCT00927810|323185302|FG000|Overall Study|Withdrawal by Subject|0|||
94382296|NCT00927810|323185303|FG001|Overall Study|Withdrawal by Subject|3|||
94382297|NCT00927810|323185304|FG002|Overall Study|Withdrawal by Subject|0|||
94382298|NCT00927810|323185305|FG003|Overall Study|Withdrawal by Subject|1|||
94382299|NCT00927810|323185302|FG000|Overall Study|Lost to Follow-up|0|||
94382300|NCT00927810|323185303|FG001|Overall Study|Lost to Follow-up|2|||
94382301|NCT00927810|323185304|FG002|Overall Study|Lost to Follow-up|1|||
94382302|NCT00927810|323185305|FG003|Overall Study|Lost to Follow-up|1|||
94382303|NCT00927810|323185302|FG000|Overall Study|Death|0|||
94382304|NCT00927810|323185303|FG001|Overall Study|Death|2|||
94382305|NCT00927810|323185304|FG002|Overall Study|Death|0|||
94382306|NCT00927810|323185305|FG003|Overall Study|Death|0|||
94382307|NCT00927810|323185302|FG000|Overall Study|Abnormal laboratory value(s)|0|||
94382308|NCT00927810|323185303|FG001|Overall Study|Abnormal laboratory value(s)|1|||
94382309|NCT00927810|323185304|FG002|Overall Study|Abnormal laboratory value(s)|0|||
94382310|NCT00927810|323185305|FG003|Overall Study|Abnormal laboratory value(s)|0|||
94382311|NCT00198029|323185309|FG000|Overall Study|Withdrawal by Subject|4|||
94382312|NCT04117607|323185310|FG000|Overall Study|Early Termination|0|||
94382313|NCT04117607|323185311|FG001|Overall Study|Early Termination|1|||
94382314|NCT04117607|323185312|FG002|Overall Study|Early Termination|0|||
94382315|NCT04117607|323185313|FG003|Overall Study|Early Termination|0|||
94382316|NCT04117607|323185314|FG004|Overall Study|Early Termination|0|||
94382317|NCT04117607|323185315|FG005|Overall Study|Early Termination|0|||
94382318|NCT04117607|323185316|FG006|Overall Study|Early Termination|1|||
94382319|NCT04117607|323185317|FG007|Overall Study|Early Termination|0|||
94382320|NCT04117607|323185318|FG008|Overall Study|Early Termination|0|||
94382321|NCT04117607|323185319|FG009|Overall Study|Early Termination|0|||
94382322|NCT04117607|323185320|FG010|Overall Study|Early Termination|0|||
94382323|NCT04117607|323185321|FG011|Overall Study|Early Termination|0|||
94382324|NCT04117607|323185322|FG012|Overall Study|Early Termination|0|||
94382325|NCT04117607|323185323|FG013|Overall Study|Early Termination|0|||
94382326|NCT00950807|323185328|FG000|Treatment Period 1|Lack of Efficacy|1|||
94312120|NCT00637273|322926821|FG002|Overall Study|Withdrawal of Consent|18|||
94312121|NCT00637273|322926819|FG000|Overall Study|Investigator Decision|1|||
94312122|NCT00637273|322926820|FG001|Overall Study|Investigator Decision|3|||
94312123|NCT00637273|322926821|FG002|Overall Study|Investigator Decision|1|||
94312124|NCT00637273|322926819|FG000|Overall Study|Administrative|2|||
94312125|NCT00637273|322926820|FG001|Overall Study|Administrative|0|||
94312126|NCT00637273|322926821|FG002|Overall Study|Administrative|0|||
94382327|NCT00950807|323185329|FG001|Treatment Period 1|Lack of Efficacy|0|||
94382328|NCT00950807|323185330|FG002|Treatment Period 1|Lack of Efficacy|0|||
94382329|NCT00950807|323185331|FG003|Treatment Period 1|Lack of Efficacy|0|||
94382330|NCT00950807|323185332|FG004|Treatment Period 1|Lack of Efficacy|0|||
94382331|NCT00950807|323185333|FG005|Treatment Period 1|Lack of Efficacy|1|||
94382332|NCT00950807|323185334|FG006|Treatment Period 1|Lack of Efficacy|0|||
94382333|NCT00950807|323185335|FG007|Treatment Period 1|Lack of Efficacy|0|||
94382334|NCT00950807|323185336|FG008|Treatment Period 1|Lack of Efficacy|0|||
94382335|NCT00950807|323185337|FG009|Treatment Period 1|Lack of Efficacy|0|||
94382336|NCT00950807|323185328|FG000|Treatment Period 1|Protocol Violation|1|||
94382337|NCT00950807|323185329|FG001|Treatment Period 1|Protocol Violation|0|||
94382338|NCT00950807|323185330|FG002|Treatment Period 1|Protocol Violation|0|||
94382339|NCT00950807|323185331|FG003|Treatment Period 1|Protocol Violation|0|||
94382340|NCT00950807|323185332|FG004|Treatment Period 1|Protocol Violation|0|||
94382341|NCT00950807|323185333|FG005|Treatment Period 1|Protocol Violation|0|||
94382342|NCT00950807|323185334|FG006|Treatment Period 1|Protocol Violation|0|||
94382343|NCT00950807|323185335|FG007|Treatment Period 1|Protocol Violation|0|||
94382344|NCT00950807|323185336|FG008|Treatment Period 1|Protocol Violation|0|||
94382345|NCT00950807|323185337|FG009|Treatment Period 1|Protocol Violation|0|||
94382346|NCT00950807|323185328|FG000|Treatment Period 1|Lost to Follow-up|0|||
94382347|NCT00950807|323185329|FG001|Treatment Period 1|Lost to Follow-up|0|||
94382348|NCT00950807|323185330|FG002|Treatment Period 1|Lost to Follow-up|1|||
94382349|NCT00950807|323185331|FG003|Treatment Period 1|Lost to Follow-up|0|||
94382350|NCT00950807|323185332|FG004|Treatment Period 1|Lost to Follow-up|0|||
94382351|NCT00950807|323185333|FG005|Treatment Period 1|Lost to Follow-up|0|||
94382352|NCT00950807|323185334|FG006|Treatment Period 1|Lost to Follow-up|0|||
94382353|NCT00950807|323185335|FG007|Treatment Period 1|Lost to Follow-up|0|||
94382354|NCT00950807|323185336|FG008|Treatment Period 1|Lost to Follow-up|0|||
94382355|NCT00950807|323185337|FG009|Treatment Period 1|Lost to Follow-up|0|||
94382356|NCT00950807|323185328|FG000|Treatment Period 1|Withdrawal by Subject|1|||
94382357|NCT00950807|323185329|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94382358|NCT00950807|323185330|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94382359|NCT00950807|323185331|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94382360|NCT00950807|323185332|FG004|Treatment Period 1|Withdrawal by Subject|1|||
94382361|NCT00950807|323185333|FG005|Treatment Period 1|Withdrawal by Subject|0|||
94382362|NCT00950807|323185334|FG006|Treatment Period 1|Withdrawal by Subject|0|||
94382363|NCT00950807|323185335|FG007|Treatment Period 1|Withdrawal by Subject|0|||
94382364|NCT00950807|323185336|FG008|Treatment Period 1|Withdrawal by Subject|1|||
94382365|NCT00950807|323185337|FG009|Treatment Period 1|Withdrawal by Subject|0|||
94382366|NCT00950807|323185328|FG000|Treatment Period 1|Adverse Event|0|||
94382367|NCT00950807|323185329|FG001|Treatment Period 1|Adverse Event|0|||
94382368|NCT00950807|323185330|FG002|Treatment Period 1|Adverse Event|0|||
94382369|NCT00950807|323185331|FG003|Treatment Period 1|Adverse Event|0|||
94382370|NCT00950807|323185332|FG004|Treatment Period 1|Adverse Event|0|||
94382371|NCT00950807|323185333|FG005|Treatment Period 1|Adverse Event|1|||
94382372|NCT00950807|323185334|FG006|Treatment Period 1|Adverse Event|0|||
94382373|NCT00950807|323185335|FG007|Treatment Period 1|Adverse Event|0|||
94382374|NCT00950807|323185336|FG008|Treatment Period 1|Adverse Event|0|||
94382375|NCT00950807|323185337|FG009|Treatment Period 1|Adverse Event|0|||
94382376|NCT00950807|323185328|FG000|Washout Period 1|Lack of Efficacy|0|||
94382377|NCT00950807|323185329|FG001|Washout Period 1|Lack of Efficacy|0|||
94382378|NCT00950807|323185330|FG002|Washout Period 1|Lack of Efficacy|0|||
94382379|NCT00950807|323185331|FG003|Washout Period 1|Lack of Efficacy|0|||
94382380|NCT00950807|323185332|FG004|Washout Period 1|Lack of Efficacy|0|||
94382381|NCT00950807|323185333|FG005|Washout Period 1|Lack of Efficacy|0|||
94382382|NCT00950807|323185334|FG006|Washout Period 1|Lack of Efficacy|1|||
94382383|NCT00950807|323185335|FG007|Washout Period 1|Lack of Efficacy|0|||
94382384|NCT00950807|323185336|FG008|Washout Period 1|Lack of Efficacy|0|||
94382385|NCT00950807|323185337|FG009|Washout Period 1|Lack of Efficacy|0|||
94382386|NCT00950807|323185328|FG000|Washout Period 1|Withdrawal by Subject|0|||
94382387|NCT00950807|323185329|FG001|Washout Period 1|Withdrawal by Subject|0|||
94382388|NCT00950807|323185330|FG002|Washout Period 1|Withdrawal by Subject|0|||
94382389|NCT00950807|323185331|FG003|Washout Period 1|Withdrawal by Subject|0|||
94382390|NCT00950807|323185332|FG004|Washout Period 1|Withdrawal by Subject|0|||
94312127|NCT00637273|322926819|FG000|Overall Study|Loss of Glucose Control|1|||
94382391|NCT00950807|323185333|FG005|Washout Period 1|Withdrawal by Subject|0|||
94382392|NCT00950807|323185334|FG006|Washout Period 1|Withdrawal by Subject|0|||
94382393|NCT00950807|323185335|FG007|Washout Period 1|Withdrawal by Subject|0|||
94382394|NCT00950807|323185336|FG008|Washout Period 1|Withdrawal by Subject|1|||
94382395|NCT00950807|323185337|FG009|Washout Period 1|Withdrawal by Subject|0|||
94312128|NCT00637273|322926820|FG001|Overall Study|Loss of Glucose Control|1|||
94312129|NCT00637273|322926821|FG002|Overall Study|Loss of Glucose Control|1|||
94312130|NCT00117338|322926822|FG000|Overall Study|Adverse Event|0|||
94312131|NCT00117338|322926823|FG001|Overall Study|Adverse Event|1|||
94312132|NCT00117338|322926822|FG000|Overall Study|Protocol Violation|3|||
94312133|NCT00117338|322926823|FG001|Overall Study|Protocol Violation|2|||
94312134|NCT00117338|322926822|FG000|Overall Study|Withdrawal by Subject|1|||
94312135|NCT00117338|322926823|FG001|Overall Study|Withdrawal by Subject|0|||
94312136|NCT00117338|322926822|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
94312137|NCT00117338|322926823|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
94312138|NCT00117338|322926822|FG000|Overall Study|Lack of Efficacy|0|||
94312139|NCT00117338|322926823|FG001|Overall Study|Lack of Efficacy|1|||
94312140|NCT02616029|322926825|FG000|Overall Study|Adverse Event|1|||
94312141|NCT02616029|322926826|FG001|Overall Study|Adverse Event|0|||
94312142|NCT02616029|322926825|FG000|Overall Study|Death|0|||
94312143|NCT02616029|322926826|FG001|Overall Study|Death|1|||
94312144|NCT02616029|322926825|FG000|Overall Study|Protocol Violation|1|||
94312145|NCT02616029|322926826|FG001|Overall Study|Protocol Violation|0|||
94312146|NCT02616029|322926825|FG000|Overall Study|Withdrew Consent|1|||
94312147|NCT02616029|322926826|FG001|Overall Study|Withdrew Consent|0|||
94312148|NCT02616029|322926825|FG000|Overall Study|Enrolled and Never Treated|1|||
94312149|NCT02616029|322926826|FG001|Overall Study|Enrolled and Never Treated|1|||
94312150|NCT00367640|322926827|FG000|Overall Study|Adverse Event|3|||
94312151|NCT00367640|322926828|FG001|Overall Study|Adverse Event|6|||
94312152|NCT00367640|322926829|FG002|Overall Study|Adverse Event|8|||
94312153|NCT00367640|322926830|FG003|Overall Study|Adverse Event|0|||
94312154|NCT00367640|322926827|FG000|Overall Study|Withdrawal by Subject|8|||
94312155|NCT00367640|322926828|FG001|Overall Study|Withdrawal by Subject|11|||
94312156|NCT00367640|322926829|FG002|Overall Study|Withdrawal by Subject|8|||
94312157|NCT00367640|322926830|FG003|Overall Study|Withdrawal by Subject|6|||
94312158|NCT00367640|322926827|FG000|Overall Study|Any other reason not above-mentioned|7|||
94312159|NCT00367640|322926828|FG001|Overall Study|Any other reason not above-mentioned|5|||
94312160|NCT00367640|322926829|FG002|Overall Study|Any other reason not above-mentioned|3|||
94312161|NCT00367640|322926830|FG003|Overall Study|Any other reason not above-mentioned|4|||
94312162|NCT00771030|322926831|FG000|Overall Study|Adverse Event|0|||
94312163|NCT00771030|322926832|FG001|Overall Study|Adverse Event|1|||
94312164|NCT00771030|322926833|FG002|Overall Study|Adverse Event|0|||
94382396|NCT00950807|323185328|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
94382397|NCT00950807|323185329|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
94382398|NCT00950807|323185330|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
94382399|NCT00950807|323185331|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
94382400|NCT00950807|323185332|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
94382401|NCT00950807|323185333|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
94382402|NCT00950807|323185334|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
94382403|NCT00950807|323185335|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
94382404|NCT00950807|323185336|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
94312165|NCT00771030|322926834|FG003|Overall Study|Adverse Event|0|||
94312166|NCT00771030|322926835|FG004|Overall Study|Adverse Event|0|||
94312167|NCT00771030|322926836|FG005|Overall Study|Adverse Event|0|||
94312168|NCT00771030|322926837|FG006|Overall Study|Adverse Event|0|||
94312169|NCT01839188|322926838|FG000|Overall Study|Withdrawal by Subject|1|||
94312170|NCT00940342|322926839|FG000|Overall Study|Adverse Event|0|||
94312171|NCT00940342|322926840|FG001|Overall Study|Adverse Event|2|||
94312172|NCT00940342|322926841|FG002|Overall Study|Adverse Event|1|||
94312173|NCT02202031|322926842|FG000|Overall Study|Lost to Follow-up|1|||
94312174|NCT02202031|322926843|FG001|Overall Study|Lost to Follow-up|0|||
94312175|NCT02202031|322926842|FG000|Overall Study|Too Busy|1|||
94312176|NCT02202031|322926843|FG001|Overall Study|Too Busy|3|||
94312177|NCT02202031|322926842|FG000|Overall Study|Illness/Medical Reason|0|||
94312178|NCT02202031|322926843|FG001|Overall Study|Illness/Medical Reason|2|||
94312179|NCT02202031|322926842|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
94312180|NCT02202031|322926843|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
94312181|NCT00138151|322926846|FG000|Overall Study|Withdrawal by Subject|3|||
94312182|NCT00138151|322926846|FG000|Overall Study|Physician Decision|1|||
94312183|NCT02214186|322926847|FG000|Overall Study|Lost to Follow-up|1|||
94312184|NCT02214186|322926848|FG001|Overall Study|Lost to Follow-up|1|||
94473414|NCT02070978|323523425|FG000|Overall Study|Terminated by Sponsor|33|||
94473415|NCT02070978|323523426|FG001|Overall Study|Terminated by Sponsor|40|||
94312185|NCT02214186|322926847|FG000|Overall Study|Protocol Violation|1|||
94312186|NCT02214186|322926848|FG001|Overall Study|Protocol Violation|1|||
94312187|NCT01651052|322926851|FG000|Overall Study|Death|21|||
94312188|NCT01651052|322926851|FG000|Overall Study|Explant|1|||
94312189|NCT01651052|322926851|FG000|Overall Study|Withdrawal by Subject|1|||
94312190|NCT01651052|322926851|FG000|Overall Study|Lost to Follow-up|3|||
94312191|NCT01024465|322926855|FG000|Overall Study|Adverse Event|2|||
94312192|NCT01024465|322926855|FG000|Overall Study|Physician Decision|1|||
94312193|NCT03078608|322926857|FG000|Overall Study|Death|1|||
94312194|NCT03078608|322926858|FG001|Overall Study|Death|2|||
94312195|NCT03078608|322926859|FG002|Overall Study|Death|0|||
94312196|NCT03078608|322926860|FG003|Overall Study|Death|0|||
94312197|NCT03078608|322926857|FG000|Overall Study|Withdrawal by Subject|8|||
94312198|NCT03078608|322926858|FG001|Overall Study|Withdrawal by Subject|1|||
94312199|NCT03078608|322926859|FG002|Overall Study|Withdrawal by Subject|0|||
94312200|NCT03078608|322926860|FG003|Overall Study|Withdrawal by Subject|0|||
94312201|NCT03078608|322926857|FG000|Overall Study|Lost to Follow-up|5|||
94312202|NCT03078608|322926858|FG001|Overall Study|Lost to Follow-up|8|||
94312203|NCT03078608|322926859|FG002|Overall Study|Lost to Follow-up|4|||
94312204|NCT03078608|322926860|FG003|Overall Study|Lost to Follow-up|1|||
94312205|NCT01455428|322926861|FG000|Overall Study|Protocol Violation|2|||
94312206|NCT01455428|322926862|FG001|Overall Study|Protocol Violation|1|||
94312207|NCT01455428|322926861|FG000|Overall Study|Adverse Event|6|||
94312208|NCT01455428|322926862|FG001|Overall Study|Adverse Event|2|||
94312209|NCT01455428|322926861|FG000|Overall Study|Lost to Follow-up|1|||
94312210|NCT01455428|322926862|FG001|Overall Study|Lost to Follow-up|1|||
94312211|NCT01455428|322926861|FG000|Overall Study|Withdrawal by Subject|2|||
94312212|NCT01455428|322926862|FG001|Overall Study|Withdrawal by Subject|5|||
94312213|NCT01455428|322926861|FG000|Overall Study|Did not meet entrance criteria|0|||
94312214|NCT01455428|322926862|FG001|Overall Study|Did not meet entrance criteria|2|||
94312215|NCT01455428|322926861|FG000|Overall Study|Insufficient clinical response|0|||
94312216|NCT01455428|322926862|FG001|Overall Study|Insufficient clinical response|2|||
94312217|NCT01455428|322926861|FG000|Overall Study|Did not receive treatment|1|||
94312218|NCT01455428|322926862|FG001|Overall Study|Did not receive treatment|1|||
94312219|NCT01455428|322926861|FG000|Overall Study|Other|2|||
94312220|NCT01455428|322926862|FG001|Overall Study|Other|4|||
94312221|NCT00257192|322926863|FG000|Overall Study|Adverse Event|21|||
94312222|NCT00257192|322926864|FG001|Overall Study|Adverse Event|10|||
94312223|NCT00257192|322926863|FG000|Overall Study|Laboratory abnormality|1|||
94312224|NCT00257192|322926864|FG001|Overall Study|Laboratory abnormality|1|||
94312225|NCT00257192|322926863|FG000|Overall Study|Lost to Follow-up|3|||
94312226|NCT00257192|322926864|FG001|Overall Study|Lost to Follow-up|3|||
94312227|NCT00257192|322926863|FG000|Overall Study|Insufficient clinical response|18|||
94312228|NCT00257192|322926864|FG001|Overall Study|Insufficient clinical response|18|||
94312229|NCT00257192|322926863|FG000|Overall Study|Withdrawal by Subject|14|||
94312230|NCT00257192|322926864|FG001|Overall Study|Withdrawal by Subject|2|||
94312231|NCT00257192|322926863|FG000|Overall Study|Randomized but not treated|0|||
94312232|NCT00257192|322926864|FG001|Overall Study|Randomized but not treated|1|||
94312233|NCT00257192|322926863|FG000|Overall Study|Study terminated by sponsor|1|||
94312234|NCT00257192|322926864|FG001|Overall Study|Study terminated by sponsor|0|||
94312235|NCT00257192|322926863|FG000|Overall Study|Miscellaneous|0|||
94312236|NCT00257192|322926864|FG001|Overall Study|Miscellaneous|4|||
94312237|NCT02086565|322926867|FG000|Overall Study|Lost to Follow-up|9|||
94312238|NCT02086565|322926868|FG001|Overall Study|Lost to Follow-up|7|||
94312239|NCT02086565|322926867|FG000|Overall Study|Withdrawal by Subject|2|||
94312240|NCT02086565|322926868|FG001|Overall Study|Withdrawal by Subject|1|||
94312241|NCT02086565|322926867|FG000|Overall Study|Death|3|||
94312242|NCT02086565|322926868|FG001|Overall Study|Death|2|||
94312243|NCT02086565|322926867|FG000|Overall Study|withdrawn by research team|2|||
94312244|NCT02086565|322926868|FG001|Overall Study|withdrawn by research team|2|||
94312245|NCT00751101|322926869|FG000|Overall Study|Withdrawal by Subject|1|||
94312246|NCT00751101|322926870|FG001|Overall Study|Withdrawal by Subject|0|||
94312247|NCT00751101|322926869|FG000|Overall Study|No HFS / Never Started Patch/|0|||
94312248|NCT00751101|322926870|FG001|Overall Study|No HFS / Never Started Patch/|4|||
94312249|NCT00751101|322926869|FG000|Overall Study|Never began capecitabine|1|||
94312250|NCT00751101|322926870|FG001|Overall Study|Never began capecitabine|0|||
94312251|NCT00751101|322926869|FG000|Overall Study|Physician Decision|0|||
94312252|NCT00751101|322926870|FG001|Overall Study|Physician Decision|1|||
94312253|NCT00739297|322926871|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
94312254|NCT00739297|322926872|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
94312255|NCT00739297|322926873|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
94312256|NCT00739297|322926874|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
94312257|NCT00739297|322926875|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
94312258|NCT00739297|322926876|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
94312259|NCT00739297|322926877|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
94312260|NCT00739297|322926871|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
94382405|NCT00950807|323185337|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
94312261|NCT00739297|322926872|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
94312262|NCT00739297|322926873|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
94312263|NCT00739297|322926874|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
94382406|NCT00950807|323185328|FG000|Washout Period 1|Adverse Event|2|||
94312264|NCT00739297|322926875|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
94312265|NCT00739297|322926876|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
94382407|NCT00950807|323185329|FG001|Washout Period 1|Adverse Event|0|||
94382408|NCT00950807|323185330|FG002|Washout Period 1|Adverse Event|0|||
94382409|NCT00950807|323185331|FG003|Washout Period 1|Adverse Event|1|||
94382410|NCT00950807|323185332|FG004|Washout Period 1|Adverse Event|1|||
94382411|NCT00950807|323185333|FG005|Washout Period 1|Adverse Event|0|||
94382412|NCT00950807|323185334|FG006|Washout Period 1|Adverse Event|0|||
94382413|NCT00950807|323185335|FG007|Washout Period 1|Adverse Event|0|||
94382414|NCT00950807|323185336|FG008|Washout Period 1|Adverse Event|0|||
94382415|NCT00950807|323185337|FG009|Washout Period 1|Adverse Event|0|||
94382416|NCT00950807|323185328|FG000|Treatment Period 2|Lack of Efficacy|1|||
94382417|NCT00950807|323185329|FG001|Treatment Period 2|Lack of Efficacy|0|||
94382418|NCT00950807|323185330|FG002|Treatment Period 2|Lack of Efficacy|0|||
94382419|NCT00950807|323185331|FG003|Treatment Period 2|Lack of Efficacy|0|||
94382420|NCT00950807|323185332|FG004|Treatment Period 2|Lack of Efficacy|0|||
94382421|NCT00950807|323185333|FG005|Treatment Period 2|Lack of Efficacy|0|||
94382422|NCT00950807|323185334|FG006|Treatment Period 2|Lack of Efficacy|0|||
94382423|NCT00950807|323185335|FG007|Treatment Period 2|Lack of Efficacy|0|||
94382424|NCT00950807|323185336|FG008|Treatment Period 2|Lack of Efficacy|0|||
94382425|NCT00950807|323185337|FG009|Treatment Period 2|Lack of Efficacy|0|||
94382426|NCT00950807|323185328|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94382427|NCT00950807|323185329|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94382428|NCT00950807|323185330|FG002|Treatment Period 2|Withdrawal by Subject|0|||
94382429|NCT00950807|323185331|FG003|Treatment Period 2|Withdrawal by Subject|0|||
94382430|NCT00950807|323185332|FG004|Treatment Period 2|Withdrawal by Subject|0|||
94382431|NCT00950807|323185333|FG005|Treatment Period 2|Withdrawal by Subject|0|||
94382432|NCT00950807|323185334|FG006|Treatment Period 2|Withdrawal by Subject|1|||
94382433|NCT00950807|323185335|FG007|Treatment Period 2|Withdrawal by Subject|2|||
94382434|NCT00950807|323185336|FG008|Treatment Period 2|Withdrawal by Subject|0|||
94382435|NCT00950807|323185337|FG009|Treatment Period 2|Withdrawal by Subject|0|||
94382436|NCT00950807|323185328|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
94382437|NCT00950807|323185329|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
94382438|NCT00950807|323185330|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
94382439|NCT00950807|323185331|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
94382440|NCT00950807|323185332|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
94382441|NCT00950807|323185333|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
94382442|NCT00950807|323185334|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
94382443|NCT00950807|323185335|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
94382444|NCT00950807|323185336|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
94382445|NCT00950807|323185337|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
94382446|NCT00950807|323185328|FG000|Treatment Period 2|Adverse Event|0|||
94382447|NCT00950807|323185329|FG001|Treatment Period 2|Adverse Event|1|||
94382448|NCT00950807|323185330|FG002|Treatment Period 2|Adverse Event|0|||
94382449|NCT00950807|323185331|FG003|Treatment Period 2|Adverse Event|1|||
94382450|NCT00950807|323185332|FG004|Treatment Period 2|Adverse Event|0|||
94382451|NCT00950807|323185333|FG005|Treatment Period 2|Adverse Event|1|||
94312266|NCT00739297|322926877|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
94312267|NCT00784784|322926878|FG000|Overall Study|Withdrawal by Subject|2|||
94312268|NCT00784784|322926879|FG001|Overall Study|Withdrawal by Subject|2|||
94312269|NCT01035255|322926886|FG000|Overall Study|Death|724|||
94312270|NCT01035255|322926887|FG001|Overall Study|Death|844|||
94312271|NCT01035255|322926886|FG000|Overall Study|Lost to Follow-up|2|||
94312272|NCT01035255|322926887|FG001|Overall Study|Lost to Follow-up|5|||
94312273|NCT01035255|322926886|FG000|Overall Study|patient's request|15|||
94312274|NCT01035255|322926887|FG001|Overall Study|patient's request|13|||
94312275|NCT01921270|322926888|FG000|Overall Study|Withdrawal by Subject|1|||
94312276|NCT00844428|322926889|FG000|Screening Period|Screen Failure|3|||
94312277|NCT00844428|322926889|FG000|Extension Treatment Period|Death|1|||
94312278|NCT00844428|322926889|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
94312279|NCT01242020|322926891|FG000|Overall Study|Withdrawal by Subject|2|||
94312280|NCT01242020|322926892|FG001|Overall Study|Withdrawal by Subject|0|||
94312281|NCT01242020|322926891|FG000|Overall Study|Failed screening|1|||
94312282|NCT01242020|322926892|FG001|Overall Study|Failed screening|0|||
94312283|NCT02375698|322926893|FG000|Overall Study|Withdrawal by Subject|0|||
94312284|NCT02375698|322926894|FG001|Overall Study|Withdrawal by Subject|2|||
94312285|NCT02375698|322926893|FG000|Overall Study|Physician Decision|2|||
94382452|NCT00950807|323185334|FG006|Treatment Period 2|Adverse Event|0|||
94382453|NCT00950807|323185335|FG007|Treatment Period 2|Adverse Event|1|||
94382454|NCT00950807|323185336|FG008|Treatment Period 2|Adverse Event|0|||
94382455|NCT00950807|323185337|FG009|Treatment Period 2|Adverse Event|0|||
94312286|NCT02375698|322926894|FG001|Overall Study|Physician Decision|0|||
94312287|NCT01638546|322926899|FG000|Overall Study|Adverse Event|1|||
94312288|NCT01638546|322926900|FG001|Overall Study|Adverse Event|3|||
94312289|NCT03280550|322926901|FG000|Overall Study|Withdrawal by Subject|2|||
94382456|NCT00950807|323185328|FG000|Washout Period 2|Lack of Efficacy|1|||
94382457|NCT00950807|323185329|FG001|Washout Period 2|Lack of Efficacy|0|||
94312290|NCT03280550|322926902|FG001|Overall Study|Withdrawal by Subject|2|||
94382458|NCT00950807|323185330|FG002|Washout Period 2|Lack of Efficacy|0|||
94382459|NCT00950807|323185331|FG003|Washout Period 2|Lack of Efficacy|0|||
94382460|NCT00950807|323185332|FG004|Washout Period 2|Lack of Efficacy|0|||
94382461|NCT00950807|323185333|FG005|Washout Period 2|Lack of Efficacy|0|||
94382462|NCT00950807|323185334|FG006|Washout Period 2|Lack of Efficacy|0|||
94382463|NCT00950807|323185335|FG007|Washout Period 2|Lack of Efficacy|0|||
94382464|NCT00950807|323185336|FG008|Washout Period 2|Lack of Efficacy|0|||
94382465|NCT00950807|323185337|FG009|Washout Period 2|Lack of Efficacy|0|||
94382466|NCT00950807|323185328|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
94382467|NCT00950807|323185329|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
94382468|NCT00950807|323185330|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
94382469|NCT00950807|323185331|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
94382470|NCT00950807|323185332|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
94382471|NCT00950807|323185333|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
94382472|NCT00950807|323185334|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
94382473|NCT00950807|323185335|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
94382474|NCT00950807|323185336|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
94382475|NCT00950807|323185337|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
94382476|NCT00950807|323185328|FG000|Washout Period 2|Adverse Event|3|||
94382477|NCT00950807|323185329|FG001|Washout Period 2|Adverse Event|0|||
94382478|NCT00950807|323185330|FG002|Washout Period 2|Adverse Event|0|||
94382479|NCT00950807|323185331|FG003|Washout Period 2|Adverse Event|1|||
94382480|NCT00950807|323185332|FG004|Washout Period 2|Adverse Event|0|||
94382481|NCT00950807|323185333|FG005|Washout Period 2|Adverse Event|0|||
94382482|NCT00950807|323185334|FG006|Washout Period 2|Adverse Event|0|||
94382483|NCT00950807|323185335|FG007|Washout Period 2|Adverse Event|0|||
94382484|NCT00950807|323185336|FG008|Washout Period 2|Adverse Event|0|||
94382485|NCT00950807|323185337|FG009|Washout Period 2|Adverse Event|0|||
94382486|NCT00950807|323185328|FG000|Treatment Period 3|Withdrawal by Subject|0|||
94382487|NCT00950807|323185329|FG001|Treatment Period 3|Withdrawal by Subject|0|||
94382488|NCT00950807|323185330|FG002|Treatment Period 3|Withdrawal by Subject|0|||
94382489|NCT00950807|323185331|FG003|Treatment Period 3|Withdrawal by Subject|0|||
94382490|NCT00950807|323185332|FG004|Treatment Period 3|Withdrawal by Subject|0|||
94382491|NCT00950807|323185333|FG005|Treatment Period 3|Withdrawal by Subject|0|||
94382492|NCT00950807|323185334|FG006|Treatment Period 3|Withdrawal by Subject|0|||
94382493|NCT00950807|323185335|FG007|Treatment Period 3|Withdrawal by Subject|0|||
94382494|NCT00950807|323185336|FG008|Treatment Period 3|Withdrawal by Subject|0|||
94382495|NCT00950807|323185337|FG009|Treatment Period 3|Withdrawal by Subject|1|||
94382496|NCT00950807|323185328|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
94382497|NCT00950807|323185329|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
94382498|NCT00950807|323185330|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
94382499|NCT00950807|323185331|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
94382500|NCT00950807|323185332|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
94382501|NCT00950807|323185333|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
94382502|NCT00950807|323185334|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
94382503|NCT00950807|323185335|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
94382504|NCT00950807|323185336|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
94382505|NCT00950807|323185337|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
94382506|NCT00950807|323185328|FG000|Treatment Period 3|Adverse Event|0|||
94382507|NCT00950807|323185329|FG001|Treatment Period 3|Adverse Event|0|||
94382508|NCT00950807|323185330|FG002|Treatment Period 3|Adverse Event|0|||
94382509|NCT00950807|323185331|FG003|Treatment Period 3|Adverse Event|0|||
94382510|NCT00950807|323185332|FG004|Treatment Period 3|Adverse Event|0|||
94382511|NCT00950807|323185333|FG005|Treatment Period 3|Adverse Event|0|||
94382512|NCT00950807|323185334|FG006|Treatment Period 3|Adverse Event|1|||
94382513|NCT00950807|323185335|FG007|Treatment Period 3|Adverse Event|0|||
94382514|NCT00950807|323185336|FG008|Treatment Period 3|Adverse Event|0|||
94382515|NCT00950807|323185337|FG009|Treatment Period 3|Adverse Event|0|||
94382516|NCT00984295|323185338|FG000|Overall Study|Lost to Follow-up|31|||
94382517|NCT00984295|323185339|FG001|Overall Study|Lost to Follow-up|12|||
94382518|NCT00984295|323185340|FG002|Overall Study|Lost to Follow-up|13|||
94382519|NCT00984295|323185338|FG000|Overall Study|Protocol Violation|2|||
94382520|NCT00984295|323185339|FG001|Overall Study|Protocol Violation|1|||
94382521|NCT00984295|323185340|FG002|Overall Study|Protocol Violation|4|||
94382522|NCT00984295|323185338|FG000|Overall Study|Withdrawal by Subject|18|||
94382523|NCT00984295|323185339|FG001|Overall Study|Withdrawal by Subject|9|||
94382524|NCT00984295|323185340|FG002|Overall Study|Withdrawal by Subject|12|||
94382525|NCT00984295|323185338|FG000|Overall Study|CAE - discontinued test vaccine|0|||
94382526|NCT00984295|323185339|FG001|Overall Study|CAE - discontinued test vaccine|1|||
94382527|NCT00984295|323185340|FG002|Overall Study|CAE - discontinued test vaccine|3|||
94382528|NCT00984295|323185338|FG000|Overall Study|Missed one or more blood samplings|3|||
94382529|NCT00984295|323185339|FG001|Overall Study|Missed one or more blood samplings|7|||
94382530|NCT00984295|323185340|FG002|Overall Study|Missed one or more blood samplings|2|||
94382531|NCT00984295|323185338|FG000|Overall Study|Incomplete safety follow-up|11|||
94382532|NCT00984295|323185339|FG001|Overall Study|Incomplete safety follow-up|2|||
94382533|NCT00984295|323185340|FG002|Overall Study|Incomplete safety follow-up|3|||
94382534|NCT04799158|323185341|FG000|Run-In Period|Adverse Event|6|||
94382535|NCT04799158|323185342|FG001|Run-In Period|Adverse Event|0|||
94382536|NCT04799158|323185343|FG002|Run-In Period|Adverse Event|0|||
94382537|NCT04799158|323185344|FG003|Run-In Period|Adverse Event|0|||
94382538|NCT04799158|323185345|FG004|Run-In Period|Adverse Event|0|||
94382539|NCT04799158|323185341|FG000|Run-In Period|Lost to Follow-up|4|||
94382540|NCT04799158|323185342|FG001|Run-In Period|Lost to Follow-up|0|||
94382541|NCT04799158|323185343|FG002|Run-In Period|Lost to Follow-up|0|||
94382542|NCT04799158|323185344|FG003|Run-In Period|Lost to Follow-up|0|||
94382543|NCT04799158|323185345|FG004|Run-In Period|Lost to Follow-up|0|||
94382544|NCT04799158|323185341|FG000|Run-In Period|Significant Protocol Deviation|1|||
94382545|NCT04799158|323185342|FG001|Run-In Period|Significant Protocol Deviation|0|||
94382546|NCT04799158|323185343|FG002|Run-In Period|Significant Protocol Deviation|0|||
94382547|NCT04799158|323185344|FG003|Run-In Period|Significant Protocol Deviation|0|||
94382548|NCT04799158|323185345|FG004|Run-In Period|Significant Protocol Deviation|0|||
94382549|NCT04799158|323185341|FG000|Run-In Period|Withdrawal by Subject|11|||
94382550|NCT04799158|323185342|FG001|Run-In Period|Withdrawal by Subject|0|||
94382551|NCT04799158|323185343|FG002|Run-In Period|Withdrawal by Subject|0|||
94382552|NCT04799158|323185344|FG003|Run-In Period|Withdrawal by Subject|0|||
94382553|NCT04799158|323185345|FG004|Run-In Period|Withdrawal by Subject|0|||
94382554|NCT04799158|323185341|FG000|Run-In Period|Miscellaneous|3|||
94382555|NCT04799158|323185342|FG001|Run-In Period|Miscellaneous|0|||
94382556|NCT04799158|323185343|FG002|Run-In Period|Miscellaneous|0|||
94382557|NCT04799158|323185344|FG003|Run-In Period|Miscellaneous|0|||
94382558|NCT04799158|323185345|FG004|Run-In Period|Miscellaneous|0|||
94382559|NCT04799158|323185341|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
94382560|NCT04799158|323185342|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
94382561|NCT04799158|323185343|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
94382562|NCT04799158|323185344|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
94382563|NCT04799158|323185345|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
94382564|NCT04799158|323185341|FG000|On-Demand Treatment Period|Adverse Event|0|||
94382565|NCT04799158|323185342|FG001|On-Demand Treatment Period|Adverse Event|1|||
94382566|NCT04799158|323185343|FG002|On-Demand Treatment Period|Adverse Event|0|||
94382567|NCT04799158|323185344|FG003|On-Demand Treatment Period|Adverse Event|0|||
94382568|NCT04799158|323185345|FG004|On-Demand Treatment Period|Adverse Event|1|||
94382569|NCT04799158|323185341|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
94382570|NCT04799158|323185342|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
94382571|NCT04799158|323185343|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
94382572|NCT04799158|323185344|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
94382573|NCT04799158|323185345|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
94382574|NCT04799158|323185341|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
94382575|NCT04799158|323185342|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
94382576|NCT04799158|323185343|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
94382577|NCT04799158|323185344|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
94382578|NCT04799158|323185345|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
94382579|NCT04799158|323185341|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
94382580|NCT04799158|323185342|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
94382581|NCT04799158|323185343|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
94382582|NCT04799158|323185344|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
94312291|NCT03280550|322926901|FG000|Overall Study|Physician Decision|0|||
94312292|NCT03280550|322926902|FG001|Overall Study|Physician Decision|1|||
94312293|NCT02698423|322926903|FG000|Overall Study|Lost to Follow-up|19|||
94312294|NCT02698423|322926904|FG001|Overall Study|Lost to Follow-up|24|||
94312295|NCT01651260|322926909|FG000|Overall Study|unable to apply product|3|||
94312296|NCT02144220|322926910|FG000|Overall Study|technology incompatibility|9|||
94312297|NCT02144220|322926910|FG000|Overall Study|Lack of Efficacy|4|||
94312298|NCT02144220|322926910|FG000|Overall Study|Physician Decision|3|||
94312299|NCT02144220|322926910|FG000|Overall Study|Withdrawal by Subject|2|||
94312300|NCT02144220|322926910|FG000|Overall Study|Protocol Violation|1|||
94312301|NCT01952015|322926913|FG000|Induction|Protocol Violation|1|||
94312302|NCT01952015|322926913|FG000|Maintenance|Adverse Event|2|||
94312303|NCT01952015|322926913|FG000|Treatment Period 3|Physician Decision|9|||
94312304|NCT02239094|322926914|FG000|Overall Study|Withdrawal by Subject|1|||
94312305|NCT02239094|322926914|FG000|Overall Study|Remitted before started|1|||
94312306|NCT01597193|322926915|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
94312307|NCT01597193|322926916|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
94312308|NCT01597193|322926917|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
94312309|NCT01597193|322926918|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
94312310|NCT01597193|322926919|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
94312311|NCT01597193|322926920|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
94382583|NCT04799158|323185345|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
94382584|NCT04799158|323185341|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
94382585|NCT04799158|323185342|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
94382586|NCT04799158|323185343|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
94382587|NCT04799158|323185344|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
94382588|NCT04799158|323185345|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
94382589|NCT04799158|323185341|FG000|On-Demand Treatment Period|Miscellaneous|0|||
94382590|NCT04799158|323185342|FG001|On-Demand Treatment Period|Miscellaneous|0|||
94382591|NCT04799158|323185343|FG002|On-Demand Treatment Period|Miscellaneous|0|||
94382592|NCT04799158|323185344|FG003|On-Demand Treatment Period|Miscellaneous|0|||
94382593|NCT04799158|323185345|FG004|On-Demand Treatment Period|Miscellaneous|1|||
94382594|NCT03276975|323185348|FG000|Overall Study|Withdrawal by Subject|1|||
94382595|NCT03276975|323185349|FG001|Overall Study|Withdrawal by Subject|0|||
94382596|NCT01226797|323185350|FG000|Overall Study|Adverse Event|1|||
94382597|NCT01226797|323185351|FG001|Overall Study|Adverse Event|0|||
94382598|NCT01226797|323185350|FG000|Overall Study|No longer willing to participate|1|||
94382599|NCT01226797|323185351|FG001|Overall Study|No longer willing to participate|0|||
94382600|NCT01226797|323185350|FG000|Overall Study|Protocol Violation|0|||
94382601|NCT01226797|323185351|FG001|Overall Study|Protocol Violation|1|||
94382602|NCT02626949|323185352|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
94382603|NCT02626949|323185353|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
94382604|NCT02626949|323185352|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
94382605|NCT02626949|323185353|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
94382606|NCT02626949|323185352|FG000|Enrolled|Lost to Follow-up|7|||
94382607|NCT02626949|323185353|FG001|Enrolled|Lost to Follow-up|6|||
94382608|NCT02626949|323185352|FG000|Enrolled|Withdrawal by Subject|3|||
94382609|NCT02626949|323185353|FG001|Enrolled|Withdrawal by Subject|2|||
94382610|NCT00661999|323185354|FG000|Overall Study|Adverse Event|11|||
94382611|NCT00661999|323185355|FG001|Overall Study|Adverse Event|5|||
94382612|NCT00661999|323185356|FG002|Overall Study|Adverse Event|8|||
94382613|NCT00661999|323185354|FG000|Overall Study|Death|8|||
94382614|NCT00661999|323185355|FG001|Overall Study|Death|6|||
94382615|NCT00661999|323185356|FG002|Overall Study|Death|3|||
94382616|NCT00661999|323185354|FG000|Overall Study|Other Reasons|5|||
94382617|NCT00661999|323185355|FG001|Overall Study|Other Reasons|12|||
94382618|NCT00661999|323185356|FG002|Overall Study|Other Reasons|23|||
94382619|NCT00661999|323185354|FG000|Overall Study|Withdrawal by Subject|30|||
94382620|NCT00661999|323185355|FG001|Overall Study|Withdrawal by Subject|23|||
94382621|NCT00661999|323185356|FG002|Overall Study|Withdrawal by Subject|14|||
94382622|NCT00661999|323185354|FG000|Overall Study|Alternative Treatment|1|||
94382623|NCT00661999|323185355|FG001|Overall Study|Alternative Treatment|0|||
94382624|NCT00661999|323185356|FG002|Overall Study|Alternative Treatment|0|||
94382625|NCT00661999|323185354|FG000|Overall Study|Other Medical Problems|4|||
94382626|NCT00661999|323185355|FG001|Overall Study|Other Medical Problems|4|||
94382627|NCT00661999|323185356|FG002|Overall Study|Other Medical Problems|9|||
94382628|NCT01691248|323185359|FG000|Overall Study|Protocol Violation|43|||
94382629|NCT01691248|323185360|FG001|Overall Study|Protocol Violation|27|||
94382630|NCT01691248|323185359|FG000|Overall Study|Adverse Event|24|||
94382631|NCT01691248|323185360|FG001|Overall Study|Adverse Event|22|||
94382632|NCT01691248|323185359|FG000|Overall Study|Withdrawal by Subject|20|||
94382633|NCT01691248|323185360|FG001|Overall Study|Withdrawal by Subject|18|||
94382634|NCT01691248|323185359|FG000|Overall Study|Confirmed CDAD|14|||
94382635|NCT01691248|323185360|FG001|Overall Study|Confirmed CDAD|31|||
94382636|NCT01691248|323185359|FG000|Overall Study|Lost to Follow-up|2|||
94382637|NCT01691248|323185360|FG001|Overall Study|Lost to Follow-up|5|||
94382638|NCT01691248|323185359|FG000|Overall Study|Reason not provided|4|||
94382639|NCT01691248|323185360|FG001|Overall Study|Reason not provided|4|||
94382640|NCT01691248|323185359|FG000|Overall Study|Not Treated|4|||
94382641|NCT01691248|323185360|FG001|Overall Study|Not Treated|7|||
94382642|NCT03329027|323187135|FG000|Overall Study|Lost to Follow-up|1|||
94382643|NCT03329027|323187136|FG001|Overall Study|Lost to Follow-up|0|||
94382644|NCT03329027|323187137|FG002|Overall Study|Lost to Follow-up|1|||
94382645|NCT03329027|323187135|FG000|Overall Study|Protocol Violation|9|||
94382646|NCT03329027|323187136|FG001|Overall Study|Protocol Violation|5|||
94382647|NCT03329027|323187137|FG002|Overall Study|Protocol Violation|7|||
94382648|NCT04849988|323187142|FG000|Overall Study|Lack of Efficacy|3|||
94382649|NCT04849988|323187143|FG001|Overall Study|Lack of Efficacy|4|||
94382650|NCT04849988|323187144|FG002|Overall Study|Lack of Efficacy|1|||
94382651|NCT04849988|323187145|FG003|Overall Study|Lack of Efficacy|4|||
94382652|NCT04849988|323187142|FG000|Overall Study|Other reasons|1|||
94382653|NCT04849988|323187143|FG001|Overall Study|Other reasons|2|||
94382654|NCT04849988|323187144|FG002|Overall Study|Other reasons|2|||
94382655|NCT04849988|323187145|FG003|Overall Study|Other reasons|1|||
94382656|NCT05431153|323187154|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94382657|NCT05431153|323187155|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94382658|NCT05431153|323187156|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94312312|NCT01597193|322926921|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
94312313|NCT01597193|322926915|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
94312314|NCT01597193|322926916|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
94312315|NCT01597193|322926917|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
94312316|NCT01597193|322926918|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
94312317|NCT01597193|322926919|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
94312318|NCT01597193|322926920|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
94312319|NCT01597193|322926921|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
94312320|NCT01597193|322926915|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
94312321|NCT01597193|322926916|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
94312322|NCT01597193|322926917|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
94312323|NCT01597193|322926918|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
94312324|NCT01597193|322926919|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
94312325|NCT01597193|322926920|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
94312326|NCT01597193|322926921|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
94312327|NCT01597193|322926915|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
94312328|NCT01597193|322926916|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
94312329|NCT01597193|322926917|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
94312330|NCT01597193|322926918|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
94312331|NCT01597193|322926919|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
94312332|NCT01597193|322926920|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
94312333|NCT01597193|322926921|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
94312334|NCT01597193|322926915|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
94312335|NCT01597193|322926916|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
94312336|NCT01597193|322926917|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
94312337|NCT01597193|322926918|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
94312338|NCT01597193|322926919|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
94312339|NCT01597193|322926920|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
94312340|NCT01597193|322926921|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
94312341|NCT02508701|322926922|FG000|Overall Study|Lost to Follow-up|9|||
94312342|NCT02508701|322926923|FG001|Overall Study|Lost to Follow-up|5|||
94312343|NCT02508701|322926924|FG002|Overall Study|Lost to Follow-up|5|||
94312344|NCT02508701|322926925|FG003|Overall Study|Lost to Follow-up|3|||
94312345|NCT03648996|322926928|FG000|Overall Study|Withdrawal by Subject|0|||
94312346|NCT03648996|322926929|FG001|Overall Study|Withdrawal by Subject|2|||
94312347|NCT03648996|322926930|FG002|Overall Study|Withdrawal by Subject|2|||
94312348|NCT03648996|322926928|FG000|Overall Study|Physician Decision|2|||
94312349|NCT03648996|322926929|FG001|Overall Study|Physician Decision|0|||
94312350|NCT03648996|322926930|FG002|Overall Study|Physician Decision|0|||
94312351|NCT01259297|322926937|FG000|Double Blind Randomized Period|Death|1|||
94312352|NCT01259297|322926938|FG001|Double Blind Randomized Period|Death|1|||
94312353|NCT01259297|322926939|FG002|Double Blind Randomized Period|Death|1|||
94312354|NCT01259297|322926940|FG003|Double Blind Randomized Period|Death|2|||
94312355|NCT01259297|322926941|FG004|Double Blind Randomized Period|Death|1|||
94312356|NCT01259297|322926942|FG005|Double Blind Randomized Period|Death|5|||
94312357|NCT01259297|322926943|FG006|Double Blind Randomized Period|Death|2|||
94312358|NCT01259297|322926944|FG007|Double Blind Randomized Period|Death|1|||
94312359|NCT01259297|322926937|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
94312360|NCT01259297|322926938|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
94312361|NCT01259297|322926939|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
94312362|NCT01259297|322926940|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
94312363|NCT01259297|322926941|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
94312364|NCT01259297|322926942|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
94312365|NCT01259297|322926943|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
94312366|NCT01259297|322926944|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
94312367|NCT01259297|322926937|FG000|Double Blind Randomized Period|Other reasons|0|||
94312368|NCT01259297|322926938|FG001|Double Blind Randomized Period|Other reasons|1|||
94312369|NCT01259297|322926939|FG002|Double Blind Randomized Period|Other reasons|0|||
94312370|NCT01259297|322926940|FG003|Double Blind Randomized Period|Other reasons|0|||
94312371|NCT01259297|322926941|FG004|Double Blind Randomized Period|Other reasons|1|||
94312372|NCT01259297|322926942|FG005|Double Blind Randomized Period|Other reasons|2|||
94312373|NCT01259297|322926943|FG006|Double Blind Randomized Period|Other reasons|3|||
94312374|NCT01259297|322926944|FG007|Double Blind Randomized Period|Other reasons|1|||
94312375|NCT03894904|322926945|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
94312376|NCT03894904|322926946|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
94382659|NCT05431153|323187157|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94382660|NCT05431153|323187158|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
94382661|NCT05431153|323187159|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
94312377|NCT03894904|322926945|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
94312378|NCT03894904|322926946|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
94312379|NCT03242759|322926947|FG000|Overall Study|Adverse Event|5|||
94312380|NCT03242759|322926948|FG001|Overall Study|Adverse Event|1|||
94312381|NCT03242759|322926947|FG000|Overall Study|Withdrawal by Subject|4|||
94312382|NCT03242759|322926948|FG001|Overall Study|Withdrawal by Subject|3|||
94312383|NCT03242759|322926947|FG000|Overall Study|Lost to Follow-up|3|||
94312384|NCT03242759|322926948|FG001|Overall Study|Lost to Follow-up|1|||
94312385|NCT03242759|322926947|FG000|Overall Study|Administrative problems|1|||
94312386|NCT03242759|322926948|FG001|Overall Study|Administrative problems|1|||
94312387|NCT03242759|322926947|FG000|Overall Study|Death|22|||
94312388|NCT03242759|322926948|FG001|Overall Study|Death|0|||
94312389|NCT03242759|322926947|FG000|Overall Study|Change visit schedule|0|||
94312390|NCT03242759|322926948|FG001|Overall Study|Change visit schedule|1|||
94312391|NCT00504166|322926951|FG000|Overall Study|Adverse Event|1|||
94312392|NCT00504166|322926952|FG001|Overall Study|Adverse Event|4|||
94312393|NCT00504166|322926951|FG000|Overall Study|Withdrawal by Subject|3|||
94312394|NCT00504166|322926952|FG001|Overall Study|Withdrawal by Subject|6|||
94312395|NCT00504166|322926951|FG000|Overall Study|Physician Decision|1|||
94312396|NCT00504166|322926952|FG001|Overall Study|Physician Decision|1|||
94312397|NCT00504166|322926951|FG000|Overall Study|Lost to Follow-up|1|||
94312398|NCT00504166|322926952|FG001|Overall Study|Lost to Follow-up|3|||
94312399|NCT00651118|322926953|FG000|Overall Study|Adverse Event|4|||
94312400|NCT00651118|322926954|FG001|Overall Study|Adverse Event|0|||
94312401|NCT00651118|322926955|FG002|Overall Study|Adverse Event|1|||
94312402|NCT00651118|322926956|FG003|Overall Study|Adverse Event|1|||
94312403|NCT00651118|322926953|FG000|Overall Study|Protocol Violation|2|||
94312404|NCT00651118|322926954|FG001|Overall Study|Protocol Violation|2|||
94312405|NCT00651118|322926955|FG002|Overall Study|Protocol Violation|6|||
94312406|NCT00651118|322926956|FG003|Overall Study|Protocol Violation|2|||
94312407|NCT00651118|322926953|FG000|Overall Study|Lost to Follow-up|2|||
94312408|NCT00651118|322926954|FG001|Overall Study|Lost to Follow-up|0|||
94312409|NCT00651118|322926955|FG002|Overall Study|Lost to Follow-up|1|||
94312410|NCT00651118|322926956|FG003|Overall Study|Lost to Follow-up|2|||
94312411|NCT00651118|322926953|FG000|Overall Study|administrative|1|||
94312412|NCT00651118|322926954|FG001|Overall Study|administrative|4|||
94312413|NCT00651118|322926955|FG002|Overall Study|administrative|2|||
94312414|NCT00651118|322926956|FG003|Overall Study|administrative|1|||
94312415|NCT00651118|322926953|FG000|Overall Study|Withdrawal by Subject|0|||
94312416|NCT00651118|322926954|FG001|Overall Study|Withdrawal by Subject|1|||
94312417|NCT00651118|322926955|FG002|Overall Study|Withdrawal by Subject|1|||
94312418|NCT00651118|322926956|FG003|Overall Study|Withdrawal by Subject|1|||
94312419|NCT03117049|322926957|FG000|Overall Study|Continued the follow-up period|109|||
94312420|NCT03117049|322926958|FG001|Overall Study|Continued the follow-up period|129|||
94312421|NCT03117049|322926957|FG000|Overall Study|Died|82|||
94312422|NCT03117049|322926958|FG001|Overall Study|Died|93|||
94312423|NCT03117049|322926957|FG000|Overall Study|Consent withdrawal|7|||
94312424|NCT03117049|322926958|FG001|Overall Study|Consent withdrawal|6|||
94312425|NCT03117049|322926957|FG000|Overall Study|Missing contact|3|||
94312426|NCT03117049|322926958|FG001|Overall Study|Missing contact|3|||
94312427|NCT02229864|322926959|FG000|Overall Study|Death|2|||
94312428|NCT02229864|322926959|FG000|Overall Study|Lost to Follow-up|1|||
94312429|NCT01929044|322926962|FG000|Overall Study|Adverse Event|1|||
94312430|NCT01929044|322926963|FG001|Overall Study|Adverse Event|0|||
94312431|NCT01929044|322926962|FG000|Overall Study|Protocol Violation|9|||
94312432|NCT01929044|322926963|FG001|Overall Study|Protocol Violation|14|||
94312433|NCT01929044|322926962|FG000|Overall Study|Not Treated|1|||
94312434|NCT01929044|322926963|FG001|Overall Study|Not Treated|3|||
94312435|NCT02518620|322926964|FG000|Overall Study|Adverse Event|23|||
94312436|NCT02518620|322926965|FG001|Overall Study|Adverse Event|11|||
94312437|NCT02518620|322926964|FG000|Overall Study|Lack of Efficacy|2|||
94312438|NCT02518620|322926965|FG001|Overall Study|Lack of Efficacy|0|||
94312439|NCT02518620|322926964|FG000|Overall Study|Non-Compliance with Study Drug|1|||
94312440|NCT02518620|322926965|FG001|Overall Study|Non-Compliance with Study Drug|0|||
94312441|NCT02518620|322926964|FG000|Overall Study|Physician Decision|1|||
94312442|NCT02518620|322926965|FG001|Overall Study|Physician Decision|1|||
94312443|NCT02518620|322926964|FG000|Overall Study|Sponsor's Decision|0|||
94312444|NCT02518620|322926965|FG001|Overall Study|Sponsor's Decision|3|||
94312445|NCT02518620|322926964|FG000|Overall Study|Lost to Follow-up|1|||
94312446|NCT02518620|322926965|FG001|Overall Study|Lost to Follow-up|1|||
94312447|NCT02518620|322926964|FG000|Overall Study|Withdrawal by Subject|17|||
94312448|NCT02518620|322926965|FG001|Overall Study|Withdrawal by Subject|9|||
94312449|NCT02518620|322926964|FG000|Overall Study|Death|1|||
94312450|NCT02518620|322926965|FG001|Overall Study|Death|0|||
94312451|NCT02518620|322926964|FG000|Overall Study|Pregnancy Wish|3|||
94312452|NCT02518620|322926965|FG001|Overall Study|Pregnancy Wish|0|||
94312453|NCT02518620|322926964|FG000|Overall Study|Pregnancy|1|||
94312454|NCT02518620|322926965|FG001|Overall Study|Pregnancy|0|||
94312455|NCT02518620|322926964|FG000|Overall Study|Relocation|2|||
94473416|NCT02070978|323523427|FG002|Overall Study|Terminated by Sponsor|39|||
94473417|NCT00171158|323524761|FG000|Core Study|Death|27|||
94473418|NCT00171158|323524761|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
94473419|NCT00171158|323524761|FG000|Core Study|Protocol Violation|4|||
94473420|NCT00171158|323524761|FG000|Core Study|Administrative problems|1|||
94473421|NCT00171158|323524761|FG000|Core Study|Adverse event, non-fatal|21|||
94473422|NCT00171158|323524761|FG000|Core Study|Consent withdrawn by subject|6|||
94473423|NCT00171158|323524761|FG000|Core Study|No longer required drug (BMT)|14|||
94473424|NCT00171158|323524761|FG000|Core Study|Abnormal Laboratory Values|2|||
94473425|NCT00171158|323524761|FG000|Core Study|Lost to Follow-up|1|||
94473426|NCT00171158|323524761|FG000|E2 Extension|Other|7|||
94473427|NCT03214679|323524762|FG000|Overall Study|Lost to Follow-up|12|||
94473428|NCT03214679|323524763|FG001|Overall Study|Lost to Follow-up|14|||
94473429|NCT03214679|323524762|FG000|Overall Study|not eligible|2|||
94473430|NCT03214679|323524763|FG001|Overall Study|not eligible|0|||
94473431|NCT03539484|323524770|FG000|Overall Study|Death|1|||
94473432|NCT03539484|323524771|FG001|Overall Study|Death|0|||
94473433|NCT03539484|323524772|FG002|Overall Study|Death|0|||
94473434|NCT03539484|323524773|FG003|Overall Study|Death|2|||
94473435|NCT03539484|323524774|FG004|Overall Study|Death|8|||
94473436|NCT03539484|323524775|FG005|Overall Study|Death|3|||
94473437|NCT03539484|323524776|FG006|Overall Study|Death|0|||
94473438|NCT03539484|323524770|FG000|Overall Study|Lost to Follow-up|0|||
94473439|NCT03539484|323524771|FG001|Overall Study|Lost to Follow-up|1|||
94473440|NCT03539484|323524772|FG002|Overall Study|Lost to Follow-up|0|||
94473441|NCT03539484|323524773|FG003|Overall Study|Lost to Follow-up|0|||
94473442|NCT03539484|323524774|FG004|Overall Study|Lost to Follow-up|1|||
94473443|NCT03539484|323524775|FG005|Overall Study|Lost to Follow-up|0|||
94473444|NCT03539484|323524776|FG006|Overall Study|Lost to Follow-up|0|||
94473445|NCT03539484|323524770|FG000|Overall Study|Withdrawal by Subject|0|||
94473446|NCT03539484|323524771|FG001|Overall Study|Withdrawal by Subject|0|||
94473447|NCT03539484|323524772|FG002|Overall Study|Withdrawal by Subject|0|||
94473448|NCT03539484|323524773|FG003|Overall Study|Withdrawal by Subject|0|||
94473449|NCT03539484|323524774|FG004|Overall Study|Withdrawal by Subject|2|||
94473450|NCT03539484|323524775|FG005|Overall Study|Withdrawal by Subject|0|||
94473451|NCT03539484|323524776|FG006|Overall Study|Withdrawal by Subject|1|||
94473452|NCT03539484|323524770|FG000|Overall Study|Study Terminated by Sponsor|0|||
94473453|NCT03539484|323524771|FG001|Overall Study|Study Terminated by Sponsor|0|||
94473454|NCT03539484|323524772|FG002|Overall Study|Study Terminated by Sponsor|1|||
94473455|NCT03539484|323524773|FG003|Overall Study|Study Terminated by Sponsor|1|||
94473456|NCT03539484|323524774|FG004|Overall Study|Study Terminated by Sponsor|2|||
94473457|NCT03539484|323524775|FG005|Overall Study|Study Terminated by Sponsor|2|||
94473458|NCT03539484|323524776|FG006|Overall Study|Study Terminated by Sponsor|1|||
94473459|NCT04472494|323524777|FG000|Pre-treatment|Other reasons|2|||
94473460|NCT04472494|323524778|FG001|Pre-treatment|Other reasons|0|||
94473461|NCT04472494|323524777|FG000|Treatment|Death|5|||
94473462|NCT04472494|323524778|FG001|Treatment|Death|2|||
94473463|NCT04472494|323524777|FG000|Treatment|Hospital discharge|1|||
94473464|NCT04472494|323524778|FG001|Treatment|Hospital discharge|1|||
94473465|NCT01972464|323524779|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
94473466|NCT01972464|323524780|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
94473467|NCT01972464|323524779|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
94473468|NCT01972464|323524780|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
94473469|NCT01972464|323524779|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
94473470|NCT01972464|323524780|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
94473471|NCT01972464|323524779|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
94473472|NCT01972464|323524780|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
94473473|NCT02734862|323524783|FG000|Part A|Death|3|||
94473474|NCT02734862|323524784|FG001|Part A|Death|4|||
94473475|NCT02734862|323524785|FG002|Part A|Death|6|||
94473476|NCT02734862|323524783|FG000|Part A|Lost to Follow-up|2|||
94473477|NCT02734862|323524784|FG001|Part A|Lost to Follow-up|1|||
94473478|NCT02734862|323524785|FG002|Part A|Lost to Follow-up|1|||
94473479|NCT02734862|323524783|FG000|Part A|Withdrawal by Subject|1|||
94473480|NCT02734862|323524784|FG001|Part A|Withdrawal by Subject|1|||
94473481|NCT02734862|323524785|FG002|Part A|Withdrawal by Subject|2|||
94473482|NCT02734862|323524783|FG000|Part A|Physician Decision|2|||
94473483|NCT02734862|323524784|FG001|Part A|Physician Decision|0|||
94473484|NCT02734862|323524785|FG002|Part A|Physician Decision|1|||
94473485|NCT02734862|323524783|FG000|Part A|Adverse Event|2|||
94473486|NCT02734862|323524784|FG001|Part A|Adverse Event|0|||
94473487|NCT02734862|323524785|FG002|Part A|Adverse Event|1|||
94473488|NCT02734862|323524783|FG000|Part A|Noncompliance|1|||
94473489|NCT02734862|323524784|FG001|Part A|Noncompliance|1|||
94473490|NCT02734862|323524785|FG002|Part A|Noncompliance|0|||
94473491|NCT02734862|323524783|FG000|Part A|Other|1|||
94473492|NCT02734862|323524784|FG001|Part A|Other|1|||
94473493|NCT02734862|323524785|FG002|Part A|Other|3|||
94473494|NCT02734862|323524783|FG000|Part B|Death|8|||
94473495|NCT02734862|323524784|FG001|Part B|Death|3|||
94473496|NCT02734862|323524785|FG002|Part B|Death|5|||
94473497|NCT02734862|323524783|FG000|Part B|Lost to Follow-up|2|||
94473498|NCT02734862|323524784|FG001|Part B|Lost to Follow-up|2|||
94473499|NCT02734862|323524785|FG002|Part B|Lost to Follow-up|0|||
94473500|NCT02734862|323524783|FG000|Part B|Withdrawal by Subject|3|||
94473501|NCT02734862|323524784|FG001|Part B|Withdrawal by Subject|1|||
94473502|NCT02734862|323524785|FG002|Part B|Withdrawal by Subject|0|||
94473503|NCT02734862|323524783|FG000|Part B|Other|0|||
94473504|NCT02734862|323524784|FG001|Part B|Other|1|||
94473505|NCT02734862|323524785|FG002|Part B|Other|0|||
94473506|NCT04854057|323524786|FG000|Overall Study|Adverse Event|0|||
94473507|NCT04854057|323524787|FG001|Overall Study|Adverse Event|1|||
94473508|NCT01909973|323524792|FG000|Overall Study|Lost to Follow-up|1|||
94473509|NCT01909973|323524793|FG001|Overall Study|Lost to Follow-up|0|||
94473510|NCT00760487|323524815|FG000|Overall Study|Unilateral implantation|3|||
94473511|NCT04278924|323524820|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
94473512|NCT04278924|323524821|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
94473513|NCT04278924|323524822|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
94473514|NCT04278924|323524823|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
94473515|NCT04278924|323524824|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
94473516|NCT04278924|323524825|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
94473517|NCT04278924|323524826|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
94473518|NCT04278924|323524820|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
94473519|NCT04278924|323524821|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
94473520|NCT04278924|323524822|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
94473521|NCT04278924|323524823|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
94473522|NCT04278924|323524824|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
94473523|NCT04278924|323524825|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
94473524|NCT04278924|323524826|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
94473525|NCT06010732|323524827|FG000|Crossover Period 1|Protocol Violation|0|||
94473526|NCT06010732|323524828|FG001|Crossover Period 1|Protocol Violation|0|||
94473527|NCT06010732|323524829|FG002|Crossover Period 1|Protocol Violation|1|||
94473528|NCT06010732|323524830|FG003|Crossover Period 1|Protocol Violation|0|||
94473529|NCT06010732|323524831|FG004|Crossover Period 1|Protocol Violation|1|||
94473530|NCT06010732|323524832|FG005|Crossover Period 1|Protocol Violation|0|||
94473531|NCT06010732|323524827|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
94473532|NCT06010732|323524828|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
94473533|NCT06010732|323524829|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
94473534|NCT06010732|323524830|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
94473535|NCT06010732|323524831|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
94473536|NCT06010732|323524832|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
94473537|NCT06010732|323524827|FG000|Crossover Period 2|Adverse Event|0|||
94473538|NCT06010732|323524828|FG001|Crossover Period 2|Adverse Event|1|||
94473539|NCT06010732|323524829|FG002|Crossover Period 2|Adverse Event|0|||
94473540|NCT06010732|323524830|FG003|Crossover Period 2|Adverse Event|0|||
94473541|NCT06010732|323524831|FG004|Crossover Period 2|Adverse Event|0|||
94473542|NCT06010732|323524832|FG005|Crossover Period 2|Adverse Event|0|||
94473543|NCT06010732|323524827|FG000|Crossover Period 2|broken denture|0|||
94473544|NCT06010732|323524828|FG001|Crossover Period 2|broken denture|0|||
94473545|NCT06010732|323524829|FG002|Crossover Period 2|broken denture|1|||
94473546|NCT06010732|323524830|FG003|Crossover Period 2|broken denture|0|||
94473547|NCT06010732|323524831|FG004|Crossover Period 2|broken denture|0|||
94473548|NCT06010732|323524832|FG005|Crossover Period 2|broken denture|0|||
94473549|NCT02081001|323524834|FG000|Overall Study|Adverse Event|0|||
94473550|NCT02081001|323524835|FG001|Overall Study|Adverse Event|0|||
94473551|NCT02081001|323524836|FG002|Overall Study|Adverse Event|0|||
94473552|NCT02081001|323524837|FG003|Overall Study|Adverse Event|0|||
94473553|NCT02081001|323524838|FG004|Overall Study|Adverse Event|1|||
94473554|NCT02081001|323524839|FG005|Overall Study|Adverse Event|0|||
94473555|NCT02081001|323524840|FG006|Overall Study|Adverse Event|0|||
94473556|NCT02081001|323524841|FG007|Overall Study|Adverse Event|0|||
94473557|NCT02081001|323524842|FG008|Overall Study|Adverse Event|0|||
94473558|NCT02081001|323524843|FG009|Overall Study|Adverse Event|0|||
94473559|NCT02081001|323524844|FG010|Overall Study|Adverse Event|0|||
94473560|NCT02081001|323524845|FG011|Overall Study|Adverse Event|0|||
94473561|NCT04865419|323524846|FG000|Overall Study|Other|1|||
94473562|NCT04865419|323524847|FG001|Overall Study|Other|2|||
94473563|NCT04865419|323524848|FG002|Overall Study|Other|2|||
94473564|NCT04865419|323524849|FG003|Overall Study|Other|1|||
94473565|NCT04865419|323524850|FG004|Overall Study|Other|3|||
94473566|NCT04865419|323524851|FG005|Overall Study|Other|0|||
94473567|NCT04865419|323524852|FG006|Overall Study|Other|0|||
94473568|NCT04865419|323524853|FG007|Overall Study|Other|1|||
94473569|NCT04865419|323524854|FG008|Overall Study|Other|0|||
94473570|NCT04865419|323524855|FG009|Overall Study|Other|0|||
94473571|NCT04865419|323524856|FG010|Overall Study|Other|0|||
94473572|NCT04865419|323524846|FG000|Overall Study|Withdrawal by Subject|0|||
94473573|NCT04865419|323524847|FG001|Overall Study|Withdrawal by Subject|1|||
94473574|NCT04865419|323524848|FG002|Overall Study|Withdrawal by Subject|1|||
94473575|NCT04865419|323524849|FG003|Overall Study|Withdrawal by Subject|0|||
94473576|NCT04865419|323524850|FG004|Overall Study|Withdrawal by Subject|0|||
94473577|NCT04865419|323524851|FG005|Overall Study|Withdrawal by Subject|0|||
94473578|NCT04865419|323524852|FG006|Overall Study|Withdrawal by Subject|0|||
94473579|NCT04865419|323524853|FG007|Overall Study|Withdrawal by Subject|1|||
94473580|NCT04865419|323524854|FG008|Overall Study|Withdrawal by Subject|2|||
94473581|NCT04865419|323524855|FG009|Overall Study|Withdrawal by Subject|1|||
94473582|NCT04865419|323524856|FG010|Overall Study|Withdrawal by Subject|0|||
94473583|NCT04865419|323524846|FG000|Overall Study|Study terminated by Sponsor|0|||
94473584|NCT04865419|323524847|FG001|Overall Study|Study terminated by Sponsor|0|||
94473585|NCT04865419|323524848|FG002|Overall Study|Study terminated by Sponsor|0|||
94473586|NCT04865419|323524849|FG003|Overall Study|Study terminated by Sponsor|2|||
94473587|NCT04865419|323524850|FG004|Overall Study|Study terminated by Sponsor|2|||
94473588|NCT04865419|323524851|FG005|Overall Study|Study terminated by Sponsor|0|||
94473589|NCT04865419|323524852|FG006|Overall Study|Study terminated by Sponsor|0|||
94473590|NCT04865419|323524853|FG007|Overall Study|Study terminated by Sponsor|0|||
94473591|NCT04865419|323524854|FG008|Overall Study|Study terminated by Sponsor|0|||
94473592|NCT04865419|323524855|FG009|Overall Study|Study terminated by Sponsor|0|||
94473593|NCT04865419|323524856|FG010|Overall Study|Study terminated by Sponsor|1|||
94473594|NCT04865419|323524846|FG000|Overall Study|Death|3|||
94473595|NCT04865419|323524847|FG001|Overall Study|Death|1|||
94473596|NCT04865419|323524848|FG002|Overall Study|Death|4|||
94473597|NCT04865419|323524849|FG003|Overall Study|Death|2|||
94473598|NCT04865419|323524850|FG004|Overall Study|Death|5|||
94473599|NCT04865419|323524851|FG005|Overall Study|Death|2|||
94473600|NCT04865419|323524852|FG006|Overall Study|Death|1|||
94473601|NCT04865419|323524853|FG007|Overall Study|Death|1|||
94473602|NCT04865419|323524854|FG008|Overall Study|Death|2|||
94473603|NCT04865419|323524855|FG009|Overall Study|Death|2|||
94473604|NCT04865419|323524856|FG010|Overall Study|Death|1|||
94473605|NCT04865419|323524846|FG000|Overall Study|Lost to Follow-up|0|||
94473606|NCT04865419|323524847|FG001|Overall Study|Lost to Follow-up|0|||
94473607|NCT04865419|323524848|FG002|Overall Study|Lost to Follow-up|0|||
94473608|NCT04865419|323524849|FG003|Overall Study|Lost to Follow-up|0|||
94473609|NCT04865419|323524850|FG004|Overall Study|Lost to Follow-up|0|||
94473610|NCT04865419|323524851|FG005|Overall Study|Lost to Follow-up|0|||
94473611|NCT04865419|323524852|FG006|Overall Study|Lost to Follow-up|0|||
94473612|NCT04865419|323524853|FG007|Overall Study|Lost to Follow-up|0|||
94473613|NCT04865419|323524854|FG008|Overall Study|Lost to Follow-up|0|||
94473614|NCT04865419|323524855|FG009|Overall Study|Lost to Follow-up|1|||
94473615|NCT04865419|323524856|FG010|Overall Study|Lost to Follow-up|0|||
94473616|NCT01348100|323524861|FG000|Overall Study|Subject Withdrew Consent|0|||
94473617|NCT01348100|323524862|FG001|Overall Study|Subject Withdrew Consent|0|||
94473618|NCT01348100|323524863|FG002|Overall Study|Subject Withdrew Consent|2|||
94473619|NCT01348100|323524864|FG003|Overall Study|Subject Withdrew Consent|0|||
94473620|NCT01348100|323524865|FG004|Overall Study|Subject Withdrew Consent|1|||
94473621|NCT01348100|323524866|FG005|Overall Study|Subject Withdrew Consent|0|||
94473622|NCT01348100|323524867|FG006|Overall Study|Subject Withdrew Consent|1|||
94473623|NCT01348100|323524861|FG000|Overall Study|Protocol Deviation|0|||
94473624|NCT01348100|323524862|FG001|Overall Study|Protocol Deviation|0|||
94473625|NCT01348100|323524863|FG002|Overall Study|Protocol Deviation|0|||
94473626|NCT01348100|323524864|FG003|Overall Study|Protocol Deviation|1|||
94473627|NCT01348100|323524865|FG004|Overall Study|Protocol Deviation|0|||
94473628|NCT01348100|323524866|FG005|Overall Study|Protocol Deviation|0|||
94473629|NCT01348100|323524867|FG006|Overall Study|Protocol Deviation|0|||
94473630|NCT01348100|323524861|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
94473631|NCT01348100|323524862|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
94473632|NCT01348100|323524863|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
94473633|NCT01348100|323524864|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
94473634|NCT01348100|323524865|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
94473635|NCT01348100|323524866|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
94473636|NCT01348100|323524867|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
94473637|NCT01348100|323524861|FG000|Overall Study|Lost to Follow-up|0|||
94473638|NCT01348100|323524862|FG001|Overall Study|Lost to Follow-up|0|||
94473639|NCT01348100|323524863|FG002|Overall Study|Lost to Follow-up|0|||
94473640|NCT01348100|323524864|FG003|Overall Study|Lost to Follow-up|0|||
94473641|NCT01348100|323524865|FG004|Overall Study|Lost to Follow-up|0|||
94473642|NCT01348100|323524866|FG005|Overall Study|Lost to Follow-up|0|||
94473643|NCT01348100|323524867|FG006|Overall Study|Lost to Follow-up|1|||
94473644|NCT01348100|323524861|FG000|Overall Study|Administrative Problems|0|||
94473645|NCT01348100|323524862|FG001|Overall Study|Administrative Problems|0|||
94473646|NCT01348100|323524863|FG002|Overall Study|Administrative Problems|0|||
94473647|NCT01348100|323524864|FG003|Overall Study|Administrative Problems|0|||
94473648|NCT01348100|323524865|FG004|Overall Study|Administrative Problems|0|||
94473649|NCT01348100|323524866|FG005|Overall Study|Administrative Problems|1|||
94473650|NCT01348100|323524867|FG006|Overall Study|Administrative Problems|1|||
94312456|NCT02518620|322926965|FG001|Overall Study|Relocation|1|||
94312457|NCT01518192|322926966|FG000|Overall Study|Lost to Follow-up|29|||
94312458|NCT01518192|322926967|FG001|Overall Study|Lost to Follow-up|26|||
94312459|NCT01518192|322926968|FG002|Overall Study|Lost to Follow-up|35|||
94312460|NCT00309777|322926978|FG000|Overall Study|Adverse Event|13|||
94312461|NCT00309777|322926979|FG001|Overall Study|Adverse Event|2|||
94312462|NCT00309777|322926980|FG002|Overall Study|Adverse Event|8|||
94312463|NCT00309777|322926981|FG003|Overall Study|Adverse Event|1|||
94312464|NCT00309777|322926978|FG000|Overall Study|Protocol Violation|4|||
94312465|NCT00309777|322926979|FG001|Overall Study|Protocol Violation|1|||
94312466|NCT00309777|322926980|FG002|Overall Study|Protocol Violation|3|||
94312467|NCT00309777|322926981|FG003|Overall Study|Protocol Violation|1|||
94312468|NCT00309777|322926978|FG000|Overall Study|Withdrawal by Subject|6|||
94312469|NCT00309777|322926979|FG001|Overall Study|Withdrawal by Subject|5|||
94312470|NCT00309777|322926980|FG002|Overall Study|Withdrawal by Subject|7|||
94312471|NCT00309777|322926981|FG003|Overall Study|Withdrawal by Subject|2|||
94312472|NCT00309777|322926978|FG000|Overall Study|Lost to Follow-up|0|||
94312473|NCT00309777|322926979|FG001|Overall Study|Lost to Follow-up|0|||
94312474|NCT00309777|322926980|FG002|Overall Study|Lost to Follow-up|1|||
94312475|NCT00309777|322926981|FG003|Overall Study|Lost to Follow-up|0|||
94312476|NCT00309777|322926978|FG000|Overall Study|Death|0|||
94312477|NCT00309777|322926979|FG001|Overall Study|Death|1|||
94312478|NCT00309777|322926980|FG002|Overall Study|Death|0|||
94312479|NCT00309777|322926981|FG003|Overall Study|Death|0|||
94312480|NCT05270694|322928225|FG000|Overall Study|Death|1|||
94312481|NCT05270694|322928225|FG000|Overall Study|Medical issues impacted ability to participate|2|||
94312482|NCT05270694|322928225|FG000|Overall Study|Lost to Follow-up|3|||
94312483|NCT05270694|322928225|FG000|Overall Study|Withdrawal by Subject|3|||
94312484|NCT01991977|322928228|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
94312485|NCT01991977|322928228|FG000|Overall Study|Withdrew after start of treatment|5|||
94312486|NCT01937130|322928231|FG000|Overall Study|Withdrawal by Subject|0|||
94312487|NCT01937130|322928232|FG001|Overall Study|Withdrawal by Subject|0|||
94312488|NCT01937130|322928233|FG002|Overall Study|Withdrawal by Subject|0|||
94312489|NCT01937130|322928234|FG003|Overall Study|Withdrawal by Subject|1|||
94312490|NCT01937130|322928231|FG000|Overall Study|Adverse Event|0|||
94312491|NCT01937130|322928232|FG001|Overall Study|Adverse Event|1|||
94312492|NCT01937130|322928233|FG002|Overall Study|Adverse Event|0|||
94312493|NCT01937130|322928234|FG003|Overall Study|Adverse Event|1|||
94312494|NCT01937130|322928231|FG000|Overall Study|Death|1|||
94312495|NCT01937130|322928232|FG001|Overall Study|Death|1|||
94312496|NCT01937130|322928233|FG002|Overall Study|Death|1|||
94312497|NCT01937130|322928234|FG003|Overall Study|Death|0|||
94312498|NCT01937130|322928231|FG000|Overall Study|Lost to Follow-up|2|||
94312499|NCT01937130|322928232|FG001|Overall Study|Lost to Follow-up|0|||
94312500|NCT01937130|322928233|FG002|Overall Study|Lost to Follow-up|2|||
94312501|NCT01937130|322928234|FG003|Overall Study|Lost to Follow-up|0|||
94312502|NCT01937130|322928231|FG000|Overall Study|Physician Decision|0|||
94312503|NCT01937130|322928232|FG001|Overall Study|Physician Decision|1|||
94312504|NCT01937130|322928233|FG002|Overall Study|Physician Decision|0|||
94312505|NCT01937130|322928234|FG003|Overall Study|Physician Decision|0|||
94312506|NCT01937130|322928231|FG000|Overall Study|Patients unable to swallow|0|||
94312507|NCT01937130|322928232|FG001|Overall Study|Patients unable to swallow|1|||
94312508|NCT01937130|322928233|FG002|Overall Study|Patients unable to swallow|0|||
94312509|NCT01937130|322928234|FG003|Overall Study|Patients unable to swallow|0|||
94312510|NCT01937130|322928231|FG000|Overall Study|Patient lost to FU due to death|2|||
94312511|NCT01937130|322928232|FG001|Overall Study|Patient lost to FU due to death|0|||
94312512|NCT01937130|322928233|FG002|Overall Study|Patient lost to FU due to death|0|||
94312513|NCT01937130|322928234|FG003|Overall Study|Patient lost to FU due to death|0|||
94312514|NCT01096446|322928235|FG000|Overall Study|Death|1|||
94312515|NCT01096446|322928236|FG001|Overall Study|Death|0|||
94312516|NCT01096446|322928235|FG000|Overall Study|Protocol Violation|2|||
94312517|NCT01096446|322928236|FG001|Overall Study|Protocol Violation|0|||
94312518|NCT01240811|322928243|FG000|Overall Study|Physician Decision|0|||
94312519|NCT01240811|322928244|FG001|Overall Study|Physician Decision|1|||
94312520|NCT01240811|322928245|FG002|Overall Study|Physician Decision|0|||
94312521|NCT01240811|322928243|FG000|Overall Study|Withdrawal by Subject|0|||
94312522|NCT01240811|322928244|FG001|Overall Study|Withdrawal by Subject|0|||
94312523|NCT01240811|322928245|FG002|Overall Study|Withdrawal by Subject|1|||
94312524|NCT00710034|322928253|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
94312525|NCT00710034|322928254|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
94312526|NCT00710034|322928253|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
94312527|NCT00710034|322928254|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
94312528|NCT00710034|322928253|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
94312529|NCT00710034|322928254|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
94312530|NCT00710034|322928253|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
94312531|NCT00710034|322928254|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
94312532|NCT00710034|322928253|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
94312533|NCT00710034|322928254|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
94473651|NCT00849290|323524868|FG000|Overall Study|Adverse Event|3|||
94473652|NCT00849290|323524868|FG000|Overall Study|Death|14|||
94473653|NCT00849290|323524868|FG000|Overall Study|Withdrawal by Subject|11|||
94473654|NCT00849290|323524868|FG000|Overall Study|Lost to Follow-up|2|||
94473655|NCT00849290|323524868|FG000|Overall Study|Protocol Violation|5|||
94473656|NCT00849290|323524868|FG000|Overall Study|Disease Progression|20|||
94473657|NCT02347072|323524869|FG000|Overall Study|Adverse Event|2|||
94473658|NCT02347072|323524869|FG000|Overall Study|Withdrawal by Subject|6|||
94473659|NCT02347072|323524869|FG000|Overall Study|Physician Decision|1|||
94473660|NCT02347072|323524869|FG000|Overall Study|Lost to Follow-up|2|||
94473661|NCT02347072|323524869|FG000|Overall Study|Protocol Violation|1|||
94473662|NCT02347072|323524869|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
94473663|NCT01808222|323524872|FG000|Overall Study|mpMR scan was not performed|1|||
94473664|NCT01216332|323524883|FG000|Overall Study|Withdrawal by Subject|4|||
94473665|NCT01216332|323524884|FG001|Overall Study|Withdrawal by Subject|0|||
94473666|NCT02655016|323524885|FG000|Overall Study|Disease progression|6|||
94473667|NCT02655016|323524886|FG001|Overall Study|Disease progression|4|||
94473668|NCT02655016|323524885|FG000|Overall Study|Site closed|0|||
94473669|NCT02655016|323524886|FG001|Overall Study|Site closed|1|||
94473670|NCT02655016|323524885|FG000|Overall Study|Death|30|||
94473671|NCT02655016|323524886|FG001|Overall Study|Death|48|||
94473672|NCT02655016|323524885|FG000|Overall Study|Lost to Follow-up|1|||
94473673|NCT02655016|323524886|FG001|Overall Study|Lost to Follow-up|1|||
94473674|NCT02655016|323524885|FG000|Overall Study|Withdrawal by Subject|18|||
94473675|NCT02655016|323524886|FG001|Overall Study|Withdrawal by Subject|36|||
94473676|NCT01124292|323524887|FG000|Overall Study|Lost to Follow-up|2|||
94473677|NCT01124292|323524888|FG001|Overall Study|Lost to Follow-up|4|||
94473678|NCT01124292|323524889|FG002|Overall Study|Lost to Follow-up|3|||
94473679|NCT01124292|323524887|FG000|Overall Study|Physician Decision|0|||
94473680|NCT01124292|323524888|FG001|Overall Study|Physician Decision|3|||
94473681|NCT01124292|323524889|FG002|Overall Study|Physician Decision|2|||
94473682|NCT01124292|323524887|FG000|Overall Study|Withdrawal by Subject|0|||
94473683|NCT01124292|323524888|FG001|Overall Study|Withdrawal by Subject|6|||
94473684|NCT01124292|323524889|FG002|Overall Study|Withdrawal by Subject|2|||
94473685|NCT01124292|323524887|FG000|Overall Study|medical issue unrelated to the study|0|||
94473686|NCT01124292|323524888|FG001|Overall Study|medical issue unrelated to the study|0|||
94473687|NCT01124292|323524889|FG002|Overall Study|medical issue unrelated to the study|2|||
94473688|NCT01124292|323524887|FG000|Overall Study|piercing track closed|0|||
94473689|NCT01124292|323524888|FG001|Overall Study|piercing track closed|2|||
94473690|NCT01124292|323524889|FG002|Overall Study|piercing track closed|1|||
94473691|NCT03951753|323524892|FG000|Overall Study|Adverse Event|1|||
94473692|NCT03951753|323524893|FG001|Overall Study|Adverse Event|0|||
94473693|NCT03951753|323524894|FG002|Overall Study|Adverse Event|3|||
94473694|NCT03951753|323524892|FG000|Overall Study|Withdrawal by Subject|3|||
94473695|NCT03951753|323524893|FG001|Overall Study|Withdrawal by Subject|1|||
94473696|NCT03951753|323524894|FG002|Overall Study|Withdrawal by Subject|0|||
94473697|NCT03951753|323524892|FG000|Overall Study|Lost to Follow-up|0|||
94473698|NCT03951753|323524893|FG001|Overall Study|Lost to Follow-up|0|||
94473699|NCT03951753|323524894|FG002|Overall Study|Lost to Follow-up|1|||
94473700|NCT03300050|323526725|FG000|Overall Study|Lost to Follow-up|2|||
94473701|NCT03300050|323526726|FG001|Overall Study|Lost to Follow-up|1|||
94473702|NCT03300050|323526727|FG002|Overall Study|Lost to Follow-up|0|||
94473703|NCT03300050|323526728|FG003|Overall Study|Lost to Follow-up|0|||
94473704|NCT03300050|323526729|FG004|Overall Study|Lost to Follow-up|1|||
94473705|NCT03300050|323526725|FG000|Overall Study|Withdrawal by Subject|1|||
94473706|NCT03300050|323526726|FG001|Overall Study|Withdrawal by Subject|1|||
94473707|NCT03300050|323526727|FG002|Overall Study|Withdrawal by Subject|1|||
94473708|NCT03300050|323526728|FG003|Overall Study|Withdrawal by Subject|0|||
94473709|NCT03300050|323526729|FG004|Overall Study|Withdrawal by Subject|0|||
94473710|NCT03300050|323526725|FG000|Overall Study|Death|0|||
94473711|NCT03300050|323526726|FG001|Overall Study|Death|0|||
94473712|NCT03300050|323526727|FG002|Overall Study|Death|1|||
94473713|NCT03300050|323526728|FG003|Overall Study|Death|0|||
94473714|NCT03300050|323526729|FG004|Overall Study|Death|0|||
94473715|NCT03300050|323526725|FG000|Overall Study|Not Eligible at Randomization|0|||
94473716|NCT03300050|323526726|FG001|Overall Study|Not Eligible at Randomization|0|||
94312534|NCT00710034|322928253|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
94473717|NCT03300050|323526727|FG002|Overall Study|Not Eligible at Randomization|1|||
94312535|NCT00710034|322928254|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
94312536|NCT00710034|322928253|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
94473718|NCT03300050|323526728|FG003|Overall Study|Not Eligible at Randomization|1|||
94473719|NCT03300050|323526729|FG004|Overall Study|Not Eligible at Randomization|0|||
94473720|NCT03084302|323526730|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
94473721|NCT03084302|323526730|FG000|Overall Study|No valid objective monitor data|6|||
94473722|NCT01411319|323526731|FG000|Overall Study|Lost to Follow-up|1|||
94473723|NCT01214668|323526732|FG000|Overall Study|Adverse Event|0|||
94473724|NCT01214668|323526733|FG001|Overall Study|Adverse Event|1|||
94473725|NCT01214668|323526734|FG002|Overall Study|Adverse Event|0|||
94312537|NCT00710034|322928254|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
94312538|NCT00710034|322928253|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
94312539|NCT00710034|322928254|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
94312540|NCT00710034|322928253|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
94312541|NCT00710034|322928254|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
94312542|NCT00710034|322928253|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
94312543|NCT00710034|322928254|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
94312544|NCT00710034|322928253|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
94312545|NCT00710034|322928254|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
94312546|NCT01283581|322928255|FG000|Overall Study|Lost to Follow-up|8|||
94312547|NCT01283581|322928256|FG001|Overall Study|Lost to Follow-up|6|||
94312548|NCT01283581|322928257|FG002|Overall Study|Lost to Follow-up|8|||
94312549|NCT01283581|322928255|FG000|Overall Study|Withdrawal by Subject|2|||
94312550|NCT01283581|322928256|FG001|Overall Study|Withdrawal by Subject|5|||
94312551|NCT01283581|322928257|FG002|Overall Study|Withdrawal by Subject|2|||
94312552|NCT01283581|322928255|FG000|Overall Study|Adverse Event|1|||
94312553|NCT01283581|322928256|FG001|Overall Study|Adverse Event|1|||
94312554|NCT01283581|322928257|FG002|Overall Study|Adverse Event|4|||
94312555|NCT01283581|322928255|FG000|Overall Study|Physician Decision|0|||
94312556|NCT01283581|322928256|FG001|Overall Study|Physician Decision|1|||
94312557|NCT01283581|322928257|FG002|Overall Study|Physician Decision|2|||
94312558|NCT01283581|322928255|FG000|Overall Study|Protocol Violation|0|||
94312559|NCT01283581|322928256|FG001|Overall Study|Protocol Violation|1|||
94312560|NCT01283581|322928257|FG002|Overall Study|Protocol Violation|2|||
94312561|NCT01283581|322928255|FG000|Overall Study|Noncompliance|1|||
94312562|NCT01283581|322928256|FG001|Overall Study|Noncompliance|0|||
94312563|NCT01283581|322928257|FG002|Overall Study|Noncompliance|0|||
94312564|NCT01283581|322928255|FG000|Overall Study|Investigator unblinded|0|||
94312565|NCT01283581|322928256|FG001|Overall Study|Investigator unblinded|0|||
94312566|NCT01283581|322928257|FG002|Overall Study|Investigator unblinded|1|||
94312567|NCT01283581|322928255|FG000|Overall Study|"Early termination"|0|||
94312568|NCT01283581|322928256|FG001|Overall Study|"Early termination"|0|||
94312569|NCT01283581|322928257|FG002|Overall Study|"Early termination"|1|||
94312570|NCT01790438|322928258|FG000|Overall Study|Adverse Event|3|||
94312571|NCT01790438|322928259|FG001|Overall Study|Adverse Event|2|||
94312572|NCT01790438|322928258|FG000|Overall Study|Death|4|||
94312573|NCT01790438|322928259|FG001|Overall Study|Death|0|||
94312574|NCT01790438|322928258|FG000|Overall Study|Lost to Follow-up|5|||
94312575|NCT01790438|322928259|FG001|Overall Study|Lost to Follow-up|2|||
94312576|NCT01790438|322928258|FG000|Overall Study|Withdrawal by Subject|13|||
94312577|NCT01790438|322928259|FG001|Overall Study|Withdrawal by Subject|2|||
94312578|NCT01790438|322928258|FG000|Overall Study|Physician Decision|3|||
94312579|NCT01790438|322928259|FG001|Overall Study|Physician Decision|1|||
94312580|NCT01790438|322928258|FG000|Overall Study|Sponsor Decision|0|||
94312581|NCT01790438|322928259|FG001|Overall Study|Sponsor Decision|3|||
94312582|NCT01790438|322928258|FG000|Overall Study|Protocol Required Discontinuation|7|||
94312583|NCT01790438|322928259|FG001|Overall Study|Protocol Required Discontinuation|1|||
94312584|NCT03653507|322928262|FG000|Overall Study|Miscellaneous|26|||
94312585|NCT03653507|322928263|FG001|Overall Study|Miscellaneous|16|||
94312586|NCT03653507|322928262|FG000|Overall Study|Withdrawal by Subject|35|||
94312587|NCT03653507|322928263|FG001|Overall Study|Withdrawal by Subject|23|||
94312588|NCT03653507|322928262|FG000|Overall Study|Protocol Deviation|2|||
94312589|NCT03653507|322928263|FG001|Overall Study|Protocol Deviation|1|||
94312590|NCT03653507|322928262|FG000|Overall Study|Progressive disease|102|||
94312591|NCT03653507|322928263|FG001|Overall Study|Progressive disease|157|||
94312592|NCT03653507|322928262|FG000|Overall Study|Lost to Follow-up|1|||
94312593|NCT03653507|322928263|FG001|Overall Study|Lost to Follow-up|1|||
94312594|NCT03653507|322928262|FG000|Overall Study|Death|24|||
94312595|NCT03653507|322928263|FG001|Overall Study|Death|22|||
94312596|NCT03653507|322928262|FG000|Overall Study|Adverse Event|34|||
94312597|NCT03653507|322928263|FG001|Overall Study|Adverse Event|15|||
94312598|NCT02090114|322928266|FG000|Overall Study|Withdrawal by Subject|3|||
94312599|NCT02090114|322928267|FG001|Overall Study|Withdrawal by Subject|6|||
94312600|NCT02090114|322928268|FG002|Overall Study|Withdrawal by Subject|2|||
94312601|NCT02090114|322928269|FG003|Overall Study|Withdrawal by Subject|1|||
94312602|NCT02090114|322928266|FG000|Overall Study|Physician Decision|5|||
94312603|NCT02090114|322928267|FG001|Overall Study|Physician Decision|0|||
94312604|NCT02090114|322928268|FG002|Overall Study|Physician Decision|1|||
94312605|NCT02090114|322928269|FG003|Overall Study|Physician Decision|1|||
94312606|NCT02090114|322928266|FG000|Overall Study|Adverse Event|1|||
94312607|NCT02090114|322928267|FG001|Overall Study|Adverse Event|2|||
94312608|NCT02090114|322928268|FG002|Overall Study|Adverse Event|2|||
94312609|NCT02090114|322928269|FG003|Overall Study|Adverse Event|0|||
94312610|NCT02090114|322928266|FG000|Overall Study|Progressive Disease|20|||
94312611|NCT02090114|322928267|FG001|Overall Study|Progressive Disease|21|||
94312612|NCT02090114|322928268|FG002|Overall Study|Progressive Disease|23|||
94312613|NCT02090114|322928269|FG003|Overall Study|Progressive Disease|6|||
94312614|NCT02090114|322928266|FG000|Overall Study|Death|1|||
94382662|NCT02458638|323187160|FG000|Overall Study|Death|309|||
94382663|NCT02458638|323187160|FG000|Overall Study|End of Cohort/End of Study|67|||
94382664|NCT02458638|323187160|FG000|Overall Study|Lost to Follow-up|31|||
94382665|NCT02458638|323187160|FG000|Overall Study|Other Reasons|4|||
94382666|NCT02458638|323187160|FG000|Overall Study|Physician Decision|1|||
94382667|NCT02458638|323187160|FG000|Overall Study|Withdrawal by Subject|47|||
94382668|NCT01884025|323187165|FG000|Overall Study|Lost to Follow-up|3|||
94382669|NCT01884025|323187166|FG001|Overall Study|Lost to Follow-up|4|||
94382670|NCT01545076|323187167|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
94382671|NCT01545076|323187168|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
94382672|NCT01545076|323187169|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
94382673|NCT01545076|323187170|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
94382674|NCT01545076|323187171|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
94382675|NCT01545076|323187167|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
94382676|NCT01545076|323187168|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
94382677|NCT01545076|323187169|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
94382678|NCT01545076|323187170|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
94382679|NCT01545076|323187171|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
94382680|NCT01545076|323187167|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
94382681|NCT01545076|323187168|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
94382682|NCT01545076|323187169|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
94382683|NCT01545076|323187170|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
94382684|NCT01545076|323187171|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
94382685|NCT01545076|323187167|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
94382686|NCT01545076|323187168|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
94382687|NCT01545076|323187169|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
94382688|NCT01545076|323187170|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
94382689|NCT01545076|323187171|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
94382690|NCT01545076|323187167|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
94382691|NCT01545076|323187168|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
94382692|NCT01545076|323187169|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
94382693|NCT01545076|323187170|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
94382694|NCT01545076|323187171|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
94382695|NCT01545076|323187167|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
94382696|NCT01545076|323187168|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
94382697|NCT01545076|323187169|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
94382698|NCT01545076|323187170|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
94382699|NCT01545076|323187171|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
94382700|NCT01545076|323187167|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
94382701|NCT01545076|323187168|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
94382702|NCT01545076|323187169|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
94382703|NCT01545076|323187170|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
94382704|NCT01545076|323187171|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
94382705|NCT01545076|323187167|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
94382706|NCT01545076|323187168|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
94382707|NCT01545076|323187169|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
94382708|NCT01545076|323187170|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
94382709|NCT01545076|323187171|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
94382710|NCT01545076|323187167|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
94382711|NCT01545076|323187168|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
94382712|NCT01545076|323187169|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
94382713|NCT01545076|323187170|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
94382714|NCT01545076|323187171|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
94382715|NCT02518113|323187172|FG000|Overall Study|Adverse Event|1|||
94382716|NCT02518113|323187173|FG001|Overall Study|Adverse Event|0|||
94382717|NCT02518113|323187174|FG002|Overall Study|Adverse Event|1|||
94382718|NCT02518113|323187175|FG003|Overall Study|Adverse Event|0|||
94382719|NCT02518113|323187172|FG000|Overall Study|Death|1|||
94382720|NCT02518113|323187173|FG001|Overall Study|Death|2|||
94382721|NCT02518113|323187174|FG002|Overall Study|Death|0|||
94382722|NCT02518113|323187175|FG003|Overall Study|Death|0|||
94382723|NCT02518113|323187172|FG000|Overall Study|Physician Decision|0|||
94382724|NCT02518113|323187173|FG001|Overall Study|Physician Decision|1|||
94382725|NCT02518113|323187174|FG002|Overall Study|Physician Decision|0|||
94382726|NCT02518113|323187175|FG003|Overall Study|Physician Decision|0|||
94382727|NCT02518113|323187172|FG000|Overall Study|Progressive Disease|1|||
94382728|NCT02518113|323187173|FG001|Overall Study|Progressive Disease|2|||
94382729|NCT02518113|323187174|FG002|Overall Study|Progressive Disease|3|||
94382730|NCT02518113|323187175|FG003|Overall Study|Progressive Disease|0|||
94473726|NCT01214668|323526735|FG003|Overall Study|Adverse Event|2|||
94473727|NCT01214668|323526736|FG004|Overall Study|Adverse Event|1|||
94312615|NCT02090114|322928267|FG001|Overall Study|Death|0|||
94312616|NCT02090114|322928268|FG002|Overall Study|Death|1|||
94312617|NCT02090114|322928269|FG003|Overall Study|Death|0|||
94312618|NCT00500149|322928270|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
94312619|NCT00500149|322928271|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
94312620|NCT00500149|322928270|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
94312621|NCT00500149|322928271|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
94312622|NCT00500149|322928270|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
94312623|NCT00500149|322928271|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
94312624|NCT00500149|322928270|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
94312625|NCT00500149|322928271|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
94312626|NCT00500149|322928270|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
94382731|NCT00220701|323187176|FG000|Overall Study|Lost to Follow-up|5|||
94382732|NCT00220701|323187177|FG001|Overall Study|Lost to Follow-up|4|||
94382733|NCT03679741|323187178|FG000|Period 1|No longer meet eligibility criteria|1|||
94382734|NCT03679741|323187179|FG001|Period 1|No longer meet eligibility criteria|0|||
94382735|NCT03679741|323187178|FG000|Period 1|Lost to Follow-up|0|||
94382736|NCT03679741|323187179|FG001|Period 1|Lost to Follow-up|1|||
94382737|NCT03679741|323187178|FG000|Period 1|Adverse Event|1|||
94382738|NCT03679741|323187179|FG001|Period 1|Adverse Event|1|||
94382739|NCT03679741|323187178|FG000|Period 1|Withdrawal by Subject|0|||
94382740|NCT03679741|323187179|FG001|Period 1|Withdrawal by Subject|1|||
94382741|NCT03679741|323187178|FG000|Period 2|Adverse Event|2|||
94382742|NCT03679741|323187179|FG001|Period 2|Adverse Event|1|||
94382743|NCT03679741|323187178|FG000|Period 2|Withdrawal by Subject|1|||
94382744|NCT03679741|323187179|FG001|Period 2|Withdrawal by Subject|1|||
94382745|NCT00520741|323187180|FG000|Overall Study|Adverse Event|16|||
94382746|NCT00520741|323187181|FG001|Overall Study|Adverse Event|56|||
94382747|NCT00520741|323187180|FG000|Overall Study|Lack of Efficacy|11|||
94382748|NCT00520741|323187181|FG001|Overall Study|Lack of Efficacy|30|||
94382749|NCT00520741|323187180|FG000|Overall Study|Withdrawal by Subject|0|||
94382750|NCT00520741|323187181|FG001|Overall Study|Withdrawal by Subject|11|||
94382751|NCT00520741|323187180|FG000|Overall Study|Protocol Violation|2|||
94382752|NCT00520741|323187181|FG001|Overall Study|Protocol Violation|15|||
94382753|NCT00520741|323187180|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
94382754|NCT00520741|323187181|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
94382755|NCT00520741|323187180|FG000|Overall Study|Lost to Follow-up|4|||
94382756|NCT00520741|323187181|FG001|Overall Study|Lost to Follow-up|4|||
94382757|NCT00520741|323187180|FG000|Overall Study|Other reasons for premature termination|0|||
94382758|NCT00520741|323187181|FG001|Overall Study|Other reasons for premature termination|6|||
94382759|NCT00527423|323187182|FG000|Overall Study|Protocol Violation|1|||
94382760|NCT00527423|323187182|FG000|Overall Study|Adverse Event|5|||
94382761|NCT00527423|323187182|FG000|Overall Study|Physician Decision|4|||
94382762|NCT00527423|323187182|FG000|Overall Study|Withdrawal by Subject|10|||
94382763|NCT00527423|323187182|FG000|Overall Study|Lost to Follow-up|4|||
94382764|NCT00527423|323187182|FG000|Overall Study|OTHER|4|||
94382765|NCT00527423|323187182|FG000|Overall Study|Death|9|||
94382766|NCT03702621|323187183|FG000|Overall Study|Physician Decision|6|||
94382767|NCT03702621|323187184|FG001|Overall Study|Physician Decision|6|||
94382768|NCT01644500|323187194|FG000|Overall Study|Adverse Event|6|||
94382769|NCT01644500|323187195|FG001|Overall Study|Adverse Event|1|||
94382770|NCT01644500|323187196|FG002|Overall Study|Adverse Event|2|||
94382771|NCT01644500|323187194|FG000|Overall Study|Death|0|||
94382772|NCT01644500|323187195|FG001|Overall Study|Death|1|||
94382773|NCT01644500|323187196|FG002|Overall Study|Death|0|||
94382774|NCT01644500|323187194|FG000|Overall Study|Lost to Follow-up|3|||
94382775|NCT01644500|323187195|FG001|Overall Study|Lost to Follow-up|8|||
94382776|NCT01644500|323187196|FG002|Overall Study|Lost to Follow-up|0|||
94382777|NCT01644500|323187194|FG000|Overall Study|Protocol Violation|1|||
94382778|NCT01644500|323187195|FG001|Overall Study|Protocol Violation|1|||
94382779|NCT01644500|323187196|FG002|Overall Study|Protocol Violation|0|||
94382780|NCT01644500|323187194|FG000|Overall Study|Withdrawal by Subject|11|||
94382781|NCT01644500|323187195|FG001|Overall Study|Withdrawal by Subject|12|||
94382782|NCT01644500|323187196|FG002|Overall Study|Withdrawal by Subject|12|||
94312627|NCT00500149|322928271|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
94312628|NCT00500149|322928270|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
94312629|NCT00500149|322928271|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
94382783|NCT01644500|323187194|FG000|Overall Study|Physician Decision|1|||
94382784|NCT01644500|323187195|FG001|Overall Study|Physician Decision|1|||
94382785|NCT01644500|323187196|FG002|Overall Study|Physician Decision|1|||
94382786|NCT02153398|323187210|FG000|Overall Study|Withdrawal by Subject|1|||
94382787|NCT02153398|323187211|FG001|Overall Study|Withdrawal by Subject|0|||
94382788|NCT02153398|323187212|FG002|Overall Study|Withdrawal by Subject|0|||
94382789|NCT02153398|323187213|FG003|Overall Study|Withdrawal by Subject|0|||
94382790|NCT02153398|323187214|FG004|Overall Study|Withdrawal by Subject|0|||
94382791|NCT02153398|323187210|FG000|Overall Study|Adverse Event|0|||
94382792|NCT02153398|323187211|FG001|Overall Study|Adverse Event|0|||
94473728|NCT01214668|323526737|FG005|Overall Study|Adverse Event|1|||
94473729|NCT01214668|323526732|FG000|Overall Study|Death|0|||
94473730|NCT01214668|323526733|FG001|Overall Study|Death|0|||
94473731|NCT01214668|323526734|FG002|Overall Study|Death|1|||
94473732|NCT01214668|323526735|FG003|Overall Study|Death|0|||
94473733|NCT01214668|323526736|FG004|Overall Study|Death|0|||
94473734|NCT01214668|323526737|FG005|Overall Study|Death|0|||
94473735|NCT01214668|323526732|FG000|Overall Study|Progressive Disease|4|||
94473736|NCT01214668|323526733|FG001|Overall Study|Progressive Disease|2|||
94473737|NCT01214668|323526734|FG002|Overall Study|Progressive Disease|5|||
94473738|NCT01214668|323526735|FG003|Overall Study|Progressive Disease|4|||
94473739|NCT01214668|323526736|FG004|Overall Study|Progressive Disease|4|||
94473740|NCT01214668|323526737|FG005|Overall Study|Progressive Disease|5|||
94473741|NCT01214668|323526732|FG000|Overall Study|Withdrawal by Subject|0|||
94473742|NCT01214668|323526733|FG001|Overall Study|Withdrawal by Subject|0|||
94473743|NCT01214668|323526734|FG002|Overall Study|Withdrawal by Subject|0|||
94473744|NCT01214668|323526735|FG003|Overall Study|Withdrawal by Subject|0|||
94473745|NCT01214668|323526736|FG004|Overall Study|Withdrawal by Subject|1|||
94473746|NCT01214668|323526737|FG005|Overall Study|Withdrawal by Subject|0|||
94473747|NCT01964989|323526738|FG000|Overall Study|Protocol Violation|3|||
94473748|NCT01964989|323526739|FG001|Overall Study|Protocol Violation|4|||
94473749|NCT01964989|323526738|FG000|Overall Study|Administrative Reason|103|||
94473750|NCT01964989|323526739|FG001|Overall Study|Administrative Reason|95|||
94473751|NCT01964989|323526738|FG000|Overall Study|Adverse Event|0|||
94473752|NCT01964989|323526739|FG001|Overall Study|Adverse Event|1|||
94473753|NCT01964989|323526738|FG000|Overall Study|Death|1|||
94473754|NCT01964989|323526739|FG001|Overall Study|Death|3|||
94473755|NCT01964989|323526738|FG000|Overall Study|Withdrawal by Subject|156|||
94473756|NCT01964989|323526739|FG001|Overall Study|Withdrawal by Subject|160|||
94473757|NCT01964989|323526738|FG000|Overall Study|Lost to Follow-up|254|||
94473758|NCT01964989|323526739|FG001|Overall Study|Lost to Follow-up|232|||
94473759|NCT01964989|323526738|FG000|Overall Study|Other|267|||
94312630|NCT00500149|322928270|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
94312631|NCT00500149|322928271|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
94312632|NCT01356602|322928272|FG000|Overall Study|Protocol Deviation|0|||
94312633|NCT01356602|322928273|FG001|Overall Study|Protocol Deviation|1|||
94312634|NCT01356602|322928274|FG002|Overall Study|Protocol Deviation|1|||
94473760|NCT01964989|323526739|FG001|Overall Study|Other|252|||
94473761|NCT00184002|323526740|FG000|Overall Study|Adverse Event|9|||
94473762|NCT00184002|323526740|FG000|Overall Study|Death|3|||
94473763|NCT00184002|323526740|FG000|Overall Study|Physician Decision|1|||
94473764|NCT00184002|323526740|FG000|Overall Study|Withdrawal by Subject|4|||
94473765|NCT02499263|323526741|FG000|Overall Study|Lost to Follow-up|9|||
94473766|NCT02499263|323526741|FG000|Overall Study|Participant's withdrawal of consent|4|||
94473767|NCT02499263|323526741|FG000|Overall Study|Lack of Efficacy|22|||
94473768|NCT02499263|323526741|FG000|Overall Study|investigator's judgment|12|||
94473769|NCT02499263|323526741|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
94473770|NCT02499263|323526741|FG000|Overall Study|Participant's decision|3|||
94473771|NCT02499263|323526741|FG000|Overall Study|Pregnancy|1|||
94473772|NCT00660595|323526760|FG000|Overall Study|Lost to Follow-up|0|||
94473773|NCT00660595|323526761|FG001|Overall Study|Lost to Follow-up|1|||
94473774|NCT00660595|323526760|FG000|Overall Study|Did not consent to participate in study|12|||
94473775|NCT00660595|323526761|FG001|Overall Study|Did not consent to participate in study|8|||
94473776|NCT00660595|323526760|FG000|Overall Study|Participant left hospital|1|||
94473777|NCT00660595|323526761|FG001|Overall Study|Participant left hospital|0|||
94473778|NCT00660595|323526760|FG000|Overall Study|Non Specified reasons|5|||
94473779|NCT00660595|323526761|FG001|Overall Study|Non Specified reasons|0|||
94473780|NCT01639703|323526777|FG000|Overall Study|Withdrawal by Subject|5|||
94473781|NCT01639703|323526777|FG000|Overall Study|Other reason|7|||
94473782|NCT01308463|323526778|FG000|Overall Study|Study Discontinued|23|||
94473783|NCT01308463|323526778|FG000|Overall Study|Death|4|||
94473784|NCT01308463|323526778|FG000|Overall Study|Revision|2|||
94473785|NCT02784288|323526779|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
94473786|NCT00493311|323526780|FG000|Overall Study|Need for rescue medication|2|||
94473787|NCT00493311|323526781|FG001|Overall Study|Need for rescue medication|2|||
94473788|NCT03959527|323526782|FG000|Overall Study|Withdrawal by Subject|8|||
94473789|NCT03959527|323526783|FG001|Overall Study|Withdrawal by Subject|3|||
94473790|NCT03959527|323526782|FG000|Overall Study|Lost to Follow-up|31|||
94473791|NCT03959527|323526783|FG001|Overall Study|Lost to Follow-up|15|||
94473792|NCT03959527|323526782|FG000|Overall Study|Did not meet eligibility criteria|1|||
94473793|NCT03959527|323526783|FG001|Overall Study|Did not meet eligibility criteria|1|||
94473794|NCT03959527|323526782|FG000|Overall Study|Protocol Violation|10|||
94473795|NCT03959527|323526783|FG001|Overall Study|Protocol Violation|5|||
94473796|NCT02020889|323526784|FG000|Overall Study|Adverse Event|0|||
94473797|NCT02020889|323526785|FG001|Overall Study|Adverse Event|1|||
94473798|NCT02020889|323526784|FG000|Overall Study|Lack of Efficacy|1|||
94473799|NCT02020889|323526785|FG001|Overall Study|Lack of Efficacy|0|||
94312635|NCT01356602|322928272|FG000|Overall Study|Administrative Problems|1|||
94382793|NCT02153398|323187212|FG002|Overall Study|Adverse Event|1|||
94382794|NCT02153398|323187213|FG003|Overall Study|Adverse Event|1|||
94382795|NCT02153398|323187214|FG004|Overall Study|Adverse Event|0|||
94382796|NCT02863575|323187216|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
94382797|NCT02863575|323187217|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
94382798|NCT02863575|323187218|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
94382799|NCT02863575|323187216|FG000|Overall Study|Withdrawal by Subject|0|||
94382800|NCT02863575|323187217|FG001|Overall Study|Withdrawal by Subject|1|||
94382801|NCT02863575|323187218|FG002|Overall Study|Withdrawal by Subject|1|||
94382802|NCT02863575|323187216|FG000|Overall Study|Adverse Event|0|||
94382803|NCT02863575|323187217|FG001|Overall Study|Adverse Event|1|||
94382804|NCT02863575|323187218|FG002|Overall Study|Adverse Event|0|||
94382805|NCT01439165|323187219|FG000|Overall Study|Protocol Violation|3|||
94382806|NCT01439165|323187220|FG001|Overall Study|Protocol Violation|0|||
94382807|NCT01439165|323187219|FG000|Overall Study|Lost to Follow-up|11|||
94382808|NCT01439165|323187220|FG001|Overall Study|Lost to Follow-up|1|||
94382809|NCT01439165|323187219|FG000|Overall Study|Withdrawal by Subject|7|||
94382810|NCT01439165|323187220|FG001|Overall Study|Withdrawal by Subject|1|||
94382811|NCT00810368|323187221|FG000|Overall Study|Lost to Follow-up|4|||
94382812|NCT00810368|323187222|FG001|Overall Study|Lost to Follow-up|2|||
94382813|NCT00810368|323187221|FG000|Overall Study|Lack of Efficacy|2|||
94382814|NCT00810368|323187222|FG001|Overall Study|Lack of Efficacy|0|||
94382815|NCT03331042|323187223|FG000|Overall Study|Protocol Violation|1|||
94382816|NCT03331042|323187224|FG001|Overall Study|Protocol Violation|0|||
94382817|NCT03331042|323187225|FG002|Overall Study|Protocol Violation|0|||
94382818|NCT03331042|323187226|FG003|Overall Study|Protocol Violation|0|||
94382819|NCT03331042|323187223|FG000|Overall Study|Physician Decision|0|||
94382820|NCT03331042|323187224|FG001|Overall Study|Physician Decision|0|||
94382821|NCT03331042|323187225|FG002|Overall Study|Physician Decision|1|||
94382822|NCT03331042|323187226|FG003|Overall Study|Physician Decision|0|||
94382823|NCT03331042|323187223|FG000|Overall Study|Lost to Follow-up|0|||
94382824|NCT03331042|323187224|FG001|Overall Study|Lost to Follow-up|0|||
94382825|NCT03331042|323187225|FG002|Overall Study|Lost to Follow-up|0|||
94382826|NCT03331042|323187226|FG003|Overall Study|Lost to Follow-up|1|||
94382827|NCT00623103|323187227|FG000|Overall Study|Adverse Event|70|||
94382828|NCT00623103|323187228|FG001|Overall Study|Adverse Event|60|||
94382829|NCT00623103|323187227|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
94382830|NCT00623103|323187228|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
94382831|NCT00623103|323187227|FG000|Overall Study|Withdrawal by Subject|18|||
94382832|NCT00623103|323187228|FG001|Overall Study|Withdrawal by Subject|24|||
94382833|NCT00623103|323187227|FG000|Overall Study|Lost to Follow-up|4|||
94382834|NCT00623103|323187228|FG001|Overall Study|Lost to Follow-up|1|||
94382835|NCT00623103|323187227|FG000|Overall Study|Administrative problems|2|||
94382836|NCT00623103|323187228|FG001|Overall Study|Administrative problems|4|||
94382837|NCT00623103|323187227|FG000|Overall Study|Death|11|||
94382838|NCT00623103|323187228|FG001|Overall Study|Death|11|||
94382839|NCT00623103|323187227|FG000|Overall Study|Protocol deviation|2|||
94382840|NCT00623103|323187228|FG001|Overall Study|Protocol deviation|1|||
94382841|NCT00322491|323187236|FG000|Overall Study|Adverse Event|1|||
94382842|NCT00322491|323187237|FG001|Overall Study|Adverse Event|0|||
94382843|NCT00322491|323187236|FG000|Overall Study|Death|1|||
94382844|NCT00322491|323187237|FG001|Overall Study|Death|2|||
94382845|NCT00560235|323187239|FG000|Phase 1|Discontinued|8|||
94382846|NCT00560235|323187240|FG001|Phase 1|Discontinued|0|||
94382847|NCT00560235|323187241|FG002|Phase 1|Discontinued|0|||
94382848|NCT00560235|323187239|FG000|Phase 1B|Discontinued|0|||
94382849|NCT00560235|323187240|FG001|Phase 1B|Discontinued|19|||
94382850|NCT00560235|323187241|FG002|Phase 1B|Discontinued|0|||
94382851|NCT00560235|323187239|FG000|Phase 2|Discontinued|0|||
94382852|NCT00560235|323187240|FG001|Phase 2|Discontinued|0|||
94382853|NCT00560235|323187241|FG002|Phase 2|Discontinued|96|||
94382854|NCT00560235|323187239|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
94382855|NCT00560235|323187240|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
94382856|NCT00560235|323187241|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
94382857|NCT00620763|323187242|FG000|Period: First Intervention|Withdrawal by Subject|0|||
94382858|NCT00620763|323187243|FG001|Period: First Intervention|Withdrawal by Subject|2|||
94382859|NCT00620763|323187242|FG000|Period: First Intervention|Protocol Violation|0|||
94382860|NCT00620763|323187243|FG001|Period: First Intervention|Protocol Violation|3|||
94382861|NCT00620763|323187242|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
94382862|NCT00620763|323187243|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
94382863|NCT00783796|323187254|FG000|Overall Study|Did not receive any stent|4|||
94382864|NCT00783796|323187254|FG000|Overall Study|Received non-XIENCE V stent|1|||
94382865|NCT00783796|323187254|FG000|Overall Study|Received commercial XIENCE V stent|1|||
94382866|NCT00712010|323187255|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
94382867|NCT00454636|323187256|FG000|Overall Study|Adverse Event|10|||
94382868|NCT00454636|323187257|FG001|Overall Study|Adverse Event|6|||
94382869|NCT00454636|323187258|FG002|Overall Study|Adverse Event|9|||
94382870|NCT00454636|323187259|FG003|Overall Study|Adverse Event|15|||
94382871|NCT00454636|323187256|FG000|Overall Study|Disease Progression|11|||
94473800|NCT02020889|323526784|FG000|Overall Study|Lost to Follow-up|1|||
94473801|NCT02020889|323526785|FG001|Overall Study|Lost to Follow-up|0|||
94473802|NCT02020889|323526784|FG000|Overall Study|Physician Decision|2|||
94473803|NCT02020889|323526785|FG001|Overall Study|Physician Decision|0|||
94473804|NCT02020889|323526784|FG000|Overall Study|Withdrawal by Subject|3|||
94473805|NCT02020889|323526785|FG001|Overall Study|Withdrawal by Subject|2|||
94473806|NCT04217317|323526789|FG000|Overall Study|Lack of Efficacy|4|||
94473807|NCT04217317|323526789|FG000|Overall Study|Physician Decision|1|||
94473808|NCT02476916|323526790|FG000|Core Period|Adverse Event|2|||
94473809|NCT02476916|323526791|FG001|Core Period|Adverse Event|2|||
94473810|NCT02476916|323526790|FG000|Core Period|Investigator decision|1|||
94473811|NCT02476916|323526791|FG001|Core Period|Investigator decision|1|||
94473812|NCT02476916|323526790|FG000|Core Period|Withdrawal by Subject|3|||
94473813|NCT02476916|323526791|FG001|Core Period|Withdrawal by Subject|0|||
94473814|NCT02476916|323526790|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
94473815|NCT02476916|323526791|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
94473816|NCT02476916|323526790|FG000|Extension Period|On Treatment|12|||
94473817|NCT02476916|323526791|FG001|Extension Period|On Treatment|17|||
94473818|NCT01210222|323526795|FG000|Overall Study|Ineligible|2|||
94473819|NCT01210222|323526795|FG000|Overall Study|Never treated|1|||
94473820|NCT00303472|323526796|FG000|Treatment Period|Adverse Event|0|||
94473821|NCT00303472|323526797|FG001|Treatment Period|Adverse Event|0|||
94473822|NCT00303472|323526798|FG002|Treatment Period|Adverse Event|0|||
94473823|NCT00303472|323526799|FG003|Treatment Period|Adverse Event|0|||
94473824|NCT00303472|323526800|FG004|Treatment Period|Adverse Event|1|||
94473825|NCT00303472|323526801|FG005|Treatment Period|Adverse Event|0|||
94473826|NCT00303472|323526802|FG006|Treatment Period|Adverse Event|0|||
94473827|NCT00303472|323526796|FG000|Treatment Period|Death|0|||
94473828|NCT00303472|323526797|FG001|Treatment Period|Death|0|||
94473829|NCT00303472|323526798|FG002|Treatment Period|Death|0|||
94473830|NCT00303472|323526799|FG003|Treatment Period|Death|1|||
94473831|NCT00303472|323526800|FG004|Treatment Period|Death|0|||
94473832|NCT00303472|323526801|FG005|Treatment Period|Death|0|||
94473833|NCT00303472|323526802|FG006|Treatment Period|Death|1|||
94473834|NCT00303472|323526796|FG000|Treatment Period|Withdrawal by Subject|0|||
94473835|NCT00303472|323526797|FG001|Treatment Period|Withdrawal by Subject|0|||
94473836|NCT00303472|323526798|FG002|Treatment Period|Withdrawal by Subject|0|||
94473837|NCT00303472|323526799|FG003|Treatment Period|Withdrawal by Subject|1|||
94473838|NCT00303472|323526800|FG004|Treatment Period|Withdrawal by Subject|0|||
94473839|NCT00303472|323526801|FG005|Treatment Period|Withdrawal by Subject|1|||
94473840|NCT00303472|323526802|FG006|Treatment Period|Withdrawal by Subject|0|||
94473841|NCT00303472|323526796|FG000|Treatment Period|Other|0|||
94473842|NCT00303472|323526797|FG001|Treatment Period|Other|0|||
94473843|NCT00303472|323526798|FG002|Treatment Period|Other|0|||
94473844|NCT00303472|323526799|FG003|Treatment Period|Other|0|||
94473845|NCT00303472|323526800|FG004|Treatment Period|Other|1|||
94473846|NCT00303472|323526801|FG005|Treatment Period|Other|0|||
94473847|NCT00303472|323526802|FG006|Treatment Period|Other|1|||
94473848|NCT00303472|323526796|FG000|Treatment Period|Disease Progression (to AML)|0|||
94473849|NCT00303472|323526797|FG001|Treatment Period|Disease Progression (to AML)|0|||
94473850|NCT00303472|323526798|FG002|Treatment Period|Disease Progression (to AML)|0|||
94473851|NCT00303472|323526799|FG003|Treatment Period|Disease Progression (to AML)|0|||
94473852|NCT00303472|323526800|FG004|Treatment Period|Disease Progression (to AML)|1|||
94473853|NCT00303472|323526801|FG005|Treatment Period|Disease Progression (to AML)|0|||
94473854|NCT00303472|323526802|FG006|Treatment Period|Disease Progression (to AML)|0|||
94473855|NCT00303472|323526796|FG000|Treatment Extension (Optional)|Adverse Event|1|||
94473856|NCT00303472|323526797|FG001|Treatment Extension (Optional)|Adverse Event|0|||
94473857|NCT00303472|323526798|FG002|Treatment Extension (Optional)|Adverse Event|1|||
94473858|NCT00303472|323526799|FG003|Treatment Extension (Optional)|Adverse Event|0|||
94473859|NCT00303472|323526800|FG004|Treatment Extension (Optional)|Adverse Event|0|||
94473860|NCT00303472|323526801|FG005|Treatment Extension (Optional)|Adverse Event|0|||
94473861|NCT00303472|323526802|FG006|Treatment Extension (Optional)|Adverse Event|0|||
94473862|NCT00303472|323526796|FG000|Treatment Extension (Optional)|Death|2|||
94473863|NCT00303472|323526797|FG001|Treatment Extension (Optional)|Death|0|||
94473864|NCT00303472|323526798|FG002|Treatment Extension (Optional)|Death|1|||
94473865|NCT00303472|323526799|FG003|Treatment Extension (Optional)|Death|0|||
94473866|NCT00303472|323526800|FG004|Treatment Extension (Optional)|Death|0|||
94473867|NCT00303472|323526801|FG005|Treatment Extension (Optional)|Death|0|||
94473868|NCT00303472|323526802|FG006|Treatment Extension (Optional)|Death|0|||
94312636|NCT01356602|322928273|FG001|Overall Study|Administrative Problems|4|||
94473869|NCT00303472|323526796|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
94473870|NCT00303472|323526797|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
94473871|NCT00303472|323526798|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
94312637|NCT01356602|322928274|FG002|Overall Study|Administrative Problems|5|||
94473872|NCT00303472|323526799|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
94473873|NCT00303472|323526800|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
94473874|NCT00303472|323526801|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
94312638|NCT01356602|322928272|FG000|Overall Study|Lost to Follow-up|4|||
94312639|NCT01356602|322928273|FG001|Overall Study|Lost to Follow-up|5|||
94312640|NCT01356602|322928274|FG002|Overall Study|Lost to Follow-up|6|||
94312641|NCT01356602|322928272|FG000|Overall Study|Withdrawal by Subject|4|||
94312642|NCT01356602|322928273|FG001|Overall Study|Withdrawal by Subject|3|||
94312643|NCT01356602|322928274|FG002|Overall Study|Withdrawal by Subject|7|||
94312644|NCT01356602|322928272|FG000|Overall Study|Lack of Efficacy|0|||
94312645|NCT01356602|322928273|FG001|Overall Study|Lack of Efficacy|1|||
94312646|NCT01356602|322928274|FG002|Overall Study|Lack of Efficacy|4|||
94312647|NCT01356602|322928272|FG000|Overall Study|Adverse Event|0|||
94312648|NCT01356602|322928273|FG001|Overall Study|Adverse Event|1|||
94312649|NCT01356602|322928274|FG002|Overall Study|Adverse Event|1|||
94312650|NCT01158534|322928277|FG000|Overall Study|Withdrawal by Subject|1|||
94312651|NCT01158534|322928277|FG000|Overall Study|Death|1|||
94312652|NCT01158534|322928277|FG000|Overall Study|Other|1|||
94312653|NCT00521339|322928278|FG000|Treatment Phase|Adverse Event|2|||
94312654|NCT00521339|322928279|FG001|Treatment Phase|Adverse Event|0|||
94312655|NCT00521339|322928280|FG002|Treatment Phase|Adverse Event|0|||
94312656|NCT00521339|322928278|FG000|Treatment Phase|Intolerability to study drug|2|||
94312657|NCT00521339|322928279|FG001|Treatment Phase|Intolerability to study drug|0|||
94312658|NCT00521339|322928280|FG002|Treatment Phase|Intolerability to study drug|0|||
94312659|NCT00521339|322928278|FG000|Treatment Phase|Lack of Efficacy|3|||
94312660|NCT00521339|322928279|FG001|Treatment Phase|Lack of Efficacy|0|||
94312661|NCT00521339|322928280|FG002|Treatment Phase|Lack of Efficacy|0|||
94312662|NCT00521339|322928278|FG000|Treatment Phase|Withdrawal by Subject|3|||
94312663|NCT00521339|322928279|FG001|Treatment Phase|Withdrawal by Subject|0|||
94312664|NCT00521339|322928280|FG002|Treatment Phase|Withdrawal by Subject|0|||
94312665|NCT00521339|322928278|FG000|Treatment Phase|Lost to Follow-up|1|||
94312666|NCT00521339|322928279|FG001|Treatment Phase|Lost to Follow-up|0|||
94312667|NCT00521339|322928280|FG002|Treatment Phase|Lost to Follow-up|0|||
94312668|NCT00521339|322928278|FG000|Treatment Phase|Protocol Violation|1|||
94312669|NCT00521339|322928279|FG001|Treatment Phase|Protocol Violation|0|||
94312670|NCT00521339|322928280|FG002|Treatment Phase|Protocol Violation|0|||
94312671|NCT00521339|322928278|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
94382872|NCT00454636|323187257|FG001|Overall Study|Disease Progression|12|||
94382873|NCT00454636|323187258|FG002|Overall Study|Disease Progression|4|||
94382874|NCT00454636|323187259|FG003|Overall Study|Disease Progression|11|||
94382875|NCT00454636|323187256|FG000|Overall Study|Protocol Violation|3|||
94382876|NCT00454636|323187257|FG001|Overall Study|Protocol Violation|2|||
94382877|NCT00454636|323187258|FG002|Overall Study|Protocol Violation|3|||
94382878|NCT00454636|323187259|FG003|Overall Study|Protocol Violation|3|||
94382879|NCT00454636|323187256|FG000|Overall Study|Death|6|||
94382880|NCT00454636|323187257|FG001|Overall Study|Death|1|||
94382881|NCT00454636|323187258|FG002|Overall Study|Death|1|||
94382882|NCT00454636|323187259|FG003|Overall Study|Death|1|||
94382883|NCT00454636|323187256|FG000|Overall Study|Patient refusal|1|||
94382884|NCT00454636|323187257|FG001|Overall Study|Patient refusal|1|||
94382885|NCT00454636|323187258|FG002|Overall Study|Patient refusal|3|||
94382886|NCT00454636|323187259|FG003|Overall Study|Patient refusal|2|||
94382887|NCT00454636|323187256|FG000|Overall Study|Lost to Follow-up|0|||
94382888|NCT00454636|323187257|FG001|Overall Study|Lost to Follow-up|1|||
94382889|NCT00454636|323187258|FG002|Overall Study|Lost to Follow-up|0|||
94382890|NCT00454636|323187259|FG003|Overall Study|Lost to Follow-up|0|||
94382891|NCT01901055|323187260|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
94382892|NCT01901055|323187261|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
94382893|NCT01901055|323187260|FG000|Randomization But Not Titrated|Physician Decision|0|||
94382894|NCT01901055|323187261|FG001|Randomization But Not Titrated|Physician Decision|1|||
94382895|NCT01901055|323187260|FG000|Started Protocol to Week 6|Physician Decision|2|||
94382896|NCT01901055|323187261|FG001|Started Protocol to Week 6|Physician Decision|1|||
94473875|NCT00303472|323526802|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
94312672|NCT00521339|322928279|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
94312673|NCT00521339|322928280|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
94312674|NCT00521339|322928278|FG000|Treatment Extension Phase|Death|0|||
94312675|NCT00521339|322928279|FG001|Treatment Extension Phase|Death|0|||
94312676|NCT00521339|322928280|FG002|Treatment Extension Phase|Death|1|||
94312677|NCT01614769|322928285|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
94312678|NCT01614769|322928286|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
94312679|NCT01614769|322928287|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
94382897|NCT01901055|323187260|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
94382898|NCT01901055|323187261|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
94382899|NCT01901055|323187260|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
94382900|NCT01901055|323187261|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
94382901|NCT01901055|323187260|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
94382902|NCT01901055|323187261|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
94382903|NCT01901055|323187260|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
94473876|NCT00303472|323526796|FG000|Treatment Extension (Optional)|Physician Decision|0|||
94473877|NCT00303472|323526797|FG001|Treatment Extension (Optional)|Physician Decision|4|||
94473878|NCT00303472|323526798|FG002|Treatment Extension (Optional)|Physician Decision|2|||
94473879|NCT00303472|323526799|FG003|Treatment Extension (Optional)|Physician Decision|3|||
94473880|NCT00303472|323526800|FG004|Treatment Extension (Optional)|Physician Decision|2|||
94473881|NCT00303472|323526801|FG005|Treatment Extension (Optional)|Physician Decision|0|||
94473882|NCT00303472|323526802|FG006|Treatment Extension (Optional)|Physician Decision|0|||
94473883|NCT00303472|323526796|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
94473884|NCT00303472|323526797|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
94473885|NCT00303472|323526798|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
94473886|NCT00303472|323526799|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
94473887|NCT00303472|323526800|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
94473888|NCT00303472|323526801|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
94473889|NCT00303472|323526802|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
94473890|NCT00303472|323526796|FG000|Treatment Extension (Optional)|Other|0|||
94473891|NCT00303472|323526797|FG001|Treatment Extension (Optional)|Other|2|||
94473892|NCT00303472|323526798|FG002|Treatment Extension (Optional)|Other|4|||
94473893|NCT00303472|323526799|FG003|Treatment Extension (Optional)|Other|2|||
94473894|NCT00303472|323526800|FG004|Treatment Extension (Optional)|Other|1|||
94473895|NCT00303472|323526801|FG005|Treatment Extension (Optional)|Other|0|||
94473896|NCT00303472|323526802|FG006|Treatment Extension (Optional)|Other|0|||
94473897|NCT00303472|323526796|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
94473898|NCT00303472|323526797|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
94473899|NCT00303472|323526798|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
94473900|NCT00303472|323526799|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
94473901|NCT00303472|323526800|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
94473902|NCT00303472|323526801|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
94473903|NCT00303472|323526802|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
94473904|NCT01939223|323526803|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
94473905|NCT01939223|323526804|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
94473906|NCT01939223|323526803|FG000|Overall Study|Disease recurrence (radiological)|1|||
94473907|NCT01939223|323526804|FG001|Overall Study|Disease recurrence (radiological)|3|||
94473908|NCT01939223|323526803|FG000|Overall Study|Study stopped by Sponsor|5|||
94473909|NCT01939223|323526804|FG001|Overall Study|Study stopped by Sponsor|7|||
94473910|NCT01939223|323526803|FG000|Overall Study|Withdrawal by Subject|6|||
94473911|NCT01939223|323526804|FG001|Overall Study|Withdrawal by Subject|0|||
94473912|NCT01134393|323526819|FG000|Overall Study|Adverse Event|18|||
94473913|NCT01134393|323526819|FG000|Overall Study|Lack of Efficacy|2|||
94473914|NCT01134393|323526819|FG000|Overall Study|Protocol Violation|12|||
94473915|NCT01134393|323526819|FG000|Overall Study|Lost to Follow-up|3|||
94473916|NCT01134393|323526819|FG000|Overall Study|Withdrawal by Subject|11|||
94473917|NCT01134393|323526819|FG000|Overall Study|Other|6|||
94473918|NCT01087203|323526823|FG000|Overall Study|Lost to Follow-up|2|||
94473919|NCT01087203|323526824|FG001|Overall Study|Lost to Follow-up|0|||
94473920|NCT01087203|323526823|FG000|Overall Study|Withdrawal by Subject|2|||
94473921|NCT01087203|323526824|FG001|Overall Study|Withdrawal by Subject|6|||
94473922|NCT01087203|323526823|FG000|Overall Study|Lack of Efficacy|1|||
94473923|NCT01087203|323526824|FG001|Overall Study|Lack of Efficacy|2|||
94473924|NCT01087203|323526823|FG000|Overall Study|Study terminated by sponsor|27|||
94473925|NCT01087203|323526824|FG001|Overall Study|Study terminated by sponsor|27|||
94473926|NCT03134911|323526825|FG000|Overall Study|Screen failure|31|||
94473927|NCT03134911|323526825|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
94473928|NCT01670045|323526826|FG000|Overall Study|Withdrawal by Subject|3|||
94473929|NCT01670045|323526826|FG000|Overall Study|Adverse Event|1|||
94473930|NCT01670045|323526826|FG000|Overall Study|Death|1|||
94473931|NCT01670045|323526826|FG000|Overall Study|Lost to Follow-up|11|||
94473932|NCT02383355|323526829|FG000|Overall Study|Adverse Event|2|||
94473933|NCT02383355|323526830|FG001|Overall Study|Adverse Event|0|||
94473934|NCT04074330|323526831|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
94473935|NCT04074330|323526832|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
94312680|NCT01614769|322928288|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
94312681|NCT01614769|322928289|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
94473936|NCT04074330|323526833|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
94473937|NCT04074330|323526834|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
94473938|NCT04074330|323526835|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
94473939|NCT04074330|323526836|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
94473940|NCT04074330|323526837|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
94473941|NCT04074330|323526838|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
94473942|NCT04074330|323526839|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
94473943|NCT04074330|323526840|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
94312682|NCT01614769|322928290|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
94473944|NCT04074330|323526831|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
94473945|NCT04074330|323526832|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
94473946|NCT04074330|323526833|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
94473947|NCT04074330|323526834|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
94473948|NCT04074330|323526835|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
94473949|NCT04074330|323526836|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
94473950|NCT04074330|323526837|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
94473951|NCT04074330|323526838|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
94473952|NCT04074330|323526839|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
94473953|NCT04074330|323526840|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
94473954|NCT04074330|323526831|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
94473955|NCT04074330|323526832|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
94473956|NCT04074330|323526833|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
94473957|NCT04074330|323526834|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
94473958|NCT04074330|323526835|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
94473959|NCT04074330|323526836|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
94473960|NCT04074330|323526837|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
94473961|NCT04074330|323526838|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
94473962|NCT04074330|323526839|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
94473963|NCT04074330|323526840|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
94473964|NCT04074330|323526831|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
94473965|NCT04074330|323526832|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
94473966|NCT04074330|323526833|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
94473967|NCT04074330|323526834|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
94473968|NCT04074330|323526835|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
94473969|NCT04074330|323526836|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
94473970|NCT04074330|323526837|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
94473971|NCT04074330|323526838|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
94473972|NCT04074330|323526839|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
94473973|NCT04074330|323526840|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
94473974|NCT04074330|323526831|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
94473975|NCT04074330|323526832|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
94473976|NCT04074330|323526833|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
94473977|NCT04074330|323526834|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
94473978|NCT04074330|323526835|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
94473979|NCT04074330|323526836|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
94473980|NCT04074330|323526837|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
94473981|NCT04074330|323526838|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
94473982|NCT04074330|323526839|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
94473983|NCT04074330|323526840|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
94473984|NCT04074330|323526831|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
94473985|NCT04074330|323526832|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
94473986|NCT04074330|323526833|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
94473987|NCT04074330|323526834|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
94473988|NCT04074330|323526835|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
94473989|NCT04074330|323526836|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
94473990|NCT04074330|323526837|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
94473991|NCT04074330|323526838|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
94473992|NCT04074330|323526839|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
94473993|NCT04074330|323526840|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
94473994|NCT04074330|323526831|FG000|Dose Expansion (up to 42 Months)|Death|0|||
94473995|NCT04074330|323526832|FG001|Dose Expansion (up to 42 Months)|Death|0|||
94473996|NCT04074330|323526833|FG002|Dose Expansion (up to 42 Months)|Death|0|||
94473997|NCT04074330|323526834|FG003|Dose Expansion (up to 42 Months)|Death|0|||
94473998|NCT04074330|323526835|FG004|Dose Expansion (up to 42 Months)|Death|0|||
94473999|NCT04074330|323526836|FG005|Dose Expansion (up to 42 Months)|Death|0|||
94474000|NCT04074330|323526837|FG006|Dose Expansion (up to 42 Months)|Death|0|||
94474001|NCT04074330|323526838|FG007|Dose Expansion (up to 42 Months)|Death|0|||
94474002|NCT04074330|323526839|FG008|Dose Expansion (up to 42 Months)|Death|1|||
94474003|NCT04074330|323526840|FG009|Dose Expansion (up to 42 Months)|Death|0|||
94474004|NCT04074330|323526831|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
94474005|NCT04074330|323526832|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
94474006|NCT04074330|323526833|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
94474007|NCT04074330|323526834|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
94312683|NCT01614769|322928285|FG000|Period 1|Protocol Violation|0|||
94312684|NCT01614769|322928286|FG001|Period 1|Protocol Violation|0|||
94312685|NCT01614769|322928287|FG002|Period 1|Protocol Violation|0|||
94312686|NCT01614769|322928288|FG003|Period 1|Protocol Violation|1|||
94312687|NCT01614769|322928289|FG004|Period 1|Protocol Violation|0|||
94312688|NCT01614769|322928290|FG005|Period 1|Protocol Violation|0|||
94312689|NCT01614769|322928285|FG000|Period 1|Withdrawal by Subject|1|||
94312690|NCT01614769|322928286|FG001|Period 1|Withdrawal by Subject|0|||
94312691|NCT01614769|322928287|FG002|Period 1|Withdrawal by Subject|0|||
94312692|NCT01614769|322928288|FG003|Period 1|Withdrawal by Subject|0|||
94312693|NCT01614769|322928289|FG004|Period 1|Withdrawal by Subject|0|||
94312694|NCT01614769|322928290|FG005|Period 1|Withdrawal by Subject|0|||
94312695|NCT01614769|322928285|FG000|Period 3|Withdrawal by Subject|0|||
94312696|NCT01614769|322928286|FG001|Period 3|Withdrawal by Subject|0|||
94312697|NCT01614769|322928287|FG002|Period 3|Withdrawal by Subject|1|||
94312698|NCT01614769|322928288|FG003|Period 3|Withdrawal by Subject|0|||
94312699|NCT01614769|322928289|FG004|Period 3|Withdrawal by Subject|0|||
94312700|NCT01614769|322928290|FG005|Period 3|Withdrawal by Subject|0|||
94312701|NCT00960440|322928293|FG000|Overall Study|Death|0|||
94312702|NCT00960440|322928294|FG001|Overall Study|Death|0|||
94312703|NCT00960440|322928295|FG002|Overall Study|Death|0|||
94312704|NCT00960440|322928296|FG003|Overall Study|Death|1|||
94312705|NCT00960440|322928293|FG000|Overall Study|Adverse Event|12|||
94312706|NCT00960440|322928294|FG001|Overall Study|Adverse Event|12|||
94312707|NCT00960440|322928295|FG002|Overall Study|Adverse Event|4|||
94312708|NCT00960440|322928296|FG003|Overall Study|Adverse Event|4|||
94312709|NCT00960440|322928293|FG000|Overall Study|Lack of Efficacy|2|||
94312710|NCT00960440|322928294|FG001|Overall Study|Lack of Efficacy|5|||
94312711|NCT00960440|322928295|FG002|Overall Study|Lack of Efficacy|3|||
94312712|NCT00960440|322928296|FG003|Overall Study|Lack of Efficacy|8|||
94312713|NCT00960440|322928293|FG000|Overall Study|Protocol Violation|2|||
94312714|NCT00960440|322928294|FG001|Overall Study|Protocol Violation|8|||
94312715|NCT00960440|322928295|FG002|Overall Study|Protocol Violation|3|||
94312716|NCT00960440|322928296|FG003|Overall Study|Protocol Violation|4|||
94312717|NCT00960440|322928293|FG000|Overall Study|Withdrawal by Subject|9|||
94312718|NCT00960440|322928294|FG001|Overall Study|Withdrawal by Subject|5|||
94312719|NCT00960440|322928295|FG002|Overall Study|Withdrawal by Subject|2|||
94312720|NCT00960440|322928296|FG003|Overall Study|Withdrawal by Subject|1|||
94312721|NCT00960440|322928293|FG000|Overall Study|Other|1|||
94312722|NCT00960440|322928294|FG001|Overall Study|Other|1|||
94312723|NCT00960440|322928295|FG002|Overall Study|Other|1|||
94312724|NCT00960440|322928296|FG003|Overall Study|Other|0|||
94312725|NCT02750813|322928297|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
94312726|NCT02750813|322928298|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
94312727|NCT02750813|322928297|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
94312728|NCT02750813|322928298|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
94312729|NCT03554005|322928299|FG000|Overall Study|Not in participant's best interest|0|||
94312730|NCT03554005|322928300|FG001|Overall Study|Not in participant's best interest|0|||
94312731|NCT03554005|322928301|FG002|Overall Study|Not in participant's best interest|0|||
94312732|NCT03554005|322928302|FG003|Overall Study|Not in participant's best interest|0|||
94312733|NCT03554005|322928303|FG004|Overall Study|Not in participant's best interest|0|||
94312734|NCT03554005|322928304|FG005|Overall Study|Not in participant's best interest|1|||
94312735|NCT03554005|322928299|FG000|Overall Study|Disease Progression|1|||
94312736|NCT03554005|322928300|FG001|Overall Study|Disease Progression|1|||
94312737|NCT03554005|322928301|FG002|Overall Study|Disease Progression|1|||
94312738|NCT03554005|322928302|FG003|Overall Study|Disease Progression|1|||
94312739|NCT03554005|322928303|FG004|Overall Study|Disease Progression|5|||
94312740|NCT03554005|322928304|FG005|Overall Study|Disease Progression|6|||
94312741|NCT03554005|322928299|FG000|Overall Study|Adverse Event|0|||
94312742|NCT03554005|322928300|FG001|Overall Study|Adverse Event|0|||
94312743|NCT03554005|322928301|FG002|Overall Study|Adverse Event|0|||
94312744|NCT03554005|322928302|FG003|Overall Study|Adverse Event|0|||
94312745|NCT03554005|322928303|FG004|Overall Study|Adverse Event|0|||
94312746|NCT03554005|322928304|FG005|Overall Study|Adverse Event|3|||
94382904|NCT01901055|323187261|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
94312747|NCT03554005|322928299|FG000|Overall Study|Physician Decision|0|||
94312748|NCT03554005|322928300|FG001|Overall Study|Physician Decision|0|||
94312749|NCT03554005|322928301|FG002|Overall Study|Physician Decision|0|||
94312750|NCT03554005|322928302|FG003|Overall Study|Physician Decision|0|||
94312751|NCT03554005|322928303|FG004|Overall Study|Physician Decision|1|||
94312752|NCT03554005|322928304|FG005|Overall Study|Physician Decision|0|||
94312753|NCT03554005|322928299|FG000|Overall Study|Other|0|||
94312754|NCT03554005|322928300|FG001|Overall Study|Other|0|||
94312755|NCT03554005|322928301|FG002|Overall Study|Other|0|||
94312756|NCT03554005|322928302|FG003|Overall Study|Other|0|||
94312757|NCT03554005|322928303|FG004|Overall Study|Other|0|||
94312758|NCT03554005|322928304|FG005|Overall Study|Other|1|||
94312759|NCT02116972|322928306|FG000|Overall Study|Adverse Event|4|||
94312760|NCT02116972|322928307|FG001|Overall Study|Adverse Event|4|||
94312761|NCT02116972|322928308|FG002|Overall Study|Adverse Event|1|||
94474008|NCT04074330|323526835|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
94474009|NCT04074330|323526836|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
94474010|NCT04074330|323526837|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
94474011|NCT04074330|323526838|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
94474012|NCT04074330|323526839|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
94474013|NCT04074330|323526840|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
94474014|NCT01903993|323526843|FG000|Overall Study|Death|118|||
94474015|NCT01903993|323526844|FG001|Overall Study|Death|121|||
94474016|NCT01903993|323526843|FG000|Overall Study|Withdrawal by Subject|15|||
94474017|NCT01903993|323526844|FG001|Overall Study|Withdrawal by Subject|4|||
94474018|NCT01903993|323526843|FG000|Overall Study|Lost to Follow-up|2|||
94474019|NCT01903993|323526844|FG001|Overall Study|Lost to Follow-up|3|||
94474020|NCT01903993|323526843|FG000|Overall Study|Study Terminated by Sponsor|8|||
94382905|NCT01901055|323187260|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
94382906|NCT01901055|323187261|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
94382907|NCT01901055|323187260|FG000|Week 24|Withdrawal by Subject|13|||
94382908|NCT01901055|323187261|FG001|Week 24|Withdrawal by Subject|19|||
94382909|NCT01901055|323187260|FG000|Week 24|Physician Decision|1|||
94382910|NCT01901055|323187261|FG001|Week 24|Physician Decision|0|||
94382911|NCT01901055|323187260|FG000|Week 36|Withdrawal by Subject|0|||
94382912|NCT01901055|323187261|FG001|Week 36|Withdrawal by Subject|5|||
94382913|NCT00282256|323187265|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
94382914|NCT00282256|323187265|FG000|Extension Treatment Period|Adverse Event|2|||
94382915|NCT00708422|323187266|FG000|Overall Study|Adverse Event|3|||
94382916|NCT00708422|323187267|FG001|Overall Study|Adverse Event|1|||
94382917|NCT00708422|323187266|FG000|Overall Study|Withdrawal by Subject|1|||
94382918|NCT00708422|323187267|FG001|Overall Study|Withdrawal by Subject|0|||
94382919|NCT00635154|323187276|FG000|Overall Study|Alternative Treatment|8|||
94382920|NCT00635154|323187276|FG000|Overall Study|Other|4|||
94382921|NCT00635154|323187276|FG000|Overall Study|Still on treatment|21|||
94382922|NCT02540356|323187277|FG000|Overall Study|Terminated due to disease progression|1|||
94382923|NCT02540356|323187278|FG001|Overall Study|Terminated due to disease progression|0|||
94382924|NCT02795104|323187279|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
94382925|NCT02795104|323187280|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
94382926|NCT02795104|323187281|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
94382927|NCT02795104|323187279|FG000|Overall Study|Withdrawal by Subject|0|||
94382928|NCT02795104|323187280|FG001|Overall Study|Withdrawal by Subject|2|||
94382929|NCT02795104|323187281|FG002|Overall Study|Withdrawal by Subject|0|||
94382930|NCT02795104|323187279|FG000|Overall Study|Lost to Follow-up|0|||
94382931|NCT02795104|323187280|FG001|Overall Study|Lost to Follow-up|0|||
94382932|NCT02795104|323187281|FG002|Overall Study|Lost to Follow-up|1|||
94382933|NCT01654380|323187282|FG000|Part B, Period 1|Physician Decision|0|||
94382934|NCT01654380|323187283|FG001|Part B, Period 1|Physician Decision|0|||
94382935|NCT01654380|323187284|FG002|Part B, Period 1|Physician Decision|1|||
94382936|NCT01654380|323187285|FG003|Part B, Period 1|Physician Decision|0|||
94382937|NCT03335371|323187286|FG000|Overall Study|Lost to Follow-up|0|||
94382938|NCT03335371|323187287|FG001|Overall Study|Lost to Follow-up|0|||
94382939|NCT03335371|323187288|FG002|Overall Study|Lost to Follow-up|0|||
94382940|NCT03335371|323187289|FG003|Overall Study|Lost to Follow-up|0|||
94382941|NCT03335371|323187290|FG004|Overall Study|Lost to Follow-up|1|||
94382942|NCT03335371|323187286|FG000|Overall Study|Withdrawal by Subject|0|||
94382943|NCT03335371|323187287|FG001|Overall Study|Withdrawal by Subject|0|||
94382944|NCT03335371|323187288|FG002|Overall Study|Withdrawal by Subject|0|||
94382945|NCT03335371|323187289|FG003|Overall Study|Withdrawal by Subject|0|||
94382946|NCT03335371|323187290|FG004|Overall Study|Withdrawal by Subject|1|||
94382947|NCT03335371|323187286|FG000|Overall Study|Randomization Error|0|||
94382948|NCT03335371|323187287|FG001|Overall Study|Randomization Error|0|||
94382949|NCT03335371|323187288|FG002|Overall Study|Randomization Error|1|||
94382950|NCT03335371|323187289|FG003|Overall Study|Randomization Error|0|||
94382951|NCT03335371|323187290|FG004|Overall Study|Randomization Error|0|||
94382952|NCT01606306|323187294|FG000|Overall Study|Lack of Efficacy|2|||
94382953|NCT01606306|323187295|FG001|Overall Study|Lack of Efficacy|1|||
94382954|NCT01606306|323187296|FG002|Overall Study|Lack of Efficacy|4|||
94382955|NCT01606306|323187297|FG003|Overall Study|Lack of Efficacy|4|||
94382956|NCT01606306|323187298|FG004|Overall Study|Lack of Efficacy|1|||
94382957|NCT01606306|323187299|FG005|Overall Study|Lack of Efficacy|2|||
94382958|NCT01606306|323187294|FG000|Overall Study|Adverse Event|1|||
94382959|NCT01606306|323187295|FG001|Overall Study|Adverse Event|0|||
94382960|NCT01606306|323187296|FG002|Overall Study|Adverse Event|1|||
94382961|NCT01606306|323187297|FG003|Overall Study|Adverse Event|1|||
94382962|NCT01606306|323187298|FG004|Overall Study|Adverse Event|2|||
94382963|NCT01606306|323187299|FG005|Overall Study|Adverse Event|0|||
94382964|NCT01606306|323187294|FG000|Overall Study|Lost to Follow-up|7|||
94474021|NCT01903993|323526844|FG001|Overall Study|Study Terminated by Sponsor|14|||
94474022|NCT01903993|323526843|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
94382965|NCT01606306|323187295|FG001|Overall Study|Lost to Follow-up|4|||
94474023|NCT01903993|323526844|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
94474024|NCT00184093|323526845|FG000|Overall Study|Adverse Event|3|||
94474025|NCT00184093|323526845|FG000|Overall Study|Lost to Follow-up|3|||
94474026|NCT00184093|323526845|FG000|Overall Study|Physician Decision|1|||
94474027|NCT00184093|323526845|FG000|Overall Study|Withdrawal by Subject|2|||
94474028|NCT02588664|323526849|FG000|Overall Study|Death|56|||
94474029|NCT02588664|323526850|FG001|Overall Study|Death|55|||
94474030|NCT02588664|323526849|FG000|Overall Study|Lost to Follow-up|1305|||
94474031|NCT02588664|323526850|FG001|Overall Study|Lost to Follow-up|990|||
94474032|NCT01607346|323526860|FG000|Overall Study|Adverse Event|3|||
94474033|NCT01098162|323526863|FG000|Overall Study|Adverse Event|37|||
94474034|NCT01098162|323526863|FG000|Overall Study|Lack of Efficacy|4|||
94474035|NCT01098162|323526863|FG000|Overall Study|Wish of Patient|7|||
94474036|NCT01098162|323526863|FG000|Overall Study|Lost to Follow-up|9|||
94474037|NCT01098162|323526863|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
94474038|NCT01098162|323526863|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
94474039|NCT01098162|323526863|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
94474040|NCT01098162|323526863|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
94474041|NCT01098162|323526863|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
94474042|NCT01098162|323526863|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
94474043|NCT01098162|323526863|FG000|Overall Study|Other Reason|1|||
94474044|NCT01098162|323526863|FG000|Overall Study|Reason Unknown|26|||
94474045|NCT02787083|323526865|FG000|Overall Study|Adverse Event|1|||
94474046|NCT02787083|323526866|FG001|Overall Study|Adverse Event|0|||
94474047|NCT02787083|323526865|FG000|Overall Study|Withdrawal by Subject|2|||
94474048|NCT02787083|323526866|FG001|Overall Study|Withdrawal by Subject|2|||
94474049|NCT01990768|323526871|FG000|Intervention Started|Found to be ineligible|14|||
94474050|NCT01990768|323526872|FG001|Intervention Started|Found to be ineligible|13|||
94474051|NCT01990768|323526873|FG002|Intervention Started|Found to be ineligible|11|||
94474052|NCT01990768|323526871|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
94474053|NCT01990768|323526872|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
94474054|NCT01990768|323526873|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
94474055|NCT01990768|323526871|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
94474056|NCT01990768|323526872|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
94474057|NCT01990768|323526873|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
94474058|NCT01990768|323526871|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
94474059|NCT01990768|323526872|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
94474060|NCT01990768|323526873|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
94474061|NCT01990768|323526871|FG000|Intervention Started|Patient care priority|1|||
94474062|NCT01990768|323526872|FG001|Intervention Started|Patient care priority|2|||
94474063|NCT01990768|323526873|FG002|Intervention Started|Patient care priority|3|||
94474064|NCT01990768|323526871|FG000|Intervention Started|IV lost|2|||
94474065|NCT01990768|323526872|FG001|Intervention Started|IV lost|2|||
94382966|NCT01606306|323187296|FG002|Overall Study|Lost to Follow-up|5|||
94382967|NCT01606306|323187297|FG003|Overall Study|Lost to Follow-up|4|||
94382968|NCT01606306|323187298|FG004|Overall Study|Lost to Follow-up|3|||
94382969|NCT01606306|323187299|FG005|Overall Study|Lost to Follow-up|5|||
94382970|NCT01606306|323187294|FG000|Overall Study|Withdrawal by Subject|4|||
94382971|NCT01606306|323187295|FG001|Overall Study|Withdrawal by Subject|3|||
94382972|NCT01606306|323187296|FG002|Overall Study|Withdrawal by Subject|4|||
94382973|NCT01606306|323187297|FG003|Overall Study|Withdrawal by Subject|4|||
94382974|NCT01606306|323187298|FG004|Overall Study|Withdrawal by Subject|5|||
94382975|NCT01606306|323187299|FG005|Overall Study|Withdrawal by Subject|4|||
94382976|NCT01606306|323187294|FG000|Overall Study|Physician Decision|1|||
94382977|NCT01606306|323187295|FG001|Overall Study|Physician Decision|2|||
94382978|NCT01606306|323187296|FG002|Overall Study|Physician Decision|0|||
94382979|NCT01606306|323187297|FG003|Overall Study|Physician Decision|0|||
94382980|NCT01606306|323187298|FG004|Overall Study|Physician Decision|0|||
94382981|NCT01606306|323187299|FG005|Overall Study|Physician Decision|0|||
94382982|NCT01046253|323187300|FG000|Second Intervention|Adverse Event|0|||
94382983|NCT01046253|323187301|FG001|Second Intervention|Adverse Event|1|||
94382984|NCT01046253|323187300|FG000|Second Intervention|Protocol Violation|0|||
94382985|NCT01046253|323187301|FG001|Second Intervention|Protocol Violation|1|||
94382986|NCT02199509|323187305|FG000|Overall Study|Suicidal Ideation|0|||
94382987|NCT02199509|323187306|FG001|Overall Study|Suicidal Ideation|1|||
94382988|NCT02199509|323187305|FG000|Overall Study|Misunderstood titration schedule|1|||
94382989|NCT02199509|323187306|FG001|Overall Study|Misunderstood titration schedule|0|||
94382990|NCT00683293|323187313|FG000|Overall Study|Withdrawal by Subject|2|||
94382991|NCT00683293|323187314|FG001|Overall Study|Withdrawal by Subject|3|||
94382992|NCT01104662|323187315|FG000|Overall Study|Adverse Event|2|||
94382993|NCT01104662|323187316|FG001|Overall Study|Adverse Event|2|||
94382994|NCT01104662|323187317|FG002|Overall Study|Adverse Event|0|||
94382995|NCT01104662|323187318|FG003|Overall Study|Adverse Event|1|||
94474066|NCT01990768|323526873|FG002|Intervention Started|IV lost|2|||
94474067|NCT01990768|323526871|FG000|Intervention Started|Required CPR|1|||
94312762|NCT02116972|322928306|FG000|Overall Study|Withdrawal by Subject|1|||
94312763|NCT02116972|322928307|FG001|Overall Study|Withdrawal by Subject|1|||
94312764|NCT02116972|322928308|FG002|Overall Study|Withdrawal by Subject|5|||
94312765|NCT02116972|322928306|FG000|Overall Study|Protocol Violation|1|||
94312766|NCT02116972|322928307|FG001|Overall Study|Protocol Violation|0|||
94312767|NCT02116972|322928308|FG002|Overall Study|Protocol Violation|1|||
94312768|NCT02116972|322928306|FG000|Overall Study|Lost to Follow-up|4|||
94312769|NCT02116972|322928307|FG001|Overall Study|Lost to Follow-up|3|||
94312770|NCT02116972|322928308|FG002|Overall Study|Lost to Follow-up|1|||
94312771|NCT02116972|322928306|FG000|Overall Study|Lack of Efficacy|6|||
94312772|NCT02116972|322928307|FG001|Overall Study|Lack of Efficacy|6|||
94312773|NCT02116972|322928308|FG002|Overall Study|Lack of Efficacy|5|||
94312774|NCT02116972|322928306|FG000|Overall Study|scheduling conflicts and relocation|3|||
94312775|NCT02116972|322928307|FG001|Overall Study|scheduling conflicts and relocation|3|||
94312776|NCT02116972|322928308|FG002|Overall Study|scheduling conflicts and relocation|6|||
94312777|NCT01400971|322928309|FG000|Overall Study|Death|82|||
94312778|NCT01400971|322928309|FG000|Overall Study|Lost to Follow-up|196|||
94312779|NCT01400971|322928309|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
94312780|NCT01400971|322928309|FG000|Overall Study|Physician Decision|57|||
94312781|NCT01400971|322928309|FG000|Overall Study|Withdrawal by Subject|158|||
94312782|NCT01400971|322928309|FG000|Overall Study|Other|422|||
94312783|NCT02650284|322928313|FG000|Overall Study|Lost to Follow-up|3|||
94312784|NCT02650284|322928314|FG001|Overall Study|Lost to Follow-up|3|||
94312785|NCT02650284|322928313|FG000|Overall Study|Consent incorrectly taken|0|||
94312786|NCT02650284|322928314|FG001|Overall Study|Consent incorrectly taken|1|||
94312787|NCT02399475|322928319|FG000|Overall Study|Physician Decision|1|||
94312788|NCT02399475|322928320|FG001|Overall Study|Physician Decision|0|||
94312789|NCT01070784|322928324|FG000|Overall Study|Withdrawal by Subject|6|||
94312790|NCT01070784|322928325|FG001|Overall Study|Withdrawal by Subject|9|||
94312791|NCT01070784|322928324|FG000|Overall Study|Adverse Event|14|||
94312792|NCT01070784|322928325|FG001|Overall Study|Adverse Event|9|||
94312793|NCT01780389|322928326|FG000|Overall Study|Adverse Event|1|||
94312794|NCT01000064|322928327|FG000|Overall Study|Withdrawal by Subject|1|||
94312795|NCT01000064|322928328|FG001|Overall Study|Withdrawal by Subject|1|||
94312796|NCT02815397|322928329|FG000|Overall Study|Physician Decision|2|||
94312797|NCT00085540|322928330|FG000|Overall Study|Withdrawal by Subject|0|||
94312798|NCT00085540|322928331|FG001|Overall Study|Withdrawal by Subject|1|||
94312799|NCT00085540|322928330|FG000|Overall Study|Protocol Violation|0|||
94312800|NCT00085540|322928331|FG001|Overall Study|Protocol Violation|1|||
94312801|NCT00798967|322928332|FG000|Overall Study|Adverse Event|2|||
94312802|NCT00798967|322928333|FG001|Overall Study|Adverse Event|3|||
94312803|NCT00798967|322928332|FG000|Overall Study|Withdrawal by Subject|0|||
94312804|NCT00798967|322928333|FG001|Overall Study|Withdrawal by Subject|1|||
94312805|NCT00798967|322928332|FG000|Overall Study|Physician Decision|1|||
94312806|NCT00798967|322928333|FG001|Overall Study|Physician Decision|0|||
94312807|NCT00798967|322928332|FG000|Overall Study|Randomized in error by site|1|||
94312808|NCT00798967|322928333|FG001|Overall Study|Randomized in error by site|0|||
94312809|NCT00633139|322928334|FG000|Overall Study|Non compliance|0|||
94312810|NCT00633139|322928335|FG001|Overall Study|Non compliance|0|||
94312811|NCT00633139|322928336|FG002|Overall Study|Non compliance|1|||
94312812|NCT00633139|322928334|FG000|Overall Study|Withdrawal by Subject|0|||
94312813|NCT00633139|322928335|FG001|Overall Study|Withdrawal by Subject|1|||
94312814|NCT00633139|322928336|FG002|Overall Study|Withdrawal by Subject|0|||
94312815|NCT04238663|322928337|FG000|Overall Study|Lost to Follow-up|0|||
94312816|NCT04238663|322928338|FG001|Overall Study|Lost to Follow-up|1|||
94312817|NCT04238663|322928339|FG002|Overall Study|Lost to Follow-up|0|||
94312818|NCT00337467|322928340|FG000|Overall Study|Adverse Event|3|||
94312819|NCT00337467|322928340|FG000|Overall Study|Subject Withdrew Consent|2|||
94312820|NCT00337467|322928340|FG000|Overall Study|Pregnancy|1|||
94312821|NCT00337467|322928340|FG000|Overall Study|Lost to Follow-up|2|||
94312822|NCT00337467|322928340|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
94312823|NCT02433210|322929872|FG000|Overall Study|Physician Decision|1|||
94312824|NCT02433210|322929873|FG001|Overall Study|Physician Decision|0|||
94312825|NCT02433210|322929874|FG002|Overall Study|Physician Decision|0|||
94312826|NCT03314519|322929877|FG000|Overall Study|Protocol Violation|3|||
94312827|NCT03314519|322929878|FG001|Overall Study|Protocol Violation|2|||
94312828|NCT02311478|322929884|FG000|Overall Study|Withdrawal by Subject|1|||
94312829|NCT02311478|322929884|FG000|Overall Study|Lost to Follow-up|5|||
94312830|NCT02311478|322929884|FG000|Overall Study|Failed IUD Insertion|1|||
94312831|NCT03504774|322929885|FG000|Overall Study|Adverse Event|2|||
94312832|NCT03504774|322929886|FG001|Overall Study|Adverse Event|0|||
94312833|NCT03504774|322929885|FG000|Overall Study|Lost to Follow-up|0|||
94312834|NCT03504774|322929886|FG001|Overall Study|Lost to Follow-up|1|||
94312835|NCT03504774|322929885|FG000|Overall Study|Protocol Violation|11|||
94312836|NCT03504774|322929886|FG001|Overall Study|Protocol Violation|3|||
94312837|NCT03504774|322929885|FG000|Overall Study|failed wk 52 DBPCFC|1|||
94312838|NCT03504774|322929886|FG001|Overall Study|failed wk 52 DBPCFC|0|||
94312839|NCT04998851|322929887|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
94382996|NCT01104662|323187319|FG004|Overall Study|Adverse Event|1|||
94382997|NCT01104662|323187320|FG005|Overall Study|Adverse Event|1|||
94382998|NCT01104662|323187321|FG006|Overall Study|Adverse Event|0|||
94382999|NCT01104662|323187322|FG007|Overall Study|Adverse Event|0|||
94383000|NCT01104662|323187315|FG000|Overall Study|Clinical Failure|1|||
94383001|NCT01104662|323187316|FG001|Overall Study|Clinical Failure|0|||
94383002|NCT01104662|323187317|FG002|Overall Study|Clinical Failure|0|||
94383003|NCT01104662|323187318|FG003|Overall Study|Clinical Failure|0|||
94383004|NCT01104662|323187319|FG004|Overall Study|Clinical Failure|0|||
94383005|NCT01104662|323187320|FG005|Overall Study|Clinical Failure|1|||
94383006|NCT01104662|323187321|FG006|Overall Study|Clinical Failure|0|||
94383007|NCT01104662|323187322|FG007|Overall Study|Clinical Failure|0|||
94383008|NCT01104662|323187315|FG000|Overall Study|Participant left investigator's care|1|||
94383009|NCT01104662|323187316|FG001|Overall Study|Participant left investigator's care|1|||
94383010|NCT01104662|323187317|FG002|Overall Study|Participant left investigator's care|0|||
94383011|NCT01104662|323187318|FG003|Overall Study|Participant left investigator's care|0|||
94383012|NCT01104662|323187319|FG004|Overall Study|Participant left investigator's care|0|||
94383013|NCT01104662|323187320|FG005|Overall Study|Participant left investigator's care|0|||
94383014|NCT01104662|323187321|FG006|Overall Study|Participant left investigator's care|0|||
94383015|NCT01104662|323187322|FG007|Overall Study|Participant left investigator's care|0|||
94383016|NCT01104662|323187315|FG000|Overall Study|Reason not specified|3|||
94383017|NCT01104662|323187316|FG001|Overall Study|Reason not specified|3|||
94383018|NCT01104662|323187317|FG002|Overall Study|Reason not specified|0|||
94383019|NCT01104662|323187318|FG003|Overall Study|Reason not specified|0|||
94383020|NCT01104662|323187319|FG004|Overall Study|Reason not specified|0|||
94383021|NCT01104662|323187320|FG005|Overall Study|Reason not specified|1|||
94383022|NCT01104662|323187321|FG006|Overall Study|Reason not specified|0|||
94383023|NCT01104662|323187322|FG007|Overall Study|Reason not specified|0|||
94383024|NCT01104662|323187315|FG000|Overall Study|Randomized but not treated|3|||
94383025|NCT01104662|323187316|FG001|Overall Study|Randomized but not treated|4|||
94383026|NCT01104662|323187317|FG002|Overall Study|Randomized but not treated|1|||
94383027|NCT01104662|323187318|FG003|Overall Study|Randomized but not treated|0|||
94383028|NCT01104662|323187319|FG004|Overall Study|Randomized but not treated|0|||
94383029|NCT01104662|323187320|FG005|Overall Study|Randomized but not treated|1|||
94383030|NCT01104662|323187321|FG006|Overall Study|Randomized but not treated|0|||
94383031|NCT01104662|323187322|FG007|Overall Study|Randomized but not treated|0|||
94383032|NCT00743197|323187323|FG000|Overall Study|Study terminated due to departure of PI.|1|||
94383033|NCT00743197|323187324|FG001|Overall Study|Study terminated due to departure of PI.|2|||
94383034|NCT02514174|323187325|FG000|Overall Study|Patient refused to continue medication|1|||
94383035|NCT02514174|323187325|FG000|Overall Study|Adverse Event|2|||
94383036|NCT02514174|323187325|FG000|Overall Study|Study closed by sponsor|9|||
94383037|NCT02514174|323187325|FG000|Overall Study|Progressive disease|11|||
94383038|NCT02514174|323187325|FG000|Overall Study|Treatment change|1|||
94383039|NCT02514174|323187325|FG000|Overall Study|Treated off study with Afatinib.|1|||
94383040|NCT03309956|323187326|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
94383041|NCT00993616|323187327|FG000|Overall Study|No tumor at entry|1|||
94383042|NCT00993616|323187327|FG000|Overall Study|Never treated|1|||
94383043|NCT02146430|323189356|FG000|Overall Study|Protocol Violation|5|||
94383044|NCT02146430|323189357|FG001|Overall Study|Protocol Violation|4|||
94383045|NCT02146430|323189358|FG002|Overall Study|Protocol Violation|8|||
94383046|NCT02146430|323189359|FG003|Overall Study|Protocol Violation|6|||
94383047|NCT02146430|323189356|FG000|Overall Study|Lack of Efficacy|13|||
94383048|NCT02146430|323189357|FG001|Overall Study|Lack of Efficacy|11|||
94383049|NCT02146430|323189358|FG002|Overall Study|Lack of Efficacy|8|||
94383050|NCT02146430|323189359|FG003|Overall Study|Lack of Efficacy|5|||
94383051|NCT02146430|323189356|FG000|Overall Study|Adverse Event|20|||
94383052|NCT02146430|323189357|FG001|Overall Study|Adverse Event|40|||
94383053|NCT02146430|323189358|FG002|Overall Study|Adverse Event|32|||
94383054|NCT02146430|323189359|FG003|Overall Study|Adverse Event|49|||
94383055|NCT02146430|323189356|FG000|Overall Study|Reason missing or not reported|2|||
94383056|NCT02146430|323189357|FG001|Overall Study|Reason missing or not reported|3|||
94383057|NCT02146430|323189358|FG002|Overall Study|Reason missing or not reported|4|||
94383058|NCT02146430|323189359|FG003|Overall Study|Reason missing or not reported|5|||
94383059|NCT02146430|323189356|FG000|Overall Study|Withdrawal by Subject|27|||
94383060|NCT02146430|323189357|FG001|Overall Study|Withdrawal by Subject|29|||
94383061|NCT02146430|323189358|FG002|Overall Study|Withdrawal by Subject|30|||
94383062|NCT02146430|323189359|FG003|Overall Study|Withdrawal by Subject|34|||
94383063|NCT01893905|323189360|FG000|Overall Study|Withdrawal by Subject|1|||
94383064|NCT01893905|323189361|FG001|Overall Study|Withdrawal by Subject|0|||
94383065|NCT01893905|323189360|FG000|Overall Study|Adverse Event|9|||
94383066|NCT01893905|323189361|FG001|Overall Study|Adverse Event|3|||
94383067|NCT01893905|323189360|FG000|Overall Study|Lack of Efficacy|5|||
94383068|NCT01893905|323189361|FG001|Overall Study|Lack of Efficacy|7|||
94383069|NCT01893905|323189360|FG000|Overall Study|Lost to Follow-up|1|||
94383070|NCT01893905|323189361|FG001|Overall Study|Lost to Follow-up|0|||
94383071|NCT01893905|323189360|FG000|Overall Study|Protocol Violation|6|||
94383072|NCT01893905|323189361|FG001|Overall Study|Protocol Violation|1|||
94383073|NCT01893905|323189360|FG000|Overall Study|Lack of adherence to treatment|2|||
94383074|NCT01893905|323189361|FG001|Overall Study|Lack of adherence to treatment|0|||
94383075|NCT01893905|323189360|FG000|Overall Study|Other reason|1|||
94383076|NCT01893905|323189361|FG001|Overall Study|Other reason|3|||
94383077|NCT02207231|323189367|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
94383078|NCT02207231|323189368|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
94383079|NCT02207231|323189369|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
94383080|NCT02207231|323189370|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
94383081|NCT02207231|323189367|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
94383082|NCT02207231|323189368|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
94383083|NCT02207231|323189369|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
94383084|NCT02207231|323189370|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
94383085|NCT02207231|323189367|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
94383086|NCT02207231|323189368|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
94383087|NCT02207231|323189369|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
94383088|NCT02207231|323189370|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
94383089|NCT02207231|323189367|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
94383090|NCT02207231|323189368|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
94383091|NCT02207231|323189369|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
94383092|NCT02207231|323189370|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
94383093|NCT02207231|323189367|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
94383094|NCT02207231|323189368|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
94383095|NCT02207231|323189369|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
94383096|NCT02207231|323189370|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
94383097|NCT02207231|323189367|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
94383098|NCT02207231|323189368|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
94383099|NCT02207231|323189369|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
94383100|NCT02207231|323189370|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
94383101|NCT02207231|323189367|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
94383102|NCT02207231|323189368|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
94383103|NCT02207231|323189369|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
94383104|NCT02207231|323189370|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
94383105|NCT02207231|323189367|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
94383106|NCT02207231|323189368|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
94383107|NCT02207231|323189369|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
94383108|NCT02207231|323189370|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
94383109|NCT02207231|323189367|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
94383110|NCT02207231|323189368|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
94383111|NCT02207231|323189369|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
94383112|NCT02207231|323189370|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
94383113|NCT02207231|323189367|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
94383114|NCT02207231|323189368|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
94383115|NCT02207231|323189369|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
94383116|NCT02207231|323189370|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
94383117|NCT02207231|323189367|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
94383118|NCT02207231|323189368|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
94383119|NCT02207231|323189369|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
94383120|NCT02207231|323189370|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
94383121|NCT02207231|323189367|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
94383122|NCT02207231|323189368|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
94383123|NCT02207231|323189369|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
94383124|NCT02207231|323189370|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
94383125|NCT02207231|323189367|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
94383126|NCT02207231|323189368|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
94383127|NCT02207231|323189369|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
94383128|NCT02207231|323189370|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
94383129|NCT02207231|323189367|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
94383130|NCT02207231|323189368|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
94383131|NCT02207231|323189369|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
94383132|NCT02207231|323189370|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
94383133|NCT02207231|323189367|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
94383134|NCT02207231|323189368|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
94312840|NCT04998851|322929888|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
94312841|NCT04998851|322929887|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|2|||
94312842|NCT04998851|322929888|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
94312843|NCT04998851|322929887|FG000|Vaccination Period (11 Months)|Reason Not Specified|0|||
94312844|NCT04998851|322929888|FG001|Vaccination Period (11 Months)|Reason Not Specified|1|||
94312845|NCT04998851|322929887|FG000|Vaccination Period (11 Months)|Ongoing in the study|4|||
94312846|NCT04998851|322929888|FG001|Vaccination Period (11 Months)|Ongoing in the study|4|||
94312847|NCT02241512|322929889|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
94312848|NCT02241512|322929890|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
94312849|NCT00931892|322929891|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
94312850|NCT00931892|322929892|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
94312851|NCT03567291|322929893|FG000|Period I|Adverse Event|14|||
94312852|NCT03567291|322929894|FG001|Period I|Adverse Event|0|||
94312853|NCT03567291|322929895|FG002|Period I|Adverse Event|0|||
94312854|NCT03567291|322929896|FG003|Period I|Adverse Event|0|||
94312855|NCT03567291|322929893|FG000|Period I|Protocol Violation|1|||
94312856|NCT03567291|322929894|FG001|Period I|Protocol Violation|0|||
94312857|NCT03567291|322929895|FG002|Period I|Protocol Violation|0|||
94312858|NCT03567291|322929896|FG003|Period I|Protocol Violation|0|||
94312859|NCT03567291|322929893|FG000|Period I|Withdrawal by Subject|23|||
94312860|NCT03567291|322929894|FG001|Period I|Withdrawal by Subject|0|||
94312861|NCT03567291|322929895|FG002|Period I|Withdrawal by Subject|0|||
94312862|NCT03567291|322929896|FG003|Period I|Withdrawal by Subject|0|||
94312863|NCT03567291|322929893|FG000|Period I|Lost to Follow-up|2|||
94312864|NCT03567291|322929894|FG001|Period I|Lost to Follow-up|0|||
94312865|NCT03567291|322929895|FG002|Period I|Lost to Follow-up|0|||
94312866|NCT03567291|322929896|FG003|Period I|Lost to Follow-up|0|||
94312867|NCT03567291|322929893|FG000|Period I|Terminated by sponsor|44|||
94312868|NCT03567291|322929894|FG001|Period I|Terminated by sponsor|0|||
94312869|NCT03567291|322929895|FG002|Period I|Terminated by sponsor|0|||
94312870|NCT03567291|322929896|FG003|Period I|Terminated by sponsor|0|||
94312871|NCT03567291|322929893|FG000|Period I|Missing or unknown|7|||
94312872|NCT03567291|322929894|FG001|Period I|Missing or unknown|0|||
94312873|NCT03567291|322929895|FG002|Period I|Missing or unknown|0|||
94312874|NCT03567291|322929896|FG003|Period I|Missing or unknown|0|||
94312875|NCT03567291|322929893|FG000|Period II|Adverse Event|0|||
94312876|NCT03567291|322929894|FG001|Period II|Adverse Event|1|||
94312877|NCT03567291|322929895|FG002|Period II|Adverse Event|0|||
94312878|NCT03567291|322929896|FG003|Period II|Adverse Event|0|||
94312879|NCT03567291|322929893|FG000|Period II|Missing or unknown|0|||
94312880|NCT03567291|322929894|FG001|Period II|Missing or unknown|2|||
94312881|NCT03567291|322929895|FG002|Period II|Missing or unknown|1|||
94312882|NCT03567291|322929896|FG003|Period II|Missing or unknown|0|||
94312883|NCT03567291|322929893|FG000|Period III|Adverse Event|0|||
94312884|NCT03567291|322929894|FG001|Period III|Adverse Event|0|||
94312885|NCT03567291|322929895|FG002|Period III|Adverse Event|0|||
94312886|NCT03567291|322929896|FG003|Period III|Adverse Event|4|||
94312887|NCT03567291|322929893|FG000|Period III|Withdrawal by Subject|0|||
94312888|NCT03567291|322929894|FG001|Period III|Withdrawal by Subject|0|||
94312889|NCT03567291|322929895|FG002|Period III|Withdrawal by Subject|0|||
94312890|NCT03567291|322929896|FG003|Period III|Withdrawal by Subject|4|||
94312891|NCT03567291|322929893|FG000|Period III|Lost to Follow-up|0|||
94312892|NCT03567291|322929894|FG001|Period III|Lost to Follow-up|0|||
94312893|NCT03567291|322929895|FG002|Period III|Lost to Follow-up|0|||
94312894|NCT03567291|322929896|FG003|Period III|Lost to Follow-up|1|||
94312895|NCT03567291|322929893|FG000|Period III|Terminated by sponsor|0|||
94312896|NCT03567291|322929894|FG001|Period III|Terminated by sponsor|0|||
94312897|NCT03567291|322929895|FG002|Period III|Terminated by sponsor|0|||
94312898|NCT03567291|322929896|FG003|Period III|Terminated by sponsor|68|||
94312899|NCT03567291|322929893|FG000|Period III|Missing or unknown|0|||
94312900|NCT03567291|322929894|FG001|Period III|Missing or unknown|0|||
94312901|NCT03567291|322929895|FG002|Period III|Missing or unknown|0|||
94312902|NCT03567291|322929896|FG003|Period III|Missing or unknown|8|||
94312903|NCT02341014|322929897|FG000|Overall Study|Adverse Event|0|||
94312904|NCT02341014|322929898|FG001|Overall Study|Adverse Event|1|||
94312905|NCT02341014|322929899|FG002|Overall Study|Adverse Event|0|||
94312906|NCT02341014|322929900|FG003|Overall Study|Adverse Event|0|||
94312907|NCT02341014|322929901|FG004|Overall Study|Adverse Event|2|||
94312908|NCT02145156|322929909|FG000|Overall Study|No match to vaccination records|60|||
94312909|NCT02145156|322929910|FG001|Overall Study|No match to vaccination records|52|||
94312910|NCT02145156|322929911|FG002|Overall Study|No match to vaccination records|41|||
94383135|NCT02207231|323189369|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
94312911|NCT02234583|322929916|FG000|Overall Study|Adverse Event|172|||
94312912|NCT02234583|322929917|FG001|Overall Study|Adverse Event|156|||
94312913|NCT02234583|322929916|FG000|Overall Study|Withdrawal by Subject|109|||
94312914|NCT02234583|322929917|FG001|Overall Study|Withdrawal by Subject|157|||
94312915|NCT02234583|322929916|FG000|Overall Study|Lost to Follow-up|0|||
94312916|NCT02234583|322929917|FG001|Overall Study|Lost to Follow-up|1|||
94312917|NCT02234583|322929916|FG000|Overall Study|Lack of Efficacy|58|||
94312918|NCT02234583|322929917|FG001|Overall Study|Lack of Efficacy|103|||
94312919|NCT02234583|322929916|FG000|Overall Study|Protocol Violation|35|||
94312920|NCT02234583|322929917|FG001|Overall Study|Protocol Violation|42|||
94312921|NCT02234583|322929916|FG000|Overall Study|Other|39|||
94312922|NCT02234583|322929917|FG001|Overall Study|Other|97|||
94312923|NCT02805907|322929918|FG000|Overall Study|Lost to Follow-up|3|||
94312924|NCT02805907|322929919|FG001|Overall Study|Lost to Follow-up|3|||
94312925|NCT00431847|322929920|FG000|Overall Study|completion of less than two study visits|6|||
94312926|NCT00431847|322929921|FG001|Overall Study|completion of less than two study visits|3|||
94312927|NCT00431847|322929922|FG002|Overall Study|completion of less than two study visits|4|||
94312928|NCT00431847|322929923|FG003|Overall Study|completion of less than two study visits|14|||
94312929|NCT00431847|322929924|FG004|Overall Study|completion of less than two study visits|0|||
94312930|NCT00431847|322929920|FG000|Overall Study|Protocol Violation|0|||
94312931|NCT00431847|322929921|FG001|Overall Study|Protocol Violation|0|||
94312932|NCT00431847|322929922|FG002|Overall Study|Protocol Violation|0|||
94312933|NCT00431847|322929923|FG003|Overall Study|Protocol Violation|0|||
94312934|NCT00431847|322929924|FG004|Overall Study|Protocol Violation|1|||
94312935|NCT03184701|322929925|FG000|Overall Study|Death|3|||
94312936|NCT03184701|322929925|FG000|Overall Study|Physician Decision|3|||
94312937|NCT03184701|322929925|FG000|Overall Study|Withdrawal by Subject|6|||
94312938|NCT03184701|322929925|FG000|Overall Study|Lost to Follow-up|5|||
94312939|NCT00590681|322929927|FG000|Overall Study|Withdrawal by Subject|7|||
94312940|NCT00590681|322929927|FG000|Overall Study|Adverse Event|8|||
94312941|NCT00590681|322929927|FG000|Overall Study|Death|3|||
94312942|NCT00590681|322929927|FG000|Overall Study|Lost to Follow-up|1|||
94312943|NCT00590681|322929927|FG000|Overall Study|disease progression|1|||
94312944|NCT00933335|322929939|FG000|Overall Study|Lost to Follow-up|1|||
94312945|NCT00933335|322929940|FG001|Overall Study|Lost to Follow-up|3|||
94312946|NCT00933335|322929939|FG000|Overall Study|Withdrawal by Subject|0|||
94312947|NCT00933335|322929940|FG001|Overall Study|Withdrawal by Subject|1|||
94312948|NCT00933335|322929939|FG000|Overall Study|Progressive Disease|0|||
94312949|NCT00933335|322929940|FG001|Overall Study|Progressive Disease|11|||
94312950|NCT00933335|322929939|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
94312951|NCT00933335|322929940|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
94312952|NCT00933335|322929939|FG000|Overall Study|Co-morbid Illness|1|||
94312953|NCT00933335|322929940|FG001|Overall Study|Co-morbid Illness|0|||
94312954|NCT03880227|322929941|FG000|First Visit|Withdrawal by Subject|1|||
94312955|NCT03880227|322929942|FG001|First Visit|Withdrawal by Subject|0|||
94312956|NCT03880227|322929943|FG002|First Visit|Withdrawal by Subject|0|||
94312957|NCT03880227|322929944|FG003|First Visit|Withdrawal by Subject|0|||
94312958|NCT03880227|322929941|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
94312959|NCT03880227|322929942|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
94312960|NCT03880227|322929943|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
94312961|NCT03880227|322929944|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
94312962|NCT03880227|322929941|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
94312963|NCT03880227|322929942|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
94312964|NCT03880227|322929943|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
94312965|NCT03880227|322929944|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
94312966|NCT03880227|322929941|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
94312967|NCT03880227|322929942|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
94312968|NCT03880227|322929943|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
94312969|NCT03880227|322929944|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
94312970|NCT03196297|322929945|FG000|Main Period|Withdrawal by Subject|4|||
94312971|NCT03196297|322929945|FG000|Extension Period|Withdrawal by Subject|1|||
94312972|NCT03196297|322929945|FG000|Extension Period|Lack of Efficacy|2|||
94312973|NCT03510663|322929948|FG000|Overall Study|Withdrawal by Subject|0|||
94312974|NCT03510663|322929949|FG001|Overall Study|Withdrawal by Subject|1|||
94312975|NCT03510663|322929950|FG002|Overall Study|Withdrawal by Subject|0|||
94312976|NCT03510663|322929951|FG003|Overall Study|Withdrawal by Subject|0|||
94312977|NCT03510663|322929952|FG004|Overall Study|Withdrawal by Subject|0|||
94312978|NCT03510663|322929953|FG005|Overall Study|Withdrawal by Subject|0|||
94312979|NCT03510663|322929954|FG006|Overall Study|Withdrawal by Subject|0|||
94312980|NCT03510663|322929955|FG007|Overall Study|Withdrawal by Subject|0|||
94312981|NCT02084134|322929960|FG000|Overall Study|Protocol Violation|4|||
94312982|NCT02084134|322929961|FG001|Overall Study|Protocol Violation|2|||
94312983|NCT02084134|322929960|FG000|Overall Study|Death|0|||
94312984|NCT02084134|322929961|FG001|Overall Study|Death|1|||
94383136|NCT02207231|323189370|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
94312985|NCT02026271|322929966|FG000|Overall Study|Adverse Event|2|||
94383137|NCT02207231|323189367|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
94312986|NCT02026271|322929967|FG001|Overall Study|Adverse Event|3|||
94312987|NCT02026271|322929968|FG002|Overall Study|Adverse Event|2|||
94474068|NCT01990768|323526872|FG001|Intervention Started|Required CPR|1|||
94312988|NCT02026271|322929969|FG003|Overall Study|Adverse Event|3|||
94312989|NCT02026271|322929970|FG004|Overall Study|Adverse Event|0|||
94474069|NCT01990768|323526873|FG002|Intervention Started|Required CPR|0|||
94474070|NCT01990768|323526871|FG000|Intervention Started|Seizure or hx of seizure|0|||
94474071|NCT01990768|323526872|FG001|Intervention Started|Seizure or hx of seizure|0|||
94474072|NCT01990768|323526873|FG002|Intervention Started|Seizure or hx of seizure|2|||
94474073|NCT01990768|323526871|FG000|Intervention Started|Discovered to be pregnant|0|||
94474074|NCT01990768|323526872|FG001|Intervention Started|Discovered to be pregnant|1|||
94474075|NCT01990768|323526873|FG002|Intervention Started|Discovered to be pregnant|0|||
94474076|NCT01990768|323526871|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
94474077|NCT01990768|323526872|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
94474078|NCT01990768|323526873|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
94474079|NCT01990768|323526871|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
94474080|NCT01990768|323526872|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
94474081|NCT01990768|323526873|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
94474082|NCT01990768|323526871|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
94474083|NCT01990768|323526872|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
94474084|NCT01990768|323526873|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
94474085|NCT01990768|323526871|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
94474086|NCT01990768|323526872|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
94474087|NCT01990768|323526873|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
94474088|NCT01990768|323526871|FG000|Prehospital Study Drug Infusion|Death|3|||
94474089|NCT01990768|323526872|FG001|Prehospital Study Drug Infusion|Death|1|||
94474090|NCT01990768|323526873|FG002|Prehospital Study Drug Infusion|Death|1|||
94474091|NCT01990768|323526871|FG000|Prehospital Study Drug Infusion|Discharged|2|||
94474092|NCT01990768|323526872|FG001|Prehospital Study Drug Infusion|Discharged|1|||
94474093|NCT01990768|323526873|FG002|Prehospital Study Drug Infusion|Discharged|0|||
94474094|NCT01990768|323526871|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
94474095|NCT01990768|323526872|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
94474096|NCT01990768|323526873|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
94474097|NCT01990768|323526871|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
94474098|NCT01990768|323526872|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
94474099|NCT01990768|323526873|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
94474100|NCT01990768|323526871|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
94474101|NCT01990768|323526872|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
94474102|NCT01990768|323526873|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
94474103|NCT01990768|323526871|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
94474104|NCT01990768|323526872|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
94474105|NCT01990768|323526873|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
94474106|NCT01990768|323526871|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
94474107|NCT01990768|323526872|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
94474108|NCT01990768|323526873|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
94474109|NCT01990768|323526871|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
94474110|NCT01990768|323526872|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
94474111|NCT01990768|323526873|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
94474112|NCT01990768|323526871|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
94474113|NCT01990768|323526872|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
94474114|NCT01990768|323526873|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
94474115|NCT01990768|323526871|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
94474116|NCT01990768|323526872|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
94474117|NCT01990768|323526873|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
94474118|NCT01990768|323526871|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
94474119|NCT01990768|323526872|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
94474120|NCT01990768|323526873|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
94474121|NCT01990768|323526871|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
94474122|NCT01990768|323526872|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
94474123|NCT01990768|323526873|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
94474124|NCT01990768|323526871|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
94474125|NCT01990768|323526872|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
94474126|NCT01990768|323526873|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
94474127|NCT01990768|323526871|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
94474128|NCT01990768|323526872|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
94474129|NCT01990768|323526873|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
94474130|NCT01990768|323526871|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
94474131|NCT01990768|323526872|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
94474132|NCT01990768|323526873|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
94474133|NCT01990768|323526871|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
94474134|NCT01990768|323526872|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
94383138|NCT02207231|323189368|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
94383139|NCT02207231|323189369|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
94383140|NCT02207231|323189370|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
94383141|NCT02207231|323189367|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
94383142|NCT02207231|323189368|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
94383143|NCT02207231|323189369|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
94383144|NCT02207231|323189370|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
94383145|NCT02207231|323189367|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
94383146|NCT02207231|323189368|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
94383147|NCT02207231|323189369|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
94383148|NCT02207231|323189370|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
94383149|NCT02207231|323189367|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
94383150|NCT02207231|323189368|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
94383151|NCT02207231|323189369|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
94383152|NCT02207231|323189370|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
94383153|NCT02207231|323189367|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
94383154|NCT02207231|323189368|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
94383155|NCT02207231|323189369|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
94383156|NCT02207231|323189370|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
94383157|NCT02207231|323189367|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
94383158|NCT02207231|323189368|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
94383159|NCT02207231|323189369|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
94383160|NCT02207231|323189370|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
94383161|NCT02524379|323189376|FG000|Overall Study|Death|1|||
94383162|NCT05346055|323189380|FG000|Overall Study|Withdrawal by Subject|1|||
94383163|NCT05346055|323189380|FG000|Overall Study|Protocol Violation|1|||
94383164|NCT05346055|323189380|FG000|Overall Study|Therapist decision|1|||
94383165|NCT00502775|323189381|FG000|Overall Study|Adverse Event|1|||
94383166|NCT00502775|323189382|FG001|Overall Study|Adverse Event|2|||
94383167|NCT00502775|323189383|FG002|Overall Study|Adverse Event|1|||
94383168|NCT00502775|323189381|FG000|Overall Study|Protocol Violation|1|||
94383169|NCT00502775|323189382|FG001|Overall Study|Protocol Violation|5|||
94383170|NCT00502775|323189383|FG002|Overall Study|Protocol Violation|2|||
94383171|NCT00502775|323189381|FG000|Overall Study|Withdrawal by Subject|1|||
94383172|NCT00502775|323189382|FG001|Overall Study|Withdrawal by Subject|1|||
94383173|NCT00502775|323189383|FG002|Overall Study|Withdrawal by Subject|2|||
94383174|NCT00502775|323189381|FG000|Overall Study|Sponsor Terminated Study|1|||
94383175|NCT00502775|323189382|FG001|Overall Study|Sponsor Terminated Study|0|||
94383176|NCT00502775|323189383|FG002|Overall Study|Sponsor Terminated Study|1|||
94383177|NCT00502775|323189381|FG000|Overall Study|Non-compliance with eDiary|4|||
94383178|NCT00502775|323189382|FG001|Overall Study|Non-compliance with eDiary|1|||
94383179|NCT00502775|323189383|FG002|Overall Study|Non-compliance with eDiary|1|||
94383180|NCT00502775|323189381|FG000|Overall Study|Subject unable to swallow capsule|1|||
94383181|NCT00502775|323189382|FG001|Overall Study|Subject unable to swallow capsule|0|||
94383182|NCT00502775|323189383|FG002|Overall Study|Subject unable to swallow capsule|1|||
94383183|NCT00502775|323189381|FG000|Overall Study|Logpad compliance <80%|1|||
94383184|NCT00502775|323189382|FG001|Overall Study|Logpad compliance <80%|0|||
94383185|NCT00502775|323189383|FG002|Overall Study|Logpad compliance <80%|0|||
94383186|NCT00502775|323189381|FG000|Overall Study|Randomized in error|0|||
94383187|NCT00502775|323189382|FG001|Overall Study|Randomized in error|1|||
94383188|NCT00502775|323189383|FG002|Overall Study|Randomized in error|1|||
94383189|NCT00502775|323189381|FG000|Overall Study|Non-compliance|0|||
94383190|NCT00502775|323189382|FG001|Overall Study|Non-compliance|2|||
94383191|NCT00502775|323189383|FG002|Overall Study|Non-compliance|2|||
94383192|NCT00502775|323189381|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
94383193|NCT00502775|323189382|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
94383194|NCT00502775|323189383|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
94383195|NCT00502775|323189381|FG000|Overall Study|Declining pollen counts|0|||
94383196|NCT00502775|323189382|FG001|Overall Study|Declining pollen counts|1|||
94383197|NCT00502775|323189383|FG002|Overall Study|Declining pollen counts|1|||
94383198|NCT00502775|323189381|FG000|Overall Study|Subject in jail|0|||
94383199|NCT00502775|323189382|FG001|Overall Study|Subject in jail|1|||
94383200|NCT00502775|323189383|FG002|Overall Study|Subject in jail|0|||
94383201|NCT00502775|323189381|FG000|Overall Study|Subject took disallowed drug|0|||
94383202|NCT00502775|323189382|FG001|Overall Study|Subject took disallowed drug|0|||
94383203|NCT00502775|323189383|FG002|Overall Study|Subject took disallowed drug|1|||
94383204|NCT00561730|323189387|FG000|Overall Study|Adverse Event|2|||
94383205|NCT00561730|323189387|FG000|Overall Study|Handling of the drug|1|||
94383206|NCT00561730|323189387|FG000|Overall Study|Lost to Follow-up|5|||
94383207|NCT00561730|323189387|FG000|Overall Study|Not specified reasons|1|||
94383208|NCT02564263|323189408|FG000|Overall Study|Adverse Event|31|||
94383209|NCT02564263|323189409|FG001|Overall Study|Adverse Event|29|||
94383210|NCT02564263|323189408|FG000|Overall Study|Death|270|||
94474135|NCT01990768|323526873|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
94474136|NCT01990768|323526871|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
94474137|NCT01990768|323526872|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
94474138|NCT01990768|323526873|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
94474139|NCT01990768|323526871|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
94474140|NCT01990768|323526872|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
94474141|NCT01990768|323526873|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
94474142|NCT01990768|323526871|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
94474143|NCT01990768|323526872|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
94474144|NCT01990768|323526873|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
94474145|NCT01990768|323526871|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
94474146|NCT01990768|323526872|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
94474147|NCT01990768|323526873|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
94474148|NCT01990768|323526871|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
94474149|NCT01990768|323526872|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
94474150|NCT01990768|323526873|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
94474151|NCT01990768|323526871|FG000|6-Month Follow-up|No contact information|5|||
94474152|NCT01990768|323526872|FG001|6-Month Follow-up|No contact information|6|||
94474153|NCT01990768|323526873|FG002|6-Month Follow-up|No contact information|5|||
94474154|NCT01990768|323526871|FG000|6-Month Follow-up|Homeless|4|||
94474155|NCT01990768|323526872|FG001|6-Month Follow-up|Homeless|3|||
94474156|NCT01990768|323526873|FG002|6-Month Follow-up|Homeless|6|||
94474157|NCT01990768|323526871|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
94474158|NCT01990768|323526872|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
94474159|NCT01990768|323526873|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
94474160|NCT01990768|323526871|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
94474161|NCT01990768|323526872|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
94474162|NCT01990768|323526873|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
94474163|NCT01990768|323526871|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
94474164|NCT01990768|323526872|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
94474165|NCT01990768|323526873|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
94474166|NCT00154375|323526874|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
94474167|NCT00154375|323526875|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
94474168|NCT00154375|323526874|FG000|Overall Study|Adverse Event|18|||
94474169|NCT00154375|323526875|FG001|Overall Study|Adverse Event|20|||
94474170|NCT00154375|323526874|FG000|Overall Study|Withdrawal by Subject|14|||
94474171|NCT00154375|323526875|FG001|Overall Study|Withdrawal by Subject|10|||
94474172|NCT00154375|323526874|FG000|Overall Study|Death|5|||
94474173|NCT00154375|323526875|FG001|Overall Study|Death|13|||
94474174|NCT00154375|323526874|FG000|Overall Study|Study drug no longer required|5|||
94474175|NCT00154375|323526875|FG001|Overall Study|Study drug no longer required|3|||
94474176|NCT00154375|323526874|FG000|Overall Study|Lost to Follow-up|2|||
94474177|NCT00154375|323526875|FG001|Overall Study|Lost to Follow-up|1|||
94474178|NCT00154375|323526874|FG000|Overall Study|Abnormal laboratory value(s)|0|||
94474179|NCT00154375|323526875|FG001|Overall Study|Abnormal laboratory value(s)|2|||
94474180|NCT00154375|323526874|FG000|Overall Study|Protocol Violation|0|||
94474181|NCT00154375|323526875|FG001|Overall Study|Protocol Violation|1|||
94474182|NCT00154375|323526874|FG000|Overall Study|Suspected progression of disease|44|||
94474183|NCT00154375|323526875|FG001|Overall Study|Suspected progression of disease|30|||
94474184|NCT04549545|323528622|FG000|Initial Period|Withdrawal by Subject|4|||
94474185|NCT04549545|323528623|FG001|Initial Period|Withdrawal by Subject|0|||
94474186|NCT04549545|323528622|FG000|Initial Period|Additional ENT Procedure|3|||
94474187|NCT04549545|323528623|FG001|Initial Period|Additional ENT Procedure|0|||
94474188|NCT04549545|323528622|FG000|Initial Period|Lost to Follow-up|3|||
94474189|NCT04549545|323528623|FG001|Initial Period|Lost to Follow-up|1|||
94474190|NCT04549545|323528622|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
94474191|NCT04549545|323528623|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
94474192|NCT04549545|323528622|FG000|Crossover Period|Additional ENT Procedure|0|||
94474193|NCT04549545|323528623|FG001|Crossover Period|Additional ENT Procedure|6|||
94474194|NCT04549545|323528622|FG000|Crossover Period|Lost to Follow-up|0|||
94474195|NCT04549545|323528623|FG001|Crossover Period|Lost to Follow-up|1|||
94474196|NCT04549545|323528622|FG000|Crossover Period|Withdrawal by Subject|0|||
94474197|NCT04549545|323528623|FG001|Crossover Period|Withdrawal by Subject|4|||
94474198|NCT01317004|323528624|FG000|Overall Study|Withdrawal by Subject|1|||
94474199|NCT01317004|323528625|FG001|Overall Study|Withdrawal by Subject|4|||
94474200|NCT01317004|323528624|FG000|Overall Study|Protocol Violation|0|||
94474201|NCT01317004|323528625|FG001|Overall Study|Protocol Violation|2|||
94474202|NCT01317004|323528624|FG000|Overall Study|Adverse Event|3|||
94474203|NCT01317004|323528625|FG001|Overall Study|Adverse Event|3|||
94474204|NCT01890759|323528627|FG000|Overall Study|Protocol Violation|0|||
94474205|NCT01890759|323528628|FG001|Overall Study|Protocol Violation|2|||
94474206|NCT01890759|323528627|FG000|Overall Study|Lost to Follow-up|0|||
94312990|NCT02026271|322929966|FG000|Overall Study|Withdrawal by Subject|0|||
94312991|NCT02026271|322929967|FG001|Overall Study|Withdrawal by Subject|0|||
94312992|NCT02026271|322929968|FG002|Overall Study|Withdrawal by Subject|0|||
94312993|NCT02026271|322929969|FG003|Overall Study|Withdrawal by Subject|0|||
94312994|NCT02026271|322929970|FG004|Overall Study|Withdrawal by Subject|1|||
94312995|NCT02275026|322929971|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
94312996|NCT02275026|322929971|FG000|Overall Study|Withdrawal by Subject|4|||
94312997|NCT02275026|322929971|FG000|Overall Study|Ineligible due to medical history|13|||
94312998|NCT02275026|322929971|FG000|Overall Study|MRI malfunction precluded testing|1|||
94312999|NCT02275026|322929971|FG000|Overall Study|Ineligible after MRI findings|1|||
94313000|NCT02275026|322929971|FG000|Overall Study|Lost to Follow-up|2|||
94313001|NCT02275026|322929971|FG000|Overall Study|Scanner failure|1|||
94313002|NCT05468086|322929972|FG000|Overall Study|Withdrawal by Subject|3|||
94313003|NCT05468086|322929972|FG000|Overall Study|Subject was found ineligible after consent|1|||
94313004|NCT04598165|322929977|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
94313005|NCT04598165|322929978|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
94313006|NCT04598165|322929977|FG000|Completed 6-week Follow-up|Death|2|||
94313007|NCT04598165|322929978|FG001|Completed 6-week Follow-up|Death|1|||
94313008|NCT04598165|322929977|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
94313009|NCT04598165|322929978|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
94313010|NCT04598165|322929977|FG000|Completed 6-week Follow-up|Ineligible|4|||
94313011|NCT04598165|322929978|FG001|Completed 6-week Follow-up|Ineligible|3|||
94313012|NCT04598165|322929977|FG000|Completed 6-week Follow-up|Partner refusal|0|||
94313013|NCT04598165|322929978|FG001|Completed 6-week Follow-up|Partner refusal|1|||
94313014|NCT04598165|322929977|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
94313015|NCT04598165|322929978|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
94313016|NCT04743635|322929982|FG000|Overall Study|Lost to Follow-up|2|||
94313017|NCT04743635|322929983|FG001|Overall Study|Lost to Follow-up|0|||
94383211|NCT02564263|323189409|FG001|Overall Study|Death|262|||
94383212|NCT02564263|323189408|FG000|Overall Study|Withdrawal by Subject|4|||
94383213|NCT02564263|323189409|FG001|Overall Study|Withdrawal by Subject|19|||
94383214|NCT02564263|323189408|FG000|Overall Study|Sponsor's decision|9|||
94383215|NCT02564263|323189409|FG001|Overall Study|Sponsor's decision|4|||
94383216|NCT02750761|323189410|FG000|Overall Study|Lost to Follow-up|0|||
94383217|NCT02750761|323189411|FG001|Overall Study|Lost to Follow-up|0|||
94383218|NCT02750761|323189412|FG002|Overall Study|Lost to Follow-up|1|||
94383219|NCT02750761|323189413|FG003|Overall Study|Lost to Follow-up|0|||
94383220|NCT02750761|323189414|FG004|Overall Study|Lost to Follow-up|0|||
94383221|NCT02750761|323189415|FG005|Overall Study|Lost to Follow-up|0|||
94383222|NCT02906709|323189416|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
94383223|NCT02906709|323189417|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
94383224|NCT02906709|323189416|FG000|Phase A (Week 0 to Week 16)|Death|0|||
94383225|NCT02906709|323189417|FG001|Phase A (Week 0 to Week 16)|Death|1|||
94383226|NCT02906709|323189416|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
94383227|NCT02906709|323189417|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
94383228|NCT02906709|323189416|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
94383229|NCT02906709|323189417|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
94383230|NCT01124149|323189418|FG000|Acute Phase|Withdrawal by Subject|22|||
94383231|NCT01124149|323189418|FG000|Acute Phase|Adverse Event|21|||
94383232|NCT01124149|323189418|FG000|Acute Phase|Lack of Efficacy|17|||
94383233|NCT01124149|323189418|FG000|Acute Phase|Protocol Violation|14|||
94383234|NCT01124149|323189418|FG000|Acute Phase|Lost to Follow-up|2|||
94383235|NCT01124149|323189418|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
94383236|NCT01124149|323189418|FG000|Acute Phase|Sponsor request|1|||
94383237|NCT01124149|323189418|FG000|Acute Phase|UC symptoms not ameliorated|1|||
94383238|NCT01124149|323189418|FG000|Acute Phase|Non-compliance|1|||
94383239|NCT01124149|323189418|FG000|Acute Phase|Low hemoglobin|1|||
94383240|NCT01124149|323189418|FG000|Acute Phase|Travelling to another country|1|||
94383241|NCT01124149|323189418|FG000|Acute Phase|Sponsor decision|1|||
94383242|NCT01124149|323189418|FG000|Maintenance Phase|Lack of Efficacy|40|||
94383243|NCT01124149|323189418|FG000|Maintenance Phase|Adverse Event|24|||
94383244|NCT01124149|323189418|FG000|Maintenance Phase|Lost to Follow-up|15|||
94383245|NCT01124149|323189418|FG000|Maintenance Phase|Withdrawal by Subject|10|||
94383246|NCT01124149|323189418|FG000|Maintenance Phase|Protocol Violation|5|||
94383247|NCT01124149|323189418|FG000|Maintenance Phase|Coordinator error|1|||
94313018|NCT00426751|322929984|FG000|Overall Study|Adverse Event|8|||
94313019|NCT00426751|322929985|FG001|Overall Study|Adverse Event|1|||
94313020|NCT00426751|322929984|FG000|Overall Study|Lost to Follow-up|7|||
94313021|NCT00426751|322929985|FG001|Overall Study|Lost to Follow-up|6|||
94313022|NCT00426751|322929984|FG000|Overall Study|Consent Withdrawn|0|||
94313023|NCT00426751|322929985|FG001|Overall Study|Consent Withdrawn|1|||
94313024|NCT00426751|322929984|FG000|Overall Study|Other Reasons|7|||
94383248|NCT01124149|323189418|FG000|Maintenance Phase|Non-compliance|1|||
94383249|NCT00436007|323189419|FG000|Overall Study|Withdrawal by Subject|5|||
94313025|NCT00426751|322929985|FG001|Overall Study|Other Reasons|12|||
94383250|NCT00436007|323189420|FG001|Overall Study|Withdrawal by Subject|3|||
94474207|NCT01890759|323528628|FG001|Overall Study|Lost to Follow-up|2|||
94474208|NCT01890759|323528627|FG000|Overall Study|Withdrawal by Subject|2|||
94474209|NCT01890759|323528628|FG001|Overall Study|Withdrawal by Subject|8|||
94474210|NCT01344759|323528629|FG000|Overall Study|Patients failed to reach sedation level|0|||
94474211|NCT01344759|323528630|FG001|Overall Study|Patients failed to reach sedation level|2|||
94474212|NCT00385827|323528631|FG000|Part 1|Adverse Event|1|||
94474213|NCT00385827|323528632|FG001|Part 1|Adverse Event|0|||
94474214|NCT00385827|323528633|FG002|Part 1|Adverse Event|0|||
94474215|NCT00385827|323528631|FG000|Part 1|Death|2|||
94474216|NCT00385827|323528632|FG001|Part 1|Death|0|||
94474217|NCT00385827|323528633|FG002|Part 1|Death|0|||
94474218|NCT00385827|323528631|FG000|Part 1|Lack of Efficacy|5|||
94474219|NCT00385827|323528632|FG001|Part 1|Lack of Efficacy|0|||
94474220|NCT00385827|323528633|FG002|Part 1|Lack of Efficacy|0|||
94474221|NCT00385827|323528631|FG000|Part 1|Other|1|||
94474222|NCT00385827|323528632|FG001|Part 1|Other|0|||
94474223|NCT00385827|323528633|FG002|Part 1|Other|0|||
94474224|NCT00385827|323528631|FG000|Part 2|Adverse Event|0|||
94474225|NCT00385827|323528632|FG001|Part 2|Adverse Event|6|||
94474226|NCT00385827|323528633|FG002|Part 2|Adverse Event|10|||
94474227|NCT00385827|323528631|FG000|Part 2|Death|0|||
94474228|NCT00385827|323528632|FG001|Part 2|Death|0|||
94474229|NCT00385827|323528633|FG002|Part 2|Death|2|||
94474230|NCT00385827|323528631|FG000|Part 2|Lack of Efficacy|0|||
94474231|NCT00385827|323528632|FG001|Part 2|Lack of Efficacy|14|||
94474232|NCT00385827|323528633|FG002|Part 2|Lack of Efficacy|13|||
94474233|NCT00385827|323528631|FG000|Part 2|Randomized but not treated|0|||
94474234|NCT00385827|323528632|FG001|Part 2|Randomized but not treated|2|||
94474235|NCT00385827|323528633|FG002|Part 2|Randomized but not treated|2|||
94474236|NCT00385827|323528631|FG000|Part 2|Other|0|||
94474237|NCT00385827|323528632|FG001|Part 2|Other|11|||
94474238|NCT00385827|323528633|FG002|Part 2|Other|21|||
94474239|NCT01190189|323528634|FG000|Overall Study|Lost to Follow-up|4|||
94474240|NCT01190189|323528634|FG000|Overall Study|Withdrawal by Subject|1|||
94474241|NCT01190189|323528634|FG000|Overall Study|Migrated/moved from study area|1|||
94474242|NCT02849704|323528640|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
94474243|NCT02849704|323528641|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
94474244|NCT02849704|323528640|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
94474245|NCT02849704|323528641|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
94474246|NCT02849704|323528640|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
94474247|NCT02849704|323528641|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
94474248|NCT03536663|323528644|FG000|Endexo|Protocol Violation|1|||
94474249|NCT00762034|323528647|FG000|Induction Period|Protocol Violation|1|||
94474250|NCT00762034|323528648|FG001|Induction Period|Protocol Violation|2|||
94474251|NCT00762034|323528647|FG000|Induction Period|Entry Criterion Not Met|12|||
94474252|NCT00762034|323528648|FG001|Induction Period|Entry Criterion Not Met|11|||
94474253|NCT00762034|323528647|FG000|Induction Period|Adverse Event|27|||
94474254|NCT00762034|323528648|FG001|Induction Period|Adverse Event|38|||
94474255|NCT00762034|323528647|FG000|Induction Period|Lost to Follow-up|1|||
94474256|NCT00762034|323528648|FG001|Induction Period|Lost to Follow-up|1|||
94474257|NCT00762034|323528647|FG000|Induction Period|Progressive Disease|73|||
94474258|NCT00762034|323528648|FG001|Induction Period|Progressive Disease|55|||
94474259|NCT00762034|323528647|FG000|Induction Period|Physician Decision|21|||
94474260|NCT00762034|323528648|FG001|Induction Period|Physician Decision|20|||
94474261|NCT00762034|323528647|FG000|Induction Period|Withdrawal by Subject|15|||
94474262|NCT00762034|323528648|FG001|Induction Period|Withdrawal by Subject|19|||
94474263|NCT00762034|323528647|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
94474264|NCT00762034|323528648|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
94474265|NCT00762034|323528647|FG000|Induction Period|Deaths Due to Study Disease|9|||
94474266|NCT00762034|323528648|FG001|Induction Period|Deaths Due to Study Disease|9|||
94474267|NCT00762034|323528647|FG000|Maintenance Period|Protocol Violation|1|||
94474268|NCT00762034|323528648|FG001|Maintenance Period|Protocol Violation|3|||
94474269|NCT00762034|323528647|FG000|Maintenance Period|Entry Criterion Not Met|0|||
94474270|NCT00762034|323528648|FG001|Maintenance Period|Entry Criterion Not Met|2|||
94474271|NCT00762034|323528647|FG000|Maintenance Period|Adverse Event|42|||
94474272|NCT00762034|323528648|FG001|Maintenance Period|Adverse Event|26|||
94474273|NCT00762034|323528647|FG000|Maintenance Period|Progressive Disease|186|||
94474274|NCT00762034|323528648|FG001|Maintenance Period|Progressive Disease|224|||
94474275|NCT00762034|323528647|FG000|Maintenance Period|Physician Decision|25|||
94474276|NCT00762034|323528648|FG001|Maintenance Period|Physician Decision|20|||
94474277|NCT00762034|323528647|FG000|Maintenance Period|Withdrawal by Subject|34|||
94474278|NCT00762034|323528648|FG001|Maintenance Period|Withdrawal by Subject|14|||
94474279|NCT00762034|323528647|FG000|Maintenance Period|Death not due to study disease|2|||
94474280|NCT00762034|323528648|FG001|Maintenance Period|Death not due to study disease|5|||
94474281|NCT00762034|323528647|FG000|Maintenance Period|Death due to study disease|3|||
94474282|NCT00762034|323528648|FG001|Maintenance Period|Death due to study disease|3|||
94474283|NCT00762034|323528647|FG000|Maintenance Period|Other|1|||
94474284|NCT00762034|323528648|FG001|Maintenance Period|Other|1|||
94474285|NCT02442206|323528649|FG000|Period 1|Adverse Event|1|||
94474286|NCT02442206|323528650|FG001|Period 1|Adverse Event|1|||
94474287|NCT02442206|323528649|FG000|Period 1|withdrew consent|0|||
94474288|NCT02442206|323528650|FG001|Period 1|withdrew consent|1|||
94474289|NCT02442206|323528649|FG000|Period 1|COPD exacerbation|0|||
94474290|NCT02442206|323528650|FG001|Period 1|COPD exacerbation|1|||
94474291|NCT02442206|323528649|FG000|Period 2|Adverse Event|1|||
94474292|NCT02442206|323528650|FG001|Period 2|Adverse Event|0|||
94474293|NCT00734656|323528651|FG000|Lab Session 1|Withdrawal by Subject|2|||
94474294|NCT00734656|323528652|FG001|Lab Session 1|Withdrawal by Subject|0|||
94474295|NCT00734656|323528653|FG002|Lab Session 1|Withdrawal by Subject|0|||
94474296|NCT00734656|323528654|FG003|Lab Session 1|Withdrawal by Subject|0|||
94474297|NCT00734656|323528651|FG000|Washout 1|Withdrawal by Subject|1|||
94474298|NCT00734656|323528652|FG001|Washout 1|Withdrawal by Subject|5|||
94474299|NCT00734656|323528653|FG002|Washout 1|Withdrawal by Subject|2|||
94474300|NCT00734656|323528654|FG003|Washout 1|Withdrawal by Subject|3|||
94474301|NCT00734656|323528651|FG000|Lab Session 2|Withdrawal by Subject|1|||
94474302|NCT00734656|323528652|FG001|Lab Session 2|Withdrawal by Subject|0|||
94474303|NCT00734656|323528653|FG002|Lab Session 2|Withdrawal by Subject|0|||
94474304|NCT00734656|323528654|FG003|Lab Session 2|Withdrawal by Subject|1|||
94474305|NCT00734656|323528651|FG000|Washout 2|Withdrawal by Subject|1|||
94474306|NCT00734656|323528652|FG001|Washout 2|Withdrawal by Subject|1|||
94474307|NCT00734656|323528653|FG002|Washout 2|Withdrawal by Subject|1|||
94474308|NCT00734656|323528654|FG003|Washout 2|Withdrawal by Subject|0|||
94474309|NCT00734656|323528651|FG000|Washout 3|Withdrawal by Subject|1|||
94474310|NCT00734656|323528652|FG001|Washout 3|Withdrawal by Subject|0|||
94474311|NCT00734656|323528653|FG002|Washout 3|Withdrawal by Subject|0|||
94474312|NCT00734656|323528654|FG003|Washout 3|Withdrawal by Subject|1|||
94474313|NCT00734656|323528651|FG000|Lab Session 4|Withdrawal by Subject|0|||
94474314|NCT00734656|323528652|FG001|Lab Session 4|Withdrawal by Subject|0|||
94474315|NCT00734656|323528653|FG002|Lab Session 4|Withdrawal by Subject|0|||
94474316|NCT00734656|323528654|FG003|Lab Session 4|Withdrawal by Subject|1|||
94474317|NCT01471444|323528655|FG000|Overall Study|Physician Decision|3|||
94474318|NCT01471444|323528656|FG001|Overall Study|Physician Decision|2|||
94474319|NCT01471444|323528655|FG000|Overall Study|Withdrawal by Subject|0|||
94474320|NCT01471444|323528656|FG001|Overall Study|Withdrawal by Subject|1|||
94474321|NCT03251482|323528657|FG000|Overall Study|Withdrawal by Subject|0|||
94474322|NCT03251482|323528658|FG001|Overall Study|Withdrawal by Subject|1|||
94474323|NCT03251482|323528659|FG002|Overall Study|Withdrawal by Subject|0|||
94474324|NCT03251482|323528660|FG003|Overall Study|Withdrawal by Subject|0|||
94474325|NCT03251482|323528661|FG004|Overall Study|Withdrawal by Subject|0|||
94474326|NCT03915626|323528662|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
94474327|NCT00802672|323528665|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
94474328|NCT00802672|323528666|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
94474329|NCT00802672|323528667|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
94474330|NCT00802672|323528665|FG000|Overall Study|Adverse Event|1|||
94474331|NCT00802672|323528666|FG001|Overall Study|Adverse Event|1|||
94474332|NCT00802672|323528667|FG002|Overall Study|Adverse Event|1|||
94474333|NCT00802672|323528665|FG000|Overall Study|Protocol Violation|2|||
94474334|NCT00802672|323528666|FG001|Overall Study|Protocol Violation|1|||
94474335|NCT00802672|323528667|FG002|Overall Study|Protocol Violation|1|||
94474336|NCT00802672|323528665|FG000|Overall Study|Lost to Follow-up|5|||
94474337|NCT00802672|323528666|FG001|Overall Study|Lost to Follow-up|5|||
94474338|NCT00802672|323528667|FG002|Overall Study|Lost to Follow-up|3|||
94474339|NCT00802672|323528665|FG000|Overall Study|Withdrawal by Subject|1|||
94474340|NCT00802672|323528666|FG001|Overall Study|Withdrawal by Subject|1|||
94474341|NCT00802672|323528667|FG002|Overall Study|Withdrawal by Subject|2|||
94474342|NCT00802672|323528665|FG000|Overall Study|other|3|||
94474343|NCT00802672|323528666|FG001|Overall Study|other|1|||
94474344|NCT00802672|323528667|FG002|Overall Study|other|2|||
94474345|NCT02634801|323528675|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
94474346|NCT02634801|323528676|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
94474347|NCT02634801|323528677|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
94474348|NCT02634801|323528675|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
94474349|NCT02634801|323528676|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
94474350|NCT02634801|323528677|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
94474351|NCT02634801|323528675|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
94474352|NCT02634801|323528676|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
94474353|NCT02634801|323528677|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
94474354|NCT02634801|323528675|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
94474355|NCT02634801|323528676|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
94474356|NCT02634801|323528677|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
94474357|NCT02634801|323528675|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
94474358|NCT02634801|323528676|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
94474359|NCT02634801|323528677|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
94474360|NCT02634801|323528675|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
94313026|NCT04229446|322929986|FG000|Overall Study|Death|12|||
94313027|NCT04229446|322929987|FG001|Overall Study|Death|10|||
94313028|NCT04229446|322929986|FG000|Overall Study|Lost to Follow-up|5|||
94313029|NCT04229446|322929987|FG001|Overall Study|Lost to Follow-up|8|||
94313030|NCT01413178|322929988|FG000|Overall Study|Toxicity|1|||
94313031|NCT01413178|322929989|FG001|Overall Study|Toxicity|0|||
94313032|NCT01413178|322929988|FG000|Overall Study|Ineligible|0|||
94313033|NCT01413178|322929989|FG001|Overall Study|Ineligible|2|||
94313034|NCT02488759|322929992|FG000|Overall Study|Disease progression|73|||
94313035|NCT02488759|322929993|FG001|Overall Study|Disease progression|111|||
94313036|NCT02488759|322929994|FG002|Overall Study|Disease progression|62|||
94313037|NCT02488759|322929995|FG003|Overall Study|Disease progression|7|||
94313038|NCT02488759|322929996|FG004|Overall Study|Disease progression|4|||
94313039|NCT02488759|322929997|FG005|Overall Study|Disease progression|2|||
94313040|NCT02488759|322929992|FG000|Overall Study|Study drug toxicity|11|||
94313041|NCT02488759|322929993|FG001|Overall Study|Study drug toxicity|33|||
94313042|NCT02488759|322929994|FG002|Overall Study|Study drug toxicity|31|||
94313043|NCT02488759|322929995|FG003|Overall Study|Study drug toxicity|0|||
94313044|NCT02488759|322929996|FG004|Overall Study|Study drug toxicity|0|||
94313045|NCT02488759|322929997|FG005|Overall Study|Study drug toxicity|2|||
94313046|NCT02488759|322929992|FG000|Overall Study|Adverse event unrelated to study drug|9|||
94313047|NCT02488759|322929993|FG001|Overall Study|Adverse event unrelated to study drug|11|||
94313048|NCT02488759|322929994|FG002|Overall Study|Adverse event unrelated to study drug|7|||
94313049|NCT02488759|322929995|FG003|Overall Study|Adverse event unrelated to study drug|0|||
94313050|NCT02488759|322929996|FG004|Overall Study|Adverse event unrelated to study drug|1|||
94313051|NCT02488759|322929997|FG005|Overall Study|Adverse event unrelated to study drug|0|||
94313052|NCT02488759|322929992|FG000|Overall Study|Participant request to discontinue study treatment|6|||
94313053|NCT02488759|322929993|FG001|Overall Study|Participant request to discontinue study treatment|8|||
94313054|NCT02488759|322929994|FG002|Overall Study|Participant request to discontinue study treatment|4|||
94313055|NCT02488759|322929995|FG003|Overall Study|Participant request to discontinue study treatment|0|||
94313056|NCT02488759|322929996|FG004|Overall Study|Participant request to discontinue study treatment|0|||
94313057|NCT02488759|322929997|FG005|Overall Study|Participant request to discontinue study treatment|0|||
94313058|NCT02488759|322929992|FG000|Overall Study|Withdrawal by Subject|4|||
94313059|NCT02488759|322929993|FG001|Overall Study|Withdrawal by Subject|0|||
94313060|NCT02488759|322929994|FG002|Overall Study|Withdrawal by Subject|3|||
94313061|NCT02488759|322929995|FG003|Overall Study|Withdrawal by Subject|0|||
94313062|NCT02488759|322929996|FG004|Overall Study|Withdrawal by Subject|0|||
94313063|NCT02488759|322929997|FG005|Overall Study|Withdrawal by Subject|2|||
94313064|NCT02488759|322929992|FG000|Overall Study|Lost to Follow-up|0|||
94313065|NCT02488759|322929993|FG001|Overall Study|Lost to Follow-up|0|||
94313066|NCT02488759|322929994|FG002|Overall Study|Lost to Follow-up|2|||
94313067|NCT02488759|322929995|FG003|Overall Study|Lost to Follow-up|0|||
94313068|NCT02488759|322929996|FG004|Overall Study|Lost to Follow-up|0|||
94313069|NCT02488759|322929997|FG005|Overall Study|Lost to Follow-up|0|||
94313070|NCT02488759|322929992|FG000|Overall Study|Maximum clinical benefit|3|||
94313071|NCT02488759|322929993|FG001|Overall Study|Maximum clinical benefit|0|||
94313072|NCT02488759|322929994|FG002|Overall Study|Maximum clinical benefit|1|||
94313073|NCT02488759|322929995|FG003|Overall Study|Maximum clinical benefit|0|||
94313074|NCT02488759|322929996|FG004|Overall Study|Maximum clinical benefit|0|||
94313075|NCT02488759|322929997|FG005|Overall Study|Maximum clinical benefit|0|||
94313076|NCT02488759|322929992|FG000|Overall Study|Other reasons|7|||
94313077|NCT02488759|322929993|FG001|Overall Study|Other reasons|32|||
94313078|NCT02488759|322929994|FG002|Overall Study|Other reasons|23|||
94313079|NCT02488759|322929995|FG003|Overall Study|Other reasons|1|||
94313080|NCT02488759|322929996|FG004|Overall Study|Other reasons|1|||
94313081|NCT02488759|322929997|FG005|Overall Study|Other reasons|1|||
94313082|NCT01678807|322930003|FG000|Overall Study|Adverse Event|4|||
94313083|NCT01678807|322930004|FG001|Overall Study|Adverse Event|4|||
94313084|NCT01678807|322930005|FG002|Overall Study|Adverse Event|0|||
94313085|NCT01678807|322930003|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
94313086|NCT01678807|322930004|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
94313087|NCT01678807|322930005|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
94313088|NCT02429427|322930006|FG000|Overall Study|Adverse Event|220|||
94313089|NCT02429427|322930007|FG001|Overall Study|Adverse Event|92|||
94313090|NCT02429427|322930006|FG000|Overall Study|Protocol Violation|10|||
94313091|NCT02429427|322930007|FG001|Overall Study|Protocol Violation|6|||
94313092|NCT02429427|322930006|FG000|Overall Study|Lost to Follow-up|15|||
94313093|NCT02429427|322930007|FG001|Overall Study|Lost to Follow-up|6|||
94313094|NCT02429427|322930006|FG000|Overall Study|Withdrawal by Subject|64|||
94313095|NCT02429427|322930007|FG001|Overall Study|Withdrawal by Subject|34|||
94313096|NCT02429427|322930006|FG000|Overall Study|Other|62|||
94313097|NCT02429427|322930007|FG001|Overall Study|Other|41|||
94313098|NCT02817555|322931489|FG000|Overall Study|Death|1|||
94313099|NCT02817555|322931490|FG001|Overall Study|Death|3|||
94313100|NCT02817555|322931489|FG000|Overall Study|moved away|1|||
94313101|NCT02817555|322931490|FG001|Overall Study|moved away|0|||
94313102|NCT02817555|322931489|FG000|Overall Study|transplant|1|||
94474361|NCT02634801|323528676|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
94474362|NCT02634801|323528677|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
94474363|NCT02634801|323528675|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
94474364|NCT02634801|323528676|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
94474365|NCT02634801|323528677|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
94474366|NCT02634801|323528675|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
94474367|NCT02634801|323528676|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
94474368|NCT02634801|323528677|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
94474369|NCT02634801|323528675|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
94474370|NCT02634801|323528676|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
94474371|NCT02634801|323528677|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
94474372|NCT02634801|323528675|FG000|Follow-up Period|Lost to Follow-up|3|||
94474373|NCT02634801|323528676|FG001|Follow-up Period|Lost to Follow-up|1|||
94474374|NCT02634801|323528677|FG002|Follow-up Period|Lost to Follow-up|2|||
94474375|NCT02634801|323528675|FG000|Follow-up Period|Physician Decision|0|||
94474376|NCT02634801|323528676|FG001|Follow-up Period|Physician Decision|0|||
94474377|NCT02634801|323528677|FG002|Follow-up Period|Physician Decision|1|||
94474378|NCT02634801|323528675|FG000|Follow-up Period|Withdrawal by Subject|1|||
94474379|NCT02634801|323528676|FG001|Follow-up Period|Withdrawal by Subject|2|||
94474380|NCT02634801|323528677|FG002|Follow-up Period|Withdrawal by Subject|5|||
94474381|NCT02634801|323528675|FG000|Follow-up Period|Adverse Event|1|||
94474382|NCT02634801|323528676|FG001|Follow-up Period|Adverse Event|5|||
94474383|NCT02634801|323528677|FG002|Follow-up Period|Adverse Event|0|||
94474384|NCT02626000|323528678|FG000|Overall Study|Decision by Sponsor|1|||
94474385|NCT02626000|323528678|FG000|Overall Study|Death|29|||
94383251|NCT00436007|323189421|FG002|Overall Study|Withdrawal by Subject|4|||
94383252|NCT00436007|323189419|FG000|Overall Study|Lost to Follow-up|14|||
94383253|NCT00436007|323189420|FG001|Overall Study|Lost to Follow-up|10|||
94383254|NCT00436007|323189421|FG002|Overall Study|Lost to Follow-up|13|||
94383255|NCT00436007|323189419|FG000|Overall Study|Physician Decision|0|||
94383256|NCT00436007|323189420|FG001|Overall Study|Physician Decision|0|||
94383257|NCT00436007|323189421|FG002|Overall Study|Physician Decision|2|||
94383258|NCT00436007|323189419|FG000|Overall Study|Death|0|||
94383259|NCT00436007|323189420|FG001|Overall Study|Death|1|||
94383260|NCT00436007|323189421|FG002|Overall Study|Death|3|||
94383261|NCT00436007|323189419|FG000|Overall Study|Other|0|||
94383262|NCT00436007|323189420|FG001|Overall Study|Other|0|||
94383263|NCT00436007|323189421|FG002|Overall Study|Other|1|||
94383264|NCT02433678|323189426|FG000|Overall Study|Lost to Follow-up|1|||
94383265|NCT02433678|323189427|FG001|Overall Study|Lost to Follow-up|2|||
94383266|NCT01781286|323189428|FG000|Overall Study|Lost to Follow-up|0|||
94383267|NCT01781286|323189429|FG001|Overall Study|Lost to Follow-up|0|||
94383268|NCT01781286|323189430|FG002|Overall Study|Lost to Follow-up|0|||
94383269|NCT01781286|323189431|FG003|Overall Study|Lost to Follow-up|0|||
94383270|NCT01781286|323189432|FG004|Overall Study|Lost to Follow-up|0|||
94383271|NCT01781286|323189433|FG005|Overall Study|Lost to Follow-up|1|||
94383272|NCT01781286|323189428|FG000|Overall Study|Time Constraints|2|||
94383273|NCT01781286|323189429|FG001|Overall Study|Time Constraints|0|||
94383274|NCT01781286|323189430|FG002|Overall Study|Time Constraints|2|||
94383275|NCT01781286|323189431|FG003|Overall Study|Time Constraints|0|||
94383276|NCT01781286|323189432|FG004|Overall Study|Time Constraints|0|||
94383277|NCT01781286|323189433|FG005|Overall Study|Time Constraints|0|||
94383278|NCT01781286|323189428|FG000|Overall Study|Noncompliance|0|||
94383279|NCT01781286|323189429|FG001|Overall Study|Noncompliance|0|||
94383280|NCT01781286|323189430|FG002|Overall Study|Noncompliance|0|||
94383281|NCT01781286|323189431|FG003|Overall Study|Noncompliance|1|||
94383282|NCT01781286|323189432|FG004|Overall Study|Noncompliance|0|||
94383283|NCT01781286|323189433|FG005|Overall Study|Noncompliance|0|||
94383284|NCT02483975|323189434|FG000|Overall Study|Adverse Event|0|||
94383285|NCT02483975|323189435|FG001|Overall Study|Adverse Event|1|||
94383286|NCT02483975|323189434|FG000|Overall Study|Lost to Follow-up|0|||
94383287|NCT02483975|323189435|FG001|Overall Study|Lost to Follow-up|1|||
94383288|NCT02483975|323189434|FG000|Overall Study|Physician Decision|2|||
94383289|NCT02483975|323189435|FG001|Overall Study|Physician Decision|0|||
94383290|NCT02720510|323189436|FG000|Overall Study|Study Terminated by the sponsor|2|||
94383291|NCT02720510|323189437|FG001|Overall Study|Study Terminated by the sponsor|0|||
94474386|NCT00759655|323528683|FG000|Overall Study|Termination of the study by sponsor|1|||
94474387|NCT02793947|323528684|FG000|Overall Study|Death|1|||
94474388|NCT02793947|323528685|FG001|Overall Study|Death|0|||
94474389|NCT02793947|323528684|FG000|Overall Study|Physician Decision|1|||
94474390|NCT02793947|323528685|FG001|Overall Study|Physician Decision|5|||
94474391|NCT02757625|323528690|FG000|Overall Study|Investigator's discretion|0|||
94383292|NCT02720510|323189436|FG000|Overall Study|Adverse Event|0|||
94383293|NCT02720510|323189437|FG001|Overall Study|Adverse Event|1|||
94383294|NCT02720510|323189436|FG000|Overall Study|Physician Decision|1|||
94383295|NCT02720510|323189437|FG001|Overall Study|Physician Decision|2|||
94383296|NCT01618266|323189444|FG000|Overall Study|Lost to Follow-up|9|||
94383297|NCT01618266|323189444|FG000|Overall Study|Treatment satisfaction|10|||
94313103|NCT02817555|322931490|FG001|Overall Study|transplant|1|||
94313104|NCT02817555|322931489|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
94383298|NCT01618266|323189444|FG000|Overall Study|Other reasons|11|||
94383299|NCT01618266|323189444|FG000|Overall Study|Lack of Efficacy|23|||
94383300|NCT01618266|323189444|FG000|Overall Study|Protocol Violation|43|||
94383301|NCT02752776|323189447|FG000|Overall Study|Adverse Event|15|||
94383302|NCT02752776|323189448|FG001|Overall Study|Adverse Event|23|||
94383303|NCT02752776|323189449|FG002|Overall Study|Adverse Event|11|||
94383304|NCT02752776|323189447|FG000|Overall Study|Lack of Efficacy|2|||
94383305|NCT02752776|323189448|FG001|Overall Study|Lack of Efficacy|6|||
94383306|NCT02752776|323189449|FG002|Overall Study|Lack of Efficacy|14|||
94383307|NCT02752776|323189447|FG000|Overall Study|Lost to Follow-up|11|||
94383308|NCT02752776|323189448|FG001|Overall Study|Lost to Follow-up|12|||
94383309|NCT02752776|323189449|FG002|Overall Study|Lost to Follow-up|4|||
94383310|NCT02752776|323189447|FG000|Overall Study|Non-compliance with study treatment|0|||
94383311|NCT02752776|323189448|FG001|Overall Study|Non-compliance with study treatment|0|||
94383312|NCT02752776|323189449|FG002|Overall Study|Non-compliance with study treatment|1|||
94383313|NCT02752776|323189447|FG000|Overall Study|Physician Decision|2|||
94383314|NCT02752776|323189448|FG001|Overall Study|Physician Decision|6|||
94383315|NCT02752776|323189449|FG002|Overall Study|Physician Decision|2|||
94383316|NCT02752776|323189447|FG000|Overall Study|Pregnancy|1|||
94383317|NCT02752776|323189448|FG001|Overall Study|Pregnancy|6|||
94383318|NCT02752776|323189449|FG002|Overall Study|Pregnancy|3|||
94383319|NCT02752776|323189447|FG000|Overall Study|Protocol Violation|10|||
94383320|NCT02752776|323189448|FG001|Overall Study|Protocol Violation|13|||
94383321|NCT02752776|323189449|FG002|Overall Study|Protocol Violation|6|||
94383322|NCT02752776|323189447|FG000|Overall Study|Subject/guardian decision|8|||
94383323|NCT02752776|323189448|FG001|Overall Study|Subject/guardian decision|6|||
94383324|NCT02752776|323189449|FG002|Overall Study|Subject/guardian decision|4|||
94383325|NCT02752776|323189447|FG000|Overall Study|Death|0|||
94383326|NCT02752776|323189448|FG001|Overall Study|Death|0|||
94383327|NCT02752776|323189449|FG002|Overall Study|Death|1|||
94383328|NCT02752776|323189447|FG000|Overall Study|Withdrawal by Subject|3|||
94383329|NCT02752776|323189448|FG001|Overall Study|Withdrawal by Subject|4|||
94383330|NCT02752776|323189449|FG002|Overall Study|Withdrawal by Subject|2|||
94383331|NCT02492958|323189450|FG000|Overall Study|Withdrawal by Subject|0|||
94383332|NCT02492958|323189451|FG001|Overall Study|Withdrawal by Subject|0|||
94383333|NCT02492958|323189452|FG002|Overall Study|Withdrawal by Subject|1|||
94383334|NCT02492958|323189453|FG003|Overall Study|Withdrawal by Subject|0|||
94383335|NCT02492958|323189450|FG000|Overall Study|Adverse Event|1|||
94383336|NCT02492958|323189451|FG001|Overall Study|Adverse Event|0|||
94383337|NCT02492958|323189452|FG002|Overall Study|Adverse Event|1|||
94383338|NCT02492958|323189453|FG003|Overall Study|Adverse Event|0|||
94383339|NCT00266409|323189454|FG000|Overall Study|Lack of Efficacy|2|||
94383340|NCT00266409|323189455|FG001|Overall Study|Lack of Efficacy|6|||
94383341|NCT00266409|323189456|FG002|Overall Study|Lack of Efficacy|1|||
94313105|NCT02817555|322931490|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
94313106|NCT01115569|322931491|FG000|Conversion/Titration Phase|Adverse Event|59|||
94313107|NCT01115569|322931492|FG001|Conversion/Titration Phase|Adverse Event|0|||
94313108|NCT01115569|322931491|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
94313109|NCT01115569|322931492|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
94313110|NCT01115569|322931491|FG000|Conversion/Titration Phase|Physician Decision|5|||
94313111|NCT01115569|322931492|FG001|Conversion/Titration Phase|Physician Decision|0|||
94313112|NCT01115569|322931491|FG000|Conversion/Titration Phase|Protocol Violation|68|||
94313113|NCT01115569|322931492|FG001|Conversion/Titration Phase|Protocol Violation|0|||
94313114|NCT01115569|322931491|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
94313115|NCT01115569|322931492|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
94313116|NCT01115569|322931491|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
94313117|NCT01115569|322931492|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
94313118|NCT01115569|322931491|FG000|Maintenance Phase|Adverse Event|0|||
94313119|NCT01115569|322931492|FG001|Maintenance Phase|Adverse Event|43|||
94313120|NCT01115569|322931491|FG000|Maintenance Phase|Lost to Follow-up|0|||
94313121|NCT01115569|322931492|FG001|Maintenance Phase|Lost to Follow-up|8|||
94313122|NCT01115569|322931491|FG000|Maintenance Phase|Physician Decision|0|||
94313123|NCT01115569|322931492|FG001|Maintenance Phase|Physician Decision|3|||
94313124|NCT01115569|322931491|FG000|Maintenance Phase|Protocol Violation|0|||
94383342|NCT00266409|323189457|FG003|Overall Study|Lack of Efficacy|2|||
94383343|NCT00266409|323189454|FG000|Overall Study|Adverse Event|7|||
94383344|NCT00266409|323189455|FG001|Overall Study|Adverse Event|2|||
94383345|NCT00266409|323189456|FG002|Overall Study|Adverse Event|1|||
94313125|NCT01115569|322931492|FG001|Maintenance Phase|Protocol Violation|9|||
94313126|NCT01115569|322931491|FG000|Maintenance Phase|Withdrawal by Subject|0|||
94313127|NCT01115569|322931492|FG001|Maintenance Phase|Withdrawal by Subject|27|||
94313128|NCT01115569|322931491|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
94383346|NCT00266409|323189457|FG003|Overall Study|Adverse Event|1|||
94383347|NCT00266409|323189454|FG000|Overall Study|Lost to Follow-up|18|||
94383348|NCT00266409|323189455|FG001|Overall Study|Lost to Follow-up|21|||
94474392|NCT02757625|323528691|FG001|Overall Study|Investigator's discretion|0|||
94474393|NCT02757625|323528692|FG002|Overall Study|Investigator's discretion|1|||
94474394|NCT02757625|323528693|FG003|Overall Study|Investigator's discretion|0|||
94474395|NCT02757625|323528690|FG000|Overall Study|Adverse Event|0|||
94474396|NCT02757625|323528691|FG001|Overall Study|Adverse Event|0|||
94474397|NCT02757625|323528692|FG002|Overall Study|Adverse Event|1|||
94474398|NCT02757625|323528693|FG003|Overall Study|Adverse Event|0|||
94474399|NCT02131233|323528694|FG000|Overall Study|Not Treated|2|||
94474400|NCT02131233|323528695|FG001|Overall Study|Not Treated|3|||
94474401|NCT02131233|323528694|FG000|Overall Study|Adverse Event|7|||
94474402|NCT02131233|323528695|FG001|Overall Study|Adverse Event|6|||
94474403|NCT02131233|323528694|FG000|Overall Study|Death|0|||
94474404|NCT02131233|323528695|FG001|Overall Study|Death|1|||
94474405|NCT02131233|323528694|FG000|Overall Study|Lack of Efficacy|6|||
94474406|NCT02131233|323528695|FG001|Overall Study|Lack of Efficacy|3|||
94474407|NCT02131233|323528694|FG000|Overall Study|Lost to Follow-up|14|||
94474408|NCT02131233|323528695|FG001|Overall Study|Lost to Follow-up|13|||
94474409|NCT02131233|323528694|FG000|Overall Study|Non-Compliance With Study Drug|8|||
94474410|NCT02131233|323528695|FG001|Overall Study|Non-Compliance With Study Drug|5|||
94474411|NCT02131233|323528694|FG000|Overall Study|Physician Decision|7|||
94474412|NCT02131233|323528695|FG001|Overall Study|Physician Decision|0|||
94474413|NCT02131233|323528694|FG000|Overall Study|Pregnancy|4|||
94474414|NCT02131233|323528695|FG001|Overall Study|Pregnancy|0|||
94474415|NCT02131233|323528694|FG000|Overall Study|Withdrawal by Subject|18|||
94474416|NCT02131233|323528695|FG001|Overall Study|Withdrawal by Subject|11|||
94474417|NCT03519919|323528696|FG000|Overall Study|Withdrawal by Subject|1|||
94474418|NCT03519919|323528696|FG000|Overall Study|Lack of Efficacy|1|||
94474419|NCT03519919|323528696|FG000|Overall Study|Screen Failure|1|||
94474420|NCT02779075|323528697|FG000|Overall Study|Withdrawal by Subject|1|||
94474421|NCT02779075|323528698|FG001|Overall Study|Withdrawal by Subject|3|||
94474422|NCT02779075|323528697|FG000|Overall Study|IV lost during 2nd study|1|||
94474423|NCT02779075|323528698|FG001|Overall Study|IV lost during 2nd study|0|||
94474424|NCT06360588|323528702|FG000|Overall Study|Adverse Event|3|||
94474425|NCT06360588|323528702|FG000|Overall Study|Death|2|||
94474426|NCT06360588|323528702|FG000|Overall Study|Disease Progression|14|||
94474427|NCT06360588|323528702|FG000|Overall Study|Withdrawal by Subject|1|||
94474428|NCT06360588|323528702|FG000|Overall Study|Lack of Efficacy|1|||
94474429|NCT06360588|323528702|FG000|Overall Study|Ineligible|1|||
94474430|NCT05980013|323528703|FG000|Overall Study|Withdrawal by Subject|0|||
94474431|NCT05980013|323528704|FG001|Overall Study|Withdrawal by Subject|1|||
94474432|NCT05980013|323528703|FG000|Overall Study|Device Error|0|||
94474433|NCT05980013|323528704|FG001|Overall Study|Device Error|1|||
94474434|NCT03066778|323528706|FG000|Overall Study|Death|195|||
94474435|NCT03066778|323528707|FG001|Overall Study|Death|205|||
94474436|NCT03066778|323528706|FG000|Overall Study|Withdrawal by Subject|5|||
94474437|NCT03066778|323528707|FG001|Overall Study|Withdrawal by Subject|7|||
94474438|NCT00791700|323528708|FG000|Overall Study|Insufficient clinical response|1|||
94474439|NCT00791700|323528709|FG001|Overall Study|Insufficient clinical response|4|||
94474440|NCT00791700|323528710|FG002|Overall Study|Insufficient clinical response|1|||
94474441|NCT00791700|323528711|FG003|Overall Study|Insufficient clinical response|8|||
94474442|NCT00791700|323528708|FG000|Overall Study|No longer willing to participate|1|||
94474443|NCT00791700|323528709|FG001|Overall Study|No longer willing to participate|1|||
94474444|NCT00791700|323528710|FG002|Overall Study|No longer willing to participate|0|||
94474445|NCT00791700|323528711|FG003|Overall Study|No longer willing to participate|8|||
94474446|NCT00791700|323528708|FG000|Overall Study|Non-compliance with study treatment|0|||
94474447|NCT00791700|323528709|FG001|Overall Study|Non-compliance with study treatment|2|||
94474448|NCT00791700|323528710|FG002|Overall Study|Non-compliance with study treatment|0|||
94474449|NCT00791700|323528711|FG003|Overall Study|Non-compliance with study treatment|4|||
94474450|NCT00791700|323528708|FG000|Overall Study|Withdrawn due to pregnancy|0|||
94313129|NCT01115569|322931492|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
94474451|NCT00791700|323528709|FG001|Overall Study|Withdrawn due to pregnancy|0|||
94474452|NCT00791700|323528710|FG002|Overall Study|Withdrawn due to pregnancy|0|||
94474453|NCT00791700|323528711|FG003|Overall Study|Withdrawn due to pregnancy|1|||
94474454|NCT00791700|323528708|FG000|Overall Study|Other|0|||
94474455|NCT00791700|323528709|FG001|Overall Study|Other|1|||
94474456|NCT00791700|323528710|FG002|Overall Study|Other|0|||
94474457|NCT00791700|323528711|FG003|Overall Study|Other|1|||
94313130|NCT01115569|322931491|FG000|Maintenance Phase|Administrative|0|||
94474458|NCT00791700|323528708|FG000|Overall Study|Death|0|||
94474459|NCT00791700|323528709|FG001|Overall Study|Death|0|||
94474460|NCT00791700|323528710|FG002|Overall Study|Death|0|||
94474461|NCT00791700|323528711|FG003|Overall Study|Death|1|||
94474462|NCT00791700|323528708|FG000|Overall Study|Lost to Follow-up|4|||
94474463|NCT00791700|323528709|FG001|Overall Study|Lost to Follow-up|3|||
94313131|NCT01115569|322931492|FG001|Maintenance Phase|Administrative|1|||
94474464|NCT00791700|323528710|FG002|Overall Study|Lost to Follow-up|4|||
94474465|NCT00791700|323528711|FG003|Overall Study|Lost to Follow-up|6|||
94474466|NCT00791700|323528708|FG000|Overall Study|Adverse Event|0|||
94474467|NCT00791700|323528709|FG001|Overall Study|Adverse Event|0|||
94383349|NCT00266409|323189456|FG002|Overall Study|Lost to Follow-up|6|||
94383350|NCT00266409|323189457|FG003|Overall Study|Lost to Follow-up|8|||
94383351|NCT00266409|323189454|FG000|Overall Study|Withdrawal by Subject|6|||
94383352|NCT00266409|323189455|FG001|Overall Study|Withdrawal by Subject|10|||
94383353|NCT00266409|323189456|FG002|Overall Study|Withdrawal by Subject|3|||
94383354|NCT00266409|323189457|FG003|Overall Study|Withdrawal by Subject|9|||
94383355|NCT00266409|323189454|FG000|Overall Study|Protocol Violation|5|||
94383356|NCT00266409|323189455|FG001|Overall Study|Protocol Violation|3|||
94383357|NCT00266409|323189456|FG002|Overall Study|Protocol Violation|4|||
94383358|NCT00266409|323189457|FG003|Overall Study|Protocol Violation|2|||
94383359|NCT00266409|323189454|FG000|Overall Study|Other|7|||
94383360|NCT00266409|323189455|FG001|Overall Study|Other|4|||
94383361|NCT00266409|323189456|FG002|Overall Study|Other|2|||
94383362|NCT00266409|323189457|FG003|Overall Study|Other|0|||
94383363|NCT01946165|323189458|FG000|Overall Study|Physician Decision|2|||
94383364|NCT01946165|323189459|FG001|Overall Study|Physician Decision|0|||
94383365|NCT01946165|323189458|FG000|Overall Study|Withdrawal by Subject|0|||
94383366|NCT01946165|323189459|FG001|Overall Study|Withdrawal by Subject|2|||
94383367|NCT00337571|323189462|FG000|Overall Study|Lack of Efficacy|3|||
94383368|NCT00337571|323189463|FG001|Overall Study|Lack of Efficacy|0|||
94383369|NCT00337571|323189464|FG002|Overall Study|Lack of Efficacy|0|||
94383370|NCT00337571|323189465|FG003|Overall Study|Lack of Efficacy|0|||
94383371|NCT00337571|323189462|FG000|Overall Study|Adverse Event|4|||
94383372|NCT00337571|323189463|FG001|Overall Study|Adverse Event|5|||
94383373|NCT00337571|323189464|FG002|Overall Study|Adverse Event|8|||
94383374|NCT00337571|323189465|FG003|Overall Study|Adverse Event|4|||
94383375|NCT00337571|323189462|FG000|Overall Study|Withdrawal by Subject|2|||
94383376|NCT00337571|323189463|FG001|Overall Study|Withdrawal by Subject|2|||
94383377|NCT00337571|323189464|FG002|Overall Study|Withdrawal by Subject|1|||
94383378|NCT00337571|323189465|FG003|Overall Study|Withdrawal by Subject|0|||
94383379|NCT00337571|323189462|FG000|Overall Study|Lost to Follow-up|3|||
94383380|NCT00337571|323189463|FG001|Overall Study|Lost to Follow-up|1|||
94383381|NCT00337571|323189464|FG002|Overall Study|Lost to Follow-up|0|||
94383382|NCT00337571|323189465|FG003|Overall Study|Lost to Follow-up|1|||
94383383|NCT00337571|323189462|FG000|Overall Study|Poor/noncompliance|1|||
94383384|NCT00337571|323189463|FG001|Overall Study|Poor/noncompliance|1|||
94383385|NCT00337571|323189464|FG002|Overall Study|Poor/noncompliance|1|||
94383386|NCT00337571|323189465|FG003|Overall Study|Poor/noncompliance|1|||
94383387|NCT00337571|323189462|FG000|Overall Study|No longer met study criteria|1|||
94383388|NCT00337571|323189463|FG001|Overall Study|No longer met study criteria|0|||
94383389|NCT00337571|323189464|FG002|Overall Study|No longer met study criteria|0|||
94383390|NCT00337571|323189465|FG003|Overall Study|No longer met study criteria|0|||
94383391|NCT00337571|323189462|FG000|Overall Study|High Potassium level|0|||
94383392|NCT00337571|323189463|FG001|Overall Study|High Potassium level|0|||
94383393|NCT00337571|323189464|FG002|Overall Study|High Potassium level|0|||
94383394|NCT00337571|323189465|FG003|Overall Study|High Potassium level|1|||
94383395|NCT01370408|323189470|FG000|Overall Study|treatment failure|9|||
94383396|NCT02545998|323189479|FG000|Overall Study|Lost to Follow-up|12|||
94383397|NCT02545998|323189480|FG001|Overall Study|Lost to Follow-up|3|||
94383398|NCT02545998|323189479|FG000|Overall Study|Withdrawal by Subject|3|||
94383399|NCT02545998|323189480|FG001|Overall Study|Withdrawal by Subject|2|||
94383400|NCT00918567|323189484|FG000|Overall Study|Lack of Efficacy|3|||
94383401|NCT00918567|323189485|FG001|Overall Study|Lack of Efficacy|1|||
94383402|NCT00918567|323189484|FG000|Overall Study|Withdrawal by Subject|1|||
94383403|NCT00918567|323189485|FG001|Overall Study|Withdrawal by Subject|1|||
94383404|NCT00918567|323189484|FG000|Overall Study|Adverse Event|1|||
94383405|NCT00918567|323189485|FG001|Overall Study|Adverse Event|0|||
94383406|NCT04646109|323189490|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
94383407|NCT04646109|323189491|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
94383408|NCT00162123|323189492|FG000|Overall Study|Disease progression|27|||
94383409|NCT00162123|323189493|FG001|Overall Study|Disease progression|19|||
94383410|NCT00162123|323189494|FG002|Overall Study|Disease progression|10|||
94383411|NCT00162123|323189495|FG003|Overall Study|Disease progression|4|||
94383412|NCT00162123|323189496|FG004|Overall Study|Disease progression|8|||
94383413|NCT00162123|323189497|FG005|Overall Study|Disease progression|3|||
94383414|NCT00162123|323189498|FG006|Overall Study|Disease progression|1|||
94383415|NCT00162123|323189499|FG007|Overall Study|Disease progression|0|||
94383416|NCT00162123|323189492|FG000|Overall Study|Study drug toxicity|6|||
94383417|NCT00162123|323189493|FG001|Overall Study|Study drug toxicity|1|||
94383418|NCT00162123|323189494|FG002|Overall Study|Study drug toxicity|5|||
94383419|NCT00162123|323189495|FG003|Overall Study|Study drug toxicity|0|||
94383420|NCT00162123|323189496|FG004|Overall Study|Study drug toxicity|4|||
94383421|NCT00162123|323189497|FG005|Overall Study|Study drug toxicity|1|||
94383422|NCT00162123|323189498|FG006|Overall Study|Study drug toxicity|1|||
94383423|NCT00162123|323189499|FG007|Overall Study|Study drug toxicity|0|||
94383424|NCT00162123|323189492|FG000|Overall Study|Death|3|||
94383425|NCT00162123|323189493|FG001|Overall Study|Death|3|||
94383426|NCT00162123|323189494|FG002|Overall Study|Death|1|||
94383427|NCT00162123|323189495|FG003|Overall Study|Death|1|||
94383428|NCT00162123|323189496|FG004|Overall Study|Death|1|||
94383429|NCT00162123|323189497|FG005|Overall Study|Death|1|||
94383430|NCT00162123|323189498|FG006|Overall Study|Death|0|||
94383431|NCT00162123|323189499|FG007|Overall Study|Death|0|||
94383432|NCT00162123|323189492|FG000|Overall Study|Withdrawal by Subject|2|||
94383433|NCT00162123|323189493|FG001|Overall Study|Withdrawal by Subject|0|||
94383434|NCT00162123|323189494|FG002|Overall Study|Withdrawal by Subject|2|||
94383435|NCT00162123|323189495|FG003|Overall Study|Withdrawal by Subject|1|||
94383436|NCT00162123|323189496|FG004|Overall Study|Withdrawal by Subject|1|||
94383437|NCT00162123|323189497|FG005|Overall Study|Withdrawal by Subject|2|||
94383438|NCT00162123|323189498|FG006|Overall Study|Withdrawal by Subject|1|||
94383439|NCT00162123|323189499|FG007|Overall Study|Withdrawal by Subject|0|||
94383440|NCT00162123|323189492|FG000|Overall Study|Deterioration without progression|2|||
94383441|NCT00162123|323189493|FG001|Overall Study|Deterioration without progression|2|||
94383442|NCT00162123|323189494|FG002|Overall Study|Deterioration without progression|3|||
94383443|NCT00162123|323189495|FG003|Overall Study|Deterioration without progression|0|||
94383444|NCT00162123|323189496|FG004|Overall Study|Deterioration without progression|1|||
94383445|NCT00162123|323189497|FG005|Overall Study|Deterioration without progression|0|||
94383446|NCT00162123|323189498|FG006|Overall Study|Deterioration without progression|0|||
94383447|NCT00162123|323189499|FG007|Overall Study|Deterioration without progression|0|||
94383448|NCT00162123|323189492|FG000|Overall Study|Adverse Event|1|||
94383449|NCT00162123|323189493|FG001|Overall Study|Adverse Event|2|||
94383450|NCT00162123|323189494|FG002|Overall Study|Adverse Event|0|||
94383451|NCT00162123|323189495|FG003|Overall Study|Adverse Event|2|||
94383452|NCT00162123|323189496|FG004|Overall Study|Adverse Event|1|||
94383453|NCT00162123|323189497|FG005|Overall Study|Adverse Event|0|||
94383454|NCT00162123|323189498|FG006|Overall Study|Adverse Event|0|||
94383455|NCT00162123|323189499|FG007|Overall Study|Adverse Event|0|||
94383456|NCT00162123|323189492|FG000|Overall Study|Not specified (before treatment)|2|||
94383457|NCT00162123|323189493|FG001|Overall Study|Not specified (before treatment)|0|||
94383458|NCT00162123|323189494|FG002|Overall Study|Not specified (before treatment)|0|||
94383459|NCT00162123|323189495|FG003|Overall Study|Not specified (before treatment)|0|||
94383460|NCT00162123|323189496|FG004|Overall Study|Not specified (before treatment)|12|||
94383461|NCT00162123|323189497|FG005|Overall Study|Not specified (before treatment)|1|||
94383462|NCT00162123|323189498|FG006|Overall Study|Not specified (before treatment)|0|||
94383463|NCT00162123|323189499|FG007|Overall Study|Not specified (before treatment)|0|||
94383464|NCT00162123|323189492|FG000|Overall Study|Not specified (after start of treatment)|0|||
94383465|NCT00162123|323189493|FG001|Overall Study|Not specified (after start of treatment)|0|||
94383466|NCT00162123|323189494|FG002|Overall Study|Not specified (after start of treatment)|0|||
94383467|NCT00162123|323189495|FG003|Overall Study|Not specified (after start of treatment)|0|||
94383468|NCT00162123|323189496|FG004|Overall Study|Not specified (after start of treatment)|3|||
94383469|NCT00162123|323189497|FG005|Overall Study|Not specified (after start of treatment)|0|||
94383470|NCT00162123|323189498|FG006|Overall Study|Not specified (after start of treatment)|0|||
94383471|NCT00162123|323189499|FG007|Overall Study|Not specified (after start of treatment)|0|||
94383472|NCT00162123|323189492|FG000|Overall Study|Physician Decision|1|||
94383473|NCT00162123|323189493|FG001|Overall Study|Physician Decision|2|||
94383474|NCT00162123|323189494|FG002|Overall Study|Physician Decision|0|||
94383475|NCT00162123|323189495|FG003|Overall Study|Physician Decision|0|||
94383476|NCT00162123|323189496|FG004|Overall Study|Physician Decision|0|||
94383477|NCT00162123|323189497|FG005|Overall Study|Physician Decision|1|||
94383478|NCT00162123|323189498|FG006|Overall Study|Physician Decision|1|||
94383479|NCT00162123|323189499|FG007|Overall Study|Physician Decision|0|||
94383480|NCT00162123|323189492|FG000|Overall Study|Tumor assessment only (not treated)|0|||
94383481|NCT00162123|323189493|FG001|Overall Study|Tumor assessment only (not treated)|0|||
94383482|NCT00162123|323189494|FG002|Overall Study|Tumor assessment only (not treated)|0|||
94383483|NCT00162123|323189495|FG003|Overall Study|Tumor assessment only (not treated)|0|||
94383484|NCT00162123|323189496|FG004|Overall Study|Tumor assessment only (not treated)|0|||
94383485|NCT00162123|323189497|FG005|Overall Study|Tumor assessment only (not treated)|0|||
94383486|NCT00162123|323189498|FG006|Overall Study|Tumor assessment only (not treated)|0|||
94383487|NCT00162123|323189499|FG007|Overall Study|Tumor assessment only (not treated)|1|||
94383488|NCT00162123|323189492|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
94383489|NCT00162123|323189493|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
94383490|NCT00162123|323189494|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
94383491|NCT00162123|323189495|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
94383492|NCT00162123|323189496|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
94383493|NCT00162123|323189497|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
94383494|NCT00162123|323189498|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
94383495|NCT00162123|323189499|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
94383496|NCT03977584|323189500|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
94383497|NCT03977584|323189501|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
94383498|NCT03977584|323189502|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
94383499|NCT00860028|323189503|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
94474468|NCT00791700|323528710|FG002|Overall Study|Adverse Event|1|||
94474469|NCT00791700|323528711|FG003|Overall Study|Adverse Event|1|||
94474470|NCT03224624|323528712|FG000|Overall Study|Lost to Follow-up|9|||
94474471|NCT03224624|323528713|FG001|Overall Study|Lost to Follow-up|4|||
94474472|NCT03224624|323528712|FG000|Overall Study|Death|1|||
94474473|NCT03224624|323528713|FG001|Overall Study|Death|0|||
94474474|NCT01884545|323528714|FG000|Overall Study|Lost to Follow-up|6|||
94474475|NCT01884545|323528715|FG001|Overall Study|Lost to Follow-up|4|||
94474476|NCT01884545|323528716|FG002|Overall Study|Lost to Follow-up|9|||
94474477|NCT01884545|323528717|FG003|Overall Study|Lost to Follow-up|4|||
94474478|NCT01884545|323528714|FG000|Overall Study|Patient withdrawn|7|||
94474479|NCT01884545|323528715|FG001|Overall Study|Patient withdrawn|12|||
94474480|NCT01884545|323528716|FG002|Overall Study|Patient withdrawn|5|||
94474481|NCT01884545|323528717|FG003|Overall Study|Patient withdrawn|5|||
94474482|NCT01884545|323528714|FG000|Overall Study|Non-adherence|0|||
94474483|NCT01884545|323528715|FG001|Overall Study|Non-adherence|2|||
94474484|NCT01884545|323528716|FG002|Overall Study|Non-adherence|0|||
94474485|NCT01884545|323528717|FG003|Overall Study|Non-adherence|0|||
94474486|NCT00551525|323528718|FG000|Overall Study|Protocol Violation|5|||
94474487|NCT00398047|323528721|FG000|Overall Study|all patient progressed before completion|3|||
94474488|NCT02306850|323528722|FG000|Overall Study|Lack of Efficacy|2|||
94474489|NCT03382418|323528723|FG000|Overall Study|Withdrawal by Subject|1|||
94474490|NCT03382418|323528724|FG001|Overall Study|Withdrawal by Subject|0|||
94474491|NCT03382418|323528725|FG002|Overall Study|Withdrawal by Subject|0|||
94474492|NCT03382418|323528723|FG000|Overall Study|Lost to Follow-up|2|||
94474493|NCT03382418|323528724|FG001|Overall Study|Lost to Follow-up|3|||
94474494|NCT03382418|323528725|FG002|Overall Study|Lost to Follow-up|0|||
94474495|NCT01386944|323528726|FG000|Overall Study|Adverse Event|26|||
94474496|NCT01386944|323528726|FG000|Overall Study|Lack of Efficacy|14|||
94474497|NCT01386944|323528726|FG000|Overall Study|Lost to Follow-up|8|||
94474498|NCT01386944|323528726|FG000|Overall Study|Unspecified reason|8|||
94474499|NCT03853291|323528727|FG000|Overall Study|Lost to Follow-up|1|||
94474500|NCT03853291|323528728|FG001|Overall Study|Lost to Follow-up|2|||
94474501|NCT03853291|323528729|FG002|Overall Study|Lost to Follow-up|0|||
94474502|NCT03853291|323528730|FG003|Overall Study|Lost to Follow-up|0|||
94474503|NCT03853291|323528731|FG004|Overall Study|Lost to Follow-up|0|||
94474504|NCT03853291|323528732|FG005|Overall Study|Lost to Follow-up|0|||
94474505|NCT03853291|323528727|FG000|Overall Study|Determined to be ineligible|1|||
94474506|NCT03853291|323528728|FG001|Overall Study|Determined to be ineligible|1|||
94474507|NCT03853291|323528729|FG002|Overall Study|Determined to be ineligible|0|||
94474508|NCT03853291|323528730|FG003|Overall Study|Determined to be ineligible|0|||
94474509|NCT03853291|323528731|FG004|Overall Study|Determined to be ineligible|0|||
94474510|NCT03853291|323528732|FG005|Overall Study|Determined to be ineligible|0|||
94474511|NCT04186221|323528736|FG000|Overall Study|Death|1|||
94474512|NCT01118663|323528739|FG000|Overall Study|Adverse Event|2|||
94474513|NCT01118663|323528740|FG001|Overall Study|Adverse Event|1|||
94474514|NCT01118663|323528739|FG000|Overall Study|Withdrawal by Subject|0|||
94474515|NCT01118663|323528740|FG001|Overall Study|Withdrawal by Subject|1|||
94474516|NCT02453256|323528742|FG000|Double Blind Period|Death|1|||
94474517|NCT02453256|323528743|FG001|Double Blind Period|Death|1|||
94474518|NCT02453256|323528742|FG000|Double Blind Period|Adverse Event|3|||
94474519|NCT02453256|323528743|FG001|Double Blind Period|Adverse Event|2|||
94474520|NCT02453256|323528742|FG000|Double Blind Period|Withdrawal by Subject|9|||
94474521|NCT02453256|323528743|FG001|Double Blind Period|Withdrawal by Subject|5|||
94474522|NCT02453256|323528742|FG000|Double Blind Period|Other|0|||
94474523|NCT02453256|323528743|FG001|Double Blind Period|Other|1|||
94474524|NCT02453256|323528742|FG000|Open Label Period|Adverse Event|1|||
94474525|NCT02453256|323528743|FG001|Open Label Period|Adverse Event|3|||
94474526|NCT02453256|323528742|FG000|Open Label Period|Death|0|||
94474527|NCT02453256|323528743|FG001|Open Label Period|Death|1|||
94313132|NCT03123354|322931493|FG000|Overall Study|Physician Decision|6|||
94313133|NCT04907539|322931494|FG000|Overall Study|Consent withdrawn|1|||
94313134|NCT04907539|322931495|FG001|Overall Study|Consent withdrawn|0|||
94313135|NCT04907539|322931494|FG000|Overall Study|Death|14|||
94313136|NCT04907539|322931495|FG001|Overall Study|Death|3|||
94313137|NCT02948777|322931504|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
94313138|NCT02043301|322931505|FG000|Overall Study|Discontinued|0|||
94313139|NCT02043301|322931506|FG001|Overall Study|Discontinued|1|||
94313140|NCT02043301|322931507|FG002|Overall Study|Discontinued|0|||
94313141|NCT03097328|322931508|FG000|Overall Study|Still on Therapy|2|||
94313142|NCT03097328|322931508|FG000|Overall Study|Progressive Disease|29|||
94313143|NCT03097328|322931508|FG000|Overall Study|Adverse Event|4|||
94313144|NCT03097328|322931508|FG000|Overall Study|Withdrawal by Subject|1|||
94474528|NCT02453256|323528742|FG000|Open Label Period|Lost to Follow-up|1|||
94474529|NCT02453256|323528743|FG001|Open Label Period|Lost to Follow-up|0|||
94313145|NCT03097328|322931508|FG000|Overall Study|Physician Decision|1|||
94313146|NCT03097328|322931508|FG000|Overall Study|Patient Decision|1|||
94474530|NCT02453256|323528742|FG000|Open Label Period|Other|0|||
94313147|NCT03097328|322931508|FG000|Overall Study|Ineligible for Study Drug|1|||
94474531|NCT02453256|323528743|FG001|Open Label Period|Other|2|||
94474532|NCT02453256|323528742|FG000|Open Label Period|Withdrawal by Subject|5|||
94474533|NCT02453256|323528743|FG001|Open Label Period|Withdrawal by Subject|1|||
94474534|NCT03373461|323528747|FG000|Part 2|Adverse Event|0|||
94474535|NCT03373461|323528748|FG001|Part 2|Adverse Event|1|||
94474536|NCT03373461|323528749|FG002|Part 2|Adverse Event|0|||
94474537|NCT03373461|323528750|FG003|Part 2|Adverse Event|0|||
94474538|NCT03373461|323528751|FG004|Part 2|Adverse Event|1|||
94474539|NCT05645432|323528752|FG000|Overall Study|Withdrawal by Subject|1|||
94474540|NCT01243177|323528753|FG000|Overall Study|Lack of Efficacy|47|||
94474541|NCT01243177|323528754|FG001|Overall Study|Lack of Efficacy|31|||
94474542|NCT01243177|323528753|FG000|Overall Study|Protocol Violation|11|||
94474543|NCT01243177|323528754|FG001|Overall Study|Protocol Violation|10|||
94474544|NCT01243177|323528753|FG000|Overall Study|Lost to Follow-up|15|||
94474545|NCT01243177|323528754|FG001|Overall Study|Lost to Follow-up|18|||
94474546|NCT01243177|323528753|FG000|Overall Study|Withdrawal by Subject|46|||
94474547|NCT01243177|323528754|FG001|Overall Study|Withdrawal by Subject|38|||
94474548|NCT01243177|323528753|FG000|Overall Study|AE, serious fatal|0|||
94474549|NCT01243177|323528754|FG001|Overall Study|AE, serious fatal|1|||
94474550|NCT01243177|323528753|FG000|Overall Study|SAE, non-fatal|7|||
94474551|NCT01243177|323528754|FG001|Overall Study|SAE, non-fatal|9|||
94474552|NCT01243177|323528753|FG000|Overall Study|AE, non-serious non-fatal|40|||
94474553|NCT01243177|323528754|FG001|Overall Study|AE, non-serious non-fatal|58|||
94474554|NCT01243177|323528753|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
94474555|NCT01243177|323528754|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
94474556|NCT01243177|323528753|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
94474557|NCT01243177|323528754|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
94474558|NCT01243177|323528753|FG000|Overall Study|Other Reason|11|||
94474559|NCT01243177|323528754|FG001|Overall Study|Other Reason|12|||
94474560|NCT01859949|323530118|FG000|Overall Study|Family Matters|0|||
94474561|NCT01859949|323530119|FG001|Overall Study|Family Matters|1|||
94474562|NCT01859949|323530118|FG000|Overall Study|Physician Decision|2|||
94474563|NCT01859949|323530119|FG001|Overall Study|Physician Decision|4|||
94474564|NCT01859949|323530118|FG000|Overall Study|Withdrawal by Subject|11|||
94474565|NCT01859949|323530119|FG001|Overall Study|Withdrawal by Subject|10|||
94474566|NCT01859949|323530118|FG000|Overall Study|Protocol Violation|1|||
94474567|NCT01859949|323530119|FG001|Overall Study|Protocol Violation|1|||
94474568|NCT01859949|323530118|FG000|Overall Study|Adverse Event|0|||
94313148|NCT01798134|322931509|FG000|Overall Study|Lost to Follow-up|1|||
94313149|NCT01798134|322931509|FG000|Overall Study|Withdrawal by Subject|3|||
94313150|NCT01798134|322931509|FG000|Overall Study|Death|2|||
94313151|NCT01798134|322931509|FG000|Overall Study|Adverse Event|3|||
94313152|NCT01798134|322931509|FG000|Overall Study|Physician Decision|3|||
94313153|NCT01798134|322931509|FG000|Overall Study|Liver transplant/surgery|4|||
94313154|NCT01703286|322931524|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
94313155|NCT01703286|322931525|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
94313156|NCT01703286|322931526|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
94313157|NCT01703286|322931527|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
94313158|NCT01703286|322931528|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
94313159|NCT01703286|322931529|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
94313160|NCT01703286|322931524|FG000|Period 2 Including Washout|Adverse Event|0|||
94313161|NCT01703286|322931525|FG001|Period 2 Including Washout|Adverse Event|0|||
94313162|NCT01703286|322931526|FG002|Period 2 Including Washout|Adverse Event|0|||
94313163|NCT01703286|322931527|FG003|Period 2 Including Washout|Adverse Event|1|||
94313164|NCT01703286|322931528|FG004|Period 2 Including Washout|Adverse Event|0|||
94313165|NCT01703286|322931529|FG005|Period 2 Including Washout|Adverse Event|0|||
94313166|NCT02531373|322931530|FG000|Overall Study|Lack of Efficacy|0|||
94313167|NCT02531373|322931531|FG001|Overall Study|Lack of Efficacy|0|||
94313168|NCT02531373|322931532|FG002|Overall Study|Lack of Efficacy|0|||
94313169|NCT02531373|322931533|FG003|Overall Study|Lack of Efficacy|0|||
94313170|NCT02531373|322931534|FG004|Overall Study|Lack of Efficacy|3|||
94313171|NCT02531373|322931535|FG005|Overall Study|Lack of Efficacy|2|||
94313172|NCT02531373|322931536|FG006|Overall Study|Lack of Efficacy|4|||
94313173|NCT02531373|322931537|FG007|Overall Study|Lack of Efficacy|8|||
94313174|NCT02531373|322931538|FG008|Overall Study|Lack of Efficacy|5|||
94313175|NCT02531373|322931530|FG000|Overall Study|Lost to Follow-up|0|||
94474569|NCT01859949|323530119|FG001|Overall Study|Adverse Event|1|||
94474570|NCT00398216|323530120|FG000|Overall Study|Adverse Event|4|||
94474571|NCT00398216|323530121|FG001|Overall Study|Adverse Event|2|||
94474572|NCT00398216|323530122|FG002|Overall Study|Adverse Event|5|||
94474573|NCT00398216|323530123|FG003|Overall Study|Adverse Event|7|||
94474574|NCT00398216|323530124|FG004|Overall Study|Adverse Event|2|||
94474575|NCT00398216|323530120|FG000|Overall Study|Protocol Violation|2|||
94474576|NCT00398216|323530121|FG001|Overall Study|Protocol Violation|4|||
94313176|NCT02531373|322931531|FG001|Overall Study|Lost to Follow-up|0|||
94313177|NCT02531373|322931532|FG002|Overall Study|Lost to Follow-up|0|||
94313178|NCT02531373|322931533|FG003|Overall Study|Lost to Follow-up|0|||
94313179|NCT02531373|322931534|FG004|Overall Study|Lost to Follow-up|0|||
94313180|NCT02531373|322931535|FG005|Overall Study|Lost to Follow-up|2|||
94474577|NCT00398216|323530122|FG002|Overall Study|Protocol Violation|5|||
94313181|NCT02531373|322931536|FG006|Overall Study|Lost to Follow-up|2|||
94313182|NCT02531373|322931537|FG007|Overall Study|Lost to Follow-up|0|||
94313183|NCT02531373|322931538|FG008|Overall Study|Lost to Follow-up|0|||
94313184|NCT02531373|322931530|FG000|Overall Study|Physician Decision|0|||
94313185|NCT02531373|322931531|FG001|Overall Study|Physician Decision|0|||
94313186|NCT02531373|322931532|FG002|Overall Study|Physician Decision|0|||
94313187|NCT02531373|322931533|FG003|Overall Study|Physician Decision|0|||
94313188|NCT02531373|322931534|FG004|Overall Study|Physician Decision|2|||
94313189|NCT02531373|322931535|FG005|Overall Study|Physician Decision|1|||
94313190|NCT02531373|322931536|FG006|Overall Study|Physician Decision|0|||
94313191|NCT02531373|322931537|FG007|Overall Study|Physician Decision|0|||
94313192|NCT02531373|322931538|FG008|Overall Study|Physician Decision|0|||
94313193|NCT02531373|322931530|FG000|Overall Study|Protocol Violation|0|||
94313194|NCT02531373|322931531|FG001|Overall Study|Protocol Violation|0|||
94313195|NCT02531373|322931532|FG002|Overall Study|Protocol Violation|0|||
94313196|NCT02531373|322931533|FG003|Overall Study|Protocol Violation|0|||
94313197|NCT02531373|322931534|FG004|Overall Study|Protocol Violation|0|||
94313198|NCT02531373|322931535|FG005|Overall Study|Protocol Violation|1|||
94313199|NCT02531373|322931536|FG006|Overall Study|Protocol Violation|1|||
94313200|NCT02531373|322931537|FG007|Overall Study|Protocol Violation|0|||
94313201|NCT02531373|322931538|FG008|Overall Study|Protocol Violation|1|||
94313202|NCT02531373|322931530|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94313203|NCT02531373|322931531|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94313204|NCT02531373|322931532|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
94313205|NCT02531373|322931533|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
94313206|NCT02531373|322931534|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
94313207|NCT02531373|322931535|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
94313208|NCT02531373|322931536|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
94313209|NCT02531373|322931537|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
94313210|NCT02531373|322931538|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
94313211|NCT02531373|322931530|FG000|Overall Study|Withdrawal by Subject|0|||
94313212|NCT02531373|322931531|FG001|Overall Study|Withdrawal by Subject|0|||
94313213|NCT02531373|322931532|FG002|Overall Study|Withdrawal by Subject|0|||
94313214|NCT02531373|322931533|FG003|Overall Study|Withdrawal by Subject|0|||
94313215|NCT02531373|322931534|FG004|Overall Study|Withdrawal by Subject|3|||
94313216|NCT02531373|322931535|FG005|Overall Study|Withdrawal by Subject|0|||
94313217|NCT02531373|322931536|FG006|Overall Study|Withdrawal by Subject|0|||
94313218|NCT02531373|322931537|FG007|Overall Study|Withdrawal by Subject|0|||
94313219|NCT02531373|322931538|FG008|Overall Study|Withdrawal by Subject|0|||
94313220|NCT01675531|322931539|FG000|Overall Study|Adverse Event|9|||
94313221|NCT01675531|322931539|FG000|Overall Study|Withdrawal by Subject|7|||
94313222|NCT01675531|322931539|FG000|Overall Study|Lack of Efficacy|1|||
94313223|NCT01675531|322931539|FG000|Overall Study|Protocol Violation|8|||
94313224|NCT02795988|322931540|FG000|Phase 1b|Withdrawal by Subject|0|||
94313225|NCT02795988|322931541|FG001|Phase 1b|Withdrawal by Subject|1|||
94313226|NCT02795988|322931542|FG002|Phase 1b|Withdrawal by Subject|0|||
94313227|NCT02795988|322931543|FG003|Phase 1b|Withdrawal by Subject|0|||
94313228|NCT02795988|322931544|FG004|Phase 1b|Withdrawal by Subject|0|||
94313229|NCT02795988|322931545|FG005|Phase 1b|Withdrawal by Subject|0|||
94313230|NCT02795988|322931546|FG006|Phase 1b|Withdrawal by Subject|0|||
94313231|NCT02795988|322931540|FG000|Phase 1b|Death|1|||
94313232|NCT02795988|322931541|FG001|Phase 1b|Death|2|||
94313233|NCT02795988|322931542|FG002|Phase 1b|Death|1|||
94313234|NCT02795988|322931543|FG003|Phase 1b|Death|0|||
94313235|NCT02795988|322931544|FG004|Phase 1b|Death|0|||
94313236|NCT02795988|322931545|FG005|Phase 1b|Death|0|||
94313237|NCT02795988|322931546|FG006|Phase 1b|Death|0|||
94313238|NCT02795988|322931540|FG000|Phase 1b|Physician Decision|0|||
94313239|NCT02795988|322931541|FG001|Phase 1b|Physician Decision|0|||
94313240|NCT02795988|322931542|FG002|Phase 1b|Physician Decision|1|||
94313241|NCT02795988|322931543|FG003|Phase 1b|Physician Decision|0|||
94313242|NCT02795988|322931544|FG004|Phase 1b|Physician Decision|0|||
94313243|NCT02795988|322931545|FG005|Phase 1b|Physician Decision|0|||
94313244|NCT02795988|322931546|FG006|Phase 1b|Physician Decision|0|||
94313245|NCT02795988|322931540|FG000|Phase 1b|Progressive Disease|2|||
94313246|NCT02795988|322931541|FG001|Phase 1b|Progressive Disease|2|||
94313247|NCT02795988|322931542|FG002|Phase 1b|Progressive Disease|0|||
94313248|NCT02795988|322931543|FG003|Phase 1b|Progressive Disease|0|||
94313249|NCT02795988|322931544|FG004|Phase 1b|Progressive Disease|0|||
94313250|NCT02795988|322931545|FG005|Phase 1b|Progressive Disease|0|||
94313251|NCT02795988|322931546|FG006|Phase 1b|Progressive Disease|0|||
94313252|NCT02795988|322931540|FG000|Phase 2|Withdrawal by Subject|0|||
94313253|NCT02795988|322931541|FG001|Phase 2|Withdrawal by Subject|0|||
94313254|NCT02795988|322931542|FG002|Phase 2|Withdrawal by Subject|0|||
94313255|NCT02795988|322931543|FG003|Phase 2|Withdrawal by Subject|1|||
94313256|NCT02795988|322931544|FG004|Phase 2|Withdrawal by Subject|0|||
94313257|NCT02795988|322931545|FG005|Phase 2|Withdrawal by Subject|0|||
94313258|NCT02795988|322931546|FG006|Phase 2|Withdrawal by Subject|0|||
94313259|NCT02795988|322931540|FG000|Phase 2|Death|0|||
94313260|NCT02795988|322931541|FG001|Phase 2|Death|0|||
94313261|NCT02795988|322931542|FG002|Phase 2|Death|0|||
94313262|NCT02795988|322931543|FG003|Phase 2|Death|17|||
94313263|NCT02795988|322931544|FG004|Phase 2|Death|17|||
94313264|NCT02795988|322931545|FG005|Phase 2|Death|0|||
94313265|NCT02795988|322931546|FG006|Phase 2|Death|0|||
94313266|NCT02795988|322931540|FG000|Phase 2|Other|0|||
94313267|NCT02795988|322931541|FG001|Phase 2|Other|0|||
94313268|NCT02795988|322931542|FG002|Phase 2|Other|0|||
94313269|NCT02795988|322931543|FG003|Phase 2|Other|1|||
94313270|NCT02795988|322931544|FG004|Phase 2|Other|0|||
94313271|NCT02795988|322931545|FG005|Phase 2|Other|0|||
94313272|NCT02795988|322931546|FG006|Phase 2|Other|0|||
94313273|NCT02795988|322931540|FG000|Phase 2 Extension|Death|0|||
94313274|NCT02795988|322931541|FG001|Phase 2 Extension|Death|0|||
94313275|NCT02795988|322931542|FG002|Phase 2 Extension|Death|0|||
94313276|NCT02795988|322931543|FG003|Phase 2 Extension|Death|0|||
94313277|NCT02795988|322931544|FG004|Phase 2 Extension|Death|0|||
94313278|NCT02795988|322931545|FG005|Phase 2 Extension|Death|5|||
94313279|NCT02795988|322931546|FG006|Phase 2 Extension|Death|6|||
94313280|NCT02795988|322931540|FG000|Phase 2 Extension|Other reasons|0|||
94313281|NCT02795988|322931541|FG001|Phase 2 Extension|Other reasons|0|||
94313282|NCT02795988|322931542|FG002|Phase 2 Extension|Other reasons|0|||
94313283|NCT02795988|322931543|FG003|Phase 2 Extension|Other reasons|0|||
94313284|NCT02795988|322931544|FG004|Phase 2 Extension|Other reasons|0|||
94313285|NCT02795988|322931545|FG005|Phase 2 Extension|Other reasons|2|||
94313286|NCT02795988|322931546|FG006|Phase 2 Extension|Other reasons|1|||
94313287|NCT04705597|322931547|FG000|Overall Study|Death|16|||
94313288|NCT04705597|322931548|FG001|Overall Study|Death|9|||
94313289|NCT04705597|322931547|FG000|Overall Study|Lost to Follow-up|1|||
94313290|NCT04705597|322931548|FG001|Overall Study|Lost to Follow-up|0|||
94313291|NCT04705597|322931547|FG000|Overall Study|Withdrawal by Subject|1|||
94313292|NCT04705597|322931548|FG001|Overall Study|Withdrawal by Subject|2|||
94313293|NCT00273858|322931549|FG000|Overall Study|Not completed 24 month observation time|334|||
94313294|NCT00273858|322931549|FG000|Overall Study|Lost to Follow-up|101|||
94313295|NCT00273858|322931549|FG000|Overall Study|Withdrawal by Subject|21|||
94313296|NCT00273858|322931549|FG000|Overall Study|Adverse Event|81|||
94313297|NCT02561000|322931553|FG000|Overall Study|Withdrawal by Subject|2|||
94313298|NCT02561000|322931554|FG001|Overall Study|Withdrawal by Subject|3|||
94313299|NCT02561000|322931555|FG002|Overall Study|Withdrawal by Subject|0|||
94313300|NCT02561000|322931553|FG000|Overall Study|Adverse Event|0|||
94313301|NCT02561000|322931554|FG001|Overall Study|Adverse Event|1|||
94313302|NCT02561000|322931555|FG002|Overall Study|Adverse Event|0|||
94313303|NCT03430245|322931556|FG000|Overall Study|Withdrawal by Subject|6|||
94474578|NCT00398216|323530123|FG003|Overall Study|Protocol Violation|7|||
94474579|NCT00398216|323530124|FG004|Overall Study|Protocol Violation|5|||
94474580|NCT00398216|323530120|FG000|Overall Study|Lost to Follow-up|1|||
94474581|NCT00398216|323530121|FG001|Overall Study|Lost to Follow-up|6|||
94474582|NCT00398216|323530122|FG002|Overall Study|Lost to Follow-up|4|||
94474583|NCT00398216|323530123|FG003|Overall Study|Lost to Follow-up|4|||
94474584|NCT00398216|323530124|FG004|Overall Study|Lost to Follow-up|1|||
94474585|NCT00398216|323530120|FG000|Overall Study|Death|0|||
94474586|NCT00398216|323530121|FG001|Overall Study|Death|3|||
94474587|NCT00398216|323530122|FG002|Overall Study|Death|0|||
94474588|NCT00398216|323530123|FG003|Overall Study|Death|0|||
94474589|NCT00398216|323530124|FG004|Overall Study|Death|0|||
94474590|NCT00398216|323530120|FG000|Overall Study|Withdrawal by Subject|1|||
94474591|NCT00398216|323530121|FG001|Overall Study|Withdrawal by Subject|0|||
94474592|NCT00398216|323530122|FG002|Overall Study|Withdrawal by Subject|3|||
94474593|NCT00398216|323530123|FG003|Overall Study|Withdrawal by Subject|1|||
94474594|NCT00398216|323530124|FG004|Overall Study|Withdrawal by Subject|2|||
94474595|NCT00398216|323530120|FG000|Overall Study|administrative reasons|3|||
94474596|NCT00398216|323530121|FG001|Overall Study|administrative reasons|4|||
94474597|NCT00398216|323530122|FG002|Overall Study|administrative reasons|4|||
94474598|NCT00398216|323530123|FG003|Overall Study|administrative reasons|3|||
94474599|NCT00398216|323530124|FG004|Overall Study|administrative reasons|3|||
94474600|NCT00398216|323530120|FG000|Overall Study|entrance criteria|0|||
94474601|NCT00398216|323530121|FG001|Overall Study|entrance criteria|0|||
94474602|NCT00398216|323530122|FG002|Overall Study|entrance criteria|0|||
94474603|NCT00398216|323530123|FG003|Overall Study|entrance criteria|0|||
94474604|NCT00398216|323530124|FG004|Overall Study|entrance criteria|2|||
94474605|NCT00410072|323530125|FG000|Day 1 to Week 48|Adverse Event|1|||
94474606|NCT00410072|323530126|FG001|Day 1 to Week 48|Adverse Event|2|||
94474607|NCT00410072|323530125|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
94474608|NCT00410072|323530126|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
94474609|NCT00410072|323530125|FG000|Day 1 to Week 48|Other|0|||
94474610|NCT00410072|323530126|FG001|Day 1 to Week 48|Other|1|||
94474611|NCT00410072|323530125|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
94474612|NCT00410072|323530126|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
94474613|NCT00410072|323530125|FG000|Day 1 to Week 48|Pregnancy|0|||
94474614|NCT00410072|323530126|FG001|Day 1 to Week 48|Pregnancy|2|||
94474615|NCT00410072|323530125|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
94474616|NCT00410072|323530126|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
94474617|NCT00410072|323530125|FG000|After Week 48 to Week 96|Adverse Event|1|||
94474618|NCT00410072|323530126|FG001|After Week 48 to Week 96|Adverse Event|2|||
94474619|NCT00410072|323530125|FG000|After Week 48 to Week 96|Death|0|||
94474620|NCT00410072|323530126|FG001|After Week 48 to Week 96|Death|1|||
94474621|NCT00410072|323530125|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
94474622|NCT00410072|323530126|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
94474623|NCT00410072|323530125|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
94313304|NCT03430245|322931556|FG000|Overall Study|Lost to Follow-up|1|||
94313305|NCT01234402|322931557|FG000|Overall Study|Lost to Follow-up|0|||
94313306|NCT01234402|322931558|FG001|Overall Study|Lost to Follow-up|1|||
94474624|NCT00410072|323530126|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
94474625|NCT00410072|323530125|FG000|After Week 48 to Week 96|Other|2|||
94474626|NCT00410072|323530126|FG001|After Week 48 to Week 96|Other|0|||
94313307|NCT01234402|322931559|FG002|Overall Study|Lost to Follow-up|3|||
94313308|NCT01234402|322931557|FG000|Overall Study|Withdrawal by Subject|1|||
94313309|NCT01234402|322931558|FG001|Overall Study|Withdrawal by Subject|3|||
94313310|NCT01234402|322931559|FG002|Overall Study|Withdrawal by Subject|4|||
94313311|NCT01234402|322931557|FG000|Overall Study|Never treated: Death|0|||
94313312|NCT01234402|322931558|FG001|Overall Study|Never treated: Death|0|||
94313313|NCT01234402|322931559|FG002|Overall Study|Never treated: Death|1|||
94313314|NCT01234402|322931557|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
94313315|NCT01234402|322931558|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
94313316|NCT01234402|322931559|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
94313317|NCT01234402|322931557|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
94313318|NCT01234402|322931558|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
94313319|NCT01234402|322931559|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
94313320|NCT00553059|322931560|FG000|Overall Study|Deemed ineligible|1|||
94313321|NCT00553059|322931561|FG001|Overall Study|Deemed ineligible|1|||
94474627|NCT00410072|323530125|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
94474628|NCT00410072|323530126|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
94474629|NCT00410072|323530125|FG000|After Week 48 to Week 96|Pregnancy|0|||
94313322|NCT00553059|322931560|FG000|Overall Study|Drug supply not available|0|||
94313323|NCT00553059|322931561|FG001|Overall Study|Drug supply not available|1|||
94474630|NCT00410072|323530126|FG001|After Week 48 to Week 96|Pregnancy|2|||
94313324|NCT06094296|322931562|FG000|Overall Study|Progressive Disease|1|||
94474631|NCT00410072|323530125|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
94474632|NCT00410072|323530126|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
94474633|NCT00376532|323530129|FG000|Overall Study|Lack sufficient blood sample|6|||
94474634|NCT00376532|323530130|FG001|Overall Study|Lack sufficient blood sample|6|||
94474635|NCT02207400|323530131|FG000|Overall Study|Adverse Event|1|||
94474636|NCT02207400|323530132|FG001|Overall Study|Adverse Event|1|||
94474637|NCT02207400|323530131|FG000|Overall Study|Lost to Follow-up|6|||
94474638|NCT02207400|323530132|FG001|Overall Study|Lost to Follow-up|7|||
94474639|NCT02207400|323530131|FG000|Overall Study|Protocol Violation|1|||
94474640|NCT02207400|323530132|FG001|Overall Study|Protocol Violation|1|||
94474641|NCT02207400|323530131|FG000|Overall Study|Withdrawal by Subject|8|||
94474642|NCT02207400|323530132|FG001|Overall Study|Withdrawal by Subject|4|||
94474643|NCT02207400|323530131|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
94474644|NCT02207400|323530132|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
94474645|NCT03396822|323530133|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
94474646|NCT03396822|323530133|FG000|Overall Study|Physician Decision|1|||
94474647|NCT04985942|323530134|FG000|Overall Study|Adverse Event|14|||
94474648|NCT04985942|323530135|FG001|Overall Study|Adverse Event|2|||
94474649|NCT04985942|323530134|FG000|Overall Study|Lack of Efficacy|0|||
94474650|NCT04985942|323530135|FG001|Overall Study|Lack of Efficacy|3|||
94474651|NCT04985942|323530134|FG000|Overall Study|Lost to Follow-up|1|||
94474652|NCT04985942|323530135|FG001|Overall Study|Lost to Follow-up|1|||
94474653|NCT04985942|323530134|FG000|Overall Study|Protocol Violation|1|||
94474654|NCT04985942|323530135|FG001|Overall Study|Protocol Violation|1|||
94474655|NCT04985942|323530134|FG000|Overall Study|Withdrawal by Subject|5|||
94474656|NCT04985942|323530135|FG001|Overall Study|Withdrawal by Subject|4|||
94474657|NCT03638466|323530136|FG000|Overall Study|Early Termination|0|||
94474658|NCT03638466|323530137|FG001|Overall Study|Early Termination|1|||
94474659|NCT02447328|323530138|FG000|Overall Study|Withdrawal by Subject|1|||
94474660|NCT04304508|323530139|FG000|Overall Study|Subject Decision|29|||
94474661|NCT04304508|323530140|FG001|Overall Study|Subject Decision|39|||
94474662|NCT04304508|323530141|FG002|Overall Study|Subject Decision|37|||
94474663|NCT04304508|323530142|FG003|Overall Study|Subject Decision|48|||
94474664|NCT04304508|323530139|FG000|Overall Study|Death|6|||
94474665|NCT04304508|323530140|FG001|Overall Study|Death|1|||
94474666|NCT04304508|323530141|FG002|Overall Study|Death|8|||
94474667|NCT04304508|323530142|FG003|Overall Study|Death|5|||
94474668|NCT04304508|323530139|FG000|Overall Study|Non-compliance With Study Drug|3|||
94474669|NCT04304508|323530140|FG001|Overall Study|Non-compliance With Study Drug|1|||
94474670|NCT04304508|323530141|FG002|Overall Study|Non-compliance With Study Drug|2|||
94474671|NCT04304508|323530142|FG003|Overall Study|Non-compliance With Study Drug|0|||
94474672|NCT04304508|323530139|FG000|Overall Study|Switching To Other Therapy|1|||
94474673|NCT04304508|323530140|FG001|Overall Study|Switching To Other Therapy|1|||
94474674|NCT04304508|323530141|FG002|Overall Study|Switching To Other Therapy|1|||
94474675|NCT04304508|323530142|FG003|Overall Study|Switching To Other Therapy|2|||
94474676|NCT04304508|323530139|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
94474677|NCT04304508|323530140|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
94474678|NCT04304508|323530141|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
94474679|NCT04304508|323530142|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
94474680|NCT04304508|323530139|FG000|Overall Study|Withdrawal by Subject|7|||
94474681|NCT04304508|323530140|FG001|Overall Study|Withdrawal by Subject|5|||
94383500|NCT00860028|323189504|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
94383501|NCT03384745|323189505|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
94383502|NCT03384745|323189506|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
94383503|NCT03384745|323189507|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
94383504|NCT03384745|323189508|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
94383505|NCT03384745|323189509|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
94383506|NCT03384745|323189510|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
94383507|NCT03384745|323189505|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
94383508|NCT03384745|323189506|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
94383509|NCT03384745|323189507|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
94383510|NCT03384745|323189508|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
94383511|NCT03384745|323189509|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
94383512|NCT03384745|323189510|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
94383513|NCT03384745|323189505|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
94383514|NCT03384745|323189506|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
94474682|NCT04304508|323530141|FG002|Overall Study|Withdrawal by Subject|11|||
94474683|NCT04304508|323530142|FG003|Overall Study|Withdrawal by Subject|6|||
94383515|NCT03384745|323189507|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
94383516|NCT03384745|323189508|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
94474684|NCT04304508|323530139|FG000|Overall Study|Logistical Difficulties|2|||
94474685|NCT04304508|323530140|FG001|Overall Study|Logistical Difficulties|2|||
94474686|NCT04304508|323530141|FG002|Overall Study|Logistical Difficulties|3|||
94474687|NCT04304508|323530142|FG003|Overall Study|Logistical Difficulties|2|||
94474688|NCT04304508|323530139|FG000|Overall Study|Missing Information|1|||
94474689|NCT04304508|323530140|FG001|Overall Study|Missing Information|2|||
94474690|NCT04304508|323530141|FG002|Overall Study|Missing Information|1|||
94474691|NCT04304508|323530142|FG003|Overall Study|Missing Information|3|||
94474692|NCT04304508|323530139|FG000|Overall Study|Other|7|||
94474693|NCT04304508|323530140|FG001|Overall Study|Other|6|||
94474694|NCT04304508|323530141|FG002|Overall Study|Other|5|||
94474695|NCT04304508|323530142|FG003|Overall Study|Other|4|||
94474696|NCT04304508|323530139|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
94474697|NCT04304508|323530140|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
94474698|NCT04304508|323530141|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
94474699|NCT04304508|323530142|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
94474700|NCT04304508|323530139|FG000|Overall Study|Physician Decision|3|||
94474701|NCT04304508|323530140|FG001|Overall Study|Physician Decision|4|||
94474702|NCT04304508|323530141|FG002|Overall Study|Physician Decision|9|||
94474703|NCT04304508|323530142|FG003|Overall Study|Physician Decision|7|||
94474704|NCT04304508|323530139|FG000|Overall Study|Study drug never administered|10|||
94474705|NCT04304508|323530140|FG001|Overall Study|Study drug never administered|4|||
94474706|NCT04304508|323530141|FG002|Overall Study|Study drug never administered|4|||
94474707|NCT04304508|323530142|FG003|Overall Study|Study drug never administered|4|||
94474708|NCT04304508|323530139|FG000|Overall Study|Adverse Event|49|||
94474709|NCT04304508|323530140|FG001|Overall Study|Adverse Event|50|||
94474710|NCT04304508|323530141|FG002|Overall Study|Adverse Event|51|||
94474711|NCT04304508|323530142|FG003|Overall Study|Adverse Event|56|||
94474712|NCT04304508|323530139|FG000|Overall Study|Lost to Follow-up|1|||
94474713|NCT04304508|323530140|FG001|Overall Study|Lost to Follow-up|5|||
94474714|NCT04304508|323530141|FG002|Overall Study|Lost to Follow-up|2|||
94474715|NCT04304508|323530142|FG003|Overall Study|Lost to Follow-up|3|||
94383517|NCT03384745|323189509|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
94383518|NCT03384745|323189510|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
94383519|NCT03384745|323189505|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
94383520|NCT03384745|323189506|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
94383521|NCT03384745|323189507|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
94383522|NCT03384745|323189508|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
94383523|NCT03384745|323189509|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
94383524|NCT03384745|323189510|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
94383525|NCT03384745|323189505|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
94383526|NCT03384745|323189506|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
94383527|NCT03384745|323189507|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
94383528|NCT03384745|323189508|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
94383529|NCT03384745|323189509|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
94383530|NCT03384745|323189510|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
94383531|NCT03384745|323189505|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
94383532|NCT03384745|323189506|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
94383533|NCT03384745|323189507|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
94383534|NCT03384745|323189508|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
94383535|NCT03384745|323189509|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
94383536|NCT03384745|323189510|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
94383537|NCT03384745|323189505|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
94383538|NCT03384745|323189506|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
94383539|NCT03384745|323189507|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
94383540|NCT03384745|323189508|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
94383541|NCT03384745|323189509|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
94383542|NCT03384745|323189510|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
94383543|NCT03384745|323189505|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
94383544|NCT03384745|323189506|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
94383545|NCT03384745|323189507|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
94383546|NCT03384745|323189508|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
94383547|NCT03384745|323189509|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
94383548|NCT03384745|323189510|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
94383549|NCT03384745|323189505|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
94383550|NCT03384745|323189506|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
94383551|NCT03384745|323189507|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
94383552|NCT03384745|323189508|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
94383553|NCT03384745|323189509|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
94474716|NCT02113007|323530149|FG000|Overall Study|Progressive disease|2|||
94474717|NCT01616758|323530150|FG000|Overall Study|Adverse Event|1|||
94474718|NCT01616758|323530150|FG000|Overall Study|Withdrawal by Subject|2|||
94474719|NCT01616758|323530150|FG000|Overall Study|Disease progression|18|||
94474720|NCT01616758|323530150|FG000|Overall Study|Study termination by Sponsor|1|||
94474721|NCT01031004|323530151|FG000|Overall Study|Protocol Violation|0|||
94474722|NCT01031004|323530152|FG001|Overall Study|Protocol Violation|1|||
94313325|NCT06094296|322931563|FG001|Overall Study|Progressive Disease|0|||
94313326|NCT06094296|322931564|FG002|Overall Study|Progressive Disease|0|||
94313327|NCT06094296|322931565|FG003|Overall Study|Progressive Disease|0|||
94313328|NCT04429503|322931570|FG000|Overall Study|Non-compliance with protocol by the subject|2|||
94313329|NCT04429503|322931571|FG001|Overall Study|Non-compliance with protocol by the subject|1|||
94313330|NCT04429503|322931572|FG002|Overall Study|Non-compliance with protocol by the subject|0|||
94313331|NCT04429503|322931570|FG000|Overall Study|Adverse Event|1|||
94313332|NCT04429503|322931571|FG001|Overall Study|Adverse Event|9|||
94313333|NCT04429503|322931572|FG002|Overall Study|Adverse Event|2|||
94313334|NCT04429503|322931570|FG000|Overall Study|Decision by the investigator/sponsor|2|||
94313335|NCT04429503|322931571|FG001|Overall Study|Decision by the investigator/sponsor|9|||
94313336|NCT04429503|322931572|FG002|Overall Study|Decision by the investigator/sponsor|3|||
94313337|NCT04429503|322931570|FG000|Overall Study|Withdrawal by Subject|9|||
94313338|NCT04429503|322931571|FG001|Overall Study|Withdrawal by Subject|17|||
94313339|NCT04429503|322931572|FG002|Overall Study|Withdrawal by Subject|8|||
94313340|NCT04429503|322931570|FG000|Overall Study|Lost to Follow-up|5|||
94313341|NCT04429503|322931571|FG001|Overall Study|Lost to Follow-up|19|||
94313342|NCT04429503|322931572|FG002|Overall Study|Lost to Follow-up|7|||
94313343|NCT04429503|322931570|FG000|Overall Study|Death|9|||
94313344|NCT04429503|322931571|FG001|Overall Study|Death|18|||
94313345|NCT04429503|322931572|FG002|Overall Study|Death|5|||
94313346|NCT01703819|322931573|FG000|Overall Study|Adverse Event|0|||
94313347|NCT01703819|322931574|FG001|Overall Study|Adverse Event|1|||
94313348|NCT01703819|322931573|FG000|Overall Study|Withdrawal by Subject|0|||
94313349|NCT01703819|322931574|FG001|Overall Study|Withdrawal by Subject|1|||
94313350|NCT03215264|322931581|FG000|Dose Level 2|Adverse Event|0|||
94313351|NCT03215264|322931582|FG001|Dose Level 2|Adverse Event|1|||
94313352|NCT03215264|322931583|FG002|Dose Level 2|Adverse Event|0|||
94313353|NCT03215264|322931581|FG000|Dose Level 3|Withdrawal by Subject|0|||
94313354|NCT03215264|322931582|FG001|Dose Level 3|Withdrawal by Subject|0|||
94313355|NCT03215264|322931583|FG002|Dose Level 3|Withdrawal by Subject|1|||
94383554|NCT03384745|323189510|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
94383555|NCT03384745|323189505|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
94383556|NCT03384745|323189506|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
94383557|NCT03384745|323189507|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
94383558|NCT03384745|323189508|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
94383559|NCT03384745|323189509|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
94383560|NCT03384745|323189510|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
94383561|NCT03384745|323189505|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
94383562|NCT03384745|323189506|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
94383563|NCT03384745|323189507|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
94383564|NCT03384745|323189508|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
94383565|NCT03384745|323189509|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
94383566|NCT03384745|323189510|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
94383567|NCT01766778|323189514|FG000|Overall Study|Adverse Event|4|||
94383568|NCT01766778|323189515|FG001|Overall Study|Adverse Event|4|||
94383569|NCT01766778|323189514|FG000|Overall Study|Withdrawal by Subject|1|||
94383570|NCT01766778|323189515|FG001|Overall Study|Withdrawal by Subject|0|||
94383571|NCT02093689|323189516|FG000|Overall Study|Physician Decision|4|||
94383572|NCT02093689|323189517|FG001|Overall Study|Physician Decision|0|||
94383573|NCT02093689|323189518|FG002|Overall Study|Physician Decision|0|||
94383574|NCT03144687|323189519|FG000|Overall Study|Death|0|||
94383575|NCT03144687|323189520|FG001|Overall Study|Death|2|||
94383576|NCT03144687|323189519|FG000|Overall Study|Lost to Follow-up|0|||
94383577|NCT03144687|323189520|FG001|Overall Study|Lost to Follow-up|1|||
94383578|NCT03144687|323189519|FG000|Overall Study|Physician Decision|0|||
94383579|NCT03144687|323189520|FG001|Overall Study|Physician Decision|1|||
94383580|NCT03144687|323189519|FG000|Overall Study|Withdrawal by Subject|1|||
94313356|NCT01849250|322931584|FG000|Overall Study|Withdrawal by Subject|1|||
94313357|NCT01849250|322931585|FG001|Overall Study|Withdrawal by Subject|0|||
94313358|NCT01849250|322931584|FG000|Overall Study|Not Evaluable|5|||
94383581|NCT03144687|323189520|FG001|Overall Study|Withdrawal by Subject|3|||
94313359|NCT01849250|322931585|FG001|Overall Study|Not Evaluable|3|||
94313360|NCT01849250|322931584|FG000|Overall Study|Screen Failure|1|||
94313361|NCT01849250|322931585|FG001|Overall Study|Screen Failure|0|||
94313362|NCT03196505|322931586|FG000|Overall Study|Physician Decision|26|||
94313363|NCT03196505|322931587|FG001|Overall Study|Physician Decision|26|||
94313364|NCT00406315|322931588|FG000|Overall Study|Death|1|||
94313365|NCT00406315|322931588|FG000|Overall Study|Adverse Event|39|||
94383582|NCT03144687|323189519|FG000|Overall Study|Not Reported|2|||
94383583|NCT03144687|323189520|FG001|Overall Study|Not Reported|0|||
94383584|NCT01478620|323189523|FG000|Overall Study|Lost to Follow-up|6|||
94383585|NCT00475020|323189524|FG000|Overall Study|Physician Decision|3|||
94383586|NCT00475020|323189524|FG000|Overall Study|Insurance Denial|1|||
94383587|NCT00475020|323189524|FG000|Overall Study|Donor not able to donate the last minute|1|||
94383588|NCT01469546|323189528|FG000|Received 5 mg Dose|Adverse Event|13|||
94383589|NCT01469546|323189528|FG000|Received 5 mg Dose|Death|2|||
94383590|NCT01469546|323189528|FG000|Received 5 mg Dose|Protocol Violation|2|||
94383591|NCT01469546|323189528|FG000|Received 5 mg Dose|Progressive Disease|3|||
94383592|NCT01469546|323189528|FG000|Received 5 mg Dose|Physician Decision|3|||
94383593|NCT02888171|323189534|FG000|Overall Study|Lost to Follow-up|2|||
94383594|NCT02888171|323189535|FG001|Overall Study|Lost to Follow-up|1|||
94383595|NCT02888171|323189534|FG000|Overall Study|Withdrawal by Subject|3|||
94383596|NCT02888171|323189535|FG001|Overall Study|Withdrawal by Subject|2|||
94383597|NCT02888171|323189534|FG000|Overall Study|Adverse Event|0|||
94383598|NCT02888171|323189535|FG001|Overall Study|Adverse Event|1|||
94383599|NCT00679367|323189538|FG000|Overall Study|Adverse Event|7|||
94383600|NCT00679367|323189538|FG000|Overall Study|inability to swallow oral drugs|1|||
94383601|NCT00679367|323189538|FG000|Overall Study|Lack of Efficacy|3|||
94383602|NCT00679367|323189538|FG000|Overall Study|Withdrawal by Subject|1|||
94383603|NCT02801877|323189539|FG000|Overall Study|Lost to Follow-up|1|||
94383604|NCT02801877|323189540|FG001|Overall Study|Lost to Follow-up|1|||
94383605|NCT02801877|323189541|FG002|Overall Study|Lost to Follow-up|2|||
94383606|NCT02801877|323189542|FG003|Overall Study|Lost to Follow-up|0|||
94383607|NCT02801877|323189539|FG000|Overall Study|Never Started Treatment|2|||
94383608|NCT02801877|323189540|FG001|Overall Study|Never Started Treatment|0|||
94383609|NCT02801877|323189541|FG002|Overall Study|Never Started Treatment|4|||
94383610|NCT02801877|323189542|FG003|Overall Study|Never Started Treatment|0|||
94383611|NCT00154102|323189543|FG000|Overall Study|investigational study phase ongoing|7|||
94383612|NCT00154102|323189544|FG001|Overall Study|investigational study phase ongoing|2|||
94383613|NCT01132118|323191734|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
94383614|NCT01132118|323191735|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
94383615|NCT01132118|323191734|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
94383616|NCT01132118|323191735|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
94383617|NCT01132118|323191734|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
94383618|NCT01132118|323191735|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
94383619|NCT02785913|323191736|FG000|Overall Study|Adverse Event|5|||
94383620|NCT02785913|323191736|FG000|Overall Study|Death|2|||
94383621|NCT02785913|323191736|FG000|Overall Study|Progression|18|||
94383622|NCT02785913|323191736|FG000|Overall Study|Not protocol specified|1|||
94383623|NCT00313703|323191737|FG000|Overall Study|Lost to Follow-up|11|||
94383624|NCT00313703|323191738|FG001|Overall Study|Lost to Follow-up|2|||
94383625|NCT00313703|323191739|FG002|Overall Study|Lost to Follow-up|5|||
94383626|NCT00313703|323191740|FG003|Overall Study|Lost to Follow-up|12|||
94383627|NCT02761980|323191745|FG000|Overall Study|Adverse Event|4|||
94383628|NCT02761980|323191746|FG001|Overall Study|Adverse Event|6|||
94383629|NCT02761980|323191747|FG002|Overall Study|Adverse Event|5|||
94383630|NCT02761980|323191748|FG003|Overall Study|Adverse Event|6|||
94383631|NCT02761980|323191745|FG000|Overall Study|Withdrawal by Subject|0|||
94383632|NCT02761980|323191746|FG001|Overall Study|Withdrawal by Subject|1|||
94383633|NCT02761980|323191747|FG002|Overall Study|Withdrawal by Subject|0|||
94383634|NCT02761980|323191748|FG003|Overall Study|Withdrawal by Subject|0|||
94383635|NCT02761980|323191745|FG000|Overall Study|Other|0|||
94313366|NCT00406315|322931588|FG000|Overall Study|Laboratory Abnormality|4|||
94313367|NCT00406315|322931588|FG000|Overall Study|Lack of Efficacy|13|||
94313368|NCT00406315|322931588|FG000|Overall Study|Other|33|||
94313369|NCT00406315|322931588|FG000|Overall Study|Lost to Follow-up|21|||
94313370|NCT00406315|322931588|FG000|Overall Study|Withdrawal by Subject|30|||
94313371|NCT02985450|322931590|FG000|Overall Study|Lost to Follow-up|7|||
94313372|NCT05372575|322931602|FG000|Overall Study|Protocol Violation|7|||
94313373|NCT05372575|322931603|FG001|Overall Study|Protocol Violation|16|||
94313374|NCT00443430|322931604|FG000|Overall Study|Lack of Efficacy|3|||
94313375|NCT00443430|322931605|FG001|Overall Study|Lack of Efficacy|3|||
94313376|NCT00443430|322931604|FG000|Overall Study|Adverse Event|1|||
94313377|NCT00443430|322931605|FG001|Overall Study|Adverse Event|1|||
94313378|NCT00053846|322931606|FG000|Overall Study|Changed mind|8|||
94313379|NCT00053846|322931607|FG001|Overall Study|Changed mind|13|||
94313380|NCT00053846|322931606|FG000|Overall Study|Became too ill|8|||
94313381|NCT00053846|322931607|FG001|Overall Study|Became too ill|7|||
94313382|NCT00053846|322931606|FG000|Overall Study|Expired|5|||
94313383|NCT00053846|322931607|FG001|Overall Study|Expired|0|||
94313384|NCT00053846|322931606|FG000|Overall Study|Became ineligible|3|||
94313385|NCT00053846|322931607|FG001|Overall Study|Became ineligible|1|||
94383636|NCT02761980|323191746|FG001|Overall Study|Other|0|||
94383637|NCT02761980|323191747|FG002|Overall Study|Other|1|||
94383638|NCT02761980|323191748|FG003|Overall Study|Other|0|||
94383639|NCT01052116|323191751|FG000|Overall Study|Lost to Follow-up|11|||
94383640|NCT01052116|323191752|FG001|Overall Study|Lost to Follow-up|17|||
94383641|NCT01052116|323191751|FG000|Overall Study|Withdrawal by Subject|3|||
94383642|NCT01052116|323191752|FG001|Overall Study|Withdrawal by Subject|6|||
94383643|NCT01052116|323191751|FG000|Overall Study|Spirometry not performed|0|||
94383644|NCT01052116|323191752|FG001|Overall Study|Spirometry not performed|4|||
94383645|NCT00101582|323191754|FG000|Overall Study|Ineligibility determined|0|||
94383646|NCT00101582|323191755|FG001|Overall Study|Ineligibility determined|1|||
94383647|NCT00101582|323191754|FG000|Overall Study|Adverse Event|1|||
94313386|NCT00053846|322931606|FG000|Overall Study|Did not return data|1|||
94313387|NCT00053846|322931607|FG001|Overall Study|Did not return data|2|||
94313388|NCT00053846|322931606|FG000|Overall Study|Quit due to side effects|1|||
94313389|NCT00053846|322931607|FG001|Overall Study|Quit due to side effects|3|||
94313390|NCT00053846|322931606|FG000|Overall Study|Pills too large|0|||
94313391|NCT00053846|322931607|FG001|Overall Study|Pills too large|1|||
94313392|NCT00592501|322931608|FG000|Overall Study|Withdrawal by Subject|1|||
94313393|NCT00592501|322931608|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
94313394|NCT00829166|322931610|FG000|Overall Study|Death|305|||
94313395|NCT00829166|322931611|FG001|Overall Study|Death|333|||
94313396|NCT00829166|322931610|FG000|Overall Study|Lost to Follow-up|5|||
94313397|NCT00829166|322931611|FG001|Overall Study|Lost to Follow-up|4|||
94313398|NCT00829166|322931610|FG000|Overall Study|Physician's Decision|4|||
94313399|NCT00829166|322931611|FG001|Overall Study|Physician's Decision|3|||
94313400|NCT00829166|322931610|FG000|Overall Study|Subject's Decision|41|||
94313401|NCT00829166|322931611|FG001|Overall Study|Subject's Decision|55|||
94313402|NCT00829166|322931610|FG000|Overall Study|Sponsor's Decision|137|||
94313403|NCT00829166|322931611|FG001|Overall Study|Sponsor's Decision|98|||
94313404|NCT00829166|322931610|FG000|Overall Study|Reason Not Specified|3|||
94383648|NCT00101582|323191755|FG001|Overall Study|Adverse Event|4|||
94383649|NCT00101582|323191754|FG000|Overall Study|Withdrawal by Subject|6|||
94383650|NCT00101582|323191755|FG001|Overall Study|Withdrawal by Subject|4|||
94383651|NCT00101582|323191754|FG000|Overall Study|Physician Decision|1|||
94383652|NCT00101582|323191755|FG001|Overall Study|Physician Decision|0|||
94383653|NCT00101582|323191754|FG000|Overall Study|Death|3|||
94383654|NCT00101582|323191755|FG001|Overall Study|Death|5|||
94383655|NCT00101582|323191754|FG000|Overall Study|Other|0|||
94383656|NCT00101582|323191755|FG001|Overall Study|Other|1|||
94383657|NCT00056160|323191756|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
94383658|NCT00056160|323191757|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
94383659|NCT00056160|323191756|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
94383660|NCT00056160|323191757|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
94383661|NCT00056160|323191756|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
94383662|NCT00056160|323191757|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
94383663|NCT00056160|323191756|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
94383664|NCT00056160|323191757|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
94383665|NCT00056160|323191756|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
94383666|NCT00056160|323191757|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
94383667|NCT00056160|323191756|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
94383668|NCT00056160|323191757|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
94383669|NCT00056160|323191756|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
94383670|NCT00056160|323191757|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
94383671|NCT00056160|323191756|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
94383672|NCT00056160|323191757|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
94383673|NCT00056160|323191756|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
94383674|NCT00056160|323191757|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
94383675|NCT00056160|323191756|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
94383676|NCT00056160|323191757|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
94383677|NCT00056160|323191756|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
94383678|NCT00056160|323191757|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
94383679|NCT00056160|323191756|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
94383680|NCT00056160|323191757|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
94383681|NCT00056160|323191756|FG000|Final Follow-up|Transferred into expanded access study.|3|||
94383682|NCT00056160|323191757|FG001|Final Follow-up|Transferred into expanded access study.|0|||
94383683|NCT00056160|323191756|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
94383684|NCT00056160|323191757|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
94383685|NCT00056160|323191756|FG000|Final Follow-up|Adverse Event|1|||
94383686|NCT00056160|323191757|FG001|Final Follow-up|Adverse Event|0|||
94383687|NCT01402908|323191761|FG000|Overall Study|Withdrawal by Subject|30|||
94383688|NCT01402908|323191762|FG001|Overall Study|Withdrawal by Subject|17|||
94383689|NCT01402908|323191761|FG000|Overall Study|Lost to Follow-up|3|||
94383690|NCT01402908|323191762|FG001|Overall Study|Lost to Follow-up|1|||
94383691|NCT01402908|323191761|FG000|Overall Study|Physician Decision|1|||
94474723|NCT01031004|323530151|FG000|Overall Study|Lost to Follow-up|1|||
94313405|NCT00829166|322931611|FG001|Overall Study|Reason Not Specified|3|||
94313406|NCT04590937|322931612|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
94383692|NCT01402908|323191762|FG001|Overall Study|Physician Decision|0|||
94383693|NCT01919190|323191763|FG000|Overall Study|Intra-op findings, etc.|3|||
94383694|NCT01919190|323191764|FG001|Overall Study|Intra-op findings, etc.|0|||
94383695|NCT01739790|323191765|FG000|Overall Study|Early Trial Termination|2|||
94383696|NCT01739790|323191766|FG001|Overall Study|Early Trial Termination|4|||
94383697|NCT02581345|323191767|FG000|Part 1: up to Week 16|Adverse Event|3|||
94383698|NCT02581345|323191768|FG001|Part 1: up to Week 16|Adverse Event|8|||
94383699|NCT02581345|323191769|FG002|Part 1: up to Week 16|Adverse Event|0|||
94474724|NCT01031004|323530152|FG001|Overall Study|Lost to Follow-up|0|||
94474725|NCT00662311|323530163|FG000|Overall Study|Respiratory Infection|1|||
94474726|NCT00662311|323530164|FG001|Overall Study|Respiratory Infection|0|||
94474727|NCT00662311|323530165|FG002|Overall Study|Respiratory Infection|0|||
94474728|NCT01467271|323530170|FG000|Overall Study|Death|84|||
94474729|NCT01467271|323530170|FG000|Overall Study|Lost to Follow-up|83|||
94474730|NCT01467271|323530170|FG000|Overall Study|Retraction of patient's consent|21|||
94474731|NCT01467271|323530170|FG000|Overall Study|Other reason|14|||
94474732|NCT01465230|323530171|FG000|Overall Study|Withdrawal by Subject|2|||
94474733|NCT02849171|323530172|FG000|Overall Study|Withdrawal by Subject|1|||
94474734|NCT02849171|323530172|FG000|Overall Study|Not treated|1|||
94474735|NCT05205005|323530173|FG000|Overall Study|Withdrawal by Subject|1|||
94474736|NCT05205005|323530174|FG001|Overall Study|Withdrawal by Subject|0|||
94474737|NCT05205005|323530173|FG000|Overall Study|Adverse Event|1|||
94474738|NCT05205005|323530174|FG001|Overall Study|Adverse Event|0|||
94474739|NCT02933528|323530175|FG000|Overall Study|Lost to Follow-up|2|||
94474740|NCT00741598|323530176|FG000|Overall Study|Lost to Follow-up|3|||
94474741|NCT00741598|323530177|FG001|Overall Study|Lost to Follow-up|4|||
94474742|NCT00741598|323530176|FG000|Overall Study|Lack of Efficacy|1|||
94474743|NCT00741598|323530177|FG001|Overall Study|Lack of Efficacy|2|||
94474744|NCT00741598|323530176|FG000|Overall Study|Physician Decision|1|||
94474745|NCT00741598|323530177|FG001|Overall Study|Physician Decision|1|||
94474746|NCT00741598|323530176|FG000|Overall Study|Pregnancy|1|||
94474747|NCT00741598|323530177|FG001|Overall Study|Pregnancy|0|||
94474748|NCT00741598|323530176|FG000|Overall Study|Withdrawal by Subject|3|||
94474749|NCT00741598|323530177|FG001|Overall Study|Withdrawal by Subject|2|||
94474750|NCT02087670|323530178|FG000|Overall Study|Withdrawal by Subject|3|||
94474751|NCT02087670|323530179|FG001|Overall Study|Withdrawal by Subject|2|||
94474752|NCT00571103|323530180|FG000|Overall Study|Withdrawal by Subject|1|||
94474753|NCT00571103|323530180|FG000|Overall Study|Lost to Follow-up|1|||
94474754|NCT02095197|323530181|FG000|Overall Study|Lost to Follow-up|0|||
94474755|NCT02095197|323530182|FG001|Overall Study|Lost to Follow-up|3|||
94474756|NCT05114564|323530184|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
94474757|NCT05114564|323530185|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
94474758|NCT05114564|323530184|FG000|First Intervention|Adverse Event|0|||
94474759|NCT05114564|323530185|FG001|First Intervention|Adverse Event|1|||
94474760|NCT03474107|323530186|FG000|Overall Study|Adverse Event|42|||
94474761|NCT03474107|323530187|FG001|Overall Study|Adverse Event|46|||
94474762|NCT03474107|323530186|FG000|Overall Study|Death|2|||
94474763|NCT03474107|323530187|FG001|Overall Study|Death|2|||
94474764|NCT03474107|323530186|FG000|Overall Study|Lost to Follow-up|0|||
94474765|NCT03474107|323530187|FG001|Overall Study|Lost to Follow-up|1|||
94474766|NCT03474107|323530186|FG000|Overall Study|Progressive Disease|177|||
94474767|NCT03474107|323530187|FG001|Overall Study|Progressive Disease|180|||
94474768|NCT03474107|323530186|FG000|Overall Study|Protocol Violation|1|||
94474769|NCT03474107|323530187|FG001|Overall Study|Protocol Violation|1|||
94474770|NCT03474107|323530186|FG000|Overall Study|Withdrawal by Subject|15|||
94474771|NCT03474107|323530187|FG001|Overall Study|Withdrawal by Subject|27|||
94474772|NCT03474107|323530186|FG000|Overall Study|Physician Decision|7|||
94474773|NCT03474107|323530187|FG001|Overall Study|Physician Decision|22|||
94474774|NCT03474107|323530186|FG000|Overall Study|Miscellaneous|1|||
94474775|NCT03474107|323530187|FG001|Overall Study|Miscellaneous|6|||
94474776|NCT03117361|323530188|FG000|Overall Study|Progressive disease|5|||
94474777|NCT03117361|323530188|FG000|Overall Study|Death|1|||
94474778|NCT03117361|323530188|FG000|Overall Study|Physician Decision|2|||
94474779|NCT03117361|323530188|FG000|Overall Study|On study treatment at the end of study|1|||
94474780|NCT03117361|323530188|FG000|Overall Study|Treatment-related adverse event|1|||
94474781|NCT01979523|323530195|FG000|Overall Study|Withdrawal by Subject|1|||
94474782|NCT01979523|323530196|FG001|Overall Study|Withdrawal by Subject|0|||
94313407|NCT01544595|322931613|FG000|Status at Week 68|Adverse Event|3|||
94313408|NCT01544595|322931614|FG001|Status at Week 68|Adverse Event|2|||
94313409|NCT01544595|322931615|FG002|Status at Week 68|Adverse Event|1|||
94313410|NCT01544595|322931616|FG003|Status at Week 68|Adverse Event|0|||
94474783|NCT02829047|323530197|FG000|Overall Study|Withdrawal by Subject|1|||
94474784|NCT02072941|323530199|FG000|Overall Study|Withdrawal by Subject|29|||
94474785|NCT02072941|323530200|FG001|Overall Study|Withdrawal by Subject|21|||
94474786|NCT02072941|323530199|FG000|Overall Study|Lost to Follow-up|4|||
94474787|NCT02072941|323530200|FG001|Overall Study|Lost to Follow-up|4|||
94474788|NCT02072941|323530199|FG000|Overall Study|Death|3|||
94474789|NCT02072941|323530200|FG001|Overall Study|Death|2|||
94474790|NCT02072941|323530199|FG000|Overall Study|Removed by Study Staff|2|||
94474791|NCT02072941|323530200|FG001|Overall Study|Removed by Study Staff|2|||
94474792|NCT00460239|323530201|FG000|Overall Study|Physician Decision|0|||
94313411|NCT01544595|322931617|FG004|Status at Week 68|Adverse Event|0|||
94474793|NCT00460239|323530202|FG001|Overall Study|Physician Decision|1|||
94474794|NCT00460239|323530203|FG002|Overall Study|Physician Decision|0|||
94474795|NCT00460239|323530204|FG003|Overall Study|Physician Decision|0|||
94474796|NCT00460239|323530205|FG004|Overall Study|Physician Decision|0|||
94474797|NCT00460239|323530206|FG005|Overall Study|Physician Decision|2|||
94474798|NCT00460239|323530207|FG006|Overall Study|Physician Decision|0|||
94474799|NCT00460239|323530208|FG007|Overall Study|Physician Decision|0|||
94474800|NCT00460239|323530209|FG008|Overall Study|Physician Decision|0|||
94474801|NCT00460239|323530201|FG000|Overall Study|Withdrawal by Subject|0|||
94474802|NCT00460239|323530202|FG001|Overall Study|Withdrawal by Subject|0|||
94474803|NCT00460239|323530203|FG002|Overall Study|Withdrawal by Subject|0|||
94474804|NCT00460239|323530204|FG003|Overall Study|Withdrawal by Subject|0|||
94474805|NCT00460239|323530205|FG004|Overall Study|Withdrawal by Subject|0|||
94474806|NCT00460239|323530206|FG005|Overall Study|Withdrawal by Subject|1|||
94474807|NCT00460239|323530207|FG006|Overall Study|Withdrawal by Subject|0|||
94474808|NCT00460239|323530208|FG007|Overall Study|Withdrawal by Subject|0|||
94474809|NCT00460239|323530209|FG008|Overall Study|Withdrawal by Subject|0|||
94474810|NCT01005901|323530210|FG000|Overall Study|Withdrawal by Subject|38|||
94474811|NCT01005901|323530211|FG001|Overall Study|Withdrawal by Subject|14|||
94474812|NCT01005901|323530210|FG000|Overall Study|Adverse Event|30|||
94474813|NCT01005901|323530211|FG001|Overall Study|Adverse Event|16|||
94474814|NCT01005901|323530210|FG000|Overall Study|Administrative problems|21|||
94474815|NCT01005901|323530211|FG001|Overall Study|Administrative problems|13|||
94474816|NCT01005901|323530210|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
94474817|NCT01005901|323530211|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
94474818|NCT01005901|323530210|FG000|Overall Study|Protocol Violation|4|||
94474819|NCT01005901|323530211|FG001|Overall Study|Protocol Violation|3|||
94474820|NCT01005901|323530210|FG000|Overall Study|Death|2|||
94474821|NCT01005901|323530211|FG001|Overall Study|Death|3|||
94474822|NCT01005901|323530210|FG000|Overall Study|Lost to Follow-up|1|||
94474823|NCT01005901|323530211|FG001|Overall Study|Lost to Follow-up|2|||
94474824|NCT01005901|323530210|FG000|Overall Study|Patient's inability to use the device|1|||
94474825|NCT01005901|323530211|FG001|Overall Study|Patient's inability to use the device|1|||
94474826|NCT01005901|323530210|FG000|Overall Study|No longer requires study drug|0|||
94474827|NCT01005901|323530211|FG001|Overall Study|No longer requires study drug|1|||
94474828|NCT00807612|323530215|FG000|Overall Study|Death|8|||
94474829|NCT00807612|323530215|FG000|Overall Study|Study early termination|5|||
94474830|NCT00807612|323530215|FG000|Overall Study|Withdrawal by Subject|1|||
94474831|NCT02959918|323530216|FG000|Overall Study|Adverse Event|1|||
94474832|NCT02959918|323530217|FG001|Overall Study|Adverse Event|1|||
94474833|NCT02959918|323530218|FG002|Overall Study|Adverse Event|2|||
94474834|NCT02959918|323530219|FG003|Overall Study|Adverse Event|0|||
94474835|NCT02959918|323530220|FG004|Overall Study|Adverse Event|0|||
94474836|NCT02959918|323530221|FG005|Overall Study|Adverse Event|2|||
94474837|NCT02959918|323530222|FG006|Overall Study|Adverse Event|2|||
94474838|NCT02959918|323530223|FG007|Overall Study|Adverse Event|1|||
94474839|NCT02959918|323530224|FG008|Overall Study|Adverse Event|2|||
94474840|NCT02959918|323530225|FG009|Overall Study|Adverse Event|1|||
94474841|NCT02959918|323530226|FG010|Overall Study|Adverse Event|1|||
94474842|NCT02959918|323530227|FG011|Overall Study|Adverse Event|3|||
94474843|NCT02959918|323530228|FG012|Overall Study|Adverse Event|2|||
94474844|NCT02959918|323530229|FG013|Overall Study|Adverse Event|4|||
94474845|NCT02959918|323530216|FG000|Overall Study|Lost to Follow-up|0|||
94474846|NCT02959918|323530217|FG001|Overall Study|Lost to Follow-up|0|||
94474847|NCT02959918|323530218|FG002|Overall Study|Lost to Follow-up|0|||
94474848|NCT02959918|323530219|FG003|Overall Study|Lost to Follow-up|0|||
94474849|NCT02959918|323530220|FG004|Overall Study|Lost to Follow-up|0|||
94474850|NCT02959918|323530221|FG005|Overall Study|Lost to Follow-up|0|||
94474851|NCT02959918|323530222|FG006|Overall Study|Lost to Follow-up|0|||
94474852|NCT02959918|323530223|FG007|Overall Study|Lost to Follow-up|0|||
94474853|NCT02959918|323530224|FG008|Overall Study|Lost to Follow-up|0|||
94474854|NCT02959918|323530225|FG009|Overall Study|Lost to Follow-up|1|||
94474855|NCT02959918|323530226|FG010|Overall Study|Lost to Follow-up|0|||
94474856|NCT02959918|323530227|FG011|Overall Study|Lost to Follow-up|0|||
94474857|NCT02959918|323530228|FG012|Overall Study|Lost to Follow-up|1|||
94474858|NCT02959918|323530229|FG013|Overall Study|Lost to Follow-up|0|||
94474859|NCT02959918|323530216|FG000|Overall Study|Withdrawal by Subject|0|||
94474860|NCT02959918|323530217|FG001|Overall Study|Withdrawal by Subject|0|||
94474861|NCT02959918|323530218|FG002|Overall Study|Withdrawal by Subject|1|||
94474862|NCT02959918|323530219|FG003|Overall Study|Withdrawal by Subject|2|||
94474863|NCT02959918|323530220|FG004|Overall Study|Withdrawal by Subject|0|||
94474864|NCT02959918|323530221|FG005|Overall Study|Withdrawal by Subject|0|||
94474865|NCT02959918|323530222|FG006|Overall Study|Withdrawal by Subject|1|||
94474866|NCT02959918|323530223|FG007|Overall Study|Withdrawal by Subject|0|||
94474867|NCT02959918|323530224|FG008|Overall Study|Withdrawal by Subject|1|||
94474868|NCT02959918|323530225|FG009|Overall Study|Withdrawal by Subject|1|||
94474869|NCT02959918|323530226|FG010|Overall Study|Withdrawal by Subject|2|||
94474870|NCT02959918|323530227|FG011|Overall Study|Withdrawal by Subject|3|||
94474871|NCT02959918|323530228|FG012|Overall Study|Withdrawal by Subject|1|||
94474872|NCT02959918|323530229|FG013|Overall Study|Withdrawal by Subject|1|||
94474873|NCT02959918|323530216|FG000|Overall Study|Protocol Violation|0|||
94474874|NCT02959918|323530217|FG001|Overall Study|Protocol Violation|0|||
94474875|NCT02959918|323530218|FG002|Overall Study|Protocol Violation|1|||
94474876|NCT02959918|323530219|FG003|Overall Study|Protocol Violation|0|||
94474877|NCT02959918|323530220|FG004|Overall Study|Protocol Violation|0|||
94474878|NCT02959918|323530221|FG005|Overall Study|Protocol Violation|1|||
94474879|NCT02959918|323530222|FG006|Overall Study|Protocol Violation|0|||
94474880|NCT02959918|323530223|FG007|Overall Study|Protocol Violation|0|||
94474881|NCT02959918|323530224|FG008|Overall Study|Protocol Violation|2|||
94474882|NCT02959918|323530225|FG009|Overall Study|Protocol Violation|1|||
94474883|NCT02959918|323530226|FG010|Overall Study|Protocol Violation|0|||
94474884|NCT02959918|323530227|FG011|Overall Study|Protocol Violation|1|||
94474885|NCT02959918|323530228|FG012|Overall Study|Protocol Violation|1|||
94474886|NCT02959918|323530229|FG013|Overall Study|Protocol Violation|0|||
94474887|NCT02959918|323530216|FG000|Overall Study|Stopping Rule Met|1|||
94474888|NCT02959918|323530217|FG001|Overall Study|Stopping Rule Met|0|||
94474889|NCT02959918|323530218|FG002|Overall Study|Stopping Rule Met|3|||
94474890|NCT02959918|323530219|FG003|Overall Study|Stopping Rule Met|4|||
94474891|NCT02959918|323530220|FG004|Overall Study|Stopping Rule Met|5|||
94474892|NCT02959918|323530221|FG005|Overall Study|Stopping Rule Met|3|||
94474893|NCT02959918|323530222|FG006|Overall Study|Stopping Rule Met|2|||
94474894|NCT02959918|323530223|FG007|Overall Study|Stopping Rule Met|4|||
94474895|NCT02959918|323530224|FG008|Overall Study|Stopping Rule Met|1|||
94474896|NCT02959918|323530225|FG009|Overall Study|Stopping Rule Met|1|||
94474897|NCT02959918|323530226|FG010|Overall Study|Stopping Rule Met|3|||
94474898|NCT02959918|323530227|FG011|Overall Study|Stopping Rule Met|5|||
94474899|NCT02959918|323530228|FG012|Overall Study|Stopping Rule Met|2|||
94474900|NCT02959918|323530229|FG013|Overall Study|Stopping Rule Met|1|||
94474901|NCT02959918|323530216|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
94474902|NCT02959918|323530217|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
94474903|NCT02959918|323530218|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
94474904|NCT02959918|323530219|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
94474905|NCT02959918|323530220|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
94474906|NCT02959918|323530221|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
94474907|NCT02959918|323530222|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
94474908|NCT02959918|323530223|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
94474909|NCT02959918|323530224|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
94474910|NCT02959918|323530225|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
94474911|NCT02959918|323530226|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
94474912|NCT02959918|323530227|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
94474913|NCT02959918|323530228|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
94474914|NCT02959918|323530229|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
94474915|NCT02959918|323530216|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
94474916|NCT02959918|323530217|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
94474917|NCT02959918|323530218|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
94474918|NCT02959918|323530219|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
94474919|NCT02959918|323530220|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
94474920|NCT02959918|323530221|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
94474921|NCT02959918|323530222|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
94474922|NCT02959918|323530223|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
94474923|NCT02959918|323530224|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
94474924|NCT02959918|323530225|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
94474925|NCT02959918|323530226|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
94474926|NCT02959918|323530227|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
94474927|NCT02959918|323530228|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
94474928|NCT02959918|323530229|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
94474929|NCT02959918|323530216|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
94474930|NCT02959918|323530217|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
94474931|NCT02959918|323530218|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
94474932|NCT02959918|323530219|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
94474933|NCT02959918|323530220|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
94474934|NCT02959918|323530221|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
94474935|NCT02959918|323530222|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
94474936|NCT02959918|323530223|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
94474937|NCT02959918|323530224|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
94474938|NCT02959918|323530225|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
94474939|NCT02959918|323530226|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
94474940|NCT02959918|323530227|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
94474941|NCT02959918|323530228|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
94313412|NCT01544595|322931618|FG005|Status at Week 68|Adverse Event|0|||
94313413|NCT01544595|322931613|FG000|Status at Week 68|Lack of Efficacy|1|||
94313414|NCT01544595|322931614|FG001|Status at Week 68|Lack of Efficacy|0|||
94474942|NCT02959918|323530229|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
94474943|NCT02959918|323530216|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
94474944|NCT02959918|323530217|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
94474945|NCT02959918|323530218|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
94474946|NCT02959918|323530219|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
94474947|NCT02959918|323530220|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
94474948|NCT02959918|323530221|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
94474949|NCT02959918|323530222|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
94474950|NCT02959918|323530223|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
94474951|NCT02959918|323530224|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
94474952|NCT02959918|323530225|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
94474953|NCT02959918|323530226|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
94474954|NCT02959918|323530227|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
94474955|NCT02959918|323530228|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
94474956|NCT02959918|323530229|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
94474957|NCT00837967|323530230|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
94474958|NCT00837967|323530231|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
94474959|NCT03061188|323530240|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
94474960|NCT03061188|323530241|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
94474961|NCT03061188|323530242|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
94474962|NCT03061188|323530243|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
94474963|NCT03061188|323530240|FG000|On Follow-up for 3 Years|Death|0|||
94474964|NCT03061188|323530241|FG001|On Follow-up for 3 Years|Death|3|||
94474965|NCT03061188|323530242|FG002|On Follow-up for 3 Years|Death|5|||
94474966|NCT03061188|323530243|FG003|On Follow-up for 3 Years|Death|4|||
94474967|NCT03061188|323530240|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
94474968|NCT03061188|323530241|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
94474969|NCT03061188|323530242|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
94474970|NCT03061188|323530243|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
94474971|NCT05446142|323530251|FG000|Period 2|Adverse Event|1|||
94474972|NCT05446142|323530252|FG001|Period 2|Adverse Event|0|||
94474973|NCT05446142|323530253|FG002|Period 2|Adverse Event|0|||
94474974|NCT05446142|323530254|FG003|Period 2|Adverse Event|0|||
94474975|NCT05446142|323530255|FG004|Period 2|Adverse Event|0|||
94474976|NCT05446142|323530256|FG005|Period 2|Adverse Event|0|||
94474977|NCT00770913|323530258|FG000|Overall Study|Adverse Event|1|||
94474978|NCT00770913|323530259|FG001|Overall Study|Adverse Event|3|||
94474979|NCT00770913|323530260|FG002|Overall Study|Adverse Event|6|||
94474980|NCT00770913|323530258|FG000|Overall Study|Refusal to continue participation|6|||
94474981|NCT00770913|323530259|FG001|Overall Study|Refusal to continue participation|4|||
94474982|NCT00770913|323530260|FG002|Overall Study|Refusal to continue participation|5|||
94474983|NCT00770913|323530258|FG000|Overall Study|Physician Decision|0|||
94474984|NCT00770913|323530259|FG001|Overall Study|Physician Decision|1|||
94474985|NCT00770913|323530260|FG002|Overall Study|Physician Decision|1|||
94474986|NCT00770913|323530258|FG000|Overall Study|Protocol Violation|3|||
94474987|NCT00770913|323530259|FG001|Overall Study|Protocol Violation|0|||
94474988|NCT00770913|323530260|FG002|Overall Study|Protocol Violation|1|||
94474989|NCT00770913|323530258|FG000|Overall Study|Incorrect drug was allocated|1|||
94474990|NCT00770913|323530259|FG001|Overall Study|Incorrect drug was allocated|0|||
94474991|NCT00770913|323530260|FG002|Overall Study|Incorrect drug was allocated|0|||
94474992|NCT00003896|323530261|FG000|Overall Study|Adverse Event|16|||
94474993|NCT00003896|323530261|FG000|Overall Study|Withdrawal by Subject|1|||
94474994|NCT00003896|323530261|FG000|Overall Study|Lack of Efficacy|1|||
94474995|NCT00003896|323530261|FG000|Overall Study|Death|3|||
94474996|NCT00003896|323530261|FG000|Overall Study|not protocol specified|3|||
94474997|NCT00003896|323530261|FG000|Overall Study|ineligible|5|||
94474998|NCT02282163|323530262|FG000|Overall Study|Protocol Violation|1|||
94474999|NCT01603407|323530263|FG000|Overall Study|Adverse Event|1|||
94475000|NCT01603407|323530264|FG001|Overall Study|Adverse Event|1|||
94475001|NCT01603407|323530265|FG002|Overall Study|Adverse Event|1|||
94475002|NCT01603407|323530263|FG000|Overall Study|Protocol Violation|2|||
94475003|NCT01603407|323530264|FG001|Overall Study|Protocol Violation|2|||
94475004|NCT01603407|323530265|FG002|Overall Study|Protocol Violation|0|||
94475005|NCT01603407|323530263|FG000|Overall Study|Withdrawal by Subject|8|||
94475006|NCT01603407|323530264|FG001|Overall Study|Withdrawal by Subject|5|||
94475007|NCT01603407|323530265|FG002|Overall Study|Withdrawal by Subject|7|||
94475008|NCT01603407|323530263|FG000|Overall Study|Lost to Follow-up|0|||
94475009|NCT01603407|323530264|FG001|Overall Study|Lost to Follow-up|3|||
94475010|NCT01603407|323530265|FG002|Overall Study|Lost to Follow-up|2|||
94475011|NCT02903420|323530266|FG000|Overall Study|Death|3|||
94475012|NCT01778751|323530267|FG000|Overall Study|Lost to Follow-up|1|||
94475013|NCT01778751|323530268|FG001|Overall Study|Lost to Follow-up|0|||
94475014|NCT01778751|323530267|FG000|Overall Study|Withdrawal by Subject|0|||
94475015|NCT01778751|323530268|FG001|Overall Study|Withdrawal by Subject|2|||
94475016|NCT01778751|323530267|FG000|Overall Study|Transfered care|1|||
94475017|NCT01778751|323530268|FG001|Overall Study|Transfered care|0|||
94475018|NCT02348008|323530269|FG000|Overall Study|Adverse Event|2|||
94475019|NCT02348008|323530270|FG001|Overall Study|Adverse Event|3|||
94475020|NCT02348008|323530271|FG002|Overall Study|Adverse Event|3|||
94475021|NCT02348008|323530269|FG000|Overall Study|Disease Progression|1|||
94475022|NCT02348008|323530270|FG001|Overall Study|Disease Progression|5|||
94475023|NCT02348008|323530271|FG002|Overall Study|Disease Progression|16|||
94475024|NCT02348008|323530269|FG000|Overall Study|Withdrawal by Subject|0|||
94475025|NCT02348008|323530270|FG001|Overall Study|Withdrawal by Subject|1|||
94475026|NCT02348008|323530271|FG002|Overall Study|Withdrawal by Subject|0|||
94475027|NCT02348008|323530269|FG000|Overall Study|Symptomatic Deterioration|0|||
94475028|NCT02348008|323530270|FG001|Overall Study|Symptomatic Deterioration|1|||
94475029|NCT02348008|323530271|FG002|Overall Study|Symptomatic Deterioration|0|||
94475030|NCT06597084|323530274|FG000|Overall Study|Withdrawal by Subject|4|||
94475031|NCT06597084|323530275|FG001|Overall Study|Withdrawal by Subject|9|||
94475032|NCT06597084|323530274|FG000|Overall Study|Consent was not given by the patient until V2|0|||
94475033|NCT06597084|323530275|FG001|Overall Study|Consent was not given by the patient until V2|3|||
94475034|NCT06597084|323530274|FG000|Overall Study|Physician Decision|1|||
94475035|NCT06597084|323530275|FG001|Overall Study|Physician Decision|0|||
94475036|NCT06597084|323530274|FG000|Overall Study|Adverse Event|3|||
94475037|NCT06597084|323530275|FG001|Overall Study|Adverse Event|2|||
94475038|NCT06597084|323530274|FG000|Overall Study|Death|4|||
94475039|NCT06597084|323530275|FG001|Overall Study|Death|0|||
94475040|NCT06597084|323530274|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
94475041|NCT06597084|323530275|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
94475042|NCT06597084|323530274|FG000|Overall Study|Lost to Follow-up|4|||
94475043|NCT06597084|323530275|FG001|Overall Study|Lost to Follow-up|2|||
94475044|NCT06597084|323530274|FG000|Overall Study|Other. Not specified|1|||
94475045|NCT06597084|323530275|FG001|Overall Study|Other. Not specified|0|||
94475046|NCT01588405|323530276|FG000|Overall Study|Adverse Event|1|||
94475047|NCT01588405|323530276|FG000|Overall Study|Clinical Worsening|1|||
94475048|NCT02557516|323530279|FG000|Overall Study|Adverse Event|1|||
94475049|NCT02557516|323530280|FG001|Overall Study|Adverse Event|0|||
94475050|NCT02557516|323530281|FG002|Overall Study|Adverse Event|2|||
94475051|NCT02557516|323530282|FG003|Overall Study|Adverse Event|1|||
94475052|NCT02557516|323530279|FG000|Overall Study|Disease progression|0|||
94475053|NCT02557516|323530280|FG001|Overall Study|Disease progression|2|||
94475054|NCT02557516|323530281|FG002|Overall Study|Disease progression|0|||
94475055|NCT02557516|323530282|FG003|Overall Study|Disease progression|0|||
94475056|NCT02557516|323530279|FG000|Overall Study|Physician Decision|0|||
94475057|NCT02557516|323530280|FG001|Overall Study|Physician Decision|2|||
94475058|NCT02557516|323530281|FG002|Overall Study|Physician Decision|0|||
94475059|NCT02557516|323530282|FG003|Overall Study|Physician Decision|0|||
94475060|NCT02557516|323530279|FG000|Overall Study|Sponsor decision|0|||
94475061|NCT02557516|323530280|FG001|Overall Study|Sponsor decision|1|||
94475062|NCT02557516|323530281|FG002|Overall Study|Sponsor decision|2|||
94475063|NCT02557516|323530282|FG003|Overall Study|Sponsor decision|8|||
94475064|NCT04587336|323530283|FG000|Overall Study|Lost to Follow-up|1|||
94475065|NCT04587336|323530284|FG001|Overall Study|Lost to Follow-up|0|||
94475066|NCT00401193|323531538|FG000|Overall Study|Adverse Event|1|||
94475067|NCT00401193|323531539|FG001|Overall Study|Adverse Event|3|||
94475068|NCT00401193|323531540|FG002|Overall Study|Adverse Event|1|||
94475069|NCT00401193|323531538|FG000|Overall Study|Protocol Violation|3|||
94475070|NCT00401193|323531539|FG001|Overall Study|Protocol Violation|1|||
94475071|NCT00401193|323531540|FG002|Overall Study|Protocol Violation|1|||
94475072|NCT00401193|323531538|FG000|Overall Study|Lost to Follow-up|6|||
94475073|NCT00401193|323531539|FG001|Overall Study|Lost to Follow-up|5|||
94475074|NCT00401193|323531540|FG002|Overall Study|Lost to Follow-up|1|||
94313415|NCT01544595|322931615|FG002|Status at Week 68|Lack of Efficacy|0|||
94313416|NCT01544595|322931616|FG003|Status at Week 68|Lack of Efficacy|0|||
94313417|NCT01544595|322931617|FG004|Status at Week 68|Lack of Efficacy|0|||
94313418|NCT01544595|322931618|FG005|Status at Week 68|Lack of Efficacy|0|||
94313419|NCT01544595|322931613|FG000|Status at Week 68|Lost to Follow-up|1|||
94475075|NCT00401193|323531538|FG000|Overall Study|Withdrawal by Subject|2|||
94475076|NCT00401193|323531539|FG001|Overall Study|Withdrawal by Subject|0|||
94475077|NCT00401193|323531540|FG002|Overall Study|Withdrawal by Subject|1|||
94475078|NCT00401193|323531538|FG000|Overall Study|Other Event|3|||
94475079|NCT00401193|323531539|FG001|Overall Study|Other Event|2|||
94475080|NCT00401193|323531540|FG002|Overall Study|Other Event|2|||
94475081|NCT02107313|323531545|FG000|Overall Study|One participant did not do the FED cohor|0|||
94475082|NCT02107313|323531546|FG001|Overall Study|One participant did not do the FED cohor|1|||
94475083|NCT03026283|323531547|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
94475084|NCT03026283|323531548|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
94475085|NCT03026283|323531549|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
94313420|NCT01544595|322931614|FG001|Status at Week 68|Lost to Follow-up|1|||
94475086|NCT03026283|323531550|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
94475087|NCT03026283|323531551|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
94475088|NCT03026283|323531552|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
94475089|NCT03026283|323531553|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
94475090|NCT03026283|323531554|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
94475091|NCT03026283|323531547|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
94475092|NCT03026283|323531548|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
94475093|NCT03026283|323531549|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
94475094|NCT03026283|323531550|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
94475095|NCT03026283|323531551|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
94475096|NCT03026283|323531552|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
94475097|NCT03026283|323531553|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
94475098|NCT03026283|323531554|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
94475099|NCT03026283|323531547|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
94475100|NCT03026283|323531548|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
94475101|NCT03026283|323531549|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
94475102|NCT03026283|323531550|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
94475103|NCT03026283|323531551|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
94475104|NCT03026283|323531552|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
94475105|NCT03026283|323531553|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
94475106|NCT03026283|323531554|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
94475107|NCT03026283|323531547|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
94475108|NCT03026283|323531548|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
94475109|NCT03026283|323531549|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
94475110|NCT03026283|323531550|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
94475111|NCT03026283|323531551|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
94475112|NCT03026283|323531552|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
94475113|NCT03026283|323531553|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
94475114|NCT03026283|323531554|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
94475115|NCT03026283|323531547|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
94475116|NCT03026283|323531548|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
94475117|NCT03026283|323531549|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
94475118|NCT03026283|323531550|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
94475119|NCT03026283|323531551|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
94475120|NCT03026283|323531552|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
94475121|NCT03026283|323531553|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
94475122|NCT03026283|323531554|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
94475123|NCT03026283|323531547|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
94475124|NCT03026283|323531548|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
94475125|NCT03026283|323531549|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
94475126|NCT03026283|323531550|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
94475127|NCT03026283|323531551|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
94475128|NCT03026283|323531552|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
94475129|NCT03026283|323531553|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
94475130|NCT03026283|323531554|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
94475131|NCT03026283|323531547|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
94475132|NCT03026283|323531548|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
94475133|NCT03026283|323531549|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
94475134|NCT03026283|323531550|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
94475135|NCT03026283|323531551|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
94475136|NCT03026283|323531552|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
94475137|NCT03026283|323531553|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
94475138|NCT03026283|323531554|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
94475139|NCT03026283|323531547|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
94475140|NCT03026283|323531548|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
94475141|NCT03026283|323531549|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
94475142|NCT03026283|323531550|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
94475143|NCT03026283|323531551|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
94475144|NCT03026283|323531552|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
94475145|NCT03026283|323531553|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
94475146|NCT03026283|323531554|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
94313421|NCT01544595|322931615|FG002|Status at Week 68|Lost to Follow-up|0|||
94313422|NCT01544595|322931616|FG003|Status at Week 68|Lost to Follow-up|0|||
94475147|NCT03026283|323531547|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
94475148|NCT03026283|323531548|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
94475149|NCT03026283|323531549|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
94475150|NCT03026283|323531550|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
94475151|NCT03026283|323531551|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
94475152|NCT03026283|323531552|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
94475153|NCT03026283|323531553|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
94475154|NCT03026283|323531554|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
94475155|NCT01054222|323531555|FG000|Overall Study|Lack of Efficacy|1|||
94475156|NCT01054222|323531555|FG000|Overall Study|Lost to Follow-up|4|||
94475157|NCT01054222|323531555|FG000|Overall Study|Withdrawal by Subject|6|||
94475158|NCT04336475|323531556|FG000|Overall Study|pain|1|||
94475159|NCT04336475|323531557|FG001|Overall Study|pain|0|||
94475160|NCT04336475|323531556|FG000|Overall Study|upper respiratory infection|1|||
94475161|NCT04336475|323531557|FG001|Overall Study|upper respiratory infection|0|||
94475162|NCT04336475|323531556|FG000|Overall Study|Lost to Follow-up|0|||
94475163|NCT04336475|323531557|FG001|Overall Study|Lost to Follow-up|2|||
94475164|NCT00199849|323531563|FG000|Overall Study|Unrelated illness or complication|0|||
94475165|NCT00199849|323531564|FG001|Overall Study|Unrelated illness or complication|1|||
94475166|NCT00199849|323531565|FG002|Overall Study|Unrelated illness or complication|0|||
94475167|NCT00199849|323531563|FG000|Overall Study|Progressive disease requiring intervention|0|||
94475168|NCT00199849|323531564|FG001|Overall Study|Progressive disease requiring intervention|0|||
94475169|NCT00199849|323531565|FG002|Overall Study|Progressive disease requiring intervention|1|||
94475170|NCT00199849|323531563|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
94475171|NCT00199849|323531564|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
94475172|NCT00199849|323531565|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
94475173|NCT03746405|323531570|FG000|Overall Study|Withdrawal by Subject|3|||
94475174|NCT03746405|323531571|FG001|Overall Study|Withdrawal by Subject|0|||
94475175|NCT03746405|323531570|FG000|Overall Study|technical difficulties|0|||
94475176|NCT03746405|323531571|FG001|Overall Study|technical difficulties|2|||
94475177|NCT03479008|323531572|FG000|Overall Study|Withdrawal by Subject|3|||
94475178|NCT00524771|323531575|FG000|Overall Study|Protocol Violation|220|||
94475179|NCT00524771|323531576|FG001|Overall Study|Protocol Violation|585|||
94475180|NCT02753816|323531577|FG000|Overall Study|Protocol Violation|0|||
94475181|NCT02753816|323531578|FG001|Overall Study|Protocol Violation|1|||
94475182|NCT02753816|323531579|FG002|Overall Study|Protocol Violation|0|||
94475183|NCT02542397|323531580|FG000|Overall Study|Death|2|||
94475184|NCT02542397|323531580|FG000|Overall Study|Physician Decision|6|||
94475185|NCT02542397|323531580|FG000|Overall Study|Withdrawal by Subject|6|||
94475186|NCT02542397|323531580|FG000|Overall Study|Lost to Follow-up|2|||
94475187|NCT02259400|323531586|FG000|Overall Study|Death|0|||
94475188|NCT02259400|323531587|FG001|Overall Study|Death|2|||
94475189|NCT01301079|323531598|FG000|Overall Study|Lost to Follow-up|2|||
94475190|NCT01301079|323531599|FG001|Overall Study|Lost to Follow-up|2|||
94475191|NCT00313586|323531600|FG000|Overall Study|Disease progression|14|||
94475192|NCT00313586|323531601|FG001|Overall Study|Disease progression|19|||
94475193|NCT00313586|323531602|FG002|Overall Study|Disease progression|10|||
94475194|NCT00313586|323531603|FG003|Overall Study|Disease progression|3|||
94475195|NCT00313586|323531600|FG000|Overall Study|Adverse Event|12|||
94475196|NCT00313586|323531601|FG001|Overall Study|Adverse Event|18|||
94475197|NCT00313586|323531602|FG002|Overall Study|Adverse Event|3|||
94475198|NCT00313586|323531603|FG003|Overall Study|Adverse Event|10|||
94475199|NCT00313586|323531600|FG000|Overall Study|Death|11|||
94475200|NCT00313586|323531601|FG001|Overall Study|Death|8|||
94313423|NCT01544595|322931617|FG004|Status at Week 68|Lost to Follow-up|0|||
94313424|NCT01544595|322931618|FG005|Status at Week 68|Lost to Follow-up|0|||
94313425|NCT01544595|322931613|FG000|Status at Week 68|Non-compliance with study treatment|1|||
94475201|NCT00313586|323531602|FG002|Overall Study|Death|1|||
94475202|NCT00313586|323531603|FG003|Overall Study|Death|7|||
94475203|NCT00313586|323531600|FG000|Overall Study|Withdrawal by Subject|13|||
94475204|NCT00313586|323531601|FG001|Overall Study|Withdrawal by Subject|6|||
94475205|NCT00313586|323531602|FG002|Overall Study|Withdrawal by Subject|6|||
94475206|NCT00313586|323531603|FG003|Overall Study|Withdrawal by Subject|2|||
94475207|NCT00313586|323531600|FG000|Overall Study|Alternative therapy|3|||
94475208|NCT00313586|323531601|FG001|Overall Study|Alternative therapy|6|||
94475209|NCT00313586|323531602|FG002|Overall Study|Alternative therapy|2|||
94475210|NCT00313586|323531603|FG003|Overall Study|Alternative therapy|0|||
94475211|NCT00313586|323531600|FG000|Overall Study|Other complicating disease|2|||
94475212|NCT00313586|323531601|FG001|Overall Study|Other complicating disease|2|||
94475213|NCT00313586|323531602|FG002|Overall Study|Other complicating disease|0|||
94475214|NCT00313586|323531603|FG003|Overall Study|Other complicating disease|0|||
94475215|NCT00313586|323531600|FG000|Overall Study|Did not achieve HI-major/better response|10|||
94475216|NCT00313586|323531601|FG001|Overall Study|Did not achieve HI-major/better response|7|||
94475217|NCT00313586|323531602|FG002|Overall Study|Did not achieve HI-major/better response|2|||
94475218|NCT00313586|323531603|FG003|Overall Study|Did not achieve HI-major/better response|1|||
94475219|NCT00313586|323531600|FG000|Overall Study|Physician Decision|2|||
94475220|NCT00313586|323531601|FG001|Overall Study|Physician Decision|1|||
94475221|NCT00313586|323531602|FG002|Overall Study|Physician Decision|0|||
94475222|NCT00313586|323531603|FG003|Overall Study|Physician Decision|0|||
94475223|NCT00313586|323531600|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
94475224|NCT00313586|323531601|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
94475225|NCT00313586|323531602|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
94475226|NCT00313586|323531603|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
94475227|NCT00313586|323531600|FG000|Overall Study|Lost insurance|0|||
94475228|NCT00313586|323531601|FG001|Overall Study|Lost insurance|1|||
94475229|NCT00313586|323531602|FG002|Overall Study|Lost insurance|0|||
94475230|NCT00313586|323531603|FG003|Overall Study|Lost insurance|0|||
94475231|NCT00313586|323531600|FG000|Overall Study|Moved|0|||
94475232|NCT00313586|323531601|FG001|Overall Study|Moved|1|||
94475233|NCT00313586|323531602|FG002|Overall Study|Moved|0|||
94475234|NCT00313586|323531603|FG003|Overall Study|Moved|0|||
94475235|NCT00313586|323531600|FG000|Overall Study|Death before starting treatment|1|||
94475236|NCT00313586|323531601|FG001|Overall Study|Death before starting treatment|0|||
94475237|NCT00313586|323531602|FG002|Overall Study|Death before starting treatment|0|||
94475238|NCT00313586|323531603|FG003|Overall Study|Death before starting treatment|0|||
94475239|NCT00264290|323531604|FG000|Intervention (8 Weeks)|Adverse Event|1|||
94475240|NCT00264290|323531605|FG001|Intervention (8 Weeks)|Adverse Event|0|||
94475241|NCT01951573|323531610|FG000|Washout Period|Adverse Event|0|||
94475242|NCT01951573|323531611|FG001|Washout Period|Adverse Event|1|||
94475243|NCT00272844|323531615|FG000|Overall Study|Withdrawal by Subject|5|||
94475244|NCT01556932|323531616|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
94475245|NCT01556932|323531617|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
94475246|NCT02869893|323531618|FG000|Overall Study|participant aversion to IV|5|||
94475247|NCT02869893|323531618|FG000|Overall Study|participant fear of MRI scanner|2|||
94475248|NCT01563913|323531619|FG000|Overall Study|Physician Decision|1|||
94475249|NCT01563913|323531620|FG001|Overall Study|Physician Decision|0|||
94475250|NCT01563913|323531619|FG000|Overall Study|Spouse Passed Away|1|||
94475251|NCT01563913|323531620|FG001|Overall Study|Spouse Passed Away|0|||
94475252|NCT03665077|323531621|FG000|Overall Study|Lost to Follow-up|2|||
94475253|NCT03665077|323531621|FG000|Overall Study|Physician Decision|2|||
94475254|NCT00435461|323531622|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
94475255|NCT00435461|323531623|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
94475256|NCT00435461|323531624|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
94475257|NCT00435461|323531622|FG000|Overall Study|Protocol Violation|6|||
94475258|NCT00435461|323531623|FG001|Overall Study|Protocol Violation|9|||
94475259|NCT00435461|323531624|FG002|Overall Study|Protocol Violation|10|||
94475260|NCT00435461|323531622|FG000|Overall Study|Participant randomized(inadequate score)|1|||
94475261|NCT00435461|323531623|FG001|Overall Study|Participant randomized(inadequate score)|0|||
94475262|NCT00435461|323531624|FG002|Overall Study|Participant randomized(inadequate score)|0|||
94475263|NCT00435461|323531622|FG000|Overall Study|Compliance less than 80 percent|1|||
94475264|NCT00435461|323531623|FG001|Overall Study|Compliance less than 80 percent|0|||
94475265|NCT00435461|323531624|FG002|Overall Study|Compliance less than 80 percent|0|||
94475266|NCT00435461|323531622|FG000|Overall Study|In error, two study medications switched|1|||
94475267|NCT00435461|323531623|FG001|Overall Study|In error, two study medications switched|0|||
94475268|NCT00435461|323531624|FG002|Overall Study|In error, two study medications switched|0|||
94475269|NCT00435461|323531622|FG000|Overall Study|Lack of Efficacy|2|||
94475270|NCT00435461|323531623|FG001|Overall Study|Lack of Efficacy|1|||
94475271|NCT00435461|323531624|FG002|Overall Study|Lack of Efficacy|0|||
94475272|NCT00435461|323531622|FG000|Overall Study|Withdrawal by Subject|1|||
94475273|NCT00435461|323531623|FG001|Overall Study|Withdrawal by Subject|0|||
94475274|NCT00435461|323531624|FG002|Overall Study|Withdrawal by Subject|2|||
94475275|NCT00435461|323531622|FG000|Overall Study|Randomized in error|1|||
94475276|NCT00435461|323531623|FG001|Overall Study|Randomized in error|0|||
94475277|NCT00435461|323531624|FG002|Overall Study|Randomized in error|0|||
94475278|NCT00435461|323531622|FG000|Overall Study|Participant could not tolerate symptoms|0|||
94475279|NCT00435461|323531623|FG001|Overall Study|Participant could not tolerate symptoms|0|||
94475280|NCT00435461|323531624|FG002|Overall Study|Participant could not tolerate symptoms|1|||
94313426|NCT01544595|322931614|FG001|Status at Week 68|Non-compliance with study treatment|0|||
94313427|NCT01544595|322931615|FG002|Status at Week 68|Non-compliance with study treatment|0|||
94313428|NCT01544595|322931616|FG003|Status at Week 68|Non-compliance with study treatment|1|||
94475281|NCT00435461|323531622|FG000|Overall Study|Participant could not swallow capsule|0|||
94475282|NCT00435461|323531623|FG001|Overall Study|Participant could not swallow capsule|0|||
94475283|NCT00435461|323531624|FG002|Overall Study|Participant could not swallow capsule|1|||
94475284|NCT00435461|323531622|FG000|Overall Study|Pregnancy|2|||
94475285|NCT00435461|323531623|FG001|Overall Study|Pregnancy|0|||
94475286|NCT00435461|323531624|FG002|Overall Study|Pregnancy|0|||
94475287|NCT00435461|323531622|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
94475288|NCT00435461|323531623|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
94475289|NCT00435461|323531624|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
94475290|NCT00435461|323531622|FG000|Overall Study|Participant ended study one day early|1|||
94313429|NCT01544595|322931617|FG004|Status at Week 68|Non-compliance with study treatment|0|||
94313430|NCT01544595|322931618|FG005|Status at Week 68|Non-compliance with study treatment|0|||
94313431|NCT01544595|322931613|FG000|Status at Week 68|Protocol Violation|2|||
94313432|NCT01544595|322931614|FG001|Status at Week 68|Protocol Violation|0|||
94313433|NCT01544595|322931615|FG002|Status at Week 68|Protocol Violation|1|||
94313434|NCT01544595|322931616|FG003|Status at Week 68|Protocol Violation|1|||
94313435|NCT01544595|322931617|FG004|Status at Week 68|Protocol Violation|0|||
94313436|NCT01544595|322931618|FG005|Status at Week 68|Protocol Violation|0|||
94313437|NCT01544595|322931613|FG000|Status at Week 68|Technical problems|1|||
94313438|NCT01544595|322931614|FG001|Status at Week 68|Technical problems|0|||
94383700|NCT02581345|323191770|FG003|Part 1: up to Week 16|Adverse Event|0|||
94383701|NCT02581345|323191767|FG000|Part 1: up to Week 16|Physician Decision|2|||
94383702|NCT02581345|323191768|FG001|Part 1: up to Week 16|Physician Decision|4|||
94383703|NCT02581345|323191769|FG002|Part 1: up to Week 16|Physician Decision|0|||
94383704|NCT02581345|323191770|FG003|Part 1: up to Week 16|Physician Decision|0|||
94383705|NCT02581345|323191767|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
94383706|NCT02581345|323191768|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
94383707|NCT02581345|323191769|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
94383708|NCT02581345|323191770|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
94383709|NCT02581345|323191767|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
94383710|NCT02581345|323191768|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
94383711|NCT02581345|323191769|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
94383712|NCT02581345|323191770|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
94383713|NCT02581345|323191767|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
94383714|NCT02581345|323191768|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
94383715|NCT02581345|323191769|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
94383716|NCT02581345|323191770|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
94383717|NCT02581345|323191767|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
94383718|NCT02581345|323191768|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
94383719|NCT02581345|323191769|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
94383720|NCT02581345|323191770|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
94383721|NCT02581345|323191767|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
94383722|NCT02581345|323191768|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
94383723|NCT02581345|323191769|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
94383724|NCT02581345|323191770|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
94383725|NCT02581345|323191767|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
94383726|NCT02581345|323191768|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
94383727|NCT02581345|323191769|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
94383728|NCT02581345|323191770|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
94383729|NCT02581345|323191767|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
94383730|NCT02581345|323191768|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
94383731|NCT02581345|323191769|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
94383732|NCT02581345|323191770|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
94383733|NCT02581345|323191767|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
94383734|NCT02581345|323191768|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
94383735|NCT02581345|323191769|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
94383736|NCT02581345|323191770|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
94383737|NCT02581345|323191767|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
94383738|NCT02581345|323191768|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
94383739|NCT02581345|323191769|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
94383740|NCT02581345|323191770|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
94383741|NCT02581345|323191767|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
94383742|NCT02581345|323191768|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
94383743|NCT02581345|323191769|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
94383744|NCT02581345|323191770|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
94383745|NCT01768858|323191771|FG000|Overall Study|Lost to Follow-up|9|||
94383746|NCT01768858|323191771|FG000|Overall Study|Lack of Efficacy|8|||
94383747|NCT01768858|323191771|FG000|Overall Study|Serious Adverse Event|1|||
94383748|NCT01768858|323191771|FG000|Overall Study|Participant moved to Germany|1|||
94383749|NCT01768858|323191771|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
94383750|NCT01768858|323191771|FG000|Overall Study|Exanthema|1|||
94383751|NCT01768858|323191771|FG000|Overall Study|Withdrawal by Subject|1|||
94383752|NCT03312530|323191772|FG000|Overall Study|Death|5|||
94383753|NCT03312530|323191773|FG001|Overall Study|Death|5|||
94383754|NCT03312530|323191774|FG002|Overall Study|Death|4|||
94383755|NCT03312530|323191775|FG003|Overall Study|Death|10|||
94383756|NCT03312530|323191776|FG004|Overall Study|Death|8|||
94383757|NCT03312530|323191772|FG000|Overall Study|Lost to Follow-up|0|||
94383758|NCT03312530|323191773|FG001|Overall Study|Lost to Follow-up|0|||
94383759|NCT03312530|323191774|FG002|Overall Study|Lost to Follow-up|0|||
94383760|NCT03312530|323191775|FG003|Overall Study|Lost to Follow-up|1|||
94475291|NCT00435461|323531623|FG001|Overall Study|Participant ended study one day early|0|||
94475292|NCT00435461|323531624|FG002|Overall Study|Participant ended study one day early|0|||
94475293|NCT00435461|323531622|FG000|Overall Study|Noncompliance with study requirements|1|||
94475294|NCT00435461|323531623|FG001|Overall Study|Noncompliance with study requirements|1|||
94475295|NCT00435461|323531624|FG002|Overall Study|Noncompliance with study requirements|1|||
94475296|NCT00435461|323531622|FG000|Overall Study|Adverse Event|1|||
94475297|NCT00435461|323531623|FG001|Overall Study|Adverse Event|2|||
94475298|NCT00435461|323531624|FG002|Overall Study|Adverse Event|6|||
94475299|NCT00435461|323531622|FG000|Overall Study|Non-Compliance of diary|2|||
94475300|NCT00435461|323531623|FG001|Overall Study|Non-Compliance of diary|0|||
94475301|NCT00435461|323531624|FG002|Overall Study|Non-Compliance of diary|1|||
94475302|NCT00435461|323531622|FG000|Overall Study|Lost to Follow-up|1|||
94475303|NCT00435461|323531623|FG001|Overall Study|Lost to Follow-up|1|||
94475304|NCT00435461|323531624|FG002|Overall Study|Lost to Follow-up|2|||
94475305|NCT00158262|323531627|FG000|Overall Study|Lost to Follow-up|1|||
94475306|NCT00158262|323531628|FG001|Overall Study|Lost to Follow-up|1|||
94475307|NCT03146741|323531629|FG000|Overall Study|Txp with non-HCV+ heart|4|||
94475308|NCT03146741|323531629|FG000|Overall Study|Listeted for MOT|2|||
94475309|NCT03146741|323531629|FG000|Overall Study|Physician Decision|2|||
94475310|NCT03146741|323531629|FG000|Overall Study|Awaiting txp|2|||
94475311|NCT03231306|323531630|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
94475312|NCT03231306|323531630|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
94475313|NCT03231306|323531630|FG000|Overall Study|Treatment delay > 21 days|2|||
94475314|NCT03231306|323531630|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
94475315|NCT03231306|323531630|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
94475316|NCT03231306|323531630|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
94475317|NCT03231306|323531630|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
94475318|NCT03231306|323531630|FG000|Overall Study|More than 1 Reason|2|||
94475319|NCT00237692|323531631|FG000|Overall Study|Lost to Follow-up|9|||
94475320|NCT00237692|323531632|FG001|Overall Study|Lost to Follow-up|3|||
94475321|NCT00237692|323531633|FG002|Overall Study|Lost to Follow-up|5|||
94475322|NCT00237692|323531634|FG003|Overall Study|Lost to Follow-up|3|||
94475323|NCT00237692|323531631|FG000|Overall Study|Death|1|||
94475324|NCT00237692|323531632|FG001|Overall Study|Death|2|||
94475325|NCT00237692|323531633|FG002|Overall Study|Death|2|||
94475326|NCT00237692|323531634|FG003|Overall Study|Death|3|||
94475327|NCT00237692|323531631|FG000|Overall Study|Excluded - did not meet criteria|4|||
94475328|NCT00237692|323531632|FG001|Overall Study|Excluded - did not meet criteria|3|||
94475329|NCT00237692|323531633|FG002|Overall Study|Excluded - did not meet criteria|5|||
94475330|NCT00237692|323531634|FG003|Overall Study|Excluded - did not meet criteria|9|||
94475331|NCT00237692|323531631|FG000|Overall Study|Withdrawal by Subject|4|||
94475332|NCT00237692|323531632|FG001|Overall Study|Withdrawal by Subject|6|||
94475333|NCT00237692|323531633|FG002|Overall Study|Withdrawal by Subject|10|||
94475334|NCT00237692|323531634|FG003|Overall Study|Withdrawal by Subject|4|||
94475335|NCT00110357|323531641|FG000|Overall Study|Deterioration without progression|2|||
94475336|NCT00110357|323531642|FG001|Overall Study|Deterioration without progression|0|||
94475337|NCT00110357|323531641|FG000|Overall Study|Disease progression/relapse|20|||
94475338|NCT00110357|323531642|FG001|Overall Study|Disease progression/relapse|15|||
94475339|NCT00110357|323531641|FG000|Overall Study|Study Closure|1|||
94475340|NCT00110357|323531642|FG001|Overall Study|Study Closure|0|||
94475341|NCT00110357|323531641|FG000|Overall Study|Study Drug Toxicity|1|||
94475342|NCT00110357|323531642|FG001|Overall Study|Study Drug Toxicity|3|||
94475343|NCT00110357|323531641|FG000|Overall Study|Withdrawal by Subject|3|||
94475344|NCT00110357|323531642|FG001|Overall Study|Withdrawal by Subject|1|||
94475345|NCT02588092|323531644|FG000|Overall Study|Death|4|||
94475346|NCT02588092|323531645|FG001|Overall Study|Death|3|||
94475347|NCT02588092|323531646|FG002|Overall Study|Death|3|||
94475348|NCT02588092|323531647|FG003|Overall Study|Death|3|||
94475349|NCT02588092|323531648|FG004|Overall Study|Death|2|||
94475350|NCT02588092|323531649|FG005|Overall Study|Death|2|||
94475351|NCT02588092|323531650|FG006|Overall Study|Death|2|||
94475352|NCT02588092|323531651|FG007|Overall Study|Death|1|||
94475353|NCT02588092|323531652|FG008|Overall Study|Death|5|||
94475354|NCT02588092|323531653|FG009|Overall Study|Death|2|||
94475355|NCT02588092|323531644|FG000|Overall Study|Withdrawal by Subject|0|||
94475356|NCT02588092|323531645|FG001|Overall Study|Withdrawal by Subject|0|||
94475357|NCT02588092|323531646|FG002|Overall Study|Withdrawal by Subject|0|||
94475358|NCT02588092|323531647|FG003|Overall Study|Withdrawal by Subject|0|||
94475359|NCT02588092|323531648|FG004|Overall Study|Withdrawal by Subject|0|||
94475360|NCT02588092|323531649|FG005|Overall Study|Withdrawal by Subject|1|||
94475361|NCT02588092|323531650|FG006|Overall Study|Withdrawal by Subject|1|||
94475362|NCT02588092|323531651|FG007|Overall Study|Withdrawal by Subject|2|||
94475363|NCT02588092|323531652|FG008|Overall Study|Withdrawal by Subject|0|||
94475364|NCT02588092|323531653|FG009|Overall Study|Withdrawal by Subject|0|||
94475365|NCT02588092|323531644|FG000|Overall Study|Started Another Treatment|0|||
94475366|NCT02588092|323531645|FG001|Overall Study|Started Another Treatment|0|||
94475367|NCT02588092|323531646|FG002|Overall Study|Started Another Treatment|0|||
94475368|NCT02588092|323531647|FG003|Overall Study|Started Another Treatment|0|||
94475369|NCT02588092|323531648|FG004|Overall Study|Started Another Treatment|1|||
94383761|NCT03312530|323191776|FG004|Overall Study|Lost to Follow-up|0|||
94383762|NCT03312530|323191772|FG000|Overall Study|Participant in another sponsor study.|0|||
94383763|NCT03312530|323191773|FG001|Overall Study|Participant in another sponsor study.|0|||
94383764|NCT03312530|323191774|FG002|Overall Study|Participant in another sponsor study.|0|||
94383765|NCT03312530|323191775|FG003|Overall Study|Participant in another sponsor study.|1|||
94383766|NCT03312530|323191776|FG004|Overall Study|Participant in another sponsor study.|0|||
94383767|NCT03312530|323191772|FG000|Overall Study|Study terminated by sponsor|1|||
94383768|NCT03312530|323191773|FG001|Overall Study|Study terminated by sponsor|0|||
94383769|NCT03312530|323191774|FG002|Overall Study|Study terminated by sponsor|2|||
94383770|NCT03312530|323191775|FG003|Overall Study|Study terminated by sponsor|3|||
94383771|NCT03312530|323191776|FG004|Overall Study|Study terminated by sponsor|7|||
94383772|NCT03312530|323191772|FG000|Overall Study|Withdrawal by Subject|0|||
94383773|NCT03312530|323191773|FG001|Overall Study|Withdrawal by Subject|1|||
94383774|NCT03312530|323191774|FG002|Overall Study|Withdrawal by Subject|0|||
94383775|NCT03312530|323191775|FG003|Overall Study|Withdrawal by Subject|0|||
94383776|NCT03312530|323191776|FG004|Overall Study|Withdrawal by Subject|0|||
94383777|NCT03312530|323191772|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
94383778|NCT03312530|323191773|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
94383779|NCT03312530|323191774|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
94383780|NCT03312530|323191775|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
94383781|NCT03312530|323191776|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
94383782|NCT03093324|323191780|FG000|Overall Study|Adverse Event|4|||
94383783|NCT03093324|323191781|FG001|Overall Study|Adverse Event|15|||
94383784|NCT03093324|323191780|FG000|Overall Study|Lost to Follow-up|1|||
94383785|NCT03093324|323191781|FG001|Overall Study|Lost to Follow-up|0|||
94383786|NCT03093324|323191780|FG000|Overall Study|Protocol Deviation|2|||
94383787|NCT03093324|323191781|FG001|Overall Study|Protocol Deviation|2|||
94383788|NCT03093324|323191780|FG000|Overall Study|Withdrawal by Subject|2|||
94383789|NCT03093324|323191781|FG001|Overall Study|Withdrawal by Subject|2|||
94383790|NCT00096265|323191782|FG000|Overall Study|Ineligible|1|||
94383791|NCT00096265|323191783|FG001|Overall Study|Ineligible|0|||
94383792|NCT00096265|323191784|FG002|Overall Study|Ineligible|0|||
94383793|NCT01691508|323191785|FG000|Overall Study|Adverse Event|3|||
94383794|NCT01691508|323191786|FG001|Overall Study|Adverse Event|3|||
94383795|NCT01691508|323191785|FG000|Overall Study|Withdrawal by Subject|1|||
94383796|NCT01691508|323191786|FG001|Overall Study|Withdrawal by Subject|0|||
94383797|NCT01290263|323191789|FG000|Overall Study|Adverse Event|0|||
94383798|NCT01290263|323191790|FG001|Overall Study|Adverse Event|0|||
94383799|NCT01290263|323191791|FG002|Overall Study|Adverse Event|0|||
94383800|NCT01290263|323191792|FG003|Overall Study|Adverse Event|1|||
94383801|NCT01290263|323191793|FG004|Overall Study|Adverse Event|1|||
94383802|NCT01290263|323191789|FG000|Overall Study|Lack of Efficacy|8|||
94383803|NCT01290263|323191790|FG001|Overall Study|Lack of Efficacy|2|||
94383804|NCT01290263|323191791|FG002|Overall Study|Lack of Efficacy|7|||
94383805|NCT01290263|323191792|FG003|Overall Study|Lack of Efficacy|24|||
94383806|NCT01290263|323191793|FG004|Overall Study|Lack of Efficacy|33|||
94383807|NCT01290263|323191789|FG000|Overall Study|Withdrawal by Subject|3|||
94383808|NCT01290263|323191790|FG001|Overall Study|Withdrawal by Subject|1|||
94383809|NCT01290263|323191791|FG002|Overall Study|Withdrawal by Subject|0|||
94383810|NCT01290263|323191792|FG003|Overall Study|Withdrawal by Subject|1|||
94383811|NCT01290263|323191793|FG004|Overall Study|Withdrawal by Subject|2|||
94383812|NCT01290263|323191789|FG000|Overall Study|Participant Non-Compliance|0|||
94383813|NCT01290263|323191790|FG001|Overall Study|Participant Non-Compliance|0|||
94383814|NCT01290263|323191791|FG002|Overall Study|Participant Non-Compliance|0|||
94383815|NCT01290263|323191792|FG003|Overall Study|Participant Non-Compliance|1|||
94383816|NCT01290263|323191793|FG004|Overall Study|Participant Non-Compliance|1|||
94383817|NCT02016300|323191794|FG000|Overall Study|Lost to Follow-up|0|||
94383818|NCT02016300|323191795|FG001|Overall Study|Lost to Follow-up|3|||
94383819|NCT00721409|323191798|FG000|Overall Study|Global deterioration of health status|2|||
94383820|NCT00721409|323191799|FG001|Overall Study|Global deterioration of health status|6|||
94383821|NCT00721409|323191800|FG002|Overall Study|Global deterioration of health status|3|||
94383822|NCT00721409|323191798|FG000|Overall Study|Death|0|||
94383823|NCT00721409|323191799|FG001|Overall Study|Death|1|||
94383824|NCT00721409|323191800|FG002|Overall Study|Death|0|||
94383825|NCT00721409|323191798|FG000|Overall Study|Randomized not Treated|0|||
94383826|NCT00721409|323191799|FG001|Overall Study|Randomized not Treated|1|||
94383827|NCT00721409|323191800|FG002|Overall Study|Randomized not Treated|4|||
94383828|NCT00721409|323191798|FG000|Overall Study|Reason not specified|1|||
94383829|NCT00721409|323191799|FG001|Overall Study|Reason not specified|0|||
94383830|NCT00721409|323191800|FG002|Overall Study|Reason not specified|2|||
94383831|NCT00721409|323191798|FG000|Overall Study|Adverse Event|0|||
94383832|NCT00721409|323191799|FG001|Overall Study|Adverse Event|13|||
94383833|NCT00721409|323191800|FG002|Overall Study|Adverse Event|2|||
94383834|NCT00721409|323191798|FG000|Overall Study|Lost to Follow-up|0|||
94383835|NCT00721409|323191799|FG001|Overall Study|Lost to Follow-up|0|||
94383836|NCT00721409|323191800|FG002|Overall Study|Lost to Follow-up|1|||
94383837|NCT00721409|323191798|FG000|Overall Study|Withdrawal by Subject|1|||
94383838|NCT00721409|323191799|FG001|Overall Study|Withdrawal by Subject|6|||
94383839|NCT00721409|323191800|FG002|Overall Study|Withdrawal by Subject|5|||
94383840|NCT00721409|323191798|FG000|Overall Study|Objective progression or relapse|8|||
94383841|NCT00721409|323191799|FG001|Overall Study|Objective progression or relapse|55|||
94383842|NCT00721409|323191800|FG002|Overall Study|Objective progression or relapse|62|||
94383843|NCT01424722|323191801|FG000|Overall Study|Sponsor terminated investigation|2258|||
94383844|NCT00995410|323191804|FG000|Overall Study|Adverse Event|51|||
94383845|NCT00995410|323191804|FG000|Overall Study|Withdrawal by Subject|7|||
94383846|NCT00995410|323191804|FG000|Overall Study|Lost to Follow-up|2|||
94383847|NCT00995410|323191804|FG000|Overall Study|Misc|28|||
94383848|NCT02684578|323191805|FG000|Overall Study|Withdrawal by Subject|10|||
94383849|NCT02684578|323191806|FG001|Overall Study|Withdrawal by Subject|7|||
94383850|NCT02684578|323191805|FG000|Overall Study|Lost to Follow-up|0|||
94383851|NCT02684578|323191806|FG001|Overall Study|Lost to Follow-up|3|||
94383852|NCT02684578|323191805|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
94383853|NCT02684578|323191806|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
94383854|NCT02684578|323191805|FG000|Overall Study|Missing follow-up data|0|||
94383855|NCT02684578|323191806|FG001|Overall Study|Missing follow-up data|1|||
94383856|NCT01505530|323191809|FG000|Overall Study|Progressive Disease|19|||
94383857|NCT01505530|323191810|FG001|Overall Study|Progressive Disease|17|||
94383858|NCT01505530|323191811|FG002|Overall Study|Progressive Disease|18|||
94383859|NCT01505530|323191809|FG000|Overall Study|Adverse Event|1|||
94383860|NCT01505530|323191810|FG001|Overall Study|Adverse Event|1|||
94383861|NCT01505530|323191811|FG002|Overall Study|Adverse Event|0|||
94383862|NCT01505530|323191809|FG000|Overall Study|Withdrawal by Subject|7|||
94383863|NCT01505530|323191810|FG001|Overall Study|Withdrawal by Subject|8|||
94383864|NCT01505530|323191811|FG002|Overall Study|Withdrawal by Subject|6|||
94383865|NCT01505530|323191809|FG000|Overall Study|Physician Decision|6|||
94383866|NCT01505530|323191810|FG001|Overall Study|Physician Decision|2|||
94383867|NCT01505530|323191811|FG002|Overall Study|Physician Decision|5|||
94383868|NCT01505530|323191809|FG000|Overall Study|Sponsor Decision|1|||
94383869|NCT01505530|323191810|FG001|Overall Study|Sponsor Decision|8|||
94383870|NCT01505530|323191811|FG002|Overall Study|Sponsor Decision|7|||
94383871|NCT01505530|323191809|FG000|Overall Study|Death|7|||
94383872|NCT01505530|323191810|FG001|Overall Study|Death|6|||
94383873|NCT01505530|323191811|FG002|Overall Study|Death|5|||
94383874|NCT01505530|323191809|FG000|Overall Study|entry criteria not met|0|||
94383875|NCT01505530|323191810|FG001|Overall Study|entry criteria not met|1|||
94383876|NCT01505530|323191811|FG002|Overall Study|entry criteria not met|0|||
94383877|NCT02236130|323191817|FG000|Overall Study|Lost to Follow-up|7|||
94383878|NCT02236130|323191818|FG001|Overall Study|Lost to Follow-up|12|||
94383879|NCT01249664|323191819|FG000|Overall Study|Withdrawal by Subject|5|||
94383880|NCT01249664|323191820|FG001|Overall Study|Withdrawal by Subject|0|||
94383881|NCT01249664|323191819|FG000|Overall Study|Adverse Event|1|||
94383882|NCT01249664|323191820|FG001|Overall Study|Adverse Event|0|||
94383883|NCT01400113|323191821|FG000|Overall Study|Withdrawal by Subject|1|||
94383884|NCT01400113|323191822|FG001|Overall Study|Withdrawal by Subject|1|||
94383885|NCT00806156|323191825|FG000|Overall Study|Death|35|||
94383886|NCT00806156|323191826|FG001|Overall Study|Death|95|||
94383887|NCT00806156|323191825|FG000|Overall Study|Did not meet eligibility criteria|1|||
94383888|NCT00806156|323191826|FG001|Overall Study|Did not meet eligibility criteria|0|||
94383889|NCT00806156|323191825|FG000|Overall Study|Study terminated by Sponsor|2|||
94383890|NCT00806156|323191826|FG001|Overall Study|Study terminated by Sponsor|40|||
94383891|NCT00806156|323191825|FG000|Overall Study|Consent withdrawn by subject|1|||
94383892|NCT00806156|323191826|FG001|Overall Study|Consent withdrawn by subject|3|||
94383893|NCT00806156|323191825|FG000|Overall Study|Lost to Follow-up|0|||
94383894|NCT00806156|323191826|FG001|Overall Study|Lost to Follow-up|1|||
94383895|NCT00525590|323191827|FG000|Overall Study|Adverse Event|3|||
94383896|NCT00525590|323191827|FG000|Overall Study|Physician Decision|3|||
94383897|NCT00525590|323191827|FG000|Overall Study|Withdrawal by Subject|16|||
94383898|NCT00525590|323191827|FG000|Overall Study|Lost to Follow-up|1|||
94383899|NCT00525590|323191827|FG000|Overall Study|Death|9|||
94383900|NCT00525590|323191827|FG000|Overall Study|Other|13|||
94383901|NCT02114697|323191828|FG000|Overall Study|Study terminated|5|||
94383902|NCT02114697|323191829|FG001|Overall Study|Study terminated|4|||
94383903|NCT01531205|323191836|FG000|Overall Study|Did not proceed to surgery|1|||
94383904|NCT03980483|323191839|FG000|Overall Study|Adverse Event|13|||
94383905|NCT03980483|323191840|FG001|Overall Study|Adverse Event|29|||
94475370|NCT02588092|323531649|FG005|Overall Study|Started Another Treatment|0|||
94475371|NCT02588092|323531650|FG006|Overall Study|Started Another Treatment|0|||
94475372|NCT02588092|323531651|FG007|Overall Study|Started Another Treatment|1|||
94475373|NCT02588092|323531652|FG008|Overall Study|Started Another Treatment|0|||
94475374|NCT02588092|323531653|FG009|Overall Study|Started Another Treatment|0|||
94475375|NCT02588092|323531644|FG000|Overall Study|Sponsor Decision|0|||
94475376|NCT02588092|323531645|FG001|Overall Study|Sponsor Decision|0|||
94475377|NCT02588092|323531646|FG002|Overall Study|Sponsor Decision|0|||
94475378|NCT02588092|323531647|FG003|Overall Study|Sponsor Decision|0|||
94475379|NCT02588092|323531648|FG004|Overall Study|Sponsor Decision|0|||
94475380|NCT02588092|323531649|FG005|Overall Study|Sponsor Decision|0|||
94475381|NCT02588092|323531650|FG006|Overall Study|Sponsor Decision|0|||
94475382|NCT02588092|323531651|FG007|Overall Study|Sponsor Decision|0|||
94475383|NCT02588092|323531652|FG008|Overall Study|Sponsor Decision|1|||
94475384|NCT02588092|323531653|FG009|Overall Study|Sponsor Decision|1|||
94475385|NCT03882957|323531654|FG000|Overall Study|Did not complete all three arms|1|||
94475386|NCT05095311|323531657|FG000|Overall Study|Lost to Follow-up|7|||
94475387|NCT05095311|323531658|FG001|Overall Study|Lost to Follow-up|0|||
94475388|NCT05095311|323531659|FG002|Overall Study|Lost to Follow-up|0|||
94475389|NCT01868165|323531660|FG000|Overall Study|Withdrawal by Subject|36|||
94475390|NCT01868165|323531660|FG000|Overall Study|Physician Decision|2|||
94475391|NCT01868165|323531660|FG000|Overall Study|Lost to Follow-up|3|||
94475392|NCT01868165|323531660|FG000|Overall Study|Death|4|||
94475393|NCT00625183|323531663|FG000|Overall Study|Disease Progression|1|||
94475394|NCT02500719|323531665|FG000|Overall Study|Lost to Follow-up|2|||
94475395|NCT02500719|323531666|FG001|Overall Study|Lost to Follow-up|3|||
94475396|NCT02500719|323531665|FG000|Overall Study|Trauma history|1|||
94475397|NCT02500719|323531666|FG001|Overall Study|Trauma history|0|||
94475398|NCT02500719|323531665|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
94475399|NCT02500719|323531666|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
94475400|NCT02500719|323531665|FG000|Overall Study|Did not meet criteria for PTSD|0|||
94475401|NCT02500719|323531666|FG001|Overall Study|Did not meet criteria for PTSD|1|||
94475402|NCT02500719|323531665|FG000|Overall Study|Claustrophobia|0|||
94475403|NCT02500719|323531666|FG001|Overall Study|Claustrophobia|1|||
94475404|NCT02500719|323531665|FG000|Overall Study|History of head trauma|0|||
94475405|NCT02500719|323531666|FG001|Overall Study|History of head trauma|1|||
94475406|NCT02710084|323531669|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
94475407|NCT02710084|323531670|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
94475408|NCT05305989|323531671|FG000|Overall Study|Other|3|||
94475409|NCT05305989|323531672|FG001|Overall Study|Other|2|||
94313439|NCT01544595|322931615|FG002|Status at Week 68|Technical problems|0|||
94313440|NCT01544595|322931616|FG003|Status at Week 68|Technical problems|1|||
94313441|NCT01544595|322931617|FG004|Status at Week 68|Technical problems|0|||
94313442|NCT01544595|322931618|FG005|Status at Week 68|Technical problems|0|||
94313443|NCT01544595|322931613|FG000|Status at Week 68|Withdrawal by Subject|0|||
94313444|NCT01544595|322931614|FG001|Status at Week 68|Withdrawal by Subject|1|||
94313445|NCT01544595|322931615|FG002|Status at Week 68|Withdrawal by Subject|1|||
94313446|NCT01544595|322931616|FG003|Status at Week 68|Withdrawal by Subject|2|||
94313447|NCT01544595|322931617|FG004|Status at Week 68|Withdrawal by Subject|0|||
94383906|NCT03980483|323191841|FG002|Overall Study|Adverse Event|11|||
94383907|NCT03980483|323191842|FG003|Overall Study|Adverse Event|2|||
94383908|NCT03980483|323191843|FG004|Overall Study|Adverse Event|2|||
94383909|NCT03980483|323191844|FG005|Overall Study|Adverse Event|2|||
94383910|NCT03980483|323191839|FG000|Overall Study|Lack of Efficacy|7|||
94383911|NCT03980483|323191840|FG001|Overall Study|Lack of Efficacy|6|||
94383912|NCT03980483|323191841|FG002|Overall Study|Lack of Efficacy|0|||
94383913|NCT03980483|323191842|FG003|Overall Study|Lack of Efficacy|3|||
94383914|NCT03980483|323191843|FG004|Overall Study|Lack of Efficacy|1|||
94383915|NCT03980483|323191844|FG005|Overall Study|Lack of Efficacy|1|||
94383916|NCT03980483|323191839|FG000|Overall Study|Lost to Follow-up|2|||
94383917|NCT03980483|323191840|FG001|Overall Study|Lost to Follow-up|4|||
94383918|NCT03980483|323191841|FG002|Overall Study|Lost to Follow-up|2|||
94383919|NCT03980483|323191842|FG003|Overall Study|Lost to Follow-up|1|||
94383920|NCT03980483|323191843|FG004|Overall Study|Lost to Follow-up|2|||
94383921|NCT03980483|323191844|FG005|Overall Study|Lost to Follow-up|0|||
94383922|NCT03980483|323191839|FG000|Overall Study|Protocol Violation|4|||
94383923|NCT03980483|323191840|FG001|Overall Study|Protocol Violation|2|||
94383924|NCT03980483|323191841|FG002|Overall Study|Protocol Violation|1|||
94475410|NCT05305989|323531673|FG002|Overall Study|Other|0|||
94475411|NCT05305989|323531671|FG000|Overall Study|Sponsor decision|2|||
94475412|NCT05305989|323531672|FG001|Overall Study|Sponsor decision|1|||
94383925|NCT03980483|323191842|FG003|Overall Study|Protocol Violation|1|||
94475413|NCT05305989|323531673|FG002|Overall Study|Sponsor decision|0|||
94383926|NCT03980483|323191843|FG004|Overall Study|Protocol Violation|0|||
94383927|NCT03980483|323191844|FG005|Overall Study|Protocol Violation|0|||
94383928|NCT03980483|323191839|FG000|Overall Study|Physician Decision|14|||
94383929|NCT03980483|323191840|FG001|Overall Study|Physician Decision|10|||
94475414|NCT05305989|323531671|FG000|Overall Study|Protocol Violation|0|||
94475415|NCT05305989|323531672|FG001|Overall Study|Protocol Violation|1|||
94475416|NCT05305989|323531673|FG002|Overall Study|Protocol Violation|0|||
94475417|NCT05305989|323531671|FG000|Overall Study|Investigator decision|1|||
94475418|NCT05305989|323531672|FG001|Overall Study|Investigator decision|2|||
94475419|NCT05305989|323531673|FG002|Overall Study|Investigator decision|0|||
94475420|NCT05305989|323531671|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
94475421|NCT05305989|323531672|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
94475422|NCT05305989|323531673|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
94475423|NCT05305989|323531671|FG000|Overall Study|Adverse Event|1|||
94475424|NCT05305989|323531672|FG001|Overall Study|Adverse Event|1|||
94475425|NCT05305989|323531673|FG002|Overall Study|Adverse Event|0|||
94475426|NCT05305989|323531671|FG000|Overall Study|Enrolled but never dosed|3|||
94475427|NCT05305989|323531672|FG001|Overall Study|Enrolled but never dosed|2|||
94475428|NCT05305989|323531673|FG002|Overall Study|Enrolled but never dosed|1|||
94475429|NCT02182830|323531674|FG000|Overall Study|Not Treated|1|||
94475430|NCT02182830|323531675|FG001|Overall Study|Not Treated|1|||
94475431|NCT02182830|323531674|FG000|Overall Study|Trial stopped, reason missing|3|||
94475432|NCT02182830|323531675|FG001|Overall Study|Trial stopped, reason missing|3|||
94475433|NCT02182830|323531674|FG000|Overall Study|Consent withdrawn|8|||
94475434|NCT02182830|323531675|FG001|Overall Study|Consent withdrawn|8|||
94475435|NCT02182830|323531674|FG000|Overall Study|Lost to Follow-up|3|||
94475436|NCT02182830|323531675|FG001|Overall Study|Lost to Follow-up|3|||
94475437|NCT05219968|323531676|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
94475438|NCT05219968|323531677|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
94475439|NCT05219968|323531678|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
94475440|NCT05219968|323531679|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
94475441|NCT05219968|323531680|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
94475442|NCT05219968|323531676|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
94475443|NCT05219968|323531677|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
94475444|NCT05219968|323531678|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
94475445|NCT05219968|323531679|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
94475446|NCT05219968|323531680|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
94475447|NCT05219968|323531676|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
94475448|NCT05219968|323531677|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
94475449|NCT05219968|323531678|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
94475450|NCT05219968|323531679|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
94475451|NCT05219968|323531680|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
94475452|NCT05219968|323531676|FG000|Week 24 Treatment Period|Adverse Event|3|||
94475453|NCT05219968|323531677|FG001|Week 24 Treatment Period|Adverse Event|0|||
94475454|NCT05219968|323531678|FG002|Week 24 Treatment Period|Adverse Event|0|||
94475455|NCT05219968|323531679|FG003|Week 24 Treatment Period|Adverse Event|0|||
94475456|NCT05219968|323531680|FG004|Week 24 Treatment Period|Adverse Event|0|||
94475457|NCT05219968|323531676|FG000|Week 24 Treatment Period|Physician Decision|0|||
94475458|NCT05219968|323531677|FG001|Week 24 Treatment Period|Physician Decision|1|||
94475459|NCT05219968|323531678|FG002|Week 24 Treatment Period|Physician Decision|0|||
94475460|NCT05219968|323531679|FG003|Week 24 Treatment Period|Physician Decision|0|||
94475461|NCT05219968|323531680|FG004|Week 24 Treatment Period|Physician Decision|0|||
94475462|NCT05219968|323531676|FG000|Week 24 Treatment Period|Other, not specified|3|||
94475463|NCT05219968|323531677|FG001|Week 24 Treatment Period|Other, not specified|0|||
94475464|NCT05219968|323531678|FG002|Week 24 Treatment Period|Other, not specified|0|||
94475465|NCT05219968|323531679|FG003|Week 24 Treatment Period|Other, not specified|0|||
94475466|NCT05219968|323531680|FG004|Week 24 Treatment Period|Other, not specified|0|||
94475467|NCT05219968|323531676|FG000|Safety Extension Period|Treatment administration failure|0|||
94475468|NCT05219968|323531677|FG001|Safety Extension Period|Treatment administration failure|0|||
94475469|NCT05219968|323531678|FG002|Safety Extension Period|Treatment administration failure|0|||
94475470|NCT05219968|323531679|FG003|Safety Extension Period|Treatment administration failure|1|||
94475471|NCT05219968|323531680|FG004|Safety Extension Period|Treatment administration failure|4|||
94475472|NCT05219968|323531676|FG000|Safety Extension Period|Bilateral dislodgement|0|||
94475473|NCT05219968|323531677|FG001|Safety Extension Period|Bilateral dislodgement|0|||
94475474|NCT05219968|323531678|FG002|Safety Extension Period|Bilateral dislodgement|4|||
94475475|NCT05219968|323531679|FG003|Safety Extension Period|Bilateral dislodgement|0|||
94475476|NCT05219968|323531680|FG004|Safety Extension Period|Bilateral dislodgement|1|||
94475477|NCT05219968|323531676|FG000|Safety Extension Period|Withdrawal by Subject|0|||
94475478|NCT05219968|323531677|FG001|Safety Extension Period|Withdrawal by Subject|0|||
94475479|NCT05219968|323531678|FG002|Safety Extension Period|Withdrawal by Subject|2|||
94475480|NCT05219968|323531679|FG003|Safety Extension Period|Withdrawal by Subject|0|||
94475481|NCT05219968|323531680|FG004|Safety Extension Period|Withdrawal by Subject|4|||
94475482|NCT05219968|323531676|FG000|Safety Extension Period|Adverse Event|0|||
94475483|NCT05219968|323531677|FG001|Safety Extension Period|Adverse Event|0|||
94475484|NCT05219968|323531678|FG002|Safety Extension Period|Adverse Event|2|||
94313448|NCT01544595|322931618|FG005|Status at Week 68|Withdrawal by Subject|0|||
94313449|NCT01544595|322931613|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
94313450|NCT01544595|322931614|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
94313451|NCT01544595|322931615|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
94313452|NCT01544595|322931616|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
94383930|NCT03980483|323191841|FG002|Overall Study|Physician Decision|7|||
94383931|NCT03980483|323191842|FG003|Overall Study|Physician Decision|4|||
94383932|NCT03980483|323191843|FG004|Overall Study|Physician Decision|4|||
94383933|NCT03980483|323191844|FG005|Overall Study|Physician Decision|2|||
94383934|NCT03980483|323191839|FG000|Overall Study|Withdrawal by Subject|38|||
94383935|NCT03980483|323191840|FG001|Overall Study|Withdrawal by Subject|21|||
94383936|NCT03980483|323191841|FG002|Overall Study|Withdrawal by Subject|15|||
94383937|NCT03980483|323191842|FG003|Overall Study|Withdrawal by Subject|5|||
94383938|NCT03980483|323191843|FG004|Overall Study|Withdrawal by Subject|3|||
94383939|NCT03980483|323191844|FG005|Overall Study|Withdrawal by Subject|4|||
94383940|NCT03980483|323191839|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
94383941|NCT03980483|323191840|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
94383942|NCT03980483|323191841|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
94383943|NCT03980483|323191842|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
94383944|NCT03980483|323191843|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
94383945|NCT03980483|323191844|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
94383946|NCT03980483|323191839|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
94383947|NCT03980483|323191840|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
94383948|NCT03980483|323191841|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
94383949|NCT03980483|323191842|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
94383950|NCT03980483|323191843|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
94383951|NCT03980483|323191844|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
94383952|NCT03980483|323191839|FG000|Overall Study|Other|0|||
94383953|NCT03980483|323191840|FG001|Overall Study|Other|1|||
94383954|NCT03980483|323191841|FG002|Overall Study|Other|0|||
94383955|NCT03980483|323191842|FG003|Overall Study|Other|0|||
94383956|NCT03980483|323191843|FG004|Overall Study|Other|0|||
94383957|NCT03980483|323191844|FG005|Overall Study|Other|0|||
94383958|NCT02001558|323191845|FG000|Overall Study|Lost to Follow-up|8|||
94383959|NCT02001558|323191846|FG001|Overall Study|Lost to Follow-up|14|||
94383960|NCT04128007|323191847|FG000|Overall Study|Withdrawal by Subject|9|||
94383961|NCT04128007|323191848|FG001|Overall Study|Withdrawal by Subject|6|||
94383962|NCT04128007|323191847|FG000|Overall Study|Protocol Violation|1|||
94383963|NCT04128007|323191848|FG001|Overall Study|Protocol Violation|0|||
94383964|NCT04128007|323191847|FG000|Overall Study|Lost to Follow-up|8|||
94383965|NCT04128007|323191848|FG001|Overall Study|Lost to Follow-up|7|||
94383966|NCT04128007|323191847|FG000|Overall Study|Adverse Event|5|||
94383967|NCT04128007|323191848|FG001|Overall Study|Adverse Event|2|||
94383968|NCT04128007|323191847|FG000|Overall Study|Not reported|0|||
94383969|NCT04128007|323191848|FG001|Overall Study|Not reported|2|||
94383970|NCT01225146|323191850|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
94383971|NCT01225146|323191851|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
94383972|NCT00814463|323191853|FG000|Overall Study|Lost to Follow-up|1|||
94383973|NCT01199861|323191854|FG000|Overall Study|Administrative problems|1|||
94383974|NCT01199861|323191855|FG001|Overall Study|Administrative problems|0|||
94383975|NCT01199861|323191854|FG000|Overall Study|Adverse Event|1|||
94383976|NCT01199861|323191855|FG001|Overall Study|Adverse Event|0|||
94383977|NCT00429923|323191856|FG000|Overall Study|Adverse Event|0|||
94383978|NCT00429923|323191857|FG001|Overall Study|Adverse Event|2|||
94383979|NCT00429923|323191858|FG002|Overall Study|Adverse Event|3|||
94383980|NCT00429923|323191856|FG000|Overall Study|Lack of Efficacy|4|||
94383981|NCT00429923|323191857|FG001|Overall Study|Lack of Efficacy|1|||
94383982|NCT00429923|323191858|FG002|Overall Study|Lack of Efficacy|33|||
94383983|NCT00429923|323191856|FG000|Overall Study|Lost to Follow-up|0|||
94383984|NCT00429923|323191857|FG001|Overall Study|Lost to Follow-up|0|||
94383985|NCT00429923|323191858|FG002|Overall Study|Lost to Follow-up|2|||
94383986|NCT00429923|323191856|FG000|Overall Study|Withdrew Consent|1|||
94383987|NCT00429923|323191857|FG001|Overall Study|Withdrew Consent|0|||
94383988|NCT00429923|323191858|FG002|Overall Study|Withdrew Consent|1|||
94383989|NCT00429923|323191856|FG000|Overall Study|Early Termination|0|||
94383990|NCT00429923|323191857|FG001|Overall Study|Early Termination|1|||
94383991|NCT00429923|323191858|FG002|Overall Study|Early Termination|0|||
94383992|NCT01939197|323191859|FG000|Overall Study|Withdrawal by Subject|1|||
94383993|NCT01939197|323191860|FG001|Overall Study|Withdrawal by Subject|0|||
94383994|NCT01939197|323191861|FG002|Overall Study|Withdrawal by Subject|0|||
94383995|NCT01939197|323191862|FG003|Overall Study|Withdrawal by Subject|0|||
94475485|NCT05219968|323531679|FG003|Safety Extension Period|Adverse Event|1|||
94475486|NCT05219968|323531680|FG004|Safety Extension Period|Adverse Event|1|||
94475487|NCT05219968|323531676|FG000|Safety Extension Period|Lost to Follow-up|0|||
94475488|NCT05219968|323531677|FG001|Safety Extension Period|Lost to Follow-up|0|||
94475489|NCT05219968|323531678|FG002|Safety Extension Period|Lost to Follow-up|0|||
94475490|NCT05219968|323531679|FG003|Safety Extension Period|Lost to Follow-up|1|||
94475491|NCT05219968|323531680|FG004|Safety Extension Period|Lost to Follow-up|0|||
94475492|NCT01048944|323533411|FG000|Overall Study|Protocol Violation|8|||
94475493|NCT01048944|323533412|FG001|Overall Study|Protocol Violation|10|||
94475494|NCT01048944|323533413|FG002|Overall Study|Protocol Violation|10|||
94475495|NCT01048944|323533414|FG003|Overall Study|Protocol Violation|2|||
94475496|NCT00824655|323533417|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
94475497|NCT00824655|323533418|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
94475498|NCT00824655|323533417|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
94475499|NCT00824655|323533418|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
94475500|NCT03782571|323533419|FG000|Period 1|Withdrawal by Subject|1|||
94475501|NCT03782571|323533420|FG001|Period 1|Withdrawal by Subject|0|||
94475502|NCT03782571|323533421|FG002|Period 1|Withdrawal by Subject|0|||
94475503|NCT03782571|323533422|FG003|Period 1|Withdrawal by Subject|0|||
94475504|NCT03782571|323533419|FG000|Period 3|Subject Unable to Attend V5|1|||
94475505|NCT03782571|323533420|FG001|Period 3|Subject Unable to Attend V5|0|||
94475506|NCT03782571|323533421|FG002|Period 3|Subject Unable to Attend V5|0|||
94475507|NCT03782571|323533422|FG003|Period 3|Subject Unable to Attend V5|0|||
94475508|NCT03782571|323533419|FG000|Period 3|Adverse Event|1|||
94475509|NCT03782571|323533420|FG001|Period 3|Adverse Event|0|||
94475510|NCT03782571|323533421|FG002|Period 3|Adverse Event|0|||
94475511|NCT03782571|323533422|FG003|Period 3|Adverse Event|0|||
94475512|NCT03504189|323533423|FG000|Overall Study|Withdrawal by Subject|1|||
94475513|NCT03504189|323533423|FG000|Overall Study|Screening Failure|1|||
94475514|NCT03504189|323533423|FG000|Overall Study|Device Failure|2|||
94475515|NCT00215644|323533426|FG000|Overall Study|Disease Progression|28|||
94475516|NCT00215644|323533427|FG001|Overall Study|Disease Progression|10|||
94475517|NCT00215644|323533426|FG000|Overall Study|Adverse Event|2|||
94475518|NCT00215644|323533427|FG001|Overall Study|Adverse Event|9|||
94475519|NCT00215644|323533426|FG000|Overall Study|Death|1|||
94475520|NCT00215644|323533427|FG001|Overall Study|Death|2|||
94475521|NCT00215644|323533426|FG000|Overall Study|Withdrawal by Subject|1|||
94475522|NCT00215644|323533427|FG001|Overall Study|Withdrawal by Subject|0|||
94475523|NCT00215644|323533426|FG000|Overall Study|Other|3|||
94475524|NCT00215644|323533427|FG001|Overall Study|Other|15|||
94475525|NCT00215644|323533426|FG000|Overall Study|Randomized but Not Treated|1|||
94475526|NCT00215644|323533427|FG001|Overall Study|Randomized but Not Treated|0|||
94475527|NCT02532257|323533430|FG000|Overall Study|Adverse Event|2|||
94475528|NCT02532257|323533430|FG000|Overall Study|Physician Decision|4|||
94475529|NCT02532257|323533430|FG000|Overall Study|Withdrawal by Subject|3|||
94475530|NCT02532257|323533430|FG000|Overall Study|Progressive Disease|10|||
94475531|NCT02090283|323533431|FG000|Overall Study|Withdrawal by Subject|6|||
94475532|NCT02090283|323533432|FG001|Overall Study|Withdrawal by Subject|6|||
94475533|NCT02090283|323533433|FG002|Overall Study|Withdrawal by Subject|6|||
94475534|NCT02090283|323533431|FG000|Overall Study|Sponsor Terminated Study|6|||
94475535|NCT02090283|323533432|FG001|Overall Study|Sponsor Terminated Study|6|||
94475536|NCT02090283|323533433|FG002|Overall Study|Sponsor Terminated Study|1|||
94475537|NCT02090283|323533431|FG000|Overall Study|Lost to Follow-up|2|||
94475538|NCT02090283|323533432|FG001|Overall Study|Lost to Follow-up|2|||
94475539|NCT02090283|323533433|FG002|Overall Study|Lost to Follow-up|3|||
94475540|NCT02090283|323533431|FG000|Overall Study|Adverse Event|1|||
94313453|NCT01544595|322931617|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
94313454|NCT01544595|322931618|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
94313455|NCT01544595|322931613|FG000|Status at Week 156|Withdrawal by Subject|9|||
94475541|NCT02090283|323533432|FG001|Overall Study|Adverse Event|1|||
94313456|NCT01544595|322931614|FG001|Status at Week 156|Withdrawal by Subject|10|||
94313457|NCT01544595|322931615|FG002|Status at Week 156|Withdrawal by Subject|4|||
94313458|NCT01544595|322931616|FG003|Status at Week 156|Withdrawal by Subject|9|||
94313459|NCT01544595|322931617|FG004|Status at Week 156|Withdrawal by Subject|20|||
94475542|NCT02090283|323533433|FG002|Overall Study|Adverse Event|0|||
94475543|NCT02090283|323533431|FG000|Overall Study|Protocol Violation|2|||
94475544|NCT02090283|323533432|FG001|Overall Study|Protocol Violation|0|||
94475545|NCT02090283|323533433|FG002|Overall Study|Protocol Violation|0|||
94475546|NCT02372383|323533436|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
94475547|NCT02372383|323533437|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
94475548|NCT02372383|323533438|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
94475549|NCT02171429|323533439|FG000|Overall Study|Other|0|||
94475550|NCT02171429|323533440|FG001|Overall Study|Other|1|||
94475551|NCT02171429|323533441|FG002|Overall Study|Other|1|||
94475552|NCT02171429|323533439|FG000|Overall Study|Non-Compliance|0|||
94475553|NCT02171429|323533440|FG001|Overall Study|Non-Compliance|0|||
94475554|NCT02171429|323533441|FG002|Overall Study|Non-Compliance|1|||
94475555|NCT02171429|323533439|FG000|Overall Study|Physician Decision|0|||
94475556|NCT02171429|323533440|FG001|Overall Study|Physician Decision|0|||
94475557|NCT02171429|323533441|FG002|Overall Study|Physician Decision|1|||
94475558|NCT02171429|323533439|FG000|Overall Study|Withdrawal by Subject|1|||
94475559|NCT02171429|323533440|FG001|Overall Study|Withdrawal by Subject|1|||
94475560|NCT02171429|323533441|FG002|Overall Study|Withdrawal by Subject|1|||
94475561|NCT02171429|323533439|FG000|Overall Study|Lost to Follow-up|0|||
94475562|NCT02171429|323533440|FG001|Overall Study|Lost to Follow-up|1|||
94475563|NCT02171429|323533441|FG002|Overall Study|Lost to Follow-up|0|||
94475564|NCT02171429|323533439|FG000|Overall Study|Death|0|||
94475565|NCT02171429|323533440|FG001|Overall Study|Death|0|||
94475566|NCT02171429|323533441|FG002|Overall Study|Death|1|||
94475567|NCT00424593|323533442|FG000|Acute Double-Blind Period|Adverse Event|16|||
94475568|NCT00424593|323533443|FG001|Acute Double-Blind Period|Adverse Event|7|||
94475569|NCT00424593|323533442|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
94475570|NCT00424593|323533443|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
94475571|NCT00424593|323533442|FG000|Acute Double-Blind Period|Protocol Violation|2|||
94475572|NCT00424593|323533443|FG001|Acute Double-Blind Period|Protocol Violation|2|||
94475573|NCT00424593|323533442|FG000|Acute Double-Blind Period|Physician Decision|1|||
94475574|NCT00424593|323533443|FG001|Acute Double-Blind Period|Physician Decision|2|||
94475575|NCT00424593|323533442|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
94475576|NCT00424593|323533443|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
94475577|NCT00424593|323533442|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
94475578|NCT00424593|323533443|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
94475579|NCT00424593|323533442|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
94475580|NCT00424593|323533443|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
94475581|NCT00424593|323533442|FG000|Dose-Blind Extension Period|Adverse Event|18|||
94475582|NCT00424593|323533443|FG001|Dose-Blind Extension Period|Adverse Event|0|||
94475583|NCT00424593|323533442|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
94475584|NCT00424593|323533443|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
94475585|NCT00424593|323533442|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
94475586|NCT00424593|323533443|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
94475587|NCT00424593|323533442|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
94475588|NCT00424593|323533443|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
94475589|NCT00424593|323533442|FG000|Dose-Blind Extension Period|Physician Decision|3|||
94475590|NCT00424593|323533443|FG001|Dose-Blind Extension Period|Physician Decision|0|||
94475591|NCT02178358|323533446|FG000|Overall Study|Withdrawal by Subject|0|||
94475592|NCT02178358|323533447|FG001|Overall Study|Withdrawal by Subject|2|||
94475593|NCT02178358|323533448|FG002|Overall Study|Withdrawal by Subject|2|||
94475594|NCT02178358|323533446|FG000|Overall Study|Lost to Follow-up|1|||
94475595|NCT02178358|323533447|FG001|Overall Study|Lost to Follow-up|0|||
94475596|NCT02178358|323533448|FG002|Overall Study|Lost to Follow-up|0|||
94475597|NCT01763203|323533449|FG000|Overall Study|Death|4|||
94475598|NCT01763203|323533450|FG001|Overall Study|Death|7|||
94475599|NCT01763203|323533449|FG000|Overall Study|Lost to Follow-up|12|||
94475600|NCT01763203|323533450|FG001|Overall Study|Lost to Follow-up|12|||
94475601|NCT01763203|323533449|FG000|Overall Study|Withdrawal by Subject|8|||
94475602|NCT01763203|323533450|FG001|Overall Study|Withdrawal by Subject|12|||
94475603|NCT01763203|323533449|FG000|Overall Study|Moved out of study region|7|||
94475604|NCT01763203|323533450|FG001|Overall Study|Moved out of study region|10|||
94475605|NCT01763203|323533449|FG000|Overall Study|Physician Decision|2|||
94475606|NCT01763203|323533450|FG001|Overall Study|Physician Decision|1|||
94475607|NCT02187861|323533451|FG000|Overall Study|Adverse Event|2|||
94475608|NCT02187861|323533452|FG001|Overall Study|Adverse Event|1|||
94475609|NCT02187861|323533453|FG002|Overall Study|Adverse Event|2|||
94475610|NCT02187861|323533454|FG003|Overall Study|Adverse Event|1|||
94475611|NCT02187861|323533451|FG000|Overall Study|Death|0|||
94475612|NCT02187861|323533452|FG001|Overall Study|Death|3|||
94475613|NCT02187861|323533453|FG002|Overall Study|Death|1|||
94475614|NCT02187861|323533454|FG003|Overall Study|Death|2|||
94475615|NCT02187861|323533451|FG000|Overall Study|Physician Decision|0|||
94475616|NCT02187861|323533452|FG001|Overall Study|Physician Decision|1|||
94475617|NCT02187861|323533453|FG002|Overall Study|Physician Decision|0|||
94313460|NCT01544595|322931618|FG005|Status at Week 156|Withdrawal by Subject|6|||
94313461|NCT01544595|322931613|FG000|Status at Week 156|Adverse Event|9|||
94313462|NCT01544595|322931614|FG001|Status at Week 156|Adverse Event|11|||
94313463|NCT01544595|322931615|FG002|Status at Week 156|Adverse Event|1|||
94313464|NCT01544595|322931616|FG003|Status at Week 156|Adverse Event|3|||
94475618|NCT02187861|323533454|FG003|Overall Study|Physician Decision|3|||
94475619|NCT02187861|323533451|FG000|Overall Study|Progressive Disease|4|||
94475620|NCT02187861|323533452|FG001|Overall Study|Progressive Disease|42|||
94475621|NCT02187861|323533453|FG002|Overall Study|Progressive Disease|19|||
94475622|NCT02187861|323533454|FG003|Overall Study|Progressive Disease|22|||
94475623|NCT02187861|323533451|FG000|Overall Study|Withdrawal by Subject|0|||
94475624|NCT02187861|323533452|FG001|Overall Study|Withdrawal by Subject|0|||
94475625|NCT02187861|323533453|FG002|Overall Study|Withdrawal by Subject|3|||
94313465|NCT01544595|322931617|FG004|Status at Week 156|Adverse Event|4|||
94475626|NCT02187861|323533454|FG003|Overall Study|Withdrawal by Subject|3|||
94475627|NCT02187861|323533451|FG000|Overall Study|Other|0|||
94475628|NCT02187861|323533452|FG001|Overall Study|Other|1|||
94475629|NCT02187861|323533453|FG002|Overall Study|Other|7|||
94475630|NCT02187861|323533454|FG003|Overall Study|Other|1|||
94475631|NCT01042392|323533456|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
94475632|NCT01042392|323533457|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
94475633|NCT01042392|323533458|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
94475634|NCT01042392|323533459|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
94475635|NCT01042392|323533456|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
94475636|NCT01042392|323533457|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
94475637|NCT01042392|323533458|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
94475638|NCT01042392|323533459|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
94475639|NCT01042392|323533456|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
94475640|NCT01042392|323533457|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
94475641|NCT01042392|323533458|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
94475642|NCT01042392|323533459|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
94475643|NCT01042392|323533456|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
94475644|NCT01042392|323533457|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
94475645|NCT01042392|323533458|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
94475646|NCT01042392|323533459|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
94475647|NCT01042392|323533456|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
94475648|NCT01042392|323533457|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
94475649|NCT01042392|323533458|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
94475650|NCT01042392|323533459|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
94475651|NCT01042392|323533456|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
94475652|NCT01042392|323533457|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
94475653|NCT01042392|323533458|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
94475654|NCT01042392|323533459|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
94475655|NCT01042392|323533456|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
94475656|NCT01042392|323533457|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
94475657|NCT01042392|323533458|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
94475658|NCT01042392|323533459|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
94475659|NCT01042392|323533456|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
94475660|NCT01042392|323533457|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
94475661|NCT01042392|323533458|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
94475662|NCT01042392|323533459|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
94475663|NCT01042392|323533456|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
94475664|NCT01042392|323533457|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
94475665|NCT01042392|323533458|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
94475666|NCT01042392|323533459|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
94475667|NCT00790556|323533462|FG000|Treatment Period 1|Physician Decision|1|||
94475668|NCT00790556|323533463|FG001|Treatment Period 1|Physician Decision|0|||
94475669|NCT00790556|323533462|FG000|Treatment Period 1|Withdrawal by Subject|1|||
94475670|NCT00790556|323533463|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94475671|NCT02768792|323533466|FG000|Overall Study|Adverse Event|1|||
94475672|NCT04819438|323533467|FG000|Overall Study|Withdrawal by Subject|1|||
94475673|NCT04819438|323533468|FG001|Overall Study|Withdrawal by Subject|0|||
94475674|NCT04819438|323533467|FG000|Overall Study|Adverse Event|0|||
94475675|NCT04819438|323533468|FG001|Overall Study|Adverse Event|1|||
94475676|NCT04819438|323533467|FG000|Overall Study|Protocol Violation|0|||
94475677|NCT04819438|323533468|FG001|Overall Study|Protocol Violation|1|||
94475678|NCT01509664|323533472|FG000|Overall Study|Lost to Follow-up|15|||
94475679|NCT01509664|323533473|FG001|Overall Study|Lost to Follow-up|21|||
94475680|NCT01882803|323533474|FG000|Overall Study|Disease Progression|1|||
94475681|NCT01882803|323533474|FG000|Overall Study|Withdrawal by Subject|9|||
94475682|NCT01882803|323533474|FG000|Overall Study|Death|68|||
94475683|NCT01882803|323533474|FG000|Overall Study|Physician Decision|3|||
94475684|NCT01882803|323533474|FG000|Overall Study|Lost to Follow-up|3|||
94475685|NCT01882803|323533474|FG000|Overall Study|Follow-up Completed|39|||
94475686|NCT01882803|323533474|FG000|Overall Study|Study Terminated by the Sponsor|6|||
94475687|NCT00705341|323533475|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
94475688|NCT00705341|323533476|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
94475689|NCT00705341|323533477|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
94475690|NCT00705341|323533478|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
94475691|NCT00705341|323533475|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
94475692|NCT00705341|323533476|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
94475693|NCT00705341|323533477|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
94313466|NCT01544595|322931618|FG005|Status at Week 156|Adverse Event|2|||
94475694|NCT00705341|323533478|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
94475695|NCT02091414|323533479|FG000|Overall Study|Withdrawal by Subject|2|||
94475696|NCT02091414|323533479|FG000|Overall Study|Death|2|||
94475697|NCT01424241|323533480|FG000|Overall Study|Withdrawal by Subject|1|||
94475698|NCT01424241|323533480|FG000|Overall Study|Time constraints|2|||
94475699|NCT02782377|323533481|FG000|Overall Study|Physician Decision|5|||
94475700|NCT04501952|323533482|FG000|Overall Study|Adverse Event|0|||
94475701|NCT04501952|323533483|FG001|Overall Study|Adverse Event|3|||
94475702|NCT04501952|323533482|FG000|Overall Study|Investigator's Discretion|0|||
94475703|NCT04501952|323533483|FG001|Overall Study|Investigator's Discretion|1|||
94475704|NCT04501952|323533482|FG000|Overall Study|Protocol Violation|1|||
94475705|NCT04501952|323533483|FG001|Overall Study|Protocol Violation|1|||
94475706|NCT04501952|323533482|FG000|Overall Study|Withdrew Consent|5|||
94475707|NCT04501952|323533483|FG001|Overall Study|Withdrew Consent|4|||
94383996|NCT01939197|323191863|FG004|Overall Study|Withdrawal by Subject|1|||
94383997|NCT01939197|323191864|FG005|Overall Study|Withdrawal by Subject|0|||
94383998|NCT01939197|323191865|FG006|Overall Study|Withdrawal by Subject|0|||
94383999|NCT01939197|323191859|FG000|Overall Study|Lost to Follow-up|0|||
94384000|NCT01939197|323191860|FG001|Overall Study|Lost to Follow-up|1|||
94384001|NCT01939197|323191861|FG002|Overall Study|Lost to Follow-up|0|||
94384002|NCT01939197|323191862|FG003|Overall Study|Lost to Follow-up|1|||
94384003|NCT01939197|323191863|FG004|Overall Study|Lost to Follow-up|3|||
94384004|NCT01939197|323191864|FG005|Overall Study|Lost to Follow-up|1|||
94384005|NCT01939197|323191865|FG006|Overall Study|Lost to Follow-up|2|||
94384006|NCT02343120|323191873|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
94384007|NCT02343120|323191874|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
94384008|NCT02343120|323191875|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
94384009|NCT02343120|323191876|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
94384010|NCT02343120|323191877|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
94384011|NCT02343120|323191873|FG000|Part 1: Dose Escalation|Death|1|||
94384012|NCT02343120|323191874|FG001|Part 1: Dose Escalation|Death|2|||
94384013|NCT02343120|323191875|FG002|Part 1: Dose Escalation|Death|2|||
94384014|NCT02343120|323191876|FG003|Part 1: Dose Escalation|Death|2|||
94384015|NCT02343120|323191877|FG004|Part 1: Dose Escalation|Death|1|||
94384016|NCT02343120|323191873|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
94384017|NCT02343120|323191874|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
94384018|NCT02343120|323191875|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
94384019|NCT02343120|323191876|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
94384020|NCT02343120|323191877|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
94384021|NCT02343120|323191873|FG000|Part 2: Expansion|Sponsor decision|0|||
94384022|NCT02343120|323191874|FG001|Part 2: Expansion|Sponsor decision|0|||
94384023|NCT02343120|323191875|FG002|Part 2: Expansion|Sponsor decision|0|||
94384024|NCT02343120|323191876|FG003|Part 2: Expansion|Sponsor decision|165|||
94384025|NCT02343120|323191877|FG004|Part 2: Expansion|Sponsor decision|67|||
94384026|NCT02343120|323191873|FG000|Part 2: Expansion|Death|0|||
94384027|NCT02343120|323191874|FG001|Part 2: Expansion|Death|0|||
94384028|NCT02343120|323191875|FG002|Part 2: Expansion|Death|0|||
94384029|NCT02343120|323191876|FG003|Part 2: Expansion|Death|74|||
94384030|NCT02343120|323191877|FG004|Part 2: Expansion|Death|17|||
94384031|NCT02343120|323191873|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
94384032|NCT02343120|323191874|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
94384033|NCT02343120|323191875|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
94384034|NCT02343120|323191876|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
94384035|NCT02343120|323191877|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
94384036|NCT02343120|323191873|FG000|Part 2: Expansion|Lost to Follow-up|0|||
94384037|NCT02343120|323191874|FG001|Part 2: Expansion|Lost to Follow-up|0|||
94384038|NCT02343120|323191875|FG002|Part 2: Expansion|Lost to Follow-up|0|||
94384039|NCT02343120|323191876|FG003|Part 2: Expansion|Lost to Follow-up|5|||
94384040|NCT02343120|323191877|FG004|Part 2: Expansion|Lost to Follow-up|2|||
94384041|NCT02343120|323191873|FG000|Part 2: Expansion|Other|0|||
94384042|NCT02343120|323191874|FG001|Part 2: Expansion|Other|0|||
94384043|NCT02343120|323191875|FG002|Part 2: Expansion|Other|0|||
94384044|NCT02343120|323191876|FG003|Part 2: Expansion|Other|1|||
94384045|NCT02343120|323191877|FG004|Part 2: Expansion|Other|5|||
94384046|NCT02343120|323191873|FG000|Part 2: Expansion|Adverse Event|0|||
94384047|NCT02343120|323191874|FG001|Part 2: Expansion|Adverse Event|0|||
94384048|NCT02343120|323191875|FG002|Part 2: Expansion|Adverse Event|0|||
94384049|NCT02343120|323191876|FG003|Part 2: Expansion|Adverse Event|1|||
94384050|NCT02343120|323191877|FG004|Part 2: Expansion|Adverse Event|1|||
94384051|NCT03184441|323191878|FG000|Overall Study|Withdrawal by Subject|1|||
94384052|NCT01471522|323191881|FG000|Overall Study|Withdrawal by Subject|28|||
94384053|NCT01471522|323191882|FG001|Overall Study|Withdrawal by Subject|22|||
94384054|NCT01471522|323191881|FG000|Overall Study|Lost to Follow-up|36|||
94384055|NCT01471522|323191882|FG001|Overall Study|Lost to Follow-up|26|||
94475708|NCT04501952|323533482|FG000|Overall Study|Lost to Follow-up|7|||
94384056|NCT01706926|323191883|FG000|Overall Study|Lost to Follow-up|0|||
94384057|NCT01706926|323191884|FG001|Overall Study|Lost to Follow-up|0|||
94384058|NCT01706926|323191885|FG002|Overall Study|Lost to Follow-up|1|||
94384059|NCT01706926|323191886|FG003|Overall Study|Lost to Follow-up|0|||
94475709|NCT04501952|323533483|FG001|Overall Study|Lost to Follow-up|2|||
94475710|NCT04501952|323533482|FG000|Overall Study|Randomized and Never Treated|13|||
94475711|NCT04501952|323533483|FG001|Overall Study|Randomized and Never Treated|9|||
94475712|NCT02080364|323533484|FG000|Baseline Period|Protocol Violation|2|||
94475713|NCT02080364|323533485|FG001|Baseline Period|Protocol Violation|1|||
94475714|NCT02080364|323533486|FG002|Baseline Period|Protocol Violation|0|||
94475715|NCT02080364|323533487|FG003|Baseline Period|Protocol Violation|0|||
94475716|NCT02080364|323533484|FG000|Baseline Period|Other|0|||
94475717|NCT02080364|323533485|FG001|Baseline Period|Other|1|||
94475718|NCT02080364|323533486|FG002|Baseline Period|Other|1|||
94475719|NCT02080364|323533487|FG003|Baseline Period|Other|0|||
94475720|NCT02080364|323533484|FG000|Treatment Period|Adverse Event|10|||
94475721|NCT02080364|323533485|FG001|Treatment Period|Adverse Event|15|||
94475722|NCT02080364|323533486|FG002|Treatment Period|Adverse Event|11|||
94475723|NCT02080364|323533487|FG003|Treatment Period|Adverse Event|14|||
94475724|NCT02080364|323533484|FG000|Treatment Period|Lost to Follow-up|2|||
94475725|NCT02080364|323533485|FG001|Treatment Period|Lost to Follow-up|3|||
94475726|NCT02080364|323533486|FG002|Treatment Period|Lost to Follow-up|5|||
94475727|NCT02080364|323533487|FG003|Treatment Period|Lost to Follow-up|0|||
94475728|NCT02080364|323533484|FG000|Treatment Period|Protocol Violation|5|||
94475729|NCT02080364|323533485|FG001|Treatment Period|Protocol Violation|3|||
94475730|NCT02080364|323533486|FG002|Treatment Period|Protocol Violation|5|||
94475731|NCT02080364|323533487|FG003|Treatment Period|Protocol Violation|1|||
94475732|NCT02080364|323533484|FG000|Treatment Period|Withdrawal by Subject|16|||
94475733|NCT02080364|323533485|FG001|Treatment Period|Withdrawal by Subject|16|||
94475734|NCT02080364|323533486|FG002|Treatment Period|Withdrawal by Subject|15|||
94475735|NCT02080364|323533487|FG003|Treatment Period|Withdrawal by Subject|10|||
94475736|NCT02080364|323533484|FG000|Treatment Period|Study Terminated by Sponsor|0|||
94475737|NCT02080364|323533485|FG001|Treatment Period|Study Terminated by Sponsor|0|||
94475738|NCT02080364|323533486|FG002|Treatment Period|Study Terminated by Sponsor|180|||
94475739|NCT02080364|323533487|FG003|Treatment Period|Study Terminated by Sponsor|183|||
94475740|NCT02080364|323533484|FG000|Treatment Period|Other|14|||
94475741|NCT02080364|323533485|FG001|Treatment Period|Other|12|||
94475742|NCT02080364|323533486|FG002|Treatment Period|Other|21|||
94475743|NCT02080364|323533487|FG003|Treatment Period|Other|16|||
94475744|NCT01188668|323533488|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
94475745|NCT01188668|323533488|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
94475746|NCT01188668|323533488|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
94475747|NCT05259917|323533489|FG000|Overall Study|Protocol Violation|0|||
94475748|NCT05259917|323533490|FG001|Overall Study|Protocol Violation|0|||
94475749|NCT05259917|323533491|FG002|Overall Study|Protocol Violation|1|||
94475750|NCT05259917|323533492|FG003|Overall Study|Protocol Violation|0|||
94475751|NCT05259917|323533493|FG004|Overall Study|Protocol Violation|0|||
94475752|NCT05259917|323533494|FG005|Overall Study|Protocol Violation|0|||
94475753|NCT05259917|323533489|FG000|Overall Study|Lost to Follow-up|0|||
94475754|NCT05259917|323533490|FG001|Overall Study|Lost to Follow-up|0|||
94475755|NCT05259917|323533491|FG002|Overall Study|Lost to Follow-up|1|||
94475756|NCT05259917|323533492|FG003|Overall Study|Lost to Follow-up|0|||
94475757|NCT05259917|323533493|FG004|Overall Study|Lost to Follow-up|0|||
94475758|NCT05259917|323533494|FG005|Overall Study|Lost to Follow-up|1|||
94313467|NCT01544595|322931613|FG000|Status at Week 156|Lost to Follow-up|4|||
94313468|NCT01544595|322931614|FG001|Status at Week 156|Lost to Follow-up|4|||
94313469|NCT01544595|322931615|FG002|Status at Week 156|Lost to Follow-up|0|||
94313470|NCT01544595|322931616|FG003|Status at Week 156|Lost to Follow-up|1|||
94313471|NCT01544595|322931617|FG004|Status at Week 156|Lost to Follow-up|4|||
94475759|NCT05259917|323533489|FG000|Overall Study|Physician Decision|0|||
94475760|NCT05259917|323533490|FG001|Overall Study|Physician Decision|1|||
94475761|NCT05259917|323533491|FG002|Overall Study|Physician Decision|0|||
94475762|NCT05259917|323533492|FG003|Overall Study|Physician Decision|0|||
94475763|NCT05259917|323533493|FG004|Overall Study|Physician Decision|0|||
94475764|NCT05259917|323533494|FG005|Overall Study|Physician Decision|0|||
94475765|NCT05259917|323533489|FG000|Overall Study|Withdrawal by Subject|0|||
94475766|NCT05259917|323533490|FG001|Overall Study|Withdrawal by Subject|1|||
94475767|NCT05259917|323533491|FG002|Overall Study|Withdrawal by Subject|0|||
94475768|NCT05259917|323533492|FG003|Overall Study|Withdrawal by Subject|0|||
94475769|NCT05259917|323533493|FG004|Overall Study|Withdrawal by Subject|1|||
94475770|NCT05259917|323533494|FG005|Overall Study|Withdrawal by Subject|1|||
94475771|NCT05259917|323533489|FG000|Overall Study|Trial Termination by Sponsor|7|||
94475772|NCT05259917|323533490|FG001|Overall Study|Trial Termination by Sponsor|2|||
94475773|NCT05259917|323533491|FG002|Overall Study|Trial Termination by Sponsor|3|||
94475774|NCT05259917|323533492|FG003|Overall Study|Trial Termination by Sponsor|5|||
94475775|NCT05259917|323533493|FG004|Overall Study|Trial Termination by Sponsor|11|||
94475776|NCT05259917|323533494|FG005|Overall Study|Trial Termination by Sponsor|4|||
94475777|NCT05259917|323533489|FG000|Overall Study|Other|1|||
94313472|NCT01544595|322931618|FG005|Status at Week 156|Lost to Follow-up|1|||
94313473|NCT01544595|322931613|FG000|Status at Week 156|Non-compliance with study treatement|0|||
94475778|NCT05259917|323533490|FG001|Overall Study|Other|0|||
94475779|NCT05259917|323533491|FG002|Overall Study|Other|2|||
94313474|NCT01544595|322931614|FG001|Status at Week 156|Non-compliance with study treatement|1|||
94313475|NCT01544595|322931615|FG002|Status at Week 156|Non-compliance with study treatement|0|||
94313476|NCT01544595|322931616|FG003|Status at Week 156|Non-compliance with study treatement|1|||
94313477|NCT01544595|322931617|FG004|Status at Week 156|Non-compliance with study treatement|0|||
94313478|NCT01544595|322931618|FG005|Status at Week 156|Non-compliance with study treatement|1|||
94313479|NCT01544595|322931613|FG000|Status at Week 156|Physician Decision|0|||
94313480|NCT01544595|322931614|FG001|Status at Week 156|Physician Decision|3|||
94313481|NCT01544595|322931615|FG002|Status at Week 156|Physician Decision|1|||
94313482|NCT01544595|322931616|FG003|Status at Week 156|Physician Decision|0|||
94313483|NCT01544595|322931617|FG004|Status at Week 156|Physician Decision|0|||
94313484|NCT01544595|322931618|FG005|Status at Week 156|Physician Decision|0|||
94313485|NCT01544595|322931613|FG000|Status at Week 156|Pregnancy|2|||
94313486|NCT01544595|322931614|FG001|Status at Week 156|Pregnancy|3|||
94313487|NCT01544595|322931615|FG002|Status at Week 156|Pregnancy|0|||
94313488|NCT01544595|322931616|FG003|Status at Week 156|Pregnancy|0|||
94313489|NCT01544595|322931617|FG004|Status at Week 156|Pregnancy|0|||
94313490|NCT01544595|322931618|FG005|Status at Week 156|Pregnancy|0|||
94313491|NCT01544595|322931613|FG000|Status at Week 156|Protocol Violation|3|||
94313492|NCT01544595|322931614|FG001|Status at Week 156|Protocol Violation|1|||
94313493|NCT01544595|322931615|FG002|Status at Week 156|Protocol Violation|2|||
94313494|NCT01544595|322931616|FG003|Status at Week 156|Protocol Violation|2|||
94313495|NCT01544595|322931617|FG004|Status at Week 156|Protocol Violation|0|||
94313496|NCT01544595|322931618|FG005|Status at Week 156|Protocol Violation|0|||
94313497|NCT01544595|322931613|FG000|Status at Week 156|Technical problems|3|||
94313498|NCT01544595|322931614|FG001|Status at Week 156|Technical problems|1|||
94313499|NCT01544595|322931615|FG002|Status at Week 156|Technical problems|0|||
94313500|NCT01544595|322931616|FG003|Status at Week 156|Technical problems|1|||
94313501|NCT01544595|322931617|FG004|Status at Week 156|Technical problems|0|||
94313502|NCT01544595|322931618|FG005|Status at Week 156|Technical problems|0|||
94313503|NCT01544595|322931613|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
94313504|NCT01544595|322931614|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
94313505|NCT01544595|322931615|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
94313506|NCT01544595|322931616|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
94313507|NCT01544595|322931617|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
94313508|NCT01544595|322931618|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
94313509|NCT01544595|322931613|FG000|Status at Week 156|Lack of Efficacy|1|||
94313510|NCT01544595|322931614|FG001|Status at Week 156|Lack of Efficacy|0|||
94313511|NCT01544595|322931615|FG002|Status at Week 156|Lack of Efficacy|1|||
94313512|NCT01544595|322931616|FG003|Status at Week 156|Lack of Efficacy|4|||
94313513|NCT01544595|322931617|FG004|Status at Week 156|Lack of Efficacy|10|||
94384060|NCT01706926|323191883|FG000|Overall Study|Withdrawal by Subject|2|||
94384061|NCT01706926|323191884|FG001|Overall Study|Withdrawal by Subject|0|||
94384062|NCT01706926|323191885|FG002|Overall Study|Withdrawal by Subject|1|||
94384063|NCT01706926|323191886|FG003|Overall Study|Withdrawal by Subject|2|||
94384064|NCT01706926|323191883|FG000|Overall Study|Other|4|||
94384065|NCT01706926|323191884|FG001|Overall Study|Other|4|||
94384066|NCT01706926|323191885|FG002|Overall Study|Other|4|||
94384067|NCT01706926|323191886|FG003|Overall Study|Other|3|||
94384068|NCT02623959|323193093|FG000|Overall Study|Progression|0|||
94384069|NCT02623959|323193094|FG001|Overall Study|Progression|1|||
94384070|NCT03093454|323193095|FG000|Overall Study|Withdrawal by Subject|1|||
94384071|NCT03093454|323193096|FG001|Overall Study|Withdrawal by Subject|1|||
94384072|NCT03093454|323193095|FG000|Overall Study|Scheduling conflict|3|||
94384073|NCT03093454|323193096|FG001|Overall Study|Scheduling conflict|1|||
94384074|NCT03093454|323193095|FG000|Overall Study|Physician Decision|2|||
94384075|NCT03093454|323193096|FG001|Overall Study|Physician Decision|1|||
94384076|NCT01367275|323193098|FG000|Overall Study|Ineligible|1|||
94384077|NCT01367275|323193098|FG000|Overall Study|Disease Progression|2|||
94384078|NCT04700449|323193101|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
94384079|NCT04700449|323193102|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
94384080|NCT04700449|323193103|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
94384081|NCT04700449|323193104|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
94384082|NCT04700449|323193101|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
94384083|NCT04700449|323193102|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
94384084|NCT04700449|323193103|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
94384085|NCT04700449|323193104|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
94384086|NCT04700449|323193101|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
94384087|NCT04700449|323193102|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
94384088|NCT04700449|323193103|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
94384089|NCT04700449|323193104|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
94384090|NCT04700449|323193101|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
94384091|NCT04700449|323193102|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
94384092|NCT04700449|323193103|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
94475780|NCT05259917|323533492|FG003|Overall Study|Other|0|||
94313514|NCT01544595|322931618|FG005|Status at Week 156|Lack of Efficacy|5|||
94313515|NCT00935220|322931629|FG000|Overall Study|Adverse Event|1|||
94313516|NCT00935220|322931629|FG000|Overall Study|Other reason (not specified)|1|||
94313517|NCT03283163|322931632|FG000|Overall Study|Lost to Follow-up|1|||
94313518|NCT03283163|322931632|FG000|Overall Study|other life commitments|6|||
94313519|NCT03283163|322931632|FG000|Overall Study|COVID-19 institution wide halting|1|||
94313520|NCT03283163|322931632|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
94313521|NCT03283163|322931632|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
94313522|NCT02160977|322931633|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
94313523|NCT02160977|322931634|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
94313524|NCT02160977|322931633|FG000|Three Months After Surgery|Lost to Follow-up|0|||
94313525|NCT02160977|322931634|FG001|Three Months After Surgery|Lost to Follow-up|2|||
94313526|NCT02160977|322931633|FG000|Six Months After Surgery|Lost to Follow-up|2|||
94313527|NCT02160977|322931634|FG001|Six Months After Surgery|Lost to Follow-up|1|||
94313528|NCT01663740|322931639|FG000|Overall Study|Lost to Follow-up|1|||
94313529|NCT01663740|322931640|FG001|Overall Study|Lost to Follow-up|4|||
94313530|NCT01663740|322931639|FG000|Overall Study|Other|9|||
94313531|NCT01663740|322931640|FG001|Overall Study|Other|2|||
94313532|NCT01663740|322931639|FG000|Overall Study|Inclusion/Exclusion not met|1|||
94313533|NCT01663740|322931640|FG001|Overall Study|Inclusion/Exclusion not met|0|||
94313534|NCT01663740|322931639|FG000|Overall Study|Death|0|||
94313535|NCT01663740|322931640|FG001|Overall Study|Death|1|||
94313536|NCT01663740|322931639|FG000|Overall Study|Withdrawal by Subject|2|||
94313537|NCT01663740|322931640|FG001|Overall Study|Withdrawal by Subject|1|||
94313538|NCT01663740|322931639|FG000|Overall Study|No end of study status|3|||
94313539|NCT01663740|322931640|FG001|Overall Study|No end of study status|0|||
94313540|NCT00370149|322931641|FG000|Overall Study|Physician Decision|16|||
94313541|NCT00370149|322931642|FG001|Overall Study|Physician Decision|16|||
94313542|NCT00370149|322931641|FG000|Overall Study|Protocol Violation|1|||
94313543|NCT00370149|322931642|FG001|Overall Study|Protocol Violation|0|||
94313544|NCT00370149|322931641|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
94313545|NCT00370149|322931642|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
94313546|NCT00370149|322931641|FG000|Overall Study|Pre-existing infection|0|||
94313547|NCT00370149|322931642|FG001|Overall Study|Pre-existing infection|1|||
94313548|NCT00370149|322931641|FG000|Overall Study|Antibiotic coated dressing placed|0|||
94313549|NCT00370149|322931642|FG001|Overall Study|Antibiotic coated dressing placed|1|||
94313550|NCT00620321|322932713|FG000|Overall Study|Adverse Event|1|||
94313551|NCT00620321|322932714|FG001|Overall Study|Adverse Event|1|||
94313552|NCT00620321|322932713|FG000|Overall Study|Death|1|||
94313553|NCT00620321|322932714|FG001|Overall Study|Death|1|||
94313554|NCT00620321|322932713|FG000|Overall Study|Physician Decision|0|||
94313555|NCT00620321|322932714|FG001|Overall Study|Physician Decision|7|||
94313556|NCT00620321|322932713|FG000|Overall Study|Progressive Disease|5|||
94313557|NCT00620321|322932714|FG001|Overall Study|Progressive Disease|5|||
94313558|NCT00620321|322932713|FG000|Overall Study|Sponsor Decision|0|||
94313559|NCT00620321|322932714|FG001|Overall Study|Sponsor Decision|1|||
94313560|NCT00620321|322932713|FG000|Overall Study|Withdrawal by Subject|1|||
94313561|NCT00620321|322932714|FG001|Overall Study|Withdrawal by Subject|1|||
94313562|NCT02410902|322932715|FG000|Overall Study|Adverse Event|2|||
94313563|NCT02410902|322932716|FG001|Overall Study|Adverse Event|3|||
94313564|NCT02410902|322932715|FG000|Overall Study|Lost to Follow-up|4|||
94313565|NCT02410902|322932716|FG001|Overall Study|Lost to Follow-up|1|||
94313566|NCT02410902|322932715|FG000|Overall Study|Protocol Violation|1|||
94384093|NCT04700449|323193104|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
94384094|NCT04700449|323193101|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
94384095|NCT04700449|323193102|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
94384096|NCT04700449|323193103|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
94384097|NCT04700449|323193104|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
94384098|NCT04700449|323193101|FG000|Stage 1: Double-Blind Period|Other|0|||
94384099|NCT04700449|323193102|FG001|Stage 1: Double-Blind Period|Other|0|||
94384100|NCT04700449|323193103|FG002|Stage 1: Double-Blind Period|Other|1|||
94384101|NCT04700449|323193104|FG003|Stage 1: Double-Blind Period|Other|0|||
94384102|NCT04700449|323193101|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
94384103|NCT04700449|323193102|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
94384104|NCT04700449|323193103|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
94384105|NCT04700449|323193104|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
94384106|NCT04700449|323193101|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
94384107|NCT04700449|323193102|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
94313567|NCT02410902|322932716|FG001|Overall Study|Protocol Violation|4|||
94384108|NCT04700449|323193103|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
94384109|NCT04700449|323193104|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
94384110|NCT04700449|323193101|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
94384111|NCT04700449|323193102|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
94313568|NCT02410902|322932715|FG000|Overall Study|Withdrawal by Subject|6|||
94313569|NCT02410902|322932716|FG001|Overall Study|Withdrawal by Subject|8|||
94384112|NCT04700449|323193103|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
94384113|NCT04700449|323193104|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
94384114|NCT04700449|323193101|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
94384115|NCT04700449|323193102|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
94384116|NCT04700449|323193103|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
94384117|NCT04700449|323193104|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
94384118|NCT04700449|323193101|FG000|Stage 2 Sub-study 1|Other|1|||
94384119|NCT04700449|323193102|FG001|Stage 2 Sub-study 1|Other|2|||
94384120|NCT04700449|323193103|FG002|Stage 2 Sub-study 1|Other|0|||
94384121|NCT04700449|323193104|FG003|Stage 2 Sub-study 1|Other|0|||
94384122|NCT04700449|323193101|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
94384123|NCT04700449|323193102|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
94384124|NCT04700449|323193103|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
94384125|NCT04700449|323193104|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
94384126|NCT04700449|323193101|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
94384127|NCT04700449|323193102|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
94384128|NCT04700449|323193103|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
94384129|NCT04700449|323193104|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
94384130|NCT04700449|323193101|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
94384131|NCT04700449|323193102|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
94384132|NCT04700449|323193103|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
94384133|NCT04700449|323193104|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
94384134|NCT04700449|323193101|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
94384135|NCT04700449|323193102|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
94384136|NCT04700449|323193103|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
94384137|NCT04700449|323193104|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
94384138|NCT04700449|323193101|FG000|Stage 2 Sub-study 2|Other|0|||
94384139|NCT04700449|323193102|FG001|Stage 2 Sub-study 2|Other|0|||
94384140|NCT04700449|323193103|FG002|Stage 2 Sub-study 2|Other|0|||
94384141|NCT04700449|323193104|FG003|Stage 2 Sub-study 2|Other|5|||
94384142|NCT01521559|323193105|FG000|Overall Study|Adverse Event|0|||
94384143|NCT01521559|323193106|FG001|Overall Study|Adverse Event|4|||
94384144|NCT01521559|323193105|FG000|Overall Study|Death|1|||
94384145|NCT01521559|323193106|FG001|Overall Study|Death|0|||
94384146|NCT01521559|323193105|FG000|Overall Study|Withdrawal by Subject|9|||
94384147|NCT01521559|323193106|FG001|Overall Study|Withdrawal by Subject|11|||
94384148|NCT01521559|323193105|FG000|Overall Study|Lost to Follow-up|3|||
94384149|NCT01521559|323193106|FG001|Overall Study|Lost to Follow-up|1|||
94384150|NCT01521559|323193105|FG000|Overall Study|Protocol Violation|1|||
94384151|NCT01521559|323193106|FG001|Overall Study|Protocol Violation|0|||
94384152|NCT01521559|323193105|FG000|Overall Study|Other|1|||
94384153|NCT01521559|323193106|FG001|Overall Study|Other|2|||
94475781|NCT05259917|323533493|FG004|Overall Study|Other|0|||
94475782|NCT05259917|323533494|FG005|Overall Study|Other|0|||
94475783|NCT00685360|323533497|FG000|Overall Study|Lost to Follow-up|0|||
94475784|NCT00685360|323533498|FG001|Overall Study|Lost to Follow-up|1|||
94475785|NCT00685360|323533499|FG002|Overall Study|Lost to Follow-up|2|||
94475786|NCT00685360|323533497|FG000|Overall Study|Adverse Event|4|||
94475787|NCT00685360|323533498|FG001|Overall Study|Adverse Event|6|||
94475788|NCT00685360|323533499|FG002|Overall Study|Adverse Event|4|||
94475789|NCT00685360|323533497|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
94313570|NCT02410902|322932715|FG000|Overall Study|Non-Compliance|8|||
94313571|NCT02410902|322932716|FG001|Overall Study|Non-Compliance|2|||
94313572|NCT02125331|322932717|FG000|Overall Study|Protocol Violation|1|||
94313573|NCT02125331|322932718|FG001|Overall Study|Protocol Violation|0|||
94313574|NCT02125331|322932717|FG000|Overall Study|technical problem|2|||
94313575|NCT02125331|322932718|FG001|Overall Study|technical problem|0|||
94313576|NCT02125331|322932717|FG000|Overall Study|screen failure|2|||
94313577|NCT02125331|322932718|FG001|Overall Study|screen failure|0|||
94313578|NCT00165646|322932719|FG000|Overall Study|Adverse Event|1|||
94313579|NCT00165646|322932720|FG001|Overall Study|Adverse Event|1|||
94313580|NCT00165646|322932721|FG002|Overall Study|Adverse Event|1|||
94313581|NCT00165646|322932719|FG000|Overall Study|Lack of Efficacy|1|||
94313582|NCT00165646|322932720|FG001|Overall Study|Lack of Efficacy|2|||
94313583|NCT00165646|322932721|FG002|Overall Study|Lack of Efficacy|0|||
94313584|NCT00165646|322932719|FG000|Overall Study|Withdrawal by Subject|0|||
94313585|NCT00165646|322932720|FG001|Overall Study|Withdrawal by Subject|2|||
94313586|NCT00165646|322932721|FG002|Overall Study|Withdrawal by Subject|1|||
94313587|NCT00165646|322932719|FG000|Overall Study|Physician Decision|2|||
94313588|NCT00165646|322932720|FG001|Overall Study|Physician Decision|0|||
94475790|NCT00685360|323533498|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
94475791|NCT00685360|323533499|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
94475792|NCT00685360|323533497|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
94475793|NCT00685360|323533498|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
94475794|NCT00685360|323533499|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
94475795|NCT00685360|323533497|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
94313589|NCT00165646|322932721|FG002|Overall Study|Physician Decision|2|||
94384154|NCT00275002|323193108|FG000|Overall Study|Death|1|||
94475796|NCT00685360|323533498|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
94475797|NCT00685360|323533499|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
94475798|NCT00685360|323533497|FG000|Overall Study|Protocol Deviation|0|||
94475799|NCT00685360|323533498|FG001|Overall Study|Protocol Deviation|1|||
94475800|NCT00685360|323533499|FG002|Overall Study|Protocol Deviation|1|||
94475801|NCT00547157|323533502|FG000|Overall Study|Other|1|||
94475802|NCT00547157|323533503|FG001|Overall Study|Other|0|||
94475803|NCT00547157|323533502|FG000|Overall Study|Death|38|||
94475804|NCT00547157|323533503|FG001|Overall Study|Death|18|||
94475805|NCT00547157|323533502|FG000|Overall Study|Withdrawal by Subject|3|||
94475806|NCT00547157|323533503|FG001|Overall Study|Withdrawal by Subject|1|||
94475807|NCT00547157|323533502|FG000|Overall Study|Administrative decision|3|||
94475808|NCT00547157|323533503|FG001|Overall Study|Administrative decision|2|||
94475809|NCT00547157|323533502|FG000|Overall Study|Lost to Follow-up|4|||
94475810|NCT00547157|323533503|FG001|Overall Study|Lost to Follow-up|2|||
94475811|NCT01151345|323533504|FG000|First Intervention Period|Protocol Violation|0|||
94475812|NCT01151345|323533505|FG001|First Intervention Period|Protocol Violation|1|||
94475813|NCT04208412|323533506|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
94475814|NCT04208412|323533507|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
94475815|NCT04208412|323533506|FG000|Overall Study|Withdrawal by Subject|1|||
94475816|NCT04208412|323533507|FG001|Overall Study|Withdrawal by Subject|0|||
94475817|NCT04208412|323533506|FG000|Overall Study|Lost to Follow-up|0|||
94475818|NCT04208412|323533507|FG001|Overall Study|Lost to Follow-up|1|||
94475819|NCT01030718|323533509|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
94475820|NCT01030718|323533510|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
94475821|NCT01030718|323533511|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
94475822|NCT01030718|323533509|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
94475823|NCT01030718|323533510|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
94475824|NCT01030718|323533511|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
94475825|NCT01030718|323533509|FG000|Studies CA180-031 and -036 Combined|Death|0|||
94475826|NCT01030718|323533510|FG001|Studies CA180-031 and -036 Combined|Death|1|||
94475827|NCT01030718|323533511|FG002|Studies CA180-031 and -036 Combined|Death|0|||
94475828|NCT01030718|323533509|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
94475829|NCT01030718|323533510|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
94475830|NCT01030718|323533511|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
94475831|NCT01030718|323533509|FG000|Study CA180-036 Only|insufficient effect|1|||
94313590|NCT00165646|322932719|FG000|Overall Study|Protocol Violation|1|||
94313591|NCT00165646|322932720|FG001|Overall Study|Protocol Violation|0|||
94475832|NCT01030718|323533510|FG001|Study CA180-036 Only|insufficient effect|1|||
94475833|NCT01030718|323533511|FG002|Study CA180-036 Only|insufficient effect|5|||
94475834|NCT01030718|323533509|FG000|Study CA180-036 Only|Adverse Event|2|||
94475835|NCT01030718|323533510|FG001|Study CA180-036 Only|Adverse Event|3|||
94475836|NCT01030718|323533511|FG002|Study CA180-036 Only|Adverse Event|0|||
94475837|NCT01030718|323533509|FG000|Study CA180-036 Only|Death|0|||
94475838|NCT01030718|323533510|FG001|Study CA180-036 Only|Death|1|||
94475839|NCT01030718|323533511|FG002|Study CA180-036 Only|Death|0|||
94475840|NCT01030718|323533509|FG000|Study CA180-036 Only|Other Reasons|0|||
94475841|NCT01030718|323533510|FG001|Study CA180-036 Only|Other Reasons|2|||
94475842|NCT01030718|323533511|FG002|Study CA180-036 Only|Other Reasons|0|||
94475843|NCT03131687|323533512|FG000|Overall Study|Adverse Event|0|||
94475844|NCT03131687|323533513|FG001|Overall Study|Adverse Event|1|||
94475845|NCT03131687|323533514|FG002|Overall Study|Adverse Event|0|||
94475846|NCT03131687|323533515|FG003|Overall Study|Adverse Event|1|||
94475847|NCT03131687|323533516|FG004|Overall Study|Adverse Event|2|||
94475848|NCT03131687|323533517|FG005|Overall Study|Adverse Event|2|||
94475849|NCT03131687|323533512|FG000|Overall Study|Death|1|||
94475850|NCT03131687|323533513|FG001|Overall Study|Death|0|||
94475851|NCT03131687|323533514|FG002|Overall Study|Death|0|||
94475852|NCT03131687|323533515|FG003|Overall Study|Death|0|||
94475853|NCT03131687|323533516|FG004|Overall Study|Death|0|||
94475854|NCT03131687|323533517|FG005|Overall Study|Death|0|||
94475855|NCT03131687|323533512|FG000|Overall Study|Withdrawal by Subject|3|||
94475856|NCT03131687|323533513|FG001|Overall Study|Withdrawal by Subject|3|||
94475857|NCT03131687|323533514|FG002|Overall Study|Withdrawal by Subject|3|||
94313592|NCT00165646|322932721|FG002|Overall Study|Protocol Violation|0|||
94475858|NCT03131687|323533515|FG003|Overall Study|Withdrawal by Subject|1|||
94475859|NCT03131687|323533516|FG004|Overall Study|Withdrawal by Subject|2|||
94475860|NCT03131687|323533517|FG005|Overall Study|Withdrawal by Subject|1|||
94475861|NCT03131687|323533512|FG000|Overall Study|Lost to Follow-up|1|||
94475862|NCT03131687|323533513|FG001|Overall Study|Lost to Follow-up|4|||
94475863|NCT03131687|323533514|FG002|Overall Study|Lost to Follow-up|0|||
94475864|NCT03131687|323533515|FG003|Overall Study|Lost to Follow-up|1|||
94475865|NCT03131687|323533516|FG004|Overall Study|Lost to Follow-up|4|||
94475866|NCT03131687|323533517|FG005|Overall Study|Lost to Follow-up|2|||
94475867|NCT03131687|323533512|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
94313593|NCT03009539|322932722|FG000|Overall Study|Lost to Follow-up|132|||
94313594|NCT03009539|322932723|FG001|Overall Study|Lost to Follow-up|113|||
94313595|NCT03009539|322932724|FG002|Overall Study|Lost to Follow-up|132|||
94313596|NCT03009539|322932725|FG003|Overall Study|Lost to Follow-up|113|||
94313597|NCT01228071|322932726|FG000|Overall Study|Protocol Violation|1|||
94313598|NCT01228071|322932726|FG000|Overall Study|Withdrawal by Subject|1|||
94313599|NCT02232516|322932730|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
94313600|NCT02232516|322932730|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
94313601|NCT02232516|322932730|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
94313602|NCT02232516|322932730|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
94313603|NCT02232516|322932730|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
94313604|NCT02232516|322932730|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
94313605|NCT02232516|322932730|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
94313606|NCT02232516|322932730|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
94313607|NCT02232516|322932730|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
94313608|NCT02232516|322932730|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
94313609|NCT02232516|322932730|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
94313610|NCT02232516|322932730|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
94313611|NCT02232516|322932730|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
94313612|NCT02232516|322932730|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
94313613|NCT02232516|322932730|FG000|Survival Follow-up|Death|15|||
94313614|NCT02232516|322932730|FG000|Survival Follow-up|Withdrawal by Subject|3|||
94313615|NCT02232516|322932730|FG000|Survival Follow-up|Lost to Follow-up|1|||
94313616|NCT02232516|322932730|FG000|Survival Follow-up|Still in follow-up|5|||
94313617|NCT01585961|322932732|FG000|Overall Study|Death|6|||
94313618|NCT01585961|322932732|FG000|Overall Study|Physician Decision|1|||
94313619|NCT01585961|322932732|FG000|Overall Study|Decision to use non-study catheter|1|||
94313620|NCT01585961|322932732|FG000|Overall Study|Withdrawal by Subject|1|||
94313621|NCT01585961|322932732|FG000|Overall Study|Lost to Follow-up|23|||
94313622|NCT01585961|322932732|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
94313623|NCT00109733|322932733|FG000|Overall Study|Protocol Violation|0|||
94313624|NCT00109733|322932734|FG001|Overall Study|Protocol Violation|1|||
94313625|NCT00109733|322932733|FG000|Overall Study|Stopped taking study drug|1|||
94313626|NCT00109733|322932734|FG001|Overall Study|Stopped taking study drug|1|||
94313627|NCT00109733|322932733|FG000|Overall Study|Non-compliant|0|||
94313628|NCT00109733|322932734|FG001|Overall Study|Non-compliant|1|||
94313629|NCT00109733|322932733|FG000|Overall Study|Could not commit time for study|1|||
94313630|NCT00109733|322932734|FG001|Overall Study|Could not commit time for study|1|||
94313631|NCT02855411|322932735|FG000|Overall Study|Study terminated by sponsor|21|||
94313632|NCT02855411|322932735|FG000|Overall Study|Does not meet entrance criteria|14|||
94313633|NCT00986258|322932736|FG000|Observation Period|Not eligible to be dosed|11|||
94313634|NCT00986258|322932736|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
94313635|NCT00986258|322932736|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
94313636|NCT00986258|322932736|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
94313637|NCT00986258|322932736|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
94313638|NCT00986258|322932736|FG000|Titration and Optimal Dose Period|Other|1|||
94313639|NCT00986258|322932736|FG000|Maintenance Period|Adverse Event|5|||
94313640|NCT00986258|322932736|FG000|Maintenance Period|Lack of Efficacy|2|||
94313641|NCT00986258|322932736|FG000|Maintenance Period|Withdrawal by Subject|2|||
94313642|NCT04964063|322932737|FG000|Overall Study|Adverse Event|4|||
94313643|NCT04964063|322932737|FG000|Overall Study|Lost to Follow-up|47|||
94313644|NCT04964063|322932737|FG000|Overall Study|Withdrawal by Subject|5|||
94313645|NCT04964063|322932737|FG000|Overall Study|Baseline Tasks Expired|41|||
94313646|NCT04964063|322932737|FG000|Overall Study|Participant withdrawn in error|1|||
94313647|NCT04230486|322932746|FG000|Overall Study|Screen Failure|1|||
94313648|NCT01740440|322932747|FG000|Overall Study|Lost to Follow-up|3|||
94313649|NCT01063751|322932749|FG000|Overall Study|Censored from analyses|42|||
94313650|NCT01063751|322932749|FG000|Overall Study|Withdrawal by Subject|34|||
94313651|NCT01063751|322932749|FG000|Overall Study|Lost to Follow-up|30|||
94313652|NCT01063751|322932749|FG000|Overall Study|Death|13|||
94313653|NCT01063751|322932749|FG000|Overall Study|Sponsored Terminated Study|60|||
94313654|NCT01063751|322932749|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
94313655|NCT01063751|322932749|FG000|Overall Study|Investigator site closed|10|||
94313656|NCT01063751|322932749|FG000|Overall Study|Revision|6|||
94313657|NCT01063751|322932749|FG000|Overall Study|Physician Decision|4|||
94313658|NCT01312428|322932759|FG000|Overall Study|Study Termination|3|||
94313659|NCT01312428|322932760|FG001|Overall Study|Study Termination|4|||
94313660|NCT03609359|322932766|FG000|Overall Study|Progression of primary disease (PD)|25|||
94313661|NCT03609359|322932766|FG000|Overall Study|Patient's refusal|1|||
94313662|NCT03609359|322932766|FG000|Overall Study|Physician Decision|1|||
94313663|NCT03609359|322932766|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
94313664|NCT00789477|322932770|FG000|Overall Study|Withdrawal by Subject|2|||
94313665|NCT00789477|322932771|FG001|Overall Study|Withdrawal by Subject|1|||
94313666|NCT00789477|322932772|FG002|Overall Study|Withdrawal by Subject|3|||
94313667|NCT00789477|322932773|FG003|Overall Study|Withdrawal by Subject|2|||
94313668|NCT00789477|322932774|FG004|Overall Study|Withdrawal by Subject|3|||
94313669|NCT00789477|322932770|FG000|Overall Study|Protocol Violation|1|||
94313670|NCT00789477|322932771|FG001|Overall Study|Protocol Violation|0|||
94475868|NCT03131687|323533513|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
94313671|NCT00789477|322932772|FG002|Overall Study|Protocol Violation|0|||
94313672|NCT00789477|322932773|FG003|Overall Study|Protocol Violation|1|||
94313673|NCT00789477|322932774|FG004|Overall Study|Protocol Violation|0|||
94313674|NCT00789477|322932770|FG000|Overall Study|Adverse Event|3|||
94313675|NCT00789477|322932771|FG001|Overall Study|Adverse Event|3|||
94313676|NCT00789477|322932772|FG002|Overall Study|Adverse Event|1|||
94313677|NCT00789477|322932773|FG003|Overall Study|Adverse Event|0|||
94313678|NCT00789477|322932774|FG004|Overall Study|Adverse Event|0|||
94313679|NCT00789477|322932770|FG000|Overall Study|Death|1|||
94313680|NCT00789477|322932771|FG001|Overall Study|Death|1|||
94313681|NCT00789477|322932772|FG002|Overall Study|Death|2|||
94313682|NCT00789477|322932773|FG003|Overall Study|Death|2|||
94313683|NCT00789477|322932774|FG004|Overall Study|Death|0|||
94313684|NCT00789477|322932770|FG000|Overall Study|Lost to Follow-up|0|||
94313685|NCT00789477|322932771|FG001|Overall Study|Lost to Follow-up|1|||
94313686|NCT00789477|322932772|FG002|Overall Study|Lost to Follow-up|4|||
94313687|NCT00789477|322932773|FG003|Overall Study|Lost to Follow-up|2|||
94313688|NCT00789477|322932774|FG004|Overall Study|Lost to Follow-up|4|||
94313689|NCT00789477|322932770|FG000|Overall Study|Lack of Efficacy|2|||
94313690|NCT00789477|322932771|FG001|Overall Study|Lack of Efficacy|0|||
94313691|NCT00789477|322932772|FG002|Overall Study|Lack of Efficacy|0|||
94313692|NCT00789477|322932773|FG003|Overall Study|Lack of Efficacy|0|||
94313693|NCT00789477|322932774|FG004|Overall Study|Lack of Efficacy|0|||
94313694|NCT00789477|322932770|FG000|Overall Study|Other|2|||
94313695|NCT00789477|322932771|FG001|Overall Study|Other|0|||
94313696|NCT00789477|322932772|FG002|Overall Study|Other|1|||
94313697|NCT00789477|322932773|FG003|Overall Study|Other|3|||
94313698|NCT00789477|322932774|FG004|Overall Study|Other|0|||
94313699|NCT04285346|322932775|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
94313700|NCT04285346|322932776|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
94313701|NCT04285346|322932775|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
94313702|NCT04285346|322932776|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
94313703|NCT04285346|322932775|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
94313704|NCT04285346|322932776|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
94313705|NCT02691247|322932779|FG000|Overall Study|Withdrawal by Subject|1|||
94313706|NCT02691247|322932780|FG001|Overall Study|Withdrawal by Subject|2|||
94313707|NCT02691247|322932781|FG002|Overall Study|Withdrawal by Subject|2|||
94313708|NCT02691247|322932779|FG000|Overall Study|Lost to Follow-up|2|||
94313709|NCT02691247|322932780|FG001|Overall Study|Lost to Follow-up|0|||
94313710|NCT02691247|322932781|FG002|Overall Study|Lost to Follow-up|1|||
94313711|NCT01844700|322932782|FG000|Overall Study|Lack of Efficacy|1|||
94313712|NCT01844700|322932783|FG001|Overall Study|Lack of Efficacy|0|||
94313713|NCT01844700|322932782|FG000|Overall Study|refused medication switch|1|||
94313714|NCT01844700|322932783|FG001|Overall Study|refused medication switch|0|||
94313715|NCT01844700|322932782|FG000|Overall Study|Withdrawal by Subject|1|||
94313716|NCT01844700|322932783|FG001|Overall Study|Withdrawal by Subject|0|||
94313717|NCT01844700|322932782|FG000|Overall Study|stopped taking meds|0|||
94313718|NCT01844700|322932783|FG001|Overall Study|stopped taking meds|1|||
94313719|NCT02552355|322932784|FG000|Overall Study|Adverse Event|0|||
94313720|NCT02552355|322932785|FG001|Overall Study|Adverse Event|2|||
94313721|NCT02552355|322932786|FG002|Overall Study|Adverse Event|2|||
94313722|NCT02552355|322932787|FG003|Overall Study|Adverse Event|0|||
94313723|NCT02552355|322932784|FG000|Overall Study|Withdrawal by Subject|0|||
94313724|NCT02552355|322932785|FG001|Overall Study|Withdrawal by Subject|0|||
94313725|NCT02552355|322932786|FG002|Overall Study|Withdrawal by Subject|0|||
94313726|NCT02552355|322932787|FG003|Overall Study|Withdrawal by Subject|1|||
94313727|NCT02224846|322932788|FG000|Period 1 (Month 3)|Adverse Event|2|||
94313728|NCT02224846|322932789|FG001|Period 1 (Month 3)|Adverse Event|1|||
94313729|NCT02224846|322932788|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
94313730|NCT02224846|322932789|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
94313731|NCT02224846|322932788|FG000|Period 1 (Month 3)|Protocol Violation|4|||
94313732|NCT02224846|322932789|FG001|Period 1 (Month 3)|Protocol Violation|8|||
94313733|NCT02224846|322932788|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
94313734|NCT02224846|322932789|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
94313735|NCT02224846|322932788|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
94313736|NCT02224846|322932789|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
94475869|NCT03131687|323533514|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
94313737|NCT02224846|322932788|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
94313738|NCT02224846|322932789|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
94313739|NCT02224846|322932788|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
94313740|NCT02224846|322932789|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
94313741|NCT02224846|322932788|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
94313742|NCT02224846|322932789|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
94475870|NCT03131687|323533515|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
94475871|NCT03131687|323533516|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
94313743|NCT02224846|322932788|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
94313744|NCT02224846|322932789|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
94313745|NCT02224846|322932788|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
94313746|NCT02224846|322932789|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
94313747|NCT02224846|322932788|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
94313748|NCT02224846|322932789|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
94313749|NCT02224846|322932788|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
94313750|NCT02224846|322932789|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
94313751|NCT02224846|322932788|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
94313752|NCT02224846|322932789|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
94313753|NCT02224846|322932788|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
94313754|NCT02224846|322932789|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
94313755|NCT02224846|322932788|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
94313756|NCT02224846|322932789|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
94313757|NCT02224846|322932788|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
94313758|NCT02224846|322932789|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
94313759|NCT02224846|322932788|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
94313760|NCT02224846|322932789|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
94313761|NCT01635933|322932792|FG000|Overall Study|Adverse Event|1|||
94313762|NCT01635933|322932793|FG001|Overall Study|Adverse Event|0|||
94313763|NCT01635933|322932792|FG000|Overall Study|Lost to Follow-up|0|||
94313764|NCT01635933|322932793|FG001|Overall Study|Lost to Follow-up|5|||
94313765|NCT01635933|322932792|FG000|Overall Study|Subject decision|1|||
94313766|NCT01635933|322932793|FG001|Overall Study|Subject decision|1|||
94313767|NCT01635933|322932792|FG000|Overall Study|Noncompliance|0|||
94313768|NCT01635933|322932793|FG001|Overall Study|Noncompliance|1|||
94313769|NCT01635933|322932792|FG000|Overall Study|No longer had transportation|0|||
94313770|NCT01635933|322932793|FG001|Overall Study|No longer had transportation|1|||
94313771|NCT01555463|322932796|FG000|Treatment|Adverse Event|6|||
94313772|NCT01555463|322932797|FG001|Treatment|Adverse Event|12|||
94313773|NCT01555463|322932796|FG000|Treatment|Withdrawal by Subject|24|||
94313774|NCT01555463|322932797|FG001|Treatment|Withdrawal by Subject|36|||
94313775|NCT01555463|322932796|FG000|Treatment|Lost to Follow-up|28|||
94313776|NCT01555463|322932797|FG001|Treatment|Lost to Follow-up|23|||
94313777|NCT01555463|322932796|FG000|Treatment|Protocol Violation|4|||
94313778|NCT01555463|322932797|FG001|Treatment|Protocol Violation|5|||
94313779|NCT01555463|322932796|FG000|Treatment|Other reason|2|||
94313780|NCT01555463|322932797|FG001|Treatment|Other reason|3|||
94313781|NCT01555463|322932796|FG000|Follow up|Adverse Event|2|||
94313782|NCT01555463|322932797|FG001|Follow up|Adverse Event|5|||
94313783|NCT01555463|322932796|FG000|Follow up|Death|0|||
94313784|NCT01555463|322932797|FG001|Follow up|Death|1|||
94313785|NCT01555463|322932796|FG000|Follow up|Withdrawal by Subject|22|||
94313786|NCT01555463|322932797|FG001|Follow up|Withdrawal by Subject|22|||
94313787|NCT01555463|322932796|FG000|Follow up|Lost to Follow-up|9|||
94313788|NCT01555463|322932797|FG001|Follow up|Lost to Follow-up|10|||
94313789|NCT01555463|322932796|FG000|Follow up|Protocol Violation|2|||
94313790|NCT01555463|322932797|FG001|Follow up|Protocol Violation|4|||
94313791|NCT01555463|322932796|FG000|Follow up|Other reason|3|||
94313792|NCT01555463|322932797|FG001|Follow up|Other reason|3|||
94313793|NCT04333433|322932798|FG000|Overall Study|Withdrawal by Subject|6|||
94313794|NCT04333433|322932799|FG001|Overall Study|Withdrawal by Subject|3|||
94313795|NCT04333433|322932798|FG000|Overall Study|Death|3|||
94313796|NCT04333433|322932799|FG001|Overall Study|Death|0|||
94313797|NCT04333433|322932798|FG000|Overall Study|Lost to Follow-up|6|||
94313798|NCT04333433|322932799|FG001|Overall Study|Lost to Follow-up|1|||
94313799|NCT04333433|322932798|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
94313800|NCT04333433|322932799|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
94313801|NCT01963117|322932800|FG000|Overall Study|Death|1|||
94313802|NCT01605396|322932801|FG000|Overall Study|Adverse Event|5|||
94313803|NCT01605396|322932802|FG001|Overall Study|Adverse Event|3|||
94313804|NCT01605396|322932801|FG000|Overall Study|Lost to Follow-up|1|||
94313805|NCT01605396|322932802|FG001|Overall Study|Lost to Follow-up|0|||
94313806|NCT01605396|322932801|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94313807|NCT01605396|322932802|FG001|Overall Study|Non-Compliance With Study Drug|1|||
94313808|NCT01605396|322932801|FG000|Overall Study|Physician Decision|2|||
94313809|NCT01605396|322932802|FG001|Overall Study|Physician Decision|2|||
94313810|NCT01605396|322932801|FG000|Overall Study|Progressive Disease|23|||
94313811|NCT01605396|322932802|FG001|Overall Study|Progressive Disease|27|||
94313812|NCT01605396|322932801|FG000|Overall Study|Withdrawal by Subject|4|||
94313813|NCT01605396|322932802|FG001|Overall Study|Withdrawal by Subject|2|||
94475872|NCT03131687|323533517|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
94475873|NCT03131687|323533512|FG000|Overall Study|Principle Investigator Decision|0|||
94475874|NCT03131687|323533513|FG001|Overall Study|Principle Investigator Decision|1|||
94475875|NCT03131687|323533514|FG002|Overall Study|Principle Investigator Decision|0|||
94475876|NCT03131687|323533515|FG003|Overall Study|Principle Investigator Decision|0|||
94475877|NCT03131687|323533516|FG004|Overall Study|Principle Investigator Decision|0|||
94475878|NCT03131687|323533517|FG005|Overall Study|Principle Investigator Decision|0|||
94475879|NCT03131687|323533512|FG000|Overall Study|Inadvertent Enrollment|0|||
94475880|NCT03131687|323533513|FG001|Overall Study|Inadvertent Enrollment|0|||
94475881|NCT03131687|323533514|FG002|Overall Study|Inadvertent Enrollment|0|||
94475882|NCT03131687|323533515|FG003|Overall Study|Inadvertent Enrollment|1|||
94475883|NCT03131687|323533516|FG004|Overall Study|Inadvertent Enrollment|0|||
94475884|NCT03131687|323533517|FG005|Overall Study|Inadvertent Enrollment|0|||
94475885|NCT01189461|323533538|FG000|Overall Study|Lack of Efficacy|13|||
94475886|NCT01189461|323533538|FG000|Overall Study|Lost to Follow-up|1|||
94475887|NCT01189461|323533538|FG000|Overall Study|Withdrawal by Subject|6|||
94475888|NCT01189461|323533538|FG000|Overall Study|Protocol Violation|1|||
94475889|NCT01189461|323533538|FG000|Overall Study|Adverse Event|2|||
94475890|NCT01189461|323533538|FG000|Overall Study|Did not meet entrance criteria|3|||
94475891|NCT01189461|323533538|FG000|Overall Study|Other|8|||
94475892|NCT00420628|323533540|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
94475893|NCT00420628|323533541|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
94475894|NCT00420628|323533540|FG000|Overall Study|Lost to Follow-up|3|||
94475895|NCT00420628|323533541|FG001|Overall Study|Lost to Follow-up|2|||
94475896|NCT00420628|323533540|FG000|Overall Study|Adverse Event|1|||
94475897|NCT00420628|323533541|FG001|Overall Study|Adverse Event|0|||
94475898|NCT05279131|323533542|FG000|Overall Study|Lost to Follow-up|1|||
94475899|NCT05279131|323533542|FG000|Overall Study|Death|1|||
94475900|NCT05279131|323533542|FG000|Overall Study|Physician Decision|1|||
94475901|NCT03092791|323533547|FG000|Overall Study|Lost to Follow-up|0|||
94475902|NCT03092791|323533548|FG001|Overall Study|Lost to Follow-up|0|||
94475903|NCT03092791|323533549|FG002|Overall Study|Lost to Follow-up|0|||
94475904|NCT03092791|323533550|FG003|Overall Study|Lost to Follow-up|0|||
94475905|NCT03092791|323533551|FG004|Overall Study|Lost to Follow-up|0|||
94475906|NCT03092791|323533552|FG005|Overall Study|Lost to Follow-up|0|||
94475907|NCT03092791|323533553|FG006|Overall Study|Lost to Follow-up|1|||
94475908|NCT03092791|323533554|FG007|Overall Study|Lost to Follow-up|0|||
94475909|NCT03092791|323533547|FG000|Overall Study|Withdrawal of Consent|0|||
94475910|NCT03092791|323533548|FG001|Overall Study|Withdrawal of Consent|0|||
94475911|NCT03092791|323533549|FG002|Overall Study|Withdrawal of Consent|0|||
94475912|NCT03092791|323533550|FG003|Overall Study|Withdrawal of Consent|0|||
94475913|NCT03092791|323533551|FG004|Overall Study|Withdrawal of Consent|4|||
94475914|NCT03092791|323533552|FG005|Overall Study|Withdrawal of Consent|12|||
94475915|NCT03092791|323533553|FG006|Overall Study|Withdrawal of Consent|6|||
94475916|NCT03092791|323533554|FG007|Overall Study|Withdrawal of Consent|4|||
94475917|NCT03092791|323533547|FG000|Overall Study|Study Termination|0|||
94475918|NCT03092791|323533548|FG001|Overall Study|Study Termination|0|||
94475919|NCT03092791|323533549|FG002|Overall Study|Study Termination|0|||
94475920|NCT03092791|323533550|FG003|Overall Study|Study Termination|0|||
94475921|NCT03092791|323533551|FG004|Overall Study|Study Termination|55|||
94475922|NCT03092791|323533552|FG005|Overall Study|Study Termination|46|||
94475923|NCT03092791|323533553|FG006|Overall Study|Study Termination|53|||
94475924|NCT03092791|323533554|FG007|Overall Study|Study Termination|55|||
94475925|NCT03092791|323533547|FG000|Overall Study|Death|0|||
94475926|NCT03092791|323533548|FG001|Overall Study|Death|0|||
94475927|NCT03092791|323533549|FG002|Overall Study|Death|0|||
94475928|NCT03092791|323533550|FG003|Overall Study|Death|0|||
94475929|NCT03092791|323533551|FG004|Overall Study|Death|0|||
94475930|NCT03092791|323533552|FG005|Overall Study|Death|1|||
94475931|NCT03092791|323533553|FG006|Overall Study|Death|0|||
94475932|NCT03092791|323533554|FG007|Overall Study|Death|1|||
94475933|NCT03092791|323533547|FG000|Overall Study|Reason Not Specified|0|||
94313814|NCT01605396|322932801|FG000|Overall Study|Transfer Off Study|4|||
94475934|NCT03092791|323533548|FG001|Overall Study|Reason Not Specified|0|||
94475935|NCT03092791|323533549|FG002|Overall Study|Reason Not Specified|0|||
94475936|NCT03092791|323533550|FG003|Overall Study|Reason Not Specified|0|||
94475937|NCT03092791|323533551|FG004|Overall Study|Reason Not Specified|1|||
94475938|NCT03092791|323533552|FG005|Overall Study|Reason Not Specified|1|||
94475939|NCT03092791|323533553|FG006|Overall Study|Reason Not Specified|0|||
94475940|NCT03092791|323533554|FG007|Overall Study|Reason Not Specified|0|||
94475941|NCT03300180|323533555|FG000|Baseline|Withdrawal by Subject|4|||
94475942|NCT03300180|323533556|FG001|Baseline|Withdrawal by Subject|6|||
94475943|NCT03300180|323533557|FG002|Baseline|Withdrawal by Subject|4|||
94475944|NCT03300180|323533555|FG000|6 Month Outcome|Withdrawal by Subject|12|||
94475945|NCT03300180|323533556|FG001|6 Month Outcome|Withdrawal by Subject|12|||
94475946|NCT03300180|323533557|FG002|6 Month Outcome|Withdrawal by Subject|19|||
94475947|NCT03300180|323533555|FG000|6 Month Outcome|Death|2|||
94475948|NCT03300180|323533556|FG001|6 Month Outcome|Death|4|||
94313815|NCT01605396|322932802|FG001|Overall Study|Transfer Off Study|5|||
94313816|NCT01323673|322932803|FG000|Overall Study|Adverse Event|0|||
94313817|NCT01323673|322932804|FG001|Overall Study|Adverse Event|1|||
94313818|NCT01323673|322932803|FG000|Overall Study|Lost to Follow-up|0|||
94313819|NCT01323673|322932804|FG001|Overall Study|Lost to Follow-up|1|||
94313820|NCT01323673|322932803|FG000|Overall Study|Protocol Violation|1|||
94313821|NCT01323673|322932804|FG001|Overall Study|Protocol Violation|0|||
94313822|NCT01323673|322932803|FG000|Overall Study|Withdrawal by Subject|2|||
94313823|NCT01323673|322932804|FG001|Overall Study|Withdrawal by Subject|3|||
94313824|NCT00001262|322932805|FG000|Overall Study|Death|10|||
94313825|NCT00001262|322932806|FG001|Overall Study|Death|11|||
94313826|NCT00001262|322932807|FG002|Overall Study|Death|0|||
94313827|NCT00001262|322932805|FG000|Overall Study|Withdrawal by Subject|0|||
94313828|NCT00001262|322932806|FG001|Overall Study|Withdrawal by Subject|3|||
94313829|NCT00001262|322932807|FG002|Overall Study|Withdrawal by Subject|0|||
94384155|NCT00275002|323193109|FG001|Overall Study|Death|0|||
94384156|NCT00275002|323193108|FG000|Overall Study|Disease progression|21|||
94384157|NCT00275002|323193109|FG001|Overall Study|Disease progression|15|||
94384158|NCT00275002|323193108|FG000|Overall Study|Adverse Event|0|||
94384159|NCT00275002|323193109|FG001|Overall Study|Adverse Event|1|||
94384160|NCT00287118|323193110|FG000|Overall Study|Adverse Event|30|||
94384161|NCT00287118|323193110|FG000|Overall Study|Death|1|||
94384162|NCT00287118|323193110|FG000|Overall Study|Lack of Efficacy|11|||
94384163|NCT00287118|323193110|FG000|Overall Study|Lost to Follow-up|1|||
94384164|NCT00287118|323193110|FG000|Overall Study|Protocol Violation|2|||
94384165|NCT00287118|323193110|FG000|Overall Study|Other|7|||
94384166|NCT00376220|323193111|FG000|Overall Study|Lost to Follow-up|7|||
94384167|NCT00376220|323193112|FG001|Overall Study|Lost to Follow-up|10|||
94384168|NCT00376220|323193111|FG000|Overall Study|Withdrawal by Subject|3|||
94384169|NCT00376220|323193112|FG001|Overall Study|Withdrawal by Subject|2|||
94384170|NCT00531206|323193115|FG000|Overall Study|Adverse Event related|5|||
94384171|NCT00531206|323193115|FG000|Overall Study|Lack of Efficacy|2|||
94384172|NCT00531206|323193115|FG000|Overall Study|Lost to Follow-up|5|||
94384173|NCT00531206|323193115|FG000|Overall Study|including non-related adverse events|8|||
94384174|NCT00920140|323193117|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
94384175|NCT00920140|323193118|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
94384176|NCT00920140|323193119|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
94384177|NCT00920140|323193120|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
94384178|NCT00920140|323193121|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
94384179|NCT00920140|323193117|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
94384180|NCT00920140|323193118|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
94384181|NCT00920140|323193119|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
94384182|NCT00920140|323193120|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
94384183|NCT00920140|323193121|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
94384184|NCT00920140|323193117|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94384185|NCT00920140|323193118|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
94384186|NCT00920140|323193119|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94384187|NCT00920140|323193120|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94384188|NCT00920140|323193121|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
94384189|NCT00920140|323193117|FG000|Phase 2|Adverse Event|0|||
94384190|NCT00920140|323193118|FG001|Phase 2|Adverse Event|0|||
94384191|NCT00920140|323193119|FG002|Phase 2|Adverse Event|14|||
94384192|NCT00920140|323193120|FG003|Phase 2|Adverse Event|2|||
94384193|NCT00920140|323193121|FG004|Phase 2|Adverse Event|3|||
94384194|NCT00920140|323193117|FG000|Phase 2|Lack of Efficacy|0|||
94384195|NCT00920140|323193118|FG001|Phase 2|Lack of Efficacy|0|||
94384196|NCT00920140|323193119|FG002|Phase 2|Lack of Efficacy|29|||
94384197|NCT00920140|323193120|FG003|Phase 2|Lack of Efficacy|14|||
94384198|NCT00920140|323193121|FG004|Phase 2|Lack of Efficacy|5|||
94384199|NCT00920140|323193117|FG000|Phase 2|Lost to Follow-up|0|||
94384200|NCT00920140|323193118|FG001|Phase 2|Lost to Follow-up|0|||
94384201|NCT00920140|323193119|FG002|Phase 2|Lost to Follow-up|0|||
94384202|NCT00920140|323193120|FG003|Phase 2|Lost to Follow-up|1|||
94384203|NCT00920140|323193121|FG004|Phase 2|Lost to Follow-up|0|||
94384204|NCT00920140|323193117|FG000|Phase 2|Physician Decision|0|||
94384205|NCT00920140|323193118|FG001|Phase 2|Physician Decision|0|||
94384206|NCT00920140|323193119|FG002|Phase 2|Physician Decision|3|||
94313830|NCT02566525|322932808|FG000|Overall Study|Protocol Violation|3|||
94384207|NCT00920140|323193120|FG003|Phase 2|Physician Decision|3|||
94384208|NCT00920140|323193121|FG004|Phase 2|Physician Decision|2|||
94384209|NCT00920140|323193117|FG000|Phase 2|Withdrawal by Subject|0|||
94384210|NCT00920140|323193118|FG001|Phase 2|Withdrawal by Subject|0|||
94384211|NCT00920140|323193119|FG002|Phase 2|Withdrawal by Subject|4|||
94384212|NCT00920140|323193120|FG003|Phase 2|Withdrawal by Subject|2|||
94384213|NCT00920140|323193121|FG004|Phase 2|Withdrawal by Subject|1|||
94384214|NCT00818883|323193122|FG000|Overall Study|Adverse Event|28|||
94313831|NCT02566525|322932809|FG001|Overall Study|Protocol Violation|5|||
94384215|NCT00818883|323193123|FG001|Overall Study|Adverse Event|19|||
94384216|NCT00818883|323193122|FG000|Overall Study|Protocol Violation|2|||
94384217|NCT00818883|323193123|FG001|Overall Study|Protocol Violation|2|||
94313832|NCT01721408|322932810|FG000|Overall Study|Adverse Event|6|||
94313833|NCT01721408|322932811|FG001|Overall Study|Adverse Event|1|||
94313834|NCT01721408|322932810|FG000|Overall Study|Death|1|||
94313835|NCT01721408|322932811|FG001|Overall Study|Death|0|||
94313836|NCT01721408|322932810|FG000|Overall Study|Insufficient clinical response|15|||
94313837|NCT01721408|322932811|FG001|Overall Study|Insufficient clinical response|6|||
94313838|NCT01721408|322932810|FG000|Overall Study|No longer willing to participate study|9|||
94313839|NCT01721408|322932811|FG001|Overall Study|No longer willing to participate study|10|||
94313840|NCT01721408|322932810|FG000|Overall Study|Protocol Violation|0|||
94313841|NCT01721408|322932811|FG001|Overall Study|Protocol Violation|2|||
94313842|NCT01721408|322932810|FG000|Overall Study|Other|3|||
94313843|NCT01721408|322932811|FG001|Overall Study|Other|3|||
94313844|NCT01721408|322932810|FG000|Overall Study|Lost to Follow-up|1|||
94313845|NCT01721408|322932811|FG001|Overall Study|Lost to Follow-up|2|||
94313846|NCT01721408|322932810|FG000|Overall Study|Does not meet entrance criteria|1|||
94313847|NCT01721408|322932811|FG001|Overall Study|Does not meet entrance criteria|0|||
94313848|NCT04594239|322932815|FG000|Overall Study|Withdrawal by Subject|3|||
94313849|NCT04594239|322932816|FG001|Overall Study|Withdrawal by Subject|4|||
94313850|NCT04594239|322932817|FG002|Overall Study|Withdrawal by Subject|2|||
94313851|NCT04594239|322932818|FG003|Overall Study|Withdrawal by Subject|4|||
94313852|NCT04594239|322932815|FG000|Overall Study|Lost to Follow-up|8|||
94313853|NCT04594239|322932816|FG001|Overall Study|Lost to Follow-up|5|||
94313854|NCT04594239|322932817|FG002|Overall Study|Lost to Follow-up|4|||
94313855|NCT04594239|322932818|FG003|Overall Study|Lost to Follow-up|6|||
94313856|NCT04594239|322932815|FG000|Overall Study|Subject relocated|0|||
94313857|NCT04594239|322932816|FG001|Overall Study|Subject relocated|0|||
94313858|NCT04594239|322932817|FG002|Overall Study|Subject relocated|0|||
94313859|NCT04594239|322932818|FG003|Overall Study|Subject relocated|1|||
94313860|NCT05128162|322932820|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
94313861|NCT05128162|322932820|FG000|Overall Study|Physician Decision|1|||
94313862|NCT00719732|322932821|FG000|Overall Study|Lost to Follow-up|20|||
94313863|NCT00719732|322932821|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
94313864|NCT00719732|322932821|FG000|Overall Study|Illness not associated with device|1|||
94313865|NCT02322892|322934592|FG000|Overall Study|Surgery cancelled|1|||
94313866|NCT02322892|322934593|FG001|Overall Study|Surgery cancelled|2|||
94313867|NCT02322892|322934592|FG000|Overall Study|Met exclusion criteria|0|||
94313868|NCT02322892|322934593|FG001|Overall Study|Met exclusion criteria|1|||
94313869|NCT02322892|322934592|FG000|Overall Study|Protocol Violation|1|||
94313870|NCT02322892|322934593|FG001|Overall Study|Protocol Violation|0|||
94313871|NCT00747617|322934594|FG000|Overall Study|Lost to Follow-up|3|||
94313872|NCT00747617|322934595|FG001|Overall Study|Lost to Follow-up|1|||
94313873|NCT01043185|322934596|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
94313874|NCT01043185|322934597|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
94313875|NCT01043185|322934598|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
94313876|NCT01043185|322934599|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
94313877|NCT01043185|322934600|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
94313878|NCT01043185|322934601|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
94313879|NCT01043185|322934602|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
94313880|NCT01043185|322934603|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
94313881|NCT01043185|322934604|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
94313882|NCT01043185|322934605|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
94313883|NCT01432262|322934606|FG000|Overall Study|Withdrawal by Subject|2|||
94313884|NCT01432262|322934607|FG001|Overall Study|Withdrawal by Subject|1|||
94313885|NCT04657016|322934608|FG000|Overall Study|Adverse Event|2|||
94313886|NCT04657016|322934609|FG001|Overall Study|Adverse Event|4|||
94313887|NCT04657016|322934608|FG000|Overall Study|Death|1|||
94313888|NCT04657016|322934609|FG001|Overall Study|Death|1|||
94313889|NCT04657016|322934608|FG000|Overall Study|Lost to Follow-up|24|||
94313890|NCT04657016|322934609|FG001|Overall Study|Lost to Follow-up|12|||
94313891|NCT04657016|322934608|FG000|Overall Study|Physician Decision|1|||
94313892|NCT04657016|322934609|FG001|Overall Study|Physician Decision|2|||
94313893|NCT04657016|322934608|FG000|Overall Study|Pregnancy|2|||
94313894|NCT04657016|322934609|FG001|Overall Study|Pregnancy|2|||
94313895|NCT04657016|322934608|FG000|Overall Study|Protocol Deviation|1|||
94313896|NCT04657016|322934609|FG001|Overall Study|Protocol Deviation|0|||
94313897|NCT04657016|322934608|FG000|Overall Study|Withdrawal by Subject|28|||
94313898|NCT04657016|322934609|FG001|Overall Study|Withdrawal by Subject|14|||
94313899|NCT04657016|322934608|FG000|Overall Study|Other - as reported by the investigator|6|||
94313900|NCT04657016|322934609|FG001|Overall Study|Other - as reported by the investigator|0|||
94313901|NCT00494871|322934610|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
94313902|NCT00494871|322934611|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
94313903|NCT00494871|322934610|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
94313904|NCT00494871|322934611|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
94313905|NCT00494871|322934610|FG000|Double-blind (DB) Treatment Period|Death|8|||
94313906|NCT00494871|322934611|FG001|Double-blind (DB) Treatment Period|Death|3|||
94475949|NCT03300180|323533557|FG002|6 Month Outcome|Death|3|||
94313907|NCT00494871|322934610|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
94313908|NCT00494871|322934611|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
94313909|NCT00494871|322934610|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
94313910|NCT00494871|322934611|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
94313911|NCT00494871|322934610|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
94313912|NCT00494871|322934611|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
94313913|NCT00494871|322934610|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
94313914|NCT00494871|322934611|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
94384218|NCT00818883|323193122|FG000|Overall Study|Lost to Follow-up|3|||
94384219|NCT00818883|323193123|FG001|Overall Study|Lost to Follow-up|2|||
94384220|NCT00818883|323193122|FG000|Overall Study|Withdrawal by Subject|16|||
94384221|NCT00818883|323193123|FG001|Overall Study|Withdrawal by Subject|14|||
94384222|NCT00818883|323193122|FG000|Overall Study|Lack of Efficacy|0|||
94384223|NCT00818883|323193123|FG001|Overall Study|Lack of Efficacy|2|||
94384224|NCT00818883|323193122|FG000|Overall Study|Other|2|||
94384225|NCT00818883|323193123|FG001|Overall Study|Other|7|||
94384226|NCT00048048|323193124|FG000|Core Treatment|Withdrawal by Subject|0|||
94384227|NCT00048048|323193125|FG001|Core Treatment|Withdrawal by Subject|0|||
94384228|NCT00048048|323193126|FG002|Core Treatment|Withdrawal by Subject|1|||
94384229|NCT00048048|323193127|FG003|Core Treatment|Withdrawal by Subject|0|||
94384230|NCT00048048|323193128|FG004|Core Treatment|Withdrawal by Subject|0|||
94384231|NCT00048048|323193129|FG005|Core Treatment|Withdrawal by Subject|0|||
94384232|NCT00048048|323193130|FG006|Core Treatment|Withdrawal by Subject|0|||
94384233|NCT00048048|323193131|FG007|Core Treatment|Withdrawal by Subject|0|||
94384234|NCT00048048|323193132|FG008|Core Treatment|Withdrawal by Subject|0|||
94384235|NCT00048048|323193133|FG009|Core Treatment|Withdrawal by Subject|0|||
94384236|NCT00048048|323193134|FG010|Core Treatment|Withdrawal by Subject|0|||
94384237|NCT00048048|323193135|FG011|Core Treatment|Withdrawal by Subject|0|||
94384238|NCT00048048|323193124|FG000|Core Treatment|Adverse Event|0|||
94384239|NCT00048048|323193125|FG001|Core Treatment|Adverse Event|0|||
94384240|NCT00048048|323193126|FG002|Core Treatment|Adverse Event|0|||
94384241|NCT00048048|323193127|FG003|Core Treatment|Adverse Event|0|||
94384242|NCT00048048|323193128|FG004|Core Treatment|Adverse Event|0|||
94384243|NCT00048048|323193129|FG005|Core Treatment|Adverse Event|0|||
94384244|NCT00048048|323193130|FG006|Core Treatment|Adverse Event|0|||
94384245|NCT00048048|323193131|FG007|Core Treatment|Adverse Event|1|||
94384246|NCT00048048|323193132|FG008|Core Treatment|Adverse Event|0|||
94384247|NCT00048048|323193133|FG009|Core Treatment|Adverse Event|0|||
94384248|NCT00048048|323193134|FG010|Core Treatment|Adverse Event|0|||
94384249|NCT00048048|323193135|FG011|Core Treatment|Adverse Event|0|||
94384250|NCT00048048|323193124|FG000|Extension Year 1|Early withdrawals|0|||
94384251|NCT00048048|323193125|FG001|Extension Year 1|Early withdrawals|0|||
94384252|NCT00048048|323193126|FG002|Extension Year 1|Early withdrawals|0|||
94384253|NCT00048048|323193127|FG003|Extension Year 1|Early withdrawals|0|||
94384254|NCT00048048|323193128|FG004|Extension Year 1|Early withdrawals|0|||
94384255|NCT00048048|323193129|FG005|Extension Year 1|Early withdrawals|0|||
94384256|NCT00048048|323193130|FG006|Extension Year 1|Early withdrawals|0|||
94384257|NCT00048048|323193131|FG007|Extension Year 1|Early withdrawals|0|||
94384258|NCT00048048|323193132|FG008|Extension Year 1|Early withdrawals|0|||
94384259|NCT00048048|323193133|FG009|Extension Year 1|Early withdrawals|2|||
94384260|NCT00048048|323193134|FG010|Extension Year 1|Early withdrawals|2|||
94384261|NCT00048048|323193135|FG011|Extension Year 1|Early withdrawals|4|||
94384262|NCT00048048|323193124|FG000|Extension Year 2|Early withdrawals|0|||
94384263|NCT00048048|323193125|FG001|Extension Year 2|Early withdrawals|0|||
94384264|NCT00048048|323193126|FG002|Extension Year 2|Early withdrawals|0|||
94384265|NCT00048048|323193127|FG003|Extension Year 2|Early withdrawals|0|||
94384266|NCT00048048|323193128|FG004|Extension Year 2|Early withdrawals|0|||
94384267|NCT00048048|323193129|FG005|Extension Year 2|Early withdrawals|0|||
94384268|NCT00048048|323193130|FG006|Extension Year 2|Early withdrawals|0|||
94384269|NCT00048048|323193131|FG007|Extension Year 2|Early withdrawals|0|||
94384270|NCT00048048|323193132|FG008|Extension Year 2|Early withdrawals|0|||
94384271|NCT00048048|323193133|FG009|Extension Year 2|Early withdrawals|0|||
94384272|NCT00048048|323193134|FG010|Extension Year 2|Early withdrawals|4|||
94384273|NCT00048048|323193135|FG011|Extension Year 2|Early withdrawals|2|||
94384274|NCT02460159|323193138|FG000|Overall Study|Adverse Event|4|||
94384275|NCT02460159|323193139|FG001|Overall Study|Adverse Event|1|||
94384276|NCT02460159|323193138|FG000|Overall Study|Withdrawal by Subject|2|||
94384277|NCT02460159|323193139|FG001|Overall Study|Withdrawal by Subject|0|||
94384278|NCT01458405|323193140|FG000|Phase 1 (up to 12 Months)|Other|0|||
94384279|NCT01458405|323193141|FG001|Phase 1 (up to 12 Months)|Other|1|||
94384280|NCT01458405|323193142|FG002|Phase 1 (up to 12 Months)|Other|0|||
94384281|NCT01458405|323193143|FG003|Phase 1 (up to 12 Months)|Other|0|||
94384282|NCT01458405|323193140|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
94384283|NCT01458405|323193141|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
94384284|NCT01458405|323193142|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
94384285|NCT01458405|323193143|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
94384286|NCT01458405|323193140|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
94384287|NCT01458405|323193141|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
94384288|NCT01458405|323193142|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
94384289|NCT01458405|323193143|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
94384290|NCT01458405|323193140|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
94384291|NCT01458405|323193141|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
94384292|NCT01458405|323193142|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
94384293|NCT01458405|323193143|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
94384294|NCT01179919|323193144|FG000|Overall Study|Protocol Violation|1|||
94384295|NCT01179919|323193144|FG000|Overall Study|Adverse Event|1|||
94384296|NCT01890915|323193145|FG000|Overall Study|Adverse Event|1|||
94384297|NCT01890915|323193146|FG001|Overall Study|Adverse Event|0|||
94384298|NCT01890915|323193145|FG000|Overall Study|Protocol Violation|2|||
94384299|NCT01890915|323193146|FG001|Overall Study|Protocol Violation|0|||
94384300|NCT01890915|323193145|FG000|Overall Study|Equipment Malfunction|0|||
94384301|NCT01890915|323193146|FG001|Overall Study|Equipment Malfunction|1|||
94384302|NCT03500484|323193147|FG000|Overall Study|Adverse Event|2|||
94384303|NCT03500484|323193148|FG001|Overall Study|Adverse Event|0|||
94384304|NCT03500484|323193147|FG000|Overall Study|Physician Decision|1|||
94384305|NCT03500484|323193148|FG001|Overall Study|Physician Decision|0|||
94384306|NCT03500484|323193147|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
94384307|NCT03500484|323193148|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
94384308|NCT00948675|323193149|FG000|Overall Study|Lost to Follow-up|1|||
94384309|NCT00948675|323193150|FG001|Overall Study|Lost to Follow-up|0|||
94384310|NCT02143102|323193151|FG000|Overall Study|Lost to Follow-up|11|||
94384311|NCT02143102|323193152|FG001|Overall Study|Lost to Follow-up|0|||
94384312|NCT02674334|323193153|FG000|Overall Study|Lost to Follow-up|5|||
94384313|NCT02674334|323193154|FG001|Overall Study|Lost to Follow-up|3|||
94384314|NCT02674334|323193153|FG000|Overall Study|participant difficulty breathing|1|||
94384315|NCT02674334|323193154|FG001|Overall Study|participant difficulty breathing|0|||
94384316|NCT02674334|323193153|FG000|Overall Study|NIRS not recording|1|||
94384317|NCT02674334|323193154|FG001|Overall Study|NIRS not recording|0|||
94384318|NCT02660242|323193163|FG000|Glucose Tabs|Lost to Follow-up|1|||
94384319|NCT02660242|323193163|FG000|Glucagon Injection|Lost to Follow-up|1|||
94384320|NCT00770510|323193164|FG000|Overall Study|Lost to Follow-up|2|||
94384321|NCT00770510|323193164|FG000|Overall Study|Pregnancy|1|||
94384322|NCT00770510|323193164|FG000|Overall Study|Withdrawal by Subject|2|||
94384323|NCT01345019|323193165|FG000|Blinded Treatment Phase|Death|147|||
94384324|NCT01345019|323193166|FG001|Blinded Treatment Phase|Death|137|||
94384325|NCT01345019|323193165|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
94384326|NCT01345019|323193166|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
94384327|NCT01345019|323193165|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
94384328|NCT01345019|323193166|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
94384329|NCT01345019|323193165|FG000|Blinded Treatment Phase|Disease Progression|12|||
94384330|NCT01345019|323193166|FG001|Blinded Treatment Phase|Disease Progression|10|||
94384331|NCT01345019|323193165|FG000|Blinded Treatment Phase|Adverse Event|6|||
94384332|NCT01345019|323193166|FG001|Blinded Treatment Phase|Adverse Event|13|||
94384333|NCT01345019|323193165|FG000|Blinded Treatment Phase|Administrative Decision|10|||
94384334|NCT01345019|323193166|FG001|Blinded Treatment Phase|Administrative Decision|8|||
94384335|NCT01345019|323193165|FG000|Blinded Treatment Phase|Noncompliance|5|||
94384336|NCT01345019|323193166|FG001|Blinded Treatment Phase|Noncompliance|3|||
94384337|NCT01345019|323193165|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
94384338|NCT01345019|323193166|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
94384339|NCT01345019|323193165|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
94384340|NCT01345019|323193166|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
94384341|NCT01345019|323193165|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
94475950|NCT03300180|323533555|FG000|6 Month Outcome|Missed Assessment|43|||
94475951|NCT03300180|323533556|FG001|6 Month Outcome|Missed Assessment|52|||
94384342|NCT01345019|323193166|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
94384343|NCT01345019|323193165|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
94384344|NCT01345019|323193166|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
94384345|NCT01345019|323193165|FG000|Open Label Treatment Phase|Death|49|||
94384346|NCT01345019|323193166|FG001|Open Label Treatment Phase|Death|48|||
94384347|NCT01345019|323193165|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
94384348|NCT01345019|323193166|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
94384349|NCT01345019|323193165|FG000|Open Label Treatment Phase|Adverse Event|30|||
94384350|NCT01345019|323193166|FG001|Open Label Treatment Phase|Adverse Event|51|||
94384351|NCT01345019|323193165|FG000|Open Label Treatment Phase|Administrative Decision|30|||
94475952|NCT03300180|323533557|FG002|6 Month Outcome|Missed Assessment|46|||
94313915|NCT00494871|322934610|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
94313916|NCT00494871|322934611|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
94313917|NCT00494871|322934610|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
94313918|NCT00494871|322934611|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
94313919|NCT00494871|322934610|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
94313920|NCT00494871|322934611|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
94313921|NCT00494871|322934610|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
94313922|NCT00494871|322934611|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
94313923|NCT00494871|322934610|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
94313924|NCT00494871|322934611|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
94313925|NCT00494871|322934610|FG000|Follow-up (FU) Period|Adverse Event|1|||
94313926|NCT00494871|322934611|FG001|Follow-up (FU) Period|Adverse Event|1|||
94313927|NCT00494871|322934610|FG000|Follow-up (FU) Period|Death|13|||
94313928|NCT00494871|322934611|FG001|Follow-up (FU) Period|Death|12|||
94313929|NCT00494871|322934610|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
94313930|NCT00494871|322934611|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
94313931|NCT00494871|322934610|FG000|Follow-up (FU) Period|Physician Decision|0|||
94313932|NCT00494871|322934611|FG001|Follow-up (FU) Period|Physician Decision|1|||
94313933|NCT00494871|322934610|FG000|Follow-up (FU) Period|Protocol Violation|1|||
94313934|NCT00494871|322934611|FG001|Follow-up (FU) Period|Protocol Violation|0|||
94313935|NCT00494871|322934610|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
94313936|NCT00494871|322934611|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
94313937|NCT00494871|322934610|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
94313938|NCT00494871|322934611|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
94313939|NCT00696657|322934612|FG000|Overall Study|Protocol Violation|0|||
94313940|NCT00696657|322934613|FG001|Overall Study|Protocol Violation|0|||
94313941|NCT00696657|322934614|FG002|Overall Study|Protocol Violation|0|||
94313942|NCT00696657|322934615|FG003|Overall Study|Protocol Violation|0|||
94313943|NCT00696657|322934616|FG004|Overall Study|Protocol Violation|0|||
94313944|NCT00696657|322934617|FG005|Overall Study|Protocol Violation|1|||
94313945|NCT00696657|322934618|FG006|Overall Study|Protocol Violation|0|||
94313946|NCT00696657|322934619|FG007|Overall Study|Protocol Violation|0|||
94313947|NCT00696657|322934620|FG008|Overall Study|Protocol Violation|1|||
94313948|NCT00696657|322934612|FG000|Overall Study|Lack of Efficacy|0|||
94313949|NCT00696657|322934613|FG001|Overall Study|Lack of Efficacy|1|||
94313950|NCT00696657|322934614|FG002|Overall Study|Lack of Efficacy|0|||
94313951|NCT00696657|322934615|FG003|Overall Study|Lack of Efficacy|0|||
94313952|NCT00696657|322934616|FG004|Overall Study|Lack of Efficacy|0|||
94313953|NCT00696657|322934617|FG005|Overall Study|Lack of Efficacy|0|||
94313954|NCT00696657|322934618|FG006|Overall Study|Lack of Efficacy|0|||
94313955|NCT00696657|322934619|FG007|Overall Study|Lack of Efficacy|0|||
94313956|NCT00696657|322934620|FG008|Overall Study|Lack of Efficacy|0|||
94313957|NCT00696657|322934612|FG000|Overall Study|Withdrawal criteria|1|||
94313958|NCT00696657|322934613|FG001|Overall Study|Withdrawal criteria|3|||
94313959|NCT00696657|322934614|FG002|Overall Study|Withdrawal criteria|2|||
94313960|NCT00696657|322934615|FG003|Overall Study|Withdrawal criteria|2|||
94313961|NCT00696657|322934616|FG004|Overall Study|Withdrawal criteria|0|||
94313962|NCT00696657|322934617|FG005|Overall Study|Withdrawal criteria|0|||
94313963|NCT00696657|322934618|FG006|Overall Study|Withdrawal criteria|1|||
94313964|NCT00696657|322934619|FG007|Overall Study|Withdrawal criteria|1|||
94313965|NCT00696657|322934620|FG008|Overall Study|Withdrawal criteria|2|||
94313966|NCT00696657|322934612|FG000|Overall Study|Unclassified|0|||
94313967|NCT00696657|322934613|FG001|Overall Study|Unclassified|1|||
94313968|NCT00696657|322934614|FG002|Overall Study|Unclassified|3|||
94313969|NCT00696657|322934615|FG003|Overall Study|Unclassified|2|||
94313970|NCT00696657|322934616|FG004|Overall Study|Unclassified|4|||
94313971|NCT00696657|322934617|FG005|Overall Study|Unclassified|2|||
94313972|NCT00696657|322934618|FG006|Overall Study|Unclassified|0|||
94313973|NCT00696657|322934619|FG007|Overall Study|Unclassified|0|||
94313974|NCT00696657|322934620|FG008|Overall Study|Unclassified|1|||
94313975|NCT00696657|322934612|FG000|Overall Study|Adverse Event|0|||
94313976|NCT00696657|322934613|FG001|Overall Study|Adverse Event|0|||
94313977|NCT00696657|322934614|FG002|Overall Study|Adverse Event|3|||
94313978|NCT00696657|322934615|FG003|Overall Study|Adverse Event|7|||
94313979|NCT00696657|322934616|FG004|Overall Study|Adverse Event|6|||
94313980|NCT00696657|322934617|FG005|Overall Study|Adverse Event|9|||
94313981|NCT00696657|322934618|FG006|Overall Study|Adverse Event|14|||
94313982|NCT00696657|322934619|FG007|Overall Study|Adverse Event|2|||
94313983|NCT00696657|322934620|FG008|Overall Study|Adverse Event|5|||
94313984|NCT00912015|322934623|FG000|Overall Study|Lack of Efficacy|1|||
94313985|NCT00912015|322934624|FG001|Overall Study|Lack of Efficacy|0|||
94313986|NCT00912015|322934625|FG002|Overall Study|Lack of Efficacy|0|||
94313987|NCT00912015|322934626|FG003|Overall Study|Lack of Efficacy|0|||
94313988|NCT00912015|322934623|FG000|Overall Study|Withdrawal by Subject|8|||
94313989|NCT00912015|322934624|FG001|Overall Study|Withdrawal by Subject|8|||
94384352|NCT01345019|323193166|FG001|Open Label Treatment Phase|Administrative Decision|15|||
94475953|NCT03300180|323533555|FG000|12 Month Outcome|Withdrawal by Subject|3|||
94475954|NCT03300180|323533556|FG001|12 Month Outcome|Withdrawal by Subject|6|||
94475955|NCT03300180|323533557|FG002|12 Month Outcome|Withdrawal by Subject|6|||
94475956|NCT03300180|323533555|FG000|12 Month Outcome|Death|9|||
94475957|NCT03300180|323533556|FG001|12 Month Outcome|Death|6|||
94475958|NCT03300180|323533557|FG002|12 Month Outcome|Death|6|||
94475959|NCT03300180|323533555|FG000|12 Month Outcome|Missed Assessment|62|||
94475960|NCT03300180|323533556|FG001|12 Month Outcome|Missed Assessment|59|||
94475961|NCT03300180|323533557|FG002|12 Month Outcome|Missed Assessment|58|||
94475962|NCT03300180|323533555|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
94475963|NCT03300180|323533556|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
94475964|NCT03300180|323533557|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
94475965|NCT03300180|323533555|FG000|18 Month Outcome Assessment|Death|8|||
94475966|NCT03300180|323533556|FG001|18 Month Outcome Assessment|Death|5|||
94475967|NCT03300180|323533557|FG002|18 Month Outcome Assessment|Death|5|||
94475968|NCT03300180|323533555|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
94475969|NCT03300180|323533556|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
94475970|NCT03300180|323533557|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
94475971|NCT03300180|323533555|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
94475972|NCT03300180|323533556|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
94475973|NCT03300180|323533557|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
94475974|NCT03300180|323533555|FG000|24 Month Outcome Assessment|Death|13|||
94475975|NCT03300180|323533556|FG001|24 Month Outcome Assessment|Death|13|||
94475976|NCT03300180|323533557|FG002|24 Month Outcome Assessment|Death|3|||
94475977|NCT03300180|323533555|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
94475978|NCT03300180|323533556|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
94475979|NCT03300180|323533557|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
94475980|NCT03877224|323533558|FG000|Overall Study|Death|3|||
94475981|NCT03877224|323533559|FG001|Overall Study|Death|2|||
94475982|NCT03877224|323533558|FG000|Overall Study|Withdrawal by Subject|1|||
94475983|NCT03877224|323533559|FG001|Overall Study|Withdrawal by Subject|6|||
94475984|NCT03877224|323533558|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
94475985|NCT03877224|323533559|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
94475986|NCT04227405|323535176|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
94475987|NCT04227405|323535177|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
94475988|NCT04227405|323535176|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
94475989|NCT04227405|323535177|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
94475990|NCT04227405|323535176|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
94475991|NCT04227405|323535177|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
94475992|NCT03630705|323535181|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
94475993|NCT03630705|323535182|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
94475994|NCT03630705|323535183|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
94475995|NCT03630705|323535184|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
94475996|NCT03630705|323535181|FG000|Overall Study|Lost to Follow-up|1|||
94475997|NCT03630705|323535182|FG001|Overall Study|Lost to Follow-up|2|||
94475998|NCT03630705|323535183|FG002|Overall Study|Lost to Follow-up|0|||
94475999|NCT03630705|323535184|FG003|Overall Study|Lost to Follow-up|0|||
94476000|NCT02155309|323535188|FG000|Overall Study|Protocol Violation|0|||
94476001|NCT02155309|323535189|FG001|Overall Study|Protocol Violation|0|||
94476002|NCT02155309|323535190|FG002|Overall Study|Protocol Violation|1|||
94476003|NCT04750278|323535195|FG000|Overall Study|Death|9|||
94476004|NCT04750278|323535196|FG001|Overall Study|Death|10|||
94476005|NCT04750278|323535197|FG002|Overall Study|Death|10|||
94476006|NCT04750278|323535195|FG000|Overall Study|Withdrawal by Subject|4|||
94476007|NCT04750278|323535196|FG001|Overall Study|Withdrawal by Subject|1|||
94476008|NCT04750278|323535197|FG002|Overall Study|Withdrawal by Subject|2|||
94476009|NCT04750278|323535195|FG000|Overall Study|Lost to Follow-up|1|||
94476010|NCT04750278|323535196|FG001|Overall Study|Lost to Follow-up|1|||
94476011|NCT04750278|323535197|FG002|Overall Study|Lost to Follow-up|1|||
94476012|NCT04750278|323535195|FG000|Overall Study|Pregnancy|1|||
94476013|NCT04750278|323535196|FG001|Overall Study|Pregnancy|0|||
94476014|NCT04750278|323535197|FG002|Overall Study|Pregnancy|0|||
94476015|NCT04750278|323535195|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
94476016|NCT04750278|323535196|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
94476017|NCT04750278|323535197|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
94476018|NCT04750278|323535195|FG000|Overall Study|Non-compliance|0|||
94476019|NCT04750278|323535196|FG001|Overall Study|Non-compliance|0|||
94476020|NCT04750278|323535197|FG002|Overall Study|Non-compliance|1|||
94476021|NCT04750278|323535195|FG000|Overall Study|Transfer to Outside Facility|0|||
94476022|NCT04750278|323535196|FG001|Overall Study|Transfer to Outside Facility|2|||
94476023|NCT04750278|323535197|FG002|Overall Study|Transfer to Outside Facility|1|||
94476024|NCT04750278|323535195|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
94476025|NCT04750278|323535196|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
94476026|NCT04750278|323535197|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
94476027|NCT04750278|323535195|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
94476028|NCT04750278|323535196|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
94476029|NCT04750278|323535197|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
94476030|NCT02579382|323535200|FG000|Main Study Phase|Lost to Follow-up|0|||
94476031|NCT02579382|323535201|FG001|Main Study Phase|Lost to Follow-up|0|||
94476032|NCT02579382|323535202|FG002|Main Study Phase|Lost to Follow-up|2|||
94476033|NCT02579382|323535203|FG003|Main Study Phase|Lost to Follow-up|0|||
94476034|NCT02579382|323535200|FG000|Main Study Phase|Withdrew Consent|0|||
94476035|NCT02579382|323535201|FG001|Main Study Phase|Withdrew Consent|0|||
94476036|NCT02579382|323535202|FG002|Main Study Phase|Withdrew Consent|0|||
94476037|NCT02579382|323535203|FG003|Main Study Phase|Withdrew Consent|2|||
94476038|NCT02579382|323535200|FG000|Main Study Phase|Lack of Efficacy|0|||
94476039|NCT02579382|323535201|FG001|Main Study Phase|Lack of Efficacy|0|||
94476040|NCT02579382|323535202|FG002|Main Study Phase|Lack of Efficacy|0|||
94476041|NCT02579382|323535203|FG003|Main Study Phase|Lack of Efficacy|1|||
94476042|NCT02579382|323535200|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
94476043|NCT02579382|323535201|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
94476044|NCT02579382|323535202|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
94476045|NCT02579382|323535203|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
94476046|NCT02579382|323535200|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
94476047|NCT02579382|323535201|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
94476048|NCT02579382|323535202|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
94476049|NCT02579382|323535203|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
94476050|NCT02579382|323535200|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
94476051|NCT02579382|323535201|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
94476052|NCT02579382|323535202|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
94476053|NCT02579382|323535203|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
94476054|NCT02579382|323535200|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
94476055|NCT02579382|323535201|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
94476056|NCT02579382|323535202|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
94476057|NCT02579382|323535203|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
94476058|NCT02579382|323535200|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
94476059|NCT02579382|323535201|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
94476060|NCT02579382|323535202|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
94476061|NCT02579382|323535203|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
94476062|NCT02579382|323535200|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
94476063|NCT02579382|323535201|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
94476064|NCT02579382|323535202|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
94476065|NCT02579382|323535203|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
94476066|NCT01775787|323535204|FG000|First 7-10 Days|Adverse Event|0|||
94476067|NCT01775787|323535205|FG001|First 7-10 Days|Adverse Event|1|||
94476068|NCT01775787|323535204|FG000|First 7-10 Days|family emergency|0|||
94476069|NCT01775787|323535205|FG001|First 7-10 Days|family emergency|1|||
94476070|NCT01775787|323535204|FG000|First 7-10 Days|time commitment|0|||
94476071|NCT01775787|323535205|FG001|First 7-10 Days|time commitment|2|||
94476072|NCT01775787|323535204|FG000|First 7-10 Days|concerns with using IV|1|||
94476073|NCT01775787|323535205|FG001|First 7-10 Days|concerns with using IV|2|||
94476074|NCT01775787|323535204|FG000|Second 7-10 Days|time commitment|0|||
94476075|NCT01775787|323535205|FG001|Second 7-10 Days|time commitment|1|||
94476076|NCT01775787|323535204|FG000|Second 7-10 Days|concerns with using IV|0|||
94476077|NCT01775787|323535205|FG001|Second 7-10 Days|concerns with using IV|1|||
94476078|NCT01299896|323535206|FG000|Overall Study|Withdrawal by Subject|1|||
94476079|NCT01299896|323535207|FG001|Overall Study|Withdrawal by Subject|7|||
94476080|NCT01299896|323535206|FG000|Overall Study|Lost to Follow-up|0|||
94476081|NCT01299896|323535207|FG001|Overall Study|Lost to Follow-up|11|||
94476082|NCT01763827|323535212|FG000|Overall Study|Withdrawal by Subject|1|||
94476083|NCT01763827|323535213|FG001|Overall Study|Withdrawal by Subject|0|||
94476084|NCT01763827|323535214|FG002|Overall Study|Withdrawal by Subject|0|||
94476085|NCT01763827|323535215|FG003|Overall Study|Withdrawal by Subject|0|||
94476086|NCT01763827|323535216|FG004|Overall Study|Withdrawal by Subject|2|||
94476087|NCT01763827|323535217|FG005|Overall Study|Withdrawal by Subject|0|||
94476088|NCT01763827|323535212|FG000|Overall Study|Decision by sponsor|2|||
94476089|NCT01763827|323535213|FG001|Overall Study|Decision by sponsor|0|||
94476090|NCT01763827|323535214|FG002|Overall Study|Decision by sponsor|3|||
94476091|NCT01763827|323535215|FG003|Overall Study|Decision by sponsor|0|||
94476092|NCT01763827|323535216|FG004|Overall Study|Decision by sponsor|2|||
94476093|NCT01763827|323535217|FG005|Overall Study|Decision by sponsor|1|||
94476094|NCT01763827|323535212|FG000|Overall Study|Lost to Follow-up|0|||
94313990|NCT00912015|322934625|FG002|Overall Study|Withdrawal by Subject|3|||
94313991|NCT00912015|322934626|FG003|Overall Study|Withdrawal by Subject|0|||
94313992|NCT00912015|322934623|FG000|Overall Study|Protocol Violation|1|||
94313993|NCT00912015|322934624|FG001|Overall Study|Protocol Violation|0|||
94313994|NCT00912015|322934625|FG002|Overall Study|Protocol Violation|0|||
94313995|NCT00912015|322934626|FG003|Overall Study|Protocol Violation|1|||
94313996|NCT00912015|322934623|FG000|Overall Study|Adverse Event|6|||
94313997|NCT00912015|322934624|FG001|Overall Study|Adverse Event|0|||
94313998|NCT00912015|322934625|FG002|Overall Study|Adverse Event|0|||
94313999|NCT00912015|322934626|FG003|Overall Study|Adverse Event|1|||
94314000|NCT01989546|322934627|FG000|Overall Study|Clinical Progression|1|||
94314001|NCT01989546|322934627|FG000|Overall Study|Disease progression on study|8|||
94314002|NCT02361762|322934628|FG000|Overall Study|Withdrawal by Subject|0|||
94314003|NCT02361762|322934629|FG001|Overall Study|Withdrawal by Subject|1|||
94314004|NCT02361762|322934628|FG000|Overall Study|Lost to Follow-up|0|||
94314005|NCT02361762|322934629|FG001|Overall Study|Lost to Follow-up|1|||
94314006|NCT00883558|322934630|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
94314007|NCT00883558|322934631|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
94314008|NCT00883558|322934632|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
94314009|NCT00883558|322934630|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
94384353|NCT01345019|323193165|FG000|Open Label Treatment Phase|Disease Progression|17|||
94384354|NCT01345019|323193166|FG001|Open Label Treatment Phase|Disease Progression|18|||
94384355|NCT01345019|323193165|FG000|Open Label Treatment Phase|Noncompliance|5|||
94384356|NCT01345019|323193166|FG001|Open Label Treatment Phase|Noncompliance|4|||
94384357|NCT01345019|323193165|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
94384358|NCT01345019|323193166|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
94384359|NCT01345019|323193165|FG000|Open Label Treatment Phase|Pregnancy|1|||
94384360|NCT01345019|323193166|FG001|Open Label Treatment Phase|Pregnancy|0|||
94384361|NCT01345019|323193165|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
94384362|NCT01345019|323193166|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
94384363|NCT01345019|323193165|FG000|Open Label Treatment Phase|Protocol Violation|0|||
94384364|NCT01345019|323193166|FG001|Open Label Treatment Phase|Protocol Violation|1|||
94384365|NCT03830164|323193169|FG000|Overall Study|Adverse Event|0|||
94384366|NCT03830164|323193170|FG001|Overall Study|Adverse Event|2|||
94384367|NCT03830164|323193171|FG002|Overall Study|Adverse Event|0|||
94384368|NCT03830164|323193169|FG000|Overall Study|Lack of Efficacy|1|||
94384369|NCT03830164|323193170|FG001|Overall Study|Lack of Efficacy|5|||
94384370|NCT03830164|323193171|FG002|Overall Study|Lack of Efficacy|0|||
94384371|NCT03830164|323193169|FG000|Overall Study|Lost to Follow-up|0|||
94384372|NCT03830164|323193170|FG001|Overall Study|Lost to Follow-up|1|||
94384373|NCT03830164|323193171|FG002|Overall Study|Lost to Follow-up|0|||
94384374|NCT03830164|323193169|FG000|Overall Study|Withdrawal by Subject|1|||
94384375|NCT03830164|323193170|FG001|Overall Study|Withdrawal by Subject|0|||
94314010|NCT00883558|322934631|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
94314011|NCT00883558|322934632|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
94314012|NCT00883558|322934630|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
94314013|NCT00883558|322934631|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
94314014|NCT00883558|322934632|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
94314015|NCT00883558|322934630|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
94314016|NCT00883558|322934631|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
94314017|NCT00883558|322934632|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
94314018|NCT00883558|322934630|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
94314019|NCT00883558|322934631|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
94314020|NCT00883558|322934632|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
94314021|NCT01252134|322934636|FG000|Period 1, 8 Hours|Personal Reasons|0|||
94314022|NCT01252134|322934637|FG001|Period 1, 8 Hours|Personal Reasons|1|||
94314023|NCT01252134|322934638|FG002|Period 1, 8 Hours|Personal Reasons|1|||
94314024|NCT01252134|322934639|FG003|Period 1, 8 Hours|Personal Reasons|0|||
94314025|NCT01252134|322934640|FG004|Period 1, 8 Hours|Personal Reasons|0|||
94314026|NCT01252134|322934641|FG005|Period 1, 8 Hours|Personal Reasons|0|||
94314027|NCT02042404|322934642|FG000|Overall Study|Death|1|||
94314028|NCT02042404|322934643|FG001|Overall Study|Death|0|||
94384376|NCT03830164|323193171|FG002|Overall Study|Withdrawal by Subject|0|||
94384377|NCT00386009|323193172|FG000|Overall Study|Adverse Event|0|||
94384378|NCT00386009|323193173|FG001|Overall Study|Adverse Event|2|||
94384379|NCT00386009|323193172|FG000|Overall Study|Death|1|||
94384380|NCT00386009|323193173|FG001|Overall Study|Death|0|||
94384381|NCT00386009|323193172|FG000|Overall Study|Entry Criteria Not Met|0|||
94314029|NCT02042404|322934642|FG000|Overall Study|Unrelated Adverse Event|3|||
94384382|NCT00386009|323193173|FG001|Overall Study|Entry Criteria Not Met|2|||
94384383|NCT00386009|323193172|FG000|Overall Study|Lost to Follow-up|1|||
94384384|NCT00386009|323193173|FG001|Overall Study|Lost to Follow-up|1|||
94476095|NCT01763827|323535213|FG001|Overall Study|Lost to Follow-up|1|||
94476096|NCT01763827|323535214|FG002|Overall Study|Lost to Follow-up|1|||
94476097|NCT01763827|323535215|FG003|Overall Study|Lost to Follow-up|1|||
94476098|NCT01763827|323535216|FG004|Overall Study|Lost to Follow-up|2|||
94476099|NCT01763827|323535217|FG005|Overall Study|Lost to Follow-up|1|||
94476100|NCT02906579|323535218|FG000|Overall Study|Adverse Event|1|||
94476101|NCT02906579|323535218|FG000|Overall Study|Physician Decision|1|||
94476102|NCT01516736|323535219|FG000|Overall Study|Withdrawal by Subject|10|||
94476103|NCT01516736|323535220|FG001|Overall Study|Withdrawal by Subject|4|||
94476104|NCT01516736|323535219|FG000|Overall Study|Adverse Event|4|||
94476105|NCT01516736|323535220|FG001|Overall Study|Adverse Event|5|||
94476106|NCT01516736|323535219|FG000|Overall Study|Death|3|||
94476107|NCT01516736|323535220|FG001|Overall Study|Death|1|||
94476108|NCT01516736|323535219|FG000|Overall Study|Physician Decision|2|||
94476109|NCT01516736|323535220|FG001|Overall Study|Physician Decision|1|||
94476110|NCT01516736|323535219|FG000|Overall Study|Lack of Efficacy|1|||
94476111|NCT01516736|323535220|FG001|Overall Study|Lack of Efficacy|0|||
94476112|NCT01516736|323535219|FG000|Overall Study|Protocol Violation|0|||
94476113|NCT01516736|323535220|FG001|Overall Study|Protocol Violation|1|||
94476114|NCT01516736|323535219|FG000|Overall Study|Other (not specified)|0|||
94476115|NCT01516736|323535220|FG001|Overall Study|Other (not specified)|1|||
94476116|NCT00905567|323535222|FG000|Washout|Withdrawal by Subject|0|||
94476117|NCT00905567|323535223|FG001|Washout|Withdrawal by Subject|1|||
94476118|NCT04892446|323535228|FG000|Overall Study|Death|4|||
94476119|NCT04892446|323535229|FG001|Overall Study|Death|4|||
94476120|NCT04892446|323535230|FG002|Overall Study|Death|0|||
94476121|NCT04892446|323535228|FG000|Overall Study|Withdrew consent|3|||
94476122|NCT04892446|323535229|FG001|Overall Study|Withdrew consent|0|||
94476123|NCT04892446|323535230|FG002|Overall Study|Withdrew consent|1|||
94476124|NCT04892446|323535228|FG000|Overall Study|Investigator's discretion|1|||
94476125|NCT04892446|323535229|FG001|Overall Study|Investigator's discretion|1|||
94476126|NCT04892446|323535230|FG002|Overall Study|Investigator's discretion|0|||
94476127|NCT04892446|323535228|FG000|Overall Study|Study terminated by sponsor|0|||
94476128|NCT04892446|323535229|FG001|Overall Study|Study terminated by sponsor|0|||
94476129|NCT04892446|323535230|FG002|Overall Study|Study terminated by sponsor|2|||
94476130|NCT04313400|323535231|FG000|Overall Study|Withdrawal by Subject|0|||
94476131|NCT04313400|323535232|FG001|Overall Study|Withdrawal by Subject|0|||
94476132|NCT04313400|323535233|FG002|Overall Study|Withdrawal by Subject|0|||
94476133|NCT04313400|323535234|FG003|Overall Study|Withdrawal by Subject|0|||
94476134|NCT04313400|323535235|FG004|Overall Study|Withdrawal by Subject|0|||
94476135|NCT04313400|323535236|FG005|Overall Study|Withdrawal by Subject|4|||
94476136|NCT04313400|323535237|FG006|Overall Study|Withdrawal by Subject|1|||
94476137|NCT04313400|323535231|FG000|Overall Study|Adverse Event|0|||
94476138|NCT04313400|323535232|FG001|Overall Study|Adverse Event|0|||
94476139|NCT04313400|323535233|FG002|Overall Study|Adverse Event|0|||
94476140|NCT04313400|323535234|FG003|Overall Study|Adverse Event|0|||
94476141|NCT04313400|323535235|FG004|Overall Study|Adverse Event|0|||
94476142|NCT04313400|323535236|FG005|Overall Study|Adverse Event|1|||
94476143|NCT04313400|323535237|FG006|Overall Study|Adverse Event|0|||
94476144|NCT04313400|323535231|FG000|Overall Study|Lost to Follow-up|0|||
94476145|NCT04313400|323535232|FG001|Overall Study|Lost to Follow-up|0|||
94476146|NCT04313400|323535233|FG002|Overall Study|Lost to Follow-up|0|||
94476147|NCT04313400|323535234|FG003|Overall Study|Lost to Follow-up|0|||
94476148|NCT04313400|323535235|FG004|Overall Study|Lost to Follow-up|0|||
94476149|NCT04313400|323535236|FG005|Overall Study|Lost to Follow-up|1|||
94476150|NCT04313400|323535237|FG006|Overall Study|Lost to Follow-up|0|||
94476151|NCT03060291|323535238|FG000|3-month Follow-up|Declined to respond|8|||
94476152|NCT03060291|323535239|FG001|3-month Follow-up|Declined to respond|10|||
94476153|NCT03060291|323535240|FG002|3-month Follow-up|Declined to respond|2|||
94476154|NCT03060291|323535238|FG000|6-month Follow-up|Declined to respond|7|||
94476155|NCT03060291|323535239|FG001|6-month Follow-up|Declined to respond|13|||
94476156|NCT03060291|323535240|FG002|6-month Follow-up|Declined to respond|4|||
94476157|NCT03060291|323535238|FG000|12-month Follow-up|Declined to respond|7|||
94476158|NCT03060291|323535239|FG001|12-month Follow-up|Declined to respond|16|||
94476159|NCT03060291|323535240|FG002|12-month Follow-up|Declined to respond|6|||
94476160|NCT03076515|323535241|FG000|Overall Study|DMC decision based on interim analysis|25|||
94314030|NCT02042404|322934643|FG001|Overall Study|Unrelated Adverse Event|0|||
94476161|NCT03076515|323535242|FG001|Overall Study|DMC decision based on interim analysis|29|||
94476162|NCT02521792|323535257|FG000|Overall Study|Study Terminated|6|||
94476163|NCT02609984|323535258|FG000|Overall Study|Death|29|||
94476164|NCT02609984|323535259|FG001|Overall Study|Death|26|||
94476165|NCT02609984|323535258|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
94476166|NCT02609984|323535259|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
94476167|NCT02609984|323535258|FG000|Overall Study|Lost to Follow-up|1|||
94476168|NCT02609984|323535259|FG001|Overall Study|Lost to Follow-up|2|||
94476169|NCT02609984|323535258|FG000|Overall Study|Withdrawal by Subject|0|||
94476170|NCT02609984|323535259|FG001|Overall Study|Withdrawal by Subject|1|||
94476171|NCT02609984|323535258|FG000|Overall Study|Disease Progression|2|||
94476172|NCT02609984|323535259|FG001|Overall Study|Disease Progression|0|||
94476173|NCT01408901|323535265|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
94476174|NCT01408901|323535266|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
94476175|NCT01408901|323535267|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
94476176|NCT01408901|323535268|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
94476177|NCT01408901|323535265|FG000|6-Week Follow-Up|Death|1|||
94476178|NCT01408901|323535266|FG001|6-Week Follow-Up|Death|0|||
94476179|NCT01408901|323535267|FG002|6-Week Follow-Up|Death|0|||
94476180|NCT01408901|323535268|FG003|6-Week Follow-Up|Death|0|||
94476181|NCT01408901|323535265|FG000|6-Week Follow-Up|Cancelled visit|0|||
94476182|NCT01408901|323535266|FG001|6-Week Follow-Up|Cancelled visit|1|||
94476183|NCT01408901|323535267|FG002|6-Week Follow-Up|Cancelled visit|0|||
94476184|NCT01408901|323535268|FG003|6-Week Follow-Up|Cancelled visit|2|||
94476185|NCT01408901|323535265|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
94476186|NCT01408901|323535266|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
94476187|NCT01408901|323535267|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
94476188|NCT01408901|323535268|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
94476189|NCT01408901|323535265|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
94476190|NCT01408901|323535266|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
94476191|NCT01408901|323535267|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
94476192|NCT01408901|323535268|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
94476193|NCT01408901|323535265|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
94476194|NCT01408901|323535266|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
94476195|NCT01408901|323535267|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
94476196|NCT01408901|323535268|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
94476197|NCT01408901|323535265|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
94476198|NCT01408901|323535266|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
94476199|NCT01408901|323535267|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
94476200|NCT01408901|323535268|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
94476201|NCT01408901|323535265|FG000|26-Week Follow-Up|Death|0|||
94476202|NCT01408901|323535266|FG001|26-Week Follow-Up|Death|1|||
94476203|NCT01408901|323535267|FG002|26-Week Follow-Up|Death|0|||
94476204|NCT01408901|323535268|FG003|26-Week Follow-Up|Death|0|||
94476205|NCT01436227|323535270|FG000|Overall Study|Adverse Event|7|||
94476206|NCT01436227|323535270|FG000|Overall Study|Death|1|||
94476207|NCT01436227|323535270|FG000|Overall Study|Lack of Efficacy|1|||
94476208|NCT01436227|323535270|FG000|Overall Study|Lost to Follow-up|3|||
94476209|NCT01436227|323535270|FG000|Overall Study|Physician Decision|1|||
94476210|NCT01436227|323535270|FG000|Overall Study|Withdrawal by Subject|7|||
94476211|NCT01436227|323535270|FG000|Overall Study|Disease progression, relapse|6|||
94476212|NCT02098395|323535272|FG000|Overall Study|Protocol Violation|2|||
94476213|NCT02098395|323535273|FG001|Overall Study|Protocol Violation|2|||
94476214|NCT02098395|323535274|FG002|Overall Study|Protocol Violation|0|||
94476215|NCT02098395|323535275|FG003|Overall Study|Protocol Violation|7|||
94476216|NCT02098395|323535272|FG000|Overall Study|Withdrawal by Subject|10|||
94476217|NCT02098395|323535273|FG001|Overall Study|Withdrawal by Subject|10|||
94476218|NCT02098395|323535274|FG002|Overall Study|Withdrawal by Subject|5|||
94476219|NCT02098395|323535275|FG003|Overall Study|Withdrawal by Subject|13|||
94476220|NCT02098395|323535272|FG000|Overall Study|Adverse Event|12|||
94476221|NCT02098395|323535273|FG001|Overall Study|Adverse Event|19|||
94476222|NCT02098395|323535274|FG002|Overall Study|Adverse Event|34|||
94476223|NCT02098395|323535275|FG003|Overall Study|Adverse Event|2|||
94476224|NCT02098395|323535272|FG000|Overall Study|Lost to Follow-up|2|||
94476225|NCT02098395|323535273|FG001|Overall Study|Lost to Follow-up|1|||
94476226|NCT02098395|323535274|FG002|Overall Study|Lost to Follow-up|0|||
94476227|NCT02098395|323535275|FG003|Overall Study|Lost to Follow-up|3|||
94476228|NCT02098395|323535272|FG000|Overall Study|Unclassified|0|||
94476229|NCT02098395|323535273|FG001|Overall Study|Unclassified|0|||
94476230|NCT02098395|323535274|FG002|Overall Study|Unclassified|3|||
94476231|NCT02098395|323535275|FG003|Overall Study|Unclassified|2|||
94476232|NCT04004260|323535280|FG000|Overall Study|Withdrawal by Subject|7|||
94476233|NCT04004260|323535281|FG001|Overall Study|Withdrawal by Subject|3|||
94476234|NCT04004260|323535280|FG000|Overall Study|Lost to Follow-up|22|||
94476235|NCT04004260|323535281|FG001|Overall Study|Lost to Follow-up|12|||
94476236|NCT04004260|323535280|FG000|Overall Study|Did not engage in intervention|13|||
94476237|NCT04004260|323535281|FG001|Overall Study|Did not engage in intervention|17|||
94476238|NCT04633226|323535282|FG000|Overall Study|Withdrawal by parent/guardian|4|||
94476239|NCT04633226|323535282|FG000|Overall Study|Randomized by mistake without study treatment|1|||
94476240|NCT01904032|323535308|FG000|Overall Study|Adverse Event|3|||
94476241|NCT01904032|323535309|FG001|Overall Study|Adverse Event|1|||
94476242|NCT01904032|323535308|FG000|Overall Study|Lost to Follow-up|4|||
94476243|NCT01904032|323535309|FG001|Overall Study|Lost to Follow-up|2|||
94476244|NCT00869128|323535310|FG000|Overall Study|lack of Compliance|6|||
94476245|NCT00869128|323535311|FG001|Overall Study|lack of Compliance|6|||
94476246|NCT00531947|323535312|FG000|Overall Study|Adverse Event|5|||
94476247|NCT00531947|323535313|FG001|Overall Study|Adverse Event|10|||
94476248|NCT00531947|323535312|FG000|Overall Study|Lost to Follow-up|12|||
94476249|NCT00531947|323535313|FG001|Overall Study|Lost to Follow-up|9|||
94476250|NCT00531947|323535312|FG000|Overall Study|Withdrawal by Subject|14|||
94476251|NCT00531947|323535313|FG001|Overall Study|Withdrawal by Subject|19|||
94476252|NCT00531947|323535312|FG000|Overall Study|Protocol Violation|2|||
94476253|NCT00531947|323535313|FG001|Overall Study|Protocol Violation|1|||
94476254|NCT00531947|323535312|FG000|Overall Study|Non-Compliance|4|||
94476255|NCT00531947|323535313|FG001|Overall Study|Non-Compliance|7|||
94476256|NCT00531947|323535312|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
94476257|NCT00531947|323535313|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
94476258|NCT03360019|323535316|FG000|Overall Study|Withdrawal by Subject|2|||
94476259|NCT03360019|323535317|FG001|Overall Study|Withdrawal by Subject|0|||
94476260|NCT03360019|323535318|FG002|Overall Study|Withdrawal by Subject|0|||
94476261|NCT03360019|323535316|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
94476262|NCT03360019|323535317|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
94476263|NCT03360019|323535318|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
94476264|NCT01462110|323535319|FG000|Overall Study|Adverse Event|1|||
94476265|NCT01462110|323535320|FG001|Overall Study|Adverse Event|0|||
94476266|NCT00656175|323535322|FG000|Overall Study|Adverse Event|1|||
94476267|NCT00656175|323535323|FG001|Overall Study|Adverse Event|0|||
94476268|NCT00656175|323535322|FG000|Overall Study|Transportation issues|0|||
94476269|NCT00656175|323535323|FG001|Overall Study|Transportation issues|1|||
94476270|NCT01429298|323535329|FG000|Overall Study|Protocol Violation|4|||
94476271|NCT01429298|323535330|FG001|Overall Study|Protocol Violation|6|||
94476272|NCT04235504|323535333|FG000|Study Phase|Withdrawal by Subject|5|||
94476273|NCT04235504|323535334|FG001|Study Phase|Withdrawal by Subject|2|||
94476274|NCT04235504|323535335|FG002|Study Phase|Withdrawal by Subject|0|||
94476275|NCT04235504|323535336|FG003|Study Phase|Withdrawal by Subject|0|||
94476276|NCT04235504|323535333|FG000|Continuation Phase|Withdrawal by Subject|0|||
94476277|NCT04235504|323535334|FG001|Continuation Phase|Withdrawal by Subject|4|||
94476278|NCT04235504|323535335|FG002|Continuation Phase|Withdrawal by Subject|0|||
94476279|NCT04235504|323535336|FG003|Continuation Phase|Withdrawal by Subject|0|||
94476280|NCT04235504|323535333|FG000|Continuation Phase|Adverse Event|0|||
94476281|NCT04235504|323535334|FG001|Continuation Phase|Adverse Event|1|||
94476282|NCT04235504|323535335|FG002|Continuation Phase|Adverse Event|0|||
94476283|NCT04235504|323535336|FG003|Continuation Phase|Adverse Event|0|||
94476284|NCT04235504|323535333|FG000|Continuation Phase|Physician Decision|1|||
94476285|NCT04235504|323535334|FG001|Continuation Phase|Physician Decision|2|||
94476286|NCT04235504|323535335|FG002|Continuation Phase|Physician Decision|1|||
94476287|NCT04235504|323535336|FG003|Continuation Phase|Physician Decision|0|||
94476288|NCT02576977|323536677|FG000|Overall Study|Adverse Event|13|||
94476289|NCT02576977|323536678|FG001|Overall Study|Adverse Event|2|||
94476290|NCT02576977|323536677|FG000|Overall Study|Death|73|||
94476291|NCT02576977|323536678|FG001|Overall Study|Death|60|||
94476292|NCT02576977|323536677|FG000|Overall Study|Screen failure|1|||
94476293|NCT02576977|323536678|FG001|Overall Study|Screen failure|0|||
94476294|NCT02576977|323536677|FG000|Overall Study|Study Terminated at Selected Sites|27|||
94476295|NCT02576977|323536678|FG001|Overall Study|Study Terminated at Selected Sites|50|||
94476296|NCT02576977|323536677|FG000|Overall Study|Withdrawal by Subject|11|||
94476297|NCT02576977|323536678|FG001|Overall Study|Withdrawal by Subject|11|||
94476298|NCT02576977|323536677|FG000|Overall Study|Final Disposition Unknown|0|||
94476299|NCT02576977|323536678|FG001|Overall Study|Final Disposition Unknown|1|||
94476300|NCT02576977|323536677|FG000|Overall Study|Lost to Follow-up|1|||
94476301|NCT02576977|323536678|FG001|Overall Study|Lost to Follow-up|0|||
94476302|NCT02576977|323536677|FG000|Overall Study|Progressive Disease|0|||
94476303|NCT02576977|323536678|FG001|Overall Study|Progressive Disease|1|||
94476304|NCT03654729|323536679|FG000|Overall Study|Death|9|||
94476305|NCT03654729|323536680|FG001|Overall Study|Death|9|||
94476306|NCT03654729|323536681|FG002|Overall Study|Death|16|||
94476307|NCT03654729|323536679|FG000|Overall Study|Withdrawal by Subject|8|||
94476308|NCT03654729|323536680|FG001|Overall Study|Withdrawal by Subject|6|||
94476309|NCT03654729|323536681|FG002|Overall Study|Withdrawal by Subject|4|||
94476310|NCT03654729|323536679|FG000|Overall Study|Study terminated by Sponsor|3|||
94476311|NCT03654729|323536680|FG001|Overall Study|Study terminated by Sponsor|5|||
94476312|NCT03654729|323536681|FG002|Overall Study|Study terminated by Sponsor|4|||
94476313|NCT03654729|323536679|FG000|Overall Study|Not reported|2|||
94476314|NCT03654729|323536680|FG001|Overall Study|Not reported|4|||
94476315|NCT03654729|323536681|FG002|Overall Study|Not reported|5|||
94476316|NCT03654729|323536679|FG000|Overall Study|Progressive disease|3|||
94476317|NCT03654729|323536680|FG001|Overall Study|Progressive disease|0|||
94476318|NCT03654729|323536681|FG002|Overall Study|Progressive disease|0|||
94476319|NCT03654729|323536679|FG000|Overall Study|Lost to Follow-up|2|||
94476320|NCT03654729|323536680|FG001|Overall Study|Lost to Follow-up|0|||
94476321|NCT03654729|323536681|FG002|Overall Study|Lost to Follow-up|0|||
94476322|NCT03654729|323536679|FG000|Overall Study|Physician Decision|2|||
94476323|NCT03654729|323536680|FG001|Overall Study|Physician Decision|0|||
94476324|NCT03654729|323536681|FG002|Overall Study|Physician Decision|0|||
94476325|NCT03654729|323536679|FG000|Overall Study|Protocol Violation|1|||
94476326|NCT03654729|323536680|FG001|Overall Study|Protocol Violation|1|||
94476327|NCT03654729|323536681|FG002|Overall Study|Protocol Violation|0|||
94476328|NCT03654729|323536679|FG000|Overall Study|Non-compliance with study drug|0|||
94476329|NCT03654729|323536680|FG001|Overall Study|Non-compliance with study drug|1|||
94476330|NCT03654729|323536681|FG002|Overall Study|Non-compliance with study drug|0|||
94476331|NCT03654729|323536679|FG000|Overall Study|Site terminated by Sponsor|1|||
94476332|NCT03654729|323536680|FG001|Overall Study|Site terminated by Sponsor|0|||
94476333|NCT03654729|323536681|FG002|Overall Study|Site terminated by Sponsor|0|||
94314031|NCT02042404|322934642|FG000|Overall Study|Inability to meet time requirements|1|||
94384385|NCT00386009|323193172|FG000|Overall Study|Protocol Violation|1|||
94384386|NCT00386009|323193173|FG001|Overall Study|Protocol Violation|0|||
94384387|NCT00386009|323193172|FG000|Overall Study|Sponsor Decision|1|||
94384388|NCT00386009|323193173|FG001|Overall Study|Sponsor Decision|1|||
94384389|NCT00386009|323193172|FG000|Overall Study|Withdrawal by Subject|5|||
94384390|NCT00386009|323193173|FG001|Overall Study|Withdrawal by Subject|4|||
94384391|NCT00995553|323193179|FG000|Overall Study|Withdrawal by Subject|2|||
94384392|NCT00995553|323193180|FG001|Overall Study|Withdrawal by Subject|6|||
94384393|NCT01273181|323193183|FG000|Phase I, Dose 1|Study termination|1|||
94384394|NCT01273181|323193184|FG001|Phase I, Dose 1|Study termination|0|||
94384395|NCT01273181|323193185|FG002|Phase I, Dose 1|Study termination|0|||
94384396|NCT01273181|323193186|FG003|Phase I, Dose 1|Study termination|0|||
94384397|NCT01273181|323193183|FG000|Phase I, Dose 2|Death during treatment|0|||
94384398|NCT01273181|323193184|FG001|Phase I, Dose 2|Death during treatment|1|||
94384399|NCT01273181|323193185|FG002|Phase I, Dose 2|Death during treatment|0|||
94384400|NCT01273181|323193186|FG003|Phase I, Dose 2|Death during treatment|0|||
94384401|NCT01273181|323193183|FG000|Phase 2, Dose 1|Study termination|0|||
94384402|NCT01273181|323193184|FG001|Phase 2, Dose 1|Study termination|0|||
94384403|NCT01273181|323193185|FG002|Phase 2, Dose 1|Study termination|1|||
94384404|NCT01273181|323193186|FG003|Phase 2, Dose 1|Study termination|0|||
94384405|NCT01273181|323193183|FG000|Phase 2, Dose 2|Death during treatment|0|||
94384406|NCT01273181|323193184|FG001|Phase 2, Dose 2|Death during treatment|0|||
94384407|NCT01273181|323193185|FG002|Phase 2, Dose 2|Death during treatment|0|||
94384408|NCT01273181|323193186|FG003|Phase 2, Dose 2|Death during treatment|1|||
94384409|NCT00604500|323193187|FG000|Overall Study|Adverse Event|2|||
94384410|NCT00604500|323193187|FG000|Overall Study|Protocol Violation|2|||
94384411|NCT00604500|323193187|FG000|Overall Study|Treatment Failure|1|||
94384412|NCT00604500|323193187|FG000|Overall Study|Withdrawal by Subject|4|||
94384413|NCT00604500|323193187|FG000|Overall Study|Administrative|1|||
94384414|NCT00604500|323193187|FG000|Overall Study|Did not meet protocol eligibility|1|||
94384415|NCT00669864|323193190|FG000|Overall Study|Lost to Follow-up|2|||
94384416|NCT00669864|323193190|FG000|Overall Study|Protocol Violation|2|||
94384417|NCT00669864|323193190|FG000|Overall Study|Withdrawal by Subject|3|||
94384418|NCT00669864|323193190|FG000|Overall Study|Other|2|||
94384419|NCT01265784|323193191|FG000|Overall Study|Lost to Follow-up|5|||
94384420|NCT01265784|323193192|FG001|Overall Study|Lost to Follow-up|3|||
94384421|NCT01265784|323193193|FG002|Overall Study|Lost to Follow-up|2|||
94384422|NCT01265784|323193191|FG000|Overall Study|Withdrawal by Subject|0|||
94476334|NCT01128400|323536682|FG000|Overall Study|Lost to Follow-up|1|||
94476335|NCT01128400|323536683|FG001|Overall Study|Lost to Follow-up|0|||
94314032|NCT02042404|322934643|FG001|Overall Study|Inability to meet time requirements|0|||
94314033|NCT02834403|322934646|FG000|Overall Study|Physician Decision|2|||
94314034|NCT02834403|322934647|FG001|Overall Study|Physician Decision|1|||
94314035|NCT02834403|322934648|FG002|Overall Study|Physician Decision|2|||
94314036|NCT02834403|322934649|FG003|Overall Study|Physician Decision|1|||
94314037|NCT02834403|322934650|FG004|Overall Study|Physician Decision|1|||
94314038|NCT02834403|322934651|FG005|Overall Study|Physician Decision|2|||
94314039|NCT02834403|322934652|FG006|Overall Study|Physician Decision|12|||
94314040|NCT02834403|322934646|FG000|Overall Study|Adverse Event|0|||
94314041|NCT02834403|322934647|FG001|Overall Study|Adverse Event|0|||
94314042|NCT02834403|322934648|FG002|Overall Study|Adverse Event|0|||
94314043|NCT02834403|322934649|FG003|Overall Study|Adverse Event|0|||
94314044|NCT02834403|322934650|FG004|Overall Study|Adverse Event|1|||
94314045|NCT02834403|322934651|FG005|Overall Study|Adverse Event|1|||
94384423|NCT01265784|323193192|FG001|Overall Study|Withdrawal by Subject|5|||
94384424|NCT01265784|323193193|FG002|Overall Study|Withdrawal by Subject|0|||
94384425|NCT01265784|323193191|FG000|Overall Study|Physician Decision|1|||
94384426|NCT01265784|323193192|FG001|Overall Study|Physician Decision|0|||
94384427|NCT01265784|323193193|FG002|Overall Study|Physician Decision|1|||
94384428|NCT01265784|323193191|FG000|Overall Study|Adverse Event|1|||
94384429|NCT01265784|323193192|FG001|Overall Study|Adverse Event|0|||
94384430|NCT01265784|323193193|FG002|Overall Study|Adverse Event|0|||
94384431|NCT01265784|323193191|FG000|Overall Study|Death|3|||
94384432|NCT01265784|323193192|FG001|Overall Study|Death|0|||
94384433|NCT01265784|323193193|FG002|Overall Study|Death|0|||
94384434|NCT01265784|323193191|FG000|Overall Study|Protocol Violation|2|||
94384435|NCT01265784|323193192|FG001|Overall Study|Protocol Violation|0|||
94384436|NCT01265784|323193193|FG002|Overall Study|Protocol Violation|0|||
94314046|NCT02834403|322934652|FG006|Overall Study|Adverse Event|3|||
94314047|NCT02834403|322934646|FG000|Overall Study|Withdrawal by Subject|0|||
94476336|NCT01128400|323536684|FG002|Overall Study|Lost to Follow-up|1|||
94314048|NCT02834403|322934647|FG001|Overall Study|Withdrawal by Subject|1|||
94314049|NCT02834403|322934648|FG002|Overall Study|Withdrawal by Subject|0|||
94314050|NCT02834403|322934649|FG003|Overall Study|Withdrawal by Subject|0|||
94314051|NCT02834403|322934650|FG004|Overall Study|Withdrawal by Subject|1|||
94314052|NCT02834403|322934651|FG005|Overall Study|Withdrawal by Subject|0|||
94314053|NCT02834403|322934652|FG006|Overall Study|Withdrawal by Subject|0|||
94314054|NCT02834403|322934646|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
94314055|NCT02834403|322934647|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
94314056|NCT02834403|322934648|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
94314057|NCT02834403|322934649|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
94314058|NCT02834403|322934650|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
94314059|NCT02834403|322934651|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
94314060|NCT02834403|322934652|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
94384437|NCT01265784|323193191|FG000|Overall Study|Incorrectly Randomized|0|||
94384438|NCT01265784|323193192|FG001|Overall Study|Incorrectly Randomized|0|||
94384439|NCT01265784|323193193|FG002|Overall Study|Incorrectly Randomized|1|||
94384440|NCT00796822|323193194|FG000|Overall Study|Lost to Follow-up|2|||
94384441|NCT00796822|323193195|FG001|Overall Study|Lost to Follow-up|0|||
94384442|NCT00796822|323193194|FG000|Overall Study|Adverse Event|1|||
94384443|NCT00796822|323193195|FG001|Overall Study|Adverse Event|0|||
94384444|NCT02672553|323193198|FG000|Overall Study|Death|3|||
94384445|NCT02672553|323193199|FG001|Overall Study|Death|5|||
94384446|NCT02672553|323193198|FG000|Overall Study|Valve Explant|1|||
94384447|NCT02672553|323193199|FG001|Overall Study|Valve Explant|0|||
94384448|NCT02672553|323193198|FG000|Overall Study|Conversion to Commercial Valve|3|||
94384449|NCT02672553|323193199|FG001|Overall Study|Conversion to Commercial Valve|0|||
94384450|NCT02672553|323193198|FG000|Overall Study|Withdrawal by Subject|3|||
94384451|NCT02672553|323193199|FG001|Overall Study|Withdrawal by Subject|3|||
94384452|NCT02672553|323193198|FG000|Overall Study|Intraoperative screen failure|2|||
94384453|NCT02672553|323193199|FG001|Overall Study|Intraoperative screen failure|0|||
94384454|NCT01004172|323193200|FG000|Overall Study|Progressive Disease in CNS Only|16|||
94384455|NCT01004172|323193200|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
94384456|NCT01004172|323193200|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
94384457|NCT01004172|323193200|FG000|Overall Study|Adverse Event|1|||
94384458|NCT01004172|323193200|FG000|Overall Study|Physician Decision|1|||
94384459|NCT01004172|323193200|FG000|Overall Study|Symptomatic Deterioration|2|||
94384460|NCT04025879|323193213|FG000|Randomization|Participant withdrew consent|0|||
94384461|NCT04025879|323193214|FG001|Randomization|Participant withdrew consent|1|||
94384462|NCT04025879|323193213|FG000|Randomization|Participant no longer met study criteria|1|||
94384463|NCT04025879|323193214|FG001|Randomization|Participant no longer met study criteria|1|||
94384464|NCT04025879|323193213|FG000|Treatment|Ongoing treatment|10|||
94384465|NCT04025879|323193214|FG001|Treatment|Ongoing treatment|8|||
94384466|NCT04025879|323193213|FG000|Treatment|Disease progression/recurrence|36|||
94384467|NCT04025879|323193214|FG001|Treatment|Disease progression/recurrence|72|||
94384468|NCT04025879|323193213|FG000|Treatment|Study drug toxicity|36|||
94384469|NCT04025879|323193214|FG001|Treatment|Study drug toxicity|13|||
94384470|NCT04025879|323193213|FG000|Treatment|Death|2|||
94384471|NCT04025879|323193214|FG001|Treatment|Death|0|||
94384472|NCT04025879|323193213|FG000|Treatment|Adverse event unrelated to study drug|21|||
94384473|NCT04025879|323193214|FG001|Treatment|Adverse event unrelated to study drug|14|||
94384474|NCT04025879|323193213|FG000|Treatment|Participant request to discontinue study treatment|16|||
94384475|NCT04025879|323193214|FG001|Treatment|Participant request to discontinue study treatment|8|||
94384476|NCT04025879|323193213|FG000|Treatment|Participant withdrew consent|1|||
94384477|NCT04025879|323193214|FG001|Treatment|Participant withdrew consent|3|||
94384478|NCT04025879|323193213|FG000|Treatment|Participant no longer meets study criteria|3|||
94384479|NCT04025879|323193214|FG001|Treatment|Participant no longer meets study criteria|2|||
94384480|NCT04025879|323193213|FG000|Treatment|Lost to Follow-up|1|||
94384481|NCT04025879|323193214|FG001|Treatment|Lost to Follow-up|0|||
94384482|NCT04025879|323193213|FG000|Treatment|Other reasons|15|||
94384483|NCT04025879|323193214|FG001|Treatment|Other reasons|17|||
94384484|NCT04025879|323193213|FG000|Treatment|Administrative reason by sponsor|0|||
94384485|NCT04025879|323193214|FG001|Treatment|Administrative reason by sponsor|1|||
94384486|NCT04025879|323193213|FG000|Treatment|Not reported|2|||
94314061|NCT00726323|322934653|FG000|Overall Study|Withdrawal by Subject|3|||
94384487|NCT04025879|323193214|FG001|Treatment|Not reported|0|||
94384488|NCT04529109|323193217|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
94384489|NCT04529109|323193218|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
94384490|NCT01432171|323193221|FG000|Overall Study|Death|1|||
94384491|NCT01432171|323193222|FG001|Overall Study|Death|2|||
94384492|NCT01432171|323193221|FG000|Overall Study|Lost to Follow-up|6|||
94384493|NCT01432171|323193222|FG001|Overall Study|Lost to Follow-up|5|||
94384494|NCT01432171|323193221|FG000|Overall Study|Withdrawal by Subject|3|||
94384495|NCT01432171|323193222|FG001|Overall Study|Withdrawal by Subject|1|||
94384496|NCT01432171|323193221|FG000|Overall Study|Noncompliance|2|||
94476337|NCT01128400|323536682|FG000|Overall Study|Screening failure|1|||
94476338|NCT01128400|323536683|FG001|Overall Study|Screening failure|0|||
94476339|NCT01128400|323536684|FG002|Overall Study|Screening failure|0|||
94476340|NCT01128400|323536682|FG000|Overall Study|were not invited to participate on taste|0|||
94476341|NCT01128400|323536683|FG001|Overall Study|were not invited to participate on taste|0|||
94476342|NCT01128400|323536684|FG002|Overall Study|were not invited to participate on taste|15|||
94476343|NCT01128400|323536682|FG000|Overall Study|Excluded due to sinus problems|0|||
94476344|NCT01128400|323536683|FG001|Overall Study|Excluded due to sinus problems|1|||
94476345|NCT01128400|323536684|FG002|Overall Study|Excluded due to sinus problems|0|||
94476346|NCT04441788|323536685|FG000|Overall Study|Voluntary Withdrawl|0|||
94476347|NCT04441788|323536686|FG001|Overall Study|Voluntary Withdrawl|1|||
94476348|NCT04441788|323536687|FG002|Overall Study|Voluntary Withdrawl|0|||
94476349|NCT04441788|323536685|FG000|Overall Study|Ineligibility|1|||
94476350|NCT04441788|323536686|FG001|Overall Study|Ineligibility|0|||
94476351|NCT04441788|323536687|FG002|Overall Study|Ineligibility|0|||
94476352|NCT04441788|323536685|FG000|Overall Study|Adverse Event|0|||
94476353|NCT04441788|323536686|FG001|Overall Study|Adverse Event|0|||
94476354|NCT04441788|323536687|FG002|Overall Study|Adverse Event|4|||
94476355|NCT04441788|323536685|FG000|Overall Study|Study Terminated by Sponsor|16|||
94476356|NCT04441788|323536686|FG001|Overall Study|Study Terminated by Sponsor|16|||
94476357|NCT04441788|323536687|FG002|Overall Study|Study Terminated by Sponsor|12|||
94476358|NCT01677182|323536688|FG000|Overall Study|Adverse Event|2|||
94476359|NCT01677182|323536689|FG001|Overall Study|Adverse Event|1|||
94476360|NCT01677182|323536690|FG002|Overall Study|Adverse Event|8|||
94476361|NCT01677182|323536688|FG000|Overall Study|Protocol Violation|5|||
94476362|NCT01677182|323536689|FG001|Overall Study|Protocol Violation|1|||
94476363|NCT01677182|323536690|FG002|Overall Study|Protocol Violation|4|||
94476364|NCT01677182|323536688|FG000|Overall Study|Lost to Follow-up|4|||
94476365|NCT01677182|323536689|FG001|Overall Study|Lost to Follow-up|0|||
94476366|NCT01677182|323536690|FG002|Overall Study|Lost to Follow-up|3|||
94476367|NCT01677182|323536688|FG000|Overall Study|Withdrawal by Subject|7|||
94476368|NCT01677182|323536689|FG001|Overall Study|Withdrawal by Subject|12|||
94476369|NCT01677182|323536690|FG002|Overall Study|Withdrawal by Subject|10|||
94476370|NCT01677182|323536688|FG000|Overall Study|Study termination|12|||
94476371|NCT01677182|323536689|FG001|Overall Study|Study termination|9|||
94476372|NCT01677182|323536690|FG002|Overall Study|Study termination|11|||
94476373|NCT01677182|323536688|FG000|Overall Study|Lack of Efficacy|3|||
94476374|NCT01677182|323536689|FG001|Overall Study|Lack of Efficacy|0|||
94476375|NCT01677182|323536690|FG002|Overall Study|Lack of Efficacy|1|||
94476376|NCT01677182|323536688|FG000|Overall Study|Other reasons|1|||
94476377|NCT01677182|323536689|FG001|Overall Study|Other reasons|5|||
94476378|NCT01677182|323536690|FG002|Overall Study|Other reasons|2|||
94476379|NCT04727528|323536694|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
94476380|NCT04727528|323536695|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
94314062|NCT00726323|322934654|FG001|Overall Study|Withdrawal by Subject|1|||
94476381|NCT04727528|323536694|FG000|Open-label Period|Randomized who did not receive treatment|1|||
94314063|NCT00726323|322934653|FG000|Overall Study|Physician Decision|1|||
94314064|NCT00726323|322934654|FG001|Overall Study|Physician Decision|0|||
94314065|NCT00726323|322934653|FG000|Overall Study|Progressive disease|23|||
94314066|NCT00726323|322934654|FG001|Overall Study|Progressive disease|16|||
94314067|NCT00726323|322934653|FG000|Overall Study|Clinical progression|0|||
94314068|NCT00726323|322934654|FG001|Overall Study|Clinical progression|3|||
94314069|NCT00726323|322934653|FG000|Overall Study|Adverse Event|9|||
94314070|NCT00726323|322934654|FG001|Overall Study|Adverse Event|9|||
94314071|NCT00726323|322934653|FG000|Overall Study|Death|1|||
94314072|NCT00726323|322934654|FG001|Overall Study|Death|0|||
94314073|NCT00726323|322934653|FG000|Overall Study|Participant wished to discontinue|0|||
94314074|NCT00726323|322934654|FG001|Overall Study|Participant wished to discontinue|1|||
94314075|NCT00726323|322934653|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
94314076|NCT00726323|322934654|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
94314077|NCT01028651|322934659|FG000|Overall Study|Death|2|||
94314078|NCT01028651|322934659|FG000|Overall Study|Adverse Event|1|||
94314079|NCT01533935|322934660|FG000|Overall Study|Adverse Event|5|||
94314080|NCT01533935|322934661|FG001|Overall Study|Adverse Event|7|||
94314081|NCT01533935|322934662|FG002|Overall Study|Adverse Event|1|||
94314082|NCT01533935|322934663|FG003|Overall Study|Adverse Event|5|||
94476382|NCT04727528|323536695|FG001|Open-label Period|Randomized who did not receive treatment|0|||
94476383|NCT04727528|323536694|FG000|Double-blind Treatment Phase|Adverse Event|0|||
94314083|NCT01533935|322934664|FG004|Overall Study|Adverse Event|3|||
94314084|NCT01533935|322934660|FG000|Overall Study|Protocol Violation|0|||
94314085|NCT01533935|322934661|FG001|Overall Study|Protocol Violation|2|||
94314086|NCT01533935|322934662|FG002|Overall Study|Protocol Violation|0|||
94476384|NCT04727528|323536695|FG001|Double-blind Treatment Phase|Adverse Event|1|||
94476385|NCT04727528|323536694|FG000|Double-blind Treatment Phase|Death|0|||
94476386|NCT04727528|323536695|FG001|Double-blind Treatment Phase|Death|1|||
94314087|NCT01533935|322934663|FG003|Overall Study|Protocol Violation|0|||
94476387|NCT04727528|323536694|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
94476388|NCT04727528|323536695|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
94476389|NCT04727528|323536694|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
94476390|NCT04727528|323536695|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
94476391|NCT04727528|323536694|FG000|Double-blind Treatment Phase|Physician Decision|0|||
94476392|NCT04727528|323536695|FG001|Double-blind Treatment Phase|Physician Decision|1|||
94476393|NCT04727528|323536694|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
94476394|NCT04727528|323536695|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
94476395|NCT02030119|323536698|FG000|Overall Study|Withdrawal by Subject|3|||
94476396|NCT02030119|323536699|FG001|Overall Study|Withdrawal by Subject|1|||
94476397|NCT02030119|323536700|FG002|Overall Study|Withdrawal by Subject|5|||
94476398|NCT02030119|323536701|FG003|Overall Study|Withdrawal by Subject|3|||
94476399|NCT02030119|323536698|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
94476400|NCT02030119|323536699|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
94476401|NCT02030119|323536700|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
94476402|NCT02030119|323536701|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
94476403|NCT01310127|323536709|FG000|Overall Study|Protocol Violation|1|||
94476404|NCT01310127|323536710|FG001|Overall Study|Protocol Violation|1|||
94476405|NCT01310127|323536709|FG000|Overall Study|advanced psc cataract outlier|1|||
94476406|NCT01310127|323536710|FG001|Overall Study|advanced psc cataract outlier|0|||
94476407|NCT00412932|323536711|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
94476408|NCT00412932|323536711|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
94476409|NCT00412932|323536711|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
94476410|NCT00412932|323536711|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
94476411|NCT00412932|323536711|FG000|Olmesartan (Olm) 20 mg|Other|1|||
94476412|NCT00412932|323536711|FG000|Olmesartan 40 mg|Adverse Event|4|||
94476413|NCT00412932|323536711|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
94476414|NCT00412932|323536711|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
94476415|NCT00412932|323536711|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
94476416|NCT00412932|323536711|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
94476417|NCT00412932|323536711|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
94476418|NCT00412932|323536711|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
94476419|NCT02781818|323536712|FG000|Overall Study|Lost to Follow-up|4|||
94476420|NCT02781818|323536713|FG001|Overall Study|Lost to Follow-up|2|||
94476421|NCT02781818|323536714|FG002|Overall Study|Lost to Follow-up|1|||
94476422|NCT00697593|323536717|FG000|Overall Study|Adverse Event|3|||
94476423|NCT00697593|323536717|FG000|Overall Study|Protocol Violation|1|||
94476424|NCT00697593|323536717|FG000|Overall Study|Lack of Efficacy|3|||
94476425|NCT00697593|323536717|FG000|Overall Study|Suspension of the study by sponsor|12|||
94476426|NCT02964338|323536718|FG000|Overall Study|Sponsor terminated study for futility|12|||
94476427|NCT02964338|323536719|FG001|Overall Study|Sponsor terminated study for futility|15|||
94476428|NCT02964338|323536720|FG002|Overall Study|Sponsor terminated study for futility|14|||
94476429|NCT02964338|323536718|FG000|Overall Study|Lack of Efficacy|0|||
94476430|NCT02964338|323536719|FG001|Overall Study|Lack of Efficacy|3|||
94476431|NCT02964338|323536720|FG002|Overall Study|Lack of Efficacy|0|||
94476432|NCT02964338|323536718|FG000|Overall Study|Lost to Follow-up|1|||
94476433|NCT02964338|323536719|FG001|Overall Study|Lost to Follow-up|0|||
94476434|NCT02964338|323536720|FG002|Overall Study|Lost to Follow-up|3|||
94476435|NCT02964338|323536718|FG000|Overall Study|Protocol Violation|0|||
94476436|NCT02964338|323536719|FG001|Overall Study|Protocol Violation|1|||
94476437|NCT02964338|323536720|FG002|Overall Study|Protocol Violation|0|||
94476438|NCT02964338|323536718|FG000|Overall Study|Withdrawal by Subject|1|||
94476439|NCT02964338|323536719|FG001|Overall Study|Withdrawal by Subject|3|||
94476440|NCT02964338|323536720|FG002|Overall Study|Withdrawal by Subject|1|||
94476441|NCT02964338|323536718|FG000|Overall Study|Adverse Event|2|||
94476442|NCT02964338|323536719|FG001|Overall Study|Adverse Event|1|||
94476443|NCT02964338|323536720|FG002|Overall Study|Adverse Event|1|||
94476444|NCT02964338|323536718|FG000|Overall Study|Non-compliant with e-diary|0|||
94476445|NCT02964338|323536719|FG001|Overall Study|Non-compliant with e-diary|1|||
94476446|NCT02964338|323536720|FG002|Overall Study|Non-compliant with e-diary|0|||
94476447|NCT02964338|323536718|FG000|Overall Study|Did not meet criteria|1|||
94476448|NCT02964338|323536719|FG001|Overall Study|Did not meet criteria|0|||
94476449|NCT02964338|323536720|FG002|Overall Study|Did not meet criteria|0|||
94476450|NCT02485483|323536721|FG000|Overall Study|Depression at baseline|15|||
94476451|NCT02485483|323536722|FG001|Overall Study|Depression at baseline|0|||
94476452|NCT02485483|323536721|FG000|Overall Study|Discontinued after baseline|39|||
94476453|NCT02485483|323536722|FG001|Overall Study|Discontinued after baseline|0|||
94476454|NCT00667563|323536726|FG000|Overall Study|Protocol Violation|24|||
94476455|NCT02075008|323536727|FG000|Overall Study|Technical problems|1|||
94476456|NCT02075008|323536727|FG000|Overall Study|Pregnancy|1|||
94476457|NCT02075008|323536727|FG000|Overall Study|Physician Decision|1|||
94476458|NCT02075008|323536727|FG000|Overall Study|Lost to Follow-up|1|||
94476459|NCT02075008|323536727|FG000|Overall Study|Lack of Efficacy|1|||
94476460|NCT02075008|323536727|FG000|Overall Study|Death|1|||
94476461|NCT02075008|323536727|FG000|Overall Study|Adverse Event|5|||
94476462|NCT02075008|323536727|FG000|Overall Study|Withdrawal by Subject|6|||
94476463|NCT02075008|323536727|FG000|Overall Study|Study terminated by Sponsor|159|||
94476464|NCT02821416|323536728|FG000|Overall Study|Adverse Event|0|||
94476465|NCT02821416|323536729|FG001|Overall Study|Adverse Event|1|||
94476466|NCT02821416|323536728|FG000|Overall Study|Withdrawal by Subject|2|||
94476467|NCT02821416|323536729|FG001|Overall Study|Withdrawal by Subject|0|||
94476468|NCT02821416|323536728|FG000|Overall Study|Lost to Follow-up|1|||
94476469|NCT02821416|323536729|FG001|Overall Study|Lost to Follow-up|0|||
94476470|NCT02465437|323536730|FG000|Overall Study|Physician Decision|0|||
94476471|NCT02465437|323536731|FG001|Overall Study|Physician Decision|0|||
94476472|NCT02465437|323536732|FG002|Overall Study|Physician Decision|1|||
94476473|NCT02465437|323536733|FG003|Overall Study|Physician Decision|0|||
94476474|NCT02465437|323536730|FG000|Overall Study|Withdrawal by Subject|1|||
94476475|NCT02465437|323536731|FG001|Overall Study|Withdrawal by Subject|0|||
94476476|NCT02465437|323536732|FG002|Overall Study|Withdrawal by Subject|0|||
94476477|NCT02465437|323536733|FG003|Overall Study|Withdrawal by Subject|1|||
94476478|NCT02465437|323536730|FG000|Overall Study|Adverse Event|0|||
94476479|NCT02465437|323536731|FG001|Overall Study|Adverse Event|1|||
94476480|NCT02465437|323536732|FG002|Overall Study|Adverse Event|0|||
94476481|NCT02465437|323536733|FG003|Overall Study|Adverse Event|0|||
94476482|NCT01001520|323536738|FG000|Medication Period 1|Withdrawal by Subject|2|||
94476483|NCT01001520|323536739|FG001|Medication Period 1|Withdrawal by Subject|2|||
94476484|NCT01001520|323536738|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
94476485|NCT01001520|323536739|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
94476486|NCT01001520|323536738|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
94476487|NCT01001520|323536739|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
94476488|NCT01001520|323536738|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
94476489|NCT01001520|323536739|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
94476490|NCT01001520|323536738|FG000|Washout Period|Withdrawal by Subject|2|||
94476491|NCT01001520|323536739|FG001|Washout Period|Withdrawal by Subject|1|||
94476492|NCT01001520|323536738|FG000|Medication Period 2|Withdrawal by Subject|0|||
94476493|NCT01001520|323536739|FG001|Medication Period 2|Withdrawal by Subject|3|||
94476494|NCT02328937|323536741|FG000|Period 1|Lost to Follow-up|0|||
94476495|NCT02328937|323536742|FG001|Period 1|Lost to Follow-up|0|||
94476496|NCT02328937|323536743|FG002|Period 1|Lost to Follow-up|0|||
94476497|NCT02328937|323536744|FG003|Period 1|Lost to Follow-up|1|||
94476498|NCT02328937|323536745|FG004|Period 1|Lost to Follow-up|0|||
94476499|NCT02328937|323536746|FG005|Period 1|Lost to Follow-up|0|||
94476500|NCT02328937|323536741|FG000|Period 2|Adverse Event|0|||
94476501|NCT02328937|323536742|FG001|Period 2|Adverse Event|0|||
94476502|NCT02328937|323536743|FG002|Period 2|Adverse Event|1|||
94476503|NCT02328937|323536744|FG003|Period 2|Adverse Event|0|||
94476504|NCT02328937|323536745|FG004|Period 2|Adverse Event|0|||
94476505|NCT02328937|323536746|FG005|Period 2|Adverse Event|0|||
94476506|NCT01737879|323536754|FG000|Overall Study|Death|1|||
94476507|NCT01737879|323536754|FG000|Overall Study|Sponsor decision|40|||
94476508|NCT00436826|323536759|FG000|Double Blind Period (DBP)|Adverse Event|2|||
94314088|NCT01533935|322934664|FG004|Overall Study|Protocol Violation|0|||
94314089|NCT01533935|322934660|FG000|Overall Study|Lost to Follow-up|0|||
94314090|NCT01533935|322934661|FG001|Overall Study|Lost to Follow-up|0|||
94314091|NCT01533935|322934662|FG002|Overall Study|Lost to Follow-up|1|||
94314092|NCT01533935|322934663|FG003|Overall Study|Lost to Follow-up|0|||
94314093|NCT01533935|322934664|FG004|Overall Study|Lost to Follow-up|0|||
94314094|NCT01533935|322934660|FG000|Overall Study|Withdrawal by Subject|0|||
94314095|NCT01533935|322934661|FG001|Overall Study|Withdrawal by Subject|4|||
94314096|NCT01533935|322934662|FG002|Overall Study|Withdrawal by Subject|5|||
94476509|NCT00436826|323536760|FG001|Double Blind Period (DBP)|Adverse Event|0|||
94476510|NCT00436826|323536761|FG002|Double Blind Period (DBP)|Adverse Event|0|||
94476511|NCT00436826|323536762|FG003|Double Blind Period (DBP)|Adverse Event|0|||
94476512|NCT00436826|323536763|FG004|Double Blind Period (DBP)|Adverse Event|0|||
94476513|NCT00436826|323536764|FG005|Double Blind Period (DBP)|Adverse Event|0|||
94476514|NCT00436826|323536759|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
94476515|NCT00436826|323536760|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
94476516|NCT00436826|323536761|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
94476517|NCT00436826|323536762|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
94476518|NCT00436826|323536763|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
94476519|NCT00436826|323536764|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
94476520|NCT00436826|323536759|FG000|Double Blind Period (DBP)|Other|10|||
94476521|NCT00436826|323536760|FG001|Double Blind Period (DBP)|Other|11|||
94476522|NCT00436826|323536761|FG002|Double Blind Period (DBP)|Other|0|||
94476523|NCT00436826|323536762|FG003|Double Blind Period (DBP)|Other|0|||
94476524|NCT00436826|323536763|FG004|Double Blind Period (DBP)|Other|0|||
94476525|NCT00436826|323536764|FG005|Double Blind Period (DBP)|Other|0|||
94476526|NCT00436826|323536759|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
94476527|NCT00436826|323536760|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
94314097|NCT01533935|322934663|FG003|Overall Study|Withdrawal by Subject|2|||
94476528|NCT00436826|323536761|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
94476529|NCT00436826|323536762|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
94476530|NCT00436826|323536763|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
94476531|NCT00436826|323536764|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
94476532|NCT00436826|323536759|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
94476533|NCT00436826|323536760|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
94476534|NCT00436826|323536761|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
94476535|NCT00436826|323536762|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
94476536|NCT00436826|323536763|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
94476537|NCT00436826|323536764|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
94476538|NCT00436826|323536759|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
94476539|NCT00436826|323536760|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
94476540|NCT00436826|323536761|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
94476541|NCT00436826|323536762|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
94476542|NCT00436826|323536763|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
94476543|NCT00436826|323536764|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
94476544|NCT00784719|323536765|FG000|Overall Study|Adverse Event|0|||
94476545|NCT00784719|323536766|FG001|Overall Study|Adverse Event|2|||
94476546|NCT00784719|323536767|FG002|Overall Study|Adverse Event|0|||
94476547|NCT00784719|323536768|FG003|Overall Study|Adverse Event|0|||
94476548|NCT00784719|323536769|FG004|Overall Study|Adverse Event|1|||
94476549|NCT00784719|323536770|FG005|Overall Study|Adverse Event|1|||
94476550|NCT00784719|323536771|FG006|Overall Study|Adverse Event|1|||
94476551|NCT00784719|323536765|FG000|Overall Study|Lost to Follow-up|0|||
94476552|NCT00784719|323536766|FG001|Overall Study|Lost to Follow-up|0|||
94476553|NCT00784719|323536767|FG002|Overall Study|Lost to Follow-up|0|||
94476554|NCT00784719|323536768|FG003|Overall Study|Lost to Follow-up|0|||
94476555|NCT00784719|323536769|FG004|Overall Study|Lost to Follow-up|1|||
94476556|NCT00784719|323536770|FG005|Overall Study|Lost to Follow-up|1|||
94476557|NCT00784719|323536771|FG006|Overall Study|Lost to Follow-up|0|||
94476558|NCT00784719|323536765|FG000|Overall Study|Other|2|||
94476559|NCT00784719|323536766|FG001|Overall Study|Other|1|||
94476560|NCT00784719|323536767|FG002|Overall Study|Other|1|||
94476561|NCT00784719|323536768|FG003|Overall Study|Other|0|||
94476562|NCT00784719|323536769|FG004|Overall Study|Other|2|||
94476563|NCT00784719|323536770|FG005|Overall Study|Other|1|||
94476564|NCT00784719|323536771|FG006|Overall Study|Other|3|||
94476565|NCT00784719|323536765|FG000|Overall Study|Withdrawal by Subject|1|||
94476566|NCT00784719|323536766|FG001|Overall Study|Withdrawal by Subject|0|||
94476567|NCT00784719|323536767|FG002|Overall Study|Withdrawal by Subject|0|||
94476568|NCT00784719|323536768|FG003|Overall Study|Withdrawal by Subject|0|||
94476569|NCT00784719|323536769|FG004|Overall Study|Withdrawal by Subject|2|||
94476570|NCT00784719|323536770|FG005|Overall Study|Withdrawal by Subject|0|||
94476571|NCT00784719|323536771|FG006|Overall Study|Withdrawal by Subject|1|||
94476572|NCT04978337|323536772|FG000|Overall Study|Withdrawal by Subject|0|||
94476573|NCT04978337|323536773|FG001|Overall Study|Withdrawal by Subject|1|||
94476574|NCT06213701|323536781|FG000|Overall Study|Withdrawal by Subject|2|||
94476575|NCT06213701|323536782|FG001|Overall Study|Withdrawal by Subject|1|||
94476576|NCT06213701|323536783|FG002|Overall Study|Withdrawal by Subject|0|||
94476577|NCT03883477|323536786|FG000|Overall Study|Death|1|||
94476578|NCT03883477|323536787|FG001|Overall Study|Death|0|||
94476579|NCT03883477|323536786|FG000|Overall Study|Protocol Violation|0|||
94476580|NCT03883477|323536787|FG001|Overall Study|Protocol Violation|1|||
94476581|NCT00985686|323536790|FG000|Overall Study|Lost to Follow-up|1|||
94476582|NCT00985686|323536791|FG001|Overall Study|Lost to Follow-up|1|||
94476583|NCT00985686|323536792|FG002|Overall Study|Lost to Follow-up|0|||
94476584|NCT00985686|323536793|FG003|Overall Study|Lost to Follow-up|2|||
94476585|NCT03046953|323536801|FG000|Overall Study|Relapse/progressive disease|21|||
94476586|NCT03046953|323536801|FG000|Overall Study|Death|2|||
94476587|NCT03046953|323536801|FG000|Overall Study|Withdrawal by Subject|3|||
94476588|NCT03472521|323536804|FG000|Overall Study|Lost to Follow-up|3|||
94476589|NCT03472521|323536805|FG001|Overall Study|Lost to Follow-up|2|||
94476590|NCT03472521|323536804|FG000|Overall Study|Discontinued intervention|3|||
94476591|NCT03472521|323536805|FG001|Overall Study|Discontinued intervention|1|||
94476592|NCT02385110|323536806|FG000|Overall Study|Early Death|1|||
94476593|NCT02385110|323536807|FG001|Overall Study|Early Death|0|||
94476594|NCT03538691|323536815|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
94476595|NCT03538691|323536816|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
94476596|NCT03538691|323536817|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
94476597|NCT03538691|323536818|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
94476598|NCT03538691|323536815|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
94476599|NCT03538691|323536816|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
94476600|NCT03538691|323536817|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
94476601|NCT03538691|323536818|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
94476602|NCT03538691|323536815|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
94476603|NCT03538691|323536816|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
94476604|NCT03538691|323536817|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
94476605|NCT03538691|323536818|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
94476606|NCT03538691|323536815|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
94476607|NCT03538691|323536816|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
94476608|NCT03538691|323536817|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
94476609|NCT03538691|323536818|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
94476610|NCT03538691|323536815|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
94476611|NCT03538691|323536816|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
94476612|NCT03538691|323536817|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
94476613|NCT03538691|323536818|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
94476614|NCT03538691|323536815|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
94476615|NCT03538691|323536816|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
94476616|NCT03538691|323536817|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
94476617|NCT03538691|323536818|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
94476618|NCT03538691|323536815|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
94476619|NCT03538691|323536816|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
94476620|NCT03538691|323536817|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
94476621|NCT03538691|323536818|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
94476622|NCT03538691|323536815|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
94476623|NCT03538691|323536816|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
94476624|NCT03538691|323536817|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
94476625|NCT03538691|323536818|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
94476626|NCT03538691|323536815|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
94476627|NCT03538691|323536816|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
94476628|NCT03538691|323536817|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
94476629|NCT03538691|323536818|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
94476630|NCT03538691|323536815|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
94476631|NCT03538691|323536816|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
94476632|NCT03538691|323536817|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
94476633|NCT03538691|323536818|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
94476634|NCT03538691|323536815|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
94476635|NCT03538691|323536816|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
94476636|NCT03538691|323536817|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
94476637|NCT03538691|323536818|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
94476638|NCT03538691|323536815|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
94476639|NCT03538691|323536816|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
94476640|NCT03538691|323536817|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
94476641|NCT03538691|323536818|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
94476642|NCT03538691|323536815|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
94476643|NCT03538691|323536816|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
94476644|NCT03538691|323536817|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
94476645|NCT03538691|323536818|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
94476646|NCT03538691|323536815|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
94476647|NCT03538691|323536816|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
94476648|NCT03538691|323536817|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
94476649|NCT03538691|323536818|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
94476650|NCT03538691|323536815|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
94476651|NCT03538691|323536816|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
94476652|NCT03538691|323536817|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
94476653|NCT03538691|323536818|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
94476654|NCT03538691|323536815|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
94476655|NCT03538691|323536816|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
94476656|NCT03538691|323536817|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
94476657|NCT03538691|323536818|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
94476658|NCT03538691|323536815|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
94476659|NCT03538691|323536816|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
94476660|NCT03538691|323536817|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
94476661|NCT03538691|323536818|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
94314098|NCT01533935|322934664|FG004|Overall Study|Withdrawal by Subject|4|||
94314099|NCT01533935|322934660|FG000|Overall Study|Other reason not defined above|1|||
94314100|NCT01533935|322934661|FG001|Overall Study|Other reason not defined above|0|||
94314101|NCT01533935|322934662|FG002|Overall Study|Other reason not defined above|1|||
94384497|NCT01432171|323193222|FG001|Overall Study|Noncompliance|3|||
94384498|NCT01432171|323193221|FG000|Overall Study|Insurance denial trial coverage|1|||
94384499|NCT01432171|323193222|FG001|Overall Study|Insurance denial trial coverage|0|||
94384500|NCT01432171|323193221|FG000|Overall Study|Patient moved to palliative care|1|||
94384501|NCT01432171|323193222|FG001|Overall Study|Patient moved to palliative care|0|||
94384502|NCT03717064|323194808|FG000|Period 2|Adverse Event|1|||
94384503|NCT01298570|323194809|FG000|Overall Study|Disease progression, relapse during acti|64|||
94384504|NCT01298570|323194810|FG001|Overall Study|Disease progression, relapse during acti|40|||
94384505|NCT01298570|323194809|FG000|Overall Study|Adverse Event|20|||
94384506|NCT01298570|323194810|FG001|Overall Study|Adverse Event|2|||
94384507|NCT01298570|323194809|FG000|Overall Study|Withdrawal by Subject|21|||
94384508|NCT01298570|323194810|FG001|Overall Study|Withdrawal by Subject|6|||
94384509|NCT01298570|323194809|FG000|Overall Study|Treatment delay > 4 weeks|4|||
94384510|NCT01298570|323194810|FG001|Overall Study|Treatment delay > 4 weeks|5|||
94384511|NCT01298570|323194809|FG000|Overall Study|Physician Decision|4|||
94384512|NCT01298570|323194810|FG001|Overall Study|Physician Decision|2|||
94384513|NCT01298570|323194809|FG000|Overall Study|Other complicating disease|2|||
94384514|NCT01298570|323194810|FG001|Overall Study|Other complicating disease|1|||
94384515|NCT01298570|323194809|FG000|Overall Study|Surgery|2|||
94384516|NCT01298570|323194810|FG001|Overall Study|Surgery|1|||
94384517|NCT01298570|323194809|FG000|Overall Study|Symptomatic progression/deterioration|3|||
94384518|NCT01298570|323194810|FG001|Overall Study|Symptomatic progression/deterioration|2|||
94384519|NCT01298570|323194809|FG000|Overall Study|Death|0|||
94384520|NCT01298570|323194810|FG001|Overall Study|Death|1|||
94384521|NCT01298570|323194809|FG000|Overall Study|Ineligibility|0|||
94384522|NCT01298570|323194810|FG001|Overall Study|Ineligibility|1|||
94384523|NCT02841709|323194811|FG000|5th Intervention|Adverse Event|2|||
94314102|NCT01533935|322934663|FG003|Overall Study|Other reason not defined above|0|||
94314103|NCT01533935|322934664|FG004|Overall Study|Other reason not defined above|1|||
94314104|NCT00879814|322934665|FG000|Overall Study|Adverse Event|0|||
94314105|NCT00879814|322934666|FG001|Overall Study|Adverse Event|1|||
94314106|NCT00879814|322934667|FG002|Overall Study|Adverse Event|0|||
94314107|NCT00879814|322934668|FG003|Overall Study|Adverse Event|0|||
94314108|NCT00879814|322934665|FG000|Overall Study|Lost to Follow-up|1|||
94314109|NCT00879814|322934666|FG001|Overall Study|Lost to Follow-up|0|||
94314110|NCT00879814|322934667|FG002|Overall Study|Lost to Follow-up|0|||
94314111|NCT00879814|322934668|FG003|Overall Study|Lost to Follow-up|2|||
94314112|NCT00879814|322934665|FG000|Overall Study|Participant Failed to Return|0|||
94314113|NCT00879814|322934666|FG001|Overall Study|Participant Failed to Return|0|||
94314114|NCT00879814|322934667|FG002|Overall Study|Participant Failed to Return|0|||
94314115|NCT00879814|322934668|FG003|Overall Study|Participant Failed to Return|1|||
94314116|NCT00879814|322934665|FG000|Overall Study|Withdrawal by Subject|3|||
94314117|NCT00879814|322934666|FG001|Overall Study|Withdrawal by Subject|1|||
94314118|NCT00879814|322934667|FG002|Overall Study|Withdrawal by Subject|1|||
94314119|NCT00879814|322934668|FG003|Overall Study|Withdrawal by Subject|2|||
94314120|NCT00879814|322934665|FG000|Overall Study|Physician Decision|0|||
94314121|NCT00879814|322934666|FG001|Overall Study|Physician Decision|0|||
94314122|NCT00879814|322934667|FG002|Overall Study|Physician Decision|1|||
94314123|NCT00879814|322934668|FG003|Overall Study|Physician Decision|0|||
94314124|NCT00879814|322934665|FG000|Overall Study|Other|0|||
94314125|NCT00879814|322934666|FG001|Overall Study|Other|0|||
94314126|NCT00879814|322934667|FG002|Overall Study|Other|1|||
94314127|NCT00879814|322934668|FG003|Overall Study|Other|0|||
94314128|NCT02280291|322934669|FG000|Overall Study|Lost to Follow-up|2|||
94314129|NCT02280291|322934670|FG001|Overall Study|Lost to Follow-up|1|||
94314130|NCT02280291|322934671|FG002|Overall Study|Lost to Follow-up|3|||
94314131|NCT02280291|322934672|FG003|Overall Study|Lost to Follow-up|8|||
94314132|NCT02280291|322934669|FG000|Overall Study|Protocol Violation|1|||
94384524|NCT02841709|323194812|FG001|5th Intervention|Adverse Event|0|||
94384525|NCT02841709|323194813|FG002|5th Intervention|Adverse Event|0|||
94384526|NCT02841709|323194814|FG003|5th Intervention|Adverse Event|0|||
94384527|NCT02841709|323194815|FG004|5th Intervention|Adverse Event|2|||
94384528|NCT00863746|323194818|FG000|Treatment|Not treated|4|||
94384529|NCT00863746|323194819|FG001|Treatment|Not treated|2|||
94314133|NCT02280291|322934670|FG001|Overall Study|Protocol Violation|0|||
94314134|NCT02280291|322934671|FG002|Overall Study|Protocol Violation|0|||
94314135|NCT02280291|322934672|FG003|Overall Study|Protocol Violation|0|||
94314136|NCT02280291|322934669|FG000|Overall Study|Other|1|||
94314137|NCT02280291|322934670|FG001|Overall Study|Other|1|||
94314138|NCT02280291|322934671|FG002|Overall Study|Other|0|||
94314139|NCT02280291|322934672|FG003|Overall Study|Other|0|||
94314140|NCT03332667|322934673|FG000|Overall Study|Adverse Event|0|||
94314141|NCT03332667|322934674|FG001|Overall Study|Adverse Event|0|||
94384530|NCT00863746|323194818|FG000|Treatment|Adverse Event|41|||
94384531|NCT00863746|323194819|FG001|Treatment|Adverse Event|16|||
94476662|NCT03538691|323536815|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
94476663|NCT03538691|323536816|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
94476664|NCT03538691|323536817|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
94476665|NCT03538691|323536818|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
94476666|NCT03538691|323536815|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
94476667|NCT03538691|323536816|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
94476668|NCT03538691|323536817|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
94476669|NCT03538691|323536818|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
94476670|NCT03538691|323536815|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
94476671|NCT03538691|323536816|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
94476672|NCT03538691|323536817|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
94476673|NCT03538691|323536818|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
94476674|NCT03538691|323536815|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
94476675|NCT03538691|323536816|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
94476676|NCT03538691|323536817|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
94476677|NCT03538691|323536818|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
94476678|NCT03538691|323536815|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
94476679|NCT03538691|323536816|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
94476680|NCT03538691|323536817|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
94476681|NCT03538691|323536818|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
94476682|NCT03538691|323536815|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
94476683|NCT03538691|323536816|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
94476684|NCT03538691|323536817|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
94476685|NCT03538691|323536818|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
94476686|NCT03538691|323536815|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
94476687|NCT03538691|323536816|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
94476688|NCT03538691|323536817|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
94476689|NCT03538691|323536818|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
94476690|NCT03538691|323536815|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
94476691|NCT03538691|323536816|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
94476692|NCT03538691|323536817|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
94476693|NCT03538691|323536818|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
94476694|NCT03538691|323536815|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
94476695|NCT03538691|323536816|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
94476696|NCT03538691|323536817|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
94476697|NCT03538691|323536818|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
94476698|NCT03538691|323536815|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
94476699|NCT03538691|323536816|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
94476700|NCT03538691|323536817|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
94476701|NCT03538691|323536818|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
94476702|NCT03538691|323536815|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
94476703|NCT03538691|323536816|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
94476704|NCT03538691|323536817|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
94476705|NCT03538691|323536818|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
94476706|NCT00765817|323536819|FG000|Overall Study|Adverse Event|13|||
94476707|NCT00765817|323536820|FG001|Overall Study|Adverse Event|1|||
94476708|NCT00765817|323536819|FG000|Overall Study|Death|0|||
94476709|NCT00765817|323536820|FG001|Overall Study|Death|1|||
94476710|NCT00765817|323536819|FG000|Overall Study|Entry criteria not met|2|||
94476711|NCT00765817|323536820|FG001|Overall Study|Entry criteria not met|2|||
94476712|NCT00765817|323536819|FG000|Overall Study|Loss of glucose control|0|||
94476713|NCT00765817|323536820|FG001|Overall Study|Loss of glucose control|2|||
94476714|NCT00765817|323536819|FG000|Overall Study|Lost to Follow-up|1|||
94476715|NCT00765817|323536820|FG001|Overall Study|Lost to Follow-up|3|||
94476716|NCT00765817|323536819|FG000|Overall Study|Physician Decision|2|||
94476717|NCT00765817|323536820|FG001|Overall Study|Physician Decision|1|||
94476718|NCT00765817|323536819|FG000|Overall Study|Protocol Violation|1|||
94476719|NCT00765817|323536820|FG001|Overall Study|Protocol Violation|1|||
94476720|NCT00765817|323536819|FG000|Overall Study|Subject decision|7|||
94476721|NCT00765817|323536820|FG001|Overall Study|Subject decision|11|||
94476722|NCT00565604|323536826|FG000|Overall Study|Failure to treat|2|||
94476723|NCT00565604|323536826|FG000|Overall Study|Lost to Follow-up|2|||
94314142|NCT03332667|322934675|FG002|Overall Study|Adverse Event|2|||
94314143|NCT03332667|322934676|FG003|Overall Study|Adverse Event|1|||
94314144|NCT03332667|322934673|FG000|Overall Study|Withdrawal by Subject|2|||
94314145|NCT03332667|322934674|FG001|Overall Study|Withdrawal by Subject|1|||
94314146|NCT03332667|322934675|FG002|Overall Study|Withdrawal by Subject|5|||
94314147|NCT03332667|322934676|FG003|Overall Study|Withdrawal by Subject|1|||
94314148|NCT03332667|322934673|FG000|Overall Study|Disease Progression or Relapse|2|||
94314149|NCT03332667|322934674|FG001|Overall Study|Disease Progression or Relapse|1|||
94314150|NCT03332667|322934675|FG002|Overall Study|Disease Progression or Relapse|3|||
94314151|NCT03332667|322934676|FG003|Overall Study|Disease Progression or Relapse|0|||
94314152|NCT03332667|322934673|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
94314153|NCT03332667|322934674|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
94314154|NCT03332667|322934675|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
94314155|NCT03332667|322934676|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
94314156|NCT03332667|322934673|FG000|Overall Study|No Treatment Received|0|||
94314157|NCT03332667|322934674|FG001|Overall Study|No Treatment Received|0|||
94314158|NCT03332667|322934675|FG002|Overall Study|No Treatment Received|1|||
94314159|NCT03332667|322934676|FG003|Overall Study|No Treatment Received|0|||
94314160|NCT01035606|322934677|FG000|Overall Study|change in health, job demands,family|3|||
94314161|NCT01035606|322934678|FG001|Overall Study|change in health, job demands,family|3|||
94314162|NCT01035606|322934679|FG002|Overall Study|change in health, job demands,family|4|||
94314163|NCT01809262|322934680|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
94314164|NCT01809262|322934681|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
94314165|NCT01809262|322934682|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
94314166|NCT01809262|322934683|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
94314167|NCT01809262|322934684|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
94314168|NCT01809262|322934685|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
94314169|NCT01809262|322934686|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
94314170|NCT01809262|322934687|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
94314171|NCT01809262|322934688|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
94314172|NCT01809262|322934689|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
94314173|NCT01809262|322934680|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
94314174|NCT01809262|322934681|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
94314175|NCT01809262|322934682|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
94314176|NCT01809262|322934683|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
94314177|NCT01809262|322934684|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
94314178|NCT01809262|322934685|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
94314179|NCT01809262|322934686|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
94314180|NCT01809262|322934687|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
94314181|NCT01809262|322934688|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
94314182|NCT01809262|322934689|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
94314183|NCT02284906|322934690|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
94314184|NCT02284906|322934691|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
94314185|NCT02284906|322934692|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
94314186|NCT02284906|322934690|FG000|Overall Study|Major Protocol Deviation|0|||
94314187|NCT02284906|322934691|FG001|Overall Study|Major Protocol Deviation|1|||
94314188|NCT02284906|322934692|FG002|Overall Study|Major Protocol Deviation|0|||
94314189|NCT02284906|322934690|FG000|Overall Study|Voluntary Withdrawal|2|||
94314190|NCT02284906|322934691|FG001|Overall Study|Voluntary Withdrawal|4|||
94314191|NCT02284906|322934692|FG002|Overall Study|Voluntary Withdrawal|5|||
94314192|NCT02284906|322934690|FG000|Overall Study|Study Termination|0|||
94314193|NCT02284906|322934691|FG001|Overall Study|Study Termination|11|||
94314194|NCT02284906|322934692|FG002|Overall Study|Study Termination|14|||
94314195|NCT02284906|322934690|FG000|Overall Study|Reason not Specified|1|||
94314196|NCT02284906|322934691|FG001|Overall Study|Reason not Specified|1|||
94314197|NCT02284906|322934692|FG002|Overall Study|Reason not Specified|0|||
94314198|NCT02064439|322934696|FG000|Overall Study|Adverse Event|51|||
94314199|NCT02064439|322934697|FG001|Overall Study|Adverse Event|47|||
94314200|NCT02064439|322934698|FG002|Overall Study|Adverse Event|46|||
94314201|NCT02064439|322934696|FG000|Overall Study|Death|0|||
94314202|NCT02064439|322934697|FG001|Overall Study|Death|2|||
94314203|NCT02064439|322934698|FG002|Overall Study|Death|3|||
94314204|NCT02064439|322934696|FG000|Overall Study|Withdrawal by Subject|29|||
94314205|NCT02064439|322934697|FG001|Overall Study|Withdrawal by Subject|18|||
94314206|NCT02064439|322934698|FG002|Overall Study|Withdrawal by Subject|26|||
94314207|NCT02064439|322934696|FG000|Overall Study|Protocol Violation|3|||
94314208|NCT02064439|322934697|FG001|Overall Study|Protocol Violation|5|||
94314209|NCT02064439|322934698|FG002|Overall Study|Protocol Violation|3|||
94314210|NCT02064439|322934696|FG000|Overall Study|Lost to Follow-up|1|||
94314211|NCT02064439|322934697|FG001|Overall Study|Lost to Follow-up|3|||
94314212|NCT02064439|322934698|FG002|Overall Study|Lost to Follow-up|4|||
94314213|NCT02064439|322934696|FG000|Overall Study|Non-compliance with study medication|21|||
94314214|NCT02064439|322934697|FG001|Overall Study|Non-compliance with study medication|19|||
94476724|NCT01133704|323538587|FG000|Overall Study|Death|44|||
94476725|NCT01133704|323538588|FG001|Overall Study|Death|26|||
94476726|NCT01133704|323538587|FG000|Overall Study|Patient refused to continue|4|||
94476727|NCT01133704|323538588|FG001|Overall Study|Patient refused to continue|0|||
94476728|NCT01133704|323538587|FG000|Overall Study|Study Closure|1|||
94476729|NCT01133704|323538588|FG001|Overall Study|Study Closure|0|||
94476730|NCT02757352|323538589|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
94476731|NCT02757352|323538590|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
94476732|NCT02757352|323538591|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
94476733|NCT02757352|323538592|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
94476734|NCT02757352|323538593|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
94476735|NCT02757352|323538594|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
94476736|NCT02757352|323538595|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
94476737|NCT02757352|323538596|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
94476738|NCT02757352|323538597|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
94476739|NCT02757352|323538598|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
94476740|NCT02757352|323538589|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
94476741|NCT02757352|323538590|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
94476742|NCT02757352|323538591|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
94476743|NCT02757352|323538592|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
94476744|NCT02757352|323538593|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
94476745|NCT02757352|323538594|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
94476746|NCT02757352|323538595|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
94476747|NCT02757352|323538596|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
94476748|NCT02757352|323538597|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
94476749|NCT02757352|323538598|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
94476750|NCT02757352|323538589|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
94476751|NCT02757352|323538590|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
94476752|NCT02757352|323538591|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
94476753|NCT02757352|323538592|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
94476754|NCT02757352|323538593|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
94476755|NCT02757352|323538594|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
94476756|NCT02757352|323538595|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
94476757|NCT02757352|323538596|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
94476758|NCT02757352|323538597|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
94476759|NCT02757352|323538598|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
94476760|NCT02757352|323538589|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
94476761|NCT02757352|323538590|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
94476762|NCT02757352|323538591|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
94476763|NCT02757352|323538592|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
94476764|NCT02757352|323538593|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
94476765|NCT02757352|323538594|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
94476766|NCT02757352|323538595|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
94476767|NCT02757352|323538596|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
94476768|NCT02757352|323538597|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
94476769|NCT02757352|323538598|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
94476770|NCT02757352|323538589|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
94476771|NCT02757352|323538590|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
94476772|NCT02757352|323538591|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
94476773|NCT02757352|323538592|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
94476774|NCT02757352|323538593|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
94476775|NCT02757352|323538594|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
94476776|NCT02757352|323538595|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
94476777|NCT02757352|323538596|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
94476778|NCT02757352|323538597|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
94476779|NCT02757352|323538598|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
94314215|NCT02064439|322934698|FG002|Overall Study|Non-compliance with study medication|23|||
94314216|NCT02064439|322934696|FG000|Overall Study|Physician Decision|0|||
94314217|NCT02064439|322934697|FG001|Overall Study|Physician Decision|1|||
94314218|NCT02064439|322934698|FG002|Overall Study|Physician Decision|1|||
94314219|NCT02064439|322934696|FG000|Overall Study|Logistical difficulties|6|||
94314220|NCT02064439|322934697|FG001|Overall Study|Logistical difficulties|5|||
94314221|NCT02064439|322934698|FG002|Overall Study|Logistical difficulties|2|||
94314222|NCT02064439|322934696|FG000|Overall Study|Efficacy outcome reached|18|||
94314223|NCT02064439|322934697|FG001|Overall Study|Efficacy outcome reached|16|||
94314224|NCT02064439|322934698|FG002|Overall Study|Efficacy outcome reached|57|||
94314225|NCT02064439|322934696|FG000|Overall Study|Safety outcome reached|12|||
94476780|NCT02757352|323538589|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
94476781|NCT02757352|323538590|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
94476782|NCT02757352|323538591|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
94476783|NCT02757352|323538592|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
94476784|NCT02757352|323538593|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
94476785|NCT02757352|323538594|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
94476786|NCT02757352|323538595|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
94476787|NCT02757352|323538596|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
94476788|NCT02757352|323538597|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
94476789|NCT02757352|323538598|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
94476790|NCT02757352|323538589|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
94476791|NCT02757352|323538590|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
94476792|NCT02757352|323538591|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
94476793|NCT02757352|323538592|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
94476794|NCT02757352|323538593|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
94476795|NCT02757352|323538594|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
94476796|NCT02757352|323538595|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
94476797|NCT02757352|323538596|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
94476798|NCT02757352|323538597|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
94476799|NCT02757352|323538598|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
94476800|NCT02757352|323538589|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
94476801|NCT02757352|323538590|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
94476802|NCT02757352|323538591|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
94476803|NCT02757352|323538592|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
94476804|NCT02757352|323538593|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
94476805|NCT02757352|323538594|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
94476806|NCT02757352|323538595|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
94476807|NCT02757352|323538596|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
94476808|NCT02757352|323538597|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
94476809|NCT02757352|323538598|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
94476810|NCT02757352|323538589|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
94476811|NCT02757352|323538590|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
94476812|NCT02757352|323538591|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
94476813|NCT02757352|323538592|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
94476814|NCT02757352|323538593|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
94476815|NCT02757352|323538594|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
94476816|NCT02757352|323538595|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
94476817|NCT02757352|323538596|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
94476818|NCT02757352|323538597|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
94476819|NCT02757352|323538598|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
94476820|NCT02757352|323538589|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
94476821|NCT02757352|323538590|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
94476822|NCT02757352|323538591|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
94476823|NCT02757352|323538592|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
94476824|NCT02757352|323538593|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
94476825|NCT02757352|323538594|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
94476826|NCT02757352|323538595|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
94476827|NCT02757352|323538596|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
94476828|NCT02757352|323538597|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
94476829|NCT02757352|323538598|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
94476830|NCT02757352|323538589|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
94476831|NCT02757352|323538590|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
94476832|NCT02757352|323538591|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
94476833|NCT02757352|323538592|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
94476834|NCT02757352|323538593|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
94476835|NCT02757352|323538594|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
94476836|NCT02757352|323538595|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
94476837|NCT02757352|323538596|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
94476838|NCT02757352|323538597|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
94476839|NCT02757352|323538598|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
94314226|NCT02064439|322934697|FG001|Overall Study|Safety outcome reached|20|||
94314227|NCT02064439|322934698|FG002|Overall Study|Safety outcome reached|10|||
94314228|NCT02064439|322934696|FG000|Overall Study|Other|2|||
94314229|NCT02064439|322934697|FG001|Overall Study|Other|2|||
94314230|NCT02064439|322934698|FG002|Overall Study|Other|7|||
94314231|NCT02433288|322934699|FG000|Overall Study|Severe non-compliance to protocol|13|||
94314232|NCT02433288|322934700|FG001|Overall Study|Severe non-compliance to protocol|7|||
94314233|NCT02433288|322934699|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
94314234|NCT02433288|322934700|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
94314235|NCT02433288|322934699|FG000|Overall Study|Withdrawal by Subject|101|||
94314236|NCT02433288|322934700|FG001|Overall Study|Withdrawal by Subject|99|||
94314237|NCT02433288|322934699|FG000|Overall Study|Lost to Follow-up|2|||
94314238|NCT02433288|322934700|FG001|Overall Study|Lost to Follow-up|14|||
94314239|NCT02433288|322934699|FG000|Overall Study|Death|0|||
94314240|NCT02433288|322934700|FG001|Overall Study|Death|3|||
94314241|NCT04504032|322934703|FG000|Overall Study|Adverse Event|1|||
94314242|NCT04504032|322934704|FG001|Overall Study|Adverse Event|2|||
94314243|NCT04504032|322934703|FG000|Overall Study|Lost to Follow-up|6|||
94314244|NCT04504032|322934704|FG001|Overall Study|Lost to Follow-up|9|||
94314245|NCT04504032|322934703|FG000|Overall Study|Protocol Violation|2|||
94314246|NCT04504032|322934704|FG001|Overall Study|Protocol Violation|0|||
94314247|NCT04504032|322934703|FG000|Overall Study|Study terminated by sponsor|1|||
94314248|NCT04504032|322934704|FG001|Overall Study|Study terminated by sponsor|2|||
94314249|NCT04504032|322934703|FG000|Overall Study|Withdrawal by Subject|9|||
94314250|NCT04504032|322934704|FG001|Overall Study|Withdrawal by Subject|11|||
94314251|NCT04504032|322934703|FG000|Overall Study|Disease progression prior to dosing|15|||
94314252|NCT04504032|322934704|FG001|Overall Study|Disease progression prior to dosing|3|||
94314253|NCT04504032|322934703|FG000|Overall Study|Drug supply issues|1|||
94314254|NCT04504032|322934704|FG001|Overall Study|Drug supply issues|1|||
94314255|NCT04504032|322934703|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
94314256|NCT04504032|322934704|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
94314257|NCT01264965|322934705|FG000|Overall Study|Withdrawal by Subject|10|||
94314258|NCT02184143|322934707|FG000|Overall Study|Withdrawal by Subject|4|||
94314259|NCT02184143|322934708|FG001|Overall Study|Withdrawal by Subject|4|||
94314260|NCT02184143|322934707|FG000|Overall Study|Lost to Follow-up|5|||
94314261|NCT02184143|322934708|FG001|Overall Study|Lost to Follow-up|3|||
94314262|NCT02184143|322934707|FG000|Overall Study|Death|1|||
94314263|NCT02184143|322934708|FG001|Overall Study|Death|0|||
94314264|NCT00321984|322934712|FG000|Overall Study|Adverse Event|9|||
94314265|NCT00321984|322934713|FG001|Overall Study|Adverse Event|6|||
94314266|NCT00321984|322934714|FG002|Overall Study|Adverse Event|8|||
94314267|NCT00321984|322934712|FG000|Overall Study|Protocol Violation|0|||
94314268|NCT00321984|322934713|FG001|Overall Study|Protocol Violation|1|||
94314269|NCT00321984|322934714|FG002|Overall Study|Protocol Violation|1|||
94314270|NCT00321984|322934712|FG000|Overall Study|Lost to Follow-up|2|||
94314271|NCT00321984|322934713|FG001|Overall Study|Lost to Follow-up|4|||
94314272|NCT00321984|322934714|FG002|Overall Study|Lost to Follow-up|2|||
94314273|NCT00321984|322934712|FG000|Overall Study|Withdrawal by Subject|8|||
94314274|NCT00321984|322934713|FG001|Overall Study|Withdrawal by Subject|6|||
94314275|NCT00321984|322934714|FG002|Overall Study|Withdrawal by Subject|5|||
94314276|NCT00321984|322934712|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
94314277|NCT00321984|322934713|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
94314278|NCT00321984|322934714|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
94314279|NCT00321984|322934712|FG000|Overall Study|Lack of Efficacy|3|||
94314280|NCT00321984|322934713|FG001|Overall Study|Lack of Efficacy|1|||
94314281|NCT00321984|322934714|FG002|Overall Study|Lack of Efficacy|3|||
94314282|NCT00321984|322934712|FG000|Overall Study|Noncompliant|0|||
94314283|NCT00321984|322934713|FG001|Overall Study|Noncompliant|0|||
94314284|NCT00321984|322934714|FG002|Overall Study|Noncompliant|2|||
94314285|NCT00321984|322934712|FG000|Overall Study|Pregnancy|0|||
94314286|NCT00321984|322934713|FG001|Overall Study|Pregnancy|1|||
94314287|NCT00321984|322934714|FG002|Overall Study|Pregnancy|0|||
94314288|NCT00321984|322934712|FG000|Overall Study|Per Subject Request|1|||
94314289|NCT00321984|322934713|FG001|Overall Study|Per Subject Request|0|||
94314290|NCT00321984|322934714|FG002|Overall Study|Per Subject Request|0|||
94314291|NCT00321984|322934712|FG000|Overall Study|Per Investigator Request|1|||
94314292|NCT00321984|322934713|FG001|Overall Study|Per Investigator Request|0|||
94314293|NCT00321984|322934714|FG002|Overall Study|Per Investigator Request|0|||
94314294|NCT00321984|322934712|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
94314295|NCT00321984|322934713|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
94314296|NCT00321984|322934714|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
94314297|NCT00339183|322934717|FG000|Overall Study|Adverse Event|5|||
94314298|NCT00339183|322934718|FG001|Overall Study|Adverse Event|3|||
94314299|NCT00339183|322934717|FG000|Overall Study|Withdrawal by Subject|16|||
94314300|NCT00339183|322934718|FG001|Overall Study|Withdrawal by Subject|19|||
94314301|NCT00339183|322934717|FG000|Overall Study|Physician Decision|2|||
94314302|NCT00339183|322934718|FG001|Overall Study|Physician Decision|4|||
94384532|NCT00863746|323194818|FG000|Treatment|non-compliant with study medication|4|||
94384533|NCT00863746|323194819|FG001|Treatment|non-compliant with study medication|0|||
94384534|NCT00863746|323194818|FG000|Treatment|Consent withdrawn|15|||
94384535|NCT00863746|323194819|FG001|Treatment|Consent withdrawn|14|||
94314303|NCT00339183|322934717|FG000|Overall Study|Lost to Follow-up|17|||
94476840|NCT02757352|323538589|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
94476841|NCT02757352|323538590|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
94476842|NCT02757352|323538591|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
94476843|NCT02757352|323538592|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
94476844|NCT02757352|323538593|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
94476845|NCT02757352|323538594|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
94476846|NCT02757352|323538595|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
94476847|NCT02757352|323538596|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
94476848|NCT02757352|323538597|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
94476849|NCT02757352|323538598|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
94476850|NCT02757352|323538589|FG000|Follow-Up Period|Adverse Event|0|||
94476851|NCT02757352|323538590|FG001|Follow-Up Period|Adverse Event|0|||
94476852|NCT02757352|323538591|FG002|Follow-Up Period|Adverse Event|0|||
94476853|NCT02757352|323538592|FG003|Follow-Up Period|Adverse Event|0|||
94476854|NCT02757352|323538593|FG004|Follow-Up Period|Adverse Event|0|||
94476855|NCT02757352|323538594|FG005|Follow-Up Period|Adverse Event|0|||
94476856|NCT02757352|323538595|FG006|Follow-Up Period|Adverse Event|1|||
94476857|NCT02757352|323538596|FG007|Follow-Up Period|Adverse Event|0|||
94476858|NCT02757352|323538597|FG008|Follow-Up Period|Adverse Event|2|||
94476859|NCT02757352|323538598|FG009|Follow-Up Period|Adverse Event|0|||
94476860|NCT02757352|323538589|FG000|Follow-Up Period|Lost to Follow-up|0|||
94476861|NCT02757352|323538590|FG001|Follow-Up Period|Lost to Follow-up|0|||
94476862|NCT02757352|323538591|FG002|Follow-Up Period|Lost to Follow-up|0|||
94476863|NCT02757352|323538592|FG003|Follow-Up Period|Lost to Follow-up|0|||
94476864|NCT02757352|323538593|FG004|Follow-Up Period|Lost to Follow-up|0|||
94476865|NCT02757352|323538594|FG005|Follow-Up Period|Lost to Follow-up|0|||
94476866|NCT02757352|323538595|FG006|Follow-Up Period|Lost to Follow-up|0|||
94476867|NCT02757352|323538596|FG007|Follow-Up Period|Lost to Follow-up|0|||
94476868|NCT02757352|323538597|FG008|Follow-Up Period|Lost to Follow-up|1|||
94476869|NCT02757352|323538598|FG009|Follow-Up Period|Lost to Follow-up|0|||
94476870|NCT02757352|323538589|FG000|Follow-Up Period|Lack of Efficacy|0|||
94476871|NCT02757352|323538590|FG001|Follow-Up Period|Lack of Efficacy|0|||
94476872|NCT02757352|323538591|FG002|Follow-Up Period|Lack of Efficacy|0|||
94476873|NCT02757352|323538592|FG003|Follow-Up Period|Lack of Efficacy|0|||
94476874|NCT02757352|323538593|FG004|Follow-Up Period|Lack of Efficacy|0|||
94476875|NCT02757352|323538594|FG005|Follow-Up Period|Lack of Efficacy|0|||
94476876|NCT02757352|323538595|FG006|Follow-Up Period|Lack of Efficacy|0|||
94476877|NCT02757352|323538596|FG007|Follow-Up Period|Lack of Efficacy|0|||
94476878|NCT02757352|323538597|FG008|Follow-Up Period|Lack of Efficacy|1|||
94476879|NCT02757352|323538598|FG009|Follow-Up Period|Lack of Efficacy|1|||
94476880|NCT02757352|323538589|FG000|Follow-Up Period|Withdrawal by Subject|0|||
94476881|NCT02757352|323538590|FG001|Follow-Up Period|Withdrawal by Subject|0|||
94476882|NCT02757352|323538591|FG002|Follow-Up Period|Withdrawal by Subject|0|||
94476883|NCT02757352|323538592|FG003|Follow-Up Period|Withdrawal by Subject|0|||
94476884|NCT02757352|323538593|FG004|Follow-Up Period|Withdrawal by Subject|0|||
94476885|NCT02757352|323538594|FG005|Follow-Up Period|Withdrawal by Subject|0|||
94476886|NCT02757352|323538595|FG006|Follow-Up Period|Withdrawal by Subject|0|||
94476887|NCT02757352|323538596|FG007|Follow-Up Period|Withdrawal by Subject|1|||
94476888|NCT02757352|323538597|FG008|Follow-Up Period|Withdrawal by Subject|6|||
94476889|NCT02757352|323538598|FG009|Follow-Up Period|Withdrawal by Subject|2|||
94476890|NCT00497146|323538599|FG000|Treatment Period|Adverse Event|6|||
94476891|NCT00497146|323538600|FG001|Treatment Period|Adverse Event|2|||
94476892|NCT00497146|323538599|FG000|Treatment Period|Withdrawal by Subject|5|||
94314304|NCT00339183|322934718|FG001|Overall Study|Lost to Follow-up|17|||
94314305|NCT00339183|322934717|FG000|Overall Study|Protocol-specified criteria|12|||
94314306|NCT00339183|322934718|FG001|Overall Study|Protocol-specified criteria|8|||
94314307|NCT00339183|322934717|FG000|Overall Study|Missing reason|3|||
94314308|NCT00339183|322934718|FG001|Overall Study|Missing reason|1|||
94314309|NCT00339183|322934717|FG000|Overall Study|Other|46|||
94314310|NCT00339183|322934718|FG001|Overall Study|Other|40|||
94314311|NCT00339183|322934717|FG000|Overall Study|Ongoing|20|||
94314312|NCT00339183|322934718|FG001|Overall Study|Ongoing|13|||
94314313|NCT00002663|322934719|FG000|Overall Study|Death|4|||
94314314|NCT00002663|322934720|FG001|Overall Study|Death|1|||
94314315|NCT00002663|322934721|FG002|Overall Study|Death|1|||
94314316|NCT00002663|322934722|FG003|Overall Study|Death|0|||
94314317|NCT00002663|322934723|FG004|Overall Study|Death|0|||
94314318|NCT00002663|322934724|FG005|Overall Study|Death|13|||
94314319|NCT00002663|322934725|FG006|Overall Study|Death|0|||
94476893|NCT00497146|323538600|FG001|Treatment Period|Withdrawal by Subject|9|||
94476894|NCT00497146|323538599|FG000|Treatment Period|Lost to Follow-up|1|||
94476895|NCT00497146|323538600|FG001|Treatment Period|Lost to Follow-up|3|||
94314320|NCT00002663|322934726|FG007|Overall Study|Death|1|||
94314321|NCT00002663|322934727|FG008|Overall Study|Death|1|||
94314322|NCT00002663|322934728|FG009|Overall Study|Death|1|||
94314323|NCT00002663|322934719|FG000|Overall Study|Lost to Follow-up|3|||
94314324|NCT00002663|322934720|FG001|Overall Study|Lost to Follow-up|0|||
94314325|NCT00002663|322934721|FG002|Overall Study|Lost to Follow-up|0|||
94314326|NCT00002663|322934722|FG003|Overall Study|Lost to Follow-up|1|||
94314327|NCT00002663|322934723|FG004|Overall Study|Lost to Follow-up|0|||
94314328|NCT00002663|322934724|FG005|Overall Study|Lost to Follow-up|1|||
94314329|NCT00002663|322934725|FG006|Overall Study|Lost to Follow-up|0|||
94314330|NCT00002663|322934726|FG007|Overall Study|Lost to Follow-up|0|||
94314331|NCT00002663|322934727|FG008|Overall Study|Lost to Follow-up|0|||
94314332|NCT00002663|322934728|FG009|Overall Study|Lost to Follow-up|0|||
94314333|NCT00002663|322934719|FG000|Overall Study|Other|0|||
94314334|NCT00002663|322934720|FG001|Overall Study|Other|1|||
94314335|NCT00002663|322934721|FG002|Overall Study|Other|0|||
94314336|NCT00002663|322934722|FG003|Overall Study|Other|0|||
94314337|NCT00002663|322934723|FG004|Overall Study|Other|0|||
94314338|NCT00002663|322934724|FG005|Overall Study|Other|1|||
94314339|NCT00002663|322934725|FG006|Overall Study|Other|1|||
94314340|NCT00002663|322934726|FG007|Overall Study|Other|0|||
94314341|NCT00002663|322934727|FG008|Overall Study|Other|0|||
94314342|NCT00002663|322934728|FG009|Overall Study|Other|0|||
94314343|NCT00002663|322934719|FG000|Overall Study|Physician Decision|0|||
94314344|NCT00002663|322934720|FG001|Overall Study|Physician Decision|0|||
94314345|NCT00002663|322934721|FG002|Overall Study|Physician Decision|0|||
94314346|NCT00002663|322934722|FG003|Overall Study|Physician Decision|0|||
94314347|NCT00002663|322934723|FG004|Overall Study|Physician Decision|1|||
94314348|NCT00002663|322934724|FG005|Overall Study|Physician Decision|0|||
94314349|NCT00002663|322934725|FG006|Overall Study|Physician Decision|0|||
94314350|NCT00002663|322934726|FG007|Overall Study|Physician Decision|0|||
94314351|NCT00002663|322934727|FG008|Overall Study|Physician Decision|1|||
94314352|NCT00002663|322934728|FG009|Overall Study|Physician Decision|1|||
94314353|NCT00002663|322934719|FG000|Overall Study|Adverse Event|0|||
94314354|NCT00002663|322934720|FG001|Overall Study|Adverse Event|0|||
94314355|NCT00002663|322934721|FG002|Overall Study|Adverse Event|0|||
94314356|NCT00002663|322934722|FG003|Overall Study|Adverse Event|1|||
94314357|NCT00002663|322934723|FG004|Overall Study|Adverse Event|0|||
94314358|NCT00002663|322934724|FG005|Overall Study|Adverse Event|0|||
94314359|NCT00002663|322934725|FG006|Overall Study|Adverse Event|0|||
94314360|NCT00002663|322934726|FG007|Overall Study|Adverse Event|1|||
94314361|NCT00002663|322934727|FG008|Overall Study|Adverse Event|0|||
94314362|NCT00002663|322934728|FG009|Overall Study|Adverse Event|0|||
94314363|NCT02142894|322934729|FG000|Overall Study|Protocol Violation|8|||
94314364|NCT02496585|322934730|FG000|Overall Study|Death|3|||
94314365|NCT02496585|322934731|FG001|Overall Study|Death|0|||
94314366|NCT02496585|322934730|FG000|Overall Study|Lost to Follow-up|2|||
94314367|NCT02496585|322934731|FG001|Overall Study|Lost to Follow-up|0|||
94314368|NCT02496585|322934730|FG000|Overall Study|Withdrawal by Subject|1|||
94314369|NCT02496585|322934731|FG001|Overall Study|Withdrawal by Subject|2|||
94314370|NCT02496585|322934730|FG000|Overall Study|Progression of Malignancy|4|||
94314371|NCT02496585|322934731|FG001|Overall Study|Progression of Malignancy|1|||
94314372|NCT00830037|322934732|FG000|Overall Study|Withdrawal by Subject|2|||
94314373|NCT00830037|322934733|FG001|Overall Study|Withdrawal by Subject|3|||
94314374|NCT00830037|322934732|FG000|Overall Study|Lost to Follow-up|1|||
94314375|NCT00830037|322934733|FG001|Overall Study|Lost to Follow-up|2|||
94314376|NCT00830037|322934732|FG000|Overall Study|Active when terminated by DSMB|15|||
94314377|NCT00830037|322934733|FG001|Overall Study|Active when terminated by DSMB|14|||
94314378|NCT01757704|322934734|FG000|Overall Study|Protocol Violation|1|||
94314379|NCT01757704|322934735|FG001|Overall Study|Protocol Violation|3|||
94314380|NCT01905397|322934736|FG000|Overall Study|Death|0|||
94314381|NCT01905397|322934737|FG001|Overall Study|Death|1|||
94314382|NCT01905397|322934736|FG000|Overall Study|Withdrawal by Subject|2|||
94314383|NCT01905397|322934737|FG001|Overall Study|Withdrawal by Subject|0|||
94314384|NCT01905397|322934736|FG000|Overall Study|Surgery canceled/aborted|9|||
94314385|NCT01905397|322934737|FG001|Overall Study|Surgery canceled/aborted|5|||
94314386|NCT01905397|322934736|FG000|Overall Study|Incision < 7 cm|2|||
94314387|NCT01905397|322934737|FG001|Overall Study|Incision < 7 cm|0|||
94314388|NCT01905397|322934736|FG000|Overall Study|Wrong treatment|1|||
94314389|NCT01905397|322934737|FG001|Overall Study|Wrong treatment|1|||
94314390|NCT01905397|322934736|FG000|Overall Study|Device not applied|3|||
94314391|NCT01905397|322934737|FG001|Overall Study|Device not applied|0|||
94314392|NCT01905397|322934736|FG000|Overall Study|Dressing not applied in operating room|1|||
94314393|NCT01905397|322934737|FG001|Overall Study|Dressing not applied in operating room|0|||
94314394|NCT01905397|322934736|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
94314395|NCT01905397|322934737|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
94314396|NCT02680847|322934738|FG000|Overall Study|Other|2|||
94314397|NCT02680847|322934739|FG001|Overall Study|Other|0|||
94314398|NCT02680847|322934740|FG002|Overall Study|Other|0|||
94314399|NCT02680847|322934738|FG000|Overall Study|No longer met eligibility criteria|2|||
94314400|NCT02680847|322934739|FG001|Overall Study|No longer met eligibility criteria|2|||
94314401|NCT02680847|322934740|FG002|Overall Study|No longer met eligibility criteria|0|||
94314402|NCT02680847|322934738|FG000|Overall Study|Unwilling to participate in study|1|||
94476896|NCT00497146|323538599|FG000|Treatment Period|Required dialysis|4|||
94476897|NCT00497146|323538600|FG001|Treatment Period|Required dialysis|1|||
94476898|NCT00497146|323538599|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
94476899|NCT00497146|323538600|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
94476900|NCT00497146|323538599|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
94476901|NCT00497146|323538600|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
94476902|NCT00497146|323538599|FG000|Treatment Period|Other Reason|2|||
94476903|NCT00497146|323538600|FG001|Treatment Period|Other Reason|3|||
94476904|NCT00497146|323538599|FG000|Long-term Follow-up Period|Adverse Event|2|||
94476905|NCT00497146|323538600|FG001|Long-term Follow-up Period|Adverse Event|2|||
94476906|NCT00497146|323538599|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
94476907|NCT00497146|323538600|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
94476908|NCT00497146|323538599|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
94476909|NCT00497146|323538600|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
94476910|NCT00497146|323538599|FG000|Long-term Follow-up Period|Other|0|||
94476911|NCT00497146|323538600|FG001|Long-term Follow-up Period|Other|1|||
94476912|NCT02315664|323538601|FG000|Overall Study|Lost to Follow-up|1|||
94476913|NCT02315664|323538602|FG001|Overall Study|Lost to Follow-up|1|||
94476914|NCT02315664|323538601|FG000|Overall Study|Withdrawal by Subject|0|||
94476915|NCT02315664|323538602|FG001|Overall Study|Withdrawal by Subject|3|||
94314403|NCT02680847|322934739|FG001|Overall Study|Unwilling to participate in study|1|||
94314404|NCT02680847|322934740|FG002|Overall Study|Unwilling to participate in study|0|||
94314405|NCT02680847|322934738|FG000|Overall Study|Lack of Efficacy|0|||
94314406|NCT02680847|322934739|FG001|Overall Study|Lack of Efficacy|0|||
94314407|NCT02680847|322934740|FG002|Overall Study|Lack of Efficacy|2|||
94314408|NCT02680847|322934738|FG000|Overall Study|Adverse Event|0|||
94314409|NCT02680847|322934739|FG001|Overall Study|Adverse Event|0|||
94314410|NCT02680847|322934740|FG002|Overall Study|Adverse Event|1|||
94314411|NCT00064662|322934741|FG000|Overall Study|Death|1|||
94476916|NCT03252145|323538603|FG000|Overall Study|Withdrawal by Subject|1|||
94476917|NCT03252145|323538604|FG001|Overall Study|Withdrawal by Subject|0|||
94476918|NCT03252145|323538603|FG000|Overall Study|Complicating Disease|1|||
94476919|NCT03252145|323538604|FG001|Overall Study|Complicating Disease|2|||
94476920|NCT03091738|323538605|FG000|Overall Study|Adverse Event|1|||
94476921|NCT03091738|323538605|FG000|Overall Study|Lost to Follow-up|1|||
94476922|NCT00391872|323538613|FG000|Overall Study|Protocol Violation|7|||
94476923|NCT00391872|323538614|FG001|Overall Study|Protocol Violation|2|||
94476924|NCT00391872|323538613|FG000|Overall Study|Withdrawal by Subject|296|||
94476925|NCT00391872|323538614|FG001|Overall Study|Withdrawal by Subject|249|||
94476926|NCT00391872|323538613|FG000|Overall Study|Reason unknown|2|||
94476927|NCT00391872|323538614|FG001|Overall Study|Reason unknown|4|||
94476928|NCT00391872|323538613|FG000|Overall Study|Lost to Follow-up|2|||
94476929|NCT00391872|323538614|FG001|Overall Study|Lost to Follow-up|0|||
94476930|NCT00905632|323538615|FG000|Overall Study|Adverse Event|0|||
94476931|NCT00905632|323538616|FG001|Overall Study|Adverse Event|0|||
94476932|NCT00905632|323538617|FG002|Overall Study|Adverse Event|0|||
94476933|NCT00905632|323538618|FG003|Overall Study|Adverse Event|0|||
94476934|NCT00905632|323538619|FG004|Overall Study|Adverse Event|0|||
94476935|NCT00905632|323538620|FG005|Overall Study|Adverse Event|1|||
94476936|NCT00905632|323538621|FG006|Overall Study|Adverse Event|4|||
94476937|NCT00758498|323538622|FG000|Overall Study|Adverse Event|2|||
94476938|NCT00758498|323538623|FG001|Overall Study|Adverse Event|2|||
94476939|NCT00758498|323538624|FG002|Overall Study|Adverse Event|3|||
94476940|NCT00758498|323538622|FG000|Overall Study|Subject legally detained out of state|1|||
94476941|NCT00758498|323538623|FG001|Overall Study|Subject legally detained out of state|0|||
94476942|NCT00758498|323538624|FG002|Overall Study|Subject legally detained out of state|0|||
94476943|NCT00758498|323538622|FG000|Overall Study|Withdrawal by Subject|0|||
94476944|NCT00758498|323538623|FG001|Overall Study|Withdrawal by Subject|0|||
94476945|NCT00758498|323538624|FG002|Overall Study|Withdrawal by Subject|1|||
94476946|NCT00758498|323538622|FG000|Overall Study|Noncompliance to study procedures|0|||
94476947|NCT00758498|323538623|FG001|Overall Study|Noncompliance to study procedures|0|||
94476948|NCT00758498|323538624|FG002|Overall Study|Noncompliance to study procedures|1|||
94476949|NCT01724177|323538627|FG000|Overall Study|Adverse Event|8|||
94476950|NCT01724177|323538627|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
94476951|NCT01724177|323538627|FG000|Overall Study|Nervous participant|1|||
94476952|NCT01724177|323538627|FG000|Overall Study|Serious Adverse Event Related|1|||
94476953|NCT04446429|323538640|FG000|Overall Study|Lost to Follow-up|6|||
94476954|NCT04446429|323538641|FG001|Overall Study|Lost to Follow-up|0|||
94476955|NCT00587795|323538644|FG000|Overall Study|Withdrawal by Subject|1|||
94314412|NCT00064662|322934742|FG001|Overall Study|Death|1|||
94476956|NCT00587795|323538645|FG001|Overall Study|Withdrawal by Subject|0|||
94476957|NCT00540644|323538646|FG000|Overall Study|Adverse Event|3|||
94476958|NCT00540644|323538647|FG001|Overall Study|Adverse Event|1|||
94314413|NCT00064662|322934741|FG000|Overall Study|Lost to Follow-up|57|||
94314414|NCT00064662|322934742|FG001|Overall Study|Lost to Follow-up|44|||
94314415|NCT00064662|322934741|FG000|Overall Study|Withdrawal by Subject|14|||
94476959|NCT00540644|323538646|FG000|Overall Study|Disease Progression|3|||
94476960|NCT00540644|323538647|FG001|Overall Study|Disease Progression|1|||
94476961|NCT00540644|323538646|FG000|Overall Study|Physician Decision|0|||
94476962|NCT00540644|323538647|FG001|Overall Study|Physician Decision|5|||
94476963|NCT00540644|323538646|FG000|Overall Study|Withdrawal by Subject|2|||
94476964|NCT00540644|323538647|FG001|Overall Study|Withdrawal by Subject|2|||
94476965|NCT00540644|323538646|FG000|Overall Study|Noncomplilance|1|||
94476966|NCT00540644|323538647|FG001|Overall Study|Noncomplilance|0|||
94476967|NCT01152996|323538648|FG000|Overall Study|Withdrawal by Subject|142|||
94476968|NCT01152996|323538648|FG000|Overall Study|Adverse Event|115|||
94476969|NCT01152996|323538648|FG000|Overall Study|Lost to Follow-up|112|||
94476970|NCT01152996|323538648|FG000|Overall Study|Lack of Efficacy|68|||
94476971|NCT01152996|323538648|FG000|Overall Study|Noncompliance|41|||
94476972|NCT01152996|323538648|FG000|Overall Study|Other|36|||
94476973|NCT01152996|323538648|FG000|Overall Study|Protocol Violation|22|||
94476974|NCT01152996|323538648|FG000|Overall Study|Elevated liver enzymes|1|||
94476975|NCT00169104|323538649|FG000|Overall Study|Withdrawal by Subject|2|||
94476976|NCT00169104|323538650|FG001|Overall Study|Withdrawal by Subject|0|||
94476977|NCT00169104|323538649|FG000|Overall Study|Protocol Violation|0|||
94476978|NCT00169104|323538650|FG001|Overall Study|Protocol Violation|1|||
94476979|NCT00169104|323538649|FG000|Overall Study|Physician Decision|0|||
94476980|NCT00169104|323538650|FG001|Overall Study|Physician Decision|1|||
94476981|NCT01540981|323538651|FG000|Overall Study|Withdrawal by Subject|1|||
94476982|NCT01540981|323538652|FG001|Overall Study|Withdrawal by Subject|0|||
94476983|NCT00809094|323538653|FG000|Overall Study|Lost to Follow-up|0|||
94476984|NCT00809094|323538654|FG001|Overall Study|Lost to Follow-up|1|||
94476985|NCT01535443|323538655|FG000|Overall Study|Physician Decision|3|||
94476986|NCT02620787|323538656|FG000|Overall Study|Adverse Event|1|||
94476987|NCT02620787|323538657|FG001|Overall Study|Adverse Event|0|||
94476988|NCT02620787|323538656|FG000|Overall Study|Eligibility Criteria Not Met|1|||
94476989|NCT02620787|323538657|FG001|Overall Study|Eligibility Criteria Not Met|0|||
94476990|NCT03299101|323538658|FG000|Overall Study|Lost to Follow-up|1|||
94476991|NCT03299101|323538658|FG000|Overall Study|Withdrawal by Subject|5|||
94476992|NCT03299101|323538658|FG000|Overall Study|Surgery was changed|3|||
94476993|NCT03299101|323538658|FG000|Overall Study|Not enough time to complete prehab|1|||
94476994|NCT03465709|323538662|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
94476995|NCT03465709|323538662|FG000|Overall Study|Withdrawal by Subject|3|||
94476996|NCT05359952|323538663|FG000|Overall Study|Lost to Follow-up|1|||
94476997|NCT05359952|323538664|FG001|Overall Study|Lost to Follow-up|0|||
94476998|NCT02028507|323538665|FG000|Overall Study|Progressive Disease|122|||
94476999|NCT02028507|323538666|FG001|Overall Study|Progressive Disease|90|||
94477000|NCT02028507|323538667|FG002|Overall Study|Progressive Disease|102|||
94477001|NCT02028507|323538668|FG003|Overall Study|Progressive Disease|89|||
94477002|NCT02028507|323538665|FG000|Overall Study|Adverse Event|8|||
94477003|NCT02028507|323538666|FG001|Overall Study|Adverse Event|25|||
94477004|NCT02028507|323538667|FG002|Overall Study|Adverse Event|3|||
94477005|NCT02028507|323538668|FG003|Overall Study|Adverse Event|16|||
94477006|NCT02028507|323538665|FG000|Overall Study|Withdrawal by Subject|6|||
94477007|NCT02028507|323538666|FG001|Overall Study|Withdrawal by Subject|8|||
94477008|NCT02028507|323538667|FG002|Overall Study|Withdrawal by Subject|5|||
94477009|NCT02028507|323538668|FG003|Overall Study|Withdrawal by Subject|9|||
94477010|NCT02028507|323538665|FG000|Overall Study|Protocol Violation|2|||
94477011|NCT02028507|323538666|FG001|Overall Study|Protocol Violation|4|||
94477012|NCT02028507|323538667|FG002|Overall Study|Protocol Violation|1|||
94477013|NCT02028507|323538668|FG003|Overall Study|Protocol Violation|3|||
94477014|NCT02028507|323538665|FG000|Overall Study|Physician Decision|0|||
94477015|NCT02028507|323538666|FG001|Overall Study|Physician Decision|4|||
94477016|NCT02028507|323538667|FG002|Overall Study|Physician Decision|0|||
94477017|NCT02028507|323538668|FG003|Overall Study|Physician Decision|0|||
94477018|NCT02028507|323538665|FG000|Overall Study|Death|1|||
94477019|NCT02028507|323538666|FG001|Overall Study|Death|0|||
94477020|NCT02028507|323538667|FG002|Overall Study|Death|1|||
94477021|NCT02028507|323538668|FG003|Overall Study|Death|3|||
94477022|NCT02028507|323538665|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
94477023|NCT02028507|323538666|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
94477024|NCT02028507|323538667|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
94477025|NCT02028507|323538668|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
94477026|NCT02028507|323538665|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
94477027|NCT02028507|323538666|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
94477028|NCT02028507|323538667|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
94477029|NCT02028507|323538668|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
94477030|NCT02028507|323538665|FG000|Overall Study|Randomized But Not Treated|3|||
94477031|NCT02028507|323538666|FG001|Overall Study|Randomized But Not Treated|6|||
94477032|NCT02028507|323538667|FG002|Overall Study|Randomized But Not Treated|0|||
94477033|NCT02028507|323538668|FG003|Overall Study|Randomized But Not Treated|4|||
94477034|NCT02028507|323538665|FG000|Overall Study|Enzyme defect|0|||
94477035|NCT02028507|323538666|FG001|Overall Study|Enzyme defect|0|||
94477036|NCT02028507|323538667|FG002|Overall Study|Enzyme defect|0|||
94477037|NCT02028507|323538668|FG003|Overall Study|Enzyme defect|1|||
94477038|NCT02028507|323538665|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
94477039|NCT02028507|323538666|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
94477040|NCT02028507|323538667|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
94477041|NCT02028507|323538668|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
94477042|NCT02028507|323538665|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
94477043|NCT02028507|323538666|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
94477044|NCT02028507|323538667|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
94477045|NCT02028507|323538668|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
94477046|NCT02258659|323538669|FG000|Overall Study|Withdrawal by Subject|1|||
94477047|NCT04202965|323538670|FG000|Overall Study|Adverse Event|3|||
94477048|NCT04202965|323538670|FG000|Overall Study|Did not meet inclusion criteria|1|||
94477049|NCT00527826|323538681|FG000|Overall Study|Adverse Event|10|||
94477050|NCT00527826|323538682|FG001|Overall Study|Adverse Event|10|||
94477051|NCT00527826|323538681|FG000|Overall Study|Lost to Follow-up|3|||
94477052|NCT00527826|323538682|FG001|Overall Study|Lost to Follow-up|2|||
94477053|NCT00527826|323538681|FG000|Overall Study|Withdrawal by Subject|5|||
94477054|NCT00527826|323538682|FG001|Overall Study|Withdrawal by Subject|8|||
94477055|NCT00527826|323538681|FG000|Overall Study|Inclusion Criteria Not Met|3|||
94477056|NCT00527826|323538682|FG001|Overall Study|Inclusion Criteria Not Met|3|||
94477057|NCT00527826|323538681|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
94477058|NCT00527826|323538682|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
94477059|NCT00527826|323538681|FG000|Overall Study|Additional Intake of Viani forte|0|||
94477060|NCT00527826|323538682|FG001|Overall Study|Additional Intake of Viani forte|1|||
94477061|NCT00527826|323538681|FG000|Overall Study|Participant moved away|0|||
94477062|NCT00527826|323538682|FG001|Overall Study|Participant moved away|1|||
94477063|NCT01421641|323538683|FG000|Overall Study|Protocol Violation|2|||
94477064|NCT01421641|323538684|FG001|Overall Study|Protocol Violation|2|||
94477065|NCT03173456|323538686|FG000|Baseline|Medication dispensing system malfunction'|0|||
94477066|NCT03173456|323538687|FG001|Baseline|Medication dispensing system malfunction'|1|||
94477067|NCT03173456|323538688|FG002|Baseline|Medication dispensing system malfunction'|0|||
94477068|NCT03173456|323538689|FG003|Baseline|Medication dispensing system malfunction'|0|||
94477069|NCT03173456|323538690|FG004|Baseline|Medication dispensing system malfunction'|2|||
94477070|NCT03173456|323538686|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
94477071|NCT03173456|323538687|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
94477072|NCT03173456|323538688|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
94477073|NCT03173456|323538689|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
94477074|NCT03173456|323538690|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
94477075|NCT00227539|323538693|FG000|Overall Study|Protocol Violation|1|||
94477076|NCT01843803|323538694|FG000|Overall Study|not a Veteran, did not see provider|1|||
94477077|NCT01843803|323538695|FG001|Overall Study|not a Veteran, did not see provider|3|||
94477078|NCT02497404|323538698|FG000|Overall Study|Adverse Event|1|||
94477079|NCT00977613|323538702|FG000|Overall Study|Lost to Follow-up|16|||
94477080|NCT05285787|323538703|FG000|Overall Study|Withdrawal by Subject|1|||
94477081|NCT05464420|323538714|FG000|Overall Study|Death|0|||
94477082|NCT05464420|323538715|FG001|Overall Study|Death|0|||
94477083|NCT05464420|323538716|FG002|Overall Study|Death|0|||
94477084|NCT05464420|323538717|FG003|Overall Study|Death|1|||
94477085|NCT05464420|323538714|FG000|Overall Study|Lost to Follow-up|16|||
94477086|NCT05464420|323538715|FG001|Overall Study|Lost to Follow-up|11|||
94477087|NCT05464420|323538716|FG002|Overall Study|Lost to Follow-up|11|||
94477088|NCT05464420|323538717|FG003|Overall Study|Lost to Follow-up|11|||
94477089|NCT05464420|323538714|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
94477090|NCT05464420|323538715|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
94477091|NCT05464420|323538716|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
94477092|NCT05464420|323538717|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
94477093|NCT05464420|323538714|FG000|Overall Study|Withdrawal by Subject|4|||
94477094|NCT05464420|323538715|FG001|Overall Study|Withdrawal by Subject|8|||
94477095|NCT05464420|323538716|FG002|Overall Study|Withdrawal by Subject|3|||
94477096|NCT05464420|323538717|FG003|Overall Study|Withdrawal by Subject|1|||
94477097|NCT05464420|323538714|FG000|Overall Study|Protocol Violation|0|||
94477098|NCT05464420|323538715|FG001|Overall Study|Protocol Violation|0|||
94477099|NCT05464420|323538716|FG002|Overall Study|Protocol Violation|1|||
94477100|NCT05464420|323538717|FG003|Overall Study|Protocol Violation|1|||
94477101|NCT05464420|323538714|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
94477102|NCT05464420|323538715|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
94477103|NCT05464420|323538716|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
94477104|NCT05464420|323538717|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
94477105|NCT01765569|323538718|FG000|Period B|Withdrawal by Subject|1|||
94477106|NCT01765569|323538718|FG000|Period C|Death|1|||
94477107|NCT05216835|323538720|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
94477108|NCT05216835|323538721|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
94477109|NCT05216835|323538722|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
94477110|NCT05216835|323538723|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
94477111|NCT05216835|323538724|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
94477112|NCT05216835|323538725|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
94477113|NCT05216835|323538726|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
94477114|NCT05216835|323538727|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
94477115|NCT05216835|323538720|FG000|Overall Study|Death|0|||
94477116|NCT05216835|323538721|FG001|Overall Study|Death|0|||
94477117|NCT05216835|323538722|FG002|Overall Study|Death|0|||
94477118|NCT05216835|323538723|FG003|Overall Study|Death|1|||
94477119|NCT05216835|323538724|FG004|Overall Study|Death|1|||
94477120|NCT05216835|323538725|FG005|Overall Study|Death|1|||
94477121|NCT05216835|323538726|FG006|Overall Study|Death|1|||
94477122|NCT05216835|323538727|FG007|Overall Study|Death|1|||
94477123|NCT05216835|323538720|FG000|Overall Study|Physician Decision|0|||
94477124|NCT05216835|323538721|FG001|Overall Study|Physician Decision|0|||
94477125|NCT05216835|323538722|FG002|Overall Study|Physician Decision|0|||
94477126|NCT05216835|323538723|FG003|Overall Study|Physician Decision|0|||
94477127|NCT05216835|323538724|FG004|Overall Study|Physician Decision|0|||
94477128|NCT05216835|323538725|FG005|Overall Study|Physician Decision|1|||
94477129|NCT05216835|323538726|FG006|Overall Study|Physician Decision|1|||
94477130|NCT05216835|323538727|FG007|Overall Study|Physician Decision|0|||
94477131|NCT05216835|323538720|FG000|Overall Study|Study terminated by Sponsor|0|||
94477132|NCT05216835|323538721|FG001|Overall Study|Study terminated by Sponsor|0|||
94477133|NCT05216835|323538722|FG002|Overall Study|Study terminated by Sponsor|0|||
94477134|NCT05216835|323538723|FG003|Overall Study|Study terminated by Sponsor|0|||
94477135|NCT05216835|323538724|FG004|Overall Study|Study terminated by Sponsor|0|||
94314416|NCT00064662|322934742|FG001|Overall Study|Withdrawal by Subject|14|||
94314417|NCT00064662|322934741|FG000|Overall Study|Administratively withdrawn|2|||
94314418|NCT00064662|322934742|FG001|Overall Study|Administratively withdrawn|2|||
94314419|NCT02203838|322934743|FG000|Overall Study|Lack of Efficacy|7|||
94314420|NCT02203838|322934744|FG001|Overall Study|Lack of Efficacy|0|||
94314421|NCT02203838|322934745|FG002|Overall Study|Lack of Efficacy|1|||
94314422|NCT02203838|322934746|FG003|Overall Study|Lack of Efficacy|1|||
94314423|NCT02203838|322934743|FG000|Overall Study|Adverse Event|46|||
94314424|NCT02203838|322934744|FG001|Overall Study|Adverse Event|6|||
94314425|NCT02203838|322934745|FG002|Overall Study|Adverse Event|3|||
94314426|NCT02203838|322934746|FG003|Overall Study|Adverse Event|2|||
94314427|NCT02203838|322934743|FG000|Overall Study|Lost to Follow-up|39|||
94384536|NCT00863746|323194818|FG000|Treatment|Lost to Follow-up|1|||
94384537|NCT00863746|323194819|FG001|Treatment|Lost to Follow-up|0|||
94384538|NCT00863746|323194818|FG000|Treatment|Protocol Violation|5|||
94384539|NCT00863746|323194819|FG001|Treatment|Protocol Violation|3|||
94384540|NCT00863746|323194818|FG000|Treatment|Other|1|||
94384541|NCT00863746|323194819|FG001|Treatment|Other|0|||
94384542|NCT00863746|323194818|FG000|Survival Follow up|Death|244|||
94384543|NCT00863746|323194819|FG001|Survival Follow up|Death|271|||
94384544|NCT00863746|323194818|FG000|Survival Follow up|Lost to Follow-up|2|||
94384545|NCT00863746|323194819|FG001|Survival Follow up|Lost to Follow-up|1|||
94384546|NCT00863746|323194818|FG000|Survival Follow up|Consent Withdrawn|7|||
94384547|NCT00863746|323194819|FG001|Survival Follow up|Consent Withdrawn|8|||
94384548|NCT02473640|323194820|FG000|Treatment Period 1|Adverse Event|1|||
94384549|NCT02127281|323194821|FG000|Overall Study|Lost to Follow-up|1|||
94384550|NCT02127281|323194822|FG001|Overall Study|Lost to Follow-up|0|||
94384551|NCT03194464|323194825|FG000|Overall Study|data not usable|2|||
94384552|NCT03103100|323194826|FG000|Overall Study|Adverse Event|1|||
94384553|NCT03103100|323194827|FG001|Overall Study|Adverse Event|0|||
94384554|NCT03103100|323194828|FG002|Overall Study|Adverse Event|0|||
94384555|NCT03103100|323194826|FG000|Overall Study|Physician Decision|1|||
94384556|NCT03103100|323194827|FG001|Overall Study|Physician Decision|0|||
94384557|NCT03103100|323194828|FG002|Overall Study|Physician Decision|2|||
94384558|NCT02227862|323194829|FG000|Overall Study|Protocol Violation|7|||
94384559|NCT02227862|323194830|FG001|Overall Study|Protocol Violation|9|||
94384560|NCT02227862|323194829|FG000|Overall Study|Other|0|||
94384561|NCT02227862|323194830|FG001|Overall Study|Other|2|||
94384562|NCT02227862|323194829|FG000|Overall Study|Adverse Event|4|||
94384563|NCT02227862|323194830|FG001|Overall Study|Adverse Event|3|||
94384564|NCT02227862|323194829|FG000|Overall Study|Withdrawal by Subject|7|||
94384565|NCT02227862|323194830|FG001|Overall Study|Withdrawal by Subject|6|||
94384566|NCT02227862|323194829|FG000|Overall Study|Lost to Follow-up|1|||
94384567|NCT02227862|323194830|FG001|Overall Study|Lost to Follow-up|2|||
94477136|NCT05216835|323538725|FG005|Overall Study|Study terminated by Sponsor|0|||
94477137|NCT05216835|323538726|FG006|Overall Study|Study terminated by Sponsor|0|||
94477138|NCT05216835|323538727|FG007|Overall Study|Study terminated by Sponsor|1|||
94314428|NCT02203838|322934744|FG001|Overall Study|Lost to Follow-up|3|||
94384568|NCT00634907|323194833|FG000|Overall Study|Withdrawal by Subject|3|||
94384569|NCT00634907|323194834|FG001|Overall Study|Withdrawal by Subject|0|||
94477139|NCT05216835|323538720|FG000|Overall Study|Withdrawal by Subject|1|||
94477140|NCT05216835|323538721|FG001|Overall Study|Withdrawal by Subject|0|||
94477141|NCT05216835|323538722|FG002|Overall Study|Withdrawal by Subject|1|||
94477142|NCT05216835|323538723|FG003|Overall Study|Withdrawal by Subject|0|||
94477143|NCT05216835|323538724|FG004|Overall Study|Withdrawal by Subject|1|||
94477144|NCT05216835|323538725|FG005|Overall Study|Withdrawal by Subject|0|||
94477145|NCT05216835|323538726|FG006|Overall Study|Withdrawal by Subject|0|||
94477146|NCT05216835|323538727|FG007|Overall Study|Withdrawal by Subject|1|||
94477147|NCT05216835|323538720|FG000|Overall Study|Other|0|||
94477148|NCT05216835|323538721|FG001|Overall Study|Other|1|||
94477149|NCT05216835|323538722|FG002|Overall Study|Other|0|||
94477150|NCT05216835|323538723|FG003|Overall Study|Other|0|||
94477151|NCT05216835|323538724|FG004|Overall Study|Other|0|||
94477152|NCT05216835|323538725|FG005|Overall Study|Other|0|||
94314429|NCT02203838|322934745|FG002|Overall Study|Lost to Follow-up|2|||
94314430|NCT02203838|322934746|FG003|Overall Study|Lost to Follow-up|1|||
94314431|NCT02203838|322934743|FG000|Overall Study|Protocol Violation|7|||
94314432|NCT02203838|322934744|FG001|Overall Study|Protocol Violation|3|||
94314433|NCT02203838|322934745|FG002|Overall Study|Protocol Violation|0|||
94314434|NCT02203838|322934746|FG003|Overall Study|Protocol Violation|0|||
94314435|NCT02203838|322934743|FG000|Overall Study|Withdrawal by Subject|83|||
94314436|NCT02203838|322934744|FG001|Overall Study|Withdrawal by Subject|10|||
94314437|NCT02203838|322934745|FG002|Overall Study|Withdrawal by Subject|8|||
94314438|NCT02203838|322934746|FG003|Overall Study|Withdrawal by Subject|11|||
94314439|NCT02203838|322934743|FG000|Overall Study|Physician Decision|27|||
94314440|NCT02203838|322934744|FG001|Overall Study|Physician Decision|0|||
94314441|NCT02203838|322934745|FG002|Overall Study|Physician Decision|2|||
94314442|NCT02203838|322934746|FG003|Overall Study|Physician Decision|3|||
94314443|NCT02203838|322934743|FG000|Overall Study|Other|1|||
94314444|NCT02203838|322934744|FG001|Overall Study|Other|0|||
94314445|NCT02203838|322934745|FG002|Overall Study|Other|0|||
94314446|NCT02203838|322934746|FG003|Overall Study|Other|0|||
94314447|NCT01096550|322934747|FG000|Overall Study|discontinued site|10|||
94314448|NCT01096550|322934748|FG001|Overall Study|discontinued site|11|||
94314449|NCT01096550|322934747|FG000|Overall Study|non-regular treatment track at clinic|1|||
94314450|NCT01096550|322934748|FG001|Overall Study|non-regular treatment track at clinic|1|||
94314451|NCT01096550|322934747|FG000|Overall Study|clinic readmission|1|||
94314452|NCT01096550|322934748|FG001|Overall Study|clinic readmission|1|||
94314453|NCT01096550|322934747|FG000|Overall Study|Withdrawal by Subject|0|||
94314454|NCT01096550|322934748|FG001|Overall Study|Withdrawal by Subject|1|||
94314455|NCT01096550|322934747|FG000|Overall Study|non-African American participant|13|||
94314456|NCT01096550|322934748|FG001|Overall Study|non-African American participant|6|||
94314457|NCT01096550|322934747|FG000|Overall Study|Lost to Follow-up|12|||
94314458|NCT01096550|322934748|FG001|Overall Study|Lost to Follow-up|9|||
94314459|NCT02538666|322934749|FG000|Pre-Treatment|Disease progression|1|||
94314460|NCT02538666|322934750|FG001|Pre-Treatment|Disease progression|0|||
94314461|NCT02538666|322934751|FG002|Pre-Treatment|Disease progression|0|||
94314462|NCT02538666|322934749|FG000|Pre-Treatment|no longer meets study criteria|1|||
94314463|NCT02538666|322934750|FG001|Pre-Treatment|no longer meets study criteria|0|||
94314464|NCT02538666|322934751|FG002|Pre-Treatment|no longer meets study criteria|0|||
94314465|NCT02538666|322934749|FG000|Pre-Treatment|Withdrew Consent|0|||
94314466|NCT02538666|322934750|FG001|Pre-Treatment|Withdrew Consent|1|||
94314467|NCT02538666|322934751|FG002|Pre-Treatment|Withdrew Consent|1|||
94314468|NCT02538666|322934749|FG000|Treatment|Disease progression|270|||
94314469|NCT02538666|322934750|FG001|Treatment|Disease progression|227|||
94314470|NCT02538666|322934751|FG002|Treatment|Disease progression|165|||
94314471|NCT02538666|322934749|FG000|Treatment|Study drug toxicity|1|||
94314472|NCT02538666|322934750|FG001|Treatment|Study drug toxicity|29|||
94314473|NCT02538666|322934751|FG002|Treatment|Study drug toxicity|92|||
94477153|NCT05216835|323538726|FG006|Overall Study|Other|0|||
94477154|NCT05216835|323538727|FG007|Overall Study|Other|0|||
94314474|NCT02538666|322934749|FG000|Treatment|Death|0|||
94314475|NCT02538666|322934750|FG001|Treatment|Death|2|||
94314476|NCT02538666|322934751|FG002|Treatment|Death|3|||
94314477|NCT02538666|322934749|FG000|Treatment|Adverse event unrelated to study drug|8|||
94314478|NCT02538666|322934750|FG001|Treatment|Adverse event unrelated to study drug|10|||
94314479|NCT02538666|322934751|FG002|Treatment|Adverse event unrelated to study drug|15|||
94314480|NCT02538666|322934749|FG000|Treatment|Participant request to discontinue study treatment|3|||
94314481|NCT02538666|322934750|FG001|Treatment|Participant request to discontinue study treatment|6|||
94314482|NCT02538666|322934751|FG002|Treatment|Participant request to discontinue study treatment|11|||
94314483|NCT02538666|322934749|FG000|Treatment|Participant withdrew consent|2|||
94314484|NCT02538666|322934750|FG001|Treatment|Participant withdrew consent|5|||
94314485|NCT02538666|322934751|FG002|Treatment|Participant withdrew consent|3|||
94477155|NCT04533438|323538728|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
94477156|NCT04533438|323538729|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
94477157|NCT02998996|323538732|FG000|Overall Study|Lost to Follow-up|0|||
94477158|NCT02998996|323538733|FG001|Overall Study|Lost to Follow-up|0|||
94477159|NCT02998996|323538734|FG002|Overall Study|Lost to Follow-up|1|||
94477160|NCT02998996|323538735|FG003|Overall Study|Lost to Follow-up|0|||
94477161|NCT02998996|323538736|FG004|Overall Study|Lost to Follow-up|0|||
94477162|NCT02998996|323538737|FG005|Overall Study|Lost to Follow-up|0|||
94477163|NCT02998996|323538732|FG000|Overall Study|Pregnancy|0|||
94477164|NCT02998996|323538733|FG001|Overall Study|Pregnancy|1|||
94477165|NCT02998996|323538734|FG002|Overall Study|Pregnancy|0|||
94477166|NCT02998996|323538735|FG003|Overall Study|Pregnancy|0|||
94477167|NCT02998996|323538736|FG004|Overall Study|Pregnancy|0|||
94477168|NCT02998996|323538737|FG005|Overall Study|Pregnancy|0|||
94477169|NCT02998996|323538732|FG000|Overall Study|Family reasons|0|||
94477170|NCT02998996|323538733|FG001|Overall Study|Family reasons|0|||
94477171|NCT02998996|323538734|FG002|Overall Study|Family reasons|0|||
94477172|NCT02998996|323538735|FG003|Overall Study|Family reasons|0|||
94477173|NCT02998996|323538736|FG004|Overall Study|Family reasons|1|||
94477174|NCT02998996|323538737|FG005|Overall Study|Family reasons|0|||
94477175|NCT00069823|323538740|FG000|Overall Study|Did not have follow-up diary cards|6|||
94477176|NCT00069823|323538741|FG001|Overall Study|Did not have follow-up diary cards|3|||
94477177|NCT01066871|323538742|FG000|Overall Study|Lost to Follow-up|0|||
94477178|NCT01066871|323538743|FG001|Overall Study|Lost to Follow-up|2|||
94477179|NCT01066871|323538744|FG002|Overall Study|Lost to Follow-up|2|||
94477180|NCT01066871|323538745|FG003|Overall Study|Lost to Follow-up|0|||
94477181|NCT01066871|323538742|FG000|Overall Study|Protocol Violation|1|||
94477182|NCT01066871|323538743|FG001|Overall Study|Protocol Violation|0|||
94477183|NCT01066871|323538744|FG002|Overall Study|Protocol Violation|3|||
94477184|NCT01066871|323538745|FG003|Overall Study|Protocol Violation|2|||
94477185|NCT01066871|323538742|FG000|Overall Study|Lack of Efficacy|0|||
94477186|NCT01066871|323538743|FG001|Overall Study|Lack of Efficacy|0|||
94477187|NCT01066871|323538744|FG002|Overall Study|Lack of Efficacy|0|||
94477188|NCT01066871|323538745|FG003|Overall Study|Lack of Efficacy|1|||
94477189|NCT01066871|323538742|FG000|Overall Study|Withdrawal by Subject|3|||
94477190|NCT01066871|323538743|FG001|Overall Study|Withdrawal by Subject|1|||
94477191|NCT01066871|323538744|FG002|Overall Study|Withdrawal by Subject|0|||
94477192|NCT01066871|323538745|FG003|Overall Study|Withdrawal by Subject|0|||
94477193|NCT01066871|323538742|FG000|Overall Study|Other|0|||
94477194|NCT01066871|323538743|FG001|Overall Study|Other|2|||
94477195|NCT01066871|323538744|FG002|Overall Study|Other|1|||
94477196|NCT01066871|323538745|FG003|Overall Study|Other|2|||
94477197|NCT00447902|323538746|FG000|Overall Study|Adverse Event|0|||
94477198|NCT00447902|323538747|FG001|Overall Study|Adverse Event|3|||
94477199|NCT00447902|323538746|FG000|Overall Study|Protocol Violation|1|||
94477200|NCT00447902|323538747|FG001|Overall Study|Protocol Violation|0|||
94477201|NCT00447902|323538746|FG000|Overall Study|Withdrawal by Subject|0|||
94477202|NCT00447902|323538747|FG001|Overall Study|Withdrawal by Subject|1|||
94477203|NCT00447902|323538746|FG000|Overall Study|included patients who discontinued|1|||
94477204|NCT00447902|323538747|FG001|Overall Study|included patients who discontinued|1|||
94477205|NCT00447902|323538746|FG000|Overall Study|Lack of Efficacy|2|||
94477206|NCT00447902|323538747|FG001|Overall Study|Lack of Efficacy|1|||
94477207|NCT04754542|323538748|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
94477208|NCT04754542|323538749|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
94477209|NCT02526160|323540902|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
94314486|NCT02538666|322934749|FG000|Treatment|Lost to Follow-up|0|||
94314487|NCT02538666|322934750|FG001|Treatment|Lost to Follow-up|1|||
94314488|NCT02538666|322934751|FG002|Treatment|Lost to Follow-up|1|||
94314489|NCT02538666|322934749|FG000|Treatment|Maximum clinical benefit|4|||
94477210|NCT02526160|323540903|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
94477211|NCT02526160|323540902|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
94477212|NCT02526160|323540903|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
94477213|NCT02526160|323540902|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
94477214|NCT02526160|323540903|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
94477215|NCT02526160|323540902|FG000|Open-Label Treatment Extension Period I|Death|0|||
94314490|NCT02538666|322934750|FG001|Treatment|Maximum clinical benefit|3|||
94477216|NCT02526160|323540903|FG001|Open-Label Treatment Extension Period I|Death|1|||
94384570|NCT00634907|323194833|FG000|Overall Study|Physician Decision|3|||
94384571|NCT00634907|323194834|FG001|Overall Study|Physician Decision|9|||
94384572|NCT00634907|323194833|FG000|Overall Study|Withdrawal by Subject|11|||
94384573|NCT00634907|323194834|FG001|Overall Study|Withdrawal by Subject|8|||
94384574|NCT02402166|323194835|FG000|Overall Study|Adverse Event|2|||
94384575|NCT02402166|323194835|FG000|Overall Study|Withdrawal by Subject|2|||
94384576|NCT02402166|323194835|FG000|Overall Study|Lost to Follow-up|1|||
94384577|NCT03831048|323194840|FG000|Overall Study|Protocol Violation|9|||
94384578|NCT03831048|323194841|FG001|Overall Study|Protocol Violation|3|||
94384579|NCT03831048|323194840|FG000|Overall Study|Death|4|||
94384580|NCT03831048|323194841|FG001|Overall Study|Death|9|||
94384581|NCT03831048|323194840|FG000|Overall Study|Re-transplant|0|||
94384582|NCT03831048|323194841|FG001|Overall Study|Re-transplant|2|||
94384583|NCT03831048|323194840|FG000|Overall Study|Protocol violation and death|1|||
94384584|NCT03831048|323194841|FG001|Overall Study|Protocol violation and death|1|||
94384585|NCT01400425|323194842|FG000|Overall Study|Withdrawal by Subject|10|||
94384586|NCT00720096|323194844|FG000|Overall Study|Withdrawal by Subject|0|||
94384587|NCT00720096|323194845|FG001|Overall Study|Withdrawal by Subject|2|||
94384588|NCT00001849|323194846|FG000|Overall Study|Death|4|||
94384589|NCT00001849|323194846|FG000|Overall Study|Lost to Follow-up|2|||
94384590|NCT00001849|323194846|FG000|Overall Study|Withdrawal by Subject|2|||
94384591|NCT00001849|323194846|FG000|Overall Study|tumor remained occult|6|||
94384592|NCT00442936|323194847|FG000|Overall Study|Protocol Violation|1|||
94384593|NCT00442936|323194848|FG001|Overall Study|Protocol Violation|0|||
94384594|NCT00442936|323194849|FG002|Overall Study|Protocol Violation|1|||
94384595|NCT00442936|323194850|FG003|Overall Study|Protocol Violation|1|||
94384596|NCT02428699|323194855|FG000|Washout Period 1|Screen Failure|1|||
94384597|NCT02428699|323194856|FG001|Washout Period 1|Screen Failure|2|||
94384598|NCT01506947|323194858|FG000|Overall Study|Lost to Follow-up|7|||
94384599|NCT01506947|323194858|FG000|Overall Study|Adverse Event|5|||
94384600|NCT01506947|323194858|FG000|Overall Study|Death|1|||
94384601|NCT01506947|323194858|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
94384602|NCT02319148|323194865|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
94384603|NCT02319148|323194866|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
94384604|NCT02319148|323194867|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
94384605|NCT02319148|323194868|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
94384606|NCT02319148|323194865|FG000|Second Intervention Period|No longer willing to participate|0|||
94384607|NCT02319148|323194866|FG001|Second Intervention Period|No longer willing to participate|1|||
94384608|NCT02319148|323194867|FG002|Second Intervention Period|No longer willing to participate|0|||
94384609|NCT02319148|323194868|FG003|Second Intervention Period|No longer willing to participate|0|||
94384610|NCT02319148|323194865|FG000|Second Intervention Period|Other|0|||
94384611|NCT02319148|323194866|FG001|Second Intervention Period|Other|0|||
94384612|NCT02319148|323194867|FG002|Second Intervention Period|Other|0|||
94384613|NCT02319148|323194868|FG003|Second Intervention Period|Other|1|||
94384614|NCT01574248|323194869|FG000|Overall Study|Withdrawal by Subject|2|||
94384615|NCT01574248|323194870|FG001|Overall Study|Withdrawal by Subject|0|||
94384616|NCT01574248|323194869|FG000|Overall Study|Missing primary endpoint data|1|||
94384617|NCT01574248|323194870|FG001|Overall Study|Missing primary endpoint data|0|||
94384618|NCT04109222|323194871|FG000|Overall Study|Adverse Event|1|||
94384619|NCT04109222|323194872|FG001|Overall Study|Adverse Event|0|||
94384620|NCT04109222|323194873|FG002|Overall Study|Adverse Event|0|||
94384621|NCT01700621|323194875|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
94384622|NCT01700621|323194876|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
94384623|NCT01700621|323194875|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
94384624|NCT01700621|323194876|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
94384625|NCT01700621|323194875|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
94384626|NCT01700621|323194876|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
94384627|NCT03594123|323194877|FG000|Overall Study|Lost to Follow-up|0|||
94384628|NCT03594123|323194878|FG001|Overall Study|Lost to Follow-up|1|||
94384629|NCT03594123|323194877|FG000|Overall Study|Adverse Event|8|||
94384630|NCT03594123|323194878|FG001|Overall Study|Adverse Event|5|||
94384631|NCT03594123|323194877|FG000|Overall Study|Site Terminated by Sponsor|4|||
94384632|NCT03594123|323194878|FG001|Overall Study|Site Terminated by Sponsor|1|||
94384633|NCT03594123|323194877|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
94384634|NCT03594123|323194878|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
94384635|NCT03594123|323194877|FG000|Overall Study|Lack of Efficacy|1|||
94384636|NCT03594123|323194878|FG001|Overall Study|Lack of Efficacy|0|||
94384637|NCT03594123|323194877|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
94384638|NCT03594123|323194878|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
94384639|NCT03365375|323194879|FG000|Overall Study|Withdrawal by Subject|0|||
94384640|NCT03365375|323194880|FG001|Overall Study|Withdrawal by Subject|1|||
94384641|NCT03365375|323194879|FG000|Overall Study|Lost to Follow-up|0|||
94384642|NCT03365375|323194880|FG001|Overall Study|Lost to Follow-up|4|||
94384643|NCT00973700|323194882|FG000|Overall Study|Withdrawal by Subject|2|||
94384644|NCT00973700|323194883|FG001|Overall Study|Withdrawal by Subject|2|||
94384645|NCT00973700|323194884|FG002|Overall Study|Withdrawal by Subject|8|||
94384646|NCT00973700|323194885|FG003|Overall Study|Withdrawal by Subject|4|||
94384647|NCT00973700|323194886|FG004|Overall Study|Withdrawal by Subject|4|||
94384648|NCT00973700|323194882|FG000|Overall Study|Lost to Follow-up|5|||
94384649|NCT00973700|323194883|FG001|Overall Study|Lost to Follow-up|0|||
94384650|NCT00973700|323194884|FG002|Overall Study|Lost to Follow-up|1|||
94384651|NCT00973700|323194885|FG003|Overall Study|Lost to Follow-up|8|||
94384652|NCT00973700|323194886|FG004|Overall Study|Lost to Follow-up|5|||
94384653|NCT00973700|323194882|FG000|Overall Study|Inappropriate enrolment|0|||
94384654|NCT00973700|323194883|FG001|Overall Study|Inappropriate enrolment|0|||
94384655|NCT00973700|323194884|FG002|Overall Study|Inappropriate enrolment|0|||
94384656|NCT00973700|323194885|FG003|Overall Study|Inappropriate enrolment|4|||
94384657|NCT00973700|323194886|FG004|Overall Study|Inappropriate enrolment|0|||
94384658|NCT00973700|323194882|FG000|Overall Study|Unable to Classify|0|||
94384659|NCT00973700|323194883|FG001|Overall Study|Unable to Classify|0|||
94384660|NCT00973700|323194884|FG002|Overall Study|Unable to Classify|1|||
94384661|NCT00973700|323194885|FG003|Overall Study|Unable to Classify|2|||
94384662|NCT00973700|323194886|FG004|Overall Study|Unable to Classify|1|||
94384663|NCT02497781|323194894|FG000|Overall Study|Withdrawal by Subject|2|||
94384664|NCT02497781|323194895|FG001|Overall Study|Withdrawal by Subject|0|||
94384665|NCT02497781|323194894|FG000|Overall Study|Lack of Efficacy|0|||
94384666|NCT02497781|323194895|FG001|Overall Study|Lack of Efficacy|1|||
94384667|NCT02497781|323194894|FG000|Overall Study|Randomised but not treated|1|||
94384668|NCT02497781|323194895|FG001|Overall Study|Randomised but not treated|1|||
94384669|NCT02497781|323194894|FG000|Overall Study|Lost to Follow-up|1|||
94384670|NCT02497781|323194895|FG001|Overall Study|Lost to Follow-up|1|||
94384671|NCT01440283|323194905|FG000|Overall Study|Death|3|||
94384672|NCT01440283|323194905|FG000|Overall Study|Withdrawal by Subject|4|||
94384673|NCT01440283|323194905|FG000|Overall Study|Physician Decision|3|||
94384674|NCT00661505|323194906|FG000|Overall Study|Adverse Event|3|||
94384675|NCT00661505|323194906|FG000|Overall Study|Protocol Violation|14|||
94384676|NCT00661505|323194906|FG000|Overall Study|Withdrawal by Subject|8|||
94384677|NCT00661505|323194906|FG000|Overall Study|Lost to Follow-up|3|||
94384678|NCT00661505|323194906|FG000|Overall Study|Other|2|||
94384679|NCT03561883|323194907|FG000|Overall Study|Adverse Event|10|||
94384680|NCT03561883|323194908|FG001|Overall Study|Adverse Event|13|||
94384681|NCT03561883|323194907|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94384682|NCT03561883|323194908|FG001|Overall Study|Non-Compliance With Study Drug|2|||
94384683|NCT03561883|323194907|FG000|Overall Study|Protocol Violation|2|||
94384684|NCT03561883|323194908|FG001|Overall Study|Protocol Violation|3|||
94384685|NCT03561883|323194907|FG000|Overall Study|Withdrawal by Subject|14|||
94384686|NCT03561883|323194908|FG001|Overall Study|Withdrawal by Subject|6|||
94384687|NCT03561883|323194907|FG000|Overall Study|Lost to Follow-up|2|||
94384688|NCT03561883|323194908|FG001|Overall Study|Lost to Follow-up|6|||
94384689|NCT03561883|323194907|FG000|Overall Study|Study Terminated by Sponsor|12|||
94384690|NCT03561883|323194908|FG001|Overall Study|Study Terminated by Sponsor|11|||
94384691|NCT03561883|323194907|FG000|Overall Study|Physician Decision|1|||
94384692|NCT03561883|323194908|FG001|Overall Study|Physician Decision|0|||
94384693|NCT03561883|323194907|FG000|Overall Study|Randomized by Mistake|1|||
94384694|NCT03561883|323194908|FG001|Overall Study|Randomized by Mistake|0|||
94384695|NCT03561883|323194907|FG000|Overall Study|Other, Not Specified|3|||
94384696|NCT03561883|323194908|FG001|Overall Study|Other, Not Specified|2|||
94384697|NCT00680121|323194911|FG000|Overall Study|Lost to Follow-up|27|||
94384698|NCT00680121|323194912|FG001|Overall Study|Lost to Follow-up|23|||
94384699|NCT02603952|323194917|FG000|Overall Study|Withdrawal by Subject|1|||
94384700|NCT02603952|323194918|FG001|Overall Study|Withdrawal by Subject|0|||
94384701|NCT02603952|323194919|FG002|Overall Study|Withdrawal by Subject|0|||
94384702|NCT02603952|323194920|FG003|Overall Study|Withdrawal by Subject|0|||
94384703|NCT02603952|323194917|FG000|Overall Study|Received oseltamivir by error|0|||
94384704|NCT02603952|323194918|FG001|Overall Study|Received oseltamivir by error|0|||
94384705|NCT02603952|323194919|FG002|Overall Study|Received oseltamivir by error|0|||
94384706|NCT02603952|323194920|FG003|Overall Study|Received oseltamivir by error|1|||
94384707|NCT01347710|323194928|FG000|Overall Study|Withdrawal by Subject|2|||
94384708|NCT01347710|323194928|FG000|Overall Study|Adverse Event|4|||
94384709|NCT01347710|323194928|FG000|Overall Study|Angio or SPECT not completed|18|||
94384710|NCT01347710|323194928|FG000|Overall Study|issue with vitals prior to dosing|1|||
94384711|NCT01347710|323194928|FG000|Overall Study|Lost to Follow-up|1|||
94477217|NCT02526160|323540902|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
94477218|NCT02526160|323540903|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
94477219|NCT02526160|323540902|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
94384712|NCT01347710|323194928|FG000|Overall Study|Physician Decision|2|||
94384713|NCT01347710|323194928|FG000|Overall Study|Other|3|||
94384714|NCT00970281|323194929|FG000|Overall Study|Lack of Efficacy|1|||
94384715|NCT00970281|323194930|FG001|Overall Study|Lack of Efficacy|14|||
94384716|NCT00970281|323194929|FG000|Overall Study|Withdrawal by Subject|0|||
94384717|NCT00970281|323194930|FG001|Overall Study|Withdrawal by Subject|1|||
94384718|NCT00970281|323194929|FG000|Overall Study|Physician Decision|1|||
94314491|NCT02538666|322934751|FG002|Treatment|Maximum clinical benefit|4|||
94314492|NCT02538666|322934749|FG000|Treatment|Poor/non-compliance|0|||
94314493|NCT02538666|322934750|FG001|Treatment|Poor/non-compliance|1|||
94314494|NCT02538666|322934751|FG002|Treatment|Poor/non-compliance|0|||
94314495|NCT02538666|322934749|FG000|Treatment|Participant no longer meets study criteria|0|||
94314496|NCT02538666|322934750|FG001|Treatment|Participant no longer meets study criteria|2|||
94314497|NCT02538666|322934751|FG002|Treatment|Participant no longer meets study criteria|0|||
94477220|NCT02526160|323540903|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
94314498|NCT02538666|322934749|FG000|Treatment|Administrative reason by sponsor|0|||
94314499|NCT02538666|322934750|FG001|Treatment|Administrative reason by sponsor|0|||
94314500|NCT02538666|322934751|FG002|Treatment|Administrative reason by sponsor|1|||
94314501|NCT02538666|322934749|FG000|Treatment|Other reasons|8|||
94314502|NCT02538666|322934750|FG001|Treatment|Other reasons|15|||
94314503|NCT02538666|322934751|FG002|Treatment|Other reasons|5|||
94314504|NCT02538666|322934749|FG000|Treatment|Not reported|2|||
94314505|NCT02538666|322934750|FG001|Treatment|Not reported|2|||
94314506|NCT02538666|322934751|FG002|Treatment|Not reported|2|||
94314507|NCT00320385|322934756|FG000|Overall Study|Lost to Follow-up|7|||
94314508|NCT00320385|322934757|FG001|Overall Study|Lost to Follow-up|10|||
94314509|NCT00320385|322934756|FG000|Overall Study|Withdrawal by Subject|6|||
94314510|NCT00320385|322934757|FG001|Overall Study|Withdrawal by Subject|7|||
94314511|NCT00320385|322934756|FG000|Overall Study|Sponsor Terminated Study|2|||
94314512|NCT00320385|322934757|FG001|Overall Study|Sponsor Terminated Study|1|||
94314513|NCT00320385|322934756|FG000|Overall Study|Investigator Decision|0|||
94314514|NCT00320385|322934757|FG001|Overall Study|Investigator Decision|1|||
94314515|NCT00320385|322934756|FG000|Overall Study|Death|1|||
94314516|NCT00320385|322934757|FG001|Overall Study|Death|2|||
94314517|NCT00320385|322934756|FG000|Overall Study|Serious Adverse Event|1|||
94314518|NCT00320385|322934757|FG001|Overall Study|Serious Adverse Event|0|||
94314519|NCT00320385|322934756|FG000|Overall Study|Withdrew Consent|1|||
94314520|NCT00320385|322934757|FG001|Overall Study|Withdrew Consent|0|||
94314521|NCT00320385|322934756|FG000|Overall Study|Adverse Event|0|||
94314522|NCT00320385|322934757|FG001|Overall Study|Adverse Event|1|||
94314523|NCT00374907|322934758|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
94314524|NCT00374907|322934759|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
94314525|NCT00374907|322934758|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
94314526|NCT00374907|322934759|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
94314527|NCT00374907|322934758|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
94314528|NCT00374907|322934759|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
94314529|NCT00374907|322934758|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
94314530|NCT00374907|322934759|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
94314531|NCT00374907|322934758|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
94314532|NCT00374907|322934759|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
94314533|NCT00222729|322934760|FG000|Overall Study|Adverse Event|3|||
94314534|NCT00783705|322934765|FG000|Overall Study|Adverse Event|2|||
94314535|NCT00783705|322934766|FG001|Overall Study|Adverse Event|0|||
94314536|NCT00783705|322934765|FG000|Overall Study|Withdrawal by Subject|3|||
94314537|NCT00783705|322934766|FG001|Overall Study|Withdrawal by Subject|2|||
94314538|NCT00783705|322934765|FG000|Overall Study|Lost to Follow-up|1|||
94314539|NCT00783705|322934766|FG001|Overall Study|Lost to Follow-up|3|||
94314540|NCT00878072|322934767|FG000|Overall Study|Withdrew consent|2|||
94314541|NCT01954121|322934775|FG000|Overall Study|Lack of Efficacy|94|||
94314542|NCT01954121|322934776|FG001|Overall Study|Lack of Efficacy|41|||
94314543|NCT01954121|322934775|FG000|Overall Study|Protocol Violation|0|||
94314544|NCT01954121|322934776|FG001|Overall Study|Protocol Violation|2|||
94314545|NCT01954121|322934775|FG000|Overall Study|Lost to Follow-up|5|||
94314546|NCT01954121|322934776|FG001|Overall Study|Lost to Follow-up|6|||
94314547|NCT01954121|322934775|FG000|Overall Study|Withdrawal by Subject|18|||
94314548|NCT01954121|322934776|FG001|Overall Study|Withdrawal by Subject|12|||
94314549|NCT01954121|322934775|FG000|Overall Study|Pregnancy|1|||
94314550|NCT01954121|322934776|FG001|Overall Study|Pregnancy|1|||
94314551|NCT01954121|322934775|FG000|Overall Study|AE, serious fatal|1|||
94314552|NCT01954121|322934776|FG001|Overall Study|AE, serious fatal|0|||
94314553|NCT01954121|322934775|FG000|Overall Study|AE, non-serious non-fatal|5|||
94314554|NCT01954121|322934776|FG001|Overall Study|AE, non-serious non-fatal|22|||
94314555|NCT01954121|322934775|FG000|Overall Study|SAE, non-fatal|1|||
94314556|NCT01954121|322934776|FG001|Overall Study|SAE, non-fatal|4|||
94314557|NCT01954121|322934775|FG000|Overall Study|Non-compliant with study procedures|1|||
94314558|NCT01954121|322934776|FG001|Overall Study|Non-compliant with study procedures|0|||
94314559|NCT01954121|322934775|FG000|Overall Study|Non-compliant patient|1|||
94314560|NCT01954121|322934776|FG001|Overall Study|Non-compliant patient|1|||
94314561|NCT01954121|322934775|FG000|Overall Study|Subject did not follow instructions|0|||
94314562|NCT01954121|322934776|FG001|Overall Study|Subject did not follow instructions|2|||
94314563|NCT03552549|322934784|FG000|Overall Study|Disease progression|25|||
94314564|NCT03552549|322934785|FG001|Overall Study|Disease progression|17|||
94477221|NCT02526160|323540902|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
94477222|NCT02526160|323540903|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
94477223|NCT02526160|323540902|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
94477224|NCT02526160|323540903|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
94477225|NCT04378569|323540904|FG000|Overall Study|Adverse Event|0|||
94477226|NCT04378569|323540905|FG001|Overall Study|Adverse Event|0|||
94477227|NCT04378569|323540906|FG002|Overall Study|Adverse Event|2|||
94477228|NCT04378569|323540907|FG003|Overall Study|Adverse Event|0|||
94477229|NCT04378569|323540908|FG004|Overall Study|Adverse Event|3|||
94477230|NCT04378569|323540909|FG005|Overall Study|Adverse Event|3|||
94477231|NCT04378569|323540904|FG000|Overall Study|Lost to Follow-up|0|||
94477232|NCT04378569|323540905|FG001|Overall Study|Lost to Follow-up|3|||
94477233|NCT04378569|323540906|FG002|Overall Study|Lost to Follow-up|1|||
94477234|NCT04378569|323540907|FG003|Overall Study|Lost to Follow-up|0|||
94477235|NCT04378569|323540908|FG004|Overall Study|Lost to Follow-up|1|||
94477236|NCT04378569|323540909|FG005|Overall Study|Lost to Follow-up|1|||
94477237|NCT04378569|323540904|FG000|Overall Study|Protocol Violation|0|||
94477238|NCT04378569|323540905|FG001|Overall Study|Protocol Violation|0|||
94477239|NCT04378569|323540906|FG002|Overall Study|Protocol Violation|0|||
94477240|NCT04378569|323540907|FG003|Overall Study|Protocol Violation|0|||
94477241|NCT04378569|323540908|FG004|Overall Study|Protocol Violation|0|||
94477242|NCT04378569|323540909|FG005|Overall Study|Protocol Violation|1|||
94477243|NCT04378569|323540904|FG000|Overall Study|Withdrawal by Subject|0|||
94477244|NCT04378569|323540905|FG001|Overall Study|Withdrawal by Subject|6|||
94477245|NCT04378569|323540906|FG002|Overall Study|Withdrawal by Subject|7|||
94477246|NCT04378569|323540907|FG003|Overall Study|Withdrawal by Subject|4|||
94477247|NCT04378569|323540908|FG004|Overall Study|Withdrawal by Subject|5|||
94477248|NCT04378569|323540909|FG005|Overall Study|Withdrawal by Subject|4|||
94477249|NCT04378569|323540904|FG000|Overall Study|Lack of response|0|||
94477250|NCT04378569|323540905|FG001|Overall Study|Lack of response|0|||
94477251|NCT04378569|323540906|FG002|Overall Study|Lack of response|1|||
94477252|NCT04378569|323540907|FG003|Overall Study|Lack of response|0|||
94477253|NCT04378569|323540908|FG004|Overall Study|Lack of response|1|||
94477254|NCT04378569|323540909|FG005|Overall Study|Lack of response|1|||
94477255|NCT01962948|323540910|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
94477256|NCT01962948|323540911|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
94477257|NCT01962948|323540912|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
94477258|NCT01962948|323540913|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
94477259|NCT04530838|323540914|FG000|Overall Study|Other|2|||
94477260|NCT04530838|323540915|FG001|Overall Study|Other|1|||
94477261|NCT04530838|323540916|FG002|Overall Study|Other|0|||
94477262|NCT04530838|323540914|FG000|Overall Study|Physician Decision|0|||
94477263|NCT04530838|323540915|FG001|Overall Study|Physician Decision|0|||
94477264|NCT04530838|323540916|FG002|Overall Study|Physician Decision|1|||
94477265|NCT04530838|323540914|FG000|Overall Study|Death|0|||
94477266|NCT04530838|323540915|FG001|Overall Study|Death|0|||
94477267|NCT04530838|323540916|FG002|Overall Study|Death|1|||
94477268|NCT04530838|323540914|FG000|Overall Study|Adverse Event|0|||
94477269|NCT04530838|323540915|FG001|Overall Study|Adverse Event|1|||
94477270|NCT04530838|323540916|FG002|Overall Study|Adverse Event|0|||
94477271|NCT04530838|323540914|FG000|Overall Study|No longer meets eligibility criteria|1|||
94477272|NCT04530838|323540915|FG001|Overall Study|No longer meets eligibility criteria|0|||
94477273|NCT04530838|323540916|FG002|Overall Study|No longer meets eligibility criteria|2|||
94477274|NCT04530838|323540914|FG000|Overall Study|Withdrawal by parent/guardian|5|||
94477275|NCT04530838|323540915|FG001|Overall Study|Withdrawal by parent/guardian|2|||
94477276|NCT04530838|323540916|FG002|Overall Study|Withdrawal by parent/guardian|2|||
94477277|NCT00803712|323540920|FG000|Overall Study|Noncompliance|3|||
94477278|NCT00803712|323540921|FG001|Overall Study|Noncompliance|0|||
94477279|NCT00803712|323540920|FG000|Overall Study|Adverse Event|5|||
94477280|NCT00803712|323540921|FG001|Overall Study|Adverse Event|0|||
94477281|NCT00803712|323540920|FG000|Overall Study|Death|8|||
94477282|NCT00803712|323540921|FG001|Overall Study|Death|7|||
94477283|NCT00803712|323540920|FG000|Overall Study|Lost to Follow-up|3|||
94477284|NCT00803712|323540921|FG001|Overall Study|Lost to Follow-up|1|||
94477285|NCT00803712|323540920|FG000|Overall Study|Withdrawal by Subject|2|||
94477286|NCT00803712|323540921|FG001|Overall Study|Withdrawal by Subject|4|||
94477287|NCT00803712|323540920|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
94477288|NCT00803712|323540921|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
94477289|NCT00803712|323540920|FG000|Overall Study|Protocol criteria (other)|0|||
94477290|NCT00803712|323540921|FG001|Overall Study|Protocol criteria (other)|2|||
94477291|NCT00803712|323540920|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
94477292|NCT00803712|323540921|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
94477293|NCT00803712|323540920|FG000|Overall Study|Administrative decision|2|||
94477294|NCT00803712|323540921|FG001|Overall Study|Administrative decision|3|||
94384719|NCT00970281|323194930|FG001|Overall Study|Physician Decision|1|||
94384720|NCT01475474|323194932|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
94384721|NCT01475474|323194932|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
94384722|NCT01030965|323194934|FG000|Overall Study|Lack of Efficacy|3|||
94384723|NCT01030965|323194935|FG001|Overall Study|Lack of Efficacy|2|||
94384724|NCT01030965|323194936|FG002|Overall Study|Lack of Efficacy|0|||
94384725|NCT01030965|323194937|FG003|Overall Study|Lack of Efficacy|3|||
94384726|NCT01030965|323194934|FG000|Overall Study|Protocol Violation|1|||
94384727|NCT01030965|323194935|FG001|Overall Study|Protocol Violation|1|||
94384728|NCT01030965|323194936|FG002|Overall Study|Protocol Violation|1|||
94384729|NCT01030965|323194937|FG003|Overall Study|Protocol Violation|1|||
94384730|NCT01030965|323194934|FG000|Overall Study|Adverse Event|0|||
94384731|NCT01030965|323194935|FG001|Overall Study|Adverse Event|1|||
94384732|NCT01030965|323194936|FG002|Overall Study|Adverse Event|2|||
94384733|NCT01030965|323194937|FG003|Overall Study|Adverse Event|1|||
94384734|NCT01030965|323194934|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
94384735|NCT01030965|323194935|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
94384736|NCT01030965|323194936|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
94384737|NCT01030965|323194937|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
94384738|NCT01030965|323194934|FG000|Overall Study|Withdrawal by Subject|0|||
94384739|NCT01030965|323194935|FG001|Overall Study|Withdrawal by Subject|1|||
94384740|NCT01030965|323194936|FG002|Overall Study|Withdrawal by Subject|0|||
94384741|NCT01030965|323194937|FG003|Overall Study|Withdrawal by Subject|2|||
94384742|NCT02097290|323194940|FG000|Overall Study|Death|6|||
94384743|NCT02097290|323194940|FG000|Overall Study|Total Withdrawals|3|||
94384744|NCT02097290|323194940|FG000|Overall Study|Attempt|8|||
94384745|NCT02534493|323194944|FG000|Overall Study|Lost to Follow-up|1|||
94384746|NCT02534493|323194944|FG000|Overall Study|Withdrawal by Subject|1|||
94384747|NCT02339909|323194945|FG000|Overall Study|Became ineligible after randomisation|89|||
94384748|NCT02339909|323194946|FG001|Overall Study|Became ineligible after randomisation|63|||
94384749|NCT02339909|323194947|FG002|Overall Study|Became ineligible after randomisation|71|||
94384750|NCT03125200|323194948|FG000|Overall Study|Study Termination|0|||
94384751|NCT03125200|323194949|FG001|Overall Study|Study Termination|0|||
94384752|NCT03125200|323194950|FG002|Overall Study|Study Termination|0|||
94384753|NCT03125200|323194951|FG003|Overall Study|Study Termination|1|||
94384754|NCT03125200|323194952|FG004|Overall Study|Study Termination|1|||
94384755|NCT03125200|323194953|FG005|Overall Study|Study Termination|2|||
94384756|NCT03125200|323194954|FG006|Overall Study|Study Termination|1|||
94384757|NCT03125200|323194948|FG000|Overall Study|Clinical Progression|0|||
94384758|NCT03125200|323194949|FG001|Overall Study|Clinical Progression|0|||
94384759|NCT03125200|323194950|FG002|Overall Study|Clinical Progression|0|||
94384760|NCT03125200|323194951|FG003|Overall Study|Clinical Progression|1|||
94384761|NCT03125200|323194952|FG004|Overall Study|Clinical Progression|0|||
94384762|NCT03125200|323194953|FG005|Overall Study|Clinical Progression|1|||
94384763|NCT03125200|323194954|FG006|Overall Study|Clinical Progression|0|||
94384764|NCT03125200|323194948|FG000|Overall Study|Progressive Disease|2|||
94384765|NCT03125200|323194949|FG001|Overall Study|Progressive Disease|1|||
94384766|NCT03125200|323194950|FG002|Overall Study|Progressive Disease|2|||
94384767|NCT03125200|323194951|FG003|Overall Study|Progressive Disease|1|||
94384768|NCT03125200|323194952|FG004|Overall Study|Progressive Disease|2|||
94384769|NCT03125200|323194953|FG005|Overall Study|Progressive Disease|0|||
94384770|NCT03125200|323194954|FG006|Overall Study|Progressive Disease|1|||
94384771|NCT03125200|323194948|FG000|Overall Study|Lack of Efficacy|0|||
94384772|NCT03125200|323194949|FG001|Overall Study|Lack of Efficacy|0|||
94384773|NCT03125200|323194950|FG002|Overall Study|Lack of Efficacy|0|||
94384774|NCT03125200|323194951|FG003|Overall Study|Lack of Efficacy|1|||
94384775|NCT03125200|323194952|FG004|Overall Study|Lack of Efficacy|0|||
94384776|NCT03125200|323194953|FG005|Overall Study|Lack of Efficacy|0|||
94384777|NCT03125200|323194954|FG006|Overall Study|Lack of Efficacy|0|||
94384778|NCT03125200|323194948|FG000|Overall Study|Toxicity|0|||
94384779|NCT03125200|323194949|FG001|Overall Study|Toxicity|0|||
94384780|NCT03125200|323194950|FG002|Overall Study|Toxicity|0|||
94384781|NCT03125200|323194951|FG003|Overall Study|Toxicity|1|||
94384782|NCT03125200|323194952|FG004|Overall Study|Toxicity|0|||
94384783|NCT03125200|323194953|FG005|Overall Study|Toxicity|0|||
94384784|NCT03125200|323194954|FG006|Overall Study|Toxicity|0|||
94384785|NCT03125200|323194948|FG000|Overall Study|Consent Withdrawn by Subject|0|||
94384786|NCT03125200|323194949|FG001|Overall Study|Consent Withdrawn by Subject|1|||
94384787|NCT03125200|323194950|FG002|Overall Study|Consent Withdrawn by Subject|0|||
94384788|NCT03125200|323194951|FG003|Overall Study|Consent Withdrawn by Subject|0|||
94384789|NCT03125200|323194952|FG004|Overall Study|Consent Withdrawn by Subject|1|||
94384790|NCT03125200|323194953|FG005|Overall Study|Consent Withdrawn by Subject|0|||
94384791|NCT03125200|323194954|FG006|Overall Study|Consent Withdrawn by Subject|1|||
94384792|NCT01658943|323194960|FG000|Overall Study|Adverse Event|6|||
94384793|NCT01658943|323194961|FG001|Overall Study|Adverse Event|13|||
94384794|NCT01658943|323194960|FG000|Overall Study|Withdrawal by Subject|9|||
94384795|NCT01658943|323194961|FG001|Overall Study|Withdrawal by Subject|2|||
94384796|NCT01658943|323194960|FG000|Overall Study|Progression/Relapse|39|||
94477295|NCT00803712|323540920|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
94477296|NCT00803712|323540921|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
94477297|NCT00703677|323540926|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
94477298|NCT02501161|323540929|FG000|Overall Study|Adverse Event|2|||
94477299|NCT02501161|323540930|FG001|Overall Study|Adverse Event|6|||
94477300|NCT02501161|323540929|FG000|Overall Study|Lost to Follow-up|7|||
94477301|NCT02501161|323540930|FG001|Overall Study|Lost to Follow-up|4|||
94477302|NCT02501161|323540929|FG000|Overall Study|Withdrawal by Subject|10|||
94477303|NCT02501161|323540930|FG001|Overall Study|Withdrawal by Subject|15|||
94477304|NCT02501161|323540929|FG000|Overall Study|Other|3|||
94477305|NCT02501161|323540930|FG001|Overall Study|Other|0|||
94477306|NCT02748057|323540931|FG000|Overall Study|Adverse Event|1|||
94477307|NCT02748057|323540932|FG001|Overall Study|Adverse Event|0|||
94477308|NCT02748057|323540931|FG000|Overall Study|Physician Decision|0|||
94477309|NCT02748057|323540932|FG001|Overall Study|Physician Decision|1|||
94477310|NCT02748057|323540931|FG000|Overall Study|Protocol Violation|2|||
94477311|NCT02748057|323540932|FG001|Overall Study|Protocol Violation|1|||
94477312|NCT02748057|323540931|FG000|Overall Study|Participant Moved|1|||
94477313|NCT02748057|323540932|FG001|Overall Study|Participant Moved|0|||
94477314|NCT02748057|323540931|FG000|Overall Study|Withdrawal by Subject|1|||
94477315|NCT02748057|323540932|FG001|Overall Study|Withdrawal by Subject|0|||
94477316|NCT02213380|323540941|FG000|Underwent Randomization|Withdrawal by Subject|2|||
94477317|NCT02213380|323540942|FG001|Underwent Randomization|Withdrawal by Subject|0|||
94477318|NCT02213380|323540941|FG000|Underwent Randomization|Not treated|3|||
94477319|NCT02213380|323540942|FG001|Underwent Randomization|Not treated|3|||
94477320|NCT02213380|323540941|FG000|Per-protocol Analysis|Protocol Violation|32|||
94477321|NCT02213380|323540942|FG001|Per-protocol Analysis|Protocol Violation|36|||
94477322|NCT01490840|323540947|FG000|Phase 1|Lost to Follow-up|1|||
94477323|NCT01490840|323540948|FG001|Phase 1|Lost to Follow-up|0|||
94477324|NCT01490840|323540947|FG000|Phase 1|Adverse Event|2|||
94477325|NCT01490840|323540948|FG001|Phase 1|Adverse Event|1|||
94477326|NCT01490840|323540947|FG000|Phase 1|Withdrawal by Subject|6|||
94477327|NCT01490840|323540948|FG001|Phase 1|Withdrawal by Subject|5|||
94477328|NCT01490840|323540947|FG000|Phase 1|Visit 6a omitted|1|||
94477329|NCT01490840|323540948|FG001|Phase 1|Visit 6a omitted|0|||
94477330|NCT01490840|323540947|FG000|Phase 2|Withdrawal by Subject|4|||
94477331|NCT01490840|323540948|FG001|Phase 2|Withdrawal by Subject|3|||
94477332|NCT01490840|323540947|FG000|Phase 2|Permanent interruption of fingolimod|0|||
94477333|NCT01490840|323540948|FG001|Phase 2|Permanent interruption of fingolimod|1|||
94477334|NCT01490840|323540947|FG000|Phase 2|Lost to Follow-up|1|||
94477335|NCT01490840|323540948|FG001|Phase 2|Lost to Follow-up|1|||
94477336|NCT01490840|323540947|FG000|Phase 2|Adverse Event|1|||
94477337|NCT01490840|323540948|FG001|Phase 2|Adverse Event|1|||
94477338|NCT01957579|323540956|FG000|Overall Study|Withdrawal of concent|0|||
94477339|NCT01957579|323540957|FG001|Overall Study|Withdrawal of concent|1|||
94477340|NCT01957579|323540958|FG002|Overall Study|Withdrawal of concent|0|||
94477341|NCT01957579|323540959|FG003|Overall Study|Withdrawal of concent|0|||
94477342|NCT01957579|323540956|FG000|Overall Study|Death|0|||
94477343|NCT01957579|323540957|FG001|Overall Study|Death|0|||
94477344|NCT01957579|323540958|FG002|Overall Study|Death|2|||
94477345|NCT01957579|323540959|FG003|Overall Study|Death|0|||
94477346|NCT01639144|323540960|FG000|Overall Study|Withdrawal by Subject|4|||
94477347|NCT01639144|323540961|FG001|Overall Study|Withdrawal by Subject|2|||
94477348|NCT01639144|323540960|FG000|Overall Study|Physician Decision|2|||
94477349|NCT01639144|323540961|FG001|Overall Study|Physician Decision|0|||
94477350|NCT01639144|323540960|FG000|Overall Study|Met postoperative exclusion criteria|4|||
94477351|NCT01639144|323540961|FG001|Overall Study|Met postoperative exclusion criteria|3|||
94477352|NCT01738919|323540962|FG000|Overall Study|Lost to Follow-up|1|||
94477353|NCT01738919|323540963|FG001|Overall Study|Lost to Follow-up|0|||
94477354|NCT01738919|323540962|FG000|Overall Study|Immigrated|0|||
94477355|NCT01738919|323540963|FG001|Overall Study|Immigrated|1|||
94477356|NCT01738919|323540962|FG000|Overall Study|Withdrawal by Subject|0|||
94477357|NCT01738919|323540963|FG001|Overall Study|Withdrawal by Subject|1|||
94477358|NCT01738919|323540962|FG000|Overall Study|Not treated in accordance to guidelines|0|||
94477359|NCT01738919|323540963|FG001|Overall Study|Not treated in accordance to guidelines|1|||
94477360|NCT02750332|323540966|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94477361|NCT02750332|323540967|FG001|Treatment Period 1|Withdrawal by Subject|1|||
94477362|NCT01473940|323540971|FG000|Induction Therapy|Death|0|||
94477363|NCT01473940|323540972|FG001|Induction Therapy|Death|0|||
94477364|NCT01473940|323540973|FG002|Induction Therapy|Death|1|||
94477365|NCT01473940|323540974|FG003|Induction Therapy|Death|1|||
94477366|NCT01473940|323540971|FG000|Induction Therapy|Progressive Disease|0|||
94477367|NCT01473940|323540972|FG001|Induction Therapy|Progressive Disease|1|||
94477368|NCT01473940|323540973|FG002|Induction Therapy|Progressive Disease|1|||
94477369|NCT01473940|323540974|FG003|Induction Therapy|Progressive Disease|0|||
94477370|NCT01473940|323540971|FG000|Maintenance Therapy|Progressive Disease|1|||
94477371|NCT01473940|323540972|FG001|Maintenance Therapy|Progressive Disease|2|||
94477372|NCT01473940|323540973|FG002|Maintenance Therapy|Progressive Disease|1|||
94477373|NCT01473940|323540974|FG003|Maintenance Therapy|Progressive Disease|4|||
94477374|NCT00547248|323540975|FG000|Overall Study|Protocol Violation|0|||
94477375|NCT00547248|323540976|FG001|Overall Study|Protocol Violation|0|||
94477376|NCT00547248|323540977|FG002|Overall Study|Protocol Violation|1|||
94477377|NCT00547248|323540978|FG003|Overall Study|Protocol Violation|1|||
94477378|NCT00547248|323540975|FG000|Overall Study|Migrated/moved from study area|0|||
94477379|NCT00547248|323540976|FG001|Overall Study|Migrated/moved from study area|0|||
94477380|NCT00547248|323540977|FG002|Overall Study|Migrated/moved from study area|2|||
94477381|NCT00547248|323540978|FG003|Overall Study|Migrated/moved from study area|0|||
94477382|NCT00547248|323540975|FG000|Overall Study|Withdrawal by Subject|0|||
94477383|NCT00547248|323540976|FG001|Overall Study|Withdrawal by Subject|0|||
94477384|NCT00547248|323540977|FG002|Overall Study|Withdrawal by Subject|7|||
94477385|NCT00547248|323540978|FG003|Overall Study|Withdrawal by Subject|1|||
94477386|NCT00534248|323540979|FG000|Overall Study|Adverse Event|19|||
94477387|NCT00534248|323540980|FG001|Overall Study|Adverse Event|29|||
94477388|NCT00534248|323540979|FG000|Overall Study|Lost to Follow-up|353|||
94477389|NCT00534248|323540980|FG001|Overall Study|Lost to Follow-up|375|||
94477390|NCT00534248|323540979|FG000|Overall Study|Other protocol specified criteria|13|||
94477391|NCT00534248|323540980|FG001|Overall Study|Other protocol specified criteria|3|||
94477392|NCT00534248|323540979|FG000|Overall Study|Physician Decision|10|||
94477393|NCT00534248|323540980|FG001|Overall Study|Physician Decision|7|||
94477394|NCT00534248|323540979|FG000|Overall Study|Protocol Violation|3|||
94477395|NCT00534248|323540980|FG001|Overall Study|Protocol Violation|4|||
94477396|NCT00534248|323540979|FG000|Overall Study|Withdrawal by Subject|263|||
94477397|NCT00534248|323540980|FG001|Overall Study|Withdrawal by Subject|255|||
94477398|NCT02630563|323540991|FG000|Overall Study|Administrative|1|||
94477399|NCT02239640|323540992|FG000|Overall Study|Withdrawal by Subject|3|||
94477400|NCT02239640|323540992|FG000|Overall Study|Lost to Follow-up|72|||
94477401|NCT02239640|323540992|FG000|Overall Study|Death|142|||
94477402|NCT02061813|323540993|FG000|Overall Study|Withdrawal by Subject|1|||
94477403|NCT02061813|323540993|FG000|Overall Study|Protocol Violation|2|||
94477404|NCT00206427|323540996|FG000|Overall Study|Adverse Event|2|||
94477405|NCT00943592|323541007|FG000|Overall Study|Death|3|||
94477406|NCT00397189|323541009|FG000|3 Weeks Period|Lost to Follow-up|5|||
94477407|NCT00397189|323541010|FG001|3 Weeks Period|Lost to Follow-up|4|||
94477408|NCT00397189|323541009|FG000|3 Weeks Period|Adverse Event|3|||
94477409|NCT00397189|323541010|FG001|3 Weeks Period|Adverse Event|2|||
94477410|NCT00397189|323541009|FG000|3 Weeks Period|Withdrawal by Subject|13|||
94477411|NCT00397189|323541010|FG001|3 Weeks Period|Withdrawal by Subject|9|||
94477412|NCT00397189|323541009|FG000|3 Weeks Period|Physician Decision|0|||
94477413|NCT00397189|323541010|FG001|3 Weeks Period|Physician Decision|2|||
94477414|NCT00397189|323541009|FG000|3 Weeks Period|Protocol Violation|0|||
94477415|NCT00397189|323541010|FG001|3 Weeks Period|Protocol Violation|3|||
94477416|NCT00397189|323541009|FG000|3 Weeks Period|Other|0|||
94477417|NCT00397189|323541010|FG001|3 Weeks Period|Other|2|||
94477418|NCT00141518|323541011|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
94477419|NCT00141518|323541012|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
94477420|NCT00141518|323541013|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
94477421|NCT00141518|323541011|FG000|Overall Study|Adverse Event|7|||
94477422|NCT00141518|323541012|FG001|Overall Study|Adverse Event|5|||
94477423|NCT00141518|323541013|FG002|Overall Study|Adverse Event|2|||
94477424|NCT00141518|323541011|FG000|Overall Study|Withdrawal by Subject|2|||
94477425|NCT00141518|323541012|FG001|Overall Study|Withdrawal by Subject|0|||
94477426|NCT00141518|323541013|FG002|Overall Study|Withdrawal by Subject|2|||
94477427|NCT00141518|323541011|FG000|Overall Study|Protocol Violation|1|||
94314565|NCT03552549|322934784|FG000|Overall Study|Adverse event in first 12 months|12|||
94477428|NCT00141518|323541012|FG001|Overall Study|Protocol Violation|1|||
94477429|NCT00141518|323541013|FG002|Overall Study|Protocol Violation|2|||
94477430|NCT00141518|323541011|FG000|Overall Study|Lack of Efficacy|5|||
94477431|NCT00141518|323541012|FG001|Overall Study|Lack of Efficacy|0|||
94477432|NCT00141518|323541013|FG002|Overall Study|Lack of Efficacy|0|||
94477433|NCT01029262|323541014|FG000|Overall Study|Adverse Event|9|||
94477434|NCT01029262|323541015|FG001|Overall Study|Adverse Event|52|||
94477435|NCT01029262|323541014|FG000|Overall Study|Lack of therapeutic effect|57|||
94477436|NCT01029262|323541015|FG001|Overall Study|Lack of therapeutic effect|76|||
94477437|NCT01029262|323541014|FG000|Overall Study|Withdrawal by Subject|10|||
94477438|NCT01029262|323541015|FG001|Overall Study|Withdrawal by Subject|17|||
94477439|NCT01029262|323541014|FG000|Overall Study|Protocol Violation|2|||
94477440|NCT01029262|323541015|FG001|Overall Study|Protocol Violation|3|||
94477441|NCT01029262|323541014|FG000|Overall Study|Miscellaneous|1|||
94477442|NCT01029262|323541015|FG001|Overall Study|Miscellaneous|9|||
94477443|NCT01029262|323541014|FG000|Overall Study|Death|0|||
94477444|NCT01029262|323541015|FG001|Overall Study|Death|3|||
94477445|NCT01768559|323541016|FG000|Overall Study|Randomized but not treated|0|||
94477446|NCT01768559|323541017|FG001|Overall Study|Randomized but not treated|0|||
94477447|NCT01768559|323541018|FG002|Overall Study|Randomized but not treated|1|||
94477448|NCT01768559|323541016|FG000|Overall Study|Adverse Event|15|||
94384797|NCT01658943|323194961|FG001|Overall Study|Progression/Relapse|40|||
94384798|NCT01658943|323194960|FG000|Overall Study|Death|4|||
94384799|NCT01658943|323194961|FG001|Overall Study|Death|2|||
94384800|NCT01658943|323194960|FG000|Overall Study|not protocol specified|4|||
94384801|NCT01658943|323194961|FG001|Overall Study|not protocol specified|1|||
94384802|NCT01658943|323194960|FG000|Overall Study|Not eligible|7|||
94384803|NCT01658943|323194961|FG001|Overall Study|Not eligible|9|||
94384804|NCT01658943|323194960|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
94384805|NCT01658943|323194961|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
94384806|NCT01569152|323194962|FG000|Phase IIa, Period 1|Early Escape|5|||
94384807|NCT01569152|323194963|FG001|Phase IIa, Period 1|Early Escape|22|||
94384808|NCT01569152|323194964|FG002|Phase IIa, Period 1|Early Escape|0|||
94384809|NCT01569152|323194962|FG000|Phase IIa, Period 1|Adverse Event|4|||
94384810|NCT01569152|323194963|FG001|Phase IIa, Period 1|Adverse Event|0|||
94384811|NCT01569152|323194964|FG002|Phase IIa, Period 1|Adverse Event|0|||
94384812|NCT01569152|323194962|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
94384813|NCT01569152|323194963|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
94384814|NCT01569152|323194964|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
94384815|NCT01569152|323194962|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
94384816|NCT01569152|323194963|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
94384817|NCT01569152|323194964|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
94384818|NCT01569152|323194962|FG000|Phase IIa, Period 1|Protocol Violation|0|||
94384819|NCT01569152|323194963|FG001|Phase IIa, Period 1|Protocol Violation|1|||
94314566|NCT03552549|322934785|FG001|Overall Study|Adverse event in first 12 months|8|||
94314567|NCT03552549|322934784|FG000|Overall Study|Withdrawal by Subject|7|||
94314568|NCT03552549|322934785|FG001|Overall Study|Withdrawal by Subject|7|||
94314569|NCT03552549|322934784|FG000|Overall Study|Unknown (no reason provided)|4|||
94314570|NCT03552549|322934785|FG001|Overall Study|Unknown (no reason provided)|2|||
94314571|NCT03552549|322934784|FG000|Overall Study|Not in participant's best interest|2|||
94314572|NCT03552549|322934785|FG001|Overall Study|Not in participant's best interest|1|||
94314573|NCT03552549|322934784|FG000|Overall Study|Did not complete study treatment|2|||
94314574|NCT03552549|322934785|FG001|Overall Study|Did not complete study treatment|3|||
94314575|NCT03552549|322934784|FG000|Overall Study|Did not meet eligibility criteria|1|||
94314576|NCT03552549|322934785|FG001|Overall Study|Did not meet eligibility criteria|0|||
94314577|NCT03552549|322934784|FG000|Overall Study|Administrative|0|||
94314578|NCT03552549|322934785|FG001|Overall Study|Administrative|14|||
94314579|NCT03382899|322934786|FG000|Overall Study|Ineligibility Determined|0|||
94314580|NCT03382899|322934787|FG001|Overall Study|Ineligibility Determined|1|||
94314581|NCT03382899|322934786|FG000|Overall Study|Lost to Follow-up|0|||
94314582|NCT03382899|322934787|FG001|Overall Study|Lost to Follow-up|1|||
94314583|NCT03382899|322934786|FG000|Overall Study|Sponsor's decision|31|||
94314584|NCT03382899|322934787|FG001|Overall Study|Sponsor's decision|28|||
94314585|NCT03382899|322934786|FG000|Overall Study|Withdrawal by Subject|0|||
94314586|NCT03382899|322934787|FG001|Overall Study|Withdrawal by Subject|5|||
94314587|NCT00872170|322934791|FG000|Overall Study|Adverse Event|1|||
94314588|NCT00872170|322934792|FG001|Overall Study|Adverse Event|0|||
94314589|NCT00540449|322934793|FG000|Overall Study|Adverse Event|12|||
94314590|NCT00540449|322934794|FG001|Overall Study|Adverse Event|32|||
94314591|NCT00540449|322934793|FG000|Overall Study|Sponsor's Decision|1|||
94314592|NCT00540449|322934794|FG001|Overall Study|Sponsor's Decision|1|||
94314593|NCT00540449|322934793|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
94314594|NCT00540449|322934794|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
94314595|NCT00540449|322934793|FG000|Overall Study|Lost to Follow-up|19|||
94314596|NCT00540449|322934794|FG001|Overall Study|Lost to Follow-up|17|||
94314597|NCT00540449|322934793|FG000|Overall Study|Subject Non-Compliant|7|||
94314598|NCT00540449|322934794|FG001|Overall Study|Subject Non-Compliant|5|||
94314599|NCT00540449|322934793|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
94314600|NCT00540449|322934794|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
94314601|NCT00540449|322934793|FG000|Overall Study|Withdrawal by Subject|10|||
94314602|NCT00540449|322934794|FG001|Overall Study|Withdrawal by Subject|10|||
94314603|NCT00540449|322934793|FG000|Overall Study|Other|1|||
94314604|NCT00540449|322934794|FG001|Overall Study|Other|4|||
94314605|NCT00968253|322934797|FG000|Overall Study|Death|0|||
94314606|NCT00968253|322934798|FG001|Overall Study|Death|0|||
94314607|NCT00968253|322934799|FG002|Overall Study|Death|2|||
94314608|NCT00968253|322934797|FG000|Overall Study|Withdrawal by Subject|0|||
94314609|NCT00968253|322934798|FG001|Overall Study|Withdrawal by Subject|0|||
94314610|NCT00968253|322934799|FG002|Overall Study|Withdrawal by Subject|1|||
94384820|NCT01569152|323194964|FG002|Phase IIa, Period 1|Protocol Violation|0|||
94384821|NCT01569152|323194962|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
94384822|NCT01569152|323194963|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
94314611|NCT00968253|322934797|FG000|Overall Study|Disease Progression|0|||
94314612|NCT00968253|322934798|FG001|Overall Study|Disease Progression|3|||
94314613|NCT00968253|322934799|FG002|Overall Study|Disease Progression|3|||
94314614|NCT00968253|322934797|FG000|Overall Study|Adverse Event|0|||
94477449|NCT01768559|323541017|FG001|Overall Study|Adverse Event|2|||
94477450|NCT01768559|323541018|FG002|Overall Study|Adverse Event|5|||
94477451|NCT01768559|323541016|FG000|Overall Study|Lack of Efficacy|6|||
94477452|NCT01768559|323541017|FG001|Overall Study|Lack of Efficacy|4|||
94477453|NCT01768559|323541018|FG002|Overall Study|Lack of Efficacy|0|||
94477454|NCT01768559|323541016|FG000|Overall Study|Poor compliance to protocol|0|||
94477455|NCT01768559|323541017|FG001|Overall Study|Poor compliance to protocol|3|||
94477456|NCT01768559|323541018|FG002|Overall Study|Poor compliance to protocol|2|||
94477457|NCT01768559|323541016|FG000|Overall Study|Other than specified|9|||
94477458|NCT01768559|323541017|FG001|Overall Study|Other than specified|8|||
94477459|NCT01768559|323541018|FG002|Overall Study|Other than specified|5|||
94477460|NCT01720524|323541021|FG000|Part A|Insufficient Clinical Response|2|||
94477461|NCT01720524|323541022|FG001|Part A|Insufficient Clinical Response|4|||
94477462|NCT01720524|323541021|FG000|Part A|Adverse Event|2|||
94477463|NCT01720524|323541022|FG001|Part A|Adverse Event|2|||
94477464|NCT01720524|323541021|FG000|Part A|Death|2|||
94477465|NCT01720524|323541022|FG001|Part A|Death|1|||
94477466|NCT01720524|323541021|FG000|Part A|Lost to Follow-up|0|||
94477467|NCT01720524|323541022|FG001|Part A|Lost to Follow-up|1|||
94477468|NCT01720524|323541021|FG000|Part A|Missed 28 day follow-up visit|1|||
94477469|NCT01720524|323541022|FG001|Part A|Missed 28 day follow-up visit|1|||
94477470|NCT01720524|323541021|FG000|Part A|Withdrawal by Subject|0|||
94477471|NCT01720524|323541022|FG001|Part A|Withdrawal by Subject|1|||
94477472|NCT01720524|323541021|FG000|Part A|Other|0|||
94477473|NCT01720524|323541022|FG001|Part A|Other|1|||
94477474|NCT01720524|323541021|FG000|Part A|Lost to Follow-up|0|||
94477475|NCT01720524|323541022|FG001|Part A|Lost to Follow-up|1|||
94477476|NCT01720524|323541021|FG000|Part B|No longer willing to participate in study|1|||
94477477|NCT01720524|323541022|FG001|Part B|No longer willing to participate in study|4|||
94477478|NCT01720524|323541021|FG000|Part B|Other|2|||
94477479|NCT01720524|323541022|FG001|Part B|Other|0|||
94477480|NCT01720524|323541021|FG000|Part B|Lost to Follow-up|2|||
94477481|NCT01720524|323541022|FG001|Part B|Lost to Follow-up|3|||
94477482|NCT01720524|323541021|FG000|Part B|Death|0|||
94477483|NCT01720524|323541022|FG001|Part B|Death|2|||
94477484|NCT00996034|323541023|FG000|Overall Study|Lost to Follow-up|2|||
94477485|NCT00996034|323541023|FG000|Overall Study|withdrawn by PI|1|||
94477486|NCT01502033|323541026|FG000|Overall Study|1 participant had scalp discomfort|1|||
94477487|NCT01502033|323541026|FG000|Overall Study|1 participant had worsening depression|1|||
94477488|NCT01502033|323541026|FG000|Overall Study|1 participant went back to school|1|||
94477489|NCT04676724|323541027|FG000|Overall Study|Adverse Event|2|||
94477490|NCT04676724|323541028|FG001|Overall Study|Adverse Event|0|||
94477491|NCT04676724|323541027|FG000|Overall Study|Lost to Follow-up|1|||
94477492|NCT04676724|323541028|FG001|Overall Study|Lost to Follow-up|0|||
94477493|NCT04676724|323541027|FG000|Overall Study|Physician Decision|0|||
94477494|NCT04676724|323541028|FG001|Overall Study|Physician Decision|1|||
94477495|NCT04676724|323541027|FG000|Overall Study|Withdrawal by Subject|3|||
94477496|NCT04676724|323541028|FG001|Overall Study|Withdrawal by Subject|2|||
94477497|NCT02585713|323541030|FG000|Overall Study|Withdrew prior to treatment|2|||
94477498|NCT02585713|323541031|FG001|Overall Study|Withdrew prior to treatment|7|||
94477499|NCT02585713|323541030|FG000|Overall Study|Other|3|||
94477500|NCT02585713|323541031|FG001|Overall Study|Other|1|||
94477501|NCT00186485|323541032|FG000|Overall Study|Lost to Follow-up|3|||
94477502|NCT01733121|323541036|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
94477503|NCT01733121|323541037|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
94477504|NCT01733121|323541036|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
94477505|NCT01733121|323541037|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
94477506|NCT01733121|323541036|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
94477507|NCT01733121|323541037|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
94477508|NCT01733121|323541036|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
94314615|NCT00968253|322934798|FG001|Overall Study|Adverse Event|0|||
94314616|NCT00968253|322934799|FG002|Overall Study|Adverse Event|1|||
94314617|NCT00137436|322936709|FG000|Overall Study|Adverse Event|13|||
94314618|NCT00137436|322936709|FG000|Overall Study|Death|2|||
94477509|NCT01733121|323541037|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
94477510|NCT02504320|323541038|FG000|Treatment Period 1|Positive Drug Screen|0|||
94477511|NCT02504320|323541039|FG001|Treatment Period 1|Positive Drug Screen|0|||
94477512|NCT02504320|323541040|FG002|Treatment Period 1|Positive Drug Screen|1|||
94477513|NCT02504320|323541041|FG003|Treatment Period 1|Positive Drug Screen|0|||
94314619|NCT00137436|322936709|FG000|Overall Study|Lack of Efficacy|17|||
94477514|NCT02504320|323541038|FG000|Treatment Period 2|Positive Drug Screen|0|||
94477515|NCT02504320|323541039|FG001|Treatment Period 2|Positive Drug Screen|1|||
94477516|NCT02504320|323541040|FG002|Treatment Period 2|Positive Drug Screen|0|||
94477517|NCT02504320|323541041|FG003|Treatment Period 2|Positive Drug Screen|0|||
94477518|NCT02504320|323541038|FG000|Treatment Period 3|Positive Drug Screen|0|||
94477519|NCT02504320|323541039|FG001|Treatment Period 3|Positive Drug Screen|0|||
94477520|NCT02504320|323541040|FG002|Treatment Period 3|Positive Drug Screen|0|||
94477521|NCT02504320|323541041|FG003|Treatment Period 3|Positive Drug Screen|1|||
94384823|NCT01569152|323194964|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
94384824|NCT01569152|323194962|FG000|Safety Extension, Period 3|Adverse Event|0|||
94384825|NCT01569152|323194963|FG001|Safety Extension, Period 3|Adverse Event|0|||
94384826|NCT01569152|323194964|FG002|Safety Extension, Period 3|Adverse Event|4|||
94384827|NCT01569152|323194962|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
94384828|NCT01569152|323194963|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
94384829|NCT01569152|323194964|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
94384830|NCT01569152|323194962|FG000|Safety Extension, Period 3|Physician Decision|0|||
94384831|NCT01569152|323194963|FG001|Safety Extension, Period 3|Physician Decision|0|||
94384832|NCT01569152|323194964|FG002|Safety Extension, Period 3|Physician Decision|2|||
94384833|NCT01569152|323194962|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
94384834|NCT01569152|323194963|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
94384835|NCT01569152|323194964|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
94384836|NCT03544138|323194965|FG000|Overall Study|Lost to Follow-up|29|||
94384837|NCT01648166|323196743|FG000|Overall Study|inadequate toenail samples|53|||
94384838|NCT01648166|323196744|FG001|Overall Study|inadequate toenail samples|100|||
94384839|NCT03444038|323196747|FG000|Overall Study|Adverse Event|12|||
94384840|NCT03444038|323196747|FG000|Overall Study|Withdrawal by Subject|7|||
94384841|NCT03444038|323196747|FG000|Overall Study|Lost to Follow-up|1|||
94384842|NCT03444038|323196747|FG000|Overall Study|Physician Decision|2|||
94384843|NCT03444038|323196747|FG000|Overall Study|Lack of Efficacy|7|||
94384844|NCT00977106|323196748|FG000|Overall Study|Adverse Event|5|||
94314620|NCT00137436|322936709|FG000|Overall Study|Withdrawal by Subject|6|||
94314621|NCT00137436|322936709|FG000|Overall Study|Other|5|||
94314622|NCT03151148|322936710|FG000|Overall Study|Lost to Follow-up|1|||
94314623|NCT03151148|322936711|FG001|Overall Study|Lost to Follow-up|0|||
94314624|NCT03151148|322936710|FG000|Overall Study|Withdrawal by Subject|1|||
94314625|NCT03151148|322936711|FG001|Overall Study|Withdrawal by Subject|0|||
94314626|NCT00701727|322936712|FG000|First Treatment Period|Adverse Event|0|||
94314627|NCT00701727|322936713|FG001|First Treatment Period|Adverse Event|0|||
94314628|NCT00701727|322936712|FG000|First Treatment Period|Withdrawal by Subject|1|||
94314629|NCT00701727|322936713|FG001|First Treatment Period|Withdrawal by Subject|0|||
94314630|NCT00701727|322936712|FG000|First Treatment Period|sponsor decision|0|||
94314631|NCT00701727|322936713|FG001|First Treatment Period|sponsor decision|1|||
94314632|NCT00701727|322936712|FG000|First Treatment Period|Lost to Follow-up|0|||
94314633|NCT00701727|322936713|FG001|First Treatment Period|Lost to Follow-up|1|||
94314634|NCT00701727|322936712|FG000|Second Treatment Period|Withdrawal by Subject|2|||
94314635|NCT00701727|322936713|FG001|Second Treatment Period|Withdrawal by Subject|0|||
94314636|NCT01520324|322936718|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
94314637|NCT01605071|322936719|FG000|Overall Study|Withdrawal by Subject|3|||
94314638|NCT01605071|322936720|FG001|Overall Study|Withdrawal by Subject|2|||
94314639|NCT00392171|322936721|FG000|Overall Study|Did not meet inclusion criteria|4|||
94314640|NCT00392171|322936721|FG000|Overall Study|Disease progression|101|||
94314641|NCT01931462|322936722|FG000|Overall Study|Withdrawal by Subject|1|||
94314642|NCT03622593|322936725|FG000|Overall Study|Withdrawal by Subject|11|||
94314643|NCT03622593|322936726|FG001|Overall Study|Withdrawal by Subject|9|||
94314644|NCT03622593|322936727|FG002|Overall Study|Withdrawal by Subject|13|||
94314645|NCT03622593|322936725|FG000|Overall Study|Death|12|||
94314646|NCT03622593|322936726|FG001|Overall Study|Death|9|||
94314647|NCT03622593|322936727|FG002|Overall Study|Death|10|||
94314648|NCT03622593|322936725|FG000|Overall Study|Lost to Follow-up|11|||
94314649|NCT03622593|322936726|FG001|Overall Study|Lost to Follow-up|5|||
94314650|NCT03622593|322936727|FG002|Overall Study|Lost to Follow-up|8|||
94314651|NCT03622593|322936725|FG000|Overall Study|Adverse Event|4|||
94314652|NCT03622593|322936726|FG001|Overall Study|Adverse Event|5|||
94314653|NCT03622593|322936727|FG002|Overall Study|Adverse Event|6|||
94314654|NCT03622593|322936725|FG000|Overall Study|Physician Decision|2|||
94314655|NCT03622593|322936726|FG001|Overall Study|Physician Decision|1|||
94314656|NCT03622593|322936727|FG002|Overall Study|Physician Decision|6|||
94314657|NCT03622593|322936725|FG000|Overall Study|Other|2|||
94314658|NCT03622593|322936726|FG001|Overall Study|Other|2|||
94314659|NCT03622593|322936727|FG002|Overall Study|Other|3|||
94314660|NCT03622593|322936725|FG000|Overall Study|Protocol Violation|0|||
94314661|NCT03622593|322936726|FG001|Overall Study|Protocol Violation|0|||
94314662|NCT03622593|322936727|FG002|Overall Study|Protocol Violation|1|||
94314663|NCT03622593|322936725|FG000|Overall Study|Pregnancy|0|||
94314664|NCT03622593|322936726|FG001|Overall Study|Pregnancy|0|||
94314665|NCT03622593|322936727|FG002|Overall Study|Pregnancy|1|||
94314666|NCT00903032|322936728|FG000|Overall Study|Withdrawal by Subject|5|||
94314667|NCT00903032|322936729|FG001|Overall Study|Withdrawal by Subject|3|||
94314668|NCT00903032|322936728|FG000|Overall Study|Lost to Follow-up|2|||
94314669|NCT00903032|322936729|FG001|Overall Study|Lost to Follow-up|2|||
94384845|NCT00977106|323196749|FG001|Overall Study|Adverse Event|6|||
94384846|NCT00977106|323196748|FG000|Overall Study|Withdrawal by Subject|2|||
94477522|NCT02504320|323541038|FG000|Treatment Period 3|Adverse Event|0|||
94314670|NCT04009096|322936730|FG000|Overall Study|Withdrawal by Subject|0|||
94384847|NCT00977106|323196749|FG001|Overall Study|Withdrawal by Subject|2|||
94477523|NCT02504320|323541039|FG001|Treatment Period 3|Adverse Event|0|||
94477524|NCT02504320|323541040|FG002|Treatment Period 3|Adverse Event|1|||
94477525|NCT02504320|323541041|FG003|Treatment Period 3|Adverse Event|0|||
94477526|NCT02420262|323541042|FG000|Overall Study|Adverse Event|1|||
94477527|NCT02420262|323541043|FG001|Overall Study|Adverse Event|0|||
94477528|NCT02420262|323541042|FG000|Overall Study|Withdrawal by Subject|1|||
94477529|NCT02420262|323541043|FG001|Overall Study|Withdrawal by Subject|4|||
94477530|NCT02420262|323541042|FG000|Overall Study|Unclassified|0|||
94477531|NCT02420262|323541043|FG001|Overall Study|Unclassified|1|||
94477532|NCT00627926|323541044|FG000|Overall Study|Adverse Event|26|||
94477533|NCT00627926|323541045|FG001|Overall Study|Adverse Event|37|||
94314671|NCT04009096|322936731|FG001|Overall Study|Withdrawal by Subject|7|||
94314672|NCT04009096|322936732|FG002|Overall Study|Withdrawal by Subject|0|||
94314673|NCT04009096|322936730|FG000|Overall Study|Physician Decision|0|||
94314674|NCT04009096|322936731|FG001|Overall Study|Physician Decision|1|||
94477534|NCT00627926|323541046|FG002|Overall Study|Adverse Event|36|||
94477535|NCT00627926|323541044|FG000|Overall Study|Death|1|||
94477536|NCT00627926|323541045|FG001|Overall Study|Death|0|||
94477537|NCT00627926|323541046|FG002|Overall Study|Death|0|||
94477538|NCT00627926|323541044|FG000|Overall Study|Lost to Follow-up|4|||
94477539|NCT00627926|323541045|FG001|Overall Study|Lost to Follow-up|3|||
94477540|NCT00627926|323541046|FG002|Overall Study|Lost to Follow-up|4|||
94477541|NCT00627926|323541044|FG000|Overall Study|Withdrawal by Subject|2|||
94477542|NCT00627926|323541045|FG001|Overall Study|Withdrawal by Subject|1|||
94477543|NCT00627926|323541046|FG002|Overall Study|Withdrawal by Subject|0|||
94477544|NCT00627926|323541044|FG000|Overall Study|Lack of Efficacy|118|||
94477545|NCT00627926|323541045|FG001|Overall Study|Lack of Efficacy|40|||
94477546|NCT00627926|323541046|FG002|Overall Study|Lack of Efficacy|38|||
94477547|NCT00627926|323541044|FG000|Overall Study|Noncompliance/unspecified|8|||
94477548|NCT00627926|323541045|FG001|Overall Study|Noncompliance/unspecified|23|||
94477549|NCT00627926|323541046|FG002|Overall Study|Noncompliance/unspecified|17|||
94477550|NCT03414229|323541047|FG000|Overall Study|Adverse Event|1|||
94477551|NCT03414229|323541048|FG001|Overall Study|Adverse Event|0|||
94477552|NCT03414229|323541049|FG002|Overall Study|Adverse Event|2|||
94477553|NCT03414229|323541050|FG003|Overall Study|Adverse Event|1|||
94477554|NCT03414229|323541047|FG000|Overall Study|Lack of Efficacy|7|||
94477555|NCT03414229|323541048|FG001|Overall Study|Lack of Efficacy|4|||
94477556|NCT03414229|323541049|FG002|Overall Study|Lack of Efficacy|1|||
94477557|NCT03414229|323541050|FG003|Overall Study|Lack of Efficacy|9|||
94477558|NCT03414229|323541047|FG000|Overall Study|Change in therapy|1|||
94477559|NCT03414229|323541048|FG001|Overall Study|Change in therapy|0|||
94477560|NCT03414229|323541049|FG002|Overall Study|Change in therapy|0|||
94477561|NCT03414229|323541050|FG003|Overall Study|Change in therapy|0|||
94477562|NCT03414229|323541047|FG000|Overall Study|Pregnancy|0|||
94477563|NCT03414229|323541048|FG001|Overall Study|Pregnancy|0|||
94477564|NCT03414229|323541049|FG002|Overall Study|Pregnancy|1|||
94477565|NCT03414229|323541050|FG003|Overall Study|Pregnancy|0|||
94477566|NCT03414229|323541047|FG000|Overall Study|Withdrawal by Subject|0|||
94477567|NCT03414229|323541048|FG001|Overall Study|Withdrawal by Subject|1|||
94477568|NCT03414229|323541049|FG002|Overall Study|Withdrawal by Subject|1|||
94477569|NCT03414229|323541050|FG003|Overall Study|Withdrawal by Subject|0|||
94477570|NCT05415462|323541052|FG000|Overall Study|Death|18|||
94477571|NCT05415462|323541053|FG001|Overall Study|Death|10|||
94477572|NCT05415462|323541052|FG000|Overall Study|Lost to Follow-up|72|||
94477573|NCT05415462|323541053|FG001|Overall Study|Lost to Follow-up|64|||
94477574|NCT05415462|323541052|FG000|Overall Study|Physician Decision|5|||
94477575|NCT05415462|323541053|FG001|Overall Study|Physician Decision|5|||
94477576|NCT05415462|323541052|FG000|Overall Study|Protocol Deviation|1|||
94477577|NCT05415462|323541053|FG001|Overall Study|Protocol Deviation|0|||
94477578|NCT05415462|323541052|FG000|Overall Study|Withdrawal by Subject|129|||
94477579|NCT05415462|323541053|FG001|Overall Study|Withdrawal by Subject|101|||
94477580|NCT05415462|323541052|FG000|Overall Study|Other Than Specified|8|||
94477581|NCT05415462|323541053|FG001|Overall Study|Other Than Specified|8|||
94477582|NCT02797678|323541054|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
94477583|NCT02797678|323541055|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
94477584|NCT02797678|323541056|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
94477585|NCT02797678|323541057|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
94477586|NCT02797678|323541054|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
94477587|NCT02797678|323541055|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
94477588|NCT02797678|323541056|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
94477589|NCT02797678|323541057|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
94477590|NCT02797678|323541054|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
94477591|NCT02797678|323541055|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
94477592|NCT02797678|323541056|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
94477593|NCT02797678|323541057|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
94477594|NCT00096538|323541059|FG000|Overall Study|Withdrawal by Subject|1|||
94477595|NCT02686164|323541060|FG000|Overall Study|Adverse Event|1|||
94477596|NCT02686164|323541060|FG000|Overall Study|Withdrawal of consent|1|||
94477597|NCT02686164|323541060|FG000|Overall Study|Clinical progression|1|||
94477598|NCT00672633|323541061|FG000|Overall Study|Withdrawal by Subject|0|||
94477599|NCT00672633|323541062|FG001|Overall Study|Withdrawal by Subject|1|||
94477600|NCT02499120|323541065|FG000|Overall Study|Death|52|||
94477601|NCT02499120|323541066|FG001|Overall Study|Death|43|||
94477602|NCT02499120|323541065|FG000|Overall Study|Lost to Follow-up|1|||
94477603|NCT02499120|323541066|FG001|Overall Study|Lost to Follow-up|2|||
94477604|NCT02499120|323541065|FG000|Overall Study|Participant refused further follow-up|1|||
94477605|NCT02499120|323541066|FG001|Overall Study|Participant refused further follow-up|0|||
94314675|NCT04009096|322936732|FG002|Overall Study|Physician Decision|0|||
94314676|NCT01070550|322936737|FG000|Overall Study|Adverse Event|43|||
94477606|NCT02499120|323541065|FG000|Overall Study|Withdrawal by Subject|2|||
94477607|NCT02499120|323541066|FG001|Overall Study|Withdrawal by Subject|5|||
94477608|NCT02499120|323541065|FG000|Overall Study|Other|9|||
94477609|NCT02499120|323541066|FG001|Overall Study|Other|10|||
94477610|NCT01931397|323541069|FG000|Overall Study|Physician Decision|2|||
94477611|NCT01931397|323541069|FG000|Overall Study|Withdrawal by Subject|8|||
94477612|NCT01931397|323541069|FG000|Overall Study|moved out of state|1|||
94477613|NCT01223937|323541070|FG000|Overall Study|Withdrawal by Subject|3|||
94477614|NCT01223937|323541071|FG001|Overall Study|Withdrawal by Subject|2|||
94477615|NCT01223937|323541070|FG000|Overall Study|Lost to Follow-up|1|||
94477616|NCT01223937|323541071|FG001|Overall Study|Lost to Follow-up|4|||
94477617|NCT01223937|323541070|FG000|Overall Study|Adverse Event|1|||
94477618|NCT01223937|323541071|FG001|Overall Study|Adverse Event|4|||
94477619|NCT01223937|323541070|FG000|Overall Study|Protocol Violation|8|||
94477620|NCT01223937|323541071|FG001|Overall Study|Protocol Violation|7|||
94477621|NCT01223937|323541070|FG000|Overall Study|Other|4|||
94314677|NCT01070550|322936738|FG001|Overall Study|Adverse Event|1|||
94314678|NCT01070550|322936739|FG002|Overall Study|Adverse Event|3|||
94314679|NCT01070550|322936740|FG003|Overall Study|Adverse Event|0|||
94314680|NCT01070550|322936741|FG004|Overall Study|Adverse Event|0|||
94314681|NCT01070550|322936742|FG005|Overall Study|Adverse Event|0|||
94314682|NCT01070550|322936737|FG000|Overall Study|Death|20|||
94314683|NCT01070550|322936738|FG001|Overall Study|Death|4|||
94314684|NCT01070550|322936739|FG002|Overall Study|Death|3|||
94314685|NCT01070550|322936740|FG003|Overall Study|Death|0|||
94314686|NCT01070550|322936741|FG004|Overall Study|Death|0|||
94314687|NCT01070550|322936742|FG005|Overall Study|Death|0|||
94314688|NCT01070550|322936737|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
94314689|NCT01070550|322936738|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
94314690|NCT01070550|322936739|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
94314691|NCT01070550|322936740|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
94314692|NCT01070550|322936741|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
94314693|NCT01070550|322936742|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
94314694|NCT01070550|322936737|FG000|Overall Study|Early termination|3|||
94314695|NCT01070550|322936738|FG001|Overall Study|Early termination|0|||
94314696|NCT01070550|322936739|FG002|Overall Study|Early termination|0|||
94314697|NCT01070550|322936740|FG003|Overall Study|Early termination|0|||
94314698|NCT01070550|322936741|FG004|Overall Study|Early termination|0|||
94314699|NCT01070550|322936742|FG005|Overall Study|Early termination|0|||
94314700|NCT01070550|322936737|FG000|Overall Study|Failed to return|450|||
94314701|NCT01070550|322936738|FG001|Overall Study|Failed to return|33|||
94314702|NCT01070550|322936739|FG002|Overall Study|Failed to return|144|||
94314703|NCT01070550|322936740|FG003|Overall Study|Failed to return|40|||
94314704|NCT01070550|322936741|FG004|Overall Study|Failed to return|1|||
94314705|NCT01070550|322936742|FG005|Overall Study|Failed to return|2|||
94314706|NCT01070550|322936737|FG000|Overall Study|Incomplete treatment|2|||
94314707|NCT01070550|322936738|FG001|Overall Study|Incomplete treatment|0|||
94314708|NCT01070550|322936739|FG002|Overall Study|Incomplete treatment|0|||
94314709|NCT01070550|322936740|FG003|Overall Study|Incomplete treatment|0|||
94314710|NCT01070550|322936741|FG004|Overall Study|Incomplete treatment|0|||
94314711|NCT01070550|322936742|FG005|Overall Study|Incomplete treatment|0|||
94477622|NCT01223937|323541071|FG001|Overall Study|Other|1|||
94477623|NCT03999749|323541075|FG000|Overall Study|Toxicity|16|||
94477624|NCT03999749|323541075|FG000|Overall Study|Withdrawal by Subject|3|||
94477625|NCT03999749|323541075|FG000|Overall Study|Disease progression|26|||
94477626|NCT03999749|323541075|FG000|Overall Study|Physician Decision|4|||
94477627|NCT03999749|323541075|FG000|Overall Study|Death|5|||
94477628|NCT03999749|323541075|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
94314712|NCT01070550|322936737|FG000|Overall Study|Lab test not done|22|||
94314713|NCT01070550|322936738|FG001|Overall Study|Lab test not done|3|||
94314714|NCT01070550|322936739|FG002|Overall Study|Lab test not done|4|||
94314715|NCT01070550|322936740|FG003|Overall Study|Lab test not done|1|||
94314716|NCT01070550|322936741|FG004|Overall Study|Lab test not done|0|||
94314717|NCT01070550|322936742|FG005|Overall Study|Lab test not done|1|||
94314718|NCT01070550|322936737|FG000|Overall Study|Lack of Efficacy|65|||
94314719|NCT01070550|322936738|FG001|Overall Study|Lack of Efficacy|1|||
94314720|NCT01070550|322936739|FG002|Overall Study|Lack of Efficacy|5|||
94314721|NCT01070550|322936740|FG003|Overall Study|Lack of Efficacy|5|||
94314722|NCT01070550|322936741|FG004|Overall Study|Lack of Efficacy|0|||
94314723|NCT01070550|322936742|FG005|Overall Study|Lack of Efficacy|1|||
94314724|NCT01070550|322936737|FG000|Overall Study|Miscellaneous|12|||
94314725|NCT01070550|322936738|FG001|Overall Study|Miscellaneous|2|||
94314726|NCT01070550|322936739|FG002|Overall Study|Miscellaneous|3|||
94314727|NCT01070550|322936740|FG003|Overall Study|Miscellaneous|1|||
94314728|NCT01070550|322936741|FG004|Overall Study|Miscellaneous|0|||
94314729|NCT01070550|322936742|FG005|Overall Study|Miscellaneous|0|||
94314730|NCT01070550|322936737|FG000|Overall Study|New treatment started|3|||
94314731|NCT01070550|322936738|FG001|Overall Study|New treatment started|1|||
94314732|NCT01070550|322936739|FG002|Overall Study|New treatment started|0|||
94314733|NCT01070550|322936740|FG003|Overall Study|New treatment started|2|||
94314734|NCT01070550|322936741|FG004|Overall Study|New treatment started|0|||
94314735|NCT01070550|322936742|FG005|Overall Study|New treatment started|0|||
94314736|NCT01070550|322936737|FG000|Overall Study|Non-responders|493|||
94314737|NCT01070550|322936738|FG001|Overall Study|Non-responders|4|||
94314738|NCT01070550|322936739|FG002|Overall Study|Non-responders|21|||
94314739|NCT01070550|322936740|FG003|Overall Study|Non-responders|20|||
94314740|NCT01070550|322936741|FG004|Overall Study|Non-responders|0|||
94314741|NCT01070550|322936742|FG005|Overall Study|Non-responders|2|||
94314742|NCT01070550|322936737|FG000|Overall Study|Not categorized|33|||
94314743|NCT01070550|322936738|FG001|Overall Study|Not categorized|2|||
94314744|NCT01070550|322936739|FG002|Overall Study|Not categorized|6|||
94314745|NCT01070550|322936740|FG003|Overall Study|Not categorized|1|||
94314746|NCT01070550|322936741|FG004|Overall Study|Not categorized|0|||
94314747|NCT01070550|322936742|FG005|Overall Study|Not categorized|1|||
94314748|NCT01070550|322936737|FG000|Overall Study|Protocol Violation|15|||
94314749|NCT01070550|322936738|FG001|Overall Study|Protocol Violation|1|||
94314750|NCT01070550|322936739|FG002|Overall Study|Protocol Violation|1|||
94314751|NCT01070550|322936740|FG003|Overall Study|Protocol Violation|1|||
94314752|NCT01070550|322936741|FG004|Overall Study|Protocol Violation|0|||
94314753|NCT01070550|322936742|FG005|Overall Study|Protocol Violation|0|||
94314754|NCT01070550|322936737|FG000|Overall Study|Relapse|44|||
94314755|NCT01070550|322936738|FG001|Overall Study|Relapse|5|||
94314756|NCT01070550|322936739|FG002|Overall Study|Relapse|14|||
94314757|NCT01070550|322936740|FG003|Overall Study|Relapse|4|||
94314758|NCT01070550|322936741|FG004|Overall Study|Relapse|0|||
94314759|NCT01070550|322936742|FG005|Overall Study|Relapse|0|||
94314760|NCT01070550|322936737|FG000|Overall Study|Result not available|3|||
94314761|NCT01070550|322936738|FG001|Overall Study|Result not available|1|||
94314762|NCT01070550|322936739|FG002|Overall Study|Result not available|3|||
94314763|NCT01070550|322936740|FG003|Overall Study|Result not available|0|||
94314764|NCT01070550|322936741|FG004|Overall Study|Result not available|0|||
94314765|NCT01070550|322936742|FG005|Overall Study|Result not available|0|||
94314766|NCT01070550|322936737|FG000|Overall Study|Screen failure|1|||
94314767|NCT01070550|322936738|FG001|Overall Study|Screen failure|0|||
94314768|NCT01070550|322936739|FG002|Overall Study|Screen failure|0|||
94314769|NCT01070550|322936740|FG003|Overall Study|Screen failure|0|||
94314770|NCT01070550|322936741|FG004|Overall Study|Screen failure|0|||
94314771|NCT01070550|322936742|FG005|Overall Study|Screen failure|0|||
94314772|NCT01070550|322936737|FG000|Overall Study|Sponsor decision|1|||
94314773|NCT01070550|322936738|FG001|Overall Study|Sponsor decision|0|||
94314774|NCT01070550|322936739|FG002|Overall Study|Sponsor decision|0|||
94314775|NCT01070550|322936740|FG003|Overall Study|Sponsor decision|0|||
94314776|NCT01070550|322936741|FG004|Overall Study|Sponsor decision|0|||
94314777|NCT01070550|322936742|FG005|Overall Study|Sponsor decision|0|||
94314778|NCT01070550|322936737|FG000|Overall Study|Treatment duration shortened|1|||
94314779|NCT01070550|322936738|FG001|Overall Study|Treatment duration shortened|0|||
94314780|NCT01070550|322936739|FG002|Overall Study|Treatment duration shortened|0|||
94314781|NCT01070550|322936740|FG003|Overall Study|Treatment duration shortened|0|||
94314782|NCT01070550|322936741|FG004|Overall Study|Treatment duration shortened|0|||
94314783|NCT01070550|322936742|FG005|Overall Study|Treatment duration shortened|0|||
94314784|NCT01070550|322936737|FG000|Overall Study|Treatment interrupted|7|||
94314785|NCT01070550|322936738|FG001|Overall Study|Treatment interrupted|0|||
94314786|NCT01070550|322936739|FG002|Overall Study|Treatment interrupted|1|||
94314787|NCT01070550|322936740|FG003|Overall Study|Treatment interrupted|1|||
94314788|NCT01070550|322936741|FG004|Overall Study|Treatment interrupted|0|||
94314789|NCT01070550|322936742|FG005|Overall Study|Treatment interrupted|0|||
94314790|NCT01070550|322936737|FG000|Overall Study|Treatment not started|14|||
94314791|NCT01070550|322936738|FG001|Overall Study|Treatment not started|2|||
94314792|NCT01070550|322936739|FG002|Overall Study|Treatment not started|4|||
94314793|NCT01070550|322936740|FG003|Overall Study|Treatment not started|0|||
94314794|NCT01070550|322936741|FG004|Overall Study|Treatment not started|0|||
94314795|NCT01070550|322936742|FG005|Overall Study|Treatment not started|0|||
94314796|NCT01070550|322936737|FG000|Overall Study|Treatment restarted|0|||
94477629|NCT00980655|323541076|FG000|Overall Study|Adverse Event|13|||
94477630|NCT00980655|323541077|FG001|Overall Study|Adverse Event|31|||
94477631|NCT00980655|323541076|FG000|Overall Study|Death|0|||
94477632|NCT00980655|323541077|FG001|Overall Study|Death|7|||
94477633|NCT00980655|323541076|FG000|Overall Study|Protocol Violation|2|||
94477634|NCT00980655|323541077|FG001|Overall Study|Protocol Violation|7|||
94477635|NCT00980655|323541076|FG000|Overall Study|Withdrawal by Subject|0|||
94477636|NCT00980655|323541077|FG001|Overall Study|Withdrawal by Subject|4|||
94477637|NCT00980655|323541076|FG000|Overall Study|Lost to Follow-up|0|||
94477638|NCT00980655|323541077|FG001|Overall Study|Lost to Follow-up|1|||
94477639|NCT00980655|323541076|FG000|Overall Study|Parent/legal guardian request|1|||
94477640|NCT00980655|323541077|FG001|Overall Study|Parent/legal guardian request|0|||
94477641|NCT00980655|323541076|FG000|Overall Study|Other|0|||
94477642|NCT00980655|323541077|FG001|Overall Study|Other|1|||
94477643|NCT00255164|323541078|FG000|Overall Study|Adverse Event|10|||
94477644|NCT00255164|323541079|FG001|Overall Study|Adverse Event|6|||
94314797|NCT01070550|322936738|FG001|Overall Study|Treatment restarted|1|||
94314798|NCT01070550|322936739|FG002|Overall Study|Treatment restarted|0|||
94314799|NCT01070550|322936740|FG003|Overall Study|Treatment restarted|0|||
94314800|NCT01070550|322936741|FG004|Overall Study|Treatment restarted|0|||
94314801|NCT01070550|322936742|FG005|Overall Study|Treatment restarted|0|||
94314802|NCT01070550|322936737|FG000|Overall Study|Treatment stopped|3|||
94314803|NCT01070550|322936738|FG001|Overall Study|Treatment stopped|0|||
94314804|NCT01070550|322936739|FG002|Overall Study|Treatment stopped|0|||
94314805|NCT01070550|322936740|FG003|Overall Study|Treatment stopped|0|||
94314806|NCT01070550|322936741|FG004|Overall Study|Treatment stopped|0|||
94314807|NCT01070550|322936742|FG005|Overall Study|Treatment stopped|0|||
94314808|NCT01070550|322936737|FG000|Overall Study|Treatment unavailable|1|||
94314809|NCT01070550|322936738|FG001|Overall Study|Treatment unavailable|0|||
94314810|NCT01070550|322936739|FG002|Overall Study|Treatment unavailable|0|||
94314811|NCT01070550|322936740|FG003|Overall Study|Treatment unavailable|0|||
94314812|NCT01070550|322936741|FG004|Overall Study|Treatment unavailable|0|||
94314813|NCT01070550|322936742|FG005|Overall Study|Treatment unavailable|0|||
94314814|NCT01070550|322936737|FG000|Overall Study|Treatment was stopped early|7|||
94314815|NCT01070550|322936738|FG001|Overall Study|Treatment was stopped early|0|||
94314816|NCT01070550|322936739|FG002|Overall Study|Treatment was stopped early|0|||
94314817|NCT01070550|322936740|FG003|Overall Study|Treatment was stopped early|0|||
94314818|NCT01070550|322936741|FG004|Overall Study|Treatment was stopped early|0|||
94314819|NCT01070550|322936742|FG005|Overall Study|Treatment was stopped early|0|||
94314820|NCT01070550|322936737|FG000|Overall Study|Other|5|||
94314821|NCT01070550|322936738|FG001|Overall Study|Other|0|||
94314822|NCT01070550|322936739|FG002|Overall Study|Other|0|||
94314823|NCT01070550|322936740|FG003|Overall Study|Other|1|||
94314824|NCT01070550|322936741|FG004|Overall Study|Other|0|||
94314825|NCT01070550|322936742|FG005|Overall Study|Other|0|||
94314826|NCT01070550|322936737|FG000|Overall Study|Withdrawal by Subject|35|||
94314827|NCT01070550|322936738|FG001|Overall Study|Withdrawal by Subject|0|||
94314828|NCT01070550|322936739|FG002|Overall Study|Withdrawal by Subject|3|||
94314829|NCT01070550|322936740|FG003|Overall Study|Withdrawal by Subject|0|||
94314830|NCT01070550|322936741|FG004|Overall Study|Withdrawal by Subject|0|||
94314831|NCT01070550|322936742|FG005|Overall Study|Withdrawal by Subject|0|||
94314832|NCT03010423|322936743|FG000|Overall Study|Study termination|8|||
94314833|NCT04426825|322936746|FG000|Overall Study|Death|17|||
94314834|NCT04426825|322936746|FG000|Overall Study|Lost to Follow-up|1|||
94314835|NCT04426825|322936746|FG000|Overall Study|Study terminated by sponsor|5|||
94314836|NCT01258348|322936747|FG000|Overall Study|Adverse Event|1|||
94314837|NCT01258348|322936748|FG001|Overall Study|Adverse Event|1|||
94314838|NCT01258348|322936749|FG002|Overall Study|Adverse Event|3|||
94314839|NCT01258348|322936750|FG003|Overall Study|Adverse Event|2|||
94314840|NCT01258348|322936751|FG004|Overall Study|Adverse Event|4|||
94314841|NCT01258348|322936747|FG000|Overall Study|Progressive Disease|0|||
94314842|NCT01258348|322936748|FG001|Overall Study|Progressive Disease|3|||
94314843|NCT01258348|322936749|FG002|Overall Study|Progressive Disease|0|||
94314844|NCT01258348|322936750|FG003|Overall Study|Progressive Disease|2|||
94314845|NCT01258348|322936751|FG004|Overall Study|Progressive Disease|2|||
94314846|NCT01258348|322936747|FG000|Overall Study|Physician Decision|0|||
94314847|NCT01258348|322936748|FG001|Overall Study|Physician Decision|0|||
94314848|NCT01258348|322936749|FG002|Overall Study|Physician Decision|0|||
94314849|NCT01258348|322936750|FG003|Overall Study|Physician Decision|2|||
94477645|NCT00255164|323541080|FG002|Overall Study|Adverse Event|9|||
94477646|NCT00255164|323541078|FG000|Overall Study|Lost to Follow-up|4|||
94314850|NCT01258348|322936751|FG004|Overall Study|Physician Decision|0|||
94314851|NCT01258348|322936747|FG000|Overall Study|Withdrawal by Subject|0|||
94314852|NCT01258348|322936748|FG001|Overall Study|Withdrawal by Subject|1|||
94477647|NCT00255164|323541079|FG001|Overall Study|Lost to Follow-up|3|||
94314853|NCT01258348|322936749|FG002|Overall Study|Withdrawal by Subject|0|||
94314854|NCT01258348|322936750|FG003|Overall Study|Withdrawal by Subject|0|||
94314855|NCT01258348|322936751|FG004|Overall Study|Withdrawal by Subject|0|||
94314856|NCT04346628|322936752|FG000|Overall Study|Lost to Follow-up|4|||
94477648|NCT00255164|323541080|FG002|Overall Study|Lost to Follow-up|4|||
94477649|NCT00255164|323541078|FG000|Overall Study|Withdrawal by Subject|18|||
94477650|NCT00255164|323541079|FG001|Overall Study|Withdrawal by Subject|17|||
94477651|NCT00255164|323541080|FG002|Overall Study|Withdrawal by Subject|8|||
94477652|NCT00255164|323541078|FG000|Overall Study|Noncompliance|0|||
94477653|NCT00255164|323541079|FG001|Overall Study|Noncompliance|1|||
94477654|NCT00255164|323541080|FG002|Overall Study|Noncompliance|2|||
94477655|NCT00255164|323541078|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
94477656|NCT00255164|323541079|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
94477657|NCT00255164|323541080|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
94477658|NCT00255164|323541078|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
94477659|NCT00255164|323541079|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
94477660|NCT00255164|323541080|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
94477661|NCT00255164|323541078|FG000|Overall Study|Possible Barrett's Esophagus|1|||
94477662|NCT00255164|323541079|FG001|Overall Study|Possible Barrett's Esophagus|3|||
94477663|NCT00255164|323541080|FG002|Overall Study|Possible Barrett's Esophagus|8|||
94477664|NCT00255164|323541078|FG000|Overall Study|Esophageal Stricture|0|||
94477665|NCT00255164|323541079|FG001|Overall Study|Esophageal Stricture|0|||
94477666|NCT00255164|323541080|FG002|Overall Study|Esophageal Stricture|1|||
94477667|NCT00255164|323541078|FG000|Overall Study|Therapeutic Failure|11|||
94477668|NCT00255164|323541079|FG001|Overall Study|Therapeutic Failure|2|||
94477669|NCT00255164|323541080|FG002|Overall Study|Therapeutic Failure|3|||
94477670|NCT04162795|323541082|FG000|Overall Study|Other|16|||
94477671|NCT04162795|323541082|FG000|Overall Study|Screen failures|10|||
94477672|NCT02029274|323541083|FG000|Overall Study|Adverse Event|1|||
94477673|NCT02029274|323541084|FG001|Overall Study|Adverse Event|0|||
94477674|NCT02029274|323541085|FG002|Overall Study|Adverse Event|2|||
94477675|NCT02029274|323541086|FG003|Overall Study|Adverse Event|2|||
94477676|NCT04265261|323541087|FG000|Overall Study|Adverse Event|2|||
94477677|NCT04265261|323541088|FG001|Overall Study|Adverse Event|0|||
94477678|NCT04265261|323541089|FG002|Overall Study|Adverse Event|0|||
94477679|NCT04265261|323541087|FG000|Overall Study|Death|1|||
94477680|NCT04265261|323541088|FG001|Overall Study|Death|0|||
94477681|NCT04265261|323541089|FG002|Overall Study|Death|0|||
94477682|NCT04265261|323541087|FG000|Overall Study|Lost to Follow-up|4|||
94477683|NCT04265261|323541088|FG001|Overall Study|Lost to Follow-up|1|||
94477684|NCT04265261|323541089|FG002|Overall Study|Lost to Follow-up|3|||
94477685|NCT04265261|323541087|FG000|Overall Study|Non-Compliance with Study Drug|1|||
94477686|NCT04265261|323541088|FG001|Overall Study|Non-Compliance with Study Drug|1|||
94477687|NCT04265261|323541089|FG002|Overall Study|Non-Compliance with Study Drug|0|||
94477688|NCT04265261|323541087|FG000|Overall Study|Physician Decision|0|||
94477689|NCT04265261|323541088|FG001|Overall Study|Physician Decision|0|||
94477690|NCT04265261|323541089|FG002|Overall Study|Physician Decision|1|||
94477691|NCT04265261|323541087|FG000|Overall Study|Protocol Deviation|0|||
94477692|NCT04265261|323541088|FG001|Overall Study|Protocol Deviation|2|||
94477693|NCT04265261|323541089|FG002|Overall Study|Protocol Deviation|0|||
94477694|NCT04265261|323541087|FG000|Overall Study|Withdrawal by Subject|2|||
94477695|NCT04265261|323541088|FG001|Overall Study|Withdrawal by Subject|1|||
94477696|NCT04265261|323541089|FG002|Overall Study|Withdrawal by Subject|4|||
94477697|NCT01971567|323542528|FG000|Overall Study|Withdrawal by Subject|3|||
94477698|NCT01971567|323542529|FG001|Overall Study|Withdrawal by Subject|2|||
94477699|NCT01971567|323542528|FG000|Overall Study|Lost to Follow-up|1|||
94477700|NCT01971567|323542529|FG001|Overall Study|Lost to Follow-up|0|||
94477701|NCT03335813|323542535|FG000|Overall Study|Withdrawal by Subject|1|||
94477702|NCT01826981|323542536|FG000|Overall Study|Lack of Efficacy|0|||
94477703|NCT01826981|323542537|FG001|Overall Study|Lack of Efficacy|1|||
94477704|NCT01826981|323542538|FG002|Overall Study|Lack of Efficacy|0|||
94477705|NCT01826981|323542539|FG003|Overall Study|Lack of Efficacy|0|||
94477706|NCT01826981|323542540|FG004|Overall Study|Lack of Efficacy|5|||
94477707|NCT01826981|323542541|FG005|Overall Study|Lack of Efficacy|0|||
94477708|NCT01826981|323542542|FG006|Overall Study|Lack of Efficacy|0|||
94477709|NCT01826981|323542543|FG007|Overall Study|Lack of Efficacy|8|||
94477710|NCT01826981|323542544|FG008|Overall Study|Lack of Efficacy|7|||
94477711|NCT01826981|323542545|FG009|Overall Study|Lack of Efficacy|0|||
94477712|NCT01826981|323542546|FG010|Overall Study|Lack of Efficacy|1|||
94477713|NCT01826981|323542547|FG011|Overall Study|Lack of Efficacy|0|||
94477714|NCT01826981|323542548|FG012|Overall Study|Lack of Efficacy|0|||
94477715|NCT01826981|323542549|FG013|Overall Study|Lack of Efficacy|3|||
94477716|NCT01826981|323542550|FG014|Overall Study|Lack of Efficacy|0|||
94477717|NCT01826981|323542536|FG000|Overall Study|Lost to Follow-up|0|||
94477718|NCT01826981|323542537|FG001|Overall Study|Lost to Follow-up|0|||
94477719|NCT01826981|323542538|FG002|Overall Study|Lost to Follow-up|0|||
94477720|NCT01826981|323542539|FG003|Overall Study|Lost to Follow-up|0|||
94477721|NCT01826981|323542540|FG004|Overall Study|Lost to Follow-up|1|||
94477722|NCT01826981|323542541|FG005|Overall Study|Lost to Follow-up|1|||
94477723|NCT01826981|323542542|FG006|Overall Study|Lost to Follow-up|0|||
94477724|NCT01826981|323542543|FG007|Overall Study|Lost to Follow-up|1|||
94477725|NCT01826981|323542544|FG008|Overall Study|Lost to Follow-up|0|||
94477726|NCT01826981|323542545|FG009|Overall Study|Lost to Follow-up|1|||
94477727|NCT01826981|323542546|FG010|Overall Study|Lost to Follow-up|1|||
94477728|NCT01826981|323542547|FG011|Overall Study|Lost to Follow-up|1|||
94477729|NCT01826981|323542548|FG012|Overall Study|Lost to Follow-up|1|||
94314857|NCT04346628|322936753|FG001|Overall Study|Lost to Follow-up|4|||
94314858|NCT04346628|322936752|FG000|Overall Study|Withdrew (had personal reasons)|2|||
94314859|NCT04346628|322936753|FG001|Overall Study|Withdrew (had personal reasons)|5|||
94314860|NCT04346628|322936752|FG000|Overall Study|Withdrew (medication intolerant)|0|||
94314861|NCT04346628|322936753|FG001|Overall Study|Withdrew (medication intolerant)|3|||
94314862|NCT04346628|322936752|FG000|Overall Study|Withdrew (declined intervention)|0|||
94314863|NCT04346628|322936753|FG001|Overall Study|Withdrew (declined intervention)|1|||
94314864|NCT01597557|322936754|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
94314865|NCT01597557|322936755|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
94314866|NCT00907881|322936763|FG000|Overall Study|Lost to Follow-up|59|||
94314867|NCT00907881|322936763|FG000|Overall Study|Noncompliance|5|||
94314868|NCT00907881|322936763|FG000|Overall Study|Withdrawal by Subject|5|||
94314869|NCT00907881|322936763|FG000|Overall Study|Protocol Violation|1|||
94314870|NCT00907881|322936763|FG000|Overall Study|Missing discontinuation information|15|||
94314871|NCT04742907|322936764|FG000|Overall Study|Adverse Event|1|||
94314872|NCT04742907|322936765|FG001|Overall Study|Adverse Event|0|||
94314873|NCT04742907|322936766|FG002|Overall Study|Adverse Event|1|||
94314874|NCT04742907|322936764|FG000|Overall Study|Lost to Follow-up|3|||
94314875|NCT04742907|322936765|FG001|Overall Study|Lost to Follow-up|3|||
94314876|NCT04742907|322936766|FG002|Overall Study|Lost to Follow-up|2|||
94314877|NCT04742907|322936764|FG000|Overall Study|Physician Decision|0|||
94314878|NCT04742907|322936765|FG001|Overall Study|Physician Decision|1|||
94314879|NCT04742907|322936766|FG002|Overall Study|Physician Decision|0|||
94314880|NCT04742907|322936764|FG000|Overall Study|Protocol Violation|1|||
94314881|NCT04742907|322936765|FG001|Overall Study|Protocol Violation|1|||
94314882|NCT04742907|322936766|FG002|Overall Study|Protocol Violation|1|||
94314883|NCT04742907|322936764|FG000|Overall Study|Withdrawal by Subject|5|||
94314884|NCT04742907|322936765|FG001|Overall Study|Withdrawal by Subject|6|||
94314885|NCT04742907|322936766|FG002|Overall Study|Withdrawal by Subject|4|||
94314886|NCT04742907|322936764|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
94314887|NCT04742907|322936765|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
94314888|NCT04742907|322936766|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
94314889|NCT04742907|322936764|FG000|Overall Study|Did Not Receive the Study Drug|2|||
94314890|NCT04742907|322936765|FG001|Overall Study|Did Not Receive the Study Drug|4|||
94314891|NCT04742907|322936766|FG002|Overall Study|Did Not Receive the Study Drug|4|||
94314892|NCT00506077|322936768|FG000|Treatment Period 1|Adverse Event|2|||
94314893|NCT00506077|322936769|FG001|Treatment Period 1|Adverse Event|1|||
94314894|NCT00506077|322936768|FG000|Treatment Period 1|Lost to Follow-up|0|||
94314895|NCT00506077|322936769|FG001|Treatment Period 1|Lost to Follow-up|2|||
94314896|NCT00506077|322936768|FG000|Treatment Period 1|Withdrawal by Subject|2|||
94314897|NCT00506077|322936769|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94314898|NCT00506077|322936768|FG000|Treatment Period 2|Adverse Event|0|||
94314899|NCT00506077|322936769|FG001|Treatment Period 2|Adverse Event|1|||
94314900|NCT00506077|322936768|FG000|Treatment Period 2|Withdrawal by Subject|1|||
94314901|NCT00506077|322936769|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94314902|NCT00850759|322936771|FG000|Overall Study|Lost to Follow-up|7|||
94314903|NCT00850759|322936772|FG001|Overall Study|Lost to Follow-up|5|||
94314904|NCT00850759|322936773|FG002|Overall Study|Lost to Follow-up|5|||
94314905|NCT00850759|322936774|FG003|Overall Study|Lost to Follow-up|3|||
94314906|NCT01005719|322936777|FG000|Period 1|Adverse Event|0|||
94314907|NCT01005719|322936778|FG001|Period 1|Adverse Event|0|||
94314908|NCT01005719|322936779|FG002|Period 1|Adverse Event|0|||
94314909|NCT01005719|322936780|FG003|Period 1|Adverse Event|1|||
94314910|NCT01005719|322936781|FG004|Period 1|Adverse Event|0|||
94314911|NCT01005719|322936782|FG005|Period 1|Adverse Event|0|||
94314912|NCT01005719|322936777|FG000|Period 1|Delay in completing study procedures|0|||
94314913|NCT01005719|322936778|FG001|Period 1|Delay in completing study procedures|0|||
94314914|NCT01005719|322936779|FG002|Period 1|Delay in completing study procedures|0|||
94314915|NCT01005719|322936780|FG003|Period 1|Delay in completing study procedures|0|||
94314916|NCT01005719|322936781|FG004|Period 1|Delay in completing study procedures|0|||
94314917|NCT01005719|322936782|FG005|Period 1|Delay in completing study procedures|1|||
94314918|NCT01005719|322936777|FG000|Period 2|Adverse Event|0|||
94314919|NCT01005719|322936778|FG001|Period 2|Adverse Event|0|||
94314920|NCT01005719|322936779|FG002|Period 2|Adverse Event|0|||
94314921|NCT01005719|322936780|FG003|Period 2|Adverse Event|0|||
94314922|NCT01005719|322936781|FG004|Period 2|Adverse Event|1|||
94314923|NCT01005719|322936782|FG005|Period 2|Adverse Event|1|||
94314924|NCT02918266|322936783|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
94314925|NCT02918266|322936784|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
94314926|NCT02918266|322936785|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
94314927|NCT02918266|322936786|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
94314928|NCT02918266|322936787|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
94314929|NCT02918266|322936788|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
94477730|NCT01826981|323542549|FG013|Overall Study|Lost to Follow-up|0|||
94477731|NCT01826981|323542550|FG014|Overall Study|Lost to Follow-up|0|||
94477732|NCT01826981|323542536|FG000|Overall Study|Withdrew Consent|0|||
94477733|NCT01826981|323542537|FG001|Overall Study|Withdrew Consent|0|||
94477734|NCT01826981|323542538|FG002|Overall Study|Withdrew Consent|0|||
94477735|NCT01826981|323542539|FG003|Overall Study|Withdrew Consent|0|||
94477736|NCT01826981|323542540|FG004|Overall Study|Withdrew Consent|0|||
94477737|NCT01826981|323542541|FG005|Overall Study|Withdrew Consent|0|||
94477738|NCT01826981|323542542|FG006|Overall Study|Withdrew Consent|1|||
94477739|NCT01826981|323542543|FG007|Overall Study|Withdrew Consent|1|||
94477740|NCT01826981|323542544|FG008|Overall Study|Withdrew Consent|0|||
94477741|NCT01826981|323542545|FG009|Overall Study|Withdrew Consent|0|||
94477742|NCT01826981|323542546|FG010|Overall Study|Withdrew Consent|0|||
94477743|NCT01826981|323542547|FG011|Overall Study|Withdrew Consent|1|||
94477744|NCT01826981|323542548|FG012|Overall Study|Withdrew Consent|0|||
94477745|NCT01826981|323542549|FG013|Overall Study|Withdrew Consent|1|||
94477746|NCT01826981|323542550|FG014|Overall Study|Withdrew Consent|0|||
94477747|NCT01826981|323542536|FG000|Overall Study|Adverse Event|0|||
94477748|NCT01826981|323542537|FG001|Overall Study|Adverse Event|0|||
94477749|NCT01826981|323542538|FG002|Overall Study|Adverse Event|0|||
94477750|NCT01826981|323542539|FG003|Overall Study|Adverse Event|0|||
94477751|NCT01826981|323542540|FG004|Overall Study|Adverse Event|1|||
94477752|NCT01826981|323542541|FG005|Overall Study|Adverse Event|0|||
94477753|NCT01826981|323542542|FG006|Overall Study|Adverse Event|0|||
94477754|NCT01826981|323542543|FG007|Overall Study|Adverse Event|0|||
94477755|NCT01826981|323542544|FG008|Overall Study|Adverse Event|0|||
94477756|NCT01826981|323542545|FG009|Overall Study|Adverse Event|0|||
94477757|NCT01826981|323542546|FG010|Overall Study|Adverse Event|0|||
94477758|NCT01826981|323542547|FG011|Overall Study|Adverse Event|0|||
94477759|NCT01826981|323542548|FG012|Overall Study|Adverse Event|0|||
94477760|NCT01826981|323542549|FG013|Overall Study|Adverse Event|0|||
94477761|NCT01826981|323542550|FG014|Overall Study|Adverse Event|0|||
94477762|NCT01826981|323542536|FG000|Overall Study|Upper G-I Haemorrhage|0|||
94477763|NCT01826981|323542537|FG001|Overall Study|Upper G-I Haemorrhage|0|||
94477764|NCT01826981|323542538|FG002|Overall Study|Upper G-I Haemorrhage|0|||
94477765|NCT01826981|323542539|FG003|Overall Study|Upper G-I Haemorrhage|0|||
94477766|NCT01826981|323542540|FG004|Overall Study|Upper G-I Haemorrhage|0|||
94477767|NCT01826981|323542541|FG005|Overall Study|Upper G-I Haemorrhage|0|||
94477768|NCT01826981|323542542|FG006|Overall Study|Upper G-I Haemorrhage|0|||
94477769|NCT01826981|323542543|FG007|Overall Study|Upper G-I Haemorrhage|0|||
94477770|NCT01826981|323542544|FG008|Overall Study|Upper G-I Haemorrhage|0|||
94477771|NCT01826981|323542545|FG009|Overall Study|Upper G-I Haemorrhage|0|||
94477772|NCT01826981|323542546|FG010|Overall Study|Upper G-I Haemorrhage|0|||
94477773|NCT01826981|323542547|FG011|Overall Study|Upper G-I Haemorrhage|0|||
94477774|NCT01826981|323542548|FG012|Overall Study|Upper G-I Haemorrhage|0|||
94477775|NCT01826981|323542549|FG013|Overall Study|Upper G-I Haemorrhage|1|||
94477776|NCT01826981|323542550|FG014|Overall Study|Upper G-I Haemorrhage|0|||
94477777|NCT01826981|323542536|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
94477778|NCT01826981|323542537|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
94477779|NCT01826981|323542538|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
94477780|NCT01826981|323542539|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
94477781|NCT01826981|323542540|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
94477782|NCT01826981|323542541|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
94477783|NCT01826981|323542542|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
94477784|NCT01826981|323542543|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
94477785|NCT01826981|323542544|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
94477786|NCT01826981|323542545|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
94477787|NCT01826981|323542546|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
94477788|NCT01826981|323542547|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
94477789|NCT01826981|323542548|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
94477790|NCT01826981|323542549|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
94477791|NCT01826981|323542550|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
94477792|NCT01239394|323542553|FG000|Overall Study|Adverse Event|1|||
94477793|NCT02861664|323542554|FG000|Overall Study|Withdrawal of Consent|0|||
94477794|NCT02861664|323542555|FG001|Overall Study|Withdrawal of Consent|1|||
94477795|NCT03498313|323542559|FG000|Experimental Period 1|Adverse Event|1|||
94477796|NCT03498313|323542560|FG001|Experimental Period 1|Adverse Event|0|||
94477797|NCT03498313|323542561|FG002|Experimental Period 1|Adverse Event|0|||
94477798|NCT03498313|323542562|FG003|Experimental Period 1|Adverse Event|1|||
94477799|NCT03498313|323542563|FG004|Experimental Period 1|Adverse Event|0|||
94477800|NCT03498313|323542564|FG005|Experimental Period 1|Adverse Event|0|||
94477801|NCT03498313|323542559|FG000|Experimental Period 1|Withdrawal by Subject|0|||
94477802|NCT03498313|323542560|FG001|Experimental Period 1|Withdrawal by Subject|1|||
94477803|NCT03498313|323542561|FG002|Experimental Period 1|Withdrawal by Subject|0|||
94477804|NCT03498313|323542562|FG003|Experimental Period 1|Withdrawal by Subject|0|||
94477805|NCT03498313|323542563|FG004|Experimental Period 1|Withdrawal by Subject|0|||
94314930|NCT02918266|322936789|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
94314931|NCT02918266|322936790|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
94314932|NCT02918266|322936791|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
94314933|NCT02918266|322936792|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
94314934|NCT02918266|322936793|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
94314935|NCT01860534|322936794|FG000|ROP #1|Needed treatment for ROP|0|||
94314936|NCT01860534|322936795|FG001|ROP #1|Needed treatment for ROP|1|||
94314937|NCT01860534|322936794|FG000|ROP #2|discharged prior to ROP #2|1|||
94314938|NCT01860534|322936795|FG001|ROP #2|discharged prior to ROP #2|0|||
94314939|NCT00788775|322936798|FG000|Overall Study|Progressive Disease|8|||
94314940|NCT00788775|322936799|FG001|Overall Study|Progressive Disease|6|||
94314941|NCT00788775|322936798|FG000|Overall Study|Withdrawal by Subject|0|||
94314942|NCT00788775|322936799|FG001|Overall Study|Withdrawal by Subject|2|||
94314943|NCT00788775|322936798|FG000|Overall Study|Patient Non-Compliance|1|||
94314944|NCT00788775|322936799|FG001|Overall Study|Patient Non-Compliance|0|||
94314945|NCT00788775|322936798|FG000|Overall Study|Patient's measurable disease resected.|1|||
94314946|NCT00788775|322936799|FG001|Overall Study|Patient's measurable disease resected.|0|||
94314947|NCT00578864|322936800|FG000|Overall Study|Death|1|||
94314948|NCT00578864|322936801|FG001|Overall Study|Death|0|||
94314949|NCT01702363|322936802|FG000|Overall Study|Adverse Event|14|||
94314950|NCT01702363|322936802|FG000|Overall Study|Lack of Efficacy|4|||
94314951|NCT01702363|322936802|FG000|Overall Study|Withdrawal by Subject|2|||
94314952|NCT01293032|322936803|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
94314953|NCT01293032|322936804|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
94314954|NCT01293032|322936805|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
94314955|NCT01293032|322936806|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
94314956|NCT01293032|322936803|FG000|Treatment|Adverse Event|0|||
94314957|NCT01293032|322936804|FG001|Treatment|Adverse Event|0|||
94314958|NCT01293032|322936805|FG002|Treatment|Adverse Event|1|||
94314959|NCT01293032|322936806|FG003|Treatment|Adverse Event|1|||
94314960|NCT01293032|322936803|FG000|Treatment|Withdrawal by Subject|2|||
94314961|NCT01293032|322936804|FG001|Treatment|Withdrawal by Subject|4|||
94314962|NCT01293032|322936805|FG002|Treatment|Withdrawal by Subject|0|||
94314963|NCT01293032|322936806|FG003|Treatment|Withdrawal by Subject|0|||
94314964|NCT01293032|322936803|FG000|Treatment|Disease Progression, relapse|0|||
94314965|NCT01293032|322936804|FG001|Treatment|Disease Progression, relapse|1|||
94314966|NCT01293032|322936805|FG002|Treatment|Disease Progression, relapse|0|||
94314967|NCT01293032|322936806|FG003|Treatment|Disease Progression, relapse|0|||
94314968|NCT03408873|322936807|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
94314969|NCT03408873|322936807|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
94314970|NCT03408873|322936807|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
94314971|NCT03408873|322936807|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
94314972|NCT03408873|322936807|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
94314973|NCT03408873|322936807|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
94314974|NCT01594476|322936808|FG000|Overall Study|Protocol Violation|1|||
94314975|NCT01594476|322936809|FG001|Overall Study|Protocol Violation|3|||
94314976|NCT01106534|322936810|FG000|Overall Study|Withdrawal by Subject|18|||
94314977|NCT01106534|322936810|FG000|Overall Study|Lost to Follow-up|2|||
94314978|NCT01106534|322936810|FG000|Overall Study|Death|16|||
94314979|NCT01106534|322936810|FG000|Overall Study|Physician Decision|1|||
94314980|NCT03799718|322936811|FG000|Overall Study|Adverse Event|2|||
94314981|NCT00446446|322936812|FG000|Overall Study|Death|10|||
94314982|NCT00446446|322936812|FG000|Overall Study|Withdrawal by Subject|6|||
94314983|NCT00446446|322936812|FG000|Overall Study|Other|4|||
94314984|NCT00446446|322936812|FG000|Overall Study|Disease Progession|2|||
94314985|NCT00446446|322936812|FG000|Overall Study|Adverse Event|1|||
94314986|NCT00446446|322936812|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
94314987|NCT00114972|322936820|FG000|Overall Study|Withdrawal by Subject|40|||
94314988|NCT00114972|322936821|FG001|Overall Study|Withdrawal by Subject|7|||
94314989|NCT00114972|322936820|FG000|Overall Study|Lost to Follow-up|8|||
94314990|NCT00114972|322936821|FG001|Overall Study|Lost to Follow-up|5|||
94314991|NCT01879618|322936822|FG000|Overall Study|Does not meet entrance criteria|1|||
94314992|NCT01879618|322936822|FG000|Overall Study|Withdrawal by Subject|1|||
94314993|NCT01879618|322936822|FG000|Overall Study|Surgery;changed schedule; not available|8|||
94314994|NCT01879618|322936822|FG000|Overall Study|Protocol Violation|6|||
94314995|NCT01879618|322936822|FG000|Overall Study|Adverse Event|5|||
94314996|NCT00610935|322936823|FG000|Overall Study|Lost to Follow-up|0|||
94314997|NCT00610935|322936824|FG001|Overall Study|Lost to Follow-up|1|||
94314998|NCT00610935|322936823|FG000|Overall Study|Withdrawal by Subject|0|||
94314999|NCT00610935|322936824|FG001|Overall Study|Withdrawal by Subject|2|||
94315000|NCT00610935|322936823|FG000|Overall Study|Sponsor Discontinuation|1|||
94315001|NCT00610935|322936824|FG001|Overall Study|Sponsor Discontinuation|0|||
94315002|NCT02399813|322936825|FG000|Overall Study|Progressive Disease-Radiographic|2|||
94315003|NCT02399813|322936825|FG000|Overall Study|Death|20|||
94315004|NCT02399813|322936825|FG000|Overall Study|Withdrawal by Subject|3|||
94315005|NCT02399813|322936825|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
94477806|NCT03498313|323542564|FG005|Experimental Period 1|Withdrawal by Subject|0|||
94477807|NCT03498313|323542559|FG000|Washout Period 1|Anovulation|1|||
94477808|NCT03498313|323542560|FG001|Washout Period 1|Anovulation|0|||
94477809|NCT03498313|323542561|FG002|Washout Period 1|Anovulation|0|||
94477810|NCT03498313|323542562|FG003|Washout Period 1|Anovulation|0|||
94477811|NCT03498313|323542563|FG004|Washout Period 1|Anovulation|0|||
94477812|NCT03498313|323542564|FG005|Washout Period 1|Anovulation|0|||
94477813|NCT03498313|323542559|FG000|Washout Period 1|Withdrawal by Subject|0|||
94477814|NCT03498313|323542560|FG001|Washout Period 1|Withdrawal by Subject|3|||
94477815|NCT03498313|323542561|FG002|Washout Period 1|Withdrawal by Subject|0|||
94477816|NCT03498313|323542562|FG003|Washout Period 1|Withdrawal by Subject|1|||
94477817|NCT03498313|323542563|FG004|Washout Period 1|Withdrawal by Subject|0|||
94477818|NCT03498313|323542564|FG005|Washout Period 1|Withdrawal by Subject|1|||
94477819|NCT03498313|323542559|FG000|Experimental Period 2|Adverse Event|0|||
94477820|NCT03498313|323542560|FG001|Experimental Period 2|Adverse Event|0|||
94477821|NCT03498313|323542561|FG002|Experimental Period 2|Adverse Event|0|||
94477822|NCT03498313|323542562|FG003|Experimental Period 2|Adverse Event|0|||
94477823|NCT03498313|323542563|FG004|Experimental Period 2|Adverse Event|1|||
94477824|NCT03498313|323542564|FG005|Experimental Period 2|Adverse Event|2|||
94477825|NCT03498313|323542559|FG000|Washout Period 2|Physician Decision|1|||
94477826|NCT03498313|323542560|FG001|Washout Period 2|Physician Decision|0|||
94477827|NCT03498313|323542561|FG002|Washout Period 2|Physician Decision|0|||
94477828|NCT03498313|323542562|FG003|Washout Period 2|Physician Decision|1|||
94477829|NCT03498313|323542563|FG004|Washout Period 2|Physician Decision|0|||
94477830|NCT03498313|323542564|FG005|Washout Period 2|Physician Decision|1|||
94477831|NCT03498313|323542559|FG000|Washout Period 2|Withdrawal by Subject|3|||
94477832|NCT03498313|323542560|FG001|Washout Period 2|Withdrawal by Subject|2|||
94477833|NCT03498313|323542561|FG002|Washout Period 2|Withdrawal by Subject|0|||
94477834|NCT03498313|323542562|FG003|Washout Period 2|Withdrawal by Subject|0|||
94477835|NCT03498313|323542563|FG004|Washout Period 2|Withdrawal by Subject|2|||
94477836|NCT03498313|323542564|FG005|Washout Period 2|Withdrawal by Subject|0|||
94477837|NCT03498313|323542559|FG000|Washout Period 2|Anovulation|0|||
94477838|NCT03498313|323542560|FG001|Washout Period 2|Anovulation|0|||
94477839|NCT03498313|323542561|FG002|Washout Period 2|Anovulation|0|||
94477840|NCT03498313|323542562|FG003|Washout Period 2|Anovulation|0|||
94477841|NCT03498313|323542563|FG004|Washout Period 2|Anovulation|0|||
94477842|NCT03498313|323542564|FG005|Washout Period 2|Anovulation|1|||
94477843|NCT00621257|323542567|FG000|Overall Study|Lost to Follow-up|4|||
94477844|NCT00621257|323542568|FG001|Overall Study|Lost to Follow-up|0|||
94477845|NCT00621257|323542569|FG002|Overall Study|Lost to Follow-up|2|||
94477846|NCT00621257|323542570|FG003|Overall Study|Lost to Follow-up|4|||
94477847|NCT00621257|323542571|FG004|Overall Study|Lost to Follow-up|7|||
94477848|NCT00621257|323542567|FG000|Overall Study|Adverse Event|0|||
94477849|NCT00621257|323542568|FG001|Overall Study|Adverse Event|1|||
94477850|NCT00621257|323542569|FG002|Overall Study|Adverse Event|1|||
94477851|NCT00621257|323542570|FG003|Overall Study|Adverse Event|0|||
94477852|NCT00621257|323542571|FG004|Overall Study|Adverse Event|0|||
94477853|NCT00621257|323542567|FG000|Overall Study|Physician Decision|0|||
94477854|NCT00621257|323542568|FG001|Overall Study|Physician Decision|2|||
94477855|NCT00621257|323542569|FG002|Overall Study|Physician Decision|0|||
94477856|NCT00621257|323542570|FG003|Overall Study|Physician Decision|1|||
94477857|NCT00621257|323542571|FG004|Overall Study|Physician Decision|1|||
94477858|NCT00621257|323542567|FG000|Overall Study|Withdrawal by Subject|0|||
94477859|NCT00621257|323542568|FG001|Overall Study|Withdrawal by Subject|0|||
94477860|NCT00621257|323542569|FG002|Overall Study|Withdrawal by Subject|0|||
94477861|NCT00621257|323542570|FG003|Overall Study|Withdrawal by Subject|1|||
94477862|NCT00621257|323542571|FG004|Overall Study|Withdrawal by Subject|1|||
94477863|NCT00929994|323542572|FG000|Overall Study|Withdrawal by Subject|1|||
94477864|NCT00929994|323542572|FG000|Overall Study|medical issue unrelated to intervention|4|||
94477865|NCT00929994|323542572|FG000|Overall Study|employment|1|||
94477866|NCT01704755|323542577|FG000|Overall Study|Adverse Event|4|||
94477867|NCT01704755|323542578|FG001|Overall Study|Adverse Event|1|||
94477868|NCT01704755|323542577|FG000|Overall Study|Lost to Follow-up|3|||
94477869|NCT01704755|323542578|FG001|Overall Study|Lost to Follow-up|4|||
94477870|NCT01704755|323542577|FG000|Overall Study|Withdrew consent|1|||
94477871|NCT01704755|323542578|FG001|Overall Study|Withdrew consent|1|||
94477872|NCT01704755|323542577|FG000|Overall Study|Other (not specified)|3|||
94477873|NCT01704755|323542578|FG001|Overall Study|Other (not specified)|1|||
94477874|NCT01704755|323542577|FG000|Overall Study|Withdrew consent and personal issues|1|||
94477875|NCT01704755|323542578|FG001|Overall Study|Withdrew consent and personal issues|0|||
94477876|NCT00613821|323542582|FG000|Overall Study|Withdrawal by Subject|1|||
94477877|NCT00613821|323542583|FG001|Overall Study|Withdrawal by Subject|0|||
94477878|NCT00613821|323542582|FG000|Overall Study|Physician Decision|1|||
94477879|NCT00613821|323542583|FG001|Overall Study|Physician Decision|1|||
94477880|NCT01806168|323542590|FG000|Overall Study|Adverse Event|1|||
94477881|NCT01806168|323542591|FG001|Overall Study|Adverse Event|0|||
94477882|NCT01806168|323542592|FG002|Overall Study|Adverse Event|0|||
94477883|NCT01806168|323542590|FG000|Overall Study|Withdrawal by Subject|0|||
94315006|NCT02399813|322936825|FG000|Overall Study|Lost to Follow-up|2|||
94315007|NCT02399813|322936825|FG000|Overall Study|Other than specified|5|||
94315008|NCT03345836|322936826|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
94477884|NCT01806168|323542591|FG001|Overall Study|Withdrawal by Subject|1|||
94477885|NCT01806168|323542592|FG002|Overall Study|Withdrawal by Subject|2|||
94477886|NCT01806168|323542590|FG000|Overall Study|Protocol Violation|0|||
94477887|NCT01806168|323542591|FG001|Overall Study|Protocol Violation|0|||
94477888|NCT01806168|323542592|FG002|Overall Study|Protocol Violation|1|||
94477889|NCT01089127|323542597|FG000|Overall Study|Adverse Event|5|||
94477890|NCT01089127|323542598|FG001|Overall Study|Adverse Event|1|||
94477891|NCT01089127|323542599|FG002|Overall Study|Adverse Event|1|||
94477892|NCT01089127|323542600|FG003|Overall Study|Adverse Event|0|||
94477893|NCT01089127|323542601|FG004|Overall Study|Adverse Event|0|||
94477894|NCT01089127|323542602|FG005|Overall Study|Adverse Event|1|||
94477895|NCT01089127|323542597|FG000|Overall Study|Subject withdrew consent|0|||
94477896|NCT01089127|323542598|FG001|Overall Study|Subject withdrew consent|1|||
94477897|NCT01089127|323542599|FG002|Overall Study|Subject withdrew consent|1|||
94477898|NCT01089127|323542600|FG003|Overall Study|Subject withdrew consent|1|||
94477899|NCT01089127|323542601|FG004|Overall Study|Subject withdrew consent|0|||
94477900|NCT01089127|323542602|FG005|Overall Study|Subject withdrew consent|2|||
94477901|NCT01089127|323542597|FG000|Overall Study|Abnormal test procedure result(s)|2|||
94477902|NCT01089127|323542598|FG001|Overall Study|Abnormal test procedure result(s)|1|||
94477903|NCT01089127|323542599|FG002|Overall Study|Abnormal test procedure result(s)|0|||
94477904|NCT01089127|323542600|FG003|Overall Study|Abnormal test procedure result(s)|0|||
94477905|NCT01089127|323542601|FG004|Overall Study|Abnormal test procedure result(s)|0|||
94477906|NCT01089127|323542602|FG005|Overall Study|Abnormal test procedure result(s)|0|||
94477907|NCT01089127|323542597|FG000|Overall Study|Lost to Follow-up|1|||
94477908|NCT01089127|323542598|FG001|Overall Study|Lost to Follow-up|1|||
94477909|NCT01089127|323542599|FG002|Overall Study|Lost to Follow-up|0|||
94477910|NCT01089127|323542600|FG003|Overall Study|Lost to Follow-up|0|||
94477911|NCT01089127|323542601|FG004|Overall Study|Lost to Follow-up|1|||
94477912|NCT01089127|323542602|FG005|Overall Study|Lost to Follow-up|0|||
94477913|NCT01089127|323542597|FG000|Overall Study|Protocol deviation|0|||
94477914|NCT01089127|323542598|FG001|Overall Study|Protocol deviation|1|||
94477915|NCT01089127|323542599|FG002|Overall Study|Protocol deviation|0|||
94477916|NCT01089127|323542600|FG003|Overall Study|Protocol deviation|0|||
94477917|NCT01089127|323542601|FG004|Overall Study|Protocol deviation|1|||
94477918|NCT01089127|323542602|FG005|Overall Study|Protocol deviation|0|||
94477919|NCT04435808|323542603|FG000|Overall Study|Study stopped by DSMB|0|||
94477920|NCT04435808|323542604|FG001|Overall Study|Study stopped by DSMB|1|||
94477921|NCT01300247|323542605|FG000|Overall Study|Death|1|||
94477922|NCT01300247|323542606|FG001|Overall Study|Death|1|||
94477923|NCT01300247|323542605|FG000|Overall Study|Lost to Follow-up|2|||
94477924|NCT01300247|323542606|FG001|Overall Study|Lost to Follow-up|0|||
94477925|NCT01300247|323542605|FG000|Overall Study|Withdrawal by Subject|1|||
94477926|NCT01300247|323542606|FG001|Overall Study|Withdrawal by Subject|0|||
94477927|NCT01300247|323542605|FG000|Overall Study|Non-Compliance|0|||
94477928|NCT01300247|323542606|FG001|Overall Study|Non-Compliance|1|||
94477929|NCT02105285|323542612|FG000|Overall Study|Adverse Event|1|||
94477930|NCT02105285|323542613|FG001|Overall Study|Adverse Event|1|||
94477931|NCT02105285|323542614|FG002|Overall Study|Adverse Event|0|||
94477932|NCT02105285|323542612|FG000|Overall Study|Protocol Violation|0|||
94477933|NCT02105285|323542613|FG001|Overall Study|Protocol Violation|1|||
94477934|NCT02105285|323542614|FG002|Overall Study|Protocol Violation|0|||
94477935|NCT02105285|323542612|FG000|Overall Study|Withdrawal by Subject|1|||
94477936|NCT02105285|323542613|FG001|Overall Study|Withdrawal by Subject|0|||
94315009|NCT03345836|322936827|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
94315010|NCT03345836|322936828|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
94315011|NCT03345836|322936829|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
94315012|NCT03345836|322936830|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
94315013|NCT03345836|322936831|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
94315014|NCT03345836|322936826|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
94477937|NCT02105285|323542614|FG002|Overall Study|Withdrawal by Subject|0|||
94477938|NCT01922258|323542615|FG000|Overall Study|Lost to Follow-up|1|||
94477939|NCT01922258|323542616|FG001|Overall Study|Lost to Follow-up|1|||
94477940|NCT01922258|323542615|FG000|Overall Study|Adverse Event|9|||
94477941|NCT01922258|323542616|FG001|Overall Study|Adverse Event|2|||
94477942|NCT01922258|323542615|FG000|Overall Study|Met Withdrawal Criteria|0|||
94477943|NCT01922258|323542616|FG001|Overall Study|Met Withdrawal Criteria|4|||
94477944|NCT01922258|323542615|FG000|Overall Study|Withdrawn by the Investigator|1|||
94477945|NCT01922258|323542616|FG001|Overall Study|Withdrawn by the Investigator|4|||
94477946|NCT01922258|323542615|FG000|Overall Study|Withdrawal by participant|5|||
94477947|NCT01922258|323542616|FG001|Overall Study|Withdrawal by participant|5|||
94477948|NCT02716779|323542617|FG000|Monotherapy|Adverse Event|0|||
94477949|NCT02716779|323542618|FG001|Monotherapy|Adverse Event|1|||
94477950|NCT02716779|323542619|FG002|Monotherapy|Adverse Event|1|||
94477951|NCT02716779|323542617|FG000|Combination Therapy|Adverse Event|0|||
94477952|NCT02716779|323542618|FG001|Combination Therapy|Adverse Event|2|||
94477953|NCT02716779|323542619|FG002|Combination Therapy|Adverse Event|1|||
94477954|NCT03293394|323542620|FG000|Follow-up (6 Months)|Adverse Event|4|||
94477955|NCT03293394|323542621|FG001|Follow-up (6 Months)|Adverse Event|2|||
94477956|NCT02360280|323542625|FG000|Overall Study|Withdrawal by Subject|2|||
94477957|NCT02360280|323542626|FG001|Overall Study|Withdrawal by Subject|0|||
94477958|NCT02360280|323542625|FG000|Overall Study|Adverse Event|0|||
94477959|NCT02360280|323542626|FG001|Overall Study|Adverse Event|1|||
94477960|NCT02360280|323542625|FG000|Overall Study|Lost to Follow-up|1|||
94477961|NCT02360280|323542626|FG001|Overall Study|Lost to Follow-up|0|||
94477962|NCT01383018|323542627|FG000|Overall Study|Adverse Event|14|||
94477963|NCT01383018|323542627|FG000|Overall Study|Death|10|||
94384848|NCT00977106|323196748|FG000|Overall Study|Lack of Efficacy|2|||
94384849|NCT00977106|323196749|FG001|Overall Study|Lack of Efficacy|2|||
94384850|NCT00977106|323196748|FG000|Overall Study|Protocol Violation|0|||
94384851|NCT00977106|323196749|FG001|Overall Study|Protocol Violation|1|||
94384852|NCT00977106|323196748|FG000|Overall Study|Other|1|||
94384853|NCT00977106|323196749|FG001|Overall Study|Other|0|||
94384854|NCT01475838|323196750|FG000|Randomized Phase|Randomized but Not Treated|0|||
94384855|NCT01475838|323196751|FG001|Randomized Phase|Randomized but Not Treated|5|||
94384856|NCT01475838|323196750|FG000|Randomized Phase|Adverse Event|6|||
94384857|NCT01475838|323196751|FG001|Randomized Phase|Adverse Event|1|||
94384858|NCT01475838|323196750|FG000|Randomized Phase|Pregnancy|0|||
94384859|NCT01475838|323196751|FG001|Randomized Phase|Pregnancy|1|||
94384860|NCT01475838|323196750|FG000|Randomized Phase|Investigators Discretion|1|||
94384861|NCT01475838|323196751|FG001|Randomized Phase|Investigators Discretion|2|||
94384862|NCT01475838|323196750|FG000|Randomized Phase|Withdrew Consent|10|||
94384863|NCT01475838|323196751|FG001|Randomized Phase|Withdrew Consent|14|||
94384864|NCT01475838|323196750|FG000|Randomized Phase|Lost to Follow-up|3|||
94384865|NCT01475838|323196751|FG001|Randomized Phase|Lost to Follow-up|4|||
94384866|NCT01475838|323196750|FG000|Randomized Phase|Participant Noncompliance|1|||
94384867|NCT01475838|323196751|FG001|Randomized Phase|Participant Noncompliance|5|||
94384868|NCT01475838|323196750|FG000|Randomized Phase|Protocol Violation|9|||
94384869|NCT01475838|323196751|FG001|Randomized Phase|Protocol Violation|4|||
94384870|NCT01475838|323196750|FG000|Extension Phase|Participant Noncompliance|1|||
94384871|NCT01475838|323196751|FG001|Extension Phase|Participant Noncompliance|0|||
94384872|NCT00048568|323196752|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
94384873|NCT00048568|323196753|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
94384874|NCT00048568|323196754|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
94384875|NCT00048568|323196752|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
94384876|NCT00048568|323196753|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
94384877|NCT00048568|323196754|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
94384878|NCT00048568|323196752|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
94384879|NCT00048568|323196753|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
94384880|NCT00048568|323196754|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
94384881|NCT00048568|323196752|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
94384882|NCT00048568|323196753|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
94384883|NCT00048568|323196754|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
94384884|NCT00048568|323196752|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
94384885|NCT00048568|323196753|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
94384886|NCT00048568|323196754|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
94384887|NCT00048568|323196752|FG000|Double-Blind Period Days 170 to 365|Death|1|||
94384888|NCT00048568|323196753|FG001|Double-Blind Period Days 170 to 365|Death|1|||
94384889|NCT00048568|323196754|FG002|Double-Blind Period Days 170 to 365|Death|0|||
94384890|NCT00048568|323196752|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
94384891|NCT00048568|323196753|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
94384892|NCT00048568|323196754|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
94384893|NCT00048568|323196752|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
94384894|NCT00048568|323196753|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
94384895|NCT00048568|323196754|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
94384896|NCT00048568|323196752|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
94384897|NCT00048568|323196753|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
94384898|NCT00048568|323196754|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
94384899|NCT00048568|323196752|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
94384900|NCT00048568|323196753|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
94384901|NCT00048568|323196754|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
94384902|NCT00048568|323196752|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
94477964|NCT01383018|323542627|FG000|Overall Study|Lost to Follow-up|5|||
94477965|NCT01383018|323542627|FG000|Overall Study|Physician Decision|5|||
94384903|NCT00048568|323196753|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
94384904|NCT00048568|323196754|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
94384905|NCT00048568|323196752|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
94384906|NCT00048568|323196753|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
94477966|NCT01383018|323542627|FG000|Overall Study|Withdrawal by Subject|9|||
94477967|NCT01383018|323542627|FG000|Overall Study|Subject not implanted|76|||
94477968|NCT01383018|323542627|FG000|Overall Study|Missed Visit|247|||
94477969|NCT01383018|323542627|FG000|Overall Study|Site closed early-not compliance related|7|||
94477970|NCT01383018|323542627|FG000|Overall Study|Patient moved away from site|1|||
94477971|NCT01383018|323542627|FG000|Overall Study|Subject Incarcerated|1|||
94477972|NCT01051817|323542629|FG000|Overall Study|Adverse Event|0|||
94477973|NCT01051817|323542630|FG001|Overall Study|Adverse Event|2|||
94477974|NCT01051817|323542629|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
94477975|NCT01051817|323542630|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
94477976|NCT01051817|323542629|FG000|Overall Study|Withdrawal by Subject|3|||
94477977|NCT01051817|323542630|FG001|Overall Study|Withdrawal by Subject|5|||
94477978|NCT01051817|323542629|FG000|Overall Study|Protocol Violation|0|||
94477979|NCT01051817|323542630|FG001|Overall Study|Protocol Violation|1|||
94477980|NCT00320788|323542631|FG000|Overall Study|Adverse Event|0|||
94477981|NCT00320788|323542632|FG001|Overall Study|Adverse Event|0|||
94477982|NCT00320788|323542633|FG002|Overall Study|Adverse Event|0|||
94477983|NCT00320788|323542634|FG003|Overall Study|Adverse Event|1|||
94477984|NCT00320788|323542635|FG004|Overall Study|Adverse Event|0|||
94477985|NCT00320788|323542631|FG000|Overall Study|Death|0|||
94477986|NCT00320788|323542632|FG001|Overall Study|Death|0|||
94477987|NCT00320788|323542633|FG002|Overall Study|Death|1|||
94477988|NCT00320788|323542634|FG003|Overall Study|Death|0|||
94477989|NCT00320788|323542635|FG004|Overall Study|Death|1|||
94477990|NCT00320788|323542631|FG000|Overall Study|Lost to Follow-up|0|||
94477991|NCT00320788|323542632|FG001|Overall Study|Lost to Follow-up|2|||
94477992|NCT00320788|323542633|FG002|Overall Study|Lost to Follow-up|1|||
94477993|NCT00320788|323542634|FG003|Overall Study|Lost to Follow-up|0|||
94477994|NCT00320788|323542635|FG004|Overall Study|Lost to Follow-up|0|||
94315015|NCT03345836|322936827|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
94315016|NCT03345836|322936828|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
94384907|NCT00048568|323196754|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
94384908|NCT00048568|323196752|FG000|Open-Label Period|Death|0|||
94384909|NCT00048568|323196753|FG001|Open-Label Period|Death|0|||
94384910|NCT00048568|323196754|FG002|Open-Label Period|Death|13|||
94384911|NCT00048568|323196752|FG000|Open-Label Period|Adverse Event|0|||
94384912|NCT00048568|323196753|FG001|Open-Label Period|Adverse Event|0|||
94384913|NCT00048568|323196754|FG002|Open-Label Period|Adverse Event|49|||
94384914|NCT00048568|323196752|FG000|Open-Label Period|Lack of Efficacy|0|||
94384915|NCT00048568|323196753|FG001|Open-Label Period|Lack of Efficacy|0|||
94384916|NCT00048568|323196754|FG002|Open-Label Period|Lack of Efficacy|32|||
94384917|NCT00048568|323196752|FG000|Open-Label Period|Withdrawal by Subject|0|||
94477995|NCT00320788|323542631|FG000|Overall Study|Decision by the Sponsor|1|||
94477996|NCT00320788|323542632|FG001|Overall Study|Decision by the Sponsor|1|||
94315017|NCT03345836|322936829|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
94315018|NCT03345836|322936830|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
94315019|NCT03345836|322936831|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
94315020|NCT03345836|322936826|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
94315021|NCT03345836|322936827|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
94315022|NCT03345836|322936828|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
94315023|NCT03345836|322936829|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
94315024|NCT03345836|322936830|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
94315025|NCT03345836|322936831|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
94315026|NCT03345836|322936826|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
94315027|NCT03345836|322936827|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
94315028|NCT03345836|322936828|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
94315029|NCT03345836|322936829|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
94315030|NCT03345836|322936830|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
94315031|NCT03345836|322936831|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
94315032|NCT03345836|322936826|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
94315033|NCT03345836|322936827|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
94315034|NCT03345836|322936828|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
94315035|NCT03345836|322936829|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
94315036|NCT03345836|322936830|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
94315037|NCT03345836|322936831|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
94315038|NCT03345836|322936826|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
94315039|NCT03345836|322936827|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
94315040|NCT03345836|322936828|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
94315041|NCT03345836|322936829|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
94315042|NCT03345836|322936830|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
94315043|NCT03345836|322936831|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
94477997|NCT00320788|323542633|FG002|Overall Study|Decision by the Sponsor|0|||
94315044|NCT03345836|322936826|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
94315045|NCT03345836|322936827|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
94315046|NCT03345836|322936828|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
94315047|NCT03345836|322936829|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
94315048|NCT03345836|322936830|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
94315049|NCT03345836|322936831|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
94315050|NCT03345836|322936826|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
94315051|NCT03345836|322936827|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
94315052|NCT03345836|322936828|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
94315053|NCT03345836|322936829|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
94315054|NCT03345836|322936830|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
94315055|NCT03345836|322936831|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
94315056|NCT03345836|322936826|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
94315057|NCT03345836|322936827|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
94315058|NCT03345836|322936828|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
94315059|NCT03345836|322936829|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
94315060|NCT03345836|322936830|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
94315061|NCT03345836|322936831|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
94315062|NCT03345836|322936826|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
94315063|NCT03345836|322936827|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
94315064|NCT03345836|322936828|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
94315065|NCT03345836|322936829|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
94315066|NCT03345836|322936830|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
94315067|NCT03345836|322936831|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
94315068|NCT03345836|322936826|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
94315069|NCT03345836|322936827|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
94315070|NCT03345836|322936828|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
94315071|NCT03345836|322936829|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
94315072|NCT03345836|322936830|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
94315073|NCT03345836|322936831|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
94315074|NCT04370028|322936834|FG000|Overall Study|Withdrawal by Subject|695|||
94315075|NCT04370028|322936834|FG000|Overall Study|Protocol Violation|9|||
94315076|NCT04370028|322936834|FG000|Overall Study|Adverse Event|3|||
94315077|NCT01095250|322936837|FG000|Overall Study|administrative reasons|8|||
94315078|NCT01095250|322936838|FG001|Overall Study|administrative reasons|10|||
94315079|NCT01095250|322936839|FG002|Overall Study|administrative reasons|7|||
94315080|NCT01095250|322936840|FG003|Overall Study|administrative reasons|5|||
94315081|NCT01095250|322936837|FG000|Overall Study|Withdrawal by Subject|0|||
94315082|NCT01095250|322936838|FG001|Overall Study|Withdrawal by Subject|0|||
94315083|NCT01095250|322936839|FG002|Overall Study|Withdrawal by Subject|1|||
94315084|NCT01095250|322936840|FG003|Overall Study|Withdrawal by Subject|0|||
94315085|NCT02582749|322936841|FG000|Overall Study|Study terminated by funder|5|||
94315086|NCT02582749|322936842|FG001|Overall Study|Study terminated by funder|10|||
94315087|NCT02582749|322936841|FG000|Overall Study|Withdrawal by Subject|0|||
94315088|NCT02582749|322936842|FG001|Overall Study|Withdrawal by Subject|1|||
94315089|NCT01915849|322936843|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
94315090|NCT01915849|322936844|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
94315091|NCT01915849|322936845|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
94315092|NCT01915849|322936846|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
94315093|NCT01915849|322936843|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
94315094|NCT01915849|322936844|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
94315095|NCT01915849|322936845|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
94315096|NCT01915849|322936846|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
94315097|NCT01798706|322936847|FG000|Overall Study|Adverse Event|15|||
94315098|NCT01798706|322936848|FG001|Overall Study|Adverse Event|10|||
94315099|NCT01798706|322936847|FG000|Overall Study|Lack of Efficacy|0|||
94315100|NCT01798706|322936848|FG001|Overall Study|Lack of Efficacy|2|||
94315101|NCT01798706|322936847|FG000|Overall Study|Poor compliance to protocol|1|||
94315102|NCT01798706|322936848|FG001|Overall Study|Poor compliance to protocol|0|||
94315103|NCT01798706|322936847|FG000|Overall Study|Other than specified above|5|||
94315104|NCT01798706|322936848|FG001|Overall Study|Other than specified above|9|||
94315105|NCT03135028|322936849|FG000|Overall Study|Death|6|||
94477998|NCT00320788|323542634|FG003|Overall Study|Decision by the Sponsor|0|||
94315106|NCT03135028|322936849|FG000|Overall Study|Study Terminated by Sponsor|2|||
94315107|NCT03135028|322936849|FG000|Overall Study|Withdrew Consent|1|||
94315108|NCT02379923|322936850|FG000|Overall Study|Death|5|||
94315109|NCT03844633|322936851|FG000|1 Week FU|Lost to Follow-up|0|||
94315110|NCT03844633|322936852|FG001|1 Week FU|Lost to Follow-up|1|||
94315111|NCT03844633|322936853|FG002|1 Week FU|Lost to Follow-up|4|||
94315112|NCT03844633|322936851|FG000|12-month Follow-up|Lost to Follow-up|7|||
94315113|NCT03844633|322936852|FG001|12-month Follow-up|Lost to Follow-up|5|||
94315114|NCT03844633|322936853|FG002|12-month Follow-up|Lost to Follow-up|8|||
94315115|NCT05896761|322936854|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
94315116|NCT05896761|322936855|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
94315117|NCT05896761|322936854|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
94315118|NCT05896761|322936855|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
94315119|NCT02028338|322936856|FG000|Overall Study|Withdrawal by Subject|3|||
94315120|NCT02028338|322936857|FG001|Overall Study|Withdrawal by Subject|1|||
94315121|NCT02028338|322936856|FG000|Overall Study|Unable to contact participant|1|||
94315122|NCT02028338|322936857|FG001|Overall Study|Unable to contact participant|0|||
94315123|NCT03288779|322936858|FG000|Overall Study|Withdrawal by Subject|3|||
94315124|NCT02588248|322936859|FG000|Overall Study|Physician Decision|4|||
94315125|NCT02588248|322936860|FG001|Overall Study|Physician Decision|3|||
94315126|NCT00601523|322936861|FG000|Overall Study|Adverse Event|42|||
94315127|NCT00601523|322936862|FG001|Overall Study|Adverse Event|14|||
94315128|NCT00601523|322936861|FG000|Overall Study|Lack of Efficacy|3|||
94315129|NCT00601523|322936862|FG001|Overall Study|Lack of Efficacy|0|||
94315130|NCT00601523|322936861|FG000|Overall Study|Protocol Violation|5|||
94315131|NCT00601523|322936862|FG001|Overall Study|Protocol Violation|1|||
94315132|NCT00601523|322936861|FG000|Overall Study|Lost to Follow-up|0|||
94315133|NCT00601523|322936862|FG001|Overall Study|Lost to Follow-up|1|||
94315134|NCT00601523|322936861|FG000|Overall Study|Withdrawal by Subject|18|||
94315135|NCT00601523|322936862|FG001|Overall Study|Withdrawal by Subject|9|||
94315136|NCT00601523|322936861|FG000|Overall Study|Other|9|||
94315137|NCT00601523|322936862|FG001|Overall Study|Other|1|||
94315138|NCT03643432|322936863|FG000|Overall Study|Lost to Follow-up|1|||
94315139|NCT03643432|322936864|FG001|Overall Study|Lost to Follow-up|0|||
94315140|NCT01987986|322936865|FG000|Overall Study|Lost to Follow-up|1|||
94315141|NCT01987986|322936866|FG001|Overall Study|Lost to Follow-up|0|||
94315142|NCT01987986|322936867|FG002|Overall Study|Lost to Follow-up|0|||
94315143|NCT01987986|322936868|FG003|Overall Study|Lost to Follow-up|0|||
94315144|NCT01987986|322936865|FG000|Overall Study|Adverse Event|1|||
94315145|NCT01987986|322936866|FG001|Overall Study|Adverse Event|0|||
94315146|NCT01987986|322936867|FG002|Overall Study|Adverse Event|2|||
94315147|NCT01987986|322936868|FG003|Overall Study|Adverse Event|0|||
94315148|NCT01617434|322936869|FG000|Overall Study|Adverse Event|12|||
94315149|NCT01617434|322936870|FG001|Overall Study|Adverse Event|3|||
94315150|NCT01617434|322936869|FG000|Overall Study|Protocol Violation|8|||
94315151|NCT01617434|322936870|FG001|Overall Study|Protocol Violation|7|||
94315152|NCT01617434|322936869|FG000|Overall Study|Withdrawal Criteria|12|||
94315153|NCT01617434|322936870|FG001|Overall Study|Withdrawal Criteria|37|||
94315154|NCT01617434|322936869|FG000|Overall Study|Unclassified|3|||
94315155|NCT01617434|322936870|FG001|Overall Study|Unclassified|4|||
94315156|NCT00705224|322936871|FG000|Overall Study|Adverse Event|1|||
94315157|NCT00705224|322936871|FG000|Overall Study|Lack of Efficacy|2|||
94315158|NCT00705224|322936871|FG000|Overall Study|Withdrawal by Subject|3|||
94315159|NCT00705224|322936871|FG000|Overall Study|Lost to Follow-up|5|||
94315160|NCT03596177|322936872|FG000|Single Blind Period|Withdrawal by Subject|1|||
94315161|NCT03596177|322936873|FG001|Single Blind Period|Withdrawal by Subject|1|||
94315162|NCT03596177|322936872|FG000|Single Blind Period|Other|1|||
94315163|NCT03596177|322936873|FG001|Single Blind Period|Other|0|||
94315164|NCT03596177|322936872|FG000|Double Blind Period|Withdrawal by Subject|0|||
94315165|NCT03596177|322936873|FG001|Double Blind Period|Withdrawal by Subject|1|||
94315166|NCT03596177|322936872|FG000|Double Blind Period|Other|0|||
94315167|NCT03596177|322936873|FG001|Double Blind Period|Other|4|||
94315168|NCT03596177|322936872|FG000|Double Blind Period|Death during safety follow-up|0|||
94315169|NCT03596177|322936873|FG001|Double Blind Period|Death during safety follow-up|1|||
94315170|NCT01921257|322936874|FG000|Overall Study|Adverse Event|1|||
94315171|NCT01921257|322936874|FG000|Overall Study|Protocol Violation|1|||
94315172|NCT01921257|322936874|FG000|Overall Study|Withdrawal by Subject|1|||
94315173|NCT03141086|322936877|FG000|Overall Study|Study Terminated By Sponsor|1|||
94315174|NCT03141086|322936878|FG001|Overall Study|Study Terminated By Sponsor|1|||
94315175|NCT03141086|322936877|FG000|Overall Study|Withdrawal by Subject|0|||
94315176|NCT03141086|322936878|FG001|Overall Study|Withdrawal by Subject|1|||
94315177|NCT03141086|322936877|FG000|Overall Study|Protocol Violation|0|||
94315178|NCT03141086|322936878|FG001|Overall Study|Protocol Violation|1|||
94315179|NCT03141086|322936877|FG000|Overall Study|Adverse Event|0|||
94315180|NCT03141086|322936878|FG001|Overall Study|Adverse Event|2|||
94315181|NCT04267562|322938409|FG000|Assessed for Eligibility|Screen Failure|64|||
94315182|NCT04267562|322938409|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
94315183|NCT04267562|322938409|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
94315184|NCT04267562|322938409|FG000|Assessed for Eligibility|Site closure|6|||
94315185|NCT04267562|322938409|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
94315186|NCT04267562|322938409|FG000|Assessed for Eligibility|Physician Decision|1|||
94315187|NCT04267562|322938409|FG000|Month 24|Elective hysterectomy|1|||
94477999|NCT00320788|323542635|FG004|Overall Study|Decision by the Sponsor|1|||
94478000|NCT00320788|323542631|FG000|Overall Study|Other|1|||
94478001|NCT00320788|323542632|FG001|Overall Study|Other|2|||
94478002|NCT00320788|323542633|FG002|Overall Study|Other|1|||
94478003|NCT00320788|323542634|FG003|Overall Study|Other|1|||
94478004|NCT00320788|323542635|FG004|Overall Study|Other|1|||
94478005|NCT00320788|323542631|FG000|Overall Study|Physician Decision|1|||
94478006|NCT00320788|323542632|FG001|Overall Study|Physician Decision|1|||
94478007|NCT00320788|323542633|FG002|Overall Study|Physician Decision|0|||
94478008|NCT00320788|323542634|FG003|Overall Study|Physician Decision|0|||
94478009|NCT00320788|323542635|FG004|Overall Study|Physician Decision|0|||
94478010|NCT00320788|323542631|FG000|Overall Study|Protocol Violation|0|||
94478011|NCT00320788|323542632|FG001|Overall Study|Protocol Violation|0|||
94478012|NCT00320788|323542633|FG002|Overall Study|Protocol Violation|0|||
94478013|NCT00320788|323542634|FG003|Overall Study|Protocol Violation|0|||
94478014|NCT00320788|323542635|FG004|Overall Study|Protocol Violation|1|||
94478015|NCT00320788|323542631|FG000|Overall Study|Withdrawal by Subject|3|||
94478016|NCT00320788|323542632|FG001|Overall Study|Withdrawal by Subject|0|||
94478017|NCT00320788|323542633|FG002|Overall Study|Withdrawal by Subject|0|||
94478018|NCT00320788|323542634|FG003|Overall Study|Withdrawal by Subject|3|||
94478019|NCT00320788|323542635|FG004|Overall Study|Withdrawal by Subject|1|||
94478020|NCT02401035|323542638|FG000|Overall Study|Withdrawal by Subject|1|||
94478021|NCT02401035|323542639|FG001|Overall Study|Withdrawal by Subject|0|||
94478022|NCT02716584|323542640|FG000|Overall Study|Lost to Follow-up|8|||
94478023|NCT02716584|323542641|FG001|Overall Study|Lost to Follow-up|5|||
94478024|NCT02149264|323542642|FG000|Overall Study|Withdrawal by Subject|9|||
94478025|NCT02149264|323542642|FG000|Overall Study|Adverse Event|7|||
94478026|NCT02149264|323542642|FG000|Overall Study|Physician Decision|3|||
94478027|NCT02149264|323542642|FG000|Overall Study|Protocol Violation|1|||
94478028|NCT00972283|323542646|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
94478029|NCT00972283|323542647|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
94478030|NCT00972283|323542646|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
94478031|NCT00972283|323542647|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
94478032|NCT00972283|323542646|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
94478033|NCT00972283|323542647|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
94478034|NCT00972283|323542646|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
94478035|NCT00972283|323542647|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
94478036|NCT00972283|323542646|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
94478037|NCT00972283|323542647|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
94478038|NCT00972283|323542646|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
94315188|NCT04267562|322938409|FG000|Month 24|Lost to Follow-up|1|||
94315189|NCT04267562|322938409|FG000|Month 36|Elective hysterectomy|2|||
94315190|NCT04267562|322938409|FG000|Month 36|Lost to Follow-up|3|||
94478039|NCT00972283|323542647|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
94478040|NCT00972283|323542646|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
94478041|NCT00972283|323542647|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
94478042|NCT00972283|323542646|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
94478043|NCT00972283|323542647|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
94478044|NCT00972283|323542646|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
94478045|NCT00972283|323542647|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
94478046|NCT00972283|323542646|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
94478047|NCT00972283|323542647|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
94478048|NCT00805129|323542648|FG000|Overall Study|Not treated|1|||
94478049|NCT02824627|323542651|FG000|Overall Study|Adverse Event|1|||
94478050|NCT02824627|323542652|FG001|Overall Study|Adverse Event|2|||
94478051|NCT02824627|323542651|FG000|Overall Study|Lost to Follow-up|2|||
94478052|NCT02824627|323542652|FG001|Overall Study|Lost to Follow-up|1|||
94478053|NCT01938846|323542653|FG000|Overall Study|Progressive disease|26|||
94478054|NCT01938846|323542654|FG001|Overall Study|Progressive disease|18|||
94478055|NCT01938846|323542655|FG002|Overall Study|Progressive disease|16|||
94478056|NCT01938846|323542653|FG000|Overall Study|Adverse Event|8|||
94478057|NCT01938846|323542654|FG001|Overall Study|Adverse Event|4|||
94478058|NCT01938846|323542655|FG002|Overall Study|Adverse Event|3|||
94478059|NCT01938846|323542653|FG000|Overall Study|Withdrawal by Subject|2|||
94478060|NCT01938846|323542654|FG001|Overall Study|Withdrawal by Subject|2|||
94478061|NCT01938846|323542655|FG002|Overall Study|Withdrawal by Subject|1|||
94478062|NCT01938846|323542653|FG000|Overall Study|Other than listed|5|||
94478063|NCT01938846|323542654|FG001|Overall Study|Other than listed|1|||
94478064|NCT01938846|323542655|FG002|Overall Study|Other than listed|4|||
94478065|NCT02324361|323542661|FG000|Overall Study|Lost to Follow-up|5|||
94478066|NCT02324361|323542662|FG001|Overall Study|Lost to Follow-up|2|||
94478067|NCT02532283|323542664|FG000|Overall Study|Adverse Event|0|||
94478068|NCT02532283|323542665|FG001|Overall Study|Adverse Event|1|||
94315191|NCT01746732|322938411|FG000|Lead-In Period|Withdrawal by Subject|1|||
94478069|NCT02532283|323542664|FG000|Overall Study|Death|1|||
94315192|NCT01746732|322938412|FG001|Lead-In Period|Withdrawal by Subject|0|||
94478070|NCT02532283|323542665|FG001|Overall Study|Death|0|||
94478071|NCT02532283|323542664|FG000|Overall Study|Lost to Follow-up|0|||
94478072|NCT02532283|323542665|FG001|Overall Study|Lost to Follow-up|1|||
94478073|NCT02532283|323542664|FG000|Overall Study|Withdrawal by Subject|8|||
94478074|NCT02532283|323542665|FG001|Overall Study|Withdrawal by Subject|3|||
94478075|NCT02308228|323542666|FG000|Overall Study|Adverse Event|3|||
94478076|NCT02308228|323542667|FG001|Overall Study|Adverse Event|4|||
94478077|NCT02308228|323542666|FG000|Overall Study|Withdrawal by Subject|5|||
94478078|NCT02308228|323542667|FG001|Overall Study|Withdrawal by Subject|3|||
94478079|NCT04376515|323542668|FG000|Overall Study|Found to have been vaccinated before study start|6|||
94478080|NCT04376515|323542669|FG001|Overall Study|Found to have been vaccinated before study start|6|||
94478081|NCT02823470|323544235|FG000|Overall Study|Adverse Event|1|||
94478082|NCT02823470|323544236|FG001|Overall Study|Adverse Event|0|||
94478083|NCT02823470|323544235|FG000|Overall Study|Study terminated by sponsor|8|||
94478084|NCT02823470|323544236|FG001|Overall Study|Study terminated by sponsor|15|||
94478085|NCT00463801|323544238|FG000|Overall Study|Protocol Violation|1|||
94478086|NCT00463801|323544238|FG000|Overall Study|Lack of Efficacy|2|||
94478087|NCT00463801|323544238|FG000|Overall Study|Adverse Event|4|||
94478088|NCT00463801|323544238|FG000|Overall Study|Lost to Follow-up|5|||
94478089|NCT00463801|323544238|FG000|Overall Study|No longer require therapy|1|||
94478090|NCT01073163|323544239|FG000|Overall Study|Adverse Event|1|||
94478091|NCT01073163|323544239|FG000|Overall Study|Disease Progression|1|||
94478092|NCT01073163|323544239|FG000|Overall Study|Early termination|1|||
94478093|NCT03272347|323544240|FG000|Overall Study|Death|0|||
94478094|NCT03272347|323544241|FG001|Overall Study|Death|0|||
94478095|NCT03272347|323544242|FG002|Overall Study|Death|0|||
94478096|NCT03272347|323544243|FG003|Overall Study|Death|1|||
94478097|NCT03272347|323544240|FG000|Overall Study|Lost to Follow-up|1|||
94478098|NCT03272347|323544241|FG001|Overall Study|Lost to Follow-up|3|||
94478099|NCT03272347|323544242|FG002|Overall Study|Lost to Follow-up|5|||
94478100|NCT03272347|323544243|FG003|Overall Study|Lost to Follow-up|1|||
94478101|NCT03272347|323544240|FG000|Overall Study|Physician Decision|4|||
94478102|NCT03272347|323544241|FG001|Overall Study|Physician Decision|2|||
94478103|NCT03272347|323544242|FG002|Overall Study|Physician Decision|5|||
94478104|NCT03272347|323544243|FG003|Overall Study|Physician Decision|4|||
94478105|NCT03272347|323544240|FG000|Overall Study|Screen Failure|1|||
94478106|NCT03272347|323544241|FG001|Overall Study|Screen Failure|0|||
94478107|NCT03272347|323544242|FG002|Overall Study|Screen Failure|0|||
94478108|NCT03272347|323544243|FG003|Overall Study|Screen Failure|0|||
94478109|NCT03272347|323544240|FG000|Overall Study|Withdrawal by Subject|5|||
94478110|NCT03272347|323544241|FG001|Overall Study|Withdrawal by Subject|1|||
94478111|NCT03272347|323544242|FG002|Overall Study|Withdrawal by Subject|2|||
94478112|NCT03272347|323544243|FG003|Overall Study|Withdrawal by Subject|1|||
94478113|NCT03859648|323544246|FG000|Overall Study|Lost to Follow-up|1|||
94478114|NCT03859648|323544246|FG000|Overall Study|Adverse Event|1|||
94478115|NCT00667992|323544251|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
94478116|NCT00667992|323544252|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
94478117|NCT00667992|323544251|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
94478118|NCT00667992|323544252|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
94478119|NCT00667992|323544251|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
94478120|NCT00667992|323544252|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
94478121|NCT00667992|323544251|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
94478122|NCT00667992|323544252|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
94478123|NCT00667992|323544251|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
94478124|NCT00667992|323544252|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
94478125|NCT00667992|323544251|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
94478126|NCT00667992|323544252|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
94478127|NCT00667992|323544251|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
94478128|NCT00667992|323544252|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
94478129|NCT00667992|323544251|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
94478130|NCT00667992|323544252|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
94478131|NCT00667992|323544251|FG000|Wash-out|Not within one doubling dilution|4|||
94478132|NCT00667992|323544252|FG001|Wash-out|Not within one doubling dilution|3|||
94315193|NCT01746732|322938413|FG002|Lead-In Period|Withdrawal by Subject|0|||
94478133|NCT00667992|323544251|FG000|Wash-out|Failure to wash-out|2|||
94315194|NCT01746732|322938411|FG000|Period 1|Physician Decision|0|||
94315195|NCT01746732|322938412|FG001|Period 1|Physician Decision|1|||
94478134|NCT00667992|323544252|FG001|Wash-out|Failure to wash-out|2|||
94478135|NCT00667992|323544251|FG000|Wash-out|Withdrawal by Subject|1|||
94478136|NCT00667992|323544252|FG001|Wash-out|Withdrawal by Subject|0|||
94478137|NCT00667992|323544251|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
94478138|NCT00667992|323544252|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
94478139|NCT00667992|323544251|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
94315196|NCT01746732|322938413|FG002|Period 1|Physician Decision|0|||
94315197|NCT01746732|322938411|FG000|Period 2|Withdrawal by Subject|0|||
94315198|NCT01746732|322938412|FG001|Period 2|Withdrawal by Subject|0|||
94315199|NCT01746732|322938413|FG002|Period 2|Withdrawal by Subject|2|||
94315200|NCT01746732|322938411|FG000|Period 2|Adverse Event|0|||
94315201|NCT01746732|322938412|FG001|Period 2|Adverse Event|0|||
94315202|NCT01746732|322938413|FG002|Period 2|Adverse Event|1|||
94315203|NCT01746732|322938411|FG000|Period 2|Lost to Follow-up|0|||
94315204|NCT01746732|322938412|FG001|Period 2|Lost to Follow-up|0|||
94315205|NCT01746732|322938413|FG002|Period 2|Lost to Follow-up|1|||
94315206|NCT02078713|322938416|FG000|Overall Study|Lost to Follow-up|49|||
94315207|NCT02078713|322938417|FG001|Overall Study|Lost to Follow-up|55|||
94315208|NCT02078713|322938418|FG002|Overall Study|Lost to Follow-up|0|||
94315209|NCT02078713|322938419|FG003|Overall Study|Lost to Follow-up|0|||
94315210|NCT02078713|322938416|FG000|Overall Study|Pregnant at baseline|3|||
94315211|NCT02078713|322938417|FG001|Overall Study|Pregnant at baseline|5|||
94315212|NCT02078713|322938418|FG002|Overall Study|Pregnant at baseline|0|||
94315213|NCT02078713|322938419|FG003|Overall Study|Pregnant at baseline|0|||
94315214|NCT02078713|322938416|FG000|Overall Study|Enrolled twice|0|||
94315215|NCT02078713|322938417|FG001|Overall Study|Enrolled twice|1|||
94315216|NCT02078713|322938418|FG002|Overall Study|Enrolled twice|0|||
94315217|NCT02078713|322938419|FG003|Overall Study|Enrolled twice|0|||
94315218|NCT01104558|322938420|FG000|Overall Study|Protocol Violation|6|||
94315219|NCT01104558|322938420|FG000|Overall Study|Missing of primary efficacy assessment|10|||
94315220|NCT01104558|322938420|FG000|Overall Study|Missing of genetic analysis results|1|||
94315221|NCT04543955|322938421|FG000|Overall Study|Company cancelled study|1|||
94315222|NCT04543955|322938422|FG001|Overall Study|Company cancelled study|0|||
94315223|NCT01755195|322938423|FG000|Overall Study|Participant noncompliance|2|||
94315224|NCT01755195|322938423|FG000|Overall Study|Switched to alternative treatment|4|||
94315225|NCT01755195|322938423|FG000|Overall Study|Withdrawal by Subject|1|||
94315226|NCT01755195|322938423|FG000|Overall Study|Participant refused to start treatment|1|||
94315227|NCT01755195|322938423|FG000|Overall Study|Participant has been consented for another trial|1|||
94315228|NCT01755195|322938423|FG000|Overall Study|Refused further treatment|3|||
94315229|NCT01755195|322938423|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
94315230|NCT02115815|322938424|FG000|Overall Study|Withdrawal by Subject|2|||
94315231|NCT02115815|322938425|FG001|Overall Study|Withdrawal by Subject|0|||
94315232|NCT02115815|322938426|FG002|Overall Study|Withdrawal by Subject|0|||
94315233|NCT02115815|322938427|FG003|Overall Study|Withdrawal by Subject|0|||
94315234|NCT02115815|322938428|FG004|Overall Study|Withdrawal by Subject|0|||
94315235|NCT02115815|322938429|FG005|Overall Study|Withdrawal by Subject|0|||
94315236|NCT02115815|322938430|FG006|Overall Study|Withdrawal by Subject|0|||
94315237|NCT02115815|322938424|FG000|Overall Study|Not enough drug to dose participant|0|||
94315238|NCT02115815|322938425|FG001|Overall Study|Not enough drug to dose participant|0|||
94315239|NCT02115815|322938426|FG002|Overall Study|Not enough drug to dose participant|0|||
94315240|NCT02115815|322938427|FG003|Overall Study|Not enough drug to dose participant|0|||
94315241|NCT02115815|322938428|FG004|Overall Study|Not enough drug to dose participant|0|||
94315242|NCT02115815|322938429|FG005|Overall Study|Not enough drug to dose participant|1|||
94315243|NCT02115815|322938430|FG006|Overall Study|Not enough drug to dose participant|0|||
94315244|NCT02115815|322938424|FG000|Overall Study|Missed appointment, randomized in error|0|||
94315245|NCT02115815|322938425|FG001|Overall Study|Missed appointment, randomized in error|0|||
94315246|NCT02115815|322938426|FG002|Overall Study|Missed appointment, randomized in error|0|||
94315247|NCT02115815|322938427|FG003|Overall Study|Missed appointment, randomized in error|0|||
94315248|NCT02115815|322938428|FG004|Overall Study|Missed appointment, randomized in error|0|||
94315249|NCT02115815|322938429|FG005|Overall Study|Missed appointment, randomized in error|1|||
94315250|NCT02115815|322938430|FG006|Overall Study|Missed appointment, randomized in error|0|||
94315251|NCT02340819|322938431|FG000|Overall Study|Adverse Event|1|||
94315252|NCT02340819|322938431|FG000|Overall Study|Withdrawal by Subject|2|||
94315253|NCT02340819|322938431|FG000|Overall Study|Discontinued with other reason|1|||
94315254|NCT04439838|322938436|FG000|Overall Study|Withdrawal by Subject|0|||
94315255|NCT04439838|322938437|FG001|Overall Study|Withdrawal by Subject|0|||
94315256|NCT04439838|322938438|FG002|Overall Study|Withdrawal by Subject|0|||
94315257|NCT04439838|322938439|FG003|Overall Study|Withdrawal by Subject|0|||
94315258|NCT04439838|322938440|FG004|Overall Study|Withdrawal by Subject|0|||
94315259|NCT04439838|322938441|FG005|Overall Study|Withdrawal by Subject|0|||
94315260|NCT04439838|322938442|FG006|Overall Study|Withdrawal by Subject|0|||
94315261|NCT04439838|322938443|FG007|Overall Study|Withdrawal by Subject|0|||
94315262|NCT04439838|322938444|FG008|Overall Study|Withdrawal by Subject|1|||
94315263|NCT00502307|322938447|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
94315264|NCT00502307|322938448|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
94315265|NCT00502307|322938449|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
94315266|NCT00502307|322938447|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
94315267|NCT00502307|322938448|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
94315268|NCT00502307|322938449|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
94315269|NCT00502307|322938447|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
94315270|NCT00502307|322938448|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
94315271|NCT00502307|322938449|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
94315272|NCT00502307|322938447|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
94315273|NCT00502307|322938448|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
94315274|NCT00502307|322938449|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
94315275|NCT00502307|322938447|FG000|Maintenance Period|Progressive disease|80|||
94315276|NCT00502307|322938448|FG001|Maintenance Period|Progressive disease|0|||
94315277|NCT00502307|322938449|FG002|Maintenance Period|Progressive disease|0|||
94315278|NCT00502307|322938447|FG000|Maintenance Period|Discontinued due to other reasons|68|||
94315279|NCT00502307|322938448|FG001|Maintenance Period|Discontinued due to other reasons|0|||
94315280|NCT00502307|322938449|FG002|Maintenance Period|Discontinued due to other reasons|0|||
94315281|NCT01881620|322938450|FG000|Overall Study|Protocol Violation|4|||
94315282|NCT00414310|322938451|FG000|Overall Study|Not treated|1|||
94315283|NCT00414310|322938452|FG001|Overall Study|Not treated|0|||
94315284|NCT01808118|322938453|FG000|Period 1|Adverse Event|15|||
94315285|NCT01808118|322938454|FG001|Period 1|Adverse Event|0|||
94315286|NCT01808118|322938455|FG002|Period 1|Adverse Event|0|||
94315287|NCT01808118|322938453|FG000|Period 1|Withdrew consent|24|||
94315288|NCT01808118|322938454|FG001|Period 1|Withdrew consent|0|||
94315289|NCT01808118|322938455|FG002|Period 1|Withdrew consent|0|||
94315290|NCT01808118|322938453|FG000|Period 1|Lost to Follow-up|9|||
94315291|NCT01808118|322938454|FG001|Period 1|Lost to Follow-up|0|||
94315292|NCT01808118|322938455|FG002|Period 1|Lost to Follow-up|0|||
94315293|NCT01808118|322938453|FG000|Period 1|Did not meet criteria for remission|303|||
94315294|NCT01808118|322938454|FG001|Period 1|Did not meet criteria for remission|0|||
94315295|NCT01808118|322938455|FG002|Period 1|Did not meet criteria for remission|0|||
94315296|NCT01808118|322938453|FG000|Period 1|Enrolled in error|7|||
94315297|NCT01808118|322938454|FG001|Period 1|Enrolled in error|0|||
94315298|NCT01808118|322938455|FG002|Period 1|Enrolled in error|0|||
94315299|NCT01808118|322938453|FG000|Period 1|Did not meet inclusion criteria|3|||
94315300|NCT01808118|322938454|FG001|Period 1|Did not meet inclusion criteria|0|||
94315301|NCT01808118|322938455|FG002|Period 1|Did not meet inclusion criteria|0|||
94315302|NCT01808118|322938453|FG000|Period 1|Non-conformance with inclusion criteria|3|||
94315303|NCT01808118|322938454|FG001|Period 1|Non-conformance with inclusion criteria|0|||
94315304|NCT01808118|322938455|FG002|Period 1|Non-conformance with inclusion criteria|0|||
94315305|NCT01808118|322938453|FG000|Period 1|Investigator decision: site closure|2|||
94315306|NCT01808118|322938454|FG001|Period 1|Investigator decision: site closure|0|||
94315307|NCT01808118|322938455|FG002|Period 1|Investigator decision: site closure|0|||
94315308|NCT01808118|322938453|FG000|Period 1|Non-compliance per sponsor|1|||
94315309|NCT01808118|322938454|FG001|Period 1|Non-compliance per sponsor|0|||
94315310|NCT01808118|322938455|FG002|Period 1|Non-compliance per sponsor|0|||
94315311|NCT01808118|322938453|FG000|Period 1|Lack of Efficacy|1|||
94315312|NCT01808118|322938454|FG001|Period 1|Lack of Efficacy|0|||
94315313|NCT01808118|322938455|FG002|Period 1|Lack of Efficacy|0|||
94315314|NCT01808118|322938453|FG000|Period 2|Adverse Event|0|||
94315315|NCT01808118|322938454|FG001|Period 2|Adverse Event|4|||
94315316|NCT01808118|322938455|FG002|Period 2|Adverse Event|0|||
94315317|NCT01808118|322938453|FG000|Period 2|Withdrew consent|0|||
94315318|NCT01808118|322938454|FG001|Period 2|Withdrew consent|7|||
94315319|NCT01808118|322938455|FG002|Period 2|Withdrew consent|6|||
94315320|NCT01808118|322938453|FG000|Period 2|Lost to Follow-up|0|||
94315321|NCT01808118|322938454|FG001|Period 2|Lost to Follow-up|0|||
94315322|NCT01808118|322938455|FG002|Period 2|Lost to Follow-up|2|||
94315323|NCT01808118|322938453|FG000|Period 2|Investigator no longer conducting trials|0|||
94315324|NCT01808118|322938454|FG001|Period 2|Investigator no longer conducting trials|1|||
94315325|NCT01808118|322938455|FG002|Period 2|Investigator no longer conducting trials|0|||
94315326|NCT01808118|322938453|FG000|Period 2|Switched to other therapy|0|||
94315327|NCT01808118|322938454|FG001|Period 2|Switched to other therapy|1|||
94315328|NCT01808118|322938455|FG002|Period 2|Switched to other therapy|0|||
94384918|NCT00048568|323196753|FG001|Open-Label Period|Withdrawal by Subject|0|||
94384919|NCT00048568|323196754|FG002|Open-Label Period|Withdrawal by Subject|26|||
94315329|NCT01254604|322938457|FG000|Overall Study|Lost to Follow-up|1|||
94315330|NCT01254604|322938458|FG001|Overall Study|Lost to Follow-up|1|||
94315331|NCT01254604|322938457|FG000|Overall Study|Protocol Violation|2|||
94315332|NCT01254604|322938458|FG001|Overall Study|Protocol Violation|2|||
94315333|NCT01254604|322938457|FG000|Overall Study|Withdrawal by Subject|2|||
94315334|NCT01254604|322938458|FG001|Overall Study|Withdrawal by Subject|4|||
94315335|NCT01254604|322938457|FG000|Overall Study|Adverse Event|3|||
94315336|NCT01254604|322938458|FG001|Overall Study|Adverse Event|2|||
94315337|NCT01441440|322938459|FG000|Overall Study|Death|1|||
94315338|NCT01441440|322938460|FG001|Overall Study|Death|0|||
94315339|NCT01441440|322938461|FG002|Overall Study|Death|1|||
94315340|NCT01441440|322938459|FG000|Overall Study|Adverse Event|2|||
94315341|NCT01441440|322938460|FG001|Overall Study|Adverse Event|9|||
94384920|NCT00048568|323196752|FG000|Open-Label Period|Pregnancy|0|||
94315342|NCT01441440|322938461|FG002|Overall Study|Adverse Event|9|||
94478140|NCT00667992|323544252|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
94478141|NCT00762762|323544258|FG000|Overall Study|Did not return for appointments|6|||
94478142|NCT00762762|323544259|FG001|Overall Study|Did not return for appointments|8|||
94478143|NCT02489448|323544260|FG000|Overall Study|Death|3|||
94478144|NCT02489448|323544260|FG000|Overall Study|Withdrawal by Subject|2|||
94478145|NCT01990573|323544261|FG000|Overall Study|Physician Decision|0|||
94478146|NCT01990573|323544262|FG001|Overall Study|Physician Decision|0|||
94478147|NCT01990573|323544263|FG002|Overall Study|Physician Decision|1|||
94478148|NCT04153565|323544265|FG000|Overall Study|Death|13|||
94478149|NCT01409915|323544267|FG000|Overall Study|Adverse Event|0|||
94478150|NCT01409915|323544268|FG001|Overall Study|Adverse Event|2|||
94478151|NCT01409915|323544267|FG000|Overall Study|Withdrawal by Subject|0|||
94478152|NCT01409915|323544268|FG001|Overall Study|Withdrawal by Subject|1|||
94478153|NCT01409915|323544267|FG000|Overall Study|Protocol Violation|1|||
94478154|NCT01409915|323544268|FG001|Overall Study|Protocol Violation|0|||
94478155|NCT02492165|323544270|FG000|Overall Study|Withdrawal by Subject|0|||
94478156|NCT02492165|323544271|FG001|Overall Study|Withdrawal by Subject|1|||
94478157|NCT02492165|323544272|FG002|Overall Study|Withdrawal by Subject|0|||
94478158|NCT02492165|323544273|FG003|Overall Study|Withdrawal by Subject|0|||
94478159|NCT01025284|323544274|FG000|Overall Study|Investigator Decision|0|||
94478160|NCT01025284|323544275|FG001|Overall Study|Investigator Decision|1|||
94478161|NCT01025284|323544276|FG002|Overall Study|Investigator Decision|0|||
94478162|NCT01025284|323544274|FG000|Overall Study|Withdrawal by Subject|0|||
94478163|NCT01025284|323544275|FG001|Overall Study|Withdrawal by Subject|1|||
94478164|NCT01025284|323544276|FG002|Overall Study|Withdrawal by Subject|0|||
94478165|NCT02937740|323544277|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
94478166|NCT02937740|323544278|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
94478167|NCT02937740|323544277|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
94478168|NCT02937740|323544278|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
94478169|NCT02937740|323544277|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
94478170|NCT02937740|323544278|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
94478171|NCT02937740|323544277|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
94478172|NCT02937740|323544278|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
94478173|NCT02937740|323544277|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
94478174|NCT02937740|323544278|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
94478175|NCT02937740|323544277|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
94478176|NCT02937740|323544278|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
94478177|NCT00493012|323544279|FG000|Overall Study|Lost to Follow-up|18|||
94478178|NCT00493012|323544280|FG001|Overall Study|Lost to Follow-up|17|||
94478179|NCT04147247|323544281|FG000|Overall Study|Progressive disease|3|||
94478180|NCT04147247|323544282|FG001|Overall Study|Progressive disease|3|||
94478181|NCT04147247|323544283|FG002|Overall Study|Progressive disease|4|||
94478182|NCT04147247|323544284|FG003|Overall Study|Progressive disease|4|||
94478183|NCT04147247|323544285|FG004|Overall Study|Progressive disease|3|||
94478184|NCT04147247|323544281|FG000|Overall Study|Physician Decision|0|||
94478185|NCT04147247|323544282|FG001|Overall Study|Physician Decision|1|||
94478186|NCT04147247|323544283|FG002|Overall Study|Physician Decision|0|||
94478187|NCT04147247|323544284|FG003|Overall Study|Physician Decision|0|||
94478188|NCT04147247|323544285|FG004|Overall Study|Physician Decision|0|||
94478189|NCT04147247|323544281|FG000|Overall Study|Clinical Disease Progression|0|||
94478190|NCT04147247|323544282|FG001|Overall Study|Clinical Disease Progression|0|||
94478191|NCT04147247|323544283|FG002|Overall Study|Clinical Disease Progression|0|||
94478192|NCT04147247|323544284|FG003|Overall Study|Clinical Disease Progression|0|||
94478193|NCT04147247|323544285|FG004|Overall Study|Clinical Disease Progression|1|||
94478194|NCT04147247|323544281|FG000|Overall Study|Adverse Event|0|||
94315343|NCT01441440|322938459|FG000|Overall Study|Lost to Follow-up|0|||
94315344|NCT01441440|322938460|FG001|Overall Study|Lost to Follow-up|2|||
94315345|NCT01441440|322938461|FG002|Overall Study|Lost to Follow-up|1|||
94315346|NCT01441440|322938459|FG000|Overall Study|Withdrawal by Subject|11|||
94315347|NCT01441440|322938460|FG001|Overall Study|Withdrawal by Subject|9|||
94315348|NCT01441440|322938461|FG002|Overall Study|Withdrawal by Subject|9|||
94315349|NCT01441440|322938459|FG000|Overall Study|Pregnancy|1|||
94315350|NCT01441440|322938460|FG001|Overall Study|Pregnancy|0|||
94315351|NCT01441440|322938461|FG002|Overall Study|Pregnancy|0|||
94315352|NCT01441440|322938459|FG000|Overall Study|Lack of Efficacy|1|||
94315353|NCT01441440|322938460|FG001|Overall Study|Lack of Efficacy|0|||
94315354|NCT01441440|322938461|FG002|Overall Study|Lack of Efficacy|1|||
94478195|NCT04147247|323544282|FG001|Overall Study|Adverse Event|0|||
94478196|NCT04147247|323544283|FG002|Overall Study|Adverse Event|1|||
94478197|NCT04147247|323544284|FG003|Overall Study|Adverse Event|0|||
94478198|NCT04147247|323544285|FG004|Overall Study|Adverse Event|1|||
94478199|NCT00305227|323544286|FG000|Overall Study|Lost to Follow-up|7|||
94478200|NCT00305227|323544287|FG001|Overall Study|Lost to Follow-up|6|||
94478201|NCT00281697|323544288|FG000|Overall Study|> 60 days since last dose of study drug|4|||
94478202|NCT00281697|323544289|FG001|Overall Study|> 60 days since last dose of study drug|4|||
94478203|NCT00281697|323544288|FG000|Overall Study|Adverse Event|54|||
94315355|NCT01441440|322938459|FG000|Overall Study|Moving|0|||
94315356|NCT01441440|322938460|FG001|Overall Study|Moving|1|||
94315357|NCT01441440|322938461|FG002|Overall Study|Moving|1|||
94315358|NCT01441440|322938459|FG000|Overall Study|Work-related matter|0|||
94315359|NCT01441440|322938460|FG001|Overall Study|Work-related matter|1|||
94315360|NCT01441440|322938461|FG002|Overall Study|Work-related matter|0|||
94315361|NCT01441440|322938459|FG000|Overall Study|Difficllty in keeping the schedule|1|||
94315362|NCT01441440|322938460|FG001|Overall Study|Difficllty in keeping the schedule|1|||
94315363|NCT01441440|322938461|FG002|Overall Study|Difficllty in keeping the schedule|0|||
94315364|NCT02023164|322938462|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
94315365|NCT02023164|322938463|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
94315366|NCT01675011|322938464|FG000|Overall Study|Trial terminated by Sponsor|3|||
94315367|NCT01675011|322938465|FG001|Overall Study|Trial terminated by Sponsor|1|||
94315368|NCT02273050|322938466|FG000|Overall Study|Adverse Event|4|||
94315369|NCT02273050|322938467|FG001|Overall Study|Adverse Event|3|||
94315370|NCT02273050|322938468|FG002|Overall Study|Adverse Event|3|||
94315371|NCT02273050|322938466|FG000|Overall Study|Death|0|||
94315372|NCT02273050|322938467|FG001|Overall Study|Death|0|||
94315373|NCT02273050|322938468|FG002|Overall Study|Death|1|||
94315374|NCT02273050|322938466|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
94315375|NCT02273050|322938467|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
94315376|NCT02273050|322938468|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
94315377|NCT02273050|322938466|FG000|Overall Study|Lack of Efficacy|0|||
94315378|NCT02273050|322938467|FG001|Overall Study|Lack of Efficacy|1|||
94315379|NCT02273050|322938468|FG002|Overall Study|Lack of Efficacy|1|||
94315380|NCT02273050|322938466|FG000|Overall Study|Withdrawal by Subject|17|||
94315381|NCT02273050|322938467|FG001|Overall Study|Withdrawal by Subject|14|||
94315382|NCT02273050|322938468|FG002|Overall Study|Withdrawal by Subject|16|||
94315383|NCT02273050|322938466|FG000|Overall Study|Lost to Follow-up|0|||
94315384|NCT02273050|322938467|FG001|Overall Study|Lost to Follow-up|2|||
94315385|NCT02273050|322938468|FG002|Overall Study|Lost to Follow-up|3|||
94315386|NCT02273050|322938466|FG000|Overall Study|Protocol Violation|3|||
94315387|NCT02273050|322938467|FG001|Overall Study|Protocol Violation|1|||
94315388|NCT02273050|322938468|FG002|Overall Study|Protocol Violation|4|||
94315389|NCT01876732|322938470|FG000|Overall Study|MMA was not over 800mg/dL|75|||
94315390|NCT00450372|322938477|FG000|Overall Study|Physician Decision|1|||
94315391|NCT00520676|322938480|FG000|Overall Study|Death|84|||
94315392|NCT00520676|322938481|FG001|Overall Study|Death|81|||
94315393|NCT00520676|322938480|FG000|Overall Study|Lost to Follow-up|6|||
94315394|NCT00520676|322938481|FG001|Overall Study|Lost to Follow-up|10|||
94315395|NCT00520676|322938480|FG000|Overall Study|Physician Decision|4|||
94315396|NCT00520676|322938481|FG001|Overall Study|Physician Decision|1|||
94315397|NCT00520676|322938480|FG000|Overall Study|Withdrawal by Subject|7|||
94315398|NCT00520676|322938481|FG001|Overall Study|Withdrawal by Subject|11|||
94315399|NCT00069095|322938485|FG000|Primary Treatment Phase|Ongoing|0|||
94315400|NCT00069095|322938486|FG001|Primary Treatment Phase|Ongoing|0|||
94315401|NCT00069095|322938487|FG002|Primary Treatment Phase|Ongoing|5|||
94315402|NCT00069095|322938488|FG003|Primary Treatment Phase|Ongoing|7|||
94315403|NCT00069095|322938489|FG004|Primary Treatment Phase|Ongoing|7|||
94315404|NCT00069095|322938490|FG005|Primary Treatment Phase|Ongoing|4|||
94315405|NCT00069095|322938485|FG000|Primary Treatment Phase|Admin/Other|29|||
94315406|NCT00069095|322938486|FG001|Primary Treatment Phase|Admin/Other|38|||
94315407|NCT00069095|322938487|FG002|Primary Treatment Phase|Admin/Other|31|||
94315408|NCT00069095|322938488|FG003|Primary Treatment Phase|Admin/Other|45|||
94315409|NCT00069095|322938489|FG004|Primary Treatment Phase|Admin/Other|48|||
94315410|NCT00069095|322938490|FG005|Primary Treatment Phase|Admin/Other|42|||
94315411|NCT00069095|322938485|FG000|Primary Treatment Phase|Adverse Event|99|||
94315412|NCT00069095|322938486|FG001|Primary Treatment Phase|Adverse Event|92|||
94315413|NCT00069095|322938487|FG002|Primary Treatment Phase|Adverse Event|71|||
94315414|NCT00069095|322938488|FG003|Primary Treatment Phase|Adverse Event|72|||
94315415|NCT00069095|322938489|FG004|Primary Treatment Phase|Adverse Event|109|||
94315416|NCT00069095|322938490|FG005|Primary Treatment Phase|Adverse Event|101|||
94315417|NCT00069095|322938485|FG000|Primary Treatment Phase|Death|14|||
94315418|NCT00069095|322938486|FG001|Primary Treatment Phase|Death|8|||
94315419|NCT00069095|322938487|FG002|Primary Treatment Phase|Death|2|||
94315420|NCT00069095|322938488|FG003|Primary Treatment Phase|Death|5|||
94315421|NCT00069095|322938489|FG004|Primary Treatment Phase|Death|8|||
94315422|NCT00069095|322938490|FG005|Primary Treatment Phase|Death|8|||
94315423|NCT00069095|322938485|FG000|Primary Treatment Phase|Failure to return|5|||
94315424|NCT00069095|322938486|FG001|Primary Treatment Phase|Failure to return|5|||
94315425|NCT00069095|322938487|FG002|Primary Treatment Phase|Failure to return|0|||
94315426|NCT00069095|322938488|FG003|Primary Treatment Phase|Failure to return|0|||
94315427|NCT00069095|322938489|FG004|Primary Treatment Phase|Failure to return|0|||
94384921|NCT00048568|323196753|FG001|Open-Label Period|Pregnancy|0|||
94384922|NCT00048568|323196754|FG002|Open-Label Period|Pregnancy|5|||
94315428|NCT00069095|322938490|FG005|Primary Treatment Phase|Failure to return|2|||
94315429|NCT00069095|322938485|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
94315430|NCT00069095|322938486|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
94315431|NCT00069095|322938487|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
94315432|NCT00069095|322938488|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
94315433|NCT00069095|322938489|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
94315434|NCT00069095|322938490|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
94315435|NCT00069095|322938485|FG000|Primary Treatment Phase|Refused treatment|15|||
94315436|NCT00069095|322938486|FG001|Primary Treatment Phase|Refused treatment|26|||
94315437|NCT00069095|322938487|FG002|Primary Treatment Phase|Refused treatment|17|||
94315438|NCT00069095|322938488|FG003|Primary Treatment Phase|Refused treatment|31|||
94315439|NCT00069095|322938489|FG004|Primary Treatment Phase|Refused treatment|24|||
94315440|NCT00069095|322938490|FG005|Primary Treatment Phase|Refused treatment|27|||
94315441|NCT00069095|322938485|FG000|Primary Treatment Phase|Withdrew|2|||
94315442|NCT00069095|322938486|FG001|Primary Treatment Phase|Withdrew|3|||
94315443|NCT00069095|322938487|FG002|Primary Treatment Phase|Withdrew|8|||
94315444|NCT00069095|322938488|FG003|Primary Treatment Phase|Withdrew|2|||
94315445|NCT00069095|322938489|FG004|Primary Treatment Phase|Withdrew|4|||
94315446|NCT00069095|322938490|FG005|Primary Treatment Phase|Withdrew|9|||
94315447|NCT00069095|322938485|FG000|Primary Treatment Phase|Other Violation|0|||
94315448|NCT00069095|322938486|FG001|Primary Treatment Phase|Other Violation|1|||
94315449|NCT00069095|322938487|FG002|Primary Treatment Phase|Other Violation|1|||
94315450|NCT00069095|322938488|FG003|Primary Treatment Phase|Other Violation|1|||
94315451|NCT00069095|322938489|FG004|Primary Treatment Phase|Other Violation|0|||
94315452|NCT00069095|322938490|FG005|Primary Treatment Phase|Other Violation|1|||
94315453|NCT00069095|322938485|FG000|Primary Treatment Phase|Violation criteria|0|||
94315454|NCT00069095|322938486|FG001|Primary Treatment Phase|Violation criteria|2|||
94315455|NCT00069095|322938487|FG002|Primary Treatment Phase|Violation criteria|4|||
94315456|NCT00069095|322938488|FG003|Primary Treatment Phase|Violation criteria|3|||
94315457|NCT00069095|322938489|FG004|Primary Treatment Phase|Violation criteria|1|||
94315458|NCT00069095|322938490|FG005|Primary Treatment Phase|Violation criteria|5|||
94315459|NCT00069095|322938485|FG000|Post-study Treatment Phase|Missing reason|1|||
94315460|NCT00069095|322938486|FG001|Post-study Treatment Phase|Missing reason|3|||
94315461|NCT00069095|322938487|FG002|Post-study Treatment Phase|Missing reason|12|||
94315462|NCT00069095|322938488|FG003|Post-study Treatment Phase|Missing reason|8|||
94315463|NCT00069095|322938489|FG004|Post-study Treatment Phase|Missing reason|18|||
94315464|NCT00069095|322938490|FG005|Post-study Treatment Phase|Missing reason|17|||
94315465|NCT00069095|322938485|FG000|Post-study Treatment Phase|Adverse Event|2|||
94315466|NCT00069095|322938486|FG001|Post-study Treatment Phase|Adverse Event|3|||
94315467|NCT00069095|322938487|FG002|Post-study Treatment Phase|Adverse Event|1|||
94315468|NCT00069095|322938488|FG003|Post-study Treatment Phase|Adverse Event|0|||
94315469|NCT00069095|322938489|FG004|Post-study Treatment Phase|Adverse Event|5|||
94315470|NCT00069095|322938490|FG005|Post-study Treatment Phase|Adverse Event|1|||
94315471|NCT00069095|322938485|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
94315472|NCT00069095|322938486|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
94315473|NCT00069095|322938487|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
94315474|NCT00069095|322938488|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
94315475|NCT00069095|322938489|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
94315476|NCT00069095|322938490|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
94315477|NCT00069095|322938485|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
94315478|NCT00069095|322938486|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
94315479|NCT00069095|322938487|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
94315480|NCT00069095|322938488|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
94315481|NCT00069095|322938489|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
94315482|NCT00069095|322938490|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
94315483|NCT00069095|322938485|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
94315484|NCT00069095|322938486|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
94315485|NCT00069095|322938487|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
94315486|NCT00069095|322938488|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
94315487|NCT00069095|322938489|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
94315488|NCT00069095|322938490|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
94315489|NCT00069095|322938485|FG000|Post-study Treatment Phase|Participant had complete response|1|||
94315490|NCT00069095|322938486|FG001|Post-study Treatment Phase|Participant had complete response|1|||
94315491|NCT00069095|322938487|FG002|Post-study Treatment Phase|Participant had complete response|0|||
94315492|NCT00069095|322938488|FG003|Post-study Treatment Phase|Participant had complete response|0|||
94315493|NCT00069095|322938489|FG004|Post-study Treatment Phase|Participant had complete response|0|||
94315494|NCT00069095|322938490|FG005|Post-study Treatment Phase|Participant had complete response|0|||
94315495|NCT00069095|322938485|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
94315496|NCT00069095|322938486|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
94315497|NCT00069095|322938487|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
94315498|NCT00069095|322938488|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
94315499|NCT00069095|322938489|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
94315500|NCT00069095|322938490|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
94315501|NCT00069095|322938485|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
94315502|NCT00069095|322938486|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
94315503|NCT00069095|322938487|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
94315504|NCT00069095|322938488|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
94315505|NCT00069095|322938489|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
94315506|NCT00069095|322938490|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
94315507|NCT00069095|322938485|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
94315508|NCT00069095|322938486|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
94315509|NCT00069095|322938487|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
94315510|NCT00069095|322938488|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
94315511|NCT00069095|322938489|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
94315512|NCT00069095|322938490|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
94315513|NCT00069095|322938485|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
94315514|NCT00069095|322938486|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
94315515|NCT00069095|322938487|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
94315516|NCT00069095|322938488|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
94315517|NCT00069095|322938489|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
94315518|NCT00069095|322938490|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
94315519|NCT00069095|322938485|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
94315520|NCT00069095|322938486|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
94315521|NCT00069095|322938487|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
94315522|NCT00069095|322938488|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
94315523|NCT00069095|322938489|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
94315524|NCT00069095|322938490|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
94315525|NCT00069095|322938485|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
94315526|NCT00069095|322938486|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
94315527|NCT00069095|322938487|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
94315528|NCT00069095|322938488|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
94315529|NCT00069095|322938489|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
94315530|NCT00069095|322938490|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
94315531|NCT00069095|322938485|FG000|Post-study Treatment Phase|Surgery|0|||
94315532|NCT00069095|322938486|FG001|Post-study Treatment Phase|Surgery|0|||
94315533|NCT00069095|322938487|FG002|Post-study Treatment Phase|Surgery|0|||
94315534|NCT00069095|322938488|FG003|Post-study Treatment Phase|Surgery|1|||
94315535|NCT00069095|322938489|FG004|Post-study Treatment Phase|Surgery|1|||
94315536|NCT00069095|322938490|FG005|Post-study Treatment Phase|Surgery|0|||
94315537|NCT00069095|322938485|FG000|Post-study Treatment Phase|Death|0|||
94315538|NCT00069095|322938486|FG001|Post-study Treatment Phase|Death|0|||
94315539|NCT00069095|322938487|FG002|Post-study Treatment Phase|Death|0|||
94315540|NCT00069095|322938488|FG003|Post-study Treatment Phase|Death|0|||
94315541|NCT00069095|322938489|FG004|Post-study Treatment Phase|Death|1|||
94315542|NCT00069095|322938490|FG005|Post-study Treatment Phase|Death|0|||
94315543|NCT00069095|322938485|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
94315544|NCT00069095|322938486|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
94315545|NCT00069095|322938487|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
94315546|NCT00069095|322938488|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
94315547|NCT00069095|322938489|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
94315548|NCT00069095|322938490|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
94315549|NCT00069095|322938485|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
94315550|NCT00069095|322938486|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
94315551|NCT00069095|322938487|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
94315552|NCT00069095|322938488|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
94315553|NCT00069095|322938489|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
94315554|NCT00069095|322938490|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
94315555|NCT00069095|322938485|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
94315556|NCT00069095|322938486|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
94315557|NCT00069095|322938487|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
94315558|NCT00069095|322938488|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
94315559|NCT00069095|322938489|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
94384923|NCT00048568|323196752|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
94384924|NCT00048568|323196753|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
94384925|NCT00048568|323196754|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
94384926|NCT00048568|323196752|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
94478204|NCT00281697|323544289|FG001|Overall Study|Adverse Event|15|||
94478205|NCT00281697|323544288|FG000|Overall Study|Death|8|||
94478206|NCT00281697|323544289|FG001|Overall Study|Death|3|||
94478207|NCT00281697|323544288|FG000|Overall Study|Disease progression|279|||
94478208|NCT00281697|323544289|FG001|Overall Study|Disease progression|149|||
94478209|NCT00281697|323544288|FG000|Overall Study|Other|5|||
94478210|NCT00281697|323544289|FG001|Overall Study|Other|6|||
94478211|NCT00281697|323544288|FG000|Overall Study|Physician's decision to withdraw|15|||
94478212|NCT00281697|323544289|FG001|Overall Study|Physician's decision to withdraw|12|||
94478213|NCT00281697|323544288|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
94478214|NCT00281697|323544289|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
94478215|NCT00281697|323544288|FG000|Overall Study|Did not receive study drug|3|||
94478216|NCT00281697|323544289|FG001|Overall Study|Did not receive study drug|2|||
94478217|NCT00632125|323544290|FG000|Overall Study|Death|82|||
94478218|NCT00632125|323544290|FG000|Overall Study|Withdrawal by Subject|44|||
94478219|NCT00632125|323544290|FG000|Overall Study|Adverse Event|36|||
94478220|NCT00632125|323544290|FG000|Overall Study|Renal transplantation|17|||
94478221|NCT00632125|323544290|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
94478222|NCT00632125|323544290|FG000|Overall Study|Non-compliance|8|||
94478223|NCT00632125|323544290|FG000|Overall Study|Development of uncontrolled hypertension|5|||
94478224|NCT00632125|323544290|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
94478225|NCT00113295|323544291|FG000|Overall Study|Adverse Event|4|||
94478226|NCT00113295|323544292|FG001|Overall Study|Adverse Event|1|||
94478227|NCT00113295|323544291|FG000|Overall Study|Unrelated Medical Illness|1|||
94478228|NCT00113295|323544292|FG001|Overall Study|Unrelated Medical Illness|0|||
94478229|NCT03130959|323544293|FG000|Overall Study|Disease progression|19|||
94478230|NCT03130959|323544294|FG001|Overall Study|Disease progression|7|||
94478231|NCT03130959|323544295|FG002|Overall Study|Disease progression|12|||
94478232|NCT03130959|323544296|FG003|Overall Study|Disease progression|7|||
94478233|NCT03130959|323544297|FG004|Overall Study|Disease progression|12|||
94478234|NCT03130959|323544298|FG005|Overall Study|Disease progression|3|||
94478235|NCT03130959|323544299|FG006|Overall Study|Disease progression|6|||
94478236|NCT03130959|323544300|FG007|Overall Study|Disease progression|3|||
94478237|NCT03130959|323544301|FG008|Overall Study|Disease progression|15|||
94478238|NCT03130959|323544302|FG009|Overall Study|Disease progression|8|||
94478239|NCT03130959|323544293|FG000|Overall Study|Study drug toxicity|2|||
94478240|NCT03130959|323544294|FG001|Overall Study|Study drug toxicity|2|||
94478241|NCT03130959|323544295|FG002|Overall Study|Study drug toxicity|1|||
94478242|NCT03130959|323544296|FG003|Overall Study|Study drug toxicity|2|||
94478243|NCT03130959|323544297|FG004|Overall Study|Study drug toxicity|1|||
94478244|NCT03130959|323544298|FG005|Overall Study|Study drug toxicity|1|||
94478245|NCT03130959|323544299|FG006|Overall Study|Study drug toxicity|3|||
94478246|NCT03130959|323544300|FG007|Overall Study|Study drug toxicity|0|||
94478247|NCT03130959|323544301|FG008|Overall Study|Study drug toxicity|3|||
94478248|NCT03130959|323544302|FG009|Overall Study|Study drug toxicity|3|||
94384927|NCT00048568|323196753|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
94384928|NCT00048568|323196754|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
94384929|NCT00048568|323196752|FG000|Open-Label Period|Unknown Reasons|0|||
94384930|NCT00048568|323196753|FG001|Open-Label Period|Unknown Reasons|0|||
94384931|NCT00048568|323196754|FG002|Open-Label Period|Unknown Reasons|25|||
94384932|NCT00048568|323196752|FG000|Open-Label Period|Lost to Follow-up|0|||
94384933|NCT00048568|323196753|FG001|Open-Label Period|Lost to Follow-up|0|||
94384934|NCT00048568|323196754|FG002|Open-Label Period|Lost to Follow-up|7|||
94384935|NCT03227445|323196755|FG000|Period 1 (28 Days)|Adverse Event|1|||
94384936|NCT03227445|323196756|FG001|Period 1 (28 Days)|Adverse Event|2|||
94384937|NCT03227445|323196757|FG002|Period 1 (28 Days)|Adverse Event|0|||
94384938|NCT03227445|323196758|FG003|Period 1 (28 Days)|Adverse Event|1|||
94384939|NCT03227445|323196755|FG000|Period 1 (28 Days)|Protocol Violation|1|||
94384940|NCT03227445|323196756|FG001|Period 1 (28 Days)|Protocol Violation|0|||
94384941|NCT03227445|323196757|FG002|Period 1 (28 Days)|Protocol Violation|0|||
94384942|NCT03227445|323196758|FG003|Period 1 (28 Days)|Protocol Violation|0|||
94384943|NCT03227445|323196755|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
94478249|NCT03130959|323544293|FG000|Overall Study|Other reasons|0|||
94478250|NCT03130959|323544294|FG001|Overall Study|Other reasons|0|||
94478251|NCT03130959|323544295|FG002|Overall Study|Other reasons|0|||
94478252|NCT03130959|323544296|FG003|Overall Study|Other reasons|0|||
94478253|NCT03130959|323544297|FG004|Overall Study|Other reasons|0|||
94478254|NCT03130959|323544298|FG005|Overall Study|Other reasons|1|||
94478255|NCT03130959|323544299|FG006|Overall Study|Other reasons|1|||
94478256|NCT03130959|323544300|FG007|Overall Study|Other reasons|0|||
94478257|NCT03130959|323544301|FG008|Overall Study|Other reasons|0|||
94478258|NCT03130959|323544302|FG009|Overall Study|Other reasons|0|||
94384944|NCT03227445|323196756|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
94384945|NCT03227445|323196757|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
94384946|NCT03227445|323196758|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
94478259|NCT03130959|323544293|FG000|Overall Study|Subject request to discontinue therapy|0|||
94478260|NCT03130959|323544294|FG001|Overall Study|Subject request to discontinue therapy|0|||
94478261|NCT03130959|323544295|FG002|Overall Study|Subject request to discontinue therapy|1|||
94315560|NCT00069095|322938490|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
94315561|NCT00069095|322938485|FG000|Post-study Treatment Phase|Investigator decision|0|||
94315562|NCT00069095|322938486|FG001|Post-study Treatment Phase|Investigator decision|0|||
94315563|NCT00069095|322938487|FG002|Post-study Treatment Phase|Investigator decision|0|||
94315564|NCT00069095|322938488|FG003|Post-study Treatment Phase|Investigator decision|0|||
94315565|NCT00069095|322938489|FG004|Post-study Treatment Phase|Investigator decision|0|||
94315566|NCT00069095|322938490|FG005|Post-study Treatment Phase|Investigator decision|1|||
94315567|NCT00069095|322938485|FG000|Follow-up Phase|Death|174|||
94315568|NCT00069095|322938486|FG001|Follow-up Phase|Death|206|||
94315569|NCT00069095|322938487|FG002|Follow-up Phase|Death|120|||
94315570|NCT00069095|322938488|FG003|Follow-up Phase|Death|112|||
94315571|NCT00069095|322938489|FG004|Follow-up Phase|Death|92|||
94315572|NCT00069095|322938490|FG005|Follow-up Phase|Death|101|||
94315573|NCT01120093|322938491|FG000|Treatment Period 1|Adverse Event|0|||
94315574|NCT01120093|322938492|FG001|Treatment Period 1|Adverse Event|0|||
94315575|NCT01120093|322938493|FG002|Treatment Period 1|Adverse Event|1|||
94315576|NCT01120093|322938494|FG003|Treatment Period 1|Adverse Event|0|||
94315577|NCT01120093|322938495|FG004|Treatment Period 1|Adverse Event|1|||
94315578|NCT01120093|322938491|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94315579|NCT01120093|322938492|FG001|Treatment Period 1|Withdrawal by Subject|1|||
94315580|NCT01120093|322938493|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94315581|NCT01120093|322938494|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94315582|NCT01120093|322938495|FG004|Treatment Period 1|Withdrawal by Subject|0|||
94315583|NCT01120093|322938491|FG000|Treatment Period 2|Adverse Event|0|||
94315584|NCT01120093|322938492|FG001|Treatment Period 2|Adverse Event|0|||
94315585|NCT01120093|322938493|FG002|Treatment Period 2|Adverse Event|0|||
94315586|NCT01120093|322938494|FG003|Treatment Period 2|Adverse Event|1|||
94315587|NCT01120093|322938495|FG004|Treatment Period 2|Adverse Event|0|||
94315588|NCT01120093|322938491|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94315589|NCT01120093|322938492|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94315590|NCT01120093|322938493|FG002|Treatment Period 2|Withdrawal by Subject|0|||
94315591|NCT01120093|322938494|FG003|Treatment Period 2|Withdrawal by Subject|0|||
94315592|NCT01120093|322938495|FG004|Treatment Period 2|Withdrawal by Subject|1|||
94315593|NCT01120093|322938491|FG000|Treatment Period 3|Lack of Efficacy|0|||
94315594|NCT01120093|322938492|FG001|Treatment Period 3|Lack of Efficacy|0|||
94315595|NCT01120093|322938493|FG002|Treatment Period 3|Lack of Efficacy|0|||
94315596|NCT01120093|322938494|FG003|Treatment Period 3|Lack of Efficacy|1|||
94315597|NCT01120093|322938495|FG004|Treatment Period 3|Lack of Efficacy|0|||
94315598|NCT01120093|322938491|FG000|Treatment Period 3|Adverse Event|0|||
94315599|NCT01120093|322938492|FG001|Treatment Period 3|Adverse Event|0|||
94315600|NCT01120093|322938493|FG002|Treatment Period 3|Adverse Event|0|||
94315601|NCT01120093|322938494|FG003|Treatment Period 3|Adverse Event|0|||
94315602|NCT01120093|322938495|FG004|Treatment Period 3|Adverse Event|1|||
94315603|NCT01120093|322938491|FG000|Treatment Period 3|Withdrawal by Subject|0|||
94315604|NCT01120093|322938492|FG001|Treatment Period 3|Withdrawal by Subject|0|||
94315605|NCT01120093|322938493|FG002|Treatment Period 3|Withdrawal by Subject|1|||
94315606|NCT01120093|322938494|FG003|Treatment Period 3|Withdrawal by Subject|0|||
94315607|NCT01120093|322938495|FG004|Treatment Period 3|Withdrawal by Subject|0|||
94315608|NCT01120093|322938491|FG000|Treatment Period 4|Adverse Event|1|||
94315609|NCT01120093|322938492|FG001|Treatment Period 4|Adverse Event|0|||
94315610|NCT01120093|322938493|FG002|Treatment Period 4|Adverse Event|0|||
94315611|NCT01120093|322938494|FG003|Treatment Period 4|Adverse Event|0|||
94315612|NCT01120093|322938495|FG004|Treatment Period 4|Adverse Event|0|||
94315613|NCT01120093|322938491|FG000|Treatment Period 5|Adverse Event|0|||
94315614|NCT01120093|322938492|FG001|Treatment Period 5|Adverse Event|1|||
94315615|NCT01120093|322938493|FG002|Treatment Period 5|Adverse Event|0|||
94315616|NCT01120093|322938494|FG003|Treatment Period 5|Adverse Event|1|||
94315617|NCT01120093|322938495|FG004|Treatment Period 5|Adverse Event|0|||
94315618|NCT00532883|322938496|FG000|Overall Study|Adverse Event|1|||
94315619|NCT00532883|322938497|FG001|Overall Study|Adverse Event|0|||
94315620|NCT00532883|322938498|FG002|Overall Study|Adverse Event|0|||
94315621|NCT00532883|322938499|FG003|Overall Study|Adverse Event|1|||
94315622|NCT00532883|322938496|FG000|Overall Study|Lost to Follow-up|1|||
94315623|NCT00532883|322938497|FG001|Overall Study|Lost to Follow-up|1|||
94315624|NCT00532883|322938498|FG002|Overall Study|Lost to Follow-up|1|||
94315625|NCT00532883|322938499|FG003|Overall Study|Lost to Follow-up|0|||
94315626|NCT00532883|322938496|FG000|Overall Study|Withdrawal by Subject|0|||
94315627|NCT00532883|322938497|FG001|Overall Study|Withdrawal by Subject|1|||
94315628|NCT00532883|322938498|FG002|Overall Study|Withdrawal by Subject|1|||
94315629|NCT00532883|322938499|FG003|Overall Study|Withdrawal by Subject|0|||
94315630|NCT00532883|322938496|FG000|Overall Study|Subject was Nonadherent|0|||
94478262|NCT03130959|323544296|FG003|Overall Study|Subject request to discontinue therapy|1|||
94315631|NCT00532883|322938497|FG001|Overall Study|Subject was Nonadherent|1|||
94315632|NCT00532883|322938498|FG002|Overall Study|Subject was Nonadherent|1|||
94315633|NCT00532883|322938499|FG003|Overall Study|Subject was Nonadherent|0|||
94315634|NCT00532883|322938496|FG000|Overall Study|Early Study Termination|4|||
94315635|NCT00532883|322938497|FG001|Overall Study|Early Study Termination|4|||
94315636|NCT00532883|322938498|FG002|Overall Study|Early Study Termination|1|||
94315637|NCT00532883|322938499|FG003|Overall Study|Early Study Termination|4|||
94315638|NCT01525849|322938502|FG000|Overall Study|Lost to Follow-up|3|||
94315639|NCT01525849|322938503|FG001|Overall Study|Lost to Follow-up|2|||
94315640|NCT01525849|322938502|FG000|Overall Study|Withdrawal by Subject|1|||
94315641|NCT01525849|322938503|FG001|Overall Study|Withdrawal by Subject|9|||
94315642|NCT01525849|322938502|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
94315643|NCT01525849|322938503|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
94315644|NCT01525849|322938502|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
94315645|NCT01525849|322938503|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
94315646|NCT01469013|322938507|FG000|Part A (Treatment Period)|Adverse Event|1|||
94315647|NCT01469013|322938508|FG001|Part A (Treatment Period)|Adverse Event|0|||
94315648|NCT01469013|322938509|FG002|Part A (Treatment Period)|Adverse Event|0|||
94315649|NCT01469013|322938510|FG003|Part A (Treatment Period)|Adverse Event|0|||
94315650|NCT01469013|322938511|FG004|Part A (Treatment Period)|Adverse Event|1|||
94315651|NCT01469013|322938512|FG005|Part A (Treatment Period)|Adverse Event|0|||
94315652|NCT01469013|322938513|FG006|Part A (Treatment Period)|Adverse Event|0|||
94315653|NCT01469013|322938514|FG007|Part A (Treatment Period)|Adverse Event|0|||
94315654|NCT01469013|322938515|FG008|Part A (Treatment Period)|Adverse Event|0|||
94315655|NCT01469013|322938516|FG009|Part A (Treatment Period)|Adverse Event|0|||
94315656|NCT01469013|322938517|FG010|Part A (Treatment Period)|Adverse Event|0|||
94315657|NCT01469013|322938518|FG011|Part A (Treatment Period)|Adverse Event|0|||
94315658|NCT01469013|322938519|FG012|Part A (Treatment Period)|Adverse Event|0|||
94315659|NCT01469013|322938507|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
94315660|NCT01469013|322938508|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
94315661|NCT01469013|322938509|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
94315662|NCT01469013|322938510|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
94315663|NCT01469013|322938511|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
94315664|NCT01469013|322938512|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
94315665|NCT01469013|322938513|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
94315666|NCT01469013|322938514|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
94315667|NCT01469013|322938515|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
94315668|NCT01469013|322938516|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
94315669|NCT01469013|322938517|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
94315670|NCT01469013|322938518|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
94315671|NCT01469013|322938519|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
94315672|NCT01469013|322938507|FG000|Part B (Extension Period)|Adverse Event|0|||
94315673|NCT01469013|322938508|FG001|Part B (Extension Period)|Adverse Event|0|||
94315674|NCT01469013|322938509|FG002|Part B (Extension Period)|Adverse Event|0|||
94315675|NCT01469013|322938510|FG003|Part B (Extension Period)|Adverse Event|0|||
94315676|NCT01469013|322938511|FG004|Part B (Extension Period)|Adverse Event|0|||
94315677|NCT01469013|322938512|FG005|Part B (Extension Period)|Adverse Event|2|||
94315678|NCT01469013|322938513|FG006|Part B (Extension Period)|Adverse Event|5|||
94315679|NCT01469013|322938514|FG007|Part B (Extension Period)|Adverse Event|5|||
94315680|NCT01469013|322938515|FG008|Part B (Extension Period)|Adverse Event|3|||
94315681|NCT01469013|322938516|FG009|Part B (Extension Period)|Adverse Event|3|||
94315682|NCT01469013|322938517|FG010|Part B (Extension Period)|Adverse Event|1|||
94315683|NCT01469013|322938518|FG011|Part B (Extension Period)|Adverse Event|6|||
94315684|NCT01469013|322938519|FG012|Part B (Extension Period)|Adverse Event|3|||
94315685|NCT01469013|322938507|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
94315686|NCT01469013|322938508|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
94315687|NCT01469013|322938509|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
94315688|NCT01469013|322938510|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
94315689|NCT01469013|322938511|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
94315690|NCT01469013|322938512|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
94478263|NCT03130959|323544297|FG004|Overall Study|Subject request to discontinue therapy|0|||
94315691|NCT01469013|322938513|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
94315692|NCT01469013|322938514|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
94315693|NCT01469013|322938515|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
94315694|NCT01469013|322938516|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
94478264|NCT03130959|323544298|FG005|Overall Study|Subject request to discontinue therapy|0|||
94478265|NCT03130959|323544299|FG006|Overall Study|Subject request to discontinue therapy|1|||
94478266|NCT03130959|323544300|FG007|Overall Study|Subject request to discontinue therapy|1|||
94478267|NCT03130959|323544301|FG008|Overall Study|Subject request to discontinue therapy|0|||
94478268|NCT03130959|323544302|FG009|Overall Study|Subject request to discontinue therapy|0|||
94478269|NCT03130959|323544293|FG000|Overall Study|Not reported|0|||
94478270|NCT03130959|323544294|FG001|Overall Study|Not reported|0|||
94478271|NCT03130959|323544295|FG002|Overall Study|Not reported|0|||
94478272|NCT03130959|323544296|FG003|Overall Study|Not reported|1|||
94478273|NCT03130959|323544297|FG004|Overall Study|Not reported|0|||
94478274|NCT03130959|323544298|FG005|Overall Study|Not reported|1|||
94478275|NCT03130959|323544299|FG006|Overall Study|Not reported|0|||
94478276|NCT03130959|323544300|FG007|Overall Study|Not reported|0|||
94478277|NCT03130959|323544301|FG008|Overall Study|Not reported|0|||
94478278|NCT03130959|323544302|FG009|Overall Study|Not reported|1|||
94478279|NCT03130959|323544293|FG000|Overall Study|Adverse Event unrelated to drug|0|||
94478280|NCT03130959|323544294|FG001|Overall Study|Adverse Event unrelated to drug|0|||
94478281|NCT03130959|323544295|FG002|Overall Study|Adverse Event unrelated to drug|1|||
94478282|NCT03130959|323544296|FG003|Overall Study|Adverse Event unrelated to drug|1|||
94478283|NCT03130959|323544297|FG004|Overall Study|Adverse Event unrelated to drug|1|||
94478284|NCT03130959|323544298|FG005|Overall Study|Adverse Event unrelated to drug|0|||
94315695|NCT01469013|322938517|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
94315696|NCT01469013|322938518|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
94315697|NCT01469013|322938519|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
94315698|NCT00793819|322938520|FG000|Overall Study|Adverse Event|8|||
94315699|NCT00793819|322938521|FG001|Overall Study|Adverse Event|4|||
94315700|NCT00793819|322938520|FG000|Overall Study|Lack of Efficacy|1|||
94315701|NCT00793819|322938521|FG001|Overall Study|Lack of Efficacy|1|||
94315702|NCT00793819|322938520|FG000|Overall Study|Withdrawal by Subject|4|||
94315703|NCT00793819|322938521|FG001|Overall Study|Withdrawal by Subject|3|||
94315704|NCT00793819|322938520|FG000|Overall Study|Lost to Follow-up|1|||
94315705|NCT00793819|322938521|FG001|Overall Study|Lost to Follow-up|1|||
94315706|NCT02868216|322938525|FG000|Overall Study|Death|0|||
94315707|NCT02868216|322938526|FG001|Overall Study|Death|1|||
94315708|NCT02868216|322938525|FG000|Overall Study|coronary artery bypass|1|||
94315709|NCT02868216|322938526|FG001|Overall Study|coronary artery bypass|0|||
94315710|NCT02868216|322938525|FG000|Overall Study|Withdrawal by Subject|7|||
94315711|NCT02868216|322938526|FG001|Overall Study|Withdrawal by Subject|5|||
94315712|NCT00525148|322938531|FG000|Overall Study|Other Adverse Event|3|||
94315713|NCT00525148|322938532|FG001|Overall Study|Other Adverse Event|5|||
94315714|NCT00525148|322938533|FG002|Overall Study|Other Adverse Event|1|||
94315715|NCT00525148|322938534|FG003|Overall Study|Other Adverse Event|8|||
94315716|NCT00525148|322938531|FG000|Overall Study|Progressive disease|18|||
94478285|NCT03130959|323544299|FG006|Overall Study|Adverse Event unrelated to drug|1|||
94478286|NCT03130959|323544300|FG007|Overall Study|Adverse Event unrelated to drug|0|||
94478287|NCT03130959|323544301|FG008|Overall Study|Adverse Event unrelated to drug|1|||
94478288|NCT03130959|323544302|FG009|Overall Study|Adverse Event unrelated to drug|1|||
94315717|NCT00525148|322938532|FG001|Overall Study|Progressive disease|30|||
94315718|NCT00525148|322938533|FG002|Overall Study|Progressive disease|6|||
94315719|NCT00525148|322938534|FG003|Overall Study|Progressive disease|49|||
94315720|NCT00525148|322938531|FG000|Overall Study|Refused continuation of study medication|0|||
94315721|NCT00525148|322938532|FG001|Overall Study|Refused continuation of study medication|2|||
94315722|NCT00525148|322938533|FG002|Overall Study|Refused continuation of study medication|0|||
94315723|NCT00525148|322938534|FG003|Overall Study|Refused continuation of study medication|1|||
94315724|NCT00525148|322938531|FG000|Overall Study|Other than stated|2|||
94315725|NCT00525148|322938532|FG001|Overall Study|Other than stated|1|||
94315726|NCT00525148|322938533|FG002|Overall Study|Other than stated|0|||
94315727|NCT00525148|322938534|FG003|Overall Study|Other than stated|3|||
94315728|NCT00752609|322938535|FG000|Overall Study|Adverse Event|2|||
94315729|NCT00752609|322938536|FG001|Overall Study|Adverse Event|2|||
94315730|NCT00752609|322938535|FG000|Overall Study|Withdrawal by Subject|3|||
94315731|NCT00752609|322938536|FG001|Overall Study|Withdrawal by Subject|0|||
94315732|NCT00752609|322938535|FG000|Overall Study|Physician Decision|1|||
94315733|NCT00752609|322938536|FG001|Overall Study|Physician Decision|0|||
94315734|NCT00752609|322938535|FG000|Overall Study|Death|1|||
94315735|NCT00752609|322938536|FG001|Overall Study|Death|0|||
94315736|NCT00752609|322938535|FG000|Overall Study|Met exclusion criteria|1|||
94315737|NCT00752609|322938536|FG001|Overall Study|Met exclusion criteria|0|||
94315738|NCT00752609|322938535|FG000|Overall Study|Received Aranesp in error|1|||
94315739|NCT00752609|322938536|FG001|Overall Study|Received Aranesp in error|0|||
94315740|NCT00938327|322938537|FG000|Overall Study|Adverse Event|2|||
94315741|NCT00938327|322938537|FG000|Overall Study|Protocol Violation|1|||
94315742|NCT00938327|322938537|FG000|Overall Study|Withdrawal by Subject|4|||
94315743|NCT00938327|322938537|FG000|Overall Study|Lost to Follow-up|37|||
94315744|NCT00938327|322938537|FG000|Overall Study|2nd dose received outside of the study|7|||
94315745|NCT00938327|322938537|FG000|Overall Study|Vaccine not received as out of stock|9|||
94315746|NCT01975272|322938538|FG000|Overall Study|Excluded after protocol amendment|1|||
94315747|NCT01975272|322938539|FG001|Overall Study|Excluded after protocol amendment|1|||
94315748|NCT01975272|322938540|FG002|Overall Study|Excluded after protocol amendment|2|||
94315749|NCT01519245|322938541|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
94315750|NCT01519245|322938542|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
94315751|NCT02739594|322938543|FG000|Overall Study|Undesired Event|3|||
94315752|NCT02739594|322938544|FG001|Overall Study|Undesired Event|4|||
94315753|NCT02739594|322938543|FG000|Overall Study|Violation of Eligibility Criteria|1|||
94315754|NCT02739594|322938544|FG001|Overall Study|Violation of Eligibility Criteria|2|||
94315755|NCT02739594|322938543|FG000|Overall Study|Protocol Violation|5|||
94315756|NCT02739594|322938544|FG001|Overall Study|Protocol Violation|6|||
94315757|NCT02739594|322938543|FG000|Overall Study|Death|4|||
94315758|NCT02739594|322938544|FG001|Overall Study|Death|2|||
94315759|NCT02739594|322938543|FG000|Overall Study|Renal Insufficiency|4|||
94315760|NCT02739594|322938544|FG001|Overall Study|Renal Insufficiency|6|||
94315761|NCT02739594|322938543|FG000|Overall Study|Administrative Reasons|1|||
94315762|NCT02739594|322938544|FG001|Overall Study|Administrative Reasons|3|||
94315763|NCT02739594|322938543|FG000|Overall Study|Withdrawal by Subject|1|||
94315764|NCT02739594|322938544|FG001|Overall Study|Withdrawal by Subject|1|||
94315765|NCT02739594|322938543|FG000|Overall Study|Lost to Follow-up|0|||
94315766|NCT02739594|322938544|FG001|Overall Study|Lost to Follow-up|1|||
94315767|NCT02739594|322938543|FG000|Overall Study|Elevated Serum Creatinine|0|||
94315768|NCT02739594|322938544|FG001|Overall Study|Elevated Serum Creatinine|1|||
94315769|NCT02739594|322938543|FG000|Overall Study|Other|6|||
94315770|NCT02739594|322938544|FG001|Overall Study|Other|2|||
94315771|NCT01465178|322938545|FG000|Overall Study|Withdrawal by Subject|1|||
94315772|NCT01465178|322938546|FG001|Overall Study|Withdrawal by Subject|0|||
94315773|NCT00804193|322938547|FG000|Overall Study|Lack of baseline fungus|32|||
94315774|NCT00804193|322938548|FG001|Overall Study|Lack of baseline fungus|31|||
94315775|NCT00804193|322938549|FG002|Overall Study|Lack of baseline fungus|19|||
94315776|NCT00804193|322938547|FG000|Overall Study|Adverse Event|0|||
94315777|NCT00804193|322938548|FG001|Overall Study|Adverse Event|0|||
94315778|NCT00804193|322938549|FG002|Overall Study|Adverse Event|2|||
94315779|NCT00804193|322938547|FG000|Overall Study|Lack of Efficacy|1|||
94315780|NCT00804193|322938548|FG001|Overall Study|Lack of Efficacy|1|||
94315781|NCT00804193|322938549|FG002|Overall Study|Lack of Efficacy|3|||
94315782|NCT00804193|322938547|FG000|Overall Study|Protocol Violation|0|||
94315783|NCT00804193|322938548|FG001|Overall Study|Protocol Violation|8|||
94315784|NCT00804193|322938549|FG002|Overall Study|Protocol Violation|2|||
94315785|NCT00804193|322938547|FG000|Overall Study|Lost to Follow-up|3|||
94315786|NCT00804193|322938548|FG001|Overall Study|Lost to Follow-up|3|||
94315787|NCT00804193|322938549|FG002|Overall Study|Lost to Follow-up|4|||
94315788|NCT00804193|322938547|FG000|Overall Study|Withdrawal by Subject|3|||
94315789|NCT00804193|322938548|FG001|Overall Study|Withdrawal by Subject|1|||
94315790|NCT00804193|322938549|FG002|Overall Study|Withdrawal by Subject|2|||
94315791|NCT00237796|322938556|FG000|Overall Study|Baseline and one other ILSS required|10|||
94315792|NCT00237796|322938557|FG001|Overall Study|Baseline and one other ILSS required|5|||
94315793|NCT01193348|322938561|FG000|Screening Period|Screen Failure|5|||
94315794|NCT01193348|322938561|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
94315795|NCT01193348|322938561|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
94315796|NCT01193348|322938561|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
94478289|NCT03130959|323544293|FG000|Overall Study|Participant withdrew consent|0|||
94478290|NCT03130959|323544294|FG001|Overall Study|Participant withdrew consent|1|||
94478291|NCT03130959|323544295|FG002|Overall Study|Participant withdrew consent|0|||
94478292|NCT03130959|323544296|FG003|Overall Study|Participant withdrew consent|2|||
94478293|NCT03130959|323544297|FG004|Overall Study|Participant withdrew consent|1|||
94478294|NCT03130959|323544298|FG005|Overall Study|Participant withdrew consent|0|||
94478295|NCT03130959|323544299|FG006|Overall Study|Participant withdrew consent|0|||
94478296|NCT03130959|323544300|FG007|Overall Study|Participant withdrew consent|0|||
94478297|NCT03130959|323544301|FG008|Overall Study|Participant withdrew consent|0|||
94478298|NCT03130959|323544302|FG009|Overall Study|Participant withdrew consent|2|||
94478299|NCT03130959|323544293|FG000|Overall Study|Administrative reason by sponsor|1|||
94478300|NCT03130959|323544294|FG001|Overall Study|Administrative reason by sponsor|0|||
94478301|NCT03130959|323544295|FG002|Overall Study|Administrative reason by sponsor|1|||
94478302|NCT03130959|323544296|FG003|Overall Study|Administrative reason by sponsor|0|||
94478303|NCT03130959|323544297|FG004|Overall Study|Administrative reason by sponsor|0|||
94478304|NCT03130959|323544298|FG005|Overall Study|Administrative reason by sponsor|0|||
94478305|NCT03130959|323544299|FG006|Overall Study|Administrative reason by sponsor|0|||
94478306|NCT03130959|323544300|FG007|Overall Study|Administrative reason by sponsor|0|||
94478307|NCT03130959|323544301|FG008|Overall Study|Administrative reason by sponsor|0|||
94478308|NCT03130959|323544302|FG009|Overall Study|Administrative reason by sponsor|0|||
94478309|NCT03130959|323544293|FG000|Overall Study|Lost to Follow-up|1|||
94478310|NCT03130959|323544294|FG001|Overall Study|Lost to Follow-up|0|||
94478311|NCT03130959|323544295|FG002|Overall Study|Lost to Follow-up|0|||
94478312|NCT03130959|323544296|FG003|Overall Study|Lost to Follow-up|0|||
94478313|NCT03130959|323544297|FG004|Overall Study|Lost to Follow-up|0|||
94478314|NCT03130959|323544298|FG005|Overall Study|Lost to Follow-up|0|||
94478315|NCT03130959|323544299|FG006|Overall Study|Lost to Follow-up|0|||
94478316|NCT03130959|323544300|FG007|Overall Study|Lost to Follow-up|0|||
94478317|NCT03130959|323544301|FG008|Overall Study|Lost to Follow-up|0|||
94478318|NCT03130959|323544302|FG009|Overall Study|Lost to Follow-up|0|||
94478319|NCT00577772|323544303|FG000|Overall Study|Lost to Follow-up|0|||
94478320|NCT00577772|323544304|FG001|Overall Study|Lost to Follow-up|1|||
94478321|NCT00572455|323544305|FG000|Stage I (14 Days)|Adverse Event|0|||
94478322|NCT00572455|323544306|FG001|Stage I (14 Days)|Adverse Event|0|||
94478323|NCT00572455|323544307|FG002|Stage I (14 Days)|Adverse Event|0|||
94478324|NCT00572455|323544308|FG003|Stage I (14 Days)|Adverse Event|0|||
94478325|NCT00572455|323544309|FG004|Stage I (14 Days)|Adverse Event|0|||
94478326|NCT00572455|323544310|FG005|Stage I (14 Days)|Adverse Event|3|||
94478327|NCT00572455|323544311|FG006|Stage I (14 Days)|Adverse Event|0|||
94478328|NCT00572455|323544312|FG007|Stage I (14 Days)|Adverse Event|0|||
94478329|NCT00572455|323544313|FG008|Stage I (14 Days)|Adverse Event|0|||
94478330|NCT00572455|323544314|FG009|Stage I (14 Days)|Adverse Event|0|||
94478331|NCT00572455|323544315|FG010|Stage I (14 Days)|Adverse Event|0|||
94478332|NCT00572455|323544316|FG011|Stage I (14 Days)|Adverse Event|0|||
94478333|NCT00572455|323544317|FG012|Stage I (14 Days)|Adverse Event|0|||
94478334|NCT00572455|323544318|FG013|Stage I (14 Days)|Adverse Event|0|||
94478335|NCT00572455|323544305|FG000|Stage I (14 Days)|Other|0|||
94478336|NCT00572455|323544306|FG001|Stage I (14 Days)|Other|0|||
94478337|NCT00572455|323544307|FG002|Stage I (14 Days)|Other|0|||
94478338|NCT00572455|323544308|FG003|Stage I (14 Days)|Other|0|||
94478339|NCT00572455|323544309|FG004|Stage I (14 Days)|Other|1|||
94478340|NCT00572455|323544310|FG005|Stage I (14 Days)|Other|0|||
94478341|NCT00572455|323544311|FG006|Stage I (14 Days)|Other|0|||
94315797|NCT01193348|322938561|FG000|Extension Treatment Period|Physician Decision|1|||
94478342|NCT00572455|323544312|FG007|Stage I (14 Days)|Other|0|||
94478343|NCT00572455|323544313|FG008|Stage I (14 Days)|Other|0|||
94478344|NCT00572455|323544314|FG009|Stage I (14 Days)|Other|0|||
94478345|NCT00572455|323544315|FG010|Stage I (14 Days)|Other|0|||
94478346|NCT00572455|323544316|FG011|Stage I (14 Days)|Other|0|||
94478347|NCT00572455|323544317|FG012|Stage I (14 Days)|Other|0|||
94478348|NCT00572455|323544318|FG013|Stage I (14 Days)|Other|0|||
94315798|NCT01193348|322938561|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
94315799|NCT03259334|322938563|FG000|Overall Study|Adverse Event|3|||
94315800|NCT03259334|322938564|FG001|Overall Study|Adverse Event|8|||
94478349|NCT00572455|323544305|FG000|Stage II (28 Days)|Adverse Event|0|||
94478350|NCT00572455|323544306|FG001|Stage II (28 Days)|Adverse Event|0|||
94478351|NCT00572455|323544307|FG002|Stage II (28 Days)|Adverse Event|0|||
94478352|NCT00572455|323544308|FG003|Stage II (28 Days)|Adverse Event|0|||
94478353|NCT00572455|323544309|FG004|Stage II (28 Days)|Adverse Event|0|||
94478354|NCT00572455|323544310|FG005|Stage II (28 Days)|Adverse Event|0|||
94478355|NCT00572455|323544311|FG006|Stage II (28 Days)|Adverse Event|0|||
94478356|NCT00572455|323544312|FG007|Stage II (28 Days)|Adverse Event|0|||
94478357|NCT00572455|323544313|FG008|Stage II (28 Days)|Adverse Event|1|||
94478358|NCT00572455|323544314|FG009|Stage II (28 Days)|Adverse Event|3|||
94478359|NCT00572455|323544315|FG010|Stage II (28 Days)|Adverse Event|3|||
94478360|NCT00572455|323544316|FG011|Stage II (28 Days)|Adverse Event|4|||
94478361|NCT00572455|323544317|FG012|Stage II (28 Days)|Adverse Event|5|||
94478362|NCT00572455|323544318|FG013|Stage II (28 Days)|Adverse Event|1|||
94478363|NCT00572455|323544305|FG000|Stage II (28 Days)|Death|0|||
94478364|NCT00572455|323544306|FG001|Stage II (28 Days)|Death|0|||
94478365|NCT00572455|323544307|FG002|Stage II (28 Days)|Death|0|||
94478366|NCT00572455|323544308|FG003|Stage II (28 Days)|Death|0|||
94478367|NCT00572455|323544309|FG004|Stage II (28 Days)|Death|0|||
94478368|NCT00572455|323544310|FG005|Stage II (28 Days)|Death|0|||
94478369|NCT00572455|323544311|FG006|Stage II (28 Days)|Death|0|||
94478370|NCT00572455|323544312|FG007|Stage II (28 Days)|Death|0|||
94478371|NCT00572455|323544313|FG008|Stage II (28 Days)|Death|1|||
94478372|NCT00572455|323544314|FG009|Stage II (28 Days)|Death|0|||
94478373|NCT00572455|323544315|FG010|Stage II (28 Days)|Death|0|||
94478374|NCT00572455|323544316|FG011|Stage II (28 Days)|Death|0|||
94478375|NCT00572455|323544317|FG012|Stage II (28 Days)|Death|0|||
94478376|NCT00572455|323544318|FG013|Stage II (28 Days)|Death|0|||
94478377|NCT00572455|323544305|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
94478378|NCT00572455|323544306|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
94478379|NCT00572455|323544307|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
94478380|NCT00572455|323544308|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
94478381|NCT00572455|323544309|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
94478382|NCT00572455|323544310|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
94478383|NCT00572455|323544311|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
94478384|NCT00572455|323544312|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
94478385|NCT00572455|323544313|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
94478386|NCT00572455|323544314|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
94478387|NCT00572455|323544315|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
94478388|NCT00572455|323544316|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
94478389|NCT00572455|323544317|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
94478390|NCT00572455|323544318|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
94478391|NCT00572455|323544305|FG000|Stage II (28 Days)|Other|0|||
94478392|NCT00572455|323544306|FG001|Stage II (28 Days)|Other|0|||
94478393|NCT00572455|323544307|FG002|Stage II (28 Days)|Other|0|||
94478394|NCT00572455|323544308|FG003|Stage II (28 Days)|Other|0|||
94478395|NCT00572455|323544309|FG004|Stage II (28 Days)|Other|0|||
94478396|NCT00572455|323544310|FG005|Stage II (28 Days)|Other|0|||
94478397|NCT00572455|323544311|FG006|Stage II (28 Days)|Other|0|||
94478398|NCT00572455|323544312|FG007|Stage II (28 Days)|Other|0|||
94478399|NCT00572455|323544313|FG008|Stage II (28 Days)|Other|1|||
94478400|NCT00572455|323544314|FG009|Stage II (28 Days)|Other|0|||
94478401|NCT00572455|323544315|FG010|Stage II (28 Days)|Other|0|||
94478402|NCT00572455|323544316|FG011|Stage II (28 Days)|Other|0|||
94478403|NCT00572455|323544317|FG012|Stage II (28 Days)|Other|0|||
94478404|NCT00572455|323544318|FG013|Stage II (28 Days)|Other|0|||
94478405|NCT00572455|323544305|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
94478406|NCT00572455|323544306|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
94478407|NCT00572455|323544307|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
94478408|NCT00572455|323544308|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
94478409|NCT00572455|323544309|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
94478410|NCT00572455|323544310|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
94478411|NCT00572455|323544311|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
94478412|NCT00572455|323544312|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
94478413|NCT00572455|323544313|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
94478414|NCT00572455|323544314|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
94478415|NCT00572455|323544315|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
94478416|NCT00572455|323544316|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
94478417|NCT00572455|323544317|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
94478418|NCT00572455|323544318|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
94478419|NCT02824224|323544319|FG000|Overall Study|Discontinued, IUS expulsion|0|||
94478420|NCT02824224|323544320|FG001|Overall Study|Discontinued, IUS expulsion|1|||
94478421|NCT02824224|323544319|FG000|Overall Study|Did not show up for allocation visit|2|||
94478422|NCT02824224|323544320|FG001|Overall Study|Did not show up for allocation visit|0|||
94478423|NCT02384538|323544321|FG000|Overall Study|Adverse Event|1|||
94478424|NCT02384538|323544322|FG001|Overall Study|Adverse Event|4|||
94478425|NCT02384538|323544321|FG000|Overall Study|Lack of Efficacy|4|||
94315801|NCT03259334|322938565|FG002|Overall Study|Adverse Event|5|||
94478426|NCT02384538|323544322|FG001|Overall Study|Lack of Efficacy|4|||
94478427|NCT02384538|323544321|FG000|Overall Study|Withdrew Consent|0|||
94478428|NCT02384538|323544322|FG001|Overall Study|Withdrew Consent|4|||
94478429|NCT02384538|323544321|FG000|Overall Study|Other|1|||
94478430|NCT02384538|323544322|FG001|Overall Study|Other|3|||
94478431|NCT02256917|323544329|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
94478432|NCT02256917|323544329|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
94478433|NCT02256917|323544329|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
94478434|NCT02256917|323544329|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
94478435|NCT02256917|323544329|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
94478436|NCT04152083|323544330|FG000|Overall Study|Lost to Follow-up|2|||
94478437|NCT04152083|323544331|FG001|Overall Study|Lost to Follow-up|1|||
94478438|NCT04152083|323544330|FG000|Overall Study|Adverse Event|1|||
94478439|NCT04152083|323544331|FG001|Overall Study|Adverse Event|0|||
94478440|NCT04152083|323544330|FG000|Overall Study|Randomized but not treated|3|||
94478441|NCT04152083|323544331|FG001|Overall Study|Randomized but not treated|2|||
94478442|NCT00856999|323544332|FG000|Overall Study|Withdrawal by Subject|5|||
94478443|NCT04547140|323544337|FG000|Overall Study|Adverse Event|0|||
94478444|NCT04547140|323544338|FG001|Overall Study|Adverse Event|1|||
94478445|NCT04547140|323544337|FG000|Overall Study|Withdrawal by Subject|0|||
94478446|NCT04547140|323544338|FG001|Overall Study|Withdrawal by Subject|1|||
94478447|NCT04547140|323544337|FG000|Overall Study|Lost to Follow-up|3|||
94478448|NCT04547140|323544338|FG001|Overall Study|Lost to Follow-up|1|||
94478449|NCT04547140|323544337|FG000|Overall Study|Death|2|||
94478450|NCT04547140|323544338|FG001|Overall Study|Death|1|||
94478451|NCT04547140|323544337|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
94478452|NCT04547140|323544338|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
94478453|NCT04547140|323544337|FG000|Overall Study|Pregnancy|1|||
94478454|NCT04547140|323544338|FG001|Overall Study|Pregnancy|0|||
94478455|NCT04547140|323544337|FG000|Overall Study|Reason Not Specified|4|||
94478456|NCT04547140|323544338|FG001|Overall Study|Reason Not Specified|1|||
94478457|NCT00003483|323544339|FG000|Overall Study|Not evaluable|1|||
94478458|NCT00105989|323544341|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
94478459|NCT00105989|323544342|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
94478460|NCT00105989|323544341|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
94478461|NCT00105989|323544342|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
94478462|NCT00105989|323544341|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
94478463|NCT00105989|323544342|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
94478464|NCT00105989|323544341|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
94478465|NCT00105989|323544342|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
94478466|NCT00105989|323544341|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
94478467|NCT00105989|323544342|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
94478468|NCT00105989|323544341|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
94478469|NCT00105989|323544342|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
94478470|NCT00105989|323544341|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
94478471|NCT00105989|323544342|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
94478472|NCT00105989|323544341|FG000|Acute - Open Label: Week 0-10|Death|1|||
94478473|NCT00105989|323544342|FG001|Acute - Open Label: Week 0-10|Death|0|||
94478474|NCT00105989|323544341|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
94478475|NCT00105989|323544342|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
94478476|NCT00105989|323544341|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
94478477|NCT00105989|323544342|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
94478478|NCT00105989|323544341|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
94478479|NCT00105989|323544342|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
94478480|NCT00105989|323544341|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
94478481|NCT00105989|323544342|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
94478482|NCT00105989|323544341|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
94478483|NCT00105989|323544342|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
94478484|NCT00105989|323544341|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
94478485|NCT00105989|323544342|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
94478486|NCT00105989|323544341|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
94478487|NCT00105989|323544342|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
94478488|NCT00105989|323544341|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
94478489|NCT00105989|323544342|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
94478490|NCT00105989|323544341|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
94478491|NCT00105989|323544342|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
94478492|NCT00105989|323544341|FG000|Continuation - Open Label:Week 10-34|Death|0|||
94478493|NCT00105989|323544342|FG001|Continuation - Open Label:Week 10-34|Death|0|||
94478494|NCT00105989|323544341|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
94478495|NCT00105989|323544342|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
94478496|NCT00105989|323544341|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
94478497|NCT00105989|323544342|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
94478498|NCT00105989|323544341|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
94478499|NCT00105989|323544342|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
94478500|NCT00105989|323544341|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
94478501|NCT00105989|323544342|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
94478502|NCT00105989|323544341|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
94478503|NCT00105989|323544342|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
94478504|NCT00105989|323544341|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
94478505|NCT00105989|323544342|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
94478506|NCT00105989|323544341|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
94315802|NCT03259334|322938563|FG000|Overall Study|Withdrawal by Subject|4|||
94315803|NCT03259334|322938564|FG001|Overall Study|Withdrawal by Subject|2|||
94478507|NCT00105989|323544342|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
94478508|NCT00105989|323544341|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
94478509|NCT00105989|323544342|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
94478510|NCT00105989|323544341|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
94478511|NCT00105989|323544342|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
94478512|NCT00105989|323544341|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
94478513|NCT00105989|323544342|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
94478514|NCT00105989|323544341|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
94478515|NCT00105989|323544342|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
94478516|NCT00105989|323544341|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
94478517|NCT00105989|323544342|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
94478518|NCT03442088|323544343|FG000|Overall Study|Adverse Event|1|||
94478519|NCT03442088|323544343|FG000|Overall Study|Lack of Efficacy|2|||
94478520|NCT03442088|323544343|FG000|Overall Study|Lost to Follow-up|2|||
94478521|NCT01869777|323544345|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
94478522|NCT00613366|323544346|FG000|Overall Study|Withdrawal by Subject|3|||
94478523|NCT00613366|323544347|FG001|Overall Study|Withdrawal by Subject|2|||
94478524|NCT03318003|323544353|FG000|Overall Study|Withdrawal by Subject|1|||
94478525|NCT03318003|323544354|FG001|Overall Study|Withdrawal by Subject|1|||
94478526|NCT03318003|323544353|FG000|Overall Study|fetal loss|0|||
94478527|NCT03318003|323544354|FG001|Overall Study|fetal loss|1|||
94478528|NCT02260817|323544356|FG000|Overall Study|Lost to Follow-up|0|||
94478529|NCT02260817|323544357|FG001|Overall Study|Lost to Follow-up|14|||
94478530|NCT02260817|323544356|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
94478531|NCT02260817|323544357|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
94478532|NCT02260817|323544356|FG000|Overall Study|Observation, no biopsy|0|||
94478533|NCT02260817|323544357|FG001|Overall Study|Observation, no biopsy|1|||
94478534|NCT02260817|323544356|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
94478535|NCT02260817|323544357|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
94478536|NCT02260817|323544356|FG000|Overall Study|Protocol Violation|0|||
94478537|NCT02260817|323544357|FG001|Overall Study|Protocol Violation|14|||
94478538|NCT00618826|323544360|FG000|Overall Study|Adverse Event|1|||
94478539|NCT01808261|323544363|FG000|Overall Study|Physician Decision|0|||
94478540|NCT01808261|323544364|FG001|Overall Study|Physician Decision|2|||
94478541|NCT01808261|323544363|FG000|Overall Study|Study Closed/Terminated|25|||
94478542|NCT01808261|323544364|FG001|Overall Study|Study Closed/Terminated|23|||
94478543|NCT01808261|323544363|FG000|Overall Study|Adverse event, non-fatal|2|||
94478544|NCT01808261|323544364|FG001|Overall Study|Adverse event, non-fatal|0|||
94478545|NCT01808261|323544363|FG000|Overall Study|Consent withdrawn by subject|6|||
94478546|NCT01808261|323544364|FG001|Overall Study|Consent withdrawn by subject|7|||
94478547|NCT01808261|323544363|FG000|Overall Study|Lost to Follow-up|3|||
94478548|NCT01808261|323544364|FG001|Overall Study|Lost to Follow-up|1|||
94478549|NCT03243305|323544365|FG000|Overall Study|Lost to Follow-up|250|||
94478550|NCT03243305|323544365|FG000|Overall Study|Withdrawal by Subject|170|||
94478551|NCT03243305|323544365|FG000|Overall Study|Pregnancy|104|||
94478552|NCT03243305|323544365|FG000|Overall Study|Non-Compliance with Study Drug|38|||
94478553|NCT03243305|323544365|FG000|Overall Study|Adverse Event|23|||
94478554|NCT03243305|323544365|FG000|Overall Study|No sexually active|26|||
94478555|NCT03243305|323544365|FG000|Overall Study|Physician Decision|22|||
94478556|NCT03243305|323544365|FG000|Overall Study|Protocol Violation|22|||
94478557|NCT03243305|323544365|FG000|Overall Study|Study method no longer primary method|12|||
94478558|NCT03243305|323544365|FG000|Overall Study|Study Terminated by Sponsor|1|||
94478559|NCT03243305|323544365|FG000|Overall Study|Early terminations|267|||
94478560|NCT00673257|323544366|FG000|Overall Study|Withdrawal by Subject|4|||
94478561|NCT00673257|323544366|FG000|Overall Study|Unable to obtain specimen|1|||
94478562|NCT02600923|323544367|FG000|Overall Study|Death|10|||
94478563|NCT02600923|323544367|FG000|Overall Study|Adverse Event|3|||
94478564|NCT02600923|323544367|FG000|Overall Study|Global deterioration of health status|2|||
94478565|NCT02600923|323544367|FG000|Overall Study|Insufficient clinical response|6|||
94478566|NCT02600923|323544367|FG000|Overall Study|Lost to Follow-up|1|||
94478567|NCT02600923|323544367|FG000|Overall Study|Withdrawal by Subject|5|||
94478568|NCT02600923|323544367|FG000|Overall Study|Objective progression or relapse|50|||
94478569|NCT02600923|323544367|FG000|Overall Study|Study terminated by Sponsor|53|||
94478570|NCT02600923|323544367|FG000|Overall Study|Not treated|1|||
94478571|NCT00792909|323544368|FG000|Overall Study|Withdrawal by Subject|0|||
94478572|NCT00792909|323544369|FG001|Overall Study|Withdrawal by Subject|1|||
94478573|NCT00792909|323544370|FG002|Overall Study|Withdrawal by Subject|0|||
94478574|NCT00941304|323544371|FG000|Overall Study|Lost to Follow-up|1|||
94478575|NCT00941304|323544372|FG001|Overall Study|Lost to Follow-up|0|||
94478576|NCT00941304|323544373|FG002|Overall Study|Lost to Follow-up|0|||
94478577|NCT00941304|323544374|FG003|Overall Study|Lost to Follow-up|0|||
94478578|NCT00941304|323544375|FG004|Overall Study|Lost to Follow-up|0|||
94478579|NCT01497067|323544379|FG000|Overall Study|Lost to Follow-up|56|||
94478580|NCT01497067|323544379|FG000|Overall Study|Adverse Event|3|||
94478581|NCT01497067|323544379|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
94478582|NCT01497067|323544379|FG000|Overall Study|Other|13|||
94478583|NCT02472886|323544382|FG000|Overall Study|Lack of Efficacy|0|||
94478584|NCT02472886|323544383|FG001|Overall Study|Lack of Efficacy|2|||
94478585|NCT02472886|323544384|FG002|Overall Study|Lack of Efficacy|1|||
94478586|NCT05568797|323544387|FG000|Overall Study|Adverse Event|0|||
94478587|NCT05568797|323544388|FG001|Overall Study|Adverse Event|8|||
94478588|NCT05568797|323544387|FG000|Overall Study|Lost to Follow-up|2|||
94478589|NCT05568797|323544388|FG001|Overall Study|Lost to Follow-up|3|||
94478590|NCT05568797|323544387|FG000|Overall Study|Withdrawal by Subject|1|||
94478591|NCT05568797|323544388|FG001|Overall Study|Withdrawal by Subject|10|||
94478592|NCT05568797|323544387|FG000|Overall Study|Other|2|||
94478593|NCT05568797|323544388|FG001|Overall Study|Other|2|||
94478594|NCT04039204|323544389|FG000|Overall Study|Withdrawal by Subject|0|||
94478595|NCT04039204|323544390|FG001|Overall Study|Withdrawal by Subject|2|||
94478596|NCT00588146|323545749|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
94478597|NCT00588146|323545750|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
94478598|NCT00940888|323545751|FG000|Overall Study|Unsuccessful Implant|4|||
94478599|NCT00940888|323545751|FG000|Overall Study|Death|461|||
94478600|NCT00940888|323545751|FG000|Overall Study|Withdrawn - Non-Death|364|||
94478601|NCT00940888|323545751|FG000|Overall Study|Lost to Follow-up|6|||
94478602|NCT02609386|323545757|FG000|Overall Study|Withdrawal by Subject|6|||
94478603|NCT02609386|323545758|FG001|Overall Study|Withdrawal by Subject|1|||
94478604|NCT02609386|323545757|FG000|Overall Study|Lost to Follow-up|3|||
94478605|NCT02609386|323545758|FG001|Overall Study|Lost to Follow-up|5|||
94478606|NCT02609386|323545757|FG000|Overall Study|Death|19|||
94478607|NCT02609386|323545758|FG001|Overall Study|Death|9|||
94478608|NCT02609386|323545757|FG000|Overall Study|Physician Decision|0|||
94478609|NCT02609386|323545758|FG001|Overall Study|Physician Decision|2|||
94478610|NCT04131712|323545759|FG000|Overall Study|COVID related|0|||
94478611|NCT04131712|323545760|FG001|Overall Study|COVID related|0|||
94478612|NCT04131712|323545761|FG002|Overall Study|COVID related|2|||
94478613|NCT04131712|323545762|FG003|Overall Study|COVID related|0|||
94478614|NCT04131712|323545759|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
94478615|NCT04131712|323545760|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
94478616|NCT04131712|323545761|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
94478617|NCT04131712|323545762|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
94478618|NCT00873730|323545763|FG000|Overall Study|Protocol Deviation|5|||
94478619|NCT00873730|323545764|FG001|Overall Study|Protocol Deviation|2|||
94478620|NCT00873730|323545763|FG000|Overall Study|Adverse Event|0|||
94478621|NCT00873730|323545764|FG001|Overall Study|Adverse Event|2|||
94478622|NCT00873730|323545763|FG000|Overall Study|Withdrawal by Subject|0|||
94478623|NCT00873730|323545764|FG001|Overall Study|Withdrawal by Subject|1|||
94478624|NCT00873730|323545763|FG000|Overall Study|Sponsor decision|1|||
94478625|NCT00873730|323545764|FG001|Overall Study|Sponsor decision|0|||
94478626|NCT02299388|323545767|FG000|Overall Study|Withdrawal by Subject|0|||
94478627|NCT02299388|323545768|FG001|Overall Study|Withdrawal by Subject|1|||
94478628|NCT00103662|323545769|FG000|Overall Study|Entered Rescue Procedure|0|||
94478629|NCT00103662|323545770|FG001|Overall Study|Entered Rescue Procedure|7|||
94478630|NCT00103662|323545769|FG000|Overall Study|Death|7|||
94478631|NCT00103662|323545770|FG001|Overall Study|Death|7|||
94478632|NCT00103662|323545769|FG000|Overall Study|Elective Withdrawal|5|||
94478633|NCT00103662|323545770|FG001|Overall Study|Elective Withdrawal|5|||
94478634|NCT00103662|323545769|FG000|Overall Study|Lost to Follow-up|0|||
94478635|NCT00103662|323545770|FG001|Overall Study|Lost to Follow-up|1|||
94478636|NCT00103662|323545769|FG000|Overall Study|Other|6|||
94478637|NCT00103662|323545770|FG001|Overall Study|Other|9|||
94478638|NCT00103662|323545769|FG000|Overall Study|Failed mobilization|0|||
94478639|NCT00103662|323545770|FG001|Overall Study|Failed mobilization|4|||
94478640|NCT00103662|323545769|FG000|Overall Study|Intercurrent illness|1|||
94478641|NCT00103662|323545770|FG001|Overall Study|Intercurrent illness|0|||
94478642|NCT03334188|323545772|FG000|Overall Study|Withdrawal by Subject|0|||
94478643|NCT03334188|323545773|FG001|Overall Study|Withdrawal by Subject|1|||
94478644|NCT03334188|323545772|FG000|Overall Study|Death|1|||
94478645|NCT03334188|323545773|FG001|Overall Study|Death|0|||
94478646|NCT03334188|323545772|FG000|Overall Study|Never had qualifying clinic visit|7|||
94478647|NCT03334188|323545773|FG001|Overall Study|Never had qualifying clinic visit|7|||
94478648|NCT03076996|323545776|FG000|Overall Study|Withdrawal by Subject|2|||
94478649|NCT03076996|323545776|FG000|Overall Study|Lost to Follow-up|3|||
94478650|NCT03076996|323545776|FG000|Overall Study|Literacy precluded participation|1|||
94478651|NCT04668209|323545779|FG000|Overall Study|Withdrawal by Subject|2|||
94478652|NCT04668209|323545780|FG001|Overall Study|Withdrawal by Subject|2|||
94478653|NCT04668209|323545779|FG000|Overall Study|Lost to Follow-up|3|||
94478654|NCT04668209|323545780|FG001|Overall Study|Lost to Follow-up|4|||
94478655|NCT04668209|323545779|FG000|Overall Study|Subject Expired|2|||
94478656|NCT04668209|323545780|FG001|Overall Study|Subject Expired|0|||
94478657|NCT04668209|323545779|FG000|Overall Study|Withdrawn from study|0|||
94478658|NCT04668209|323545780|FG001|Overall Study|Withdrawn from study|1|||
94478659|NCT04668209|323545779|FG000|Overall Study|Adverse Event|0|||
94478660|NCT04668209|323545780|FG001|Overall Study|Adverse Event|1|||
94478661|NCT00536510|323545781|FG000|Overall Study|Adverse Event|27|||
94478662|NCT00536510|323545782|FG001|Overall Study|Adverse Event|4|||
94478663|NCT00536510|323545781|FG000|Overall Study|Lost to Follow-up|11|||
94478664|NCT00536510|323545782|FG001|Overall Study|Lost to Follow-up|8|||
94478665|NCT00536510|323545781|FG000|Overall Study|Protocol Violation|4|||
94478666|NCT00536510|323545782|FG001|Overall Study|Protocol Violation|5|||
94478667|NCT00536510|323545781|FG000|Overall Study|Withdrawal by Subject|16|||
94478668|NCT00536510|323545782|FG001|Overall Study|Withdrawal by Subject|9|||
94478669|NCT00536510|323545781|FG000|Overall Study|Flushing with Product|20|||
94478670|NCT00536510|323545782|FG001|Overall Study|Flushing with Product|0|||
94478671|NCT00536510|323545781|FG000|Overall Study|Laboratory Adverse Event|2|||
94478672|NCT00536510|323545782|FG001|Overall Study|Laboratory Adverse Event|1|||
94478673|NCT00536510|323545781|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
94478674|NCT00536510|323545782|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
94478675|NCT02144077|323545783|FG000|Overall Study|Withdrawal by Subject|3|||
94478676|NCT02144077|323545784|FG001|Overall Study|Withdrawal by Subject|3|||
94478677|NCT02144077|323545783|FG000|Overall Study|Adverse Event|2|||
94478678|NCT02144077|323545784|FG001|Overall Study|Adverse Event|3|||
94478679|NCT02144077|323545783|FG000|Overall Study|Lost to Follow-up|2|||
94478680|NCT02144077|323545784|FG001|Overall Study|Lost to Follow-up|2|||
94478681|NCT02144077|323545783|FG000|Overall Study|Protocol Violation|1|||
94478682|NCT02144077|323545784|FG001|Overall Study|Protocol Violation|2|||
94478683|NCT02144077|323545783|FG000|Overall Study|Death|0|||
94478684|NCT02144077|323545784|FG001|Overall Study|Death|1|||
94478685|NCT02144077|323545783|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
94478686|NCT02144077|323545784|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
94478687|NCT00943397|323545793|FG000|Overall Study|Adverse Event|0|||
94478688|NCT00943397|323545794|FG001|Overall Study|Adverse Event|6|||
94478689|NCT00943397|323545793|FG000|Overall Study|Lost to Follow-up|0|||
94478690|NCT00943397|323545794|FG001|Overall Study|Lost to Follow-up|4|||
94478691|NCT00943397|323545793|FG000|Overall Study|Protocol Violation|2|||
94478692|NCT00943397|323545794|FG001|Overall Study|Protocol Violation|5|||
94384947|NCT03227445|323196755|FG000|Period 2 (28 Days)|Adverse Event|1|||
94478693|NCT00943397|323545793|FG000|Overall Study|Withdrawal by Subject|1|||
94478694|NCT00943397|323545794|FG001|Overall Study|Withdrawal by Subject|1|||
94478695|NCT00943397|323545793|FG000|Overall Study|Site terminated and other|12|||
94478696|NCT00943397|323545794|FG001|Overall Study|Site terminated and other|56|||
94478697|NCT01135524|323545795|FG000|Overall Study|Withdrawal by Subject|14|||
94478698|NCT01135524|323545795|FG000|Overall Study|Adverse Event|20|||
94478699|NCT01135524|323545795|FG000|Overall Study|Lost to Follow-up|3|||
94478700|NCT01135524|323545795|FG000|Overall Study|Administrative|151|||
94478701|NCT01135524|323545795|FG000|Overall Study|Lack of Efficacy|8|||
94478702|NCT01247350|323545797|FG000|Overall Study|Adverse Event|0|||
94478703|NCT01247350|323545798|FG001|Overall Study|Adverse Event|0|||
94478704|NCT01247350|323545799|FG002|Overall Study|Adverse Event|1|||
94478705|NCT01247350|323545800|FG003|Overall Study|Adverse Event|0|||
94478706|NCT01247350|323545801|FG004|Overall Study|Adverse Event|0|||
94478707|NCT01247350|323545797|FG000|Overall Study|Withdrawal by Subject|0|||
94478708|NCT01247350|323545798|FG001|Overall Study|Withdrawal by Subject|0|||
94478709|NCT01247350|323545799|FG002|Overall Study|Withdrawal by Subject|0|||
94478710|NCT01247350|323545800|FG003|Overall Study|Withdrawal by Subject|1|||
94478711|NCT01247350|323545801|FG004|Overall Study|Withdrawal by Subject|0|||
94478712|NCT01247350|323545797|FG000|Overall Study|Entry criteria not met|0|||
94478713|NCT01247350|323545798|FG001|Overall Study|Entry criteria not met|0|||
94478714|NCT01247350|323545799|FG002|Overall Study|Entry criteria not met|0|||
94478715|NCT01247350|323545800|FG003|Overall Study|Entry criteria not met|0|||
94478716|NCT01247350|323545801|FG004|Overall Study|Entry criteria not met|1|||
94478717|NCT01266824|323545802|FG000|Overall Study|Study terminated prior to completion|2|||
94478718|NCT01266824|323545803|FG001|Overall Study|Study terminated prior to completion|3|||
94478719|NCT01711983|323545804|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
94478720|NCT01711983|323545804|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
94478721|NCT01711983|323545804|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
94478722|NCT01711983|323545804|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
94478723|NCT03286218|323545818|FG000|Qualification Phase Period 1|Adverse Event|1|||
94478724|NCT03286218|323545819|FG001|Qualification Phase Period 1|Adverse Event|0|||
94478725|NCT03286218|323545820|FG002|Qualification Phase Period 1|Adverse Event|0|||
94478726|NCT03286218|323545821|FG003|Qualification Phase Period 1|Adverse Event|0|||
94384948|NCT03227445|323196756|FG001|Period 2 (28 Days)|Adverse Event|0|||
94384949|NCT03227445|323196757|FG002|Period 2 (28 Days)|Adverse Event|2|||
94384950|NCT03227445|323196758|FG003|Period 2 (28 Days)|Adverse Event|1|||
94384951|NCT03227445|323196755|FG000|Period 2 (28 Days)|Protocol Violation|0|||
94384952|NCT03227445|323196756|FG001|Period 2 (28 Days)|Protocol Violation|0|||
94384953|NCT03227445|323196757|FG002|Period 2 (28 Days)|Protocol Violation|0|||
94384954|NCT03227445|323196758|FG003|Period 2 (28 Days)|Protocol Violation|1|||
94478727|NCT03286218|323545822|FG004|Qualification Phase Period 1|Adverse Event|0|||
94478728|NCT03286218|323545823|FG005|Qualification Phase Period 1|Adverse Event|0|||
94478729|NCT03286218|323545824|FG006|Qualification Phase Period 1|Adverse Event|0|||
94478730|NCT03286218|323545825|FG007|Qualification Phase Period 1|Adverse Event|0|||
94478731|NCT03286218|323545826|FG008|Qualification Phase Period 1|Adverse Event|0|||
94478732|NCT03286218|323545827|FG009|Qualification Phase Period 1|Adverse Event|0|||
94478733|NCT03286218|323545828|FG010|Qualification Phase Period 1|Adverse Event|0|||
94478734|NCT03286218|323545829|FG011|Qualification Phase Period 1|Adverse Event|0|||
94478735|NCT03286218|323545818|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
94478736|NCT03286218|323545819|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
94478737|NCT03286218|323545820|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
94478738|NCT03286218|323545821|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
94478739|NCT03286218|323545822|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
94478740|NCT03286218|323545823|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
94478741|NCT03286218|323545824|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
94478742|NCT03286218|323545825|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
94478743|NCT03286218|323545826|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
94478744|NCT03286218|323545827|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
94478745|NCT03286218|323545828|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
94478746|NCT03286218|323545829|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
94478747|NCT03286218|323545818|FG000|Qualification Phase Period 2|Adverse Event|0|||
94478748|NCT03286218|323545819|FG001|Qualification Phase Period 2|Adverse Event|1|||
94478749|NCT03286218|323545820|FG002|Qualification Phase Period 2|Adverse Event|0|||
94478750|NCT03286218|323545821|FG003|Qualification Phase Period 2|Adverse Event|0|||
94478751|NCT03286218|323545822|FG004|Qualification Phase Period 2|Adverse Event|0|||
94478752|NCT03286218|323545823|FG005|Qualification Phase Period 2|Adverse Event|0|||
94478753|NCT03286218|323545824|FG006|Qualification Phase Period 2|Adverse Event|0|||
94478754|NCT03286218|323545825|FG007|Qualification Phase Period 2|Adverse Event|0|||
94478755|NCT03286218|323545826|FG008|Qualification Phase Period 2|Adverse Event|0|||
94478756|NCT03286218|323545827|FG009|Qualification Phase Period 2|Adverse Event|0|||
94478757|NCT03286218|323545828|FG010|Qualification Phase Period 2|Adverse Event|0|||
94478758|NCT03286218|323545829|FG011|Qualification Phase Period 2|Adverse Event|0|||
94478759|NCT03286218|323545818|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
94478760|NCT03286218|323545819|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
94478761|NCT03286218|323545820|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
94478762|NCT03286218|323545821|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
94478763|NCT03286218|323545822|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
94478764|NCT03286218|323545823|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
94478765|NCT03286218|323545824|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
94478766|NCT03286218|323545825|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
94478767|NCT03286218|323545826|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
94478768|NCT03286218|323545827|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
94478769|NCT03286218|323545828|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
94478770|NCT03286218|323545829|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
94478771|NCT03286218|323545818|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
94478772|NCT03286218|323545819|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
94478773|NCT03286218|323545820|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
94478774|NCT03286218|323545821|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
94478775|NCT03286218|323545822|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
94478776|NCT03286218|323545823|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
94478777|NCT03286218|323545824|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
94478778|NCT03286218|323545825|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
94478779|NCT03286218|323545826|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
94478780|NCT03286218|323545827|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
94478781|NCT03286218|323545828|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
94478782|NCT03286218|323545829|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
94478783|NCT03286218|323545818|FG000|Qualification Phase Period 2|Protocol Violation|2|||
94478784|NCT03286218|323545819|FG001|Qualification Phase Period 2|Protocol Violation|0|||
94478785|NCT03286218|323545820|FG002|Qualification Phase Period 2|Protocol Violation|0|||
94478786|NCT03286218|323545821|FG003|Qualification Phase Period 2|Protocol Violation|0|||
94478787|NCT03286218|323545822|FG004|Qualification Phase Period 2|Protocol Violation|0|||
94478788|NCT03286218|323545823|FG005|Qualification Phase Period 2|Protocol Violation|0|||
94315804|NCT03259334|322938565|FG002|Overall Study|Withdrawal by Subject|4|||
94315805|NCT03259334|322938563|FG000|Overall Study|Physician Decision|1|||
94315806|NCT03259334|322938564|FG001|Overall Study|Physician Decision|0|||
94478789|NCT03286218|323545824|FG006|Qualification Phase Period 2|Protocol Violation|0|||
94315807|NCT03259334|322938565|FG002|Overall Study|Physician Decision|0|||
94478790|NCT03286218|323545825|FG007|Qualification Phase Period 2|Protocol Violation|0|||
94478791|NCT03286218|323545826|FG008|Qualification Phase Period 2|Protocol Violation|0|||
94478792|NCT03286218|323545827|FG009|Qualification Phase Period 2|Protocol Violation|0|||
94478793|NCT03286218|323545828|FG010|Qualification Phase Period 2|Protocol Violation|0|||
94478794|NCT03286218|323545829|FG011|Qualification Phase Period 2|Protocol Violation|0|||
94478795|NCT03286218|323545818|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
94478796|NCT03286218|323545819|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
94478797|NCT03286218|323545820|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
94478798|NCT03286218|323545821|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
94478799|NCT03286218|323545822|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
94478800|NCT03286218|323545823|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
94478801|NCT03286218|323545824|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
94478802|NCT03286218|323545825|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
94478803|NCT03286218|323545826|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
94478804|NCT03286218|323545827|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
94478805|NCT03286218|323545828|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
94478806|NCT03286218|323545829|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
94478807|NCT03286218|323545818|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
94478808|NCT03286218|323545819|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
94478809|NCT03286218|323545820|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
94478810|NCT03286218|323545821|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
94478811|NCT03286218|323545822|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
94478812|NCT03286218|323545823|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
94478813|NCT03286218|323545824|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
94478814|NCT03286218|323545825|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
94478815|NCT03286218|323545826|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
94478816|NCT03286218|323545827|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
94478817|NCT03286218|323545828|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
94478818|NCT03286218|323545829|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
94478819|NCT03286218|323545818|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
94478820|NCT03286218|323545819|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
94478821|NCT03286218|323545820|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
94478822|NCT03286218|323545821|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
94478823|NCT03286218|323545822|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
94478824|NCT03286218|323545823|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
94478825|NCT03286218|323545824|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
94478826|NCT03286218|323545825|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
94478827|NCT03286218|323545826|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
94478828|NCT03286218|323545827|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
94478829|NCT03286218|323545828|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
94478830|NCT03286218|323545829|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
94478831|NCT02532374|323545832|FG000|Overall Study|Withdrawal by Subject|1|||
94478832|NCT02532374|323545832|FG000|Overall Study|Physician Decision|1|||
94478833|NCT02438280|323545833|FG000|Overall Study|Physician Decision|1|||
94478834|NCT02438280|323545834|FG001|Overall Study|Physician Decision|0|||
94478835|NCT00447772|323545835|FG000|Overall Study|Lack of Efficacy|3|||
94478836|NCT00447772|323545835|FG000|Overall Study|Insufficient compliance|6|||
94478837|NCT00447772|323545835|FG000|Overall Study|Discontinuation of drug therapy|1|||
94478838|NCT00447772|323545835|FG000|Overall Study|Lost to Follow-up|9|||
94478839|NCT00447772|323545835|FG000|Overall Study|Withdrawal by Subject|1|||
94478840|NCT00447772|323545835|FG000|Overall Study|Unable to attend all study visits|2|||
94478841|NCT00447772|323545835|FG000|Overall Study|Adverse Event|1|||
94478842|NCT00447772|323545835|FG000|Overall Study|Patient relocated|1|||
94478843|NCT00447772|323545835|FG000|Overall Study|Incomplete documentation at visit 1|1|||
94478844|NCT00447772|323545835|FG000|Overall Study|Chemotherapy for lung cancer|1|||
94478845|NCT00447772|323545835|FG000|Overall Study|Premature re-injection required|1|||
94478846|NCT01896193|323545836|FG000|Overall Study|Lack of Efficacy|20|||
94478847|NCT01896193|323545837|FG001|Overall Study|Lack of Efficacy|11|||
94478848|NCT01896193|323545836|FG000|Overall Study|Protocol Violation|0|||
94478849|NCT01896193|323545837|FG001|Overall Study|Protocol Violation|1|||
94478850|NCT01896193|323545836|FG000|Overall Study|Withdrew Consent|1|||
94478851|NCT01896193|323545837|FG001|Overall Study|Withdrew Consent|0|||
94478852|NCT06400238|323545838|FG000|Overall Study|Started Protocol Therapy|2|||
94478853|NCT06400238|323545838|FG000|Overall Study|Adverse Event|1|||
94478854|NCT06400238|323545838|FG000|Overall Study|Death|1|||
94478855|NCT06400238|323545838|FG000|Overall Study|Disease Progression|27|||
94478856|NCT06400238|323545838|FG000|Overall Study|Withdrawal by Subject|2|||
94478857|NCT06400238|323545838|FG000|Overall Study|Physician Decision|2|||
94478858|NCT00922116|323545839|FG000|Overall Study|Adverse Event|4|||
94478859|NCT00922116|323545839|FG000|Overall Study|Death|1|||
94478860|NCT00922116|323545839|FG000|Overall Study|Lost to Follow-up|1|||
94478861|NCT00922116|323545839|FG000|Overall Study|Withdrawal by Subject|4|||
94478862|NCT00922116|323545839|FG000|Overall Study|Other|5|||
94478863|NCT00905424|323545842|FG000|Overall Study|Lost to Follow-up|3|||
94478864|NCT00905424|323545843|FG001|Overall Study|Lost to Follow-up|3|||
94478865|NCT00905424|323545842|FG000|Overall Study|Withdrawal by Subject|1|||
94478866|NCT00905424|323545843|FG001|Overall Study|Withdrawal by Subject|2|||
94478867|NCT00905424|323545842|FG000|Overall Study|Adverse Event|4|||
94478868|NCT00905424|323545843|FG001|Overall Study|Adverse Event|2|||
94478869|NCT00905424|323545842|FG000|Overall Study|Non-compliance with study medication|2|||
94478870|NCT00905424|323545843|FG001|Overall Study|Non-compliance with study medication|0|||
94478871|NCT00905424|323545842|FG000|Overall Study|Sponsor decision|1|||
94478872|NCT00905424|323545843|FG001|Overall Study|Sponsor decision|0|||
94478873|NCT00905424|323545842|FG000|Overall Study|Positive urine drug screen|0|||
94478874|NCT00905424|323545843|FG001|Overall Study|Positive urine drug screen|1|||
94478875|NCT00905424|323545842|FG000|Overall Study|Non-adherence to visit schedule|0|||
94478876|NCT00905424|323545843|FG001|Overall Study|Non-adherence to visit schedule|1|||
94478877|NCT00426764|323545844|FG000|Overall Study|Protocol Violation|1|||
94478878|NCT00426764|323545844|FG000|Overall Study|Withdrawal by Subject|4|||
94478879|NCT00426764|323545844|FG000|Overall Study|Physician Decision|6|||
94478880|NCT00426764|323545844|FG000|Overall Study|Compassionate Use|1|||
94315808|NCT03259334|322938563|FG000|Overall Study|Lost to Follow-up|0|||
94315809|NCT03259334|322938564|FG001|Overall Study|Lost to Follow-up|2|||
94315810|NCT03259334|322938565|FG002|Overall Study|Lost to Follow-up|1|||
94478881|NCT00426764|323545844|FG000|Overall Study|Progressive Disease|83|||
94315811|NCT03259334|322938563|FG000|Overall Study|Protocol Deviation|0|||
94315812|NCT03259334|322938564|FG001|Overall Study|Protocol Deviation|3|||
94315813|NCT03259334|322938565|FG002|Overall Study|Protocol Deviation|2|||
94315814|NCT03259334|322938563|FG000|Overall Study|Lack of Efficacy|2|||
94478882|NCT00426764|323545844|FG000|Overall Study|Adverse Event|24|||
94478883|NCT00426764|323545844|FG000|Overall Study|Other|1|||
94478884|NCT00426764|323545844|FG000|Overall Study|Death|1|||
94478885|NCT00426764|323545844|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
94478886|NCT01166750|323545847|FG000|Overall Study|Lost to Follow-up|1|||
94315815|NCT03259334|322938564|FG001|Overall Study|Lack of Efficacy|0|||
94315816|NCT03259334|322938565|FG002|Overall Study|Lack of Efficacy|1|||
94315817|NCT03259334|322938563|FG000|Overall Study|Randomized but never treated|0|||
94315818|NCT03259334|322938564|FG001|Overall Study|Randomized but never treated|2|||
94315819|NCT03259334|322938565|FG002|Overall Study|Randomized but never treated|0|||
94315820|NCT01187901|322938566|FG000|Overall Study|Protocol Violation|1|||
94315821|NCT01187901|322938567|FG001|Overall Study|Protocol Violation|0|||
94315822|NCT01187901|322938566|FG000|Overall Study|Lost to Follow-up|1|||
94315823|NCT01187901|322938567|FG001|Overall Study|Lost to Follow-up|2|||
94315824|NCT01187901|322938566|FG000|Overall Study|Unrelated Health Reasons|1|||
94315825|NCT01187901|322938567|FG001|Overall Study|Unrelated Health Reasons|2|||
94315826|NCT01187901|322938566|FG000|Overall Study|Suspected Allergic Reaction|1|||
94315827|NCT01187901|322938567|FG001|Overall Study|Suspected Allergic Reaction|1|||
94315828|NCT01187901|322938566|FG000|Overall Study|Adverse Event|3|||
94315829|NCT01187901|322938567|FG001|Overall Study|Adverse Event|0|||
94315830|NCT01187901|322938566|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
94315831|NCT01187901|322938567|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
94315832|NCT01187901|322938566|FG000|Overall Study|Pregnancy|0|||
94315833|NCT01187901|322938567|FG001|Overall Study|Pregnancy|2|||
94315834|NCT00369668|322938569|FG000|Overall Study|Lack of Efficacy|4|||
94315835|NCT00369668|322938570|FG001|Overall Study|Lack of Efficacy|5|||
94315836|NCT00369668|322938571|FG002|Overall Study|Lack of Efficacy|7|||
94315837|NCT02149836|322938572|FG000|Overall Study|Withdrawal by Subject|1|||
94315838|NCT04973228|322938573|FG000|Overall Study|Adverse Event|2|||
94315839|NCT04973228|322938574|FG001|Overall Study|Adverse Event|3|||
94315840|NCT04973228|322938573|FG000|Overall Study|Lack of Efficacy|1|||
94315841|NCT04973228|322938574|FG001|Overall Study|Lack of Efficacy|3|||
94315842|NCT04973228|322938573|FG000|Overall Study|Lost to Follow-up|12|||
94315843|NCT04973228|322938574|FG001|Overall Study|Lost to Follow-up|4|||
94315844|NCT04973228|322938573|FG000|Overall Study|Withdrawal by Subject|11|||
94315845|NCT04973228|322938574|FG001|Overall Study|Withdrawal by Subject|4|||
94315846|NCT04973228|322938573|FG000|Overall Study|Did not tolerate application|1|||
94315847|NCT04973228|322938574|FG001|Overall Study|Did not tolerate application|0|||
94315848|NCT04973228|322938573|FG000|Overall Study|Wanted to early terminate and use own product|0|||
94315849|NCT04973228|322938574|FG001|Overall Study|Wanted to early terminate and use own product|1|||
94315850|NCT04973228|322938573|FG000|Overall Study|Missed visits due to new work schedule|1|||
94315851|NCT04973228|322938574|FG001|Overall Study|Missed visits due to new work schedule|0|||
94315852|NCT00091390|322938589|FG000|Overall Study|Protocol Violation|1|||
94315853|NCT00091390|322938589|FG000|Overall Study|No protocol treatment|3|||
94315854|NCT02626819|322939984|FG000|Overall Study|Lost to Follow-up|3|||
94315855|NCT02626819|322939985|FG001|Overall Study|Lost to Follow-up|2|||
94315856|NCT02626819|322939984|FG000|Overall Study|Withdrawal by Subject|1|||
94315857|NCT02626819|322939985|FG001|Overall Study|Withdrawal by Subject|0|||
94315858|NCT02626819|322939984|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
94315859|NCT02626819|322939985|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
94315860|NCT02819310|322939986|FG000|Overall Study|Withdrawal by Subject|37|||
94478887|NCT01166750|323545848|FG001|Overall Study|Lost to Follow-up|0|||
94478888|NCT05225389|323545849|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
94478889|NCT01585246|323545850|FG000|Overall Study|Lost to Follow-up|0|||
94478890|NCT01585246|323545851|FG001|Overall Study|Lost to Follow-up|0|||
94478891|NCT01585246|323545852|FG002|Overall Study|Lost to Follow-up|2|||
94478892|NCT01585246|323545853|FG003|Overall Study|Lost to Follow-up|1|||
94478893|NCT01585246|323545854|FG004|Overall Study|Lost to Follow-up|0|||
94478894|NCT01585246|323545850|FG000|Overall Study|Protocol Violation|0|||
94478895|NCT01585246|323545851|FG001|Overall Study|Protocol Violation|0|||
94478896|NCT01585246|323545852|FG002|Overall Study|Protocol Violation|0|||
94478897|NCT01585246|323545853|FG003|Overall Study|Protocol Violation|0|||
94478898|NCT01585246|323545854|FG004|Overall Study|Protocol Violation|1|||
94478899|NCT01585246|323545850|FG000|Overall Study|Withdrawal by Subject|0|||
94478900|NCT01585246|323545851|FG001|Overall Study|Withdrawal by Subject|0|||
94478901|NCT01585246|323545852|FG002|Overall Study|Withdrawal by Subject|1|||
94478902|NCT01585246|323545853|FG003|Overall Study|Withdrawal by Subject|2|||
94478903|NCT01585246|323545854|FG004|Overall Study|Withdrawal by Subject|1|||
94478904|NCT01585246|323545850|FG000|Overall Study|Other|0|||
94478905|NCT01585246|323545851|FG001|Overall Study|Other|1|||
94478906|NCT01585246|323545852|FG002|Overall Study|Other|1|||
94478907|NCT01585246|323545853|FG003|Overall Study|Other|1|||
94478908|NCT01585246|323545854|FG004|Overall Study|Other|0|||
94478909|NCT02227784|323545856|FG000|Double-Blind Phase|Adverse Event|3|||
94478910|NCT02227784|323545857|FG001|Double-Blind Phase|Adverse Event|2|||
94478911|NCT02227784|323545858|FG002|Double-Blind Phase|Adverse Event|1|||
94478912|NCT02227784|323545859|FG003|Double-Blind Phase|Adverse Event|3|||
94478913|NCT02227784|323545860|FG004|Double-Blind Phase|Adverse Event|0|||
94478914|NCT02227784|323545856|FG000|Double-Blind Phase|Physician Decision|1|||
94478915|NCT02227784|323545857|FG001|Double-Blind Phase|Physician Decision|0|||
94478916|NCT02227784|323545858|FG002|Double-Blind Phase|Physician Decision|0|||
94478917|NCT02227784|323545859|FG003|Double-Blind Phase|Physician Decision|1|||
94478918|NCT02227784|323545860|FG004|Double-Blind Phase|Physician Decision|0|||
94478919|NCT02227784|323545856|FG000|Double-Blind Phase|Protocol Violation|0|||
94478920|NCT02227784|323545857|FG001|Double-Blind Phase|Protocol Violation|0|||
94478921|NCT02227784|323545858|FG002|Double-Blind Phase|Protocol Violation|1|||
94478922|NCT02227784|323545859|FG003|Double-Blind Phase|Protocol Violation|1|||
94478923|NCT02227784|323545860|FG004|Double-Blind Phase|Protocol Violation|0|||
94478924|NCT02227784|323545856|FG000|Double-Blind Phase|Sponsor Decision|34|||
94478925|NCT02227784|323545857|FG001|Double-Blind Phase|Sponsor Decision|15|||
94478926|NCT02227784|323545858|FG002|Double-Blind Phase|Sponsor Decision|14|||
94478927|NCT02227784|323545859|FG003|Double-Blind Phase|Sponsor Decision|32|||
94478928|NCT02227784|323545860|FG004|Double-Blind Phase|Sponsor Decision|0|||
94478929|NCT02227784|323545856|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
94478930|NCT02227784|323545857|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
94478931|NCT02227784|323545858|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
94478932|NCT02227784|323545859|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
94478933|NCT02227784|323545860|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
94478934|NCT02227784|323545856|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
94478935|NCT02227784|323545857|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
94478936|NCT02227784|323545858|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
94478937|NCT02227784|323545859|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
94478938|NCT02227784|323545860|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
94478939|NCT02227784|323545856|FG000|Open-Label Extension Phase (OLE)|Death|0|||
94478940|NCT02227784|323545857|FG001|Open-Label Extension Phase (OLE)|Death|0|||
94478941|NCT02227784|323545858|FG002|Open-Label Extension Phase (OLE)|Death|0|||
94478942|NCT02227784|323545859|FG003|Open-Label Extension Phase (OLE)|Death|0|||
94478943|NCT02227784|323545860|FG004|Open-Label Extension Phase (OLE)|Death|1|||
94478944|NCT02227784|323545856|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
94478945|NCT02227784|323545857|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
94478946|NCT02227784|323545858|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
94478947|NCT02227784|323545859|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
94478948|NCT02227784|323545860|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
94478949|NCT02227784|323545856|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
94478950|NCT02227784|323545857|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
94478951|NCT02227784|323545858|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
94478952|NCT02227784|323545859|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
94478953|NCT02227784|323545860|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
94478954|NCT00964028|323545872|FG000|Overall Study|Withdrawal by Subject|0|||
94478955|NCT00964028|323545873|FG001|Overall Study|Withdrawal by Subject|1|||
94478956|NCT00534638|323545876|FG000|Overall Study|Withdrawal by Subject|3|||
94478957|NCT00534638|323545877|FG001|Overall Study|Withdrawal by Subject|4|||
94478958|NCT00534638|323545876|FG000|Overall Study|Migrated/moved from study area|13|||
94478959|NCT00534638|323545877|FG001|Overall Study|Migrated/moved from study area|11|||
94478960|NCT00534638|323545876|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
94478961|NCT00534638|323545877|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
94478962|NCT00534638|323545876|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
94478963|NCT00534638|323545877|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
94478964|NCT00534638|323545876|FG000|Overall Study|Other|1685|||
94478965|NCT00534638|323545877|FG001|Overall Study|Other|902|||
94384955|NCT03227445|323196755|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
94384956|NCT03227445|323196756|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
94384957|NCT03227445|323196757|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
94384958|NCT03227445|323196758|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
94384959|NCT03992196|323196761|FG000|Enrollment|lost to follow-up prior dosing|1|||
94384960|NCT03992196|323196762|FG001|Enrollment|lost to follow-up prior dosing|0|||
94384961|NCT03992196|323196763|FG002|Enrollment|lost to follow-up prior dosing|0|||
94384962|NCT03992196|323196761|FG000|Treatment|Protocol Violation|0|||
94384963|NCT03992196|323196762|FG001|Treatment|Protocol Violation|0|||
94384964|NCT03992196|323196763|FG002|Treatment|Protocol Violation|1|||
94384965|NCT03992196|323196761|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
94384966|NCT03992196|323196762|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
94384967|NCT03992196|323196763|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
94384968|NCT03992196|323196761|FG000|Treatment|Withdrawal due to non-compliance|0|||
94384969|NCT03992196|323196762|FG001|Treatment|Withdrawal due to non-compliance|0|||
94384970|NCT03992196|323196763|FG002|Treatment|Withdrawal due to non-compliance|1|||
94384971|NCT03992196|323196761|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
94384972|NCT03992196|323196762|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
94384973|NCT03992196|323196763|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
94384974|NCT03992196|323196761|FG000|Treatment|Withdrawal by parent/guardian|0|||
94384975|NCT03992196|323196762|FG001|Treatment|Withdrawal by parent/guardian|0|||
94384976|NCT03992196|323196763|FG002|Treatment|Withdrawal by parent/guardian|2|||
94384977|NCT02388763|323196764|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
94384978|NCT02388763|323196765|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
94384979|NCT02388763|323196764|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
94384980|NCT02388763|323196765|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
94384981|NCT02194998|323196770|FG000|On-HCV Treatment|Did not pick up study medication|0|||
94384982|NCT02194998|323196771|FG001|On-HCV Treatment|Did not pick up study medication|1|||
94384983|NCT02194998|323196772|FG002|On-HCV Treatment|Did not pick up study medication|0|||
94384984|NCT02194998|323196773|FG003|On-HCV Treatment|Did not pick up study medication|0|||
94384985|NCT02194998|323196770|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
94384986|NCT02194998|323196771|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
94384987|NCT02194998|323196772|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
94384988|NCT02194998|323196773|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
94384989|NCT01025037|323196776|FG000|Overall Study|Adverse Event|3|||
94384990|NCT01025037|323196776|FG000|Overall Study|Lost to Follow-up|7|||
94384991|NCT01025037|323196776|FG000|Overall Study|Withdrawal by Subject|1|||
94384992|NCT01399736|323196777|FG000|Overall Study|Withdrawal by Subject|4|||
94384993|NCT01399736|323196778|FG001|Overall Study|Withdrawal by Subject|2|||
94384994|NCT01399736|323196777|FG000|Overall Study|Lost to Follow-up|0|||
94384995|NCT01399736|323196778|FG001|Overall Study|Lost to Follow-up|2|||
94384996|NCT00424489|323196779|FG000|Overall Study|Death|3|||
94384997|NCT00449150|323196780|FG000|Overall Study|Adverse Event|11|||
94384998|NCT00449150|323196781|FG001|Overall Study|Adverse Event|18|||
94384999|NCT00449150|323196782|FG002|Overall Study|Adverse Event|9|||
94385000|NCT00449150|323196780|FG000|Overall Study|Lack of Efficacy|1|||
94385001|NCT00449150|323196781|FG001|Overall Study|Lack of Efficacy|2|||
94385002|NCT00449150|323196782|FG002|Overall Study|Lack of Efficacy|2|||
94385003|NCT00449150|323196780|FG000|Overall Study|Other|16|||
94385004|NCT00449150|323196781|FG001|Overall Study|Other|13|||
94385005|NCT00449150|323196782|FG002|Overall Study|Other|14|||
94385006|NCT00449150|323196780|FG000|Overall Study|Withdrawal by Subject|17|||
94385007|NCT00449150|323196781|FG001|Overall Study|Withdrawal by Subject|18|||
94385008|NCT00449150|323196782|FG002|Overall Study|Withdrawal by Subject|21|||
94385009|NCT00449150|323196780|FG000|Overall Study|Protocol Violation|1|||
94385010|NCT00449150|323196781|FG001|Overall Study|Protocol Violation|2|||
94385011|NCT00449150|323196782|FG002|Overall Study|Protocol Violation|1|||
94385012|NCT02636907|323196786|FG000|Autoinjector Assessment Period|Adverse Event|2|||
94385013|NCT02636907|323196786|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
94385014|NCT02636907|323196786|FG000|Extension Phase|Adverse Event|2|||
94385015|NCT02636907|323196786|FG000|Extension Phase|Withdrawal by Subject|4|||
94385016|NCT02636907|323196786|FG000|Extension Phase|Physician Decision|1|||
94385017|NCT02636907|323196786|FG000|Extension Phase|Lost to Follow-up|2|||
94385018|NCT02636907|323196786|FG000|Extension Phase|Lack of Efficacy|1|||
94478966|NCT02106351|323545881|FG000|Treatment Cycle 1|Adverse Event|2|||
94385019|NCT02796664|323196788|FG000|Overall Study|Withdrawal by Subject|0|||
94385020|NCT02796664|323196789|FG001|Overall Study|Withdrawal by Subject|3|||
94385021|NCT02796664|323196788|FG000|Overall Study|Noncompliance|1|||
94478967|NCT02106351|323545882|FG001|Treatment Cycle 1|Adverse Event|0|||
94478968|NCT02106351|323545883|FG002|Treatment Cycle 1|Adverse Event|0|||
94478969|NCT02106351|323545881|FG000|Treatment Cycle 1|Consent withdrawn|1|||
94478970|NCT02106351|323545882|FG001|Treatment Cycle 1|Consent withdrawn|0|||
94478971|NCT02106351|323545883|FG002|Treatment Cycle 1|Consent withdrawn|2|||
94478972|NCT02106351|323545881|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
94478973|NCT02106351|323545882|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
94478974|NCT02106351|323545883|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
94478975|NCT02106351|323545881|FG000|Treatment Cycle 1|Other|0|||
94478976|NCT02106351|323545882|FG001|Treatment Cycle 1|Other|3|||
94478977|NCT02106351|323545883|FG002|Treatment Cycle 1|Other|1|||
94478978|NCT02106351|323545881|FG000|Treatment Cycle 1|Randomised but not treated|1|||
94478979|NCT02106351|323545882|FG001|Treatment Cycle 1|Randomised but not treated|0|||
94478980|NCT02106351|323545883|FG002|Treatment Cycle 1|Randomised but not treated|1|||
94478981|NCT02106351|323545881|FG000|Treatment Cycle 2|Adverse Event|0|||
94478982|NCT02106351|323545882|FG001|Treatment Cycle 2|Adverse Event|2|||
94478983|NCT02106351|323545883|FG002|Treatment Cycle 2|Adverse Event|0|||
94478984|NCT02106351|323545881|FG000|Treatment Cycle 2|Consent withdrawn|0|||
94478985|NCT02106351|323545882|FG001|Treatment Cycle 2|Consent withdrawn|1|||
94478986|NCT02106351|323545883|FG002|Treatment Cycle 2|Consent withdrawn|1|||
94478987|NCT02106351|323545881|FG000|Treatment Cycle 2|Other|0|||
94478988|NCT02106351|323545882|FG001|Treatment Cycle 2|Other|2|||
94478989|NCT02106351|323545883|FG002|Treatment Cycle 2|Other|2|||
94478990|NCT02106351|323545881|FG000|Treatment Cycle 3|Adverse Event|0|||
94478991|NCT02106351|323545882|FG001|Treatment Cycle 3|Adverse Event|1|||
94478992|NCT02106351|323545883|FG002|Treatment Cycle 3|Adverse Event|0|||
94478993|NCT02106351|323545881|FG000|Treatment Cycle 3|Consent withdrawn|0|||
94478994|NCT02106351|323545882|FG001|Treatment Cycle 3|Consent withdrawn|0|||
94478995|NCT02106351|323545883|FG002|Treatment Cycle 3|Consent withdrawn|2|||
94478996|NCT02106351|323545881|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
94478997|NCT02106351|323545882|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
94478998|NCT02106351|323545883|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
94478999|NCT02106351|323545881|FG000|Treatment Cycle 3|Other|0|||
94479000|NCT02106351|323545882|FG001|Treatment Cycle 3|Other|2|||
94479001|NCT02106351|323545883|FG002|Treatment Cycle 3|Other|3|||
94479002|NCT02106351|323545881|FG000|Treatment Cycle 4|Consent withdrawn|0|||
94479003|NCT02106351|323545882|FG001|Treatment Cycle 4|Consent withdrawn|0|||
94479004|NCT02106351|323545883|FG002|Treatment Cycle 4|Consent withdrawn|2|||
94479005|NCT02106351|323545881|FG000|Treatment Cycle 4|Other|0|||
94479006|NCT02106351|323545882|FG001|Treatment Cycle 4|Other|1|||
94479007|NCT02106351|323545883|FG002|Treatment Cycle 4|Other|0|||
94479008|NCT00520039|323545887|FG000|Overall Study|Exclusion criteria met at first visit|7|||
94479009|NCT00520039|323545888|FG001|Overall Study|Exclusion criteria met at first visit|5|||
94479010|NCT02329327|323545889|FG000|Overall Study|Death|78|||
94479011|NCT02329327|323545890|FG001|Overall Study|Death|0|||
94479012|NCT02329327|323545889|FG000|Overall Study|Withdrawal by Subject|3|||
94479013|NCT02329327|323545890|FG001|Overall Study|Withdrawal by Subject|0|||
94479014|NCT02329327|323545889|FG000|Overall Study|Lost to Follow-up|4|||
94479015|NCT02329327|323545890|FG001|Overall Study|Lost to Follow-up|0|||
94479016|NCT03560869|323545891|FG000|Overall Study|Withdrawal by Subject|3|||
94479017|NCT03560869|323545892|FG001|Overall Study|Withdrawal by Subject|4|||
94479018|NCT03560869|323545891|FG000|Overall Study|Screening failure|4|||
94479019|NCT03560869|323545892|FG001|Overall Study|Screening failure|4|||
94479020|NCT03560869|323545891|FG000|Overall Study|Withdrawal by PI|0|||
94479021|NCT03560869|323545892|FG001|Overall Study|Withdrawal by PI|1|||
94479022|NCT01801111|323545893|FG000|Overall Study|Adverse Event|12|||
94479023|NCT01801111|323545893|FG000|Overall Study|Death|8|||
94479024|NCT01801111|323545893|FG000|Overall Study|Physician Decision|5|||
94479025|NCT01801111|323545893|FG000|Overall Study|Other|1|||
94479026|NCT01801111|323545893|FG000|Overall Study|Withdrawal by Subject|4|||
94479027|NCT01801111|323545893|FG000|Overall Study|Study Terminated by Sponsor|27|||
94479028|NCT01801111|323545893|FG000|Overall Study|Progressive Disease|81|||
94479029|NCT01210482|323545894|FG000|Overall Study|Protocol Violation|1|||
94479030|NCT01210482|323545894|FG000|Overall Study|Case Report Forms were not collected|18|||
94479031|NCT01210482|323545894|FG000|Overall Study|Duplicated|2|||
94479032|NCT01210482|323545894|FG000|Overall Study|No Drug Administration|28|||
94479033|NCT02058589|323545896|FG000|Overall Study|Serious Adverse Event|1|||
94315861|NCT02819310|322939986|FG000|Overall Study|Lost to Follow-up|16|||
94315862|NCT02819310|322939986|FG000|Overall Study|Adverse Event|13|||
94479034|NCT02058589|323545897|FG001|Overall Study|Serious Adverse Event|1|||
94479035|NCT02058589|323545896|FG000|Overall Study|Non-Serious Adverse Event|1|||
94479036|NCT02058589|323545897|FG001|Overall Study|Non-Serious Adverse Event|0|||
94479037|NCT02058589|323545896|FG000|Overall Study|Withdrawal by Subject|0|||
94479038|NCT02058589|323545897|FG001|Overall Study|Withdrawal by Subject|1|||
94479039|NCT00490971|323545906|FG000|Acute/Continuation|Adverse Event|62|||
94479040|NCT00490971|323545907|FG001|Acute/Continuation|Adverse Event|13|||
94479041|NCT00490971|323545908|FG002|Acute/Continuation|Adverse Event|0|||
94479042|NCT00490971|323545909|FG003|Acute/Continuation|Adverse Event|0|||
94479043|NCT00490971|323545910|FG004|Acute/Continuation|Adverse Event|0|||
94479044|NCT00490971|323545906|FG000|Acute/Continuation|Death|2|||
94479045|NCT00490971|323545907|FG001|Acute/Continuation|Death|0|||
94479046|NCT00490971|323545908|FG002|Acute/Continuation|Death|0|||
94479047|NCT00490971|323545909|FG003|Acute/Continuation|Death|0|||
94479048|NCT00490971|323545910|FG004|Acute/Continuation|Death|0|||
94479049|NCT00490971|323545906|FG000|Acute/Continuation|Lack of Efficacy|106|||
94479050|NCT00490971|323545907|FG001|Acute/Continuation|Lack of Efficacy|12|||
94479051|NCT00490971|323545908|FG002|Acute/Continuation|Lack of Efficacy|0|||
94479052|NCT00490971|323545909|FG003|Acute/Continuation|Lack of Efficacy|0|||
94479053|NCT00490971|323545910|FG004|Acute/Continuation|Lack of Efficacy|0|||
94479054|NCT00490971|323545906|FG000|Acute/Continuation|Lost to Follow-up|23|||
94479055|NCT00490971|323545907|FG001|Acute/Continuation|Lost to Follow-up|7|||
94479056|NCT00490971|323545908|FG002|Acute/Continuation|Lost to Follow-up|0|||
94479057|NCT00490971|323545909|FG003|Acute/Continuation|Lost to Follow-up|0|||
94479058|NCT00490971|323545910|FG004|Acute/Continuation|Lost to Follow-up|0|||
94479059|NCT00490971|323545906|FG000|Acute/Continuation|Protocol Violation|10|||
94479060|NCT00490971|323545907|FG001|Acute/Continuation|Protocol Violation|2|||
94479061|NCT00490971|323545908|FG002|Acute/Continuation|Protocol Violation|0|||
94479062|NCT00490971|323545909|FG003|Acute/Continuation|Protocol Violation|0|||
94479063|NCT00490971|323545910|FG004|Acute/Continuation|Protocol Violation|0|||
94479064|NCT00490971|323545906|FG000|Acute/Continuation|Withdrawal by Subject|92|||
94479065|NCT00490971|323545907|FG001|Acute/Continuation|Withdrawal by Subject|24|||
94479066|NCT00490971|323545908|FG002|Acute/Continuation|Withdrawal by Subject|0|||
94479067|NCT00490971|323545909|FG003|Acute/Continuation|Withdrawal by Subject|0|||
94479068|NCT00490971|323545910|FG004|Acute/Continuation|Withdrawal by Subject|0|||
94479069|NCT00490971|323545906|FG000|Acute/Continuation|Other|11|||
94479070|NCT00490971|323545907|FG001|Acute/Continuation|Other|4|||
94479071|NCT00490971|323545908|FG002|Acute/Continuation|Other|0|||
94479072|NCT00490971|323545909|FG003|Acute/Continuation|Other|0|||
94479073|NCT00490971|323545910|FG004|Acute/Continuation|Other|0|||
94479074|NCT00490971|323545906|FG000|Maintenance|Adverse Event|0|||
94479075|NCT00490971|323545907|FG001|Maintenance|Adverse Event|0|||
94479076|NCT00490971|323545908|FG002|Maintenance|Adverse Event|4|||
94479077|NCT00490971|323545909|FG003|Maintenance|Adverse Event|5|||
94479078|NCT00490971|323545910|FG004|Maintenance|Adverse Event|7|||
94479079|NCT00490971|323545906|FG000|Maintenance|Death|0|||
94479080|NCT00490971|323545907|FG001|Maintenance|Death|0|||
94479081|NCT00490971|323545908|FG002|Maintenance|Death|0|||
94479082|NCT00490971|323545909|FG003|Maintenance|Death|2|||
94479083|NCT00490971|323545910|FG004|Maintenance|Death|0|||
94479084|NCT00490971|323545906|FG000|Maintenance|Lost to Follow-up|0|||
94479085|NCT00490971|323545907|FG001|Maintenance|Lost to Follow-up|0|||
94479086|NCT00490971|323545908|FG002|Maintenance|Lost to Follow-up|5|||
94479087|NCT00490971|323545909|FG003|Maintenance|Lost to Follow-up|8|||
94479088|NCT00490971|323545910|FG004|Maintenance|Lost to Follow-up|10|||
94479089|NCT00490971|323545906|FG000|Maintenance|Pregnancy|0|||
94479090|NCT00490971|323545907|FG001|Maintenance|Pregnancy|0|||
94479091|NCT00490971|323545908|FG002|Maintenance|Pregnancy|1|||
94479092|NCT00490971|323545909|FG003|Maintenance|Pregnancy|0|||
94479093|NCT00490971|323545910|FG004|Maintenance|Pregnancy|0|||
94479094|NCT00490971|323545906|FG000|Maintenance|Protocol Violation|0|||
94479095|NCT00490971|323545907|FG001|Maintenance|Protocol Violation|0|||
94479096|NCT00490971|323545908|FG002|Maintenance|Protocol Violation|4|||
94479097|NCT00490971|323545909|FG003|Maintenance|Protocol Violation|1|||
94479098|NCT00490971|323545910|FG004|Maintenance|Protocol Violation|1|||
94479099|NCT00490971|323545906|FG000|Maintenance|Withdrawal by Subject|0|||
94479100|NCT00490971|323545907|FG001|Maintenance|Withdrawal by Subject|0|||
94479101|NCT00490971|323545908|FG002|Maintenance|Withdrawal by Subject|26|||
94479102|NCT00490971|323545909|FG003|Maintenance|Withdrawal by Subject|28|||
94479103|NCT00490971|323545910|FG004|Maintenance|Withdrawal by Subject|18|||
94479104|NCT00490971|323545906|FG000|Maintenance|Other|0|||
94479105|NCT00490971|323545907|FG001|Maintenance|Other|0|||
94479106|NCT00490971|323545908|FG002|Maintenance|Other|11|||
94479107|NCT00490971|323545909|FG003|Maintenance|Other|9|||
94479108|NCT00490971|323545910|FG004|Maintenance|Other|3|||
94479109|NCT03677869|323545911|FG000|Overall Study|Withdrawal by Subject|1|||
94479110|NCT01844817|323548090|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
94315863|NCT02819310|322939986|FG000|Overall Study|Lack of Efficacy|5|||
94315864|NCT02819310|322939986|FG000|Overall Study|Physician Decision|8|||
94479111|NCT01844817|323548091|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
94479112|NCT01844817|323548090|FG000|Treatment|Progressive Disease|27|||
94479113|NCT01844817|323548091|FG001|Treatment|Progressive Disease|36|||
94315865|NCT02819310|322939986|FG000|Overall Study|Protocol Violation|30|||
94479114|NCT01844817|323548090|FG000|Treatment|Adverse Event|17|||
94479115|NCT01844817|323548091|FG001|Treatment|Adverse Event|9|||
94479116|NCT01844817|323548090|FG000|Treatment|Withdrawal by Subject|10|||
94479117|NCT01844817|323548091|FG001|Treatment|Withdrawal by Subject|6|||
94479118|NCT01844817|323548090|FG000|Treatment|Death|10|||
94479119|NCT01844817|323548091|FG001|Treatment|Death|8|||
94479120|NCT01844817|323548090|FG000|Treatment|Lost to Follow-up|0|||
94479121|NCT01844817|323548091|FG001|Treatment|Lost to Follow-up|1|||
94479122|NCT01844817|323548090|FG000|Treatment|Other|0|||
94479123|NCT01844817|323548091|FG001|Treatment|Other|3|||
94479124|NCT01223404|323548096|FG000|First Intervention (1 Day)|Adverse Event|0|||
94479125|NCT01223404|323548097|FG001|First Intervention (1 Day)|Adverse Event|0|||
94479126|NCT01223404|323548098|FG002|First Intervention (1 Day)|Adverse Event|0|||
94479127|NCT01223404|323548099|FG003|First Intervention (1 Day)|Adverse Event|1|||
94479128|NCT01223404|323548100|FG004|First Intervention (1 Day)|Adverse Event|0|||
94479129|NCT01223404|323548101|FG005|First Intervention (1 Day)|Adverse Event|0|||
94479130|NCT01223404|323548096|FG000|Second Intervention (1 Day)|Adverse Event|1|||
94479131|NCT01223404|323548097|FG001|Second Intervention (1 Day)|Adverse Event|0|||
94479132|NCT01223404|323548098|FG002|Second Intervention (1 Day)|Adverse Event|0|||
94479133|NCT01223404|323548099|FG003|Second Intervention (1 Day)|Adverse Event|0|||
94479134|NCT01223404|323548100|FG004|Second Intervention (1 Day)|Adverse Event|0|||
94479135|NCT01223404|323548101|FG005|Second Intervention (1 Day)|Adverse Event|0|||
94479136|NCT01223404|323548096|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
94479137|NCT01223404|323548097|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
94479138|NCT01223404|323548098|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
94479139|NCT01223404|323548099|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
94479140|NCT01223404|323548100|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
94479141|NCT01223404|323548101|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
94479142|NCT00707057|323548102|FG000|Overall Study|Withdrawal by Subject|8|||
94479143|NCT00707057|323548103|FG001|Overall Study|Withdrawal by Subject|3|||
94315866|NCT03488472|322939987|FG000|Overall Study|disease progression additional mets|1|||
94315867|NCT01793051|322939992|FG000|Overall Study|Withdrawal by Subject|6|||
94315868|NCT01793051|322939993|FG001|Overall Study|Withdrawal by Subject|4|||
94315869|NCT01793051|322939992|FG000|Overall Study|Adverse Event|0|||
94315870|NCT01793051|322939993|FG001|Overall Study|Adverse Event|2|||
94315871|NCT01793051|322939992|FG000|Overall Study|Too ill to continue|1|||
94315872|NCT01793051|322939993|FG001|Overall Study|Too ill to continue|0|||
94315873|NCT01793051|322939992|FG000|Overall Study|Switched chemo|1|||
94315874|NCT01793051|322939993|FG001|Overall Study|Switched chemo|1|||
94315875|NCT01793051|322939992|FG000|Overall Study|Lack of compliance|1|||
94315876|NCT01793051|322939993|FG001|Overall Study|Lack of compliance|0|||
94315877|NCT01793051|322939992|FG000|Overall Study|Requested to be removed from the study|1|||
94315878|NCT01793051|322939993|FG001|Overall Study|Requested to be removed from the study|1|||
94315879|NCT04467164|322939996|FG000|Washout (1 Week)|Lost to Follow-up|2|||
94315880|NCT04467164|322939997|FG001|Washout (1 Week)|Lost to Follow-up|0|||
94315881|NCT03276936|322939998|FG000|Overall Study|Adverse Event|4|||
94315882|NCT03276936|322939999|FG001|Overall Study|Adverse Event|2|||
94315883|NCT03276936|322939998|FG000|Overall Study|Lost to Follow-up|16|||
94315884|NCT03276936|322939999|FG001|Overall Study|Lost to Follow-up|13|||
94315885|NCT03276936|322939998|FG000|Overall Study|Withdrawal by Subject|30|||
94315886|NCT03276936|322939999|FG001|Overall Study|Withdrawal by Subject|20|||
94315887|NCT03276936|322939998|FG000|Overall Study|Not mentioned|6|||
94315888|NCT03276936|322939999|FG001|Overall Study|Not mentioned|3|||
94315889|NCT03041116|322940000|FG000|Double-blind|Death|0|||
94315890|NCT03041116|322940001|FG001|Double-blind|Death|2|||
94315891|NCT03041116|322940000|FG000|Double-blind|Withdrawal by Subject|0|||
94315892|NCT03041116|322940001|FG001|Double-blind|Withdrawal by Subject|4|||
94315893|NCT03041116|322940000|FG000|Open-label|Death|1|||
94315894|NCT03041116|322940001|FG001|Open-label|Death|0|||
94315895|NCT03041116|322940000|FG000|Open-label|Termination of the study by Sponsor|39|||
94479144|NCT00707057|323548102|FG000|Overall Study|Dosed incorrectly|0|||
94479145|NCT00707057|323548103|FG001|Overall Study|Dosed incorrectly|1|||
94479146|NCT01697800|323548104|FG000|Overall Study|Death|0|||
94479147|NCT01697800|323548105|FG001|Overall Study|Death|1|||
94479148|NCT01302418|323548106|FG000|Overall Study|Protocol Violation|9|||
94479149|NCT01302418|323548106|FG000|Overall Study|Non-evaluable|9|||
94479150|NCT00954122|323548107|FG000|Overall Study|Withdrawal by Subject|5|||
94479151|NCT00954122|323548107|FG000|Overall Study|Adverse Event|1|||
94479152|NCT00954122|323548107|FG000|Overall Study|Safety Reason|1|||
94479153|NCT01000974|323548110|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
94479154|NCT01000974|323548111|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
94479155|NCT01000974|323548112|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
94479156|NCT01000974|323548110|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
94479157|NCT01000974|323548111|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
94479158|NCT01000974|323548112|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
94479159|NCT01000974|323548110|FG000|Primary Vaccination Phase|Protocol Violation|40|||
94479160|NCT01000974|323548111|FG001|Primary Vaccination Phase|Protocol Violation|3|||
94479161|NCT01000974|323548112|FG002|Primary Vaccination Phase|Protocol Violation|2|||
94479162|NCT01000974|323548110|FG000|Primary Vaccination Phase|Adverse Event|14|||
94479163|NCT01000974|323548111|FG001|Primary Vaccination Phase|Adverse Event|2|||
94479164|NCT01000974|323548112|FG002|Primary Vaccination Phase|Adverse Event|2|||
94479165|NCT01000974|323548110|FG000|Primary Vaccination Phase|Other|4|||
94479166|NCT01000974|323548111|FG001|Primary Vaccination Phase|Other|9|||
94315896|NCT03041116|322940001|FG001|Open-label|Termination of the study by Sponsor|37|||
94315897|NCT03041116|322940000|FG000|Open-label|Withdrawal by Subject|1|||
94315898|NCT03041116|322940001|FG001|Open-label|Withdrawal by Subject|0|||
94479167|NCT01000974|323548112|FG002|Primary Vaccination Phase|Other|12|||
94385022|NCT02796664|323196789|FG001|Overall Study|Noncompliance|1|||
94385023|NCT02796664|323196788|FG000|Overall Study|Death|0|||
94385024|NCT02796664|323196789|FG001|Overall Study|Death|1|||
94385025|NCT03247556|323196790|FG000|Overall Study|Adverse Event|1|||
94385026|NCT03247556|323196791|FG001|Overall Study|Adverse Event|4|||
94385027|NCT03247556|323196792|FG002|Overall Study|Adverse Event|5|||
94385028|NCT03247556|323196790|FG000|Overall Study|Lost to Follow-up|5|||
94385029|NCT03247556|323196791|FG001|Overall Study|Lost to Follow-up|5|||
94385030|NCT03247556|323196792|FG002|Overall Study|Lost to Follow-up|4|||
94385031|NCT03247556|323196790|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
94385032|NCT03247556|323196791|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
94385033|NCT03247556|323196792|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
94385034|NCT03247556|323196790|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
94385035|NCT03247556|323196791|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
94385036|NCT03247556|323196792|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
94385037|NCT03247556|323196790|FG000|Overall Study|Protocol Violation|2|||
94385038|NCT03247556|323196791|FG001|Overall Study|Protocol Violation|0|||
94385039|NCT03247556|323196792|FG002|Overall Study|Protocol Violation|1|||
94385040|NCT03247556|323196790|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
94385041|NCT03247556|323196791|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
94385042|NCT03247556|323196792|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
94385043|NCT02246478|323196793|FG000|Multiple-dose Phase|Protocol Violation|1|||
94385044|NCT02246478|323196794|FG001|Multiple-dose Phase|Protocol Violation|0|||
94385045|NCT02246478|323196795|FG002|Multiple-dose Phase|Protocol Violation|0|||
94385046|NCT02246478|323196796|FG003|Multiple-dose Phase|Protocol Violation|1|||
94385047|NCT00860405|323196799|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
94385048|NCT00860405|323196800|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
94385049|NCT01074554|323196805|FG000|Overall Study|Adverse Event|3|||
94385050|NCT01074554|323196806|FG001|Overall Study|Adverse Event|3|||
94385051|NCT01074554|323196805|FG000|Overall Study|Lost to Follow-up|0|||
94385052|NCT01074554|323196806|FG001|Overall Study|Lost to Follow-up|1|||
94385053|NCT00497796|323196807|FG000|Overall Study|Adverse event (not related)|9|||
94385054|NCT00497796|323196808|FG001|Overall Study|Adverse event (not related)|9|||
94385055|NCT00497796|323196807|FG000|Overall Study|Adverse event (related)|5|||
94385056|NCT00497796|323196808|FG001|Overall Study|Adverse event (related)|4|||
94385057|NCT00497796|323196807|FG000|Overall Study|CMV infection or disease treatment|30|||
94385058|NCT00497796|323196808|FG001|Overall Study|CMV infection or disease treatment|4|||
94385059|NCT00497796|323196807|FG000|Overall Study|Consent withdrawn|10|||
94385060|NCT00497796|323196808|FG001|Overall Study|Consent withdrawn|3|||
94385061|NCT00497796|323196807|FG000|Overall Study|Investigator/sponsor discretion|31|||
94385062|NCT00497796|323196808|FG001|Overall Study|Investigator/sponsor discretion|34|||
94385063|NCT00497796|323196807|FG000|Overall Study|Lost to Follow-up|0|||
94385064|NCT00497796|323196808|FG001|Overall Study|Lost to Follow-up|1|||
94385065|NCT00497796|323196807|FG000|Overall Study|Not applicable (randomized not treated)|0|||
94385066|NCT00497796|323196808|FG001|Overall Study|Not applicable (randomized not treated)|4|||
94385067|NCT02899338|323196817|FG000|Overall Study|Adverse Event|1|||
94385068|NCT02899338|323196818|FG001|Overall Study|Adverse Event|2|||
94385069|NCT02899338|323196817|FG000|Overall Study|Withdrawal by Subject|2|||
94385070|NCT02899338|323196818|FG001|Overall Study|Withdrawal by Subject|0|||
94385071|NCT01457053|323196819|FG000|Overall Study|Unable to undergo selected treatment|1|||
94385072|NCT01457053|323196820|FG001|Overall Study|Unable to undergo selected treatment|1|||
94385073|NCT02780687|323196821|FG000|Overall Study|Adverse Event|1|||
94385074|NCT02780687|323196822|FG001|Overall Study|Adverse Event|1|||
94385075|NCT02780687|323196821|FG000|Overall Study|Withdrawal by Subject|2|||
94385076|NCT02780687|323196822|FG001|Overall Study|Withdrawal by Subject|1|||
94385077|NCT02780687|323196821|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
94385078|NCT02780687|323196822|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
94385079|NCT02780687|323196821|FG000|Overall Study|progressive disease|29|||
94385080|NCT02780687|323196822|FG001|Overall Study|progressive disease|6|||
94385081|NCT02353169|323196823|FG000|Overall Study|QTc > 450 msec|1|||
94385082|NCT02353169|323196824|FG001|Overall Study|QTc > 450 msec|1|||
94385083|NCT02353169|323196825|FG002|Overall Study|QTc > 450 msec|1|||
94385084|NCT02353169|323196826|FG003|Overall Study|QTc > 450 msec|1|||
94385085|NCT02353169|323196823|FG000|Overall Study|OR team declined|2|||
94385086|NCT02353169|323196824|FG001|Overall Study|OR team declined|0|||
94385087|NCT02353169|323196825|FG002|Overall Study|OR team declined|0|||
94385088|NCT02353169|323196826|FG003|Overall Study|OR team declined|0|||
94385089|NCT02353169|323196823|FG000|Overall Study|Inhalational induction|0|||
94385090|NCT02353169|323196824|FG001|Overall Study|Inhalational induction|2|||
94385091|NCT02353169|323196825|FG002|Overall Study|Inhalational induction|0|||
94385092|NCT02353169|323196826|FG003|Overall Study|Inhalational induction|0|||
94385093|NCT02353169|323196823|FG000|Overall Study|ECG data error|0|||
94385094|NCT02353169|323196824|FG001|Overall Study|ECG data error|3|||
94385095|NCT02353169|323196825|FG002|Overall Study|ECG data error|2|||
94385096|NCT02353169|323196826|FG003|Overall Study|ECG data error|2|||
94385097|NCT02353169|323196823|FG000|Overall Study|Pre-op medication|0|||
94479168|NCT01000974|323548110|FG000|Booster Vaccination Phase|Protocol Violation|0|||
94479169|NCT01000974|323548111|FG001|Booster Vaccination Phase|Protocol Violation|0|||
94479170|NCT01000974|323548112|FG002|Booster Vaccination Phase|Protocol Violation|2|||
94479171|NCT01000974|323548110|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
94479172|NCT01000974|323548111|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
94479173|NCT01000974|323548112|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
94479174|NCT01000974|323548110|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
94479175|NCT01000974|323548111|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
94479176|NCT01000974|323548112|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
94479177|NCT01000974|323548110|FG000|Booster Vaccination Phase|Other|24|||
94479178|NCT01000974|323548111|FG001|Booster Vaccination Phase|Other|6|||
94479179|NCT01000974|323548112|FG002|Booster Vaccination Phase|Other|4|||
94479180|NCT02019550|323548114|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
94479181|NCT02019550|323548115|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
94479182|NCT01307891|323548116|FG000|Overall Study|Progressive Disease|3|||
94479183|NCT01307891|323548117|FG001|Overall Study|Progressive Disease|1|||
94479184|NCT03365934|323548119|FG000|Overall Study|Adverse Event|1|||
94479185|NCT03365934|323548119|FG000|Overall Study|Withdrawal by Subject|1|||
94479186|NCT04771013|323548129|FG000|Overall Study|Withdrawal by Subject|2|||
94479187|NCT04771013|323548130|FG001|Overall Study|Withdrawal by Subject|0|||
94479188|NCT04771013|323548129|FG000|Overall Study|Death|0|||
94479189|NCT04771013|323548130|FG001|Overall Study|Death|5|||
94479190|NCT04771013|323548129|FG000|Overall Study|Referred to another hospital before day 20|0|||
94315899|NCT00833248|322940002|FG000|Overall Study|Adverse Event|3|||
94315900|NCT00833248|322940003|FG001|Overall Study|Adverse Event|0|||
94315901|NCT00833248|322940002|FG000|Overall Study|Protocol Violation|1|||
94315902|NCT00833248|322940003|FG001|Overall Study|Protocol Violation|2|||
94315903|NCT00833248|322940002|FG000|Overall Study|Withdrawal by Subject|0|||
94315904|NCT00833248|322940003|FG001|Overall Study|Withdrawal by Subject|1|||
94315905|NCT02436577|322940004|FG000|Overall Study|Protocol Deviation|0|||
94315906|NCT02436577|322940005|FG001|Overall Study|Protocol Deviation|1|||
94315907|NCT02436577|322940006|FG002|Overall Study|Protocol Deviation|0|||
94315908|NCT02436577|322940007|FG003|Overall Study|Protocol Deviation|0|||
94315909|NCT02436577|322940008|FG004|Overall Study|Protocol Deviation|0|||
94315910|NCT02436577|322940009|FG005|Overall Study|Protocol Deviation|0|||
94315911|NCT00372190|322940010|FG000|Overall Study|Lost to Follow-up|3|||
94315912|NCT00372190|322940011|FG001|Overall Study|Lost to Follow-up|1|||
94315913|NCT05058664|322940014|FG000|Overall Study|No follow-up data provided|4|||
94315914|NCT05058664|322940015|FG001|Overall Study|No follow-up data provided|0|||
94315915|NCT05058664|322940016|FG002|Overall Study|No follow-up data provided|2|||
94315916|NCT05058664|322940014|FG000|Overall Study|Withdrawal by Subject|0|||
94315917|NCT05058664|322940015|FG001|Overall Study|Withdrawal by Subject|0|||
94315918|NCT05058664|322940016|FG002|Overall Study|Withdrawal by Subject|1|||
94315919|NCT03484923|322940017|FG000|Overall Study|Adverse Event|3|||
94315920|NCT03484923|322940018|FG001|Overall Study|Adverse Event|3|||
94315921|NCT03484923|322940019|FG002|Overall Study|Adverse Event|5|||
94315922|NCT03484923|322940020|FG003|Overall Study|Adverse Event|11|||
94315923|NCT03484923|322940021|FG004|Overall Study|Adverse Event|1|||
94315924|NCT03484923|322940017|FG000|Overall Study|Death|2|||
94315925|NCT03484923|322940018|FG001|Overall Study|Death|2|||
94315926|NCT03484923|322940019|FG002|Overall Study|Death|3|||
94315927|NCT03484923|322940020|FG003|Overall Study|Death|0|||
94315928|NCT03484923|322940021|FG004|Overall Study|Death|1|||
94315929|NCT03484923|322940017|FG000|Overall Study|Physician Decision|6|||
94315930|NCT03484923|322940018|FG001|Overall Study|Physician Decision|7|||
94315931|NCT03484923|322940019|FG002|Overall Study|Physician Decision|6|||
94315932|NCT03484923|322940020|FG003|Overall Study|Physician Decision|3|||
94315933|NCT03484923|322940021|FG004|Overall Study|Physician Decision|2|||
94315934|NCT03484923|322940017|FG000|Overall Study|Progressive disease|33|||
94315935|NCT03484923|322940018|FG001|Overall Study|Progressive disease|28|||
94315936|NCT03484923|322940019|FG002|Overall Study|Progressive disease|26|||
94315937|NCT03484923|322940020|FG003|Overall Study|Progressive disease|30|||
94479191|NCT04771013|323548130|FG001|Overall Study|Referred to another hospital before day 20|1|||
94479192|NCT01255904|323548132|FG000|Overall Study|Physician Decision|1|||
94479193|NCT01255904|323548133|FG001|Overall Study|Physician Decision|4|||
94479194|NCT01705080|323548138|FG000|Overall Study|Missed visit|10|||
94479195|NCT01705080|323548139|FG001|Overall Study|Missed visit|4|||
94315938|NCT03484923|322940021|FG004|Overall Study|Progressive disease|16|||
94315939|NCT03484923|322940017|FG000|Overall Study|Subject Decision|1|||
94315940|NCT03484923|322940018|FG001|Overall Study|Subject Decision|3|||
94315941|NCT03484923|322940019|FG002|Overall Study|Subject Decision|3|||
94315942|NCT03484923|322940020|FG003|Overall Study|Subject Decision|0|||
94315943|NCT03484923|322940021|FG004|Overall Study|Subject Decision|1|||
94315944|NCT05131451|322940024|FG000|Overall Study|Protocol Violation|1|||
94479196|NCT01705080|323548140|FG002|Overall Study|Missed visit|1|||
94315945|NCT05131451|322940025|FG001|Overall Study|Protocol Violation|0|||
94315946|NCT00972244|322940026|FG000|Overall Study|Incorrect Enrolment|1|||
94315947|NCT00972244|322940027|FG001|Overall Study|Incorrect Enrolment|0|||
94479197|NCT01705080|323548138|FG000|Overall Study|Death|4|||
94479198|NCT01705080|323548139|FG001|Overall Study|Death|4|||
94479199|NCT01705080|323548140|FG002|Overall Study|Death|6|||
94479200|NCT01705080|323548138|FG000|Overall Study|Withdrawal by Subject|61|||
94479201|NCT01705080|323548139|FG001|Overall Study|Withdrawal by Subject|44|||
94479202|NCT01705080|323548140|FG002|Overall Study|Withdrawal by Subject|9|||
94479203|NCT02915159|323548142|FG000|Overall Study|Participant no longer meets criteria|2|||
94479204|NCT02915159|323548143|FG001|Overall Study|Participant no longer meets criteria|0|||
94479205|NCT02915159|323548142|FG000|Overall Study|poor/non-compliance|1|||
94479206|NCT02915159|323548143|FG001|Overall Study|poor/non-compliance|0|||
94479207|NCT02915159|323548142|FG000|Overall Study|Participant withdrew consent|5|||
94479208|NCT02915159|323548143|FG001|Overall Study|Participant withdrew consent|1|||
94479209|NCT02915159|323548142|FG000|Overall Study|Request to discontinue treatment|1|||
94479210|NCT02915159|323548143|FG001|Overall Study|Request to discontinue treatment|2|||
94479211|NCT02915159|323548142|FG000|Overall Study|Adverse Event|2|||
94479212|NCT02915159|323548143|FG001|Overall Study|Adverse Event|2|||
94479213|NCT02915159|323548142|FG000|Overall Study|Lack of Efficacy|0|||
94479214|NCT02915159|323548143|FG001|Overall Study|Lack of Efficacy|3|||
94479215|NCT03872843|323548144|FG000|Overall Study|Lost to Follow-up|5|||
94479216|NCT03872843|323548145|FG001|Overall Study|Lost to Follow-up|7|||
94479217|NCT03373760|323548146|FG000|Overall Study|Adverse Event|8|||
94479218|NCT03373760|323548146|FG000|Overall Study|Disease Progression|46|||
94479219|NCT03373760|323548146|FG000|Overall Study|Death|4|||
94479220|NCT00357877|323548147|FG000|Overall Study|Death|2|||
94479221|NCT00357877|323548148|FG001|Overall Study|Death|1|||
94479222|NCT00357877|323548147|FG000|Overall Study|Lost to Follow-up|20|||
94479223|NCT00357877|323548148|FG001|Overall Study|Lost to Follow-up|23|||
94479224|NCT00357877|323548147|FG000|Overall Study|Withdrawal by Subject|3|||
94479225|NCT00357877|323548148|FG001|Overall Study|Withdrawal by Subject|3|||
94479226|NCT00357877|323548147|FG000|Overall Study|Administrative withdrawal|1|||
94479227|NCT00357877|323548148|FG001|Overall Study|Administrative withdrawal|1|||
94479228|NCT00357877|323548147|FG000|Overall Study|Other|0|||
94479229|NCT00357877|323548148|FG001|Overall Study|Other|2|||
94479230|NCT01968811|323548149|FG000|Overall Study|Protocol Violation|4|||
94479231|NCT01968811|323548149|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
94479232|NCT01254656|323548150|FG000|Overall Study|Discontinued due to termination of study|40|||
94479233|NCT01254656|323548151|FG001|Overall Study|Discontinued due to termination of study|39|||
94479234|NCT01254656|323548152|FG002|Overall Study|Discontinued due to termination of study|13|||
94479235|NCT01254656|323548150|FG000|Overall Study|Lack of Efficacy|3|||
94479236|NCT01254656|323548151|FG001|Overall Study|Lack of Efficacy|0|||
94479237|NCT01254656|323548152|FG002|Overall Study|Lack of Efficacy|0|||
94479238|NCT01254656|323548150|FG000|Overall Study|Lost to Follow-up|1|||
94479239|NCT01254656|323548151|FG001|Overall Study|Lost to Follow-up|0|||
94479240|NCT01254656|323548152|FG002|Overall Study|Lost to Follow-up|2|||
94479241|NCT01254656|323548150|FG000|Overall Study|Withdrawal by Subject|2|||
94479242|NCT01254656|323548151|FG001|Overall Study|Withdrawal by Subject|2|||
94479243|NCT01254656|323548152|FG002|Overall Study|Withdrawal by Subject|1|||
94479244|NCT01254656|323548150|FG000|Overall Study|Pregnancy|0|||
94479245|NCT01254656|323548151|FG001|Overall Study|Pregnancy|0|||
94479246|NCT01254656|323548152|FG002|Overall Study|Pregnancy|2|||
94479247|NCT01254656|323548150|FG000|Overall Study|Adverse Event|1|||
94479248|NCT01254656|323548151|FG001|Overall Study|Adverse Event|1|||
94479249|NCT01254656|323548152|FG002|Overall Study|Adverse Event|0|||
94479250|NCT01254656|323548150|FG000|Overall Study|Death|0|||
94479251|NCT01254656|323548151|FG001|Overall Study|Death|1|||
94479252|NCT01254656|323548152|FG002|Overall Study|Death|0|||
94479253|NCT00715299|323548153|FG000|Overall Study|Withdrawal by Subject|1|||
94479254|NCT00715299|323548153|FG000|Overall Study|Adverse Event|3|||
94479255|NCT00715299|323548153|FG000|Overall Study|failed the pre-screen exercise test|2|||
94479256|NCT01059773|323548159|FG000|Overall Study|Adverse Event|2|||
94479257|NCT01059773|323548160|FG001|Overall Study|Adverse Event|2|||
94479258|NCT01059773|323548159|FG000|Overall Study|Withdrawal by Subject|1|||
94479259|NCT01059773|323548160|FG001|Overall Study|Withdrawal by Subject|5|||
94479260|NCT01059773|323548159|FG000|Overall Study|Lost to Follow-up|1|||
94479261|NCT01059773|323548160|FG001|Overall Study|Lost to Follow-up|1|||
94479262|NCT01059773|323548159|FG000|Overall Study|Pregnancy|1|||
94479263|NCT01059773|323548160|FG001|Overall Study|Pregnancy|1|||
94479264|NCT01059773|323548159|FG000|Overall Study|Protocol Violation|6|||
94479265|NCT01059773|323548160|FG001|Overall Study|Protocol Violation|2|||
94479266|NCT01059773|323548159|FG000|Overall Study|Physician Decision|5|||
94479267|NCT01059773|323548160|FG001|Overall Study|Physician Decision|4|||
94479268|NCT01059773|323548159|FG000|Overall Study|Lack of Efficacy|3|||
94479269|NCT01059773|323548160|FG001|Overall Study|Lack of Efficacy|3|||
94479270|NCT01059773|323548159|FG000|Overall Study|Death|0|||
94479271|NCT01059773|323548160|FG001|Overall Study|Death|1|||
94479272|NCT01059773|323548159|FG000|Overall Study|Malignancy including squamous cell skin|0|||
94479273|NCT01059773|323548160|FG001|Overall Study|Malignancy including squamous cell skin|1|||
94479274|NCT01059773|323548159|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
94479275|NCT01059773|323548160|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
94479276|NCT01059773|323548159|FG000|Overall Study|Other|1|||
94479277|NCT01059773|323548160|FG001|Overall Study|Other|3|||
94479278|NCT00735943|323548162|FG000|Overall Study|Lost to Follow-up|1|||
94479279|NCT00735943|323548162|FG000|Overall Study|Adverse Event|1|||
94479280|NCT00872521|323548163|FG000|Completed PAD Induction|Patient choice|0|||
94479281|NCT00872521|323548164|FG001|Completed PAD Induction|Patient choice|1|||
94315948|NCT00972244|322940028|FG002|Overall Study|Incorrect Enrolment|0|||
94315949|NCT00972244|322940029|FG003|Overall Study|Incorrect Enrolment|0|||
94479282|NCT00872521|323548165|FG002|Completed PAD Induction|Patient choice|0|||
94479283|NCT00872521|323548163|FG000|Completed PAD Induction|Disease progression|0|||
94479284|NCT00872521|323548164|FG001|Completed PAD Induction|Disease progression|2|||
94479285|NCT00872521|323548165|FG002|Completed PAD Induction|Disease progression|0|||
94479286|NCT00872521|323548163|FG000|Completed PAD Induction|Adverse Event|4|||
94479287|NCT00872521|323548164|FG001|Completed PAD Induction|Adverse Event|0|||
94479288|NCT00872521|323548165|FG002|Completed PAD Induction|Adverse Event|0|||
94479289|NCT00872521|323548163|FG000|Completed PAD Induction|Death|1|||
94479290|NCT00872521|323548164|FG001|Completed PAD Induction|Death|1|||
94479291|NCT00872521|323548165|FG002|Completed PAD Induction|Death|0|||
94479292|NCT00872521|323548163|FG000|Primary Endpoint Analysis|Other|1|||
94479293|NCT00872521|323548164|FG001|Primary Endpoint Analysis|Other|2|||
94479294|NCT00872521|323548165|FG002|Primary Endpoint Analysis|Other|0|||
94479295|NCT00872521|323548163|FG000|Primary Endpoint Analysis|Patient choice|0|||
94479296|NCT00872521|323548164|FG001|Primary Endpoint Analysis|Patient choice|1|||
94479297|NCT00872521|323548165|FG002|Primary Endpoint Analysis|Patient choice|0|||
94479298|NCT00872521|323548163|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
94479299|NCT00872521|323548164|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
94479300|NCT00872521|323548165|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
94479301|NCT00872521|323548163|FG000|Primary Endpoint Analysis|Patient response missing|0|||
94479302|NCT00872521|323548164|FG001|Primary Endpoint Analysis|Patient response missing|0|||
94479303|NCT00872521|323548165|FG002|Primary Endpoint Analysis|Patient response missing|1|||
94479304|NCT00872521|323548163|FG000|Completed 3-month Follow up|Other|0|||
94479305|NCT00872521|323548164|FG001|Completed 3-month Follow up|Other|2|||
94479306|NCT00872521|323548165|FG002|Completed 3-month Follow up|Other|0|||
94479307|NCT00872521|323548163|FG000|Completed 3-month Follow up|Physician Decision|0|||
94479308|NCT00872521|323548164|FG001|Completed 3-month Follow up|Physician Decision|1|||
94479309|NCT00872521|323548165|FG002|Completed 3-month Follow up|Physician Decision|0|||
94479310|NCT00872521|323548163|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
94479311|NCT00872521|323548164|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
94479312|NCT00872521|323548165|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
94479313|NCT03410992|323548168|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
94479314|NCT03410992|323548169|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
94479315|NCT03410992|323548170|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
94479316|NCT03410992|323548171|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
94479317|NCT03410992|323548172|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
94315950|NCT00972244|322940030|FG004|Overall Study|Incorrect Enrolment|0|||
94315951|NCT00972244|322940026|FG000|Overall Study|Adverse Event|0|||
94315952|NCT00972244|322940027|FG001|Overall Study|Adverse Event|1|||
94315953|NCT00972244|322940028|FG002|Overall Study|Adverse Event|1|||
94315954|NCT00972244|322940029|FG003|Overall Study|Adverse Event|0|||
94315955|NCT00972244|322940030|FG004|Overall Study|Adverse Event|0|||
94315956|NCT00972244|322940026|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
94315957|NCT00972244|322940027|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
94315958|NCT00972244|322940028|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
94315959|NCT00972244|322940029|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
94315960|NCT00972244|322940030|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
94315961|NCT00972244|322940026|FG000|Overall Study|Withdrawal by Subject|1|||
94315962|NCT00972244|322940027|FG001|Overall Study|Withdrawal by Subject|2|||
94315963|NCT00972244|322940028|FG002|Overall Study|Withdrawal by Subject|1|||
94315964|NCT00972244|322940029|FG003|Overall Study|Withdrawal by Subject|0|||
94315965|NCT00972244|322940030|FG004|Overall Study|Withdrawal by Subject|1|||
94315966|NCT00972244|322940026|FG000|Overall Study|Safety|0|||
94315967|NCT00972244|322940027|FG001|Overall Study|Safety|0|||
94315968|NCT00972244|322940028|FG002|Overall Study|Safety|0|||
94315969|NCT00972244|322940029|FG003|Overall Study|Safety|0|||
94315970|NCT00972244|322940030|FG004|Overall Study|Safety|1|||
94315971|NCT00972244|322940026|FG000|Overall Study|Death|1|||
94315972|NCT00972244|322940027|FG001|Overall Study|Death|0|||
94315973|NCT00972244|322940028|FG002|Overall Study|Death|0|||
94315974|NCT00972244|322940029|FG003|Overall Study|Death|0|||
94315975|NCT00972244|322940030|FG004|Overall Study|Death|0|||
94315976|NCT00972244|322940026|FG000|Overall Study|Various|0|||
94315977|NCT00972244|322940027|FG001|Overall Study|Various|0|||
94315978|NCT00972244|322940028|FG002|Overall Study|Various|0|||
94315979|NCT00972244|322940029|FG003|Overall Study|Various|0|||
94315980|NCT00972244|322940030|FG004|Overall Study|Various|2|||
94315981|NCT01763905|322940036|FG000|Overall Study|Withdrawal by Subject|1|||
94315982|NCT01763905|322940037|FG001|Overall Study|Withdrawal by Subject|1|||
94315983|NCT01763905|322940038|FG002|Overall Study|Withdrawal by Subject|0|||
94315984|NCT01763905|322940039|FG003|Overall Study|Withdrawal by Subject|1|||
94315985|NCT01763905|322940036|FG000|Overall Study|Decision by sponsor|5|||
94315986|NCT01763905|322940037|FG001|Overall Study|Decision by sponsor|0|||
94315987|NCT01763905|322940038|FG002|Overall Study|Decision by sponsor|8|||
94315988|NCT01763905|322940039|FG003|Overall Study|Decision by sponsor|0|||
94315989|NCT01763905|322940036|FG000|Overall Study|Lost to Follow-up|0|||
94315990|NCT01763905|322940037|FG001|Overall Study|Lost to Follow-up|0|||
94315991|NCT01763905|322940038|FG002|Overall Study|Lost to Follow-up|1|||
94315992|NCT01763905|322940039|FG003|Overall Study|Lost to Follow-up|0|||
94315993|NCT03165721|322940040|FG000|Overall Study|Refused further treatment|3|||
94315994|NCT03165721|322940041|FG001|Overall Study|Refused further treatment|0|||
94315995|NCT03165721|322940042|FG002|Overall Study|Refused further treatment|0|||
94315996|NCT03165721|322940040|FG000|Overall Study|Physician Decision|1|||
94315997|NCT03165721|322940041|FG001|Overall Study|Physician Decision|0|||
94315998|NCT03165721|322940042|FG002|Overall Study|Physician Decision|0|||
94315999|NCT01554956|322940047|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
94316000|NCT01554956|322940048|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
94316001|NCT01554956|322940049|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
94316002|NCT01554956|322940047|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
94316003|NCT01554956|322940048|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
94316004|NCT01554956|322940049|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
94316005|NCT01554956|322940047|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
94316006|NCT01554956|322940048|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
94316007|NCT01554956|322940049|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
94316008|NCT03350750|322940052|FG000|Overall Study|Death|1|||
94316009|NCT03350750|322940053|FG001|Overall Study|Death|1|||
94316010|NCT02417233|322940054|FG000|Overall Study|Death|4|||
94316011|NCT02417233|322940055|FG001|Overall Study|Death|10|||
94316012|NCT02417233|322940056|FG002|Overall Study|Death|14|||
94316013|NCT02417233|322940054|FG000|Overall Study|Lost to Follow-up|27|||
94316014|NCT02417233|322940055|FG001|Overall Study|Lost to Follow-up|39|||
94316015|NCT02417233|322940056|FG002|Overall Study|Lost to Follow-up|34|||
94316016|NCT02417233|322940054|FG000|Overall Study|Protocol Violation|2|||
94316017|NCT02417233|322940055|FG001|Overall Study|Protocol Violation|0|||
94316018|NCT02417233|322940056|FG002|Overall Study|Protocol Violation|2|||
94316019|NCT02417233|322940054|FG000|Overall Study|Withdrawal by Subject|2|||
94316020|NCT02417233|322940055|FG001|Overall Study|Withdrawal by Subject|1|||
94316021|NCT02417233|322940056|FG002|Overall Study|Withdrawal by Subject|8|||
94316022|NCT02417233|322940054|FG000|Overall Study|Relocation out of study area|1|||
94316023|NCT02417233|322940055|FG001|Overall Study|Relocation out of study area|0|||
94316024|NCT02417233|322940056|FG002|Overall Study|Relocation out of study area|1|||
94316025|NCT02417233|322940054|FG000|Overall Study|Mentally unstable|0|||
94316026|NCT02417233|322940055|FG001|Overall Study|Mentally unstable|1|||
94316027|NCT02417233|322940056|FG002|Overall Study|Mentally unstable|0|||
94316028|NCT00995345|322940057|FG000|Overall Study|Withdrawal by Subject|4|||
94316029|NCT00995345|322940058|FG001|Overall Study|Withdrawal by Subject|2|||
94316030|NCT00995345|322940059|FG002|Overall Study|Withdrawal by Subject|1|||
94316031|NCT00995345|322940060|FG003|Overall Study|Withdrawal by Subject|3|||
94316032|NCT00995345|322940061|FG004|Overall Study|Withdrawal by Subject|1|||
94316033|NCT00995345|322940057|FG000|Overall Study|Adverse Event|3|||
94316034|NCT00995345|322940058|FG001|Overall Study|Adverse Event|1|||
94316035|NCT00995345|322940059|FG002|Overall Study|Adverse Event|2|||
94316036|NCT00995345|322940060|FG003|Overall Study|Adverse Event|0|||
94316037|NCT00995345|322940061|FG004|Overall Study|Adverse Event|1|||
94316038|NCT00995345|322940057|FG000|Overall Study|Lost to Follow-up|2|||
94316039|NCT00995345|322940058|FG001|Overall Study|Lost to Follow-up|2|||
94316040|NCT00995345|322940059|FG002|Overall Study|Lost to Follow-up|2|||
94316041|NCT00995345|322940060|FG003|Overall Study|Lost to Follow-up|1|||
94316042|NCT00995345|322940061|FG004|Overall Study|Lost to Follow-up|0|||
94316043|NCT00995345|322940057|FG000|Overall Study|all other reasons combined|2|||
94316044|NCT00995345|322940058|FG001|Overall Study|all other reasons combined|2|||
94316045|NCT00995345|322940059|FG002|Overall Study|all other reasons combined|2|||
94316046|NCT00995345|322940060|FG003|Overall Study|all other reasons combined|1|||
94316047|NCT00995345|322940061|FG004|Overall Study|all other reasons combined|3|||
94316048|NCT02651194|322940062|FG000|Overall Study|Lost to Follow-up|3|||
94316049|NCT02651194|322940062|FG000|Overall Study|Other|2|||
94316050|NCT01259856|322940069|FG000|Overall Study|Adverse Event|12|||
94316051|NCT01259856|322940070|FG001|Overall Study|Adverse Event|9|||
94316052|NCT01259856|322940069|FG000|Overall Study|Death|0|||
94316053|NCT01259856|322940070|FG001|Overall Study|Death|1|||
94316054|NCT01259856|322940069|FG000|Overall Study|Lack of Efficacy|3|||
94316055|NCT01259856|322940070|FG001|Overall Study|Lack of Efficacy|1|||
94316056|NCT01259856|322940069|FG000|Overall Study|Lost to Follow-up|1|||
94316057|NCT01259856|322940070|FG001|Overall Study|Lost to Follow-up|1|||
94316058|NCT01259856|322940069|FG000|Overall Study|Physician Decision|2|||
94316059|NCT01259856|322940070|FG001|Overall Study|Physician Decision|1|||
94316060|NCT01259856|322940069|FG000|Overall Study|Withdrawal by Subject|9|||
94316061|NCT01259856|322940070|FG001|Overall Study|Withdrawal by Subject|10|||
94316062|NCT01259856|322940069|FG000|Overall Study|Treatment never started|0|||
94316063|NCT01259856|322940070|FG001|Overall Study|Treatment never started|6|||
94316064|NCT01259856|322940069|FG000|Overall Study|Study closure by sponsor|40|||
94316065|NCT01259856|322940070|FG001|Overall Study|Study closure by sponsor|41|||
94316066|NCT01259856|322940069|FG000|Overall Study|Patient developed other disease|0|||
94316067|NCT01259856|322940070|FG001|Overall Study|Patient developed other disease|1|||
94316068|NCT01259856|322940069|FG000|Overall Study|Transfer to another study|0|||
94316069|NCT01259856|322940070|FG001|Overall Study|Transfer to another study|1|||
94316070|NCT01259856|322940069|FG000|Overall Study|Unknown/missing|2|||
94316071|NCT01259856|322940070|FG001|Overall Study|Unknown/missing|2|||
94316072|NCT03116399|322940075|FG000|Overall Study|Death|8|||
94316073|NCT03116399|322940076|FG001|Overall Study|Death|3|||
94316074|NCT03116399|322940075|FG000|Overall Study|Lost to Follow-up|7|||
94316075|NCT03116399|322940076|FG001|Overall Study|Lost to Follow-up|11|||
94316076|NCT03116399|322940075|FG000|Overall Study|Investigator Decision|1|||
94316077|NCT03116399|322940076|FG001|Overall Study|Investigator Decision|1|||
94316078|NCT03116399|322940075|FG000|Overall Study|Withdrawal by Subject|24|||
94316079|NCT03116399|322940076|FG001|Overall Study|Withdrawal by Subject|9|||
94316080|NCT00905307|322940077|FG000|Overall Study|Switched to Open Label Rescue|7|||
94316081|NCT00905307|322940078|FG001|Overall Study|Switched to Open Label Rescue|17|||
94316082|NCT00905307|322940079|FG002|Overall Study|Switched to Open Label Rescue|11|||
94316083|NCT00905307|322940080|FG003|Overall Study|Switched to Open Label Rescue|11|||
94316084|NCT00905307|322940081|FG004|Overall Study|Switched to Open Label Rescue|4|||
94316085|NCT00905307|322940082|FG005|Overall Study|Switched to Open Label Rescue|15|||
94316086|NCT00905307|322940077|FG000|Overall Study|Lost to Follow-up|0|||
94316087|NCT00905307|322940078|FG001|Overall Study|Lost to Follow-up|0|||
94316088|NCT00905307|322940079|FG002|Overall Study|Lost to Follow-up|0|||
94316089|NCT00905307|322940080|FG003|Overall Study|Lost to Follow-up|0|||
94316090|NCT00905307|322940081|FG004|Overall Study|Lost to Follow-up|1|||
94316091|NCT00905307|322940082|FG005|Overall Study|Lost to Follow-up|1|||
94316092|NCT00905307|322940077|FG000|Overall Study|Adverse Event|3|||
94316093|NCT00905307|322940078|FG001|Overall Study|Adverse Event|4|||
94316094|NCT00905307|322940079|FG002|Overall Study|Adverse Event|5|||
94316095|NCT00905307|322940080|FG003|Overall Study|Adverse Event|11|||
94316096|NCT00905307|322940081|FG004|Overall Study|Adverse Event|3|||
94316097|NCT00905307|322940082|FG005|Overall Study|Adverse Event|5|||
94316098|NCT00905307|322940077|FG000|Overall Study|Withdrawal by Subject|5|||
94316099|NCT00905307|322940078|FG001|Overall Study|Withdrawal by Subject|13|||
94316100|NCT00905307|322940079|FG002|Overall Study|Withdrawal by Subject|15|||
94316101|NCT00905307|322940080|FG003|Overall Study|Withdrawal by Subject|11|||
94316102|NCT00905307|322940081|FG004|Overall Study|Withdrawal by Subject|4|||
94316103|NCT00905307|322940082|FG005|Overall Study|Withdrawal by Subject|13|||
94316104|NCT00905307|322940077|FG000|Overall Study|Protocol Violation|1|||
94316105|NCT00905307|322940078|FG001|Overall Study|Protocol Violation|0|||
94316106|NCT00905307|322940079|FG002|Overall Study|Protocol Violation|1|||
94316107|NCT00905307|322940080|FG003|Overall Study|Protocol Violation|0|||
94316108|NCT00905307|322940081|FG004|Overall Study|Protocol Violation|0|||
94316109|NCT00905307|322940082|FG005|Overall Study|Protocol Violation|0|||
94316110|NCT00905307|322940077|FG000|Overall Study|Lack of Efficacy|6|||
94316111|NCT00905307|322940078|FG001|Overall Study|Lack of Efficacy|3|||
94316112|NCT00905307|322940079|FG002|Overall Study|Lack of Efficacy|5|||
94316113|NCT00905307|322940080|FG003|Overall Study|Lack of Efficacy|4|||
94316114|NCT00905307|322940081|FG004|Overall Study|Lack of Efficacy|4|||
94316115|NCT00905307|322940082|FG005|Overall Study|Lack of Efficacy|8|||
94316116|NCT02702193|322940083|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
94316117|NCT02702193|322940084|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
94316118|NCT02702193|322940083|FG000|4 Month Follow up|Withdrawal by Subject|1|||
94316119|NCT02702193|322940084|FG001|4 Month Follow up|Withdrawal by Subject|0|||
94316120|NCT02702193|322940083|FG000|4 Month Follow up|Lost to Follow-up|17|||
94316121|NCT02702193|322940084|FG001|4 Month Follow up|Lost to Follow-up|18|||
94316122|NCT02702193|322940083|FG000|8 Month Follow up|Withdrawal by Subject|1|||
94316123|NCT02702193|322940084|FG001|8 Month Follow up|Withdrawal by Subject|0|||
94316124|NCT02702193|322940083|FG000|8 Month Follow up|Lost to Follow-up|14|||
94316125|NCT02702193|322940084|FG001|8 Month Follow up|Lost to Follow-up|18|||
94316126|NCT02702193|322940083|FG000|12 Month Follow up|Withdrawal by Subject|1|||
94316127|NCT02702193|322940084|FG001|12 Month Follow up|Withdrawal by Subject|0|||
94316128|NCT02702193|322940083|FG000|12 Month Follow up|Lost to Follow-up|16|||
94316129|NCT02702193|322940084|FG001|12 Month Follow up|Lost to Follow-up|18|||
94316130|NCT03161678|322940085|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
94316131|NCT03161678|322940086|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
94316132|NCT03161678|322940087|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
94316133|NCT03161678|322940088|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
94316134|NCT03161678|322940089|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
94316135|NCT03161678|322940090|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
94316136|NCT03161678|322940085|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
94316137|NCT03161678|322940086|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
94316138|NCT03161678|322940087|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
94316139|NCT03161678|322940088|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
94316140|NCT03161678|322940089|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
94316141|NCT03161678|322940090|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
94316142|NCT03161678|322940085|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
94316143|NCT03161678|322940086|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
94316144|NCT03161678|322940087|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
94316145|NCT03161678|322940088|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
94316146|NCT03161678|322940089|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
94316147|NCT03161678|322940090|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
94316148|NCT03161678|322940085|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
94316149|NCT03161678|322940086|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
94316150|NCT03161678|322940087|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
94316151|NCT03161678|322940088|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
94316152|NCT03161678|322940089|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
94316153|NCT03161678|322940090|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
94316154|NCT01379534|322940091|FG000|Treatment Phase|Withdrawal by Subject|2|||
94316155|NCT01379534|322940092|FG001|Treatment Phase|Withdrawal by Subject|2|||
94316156|NCT01379534|322940091|FG000|Treatment Phase|Progressive disease|13|||
94316157|NCT01379534|322940092|FG001|Treatment Phase|Progressive disease|22|||
94316158|NCT01379534|322940091|FG000|Treatment Phase|Adverse Event|7|||
94316159|NCT01379534|322940092|FG001|Treatment Phase|Adverse Event|7|||
94316160|NCT01379534|322940091|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
94385098|NCT02353169|323196824|FG001|Overall Study|Pre-op medication|0|||
94385099|NCT02353169|323196825|FG002|Overall Study|Pre-op medication|1|||
94385100|NCT02353169|323196826|FG003|Overall Study|Pre-op medication|0|||
94385101|NCT00874237|323196828|FG000|Overall Study|Physician Decision|0|||
94385102|NCT00874237|323196829|FG001|Overall Study|Physician Decision|1|||
94385103|NCT00874237|323196830|FG002|Overall Study|Physician Decision|0|||
94385104|NCT00874237|323196831|FG003|Overall Study|Physician Decision|0|||
94385105|NCT00874237|323196832|FG004|Overall Study|Physician Decision|0|||
94385106|NCT00874237|323196833|FG005|Overall Study|Physician Decision|0|||
94385107|NCT00874237|323196828|FG000|Overall Study|Withdrawal by Subject|0|||
94385108|NCT00874237|323196829|FG001|Overall Study|Withdrawal by Subject|0|||
94385109|NCT00874237|323196830|FG002|Overall Study|Withdrawal by Subject|1|||
94385110|NCT00874237|323196831|FG003|Overall Study|Withdrawal by Subject|0|||
94385111|NCT00874237|323196832|FG004|Overall Study|Withdrawal by Subject|0|||
94385112|NCT00874237|323196833|FG005|Overall Study|Withdrawal by Subject|0|||
94385113|NCT03752528|323196834|FG000|Part A|Lost to Follow-up|1|||
94385114|NCT03752528|323196834|FG000|Part A|Protocol Violation|1|||
94385115|NCT03752528|323196834|FG000|Part B|Protocol Violation|1|||
94385116|NCT03752528|323196834|FG000|Part B|Study terminated by sponsor|3|||
94385117|NCT00414765|323196835|FG000|Overall Study|Adverse Event|5|||
94385118|NCT00414765|323196836|FG001|Overall Study|Adverse Event|9|||
94385119|NCT00414765|323196835|FG000|Overall Study|Withdrawal by Subject|1|||
94385120|NCT00414765|323196836|FG001|Overall Study|Withdrawal by Subject|1|||
94385121|NCT00414765|323196835|FG000|Overall Study|Disease Progression|0|||
94385122|NCT00414765|323196836|FG001|Overall Study|Disease Progression|1|||
94385123|NCT04534283|323196837|FG000|Overall Study|Physician Decision|2|||
94385124|NCT04534283|323196837|FG000|Overall Study|Withdrawal by Subject|1|||
94385125|NCT04534283|323196837|FG000|Overall Study|Disease Progression|12|||
94479318|NCT03410992|323548173|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
94316161|NCT01379534|322940092|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
94385126|NCT04534283|323196837|FG000|Overall Study|Adverse Event|1|||
94385127|NCT00117949|323196839|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
94316162|NCT01379534|322940091|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
94316163|NCT01379534|322940092|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
94316164|NCT01379534|322940091|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
94385128|NCT00117949|323196840|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
94385129|NCT00117949|323196841|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
94385130|NCT00117949|323196842|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
94479319|NCT03410992|323548174|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
94479320|NCT03410992|323548175|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
94479321|NCT03410992|323548176|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
94479322|NCT03410992|323548177|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
94479323|NCT03410992|323548178|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
94479324|NCT03410992|323548168|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
94479325|NCT03410992|323548169|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
94479326|NCT03410992|323548170|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
94479327|NCT03410992|323548171|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
94479328|NCT03410992|323548172|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
94479329|NCT03410992|323548173|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
94479330|NCT03410992|323548174|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
94316165|NCT01379534|322940092|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
94316166|NCT01379534|322940091|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
94316167|NCT01379534|322940092|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
94479331|NCT03410992|323548175|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
94479332|NCT03410992|323548176|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
94479333|NCT03410992|323548177|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
94479334|NCT03410992|323548178|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
94479335|NCT03410992|323548168|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
94479336|NCT03410992|323548169|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
94479337|NCT03410992|323548170|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
94479338|NCT03410992|323548171|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
94479339|NCT03410992|323548172|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
94479340|NCT03410992|323548173|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
94479341|NCT03410992|323548174|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
94479342|NCT03410992|323548175|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
94479343|NCT03410992|323548176|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
94316168|NCT00740779|322940093|FG000|Overall Study|Adverse Event|4|||
94316169|NCT00740779|322940094|FG001|Overall Study|Adverse Event|6|||
94316170|NCT00740779|322940095|FG002|Overall Study|Adverse Event|3|||
94316171|NCT00740779|322940093|FG000|Overall Study|Protocol Violation|1|||
94316172|NCT00740779|322940094|FG001|Overall Study|Protocol Violation|1|||
94316173|NCT00740779|322940095|FG002|Overall Study|Protocol Violation|1|||
94316174|NCT00740779|322940093|FG000|Overall Study|Lack of Efficacy|0|||
94316175|NCT00740779|322940094|FG001|Overall Study|Lack of Efficacy|0|||
94316176|NCT00740779|322940095|FG002|Overall Study|Lack of Efficacy|2|||
94316177|NCT00740779|322940093|FG000|Overall Study|Withdrawal by Subject|2|||
94316178|NCT00740779|322940094|FG001|Overall Study|Withdrawal by Subject|4|||
94316179|NCT00740779|322940095|FG002|Overall Study|Withdrawal by Subject|2|||
94316180|NCT00740779|322940093|FG000|Overall Study|Lost to Follow-up|2|||
94316181|NCT00740779|322940094|FG001|Overall Study|Lost to Follow-up|3|||
94316182|NCT00740779|322940095|FG002|Overall Study|Lost to Follow-up|5|||
94316183|NCT00850460|322940096|FG000|Overall Study|Lost to Follow-up|4|||
94316184|NCT00850460|322940097|FG001|Overall Study|Lost to Follow-up|4|||
94316185|NCT02213198|322940105|FG000|Baseline|No show for intake|7|||
94316186|NCT02213198|322940106|FG001|Baseline|No show for intake|9|||
94316187|NCT02213198|322940105|FG000|Baseline|Withdrawal by Subject|34|||
94316188|NCT02213198|322940106|FG001|Baseline|Withdrawal by Subject|11|||
94316189|NCT02213198|322940105|FG000|Baseline|transferred out of clinic|7|||
94316190|NCT02213198|322940106|FG001|Baseline|transferred out of clinic|9|||
94316191|NCT02213198|322940105|FG000|Baseline|Lost to Follow-up|40|||
94316192|NCT02213198|322940106|FG001|Baseline|Lost to Follow-up|21|||
94316193|NCT02213198|322940105|FG000|Baseline|incarcerated,violent|0|||
94316194|NCT02213198|322940106|FG001|Baseline|incarcerated,violent|1|||
94316195|NCT02213198|322940105|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
94316196|NCT02213198|322940106|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
94316197|NCT02213198|322940105|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
94316198|NCT02213198|322940106|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
94316199|NCT02213198|322940105|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
94479344|NCT03410992|323548177|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
94479345|NCT03410992|323548178|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
94479346|NCT03410992|323548168|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
94316200|NCT02213198|322940106|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
94316201|NCT02213198|322940105|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
94479347|NCT03410992|323548169|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
94479348|NCT03410992|323548170|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
94316202|NCT02213198|322940106|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
94316203|NCT02213198|322940105|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
94479349|NCT03410992|323548171|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
94479350|NCT03410992|323548172|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
94479351|NCT03410992|323548173|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
94479352|NCT03410992|323548174|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
94479353|NCT03410992|323548175|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
94479354|NCT03410992|323548176|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
94479355|NCT03410992|323548177|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
94479356|NCT03410992|323548178|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
94479357|NCT03410992|323548168|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
94479358|NCT03410992|323548169|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
94479359|NCT03410992|323548170|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
94479360|NCT03410992|323548171|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
94479361|NCT03410992|323548172|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
94479362|NCT03410992|323548173|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
94479363|NCT03410992|323548174|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
94316204|NCT02213198|322940106|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
94316205|NCT02213198|322940105|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
94316206|NCT02213198|322940106|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
94316207|NCT00496873|322940107|FG000|Overall Study|Ineligible|2|||
94316208|NCT00496873|322940107|FG000|Overall Study|Death|2|||
94479364|NCT03410992|323548175|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
94479365|NCT03410992|323548176|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
94479366|NCT03410992|323548177|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
94479367|NCT03410992|323548178|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
94479368|NCT03410992|323548168|FG000|Week 16 Assessment|Incorrect escapers|0|||
94479369|NCT03410992|323548169|FG001|Week 16 Assessment|Incorrect escapers|6|||
94479370|NCT03410992|323548170|FG002|Week 16 Assessment|Incorrect escapers|0|||
94479371|NCT03410992|323548171|FG003|Week 16 Assessment|Incorrect escapers|0|||
94479372|NCT03410992|323548172|FG004|Week 16 Assessment|Incorrect escapers|0|||
94479373|NCT03410992|323548173|FG005|Week 16 Assessment|Incorrect escapers|0|||
94479374|NCT03410992|323548174|FG006|Week 16 Assessment|Incorrect escapers|0|||
94479375|NCT03410992|323548175|FG007|Week 16 Assessment|Incorrect escapers|0|||
94479376|NCT03410992|323548176|FG008|Week 16 Assessment|Incorrect escapers|0|||
94479377|NCT03410992|323548177|FG009|Week 16 Assessment|Incorrect escapers|0|||
94479378|NCT03410992|323548178|FG010|Week 16 Assessment|Incorrect escapers|0|||
94479379|NCT03410992|323548168|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
94479380|NCT03410992|323548169|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
94479381|NCT03410992|323548170|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
94479382|NCT03410992|323548171|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
94479383|NCT03410992|323548172|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
94479384|NCT03410992|323548173|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
94479385|NCT03410992|323548174|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
94479386|NCT03410992|323548175|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
94479387|NCT03410992|323548176|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
94479388|NCT03410992|323548177|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
94479389|NCT03410992|323548178|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
94479390|NCT03410992|323548168|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
94479391|NCT03410992|323548169|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
94479392|NCT03410992|323548170|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
94479393|NCT03410992|323548171|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
94479394|NCT03410992|323548172|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
94479395|NCT03410992|323548173|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
94479396|NCT03410992|323548174|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
94479397|NCT03410992|323548175|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
94479398|NCT03410992|323548176|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
94479399|NCT03410992|323548177|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
94479400|NCT03410992|323548178|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
94479401|NCT03410992|323548168|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
94316209|NCT00496873|322940107|FG000|Overall Study|Withdrawal by Subject|3|||
94316210|NCT02775864|322940108|FG000|Overall Study|Data ended end of 2010|1764|||
94316211|NCT02775864|322940109|FG001|Overall Study|Data ended end of 2010|2880|||
94316212|NCT02775864|322940110|FG002|Overall Study|Data ended end of 2010|1140|||
94316213|NCT02775864|322940111|FG003|Overall Study|Data ended end of 2010|1194|||
94479402|NCT03410992|323548169|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
94479403|NCT03410992|323548170|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
94479404|NCT03410992|323548171|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
94479405|NCT03410992|323548172|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
94479406|NCT03410992|323548173|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
94479407|NCT03410992|323548174|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
94479408|NCT03410992|323548175|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
94479409|NCT03410992|323548176|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
94479410|NCT03410992|323548177|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
94479411|NCT03410992|323548178|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
94479412|NCT03410992|323548168|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
94479413|NCT03410992|323548169|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
94479414|NCT03410992|323548170|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
94479415|NCT03410992|323548171|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
94479416|NCT03410992|323548172|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
94479417|NCT03410992|323548173|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
94479418|NCT03410992|323548174|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
94479419|NCT03410992|323548175|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
94479420|NCT03410992|323548176|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
94479421|NCT03410992|323548177|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
94479422|NCT03410992|323548178|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
94479423|NCT03410992|323548168|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
94479424|NCT03410992|323548169|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
94479425|NCT03410992|323548170|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
94479426|NCT03410992|323548171|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
94479427|NCT03410992|323548172|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
94479428|NCT03410992|323548173|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
94479429|NCT03410992|323548174|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
94479430|NCT03410992|323548175|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
94479431|NCT03410992|323548176|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
94479432|NCT03410992|323548177|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
94479433|NCT03410992|323548178|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
94479434|NCT03410992|323548168|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
94479435|NCT03410992|323548169|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
94479436|NCT03410992|323548170|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
94479437|NCT03410992|323548171|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
94479438|NCT03410992|323548172|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
94479439|NCT03410992|323548173|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
94479440|NCT03410992|323548174|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
94479441|NCT03410992|323548175|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
94479442|NCT03410992|323548176|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
94479443|NCT03410992|323548177|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
94479444|NCT03410992|323548178|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
94479445|NCT02976519|323548179|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
94479446|NCT02976519|323548180|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
94479447|NCT02976519|323548181|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
94479448|NCT02976519|323548182|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
94479449|NCT02976519|323548183|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
94479450|NCT02976519|323548184|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
94479451|NCT02976519|323548185|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
94479452|NCT02976519|323548179|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
94479453|NCT02976519|323548180|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
94479454|NCT02976519|323548181|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
94479455|NCT02976519|323548182|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
94479456|NCT02976519|323548183|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
94479457|NCT02976519|323548184|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
94479458|NCT02976519|323548185|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
94479459|NCT02976519|323548179|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
94479460|NCT02976519|323548180|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
94479461|NCT02976519|323548181|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
94479462|NCT02976519|323548182|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
94479463|NCT02976519|323548183|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
94479464|NCT02976519|323548184|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
94479465|NCT02976519|323548185|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
94479466|NCT02976519|323548179|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
94479467|NCT02976519|323548180|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
94479468|NCT02976519|323548181|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
94479469|NCT02976519|323548182|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
94479470|NCT02976519|323548183|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
94479471|NCT02976519|323548184|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
94479472|NCT02976519|323548185|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
94479473|NCT02976519|323548179|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
94479474|NCT02976519|323548180|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
94479475|NCT02976519|323548181|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
94479476|NCT02976519|323548182|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
94479477|NCT02976519|323548183|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
94479478|NCT02976519|323548184|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
94479479|NCT02976519|323548185|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
94479480|NCT03904420|323548186|FG000|Overall Study|Study terminated|2|||
94479481|NCT03904420|323548187|FG001|Overall Study|Study terminated|2|||
94479482|NCT01468454|323548188|FG000|Overall Study|Did not have surgery after PET|9|||
94479483|NCT02982863|323548191|FG000|Overall Study|Not eligible patients|809|||
94479484|NCT02982863|323548192|FG001|Overall Study|Not eligible patients|4261|||
94479485|NCT02982863|323548193|FG002|Overall Study|Not eligible patients|1852|||
94479486|NCT02982863|323548194|FG003|Overall Study|Not eligible patients|1400|||
94479487|NCT02982863|323548195|FG004|Overall Study|Not eligible patients|492|||
94479488|NCT02457195|323548196|FG000|Overall Study|Adverse Event|3|||
94479489|NCT02457195|323548196|FG000|Overall Study|Protocol Violation|2|||
94479490|NCT02457195|323548196|FG000|Overall Study|Withdrawal by Subject|4|||
94479491|NCT02896569|323548197|FG000|Overall Study|Lost to Follow-up|2|||
94479492|NCT02896569|323548198|FG001|Overall Study|Lost to Follow-up|1|||
94479493|NCT02896569|323548197|FG000|Overall Study|Physician Decision|1|||
94479494|NCT02896569|323548198|FG001|Overall Study|Physician Decision|3|||
94479495|NCT02896569|323548197|FG000|Overall Study|Adverse Event|0|||
94479496|NCT02896569|323548198|FG001|Overall Study|Adverse Event|1|||
94479497|NCT02896569|323548197|FG000|Overall Study|Withdrawal by Subject|1|||
94479498|NCT02896569|323548198|FG001|Overall Study|Withdrawal by Subject|0|||
94479499|NCT01576575|323548201|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
94479500|NCT01576575|323548201|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
94479501|NCT01576575|323548201|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
94479502|NCT02168491|323548202|FG000|Overall Study|Withdrawal by Subject|1|||
94479503|NCT03874013|323548203|FG000|Overall Study|Adverse Event|0|||
94479504|NCT03874013|323548204|FG001|Overall Study|Adverse Event|1|||
94479505|NCT00627497|323548205|FG000|Overall Study|Lost to Follow-up|1|||
94479506|NCT00627497|323548206|FG001|Overall Study|Lost to Follow-up|1|||
94479507|NCT00627497|323548207|FG002|Overall Study|Lost to Follow-up|0|||
94479508|NCT00627497|323548208|FG003|Overall Study|Lost to Follow-up|0|||
94479509|NCT00810069|323548209|FG000|Lead-in Period I|Adverse Event|43|||
94479510|NCT00810069|323548210|FG001|Lead-in Period I|Adverse Event|0|||
94479511|NCT00810069|323548211|FG002|Lead-in Period I|Adverse Event|0|||
94479512|NCT00810069|323548209|FG000|Lead-in Period I|Lack of Efficacy|1|||
94479513|NCT00810069|323548210|FG001|Lead-in Period I|Lack of Efficacy|0|||
94479514|NCT00810069|323548211|FG002|Lead-in Period I|Lack of Efficacy|0|||
94479515|NCT00810069|323548209|FG000|Lead-in Period I|Lost to Follow-up|19|||
94479516|NCT00810069|323548210|FG001|Lead-in Period I|Lost to Follow-up|0|||
94479517|NCT00810069|323548211|FG002|Lead-in Period I|Lost to Follow-up|0|||
94479518|NCT00810069|323548209|FG000|Lead-in Period I|Physician Decision|1|||
94479519|NCT00810069|323548210|FG001|Lead-in Period I|Physician Decision|0|||
94479520|NCT00810069|323548211|FG002|Lead-in Period I|Physician Decision|0|||
94479521|NCT00810069|323548209|FG000|Lead-in Period I|Protocol Violation|1|||
94479522|NCT00810069|323548210|FG001|Lead-in Period I|Protocol Violation|0|||
94479523|NCT00810069|323548211|FG002|Lead-in Period I|Protocol Violation|0|||
94479524|NCT00810069|323548209|FG000|Lead-in Period I|Withdrawal by Subject|46|||
94479525|NCT00810069|323548210|FG001|Lead-in Period I|Withdrawal by Subject|0|||
94479526|NCT00810069|323548211|FG002|Lead-in Period I|Withdrawal by Subject|0|||
94479527|NCT00810069|323548209|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
94479528|NCT00810069|323548210|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
94479529|NCT00810069|323548211|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
94479530|NCT00810069|323548209|FG000|Lead-in Period I|Randomization criteria not met|158|||
94479531|NCT00810069|323548210|FG001|Lead-in Period I|Randomization criteria not met|0|||
94479532|NCT00810069|323548211|FG002|Lead-in Period I|Randomization criteria not met|0|||
94479533|NCT00810069|323548209|FG000|Double-Blind Period II|Adverse Event|0|||
94479534|NCT00810069|323548210|FG001|Double-Blind Period II|Adverse Event|9|||
94479535|NCT00810069|323548211|FG002|Double-Blind Period II|Adverse Event|8|||
94316214|NCT02775864|322940108|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
94479536|NCT00810069|323548209|FG000|Double-Blind Period II|Lack of Efficacy|0|||
94479537|NCT00810069|323548210|FG001|Double-Blind Period II|Lack of Efficacy|7|||
94479538|NCT00810069|323548211|FG002|Double-Blind Period II|Lack of Efficacy|12|||
94479539|NCT00810069|323548209|FG000|Double-Blind Period II|Lost to Follow-up|0|||
94479540|NCT00810069|323548210|FG001|Double-Blind Period II|Lost to Follow-up|9|||
94479541|NCT00810069|323548211|FG002|Double-Blind Period II|Lost to Follow-up|9|||
94479542|NCT00810069|323548209|FG000|Double-Blind Period II|Physician Decision|0|||
94479543|NCT00810069|323548210|FG001|Double-Blind Period II|Physician Decision|0|||
94479544|NCT00810069|323548211|FG002|Double-Blind Period II|Physician Decision|1|||
94479545|NCT00810069|323548209|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
94479546|NCT00810069|323548210|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
94479547|NCT00810069|323548211|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
94479548|NCT00810069|323548209|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
94479549|NCT00810069|323548210|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
94479550|NCT00810069|323548211|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
94479551|NCT00810069|323548209|FG000|Double-Blind Period II|Clinical relapse|0|||
94479552|NCT00810069|323548210|FG001|Double-Blind Period II|Clinical relapse|3|||
94479553|NCT00810069|323548211|FG002|Double-Blind Period II|Clinical relapse|0|||
94479554|NCT00810069|323548209|FG000|Double-Blind Period II|Protocol Violation|0|||
94479555|NCT00810069|323548210|FG001|Double-Blind Period II|Protocol Violation|7|||
94479556|NCT00810069|323548211|FG002|Double-Blind Period II|Protocol Violation|6|||
94479557|NCT00327717|323548212|FG000|Overall Study|Adverse Event|6|||
94479558|NCT00327717|323548213|FG001|Overall Study|Adverse Event|6|||
94479559|NCT00327717|323548212|FG000|Overall Study|Lack of Efficacy|0|||
94479560|NCT00327717|323548213|FG001|Overall Study|Lack of Efficacy|1|||
94479561|NCT00327717|323548212|FG000|Overall Study|Withdrawal by Subject|3|||
94479562|NCT00327717|323548213|FG001|Overall Study|Withdrawal by Subject|7|||
94479563|NCT01158261|323548214|FG000|Overall Study|Lost to Follow-up|9|||
94479564|NCT01158261|323548214|FG000|Overall Study|Death|7|||
94479565|NCT01158261|323548214|FG000|Overall Study|Withdrawal by Subject|1|||
94479566|NCT03143101|323548215|FG000|Overall Study|Withdrawal by Subject|0|||
94479567|NCT03143101|323548216|FG001|Overall Study|Withdrawal by Subject|1|||
94479568|NCT03143101|323548217|FG002|Overall Study|Withdrawal by Subject|0|||
94479569|NCT03143101|323548215|FG000|Overall Study|Lost to Follow-up|2|||
94479570|NCT03143101|323548216|FG001|Overall Study|Lost to Follow-up|2|||
94479571|NCT03143101|323548217|FG002|Overall Study|Lost to Follow-up|0|||
94479572|NCT01601496|323548220|FG000|Overall Study|Physician Decision|1|||
94479573|NCT01601496|323548220|FG000|Overall Study|Withdrawal by Subject|1|||
94479574|NCT01601496|323548220|FG000|Overall Study|Lost to Follow-up|6|||
94479575|NCT01601496|323548220|FG000|Overall Study|Death|4|||
94479576|NCT01601496|323548220|FG000|Overall Study|Other: patient refusal to continue|3|||
94479577|NCT00991289|323548221|FG000|Overall Study|Adverse Event|1|||
94479578|NCT00991289|323548221|FG000|Overall Study|Physician Decision|2|||
94479579|NCT00991289|323548221|FG000|Overall Study|Withdrawal by Subject|3|||
94479580|NCT00991289|323548221|FG000|Overall Study|Lost to Follow-up|4|||
94479581|NCT00991289|323548221|FG000|Overall Study|Protocol Violation|2|||
94479582|NCT00379899|323548223|FG000|Overall Study|Adverse Event|7|||
94479583|NCT00379899|323548224|FG001|Overall Study|Adverse Event|3|||
94479584|NCT00379899|323548223|FG000|Overall Study|Death|10|||
94479585|NCT00379899|323548224|FG001|Overall Study|Death|10|||
94479586|NCT00379899|323548223|FG000|Overall Study|Lost to Follow-up|2|||
94479587|NCT00379899|323548224|FG001|Overall Study|Lost to Follow-up|4|||
94479588|NCT00379899|323548223|FG000|Overall Study|Physician Decision|3|||
94479589|NCT00379899|323548224|FG001|Overall Study|Physician Decision|4|||
94479590|NCT00379899|323548223|FG000|Overall Study|Withdrawal by Subject|5|||
94479591|NCT00379899|323548224|FG001|Overall Study|Withdrawal by Subject|5|||
94479592|NCT00379899|323548223|FG000|Overall Study|Ineligibility determined|0|||
94479593|NCT00379899|323548224|FG001|Overall Study|Ineligibility determined|1|||
94479594|NCT00379899|323548223|FG000|Overall Study|Noncompliance|1|||
94479595|NCT00379899|323548224|FG001|Overall Study|Noncompliance|1|||
94479596|NCT00379899|323548223|FG000|Overall Study|Parathyroidectomy|0|||
94479597|NCT00379899|323548224|FG001|Overall Study|Parathyroidectomy|2|||
94479598|NCT00379899|323548223|FG000|Overall Study|Renal transplantation|5|||
94479599|NCT00379899|323548224|FG001|Overall Study|Renal transplantation|4|||
94479600|NCT00379899|323548223|FG000|Overall Study|Coronary artery bypass graft|1|||
94479601|NCT00379899|323548224|FG001|Overall Study|Coronary artery bypass graft|1|||
94479602|NCT00379899|323548223|FG000|Overall Study|Other protocol-specified criteria|3|||
94479603|NCT00379899|323548224|FG001|Overall Study|Other protocol-specified criteria|4|||
94479604|NCT00379899|323548223|FG000|Overall Study|Other|3|||
94479605|NCT00379899|323548224|FG001|Overall Study|Other|1|||
94479606|NCT00992017|323548225|FG000|Overall Study|Lost to Follow-up|2|||
94479607|NCT00992017|323548225|FG000|Overall Study|Withdrawal by Subject|2|||
94479608|NCT00992017|323548225|FG000|Overall Study|Unable to get to clinic|5|||
94479609|NCT00992017|323548225|FG000|Overall Study|Not adhere to study requirements|1|||
94479610|NCT01827592|323548228|FG000|Overall Study|Adverse Event|11|||
94479611|NCT01827592|323548229|FG001|Overall Study|Adverse Event|9|||
94479612|NCT01827592|323548230|FG002|Overall Study|Adverse Event|2|||
94479613|NCT01827592|323548228|FG000|Overall Study|Physician Decision|0|||
94479614|NCT01827592|323548229|FG001|Overall Study|Physician Decision|2|||
94479615|NCT01827592|323548230|FG002|Overall Study|Physician Decision|1|||
94479616|NCT01827592|323548228|FG000|Overall Study|Protocol Violation|2|||
94479617|NCT01827592|323548229|FG001|Overall Study|Protocol Violation|1|||
94479618|NCT01827592|323548230|FG002|Overall Study|Protocol Violation|0|||
94479619|NCT01827592|323548228|FG000|Overall Study|Lost to Follow-up|1|||
94479620|NCT01827592|323548229|FG001|Overall Study|Lost to Follow-up|2|||
94479621|NCT01827592|323548230|FG002|Overall Study|Lost to Follow-up|2|||
94479622|NCT01827592|323548228|FG000|Overall Study|Withdrawal by Subject|12|||
94479623|NCT01827592|323548229|FG001|Overall Study|Withdrawal by Subject|11|||
94479624|NCT01827592|323548230|FG002|Overall Study|Withdrawal by Subject|11|||
94479625|NCT01827592|323548228|FG000|Overall Study|Patient's substantial non-compliance|1|||
94479626|NCT01827592|323548229|FG001|Overall Study|Patient's substantial non-compliance|1|||
94479627|NCT01827592|323548230|FG002|Overall Study|Patient's substantial non-compliance|6|||
94479628|NCT01827592|323548228|FG000|Overall Study|Trial terminated by Sponsor|47|||
94479629|NCT01827592|323548229|FG001|Overall Study|Trial terminated by Sponsor|53|||
94479630|NCT01827592|323548230|FG002|Overall Study|Trial terminated by Sponsor|51|||
94479631|NCT01827592|323548228|FG000|Overall Study|Others|0|||
94479632|NCT01827592|323548229|FG001|Overall Study|Others|1|||
94479633|NCT01827592|323548230|FG002|Overall Study|Others|3|||
94479634|NCT00571662|323548231|FG000|Overall Study|Withdrawal by Subject|2|||
94479635|NCT00571662|323548231|FG000|Overall Study|psychiatric instability|1|||
94479636|NCT00571662|323548231|FG000|Overall Study|Adverse Event|5|||
94479637|NCT05404711|323548232|FG000|Completed Study Visit|Withdrawal by Subject|1|||
94479638|NCT05404711|323548232|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
94479639|NCT05404711|323548232|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
94479640|NCT05404711|323548232|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
94479641|NCT05404711|323548232|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
94479642|NCT05404711|323548232|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
94479643|NCT05176717|323548233|FG000|Overall Study|Sponsor Decision|1|||
94479644|NCT05176717|323548234|FG001|Overall Study|Sponsor Decision|2|||
94479645|NCT05176717|323548235|FG002|Overall Study|Sponsor Decision|2|||
94479646|NCT03284853|323548236|FG000|Overall Study|Adverse Event|40|||
94479647|NCT03284853|323548237|FG001|Overall Study|Adverse Event|4|||
94479648|NCT03284853|323548236|FG000|Overall Study|Withdrawal by Subject|5|||
94479649|NCT03284853|323548237|FG001|Overall Study|Withdrawal by Subject|1|||
94479650|NCT03284853|323548236|FG000|Overall Study|Lost to Follow-up|1|||
94479651|NCT03284853|323548237|FG001|Overall Study|Lost to Follow-up|0|||
94479652|NCT03284853|323548236|FG000|Overall Study|Lack of Efficacy|1|||
94479653|NCT03284853|323548237|FG001|Overall Study|Lack of Efficacy|0|||
94479654|NCT03284853|323548236|FG000|Overall Study|Disallowed Concurrent Medication|1|||
94479655|NCT03284853|323548237|FG001|Overall Study|Disallowed Concurrent Medication|1|||
94479656|NCT03284853|323548236|FG000|Overall Study|Protocol Violation|3|||
94479657|NCT03284853|323548237|FG001|Overall Study|Protocol Violation|3|||
94479658|NCT03284853|323548236|FG000|Overall Study|Death|0|||
94479659|NCT03284853|323548237|FG001|Overall Study|Death|1|||
94479660|NCT03284853|323548236|FG000|Overall Study|Other - Reason not reported in CSR|4|||
94479661|NCT03284853|323548237|FG001|Overall Study|Other - Reason not reported in CSR|3|||
94479662|NCT04888494|323548240|FG000|Overall Study|Lost to Follow-up|2|||
94479663|NCT04888494|323548241|FG001|Overall Study|Lost to Follow-up|3|||
94479664|NCT04888494|323548240|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
94479665|NCT04888494|323548241|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
94479666|NCT03430856|323548242|FG000|Overall Study|Adverse Event|0|||
94479667|NCT03430856|323548243|FG001|Overall Study|Adverse Event|1|||
94479668|NCT03430856|323548244|FG002|Overall Study|Adverse Event|0|||
94479669|NCT03430856|323548242|FG000|Overall Study|Rescue criteria|1|||
94479670|NCT03430856|323548243|FG001|Overall Study|Rescue criteria|1|||
94479671|NCT03430856|323548244|FG002|Overall Study|Rescue criteria|0|||
94316215|NCT02775864|322940109|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
94316216|NCT02775864|322940110|FG002|Overall Study|Medicaid eligibility discontinued|720|||
94316217|NCT02775864|322940111|FG003|Overall Study|Medicaid eligibility discontinued|890|||
94316218|NCT03238235|322940112|FG000|Overall Study|Adverse Event|2|||
94316219|NCT03238235|322940113|FG001|Overall Study|Adverse Event|0|||
94316220|NCT03238235|322940112|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
94316221|NCT03238235|322940113|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
94316222|NCT01318083|322940114|FG000|Overall Study|Adverse Event|4|||
94316223|NCT01318083|322940115|FG001|Overall Study|Adverse Event|1|||
94316224|NCT01318083|322940116|FG002|Overall Study|Adverse Event|2|||
94316225|NCT01318083|322940114|FG000|Overall Study|Withdrawal by Subject|1|||
94316226|NCT01318083|322940115|FG001|Overall Study|Withdrawal by Subject|0|||
94316227|NCT01318083|322940116|FG002|Overall Study|Withdrawal by Subject|2|||
94316228|NCT01318083|322940114|FG000|Overall Study|Lack of Efficacy|0|||
94316229|NCT01318083|322940115|FG001|Overall Study|Lack of Efficacy|0|||
94316230|NCT01318083|322940116|FG002|Overall Study|Lack of Efficacy|1|||
94479672|NCT03430856|323548242|FG000|Overall Study|Voluntary withdrawal of consent|1|||
94479673|NCT03430856|323548243|FG001|Overall Study|Voluntary withdrawal of consent|1|||
94479674|NCT03430856|323548244|FG002|Overall Study|Voluntary withdrawal of consent|1|||
94479675|NCT01949142|323548245|FG000|Overall Study|Withdrawal of consent|1|||
94479676|NCT01949142|323548246|FG001|Overall Study|Withdrawal of consent|0|||
94479677|NCT01949142|323548245|FG000|Overall Study|Lost to Follow-up|1|||
94316231|NCT01318083|322940114|FG000|Overall Study|Treatment Complications|1|||
94316232|NCT01318083|322940115|FG001|Overall Study|Treatment Complications|0|||
94316233|NCT01318083|322940116|FG002|Overall Study|Treatment Complications|0|||
94479678|NCT01949142|323548246|FG001|Overall Study|Lost to Follow-up|1|||
94479679|NCT01949142|323548245|FG000|Overall Study|Parent changed their mind|1|||
94479680|NCT01949142|323548246|FG001|Overall Study|Parent changed their mind|0|||
94479681|NCT01395810|323548253|FG000|Overall Study|Adverse Event|0|||
94479682|NCT01395810|323548254|FG001|Overall Study|Adverse Event|1|||
94479683|NCT01395810|323548255|FG002|Overall Study|Adverse Event|0|||
94479684|NCT01395810|323548256|FG003|Overall Study|Adverse Event|0|||
94479685|NCT01395810|323548253|FG000|Overall Study|Lack of Efficacy|0|||
94479686|NCT01395810|323548254|FG001|Overall Study|Lack of Efficacy|1|||
94479687|NCT01395810|323548255|FG002|Overall Study|Lack of Efficacy|0|||
94479688|NCT01395810|323548256|FG003|Overall Study|Lack of Efficacy|0|||
94479689|NCT01395810|323548253|FG000|Overall Study|Withdrawal criteria|0|||
94479690|NCT01395810|323548254|FG001|Overall Study|Withdrawal criteria|2|||
94479691|NCT01395810|323548255|FG002|Overall Study|Withdrawal criteria|0|||
94479692|NCT01395810|323548256|FG003|Overall Study|Withdrawal criteria|0|||
94479693|NCT01395810|323548253|FG000|Overall Study|Unclassified|2|||
94479694|NCT01395810|323548254|FG001|Overall Study|Unclassified|0|||
94479695|NCT01395810|323548255|FG002|Overall Study|Unclassified|0|||
94479696|NCT01395810|323548256|FG003|Overall Study|Unclassified|0|||
94479697|NCT05027815|323548257|FG000|Overall Study|Death|2|||
94479698|NCT05027815|323548258|FG001|Overall Study|Death|1|||
94479699|NCT01919164|323549721|FG000|Overall Study|Adverse Event|6|||
94479700|NCT01919164|323549722|FG001|Overall Study|Adverse Event|4|||
94479701|NCT01919164|323549723|FG002|Overall Study|Adverse Event|9|||
94479702|NCT01919164|323549724|FG003|Overall Study|Adverse Event|3|||
94479703|NCT01919164|323549725|FG004|Overall Study|Adverse Event|2|||
94479704|NCT01919164|323549721|FG000|Overall Study|Lost to Follow-up|2|||
94479705|NCT01919164|323549722|FG001|Overall Study|Lost to Follow-up|2|||
94479706|NCT01919164|323549723|FG002|Overall Study|Lost to Follow-up|2|||
94479707|NCT01919164|323549724|FG003|Overall Study|Lost to Follow-up|0|||
94479708|NCT01919164|323549725|FG004|Overall Study|Lost to Follow-up|4|||
94479709|NCT01919164|323549721|FG000|Overall Study|Death|1|||
94479710|NCT01919164|323549722|FG001|Overall Study|Death|0|||
94479711|NCT01919164|323549723|FG002|Overall Study|Death|0|||
94479712|NCT01919164|323549724|FG003|Overall Study|Death|0|||
94479713|NCT01919164|323549725|FG004|Overall Study|Death|0|||
94479714|NCT01919164|323549721|FG000|Overall Study|Protocol Violation|6|||
94479715|NCT01919164|323549722|FG001|Overall Study|Protocol Violation|0|||
94479716|NCT01919164|323549723|FG002|Overall Study|Protocol Violation|3|||
94479717|NCT01919164|323549724|FG003|Overall Study|Protocol Violation|2|||
94479718|NCT01919164|323549725|FG004|Overall Study|Protocol Violation|2|||
94479719|NCT01919164|323549721|FG000|Overall Study|Disease progression|2|||
94479720|NCT01919164|323549722|FG001|Overall Study|Disease progression|2|||
94479721|NCT01919164|323549723|FG002|Overall Study|Disease progression|1|||
94479722|NCT01919164|323549724|FG003|Overall Study|Disease progression|2|||
94479723|NCT01919164|323549725|FG004|Overall Study|Disease progression|1|||
94479724|NCT01919164|323549721|FG000|Overall Study|Withdrew consent|13|||
94479725|NCT01919164|323549722|FG001|Overall Study|Withdrew consent|13|||
94479726|NCT01919164|323549723|FG002|Overall Study|Withdrew consent|14|||
94479727|NCT01919164|323549724|FG003|Overall Study|Withdrew consent|14|||
94479728|NCT01919164|323549725|FG004|Overall Study|Withdrew consent|9|||
94479729|NCT01919164|323549721|FG000|Overall Study|Other Un-specified|13|||
94479730|NCT01919164|323549722|FG001|Overall Study|Other Un-specified|9|||
94479731|NCT01919164|323549723|FG002|Overall Study|Other Un-specified|8|||
94479732|NCT01919164|323549724|FG003|Overall Study|Other Un-specified|7|||
94479733|NCT01919164|323549725|FG004|Overall Study|Other Un-specified|15|||
94479734|NCT00669318|323549726|FG000|Overall Study|Withdrawal by Subject|2|||
94479735|NCT02121795|323549727|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
94479736|NCT02121795|323549728|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
94479737|NCT02121795|323549727|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
94479738|NCT02121795|323549728|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
94479739|NCT02121795|323549727|FG000|Double-Blind Phase|Lost to Follow-up|7|||
94479740|NCT02121795|323549728|FG001|Double-Blind Phase|Lost to Follow-up|4|||
94479741|NCT02121795|323549727|FG000|Double-Blind Phase|Physician Decision|2|||
94479742|NCT02121795|323549728|FG001|Double-Blind Phase|Physician Decision|5|||
94479743|NCT02121795|323549727|FG000|Double-Blind Phase|Adverse Event|5|||
94479744|NCT02121795|323549728|FG001|Double-Blind Phase|Adverse Event|0|||
94479745|NCT02121795|323549727|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
94479746|NCT02121795|323549728|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
94479747|NCT02121795|323549727|FG000|Double-Blind Phase|Protocol Violation|0|||
94479748|NCT02121795|323549728|FG001|Double-Blind Phase|Protocol Violation|3|||
94479749|NCT02121795|323549727|FG000|Double-Blind Phase|Death|1|||
94479750|NCT02121795|323549728|FG001|Double-Blind Phase|Death|1|||
94479751|NCT02121795|323549727|FG000|Open-Label Phase|Physician Decision|8|||
94479752|NCT02121795|323549728|FG001|Open-Label Phase|Physician Decision|8|||
94479753|NCT02121795|323549727|FG000|Open-Label Phase|Withdrawal by Subject|3|||
94479754|NCT02121795|323549728|FG001|Open-Label Phase|Withdrawal by Subject|2|||
94479755|NCT02121795|323549727|FG000|Open-Label Phase|Lost to Follow-up|1|||
94479756|NCT02121795|323549728|FG001|Open-Label Phase|Lost to Follow-up|0|||
94479757|NCT00666211|323549731|FG000|Overall Study|Withdrawal by Subject|10|||
94479758|NCT00666211|323549732|FG001|Overall Study|Withdrawal by Subject|13|||
94479759|NCT00666211|323549731|FG000|Overall Study|went off medication, no more pain|1|||
94479760|NCT00666211|323549732|FG001|Overall Study|went off medication, no more pain|0|||
94316234|NCT01318083|322940114|FG000|Overall Study|Lack of Study Medication Compliance|0|||
94316235|NCT01318083|322940115|FG001|Overall Study|Lack of Study Medication Compliance|1|||
94316236|NCT01318083|322940116|FG002|Overall Study|Lack of Study Medication Compliance|0|||
94316237|NCT01355068|322940119|FG000|First Intervention Period|Adverse Event|0|||
94316238|NCT01355068|322940120|FG001|First Intervention Period|Adverse Event|1|||
94316239|NCT01355068|322940119|FG000|First Intervention Period|Withdrawal by Subject|0|||
94316240|NCT01355068|322940120|FG001|First Intervention Period|Withdrawal by Subject|1|||
94316241|NCT00524745|322940127|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
94316242|NCT00524745|322940128|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
94479761|NCT00666211|323549731|FG000|Overall Study|patient non-compliant|6|||
94479762|NCT00666211|323549732|FG001|Overall Study|patient non-compliant|6|||
94479763|NCT00666211|323549731|FG000|Overall Study|disease progression|1|||
94479764|NCT00666211|323549732|FG001|Overall Study|disease progression|8|||
94479765|NCT00666211|323549731|FG000|Overall Study|Lost to Follow-up|2|||
94479766|NCT00666211|323549732|FG001|Overall Study|Lost to Follow-up|0|||
94479767|NCT00666211|323549731|FG000|Overall Study|toxicity|0|||
94479768|NCT00666211|323549732|FG001|Overall Study|toxicity|2|||
94479769|NCT00666211|323549731|FG000|Overall Study|hospital admission|0|||
94479770|NCT00666211|323549732|FG001|Overall Study|hospital admission|5|||
94479771|NCT00666211|323549731|FG000|Overall Study|Death|0|||
94479772|NCT00666211|323549732|FG001|Overall Study|Death|2|||
94479773|NCT00666211|323549731|FG000|Overall Study|off tx for other complicating disease|0|||
94479774|NCT00666211|323549732|FG001|Overall Study|off tx for other complicating disease|1|||
94479775|NCT00666211|323549731|FG000|Overall Study|Physician Decision|0|||
94479776|NCT00666211|323549732|FG001|Overall Study|Physician Decision|1|||
94479777|NCT03280056|323549733|FG000|Overall Study|Withdrawal by Subject|12|||
94479778|NCT03280056|323549734|FG001|Overall Study|Withdrawal by Subject|14|||
94479779|NCT03280056|323549733|FG000|Overall Study|Death|9|||
94479780|NCT03280056|323549734|FG001|Overall Study|Death|2|||
94479781|NCT03280056|323549733|FG000|Overall Study|Adverse Event|1|||
94479782|NCT03280056|323549734|FG001|Overall Study|Adverse Event|3|||
94479783|NCT03280056|323549733|FG000|Overall Study|Lost to Follow-up|1|||
94479784|NCT03280056|323549734|FG001|Overall Study|Lost to Follow-up|1|||
94479785|NCT03280056|323549733|FG000|Overall Study|Physician Decision|0|||
94479786|NCT03280056|323549734|FG001|Overall Study|Physician Decision|1|||
94479787|NCT03280056|323549733|FG000|Overall Study|Early Discontinuation|1|||
94479788|NCT03280056|323549734|FG001|Overall Study|Early Discontinuation|0|||
94479789|NCT00610168|323549736|FG000|Overall Study|Withdrawal by Subject|2|||
94479790|NCT00610168|323549737|FG001|Overall Study|Withdrawal by Subject|0|||
94479791|NCT00130689|323549740|FG000|Overall Study|Progressive Disease|29|||
94479792|NCT00130689|323549740|FG000|Overall Study|Death|1|||
94479793|NCT00130689|323549740|FG000|Overall Study|Clinical Deterioration|4|||
94479794|NCT00130689|323549740|FG000|Overall Study|Withdrawal by Subject|3|||
94479795|NCT00130689|323549740|FG000|Overall Study|Ineligible|6|||
94479796|NCT00766597|323549741|FG000|Overall Study|Unexpected closure of study|4|||
94479797|NCT00766597|323549741|FG000|Overall Study|Without CCR5-tropic virus|5|||
94479798|NCT00878800|323549742|FG000|Overall Study|Adverse Event|0|||
94479799|NCT00878800|323549743|FG001|Overall Study|Adverse Event|0|||
94479800|NCT00878800|323549744|FG002|Overall Study|Adverse Event|2|||
94479801|NCT00878800|323549745|FG003|Overall Study|Adverse Event|0|||
94479802|NCT00878800|323549746|FG004|Overall Study|Adverse Event|1|||
94479803|NCT00878800|323549742|FG000|Overall Study|Progressive disease|1|||
94479804|NCT00878800|323549743|FG001|Overall Study|Progressive disease|5|||
94479805|NCT00878800|323549744|FG002|Overall Study|Progressive disease|6|||
94479806|NCT00878800|323549745|FG003|Overall Study|Progressive disease|5|||
94479807|NCT00878800|323549746|FG004|Overall Study|Progressive disease|13|||
94479808|NCT00878800|323549742|FG000|Overall Study|Withdrew consent|1|||
94479809|NCT00878800|323549743|FG001|Overall Study|Withdrew consent|1|||
94479810|NCT00878800|323549744|FG002|Overall Study|Withdrew consent|0|||
94479811|NCT00878800|323549745|FG003|Overall Study|Withdrew consent|1|||
94479812|NCT00878800|323549746|FG004|Overall Study|Withdrew consent|1|||
94479813|NCT00878800|323549742|FG000|Overall Study|Death|0|||
94479814|NCT00878800|323549743|FG001|Overall Study|Death|0|||
94479815|NCT00878800|323549744|FG002|Overall Study|Death|1|||
94479816|NCT00878800|323549745|FG003|Overall Study|Death|0|||
94316243|NCT00524745|322940129|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
94316244|NCT00524745|322940130|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
94479817|NCT00878800|323549746|FG004|Overall Study|Death|0|||
94479818|NCT00878800|323549742|FG000|Overall Study|Other|1|||
94479819|NCT00878800|323549743|FG001|Overall Study|Other|1|||
94479820|NCT00878800|323549744|FG002|Overall Study|Other|0|||
94479821|NCT00878800|323549745|FG003|Overall Study|Other|0|||
94479822|NCT00878800|323549746|FG004|Overall Study|Other|1|||
94479823|NCT04878055|323549747|FG000|Overall Study|Patient transferred in another department|0|||
94479824|NCT04878055|323549748|FG001|Overall Study|Patient transferred in another department|2|||
94479825|NCT04878055|323549747|FG000|Overall Study|Physician Decision|1|||
94479826|NCT04878055|323549748|FG001|Overall Study|Physician Decision|1|||
94479827|NCT04878055|323549747|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
94479828|NCT04878055|323549748|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
94479829|NCT04878055|323549747|FG000|Overall Study|Adverse Event|12|||
94479830|NCT04878055|323549748|FG001|Overall Study|Adverse Event|7|||
94479831|NCT04878055|323549747|FG000|Overall Study|Other|5|||
94479832|NCT04878055|323549748|FG001|Overall Study|Other|0|||
94479833|NCT04878055|323549747|FG000|Overall Study|Withdrawal by Subject|7|||
94479834|NCT04878055|323549748|FG001|Overall Study|Withdrawal by Subject|3|||
94479835|NCT04878055|323549747|FG000|Overall Study|Lost to Follow-up|10|||
94479836|NCT04878055|323549748|FG001|Overall Study|Lost to Follow-up|1|||
94479837|NCT02907463|323549749|FG000|Overall Study|Lost to Follow-up|17|||
94479838|NCT02907463|323549749|FG000|Overall Study|Death|10|||
94479839|NCT02907463|323549749|FG000|Overall Study|Withdrawal by Subject|4|||
94479840|NCT02907463|323549749|FG000|Overall Study|MIS Approach was not used|2|||
94479841|NCT02907463|323549749|FG000|Overall Study|Not Implanted with Study Device|2|||
94479842|NCT02907463|323549749|FG000|Overall Study|Device Explanted|1|||
94479843|NCT02907463|323549749|FG000|Overall Study|Missing Exit Form|1|||
94479844|NCT01064414|323549750|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
94479845|NCT01064414|323549751|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
94479846|NCT01064414|323549752|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
94479847|NCT01064414|323549750|FG000|Core Period: Baseline to Week 26|Death|0|||
94479848|NCT01064414|323549751|FG001|Core Period: Baseline to Week 26|Death|1|||
94479849|NCT01064414|323549752|FG002|Core Period: Baseline to Week 26|Death|0|||
94479850|NCT01064414|323549750|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
94479851|NCT01064414|323549751|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
94479852|NCT01064414|323549752|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
94479853|NCT01064414|323549750|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
94479854|NCT01064414|323549751|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
94479855|NCT01064414|323549752|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
94479856|NCT01064414|323549750|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
94479857|NCT01064414|323549751|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
94479858|NCT01064414|323549752|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
94479859|NCT01064414|323549750|FG000|Core Period: Baseline to Week 26|Other|4|||
94479860|NCT01064414|323549751|FG001|Core Period: Baseline to Week 26|Other|7|||
94479861|NCT01064414|323549752|FG002|Core Period: Baseline to Week 26|Other|2|||
94479862|NCT01064414|323549750|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
94479863|NCT01064414|323549751|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
94479864|NCT01064414|323549752|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
94479865|NCT01064414|323549750|FG000|Extension Period: Week 26 to Week 52|Death|0|||
94479866|NCT01064414|323549751|FG001|Extension Period: Week 26 to Week 52|Death|1|||
94479867|NCT01064414|323549752|FG002|Extension Period: Week 26 to Week 52|Death|0|||
94479868|NCT01064414|323549750|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
94479869|NCT01064414|323549751|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
94479870|NCT01064414|323549752|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
94479871|NCT01064414|323549750|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
94479872|NCT01064414|323549751|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
94479873|NCT01064414|323549752|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
94479874|NCT01064414|323549750|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
94479875|NCT01064414|323549751|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
94479876|NCT01064414|323549752|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
94479877|NCT01064414|323549750|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
94479878|NCT01064414|323549751|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
94479879|NCT01064414|323549752|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
94479880|NCT01064414|323549750|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
94479881|NCT01064414|323549751|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
94479882|NCT01064414|323549752|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
94479883|NCT01064414|323549750|FG000|Extension Period: Week 26 to Week 52|Other|5|||
94479884|NCT01064414|323549751|FG001|Extension Period: Week 26 to Week 52|Other|2|||
94479885|NCT01064414|323549752|FG002|Extension Period: Week 26 to Week 52|Other|1|||
94479886|NCT00249873|323549753|FG000|Overall Study|Not treated|7|||
94479887|NCT00249873|323549754|FG001|Overall Study|Not treated|8|||
94316245|NCT00256867|322940131|FG000|Overall Study|Adverse Event|0|||
94316246|NCT00256867|322940132|FG001|Overall Study|Adverse Event|1|||
94316247|NCT00256867|322940133|FG002|Overall Study|Adverse Event|1|||
94316248|NCT00256867|322940134|FG003|Overall Study|Adverse Event|1|||
94316249|NCT00256867|322940135|FG004|Overall Study|Adverse Event|2|||
94479888|NCT00249873|323549753|FG000|Overall Study|Significant thrombocytopenia|9|||
94316250|NCT00256867|322940136|FG005|Overall Study|Adverse Event|2|||
94479889|NCT00249873|323549754|FG001|Overall Study|Significant thrombocytopenia|8|||
94479890|NCT00249873|323549753|FG000|Overall Study|Severe allergic reaction|8|||
94479891|NCT00249873|323549754|FG001|Overall Study|Severe allergic reaction|1|||
94479892|NCT00249873|323549753|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
94479893|NCT00249873|323549754|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
94479894|NCT00249873|323549753|FG000|Overall Study|Other Serious Adverse Event|86|||
94479895|NCT00249873|323549754|FG001|Overall Study|Other Serious Adverse Event|97|||
94479896|NCT00249873|323549753|FG000|Overall Study|Qualifying condition not present|20|||
94479897|NCT00249873|323549754|FG001|Overall Study|Qualifying condition not present|23|||
94479898|NCT00249873|323549753|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
94479899|NCT00249873|323549754|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
94479900|NCT00249873|323549753|FG000|Overall Study|Withdrawal by Subject|504|||
94479901|NCT00249873|323549754|FG001|Overall Study|Withdrawal by Subject|466|||
94479902|NCT00249873|323549753|FG000|Overall Study|Lost to Follow-up|4|||
94479903|NCT00249873|323549754|FG001|Overall Study|Lost to Follow-up|7|||
94479904|NCT00249873|323549753|FG000|Overall Study|Minor bleeding|99|||
94479905|NCT00249873|323549754|FG001|Overall Study|Minor bleeding|37|||
94479906|NCT00249873|323549753|FG000|Overall Study|Non-compliance|41|||
94479907|NCT00249873|323549754|FG001|Overall Study|Non-compliance|46|||
94479908|NCT00249873|323549753|FG000|Overall Study|Other non serious Adverse Event|112|||
94479909|NCT00249873|323549754|FG001|Overall Study|Other non serious Adverse Event|108|||
94479910|NCT00249873|323549753|FG000|Overall Study|Other contraindicated medication|1|||
94479911|NCT00249873|323549754|FG001|Overall Study|Other contraindicated medication|0|||
94479912|NCT00249873|323549753|FG000|Overall Study|Patient not wish to continue after May08|3|||
94479913|NCT00249873|323549754|FG001|Overall Study|Patient not wish to continue after May08|4|||
94479914|NCT00249873|323549753|FG000|Overall Study|Physician withdrew consent|59|||
94479915|NCT00249873|323549754|FG001|Overall Study|Physician withdrew consent|60|||
94479916|NCT00249873|323549753|FG000|Overall Study|Open label clopidogrel required|31|||
94479917|NCT00249873|323549754|FG001|Overall Study|Open label clopidogrel required|42|||
94479918|NCT00249873|323549753|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
94479919|NCT00249873|323549754|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
94479920|NCT00249873|323549753|FG000|Overall Study|Oral anticoagulant required|159|||
94479921|NCT00249873|323549754|FG001|Overall Study|Oral anticoagulant required|157|||
94479922|NCT00249873|323549753|FG000|Overall Study|Study drug intolerance|5|||
94479923|NCT00249873|323549754|FG001|Overall Study|Study drug intolerance|0|||
94479924|NCT00249873|323549753|FG000|Overall Study|Surgery/ procedure|9|||
94479925|NCT00249873|323549754|FG001|Overall Study|Surgery/ procedure|9|||
94479926|NCT00249873|323549753|FG000|Overall Study|Event related to cardiac condition|12|||
94479927|NCT00249873|323549754|FG001|Overall Study|Event related to cardiac condition|21|||
94479928|NCT00249873|323549753|FG000|Overall Study|Thromboembolic/outcome event|82|||
94479929|NCT00249873|323549754|FG001|Overall Study|Thromboembolic/outcome event|122|||
94479930|NCT02595502|323549755|FG000|Period 1|Adverse Event|0|||
94479931|NCT02595502|323549756|FG001|Period 1|Adverse Event|1|||
94479932|NCT02595502|323549755|FG000|Period 1|Withdrawal by Subject|1|||
94479933|NCT02595502|323549756|FG001|Period 1|Withdrawal by Subject|0|||
94479934|NCT02595502|323549755|FG000|Period 1|Lost to Follow-up|0|||
94479935|NCT02595502|323549756|FG001|Period 1|Lost to Follow-up|1|||
94479936|NCT02595502|323549755|FG000|Period 2|Adverse Event|1|||
94479937|NCT02595502|323549756|FG001|Period 2|Adverse Event|1|||
94479938|NCT02595502|323549755|FG000|Period 2|Received incorrect lens at Period 1|0|||
94479939|NCT02595502|323549756|FG001|Period 2|Received incorrect lens at Period 1|1|||
94479940|NCT02595502|323549755|FG000|Period 3|Protocol Violation|0|||
94479941|NCT02595502|323549756|FG001|Period 3|Protocol Violation|1|||
94479942|NCT02595502|323549755|FG000|Period 3|Lost to Follow-up|1|||
94479943|NCT02595502|323549756|FG001|Period 3|Lost to Follow-up|0|||
94479944|NCT02595502|323549755|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
94479945|NCT02595502|323549756|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
94479946|NCT00974311|323549757|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
94479947|NCT00974311|323549758|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
94479948|NCT00974311|323549757|FG000|DB Phase (up to 24 Months)|Death|561|||
94479949|NCT00974311|323549758|FG001|DB Phase (up to 24 Months)|Death|298|||
94479950|NCT00974311|323549757|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
94479951|NCT00974311|323549758|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
94479952|NCT00974311|323549757|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
94479953|NCT00974311|323549758|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
94479954|NCT00974311|323549757|FG000|DB Phase (up to 24 Months)|Other|1|||
94479955|NCT00974311|323549758|FG001|DB Phase (up to 24 Months)|Other|0|||
94479956|NCT00974311|323549757|FG000|OLE Phase (up to 77 Months)|Death|14|||
94479957|NCT00974311|323549758|FG001|OLE Phase (up to 77 Months)|Death|21|||
94479958|NCT00974311|323549757|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
94479959|NCT00974311|323549758|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
94479960|NCT00974311|323549757|FG000|OLE Phase (up to 77 Months)|Other|15|||
94479961|NCT00974311|323549758|FG001|OLE Phase (up to 77 Months)|Other|2|||
94479962|NCT00974311|323549757|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
94479963|NCT00974311|323549758|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
94479964|NCT03131167|323549760|FG000|Overall Study|Other (Unspecified)|0|||
94479965|NCT03131167|323549761|FG001|Overall Study|Other (Unspecified)|0|||
94479966|NCT03131167|323549762|FG002|Overall Study|Other (Unspecified)|0|||
94479967|NCT03131167|323549763|FG003|Overall Study|Other (Unspecified)|0|||
94479968|NCT03131167|323549764|FG004|Overall Study|Other (Unspecified)|0|||
94479969|NCT03131167|323549765|FG005|Overall Study|Other (Unspecified)|1|||
94479970|NCT03131167|323549766|FG006|Overall Study|Other (Unspecified)|0|||
94479971|NCT03131167|323549767|FG007|Overall Study|Other (Unspecified)|0|||
94479972|NCT03131167|323549768|FG008|Overall Study|Other (Unspecified)|0|||
94479973|NCT03131167|323549769|FG009|Overall Study|Other (Unspecified)|0|||
94479974|NCT03131167|323549770|FG010|Overall Study|Other (Unspecified)|0|||
94479975|NCT03131167|323549771|FG011|Overall Study|Other (Unspecified)|0|||
94479976|NCT03131167|323549772|FG012|Overall Study|Other (Unspecified)|0|||
94479977|NCT02849743|323549776|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
94479978|NCT02849743|323549777|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
94479979|NCT02849743|323549776|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
94479980|NCT02849743|323549777|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
94479981|NCT01096160|323549780|FG000|Overall Study|Adverse Event|0|||
94479982|NCT01096160|323549781|FG001|Overall Study|Adverse Event|0|||
94479983|NCT01096160|323549782|FG002|Overall Study|Adverse Event|1|||
94479984|NCT01096160|323549783|FG003|Overall Study|Adverse Event|0|||
94479985|NCT01096160|323549784|FG004|Overall Study|Adverse Event|0|||
94479986|NCT01096160|323549785|FG005|Overall Study|Adverse Event|0|||
94479987|NCT01096160|323549786|FG006|Overall Study|Adverse Event|0|||
94479988|NCT01096160|323549787|FG007|Overall Study|Adverse Event|0|||
94479989|NCT01096160|323549788|FG008|Overall Study|Adverse Event|0|||
94479990|NCT01096160|323549789|FG009|Overall Study|Adverse Event|1|||
94479991|NCT01096160|323549780|FG000|Overall Study|Met stopping criteria per protocol|0|||
94479992|NCT01096160|323549781|FG001|Overall Study|Met stopping criteria per protocol|0|||
94479993|NCT01096160|323549782|FG002|Overall Study|Met stopping criteria per protocol|0|||
94479994|NCT01096160|323549783|FG003|Overall Study|Met stopping criteria per protocol|0|||
94479995|NCT01096160|323549784|FG004|Overall Study|Met stopping criteria per protocol|1|||
94479996|NCT01096160|323549785|FG005|Overall Study|Met stopping criteria per protocol|0|||
94479997|NCT01096160|323549786|FG006|Overall Study|Met stopping criteria per protocol|2|||
94479998|NCT01096160|323549787|FG007|Overall Study|Met stopping criteria per protocol|0|||
94479999|NCT01096160|323549788|FG008|Overall Study|Met stopping criteria per protocol|2|||
94480000|NCT01096160|323549789|FG009|Overall Study|Met stopping criteria per protocol|0|||
94480001|NCT01610037|323549790|FG000|All Patients|Adverse Event|27|||
94480002|NCT01610037|323549791|FG001|All Patients|Adverse Event|22|||
94480003|NCT01610037|323549792|FG002|All Patients|Adverse Event|26|||
94480004|NCT01610037|323549790|FG000|All Patients|Withdrawal by Subject|12|||
94480005|NCT01610037|323549791|FG001|All Patients|Withdrawal by Subject|10|||
94480006|NCT01610037|323549792|FG002|All Patients|Withdrawal by Subject|20|||
94480007|NCT01610037|323549790|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
94480008|NCT01610037|323549791|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
94480009|NCT01610037|323549792|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
94480010|NCT01610037|323549790|FG000|All Patients|Death|4|||
94480011|NCT01610037|323549791|FG001|All Patients|Death|2|||
94480012|NCT01610037|323549792|FG002|All Patients|Death|1|||
94480013|NCT01610037|323549790|FG000|All Patients|Protocol deviation|4|||
94480014|NCT01610037|323549791|FG001|All Patients|Protocol deviation|3|||
94480015|NCT01610037|323549792|FG002|All Patients|Protocol deviation|3|||
94480016|NCT01610037|323549790|FG000|All Patients|Abnormal laboratory value|1|||
94480017|NCT01610037|323549791|FG001|All Patients|Abnormal laboratory value|1|||
94480018|NCT01610037|323549792|FG002|All Patients|Abnormal laboratory value|0|||
94480019|NCT01610037|323549790|FG000|All Patients|Administrative problems|1|||
94480020|NCT01610037|323549791|FG001|All Patients|Administrative problems|4|||
94480021|NCT01610037|323549792|FG002|All Patients|Administrative problems|4|||
94480022|NCT01610037|323549790|FG000|All Patients|Lost to Follow-up|1|||
94480023|NCT01610037|323549791|FG001|All Patients|Lost to Follow-up|0|||
94480024|NCT01610037|323549792|FG002|All Patients|Lost to Follow-up|0|||
94480025|NCT01610037|323549790|FG000|All Patients|Abnormal test procedure result(s)|0|||
94480026|NCT01610037|323549791|FG001|All Patients|Abnormal test procedure result(s)|1|||
94480027|NCT01610037|323549792|FG002|All Patients|Abnormal test procedure result(s)|3|||
94480028|NCT01610037|323549790|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
94480029|NCT01610037|323549791|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
94480030|NCT01610037|323549792|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
94480031|NCT01610037|323549790|FG000|Treatment and Follow up Period|Death|10|||
94480032|NCT01610037|323549791|FG001|Treatment and Follow up Period|Death|5|||
94480033|NCT01610037|323549792|FG002|Treatment and Follow up Period|Death|4|||
94480034|NCT01610037|323549790|FG000|Treatment and Follow up Period|Administrative problems|1|||
94480035|NCT01610037|323549791|FG001|Treatment and Follow up Period|Administrative problems|3|||
94480036|NCT01610037|323549792|FG002|Treatment and Follow up Period|Administrative problems|2|||
94480037|NCT01610037|323549790|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
94480038|NCT01610037|323549791|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
94480039|NCT01610037|323549792|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
94480040|NCT00705757|323549793|FG000|Overall Study|Lack of Efficacy|5|||
94480041|NCT00705757|323549794|FG001|Overall Study|Lack of Efficacy|1|||
94480042|NCT00705757|323549795|FG002|Overall Study|Lack of Efficacy|3|||
94480043|NCT00705757|323549793|FG000|Overall Study|Lost to Follow-up|7|||
94480044|NCT00705757|323549794|FG001|Overall Study|Lost to Follow-up|6|||
94480045|NCT00705757|323549795|FG002|Overall Study|Lost to Follow-up|6|||
94480046|NCT00705757|323549793|FG000|Overall Study|Withdrawal by Subject|1|||
94480047|NCT00705757|323549794|FG001|Overall Study|Withdrawal by Subject|1|||
94480048|NCT00705757|323549795|FG002|Overall Study|Withdrawal by Subject|2|||
94480049|NCT05209880|323549796|FG000|1-Month Follow-up|Spoke with Doctor|5|||
94480050|NCT05209880|323549797|FG001|1-Month Follow-up|Spoke with Doctor|5|||
94480051|NCT05209880|323549796|FG000|1-Month Follow-up|Lost to Follow-up|7|||
94480052|NCT05209880|323549797|FG001|1-Month Follow-up|Lost to Follow-up|9|||
94480053|NCT05209880|323549796|FG000|1-Month Follow-up|Discontinued|0|||
94480054|NCT05209880|323549797|FG001|1-Month Follow-up|Discontinued|1|||
94480055|NCT05209880|323549796|FG000|3-Month Follow-up|Spoke with Doctor|17|||
94480056|NCT05209880|323549797|FG001|3-Month Follow-up|Spoke with Doctor|7|||
94480057|NCT05209880|323549796|FG000|3-Month Follow-up|Lost to Follow-up|8|||
94480058|NCT05209880|323549797|FG001|3-Month Follow-up|Lost to Follow-up|10|||
94480059|NCT05209880|323549796|FG000|3-Month Follow-up|Discontinued|1|||
94480060|NCT05209880|323549797|FG001|3-Month Follow-up|Discontinued|3|||
94480061|NCT05209880|323549796|FG000|6-Month Follow-up|Spoke with Doctor|25|||
94480062|NCT05209880|323549797|FG001|6-Month Follow-up|Spoke with Doctor|14|||
94480063|NCT05209880|323549796|FG000|6-Month Follow-up|Lost to Follow-up|9|||
94480064|NCT05209880|323549797|FG001|6-Month Follow-up|Lost to Follow-up|14|||
94480065|NCT05209880|323549796|FG000|6-Month Follow-up|Discontinued|1|||
94480066|NCT05209880|323549797|FG001|6-Month Follow-up|Discontinued|3|||
94480067|NCT05200845|323549800|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
94480068|NCT05200845|323549801|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
94480069|NCT05200845|323549802|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
94480070|NCT05200845|323549803|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
94480071|NCT05200845|323549800|FG000|Overall Study|Withdrawal by Subject|0|||
94480072|NCT05200845|323549801|FG001|Overall Study|Withdrawal by Subject|1|||
94480073|NCT05200845|323549802|FG002|Overall Study|Withdrawal by Subject|1|||
94480074|NCT05200845|323549803|FG003|Overall Study|Withdrawal by Subject|0|||
94480075|NCT00321906|323549804|FG000|Overall Study|Adverse Event|36|||
94480076|NCT00321906|323549805|FG001|Overall Study|Adverse Event|44|||
94480077|NCT00321906|323549804|FG000|Overall Study|Death|9|||
94480078|NCT00321906|323549805|FG001|Overall Study|Death|6|||
94480079|NCT00321906|323549804|FG000|Overall Study|Lost to Follow-up|1|||
94480080|NCT00321906|323549805|FG001|Overall Study|Lost to Follow-up|2|||
94480081|NCT00321906|323549804|FG000|Overall Study|Withdrawal by Subject|0|||
94480082|NCT00321906|323549805|FG001|Overall Study|Withdrawal by Subject|4|||
94480083|NCT03743025|323549806|FG000|Overall Study|Surgery was cancelled|2|||
94480084|NCT03743025|323549807|FG001|Overall Study|Surgery was cancelled|1|||
94480085|NCT00807885|323549811|FG000|Overall Study|Lost to Follow-up|0|||
94480086|NCT00807885|323549812|FG001|Overall Study|Lost to Follow-up|0|||
94480087|NCT00807885|323549813|FG002|Overall Study|Lost to Follow-up|0|||
94480088|NCT00807885|323549814|FG003|Overall Study|Lost to Follow-up|0|||
94480089|NCT00807885|323549815|FG004|Overall Study|Lost to Follow-up|0|||
94480090|NCT00807885|323549816|FG005|Overall Study|Lost to Follow-up|1|||
94480091|NCT00807885|323549817|FG006|Overall Study|Lost to Follow-up|0|||
94480092|NCT00807885|323549818|FG007|Overall Study|Lost to Follow-up|0|||
94480093|NCT00807885|323549819|FG008|Overall Study|Lost to Follow-up|0|||
94480094|NCT01534273|323549823|FG000|Period 1|Physician Decision|0|||
94480095|NCT01534273|323549824|FG001|Period 1|Physician Decision|0|||
94480096|NCT01534273|323549825|FG002|Period 1|Physician Decision|0|||
94480097|NCT01534273|323549826|FG003|Period 1|Physician Decision|1|||
94480098|NCT01534273|323549827|FG004|Period 1|Physician Decision|0|||
94480099|NCT01534273|323549828|FG005|Period 1|Physician Decision|0|||
94480100|NCT01534273|323549829|FG006|Period 1|Physician Decision|0|||
94480101|NCT00593918|323549832|FG000|Overall Study|Withdrawal by Subject|5|||
94480102|NCT00593918|323549833|FG001|Overall Study|Withdrawal by Subject|24|||
94480103|NCT02417753|323549836|FG000|Overall Study|Death|1|||
94480104|NCT04805671|323549839|FG000|Overall Study|Death|2|||
94480105|NCT04805671|323549840|FG001|Overall Study|Death|7|||
94480106|NCT04805671|323549839|FG000|Overall Study|Lost to Follow-up|1|||
94480107|NCT04805671|323549840|FG001|Overall Study|Lost to Follow-up|0|||
94480108|NCT04805671|323549839|FG000|Overall Study|Withdrawal by Subject|9|||
94480109|NCT04805671|323549840|FG001|Overall Study|Withdrawal by Subject|7|||
94480110|NCT04805671|323549839|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
94480111|NCT04805671|323549840|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
94480112|NCT03804268|323549841|FG000|Overall Study|Adverse Event|2|||
94480113|NCT03804268|323549842|FG001|Overall Study|Adverse Event|2|||
94480114|NCT03804268|323549841|FG000|Overall Study|Withdrawal by Subject|2|||
94480115|NCT03804268|323549842|FG001|Overall Study|Withdrawal by Subject|0|||
94480116|NCT03804268|323549841|FG000|Overall Study|Lost to Follow-up|1|||
94480117|NCT03804268|323549842|FG001|Overall Study|Lost to Follow-up|0|||
94480118|NCT03804268|323549841|FG000|Overall Study|Physician Decision|2|||
94480119|NCT03804268|323549842|FG001|Overall Study|Physician Decision|0|||
94480120|NCT00871234|323549843|FG000|Overall Study|Adverse Event|2|||
94480121|NCT00871234|323549843|FG000|Overall Study|Lost to Follow-up|3|||
94480122|NCT00385918|323549844|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
94480123|NCT00385918|323549845|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
94480124|NCT00385918|323549846|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
94480125|NCT00385918|323549844|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
94480126|NCT00385918|323549845|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
94480127|NCT00385918|323549846|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
94480128|NCT00385918|323549844|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
94480129|NCT00385918|323549845|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
94480130|NCT00385918|323549846|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
94480131|NCT00385918|323549844|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
94480132|NCT00385918|323549845|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
94480133|NCT00385918|323549846|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
94480134|NCT00385918|323549844|FG000|Intervention Phase After Randomization|Physician Decision|1|||
94480135|NCT00385918|323549845|FG001|Intervention Phase After Randomization|Physician Decision|0|||
94480136|NCT00385918|323549846|FG002|Intervention Phase After Randomization|Physician Decision|0|||
94480137|NCT00385918|323549844|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
94480138|NCT00385918|323549845|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
94480139|NCT00385918|323549846|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
94480140|NCT02256839|323549847|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
94480141|NCT02256839|323549848|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
94480142|NCT01261390|323549849|FG000|Overall Study|Significant Concurrent Illness|1|||
94480143|NCT01261390|323549850|FG001|Overall Study|Significant Concurrent Illness|0|||
94480144|NCT01261390|323549851|FG002|Overall Study|Significant Concurrent Illness|1|||
94480145|NCT01261390|323549852|FG003|Overall Study|Significant Concurrent Illness|0|||
94480146|NCT01261390|323549849|FG000|Overall Study|Dissatisfaction with Treatment|2|||
94480147|NCT01261390|323549850|FG001|Overall Study|Dissatisfaction with Treatment|1|||
94480148|NCT01261390|323549851|FG002|Overall Study|Dissatisfaction with Treatment|1|||
94480149|NCT01261390|323549852|FG003|Overall Study|Dissatisfaction with Treatment|2|||
94480150|NCT01261390|323549849|FG000|Overall Study|Relocation|0|||
94480151|NCT01261390|323549850|FG001|Overall Study|Relocation|1|||
94480152|NCT01261390|323549851|FG002|Overall Study|Relocation|0|||
94480153|NCT01261390|323549852|FG003|Overall Study|Relocation|0|||
94480154|NCT01261390|323549849|FG000|Overall Study|Loss of Interest in the Study|3|||
94480155|NCT01261390|323549850|FG001|Overall Study|Loss of Interest in the Study|1|||
94480156|NCT01261390|323549851|FG002|Overall Study|Loss of Interest in the Study|0|||
94480157|NCT01261390|323549852|FG003|Overall Study|Loss of Interest in the Study|0|||
94480158|NCT01261390|323549849|FG000|Overall Study|Lost to Follow-up|1|||
94480159|NCT01261390|323549850|FG001|Overall Study|Lost to Follow-up|6|||
94480160|NCT01261390|323549851|FG002|Overall Study|Lost to Follow-up|5|||
94480161|NCT01261390|323549852|FG003|Overall Study|Lost to Follow-up|6|||
94480162|NCT00810199|323549853|FG000|Overall Study|Adverse Event|24|||
94480163|NCT00810199|323549854|FG001|Overall Study|Adverse Event|26|||
94480164|NCT00810199|323549853|FG000|Overall Study|Death|4|||
94480165|NCT00810199|323549854|FG001|Overall Study|Death|6|||
94480166|NCT00810199|323549853|FG000|Overall Study|Withdrew consent|9|||
94480167|NCT00810199|323549854|FG001|Overall Study|Withdrew consent|12|||
94480168|NCT00810199|323549853|FG000|Overall Study|Insufficient therapeutic response|5|||
94480169|NCT00810199|323549854|FG001|Overall Study|Insufficient therapeutic response|14|||
94480170|NCT00810199|323549853|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
94480171|NCT00810199|323549854|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
94480172|NCT00810199|323549853|FG000|Overall Study|Administrative/Other|5|||
94480173|NCT00810199|323549854|FG001|Overall Study|Administrative/Other|6|||
94480174|NCT00810199|323549853|FG000|Overall Study|Protocol Violation|2|||
94480175|NCT00810199|323549854|FG001|Overall Study|Protocol Violation|6|||
94316251|NCT00256867|322940137|FG006|Overall Study|Adverse Event|1|||
94316252|NCT00256867|322940138|FG007|Overall Study|Adverse Event|4|||
94316253|NCT00256867|322940131|FG000|Overall Study|Lost to Follow-up|2|||
94316254|NCT00256867|322940132|FG001|Overall Study|Lost to Follow-up|2|||
94316255|NCT00256867|322940133|FG002|Overall Study|Lost to Follow-up|2|||
94316256|NCT00256867|322940134|FG003|Overall Study|Lost to Follow-up|3|||
94316257|NCT00256867|322940135|FG004|Overall Study|Lost to Follow-up|2|||
94480176|NCT00810199|323549853|FG000|Overall Study|Failure to return|1|||
94385131|NCT00117949|323196839|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
94385132|NCT00117949|323196840|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
94385133|NCT00117949|323196841|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
94385134|NCT00117949|323196842|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
94385135|NCT00117949|323196839|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
94385136|NCT00117949|323196840|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
94385137|NCT00117949|323196841|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
94385138|NCT00117949|323196842|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
94385139|NCT00117949|323196839|FG000|Overall Study|PSA increase >=10ng/mL|0|||
94385140|NCT00117949|323196840|FG001|Overall Study|PSA increase >=10ng/mL|1|||
94385141|NCT00117949|323196841|FG002|Overall Study|PSA increase >=10ng/mL|1|||
94385142|NCT00117949|323196842|FG003|Overall Study|PSA increase >=10ng/mL|0|||
94385143|NCT00117949|323196839|FG000|Overall Study|PSA reduction <=50%|0|||
94385144|NCT00117949|323196840|FG001|Overall Study|PSA reduction <=50%|2|||
94385145|NCT00117949|323196841|FG002|Overall Study|PSA reduction <=50%|2|||
94385146|NCT00117949|323196842|FG003|Overall Study|PSA reduction <=50%|4|||
94385147|NCT00117949|323196839|FG000|Overall Study|Hepatic abnormalities|0|||
94385148|NCT00117949|323196840|FG001|Overall Study|Hepatic abnormalities|1|||
94385149|NCT00117949|323196841|FG002|Overall Study|Hepatic abnormalities|0|||
94385150|NCT00117949|323196842|FG003|Overall Study|Hepatic abnormalities|1|||
94385151|NCT00950872|323196852|FG000|Overall Study|Withdrawal by Subject|1|||
94385152|NCT00950872|323196852|FG000|Overall Study|Did not have surgery|2|||
94385153|NCT00408902|323196853|FG000|Overall Study|Lack of Efficacy|7|||
94385154|NCT00408902|323196853|FG000|Overall Study|Adverse Event|3|||
94385155|NCT01139164|323196854|FG000|Overall Study|Withdrawn prior to study start|0|||
94385156|NCT01139164|323196855|FG001|Overall Study|Withdrawn prior to study start|2|||
94385157|NCT01139164|323196856|FG002|Overall Study|Withdrawn prior to study start|0|||
94385158|NCT00878995|323196857|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
94385159|NCT00878995|323196858|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
94385160|NCT01759290|323196859|FG000|Overall Study|Subjects withdrawn consent|5|||
94385161|NCT01759290|323196859|FG000|Overall Study|Physician Decision|2|||
94385162|NCT01759290|323196859|FG000|Overall Study|Death|17|||
94385163|NCT01759290|323196859|FG000|Overall Study|Lost to Follow-up|53|||
94385164|NCT01759290|323196859|FG000|Overall Study|Unknown reason|4|||
94385165|NCT00841100|323196860|FG000|Phase 1 (28 Days)|Adverse Event|1|||
94385166|NCT00841100|323196860|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
94385167|NCT01355081|323196863|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
94385168|NCT01355081|323196864|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
94385169|NCT01355081|323196865|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
94385170|NCT01355081|323196863|FG000|Overall Study|Major Protocol Deviation|0|||
94385171|NCT01355081|323196864|FG001|Overall Study|Major Protocol Deviation|1|||
94385172|NCT01355081|323196865|FG002|Overall Study|Major Protocol Deviation|0|||
94385173|NCT01355081|323196863|FG000|Overall Study|Lost to Follow-up|0|||
94385174|NCT01355081|323196864|FG001|Overall Study|Lost to Follow-up|0|||
94385175|NCT01355081|323196865|FG002|Overall Study|Lost to Follow-up|1|||
94385176|NCT01355081|323196863|FG000|Overall Study|Withdrawal of Consent|2|||
94385177|NCT01355081|323196864|FG001|Overall Study|Withdrawal of Consent|3|||
94385178|NCT01355081|323196865|FG002|Overall Study|Withdrawal of Consent|3|||
94385179|NCT01355081|323196863|FG000|Overall Study|Lack of Efficacy|2|||
94385180|NCT01355081|323196864|FG001|Overall Study|Lack of Efficacy|1|||
94385181|NCT01355081|323196865|FG002|Overall Study|Lack of Efficacy|1|||
94385182|NCT01355081|323196863|FG000|Overall Study|Non Compliance with Study Medication|0|||
94385183|NCT01355081|323196864|FG001|Overall Study|Non Compliance with Study Medication|1|||
94385184|NCT01355081|323196865|FG002|Overall Study|Non Compliance with Study Medication|0|||
94385185|NCT01790568|323196866|FG000|Overall Study|Progression prior to transplant|0|||
94385186|NCT01790568|323196867|FG001|Overall Study|Progression prior to transplant|1|||
94385187|NCT00352690|323196868|FG000|Overall Study|Determined to be ineligible|2|||
94385188|NCT00352690|323196869|FG001|Overall Study|Determined to be ineligible|0|||
94385189|NCT03595657|323196870|FG000|Overall Study|Adverse Event|14|||
94385190|NCT03595657|323196870|FG000|Overall Study|Death|1|||
94385191|NCT03595657|323196870|FG000|Overall Study|Lack of Efficacy|40|||
94385192|NCT03595657|323196870|FG000|Overall Study|Withdrawal by Subject|10|||
94385193|NCT03595657|323196870|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
94385194|NCT03595657|323196870|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
94385195|NCT00694551|323196885|FG000|Overall Study|Disease Progression|1|||
94385196|NCT00694551|323196886|FG001|Overall Study|Disease Progression|0|||
94385197|NCT00694551|323196887|FG002|Overall Study|Disease Progression|1|||
94316258|NCT00256867|322940136|FG005|Overall Study|Lost to Follow-up|0|||
94316259|NCT00256867|322940137|FG006|Overall Study|Lost to Follow-up|1|||
94316260|NCT00256867|322940138|FG007|Overall Study|Lost to Follow-up|2|||
94316261|NCT00256867|322940131|FG000|Overall Study|Protocol Violation|0|||
94316262|NCT00256867|322940132|FG001|Overall Study|Protocol Violation|0|||
94316263|NCT00256867|322940133|FG002|Overall Study|Protocol Violation|0|||
94316264|NCT00256867|322940134|FG003|Overall Study|Protocol Violation|1|||
94316265|NCT00256867|322940135|FG004|Overall Study|Protocol Violation|0|||
94316266|NCT00256867|322940136|FG005|Overall Study|Protocol Violation|1|||
94316267|NCT00256867|322940137|FG006|Overall Study|Protocol Violation|0|||
94316268|NCT00256867|322940138|FG007|Overall Study|Protocol Violation|1|||
94316269|NCT00256867|322940131|FG000|Overall Study|Withdrawal by Subject|0|||
94316270|NCT00256867|322940132|FG001|Overall Study|Withdrawal by Subject|0|||
94316271|NCT00256867|322940133|FG002|Overall Study|Withdrawal by Subject|1|||
94480177|NCT00810199|323549854|FG001|Overall Study|Failure to return|4|||
94480178|NCT00810199|323549853|FG000|Overall Study|Did not receive study drug|2|||
94480179|NCT00810199|323549854|FG001|Overall Study|Did not receive study drug|1|||
94480180|NCT00753675|323549857|FG000|Overall Study|other reason|11|||
94480181|NCT00753675|323549858|FG001|Overall Study|other reason|12|||
94480182|NCT00753675|323549859|FG002|Overall Study|other reason|13|||
94480183|NCT00753675|323549857|FG000|Overall Study|Death|1|||
94480184|NCT00753675|323549858|FG001|Overall Study|Death|2|||
94480185|NCT00753675|323549859|FG002|Overall Study|Death|4|||
94480186|NCT00753675|323549857|FG000|Overall Study|Adverse Event|11|||
94480187|NCT00753675|323549858|FG001|Overall Study|Adverse Event|9|||
94480188|NCT00753675|323549859|FG002|Overall Study|Adverse Event|4|||
94480189|NCT00753675|323549857|FG000|Overall Study|Objective progression of disease|35|||
94480190|NCT00753675|323549858|FG001|Overall Study|Objective progression of disease|35|||
94480191|NCT00753675|323549859|FG002|Overall Study|Objective progression of disease|35|||
94480192|NCT00753675|323549857|FG000|Overall Study|Withdrawal by Subject|0|||
94480193|NCT00753675|323549858|FG001|Overall Study|Withdrawal by Subject|1|||
94480194|NCT00753675|323549859|FG002|Overall Study|Withdrawal by Subject|0|||
94480195|NCT00753675|323549857|FG000|Overall Study|Lost to Follow-up|1|||
94480196|NCT00753675|323549858|FG001|Overall Study|Lost to Follow-up|0|||
94480197|NCT00753675|323549859|FG002|Overall Study|Lost to Follow-up|0|||
94480198|NCT03283930|323549861|FG000|Overall Study|Scheduling conflict|8|||
94480199|NCT03283930|323549862|FG001|Overall Study|Scheduling conflict|10|||
94480200|NCT03283930|323549861|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
94480201|NCT03283930|323549862|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
94480202|NCT03283930|323549861|FG000|Overall Study|Technical software issue|2|||
94480203|NCT03283930|323549862|FG001|Overall Study|Technical software issue|2|||
94480204|NCT05502302|323549863|FG000|Overall Study|Lost to Follow-up|6|||
94480205|NCT05502302|323549863|FG000|Overall Study|Death|2|||
94480206|NCT00101868|323549864|FG000|Overall Study|Death|10|||
94480207|NCT00101868|323549865|FG001|Overall Study|Death|10|||
94480208|NCT00101868|323549864|FG000|Overall Study|Withdrawal by Subject|8|||
94480209|NCT00101868|323549865|FG001|Overall Study|Withdrawal by Subject|9|||
94480210|NCT00101868|323549864|FG000|Overall Study|Protocol Violation|3|||
94480211|NCT00101868|323549865|FG001|Overall Study|Protocol Violation|0|||
94480212|NCT00101868|323549864|FG000|Overall Study|Lost to Follow-up|8|||
94480213|NCT00101868|323549865|FG001|Overall Study|Lost to Follow-up|13|||
94480214|NCT05259163|323552108|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
94480215|NCT05259163|323552109|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
94480216|NCT02100839|323552112|FG000|Multiple Ascending Dose|Adverse Event|2|||
94480217|NCT02100839|323552113|FG001|Multiple Ascending Dose|Adverse Event|0|||
94480218|NCT02100839|323552112|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
94480219|NCT02100839|323552113|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
94480220|NCT03512353|323552114|FG000|Overall Study|Sponsor Decision|3|||
94480221|NCT03512353|323552114|FG000|Overall Study|Death|1|||
94480222|NCT03569098|323552115|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
94480223|NCT03569098|323552116|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
94480224|NCT03569098|323552117|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
94480225|NCT03569098|323552115|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
94480226|NCT03569098|323552116|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
94480227|NCT03569098|323552117|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
94480228|NCT03569098|323552115|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
94480229|NCT03569098|323552116|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
94480230|NCT03569098|323552117|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
94480231|NCT03569098|323552115|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
94480232|NCT03569098|323552116|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
94480233|NCT03569098|323552117|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
94480234|NCT03569098|323552115|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
94480235|NCT03569098|323552116|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
94480236|NCT03569098|323552117|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
94480237|NCT03569098|323552115|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
94480238|NCT03569098|323552116|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
94480239|NCT03569098|323552117|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
94480240|NCT03569098|323552115|FG000|Double-Blind Treatment Cycle 1|Other|1|||
94480241|NCT03569098|323552116|FG001|Double-Blind Treatment Cycle 1|Other|0|||
94480242|NCT03569098|323552117|FG002|Double-Blind Treatment Cycle 1|Other|1|||
94480243|NCT03569098|323552115|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
94480244|NCT03569098|323552116|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
94480245|NCT03569098|323552117|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
94480246|NCT03569098|323552115|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
94480247|NCT03569098|323552116|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
94480248|NCT03569098|323552117|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
94385210|NCT04888507|323198886|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
94385217|NCT04809974|323198889|FG000|Lead-in Phase|Withdrawal by Subject|3|||
94385218|NCT04809974|323198890|FG001|Lead-in Phase|Withdrawal by Subject|0|||
94385219|NCT04809974|323198891|FG002|Lead-in Phase|Withdrawal by Subject|0|||
94385220|NCT04809974|323198889|FG000|Lead-in Phase|No longer eligible|11|||
94385221|NCT04809974|323198890|FG001|Lead-in Phase|No longer eligible|0|||
94385222|NCT04809974|323198891|FG002|Lead-in Phase|No longer eligible|0|||
94385223|NCT04809974|323198889|FG000|Randomized Phase|Lost to Follow-up|0|||
94385224|NCT04809974|323198890|FG001|Randomized Phase|Lost to Follow-up|1|||
94385225|NCT04809974|323198891|FG002|Randomized Phase|Lost to Follow-up|5|||
94385226|NCT04809974|323198889|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
94385227|NCT04809974|323198890|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
94385228|NCT04809974|323198891|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
94385229|NCT04809974|323198889|FG000|Randomized Phase|Adverse Event|0|||
94385230|NCT04809974|323198890|FG001|Randomized Phase|Adverse Event|1|||
94385231|NCT04809974|323198891|FG002|Randomized Phase|Adverse Event|4|||
94385232|NCT04809974|323198889|FG000|Randomized Phase|Withdrawal by Subject|0|||
94385233|NCT04809974|323198890|FG001|Randomized Phase|Withdrawal by Subject|0|||
94385234|NCT04809974|323198891|FG002|Randomized Phase|Withdrawal by Subject|5|||
94385247|NCT03815942|323198909|FG000|Overall Study|Withdrawal by Subject|0|||
94385248|NCT03815942|323198910|FG001|Overall Study|Withdrawal by Subject|17|||
94385249|NCT04152200|323198912|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
94385250|NCT04152200|323198913|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
94385257|NCT02424188|323198917|FG000|Overall Study|Death|2|||
94385258|NCT02424188|323198918|FG001|Overall Study|Death|2|||
94385259|NCT02424188|323198917|FG000|Overall Study|Lost to Follow-up|1|||
94385260|NCT02424188|323198918|FG001|Overall Study|Lost to Follow-up|3|||
94385261|NCT02424188|323198917|FG000|Overall Study|Incarceration|1|||
94385262|NCT02424188|323198918|FG001|Overall Study|Incarceration|0|||
94480249|NCT03569098|323552115|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
94480250|NCT03569098|323552116|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
94480251|NCT03569098|323552117|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
94480252|NCT03569098|323552115|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
94480253|NCT03569098|323552116|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
94480254|NCT03569098|323552117|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
94480255|NCT03569098|323552115|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
94480256|NCT03569098|323552116|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
94480257|NCT03569098|323552117|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
94480258|NCT03569098|323552115|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
94480259|NCT03569098|323552116|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
94480260|NCT03569098|323552117|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
94480261|NCT01845597|323552118|FG000|Overall Study|Death|8|||
94480262|NCT01845597|323552118|FG000|Overall Study|Lost to Follow-up|22|||
94480263|NCT02581488|323552121|FG000|Overall Study|Adverse Event|6|||
94480264|NCT02581488|323552122|FG001|Overall Study|Adverse Event|7|||
94480265|NCT02581488|323552121|FG000|Overall Study|Lost to Follow-up|1|||
94480266|NCT02581488|323552122|FG001|Overall Study|Lost to Follow-up|0|||
94480267|NCT02581488|323552121|FG000|Overall Study|Withdrawal by Subject|1|||
94480268|NCT02581488|323552122|FG001|Overall Study|Withdrawal by Subject|0|||
94480269|NCT02581488|323552121|FG000|Overall Study|Non-Compliance|1|||
94480270|NCT02581488|323552122|FG001|Overall Study|Non-Compliance|0|||
94480271|NCT02581488|323552121|FG000|Overall Study|Protocol Violation|0|||
94480272|NCT02581488|323552122|FG001|Overall Study|Protocol Violation|4|||
94480273|NCT01877668|323552123|FG000|Overall Study|Death|0|||
94480274|NCT01877668|323552124|FG001|Overall Study|Death|0|||
94480275|NCT01877668|323552125|FG002|Overall Study|Death|0|||
94480276|NCT01877668|323552126|FG003|Overall Study|Death|1|||
94480277|NCT01877668|323552127|FG004|Overall Study|Death|0|||
94480278|NCT01877668|323552123|FG000|Overall Study|No longer met study criteria|1|||
94480279|NCT01877668|323552124|FG001|Overall Study|No longer met study criteria|0|||
94480280|NCT01877668|323552125|FG002|Overall Study|No longer met study criteria|1|||
94480281|NCT01877668|323552126|FG003|Overall Study|No longer met study criteria|0|||
94480282|NCT01877668|323552127|FG004|Overall Study|No longer met study criteria|0|||
94480283|NCT01877668|323552123|FG000|Overall Study|Insufficient clinical response|0|||
94480284|NCT01877668|323552124|FG001|Overall Study|Insufficient clinical response|1|||
94480285|NCT01877668|323552125|FG002|Overall Study|Insufficient clinical response|2|||
94480286|NCT01877668|323552126|FG003|Overall Study|Insufficient clinical response|2|||
94480287|NCT01877668|323552127|FG004|Overall Study|Insufficient clinical response|0|||
94480288|NCT01877668|323552123|FG000|Overall Study|Lost to Follow-up|0|||
94480289|NCT01877668|323552124|FG001|Overall Study|Lost to Follow-up|2|||
94480290|NCT01877668|323552125|FG002|Overall Study|Lost to Follow-up|1|||
94480291|NCT01877668|323552126|FG003|Overall Study|Lost to Follow-up|0|||
94480292|NCT01877668|323552127|FG004|Overall Study|Lost to Follow-up|0|||
94480293|NCT01877668|323552123|FG000|Overall Study|Withdrawal by Subject|2|||
94480294|NCT01877668|323552124|FG001|Overall Study|Withdrawal by Subject|0|||
94480295|NCT01877668|323552125|FG002|Overall Study|Withdrawal by Subject|3|||
94480296|NCT01877668|323552126|FG003|Overall Study|Withdrawal by Subject|2|||
94480297|NCT01877668|323552127|FG004|Overall Study|Withdrawal by Subject|2|||
94480298|NCT01877668|323552123|FG000|Overall Study|Other|1|||
94480299|NCT01877668|323552124|FG001|Overall Study|Other|1|||
94480300|NCT01877668|323552125|FG002|Overall Study|Other|1|||
94480301|NCT01877668|323552126|FG003|Overall Study|Other|1|||
94480302|NCT01877668|323552127|FG004|Overall Study|Other|3|||
94480303|NCT01877668|323552123|FG000|Overall Study|Protocol Violation|1|||
94480304|NCT01877668|323552124|FG001|Overall Study|Protocol Violation|1|||
94480305|NCT01877668|323552125|FG002|Overall Study|Protocol Violation|0|||
94480306|NCT01877668|323552126|FG003|Overall Study|Protocol Violation|0|||
94480307|NCT01877668|323552127|FG004|Overall Study|Protocol Violation|3|||
94480308|NCT01877668|323552123|FG000|Overall Study|Adverse event related to study drug|2|||
94480309|NCT01877668|323552124|FG001|Overall Study|Adverse event related to study drug|2|||
94480310|NCT01877668|323552125|FG002|Overall Study|Adverse event related to study drug|2|||
94480311|NCT01877668|323552126|FG003|Overall Study|Adverse event related to study drug|2|||
94480312|NCT01877668|323552127|FG004|Overall Study|Adverse event related to study drug|1|||
94480313|NCT01877668|323552123|FG000|Overall Study|Adverse event unrelated to study drug|4|||
94480314|NCT01877668|323552124|FG001|Overall Study|Adverse event unrelated to study drug|1|||
94480315|NCT01877668|323552125|FG002|Overall Study|Adverse event unrelated to study drug|2|||
94480316|NCT01877668|323552126|FG003|Overall Study|Adverse event unrelated to study drug|0|||
94480317|NCT01877668|323552127|FG004|Overall Study|Adverse event unrelated to study drug|1|||
94480318|NCT05133323|323552128|FG000|Overall Study|Lack of Efficacy|0|||
94480319|NCT05133323|323552129|FG001|Overall Study|Lack of Efficacy|0|||
94480320|NCT05133323|323552130|FG002|Overall Study|Lack of Efficacy|1|||
94480321|NCT05133323|323552128|FG000|Overall Study|Withdrawal by Subject|2|||
94480322|NCT05133323|323552129|FG001|Overall Study|Withdrawal by Subject|1|||
94480323|NCT05133323|323552130|FG002|Overall Study|Withdrawal by Subject|0|||
94316272|NCT00256867|322940134|FG003|Overall Study|Withdrawal by Subject|1|||
94316273|NCT00256867|322940135|FG004|Overall Study|Withdrawal by Subject|2|||
94316274|NCT00256867|322940136|FG005|Overall Study|Withdrawal by Subject|2|||
94480324|NCT02683239|323552131|FG000|Overall Study|Protocol Violation|35|||
94480325|NCT02683239|323552132|FG001|Overall Study|Protocol Violation|23|||
94480326|NCT02683239|323552133|FG002|Overall Study|Protocol Violation|26|||
94480327|NCT02683239|323552134|FG003|Overall Study|Protocol Violation|4|||
94480328|NCT02683239|323552135|FG004|Overall Study|Protocol Violation|35|||
94480329|NCT02683239|323552136|FG005|Overall Study|Protocol Violation|4|||
94480330|NCT02683239|323552137|FG006|Overall Study|Protocol Violation|5|||
94480331|NCT02683239|323552131|FG000|Overall Study|Adverse Event|64|||
94480332|NCT02683239|323552132|FG001|Overall Study|Adverse Event|39|||
94480333|NCT02683239|323552133|FG002|Overall Study|Adverse Event|42|||
94480334|NCT02683239|323552134|FG003|Overall Study|Adverse Event|16|||
94480335|NCT02683239|323552135|FG004|Overall Study|Adverse Event|189|||
94480336|NCT02683239|323552136|FG005|Overall Study|Adverse Event|9|||
94480337|NCT02683239|323552137|FG006|Overall Study|Adverse Event|9|||
94480338|NCT02683239|323552131|FG000|Overall Study|Physician Decision|38|||
94480339|NCT02683239|323552132|FG001|Overall Study|Physician Decision|19|||
94480340|NCT02683239|323552133|FG002|Overall Study|Physician Decision|14|||
94480341|NCT02683239|323552134|FG003|Overall Study|Physician Decision|73|||
94480342|NCT02683239|323552135|FG004|Overall Study|Physician Decision|143|||
94480343|NCT02683239|323552136|FG005|Overall Study|Physician Decision|14|||
94480344|NCT02683239|323552137|FG006|Overall Study|Physician Decision|15|||
94480345|NCT02683239|323552131|FG000|Overall Study|Withdrawal by Subject|187|||
94480346|NCT02683239|323552132|FG001|Overall Study|Withdrawal by Subject|99|||
94480347|NCT02683239|323552133|FG002|Overall Study|Withdrawal by Subject|91|||
94480348|NCT02683239|323552134|FG003|Overall Study|Withdrawal by Subject|18|||
94316275|NCT00256867|322940137|FG006|Overall Study|Withdrawal by Subject|3|||
94316276|NCT00256867|322940138|FG007|Overall Study|Withdrawal by Subject|2|||
94316277|NCT00256867|322940131|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
94316278|NCT00256867|322940132|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
94316279|NCT00256867|322940133|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
94316280|NCT00256867|322940134|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
94316281|NCT00256867|322940135|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
94316282|NCT00256867|322940136|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
94316283|NCT00256867|322940137|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
94316284|NCT00256867|322940138|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
94316285|NCT00256867|322940131|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
94316286|NCT00256867|322940132|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
94316287|NCT00256867|322940133|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
94316288|NCT00256867|322940134|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
94316289|NCT00256867|322940135|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
94316290|NCT00256867|322940136|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
94316291|NCT00256867|322940137|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
94316292|NCT00256867|322940138|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
94316293|NCT00256867|322940131|FG000|Overall Study|Investigator's Decision|0|||
94316294|NCT00256867|322940132|FG001|Overall Study|Investigator's Decision|0|||
94316295|NCT00256867|322940133|FG002|Overall Study|Investigator's Decision|0|||
94316296|NCT00256867|322940134|FG003|Overall Study|Investigator's Decision|0|||
94316297|NCT00256867|322940135|FG004|Overall Study|Investigator's Decision|1|||
94316298|NCT00256867|322940136|FG005|Overall Study|Investigator's Decision|0|||
94316299|NCT00256867|322940137|FG006|Overall Study|Investigator's Decision|0|||
94316300|NCT00256867|322940138|FG007|Overall Study|Investigator's Decision|0|||
94316301|NCT00256867|322940131|FG000|Overall Study|Non-compliance with study medication|0|||
94316302|NCT00256867|322940132|FG001|Overall Study|Non-compliance with study medication|0|||
94316303|NCT00256867|322940133|FG002|Overall Study|Non-compliance with study medication|0|||
94316304|NCT00256867|322940134|FG003|Overall Study|Non-compliance with study medication|0|||
94316305|NCT00256867|322940135|FG004|Overall Study|Non-compliance with study medication|0|||
94316306|NCT00256867|322940136|FG005|Overall Study|Non-compliance with study medication|0|||
94316307|NCT00256867|322940137|FG006|Overall Study|Non-compliance with study medication|0|||
94316308|NCT00256867|322940138|FG007|Overall Study|Non-compliance with study medication|1|||
94316309|NCT00256867|322940131|FG000|Overall Study|Participant travelled Overseas|0|||
94316310|NCT00256867|322940132|FG001|Overall Study|Participant travelled Overseas|1|||
94316311|NCT00256867|322940133|FG002|Overall Study|Participant travelled Overseas|0|||
94316312|NCT00256867|322940134|FG003|Overall Study|Participant travelled Overseas|0|||
94316313|NCT00256867|322940135|FG004|Overall Study|Participant travelled Overseas|0|||
94316314|NCT00256867|322940136|FG005|Overall Study|Participant travelled Overseas|0|||
94480349|NCT02683239|323552135|FG004|Overall Study|Withdrawal by Subject|248|||
94480350|NCT02683239|323552136|FG005|Overall Study|Withdrawal by Subject|22|||
94480351|NCT02683239|323552137|FG006|Overall Study|Withdrawal by Subject|28|||
94480352|NCT02683239|323552131|FG000|Overall Study|Lost to Follow-up|77|||
94480353|NCT02683239|323552132|FG001|Overall Study|Lost to Follow-up|24|||
94480354|NCT02683239|323552133|FG002|Overall Study|Lost to Follow-up|25|||
94480355|NCT02683239|323552134|FG003|Overall Study|Lost to Follow-up|7|||
94480356|NCT02683239|323552135|FG004|Overall Study|Lost to Follow-up|88|||
94480357|NCT02683239|323552136|FG005|Overall Study|Lost to Follow-up|8|||
94480358|NCT02683239|323552137|FG006|Overall Study|Lost to Follow-up|11|||
94480359|NCT02683239|323552131|FG000|Overall Study|Death|9|||
94480360|NCT02683239|323552132|FG001|Overall Study|Death|5|||
94480361|NCT02683239|323552133|FG002|Overall Study|Death|8|||
94480362|NCT02683239|323552134|FG003|Overall Study|Death|0|||
94480363|NCT02683239|323552135|FG004|Overall Study|Death|12|||
94480364|NCT02683239|323552136|FG005|Overall Study|Death|1|||
94480365|NCT02683239|323552137|FG006|Overall Study|Death|0|||
94480366|NCT02683239|323552131|FG000|Overall Study|Lack of Efficacy|50|||
94480367|NCT02683239|323552132|FG001|Overall Study|Lack of Efficacy|23|||
94480368|NCT02683239|323552133|FG002|Overall Study|Lack of Efficacy|12|||
94480369|NCT02683239|323552134|FG003|Overall Study|Lack of Efficacy|2|||
94480370|NCT02683239|323552135|FG004|Overall Study|Lack of Efficacy|29|||
94480371|NCT02683239|323552136|FG005|Overall Study|Lack of Efficacy|2|||
94480372|NCT02683239|323552137|FG006|Overall Study|Lack of Efficacy|3|||
94480373|NCT02683239|323552131|FG000|Overall Study|Missing data|0|||
94480374|NCT02683239|323552132|FG001|Overall Study|Missing data|1|||
94480375|NCT02683239|323552133|FG002|Overall Study|Missing data|1|||
94480376|NCT02683239|323552134|FG003|Overall Study|Missing data|0|||
94480377|NCT02683239|323552135|FG004|Overall Study|Missing data|1|||
94480378|NCT02683239|323552136|FG005|Overall Study|Missing data|0|||
94480379|NCT02683239|323552137|FG006|Overall Study|Missing data|0|||
94480380|NCT03627832|323552138|FG000|Overall Study|Withdrawal by Subject|10|||
94480381|NCT03627832|323552139|FG001|Overall Study|Withdrawal by Subject|1|||
94480382|NCT00368108|323552140|FG000|Overall Study|Adverse Event|38|||
94480383|NCT00368108|323552141|FG001|Overall Study|Adverse Event|26|||
94480384|NCT00368108|323552142|FG002|Overall Study|Adverse Event|44|||
94480385|NCT00368108|323552140|FG000|Overall Study|Abnormal Laboratory Value|0|||
94480386|NCT00368108|323552141|FG001|Overall Study|Abnormal Laboratory Value|0|||
94480387|NCT00368108|323552142|FG002|Overall Study|Abnormal Laboratory Value|3|||
94480388|NCT00368108|323552140|FG000|Overall Study|Protocol Violation|5|||
94480389|NCT00368108|323552141|FG001|Overall Study|Protocol Violation|9|||
94480390|NCT00368108|323552142|FG002|Overall Study|Protocol Violation|9|||
94480391|NCT00368108|323552140|FG000|Overall Study|Withdrawal by Subject|9|||
94480392|NCT00368108|323552141|FG001|Overall Study|Withdrawal by Subject|3|||
94480393|NCT00368108|323552142|FG002|Overall Study|Withdrawal by Subject|5|||
94480394|NCT00368108|323552140|FG000|Overall Study|Lack of Efficacy|7|||
94480395|NCT00368108|323552141|FG001|Overall Study|Lack of Efficacy|8|||
94480396|NCT00368108|323552142|FG002|Overall Study|Lack of Efficacy|5|||
94480397|NCT00368108|323552140|FG000|Overall Study|Physician Decision|2|||
94480398|NCT00368108|323552141|FG001|Overall Study|Physician Decision|0|||
94480399|NCT00368108|323552142|FG002|Overall Study|Physician Decision|1|||
94480400|NCT00368108|323552140|FG000|Overall Study|Other|3|||
94480401|NCT00368108|323552141|FG001|Overall Study|Other|7|||
94480402|NCT00368108|323552142|FG002|Overall Study|Other|1|||
94480403|NCT04613739|323552143|FG000|Overall Study|Lost to Follow-up|6|||
94480404|NCT04613739|323552144|FG001|Overall Study|Lost to Follow-up|9|||
94480405|NCT04613739|323552143|FG000|Overall Study|potentially duplicative/fraudulent|1|||
94480406|NCT04613739|323552144|FG001|Overall Study|potentially duplicative/fraudulent|3|||
94480407|NCT01831427|323552145|FG000|Overall Study|Adverse Event|0|||
94480408|NCT01831427|323552146|FG001|Overall Study|Adverse Event|1|||
94480409|NCT01831427|323552147|FG002|Overall Study|Adverse Event|0|||
94480410|NCT01831427|323552148|FG003|Overall Study|Adverse Event|0|||
94480411|NCT01831427|323552149|FG004|Overall Study|Adverse Event|0|||
94480412|NCT01831427|323552150|FG005|Overall Study|Adverse Event|1|||
94480413|NCT01831427|323552151|FG006|Overall Study|Adverse Event|0|||
94480414|NCT01831427|323552152|FG007|Overall Study|Adverse Event|1|||
94480415|NCT01831427|323552153|FG008|Overall Study|Adverse Event|0|||
94480416|NCT01831427|323552154|FG009|Overall Study|Adverse Event|0|||
94480417|NCT01831427|323552155|FG010|Overall Study|Adverse Event|2|||
94480418|NCT01831427|323552145|FG000|Overall Study|Investigator's Discretion|0|||
94480419|NCT01831427|323552146|FG001|Overall Study|Investigator's Discretion|0|||
94480420|NCT01831427|323552147|FG002|Overall Study|Investigator's Discretion|0|||
94480421|NCT01831427|323552148|FG003|Overall Study|Investigator's Discretion|1|||
94480422|NCT01831427|323552149|FG004|Overall Study|Investigator's Discretion|0|||
94480423|NCT01831427|323552150|FG005|Overall Study|Investigator's Discretion|0|||
94480424|NCT01831427|323552151|FG006|Overall Study|Investigator's Discretion|0|||
94480425|NCT01831427|323552152|FG007|Overall Study|Investigator's Discretion|0|||
94480426|NCT01831427|323552153|FG008|Overall Study|Investigator's Discretion|0|||
94480427|NCT01831427|323552154|FG009|Overall Study|Investigator's Discretion|0|||
94480428|NCT01831427|323552155|FG010|Overall Study|Investigator's Discretion|0|||
94480429|NCT01831427|323552145|FG000|Overall Study|Withdrew Consent|0|||
94480430|NCT01831427|323552146|FG001|Overall Study|Withdrew Consent|0|||
94480431|NCT01831427|323552147|FG002|Overall Study|Withdrew Consent|0|||
94480432|NCT01831427|323552148|FG003|Overall Study|Withdrew Consent|0|||
94480433|NCT01831427|323552149|FG004|Overall Study|Withdrew Consent|0|||
94480434|NCT01831427|323552150|FG005|Overall Study|Withdrew Consent|0|||
94316315|NCT00256867|322940137|FG006|Overall Study|Participant travelled Overseas|0|||
94316316|NCT00256867|322940138|FG007|Overall Study|Participant travelled Overseas|0|||
94316317|NCT00256867|322940131|FG000|Overall Study|Participant out of assessment window|0|||
94316318|NCT00256867|322940132|FG001|Overall Study|Participant out of assessment window|0|||
94316319|NCT00256867|322940133|FG002|Overall Study|Participant out of assessment window|1|||
94316320|NCT00256867|322940134|FG003|Overall Study|Participant out of assessment window|0|||
94316321|NCT00256867|322940135|FG004|Overall Study|Participant out of assessment window|0|||
94316322|NCT00256867|322940136|FG005|Overall Study|Participant out of assessment window|0|||
94316323|NCT00256867|322940137|FG006|Overall Study|Participant out of assessment window|0|||
94316324|NCT00256867|322940138|FG007|Overall Study|Participant out of assessment window|0|||
94316325|NCT00256867|322940131|FG000|Overall Study|Withdrawal by participant|0|||
94316326|NCT00256867|322940132|FG001|Overall Study|Withdrawal by participant|0|||
94316327|NCT00256867|322940133|FG002|Overall Study|Withdrawal by participant|0|||
94316328|NCT00256867|322940134|FG003|Overall Study|Withdrawal by participant|0|||
94316329|NCT00256867|322940135|FG004|Overall Study|Withdrawal by participant|0|||
94316330|NCT00256867|322940136|FG005|Overall Study|Withdrawal by participant|1|||
94316331|NCT00256867|322940137|FG006|Overall Study|Withdrawal by participant|0|||
94316332|NCT00256867|322940138|FG007|Overall Study|Withdrawal by participant|0|||
94316333|NCT03229759|322940139|FG000|Overall Study|Screen Failure|30|||
94316334|NCT00527111|322940140|FG000|Overall Study|Adverse Event|14|||
94316335|NCT00527111|322940141|FG001|Overall Study|Adverse Event|13|||
94316336|NCT00527111|322940140|FG000|Overall Study|Death|0|||
94316337|NCT00527111|322940141|FG001|Overall Study|Death|1|||
94316338|NCT00527111|322940140|FG000|Overall Study|Investigator Request|2|||
94316339|NCT00527111|322940141|FG001|Overall Study|Investigator Request|1|||
94316340|NCT00527111|322940140|FG000|Overall Study|Patient Request|2|||
94316341|NCT00527111|322940141|FG001|Overall Study|Patient Request|5|||
94316342|NCT00527111|322940140|FG000|Overall Study|Other|2|||
94385285|NCT02777528|323198930|FG000|Overall Study|Still in study|24|||
94385286|NCT02777528|323198931|FG001|Overall Study|Still in study|10|||
94385287|NCT02777528|323198932|FG002|Overall Study|Still in study|1|||
94385288|NCT02777528|323198930|FG000|Overall Study|Study Device Explanted|1|||
94385289|NCT02777528|323198931|FG001|Overall Study|Study Device Explanted|0|||
94385290|NCT02777528|323198932|FG002|Overall Study|Study Device Explanted|0|||
94385291|NCT02777528|323198930|FG000|Overall Study|Death|14|||
94385292|NCT02777528|323198931|FG001|Overall Study|Death|7|||
94385293|NCT02777528|323198932|FG002|Overall Study|Death|1|||
94385294|NCT02777528|323198930|FG000|Overall Study|Withdrawal by Subject|2|||
94385295|NCT02777528|323198931|FG001|Overall Study|Withdrawal by Subject|2|||
94385296|NCT02777528|323198932|FG002|Overall Study|Withdrawal by Subject|1|||
94385297|NCT02777528|323198930|FG000|Overall Study|Physician Decision|2|||
94385298|NCT02777528|323198931|FG001|Overall Study|Physician Decision|1|||
94385299|NCT02777528|323198932|FG002|Overall Study|Physician Decision|0|||
94385300|NCT02777528|323198930|FG000|Overall Study|Lost to Follow-up|2|||
94385301|NCT02777528|323198931|FG001|Overall Study|Lost to Follow-up|0|||
94385302|NCT02777528|323198932|FG002|Overall Study|Lost to Follow-up|0|||
94385303|NCT02777528|323198930|FG000|Overall Study|Discontinued due to Other|1|||
94385304|NCT02777528|323198931|FG001|Overall Study|Discontinued due to Other|0|||
94385305|NCT02777528|323198932|FG002|Overall Study|Discontinued due to Other|0|||
94385320|NCT05628675|323198940|FG000|Overall Study|Lost to Follow-up|2|||
94385321|NCT05628675|323198940|FG000|Overall Study|Withdrawal by Subject|1|||
94316343|NCT00527111|322940141|FG001|Overall Study|Other|2|||
94316344|NCT04072146|322940142|FG000|Overall Study|Adverse Event|0|||
94316345|NCT04072146|322940143|FG001|Overall Study|Adverse Event|1|||
94480435|NCT01831427|323552151|FG006|Overall Study|Withdrew Consent|2|||
94480436|NCT01831427|323552152|FG007|Overall Study|Withdrew Consent|0|||
94480437|NCT01831427|323552153|FG008|Overall Study|Withdrew Consent|0|||
94480438|NCT01831427|323552154|FG009|Overall Study|Withdrew Consent|1|||
94480439|NCT01831427|323552155|FG010|Overall Study|Withdrew Consent|1|||
94480440|NCT01093586|323552156|FG000|Overall Study|Failed to engraft|3|||
94480441|NCT01051557|323552157|FG000|Overall Study|Physician Decision|1|||
94480442|NCT01051557|323552158|FG001|Overall Study|Physician Decision|0|||
94480443|NCT01051557|323552159|FG002|Overall Study|Physician Decision|0|||
94480444|NCT01051557|323552160|FG003|Overall Study|Physician Decision|0|||
94480445|NCT01051557|323552161|FG004|Overall Study|Physician Decision|0|||
94480446|NCT01051557|323552162|FG005|Overall Study|Physician Decision|0|||
94480447|NCT01051557|323552163|FG006|Overall Study|Physician Decision|0|||
94480448|NCT01051557|323552157|FG000|Overall Study|disease progression|3|||
94480449|NCT01051557|323552158|FG001|Overall Study|disease progression|3|||
94480450|NCT01051557|323552159|FG002|Overall Study|disease progression|5|||
94480451|NCT01051557|323552160|FG003|Overall Study|disease progression|2|||
94480452|NCT01051557|323552161|FG004|Overall Study|disease progression|4|||
94480453|NCT01051557|323552162|FG005|Overall Study|disease progression|3|||
94480454|NCT01051557|323552163|FG006|Overall Study|disease progression|1|||
94316346|NCT04070378|322940144|FG000|Overall Study|Withdrawal by Subject|2|||
94316347|NCT04070378|322940144|FG000|Overall Study|Screen Failure|6|||
94316348|NCT04070378|322940144|FG000|Overall Study|Physician Decision|1|||
94316349|NCT04070378|322940144|FG000|Overall Study|Adverse Event|1|||
94316350|NCT00992446|322940149|FG000|Overall Study|Disease Progression|1|||
94316351|NCT00992446|322940149|FG000|Overall Study|Withdrawal by Subject|2|||
94316352|NCT00992446|322940149|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
94316353|NCT03050359|322941366|FG000|Overall Study|Randomized But Not Treated|2|||
94316354|NCT03050359|322941367|FG001|Overall Study|Randomized But Not Treated|0|||
94316355|NCT03050359|322941366|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
94316356|NCT03050359|322941367|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
94316357|NCT03050359|322941366|FG000|Overall Study|Significant Protocol Deviation|2|||
94316358|NCT03050359|322941367|FG001|Overall Study|Significant Protocol Deviation|3|||
94316359|NCT03050359|322941366|FG000|Overall Study|Lost to Follow-up|2|||
94316360|NCT03050359|322941367|FG001|Overall Study|Lost to Follow-up|1|||
94316361|NCT03050359|322941366|FG000|Overall Study|Voluntary Withdrawal|4|||
94316362|NCT03050359|322941367|FG001|Overall Study|Voluntary Withdrawal|6|||
94316363|NCT03050359|322941366|FG000|Overall Study|Pregnancy|1|||
94316364|NCT03050359|322941367|FG001|Overall Study|Pregnancy|0|||
94316365|NCT03050359|322941366|FG000|Overall Study|Reason Not Specified|1|||
94316366|NCT03050359|322941367|FG001|Overall Study|Reason Not Specified|0|||
94316367|NCT00059215|322941369|FG000|Overall Study|Adverse Event|5|||
94316368|NCT00059215|322941370|FG001|Overall Study|Adverse Event|5|||
94316369|NCT00059215|322941371|FG002|Overall Study|Adverse Event|9|||
94316370|NCT00059215|322941372|FG003|Overall Study|Adverse Event|9|||
94316371|NCT00059215|322941369|FG000|Overall Study|Death|0|||
94316372|NCT00059215|322941370|FG001|Overall Study|Death|0|||
94316373|NCT00059215|322941371|FG002|Overall Study|Death|3|||
94316374|NCT00059215|322941372|FG003|Overall Study|Death|0|||
94316375|NCT00059215|322941369|FG000|Overall Study|Lost to Follow-up|1|||
94316376|NCT00059215|322941370|FG001|Overall Study|Lost to Follow-up|2|||
94316377|NCT00059215|322941371|FG002|Overall Study|Lost to Follow-up|0|||
94316378|NCT00059215|322941372|FG003|Overall Study|Lost to Follow-up|0|||
94316379|NCT00059215|322941369|FG000|Overall Study|Withdrawal by Subject|4|||
94316380|NCT00059215|322941370|FG001|Overall Study|Withdrawal by Subject|4|||
94316381|NCT00059215|322941371|FG002|Overall Study|Withdrawal by Subject|1|||
94316382|NCT00059215|322941372|FG003|Overall Study|Withdrawal by Subject|3|||
94316383|NCT00059215|322941369|FG000|Overall Study|Protocol Violation|1|||
94316384|NCT00059215|322941370|FG001|Overall Study|Protocol Violation|0|||
94316385|NCT00059215|322941371|FG002|Overall Study|Protocol Violation|1|||
94316386|NCT00059215|322941372|FG003|Overall Study|Protocol Violation|0|||
94316387|NCT00059215|322941369|FG000|Overall Study|Protocol entry criteria not met|1|||
94316388|NCT00059215|322941370|FG001|Overall Study|Protocol entry criteria not met|1|||
94316389|NCT00059215|322941371|FG002|Overall Study|Protocol entry criteria not met|0|||
94316390|NCT00059215|322941372|FG003|Overall Study|Protocol entry criteria not met|2|||
94316391|NCT00059215|322941369|FG000|Overall Study|Physician Decision|1|||
94316392|NCT00059215|322941370|FG001|Overall Study|Physician Decision|2|||
94316393|NCT00059215|322941371|FG002|Overall Study|Physician Decision|1|||
94316394|NCT00059215|322941372|FG003|Overall Study|Physician Decision|1|||
94316395|NCT01701583|322941375|FG000|Overall Study|Withdrawal by Subject|2|||
94316396|NCT01701583|322941376|FG001|Overall Study|Withdrawal by Subject|0|||
94316397|NCT01998581|322941377|FG000|Overall Study|Refused repeat treatment|20|||
94316398|NCT01998581|322941378|FG001|Overall Study|Refused repeat treatment|4|||
94316399|NCT01998581|322941377|FG000|Overall Study|Protocol Violation|1|||
94316400|NCT01998581|322941378|FG001|Overall Study|Protocol Violation|0|||
94316401|NCT01998581|322941377|FG000|Overall Study|Withdrawal by Subject|8|||
94316402|NCT01998581|322941378|FG001|Overall Study|Withdrawal by Subject|1|||
94480455|NCT01051557|323552157|FG000|Overall Study|Withdrawal by Subject|0|||
94480456|NCT01051557|323552158|FG001|Overall Study|Withdrawal by Subject|0|||
94316403|NCT01998581|322941377|FG000|Overall Study|Lost to Follow-up|12|||
94316404|NCT01998581|322941378|FG001|Overall Study|Lost to Follow-up|4|||
94316405|NCT01998581|322941377|FG000|Overall Study|Adverse Event|1|||
94316406|NCT01998581|322941378|FG001|Overall Study|Adverse Event|1|||
94316407|NCT01998581|322941377|FG000|Overall Study|Other reasons|3|||
94316408|NCT01998581|322941378|FG001|Overall Study|Other reasons|2|||
94316409|NCT01998581|322941377|FG000|Overall Study|Randomized but withdrew before treatment|1|||
94316410|NCT01998581|322941378|FG001|Overall Study|Randomized but withdrew before treatment|0|||
94316411|NCT00943319|322941379|FG000|Overall Study|Death|1|||
94316412|NCT00615290|322941383|FG000|Overall Study|Adverse Event|2|||
94316413|NCT00615290|322941383|FG000|Overall Study|Lost to Follow-up|3|||
94316414|NCT00615290|322941383|FG000|Overall Study|Withdrawal by Subject|1|||
94316415|NCT00615290|322941383|FG000|Overall Study|Other|2|||
94316416|NCT02245568|322941384|FG000|Overall Study|Study terminated by Sponsor|346|||
94316417|NCT02245568|322941384|FG000|Overall Study|Adverse Event|144|||
94316418|NCT02245568|322941384|FG000|Overall Study|Lack of Efficacy|98|||
94316419|NCT02245568|322941384|FG000|Overall Study|Withdrawal by Caregiver|85|||
94316420|NCT02245568|322941384|FG000|Overall Study|Withdrawal by Subject|77|||
94316421|NCT02245568|322941384|FG000|Overall Study|Withdrawal by Legal Representative|31|||
94316422|NCT02245568|322941384|FG000|Overall Study|Missing (Site closure)|16|||
94316423|NCT02245568|322941384|FG000|Overall Study|Physician Decision|14|||
94316424|NCT02245568|322941384|FG000|Overall Study|Non-compliance with study drug|11|||
94316425|NCT02245568|322941384|FG000|Overall Study|Death|9|||
94316426|NCT02245568|322941384|FG000|Overall Study|Blue staining|6|||
94316427|NCT02245568|322941384|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
94316428|NCT02245568|322941384|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
94316429|NCT02245568|322941384|FG000|Overall Study|Lost to Follow-up|5|||
94316430|NCT02849990|322941385|FG000|Overall Study|Adverse Event|1|||
94316431|NCT02849990|322941385|FG000|Overall Study|Withdrawal by Subject|1|||
94316432|NCT03650452|322941386|FG000|Overall Study|Physician Decision|1|||
94316433|NCT03650452|322941387|FG001|Overall Study|Physician Decision|0|||
94316434|NCT03650452|322941386|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
94316435|NCT03650452|322941387|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
94316436|NCT03650452|322941386|FG000|Overall Study|Adverse Event|3|||
94316437|NCT03650452|322941387|FG001|Overall Study|Adverse Event|4|||
94316438|NCT03650452|322941386|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
94316439|NCT03650452|322941387|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
94316440|NCT01781429|322941389|FG000|Overall Study|Death|0|||
94316441|NCT01781429|322941390|FG001|Overall Study|Death|0|||
94316442|NCT01781429|322941391|FG002|Overall Study|Death|0|||
94316443|NCT01781429|322941392|FG003|Overall Study|Death|0|||
94316444|NCT01781429|322941393|FG004|Overall Study|Death|0|||
94316445|NCT01781429|322941394|FG005|Overall Study|Death|0|||
94316446|NCT01781429|322941395|FG006|Overall Study|Death|0|||
94316447|NCT01781429|322941396|FG007|Overall Study|Death|0|||
94316448|NCT01781429|322941397|FG008|Overall Study|Death|0|||
94316449|NCT01781429|322941398|FG009|Overall Study|Death|1|||
94316450|NCT01781429|322941399|FG010|Overall Study|Death|0|||
94316451|NCT01781429|322941400|FG011|Overall Study|Death|0|||
94316452|NCT01781429|322941401|FG012|Overall Study|Death|1|||
94385328|NCT04540497|323198955|FG000|Overall Study|Adverse Event|0|||
94385329|NCT04540497|323198956|FG001|Overall Study|Adverse Event|2|||
94385330|NCT04540497|323198955|FG000|Overall Study|Lost to Follow-up|1|||
94385331|NCT04540497|323198956|FG001|Overall Study|Lost to Follow-up|0|||
94385332|NCT04540497|323198955|FG000|Overall Study|Withdrawal by Subject|1|||
94385333|NCT04540497|323198956|FG001|Overall Study|Withdrawal by Subject|1|||
94385334|NCT04540497|323198955|FG000|Overall Study|Miscellaneous|2|||
94385335|NCT04540497|323198956|FG001|Overall Study|Miscellaneous|1|||
94385336|NCT05818137|323198957|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
94385337|NCT05818137|323198957|FG000|Extension Treatment Period|Ongoing participants|44|||
94316453|NCT01781429|322941402|FG013|Overall Study|Death|0|||
94480457|NCT01051557|323552159|FG002|Overall Study|Withdrawal by Subject|1|||
94480458|NCT01051557|323552160|FG003|Overall Study|Withdrawal by Subject|0|||
94480459|NCT01051557|323552161|FG004|Overall Study|Withdrawal by Subject|2|||
94480460|NCT01051557|323552162|FG005|Overall Study|Withdrawal by Subject|0|||
94480461|NCT01051557|323552163|FG006|Overall Study|Withdrawal by Subject|1|||
94480462|NCT01051557|323552157|FG000|Overall Study|Adverse Event|0|||
94480463|NCT01051557|323552158|FG001|Overall Study|Adverse Event|0|||
94480464|NCT01051557|323552159|FG002|Overall Study|Adverse Event|0|||
94480465|NCT01051557|323552160|FG003|Overall Study|Adverse Event|1|||
94480466|NCT01051557|323552161|FG004|Overall Study|Adverse Event|1|||
94480467|NCT01051557|323552162|FG005|Overall Study|Adverse Event|3|||
94480468|NCT01051557|323552163|FG006|Overall Study|Adverse Event|4|||
94480469|NCT02302846|323552169|FG000|Overall Study|Withdrawal by Subject|1|||
94480470|NCT01178125|323552170|FG000|Overall Study|Lost to Follow-up|397|||
94480471|NCT01178125|323552170|FG000|Overall Study|Adverse Event|244|||
94480472|NCT01178125|323552170|FG000|Overall Study|Withdrawal by Subject|209|||
94480473|NCT01178125|323552170|FG000|Overall Study|Noncompliance|184|||
94480474|NCT01178125|323552170|FG000|Overall Study|Pregnancy|55|||
94480475|NCT01178125|323552170|FG000|Overall Study|Other Reason|39|||
94480476|NCT01178125|323552170|FG000|Overall Study|Sponsor Decision|28|||
94480477|NCT01178125|323552170|FG000|Overall Study|Protocol Violation|17|||
94480478|NCT01178125|323552170|FG000|Overall Study|Investigator Decision|5|||
94480479|NCT01004978|323552171|FG000|Overall Study|Disease progression|31|||
94480480|NCT01004978|323552172|FG001|Overall Study|Disease progression|48|||
94480481|NCT01004978|323552171|FG000|Overall Study|Adverse Event|42|||
94480482|NCT01004978|323552172|FG001|Overall Study|Adverse Event|22|||
94480483|NCT01004978|323552171|FG000|Overall Study|Death|3|||
94480484|NCT01004978|323552172|FG001|Overall Study|Death|2|||
94480485|NCT01004978|323552171|FG000|Overall Study|Withdrawal by Subject|16|||
94480486|NCT01004978|323552172|FG001|Overall Study|Withdrawal by Subject|16|||
94480487|NCT01004978|323552171|FG000|Overall Study|Alternative therapy|4|||
94480488|NCT01004978|323552172|FG001|Overall Study|Alternative therapy|8|||
94480489|NCT01004978|323552171|FG000|Overall Study|Physician Decision|6|||
94480490|NCT01004978|323552172|FG001|Overall Study|Physician Decision|3|||
94480491|NCT01004978|323552171|FG000|Overall Study|Other complicating disease|2|||
94480492|NCT01004978|323552172|FG001|Overall Study|Other complicating disease|2|||
94480493|NCT01004978|323552171|FG000|Overall Study|Protocol Violation|2|||
94480494|NCT01004978|323552172|FG001|Overall Study|Protocol Violation|3|||
94480495|NCT01004978|323552171|FG000|Overall Study|Non-compliance|3|||
94480496|NCT01004978|323552172|FG001|Overall Study|Non-compliance|2|||
94480497|NCT01004978|323552171|FG000|Overall Study|Ineligible|1|||
94480498|NCT01004978|323552172|FG001|Overall Study|Ineligible|0|||
94480499|NCT01004978|323552171|FG000|Overall Study|Unblinded|0|||
94480500|NCT01004978|323552172|FG001|Overall Study|Unblinded|1|||
94480501|NCT01004978|323552171|FG000|Overall Study|Performance status worsening|0|||
94480502|NCT01004978|323552172|FG001|Overall Study|Performance status worsening|1|||
94480503|NCT01004978|323552171|FG000|Overall Study|Never started treatment|8|||
94480504|NCT01004978|323552172|FG001|Overall Study|Never started treatment|9|||
94480505|NCT00411450|323552174|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
94480506|NCT01348139|323552178|FG000|Period 1|Adverse Event|1|||
94480507|NCT01348139|323552179|FG001|Period 1|Adverse Event|0|||
94480508|NCT01348139|323552180|FG002|Period 1|Adverse Event|0|||
94480509|NCT01348139|323552181|FG003|Period 1|Adverse Event|0|||
94480510|NCT01348139|323552182|FG004|Period 1|Adverse Event|0|||
94480511|NCT01348139|323552183|FG005|Period 1|Adverse Event|0|||
94480512|NCT02762084|323552184|FG000|Overall Study|Withdrawal by Subject|1|||
94316454|NCT01781429|322941403|FG014|Overall Study|Death|1|||
94316455|NCT01781429|322941404|FG015|Overall Study|Death|0|||
94316456|NCT01781429|322941389|FG000|Overall Study|Withdrawal by Subject|0|||
94316457|NCT01781429|322941390|FG001|Overall Study|Withdrawal by Subject|0|||
94316458|NCT01781429|322941391|FG002|Overall Study|Withdrawal by Subject|0|||
94316459|NCT01781429|322941392|FG003|Overall Study|Withdrawal by Subject|0|||
94316460|NCT01781429|322941393|FG004|Overall Study|Withdrawal by Subject|0|||
94316461|NCT01781429|322941394|FG005|Overall Study|Withdrawal by Subject|0|||
94480513|NCT02762084|323552185|FG001|Overall Study|Withdrawal by Subject|0|||
94480514|NCT02762084|323552186|FG002|Overall Study|Withdrawal by Subject|0|||
94316462|NCT01781429|322941395|FG006|Overall Study|Withdrawal by Subject|0|||
94316463|NCT01781429|322941396|FG007|Overall Study|Withdrawal by Subject|0|||
94480515|NCT02762084|323552184|FG000|Overall Study|Adverse Event|0|||
94480516|NCT02762084|323552185|FG001|Overall Study|Adverse Event|0|||
94480517|NCT02762084|323552186|FG002|Overall Study|Adverse Event|1|||
94480518|NCT02346708|323552189|FG000|Overall Study|Adverse Event|2|||
94480519|NCT02346708|323552190|FG001|Overall Study|Adverse Event|0|||
94480520|NCT02346708|323552189|FG000|Overall Study|Protocol Violation|0|||
94480521|NCT02346708|323552190|FG001|Overall Study|Protocol Violation|1|||
94480522|NCT05225558|323552193|FG000|Overall Study|Withdrawal by Subject|4|||
94480523|NCT05225558|323552194|FG001|Overall Study|Withdrawal by Subject|3|||
94480524|NCT05225558|323552193|FG000|Overall Study|Adverse Event|1|||
94480525|NCT05225558|323552194|FG001|Overall Study|Adverse Event|0|||
94480526|NCT05225558|323552193|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
94480527|NCT05225558|323552194|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
94480528|NCT05225558|323552193|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
94480529|NCT05225558|323552194|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
94480530|NCT01278342|323552195|FG000|Overall Study|Physician Decision|0|||
94480531|NCT01278342|323552196|FG001|Overall Study|Physician Decision|1|||
94480532|NCT01278342|323552197|FG002|Overall Study|Physician Decision|0|||
94480533|NCT01278342|323552195|FG000|Overall Study|Lost to Follow-up|1|||
94480534|NCT01278342|323552196|FG001|Overall Study|Lost to Follow-up|0|||
94480535|NCT01278342|323552197|FG002|Overall Study|Lost to Follow-up|0|||
94480536|NCT01278342|323552195|FG000|Overall Study|Administrative problems|2|||
94480537|NCT01278342|323552196|FG001|Overall Study|Administrative problems|0|||
94480538|NCT01278342|323552197|FG002|Overall Study|Administrative problems|0|||
94480539|NCT01278342|323552195|FG000|Overall Study|Other|1|||
94480540|NCT01278342|323552196|FG001|Overall Study|Other|0|||
94480541|NCT01278342|323552197|FG002|Overall Study|Other|0|||
94480542|NCT00875563|323552201|FG000|Overall Study|Death|4|||
94480543|NCT00875563|323552201|FG000|Overall Study|Withdrawal by Subject|7|||
94480544|NCT00875563|323552201|FG000|Overall Study|No long-term (3-5 year) consent|6|||
94480545|NCT00875563|323552201|FG000|Overall Study|Still be eligible for follow-up|7|||
94480546|NCT01462630|323552202|FG000|Overall Study|Did not initiate therapy|3|||
94480547|NCT01462630|323552202|FG000|Overall Study|Death|1|||
94480548|NCT01462630|323552202|FG000|Overall Study|Protocol Violation|2|||
94480549|NCT01462630|323552202|FG000|Overall Study|Adverse Event|1|||
94480550|NCT01765296|323552203|FG000|Overall Study|Protocol Violation|0|||
94480551|NCT01765296|323552204|FG001|Overall Study|Protocol Violation|5|||
94480552|NCT01765296|323552205|FG002|Overall Study|Protocol Violation|4|||
94480553|NCT01765296|323552203|FG000|Overall Study|Withdrawal by Subject|4|||
94480554|NCT01765296|323552204|FG001|Overall Study|Withdrawal by Subject|2|||
94480555|NCT01765296|323552205|FG002|Overall Study|Withdrawal by Subject|2|||
94480556|NCT01765296|323552203|FG000|Overall Study|Adverse Event|1|||
94480557|NCT01765296|323552204|FG001|Overall Study|Adverse Event|13|||
94480558|NCT01765296|323552205|FG002|Overall Study|Adverse Event|5|||
94480559|NCT01765296|323552203|FG000|Overall Study|Lack of Efficacy|0|||
94480560|NCT01765296|323552204|FG001|Overall Study|Lack of Efficacy|0|||
94480561|NCT01765296|323552205|FG002|Overall Study|Lack of Efficacy|2|||
94480562|NCT01619852|323552206|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
94480563|NCT01619852|323552207|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
94480564|NCT01619852|323552206|FG000|3 Month Follow up|Lost to Follow-up|31|||
94480565|NCT01619852|323552207|FG001|3 Month Follow up|Lost to Follow-up|34|||
94480566|NCT03933449|323552208|FG000|Overall Study|Adverse Event|6|||
94316464|NCT01781429|322941397|FG008|Overall Study|Withdrawal by Subject|1|||
94316465|NCT01781429|322941398|FG009|Overall Study|Withdrawal by Subject|3|||
94316466|NCT01781429|322941399|FG010|Overall Study|Withdrawal by Subject|1|||
94316467|NCT01781429|322941400|FG011|Overall Study|Withdrawal by Subject|1|||
94316468|NCT01781429|322941401|FG012|Overall Study|Withdrawal by Subject|5|||
94316469|NCT01781429|322941402|FG013|Overall Study|Withdrawal by Subject|2|||
94316470|NCT01781429|322941403|FG014|Overall Study|Withdrawal by Subject|3|||
94316471|NCT01781429|322941404|FG015|Overall Study|Withdrawal by Subject|0|||
94480567|NCT03933449|323552209|FG001|Overall Study|Adverse Event|4|||
94480568|NCT03933449|323552208|FG000|Overall Study|Death|55|||
94480569|NCT03933449|323552209|FG001|Overall Study|Death|57|||
94480570|NCT03933449|323552208|FG000|Overall Study|Sponsor Decision|1|||
94316472|NCT01781429|322941389|FG000|Overall Study|Disease Progression|1|||
94316473|NCT01781429|322941390|FG001|Overall Study|Disease Progression|0|||
94316474|NCT01781429|322941391|FG002|Overall Study|Disease Progression|1|||
94316475|NCT01781429|322941392|FG003|Overall Study|Disease Progression|1|||
94316476|NCT01781429|322941393|FG004|Overall Study|Disease Progression|1|||
94316477|NCT01781429|322941394|FG005|Overall Study|Disease Progression|4|||
94316478|NCT01781429|322941395|FG006|Overall Study|Disease Progression|7|||
94316479|NCT01781429|322941396|FG007|Overall Study|Disease Progression|4|||
94316480|NCT01781429|322941397|FG008|Overall Study|Disease Progression|6|||
94316481|NCT01781429|322941398|FG009|Overall Study|Disease Progression|15|||
94316482|NCT01781429|322941399|FG010|Overall Study|Disease Progression|15|||
94480571|NCT03933449|323552209|FG001|Overall Study|Sponsor Decision|0|||
94480572|NCT02592447|323552210|FG000|Overall Study|Lost to Follow-up|1|||
94480573|NCT02592447|323552211|FG001|Overall Study|Lost to Follow-up|0|||
94480574|NCT02592447|323552210|FG000|Overall Study|Ineligible after randomization|1|||
94480575|NCT02592447|323552211|FG001|Overall Study|Ineligible after randomization|0|||
94316483|NCT01781429|322941400|FG011|Overall Study|Disease Progression|15|||
94316484|NCT01781429|322941401|FG012|Overall Study|Disease Progression|15|||
94480576|NCT02592447|323552210|FG000|Overall Study|Withdrawal by Subject|0|||
94480577|NCT02592447|323552211|FG001|Overall Study|Withdrawal by Subject|1|||
94480578|NCT03478371|323552212|FG000|Overall Study|non-compliance|1|||
94480579|NCT03478371|323552212|FG000|Overall Study|Lost to Follow-up|4|||
94480580|NCT06060496|323552216|FG000|Overall Study|Withdrawal by Subject|2|||
94480581|NCT06060496|323552216|FG000|Overall Study|Lost to Follow-up|2|||
94480582|NCT02221648|323552217|FG000|Overall Study|Withdrawal by Subject|3|||
94480583|NCT02221648|323552218|FG001|Overall Study|Withdrawal by Subject|3|||
94480584|NCT02420119|323552219|FG000|Overall Study|insufficient laboratory data|5|||
94480585|NCT03489343|323552220|FG000|Overall Study|Documented progressive disease|1|||
94480586|NCT03489343|323552221|FG001|Overall Study|Documented progressive disease|0|||
94480587|NCT03489343|323552222|FG002|Overall Study|Documented progressive disease|3|||
94480588|NCT03489343|323552223|FG003|Overall Study|Documented progressive disease|1|||
94480589|NCT03489343|323552224|FG004|Overall Study|Documented progressive disease|3|||
94480590|NCT03489343|323552225|FG005|Overall Study|Documented progressive disease|5|||
94480591|NCT03489343|323552226|FG006|Overall Study|Documented progressive disease|4|||
94480592|NCT03489343|323552220|FG000|Overall Study|Adverse Event|0|||
94480593|NCT03489343|323552221|FG001|Overall Study|Adverse Event|1|||
94480594|NCT03489343|323552222|FG002|Overall Study|Adverse Event|0|||
94480595|NCT03489343|323552223|FG003|Overall Study|Adverse Event|0|||
94480596|NCT03489343|323552224|FG004|Overall Study|Adverse Event|0|||
94480597|NCT03489343|323552225|FG005|Overall Study|Adverse Event|1|||
94480598|NCT03489343|323552226|FG006|Overall Study|Adverse Event|0|||
94480599|NCT03489343|323552220|FG000|Overall Study|Withdrawal by Subject|0|||
94480600|NCT03489343|323552221|FG001|Overall Study|Withdrawal by Subject|0|||
94480601|NCT03489343|323552222|FG002|Overall Study|Withdrawal by Subject|0|||
94480602|NCT03489343|323552223|FG003|Overall Study|Withdrawal by Subject|1|||
94480603|NCT03489343|323552224|FG004|Overall Study|Withdrawal by Subject|0|||
94480604|NCT03489343|323552225|FG005|Overall Study|Withdrawal by Subject|1|||
94480605|NCT03489343|323552226|FG006|Overall Study|Withdrawal by Subject|1|||
94480606|NCT03489343|323552220|FG000|Overall Study|Clinical progression|0|||
94480607|NCT03489343|323552221|FG001|Overall Study|Clinical progression|0|||
94480608|NCT03489343|323552222|FG002|Overall Study|Clinical progression|0|||
94480609|NCT03489343|323552223|FG003|Overall Study|Clinical progression|1|||
94480610|NCT03489343|323552224|FG004|Overall Study|Clinical progression|0|||
94480611|NCT03489343|323552225|FG005|Overall Study|Clinical progression|0|||
94480612|NCT03489343|323552226|FG006|Overall Study|Clinical progression|1|||
94480613|NCT01630135|323552227|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
94480614|NCT01630135|323552228|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
94480615|NCT02899065|323552229|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
94480616|NCT02899065|323552230|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
94480617|NCT02899065|323552229|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
94480618|NCT02899065|323552230|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
94480619|NCT02899065|323552229|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
94480620|NCT02899065|323552230|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
94480621|NCT00971867|323552231|FG000|Overall Study|Adverse Event|4|||
94480622|NCT00971867|323552231|FG000|Overall Study|Participant Withdrew Consent|1|||
94480623|NCT00971867|323552231|FG000|Overall Study|Disease Progression|6|||
94480624|NCT03113968|323552232|FG000|Overall Study|Withdrawal by Subject|31|||
94480625|NCT03113968|323552233|FG001|Overall Study|Withdrawal by Subject|4|||
94480626|NCT04552132|323552234|FG000|Overall Study|Lost to Follow-up|4|||
94480627|NCT04552132|323552235|FG001|Overall Study|Lost to Follow-up|3|||
94480628|NCT04552132|323552234|FG000|Overall Study|Protocol Violation|1|||
94480629|NCT04552132|323552235|FG001|Overall Study|Protocol Violation|0|||
94480630|NCT00901342|323552236|FG000|Overall Study|Adverse Event|1|||
94480631|NCT00901342|323552236|FG000|Overall Study|Death|4|||
94480632|NCT00901342|323552236|FG000|Overall Study|Disease progression|1|||
94480633|NCT00901342|323552236|FG000|Overall Study|Withdrawal by Subject|9|||
94480634|NCT03380377|323552239|FG000|Overall Study|Physician Decision|1|||
94480635|NCT03380377|323552239|FG000|Overall Study|Withdrawal by Subject|1|||
94480636|NCT00128661|323552242|FG000|Overall Study|Adverse Event|14|||
94480637|NCT00128661|323552243|FG001|Overall Study|Adverse Event|11|||
94480638|NCT00128661|323552242|FG000|Overall Study|Lost to Follow-up|10|||
94480639|NCT00128661|323552243|FG001|Overall Study|Lost to Follow-up|7|||
94480640|NCT00128661|323552242|FG000|Overall Study|Withdrawal by Subject|243|||
94316485|NCT01781429|322941402|FG013|Overall Study|Disease Progression|4|||
94316486|NCT01781429|322941403|FG014|Overall Study|Disease Progression|11|||
94480641|NCT00128661|323552243|FG001|Overall Study|Withdrawal by Subject|232|||
94480642|NCT00128661|323552242|FG000|Overall Study|Other|7|||
94480643|NCT00128661|323552243|FG001|Overall Study|Other|8|||
94480644|NCT03311841|323552244|FG000|14-day Wash-out|Adverse Event|0|||
94480645|NCT03311841|323552245|FG001|14-day Wash-out|Adverse Event|1|||
94480646|NCT03311841|323552246|FG002|14-day Wash-out|Adverse Event|0|||
94480647|NCT03311841|323552247|FG003|14-day Wash-out|Adverse Event|0|||
94480648|NCT03311841|323552248|FG004|14-day Wash-out|Adverse Event|0|||
94480649|NCT03311841|323552244|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
94480650|NCT03311841|323552245|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
94480651|NCT03311841|323552246|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
94316487|NCT01781429|322941404|FG015|Overall Study|Disease Progression|0|||
94480652|NCT03311841|323552247|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
94480653|NCT03311841|323552248|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
94480654|NCT02782741|323552249|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
94480655|NCT02782741|323552250|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
94480656|NCT02782741|323552251|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
94480657|NCT02782741|323552249|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
94480658|NCT02782741|323552250|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
94480659|NCT02782741|323552251|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
94480660|NCT02782741|323552249|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
94480661|NCT02782741|323552250|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
94480662|NCT02782741|323552251|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
94480663|NCT02782741|323552249|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
94480664|NCT02782741|323552250|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
94480665|NCT02782741|323552251|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
94480666|NCT02782741|323552249|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
94480667|NCT02782741|323552250|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
94480668|NCT02782741|323552251|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
94480669|NCT00196105|323552253|FG000|Overall Study|Lost to Follow-up|4|||
94480670|NCT00196105|323552254|FG001|Overall Study|Lost to Follow-up|5|||
94480671|NCT00196105|323552255|FG002|Overall Study|Lost to Follow-up|7|||
94480672|NCT03014206|323552256|FG000|Overall Study|Registration Violation|12|||
94480673|NCT01839916|323552266|FG000|Overall Study|Death|9|||
94480674|NCT01839916|323552266|FG000|Overall Study|Physician Decision|17|||
94480675|NCT01839916|323552266|FG000|Overall Study|Relapse|12|||
94480676|NCT01839916|323552266|FG000|Overall Study|GVHD|2|||
94480677|NCT01839916|323552266|FG000|Overall Study|Graft Failure|1|||
94480678|NCT02104895|323552267|FG000|Overall Study|Withdrawal by Subject|0|||
94480679|NCT02104895|323552268|FG001|Overall Study|Withdrawal by Subject|14|||
94480680|NCT04877990|323552269|FG000|Treatment|Other reasons|3|||
94480681|NCT04877990|323552270|FG001|Treatment|Other reasons|1|||
94480682|NCT04877990|323552269|FG000|Treatment|Administrative reasons by sponsor|17|||
94480683|NCT04877990|323552270|FG001|Treatment|Administrative reasons by sponsor|33|||
94480684|NCT04877990|323552269|FG000|Treatment|Withdrawal by Subject|2|||
94480685|NCT04877990|323552270|FG001|Treatment|Withdrawal by Subject|6|||
94480686|NCT04877990|323552269|FG000|Treatment|Adverse Event|2|||
94480687|NCT04877990|323552270|FG001|Treatment|Adverse Event|1|||
94480688|NCT04001803|323552272|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
94480689|NCT04001803|323552272|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
94480690|NCT04001803|323552272|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
94480691|NCT04001803|323552272|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
94480692|NCT04001803|323552272|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
94480693|NCT04001803|323552272|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
94480694|NCT04001803|323552272|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
94480695|NCT04001803|323552272|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
94480696|NCT04001803|323552272|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
94480697|NCT04001803|323552272|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
94480698|NCT00325819|323552275|FG000|Overall Study|Study product lost in mail|2|||
94480699|NCT00325819|323552276|FG001|Overall Study|Study product lost in mail|1|||
94480700|NCT00325819|323552275|FG000|Overall Study|Did not take a dose of study product|4|||
94480701|NCT00325819|323552276|FG001|Overall Study|Did not take a dose of study product|9|||
94480702|NCT00325819|323552275|FG000|Overall Study|Lost to Follow-up|3|||
94480703|NCT00325819|323552276|FG001|Overall Study|Lost to Follow-up|3|||
94480704|NCT02143024|323552277|FG000|Overall Study|Lost to Follow-up|1|||
94480705|NCT02143024|323552278|FG001|Overall Study|Lost to Follow-up|1|||
94480706|NCT02143024|323552277|FG000|Overall Study|Withdrawal by Subject|1|||
94480707|NCT02143024|323552278|FG001|Overall Study|Withdrawal by Subject|0|||
94480708|NCT01945944|323552281|FG000|Overall Study|Adverse Event|0|||
94480709|NCT01945944|323552282|FG001|Overall Study|Adverse Event|2|||
94480710|NCT01945944|323552281|FG000|Overall Study|Physician Decision|1|||
94480711|NCT01945944|323552282|FG001|Overall Study|Physician Decision|0|||
94480712|NCT01945944|323552281|FG000|Overall Study|Withdrawal by Subject|0|||
94480713|NCT01945944|323552282|FG001|Overall Study|Withdrawal by Subject|1|||
94480714|NCT02346877|323552283|FG000|Overall Study|Adverse Event|1|||
94480715|NCT02346877|323552284|FG001|Overall Study|Adverse Event|0|||
94480716|NCT02346877|323552283|FG000|Overall Study|Administrative Decision|1|||
94480717|NCT02346877|323552284|FG001|Overall Study|Administrative Decision|0|||
94480718|NCT02346877|323552283|FG000|Overall Study|Sponsor Decision|12|||
94480719|NCT02346877|323552284|FG001|Overall Study|Sponsor Decision|0|||
94480720|NCT02346877|323552283|FG000|Overall Study|Missing|5|||
94480721|NCT02346877|323552284|FG001|Overall Study|Missing|0|||
94480722|NCT01817075|323552285|FG000|Overall Study|Adverse Event|7|||
94480723|NCT01817075|323552286|FG001|Overall Study|Adverse Event|5|||
94480724|NCT01817075|323552285|FG000|Overall Study|Physician Decision|9|||
94480725|NCT01817075|323552286|FG001|Overall Study|Physician Decision|12|||
94480726|NCT01817075|323552285|FG000|Overall Study|Withdrawal by Subject|31|||
94480727|NCT01817075|323552286|FG001|Overall Study|Withdrawal by Subject|15|||
94480728|NCT01817075|323552285|FG000|Overall Study|Received Sorafenib after enrollment|0|||
94480729|NCT01817075|323552286|FG001|Overall Study|Received Sorafenib after enrollment|1|||
94480730|NCT01817075|323552285|FG000|Overall Study|Ineligible|0|||
94480731|NCT01817075|323552286|FG001|Overall Study|Ineligible|2|||
94480732|NCT01683604|323552287|FG000|Overall Study|Adverse Event|2|||
94480733|NCT01683604|323552287|FG000|Overall Study|Lack of Efficacy|1|||
94480734|NCT01683604|323552287|FG000|Overall Study|Other|2|||
94480735|NCT05251233|323553914|FG000|Overall Study|Disease progression - did not start treatment|0|||
94480736|NCT05251233|323553915|FG001|Overall Study|Disease progression - did not start treatment|0|||
94480737|NCT05251233|323553916|FG002|Overall Study|Disease progression - did not start treatment|5|||
94480738|NCT05251233|323553914|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
94480739|NCT05251233|323553915|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
94480740|NCT05251233|323553916|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
94480741|NCT05251233|323553914|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
94480742|NCT05251233|323553915|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
94480743|NCT05251233|323553916|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
94480744|NCT05251233|323553914|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
94480745|NCT05251233|323553915|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
94480746|NCT05251233|323553916|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
94480747|NCT05251233|323553914|FG000|Overall Study|Death - did not start treatment|3|||
94480748|NCT05251233|323553915|FG001|Overall Study|Death - did not start treatment|0|||
94480749|NCT05251233|323553916|FG002|Overall Study|Death - did not start treatment|0|||
94480750|NCT05251233|323553914|FG000|Overall Study|Withdrawal by Subject|2|||
94480751|NCT05251233|323553915|FG001|Overall Study|Withdrawal by Subject|2|||
94480752|NCT05251233|323553916|FG002|Overall Study|Withdrawal by Subject|0|||
94480753|NCT05251233|323553914|FG000|Overall Study|Other complicating disease|2|||
94480754|NCT05251233|323553915|FG001|Overall Study|Other complicating disease|1|||
94480755|NCT05251233|323553916|FG002|Overall Study|Other complicating disease|0|||
94480756|NCT05251233|323553914|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
94480757|NCT05251233|323553915|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
94480758|NCT05251233|323553916|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
94480759|NCT05251233|323553914|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
94480760|NCT05251233|323553915|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
94480761|NCT05251233|323553916|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
94480762|NCT03778294|323553917|FG000|Overall Study|Death|1|||
94480763|NCT03778294|323553917|FG000|Overall Study|Issues with insurance|1|||
94480764|NCT03778294|323553917|FG000|Overall Study|disease progression before treatment|2|||
94480765|NCT02624947|323553919|FG000|Maternal Participants|Adverse Event|5|||
94480766|NCT02624947|323553920|FG001|Maternal Participants|Adverse Event|0|||
94480767|NCT02624947|323553919|FG000|Maternal Participants|Investigator Decision|5|||
94480768|NCT02624947|323553920|FG001|Maternal Participants|Investigator Decision|3|||
94480769|NCT02624947|323553919|FG000|Maternal Participants|Lost to Follow-up|54|||
94480770|NCT02624947|323553920|FG001|Maternal Participants|Lost to Follow-up|24|||
94480771|NCT02624947|323553919|FG000|Maternal Participants|Non Compliance|8|||
94480772|NCT02624947|323553920|FG001|Maternal Participants|Non Compliance|5|||
94480773|NCT02624947|323553919|FG000|Maternal Participants|Sponsor Request|1|||
94480774|NCT02624947|323553920|FG001|Maternal Participants|Sponsor Request|1|||
94480775|NCT02624947|323553919|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
94480776|NCT02624947|323553920|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
94480777|NCT02624947|323553919|FG000|Maternal Participants|Miscellaneous|23|||
94480778|NCT02624947|323553920|FG001|Maternal Participants|Miscellaneous|15|||
94480779|NCT02624947|323553919|FG000|Infant Participants|Adverse Event|18|||
94480780|NCT02624947|323553920|FG001|Infant Participants|Adverse Event|11|||
94480781|NCT02624947|323553919|FG000|Infant Participants|Investigator Decision|5|||
94480782|NCT02624947|323553920|FG001|Infant Participants|Investigator Decision|4|||
94480783|NCT02624947|323553919|FG000|Infant Participants|Lost to Follow-up|93|||
94480784|NCT02624947|323553920|FG001|Infant Participants|Lost to Follow-up|58|||
94480785|NCT02624947|323553919|FG000|Infant Participants|Non Compliance|17|||
94480786|NCT02624947|323553920|FG001|Infant Participants|Non Compliance|7|||
94316488|NCT01781429|322941389|FG000|Overall Study|Unacceptable Toxicity|0|||
94480787|NCT02624947|323553919|FG000|Infant Participants|Sponsor Request|0|||
94480788|NCT02624947|323553920|FG001|Infant Participants|Sponsor Request|1|||
94480789|NCT02624947|323553919|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
94480790|NCT02624947|323553920|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
94480791|NCT02624947|323553919|FG000|Infant Participants|Miscellaneous|50|||
94316489|NCT01781429|322941390|FG001|Overall Study|Unacceptable Toxicity|0|||
94316490|NCT01781429|322941391|FG002|Overall Study|Unacceptable Toxicity|0|||
94316491|NCT01781429|322941392|FG003|Overall Study|Unacceptable Toxicity|0|||
94316492|NCT01781429|322941393|FG004|Overall Study|Unacceptable Toxicity|0|||
94316493|NCT01781429|322941394|FG005|Overall Study|Unacceptable Toxicity|0|||
94316494|NCT01781429|322941395|FG006|Overall Study|Unacceptable Toxicity|0|||
94316495|NCT01781429|322941396|FG007|Overall Study|Unacceptable Toxicity|0|||
94316496|NCT01781429|322941397|FG008|Overall Study|Unacceptable Toxicity|0|||
94316497|NCT01781429|322941398|FG009|Overall Study|Unacceptable Toxicity|0|||
94316498|NCT01781429|322941399|FG010|Overall Study|Unacceptable Toxicity|0|||
94316499|NCT01781429|322941400|FG011|Overall Study|Unacceptable Toxicity|2|||
94316500|NCT01781429|322941401|FG012|Overall Study|Unacceptable Toxicity|0|||
94316501|NCT01781429|322941402|FG013|Overall Study|Unacceptable Toxicity|0|||
94316502|NCT01781429|322941403|FG014|Overall Study|Unacceptable Toxicity|0|||
94316503|NCT01781429|322941404|FG015|Overall Study|Unacceptable Toxicity|0|||
94316504|NCT01781429|322941389|FG000|Overall Study|Patient Condition Changed|0|||
94316505|NCT01781429|322941390|FG001|Overall Study|Patient Condition Changed|0|||
94316506|NCT01781429|322941391|FG002|Overall Study|Patient Condition Changed|0|||
94316507|NCT01781429|322941392|FG003|Overall Study|Patient Condition Changed|0|||
94316508|NCT01781429|322941393|FG004|Overall Study|Patient Condition Changed|0|||
94316509|NCT01781429|322941394|FG005|Overall Study|Patient Condition Changed|0|||
94316510|NCT01781429|322941395|FG006|Overall Study|Patient Condition Changed|0|||
94316511|NCT01781429|322941396|FG007|Overall Study|Patient Condition Changed|0|||
94316512|NCT01781429|322941397|FG008|Overall Study|Patient Condition Changed|0|||
94316513|NCT01781429|322941398|FG009|Overall Study|Patient Condition Changed|4|||
94316514|NCT01781429|322941399|FG010|Overall Study|Patient Condition Changed|0|||
94316515|NCT01781429|322941400|FG011|Overall Study|Patient Condition Changed|1|||
94316516|NCT01781429|322941401|FG012|Overall Study|Patient Condition Changed|0|||
94316517|NCT01781429|322941402|FG013|Overall Study|Patient Condition Changed|1|||
94316518|NCT01781429|322941403|FG014|Overall Study|Patient Condition Changed|0|||
94316519|NCT01781429|322941404|FG015|Overall Study|Patient Condition Changed|0|||
94316520|NCT01781429|322941389|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
94316521|NCT01781429|322941390|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
94316522|NCT01781429|322941391|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
94316523|NCT01781429|322941392|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
94316524|NCT01781429|322941393|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
94316525|NCT01781429|322941394|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
94316526|NCT01781429|322941395|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
94316527|NCT01781429|322941396|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
94316528|NCT01781429|322941397|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
94316529|NCT01781429|322941398|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
94316530|NCT01781429|322941399|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
94316531|NCT01781429|322941400|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
94316532|NCT01781429|322941401|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
94316533|NCT01781429|322941402|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
94316534|NCT01781429|322941403|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
94316535|NCT01781429|322941404|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
94316536|NCT01781429|322941389|FG000|Overall Study|Enrolled, but not treated|0|||
94316537|NCT01781429|322941390|FG001|Overall Study|Enrolled, but not treated|0|||
94316538|NCT01781429|322941391|FG002|Overall Study|Enrolled, but not treated|0|||
94316539|NCT01781429|322941392|FG003|Overall Study|Enrolled, but not treated|0|||
94316540|NCT01781429|322941393|FG004|Overall Study|Enrolled, but not treated|0|||
94316541|NCT01781429|322941394|FG005|Overall Study|Enrolled, but not treated|0|||
94316542|NCT01781429|322941395|FG006|Overall Study|Enrolled, but not treated|0|||
94316543|NCT01781429|322941396|FG007|Overall Study|Enrolled, but not treated|0|||
94316544|NCT01781429|322941397|FG008|Overall Study|Enrolled, but not treated|0|||
94316545|NCT01781429|322941398|FG009|Overall Study|Enrolled, but not treated|0|||
94316546|NCT01781429|322941399|FG010|Overall Study|Enrolled, but not treated|1|||
94316547|NCT01781429|322941400|FG011|Overall Study|Enrolled, but not treated|0|||
94316548|NCT01781429|322941401|FG012|Overall Study|Enrolled, but not treated|0|||
94316549|NCT01781429|322941402|FG013|Overall Study|Enrolled, but not treated|0|||
94316550|NCT01781429|322941403|FG014|Overall Study|Enrolled, but not treated|0|||
94316551|NCT01781429|322941404|FG015|Overall Study|Enrolled, but not treated|0|||
94316552|NCT02678741|322941405|FG000|Overall Study|Death|4|||
94316553|NCT02678741|322941405|FG000|Overall Study|Withdrawal by Subject|1|||
94316554|NCT02678741|322941405|FG000|Overall Study|ineligible|3|||
94316555|NCT02678741|322941405|FG000|Overall Study|Not RECIST Measurable|2|||
94316556|NCT02678741|322941405|FG000|Overall Study|Lack of Efficacy|10|||
94316557|NCT01725152|322941406|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
94316558|NCT01725152|322941407|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
94316559|NCT01725152|322941406|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
94316560|NCT01725152|322941407|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
94316561|NCT01725152|322941406|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
94316562|NCT01725152|322941407|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
94316563|NCT01725152|322941406|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
94316564|NCT01725152|322941407|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
94316565|NCT02044159|322941408|FG000|Overall Study|Consent declined (deferred consent)|2|||
94316566|NCT02044159|322941409|FG001|Overall Study|Consent declined (deferred consent)|4|||
94316567|NCT02044159|322941408|FG000|Overall Study|No longer eligible, drug not given|1|||
94316568|NCT02044159|322941409|FG001|Overall Study|No longer eligible, drug not given|0|||
94316569|NCT02044159|322941408|FG000|Overall Study|Nurse declined to give study drug|1|||
94316570|NCT02044159|322941409|FG001|Overall Study|Nurse declined to give study drug|0|||
94316571|NCT01111539|322941412|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
94316572|NCT01111539|322941413|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
94316573|NCT01111539|322941414|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
94316574|NCT01111539|322941415|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
94316575|NCT01111539|322941416|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
94316576|NCT01111539|322941412|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
94316577|NCT01111539|322941413|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
94316578|NCT01111539|322941414|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
94316579|NCT01111539|322941415|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
94316580|NCT01111539|322941416|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
94316581|NCT01111539|322941412|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
94316582|NCT01111539|322941413|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
94316583|NCT01111539|322941414|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
94316584|NCT01111539|322941415|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
94316585|NCT01111539|322941416|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
94316586|NCT01111539|322941412|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
94316587|NCT01111539|322941413|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
94316588|NCT01111539|322941414|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
94316589|NCT01111539|322941415|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
94316590|NCT01111539|322941416|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
94316591|NCT01111539|322941412|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
94316592|NCT01111539|322941413|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
94316593|NCT01111539|322941414|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
94316594|NCT01111539|322941415|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
94316595|NCT01111539|322941416|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
94316596|NCT01111539|322941412|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
94316597|NCT01111539|322941413|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
94316598|NCT01111539|322941414|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
94316599|NCT01111539|322941415|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
94316600|NCT01111539|322941416|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
94316601|NCT01111539|322941412|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
94316602|NCT01111539|322941413|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
94316603|NCT01111539|322941414|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
94316604|NCT01111539|322941415|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
94316605|NCT01111539|322941416|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
94316606|NCT01111539|322941412|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
94316607|NCT01111539|322941413|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
94316608|NCT01111539|322941414|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
94316609|NCT01111539|322941415|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
94316610|NCT01111539|322941416|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
94316611|NCT01111539|322941412|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
94316612|NCT01111539|322941413|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
94316613|NCT01111539|322941414|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
94316614|NCT01111539|322941415|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
94316615|NCT01111539|322941416|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
94316616|NCT01111539|322941412|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
94316617|NCT01111539|322941413|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
94316618|NCT01111539|322941414|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
94316619|NCT01111539|322941415|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
94316620|NCT01111539|322941416|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
94316621|NCT01111539|322941412|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
94316622|NCT01111539|322941413|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
94316623|NCT01111539|322941414|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
94316624|NCT01111539|322941415|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
94316625|NCT01111539|322941416|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
94316626|NCT01111539|322941412|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
94316627|NCT01111539|322941413|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
94480792|NCT02624947|323553920|FG001|Infant Participants|Miscellaneous|26|||
94480793|NCT00823264|323553930|FG000|Overall Study|Protocol Violation|2|||
94480794|NCT00823264|323553931|FG001|Overall Study|Protocol Violation|0|||
94480795|NCT01714544|323553932|FG000|Overall Study|Lost to Follow-up|1|||
94480796|NCT01714544|323553932|FG000|Overall Study|Physician Decision|1|||
94480797|NCT01714544|323553932|FG000|Overall Study|Withdrawal by Subject|1|||
94480798|NCT00994110|323553933|FG000|Overall Study|Withdrawal by Subject|9|||
94480799|NCT00994110|323553934|FG001|Overall Study|Withdrawal by Subject|9|||
94480800|NCT00994110|323553933|FG000|Overall Study|Not Treated|4|||
94480801|NCT00994110|323553934|FG001|Overall Study|Not Treated|8|||
94480802|NCT00994110|323553933|FG000|Overall Study|Adverse Event|1|||
94480803|NCT00994110|323553934|FG001|Overall Study|Adverse Event|0|||
94480804|NCT00994110|323553933|FG000|Overall Study|Patient not resected|41|||
94480805|NCT00994110|323553934|FG001|Overall Study|Patient not resected|52|||
94480806|NCT00994110|323553933|FG000|Overall Study|Pt not eligible|10|||
94480807|NCT00994110|323553934|FG001|Overall Study|Pt not eligible|5|||
94480808|NCT02169505|323553936|FG000|Overall Study|Withdrawal by Subject|1|||
94480809|NCT02326272|323553937|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94480810|NCT02326272|323553938|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
94480811|NCT02326272|323553939|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
94480812|NCT02326272|323553940|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94480813|NCT02326272|323553941|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94480814|NCT02326272|323553942|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94480815|NCT02326272|323553943|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94480816|NCT02326272|323553944|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94480817|NCT02326272|323553945|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94480818|NCT02326272|323553946|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94480819|NCT02326272|323553947|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94480820|NCT02326272|323553948|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94480821|NCT02326272|323553949|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94480822|NCT02326272|323553950|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94480823|NCT02326272|323553951|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
94480824|NCT02326272|323553937|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
94480825|NCT02326272|323553938|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
94480826|NCT02326272|323553939|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94480827|NCT02326272|323553940|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94480828|NCT02326272|323553941|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94480829|NCT02326272|323553942|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94480830|NCT02326272|323553943|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94480831|NCT02326272|323553944|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94480832|NCT02326272|323553945|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94480833|NCT02326272|323553946|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94480834|NCT02326272|323553947|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94480835|NCT02326272|323553948|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94480836|NCT02326272|323553949|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94480837|NCT02326272|323553950|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94480838|NCT02326272|323553951|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
94480839|NCT02326272|323553937|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
94480840|NCT02326272|323553938|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
94480841|NCT02326272|323553939|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
94480842|NCT02326272|323553940|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94480843|NCT02326272|323553941|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94480844|NCT02326272|323553942|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94480845|NCT02326272|323553943|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94480846|NCT02326272|323553944|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94480847|NCT02326272|323553945|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94480848|NCT02326272|323553946|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94480849|NCT02326272|323553947|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94480850|NCT02326272|323553948|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94480851|NCT02326272|323553949|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94480852|NCT02326272|323553950|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94480853|NCT02326272|323553951|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
94480854|NCT02326272|323553937|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
94480855|NCT02326272|323553938|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
94480856|NCT02326272|323553939|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
94480857|NCT02326272|323553940|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
94480858|NCT02326272|323553941|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
94480859|NCT02326272|323553942|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
94480860|NCT02326272|323553943|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
94316628|NCT01111539|322941414|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
94316629|NCT01111539|322941415|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
94316630|NCT01111539|322941416|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
94316631|NCT01111539|322941412|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
94316632|NCT01111539|322941413|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
94316633|NCT01111539|322941414|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
94316634|NCT01111539|322941415|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
94316635|NCT01111539|322941416|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
94316636|NCT01111539|322941412|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
94316637|NCT01111539|322941413|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
94316638|NCT01111539|322941414|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
94316639|NCT01111539|322941415|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
94316640|NCT01111539|322941416|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
94316641|NCT03580382|322941417|FG000|Overall Study|Early Termination of Study|0|||
94316642|NCT03580382|322941418|FG001|Overall Study|Early Termination of Study|3|||
94316643|NCT03539458|322941421|FG000|Overall Study|Death|1|||
94316644|NCT01984346|322941422|FG000|Overall Study|Physician Decision|4|||
94316645|NCT01984346|322941423|FG001|Overall Study|Physician Decision|2|||
94316646|NCT01984346|322941422|FG000|Overall Study|Withdrawal by Subject|2|||
94316647|NCT01984346|322941423|FG001|Overall Study|Withdrawal by Subject|2|||
94316648|NCT01984346|322941422|FG000|Overall Study|Enrollment Closed|8|||
94316649|NCT01984346|322941423|FG001|Overall Study|Enrollment Closed|1|||
94316650|NCT01984346|322941422|FG000|Overall Study|Insurance Coverage|1|||
94316651|NCT01984346|322941423|FG001|Overall Study|Insurance Coverage|0|||
94316652|NCT01984346|322941422|FG000|Overall Study|Intra-operative Exclusion|2|||
94316653|NCT01984346|322941423|FG001|Overall Study|Intra-operative Exclusion|0|||
94316654|NCT03100942|322941424|FG000|Randomized Treatment Period|Withdrew Consent|4|||
94316655|NCT03100942|322941425|FG001|Randomized Treatment Period|Withdrew Consent|5|||
94316656|NCT03100942|322941426|FG002|Randomized Treatment Period|Withdrew Consent|3|||
94316657|NCT03100942|322941427|FG003|Randomized Treatment Period|Withdrew Consent|3|||
94316658|NCT03100942|322941428|FG004|Randomized Treatment Period|Withdrew Consent|0|||
94316659|NCT03100942|322941429|FG005|Randomized Treatment Period|Withdrew Consent|0|||
94316660|NCT03100942|322941430|FG006|Randomized Treatment Period|Withdrew Consent|0|||
94316661|NCT03100942|322941424|FG000|Randomized Treatment Period|Adverse Event|5|||
94316662|NCT03100942|322941425|FG001|Randomized Treatment Period|Adverse Event|2|||
94316663|NCT03100942|322941426|FG002|Randomized Treatment Period|Adverse Event|1|||
94316664|NCT03100942|322941427|FG003|Randomized Treatment Period|Adverse Event|0|||
94316665|NCT03100942|322941428|FG004|Randomized Treatment Period|Adverse Event|0|||
94316666|NCT03100942|322941429|FG005|Randomized Treatment Period|Adverse Event|0|||
94316667|NCT03100942|322941430|FG006|Randomized Treatment Period|Adverse Event|0|||
94316668|NCT03100942|322941424|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
94316669|NCT03100942|322941425|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
94316670|NCT03100942|322941426|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
94316671|NCT03100942|322941427|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
94316672|NCT03100942|322941428|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
94316673|NCT03100942|322941429|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
94316674|NCT03100942|322941430|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
94316675|NCT03100942|322941424|FG000|Randomized Treatment Period|Protocol Violation|0|||
94316676|NCT03100942|322941425|FG001|Randomized Treatment Period|Protocol Violation|1|||
94316677|NCT03100942|322941426|FG002|Randomized Treatment Period|Protocol Violation|1|||
94316678|NCT03100942|322941427|FG003|Randomized Treatment Period|Protocol Violation|1|||
94316679|NCT03100942|322941428|FG004|Randomized Treatment Period|Protocol Violation|0|||
94316680|NCT03100942|322941429|FG005|Randomized Treatment Period|Protocol Violation|0|||
94316681|NCT03100942|322941430|FG006|Randomized Treatment Period|Protocol Violation|0|||
94316682|NCT03100942|322941424|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
94316683|NCT03100942|322941425|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
94316684|NCT03100942|322941426|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
94316685|NCT03100942|322941427|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
94316686|NCT03100942|322941428|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
94480861|NCT02326272|323553944|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
94480862|NCT02326272|323553945|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
94316687|NCT03100942|322941429|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
94316688|NCT03100942|322941430|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
94316689|NCT03100942|322941424|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
94316690|NCT03100942|322941425|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
94316691|NCT03100942|322941426|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
94316692|NCT03100942|322941427|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
94316693|NCT03100942|322941428|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
94316694|NCT03100942|322941429|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
94316695|NCT03100942|322941430|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
94316696|NCT03100942|322941424|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
94316697|NCT03100942|322941425|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
94316698|NCT03100942|322941426|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
94316699|NCT03100942|322941427|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
94316700|NCT03100942|322941428|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
94316701|NCT03100942|322941429|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
94316702|NCT03100942|322941430|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
94316703|NCT00769704|322941432|FG000|Overall Study|Lost to Follow-up|3|||
94316704|NCT00769704|322941433|FG001|Overall Study|Lost to Follow-up|2|||
94316705|NCT00769704|322941432|FG000|Overall Study|Death|95|||
94316706|NCT00769704|322941433|FG001|Overall Study|Death|190|||
94316707|NCT00769704|322941432|FG000|Overall Study|Withdrawal by Subject|12|||
94316708|NCT00769704|322941433|FG001|Overall Study|Withdrawal by Subject|5|||
94316709|NCT00769704|322941432|FG000|Overall Study|Other|1|||
94316710|NCT00769704|322941433|FG001|Overall Study|Other|2|||
94316711|NCT01617681|322941435|FG000|Period 1 Double Blind|Adverse Event|2|||
94316712|NCT01617681|322941436|FG001|Period 1 Double Blind|Adverse Event|0|||
94316713|NCT01617681|322941437|FG002|Period 1 Double Blind|Adverse Event|0|||
94316714|NCT01617681|322941438|FG003|Period 1 Double Blind|Adverse Event|2|||
94316715|NCT01617681|322941439|FG004|Period 1 Double Blind|Adverse Event|0|||
94316716|NCT01617681|322941435|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
94316717|NCT01617681|322941436|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
94316718|NCT01617681|322941437|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
94316719|NCT01617681|322941438|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
94316720|NCT01617681|322941439|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
94316721|NCT01617681|322941435|FG000|Period 2 Open Label|Adverse Event|0|||
94316722|NCT01617681|322941436|FG001|Period 2 Open Label|Adverse Event|0|||
94316723|NCT01617681|322941437|FG002|Period 2 Open Label|Adverse Event|0|||
94316724|NCT01617681|322941438|FG003|Period 2 Open Label|Adverse Event|0|||
94316725|NCT01617681|322941439|FG004|Period 2 Open Label|Adverse Event|3|||
94316726|NCT01617681|322941435|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
94316727|NCT01617681|322941436|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
94316728|NCT01617681|322941437|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
94316729|NCT01617681|322941438|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
94316730|NCT01617681|322941439|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
94316731|NCT01202227|322941447|FG000|Overall Study|Adverse Event|16|||
94316732|NCT01202227|322941447|FG000|Overall Study|Withdrawal by Subject|2|||
94316733|NCT01202227|322941447|FG000|Overall Study|Lack of Efficacy|1|||
94316734|NCT00411788|322941448|FG000|Overall Study|Protocol Violation|1|||
94316735|NCT00411788|322941448|FG000|Overall Study|Adverse Event|1|||
94316736|NCT02935634|322941449|FG000|Randomization|Participant withdrew consent|0|||
94316737|NCT02935634|322941450|FG001|Randomization|Participant withdrew consent|1|||
94316738|NCT02935634|322941451|FG002|Randomization|Participant withdrew consent|0|||
94316739|NCT02935634|322941452|FG003|Randomization|Participant withdrew consent|0|||
94316740|NCT02935634|322941453|FG004|Randomization|Participant withdrew consent|0|||
94316741|NCT02935634|322941454|FG005|Randomization|Participant withdrew consent|0|||
94316742|NCT02935634|322941449|FG000|Randomization|Death|2|||
94316743|NCT02935634|322941450|FG001|Randomization|Death|1|||
94316744|NCT02935634|322941451|FG002|Randomization|Death|1|||
94316745|NCT02935634|322941452|FG003|Randomization|Death|0|||
94316746|NCT02935634|322941453|FG004|Randomization|Death|0|||
94316747|NCT02935634|322941454|FG005|Randomization|Death|0|||
94316748|NCT02935634|322941449|FG000|Randomization|Other reasons|0|||
94316749|NCT02935634|322941450|FG001|Randomization|Other reasons|2|||
94316750|NCT02935634|322941451|FG002|Randomization|Other reasons|2|||
94316751|NCT02935634|322941452|FG003|Randomization|Other reasons|0|||
94316752|NCT02935634|322941453|FG004|Randomization|Other reasons|0|||
94316753|NCT02935634|322941454|FG005|Randomization|Other reasons|0|||
94316754|NCT02935634|322941449|FG000|Treatment: Track 1|Disease progression|15|||
94316755|NCT02935634|322941450|FG001|Treatment: Track 1|Disease progression|17|||
94316756|NCT02935634|322941451|FG002|Treatment: Track 1|Disease progression|28|||
94316757|NCT02935634|322941452|FG003|Treatment: Track 1|Disease progression|4|||
94316758|NCT02935634|322941453|FG004|Treatment: Track 1|Disease progression|6|||
94316759|NCT02935634|322941454|FG005|Treatment: Track 1|Disease progression|2|||
94316760|NCT02935634|322941449|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
94316761|NCT02935634|322941450|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
94316762|NCT02935634|322941451|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
94316763|NCT02935634|322941452|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
94316764|NCT02935634|322941453|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
94316765|NCT02935634|322941454|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
94316766|NCT02935634|322941449|FG000|Treatment: Track 1|Lost to Follow-up|1|||
94316767|NCT02935634|322941450|FG001|Treatment: Track 1|Lost to Follow-up|0|||
94316768|NCT02935634|322941451|FG002|Treatment: Track 1|Lost to Follow-up|0|||
94316769|NCT02935634|322941452|FG003|Treatment: Track 1|Lost to Follow-up|0|||
94316770|NCT02935634|322941453|FG004|Treatment: Track 1|Lost to Follow-up|0|||
94316771|NCT02935634|322941454|FG005|Treatment: Track 1|Lost to Follow-up|0|||
94316772|NCT02935634|322941449|FG000|Treatment: Track 1|Study drug toxicity|2|||
94316773|NCT02935634|322941450|FG001|Treatment: Track 1|Study drug toxicity|1|||
94316774|NCT02935634|322941451|FG002|Treatment: Track 1|Study drug toxicity|3|||
94316775|NCT02935634|322941452|FG003|Treatment: Track 1|Study drug toxicity|0|||
94316776|NCT02935634|322941453|FG004|Treatment: Track 1|Study drug toxicity|0|||
94316777|NCT02935634|322941454|FG005|Treatment: Track 1|Study drug toxicity|1|||
94316778|NCT02935634|322941449|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
94316779|NCT02935634|322941450|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
94316780|NCT02935634|322941451|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
94316781|NCT02935634|322941452|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
94316782|NCT02935634|322941453|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
94480863|NCT02326272|323553946|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
94480864|NCT02326272|323553947|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
94480865|NCT02326272|323553948|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
94480866|NCT02326272|323553949|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
94480867|NCT02326272|323553950|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
94480868|NCT02326272|323553951|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
94480869|NCT02326272|323553937|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
94480870|NCT02326272|323553938|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
94480871|NCT02326272|323553939|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
94480872|NCT02326272|323553940|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
94480873|NCT02326272|323553941|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
94480874|NCT02326272|323553942|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
94480875|NCT02326272|323553943|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
94480876|NCT02326272|323553944|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
94480877|NCT02326272|323553945|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
94480878|NCT02326272|323553946|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
94480879|NCT02326272|323553947|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
94480880|NCT02326272|323553948|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
94480881|NCT02326272|323553949|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
94480882|NCT02326272|323553950|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
94480883|NCT02326272|323553951|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
94480884|NCT02326272|323553937|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
94480885|NCT02326272|323553938|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
94480886|NCT02326272|323553939|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
94480887|NCT02326272|323553940|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
94480888|NCT02326272|323553941|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
94480889|NCT02326272|323553942|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
94480890|NCT02326272|323553943|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
94480891|NCT02326272|323553944|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
94480892|NCT02326272|323553945|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
94480893|NCT02326272|323553946|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
94480894|NCT02326272|323553947|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
94480895|NCT02326272|323553948|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
94480896|NCT02326272|323553949|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
94480897|NCT02326272|323553950|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
94480898|NCT02326272|323553951|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
94480899|NCT02326272|323553937|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
94480900|NCT02326272|323553938|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
94480901|NCT02326272|323553939|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
94480902|NCT02326272|323553940|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
94480903|NCT02326272|323553941|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
94480904|NCT02326272|323553942|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
94480905|NCT02326272|323553943|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
94480906|NCT02326272|323553944|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
94480907|NCT02326272|323553945|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
94480908|NCT02326272|323553946|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
94480909|NCT02326272|323553947|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
94480910|NCT02326272|323553948|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
94480911|NCT02326272|323553949|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
94480912|NCT02326272|323553950|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
94480913|NCT02326272|323553951|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
94480914|NCT02326272|323553937|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94480915|NCT02326272|323553938|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94480916|NCT02326272|323553939|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94480917|NCT02326272|323553940|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94480918|NCT02326272|323553941|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
94316783|NCT02935634|322941454|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
94316784|NCT02935634|322941449|FG000|Treatment: Track 1|Participant withdrew consent|2|||
94316785|NCT02935634|322941450|FG001|Treatment: Track 1|Participant withdrew consent|0|||
94316786|NCT02935634|322941451|FG002|Treatment: Track 1|Participant withdrew consent|1|||
94316787|NCT02935634|322941452|FG003|Treatment: Track 1|Participant withdrew consent|0|||
94316788|NCT02935634|322941453|FG004|Treatment: Track 1|Participant withdrew consent|1|||
94316789|NCT02935634|322941454|FG005|Treatment: Track 1|Participant withdrew consent|0|||
94316790|NCT02935634|322941449|FG000|Treatment: Track 1|Other reasons|0|||
94316791|NCT02935634|322941450|FG001|Treatment: Track 1|Other reasons|0|||
94316792|NCT02935634|322941451|FG002|Treatment: Track 1|Other reasons|2|||
94316793|NCT02935634|322941452|FG003|Treatment: Track 1|Other reasons|0|||
94316794|NCT02935634|322941453|FG004|Treatment: Track 1|Other reasons|0|||
94316795|NCT02935634|322941454|FG005|Treatment: Track 1|Other reasons|0|||
94316796|NCT02935634|322941449|FG000|Treatment: Track 2|Disease progression|13|||
94316797|NCT02935634|322941450|FG001|Treatment: Track 2|Disease progression|26|||
94316798|NCT02935634|322941451|FG002|Treatment: Track 2|Disease progression|20|||
94316799|NCT02935634|322941452|FG003|Treatment: Track 2|Disease progression|5|||
94316800|NCT02935634|322941453|FG004|Treatment: Track 2|Disease progression|1|||
94316801|NCT02935634|322941454|FG005|Treatment: Track 2|Disease progression|4|||
94316802|NCT02935634|322941449|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
94316803|NCT02935634|322941450|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
94316804|NCT02935634|322941451|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
94316805|NCT02935634|322941452|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
94316806|NCT02935634|322941453|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
94316807|NCT02935634|322941454|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
94316808|NCT02935634|322941449|FG000|Treatment: Track 2|Study drug toxicity|7|||
94316809|NCT02935634|322941450|FG001|Treatment: Track 2|Study drug toxicity|3|||
94316810|NCT02935634|322941451|FG002|Treatment: Track 2|Study drug toxicity|0|||
94316811|NCT02935634|322941452|FG003|Treatment: Track 2|Study drug toxicity|0|||
94316812|NCT02935634|322941453|FG004|Treatment: Track 2|Study drug toxicity|0|||
94316813|NCT02935634|322941454|FG005|Treatment: Track 2|Study drug toxicity|0|||
94316814|NCT02935634|322941449|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
94316815|NCT02935634|322941450|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
94316816|NCT02935634|322941451|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
94316817|NCT02935634|322941452|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
94316818|NCT02935634|322941453|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
94316819|NCT02935634|322941454|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
94316820|NCT02935634|322941449|FG000|Treatment: Track 2|Participant withdrew consent|0|||
94316821|NCT02935634|322941450|FG001|Treatment: Track 2|Participant withdrew consent|1|||
94316822|NCT02935634|322941451|FG002|Treatment: Track 2|Participant withdrew consent|1|||
94316823|NCT02935634|322941452|FG003|Treatment: Track 2|Participant withdrew consent|0|||
94316824|NCT02935634|322941453|FG004|Treatment: Track 2|Participant withdrew consent|1|||
94316825|NCT02935634|322941454|FG005|Treatment: Track 2|Participant withdrew consent|0|||
94316826|NCT01428063|322941455|FG000|Overall Study|Lack of Efficacy|8|||
94316827|NCT01428063|322941456|FG001|Overall Study|Lack of Efficacy|4|||
94316828|NCT01428063|322941457|FG002|Overall Study|Lack of Efficacy|1|||
94316829|NCT01428063|322941455|FG000|Overall Study|Adverse Event|2|||
94316830|NCT01428063|322941456|FG001|Overall Study|Adverse Event|3|||
94316831|NCT01428063|322941457|FG002|Overall Study|Adverse Event|0|||
94316832|NCT01428063|322941455|FG000|Overall Study|Lost to Follow-up|0|||
94316833|NCT01428063|322941456|FG001|Overall Study|Lost to Follow-up|2|||
94316834|NCT01428063|322941457|FG002|Overall Study|Lost to Follow-up|0|||
94316835|NCT01428063|322941455|FG000|Overall Study|No longer meets study criteria|0|||
94316836|NCT01428063|322941456|FG001|Overall Study|No longer meets study criteria|1|||
94316837|NCT01428063|322941457|FG002|Overall Study|No longer meets study criteria|0|||
94316838|NCT00316303|322941462|FG000|Overall Study|Lost to Follow-up|11|||
94316839|NCT00316303|322941463|FG001|Overall Study|Lost to Follow-up|16|||
94316840|NCT01753076|322941466|FG000|Overall Study|Adverse Event|17|||
94316841|NCT01753076|322941467|FG001|Overall Study|Adverse Event|18|||
94316842|NCT01753076|322941466|FG000|Overall Study|Lack of Efficacy|3|||
94316843|NCT01753076|322941467|FG001|Overall Study|Lack of Efficacy|1|||
94316844|NCT01753076|322941466|FG000|Overall Study|Lost to Follow-up|2|||
94316845|NCT01753076|322941467|FG001|Overall Study|Lost to Follow-up|1|||
94316846|NCT01753076|322941466|FG000|Overall Study|Physician Decision|4|||
94316847|NCT01753076|322941467|FG001|Overall Study|Physician Decision|2|||
94316848|NCT01753076|322941466|FG000|Overall Study|Withdrawal by Subject|14|||
94316849|NCT01753076|322941467|FG001|Overall Study|Withdrawal by Subject|24|||
94316850|NCT01753076|322941466|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
94316851|NCT01753076|322941467|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
94316852|NCT02575079|322941468|FG000|Overall Study|Death|3|||
94316853|NCT02575079|322941469|FG001|Overall Study|Death|0|||
94316854|NCT02575079|322941468|FG000|Overall Study|Withdrawal by Subject|3|||
94316855|NCT02575079|322941469|FG001|Overall Study|Withdrawal by Subject|0|||
94316856|NCT02389816|322941470|FG000|Overall Study|Randomized but Not Treated|1|||
94316857|NCT02389816|322941471|FG001|Overall Study|Randomized but Not Treated|0|||
94316858|NCT02389816|322941472|FG002|Overall Study|Randomized but Not Treated|0|||
94316859|NCT02389816|322941470|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
94316860|NCT02389816|322941471|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
94316861|NCT02389816|322941472|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
94316862|NCT02389816|322941470|FG000|Overall Study|Major Protocol Deviation|1|||
94316863|NCT02389816|322941471|FG001|Overall Study|Major Protocol Deviation|0|||
94316864|NCT02389816|322941472|FG002|Overall Study|Major Protocol Deviation|0|||
94316865|NCT02389816|322941470|FG000|Overall Study|Lost to Follow-up|1|||
94316866|NCT02389816|322941471|FG001|Overall Study|Lost to Follow-up|0|||
94316867|NCT02389816|322941472|FG002|Overall Study|Lost to Follow-up|0|||
94316868|NCT02389816|322941470|FG000|Overall Study|Withdrawal of Consent|6|||
94316869|NCT02389816|322941471|FG001|Overall Study|Withdrawal of Consent|4|||
94316870|NCT02389816|322941472|FG002|Overall Study|Withdrawal of Consent|4|||
94316871|NCT02389816|322941470|FG000|Overall Study|Lack of Efficacy|1|||
94316872|NCT02389816|322941471|FG001|Overall Study|Lack of Efficacy|0|||
94316873|NCT02389816|322941472|FG002|Overall Study|Lack of Efficacy|0|||
94316874|NCT02389816|322941470|FG000|Overall Study|Non Compliance with Study Drug|1|||
94316875|NCT02389816|322941471|FG001|Overall Study|Non Compliance with Study Drug|1|||
94316876|NCT02389816|322941472|FG002|Overall Study|Non Compliance with Study Drug|1|||
94316877|NCT02389816|322941470|FG000|Overall Study|Reason not Specified|0|||
94316878|NCT02389816|322941471|FG001|Overall Study|Reason not Specified|2|||
94316879|NCT02389816|322941472|FG002|Overall Study|Reason not Specified|0|||
94316880|NCT00471536|322941473|FG000|Overall Study|Withdrawal by Subject|1|||
94316881|NCT03649321|322941474|FG000|Overall Study|Withdrawal by Subject|1|||
94316882|NCT03649321|322941475|FG001|Overall Study|Withdrawal by Subject|0|||
94316883|NCT03649321|322941474|FG000|Overall Study|Death|1|||
94316884|NCT03649321|322941475|FG001|Overall Study|Death|0|||
94316885|NCT01253044|322941477|FG000|Overall Study|Lost to Follow-up|38|||
94316886|NCT01253044|322941478|FG001|Overall Study|Lost to Follow-up|29|||
94316887|NCT03885726|322941479|FG000|Overall Study|Staffing issues/lost interest|1|||
94316888|NCT03885726|322941479|FG000|Overall Study|Early discharge from hospital|3|||
94316889|NCT00069576|322941480|FG000|Original Trial|Lost to Follow-up|25|||
94316890|NCT00069576|322941481|FG001|Original Trial|Lost to Follow-up|33|||
94316891|NCT00069576|322941480|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
94316892|NCT00069576|322941481|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
94316893|NCT01603641|322941484|FG000|Overall Study|Did not Receive Treatment|3|||
94316894|NCT01603641|322941484|FG000|Overall Study|Adverse Event|1|||
94316895|NCT01603641|322941484|FG000|Overall Study|Lack of Efficacy|1|||
94316896|NCT01603641|322941484|FG000|Overall Study|Lost to Follow-up|6|||
94316897|NCT01603641|322941484|FG000|Overall Study|Personal Reasons|18|||
94316898|NCT01603641|322941484|FG000|Overall Study|Other Miscellaneous Reasons|6|||
94316899|NCT05091060|322941485|FG000|Overall Study|Lost to Follow-up|1|||
94316900|NCT02065869|322941486|FG000|Overall Study|Death|7|||
94316901|NCT02065869|322941486|FG000|Overall Study|Disease relapse|16|||
94316902|NCT02065869|322941486|FG000|Overall Study|Lost to Follow-up|4|||
94316903|NCT02065869|322941486|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
94316904|NCT02065869|322941486|FG000|Overall Study|Withdrawal by Subject|1|||
94316905|NCT02761993|322941489|FG000|Overall Study|Adverse Event|0|||
94316906|NCT02761993|322941490|FG001|Overall Study|Adverse Event|2|||
94316907|NCT02761993|322941491|FG002|Overall Study|Adverse Event|0|||
94316908|NCT02761993|322941489|FG000|Overall Study|Lost to Follow-up|1|||
94316909|NCT02761993|322941490|FG001|Overall Study|Lost to Follow-up|3|||
94316910|NCT02761993|322941491|FG002|Overall Study|Lost to Follow-up|2|||
94316911|NCT02761993|322941489|FG000|Overall Study|Withdrawal by Subject|1|||
94316912|NCT02761993|322941490|FG001|Overall Study|Withdrawal by Subject|1|||
94316913|NCT02761993|322941491|FG002|Overall Study|Withdrawal by Subject|2|||
94316914|NCT01842620|322941492|FG000|Period 1|Withdrawal by Subject|1|||
94316915|NCT01842620|322941493|FG001|Period 1|Withdrawal by Subject|0|||
94316916|NCT03827473|322941500|FG000|Overall Study|Withdrawal by Subject|1|||
94316917|NCT03827473|322941501|FG001|Overall Study|Withdrawal by Subject|0|||
94316918|NCT01687413|322941502|FG000|Overall Study|Withdrawal by Subject|0|||
94316919|NCT01687413|322941503|FG001|Overall Study|Withdrawal by Subject|2|||
94316920|NCT01687413|322941502|FG000|Overall Study|Not eligible|0|||
94316921|NCT01687413|322941503|FG001|Overall Study|Not eligible|2|||
94316922|NCT01687413|322941502|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
94316923|NCT01687413|322941503|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
94316924|NCT03625986|322942908|FG000|Randomization Period|Lost to Follow-up|7|||
94316925|NCT03625986|322942909|FG001|Randomization Period|Lost to Follow-up|12|||
94316926|NCT03625986|322942908|FG000|Randomization Period|Withdrawal by Subject|10|||
94316927|NCT03625986|322942909|FG001|Randomization Period|Withdrawal by Subject|6|||
94316928|NCT02279524|322942910|FG000|Overall Study|Withdrawal by Subject|3|||
94316929|NCT02279524|322942911|FG001|Overall Study|Withdrawal by Subject|6|||
94316930|NCT02279524|322942912|FG002|Overall Study|Withdrawal by Subject|3|||
94316931|NCT02279524|322942910|FG000|Overall Study|Adverse Event|4|||
94316932|NCT02279524|322942911|FG001|Overall Study|Adverse Event|3|||
94316933|NCT02279524|322942912|FG002|Overall Study|Adverse Event|2|||
94316934|NCT02279524|322942910|FG000|Overall Study|Lost to Follow-up|1|||
94316935|NCT02279524|322942911|FG001|Overall Study|Lost to Follow-up|1|||
94316936|NCT02279524|322942912|FG002|Overall Study|Lost to Follow-up|0|||
94316937|NCT02279524|322942910|FG000|Overall Study|Disallowed medication|1|||
94316938|NCT02279524|322942911|FG001|Overall Study|Disallowed medication|1|||
94316939|NCT02279524|322942912|FG002|Overall Study|Disallowed medication|2|||
94316940|NCT02279524|322942910|FG000|Overall Study|Bariatric surgery|1|||
94316941|NCT02279524|322942911|FG001|Overall Study|Bariatric surgery|0|||
94316942|NCT02279524|322942912|FG002|Overall Study|Bariatric surgery|0|||
94316943|NCT03509207|322942913|FG000|Overall Study|Death|2|||
94316944|NCT00028002|322942916|FG000|Overall Study|Withdrawal by Subject|3|||
94316945|NCT00028002|322942916|FG000|Overall Study|Ineligible|8|||
94316946|NCT02653976|322942920|FG000|Overall Study|Withdrawal by Subject|5|||
94316947|NCT02653976|322942920|FG000|Overall Study|Death|4|||
94316948|NCT03703375|322942922|FG000|Randomization Period|Withdrawal by Subject|0|||
94316949|NCT03703375|322942923|FG001|Randomization Period|Withdrawal by Subject|0|||
94316950|NCT03703375|322942924|FG002|Randomization Period|Withdrawal by Subject|0|||
94316951|NCT03703375|322942925|FG003|Randomization Period|Withdrawal by Subject|1|||
94316952|NCT03703375|322942922|FG000|Randomization Period|Completed safety run-in treatment|7|||
94316953|NCT03703375|322942923|FG001|Randomization Period|Completed safety run-in treatment|0|||
94316954|NCT03703375|322942924|FG002|Randomization Period|Completed safety run-in treatment|0|||
94316955|NCT03703375|322942925|FG003|Randomization Period|Completed safety run-in treatment|0|||
94316956|NCT03703375|322942922|FG000|Treatment Period|Other Reasons|0|||
94316957|NCT03703375|322942923|FG001|Treatment Period|Other Reasons|1|||
94316958|NCT03703375|322942924|FG002|Treatment Period|Other Reasons|0|||
94316959|NCT03703375|322942925|FG003|Treatment Period|Other Reasons|3|||
94316960|NCT03703375|322942922|FG000|Treatment Period|Consent Withdrawal|0|||
94316961|NCT03703375|322942923|FG001|Treatment Period|Consent Withdrawal|0|||
94316962|NCT03703375|322942924|FG002|Treatment Period|Consent Withdrawal|0|||
94316963|NCT03703375|322942925|FG003|Treatment Period|Consent Withdrawal|1|||
94316964|NCT03703375|322942922|FG000|Treatment Period|Death|1|||
94316965|NCT03703375|322942923|FG001|Treatment Period|Death|0|||
94316966|NCT03703375|322942924|FG002|Treatment Period|Death|1|||
94316967|NCT03703375|322942925|FG003|Treatment Period|Death|2|||
94316968|NCT03703375|322942922|FG000|Treatment Period|Toxicity of Study Treatment|2|||
94316969|NCT03703375|322942923|FG001|Treatment Period|Toxicity of Study Treatment|0|||
94316970|NCT03703375|322942924|FG002|Treatment Period|Toxicity of Study Treatment|4|||
94316971|NCT03703375|322942925|FG003|Treatment Period|Toxicity of Study Treatment|1|||
94316972|NCT03703375|322942922|FG000|Treatment Period|Progression|32|||
94316973|NCT03703375|322942923|FG001|Treatment Period|Progression|1|||
94316974|NCT03703375|322942924|FG002|Treatment Period|Progression|7|||
94316975|NCT03703375|322942925|FG003|Treatment Period|Progression|11|||
94316976|NCT03703375|322942922|FG000|Treatment Period|Completed treatment|7|||
94316977|NCT03703375|322942923|FG001|Treatment Period|Completed treatment|2|||
94316978|NCT03703375|322942924|FG002|Treatment Period|Completed treatment|0|||
94316979|NCT03703375|322942925|FG003|Treatment Period|Completed treatment|0|||
94316980|NCT00366548|322942926|FG000|Infant Series|Adverse Event|1|||
94316981|NCT00366548|322942927|FG001|Infant Series|Adverse Event|3|||
94316982|NCT00366548|322942926|FG000|Infant Series|Protocol Violation|0|||
94316983|NCT00366548|322942927|FG001|Infant Series|Protocol Violation|1|||
94316984|NCT00366548|322942926|FG000|Infant Series|Withdrawal by Subject|3|||
94316985|NCT00366548|322942927|FG001|Infant Series|Withdrawal by Subject|1|||
94316986|NCT00366548|322942926|FG000|After Infant Series|Withdrawal by Subject|3|||
94316987|NCT00366548|322942927|FG001|After Infant Series|Withdrawal by Subject|1|||
94316988|NCT00366548|322942926|FG000|After Infant Series|Adverse Event|2|||
94316989|NCT00366548|322942927|FG001|After Infant Series|Adverse Event|0|||
94316990|NCT00366548|322942926|FG000|After Infant Series|Lost to Follow-up|1|||
94316991|NCT00366548|322942927|FG001|After Infant Series|Lost to Follow-up|0|||
94316992|NCT02273752|322942928|FG000|Overall Study|Trial was terminated early|2|||
94316993|NCT01863849|322942930|FG000|Overall Study|Lost to Follow-up|1|||
94316994|NCT01863849|322942931|FG001|Overall Study|Lost to Follow-up|0|||
94316995|NCT01728584|322942934|FG000|Overall Study|Adverse Event|1|||
94480919|NCT02326272|323553942|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
94480920|NCT02326272|323553943|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
94480921|NCT02326272|323553944|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
94480922|NCT02326272|323553945|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
94480923|NCT02326272|323553946|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94480924|NCT02326272|323553947|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94480925|NCT02326272|323553948|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94480926|NCT02326272|323553949|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94480927|NCT02326272|323553950|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94480928|NCT02326272|323553951|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
94480929|NCT02326272|323553937|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94480930|NCT02326272|323553938|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94480931|NCT02326272|323553939|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94480932|NCT02326272|323553940|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94480933|NCT02326272|323553941|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94480934|NCT02326272|323553942|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
94480935|NCT02326272|323553943|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
94480936|NCT02326272|323553944|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94480937|NCT02326272|323553945|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
94480938|NCT02326272|323553946|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
94480939|NCT02326272|323553947|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94480940|NCT02326272|323553948|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94480941|NCT02326272|323553949|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94480942|NCT02326272|323553950|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94480943|NCT02326272|323553951|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
94480944|NCT02326272|323553937|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94480945|NCT02326272|323553938|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94480946|NCT02326272|323553939|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94480947|NCT02326272|323553940|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94480948|NCT02326272|323553941|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94480949|NCT02326272|323553942|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
94480950|NCT02326272|323553943|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94480951|NCT02326272|323553944|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
94480952|NCT02326272|323553945|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94480953|NCT02326272|323553946|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94480954|NCT02326272|323553947|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94480955|NCT02326272|323553948|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94480956|NCT02326272|323553949|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94480957|NCT02326272|323553950|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94480958|NCT02326272|323553951|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
94316996|NCT01728584|322942935|FG001|Overall Study|Adverse Event|0|||
94316997|NCT01728584|322942936|FG002|Overall Study|Adverse Event|0|||
94316998|NCT01728584|322942937|FG003|Overall Study|Adverse Event|0|||
94316999|NCT01728584|322942934|FG000|Overall Study|Physician Decision|4|||
94317000|NCT01728584|322942935|FG001|Overall Study|Physician Decision|0|||
94317001|NCT01728584|322942936|FG002|Overall Study|Physician Decision|1|||
94317002|NCT01728584|322942937|FG003|Overall Study|Physician Decision|0|||
94317003|NCT01728584|322942934|FG000|Overall Study|Withdrawal by Subject|1|||
94317004|NCT01728584|322942935|FG001|Overall Study|Withdrawal by Subject|0|||
94317005|NCT01728584|322942936|FG002|Overall Study|Withdrawal by Subject|0|||
94317006|NCT01728584|322942937|FG003|Overall Study|Withdrawal by Subject|0|||
94317007|NCT01728584|322942934|FG000|Overall Study|Screen failure|1|||
94317008|NCT01728584|322942935|FG001|Overall Study|Screen failure|0|||
94317009|NCT01728584|322942936|FG002|Overall Study|Screen failure|0|||
94317010|NCT01728584|322942937|FG003|Overall Study|Screen failure|0|||
94317011|NCT01728584|322942934|FG000|Overall Study|Other reason (not specified)|1|||
94317012|NCT01728584|322942935|FG001|Overall Study|Other reason (not specified)|0|||
94317013|NCT01728584|322942936|FG002|Overall Study|Other reason (not specified)|0|||
94317014|NCT01728584|322942937|FG003|Overall Study|Other reason (not specified)|1|||
94317015|NCT00913978|322942944|FG000|Overall Study|Surgeon choice|1|||
94317016|NCT00913978|322942945|FG001|Overall Study|Surgeon choice|3|||
94317017|NCT01327651|322942946|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
94317018|NCT01327651|322942947|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
94317019|NCT01327651|322942948|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
94317020|NCT01327651|322942949|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
94317021|NCT01327651|322942950|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
94317022|NCT01327651|322942951|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
94317023|NCT01327651|322942952|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
94317024|NCT01327651|322942953|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
94317025|NCT01327651|322942954|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
94317026|NCT01327651|322942946|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
94480959|NCT02326272|323553937|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94480960|NCT02326272|323553938|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94480961|NCT02326272|323553939|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94480962|NCT02326272|323553940|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
94480963|NCT02326272|323553941|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94480964|NCT02326272|323553942|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
94480965|NCT02326272|323553943|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
94480966|NCT02326272|323553944|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
94480967|NCT02326272|323553945|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94480968|NCT02326272|323553946|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
94480969|NCT02326272|323553947|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94480970|NCT02326272|323553948|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94480971|NCT02326272|323553949|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94480972|NCT02326272|323553950|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94480973|NCT02326272|323553951|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
94480974|NCT02326272|323553937|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
94480975|NCT02326272|323553938|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
94480976|NCT02326272|323553939|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
94480977|NCT02326272|323553940|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
94480978|NCT02326272|323553941|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
94480979|NCT02326272|323553942|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
94480980|NCT02326272|323553943|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
94480981|NCT02326272|323553944|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
94480982|NCT02326272|323553945|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
94480983|NCT02326272|323553946|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
94480984|NCT02326272|323553947|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
94480985|NCT02326272|323553948|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
94480986|NCT02326272|323553949|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
94480987|NCT02326272|323553950|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
94480988|NCT02326272|323553951|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
94480989|NCT02326272|323553937|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94480990|NCT02326272|323553938|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94480991|NCT02326272|323553939|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94480992|NCT02326272|323553940|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94480993|NCT02326272|323553941|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94480994|NCT02326272|323553942|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94480995|NCT02326272|323553943|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
94480996|NCT02326272|323553944|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94480997|NCT02326272|323553945|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94480998|NCT02326272|323553946|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94480999|NCT02326272|323553947|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94481000|NCT02326272|323553948|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94481001|NCT02326272|323553949|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94481002|NCT02326272|323553950|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94481003|NCT02326272|323553951|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
94481004|NCT02326272|323553937|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
94481005|NCT02326272|323553938|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
94481006|NCT02326272|323553939|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
94481007|NCT02326272|323553940|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
94481008|NCT02326272|323553941|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
94481009|NCT02326272|323553942|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
94481010|NCT02326272|323553943|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
94481011|NCT02326272|323553944|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
94481012|NCT02326272|323553945|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
94481013|NCT02326272|323553946|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
94481014|NCT02326272|323553947|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
94481015|NCT02326272|323553948|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
94481016|NCT02326272|323553949|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
94481017|NCT02326272|323553950|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
94481018|NCT02326272|323553951|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
94317027|NCT01327651|322942947|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
94481019|NCT02326272|323553937|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94481020|NCT02326272|323553938|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94481021|NCT02326272|323553939|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94481022|NCT02326272|323553940|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94481023|NCT02326272|323553941|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94481024|NCT02326272|323553942|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
94481025|NCT02326272|323553943|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
94481026|NCT02326272|323553944|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
94481027|NCT02326272|323553945|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
94481028|NCT02326272|323553946|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94481029|NCT02326272|323553947|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94481030|NCT02326272|323553948|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94481031|NCT02326272|323553949|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94481032|NCT02326272|323553950|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94481033|NCT02326272|323553951|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
94481034|NCT02326272|323553937|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
94481035|NCT02326272|323553938|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
94481036|NCT02326272|323553939|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
94481037|NCT02326272|323553940|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
94481038|NCT02326272|323553941|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
94481039|NCT02326272|323553942|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
94481040|NCT02326272|323553943|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
94481041|NCT02326272|323553944|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
94481042|NCT02326272|323553945|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
94481043|NCT02326272|323553946|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
94481044|NCT02326272|323553947|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
94481045|NCT02326272|323553948|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
94481046|NCT02326272|323553949|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
94481047|NCT02326272|323553950|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
94481048|NCT02326272|323553951|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
94481049|NCT02326272|323553937|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
94481050|NCT02326272|323553938|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
94481051|NCT02326272|323553939|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
94481052|NCT02326272|323553940|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
94481053|NCT02326272|323553941|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
94481054|NCT02326272|323553942|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
94481055|NCT02326272|323553943|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
94481056|NCT02326272|323553944|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
94481057|NCT02326272|323553945|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
94481058|NCT02326272|323553946|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
94481059|NCT02326272|323553947|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
94481060|NCT02326272|323553948|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
94481061|NCT02326272|323553949|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
94481062|NCT02326272|323553950|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
94481063|NCT02326272|323553951|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
94481064|NCT02326272|323553937|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
94481065|NCT02326272|323553938|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
94481066|NCT02326272|323553939|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
94481067|NCT02326272|323553940|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
94481068|NCT02326272|323553941|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
94481069|NCT02326272|323553942|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
94481070|NCT02326272|323553943|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
94481071|NCT02326272|323553944|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
94481072|NCT02326272|323553945|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
94481073|NCT02326272|323553946|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
94317028|NCT01327651|322942948|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
94317029|NCT01327651|322942949|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
94317030|NCT01327651|322942950|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
94317031|NCT01327651|322942951|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
94317032|NCT01327651|322942952|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
94481074|NCT02326272|323553947|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
94481075|NCT02326272|323553948|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
94481076|NCT02326272|323553949|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
94481077|NCT02326272|323553950|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
94481078|NCT02326272|323553951|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
94317033|NCT01327651|322942953|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
94317034|NCT01327651|322942954|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
94317035|NCT01327651|322942946|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
94317036|NCT01327651|322942947|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
94317037|NCT01327651|322942948|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
94317038|NCT01327651|322942949|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
94317039|NCT01327651|322942950|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
94317040|NCT01327651|322942951|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
94317041|NCT01327651|322942952|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
94317042|NCT01327651|322942953|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
94317043|NCT01327651|322942954|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
94317044|NCT01327651|322942946|FG000|Post Study Follow-up|Lost to Follow-up|0|||
94317045|NCT01327651|322942947|FG001|Post Study Follow-up|Lost to Follow-up|1|||
94317046|NCT01327651|322942948|FG002|Post Study Follow-up|Lost to Follow-up|1|||
94317047|NCT01327651|322942949|FG003|Post Study Follow-up|Lost to Follow-up|0|||
94317048|NCT01327651|322942950|FG004|Post Study Follow-up|Lost to Follow-up|0|||
94317049|NCT01327651|322942951|FG005|Post Study Follow-up|Lost to Follow-up|0|||
94317050|NCT01327651|322942952|FG006|Post Study Follow-up|Lost to Follow-up|4|||
94317051|NCT01327651|322942953|FG007|Post Study Follow-up|Lost to Follow-up|1|||
94317052|NCT01327651|322942954|FG008|Post Study Follow-up|Lost to Follow-up|2|||
94317053|NCT01201798|322942962|FG000|Overall Study|Adverse Event|2|||
94317054|NCT01201798|322942963|FG001|Overall Study|Adverse Event|0|||
94317055|NCT01201798|322942962|FG000|Overall Study|Lost to Follow-up|3|||
94317056|NCT01201798|322942963|FG001|Overall Study|Lost to Follow-up|5|||
94317057|NCT01201798|322942962|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
94317058|NCT01201798|322942963|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
94317059|NCT01201798|322942962|FG000|Overall Study|Noncompliance|1|||
94317060|NCT01201798|322942963|FG001|Overall Study|Noncompliance|0|||
94317061|NCT01201798|322942962|FG000|Overall Study|Protocol Violation|1|||
94317062|NCT01201798|322942963|FG001|Overall Study|Protocol Violation|1|||
94317063|NCT01201798|322942962|FG000|Overall Study|Treatment Failure|1|||
94317064|NCT01201798|322942963|FG001|Overall Study|Treatment Failure|8|||
94481079|NCT02326272|323553937|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94481080|NCT02326272|323553938|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94481081|NCT02326272|323553939|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94481082|NCT02326272|323553940|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94481083|NCT02326272|323553941|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94481084|NCT02326272|323553942|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94481085|NCT02326272|323553943|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94481086|NCT02326272|323553944|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94481087|NCT02326272|323553945|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94481088|NCT02326272|323553946|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94481089|NCT02326272|323553947|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
94481090|NCT02326272|323553948|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
94481091|NCT02326272|323553949|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
94481092|NCT02326272|323553950|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
94481093|NCT02326272|323553951|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
94481094|NCT02326272|323553937|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94481095|NCT02326272|323553938|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94481096|NCT02326272|323553939|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94481097|NCT02326272|323553940|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94317065|NCT00748540|322942974|FG000|Overall Study|Physician Decision|1|||
94317066|NCT01930799|322942977|FG000|Overall Study|Withdrawal by Subject|3|||
94317067|NCT01930799|322942977|FG000|Overall Study|Lost to Follow-up|5|||
94317068|NCT02402218|322942980|FG000|Overall Study|Did not pickup study medication|12|||
94317069|NCT02402218|322942981|FG001|Overall Study|Did not pickup study medication|9|||
94317070|NCT02402218|322942982|FG002|Overall Study|Did not pickup study medication|13|||
94317071|NCT02402218|322942980|FG000|Overall Study|Lack of Efficacy|0|||
94317072|NCT02402218|322942981|FG001|Overall Study|Lack of Efficacy|1|||
94317073|NCT02402218|322942982|FG002|Overall Study|Lack of Efficacy|1|||
94317074|NCT02402218|322942980|FG000|Overall Study|Death|1|||
94317075|NCT02402218|322942981|FG001|Overall Study|Death|0|||
94317076|NCT02402218|322942982|FG002|Overall Study|Death|0|||
94317077|NCT02402218|322942980|FG000|Overall Study|Reinfection|0|||
94317078|NCT02402218|322942981|FG001|Overall Study|Reinfection|0|||
94317079|NCT02402218|322942982|FG002|Overall Study|Reinfection|1|||
94317080|NCT02402218|322942980|FG000|Overall Study|Adverse Event|0|||
94317081|NCT02402218|322942981|FG001|Overall Study|Adverse Event|2|||
94317082|NCT02402218|322942982|FG002|Overall Study|Adverse Event|1|||
94317083|NCT02402218|322942980|FG000|Overall Study|Withdrawal by Subject|1|||
94317084|NCT02402218|322942981|FG001|Overall Study|Withdrawal by Subject|1|||
94317085|NCT02402218|322942982|FG002|Overall Study|Withdrawal by Subject|1|||
94317086|NCT00875017|322942983|FG000|First Intervention|Withdrawal by Subject|1|||
94317087|NCT00875017|322942984|FG001|First Intervention|Withdrawal by Subject|0|||
94317088|NCT00875017|322942985|FG002|First Intervention|Withdrawal by Subject|1|||
94317089|NCT00875017|322942986|FG003|First Intervention|Withdrawal by Subject|0|||
94317090|NCT00875017|322942987|FG004|First Intervention|Withdrawal by Subject|0|||
94317091|NCT00875017|322942988|FG005|First Intervention|Withdrawal by Subject|0|||
94317092|NCT00875017|322942983|FG000|First Intervention|Adverse Event|0|||
94317093|NCT00875017|322942984|FG001|First Intervention|Adverse Event|0|||
94317094|NCT00875017|322942985|FG002|First Intervention|Adverse Event|0|||
94317095|NCT00875017|322942986|FG003|First Intervention|Adverse Event|1|||
94317096|NCT00875017|322942987|FG004|First Intervention|Adverse Event|0|||
94317097|NCT00875017|322942988|FG005|First Intervention|Adverse Event|0|||
94317098|NCT00875017|322942983|FG000|First Intervention|Problems collecting rectal effluent|1|||
94317099|NCT00875017|322942984|FG001|First Intervention|Problems collecting rectal effluent|0|||
94317100|NCT00875017|322942985|FG002|First Intervention|Problems collecting rectal effluent|0|||
94317101|NCT00875017|322942986|FG003|First Intervention|Problems collecting rectal effluent|0|||
94317102|NCT00875017|322942987|FG004|First Intervention|Problems collecting rectal effluent|0|||
94317103|NCT00875017|322942988|FG005|First Intervention|Problems collecting rectal effluent|0|||
94317104|NCT00875017|322942983|FG000|First Intervention|Intolerance to nasogastric tube|0|||
94317105|NCT00875017|322942984|FG001|First Intervention|Intolerance to nasogastric tube|0|||
94317106|NCT00875017|322942985|FG002|First Intervention|Intolerance to nasogastric tube|0|||
94317107|NCT00875017|322942986|FG003|First Intervention|Intolerance to nasogastric tube|0|||
94317108|NCT00875017|322942987|FG004|First Intervention|Intolerance to nasogastric tube|1|||
94317109|NCT00875017|322942988|FG005|First Intervention|Intolerance to nasogastric tube|0|||
94317110|NCT00875017|322942983|FG000|Washout|Problem collecting rectal effluent|0|||
94317111|NCT00875017|322942984|FG001|Washout|Problem collecting rectal effluent|0|||
94317112|NCT00875017|322942985|FG002|Washout|Problem collecting rectal effluent|1|||
94317113|NCT00875017|322942986|FG003|Washout|Problem collecting rectal effluent|0|||
94317114|NCT00875017|322942987|FG004|Washout|Problem collecting rectal effluent|0|||
94317115|NCT00875017|322942988|FG005|Washout|Problem collecting rectal effluent|0|||
94317116|NCT00875017|322942983|FG000|Second Intervention|Adverse Event|0|||
94317117|NCT00875017|322942984|FG001|Second Intervention|Adverse Event|0|||
94317118|NCT00875017|322942985|FG002|Second Intervention|Adverse Event|0|||
94317119|NCT00875017|322942986|FG003|Second Intervention|Adverse Event|1|||
94317120|NCT00875017|322942987|FG004|Second Intervention|Adverse Event|0|||
94317121|NCT00875017|322942988|FG005|Second Intervention|Adverse Event|0|||
94317122|NCT00875017|322942983|FG000|Washout|Problems collecting rectal effluent|0|||
94317123|NCT00875017|322942984|FG001|Washout|Problems collecting rectal effluent|1|||
94317124|NCT00875017|322942985|FG002|Washout|Problems collecting rectal effluent|0|||
94317125|NCT00875017|322942986|FG003|Washout|Problems collecting rectal effluent|0|||
94317126|NCT00875017|322942987|FG004|Washout|Problems collecting rectal effluent|0|||
94317127|NCT00875017|322942988|FG005|Washout|Problems collecting rectal effluent|0|||
94317128|NCT00875017|322942983|FG000|Third Intervention|Adverse Event|0|||
94317129|NCT00875017|322942984|FG001|Third Intervention|Adverse Event|1|||
94317130|NCT00875017|322942985|FG002|Third Intervention|Adverse Event|1|||
94317131|NCT00875017|322942986|FG003|Third Intervention|Adverse Event|0|||
94317132|NCT00875017|322942987|FG004|Third Intervention|Adverse Event|0|||
94317133|NCT00875017|322942988|FG005|Third Intervention|Adverse Event|0|||
94317134|NCT00875017|322942983|FG000|Washout|Withdrawal by Subject|0|||
94317135|NCT00875017|322942984|FG001|Washout|Withdrawal by Subject|0|||
94317136|NCT00875017|322942985|FG002|Washout|Withdrawal by Subject|0|||
94317137|NCT00875017|322942986|FG003|Washout|Withdrawal by Subject|0|||
94317138|NCT00875017|322942987|FG004|Washout|Withdrawal by Subject|1|||
94317139|NCT00875017|322942988|FG005|Washout|Withdrawal by Subject|0|||
94317140|NCT00875017|322942983|FG000|Fourth Intervention|Inability to comply with fasting|0|||
94317141|NCT00875017|322942984|FG001|Fourth Intervention|Inability to comply with fasting|0|||
94317142|NCT00875017|322942985|FG002|Fourth Intervention|Inability to comply with fasting|0|||
94317143|NCT00875017|322942986|FG003|Fourth Intervention|Inability to comply with fasting|0|||
94317144|NCT00875017|322942987|FG004|Fourth Intervention|Inability to comply with fasting|0|||
94317145|NCT00875017|322942988|FG005|Fourth Intervention|Inability to comply with fasting|1|||
94317146|NCT03807739|322942989|FG000|Overall Study|Adverse Event|1|||
94317147|NCT03807739|322942990|FG001|Overall Study|Adverse Event|0|||
94317148|NCT03807739|322942991|FG002|Overall Study|Adverse Event|0|||
94317149|NCT03807739|322942992|FG003|Overall Study|Adverse Event|0|||
94317150|NCT03807739|322942989|FG000|Overall Study|Withdrawal by Subject|1|||
94317151|NCT03807739|322942990|FG001|Overall Study|Withdrawal by Subject|0|||
94317152|NCT03807739|322942991|FG002|Overall Study|Withdrawal by Subject|0|||
94317153|NCT03807739|322942992|FG003|Overall Study|Withdrawal by Subject|0|||
94317154|NCT03342469|322942993|FG000|Overall Study|Withdrawal by Subject|0|||
94317155|NCT03342469|322942994|FG001|Overall Study|Withdrawal by Subject|1|||
94317156|NCT03342469|322942995|FG002|Overall Study|Withdrawal by Subject|0|||
94317157|NCT03342469|322942996|FG003|Overall Study|Withdrawal by Subject|0|||
94317158|NCT02689219|322942997|FG000|Overall Study|Death|1|||
94317159|NCT02689219|322942998|FG001|Overall Study|Death|1|||
94317160|NCT02689219|322942997|FG000|Overall Study|Disease Progression|10|||
94317161|NCT02689219|322942998|FG001|Overall Study|Disease Progression|6|||
94317162|NCT03375112|322943002|FG000|Overall Study|Withdrawal by Subject|3|||
94317163|NCT03375112|322943003|FG001|Overall Study|Withdrawal by Subject|0|||
94317164|NCT00243230|322943004|FG000|Double-Blind Period|Adverse Event|0|||
94317165|NCT00243230|322943005|FG001|Double-Blind Period|Adverse Event|2|||
94317166|NCT00243230|322943006|FG002|Double-Blind Period|Adverse Event|2|||
94317167|NCT00243230|322943007|FG003|Double-Blind Period|Adverse Event|0|||
94317168|NCT00243230|322943004|FG000|Double-Blind Period|Withdrawal by Subject|1|||
94317169|NCT00243230|322943005|FG001|Double-Blind Period|Withdrawal by Subject|0|||
94317170|NCT00243230|322943006|FG002|Double-Blind Period|Withdrawal by Subject|0|||
94317171|NCT00243230|322943007|FG003|Double-Blind Period|Withdrawal by Subject|0|||
94317172|NCT00243230|322943004|FG000|Double-Blind Period|Protocol Violation|0|||
94317173|NCT00243230|322943005|FG001|Double-Blind Period|Protocol Violation|0|||
94317174|NCT00243230|322943006|FG002|Double-Blind Period|Protocol Violation|1|||
94317175|NCT00243230|322943007|FG003|Double-Blind Period|Protocol Violation|0|||
94317176|NCT00243230|322943004|FG000|Double-Blind Period|Randomized but Not Treated|0|||
94317177|NCT00243230|322943005|FG001|Double-Blind Period|Randomized but Not Treated|0|||
94317178|NCT00243230|322943006|FG002|Double-Blind Period|Randomized but Not Treated|2|||
94317179|NCT00243230|322943007|FG003|Double-Blind Period|Randomized but Not Treated|0|||
94317180|NCT00243230|322943004|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
94317181|NCT00243230|322943005|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
94317182|NCT00243230|322943006|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
94317183|NCT00243230|322943007|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
94317184|NCT00243230|322943004|FG000|Open Label Period|Adverse Event|0|||
94317185|NCT00243230|322943005|FG001|Open Label Period|Adverse Event|0|||
94317186|NCT00243230|322943006|FG002|Open Label Period|Adverse Event|0|||
94317187|NCT00243230|322943007|FG003|Open Label Period|Adverse Event|2|||
94317188|NCT00243230|322943004|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
94317189|NCT00243230|322943005|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
94317190|NCT00243230|322943006|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
94317191|NCT00243230|322943007|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
94317192|NCT00243230|322943004|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
94317193|NCT00243230|322943005|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
94317194|NCT00243230|322943006|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
94317195|NCT00243230|322943007|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
94317196|NCT00243230|322943004|FG000|Open Label Period|Lost to Follow-up|0|||
94317197|NCT00243230|322943005|FG001|Open Label Period|Lost to Follow-up|0|||
94317198|NCT00243230|322943006|FG002|Open Label Period|Lost to Follow-up|0|||
94317199|NCT00243230|322943007|FG003|Open Label Period|Lost to Follow-up|2|||
94317200|NCT00243230|322943004|FG000|Open Label Period|Withdrawal by Subject|0|||
94317201|NCT00243230|322943005|FG001|Open Label Period|Withdrawal by Subject|0|||
94317202|NCT00243230|322943006|FG002|Open Label Period|Withdrawal by Subject|0|||
94317203|NCT00243230|322943007|FG003|Open Label Period|Withdrawal by Subject|2|||
94317204|NCT00243230|322943004|FG000|Open Label Period|Protocol Violation|0|||
94317205|NCT00243230|322943005|FG001|Open Label Period|Protocol Violation|0|||
94317206|NCT00243230|322943006|FG002|Open Label Period|Protocol Violation|0|||
94317207|NCT00243230|322943007|FG003|Open Label Period|Protocol Violation|2|||
94317208|NCT00243230|322943004|FG000|Open Label Period|Administrative Reason|0|||
94317209|NCT00243230|322943005|FG001|Open Label Period|Administrative Reason|0|||
94317210|NCT00243230|322943006|FG002|Open Label Period|Administrative Reason|0|||
94317211|NCT00243230|322943007|FG003|Open Label Period|Administrative Reason|63|||
94317212|NCT05515601|322943015|FG000|Overall Study|Withdrawal by Subject|1|||
94317213|NCT05515601|322943016|FG001|Overall Study|Withdrawal by Subject|3|||
94317214|NCT05515601|322943017|FG002|Overall Study|Withdrawal by Subject|2|||
94317215|NCT05515601|322943018|FG003|Overall Study|Withdrawal by Subject|1|||
94317216|NCT05515601|322943019|FG004|Overall Study|Withdrawal by Subject|1|||
94317217|NCT05515601|322943020|FG005|Overall Study|Withdrawal by Subject|1|||
94317218|NCT05515601|322943015|FG000|Overall Study|Lost to Follow-up|0|||
94317219|NCT05515601|322943016|FG001|Overall Study|Lost to Follow-up|0|||
94317220|NCT05515601|322943017|FG002|Overall Study|Lost to Follow-up|0|||
94317221|NCT05515601|322943018|FG003|Overall Study|Lost to Follow-up|0|||
94317222|NCT05515601|322943019|FG004|Overall Study|Lost to Follow-up|1|||
94317223|NCT05515601|322943020|FG005|Overall Study|Lost to Follow-up|0|||
94481098|NCT02326272|323553941|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94481099|NCT02326272|323553942|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94481100|NCT02326272|323553943|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94481101|NCT02326272|323553944|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94481102|NCT02326272|323553945|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94481103|NCT02326272|323553946|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94481104|NCT02326272|323553947|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
94481105|NCT02326272|323553948|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94481106|NCT02326272|323553949|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
94481107|NCT02326272|323553950|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94481108|NCT02326272|323553951|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
94481109|NCT02326272|323553937|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94481110|NCT02326272|323553938|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94481111|NCT02326272|323553939|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94481112|NCT02326272|323553940|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94481113|NCT02326272|323553941|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94481114|NCT02326272|323553942|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94481115|NCT02326272|323553943|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94481116|NCT02326272|323553944|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94481117|NCT02326272|323553945|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94481118|NCT02326272|323553946|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94481119|NCT02326272|323553947|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94481120|NCT02326272|323553948|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
94481121|NCT02326272|323553949|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94481122|NCT02326272|323553950|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94481123|NCT02326272|323553951|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
94481124|NCT02326272|323553937|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94481125|NCT02326272|323553938|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94481126|NCT02326272|323553939|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94481127|NCT02326272|323553940|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94481128|NCT02326272|323553941|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94481129|NCT02326272|323553942|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94481130|NCT02326272|323553943|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94481131|NCT02326272|323553944|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94317224|NCT00777491|322943021|FG000|Overall Study|Protocol Violation|0|||
94317225|NCT00777491|322943022|FG001|Overall Study|Protocol Violation|2|||
94317226|NCT00777491|322943021|FG000|Overall Study|Did not receive any protocol treatment|2|||
94317227|NCT00777491|322943022|FG001|Overall Study|Did not receive any protocol treatment|0|||
94317228|NCT00364845|322943023|FG000|Overall Study|Adverse Event|1|||
94317229|NCT00364845|322943024|FG001|Overall Study|Adverse Event|0|||
94317230|NCT00364845|322943023|FG000|Overall Study|Withdrawal by Subject|2|||
94317231|NCT00364845|322943024|FG001|Overall Study|Withdrawal by Subject|1|||
94317232|NCT00364845|322943023|FG000|Overall Study|Physician Decision|8|||
94317233|NCT00364845|322943024|FG001|Overall Study|Physician Decision|8|||
94317234|NCT00364845|322943023|FG000|Overall Study|Lost to Follow-up|0|||
94317235|NCT00364845|322943024|FG001|Overall Study|Lost to Follow-up|1|||
94317236|NCT00364845|322943023|FG000|Overall Study|Death|0|||
94317237|NCT00364845|322943024|FG001|Overall Study|Death|1|||
94481132|NCT02326272|323553945|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94481133|NCT02326272|323553946|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94481134|NCT02326272|323553947|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
94481135|NCT02326272|323553948|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94481136|NCT02326272|323553949|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
94481137|NCT02326272|323553950|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
94481138|NCT02326272|323553951|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
94481139|NCT02326272|323553937|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94481140|NCT02326272|323553938|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94481141|NCT02326272|323553939|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94481142|NCT02326272|323553940|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94481143|NCT02326272|323553941|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94317238|NCT01912768|322943027|FG000|Overall Study|Adverse Event|2|||
94317239|NCT01912768|322943028|FG001|Overall Study|Adverse Event|0|||
94317240|NCT01912768|322943027|FG000|Overall Study|Lost to Follow-up|2|||
94317241|NCT01912768|322943028|FG001|Overall Study|Lost to Follow-up|1|||
94317242|NCT01912768|322943027|FG000|Overall Study|Withdrawal by Subject|5|||
94317243|NCT01912768|322943028|FG001|Overall Study|Withdrawal by Subject|3|||
94317244|NCT01912768|322943027|FG000|Overall Study|Randomized in error|1|||
94317245|NCT01912768|322943028|FG001|Overall Study|Randomized in error|0|||
94317246|NCT00524316|322943029|FG000|Overall Study|Withdrawal by Subject|2|||
94317247|NCT00524316|322943029|FG000|Overall Study|Adverse Event|7|||
94317248|NCT00524316|322943029|FG000|Overall Study|Disease Progression|7|||
94317249|NCT00540436|322943030|FG000|First 12-Week Treatment Period|Adverse Event|1|||
94317250|NCT00540436|322943030|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
94317251|NCT00540436|322943030|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
94317252|NCT00540436|322943030|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
94317253|NCT02427477|322943034|FG000|Period 1|Adverse Event|1|||
94317254|NCT02427477|322943035|FG001|Period 1|Adverse Event|0|||
94317255|NCT03453151|322943036|FG000|Overall Study|Withdrawal by Subject|1|||
94317256|NCT03453151|322943036|FG000|Overall Study|Physician Decision|3|||
94317257|NCT00142519|322943037|FG000|Overall Study|Not Treated|7|||
94317258|NCT00142519|322943038|FG001|Overall Study|Not Treated|9|||
94317259|NCT00142519|322943037|FG000|Overall Study|Protocol Violation|1|||
94317260|NCT00142519|322943038|FG001|Overall Study|Protocol Violation|0|||
94317261|NCT00142519|322943037|FG000|Overall Study|Withdrawal by Subject|10|||
94317262|NCT00142519|322943038|FG001|Overall Study|Withdrawal by Subject|7|||
94317263|NCT01204658|322943039|FG000|Primary Phase|Adverse Event|0|||
94317264|NCT01204658|322943040|FG001|Primary Phase|Adverse Event|0|||
94317265|NCT01204658|322943041|FG002|Primary Phase|Adverse Event|1|||
94317266|NCT01204658|322943042|FG003|Primary Phase|Adverse Event|0|||
94317267|NCT00786838|322943043|FG000|Overall Study|Physician Decision|4|||
94317268|NCT00786838|322943043|FG000|Overall Study|Death|4|||
94317269|NCT00786838|322943043|FG000|Overall Study|Adverse Event|6|||
94317270|NCT00786838|322943043|FG000|Overall Study|Progressive disease|31|||
94317271|NCT00786838|322943043|FG000|Overall Study|Withdrawal by Subject|4|||
94317272|NCT02065622|322943044|FG000|Induction Study|Adverse Event|13|||
94317273|NCT02065622|322943045|FG001|Induction Study|Adverse Event|19|||
94317274|NCT02065622|322943046|FG002|Induction Study|Adverse Event|0|||
94317275|NCT02065622|322943047|FG003|Induction Study|Adverse Event|0|||
94317276|NCT02065622|322943048|FG004|Induction Study|Adverse Event|0|||
94317277|NCT02065622|322943044|FG000|Induction Study|Withdrawal by Subject|3|||
94317278|NCT02065622|322943045|FG001|Induction Study|Withdrawal by Subject|5|||
94317279|NCT02065622|322943046|FG002|Induction Study|Withdrawal by Subject|0|||
94317280|NCT02065622|322943047|FG003|Induction Study|Withdrawal by Subject|0|||
94317281|NCT02065622|322943048|FG004|Induction Study|Withdrawal by Subject|0|||
94317282|NCT02065622|322943044|FG000|Induction Study|Lost to Follow-up|1|||
94317283|NCT02065622|322943045|FG001|Induction Study|Lost to Follow-up|0|||
94317284|NCT02065622|322943046|FG002|Induction Study|Lost to Follow-up|0|||
94317285|NCT02065622|322943047|FG003|Induction Study|Lost to Follow-up|0|||
94317286|NCT02065622|322943048|FG004|Induction Study|Lost to Follow-up|0|||
94317287|NCT02065622|322943044|FG000|Induction Study|Lack of Efficacy|22|||
94317288|NCT02065622|322943045|FG001|Induction Study|Lack of Efficacy|27|||
94317289|NCT02065622|322943046|FG002|Induction Study|Lack of Efficacy|0|||
94317290|NCT02065622|322943047|FG003|Induction Study|Lack of Efficacy|0|||
94317291|NCT02065622|322943048|FG004|Induction Study|Lack of Efficacy|0|||
94317292|NCT02065622|322943044|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
94317293|NCT02065622|322943045|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
94317294|NCT02065622|322943046|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
94317295|NCT02065622|322943047|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
94317296|NCT02065622|322943048|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
94317297|NCT02065622|322943044|FG000|Induction Study|Subject Noncompliance|1|||
94317298|NCT02065622|322943045|FG001|Induction Study|Subject Noncompliance|1|||
94317299|NCT02065622|322943046|FG002|Induction Study|Subject Noncompliance|0|||
94317300|NCT02065622|322943047|FG003|Induction Study|Subject Noncompliance|0|||
94317301|NCT02065622|322943048|FG004|Induction Study|Subject Noncompliance|0|||
94317302|NCT02065622|322943044|FG000|Induction Study|Other, Not Specified|3|||
94317303|NCT02065622|322943045|FG001|Induction Study|Other, Not Specified|2|||
94317304|NCT02065622|322943046|FG002|Induction Study|Other, Not Specified|0|||
94317305|NCT02065622|322943047|FG003|Induction Study|Other, Not Specified|0|||
94317306|NCT02065622|322943048|FG004|Induction Study|Other, Not Specified|0|||
94317307|NCT02065622|322943044|FG000|Maintenance Study|Adverse Event|0|||
94317308|NCT02065622|322943045|FG001|Maintenance Study|Adverse Event|0|||
94317309|NCT02065622|322943046|FG002|Maintenance Study|Adverse Event|25|||
94317310|NCT02065622|322943047|FG003|Maintenance Study|Adverse Event|22|||
94317311|NCT02065622|322943048|FG004|Maintenance Study|Adverse Event|11|||
94317312|NCT02065622|322943044|FG000|Maintenance Study|Withdrawal by Subject|0|||
94317313|NCT02065622|322943045|FG001|Maintenance Study|Withdrawal by Subject|0|||
94317314|NCT02065622|322943046|FG002|Maintenance Study|Withdrawal by Subject|11|||
94317315|NCT02065622|322943047|FG003|Maintenance Study|Withdrawal by Subject|5|||
94317316|NCT02065622|322943048|FG004|Maintenance Study|Withdrawal by Subject|7|||
94317317|NCT02065622|322943044|FG000|Maintenance Study|Lost to Follow-up|0|||
94317318|NCT02065622|322943045|FG001|Maintenance Study|Lost to Follow-up|0|||
94481144|NCT02326272|323553942|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94481145|NCT02326272|323553943|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94481146|NCT02326272|323553944|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94481147|NCT02326272|323553945|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94317319|NCT02065622|322943046|FG002|Maintenance Study|Lost to Follow-up|4|||
94317320|NCT02065622|322943047|FG003|Maintenance Study|Lost to Follow-up|1|||
94317321|NCT02065622|322943048|FG004|Maintenance Study|Lost to Follow-up|1|||
94317322|NCT02065622|322943044|FG000|Maintenance Study|Lack of Efficacy|0|||
94317323|NCT02065622|322943045|FG001|Maintenance Study|Lack of Efficacy|0|||
94317324|NCT02065622|322943046|FG002|Maintenance Study|Lack of Efficacy|70|||
94317325|NCT02065622|322943047|FG003|Maintenance Study|Lack of Efficacy|55|||
94317326|NCT02065622|322943048|FG004|Maintenance Study|Lack of Efficacy|19|||
94317327|NCT02065622|322943044|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
94317328|NCT02065622|322943045|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
94317329|NCT02065622|322943046|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
94317330|NCT02065622|322943047|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
94317331|NCT02065622|322943048|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
94317332|NCT02065622|322943044|FG000|Maintenance Study|Subject Non-Compliance|0|||
94317333|NCT02065622|322943045|FG001|Maintenance Study|Subject Non-Compliance|0|||
94317334|NCT02065622|322943046|FG002|Maintenance Study|Subject Non-Compliance|1|||
94317335|NCT02065622|322943047|FG003|Maintenance Study|Subject Non-Compliance|3|||
94317336|NCT02065622|322943048|FG004|Maintenance Study|Subject Non-Compliance|2|||
94317337|NCT02065622|322943044|FG000|Maintenance Study|Other, Not Specified|0|||
94317338|NCT02065622|322943045|FG001|Maintenance Study|Other, Not Specified|0|||
94317339|NCT02065622|322943046|FG002|Maintenance Study|Other, Not Specified|6|||
94317340|NCT02065622|322943047|FG003|Maintenance Study|Other, Not Specified|14|||
94317341|NCT02065622|322943048|FG004|Maintenance Study|Other, Not Specified|2|||
94317342|NCT02065622|322943044|FG000|Maintenance Study|Unknown Reason|0|||
94317343|NCT02065622|322943045|FG001|Maintenance Study|Unknown Reason|0|||
94317344|NCT02065622|322943046|FG002|Maintenance Study|Unknown Reason|0|||
94317345|NCT02065622|322943047|FG003|Maintenance Study|Unknown Reason|1|||
94317346|NCT02065622|322943048|FG004|Maintenance Study|Unknown Reason|0|||
94317347|NCT04937816|322943049|FG000|Overall Study|Study drug stopped, reason missing|5|||
94317348|NCT04937816|322943050|FG001|Overall Study|Study drug stopped, reason missing|3|||
94317349|NCT04937816|322943051|FG002|Overall Study|Study drug stopped, reason missing|4|||
94317350|NCT04937816|322943052|FG003|Overall Study|Study drug stopped, reason missing|6|||
94317351|NCT04937816|322943053|FG004|Overall Study|Study drug stopped, reason missing|1|||
94317352|NCT04937816|322943054|FG005|Overall Study|Study drug stopped, reason missing|0|||
94317353|NCT04937816|322943055|FG006|Overall Study|Study drug stopped, reason missing|0|||
94317354|NCT04937816|322943049|FG000|Overall Study|Other than stated below|173|||
94317355|NCT04937816|322943050|FG001|Overall Study|Other than stated below|143|||
94317356|NCT04937816|322943051|FG002|Overall Study|Other than stated below|125|||
94317357|NCT04937816|322943052|FG003|Overall Study|Other than stated below|44|||
94317358|NCT04937816|322943053|FG004|Overall Study|Other than stated below|45|||
94317359|NCT04937816|322943054|FG005|Overall Study|Other than stated below|28|||
94317360|NCT04937816|322943055|FG006|Overall Study|Other than stated below|31|||
94317361|NCT04937816|322943049|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
94317362|NCT04937816|322943050|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
94317363|NCT04937816|322943051|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
94317364|NCT04937816|322943052|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
94317365|NCT04937816|322943053|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
94317366|NCT04937816|322943054|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
94317367|NCT04937816|322943055|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
94317368|NCT04937816|322943049|FG000|Overall Study|Lost to Follow-up|15|||
94317369|NCT04937816|322943050|FG001|Overall Study|Lost to Follow-up|9|||
94317370|NCT04937816|322943051|FG002|Overall Study|Lost to Follow-up|6|||
94317371|NCT04937816|322943052|FG003|Overall Study|Lost to Follow-up|6|||
94317372|NCT04937816|322943053|FG004|Overall Study|Lost to Follow-up|16|||
94317373|NCT04937816|322943054|FG005|Overall Study|Lost to Follow-up|11|||
94317374|NCT04937816|322943055|FG006|Overall Study|Lost to Follow-up|17|||
94481148|NCT02326272|323553946|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94481149|NCT02326272|323553947|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94317375|NCT04937816|322943049|FG000|Overall Study|Protocol Violation|15|||
94317376|NCT04937816|322943050|FG001|Overall Study|Protocol Violation|15|||
94317377|NCT04937816|322943051|FG002|Overall Study|Protocol Violation|12|||
94317378|NCT04937816|322943052|FG003|Overall Study|Protocol Violation|30|||
94317379|NCT04937816|322943053|FG004|Overall Study|Protocol Violation|24|||
94317380|NCT04937816|322943054|FG005|Overall Study|Protocol Violation|5|||
94317381|NCT04937816|322943055|FG006|Overall Study|Protocol Violation|5|||
94317382|NCT04937816|322943049|FG000|Overall Study|Adverse Event|303|||
94317383|NCT04937816|322943050|FG001|Overall Study|Adverse Event|267|||
94317384|NCT04937816|322943051|FG002|Overall Study|Adverse Event|273|||
94317385|NCT04937816|322943052|FG003|Overall Study|Adverse Event|553|||
94317386|NCT04937816|322943053|FG004|Overall Study|Adverse Event|575|||
94317387|NCT04937816|322943054|FG005|Overall Study|Adverse Event|343|||
94317388|NCT04937816|322943055|FG006|Overall Study|Adverse Event|337|||
94317389|NCT04937816|322943049|FG000|Overall Study|Not treated|4|||
94317390|NCT04937816|322943050|FG001|Overall Study|Not treated|2|||
94317391|NCT04937816|322943051|FG002|Overall Study|Not treated|2|||
94317392|NCT04937816|322943052|FG003|Overall Study|Not treated|2|||
94317393|NCT04937816|322943053|FG004|Overall Study|Not treated|1|||
94317394|NCT04937816|322943054|FG005|Overall Study|Not treated|4|||
94317395|NCT04937816|322943055|FG006|Overall Study|Not treated|0|||
94317396|NCT03422133|322943060|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
94317397|NCT03422133|322943061|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
94317398|NCT03003403|322943062|FG000|Overall Study|Ineligible|8|||
94317399|NCT03003403|322943063|FG001|Overall Study|Ineligible|7|||
94317400|NCT03003403|322943062|FG000|Overall Study|Withdrawal by Subject|3|||
94317401|NCT03003403|322943063|FG001|Overall Study|Withdrawal by Subject|1|||
94317402|NCT01431144|322945051|FG000|Overall Study|Implant mobility and removal|2|||
94317403|NCT01431144|322945052|FG001|Overall Study|Implant mobility and removal|0|||
94317404|NCT00953043|322945053|FG000|Overall Study|Withdrawal by Subject|4|||
94317405|NCT00953043|322945054|FG001|Overall Study|Withdrawal by Subject|0|||
94317406|NCT00953043|322945053|FG000|Overall Study|Physician Decision|0|||
94317407|NCT00953043|322945054|FG001|Overall Study|Physician Decision|2|||
94317408|NCT02922634|322945056|FG000|Overall Study|Withdrawal by Subject|5|||
94317409|NCT02922634|322945056|FG000|Overall Study|Did not have their surgery|5|||
94317410|NCT00492856|322945058|FG000|Induction|Adverse Event|2|||
94317411|NCT00492856|322945059|FG001|Induction|Adverse Event|0|||
94317412|NCT00492856|322945060|FG002|Induction|Adverse Event|0|||
94317413|NCT00492856|322945061|FG003|Induction|Adverse Event|0|||
94317414|NCT00492856|322945058|FG000|Induction|Withdrawal by Subject|1|||
94317415|NCT00492856|322945059|FG001|Induction|Withdrawal by Subject|0|||
94317416|NCT00492856|322945060|FG002|Induction|Withdrawal by Subject|0|||
94317417|NCT00492856|322945061|FG003|Induction|Withdrawal by Subject|0|||
94317418|NCT00492856|322945058|FG000|Induction|Death|3|||
94317419|NCT00492856|322945059|FG001|Induction|Death|0|||
94317420|NCT00492856|322945060|FG002|Induction|Death|0|||
94317421|NCT00492856|322945061|FG003|Induction|Death|0|||
94317422|NCT00492856|322945058|FG000|Consolidation|Adverse Event|6|||
94317423|NCT00492856|322945059|FG001|Consolidation|Adverse Event|0|||
94317424|NCT00492856|322945060|FG002|Consolidation|Adverse Event|0|||
94317425|NCT00492856|322945061|FG003|Consolidation|Adverse Event|0|||
94317426|NCT00492856|322945058|FG000|Consolidation|Not protocol specified|2|||
94317427|NCT00492856|322945059|FG001|Consolidation|Not protocol specified|0|||
94317428|NCT00492856|322945060|FG002|Consolidation|Not protocol specified|0|||
94317429|NCT00492856|322945061|FG003|Consolidation|Not protocol specified|0|||
94317430|NCT00492856|322945058|FG000|Consolidation|Lost to Follow-up|1|||
94317431|NCT00492856|322945059|FG001|Consolidation|Lost to Follow-up|0|||
94317432|NCT00492856|322945060|FG002|Consolidation|Lost to Follow-up|0|||
94317433|NCT00492856|322945061|FG003|Consolidation|Lost to Follow-up|0|||
94317434|NCT00492856|322945058|FG000|Post-consolidation|Adverse Event|0|||
94317435|NCT00492856|322945059|FG001|Post-consolidation|Adverse Event|4|||
94317436|NCT00492856|322945060|FG002|Post-consolidation|Adverse Event|0|||
94317437|NCT00492856|322945061|FG003|Post-consolidation|Adverse Event|1|||
94317438|NCT00492856|322945058|FG000|Post-consolidation|Withdrawal by Subject|0|||
94317439|NCT00492856|322945059|FG001|Post-consolidation|Withdrawal by Subject|4|||
94317440|NCT00492856|322945060|FG002|Post-consolidation|Withdrawal by Subject|0|||
94317441|NCT00492856|322945061|FG003|Post-consolidation|Withdrawal by Subject|0|||
94317442|NCT00492856|322945058|FG000|Post-consolidation|Death|0|||
94317443|NCT00492856|322945059|FG001|Post-consolidation|Death|1|||
94317444|NCT00492856|322945060|FG002|Post-consolidation|Death|0|||
94317445|NCT00492856|322945061|FG003|Post-consolidation|Death|0|||
94317446|NCT00492856|322945058|FG000|Post-consolidation|Not protocol specified|0|||
94481150|NCT02326272|323553948|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
94481151|NCT02326272|323553949|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94317447|NCT00492856|322945059|FG001|Post-consolidation|Not protocol specified|1|||
94317448|NCT00492856|322945060|FG002|Post-consolidation|Not protocol specified|0|||
94317449|NCT00492856|322945061|FG003|Post-consolidation|Not protocol specified|0|||
94317450|NCT00492856|322945058|FG000|Post-consolidation|Lost to Follow-up|0|||
94317451|NCT00492856|322945059|FG001|Post-consolidation|Lost to Follow-up|2|||
94317452|NCT00492856|322945060|FG002|Post-consolidation|Lost to Follow-up|0|||
94317453|NCT00492856|322945061|FG003|Post-consolidation|Lost to Follow-up|0|||
94317454|NCT00492856|322945058|FG000|Post-consolidation|Observation Arm|0|||
94317455|NCT00492856|322945059|FG001|Post-consolidation|Observation Arm|0|||
94317456|NCT00492856|322945060|FG002|Post-consolidation|Observation Arm|27|||
94317457|NCT00492856|322945061|FG003|Post-consolidation|Observation Arm|0|||
94317458|NCT00051558|322945062|FG000|Overall Study|Adverse Event|30|||
94317459|NCT00051558|322945063|FG001|Overall Study|Adverse Event|18|||
94317460|NCT00051558|322945062|FG000|Overall Study|Withdrawal by Subject|29|||
94317461|NCT00051558|322945063|FG001|Overall Study|Withdrawal by Subject|42|||
94317462|NCT00051558|322945062|FG000|Overall Study|Death|9|||
94317463|NCT00051558|322945063|FG001|Overall Study|Death|15|||
94317464|NCT00051558|322945062|FG000|Overall Study|Lost to Follow-up|4|||
94317465|NCT00051558|322945063|FG001|Overall Study|Lost to Follow-up|13|||
94317466|NCT00051558|322945062|FG000|Overall Study|Protocol Violation|3|||
94317467|NCT00051558|322945063|FG001|Overall Study|Protocol Violation|4|||
94317468|NCT00051558|322945062|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
94317469|NCT00051558|322945063|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
94317470|NCT00051558|322945062|FG000|Overall Study|Sponsor Decision|6|||
94317471|NCT00051558|322945063|FG001|Overall Study|Sponsor Decision|1|||
94317472|NCT00051558|322945062|FG000|Overall Study|Other|2|||
94317473|NCT00051558|322945063|FG001|Overall Study|Other|1|||
94317474|NCT00051558|322945062|FG000|Overall Study|Significant Lab Value|2|||
94317475|NCT00051558|322945063|FG001|Overall Study|Significant Lab Value|0|||
94317476|NCT00051558|322945062|FG000|Overall Study|Physician Decision|5|||
94317477|NCT00051558|322945063|FG001|Overall Study|Physician Decision|0|||
94317478|NCT05525975|322945064|FG000|Overall Study|Surgery cancellation|4|||
94317479|NCT05525975|322945065|FG001|Overall Study|Surgery cancellation|5|||
94317480|NCT05525975|322945064|FG000|Overall Study|didn't fill prescription|1|||
94317481|NCT05525975|322945065|FG001|Overall Study|didn't fill prescription|0|||
94317482|NCT05525975|322945064|FG000|Overall Study|Withdrawal by Subject|0|||
94317483|NCT05525975|322945065|FG001|Overall Study|Withdrawal by Subject|3|||
94317484|NCT01251276|322945071|FG000|Overall Study|Protocol Violation|1|||
94317485|NCT01251276|322945072|FG001|Overall Study|Protocol Violation|0|||
94317486|NCT01251276|322945071|FG000|Overall Study|Lost to Follow-up|0|||
94317487|NCT01251276|322945072|FG001|Overall Study|Lost to Follow-up|1|||
94317488|NCT01345123|322945074|FG000|Overall Study|participants no longer with health plan|79|||
94317489|NCT01345123|322945075|FG001|Overall Study|participants no longer with health plan|85|||
94317490|NCT01345123|322945076|FG002|Overall Study|participants no longer with health plan|88|||
94317491|NCT01830543|322945077|FG000|Overall Study|Subject Decision|19|||
94317492|NCT01830543|322945078|FG001|Overall Study|Subject Decision|21|||
94317493|NCT01830543|322945079|FG002|Overall Study|Subject Decision|57|||
94317494|NCT01830543|322945077|FG000|Overall Study|Adverse Event|91|||
94317495|NCT01830543|322945078|FG001|Overall Study|Adverse Event|77|||
94317496|NCT01830543|322945079|FG002|Overall Study|Adverse Event|76|||
94317497|NCT01830543|322945077|FG000|Overall Study|Death|20|||
94317498|NCT01830543|322945078|FG001|Overall Study|Death|22|||
94317499|NCT01830543|322945079|FG002|Overall Study|Death|22|||
94317500|NCT01830543|322945077|FG000|Overall Study|Protocol Violation|3|||
94317501|NCT01830543|322945078|FG001|Overall Study|Protocol Violation|7|||
94317502|NCT01830543|322945079|FG002|Overall Study|Protocol Violation|7|||
94317503|NCT01830543|322945077|FG000|Overall Study|Physician Decision|11|||
94317504|NCT01830543|322945078|FG001|Overall Study|Physician Decision|5|||
94317505|NCT01830543|322945079|FG002|Overall Study|Physician Decision|12|||
94317506|NCT01830543|322945077|FG000|Overall Study|Withdrawal by consent|3|||
94317507|NCT01830543|322945078|FG001|Overall Study|Withdrawal by consent|3|||
94317508|NCT01830543|322945079|FG002|Overall Study|Withdrawal by consent|3|||
94317509|NCT01830543|322945077|FG000|Overall Study|Other|12|||
94317510|NCT01830543|322945078|FG001|Overall Study|Other|17|||
94317511|NCT01830543|322945079|FG002|Overall Study|Other|37|||
94317512|NCT00625365|322945080|FG000|Overall Study|Withdrawal by Subject|1|||
94317513|NCT00625365|322945080|FG000|Overall Study|No IV access|5|||
94481152|NCT02326272|323553950|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
94481153|NCT02326272|323553951|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
94317514|NCT00625365|322945080|FG000|Overall Study|VSD|1|||
94317515|NCT00262080|322945081|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
94317516|NCT00262080|322945082|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
94317517|NCT00262080|322945083|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
94317518|NCT00262080|322945081|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
94317519|NCT00262080|322945082|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
94317520|NCT00262080|322945083|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
94317521|NCT00262080|322945081|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
94317522|NCT00262080|322945082|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
94317523|NCT00262080|322945083|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
94317524|NCT00262080|322945081|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
94317525|NCT00262080|322945082|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
94317526|NCT00262080|322945083|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
94317527|NCT00262080|322945081|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
94317528|NCT00262080|322945082|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
94317529|NCT00262080|322945083|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
94317530|NCT00262080|322945081|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
94317531|NCT00262080|322945082|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
94317532|NCT00262080|322945083|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
94317533|NCT02808312|322945084|FG000|Overall Study|Enrolled but Never Treated|0|||
94317534|NCT02808312|322945085|FG001|Overall Study|Enrolled but Never Treated|0|||
94317535|NCT02808312|322945086|FG002|Overall Study|Enrolled but Never Treated|1|||
94317536|NCT02808312|322945087|FG003|Overall Study|Enrolled but Never Treated|0|||
94317537|NCT02808312|322945088|FG004|Overall Study|Enrolled but Never Treated|0|||
94317538|NCT03628417|322945089|FG000|Overall Study|Death|1|||
94317539|NCT03628417|322945090|FG001|Overall Study|Death|1|||
94317540|NCT05151471|322945098|FG000|Overall Study|Adverse Event|21|||
94317541|NCT05151471|322945099|FG001|Overall Study|Adverse Event|16|||
94317542|NCT05151471|322945098|FG000|Overall Study|Death|1|||
94317543|NCT05151471|322945099|FG001|Overall Study|Death|0|||
94317544|NCT05151471|322945098|FG000|Overall Study|Lost to Follow-up|0|||
94317545|NCT05151471|322945099|FG001|Overall Study|Lost to Follow-up|1|||
94317546|NCT05151471|322945098|FG000|Overall Study|Withdrawal by Subject|7|||
94317547|NCT05151471|322945099|FG001|Overall Study|Withdrawal by Subject|9|||
94317548|NCT05151471|322945098|FG000|Overall Study|Study terminated by sponsor|49|||
94317549|NCT05151471|322945099|FG001|Overall Study|Study terminated by sponsor|47|||
94317550|NCT05151471|322945098|FG000|Overall Study|Other|2|||
94317551|NCT05151471|322945099|FG001|Overall Study|Other|1|||
94317552|NCT01623531|322945100|FG000|Overall Study|Death|1|||
94317553|NCT01623531|322945101|FG001|Overall Study|Death|0|||
94317554|NCT01623531|322945100|FG000|Overall Study|Protocol Violation|2|||
94317555|NCT01623531|322945101|FG001|Overall Study|Protocol Violation|1|||
94317556|NCT01623531|322945100|FG000|Overall Study|Missing data at primary outcome time poi|1|||
94317557|NCT01623531|322945101|FG001|Overall Study|Missing data at primary outcome time poi|1|||
94317558|NCT03439748|322945102|FG000|Overall Study|Withdrawal by Subject|11|||
94317559|NCT03439748|322945103|FG001|Overall Study|Withdrawal by Subject|17|||
94317560|NCT01856595|322945104|FG000|Overall Study|Withdrawal by Subject|0|||
94317561|NCT01856595|322945105|FG001|Overall Study|Withdrawal by Subject|1|||
94317562|NCT01856595|322945106|FG002|Overall Study|Withdrawal by Subject|0|||
94317563|NCT01856595|322945107|FG003|Overall Study|Withdrawal by Subject|0|||
94317564|NCT01856595|322945108|FG004|Overall Study|Withdrawal by Subject|0|||
94317565|NCT01856595|322945109|FG005|Overall Study|Withdrawal by Subject|0|||
94317566|NCT01856595|322945110|FG006|Overall Study|Withdrawal by Subject|1|||
94317567|NCT01856595|322945111|FG007|Overall Study|Withdrawal by Subject|0|||
94317568|NCT01856595|322945112|FG008|Overall Study|Withdrawal by Subject|0|||
94317569|NCT01718509|322945115|FG000|Overall Study|Lost to Follow-up|18|||
94317570|NCT01718509|322945116|FG001|Overall Study|Lost to Follow-up|15|||
94317571|NCT01718509|322945115|FG000|Overall Study|Withdrawal by Subject|7|||
94317572|NCT01718509|322945116|FG001|Overall Study|Withdrawal by Subject|13|||
94317573|NCT01718509|322945115|FG000|Overall Study|Adverse Event|5|||
94317574|NCT01718509|322945116|FG001|Overall Study|Adverse Event|7|||
94317575|NCT01718509|322945115|FG000|Overall Study|Other|13|||
94317576|NCT01718509|322945116|FG001|Overall Study|Other|11|||
94317577|NCT01718509|322945115|FG000|Overall Study|Protocol Violation|4|||
94317578|NCT01718509|322945116|FG001|Overall Study|Protocol Violation|2|||
94481154|NCT02326272|323553937|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94481155|NCT02326272|323553938|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94317579|NCT01718509|322945115|FG000|Overall Study|Lack of Efficacy|1|||
94317580|NCT01718509|322945116|FG001|Overall Study|Lack of Efficacy|0|||
94317581|NCT03456713|322945118|FG000|Overall Study|Lost to Follow-up|1|||
94317582|NCT03456713|322945119|FG001|Overall Study|Lost to Follow-up|0|||
94317583|NCT03456713|322945120|FG002|Overall Study|Lost to Follow-up|0|||
94317584|NCT03456713|322945121|FG003|Overall Study|Lost to Follow-up|0|||
94317585|NCT01263691|322945125|FG000|Overall Study|Lost to Follow-up|1|||
94317586|NCT01263691|322945126|FG001|Overall Study|Lost to Follow-up|0|||
94317587|NCT01263691|322945127|FG002|Overall Study|Lost to Follow-up|1|||
94317588|NCT01263691|322945128|FG003|Overall Study|Lost to Follow-up|1|||
94317589|NCT01263691|322945129|FG004|Overall Study|Lost to Follow-up|0|||
94317590|NCT01263691|322945130|FG005|Overall Study|Lost to Follow-up|0|||
94317591|NCT01263691|322945125|FG000|Overall Study|Withdrawal by Subject|1|||
94317592|NCT01263691|322945126|FG001|Overall Study|Withdrawal by Subject|0|||
94317593|NCT01263691|322945127|FG002|Overall Study|Withdrawal by Subject|0|||
94317594|NCT01263691|322945128|FG003|Overall Study|Withdrawal by Subject|0|||
94317595|NCT01263691|322945129|FG004|Overall Study|Withdrawal by Subject|0|||
94317596|NCT01263691|322945130|FG005|Overall Study|Withdrawal by Subject|0|||
94317597|NCT01263691|322945125|FG000|Overall Study|Adverse Event|1|||
94317598|NCT01263691|322945126|FG001|Overall Study|Adverse Event|0|||
94317599|NCT01263691|322945127|FG002|Overall Study|Adverse Event|0|||
94317600|NCT01263691|322945128|FG003|Overall Study|Adverse Event|0|||
94317601|NCT01263691|322945129|FG004|Overall Study|Adverse Event|0|||
94317602|NCT01263691|322945130|FG005|Overall Study|Adverse Event|0|||
94317603|NCT00365716|322945135|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
94317604|NCT00365716|322945136|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
94317605|NCT00365716|322945137|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
94317606|NCT00365716|322945138|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
94317607|NCT00365716|322945139|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
94317608|NCT00365716|322945140|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
94317609|NCT00365716|322945141|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
94317610|NCT00365716|322945135|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
94317611|NCT00365716|322945136|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
94317612|NCT00365716|322945137|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
94317613|NCT00365716|322945138|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
94317614|NCT00365716|322945139|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
94317615|NCT00365716|322945140|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
94317616|NCT00365716|322945141|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
94317617|NCT00365716|322945135|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
94317618|NCT00365716|322945136|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
94317619|NCT00365716|322945137|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
94317620|NCT00365716|322945138|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
94317621|NCT00365716|322945139|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
94317622|NCT00365716|322945140|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
94317623|NCT00365716|322945141|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
94317624|NCT00365716|322945135|FG000|Base Study (Day 1 to Month 7)|Other|0|||
94317625|NCT00365716|322945136|FG001|Base Study (Day 1 to Month 7)|Other|1|||
94317626|NCT00365716|322945137|FG002|Base Study (Day 1 to Month 7)|Other|0|||
94317627|NCT00365716|322945138|FG003|Base Study (Day 1 to Month 7)|Other|0|||
94317628|NCT00365716|322945139|FG004|Base Study (Day 1 to Month 7)|Other|0|||
94317629|NCT00365716|322945140|FG005|Base Study (Day 1 to Month 7)|Other|0|||
94317630|NCT00365716|322945141|FG006|Base Study (Day 1 to Month 7)|Other|0|||
94317631|NCT00365716|322945135|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
94317632|NCT00365716|322945136|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
94317633|NCT00365716|322945137|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
94317634|NCT00365716|322945138|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
94317635|NCT00365716|322945139|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
94317636|NCT00365716|322945140|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
94317637|NCT00365716|322945141|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
94317638|NCT00365716|322945135|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
94317639|NCT00365716|322945136|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
94317640|NCT00365716|322945137|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
94317641|NCT00365716|322945138|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
94317642|NCT00365716|322945139|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
94317643|NCT00365716|322945140|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
94317644|NCT00365716|322945141|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
94317645|NCT00365716|322945135|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
94317646|NCT00365716|322945136|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
94317647|NCT00365716|322945137|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
94317648|NCT00365716|322945138|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
94317649|NCT00365716|322945139|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
94317650|NCT00365716|322945140|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
94317651|NCT00365716|322945141|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
94317652|NCT00365716|322945135|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
94317653|NCT00365716|322945136|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
94317654|NCT00365716|322945137|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
94317655|NCT00365716|322945138|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
94317656|NCT00365716|322945139|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
94317657|NCT00365716|322945140|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
94317658|NCT00365716|322945141|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
94317659|NCT00365716|322945135|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
94317660|NCT00365716|322945136|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
94317661|NCT00365716|322945137|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
94317662|NCT00365716|322945138|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
94317663|NCT00365716|322945139|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
94317664|NCT00365716|322945140|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
94317665|NCT00365716|322945141|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
94317666|NCT00365716|322945135|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
94317667|NCT00365716|322945136|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
94317668|NCT00365716|322945137|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
94317669|NCT00365716|322945138|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
94317670|NCT00365716|322945139|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
94481156|NCT02326272|323553939|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94481157|NCT02326272|323553940|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94481158|NCT02326272|323553941|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94481159|NCT02326272|323553942|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94481160|NCT02326272|323553943|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94481161|NCT02326272|323553944|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94481162|NCT02326272|323553945|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94481163|NCT02326272|323553946|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94481164|NCT02326272|323553947|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94481165|NCT02326272|323553948|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
94481166|NCT02326272|323553949|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
94481167|NCT02326272|323553950|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
94481168|NCT02326272|323553951|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
94481169|NCT02326272|323553937|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
94481170|NCT02326272|323553938|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
94481171|NCT02326272|323553939|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
94481172|NCT02326272|323553940|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
94481173|NCT02326272|323553941|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
94481174|NCT02326272|323553942|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
94481175|NCT02326272|323553943|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
94481176|NCT02326272|323553944|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
94481177|NCT02326272|323553945|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
94481178|NCT02326272|323553946|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
94481179|NCT02326272|323553947|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
94481180|NCT02326272|323553948|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
94481181|NCT02326272|323553949|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
94481182|NCT02326272|323553950|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
94481183|NCT02326272|323553951|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
94481184|NCT02326272|323553937|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
94481185|NCT02326272|323553938|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
94481186|NCT02326272|323553939|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
94481187|NCT02326272|323553940|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
94481188|NCT02326272|323553941|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
94481189|NCT02326272|323553942|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
94481190|NCT02326272|323553943|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
94481191|NCT02326272|323553944|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
94481192|NCT02326272|323553945|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
94481193|NCT02326272|323553946|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
94481194|NCT02326272|323553947|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
94481195|NCT02326272|323553948|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
94481196|NCT02326272|323553949|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
94481197|NCT02326272|323553950|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
94481198|NCT02326272|323553951|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
94481199|NCT00232557|323553955|FG000|Overall Study|Lost to Follow-up|3|||
94481200|NCT00232557|323553956|FG001|Overall Study|Lost to Follow-up|5|||
94481201|NCT01265394|323553959|FG000|Overall Study|Subjects withdrawn|37|||
94481202|NCT00115778|323553962|FG000|Overall Study|Withdrawal by Subject|0|||
94481203|NCT00115778|323553963|FG001|Overall Study|Withdrawal by Subject|1|||
94481204|NCT00268983|323553964|FG000|Overall Study|Death|3|||
94481205|NCT00268983|323553965|FG001|Overall Study|Death|0|||
94481206|NCT01719380|323553968|FG000|Overall Study|Adverse Event|0|||
94481207|NCT01719380|323553969|FG001|Overall Study|Adverse Event|0|||
94481208|NCT01719380|323553970|FG002|Overall Study|Adverse Event|1|||
94481209|NCT01719380|323553971|FG003|Overall Study|Adverse Event|2|||
94481210|NCT01719380|323553972|FG004|Overall Study|Adverse Event|0|||
94481211|NCT01719380|323553973|FG005|Overall Study|Adverse Event|1|||
94481212|NCT01719380|323553974|FG006|Overall Study|Adverse Event|0|||
94481213|NCT01719380|323553975|FG007|Overall Study|Adverse Event|1|||
94481214|NCT01719380|323553976|FG008|Overall Study|Adverse Event|4|||
94481215|NCT01719380|323553977|FG009|Overall Study|Adverse Event|3|||
94317671|NCT00365716|322945140|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
94317672|NCT00365716|322945141|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
94481216|NCT01719380|323553968|FG000|Overall Study|Death|0|||
94317673|NCT00365716|322945135|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
94317674|NCT00365716|322945136|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
94481217|NCT01719380|323553969|FG001|Overall Study|Death|1|||
94481218|NCT01719380|323553970|FG002|Overall Study|Death|0|||
94481219|NCT01719380|323553971|FG003|Overall Study|Death|0|||
94481220|NCT01719380|323553972|FG004|Overall Study|Death|0|||
94481221|NCT01719380|323553973|FG005|Overall Study|Death|0|||
94481222|NCT01719380|323553974|FG006|Overall Study|Death|0|||
94481223|NCT01719380|323553975|FG007|Overall Study|Death|0|||
94481224|NCT01719380|323553976|FG008|Overall Study|Death|3|||
94481225|NCT01719380|323553977|FG009|Overall Study|Death|3|||
94481226|NCT01719380|323553968|FG000|Overall Study|Participant/Guardian Decision|0|||
94481227|NCT01719380|323553969|FG001|Overall Study|Participant/Guardian Decision|0|||
94481228|NCT01719380|323553970|FG002|Overall Study|Participant/Guardian Decision|1|||
94481229|NCT01719380|323553971|FG003|Overall Study|Participant/Guardian Decision|0|||
94481230|NCT01719380|323553972|FG004|Overall Study|Participant/Guardian Decision|0|||
94481231|NCT01719380|323553973|FG005|Overall Study|Participant/Guardian Decision|0|||
94481232|NCT01719380|323553974|FG006|Overall Study|Participant/Guardian Decision|0|||
94481233|NCT01719380|323553975|FG007|Overall Study|Participant/Guardian Decision|0|||
94481234|NCT01719380|323553976|FG008|Overall Study|Participant/Guardian Decision|2|||
94481235|NCT01719380|323553977|FG009|Overall Study|Participant/Guardian Decision|2|||
94481236|NCT01719380|323553968|FG000|Overall Study|Physician Decision|0|||
94481237|NCT01719380|323553969|FG001|Overall Study|Physician Decision|0|||
94481238|NCT01719380|323553970|FG002|Overall Study|Physician Decision|2|||
94481239|NCT01719380|323553971|FG003|Overall Study|Physician Decision|0|||
94481240|NCT01719380|323553972|FG004|Overall Study|Physician Decision|0|||
94481241|NCT01719380|323553973|FG005|Overall Study|Physician Decision|0|||
94481242|NCT01719380|323553974|FG006|Overall Study|Physician Decision|0|||
94481243|NCT01719380|323553975|FG007|Overall Study|Physician Decision|0|||
94481244|NCT01719380|323553976|FG008|Overall Study|Physician Decision|1|||
94481245|NCT01719380|323553977|FG009|Overall Study|Physician Decision|1|||
94481246|NCT01719380|323553968|FG000|Overall Study|Lack of Efficacy|2|||
94481247|NCT01719380|323553969|FG001|Overall Study|Lack of Efficacy|6|||
94481248|NCT01719380|323553970|FG002|Overall Study|Lack of Efficacy|5|||
94481249|NCT01719380|323553971|FG003|Overall Study|Lack of Efficacy|6|||
94481250|NCT01719380|323553972|FG004|Overall Study|Lack of Efficacy|3|||
94481251|NCT01719380|323553973|FG005|Overall Study|Lack of Efficacy|7|||
94481252|NCT01719380|323553974|FG006|Overall Study|Lack of Efficacy|10|||
94481253|NCT01719380|323553975|FG007|Overall Study|Lack of Efficacy|6|||
94481254|NCT01719380|323553976|FG008|Overall Study|Lack of Efficacy|39|||
94481255|NCT01719380|323553977|FG009|Overall Study|Lack of Efficacy|42|||
94481256|NCT01719380|323553968|FG000|Overall Study|Progressive Disease|0|||
94481257|NCT01719380|323553969|FG001|Overall Study|Progressive Disease|0|||
94481258|NCT01719380|323553970|FG002|Overall Study|Progressive Disease|0|||
94481259|NCT01719380|323553971|FG003|Overall Study|Progressive Disease|0|||
94481260|NCT01719380|323553972|FG004|Overall Study|Progressive Disease|0|||
94481261|NCT01719380|323553973|FG005|Overall Study|Progressive Disease|0|||
94481262|NCT01719380|323553974|FG006|Overall Study|Progressive Disease|0|||
94481263|NCT01719380|323553975|FG007|Overall Study|Progressive Disease|0|||
94481264|NCT01719380|323553976|FG008|Overall Study|Progressive Disease|1|||
94481265|NCT01719380|323553977|FG009|Overall Study|Progressive Disease|0|||
94481266|NCT03713684|323553978|FG000|Overall Study|Adverse Event|1|||
94481267|NCT03713684|323553979|FG001|Overall Study|Adverse Event|3|||
94481268|NCT03713684|323553980|FG002|Overall Study|Adverse Event|1|||
94481269|NCT03713684|323553981|FG003|Overall Study|Adverse Event|0|||
94481270|NCT03713684|323553978|FG000|Overall Study|Poor compliance to protocol|2|||
94481271|NCT03713684|323553979|FG001|Overall Study|Poor compliance to protocol|1|||
94481272|NCT03713684|323553980|FG002|Overall Study|Poor compliance to protocol|0|||
94481273|NCT03713684|323553981|FG003|Overall Study|Poor compliance to protocol|1|||
94481274|NCT03713684|323553978|FG000|Overall Study|Withdrawal by Subject|14|||
94481275|NCT03713684|323553979|FG001|Overall Study|Withdrawal by Subject|6|||
94481276|NCT03713684|323553980|FG002|Overall Study|Withdrawal by Subject|14|||
94481277|NCT03713684|323553981|FG003|Overall Study|Withdrawal by Subject|16|||
94481278|NCT03713684|323553978|FG000|Overall Study|Other than specified|69|||
94481279|NCT03713684|323553979|FG001|Overall Study|Other than specified|77|||
94481280|NCT03713684|323553980|FG002|Overall Study|Other than specified|73|||
94481281|NCT03713684|323553981|FG003|Overall Study|Other than specified|70|||
94481282|NCT03075267|323553988|FG000|Overall Study|Protocol Violation|1|||
94481283|NCT03075267|323553989|FG001|Overall Study|Protocol Violation|0|||
94481284|NCT03075267|323553990|FG002|Overall Study|Protocol Violation|0|||
94481285|NCT04607135|323553991|FG000|Overall Study|Physician Decision|1|||
94481286|NCT04607135|323553991|FG000|Overall Study|Withdrawal by Subject|1|||
94481287|NCT04607135|323553991|FG000|Overall Study|Equipment not working|3|||
94481288|NCT01411852|323553992|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
94481289|NCT01411852|323553993|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
94481290|NCT01411852|323553992|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
94481291|NCT01411852|323553993|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
94481292|NCT01411852|323553992|FG000|Prehospital Intervention Phase|Found to be under age|0|||
94481293|NCT01411852|323553993|FG001|Prehospital Intervention Phase|Found to be under age|1|||
94481294|NCT01411852|323553992|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
94481295|NCT01411852|323553993|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
94481296|NCT01411852|323553992|FG000|Hospital Intervention Phase|Severe head injury|5|||
94481297|NCT01411852|323553993|FG001|Hospital Intervention Phase|Severe head injury|4|||
94481298|NCT01411852|323553992|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
94481299|NCT01411852|323553993|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
94317675|NCT00365716|322945137|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
94317676|NCT00365716|322945138|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
94385699|NCT06165744|323198982|FG000|Overall Study|Non device-related adverse event|1|||
94385700|NCT01314118|323198983|FG000|Overall Study|Adverse Event|9|||
94385701|NCT01314118|323198983|FG000|Overall Study|Progressive disease|27|||
94481300|NCT01411852|323553992|FG000|Hospital Intervention Phase|Miscommunication error|1|||
94481301|NCT01411852|323553993|FG001|Hospital Intervention Phase|Miscommunication error|2|||
94481302|NCT01411852|323553992|FG000|Hospital Intervention Phase|CPR administered|3|||
94481303|NCT01411852|323553993|FG001|Hospital Intervention Phase|CPR administered|1|||
94481304|NCT01411852|323553992|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
94481305|NCT01411852|323553993|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
94481306|NCT01411852|323553992|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
94481307|NCT01411852|323553993|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
94481308|NCT01411852|323553992|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
94481309|NCT01411852|323553993|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
94481310|NCT01411852|323553992|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
94481311|NCT01411852|323553993|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
94481312|NCT01411852|323553992|FG000|Hospital Intervention Phase|Other ineligible|2|||
94481313|NCT01411852|323553993|FG001|Hospital Intervention Phase|Other ineligible|2|||
94481314|NCT01411852|323553992|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
94481315|NCT01411852|323553993|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
94481316|NCT01411852|323553992|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
94481317|NCT01411852|323553993|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
94481318|NCT01411852|323553992|FG000|Hospital Intervention Phase|Vascular access failed|1|||
94481319|NCT01411852|323553993|FG001|Hospital Intervention Phase|Vascular access failed|0|||
94481320|NCT01272908|323553994|FG000|Initial Treatment Period|Adverse Event|1|||
94481321|NCT01272908|323553994|FG000|Initial Treatment Period|Lack of Efficacy|5|||
94481322|NCT01272908|323553994|FG000|Initial Treatment Period|Protocol Violation|1|||
94481323|NCT01272908|323553994|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
94481324|NCT01272908|323553994|FG000|Re-Treatment Period|Adverse Event|2|||
94481325|NCT01272908|323553994|FG000|Re-Treatment Period|Lack of Efficacy|3|||
94481326|NCT01272908|323553994|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
94481327|NCT02131064|323553995|FG000|Overall Study|Death|5|||
94481328|NCT02131064|323553996|FG001|Overall Study|Death|6|||
94481329|NCT02131064|323553995|FG000|Overall Study|Lost to Follow-up|4|||
94481330|NCT02131064|323553996|FG001|Overall Study|Lost to Follow-up|8|||
94481331|NCT02131064|323553995|FG000|Overall Study|Withdrawal by Subject|14|||
94481332|NCT02131064|323553996|FG001|Overall Study|Withdrawal by Subject|18|||
94481333|NCT02131064|323553995|FG000|Overall Study|Other|2|||
94481334|NCT02131064|323553996|FG001|Overall Study|Other|2|||
94481335|NCT01619865|323553999|FG000|Overall Study|Adverse Event|1|||
94481336|NCT01619865|323553999|FG000|Overall Study|Death|2|||
94481337|NCT01619865|323553999|FG000|Overall Study|subject not able to comply|1|||
94481338|NCT03126786|323554000|FG000|Overall Study|Adverse Event|3|||
94481339|NCT03126786|323554001|FG001|Overall Study|Adverse Event|0|||
94481340|NCT03126786|323554000|FG000|Overall Study|Lost to Follow-up|0|||
94481341|NCT03126786|323554001|FG001|Overall Study|Lost to Follow-up|1|||
94481342|NCT03126786|323554000|FG000|Overall Study|Withdrawal by Subject|3|||
94385702|NCT01314118|323198983|FG000|Overall Study|Physician Decision|11|||
94385703|NCT01314118|323198983|FG000|Overall Study|Death|4|||
94385704|NCT01314118|323198983|FG000|Overall Study|Protocol Violation|5|||
94385705|NCT01314118|323198983|FG000|Overall Study|Withdrawal by Subject|11|||
94385706|NCT01314118|323198983|FG000|Overall Study|Other|2|||
94385707|NCT01314118|323198983|FG000|Overall Study|Ongoing|62|||
94481343|NCT03126786|323554001|FG001|Overall Study|Withdrawal by Subject|1|||
94481344|NCT02111174|323554002|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
94481345|NCT02111174|323554003|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
94481346|NCT02111174|323554002|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
94481347|NCT02111174|323554003|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
94481348|NCT02111174|323554002|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
94481349|NCT02111174|323554003|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
94481350|NCT02111174|323554002|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
94481351|NCT02111174|323554003|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
94481352|NCT01657162|323554004|FG000|Overall Study|Adverse Event|26|||
94481353|NCT01657162|323554005|FG001|Overall Study|Adverse Event|36|||
94481354|NCT01657162|323554004|FG000|Overall Study|Withdrawal by Subject|13|||
94481355|NCT01657162|323554005|FG001|Overall Study|Withdrawal by Subject|13|||
94481356|NCT01657162|323554004|FG000|Overall Study|Continuing Significant Deterioration|9|||
94481357|NCT01657162|323554005|FG001|Overall Study|Continuing Significant Deterioration|3|||
94481358|NCT01657162|323554004|FG000|Overall Study|Refusal of Treatment|4|||
94317677|NCT00365716|322945139|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
94317678|NCT00365716|322945140|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
94317679|NCT00365716|322945141|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
94317680|NCT00365716|322945135|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
94317681|NCT00365716|322945136|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
94317682|NCT00365716|322945137|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
94317683|NCT00365716|322945138|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
94317684|NCT00365716|322945139|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
94317685|NCT00365716|322945140|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
94317686|NCT00365716|322945141|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
94317687|NCT00365716|322945135|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
94317688|NCT00365716|322945136|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
94317689|NCT00365716|322945137|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
94317690|NCT00365716|322945138|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
94317691|NCT00365716|322945139|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
94317692|NCT00365716|322945140|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
94317693|NCT00365716|322945141|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
94317694|NCT00365716|322945135|FG000|Extension 1|Lost to Follow-up|0|||
94317695|NCT00365716|322945136|FG001|Extension 1|Lost to Follow-up|0|||
94317696|NCT00365716|322945137|FG002|Extension 1|Lost to Follow-up|0|||
94317697|NCT00365716|322945138|FG003|Extension 1|Lost to Follow-up|0|||
94317698|NCT00365716|322945139|FG004|Extension 1|Lost to Follow-up|0|||
94317699|NCT00365716|322945140|FG005|Extension 1|Lost to Follow-up|1|||
94317700|NCT00365716|322945141|FG006|Extension 1|Lost to Follow-up|0|||
94317701|NCT00365716|322945135|FG000|Extension 1|Other|0|||
94317702|NCT00365716|322945136|FG001|Extension 1|Other|0|||
94317703|NCT00365716|322945137|FG002|Extension 1|Other|0|||
94317704|NCT00365716|322945138|FG003|Extension 1|Other|0|||
94317705|NCT00365716|322945139|FG004|Extension 1|Other|0|||
94317706|NCT00365716|322945140|FG005|Extension 1|Other|9|||
94317707|NCT00365716|322945141|FG006|Extension 1|Other|0|||
94317708|NCT00365716|322945135|FG000|Extension 1|Moved|0|||
94317709|NCT00365716|322945136|FG001|Extension 1|Moved|0|||
94317710|NCT00365716|322945137|FG002|Extension 1|Moved|0|||
94317711|NCT00365716|322945138|FG003|Extension 1|Moved|0|||
94317712|NCT00365716|322945139|FG004|Extension 1|Moved|0|||
94317713|NCT00365716|322945140|FG005|Extension 1|Moved|4|||
94317714|NCT00365716|322945141|FG006|Extension 1|Moved|0|||
94317715|NCT00365716|322945135|FG000|Extension 1|Withdrawal by Subject|0|||
94317716|NCT00365716|322945136|FG001|Extension 1|Withdrawal by Subject|0|||
94317717|NCT00365716|322945137|FG002|Extension 1|Withdrawal by Subject|0|||
94317718|NCT00365716|322945138|FG003|Extension 1|Withdrawal by Subject|0|||
94317719|NCT00365716|322945139|FG004|Extension 1|Withdrawal by Subject|0|||
94317720|NCT00365716|322945140|FG005|Extension 1|Withdrawal by Subject|3|||
94317721|NCT00365716|322945141|FG006|Extension 1|Withdrawal by Subject|0|||
94317722|NCT00365716|322945135|FG000|Extension 1|Pregnancy|0|||
94317723|NCT00365716|322945136|FG001|Extension 1|Pregnancy|0|||
94317724|NCT00365716|322945137|FG002|Extension 1|Pregnancy|0|||
94317725|NCT00365716|322945138|FG003|Extension 1|Pregnancy|0|||
94317726|NCT00365716|322945139|FG004|Extension 1|Pregnancy|0|||
94317727|NCT00365716|322945140|FG005|Extension 1|Pregnancy|4|||
94317728|NCT00365716|322945141|FG006|Extension 1|Pregnancy|0|||
94317729|NCT00365716|322945135|FG000|Extension 1|Protocol Violation|0|||
94317730|NCT00365716|322945136|FG001|Extension 1|Protocol Violation|0|||
94317731|NCT00365716|322945137|FG002|Extension 1|Protocol Violation|0|||
94481359|NCT01657162|323554005|FG001|Overall Study|Refusal of Treatment|6|||
94481360|NCT01657162|323554004|FG000|Overall Study|Lost to Follow-up|3|||
94317732|NCT00365716|322945138|FG003|Extension 1|Protocol Violation|0|||
94317733|NCT00365716|322945139|FG004|Extension 1|Protocol Violation|0|||
94317734|NCT00365716|322945140|FG005|Extension 1|Protocol Violation|1|||
94317735|NCT00365716|322945141|FG006|Extension 1|Protocol Violation|0|||
94317736|NCT00365716|322945135|FG000|Extension 2|Lost to Follow-up|0|||
94317737|NCT00365716|322945136|FG001|Extension 2|Lost to Follow-up|0|||
94317738|NCT00365716|322945137|FG002|Extension 2|Lost to Follow-up|0|||
94317739|NCT00365716|322945138|FG003|Extension 2|Lost to Follow-up|0|||
94317740|NCT00365716|322945139|FG004|Extension 2|Lost to Follow-up|0|||
94481361|NCT01657162|323554005|FG001|Overall Study|Lost to Follow-up|4|||
94481362|NCT01657162|323554004|FG000|Overall Study|Death|2|||
94481363|NCT01657162|323554005|FG001|Overall Study|Death|3|||
94481364|NCT01657162|323554004|FG000|Overall Study|Inability to Complete Study Procedures|1|||
94481365|NCT01657162|323554005|FG001|Overall Study|Inability to Complete Study Procedures|7|||
94481366|NCT01657162|323554004|FG000|Overall Study|Protocol Violation|1|||
94481367|NCT01657162|323554005|FG001|Overall Study|Protocol Violation|0|||
94481368|NCT01657162|323554004|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
94481369|NCT01657162|323554005|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
94481370|NCT01657162|323554004|FG000|Overall Study|Other than Specified|0|||
94481371|NCT01657162|323554005|FG001|Overall Study|Other than Specified|2|||
94481372|NCT00838097|323554006|FG000|Overall Study|Ineligibility determined|6|||
94481373|NCT00838097|323554006|FG000|Overall Study|Adverse Event|2|||
94481374|NCT00838097|323554006|FG000|Overall Study|Withdrawal by Subject|3|||
94481375|NCT00838097|323554006|FG000|Overall Study|Requirement for alternative therapy|2|||
94481376|NCT00838097|323554006|FG000|Overall Study|Physician Decision|4|||
94481377|NCT00838097|323554006|FG000|Overall Study|Lost to Follow-up|11|||
94481378|NCT00838097|323554006|FG000|Overall Study|Death|6|||
94481379|NCT00838097|323554006|FG000|Overall Study|Protocol-specified criteria|142|||
94481380|NCT03421379|323554009|FG000|Period 1|Withdrawal by Subject|0|||
94481381|NCT03421379|323554010|FG001|Period 1|Withdrawal by Subject|1|||
94481382|NCT03421379|323554009|FG000|Period 1|Physician Decision|1|||
94481383|NCT03421379|323554010|FG001|Period 1|Physician Decision|1|||
94481384|NCT03421379|323554009|FG000|Period 1|Did not receive treatment|1|||
94481385|NCT03421379|323554010|FG001|Period 1|Did not receive treatment|2|||
94481386|NCT04157088|323554011|FG000|Overall Study|Study terminated by sponsor|23|||
94481387|NCT04157088|323554011|FG000|Overall Study|Withdrawal by Subject|4|||
94481388|NCT04157088|323554011|FG000|Overall Study|Lost to Follow-up|2|||
94481389|NCT04157088|323554011|FG000|Overall Study|Death|1|||
94481390|NCT02421419|323554012|FG000|Overall Study|Physician Decision|0|||
94481391|NCT02421419|323554013|FG001|Overall Study|Physician Decision|0|||
94481392|NCT02421419|323554014|FG002|Overall Study|Physician Decision|1|||
94481393|NCT04577794|323554017|FG000|Overall Study|Adverse Event|1|||
94481394|NCT04577794|323554018|FG001|Overall Study|Adverse Event|1|||
94481395|NCT02155985|323554022|FG000|Overall Study|Withdrawal by Subject|0|||
94481396|NCT02155985|323554023|FG001|Overall Study|Withdrawal by Subject|0|||
94481397|NCT02155985|323554024|FG002|Overall Study|Withdrawal by Subject|1|||
94481398|NCT02155985|323554022|FG000|Overall Study|Lost to Follow-up|1|||
94481399|NCT02155985|323554023|FG001|Overall Study|Lost to Follow-up|0|||
94481400|NCT02155985|323554024|FG002|Overall Study|Lost to Follow-up|0|||
94481401|NCT02998151|323554025|FG000|Overall Study|Withdrawal by Subject|3|||
94481402|NCT02998151|323554025|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
94481403|NCT02998151|323554025|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
94317741|NCT00365716|322945140|FG005|Extension 2|Lost to Follow-up|0|||
94317742|NCT00365716|322945141|FG006|Extension 2|Lost to Follow-up|2|||
94317743|NCT00365716|322945135|FG000|Extension 2|Other|0|||
94317744|NCT00365716|322945136|FG001|Extension 2|Other|0|||
94317745|NCT00365716|322945137|FG002|Extension 2|Other|0|||
94317746|NCT00365716|322945138|FG003|Extension 2|Other|0|||
94317747|NCT00365716|322945139|FG004|Extension 2|Other|0|||
94317748|NCT00365716|322945140|FG005|Extension 2|Other|0|||
94317749|NCT00365716|322945141|FG006|Extension 2|Other|3|||
94317750|NCT00365716|322945135|FG000|Extension 2|Withdrawal by Subject|0|||
94317751|NCT00365716|322945136|FG001|Extension 2|Withdrawal by Subject|0|||
94317752|NCT00365716|322945137|FG002|Extension 2|Withdrawal by Subject|0|||
94317753|NCT00365716|322945138|FG003|Extension 2|Withdrawal by Subject|0|||
94317754|NCT00365716|322945139|FG004|Extension 2|Withdrawal by Subject|0|||
94317755|NCT00365716|322945140|FG005|Extension 2|Withdrawal by Subject|0|||
94317756|NCT00365716|322945141|FG006|Extension 2|Withdrawal by Subject|5|||
94317757|NCT01727713|322945148|FG000|Overall Study|Lost to Follow-up|5|||
94317758|NCT01727713|322945148|FG000|Overall Study|Adverse Event|10|||
94317759|NCT01727713|322945148|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
94317760|NCT01727713|322945148|FG000|Overall Study|Withdrawal by Subject|13|||
94481404|NCT00181883|323554029|FG000|Overall Study|Lack of Efficacy|2|||
94481405|NCT00181883|323554029|FG000|Overall Study|Treatment Limiting AEs|3|||
94481406|NCT00181883|323554029|FG000|Overall Study|Withdrawal by Subject|4|||
94481407|NCT00181883|323554029|FG000|Overall Study|Lost to Follow-up|1|||
94481408|NCT03839394|323554030|FG000|Overall Study|Lost to Follow-up|6|||
94481409|NCT03839394|323554031|FG001|Overall Study|Lost to Follow-up|8|||
94481410|NCT03839394|323554030|FG000|Overall Study|Withdrawal by Subject|0|||
94317761|NCT01727713|322945148|FG000|Overall Study|Protocol Deviation|2|||
94317762|NCT00532948|322945149|FG000|Overall Study|Protocol Violation|1|||
94385708|NCT05456529|323198984|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
94385709|NCT05456529|323198984|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
94385710|NCT05456529|323198984|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
94385711|NCT05456529|323198984|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
94385712|NCT05456529|323198984|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
94385713|NCT05456529|323198984|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
94385714|NCT05456529|323198984|FG000|44-week Long-term Safety Period|Physician Decision|2|||
94385715|NCT05456529|323198984|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
94385716|NCT05456529|323198984|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
94385717|NCT05456529|323198984|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
94385718|NCT05456529|323198984|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
94385719|NCT04455633|323198985|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
94385720|NCT04455633|323198986|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
94385721|NCT04455633|323198987|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
94385722|NCT04455633|323198985|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
94385723|NCT04455633|323198986|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
94385724|NCT04455633|323198987|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
94385725|NCT04455633|323198985|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
94385726|NCT04455633|323198986|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
94385727|NCT04455633|323198987|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
94385728|NCT04455633|323198985|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
94385729|NCT04455633|323198986|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
94385730|NCT04455633|323198987|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
94385740|NCT02854436|323198999|FG000|Overall Study|Adverse Event|1|||
94385741|NCT02854436|323198999|FG000|Overall Study|Death|208|||
94385742|NCT02854436|323198999|FG000|Overall Study|Lost to Follow-up|5|||
94385743|NCT02854436|323198999|FG000|Overall Study|Withdrawal by Subject|24|||
94385744|NCT02854436|323198999|FG000|Overall Study|Other|45|||
94385745|NCT02854436|323198999|FG000|Overall Study|Physician Decision|6|||
94385749|NCT03558828|323199006|FG000|Overall Study|Lost to Follow-up|4|||
94385750|NCT03558828|323199007|FG001|Overall Study|Lost to Follow-up|3|||
94385751|NCT03558828|323199008|FG002|Overall Study|Lost to Follow-up|3|||
94385752|NCT03558828|323199009|FG003|Overall Study|Lost to Follow-up|5|||
94385753|NCT03558828|323199010|FG004|Overall Study|Lost to Follow-up|2|||
94385754|NCT03558828|323199011|FG005|Overall Study|Lost to Follow-up|3|||
94385755|NCT03558828|323199006|FG000|Overall Study|dropped before the intervention|1|||
94385756|NCT03558828|323199007|FG001|Overall Study|dropped before the intervention|1|||
94385757|NCT03558828|323199008|FG002|Overall Study|dropped before the intervention|0|||
94385758|NCT03558828|323199009|FG003|Overall Study|dropped before the intervention|0|||
94385759|NCT03558828|323199010|FG004|Overall Study|dropped before the intervention|0|||
94385760|NCT03558828|323199011|FG005|Overall Study|dropped before the intervention|0|||
94385761|NCT05518487|323199012|FG000|Overall Study|Withdrawal by Subject|3|||
94317763|NCT00532948|322945150|FG001|Overall Study|Protocol Violation|0|||
94317764|NCT00532948|322945151|FG002|Overall Study|Protocol Violation|0|||
94317765|NCT00532948|322945149|FG000|Overall Study|Death|3|||
94317766|NCT00532948|322945150|FG001|Overall Study|Death|3|||
94317767|NCT00532948|322945151|FG002|Overall Study|Death|4|||
94317768|NCT00532948|322945149|FG000|Overall Study|Violation of selection criteria at entry|0|||
94317769|NCT00532948|322945150|FG001|Overall Study|Violation of selection criteria at entry|1|||
94317770|NCT00532948|322945151|FG002|Overall Study|Violation of selection criteria at entry|0|||
94317771|NCT00532948|322945149|FG000|Overall Study|Failure to return|0|||
94317772|NCT00532948|322945150|FG001|Overall Study|Failure to return|1|||
94317773|NCT00532948|322945151|FG002|Overall Study|Failure to return|0|||
94317774|NCT02345252|322945154|FG000|Double-Blind Phase|Adverse Event|2|||
94317775|NCT02345252|322945155|FG001|Double-Blind Phase|Adverse Event|3|||
94317776|NCT02345252|322945154|FG000|Double-Blind Phase|Death|1|||
94317777|NCT02345252|322945155|FG001|Double-Blind Phase|Death|2|||
94317778|NCT02345252|322945154|FG000|Double-Blind Phase|Lack of Efficacy|1|||
94317779|NCT02345252|322945155|FG001|Double-Blind Phase|Lack of Efficacy|0|||
94317780|NCT02345252|322945154|FG000|Double-Blind Phase|Investigator's Discretion|4|||
94317781|NCT02345252|322945155|FG001|Double-Blind Phase|Investigator's Discretion|6|||
94317782|NCT02345252|322945154|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
94317783|NCT02345252|322945155|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
94317784|NCT02345252|322945154|FG000|Double-Blind Phase|Protocol Violation|2|||
94317785|NCT02345252|322945155|FG001|Double-Blind Phase|Protocol Violation|1|||
94317786|NCT02345252|322945154|FG000|Double-Blind Phase|Withdrew Consent|21|||
94317787|NCT02345252|322945155|FG001|Double-Blind Phase|Withdrew Consent|23|||
94317788|NCT02345252|322945154|FG000|Double-Blind Phase|Lost to Follow-up|8|||
94317789|NCT02345252|322945155|FG001|Double-Blind Phase|Lost to Follow-up|10|||
94317790|NCT02345252|322945154|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
94317791|NCT02345252|322945155|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
94317792|NCT01087528|322945162|FG000|Overall Study|Withdrawal by Subject|1|||
94317793|NCT01087528|322945162|FG000|Overall Study|Incomplete CE procedure|6|||
94317794|NCT00358917|322945163|FG000|Overall Study|Adverse Event|14|||
94317795|NCT00358917|322945164|FG001|Overall Study|Adverse Event|21|||
94317796|NCT00358917|322945163|FG000|Overall Study|Withdrawal by Subject|5|||
94317797|NCT00358917|322945164|FG001|Overall Study|Withdrawal by Subject|7|||
94317798|NCT00358917|322945163|FG000|Overall Study|Lost to Follow-up|20|||
94317799|NCT00358917|322945164|FG001|Overall Study|Lost to Follow-up|17|||
94317800|NCT00358917|322945163|FG000|Overall Study|Noncompliance|12|||
94317801|NCT00358917|322945164|FG001|Overall Study|Noncompliance|11|||
94317802|NCT00358917|322945163|FG000|Overall Study|Death|2|||
94317803|NCT00358917|322945164|FG001|Overall Study|Death|3|||
94317804|NCT00358917|322945163|FG000|Overall Study|Virologic failure|11|||
94317805|NCT00358917|322945164|FG001|Overall Study|Virologic failure|8|||
94317806|NCT00358917|322945163|FG000|Overall Study|Unable to Continue Participation|2|||
94317807|NCT00358917|322945164|FG001|Overall Study|Unable to Continue Participation|2|||
94317808|NCT01952834|322945166|FG000|Overall Study|Adverse Event|1|||
94317809|NCT00515008|322945170|FG000|Overall Study|Lost to Follow-up|1|||
94317810|NCT00515008|322945171|FG001|Overall Study|Lost to Follow-up|0|||
94317811|NCT00515008|322945170|FG000|Overall Study|Declined|0|||
94317812|NCT00515008|322945171|FG001|Overall Study|Declined|3|||
94317813|NCT00515008|322945170|FG000|Overall Study|Left the Boston Area|1|||
94317814|NCT00515008|322945171|FG001|Overall Study|Left the Boston Area|1|||
94317815|NCT00515008|322945170|FG000|Overall Study|Scheduling conflict|1|||
94317816|NCT00515008|322945171|FG001|Overall Study|Scheduling conflict|0|||
94317817|NCT02371759|322945172|FG000|Overall Study|Protocol Violation|3|||
94317818|NCT02371759|322945173|FG001|Overall Study|Protocol Violation|1|||
94317819|NCT02371759|322945174|FG002|Overall Study|Protocol Violation|1|||
94317820|NCT02371759|322945175|FG003|Overall Study|Protocol Violation|0|||
94317821|NCT02371759|322945176|FG004|Overall Study|Protocol Violation|3|||
94317822|NCT02371759|322945177|FG005|Overall Study|Protocol Violation|1|||
94317823|NCT02371759|322945178|FG006|Overall Study|Protocol Violation|0|||
94317824|NCT02371759|322945179|FG007|Overall Study|Protocol Violation|3|||
94317825|NCT02371759|322945172|FG000|Overall Study|Withdrawal by Subject|0|||
94317826|NCT02371759|322945173|FG001|Overall Study|Withdrawal by Subject|0|||
94317827|NCT02371759|322945174|FG002|Overall Study|Withdrawal by Subject|0|||
94317828|NCT02371759|322945175|FG003|Overall Study|Withdrawal by Subject|0|||
94317829|NCT02371759|322945176|FG004|Overall Study|Withdrawal by Subject|0|||
94317830|NCT02371759|322945177|FG005|Overall Study|Withdrawal by Subject|0|||
94317831|NCT02371759|322945178|FG006|Overall Study|Withdrawal by Subject|0|||
94317832|NCT02371759|322945179|FG007|Overall Study|Withdrawal by Subject|1|||
94317833|NCT04160468|322945185|FG000|Overall Study|Lost to Follow-up|19|||
94317834|NCT04160468|322945186|FG001|Overall Study|Lost to Follow-up|4|||
94317835|NCT04160468|322945185|FG000|Overall Study|Randomized but not dosed|6|||
94317836|NCT04160468|322945186|FG001|Overall Study|Randomized but not dosed|0|||
94317837|NCT04160468|322945185|FG000|Overall Study|Withdrawal by Subject|4|||
94385798|NCT02191891|323199020|FG000|Overall Study|Withdrawal by Subject|0|||
94385799|NCT02191891|323199021|FG001|Overall Study|Withdrawal by Subject|1|||
94385800|NCT02191891|323199022|FG002|Overall Study|Withdrawal by Subject|0|||
94385801|NCT02191891|323199023|FG003|Overall Study|Withdrawal by Subject|0|||
94385802|NCT02191891|323199024|FG004|Overall Study|Withdrawal by Subject|1|||
94385803|NCT02191891|323199020|FG000|Overall Study|Adverse Event|0|||
94385804|NCT02191891|323199021|FG001|Overall Study|Adverse Event|1|||
94385805|NCT02191891|323199022|FG002|Overall Study|Adverse Event|0|||
94385806|NCT02191891|323199023|FG003|Overall Study|Adverse Event|0|||
94385807|NCT02191891|323199024|FG004|Overall Study|Adverse Event|2|||
94385808|NCT02191891|323199020|FG000|Overall Study|Disease Progression|4|||
94385809|NCT02191891|323199021|FG001|Overall Study|Disease Progression|10|||
94385810|NCT02191891|323199022|FG002|Overall Study|Disease Progression|4|||
94385811|NCT02191891|323199023|FG003|Overall Study|Disease Progression|2|||
94385812|NCT02191891|323199024|FG004|Overall Study|Disease Progression|7|||
94481411|NCT03839394|323554031|FG001|Overall Study|Withdrawal by Subject|2|||
94481412|NCT02895295|323554035|FG000|Overall Study|Survey Non-response|71|||
94481413|NCT02895295|323554036|FG001|Overall Study|Survey Non-response|94|||
94481414|NCT02895295|323554037|FG002|Overall Study|Survey Non-response|92|||
94481415|NCT01367249|323554038|FG000|Overall Study|Withdrawal by Subject|6|||
94481416|NCT01367249|323554039|FG001|Overall Study|Withdrawal by Subject|6|||
94481417|NCT01367249|323554038|FG000|Overall Study|Other|3|||
94481418|NCT01367249|323554039|FG001|Overall Study|Other|10|||
94481419|NCT01190813|323554041|FG000|Overall Study|Lost to Follow-up|1|||
94481420|NCT01190813|323554042|FG001|Overall Study|Lost to Follow-up|2|||
94481421|NCT01190813|323554041|FG000|Overall Study|Withdrawal by Subject|2|||
94481422|NCT01190813|323554042|FG001|Overall Study|Withdrawal by Subject|1|||
94481423|NCT01190813|323554041|FG000|Overall Study|Refused study treatment after randomized|1|||
94481424|NCT01190813|323554042|FG001|Overall Study|Refused study treatment after randomized|0|||
94481425|NCT01190813|323554041|FG000|Overall Study|Adverse Event|0|||
94481426|NCT01190813|323554042|FG001|Overall Study|Adverse Event|1|||
94481427|NCT05212168|323554043|FG000|Overall Study|Lost to Follow-up|0|||
94481428|NCT05212168|323554044|FG001|Overall Study|Lost to Follow-up|3|||
94481429|NCT05212168|323554043|FG000|Overall Study|Study terminated by sponsor|30|||
94481430|NCT05212168|323554044|FG001|Overall Study|Study terminated by sponsor|27|||
94481431|NCT05212168|323554043|FG000|Overall Study|Other|4|||
94481432|NCT05212168|323554044|FG001|Overall Study|Other|7|||
94481433|NCT04614324|323554047|FG000|Overall Study|Lost to Follow-up|3|||
94481434|NCT04614324|323554047|FG000|Overall Study|Physician Decision|1|||
94481435|NCT04614324|323554047|FG000|Overall Study|Withdrawal by Subject|2|||
94481436|NCT04614324|323554047|FG000|Overall Study|Remaining in Follow up|123|||
94481437|NCT01212094|323555813|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
94481438|NCT01212094|323555814|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
94317838|NCT04160468|322945186|FG001|Overall Study|Withdrawal by Subject|1|||
94317839|NCT04160468|322945185|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
94481439|NCT01212094|323555815|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
94481440|NCT01212094|323555813|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
94481441|NCT01212094|323555814|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
94481442|NCT01212094|323555815|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
94481443|NCT01212094|323555813|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
94481444|NCT01212094|323555814|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
94481445|NCT01212094|323555815|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
94481446|NCT01212094|323555813|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
94481447|NCT01212094|323555814|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
94481448|NCT01212094|323555815|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
94481449|NCT01212094|323555813|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
94481450|NCT01212094|323555814|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
94481451|NCT01212094|323555815|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
94481452|NCT01212094|323555813|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
94481453|NCT01212094|323555814|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
94481454|NCT01212094|323555815|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
94481455|NCT04826484|323555816|FG000|Overall Study|Lost to Follow-up|2|||
94481456|NCT04826484|323555817|FG001|Overall Study|Lost to Follow-up|0|||
94481457|NCT02250300|323555818|FG000|Expansion Phase|Death|6|||
94481458|NCT02250300|323555819|FG001|Expansion Phase|Death|7|||
94481459|NCT02250300|323555820|FG002|Expansion Phase|Death|0|||
94481460|NCT02250300|323555821|FG003|Expansion Phase|Death|0|||
94481461|NCT02317991|323555822|FG000|Overall Study|Adverse Event|12|||
94481462|NCT02317991|323555822|FG000|Overall Study|Death|4|||
94481463|NCT02317991|323555822|FG000|Overall Study|Withdrawal by Subject|8|||
94481464|NCT02317991|323555822|FG000|Overall Study|Progressive Disease|41|||
94481465|NCT04194489|323555825|FG000|Overall Study|Withdrawal by Subject|5|||
94481466|NCT04194489|323555825|FG000|Overall Study|Lost to Follow-up|48|||
94481467|NCT00377637|323555827|FG000|Induction Phase|Adverse Event|12|||
94481468|NCT00377637|323555828|FG001|Induction Phase|Adverse Event|21|||
94481469|NCT00377637|323555829|FG002|Induction Phase|Adverse Event|0|||
94481470|NCT00377637|323555830|FG003|Induction Phase|Adverse Event|0|||
94481471|NCT00377637|323555827|FG000|Induction Phase|Deterioration/serum creatinine|2|||
94481472|NCT00377637|323555828|FG001|Induction Phase|Deterioration/serum creatinine|0|||
94481473|NCT00377637|323555829|FG002|Induction Phase|Deterioration/serum creatinine|0|||
94481474|NCT00377637|323555830|FG003|Induction Phase|Deterioration/serum creatinine|0|||
94481475|NCT00377637|323555827|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
94481476|NCT00377637|323555828|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
94481477|NCT00377637|323555829|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
94481478|NCT00377637|323555830|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
94481479|NCT00377637|323555827|FG000|Induction Phase|Lost to Follow-up|2|||
94317840|NCT04160468|322945186|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
94317841|NCT04160468|322945185|FG000|Overall Study|Participant incarcerated|1|||
94317842|NCT04160468|322945186|FG001|Overall Study|Participant incarcerated|0|||
94317843|NCT01402284|322945187|FG000|Overall Study|Withdrawal consent|2|||
94317844|NCT01402284|322945187|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
94317845|NCT01402284|322945187|FG000|Overall Study|Physician Decision|1|||
94317846|NCT01402284|322945187|FG000|Overall Study|Disease progression on study|10|||
94317847|NCT02928406|322945190|FG000|Overall Study|Death|780|||
94317848|NCT02928406|322945190|FG000|Overall Study|Progressive disease|3|||
94317849|NCT02928406|322945190|FG000|Overall Study|Lost to Follow-up|49|||
94317850|NCT02928406|322945190|FG000|Overall Study|Non-compliance|2|||
94317851|NCT02928406|322945190|FG000|Overall Study|Withdrawal by Subject|40|||
94317852|NCT02928406|322945190|FG000|Overall Study|Study terminated by sponsor|57|||
94317853|NCT02928406|322945190|FG000|Overall Study|Physician Decision|1|||
94317854|NCT02928406|322945190|FG000|Overall Study|Various reasons|72|||
94317855|NCT01423617|322945191|FG000|Overall Study|Lost to Follow-up|0|||
94317856|NCT01423617|322945192|FG001|Overall Study|Lost to Follow-up|1|||
94317857|NCT03987620|322945193|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
94317858|NCT03987620|322945194|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
94317859|NCT03987620|322945193|FG000|Overall Study|Adverse Event|3|||
94317860|NCT03987620|322945194|FG001|Overall Study|Adverse Event|0|||
94317861|NCT03987620|322945193|FG000|Overall Study|Lost to Follow-up|1|||
94317862|NCT03987620|322945194|FG001|Overall Study|Lost to Follow-up|2|||
94317863|NCT03987620|322945193|FG000|Overall Study|Physician Decision|0|||
94317864|NCT03987620|322945194|FG001|Overall Study|Physician Decision|1|||
94317865|NCT03987620|322945193|FG000|Overall Study|Pregnancy|1|||
94317866|NCT03987620|322945194|FG001|Overall Study|Pregnancy|0|||
94317867|NCT03987620|322945193|FG000|Overall Study|Withdrawal by Subject|7|||
94317868|NCT03987620|322945194|FG001|Overall Study|Withdrawal by Subject|1|||
94317869|NCT03987620|322945193|FG000|Overall Study|Other|2|||
94317870|NCT03987620|322945194|FG001|Overall Study|Other|5|||
94317871|NCT01515306|322945195|FG000|Overall Study|Adverse Event|3|||
94317872|NCT01515306|322945196|FG001|Overall Study|Adverse Event|2|||
94317873|NCT01515306|322945195|FG000|Overall Study|Progressive Disease|19|||
94317874|NCT01515306|322945196|FG001|Overall Study|Progressive Disease|9|||
94317875|NCT01515306|322945195|FG000|Overall Study|Withdrawal by Subject|1|||
94317876|NCT01515306|322945196|FG001|Overall Study|Withdrawal by Subject|2|||
94317877|NCT01515306|322945195|FG000|Overall Study|Physician Decision|1|||
94317878|NCT01515306|322945196|FG001|Overall Study|Physician Decision|1|||
94317879|NCT03201198|322945199|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
94317880|NCT03201198|322945200|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
94317881|NCT03201198|322945199|FG000|Overall Study|Withdrawal by Subject|2|||
94317882|NCT03201198|322945200|FG001|Overall Study|Withdrawal by Subject|3|||
94317883|NCT00471445|322945205|FG000|Overall Study|Withdrawal by Subject|1|||
94317884|NCT00471445|322945206|FG001|Overall Study|Withdrawal by Subject|1|||
94317885|NCT00471445|322945205|FG000|Overall Study|Ineligible|1|||
94317886|NCT00471445|322945206|FG001|Overall Study|Ineligible|0|||
94317887|NCT00471445|322945205|FG000|Overall Study|Protocol Violation|0|||
94317888|NCT00471445|322945206|FG001|Overall Study|Protocol Violation|1|||
94385869|NCT03315455|323199045|FG000|Overall Study|Ongoing in the Study|13|||
94385870|NCT03315455|323199046|FG001|Overall Study|Ongoing in the Study|24|||
94317889|NCT03591146|322945210|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
94317890|NCT03591146|322945211|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
94317891|NCT03591146|322945212|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
94317892|NCT03591146|322945213|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
94317893|NCT03591146|322945214|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
94385871|NCT03315455|323199047|FG002|Overall Study|Ongoing in the Study|17|||
94385872|NCT03315455|323199048|FG003|Overall Study|Ongoing in the Study|15|||
94385873|NCT03315455|323199045|FG000|Overall Study|Withdrawal by Subject|0|||
94385874|NCT03315455|323199046|FG001|Overall Study|Withdrawal by Subject|1|||
94317894|NCT03591146|322945210|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
94317895|NCT03591146|322945211|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
94317896|NCT03591146|322945212|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
94385875|NCT03315455|323199047|FG002|Overall Study|Withdrawal by Subject|0|||
94385876|NCT03315455|323199048|FG003|Overall Study|Withdrawal by Subject|0|||
94385893|NCT03130699|323199051|FG000|Overall Study|Lost to Follow-up|34|||
94385894|NCT03130699|323199052|FG001|Overall Study|Lost to Follow-up|37|||
94385895|NCT03130699|323199053|FG002|Overall Study|Lost to Follow-up|26|||
94385896|NCT03130699|323199051|FG000|Overall Study|Withdrawal by Subject|5|||
94385897|NCT03130699|323199052|FG001|Overall Study|Withdrawal by Subject|1|||
94385898|NCT03130699|323199053|FG002|Overall Study|Withdrawal by Subject|0|||
94385899|NCT03130699|323199051|FG000|Overall Study|Withdrawal by PI|1|||
94385900|NCT03130699|323199052|FG001|Overall Study|Withdrawal by PI|2|||
94385901|NCT03130699|323199053|FG002|Overall Study|Withdrawal by PI|5|||
94385902|NCT03130699|323199051|FG000|Overall Study|Death|0|||
94385903|NCT03130699|323199052|FG001|Overall Study|Death|0|||
94385904|NCT03130699|323199053|FG002|Overall Study|Death|1|||
94481480|NCT00377637|323555828|FG001|Induction Phase|Lost to Follow-up|1|||
94481481|NCT00377637|323555829|FG002|Induction Phase|Lost to Follow-up|0|||
94481482|NCT00377637|323555830|FG003|Induction Phase|Lost to Follow-up|0|||
94481483|NCT00377637|323555827|FG000|Induction Phase|Death|1|||
94481484|NCT00377637|323555828|FG001|Induction Phase|Death|3|||
94481485|NCT00377637|323555829|FG002|Induction Phase|Death|0|||
94481486|NCT00377637|323555830|FG003|Induction Phase|Death|0|||
94481487|NCT00377637|323555827|FG000|Induction Phase|Withdrawal by Subject|5|||
94481488|NCT00377637|323555828|FG001|Induction Phase|Withdrawal by Subject|6|||
94481489|NCT00377637|323555829|FG002|Induction Phase|Withdrawal by Subject|0|||
94481490|NCT00377637|323555830|FG003|Induction Phase|Withdrawal by Subject|0|||
94481491|NCT00377637|323555827|FG000|Induction Phase|Physician Decision|3|||
94481492|NCT00377637|323555828|FG001|Induction Phase|Physician Decision|1|||
94481493|NCT00377637|323555829|FG002|Induction Phase|Physician Decision|0|||
94481494|NCT00377637|323555830|FG003|Induction Phase|Physician Decision|0|||
94481495|NCT00377637|323555827|FG000|Induction Phase|Sponsor decision|1|||
94481496|NCT00377637|323555828|FG001|Induction Phase|Sponsor decision|2|||
94481497|NCT00377637|323555829|FG002|Induction Phase|Sponsor decision|0|||
94481498|NCT00377637|323555830|FG003|Induction Phase|Sponsor decision|0|||
94481499|NCT00377637|323555827|FG000|Induction Phase|Non-Compliance|1|||
94481500|NCT00377637|323555828|FG001|Induction Phase|Non-Compliance|0|||
94481501|NCT00377637|323555829|FG002|Induction Phase|Non-Compliance|0|||
94481502|NCT00377637|323555830|FG003|Induction Phase|Non-Compliance|0|||
94481503|NCT00377637|323555827|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
94481504|NCT00377637|323555828|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
94481505|NCT00377637|323555829|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
94481506|NCT00377637|323555830|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
94481507|NCT00377637|323555827|FG000|Maintenance Phase|Adverse Event|0|||
94481508|NCT00377637|323555828|FG001|Maintenance Phase|Adverse Event|0|||
94481509|NCT00377637|323555829|FG002|Maintenance Phase|Adverse Event|29|||
94481510|NCT00377637|323555830|FG003|Maintenance Phase|Adverse Event|43|||
94481511|NCT00377637|323555827|FG000|Maintenance Phase|Physician Decision|0|||
94481512|NCT00377637|323555828|FG001|Maintenance Phase|Physician Decision|0|||
94481513|NCT00377637|323555829|FG002|Maintenance Phase|Physician Decision|5|||
94481514|NCT00377637|323555830|FG003|Maintenance Phase|Physician Decision|4|||
94481515|NCT00377637|323555827|FG000|Maintenance Phase|Lost to Follow-up|0|||
94481516|NCT00377637|323555828|FG001|Maintenance Phase|Lost to Follow-up|0|||
94481517|NCT00377637|323555829|FG002|Maintenance Phase|Lost to Follow-up|3|||
94481518|NCT00377637|323555830|FG003|Maintenance Phase|Lost to Follow-up|1|||
94481519|NCT00377637|323555827|FG000|Maintenance Phase|Withdrawal by Subject|0|||
94481520|NCT00377637|323555828|FG001|Maintenance Phase|Withdrawal by Subject|0|||
94481521|NCT00377637|323555829|FG002|Maintenance Phase|Withdrawal by Subject|3|||
94481522|NCT00377637|323555830|FG003|Maintenance Phase|Withdrawal by Subject|3|||
94481523|NCT00377637|323555827|FG000|Maintenance Phase|Sponsor decision|0|||
94481524|NCT00377637|323555828|FG001|Maintenance Phase|Sponsor decision|0|||
94481525|NCT00377637|323555829|FG002|Maintenance Phase|Sponsor decision|2|||
94481526|NCT00377637|323555830|FG003|Maintenance Phase|Sponsor decision|3|||
94481527|NCT00377637|323555827|FG000|Maintenance Phase|Non-compliance|0|||
94481528|NCT00377637|323555828|FG001|Maintenance Phase|Non-compliance|0|||
94481529|NCT00377637|323555829|FG002|Maintenance Phase|Non-compliance|1|||
94481530|NCT00377637|323555830|FG003|Maintenance Phase|Non-compliance|1|||
94481531|NCT00377637|323555827|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
94481532|NCT00377637|323555828|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
94481533|NCT00377637|323555829|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
94481534|NCT00377637|323555830|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
94481535|NCT00377637|323555827|FG000|Maintenance Phase|Death|0|||
94481536|NCT00377637|323555828|FG001|Maintenance Phase|Death|0|||
94481537|NCT00377637|323555829|FG002|Maintenance Phase|Death|0|||
94481538|NCT00377637|323555830|FG003|Maintenance Phase|Death|1|||
94481539|NCT00522548|323555831|FG000|Overall Study|Adverse Event|2|||
94481540|NCT00522548|323555832|FG001|Overall Study|Adverse Event|2|||
94481541|NCT00522548|323555831|FG000|Overall Study|Withdrawal by Subject|0|||
94481542|NCT00522548|323555832|FG001|Overall Study|Withdrawal by Subject|2|||
94481543|NCT01519817|323555834|FG000|Overall Study|Withdrawal by Subject|1|||
94481544|NCT01519817|323555835|FG001|Overall Study|Withdrawal by Subject|0|||
94481545|NCT01519817|323555836|FG002|Overall Study|Withdrawal by Subject|0|||
94481546|NCT01519817|323555837|FG003|Overall Study|Withdrawal by Subject|0|||
94481547|NCT01519817|323555834|FG000|Overall Study|Off study due to infection|0|||
94481548|NCT01519817|323555835|FG001|Overall Study|Off study due to infection|0|||
94481549|NCT01519817|323555836|FG002|Overall Study|Off study due to infection|0|||
94481550|NCT01519817|323555837|FG003|Overall Study|Off study due to infection|1|||
94481551|NCT04085601|323555838|FG000|Overall Study|Lost to Follow-up|1|||
94481552|NCT04085601|323555839|FG001|Overall Study|Lost to Follow-up|0|||
94481553|NCT04085601|323555838|FG000|Overall Study|Death|1|||
94481554|NCT04085601|323555839|FG001|Overall Study|Death|1|||
94481555|NCT04155463|323555840|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
94481556|NCT04155463|323555841|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
94481557|NCT05137717|323555843|FG000|Overall Study|Death|2|||
94481558|NCT05137717|323555843|FG000|Overall Study|Withdrawal by Subject|6|||
94481559|NCT02035553|323555844|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
94481560|NCT02035553|323555845|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
94481561|NCT02035553|323555844|FG000|Overall Study|Adverse Event|10|||
94481562|NCT02035553|323555845|FG001|Overall Study|Adverse Event|6|||
94481563|NCT02035553|323555844|FG000|Overall Study|Physician Decision|3|||
94481564|NCT02035553|323555845|FG001|Overall Study|Physician Decision|2|||
94481565|NCT02035553|323555844|FG000|Overall Study|Lack of Efficacy|1|||
94481566|NCT02035553|323555845|FG001|Overall Study|Lack of Efficacy|1|||
94481567|NCT02035553|323555844|FG000|Overall Study|Withdrawal by Subject|4|||
94481568|NCT02035553|323555845|FG001|Overall Study|Withdrawal by Subject|7|||
94481569|NCT02035553|323555844|FG000|Overall Study|Non-compliance with Study Drug|0|||
94481570|NCT02035553|323555845|FG001|Overall Study|Non-compliance with Study Drug|1|||
94481571|NCT02035553|323555844|FG000|Overall Study|Lost to Follow-up|0|||
94481572|NCT02035553|323555845|FG001|Overall Study|Lost to Follow-up|1|||
94481573|NCT02035553|323555844|FG000|Overall Study|Other Reason|0|||
94481574|NCT02035553|323555845|FG001|Overall Study|Other Reason|4|||
94481575|NCT01854697|323555846|FG000|Overall Study|Adverse Event|1|||
94481576|NCT01854697|323555847|FG001|Overall Study|Adverse Event|0|||
94481577|NCT01854697|323555848|FG002|Overall Study|Adverse Event|0|||
94481578|NCT01854697|323555849|FG003|Overall Study|Adverse Event|0|||
94481579|NCT01854697|323555850|FG004|Overall Study|Adverse Event|1|||
94481580|NCT01854697|323555846|FG000|Overall Study|Lost to Follow-up|4|||
94481581|NCT01854697|323555847|FG001|Overall Study|Lost to Follow-up|1|||
94481582|NCT01854697|323555848|FG002|Overall Study|Lost to Follow-up|1|||
94481583|NCT01854697|323555849|FG003|Overall Study|Lost to Follow-up|2|||
94481584|NCT01854697|323555850|FG004|Overall Study|Lost to Follow-up|0|||
94481585|NCT01854697|323555846|FG000|Overall Study|To enter another AbbVie study|1|||
94481586|NCT01854697|323555847|FG001|Overall Study|To enter another AbbVie study|0|||
94481587|NCT01854697|323555848|FG002|Overall Study|To enter another AbbVie study|0|||
94481588|NCT01854697|323555849|FG003|Overall Study|To enter another AbbVie study|0|||
94481589|NCT01854697|323555850|FG004|Overall Study|To enter another AbbVie study|1|||
94481590|NCT01854697|323555846|FG000|Overall Study|Withdrew Consent|0|||
94481591|NCT01854697|323555847|FG001|Overall Study|Withdrew Consent|1|||
94481592|NCT01854697|323555848|FG002|Overall Study|Withdrew Consent|0|||
94481593|NCT01854697|323555849|FG003|Overall Study|Withdrew Consent|1|||
94481594|NCT01854697|323555850|FG004|Overall Study|Withdrew Consent|0|||
94481595|NCT01854697|323555846|FG000|Overall Study|Other|0|||
94317897|NCT03591146|322945213|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
94317898|NCT03591146|322945214|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
94317899|NCT03591146|322945210|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
94317900|NCT03591146|322945211|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
94481596|NCT01854697|323555847|FG001|Overall Study|Other|1|||
94481597|NCT01854697|323555848|FG002|Overall Study|Other|1|||
94481598|NCT01854697|323555849|FG003|Overall Study|Other|0|||
94481599|NCT01854697|323555850|FG004|Overall Study|Other|0|||
94481600|NCT00369915|323555853|FG000|Overall Study|expected side effects|2|||
94481601|NCT00369915|323555854|FG001|Overall Study|expected side effects|1|||
94481602|NCT00369915|323555853|FG000|Overall Study|Withdrawal by Subject|4|||
94481603|NCT00369915|323555854|FG001|Overall Study|Withdrawal by Subject|1|||
94481604|NCT00369915|323555853|FG000|Overall Study|W/drawl by investigators|0|||
94317901|NCT03591146|322945212|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
94317902|NCT03591146|322945213|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
94317903|NCT03591146|322945214|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
94317904|NCT03591146|322945210|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
94317905|NCT03591146|322945211|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
94317906|NCT03591146|322945212|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
94317907|NCT03591146|322945213|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
94317908|NCT03591146|322945214|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
94317909|NCT04715230|322945222|FG000|Overall Study|Withdrawal by Subject|1|||
94317910|NCT04715230|322945223|FG001|Overall Study|Withdrawal by Subject|0|||
94317911|NCT04715230|322945224|FG002|Overall Study|Withdrawal by Subject|0|||
94317912|NCT04715230|322945222|FG000|Overall Study|Lost to Follow-up|0|||
94317913|NCT04715230|322945223|FG001|Overall Study|Lost to Follow-up|5|||
94317914|NCT04715230|322945224|FG002|Overall Study|Lost to Follow-up|1|||
94317915|NCT01005732|322945225|FG000|Overall Study|Lost to Follow-up|10|||
94317916|NCT01005732|322945225|FG000|Overall Study|Death|1|||
94317917|NCT04570657|322945226|FG000|Overall Study|Adverse Event|0|||
94317918|NCT04570657|322945227|FG001|Overall Study|Adverse Event|0|||
94317919|NCT04570657|322945228|FG002|Overall Study|Adverse Event|1|||
94317920|NCT04570657|322945226|FG000|Overall Study|Lost to Follow-up|0|||
94317921|NCT04570657|322945227|FG001|Overall Study|Lost to Follow-up|0|||
94317922|NCT04570657|322945228|FG002|Overall Study|Lost to Follow-up|1|||
94317923|NCT04570657|322945226|FG000|Overall Study|Physician Decision|0|||
94317924|NCT04570657|322945227|FG001|Overall Study|Physician Decision|1|||
94317925|NCT04570657|322945228|FG002|Overall Study|Physician Decision|0|||
94317926|NCT04570657|322945226|FG000|Overall Study|Withdrawal by Subject|1|||
94317927|NCT04570657|322945227|FG001|Overall Study|Withdrawal by Subject|2|||
94317928|NCT04570657|322945228|FG002|Overall Study|Withdrawal by Subject|2|||
94317929|NCT01072539|322945231|FG000|Overall Study|Treated prior to the Site Initiation|1|||
94317930|NCT01072539|322945231|FG000|Overall Study|Protocol Violation|2|||
94317931|NCT01767194|322945234|FG000|Overall Study|Adverse Event|1|||
94317932|NCT01767194|322945235|FG001|Overall Study|Adverse Event|1|||
94317933|NCT01767194|322945234|FG000|Overall Study|Death|0|||
94317934|NCT01767194|322945235|FG001|Overall Study|Death|1|||
94317935|NCT01767194|322945234|FG000|Overall Study|Lack of Efficacy|12|||
94317936|NCT01767194|322945235|FG001|Overall Study|Lack of Efficacy|11|||
94317937|NCT01767194|322945234|FG000|Overall Study|Physician Decision|2|||
94317938|NCT01767194|322945235|FG001|Overall Study|Physician Decision|23|||
94317939|NCT01767194|322945234|FG000|Overall Study|Withdrawal by Subject|0|||
94317940|NCT01767194|322945235|FG001|Overall Study|Withdrawal by Subject|1|||
94317941|NCT01767194|322945234|FG000|Overall Study|Ineligible|1|||
94317942|NCT01767194|322945235|FG001|Overall Study|Ineligible|1|||
94317943|NCT01767194|322945234|FG000|Overall Study|Refusal by patient/parent|2|||
94317944|NCT01767194|322945235|FG001|Overall Study|Refusal by patient/parent|4|||
94317945|NCT01767194|322945234|FG000|Overall Study|Criteria not met on time for next cycle|0|||
94317946|NCT01767194|322945235|FG001|Overall Study|Criteria not met on time for next cycle|1|||
94317947|NCT01752842|322945240|FG000|Overall Study|Adverse Event|3|||
94317948|NCT01752842|322945241|FG001|Overall Study|Adverse Event|0|||
94317949|NCT01752842|322945240|FG000|Overall Study|Withdrawal by Subject|0|||
94317950|NCT01752842|322945241|FG001|Overall Study|Withdrawal by Subject|2|||
94317951|NCT00074412|322947262|FG000|Overall Study|Death|30|||
94317952|NCT00074412|322947263|FG001|Overall Study|Death|26|||
94317953|NCT00074412|322947262|FG000|Overall Study|Lost to Follow-up|52|||
94317954|NCT00074412|322947263|FG001|Overall Study|Lost to Follow-up|58|||
94317955|NCT00418834|322947264|FG000|Overall Study|Adverse Event|16|||
94317956|NCT00418834|322947265|FG001|Overall Study|Adverse Event|9|||
94317957|NCT00418834|322947264|FG000|Overall Study|Lost to Follow-up|0|||
94317958|NCT00418834|322947265|FG001|Overall Study|Lost to Follow-up|1|||
94317959|NCT00418834|322947264|FG000|Overall Study|Protocol Violation|4|||
94317960|NCT00418834|322947265|FG001|Overall Study|Protocol Violation|3|||
94317961|NCT00418834|322947264|FG000|Overall Study|Withdrawal by Subject|3|||
94317962|NCT00418834|322947265|FG001|Overall Study|Withdrawal by Subject|7|||
94317963|NCT01953328|322947266|FG000|Overall Study|Withdrawal by Subject|0|||
94317964|NCT01953328|322947267|FG001|Overall Study|Withdrawal by Subject|0|||
94317965|NCT01953328|322947268|FG002|Overall Study|Withdrawal by Subject|0|||
94317966|NCT01953328|322947269|FG003|Overall Study|Withdrawal by Subject|0|||
94317967|NCT01953328|322947270|FG004|Overall Study|Withdrawal by Subject|1|||
94317968|NCT01953328|322947271|FG005|Overall Study|Withdrawal by Subject|0|||
94317969|NCT01953328|322947272|FG006|Overall Study|Withdrawal by Subject|0|||
94317970|NCT01953328|322947273|FG007|Overall Study|Withdrawal by Subject|0|||
94317971|NCT01953328|322947266|FG000|Overall Study|Lost to Follow-up|0|||
94317972|NCT01953328|322947267|FG001|Overall Study|Lost to Follow-up|0|||
94317973|NCT01953328|322947268|FG002|Overall Study|Lost to Follow-up|0|||
94317974|NCT01953328|322947269|FG003|Overall Study|Lost to Follow-up|0|||
94317975|NCT01953328|322947270|FG004|Overall Study|Lost to Follow-up|1|||
94481605|NCT00369915|323555854|FG001|Overall Study|W/drawl by investigators|1|||
94317976|NCT01953328|322947271|FG005|Overall Study|Lost to Follow-up|0|||
94317977|NCT01953328|322947272|FG006|Overall Study|Lost to Follow-up|0|||
94317978|NCT01953328|322947273|FG007|Overall Study|Lost to Follow-up|0|||
94317979|NCT04494633|322947276|FG000|Overall Study|Lost to Follow-up|5|||
94317980|NCT04494633|322947277|FG001|Overall Study|Lost to Follow-up|3|||
94317981|NCT04494633|322947276|FG000|Overall Study|Protocol Violation|1|||
94317982|NCT04494633|322947277|FG001|Overall Study|Protocol Violation|1|||
94317983|NCT00423085|322947279|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
94317984|NCT00423085|322947280|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
94317985|NCT00423085|322947281|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
94317986|NCT00423085|322947282|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
94317987|NCT00423085|322947279|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
94317988|NCT00423085|322947280|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
94317989|NCT00423085|322947281|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
94317990|NCT00423085|322947282|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
94317991|NCT00423085|322947279|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
94317992|NCT00423085|322947280|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
94317993|NCT00423085|322947281|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
94317994|NCT00423085|322947282|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
94317995|NCT00423085|322947279|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
94317996|NCT00423085|322947280|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
94317997|NCT00423085|322947281|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
94317998|NCT00423085|322947282|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
94317999|NCT00423085|322947279|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
94318000|NCT00423085|322947280|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
94318001|NCT00423085|322947281|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
94318002|NCT00423085|322947282|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
94318003|NCT00423085|322947279|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
94318004|NCT00423085|322947280|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
94318005|NCT00423085|322947281|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
94318006|NCT00423085|322947282|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
94318007|NCT00423085|322947279|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
94318008|NCT00423085|322947280|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
94318009|NCT00423085|322947281|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
94318010|NCT00423085|322947282|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
94318011|NCT00423085|322947279|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
94318012|NCT00423085|322947280|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
94318013|NCT00423085|322947281|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
94318014|NCT00423085|322947282|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
94318015|NCT00423085|322947279|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
94318016|NCT00423085|322947280|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
94318017|NCT00423085|322947281|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
94318018|NCT00423085|322947282|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
94318019|NCT00423085|322947279|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
94318020|NCT00423085|322947280|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
94318021|NCT00423085|322947281|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
94318022|NCT00423085|322947282|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
94318023|NCT00423085|322947279|FG000|52-Week Open-Label Extension Phase|Death|0|||
94318024|NCT00423085|322947280|FG001|52-Week Open-Label Extension Phase|Death|0|||
94318025|NCT00423085|322947281|FG002|52-Week Open-Label Extension Phase|Death|0|||
94318026|NCT00423085|322947282|FG003|52-Week Open-Label Extension Phase|Death|2|||
94318027|NCT01051986|322947288|FG000|Overall Study|Death|1|||
94318028|NCT01051986|322947289|FG001|Overall Study|Death|0|||
94318029|NCT01051986|322947288|FG000|Overall Study|Withdrawal by Subject|2|||
94318030|NCT01051986|322947289|FG001|Overall Study|Withdrawal by Subject|1|||
94318031|NCT01051986|322947288|FG000|Overall Study|Protocol Violation|2|||
94318032|NCT01051986|322947289|FG001|Overall Study|Protocol Violation|3|||
94318033|NCT01795898|322947290|FG000|Overall Study|Adverse Event|27|||
94318034|NCT01795898|322947290|FG000|Overall Study|Lost to Follow-up|20|||
94318035|NCT01795898|322947290|FG000|Overall Study|Withdrawal of consent|6|||
94318036|NCT01795898|322947290|FG000|Overall Study|Diagnosed with metastasis|1|||
94318037|NCT01795898|322947290|FG000|Overall Study|No pain|1|||
94318038|NCT01795898|322947290|FG000|Overall Study|Death|1|||
94318039|NCT01795898|322947290|FG000|Overall Study|Withdrew consent & had adverse events|3|||
94318040|NCT01795898|322947290|FG000|Overall Study|Physician Decision|1|||
94318041|NCT01361009|322947291|FG000|Overall Study|Protocol Violation|116|||
94318042|NCT01826422|322947292|FG000|Overall Study|Withdrawal by Subject|1|||
94318043|NCT01826422|322947293|FG001|Overall Study|Withdrawal by Subject|3|||
94318044|NCT00718419|322947294|FG000|Overall Study|Adverse Event|2|||
94318045|NCT00718419|322947295|FG001|Overall Study|Adverse Event|1|||
94318046|NCT00718419|322947294|FG000|Overall Study|Physician Decision|1|||
94318047|NCT00718419|322947295|FG001|Overall Study|Physician Decision|6|||
94318048|NCT00718419|322947294|FG000|Overall Study|Sponsor decision|0|||
94318049|NCT00718419|322947295|FG001|Overall Study|Sponsor decision|1|||
94318050|NCT00718419|322947294|FG000|Overall Study|Withdrawal by Subject|0|||
94318051|NCT00718419|322947295|FG001|Overall Study|Withdrawal by Subject|5|||
94318052|NCT00718419|322947294|FG000|Overall Study|Progressive Disease|7|||
94318053|NCT00718419|322947295|FG001|Overall Study|Progressive Disease|25|||
94318054|NCT00718419|322947294|FG000|Overall Study|Death Due to Progressive Disease|2|||
94318055|NCT00718419|322947295|FG001|Overall Study|Death Due to Progressive Disease|0|||
94318056|NCT00718419|322947294|FG000|Overall Study|Death Due to Study Drug Related|0|||
94318057|NCT00718419|322947295|FG001|Overall Study|Death Due to Study Drug Related|1|||
94318058|NCT00718419|322947294|FG000|Overall Study|Death Due to Adverse Events|1|||
94318059|NCT00718419|322947295|FG001|Overall Study|Death Due to Adverse Events|0|||
94318060|NCT00623467|322947296|FG000|Overall Study|Lost to Follow-up|1|||
94318061|NCT00623467|322947296|FG000|Overall Study|Protocol Violation|4|||
94318062|NCT00623467|322947296|FG000|Overall Study|Withdrawal by Subject|2|||
94318063|NCT02179515|322947298|FG000|Overall Study|switched to alternative treatment|0|||
94318064|NCT02179515|322947299|FG001|Overall Study|switched to alternative treatment|1|||
94318065|NCT02179515|322947300|FG002|Overall Study|switched to alternative treatment|1|||
94318066|NCT02179515|322947298|FG000|Overall Study|Death|0|||
94318067|NCT02179515|322947299|FG001|Overall Study|Death|1|||
94318068|NCT02179515|322947300|FG002|Overall Study|Death|1|||
94318069|NCT02179515|322947298|FG000|Overall Study|refused further treatment|0|||
94318070|NCT02179515|322947299|FG001|Overall Study|refused further treatment|3|||
94318071|NCT02179515|322947300|FG002|Overall Study|refused further treatment|4|||
94318072|NCT02179515|322947298|FG000|Overall Study|Disease progression on study|2|||
94318073|NCT02179515|322947299|FG001|Overall Study|Disease progression on study|11|||
94318074|NCT02179515|322947300|FG002|Overall Study|Disease progression on study|8|||
94318075|NCT00782418|322947301|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
94318076|NCT00782418|322947302|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
94318077|NCT00782418|322947303|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
94318078|NCT00782418|322947304|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
94318079|NCT00782418|322947305|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
94318080|NCT00782418|322947306|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
94318081|NCT00782418|322947307|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
94318082|NCT00782418|322947301|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
94318083|NCT00782418|322947302|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
94318084|NCT00782418|322947303|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
94318085|NCT00782418|322947304|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
94318086|NCT00782418|322947305|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
94318087|NCT00782418|322947306|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
94318088|NCT00782418|322947307|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
94318089|NCT01457118|322947308|FG000|Overall Study|Adverse Event|1|||
94318090|NCT01457118|322947309|FG001|Overall Study|Adverse Event|0|||
94318091|NCT01457118|322947310|FG002|Overall Study|Adverse Event|0|||
94318092|NCT01457118|322947311|FG003|Overall Study|Adverse Event|1|||
94318093|NCT01457118|322947308|FG000|Overall Study|Clinical Progression|0|||
94318094|NCT01457118|322947309|FG001|Overall Study|Clinical Progression|1|||
94318095|NCT01457118|322947310|FG002|Overall Study|Clinical Progression|0|||
94318096|NCT01457118|322947311|FG003|Overall Study|Clinical Progression|1|||
94318097|NCT01457118|322947308|FG000|Overall Study|Physician Decision|2|||
94318098|NCT01457118|322947309|FG001|Overall Study|Physician Decision|0|||
94318099|NCT01457118|322947310|FG002|Overall Study|Physician Decision|0|||
94318100|NCT01457118|322947311|FG003|Overall Study|Physician Decision|0|||
94318101|NCT01457118|322947308|FG000|Overall Study|Progressive Disease by RECIST|12|||
94318102|NCT01457118|322947309|FG001|Overall Study|Progressive Disease by RECIST|3|||
94318103|NCT01457118|322947310|FG002|Overall Study|Progressive Disease by RECIST|1|||
94318104|NCT01457118|322947311|FG003|Overall Study|Progressive Disease by RECIST|0|||
94318105|NCT01457118|322947308|FG000|Overall Study|Withdrawal by Subject|5|||
94318106|NCT01457118|322947309|FG001|Overall Study|Withdrawal by Subject|0|||
94318107|NCT01457118|322947310|FG002|Overall Study|Withdrawal by Subject|0|||
94318108|NCT01457118|322947311|FG003|Overall Study|Withdrawal by Subject|0|||
94318109|NCT02324842|322947312|FG000|Overall Study|Lost to Follow-up|1|||
94318110|NCT02324842|322947313|FG001|Overall Study|Lost to Follow-up|1|||
94318111|NCT02324842|322947314|FG002|Overall Study|Lost to Follow-up|2|||
94318112|NCT01401010|322947319|FG000|Overall Study|Could not interpret assay results|1|||
94318113|NCT01401010|322947320|FG001|Overall Study|Could not interpret assay results|0|||
94318114|NCT01425190|322947321|FG000|Overall Study|Full dose not consumed.|1|||
94318115|NCT01425190|322947322|FG001|Overall Study|Full dose not consumed.|0|||
94318116|NCT01425190|322947323|FG002|Overall Study|Full dose not consumed.|0|||
94318117|NCT01912729|322947324|FG000|Overall Study|Withdrawal by Subject|0|||
94318118|NCT01912729|322947325|FG001|Overall Study|Withdrawal by Subject|1|||
94318119|NCT03007953|322947328|FG000|Overall Study|Withdrawal by Subject|5|||
94318120|NCT03007953|322947329|FG001|Overall Study|Withdrawal by Subject|2|||
94318121|NCT03007953|322947328|FG000|Overall Study|Death|5|||
94318122|NCT03007953|322947329|FG001|Overall Study|Death|7|||
94318123|NCT03007953|322947328|FG000|Overall Study|Lost to Follow-up|3|||
94318124|NCT03007953|322947329|FG001|Overall Study|Lost to Follow-up|2|||
94318125|NCT03007953|322947328|FG000|Overall Study|Enrolled in Hospice|3|||
94318126|NCT03007953|322947329|FG001|Overall Study|Enrolled in Hospice|2|||
94318127|NCT02993224|322947330|FG000|Core Phase - Period 1|Adverse Event|4|||
94318128|NCT02993224|322947330|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
94318129|NCT02993224|322947330|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
94318130|NCT02993224|322947330|FG000|Core Phase- Period 2|Adverse Event|1|||
94318131|NCT02993224|322947330|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
94318132|NCT02993224|322947330|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
94318133|NCT02993224|322947330|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
94318134|NCT02993224|322947330|FG000|Extension Phase|Adverse Event|3|||
94318135|NCT02993224|322947330|FG000|Extension Phase|Withdrawal by Subject|3|||
94318136|NCT02993224|322947330|FG000|Extension Phase|Lost to Follow-up|2|||
94318137|NCT02993224|322947330|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
94318138|NCT04436822|322947331|FG000|Overall Study|Physician Decision|2|||
94318139|NCT04436822|322947332|FG001|Overall Study|Physician Decision|0|||
94318140|NCT04436822|322947331|FG000|Overall Study|Sponsor request|1|||
94318141|NCT04436822|322947332|FG001|Overall Study|Sponsor request|0|||
94318142|NCT04436822|322947331|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94318143|NCT04436822|322947332|FG001|Overall Study|Withdrawal by parent/guardian|3|||
94318144|NCT04436822|322947331|FG000|Overall Study|Unsuccessful procedure|0|||
94318145|NCT04436822|322947332|FG001|Overall Study|Unsuccessful procedure|1|||
94318146|NCT04436822|322947331|FG000|Overall Study|Withdrawal due to Covid-19|8|||
94318147|NCT04436822|322947332|FG001|Overall Study|Withdrawal due to Covid-19|1|||
94318148|NCT04436822|322947331|FG000|Overall Study|Withdrawal by Subject|1|||
94318149|NCT04436822|322947332|FG001|Overall Study|Withdrawal by Subject|0|||
94318150|NCT04436822|322947331|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
94318151|NCT04436822|322947332|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
94318152|NCT02491073|322947335|FG000|Overall Study|screen failure|1|||
94318153|NCT02491073|322947336|FG001|Overall Study|screen failure|0|||
94318154|NCT01165021|322947337|FG000|Overall Study|Death|1|||
94318155|NCT03738566|322947338|FG000|Initial Study Phase|Withdrawal by Subject|1|||
94318156|NCT03738566|322947339|FG001|Initial Study Phase|Withdrawal by Subject|1|||
94318157|NCT03738566|322947340|FG002|Initial Study Phase|Withdrawal by Subject|2|||
94318158|NCT03738566|322947341|FG003|Initial Study Phase|Withdrawal by Subject|0|||
94318159|NCT03738566|322947338|FG000|Initial Study Phase|Death|0|||
94318160|NCT03738566|322947339|FG001|Initial Study Phase|Death|1|||
94318161|NCT03738566|322947340|FG002|Initial Study Phase|Death|0|||
94318162|NCT03738566|322947341|FG003|Initial Study Phase|Death|0|||
94318163|NCT03738566|322947338|FG000|Initial Study Phase|Treatment failure|5|||
94318164|NCT03738566|322947339|FG001|Initial Study Phase|Treatment failure|0|||
94318165|NCT03738566|322947340|FG002|Initial Study Phase|Treatment failure|0|||
94318166|NCT03738566|322947341|FG003|Initial Study Phase|Treatment failure|0|||
94318167|NCT03738566|322947338|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
94318168|NCT03738566|322947339|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
94318169|NCT03738566|322947340|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
94318170|NCT03738566|322947341|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
94318171|NCT03977727|322947342|FG000|Second Treatment|Lost to Follow-up|0|||
94318172|NCT03977727|322947343|FG001|Second Treatment|Lost to Follow-up|3|||
94318173|NCT00488618|322947344|FG000|Overall Study|Adverse Event|13|||
94318174|NCT00488618|322947345|FG001|Overall Study|Adverse Event|17|||
94318175|NCT00488618|322947344|FG000|Overall Study|Insufficient Therapeutic Response|18|||
94318176|NCT00488618|322947345|FG001|Overall Study|Insufficient Therapeutic Response|11|||
94318177|NCT00488618|322947344|FG000|Overall Study|Protocol Violation|0|||
94318178|NCT00488618|322947345|FG001|Overall Study|Protocol Violation|2|||
94318179|NCT00488618|322947344|FG000|Overall Study|Withdrawal of Consent|15|||
94318180|NCT00488618|322947345|FG001|Overall Study|Withdrawal of Consent|13|||
94318181|NCT00488618|322947344|FG000|Overall Study|Lost to Follow-up|1|||
94318182|NCT00488618|322947345|FG001|Overall Study|Lost to Follow-up|0|||
94318183|NCT01689207|322947346|FG000|Overall Study|Adverse Event|0|||
94318184|NCT01689207|322947347|FG001|Overall Study|Adverse Event|1|||
94318185|NCT01689207|322947348|FG002|Overall Study|Adverse Event|0|||
94318186|NCT01689207|322947349|FG003|Overall Study|Adverse Event|0|||
94318187|NCT01689207|322947350|FG004|Overall Study|Adverse Event|2|||
94318188|NCT01689207|322947351|FG005|Overall Study|Adverse Event|1|||
94318189|NCT01689207|322947352|FG006|Overall Study|Adverse Event|0|||
94318190|NCT01689207|322947353|FG007|Overall Study|Adverse Event|0|||
94318191|NCT01689207|322947354|FG008|Overall Study|Adverse Event|1|||
94318192|NCT01689207|322947355|FG009|Overall Study|Adverse Event|0|||
94318193|NCT01689207|322947356|FG010|Overall Study|Adverse Event|0|||
94318194|NCT05118386|322947357|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
94318195|NCT05118386|322947358|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
94318196|NCT05118386|322947359|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
94318197|NCT05118386|322947360|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
94318198|NCT05118386|322947361|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
94318199|NCT05118386|322947362|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
94318200|NCT05118386|322947357|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
94318201|NCT05118386|322947358|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
94318202|NCT05118386|322947359|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
94318203|NCT05118386|322947360|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
94318204|NCT05118386|322947361|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
94318205|NCT05118386|322947362|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
94318206|NCT02426658|322947365|FG000|Overall Study|Withdrawal by Subject|1|||
94318207|NCT02426658|322947365|FG000|Overall Study|Patient expired before treatment|2|||
94318208|NCT01199263|322947366|FG000|Overall Study|Ineligible|0|||
94318209|NCT01199263|322947367|FG001|Overall Study|Ineligible|2|||
94318210|NCT01199263|322947366|FG000|Overall Study|Never Treated|6|||
94318211|NCT01199263|322947367|FG001|Overall Study|Never Treated|0|||
94318212|NCT03255291|322947368|FG000|Overall Study|Determined to be ineligible|10|||
94318213|NCT03255291|322947369|FG001|Overall Study|Determined to be ineligible|12|||
94318214|NCT03255291|322947370|FG002|Overall Study|Determined to be ineligible|6|||
94318215|NCT03255291|322947371|FG003|Overall Study|Determined to be ineligible|6|||
94318216|NCT03255291|322947372|FG004|Overall Study|Determined to be ineligible|5|||
94318217|NCT03255291|322947373|FG005|Overall Study|Determined to be ineligible|10|||
94318218|NCT03255291|322947368|FG000|Overall Study|Baseline data collection issues|3|||
94318219|NCT03255291|322947369|FG001|Overall Study|Baseline data collection issues|0|||
94318220|NCT03255291|322947370|FG002|Overall Study|Baseline data collection issues|0|||
94318221|NCT03255291|322947371|FG003|Overall Study|Baseline data collection issues|0|||
94318222|NCT03255291|322947372|FG004|Overall Study|Baseline data collection issues|2|||
94318223|NCT03255291|322947373|FG005|Overall Study|Baseline data collection issues|0|||
94318224|NCT01655823|322947374|FG000|Overall Study|Lost to Follow-up|0|||
94318225|NCT01655823|322947375|FG001|Overall Study|Lost to Follow-up|1|||
94318226|NCT01655823|322947376|FG002|Overall Study|Lost to Follow-up|0|||
94318227|NCT01655823|322947377|FG003|Overall Study|Lost to Follow-up|0|||
94318228|NCT01655823|322947378|FG004|Overall Study|Lost to Follow-up|1|||
94318229|NCT01655823|322947374|FG000|Overall Study|Withdrawal by Subject|0|||
94318230|NCT01655823|322947375|FG001|Overall Study|Withdrawal by Subject|1|||
94318231|NCT01655823|322947376|FG002|Overall Study|Withdrawal by Subject|0|||
94318232|NCT01655823|322947377|FG003|Overall Study|Withdrawal by Subject|1|||
94318233|NCT01655823|322947378|FG004|Overall Study|Withdrawal by Subject|0|||
94318234|NCT00303108|322947379|FG000|Overall Study|Adverse Event|5|||
94318235|NCT00303108|322947380|FG001|Overall Study|Adverse Event|6|||
94318236|NCT00303108|322947381|FG002|Overall Study|Adverse Event|7|||
94318237|NCT00303108|322947379|FG000|Overall Study|Patient Request|4|||
94318238|NCT00303108|322947380|FG001|Overall Study|Patient Request|2|||
94318239|NCT00303108|322947381|FG002|Overall Study|Patient Request|8|||
94318240|NCT00303108|322947379|FG000|Overall Study|Failed Entry|1|||
94318241|NCT00303108|322947380|FG001|Overall Study|Failed Entry|0|||
94318242|NCT00303108|322947381|FG002|Overall Study|Failed Entry|1|||
94318243|NCT00303108|322947379|FG000|Overall Study|ineligible|2|||
94318244|NCT00303108|322947380|FG001|Overall Study|ineligible|1|||
94318245|NCT00303108|322947381|FG002|Overall Study|ineligible|0|||
94318246|NCT00894413|322947382|FG000|Overall Study|Physician Decision|0|||
94318247|NCT00894413|322947383|FG001|Overall Study|Physician Decision|2|||
94318248|NCT00894413|322947382|FG000|Overall Study|Adverse Event|0|||
94318249|NCT00894413|322947383|FG001|Overall Study|Adverse Event|2|||
94318250|NCT00894413|322947382|FG000|Overall Study|Withdrawal by Subject|0|||
94318251|NCT00894413|322947383|FG001|Overall Study|Withdrawal by Subject|4|||
94318252|NCT04737031|322947388|FG000|Overall Study|Patients who did not have a treatment visit|0|||
94318253|NCT04737031|322947389|FG001|Overall Study|Patients who did not have a treatment visit|31|||
94318254|NCT04737031|322947390|FG002|Overall Study|Patients who did not have a treatment visit|93|||
94318255|NCT04737031|322947391|FG003|Overall Study|Patients who did not have a treatment visit|227|||
94318256|NCT01468909|322947392|FG000|Overall Study|Never Treated|2|||
94318257|NCT01468909|322947393|FG001|Overall Study|Never Treated|2|||
94318258|NCT01079962|322947408|FG000|Overall Study|Adverse Event|2|||
94318259|NCT01079962|322947409|FG001|Overall Study|Adverse Event|2|||
94318260|NCT01079962|322947408|FG000|Overall Study|Withdrawal by Subject|5|||
94318261|NCT01079962|322947409|FG001|Overall Study|Withdrawal by Subject|7|||
94318262|NCT01079962|322947408|FG000|Overall Study|Protocol Violation|2|||
94318263|NCT01079962|322947409|FG001|Overall Study|Protocol Violation|2|||
94318264|NCT01079962|322947408|FG000|Overall Study|No blood pressure (BP) control|3|||
94318265|NCT01079962|322947409|FG001|Overall Study|No blood pressure (BP) control|0|||
94318266|NCT01079962|322947408|FG000|Overall Study|Inclusion/exclusion criteria|1|||
94318267|NCT01079962|322947409|FG001|Overall Study|Inclusion/exclusion criteria|3|||
94318268|NCT01079962|322947408|FG000|Overall Study|Participant not returning for next visit|1|||
94318269|NCT01079962|322947409|FG001|Overall Study|Participant not returning for next visit|0|||
94318270|NCT01079962|322947408|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
94318271|NCT01079962|322947409|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
94318272|NCT01331239|322947410|FG000|Part II: Core Study|Adverse Event|0|||
94318273|NCT01331239|322947411|FG001|Part II: Core Study|Adverse Event|3|||
94318274|NCT01331239|322947412|FG002|Part II: Core Study|Adverse Event|0|||
94318275|NCT01331239|322947410|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
94318276|NCT01331239|322947411|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
94318277|NCT01331239|322947412|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
94318278|NCT01331239|322947410|FG000|Part II: Core Study|Withdrawal by Subject|0|||
94318279|NCT01331239|322947411|FG001|Part II: Core Study|Withdrawal by Subject|2|||
94318280|NCT01331239|322947412|FG002|Part II: Core Study|Withdrawal by Subject|0|||
94318281|NCT01331239|322947410|FG000|Part II: Core Study|Administrative problems|0|||
94318282|NCT01331239|322947411|FG001|Part II: Core Study|Administrative problems|1|||
94318283|NCT01331239|322947412|FG002|Part II: Core Study|Administrative problems|0|||
94318284|NCT00946530|322947413|FG000|Overall Study|Withdrawal by Subject|0|||
94318285|NCT00946530|322947414|FG001|Overall Study|Withdrawal by Subject|3|||
94318286|NCT00946530|322947415|FG002|Overall Study|Withdrawal by Subject|0|||
94318287|NCT00946530|322947416|FG003|Overall Study|Withdrawal by Subject|3|||
94318288|NCT00946530|322947413|FG000|Overall Study|Physician Decision|1|||
94481606|NCT00917124|323555855|FG000|Overall Study|Protocol Violation|4|||
94318289|NCT00946530|322947414|FG001|Overall Study|Physician Decision|1|||
94481607|NCT00917124|323555856|FG001|Overall Study|Protocol Violation|6|||
94318290|NCT00946530|322947415|FG002|Overall Study|Physician Decision|1|||
94318291|NCT00946530|322947416|FG003|Overall Study|Physician Decision|1|||
94318292|NCT01008995|322947417|FG000|Controlled Period|Adverse Event|1|||
94318293|NCT01008995|322947418|FG001|Controlled Period|Adverse Event|2|||
94318294|NCT01008995|322947419|FG002|Controlled Period|Adverse Event|0|||
94318295|NCT01008995|322947420|FG003|Controlled Period|Adverse Event|0|||
94318296|NCT01008995|322947417|FG000|Controlled Period|Other|2|||
94318297|NCT01008995|322947418|FG001|Controlled Period|Other|1|||
94318298|NCT01008995|322947419|FG002|Controlled Period|Other|0|||
94318299|NCT01008995|322947420|FG003|Controlled Period|Other|0|||
94318300|NCT01008995|322947417|FG000|After Controlled Period|Adverse Event|0|||
94318301|NCT01008995|322947418|FG001|After Controlled Period|Adverse Event|0|||
94318302|NCT01008995|322947419|FG002|After Controlled Period|Adverse Event|1|||
94318303|NCT01008995|322947420|FG003|After Controlled Period|Adverse Event|1|||
94318304|NCT01008995|322947417|FG000|After Controlled Period|Other|0|||
94318305|NCT01008995|322947418|FG001|After Controlled Period|Other|0|||
94318306|NCT01008995|322947419|FG002|After Controlled Period|Other|1|||
94318307|NCT01008995|322947420|FG003|After Controlled Period|Other|0|||
94318308|NCT00115804|322947421|FG000|Overall Study|Adverse Event|2|||
94318309|NCT00406640|322947426|FG000|Acute Phase|Adverse Event|18|||
94318310|NCT00406640|322947427|FG001|Acute Phase|Adverse Event|13|||
94318311|NCT00406640|322947426|FG000|Acute Phase|Failed to Return|5|||
94318312|NCT00406640|322947427|FG001|Acute Phase|Failed to Return|1|||
94318313|NCT00406640|322947426|FG000|Acute Phase|Physician Decision|0|||
94318314|NCT00406640|322947427|FG001|Acute Phase|Physician Decision|1|||
94318315|NCT00406640|322947426|FG000|Acute Phase|Lost to Follow-up|7|||
94318316|NCT00406640|322947427|FG001|Acute Phase|Lost to Follow-up|4|||
94318317|NCT00406640|322947426|FG000|Acute Phase|Protocol deviation|4|||
94318318|NCT00406640|322947427|FG001|Acute Phase|Protocol deviation|10|||
94318319|NCT00406640|322947426|FG000|Acute Phase|Protocol Violation|3|||
94318320|NCT00406640|322947427|FG001|Acute Phase|Protocol Violation|2|||
94318321|NCT00406640|322947426|FG000|Acute Phase|Withdrawal by Subject|11|||
94318322|NCT00406640|322947427|FG001|Acute Phase|Withdrawal by Subject|9|||
94318323|NCT00406640|322947426|FG000|Acute Phase|Lack of Efficacy|3|||
94318324|NCT00406640|322947427|FG001|Acute Phase|Lack of Efficacy|3|||
94318325|NCT00406640|322947426|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
94318326|NCT00406640|322947427|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
94318327|NCT00406640|322947426|FG000|DB Continuation Phase for Responders|Death|1|||
94318328|NCT00406640|322947427|FG001|DB Continuation Phase for Responders|Death|0|||
94318329|NCT00406640|322947426|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
94318330|NCT00406640|322947427|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
94318331|NCT00406640|322947426|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
94318332|NCT00406640|322947427|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
94318333|NCT00406640|322947426|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
94318334|NCT00406640|322947427|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
94318335|NCT00406640|322947426|FG000|DB Continuation Phase for Responders|non-compliance|7|||
94318336|NCT00406640|322947427|FG001|DB Continuation Phase for Responders|non-compliance|5|||
94318337|NCT00406640|322947426|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
94318338|NCT00406640|322947427|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
94318339|NCT00406640|322947426|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
94318340|NCT00406640|322947427|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
94318341|NCT00406640|322947426|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
94318342|NCT00406640|322947427|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
94318343|NCT00406640|322947426|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
94318344|NCT00406640|322947427|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
94318345|NCT00406640|322947426|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
94318346|NCT00406640|322947427|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
94318347|NCT00406640|322947426|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
94318348|NCT00406640|322947427|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
94318349|NCT00406640|322947426|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
94318350|NCT00406640|322947427|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
94318351|NCT00406640|322947426|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
94318352|NCT00406640|322947427|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
94318353|NCT00406640|322947426|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
94318354|NCT00406640|322947427|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
94318355|NCT00406640|322947426|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
94318356|NCT00406640|322947427|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
94318357|NCT01454401|322947428|FG000|Overall Study|Death|1|||
94318358|NCT01454401|322947428|FG000|Overall Study|hospitalised|1|||
94318359|NCT01454401|322947428|FG000|Overall Study|osteomyelitis|2|||
94318360|NCT01454401|322947428|FG000|Overall Study|non-adherence|1|||
94318361|NCT05301322|322947434|FG000|Overall Study|Adverse Event|7|||
94318362|NCT05301322|322947435|FG001|Overall Study|Adverse Event|3|||
94318363|NCT05301322|322947434|FG000|Overall Study|Death|0|||
94318364|NCT05301322|322947435|FG001|Overall Study|Death|1|||
94318365|NCT05301322|322947434|FG000|Overall Study|Lost to Follow-up|2|||
94318366|NCT05301322|322947435|FG001|Overall Study|Lost to Follow-up|1|||
94318367|NCT05301322|322947434|FG000|Overall Study|Protocol Violation|3|||
94318368|NCT05301322|322947435|FG001|Overall Study|Protocol Violation|1|||
94318369|NCT05301322|322947434|FG000|Overall Study|Withdrawal by Subject|3|||
94318370|NCT05301322|322947435|FG001|Overall Study|Withdrawal by Subject|0|||
94318371|NCT05301322|322947434|FG000|Overall Study|Other|4|||
94318372|NCT05301322|322947435|FG001|Overall Study|Other|0|||
94318373|NCT03829332|322947438|FG000|Overall Study|Death|225|||
94318374|NCT03829332|322947439|FG001|Overall Study|Death|230|||
94318375|NCT03829332|322947438|FG000|Overall Study|Lost to Follow-up|1|||
94318376|NCT03829332|322947439|FG001|Overall Study|Lost to Follow-up|3|||
94318377|NCT03829332|322947438|FG000|Overall Study|Physician Decision|1|||
94318378|NCT03829332|322947439|FG001|Overall Study|Physician Decision|0|||
94318379|NCT03829332|322947438|FG000|Overall Study|Sponsor Decision|71|||
94318380|NCT03829332|322947439|FG001|Overall Study|Sponsor Decision|72|||
94318381|NCT03829332|322947438|FG000|Overall Study|Withdrawal by Subject|11|||
94318382|NCT03829332|322947439|FG001|Overall Study|Withdrawal by Subject|9|||
94318383|NCT00430521|322947440|FG000|Overall Study|Adverse Event|0|||
94318384|NCT00430521|322947441|FG001|Overall Study|Adverse Event|0|||
94318385|NCT00430521|322947442|FG002|Overall Study|Adverse Event|0|||
94318386|NCT00430521|322947443|FG003|Overall Study|Adverse Event|0|||
94318387|NCT00430521|322947444|FG004|Overall Study|Adverse Event|0|||
94318388|NCT00430521|322947445|FG005|Overall Study|Adverse Event|2|||
94318389|NCT00430521|322947446|FG006|Overall Study|Adverse Event|1|||
94318390|NCT00430521|322947447|FG007|Overall Study|Adverse Event|0|||
94318391|NCT00430521|322947440|FG000|Overall Study|Lost to Follow-up|7|||
94318392|NCT00430521|322947441|FG001|Overall Study|Lost to Follow-up|8|||
94318393|NCT00430521|322947442|FG002|Overall Study|Lost to Follow-up|3|||
94318394|NCT00430521|322947443|FG003|Overall Study|Lost to Follow-up|5|||
94481608|NCT01716663|323555857|FG000|Overall Study|Withdrawn prior to procedure|4|||
94481609|NCT01716663|323555857|FG000|Overall Study|Treated with non-study catheter|2|||
94481610|NCT03200548|323555863|FG000|Overall Study|Withdrawal by Subject|5|||
94481611|NCT03200548|323555864|FG001|Overall Study|Withdrawal by Subject|11|||
94481612|NCT03200548|323555865|FG002|Overall Study|Withdrawal by Subject|7|||
94481613|NCT03200548|323555866|FG003|Overall Study|Withdrawal by Subject|6|||
94481614|NCT00716456|323555869|FG000|Overall Study|Adverse Event|0|||
94481615|NCT00716456|323555870|FG001|Overall Study|Adverse Event|2|||
94481616|NCT00716456|323555871|FG002|Overall Study|Adverse Event|0|||
94481617|NCT00468585|323555878|FG000|Overall Study|Patient not treated|1|||
94481618|NCT00468585|323555879|FG001|Overall Study|Patient not treated|0|||
94481619|NCT00468585|323555880|FG002|Overall Study|Patient not treated|1|||
94481620|NCT00468585|323555881|FG003|Overall Study|Patient not treated|0|||
94481621|NCT00468585|323555878|FG000|Overall Study|Patient found to be ineligible|0|||
94481622|NCT00468585|323555879|FG001|Overall Study|Patient found to be ineligible|0|||
94481623|NCT00468585|323555880|FG002|Overall Study|Patient found to be ineligible|1|||
94481624|NCT00468585|323555881|FG003|Overall Study|Patient found to be ineligible|0|||
94481625|NCT00468585|323555878|FG000|Overall Study|Adverse Event|0|||
94318395|NCT00430521|322947444|FG004|Overall Study|Lost to Follow-up|5|||
94318396|NCT00430521|322947445|FG005|Overall Study|Lost to Follow-up|2|||
94318397|NCT00430521|322947446|FG006|Overall Study|Lost to Follow-up|8|||
94318398|NCT00430521|322947447|FG007|Overall Study|Lost to Follow-up|10|||
94318399|NCT00430521|322947440|FG000|Overall Study|Pregnancy|0|||
94318400|NCT00430521|322947441|FG001|Overall Study|Pregnancy|0|||
94318401|NCT00430521|322947442|FG002|Overall Study|Pregnancy|0|||
94481626|NCT00468585|323555879|FG001|Overall Study|Adverse Event|0|||
94481627|NCT00468585|323555880|FG002|Overall Study|Adverse Event|1|||
94481628|NCT00468585|323555881|FG003|Overall Study|Adverse Event|0|||
94481629|NCT00468585|323555878|FG000|Overall Study|Withdrawal by Subject|0|||
94481630|NCT00468585|323555879|FG001|Overall Study|Withdrawal by Subject|0|||
94481631|NCT00468585|323555880|FG002|Overall Study|Withdrawal by Subject|2|||
94481632|NCT00468585|323555881|FG003|Overall Study|Withdrawal by Subject|1|||
94481633|NCT02427841|323555884|FG000|Overall Study|Lack of Efficacy|5|||
94481634|NCT02427841|323555884|FG000|Overall Study|Physician Decision|2|||
94481635|NCT02427841|323555884|FG000|Overall Study|Withdrawal by Subject|1|||
94481636|NCT00511810|323555885|FG000|Overall Study|Lost to Follow-up|1|||
94481637|NCT00511810|323555886|FG001|Overall Study|Lost to Follow-up|2|||
94481638|NCT00511810|323555885|FG000|Overall Study|Lack of Efficacy|0|||
94481639|NCT00511810|323555886|FG001|Overall Study|Lack of Efficacy|2|||
94481640|NCT00511810|323555885|FG000|Overall Study|Refused second scn|0|||
94481641|NCT00511810|323555886|FG001|Overall Study|Refused second scn|1|||
94481642|NCT00313846|323555887|FG000|Overall Study|Withdrawal by Subject|2|||
94481643|NCT00313846|323555888|FG001|Overall Study|Withdrawal by Subject|0|||
94481644|NCT00313846|323555887|FG000|Overall Study|Adverse Event|1|||
94481645|NCT00313846|323555888|FG001|Overall Study|Adverse Event|8|||
94481646|NCT00313846|323555887|FG000|Overall Study|Administrative|2|||
94481647|NCT00313846|323555888|FG001|Overall Study|Administrative|3|||
94481648|NCT02154139|323555889|FG000|Overall Study|Injection not administered|2|||
94481649|NCT02154139|323555889|FG000|Overall Study|Other|2|||
94481650|NCT02154139|323555889|FG000|Overall Study|Investigator transferred|3|||
94481651|NCT03257436|323555890|FG000|Overall Study|Withdrawal by Subject|76|||
94481652|NCT03257436|323555890|FG000|Overall Study|Death|19|||
94481653|NCT00970489|323555891|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
94481654|NCT00970489|323555892|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
94481655|NCT01932697|323555893|FG000|Overall Study|Received a different amount of tx|1|||
94481656|NCT01932697|323555894|FG001|Overall Study|Received a different amount of tx|0|||
94481657|NCT01932697|323555893|FG000|Overall Study|Ineligible|1|||
94481658|NCT01932697|323555894|FG001|Overall Study|Ineligible|0|||
94481659|NCT01723072|323555895|FG000|Overall Study|Withdrawal by Subject|7|||
94318402|NCT00430521|322947443|FG003|Overall Study|Pregnancy|0|||
94318403|NCT00430521|322947444|FG004|Overall Study|Pregnancy|0|||
94318404|NCT00430521|322947445|FG005|Overall Study|Pregnancy|0|||
94318405|NCT00430521|322947446|FG006|Overall Study|Pregnancy|1|||
94318406|NCT00430521|322947447|FG007|Overall Study|Pregnancy|0|||
94481660|NCT01723072|323555896|FG001|Overall Study|Withdrawal by Subject|13|||
94481661|NCT01723072|323555895|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
94481662|NCT01723072|323555896|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
94481663|NCT01723072|323555895|FG000|Overall Study|Other|4|||
94481664|NCT01723072|323555896|FG001|Overall Study|Other|3|||
94318407|NCT00430521|322947440|FG000|Overall Study|Vaccine Expired|0|||
94318408|NCT00430521|322947441|FG001|Overall Study|Vaccine Expired|0|||
94481665|NCT00809445|323555902|FG000|1 Month Follow-up|Lost contact|1|||
94481666|NCT00809445|323555903|FG001|1 Month Follow-up|Lost contact|2|||
94481667|NCT00809445|323555904|FG002|1 Month Follow-up|Lost contact|1|||
94481668|NCT00809445|323555902|FG000|1 Month Follow-up|Withdrew consent|1|||
94318409|NCT00430521|322947442|FG002|Overall Study|Vaccine Expired|0|||
94318410|NCT00430521|322947443|FG003|Overall Study|Vaccine Expired|0|||
94318411|NCT00430521|322947444|FG004|Overall Study|Vaccine Expired|0|||
94481669|NCT00809445|323555903|FG001|1 Month Follow-up|Withdrew consent|1|||
94318412|NCT00430521|322947445|FG005|Overall Study|Vaccine Expired|1|||
94318413|NCT00430521|322947446|FG006|Overall Study|Vaccine Expired|0|||
94318414|NCT00430521|322947447|FG007|Overall Study|Vaccine Expired|0|||
94318415|NCT00430521|322947440|FG000|Overall Study|Protocol Violation|1|||
94318416|NCT00430521|322947441|FG001|Overall Study|Protocol Violation|0|||
94318417|NCT00430521|322947442|FG002|Overall Study|Protocol Violation|0|||
94318418|NCT00430521|322947443|FG003|Overall Study|Protocol Violation|0|||
94318419|NCT00430521|322947444|FG004|Overall Study|Protocol Violation|0|||
94318420|NCT00430521|322947445|FG005|Overall Study|Protocol Violation|0|||
94318421|NCT00430521|322947446|FG006|Overall Study|Protocol Violation|0|||
94318422|NCT00430521|322947447|FG007|Overall Study|Protocol Violation|0|||
94318423|NCT00430521|322947440|FG000|Overall Study|Withdrawal by Subject|3|||
94318424|NCT00430521|322947441|FG001|Overall Study|Withdrawal by Subject|1|||
94318425|NCT00430521|322947442|FG002|Overall Study|Withdrawal by Subject|0|||
94318426|NCT00430521|322947443|FG003|Overall Study|Withdrawal by Subject|3|||
94318427|NCT00430521|322947444|FG004|Overall Study|Withdrawal by Subject|0|||
94318428|NCT00430521|322947445|FG005|Overall Study|Withdrawal by Subject|0|||
94318429|NCT00430521|322947446|FG006|Overall Study|Withdrawal by Subject|0|||
94318430|NCT00430521|322947447|FG007|Overall Study|Withdrawal by Subject|2|||
94318431|NCT03725202|322949447|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
94318432|NCT03725202|322949448|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
94318433|NCT03725202|322949449|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
94318434|NCT03725202|322949450|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
94318435|NCT03725202|322949451|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
94318436|NCT03725202|322949452|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
94318437|NCT03725202|322949453|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
94318438|NCT03725202|322949454|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
94318439|NCT03725202|322949447|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
94318440|NCT03725202|322949448|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
94318441|NCT03725202|322949449|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
94318442|NCT03725202|322949450|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
94318443|NCT03725202|322949451|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
94318444|NCT03725202|322949452|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
94318445|NCT03725202|322949453|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
94318446|NCT03725202|322949454|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
94318447|NCT03725202|322949447|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
94318448|NCT03725202|322949448|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
94318449|NCT03725202|322949449|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
94318450|NCT03725202|322949450|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
94318451|NCT03725202|322949451|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
94318452|NCT03725202|322949452|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
94318453|NCT03725202|322949453|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
94318454|NCT03725202|322949454|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
94318455|NCT03725202|322949447|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
94318456|NCT03725202|322949448|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
94318457|NCT03725202|322949449|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
94318458|NCT03725202|322949450|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
94318459|NCT03725202|322949451|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
94318460|NCT03725202|322949452|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
94318461|NCT03725202|322949453|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
94318462|NCT03725202|322949454|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
94318463|NCT03725202|322949447|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
94318464|NCT03725202|322949448|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
94318465|NCT03725202|322949449|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
94318466|NCT03725202|322949450|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
94318467|NCT03725202|322949451|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
94318468|NCT03725202|322949452|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
94318469|NCT03725202|322949453|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
94318470|NCT03725202|322949454|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
94318471|NCT03725202|322949447|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
94318472|NCT03725202|322949448|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
94318473|NCT03725202|322949449|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
94318474|NCT03725202|322949450|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
94318475|NCT03725202|322949451|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
94318476|NCT03725202|322949452|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
94318477|NCT03725202|322949453|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
94318478|NCT03725202|322949454|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
94318479|NCT03725202|322949447|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
94318480|NCT03725202|322949448|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
94318481|NCT03725202|322949449|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
94318482|NCT03725202|322949450|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
94318483|NCT03725202|322949451|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
94318484|NCT03725202|322949452|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
94318485|NCT03725202|322949453|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
94318486|NCT03725202|322949454|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
94318487|NCT03725202|322949447|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
94318488|NCT03725202|322949448|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
94318489|NCT03725202|322949449|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
94318490|NCT03725202|322949450|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
94318491|NCT03725202|322949451|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
94318492|NCT03725202|322949452|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
94318493|NCT03725202|322949453|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
94386245|NCT05516108|323200656|FG000|Overall Study|Time Commitment|3|||
94386246|NCT05516108|323200657|FG001|Overall Study|Time Commitment|1|||
94386247|NCT05516108|323200656|FG000|Overall Study|Reason Unknown|2|||
94386248|NCT05516108|323200657|FG001|Overall Study|Reason Unknown|4|||
94386277|NCT06354270|323200662|FG000|Overall Study|Withdrawal by Subject|1|||
94386278|NCT06354270|323200663|FG001|Overall Study|Withdrawal by Subject|0|||
94481670|NCT00809445|323555904|FG002|1 Month Follow-up|Withdrew consent|1|||
94481671|NCT00809445|323555902|FG000|1 Month Follow-up|Death|0|||
94481672|NCT00809445|323555903|FG001|1 Month Follow-up|Death|1|||
94481673|NCT00809445|323555904|FG002|1 Month Follow-up|Death|1|||
94481674|NCT00809445|323555902|FG000|1 Month Follow-up|Incarcerated|0|||
94481675|NCT00809445|323555903|FG001|1 Month Follow-up|Incarcerated|0|||
94481676|NCT00809445|323555904|FG002|1 Month Follow-up|Incarcerated|1|||
94481677|NCT00809445|323555902|FG000|6 Month Follow-up|Lost contact|16|||
94481678|NCT00809445|323555903|FG001|6 Month Follow-up|Lost contact|14|||
94481679|NCT00809445|323555904|FG002|6 Month Follow-up|Lost contact|14|||
94481680|NCT00809445|323555902|FG000|6 Month Follow-up|Death|2|||
94481681|NCT00809445|323555903|FG001|6 Month Follow-up|Death|1|||
94481682|NCT00809445|323555904|FG002|6 Month Follow-up|Death|1|||
94481683|NCT00809445|323555902|FG000|6 Month Follow-up|Incarcerated|6|||
94481684|NCT00809445|323555903|FG001|6 Month Follow-up|Incarcerated|8|||
94481685|NCT00809445|323555904|FG002|6 Month Follow-up|Incarcerated|8|||
94481686|NCT00809445|323555902|FG000|6 Month Follow-up|Withdrew consent|0|||
94481687|NCT00809445|323555903|FG001|6 Month Follow-up|Withdrew consent|0|||
94481688|NCT00809445|323555904|FG002|6 Month Follow-up|Withdrew consent|1|||
94481689|NCT01048541|323555905|FG000|Overall Study|Withdrawal by Subject|1|||
94481690|NCT01048541|323555906|FG001|Overall Study|Withdrawal by Subject|0|||
94481691|NCT05358821|323555910|FG000|Overall Study|Withdrawal by Subject|0|||
94481692|NCT05358821|323555911|FG001|Overall Study|Withdrawal by Subject|1|||
94481693|NCT05358821|323555912|FG002|Overall Study|Withdrawal by Subject|0|||
94481694|NCT05358821|323555910|FG000|Overall Study|Withdrawal of Consent|0|||
94481695|NCT05358821|323555911|FG001|Overall Study|Withdrawal of Consent|0|||
94481696|NCT05358821|323555912|FG002|Overall Study|Withdrawal of Consent|1|||
94481697|NCT02096211|323555913|FG000|Overall Study|Death|2|||
94481698|NCT02096211|323555913|FG000|Overall Study|Withdrawal by Subject|8|||
94481699|NCT02096211|323555913|FG000|Overall Study|Revision of implant|7|||
94481700|NCT02096211|323555913|FG000|Overall Study|Lost to Follow-up|43|||
94481701|NCT02364388|323555916|FG000|Overall Study|Protocol Violation|1|||
94481702|NCT02364388|323555916|FG000|Overall Study|Technical Failure|3|||
94481703|NCT02364388|323555916|FG000|Overall Study|No OA/US data|2|||
94386304|NCT03370276|323200672|FG000|Overall Study|Death|0|||
94386305|NCT03370276|323200673|FG001|Overall Study|Death|2|||
94386306|NCT03370276|323200674|FG002|Overall Study|Death|5|||
94386316|NCT04977336|323200681|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
94386317|NCT04977336|323200682|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
94386318|NCT04977336|323200683|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
94386319|NCT04977336|323200684|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
94386320|NCT04977336|323200685|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
94386321|NCT04977336|323200681|FG000|Overall Study|Lost to Follow-up|0|||
94386322|NCT04977336|323200682|FG001|Overall Study|Lost to Follow-up|0|||
94386323|NCT04977336|323200683|FG002|Overall Study|Lost to Follow-up|1|||
94386324|NCT04977336|323200684|FG003|Overall Study|Lost to Follow-up|0|||
94386325|NCT04977336|323200685|FG004|Overall Study|Lost to Follow-up|0|||
94386326|NCT01378975|323200694|FG000|Overall Study|Death|77|||
94386327|NCT01378975|323200695|FG001|Overall Study|Death|46|||
94386328|NCT01378975|323200694|FG000|Overall Study|Investigator Request|1|||
94481704|NCT02364388|323555916|FG000|Overall Study|No Biopsy|2|||
94481705|NCT03586050|323555917|FG000|Overall Study|Death|3|||
94481706|NCT03586050|323555917|FG000|Overall Study|Withdrawal by Subject|2|||
94481707|NCT04767373|323555918|FG000|Overall Study|Death|6|||
94386329|NCT01378975|323200695|FG001|Overall Study|Investigator Request|0|||
94386330|NCT01378975|323200694|FG000|Overall Study|Lost to Follow-up|4|||
94386331|NCT01378975|323200695|FG001|Overall Study|Lost to Follow-up|1|||
94386332|NCT01378975|323200694|FG000|Overall Study|Withdrew Consent|4|||
94386333|NCT01378975|323200695|FG001|Overall Study|Withdrew Consent|3|||
94386334|NCT05277389|323200698|FG000|Overall Study|Lost to Follow-up|1|||
94481708|NCT04767373|323555919|FG001|Overall Study|Death|3|||
94481709|NCT04767373|323555918|FG000|Overall Study|Lost to Follow-up|67|||
94481710|NCT04767373|323555919|FG001|Overall Study|Lost to Follow-up|35|||
94481711|NCT04767373|323555918|FG000|Overall Study|Physician Decision|15|||
94481712|NCT04767373|323555919|FG001|Overall Study|Physician Decision|4|||
94386335|NCT05277389|323200699|FG001|Overall Study|Lost to Follow-up|4|||
94318494|NCT03725202|322949454|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
94318495|NCT03725202|322949447|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
94318496|NCT03725202|322949448|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
94318497|NCT03725202|322949449|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
94318498|NCT03725202|322949450|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
94318499|NCT03725202|322949451|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
94318500|NCT03725202|322949452|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
94318501|NCT03725202|322949453|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
94318502|NCT03725202|322949454|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
94318503|NCT03725202|322949447|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
94318504|NCT03725202|322949448|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
94318505|NCT03725202|322949449|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
94318506|NCT03725202|322949450|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
94318507|NCT03725202|322949451|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
94318508|NCT03725202|322949452|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
94318509|NCT03725202|322949453|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
94318510|NCT03725202|322949454|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
94318511|NCT03725202|322949447|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
94318512|NCT03725202|322949448|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
94318513|NCT03725202|322949449|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
94318514|NCT03725202|322949450|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
94318515|NCT03725202|322949451|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
94318516|NCT03725202|322949452|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
94318517|NCT03725202|322949453|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
94318518|NCT03725202|322949454|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
94318519|NCT03725202|322949447|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
94318520|NCT03725202|322949448|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
94318521|NCT03725202|322949449|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
94318522|NCT03725202|322949450|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
94318523|NCT03725202|322949451|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
94318524|NCT03725202|322949452|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
94318525|NCT03725202|322949453|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
94318526|NCT03725202|322949454|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
94318527|NCT01328249|322949457|FG000|Overall Study|Adverse Event|3|||
94318528|NCT01328249|322949458|FG001|Overall Study|Adverse Event|0|||
94318529|NCT01328249|322949457|FG000|Overall Study|Disease progression|1|||
94318530|NCT01328249|322949458|FG001|Overall Study|Disease progression|0|||
94318531|NCT01328249|322949457|FG000|Overall Study|Withdrawal by Subject|1|||
94318532|NCT01328249|322949458|FG001|Overall Study|Withdrawal by Subject|1|||
94318533|NCT01328249|322949457|FG000|Overall Study|Moved before end of treatment visit|1|||
94318534|NCT01328249|322949458|FG001|Overall Study|Moved before end of treatment visit|0|||
94318535|NCT01328249|322949457|FG000|Overall Study|Subject choice|1|||
94318536|NCT01328249|322949458|FG001|Overall Study|Subject choice|1|||
94318537|NCT01328249|322949457|FG000|Overall Study|Protocol Violation|0|||
94318538|NCT01328249|322949458|FG001|Overall Study|Protocol Violation|1|||
94318539|NCT02330549|322949459|FG000|Overall Study|Adverse Event|1|||
94318540|NCT02330549|322949460|FG001|Overall Study|Adverse Event|0|||
94318541|NCT02330549|322949459|FG000|Overall Study|Subject withdrew consent|2|||
94318542|NCT02330549|322949460|FG001|Overall Study|Subject withdrew consent|1|||
94318543|NCT02330549|322949459|FG000|Overall Study|Failure to meet randomization criteria|1|||
94318544|NCT02330549|322949460|FG001|Overall Study|Failure to meet randomization criteria|0|||
94318545|NCT02364947|322949464|FG000|Overall Study|Withdrawal by Subject|10|||
94318546|NCT02364947|322949465|FG001|Overall Study|Withdrawal by Subject|8|||
94318547|NCT02364947|322949466|FG002|Overall Study|Withdrawal by Subject|9|||
94318548|NCT02364947|322949464|FG000|Overall Study|Adverse Event|45|||
94318549|NCT02364947|322949465|FG001|Overall Study|Adverse Event|33|||
94318550|NCT02364947|322949466|FG002|Overall Study|Adverse Event|11|||
94386336|NCT06096168|323200700|FG000|Overall Study|Death|30|||
94386337|NCT06096168|323200700|FG000|Overall Study|Revision|2|||
94386341|NCT04803357|323200704|FG000|Overall Study|Withdrawal by Subject|31|||
94318551|NCT02364947|322949464|FG000|Overall Study|Protocol Violation|1|||
94318552|NCT02364947|322949465|FG001|Overall Study|Protocol Violation|1|||
94318553|NCT02364947|322949466|FG002|Overall Study|Protocol Violation|1|||
94318554|NCT02364947|322949464|FG000|Overall Study|Physician Decision|3|||
94318555|NCT02364947|322949465|FG001|Overall Study|Physician Decision|2|||
94318556|NCT02364947|322949466|FG002|Overall Study|Physician Decision|5|||
94318557|NCT02364947|322949464|FG000|Overall Study|Death|0|||
94318558|NCT02364947|322949465|FG001|Overall Study|Death|1|||
94318559|NCT02364947|322949466|FG002|Overall Study|Death|0|||
94386342|NCT04803357|323200705|FG001|Overall Study|Withdrawal by Subject|5|||
94386357|NCT04647253|323200727|FG000|Overall Study|Death ≤ 365 Days|16|||
94386358|NCT04647253|323200728|FG001|Overall Study|Death ≤ 365 Days|7|||
94386359|NCT04647253|323200727|FG000|Overall Study|Physician Decision|0|||
94386360|NCT04647253|323200728|FG001|Overall Study|Physician Decision|1|||
94386361|NCT04647253|323200727|FG000|Overall Study|Withdrawal by Subject|7|||
94386362|NCT04647253|323200728|FG001|Overall Study|Withdrawal by Subject|2|||
94386363|NCT04647253|323200727|FG000|Overall Study|Missed 12-Month Visit|9|||
94386364|NCT04647253|323200728|FG001|Overall Study|Missed 12-Month Visit|7|||
94386365|NCT04647253|323200727|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
94386366|NCT04647253|323200728|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
94481713|NCT04767373|323555918|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94481714|NCT04767373|323555919|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
94481715|NCT04767373|323555918|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
94481716|NCT04767373|323555919|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
94318560|NCT02163993|322949467|FG000|Treatment Period|Adverse Event|0|||
94318561|NCT02163993|322949468|FG001|Treatment Period|Adverse Event|1|||
94318562|NCT02163993|322949469|FG002|Treatment Period|Adverse Event|0|||
94318563|NCT02163993|322949470|FG003|Treatment Period|Adverse Event|0|||
94318564|NCT02163993|322949471|FG004|Treatment Period|Adverse Event|1|||
94318565|NCT02163993|322949467|FG000|Treatment Period|Lost to Follow-up|2|||
94318566|NCT02163993|322949468|FG001|Treatment Period|Lost to Follow-up|3|||
94318567|NCT02163993|322949469|FG002|Treatment Period|Lost to Follow-up|1|||
94318568|NCT02163993|322949470|FG003|Treatment Period|Lost to Follow-up|3|||
94318569|NCT02163993|322949471|FG004|Treatment Period|Lost to Follow-up|1|||
94318570|NCT02163993|322949467|FG000|Treatment Period|Physician Decision|1|||
94318571|NCT02163993|322949468|FG001|Treatment Period|Physician Decision|0|||
94318572|NCT02163993|322949469|FG002|Treatment Period|Physician Decision|0|||
94318573|NCT02163993|322949470|FG003|Treatment Period|Physician Decision|0|||
94318574|NCT02163993|322949471|FG004|Treatment Period|Physician Decision|0|||
94318575|NCT02163993|322949467|FG000|Treatment Period|Protocol Violation|2|||
94318576|NCT02163993|322949468|FG001|Treatment Period|Protocol Violation|1|||
94318577|NCT02163993|322949469|FG002|Treatment Period|Protocol Violation|0|||
94318578|NCT02163993|322949470|FG003|Treatment Period|Protocol Violation|1|||
94318579|NCT02163993|322949471|FG004|Treatment Period|Protocol Violation|2|||
94318580|NCT02163993|322949467|FG000|Treatment Period|Withdrawal by Subject|6|||
94318581|NCT02163993|322949468|FG001|Treatment Period|Withdrawal by Subject|4|||
94318582|NCT02163993|322949469|FG002|Treatment Period|Withdrawal by Subject|1|||
94318583|NCT02163993|322949470|FG003|Treatment Period|Withdrawal by Subject|4|||
94318584|NCT02163993|322949471|FG004|Treatment Period|Withdrawal by Subject|1|||
94318585|NCT02163993|322949467|FG000|Treatment Period|Not treated|1|||
94318586|NCT02163993|322949468|FG001|Treatment Period|Not treated|0|||
94318587|NCT02163993|322949469|FG002|Treatment Period|Not treated|0|||
94318588|NCT02163993|322949470|FG003|Treatment Period|Not treated|1|||
94318589|NCT02163993|322949471|FG004|Treatment Period|Not treated|2|||
94318590|NCT02163993|322949467|FG000|Post-treatment Period|Adverse Event|0|||
94318591|NCT02163993|322949468|FG001|Post-treatment Period|Adverse Event|0|||
94318592|NCT02163993|322949469|FG002|Post-treatment Period|Adverse Event|1|||
94318593|NCT02163993|322949470|FG003|Post-treatment Period|Adverse Event|0|||
94318594|NCT02163993|322949471|FG004|Post-treatment Period|Adverse Event|0|||
94318595|NCT02163993|322949467|FG000|Post-treatment Period|Lost to Follow-up|2|||
94318596|NCT02163993|322949468|FG001|Post-treatment Period|Lost to Follow-up|2|||
94318597|NCT02163993|322949469|FG002|Post-treatment Period|Lost to Follow-up|3|||
94318598|NCT02163993|322949470|FG003|Post-treatment Period|Lost to Follow-up|1|||
94318599|NCT02163993|322949471|FG004|Post-treatment Period|Lost to Follow-up|0|||
94318600|NCT02163993|322949467|FG000|Post-treatment Period|Protocol Violation|0|||
94318601|NCT02163993|322949468|FG001|Post-treatment Period|Protocol Violation|0|||
94318602|NCT02163993|322949469|FG002|Post-treatment Period|Protocol Violation|0|||
94318603|NCT02163993|322949470|FG003|Post-treatment Period|Protocol Violation|0|||
94318604|NCT02163993|322949471|FG004|Post-treatment Period|Protocol Violation|1|||
94318605|NCT02163993|322949467|FG000|Post-treatment Period|Withdrawal by Subject|2|||
94318606|NCT02163993|322949468|FG001|Post-treatment Period|Withdrawal by Subject|4|||
94318607|NCT02163993|322949469|FG002|Post-treatment Period|Withdrawal by Subject|0|||
94318608|NCT02163993|322949470|FG003|Post-treatment Period|Withdrawal by Subject|1|||
94318609|NCT02163993|322949471|FG004|Post-treatment Period|Withdrawal by Subject|2|||
94318610|NCT03331666|322949472|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
94318611|NCT03331666|322949473|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
94318612|NCT02326467|322949474|FG000|Overall Study|Withdrawal by Subject|1|||
94318613|NCT04263142|322949475|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
94318614|NCT04263142|322949476|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
94318615|NCT04263142|322949477|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
94318616|NCT04263142|322949478|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
94318617|NCT04263142|322949479|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
94318618|NCT04263142|322949475|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
94318619|NCT04263142|322949476|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
94318620|NCT04263142|322949477|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
94318621|NCT04263142|322949478|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
94318622|NCT04263142|322949479|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
94318623|NCT01429792|322949480|FG000|Overall Study|Other Reasons|67|||
94318624|NCT01429792|322949480|FG000|Overall Study|Unknown Disposition|94|||
94318625|NCT01429792|322949480|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
94318626|NCT01429792|322949480|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
94318627|NCT01429792|322949480|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
94318628|NCT01429792|322949480|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
94318629|NCT01429792|322949480|FG000|Overall Study|Withdrawal by Subject|70|||
94318630|NCT01429792|322949480|FG000|Overall Study|Lost to Follow-up|88|||
94318631|NCT00115349|322949485|FG000|Overall Study|Study closed due to low enrollment.|11|||
94318632|NCT00115349|322949486|FG001|Overall Study|Study closed due to low enrollment.|9|||
94318633|NCT02116660|322949487|FG000|Overall Study|Deteriorating renal function|0|||
94318634|NCT02116660|322949488|FG001|Overall Study|Deteriorating renal function|1|||
94318635|NCT02116660|322949487|FG000|Overall Study|Adverse Event|1|||
94318636|NCT02116660|322949488|FG001|Overall Study|Adverse Event|1|||
94318637|NCT02116660|322949487|FG000|Overall Study|Withdrawal by Subject|0|||
94318638|NCT02116660|322949488|FG001|Overall Study|Withdrawal by Subject|2|||
94318639|NCT02116660|322949487|FG000|Overall Study|Organization reason|1|||
94481717|NCT04767373|323555918|FG000|Overall Study|Other|1|||
94481718|NCT04767373|323555919|FG001|Overall Study|Other|2|||
94481719|NCT02658669|323555921|FG000|Overall Study|Lost to Follow-up|7|||
94481720|NCT02658669|323555922|FG001|Overall Study|Lost to Follow-up|5|||
94481721|NCT05227118|323555923|FG000|Overall Study|Adverse Event|0|||
94481722|NCT05227118|323555924|FG001|Overall Study|Adverse Event|0|||
94481723|NCT05227118|323555925|FG002|Overall Study|Adverse Event|1|||
94481724|NCT05227118|323555926|FG003|Overall Study|Adverse Event|0|||
94481725|NCT05227118|323555923|FG000|Overall Study|Withdrawal by Subject|0|||
94481726|NCT05227118|323555924|FG001|Overall Study|Withdrawal by Subject|0|||
94481727|NCT05227118|323555925|FG002|Overall Study|Withdrawal by Subject|2|||
94481728|NCT05227118|323555926|FG003|Overall Study|Withdrawal by Subject|0|||
94481729|NCT01435759|323555927|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
94481730|NCT01435759|323555928|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
94481731|NCT01435759|323555929|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
94481732|NCT01435759|323555930|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
94481733|NCT01435759|323555931|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
94481734|NCT01435759|323555932|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
94481735|NCT01435759|323555927|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
94481736|NCT01435759|323555928|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
94481737|NCT01435759|323555929|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
94481738|NCT01435759|323555930|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
94481739|NCT01435759|323555931|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
94481740|NCT01435759|323555932|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
94481741|NCT01435759|323555927|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
94481742|NCT01435759|323555928|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
94481743|NCT01435759|323555929|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
94481744|NCT01435759|323555930|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
94481745|NCT01435759|323555931|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
94481746|NCT01435759|323555932|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
94481747|NCT01435759|323555927|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
94481748|NCT01435759|323555928|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
94481749|NCT01435759|323555929|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
94481750|NCT01435759|323555930|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
94481751|NCT01435759|323555931|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
94481752|NCT01435759|323555932|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
94481753|NCT01435759|323555927|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
94481754|NCT01435759|323555928|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
94481755|NCT01435759|323555929|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
94481756|NCT01435759|323555930|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
94481757|NCT01435759|323555931|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
94481758|NCT01435759|323555932|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
94481759|NCT01435759|323555927|FG000|Antidepressant Lead-in Phase|Other|119|||
94481760|NCT01435759|323555928|FG001|Antidepressant Lead-in Phase|Other|0|||
94481761|NCT01435759|323555929|FG002|Antidepressant Lead-in Phase|Other|0|||
94481762|NCT01435759|323555930|FG003|Antidepressant Lead-in Phase|Other|0|||
94481763|NCT01435759|323555931|FG004|Antidepressant Lead-in Phase|Other|0|||
94481764|NCT01435759|323555932|FG005|Antidepressant Lead-in Phase|Other|0|||
94481765|NCT01435759|323555927|FG000|Double-blind Phase|Adverse Event|7|||
94481766|NCT01435759|323555928|FG001|Double-blind Phase|Adverse Event|0|||
94481767|NCT01435759|323555929|FG002|Double-blind Phase|Adverse Event|1|||
94481768|NCT01435759|323555930|FG003|Double-blind Phase|Adverse Event|1|||
94318640|NCT02116660|322949488|FG001|Overall Study|Organization reason|0|||
94318641|NCT02750800|322949489|FG000|Overall Study|Adverse Event|18|||
94318642|NCT02750800|322949489|FG000|Overall Study|Lost to Follow-up|12|||
94318643|NCT02750800|322949489|FG000|Overall Study|Investigator decision|53|||
94318644|NCT02750800|322949489|FG000|Overall Study|Patient request|12|||
94318645|NCT02750800|322949489|FG000|Overall Study|Other, not specified|3|||
94318646|NCT03298412|322949491|FG000|Run-in Period|Other, Not Specified|1|||
94318647|NCT03298412|322949491|FG000|Run-in Period|Disease Progression|1|||
94318648|NCT03298412|322949491|FG000|Run-in Period|Ineligibility Determined|1|||
94318649|NCT03298412|322949491|FG000|Run-in Period|Decision by Sponsor|6|||
94481769|NCT01435759|323555931|FG004|Double-blind Phase|Adverse Event|1|||
94481770|NCT01435759|323555932|FG005|Double-blind Phase|Adverse Event|3|||
94481771|NCT01435759|323555927|FG000|Double-blind Phase|Protocol Violation|2|||
94318650|NCT01104584|322949496|FG000|Overall Study|Study drug never administered|21|||
94481772|NCT01435759|323555928|FG001|Double-blind Phase|Protocol Violation|0|||
94386411|NCT01210001|323202599|FG000|Overall Study|Not treated|1|||
94386412|NCT01210001|323202600|FG001|Overall Study|Not treated|0|||
94386413|NCT01210001|323202601|FG002|Overall Study|Not treated|0|||
94386414|NCT01210001|323202599|FG000|Overall Study|Adverse Event|4|||
94386415|NCT01210001|323202600|FG001|Overall Study|Adverse Event|2|||
94386416|NCT01210001|323202601|FG002|Overall Study|Adverse Event|5|||
94386417|NCT01210001|323202599|FG000|Overall Study|Non compliant with protocol|2|||
94386418|NCT01210001|323202600|FG001|Overall Study|Non compliant with protocol|2|||
94386419|NCT01210001|323202601|FG002|Overall Study|Non compliant with protocol|3|||
94386420|NCT01210001|323202599|FG000|Overall Study|Lost to Follow-up|4|||
94386421|NCT01210001|323202600|FG001|Overall Study|Lost to Follow-up|3|||
94386422|NCT01210001|323202601|FG002|Overall Study|Lost to Follow-up|2|||
94386423|NCT01210001|323202599|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
94386424|NCT01210001|323202600|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
94386425|NCT01210001|323202601|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
94386426|NCT01210001|323202599|FG000|Overall Study|Other reason not defined above|2|||
94386427|NCT01210001|323202600|FG001|Overall Study|Other reason not defined above|2|||
94386428|NCT01210001|323202601|FG002|Overall Study|Other reason not defined above|1|||
94386429|NCT00788125|323202602|FG000|Overall Study|Death|6|||
94386430|NCT01703832|323202606|FG000|Overall Study|Withdrawal by Subject|1|||
94386431|NCT01703832|323202607|FG001|Overall Study|Withdrawal by Subject|0|||
94386432|NCT01991470|323202608|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
94386433|NCT01991470|323202608|FG000|Enlite 1 Period|Adverse Event|1|||
94386434|NCT01991470|323202608|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
94386435|NCT01991470|323202608|FG000|Enlite 3 Period|Lost to Follow-up|1|||
94386436|NCT01991470|323202608|FG000|Enlite 3 Period|Physician Decision|2|||
94386437|NCT01991470|323202608|FG000|Enlite 3 Period|Physician Decision|8|||
94386438|NCT01991470|323202608|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
94386439|NCT00543309|323202609|FG000|Overall Study|Physician Decision|0|||
94386440|NCT00543309|323202610|FG001|Overall Study|Physician Decision|1|||
94386441|NCT00543309|323202611|FG002|Overall Study|Physician Decision|0|||
94386442|NCT00727571|323202617|FG000|Overall Study|Ineligibility determined|1|||
94386443|NCT00727571|323202618|FG001|Overall Study|Ineligibility determined|1|||
94386444|NCT00727571|323202619|FG002|Overall Study|Ineligibility determined|1|||
94386445|NCT00727571|323202620|FG003|Overall Study|Ineligibility determined|0|||
94386446|NCT00727571|323202617|FG000|Overall Study|Death|0|||
94386447|NCT00727571|323202618|FG001|Overall Study|Death|19|||
94386448|NCT00727571|323202619|FG002|Overall Study|Death|5|||
94386449|NCT00727571|323202620|FG003|Overall Study|Death|1|||
94386450|NCT00727571|323202617|FG000|Overall Study|Physician Decision|0|||
94386451|NCT00727571|323202618|FG001|Overall Study|Physician Decision|5|||
94386452|NCT00727571|323202619|FG002|Overall Study|Physician Decision|0|||
94386453|NCT00727571|323202620|FG003|Overall Study|Physician Decision|0|||
94386454|NCT00727571|323202617|FG000|Overall Study|Withdrawal by Subject|0|||
94386455|NCT00727571|323202618|FG001|Overall Study|Withdrawal by Subject|10|||
94386456|NCT00727571|323202619|FG002|Overall Study|Withdrawal by Subject|11|||
94386457|NCT00727571|323202620|FG003|Overall Study|Withdrawal by Subject|0|||
94386458|NCT00727571|323202617|FG000|Overall Study|Subject Non Compliance|0|||
94386459|NCT00727571|323202618|FG001|Overall Study|Subject Non Compliance|6|||
94386460|NCT00727571|323202619|FG002|Overall Study|Subject Non Compliance|0|||
94386461|NCT00727571|323202620|FG003|Overall Study|Subject Non Compliance|4|||
94386462|NCT00727571|323202617|FG000|Overall Study|Dismissed from nursing home|0|||
94386463|NCT00727571|323202618|FG001|Overall Study|Dismissed from nursing home|9|||
94386464|NCT00727571|323202619|FG002|Overall Study|Dismissed from nursing home|5|||
94386465|NCT00727571|323202620|FG003|Overall Study|Dismissed from nursing home|0|||
94386466|NCT00727571|323202617|FG000|Overall Study|Hospitalization|0|||
94386467|NCT00727571|323202618|FG001|Overall Study|Hospitalization|1|||
94386468|NCT00727571|323202619|FG002|Overall Study|Hospitalization|0|||
94386469|NCT00727571|323202620|FG003|Overall Study|Hospitalization|1|||
94386470|NCT00727571|323202617|FG000|Overall Study|AE not leading to hospitalization|0|||
94386471|NCT00727571|323202618|FG001|Overall Study|AE not leading to hospitalization|0|||
94386472|NCT00727571|323202619|FG002|Overall Study|AE not leading to hospitalization|2|||
94386473|NCT00727571|323202620|FG003|Overall Study|AE not leading to hospitalization|0|||
94386474|NCT00727571|323202617|FG000|Overall Study|Other|0|||
94386475|NCT00727571|323202618|FG001|Overall Study|Other|4|||
94386476|NCT00727571|323202619|FG002|Overall Study|Other|6|||
94386477|NCT00727571|323202620|FG003|Overall Study|Other|0|||
94386478|NCT03164772|323202621|FG000|Overall Study|Death|4|||
94386479|NCT03164772|323202622|FG001|Overall Study|Death|2|||
94386480|NCT03164772|323202621|FG000|Overall Study|Adverse Event|1|||
94386481|NCT03164772|323202622|FG001|Overall Study|Adverse Event|4|||
94386482|NCT03164772|323202621|FG000|Overall Study|Progressive Disease|11|||
94386483|NCT03164772|323202622|FG001|Overall Study|Progressive Disease|21|||
94386484|NCT03164772|323202621|FG000|Overall Study|Physician Decision|2|||
94386485|NCT03164772|323202622|FG001|Overall Study|Physician Decision|0|||
94386486|NCT03164772|323202621|FG000|Overall Study|Withdrawal by Subject|0|||
94386487|NCT03164772|323202622|FG001|Overall Study|Withdrawal by Subject|4|||
94386488|NCT00762086|323202623|FG000|Overall Study|Adverse Event|2|||
94318651|NCT01104584|322949496|FG000|Overall Study|Study prematurely discontinued|2|||
94318652|NCT04402008|322949499|FG000|Overall Study|Adverse Event|0|||
94318653|NCT04402008|322949500|FG001|Overall Study|Adverse Event|0|||
94318654|NCT04402008|322949501|FG002|Overall Study|Adverse Event|0|||
94318655|NCT04402008|322949502|FG003|Overall Study|Adverse Event|1|||
94318656|NCT04402008|322949503|FG004|Overall Study|Adverse Event|0|||
94318657|NCT04402008|322949504|FG005|Overall Study|Adverse Event|0|||
94318658|NCT04402008|322949505|FG006|Overall Study|Adverse Event|0|||
94318659|NCT04402008|322949499|FG000|Overall Study|Disease Progression|3|||
94318660|NCT04402008|322949500|FG001|Overall Study|Disease Progression|2|||
94318661|NCT04402008|322949501|FG002|Overall Study|Disease Progression|3|||
94318662|NCT04402008|322949502|FG003|Overall Study|Disease Progression|3|||
94318663|NCT04402008|322949503|FG004|Overall Study|Disease Progression|4|||
94318664|NCT04402008|322949504|FG005|Overall Study|Disease Progression|3|||
94318665|NCT04402008|322949505|FG006|Overall Study|Disease Progression|10|||
94318666|NCT04402008|322949499|FG000|Overall Study|Withdrawal by Subject|0|||
94318667|NCT04402008|322949500|FG001|Overall Study|Withdrawal by Subject|1|||
94318668|NCT04402008|322949501|FG002|Overall Study|Withdrawal by Subject|0|||
94318669|NCT04402008|322949502|FG003|Overall Study|Withdrawal by Subject|0|||
94318670|NCT04402008|322949503|FG004|Overall Study|Withdrawal by Subject|1|||
94318671|NCT04402008|322949504|FG005|Overall Study|Withdrawal by Subject|0|||
94318672|NCT04402008|322949505|FG006|Overall Study|Withdrawal by Subject|0|||
94318673|NCT04402008|322949499|FG000|Overall Study|Sponsor Decision|0|||
94318674|NCT04402008|322949500|FG001|Overall Study|Sponsor Decision|0|||
94318675|NCT04402008|322949501|FG002|Overall Study|Sponsor Decision|0|||
94318676|NCT04402008|322949502|FG003|Overall Study|Sponsor Decision|0|||
94318677|NCT04402008|322949503|FG004|Overall Study|Sponsor Decision|0|||
94318678|NCT04402008|322949504|FG005|Overall Study|Sponsor Decision|0|||
94318679|NCT04402008|322949505|FG006|Overall Study|Sponsor Decision|3|||
94318680|NCT04402008|322949499|FG000|Overall Study|Death|0|||
94318681|NCT04402008|322949500|FG001|Overall Study|Death|0|||
94318682|NCT04402008|322949501|FG002|Overall Study|Death|0|||
94318683|NCT04402008|322949502|FG003|Overall Study|Death|0|||
94318684|NCT04402008|322949503|FG004|Overall Study|Death|1|||
94318685|NCT04402008|322949504|FG005|Overall Study|Death|0|||
94318686|NCT04402008|322949505|FG006|Overall Study|Death|2|||
94386489|NCT00762086|323202624|FG001|Overall Study|Adverse Event|0|||
94386490|NCT00762086|323202623|FG000|Overall Study|Lost to Follow-up|0|||
94386491|NCT00762086|323202624|FG001|Overall Study|Lost to Follow-up|2|||
94386492|NCT00762086|323202623|FG000|Overall Study|Non compliance|1|||
94386493|NCT00762086|323202624|FG001|Overall Study|Non compliance|0|||
94386494|NCT00762086|323202623|FG000|Overall Study|Withdrawal by Subject|2|||
94386495|NCT00762086|323202624|FG001|Overall Study|Withdrawal by Subject|2|||
94386496|NCT00762086|323202623|FG000|Overall Study|Ineligible to participate in the study|1|||
94386497|NCT00762086|323202624|FG001|Overall Study|Ineligible to participate in the study|0|||
94386498|NCT02192099|323202627|FG000|Overall Study|Adverse Event|1|||
94386499|NCT02192099|323202627|FG000|Overall Study|Lost to Follow-up|2|||
94386500|NCT02192099|323202627|FG000|Overall Study|Physician Decision|1|||
94386501|NCT02192099|323202627|FG000|Overall Study|Pregnancy|1|||
94386502|NCT02192099|323202627|FG000|Overall Study|Protocol Violation|8|||
94386503|NCT02192099|323202627|FG000|Overall Study|Study Terminated by Sponsor|32|||
94386504|NCT02192099|323202627|FG000|Overall Study|Withdrawal by Subject|11|||
94386505|NCT02192099|323202627|FG000|Overall Study|Miscellaneous Reasons|5|||
94386506|NCT04099888|323202630|FG000|Overall Study|Study terminated by sponsor|9|||
94386507|NCT04099888|323202631|FG001|Overall Study|Study terminated by sponsor|11|||
94386508|NCT04099888|323202630|FG000|Overall Study|Lost to Follow-up|1|||
94386509|NCT04099888|323202631|FG001|Overall Study|Lost to Follow-up|1|||
94386510|NCT04099888|323202630|FG000|Overall Study|Withdrawal by Subject|5|||
94386511|NCT04099888|323202631|FG001|Overall Study|Withdrawal by Subject|6|||
94386512|NCT04099888|323202630|FG000|Overall Study|Death|5|||
94386513|NCT04099888|323202631|FG001|Overall Study|Death|2|||
94386514|NCT04099888|323202630|FG000|Overall Study|Other|1|||
94386515|NCT04099888|323202631|FG001|Overall Study|Other|0|||
94386516|NCT04538170|323202634|FG000|Overall Study|Withdrawal by Subject|104|||
94386517|NCT04538170|323202635|FG001|Overall Study|Withdrawal by Subject|210|||
94386518|NCT01045096|323202636|FG000|Overall Study|Withdrawal by Subject|2|||
94386519|NCT01045096|323202637|FG001|Overall Study|Withdrawal by Subject|0|||
94386520|NCT01045096|323202638|FG002|Overall Study|Withdrawal by Subject|0|||
94386521|NCT01045096|323202636|FG000|Overall Study|Other|1|||
94386522|NCT01045096|323202637|FG001|Overall Study|Other|0|||
94386523|NCT01045096|323202638|FG002|Overall Study|Other|0|||
94386524|NCT01626079|323202639|FG000|Overall Study|Death|167|||
94386525|NCT01626079|323202640|FG001|Overall Study|Death|192|||
94318687|NCT04402008|322949499|FG000|Overall Study|Other|0|||
94318688|NCT04402008|322949500|FG001|Overall Study|Other|0|||
94318689|NCT04402008|322949501|FG002|Overall Study|Other|0|||
94318690|NCT04402008|322949502|FG003|Overall Study|Other|0|||
94318691|NCT04402008|322949503|FG004|Overall Study|Other|0|||
94318692|NCT04402008|322949504|FG005|Overall Study|Other|0|||
94386526|NCT01626079|323202641|FG002|Overall Study|Death|39|||
94386527|NCT01626079|323202639|FG000|Overall Study|Withdrawal by Subject|23|||
94481773|NCT01435759|323555929|FG002|Double-blind Phase|Protocol Violation|1|||
94481774|NCT01435759|323555930|FG003|Double-blind Phase|Protocol Violation|2|||
94481775|NCT01435759|323555931|FG004|Double-blind Phase|Protocol Violation|0|||
94481776|NCT01435759|323555932|FG005|Double-blind Phase|Protocol Violation|1|||
94481777|NCT01435759|323555927|FG000|Double-blind Phase|Withdrawal by Subject|17|||
94481778|NCT01435759|323555928|FG001|Double-blind Phase|Withdrawal by Subject|4|||
94481779|NCT01435759|323555929|FG002|Double-blind Phase|Withdrawal by Subject|3|||
94481780|NCT01435759|323555930|FG003|Double-blind Phase|Withdrawal by Subject|4|||
94481781|NCT01435759|323555931|FG004|Double-blind Phase|Withdrawal by Subject|2|||
94481782|NCT01435759|323555932|FG005|Double-blind Phase|Withdrawal by Subject|2|||
94481783|NCT01435759|323555927|FG000|Double-blind Phase|Lost to Follow-up|31|||
94481784|NCT01435759|323555928|FG001|Double-blind Phase|Lost to Follow-up|1|||
94481785|NCT01435759|323555929|FG002|Double-blind Phase|Lost to Follow-up|2|||
94481786|NCT01435759|323555930|FG003|Double-blind Phase|Lost to Follow-up|0|||
94481787|NCT01435759|323555931|FG004|Double-blind Phase|Lost to Follow-up|3|||
94481788|NCT01435759|323555932|FG005|Double-blind Phase|Lost to Follow-up|3|||
94481789|NCT01435759|323555927|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
94481790|NCT01435759|323555928|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
94481791|NCT01435759|323555929|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
94481792|NCT01435759|323555930|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
94481793|NCT01435759|323555931|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
94481794|NCT01435759|323555932|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
94481795|NCT01435759|323555927|FG000|Double-blind Phase|Other|8|||
94481796|NCT01435759|323555928|FG001|Double-blind Phase|Other|2|||
94481797|NCT01435759|323555929|FG002|Double-blind Phase|Other|0|||
94481798|NCT01435759|323555930|FG003|Double-blind Phase|Other|2|||
94481799|NCT01435759|323555931|FG004|Double-blind Phase|Other|0|||
94481800|NCT01435759|323555932|FG005|Double-blind Phase|Other|0|||
94481801|NCT03727841|323555933|FG000|Overall Study|Physician Decision|3|||
94481802|NCT03727841|323555934|FG001|Overall Study|Physician Decision|1|||
94481803|NCT01951417|323555960|FG000|Overall Study|Withdrawal by Subject|1|||
94481804|NCT01951417|323555960|FG000|Overall Study|Protocol Violation|2|||
94481805|NCT01951417|323555960|FG000|Overall Study|Lost to Follow-up|6|||
94481806|NCT01676701|323555961|FG000|Overall Study|Protocol Violation|1|||
94481807|NCT01676701|323555962|FG001|Overall Study|Protocol Violation|0|||
94481808|NCT01676701|323555961|FG000|Overall Study|Sponsor Decision|3|||
94481809|NCT01676701|323555962|FG001|Overall Study|Sponsor Decision|4|||
94481810|NCT05490771|323555964|FG000|Overall Study|Disease progression|18|||
94481811|NCT05490771|323555964|FG000|Overall Study|Adverse Event|3|||
94481812|NCT05490771|323555964|FG000|Overall Study|Other complicating disease|1|||
94481813|NCT05490771|323555964|FG000|Overall Study|Withdrawal by Subject|3|||
94481814|NCT05490771|323555964|FG000|Overall Study|Physician Decision|1|||
94481815|NCT05490771|323555964|FG000|Overall Study|Still on treatment|2|||
94481816|NCT05490771|323555964|FG000|Overall Study|Never start protocol therapy|5|||
94481817|NCT05490771|323555964|FG000|Overall Study|Ineligible|2|||
94481818|NCT00549549|323555967|FG000|Overall Study|Adverse Event|5|||
94481819|NCT00549549|323555968|FG001|Overall Study|Adverse Event|3|||
94481820|NCT00549549|323555969|FG002|Overall Study|Adverse Event|1|||
94481821|NCT00549549|323555970|FG003|Overall Study|Adverse Event|9|||
94481822|NCT00549549|323555967|FG000|Overall Study|Lack of Efficacy|9|||
94481823|NCT00549549|323555968|FG001|Overall Study|Lack of Efficacy|6|||
94481824|NCT00549549|323555969|FG002|Overall Study|Lack of Efficacy|4|||
94481825|NCT00549549|323555970|FG003|Overall Study|Lack of Efficacy|2|||
94481826|NCT00549549|323555967|FG000|Overall Study|Lost to Follow-up|1|||
94481827|NCT00549549|323555968|FG001|Overall Study|Lost to Follow-up|0|||
94481828|NCT00549549|323555969|FG002|Overall Study|Lost to Follow-up|1|||
94481829|NCT00549549|323555970|FG003|Overall Study|Lost to Follow-up|2|||
94481830|NCT00549549|323555967|FG000|Overall Study|Withdrawal by Subject|0|||
94481831|NCT00549549|323555968|FG001|Overall Study|Withdrawal by Subject|4|||
94481832|NCT00549549|323555969|FG002|Overall Study|Withdrawal by Subject|1|||
94481833|NCT00549549|323555970|FG003|Overall Study|Withdrawal by Subject|0|||
94481834|NCT00549549|323555967|FG000|Overall Study|Other|9|||
94481835|NCT00549549|323555968|FG001|Overall Study|Other|9|||
94318693|NCT04402008|322949505|FG006|Overall Study|Other|5|||
94318694|NCT01576016|322949511|FG000|Lead Safety|Death|132|||
94318695|NCT01576016|322949512|FG001|Lead Safety|Death|0|||
94481836|NCT00549549|323555969|FG002|Overall Study|Other|9|||
94481837|NCT00549549|323555970|FG003|Overall Study|Other|11|||
94481838|NCT00549549|323555967|FG000|Overall Study|Randomized but not treated|0|||
94481839|NCT00549549|323555968|FG001|Overall Study|Randomized but not treated|0|||
94481840|NCT00549549|323555969|FG002|Overall Study|Randomized but not treated|1|||
94481841|NCT00549549|323555970|FG003|Overall Study|Randomized but not treated|1|||
94481842|NCT04058028|323555974|FG000|Overall Study|Withdrawal of Consent from Study|12|||
94481843|NCT04058028|323555975|FG001|Overall Study|Withdrawal of Consent from Study|8|||
94481844|NCT04058028|323555976|FG002|Overall Study|Withdrawal of Consent from Study|6|||
94481845|NCT04058028|323555977|FG003|Overall Study|Withdrawal of Consent from Study|7|||
94481846|NCT04058028|323555974|FG000|Overall Study|Decision by Sponsor|13|||
94481847|NCT04058028|323555975|FG001|Overall Study|Decision by Sponsor|4|||
94481848|NCT04058028|323555976|FG002|Overall Study|Decision by Sponsor|1|||
94481849|NCT04058028|323555977|FG003|Overall Study|Decision by Sponsor|35|||
94481850|NCT04058028|323555974|FG000|Overall Study|Lost to Follow-up|1|||
94481851|NCT04058028|323555975|FG001|Overall Study|Lost to Follow-up|1|||
94481852|NCT04058028|323555976|FG002|Overall Study|Lost to Follow-up|1|||
94481853|NCT04058028|323555977|FG003|Overall Study|Lost to Follow-up|0|||
94481854|NCT04058028|323555974|FG000|Overall Study|Death|0|||
94481855|NCT04058028|323555975|FG001|Overall Study|Death|1|||
94481856|NCT04058028|323555976|FG002|Overall Study|Death|0|||
94481857|NCT04058028|323555977|FG003|Overall Study|Death|0|||
94481858|NCT01598610|323555980|FG000|Overall Study|Adverse Event|1|||
94481859|NCT04346199|323555981|FG000|Overall Study|Death|8|||
94481860|NCT04346199|323555982|FG001|Overall Study|Death|9|||
94481861|NCT04346199|323555981|FG000|Overall Study|Lost to Follow-up|0|||
94481862|NCT04346199|323555982|FG001|Overall Study|Lost to Follow-up|1|||
94481863|NCT04346199|323555981|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
94481864|NCT04346199|323555982|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
94481865|NCT04346199|323555981|FG000|Overall Study|Withdrawal by Subject|5|||
94481866|NCT04346199|323555982|FG001|Overall Study|Withdrawal by Subject|1|||
94481867|NCT03771963|323555983|FG000|Overall Study|Lost to Follow-up|22|||
94481868|NCT03771963|323555983|FG000|Overall Study|Withdrawal of Consent|10|||
94481869|NCT01026948|323555984|FG000|Overall Study|Physician Decision|8|||
94481870|NCT01705977|323555985|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
94481871|NCT01705977|323555986|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
94481872|NCT01705977|323555985|FG000|Treatment Period (Year 1)|Adverse Event|57|||
94481873|NCT01705977|323555986|FG001|Treatment Period (Year 1)|Adverse Event|49|||
94481874|NCT01705977|323555985|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
94481875|NCT01705977|323555986|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
94481876|NCT01705977|323555985|FG000|Treatment Period (Year 1)|Site closure|3|||
94481877|NCT01705977|323555986|FG001|Treatment Period (Year 1)|Site closure|2|||
94481878|NCT01705977|323555985|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
94481879|NCT01705977|323555986|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
94481880|NCT01705977|323555985|FG000|Treatment Period (Year 1)|Physician Decision|48|||
94481881|NCT01705977|323555986|FG001|Treatment Period (Year 1)|Physician Decision|38|||
94481882|NCT01705977|323555985|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
94481883|NCT01705977|323555986|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
94481884|NCT01705977|323555985|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
94481885|NCT01705977|323555986|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
94481886|NCT01705977|323555985|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
94481887|NCT01705977|323555986|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
94481888|NCT01705977|323555985|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
94481889|NCT01705977|323555986|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
94481890|NCT01705977|323555985|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
94481891|NCT01705977|323555986|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
94481892|NCT01705977|323555985|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
94481893|NCT01705977|323555986|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
94481894|NCT03066830|323555987|FG000|Overall Study|At the Participant's own Request|16|||
94481895|NCT03066830|323555988|FG001|Overall Study|At the Participant's own Request|17|||
94481896|NCT03066830|323555987|FG000|Overall Study|Other|3|||
94481897|NCT03066830|323555988|FG001|Overall Study|Other|0|||
94481898|NCT03066830|323555987|FG000|Overall Study|Poor Compliance to Protocol|1|||
94481899|NCT03066830|323555988|FG001|Overall Study|Poor Compliance to Protocol|0|||
94481900|NCT03066830|323555987|FG000|Overall Study|Adverse Event|2|||
94481901|NCT03066830|323555988|FG001|Overall Study|Adverse Event|2|||
94481902|NCT03066830|323555987|FG000|Overall Study|Lost to Follow-up|11|||
94481903|NCT03066830|323555988|FG001|Overall Study|Lost to Follow-up|3|||
94481904|NCT02688933|323555989|FG000|Overall Study|Adverse Event|3|||
94481905|NCT02688933|323555990|FG001|Overall Study|Adverse Event|1|||
94481906|NCT02688933|323555989|FG000|Overall Study|Lack of Efficacy|2|||
94481907|NCT02688933|323555990|FG001|Overall Study|Lack of Efficacy|2|||
94481908|NCT02688933|323555989|FG000|Overall Study|Poor compliance to protocol|7|||
94481909|NCT02688933|323555990|FG001|Overall Study|Poor compliance to protocol|4|||
94481910|NCT02688933|323555989|FG000|Overall Study|Hypoglycemia|2|||
94481911|NCT02688933|323555990|FG001|Overall Study|Hypoglycemia|0|||
94481912|NCT02688933|323555989|FG000|Overall Study|Other than Specified|14|||
94481913|NCT02688933|323555990|FG001|Overall Study|Other than Specified|25|||
94481914|NCT02688933|323555989|FG000|Overall Study|Lost to Follow-up|1|||
94481915|NCT02688933|323555990|FG001|Overall Study|Lost to Follow-up|5|||
94481916|NCT02039778|323555992|FG000|Overall Study|Death|2|||
94481917|NCT02039778|323555992|FG000|Overall Study|Withdrawal by Subject|1|||
94481918|NCT02039778|323555992|FG000|Overall Study|Never started the protocol treatment|1|||
94481919|NCT01676012|323556003|FG000|Overall Study|Adverse Event|2|||
94481920|NCT01676012|323556003|FG000|Overall Study|incomplete set of videos|1|||
94481921|NCT02849080|323556004|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
94481922|NCT02849080|323556005|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
94318696|NCT01576016|322949511|FG000|Lead Safety|Withdrawal by Subject|81|||
94318697|NCT01576016|322949512|FG001|Lead Safety|Withdrawal by Subject|0|||
94318698|NCT01576016|322949511|FG000|Lead Safety|System Explanted without Replacement|24|||
94318699|NCT01576016|322949512|FG001|Lead Safety|System Explanted without Replacement|0|||
94318700|NCT01576016|322949511|FG000|Lead Safety|Physician Decision|14|||
94318701|NCT01576016|322949512|FG001|Lead Safety|Physician Decision|0|||
94318702|NCT01576016|322949511|FG000|Lead Safety|Lost to Follow-up|13|||
94318703|NCT01576016|322949512|FG001|Lead Safety|Lost to Follow-up|0|||
94318704|NCT01576016|322949511|FG000|Lead Safety|Unsuccessful implant|2|||
94318705|NCT01576016|322949512|FG001|Lead Safety|Unsuccessful implant|0|||
94318706|NCT01576016|322949511|FG000|Lead Safety|Sponsor request|1|||
94318707|NCT01576016|322949512|FG001|Lead Safety|Sponsor request|0|||
94318708|NCT01576016|322949511|FG000|Lead Safety|Device replaced with CRT-D|1|||
94318709|NCT01576016|322949512|FG001|Lead Safety|Device replaced with CRT-D|0|||
94318710|NCT01576016|322949511|FG000|Lead Safety|Patient on Palliative Care|1|||
94318711|NCT01576016|322949512|FG001|Lead Safety|Patient on Palliative Care|0|||
94318712|NCT01576016|322949511|FG000|Lead Safety|Patient noncompliance|1|||
94318713|NCT01576016|322949512|FG001|Lead Safety|Patient noncompliance|0|||
94318714|NCT01576016|322949511|FG000|Lead Safety|Too far from study site|1|||
94318715|NCT01576016|322949512|FG001|Lead Safety|Too far from study site|0|||
94318716|NCT01576016|322949511|FG000|Lead Safety|System deactivated|1|||
94318717|NCT01576016|322949512|FG001|Lead Safety|System deactivated|0|||
94386528|NCT01626079|323202640|FG001|Overall Study|Withdrawal by Subject|37|||
94386529|NCT01626079|323202641|FG002|Overall Study|Withdrawal by Subject|5|||
94386530|NCT01626079|323202639|FG000|Overall Study|Lost to Follow-up|7|||
94386531|NCT01626079|323202640|FG001|Overall Study|Lost to Follow-up|4|||
94386532|NCT01626079|323202641|FG002|Overall Study|Lost to Follow-up|2|||
94386533|NCT01626079|323202639|FG000|Overall Study|Missed Visits|1|||
94386534|NCT01626079|323202640|FG001|Overall Study|Missed Visits|4|||
94386535|NCT01626079|323202641|FG002|Overall Study|Missed Visits|6|||
94386536|NCT05150964|323202642|FG000|Overall Study|Lost to Follow-up|2|||
94386537|NCT01856309|323202645|FG000|Overall Study|Death|4|||
94386538|NCT01856309|323202646|FG001|Overall Study|Death|6|||
94386539|NCT01856309|323202647|FG002|Overall Study|Death|11|||
94386540|NCT01856309|323202648|FG003|Overall Study|Death|6|||
94386541|NCT01856309|323202645|FG000|Overall Study|Lost to Follow-up|6|||
94386542|NCT01856309|323202646|FG001|Overall Study|Lost to Follow-up|2|||
94386543|NCT01856309|323202647|FG002|Overall Study|Lost to Follow-up|4|||
94386544|NCT01856309|323202648|FG003|Overall Study|Lost to Follow-up|8|||
94386545|NCT01856309|323202645|FG000|Overall Study|Withdrawal by Subject|11|||
94386546|NCT01856309|323202646|FG001|Overall Study|Withdrawal by Subject|13|||
94386547|NCT01856309|323202647|FG002|Overall Study|Withdrawal by Subject|28|||
94386548|NCT01856309|323202648|FG003|Overall Study|Withdrawal by Subject|26|||
94386549|NCT01856309|323202645|FG000|Overall Study|Other|227|||
94386550|NCT01856309|323202646|FG001|Overall Study|Other|225|||
94386551|NCT01856309|323202647|FG002|Overall Study|Other|447|||
94386552|NCT01856309|323202648|FG003|Overall Study|Other|469|||
94386553|NCT01856309|323202645|FG000|Overall Study|Lack of Efficacy|14|||
94386554|NCT01856309|323202646|FG001|Overall Study|Lack of Efficacy|9|||
94386555|NCT01856309|323202647|FG002|Overall Study|Lack of Efficacy|40|||
94386556|NCT01856309|323202648|FG003|Overall Study|Lack of Efficacy|25|||
94386557|NCT01856309|323202645|FG000|Overall Study|Adverse Event|31|||
94386558|NCT01856309|323202646|FG001|Overall Study|Adverse Event|31|||
94386559|NCT01856309|323202647|FG002|Overall Study|Adverse Event|55|||
94386560|NCT01856309|323202648|FG003|Overall Study|Adverse Event|65|||
94386561|NCT01856309|323202645|FG000|Overall Study|Pregnancy|0|||
94386562|NCT01856309|323202646|FG001|Overall Study|Pregnancy|0|||
94386563|NCT01856309|323202647|FG002|Overall Study|Pregnancy|0|||
94386564|NCT01856309|323202648|FG003|Overall Study|Pregnancy|1|||
94386565|NCT01856309|323202645|FG000|Overall Study|Physician Decision|6|||
94386566|NCT01856309|323202646|FG001|Overall Study|Physician Decision|1|||
94386567|NCT01856309|323202647|FG002|Overall Study|Physician Decision|6|||
94386568|NCT01856309|323202648|FG003|Overall Study|Physician Decision|8|||
94386569|NCT01856309|323202645|FG000|Overall Study|Noncompliance With Study Drug|0|||
94386570|NCT01856309|323202646|FG001|Overall Study|Noncompliance With Study Drug|1|||
94386571|NCT01856309|323202647|FG002|Overall Study|Noncompliance With Study Drug|4|||
94386572|NCT01856309|323202648|FG003|Overall Study|Noncompliance With Study Drug|1|||
94318718|NCT01576016|322949511|FG000|Lead Safety|Patient no longer followed by study PI|1|||
94318719|NCT01576016|322949512|FG001|Lead Safety|Patient no longer followed by study PI|0|||
94386573|NCT00944697|323202649|FG000|Overall Study|Withdrawal by Subject|1|||
94386574|NCT00944697|323202650|FG001|Overall Study|Withdrawal by Subject|1|||
94386575|NCT00944697|323202649|FG000|Overall Study|Adverse Event|0|||
94318720|NCT01576016|322949511|FG000|MRI Safety|Withdrawal by Subject|0|||
94318721|NCT01576016|322949512|FG001|MRI Safety|Withdrawal by Subject|10|||
94318722|NCT01576016|322949511|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
94386576|NCT00944697|323202650|FG001|Overall Study|Adverse Event|3|||
94386577|NCT00944697|323202649|FG000|Overall Study|Administrative|1|||
94386578|NCT00944697|323202650|FG001|Overall Study|Administrative|1|||
94386579|NCT00337077|323202651|FG000|Overall Study|Progressive disease|25|||
94318723|NCT01576016|322949512|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
94318724|NCT01576016|322949511|FG000|MRI Safety|Has not yet completed MRI scan|0|||
94318725|NCT01576016|322949512|FG001|MRI Safety|Has not yet completed MRI scan|56|||
94318726|NCT01576016|322949511|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
94318727|NCT01576016|322949512|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
94318728|NCT02411201|322949515|FG000|Overall Study|Adverse Event|2|||
94318729|NCT02411201|322949515|FG000|Overall Study|Withdrawal by Subject|2|||
94318730|NCT02411201|322949515|FG000|Overall Study|Age group completed|2|||
94318731|NCT00798694|322949516|FG000|Overall Study|Lost to Follow-up|1|||
94318732|NCT00798694|322949517|FG001|Overall Study|Lost to Follow-up|1|||
94318733|NCT00798694|322949516|FG000|Overall Study|Physician Decision|1|||
94318734|NCT00798694|322949517|FG001|Overall Study|Physician Decision|0|||
94318735|NCT00436566|322949522|FG000|Overall Study|Withdrawal by Subject|2|||
94318736|NCT00436566|322949522|FG000|Overall Study|Protocol Violation|1|||
94318737|NCT01980706|322949523|FG000|Overall Study|Withdrawal by Subject|9|||
94318738|NCT01980706|322949524|FG001|Overall Study|Withdrawal by Subject|6|||
94318739|NCT01980706|322949525|FG002|Overall Study|Withdrawal by Subject|2|||
94318740|NCT01980706|322949523|FG000|Overall Study|Adverse Event|1|||
94318741|NCT01980706|322949524|FG001|Overall Study|Adverse Event|2|||
94318742|NCT01980706|322949525|FG002|Overall Study|Adverse Event|5|||
94318743|NCT01980706|322949523|FG000|Overall Study|Lost to Follow-up|3|||
94318744|NCT01980706|322949524|FG001|Overall Study|Lost to Follow-up|4|||
94318745|NCT01980706|322949525|FG002|Overall Study|Lost to Follow-up|3|||
94318746|NCT01980706|322949523|FG000|Overall Study|miscellaneous|4|||
94318747|NCT01980706|322949524|FG001|Overall Study|miscellaneous|5|||
94318748|NCT01980706|322949525|FG002|Overall Study|miscellaneous|3|||
94318749|NCT01163253|322949528|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
94318750|NCT01163253|322949529|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
94318751|NCT01163253|322949528|FG000|Overall Study|Study Terminated by Sponsor|978|||
94318752|NCT01163253|322949529|FG001|Overall Study|Study Terminated by Sponsor|349|||
94318753|NCT01163253|322949528|FG000|Overall Study|Protocol Violation|43|||
94318754|NCT01163253|322949529|FG001|Overall Study|Protocol Violation|12|||
94318755|NCT01163253|322949528|FG000|Overall Study|Withdrawal by Subject|199|||
94318756|NCT01163253|322949529|FG001|Overall Study|Withdrawal by Subject|50|||
94318757|NCT01163253|322949528|FG000|Overall Study|Medication Error|1|||
94318758|NCT01163253|322949529|FG001|Overall Study|Medication Error|0|||
94318759|NCT01163253|322949528|FG000|Overall Study|Lost to Follow-up|125|||
94318760|NCT01163253|322949529|FG001|Overall Study|Lost to Follow-up|23|||
94318761|NCT01163253|322949528|FG000|Overall Study|Insufficient Clinical Response|423|||
94318762|NCT01163253|322949529|FG001|Overall Study|Insufficient Clinical Response|29|||
94318763|NCT01163253|322949528|FG000|Overall Study|Adverse Event|300|||
94318764|NCT01163253|322949529|FG001|Overall Study|Adverse Event|78|||
94318765|NCT01163253|322949528|FG000|Overall Study|Death|17|||
94318766|NCT01163253|322949529|FG001|Overall Study|Death|5|||
94318767|NCT01163253|322949528|FG000|Overall Study|Ongoing|13|||
94318768|NCT01163253|322949529|FG001|Overall Study|Ongoing|4|||
94318769|NCT01163253|322949528|FG000|Overall Study|Other Unspecified|170|||
94318770|NCT01163253|322949529|FG001|Overall Study|Other Unspecified|34|||
94318771|NCT01153763|322949534|FG000|Overall Study|Study Closed|16|||
94318772|NCT01153763|322949534|FG000|Overall Study|Lost to Follow-up|1|||
94318773|NCT01153763|322949534|FG000|Overall Study|Physician Decision|2|||
94318774|NCT01153763|322949534|FG000|Overall Study|Withdrawal by Subject|2|||
94318775|NCT01019486|322949535|FG000|Overall Study|Withdrawal by Subject|1|||
94318776|NCT01019486|322949536|FG001|Overall Study|Withdrawal by Subject|1|||
94318777|NCT01019486|322949537|FG002|Overall Study|Withdrawal by Subject|1|||
94318778|NCT01766336|322949543|FG000|Overall Study|Adverse Event|11|||
94318779|NCT01766336|322949544|FG001|Overall Study|Adverse Event|8|||
94318780|NCT01766336|322949543|FG000|Overall Study|Death|4|||
94318781|NCT01766336|322949544|FG001|Overall Study|Death|3|||
94318782|NCT01766336|322949543|FG000|Overall Study|Lost to Follow-up|1|||
94318783|NCT01766336|322949544|FG001|Overall Study|Lost to Follow-up|3|||
94386580|NCT00337077|323202652|FG001|Overall Study|Progressive disease|37|||
94386581|NCT00337077|323202653|FG002|Overall Study|Progressive disease|19|||
94386582|NCT00337077|323202651|FG000|Overall Study|Adverse Event|7|||
94318784|NCT01766336|322949543|FG000|Overall Study|Physician Decision|4|||
94318785|NCT01766336|322949544|FG001|Overall Study|Physician Decision|2|||
94318786|NCT01766336|322949543|FG000|Overall Study|Protocol Violation|0|||
94318787|NCT01766336|322949544|FG001|Overall Study|Protocol Violation|1|||
94318788|NCT01766336|322949543|FG000|Overall Study|Sponsor Decision|52|||
94318789|NCT01766336|322949544|FG001|Overall Study|Sponsor Decision|43|||
94318790|NCT01766336|322949543|FG000|Overall Study|Withdrawal by Subject|18|||
94318791|NCT01766336|322949544|FG001|Overall Study|Withdrawal by Subject|15|||
94318792|NCT03029650|322949545|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
94318793|NCT03029650|322949546|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
94318794|NCT03029650|322949545|FG000|Washout (1 Week)|Physician Decision|0|||
94318795|NCT03029650|322949546|FG001|Washout (1 Week)|Physician Decision|1|||
94318796|NCT04360187|322949547|FG000|Double-Blind Treatment|Adverse Event|9|||
94386583|NCT00337077|323202652|FG001|Overall Study|Adverse Event|7|||
94386584|NCT00337077|323202653|FG002|Overall Study|Adverse Event|1|||
94481923|NCT02849080|323556006|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
94481924|NCT02849080|323556007|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
94481925|NCT02849080|323556004|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
94481926|NCT02849080|323556005|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
94481927|NCT02849080|323556006|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
94481928|NCT02849080|323556007|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
94481929|NCT02849080|323556004|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
94481930|NCT02849080|323556005|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
94481931|NCT02849080|323556006|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
94481932|NCT02849080|323556007|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
94481933|NCT02849080|323556004|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
94481934|NCT02849080|323556005|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
94481935|NCT02849080|323556006|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
94481936|NCT02849080|323556007|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
94318797|NCT04360187|322949548|FG001|Double-Blind Treatment|Adverse Event|11|||
94318798|NCT04360187|322949547|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
94318799|NCT04360187|322949548|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
94318800|NCT04360187|322949547|FG000|Double-Blind Treatment|Physician Decision|1|||
94318801|NCT04360187|322949548|FG001|Double-Blind Treatment|Physician Decision|0|||
94318802|NCT04360187|322949547|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
94318803|NCT04360187|322949548|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
94318804|NCT04360187|322949547|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
94318805|NCT04360187|322949548|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
94318806|NCT04360187|322949547|FG000|Follow-Up|Lost to Follow-up|1|||
94318807|NCT04360187|322949548|FG001|Follow-Up|Lost to Follow-up|0|||
94318808|NCT03628508|322949554|FG000|Overall Study|Lost to Follow-up|1|||
94318809|NCT00988559|322949555|FG000|Overall Study|Withdrawal by Subject|1|||
94318810|NCT00988559|322949556|FG001|Overall Study|Withdrawal by Subject|1|||
94318811|NCT00988559|322949557|FG002|Overall Study|Withdrawal by Subject|0|||
94318812|NCT00988559|322949558|FG003|Overall Study|Withdrawal by Subject|1|||
94318813|NCT00988559|322949555|FG000|Overall Study|Pregnancy|0|||
94318814|NCT00988559|322949556|FG001|Overall Study|Pregnancy|1|||
94318815|NCT00988559|322949557|FG002|Overall Study|Pregnancy|1|||
94318816|NCT00988559|322949558|FG003|Overall Study|Pregnancy|0|||
94318817|NCT00988559|322949555|FG000|Overall Study|Lost to Follow-up|0|||
94318818|NCT00988559|322949556|FG001|Overall Study|Lost to Follow-up|0|||
94318819|NCT00988559|322949557|FG002|Overall Study|Lost to Follow-up|1|||
94318820|NCT00988559|322949558|FG003|Overall Study|Lost to Follow-up|0|||
94318821|NCT01814800|322949559|FG000|Overall Study|Adverse Event|2|||
94318822|NCT01814800|322949559|FG000|Overall Study|Pregnancy|1|||
94318823|NCT01814800|322949559|FG000|Overall Study|Sponsor decision|1|||
94318824|NCT01814800|322949559|FG000|Overall Study|Subject relocation|1|||
94318825|NCT00952289|322949560|FG000|All Participants|Death|9|||
94318826|NCT00952289|322949561|FG001|All Participants|Death|9|||
94318827|NCT00952289|322949560|FG000|All Participants|Adverse Event|8|||
94318828|NCT00952289|322949561|FG001|All Participants|Adverse Event|8|||
94318829|NCT00952289|322949560|FG000|All Participants|Disease progression|3|||
94318830|NCT00952289|322949561|FG001|All Participants|Disease progression|12|||
94318831|NCT00952289|322949560|FG000|All Participants|Withdrawal by Subject|1|||
94318832|NCT00952289|322949561|FG001|All Participants|Withdrawal by Subject|10|||
94318833|NCT00952289|322949560|FG000|All Participants|Data lost during site relocation|0|||
94318834|NCT00952289|322949561|FG001|All Participants|Data lost during site relocation|1|||
94318835|NCT00952289|322949560|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
94318836|NCT00952289|322949561|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
94318837|NCT00952289|322949560|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
94318838|NCT00952289|322949561|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
94318839|NCT00952289|322949560|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
94318840|NCT00952289|322949561|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
94318841|NCT00952289|322949560|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
94318842|NCT00952289|322949561|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
94318843|NCT00952289|322949560|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
94318844|NCT00952289|322949561|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
94318845|NCT01477892|322949562|FG000|Overall Study|Withdrawal by Subject|0|||
94318846|NCT01477892|322949563|FG001|Overall Study|Withdrawal by Subject|2|||
94481937|NCT02849080|323556004|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
94481938|NCT02849080|323556005|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
94481939|NCT02849080|323556006|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
94318847|NCT03599141|322949565|FG000|Overall Study|Lost to Follow-up|3|||
94318848|NCT03599141|322949566|FG001|Overall Study|Lost to Follow-up|1|||
94318849|NCT00488033|322949572|FG000|Overall Study|Withdrawal by Subject|1|||
94318850|NCT00488033|322949573|FG001|Overall Study|Withdrawal by Subject|0|||
94481940|NCT02849080|323556007|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
94481941|NCT02849080|323556004|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
94481942|NCT02849080|323556005|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
94481943|NCT02849080|323556006|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
94481944|NCT02849080|323556007|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
94481945|NCT03506438|323557984|FG000|Overall Study|Lost to Follow-up|8|||
94318851|NCT01745393|322949574|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
94318852|NCT01745393|322949575|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
94318853|NCT01745393|322949574|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
94318854|NCT01745393|322949575|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
94318855|NCT01745393|322949574|FG000|12-month Follow-up|Lost to Follow-up|6|||
94318856|NCT01745393|322949575|FG001|12-month Follow-up|Lost to Follow-up|5|||
94318857|NCT02435277|322949581|FG000|Overall Study|Adverse Event|1|||
94318858|NCT02435277|322949582|FG001|Overall Study|Adverse Event|1|||
94318859|NCT02435277|322949583|FG002|Overall Study|Adverse Event|0|||
94318860|NCT02435277|322949584|FG003|Overall Study|Adverse Event|0|||
94318861|NCT02435277|322949581|FG000|Overall Study|Withdrawal by Subject|1|||
94318862|NCT02435277|322949582|FG001|Overall Study|Withdrawal by Subject|0|||
94318863|NCT02435277|322949583|FG002|Overall Study|Withdrawal by Subject|0|||
94318864|NCT02435277|322949584|FG003|Overall Study|Withdrawal by Subject|0|||
94318865|NCT03126539|322949587|FG000|Overall Study|Lost to Follow-up|1|||
94318866|NCT03126539|322949588|FG001|Overall Study|Lost to Follow-up|1|||
94318867|NCT03126539|322949589|FG002|Overall Study|Lost to Follow-up|1|||
94318868|NCT03126539|322949590|FG003|Overall Study|Lost to Follow-up|0|||
94318869|NCT03126539|322949591|FG004|Overall Study|Lost to Follow-up|0|||
94318870|NCT00444626|322949592|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
94318871|NCT00444626|322949592|FG000|Initial Treatment Period|Adverse Event|1|||
94318872|NCT00444626|322949592|FG000|Initial Treatment Period|Lost to Follow-up|9|||
94318873|NCT00008138|322949593|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
94318874|NCT00008138|322949593|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
94318875|NCT00008138|322949593|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
94318876|NCT00008138|322949593|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
94318877|NCT00008138|322949593|FG000|Interval Debulking|Withdrawal by Subject|2|||
94318878|NCT00008138|322949593|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
94318879|NCT00008138|322949593|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
94318880|NCT00008138|322949593|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
94318881|NCT00516269|322949594|FG000|Overall Study|Adverse Event|2|||
94318882|NCT00516269|322949595|FG001|Overall Study|Adverse Event|1|||
94318883|NCT00516269|322949594|FG000|Overall Study|Lost to Follow-up|0|||
94318884|NCT00516269|322949595|FG001|Overall Study|Lost to Follow-up|1|||
94318885|NCT00516269|322949594|FG000|Overall Study|Protocol Violation|0|||
94318886|NCT00516269|322949595|FG001|Overall Study|Protocol Violation|1|||
94318887|NCT02635737|322949599|FG000|Overall Study|Protocol Violation|1|||
94318888|NCT02596711|322949600|FG000|Overall Study|Lost to Follow-up|1|||
94318889|NCT02596711|322949601|FG001|Overall Study|Lost to Follow-up|2|||
94318890|NCT02596711|322949602|FG002|Overall Study|Lost to Follow-up|3|||
94318891|NCT01552928|322949603|FG000|Period 3|Adverse Event|0|||
94318892|NCT01552928|322949604|FG001|Period 3|Adverse Event|0|||
94318893|NCT01552928|322949605|FG002|Period 3|Adverse Event|1|||
94318894|NCT01552928|322949606|FG003|Period 3|Adverse Event|0|||
94318895|NCT01511419|322949608|FG000|Dose 2|Physician Decision|1|||
94318896|NCT01511419|322949609|FG001|Dose 2|Physician Decision|0|||
94318897|NCT00352755|322951108|FG000|Overall Study|Physician Decision|1|||
94318898|NCT00352755|322951108|FG000|Overall Study|Adverse Event|1|||
94318899|NCT02397694|322951110|FG000|Double-Blinded Phase|Adverse Event|1|||
94318900|NCT02397694|322951111|FG001|Double-Blinded Phase|Adverse Event|0|||
94318901|NCT02397694|322951110|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
94318902|NCT02397694|322951111|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
94318903|NCT02397694|322951110|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
94318904|NCT02397694|322951111|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
94318905|NCT02397694|322951110|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
94318906|NCT02397694|322951111|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
94318907|NCT02397694|322951110|FG000|Open Label Extension Phase|Protocol Violation|1|||
94318908|NCT02397694|322951111|FG001|Open Label Extension Phase|Protocol Violation|0|||
94318909|NCT02397694|322951110|FG000|Open Label Extension Phase|Withdrew Consent|3|||
94318910|NCT02397694|322951111|FG001|Open Label Extension Phase|Withdrew Consent|1|||
94318911|NCT02397694|322951110|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
94318912|NCT02397694|322951111|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
94318913|NCT03497429|322951113|FG000|Overall Study|Progressive disease|3|||
94318914|NCT03497429|322951114|FG001|Overall Study|Progressive disease|4|||
94318915|NCT03497429|322951113|FG000|Overall Study|Adverse Event|0|||
94481946|NCT03506438|323557985|FG001|Overall Study|Lost to Follow-up|7|||
94481947|NCT03506438|323557986|FG002|Overall Study|Lost to Follow-up|8|||
94481948|NCT03506438|323557987|FG003|Overall Study|Lost to Follow-up|7|||
94318916|NCT03497429|322951114|FG001|Overall Study|Adverse Event|2|||
94318917|NCT00506948|322951115|FG000|Overall Study|Death|4|||
94318918|NCT00506948|322951115|FG000|Overall Study|Adverse Event|5|||
94318919|NCT00506948|322951115|FG000|Overall Study|Physician Decision|1|||
94481949|NCT03506438|323557988|FG004|Overall Study|Lost to Follow-up|0|||
94318920|NCT01303380|322951116|FG000|Overall Study|Lack of compliance to study procedures|1|||
94318921|NCT03621943|322951117|FG000|First Randomized Intervention|Lost to Follow-up|51|||
94318922|NCT03621943|322951118|FG001|First Randomized Intervention|Lost to Follow-up|54|||
94318923|NCT03621943|322951117|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
94318924|NCT03621943|322951118|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
94318925|NCT03621943|322951117|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
94318926|NCT03621943|322951118|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
94318927|NCT03621943|322951117|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
94318928|NCT03621943|322951118|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
94318929|NCT01215734|322951119|FG000|Overall Study|Death|0|||
94318930|NCT01215734|322951120|FG001|Overall Study|Death|1|||
94318931|NCT00315705|322951121|FG000|Phase 1|Refused further treatment|1|||
94318932|NCT00315705|322951121|FG000|Phase 1|Failure to achieve response|8|||
94318933|NCT00315705|322951121|FG000|Phase 1|Disease relapse|4|||
94318934|NCT00315705|322951121|FG000|Phase 1|Scheduled for transplant|9|||
94318935|NCT00315705|322951121|FG000|Phase 1|Death|3|||
94318936|NCT00315705|322951121|FG000|Phase 2|Physician Decision|4|||
94318937|NCT00315705|322951121|FG000|Phase 2|Adverse Event|1|||
94318938|NCT00315705|322951121|FG000|Phase 2|Failure to achieve response|3|||
94318939|NCT00315705|322951121|FG000|Phase 2|Disease relapse|1|||
94318940|NCT00315705|322951121|FG000|Phase 2|Scheduled for transplant|8|||
94318941|NCT00315705|322951121|FG000|Phase 2|Other|1|||
94318942|NCT00315705|322951121|FG000|Phase 2|Death|7|||
94481950|NCT03506438|323557989|FG005|Overall Study|Lost to Follow-up|0|||
94481951|NCT03234036|323557990|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
94481952|NCT03234036|323557991|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
94481953|NCT03234036|323557992|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
94318943|NCT00948818|322951122|FG000|Overall Study|Adverse Event|10|||
94318944|NCT00948818|322951123|FG001|Overall Study|Adverse Event|32|||
94318945|NCT00948818|322951122|FG000|Overall Study|Protocol Violation|9|||
94318946|NCT00948818|322951123|FG001|Overall Study|Protocol Violation|10|||
94318947|NCT00948818|322951122|FG000|Overall Study|Withdrawal by Subject|25|||
94318948|NCT00948818|322951123|FG001|Overall Study|Withdrawal by Subject|25|||
94318949|NCT00948818|322951122|FG000|Overall Study|Lost to Follow-up|10|||
94318950|NCT00948818|322951123|FG001|Overall Study|Lost to Follow-up|17|||
94318951|NCT00948818|322951122|FG000|Overall Study|Lack of Efficacy|4|||
94318952|NCT00948818|322951123|FG001|Overall Study|Lack of Efficacy|5|||
94318953|NCT00948818|322951122|FG000|Overall Study|Other Reason|4|||
94318954|NCT00948818|322951123|FG001|Overall Study|Other Reason|5|||
94318955|NCT01716533|322951124|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
94318956|NCT01716533|322951125|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
94318957|NCT01716533|322951126|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
94318958|NCT01716533|322951127|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
94318959|NCT01716533|322951124|FG000|Overall Study|Withdrawal by Subject|0|||
94318960|NCT01716533|322951125|FG001|Overall Study|Withdrawal by Subject|0|||
94318961|NCT01716533|322951126|FG002|Overall Study|Withdrawal by Subject|0|||
94318962|NCT01716533|322951127|FG003|Overall Study|Withdrawal by Subject|5|||
94318963|NCT01716533|322951124|FG000|Overall Study|Death|0|||
94318964|NCT01716533|322951125|FG001|Overall Study|Death|0|||
94318965|NCT01716533|322951126|FG002|Overall Study|Death|0|||
94318966|NCT01716533|322951127|FG003|Overall Study|Death|2|||
94318967|NCT01716533|322951124|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
94318968|NCT01716533|322951125|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
94318969|NCT01716533|322951126|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
94318970|NCT01716533|322951127|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
94318971|NCT00495495|322951129|FG000|Overall Study|Protocol Violation|99|||
94318972|NCT00745368|322951130|FG000|Overall Study|Unable to provide sample|3|||
94318973|NCT00434512|322951134|FG000|Overall Study|Migrated/moved from study area|0|||
94318974|NCT00434512|322951135|FG001|Overall Study|Migrated/moved from study area|0|||
94318975|NCT00434512|322951136|FG002|Overall Study|Migrated/moved from study area|0|||
94318976|NCT00434512|322951137|FG003|Overall Study|Migrated/moved from study area|1|||
94318977|NCT00434512|322951138|FG004|Overall Study|Migrated/moved from study area|1|||
94481954|NCT03234036|323557993|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
94481955|NCT00003537|323557996|FG000|Overall Study|Not evalauable|1|||
94481956|NCT00737100|323558009|FG000|Overall Study|Adverse Event|6|||
94481957|NCT00737100|323558010|FG001|Overall Study|Adverse Event|5|||
94481958|NCT00737100|323558011|FG002|Overall Study|Adverse Event|3|||
94481959|NCT00737100|323558009|FG000|Overall Study|Lost to Follow-up|0|||
94481960|NCT00737100|323558010|FG001|Overall Study|Lost to Follow-up|1|||
94318978|NCT00434512|322951139|FG005|Overall Study|Migrated/moved from study area|1|||
94318979|NCT00434512|322951134|FG000|Overall Study|Other|0|||
94318980|NCT00434512|322951135|FG001|Overall Study|Other|1|||
94318981|NCT00434512|322951136|FG002|Overall Study|Other|0|||
94318982|NCT00434512|322951137|FG003|Overall Study|Other|0|||
94318983|NCT00434512|322951138|FG004|Overall Study|Other|0|||
94318984|NCT00434512|322951139|FG005|Overall Study|Other|0|||
94318985|NCT02939937|322951140|FG000|Overall Study|Adverse Event|5|||
94318986|NCT02939937|322951141|FG001|Overall Study|Adverse Event|0|||
94318987|NCT02939937|322951140|FG000|Overall Study|Lost to Follow-up|1|||
94318988|NCT02939937|322951141|FG001|Overall Study|Lost to Follow-up|3|||
94318989|NCT00568958|322951145|FG000|Allocation|Withdrawal by Subject|7|||
94318990|NCT00568958|322951146|FG001|Allocation|Withdrawal by Subject|3|||
94318991|NCT00568958|322951145|FG000|Allocation|Physician Decision|2|||
94318992|NCT00568958|322951146|FG001|Allocation|Physician Decision|0|||
94318993|NCT00568958|322951145|FG000|Follow-Up|Withdrawal by Subject|6|||
94318994|NCT00568958|322951146|FG001|Follow-Up|Withdrawal by Subject|6|||
94318995|NCT00568958|322951145|FG000|Follow-Up|Physician Decision|1|||
94318996|NCT00568958|322951146|FG001|Follow-Up|Physician Decision|1|||
94318997|NCT00568958|322951145|FG000|Follow-Up|Family Emergency|1|||
94318998|NCT00568958|322951146|FG001|Follow-Up|Family Emergency|0|||
94318999|NCT00568958|322951145|FG000|Follow-Up|Adverse Event|1|||
94319000|NCT00568958|322951146|FG001|Follow-Up|Adverse Event|0|||
94319001|NCT00441441|322951147|FG000|Overall Study|Adverse Event|2|||
94319002|NCT00441441|322951148|FG001|Overall Study|Adverse Event|1|||
94319003|NCT00441441|322951147|FG000|Overall Study|Protocol Violation|4|||
94319004|NCT00441441|322951148|FG001|Overall Study|Protocol Violation|6|||
94319005|NCT00441441|322951147|FG000|Overall Study|Exacerbation of asthma|1|||
94319006|NCT00441441|322951148|FG001|Overall Study|Exacerbation of asthma|2|||
94319007|NCT00441441|322951147|FG000|Overall Study|Withdrawal by Subject|1|||
94319008|NCT00441441|322951148|FG001|Overall Study|Withdrawal by Subject|2|||
94319009|NCT00441441|322951147|FG000|Overall Study|Other|3|||
94319010|NCT00441441|322951148|FG001|Overall Study|Other|3|||
94319011|NCT00882999|322951159|FG000|Overall Study|Adverse Event|0|||
94319012|NCT00882999|322951160|FG001|Overall Study|Adverse Event|0|||
94319013|NCT00882999|322951161|FG002|Overall Study|Adverse Event|0|||
94319014|NCT00882999|322951162|FG003|Overall Study|Adverse Event|0|||
94319015|NCT00882999|322951163|FG004|Overall Study|Adverse Event|1|||
94319016|NCT00882999|322951164|FG005|Overall Study|Adverse Event|0|||
94319017|NCT00882999|322951165|FG006|Overall Study|Adverse Event|0|||
94319018|NCT00882999|322951159|FG000|Overall Study|Death|0|||
94319019|NCT00882999|322951160|FG001|Overall Study|Death|1|||
94319020|NCT00882999|322951161|FG002|Overall Study|Death|0|||
94319021|NCT00882999|322951162|FG003|Overall Study|Death|0|||
94319022|NCT00882999|322951163|FG004|Overall Study|Death|0|||
94319023|NCT00882999|322951164|FG005|Overall Study|Death|0|||
94319024|NCT00882999|322951165|FG006|Overall Study|Death|0|||
94319025|NCT00882999|322951159|FG000|Overall Study|Withdrawal by Subject|7|||
94319026|NCT00882999|322951160|FG001|Overall Study|Withdrawal by Subject|6|||
94319027|NCT00882999|322951161|FG002|Overall Study|Withdrawal by Subject|3|||
94319028|NCT00882999|322951162|FG003|Overall Study|Withdrawal by Subject|3|||
94481961|NCT00737100|323558011|FG002|Overall Study|Lost to Follow-up|0|||
94481962|NCT00737100|323558009|FG000|Overall Study|Withdrawal by Subject|0|||
94481963|NCT00737100|323558010|FG001|Overall Study|Withdrawal by Subject|0|||
94481964|NCT00737100|323558011|FG002|Overall Study|Withdrawal by Subject|3|||
94481965|NCT00737100|323558009|FG000|Overall Study|Reason discontinued not explained above|1|||
94481966|NCT00737100|323558010|FG001|Overall Study|Reason discontinued not explained above|1|||
94481967|NCT00737100|323558011|FG002|Overall Study|Reason discontinued not explained above|1|||
94481968|NCT02185417|323558012|FG000|Overall Study|Death|448|||
94481969|NCT02185417|323558013|FG001|Overall Study|Death|446|||
94481970|NCT02185417|323558014|FG002|Overall Study|Death|0|||
94481971|NCT02185417|323558012|FG000|Overall Study|Withdrawal by Subject|7|||
94481972|NCT02185417|323558013|FG001|Overall Study|Withdrawal by Subject|12|||
94481973|NCT02185417|323558014|FG002|Overall Study|Withdrawal by Subject|0|||
94481974|NCT05556148|323558015|FG000|Overall Study|Early Termination|29|||
94481975|NCT05556148|323558015|FG000|Overall Study|Baseline Tasks Expired|4|||
94481976|NCT05556148|323558015|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
94481977|NCT05556148|323558015|FG000|Overall Study|No Longer Wished to Participate|1|||
94481978|NCT05556148|323558015|FG000|Overall Study|Bacterial Conjunctivitis|1|||
94481979|NCT00458003|323558018|FG000|Overall Study|Non protocol spinal anesthesia|1|||
94481980|NCT00458003|323558019|FG001|Overall Study|Non protocol spinal anesthesia|1|||
94481981|NCT00165503|323558020|FG000|Overall Study|Death|1|||
94319029|NCT00882999|322951163|FG004|Overall Study|Withdrawal by Subject|6|||
94319030|NCT00882999|322951164|FG005|Overall Study|Withdrawal by Subject|5|||
94319031|NCT00882999|322951165|FG006|Overall Study|Withdrawal by Subject|5|||
94319032|NCT00882999|322951159|FG000|Overall Study|Lost to Follow-up|0|||
94319033|NCT00882999|322951160|FG001|Overall Study|Lost to Follow-up|1|||
94319034|NCT00882999|322951161|FG002|Overall Study|Lost to Follow-up|1|||
94319035|NCT00882999|322951162|FG003|Overall Study|Lost to Follow-up|2|||
94319036|NCT00882999|322951163|FG004|Overall Study|Lost to Follow-up|1|||
94481982|NCT00165503|323558020|FG000|Overall Study|Lost to Follow-up|12|||
94319037|NCT00882999|322951164|FG005|Overall Study|Lost to Follow-up|1|||
94319038|NCT00882999|322951165|FG006|Overall Study|Lost to Follow-up|2|||
94319039|NCT00882999|322951159|FG000|Overall Study|Physician Decision|1|||
94319040|NCT00882999|322951160|FG001|Overall Study|Physician Decision|0|||
94481983|NCT00165503|323558020|FG000|Overall Study|Unresectable|3|||
94319041|NCT00882999|322951161|FG002|Overall Study|Physician Decision|0|||
94319042|NCT00882999|322951162|FG003|Overall Study|Physician Decision|0|||
94319043|NCT00882999|322951163|FG004|Overall Study|Physician Decision|0|||
94319044|NCT00882999|322951164|FG005|Overall Study|Physician Decision|1|||
94319045|NCT00882999|322951165|FG006|Overall Study|Physician Decision|1|||
94319046|NCT00643487|322951166|FG000|Overall Study|Technical difficulty|3|||
94319047|NCT01217190|322951170|FG000|Second Dosing|Withdrawal by Subject|0|||
94319048|NCT01217190|322951171|FG001|Second Dosing|Withdrawal by Subject|2|||
94319049|NCT02130427|322951172|FG000|Overall Study|Imaging results not interpretable|30|||
94319050|NCT00543569|322951177|FG000|Overall Study|Death|2|||
94319051|NCT00543569|322951178|FG001|Overall Study|Death|2|||
94319052|NCT00543569|322951179|FG002|Overall Study|Death|3|||
94319053|NCT00543569|322951180|FG003|Overall Study|Death|1|||
94319054|NCT00543569|322951177|FG000|Overall Study|Lost to Follow-up|0|||
94319055|NCT00543569|322951178|FG001|Overall Study|Lost to Follow-up|0|||
94319056|NCT00543569|322951179|FG002|Overall Study|Lost to Follow-up|1|||
94319057|NCT00543569|322951180|FG003|Overall Study|Lost to Follow-up|1|||
94319058|NCT00543569|322951177|FG000|Overall Study|Miscellaneous Reasons|7|||
94319059|NCT00543569|322951178|FG001|Overall Study|Miscellaneous Reasons|3|||
94319060|NCT00543569|322951179|FG002|Overall Study|Miscellaneous Reasons|11|||
94319061|NCT00543569|322951180|FG003|Overall Study|Miscellaneous Reasons|4|||
94319062|NCT00543569|322951177|FG000|Overall Study|Randomized but never received study drug|3|||
94319063|NCT00543569|322951178|FG001|Overall Study|Randomized but never received study drug|3|||
94319064|NCT00543569|322951179|FG002|Overall Study|Randomized but never received study drug|5|||
94319065|NCT00543569|322951180|FG003|Overall Study|Randomized but never received study drug|3|||
94319066|NCT01100307|322951187|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
94319067|NCT01100307|322951188|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
94319068|NCT01100307|322951187|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
94319069|NCT01100307|322951188|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
94319070|NCT01100307|322951187|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
94319071|NCT01100307|322951188|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
94319072|NCT01100307|322951187|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
94319073|NCT01100307|322951188|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
94319074|NCT01100307|322951187|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
94319075|NCT01100307|322951188|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
94319076|NCT01100307|322951187|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
94319077|NCT01100307|322951188|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
94319078|NCT04544709|322951192|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
94319079|NCT05836818|322951195|FG000|Overall Study|Physician Decision|1|||
94319080|NCT05836818|322951196|FG001|Overall Study|Physician Decision|1|||
94319081|NCT05836818|322951197|FG002|Overall Study|Physician Decision|0|||
94319082|NCT05836818|322951195|FG000|Overall Study|Withdrawal by Subject|0|||
94319083|NCT05836818|322951196|FG001|Overall Study|Withdrawal by Subject|0|||
94319084|NCT05836818|322951197|FG002|Overall Study|Withdrawal by Subject|1|||
94319085|NCT05836818|322951195|FG000|Overall Study|Later found to be previously vaccinated|0|||
94319086|NCT05836818|322951196|FG001|Overall Study|Later found to be previously vaccinated|1|||
94386585|NCT00337077|323202651|FG000|Overall Study|Death|0|||
94386586|NCT00337077|323202652|FG001|Overall Study|Death|1|||
94386587|NCT00337077|323202653|FG002|Overall Study|Death|0|||
94386588|NCT00337077|323202651|FG000|Overall Study|Withdrawal by Subject|7|||
94386589|NCT00337077|323202652|FG001|Overall Study|Withdrawal by Subject|2|||
94386590|NCT00337077|323202653|FG002|Overall Study|Withdrawal by Subject|2|||
94386591|NCT00337077|323202651|FG000|Overall Study|Alternative therapy|1|||
94386592|NCT00337077|323202652|FG001|Overall Study|Alternative therapy|0|||
94386593|NCT00337077|323202653|FG002|Overall Study|Alternative therapy|0|||
94386594|NCT00337077|323202651|FG000|Overall Study|Physician Decision|1|||
94386595|NCT00337077|323202652|FG001|Overall Study|Physician Decision|4|||
94386596|NCT00337077|323202653|FG002|Overall Study|Physician Decision|2|||
94386597|NCT00337077|323202651|FG000|Overall Study|Never started treatment|1|||
94386598|NCT00337077|323202652|FG001|Overall Study|Never started treatment|1|||
94386599|NCT00337077|323202653|FG002|Overall Study|Never started treatment|0|||
94386600|NCT00337077|323202651|FG000|Overall Study|Ineligible|1|||
94386601|NCT00337077|323202652|FG001|Overall Study|Ineligible|1|||
94386602|NCT00337077|323202653|FG002|Overall Study|Ineligible|1|||
94386603|NCT03657160|323202654|FG000|Overall Study|Adverse Event|5|||
94386604|NCT03657160|323202655|FG001|Overall Study|Adverse Event|6|||
94386605|NCT03657160|323202654|FG000|Overall Study|Protocol Deviation|3|||
94386606|NCT03657160|323202655|FG001|Overall Study|Protocol Deviation|0|||
94319087|NCT05836818|322951197|FG002|Overall Study|Later found to be previously vaccinated|3|||
94319088|NCT05836818|322951195|FG000|Overall Study|Pregnancy|0|||
94319089|NCT05836818|322951196|FG001|Overall Study|Pregnancy|1|||
94319090|NCT05836818|322951197|FG002|Overall Study|Pregnancy|0|||
94386607|NCT03657160|323202654|FG000|Overall Study|Withdrawal by Subject|18|||
94386608|NCT03657160|323202655|FG001|Overall Study|Withdrawal by Subject|16|||
94386609|NCT03657160|323202654|FG000|Overall Study|Site Termination|1|||
94386610|NCT03657160|323202655|FG001|Overall Study|Site Termination|0|||
94319091|NCT05836818|322951195|FG000|Overall Study|Allergic to vaccines|0|||
94319092|NCT05836818|322951196|FG001|Overall Study|Allergic to vaccines|1|||
94319093|NCT05836818|322951197|FG002|Overall Study|Allergic to vaccines|0|||
94319094|NCT01081873|322951198|FG000|Overall Study|Death|86|||
94319095|NCT01081873|322951198|FG000|Overall Study|Withdrawal by Subject|10|||
94319096|NCT01081873|322951198|FG000|Overall Study|Lost to Follow-up|142|||
94319097|NCT01081873|322951198|FG000|Overall Study|Progression of prostate cancer|13|||
94319098|NCT01081873|322951198|FG000|Overall Study|Other|47|||
94319099|NCT01419665|322951199|FG000|Combination Treatment|Adverse Event|7|||
94319100|NCT01419665|322951200|FG001|Combination Treatment|Adverse Event|10|||
94319101|NCT01419665|322951199|FG000|Combination Treatment|Physician Decision|5|||
94319102|NCT01419665|322951200|FG001|Combination Treatment|Physician Decision|8|||
94319103|NCT01419665|322951199|FG000|Combination Treatment|Protocol Violation|6|||
94319104|NCT01419665|322951200|FG001|Combination Treatment|Protocol Violation|2|||
94319105|NCT01419665|322951199|FG000|Combination Treatment|disease progression|10|||
94319106|NCT01419665|322951200|FG001|Combination Treatment|disease progression|9|||
94319107|NCT01419665|322951199|FG000|Combination Treatment|Death|5|||
94319108|NCT01419665|322951200|FG001|Combination Treatment|Death|7|||
94319109|NCT01419665|322951199|FG000|Combination Treatment|administrative problems|0|||
94319110|NCT01419665|322951200|FG001|Combination Treatment|administrative problems|1|||
94319111|NCT01419665|322951199|FG000|Combination Treatment|Withdrawal by Subject|5|||
94319112|NCT01419665|322951200|FG001|Combination Treatment|Withdrawal by Subject|4|||
94319113|NCT01419665|322951199|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
94319114|NCT01419665|322951200|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
94319115|NCT01419665|322951199|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
94319116|NCT01419665|322951200|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
94319117|NCT01419665|322951199|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
94319118|NCT01419665|322951200|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
94319119|NCT01419665|322951199|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
94319120|NCT01419665|322951200|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
94319121|NCT01419665|322951199|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
94319122|NCT01419665|322951200|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
94319123|NCT01419665|322951199|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
94319124|NCT01419665|322951200|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
94319125|NCT01419665|322951199|FG000|Maintenance Treatment and/or Follow up|Death|1|||
94319126|NCT01419665|322951200|FG001|Maintenance Treatment and/or Follow up|Death|2|||
94319127|NCT01419665|322951199|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
94319128|NCT01419665|322951200|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
94319129|NCT01419665|322951199|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
94319130|NCT01419665|322951200|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
94319131|NCT01419665|322951199|FG000|Open Label Phase|Death|1|||
94319132|NCT01419665|322951200|FG001|Open Label Phase|Death|0|||
94319133|NCT01419665|322951199|FG000|Open Label Phase|disease progression|0|||
94319134|NCT01419665|322951200|FG001|Open Label Phase|disease progression|1|||
94319135|NCT03855137|322951205|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
94319136|NCT03855137|322951206|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
94319137|NCT03855137|322951207|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
94386611|NCT03657160|323202654|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
94386612|NCT03657160|323202655|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
94386613|NCT03657160|323202654|FG000|Overall Study|Death|33|||
94386614|NCT03657160|323202655|FG001|Overall Study|Death|26|||
94386615|NCT03657160|323202654|FG000|Overall Study|Death (COVID-19-Related)|1|||
94386616|NCT03657160|323202655|FG001|Overall Study|Death (COVID-19-Related)|0|||
94386617|NCT03657160|323202654|FG000|Overall Study|Reason Not Specified|5|||
94386618|NCT03657160|323202655|FG001|Overall Study|Reason Not Specified|5|||
94386619|NCT03657160|323202654|FG000|Overall Study|Other (COVID-19-Related)|0|||
94386620|NCT03657160|323202655|FG001|Overall Study|Other (COVID-19-Related)|1|||
94386621|NCT04276883|323202656|FG000|Overall Study|Withdrawal by Subject|2|||
94386622|NCT04276883|323202657|FG001|Overall Study|Withdrawal by Subject|3|||
94386623|NCT04276883|323202658|FG002|Overall Study|Withdrawal by Subject|6|||
94386624|NCT04276883|323202656|FG000|Overall Study|Lost to Follow-up|1|||
94386625|NCT04276883|323202657|FG001|Overall Study|Lost to Follow-up|3|||
94386626|NCT04276883|323202658|FG002|Overall Study|Lost to Follow-up|0|||
94386627|NCT04276883|323202656|FG000|Overall Study|Adverse Event|0|||
94319138|NCT03855137|322951205|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
94319139|NCT03855137|322951206|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
94319140|NCT03855137|322951207|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
94319141|NCT03855137|322951205|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
94319142|NCT03855137|322951206|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
94319143|NCT03855137|322951207|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
94319144|NCT03855137|322951205|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
94319145|NCT03855137|322951206|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
94319146|NCT03855137|322951207|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
94319147|NCT03855137|322951205|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
94319148|NCT03855137|322951206|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
94319149|NCT03855137|322951207|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
94319150|NCT03855137|322951205|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
94319151|NCT03855137|322951206|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
94319152|NCT03855137|322951207|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
94319153|NCT03855137|322951205|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
94319154|NCT03855137|322951206|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
94319155|NCT03855137|322951207|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
94319156|NCT03855137|322951205|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
94319157|NCT03855137|322951206|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
94319158|NCT03855137|322951207|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
94319159|NCT03855137|322951205|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
94319160|NCT03855137|322951206|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
94319161|NCT03855137|322951207|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
94319162|NCT03855137|322951205|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
94319163|NCT03855137|322951206|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
94319164|NCT03855137|322951207|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
94319165|NCT04369430|322951208|FG000|Overall Study|Adverse Event|2|||
94319166|NCT04369430|322951209|FG001|Overall Study|Adverse Event|3|||
94319167|NCT04369430|322951208|FG000|Overall Study|Death|1|||
94319168|NCT04369430|322951209|FG001|Overall Study|Death|0|||
94319169|NCT04369430|322951208|FG000|Overall Study|Withdrawal by Subject|4|||
94319170|NCT04369430|322951209|FG001|Overall Study|Withdrawal by Subject|3|||
94319171|NCT04369430|322951208|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
94319172|NCT04369430|322951209|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
94319173|NCT04369430|322951208|FG000|Overall Study|Lost to Follow-up|0|||
94319174|NCT04369430|322951209|FG001|Overall Study|Lost to Follow-up|1|||
94319175|NCT02683525|322951210|FG000|Overall Study|Lost to Follow-up|1|||
94319176|NCT02683525|322951210|FG000|Overall Study|Physician Decision|1|||
94319177|NCT02683525|322951210|FG000|Overall Study|Disease Progression|6|||
94319178|NCT01067508|322951211|FG000|Overall Study|Physician Decision|0|||
94319179|NCT01067508|322951212|FG001|Overall Study|Physician Decision|1|||
94319180|NCT01067508|322951211|FG000|Overall Study|Withdrawal by Subject|0|||
94319181|NCT01067508|322951212|FG001|Overall Study|Withdrawal by Subject|1|||
94319182|NCT03352414|322951215|FG000|Overall Study|Ineligible by operative criteria|12|||
94319183|NCT03352414|322951216|FG001|Overall Study|Ineligible by operative criteria|10|||
94319184|NCT03213626|322951219|FG000|Overall Study|Adverse Event|1|||
94319185|NCT03213626|322951219|FG000|Overall Study|Progressive Disease|6|||
94319186|NCT00926796|322951220|FG000|Overall Study|Did not receive randomized treatment|4|||
94319187|NCT00926796|322951221|FG001|Overall Study|Did not receive randomized treatment|7|||
94319188|NCT00926796|322951220|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
94319189|NCT00926796|322951221|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
94319190|NCT00926796|322951220|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
94319191|NCT00926796|322951221|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
94319192|NCT00926796|322951220|FG000|Overall Study|Adverse Event|7|||
94319193|NCT00926796|322951221|FG001|Overall Study|Adverse Event|14|||
94319194|NCT00926796|322951220|FG000|Overall Study|Lost to Follow-up|22|||
94319195|NCT00926796|322951221|FG001|Overall Study|Lost to Follow-up|13|||
94319196|NCT00926796|322951220|FG000|Overall Study|Protocol Violation|15|||
94319197|NCT00926796|322951221|FG001|Overall Study|Protocol Violation|11|||
94319198|NCT00926796|322951220|FG000|Overall Study|Withdrawal by Subject|1|||
94319199|NCT00926796|322951221|FG001|Overall Study|Withdrawal by Subject|0|||
94319200|NCT02020031|322953471|FG000|Overall Study|Physician Decision|1|||
94319201|NCT02020031|322953472|FG001|Overall Study|Physician Decision|1|||
94319202|NCT04191967|322953473|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
94319203|NCT04191967|322953473|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
94319204|NCT02614287|322953474|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
94319205|NCT02614287|322953475|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
94319206|NCT02614287|322953474|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
94319207|NCT02614287|322953475|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
94386628|NCT04276883|323202657|FG001|Overall Study|Adverse Event|1|||
94386629|NCT04276883|323202658|FG002|Overall Study|Adverse Event|0|||
94386630|NCT04276883|323202656|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
94386631|NCT04276883|323202657|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
94386632|NCT04276883|323202658|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
94386633|NCT01492400|323202661|FG000|Overall Study|Miscellaneous Reasons|2|||
94386634|NCT01492400|323202662|FG001|Overall Study|Miscellaneous Reasons|3|||
94386635|NCT01492400|323202661|FG000|Overall Study|Personal Reasons|0|||
94319208|NCT02614287|322953474|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
94319209|NCT02614287|322953475|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
94319210|NCT02614287|322953474|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
94319211|NCT02614287|322953475|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
94319212|NCT02614287|322953474|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
94319213|NCT02614287|322953475|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
94319214|NCT02614287|322953474|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
94319215|NCT02614287|322953475|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
94319216|NCT02614287|322953474|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
94319217|NCT02614287|322953475|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
94319218|NCT02614287|322953474|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
94319219|NCT02614287|322953475|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
94319220|NCT00683475|322953478|FG000|Overall Study|Withdrawal by Subject|1|||
94319221|NCT00683475|322953479|FG001|Overall Study|Withdrawal by Subject|0|||
94319222|NCT00683475|322953478|FG000|Overall Study|Never Treated: Adverse Event|2|||
94319223|NCT00683475|322953479|FG001|Overall Study|Never Treated: Adverse Event|3|||
94319224|NCT00683475|322953478|FG000|Overall Study|Never Treated: Progressive Disease|1|||
94319225|NCT00683475|322953479|FG001|Overall Study|Never Treated: Progressive Disease|0|||
94319226|NCT02723604|322953482|FG000|Overall Study|ineligible|1|||
94319227|NCT02723604|322953482|FG000|Overall Study|never received treatment|1|||
94319228|NCT03987919|322953483|FG000|Overall Study|Adverse Event|1|||
94319229|NCT03987919|322953484|FG001|Overall Study|Adverse Event|4|||
94319230|NCT03987919|322953485|FG002|Overall Study|Adverse Event|1|||
94319231|NCT03987919|322953486|FG003|Overall Study|Adverse Event|3|||
94319232|NCT03987919|322953483|FG000|Overall Study|Death|4|||
94319233|NCT03987919|322953484|FG001|Overall Study|Death|4|||
94319234|NCT03987919|322953485|FG002|Overall Study|Death|4|||
94319235|NCT03987919|322953486|FG003|Overall Study|Death|1|||
94319236|NCT03987919|322953483|FG000|Overall Study|Lost to Follow-up|5|||
94319237|NCT03987919|322953484|FG001|Overall Study|Lost to Follow-up|6|||
94319238|NCT03987919|322953485|FG002|Overall Study|Lost to Follow-up|8|||
94319239|NCT03987919|322953486|FG003|Overall Study|Lost to Follow-up|12|||
94319240|NCT03987919|322953483|FG000|Overall Study|Physician Decision|0|||
94319241|NCT03987919|322953484|FG001|Overall Study|Physician Decision|2|||
94319242|NCT03987919|322953485|FG002|Overall Study|Physician Decision|0|||
94319243|NCT03987919|322953486|FG003|Overall Study|Physician Decision|4|||
94319244|NCT03987919|322953483|FG000|Overall Study|Pregnancy|1|||
94319245|NCT03987919|322953484|FG001|Overall Study|Pregnancy|0|||
94319246|NCT03987919|322953485|FG002|Overall Study|Pregnancy|1|||
94319247|NCT03987919|322953486|FG003|Overall Study|Pregnancy|1|||
94319248|NCT03987919|322953483|FG000|Overall Study|Protocol Violation|0|||
94319249|NCT03987919|322953484|FG001|Overall Study|Protocol Violation|1|||
94319250|NCT03987919|322953485|FG002|Overall Study|Protocol Violation|0|||
94319251|NCT03987919|322953486|FG003|Overall Study|Protocol Violation|0|||
94319252|NCT03987919|322953483|FG000|Overall Study|Site terminated by Sponsor|0|||
94319253|NCT03987919|322953484|FG001|Overall Study|Site terminated by Sponsor|0|||
94319254|NCT03987919|322953485|FG002|Overall Study|Site terminated by Sponsor|0|||
94319255|NCT03987919|322953486|FG003|Overall Study|Site terminated by Sponsor|1|||
94319256|NCT03987919|322953483|FG000|Overall Study|Withdrawal by Subject|7|||
94319257|NCT03987919|322953484|FG001|Overall Study|Withdrawal by Subject|7|||
94319258|NCT03987919|322953485|FG002|Overall Study|Withdrawal by Subject|8|||
94319259|NCT03987919|322953486|FG003|Overall Study|Withdrawal by Subject|4|||
94319260|NCT03987919|322953483|FG000|Overall Study|Other - as reported by the investigator|1|||
94319261|NCT03987919|322953484|FG001|Overall Study|Other - as reported by the investigator|3|||
94319262|NCT03987919|322953485|FG002|Overall Study|Other - as reported by the investigator|2|||
94319263|NCT03987919|322953486|FG003|Overall Study|Other - as reported by the investigator|0|||
94319264|NCT00523341|322953487|FG000|Overall Study|Withdrawal by Subject|399|||
94319265|NCT00523341|322953488|FG001|Overall Study|Withdrawal by Subject|427|||
94319266|NCT00523341|322953487|FG000|Overall Study|Other|181|||
94319267|NCT00523341|322953488|FG001|Overall Study|Other|198|||
94319268|NCT00523341|322953487|FG000|Overall Study|Adverse Event|122|||
94319269|NCT00523341|322953488|FG001|Overall Study|Adverse Event|155|||
94319270|NCT00523341|322953487|FG000|Overall Study|Death|101|||
94319271|NCT00523341|322953488|FG001|Overall Study|Death|110|||
94319272|NCT00523341|322953487|FG000|Overall Study|Lost to Follow-up|73|||
94319273|NCT00523341|322953488|FG001|Overall Study|Lost to Follow-up|61|||
94319274|NCT00523341|322953487|FG000|Overall Study|Non-compliance|20|||
94319275|NCT00523341|322953488|FG001|Overall Study|Non-compliance|13|||
94319276|NCT00523341|322953487|FG000|Overall Study|Physician Decision|14|||
94319277|NCT00523341|322953488|FG001|Overall Study|Physician Decision|13|||
94319278|NCT00523341|322953487|FG000|Overall Study|Requirement for Alternative Therapy|4|||
94319279|NCT00523341|322953488|FG001|Overall Study|Requirement for Alternative Therapy|14|||
94386636|NCT01492400|323202662|FG001|Overall Study|Personal Reasons|5|||
94386637|NCT01492400|323202661|FG000|Overall Study|Lost to Follow-up|3|||
94386638|NCT01492400|323202662|FG001|Overall Study|Lost to Follow-up|1|||
94319280|NCT00523341|322953487|FG000|Overall Study|Protocol Deviation|6|||
94319281|NCT00523341|322953488|FG001|Overall Study|Protocol Deviation|5|||
94319282|NCT00523341|322953487|FG000|Overall Study|Ineligibility Determined|3|||
94319283|NCT00523341|322953488|FG001|Overall Study|Ineligibility Determined|4|||
94319284|NCT00523341|322953487|FG000|Overall Study|Disease Progression|1|||
94319285|NCT00523341|322953488|FG001|Overall Study|Disease Progression|0|||
94319286|NCT00254293|322953493|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
94319287|NCT00254293|322953494|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
94319288|NCT00254293|322953495|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
94319289|NCT00254293|322953496|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
94319290|NCT00254293|322953497|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
94319291|NCT00254293|322953498|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
94319292|NCT00254293|322953499|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
94319293|NCT00254293|322953493|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
94319294|NCT00254293|322953494|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
94319295|NCT00254293|322953495|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
94319296|NCT00254293|322953496|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
94319297|NCT00254293|322953497|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
94319298|NCT00254293|322953498|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
94319299|NCT00254293|322953499|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
94319300|NCT00254293|322953493|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
94319301|NCT00254293|322953494|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
94319302|NCT00254293|322953495|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
94319303|NCT00254293|322953496|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
94319304|NCT00254293|322953497|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
94319305|NCT00254293|322953498|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
94319306|NCT00254293|322953499|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
94319307|NCT00254293|322953493|FG000|LTE Open Label Variable SC Dosing|Death|0|||
94319308|NCT00254293|322953494|FG001|LTE Open Label Variable SC Dosing|Death|0|||
94319309|NCT00254293|322953495|FG002|LTE Open Label Variable SC Dosing|Death|1|||
94319310|NCT00254293|322953496|FG003|LTE Open Label Variable SC Dosing|Death|0|||
94319311|NCT00254293|322953497|FG004|LTE Open Label Variable SC Dosing|Death|0|||
94319312|NCT00254293|322953498|FG005|LTE Open Label Variable SC Dosing|Death|0|||
94319313|NCT00254293|322953499|FG006|LTE Open Label Variable SC Dosing|Death|0|||
94319314|NCT00254293|322953493|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
94319315|NCT00254293|322953494|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
94319316|NCT00254293|322953495|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
94319317|NCT00254293|322953496|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
94319318|NCT00254293|322953497|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
94319319|NCT00254293|322953498|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
94319320|NCT00254293|322953499|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
94319321|NCT00254293|322953493|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
94319322|NCT00254293|322953494|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
94319323|NCT00254293|322953495|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
94319324|NCT00254293|322953496|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
94319325|NCT00254293|322953497|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
94319326|NCT00254293|322953498|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
94319327|NCT00254293|322953499|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
94319328|NCT00254293|322953493|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
94319329|NCT00254293|322953494|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
94319330|NCT00254293|322953495|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
94319331|NCT00254293|322953496|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
94319332|NCT00254293|322953497|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
94319333|NCT00254293|322953498|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
94319334|NCT00254293|322953499|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
94319335|NCT00254293|322953493|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
94319336|NCT00254293|322953494|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
94319337|NCT00254293|322953495|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
94319338|NCT00254293|322953496|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
94319339|NCT00254293|322953497|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
94319340|NCT00254293|322953498|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
94319341|NCT00254293|322953499|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
94319342|NCT00254293|322953493|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
94319343|NCT00254293|322953494|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
94319344|NCT00254293|322953495|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
94319345|NCT00254293|322953496|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
94319346|NCT00254293|322953497|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
94386639|NCT01492400|323202661|FG000|Overall Study|Pregnancy|0|||
94386640|NCT01492400|323202662|FG001|Overall Study|Pregnancy|1|||
94319347|NCT00254293|322953498|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
94319348|NCT00254293|322953499|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
94319349|NCT00254293|322953493|FG000|LTE Open Label Variable SC Dosing|Other|0|||
94319350|NCT00254293|322953494|FG001|LTE Open Label Variable SC Dosing|Other|0|||
94319351|NCT00254293|322953495|FG002|LTE Open Label Variable SC Dosing|Other|2|||
94319352|NCT00254293|322953496|FG003|LTE Open Label Variable SC Dosing|Other|0|||
94319353|NCT00254293|322953497|FG004|LTE Open Label Variable SC Dosing|Other|0|||
94319354|NCT00254293|322953498|FG005|LTE Open Label Variable SC Dosing|Other|0|||
94319355|NCT00254293|322953499|FG006|LTE Open Label Variable SC Dosing|Other|0|||
94319356|NCT00254293|322953493|FG000|LTE Open Label Fixed Dosing|Death|0|||
94319357|NCT00254293|322953494|FG001|LTE Open Label Fixed Dosing|Death|0|||
94319358|NCT00254293|322953495|FG002|LTE Open Label Fixed Dosing|Death|0|||
94319359|NCT00254293|322953496|FG003|LTE Open Label Fixed Dosing|Death|0|||
94319360|NCT00254293|322953497|FG004|LTE Open Label Fixed Dosing|Death|0|||
94319361|NCT00254293|322953498|FG005|LTE Open Label Fixed Dosing|Death|0|||
94319362|NCT00254293|322953499|FG006|LTE Open Label Fixed Dosing|Death|3|||
94319363|NCT00254293|322953493|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
94319364|NCT00254293|322953494|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
94319365|NCT00254293|322953495|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
94319366|NCT00254293|322953496|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
94319367|NCT00254293|322953497|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
94319368|NCT00254293|322953498|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
94319369|NCT00254293|322953499|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
94319370|NCT00254293|322953493|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
94386641|NCT01492400|323202661|FG000|Overall Study|Lack of Efficacy|1|||
94386642|NCT01492400|323202662|FG001|Overall Study|Lack of Efficacy|1|||
94386643|NCT01492400|323202661|FG000|Overall Study|Adverse Event|10|||
94386644|NCT01492400|323202662|FG001|Overall Study|Adverse Event|5|||
94386645|NCT00320112|323202663|FG000|Overall Study|Lost to Follow-up|3|||
94386646|NCT00320112|323202664|FG001|Overall Study|Lost to Follow-up|4|||
94386647|NCT00320112|323202663|FG000|Overall Study|Withdrawal by Subject|3|||
94386648|NCT00320112|323202664|FG001|Overall Study|Withdrawal by Subject|0|||
94386649|NCT00320112|323202663|FG000|Overall Study|Death|2|||
94386650|NCT00320112|323202664|FG001|Overall Study|Death|1|||
94386651|NCT02430870|323202669|FG000|Part 2|Voluntary Withdrawal|0|||
94386652|NCT02430870|323202670|FG001|Part 2|Voluntary Withdrawal|0|||
94386653|NCT02430870|323202671|FG002|Part 2|Voluntary Withdrawal|0|||
94386654|NCT02430870|323202672|FG003|Part 2|Voluntary Withdrawal|0|||
94386655|NCT02430870|323202673|FG004|Part 2|Voluntary Withdrawal|0|||
94386656|NCT02430870|323202674|FG005|Part 2|Voluntary Withdrawal|0|||
94386657|NCT02430870|323202675|FG006|Part 2|Voluntary Withdrawal|1|||
94386658|NCT02430870|323202676|FG007|Part 2|Voluntary Withdrawal|0|||
94386659|NCT02430870|323202669|FG000|Part 2|Other Reason Not Specified|0|||
94386660|NCT02430870|323202670|FG001|Part 2|Other Reason Not Specified|0|||
94386661|NCT02430870|323202671|FG002|Part 2|Other Reason Not Specified|0|||
94386662|NCT02430870|323202672|FG003|Part 2|Other Reason Not Specified|0|||
94386663|NCT02430870|323202673|FG004|Part 2|Other Reason Not Specified|0|||
94386664|NCT02430870|323202674|FG005|Part 2|Other Reason Not Specified|0|||
94386665|NCT02430870|323202675|FG006|Part 2|Other Reason Not Specified|0|||
94386666|NCT02430870|323202676|FG007|Part 2|Other Reason Not Specified|1|||
94386667|NCT03049488|323202677|FG000|Overall Study|Lost to Follow-up|1|||
94386668|NCT03049488|323202678|FG001|Overall Study|Lost to Follow-up|1|||
94386669|NCT03049488|323202679|FG002|Overall Study|Lost to Follow-up|0|||
94386670|NCT03049488|323202680|FG003|Overall Study|Lost to Follow-up|0|||
94386671|NCT03049488|323202681|FG004|Overall Study|Lost to Follow-up|0|||
94386672|NCT03049488|323202682|FG005|Overall Study|Lost to Follow-up|0|||
94386673|NCT03049488|323202677|FG000|Overall Study|Moved from Area|1|||
94386674|NCT03049488|323202678|FG001|Overall Study|Moved from Area|0|||
94386675|NCT03049488|323202679|FG002|Overall Study|Moved from Area|0|||
94386676|NCT03049488|323202680|FG003|Overall Study|Moved from Area|1|||
94386677|NCT03049488|323202681|FG004|Overall Study|Moved from Area|1|||
94386678|NCT03049488|323202682|FG005|Overall Study|Moved from Area|0|||
94386679|NCT03049488|323202677|FG000|Overall Study|Physician Decision|0|||
94386680|NCT03049488|323202678|FG001|Overall Study|Physician Decision|1|||
94386681|NCT03049488|323202679|FG002|Overall Study|Physician Decision|0|||
94386682|NCT03049488|323202680|FG003|Overall Study|Physician Decision|0|||
94386683|NCT03049488|323202681|FG004|Overall Study|Physician Decision|0|||
94386684|NCT03049488|323202682|FG005|Overall Study|Physician Decision|0|||
94386685|NCT03049488|323202677|FG000|Overall Study|Withdrawal by Subject|0|||
94386686|NCT03049488|323202678|FG001|Overall Study|Withdrawal by Subject|0|||
94386687|NCT03049488|323202679|FG002|Overall Study|Withdrawal by Subject|0|||
94386688|NCT03049488|323202680|FG003|Overall Study|Withdrawal by Subject|1|||
94386689|NCT03049488|323202681|FG004|Overall Study|Withdrawal by Subject|1|||
94386690|NCT03049488|323202682|FG005|Overall Study|Withdrawal by Subject|0|||
94386691|NCT01448057|323202684|FG000|Overall Study|Protocol Violation|3|||
94386692|NCT01448057|323202685|FG001|Overall Study|Protocol Violation|2|||
94386693|NCT01448057|323202684|FG000|Overall Study|Lost to Follow-up|3|||
94481984|NCT01781962|323558021|FG000|Overall Study|Other Miscellaneous Reasons|5|||
94481985|NCT03006562|323558022|FG000|Overall Study|Lost to Follow-up|0|||
94481986|NCT03006562|323558023|FG001|Overall Study|Lost to Follow-up|1|||
94481987|NCT00614874|323558024|FG000|Overall Study|Protocol Violation|1|||
94319371|NCT00254293|322953494|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
94319372|NCT00254293|322953495|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
94319373|NCT00254293|322953496|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
94319374|NCT00254293|322953497|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
94481988|NCT00614874|323558024|FG000|Overall Study|Withdrawal by Subject|1|||
94481989|NCT05417412|323558027|FG000|Overall Study|Lost to Follow-up|2|||
94481990|NCT01841970|323558032|FG000|Overall Study|Withdrawal by Subject|1|||
94481991|NCT01841970|323558032|FG000|Overall Study|Physician Decision|2|||
94481992|NCT01841970|323558032|FG000|Overall Study|Lost to Follow-up|8|||
94481993|NCT03428100|323558033|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
94481994|NCT03428100|323558034|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
94481995|NCT03428100|323558035|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
94481996|NCT03428100|323558036|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
94481997|NCT03428100|323558037|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
94481998|NCT03428100|323558038|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
94481999|NCT03428100|323558039|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
94319375|NCT00254293|322953498|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
94319376|NCT00254293|322953499|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
94319377|NCT00254293|322953493|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
94319378|NCT00254293|322953494|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
94319379|NCT00254293|322953495|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
94319380|NCT00254293|322953496|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
94319381|NCT00254293|322953497|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
94319382|NCT00254293|322953498|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
94319383|NCT00254293|322953499|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
94319384|NCT00254293|322953493|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
94319385|NCT00254293|322953494|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
94319386|NCT00254293|322953495|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
94319387|NCT00254293|322953496|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
94319388|NCT00254293|322953497|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
94319389|NCT00254293|322953498|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
94319390|NCT00254293|322953499|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
94319391|NCT00254293|322953493|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
94319392|NCT00254293|322953494|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
94319393|NCT00254293|322953495|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
94319394|NCT00254293|322953496|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
94319395|NCT00254293|322953497|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
94319396|NCT00254293|322953498|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
94319397|NCT00254293|322953499|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
94319398|NCT00254293|322953493|FG000|LTE Open Label Fixed Dosing|Other|0|||
94319399|NCT00254293|322953494|FG001|LTE Open Label Fixed Dosing|Other|0|||
94319400|NCT00254293|322953495|FG002|LTE Open Label Fixed Dosing|Other|0|||
94319401|NCT00254293|322953496|FG003|LTE Open Label Fixed Dosing|Other|0|||
94319402|NCT00254293|322953497|FG004|LTE Open Label Fixed Dosing|Other|0|||
94319403|NCT00254293|322953498|FG005|LTE Open Label Fixed Dosing|Other|0|||
94319404|NCT00254293|322953499|FG006|LTE Open Label Fixed Dosing|Other|1|||
94319405|NCT00853489|322953500|FG000|Overall Study|Lost to Follow-up|5|||
94319406|NCT00853489|322953501|FG001|Overall Study|Lost to Follow-up|2|||
94319407|NCT03137121|322953502|FG000|Overall Study|Withdrawal by Subject|0|||
94319408|NCT03137121|322953503|FG001|Overall Study|Withdrawal by Subject|1|||
94319409|NCT03196193|322953506|FG000|Overall Study|Adverse Event|1|||
94319410|NCT03196193|322953507|FG001|Overall Study|Adverse Event|0|||
94319411|NCT03196193|322953506|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
94319412|NCT03196193|322953507|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
94482000|NCT03428100|323558040|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
94319413|NCT02709083|322953508|FG000|Overall Study|Original PI left institution|7|||
94319414|NCT00111475|322953512|FG000|Overall Study|Lost to Follow-up|0|||
94319415|NCT00111475|322953513|FG001|Overall Study|Lost to Follow-up|0|||
94319416|NCT00111475|322953514|FG002|Overall Study|Lost to Follow-up|0|||
94319417|NCT00111475|322953515|FG003|Overall Study|Lost to Follow-up|0|||
94319418|NCT00111475|322953516|FG004|Overall Study|Lost to Follow-up|0|||
94319419|NCT00111475|322953517|FG005|Overall Study|Lost to Follow-up|1|||
94319420|NCT00111475|322953518|FG006|Overall Study|Lost to Follow-up|0|||
94319421|NCT00111475|322953519|FG007|Overall Study|Lost to Follow-up|0|||
94319422|NCT00111475|322953520|FG008|Overall Study|Lost to Follow-up|0|||
94319423|NCT00111475|322953521|FG009|Overall Study|Lost to Follow-up|0|||
94482001|NCT03428100|323558041|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
94319424|NCT01354353|322953522|FG000|Overall Study|Adverse Event|1|||
94319425|NCT01354353|322953523|FG001|Overall Study|Adverse Event|0|||
94319426|NCT01354353|322953524|FG002|Overall Study|Adverse Event|0|||
94319427|NCT01354353|322953525|FG003|Overall Study|Adverse Event|4|||
94319428|NCT01354353|322953526|FG004|Overall Study|Adverse Event|0|||
94319429|NCT01354353|322953527|FG005|Overall Study|Adverse Event|5|||
94319430|NCT01354353|322953522|FG000|Overall Study|Entry Criteria Not Met|0|||
94319431|NCT01354353|322953523|FG001|Overall Study|Entry Criteria Not Met|0|||
94319432|NCT01354353|322953524|FG002|Overall Study|Entry Criteria Not Met|0|||
94319433|NCT01354353|322953525|FG003|Overall Study|Entry Criteria Not Met|1|||
94319434|NCT01354353|322953526|FG004|Overall Study|Entry Criteria Not Met|1|||
94319435|NCT01354353|322953527|FG005|Overall Study|Entry Criteria Not Met|0|||
94319436|NCT01354353|322953522|FG000|Overall Study|Physician Decision|0|||
94319437|NCT01354353|322953523|FG001|Overall Study|Physician Decision|1|||
94319438|NCT01354353|322953524|FG002|Overall Study|Physician Decision|1|||
94319439|NCT01354353|322953525|FG003|Overall Study|Physician Decision|0|||
94319440|NCT01354353|322953526|FG004|Overall Study|Physician Decision|0|||
94319441|NCT01354353|322953527|FG005|Overall Study|Physician Decision|0|||
94319442|NCT01354353|322953522|FG000|Overall Study|Withdrawal by Subject|2|||
94319443|NCT01354353|322953523|FG001|Overall Study|Withdrawal by Subject|0|||
94319444|NCT01354353|322953524|FG002|Overall Study|Withdrawal by Subject|1|||
94319445|NCT01354353|322953525|FG003|Overall Study|Withdrawal by Subject|0|||
94319446|NCT01354353|322953526|FG004|Overall Study|Withdrawal by Subject|0|||
94319447|NCT01354353|322953527|FG005|Overall Study|Withdrawal by Subject|1|||
94319448|NCT03583372|322953528|FG000|Overall Study|Withdrawal by Subject|6|||
94319449|NCT03583372|322953529|FG001|Overall Study|Withdrawal by Subject|11|||
94319450|NCT03583372|322953530|FG002|Overall Study|Withdrawal by Subject|7|||
94319451|NCT03583372|322953531|FG003|Overall Study|Withdrawal by Subject|8|||
94319452|NCT03583372|322953528|FG000|Overall Study|Lost to Follow-up|4|||
94319453|NCT03583372|322953529|FG001|Overall Study|Lost to Follow-up|6|||
94319454|NCT03583372|322953530|FG002|Overall Study|Lost to Follow-up|3|||
94319455|NCT03583372|322953531|FG003|Overall Study|Lost to Follow-up|2|||
94319456|NCT03583372|322953528|FG000|Overall Study|Adverse Event|1|||
94319457|NCT03583372|322953529|FG001|Overall Study|Adverse Event|3|||
94319458|NCT03583372|322953530|FG002|Overall Study|Adverse Event|4|||
94319459|NCT03583372|322953531|FG003|Overall Study|Adverse Event|4|||
94319460|NCT03583372|322953528|FG000|Overall Study|Physician Decision|0|||
94319461|NCT03583372|322953529|FG001|Overall Study|Physician Decision|1|||
94319462|NCT03583372|322953530|FG002|Overall Study|Physician Decision|1|||
94319463|NCT03583372|322953531|FG003|Overall Study|Physician Decision|1|||
94319464|NCT03583372|322953528|FG000|Overall Study|Lack of Efficacy|0|||
94319465|NCT03583372|322953529|FG001|Overall Study|Lack of Efficacy|1|||
94319466|NCT03583372|322953530|FG002|Overall Study|Lack of Efficacy|0|||
94319467|NCT03583372|322953531|FG003|Overall Study|Lack of Efficacy|1|||
94319468|NCT03583372|322953528|FG000|Overall Study|Death|1|||
94319469|NCT03583372|322953529|FG001|Overall Study|Death|0|||
94319470|NCT03583372|322953530|FG002|Overall Study|Death|0|||
94319471|NCT03583372|322953531|FG003|Overall Study|Death|0|||
94319472|NCT03583372|322953528|FG000|Overall Study|Protocol Violation|0|||
94319473|NCT03583372|322953529|FG001|Overall Study|Protocol Violation|1|||
94319474|NCT03583372|322953530|FG002|Overall Study|Protocol Violation|0|||
94319475|NCT03583372|322953531|FG003|Overall Study|Protocol Violation|0|||
94319476|NCT03583372|322953528|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
94319477|NCT03583372|322953529|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
94319478|NCT03583372|322953530|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
94319479|NCT03583372|322953531|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
94319480|NCT03583372|322953528|FG000|Overall Study|Did Not Receive Study Drug|0|||
94319481|NCT03583372|322953529|FG001|Overall Study|Did Not Receive Study Drug|1|||
94319482|NCT03583372|322953530|FG002|Overall Study|Did Not Receive Study Drug|0|||
94319483|NCT03583372|322953531|FG003|Overall Study|Did Not Receive Study Drug|0|||
94319484|NCT03583372|322953528|FG000|Overall Study|Captured as Other in the Database|1|||
94319485|NCT03583372|322953529|FG001|Overall Study|Captured as Other in the Database|2|||
94319486|NCT03583372|322953530|FG002|Overall Study|Captured as Other in the Database|4|||
94319487|NCT03583372|322953531|FG003|Overall Study|Captured as Other in the Database|1|||
94319488|NCT02796391|322953532|FG000|Overall Study|Lost to Follow-up|2|||
94319489|NCT02796391|322953533|FG001|Overall Study|Lost to Follow-up|2|||
94319490|NCT02796391|322953534|FG002|Overall Study|Lost to Follow-up|13|||
94319491|NCT02796391|322953535|FG003|Overall Study|Lost to Follow-up|8|||
94319492|NCT02796391|322953536|FG004|Overall Study|Lost to Follow-up|14|||
94319493|NCT02796391|322953537|FG005|Overall Study|Lost to Follow-up|13|||
94319494|NCT02796391|322953532|FG000|Overall Study|COVID|0|||
94319495|NCT02796391|322953533|FG001|Overall Study|COVID|0|||
94482002|NCT03428100|323558042|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
94482003|NCT03428100|323558043|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
94319496|NCT02796391|322953534|FG002|Overall Study|COVID|5|||
94319497|NCT02796391|322953535|FG003|Overall Study|COVID|5|||
94319498|NCT02796391|322953536|FG004|Overall Study|COVID|2|||
94319499|NCT02796391|322953537|FG005|Overall Study|COVID|4|||
94319500|NCT02796391|322953532|FG000|Overall Study|Participant did not like study cigarettes|0|||
94319501|NCT02796391|322953533|FG001|Overall Study|Participant did not like study cigarettes|0|||
94319502|NCT02796391|322953534|FG002|Overall Study|Participant did not like study cigarettes|3|||
94319503|NCT02796391|322953535|FG003|Overall Study|Participant did not like study cigarettes|0|||
94319504|NCT02796391|322953536|FG004|Overall Study|Participant did not like study cigarettes|0|||
94319505|NCT02796391|322953537|FG005|Overall Study|Participant did not like study cigarettes|0|||
94319506|NCT02796391|322953532|FG000|Overall Study|Withdrawal by Subject|1|||
94319507|NCT02796391|322953533|FG001|Overall Study|Withdrawal by Subject|1|||
94319508|NCT02796391|322953534|FG002|Overall Study|Withdrawal by Subject|4|||
94319509|NCT02796391|322953535|FG003|Overall Study|Withdrawal by Subject|3|||
94319510|NCT02796391|322953536|FG004|Overall Study|Withdrawal by Subject|4|||
94319511|NCT02796391|322953537|FG005|Overall Study|Withdrawal by Subject|3|||
94319512|NCT02796391|322953532|FG000|Overall Study|Adverse Event|0|||
94319513|NCT02796391|322953533|FG001|Overall Study|Adverse Event|0|||
94319514|NCT02796391|322953534|FG002|Overall Study|Adverse Event|0|||
94319515|NCT02796391|322953535|FG003|Overall Study|Adverse Event|1|||
94319516|NCT02796391|322953536|FG004|Overall Study|Adverse Event|0|||
94319517|NCT02796391|322953537|FG005|Overall Study|Adverse Event|0|||
94319518|NCT02796391|322953532|FG000|Overall Study|Protocol Violation|0|||
94319519|NCT02796391|322953533|FG001|Overall Study|Protocol Violation|0|||
94319520|NCT02796391|322953534|FG002|Overall Study|Protocol Violation|0|||
94319521|NCT02796391|322953535|FG003|Overall Study|Protocol Violation|1|||
94319522|NCT02796391|322953536|FG004|Overall Study|Protocol Violation|0|||
94319523|NCT02796391|322953537|FG005|Overall Study|Protocol Violation|0|||
94319524|NCT02681055|322953540|FG000|Weeks 5-12|Adverse Event|1|||
94319525|NCT00831441|322953541|FG000|Randomized|Death|82|||
94319526|NCT00831441|322953542|FG001|Randomized|Death|81|||
94319527|NCT00831441|322953541|FG000|Randomized|Adverse Event|248|||
94319528|NCT00831441|322953542|FG001|Randomized|Adverse Event|321|||
94319529|NCT00831441|322953541|FG000|Randomized|Emergency procedure|2|||
94319530|NCT00831441|322953542|FG001|Randomized|Emergency procedure|2|||
94319531|NCT00831441|322953541|FG000|Randomized|Elective procedure|26|||
94319532|NCT00831441|322953542|FG001|Randomized|Elective procedure|25|||
94319533|NCT00831441|322953541|FG000|Randomized|Physician Decision|26|||
94319534|NCT00831441|322953542|FG001|Randomized|Physician Decision|35|||
94319535|NCT00831441|322953541|FG000|Randomized|No longer met criteria|13|||
94319536|NCT00831441|322953542|FG001|Randomized|No longer met criteria|19|||
94319537|NCT00831441|322953541|FG000|Randomized|Withdrawal by Subject|178|||
94319538|NCT00831441|322953542|FG001|Randomized|Withdrawal by Subject|212|||
94319539|NCT00831441|322953541|FG000|Randomized|Lost to Follow-up|26|||
94319540|NCT00831441|322953542|FG001|Randomized|Lost to Follow-up|35|||
94319541|NCT00831441|322953541|FG000|Randomized|Administrative reason by sponsor|2780|||
94319542|NCT00831441|322953542|FG001|Randomized|Administrative reason by sponsor|2671|||
94319543|NCT00831441|322953541|FG000|Randomized|poor/non-compliance|30|||
94319544|NCT00831441|322953542|FG001|Randomized|poor/non-compliance|38|||
94319545|NCT00831441|322953541|FG000|Randomized|non-specified|276|||
94319546|NCT00831441|322953542|FG001|Randomized|non-specified|266|||
94319547|NCT00831441|322953541|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
94319548|NCT00831441|322953542|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
94319549|NCT00831441|322953541|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
94319550|NCT00831441|322953542|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
94319551|NCT00831441|322953541|FG000|Follow Up (30 Days)|Death|63|||
94319552|NCT00831441|322953542|FG001|Follow Up (30 Days)|Death|86|||
94319553|NCT00831441|322953541|FG000|Follow Up (30 Days)|non-specified|16|||
94386694|NCT01448057|323202685|FG001|Overall Study|Lost to Follow-up|0|||
94386695|NCT01448057|323202684|FG000|Overall Study|Adverse Event|0|||
94386696|NCT01448057|323202685|FG001|Overall Study|Adverse Event|2|||
94386697|NCT01448057|323202684|FG000|Overall Study|Withdrawal by Subject|2|||
94386698|NCT01448057|323202685|FG001|Overall Study|Withdrawal by Subject|0|||
94386699|NCT03883906|323202689|FG000|Overall Study|Withdrawal by Subject|2|||
94386700|NCT03883906|323202689|FG000|Overall Study|Physician Decision|5|||
94386701|NCT00486837|323202690|FG000|Overall Study|Withdrawal by Subject|1|||
94386702|NCT00486837|323202691|FG001|Overall Study|Withdrawal by Subject|0|||
94386703|NCT00486837|323202690|FG000|Overall Study|Adverse Event|1|||
94386704|NCT00486837|323202691|FG001|Overall Study|Adverse Event|1|||
94386705|NCT00486837|323202690|FG000|Overall Study|Protocol Violation|4|||
94319554|NCT00831441|322953542|FG001|Follow Up (30 Days)|non-specified|26|||
94319555|NCT00831441|322953541|FG000|Follow Up (30 Days)|missing end of study status|0|||
94319556|NCT00831441|322953542|FG001|Follow Up (30 Days)|missing end of study status|1|||
94319557|NCT01030458|322953548|FG000|Overall Study|Lost to Follow-up|9|||
94319558|NCT01030458|322953549|FG001|Overall Study|Lost to Follow-up|10|||
94386706|NCT00486837|323202691|FG001|Overall Study|Protocol Violation|2|||
94319559|NCT01030458|322953548|FG000|Overall Study|Withdrawal by Subject|2|||
94319560|NCT01030458|322953549|FG001|Overall Study|Withdrawal by Subject|3|||
94319561|NCT01030458|322953548|FG000|Overall Study|Logistical reasons|9|||
94319562|NCT01030458|322953549|FG001|Overall Study|Logistical reasons|5|||
94319563|NCT01030458|322953548|FG000|Overall Study|Moved or changed job|6|||
94319564|NCT01030458|322953549|FG001|Overall Study|Moved or changed job|13|||
94319565|NCT01030458|322953548|FG000|Overall Study|Side effect of medication|1|||
94319566|NCT01030458|322953549|FG001|Overall Study|Side effect of medication|1|||
94386707|NCT00486837|323202690|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
94319567|NCT04348656|322953551|FG000|Overall Study|Withdrawal by Subject|2|||
94319568|NCT04348656|322953552|FG001|Overall Study|Withdrawal by Subject|0|||
94319569|NCT04348656|322953551|FG000|Overall Study|Lost to Follow-up|11|||
94319570|NCT04348656|322953552|FG001|Overall Study|Lost to Follow-up|6|||
94319571|NCT01395368|322953556|FG000|Overall Study|Physician Decision|14|||
94319572|NCT01395368|322953556|FG000|Overall Study|Withdrawal by Subject|2|||
94319573|NCT00288860|322953560|FG000|Overall Study|Did not complete intake|4|||
94319574|NCT00288860|322953561|FG001|Overall Study|Did not complete intake|8|||
94319575|NCT00288860|322953560|FG000|Overall Study|Death|4|||
94319576|NCT00288860|322953561|FG001|Overall Study|Death|3|||
94319577|NCT00288860|322953560|FG000|Overall Study|Withdrawal by Subject|20|||
94319578|NCT00288860|322953561|FG001|Overall Study|Withdrawal by Subject|15|||
94319579|NCT00288860|322953560|FG000|Overall Study|Lost to Follow-up|74|||
94319580|NCT00288860|322953561|FG001|Overall Study|Lost to Follow-up|71|||
94319581|NCT03072719|322953562|FG000|Overall Study|Adverse Event|1|||
94319582|NCT03072719|322953563|FG001|Overall Study|Adverse Event|1|||
94482004|NCT03428100|323558044|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
94482005|NCT03428100|323558045|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
94482006|NCT03428100|323558046|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
94482007|NCT03428100|323558047|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
94482008|NCT03428100|323558048|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
94482009|NCT03428100|323558049|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
94482010|NCT03428100|323558050|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
94482011|NCT03428100|323558051|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
94482012|NCT03428100|323558033|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
94482013|NCT03428100|323558034|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
94482014|NCT03428100|323558035|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
94319583|NCT05142332|322953564|FG000|Overall Study|Withdrawal by Subject|0|||
94319584|NCT05142332|322953565|FG001|Overall Study|Withdrawal by Subject|1|||
94319585|NCT05142332|322953566|FG002|Overall Study|Withdrawal by Subject|2|||
94319586|NCT05142332|322953567|FG003|Overall Study|Withdrawal by Subject|0|||
94319587|NCT05142332|322953568|FG004|Overall Study|Withdrawal by Subject|0|||
94319588|NCT05142332|322953569|FG005|Overall Study|Withdrawal by Subject|2|||
94319589|NCT05142332|322953570|FG006|Overall Study|Withdrawal by Subject|6|||
94319590|NCT05142332|322953564|FG000|Overall Study|Left ED|3|||
94319591|NCT05142332|322953565|FG001|Overall Study|Left ED|0|||
94319592|NCT05142332|322953566|FG002|Overall Study|Left ED|4|||
94319593|NCT05142332|322953567|FG003|Overall Study|Left ED|6|||
94319594|NCT05142332|322953568|FG004|Overall Study|Left ED|1|||
94319595|NCT05142332|322953569|FG005|Overall Study|Left ED|2|||
94319596|NCT05142332|322953570|FG006|Overall Study|Left ED|6|||
94319597|NCT05142332|322953564|FG000|Overall Study|Physician Decision|0|||
94319598|NCT05142332|322953565|FG001|Overall Study|Physician Decision|0|||
94319599|NCT05142332|322953566|FG002|Overall Study|Physician Decision|2|||
94319600|NCT05142332|322953567|FG003|Overall Study|Physician Decision|1|||
94319601|NCT05142332|322953568|FG004|Overall Study|Physician Decision|0|||
94319602|NCT05142332|322953569|FG005|Overall Study|Physician Decision|0|||
94319603|NCT05142332|322953570|FG006|Overall Study|Physician Decision|3|||
94319604|NCT05142332|322953564|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
94319605|NCT05142332|322953565|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
94319606|NCT05142332|322953566|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
94319607|NCT05142332|322953567|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
94319608|NCT05142332|322953568|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
94319609|NCT05142332|322953569|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
94319610|NCT05142332|322953570|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
94319611|NCT01757405|322953571|FG000|Overall Study|Lost to Follow-up|1|||
94319612|NCT01757405|322953572|FG001|Overall Study|Lost to Follow-up|1|||
94319613|NCT01757405|322953571|FG000|Overall Study|Withdrawal by Subject|0|||
94319614|NCT01757405|322953572|FG001|Overall Study|Withdrawal by Subject|1|||
94319615|NCT00390416|322953573|FG000|Overall Study|Withdrawal by Subject|1|||
94319616|NCT00390416|322953573|FG000|Overall Study|Not treated|3|||
94482015|NCT03428100|323558036|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
94319617|NCT01592409|322953574|FG000|Overall Study|Withdrawal by Subject|0|||
94319618|NCT01592409|322953575|FG001|Overall Study|Withdrawal by Subject|1|||
94319619|NCT01248130|322953576|FG000|Overall Study|Protocol Violation|1|||
94319620|NCT01248130|322953577|FG001|Overall Study|Protocol Violation|0|||
94319621|NCT01248130|322953576|FG000|Overall Study|Ineligible|1|||
94319622|NCT01248130|322953577|FG001|Overall Study|Ineligible|0|||
94319623|NCT02052778|322953578|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
94319624|NCT02052778|322953579|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
94319625|NCT02052778|322953580|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
94319626|NCT02052778|322953581|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
94319627|NCT02052778|322953582|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
94319628|NCT02052778|322953583|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
94319629|NCT02052778|322953584|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
94319630|NCT02052778|322953585|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
94319631|NCT02052778|322953586|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
94319632|NCT02052778|322953587|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
94319633|NCT02052778|322953588|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
94319634|NCT02052778|322953589|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
94319635|NCT02052778|322953590|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
94319636|NCT02052778|322953591|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
94319637|NCT02052778|322953592|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
94319638|NCT02052778|322953593|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
94319639|NCT02052778|322953594|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
94319640|NCT02052778|322953595|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
94319641|NCT02052778|322953596|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
94319642|NCT02052778|322953597|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
94319643|NCT02052778|322953598|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
94319644|NCT02052778|322953599|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
94319645|NCT02052778|322953600|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
94319646|NCT02052778|322953578|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
94319647|NCT02052778|322953579|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
94319648|NCT02052778|322953580|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
94319649|NCT02052778|322953581|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
94319650|NCT02052778|322953582|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
94319651|NCT02052778|322953583|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
94319652|NCT02052778|322953584|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
94319653|NCT02052778|322953585|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
94319654|NCT02052778|322953586|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
94319655|NCT02052778|322953587|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
94319656|NCT02052778|322953588|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
94319657|NCT02052778|322953589|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
94319658|NCT02052778|322953590|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
94319659|NCT02052778|322953591|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
94319660|NCT02052778|322953592|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
94319661|NCT02052778|322953593|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
94319662|NCT02052778|322953594|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
94319663|NCT02052778|322953595|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
94319664|NCT02052778|322953596|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
94319665|NCT02052778|322953597|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
94319666|NCT02052778|322953598|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
94319667|NCT02052778|322953599|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
94319668|NCT02052778|322953600|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
94319669|NCT02052778|322953578|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319670|NCT02052778|322953579|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319671|NCT02052778|322953580|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319672|NCT02052778|322953581|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319673|NCT02052778|322953582|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319674|NCT02052778|322953583|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319675|NCT02052778|322953584|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319676|NCT02052778|322953585|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319677|NCT02052778|322953586|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319678|NCT02052778|322953587|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319679|NCT02052778|322953588|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319680|NCT02052778|322953589|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319681|NCT02052778|322953590|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319682|NCT02052778|322953591|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
94386708|NCT00486837|323202691|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
94386709|NCT02468778|323202694|FG000|Overall Study|Death|2|||
94386710|NCT02468778|323202695|FG001|Overall Study|Death|1|||
94386711|NCT02468778|323202696|FG002|Overall Study|Death|0|||
94386712|NCT02468778|323202694|FG000|Overall Study|Lost to Follow-up|1|||
94386713|NCT02468778|323202695|FG001|Overall Study|Lost to Follow-up|2|||
94386714|NCT02468778|323202696|FG002|Overall Study|Lost to Follow-up|2|||
94386715|NCT02468778|323202694|FG000|Overall Study|Withdrawal by Subject|0|||
94319683|NCT02052778|322953592|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319684|NCT02052778|322953593|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319685|NCT02052778|322953594|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319686|NCT02052778|322953595|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319687|NCT02052778|322953596|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319688|NCT02052778|322953597|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319689|NCT02052778|322953598|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319690|NCT02052778|322953599|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319691|NCT02052778|322953600|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
94319692|NCT02052778|322953578|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
94319693|NCT02052778|322953579|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
94319694|NCT02052778|322953580|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
94319695|NCT02052778|322953581|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
94319696|NCT02052778|322953582|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
94319697|NCT02052778|322953583|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
94319698|NCT02052778|322953584|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
94482016|NCT03428100|323558037|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
94482017|NCT03428100|323558038|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
94482018|NCT03428100|323558039|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
94482019|NCT03428100|323558040|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
94482020|NCT03428100|323558041|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
94482021|NCT03428100|323558042|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
94482022|NCT03428100|323558043|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
94482023|NCT03428100|323558044|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
94482024|NCT03428100|323558045|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
94482025|NCT03428100|323558046|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
94482026|NCT03428100|323558047|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
94482027|NCT03428100|323558048|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
94482028|NCT03428100|323558049|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
94482029|NCT03428100|323558050|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
94482030|NCT03428100|323558051|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
94482031|NCT03428100|323558033|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
94319699|NCT02052778|322953585|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
94319700|NCT02052778|322953586|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
94319701|NCT02052778|322953587|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
94319702|NCT02052778|322953588|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
94319703|NCT02052778|322953589|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
94319704|NCT02052778|322953590|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
94319705|NCT02052778|322953591|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
94319706|NCT02052778|322953592|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
94482032|NCT03428100|323558034|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
94482033|NCT03428100|323558035|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
94482034|NCT03428100|323558036|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
94482035|NCT03428100|323558037|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
94482036|NCT03428100|323558038|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
94482037|NCT03428100|323558039|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
94482038|NCT03428100|323558040|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
94482039|NCT03428100|323558041|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
94482040|NCT03428100|323558042|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
94482041|NCT03428100|323558043|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
94482042|NCT03428100|323558044|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
94482043|NCT03428100|323558045|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
94482044|NCT03428100|323558046|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
94482045|NCT03428100|323558047|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
94482046|NCT03428100|323558048|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
94482047|NCT03428100|323558049|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
94482048|NCT03428100|323558050|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
94482049|NCT03428100|323558051|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
94319707|NCT02052778|322953593|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
94319708|NCT02052778|322953594|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
94319709|NCT02052778|322953595|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
94319710|NCT02052778|322953596|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
94319711|NCT02052778|322953597|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
94319712|NCT02052778|322953598|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
94319713|NCT02052778|322953599|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
94482050|NCT03428100|323558033|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
94482051|NCT03428100|323558034|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
94482052|NCT03428100|323558035|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
94482053|NCT03428100|323558036|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
94319714|NCT02052778|322953600|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
94319715|NCT02052778|322953578|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319716|NCT02052778|322953579|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319717|NCT02052778|322953580|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319718|NCT02052778|322953581|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319719|NCT02052778|322953582|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319720|NCT02052778|322953583|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319721|NCT02052778|322953584|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319722|NCT02052778|322953585|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319723|NCT02052778|322953586|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
94319724|NCT02052778|322953587|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319725|NCT02052778|322953588|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319726|NCT02052778|322953589|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319727|NCT02052778|322953590|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319728|NCT02052778|322953591|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
94319729|NCT02052778|322953592|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319730|NCT02052778|322953593|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319731|NCT02052778|322953594|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319732|NCT02052778|322953595|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319733|NCT02052778|322953596|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319734|NCT02052778|322953597|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319735|NCT02052778|322953598|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319736|NCT02052778|322953599|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319737|NCT02052778|322953600|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
94319738|NCT02052778|322953578|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319739|NCT02052778|322953579|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319740|NCT02052778|322953580|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319741|NCT02052778|322953581|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319742|NCT02052778|322953582|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319743|NCT02052778|322953583|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
94319744|NCT02052778|322953584|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94386716|NCT02468778|323202695|FG001|Overall Study|Withdrawal by Subject|1|||
94386717|NCT02468778|323202696|FG002|Overall Study|Withdrawal by Subject|1|||
94386718|NCT00777829|323202701|FG000|Overall Study|Withdrawal by Subject|0|||
94386719|NCT00777829|323202702|FG001|Overall Study|Withdrawal by Subject|2|||
94386720|NCT00745095|323202708|FG000|Overall Study|Declined to participate|1|||
94386721|NCT00745095|323202709|FG001|Overall Study|Declined to participate|0|||
94386722|NCT00745095|323202710|FG002|Overall Study|Declined to participate|0|||
94386723|NCT00745095|323202711|FG003|Overall Study|Declined to participate|0|||
94386724|NCT00745095|323202712|FG004|Overall Study|Declined to participate|92|||
94386725|NCT00745095|323202713|FG005|Overall Study|Declined to participate|95|||
94386726|NCT00745095|323202708|FG000|Overall Study|Ineligible due to GFR criteria|0|||
94386727|NCT00745095|323202709|FG001|Overall Study|Ineligible due to GFR criteria|2|||
94386728|NCT00745095|323202710|FG002|Overall Study|Ineligible due to GFR criteria|3|||
94386729|NCT00745095|323202711|FG003|Overall Study|Ineligible due to GFR criteria|3|||
94386730|NCT00745095|323202712|FG004|Overall Study|Ineligible due to GFR criteria|30|||
94386731|NCT00745095|323202713|FG005|Overall Study|Ineligible due to GFR criteria|28|||
94386732|NCT01941030|323202720|FG000|Overall Study|Death|3|||
94386733|NCT01941030|323202721|FG001|Overall Study|Death|2|||
94386734|NCT01941030|323202720|FG000|Overall Study|Lost to Follow-up|6|||
94386735|NCT01941030|323202721|FG001|Overall Study|Lost to Follow-up|5|||
94386736|NCT01941030|323202720|FG000|Overall Study|Withdrawal by Subject|4|||
94386737|NCT01941030|323202721|FG001|Overall Study|Withdrawal by Subject|6|||
94386738|NCT01044732|323202722|FG000|Overall Study|Lost to Follow-up|2|||
94386739|NCT01044732|323202723|FG001|Overall Study|Lost to Follow-up|1|||
94386740|NCT01044732|323202722|FG000|Overall Study|Physician Decision|5|||
94386741|NCT01044732|323202723|FG001|Overall Study|Physician Decision|3|||
94386742|NCT01044732|323202722|FG000|Overall Study|Protocol Violation|11|||
94386743|NCT01044732|323202723|FG001|Overall Study|Protocol Violation|12|||
94386744|NCT01044732|323202722|FG000|Overall Study|Withdrawal by Subject|0|||
94386745|NCT01044732|323202723|FG001|Overall Study|Withdrawal by Subject|1|||
94386746|NCT01044732|323202722|FG000|Overall Study|Inadequate bowel preparation|11|||
94482054|NCT03428100|323558037|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
94319745|NCT02052778|322953585|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319746|NCT02052778|322953586|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319747|NCT02052778|322953587|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319748|NCT02052778|322953588|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319749|NCT02052778|322953589|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319750|NCT02052778|322953590|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
94319751|NCT02052778|322953591|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319752|NCT02052778|322953592|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319753|NCT02052778|322953593|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319754|NCT02052778|322953594|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319755|NCT02052778|322953595|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319756|NCT02052778|322953596|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319757|NCT02052778|322953597|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319758|NCT02052778|322953598|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319759|NCT02052778|322953599|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319760|NCT02052778|322953600|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
94319761|NCT02052778|322953578|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
94319762|NCT02052778|322953579|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
94319763|NCT02052778|322953580|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
94319764|NCT02052778|322953581|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
94319765|NCT02052778|322953582|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
94319766|NCT02052778|322953583|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
94319767|NCT02052778|322953584|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
94319768|NCT02052778|322953585|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
94319769|NCT02052778|322953586|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
94319770|NCT02052778|322953587|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
94319771|NCT02052778|322953588|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
94319772|NCT02052778|322953589|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
94319773|NCT02052778|322953590|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
94319774|NCT02052778|322953591|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
94319775|NCT02052778|322953592|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
94319776|NCT02052778|322953593|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
94319777|NCT02052778|322953594|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
94319778|NCT02052778|322953595|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
94319779|NCT02052778|322953596|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
94319780|NCT02052778|322953597|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
94319781|NCT02052778|322953598|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
94319782|NCT02052778|322953599|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
94319783|NCT02052778|322953600|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
94319784|NCT02052778|322953578|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
94319785|NCT02052778|322953579|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
94319786|NCT02052778|322953580|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
94386747|NCT01044732|323202723|FG001|Overall Study|Inadequate bowel preparation|17|||
94386748|NCT01044732|323202722|FG000|Overall Study|Inability to reach cecum|5|||
94386749|NCT01044732|323202723|FG001|Overall Study|Inability to reach cecum|2|||
94386750|NCT01044732|323202722|FG000|Overall Study|Technical error or malfunction|15|||
94386751|NCT01044732|323202723|FG001|Overall Study|Technical error or malfunction|14|||
94386752|NCT02079532|323202730|FG000|Overall Study|Adverse Event|7|||
94386753|NCT02079532|323202730|FG000|Overall Study|Additional or changed therapy|2|||
94386754|NCT02079532|323202730|FG000|Overall Study|Lack of Efficacy|9|||
94386755|NCT02079532|323202730|FG000|Overall Study|Protocol Violation|3|||
94386756|NCT02079532|323202730|FG000|Overall Study|Withdrawal by Subject|1|||
94386757|NCT02079532|323202730|FG000|Overall Study|Administrative problems|1|||
94386758|NCT02079532|323202730|FG000|Overall Study|Inclusion into ReFIRST|3|||
94386759|NCT02079532|323202730|FG000|Overall Study|Other|3|||
94386760|NCT02682602|323202731|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
94386761|NCT02682602|323202732|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
94386762|NCT02682602|323202731|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
94386763|NCT02682602|323202732|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
94386764|NCT00076102|323204694|FG000|Overall Study|Clinical progression|1|||
94386765|NCT00076102|323204694|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
94386766|NCT00076102|323204694|FG000|Overall Study|plexiform neurofibroma surgery|1|||
94386767|NCT00076102|323204694|FG000|Overall Study|refusal of further therapy|2|||
94386768|NCT02395822|323204700|FG000|Overall Study|Withdrawal by Subject|1|||
94386769|NCT02395822|323204700|FG000|Overall Study|Death|1|||
94319787|NCT02052778|322953581|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
94319788|NCT02052778|322953582|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
94319789|NCT02052778|322953583|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
94319790|NCT02052778|322953584|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
94319791|NCT02052778|322953585|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
94319792|NCT02052778|322953586|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
94319793|NCT02052778|322953587|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
94319794|NCT02052778|322953588|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
94319795|NCT02052778|322953589|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
94319796|NCT02052778|322953590|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
94319797|NCT02052778|322953591|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
94319798|NCT02052778|322953592|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
94319799|NCT02052778|322953593|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
94319800|NCT02052778|322953594|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
94319801|NCT02052778|322953595|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
94319802|NCT02052778|322953596|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
94319803|NCT02052778|322953597|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
94319804|NCT02052778|322953598|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
94319805|NCT02052778|322953599|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
94319806|NCT02052778|322953600|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
94319807|NCT02052778|322953578|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
94319808|NCT02052778|322953579|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
94319809|NCT02052778|322953580|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
94319810|NCT02052778|322953581|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
94319811|NCT02052778|322953582|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
94319812|NCT02052778|322953583|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
94319813|NCT02052778|322953584|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
94319814|NCT02052778|322953585|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
94319815|NCT02052778|322953586|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
94319816|NCT02052778|322953587|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
94319817|NCT02052778|322953588|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
94319818|NCT02052778|322953589|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
94319819|NCT02052778|322953590|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
94319820|NCT02052778|322953591|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
94319821|NCT02052778|322953592|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
94319822|NCT02052778|322953593|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
94319823|NCT02052778|322953594|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
94319824|NCT02052778|322953595|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
94319825|NCT02052778|322953596|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
94319826|NCT02052778|322953597|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
94319827|NCT02052778|322953598|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
94319828|NCT02052778|322953599|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
94319829|NCT02052778|322953600|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
94319830|NCT02052778|322953578|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319831|NCT02052778|322953579|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319832|NCT02052778|322953580|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319833|NCT02052778|322953581|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319834|NCT02052778|322953582|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319835|NCT02052778|322953583|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319836|NCT02052778|322953584|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319837|NCT02052778|322953585|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319838|NCT02052778|322953586|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319839|NCT02052778|322953587|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319840|NCT02052778|322953588|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319841|NCT02052778|322953589|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319842|NCT02052778|322953590|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319843|NCT02052778|322953591|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319844|NCT02052778|322953592|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
94319845|NCT02052778|322953593|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
94319846|NCT02052778|322953594|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319847|NCT02052778|322953595|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319848|NCT02052778|322953596|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319849|NCT02052778|322953597|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319850|NCT02052778|322953598|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319851|NCT02052778|322953599|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319852|NCT02052778|322953600|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
94319853|NCT02052778|322953578|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319854|NCT02052778|322953579|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319855|NCT02052778|322953580|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319856|NCT02052778|322953581|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319857|NCT02052778|322953582|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319858|NCT02052778|322953583|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319859|NCT02052778|322953584|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319860|NCT02052778|322953585|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319861|NCT02052778|322953586|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319862|NCT02052778|322953587|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319863|NCT02052778|322953588|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319864|NCT02052778|322953589|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319865|NCT02052778|322953590|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319866|NCT02052778|322953591|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319867|NCT02052778|322953592|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
94319868|NCT02052778|322953593|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
94319869|NCT02052778|322953594|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319870|NCT02052778|322953595|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319871|NCT02052778|322953596|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319872|NCT02052778|322953597|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
94386770|NCT00453362|323204703|FG000|Overall Study|Adverse Event|5|||
94386771|NCT00453362|323204703|FG000|Overall Study|Death|7|||
94386772|NCT00453362|323204703|FG000|Overall Study|Physician Decision|2|||
94386773|NCT00453362|323204703|FG000|Overall Study|Withdrawal by Subject|3|||
94386774|NCT00453362|323204703|FG000|Overall Study|Progression of disease|56|||
94386775|NCT00453362|323204703|FG000|Overall Study|Screening Failure|14|||
94386776|NCT04885296|323204704|FG000|Period 1|Covid-19 Related|1|||
94386777|NCT04885296|323204705|FG001|Period 1|Covid-19 Related|0|||
94386778|NCT04885296|323204704|FG000|Period 1|Adverse Event|0|||
94386779|NCT04885296|323204705|FG001|Period 1|Adverse Event|1|||
94386780|NCT04885296|323204704|FG000|Period 1|Withdrawal by Subject|1|||
94386781|NCT04885296|323204705|FG001|Period 1|Withdrawal by Subject|1|||
94386782|NCT04885296|323204704|FG000|Period 1|Test Article No Longer Available|1|||
94386783|NCT04885296|323204705|FG001|Period 1|Test Article No Longer Available|0|||
94386784|NCT04885296|323204704|FG000|Period 1|Dispensed Study lens in Error|1|||
94386785|NCT04885296|323204705|FG001|Period 1|Dispensed Study lens in Error|0|||
94386786|NCT04885296|323204704|FG000|Period 1|Lost to Follow-up|1|||
94386787|NCT04885296|323204705|FG001|Period 1|Lost to Follow-up|0|||
94386788|NCT04885296|323204704|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
94386789|NCT04885296|323204705|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
94386790|NCT03100903|323204706|FG000|Overall Study|Withdrawal by Subject|0|||
94386791|NCT03100903|323204707|FG001|Overall Study|Withdrawal by Subject|0|||
94386792|NCT03100903|323204708|FG002|Overall Study|Withdrawal by Subject|1|||
94386793|NCT00433147|323204709|FG000|Overall Study|Adverse Event|0|||
94386794|NCT00433147|323204710|FG001|Overall Study|Adverse Event|1|||
94386795|NCT00433147|323204711|FG002|Overall Study|Adverse Event|0|||
94386796|NCT00433147|323204712|FG003|Overall Study|Adverse Event|0|||
94386797|NCT01027143|323204713|FG000|Overall Study|Lost to Follow-up|9|||
94386798|NCT01027143|323204714|FG001|Overall Study|Lost to Follow-up|4|||
94386799|NCT03292653|323204716|FG000|Overall Study|Adverse Event|0|||
94386800|NCT03292653|323204717|FG001|Overall Study|Adverse Event|0|||
94386801|NCT03292653|323204718|FG002|Overall Study|Adverse Event|1|||
94386802|NCT03292653|323204716|FG000|Overall Study|Did not Receive Treatment|1|||
94386803|NCT03292653|323204717|FG001|Overall Study|Did not Receive Treatment|0|||
94386804|NCT03292653|323204718|FG002|Overall Study|Did not Receive Treatment|0|||
94386805|NCT02918877|323204719|FG000|Overall Study|Withdrawal by Subject|2|||
94386806|NCT02918877|323204720|FG001|Overall Study|Withdrawal by Subject|2|||
94386807|NCT02918877|323204719|FG000|Overall Study|Surgery cancelled|1|||
94386808|NCT02918877|323204720|FG001|Overall Study|Surgery cancelled|0|||
94386809|NCT02918877|323204719|FG000|Overall Study|Physician Decision|1|||
94386810|NCT02918877|323204720|FG001|Overall Study|Physician Decision|0|||
94386811|NCT02918877|323204719|FG000|Overall Study|Received intraoperative steroids|1|||
94386812|NCT02918877|323204720|FG001|Overall Study|Received intraoperative steroids|0|||
94386813|NCT02918877|323204719|FG000|Overall Study|Unable to obtain lab samples|1|||
94386814|NCT02918877|323204720|FG001|Overall Study|Unable to obtain lab samples|0|||
94386815|NCT02918877|323204719|FG000|Overall Study|Unsafe to perform BAL|0|||
94386816|NCT02918877|323204720|FG001|Overall Study|Unsafe to perform BAL|1|||
94386817|NCT00883090|323204721|FG000|Overall Study|Sponsor's decision|1|||
94319873|NCT02052778|322953598|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319874|NCT02052778|322953599|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319875|NCT02052778|322953600|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
94319876|NCT02052778|322953578|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
94319877|NCT02052778|322953579|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
94319878|NCT02052778|322953580|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
94319879|NCT02052778|322953581|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
94319880|NCT02052778|322953582|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
94319881|NCT02052778|322953583|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
94319882|NCT02052778|322953584|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
94319883|NCT02052778|322953585|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
94319884|NCT02052778|322953586|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
94319885|NCT02052778|322953587|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
94319886|NCT02052778|322953588|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
94319887|NCT02052778|322953589|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
94319888|NCT02052778|322953590|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
94319889|NCT02052778|322953591|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
94319890|NCT02052778|322953592|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
94319891|NCT02052778|322953593|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
94319892|NCT02052778|322953594|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
94319893|NCT02052778|322953595|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
94319894|NCT02052778|322953596|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
94319895|NCT02052778|322953597|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
94319896|NCT02052778|322953598|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
94319897|NCT02052778|322953599|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
94319898|NCT02052778|322953600|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
94319899|NCT02052778|322953578|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319900|NCT02052778|322953579|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319901|NCT02052778|322953580|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319902|NCT02052778|322953581|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319903|NCT02052778|322953582|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319904|NCT02052778|322953583|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319905|NCT02052778|322953584|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319906|NCT02052778|322953585|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319907|NCT02052778|322953586|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319908|NCT02052778|322953587|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319909|NCT02052778|322953588|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319910|NCT02052778|322953589|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319911|NCT02052778|322953590|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319912|NCT02052778|322953591|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319913|NCT02052778|322953592|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
94319914|NCT02052778|322953593|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
94319915|NCT02052778|322953594|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
94319916|NCT02052778|322953595|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319917|NCT02052778|322953596|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
94319918|NCT02052778|322953597|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319919|NCT02052778|322953598|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319920|NCT02052778|322953599|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319921|NCT02052778|322953600|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
94319922|NCT02052778|322953578|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319923|NCT02052778|322953579|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319924|NCT02052778|322953580|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319925|NCT02052778|322953581|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319926|NCT02052778|322953582|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319927|NCT02052778|322953583|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319928|NCT02052778|322953584|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319929|NCT02052778|322953585|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319930|NCT02052778|322953586|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319931|NCT02052778|322953587|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319932|NCT02052778|322953588|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319933|NCT02052778|322953589|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319934|NCT02052778|322953590|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319935|NCT02052778|322953591|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319936|NCT02052778|322953592|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319937|NCT02052778|322953593|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319938|NCT02052778|322953594|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319939|NCT02052778|322953595|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319940|NCT02052778|322953596|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319941|NCT02052778|322953597|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319942|NCT02052778|322953598|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319943|NCT02052778|322953599|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
94319944|NCT02052778|322953600|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
94319945|NCT02052778|322953578|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319946|NCT02052778|322953579|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319947|NCT02052778|322953580|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319948|NCT02052778|322953581|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319949|NCT02052778|322953582|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319950|NCT02052778|322953583|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319951|NCT02052778|322953584|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319952|NCT02052778|322953585|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319953|NCT02052778|322953586|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319954|NCT02052778|322953587|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319955|NCT02052778|322953588|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319956|NCT02052778|322953589|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319957|NCT02052778|322953590|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319958|NCT02052778|322953591|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319959|NCT02052778|322953592|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319960|NCT02052778|322953593|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319961|NCT02052778|322953594|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319962|NCT02052778|322953595|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319963|NCT02052778|322953596|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319964|NCT02052778|322953597|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319965|NCT02052778|322953598|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319966|NCT02052778|322953599|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
94319967|NCT02052778|322953600|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
94319968|NCT02052778|322953578|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319969|NCT02052778|322953579|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319970|NCT02052778|322953580|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319971|NCT02052778|322953581|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319972|NCT02052778|322953582|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319973|NCT02052778|322953583|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319974|NCT02052778|322953584|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319975|NCT02052778|322953585|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319976|NCT02052778|322953586|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319977|NCT02052778|322953587|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319978|NCT02052778|322953588|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319979|NCT02052778|322953589|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319980|NCT02052778|322953590|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319981|NCT02052778|322953591|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319982|NCT02052778|322953592|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319983|NCT02052778|322953593|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319984|NCT02052778|322953594|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319985|NCT02052778|322953595|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319986|NCT02052778|322953596|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319987|NCT02052778|322953597|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319988|NCT02052778|322953598|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319989|NCT02052778|322953599|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
94319990|NCT02052778|322953600|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
94319991|NCT02052778|322953578|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94319992|NCT02052778|322953579|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94319993|NCT02052778|322953580|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94319994|NCT02052778|322953581|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94319995|NCT02052778|322953582|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94319996|NCT02052778|322953583|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94319997|NCT02052778|322953584|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94319998|NCT02052778|322953585|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94319999|NCT02052778|322953586|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94320000|NCT02052778|322953587|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94320001|NCT02052778|322953588|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94482055|NCT03428100|323558038|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
94482056|NCT03428100|323558039|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
94320002|NCT02052778|322953589|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94320003|NCT02052778|322953590|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94320004|NCT02052778|322953591|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94320005|NCT02052778|322953592|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94320006|NCT02052778|322953593|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94320007|NCT02052778|322953594|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94320008|NCT02052778|322953595|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94320009|NCT02052778|322953596|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94320010|NCT02052778|322953597|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94320011|NCT02052778|322953598|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94320012|NCT02052778|322953599|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
94320013|NCT02052778|322953600|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
94320014|NCT02052778|322953578|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320015|NCT02052778|322953579|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320016|NCT02052778|322953580|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320017|NCT02052778|322953581|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320018|NCT02052778|322953582|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320019|NCT02052778|322953583|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320020|NCT02052778|322953584|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320021|NCT02052778|322953585|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320022|NCT02052778|322953586|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320023|NCT02052778|322953587|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320024|NCT02052778|322953588|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320025|NCT02052778|322953589|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320026|NCT02052778|322953590|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320027|NCT02052778|322953591|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320028|NCT02052778|322953592|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320029|NCT02052778|322953593|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320030|NCT02052778|322953594|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320031|NCT02052778|322953595|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320032|NCT02052778|322953596|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320033|NCT02052778|322953597|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320034|NCT02052778|322953598|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94386818|NCT00883090|323204721|FG000|Overall Study|Withdrawal by Subject|1|||
94386819|NCT02532764|323204722|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
94386820|NCT02532764|323204723|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
94386821|NCT02532764|323204724|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
94386822|NCT02532764|323204725|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
94386823|NCT02532764|323204726|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
94386824|NCT02532764|323204727|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
94386825|NCT02532764|323204728|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
94386826|NCT02532764|323204729|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
94386827|NCT02532764|323204730|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
94386828|NCT02532764|323204731|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
94386829|NCT01492361|323204732|FG000|Overall Study|Withdrawal by Subject|281|||
94386830|NCT01492361|323204733|FG001|Overall Study|Withdrawal by Subject|297|||
94386831|NCT01492361|323204732|FG000|Overall Study|Physician Decision|12|||
94386832|NCT01492361|323204733|FG001|Overall Study|Physician Decision|12|||
94386833|NCT01492361|323204732|FG000|Overall Study|Lost to Follow-up|6|||
94386834|NCT01492361|323204733|FG001|Overall Study|Lost to Follow-up|13|||
94386835|NCT01492361|323204732|FG000|Overall Study|Other than specified above|106|||
94386836|NCT01492361|323204733|FG001|Overall Study|Other than specified above|138|||
94386837|NCT03527745|323204734|FG000|Overall Study|Lost to Follow-up|3|||
94386838|NCT03527745|323204735|FG001|Overall Study|Lost to Follow-up|6|||
94386839|NCT03527745|323204736|FG002|Overall Study|Lost to Follow-up|7|||
94386840|NCT03527745|323204737|FG003|Overall Study|Lost to Follow-up|9|||
94386841|NCT03527745|323204738|FG004|Overall Study|Lost to Follow-up|0|||
94386842|NCT03527745|323204739|FG005|Overall Study|Lost to Follow-up|2|||
94386843|NCT03527745|323204740|FG006|Overall Study|Lost to Follow-up|3|||
94386844|NCT03527745|323204741|FG007|Overall Study|Lost to Follow-up|2|||
94386845|NCT03527745|323204742|FG008|Overall Study|Lost to Follow-up|3|||
94386846|NCT03527745|323204743|FG009|Overall Study|Lost to Follow-up|2|||
94386847|NCT03527745|323204744|FG010|Overall Study|Lost to Follow-up|1|||
94386848|NCT03527745|323204745|FG011|Overall Study|Lost to Follow-up|1|||
94386849|NCT03527745|323204746|FG012|Overall Study|Lost to Follow-up|0|||
94386850|NCT03527745|323204747|FG013|Overall Study|Lost to Follow-up|0|||
94386851|NCT03527745|323204748|FG014|Overall Study|Lost to Follow-up|0|||
94386852|NCT03527745|323204749|FG015|Overall Study|Lost to Follow-up|0|||
94386853|NCT03527745|323204750|FG016|Overall Study|Lost to Follow-up|1|||
94320035|NCT02052778|322953599|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
94320036|NCT02052778|322953600|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
94320037|NCT02052778|322953578|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
94320038|NCT02052778|322953579|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
94320039|NCT02052778|322953580|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
94320040|NCT02052778|322953581|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
94320041|NCT02052778|322953582|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
94320042|NCT02052778|322953583|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
94320043|NCT02052778|322953584|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
94320044|NCT02052778|322953585|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
94320045|NCT02052778|322953586|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
94320046|NCT02052778|322953587|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
94320047|NCT02052778|322953588|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
94320048|NCT02052778|322953589|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
94320049|NCT02052778|322953590|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
94320050|NCT02052778|322953591|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
94320051|NCT02052778|322953592|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
94320052|NCT02052778|322953593|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
94320053|NCT02052778|322953594|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
94320054|NCT02052778|322953595|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
94320055|NCT02052778|322953596|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
94320056|NCT02052778|322953597|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
94320057|NCT02052778|322953598|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
94320058|NCT02052778|322953599|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
94320059|NCT02052778|322953600|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
94320060|NCT02052778|322953578|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320061|NCT02052778|322953579|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320062|NCT02052778|322953580|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320063|NCT02052778|322953581|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320064|NCT02052778|322953582|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320065|NCT02052778|322953583|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320066|NCT02052778|322953584|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320067|NCT02052778|322953585|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320068|NCT02052778|322953586|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320069|NCT02052778|322953587|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320070|NCT02052778|322953588|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320071|NCT02052778|322953589|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320072|NCT02052778|322953590|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320073|NCT02052778|322953591|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320074|NCT02052778|322953592|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320075|NCT02052778|322953593|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320076|NCT02052778|322953594|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320077|NCT02052778|322953595|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320078|NCT02052778|322953596|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320079|NCT02052778|322953597|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320080|NCT02052778|322953598|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320081|NCT02052778|322953599|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
94320082|NCT02052778|322953600|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
94320083|NCT01911845|322953601|FG000|Overall Study|Adverse Event|2|||
94320084|NCT01911845|322953601|FG000|Overall Study|Lost to Follow-up|1|||
94320085|NCT01911845|322953601|FG000|Overall Study|Other (not specified)|3|||
94320086|NCT01188564|322953612|FG000|Double-blind Phase|randomized not treated|1|||
94320087|NCT01188564|322953613|FG001|Double-blind Phase|randomized not treated|0|||
94320088|NCT01934894|322953614|FG000|Overall Study|Adverse Event|1|||
94320089|NCT01934894|322953615|FG001|Overall Study|Adverse Event|2|||
94320090|NCT01934894|322953614|FG000|Overall Study|Death|2|||
94320091|NCT01934894|322953615|FG001|Overall Study|Death|0|||
94320092|NCT01934894|322953614|FG000|Overall Study|Withdrawal by Subject|0|||
94320093|NCT01934894|322953615|FG001|Overall Study|Withdrawal by Subject|1|||
94320094|NCT01934894|322953614|FG000|Overall Study|Progressive Disease|3|||
94320095|NCT01934894|322953615|FG001|Overall Study|Progressive Disease|2|||
94320096|NCT00779324|322953616|FG000|Overall Study|Lost to Follow-up|2|||
94320097|NCT00779324|322953617|FG001|Overall Study|Lost to Follow-up|1|||
94320098|NCT00779324|322953616|FG000|Overall Study|Withdrawal by Subject|4|||
94320099|NCT00779324|322953617|FG001|Overall Study|Withdrawal by Subject|2|||
94320100|NCT00779324|322953616|FG000|Overall Study|Missed visit|1|||
94320101|NCT00779324|322953617|FG001|Overall Study|Missed visit|1|||
94320102|NCT01496430|322953618|FG000|Overall Study|Adverse Event|0|||
94320103|NCT01496430|322953619|FG001|Overall Study|Adverse Event|0|||
94320104|NCT01496430|322953620|FG002|Overall Study|Adverse Event|1|||
94320105|NCT01496430|322953618|FG000|Overall Study|Major Protocol Deviation|0|||
94320106|NCT01496430|322953619|FG001|Overall Study|Major Protocol Deviation|0|||
94320107|NCT01496430|322953620|FG002|Overall Study|Major Protocol Deviation|1|||
94320108|NCT01496430|322953618|FG000|Overall Study|Lost to Follow-up|2|||
94320109|NCT01496430|322953619|FG001|Overall Study|Lost to Follow-up|3|||
94320110|NCT01496430|322953620|FG002|Overall Study|Lost to Follow-up|1|||
94320111|NCT01496430|322953618|FG000|Overall Study|Voluntary Withdrawal|2|||
94320112|NCT01496430|322953619|FG001|Overall Study|Voluntary Withdrawal|1|||
94320113|NCT01496430|322953620|FG002|Overall Study|Voluntary Withdrawal|6|||
94320114|NCT01496430|322953618|FG000|Overall Study|Principal Investigator Discretion|0|||
94320115|NCT01496430|322953619|FG001|Overall Study|Principal Investigator Discretion|1|||
94320116|NCT01496430|322953620|FG002|Overall Study|Principal Investigator Discretion|1|||
94320117|NCT01496430|322953618|FG000|Overall Study|Other|2|||
94320118|NCT01496430|322953619|FG001|Overall Study|Other|0|||
94320119|NCT01496430|322953620|FG002|Overall Study|Other|0|||
94320120|NCT02605447|322953628|FG000|Overall Study|Death|66|||
94320121|NCT02605447|322953628|FG000|Overall Study|Physician Decision|1|||
94320122|NCT02605447|322953628|FG000|Overall Study|Lost to Follow-up|24|||
94320123|NCT02605447|322953628|FG000|Overall Study|Withdrawal by Subject|10|||
94320124|NCT02605447|322953628|FG000|Overall Study|Not disclosed|1|||
94320125|NCT02993146|322953630|FG000|Overall Study|Withdrawal by Subject|0|||
94320126|NCT02993146|322953631|FG001|Overall Study|Withdrawal by Subject|0|||
94320127|NCT02993146|322953632|FG002|Overall Study|Withdrawal by Subject|1|||
94320128|NCT02993146|322953633|FG003|Overall Study|Withdrawal by Subject|1|||
94320129|NCT02951988|322953634|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
94320130|NCT02951988|322953635|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
94320131|NCT02951988|322953636|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
94320132|NCT02951988|322953637|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
94320133|NCT02951988|322953634|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
94320134|NCT02951988|322953635|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
94320135|NCT02951988|322953636|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
94320136|NCT02951988|322953637|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
94320137|NCT02951988|322953634|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
94320138|NCT02951988|322953635|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
94320139|NCT02951988|322953636|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
94320140|NCT02951988|322953637|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
94320141|NCT02951988|322953634|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
94320142|NCT02951988|322953635|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
94320143|NCT02951988|322953636|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
94320144|NCT02951988|322953637|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
94320145|NCT02951988|322953634|FG000|Open-Label Treatment Period|Protocol Violation|22|||
94320146|NCT02951988|322953635|FG001|Open-Label Treatment Period|Protocol Violation|0|||
94320147|NCT02951988|322953636|FG002|Open-Label Treatment Period|Protocol Violation|0|||
94320148|NCT02951988|322953637|FG003|Open-Label Treatment Period|Protocol Violation|0|||
94320149|NCT02951988|322953634|FG000|Open-Label Treatment Period|Pregnancy|2|||
94320150|NCT02951988|322953635|FG001|Open-Label Treatment Period|Pregnancy|0|||
94320151|NCT02951988|322953636|FG002|Open-Label Treatment Period|Pregnancy|0|||
94320152|NCT02951988|322953637|FG003|Open-Label Treatment Period|Pregnancy|0|||
94320153|NCT02951988|322953634|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
94320154|NCT02951988|322953635|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
94320155|NCT02951988|322953636|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
94320156|NCT02951988|322953637|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
94320157|NCT02951988|322953634|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
94320158|NCT02951988|322953635|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
94320159|NCT02951988|322953636|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
94320160|NCT02951988|322953637|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
94320161|NCT02951988|322953634|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
94320162|NCT02951988|322953635|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
94320163|NCT02951988|322953636|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
94320164|NCT02951988|322953637|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
94320165|NCT02951988|322953634|FG000|Open-Label Treatment Period|Adverse Event|45|||
94320166|NCT02951988|322953635|FG001|Open-Label Treatment Period|Adverse Event|0|||
94320167|NCT02951988|322953636|FG002|Open-Label Treatment Period|Adverse Event|0|||
94320168|NCT02951988|322953637|FG003|Open-Label Treatment Period|Adverse Event|0|||
94320169|NCT02951988|322953634|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
94320170|NCT02951988|322953635|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
94320171|NCT02951988|322953636|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
94320172|NCT02951988|322953637|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
94320173|NCT02951988|322953634|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
94320174|NCT02951988|322953635|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
94320175|NCT02951988|322953636|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
94320176|NCT02951988|322953637|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
94320177|NCT02951988|322953634|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
94320178|NCT02951988|322953635|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
94320179|NCT02951988|322953636|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
94320180|NCT02951988|322953637|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
94320181|NCT02951988|322953634|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
94320182|NCT02951988|322953635|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
94320183|NCT02951988|322953636|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
94320184|NCT02951988|322953637|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
94320185|NCT02951988|322953634|FG000|Double-Blind Treatment Period|Pregnancy|0|||
94320186|NCT02951988|322953635|FG001|Double-Blind Treatment Period|Pregnancy|1|||
94320187|NCT02951988|322953636|FG002|Double-Blind Treatment Period|Pregnancy|1|||
94320188|NCT02951988|322953637|FG003|Double-Blind Treatment Period|Pregnancy|0|||
94320189|NCT02951988|322953634|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
94320190|NCT02951988|322953635|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
94320191|NCT02951988|322953636|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
94320192|NCT02951988|322953637|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
94320193|NCT02951988|322953634|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
94320194|NCT02951988|322953635|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
94320195|NCT02951988|322953636|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
94320196|NCT02951988|322953637|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
94320197|NCT02951988|322953634|FG000|Double-Blind Treatment Period|Adverse Event|0|||
94320198|NCT02951988|322953635|FG001|Double-Blind Treatment Period|Adverse Event|8|||
94320199|NCT02951988|322953636|FG002|Double-Blind Treatment Period|Adverse Event|3|||
94320200|NCT02951988|322953637|FG003|Double-Blind Treatment Period|Adverse Event|6|||
94320201|NCT02951988|322953634|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
94320202|NCT02951988|322953635|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
94320203|NCT02951988|322953636|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
94320204|NCT02951988|322953637|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
94320205|NCT01599754|322953638|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
94320206|NCT01599754|322953639|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
94320207|NCT01599754|322953638|FG000|Overall Study|Participant noncompliance|4|||
94320208|NCT01599754|322953639|FG001|Overall Study|Participant noncompliance|4|||
94320209|NCT01599754|322953638|FG000|Overall Study|Lost to Follow-up|13|||
94320210|NCT01599754|322953639|FG001|Overall Study|Lost to Follow-up|6|||
94320211|NCT01599754|322953638|FG000|Overall Study|Death|31|||
94320212|NCT01599754|322953639|FG001|Overall Study|Death|33|||
94320213|NCT01599754|322953638|FG000|Overall Study|Adverse Event|3|||
94320214|NCT01599754|322953639|FG001|Overall Study|Adverse Event|2|||
94320215|NCT01599754|322953638|FG000|Overall Study|Investigator decision|1|||
94320216|NCT01599754|322953639|FG001|Overall Study|Investigator decision|3|||
94320217|NCT01599754|322953638|FG000|Overall Study|Withdrawal by Subject|24|||
94320218|NCT01599754|322953639|FG001|Overall Study|Withdrawal by Subject|25|||
94320219|NCT01599754|322953638|FG000|Overall Study|Study terminated by sponsor|282|||
94320220|NCT01599754|322953639|FG001|Overall Study|Study terminated by sponsor|285|||
94320221|NCT03136185|322953640|FG000|Overall Study|Adverse Event|0|||
94320222|NCT03136185|322953641|FG001|Overall Study|Adverse Event|1|||
94320223|NCT03136185|322953642|FG002|Overall Study|Adverse Event|3|||
94320224|NCT03136185|322953643|FG003|Overall Study|Adverse Event|1|||
94320225|NCT03136185|322953644|FG004|Overall Study|Adverse Event|2|||
94320226|NCT03136185|322953645|FG005|Overall Study|Adverse Event|2|||
94320227|NCT03136185|322953646|FG006|Overall Study|Adverse Event|5|||
94320228|NCT03136185|322953647|FG007|Overall Study|Adverse Event|1|||
94320229|NCT03136185|322953648|FG008|Overall Study|Adverse Event|1|||
94320230|NCT03136185|322953640|FG000|Overall Study|Death|0|||
94320231|NCT03136185|322953641|FG001|Overall Study|Death|0|||
94320232|NCT03136185|322953642|FG002|Overall Study|Death|0|||
94320233|NCT03136185|322953643|FG003|Overall Study|Death|1|||
94320234|NCT03136185|322953644|FG004|Overall Study|Death|1|||
94320235|NCT03136185|322953645|FG005|Overall Study|Death|0|||
94320236|NCT03136185|322953646|FG006|Overall Study|Death|1|||
94320237|NCT03136185|322953647|FG007|Overall Study|Death|0|||
94320238|NCT03136185|322953648|FG008|Overall Study|Death|0|||
94320239|NCT03136185|322953640|FG000|Overall Study|Physician Decision|3|||
94320240|NCT03136185|322953641|FG001|Overall Study|Physician Decision|1|||
94320241|NCT03136185|322953642|FG002|Overall Study|Physician Decision|1|||
94320242|NCT03136185|322953643|FG003|Overall Study|Physician Decision|2|||
94320243|NCT03136185|322953644|FG004|Overall Study|Physician Decision|1|||
94482057|NCT03428100|323558040|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
94482058|NCT03428100|323558041|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
94482059|NCT03428100|323558042|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
94320244|NCT03136185|322953645|FG005|Overall Study|Physician Decision|2|||
94320245|NCT03136185|322953646|FG006|Overall Study|Physician Decision|1|||
94320246|NCT03136185|322953647|FG007|Overall Study|Physician Decision|0|||
94320247|NCT03136185|322953648|FG008|Overall Study|Physician Decision|1|||
94320248|NCT03136185|322953640|FG000|Overall Study|Protocol Defined Disease Progression|0|||
94320249|NCT03136185|322953641|FG001|Overall Study|Protocol Defined Disease Progression|0|||
94320250|NCT03136185|322953642|FG002|Overall Study|Protocol Defined Disease Progression|1|||
94320251|NCT03136185|322953643|FG003|Overall Study|Protocol Defined Disease Progression|0|||
94320252|NCT03136185|322953644|FG004|Overall Study|Protocol Defined Disease Progression|0|||
94320253|NCT03136185|322953645|FG005|Overall Study|Protocol Defined Disease Progression|1|||
94320254|NCT03136185|322953646|FG006|Overall Study|Protocol Defined Disease Progression|0|||
94320255|NCT03136185|322953647|FG007|Overall Study|Protocol Defined Disease Progression|1|||
94320256|NCT03136185|322953648|FG008|Overall Study|Protocol Defined Disease Progression|1|||
94320257|NCT03136185|322953640|FG000|Overall Study|Withdrawal by Subject|1|||
94320258|NCT03136185|322953641|FG001|Overall Study|Withdrawal by Subject|0|||
94320259|NCT03136185|322953642|FG002|Overall Study|Withdrawal by Subject|1|||
94320260|NCT03136185|322953643|FG003|Overall Study|Withdrawal by Subject|1|||
94320261|NCT03136185|322953644|FG004|Overall Study|Withdrawal by Subject|1|||
94320262|NCT03136185|322953645|FG005|Overall Study|Withdrawal by Subject|1|||
94320263|NCT03136185|322953646|FG006|Overall Study|Withdrawal by Subject|2|||
94320264|NCT03136185|322953647|FG007|Overall Study|Withdrawal by Subject|3|||
94320265|NCT03136185|322953648|FG008|Overall Study|Withdrawal by Subject|3|||
94320266|NCT03136185|322953640|FG000|Overall Study|Not Reported|4|||
94320267|NCT03136185|322953641|FG001|Overall Study|Not Reported|1|||
94320268|NCT03136185|322953642|FG002|Overall Study|Not Reported|0|||
94320269|NCT03136185|322953643|FG003|Overall Study|Not Reported|1|||
94320270|NCT03136185|322953644|FG004|Overall Study|Not Reported|0|||
94320271|NCT03136185|322953645|FG005|Overall Study|Not Reported|2|||
94320272|NCT03136185|322953646|FG006|Overall Study|Not Reported|1|||
94320273|NCT03136185|322953647|FG007|Overall Study|Not Reported|1|||
94320274|NCT03136185|322953648|FG008|Overall Study|Not Reported|0|||
94320275|NCT00807846|322953649|FG000|Overall Study|Adverse Event|5|||
94320276|NCT00807846|322953650|FG001|Overall Study|Adverse Event|0|||
94320277|NCT00807846|322953649|FG000|Overall Study|Lack of Efficacy|2|||
94320278|NCT00807846|322953650|FG001|Overall Study|Lack of Efficacy|0|||
94320279|NCT00807846|322953649|FG000|Overall Study|Protocol Violation|2|||
94320280|NCT00807846|322953650|FG001|Overall Study|Protocol Violation|1|||
94320281|NCT00807846|322953649|FG000|Overall Study|Withdrawal by Subject|2|||
94320282|NCT00807846|322953650|FG001|Overall Study|Withdrawal by Subject|1|||
94320283|NCT00807846|322953649|FG000|Overall Study|Other|1|||
94320284|NCT00807846|322953650|FG001|Overall Study|Other|2|||
94320285|NCT00634244|322953652|FG000|Overall Study|Never started treatment|0|||
94320286|NCT00634244|322953653|FG001|Overall Study|Never started treatment|1|||
94320287|NCT00634244|322953654|FG002|Overall Study|Never started treatment|0|||
94320288|NCT00634244|322953652|FG000|Overall Study|Death|1|||
94320289|NCT00634244|322953653|FG001|Overall Study|Death|6|||
94320290|NCT00634244|322953654|FG002|Overall Study|Death|0|||
94320291|NCT00634244|322953652|FG000|Overall Study|Adverse Event|0|||
94320292|NCT00634244|322953653|FG001|Overall Study|Adverse Event|2|||
94320293|NCT00634244|322953654|FG002|Overall Study|Adverse Event|0|||
94320294|NCT00634244|322953652|FG000|Overall Study|Withdrawal by Subject|0|||
94320295|NCT00634244|322953653|FG001|Overall Study|Withdrawal by Subject|1|||
94320296|NCT00634244|322953654|FG002|Overall Study|Withdrawal by Subject|0|||
94320297|NCT00634244|322953652|FG000|Overall Study|Physician Decision|0|||
94320298|NCT00634244|322953653|FG001|Overall Study|Physician Decision|1|||
94320299|NCT00634244|322953654|FG002|Overall Study|Physician Decision|0|||
94320300|NCT00634244|322953652|FG000|Overall Study|Disease progression/relapse|0|||
94320301|NCT00634244|322953653|FG001|Overall Study|Disease progression/relapse|1|||
94320302|NCT00634244|322953654|FG002|Overall Study|Disease progression/relapse|0|||
94320303|NCT00634244|322953652|FG000|Overall Study|Other complicating disease|0|||
94320304|NCT00634244|322953653|FG001|Overall Study|Other complicating disease|1|||
94320305|NCT00634244|322953654|FG002|Overall Study|Other complicating disease|0|||
94320306|NCT02632110|322953655|FG000|Overall Study|Withdrawal by Subject|1|||
94320307|NCT02632110|322953656|FG001|Overall Study|Withdrawal by Subject|1|||
94320308|NCT02632110|322953657|FG002|Overall Study|Withdrawal by Subject|0|||
94320309|NCT02632110|322953658|FG003|Overall Study|Withdrawal by Subject|0|||
94320310|NCT02632110|322953659|FG004|Overall Study|Withdrawal by Subject|1|||
94320311|NCT02632110|322953660|FG005|Overall Study|Withdrawal by Subject|1|||
94320312|NCT02632110|322953661|FG006|Overall Study|Withdrawal by Subject|3|||
94320313|NCT02632110|322953662|FG007|Overall Study|Withdrawal by Subject|3|||
94320314|NCT02632110|322953663|FG008|Overall Study|Withdrawal by Subject|1|||
94482060|NCT03428100|323558043|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
94320315|NCT02632110|322953664|FG009|Overall Study|Withdrawal by Subject|1|||
94320316|NCT01341652|322953665|FG000|Overall Study|Incorrect Random Assignment|0|||
94320317|NCT01341652|322953666|FG001|Overall Study|Incorrect Random Assignment|1|||
94320318|NCT01341652|322953665|FG000|Overall Study|ineligible; presence metastatic disease|0|||
94320319|NCT01341652|322953666|FG001|Overall Study|ineligible; presence metastatic disease|1|||
94320320|NCT00101192|322953670|FG000|Overall Study|Ineligible|6|||
94320321|NCT00101192|322953670|FG000|Overall Study|Inevaluable|1|||
94320322|NCT00905021|322953676|FG000|Overall Study|Adverse Event|2|||
94320323|NCT00632463|322953678|FG000|Overall Study|Adverse Event|0|||
94320324|NCT00632463|322953679|FG001|Overall Study|Adverse Event|1|||
94320325|NCT00632463|322953680|FG002|Overall Study|Adverse Event|0|||
94386854|NCT03527745|323204751|FG017|Overall Study|Lost to Follow-up|0|||
94386855|NCT03527745|323204752|FG018|Overall Study|Lost to Follow-up|0|||
94386856|NCT03527745|323204753|FG019|Overall Study|Lost to Follow-up|1|||
94386857|NCT03527745|323204754|FG020|Overall Study|Lost to Follow-up|1|||
94320326|NCT00937768|322953681|FG000|Overall Study|Refused Further Treatment|3|||
94320327|NCT00937768|322953682|FG001|Overall Study|Refused Further Treatment|2|||
94320328|NCT00937768|322953681|FG000|Overall Study|Disease Progression|1|||
94320329|NCT00937768|322953682|FG001|Overall Study|Disease Progression|1|||
94320330|NCT00937768|322953681|FG000|Overall Study|Alternate Treatment|0|||
94320331|NCT00937768|322953682|FG001|Overall Study|Alternate Treatment|1|||
94320332|NCT00937768|322953681|FG000|Overall Study|No Further Funding|4|||
94320333|NCT00937768|322953682|FG001|Overall Study|No Further Funding|4|||
94320334|NCT02998554|322953683|FG000|Overall Study|Adverse Event|8|||
94320335|NCT02998554|322953684|FG001|Overall Study|Adverse Event|3|||
94320336|NCT02998554|322953683|FG000|Overall Study|Protocol deviation|1|||
94320337|NCT02998554|322953684|FG001|Overall Study|Protocol deviation|0|||
94320338|NCT02998554|322953683|FG000|Overall Study|Withdrawal by Subject|2|||
94320339|NCT02998554|322953684|FG001|Overall Study|Withdrawal by Subject|6|||
94320340|NCT02998554|322953683|FG000|Overall Study|Lost to Follow-up|0|||
94320341|NCT02998554|322953684|FG001|Overall Study|Lost to Follow-up|1|||
94320342|NCT02998554|322953683|FG000|Overall Study|Lack of Efficacy|0|||
94320343|NCT02998554|322953684|FG001|Overall Study|Lack of Efficacy|1|||
94320344|NCT03260205|322953689|FG000|Overall Study|Adverse Event|2|||
94320345|NCT03260205|322953690|FG001|Overall Study|Adverse Event|0|||
94320346|NCT03260205|322953691|FG002|Overall Study|Adverse Event|2|||
94320347|NCT03260205|322953692|FG003|Overall Study|Adverse Event|2|||
94320348|NCT03260205|322953693|FG004|Overall Study|Adverse Event|4|||
94320349|NCT03260205|322953689|FG000|Overall Study|Lost to Follow-up|2|||
94320350|NCT03260205|322953690|FG001|Overall Study|Lost to Follow-up|2|||
94320351|NCT03260205|322953691|FG002|Overall Study|Lost to Follow-up|1|||
94320352|NCT03260205|322953692|FG003|Overall Study|Lost to Follow-up|1|||
94320353|NCT03260205|322953693|FG004|Overall Study|Lost to Follow-up|5|||
94320354|NCT03260205|322953689|FG000|Overall Study|Protocol Violation|0|||
94320355|NCT03260205|322953690|FG001|Overall Study|Protocol Violation|0|||
94320356|NCT03260205|322953691|FG002|Overall Study|Protocol Violation|2|||
94320357|NCT03260205|322953692|FG003|Overall Study|Protocol Violation|0|||
94320358|NCT03260205|322953693|FG004|Overall Study|Protocol Violation|1|||
94320359|NCT03260205|322953689|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
94320360|NCT03260205|322953690|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
94320361|NCT03260205|322953691|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
94320362|NCT03260205|322953692|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
94320363|NCT03260205|322953693|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
94320364|NCT03260205|322953689|FG000|Overall Study|Other: Unspecified|0|||
94320365|NCT03260205|322953690|FG001|Overall Study|Other: Unspecified|0|||
94320366|NCT03260205|322953691|FG002|Overall Study|Other: Unspecified|3|||
94320367|NCT03260205|322953692|FG003|Overall Study|Other: Unspecified|1|||
94320368|NCT03260205|322953693|FG004|Overall Study|Other: Unspecified|1|||
94320369|NCT03260205|322953689|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
94320370|NCT03260205|322953690|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
94320371|NCT03260205|322953691|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
94320372|NCT03260205|322953692|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
94320373|NCT03260205|322953693|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
94320374|NCT02349789|322955789|FG000|Overall Study|Withdrawal by Subject|2|||
94320375|NCT02669862|322955793|FG000|Overall Study|Lost to Follow-up|0|||
94320376|NCT02669862|322955794|FG001|Overall Study|Lost to Follow-up|2|||
94320377|NCT02669862|322955795|FG002|Overall Study|Lost to Follow-up|1|||
94320378|NCT02669862|322955793|FG000|Overall Study|Withdrawal by Subject|2|||
94320379|NCT02669862|322955794|FG001|Overall Study|Withdrawal by Subject|2|||
94320380|NCT02669862|322955795|FG002|Overall Study|Withdrawal by Subject|3|||
94320381|NCT02669862|322955793|FG000|Overall Study|moved|0|||
94320382|NCT02669862|322955794|FG001|Overall Study|moved|1|||
94320383|NCT02669862|322955795|FG002|Overall Study|moved|0|||
94320384|NCT02669862|322955793|FG000|Overall Study|Protocol Violation|0|||
94320385|NCT02669862|322955794|FG001|Overall Study|Protocol Violation|0|||
94320386|NCT02669862|322955795|FG002|Overall Study|Protocol Violation|1|||
94320387|NCT01026389|322955803|FG000|Overall Study|Withdrawal by Subject|1|||
94320388|NCT01026389|322955804|FG001|Overall Study|Withdrawal by Subject|3|||
94386858|NCT03527745|323204755|FG021|Overall Study|Lost to Follow-up|5|||
94320389|NCT01026389|322955803|FG000|Overall Study|change of treatment, patient moved|4|||
94320390|NCT01026389|322955804|FG001|Overall Study|change of treatment, patient moved|2|||
94320391|NCT00836277|322955805|FG000|Overall Study|Not evaluable for response|6|||
94320392|NCT02006667|322955806|FG000|Overall Study|Adverse Event|3|||
94320393|NCT02006667|322955806|FG000|Overall Study|Death|2|||
94320394|NCT02006667|322955806|FG000|Overall Study|Withdrawal by Subject|1|||
94320395|NCT05631548|322955815|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
94320396|NCT05631548|322955816|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
94386859|NCT03527745|323204756|FG022|Overall Study|Lost to Follow-up|6|||
94386860|NCT03527745|323204757|FG023|Overall Study|Lost to Follow-up|8|||
94386861|NCT03527745|323204758|FG024|Overall Study|Lost to Follow-up|1|||
94386862|NCT03527745|323204759|FG025|Overall Study|Lost to Follow-up|3|||
94386863|NCT04015232|323204764|FG000|Overall Study|Withdrawal by Subject|7|||
94386864|NCT04015232|323204765|FG001|Overall Study|Withdrawal by Subject|4|||
94386865|NCT04015232|323204764|FG000|Overall Study|Protocol Violation|1|||
94386866|NCT04015232|323204765|FG001|Overall Study|Protocol Violation|0|||
94386867|NCT04015232|323204764|FG000|Overall Study|Medical Grounds|3|||
94386868|NCT04015232|323204765|FG001|Overall Study|Medical Grounds|3|||
94386869|NCT03583606|323204766|FG000|Overall Study|Lost to Follow-up|0|||
94386870|NCT03583606|323204767|FG001|Overall Study|Lost to Follow-up|1|||
94386871|NCT03583606|323204768|FG002|Overall Study|Lost to Follow-up|0|||
94386872|NCT03583606|323204766|FG000|Overall Study|Ineligible at baseline|1|||
94386873|NCT03583606|323204767|FG001|Overall Study|Ineligible at baseline|0|||
94386874|NCT03583606|323204768|FG002|Overall Study|Ineligible at baseline|0|||
94386875|NCT01315249|323204769|FG000|Overall Study|Adverse Event|22|||
94386876|NCT01315249|323204770|FG001|Overall Study|Adverse Event|26|||
94386877|NCT01315249|323204769|FG000|Overall Study|Withdrawal by Subject|11|||
94386878|NCT01315249|323204770|FG001|Overall Study|Withdrawal by Subject|10|||
94386879|NCT01315249|323204769|FG000|Overall Study|Protocol Violation|8|||
94386880|NCT01315249|323204770|FG001|Overall Study|Protocol Violation|5|||
94386881|NCT01315249|323204769|FG000|Overall Study|Abnormal test results|1|||
94386882|NCT01315249|323204770|FG001|Overall Study|Abnormal test results|2|||
94386883|NCT01315249|323204769|FG000|Overall Study|Administrative problems|1|||
94386884|NCT01315249|323204770|FG001|Overall Study|Administrative problems|0|||
94386885|NCT01315249|323204769|FG000|Overall Study|inability to use device|1|||
94386886|NCT01315249|323204770|FG001|Overall Study|inability to use device|0|||
94386887|NCT01315249|323204769|FG000|Overall Study|Lack of Efficacy|0|||
94386888|NCT01315249|323204770|FG001|Overall Study|Lack of Efficacy|1|||
94386889|NCT01315249|323204769|FG000|Overall Study|Lost to Follow-up|0|||
94386890|NCT01315249|323204770|FG001|Overall Study|Lost to Follow-up|2|||
94386891|NCT01315249|323204769|FG000|Overall Study|Death|0|||
94386892|NCT01315249|323204770|FG001|Overall Study|Death|1|||
94386893|NCT01087970|323204773|FG000|Overall Study|Protocol Violation|2|||
94386894|NCT00264797|323204776|FG000|Overall Study|Withdrawal by Subject|11|||
94386895|NCT00264797|323204777|FG001|Overall Study|Withdrawal by Subject|11|||
94386896|NCT00264797|323204776|FG000|Overall Study|Lost to Follow-up|9|||
94386897|NCT00264797|323204777|FG001|Overall Study|Lost to Follow-up|17|||
94320397|NCT01260467|322955821|FG000|Overall Study|Withdrawal by Subject|2|||
94320398|NCT02488551|322955822|FG000|Overall Study|Lost to Follow-up|4|||
94320399|NCT02488551|322955823|FG001|Overall Study|Lost to Follow-up|7|||
94320400|NCT02488551|322955824|FG002|Overall Study|Lost to Follow-up|0|||
94320401|NCT02488551|322955825|FG003|Overall Study|Lost to Follow-up|0|||
94320402|NCT02488551|322955822|FG000|Overall Study|Military Deployment|1|||
94320403|NCT02488551|322955823|FG001|Overall Study|Military Deployment|1|||
94320404|NCT02488551|322955824|FG002|Overall Study|Military Deployment|0|||
94320405|NCT02488551|322955825|FG003|Overall Study|Military Deployment|0|||
94320406|NCT03364608|322955826|FG000|Overall Study|Withdrawal by Subject|4|||
94320407|NCT03364608|322955826|FG000|Overall Study|Protocol Violation|2|||
94320408|NCT03364608|322955826|FG000|Overall Study|Lost to Follow-up|2|||
94320409|NCT03888391|322955827|FG000|Overall Study|Lost to Follow-up|15|||
94320410|NCT01958125|322955831|FG000|Overall Study|Missing diary data|2|||
94320411|NCT01958125|322955832|FG001|Overall Study|Missing diary data|6|||
94320412|NCT01958125|322955831|FG000|Overall Study|No headache attacks|0|||
94320413|NCT01958125|322955832|FG001|Overall Study|No headache attacks|2|||
94320414|NCT04804033|322955835|FG000|Period 1: DBT Phase|Adverse Event|1|||
94320415|NCT04804033|322955836|FG001|Period 1: DBT Phase|Adverse Event|5|||
94320416|NCT04804033|322955837|FG002|Period 1: DBT Phase|Adverse Event|3|||
94320417|NCT04804033|322955838|FG003|Period 1: DBT Phase|Adverse Event|4|||
94320418|NCT04804033|322955835|FG000|Period 1: DBT Phase|Death|1|||
94320419|NCT04804033|322955836|FG001|Period 1: DBT Phase|Death|0|||
94320420|NCT04804033|322955837|FG002|Period 1: DBT Phase|Death|0|||
94320421|NCT04804033|322955838|FG003|Period 1: DBT Phase|Death|0|||
94386898|NCT00264797|323204776|FG000|Overall Study|Moved from area|3|||
94320422|NCT04804033|322955835|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
94320423|NCT04804033|322955836|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
94320424|NCT04804033|322955837|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
94320425|NCT04804033|322955838|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
94320426|NCT04804033|322955835|FG000|Period 1: DBT Phase|Non-compliance|1|||
94320427|NCT04804033|322955836|FG001|Period 1: DBT Phase|Non-compliance|0|||
94320428|NCT04804033|322955837|FG002|Period 1: DBT Phase|Non-compliance|1|||
94320429|NCT04804033|322955838|FG003|Period 1: DBT Phase|Non-compliance|2|||
94386899|NCT00264797|323204777|FG001|Overall Study|Moved from area|1|||
94386900|NCT00264797|323204776|FG000|Overall Study|Practical Problems|2|||
94386901|NCT00264797|323204777|FG001|Overall Study|Practical Problems|3|||
94386902|NCT00264797|323204776|FG000|Overall Study|Incarceration|4|||
94386903|NCT00264797|323204777|FG001|Overall Study|Incarceration|5|||
94386904|NCT00264797|323204776|FG000|Overall Study|Pressure/advice from Outsiders|1|||
94386905|NCT00264797|323204777|FG001|Overall Study|Pressure/advice from Outsiders|1|||
94320430|NCT04804033|322955835|FG000|Period 1: DBT Phase|Other|0|||
94320431|NCT04804033|322955836|FG001|Period 1: DBT Phase|Other|1|||
94320432|NCT04804033|322955837|FG002|Period 1: DBT Phase|Other|0|||
94320433|NCT04804033|322955838|FG003|Period 1: DBT Phase|Other|0|||
94320434|NCT04804033|322955835|FG000|Period 1: DBT Phase|Pregnancy|2|||
94320435|NCT04804033|322955836|FG001|Period 1: DBT Phase|Pregnancy|0|||
94320436|NCT04804033|322955837|FG002|Period 1: DBT Phase|Pregnancy|0|||
94320437|NCT04804033|322955838|FG003|Period 1: DBT Phase|Pregnancy|0|||
94320438|NCT04804033|322955835|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
94320439|NCT04804033|322955836|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
94320440|NCT04804033|322955837|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
94320441|NCT04804033|322955838|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
94320442|NCT04804033|322955835|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
94320443|NCT04804033|322955836|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
94320444|NCT04804033|322955837|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
94320445|NCT04804033|322955838|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
94320446|NCT04804033|322955835|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
94320447|NCT04804033|322955836|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
94320448|NCT04804033|322955837|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
94320449|NCT04804033|322955838|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
94320450|NCT04804033|322955835|FG000|Period 2: OLE Phase|Adverse Event|3|||
94320451|NCT04804033|322955836|FG001|Period 2: OLE Phase|Adverse Event|4|||
94320452|NCT04804033|322955837|FG002|Period 2: OLE Phase|Adverse Event|2|||
94320453|NCT04804033|322955838|FG003|Period 2: OLE Phase|Adverse Event|0|||
94320454|NCT04804033|322955835|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
94320455|NCT04804033|322955836|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
94320456|NCT04804033|322955837|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
94320457|NCT04804033|322955838|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
94320458|NCT04804033|322955835|FG000|Period 2: OLE Phase|Non-compliance|2|||
94320459|NCT04804033|322955836|FG001|Period 2: OLE Phase|Non-compliance|2|||
94320460|NCT04804033|322955837|FG002|Period 2: OLE Phase|Non-compliance|0|||
94320461|NCT04804033|322955838|FG003|Period 2: OLE Phase|Non-compliance|1|||
94320462|NCT04804033|322955835|FG000|Period 2: OLE Phase|Other|0|||
94320463|NCT04804033|322955836|FG001|Period 2: OLE Phase|Other|2|||
94320464|NCT04804033|322955837|FG002|Period 2: OLE Phase|Other|0|||
94320465|NCT04804033|322955838|FG003|Period 2: OLE Phase|Other|0|||
94320466|NCT04804033|322955835|FG000|Period 2: OLE Phase|Physician Decision|1|||
94320467|NCT04804033|322955836|FG001|Period 2: OLE Phase|Physician Decision|1|||
94320468|NCT04804033|322955837|FG002|Period 2: OLE Phase|Physician Decision|0|||
94320469|NCT04804033|322955838|FG003|Period 2: OLE Phase|Physician Decision|0|||
94320470|NCT04804033|322955835|FG000|Period 2: OLE Phase|Pregnancy|0|||
94320471|NCT04804033|322955836|FG001|Period 2: OLE Phase|Pregnancy|0|||
94320472|NCT04804033|322955837|FG002|Period 2: OLE Phase|Pregnancy|2|||
94320473|NCT04804033|322955838|FG003|Period 2: OLE Phase|Pregnancy|0|||
94320474|NCT04804033|322955835|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
94320475|NCT04804033|322955836|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
94320476|NCT04804033|322955837|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
94320477|NCT04804033|322955838|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
94320478|NCT04804033|322955835|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
94320479|NCT04804033|322955836|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
94320480|NCT04804033|322955837|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
94320481|NCT04804033|322955838|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
94320482|NCT04804033|322955835|FG000|Period 2: OLE Phase|Not reported|0|||
94320483|NCT04804033|322955836|FG001|Period 2: OLE Phase|Not reported|2|||
94320484|NCT04804033|322955837|FG002|Period 2: OLE Phase|Not reported|0|||
94320485|NCT04804033|322955838|FG003|Period 2: OLE Phase|Not reported|0|||
94320486|NCT04804033|322955835|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
94320487|NCT04804033|322955836|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
94320488|NCT04804033|322955837|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
94320489|NCT04804033|322955838|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
94320490|NCT04804033|322955835|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
94320491|NCT04804033|322955836|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
94320492|NCT04804033|322955837|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
94320493|NCT04804033|322955838|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
94320494|NCT04804033|322955835|FG000|Period 3: Follow-up Phase|Other|0|||
94320495|NCT04804033|322955836|FG001|Period 3: Follow-up Phase|Other|1|||
94320496|NCT04804033|322955837|FG002|Period 3: Follow-up Phase|Other|2|||
94320497|NCT04804033|322955838|FG003|Period 3: Follow-up Phase|Other|1|||
94320498|NCT04804033|322955835|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
94320499|NCT04804033|322955836|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
94320500|NCT04804033|322955837|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
94320501|NCT04804033|322955838|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
94320502|NCT04804033|322955835|FG000|Period 3: Follow-up Phase|Not reported|18|||
94320503|NCT04804033|322955836|FG001|Period 3: Follow-up Phase|Not reported|15|||
94320504|NCT04804033|322955837|FG002|Period 3: Follow-up Phase|Not reported|1|||
94320505|NCT04804033|322955838|FG003|Period 3: Follow-up Phase|Not reported|4|||
94320506|NCT00862849|322955840|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
94320507|NCT00862849|322955841|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
94320508|NCT00862849|322955842|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
94320509|NCT00862849|322955843|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
94320510|NCT00862849|322955844|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
94320511|NCT00862849|322955845|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
94320512|NCT00862849|322955840|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
94320513|NCT00862849|322955841|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
94320514|NCT00862849|322955842|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
94320515|NCT00862849|322955843|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
94320516|NCT00862849|322955844|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
94320517|NCT00862849|322955845|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
94320518|NCT03150095|322955846|FG000|Overall Study|Death|0|||
94320519|NCT03150095|322955847|FG001|Overall Study|Death|1|||
94320520|NCT03150095|322955846|FG000|Overall Study|Lost to Follow-up|1|||
94320521|NCT03150095|322955847|FG001|Overall Study|Lost to Follow-up|1|||
94320522|NCT03150095|322955846|FG000|Overall Study|Withdrawal by Subject|4|||
94320523|NCT03150095|322955847|FG001|Overall Study|Withdrawal by Subject|0|||
94320524|NCT03150095|322955846|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
94320525|NCT03150095|322955847|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
94320526|NCT00617409|322955848|FG000|Overall Study|Withdrawal by Subject|4|||
94320527|NCT00617409|322955849|FG001|Overall Study|Withdrawal by Subject|1|||
94320528|NCT00617409|322955850|FG002|Overall Study|Withdrawal by Subject|2|||
94320529|NCT00617409|322955848|FG000|Overall Study|Adverse Event|0|||
94320530|NCT00617409|322955849|FG001|Overall Study|Adverse Event|2|||
94320531|NCT00617409|322955850|FG002|Overall Study|Adverse Event|3|||
94320532|NCT00617409|322955848|FG000|Overall Study|Disease Progression|8|||
94320533|NCT00617409|322955849|FG001|Overall Study|Disease Progression|8|||
94320534|NCT00617409|322955850|FG002|Overall Study|Disease Progression|18|||
94320535|NCT00617409|322955848|FG000|Overall Study|Death|3|||
94320536|NCT00617409|322955849|FG001|Overall Study|Death|5|||
94320537|NCT00617409|322955850|FG002|Overall Study|Death|4|||
94320538|NCT00617409|322955848|FG000|Overall Study|Alternative Therapy|1|||
94320539|NCT00617409|322955849|FG001|Overall Study|Alternative Therapy|2|||
94320540|NCT00617409|322955850|FG002|Overall Study|Alternative Therapy|0|||
94320541|NCT00668200|322955859|FG000|Overall Study|Withdrawal by Subject|2|||
94320542|NCT00668200|322955859|FG000|Overall Study|Lost to Follow-up|1|||
94320543|NCT02509598|322955860|FG000|Overall Study|Withdrawal by Subject|1|||
94320544|NCT04056455|322955861|FG000|Overall Study|Adverse Event|1|||
94320545|NCT04056455|322955862|FG001|Overall Study|Adverse Event|0|||
94320546|NCT02196038|322955863|FG000|Overall Study|Death|16|||
94320547|NCT02196038|322955864|FG001|Overall Study|Death|21|||
94320548|NCT02196038|322955863|FG000|Overall Study|Withdrawal by Subject|0|||
94320549|NCT02196038|322955864|FG001|Overall Study|Withdrawal by Subject|1|||
94320550|NCT02196038|322955863|FG000|Overall Study|Lost to Follow-up|1|||
94320551|NCT02196038|322955864|FG001|Overall Study|Lost to Follow-up|0|||
94320552|NCT02512068|322955865|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
94320553|NCT02512068|322955866|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
94320554|NCT02512068|322955865|FG000|Overall Study|Major Protocol Deviation|1|||
94320555|NCT02512068|322955866|FG001|Overall Study|Major Protocol Deviation|0|||
94320556|NCT02512068|322955865|FG000|Overall Study|Voluntary Withdrawal|0|||
94320557|NCT02512068|322955866|FG001|Overall Study|Voluntary Withdrawal|1|||
94320558|NCT02512068|322955865|FG000|Overall Study|Lack of Efficacy|0|||
94320559|NCT02512068|322955866|FG001|Overall Study|Lack of Efficacy|1|||
94320560|NCT02512068|322955865|FG000|Overall Study|Reason Not Specified|3|||
94320561|NCT02512068|322955866|FG001|Overall Study|Reason Not Specified|5|||
94320562|NCT05373706|322955870|FG000|Overall Study|Lost to Follow-up|2|||
94320563|NCT05373706|322955871|FG001|Overall Study|Lost to Follow-up|2|||
94320564|NCT01474746|322955872|FG000|Overall Study|Lost to Follow-up|1|||
94320565|NCT01474746|322955873|FG001|Overall Study|Lost to Follow-up|1|||
94320566|NCT01474746|322955872|FG000|Overall Study|Withdrawal by Subject|2|||
94320567|NCT01474746|322955873|FG001|Overall Study|Withdrawal by Subject|1|||
94320568|NCT03633227|322955874|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
94320569|NCT03633227|322955875|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
94320570|NCT03633227|322955874|FG000|Double Blind (DB), up to Week 48|Death|2|||
94320571|NCT03633227|322955875|FG001|Double Blind (DB), up to Week 48|Death|1|||
94320572|NCT03633227|322955874|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
94320573|NCT03633227|322955875|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
94320574|NCT03633227|322955874|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
94320575|NCT03633227|322955875|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
94320576|NCT03633227|322955874|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
94320577|NCT03633227|322955875|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
94320578|NCT03633227|322955874|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
94320579|NCT03633227|322955875|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
94320580|NCT03633227|322955874|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
94320581|NCT03633227|322955875|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
94320582|NCT03633227|322955874|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
94320583|NCT03633227|322955875|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
94320584|NCT03633227|322955874|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
94320585|NCT03633227|322955875|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
94320586|NCT03633227|322955874|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
94320587|NCT03633227|322955875|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
94320588|NCT03633227|322955874|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
94320589|NCT03633227|322955875|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
94320590|NCT03633227|322955874|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
94320591|NCT03633227|322955875|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
94320592|NCT00195260|322955879|FG000|Part 1: Dose Escalation|Adverse Event|0|||
94320593|NCT00195260|322955880|FG001|Part 1: Dose Escalation|Adverse Event|1|||
94320594|NCT00195260|322955881|FG002|Part 1: Dose Escalation|Adverse Event|0|||
94320595|NCT00195260|322955882|FG003|Part 1: Dose Escalation|Adverse Event|1|||
94320596|NCT00195260|322955883|FG004|Part 1: Dose Escalation|Adverse Event|1|||
94320597|NCT00195260|322955884|FG005|Part 1: Dose Escalation|Adverse Event|0|||
94320598|NCT00195260|322955885|FG006|Part 1: Dose Escalation|Adverse Event|3|||
94320599|NCT00195260|322955886|FG007|Part 1: Dose Escalation|Adverse Event|0|||
94320600|NCT00195260|322955887|FG008|Part 1: Dose Escalation|Adverse Event|0|||
94320601|NCT00195260|322955888|FG009|Part 1: Dose Escalation|Adverse Event|0|||
94320602|NCT00195260|322955889|FG010|Part 1: Dose Escalation|Adverse Event|0|||
94320603|NCT00195260|322955879|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94320604|NCT00195260|322955880|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94386906|NCT00264797|323204776|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
94386907|NCT00264797|323204777|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
94386908|NCT00264797|323204776|FG000|Overall Study|Other|3|||
94386909|NCT00264797|323204777|FG001|Overall Study|Other|4|||
94386910|NCT00755196|323204779|FG000|Overall Study|Lost to Follow-up|1|||
94386911|NCT00755196|323204779|FG000|Overall Study|Lack of Efficiency|1|||
94386912|NCT01604850|323204780|FG000|Overall Study|Enrolled but never treated|0|||
94386913|NCT01604850|323204781|FG001|Overall Study|Enrolled but never treated|1|||
94386914|NCT01604850|323204780|FG000|Overall Study|Efficacy Failure|50|||
94386915|NCT01604850|323204781|FG001|Overall Study|Efficacy Failure|29|||
94386916|NCT01604850|323204780|FG000|Overall Study|Lost to Follow-up|1|||
94386917|NCT01604850|323204781|FG001|Overall Study|Lost to Follow-up|0|||
94386918|NCT01604850|323204780|FG000|Overall Study|Subject withdrew consent|1|||
94386919|NCT01604850|323204781|FG001|Overall Study|Subject withdrew consent|0|||
94386920|NCT01153984|323204782|FG000|Overall Study|Withdrawal by Subject|1|||
94386921|NCT01153984|323204782|FG000|Overall Study|Adverse Event|1|||
94386922|NCT03552757|323204783|FG000|Overall Study|Withdrawal by Subject|10|||
94386923|NCT03552757|323204784|FG001|Overall Study|Withdrawal by Subject|5|||
94386924|NCT03552757|323204785|FG002|Overall Study|Withdrawal by Subject|12|||
94386925|NCT03552757|323204783|FG000|Overall Study|Lost to Follow-up|2|||
94386926|NCT03552757|323204784|FG001|Overall Study|Lost to Follow-up|7|||
94386927|NCT03552757|323204785|FG002|Overall Study|Lost to Follow-up|7|||
94386928|NCT03552757|323204783|FG000|Overall Study|Death|1|||
94386929|NCT03552757|323204784|FG001|Overall Study|Death|1|||
94386930|NCT03552757|323204785|FG002|Overall Study|Death|1|||
94386931|NCT00445003|323204794|FG000|Overall Study|Death|1|||
94386932|NCT00445003|323204795|FG001|Overall Study|Death|2|||
94386933|NCT00445003|323204796|FG002|Overall Study|Death|1|||
94386934|NCT00445003|323204794|FG000|Overall Study|Missed Visit|3|||
94386935|NCT00445003|323204795|FG001|Overall Study|Missed Visit|5|||
94386936|NCT00445003|323204796|FG002|Overall Study|Missed Visit|1|||
94386937|NCT00445003|323204794|FG000|Overall Study|Dropped|1|||
94386938|NCT00445003|323204795|FG001|Overall Study|Dropped|3|||
94386939|NCT00445003|323204796|FG002|Overall Study|Dropped|2|||
94386940|NCT00760266|323204799|FG000|Overall Study|Adverse Event|13|||
94320605|NCT00195260|322955881|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94320606|NCT00195260|322955882|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94320607|NCT00195260|322955883|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
94320608|NCT00195260|322955884|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94386941|NCT00760266|323204800|FG001|Overall Study|Adverse Event|7|||
94386942|NCT00760266|323204799|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94386943|NCT00760266|323204800|FG001|Overall Study|Abnormal laboratory value(s)|0|||
94320609|NCT00195260|322955885|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94386944|NCT00760266|323204799|FG000|Overall Study|Abnormal test procedure result(s)|1|||
94386945|NCT00760266|323204800|FG001|Overall Study|Abnormal test procedure result(s)|0|||
94386946|NCT00760266|323204799|FG000|Overall Study|Lack of Efficacy|2|||
94386947|NCT00760266|323204800|FG001|Overall Study|Lack of Efficacy|2|||
94386948|NCT00760266|323204799|FG000|Overall Study|Protocol deviation|2|||
94386949|NCT00760266|323204800|FG001|Overall Study|Protocol deviation|4|||
94386950|NCT00760266|323204799|FG000|Overall Study|Patient withdrew consent|3|||
94320610|NCT00195260|322955886|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
94320611|NCT00195260|322955887|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94320612|NCT00195260|322955888|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94320613|NCT00195260|322955889|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94320614|NCT00195260|322955879|FG000|Part 1: Dose Escalation|Death|0|||
94320615|NCT00195260|322955880|FG001|Part 1: Dose Escalation|Death|0|||
94320616|NCT00195260|322955881|FG002|Part 1: Dose Escalation|Death|0|||
94320617|NCT00195260|322955882|FG003|Part 1: Dose Escalation|Death|0|||
94320618|NCT00195260|322955883|FG004|Part 1: Dose Escalation|Death|0|||
94320619|NCT00195260|322955884|FG005|Part 1: Dose Escalation|Death|0|||
94320620|NCT00195260|322955885|FG006|Part 1: Dose Escalation|Death|0|||
94320621|NCT00195260|322955886|FG007|Part 1: Dose Escalation|Death|1|||
94320622|NCT00195260|322955887|FG008|Part 1: Dose Escalation|Death|0|||
94320623|NCT00195260|322955888|FG009|Part 1: Dose Escalation|Death|0|||
94320624|NCT00195260|322955889|FG010|Part 1: Dose Escalation|Death|0|||
94320625|NCT00195260|322955879|FG000|Part 1: Dose Escalation|Disease Progression|3|||
94320626|NCT00195260|322955880|FG001|Part 1: Dose Escalation|Disease Progression|2|||
94320627|NCT00195260|322955881|FG002|Part 1: Dose Escalation|Disease Progression|5|||
94320628|NCT00195260|322955882|FG003|Part 1: Dose Escalation|Disease Progression|6|||
94320629|NCT00195260|322955883|FG004|Part 1: Dose Escalation|Disease Progression|4|||
94320630|NCT00195260|322955884|FG005|Part 1: Dose Escalation|Disease Progression|6|||
94320631|NCT00195260|322955885|FG006|Part 1: Dose Escalation|Disease Progression|7|||
94320632|NCT00195260|322955886|FG007|Part 1: Dose Escalation|Disease Progression|4|||
94320633|NCT00195260|322955887|FG008|Part 1: Dose Escalation|Disease Progression|0|||
94386951|NCT00760266|323204800|FG001|Overall Study|Patient withdrew consent|3|||
94386952|NCT00760266|323204799|FG000|Overall Study|Lost to Follow-up|2|||
94386953|NCT00760266|323204800|FG001|Overall Study|Lost to Follow-up|1|||
94386954|NCT00760266|323204799|FG000|Overall Study|Administrative Problems|0|||
94386955|NCT00760266|323204800|FG001|Overall Study|Administrative Problems|1|||
94386956|NCT00623779|323204803|FG000|Overall Study|Adverse Event|1|||
94386957|NCT00623779|323204804|FG001|Overall Study|Adverse Event|3|||
94386958|NCT00623779|323204805|FG002|Overall Study|Adverse Event|0|||
94386959|NCT00623779|323204803|FG000|Overall Study|Criteria from CSR|2|||
94386960|NCT00623779|323204804|FG001|Overall Study|Criteria from CSR|0|||
94386961|NCT00623779|323204805|FG002|Overall Study|Criteria from CSR|1|||
94386962|NCT01617668|323204806|FG000|Overall Study|Adverse Event|7|||
94386963|NCT01617668|323204807|FG001|Overall Study|Adverse Event|0|||
94386964|NCT01617668|323204808|FG002|Overall Study|Adverse Event|12|||
94386965|NCT01617668|323204809|FG003|Overall Study|Adverse Event|5|||
94386966|NCT01617668|323204806|FG000|Overall Study|Physician Decision|1|||
94386967|NCT01617668|323204807|FG001|Overall Study|Physician Decision|2|||
94386968|NCT01617668|323204808|FG002|Overall Study|Physician Decision|3|||
94386969|NCT01617668|323204809|FG003|Overall Study|Physician Decision|0|||
94386970|NCT01617668|323204806|FG000|Overall Study|Progressive Disease|4|||
94386971|NCT01617668|323204807|FG001|Overall Study|Progressive Disease|4|||
94386972|NCT01617668|323204808|FG002|Overall Study|Progressive Disease|6|||
94386973|NCT01617668|323204809|FG003|Overall Study|Progressive Disease|9|||
94386974|NCT01617668|323204806|FG000|Overall Study|Subject/guardian decision|1|||
94386975|NCT01617668|323204807|FG001|Overall Study|Subject/guardian decision|3|||
94386976|NCT01617668|323204808|FG002|Overall Study|Subject/guardian decision|2|||
94386977|NCT01617668|323204809|FG003|Overall Study|Subject/guardian decision|1|||
94386978|NCT04006171|323204811|FG000|Overall Study|Withdrawal by Subject|8|||
94386979|NCT04006171|323204812|FG001|Overall Study|Withdrawal by Subject|7|||
94386980|NCT04006171|323204811|FG000|Overall Study|missing serum samples|2|||
94386981|NCT04006171|323204812|FG001|Overall Study|missing serum samples|2|||
94386982|NCT04006171|323204811|FG000|Overall Study|insufficient sample volume|2|||
94482061|NCT03428100|323558044|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
94482062|NCT03428100|323558045|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
94482063|NCT03428100|323558046|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
94482064|NCT03428100|323558047|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
94482065|NCT03428100|323558048|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
94482066|NCT03428100|323558049|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
94320634|NCT00195260|322955888|FG009|Part 1: Dose Escalation|Disease Progression|0|||
94320635|NCT00195260|322955889|FG010|Part 1: Dose Escalation|Disease Progression|0|||
94320636|NCT00195260|322955879|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
94320637|NCT00195260|322955880|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
94320638|NCT00195260|322955881|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
94320639|NCT00195260|322955882|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
94320640|NCT00195260|322955883|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
94386983|NCT04006171|323204812|FG001|Overall Study|insufficient sample volume|3|||
94386984|NCT02073643|323204817|FG000|Overall Study|Lost to Follow-up|24|||
94386985|NCT01062256|323204818|FG000|Overall Study|Adverse Event|1|||
94386986|NCT01062256|323204819|FG001|Overall Study|Adverse Event|0|||
94386987|NCT01062256|323204820|FG002|Overall Study|Adverse Event|0|||
94386988|NCT01062256|323204818|FG000|Overall Study|Withdrawal by Subject|1|||
94320641|NCT00195260|322955884|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
94320642|NCT00195260|322955885|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
94320643|NCT00195260|322955886|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
94320644|NCT00195260|322955887|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
94320645|NCT00195260|322955888|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
94320646|NCT00195260|322955889|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
94320647|NCT00195260|322955879|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
94320648|NCT00195260|322955880|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
94320649|NCT00195260|322955881|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
94320650|NCT00195260|322955882|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
94320651|NCT00195260|322955883|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
94320652|NCT00195260|322955884|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
94320653|NCT00195260|322955885|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
94320654|NCT00195260|322955886|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
94320655|NCT00195260|322955887|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
94320656|NCT00195260|322955888|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
94320657|NCT00195260|322955889|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
94320658|NCT00195260|322955879|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
94320659|NCT00195260|322955880|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
94320660|NCT00195260|322955881|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
94320661|NCT00195260|322955882|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
94320662|NCT00195260|322955883|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
94320663|NCT00195260|322955884|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
94320664|NCT00195260|322955885|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
94320665|NCT00195260|322955886|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
94320666|NCT00195260|322955887|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
94320667|NCT00195260|322955888|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
94320668|NCT00195260|322955889|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
94320669|NCT00195260|322955879|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
94320670|NCT00195260|322955880|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
94320671|NCT00195260|322955881|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
94320672|NCT00195260|322955882|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
94320673|NCT00195260|322955883|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
94320674|NCT00195260|322955884|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
94320675|NCT00195260|322955885|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
94320676|NCT00195260|322955886|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
94320677|NCT00195260|322955887|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
94320678|NCT00195260|322955888|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
94320679|NCT00195260|322955889|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
94320680|NCT00195260|322955879|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
94320681|NCT00195260|322955880|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
94320682|NCT00195260|322955881|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
94320683|NCT00195260|322955882|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
94320684|NCT00195260|322955883|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
94320685|NCT00195260|322955884|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
94320686|NCT00195260|322955885|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
94320687|NCT00195260|322955886|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
94320688|NCT00195260|322955887|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
94320689|NCT00195260|322955888|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
94320690|NCT00195260|322955889|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
94320691|NCT01606761|322955890|FG000|Prior to Week 24|Lost to Follow-up|0|||
94320692|NCT01606761|322955891|FG001|Prior to Week 24|Lost to Follow-up|3|||
94320693|NCT01606761|322955892|FG002|Prior to Week 24|Lost to Follow-up|2|||
94320694|NCT01606761|322955893|FG003|Prior to Week 24|Lost to Follow-up|0|||
94320695|NCT01606761|322955894|FG004|Prior to Week 24|Lost to Follow-up|0|||
94320696|NCT01606761|322955890|FG000|Prior to Week 24|Withdrawal by Subject|12|||
94320697|NCT01606761|322955891|FG001|Prior to Week 24|Withdrawal by Subject|10|||
94320698|NCT01606761|322955892|FG002|Prior to Week 24|Withdrawal by Subject|9|||
94320699|NCT01606761|322955893|FG003|Prior to Week 24|Withdrawal by Subject|0|||
94386989|NCT01062256|323204819|FG001|Overall Study|Withdrawal by Subject|1|||
94386990|NCT01062256|323204820|FG002|Overall Study|Withdrawal by Subject|1|||
94386991|NCT01062256|323204818|FG000|Overall Study|Ineligible|1|||
94386992|NCT01062256|323204819|FG001|Overall Study|Ineligible|4|||
94386993|NCT01062256|323204820|FG002|Overall Study|Ineligible|3|||
94386994|NCT01062256|323204818|FG000|Overall Study|Administrative|0|||
94386995|NCT01062256|323204819|FG001|Overall Study|Administrative|2|||
94386996|NCT01062256|323204820|FG002|Overall Study|Administrative|0|||
94386997|NCT03912337|323204825|FG000|Overall Study|Withdrawal of Consent From Study|1|||
94386998|NCT03912337|323204826|FG001|Overall Study|Withdrawal of Consent From Study|0|||
94386999|NCT03912337|323204825|FG000|Overall Study|Lost to Follow-up|1|||
94387000|NCT03912337|323204826|FG001|Overall Study|Lost to Follow-up|1|||
94387001|NCT00854308|323204836|FG000|Overall Study|Disease progression|42|||
94387002|NCT00854308|323204837|FG001|Overall Study|Disease progression|50|||
94387003|NCT00854308|323204836|FG000|Overall Study|Adverse Event|8|||
94387004|NCT00854308|323204837|FG001|Overall Study|Adverse Event|3|||
94387005|NCT00854308|323204836|FG000|Overall Study|Death|2|||
94387006|NCT00854308|323204837|FG001|Overall Study|Death|5|||
94387007|NCT00854308|323204836|FG000|Overall Study|Physician Decision|6|||
94387008|NCT00854308|323204837|FG001|Overall Study|Physician Decision|6|||
94387009|NCT00854308|323204836|FG000|Overall Study|Withdrawal by Subject|4|||
94387010|NCT00854308|323204837|FG001|Overall Study|Withdrawal by Subject|2|||
94482067|NCT03428100|323558050|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
94482068|NCT03428100|323558051|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
94482069|NCT03428100|323558033|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
94482070|NCT03428100|323558034|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
94482071|NCT03428100|323558035|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
94482072|NCT03428100|323558036|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
94482073|NCT03428100|323558037|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
94482074|NCT03428100|323558038|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
94482075|NCT03428100|323558039|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
94482076|NCT03428100|323558040|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
94482077|NCT03428100|323558041|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
94482078|NCT03428100|323558042|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
94482079|NCT03428100|323558043|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
94482080|NCT03428100|323558044|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
94482081|NCT03428100|323558045|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
94482082|NCT03428100|323558046|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
94482083|NCT03428100|323558047|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
94482084|NCT03428100|323558048|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
94482085|NCT03428100|323558049|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
94482086|NCT03428100|323558050|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
94482087|NCT03428100|323558051|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
94482088|NCT03428100|323558033|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
94482089|NCT03428100|323558034|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
94482090|NCT03428100|323558035|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
94482091|NCT03428100|323558036|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
94482092|NCT03428100|323558037|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
94482093|NCT03428100|323558038|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
94482094|NCT03428100|323558039|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
94482095|NCT03428100|323558040|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
94482096|NCT03428100|323558041|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
94482097|NCT03428100|323558042|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
94482098|NCT03428100|323558043|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
94482099|NCT03428100|323558044|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
94482100|NCT03428100|323558045|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
94482101|NCT03428100|323558046|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
94482102|NCT03428100|323558047|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
94482103|NCT03428100|323558048|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
94482104|NCT03428100|323558049|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
94482105|NCT03428100|323558050|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
94482106|NCT03428100|323558051|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
94482107|NCT03428100|323558033|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
94482108|NCT03428100|323558034|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
94482109|NCT03428100|323558035|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
94482110|NCT03428100|323558036|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
94482111|NCT03428100|323558037|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
94482112|NCT03428100|323558038|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
94482113|NCT03428100|323558039|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
94482114|NCT03428100|323558040|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
94482115|NCT03428100|323558041|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
94482116|NCT03428100|323558042|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
94482117|NCT03428100|323558043|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
94482118|NCT03428100|323558044|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
94482119|NCT03428100|323558045|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
94482120|NCT03428100|323558046|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
94387011|NCT00854308|323204836|FG000|Overall Study|Sponsor's decision to terminate study|0|||
94387012|NCT00854308|323204837|FG001|Overall Study|Sponsor's decision to terminate study|1|||
94482121|NCT03428100|323558047|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
94482122|NCT03428100|323558048|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
94482123|NCT03428100|323558049|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
94482124|NCT03428100|323558050|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
94482125|NCT03428100|323558051|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
94482126|NCT03428100|323558033|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
94482127|NCT03428100|323558034|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
94320700|NCT01606761|322955894|FG004|Prior to Week 24|Withdrawal by Subject|0|||
94320701|NCT01606761|322955890|FG000|Prior to Week 24|Adverse Event|11|||
94320702|NCT01606761|322955891|FG001|Prior to Week 24|Adverse Event|18|||
94320703|NCT01606761|322955892|FG002|Prior to Week 24|Adverse Event|22|||
94320704|NCT01606761|322955893|FG003|Prior to Week 24|Adverse Event|0|||
94320705|NCT01606761|322955894|FG004|Prior to Week 24|Adverse Event|0|||
94320706|NCT01606761|322955890|FG000|Prior to Week 24|Lack of Efficacy|15|||
94320707|NCT01606761|322955891|FG001|Prior to Week 24|Lack of Efficacy|14|||
94320708|NCT01606761|322955892|FG002|Prior to Week 24|Lack of Efficacy|8|||
94320709|NCT01606761|322955893|FG003|Prior to Week 24|Lack of Efficacy|0|||
94320710|NCT01606761|322955894|FG004|Prior to Week 24|Lack of Efficacy|0|||
94320711|NCT01606761|322955890|FG000|Prior to Week 24|Physician Decision|0|||
94320712|NCT01606761|322955891|FG001|Prior to Week 24|Physician Decision|3|||
94320713|NCT01606761|322955892|FG002|Prior to Week 24|Physician Decision|1|||
94320714|NCT01606761|322955893|FG003|Prior to Week 24|Physician Decision|0|||
94320715|NCT01606761|322955894|FG004|Prior to Week 24|Physician Decision|0|||
94320716|NCT01606761|322955890|FG000|Prior to Week 24|Other|4|||
94320717|NCT01606761|322955891|FG001|Prior to Week 24|Other|7|||
94320718|NCT01606761|322955892|FG002|Prior to Week 24|Other|5|||
94320719|NCT01606761|322955893|FG003|Prior to Week 24|Other|0|||
94320720|NCT01606761|322955894|FG004|Prior to Week 24|Other|0|||
94320721|NCT01606761|322955890|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
94320722|NCT01606761|322955891|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
94320723|NCT01606761|322955892|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
94320724|NCT01606761|322955893|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
94320725|NCT01606761|322955894|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
94320726|NCT01606761|322955890|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
94320727|NCT01606761|322955891|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
94320728|NCT01606761|322955892|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
94320729|NCT01606761|322955893|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
94320730|NCT01606761|322955894|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
94320731|NCT01606761|322955890|FG000|Week 24 to Week 52|Adverse Event|0|||
94320732|NCT01606761|322955891|FG001|Week 24 to Week 52|Adverse Event|11|||
94320733|NCT01606761|322955892|FG002|Week 24 to Week 52|Adverse Event|14|||
94320734|NCT01606761|322955893|FG003|Week 24 to Week 52|Adverse Event|3|||
94320735|NCT01606761|322955894|FG004|Week 24 to Week 52|Adverse Event|15|||
94320736|NCT01606761|322955890|FG000|Week 24 to Week 52|Death|0|||
94320737|NCT01606761|322955891|FG001|Week 24 to Week 52|Death|0|||
94320738|NCT01606761|322955892|FG002|Week 24 to Week 52|Death|2|||
94320739|NCT01606761|322955893|FG003|Week 24 to Week 52|Death|1|||
94320740|NCT01606761|322955894|FG004|Week 24 to Week 52|Death|0|||
94320741|NCT01606761|322955890|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
94320742|NCT01606761|322955891|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
94320743|NCT01606761|322955892|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
94320744|NCT01606761|322955893|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
94320745|NCT01606761|322955894|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
94320746|NCT01606761|322955890|FG000|Week 24 to Week 52|Physician Decision|0|||
94320747|NCT01606761|322955891|FG001|Week 24 to Week 52|Physician Decision|1|||
94320748|NCT01606761|322955892|FG002|Week 24 to Week 52|Physician Decision|1|||
94320749|NCT01606761|322955893|FG003|Week 24 to Week 52|Physician Decision|0|||
94320750|NCT01606761|322955894|FG004|Week 24 to Week 52|Physician Decision|0|||
94482128|NCT03428100|323558035|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
94482129|NCT03428100|323558036|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
94482130|NCT03428100|323558037|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
94482131|NCT03428100|323558038|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
94482132|NCT03428100|323558039|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
94482133|NCT03428100|323558040|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
94320751|NCT01606761|322955890|FG000|Week 24 to Week 52|Other|0|||
94320752|NCT01606761|322955891|FG001|Week 24 to Week 52|Other|1|||
94320753|NCT01606761|322955892|FG002|Week 24 to Week 52|Other|5|||
94320754|NCT01606761|322955893|FG003|Week 24 to Week 52|Other|2|||
94320755|NCT01606761|322955894|FG004|Week 24 to Week 52|Other|2|||
94320756|NCT01606761|322955890|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
94320757|NCT01606761|322955891|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
94320758|NCT01606761|322955892|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
94320759|NCT01606761|322955893|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
94320760|NCT01606761|322955894|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
94320761|NCT01606761|322955890|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
94320762|NCT01606761|322955891|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
94387013|NCT00958243|323204842|FG000|Overall Study|Withdrawal by Subject|0|||
94387014|NCT00958243|323204843|FG001|Overall Study|Withdrawal by Subject|1|||
94387015|NCT00958243|323204844|FG002|Overall Study|Withdrawal by Subject|3|||
94387016|NCT00958243|323204845|FG003|Overall Study|Withdrawal by Subject|1|||
94387017|NCT00958243|323204846|FG004|Overall Study|Withdrawal by Subject|1|||
94387018|NCT00958243|323204847|FG005|Overall Study|Withdrawal by Subject|5|||
94387019|NCT00958243|323204842|FG000|Overall Study|Lost to Follow-up|2|||
94387020|NCT00958243|323204843|FG001|Overall Study|Lost to Follow-up|5|||
94387021|NCT00958243|323204844|FG002|Overall Study|Lost to Follow-up|11|||
94387022|NCT00958243|323204845|FG003|Overall Study|Lost to Follow-up|2|||
94387023|NCT00958243|323204846|FG004|Overall Study|Lost to Follow-up|8|||
94387024|NCT00958243|323204847|FG005|Overall Study|Lost to Follow-up|5|||
94387025|NCT02016170|323204858|FG000|Overall Study|Adverse Event|1|||
94387026|NCT02016170|323204859|FG001|Overall Study|Adverse Event|1|||
94387027|NCT02016170|323204860|FG002|Overall Study|Adverse Event|0|||
94387028|NCT02016170|323204858|FG000|Overall Study|Protocol Violation|1|||
94387029|NCT02016170|323204859|FG001|Overall Study|Protocol Violation|0|||
94387030|NCT02016170|323204860|FG002|Overall Study|Protocol Violation|0|||
94387031|NCT02930005|323204864|FG000|Overall Study|Lost to Follow-up|1|||
94387032|NCT02930005|323204865|FG001|Overall Study|Lost to Follow-up|5|||
94387033|NCT01974141|323204866|FG000|Overall Study|Other Reasons|28|||
94387034|NCT01974141|323204867|FG001|Overall Study|Other Reasons|18|||
94387035|NCT01974141|323204866|FG000|Overall Study|Protocol Violation|2|||
94387036|NCT01974141|323204867|FG001|Overall Study|Protocol Violation|6|||
94387037|NCT01974141|323204866|FG000|Overall Study|Personal Reasons|21|||
94387038|NCT01974141|323204867|FG001|Overall Study|Personal Reasons|20|||
94387039|NCT01974141|323204866|FG000|Overall Study|Lost to Follow-up|38|||
94387040|NCT01974141|323204867|FG001|Overall Study|Lost to Follow-up|29|||
94387041|NCT01974141|323204866|FG000|Overall Study|Pregnancy|3|||
94387042|NCT01974141|323204867|FG001|Overall Study|Pregnancy|3|||
94387043|NCT01974141|323204866|FG000|Overall Study|Lack of Efficacy|0|||
94387044|NCT01974141|323204867|FG001|Overall Study|Lack of Efficacy|1|||
94387045|NCT01974141|323204866|FG000|Overall Study|Adverse Event|4|||
94387046|NCT01974141|323204867|FG001|Overall Study|Adverse Event|5|||
94387047|NCT02003183|323204868|FG000|Overall Study|Lost to Follow-up|0|||
94387048|NCT02003183|323204869|FG001|Overall Study|Lost to Follow-up|2|||
94387049|NCT00626548|323204874|FG000|Overall Study|Adverse Event|164|||
94387050|NCT00626548|323204875|FG001|Overall Study|Adverse Event|44|||
94387051|NCT00626548|323204874|FG000|Overall Study|Withdrawal by Subject|42|||
94387052|NCT00626548|323204875|FG001|Overall Study|Withdrawal by Subject|46|||
94387053|NCT00626548|323204874|FG000|Overall Study|Protocol Violation|4|||
94387054|NCT00626548|323204875|FG001|Overall Study|Protocol Violation|11|||
94387055|NCT00626548|323204874|FG000|Overall Study|Lost to Follow-up|2|||
94387056|NCT00626548|323204875|FG001|Overall Study|Lost to Follow-up|2|||
94387057|NCT00626548|323204874|FG000|Overall Study|Other termination reason|493|||
94387058|NCT00626548|323204875|FG001|Overall Study|Other termination reason|613|||
94387059|NCT00406848|323204876|FG000|Overall Study|Withdrawal by Subject|27|||
94387060|NCT00406848|323204877|FG001|Overall Study|Withdrawal by Subject|22|||
94387061|NCT00406848|323204876|FG000|Overall Study|Adverse Event|38|||
94387062|NCT00406848|323204877|FG001|Overall Study|Adverse Event|7|||
94387063|NCT00406848|323204876|FG000|Overall Study|Lack of Efficacy|9|||
94387064|NCT00406848|323204877|FG001|Overall Study|Lack of Efficacy|14|||
94387065|NCT00406848|323204876|FG000|Overall Study|Protocol Violation|10|||
94387066|NCT00406848|323204877|FG001|Overall Study|Protocol Violation|6|||
94387067|NCT00406848|323204876|FG000|Overall Study|Lost to Follow-up|6|||
94387068|NCT00406848|323204877|FG001|Overall Study|Lost to Follow-up|2|||
94387069|NCT00406848|323204876|FG000|Overall Study|Physician Decision|2|||
94387070|NCT00406848|323204877|FG001|Overall Study|Physician Decision|2|||
94387071|NCT00406848|323204876|FG000|Overall Study|Sponsor Decision|1|||
94387072|NCT00406848|323204877|FG001|Overall Study|Sponsor Decision|1|||
94387073|NCT00870870|323204878|FG000|Overall Study|Withdrawal by Subject|0|||
94387074|NCT00870870|323204879|FG001|Overall Study|Withdrawal by Subject|1|||
94387075|NCT00870870|323204880|FG002|Overall Study|Withdrawal by Subject|1|||
94387076|NCT00870870|323204881|FG003|Overall Study|Withdrawal by Subject|3|||
94387077|NCT00870870|323204878|FG000|Overall Study|Adverse Event|0|||
94387078|NCT00870870|323204879|FG001|Overall Study|Adverse Event|0|||
94387079|NCT00870870|323204880|FG002|Overall Study|Adverse Event|2|||
94387080|NCT00870870|323204881|FG003|Overall Study|Adverse Event|2|||
94387081|NCT02480764|323204882|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
94387082|NCT02480764|323204883|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
94387083|NCT02480764|323204884|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
94387084|NCT02480764|323204882|FG000|Overall Study|Major Protocol Deviation|1|||
94387085|NCT02480764|323204883|FG001|Overall Study|Major Protocol Deviation|4|||
94387086|NCT02480764|323204884|FG002|Overall Study|Major Protocol Deviation|3|||
94387087|NCT02480764|323204882|FG000|Overall Study|Lost to Follow-up|0|||
94387088|NCT02480764|323204883|FG001|Overall Study|Lost to Follow-up|1|||
94387089|NCT02480764|323204884|FG002|Overall Study|Lost to Follow-up|2|||
94387090|NCT02480764|323204882|FG000|Overall Study|Voluntary Withdrawal|6|||
94387091|NCT02480764|323204883|FG001|Overall Study|Voluntary Withdrawal|5|||
94482134|NCT03428100|323558041|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
94482135|NCT03428100|323558042|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
94320763|NCT01606761|322955892|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
94320764|NCT01606761|322955893|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
94320765|NCT01606761|322955894|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
94320766|NCT01606761|322955890|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
94320767|NCT01606761|322955891|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
94320768|NCT01606761|322955892|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
94320769|NCT01606761|322955893|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
94320770|NCT01606761|322955894|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
94320771|NCT01606761|322955890|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
94320772|NCT01606761|322955891|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
94320773|NCT01606761|322955892|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
94320774|NCT01606761|322955893|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
94320775|NCT01606761|322955894|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
94320776|NCT03011840|322955895|FG000|Overall Study|Not received PIL in post PIL phase|0|||
94320777|NCT03011840|322955896|FG001|Overall Study|Not received PIL in post PIL phase|21|||
94320778|NCT02618928|322955901|FG000|Overall Study|Failure to Return|28|||
94320779|NCT02618928|322955901|FG000|Overall Study|Insufficient Virological Response|1|||
94320780|NCT02618928|322955901|FG000|Overall Study|Withdrawal by Subject|2|||
94320781|NCT02618928|322955901|FG000|Overall Study|Death|3|||
94320782|NCT02618928|322955901|FG000|Overall Study|Other|11|||
94320783|NCT02618928|322955901|FG000|Overall Study|Missing|6|||
94320784|NCT02618928|322955901|FG000|Overall Study|Treatment Never Started|7|||
94320785|NCT04146467|322955908|FG000|Overall Study|Adverse Event|0|||
94320786|NCT04146467|322955909|FG001|Overall Study|Adverse Event|1|||
94320787|NCT04146467|322955908|FG000|Overall Study|Lost to Follow-up|0|||
94320788|NCT04146467|322955909|FG001|Overall Study|Lost to Follow-up|2|||
94320789|NCT02953782|322955910|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
94320790|NCT02953782|322955911|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
94320791|NCT02953782|322955912|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
94320792|NCT02953782|322955913|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
94320793|NCT02953782|322955914|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
94320794|NCT02953782|322955915|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
94320795|NCT02953782|322955916|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
94320796|NCT02953782|322955917|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
94320797|NCT02953782|322955910|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
94320798|NCT02953782|322955911|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
94320799|NCT02953782|322955912|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
94320800|NCT02953782|322955913|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
94320801|NCT02953782|322955914|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
94320802|NCT02953782|322955915|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
94320803|NCT02953782|322955916|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
94320804|NCT02953782|322955917|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
94320805|NCT02953782|322955910|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
94320806|NCT02953782|322955911|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
94320807|NCT02953782|322955912|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
94320808|NCT02953782|322955913|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
94320809|NCT02953782|322955914|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
94320810|NCT02953782|322955915|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
94320811|NCT02953782|322955916|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
94320812|NCT02953782|322955917|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
94320813|NCT02953782|322955910|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
94320814|NCT02953782|322955911|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
94320815|NCT02953782|322955912|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
94320816|NCT02953782|322955913|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
94320817|NCT02953782|322955914|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
94320818|NCT02953782|322955915|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
94320819|NCT02953782|322955916|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
94320820|NCT02953782|322955917|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
94482136|NCT03428100|323558043|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
94320821|NCT02953782|322955910|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
94320822|NCT02953782|322955911|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
94320823|NCT02953782|322955912|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
94320824|NCT02953782|322955913|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
94320825|NCT02953782|322955914|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
94387092|NCT02480764|323204884|FG002|Overall Study|Voluntary Withdrawal|10|||
94387093|NCT02480764|323204882|FG000|Overall Study|Lack of Efficacy|0|||
94387094|NCT02480764|323204883|FG001|Overall Study|Lack of Efficacy|3|||
94387095|NCT02480764|323204884|FG002|Overall Study|Lack of Efficacy|3|||
94387096|NCT02480764|323204882|FG000|Overall Study|Reason not Specified|0|||
94387097|NCT02480764|323204883|FG001|Overall Study|Reason not Specified|1|||
94387098|NCT02480764|323204884|FG002|Overall Study|Reason not Specified|0|||
94387099|NCT03629249|323204885|FG000|Overall Study|Study terminated by sponsor|197|||
94387100|NCT03629249|323204886|FG001|Overall Study|Study terminated by sponsor|197|||
94387101|NCT03629249|323204887|FG002|Overall Study|Study terminated by sponsor|194|||
94387102|NCT03629249|323204885|FG000|Overall Study|Protocol deviation|0|||
94387103|NCT03629249|323204886|FG001|Overall Study|Protocol deviation|2|||
94387104|NCT03629249|323204887|FG002|Overall Study|Protocol deviation|5|||
94387105|NCT03629249|323204885|FG000|Overall Study|Subject decision|1|||
94387106|NCT03629249|323204886|FG001|Overall Study|Subject decision|1|||
94387107|NCT03629249|323204887|FG002|Overall Study|Subject decision|3|||
94387108|NCT03629249|323204885|FG000|Overall Study|Adverse Event|1|||
94387109|NCT03629249|323204886|FG001|Overall Study|Adverse Event|1|||
94387110|NCT03629249|323204887|FG002|Overall Study|Adverse Event|0|||
94387111|NCT03629249|323204885|FG000|Overall Study|Death|1|||
94387112|NCT03629249|323204886|FG001|Overall Study|Death|0|||
94387113|NCT03629249|323204887|FG002|Overall Study|Death|0|||
94387114|NCT03629249|323204885|FG000|Overall Study|Physician Decision|1|||
94387115|NCT03629249|323204886|FG001|Overall Study|Physician Decision|0|||
94387116|NCT03629249|323204887|FG002|Overall Study|Physician Decision|0|||
94387117|NCT00319735|323204896|FG000|Overall Study|Death|2|||
94387118|NCT03420300|323204900|FG000|Overall Study|Death|2|||
94387119|NCT03262012|323204905|FG000|Overall Study|Withdrawal by Subject|15|||
94387120|NCT03262012|323204906|FG001|Overall Study|Withdrawal by Subject|13|||
94387121|NCT03262012|323204907|FG002|Overall Study|Withdrawal by Subject|8|||
94387122|NCT03262012|323204908|FG003|Overall Study|Withdrawal by Subject|7|||
94387123|NCT03262012|323204905|FG000|Overall Study|Adverse Event|10|||
94387124|NCT03262012|323204906|FG001|Overall Study|Adverse Event|12|||
94387125|NCT03262012|323204907|FG002|Overall Study|Adverse Event|4|||
94387126|NCT03262012|323204908|FG003|Overall Study|Adverse Event|6|||
94387127|NCT03262012|323204905|FG000|Overall Study|Physician Decision|2|||
94387128|NCT03262012|323204906|FG001|Overall Study|Physician Decision|5|||
94387129|NCT03262012|323204907|FG002|Overall Study|Physician Decision|1|||
94387130|NCT03262012|323204908|FG003|Overall Study|Physician Decision|0|||
94387131|NCT03262012|323204905|FG000|Overall Study|Lack of Efficacy|0|||
94387132|NCT03262012|323204906|FG001|Overall Study|Lack of Efficacy|5|||
94387133|NCT03262012|323204907|FG002|Overall Study|Lack of Efficacy|1|||
94387134|NCT03262012|323204908|FG003|Overall Study|Lack of Efficacy|2|||
94387135|NCT03262012|323204905|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
94387136|NCT03262012|323204906|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
94387137|NCT03262012|323204907|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
94387138|NCT03262012|323204908|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
94387139|NCT04149964|323204911|FG000|Overall Study|Lost to Follow-up|19|||
94387140|NCT04149964|323204912|FG001|Overall Study|Lost to Follow-up|18|||
94387141|NCT00444145|323206045|FG000|Overall Study|Withdrawal by Subject|2|||
94387142|NCT00444145|323206045|FG000|Overall Study|Lost to Follow-up|1|||
94482137|NCT03428100|323558044|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
94482138|NCT03428100|323558045|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
94482139|NCT03428100|323558046|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
94482140|NCT03428100|323558047|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
94482141|NCT03428100|323558048|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
94482142|NCT03428100|323558049|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
94482143|NCT03428100|323558050|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
94482144|NCT03428100|323558051|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
94482145|NCT03428100|323558033|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
94482146|NCT03428100|323558034|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
94482147|NCT03428100|323558035|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
94482148|NCT03428100|323558036|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
94482149|NCT03428100|323558037|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
94482150|NCT03428100|323558038|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
94482151|NCT03428100|323558039|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
94482152|NCT03428100|323558040|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
94387143|NCT00444145|323206045|FG000|Overall Study|non-compliant|11|||
94482153|NCT03428100|323558041|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
94482154|NCT03428100|323558042|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
94387144|NCT00444145|323206045|FG000|Overall Study|Screen Failures|5|||
94387145|NCT01374919|323206046|FG000|Overall Study|Withdrawal by Subject|2|||
94387146|NCT00414466|323206047|FG000|Overall Study|Adverse Event|0|||
94387147|NCT00414466|323206048|FG001|Overall Study|Adverse Event|0|||
94387148|NCT00414466|323206049|FG002|Overall Study|Adverse Event|1|||
94320826|NCT02953782|322955915|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
94320827|NCT02953782|322955916|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
94320828|NCT02953782|322955917|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
94320829|NCT02953782|322955910|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
94320830|NCT02953782|322955911|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
94320831|NCT02953782|322955912|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
94320832|NCT02953782|322955913|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
94320833|NCT02953782|322955914|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
94320834|NCT02953782|322955915|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
94320835|NCT02953782|322955916|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
94320836|NCT02953782|322955917|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
94320837|NCT02953782|322955910|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
94320838|NCT02953782|322955911|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
94320839|NCT02953782|322955912|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
94320840|NCT02953782|322955913|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
94320841|NCT02953782|322955914|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
94320842|NCT02953782|322955915|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
94320843|NCT02953782|322955916|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
94320844|NCT02953782|322955917|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
94320845|NCT02953782|322955910|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
94320846|NCT02953782|322955911|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
94320847|NCT02953782|322955912|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
94320848|NCT02953782|322955913|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
94320849|NCT02953782|322955914|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
94320850|NCT02953782|322955915|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
94320851|NCT02953782|322955916|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
94320852|NCT02953782|322955917|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
94320853|NCT02164513|322955918|FG000|Overall Study|Adverse Event|162|||
94320854|NCT02164513|322955919|FG001|Overall Study|Adverse Event|180|||
94320855|NCT02164513|322955920|FG002|Overall Study|Adverse Event|111|||
94320856|NCT02164513|322955918|FG000|Overall Study|Other: Study Closed or terminated|5|||
94320857|NCT02164513|322955919|FG001|Overall Study|Other: Study Closed or terminated|2|||
94320858|NCT02164513|322955920|FG002|Overall Study|Other: Study Closed or terminated|4|||
94320859|NCT02164513|322955918|FG000|Overall Study|Lost to Follow-up|30|||
94320860|NCT02164513|322955919|FG001|Overall Study|Lost to Follow-up|36|||
94320861|NCT02164513|322955920|FG002|Overall Study|Lost to Follow-up|22|||
94320862|NCT02164513|322955918|FG000|Overall Study|Physician Decision|47|||
94320863|NCT02164513|322955919|FG001|Overall Study|Physician Decision|57|||
94320864|NCT02164513|322955920|FG002|Overall Study|Physician Decision|28|||
94320865|NCT02164513|322955918|FG000|Overall Study|Withdrawal by Subject|192|||
94320866|NCT02164513|322955919|FG001|Overall Study|Withdrawal by Subject|261|||
94320867|NCT02164513|322955920|FG002|Overall Study|Withdrawal by Subject|130|||
94320868|NCT02164513|322955918|FG000|Overall Study|Other: Reason not provided by site|1|||
94320869|NCT02164513|322955919|FG001|Overall Study|Other: Reason not provided by site|0|||
94320870|NCT02164513|322955920|FG002|Overall Study|Other: Reason not provided by site|0|||
94320871|NCT01683071|322955921|FG000|Part 1|Lack of Efficacy|1|||
94320872|NCT01683071|322955922|FG001|Part 1|Lack of Efficacy|0|||
94320873|NCT01683071|322955923|FG002|Part 1|Lack of Efficacy|0|||
94320874|NCT01683071|322955924|FG003|Part 1|Lack of Efficacy|3|||
94320875|NCT01683071|322955925|FG004|Part 1|Lack of Efficacy|0|||
94320876|NCT01683071|322955926|FG005|Part 1|Lack of Efficacy|0|||
94320877|NCT01683071|322955921|FG000|Part 1|Withdrawal by Subject|1|||
94320878|NCT01683071|322955922|FG001|Part 1|Withdrawal by Subject|2|||
94320879|NCT01683071|322955923|FG002|Part 1|Withdrawal by Subject|2|||
94320880|NCT01683071|322955924|FG003|Part 1|Withdrawal by Subject|1|||
94320881|NCT01683071|322955925|FG004|Part 1|Withdrawal by Subject|0|||
94320882|NCT01683071|322955926|FG005|Part 1|Withdrawal by Subject|0|||
94320883|NCT01683071|322955921|FG000|Part 1|Surgery Cancelled|1|||
94320884|NCT01683071|322955922|FG001|Part 1|Surgery Cancelled|0|||
94320885|NCT01683071|322955923|FG002|Part 1|Surgery Cancelled|0|||
94320886|NCT01683071|322955924|FG003|Part 1|Surgery Cancelled|0|||
94320887|NCT01683071|322955925|FG004|Part 1|Surgery Cancelled|0|||
94320888|NCT01683071|322955926|FG005|Part 1|Surgery Cancelled|0|||
94320889|NCT01683071|322955921|FG000|Part 1|Did not receive study drug|1|||
94320890|NCT01683071|322955922|FG001|Part 1|Did not receive study drug|0|||
94320891|NCT01683071|322955923|FG002|Part 1|Did not receive study drug|0|||
94320892|NCT01683071|322955924|FG003|Part 1|Did not receive study drug|1|||
94320893|NCT01683071|322955925|FG004|Part 1|Did not receive study drug|0|||
94320894|NCT01683071|322955926|FG005|Part 1|Did not receive study drug|0|||
94320895|NCT01683071|322955921|FG000|Part 1|Early termination; met exclusion criteria|0|||
94320896|NCT01683071|322955922|FG001|Part 1|Early termination; met exclusion criteria|2|||
94320897|NCT01683071|322955923|FG002|Part 1|Early termination; met exclusion criteria|1|||
94320898|NCT01683071|322955924|FG003|Part 1|Early termination; met exclusion criteria|0|||
94387149|NCT00414466|323206050|FG003|Overall Study|Adverse Event|1|||
94387150|NCT00414466|323206047|FG000|Overall Study|Lack of Efficacy|1|||
94387151|NCT00414466|323206048|FG001|Overall Study|Lack of Efficacy|0|||
94387152|NCT00414466|323206049|FG002|Overall Study|Lack of Efficacy|0|||
94387153|NCT00414466|323206050|FG003|Overall Study|Lack of Efficacy|0|||
94387154|NCT00414466|323206047|FG000|Overall Study|Withdrawn by Sponsor|1|||
94387155|NCT00414466|323206048|FG001|Overall Study|Withdrawn by Sponsor|0|||
94387156|NCT00414466|323206049|FG002|Overall Study|Withdrawn by Sponsor|0|||
94387157|NCT00414466|323206050|FG003|Overall Study|Withdrawn by Sponsor|0|||
94387158|NCT04526210|323206056|FG000|Overall Study|Sponsor decision|7|||
94387159|NCT04526210|323206057|FG001|Overall Study|Sponsor decision|5|||
94387160|NCT04526210|323206056|FG000|Overall Study|Withdrawal by Subject|3|||
94387161|NCT04526210|323206057|FG001|Overall Study|Withdrawal by Subject|2|||
94387162|NCT01781637|323206058|FG000|Overall Study|Adverse Event|1|||
94387163|NCT01781637|323206059|FG001|Overall Study|Adverse Event|0|||
94387164|NCT01781637|323206058|FG000|Overall Study|Lack of Efficacy|2|||
94387165|NCT01781637|323206059|FG001|Overall Study|Lack of Efficacy|6|||
94387166|NCT01781637|323206058|FG000|Overall Study|Withdrawal by Subject|1|||
94387167|NCT01781637|323206059|FG001|Overall Study|Withdrawal by Subject|0|||
94387168|NCT02684344|323206061|FG000|Overall Study|Withdrawal by Subject|0|||
94387169|NCT02684344|323206062|FG001|Overall Study|Withdrawal by Subject|1|||
94387170|NCT03480425|323206063|FG000|Overall Study|Force transducer technical failure|1|||
94387171|NCT00862979|323206074|FG000|Overall Study|Adverse Event|6|||
94387172|NCT00862979|323206075|FG001|Overall Study|Adverse Event|3|||
94387173|NCT00862979|323206074|FG000|Overall Study|Protocol Violation|0|||
94387174|NCT00862979|323206075|FG001|Overall Study|Protocol Violation|1|||
94387175|NCT00862979|323206074|FG000|Overall Study|Patient withdrew consent|2|||
94387176|NCT00862979|323206075|FG001|Overall Study|Patient withdrew consent|1|||
94320899|NCT01683071|322955925|FG004|Part 1|Early termination; met exclusion criteria|0|||
94320900|NCT01683071|322955926|FG005|Part 1|Early termination; met exclusion criteria|0|||
94320901|NCT01683071|322955921|FG000|Part 2|Lack of Efficacy|0|||
94320902|NCT01683071|322955922|FG001|Part 2|Lack of Efficacy|0|||
94320903|NCT01683071|322955923|FG002|Part 2|Lack of Efficacy|0|||
94320904|NCT01683071|322955924|FG003|Part 2|Lack of Efficacy|0|||
94320905|NCT01683071|322955925|FG004|Part 2|Lack of Efficacy|3|||
94320906|NCT01683071|322955926|FG005|Part 2|Lack of Efficacy|4|||
94320907|NCT01683071|322955921|FG000|Part 2|Lost to Follow-up|0|||
94320908|NCT01683071|322955922|FG001|Part 2|Lost to Follow-up|0|||
94320909|NCT01683071|322955923|FG002|Part 2|Lost to Follow-up|0|||
94320910|NCT01683071|322955924|FG003|Part 2|Lost to Follow-up|0|||
94320911|NCT01683071|322955925|FG004|Part 2|Lost to Follow-up|2|||
94320912|NCT01683071|322955926|FG005|Part 2|Lost to Follow-up|0|||
94320913|NCT01683071|322955921|FG000|Part 2|Withdrawal by Subject|0|||
94320914|NCT01683071|322955922|FG001|Part 2|Withdrawal by Subject|0|||
94320915|NCT01683071|322955923|FG002|Part 2|Withdrawal by Subject|0|||
94320916|NCT01683071|322955924|FG003|Part 2|Withdrawal by Subject|0|||
94320917|NCT01683071|322955925|FG004|Part 2|Withdrawal by Subject|3|||
94320918|NCT01683071|322955926|FG005|Part 2|Withdrawal by Subject|3|||
94320919|NCT01683071|322955921|FG000|Part 2|Surgery cancelled|0|||
94320920|NCT01683071|322955922|FG001|Part 2|Surgery cancelled|0|||
94320921|NCT01683071|322955923|FG002|Part 2|Surgery cancelled|0|||
94320922|NCT01683071|322955924|FG003|Part 2|Surgery cancelled|0|||
94320923|NCT01683071|322955925|FG004|Part 2|Surgery cancelled|4|||
94320924|NCT01683071|322955926|FG005|Part 2|Surgery cancelled|2|||
94320925|NCT01683071|322955921|FG000|Part 2|Did not receive study drug|0|||
94320926|NCT01683071|322955922|FG001|Part 2|Did not receive study drug|0|||
94320927|NCT01683071|322955923|FG002|Part 2|Did not receive study drug|0|||
94320928|NCT01683071|322955924|FG003|Part 2|Did not receive study drug|0|||
94320929|NCT01683071|322955925|FG004|Part 2|Did not receive study drug|2|||
94320930|NCT01683071|322955926|FG005|Part 2|Did not receive study drug|1|||
94320931|NCT01683071|322955921|FG000|Part 2|Met exclusion criterion|0|||
94320932|NCT01683071|322955922|FG001|Part 2|Met exclusion criterion|0|||
94320933|NCT01683071|322955923|FG002|Part 2|Met exclusion criterion|0|||
94320934|NCT01683071|322955924|FG003|Part 2|Met exclusion criterion|0|||
94320935|NCT01683071|322955925|FG004|Part 2|Met exclusion criterion|1|||
94320936|NCT01683071|322955926|FG005|Part 2|Met exclusion criterion|1|||
94320937|NCT01683071|322955921|FG000|Part 2|Protocol deviation|0|||
94320938|NCT01683071|322955922|FG001|Part 2|Protocol deviation|0|||
94320939|NCT01683071|322955923|FG002|Part 2|Protocol deviation|0|||
94320940|NCT01683071|322955924|FG003|Part 2|Protocol deviation|0|||
94320941|NCT01683071|322955925|FG004|Part 2|Protocol deviation|1|||
94320942|NCT01683071|322955926|FG005|Part 2|Protocol deviation|2|||
94320943|NCT01683071|322955921|FG000|Part 2|Withdrawal by investigator decision|0|||
94387177|NCT00862979|323206074|FG000|Overall Study|Administrative problems|0|||
94387178|NCT00862979|323206075|FG001|Overall Study|Administrative problems|1|||
94387179|NCT00862979|323206074|FG000|Overall Study|Death|0|||
94387180|NCT00862979|323206075|FG001|Overall Study|Death|1|||
94320944|NCT01683071|322955922|FG001|Part 2|Withdrawal by investigator decision|0|||
94320945|NCT01683071|322955923|FG002|Part 2|Withdrawal by investigator decision|0|||
94320946|NCT01683071|322955924|FG003|Part 2|Withdrawal by investigator decision|0|||
94387181|NCT01882647|323206076|FG000|Overall Study|Lost to Follow-up|2|||
94320947|NCT01683071|322955925|FG004|Part 2|Withdrawal by investigator decision|1|||
94320948|NCT01683071|322955926|FG005|Part 2|Withdrawal by investigator decision|2|||
94320949|NCT01810042|322955927|FG000|Overall Study|Lost to Follow-up|10|||
94320950|NCT03707158|322955928|FG000|Midtreatment|Lost to Follow-up|16|||
94320951|NCT03707158|322955929|FG001|Midtreatment|Lost to Follow-up|7|||
94320952|NCT03707158|322955928|FG000|Midtreatment|Withdrawal by Subject|28|||
94320953|NCT03707158|322955929|FG001|Midtreatment|Withdrawal by Subject|19|||
94320954|NCT03707158|322955928|FG000|Posttreatment|Lost to Follow-up|0|||
94320955|NCT03707158|322955929|FG001|Posttreatment|Lost to Follow-up|5|||
94320956|NCT03707158|322955928|FG000|Follow-up|Lost to Follow-up|19|||
94320957|NCT03707158|322955929|FG001|Follow-up|Lost to Follow-up|18|||
94320958|NCT03707158|322955928|FG000|Follow-up|Withdrawal by Subject|13|||
94320959|NCT03707158|322955929|FG001|Follow-up|Withdrawal by Subject|6|||
94320960|NCT01968187|322955935|FG000|Overall Study|Adverse Event|0|||
94320961|NCT01968187|322955936|FG001|Overall Study|Adverse Event|1|||
94320962|NCT01968187|322955935|FG000|Overall Study|Randomized but not treated|1|||
94320963|NCT01968187|322955936|FG001|Overall Study|Randomized but not treated|0|||
94320964|NCT00808249|322955939|FG000|Overall Study|Adverse Event|4|||
94320965|NCT00808249|322955940|FG001|Overall Study|Adverse Event|7|||
94320966|NCT00808249|322955941|FG002|Overall Study|Adverse Event|10|||
94320967|NCT00808249|322955942|FG003|Overall Study|Adverse Event|6|||
94320968|NCT00808249|322955939|FG000|Overall Study|Lost to Follow-up|2|||
94320969|NCT00808249|322955940|FG001|Overall Study|Lost to Follow-up|3|||
94320970|NCT00808249|322955941|FG002|Overall Study|Lost to Follow-up|3|||
94320971|NCT00808249|322955942|FG003|Overall Study|Lost to Follow-up|5|||
94320972|NCT00808249|322955939|FG000|Overall Study|Withdrawal by Subject|4|||
94320973|NCT00808249|322955940|FG001|Overall Study|Withdrawal by Subject|0|||
94320974|NCT00808249|322955941|FG002|Overall Study|Withdrawal by Subject|2|||
94320975|NCT00808249|322955942|FG003|Overall Study|Withdrawal by Subject|4|||
94320976|NCT00808249|322955939|FG000|Overall Study|Protocol Violation|3|||
94320977|NCT00808249|322955940|FG001|Overall Study|Protocol Violation|3|||
94320978|NCT00808249|322955941|FG002|Overall Study|Protocol Violation|3|||
94320979|NCT00808249|322955942|FG003|Overall Study|Protocol Violation|0|||
94320980|NCT00808249|322955939|FG000|Overall Study|Lack of Efficacy|1|||
94320981|NCT00808249|322955940|FG001|Overall Study|Lack of Efficacy|1|||
94320982|NCT00808249|322955941|FG002|Overall Study|Lack of Efficacy|0|||
94320983|NCT00808249|322955942|FG003|Overall Study|Lack of Efficacy|0|||
94320984|NCT00808249|322955939|FG000|Overall Study|study specific discontinuation criteria|1|||
94320985|NCT00808249|322955940|FG001|Overall Study|study specific discontinuation criteria|0|||
94320986|NCT00808249|322955941|FG002|Overall Study|study specific discontinuation criteria|1|||
94320987|NCT00808249|322955942|FG003|Overall Study|study specific discontinuation criteria|0|||
94320988|NCT00808249|322955939|FG000|Overall Study|All other reasons|2|||
94320989|NCT00808249|322955940|FG001|Overall Study|All other reasons|1|||
94320990|NCT00808249|322955941|FG002|Overall Study|All other reasons|3|||
94320991|NCT00808249|322955942|FG003|Overall Study|All other reasons|1|||
94320992|NCT05108805|322955945|FG000|Overall Study|T-cell expansion was not successful.|5|||
94320993|NCT04095286|322955946|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
94320994|NCT04095286|322955947|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
94320995|NCT04095286|322955948|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
94320996|NCT04095286|322955949|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
94320997|NCT04095286|322955950|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
94320998|NCT04095286|322955951|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
94320999|NCT04095286|322955946|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
94387182|NCT01882647|323206077|FG001|Overall Study|Lost to Follow-up|2|||
94387183|NCT01882647|323206076|FG000|Overall Study|Withdrawal by Subject|0|||
94387184|NCT01882647|323206077|FG001|Overall Study|Withdrawal by Subject|4|||
94387185|NCT02937701|323206078|FG000|Day 1 to Week 22|Adverse Event|11|||
94387186|NCT02937701|323206079|FG001|Day 1 to Week 22|Adverse Event|14|||
94387187|NCT02937701|323206080|FG002|Day 1 to Week 22|Adverse Event|0|||
94387188|NCT02937701|323206081|FG003|Day 1 to Week 22|Adverse Event|0|||
94387189|NCT02937701|323206082|FG004|Day 1 to Week 22|Adverse Event|0|||
94387190|NCT02937701|323206078|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
94387191|NCT02937701|323206079|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
94387192|NCT02937701|323206080|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
94387193|NCT02937701|323206081|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
94387194|NCT02937701|323206082|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
94387195|NCT02937701|323206078|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
94387196|NCT02937701|323206079|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
94387197|NCT02937701|323206080|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
94387198|NCT02937701|323206081|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
94321000|NCT04095286|322955947|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
94321001|NCT04095286|322955948|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
94387199|NCT02937701|323206082|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
94321002|NCT04095286|322955949|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
94321003|NCT04095286|322955950|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
94321004|NCT04095286|322955951|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
94321005|NCT04095286|322955946|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
94321006|NCT04095286|322955947|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
94321007|NCT04095286|322955948|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
94321008|NCT04095286|322955949|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
94321009|NCT04095286|322955950|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
94321010|NCT04095286|322955951|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
94321011|NCT04095286|322955946|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
94321012|NCT04095286|322955947|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
94321013|NCT04095286|322955948|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
94321014|NCT04095286|322955949|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
94321015|NCT04095286|322955950|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
94321016|NCT04095286|322955951|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
94321017|NCT04095286|322955946|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
94321018|NCT04095286|322955947|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
94321019|NCT04095286|322955948|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
94321020|NCT04095286|322955949|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
94321021|NCT04095286|322955950|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
94321022|NCT04095286|322955951|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
94321023|NCT04752189|322955952|FG000|Overall Study|Withdrawal by Subject|0|||
94321024|NCT04752189|322955953|FG001|Overall Study|Withdrawal by Subject|150|||
94321025|NCT04752189|322955952|FG000|Overall Study|Lost to Follow-up|261|||
94321026|NCT04752189|322955953|FG001|Overall Study|Lost to Follow-up|126|||
94321027|NCT02625324|322957654|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
94321028|NCT02625324|322957654|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
94321029|NCT02625324|322957654|FG000|6-Month Follow-up Subject Accountability|Death|5|||
94321030|NCT02625324|322957654|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
94321031|NCT02625324|322957654|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
94321032|NCT02625324|322957654|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
94321033|NCT02625324|322957654|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
94321034|NCT02625324|322957654|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
94321035|NCT02625324|322957654|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
94321036|NCT02625324|322957654|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
94321037|NCT02625324|322957654|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
94321038|NCT02625324|322957654|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
94321039|NCT02625324|322957654|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
94321040|NCT02625324|322957654|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
94321041|NCT02625324|322957654|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
94321042|NCT02625324|322957654|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
94321043|NCT02625324|322957654|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
94321044|NCT00960934|322957664|FG000|Overall Study|Adverse Event|2|||
94321045|NCT00960934|322957665|FG001|Overall Study|Adverse Event|3|||
94321046|NCT00960934|322957666|FG002|Overall Study|Adverse Event|3|||
94321047|NCT00960934|322957667|FG003|Overall Study|Adverse Event|2|||
94321048|NCT00960934|322957668|FG004|Overall Study|Adverse Event|4|||
94321049|NCT00960934|322957669|FG005|Overall Study|Adverse Event|3|||
94321050|NCT00960934|322957664|FG000|Overall Study|Lack of Efficacy|1|||
94321051|NCT00960934|322957665|FG001|Overall Study|Lack of Efficacy|0|||
94321052|NCT00960934|322957666|FG002|Overall Study|Lack of Efficacy|0|||
94321053|NCT00960934|322957667|FG003|Overall Study|Lack of Efficacy|0|||
94321054|NCT00960934|322957668|FG004|Overall Study|Lack of Efficacy|0|||
94321055|NCT00960934|322957669|FG005|Overall Study|Lack of Efficacy|0|||
94321056|NCT00960934|322957664|FG000|Overall Study|Lost to Follow-up|0|||
94321057|NCT00960934|322957665|FG001|Overall Study|Lost to Follow-up|1|||
94321058|NCT00960934|322957666|FG002|Overall Study|Lost to Follow-up|0|||
94321059|NCT00960934|322957667|FG003|Overall Study|Lost to Follow-up|0|||
94321060|NCT00960934|322957668|FG004|Overall Study|Lost to Follow-up|0|||
94321061|NCT00960934|322957669|FG005|Overall Study|Lost to Follow-up|0|||
94321062|NCT00960934|322957664|FG000|Overall Study|Other|2|||
94321063|NCT00960934|322957665|FG001|Overall Study|Other|1|||
94321064|NCT00960934|322957666|FG002|Overall Study|Other|5|||
94321065|NCT00960934|322957667|FG003|Overall Study|Other|4|||
94321066|NCT00960934|322957668|FG004|Overall Study|Other|2|||
94321067|NCT00960934|322957669|FG005|Overall Study|Other|2|||
94321068|NCT00960934|322957664|FG000|Overall Study|Physician Decision|0|||
94321069|NCT00960934|322957665|FG001|Overall Study|Physician Decision|1|||
94321070|NCT00960934|322957666|FG002|Overall Study|Physician Decision|0|||
94321071|NCT00960934|322957667|FG003|Overall Study|Physician Decision|0|||
94321072|NCT00960934|322957668|FG004|Overall Study|Physician Decision|0|||
94321073|NCT00960934|322957669|FG005|Overall Study|Physician Decision|0|||
94321074|NCT00960934|322957664|FG000|Overall Study|Progressive Disease|1|||
94321075|NCT00960934|322957665|FG001|Overall Study|Progressive Disease|1|||
94321076|NCT00960934|322957666|FG002|Overall Study|Progressive Disease|0|||
94321077|NCT00960934|322957667|FG003|Overall Study|Progressive Disease|0|||
94321078|NCT00960934|322957668|FG004|Overall Study|Progressive Disease|1|||
94321079|NCT00960934|322957669|FG005|Overall Study|Progressive Disease|1|||
94321080|NCT00960934|322957664|FG000|Overall Study|Protocol Violation|3|||
94321081|NCT00960934|322957665|FG001|Overall Study|Protocol Violation|4|||
94321082|NCT00960934|322957666|FG002|Overall Study|Protocol Violation|0|||
94321083|NCT00960934|322957667|FG003|Overall Study|Protocol Violation|3|||
94321084|NCT00960934|322957668|FG004|Overall Study|Protocol Violation|3|||
94321085|NCT00960934|322957669|FG005|Overall Study|Protocol Violation|2|||
94321086|NCT00960934|322957664|FG000|Overall Study|Withdrawal by Subject|5|||
94321087|NCT00960934|322957665|FG001|Overall Study|Withdrawal by Subject|6|||
94321088|NCT00960934|322957666|FG002|Overall Study|Withdrawal by Subject|4|||
94321089|NCT00960934|322957667|FG003|Overall Study|Withdrawal by Subject|5|||
94321090|NCT00960934|322957668|FG004|Overall Study|Withdrawal by Subject|5|||
94321091|NCT00960934|322957669|FG005|Overall Study|Withdrawal by Subject|7|||
94321092|NCT00960934|322957664|FG000|Overall Study|Study Terminated by Sponsor|50|||
94321093|NCT00960934|322957665|FG001|Overall Study|Study Terminated by Sponsor|46|||
94321094|NCT00960934|322957666|FG002|Overall Study|Study Terminated by Sponsor|52|||
94321095|NCT00960934|322957667|FG003|Overall Study|Study Terminated by Sponsor|50|||
94321096|NCT00960934|322957668|FG004|Overall Study|Study Terminated by Sponsor|49|||
94321097|NCT00960934|322957669|FG005|Overall Study|Study Terminated by Sponsor|49|||
94321098|NCT01640925|322957670|FG000|Overall Study|Withdrawal by Subject|1|||
94321099|NCT01640925|322957671|FG001|Overall Study|Withdrawal by Subject|0|||
94321100|NCT01640925|322957670|FG000|Overall Study|Previously enrolled in this trial|13|||
94321101|NCT01640925|322957671|FG001|Overall Study|Previously enrolled in this trial|11|||
94321102|NCT00871377|322957677|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
94321103|NCT00871377|322957678|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
94321104|NCT00871377|322957679|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
94321105|NCT00871377|322957680|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
94321106|NCT00871377|322957681|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
94321107|NCT00871377|322957682|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
94321108|NCT00871377|322957677|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
94321109|NCT00871377|322957678|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
94321110|NCT00871377|322957679|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
94321111|NCT00871377|322957680|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
94321112|NCT00871377|322957681|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
94321113|NCT00871377|322957682|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
94321114|NCT00871377|322957677|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
94321115|NCT00871377|322957678|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
94321116|NCT00871377|322957679|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
94321117|NCT00871377|322957680|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
94321118|NCT00871377|322957681|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
94321119|NCT00871377|322957682|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
94321120|NCT00871377|322957677|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
94321121|NCT00871377|322957678|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
94321122|NCT00871377|322957679|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
94321123|NCT00871377|322957680|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
94321124|NCT00871377|322957681|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
94321125|NCT00871377|322957682|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
94321126|NCT00871377|322957677|FG000|Third Intervention (10 Weeks)|Death|0|||
94321127|NCT00871377|322957678|FG001|Third Intervention (10 Weeks)|Death|0|||
94321128|NCT00871377|322957679|FG002|Third Intervention (10 Weeks)|Death|0|||
94321129|NCT00871377|322957680|FG003|Third Intervention (10 Weeks)|Death|1|||
94321130|NCT00871377|322957681|FG004|Third Intervention (10 Weeks)|Death|0|||
94321131|NCT00871377|322957682|FG005|Third Intervention (10 Weeks)|Death|0|||
94321132|NCT01944969|322957684|FG000|Overall Study|Adverse Event|1|||
94321133|NCT01944969|322957684|FG000|Overall Study|Lack of Efficacy|1|||
94321134|NCT01944969|322957684|FG000|Overall Study|Non-compliance with IMP|1|||
94321135|NCT01944969|322957684|FG000|Overall Study|Administrative or other reasons|23|||
94321136|NCT02370498|322957687|FG000|Overall Study|Adverse Event|10|||
94321137|NCT02370498|322957688|FG001|Overall Study|Adverse Event|8|||
94321138|NCT02370498|322957687|FG000|Overall Study|Death|263|||
94321139|NCT02370498|322957688|FG001|Overall Study|Death|265|||
94321140|NCT02370498|322957687|FG000|Overall Study|Protocol Violation|1|||
94321141|NCT02370498|322957688|FG001|Overall Study|Protocol Violation|2|||
94321142|NCT02370498|322957687|FG000|Overall Study|Withdrawal by Subject|7|||
94321143|NCT02370498|322957688|FG001|Overall Study|Withdrawal by Subject|12|||
94321144|NCT02370498|322957687|FG000|Overall Study|Sponsor's decision|15|||
94321145|NCT02370498|322957688|FG001|Overall Study|Sponsor's decision|9|||
94321146|NCT00848549|322957691|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
94321147|NCT00848549|322957692|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
94321148|NCT00848549|322957691|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
94482155|NCT03428100|323558043|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
94482156|NCT03428100|323558044|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
94482157|NCT03428100|323558045|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
94482158|NCT03428100|323558046|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
94482159|NCT03428100|323558047|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
94482160|NCT03428100|323558048|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
94482161|NCT03428100|323558049|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
94482162|NCT03428100|323558050|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
94482163|NCT03428100|323558051|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
94482164|NCT03428100|323558033|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
94482165|NCT03428100|323558034|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
94482166|NCT03428100|323558035|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
94482167|NCT03428100|323558036|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
94482168|NCT03428100|323558037|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
94482169|NCT03428100|323558038|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
94482170|NCT03428100|323558039|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
94482171|NCT03428100|323558040|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
94482172|NCT03428100|323558041|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
94482173|NCT03428100|323558042|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
94482174|NCT03428100|323558043|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
94482175|NCT03428100|323558044|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
94482176|NCT03428100|323558045|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
94482177|NCT03428100|323558046|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
94482178|NCT03428100|323558047|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
94482179|NCT03428100|323558048|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
94482180|NCT03428100|323558049|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
94482181|NCT03428100|323558050|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
94482182|NCT03428100|323558051|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
94482183|NCT03428100|323558033|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
94482184|NCT03428100|323558034|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
94482185|NCT03428100|323558035|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
94482186|NCT03428100|323558036|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
94321149|NCT00848549|322957692|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
94321150|NCT00848549|322957691|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
94321151|NCT00848549|322957692|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
94321152|NCT00848549|322957691|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
94321153|NCT00848549|322957692|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
94321154|NCT00848549|322957691|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
94321155|NCT00848549|322957692|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
94321156|NCT00848549|322957691|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
94321157|NCT00848549|322957692|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
94321158|NCT00848549|322957691|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
94321159|NCT00848549|322957692|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
94321160|NCT00848549|322957691|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
94321161|NCT00848549|322957692|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
94321162|NCT00848549|322957691|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
94321163|NCT00848549|322957692|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
94321164|NCT00848549|322957691|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
94321165|NCT00848549|322957692|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
94321166|NCT00848549|322957691|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
94321167|NCT00848549|322957692|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
94321168|NCT00848549|322957691|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
94321169|NCT00848549|322957692|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
94321170|NCT00848549|322957691|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
94321171|NCT00848549|322957692|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
94321172|NCT00848549|322957691|FG000|E2090-E044-314 (Extension Study)|Other|5|||
94321173|NCT00848549|322957692|FG001|E2090-E044-314 (Extension Study)|Other|6|||
94321174|NCT02561299|322957693|FG000|Overall Study|Death|2|||
94321175|NCT02561299|322957694|FG001|Overall Study|Death|4|||
94321176|NCT02561299|322957693|FG000|Overall Study|Lost to Follow-up|1|||
94321177|NCT02561299|322957694|FG001|Overall Study|Lost to Follow-up|0|||
94321178|NCT02561299|322957693|FG000|Overall Study|Withdrawal by Subject|2|||
94321179|NCT02561299|322957694|FG001|Overall Study|Withdrawal by Subject|2|||
94321180|NCT00630812|322957697|FG000|Randomisation to First Dose|Adverse Event|1|||
94482187|NCT03428100|323558037|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
94482188|NCT03428100|323558038|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
94482189|NCT03428100|323558039|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
94387200|NCT02937701|323206078|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
94387201|NCT02937701|323206079|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
94387202|NCT02937701|323206080|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
94387203|NCT02937701|323206081|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
94387204|NCT02937701|323206082|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
94387205|NCT02937701|323206078|FG000|Day 1 to Week 22|Death|1|||
94387206|NCT02937701|323206079|FG001|Day 1 to Week 22|Death|1|||
94387207|NCT02937701|323206080|FG002|Day 1 to Week 22|Death|0|||
94387208|NCT02937701|323206081|FG003|Day 1 to Week 22|Death|0|||
94387209|NCT02937701|323206082|FG004|Day 1 to Week 22|Death|0|||
94387210|NCT02937701|323206078|FG000|Day 1 to Week 22|Protocol Violation|1|||
94387211|NCT02937701|323206079|FG001|Day 1 to Week 22|Protocol Violation|1|||
94387212|NCT02937701|323206080|FG002|Day 1 to Week 22|Protocol Violation|0|||
94387213|NCT02937701|323206081|FG003|Day 1 to Week 22|Protocol Violation|0|||
94387214|NCT02937701|323206082|FG004|Day 1 to Week 22|Protocol Violation|0|||
94387215|NCT02937701|323206078|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
94387216|NCT02937701|323206079|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
94387217|NCT02937701|323206080|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
94387218|NCT02937701|323206081|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
94387219|NCT02937701|323206082|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
94387220|NCT02937701|323206078|FG000|Day 1 to Week 22|Physician Decision|2|||
94387221|NCT02937701|323206079|FG001|Day 1 to Week 22|Physician Decision|0|||
94387222|NCT02937701|323206080|FG002|Day 1 to Week 22|Physician Decision|0|||
94387223|NCT02937701|323206081|FG003|Day 1 to Week 22|Physician Decision|0|||
94387224|NCT02937701|323206082|FG004|Day 1 to Week 22|Physician Decision|0|||
94387225|NCT02937701|323206078|FG000|Day 1 to Week 22|Other|1|||
94387226|NCT02937701|323206079|FG001|Day 1 to Week 22|Other|0|||
94387227|NCT02937701|323206080|FG002|Day 1 to Week 22|Other|0|||
94387228|NCT02937701|323206081|FG003|Day 1 to Week 22|Other|0|||
94387229|NCT02937701|323206082|FG004|Day 1 to Week 22|Other|0|||
94387230|NCT02937701|323206078|FG000|Week 22 to Week 50|Adverse Event|0|||
94387231|NCT02937701|323206079|FG001|Week 22 to Week 50|Adverse Event|0|||
94387232|NCT02937701|323206080|FG002|Week 22 to Week 50|Adverse Event|10|||
94387233|NCT02937701|323206081|FG003|Week 22 to Week 50|Adverse Event|3|||
94387234|NCT02937701|323206082|FG004|Week 22 to Week 50|Adverse Event|3|||
94387235|NCT02937701|323206078|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
94387236|NCT02937701|323206079|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
94387237|NCT02937701|323206080|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
94387238|NCT02937701|323206081|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
94387239|NCT02937701|323206082|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
94387240|NCT02937701|323206078|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
94387241|NCT02937701|323206079|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
94387242|NCT02937701|323206080|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
94387243|NCT02937701|323206081|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
94387244|NCT02937701|323206082|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
94387245|NCT02937701|323206078|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
94387246|NCT02937701|323206079|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
94387247|NCT02937701|323206080|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
94387248|NCT02937701|323206081|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
94387249|NCT02937701|323206082|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
94387250|NCT02937701|323206078|FG000|Week 22 to Week 50|Physician Decision|0|||
94387251|NCT02937701|323206079|FG001|Week 22 to Week 50|Physician Decision|0|||
94387252|NCT02937701|323206080|FG002|Week 22 to Week 50|Physician Decision|2|||
94387253|NCT02937701|323206081|FG003|Week 22 to Week 50|Physician Decision|0|||
94387254|NCT02937701|323206082|FG004|Week 22 to Week 50|Physician Decision|1|||
94387255|NCT02937701|323206078|FG000|Week 22 to Week 50|Other|0|||
94387256|NCT02937701|323206079|FG001|Week 22 to Week 50|Other|0|||
94387257|NCT02937701|323206080|FG002|Week 22 to Week 50|Other|0|||
94321181|NCT00630812|322957698|FG001|Randomisation to First Dose|Adverse Event|1|||
94321182|NCT00630812|322957697|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
94321183|NCT00630812|322957698|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
94321184|NCT00630812|322957697|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
94321185|NCT00630812|322957698|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
94321186|NCT00630812|322957697|FG000|Randomisation to First Dose|Protocol Violation|4|||
94321187|NCT00630812|322957698|FG001|Randomisation to First Dose|Protocol Violation|1|||
94387258|NCT02937701|323206081|FG003|Week 22 to Week 50|Other|0|||
94387259|NCT02937701|323206082|FG004|Week 22 to Week 50|Other|1|||
94482190|NCT03428100|323558040|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
94482191|NCT03428100|323558041|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
94321188|NCT00630812|322957697|FG000|Double Blind Treatment Period|Adverse Event|13|||
94321189|NCT00630812|322957698|FG001|Double Blind Treatment Period|Adverse Event|5|||
94387260|NCT01941095|323206085|FG000|Overall Study|Insufficient therapeutic response|13|||
94387261|NCT01941095|323206085|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
94387262|NCT01941095|323206085|FG000|Overall Study|Adverse Event|11|||
94387263|NCT01941095|323206085|FG000|Overall Study|Physician Decision|3|||
94387264|NCT01941095|323206085|FG000|Overall Study|Withdrawal by Subject|17|||
94321190|NCT00630812|322957697|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
94321191|NCT00630812|322957698|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
94321192|NCT00630812|322957697|FG000|Double Blind Treatment Period|Physician Decision|2|||
94321193|NCT00630812|322957698|FG001|Double Blind Treatment Period|Physician Decision|1|||
94321194|NCT00630812|322957697|FG000|Double Blind Treatment Period|Protocol Violation|1|||
94321195|NCT00630812|322957698|FG001|Double Blind Treatment Period|Protocol Violation|0|||
94321196|NCT00630812|322957697|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
94321197|NCT00630812|322957698|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
94387265|NCT01941095|323206085|FG000|Overall Study|Lost to Follow-up|10|||
94387266|NCT03311646|323206086|FG000|Overall Study|Physician Decision|1|||
94321198|NCT00630812|322957697|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
94321199|NCT00630812|322957698|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
94321200|NCT00630812|322957697|FG000|Double Blind Treatment Period|Non-compliance|0|||
94321201|NCT00630812|322957698|FG001|Double Blind Treatment Period|Non-compliance|1|||
94321202|NCT03421964|322957701|FG000|Overall Study|Lost to Follow-up|11|||
94321203|NCT03421964|322957702|FG001|Overall Study|Lost to Follow-up|21|||
94321204|NCT03421964|322957701|FG000|Overall Study|Withdrawal by Subject|9|||
94321205|NCT03421964|322957702|FG001|Overall Study|Withdrawal by Subject|3|||
94321206|NCT03421964|322957701|FG000|Overall Study|Incarcerated|1|||
94321207|NCT03421964|322957702|FG001|Overall Study|Incarcerated|0|||
94321208|NCT03421964|322957701|FG000|Overall Study|Inpt Treatment Facility|1|||
94321209|NCT03421964|322957702|FG001|Overall Study|Inpt Treatment Facility|1|||
94321210|NCT03421964|322957701|FG000|Overall Study|Virtual Platform Issues|1|||
94321211|NCT03421964|322957702|FG001|Overall Study|Virtual Platform Issues|1|||
94321212|NCT01994226|322957703|FG000|Overall Study|Protocol Violation|13|||
94321213|NCT01994226|322957704|FG001|Overall Study|Protocol Violation|10|||
94321214|NCT01994226|322957703|FG000|Overall Study|Early Cessation of treatment|6|||
94321215|NCT01994226|322957704|FG001|Overall Study|Early Cessation of treatment|11|||
94321216|NCT02938585|322957705|FG000|Overall Study|Withdrawal by parent or guardian|0|||
94321217|NCT02938585|322957706|FG001|Overall Study|Withdrawal by parent or guardian|1|||
94321218|NCT02938585|322957707|FG002|Overall Study|Withdrawal by parent or guardian|0|||
94321219|NCT02938585|322957708|FG003|Overall Study|Withdrawal by parent or guardian|0|||
94321220|NCT02938585|322957705|FG000|Overall Study|Withdrawal by Subject|0|||
94321221|NCT02938585|322957706|FG001|Overall Study|Withdrawal by Subject|0|||
94321222|NCT02938585|322957707|FG002|Overall Study|Withdrawal by Subject|0|||
94321223|NCT02938585|322957708|FG003|Overall Study|Withdrawal by Subject|5|||
94321224|NCT01774344|322957716|FG000|Overall Study|Withdrawal by Subject|3|||
94321225|NCT01774344|322957717|FG001|Overall Study|Withdrawal by Subject|10|||
94321226|NCT01774344|322957716|FG000|Overall Study|Protocol Violation|0|||
94321227|NCT01774344|322957717|FG001|Overall Study|Protocol Violation|1|||
94321228|NCT01774344|322957716|FG000|Overall Study|Lost to Follow-up|4|||
94321229|NCT01774344|322957717|FG001|Overall Study|Lost to Follow-up|10|||
94321230|NCT01774344|322957716|FG000|Overall Study|End of survival follow-up not available|2|||
94321231|NCT01774344|322957717|FG001|Overall Study|End of survival follow-up not available|2|||
94321232|NCT01774344|322957716|FG000|Overall Study|Data collection finished|4|||
94321233|NCT01774344|322957717|FG001|Overall Study|Data collection finished|14|||
94321234|NCT01774344|322957716|FG000|Overall Study|Other|0|||
94321235|NCT01774344|322957717|FG001|Overall Study|Other|1|||
94321236|NCT01774344|322957716|FG000|Overall Study|Did not enter Survival Follow up|49|||
94321237|NCT01774344|322957717|FG001|Overall Study|Did not enter Survival Follow up|83|||
94321238|NCT01409031|322957718|FG000|Overall Study|transferred to other hosp|1|||
94321239|NCT01409031|322957719|FG001|Overall Study|transferred to other hosp|0|||
94321240|NCT04507867|322957729|FG000|Overall Study|Death|7|||
94321241|NCT04507867|322957730|FG001|Overall Study|Death|1|||
94321242|NCT02546674|322957733|FG000|Overall Study|Adverse Event|19|||
94321243|NCT02546674|322957733|FG000|Overall Study|Death|1|||
94321244|NCT02546674|322957733|FG000|Overall Study|Lost to Follow-up|1|||
94321245|NCT02546674|322957733|FG000|Overall Study|Physician Decision|13|||
94321246|NCT02546674|322957733|FG000|Overall Study|Pregnancy|1|||
94321247|NCT02546674|322957733|FG000|Overall Study|Progressive Disease|2|||
94321248|NCT02546674|322957733|FG000|Overall Study|Protocol Deviation|2|||
94321249|NCT02546674|322957733|FG000|Overall Study|Subject/Guardian Decision|6|||
94321250|NCT02546674|322957733|FG000|Overall Study|Withdrawal of Informed Consent|3|||
94321251|NCT01094730|322957736|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
94321252|NCT01094730|322957737|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
94321253|NCT01094730|322957736|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
94321254|NCT01094730|322957737|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
94321255|NCT01094730|322957736|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
94321256|NCT01094730|322957737|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
94321257|NCT01094730|322957736|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
94321258|NCT01094730|322957737|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
94321259|NCT01094730|322957736|FG000|Period 2 (14 Days)|Protocol Violation|2|||
94321260|NCT01094730|322957737|FG001|Period 2 (14 Days)|Protocol Violation|0|||
94387267|NCT03311646|323206086|FG000|Overall Study|Withdrawal by Subject|5|||
94321261|NCT01094730|322957736|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
94321262|NCT01094730|322957737|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
94321263|NCT01094730|322957736|FG000|Period 2 (14 Days)|Adverse Event|0|||
94321264|NCT01094730|322957737|FG001|Period 2 (14 Days)|Adverse Event|1|||
94321265|NCT01094730|322957736|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
94321266|NCT01094730|322957737|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
94321267|NCT02492997|322957738|FG000|Overall Study|Withdrawal by Subject|1|||
94321268|NCT02492997|322957739|FG001|Overall Study|Withdrawal by Subject|0|||
94321269|NCT02492997|322957738|FG000|Overall Study|Gained Weight|1|||
94321270|NCT02492997|322957739|FG001|Overall Study|Gained Weight|0|||
94321271|NCT02492997|322957738|FG000|Overall Study|Lost to Follow-up|0|||
94321272|NCT02492997|322957739|FG001|Overall Study|Lost to Follow-up|1|||
94321273|NCT01842308|322957744|FG000|Overall Study|Withdrawal by Subject|0|||
94321274|NCT01842308|322957745|FG001|Overall Study|Withdrawal by Subject|0|||
94321275|NCT01842308|322957746|FG002|Overall Study|Withdrawal by Subject|0|||
94321276|NCT01842308|322957747|FG003|Overall Study|Withdrawal by Subject|0|||
94321277|NCT01842308|322957748|FG004|Overall Study|Withdrawal by Subject|1|||
94321278|NCT02175771|322957750|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
94321279|NCT02175771|322957751|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
94321280|NCT02175771|322957752|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
94321281|NCT02175771|322957753|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
94321282|NCT02175771|322957754|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
94321283|NCT02175771|322957755|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
94321284|NCT02175771|322957756|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
94321285|NCT02175771|322957757|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
94321286|NCT02175771|322957758|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
94321287|NCT02175771|322957750|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
94321288|NCT02175771|322957751|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
94321289|NCT02175771|322957752|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
94321290|NCT02175771|322957753|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
94321291|NCT02175771|322957754|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
94321292|NCT02175771|322957755|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
94321293|NCT02175771|322957756|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
94321294|NCT02175771|322957757|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
94321295|NCT02175771|322957758|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
94321296|NCT02175771|322957750|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
94321297|NCT02175771|322957751|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
94321298|NCT02175771|322957752|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
94321299|NCT02175771|322957753|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
94321300|NCT02175771|322957754|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
94321301|NCT02175771|322957755|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
94321302|NCT02175771|322957756|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
94321303|NCT02175771|322957757|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
94321304|NCT02175771|322957758|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
94321305|NCT02175771|322957750|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
94321306|NCT02175771|322957751|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
94321307|NCT02175771|322957752|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
94321308|NCT02175771|322957753|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
94321309|NCT02175771|322957754|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
94321310|NCT02175771|322957755|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
94321311|NCT02175771|322957756|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
94321312|NCT02175771|322957757|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
94321313|NCT02175771|322957758|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
94321314|NCT02175771|322957750|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
94321315|NCT02175771|322957751|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
94321316|NCT02175771|322957752|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
94321317|NCT02175771|322957753|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
94321318|NCT02175771|322957754|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
94321319|NCT02175771|322957755|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
94321320|NCT02175771|322957756|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
94321321|NCT02175771|322957757|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
94321322|NCT02175771|322957758|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
94321323|NCT02175771|322957750|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
94321324|NCT02175771|322957751|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
94321325|NCT02175771|322957752|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
94321326|NCT02175771|322957753|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
94321327|NCT02175771|322957754|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
94482192|NCT03428100|323558042|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
94321328|NCT02175771|322957755|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
94321329|NCT02175771|322957756|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
94321330|NCT02175771|322957757|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
94321331|NCT02175771|322957758|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
94321332|NCT02175771|322957750|FG000|Run-In Period (Pre-assignment)|Other|8|||
94321333|NCT02175771|322957751|FG001|Run-In Period (Pre-assignment)|Other|0|||
94321334|NCT02175771|322957752|FG002|Run-In Period (Pre-assignment)|Other|0|||
94321335|NCT02175771|322957753|FG003|Run-In Period (Pre-assignment)|Other|0|||
94321336|NCT02175771|322957754|FG004|Run-In Period (Pre-assignment)|Other|0|||
94321337|NCT02175771|322957755|FG005|Run-In Period (Pre-assignment)|Other|0|||
94321338|NCT02175771|322957756|FG006|Run-In Period (Pre-assignment)|Other|0|||
94321339|NCT02175771|322957757|FG007|Run-In Period (Pre-assignment)|Other|0|||
94321340|NCT02175771|322957758|FG008|Run-In Period (Pre-assignment)|Other|0|||
94321341|NCT02175771|322957750|FG000|Treatment Period|Adverse Event|0|||
94321342|NCT02175771|322957751|FG001|Treatment Period|Adverse Event|2|||
94321343|NCT02175771|322957752|FG002|Treatment Period|Adverse Event|1|||
94321344|NCT02175771|322957753|FG003|Treatment Period|Adverse Event|1|||
94321345|NCT02175771|322957754|FG004|Treatment Period|Adverse Event|1|||
94321346|NCT02175771|322957755|FG005|Treatment Period|Adverse Event|3|||
94321347|NCT02175771|322957756|FG006|Treatment Period|Adverse Event|2|||
94321348|NCT02175771|322957757|FG007|Treatment Period|Adverse Event|0|||
94321349|NCT02175771|322957758|FG008|Treatment Period|Adverse Event|1|||
94321350|NCT02175771|322957750|FG000|Treatment Period|Withdrawal by Subject|0|||
94321351|NCT02175771|322957751|FG001|Treatment Period|Withdrawal by Subject|9|||
94321352|NCT02175771|322957752|FG002|Treatment Period|Withdrawal by Subject|3|||
94321353|NCT02175771|322957753|FG003|Treatment Period|Withdrawal by Subject|6|||
94321354|NCT02175771|322957754|FG004|Treatment Period|Withdrawal by Subject|2|||
94321355|NCT02175771|322957755|FG005|Treatment Period|Withdrawal by Subject|4|||
94321356|NCT02175771|322957756|FG006|Treatment Period|Withdrawal by Subject|2|||
94321357|NCT02175771|322957757|FG007|Treatment Period|Withdrawal by Subject|9|||
94321358|NCT02175771|322957758|FG008|Treatment Period|Withdrawal by Subject|2|||
94321359|NCT02175771|322957750|FG000|Treatment Period|Noncompliance|0|||
94321360|NCT02175771|322957751|FG001|Treatment Period|Noncompliance|1|||
94321361|NCT02175771|322957752|FG002|Treatment Period|Noncompliance|2|||
94321362|NCT02175771|322957753|FG003|Treatment Period|Noncompliance|0|||
94321363|NCT02175771|322957754|FG004|Treatment Period|Noncompliance|0|||
94321364|NCT02175771|322957755|FG005|Treatment Period|Noncompliance|0|||
94321365|NCT02175771|322957756|FG006|Treatment Period|Noncompliance|0|||
94321366|NCT02175771|322957757|FG007|Treatment Period|Noncompliance|0|||
94387268|NCT03311646|323206086|FG000|Overall Study|Lost to Follow-up|5|||
94387269|NCT03311646|323206086|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
94387270|NCT01717976|323206087|FG000|Overall Study|Protocol Violation|0|||
94387271|NCT01717976|323206088|FG001|Overall Study|Protocol Violation|1|||
94387272|NCT00728949|323206089|FG000|Overall Study|Adverse Event|8|||
94387273|NCT00728949|323206090|FG001|Overall Study|Adverse Event|0|||
94387274|NCT00728949|323206089|FG000|Overall Study|Withdrawal by Subject|2|||
94387275|NCT00728949|323206090|FG001|Overall Study|Withdrawal by Subject|2|||
94387276|NCT00728949|323206089|FG000|Overall Study|Abnormal Lab Results|0|||
94387277|NCT00728949|323206090|FG001|Overall Study|Abnormal Lab Results|2|||
94387278|NCT00728949|323206089|FG000|Overall Study|On treatment at cutoff date|1|||
94387279|NCT00728949|323206090|FG001|Overall Study|On treatment at cutoff date|0|||
94387280|NCT03127137|323206091|FG000|Overall Study|Requested sedation after consent|1|||
94387281|NCT03127137|323206092|FG001|Overall Study|Requested sedation after consent|0|||
94387282|NCT03127137|323206091|FG000|Overall Study|Malfunction in electronic data collection|1|||
94387283|NCT03127137|323206092|FG001|Overall Study|Malfunction in electronic data collection|0|||
94387284|NCT03127137|323206091|FG000|Overall Study|Post procedure testing could not be obtained|0|||
94387285|NCT03127137|323206092|FG001|Overall Study|Post procedure testing could not be obtained|1|||
94387286|NCT02896361|323206093|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
94387287|NCT02896361|323206094|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
94387288|NCT02896361|323206095|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
94387289|NCT02896361|323206093|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
94387290|NCT02896361|323206094|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
94387291|NCT02896361|323206095|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
94387292|NCT03952143|323206099|FG000|Lead-In Period|Adverse Event|2|||
94387293|NCT03952143|323206100|FG001|Lead-In Period|Adverse Event|0|||
94387294|NCT03952143|323206101|FG002|Lead-In Period|Adverse Event|0|||
94387295|NCT03952143|323206099|FG000|Lead-In Period|Lack of Efficacy|2|||
94387296|NCT03952143|323206100|FG001|Lead-In Period|Lack of Efficacy|0|||
94387297|NCT03952143|323206101|FG002|Lead-In Period|Lack of Efficacy|0|||
94387298|NCT03952143|323206099|FG000|Lead-In Period|Physician Decision|5|||
94387299|NCT03952143|323206100|FG001|Lead-In Period|Physician Decision|0|||
94321367|NCT02175771|322957758|FG008|Treatment Period|Noncompliance|1|||
94387300|NCT03952143|323206101|FG002|Lead-In Period|Physician Decision|0|||
94321368|NCT02175771|322957750|FG000|Treatment Period|Protocol Violation|0|||
94321369|NCT02175771|322957751|FG001|Treatment Period|Protocol Violation|0|||
94321370|NCT02175771|322957752|FG002|Treatment Period|Protocol Violation|0|||
94321371|NCT02175771|322957753|FG003|Treatment Period|Protocol Violation|0|||
94482193|NCT03428100|323558043|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
94482194|NCT03428100|323558044|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
94482195|NCT03428100|323558045|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
94482196|NCT03428100|323558046|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
94482197|NCT03428100|323558047|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
94482198|NCT03428100|323558048|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
94482199|NCT03428100|323558049|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
94482200|NCT03428100|323558050|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
94482201|NCT03428100|323558051|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
94482202|NCT03428100|323558033|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
94482203|NCT03428100|323558034|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
94482204|NCT03428100|323558035|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
94482205|NCT03428100|323558036|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
94482206|NCT03428100|323558037|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
94482207|NCT03428100|323558038|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
94482208|NCT03428100|323558039|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
94482209|NCT03428100|323558040|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
94482210|NCT03428100|323558041|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
94482211|NCT03428100|323558042|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
94482212|NCT03428100|323558043|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
94482213|NCT03428100|323558044|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
94482214|NCT03428100|323558045|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
94482215|NCT03428100|323558046|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
94482216|NCT03428100|323558047|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
94482217|NCT03428100|323558048|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
94482218|NCT03428100|323558049|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
94482219|NCT03428100|323558050|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
94482220|NCT03428100|323558051|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
94482221|NCT03428100|323558033|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
94482222|NCT03428100|323558034|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
94482223|NCT03428100|323558035|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
94482224|NCT03428100|323558036|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
94482225|NCT03428100|323558037|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
94482226|NCT03428100|323558038|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
94482227|NCT03428100|323558039|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
94482228|NCT03428100|323558040|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
94482229|NCT03428100|323558041|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
94482230|NCT03428100|323558042|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
94482231|NCT03428100|323558043|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
94482232|NCT03428100|323558044|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
94482233|NCT03428100|323558045|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
94482234|NCT03428100|323558046|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
94482235|NCT03428100|323558047|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
94482236|NCT03428100|323558048|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
94482237|NCT03428100|323558049|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
94482238|NCT03428100|323558050|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
94482239|NCT03428100|323558051|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
94482240|NCT04556760|323558052|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
94482241|NCT04556760|323558053|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
94482242|NCT04556760|323558054|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
94482243|NCT04556760|323558055|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
94482244|NCT04556760|323558056|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
94482245|NCT04556760|323558057|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
94482246|NCT04556760|323558052|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
94482247|NCT04556760|323558053|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
94482248|NCT04556760|323558054|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
94482249|NCT04556760|323558055|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
94482250|NCT04556760|323558056|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
94321372|NCT02175771|322957754|FG004|Treatment Period|Protocol Violation|0|||
94321373|NCT02175771|322957755|FG005|Treatment Period|Protocol Violation|0|||
94321374|NCT02175771|322957756|FG006|Treatment Period|Protocol Violation|0|||
94321375|NCT02175771|322957757|FG007|Treatment Period|Protocol Violation|1|||
94321376|NCT02175771|322957758|FG008|Treatment Period|Protocol Violation|0|||
94321377|NCT02175771|322957750|FG000|Treatment Period|Disease progression|0|||
94321378|NCT02175771|322957751|FG001|Treatment Period|Disease progression|0|||
94321379|NCT02175771|322957752|FG002|Treatment Period|Disease progression|0|||
94321380|NCT02175771|322957753|FG003|Treatment Period|Disease progression|0|||
94321381|NCT02175771|322957754|FG004|Treatment Period|Disease progression|0|||
94321382|NCT02175771|322957755|FG005|Treatment Period|Disease progression|0|||
94321383|NCT02175771|322957756|FG006|Treatment Period|Disease progression|0|||
94321384|NCT02175771|322957757|FG007|Treatment Period|Disease progression|2|||
94321385|NCT02175771|322957758|FG008|Treatment Period|Disease progression|0|||
94321386|NCT02175771|322957750|FG000|Treatment Period|Lost to Follow-up|0|||
94321387|NCT02175771|322957751|FG001|Treatment Period|Lost to Follow-up|3|||
94321388|NCT02175771|322957752|FG002|Treatment Period|Lost to Follow-up|1|||
94321389|NCT02175771|322957753|FG003|Treatment Period|Lost to Follow-up|3|||
94321390|NCT02175771|322957754|FG004|Treatment Period|Lost to Follow-up|1|||
94321391|NCT02175771|322957755|FG005|Treatment Period|Lost to Follow-up|2|||
94321392|NCT02175771|322957756|FG006|Treatment Period|Lost to Follow-up|1|||
94321393|NCT02175771|322957757|FG007|Treatment Period|Lost to Follow-up|2|||
94321394|NCT02175771|322957758|FG008|Treatment Period|Lost to Follow-up|2|||
94321395|NCT02175771|322957750|FG000|Treatment Period|Lack of Efficacy|0|||
94321396|NCT02175771|322957751|FG001|Treatment Period|Lack of Efficacy|0|||
94321397|NCT02175771|322957752|FG002|Treatment Period|Lack of Efficacy|0|||
94321398|NCT02175771|322957753|FG003|Treatment Period|Lack of Efficacy|0|||
94321399|NCT02175771|322957754|FG004|Treatment Period|Lack of Efficacy|0|||
94321400|NCT02175771|322957755|FG005|Treatment Period|Lack of Efficacy|1|||
94321401|NCT02175771|322957756|FG006|Treatment Period|Lack of Efficacy|0|||
94321402|NCT02175771|322957757|FG007|Treatment Period|Lack of Efficacy|1|||
94321403|NCT02175771|322957758|FG008|Treatment Period|Lack of Efficacy|0|||
94321404|NCT02175771|322957750|FG000|Treatment Period|Other|0|||
94321405|NCT02175771|322957751|FG001|Treatment Period|Other|1|||
94321406|NCT02175771|322957752|FG002|Treatment Period|Other|0|||
94321407|NCT02175771|322957753|FG003|Treatment Period|Other|3|||
94321408|NCT02175771|322957754|FG004|Treatment Period|Other|1|||
94321409|NCT02175771|322957755|FG005|Treatment Period|Other|0|||
94321410|NCT02175771|322957756|FG006|Treatment Period|Other|0|||
94321411|NCT02175771|322957757|FG007|Treatment Period|Other|2|||
94321412|NCT02175771|322957758|FG008|Treatment Period|Other|0|||
94321413|NCT03364673|322957759|FG000|Overall Study|Withdrawal by Subject|2|||
94321414|NCT03364673|322957759|FG000|Overall Study|Injury unrelated to study|3|||
94321415|NCT02232087|322957760|FG000|Overall Study|Withdrawal by Subject|2|||
94321416|NCT02232087|322957761|FG001|Overall Study|Withdrawal by Subject|0|||
94321417|NCT02232087|322957762|FG002|Overall Study|Withdrawal by Subject|0|||
94321418|NCT02232087|322957763|FG003|Overall Study|Withdrawal by Subject|0|||
94321419|NCT02232087|322957764|FG004|Overall Study|Withdrawal by Subject|0|||
94321420|NCT02232087|322957765|FG005|Overall Study|Withdrawal by Subject|1|||
94321421|NCT02232087|322957760|FG000|Overall Study|poor inhalation technique|0|||
94321422|NCT02232087|322957761|FG001|Overall Study|poor inhalation technique|1|||
94321423|NCT02232087|322957762|FG002|Overall Study|poor inhalation technique|0|||
94321424|NCT02232087|322957763|FG003|Overall Study|poor inhalation technique|0|||
94321425|NCT02232087|322957764|FG004|Overall Study|poor inhalation technique|0|||
94321426|NCT02232087|322957765|FG005|Overall Study|poor inhalation technique|2|||
94321427|NCT02232087|322957760|FG000|Overall Study|protocol stop criteria|0|||
94321428|NCT02232087|322957761|FG001|Overall Study|protocol stop criteria|1|||
94321429|NCT02232087|322957762|FG002|Overall Study|protocol stop criteria|0|||
94321430|NCT02232087|322957763|FG003|Overall Study|protocol stop criteria|1|||
94321431|NCT02232087|322957764|FG004|Overall Study|protocol stop criteria|0|||
94321432|NCT02232087|322957765|FG005|Overall Study|protocol stop criteria|0|||
94482251|NCT04556760|323558057|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
94321433|NCT02232087|322957760|FG000|Overall Study|Adverse Event|0|||
94321434|NCT02232087|322957761|FG001|Overall Study|Adverse Event|0|||
94321435|NCT02232087|322957762|FG002|Overall Study|Adverse Event|0|||
94321436|NCT02232087|322957763|FG003|Overall Study|Adverse Event|0|||
94321437|NCT02232087|322957764|FG004|Overall Study|Adverse Event|1|||
94321438|NCT02232087|322957765|FG005|Overall Study|Adverse Event|0|||
94321439|NCT02504268|322957767|FG000|Overall Study|Adverse Event|18|||
94321440|NCT02504268|322957768|FG001|Overall Study|Adverse Event|8|||
94321441|NCT02504268|322957769|FG002|Overall Study|Adverse Event|14|||
94321442|NCT02504268|322957770|FG003|Overall Study|Adverse Event|0|||
94482252|NCT02157519|323558060|FG000|Overall Study|Death|3|||
94321443|NCT02504268|322957771|FG004|Overall Study|Adverse Event|0|||
94321444|NCT02504268|322957772|FG005|Overall Study|Adverse Event|0|||
94321445|NCT02504268|322957773|FG006|Overall Study|Adverse Event|0|||
94321446|NCT02504268|322957774|FG007|Overall Study|Adverse Event|0|||
94321447|NCT02504268|322957775|FG008|Overall Study|Adverse Event|0|||
94482253|NCT02157519|323558061|FG001|Overall Study|Death|1|||
94482254|NCT02157519|323558060|FG000|Overall Study|Withdrawal by Subject|7|||
94482255|NCT02157519|323558061|FG001|Overall Study|Withdrawal by Subject|0|||
94482256|NCT02157519|323558060|FG000|Overall Study|Lost to Follow-up|1|||
94482257|NCT02157519|323558061|FG001|Overall Study|Lost to Follow-up|0|||
94482258|NCT01656395|323558062|FG000|Overall Study|Adverse Event|1|||
94482259|NCT01656395|323558063|FG001|Overall Study|Adverse Event|14|||
94482260|NCT01656395|323558064|FG002|Overall Study|Adverse Event|5|||
94482261|NCT01656395|323558065|FG003|Overall Study|Adverse Event|4|||
94482262|NCT01656395|323558066|FG004|Overall Study|Adverse Event|5|||
94482263|NCT01656395|323558067|FG005|Overall Study|Adverse Event|7|||
94482264|NCT01656395|323558068|FG006|Overall Study|Adverse Event|0|||
94482265|NCT01656395|323558069|FG007|Overall Study|Adverse Event|0|||
94482266|NCT01656395|323558062|FG000|Overall Study|Lack of Efficacy|1|||
94482267|NCT01656395|323558063|FG001|Overall Study|Lack of Efficacy|8|||
94482268|NCT01656395|323558064|FG002|Overall Study|Lack of Efficacy|6|||
94482269|NCT01656395|323558065|FG003|Overall Study|Lack of Efficacy|1|||
94482270|NCT01656395|323558066|FG004|Overall Study|Lack of Efficacy|1|||
94482271|NCT01656395|323558067|FG005|Overall Study|Lack of Efficacy|6|||
94482272|NCT01656395|323558068|FG006|Overall Study|Lack of Efficacy|0|||
94482273|NCT01656395|323558069|FG007|Overall Study|Lack of Efficacy|0|||
94482274|NCT01656395|323558062|FG000|Overall Study|Lost to Follow-up|1|||
94482275|NCT01656395|323558063|FG001|Overall Study|Lost to Follow-up|0|||
94482276|NCT01656395|323558064|FG002|Overall Study|Lost to Follow-up|0|||
94482277|NCT01656395|323558065|FG003|Overall Study|Lost to Follow-up|0|||
94482278|NCT01656395|323558066|FG004|Overall Study|Lost to Follow-up|0|||
94482279|NCT01656395|323558067|FG005|Overall Study|Lost to Follow-up|0|||
94482280|NCT01656395|323558068|FG006|Overall Study|Lost to Follow-up|0|||
94482281|NCT01656395|323558069|FG007|Overall Study|Lost to Follow-up|0|||
94321448|NCT02504268|322957767|FG000|Overall Study|Withdrawal of Consent|11|||
94321449|NCT02504268|322957768|FG001|Overall Study|Withdrawal of Consent|10|||
94482282|NCT01656395|323558062|FG000|Overall Study|Non-Compliance with Study Drug|1|||
94482283|NCT01656395|323558063|FG001|Overall Study|Non-Compliance with Study Drug|1|||
94482284|NCT01656395|323558064|FG002|Overall Study|Non-Compliance with Study Drug|0|||
94482285|NCT01656395|323558065|FG003|Overall Study|Non-Compliance with Study Drug|0|||
94321450|NCT02504268|322957769|FG002|Overall Study|Withdrawal of Consent|3|||
94321451|NCT02504268|322957770|FG003|Overall Study|Withdrawal of Consent|0|||
94321452|NCT02504268|322957771|FG004|Overall Study|Withdrawal of Consent|0|||
94321453|NCT02504268|322957772|FG005|Overall Study|Withdrawal of Consent|0|||
94321454|NCT02504268|322957773|FG006|Overall Study|Withdrawal of Consent|0|||
94321455|NCT02504268|322957774|FG007|Overall Study|Withdrawal of Consent|0|||
94321456|NCT02504268|322957775|FG008|Overall Study|Withdrawal of Consent|0|||
94321457|NCT02504268|322957767|FG000|Overall Study|Pregnancy|2|||
94321458|NCT02504268|322957768|FG001|Overall Study|Pregnancy|0|||
94321459|NCT02504268|322957769|FG002|Overall Study|Pregnancy|0|||
94321460|NCT02504268|322957770|FG003|Overall Study|Pregnancy|0|||
94321461|NCT02504268|322957771|FG004|Overall Study|Pregnancy|0|||
94387301|NCT03952143|323206099|FG000|Lead-In Period|Protocol Violation|5|||
94387302|NCT03952143|323206100|FG001|Lead-In Period|Protocol Violation|0|||
94387303|NCT03952143|323206101|FG002|Lead-In Period|Protocol Violation|0|||
94321462|NCT02504268|322957772|FG005|Overall Study|Pregnancy|0|||
94387304|NCT03952143|323206099|FG000|Lead-In Period|Withdrawal by Subject|19|||
94387305|NCT03952143|323206100|FG001|Lead-In Period|Withdrawal by Subject|0|||
94387306|NCT03952143|323206101|FG002|Lead-In Period|Withdrawal by Subject|0|||
94387307|NCT03952143|323206099|FG000|Treatment Period|Adverse Event|0|||
94387308|NCT03952143|323206100|FG001|Treatment Period|Adverse Event|0|||
94387309|NCT03952143|323206101|FG002|Treatment Period|Adverse Event|1|||
94387310|NCT03952143|323206099|FG000|Treatment Period|Lost to Follow-up|0|||
94387311|NCT03952143|323206100|FG001|Treatment Period|Lost to Follow-up|2|||
94387312|NCT03952143|323206101|FG002|Treatment Period|Lost to Follow-up|0|||
94387313|NCT03952143|323206099|FG000|Treatment Period|Physician Decision|0|||
94387314|NCT03952143|323206100|FG001|Treatment Period|Physician Decision|0|||
94387315|NCT03952143|323206101|FG002|Treatment Period|Physician Decision|2|||
94387316|NCT03952143|323206099|FG000|Treatment Period|Protocol Violation|0|||
94321463|NCT02504268|322957773|FG006|Overall Study|Pregnancy|0|||
94387317|NCT03952143|323206100|FG001|Treatment Period|Protocol Violation|0|||
94321464|NCT02504268|322957774|FG007|Overall Study|Pregnancy|0|||
94482286|NCT01656395|323558066|FG004|Overall Study|Non-Compliance with Study Drug|1|||
94482287|NCT01656395|323558067|FG005|Overall Study|Non-Compliance with Study Drug|1|||
94321465|NCT02504268|322957775|FG008|Overall Study|Pregnancy|0|||
94321466|NCT02504268|322957767|FG000|Overall Study|Lost to Follow-up|3|||
94321467|NCT02504268|322957768|FG001|Overall Study|Lost to Follow-up|6|||
94321468|NCT02504268|322957769|FG002|Overall Study|Lost to Follow-up|4|||
94387318|NCT03952143|323206101|FG002|Treatment Period|Protocol Violation|1|||
94387319|NCT03952143|323206099|FG000|Treatment Period|Withdrawal by Subject|0|||
94482288|NCT01656395|323558068|FG006|Overall Study|Non-Compliance with Study Drug|0|||
94482289|NCT01656395|323558069|FG007|Overall Study|Non-Compliance with Study Drug|0|||
94482290|NCT01656395|323558062|FG000|Overall Study|Other|0|||
94321469|NCT02504268|322957770|FG003|Overall Study|Lost to Follow-up|0|||
94387320|NCT03952143|323206100|FG001|Treatment Period|Withdrawal by Subject|5|||
94387321|NCT03952143|323206101|FG002|Treatment Period|Withdrawal by Subject|26|||
94387322|NCT03952143|323206099|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
94387323|NCT03952143|323206100|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
94387324|NCT03952143|323206101|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
94387325|NCT03952143|323206099|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
94387326|NCT03952143|323206100|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
94387327|NCT03952143|323206101|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
94387328|NCT02731157|323206102|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
94387329|NCT01239121|323206103|FG000|Overall Study|Withdrawal by Subject|2|||
94387330|NCT01239121|323206104|FG001|Overall Study|Withdrawal by Subject|4|||
94387331|NCT01239121|323206105|FG002|Overall Study|Withdrawal by Subject|0|||
94387332|NCT00220337|323206107|FG000|Overall Study|Adverse Event|70|||
94387333|NCT00220337|323206107|FG000|Overall Study|Lack of Efficacy|17|||
94387334|NCT00220337|323206107|FG000|Overall Study|Withdrawal by Subject|68|||
94387335|NCT00220337|323206107|FG000|Overall Study|Protocol Violation|2|||
94387336|NCT00220337|323206107|FG000|Overall Study|Lost to Follow-up|5|||
94387337|NCT00220337|323206107|FG000|Overall Study|Other|12|||
94387338|NCT00220337|323206107|FG000|Overall Study|Unsatisfactory compliance|5|||
94387339|NCT03661528|323206112|FG000|Overall Study|Death|1|||
94387340|NCT03661528|323206113|FG001|Overall Study|Death|0|||
94387341|NCT03661528|323206112|FG000|Overall Study|Physician Decision|3|||
94387342|NCT03661528|323206113|FG001|Overall Study|Physician Decision|1|||
94387343|NCT03661528|323206112|FG000|Overall Study|Other than Specified|5|||
94387344|NCT03661528|323206113|FG001|Overall Study|Other than Specified|2|||
94387345|NCT03661528|323206112|FG000|Overall Study|Withdrawal by Subject|5|||
94387346|NCT03661528|323206113|FG001|Overall Study|Withdrawal by Subject|3|||
94387347|NCT03661528|323206112|FG000|Overall Study|Disease Progression|8|||
94387348|NCT03661528|323206113|FG001|Overall Study|Disease Progression|13|||
94387349|NCT03661528|323206112|FG000|Overall Study|Adverse Event|61|||
94387350|NCT03661528|323206113|FG001|Overall Study|Adverse Event|55|||
94387351|NCT02732210|323206116|FG000|Overall Study|Site Closed|0|||
94387352|NCT02732210|323206117|FG001|Overall Study|Site Closed|11|||
94321470|NCT02504268|322957771|FG004|Overall Study|Lost to Follow-up|0|||
94321471|NCT02504268|322957772|FG005|Overall Study|Lost to Follow-up|0|||
94321472|NCT02504268|322957773|FG006|Overall Study|Lost to Follow-up|0|||
94321473|NCT02504268|322957774|FG007|Overall Study|Lost to Follow-up|0|||
94321474|NCT02504268|322957775|FG008|Overall Study|Lost to Follow-up|0|||
94321475|NCT02504268|322957767|FG000|Overall Study|Death|1|||
94321476|NCT02504268|322957768|FG001|Overall Study|Death|1|||
94321477|NCT02504268|322957769|FG002|Overall Study|Death|0|||
94321478|NCT02504268|322957770|FG003|Overall Study|Death|0|||
94321479|NCT02504268|322957771|FG004|Overall Study|Death|0|||
94321480|NCT02504268|322957772|FG005|Overall Study|Death|0|||
94321481|NCT02504268|322957773|FG006|Overall Study|Death|0|||
94321482|NCT02504268|322957774|FG007|Overall Study|Death|0|||
94321483|NCT02504268|322957775|FG008|Overall Study|Death|0|||
94321484|NCT02504268|322957767|FG000|Overall Study|Subject Request to Discontinue|11|||
94321485|NCT02504268|322957768|FG001|Overall Study|Subject Request to Discontinue|3|||
94321486|NCT02504268|322957769|FG002|Overall Study|Subject Request to Discontinue|6|||
94321487|NCT02504268|322957770|FG003|Overall Study|Subject Request to Discontinue|0|||
94321488|NCT02504268|322957771|FG004|Overall Study|Subject Request to Discontinue|0|||
94321489|NCT02504268|322957772|FG005|Overall Study|Subject Request to Discontinue|0|||
94321490|NCT02504268|322957773|FG006|Overall Study|Subject Request to Discontinue|0|||
94321491|NCT02504268|322957774|FG007|Overall Study|Subject Request to Discontinue|0|||
94321492|NCT02504268|322957775|FG008|Overall Study|Subject Request to Discontinue|0|||
94321493|NCT02504268|322957767|FG000|Overall Study|No Longer Meets Study Criteria|2|||
94321494|NCT02504268|322957768|FG001|Overall Study|No Longer Meets Study Criteria|3|||
94321495|NCT02504268|322957769|FG002|Overall Study|No Longer Meets Study Criteria|0|||
94321496|NCT02504268|322957770|FG003|Overall Study|No Longer Meets Study Criteria|0|||
94321497|NCT02504268|322957771|FG004|Overall Study|No Longer Meets Study Criteria|0|||
94321498|NCT02504268|322957772|FG005|Overall Study|No Longer Meets Study Criteria|0|||
94321499|NCT02504268|322957773|FG006|Overall Study|No Longer Meets Study Criteria|0|||
94321500|NCT02504268|322957774|FG007|Overall Study|No Longer Meets Study Criteria|0|||
94321501|NCT02504268|322957775|FG008|Overall Study|No Longer Meets Study Criteria|0|||
94321502|NCT02504268|322957767|FG000|Overall Study|Lack of Efficacy|11|||
94321503|NCT02504268|322957768|FG001|Overall Study|Lack of Efficacy|35|||
94321504|NCT02504268|322957769|FG002|Overall Study|Lack of Efficacy|9|||
94321505|NCT02504268|322957770|FG003|Overall Study|Lack of Efficacy|0|||
94321506|NCT02504268|322957771|FG004|Overall Study|Lack of Efficacy|0|||
94321507|NCT02504268|322957772|FG005|Overall Study|Lack of Efficacy|0|||
94321508|NCT02504268|322957773|FG006|Overall Study|Lack of Efficacy|0|||
94387353|NCT02732210|323206116|FG000|Overall Study|Study Ended|13|||
94387354|NCT02732210|323206117|FG001|Overall Study|Study Ended|13|||
94387355|NCT02732210|323206116|FG000|Overall Study|Withdrawal by Subject|28|||
94387356|NCT02732210|323206117|FG001|Overall Study|Withdrawal by Subject|87|||
94387357|NCT02732210|323206116|FG000|Overall Study|Lost to Follow-up|5|||
94387358|NCT02732210|323206117|FG001|Overall Study|Lost to Follow-up|57|||
94387359|NCT02732210|323206116|FG000|Overall Study|Death|4|||
94387360|NCT02732210|323206117|FG001|Overall Study|Death|15|||
94387361|NCT02732210|323206116|FG000|Overall Study|Other|35|||
94387362|NCT02732210|323206117|FG001|Overall Study|Other|103|||
94387363|NCT02732210|323206116|FG000|Overall Study|Missing|0|||
94387364|NCT02732210|323206117|FG001|Overall Study|Missing|8|||
94387365|NCT00925769|323206118|FG000|Overall Study|Major toxicity|1|||
94387366|NCT00925769|323206119|FG001|Overall Study|Major toxicity|0|||
94387367|NCT00925769|323206120|FG002|Overall Study|Major toxicity|1|||
94321509|NCT02504268|322957774|FG007|Overall Study|Lack of Efficacy|0|||
94321510|NCT02504268|322957775|FG008|Overall Study|Lack of Efficacy|0|||
94321511|NCT02504268|322957767|FG000|Overall Study|Poor/Non-Compliance|3|||
94321512|NCT02504268|322957768|FG001|Overall Study|Poor/Non-Compliance|2|||
94321513|NCT02504268|322957769|FG002|Overall Study|Poor/Non-Compliance|3|||
94321514|NCT02504268|322957770|FG003|Overall Study|Poor/Non-Compliance|0|||
94321515|NCT02504268|322957771|FG004|Overall Study|Poor/Non-Compliance|0|||
94321516|NCT02504268|322957772|FG005|Overall Study|Poor/Non-Compliance|0|||
94321517|NCT02504268|322957773|FG006|Overall Study|Poor/Non-Compliance|0|||
94321518|NCT02504268|322957774|FG007|Overall Study|Poor/Non-Compliance|0|||
94321519|NCT02504268|322957775|FG008|Overall Study|Poor/Non-Compliance|0|||
94321520|NCT02504268|322957767|FG000|Overall Study|Not Disclosed|1|||
94321521|NCT02504268|322957768|FG001|Overall Study|Not Disclosed|0|||
94321522|NCT02504268|322957769|FG002|Overall Study|Not Disclosed|2|||
94321523|NCT02504268|322957770|FG003|Overall Study|Not Disclosed|0|||
94321524|NCT02504268|322957771|FG004|Overall Study|Not Disclosed|0|||
94321525|NCT02504268|322957772|FG005|Overall Study|Not Disclosed|0|||
94321526|NCT02504268|322957773|FG006|Overall Study|Not Disclosed|0|||
94321527|NCT02504268|322957774|FG007|Overall Study|Not Disclosed|0|||
94321528|NCT02504268|322957775|FG008|Overall Study|Not Disclosed|0|||
94321529|NCT03025217|322957776|FG000|Overall Study|Pregnancy|1|||
94321530|NCT03025217|322957776|FG000|Overall Study|Lost to Follow-up|1|||
94321531|NCT03025217|322957776|FG000|Overall Study|Not eligible, poor English|2|||
94321532|NCT04069156|322957777|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
94321533|NCT04069156|322957778|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
94321534|NCT04069156|322957777|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
94321535|NCT04069156|322957778|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
94321536|NCT04069156|322957777|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
94321537|NCT04069156|322957778|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
94321538|NCT04069156|322957777|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
94321539|NCT04069156|322957778|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
94321540|NCT02208024|322957779|FG000|Overall Study|Withdrawal by Subject|1|||
94321541|NCT02108600|322957781|FG000|Overall Study|Withdrawal by Subject|2|||
94321542|NCT02108600|322957782|FG001|Overall Study|Withdrawal by Subject|0|||
94321543|NCT02108600|322957781|FG000|Overall Study|Lost to Follow-up|1|||
94321544|NCT02108600|322957782|FG001|Overall Study|Lost to Follow-up|1|||
94321545|NCT04032171|322957786|FG000|Overall Study|Study Termination|1|||
94321546|NCT04032171|322957787|FG001|Overall Study|Study Termination|0|||
94321547|NCT02124707|322957788|FG000|Overall Study|Adverse Event|5|||
94321548|NCT02124707|322957788|FG000|Overall Study|Physician Decision|1|||
94321549|NCT02124707|322957788|FG000|Overall Study|Death|1|||
94321550|NCT00718666|322957794|FG000|Booster Phase Year 5|No active participation request|0|||
94321551|NCT00718666|322957795|FG001|Booster Phase Year 5|No active participation request|0|||
94321552|NCT00718666|322957796|FG002|Booster Phase Year 5|No active participation request|1|||
94321553|NCT00718666|322957794|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
94321554|NCT00718666|322957795|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
94387368|NCT00925769|323206121|FG003|Overall Study|Major toxicity|1|||
94387369|NCT00925769|323206122|FG004|Overall Study|Major toxicity|0|||
94387370|NCT00925769|323206123|FG005|Overall Study|Major toxicity|0|||
94387371|NCT00925769|323206118|FG000|Overall Study|Disease progression|4|||
94387372|NCT00925769|323206119|FG001|Overall Study|Disease progression|5|||
94321555|NCT00718666|322957796|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
94321556|NCT00718666|322957794|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
94321557|NCT00718666|322957795|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
94321558|NCT00718666|322957796|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
94321559|NCT00718666|322957794|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
94321560|NCT00718666|322957795|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
94321561|NCT00718666|322957796|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
94321562|NCT00997321|322957797|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
94321563|NCT00997321|322957798|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
94321564|NCT00421343|322957802|FG000|Overall Study|Death|1|||
94321565|NCT00421343|322957802|FG000|Overall Study|Withdrawal by Subject|2|||
94321566|NCT00421343|322957802|FG000|Overall Study|Lost to Follow-up|3|||
94321567|NCT03471767|322957805|FG000|Overall Study|Withdrawal by Subject|3|||
94321568|NCT03471767|322957806|FG001|Overall Study|Withdrawal by Subject|1|||
94387373|NCT00925769|323206120|FG002|Overall Study|Disease progression|3|||
94387374|NCT00925769|323206121|FG003|Overall Study|Disease progression|4|||
94321569|NCT03471767|322957805|FG000|Overall Study|Adverse Event|1|||
94321570|NCT03471767|322957806|FG001|Overall Study|Adverse Event|0|||
94321571|NCT03471767|322957805|FG000|Overall Study|Lost to Follow-up|1|||
94321572|NCT03471767|322957806|FG001|Overall Study|Lost to Follow-up|0|||
94321573|NCT03471767|322957805|FG000|Overall Study|PI Withdrawal|1|||
94321574|NCT03471767|322957806|FG001|Overall Study|PI Withdrawal|3|||
94321575|NCT03806179|322957809|FG000|Overall Study|Progressive disease|0|||
94321576|NCT03806179|322957810|FG001|Overall Study|Progressive disease|2|||
94321577|NCT01151579|322957811|FG000|Overall Study|Physician Decision|3|||
94321578|NCT01151579|322957812|FG001|Overall Study|Physician Decision|1|||
94321579|NCT01151579|322957811|FG000|Overall Study|Withdrawal by Subject|3|||
94321580|NCT01151579|322957812|FG001|Overall Study|Withdrawal by Subject|2|||
94321581|NCT01151579|322957811|FG000|Overall Study|Not meet inclusion criteria|6|||
94321582|NCT01151579|322957812|FG001|Overall Study|Not meet inclusion criteria|4|||
94321583|NCT04799405|322957823|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
94321584|NCT00603980|322957824|FG000|Study Qualification|Protocol Violation|3|||
94321585|NCT00603980|322957824|FG000|Study Qualification|Inconsistent data reporting|13|||
94321586|NCT00603980|322957824|FG000|Main Study|14th subject completed trial|1|||
94321587|NCT01029002|322957825|FG000|Overall Study|Lost to Follow-up|2|||
94321588|NCT01029002|322957826|FG001|Overall Study|Lost to Follow-up|4|||
94321589|NCT01627067|322957827|FG000|Overall Study|Screen Failure|1|||
94321590|NCT01551758|322957828|FG000|Overall Study|Adverse Event|29|||
94321591|NCT01551758|322957829|FG001|Overall Study|Adverse Event|43|||
94321592|NCT01551758|322957828|FG000|Overall Study|Lack of Efficacy|0|||
94321593|NCT01551758|322957829|FG001|Overall Study|Lack of Efficacy|1|||
94321594|NCT01551758|322957828|FG000|Overall Study|Protocol Violation|5|||
94321595|NCT01551758|322957829|FG001|Overall Study|Protocol Violation|6|||
94321596|NCT01551758|322957828|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
94321597|NCT01551758|322957829|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
94321598|NCT01551758|322957828|FG000|Overall Study|Lost to Follow-up|29|||
94321599|NCT01551758|322957829|FG001|Overall Study|Lost to Follow-up|25|||
94321600|NCT01551758|322957828|FG000|Overall Study|Physician Decision|9|||
94321601|NCT01551758|322957829|FG001|Overall Study|Physician Decision|3|||
94321602|NCT01551758|322957828|FG000|Overall Study|Withdrawal by Subject|14|||
94321603|NCT01551758|322957829|FG001|Overall Study|Withdrawal by Subject|17|||
94321604|NCT04569084|322957833|FG000|Overall Study|Adverse Event|10|||
94321605|NCT04569084|322957834|FG001|Overall Study|Adverse Event|14|||
94321606|NCT04569084|322957833|FG000|Overall Study|Death|2|||
94321607|NCT04569084|322957834|FG001|Overall Study|Death|3|||
94321608|NCT04569084|322957833|FG000|Overall Study|Lost to Follow-up|1|||
94321609|NCT04569084|322957834|FG001|Overall Study|Lost to Follow-up|1|||
94321610|NCT04569084|322957833|FG000|Overall Study|Physician Decision|3|||
94321611|NCT04569084|322957834|FG001|Overall Study|Physician Decision|3|||
94321612|NCT04569084|322957833|FG000|Overall Study|Protocol Violation|2|||
94321613|NCT04569084|322957834|FG001|Overall Study|Protocol Violation|1|||
94321614|NCT04569084|322957833|FG000|Overall Study|Withdrawal by Subject|20|||
94321615|NCT04569084|322957834|FG001|Overall Study|Withdrawal by Subject|21|||
94321616|NCT04569084|322957833|FG000|Overall Study|Study terminated by sponsor|26|||
94321617|NCT04569084|322957834|FG001|Overall Study|Study terminated by sponsor|23|||
94321618|NCT04569084|322957833|FG000|Overall Study|Other|3|||
94321619|NCT04569084|322957834|FG001|Overall Study|Other|5|||
94321620|NCT02773238|322957835|FG000|Overall Study|Lack of Efficacy|4|||
94321621|NCT00755846|322959213|FG000|Overall Study|Adverse Event|0|||
94321622|NCT00755846|322959214|FG001|Overall Study|Adverse Event|0|||
94321623|NCT00755846|322959215|FG002|Overall Study|Adverse Event|0|||
94321624|NCT00755846|322959216|FG003|Overall Study|Adverse Event|1|||
94321625|NCT00755846|322959217|FG004|Overall Study|Adverse Event|3|||
94321626|NCT00755846|322959218|FG005|Overall Study|Adverse Event|2|||
94321627|NCT00755846|322959213|FG000|Overall Study|Protocol Violation|1|||
94321628|NCT00755846|322959214|FG001|Overall Study|Protocol Violation|1|||
94321629|NCT00755846|322959215|FG002|Overall Study|Protocol Violation|1|||
94321630|NCT00755846|322959216|FG003|Overall Study|Protocol Violation|1|||
94321631|NCT00755846|322959217|FG004|Overall Study|Protocol Violation|1|||
94321632|NCT00755846|322959218|FG005|Overall Study|Protocol Violation|1|||
94321633|NCT00755846|322959213|FG000|Overall Study|Lost to Follow-up|0|||
94321634|NCT00755846|322959214|FG001|Overall Study|Lost to Follow-up|2|||
94321635|NCT00755846|322959215|FG002|Overall Study|Lost to Follow-up|1|||
94321636|NCT00755846|322959216|FG003|Overall Study|Lost to Follow-up|0|||
94321637|NCT00755846|322959217|FG004|Overall Study|Lost to Follow-up|4|||
94321638|NCT00755846|322959218|FG005|Overall Study|Lost to Follow-up|2|||
94321639|NCT00755846|322959213|FG000|Overall Study|Withdrawal by Subject|2|||
94321640|NCT00755846|322959214|FG001|Overall Study|Withdrawal by Subject|3|||
94321641|NCT00755846|322959215|FG002|Overall Study|Withdrawal by Subject|5|||
94321642|NCT00755846|322959216|FG003|Overall Study|Withdrawal by Subject|2|||
94321643|NCT00755846|322959217|FG004|Overall Study|Withdrawal by Subject|0|||
94321644|NCT00755846|322959218|FG005|Overall Study|Withdrawal by Subject|1|||
94321645|NCT00755846|322959213|FG000|Overall Study|Hyperglycemic Rescue|21|||
94321646|NCT00755846|322959214|FG001|Overall Study|Hyperglycemic Rescue|7|||
94321647|NCT00755846|322959215|FG002|Overall Study|Hyperglycemic Rescue|5|||
94321648|NCT00755846|322959216|FG003|Overall Study|Hyperglycemic Rescue|8|||
94321649|NCT00755846|322959217|FG004|Overall Study|Hyperglycemic Rescue|8|||
94321650|NCT00755846|322959218|FG005|Overall Study|Hyperglycemic Rescue|7|||
94321651|NCT00755846|322959213|FG000|Overall Study|Physician Decision|1|||
94321652|NCT00755846|322959214|FG001|Overall Study|Physician Decision|3|||
94321653|NCT00755846|322959215|FG002|Overall Study|Physician Decision|0|||
94321654|NCT00755846|322959216|FG003|Overall Study|Physician Decision|1|||
94321655|NCT00755846|322959217|FG004|Overall Study|Physician Decision|0|||
94321656|NCT00755846|322959218|FG005|Overall Study|Physician Decision|1|||
94321657|NCT00755846|322959213|FG000|Overall Study|Administrative Error|0|||
94321658|NCT00755846|322959214|FG001|Overall Study|Administrative Error|1|||
94321659|NCT00755846|322959215|FG002|Overall Study|Administrative Error|0|||
94321660|NCT00755846|322959216|FG003|Overall Study|Administrative Error|0|||
94321661|NCT00755846|322959217|FG004|Overall Study|Administrative Error|0|||
94321662|NCT00755846|322959218|FG005|Overall Study|Administrative Error|0|||
94321663|NCT00755846|322959213|FG000|Overall Study|Participant Non-compliance|0|||
94321664|NCT00755846|322959214|FG001|Overall Study|Participant Non-compliance|0|||
94321665|NCT00755846|322959215|FG002|Overall Study|Participant Non-compliance|0|||
94321666|NCT00755846|322959216|FG003|Overall Study|Participant Non-compliance|0|||
94321667|NCT00755846|322959217|FG004|Overall Study|Participant Non-compliance|1|||
94321668|NCT00755846|322959218|FG005|Overall Study|Participant Non-compliance|0|||
94321669|NCT00786032|322959221|FG000|Overall Study|Death|4|||
94321670|NCT00786032|322959221|FG000|Overall Study|Withdrawal by Subject|14|||
94321671|NCT00786032|322959221|FG000|Overall Study|Did not complete in the timeframe|6|||
94321672|NCT02457182|322959222|FG000|Overall Study|Lost to Follow-up|1|||
94321673|NCT02457182|322959223|FG001|Overall Study|Lost to Follow-up|0|||
94321674|NCT00311181|322959224|FG000|Overall Study|Final DFTs were not obtained|96|||
94321675|NCT02294318|322959227|FG000|Overall Study|Worsening of drinking|3|||
94321676|NCT02294318|322959228|FG001|Overall Study|Worsening of drinking|0|||
94321677|NCT02294318|322959227|FG000|Overall Study|Not exposed to intervention|0|||
94321678|NCT02294318|322959228|FG001|Overall Study|Not exposed to intervention|2|||
94321679|NCT02429258|322959229|FG000|Overall Study|Withdrawal by Subject|2|||
94321680|NCT02429258|322959230|FG001|Overall Study|Withdrawal by Subject|0|||
94321681|NCT02429258|322959229|FG000|Overall Study|Protocol Violation|0|||
94321682|NCT02429258|322959230|FG001|Overall Study|Protocol Violation|1|||
94321683|NCT01694420|322959236|FG000|Overall Study|Lost to Follow-up|3|||
94321684|NCT00762372|322959237|FG000|Overall Study|Adverse Event|1|||
94321685|NCT00762372|322959238|FG001|Overall Study|Adverse Event|0|||
94321686|NCT00762372|322959239|FG002|Overall Study|Adverse Event|0|||
94321687|NCT03364335|322959240|FG000|Overall Study|Adverse Event|3|||
94321688|NCT03364335|322959241|FG001|Overall Study|Adverse Event|4|||
94321689|NCT03364335|322959242|FG002|Overall Study|Adverse Event|1|||
94321690|NCT03364335|322959243|FG003|Overall Study|Adverse Event|2|||
94321691|NCT03364335|322959244|FG004|Overall Study|Adverse Event|0|||
94321692|NCT03364335|322959240|FG000|Overall Study|Lost to Follow-up|7|||
94321693|NCT03364335|322959241|FG001|Overall Study|Lost to Follow-up|7|||
94321694|NCT03364335|322959242|FG002|Overall Study|Lost to Follow-up|10|||
94321695|NCT03364335|322959243|FG003|Overall Study|Lost to Follow-up|11|||
94321696|NCT03364335|322959244|FG004|Overall Study|Lost to Follow-up|11|||
94321697|NCT01194804|322959245|FG000|Overall Study|Withdrawal by Subject|1|||
94321698|NCT00748553|322959246|FG000|Overall Study|Adverse Event|0|||
94321699|NCT00748553|322959247|FG001|Overall Study|Adverse Event|1|||
94321700|NCT00748553|322959246|FG000|Overall Study|disease progression|2|||
94321701|NCT00748553|322959247|FG001|Overall Study|disease progression|0|||
94321702|NCT00748553|322959246|FG000|Overall Study|noncompliance|1|||
94321703|NCT00748553|322959247|FG001|Overall Study|noncompliance|0|||
94321704|NCT01346371|322959248|FG000|Overall Study|Lost to Follow-up|2|||
94321705|NCT01346371|322959249|FG001|Overall Study|Lost to Follow-up|0|||
94321706|NCT01670656|322959254|FG000|Overall Study|Non-compliance with study drug|0|||
94321707|NCT01670656|322959255|FG001|Overall Study|Non-compliance with study drug|0|||
94321708|NCT01670656|322959256|FG002|Overall Study|Non-compliance with study drug|3|||
94321709|NCT01670656|322959257|FG003|Overall Study|Non-compliance with study drug|0|||
94321710|NCT01670656|322959258|FG004|Overall Study|Non-compliance with study drug|1|||
94321711|NCT01670656|322959254|FG000|Overall Study|Pregnancy|0|||
94321712|NCT01670656|322959255|FG001|Overall Study|Pregnancy|0|||
94321713|NCT01670656|322959256|FG002|Overall Study|Pregnancy|0|||
94321714|NCT01670656|322959257|FG003|Overall Study|Pregnancy|0|||
94321715|NCT01670656|322959258|FG004|Overall Study|Pregnancy|1|||
94321716|NCT01670656|322959254|FG000|Overall Study|Withdrawal by Subject|1|||
94321717|NCT01670656|322959255|FG001|Overall Study|Withdrawal by Subject|1|||
94321718|NCT01670656|322959256|FG002|Overall Study|Withdrawal by Subject|0|||
94321719|NCT01670656|322959257|FG003|Overall Study|Withdrawal by Subject|0|||
94321720|NCT01670656|322959258|FG004|Overall Study|Withdrawal by Subject|0|||
94321721|NCT01670656|322959254|FG000|Overall Study|Non-compliance with protocol|0|||
94321722|NCT01670656|322959255|FG001|Overall Study|Non-compliance with protocol|3|||
94321723|NCT01670656|322959256|FG002|Overall Study|Non-compliance with protocol|1|||
94321724|NCT01670656|322959257|FG003|Overall Study|Non-compliance with protocol|1|||
94321725|NCT01670656|322959258|FG004|Overall Study|Non-compliance with protocol|2|||
94482291|NCT01656395|323558063|FG001|Overall Study|Other|0|||
94482292|NCT01656395|323558064|FG002|Overall Study|Other|1|||
94482293|NCT01656395|323558065|FG003|Overall Study|Other|0|||
94482294|NCT01656395|323558066|FG004|Overall Study|Other|0|||
94482295|NCT01656395|323558067|FG005|Overall Study|Other|1|||
94482296|NCT01656395|323558068|FG006|Overall Study|Other|0|||
94482297|NCT01656395|323558069|FG007|Overall Study|Other|0|||
94482298|NCT01656395|323558062|FG000|Overall Study|Physician Decision|2|||
94482299|NCT01656395|323558063|FG001|Overall Study|Physician Decision|3|||
94482300|NCT01656395|323558064|FG002|Overall Study|Physician Decision|3|||
94482301|NCT01656395|323558065|FG003|Overall Study|Physician Decision|2|||
94482302|NCT01656395|323558066|FG004|Overall Study|Physician Decision|3|||
94482303|NCT01656395|323558067|FG005|Overall Study|Physician Decision|3|||
94482304|NCT01656395|323558068|FG006|Overall Study|Physician Decision|0|||
94482305|NCT01656395|323558069|FG007|Overall Study|Physician Decision|0|||
94482306|NCT01656395|323558062|FG000|Overall Study|Pregnancy|0|||
94482307|NCT01656395|323558063|FG001|Overall Study|Pregnancy|0|||
94482308|NCT01656395|323558064|FG002|Overall Study|Pregnancy|1|||
94482309|NCT01656395|323558065|FG003|Overall Study|Pregnancy|0|||
94482310|NCT01656395|323558066|FG004|Overall Study|Pregnancy|0|||
94482311|NCT01656395|323558067|FG005|Overall Study|Pregnancy|0|||
94482312|NCT01656395|323558068|FG006|Overall Study|Pregnancy|0|||
94482313|NCT01656395|323558069|FG007|Overall Study|Pregnancy|0|||
94482314|NCT01656395|323558062|FG000|Overall Study|Progressive Disease|0|||
94482315|NCT01656395|323558063|FG001|Overall Study|Progressive Disease|0|||
94482316|NCT01656395|323558064|FG002|Overall Study|Progressive Disease|0|||
94482317|NCT01656395|323558065|FG003|Overall Study|Progressive Disease|0|||
94482318|NCT01656395|323558066|FG004|Overall Study|Progressive Disease|0|||
94482319|NCT01656395|323558067|FG005|Overall Study|Progressive Disease|1|||
94482320|NCT01656395|323558068|FG006|Overall Study|Progressive Disease|0|||
94321726|NCT01670656|322959254|FG000|Overall Study|Adverse Event|2|||
94321727|NCT01670656|322959255|FG001|Overall Study|Adverse Event|2|||
94321728|NCT01670656|322959256|FG002|Overall Study|Adverse Event|2|||
94321729|NCT01670656|322959257|FG003|Overall Study|Adverse Event|3|||
94321730|NCT01670656|322959258|FG004|Overall Study|Adverse Event|3|||
94321731|NCT01670656|322959254|FG000|Overall Study|Subject withdrew consent|0|||
94321732|NCT01670656|322959255|FG001|Overall Study|Subject withdrew consent|1|||
94321733|NCT01670656|322959256|FG002|Overall Study|Subject withdrew consent|2|||
94321734|NCT01670656|322959257|FG003|Overall Study|Subject withdrew consent|1|||
94321735|NCT01670656|322959258|FG004|Overall Study|Subject withdrew consent|1|||
94321736|NCT01670656|322959254|FG000|Overall Study|Lost to Follow-up|0|||
94321737|NCT01670656|322959255|FG001|Overall Study|Lost to Follow-up|0|||
94321738|NCT01670656|322959256|FG002|Overall Study|Lost to Follow-up|0|||
94321739|NCT01670656|322959257|FG003|Overall Study|Lost to Follow-up|0|||
94482321|NCT01656395|323558069|FG007|Overall Study|Progressive Disease|0|||
94482322|NCT01656395|323558062|FG000|Overall Study|Protocol Violation|6|||
94482323|NCT01656395|323558063|FG001|Overall Study|Protocol Violation|6|||
94321740|NCT01670656|322959258|FG004|Overall Study|Lost to Follow-up|3|||
94321741|NCT01670656|322959254|FG000|Overall Study|Subject moved|0|||
94321742|NCT01670656|322959255|FG001|Overall Study|Subject moved|0|||
94321743|NCT01670656|322959256|FG002|Overall Study|Subject moved|0|||
94321744|NCT01670656|322959257|FG003|Overall Study|Subject moved|1|||
94321745|NCT01670656|322959258|FG004|Overall Study|Subject moved|0|||
94321746|NCT02702518|322959259|FG000|Overall Study|Lost to Follow-up|3|||
94321747|NCT02702518|322959260|FG001|Overall Study|Lost to Follow-up|4|||
94321748|NCT00165841|322959261|FG000|Overall Study|Adverse Event|2|||
94321749|NCT00165841|322959262|FG001|Overall Study|Adverse Event|3|||
94321750|NCT00165841|322959261|FG000|Overall Study|Lack of Efficacy|6|||
94321751|NCT00165841|322959262|FG001|Overall Study|Lack of Efficacy|33|||
94321752|NCT00165841|322959261|FG000|Overall Study|Lost to Follow-up|4|||
94321753|NCT00165841|322959262|FG001|Overall Study|Lost to Follow-up|4|||
94321754|NCT00165841|322959261|FG000|Overall Study|Withdrawal by Subject|7|||
94321755|NCT00165841|322959262|FG001|Overall Study|Withdrawal by Subject|8|||
94321756|NCT00165841|322959261|FG000|Overall Study|Physician Decision|1|||
94321757|NCT00165841|322959262|FG001|Overall Study|Physician Decision|0|||
94321758|NCT00165841|322959261|FG000|Overall Study|Protocol Violation|6|||
94321759|NCT00165841|322959262|FG001|Overall Study|Protocol Violation|8|||
94321760|NCT00165841|322959261|FG000|Overall Study|Other|3|||
94321761|NCT00165841|322959262|FG001|Overall Study|Other|5|||
94321762|NCT00165841|322959261|FG000|Overall Study|Medication Noncompliance|1|||
94321763|NCT00165841|322959262|FG001|Overall Study|Medication Noncompliance|1|||
94482324|NCT01656395|323558064|FG002|Overall Study|Protocol Violation|9|||
94482325|NCT01656395|323558065|FG003|Overall Study|Protocol Violation|2|||
94321764|NCT00789958|322959263|FG000|Overall Study|Adverse Event|3|||
94482326|NCT01656395|323558066|FG004|Overall Study|Protocol Violation|4|||
94482327|NCT01656395|323558067|FG005|Overall Study|Protocol Violation|10|||
94321765|NCT00789958|322959263|FG000|Overall Study|Withdrawal by Subject|4|||
94321766|NCT00789958|322959263|FG000|Overall Study|Progression|3|||
94321767|NCT00789958|322959263|FG000|Overall Study|not protocol specified|1|||
94321768|NCT00789958|322959263|FG000|Overall Study|Not eligible/not analyzable|26|||
94482328|NCT01656395|323558068|FG006|Overall Study|Protocol Violation|0|||
94482329|NCT01656395|323558069|FG007|Overall Study|Protocol Violation|0|||
94387375|NCT00925769|323206122|FG004|Overall Study|Disease progression|2|||
94387376|NCT00925769|323206123|FG005|Overall Study|Disease progression|3|||
94387377|NCT00925769|323206118|FG000|Overall Study|Death|0|||
94387378|NCT00925769|323206119|FG001|Overall Study|Death|0|||
94387379|NCT00925769|323206120|FG002|Overall Study|Death|1|||
94387380|NCT00925769|323206121|FG003|Overall Study|Death|0|||
94387381|NCT00925769|323206122|FG004|Overall Study|Death|0|||
94387382|NCT00925769|323206123|FG005|Overall Study|Death|0|||
94387383|NCT00925769|323206118|FG000|Overall Study|Physician Decision|1|||
94387384|NCT00925769|323206119|FG001|Overall Study|Physician Decision|0|||
94387385|NCT00925769|323206120|FG002|Overall Study|Physician Decision|0|||
94387386|NCT00925769|323206121|FG003|Overall Study|Physician Decision|0|||
94387387|NCT00925769|323206122|FG004|Overall Study|Physician Decision|0|||
94387388|NCT00925769|323206123|FG005|Overall Study|Physician Decision|0|||
94387389|NCT00925769|323206118|FG000|Overall Study|Missing documentation|0|||
94387390|NCT00925769|323206119|FG001|Overall Study|Missing documentation|1|||
94387391|NCT00925769|323206120|FG002|Overall Study|Missing documentation|0|||
94387392|NCT00925769|323206121|FG003|Overall Study|Missing documentation|0|||
94387393|NCT00925769|323206122|FG004|Overall Study|Missing documentation|0|||
94387394|NCT00925769|323206123|FG005|Overall Study|Missing documentation|0|||
94387395|NCT00925769|323206118|FG000|Overall Study|End of study visit not done|0|||
94387396|NCT00925769|323206119|FG001|Overall Study|End of study visit not done|0|||
94387397|NCT00925769|323206120|FG002|Overall Study|End of study visit not done|1|||
94387398|NCT00925769|323206121|FG003|Overall Study|End of study visit not done|0|||
94387399|NCT00925769|323206122|FG004|Overall Study|End of study visit not done|0|||
94387400|NCT00925769|323206123|FG005|Overall Study|End of study visit not done|0|||
94387401|NCT00925769|323206118|FG000|Overall Study|Participant is unable to swallow drug|0|||
94387402|NCT00925769|323206119|FG001|Overall Study|Participant is unable to swallow drug|0|||
94387403|NCT00925769|323206120|FG002|Overall Study|Participant is unable to swallow drug|0|||
94387404|NCT00925769|323206121|FG003|Overall Study|Participant is unable to swallow drug|1|||
94387405|NCT00925769|323206122|FG004|Overall Study|Participant is unable to swallow drug|0|||
94387406|NCT00925769|323206123|FG005|Overall Study|Participant is unable to swallow drug|0|||
94387407|NCT00925769|323206118|FG000|Overall Study|Adverse Event|0|||
94387408|NCT00925769|323206119|FG001|Overall Study|Adverse Event|0|||
94387409|NCT00925769|323206120|FG002|Overall Study|Adverse Event|0|||
94387410|NCT00925769|323206121|FG003|Overall Study|Adverse Event|0|||
94387411|NCT00925769|323206122|FG004|Overall Study|Adverse Event|1|||
94387412|NCT00925769|323206123|FG005|Overall Study|Adverse Event|0|||
94387413|NCT02017964|323206124|FG000|Overall Study|Patient deemed ineligible|1|||
94387414|NCT00686959|323206128|FG000|Overall Study|Participants censored (no death events)|124|||
94387415|NCT00686959|323206129|FG001|Overall Study|Participants censored (no death events)|117|||
94387416|NCT01876706|323206130|FG000|Overall Study|BPH Intervention|9|||
94387417|NCT01876706|323206130|FG000|Overall Study|Lost to Follow-up|7|||
94387418|NCT01876706|323206130|FG000|Overall Study|Withdrawals|6|||
94387419|NCT01876706|323206130|FG000|Overall Study|Death|3|||
94387420|NCT01038856|323206131|FG000|Overall Study|Adverse Event|2|||
94387421|NCT00659607|323206132|FG000|Overall Study|No blood pressure recorded|147|||
94387422|NCT00659607|323206132|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
94387423|NCT00659607|323206132|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
94387424|NCT00659607|323206132|FG000|Overall Study|No recorded efficacy data|15|||
94387425|NCT00659607|323206132|FG000|Overall Study|Inconsistent BP measuring date|2|||
94387426|NCT04638153|323206137|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94387427|NCT04638153|323206138|FG001|Overall Study|Withdrawal by parent/guardian|0|||
94387428|NCT04638153|323206139|FG002|Overall Study|Withdrawal by parent/guardian|1|||
94387429|NCT04638153|323206137|FG000|Overall Study|Study terminated by sponsor|4|||
94387430|NCT04638153|323206138|FG001|Overall Study|Study terminated by sponsor|2|||
94387431|NCT04638153|323206139|FG002|Overall Study|Study terminated by sponsor|14|||
94387432|NCT01434693|323206145|FG000|Overall Study|Adverse Event|1|||
94387433|NCT01434693|323206146|FG001|Overall Study|Adverse Event|0|||
94387434|NCT01434693|323206147|FG002|Overall Study|Adverse Event|0|||
94387435|NCT01434693|323206148|FG003|Overall Study|Adverse Event|0|||
94387436|NCT01434693|323206145|FG000|Overall Study|Withdrawal by Subject|1|||
94387437|NCT01434693|323206146|FG001|Overall Study|Withdrawal by Subject|0|||
94387438|NCT01434693|323206147|FG002|Overall Study|Withdrawal by Subject|1|||
94387439|NCT01434693|323206148|FG003|Overall Study|Withdrawal by Subject|1|||
94387440|NCT01434693|323206145|FG000|Overall Study|Lost to Follow-up|1|||
94387441|NCT01434693|323206146|FG001|Overall Study|Lost to Follow-up|0|||
94387442|NCT01434693|323206147|FG002|Overall Study|Lost to Follow-up|0|||
94387443|NCT01434693|323206148|FG003|Overall Study|Lost to Follow-up|0|||
94387444|NCT00912288|323206149|FG000|Overall Study|Death|0|||
94387445|NCT00912288|323206150|FG001|Overall Study|Death|1|||
94387446|NCT00912288|323206149|FG000|Overall Study|Adverse Event|1|||
94387447|NCT00912288|323206150|FG001|Overall Study|Adverse Event|1|||
94387448|NCT00912288|323206149|FG000|Overall Study|Lost to Follow-up|1|||
94387449|NCT00912288|323206150|FG001|Overall Study|Lost to Follow-up|0|||
94387450|NCT00912288|323206149|FG000|Overall Study|Protocol Violation|1|||
94387451|NCT00912288|323206150|FG001|Overall Study|Protocol Violation|0|||
94387452|NCT00912288|323206149|FG000|Overall Study|Withdrawal by Subject|3|||
94387453|NCT00912288|323206150|FG001|Overall Study|Withdrawal by Subject|3|||
94387454|NCT00912288|323206149|FG000|Overall Study|Study terminated by sponsor|34|||
94387455|NCT00912288|323206150|FG001|Overall Study|Study terminated by sponsor|35|||
94387456|NCT00912288|323206149|FG000|Overall Study|Other|1|||
94387457|NCT00912288|323206150|FG001|Overall Study|Other|0|||
94387458|NCT03002077|323206152|FG000|Overall Study|Non-compliance with Study Drug|4|||
94387459|NCT03002077|323206152|FG000|Overall Study|Non-compliance w/Background ADT|1|||
94387460|NCT03002077|323206152|FG000|Overall Study|Study Terminated by Sponsor|257|||
94387461|NCT03002077|323206152|FG000|Overall Study|Site Terminated by Sponsor|5|||
94387462|NCT03002077|323206152|FG000|Overall Study|Miscellaneous Reasons|10|||
94387463|NCT03002077|323206152|FG000|Overall Study|Adverse Event|23|||
94387464|NCT03002077|323206152|FG000|Overall Study|Lack of Efficacy|20|||
94387465|NCT03002077|323206152|FG000|Overall Study|Withdrawal by Subject|72|||
94387466|NCT03002077|323206152|FG000|Overall Study|Lost to Follow-up|21|||
94387467|NCT03002077|323206152|FG000|Overall Study|Pregnancy|4|||
94387468|NCT03002077|323206152|FG000|Overall Study|Protocol Violation|21|||
94387469|NCT04320849|323206153|FG000|Overall Study|Withdrawal by Subject|4|||
94387470|NCT04320849|323206153|FG000|Overall Study|Imaging data unavailable|2|||
94387471|NCT04320849|323206153|FG000|Overall Study|Incomplete imaging|2|||
94387472|NCT00119379|323206154|FG000|Overall Study|Adverse Event|4|||
94387473|NCT00119379|323206155|FG001|Overall Study|Adverse Event|1|||
94387474|NCT01402947|323206158|FG000|First Intervention|Adverse Event|0|||
94387475|NCT01402947|323206159|FG001|First Intervention|Adverse Event|1|||
94387476|NCT00591630|323206160|FG000|Overall Study|Death|0|||
94387477|NCT00591630|323206161|FG001|Overall Study|Death|0|||
94387478|NCT00591630|323206162|FG002|Overall Study|Death|1|||
94387479|NCT00591630|323206163|FG003|Overall Study|Death|0|||
94387480|NCT00463606|323206164|FG000|Overall Study|Adverse Event|21|||
94387481|NCT00463606|323206165|FG001|Overall Study|Adverse Event|18|||
94387482|NCT00463606|323206166|FG002|Overall Study|Adverse Event|11|||
94387483|NCT00463606|323206164|FG000|Overall Study|Withdrawal by Subject|11|||
94387484|NCT00463606|323206165|FG001|Overall Study|Withdrawal by Subject|11|||
94387485|NCT00463606|323206166|FG002|Overall Study|Withdrawal by Subject|5|||
94387486|NCT00463606|323206164|FG000|Overall Study|Lost to Follow-up|2|||
94387487|NCT00463606|323206165|FG001|Overall Study|Lost to Follow-up|2|||
94387488|NCT00463606|323206166|FG002|Overall Study|Lost to Follow-up|3|||
94387489|NCT00463606|323206164|FG000|Overall Study|Subject noncompliance|1|||
94387490|NCT00463606|323206165|FG001|Overall Study|Subject noncompliance|1|||
94387491|NCT00463606|323206166|FG002|Overall Study|Subject noncompliance|0|||
94387492|NCT00463606|323206164|FG000|Overall Study|Subject moved out of town|1|||
94387493|NCT00463606|323206165|FG001|Overall Study|Subject moved out of town|0|||
94387494|NCT00463606|323206166|FG002|Overall Study|Subject moved out of town|0|||
94387495|NCT00463606|323206164|FG000|Overall Study|Physician Decision|0|||
94387496|NCT00463606|323206165|FG001|Overall Study|Physician Decision|1|||
94321769|NCT01575197|322959264|FG000|Overall Study|Migration out of study area|1|||
94321770|NCT01575197|322959265|FG001|Overall Study|Migration out of study area|5|||
94482330|NCT01656395|323558062|FG000|Overall Study|Screen Failure|2|||
94482331|NCT01656395|323558063|FG001|Overall Study|Screen Failure|1|||
94321771|NCT01575197|322959266|FG002|Overall Study|Migration out of study area|4|||
94321772|NCT01575197|322959264|FG000|Overall Study|SAE|0|||
94321773|NCT01575197|322959265|FG001|Overall Study|SAE|1|||
94321774|NCT01575197|322959266|FG002|Overall Study|SAE|0|||
94321775|NCT01575197|322959264|FG000|Overall Study|Lost to Follow-up|0|||
94321776|NCT01575197|322959265|FG001|Overall Study|Lost to Follow-up|1|||
94482332|NCT01656395|323558064|FG002|Overall Study|Screen Failure|7|||
94482333|NCT01656395|323558065|FG003|Overall Study|Screen Failure|1|||
94482334|NCT01656395|323558066|FG004|Overall Study|Screen Failure|0|||
94482335|NCT01656395|323558067|FG005|Overall Study|Screen Failure|8|||
94482336|NCT01656395|323558068|FG006|Overall Study|Screen Failure|0|||
94482337|NCT01656395|323558069|FG007|Overall Study|Screen Failure|0|||
94321777|NCT01575197|322959266|FG002|Overall Study|Lost to Follow-up|0|||
94321778|NCT01575197|322959264|FG000|Overall Study|Withdrawal by Subject|0|||
94321779|NCT01575197|322959265|FG001|Overall Study|Withdrawal by Subject|1|||
94387497|NCT00463606|323206166|FG002|Overall Study|Physician Decision|0|||
94387498|NCT00463606|323206164|FG000|Overall Study|Sponsor request|0|||
94387499|NCT00463606|323206165|FG001|Overall Study|Sponsor request|1|||
94387500|NCT00463606|323206166|FG002|Overall Study|Sponsor request|0|||
94387501|NCT00463606|323206164|FG000|Overall Study|Exclusion criteria violation|2|||
94387502|NCT00463606|323206165|FG001|Overall Study|Exclusion criteria violation|0|||
94387503|NCT00463606|323206166|FG002|Overall Study|Exclusion criteria violation|0|||
94387504|NCT00463606|323206164|FG000|Overall Study|Coordinator error|1|||
94321780|NCT01575197|322959266|FG002|Overall Study|Withdrawal by Subject|1|||
94321781|NCT01575197|322959264|FG000|Overall Study|Protocol Violation|2|||
94321782|NCT01575197|322959265|FG001|Overall Study|Protocol Violation|1|||
94321783|NCT01575197|322959266|FG002|Overall Study|Protocol Violation|1|||
94321784|NCT01000727|322959269|FG000|Overall Study|Lost to Follow-up|41|||
94321785|NCT01000727|322959270|FG001|Overall Study|Lost to Follow-up|43|||
94387505|NCT00463606|323206165|FG001|Overall Study|Coordinator error|0|||
94321786|NCT01000727|322959269|FG000|Overall Study|Withdrawal by Subject|111|||
94321787|NCT01000727|322959270|FG001|Overall Study|Withdrawal by Subject|109|||
94321788|NCT01000727|322959269|FG000|Overall Study|Study closed/terminated|23|||
94321789|NCT01000727|322959270|FG001|Overall Study|Study closed/terminated|24|||
94321790|NCT03303092|322959271|FG000|Overall Study|Adverse Event|1|||
94321791|NCT03303092|322959272|FG001|Overall Study|Adverse Event|0|||
94321792|NCT03303092|322959273|FG002|Overall Study|Adverse Event|1|||
94321793|NCT03303092|322959271|FG000|Overall Study|Protocol Violation|1|||
94321794|NCT03303092|322959272|FG001|Overall Study|Protocol Violation|5|||
94321795|NCT03303092|322959273|FG002|Overall Study|Protocol Violation|1|||
94321796|NCT03303092|322959271|FG000|Overall Study|Withdrawal by Subject|1|||
94321797|NCT03303092|322959272|FG001|Overall Study|Withdrawal by Subject|1|||
94321798|NCT03303092|322959273|FG002|Overall Study|Withdrawal by Subject|3|||
94321799|NCT03544268|322959277|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
94321800|NCT03544268|322959278|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
94321801|NCT01697267|322959279|FG000|Overall Study|Death|3|||
94321802|NCT01697267|322959280|FG001|Overall Study|Death|1|||
94321803|NCT01697267|322959279|FG000|Overall Study|Withdrawal by Subject|5|||
94321804|NCT01697267|322959280|FG001|Overall Study|Withdrawal by Subject|5|||
94321805|NCT01697267|322959279|FG000|Overall Study|Adverse Event|2|||
94321806|NCT01697267|322959280|FG001|Overall Study|Adverse Event|1|||
94321807|NCT01697267|322959279|FG000|Overall Study|Lost to Follow-up|2|||
94321808|NCT01697267|322959280|FG001|Overall Study|Lost to Follow-up|4|||
94321809|NCT01697267|322959279|FG000|Overall Study|Physician Decision|2|||
94321810|NCT01697267|322959280|FG001|Overall Study|Physician Decision|4|||
94321811|NCT04410198|322959281|FG000|Overall Study|Death|10|||
94321812|NCT04410198|322959281|FG000|Overall Study|Withdrawal by Subject|7|||
94321813|NCT04410198|322959281|FG000|Overall Study|Transferred/Relocation|4|||
94321814|NCT04410198|322959281|FG000|Overall Study|Kidney Transplant|9|||
94321815|NCT04410198|322959281|FG000|Overall Study|Adverse Event|4|||
94321816|NCT04410198|322959281|FG000|Overall Study|Physician Decision|2|||
94321817|NCT04410198|322959281|FG000|Overall Study|Other than specified|1|||
94321818|NCT04031404|322959284|FG000|Baseline|Lost to Follow-up|0|||
94321819|NCT04031404|322959285|FG001|Baseline|Lost to Follow-up|1|||
94321820|NCT04031404|322959284|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
94321821|NCT04031404|322959285|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
94321822|NCT04031404|322959284|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
94321823|NCT04031404|322959285|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
94321824|NCT04031404|322959284|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
94321825|NCT04031404|322959285|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
94321826|NCT04031404|322959284|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
94321827|NCT04031404|322959285|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
94321828|NCT01626352|322959286|FG000|Overall Study|Disease Progression|3|||
94321829|NCT01626352|322959286|FG000|Overall Study|Intercurrent Illness|2|||
94321830|NCT01626352|322959286|FG000|Overall Study|Death|2|||
94321831|NCT01626352|322959286|FG000|Overall Study|Withdrawal by Subject|1|||
94321832|NCT01626352|322959286|FG000|Overall Study|Non-Compliance|1|||
94321833|NCT01626352|322959286|FG000|Overall Study|Never Treated|1|||
94321834|NCT02695524|322959287|FG000|Overall Study|Lost to Follow-up|3|||
94321835|NCT02695524|322959288|FG001|Overall Study|Lost to Follow-up|2|||
94321836|NCT02695524|322959287|FG000|Overall Study|Death|0|||
94321837|NCT02695524|322959288|FG001|Overall Study|Death|1|||
94321838|NCT00377611|322959291|FG000|Overall Study|Adverse Event|2|||
94321839|NCT00377611|322959292|FG001|Overall Study|Adverse Event|9|||
94321840|NCT00377611|322959291|FG000|Overall Study|Protocol Violation|2|||
94321841|NCT00377611|322959292|FG001|Overall Study|Protocol Violation|0|||
94321842|NCT00377611|322959291|FG000|Overall Study|Withdrawal by Subject|0|||
94321843|NCT00377611|322959292|FG001|Overall Study|Withdrawal by Subject|5|||
94321844|NCT00377611|322959291|FG000|Overall Study|Lost to Follow-up|18|||
94387506|NCT00463606|323206166|FG002|Overall Study|Coordinator error|0|||
94387507|NCT00463606|323206164|FG000|Overall Study|Patient randomized in error|1|||
94387508|NCT00463606|323206165|FG001|Overall Study|Patient randomized in error|0|||
94387509|NCT00463606|323206166|FG002|Overall Study|Patient randomized in error|0|||
94321845|NCT00377611|322959292|FG001|Overall Study|Lost to Follow-up|16|||
94321846|NCT00377611|322959291|FG000|Overall Study|Other|0|||
94321847|NCT00377611|322959292|FG001|Overall Study|Other|3|||
94321848|NCT05674344|322959293|FG000|Overall Study|Screen Fail|21|||
94321849|NCT05674344|322959293|FG000|Overall Study|Incomplete study procedures|3|||
94321850|NCT00111917|322959294|FG000|Overall Study|Withdrawal by Subject|1|||
94321851|NCT00111917|322959295|FG001|Overall Study|Withdrawal by Subject|1|||
94321852|NCT00798655|322959296|FG000|Overall Study|Did not receive at least one dose of pan|2|||
94321853|NCT00343291|322959297|FG000|Overall Study|Adverse Event|13|||
94321854|NCT00343291|322959298|FG001|Overall Study|Adverse Event|13|||
94321855|NCT00343291|322959297|FG000|Overall Study|Death|3|||
94321856|NCT00343291|322959298|FG001|Overall Study|Death|2|||
94321857|NCT00343291|322959297|FG000|Overall Study|Progressive disease|33|||
94321858|NCT00343291|322959298|FG001|Overall Study|Progressive disease|34|||
94321859|NCT00343291|322959297|FG000|Overall Study|Withdrawal by Subject|0|||
94321860|NCT00343291|322959298|FG001|Overall Study|Withdrawal by Subject|2|||
94321861|NCT00343291|322959297|FG000|Overall Study|Other|8|||
94321862|NCT00343291|322959298|FG001|Overall Study|Other|5|||
94321863|NCT04831515|322959299|FG000|First Intervention|Adverse Event|0|||
94321864|NCT04831515|322959300|FG001|First Intervention|Adverse Event|1|||
94321865|NCT02338492|322959306|FG000|Overall Study|Death|32|||
94321866|NCT02338492|322959306|FG000|Overall Study|Adverse Event|3|||
94321867|NCT02338492|322959306|FG000|Overall Study|Lost to Follow-up|4|||
94321868|NCT02338492|322959306|FG000|Overall Study|Reason not captured above|6|||
94321869|NCT00756886|322959307|FG000|Overall Study|Lost to Follow-up|1|||
94321870|NCT00756886|322959308|FG001|Overall Study|Lost to Follow-up|0|||
94321871|NCT00756886|322959307|FG000|Overall Study|Adverse Event|0|||
94321872|NCT00756886|322959308|FG001|Overall Study|Adverse Event|3|||
94321873|NCT00756886|322959307|FG000|Overall Study|Lack of Efficacy|1|||
94321874|NCT00756886|322959308|FG001|Overall Study|Lack of Efficacy|0|||
94321875|NCT00756886|322959307|FG000|Overall Study|Ineligible|9|||
94321876|NCT00756886|322959308|FG001|Overall Study|Ineligible|4|||
94321877|NCT00174785|322959309|FG000|Overall Study|Adverse Event|293|||
94321878|NCT00174785|322959310|FG001|Overall Study|Adverse Event|191|||
94321879|NCT00174785|322959309|FG000|Overall Study|Protocol Violation|14|||
94321880|NCT00174785|322959310|FG001|Overall Study|Protocol Violation|14|||
94321881|NCT00174785|322959309|FG000|Overall Study|Withdrawal by Subject|173|||
94321882|NCT00174785|322959310|FG001|Overall Study|Withdrawal by Subject|175|||
94321883|NCT00174785|322959309|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
94321884|NCT00174785|322959310|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
94321885|NCT00174785|322959309|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
94321886|NCT00174785|322959310|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
94321887|NCT00174785|322959309|FG000|Overall Study|Other prohibited medication|5|||
94321888|NCT00174785|322959310|FG001|Overall Study|Other prohibited medication|3|||
94321889|NCT00174785|322959309|FG000|Overall Study|Family request|6|||
94321890|NCT00174785|322959310|FG001|Overall Study|Family request|8|||
94321891|NCT00174785|322959309|FG000|Overall Study|Not pre-specified/Not coded|56|||
94321892|NCT00174785|322959310|FG001|Overall Study|Not pre-specified/Not coded|70|||
94321893|NCT01754922|322959311|FG000|Overall Study|Adverse Event|0|||
94321894|NCT01754922|322959312|FG001|Overall Study|Adverse Event|1|||
94321895|NCT00310388|322959313|FG000|Primary Reporting Phase|Adverse Event|101|||
94321896|NCT00310388|322959314|FG001|Primary Reporting Phase|Adverse Event|0|||
94321897|NCT00310388|322959313|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
94321898|NCT00310388|322959314|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
94321899|NCT00310388|322959313|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
94321900|NCT00310388|322959314|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
94321901|NCT00310388|322959313|FG000|Primary Reporting Phase|Protocol Violation|10|||
94321902|NCT00310388|322959314|FG001|Primary Reporting Phase|Protocol Violation|0|||
94321903|NCT00310388|322959313|FG000|Primary Reporting Phase|Pregnancy|3|||
94321904|NCT00310388|322959314|FG001|Primary Reporting Phase|Pregnancy|0|||
94321905|NCT00310388|322959313|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
94321906|NCT00310388|322959314|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
94321907|NCT00310388|322959313|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
94321908|NCT00310388|322959314|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
94321909|NCT00310388|322959313|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
94321910|NCT00310388|322959314|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
94321911|NCT00310388|322959313|FG000|Primary Reporting Phase|Physician Decision|2|||
94321912|NCT00310388|322959314|FG001|Primary Reporting Phase|Physician Decision|0|||
94321913|NCT00310388|322959313|FG000|Primary Reporting Phase|Request of the sponsor|19|||
94321914|NCT00310388|322959314|FG001|Primary Reporting Phase|Request of the sponsor|0|||
94321915|NCT00310388|322959313|FG000|Primary Reporting Phase|Failed to return|8|||
94321916|NCT00310388|322959314|FG001|Primary Reporting Phase|Failed to return|0|||
94321917|NCT00310388|322959313|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
94321918|NCT00310388|322959314|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
94321919|NCT00310388|322959313|FG000|Primary Reporting Phase|Participant request|2|||
94321920|NCT00310388|322959314|FG001|Primary Reporting Phase|Participant request|0|||
94321921|NCT00310388|322959313|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
94321922|NCT00310388|322959314|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
94321923|NCT00310388|322959313|FG000|Primary Reporting Phase|Discontinuation of study|1|||
94321924|NCT00310388|322959314|FG001|Primary Reporting Phase|Discontinuation of study|0|||
94321925|NCT00310388|322959313|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
94321926|NCT00310388|322959314|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
94321927|NCT00310388|322959313|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
94321928|NCT00310388|322959314|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
94321929|NCT00310388|322959313|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
94321930|NCT00310388|322959314|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
94321931|NCT00310388|322959313|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
94321932|NCT00310388|322959314|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
94321933|NCT00310388|322959313|FG000|Primary Reporting Phase|Participant passed away|1|||
94321934|NCT00310388|322959314|FG001|Primary Reporting Phase|Participant passed away|0|||
94321935|NCT00310388|322959313|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
94321936|NCT00310388|322959314|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
94321937|NCT00310388|322959313|FG000|Primary Reporting Phase|Missing|1|||
94321938|NCT00310388|322959314|FG001|Primary Reporting Phase|Missing|0|||
94321939|NCT00310388|322959313|FG000|Primary Reporting Phase|Other|1|||
94321940|NCT00310388|322959314|FG001|Primary Reporting Phase|Other|0|||
94321941|NCT00310388|322959313|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
94321942|NCT00310388|322959314|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
94321943|NCT00310388|322959313|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
94321944|NCT00310388|322959314|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
94321945|NCT00310388|322959313|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
94321946|NCT00310388|322959314|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
94321947|NCT00310388|322959313|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
94321948|NCT00310388|322959314|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
94321949|NCT01610076|322959317|FG000|Overall Study|Technical issue with video|0|||
94321950|NCT01610076|322959318|FG001|Overall Study|Technical issue with video|1|||
94321951|NCT01610076|322959317|FG000|Overall Study|Lost to Follow-up|3|||
94321952|NCT01610076|322959318|FG001|Overall Study|Lost to Follow-up|4|||
94321953|NCT04017442|322959320|FG000|Overall Study|Withdrawal by Subject|0|||
94321954|NCT04017442|322959321|FG001|Overall Study|Withdrawal by Subject|3|||
94321955|NCT04017442|322959320|FG000|Overall Study|Lost to Follow-up|21|||
94321956|NCT04017442|322959321|FG001|Overall Study|Lost to Follow-up|19|||
94321957|NCT02586233|322959327|FG000|Overall Study|Randomized but did not receive treatment|0|||
94321958|NCT02586233|322959328|FG001|Overall Study|Randomized but did not receive treatment|1|||
94482338|NCT01656395|323558062|FG000|Overall Study|Withdrawal by Subject|3|||
94482339|NCT01656395|323558063|FG001|Overall Study|Withdrawal by Subject|1|||
94482340|NCT01656395|323558064|FG002|Overall Study|Withdrawal by Subject|4|||
94482341|NCT01656395|323558065|FG003|Overall Study|Withdrawal by Subject|2|||
94482342|NCT01656395|323558066|FG004|Overall Study|Withdrawal by Subject|0|||
94482343|NCT01656395|323558067|FG005|Overall Study|Withdrawal by Subject|3|||
94482344|NCT01656395|323558068|FG006|Overall Study|Withdrawal by Subject|0|||
94482345|NCT01656395|323558069|FG007|Overall Study|Withdrawal by Subject|0|||
94482346|NCT00676403|323558070|FG000|Overall Study|Adverse Event|1|||
94482347|NCT00676403|323558071|FG001|Overall Study|Adverse Event|2|||
94482348|NCT00676403|323558072|FG002|Overall Study|Adverse Event|0|||
94482349|NCT00676403|323558073|FG003|Overall Study|Adverse Event|5|||
94482350|NCT00676403|323558074|FG004|Overall Study|Adverse Event|1|||
94482351|NCT00676403|323558075|FG005|Overall Study|Adverse Event|2|||
94482352|NCT00676403|323558070|FG000|Overall Study|Lost to Follow-up|0|||
94482353|NCT00676403|323558071|FG001|Overall Study|Lost to Follow-up|0|||
94321959|NCT02586233|322959329|FG002|Overall Study|Randomized but did not receive treatment|0|||
94321960|NCT02586233|322959330|FG003|Overall Study|Randomized but did not receive treatment|0|||
94321961|NCT02586233|322959331|FG004|Overall Study|Randomized but did not receive treatment|0|||
94321962|NCT02586233|322959332|FG005|Overall Study|Randomized but did not receive treatment|2|||
94321963|NCT02586233|322959333|FG006|Overall Study|Randomized but did not receive treatment|2|||
94321964|NCT02586233|322959327|FG000|Overall Study|Death|0|||
94321965|NCT02586233|322959328|FG001|Overall Study|Death|1|||
94321966|NCT02586233|322959329|FG002|Overall Study|Death|0|||
94321967|NCT02586233|322959330|FG003|Overall Study|Death|0|||
94321968|NCT02586233|322959331|FG004|Overall Study|Death|2|||
94321969|NCT02586233|322959332|FG005|Overall Study|Death|0|||
94321970|NCT02586233|322959333|FG006|Overall Study|Death|0|||
94321971|NCT01894477|322959334|FG000|Overall Study|Protocol Violation|0|||
94321972|NCT01894477|322959335|FG001|Overall Study|Protocol Violation|1|||
94321973|NCT01894477|322959334|FG000|Overall Study|protocol changed due SC changed to cord|0|||
94321974|NCT01894477|322959335|FG001|Overall Study|protocol changed due SC changed to cord|1|||
94321975|NCT02387372|322959336|FG000|Overall Study|Not Treated|1|||
94482354|NCT00676403|323558072|FG002|Overall Study|Lost to Follow-up|0|||
94482355|NCT00676403|323558073|FG003|Overall Study|Lost to Follow-up|0|||
94482356|NCT00676403|323558074|FG004|Overall Study|Lost to Follow-up|0|||
94482357|NCT00676403|323558075|FG005|Overall Study|Lost to Follow-up|1|||
94482358|NCT00676403|323558070|FG000|Overall Study|Reason Unspecified|1|||
94482359|NCT00676403|323558071|FG001|Overall Study|Reason Unspecified|0|||
94482360|NCT00676403|323558072|FG002|Overall Study|Reason Unspecified|1|||
94482361|NCT00676403|323558073|FG003|Overall Study|Reason Unspecified|0|||
94482362|NCT00676403|323558074|FG004|Overall Study|Reason Unspecified|0|||
94482363|NCT00676403|323558075|FG005|Overall Study|Reason Unspecified|1|||
94321976|NCT02387372|322959337|FG001|Overall Study|Not Treated|0|||
94321977|NCT00238303|322959338|FG000|Overall Study|Withdrawal by Subject|11|||
94321978|NCT00238303|322959339|FG001|Overall Study|Withdrawal by Subject|1|||
94321979|NCT00238303|322959340|FG002|Overall Study|Withdrawal by Subject|2|||
94321980|NCT00238303|322959338|FG000|Overall Study|Death|1|||
94321981|NCT00238303|322959339|FG001|Overall Study|Death|0|||
94321982|NCT00238303|322959340|FG002|Overall Study|Death|1|||
94321983|NCT00238303|322959338|FG000|Overall Study|Other Medical Problems|2|||
94321984|NCT00238303|322959339|FG001|Overall Study|Other Medical Problems|0|||
94321985|NCT00238303|322959340|FG002|Overall Study|Other Medical Problems|2|||
94321986|NCT00238303|322959338|FG000|Overall Study|Poor tolerance of study treatment|1|||
94321987|NCT00238303|322959339|FG001|Overall Study|Poor tolerance of study treatment|0|||
94321988|NCT00238303|322959340|FG002|Overall Study|Poor tolerance of study treatment|1|||
94321989|NCT00238303|322959338|FG000|Overall Study|Adverse Event|0|||
94321990|NCT00238303|322959339|FG001|Overall Study|Adverse Event|1|||
94321991|NCT00238303|322959340|FG002|Overall Study|Adverse Event|3|||
94321992|NCT00937560|322959341|FG000|Initial Treatment|Death|6|||
94321993|NCT00937560|322959341|FG000|Initial Treatment|Withdraw consent|3|||
94321994|NCT00937560|322959341|FG000|Initial Treatment|Adverse Event|1|||
94321995|NCT00937560|322959341|FG000|Initial Treatment|Lost to Follow-up|1|||
94387510|NCT00463606|323206164|FG000|Overall Study|Participation in another ABT-335 trial|1|||
94387511|NCT00463606|323206165|FG001|Overall Study|Participation in another ABT-335 trial|0|||
94387512|NCT00463606|323206166|FG002|Overall Study|Participation in another ABT-335 trial|0|||
94387513|NCT00463606|323206164|FG000|Overall Study|Protocol Violation|0|||
94387514|NCT00463606|323206165|FG001|Overall Study|Protocol Violation|0|||
94387515|NCT00463606|323206166|FG002|Overall Study|Protocol Violation|1|||
94387516|NCT03805438|323207632|FG000|Overall Study|Lack of Efficacy|1|||
94387517|NCT03805438|323207632|FG000|Overall Study|Protocol Violation|1|||
94387518|NCT01494506|323207638|FG000|Overall Study|Lack of Efficacy|77|||
94387519|NCT01494506|323207639|FG001|Overall Study|Lack of Efficacy|83|||
94387520|NCT01494506|323207640|FG002|Overall Study|Lack of Efficacy|57|||
94387521|NCT01494506|323207638|FG000|Overall Study|Adverse Event|17|||
94387522|NCT01494506|323207639|FG001|Overall Study|Adverse Event|10|||
94387523|NCT01494506|323207640|FG002|Overall Study|Adverse Event|11|||
94387524|NCT01494506|323207638|FG000|Overall Study|Death|9|||
94387525|NCT01494506|323207639|FG001|Overall Study|Death|5|||
94387526|NCT01494506|323207640|FG002|Overall Study|Death|2|||
94387527|NCT01494506|323207638|FG000|Overall Study|Physician Decision|7|||
94387528|NCT01494506|323207639|FG001|Overall Study|Physician Decision|5|||
94387529|NCT01494506|323207640|FG002|Overall Study|Physician Decision|4|||
94387530|NCT01494506|323207638|FG000|Overall Study|Withdrawal by Subject|17|||
94387531|NCT01494506|323207639|FG001|Overall Study|Withdrawal by Subject|20|||
94387532|NCT01494506|323207640|FG002|Overall Study|Withdrawal by Subject|14|||
94387533|NCT01494506|323207638|FG000|Overall Study|Clinical Deterioration|21|||
94387534|NCT01494506|323207639|FG001|Overall Study|Clinical Deterioration|17|||
94387535|NCT01494506|323207640|FG002|Overall Study|Clinical Deterioration|13|||
94387536|NCT01494506|323207638|FG000|Overall Study|Sponsor Decision|0|||
94387537|NCT01494506|323207639|FG001|Overall Study|Sponsor Decision|0|||
94387538|NCT01494506|323207640|FG002|Overall Study|Sponsor Decision|1|||
94387539|NCT01494506|323207638|FG000|Overall Study|Other|0|||
94387540|NCT01494506|323207639|FG001|Overall Study|Other|3|||
94387541|NCT01494506|323207640|FG002|Overall Study|Other|1|||
94387542|NCT01996033|323207642|FG000|Overall Study|Death|1|||
94387543|NCT01996033|323207642|FG000|Overall Study|Physician Decision|1|||
94387544|NCT01996033|323207642|FG000|Overall Study|Withdrawal by Subject|4|||
94387545|NCT01996033|323207642|FG000|Overall Study|Lost to Follow-up|3|||
94387546|NCT01029353|323207647|FG000|Overall Study|Lost to Follow-up|4|||
94387547|NCT01029353|323207648|FG001|Overall Study|Lost to Follow-up|5|||
94387548|NCT01029353|323207649|FG002|Overall Study|Lost to Follow-up|5|||
94387549|NCT01029353|323207650|FG003|Overall Study|Lost to Follow-up|4|||
94387550|NCT01029353|323207647|FG000|Overall Study|Consent Withdrawn|2|||
94387551|NCT01029353|323207648|FG001|Overall Study|Consent Withdrawn|0|||
94387552|NCT01029353|323207649|FG002|Overall Study|Consent Withdrawn|0|||
94387553|NCT01029353|323207650|FG003|Overall Study|Consent Withdrawn|0|||
94387554|NCT01029353|323207647|FG000|Overall Study|Primary Outcome Indeterminate|1|||
94387555|NCT01029353|323207648|FG001|Overall Study|Primary Outcome Indeterminate|3|||
94387556|NCT01029353|323207649|FG002|Overall Study|Primary Outcome Indeterminate|2|||
94387557|NCT01029353|323207650|FG003|Overall Study|Primary Outcome Indeterminate|0|||
94387558|NCT01287013|323207651|FG000|Overall Study|Non-evaluable|3|||
94387559|NCT01287013|323207652|FG001|Overall Study|Non-evaluable|5|||
94387560|NCT01287013|323207653|FG002|Overall Study|Non-evaluable|21|||
94387561|NCT00051025|323207657|FG000|Overall Study|Progressive Disease|1|||
94482364|NCT00676403|323558070|FG000|Overall Study|Withdrawal by Subject|0|||
94387562|NCT00051025|323207658|FG001|Overall Study|Progressive Disease|1|||
94321996|NCT00937560|322959341|FG000|Initial Treatment|No end of study page|10|||
94387563|NCT00051025|323207657|FG000|Overall Study|Adverse Event|1|||
94482365|NCT00676403|323558071|FG001|Overall Study|Withdrawal by Subject|0|||
94387564|NCT00051025|323207658|FG001|Overall Study|Adverse Event|1|||
94482366|NCT00676403|323558072|FG002|Overall Study|Withdrawal by Subject|0|||
94321997|NCT00937560|322959341|FG000|Maintenance Treatment|Death|12|||
94387565|NCT00051025|323207657|FG000|Overall Study|Withdrawal by Subject|0|||
94387566|NCT00051025|323207658|FG001|Overall Study|Withdrawal by Subject|1|||
94387567|NCT00051025|323207657|FG000|Overall Study|Death|0|||
94387568|NCT00051025|323207658|FG001|Overall Study|Death|1|||
94321998|NCT00937560|322959341|FG000|Maintenance Treatment|Withdraw consent|5|||
94321999|NCT00937560|322959341|FG000|Maintenance Treatment|According to protocol|1|||
94322000|NCT03521687|322959342|FG000|Overall Study|Adverse Event|4|||
94322001|NCT03521687|322959342|FG000|Overall Study|Physician Decision|1|||
94322002|NCT00678587|322959343|FG000|Overall Study|Adverse Event|3|||
94322003|NCT00678587|322959344|FG001|Overall Study|Adverse Event|3|||
94322004|NCT00678587|322959343|FG000|Overall Study|Lack of Efficacy|1|||
94322005|NCT00678587|322959344|FG001|Overall Study|Lack of Efficacy|0|||
94322006|NCT00678587|322959343|FG000|Overall Study|Protocol Violation|2|||
94322007|NCT00678587|322959344|FG001|Overall Study|Protocol Violation|1|||
94322008|NCT00678587|322959343|FG000|Overall Study|Study Closed/Terminated|1|||
94322009|NCT00678587|322959344|FG001|Overall Study|Study Closed/Terminated|0|||
94322010|NCT00678587|322959343|FG000|Overall Study|Lost to Follow-up|3|||
94322011|NCT00678587|322959344|FG001|Overall Study|Lost to Follow-up|5|||
94322012|NCT00678587|322959343|FG000|Overall Study|Investigator Discretion|2|||
94322013|NCT00678587|322959344|FG001|Overall Study|Investigator Discretion|6|||
94322014|NCT00678587|322959343|FG000|Overall Study|Withdrew Consent|8|||
94322015|NCT00678587|322959344|FG001|Overall Study|Withdrew Consent|3|||
94322016|NCT01276457|322959349|FG000|Core Study|Adverse Event|6|||
94322017|NCT01276457|322959350|FG001|Core Study|Adverse Event|3|||
94322018|NCT01276457|322959349|FG000|Core Study|Lost to Follow-up|1|||
94322019|NCT01276457|322959350|FG001|Core Study|Lost to Follow-up|2|||
94322020|NCT01276457|322959349|FG000|Core Study|Administrative problems|1|||
94322021|NCT01276457|322959350|FG001|Core Study|Administrative problems|1|||
94322022|NCT01276457|322959349|FG000|Core Study|Death|2|||
94322023|NCT01276457|322959350|FG001|Core Study|Death|2|||
94322024|NCT01276457|322959349|FG000|Core Study|Lack of Efficacy|3|||
94322025|NCT01276457|322959350|FG001|Core Study|Lack of Efficacy|12|||
94322026|NCT01276457|322959349|FG000|Extension Study|Lost to Follow-up|3|||
94322027|NCT01276457|322959350|FG001|Extension Study|Lost to Follow-up|0|||
94322028|NCT01276457|322959349|FG000|Extension Study|Death|0|||
94322029|NCT01276457|322959350|FG001|Extension Study|Death|1|||
94322030|NCT01276457|322959349|FG000|Extension Study|Lack of Efficacy|3|||
94322031|NCT01276457|322959350|FG001|Extension Study|Lack of Efficacy|1|||
94322032|NCT01995136|322960680|FG000|Overall Study|Change in residence|1|||
94322033|NCT00781599|322960691|FG000|Overall Study|Lost to Follow-up|7|||
94322034|NCT00781599|322960692|FG001|Overall Study|Lost to Follow-up|4|||
94322035|NCT01106625|322960697|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
94322036|NCT01106625|322960698|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
94322037|NCT01106625|322960699|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
94322038|NCT01106625|322960697|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
94322039|NCT01106625|322960698|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
94322040|NCT01106625|322960699|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
94322041|NCT01106625|322960697|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
94322042|NCT01106625|322960698|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
94322043|NCT01106625|322960699|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
94322044|NCT01106625|322960697|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
94322045|NCT01106625|322960698|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
94322046|NCT01106625|322960699|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
94322047|NCT01106625|322960697|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
94322048|NCT01106625|322960698|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
94322049|NCT01106625|322960699|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
94322050|NCT01106625|322960697|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
94322051|NCT01106625|322960698|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
94322052|NCT01106625|322960699|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
94322053|NCT01106625|322960697|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
94322054|NCT01106625|322960698|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
94322055|NCT01106625|322960699|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
94322056|NCT01106625|322960697|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
94322057|NCT01106625|322960698|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
94322058|NCT01106625|322960699|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
94322059|NCT01106625|322960697|FG000|Core Period: Baseline to Week 26|Other|8|||
94322060|NCT01106625|322960698|FG001|Core Period: Baseline to Week 26|Other|7|||
94322061|NCT01106625|322960699|FG002|Core Period: Baseline to Week 26|Other|4|||
94322062|NCT01106625|322960697|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
94322063|NCT01106625|322960698|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
94322064|NCT01106625|322960699|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
94322065|NCT01106625|322960697|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
94322066|NCT01106625|322960698|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
94322067|NCT01106625|322960699|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
94322068|NCT01106625|322960697|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
94322069|NCT01106625|322960698|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
94322070|NCT01106625|322960699|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
94322071|NCT01106625|322960697|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
94322072|NCT01106625|322960698|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
94322073|NCT01106625|322960699|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
94322074|NCT01106625|322960697|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
94482367|NCT00676403|323558073|FG003|Overall Study|Withdrawal by Subject|0|||
94482368|NCT00676403|323558074|FG004|Overall Study|Withdrawal by Subject|0|||
94482369|NCT00676403|323558075|FG005|Overall Study|Withdrawal by Subject|1|||
94482370|NCT04073303|323558077|FG000|Overall Study|Adverse Event|0|||
94322075|NCT01106625|322960698|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
94322076|NCT01106625|322960699|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
94322077|NCT01106625|322960697|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
94322078|NCT01106625|322960698|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
94482371|NCT04073303|323558078|FG001|Overall Study|Adverse Event|2|||
94482372|NCT04073303|323558077|FG000|Overall Study|Withdrawal by Subject|16|||
94482373|NCT04073303|323558078|FG001|Overall Study|Withdrawal by Subject|36|||
94482374|NCT04073303|323558077|FG000|Overall Study|Lost to Follow-up|6|||
94482375|NCT04073303|323558078|FG001|Overall Study|Lost to Follow-up|1|||
94322079|NCT01106625|322960699|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
94322080|NCT01106625|322960697|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
94322081|NCT01106625|322960698|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
94322082|NCT01106625|322960699|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
94322083|NCT01106625|322960697|FG000|Extension Period: Week 26 to Week 52|Other|5|||
94322084|NCT01106625|322960698|FG001|Extension Period: Week 26 to Week 52|Other|5|||
94482376|NCT04073303|323558077|FG000|Overall Study|Protocol Deviation|0|||
94482377|NCT04073303|323558078|FG001|Overall Study|Protocol Deviation|4|||
94482378|NCT04073303|323558077|FG000|Overall Study|Other|1|||
94482379|NCT04073303|323558078|FG001|Overall Study|Other|1|||
94482380|NCT04144322|323558079|FG000|Overall Study|Lack of Efficacy|2|||
94482381|NCT04144322|323558080|FG001|Overall Study|Lack of Efficacy|2|||
94482382|NCT03193047|323558081|FG000|Overall Study|Physician Decision|1|||
94322085|NCT01106625|322960699|FG002|Extension Period: Week 26 to Week 52|Other|4|||
94322086|NCT01088438|322960700|FG000|Overall Study|Withdrawal by Subject|11|||
94322087|NCT01088438|322960701|FG001|Overall Study|Withdrawal by Subject|6|||
94322088|NCT01088438|322960700|FG000|Overall Study|Lost to Follow-up|18|||
94322089|NCT01088438|322960701|FG001|Overall Study|Lost to Follow-up|30|||
94322090|NCT00289185|322960702|FG000|Overall Study|Withdrawal by Subject|4|||
94322091|NCT00289185|322960703|FG001|Overall Study|Withdrawal by Subject|8|||
94322092|NCT00289185|322960702|FG000|Overall Study|Lost to Follow-up|23|||
94322093|NCT00289185|322960703|FG001|Overall Study|Lost to Follow-up|17|||
94322094|NCT00289185|322960702|FG000|Overall Study|Death|1|||
94322095|NCT00289185|322960703|FG001|Overall Study|Death|1|||
94322096|NCT01658579|322960704|FG000|Treatment Period A|Other|0|||
94322097|NCT01658579|322960705|FG001|Treatment Period A|Other|0|||
94482383|NCT03193047|323558082|FG001|Overall Study|Physician Decision|0|||
94482384|NCT03193047|323558081|FG000|Overall Study|Participant Left State|1|||
94322098|NCT01658579|322960706|FG002|Treatment Period A|Other|1|||
94322099|NCT01658579|322960707|FG003|Treatment Period A|Other|1|||
94322100|NCT01658579|322960704|FG000|Treatment Period A|Adverse Event|1|||
94322101|NCT01658579|322960705|FG001|Treatment Period A|Adverse Event|0|||
94322102|NCT01658579|322960706|FG002|Treatment Period A|Adverse Event|0|||
94322103|NCT01658579|322960707|FG003|Treatment Period A|Adverse Event|0|||
94322104|NCT01658579|322960704|FG000|Treatment Period B|Other|0|||
94322105|NCT01658579|322960705|FG001|Treatment Period B|Other|0|||
94322106|NCT01658579|322960706|FG002|Treatment Period B|Other|0|||
94322107|NCT01658579|322960707|FG003|Treatment Period B|Other|1|||
94322108|NCT00511342|322960708|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
94322109|NCT00511342|322960709|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
94322110|NCT00511342|322960708|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
94322111|NCT00511342|322960709|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
94322112|NCT00511342|322960708|FG000|Overall Study|Pregnancy|0|||
94322113|NCT00511342|322960709|FG001|Overall Study|Pregnancy|1|||
94322114|NCT00511342|322960708|FG000|Overall Study|Pregnancy wish|0|||
94322115|NCT00511342|322960709|FG001|Overall Study|Pregnancy wish|1|||
94482385|NCT03193047|323558082|FG001|Overall Study|Participant Left State|0|||
94482386|NCT04613518|323558093|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
94482387|NCT04613518|323558094|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
94322116|NCT00511342|322960708|FG000|Overall Study|Lost to Follow-up|1|||
94322117|NCT00511342|322960709|FG001|Overall Study|Lost to Follow-up|5|||
94322118|NCT00511342|322960708|FG000|Overall Study|Other Reason|2|||
94322119|NCT00511342|322960709|FG001|Overall Study|Other Reason|2|||
94322120|NCT01124448|322960712|FG000|Overall Study|Lost to Follow-up|0|||
94322121|NCT01124448|322960713|FG001|Overall Study|Lost to Follow-up|3|||
94322122|NCT01124448|322960712|FG000|Overall Study|Protocol Violation|2|||
94322123|NCT01124448|322960713|FG001|Overall Study|Protocol Violation|0|||
94322124|NCT00987623|322960714|FG000|Overall Study|Lost to Follow-up|2|||
94322125|NCT00987623|322960715|FG001|Overall Study|Lost to Follow-up|1|||
94322126|NCT00987623|322960714|FG000|Overall Study|Time/job conflict|2|||
94322127|NCT00987623|322960715|FG001|Overall Study|Time/job conflict|0|||
94322128|NCT00987623|322960714|FG000|Overall Study|Discomfort|1|||
94322129|NCT00987623|322960715|FG001|Overall Study|Discomfort|0|||
94322130|NCT00987623|322960714|FG000|Overall Study|Biomicroscopy|0|||
94322131|NCT00987623|322960715|FG001|Overall Study|Biomicroscopy|1|||
94322132|NCT00987623|322960714|FG000|Overall Study|Influenza|0|||
94322133|NCT00987623|322960715|FG001|Overall Study|Influenza|1|||
94322134|NCT03198754|322960716|FG000|Overall Study|Withdrawal by Subject|5|||
94322135|NCT03198754|322960717|FG001|Overall Study|Withdrawal by Subject|4|||
94322136|NCT03198754|322960716|FG000|Overall Study|Lost to Follow-up|4|||
94322137|NCT03198754|322960717|FG001|Overall Study|Lost to Follow-up|3|||
94322138|NCT03198754|322960716|FG000|Overall Study|Ineligible|2|||
94322139|NCT03198754|322960717|FG001|Overall Study|Ineligible|1|||
94322140|NCT00084929|322960718|FG000|Overall Study|ineligible - medical contraindication|1|||
94322141|NCT00084929|322960718|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
94322142|NCT00084929|322960718|FG000|Overall Study|Ineligible - Medical history|6|||
94322143|NCT00084929|322960718|FG000|Overall Study|Withdrawal by Subject|10|||
94322144|NCT00084929|322960718|FG000|Overall Study|Missing/incomplete CTC exam|9|||
94322145|NCT00084929|322960718|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
94322146|NCT02108951|322960719|FG000|Overall Study|Lost to Follow-up|1|||
94322147|NCT02108951|322960719|FG000|Overall Study|Patient's/guardian's decision|1|||
94322148|NCT02108951|322960719|FG000|Overall Study|Study Terminated by Sponsor|14|||
94322149|NCT04397718|322960725|FG000|Overall Study|Death|7|||
94322150|NCT04397718|322960726|FG001|Overall Study|Death|11|||
94322151|NCT04397718|322960725|FG000|Overall Study|Lost to Follow-up|0|||
94322152|NCT04397718|322960726|FG001|Overall Study|Lost to Follow-up|4|||
94322153|NCT01357915|322960730|FG000|Overall Study|Lost to Follow-up|3|||
94322154|NCT01357915|322960731|FG001|Overall Study|Lost to Follow-up|0|||
94322155|NCT01514188|322960738|FG000|Overall Study|Adverse Event|3|||
94322156|NCT01514188|322960739|FG001|Overall Study|Adverse Event|5|||
94387569|NCT01203878|323207659|FG000|Overall Study|Withdrawal by Subject|0|||
94387570|NCT01203878|323207660|FG001|Overall Study|Withdrawal by Subject|0|||
94387571|NCT01203878|323207661|FG002|Overall Study|Withdrawal by Subject|1|||
94387572|NCT01203878|323207659|FG000|Overall Study|Adverse Event|0|||
94387573|NCT01203878|323207660|FG001|Overall Study|Adverse Event|0|||
94387574|NCT01203878|323207661|FG002|Overall Study|Adverse Event|2|||
94387575|NCT00472290|323207665|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
94387576|NCT00472290|323207665|FG000|Overall Study|Protocol Specified Criteria|7|||
94387577|NCT00472290|323207665|FG000|Overall Study|Administrative Decision|37|||
94387578|NCT00472290|323207665|FG000|Overall Study|Death|3|||
94387579|NCT00472290|323207665|FG000|Overall Study|Lost to Follow-up|1|||
94387580|NCT00472290|323207665|FG000|Overall Study|Lack of Efficacy|1|||
94387581|NCT00472290|323207665|FG000|Overall Study|Disease Progression|4|||
94387582|NCT00472290|323207665|FG000|Overall Study|Withdrawal by Subject|5|||
94387583|NCT00472290|323207665|FG000|Overall Study|Adverse Event|6|||
94387584|NCT00472290|323207665|FG000|Overall Study|Requirement for alternative therapy|7|||
94387585|NCT00336479|323207669|FG000|Overall Study|Adverse Event|8|||
94387586|NCT00336479|323207670|FG001|Overall Study|Adverse Event|11|||
94387587|NCT00336479|323207671|FG002|Overall Study|Adverse Event|18|||
94387588|NCT00336479|323207672|FG003|Overall Study|Adverse Event|4|||
94387589|NCT00336479|323207669|FG000|Overall Study|Noncompliant|1|||
94387590|NCT00336479|323207670|FG001|Overall Study|Noncompliant|7|||
94387591|NCT00336479|323207671|FG002|Overall Study|Noncompliant|3|||
94387592|NCT00336479|323207672|FG003|Overall Study|Noncompliant|0|||
94387593|NCT00336479|323207669|FG000|Overall Study|Physician Decision|2|||
94387594|NCT00336479|323207670|FG001|Overall Study|Physician Decision|3|||
94387595|NCT00336479|323207671|FG002|Overall Study|Physician Decision|1|||
94387596|NCT00336479|323207672|FG003|Overall Study|Physician Decision|0|||
94387597|NCT00336479|323207669|FG000|Overall Study|Lost to Follow-up|3|||
94387598|NCT00336479|323207670|FG001|Overall Study|Lost to Follow-up|2|||
94387599|NCT00336479|323207671|FG002|Overall Study|Lost to Follow-up|0|||
94387600|NCT00336479|323207672|FG003|Overall Study|Lost to Follow-up|0|||
94387601|NCT00336479|323207669|FG000|Overall Study|Withdrawal by Subject|3|||
94387602|NCT00336479|323207670|FG001|Overall Study|Withdrawal by Subject|2|||
94387603|NCT00336479|323207671|FG002|Overall Study|Withdrawal by Subject|3|||
94387604|NCT00336479|323207672|FG003|Overall Study|Withdrawal by Subject|0|||
94387605|NCT00336479|323207669|FG000|Overall Study|Other|0|||
94387606|NCT00336479|323207670|FG001|Overall Study|Other|0|||
94387607|NCT00336479|323207671|FG002|Overall Study|Other|1|||
94322157|NCT01514188|322960738|FG000|Overall Study|Withdrawal by Subject|2|||
94322158|NCT01514188|322960739|FG001|Overall Study|Withdrawal by Subject|4|||
94322159|NCT01514188|322960738|FG000|Overall Study|Protocol Violation|2|||
94322160|NCT01514188|322960739|FG001|Overall Study|Protocol Violation|4|||
94322161|NCT01514188|322960738|FG000|Overall Study|Physician Decision|0|||
94387608|NCT00336479|323207672|FG003|Overall Study|Other|0|||
94387609|NCT00336479|323207669|FG000|Overall Study|Virologic Stopping Rule|20|||
94322162|NCT01514188|322960739|FG001|Overall Study|Physician Decision|2|||
94322163|NCT01514188|322960738|FG000|Overall Study|Disease Progression|13|||
94322164|NCT01514188|322960739|FG001|Overall Study|Disease Progression|14|||
94322165|NCT01514188|322960738|FG000|Overall Study|Death|1|||
94322166|NCT01514188|322960739|FG001|Overall Study|Death|3|||
94322167|NCT01514188|322960738|FG000|Overall Study|Other|2|||
94322168|NCT01514188|322960739|FG001|Overall Study|Other|1|||
94322169|NCT02932332|322960740|FG000|Overall Study|Withdrawal by Subject|1|||
94322170|NCT02932332|322960741|FG001|Overall Study|Withdrawal by Subject|1|||
94322171|NCT02932332|322960742|FG002|Overall Study|Withdrawal by Subject|0|||
94322172|NCT02932332|322960743|FG003|Overall Study|Withdrawal by Subject|1|||
94322173|NCT02932332|322960740|FG000|Overall Study|Chest pain|0|||
94387610|NCT00336479|323207670|FG001|Overall Study|Virologic Stopping Rule|0|||
94387611|NCT00336479|323207671|FG002|Overall Study|Virologic Stopping Rule|0|||
94387612|NCT00336479|323207672|FG003|Overall Study|Virologic Stopping Rule|0|||
94387613|NCT01479439|323207678|FG000|Overall Study|Adverse Event|1|||
94387614|NCT01479439|323207679|FG001|Overall Study|Adverse Event|0|||
94387615|NCT01479439|323207680|FG002|Overall Study|Adverse Event|0|||
94387616|NCT01479439|323207678|FG000|Overall Study|Lost to Follow-up|0|||
94387617|NCT01479439|323207679|FG001|Overall Study|Lost to Follow-up|1|||
94387618|NCT01479439|323207680|FG002|Overall Study|Lost to Follow-up|0|||
94387619|NCT01479439|323207678|FG000|Overall Study|Protocol Violation|0|||
94387620|NCT01479439|323207679|FG001|Overall Study|Protocol Violation|0|||
94387621|NCT01479439|323207680|FG002|Overall Study|Protocol Violation|2|||
94387622|NCT01936948|323207681|FG000|Overall Study|no 30-day follow-up data|0|||
94387623|NCT01936948|323207682|FG001|Overall Study|no 30-day follow-up data|3|||
94387624|NCT01936948|323207683|FG002|Overall Study|no 30-day follow-up data|3|||
94387625|NCT01936948|323207684|FG003|Overall Study|no 30-day follow-up data|3|||
94387626|NCT02365207|323207685|FG000|Overall Study|Withdrawal by Subject|1|||
94387627|NCT02365207|323207685|FG000|Overall Study|Physician Decision|1|||
94387628|NCT01722877|323207690|FG000|Overall Study|Death|1|||
94387629|NCT01722877|323207690|FG000|Overall Study|Lost to Follow-up|1|||
94387630|NCT01395030|323207691|FG000|Overall Study|Did not complete FCH PET/CT|7|||
94387631|NCT02079766|323207692|FG000|Overall Study|Physician Decision|1|||
94387632|NCT02079766|323207693|FG001|Overall Study|Physician Decision|0|||
94387633|NCT02079766|323207692|FG000|Overall Study|Withdrawal by Subject|1|||
94387634|NCT02079766|323207693|FG001|Overall Study|Withdrawal by Subject|0|||
94387635|NCT02373098|323207695|FG000|Overall Study|Lost to Follow-up|1|||
94387636|NCT02373098|323207696|FG001|Overall Study|Lost to Follow-up|0|||
94387637|NCT02373098|323207695|FG000|Overall Study|Protocol Violation|3|||
94387638|NCT02373098|323207696|FG001|Overall Study|Protocol Violation|0|||
94387639|NCT02373098|323207695|FG000|Overall Study|Withdrawal by Subject|5|||
94387640|NCT02373098|323207696|FG001|Overall Study|Withdrawal by Subject|0|||
94387641|NCT02373098|323207695|FG000|Overall Study|Adverse Event|3|||
94387642|NCT02373098|323207696|FG001|Overall Study|Adverse Event|0|||
94387643|NCT01001208|323207697|FG000|Overall Study|Adverse Event|10|||
94387644|NCT01001208|323207698|FG001|Overall Study|Adverse Event|5|||
94387645|NCT01001208|323207697|FG000|Overall Study|Lost to Follow-up|5|||
94387646|NCT01001208|323207698|FG001|Overall Study|Lost to Follow-up|9|||
94387647|NCT01001208|323207697|FG000|Overall Study|Physician Decision|1|||
94387648|NCT01001208|323207698|FG001|Overall Study|Physician Decision|0|||
94387649|NCT01001208|323207697|FG000|Overall Study|Withdrawal by Subject|4|||
94387650|NCT01001208|323207698|FG001|Overall Study|Withdrawal by Subject|5|||
94387651|NCT01001208|323207697|FG000|Overall Study|Ineligibility Determined|4|||
94387652|NCT01001208|323207698|FG001|Overall Study|Ineligibility Determined|2|||
94387653|NCT01001208|323207697|FG000|Overall Study|Noncompliance|4|||
94387654|NCT01001208|323207698|FG001|Overall Study|Noncompliance|7|||
94387655|NCT01001208|323207697|FG000|Overall Study|Disease Progression|0|||
94387656|NCT01001208|323207698|FG001|Overall Study|Disease Progression|3|||
94387657|NCT01001208|323207697|FG000|Overall Study|Other|0|||
94387658|NCT01001208|323207698|FG001|Overall Study|Other|2|||
94387659|NCT05067647|323207701|FG000|Overall Study|Lost to Follow-up|1|||
94387660|NCT02008565|323207704|FG000|Overall Study|Protocol Violation|1|||
94387661|NCT02008565|323207705|FG001|Overall Study|Protocol Violation|1|||
94322174|NCT02932332|322960741|FG001|Overall Study|Chest pain|0|||
94322175|NCT02932332|322960742|FG002|Overall Study|Chest pain|0|||
94387662|NCT02008565|323207706|FG002|Overall Study|Protocol Violation|2|||
94387663|NCT02008565|323207707|FG003|Overall Study|Protocol Violation|0|||
94387664|NCT02781727|323207708|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
94387665|NCT02781727|323207709|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
94387666|NCT02781727|323207708|FG000|Treatment Period|Withdrawal by Subject|1|||
94387667|NCT02781727|323207709|FG001|Treatment Period|Withdrawal by Subject|0|||
94387668|NCT02781727|323207708|FG000|Treatment Period|Lost to Follow-up|0|||
94387669|NCT02781727|323207709|FG001|Treatment Period|Lost to Follow-up|1|||
94387670|NCT02327130|323207710|FG000|Overall Study|Discharged in less than 5 days|5|||
94387671|NCT02327130|323207710|FG000|Overall Study|Physician Decision|2|||
94387672|NCT02327130|323207710|FG000|Overall Study|Unable to provide breath sample|1|||
94322176|NCT02932332|322960743|FG003|Overall Study|Chest pain|1|||
94322177|NCT02932332|322960740|FG000|Overall Study|Not Dyspneic cough|1|||
94322178|NCT02932332|322960741|FG001|Overall Study|Not Dyspneic cough|2|||
94322179|NCT02932332|322960742|FG002|Overall Study|Not Dyspneic cough|1|||
94322180|NCT02932332|322960743|FG003|Overall Study|Not Dyspneic cough|0|||
94322181|NCT01021852|322960745|FG000|Treatment Period 1|Adverse Event|3|||
94322182|NCT01021852|322960746|FG001|Treatment Period 1|Adverse Event|1|||
94322183|NCT01021852|322960747|FG002|Treatment Period 1|Adverse Event|1|||
94322184|NCT01021852|322960748|FG003|Treatment Period 1|Adverse Event|0|||
94322185|NCT01021852|322960749|FG004|Treatment Period 1|Adverse Event|2|||
94322186|NCT01021852|322960750|FG005|Treatment Period 1|Adverse Event|2|||
94322187|NCT01021852|322960751|FG006|Treatment Period 1|Adverse Event|0|||
94322188|NCT01021852|322960752|FG007|Treatment Period 1|Adverse Event|0|||
94322189|NCT01021852|322960745|FG000|Treatment Period 1|Pregnancy|0|||
94322190|NCT01021852|322960746|FG001|Treatment Period 1|Pregnancy|0|||
94322191|NCT01021852|322960747|FG002|Treatment Period 1|Pregnancy|1|||
94322192|NCT01021852|322960748|FG003|Treatment Period 1|Pregnancy|0|||
94322193|NCT01021852|322960749|FG004|Treatment Period 1|Pregnancy|0|||
94322194|NCT01021852|322960750|FG005|Treatment Period 1|Pregnancy|0|||
94322195|NCT01021852|322960751|FG006|Treatment Period 1|Pregnancy|0|||
94322196|NCT01021852|322960752|FG007|Treatment Period 1|Pregnancy|0|||
94322197|NCT01021852|322960745|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94322198|NCT01021852|322960746|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94322199|NCT01021852|322960747|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94322200|NCT01021852|322960748|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94322201|NCT01021852|322960749|FG004|Treatment Period 1|Withdrawal by Subject|1|||
94322202|NCT01021852|322960750|FG005|Treatment Period 1|Withdrawal by Subject|0|||
94322203|NCT01021852|322960751|FG006|Treatment Period 1|Withdrawal by Subject|0|||
94322204|NCT01021852|322960752|FG007|Treatment Period 1|Withdrawal by Subject|1|||
94322205|NCT01021852|322960745|FG000|Treatment Period 1|Not Treated|0|||
94322206|NCT01021852|322960746|FG001|Treatment Period 1|Not Treated|0|||
94322207|NCT01021852|322960747|FG002|Treatment Period 1|Not Treated|0|||
94322208|NCT01021852|322960748|FG003|Treatment Period 1|Not Treated|2|||
94387673|NCT02327130|323207710|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
94387674|NCT02327130|323207710|FG000|Overall Study|Met exclusion criteria|3|||
94387675|NCT04185909|323207711|FG000|Overall Study|Lost to Follow-up|1|||
94387676|NCT00857623|323207712|FG000|Overall Study|Adverse Event|5|||
94387677|NCT00857623|323207713|FG001|Overall Study|Adverse Event|2|||
94387678|NCT00857623|323207712|FG000|Overall Study|Study-specific discontinuation criteria|5|||
94387679|NCT00857623|323207713|FG001|Overall Study|Study-specific discontinuation criteria|3|||
94387680|NCT00857623|323207712|FG000|Overall Study|Withdrawal by Subject|2|||
94387681|NCT00857623|323207713|FG001|Overall Study|Withdrawal by Subject|1|||
94387682|NCT00857623|323207712|FG000|Overall Study|Lack of Efficacy|1|||
94387683|NCT00857623|323207713|FG001|Overall Study|Lack of Efficacy|1|||
94387684|NCT00857623|323207712|FG000|Overall Study|Severe non-compliance to protocol|1|||
94387685|NCT00857623|323207713|FG001|Overall Study|Severe non-compliance to protocol|1|||
94387686|NCT00857623|323207712|FG000|Overall Study|Intake of prohibited medication|0|||
94387687|NCT00857623|323207713|FG001|Overall Study|Intake of prohibited medication|1|||
94387688|NCT00857623|323207712|FG000|Overall Study|Positive for HEP C|0|||
94387689|NCT00857623|323207713|FG001|Overall Study|Positive for HEP C|1|||
94387690|NCT02193178|323207714|FG000|Overall Study|Lost to Follow-up|1|||
94387691|NCT02193178|323207714|FG000|Overall Study|Dry eyes|1|||
94387692|NCT03435081|323207715|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
94387693|NCT03435081|323207716|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
94387694|NCT03435081|323207717|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
94387695|NCT03435081|323207715|FG000|Week 0 to Week 16|Adverse Event|2|||
94387696|NCT03435081|323207716|FG001|Week 0 to Week 16|Adverse Event|2|||
94387697|NCT03435081|323207717|FG002|Week 0 to Week 16|Adverse Event|2|||
94387698|NCT03435081|323207715|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
94387699|NCT03435081|323207716|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
94387700|NCT03435081|323207717|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
94387701|NCT03435081|323207715|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
94387702|NCT03435081|323207716|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
94387703|NCT03435081|323207717|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
94387704|NCT03435081|323207715|FG000|Week 0 to Week 16|Pregnancy|1|||
94387705|NCT03435081|323207716|FG001|Week 0 to Week 16|Pregnancy|0|||
94322209|NCT01021852|322960749|FG004|Treatment Period 1|Not Treated|0|||
94322210|NCT01021852|322960750|FG005|Treatment Period 1|Not Treated|0|||
94322211|NCT01021852|322960751|FG006|Treatment Period 1|Not Treated|0|||
94322212|NCT01021852|322960752|FG007|Treatment Period 1|Not Treated|0|||
94322213|NCT01021852|322960745|FG000|Washout Period-Placebo|Adverse Event|0|||
94322214|NCT01021852|322960746|FG001|Washout Period-Placebo|Adverse Event|0|||
94322215|NCT01021852|322960747|FG002|Washout Period-Placebo|Adverse Event|0|||
94322216|NCT01021852|322960748|FG003|Washout Period-Placebo|Adverse Event|1|||
94322217|NCT01021852|322960749|FG004|Washout Period-Placebo|Adverse Event|0|||
94322218|NCT01021852|322960750|FG005|Washout Period-Placebo|Adverse Event|1|||
94322219|NCT01021852|322960751|FG006|Washout Period-Placebo|Adverse Event|0|||
94387706|NCT03435081|323207717|FG002|Week 0 to Week 16|Pregnancy|0|||
94387707|NCT03435081|323207715|FG000|Week 0 to Week 16|Non-compliance|1|||
94387708|NCT03435081|323207716|FG001|Week 0 to Week 16|Non-compliance|0|||
94322220|NCT01021852|322960752|FG007|Washout Period-Placebo|Adverse Event|0|||
94322221|NCT01021852|322960745|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
94322222|NCT01021852|322960746|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
94322223|NCT01021852|322960747|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
94322224|NCT01021852|322960748|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
94322225|NCT01021852|322960749|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
94322226|NCT01021852|322960750|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
94322227|NCT01021852|322960751|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
94322228|NCT01021852|322960752|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
94322229|NCT01021852|322960745|FG000|Washout Period-Placebo|Protocol Violation|0|||
94322230|NCT01021852|322960746|FG001|Washout Period-Placebo|Protocol Violation|0|||
94322231|NCT01021852|322960747|FG002|Washout Period-Placebo|Protocol Violation|0|||
94322232|NCT01021852|322960748|FG003|Washout Period-Placebo|Protocol Violation|0|||
94322233|NCT01021852|322960749|FG004|Washout Period-Placebo|Protocol Violation|0|||
94322234|NCT01021852|322960750|FG005|Washout Period-Placebo|Protocol Violation|0|||
94387709|NCT03435081|323207717|FG002|Week 0 to Week 16|Non-compliance|2|||
94387710|NCT03435081|323207715|FG000|Week 0 to Week 16|Inadequate Response|0|||
94387711|NCT03435081|323207716|FG001|Week 0 to Week 16|Inadequate Response|1|||
94387712|NCT03435081|323207717|FG002|Week 0 to Week 16|Inadequate Response|0|||
94387713|NCT03435081|323207715|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
94387714|NCT03435081|323207716|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
94387715|NCT03435081|323207717|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
94387716|NCT03435081|323207715|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
94387717|NCT03435081|323207716|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
94387718|NCT03435081|323207717|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
94387719|NCT03435081|323207715|FG000|Week 16 to Week 104|Adverse Event|1|||
94387720|NCT03435081|323207716|FG001|Week 16 to Week 104|Adverse Event|0|||
94387721|NCT03435081|323207717|FG002|Week 16 to Week 104|Adverse Event|2|||
94387722|NCT03435081|323207715|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
94387723|NCT03435081|323207716|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
94387724|NCT03435081|323207717|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
94387725|NCT03435081|323207715|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
94387726|NCT03435081|323207716|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
94387727|NCT03435081|323207717|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
94387728|NCT03435081|323207715|FG000|Week 16 to Week 104|Non--Compliance|0|||
94387729|NCT03435081|323207716|FG001|Week 16 to Week 104|Non--Compliance|0|||
94387730|NCT03435081|323207717|FG002|Week 16 to Week 104|Non--Compliance|1|||
94387731|NCT00420238|323207719|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
94387732|NCT00420238|323207720|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
94387733|NCT00420238|323207719|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
94387734|NCT00420238|323207720|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
94387735|NCT00420238|323207719|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
94387736|NCT00420238|323207720|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
94387737|NCT00420238|323207719|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
94387738|NCT00420238|323207720|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
94387739|NCT00420238|323207719|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
94387740|NCT00420238|323207720|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
94387741|NCT00420238|323207719|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
94387742|NCT00420238|323207720|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
94387743|NCT05214560|323207721|FG000|Overall Study|Screening Failure|1|||
94387744|NCT05214560|323207721|FG000|Overall Study|Physician Decision|4|||
94387745|NCT05214560|323207721|FG000|Overall Study|Withdrawal by Subject|1|||
94387746|NCT05214560|323207721|FG000|Overall Study|Lost to Follow-up|2|||
94387747|NCT05214560|323207721|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
94387748|NCT05214560|323207721|FG000|Overall Study|Study physician not available for the anesthesia|3|||
94387749|NCT05214560|323207721|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
94387750|NCT05214560|323207721|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
94387751|NCT05214560|323207721|FG000|Overall Study|Surgery not performed|3|||
94387752|NCT04510285|323207722|FG000|Overall Study|Death|1|||
94387753|NCT01417078|323207723|FG000|Overall Study|Withdrawal by Subject|1|||
94387754|NCT00048581|323207725|FG000|Double-Blind Period|Adverse Event|9|||
94387755|NCT00048581|323207726|FG001|Double-Blind Period|Adverse Event|5|||
94387756|NCT00048581|323207727|FG002|Double-Blind Period|Adverse Event|0|||
94387757|NCT00048581|323207725|FG000|Double-Blind Period|Lack of Efficacy|14|||
94387758|NCT00048581|323207726|FG001|Double-Blind Period|Lack of Efficacy|27|||
94387759|NCT00048581|323207727|FG002|Double-Blind Period|Lack of Efficacy|0|||
94322235|NCT01021852|322960751|FG006|Washout Period-Placebo|Protocol Violation|1|||
94322236|NCT01021852|322960752|FG007|Washout Period-Placebo|Protocol Violation|0|||
94322237|NCT01021852|322960745|FG000|Washout Period-No Drug|Adverse Event|1|||
94322238|NCT01021852|322960746|FG001|Washout Period-No Drug|Adverse Event|0|||
94322239|NCT01021852|322960747|FG002|Washout Period-No Drug|Adverse Event|0|||
94322240|NCT01021852|322960748|FG003|Washout Period-No Drug|Adverse Event|0|||
94322241|NCT01021852|322960749|FG004|Washout Period-No Drug|Adverse Event|0|||
94322242|NCT01021852|322960750|FG005|Washout Period-No Drug|Adverse Event|1|||
94322243|NCT01021852|322960751|FG006|Washout Period-No Drug|Adverse Event|0|||
94322244|NCT01021852|322960752|FG007|Washout Period-No Drug|Adverse Event|0|||
94322245|NCT01021852|322960745|FG000|Treatment Period 2|Adverse Event|0|||
94322246|NCT01021852|322960746|FG001|Treatment Period 2|Adverse Event|1|||
94322247|NCT01021852|322960747|FG002|Treatment Period 2|Adverse Event|0|||
94322248|NCT01021852|322960748|FG003|Treatment Period 2|Adverse Event|0|||
94322249|NCT01021852|322960749|FG004|Treatment Period 2|Adverse Event|1|||
94322250|NCT01021852|322960750|FG005|Treatment Period 2|Adverse Event|0|||
94322251|NCT01021852|322960751|FG006|Treatment Period 2|Adverse Event|1|||
94322252|NCT01021852|322960752|FG007|Treatment Period 2|Adverse Event|0|||
94322253|NCT01021852|322960745|FG000|Treatment Period 2|Lack of Efficacy|0|||
94322254|NCT01021852|322960746|FG001|Treatment Period 2|Lack of Efficacy|0|||
94322255|NCT01021852|322960747|FG002|Treatment Period 2|Lack of Efficacy|0|||
94322256|NCT01021852|322960748|FG003|Treatment Period 2|Lack of Efficacy|0|||
94322257|NCT01021852|322960749|FG004|Treatment Period 2|Lack of Efficacy|0|||
94322258|NCT01021852|322960750|FG005|Treatment Period 2|Lack of Efficacy|1|||
94322259|NCT01021852|322960751|FG006|Treatment Period 2|Lack of Efficacy|0|||
94322260|NCT01021852|322960752|FG007|Treatment Period 2|Lack of Efficacy|0|||
94322261|NCT01021852|322960745|FG000|Treatment Period 2|Physician Decision|0|||
94322262|NCT01021852|322960746|FG001|Treatment Period 2|Physician Decision|0|||
94322263|NCT01021852|322960747|FG002|Treatment Period 2|Physician Decision|1|||
94322264|NCT01021852|322960748|FG003|Treatment Period 2|Physician Decision|0|||
94322265|NCT01021852|322960749|FG004|Treatment Period 2|Physician Decision|0|||
94322266|NCT01021852|322960750|FG005|Treatment Period 2|Physician Decision|0|||
94322267|NCT01021852|322960751|FG006|Treatment Period 2|Physician Decision|0|||
94322268|NCT01021852|322960752|FG007|Treatment Period 2|Physician Decision|0|||
94322269|NCT01021852|322960745|FG000|Treatment Period 2|Protocol Violation|0|||
94322270|NCT01021852|322960746|FG001|Treatment Period 2|Protocol Violation|0|||
94322271|NCT01021852|322960747|FG002|Treatment Period 2|Protocol Violation|0|||
94322272|NCT01021852|322960748|FG003|Treatment Period 2|Protocol Violation|0|||
94322273|NCT01021852|322960749|FG004|Treatment Period 2|Protocol Violation|1|||
94322274|NCT01021852|322960750|FG005|Treatment Period 2|Protocol Violation|0|||
94322275|NCT01021852|322960751|FG006|Treatment Period 2|Protocol Violation|1|||
94322276|NCT01021852|322960752|FG007|Treatment Period 2|Protocol Violation|0|||
94322277|NCT01021852|322960745|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94322278|NCT01021852|322960746|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94322279|NCT01021852|322960747|FG002|Treatment Period 2|Withdrawal by Subject|0|||
94322280|NCT01021852|322960748|FG003|Treatment Period 2|Withdrawal by Subject|0|||
94322281|NCT01021852|322960749|FG004|Treatment Period 2|Withdrawal by Subject|0|||
94322282|NCT01021852|322960750|FG005|Treatment Period 2|Withdrawal by Subject|0|||
94322283|NCT01021852|322960751|FG006|Treatment Period 2|Withdrawal by Subject|1|||
94322284|NCT01021852|322960752|FG007|Treatment Period 2|Withdrawal by Subject|2|||
94322285|NCT00702052|322960757|FG000|Overall Study|Adverse Event|23|||
94322286|NCT00702052|322960757|FG000|Overall Study|Disease Progression|30|||
94322287|NCT00702052|322960757|FG000|Overall Study|Withdrawal by Subject|5|||
94322288|NCT03670641|322960758|FG000|Overall Study|Lost to Follow-up|3|||
94322289|NCT01096849|322960759|FG000|Overall Study|Consent Withdrawn|1|||
94322290|NCT01096849|322960760|FG001|Overall Study|Consent Withdrawn|4|||
94322291|NCT01096849|322960761|FG002|Overall Study|Consent Withdrawn|2|||
94322292|NCT01096849|322960759|FG000|Overall Study|Lack of Efficacy|0|||
94322293|NCT01096849|322960760|FG001|Overall Study|Lack of Efficacy|2|||
94322294|NCT01096849|322960761|FG002|Overall Study|Lack of Efficacy|0|||
94322295|NCT01096849|322960759|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
94322296|NCT01096849|322960760|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
94322297|NCT01096849|322960761|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
94322298|NCT01096849|322960759|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
94322299|NCT01096849|322960760|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
94322300|NCT01096849|322960761|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
94322301|NCT01096849|322960759|FG000|Overall Study|Administrative Reasons|0|||
94322302|NCT01096849|322960760|FG001|Overall Study|Administrative Reasons|1|||
94322303|NCT01096849|322960761|FG002|Overall Study|Administrative Reasons|2|||
94322304|NCT01096849|322960759|FG000|Overall Study|Lost to Follow-up|1|||
94322305|NCT01096849|322960760|FG001|Overall Study|Lost to Follow-up|3|||
94322306|NCT01096849|322960761|FG002|Overall Study|Lost to Follow-up|1|||
94322307|NCT04167306|322960763|FG000|Overall Study|Lost to Follow-up|2|||
94322308|NCT04167306|322960764|FG001|Overall Study|Lost to Follow-up|2|||
94322309|NCT04167306|322960765|FG002|Overall Study|Lost to Follow-up|5|||
94322310|NCT04167306|322960766|FG003|Overall Study|Lost to Follow-up|5|||
94322311|NCT04167306|322960763|FG000|Overall Study|Adverse Event|13|||
94322312|NCT04167306|322960764|FG001|Overall Study|Adverse Event|14|||
94322313|NCT04167306|322960765|FG002|Overall Study|Adverse Event|5|||
94322314|NCT04167306|322960766|FG003|Overall Study|Adverse Event|4|||
94322315|NCT04167306|322960763|FG000|Overall Study|Withdrawal by Subject|4|||
94322316|NCT04167306|322960764|FG001|Overall Study|Withdrawal by Subject|6|||
94322317|NCT04167306|322960765|FG002|Overall Study|Withdrawal by Subject|8|||
94322318|NCT04167306|322960766|FG003|Overall Study|Withdrawal by Subject|3|||
94322319|NCT04167306|322960763|FG000|Overall Study|covid|1|||
94322320|NCT04167306|322960764|FG001|Overall Study|covid|1|||
94322321|NCT04167306|322960765|FG002|Overall Study|covid|2|||
94322322|NCT04167306|322960766|FG003|Overall Study|covid|1|||
94322323|NCT04167306|322960763|FG000|Overall Study|concomitant medication|0|||
94322324|NCT04167306|322960764|FG001|Overall Study|concomitant medication|0|||
94322325|NCT04167306|322960765|FG002|Overall Study|concomitant medication|0|||
94322326|NCT04167306|322960766|FG003|Overall Study|concomitant medication|1|||
94322327|NCT04167306|322960763|FG000|Overall Study|Alcohol treatment|0|||
94322328|NCT04167306|322960764|FG001|Overall Study|Alcohol treatment|4|||
94322329|NCT04167306|322960765|FG002|Overall Study|Alcohol treatment|3|||
94322330|NCT04167306|322960766|FG003|Overall Study|Alcohol treatment|2|||
94322331|NCT04167306|322960763|FG000|Overall Study|non-compliance|0|||
94322332|NCT04167306|322960764|FG001|Overall Study|non-compliance|0|||
94322333|NCT04167306|322960765|FG002|Overall Study|non-compliance|1|||
94322334|NCT04167306|322960766|FG003|Overall Study|non-compliance|0|||
94322335|NCT04167306|322960763|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
94322336|NCT04167306|322960764|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
94322337|NCT04167306|322960765|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
94322338|NCT04167306|322960766|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
94322339|NCT01232894|322960769|FG000|Overall Study|Lost to Follow-up|0|||
94322340|NCT01232894|322960770|FG001|Overall Study|Lost to Follow-up|1|||
94322341|NCT01232894|322960769|FG000|Overall Study|Death|1|||
94322342|NCT01232894|322960770|FG001|Overall Study|Death|0|||
94322343|NCT01232894|322960769|FG000|Overall Study|Protocol Violation|1|||
94322344|NCT01232894|322960770|FG001|Overall Study|Protocol Violation|1|||
94322345|NCT01232894|322960769|FG000|Overall Study|Withdrawal by Subject|8|||
94322346|NCT01232894|322960770|FG001|Overall Study|Withdrawal by Subject|5|||
94322347|NCT01232894|322960769|FG000|Overall Study|Physician Decision|2|||
94322348|NCT01232894|322960770|FG001|Overall Study|Physician Decision|1|||
94322349|NCT03731364|322960773|FG000|Overall Study|Adverse Event|0|||
94322350|NCT03731364|322960774|FG001|Overall Study|Adverse Event|0|||
94322351|NCT03731364|322960775|FG002|Overall Study|Adverse Event|1|||
94322352|NCT03731364|322960776|FG003|Overall Study|Adverse Event|2|||
94322353|NCT03731364|322960777|FG004|Overall Study|Adverse Event|1|||
94322354|NCT04387136|322960778|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
94322355|NCT04387136|322960779|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
94322356|NCT02104804|322960782|FG000|Overall Study|Did not take study medication|0|||
94322357|NCT02104804|322960783|FG001|Overall Study|Did not take study medication|1|||
94322358|NCT02104804|322960782|FG000|Overall Study|Study specific discontinuation criteria|6|||
94322359|NCT02104804|322960783|FG001|Overall Study|Study specific discontinuation criteria|1|||
94322360|NCT02104804|322960782|FG000|Overall Study|Other listed|2|||
94322361|NCT02104804|322960783|FG001|Overall Study|Other listed|1|||
94322362|NCT02104804|322960782|FG000|Overall Study|Protocol Violation|0|||
94322363|NCT02104804|322960783|FG001|Overall Study|Protocol Violation|1|||
94322364|NCT02104804|322960782|FG000|Overall Study|Adverse Event|4|||
94322365|NCT02104804|322960783|FG001|Overall Study|Adverse Event|3|||
94322366|NCT02104804|322960782|FG000|Overall Study|Withdrawal by Subject|4|||
94322367|NCT02104804|322960783|FG001|Overall Study|Withdrawal by Subject|12|||
94322368|NCT05319080|322960787|FG000|Overall Study|Withdrawal by Subject|2|||
94322369|NCT05319080|322960787|FG000|Overall Study|Physician Decision|4|||
94322370|NCT03259490|322960795|FG000|Period 1|Withdrawal by Subject|0|||
94322371|NCT03259490|322960796|FG001|Period 1|Withdrawal by Subject|1|||
94322372|NCT03259490|322960795|FG000|Period 2|Protocol Violation|1|||
94322373|NCT03259490|322960796|FG001|Period 2|Protocol Violation|0|||
94322374|NCT03095521|322960797|FG000|Overall Study|Withdrawal by Subject|0|||
94322375|NCT03095521|322960798|FG001|Overall Study|Withdrawal by Subject|1|||
94322376|NCT03095521|322960797|FG000|Overall Study|Lost to Follow-up|0|||
94322377|NCT03095521|322960798|FG001|Overall Study|Lost to Follow-up|1|||
94322378|NCT03076190|322960799|FG000|Overall Study|Lost to Follow-up|9|||
94322379|NCT03076190|322960800|FG001|Overall Study|Lost to Follow-up|34|||
94322380|NCT03076190|322960799|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
94322381|NCT03076190|322960800|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
94322382|NCT00434122|322960801|FG000|Overall Study|Non-compliance with protocol|0|||
94322383|NCT00434122|322960802|FG001|Overall Study|Non-compliance with protocol|1|||
94322384|NCT00434122|322960801|FG000|Overall Study|loss of subject contact|1|||
94322385|NCT00434122|322960802|FG001|Overall Study|loss of subject contact|1|||
94322386|NCT00434122|322960801|FG000|Overall Study|Personal reasons|1|||
94322387|NCT00434122|322960802|FG001|Overall Study|Personal reasons|1|||
94322388|NCT00434122|322960801|FG000|Overall Study|Large follicle size|2|||
94322389|NCT00434122|322960802|FG001|Overall Study|Large follicle size|2|||
94322390|NCT00434122|322960801|FG000|Overall Study|Low follicular response.|1|||
94322391|NCT00434122|322960802|FG001|Overall Study|Low follicular response.|2|||
94322392|NCT00434122|322960801|FG000|Overall Study|Travelling of subject.|1|||
94322393|NCT00434122|322960802|FG001|Overall Study|Travelling of subject.|0|||
94322394|NCT01963208|322960803|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
94322395|NCT01963208|322960804|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
94322396|NCT01963208|322960805|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
94322397|NCT01963208|322960806|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
94322398|NCT01963208|322960807|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
94322399|NCT01963208|322960808|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
94322400|NCT01963208|322960803|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
94322401|NCT01963208|322960804|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
94322402|NCT01963208|322960805|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
94322403|NCT01963208|322960806|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
94322404|NCT01963208|322960807|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
94322405|NCT01963208|322960808|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
94322406|NCT01963208|322960803|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
94322407|NCT01963208|322960804|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
94322408|NCT01963208|322960805|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
94322409|NCT01963208|322960806|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
94322410|NCT01963208|322960807|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
94322411|NCT01963208|322960808|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
94322412|NCT01963208|322960803|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
94322413|NCT01963208|322960804|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
94322414|NCT01963208|322960805|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
94322415|NCT01963208|322960806|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
94322416|NCT01963208|322960807|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
94322417|NCT01963208|322960808|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
94322418|NCT01963208|322960803|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
94322419|NCT01963208|322960804|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
94322420|NCT01963208|322960805|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
94322421|NCT01963208|322960806|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
94322422|NCT01963208|322960807|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
94322423|NCT01963208|322960808|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
94322424|NCT01963208|322960803|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
94322425|NCT01963208|322960804|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
94322426|NCT01963208|322960805|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
94322427|NCT01963208|322960806|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
94322428|NCT01963208|322960807|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
94322429|NCT01963208|322960808|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
94322430|NCT01963208|322960803|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
94322431|NCT01963208|322960804|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
94322432|NCT01963208|322960805|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
94322433|NCT01963208|322960806|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
94322434|NCT01963208|322960807|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
94322435|NCT01963208|322960808|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
94322436|NCT01963208|322960803|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
94322437|NCT01963208|322960804|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
94322438|NCT01963208|322960805|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
94322439|NCT01963208|322960806|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
94322440|NCT01963208|322960807|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
94322441|NCT01963208|322960808|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
94322442|NCT01963208|322960803|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
94322443|NCT01963208|322960804|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
94322444|NCT01963208|322960805|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
94322445|NCT01963208|322960806|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
94322446|NCT01963208|322960807|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
94322447|NCT01963208|322960808|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
94322448|NCT01963208|322960803|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
94322449|NCT01963208|322960804|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
94322450|NCT01963208|322960805|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
94322451|NCT01963208|322960806|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
94322452|NCT01963208|322960807|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
94322453|NCT01963208|322960808|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
94322454|NCT01963208|322960803|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
94322455|NCT01963208|322960804|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
94322456|NCT01963208|322960805|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
94322457|NCT01963208|322960806|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
94322458|NCT01963208|322960807|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
94322459|NCT01963208|322960808|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
94322460|NCT01963208|322960803|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
94322461|NCT01963208|322960804|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
94322462|NCT01963208|322960805|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
94387760|NCT00048581|323207725|FG000|Double-Blind Period|Lost to Follow-up|5|||
94387761|NCT00048581|323207726|FG001|Double-Blind Period|Lost to Follow-up|0|||
94387762|NCT00048581|323207727|FG002|Double-Blind Period|Lost to Follow-up|0|||
94387763|NCT00048581|323207725|FG000|Double-Blind Period|Withdrawal by Subject|5|||
94387764|NCT00048581|323207726|FG001|Double-Blind Period|Withdrawal by Subject|2|||
94387765|NCT00048581|323207727|FG002|Double-Blind Period|Withdrawal by Subject|0|||
94387766|NCT00048581|323207725|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
94387767|NCT00048581|323207726|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
94387768|NCT00048581|323207727|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
94387769|NCT00048581|323207725|FG000|Double-Blind Period|Investigator Decision|1|||
94387770|NCT00048581|323207726|FG001|Double-Blind Period|Investigator Decision|0|||
94387771|NCT00048581|323207727|FG002|Double-Blind Period|Investigator Decision|0|||
94322463|NCT01963208|322960806|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
94322464|NCT01963208|322960807|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
94322465|NCT01963208|322960808|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
94322466|NCT01963208|322960803|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
94322467|NCT01963208|322960804|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
94322468|NCT01963208|322960805|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
94322469|NCT01963208|322960806|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
94322470|NCT01963208|322960807|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
94322471|NCT01963208|322960808|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
94322472|NCT01963208|322960803|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
94322473|NCT01963208|322960804|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
94322474|NCT01963208|322960805|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
94322475|NCT01963208|322960806|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
94322476|NCT01963208|322960807|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
94322477|NCT01963208|322960808|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
94322478|NCT01536119|322960811|FG000|Overall Study|Lost to Follow-up|17|||
94322479|NCT01536119|322960812|FG001|Overall Study|Lost to Follow-up|14|||
94322480|NCT01208038|322960813|FG000|Overall Study|Withdrawal by Subject|1|||
94322481|NCT03784027|322960816|FG000|Period 1|Withdrawal by Subject|0|||
94322482|NCT03784027|322960817|FG001|Period 1|Withdrawal by Subject|1|||
94322483|NCT01877382|322960818|FG000|Dose Escalation|Progressive disease|2|||
94322484|NCT01877382|322960819|FG001|Dose Escalation|Progressive disease|0|||
94322485|NCT01877382|322960820|FG002|Dose Escalation|Progressive disease|1|||
94322486|NCT01877382|322960821|FG003|Dose Escalation|Progressive disease|6|||
94322487|NCT01877382|322960822|FG004|Dose Escalation|Progressive disease|1|||
94322488|NCT01877382|322960823|FG005|Dose Escalation|Progressive disease|0|||
94322489|NCT01877382|322960824|FG006|Dose Escalation|Progressive disease|3|||
94322490|NCT01877382|322960825|FG007|Dose Escalation|Progressive disease|10|||
94322491|NCT01877382|322960826|FG008|Dose Escalation|Progressive disease|4|||
94322492|NCT01877382|322960827|FG009|Dose Escalation|Progressive disease|2|||
94322493|NCT01877382|322960828|FG010|Dose Escalation|Progressive disease|3|||
94322494|NCT01877382|322960829|FG011|Dose Escalation|Progressive disease|3|||
94322495|NCT01877382|322960830|FG012|Dose Escalation|Progressive disease|13|||
94322496|NCT01877382|322960831|FG013|Dose Escalation|Progressive disease|1|||
94322497|NCT01877382|322960832|FG014|Dose Escalation|Progressive disease|0|||
94322498|NCT01877382|322960818|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
94322499|NCT01877382|322960819|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322500|NCT01877382|322960820|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322501|NCT01877382|322960821|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
94322502|NCT01877382|322960822|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322503|NCT01877382|322960823|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322504|NCT01877382|322960824|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
94322505|NCT01877382|322960825|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322506|NCT01877382|322960826|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322507|NCT01877382|322960827|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94387772|NCT00048581|323207725|FG000|Open-Label Period|Death|0|||
94387773|NCT00048581|323207726|FG001|Open-Label Period|Death|0|||
94387774|NCT00048581|323207727|FG002|Open-Label Period|Death|4|||
94387775|NCT00048581|323207725|FG000|Open-Label Period|Adverse Event|0|||
94322508|NCT01877382|322960828|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322509|NCT01877382|322960829|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322510|NCT01877382|322960830|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322511|NCT01877382|322960831|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322512|NCT01877382|322960832|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94387776|NCT00048581|323207726|FG001|Open-Label Period|Adverse Event|0|||
94387777|NCT00048581|323207727|FG002|Open-Label Period|Adverse Event|37|||
94387778|NCT00048581|323207725|FG000|Open-Label Period|Lack of Efficacy|0|||
94322513|NCT01877382|322960818|FG000|Dose Escalation|Clinical progression|0|||
94322514|NCT01877382|322960819|FG001|Dose Escalation|Clinical progression|1|||
94322515|NCT01877382|322960820|FG002|Dose Escalation|Clinical progression|0|||
94322516|NCT01877382|322960821|FG003|Dose Escalation|Clinical progression|2|||
94322517|NCT01877382|322960822|FG004|Dose Escalation|Clinical progression|0|||
94322518|NCT01877382|322960823|FG005|Dose Escalation|Clinical progression|0|||
94322519|NCT01877382|322960824|FG006|Dose Escalation|Clinical progression|1|||
94322520|NCT01877382|322960825|FG007|Dose Escalation|Clinical progression|0|||
94482388|NCT04613518|323558095|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
94482389|NCT04613518|323558093|FG000|Double-Blind Treatment Period|Adverse Event|2|||
94482390|NCT04613518|323558094|FG001|Double-Blind Treatment Period|Adverse Event|0|||
94482391|NCT04613518|323558095|FG002|Double-Blind Treatment Period|Adverse Event|1|||
94482392|NCT04613518|323558093|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
94482393|NCT04613518|323558094|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
94482394|NCT04613518|323558095|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
94482395|NCT04613518|323558093|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
94482396|NCT04613518|323558094|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
94482397|NCT04613518|323558095|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
94482398|NCT04613518|323558093|FG000|Double-Blind Treatment Period|Other Reasons|2|||
94482399|NCT04613518|323558094|FG001|Double-Blind Treatment Period|Other Reasons|0|||
94482400|NCT04613518|323558095|FG002|Double-Blind Treatment Period|Other Reasons|0|||
94482401|NCT04613518|323558093|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
94482402|NCT04613518|323558094|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
94482403|NCT04613518|323558095|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
94482404|NCT04613518|323558093|FG000|Open-Label Treatment Period|Adverse Event|1|||
94482405|NCT04613518|323558094|FG001|Open-Label Treatment Period|Adverse Event|0|||
94322521|NCT01877382|322960826|FG008|Dose Escalation|Clinical progression|0|||
94322522|NCT01877382|322960827|FG009|Dose Escalation|Clinical progression|1|||
94322523|NCT01877382|322960828|FG010|Dose Escalation|Clinical progression|0|||
94322524|NCT01877382|322960829|FG011|Dose Escalation|Clinical progression|0|||
94322525|NCT01877382|322960830|FG012|Dose Escalation|Clinical progression|2|||
94322526|NCT01877382|322960831|FG013|Dose Escalation|Clinical progression|1|||
94482406|NCT04613518|323558095|FG002|Open-Label Treatment Period|Adverse Event|3|||
94482407|NCT04613518|323558093|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
94482408|NCT04613518|323558094|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
94482409|NCT04613518|323558095|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
94482410|NCT04613518|323558093|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
94482411|NCT04613518|323558094|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
94482412|NCT04613518|323558095|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
94482413|NCT04613518|323558093|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
94482414|NCT04613518|323558094|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
94482415|NCT04613518|323558095|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
94482416|NCT04613518|323558093|FG000|Open-Label Treatment Period|Other reasons|1|||
94482417|NCT04613518|323558094|FG001|Open-Label Treatment Period|Other reasons|0|||
94482418|NCT04613518|323558095|FG002|Open-Label Treatment Period|Other reasons|0|||
94482419|NCT00149396|323558098|FG000|Overall Study|Death|15|||
94482420|NCT00149396|323558098|FG000|Overall Study|Withdrawal by Subject|1|||
94482421|NCT00149396|323558098|FG000|Overall Study|Subject noncompliance|2|||
94482422|NCT00149396|323558098|FG000|Overall Study|other treatment|5|||
94482423|NCT02689804|323558104|FG000|Overall Study|Withdrawal by Subject|2|||
94482424|NCT02689804|323558105|FG001|Overall Study|Withdrawal by Subject|0|||
94482425|NCT01211145|323558106|FG000|Overall Study|Reason not specified|3|||
94482426|NCT01211145|323558107|FG001|Overall Study|Reason not specified|2|||
94482427|NCT01211145|323558108|FG002|Overall Study|Reason not specified|2|||
94482428|NCT01211145|323558109|FG003|Overall Study|Reason not specified|1|||
94482429|NCT01211145|323558106|FG000|Overall Study|Lost to Follow-up|3|||
94482430|NCT01211145|323558107|FG001|Overall Study|Lost to Follow-up|2|||
94482431|NCT01211145|323558108|FG002|Overall Study|Lost to Follow-up|1|||
94482432|NCT01211145|323558109|FG003|Overall Study|Lost to Follow-up|2|||
94482433|NCT01211145|323558106|FG000|Overall Study|Study-specific withdrawal criteria|1|||
94482434|NCT01211145|323558107|FG001|Overall Study|Study-specific withdrawal criteria|0|||
94482435|NCT01211145|323558108|FG002|Overall Study|Study-specific withdrawal criteria|0|||
94322527|NCT01877382|322960832|FG014|Dose Escalation|Clinical progression|0|||
94322528|NCT01877382|322960818|FG000|Dose Escalation|Adverse Event|0|||
94482436|NCT01211145|323558109|FG003|Overall Study|Study-specific withdrawal criteria|0|||
94322529|NCT01877382|322960819|FG001|Dose Escalation|Adverse Event|0|||
94322530|NCT01877382|322960820|FG002|Dose Escalation|Adverse Event|0|||
94322531|NCT01877382|322960821|FG003|Dose Escalation|Adverse Event|4|||
94322532|NCT01877382|322960822|FG004|Dose Escalation|Adverse Event|1|||
94322533|NCT01877382|322960823|FG005|Dose Escalation|Adverse Event|2|||
94322534|NCT01877382|322960824|FG006|Dose Escalation|Adverse Event|1|||
94322535|NCT01877382|322960825|FG007|Dose Escalation|Adverse Event|2|||
94322536|NCT01877382|322960826|FG008|Dose Escalation|Adverse Event|0|||
94322537|NCT01877382|322960827|FG009|Dose Escalation|Adverse Event|0|||
94322538|NCT01877382|322960828|FG010|Dose Escalation|Adverse Event|0|||
94322539|NCT01877382|322960829|FG011|Dose Escalation|Adverse Event|0|||
94322540|NCT01877382|322960830|FG012|Dose Escalation|Adverse Event|1|||
94322541|NCT01877382|322960831|FG013|Dose Escalation|Adverse Event|0|||
94322542|NCT01877382|322960832|FG014|Dose Escalation|Adverse Event|0|||
94322543|NCT01877382|322960818|FG000|Dose Escalation|Withdrawal by Subject|0|||
94322544|NCT01877382|322960819|FG001|Dose Escalation|Withdrawal by Subject|0|||
94322545|NCT01877382|322960820|FG002|Dose Escalation|Withdrawal by Subject|0|||
94322546|NCT01877382|322960821|FG003|Dose Escalation|Withdrawal by Subject|0|||
94322547|NCT01877382|322960822|FG004|Dose Escalation|Withdrawal by Subject|0|||
94322548|NCT01877382|322960823|FG005|Dose Escalation|Withdrawal by Subject|3|||
94322549|NCT01877382|322960824|FG006|Dose Escalation|Withdrawal by Subject|2|||
94322550|NCT01877382|322960825|FG007|Dose Escalation|Withdrawal by Subject|1|||
94322551|NCT01877382|322960826|FG008|Dose Escalation|Withdrawal by Subject|1|||
94322552|NCT01877382|322960827|FG009|Dose Escalation|Withdrawal by Subject|0|||
94322553|NCT01877382|322960828|FG010|Dose Escalation|Withdrawal by Subject|0|||
94322554|NCT01877382|322960829|FG011|Dose Escalation|Withdrawal by Subject|0|||
94322555|NCT01877382|322960830|FG012|Dose Escalation|Withdrawal by Subject|0|||
94322556|NCT01877382|322960831|FG013|Dose Escalation|Withdrawal by Subject|0|||
94322557|NCT01877382|322960832|FG014|Dose Escalation|Withdrawal by Subject|0|||
94322558|NCT01877382|322960818|FG000|Dose Escalation|Protocol Violation|0|||
94322559|NCT01877382|322960819|FG001|Dose Escalation|Protocol Violation|0|||
94322560|NCT01877382|322960820|FG002|Dose Escalation|Protocol Violation|0|||
94322561|NCT01877382|322960821|FG003|Dose Escalation|Protocol Violation|0|||
94322562|NCT01877382|322960822|FG004|Dose Escalation|Protocol Violation|0|||
94322563|NCT01877382|322960823|FG005|Dose Escalation|Protocol Violation|0|||
94322564|NCT01877382|322960824|FG006|Dose Escalation|Protocol Violation|1|||
94322565|NCT01877382|322960825|FG007|Dose Escalation|Protocol Violation|0|||
94322566|NCT01877382|322960826|FG008|Dose Escalation|Protocol Violation|0|||
94322567|NCT01877382|322960827|FG009|Dose Escalation|Protocol Violation|0|||
94322568|NCT01877382|322960828|FG010|Dose Escalation|Protocol Violation|0|||
94322569|NCT01877382|322960829|FG011|Dose Escalation|Protocol Violation|0|||
94322570|NCT01877382|322960830|FG012|Dose Escalation|Protocol Violation|0|||
94322571|NCT01877382|322960831|FG013|Dose Escalation|Protocol Violation|0|||
94322572|NCT01877382|322960832|FG014|Dose Escalation|Protocol Violation|0|||
94322573|NCT01877382|322960818|FG000|Dose Escalation|Study terminated by sponsor|0|||
94322574|NCT01877382|322960819|FG001|Dose Escalation|Study terminated by sponsor|0|||
94322575|NCT01877382|322960820|FG002|Dose Escalation|Study terminated by sponsor|0|||
94322576|NCT01877382|322960821|FG003|Dose Escalation|Study terminated by sponsor|0|||
94322577|NCT01877382|322960822|FG004|Dose Escalation|Study terminated by sponsor|0|||
94322578|NCT01877382|322960823|FG005|Dose Escalation|Study terminated by sponsor|0|||
94322579|NCT01877382|322960824|FG006|Dose Escalation|Study terminated by sponsor|0|||
94322580|NCT01877382|322960825|FG007|Dose Escalation|Study terminated by sponsor|1|||
94322581|NCT01877382|322960826|FG008|Dose Escalation|Study terminated by sponsor|1|||
94322582|NCT01877382|322960827|FG009|Dose Escalation|Study terminated by sponsor|0|||
94322583|NCT01877382|322960828|FG010|Dose Escalation|Study terminated by sponsor|0|||
94322584|NCT01877382|322960829|FG011|Dose Escalation|Study terminated by sponsor|0|||
94322585|NCT01877382|322960830|FG012|Dose Escalation|Study terminated by sponsor|3|||
94322586|NCT01877382|322960831|FG013|Dose Escalation|Study terminated by sponsor|0|||
94322587|NCT01877382|322960832|FG014|Dose Escalation|Study terminated by sponsor|0|||
94322588|NCT01877382|322960818|FG000|Dose Escalation|Death|0|||
94322589|NCT01877382|322960819|FG001|Dose Escalation|Death|0|||
94322590|NCT01877382|322960820|FG002|Dose Escalation|Death|0|||
94322591|NCT01877382|322960821|FG003|Dose Escalation|Death|0|||
94322592|NCT01877382|322960822|FG004|Dose Escalation|Death|0|||
94322593|NCT01877382|322960823|FG005|Dose Escalation|Death|0|||
94322594|NCT01877382|322960824|FG006|Dose Escalation|Death|0|||
94322595|NCT01877382|322960825|FG007|Dose Escalation|Death|1|||
94322596|NCT01877382|322960826|FG008|Dose Escalation|Death|0|||
94322597|NCT01877382|322960827|FG009|Dose Escalation|Death|0|||
94322598|NCT01877382|322960828|FG010|Dose Escalation|Death|0|||
94322599|NCT01877382|322960829|FG011|Dose Escalation|Death|0|||
94322600|NCT01877382|322960830|FG012|Dose Escalation|Death|1|||
94322601|NCT01877382|322960831|FG013|Dose Escalation|Death|1|||
94322602|NCT01877382|322960832|FG014|Dose Escalation|Death|0|||
94322603|NCT01877382|322960818|FG000|Dose Expansion|Progressive disease|0|||
94322604|NCT01877382|322960819|FG001|Dose Expansion|Progressive disease|0|||
94322605|NCT01877382|322960820|FG002|Dose Expansion|Progressive disease|0|||
94322606|NCT01877382|322960821|FG003|Dose Expansion|Progressive disease|0|||
94482437|NCT01211145|323558106|FG000|Overall Study|Severe noncompliance to protocol|1|||
94322607|NCT01877382|322960822|FG004|Dose Expansion|Progressive disease|0|||
94322608|NCT01877382|322960823|FG005|Dose Expansion|Progressive disease|0|||
94482438|NCT01211145|323558107|FG001|Overall Study|Severe noncompliance to protocol|0|||
94322609|NCT01877382|322960824|FG006|Dose Expansion|Progressive disease|0|||
94322610|NCT01877382|322960825|FG007|Dose Expansion|Progressive disease|0|||
94322611|NCT01877382|322960826|FG008|Dose Expansion|Progressive disease|0|||
94322612|NCT01877382|322960827|FG009|Dose Expansion|Progressive disease|0|||
94322613|NCT01877382|322960828|FG010|Dose Expansion|Progressive disease|0|||
94322614|NCT01877382|322960829|FG011|Dose Expansion|Progressive disease|0|||
94322615|NCT01877382|322960830|FG012|Dose Expansion|Progressive disease|0|||
94322616|NCT01877382|322960831|FG013|Dose Expansion|Progressive disease|0|||
94322617|NCT01877382|322960832|FG014|Dose Expansion|Progressive disease|11|||
94322618|NCT01877382|322960818|FG000|Dose Expansion|Clinical progression|0|||
94322619|NCT01877382|322960819|FG001|Dose Expansion|Clinical progression|0|||
94322620|NCT01877382|322960820|FG002|Dose Expansion|Clinical progression|0|||
94322621|NCT01877382|322960821|FG003|Dose Expansion|Clinical progression|0|||
94322622|NCT01877382|322960822|FG004|Dose Expansion|Clinical progression|0|||
94322623|NCT01877382|322960823|FG005|Dose Expansion|Clinical progression|0|||
94322624|NCT01877382|322960824|FG006|Dose Expansion|Clinical progression|0|||
94322625|NCT01877382|322960825|FG007|Dose Expansion|Clinical progression|0|||
94322626|NCT01877382|322960826|FG008|Dose Expansion|Clinical progression|0|||
94322627|NCT01877382|322960827|FG009|Dose Expansion|Clinical progression|0|||
94322628|NCT01877382|322960828|FG010|Dose Expansion|Clinical progression|0|||
94322629|NCT01877382|322960829|FG011|Dose Expansion|Clinical progression|0|||
94322630|NCT01877382|322960830|FG012|Dose Expansion|Clinical progression|0|||
94322631|NCT01877382|322960831|FG013|Dose Expansion|Clinical progression|0|||
94322632|NCT01877382|322960832|FG014|Dose Expansion|Clinical progression|6|||
94322633|NCT01877382|322960818|FG000|Dose Expansion|Adverse Event|0|||
94322634|NCT01877382|322960819|FG001|Dose Expansion|Adverse Event|0|||
94322635|NCT01877382|322960820|FG002|Dose Expansion|Adverse Event|0|||
94322636|NCT01877382|322960821|FG003|Dose Expansion|Adverse Event|0|||
94322637|NCT01877382|322960822|FG004|Dose Expansion|Adverse Event|0|||
94322638|NCT01877382|322960823|FG005|Dose Expansion|Adverse Event|0|||
94322639|NCT01877382|322960824|FG006|Dose Expansion|Adverse Event|0|||
94322640|NCT01877382|322960825|FG007|Dose Expansion|Adverse Event|0|||
94322641|NCT01877382|322960826|FG008|Dose Expansion|Adverse Event|0|||
94322642|NCT01877382|322960827|FG009|Dose Expansion|Adverse Event|0|||
94322643|NCT01877382|322960828|FG010|Dose Expansion|Adverse Event|0|||
94322644|NCT01877382|322960829|FG011|Dose Expansion|Adverse Event|0|||
94322645|NCT01877382|322960830|FG012|Dose Expansion|Adverse Event|0|||
94322646|NCT01877382|322960831|FG013|Dose Expansion|Adverse Event|0|||
94322647|NCT01877382|322960832|FG014|Dose Expansion|Adverse Event|1|||
94387779|NCT00048581|323207726|FG001|Open-Label Period|Lack of Efficacy|0|||
94387780|NCT00048581|323207727|FG002|Open-Label Period|Lack of Efficacy|69|||
94387781|NCT00048581|323207725|FG000|Open-Label Period|Lost to Follow-up|0|||
94387782|NCT00048581|323207726|FG001|Open-Label Period|Lost to Follow-up|0|||
94387783|NCT00048581|323207727|FG002|Open-Label Period|Lost to Follow-up|14|||
94387784|NCT00048581|323207725|FG000|Open-Label Period|Withdrawal by Subject|0|||
94387785|NCT00048581|323207726|FG001|Open-Label Period|Withdrawal by Subject|0|||
94387786|NCT00048581|323207727|FG002|Open-Label Period|Withdrawal by Subject|20|||
94387787|NCT00048581|323207725|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
94387788|NCT00048581|323207726|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
94387789|NCT00048581|323207727|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
94387790|NCT00048581|323207725|FG000|Open-Label Period|Poor/Non-compliance|0|||
94387791|NCT00048581|323207726|FG001|Open-Label Period|Poor/Non-compliance|0|||
94387792|NCT00048581|323207727|FG002|Open-Label Period|Poor/Non-compliance|5|||
94387793|NCT00048581|323207725|FG000|Open-Label Period|Pregnancy|0|||
94387794|NCT00048581|323207726|FG001|Open-Label Period|Pregnancy|0|||
94387795|NCT00048581|323207727|FG002|Open-Label Period|Pregnancy|7|||
94387796|NCT00048581|323207725|FG000|Open-Label Period|Study Site Closure|0|||
94387797|NCT00048581|323207726|FG001|Open-Label Period|Study Site Closure|0|||
94387798|NCT00048581|323207727|FG002|Open-Label Period|Study Site Closure|2|||
94387799|NCT00048581|323207725|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
94387800|NCT00048581|323207726|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
94387801|NCT00048581|323207727|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
94387802|NCT00048581|323207725|FG000|Open-Label Period|Problem With Transportation To Site|0|||
94322648|NCT01877382|322960818|FG000|Dose Expansion|Death|0|||
94387803|NCT00048581|323207726|FG001|Open-Label Period|Problem With Transportation To Site|0|||
94387804|NCT00048581|323207727|FG002|Open-Label Period|Problem With Transportation To Site|1|||
94387805|NCT00048581|323207725|FG000|Open-Label Period|Primary Investigator Retired|0|||
94387806|NCT00048581|323207726|FG001|Open-Label Period|Primary Investigator Retired|0|||
94322649|NCT01877382|322960819|FG001|Dose Expansion|Death|0|||
94322650|NCT01877382|322960820|FG002|Dose Expansion|Death|0|||
94322651|NCT01877382|322960821|FG003|Dose Expansion|Death|0|||
94322652|NCT01877382|322960822|FG004|Dose Expansion|Death|0|||
94322653|NCT01877382|322960823|FG005|Dose Expansion|Death|0|||
94322654|NCT01877382|322960824|FG006|Dose Expansion|Death|0|||
94322655|NCT01877382|322960825|FG007|Dose Expansion|Death|0|||
94322656|NCT01877382|322960826|FG008|Dose Expansion|Death|0|||
94322657|NCT01877382|322960827|FG009|Dose Expansion|Death|0|||
94322658|NCT01877382|322960828|FG010|Dose Expansion|Death|0|||
94322659|NCT01877382|322960829|FG011|Dose Expansion|Death|0|||
94322660|NCT01877382|322960830|FG012|Dose Expansion|Death|0|||
94322661|NCT01877382|322960831|FG013|Dose Expansion|Death|0|||
94322662|NCT01877382|322960832|FG014|Dose Expansion|Death|1|||
94322663|NCT01877382|322960818|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322664|NCT01877382|322960819|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322665|NCT01877382|322960820|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322666|NCT01877382|322960821|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322667|NCT01877382|322960822|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322668|NCT01877382|322960823|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322669|NCT01877382|322960824|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322670|NCT01877382|322960825|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322671|NCT01877382|322960826|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322672|NCT01877382|322960827|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322673|NCT01877382|322960828|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322674|NCT01877382|322960829|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322675|NCT01877382|322960830|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322676|NCT01877382|322960831|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
94322677|NCT01877382|322960832|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
94322678|NCT00479557|322960833|FG000|Overall Study|Death|0|||
94322679|NCT00479557|322960834|FG001|Overall Study|Death|0|||
94322680|NCT00479557|322960835|FG002|Overall Study|Death|0|||
94322681|NCT00479557|322960836|FG003|Overall Study|Death|0|||
94322682|NCT00479557|322960837|FG004|Overall Study|Death|0|||
94322683|NCT00479557|322960838|FG005|Overall Study|Death|1|||
94322684|NCT00479557|322960839|FG006|Overall Study|Death|0|||
94322685|NCT00479557|322960833|FG000|Overall Study|Lack of Efficacy|1|||
94322686|NCT00479557|322960834|FG001|Overall Study|Lack of Efficacy|0|||
94322687|NCT00479557|322960835|FG002|Overall Study|Lack of Efficacy|0|||
94322688|NCT00479557|322960836|FG003|Overall Study|Lack of Efficacy|0|||
94322689|NCT00479557|322960837|FG004|Overall Study|Lack of Efficacy|0|||
94322690|NCT00479557|322960838|FG005|Overall Study|Lack of Efficacy|0|||
94322691|NCT00479557|322960839|FG006|Overall Study|Lack of Efficacy|0|||
94322692|NCT00479557|322960833|FG000|Overall Study|Lost to Follow-up|0|||
94322693|NCT00479557|322960834|FG001|Overall Study|Lost to Follow-up|2|||
94322694|NCT00479557|322960835|FG002|Overall Study|Lost to Follow-up|0|||
94322695|NCT00479557|322960836|FG003|Overall Study|Lost to Follow-up|2|||
94322696|NCT00479557|322960837|FG004|Overall Study|Lost to Follow-up|0|||
94322697|NCT00479557|322960838|FG005|Overall Study|Lost to Follow-up|0|||
94322698|NCT00479557|322960839|FG006|Overall Study|Lost to Follow-up|0|||
94322699|NCT00479557|322960833|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
94322700|NCT00479557|322960834|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
94322701|NCT00479557|322960835|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
94322702|NCT00479557|322960836|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
94322703|NCT00479557|322960837|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
94322704|NCT00479557|322960838|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
94322705|NCT00479557|322960839|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
94322706|NCT00479557|322960833|FG000|Overall Study|AE not related to Study Drug|1|||
94322707|NCT00479557|322960834|FG001|Overall Study|AE not related to Study Drug|3|||
94322708|NCT00479557|322960835|FG002|Overall Study|AE not related to Study Drug|0|||
94322709|NCT00479557|322960836|FG003|Overall Study|AE not related to Study Drug|0|||
94322710|NCT00479557|322960837|FG004|Overall Study|AE not related to Study Drug|2|||
94322711|NCT00479557|322960838|FG005|Overall Study|AE not related to Study Drug|2|||
94322712|NCT00479557|322960839|FG006|Overall Study|AE not related to Study Drug|1|||
94322713|NCT00479557|322960833|FG000|Overall Study|Caregiver Request|2|||
94322714|NCT00479557|322960834|FG001|Overall Study|Caregiver Request|2|||
94322715|NCT00479557|322960835|FG002|Overall Study|Caregiver Request|2|||
94322716|NCT00479557|322960836|FG003|Overall Study|Caregiver Request|0|||
94322717|NCT00479557|322960837|FG004|Overall Study|Caregiver Request|1|||
94322718|NCT00479557|322960838|FG005|Overall Study|Caregiver Request|2|||
94322719|NCT00479557|322960839|FG006|Overall Study|Caregiver Request|0|||
94322720|NCT00479557|322960833|FG000|Overall Study|Investigator Request|0|||
94322721|NCT00479557|322960834|FG001|Overall Study|Investigator Request|0|||
94322722|NCT00479557|322960835|FG002|Overall Study|Investigator Request|1|||
94322723|NCT00479557|322960836|FG003|Overall Study|Investigator Request|0|||
94322724|NCT00479557|322960837|FG004|Overall Study|Investigator Request|0|||
94322725|NCT00479557|322960838|FG005|Overall Study|Investigator Request|0|||
94322726|NCT00479557|322960839|FG006|Overall Study|Investigator Request|0|||
94322727|NCT00479557|322960833|FG000|Overall Study|Subject Request|3|||
94322728|NCT00479557|322960834|FG001|Overall Study|Subject Request|0|||
94322729|NCT00479557|322960835|FG002|Overall Study|Subject Request|1|||
94322730|NCT00479557|322960836|FG003|Overall Study|Subject Request|1|||
94322731|NCT00479557|322960837|FG004|Overall Study|Subject Request|1|||
94322732|NCT00479557|322960838|FG005|Overall Study|Subject Request|4|||
94322733|NCT00479557|322960839|FG006|Overall Study|Subject Request|1|||
94322734|NCT00479557|322960833|FG000|Overall Study|Other|2|||
94322735|NCT00479557|322960834|FG001|Overall Study|Other|3|||
94322736|NCT00479557|322960835|FG002|Overall Study|Other|1|||
94322737|NCT00479557|322960836|FG003|Overall Study|Other|0|||
94322738|NCT00479557|322960837|FG004|Overall Study|Other|0|||
94322739|NCT00479557|322960838|FG005|Overall Study|Other|3|||
94322740|NCT00479557|322960839|FG006|Overall Study|Other|0|||
94322741|NCT03225716|322962903|FG000|Overall Study|Withdrawal by Subject|2|||
94322742|NCT03225716|322962904|FG001|Overall Study|Withdrawal by Subject|2|||
94322743|NCT03225716|322962905|FG002|Overall Study|Withdrawal by Subject|0|||
94322744|NCT03225716|322962903|FG000|Overall Study|Lack of Efficacy|1|||
94322745|NCT03225716|322962904|FG001|Overall Study|Lack of Efficacy|0|||
94322746|NCT03225716|322962905|FG002|Overall Study|Lack of Efficacy|0|||
94322747|NCT03225716|322962903|FG000|Overall Study|Adverse Event|2|||
94322748|NCT03225716|322962904|FG001|Overall Study|Adverse Event|0|||
94322749|NCT03225716|322962905|FG002|Overall Study|Adverse Event|1|||
94322750|NCT03225716|322962903|FG000|Overall Study|Study early termination by Sponsor|0|||
94322751|NCT03225716|322962904|FG001|Overall Study|Study early termination by Sponsor|0|||
94322752|NCT03225716|322962905|FG002|Overall Study|Study early termination by Sponsor|2|||
94322753|NCT00082758|322962906|FG000|Overall Study|Adverse Event|0|||
94322754|NCT00082758|322962907|FG001|Overall Study|Adverse Event|2|||
94322755|NCT00082758|322962908|FG002|Overall Study|Adverse Event|0|||
94322756|NCT00082758|322962906|FG000|Overall Study|Lack of Efficacy|12|||
94322757|NCT00082758|322962907|FG001|Overall Study|Lack of Efficacy|13|||
94322758|NCT00082758|322962908|FG002|Overall Study|Lack of Efficacy|0|||
94322759|NCT00082758|322962906|FG000|Overall Study|Physician Decision|0|||
94322760|NCT00082758|322962907|FG001|Overall Study|Physician Decision|1|||
94322761|NCT00082758|322962908|FG002|Overall Study|Physician Decision|0|||
94322762|NCT00082758|322962906|FG000|Overall Study|Withdrawal by Subject|3|||
94322763|NCT00082758|322962907|FG001|Overall Study|Withdrawal by Subject|0|||
94322764|NCT00082758|322962908|FG002|Overall Study|Withdrawal by Subject|0|||
94322765|NCT00082758|322962906|FG000|Overall Study|Protocol Violation|0|||
94322766|NCT00082758|322962907|FG001|Overall Study|Protocol Violation|1|||
94322767|NCT00082758|322962908|FG002|Overall Study|Protocol Violation|0|||
94322768|NCT01114373|322962913|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
94322769|NCT01114373|322962914|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
94322770|NCT01114373|322962913|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
94322771|NCT01114373|322962914|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
94322772|NCT01114373|322962913|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
94322773|NCT01114373|322962914|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
94322774|NCT01114373|322962913|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
94322775|NCT01114373|322962914|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
94322776|NCT01107405|322962915|FG000|Overall Study|Adverse Event|1|||
94322777|NCT01107405|322962916|FG001|Overall Study|Adverse Event|1|||
94322778|NCT01107405|322962917|FG002|Overall Study|Adverse Event|0|||
94322779|NCT01107405|322962918|FG003|Overall Study|Adverse Event|0|||
94322780|NCT01107405|322962919|FG004|Overall Study|Adverse Event|2|||
94322781|NCT01107405|322962915|FG000|Overall Study|Withdrawal by Subject|1|||
94322782|NCT01107405|322962916|FG001|Overall Study|Withdrawal by Subject|0|||
94322783|NCT01107405|322962917|FG002|Overall Study|Withdrawal by Subject|1|||
94322784|NCT01107405|322962918|FG003|Overall Study|Withdrawal by Subject|2|||
94322785|NCT01107405|322962919|FG004|Overall Study|Withdrawal by Subject|1|||
94322786|NCT01107405|322962915|FG000|Overall Study|Protocol Violation|0|||
94322787|NCT01107405|322962916|FG001|Overall Study|Protocol Violation|0|||
94322788|NCT01107405|322962917|FG002|Overall Study|Protocol Violation|1|||
94322789|NCT01107405|322962918|FG003|Overall Study|Protocol Violation|1|||
94322790|NCT01107405|322962919|FG004|Overall Study|Protocol Violation|0|||
94482439|NCT01211145|323558108|FG002|Overall Study|Severe noncompliance to protocol|0|||
94322791|NCT01653158|322962920|FG000|Overall Study|Death|0|||
94322792|NCT01653158|322962921|FG001|Overall Study|Death|0|||
94322793|NCT01653158|322962922|FG002|Overall Study|Death|0|||
94322794|NCT01653158|322962923|FG003|Overall Study|Death|1|||
94322795|NCT01653158|322962924|FG004|Overall Study|Death|0|||
94322796|NCT01653158|322962925|FG005|Overall Study|Death|0|||
94322797|NCT01653158|322962926|FG006|Overall Study|Death|0|||
94322798|NCT01653158|322962927|FG007|Overall Study|Death|2|||
94322799|NCT01653158|322962920|FG000|Overall Study|Adverse Event|0|||
94322800|NCT01653158|322962921|FG001|Overall Study|Adverse Event|0|||
94322801|NCT01653158|322962922|FG002|Overall Study|Adverse Event|0|||
94322802|NCT01653158|322962923|FG003|Overall Study|Adverse Event|1|||
94322803|NCT01653158|322962924|FG004|Overall Study|Adverse Event|0|||
94322804|NCT01653158|322962925|FG005|Overall Study|Adverse Event|0|||
94322805|NCT01653158|322962926|FG006|Overall Study|Adverse Event|0|||
94322806|NCT01653158|322962927|FG007|Overall Study|Adverse Event|3|||
94322807|NCT01653158|322962920|FG000|Overall Study|Other|0|||
94322808|NCT01653158|322962921|FG001|Overall Study|Other|0|||
94322809|NCT01653158|322962922|FG002|Overall Study|Other|0|||
94322810|NCT01653158|322962923|FG003|Overall Study|Other|0|||
94322811|NCT01653158|322962924|FG004|Overall Study|Other|0|||
94322812|NCT01653158|322962925|FG005|Overall Study|Other|0|||
94322813|NCT01653158|322962926|FG006|Overall Study|Other|0|||
94322814|NCT01653158|322962927|FG007|Overall Study|Other|1|||
94322815|NCT01653158|322962920|FG000|Overall Study|Progressive disease|0|||
94322816|NCT01653158|322962921|FG001|Overall Study|Progressive disease|0|||
94322817|NCT01653158|322962922|FG002|Overall Study|Progressive disease|0|||
94322818|NCT01653158|322962923|FG003|Overall Study|Progressive disease|0|||
94322819|NCT01653158|322962924|FG004|Overall Study|Progressive disease|1|||
94322820|NCT01653158|322962925|FG005|Overall Study|Progressive disease|1|||
94322821|NCT01653158|322962926|FG006|Overall Study|Progressive disease|2|||
94322822|NCT01653158|322962927|FG007|Overall Study|Progressive disease|9|||
94322823|NCT01653158|322962920|FG000|Overall Study|Withdrawal by Subject|1|||
94322824|NCT01653158|322962921|FG001|Overall Study|Withdrawal by Subject|0|||
94322825|NCT01653158|322962922|FG002|Overall Study|Withdrawal by Subject|0|||
94322826|NCT01653158|322962923|FG003|Overall Study|Withdrawal by Subject|0|||
94322827|NCT01653158|322962924|FG004|Overall Study|Withdrawal by Subject|0|||
94322828|NCT01653158|322962925|FG005|Overall Study|Withdrawal by Subject|0|||
94322829|NCT01653158|322962926|FG006|Overall Study|Withdrawal by Subject|0|||
94322830|NCT01653158|322962927|FG007|Overall Study|Withdrawal by Subject|0|||
94322831|NCT00980343|322962928|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
94322832|NCT00980343|322962929|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
94322833|NCT03444870|322962936|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
94322834|NCT03444870|322962937|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
94387807|NCT00048581|323207727|FG002|Open-Label Period|Primary Investigator Retired|2|||
94387808|NCT00048581|323207725|FG000|Open-Label Period|Study Ended By Sponsor|0|||
94387809|NCT00048581|323207726|FG001|Open-Label Period|Study Ended By Sponsor|0|||
94387810|NCT00048581|323207727|FG002|Open-Label Period|Study Ended By Sponsor|1|||
94387811|NCT01406795|323207728|FG000|Overall Study|Withdrawal by Subject|1|||
94387812|NCT03338972|323207729|FG000|Overall Study|Death|1|||
94387813|NCT03338972|323207730|FG001|Overall Study|Death|1|||
94387814|NCT03338972|323207731|FG002|Overall Study|Death|0|||
94387815|NCT03338972|323207732|FG003|Overall Study|Death|0|||
94387816|NCT03338972|323207729|FG000|Overall Study|Withdrawal by Subject|1|||
94387817|NCT03338972|323207730|FG001|Overall Study|Withdrawal by Subject|0|||
94387818|NCT03338972|323207731|FG002|Overall Study|Withdrawal by Subject|0|||
94387819|NCT03338972|323207732|FG003|Overall Study|Withdrawal by Subject|0|||
94387820|NCT00822926|323207737|FG000|Second Injection Visit|Lost to Follow-up|1|||
94387821|NCT00822926|323207738|FG001|Second Injection Visit|Lost to Follow-up|0|||
94387822|NCT00822926|323207737|FG000|Second Injection Visit|Withdrawal by Subject|0|||
94387823|NCT00822926|323207738|FG001|Second Injection Visit|Withdrawal by Subject|1|||
94322835|NCT03444870|322962938|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
94322836|NCT03444870|322962939|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
94322837|NCT03444870|322962940|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
94322838|NCT03444870|322962941|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
94322839|NCT03444870|322962936|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
94322840|NCT03444870|322962937|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
94322841|NCT03444870|322962938|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
94322842|NCT03444870|322962939|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
94322843|NCT03444870|322962940|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
94322844|NCT03444870|322962941|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
94322845|NCT03444870|322962936|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
94322846|NCT03444870|322962937|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
94322847|NCT03444870|322962938|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
94322848|NCT03444870|322962939|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
94322849|NCT03444870|322962940|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
94322850|NCT03444870|322962941|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
94322851|NCT03444870|322962936|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
94322852|NCT03444870|322962937|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
94387824|NCT02719522|323207739|FG000|Overall Study|Implant Failure|4|||
94482440|NCT01211145|323558109|FG003|Overall Study|Severe noncompliance to protocol|0|||
94322853|NCT03444870|322962938|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
94322854|NCT03444870|322962939|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
94322855|NCT03444870|322962940|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
94322856|NCT03444870|322962941|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
94322857|NCT03444870|322962936|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
94387825|NCT02719522|323207739|FG000|Overall Study|Death|2|||
94387826|NCT02719522|323207739|FG000|Overall Study|Lost to Follow-up|5|||
94387827|NCT03018249|323207746|FG000|Overall Study|Withdrawal by Subject|2|||
94387828|NCT03018249|323207747|FG001|Overall Study|Withdrawal by Subject|2|||
94322858|NCT03444870|322962937|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
94322859|NCT03444870|322962938|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
94322860|NCT03444870|322962939|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
94322861|NCT03444870|322962940|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
94322862|NCT03444870|322962941|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
94322863|NCT03444870|322962936|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
94322864|NCT03444870|322962937|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
94322865|NCT03444870|322962938|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
94322866|NCT03444870|322962939|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
94322867|NCT03444870|322962940|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
94322868|NCT03444870|322962941|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
94322869|NCT03444870|322962936|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
94322870|NCT03444870|322962937|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
94322871|NCT03444870|322962938|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
94322872|NCT03444870|322962939|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
94322873|NCT03444870|322962940|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
94322874|NCT03444870|322962941|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
94322875|NCT03444870|322962936|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
94322876|NCT03444870|322962937|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
94322877|NCT03444870|322962938|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
94322878|NCT03444870|322962939|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
94322879|NCT03444870|322962940|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
94322880|NCT03444870|322962941|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
94322881|NCT03444870|322962936|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
94322882|NCT03444870|322962937|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
94322883|NCT03444870|322962938|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
94322884|NCT03444870|322962939|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
94322885|NCT03444870|322962940|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
94322886|NCT03444870|322962941|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
94322887|NCT03444870|322962936|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
94322888|NCT03444870|322962937|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
94322889|NCT03444870|322962938|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
94322890|NCT03444870|322962939|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
94322891|NCT03444870|322962940|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
94322892|NCT03444870|322962941|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
94322893|NCT03444870|322962936|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
94322894|NCT03444870|322962937|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
94322895|NCT03444870|322962938|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
94322896|NCT03444870|322962939|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
94322897|NCT03444870|322962940|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
94322898|NCT03444870|322962941|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
94322899|NCT03444870|322962936|FG000|Open-Label Extension (OLE) Period|Death|0|||
94322900|NCT03444870|322962937|FG001|Open-Label Extension (OLE) Period|Death|0|||
94322901|NCT03444870|322962938|FG002|Open-Label Extension (OLE) Period|Death|0|||
94322902|NCT03444870|322962939|FG003|Open-Label Extension (OLE) Period|Death|0|||
94322903|NCT03444870|322962940|FG004|Open-Label Extension (OLE) Period|Death|1|||
94322904|NCT03444870|322962941|FG005|Open-Label Extension (OLE) Period|Death|0|||
94322905|NCT00848250|322962943|FG000|Overall Study|surgery was completed without cardiopulm|0|||
94322906|NCT00848250|322962944|FG001|Overall Study|surgery was completed without cardiopulm|1|||
94322907|NCT01397552|322962957|FG000|Overall Study|Adverse Event|1|||
94322908|NCT01397552|322962958|FG001|Overall Study|Adverse Event|0|||
94322909|NCT01397552|322962957|FG000|Overall Study|Withdrawal by Subject|2|||
94322910|NCT01397552|322962958|FG001|Overall Study|Withdrawal by Subject|1|||
94322911|NCT00423735|322962959|FG000|Overall Study|Ineligible / No protocol treatment|8|||
94322912|NCT00423735|322962960|FG001|Overall Study|Ineligible / No protocol treatment|6|||
94322913|NCT00423735|322962961|FG002|Overall Study|Ineligible / No protocol treatment|0|||
94322914|NCT02864940|322962962|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
94322915|NCT02864940|322962963|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
94322916|NCT00579501|322962964|FG000|Overall Study|Death|1|||
94322917|NCT00579501|322962964|FG000|Overall Study|End of neoadjuvant therapy|25|||
94322918|NCT00579501|322962964|FG000|Overall Study|toxicity|1|||
94322919|NCT00579501|322962964|FG000|Overall Study|Secondary lesion|1|||
94322920|NCT00579501|322962964|FG000|Overall Study|Radiation therapy before surgery|1|||
94322921|NCT03558555|322962965|FG000|Overall Study|Lost to Follow-up|2|||
94322922|NCT03558555|322962966|FG001|Overall Study|Lost to Follow-up|1|||
94322923|NCT04096326|322962967|FG000|Overall Study|Withdrawal by Subject|0|||
94322924|NCT04096326|322962968|FG001|Overall Study|Withdrawal by Subject|0|||
94322925|NCT04096326|322962969|FG002|Overall Study|Withdrawal by Subject|0|||
94387829|NCT00385593|323207748|FG000|Overall Study|Adverse Event|3|||
94322926|NCT04096326|322962970|FG003|Overall Study|Withdrawal by Subject|0|||
94322927|NCT04096326|322962971|FG004|Overall Study|Withdrawal by Subject|0|||
94322928|NCT04096326|322962972|FG005|Overall Study|Withdrawal by Subject|0|||
94322929|NCT04096326|322962973|FG006|Overall Study|Withdrawal by Subject|1|||
94322930|NCT04096326|322962974|FG007|Overall Study|Withdrawal by Subject|0|||
94322931|NCT04096326|322962975|FG008|Overall Study|Withdrawal by Subject|0|||
94322932|NCT04096326|322962976|FG009|Overall Study|Withdrawal by Subject|0|||
94322933|NCT04096326|322962967|FG000|Overall Study|Lost to Follow-up|0|||
94322934|NCT04096326|322962968|FG001|Overall Study|Lost to Follow-up|1|||
94322935|NCT04096326|322962969|FG002|Overall Study|Lost to Follow-up|0|||
94322936|NCT04096326|322962970|FG003|Overall Study|Lost to Follow-up|0|||
94322937|NCT04096326|322962971|FG004|Overall Study|Lost to Follow-up|0|||
94322938|NCT04096326|322962972|FG005|Overall Study|Lost to Follow-up|0|||
94322939|NCT04096326|322962973|FG006|Overall Study|Lost to Follow-up|0|||
94322940|NCT04096326|322962974|FG007|Overall Study|Lost to Follow-up|0|||
94322941|NCT04096326|322962975|FG008|Overall Study|Lost to Follow-up|0|||
94322942|NCT04096326|322962976|FG009|Overall Study|Lost to Follow-up|0|||
94322943|NCT04096326|322962967|FG000|Overall Study|COVID-19-related reasons|0|||
94322944|NCT04096326|322962968|FG001|Overall Study|COVID-19-related reasons|0|||
94322945|NCT04096326|322962969|FG002|Overall Study|COVID-19-related reasons|0|||
94322946|NCT04096326|322962970|FG003|Overall Study|COVID-19-related reasons|0|||
94322947|NCT04096326|322962971|FG004|Overall Study|COVID-19-related reasons|1|||
94322948|NCT04096326|322962972|FG005|Overall Study|COVID-19-related reasons|5|||
94322949|NCT04096326|322962973|FG006|Overall Study|COVID-19-related reasons|0|||
94322950|NCT04096326|322962974|FG007|Overall Study|COVID-19-related reasons|0|||
94322951|NCT04096326|322962975|FG008|Overall Study|COVID-19-related reasons|0|||
94322952|NCT04096326|322962976|FG009|Overall Study|COVID-19-related reasons|0|||
94322953|NCT01363713|322962985|FG000|Overall Study|Adverse Event|1|||
94322954|NCT01363713|322962985|FG000|Overall Study|Protocol Violation|3|||
94322955|NCT01363713|322962985|FG000|Overall Study|Withdrawal by Subject|2|||
94322956|NCT03943953|322962986|FG000|Trial of ITG 1|Lost to Follow-up|19|||
94322957|NCT03943953|322962987|FG001|Trial of ITG 1|Lost to Follow-up|1|||
94322958|NCT03943953|322962986|FG000|Trial of ITG 2|Lost to Follow-up|8|||
94322959|NCT03943953|322962987|FG001|Trial of ITG 2|Lost to Follow-up|0|||
94322960|NCT03943953|322962986|FG000|Trial of ITG 3|Lost to Follow-up|2|||
94322961|NCT03943953|322962987|FG001|Trial of ITG 3|Lost to Follow-up|0|||
94322962|NCT03943953|322962986|FG000|Trial of ITG 4|Lost to Follow-up|2|||
94322963|NCT03943953|322962987|FG001|Trial of ITG 4|Lost to Follow-up|0|||
94322964|NCT00844649|322962995|FG000|Overall Study|Progressive Disease|196|||
94322965|NCT00844649|322962996|FG001|Overall Study|Progressive Disease|245|||
94322966|NCT00844649|322962995|FG000|Overall Study|Adverse Event|128|||
94322967|NCT00844649|322962996|FG001|Overall Study|Adverse Event|73|||
94322968|NCT00844649|322962995|FG000|Overall Study|Physician Decision|25|||
94322969|NCT00844649|322962996|FG001|Overall Study|Physician Decision|18|||
94322970|NCT00844649|322962995|FG000|Overall Study|Protocol Violation|10|||
94322971|NCT00844649|322962996|FG001|Overall Study|Protocol Violation|6|||
94322972|NCT00844649|322962995|FG000|Overall Study|Withdrawal by Subject|28|||
94322973|NCT00844649|322962996|FG001|Overall Study|Withdrawal by Subject|39|||
94322974|NCT00844649|322962995|FG000|Overall Study|Other|7|||
94322975|NCT00844649|322962996|FG001|Overall Study|Other|10|||
94322976|NCT00844649|322962995|FG000|Overall Study|Withdrew prior to starting treatment|11|||
94322977|NCT00844649|322962996|FG001|Overall Study|Withdrew prior to starting treatment|27|||
94322978|NCT00642746|322962997|FG000|Overall Study|Patient unevaluable|1|||
94322979|NCT00642746|322962998|FG001|Overall Study|Patient unevaluable|0|||
94322980|NCT00608530|322962999|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
94322981|NCT00608530|322963000|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
94322982|NCT00608530|322963001|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
94322983|NCT00608530|322963002|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
94322984|NCT00608530|322962999|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
94322985|NCT00608530|322963000|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
94322986|NCT00608530|322963001|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
94322987|NCT00608530|322963002|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
94322988|NCT00608530|322962999|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
94322989|NCT00608530|322963000|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
94322990|NCT00608530|322963001|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
94322991|NCT00608530|322963002|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
94387830|NCT00385593|323207749|FG001|Overall Study|Adverse Event|2|||
94322992|NCT00608530|322962999|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
94322993|NCT00608530|322963000|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
94322994|NCT00608530|322963001|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
94322995|NCT00608530|322963002|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
94322996|NCT00608530|322962999|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
94322997|NCT00608530|322963000|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
94322998|NCT00608530|322963001|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
94322999|NCT00608530|322963002|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
94323000|NCT00608530|322962999|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
94323001|NCT00608530|322963000|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
94323002|NCT00608530|322963001|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
94323003|NCT00608530|322963002|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
94323004|NCT00077610|322963003|FG000|Overall Study|Adverse Event|9|||
94323005|NCT00077610|322963004|FG001|Overall Study|Adverse Event|7|||
94323006|NCT00077610|322963005|FG002|Overall Study|Adverse Event|1|||
94323007|NCT00077610|322963003|FG000|Overall Study|Lost to Follow-up|0|||
94323008|NCT00077610|322963004|FG001|Overall Study|Lost to Follow-up|1|||
94323009|NCT00077610|322963005|FG002|Overall Study|Lost to Follow-up|2|||
94323010|NCT00077610|322963003|FG000|Overall Study|Withdrawal by Subject|4|||
94323011|NCT00077610|322963004|FG001|Overall Study|Withdrawal by Subject|10|||
94323012|NCT00077610|322963005|FG002|Overall Study|Withdrawal by Subject|6|||
94323013|NCT00077610|322963003|FG000|Overall Study|Death|17|||
94323014|NCT00077610|322963004|FG001|Overall Study|Death|13|||
94323015|NCT00077610|322963005|FG002|Overall Study|Death|13|||
94323016|NCT00077610|322963003|FG000|Overall Study|Renal transplant|12|||
94323017|NCT00077610|322963004|FG001|Overall Study|Renal transplant|15|||
94323018|NCT00077610|322963005|FG002|Overall Study|Renal transplant|11|||
94323019|NCT00077610|322963003|FG000|Overall Study|Withdrew from dialysis care|5|||
94323020|NCT00077610|322963004|FG001|Overall Study|Withdrew from dialysis care|0|||
94323021|NCT00077610|322963005|FG002|Overall Study|Withdrew from dialysis care|3|||
94323022|NCT00077610|322963003|FG000|Overall Study|Insufficient Therapeutic Response|1|||
94323023|NCT00077610|322963004|FG001|Overall Study|Insufficient Therapeutic Response|0|||
94323024|NCT00077610|322963005|FG002|Overall Study|Insufficient Therapeutic Response|0|||
94323025|NCT00077610|322963003|FG000|Overall Study|Multiple blood transfusions|0|||
94323026|NCT00077610|322963004|FG001|Overall Study|Multiple blood transfusions|0|||
94323027|NCT00077610|322963005|FG002|Overall Study|Multiple blood transfusions|1|||
94323028|NCT00077610|322963003|FG000|Overall Study|Principal Investigator's decision|1|||
94323029|NCT00077610|322963004|FG001|Overall Study|Principal Investigator's decision|0|||
94323030|NCT00077610|322963005|FG002|Overall Study|Principal Investigator's decision|1|||
94323031|NCT00077610|322963003|FG000|Overall Study|Worsening of health condition|1|||
94323032|NCT00077610|322963004|FG001|Overall Study|Worsening of health condition|1|||
94323033|NCT00077610|322963005|FG002|Overall Study|Worsening of health condition|0|||
94323034|NCT00077610|322963003|FG000|Overall Study|Given Epogen in hospital|1|||
94323035|NCT00077610|322963004|FG001|Overall Study|Given Epogen in hospital|0|||
94323036|NCT00077610|322963005|FG002|Overall Study|Given Epogen in hospital|0|||
94323037|NCT00077610|322963003|FG000|Overall Study|Transferred to other unit|0|||
94323038|NCT00077610|322963004|FG001|Overall Study|Transferred to other unit|0|||
94323039|NCT00077610|322963005|FG002|Overall Study|Transferred to other unit|1|||
94323040|NCT00077610|322963003|FG000|Overall Study|Transferred to nursing home|0|||
94323041|NCT00077610|322963004|FG001|Overall Study|Transferred to nursing home|0|||
94323042|NCT00077610|322963005|FG002|Overall Study|Transferred to nursing home|1|||
94323043|NCT00077610|322963003|FG000|Overall Study|Transfer to satellite unit|1|||
94323044|NCT00077610|322963004|FG001|Overall Study|Transfer to satellite unit|0|||
94323045|NCT00077610|322963005|FG002|Overall Study|Transfer to satellite unit|0|||
94323046|NCT00077610|322963003|FG000|Overall Study|Transfer to other center for surgery|1|||
94323047|NCT00077610|322963004|FG001|Overall Study|Transfer to other center for surgery|0|||
94323048|NCT00077610|322963005|FG002|Overall Study|Transfer to other center for surgery|0|||
94323049|NCT00077610|322963003|FG000|Overall Study|Change in dialysis modality|1|||
94323050|NCT00077610|322963004|FG001|Overall Study|Change in dialysis modality|0|||
94323051|NCT00077610|322963005|FG002|Overall Study|Change in dialysis modality|0|||
94323052|NCT00077610|322963003|FG000|Overall Study|Relocation|0|||
94323053|NCT00077610|322963004|FG001|Overall Study|Relocation|8|||
94323054|NCT00077610|322963005|FG002|Overall Study|Relocation|5|||
94323055|NCT00077610|322963003|FG000|Overall Study|Financial issues|0|||
94323056|NCT00077610|322963004|FG001|Overall Study|Financial issues|1|||
94323057|NCT00077610|322963005|FG002|Overall Study|Financial issues|0|||
94323058|NCT00077610|322963003|FG000|Overall Study|Sponsors decision to withdraw|0|||
94323059|NCT00077610|322963004|FG001|Overall Study|Sponsors decision to withdraw|0|||
94323060|NCT00077610|322963005|FG002|Overall Study|Sponsors decision to withdraw|1|||
94323061|NCT00305253|322963006|FG000|Overall Study|Withdrawal by Subject|0|||
94323062|NCT00305253|322963007|FG001|Overall Study|Withdrawal by Subject|1|||
94323063|NCT05086289|322963020|FG000|Overall Study|Adverse Event|4|||
94323064|NCT05086289|322963021|FG001|Overall Study|Adverse Event|2|||
94323065|NCT05086289|322963020|FG000|Overall Study|Lost to Follow-up|2|||
94323066|NCT05086289|322963021|FG001|Overall Study|Lost to Follow-up|0|||
94323067|NCT05086289|322963020|FG000|Overall Study|Non-compliance with study drug|2|||
94323068|NCT05086289|322963021|FG001|Overall Study|Non-compliance with study drug|1|||
94323069|NCT05086289|322963020|FG000|Overall Study|Physician Decision|2|||
94323070|NCT05086289|322963021|FG001|Overall Study|Physician Decision|0|||
94323071|NCT05086289|322963020|FG000|Overall Study|Withdrawal by Subject|5|||
94323072|NCT05086289|322963021|FG001|Overall Study|Withdrawal by Subject|2|||
94323073|NCT02045212|322963022|FG000|Overall Study|Adverse Event|0|||
94323074|NCT02045212|322963023|FG001|Overall Study|Adverse Event|1|||
94323075|NCT02045212|322963022|FG000|Overall Study|Withdrawal by Subject|1|||
94323076|NCT02045212|322963023|FG001|Overall Study|Withdrawal by Subject|0|||
94323077|NCT02045212|322963022|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
94323078|NCT02045212|322963023|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
94323079|NCT03970395|322963036|FG000|Overall Study|Withdrawal by Subject|3|||
94323080|NCT03970395|322963037|FG001|Overall Study|Withdrawal by Subject|4|||
94323081|NCT03970395|322963036|FG000|Overall Study|Lost to Follow-up|4|||
94323082|NCT03970395|322963037|FG001|Overall Study|Lost to Follow-up|8|||
94323083|NCT00621855|322963038|FG000|Overall Study|Adverse Event|32|||
94323084|NCT00621855|322963039|FG001|Overall Study|Adverse Event|31|||
94323085|NCT00621855|322963040|FG002|Overall Study|Adverse Event|48|||
94323086|NCT00621855|322963041|FG003|Overall Study|Adverse Event|34|||
94323087|NCT00621855|322963042|FG004|Overall Study|Adverse Event|31|||
94323088|NCT00621855|322963038|FG000|Overall Study|Lost to Follow-up|0|||
94323089|NCT00621855|322963039|FG001|Overall Study|Lost to Follow-up|1|||
94323090|NCT00621855|322963040|FG002|Overall Study|Lost to Follow-up|3|||
94323091|NCT00621855|322963041|FG003|Overall Study|Lost to Follow-up|4|||
94323092|NCT00621855|322963042|FG004|Overall Study|Lost to Follow-up|1|||
94323093|NCT00621855|322963038|FG000|Overall Study|Protocol Violation|16|||
94323094|NCT00621855|322963039|FG001|Overall Study|Protocol Violation|8|||
94323095|NCT00621855|322963040|FG002|Overall Study|Protocol Violation|6|||
94323096|NCT00621855|322963041|FG003|Overall Study|Protocol Violation|7|||
94323097|NCT00621855|322963042|FG004|Overall Study|Protocol Violation|8|||
94323098|NCT00621855|322963038|FG000|Overall Study|Withdrawal by Subject|16|||
94323099|NCT00621855|322963039|FG001|Overall Study|Withdrawal by Subject|11|||
94323100|NCT00621855|322963040|FG002|Overall Study|Withdrawal by Subject|13|||
94323101|NCT00621855|322963041|FG003|Overall Study|Withdrawal by Subject|13|||
94482441|NCT01211145|323558106|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
94482442|NCT01211145|323558107|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
94482443|NCT01211145|323558108|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
94482444|NCT01211145|323558109|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
94323102|NCT00621855|322963042|FG004|Overall Study|Withdrawal by Subject|9|||
94323103|NCT00621855|322963038|FG000|Overall Study|Other|9|||
94323104|NCT00621855|322963039|FG001|Overall Study|Other|7|||
94323105|NCT00621855|322963040|FG002|Overall Study|Other|6|||
94323106|NCT00621855|322963041|FG003|Overall Study|Other|5|||
94323107|NCT00621855|322963042|FG004|Overall Study|Other|4|||
94323108|NCT00621855|322963038|FG000|Overall Study|Patients did not receive study drug|3|||
94323109|NCT00621855|322963039|FG001|Overall Study|Patients did not receive study drug|3|||
94323110|NCT00621855|322963040|FG002|Overall Study|Patients did not receive study drug|5|||
94323111|NCT00621855|322963041|FG003|Overall Study|Patients did not receive study drug|4|||
94323112|NCT00621855|322963042|FG004|Overall Study|Patients did not receive study drug|2|||
94323113|NCT00125190|322963043|FG000|Overall Study|Subject/Parent Decision|7|||
94323114|NCT00125190|322963043|FG000|Overall Study|Non-compliance|2|||
94323115|NCT00125190|322963043|FG000|Overall Study|Adverse Event|1|||
94323116|NCT00125190|322963043|FG000|Overall Study|Other|1|||
94323117|NCT00125190|322963043|FG000|Overall Study|Lost to Follow-up|4|||
94323118|NCT02128763|322963045|FG000|Overall Study|Death|1|||
94323119|NCT02128763|322963046|FG001|Overall Study|Death|0|||
94323120|NCT02128763|322963045|FG000|Overall Study|Lost to Follow-up|19|||
94323121|NCT02128763|322963046|FG001|Overall Study|Lost to Follow-up|16|||
94323122|NCT01934192|322963047|FG000|Overall Study|Protocol Violation|0|||
94323123|NCT01934192|322963048|FG001|Overall Study|Protocol Violation|0|||
94323124|NCT01934192|322963049|FG002|Overall Study|Protocol Violation|0|||
94323125|NCT01934192|322963050|FG003|Overall Study|Protocol Violation|1|||
94323126|NCT01934192|322963047|FG000|Overall Study|Other: reached stopping criteria|6|||
94323127|NCT01934192|322963048|FG001|Overall Study|Other: reached stopping criteria|5|||
94323128|NCT01934192|322963049|FG002|Overall Study|Other: reached stopping criteria|1|||
94323129|NCT01934192|322963050|FG003|Overall Study|Other: reached stopping criteria|0|||
94323130|NCT01934192|322963047|FG000|Overall Study|Physician Decision|3|||
94323131|NCT01934192|322963048|FG001|Overall Study|Physician Decision|2|||
94323132|NCT01934192|322963049|FG002|Overall Study|Physician Decision|0|||
94323133|NCT01934192|322963050|FG003|Overall Study|Physician Decision|0|||
94323134|NCT01189435|322963051|FG000|Overall Study|Withdrawal by Subject|1|||
94323135|NCT01189435|322963051|FG000|Overall Study|Physician Decision|1|||
94323136|NCT02357849|322963054|FG000|Overall Study|Withdrawal by Subject|2|||
94323137|NCT02357849|322963055|FG001|Overall Study|Withdrawal by Subject|3|||
94323138|NCT01253421|322963058|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
94323139|NCT01253421|322963059|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
94323140|NCT01253421|322963060|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
94323141|NCT01253421|322963061|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
94323142|NCT01253421|322963062|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
94323143|NCT01253421|322963058|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
94323144|NCT01253421|322963059|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
94323145|NCT01253421|322963060|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
94482445|NCT01211145|323558106|FG000|Overall Study|Patient decision|2|||
94323146|NCT01253421|322963061|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
94323147|NCT01253421|322963062|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
94323148|NCT01253421|322963058|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
94323149|NCT01253421|322963059|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
94323150|NCT01253421|322963060|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
94323151|NCT01253421|322963061|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
94323152|NCT01253421|322963062|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
94323153|NCT01253421|322963058|FG000|Assessment and Scheduling|Physician Decision|1|||
94323154|NCT01253421|322963059|FG001|Assessment and Scheduling|Physician Decision|0|||
94323155|NCT01253421|322963060|FG002|Assessment and Scheduling|Physician Decision|0|||
94323156|NCT01253421|322963061|FG003|Assessment and Scheduling|Physician Decision|0|||
94323157|NCT01253421|322963062|FG004|Assessment and Scheduling|Physician Decision|0|||
94323158|NCT01253421|322963058|FG000|Drug+Scanning Visit|Physician Decision|0|||
94323159|NCT01253421|322963059|FG001|Drug+Scanning Visit|Physician Decision|0|||
94323160|NCT01253421|322963060|FG002|Drug+Scanning Visit|Physician Decision|0|||
94323161|NCT01253421|322963061|FG003|Drug+Scanning Visit|Physician Decision|0|||
94323162|NCT01253421|322963062|FG004|Drug+Scanning Visit|Physician Decision|1|||
94323163|NCT00929734|322963063|FG000|Overall Study|Lost to Follow-up|2|||
94323164|NCT00929734|322963064|FG001|Overall Study|Lost to Follow-up|1|||
94323165|NCT00929734|322963063|FG000|Overall Study|Withdrawal by Subject|0|||
94323166|NCT00929734|322963064|FG001|Overall Study|Withdrawal by Subject|2|||
94323167|NCT03282357|322963065|FG000|Overall Study|Lost to Follow-up|3|||
94323168|NCT03282357|322963065|FG000|Overall Study|Withdrawal by Subject|4|||
94323169|NCT03282357|322963065|FG000|Overall Study|Adverse Event|1|||
94323170|NCT03282357|322963065|FG000|Overall Study|Other|9|||
94323171|NCT01449682|322963066|FG000|Overall Study|Death|0|||
94323172|NCT01449682|322963067|FG001|Overall Study|Death|1|||
94323173|NCT01449682|322963066|FG000|Overall Study|Adverse Event|1|||
94323174|NCT01449682|322963067|FG001|Overall Study|Adverse Event|0|||
94323175|NCT04105244|322963068|FG000|Overall Study|Withdrawal by Subject|10|||
94323176|NCT04105244|322963069|FG001|Overall Study|Withdrawal by Subject|12|||
94323177|NCT04105244|322963068|FG000|Overall Study|Lost to Follow-up|20|||
94323178|NCT04105244|322963069|FG001|Overall Study|Lost to Follow-up|15|||
94323179|NCT04105244|322963068|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
94323180|NCT04105244|322963069|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
94323181|NCT04105244|322963068|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
94323182|NCT04105244|322963069|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
94323183|NCT02112994|322963070|FG000|Overall Study|Progressive Disease|0|||
94323184|NCT02112994|322963071|FG001|Overall Study|Progressive Disease|0|||
94323185|NCT02112994|322963072|FG002|Overall Study|Progressive Disease|1|||
94323186|NCT02112994|322963070|FG000|Overall Study|Pregnancy|0|||
94323187|NCT02112994|322963071|FG001|Overall Study|Pregnancy|1|||
94323188|NCT02112994|322963072|FG002|Overall Study|Pregnancy|1|||
94323189|NCT02112994|322963070|FG000|Overall Study|Liver Transplant|0|||
94323190|NCT02112994|322963071|FG001|Overall Study|Liver Transplant|1|||
94323191|NCT02112994|322963072|FG002|Overall Study|Liver Transplant|0|||
94323192|NCT02112994|322963070|FG000|Overall Study|Withdrawal by Subject|0|||
94323193|NCT02112994|322963071|FG001|Overall Study|Withdrawal by Subject|0|||
94323194|NCT02112994|322963072|FG002|Overall Study|Withdrawal by Subject|1|||
94323195|NCT04633473|322963076|FG000|Overall Study|Withdrawal by Subject|6|||
94323196|NCT00099359|322963081|FG000|Overall Study|Death|11|||
94323197|NCT00099359|322963082|FG001|Overall Study|Death|15|||
94323198|NCT00099359|322963083|FG002|Overall Study|Death|17|||
94323199|NCT00099359|322963081|FG000|Overall Study|Withdrawal by Subject|19|||
94323200|NCT00099359|322963082|FG001|Overall Study|Withdrawal by Subject|19|||
94323201|NCT00099359|322963083|FG002|Overall Study|Withdrawal by Subject|23|||
94323202|NCT00099359|322963081|FG000|Overall Study|Lost to Follow-up|15|||
94323203|NCT00099359|322963082|FG001|Overall Study|Lost to Follow-up|24|||
94323204|NCT00099359|322963083|FG002|Overall Study|Lost to Follow-up|24|||
94323205|NCT00099359|322963081|FG000|Overall Study|moved out of area|9|||
94323206|NCT00099359|322963082|FG001|Overall Study|moved out of area|7|||
94323207|NCT00099359|322963083|FG002|Overall Study|moved out of area|4|||
94323208|NCT01982773|322963084|FG000|Overall Study|Withdrawal by Subject|1|||
94323209|NCT01982773|322963085|FG001|Overall Study|Withdrawal by Subject|3|||
94323210|NCT01982773|322963084|FG000|Overall Study|Lost to Follow-up|7|||
94323211|NCT01982773|322963085|FG001|Overall Study|Lost to Follow-up|1|||
94323212|NCT03294681|322963086|FG000|Overall Study|Withdrawal by Subject|1|||
94323213|NCT02509494|322963087|FG000|Overall Study|Lost to Follow-up|8|||
94323214|NCT02509494|322963088|FG001|Overall Study|Lost to Follow-up|47|||
94323215|NCT02509494|322963089|FG002|Overall Study|Lost to Follow-up|19|||
94323216|NCT02509494|322963090|FG003|Overall Study|Lost to Follow-up|6|||
94323217|NCT02509494|322963091|FG004|Overall Study|Lost to Follow-up|3|||
94323218|NCT02509494|322963092|FG005|Overall Study|Lost to Follow-up|3|||
94323219|NCT02509494|322963093|FG006|Overall Study|Lost to Follow-up|1|||
94323220|NCT02509494|322963094|FG007|Overall Study|Lost to Follow-up|3|||
94323221|NCT02509494|322963095|FG008|Overall Study|Lost to Follow-up|1|||
94323222|NCT02509494|322963087|FG000|Overall Study|Physician Decision|2|||
94323223|NCT02509494|322963088|FG001|Overall Study|Physician Decision|1|||
94323224|NCT02509494|322963089|FG002|Overall Study|Physician Decision|0|||
94323225|NCT02509494|322963090|FG003|Overall Study|Physician Decision|0|||
94323226|NCT02509494|322963091|FG004|Overall Study|Physician Decision|0|||
94323227|NCT02509494|322963092|FG005|Overall Study|Physician Decision|0|||
94323228|NCT02509494|322963093|FG006|Overall Study|Physician Decision|0|||
94323229|NCT02509494|322963094|FG007|Overall Study|Physician Decision|0|||
94323230|NCT02509494|322963095|FG008|Overall Study|Physician Decision|0|||
94323231|NCT02509494|322963087|FG000|Overall Study|Withdrawal by Subject|4|||
94323232|NCT02509494|322963088|FG001|Overall Study|Withdrawal by Subject|17|||
94323233|NCT02509494|322963089|FG002|Overall Study|Withdrawal by Subject|7|||
94323234|NCT02509494|322963090|FG003|Overall Study|Withdrawal by Subject|5|||
94323235|NCT02509494|322963091|FG004|Overall Study|Withdrawal by Subject|0|||
94323236|NCT02509494|322963092|FG005|Overall Study|Withdrawal by Subject|6|||
94323237|NCT02509494|322963093|FG006|Overall Study|Withdrawal by Subject|1|||
94323238|NCT02509494|322963094|FG007|Overall Study|Withdrawal by Subject|2|||
94323239|NCT02509494|322963095|FG008|Overall Study|Withdrawal by Subject|1|||
94323240|NCT02509494|322963087|FG000|Overall Study|Death|0|||
94323241|NCT02509494|322963088|FG001|Overall Study|Death|1|||
94323242|NCT02509494|322963089|FG002|Overall Study|Death|0|||
94323243|NCT02509494|322963090|FG003|Overall Study|Death|0|||
94323244|NCT02509494|322963091|FG004|Overall Study|Death|1|||
94323245|NCT02509494|322963092|FG005|Overall Study|Death|0|||
94323246|NCT02509494|322963093|FG006|Overall Study|Death|0|||
94323247|NCT02509494|322963094|FG007|Overall Study|Death|1|||
94323248|NCT02509494|322963095|FG008|Overall Study|Death|0|||
94323249|NCT02509494|322963087|FG000|Overall Study|Other|0|||
94323250|NCT02509494|322963088|FG001|Overall Study|Other|4|||
94323251|NCT02509494|322963089|FG002|Overall Study|Other|5|||
94323252|NCT02509494|322963090|FG003|Overall Study|Other|0|||
94323253|NCT02509494|322963091|FG004|Overall Study|Other|0|||
94323254|NCT02509494|322963092|FG005|Overall Study|Other|0|||
94323255|NCT02509494|322963093|FG006|Overall Study|Other|0|||
94323256|NCT02509494|322963094|FG007|Overall Study|Other|0|||
94323257|NCT02509494|322963095|FG008|Overall Study|Other|0|||
94323258|NCT02509494|322963087|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94323259|NCT02509494|322963088|FG001|Overall Study|Non-Compliance With Study Drug|11|||
94323260|NCT02509494|322963089|FG002|Overall Study|Non-Compliance With Study Drug|7|||
94323261|NCT02509494|322963090|FG003|Overall Study|Non-Compliance With Study Drug|0|||
94323262|NCT02509494|322963091|FG004|Overall Study|Non-Compliance With Study Drug|1|||
94323263|NCT02509494|322963092|FG005|Overall Study|Non-Compliance With Study Drug|2|||
94323264|NCT02509494|322963093|FG006|Overall Study|Non-Compliance With Study Drug|1|||
94323265|NCT02509494|322963094|FG007|Overall Study|Non-Compliance With Study Drug|1|||
94323266|NCT02509494|322963095|FG008|Overall Study|Non-Compliance With Study Drug|0|||
94323267|NCT01348425|322963096|FG000|Overall Study|Imaging was not taken.|1|||
94323268|NCT01348425|322963097|FG001|Overall Study|Imaging was not taken.|1|||
94323269|NCT01185249|322963098|FG000|Overall Study|Patients discharged or change in status|42|||
94323270|NCT02115113|322964839|FG000|Participants in Run-in Period|Death|0|||
94323271|NCT02115113|322964840|FG001|Participants in Run-in Period|Death|0|||
94323272|NCT02115113|322964841|FG002|Participants in Run-in Period|Death|1|||
94323273|NCT02115113|322964839|FG000|Participants in Run-in Period|Administrative problems|0|||
94323274|NCT02115113|322964840|FG001|Participants in Run-in Period|Administrative problems|0|||
94323275|NCT02115113|322964841|FG002|Participants in Run-in Period|Administrative problems|1|||
94323276|NCT02115113|322964839|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
94323277|NCT02115113|322964840|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
94323278|NCT02115113|322964841|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
94323279|NCT02115113|322964839|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
94323280|NCT02115113|322964840|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
94323281|NCT02115113|322964841|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
94323282|NCT02115113|322964839|FG000|Participants Randomized|Lost to Follow-up|1|||
94323283|NCT02115113|322964840|FG001|Participants Randomized|Lost to Follow-up|0|||
94323284|NCT02115113|322964841|FG002|Participants Randomized|Lost to Follow-up|0|||
94323285|NCT02115113|322964839|FG000|Participants Randomized|Death|1|||
94323286|NCT02115113|322964840|FG001|Participants Randomized|Death|0|||
94323287|NCT02115113|322964841|FG002|Participants Randomized|Death|0|||
94323288|NCT00789191|322964845|FG000|Overall Study|Adverse Event|2|||
94323289|NCT00789191|322964846|FG001|Overall Study|Adverse Event|4|||
94323290|NCT00789191|322964845|FG000|Overall Study|Lack of Efficacy|0|||
94323291|NCT00789191|322964846|FG001|Overall Study|Lack of Efficacy|5|||
94323292|NCT00789191|322964845|FG000|Overall Study|Protocol Violation|5|||
94323293|NCT00789191|322964846|FG001|Overall Study|Protocol Violation|3|||
94323294|NCT00789191|322964845|FG000|Overall Study|Withdrawal Criteria|2|||
94323295|NCT00789191|322964846|FG001|Overall Study|Withdrawal Criteria|4|||
94323296|NCT00789191|322964845|FG000|Overall Study|Unclassified|5|||
94323297|NCT00789191|322964846|FG001|Overall Study|Unclassified|3|||
94323298|NCT01009983|322964847|FG000|Overall Study|necessary scans not completed|1|||
94323299|NCT02395653|322964848|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
94323300|NCT02395653|322964848|FG000|Overall Study|Consent Withdrawn at Screening|1|||
94323301|NCT02395653|322964848|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
94323302|NCT02395653|322964848|FG000|Overall Study|Investigator Decision at Screening|1|||
94323303|NCT02395653|322964848|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
94323304|NCT02395653|322964848|FG000|Overall Study|Withdrawal by Subject|1|||
94323305|NCT02395653|322964848|FG000|Overall Study|Lost to Follow-up|1|||
94323306|NCT02670915|322964849|FG000|Overall Study|Withdrawal by Subject|0|||
94323307|NCT02670915|322964850|FG001|Overall Study|Withdrawal by Subject|1|||
94323308|NCT02670915|322964851|FG002|Overall Study|Withdrawal by Subject|4|||
94323309|NCT02670915|322964849|FG000|Overall Study|Withdrawal by parent/guardian|4|||
94323310|NCT02670915|322964850|FG001|Overall Study|Withdrawal by parent/guardian|4|||
94323311|NCT02670915|322964851|FG002|Overall Study|Withdrawal by parent/guardian|1|||
94323312|NCT02670915|322964849|FG000|Overall Study|Unclassified|0|||
94323313|NCT02670915|322964850|FG001|Overall Study|Unclassified|3|||
94323314|NCT02670915|322964851|FG002|Overall Study|Unclassified|0|||
94323315|NCT00818207|322964855|FG000|Overall Study|Adverse Event|6|||
94323316|NCT00818207|322964856|FG001|Overall Study|Adverse Event|0|||
94323317|NCT00818207|322964855|FG000|Overall Study|Lost to Follow-up|160|||
94323318|NCT00818207|322964856|FG001|Overall Study|Lost to Follow-up|146|||
94323319|NCT00818207|322964855|FG000|Overall Study|Multiple reasons|11|||
94323320|NCT00818207|322964856|FG001|Overall Study|Multiple reasons|12|||
94323321|NCT00818207|322964855|FG000|Overall Study|Withdrawal by Subject|42|||
94323322|NCT00818207|322964856|FG001|Overall Study|Withdrawal by Subject|104|||
94323323|NCT00818207|322964855|FG000|Overall Study|Death|3|||
94323324|NCT00818207|322964856|FG001|Overall Study|Death|5|||
94323325|NCT02616185|322964857|FG000|Overall Study|Death|0|||
94323326|NCT02616185|322964858|FG001|Overall Study|Death|0|||
94323327|NCT02616185|322964859|FG002|Overall Study|Death|0|||
94323328|NCT02616185|322964860|FG003|Overall Study|Death|1|||
94323329|NCT02616185|322964861|FG004|Overall Study|Death|2|||
94323330|NCT02616185|322964862|FG005|Overall Study|Death|0|||
94323331|NCT02616185|322964863|FG006|Overall Study|Death|0|||
94323332|NCT02616185|322964864|FG007|Overall Study|Death|2|||
94323333|NCT02616185|322964865|FG008|Overall Study|Death|1|||
94323334|NCT02616185|322964857|FG000|Overall Study|Study terminated by sponsor|0|||
94323335|NCT02616185|322964858|FG001|Overall Study|Study terminated by sponsor|0|||
94323336|NCT02616185|322964859|FG002|Overall Study|Study terminated by sponsor|1|||
94323337|NCT02616185|322964860|FG003|Overall Study|Study terminated by sponsor|0|||
94323338|NCT02616185|322964861|FG004|Overall Study|Study terminated by sponsor|0|||
94323339|NCT02616185|322964862|FG005|Overall Study|Study terminated by sponsor|0|||
94323340|NCT02616185|322964863|FG006|Overall Study|Study terminated by sponsor|5|||
94323341|NCT02616185|322964864|FG007|Overall Study|Study terminated by sponsor|2|||
94323342|NCT02616185|322964865|FG008|Overall Study|Study terminated by sponsor|0|||
94323343|NCT02616185|322964857|FG000|Overall Study|Participant refused further follow-up|1|||
94323344|NCT02616185|322964858|FG001|Overall Study|Participant refused further follow-up|1|||
94323345|NCT02616185|322964859|FG002|Overall Study|Participant refused further follow-up|2|||
94323346|NCT02616185|322964860|FG003|Overall Study|Participant refused further follow-up|3|||
94323347|NCT02616185|322964861|FG004|Overall Study|Participant refused further follow-up|4|||
94323348|NCT02616185|322964862|FG005|Overall Study|Participant refused further follow-up|0|||
94323349|NCT02616185|322964863|FG006|Overall Study|Participant refused further follow-up|3|||
94482446|NCT01211145|323558107|FG001|Overall Study|Patient decision|1|||
94482447|NCT01211145|323558108|FG002|Overall Study|Patient decision|0|||
94482448|NCT01211145|323558109|FG003|Overall Study|Patient decision|2|||
94482449|NCT05607576|323558112|FG000|Overall Study|immediate sensor error|2|||
94482450|NCT05607576|323558112|FG000|Overall Study|Physician Decision|2|||
94482451|NCT04467515|323558113|FG000|Overall Study|Lost to Follow-up|1|||
94482452|NCT04467515|323558114|FG001|Overall Study|Lost to Follow-up|0|||
94482453|NCT04467515|323558115|FG002|Overall Study|Lost to Follow-up|0|||
94482454|NCT04467515|323558113|FG000|Overall Study|Withdrawal by Subject|1|||
94482455|NCT04467515|323558114|FG001|Overall Study|Withdrawal by Subject|0|||
94482456|NCT04467515|323558115|FG002|Overall Study|Withdrawal by Subject|1|||
94323350|NCT02616185|322964864|FG007|Overall Study|Participant refused further follow-up|4|||
94323351|NCT02616185|322964865|FG008|Overall Study|Participant refused further follow-up|3|||
94323352|NCT02616185|322964857|FG000|Overall Study|Not reported|0|||
94323353|NCT02616185|322964858|FG001|Overall Study|Not reported|0|||
94323354|NCT02616185|322964859|FG002|Overall Study|Not reported|0|||
94323355|NCT02616185|322964860|FG003|Overall Study|Not reported|1|||
94323356|NCT02616185|322964861|FG004|Overall Study|Not reported|3|||
94323357|NCT02616185|322964862|FG005|Overall Study|Not reported|1|||
94323358|NCT02616185|322964863|FG006|Overall Study|Not reported|0|||
94323359|NCT02616185|322964864|FG007|Overall Study|Not reported|5|||
94323360|NCT02616185|322964865|FG008|Overall Study|Not reported|2|||
94323361|NCT02494778|322964866|FG000|Overall Study|Death|3|||
94323362|NCT02494778|322964866|FG000|Overall Study|Other|173|||
94482457|NCT04467515|323558113|FG000|Overall Study|Progressive Disease|0|||
94482458|NCT04467515|323558114|FG001|Overall Study|Progressive Disease|1|||
94323363|NCT02494778|322964866|FG000|Overall Study|Lack of Efficacy|4|||
94323364|NCT02494778|322964866|FG000|Overall Study|Adverse Event|18|||
94323365|NCT02494778|322964866|FG000|Overall Study|Withdrawal by Subject|20|||
94323366|NCT02494778|322964866|FG000|Overall Study|Lost to Follow-up|2|||
94323367|NCT02494778|322964866|FG000|Overall Study|Noncompliant with study drug admin.|1|||
94323368|NCT00296725|322964869|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
94323369|NCT00296725|322964869|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
94323370|NCT00296725|322964869|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
94323371|NCT02622724|322964870|FG000|Overall Study|Death|51|||
94323372|NCT02622724|322964871|FG001|Overall Study|Death|53|||
94323373|NCT02622724|322964870|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
94323374|NCT02622724|322964871|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
94323375|NCT02622724|322964870|FG000|Overall Study|Early termination of study|38|||
94323376|NCT02622724|322964871|FG001|Overall Study|Early termination of study|43|||
94323377|NCT00487084|322964874|FG000|Overall Study|Did not receive intervention|4|||
94323378|NCT00487084|322964875|FG001|Overall Study|Did not receive intervention|3|||
94323379|NCT00487084|322964876|FG002|Overall Study|Did not receive intervention|5|||
94323380|NCT00356863|322964877|FG000|Overall Study|Death|16|||
94323381|NCT00356863|322964878|FG001|Overall Study|Death|32|||
94323382|NCT00356863|322964877|FG000|Overall Study|Lost to Follow-up|76|||
94323383|NCT00356863|322964878|FG001|Overall Study|Lost to Follow-up|43|||
94323384|NCT00333619|322964884|FG000|Overall Study|Death|12|||
94323385|NCT00333619|322964885|FG001|Overall Study|Death|6|||
94323386|NCT00333619|322964884|FG000|Overall Study|Withdrawal by Subject|6|||
94323387|NCT00333619|322964885|FG001|Overall Study|Withdrawal by Subject|1|||
94323388|NCT00333619|322964884|FG000|Overall Study|Lost to Follow-up|3|||
94323389|NCT00333619|322964885|FG001|Overall Study|Lost to Follow-up|3|||
94323390|NCT03446651|322964888|FG000|Overall Study|Lost to Follow-up|4|||
94323391|NCT03446651|322964889|FG001|Overall Study|Lost to Follow-up|0|||
94323392|NCT03446651|322964888|FG000|Overall Study|Open Label Participants|5|||
94323393|NCT03446651|322964889|FG001|Overall Study|Open Label Participants|0|||
94323394|NCT03712345|322964892|FG000|Overall Study|Failure to meet randomization criteria|0|||
94323395|NCT03712345|322964893|FG001|Overall Study|Failure to meet randomization criteria|0|||
94323396|NCT03712345|322964894|FG002|Overall Study|Failure to meet randomization criteria|1|||
94323397|NCT02156492|322964897|FG000|Period 1|No Reason Given|0|||
94323398|NCT02156492|322964898|FG001|Period 1|No Reason Given|1|||
94323399|NCT02156492|322964899|FG002|Period 1|No Reason Given|0|||
94323400|NCT02156492|322964897|FG000|Period 3|Adverse Event|0|||
94323401|NCT02156492|322964898|FG001|Period 3|Adverse Event|1|||
94323402|NCT02156492|322964899|FG002|Period 3|Adverse Event|0|||
94323403|NCT02420223|322964906|FG000|Overall Study|Adverse Event|1|||
94323404|NCT02420223|322964907|FG001|Overall Study|Adverse Event|0|||
94323405|NCT02420223|322964906|FG000|Overall Study|Physician Decision|0|||
94323406|NCT02420223|322964907|FG001|Overall Study|Physician Decision|2|||
94323407|NCT01332019|322964908|FG000|Overall Study|Was Not Dosed|1|||
94323408|NCT01332019|322964909|FG001|Overall Study|Was Not Dosed|0|||
94323409|NCT01332019|322964908|FG000|Overall Study|Other|16|||
94323410|NCT01332019|322964909|FG001|Overall Study|Other|18|||
94323411|NCT01332019|322964908|FG000|Overall Study|Death|2|||
94323412|NCT01332019|322964909|FG001|Overall Study|Death|1|||
94323413|NCT01332019|322964908|FG000|Overall Study|Physician Decision|4|||
94323414|NCT01332019|322964909|FG001|Overall Study|Physician Decision|3|||
94323415|NCT01332019|322964908|FG000|Overall Study|Withdrawal by Subject|73|||
94323416|NCT01332019|322964909|FG001|Overall Study|Withdrawal by Subject|71|||
94323417|NCT01332019|322964908|FG000|Overall Study|Lost to Follow-up|4|||
94323418|NCT01332019|322964909|FG001|Overall Study|Lost to Follow-up|7|||
94323419|NCT01332019|322964908|FG000|Overall Study|Adverse Event|13|||
94323420|NCT01332019|322964909|FG001|Overall Study|Adverse Event|22|||
94323421|NCT02924688|322964912|FG000|Overall Study|Adverse Event|9|||
94323422|NCT02924688|322964913|FG001|Overall Study|Adverse Event|3|||
94323423|NCT02924688|322964914|FG002|Overall Study|Adverse Event|2|||
94323424|NCT02924688|322964915|FG003|Overall Study|Adverse Event|2|||
94387831|NCT00385593|323207748|FG000|Overall Study|Withdrawal by Subject|17|||
94323425|NCT02924688|322964916|FG004|Overall Study|Adverse Event|3|||
94323426|NCT02924688|322964917|FG005|Overall Study|Adverse Event|2|||
94323427|NCT02924688|322964912|FG000|Overall Study|Lack of Efficacy|2|||
94323428|NCT02924688|322964913|FG001|Overall Study|Lack of Efficacy|3|||
94323429|NCT02924688|322964914|FG002|Overall Study|Lack of Efficacy|4|||
94323430|NCT02924688|322964915|FG003|Overall Study|Lack of Efficacy|2|||
94323431|NCT02924688|322964916|FG004|Overall Study|Lack of Efficacy|1|||
94323432|NCT02924688|322964917|FG005|Overall Study|Lack of Efficacy|1|||
94323433|NCT02924688|322964912|FG000|Overall Study|Protocol Violation|3|||
94323434|NCT02924688|322964913|FG001|Overall Study|Protocol Violation|7|||
94323435|NCT02924688|322964914|FG002|Overall Study|Protocol Violation|5|||
94387832|NCT00385593|323207749|FG001|Overall Study|Withdrawal by Subject|7|||
94323436|NCT02924688|322964915|FG003|Overall Study|Protocol Violation|6|||
94323437|NCT02924688|322964916|FG004|Overall Study|Protocol Violation|2|||
94323438|NCT02924688|322964917|FG005|Overall Study|Protocol Violation|2|||
94323439|NCT02924688|322964912|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
94387833|NCT00385593|323207748|FG000|Overall Study|Lost to Follow-up|12|||
94482459|NCT04467515|323558115|FG002|Overall Study|Progressive Disease|3|||
94482460|NCT04467515|323558113|FG000|Overall Study|Death|0|||
94482461|NCT04467515|323558114|FG001|Overall Study|Death|1|||
94482462|NCT04467515|323558115|FG002|Overall Study|Death|0|||
94482463|NCT05067972|323558116|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
94482464|NCT05067972|323558117|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
94482465|NCT05067972|323558118|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
94482466|NCT05067972|323558119|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
94482467|NCT05067972|323558120|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
94482468|NCT05067972|323558121|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
94482469|NCT05067972|323558122|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
94482470|NCT05067972|323558116|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
94482471|NCT05067972|323558117|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
94482472|NCT05067972|323558118|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
94482473|NCT05067972|323558119|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
94482474|NCT05067972|323558120|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
94482475|NCT05067972|323558121|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
94482476|NCT05067972|323558122|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
94482477|NCT05067972|323558116|FG000|Part 1: Treatment|Progressive Disease|3|||
94482478|NCT05067972|323558117|FG001|Part 1: Treatment|Progressive Disease|3|||
94482479|NCT05067972|323558118|FG002|Part 1: Treatment|Progressive Disease|4|||
94482480|NCT05067972|323558119|FG003|Part 1: Treatment|Progressive Disease|2|||
94482481|NCT05067972|323558120|FG004|Part 1: Treatment|Progressive Disease|3|||
94482482|NCT05067972|323558121|FG005|Part 1: Treatment|Progressive Disease|0|||
94323440|NCT02924688|322964913|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
94323441|NCT02924688|322964914|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
94323442|NCT02924688|322964915|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
94323443|NCT02924688|322964916|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
94323444|NCT02924688|322964917|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
94323445|NCT02924688|322964912|FG000|Overall Study|Lost to Follow-up|2|||
94323446|NCT02924688|322964913|FG001|Overall Study|Lost to Follow-up|4|||
94323447|NCT02924688|322964914|FG002|Overall Study|Lost to Follow-up|2|||
94323448|NCT02924688|322964915|FG003|Overall Study|Lost to Follow-up|4|||
94323449|NCT02924688|322964916|FG004|Overall Study|Lost to Follow-up|2|||
94323450|NCT02924688|322964917|FG005|Overall Study|Lost to Follow-up|4|||
94323451|NCT02924688|322964912|FG000|Overall Study|Physician Decision|2|||
94323452|NCT02924688|322964913|FG001|Overall Study|Physician Decision|1|||
94323453|NCT02924688|322964914|FG002|Overall Study|Physician Decision|0|||
94323454|NCT02924688|322964915|FG003|Overall Study|Physician Decision|1|||
94323455|NCT02924688|322964916|FG004|Overall Study|Physician Decision|1|||
94323456|NCT02924688|322964917|FG005|Overall Study|Physician Decision|1|||
94323457|NCT02924688|322964912|FG000|Overall Study|Withdrawal by Subject|14|||
94323458|NCT02924688|322964913|FG001|Overall Study|Withdrawal by Subject|13|||
94323459|NCT02924688|322964914|FG002|Overall Study|Withdrawal by Subject|9|||
94323460|NCT02924688|322964915|FG003|Overall Study|Withdrawal by Subject|12|||
94323461|NCT02924688|322964916|FG004|Overall Study|Withdrawal by Subject|13|||
94323462|NCT02924688|322964917|FG005|Overall Study|Withdrawal by Subject|14|||
94323463|NCT01093755|322964918|FG000|Overall Study|Withdrawal by Subject|3|||
94323464|NCT01093755|322964919|FG001|Overall Study|Withdrawal by Subject|4|||
94323465|NCT03115112|322964920|FG000|Overall Study|Adverse Event|5|||
94323466|NCT03115112|322964921|FG001|Overall Study|Adverse Event|1|||
94323467|NCT03115112|322964920|FG000|Overall Study|Withdrawal by Subject|4|||
94323468|NCT03115112|322964921|FG001|Overall Study|Withdrawal by Subject|2|||
94323469|NCT03115112|322964920|FG000|Overall Study|Lost to Follow-up|0|||
94323470|NCT03115112|322964921|FG001|Overall Study|Lost to Follow-up|1|||
94387834|NCT00385593|323207749|FG001|Overall Study|Lost to Follow-up|8|||
94387835|NCT00385593|323207748|FG000|Overall Study|Protocol Violation|7|||
94387836|NCT00385593|323207749|FG001|Overall Study|Protocol Violation|4|||
94387837|NCT00385593|323207748|FG000|Overall Study|Several reasons|17|||
94387838|NCT00385593|323207749|FG001|Overall Study|Several reasons|15|||
94387839|NCT00385593|323207748|FG000|Overall Study|Incorrect inclusion|2|||
94387840|NCT00385593|323207749|FG001|Overall Study|Incorrect inclusion|0|||
94387841|NCT00385593|323207748|FG000|Overall Study|Incorrect randomization|0|||
94387842|NCT00385593|323207749|FG001|Overall Study|Incorrect randomization|1|||
94387843|NCT03725605|323207750|FG000|Overall Study|Unsuccessful TIL expansion|2|||
94323471|NCT03115112|322964920|FG000|Overall Study|Death|1|||
94323472|NCT03115112|322964921|FG001|Overall Study|Death|0|||
94323473|NCT03115112|322964920|FG000|Overall Study|Pregnancy|1|||
94323474|NCT03115112|322964921|FG001|Overall Study|Pregnancy|0|||
94323475|NCT03115112|322964920|FG000|Overall Study|Site closure|1|||
94387844|NCT02421952|323207754|FG000|Overall Study|Diary Not Returned|93|||
94387845|NCT02421952|323207754|FG000|Overall Study|Failed seriation task|13|||
94387846|NCT02421952|323207754|FG000|Overall Study|Subject uncooperative for baseline test|2|||
94482483|NCT05067972|323558122|FG006|Part 1: Treatment|Progressive Disease|2|||
94482484|NCT05067972|323558116|FG000|Part 1: Treatment|Physician Decision|0|||
94482485|NCT05067972|323558117|FG001|Part 1: Treatment|Physician Decision|0|||
94323476|NCT03115112|322964921|FG001|Overall Study|Site closure|1|||
94323477|NCT02168803|322964922|FG000|Overall Study|Lost to Follow-up|1|||
94323478|NCT02168803|322964923|FG001|Overall Study|Lost to Follow-up|0|||
94323479|NCT02168803|322964924|FG002|Overall Study|Lost to Follow-up|1|||
94323480|NCT02168803|322964922|FG000|Overall Study|Withdrawal by Subject|1|||
94323481|NCT02168803|322964923|FG001|Overall Study|Withdrawal by Subject|1|||
94323482|NCT02168803|322964924|FG002|Overall Study|Withdrawal by Subject|2|||
94323483|NCT02168803|322964922|FG000|Overall Study|Physician Decision|0|||
94323484|NCT02168803|322964923|FG001|Overall Study|Physician Decision|1|||
94323485|NCT02168803|322964924|FG002|Overall Study|Physician Decision|0|||
94323486|NCT02168803|322964922|FG000|Overall Study|Adverse Event|0|||
94323487|NCT02168803|322964923|FG001|Overall Study|Adverse Event|1|||
94323488|NCT02168803|322964924|FG002|Overall Study|Adverse Event|1|||
94323489|NCT02168803|322964922|FG000|Overall Study|Death|0|||
94323490|NCT02168803|322964923|FG001|Overall Study|Death|0|||
94323491|NCT02168803|322964924|FG002|Overall Study|Death|1|||
94323492|NCT02168803|322964922|FG000|Overall Study|Sponsor Decision|0|||
94323493|NCT02168803|322964923|FG001|Overall Study|Sponsor Decision|0|||
94323494|NCT02168803|322964924|FG002|Overall Study|Sponsor Decision|1|||
94323495|NCT01170702|322964926|FG000|Overall Study|Exclusion criteria met after consent|1|||
94323496|NCT01170702|322964927|FG001|Overall Study|Exclusion criteria met after consent|2|||
94323497|NCT01170702|322964928|FG002|Overall Study|Exclusion criteria met after consent|0|||
94323498|NCT01170702|322964929|FG003|Overall Study|Exclusion criteria met after consent|2|||
94323499|NCT02106455|322964934|FG000|Overall Study|Case Report Form Uncollected|6|||
94323500|NCT02106455|322964934|FG000|Overall Study|Protocol Deviation|2|||
94323501|NCT00229203|322964935|FG000|Overall Study|Progressive disease|18|||
94323502|NCT00229203|322964936|FG001|Overall Study|Progressive disease|9|||
94323503|NCT00229203|322964935|FG000|Overall Study|Toxicity|6|||
94323504|NCT00229203|322964936|FG001|Overall Study|Toxicity|1|||
94323505|NCT00229203|322964935|FG000|Overall Study|Death|4|||
94323506|NCT00229203|322964936|FG001|Overall Study|Death|2|||
94323507|NCT00229203|322964935|FG000|Overall Study|Other|3|||
94323508|NCT00229203|322964936|FG001|Overall Study|Other|3|||
94323509|NCT00229203|322964935|FG000|Overall Study|Withdrawal by Subject|1|||
94323510|NCT00229203|322964936|FG001|Overall Study|Withdrawal by Subject|4|||
94323511|NCT00501046|322964937|FG000|Overall Study|Adverse Event|21|||
94323512|NCT00501046|322964938|FG001|Overall Study|Adverse Event|25|||
94323513|NCT00501046|322964937|FG000|Overall Study|Death|23|||
94323514|NCT00501046|322964938|FG001|Overall Study|Death|30|||
94323515|NCT00501046|322964937|FG000|Overall Study|Lost to Follow-up|14|||
94323516|NCT00501046|322964938|FG001|Overall Study|Lost to Follow-up|13|||
94323517|NCT00501046|322964937|FG000|Overall Study|Physician Decision|7|||
94323518|NCT00501046|322964938|FG001|Overall Study|Physician Decision|2|||
94323519|NCT00501046|322964937|FG000|Overall Study|Pregnancy|0|||
94323520|NCT00501046|322964938|FG001|Overall Study|Pregnancy|3|||
94323521|NCT00501046|322964937|FG000|Overall Study|Protocol Violation|2|||
94323522|NCT00501046|322964938|FG001|Overall Study|Protocol Violation|1|||
94323523|NCT00501046|322964937|FG000|Overall Study|Withdrawal by Subject|84|||
94323524|NCT00501046|322964938|FG001|Overall Study|Withdrawal by Subject|83|||
94323525|NCT00501046|322964937|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
94323526|NCT00501046|322964938|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
94323527|NCT03457103|322964939|FG000|Overall Study|illness/hospitalization|4|||
94323528|NCT03457103|322964940|FG001|Overall Study|illness/hospitalization|2|||
94323529|NCT03457103|322964939|FG000|Overall Study|Lost to Follow-up|2|||
94323530|NCT03457103|322964940|FG001|Overall Study|Lost to Follow-up|1|||
94323531|NCT03457103|322964939|FG000|Overall Study|Withdrawal by Subject|1|||
94323532|NCT03457103|322964940|FG001|Overall Study|Withdrawal by Subject|2|||
94323533|NCT03457103|322964939|FG000|Overall Study|financial/ insurance issues|1|||
94323534|NCT03457103|322964940|FG001|Overall Study|financial/ insurance issues|1|||
94323535|NCT04321252|322964941|FG000|Overall Study|Withdrawal by Subject|0|||
94323536|NCT04321252|322964942|FG001|Overall Study|Withdrawal by Subject|0|||
94323537|NCT04321252|322964943|FG002|Overall Study|Withdrawal by Subject|0|||
94323538|NCT04321252|322964944|FG003|Overall Study|Withdrawal by Subject|0|||
94323539|NCT04321252|322964945|FG004|Overall Study|Withdrawal by Subject|0|||
94323540|NCT04321252|322964946|FG005|Overall Study|Withdrawal by Subject|1|||
94323541|NCT04321252|322964947|FG006|Overall Study|Withdrawal by Subject|0|||
94323542|NCT04321252|322964948|FG007|Overall Study|Withdrawal by Subject|0|||
94323543|NCT04321252|322964949|FG008|Overall Study|Withdrawal by Subject|0|||
94323544|NCT00259740|322964950|FG000|Overall Study|Physician Decision|1|||
94323545|NCT00259740|322964951|FG001|Overall Study|Physician Decision|1|||
94323546|NCT00259740|322964950|FG000|Overall Study|Adverse Event|0|||
94323547|NCT00259740|322964951|FG001|Overall Study|Adverse Event|2|||
94387847|NCT02421952|323207754|FG000|Overall Study|Surgery cancelled|1|||
94323548|NCT00259740|322964950|FG000|Overall Study|Withdrawal by Subject|2|||
94323549|NCT00259740|322964951|FG001|Overall Study|Withdrawal by Subject|6|||
94323550|NCT00259740|322964950|FG000|Overall Study|Death|1|||
94323551|NCT00259740|322964951|FG001|Overall Study|Death|1|||
94323552|NCT00259740|322964950|FG000|Overall Study|Disease progression|19|||
94323553|NCT00259740|322964951|FG001|Overall Study|Disease progression|36|||
94323554|NCT00259740|322964950|FG000|Overall Study|Ongoing|17|||
94323555|NCT00259740|322964951|FG001|Overall Study|Ongoing|3|||
94323556|NCT00259740|322964950|FG000|Overall Study|Other|3|||
94323557|NCT00259740|322964951|FG001|Overall Study|Other|0|||
94323558|NCT00259740|322964950|FG000|Overall Study|Requirement for alternative therapy|0|||
94323559|NCT00259740|322964951|FG001|Overall Study|Requirement for alternative therapy|4|||
94323560|NCT00194025|322964952|FG000|Overall Study|Adverse Event|1|||
94323561|NCT00194025|322964952|FG000|Overall Study|non-adherence with study medication|4|||
94323562|NCT03341923|322964954|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
94323563|NCT03341923|322964955|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
94323564|NCT02432040|322964956|FG000|Overall Study|Lack of Efficacy|3|||
94323565|NCT02432040|322964957|FG001|Overall Study|Lack of Efficacy|0|||
94323566|NCT02432040|322964956|FG000|Overall Study|Lost to Follow-up|4|||
94323567|NCT02432040|322964957|FG001|Overall Study|Lost to Follow-up|5|||
94323568|NCT02432040|322964956|FG000|Overall Study|Physician Decision|1|||
94323569|NCT02432040|322964957|FG001|Overall Study|Physician Decision|1|||
94323570|NCT01952730|322964959|FG000|Overall Study|FDA shut down core lab used by study|1|||
94323571|NCT01098461|322964960|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
94323572|NCT01098461|322964961|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
94323573|NCT01098461|322964962|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
94323574|NCT01098461|322964963|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
94323575|NCT01098461|322964960|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
94323576|NCT01098461|322964961|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
94323577|NCT01098461|322964962|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
94323578|NCT01098461|322964963|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
94323579|NCT01098461|322964960|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
94323580|NCT01098461|322964961|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
94323581|NCT01098461|322964962|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
94323582|NCT01098461|322964963|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
94323583|NCT01098461|322964960|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
94323584|NCT01098461|322964961|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
94323585|NCT01098461|322964962|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
94323586|NCT01098461|322964963|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
94323587|NCT01098461|322964960|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
94323588|NCT01098461|322964961|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
94323589|NCT01098461|322964962|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
94323590|NCT01098461|322964963|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
94323591|NCT01098461|322964960|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
94323592|NCT01098461|322964961|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
94323593|NCT01098461|322964962|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
94323594|NCT01098461|322964963|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
94323595|NCT01098461|322964960|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
94323596|NCT01098461|322964961|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
94323597|NCT01098461|322964962|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
94323598|NCT01098461|322964963|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
94323599|NCT03442829|322964965|FG000|Overall Study|Scheduling clash|3|||
94323600|NCT03442829|322964966|FG001|Overall Study|Scheduling clash|1|||
94323601|NCT03442829|322964965|FG000|Overall Study|Illness unrelated to study|1|||
94323602|NCT03442829|322964966|FG001|Overall Study|Illness unrelated to study|1|||
94323603|NCT01486784|322964967|FG000|Overall Study|Withdrawal by Subject|0|||
94323604|NCT01486784|322964968|FG001|Overall Study|Withdrawal by Subject|0|||
94323605|NCT01486784|322964969|FG002|Overall Study|Withdrawal by Subject|1|||
94323606|NCT01486784|322964970|FG003|Overall Study|Withdrawal by Subject|0|||
94323607|NCT01486784|322964971|FG004|Overall Study|Withdrawal by Subject|1|||
94323608|NCT01486784|322964972|FG005|Overall Study|Withdrawal by Subject|2|||
94323609|NCT01486784|322964967|FG000|Overall Study|Subject did not meet entry criteria|0|||
94323610|NCT01486784|322964968|FG001|Overall Study|Subject did not meet entry criteria|0|||
94323611|NCT01486784|322964969|FG002|Overall Study|Subject did not meet entry criteria|0|||
94323612|NCT01486784|322964970|FG003|Overall Study|Subject did not meet entry criteria|0|||
94323613|NCT01486784|322964971|FG004|Overall Study|Subject did not meet entry criteria|1|||
94323614|NCT01486784|322964972|FG005|Overall Study|Subject did not meet entry criteria|0|||
94323615|NCT01486784|322964967|FG000|Overall Study|Death|0|||
94323616|NCT01486784|322964968|FG001|Overall Study|Death|0|||
94323617|NCT01486784|322964969|FG002|Overall Study|Death|0|||
94323618|NCT01486784|322964970|FG003|Overall Study|Death|0|||
94323619|NCT01486784|322964971|FG004|Overall Study|Death|0|||
94323620|NCT01486784|322964972|FG005|Overall Study|Death|1|||
94323621|NCT02841787|322964973|FG000|Overall Study|Lost to Follow-up|1|||
94323622|NCT02841787|322964974|FG001|Overall Study|Lost to Follow-up|0|||
94323623|NCT02841787|322964975|FG002|Overall Study|Lost to Follow-up|0|||
94323624|NCT02841787|322964973|FG000|Overall Study|Symptoms dropped below threshold|1|||
94323625|NCT02841787|322964974|FG001|Overall Study|Symptoms dropped below threshold|0|||
94323626|NCT02841787|322964975|FG002|Overall Study|Symptoms dropped below threshold|0|||
94323627|NCT02841787|322964973|FG000|Overall Study|Withdrawal by Subject|1|||
94323628|NCT02841787|322964974|FG001|Overall Study|Withdrawal by Subject|4|||
94323629|NCT02841787|322964975|FG002|Overall Study|Withdrawal by Subject|0|||
94323630|NCT02493426|322964976|FG000|Overall Study|Withdrawal by Subject|0|||
94323631|NCT02493426|322964977|FG001|Overall Study|Withdrawal by Subject|1|||
94323632|NCT01069523|322964978|FG000|Overall Study|Withdrawal by Subject|4|||
94323633|NCT01069523|322964979|FG001|Overall Study|Withdrawal by Subject|7|||
94323634|NCT00712322|322964982|FG000|Overall Study|Protocol deviation|0|||
94323635|NCT00712322|322964983|FG001|Overall Study|Protocol deviation|1|||
94323636|NCT00712322|322964984|FG002|Overall Study|Protocol deviation|0|||
94323637|NCT04533815|322964985|FG000|Overall Study|Adverse Event|2|||
94323638|NCT04533815|322964985|FG000|Overall Study|Site withdrew|5|||
94323639|NCT00488592|322964988|FG000|Overall Study|Withdrawal by Subject|1|||
94323640|NCT00488592|322964988|FG000|Overall Study|Disease progression|1|||
94323641|NCT00488592|322964988|FG000|Overall Study|Enrolled but not treated|1|||
94323642|NCT01577160|322964989|FG000|Overall Study|Adverse Event|9|||
94323643|NCT01577160|322964989|FG000|Overall Study|Lack of Efficacy|15|||
94323644|NCT01577160|322964989|FG000|Overall Study|Lost to Follow-up|40|||
94323645|NCT01577160|322964989|FG000|Overall Study|Withdrawal by Subject|18|||
94323646|NCT01577160|322964989|FG000|Overall Study|Subject Uncooperative|7|||
94323647|NCT01577160|322964989|FG000|Overall Study|Other|9|||
94323648|NCT01586156|322964991|FG000|Overall Study|Pregnancy|0|||
94323649|NCT01586156|322964992|FG001|Overall Study|Pregnancy|1|||
94323650|NCT01586156|322964993|FG002|Overall Study|Pregnancy|0|||
94323651|NCT00547378|322964994|FG000|Randomized Cohort|Withdrawal by Subject|7|||
94323652|NCT00547378|322964995|FG001|Randomized Cohort|Withdrawal by Subject|5|||
94323653|NCT00547378|322964996|FG002|Randomized Cohort|Withdrawal by Subject|0|||
94323654|NCT00547378|322964994|FG000|Randomized Cohort|Death|0|||
94323655|NCT00547378|322964995|FG001|Randomized Cohort|Death|1|||
94323656|NCT00547378|322964996|FG002|Randomized Cohort|Death|0|||
94323657|NCT00547378|322964994|FG000|Randomized Cohort|Lost to Follow-up|1|||
94323658|NCT00547378|322964995|FG001|Randomized Cohort|Lost to Follow-up|0|||
94323659|NCT00547378|322964996|FG002|Randomized Cohort|Lost to Follow-up|0|||
94323660|NCT00547378|322964994|FG000|Randomized Cohort|Adverse Event|1|||
94323661|NCT00547378|322964995|FG001|Randomized Cohort|Adverse Event|0|||
94323662|NCT00547378|322964996|FG002|Randomized Cohort|Adverse Event|0|||
94323663|NCT00547378|322964994|FG000|Randomized Cohort|Other reasons|2|||
94323664|NCT00547378|322964995|FG001|Randomized Cohort|Other reasons|0|||
94323665|NCT00547378|322964996|FG002|Randomized Cohort|Other reasons|0|||
94323666|NCT00547378|322964994|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
94323667|NCT00547378|322964995|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
94323668|NCT00547378|322964996|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
94323669|NCT00547378|322964994|FG000|All Implanted Cohort|Adverse Event|4|||
94323670|NCT00547378|322964995|FG001|All Implanted Cohort|Adverse Event|10|||
94323671|NCT00547378|322964996|FG002|All Implanted Cohort|Adverse Event|17|||
94323672|NCT00547378|322964994|FG000|All Implanted Cohort|Lost to Follow-up|0|||
94323673|NCT00547378|322964995|FG001|All Implanted Cohort|Lost to Follow-up|1|||
94323674|NCT00547378|322964996|FG002|All Implanted Cohort|Lost to Follow-up|14|||
94323675|NCT00547378|322964994|FG000|All Implanted Cohort|Death|3|||
94323676|NCT00547378|322964995|FG001|All Implanted Cohort|Death|1|||
94323677|NCT00547378|322964996|FG002|All Implanted Cohort|Death|4|||
94323678|NCT00547378|322964994|FG000|All Implanted Cohort|Physician Decision|0|||
94323679|NCT00547378|322964995|FG001|All Implanted Cohort|Physician Decision|2|||
94323680|NCT00547378|322964996|FG002|All Implanted Cohort|Physician Decision|6|||
94323681|NCT00547378|322964994|FG000|All Implanted Cohort|Site closure|2|||
94323682|NCT00547378|322964995|FG001|All Implanted Cohort|Site closure|0|||
94323683|NCT00547378|322964996|FG002|All Implanted Cohort|Site closure|1|||
94323684|NCT00547378|322964994|FG000|All Implanted Cohort|Other reasons|1|||
94323685|NCT00547378|322964995|FG001|All Implanted Cohort|Other reasons|0|||
94323686|NCT00547378|322964996|FG002|All Implanted Cohort|Other reasons|1|||
94323687|NCT03550131|322964998|FG000|Overall Study|Lost to Follow-up|16|||
94323688|NCT03550131|322964999|FG001|Overall Study|Lost to Follow-up|24|||
94323689|NCT03550131|322964998|FG000|Overall Study|Withdrawal by Subject|36|||
94323690|NCT03550131|322964999|FG001|Overall Study|Withdrawal by Subject|28|||
94323691|NCT03550131|322964998|FG000|Overall Study|Illness of dyad member|10|||
94323692|NCT03550131|322964999|FG001|Overall Study|Illness of dyad member|2|||
94323693|NCT03550131|322964998|FG000|Overall Study|Death of person with dementia|4|||
94323694|NCT03550131|322964999|FG001|Overall Study|Death of person with dementia|8|||
94323695|NCT00414960|322965000|FG000|Overall Study|Adverse Event|4|||
94323696|NCT00414960|322965001|FG001|Overall Study|Adverse Event|0|||
94323697|NCT00414960|322965000|FG000|Overall Study|Withdrawal by Subject|3|||
94323698|NCT00414960|322965001|FG001|Overall Study|Withdrawal by Subject|0|||
94323699|NCT00414960|322965000|FG000|Overall Study|Physician Decision|0|||
94323700|NCT00414960|322965001|FG001|Overall Study|Physician Decision|1|||
94323701|NCT05254613|322966977|FG000|Overall Study|Lost to Follow-up|0|||
94323702|NCT05254613|322966978|FG001|Overall Study|Lost to Follow-up|0|||
94387848|NCT01223365|323207755|FG000|Open-label Titration Period|Enrolled but not treated|1|||
94387849|NCT01223365|323207755|FG000|Open-label Titration Period|Adverse Event|23|||
94387850|NCT01223365|323207755|FG000|Open-label Titration Period|Lack of Efficacy|3|||
94387851|NCT01223365|323207755|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
94387852|NCT01223365|323207755|FG000|Open-label Titration Period|Protocol Violation|1|||
94387853|NCT01223365|323207755|FG000|Open-label Titration Period|Lost to Follow-up|2|||
94387854|NCT01223365|323207755|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
94387855|NCT01223365|323207755|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
94387856|NCT01223365|323207755|FG000|Open-label Titration Period|Starting physical therapy|1|||
94387857|NCT01223365|323207755|FG000|Open-label Treatment Period|Adverse Event|39|||
94387858|NCT01223365|323207755|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
94387859|NCT01223365|323207755|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
94387860|NCT01223365|323207755|FG000|Open-label Treatment Period|Protocol Violation|15|||
94387861|NCT01223365|323207755|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
94387862|NCT01223365|323207755|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
94387863|NCT01223365|323207755|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
94387864|NCT01223365|323207755|FG000|Open-label Treatment Period|Moved out of area|2|||
94387865|NCT01223365|323207755|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
94387866|NCT01223365|323207755|FG000|Open-label Treatment Period|"Out of window"|1|||
94387867|NCT01223365|323207755|FG000|Open-label Treatment Period|Starting physical therapy|1|||
94387868|NCT01223365|323207755|FG000|Open-label Treatment Period|Physician Decision|2|||
94387869|NCT00366899|323208918|FG000|Infant Series|Withdrawal by Subject|4|||
94387870|NCT00366899|323208919|FG001|Infant Series|Withdrawal by Subject|7|||
94387871|NCT00366899|323208918|FG000|Infant Series|Protocol Violation|2|||
94387872|NCT00366899|323208919|FG001|Infant Series|Protocol Violation|1|||
94387873|NCT00366899|323208918|FG000|Infant Series|Failed to return|1|||
94387874|NCT00366899|323208919|FG001|Infant Series|Failed to return|1|||
94387875|NCT00366899|323208918|FG000|Infant Series|Lost to Follow-up|0|||
94387876|NCT00366899|323208919|FG001|Infant Series|Lost to Follow-up|2|||
94387877|NCT00366899|323208918|FG000|Infant Series|Adverse Event|0|||
94387878|NCT00366899|323208919|FG001|Infant Series|Adverse Event|1|||
94323703|NCT05254613|322966979|FG002|Overall Study|Lost to Follow-up|1|||
94323704|NCT01885078|322966981|FG000|Treatment Period|Adverse Event|52|||
94323705|NCT01885078|322966982|FG001|Treatment Period|Adverse Event|136|||
94323706|NCT01885078|322966983|FG002|Treatment Period|Adverse Event|30|||
94323707|NCT01885078|322966984|FG003|Treatment Period|Adverse Event|73|||
94323708|NCT01885078|322966985|FG004|Treatment Period|Adverse Event|17|||
94323709|NCT01885078|322966986|FG005|Treatment Period|Adverse Event|72|||
94323710|NCT01885078|322966987|FG006|Treatment Period|Adverse Event|24|||
94323711|NCT01885078|322966988|FG007|Treatment Period|Adverse Event|5|||
94323712|NCT01885078|322966989|FG008|Treatment Period|Adverse Event|0|||
94323713|NCT01885078|322966990|FG009|Treatment Period|Adverse Event|0|||
94323714|NCT01885078|322966981|FG000|Treatment Period|Death|13|||
94323715|NCT01885078|322966982|FG001|Treatment Period|Death|33|||
94323716|NCT01885078|322966983|FG002|Treatment Period|Death|5|||
94323717|NCT01885078|322966984|FG003|Treatment Period|Death|9|||
94323718|NCT01885078|322966985|FG004|Treatment Period|Death|2|||
94323719|NCT01885078|322966986|FG005|Treatment Period|Death|10|||
94323720|NCT01885078|322966987|FG006|Treatment Period|Death|3|||
94323721|NCT01885078|322966988|FG007|Treatment Period|Death|2|||
94323722|NCT01885078|322966989|FG008|Treatment Period|Death|0|||
94323723|NCT01885078|322966990|FG009|Treatment Period|Death|0|||
94387879|NCT00366899|323208918|FG000|Infant Series|Physician Decision|1|||
94387880|NCT00366899|323208919|FG001|Infant Series|Physician Decision|0|||
94387881|NCT00366899|323208918|FG000|Infant Series|Randomized but not consented|1|||
94387882|NCT00366899|323208919|FG001|Infant Series|Randomized but not consented|0|||
94387883|NCT00366899|323208918|FG000|After Infant Series|Lost to Follow-up|4|||
94387884|NCT00366899|323208919|FG001|After Infant Series|Lost to Follow-up|3|||
94387885|NCT00366899|323208918|FG000|After Infant Series|Withdrawal by Subject|1|||
94387886|NCT00366899|323208919|FG001|After Infant Series|Withdrawal by Subject|4|||
94387887|NCT00366899|323208918|FG000|After Infant Series|Adverse Event|1|||
94387888|NCT00366899|323208919|FG001|After Infant Series|Adverse Event|2|||
94323724|NCT01885078|322966981|FG000|Treatment Period|Lack of Efficacy|12|||
94323725|NCT01885078|322966982|FG001|Treatment Period|Lack of Efficacy|33|||
94323726|NCT01885078|322966983|FG002|Treatment Period|Lack of Efficacy|10|||
94323727|NCT01885078|322966984|FG003|Treatment Period|Lack of Efficacy|23|||
94387889|NCT00366899|323208918|FG000|After Infant Series|Protocol Violation|1|||
94387890|NCT00366899|323208919|FG001|After Infant Series|Protocol Violation|0|||
94387891|NCT00366899|323208918|FG000|Toddler Dose|Withdrawal by Subject|1|||
94323728|NCT01885078|322966985|FG004|Treatment Period|Lack of Efficacy|24|||
94323729|NCT01885078|322966986|FG005|Treatment Period|Lack of Efficacy|58|||
94323730|NCT01885078|322966987|FG006|Treatment Period|Lack of Efficacy|9|||
94323731|NCT01885078|322966988|FG007|Treatment Period|Lack of Efficacy|5|||
94387892|NCT00366899|323208919|FG001|Toddler Dose|Withdrawal by Subject|1|||
94387893|NCT00366899|323208918|FG000|Toddler Dose|Protocol Violation|1|||
94387894|NCT00366899|323208919|FG001|Toddler Dose|Protocol Violation|0|||
94387895|NCT01619800|323208920|FG000|Overall Study|study terminated|2|||
94323732|NCT01885078|322966989|FG008|Treatment Period|Lack of Efficacy|0|||
94323733|NCT01885078|322966990|FG009|Treatment Period|Lack of Efficacy|0|||
94323734|NCT01885078|322966981|FG000|Treatment Period|Lost to Follow-up|16|||
94323735|NCT01885078|322966982|FG001|Treatment Period|Lost to Follow-up|19|||
94323736|NCT01885078|322966983|FG002|Treatment Period|Lost to Follow-up|7|||
94323737|NCT01885078|322966984|FG003|Treatment Period|Lost to Follow-up|9|||
94323738|NCT01885078|322966985|FG004|Treatment Period|Lost to Follow-up|2|||
94323739|NCT01885078|322966986|FG005|Treatment Period|Lost to Follow-up|8|||
94323740|NCT01885078|322966987|FG006|Treatment Period|Lost to Follow-up|2|||
94323741|NCT01885078|322966988|FG007|Treatment Period|Lost to Follow-up|0|||
94323742|NCT01885078|322966989|FG008|Treatment Period|Lost to Follow-up|0|||
94323743|NCT01885078|322966990|FG009|Treatment Period|Lost to Follow-up|0|||
94323744|NCT01885078|322966981|FG000|Treatment Period|Physician Decision|19|||
94323745|NCT01885078|322966982|FG001|Treatment Period|Physician Decision|21|||
94323746|NCT01885078|322966983|FG002|Treatment Period|Physician Decision|5|||
94323747|NCT01885078|322966984|FG003|Treatment Period|Physician Decision|12|||
94323748|NCT01885078|322966985|FG004|Treatment Period|Physician Decision|9|||
94323749|NCT01885078|322966986|FG005|Treatment Period|Physician Decision|24|||
94323750|NCT01885078|322966987|FG006|Treatment Period|Physician Decision|4|||
94323751|NCT01885078|322966988|FG007|Treatment Period|Physician Decision|3|||
94323752|NCT01885078|322966989|FG008|Treatment Period|Physician Decision|0|||
94323753|NCT01885078|322966990|FG009|Treatment Period|Physician Decision|0|||
94323754|NCT01885078|322966981|FG000|Treatment Period|Protocol Violation|3|||
94323755|NCT01885078|322966982|FG001|Treatment Period|Protocol Violation|5|||
94323756|NCT01885078|322966983|FG002|Treatment Period|Protocol Violation|0|||
94323757|NCT01885078|322966984|FG003|Treatment Period|Protocol Violation|3|||
94323758|NCT01885078|322966985|FG004|Treatment Period|Protocol Violation|1|||
94323759|NCT01885078|322966986|FG005|Treatment Period|Protocol Violation|6|||
94323760|NCT01885078|322966987|FG006|Treatment Period|Protocol Violation|0|||
94323761|NCT01885078|322966988|FG007|Treatment Period|Protocol Violation|0|||
94323762|NCT01885078|322966989|FG008|Treatment Period|Protocol Violation|0|||
94323763|NCT01885078|322966990|FG009|Treatment Period|Protocol Violation|0|||
94323764|NCT01885078|322966981|FG000|Treatment Period|Sponsor Decision|245|||
94323765|NCT01885078|322966982|FG001|Treatment Period|Sponsor Decision|648|||
94323766|NCT01885078|322966983|FG002|Treatment Period|Sponsor Decision|49|||
94323767|NCT01885078|322966984|FG003|Treatment Period|Sponsor Decision|90|||
94323768|NCT01885078|322966985|FG004|Treatment Period|Sponsor Decision|20|||
94323769|NCT01885078|322966986|FG005|Treatment Period|Sponsor Decision|38|||
94323770|NCT01885078|322966987|FG006|Treatment Period|Sponsor Decision|162|||
94323771|NCT01885078|322966988|FG007|Treatment Period|Sponsor Decision|3|||
94323772|NCT01885078|322966989|FG008|Treatment Period|Sponsor Decision|0|||
94323773|NCT01885078|322966990|FG009|Treatment Period|Sponsor Decision|0|||
94323774|NCT01885078|322966981|FG000|Treatment Period|Withdrawal by Subject|72|||
94323775|NCT01885078|322966982|FG001|Treatment Period|Withdrawal by Subject|132|||
94323776|NCT01885078|322966983|FG002|Treatment Period|Withdrawal by Subject|25|||
94323777|NCT01885078|322966984|FG003|Treatment Period|Withdrawal by Subject|63|||
94323778|NCT01885078|322966985|FG004|Treatment Period|Withdrawal by Subject|15|||
94323779|NCT01885078|322966986|FG005|Treatment Period|Withdrawal by Subject|34|||
94323780|NCT01885078|322966987|FG006|Treatment Period|Withdrawal by Subject|17|||
94323781|NCT01885078|322966988|FG007|Treatment Period|Withdrawal by Subject|10|||
94323782|NCT01885078|322966989|FG008|Treatment Period|Withdrawal by Subject|0|||
94323783|NCT01885078|322966990|FG009|Treatment Period|Withdrawal by Subject|0|||
94323784|NCT01885078|322966981|FG000|Treatment Period|Other|0|||
94323785|NCT01885078|322966982|FG001|Treatment Period|Other|0|||
94323786|NCT01885078|322966983|FG002|Treatment Period|Other|0|||
94323787|NCT01885078|322966984|FG003|Treatment Period|Other|1|||
94323788|NCT01885078|322966985|FG004|Treatment Period|Other|0|||
94323789|NCT01885078|322966986|FG005|Treatment Period|Other|0|||
94323790|NCT01885078|322966987|FG006|Treatment Period|Other|0|||
94323791|NCT01885078|322966988|FG007|Treatment Period|Other|0|||
94323792|NCT01885078|322966989|FG008|Treatment Period|Other|0|||
94323793|NCT01885078|322966990|FG009|Treatment Period|Other|0|||
94323794|NCT01885078|322966981|FG000|Step-down Period|Sponsor Decision|0|||
94323795|NCT01885078|322966982|FG001|Step-down Period|Sponsor Decision|0|||
94323796|NCT01885078|322966983|FG002|Step-down Period|Sponsor Decision|0|||
94323797|NCT01885078|322966984|FG003|Step-down Period|Sponsor Decision|0|||
94323798|NCT01885078|322966985|FG004|Step-down Period|Sponsor Decision|0|||
94323799|NCT01885078|322966986|FG005|Step-down Period|Sponsor Decision|0|||
94323800|NCT01885078|322966987|FG006|Step-down Period|Sponsor Decision|0|||
94323801|NCT01885078|322966988|FG007|Step-down Period|Sponsor Decision|0|||
94323802|NCT01885078|322966989|FG008|Step-down Period|Sponsor Decision|1|||
94323803|NCT01885078|322966990|FG009|Step-down Period|Sponsor Decision|1|||
94387896|NCT01619800|323208921|FG001|Overall Study|study terminated|0|||
94323804|NCT01885078|322966981|FG000|Step-down Period|Adverse Event|0|||
94323805|NCT01885078|322966982|FG001|Step-down Period|Adverse Event|0|||
94323806|NCT01885078|322966983|FG002|Step-down Period|Adverse Event|0|||
94323807|NCT01885078|322966984|FG003|Step-down Period|Adverse Event|0|||
94323808|NCT01885078|322966985|FG004|Step-down Period|Adverse Event|0|||
94323809|NCT01885078|322966986|FG005|Step-down Period|Adverse Event|0|||
94323810|NCT01885078|322966987|FG006|Step-down Period|Adverse Event|0|||
94323811|NCT01885078|322966988|FG007|Step-down Period|Adverse Event|0|||
94323812|NCT01885078|322966989|FG008|Step-down Period|Adverse Event|29|||
94323813|NCT01885078|322966990|FG009|Step-down Period|Adverse Event|38|||
94323814|NCT01885078|322966981|FG000|Step-down Period|Withdrawal by Subject|0|||
94323815|NCT01885078|322966982|FG001|Step-down Period|Withdrawal by Subject|0|||
94323816|NCT01885078|322966983|FG002|Step-down Period|Withdrawal by Subject|0|||
94323817|NCT01885078|322966984|FG003|Step-down Period|Withdrawal by Subject|0|||
94323818|NCT01885078|322966985|FG004|Step-down Period|Withdrawal by Subject|0|||
94323819|NCT01885078|322966986|FG005|Step-down Period|Withdrawal by Subject|0|||
94323820|NCT01885078|322966987|FG006|Step-down Period|Withdrawal by Subject|0|||
94323821|NCT01885078|322966988|FG007|Step-down Period|Withdrawal by Subject|0|||
94323822|NCT01885078|322966989|FG008|Step-down Period|Withdrawal by Subject|25|||
94323823|NCT01885078|322966990|FG009|Step-down Period|Withdrawal by Subject|15|||
94323824|NCT01885078|322966981|FG000|Step-down Period|Physician Decision|0|||
94323825|NCT01885078|322966982|FG001|Step-down Period|Physician Decision|0|||
94323826|NCT01885078|322966983|FG002|Step-down Period|Physician Decision|0|||
94323827|NCT01885078|322966984|FG003|Step-down Period|Physician Decision|0|||
94323828|NCT01885078|322966985|FG004|Step-down Period|Physician Decision|0|||
94323829|NCT01885078|322966986|FG005|Step-down Period|Physician Decision|0|||
94323830|NCT01885078|322966987|FG006|Step-down Period|Physician Decision|0|||
94323831|NCT01885078|322966988|FG007|Step-down Period|Physician Decision|0|||
94323832|NCT01885078|322966989|FG008|Step-down Period|Physician Decision|7|||
94323833|NCT01885078|322966990|FG009|Step-down Period|Physician Decision|2|||
94323834|NCT01885078|322966981|FG000|Step-down Period|Death|0|||
94323835|NCT01885078|322966982|FG001|Step-down Period|Death|0|||
94323836|NCT01885078|322966983|FG002|Step-down Period|Death|0|||
94323837|NCT01885078|322966984|FG003|Step-down Period|Death|0|||
94323838|NCT01885078|322966985|FG004|Step-down Period|Death|0|||
94323839|NCT01885078|322966986|FG005|Step-down Period|Death|0|||
94323840|NCT01885078|322966987|FG006|Step-down Period|Death|0|||
94323841|NCT01885078|322966988|FG007|Step-down Period|Death|0|||
94323842|NCT01885078|322966989|FG008|Step-down Period|Death|4|||
94323843|NCT01885078|322966990|FG009|Step-down Period|Death|3|||
94323844|NCT01885078|322966981|FG000|Step-down Period|Lost to Follow-up|0|||
94323845|NCT01885078|322966982|FG001|Step-down Period|Lost to Follow-up|0|||
94323846|NCT01885078|322966983|FG002|Step-down Period|Lost to Follow-up|0|||
94323847|NCT01885078|322966984|FG003|Step-down Period|Lost to Follow-up|0|||
94323848|NCT01885078|322966985|FG004|Step-down Period|Lost to Follow-up|0|||
94323849|NCT01885078|322966986|FG005|Step-down Period|Lost to Follow-up|0|||
94323850|NCT01885078|322966987|FG006|Step-down Period|Lost to Follow-up|0|||
94323851|NCT01885078|322966988|FG007|Step-down Period|Lost to Follow-up|0|||
94323852|NCT01885078|322966989|FG008|Step-down Period|Lost to Follow-up|1|||
94323853|NCT01885078|322966990|FG009|Step-down Period|Lost to Follow-up|1|||
94323854|NCT01885078|322966981|FG000|Step-down Period|Lack of Efficacy|0|||
94323855|NCT01885078|322966982|FG001|Step-down Period|Lack of Efficacy|0|||
94323856|NCT01885078|322966983|FG002|Step-down Period|Lack of Efficacy|0|||
94323857|NCT01885078|322966984|FG003|Step-down Period|Lack of Efficacy|0|||
94323858|NCT01885078|322966985|FG004|Step-down Period|Lack of Efficacy|0|||
94323859|NCT01885078|322966986|FG005|Step-down Period|Lack of Efficacy|0|||
94323860|NCT01885078|322966987|FG006|Step-down Period|Lack of Efficacy|0|||
94323861|NCT01885078|322966988|FG007|Step-down Period|Lack of Efficacy|0|||
94323862|NCT01885078|322966989|FG008|Step-down Period|Lack of Efficacy|1|||
94323863|NCT01885078|322966990|FG009|Step-down Period|Lack of Efficacy|0|||
94323864|NCT01885078|322966981|FG000|Step-down Period|Protocol Violation|0|||
94323865|NCT01885078|322966982|FG001|Step-down Period|Protocol Violation|0|||
94323866|NCT01885078|322966983|FG002|Step-down Period|Protocol Violation|0|||
94323867|NCT01885078|322966984|FG003|Step-down Period|Protocol Violation|0|||
94323868|NCT01885078|322966985|FG004|Step-down Period|Protocol Violation|0|||
94323869|NCT01885078|322966986|FG005|Step-down Period|Protocol Violation|0|||
94323870|NCT01885078|322966987|FG006|Step-down Period|Protocol Violation|0|||
94323871|NCT01885078|322966988|FG007|Step-down Period|Protocol Violation|0|||
94323872|NCT01885078|322966989|FG008|Step-down Period|Protocol Violation|1|||
94323873|NCT01885078|322966990|FG009|Step-down Period|Protocol Violation|1|||
94323874|NCT03004469|322967000|FG000|Overall Study|Adverse Event|6|||
94323875|NCT03004469|322967001|FG001|Overall Study|Adverse Event|4|||
94323876|NCT03004469|322967002|FG002|Overall Study|Adverse Event|6|||
94323877|NCT03004469|322967000|FG000|Overall Study|Lack of Efficacy|1|||
94323878|NCT03004469|322967001|FG001|Overall Study|Lack of Efficacy|0|||
94323879|NCT03004469|322967002|FG002|Overall Study|Lack of Efficacy|1|||
94323880|NCT03004469|322967000|FG000|Overall Study|Lost to Follow-up|23|||
94323881|NCT03004469|322967001|FG001|Overall Study|Lost to Follow-up|14|||
94323882|NCT03004469|322967002|FG002|Overall Study|Lost to Follow-up|6|||
94323883|NCT03004469|322967000|FG000|Overall Study|Non-Compliance with Study Drug|2|||
94323884|NCT03004469|322967001|FG001|Overall Study|Non-Compliance with Study Drug|0|||
94323885|NCT03004469|322967002|FG002|Overall Study|Non-Compliance with Study Drug|0|||
94323886|NCT03004469|322967000|FG000|Overall Study|Protocol Violation|0|||
94323887|NCT03004469|322967001|FG001|Overall Study|Protocol Violation|0|||
94387897|NCT00419770|323208923|FG000|Overall Study|Withdrawal by Subject|5|||
94387898|NCT00419770|323208924|FG001|Overall Study|Withdrawal by Subject|1|||
94387899|NCT02848326|323208925|FG000|Treatment Period|Adverse Event|5|||
94387900|NCT02848326|323208926|FG001|Treatment Period|Adverse Event|4|||
94387901|NCT02848326|323208927|FG002|Treatment Period|Adverse Event|11|||
94387902|NCT02848326|323208928|FG003|Treatment Period|Adverse Event|6|||
94387903|NCT02848326|323208929|FG004|Treatment Period|Adverse Event|5|||
94387904|NCT02848326|323208930|FG005|Treatment Period|Adverse Event|7|||
94387905|NCT02848326|323208925|FG000|Treatment Period|Withdrawal of Consent|20|||
94387906|NCT02848326|323208926|FG001|Treatment Period|Withdrawal of Consent|6|||
94387907|NCT02848326|323208927|FG002|Treatment Period|Withdrawal of Consent|9|||
94387908|NCT02848326|323208928|FG003|Treatment Period|Withdrawal of Consent|6|||
94387909|NCT02848326|323208929|FG004|Treatment Period|Withdrawal of Consent|9|||
94387910|NCT02848326|323208930|FG005|Treatment Period|Withdrawal of Consent|6|||
94387911|NCT02848326|323208925|FG000|Treatment Period|Lost to Follow-up|5|||
94387912|NCT02848326|323208926|FG001|Treatment Period|Lost to Follow-up|1|||
94387913|NCT02848326|323208927|FG002|Treatment Period|Lost to Follow-up|11|||
94387914|NCT02848326|323208928|FG003|Treatment Period|Lost to Follow-up|7|||
94387915|NCT02848326|323208929|FG004|Treatment Period|Lost to Follow-up|2|||
94387916|NCT02848326|323208930|FG005|Treatment Period|Lost to Follow-up|3|||
94387917|NCT02848326|323208925|FG000|Treatment Period|Pregnancy|0|||
94387918|NCT02848326|323208926|FG001|Treatment Period|Pregnancy|0|||
94387919|NCT02848326|323208927|FG002|Treatment Period|Pregnancy|1|||
94387920|NCT02848326|323208928|FG003|Treatment Period|Pregnancy|1|||
94387921|NCT02848326|323208929|FG004|Treatment Period|Pregnancy|0|||
94387922|NCT02848326|323208930|FG005|Treatment Period|Pregnancy|1|||
94387923|NCT02848326|323208925|FG000|Treatment Period|Protocol Violation|4|||
94387924|NCT02848326|323208926|FG001|Treatment Period|Protocol Violation|3|||
94323888|NCT03004469|322967002|FG002|Overall Study|Protocol Violation|1|||
94323889|NCT03004469|322967000|FG000|Overall Study|Withdrawal by Subject|29|||
94323890|NCT03004469|322967001|FG001|Overall Study|Withdrawal by Subject|27|||
94323891|NCT03004469|322967002|FG002|Overall Study|Withdrawal by Subject|10|||
94323892|NCT03004469|322967000|FG000|Overall Study|Other unspecified reason|0|||
94323893|NCT03004469|322967001|FG001|Overall Study|Other unspecified reason|4|||
94323894|NCT03004469|322967002|FG002|Overall Study|Other unspecified reason|1|||
94323895|NCT01089582|322967007|FG000|Overall Study|Death|2|||
94323896|NCT01089582|322967007|FG000|Overall Study|Adverse Event|15|||
94323897|NCT01089582|322967007|FG000|Overall Study|Lost to Follow-up|8|||
94323898|NCT01089582|322967007|FG000|Overall Study|Other|4|||
94323899|NCT01089582|322967007|FG000|Overall Study|Withdrawal by Subject|1|||
94323900|NCT04247815|322967008|FG000|Overall Study|Adverse Event|1|||
94323901|NCT04247815|322967009|FG001|Overall Study|Adverse Event|0|||
94323902|NCT04247815|322967008|FG000|Overall Study|Withdrawal by Subject|1|||
94323903|NCT04247815|322967009|FG001|Overall Study|Withdrawal by Subject|0|||
94323904|NCT04247815|322967008|FG000|Overall Study|Protocol Violation|0|||
94323905|NCT04247815|322967009|FG001|Overall Study|Protocol Violation|1|||
94323906|NCT02207556|322967010|FG000|Overall Study|Physician Decision|1|||
94323907|NCT02207556|322967011|FG001|Overall Study|Physician Decision|0|||
94323908|NCT02207556|322967010|FG000|Overall Study|Withdrawal by Subject|1|||
94323909|NCT02207556|322967011|FG001|Overall Study|Withdrawal by Subject|0|||
94323910|NCT02207556|322967010|FG000|Overall Study|Death|0|||
94323911|NCT02207556|322967011|FG001|Overall Study|Death|5|||
94323912|NCT00992784|322967012|FG000|Overall Study|Adverse Event|2|||
94323913|NCT00992784|322967013|FG001|Overall Study|Adverse Event|1|||
94323914|NCT00992784|322967014|FG002|Overall Study|Adverse Event|0|||
94323915|NCT00992784|322967012|FG000|Overall Study|Withdrawal by Subject|1|||
94323916|NCT00992784|322967013|FG001|Overall Study|Withdrawal by Subject|1|||
94323917|NCT00992784|322967014|FG002|Overall Study|Withdrawal by Subject|1|||
94323918|NCT04580394|322967020|FG000|First Intervention|Incorrectly Randomized|1|||
94323919|NCT04580394|322967020|FG000|First Intervention|Physician Decision|1|||
94323920|NCT04580394|322967020|FG000|First Intervention|Lost to Follow-up|1|||
94323921|NCT04580394|322967020|FG000|Washout (One Week)|Withdrawal by Subject|1|||
94323922|NCT04580394|322967020|FG000|Washout (One Week)|Adverse Event|1|||
94323923|NCT04580394|322967020|FG000|Washout (One Week)|Withdrawal by Subject|2|||
94323924|NCT04580394|322967020|FG000|Third Intervention|Adverse Event|1|||
94323925|NCT04580394|322967020|FG000|Third Intervention|Withdrawal by Subject|1|||
94323926|NCT04580394|322967020|FG000|Washout (One Week)|Withdrawal by Subject|2|||
94323927|NCT00424294|322967024|FG000|Overall Study|Adverse Event|4|||
94387925|NCT02848326|323208927|FG002|Treatment Period|Protocol Violation|4|||
94387926|NCT02848326|323208928|FG003|Treatment Period|Protocol Violation|2|||
94387927|NCT02848326|323208929|FG004|Treatment Period|Protocol Violation|3|||
94323928|NCT00424294|322967025|FG001|Overall Study|Adverse Event|10|||
94323929|NCT00424294|322967024|FG000|Overall Study|Lack of Efficacy|2|||
94323930|NCT00424294|322967025|FG001|Overall Study|Lack of Efficacy|1|||
94323931|NCT00424294|322967024|FG000|Overall Study|Withdrawal by Subject|1|||
94323932|NCT00424294|322967025|FG001|Overall Study|Withdrawal by Subject|2|||
94323933|NCT00424294|322967024|FG000|Overall Study|Other|0|||
94323934|NCT00424294|322967025|FG001|Overall Study|Other|2|||
94323935|NCT00424294|322967024|FG000|Overall Study|Randomized but not Treated|1|||
94323936|NCT00424294|322967025|FG001|Overall Study|Randomized but not Treated|0|||
94323937|NCT01025817|322967032|FG000|Completed Study Medication|Adverse Event|66|||
94323938|NCT01025817|322967033|FG001|Completed Study Medication|Adverse Event|39|||
94323939|NCT01025817|322967032|FG000|Completed Study Medication|Protocol Deviation|9|||
94323940|NCT01025817|322967033|FG001|Completed Study Medication|Protocol Deviation|8|||
94323941|NCT01025817|322967032|FG000|Completed Study Medication|Withdrawal by Subject|8|||
94323942|NCT01025817|322967033|FG001|Completed Study Medication|Withdrawal by Subject|9|||
94323943|NCT01025817|322967032|FG000|Completed Study Medication|Administrative problems|7|||
94323944|NCT01025817|322967033|FG001|Completed Study Medication|Administrative problems|5|||
94323945|NCT01025817|322967032|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
94323946|NCT01025817|322967033|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
94323947|NCT01025817|322967032|FG000|Completed Study Medication|Abnormal test procedure|4|||
94323948|NCT01025817|322967033|FG001|Completed Study Medication|Abnormal test procedure|0|||
94323949|NCT01025817|322967032|FG000|Completed Study Medication|Graft loss|2|||
94323950|NCT01025817|322967033|FG001|Completed Study Medication|Graft loss|5|||
94323951|NCT01025817|322967032|FG000|Completed Study Medication|Death|2|||
94323952|NCT01025817|322967033|FG001|Completed Study Medication|Death|2|||
94323953|NCT01025817|322967032|FG000|Completed Study Medication|Abnormal lab values|0|||
94323954|NCT01025817|322967033|FG001|Completed Study Medication|Abnormal lab values|2|||
94323955|NCT01025817|322967032|FG000|Completed Study Medication|Subject no longer required study drug|0|||
94323956|NCT01025817|322967033|FG001|Completed Study Medication|Subject no longer required study drug|1|||
94323957|NCT01025817|322967032|FG000|Completed Study Medication|Lost to Follow-up|0|||
94323958|NCT01025817|322967033|FG001|Completed Study Medication|Lost to Follow-up|1|||
94323959|NCT01025817|322967032|FG000|Completed Study|Withdrawal by Subject|8|||
94323960|NCT01025817|322967033|FG001|Completed Study|Withdrawal by Subject|16|||
94323961|NCT01025817|322967032|FG000|Completed Study|Death|6|||
94323962|NCT01025817|322967033|FG001|Completed Study|Death|5|||
94323963|NCT01025817|322967032|FG000|Completed Study|Missing|2|||
94323964|NCT01025817|322967033|FG001|Completed Study|Missing|0|||
94323965|NCT01025817|322967032|FG000|Completed Study|Lost to Follow-up|0|||
94323966|NCT01025817|322967033|FG001|Completed Study|Lost to Follow-up|1|||
94323967|NCT00973921|322967034|FG000|Overall Study|IVUS results were not available|9|||
94323968|NCT02237157|322967035|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
94323969|NCT02237157|322967036|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
94323970|NCT02237157|322967037|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
94323971|NCT02237157|322967038|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
94323972|NCT02237157|322967035|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
94323973|NCT02237157|322967036|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
94323974|NCT02237157|322967037|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
94323975|NCT02237157|322967038|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
94323976|NCT01996748|322967039|FG000|Overall Study|Personal reason|1|||
94323977|NCT01996748|322967040|FG001|Overall Study|Personal reason|0|||
94323978|NCT01996748|322967039|FG000|Overall Study|Physician Decision|2|||
94323979|NCT01996748|322967040|FG001|Overall Study|Physician Decision|0|||
94323980|NCT01996748|322967039|FG000|Overall Study|Adverse Event|1|||
94323981|NCT01996748|322967040|FG001|Overall Study|Adverse Event|4|||
94323982|NCT01996748|322967039|FG000|Overall Study|Withdrawal by Subject|0|||
94323983|NCT01996748|322967040|FG001|Overall Study|Withdrawal by Subject|1|||
94323984|NCT01996748|322967039|FG000|Overall Study|Lost to Follow-up|4|||
94323985|NCT01996748|322967040|FG001|Overall Study|Lost to Follow-up|1|||
94323986|NCT00242580|322967044|FG000|Overall Study|Adverse Event|3|||
94323987|NCT00242580|322967045|FG001|Overall Study|Adverse Event|0|||
94323988|NCT00242580|322967046|FG002|Overall Study|Adverse Event|2|||
94323989|NCT00242580|322967044|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
94323990|NCT00242580|322967045|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
94323991|NCT00242580|322967046|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
94323992|NCT00242580|322967044|FG000|Overall Study|Protocol Violation|0|||
94323993|NCT00242580|322967045|FG001|Overall Study|Protocol Violation|0|||
94323994|NCT00242580|322967046|FG002|Overall Study|Protocol Violation|1|||
94323995|NCT00242580|322967044|FG000|Overall Study|Subject withdrew consent|2|||
94323996|NCT00242580|322967045|FG001|Overall Study|Subject withdrew consent|2|||
94323997|NCT00242580|322967046|FG002|Overall Study|Subject withdrew consent|5|||
94323998|NCT00242580|322967044|FG000|Overall Study|Lost to Follow-up|0|||
94323999|NCT00242580|322967045|FG001|Overall Study|Lost to Follow-up|3|||
94324000|NCT00242580|322967046|FG002|Overall Study|Lost to Follow-up|0|||
94324001|NCT00242580|322967044|FG000|Overall Study|Death|1|||
94324002|NCT00242580|322967045|FG001|Overall Study|Death|2|||
94324003|NCT00242580|322967046|FG002|Overall Study|Death|1|||
94324004|NCT00403559|322967047|FG000|Overall Study|Adverse Event|0|||
94482486|NCT05067972|323558118|FG002|Part 1: Treatment|Physician Decision|0|||
94324005|NCT00403559|322967048|FG001|Overall Study|Adverse Event|1|||
94324006|NCT00403559|322967047|FG000|Overall Study|Lost to Follow-up|3|||
94324007|NCT00403559|322967048|FG001|Overall Study|Lost to Follow-up|3|||
94324008|NCT00403559|322967047|FG000|Overall Study|Withdrawal by Subject|1|||
94324009|NCT00403559|322967048|FG001|Overall Study|Withdrawal by Subject|0|||
94324010|NCT03105700|322967049|FG000|Overall Study|screen fail|3|||
94324011|NCT03105700|322967049|FG000|Overall Study|Lost to Follow-up|4|||
94324012|NCT00980980|322967050|FG000|Overall Study|Withdrawal by Hospital|0|||
94324013|NCT00980980|322967051|FG001|Overall Study|Withdrawal by Hospital|1|||
94324014|NCT00980980|322967052|FG002|Overall Study|Withdrawal by Hospital|0|||
94324015|NCT00417976|322967054|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
94324016|NCT00417976|322967054|FG000|Overall Study|Treatment -related toxicity|2|||
94324017|NCT00910429|322967058|FG000|Overall Study|Death|18|||
94324018|NCT00910429|322967059|FG001|Overall Study|Death|12|||
94324019|NCT00910429|322967058|FG000|Overall Study|Withdrawal by Subject|3|||
94324020|NCT00910429|322967059|FG001|Overall Study|Withdrawal by Subject|2|||
94324021|NCT00910429|322967058|FG000|Overall Study|Protocol Violation|1|||
94324022|NCT00910429|322967059|FG001|Overall Study|Protocol Violation|0|||
94324023|NCT00910429|322967058|FG000|Overall Study|Lost to Follow-up|2|||
94324024|NCT00910429|322967059|FG001|Overall Study|Lost to Follow-up|1|||
94324025|NCT00910429|322967058|FG000|Overall Study|Adverse Event|10|||
94324026|NCT00910429|322967059|FG001|Overall Study|Adverse Event|5|||
94324027|NCT00910429|322967058|FG000|Overall Study|Drug non-compliance|1|||
94324028|NCT00910429|322967059|FG001|Overall Study|Drug non-compliance|0|||
94324029|NCT00910429|322967058|FG000|Overall Study|Lack of Efficacy|4|||
94324030|NCT00910429|322967059|FG001|Overall Study|Lack of Efficacy|1|||
94324031|NCT00751114|322967062|FG000|Overall Study|Adverse Event|2|||
94324032|NCT00751114|322967063|FG001|Overall Study|Adverse Event|4|||
94324033|NCT00751114|322967062|FG000|Overall Study|Protocol Violation|8|||
94324034|NCT00751114|322967063|FG001|Overall Study|Protocol Violation|9|||
94324035|NCT00751114|322967062|FG000|Overall Study|Withdrawal by Subject|9|||
94324036|NCT00751114|322967063|FG001|Overall Study|Withdrawal by Subject|4|||
94324037|NCT00751114|322967062|FG000|Overall Study|Lost to Follow-up|4|||
94324038|NCT00751114|322967063|FG001|Overall Study|Lost to Follow-up|7|||
94324039|NCT00751114|322967062|FG000|Overall Study|Lack of Efficacy|0|||
94324040|NCT00751114|322967063|FG001|Overall Study|Lack of Efficacy|7|||
94324041|NCT00751114|322967062|FG000|Overall Study|Not Treated|13|||
94324042|NCT00751114|322967063|FG001|Overall Study|Not Treated|1|||
94324043|NCT00751114|322967062|FG000|Overall Study|Out of country for 2 months|1|||
94324044|NCT00751114|322967063|FG001|Overall Study|Out of country for 2 months|0|||
94324045|NCT00751114|322967062|FG000|Overall Study|Move to another city|1|||
94324046|NCT00751114|322967063|FG001|Overall Study|Move to another city|0|||
94324047|NCT02358369|322967064|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
94324048|NCT02358369|322967065|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
94324049|NCT02358369|322967066|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
94324050|NCT02358369|322967067|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
94324051|NCT02358369|322967068|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
94324052|NCT02358369|322967064|FG000|Treatment Period A/B|Adverse Event|0|||
94324053|NCT02358369|322967065|FG001|Treatment Period A/B|Adverse Event|0|||
94324054|NCT02358369|322967066|FG002|Treatment Period A/B|Adverse Event|1|||
94324055|NCT02358369|322967067|FG003|Treatment Period A/B|Adverse Event|2|||
94324056|NCT02358369|322967068|FG004|Treatment Period A/B|Adverse Event|0|||
94324057|NCT02358369|322967064|FG000|Treatment Period A/B|Death|0|||
94324058|NCT02358369|322967065|FG001|Treatment Period A/B|Death|0|||
94324059|NCT02358369|322967066|FG002|Treatment Period A/B|Death|1|||
94324060|NCT02358369|322967067|FG003|Treatment Period A/B|Death|0|||
94324061|NCT02358369|322967068|FG004|Treatment Period A/B|Death|0|||
94324062|NCT02358369|322967064|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
94324063|NCT02358369|322967065|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
94324064|NCT02358369|322967066|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
94324065|NCT02358369|322967067|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
94324066|NCT02358369|322967068|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
94324067|NCT02358369|322967064|FG000|Treatment Period C|Adverse Event|0|||
94324068|NCT02358369|322967065|FG001|Treatment Period C|Adverse Event|0|||
94324069|NCT02358369|322967066|FG002|Treatment Period C|Adverse Event|0|||
94324070|NCT02358369|322967067|FG003|Treatment Period C|Adverse Event|0|||
94324071|NCT02358369|322967068|FG004|Treatment Period C|Adverse Event|7|||
94324072|NCT04465396|322967069|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
94324073|NCT04465396|322967070|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
94324074|NCT04465396|322967071|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
94324075|NCT04465396|322967072|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
94324076|NCT02219087|322967073|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
94324077|NCT02219087|322967074|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
94324078|NCT04191577|322967075|FG000|Overall Study|Withdrawal by Subject|2|||
94324079|NCT04191577|322967076|FG001|Overall Study|Withdrawal by Subject|2|||
94324080|NCT04191577|322967077|FG002|Overall Study|Withdrawal by Subject|1|||
94324081|NCT04191577|322967075|FG000|Overall Study|Physician Decision|1|||
94324082|NCT04191577|322967076|FG001|Overall Study|Physician Decision|1|||
94324083|NCT04191577|322967077|FG002|Overall Study|Physician Decision|0|||
94324084|NCT04191577|322967075|FG000|Overall Study|Adverse Event|0|||
94324085|NCT04191577|322967076|FG001|Overall Study|Adverse Event|0|||
94324086|NCT04191577|322967077|FG002|Overall Study|Adverse Event|1|||
94324087|NCT04191577|322967075|FG000|Overall Study|Death|0|||
94324088|NCT04191577|322967076|FG001|Overall Study|Death|0|||
94324089|NCT04191577|322967077|FG002|Overall Study|Death|1|||
94324090|NCT00448916|322967078|FG000|Overall Study|Adverse Event|2|||
94324091|NCT00448916|322967079|FG001|Overall Study|Adverse Event|2|||
94324092|NCT00448916|322967080|FG002|Overall Study|Adverse Event|3|||
94324093|NCT00448916|322967081|FG003|Overall Study|Adverse Event|2|||
94324094|NCT00448916|322967078|FG000|Overall Study|Lack of Efficacy|1|||
94324095|NCT00448916|322967079|FG001|Overall Study|Lack of Efficacy|0|||
94324096|NCT00448916|322967080|FG002|Overall Study|Lack of Efficacy|2|||
94324097|NCT00448916|322967081|FG003|Overall Study|Lack of Efficacy|1|||
94324098|NCT00448916|322967078|FG000|Overall Study|Withdrawal by Subject|3|||
94324099|NCT00448916|322967079|FG001|Overall Study|Withdrawal by Subject|3|||
94324100|NCT00448916|322967080|FG002|Overall Study|Withdrawal by Subject|1|||
94324101|NCT00448916|322967081|FG003|Overall Study|Withdrawal by Subject|1|||
94324102|NCT00448916|322967078|FG000|Overall Study|Other|1|||
94324103|NCT00448916|322967079|FG001|Overall Study|Other|0|||
94324104|NCT00448916|322967080|FG002|Overall Study|Other|0|||
94324105|NCT00448916|322967081|FG003|Overall Study|Other|0|||
94324106|NCT00448916|322967078|FG000|Overall Study|Lost to Follow-up|0|||
94324107|NCT00448916|322967079|FG001|Overall Study|Lost to Follow-up|1|||
94324108|NCT00448916|322967080|FG002|Overall Study|Lost to Follow-up|0|||
94324109|NCT00448916|322967081|FG003|Overall Study|Lost to Follow-up|1|||
94324110|NCT00448916|322967078|FG000|Overall Study|Protocol Violation|0|||
94324111|NCT00448916|322967079|FG001|Overall Study|Protocol Violation|0|||
94324112|NCT00448916|322967080|FG002|Overall Study|Protocol Violation|0|||
94324113|NCT00448916|322967081|FG003|Overall Study|Protocol Violation|1|||
94324114|NCT00738374|322967087|FG000|Induction Treatment Phase|Adverse Event|14|||
94324115|NCT00738374|322967088|FG001|Induction Treatment Phase|Adverse Event|0|||
94324116|NCT00738374|322967089|FG002|Induction Treatment Phase|Adverse Event|0|||
94324117|NCT00738374|322967090|FG003|Induction Treatment Phase|Adverse Event|0|||
94324118|NCT00738374|322967087|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
94324119|NCT00738374|322967088|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
94324120|NCT00738374|322967089|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
94324121|NCT00738374|322967090|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
94324122|NCT00738374|322967087|FG000|Induction Treatment Phase|Physician Decision|2|||
94324123|NCT00738374|322967088|FG001|Induction Treatment Phase|Physician Decision|0|||
94324124|NCT00738374|322967089|FG002|Induction Treatment Phase|Physician Decision|0|||
94324125|NCT00738374|322967090|FG003|Induction Treatment Phase|Physician Decision|0|||
94324126|NCT00738374|322967087|FG000|Induction Treatment Phase|Protocol Violation|2|||
94324127|NCT00738374|322967088|FG001|Induction Treatment Phase|Protocol Violation|0|||
94324128|NCT00738374|322967089|FG002|Induction Treatment Phase|Protocol Violation|0|||
94324129|NCT00738374|322967090|FG003|Induction Treatment Phase|Protocol Violation|0|||
94324130|NCT00738374|322967087|FG000|Induction Treatment Phase|Non-compliance|1|||
94324131|NCT00738374|322967088|FG001|Induction Treatment Phase|Non-compliance|0|||
94324132|NCT00738374|322967089|FG002|Induction Treatment Phase|Non-compliance|0|||
94324133|NCT00738374|322967090|FG003|Induction Treatment Phase|Non-compliance|0|||
94324134|NCT00738374|322967087|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
94324135|NCT00738374|322967088|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
94324136|NCT00738374|322967089|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
94324137|NCT00738374|322967090|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
94324138|NCT00738374|322967087|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
94324139|NCT00738374|322967088|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
94324140|NCT00738374|322967089|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
94324141|NCT00738374|322967090|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
94324142|NCT00738374|322967087|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
94324143|NCT00738374|322967088|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
94324144|NCT00738374|322967089|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
94324145|NCT00738374|322967090|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
94324146|NCT00738374|322967087|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
94324147|NCT00738374|322967088|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
94324148|NCT00738374|322967089|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
94324149|NCT00738374|322967090|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
94324150|NCT00738374|322967087|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
94324151|NCT00738374|322967088|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
94324152|NCT00738374|322967089|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
94324153|NCT00738374|322967090|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
94324154|NCT00738374|322967087|FG000|Maintenance Treatment/Observation Phase|Other|0|||
94324155|NCT00738374|322967088|FG001|Maintenance Treatment/Observation Phase|Other|1|||
94387928|NCT02848326|323208930|FG005|Treatment Period|Protocol Violation|3|||
94387929|NCT02848326|323208925|FG000|Treatment Period|Non-compliance with Study Drug|4|||
94387930|NCT02848326|323208926|FG001|Treatment Period|Non-compliance with Study Drug|0|||
94387931|NCT02848326|323208927|FG002|Treatment Period|Non-compliance with Study Drug|0|||
94387932|NCT02848326|323208928|FG003|Treatment Period|Non-compliance with Study Drug|1|||
94387933|NCT02848326|323208929|FG004|Treatment Period|Non-compliance with Study Drug|0|||
94387934|NCT02848326|323208930|FG005|Treatment Period|Non-compliance with Study Drug|0|||
94387935|NCT02848326|323208925|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
94387936|NCT02848326|323208926|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
94387937|NCT02848326|323208927|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
94387938|NCT02848326|323208928|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
94387939|NCT02848326|323208929|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
94387940|NCT02848326|323208930|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
94387941|NCT02848326|323208925|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
94387942|NCT02848326|323208926|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
94387943|NCT02848326|323208927|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
94387944|NCT02848326|323208928|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
94387945|NCT02848326|323208929|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
94387946|NCT02848326|323208930|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
94387947|NCT02637232|323208932|FG000|Overall Study|Lost to Follow-up|42|||
94387948|NCT02637232|323208932|FG000|Overall Study|Adverse Event|11|||
94387949|NCT02637232|323208932|FG000|Overall Study|patient 's decision|2|||
94387950|NCT02999178|323208933|FG000|Overall Study|Adverse Event|85|||
94387951|NCT02999178|323208934|FG001|Overall Study|Adverse Event|62|||
94387952|NCT02999178|323208933|FG000|Overall Study|Protocol Violation|1|||
94387953|NCT02999178|323208934|FG001|Overall Study|Protocol Violation|2|||
94387954|NCT02999178|323208933|FG000|Overall Study|Lost to Follow-up|0|||
94387955|NCT02999178|323208934|FG001|Overall Study|Lost to Follow-up|2|||
94387956|NCT02999178|323208933|FG000|Overall Study|Withdrawal by Subject|21|||
94387957|NCT02999178|323208934|FG001|Overall Study|Withdrawal by Subject|21|||
94387958|NCT02999178|323208933|FG000|Overall Study|Other reason not defined above|7|||
94387959|NCT02999178|323208934|FG001|Overall Study|Other reason not defined above|13|||
94387960|NCT00090857|323208935|FG000|Overall Study|Lost to Follow-up|0|||
94387961|NCT00090857|323208936|FG001|Overall Study|Lost to Follow-up|1|||
94387962|NCT00090857|323208935|FG000|Overall Study|Withdrawal by Subject|2|||
94387963|NCT00090857|323208936|FG001|Overall Study|Withdrawal by Subject|0|||
94387964|NCT00090857|323208935|FG000|Overall Study|Adverse Event|2|||
94387965|NCT00090857|323208936|FG001|Overall Study|Adverse Event|2|||
94387966|NCT05097326|323208937|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
94387967|NCT05097326|323208938|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
94387968|NCT01244126|323208939|FG000|Overall Study|Protocol Violation|3|||
94387969|NCT01244126|323208940|FG001|Overall Study|Protocol Violation|3|||
94387970|NCT01244126|323208941|FG002|Overall Study|Protocol Violation|9|||
94387971|NCT01451762|323208942|FG000|Overall Study|Lost to Follow-up|3|||
94387972|NCT01451762|323208943|FG001|Overall Study|Lost to Follow-up|6|||
94387973|NCT01451762|323208944|FG002|Overall Study|Lost to Follow-up|6|||
94387974|NCT00630305|323208945|FG000|Overall Study|Withdrawal by Subject|1|||
94387975|NCT00630305|323208945|FG000|Overall Study|Inability to insert contact lens|1|||
94387976|NCT03471078|323208956|FG000|Overall Study|Withdrawal by Subject|9|||
94387977|NCT03471078|323208957|FG001|Overall Study|Withdrawal by Subject|1|||
94387978|NCT03471078|323208956|FG000|Overall Study|Adverse Event|4|||
94387979|NCT03471078|323208957|FG001|Overall Study|Adverse Event|1|||
94387980|NCT03471078|323208956|FG000|Overall Study|Physician Decision|3|||
94387981|NCT03471078|323208957|FG001|Overall Study|Physician Decision|2|||
94387982|NCT03471078|323208956|FG000|Overall Study|Death|2|||
94387983|NCT03471078|323208957|FG001|Overall Study|Death|0|||
94387984|NCT03471078|323208956|FG000|Overall Study|Other|3|||
94387985|NCT03471078|323208957|FG001|Overall Study|Other|2|||
94387986|NCT02817841|323208958|FG000|Overall Study|Lost to Follow-up|287|||
94387987|NCT02817841|323208958|FG000|Overall Study|Withdrawal by Subject|183|||
94387988|NCT02817841|323208958|FG000|Overall Study|Adverse event not related to bleeding|131|||
94324156|NCT00738374|322967089|FG002|Maintenance Treatment/Observation Phase|Other|0|||
94324157|NCT00738374|322967090|FG003|Maintenance Treatment/Observation Phase|Other|0|||
94324158|NCT00632541|322967091|FG000|Overall Study|Adverse Event|7|||
94324159|NCT00064350|322967094|FG000|Induction Treatment|Disease Progression|5|||
94324160|NCT00064350|322967095|FG001|Induction Treatment|Disease Progression|1|||
94324161|NCT00064350|322967096|FG002|Induction Treatment|Disease Progression|110|||
94324162|NCT00064350|322967094|FG000|Induction Treatment|Adverse Event|0|||
94324163|NCT00064350|322967095|FG001|Induction Treatment|Adverse Event|2|||
94324164|NCT00064350|322967096|FG002|Induction Treatment|Adverse Event|49|||
94324165|NCT00064350|322967094|FG000|Induction Treatment|Death|0|||
94387989|NCT02817841|323208958|FG000|Overall Study|Adverse event related to bleeding|51|||
94387990|NCT02817841|323208958|FG000|Overall Study|Pregnancy|32|||
94387991|NCT02817841|323208958|FG000|Overall Study|Pregnancy wish|17|||
94387992|NCT02817841|323208958|FG000|Overall Study|Other reasons|53|||
94324166|NCT00064350|322967095|FG001|Induction Treatment|Death|0|||
94387993|NCT02817841|323208958|FG000|Overall Study|Protocol Violation|94|||
94387994|NCT04720664|323208959|FG000|Overall Study|Adverse Event|2|||
94387995|NCT04720664|323208959|FG000|Overall Study|Lack of Efficacy|9|||
94387996|NCT00365300|323208967|FG000|Open-label Phase|Adverse Event|4|||
94387997|NCT00365300|323208968|FG001|Open-label Phase|Adverse Event|0|||
94387998|NCT00365300|323208967|FG000|Open-label Phase|Failed to Return|1|||
94387999|NCT00365300|323208968|FG001|Open-label Phase|Failed to Return|0|||
94388000|NCT00365300|323208967|FG000|Open-label Phase|Physician Decision|1|||
94388001|NCT00365300|323208968|FG001|Open-label Phase|Physician Decision|0|||
94388002|NCT00365300|323208967|FG000|Open-label Phase|Noncompliance|9|||
94388003|NCT00365300|323208968|FG001|Open-label Phase|Noncompliance|0|||
94388004|NCT00365300|323208967|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
94388005|NCT00365300|323208968|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
94388006|NCT00365300|323208967|FG000|Open-label Phase|Protocol Violation|1|||
94388007|NCT00365300|323208968|FG001|Open-label Phase|Protocol Violation|0|||
94388008|NCT00365300|323208967|FG000|Open-label Phase|Lack of Efficacy|1|||
94388009|NCT00365300|323208968|FG001|Open-label Phase|Lack of Efficacy|0|||
94388010|NCT00365300|323208967|FG000|Open-label Phase|Patient skipped open label phase|1|||
94388011|NCT00365300|323208968|FG001|Open-label Phase|Patient skipped open label phase|0|||
94388012|NCT00365300|323208967|FG000|Double-blind Phase|Failed to return|1|||
94388013|NCT00365300|323208968|FG001|Double-blind Phase|Failed to return|0|||
94388014|NCT00365300|323208967|FG000|Double-blind Phase|Noncompliance|1|||
94388015|NCT00365300|323208968|FG001|Double-blind Phase|Noncompliance|1|||
94324167|NCT00064350|322967096|FG002|Induction Treatment|Death|9|||
94324168|NCT00064350|322967094|FG000|Induction Treatment|Withdrawal by Subject|0|||
94324169|NCT00064350|322967095|FG001|Induction Treatment|Withdrawal by Subject|0|||
94324170|NCT00064350|322967096|FG002|Induction Treatment|Withdrawal by Subject|21|||
94324171|NCT00064350|322967094|FG000|Induction Treatment|Ineligible or never started treatment|3|||
94324172|NCT00064350|322967095|FG001|Induction Treatment|Ineligible or never started treatment|6|||
94324173|NCT00064350|322967096|FG002|Induction Treatment|Ineligible or never started treatment|34|||
94324174|NCT00064350|322967094|FG000|Induction Treatment|Other|0|||
94324175|NCT00064350|322967095|FG001|Induction Treatment|Other|0|||
94324176|NCT00064350|322967096|FG002|Induction Treatment|Other|13|||
94324177|NCT00064350|322967094|FG000|Randomization|Adverse Event|8|||
94324178|NCT00064350|322967095|FG001|Randomization|Adverse Event|3|||
94324179|NCT00064350|322967096|FG002|Randomization|Adverse Event|0|||
94324180|NCT00064350|322967094|FG000|Randomization|Death|3|||
94324181|NCT00064350|322967095|FG001|Randomization|Death|0|||
94324182|NCT00064350|322967096|FG002|Randomization|Death|0|||
94324183|NCT00064350|322967094|FG000|Randomization|Withdrawal by Subject|1|||
94324184|NCT00064350|322967095|FG001|Randomization|Withdrawal by Subject|0|||
94324185|NCT00064350|322967096|FG002|Randomization|Withdrawal by Subject|0|||
94324186|NCT00064350|322967094|FG000|Randomization|Ineligible or never started treatment|9|||
94324187|NCT00064350|322967095|FG001|Randomization|Ineligible or never started treatment|15|||
94324188|NCT00064350|322967096|FG002|Randomization|Ineligible or never started treatment|0|||
94324189|NCT00064350|322967094|FG000|Randomization|Other|5|||
94324190|NCT00064350|322967095|FG001|Randomization|Other|0|||
94324191|NCT00064350|322967096|FG002|Randomization|Other|0|||
94324192|NCT00064350|322967094|FG000|Cross-Over|Adverse Event|0|||
94324193|NCT00064350|322967095|FG001|Cross-Over|Adverse Event|1|||
94324194|NCT00064350|322967096|FG002|Cross-Over|Adverse Event|0|||
94324195|NCT00064350|322967094|FG000|Cross-Over|Death|1|||
94324196|NCT00064350|322967095|FG001|Cross-Over|Death|3|||
94324197|NCT00064350|322967096|FG002|Cross-Over|Death|0|||
94324198|NCT00064350|322967094|FG000|Cross-Over|Withdrawal by Subject|2|||
94324199|NCT00064350|322967095|FG001|Cross-Over|Withdrawal by Subject|2|||
94324200|NCT00064350|322967096|FG002|Cross-Over|Withdrawal by Subject|0|||
94324201|NCT00064350|322967094|FG000|Cross-Over|Ineligible or never started treatment|3|||
94324202|NCT00064350|322967095|FG001|Cross-Over|Ineligible or never started treatment|6|||
94324203|NCT00064350|322967096|FG002|Cross-Over|Ineligible or never started treatment|0|||
94324204|NCT00064350|322967094|FG000|Cross-Over|Other|0|||
94324205|NCT00064350|322967095|FG001|Cross-Over|Other|2|||
94388016|NCT00365300|323208967|FG000|Double-blind Phase|Withdrawal by Subject|0|||
94482487|NCT05067972|323558119|FG003|Part 1: Treatment|Physician Decision|1|||
94482488|NCT05067972|323558120|FG004|Part 1: Treatment|Physician Decision|0|||
94324206|NCT00064350|322967096|FG002|Cross-Over|Other|0|||
94324207|NCT01283997|322969417|FG000|Overall Study|Physician Decision|8|||
94324208|NCT01283997|322969418|FG001|Overall Study|Physician Decision|10|||
94324209|NCT01283997|322969417|FG000|Overall Study|Withdrawal by Subject|3|||
94324210|NCT01283997|322969418|FG001|Overall Study|Withdrawal by Subject|2|||
94324211|NCT01283997|322969417|FG000|Overall Study|Physically unable to continue|0|||
94324212|NCT01283997|322969418|FG001|Overall Study|Physically unable to continue|1|||
94388017|NCT00365300|323208968|FG001|Double-blind Phase|Withdrawal by Subject|1|||
94388018|NCT00365300|323208967|FG000|Double-blind Phase|Protocol Violation|3|||
94388019|NCT00365300|323208968|FG001|Double-blind Phase|Protocol Violation|1|||
94388020|NCT00365300|323208967|FG000|Double-blind Phase|Lack of Efficacy|6|||
94324213|NCT01283997|322969417|FG000|Overall Study|Progressive disease|1|||
94324214|NCT01283997|322969418|FG001|Overall Study|Progressive disease|0|||
94324215|NCT01283997|322969417|FG000|Overall Study|Other|4|||
94324216|NCT01283997|322969418|FG001|Overall Study|Other|4|||
94324217|NCT01179347|322969419|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
94324218|NCT01179347|322969420|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
94324219|NCT01179347|322969419|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
94324220|NCT01179347|322969420|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
94324221|NCT01179347|322969419|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
94324222|NCT01179347|322969420|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
94324223|NCT01179347|322969419|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
94324224|NCT01179347|322969420|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
94324225|NCT01179347|322969419|FG000|Double-blind Period (12 Weeks)|Other|2|||
94324226|NCT01179347|322969420|FG001|Double-blind Period (12 Weeks)|Other|4|||
94324227|NCT01179347|322969419|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
94324228|NCT01179347|322969420|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
94324229|NCT01179347|322969419|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
94324230|NCT01179347|322969420|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
94324231|NCT01179347|322969419|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
94324232|NCT01179347|322969420|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
94324233|NCT01179347|322969419|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
94324234|NCT01179347|322969420|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
94324235|NCT01179347|322969419|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
94324236|NCT01179347|322969420|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
94324237|NCT01179347|322969419|FG000|Open-label Period (12 Weeks)|Other|7|||
94324238|NCT01179347|322969420|FG001|Open-label Period (12 Weeks)|Other|4|||
94324239|NCT01116687|322969422|FG000|Overall Study|Withdrawal by Subject|4|||
94324240|NCT00424528|322969423|FG000|Overall Study|Adverse Event|2|||
94324241|NCT00424528|322969424|FG001|Overall Study|Adverse Event|1|||
94324242|NCT00424528|322969425|FG002|Overall Study|Adverse Event|2|||
94324243|NCT00424528|322969423|FG000|Overall Study|Protocol Violation|1|||
94324244|NCT00424528|322969424|FG001|Overall Study|Protocol Violation|1|||
94324245|NCT00424528|322969425|FG002|Overall Study|Protocol Violation|0|||
94324246|NCT00424528|322969423|FG000|Overall Study|Lost to Follow-up|0|||
94324247|NCT00424528|322969424|FG001|Overall Study|Lost to Follow-up|1|||
94324248|NCT00424528|322969425|FG002|Overall Study|Lost to Follow-up|0|||
94324249|NCT00424528|322969423|FG000|Overall Study|noncompliance with study requirements|2|||
94324250|NCT00424528|322969424|FG001|Overall Study|noncompliance with study requirements|1|||
94324251|NCT00424528|322969425|FG002|Overall Study|noncompliance with study requirements|2|||
94324252|NCT01369849|322969426|FG000|Overall Study|Ineligible prior to treatment|0|||
94324253|NCT01369849|322969427|FG001|Overall Study|Ineligible prior to treatment|0|||
94324254|NCT01369849|322969428|FG002|Overall Study|Ineligible prior to treatment|1|||
94324255|NCT01369849|322969426|FG000|Overall Study|Ineligible after receiving treatment|0|||
94324256|NCT01369849|322969427|FG001|Overall Study|Ineligible after receiving treatment|1|||
94324257|NCT01369849|322969428|FG002|Overall Study|Ineligible after receiving treatment|0|||
94324258|NCT01895452|322969430|FG000|Overall Study|Adverse Event|1|||
94324259|NCT01895452|322969431|FG001|Overall Study|Adverse Event|4|||
94324260|NCT01895452|322969430|FG000|Overall Study|Lost to Follow-up|1|||
94324261|NCT01895452|322969431|FG001|Overall Study|Lost to Follow-up|5|||
94324262|NCT01895452|322969430|FG000|Overall Study|Pregnancy|0|||
94324263|NCT01895452|322969431|FG001|Overall Study|Pregnancy|1|||
94324264|NCT01895452|322969430|FG000|Overall Study|Withdrawal by Subject|2|||
94324265|NCT01895452|322969431|FG001|Overall Study|Withdrawal by Subject|14|||
94324266|NCT01895452|322969430|FG000|Overall Study|Underlying disease|0|||
94324267|NCT01895452|322969431|FG001|Overall Study|Underlying disease|3|||
94324268|NCT01895452|322969430|FG000|Overall Study|Noncompliance with study drug|0|||
94324269|NCT01895452|322969431|FG001|Overall Study|Noncompliance with study drug|1|||
94324270|NCT00118482|322969434|FG000|Overall Study|Lost to Follow-up|7|||
94324271|NCT00118482|322969435|FG001|Overall Study|Lost to Follow-up|7|||
94324272|NCT00118482|322969434|FG000|Overall Study|Withdrawal by Subject|23|||
94324273|NCT00118482|322969435|FG001|Overall Study|Withdrawal by Subject|22|||
94324274|NCT04863014|322969439|FG000|Overall Study|Lost to Follow-up|3|||
94324275|NCT04863014|322969440|FG001|Overall Study|Lost to Follow-up|2|||
94324276|NCT04863014|322969439|FG000|Overall Study|Subject Decision|0|||
94324277|NCT04863014|322969440|FG001|Overall Study|Subject Decision|4|||
94324278|NCT01318512|322969441|FG000|Maintenance Period (6 Months)|Death|2|||
94324279|NCT01318512|322969441|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
94324280|NCT00975195|322969442|FG000|Overall Study|Adverse Event|108|||
94324281|NCT00975195|322969443|FG001|Overall Study|Adverse Event|101|||
94324282|NCT00975195|322969442|FG000|Overall Study|Lack of Efficacy|6|||
94324283|NCT00975195|322969443|FG001|Overall Study|Lack of Efficacy|6|||
94324284|NCT00975195|322969442|FG000|Overall Study|Protocol Violation|27|||
94324285|NCT00975195|322969443|FG001|Overall Study|Protocol Violation|23|||
94324286|NCT00975195|322969442|FG000|Overall Study|Lost to Follow-up|9|||
94324287|NCT00975195|322969443|FG001|Overall Study|Lost to Follow-up|7|||
94324288|NCT00975195|322969442|FG000|Overall Study|Withdrawal by Subject|48|||
94324289|NCT00975195|322969443|FG001|Overall Study|Withdrawal by Subject|61|||
94324290|NCT00975195|322969442|FG000|Overall Study|Other reason not defined above|29|||
94324291|NCT00975195|322969443|FG001|Overall Study|Other reason not defined above|33|||
94324292|NCT00975195|322969442|FG000|Overall Study|Not treated|1|||
94324293|NCT00975195|322969443|FG001|Overall Study|Not treated|2|||
94324294|NCT00363246|322969444|FG000|Overall Study|Death|40|||
94324295|NCT00363246|322969444|FG000|Overall Study|Withdrawal by Subject|19|||
94324296|NCT00363246|322969444|FG000|Overall Study|Lost to Follow-up|14|||
94324297|NCT00363246|322969444|FG000|Overall Study|Bad health|6|||
94324298|NCT00363246|322969444|FG000|Overall Study|Stopped using wheelchair|11|||
94324299|NCT00363246|322969444|FG000|Overall Study|Subject expressed security concerns|2|||
94324300|NCT00363246|322969444|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
94324301|NCT01608724|322969445|FG000|Overall Study|Withdrawal by Subject|131|||
94324302|NCT01608724|322969445|FG000|Overall Study|Lost to Follow-up|41|||
94324303|NCT01608724|322969445|FG000|Overall Study|Study-specific discontinuation criteria|32|||
94324304|NCT01608724|322969445|FG000|Overall Study|Adverse Event|29|||
94324305|NCT01608724|322969445|FG000|Overall Study|Protocol Violation|6|||
94324306|NCT01608724|322969445|FG000|Overall Study|bood sugar too high, etc.|3|||
94324307|NCT01608724|322969445|FG000|Overall Study|Safety reasons|1|||
94324308|NCT00264849|322969446|FG000|Overall Study|Adverse Event|7|||
94324309|NCT00264849|322969447|FG001|Overall Study|Adverse Event|2|||
94324310|NCT00264849|322969446|FG000|Overall Study|Withdrawal by Subject|7|||
94324311|NCT00264849|322969447|FG001|Overall Study|Withdrawal by Subject|11|||
94324312|NCT00264849|322969446|FG000|Overall Study|Protocol Violation|5|||
94324313|NCT00264849|322969447|FG001|Overall Study|Protocol Violation|3|||
94324314|NCT00264849|322969446|FG000|Overall Study|Lack of Efficacy|1|||
94324315|NCT00264849|322969447|FG001|Overall Study|Lack of Efficacy|6|||
94324316|NCT00264849|322969446|FG000|Overall Study|Lost to Follow-up|0|||
94324317|NCT00264849|322969447|FG001|Overall Study|Lost to Follow-up|2|||
94324318|NCT00264849|322969446|FG000|Overall Study|Death|0|||
94324319|NCT00264849|322969447|FG001|Overall Study|Death|1|||
94324320|NCT00264849|322969446|FG000|Overall Study|Administrative Problems|2|||
94324321|NCT00264849|322969447|FG001|Overall Study|Administrative Problems|0|||
94324322|NCT00717366|322969451|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
94324323|NCT00717366|322969452|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
94324324|NCT00717366|322969451|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
94324325|NCT00717366|322969452|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
94324326|NCT00717366|322969451|FG000|Core Study Period (20 Weeks)|Death|0|||
94324327|NCT00717366|322969452|FG001|Core Study Period (20 Weeks)|Death|1|||
94324328|NCT00717366|322969451|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
94324329|NCT00717366|322969452|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
94324330|NCT00717366|322969451|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
94324331|NCT00717366|322969452|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
94324332|NCT00717366|322969451|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
94324333|NCT00717366|322969452|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
94324334|NCT00717366|322969451|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
94324335|NCT00717366|322969452|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
94324336|NCT01822691|322969453|FG000|Overall Study|Withdrawal by Subject|2|||
94324337|NCT02756650|322969454|FG000|Overall Study|Physician Decision|1|||
94324338|NCT02756650|322969454|FG000|Overall Study|Adverse Event|1|||
94324339|NCT01553916|322969455|FG000|Overall Study|Withdrawal by Subject|2|||
94324340|NCT01553916|322969455|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
94324341|NCT03089216|322969460|FG000|Overall Study|Adverse Event|0|||
94324342|NCT03089216|322969461|FG001|Overall Study|Adverse Event|0|||
94324343|NCT03089216|322969462|FG002|Overall Study|Adverse Event|0|||
94324344|NCT03089216|322969463|FG003|Overall Study|Adverse Event|1|||
94324345|NCT00077376|322969464|FG000|Overall Study|Adverse Event|8|||
94324346|NCT00077376|322969464|FG000|Overall Study|Withdrawal by Subject|2|||
94324347|NCT00077376|322969464|FG000|Overall Study|Death|1|||
94324348|NCT00077376|322969464|FG000|Overall Study|Physician Decision|1|||
94324349|NCT00077376|322969464|FG000|Overall Study|Alternative therapy|5|||
94324350|NCT00077376|322969464|FG000|Overall Study|Complicating disease|1|||
94324351|NCT00077376|322969464|FG000|Overall Study|Still on treatment|1|||
94324352|NCT00077376|322969464|FG000|Overall Study|Symptomatic deterioration|1|||
94324353|NCT00077376|322969464|FG000|Overall Study|Surgery|1|||
94324354|NCT00077376|322969464|FG000|Overall Study|Insurance ran out|1|||
94324355|NCT04348591|322969465|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
94324356|NCT04348591|322969466|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
94324357|NCT04348591|322969465|FG000|Imaging Session (120 Min)|Physician Decision|0|||
94324358|NCT04348591|322969466|FG001|Imaging Session (120 Min)|Physician Decision|1|||
94324359|NCT04348591|322969465|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
94324360|NCT04348591|322969466|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
94324361|NCT00622869|322969468|FG000|Overall Study|Subject Withdrew Consent|13|||
94324362|NCT00622869|322969469|FG001|Overall Study|Subject Withdrew Consent|17|||
94324363|NCT00622869|322969470|FG002|Overall Study|Subject Withdrew Consent|11|||
94324364|NCT00622869|322969468|FG000|Overall Study|Administrative Problems|11|||
94324365|NCT00622869|322969469|FG001|Overall Study|Administrative Problems|17|||
94324366|NCT00622869|322969470|FG002|Overall Study|Administrative Problems|13|||
94324367|NCT00622869|322969468|FG000|Overall Study|Death|12|||
94324368|NCT00622869|322969469|FG001|Overall Study|Death|15|||
94324369|NCT00622869|322969470|FG002|Overall Study|Death|10|||
94324370|NCT00622869|322969468|FG000|Overall Study|Lost to Follow-up|2|||
94324371|NCT00622869|322969469|FG001|Overall Study|Lost to Follow-up|4|||
94388021|NCT00365300|323208968|FG001|Double-blind Phase|Lack of Efficacy|6|||
94388022|NCT00243932|323208969|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
94388023|NCT00243932|323208970|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
94388024|NCT00243932|323208971|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
94388025|NCT01179048|323208972|FG000|Overall Study|Withdrawn - does not allow contact|4|||
94388026|NCT01179048|323208973|FG001|Overall Study|Withdrawn - does not allow contact|8|||
94388027|NCT01179048|323208972|FG000|Overall Study|Lost to Follow-up|8|||
94388028|NCT01179048|323208973|FG001|Overall Study|Lost to Follow-up|9|||
94388029|NCT01179048|323208972|FG000|Overall Study|Alive|127|||
94388030|NCT01179048|323208973|FG001|Overall Study|Alive|142|||
94388031|NCT00528606|323208976|FG000|Overall Study|Withdrew consent|4|||
94388032|NCT00528606|323208977|FG001|Overall Study|Withdrew consent|3|||
94388033|NCT00528606|323208976|FG000|Overall Study|Lost to Follow-up|4|||
94388034|NCT00528606|323208977|FG001|Overall Study|Lost to Follow-up|1|||
94388035|NCT00528606|323208976|FG000|Overall Study|Adverse Event|3|||
94388036|NCT00528606|323208977|FG001|Overall Study|Adverse Event|0|||
94388037|NCT00528606|323208976|FG000|Overall Study|Other|2|||
94388038|NCT00528606|323208977|FG001|Overall Study|Other|0|||
94388039|NCT01471093|323208978|FG000|Overall Study|Adverse Event|1|||
94388040|NCT01471093|323208979|FG001|Overall Study|Adverse Event|0|||
94388041|NCT01471093|323208980|FG002|Overall Study|Adverse Event|0|||
94388042|NCT01471093|323208981|FG003|Overall Study|Adverse Event|0|||
94388043|NCT02465567|323208986|FG000|Overall Study|Adverse Event|118|||
94388044|NCT02465567|323208987|FG001|Overall Study|Adverse Event|113|||
94388045|NCT02465567|323208988|FG002|Overall Study|Adverse Event|147|||
94388046|NCT02465567|323208989|FG003|Overall Study|Adverse Event|138|||
94388047|NCT02465567|323208986|FG000|Overall Study|Lack of Efficacy|103|||
94388048|NCT02465567|323208987|FG001|Overall Study|Lack of Efficacy|102|||
94388049|NCT02465567|323208988|FG002|Overall Study|Lack of Efficacy|171|||
94388050|NCT02465567|323208989|FG003|Overall Study|Lack of Efficacy|135|||
94388051|NCT02465567|323208986|FG000|Overall Study|Withdrawal by Subject|104|||
94388052|NCT02465567|323208987|FG001|Overall Study|Withdrawal by Subject|94|||
94388053|NCT02465567|323208988|FG002|Overall Study|Withdrawal by Subject|123|||
94388054|NCT02465567|323208989|FG003|Overall Study|Withdrawal by Subject|130|||
94388055|NCT02465567|323208986|FG000|Overall Study|Physician Decision|23|||
94388056|NCT02465567|323208987|FG001|Overall Study|Physician Decision|33|||
94388057|NCT02465567|323208988|FG002|Overall Study|Physician Decision|38|||
94388058|NCT02465567|323208989|FG003|Overall Study|Physician Decision|28|||
94388059|NCT02465567|323208986|FG000|Overall Study|Major Protocol Deviation|24|||
94388060|NCT02465567|323208987|FG001|Overall Study|Major Protocol Deviation|26|||
94388061|NCT02465567|323208988|FG002|Overall Study|Major Protocol Deviation|22|||
94388062|NCT02465567|323208989|FG003|Overall Study|Major Protocol Deviation|25|||
94324372|NCT00622869|322969470|FG002|Overall Study|Lost to Follow-up|2|||
94388063|NCT02465567|323208986|FG000|Overall Study|Lost to Follow-up|25|||
94388064|NCT02465567|323208987|FG001|Overall Study|Lost to Follow-up|21|||
94388065|NCT02465567|323208988|FG002|Overall Study|Lost to Follow-up|19|||
94388066|NCT02465567|323208989|FG003|Overall Study|Lost to Follow-up|15|||
94324373|NCT00622869|322969468|FG000|Overall Study|Graft Loss|5|||
94324374|NCT00622869|322969469|FG001|Overall Study|Graft Loss|3|||
94324375|NCT00622869|322969470|FG002|Overall Study|Graft Loss|2|||
94324376|NCT00622869|322969468|FG000|Overall Study|Missing|0|||
94324377|NCT00622869|322969469|FG001|Overall Study|Missing|1|||
94324378|NCT00622869|322969470|FG002|Overall Study|Missing|1|||
94324379|NCT01778127|322969473|FG000|Overall Study|Lost to Follow-up|5|||
94324380|NCT01778127|322969474|FG001|Overall Study|Lost to Follow-up|1|||
94324381|NCT01778127|322969475|FG002|Overall Study|Lost to Follow-up|2|||
94324382|NCT01778127|322969473|FG000|Overall Study|Withdrawal by Subject|3|||
94324383|NCT01778127|322969474|FG001|Overall Study|Withdrawal by Subject|1|||
94324384|NCT01778127|322969475|FG002|Overall Study|Withdrawal by Subject|4|||
94324385|NCT02720016|322969476|FG000|Overall Study|Separation of couple|6|||
94324386|NCT02720016|322969477|FG001|Overall Study|Separation of couple|8|||
94324387|NCT02720016|322969478|FG002|Overall Study|Separation of couple|2|||
94388067|NCT02465567|323208986|FG000|Overall Study|Protocol Specified Criteria|20|||
94388068|NCT02465567|323208987|FG001|Overall Study|Protocol Specified Criteria|10|||
94388069|NCT02465567|323208988|FG002|Overall Study|Protocol Specified Criteria|9|||
94324388|NCT02720016|322969476|FG000|Overall Study|Withdrawal by Subject|6|||
94388070|NCT02465567|323208989|FG003|Overall Study|Protocol Specified Criteria|12|||
94388071|NCT02465567|323208986|FG000|Overall Study|Administrative Reasons|12|||
94388072|NCT02465567|323208987|FG001|Overall Study|Administrative Reasons|9|||
94388073|NCT02465567|323208988|FG002|Overall Study|Administrative Reasons|11|||
94388074|NCT02465567|323208989|FG003|Overall Study|Administrative Reasons|5|||
94324389|NCT02720016|322969477|FG001|Overall Study|Withdrawal by Subject|6|||
94324390|NCT02720016|322969478|FG002|Overall Study|Withdrawal by Subject|4|||
94388075|NCT02465567|323208986|FG000|Overall Study|Randomized but not treated|1|||
94388076|NCT02465567|323208987|FG001|Overall Study|Randomized but not treated|5|||
94388077|NCT02465567|323208988|FG002|Overall Study|Randomized but not treated|4|||
94388078|NCT02465567|323208989|FG003|Overall Study|Randomized but not treated|5|||
94388079|NCT02465567|323208986|FG000|Overall Study|enrolled in >1 studies|18|||
94388080|NCT02465567|323208987|FG001|Overall Study|enrolled in >1 studies|11|||
94388081|NCT02465567|323208988|FG002|Overall Study|enrolled in >1 studies|19|||
94388082|NCT02465567|323208989|FG003|Overall Study|enrolled in >1 studies|15|||
94388083|NCT02465567|323208986|FG000|Overall Study|missing PI Signature|1|||
94388084|NCT02465567|323208987|FG001|Overall Study|missing PI Signature|0|||
94388085|NCT02465567|323208988|FG002|Overall Study|missing PI Signature|0|||
94388086|NCT02465567|323208989|FG003|Overall Study|missing PI Signature|0|||
94388087|NCT00569374|323208991|FG000|Overall Study|Withdrawal by Subject|4|||
94388088|NCT01666730|323208992|FG000|Overall Study|Adverse Event|16|||
94388089|NCT01666730|323208992|FG000|Overall Study|Death|2|||
94388090|NCT01666730|323208992|FG000|Overall Study|Physician Decision|5|||
94388091|NCT01666730|323208992|FG000|Overall Study|Withdrawal by Subject|9|||
94388092|NCT01666730|323208992|FG000|Overall Study|Disease progression/relapse|18|||
94388093|NCT01735630|323208993|FG000|Overall Study|Adverse Event|8|||
94388094|NCT01735630|323208994|FG001|Overall Study|Adverse Event|7|||
94388095|NCT01735630|323208993|FG000|Overall Study|Lost to Follow-up|1|||
94388096|NCT01735630|323208994|FG001|Overall Study|Lost to Follow-up|0|||
94388097|NCT01735630|323208993|FG000|Overall Study|Physician Decision|0|||
94388098|NCT01735630|323208994|FG001|Overall Study|Physician Decision|1|||
94388099|NCT01735630|323208993|FG000|Overall Study|Sponsor Decision|2|||
94388100|NCT01735630|323208994|FG001|Overall Study|Sponsor Decision|1|||
94388101|NCT01735630|323208993|FG000|Overall Study|Withdrawal by Subject|7|||
94388102|NCT01735630|323208994|FG001|Overall Study|Withdrawal by Subject|9|||
94388103|NCT03099538|323208995|FG000|Overall Study|Lack of Efficacy|3|||
94388104|NCT02178722|323208996|FG000|Overall Study|Withdrawal by Subject|0|||
94388105|NCT02178722|323208997|FG001|Overall Study|Withdrawal by Subject|0|||
94388106|NCT02178722|323208998|FG002|Overall Study|Withdrawal by Subject|0|||
94388107|NCT02178722|323208999|FG003|Overall Study|Withdrawal by Subject|2|||
94388108|NCT02178722|323209000|FG004|Overall Study|Withdrawal by Subject|33|||
94388109|NCT02178722|323208996|FG000|Overall Study|Death|2|||
94388110|NCT02178722|323208997|FG001|Overall Study|Death|13|||
94388111|NCT02178722|323208998|FG002|Overall Study|Death|12|||
94388112|NCT02178722|323208999|FG003|Overall Study|Death|12|||
94388113|NCT02178722|323209000|FG004|Overall Study|Death|205|||
94388114|NCT02178722|323208996|FG000|Overall Study|Lost to Follow-up|0|||
94388115|NCT02178722|323208997|FG001|Overall Study|Lost to Follow-up|0|||
94388116|NCT02178722|323208998|FG002|Overall Study|Lost to Follow-up|0|||
94388117|NCT02178722|323208999|FG003|Overall Study|Lost to Follow-up|2|||
94388118|NCT02178722|323209000|FG004|Overall Study|Lost to Follow-up|11|||
94388119|NCT02178722|323208996|FG000|Overall Study|Study terminated by Sponsor|2|||
94388120|NCT02178722|323208997|FG001|Overall Study|Study terminated by Sponsor|7|||
94388121|NCT02178722|323208998|FG002|Overall Study|Study terminated by Sponsor|6|||
94388122|NCT02178722|323208999|FG003|Overall Study|Study terminated by Sponsor|4|||
94388123|NCT02178722|323209000|FG004|Overall Study|Study terminated by Sponsor|128|||
94388124|NCT02178722|323208996|FG000|Overall Study|Physician Decision|0|||
94388125|NCT02178722|323208997|FG001|Overall Study|Physician Decision|0|||
94388126|NCT02178722|323208998|FG002|Overall Study|Physician Decision|0|||
94388127|NCT02178722|323208999|FG003|Overall Study|Physician Decision|0|||
94388128|NCT02178722|323209000|FG004|Overall Study|Physician Decision|3|||
94388129|NCT02178722|323208996|FG000|Overall Study|Other|0|||
94388130|NCT02178722|323208997|FG001|Overall Study|Other|0|||
94388131|NCT02178722|323208998|FG002|Overall Study|Other|0|||
94388132|NCT02178722|323208999|FG003|Overall Study|Other|0|||
94388133|NCT02178722|323209000|FG004|Overall Study|Other|2|||
94388134|NCT00440557|323209001|FG000|Overall Study|Withdrawal by Subject|10|||
94388135|NCT00440557|323209002|FG001|Overall Study|Withdrawal by Subject|5|||
94388136|NCT00440557|323209003|FG002|Overall Study|Withdrawal by Subject|11|||
94388137|NCT00440557|323209001|FG000|Overall Study|Lost to Follow-up|1|||
94388138|NCT00440557|323209002|FG001|Overall Study|Lost to Follow-up|2|||
94388139|NCT00440557|323209003|FG002|Overall Study|Lost to Follow-up|6|||
94388140|NCT00440557|323209001|FG000|Overall Study|Adverse Event|3|||
94388141|NCT00440557|323209002|FG001|Overall Study|Adverse Event|3|||
94388142|NCT00440557|323209003|FG002|Overall Study|Adverse Event|5|||
94388143|NCT00440557|323209001|FG000|Overall Study|Death|2|||
94388144|NCT00440557|323209002|FG001|Overall Study|Death|6|||
94388145|NCT00440557|323209003|FG002|Overall Study|Death|3|||
94388146|NCT00440557|323209001|FG000|Overall Study|Began Dialysis|4|||
94388147|NCT00440557|323209002|FG001|Overall Study|Began Dialysis|1|||
94388148|NCT00440557|323209003|FG002|Overall Study|Began Dialysis|4|||
94388149|NCT00440557|323209001|FG000|Overall Study|Principal Investigator decision|0|||
94388150|NCT00440557|323209002|FG001|Overall Study|Principal Investigator decision|3|||
94388151|NCT00440557|323209003|FG002|Overall Study|Principal Investigator decision|1|||
94388152|NCT00440557|323209001|FG000|Overall Study|Patient moved|1|||
94388153|NCT00440557|323209002|FG001|Overall Study|Patient moved|2|||
94388154|NCT00440557|323209003|FG002|Overall Study|Patient moved|1|||
94388155|NCT00440557|323209001|FG000|Overall Study|Principal Investigator's office closed|3|||
94388156|NCT00440557|323209002|FG001|Overall Study|Principal Investigator's office closed|6|||
94388157|NCT00440557|323209003|FG002|Overall Study|Principal Investigator's office closed|4|||
94388158|NCT00440557|323209001|FG000|Overall Study|Patient transferred to nursing home|0|||
94388159|NCT00440557|323209002|FG001|Overall Study|Patient transferred to nursing home|1|||
94388160|NCT00440557|323209003|FG002|Overall Study|Patient transferred to nursing home|0|||
94388161|NCT00440557|323209001|FG000|Overall Study|Patient had surgery|1|||
94388162|NCT00440557|323209002|FG001|Overall Study|Patient had surgery|0|||
94388163|NCT00440557|323209003|FG002|Overall Study|Patient had surgery|0|||
94388164|NCT03340727|323209004|FG000|Overall Study|Death|1|||
94388165|NCT03340727|323209005|FG001|Overall Study|Death|0|||
94388166|NCT03340727|323209004|FG000|Overall Study|Lost to Follow-up|31|||
94388167|NCT03340727|323209005|FG001|Overall Study|Lost to Follow-up|35|||
94388168|NCT03340727|323209004|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
94388169|NCT03340727|323209005|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
94388170|NCT03340727|323209004|FG000|Overall Study|Transferred to another facility|10|||
94388171|NCT03340727|323209005|FG001|Overall Study|Transferred to another facility|7|||
94388172|NCT03340727|323209004|FG000|Overall Study|Withdrawal by Subject|28|||
94388173|NCT03340727|323209005|FG001|Overall Study|Withdrawal by Subject|17|||
94388174|NCT01572948|323209006|FG000|Overall Study|Lost to Follow-up|1|||
94388175|NCT01572948|323209007|FG001|Overall Study|Lost to Follow-up|0|||
94388176|NCT01572948|323209006|FG000|Overall Study|unable to contact|0|||
94388177|NCT01572948|323209007|FG001|Overall Study|unable to contact|1|||
94388178|NCT03553823|323209008|FG000|Overall Study|Physician Decision|0|||
94388179|NCT03553823|323209009|FG001|Overall Study|Physician Decision|1|||
94388180|NCT03603314|323209010|FG000|Overall Study|Lost to Follow-up|0|||
94388181|NCT03603314|323209011|FG001|Overall Study|Lost to Follow-up|3|||
94388182|NCT03603314|323209012|FG002|Overall Study|Lost to Follow-up|0|||
94388183|NCT03603314|323209010|FG000|Overall Study|Protocol Violation|0|||
94388184|NCT03603314|323209011|FG001|Overall Study|Protocol Violation|1|||
94388185|NCT03603314|323209012|FG002|Overall Study|Protocol Violation|0|||
94388186|NCT03603314|323209010|FG000|Overall Study|Adverse Event|2|||
94388187|NCT03603314|323209011|FG001|Overall Study|Adverse Event|0|||
94324391|NCT02720016|322969476|FG000|Overall Study|Scheduling issues|2|||
94324392|NCT02720016|322969477|FG001|Overall Study|Scheduling issues|4|||
94324393|NCT02720016|322969478|FG002|Overall Study|Scheduling issues|7|||
94324394|NCT02720016|322969476|FG000|Overall Study|Childcare|2|||
94324395|NCT02720016|322969477|FG001|Overall Study|Childcare|0|||
94324396|NCT02720016|322969478|FG002|Overall Study|Childcare|2|||
94324397|NCT02720016|322969476|FG000|Overall Study|Withdrawal by PI|2|||
94324398|NCT02720016|322969477|FG001|Overall Study|Withdrawal by PI|2|||
94324399|NCT02720016|322969478|FG002|Overall Study|Withdrawal by PI|0|||
94324400|NCT02720016|322969476|FG000|Overall Study|Moved away|2|||
94324401|NCT02720016|322969477|FG001|Overall Study|Moved away|0|||
94324402|NCT02720016|322969478|FG002|Overall Study|Moved away|0|||
94324403|NCT02720016|322969476|FG000|Overall Study|Not Primary Health Concern|0|||
94324404|NCT02720016|322969477|FG001|Overall Study|Not Primary Health Concern|0|||
94324405|NCT02720016|322969478|FG002|Overall Study|Not Primary Health Concern|2|||
94324406|NCT02720016|322969476|FG000|Overall Study|Transportation issues|0|||
94324407|NCT02720016|322969477|FG001|Overall Study|Transportation issues|0|||
94324408|NCT02720016|322969478|FG002|Overall Study|Transportation issues|1|||
94324409|NCT02720016|322969476|FG000|Overall Study|Other|0|||
94324410|NCT02720016|322969477|FG001|Overall Study|Other|0|||
94324411|NCT02720016|322969478|FG002|Overall Study|Other|2|||
94324412|NCT03722784|322969483|FG000|Overall Study|Withdrawal by Subject|1|||
94324413|NCT03722784|322969484|FG001|Overall Study|Withdrawal by Subject|0|||
94324414|NCT03722784|322969483|FG000|Overall Study|Physician Decision|1|||
94324415|NCT03722784|322969484|FG001|Overall Study|Physician Decision|1|||
94324416|NCT03722784|322969483|FG000|Overall Study|Protocol Violation|0|||
94324417|NCT03722784|322969484|FG001|Overall Study|Protocol Violation|1|||
94324418|NCT04501679|322969485|FG000|Overall Study|Pregnancy|0|||
94324419|NCT04501679|322969486|FG001|Overall Study|Pregnancy|1|||
94324420|NCT04501679|322969485|FG000|Overall Study|Adverse Event|4|||
94324421|NCT04501679|322969486|FG001|Overall Study|Adverse Event|2|||
94324422|NCT04501679|322969485|FG000|Overall Study|Withdrawal by Subject|2|||
94388188|NCT03603314|323209012|FG002|Overall Study|Adverse Event|0|||
94388189|NCT03603314|323209010|FG000|Overall Study|Physician Decision|1|||
94388190|NCT03603314|323209011|FG001|Overall Study|Physician Decision|1|||
94388191|NCT03603314|323209012|FG002|Overall Study|Physician Decision|0|||
94388192|NCT03603314|323209010|FG000|Overall Study|Withdrawal by Subject|4|||
94388193|NCT03603314|323209011|FG001|Overall Study|Withdrawal by Subject|5|||
94324423|NCT04501679|322969486|FG001|Overall Study|Withdrawal by Subject|0|||
94324424|NCT04501679|322969485|FG000|Overall Study|Physician Decision|1|||
94324425|NCT04501679|322969486|FG001|Overall Study|Physician Decision|0|||
94324426|NCT04501679|322969485|FG000|Overall Study|Lost to Follow-up|2|||
94388194|NCT03603314|323209012|FG002|Overall Study|Withdrawal by Subject|3|||
94388195|NCT03603314|323209010|FG000|Overall Study|Other|0|||
94388196|NCT03603314|323209011|FG001|Overall Study|Other|1|||
94324427|NCT04501679|322969486|FG001|Overall Study|Lost to Follow-up|0|||
94324428|NCT03288493|322969489|FG000|Overall Study|Withdrawal by Subject|4|||
94324429|NCT03288493|322969490|FG001|Overall Study|Withdrawal by Subject|0|||
94324430|NCT03288493|322969491|FG002|Overall Study|Withdrawal by Subject|0|||
94324431|NCT03288493|322969492|FG003|Overall Study|Withdrawal by Subject|0|||
94324432|NCT03288493|322969493|FG004|Overall Study|Withdrawal by Subject|0|||
94324433|NCT03288493|322969494|FG005|Overall Study|Withdrawal by Subject|2|||
94324434|NCT03288493|322969495|FG006|Overall Study|Withdrawal by Subject|0|||
94324435|NCT03288493|322969489|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
94324436|NCT03288493|322969490|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
94324437|NCT03288493|322969491|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
94324438|NCT03288493|322969492|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
94324439|NCT03288493|322969493|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
94324440|NCT03288493|322969494|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
94324441|NCT03288493|322969495|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
94324442|NCT03288493|322969489|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
94324443|NCT03288493|322969490|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
94324444|NCT03288493|322969491|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
94324445|NCT03288493|322969492|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
94324446|NCT03288493|322969493|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
94324447|NCT03288493|322969494|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
94324448|NCT03288493|322969495|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
94324449|NCT03288493|322969489|FG000|Overall Study|Death|2|||
94324450|NCT03288493|322969490|FG001|Overall Study|Death|0|||
94324451|NCT03288493|322969491|FG002|Overall Study|Death|0|||
94324452|NCT03288493|322969492|FG003|Overall Study|Death|0|||
94324453|NCT03288493|322969493|FG004|Overall Study|Death|0|||
94324454|NCT03288493|322969494|FG005|Overall Study|Death|0|||
94324455|NCT03288493|322969495|FG006|Overall Study|Death|0|||
94324456|NCT03288493|322969489|FG000|Overall Study|other reason not listed above|2|||
94324457|NCT03288493|322969490|FG001|Overall Study|other reason not listed above|0|||
94324458|NCT03288493|322969491|FG002|Overall Study|other reason not listed above|0|||
94324459|NCT03288493|322969492|FG003|Overall Study|other reason not listed above|0|||
94324460|NCT03288493|322969493|FG004|Overall Study|other reason not listed above|0|||
94324461|NCT03288493|322969494|FG005|Overall Study|other reason not listed above|0|||
94324462|NCT03288493|322969495|FG006|Overall Study|other reason not listed above|0|||
94324463|NCT01317615|322969496|FG000|Overall Study|Disease progression|25|||
94324464|NCT01317615|322969496|FG000|Overall Study|New cancer therapy|5|||
94324465|NCT01317615|322969496|FG000|Overall Study|Death|6|||
94324466|NCT01317615|322969496|FG000|Overall Study|Withdrawal by Subject|5|||
94324467|NCT01317615|322969496|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94324468|NCT01317615|322969496|FG000|Overall Study|Adverse Event|7|||
94324469|NCT01968954|322969497|FG000|Overall Study|Adverse Event|6|||
94324470|NCT01968954|322969498|FG001|Overall Study|Adverse Event|3|||
94324471|NCT01968954|322969497|FG000|Overall Study|Death|1|||
94324472|NCT01968954|322969498|FG001|Overall Study|Death|2|||
94324473|NCT01968954|322969497|FG000|Overall Study|Lost to Follow-up|6|||
94324474|NCT01968954|322969498|FG001|Overall Study|Lost to Follow-up|4|||
94324475|NCT01968954|322969497|FG000|Overall Study|Withdrawal by Subject|20|||
94324476|NCT01968954|322969498|FG001|Overall Study|Withdrawal by Subject|23|||
94324477|NCT01968954|322969497|FG000|Overall Study|Other|7|||
94324478|NCT01968954|322969498|FG001|Overall Study|Other|8|||
94324479|NCT01968954|322969497|FG000|Overall Study|Protocol Violation|0|||
94324480|NCT01968954|322969498|FG001|Overall Study|Protocol Violation|1|||
94324481|NCT01968954|322969497|FG000|Overall Study|Did not met inclusion criteria|0|||
94324482|NCT01968954|322969498|FG001|Overall Study|Did not met inclusion criteria|2|||
94324483|NCT00645567|322969499|FG000|Overall Study|Adverse Event|1|||
94324484|NCT04664855|322969500|FG000|Overall Study|Withdrawal by Subject|0|||
94324485|NCT04664855|322969501|FG001|Overall Study|Withdrawal by Subject|2|||
94324486|NCT02648724|322969502|FG000|Overall Study|Withdrawal by Subject|0|||
94324487|NCT02648724|322969503|FG001|Overall Study|Withdrawal by Subject|1|||
94324488|NCT02648724|322969504|FG002|Overall Study|Withdrawal by Subject|1|||
94324489|NCT02648724|322969505|FG003|Overall Study|Withdrawal by Subject|0|||
94324490|NCT02648724|322969506|FG004|Overall Study|Withdrawal by Subject|1|||
94324491|NCT02648724|322969507|FG005|Overall Study|Withdrawal by Subject|0|||
94324492|NCT02648724|322969508|FG006|Overall Study|Withdrawal by Subject|0|||
94324493|NCT02648724|322969502|FG000|Overall Study|Progressive disease|2|||
94324494|NCT02648724|322969503|FG001|Overall Study|Progressive disease|2|||
94388197|NCT03603314|323209012|FG002|Overall Study|Other|0|||
94324495|NCT02648724|322969504|FG002|Overall Study|Progressive disease|2|||
94324496|NCT02648724|322969505|FG003|Overall Study|Progressive disease|3|||
94324497|NCT02648724|322969506|FG004|Overall Study|Progressive disease|22|||
94324498|NCT02648724|322969507|FG005|Overall Study|Progressive disease|7|||
94324499|NCT02648724|322969508|FG006|Overall Study|Progressive disease|8|||
94324500|NCT02648724|322969502|FG000|Overall Study|Other reason (unknown)|1|||
94324501|NCT02648724|322969503|FG001|Overall Study|Other reason (unknown)|0|||
94324502|NCT02648724|322969504|FG002|Overall Study|Other reason (unknown)|0|||
94324503|NCT02648724|322969505|FG003|Overall Study|Other reason (unknown)|0|||
94324504|NCT02648724|322969506|FG004|Overall Study|Other reason (unknown)|0|||
94324505|NCT02648724|322969507|FG005|Overall Study|Other reason (unknown)|0|||
94324506|NCT02648724|322969508|FG006|Overall Study|Other reason (unknown)|0|||
94324507|NCT02648724|322969502|FG000|Overall Study|Protocol Violation|0|||
94324508|NCT02648724|322969503|FG001|Overall Study|Protocol Violation|0|||
94324509|NCT02648724|322969504|FG002|Overall Study|Protocol Violation|0|||
94324510|NCT02648724|322969505|FG003|Overall Study|Protocol Violation|0|||
94324511|NCT02648724|322969506|FG004|Overall Study|Protocol Violation|1|||
94324512|NCT02648724|322969507|FG005|Overall Study|Protocol Violation|0|||
94324513|NCT02648724|322969508|FG006|Overall Study|Protocol Violation|0|||
94324514|NCT02648724|322969502|FG000|Overall Study|Death|0|||
94324515|NCT02648724|322969503|FG001|Overall Study|Death|0|||
94324516|NCT02648724|322969504|FG002|Overall Study|Death|0|||
94324517|NCT02648724|322969505|FG003|Overall Study|Death|0|||
94324518|NCT02648724|322969506|FG004|Overall Study|Death|0|||
94324519|NCT02648724|322969507|FG005|Overall Study|Death|0|||
94324520|NCT02648724|322969508|FG006|Overall Study|Death|3|||
94324521|NCT02648724|322969502|FG000|Overall Study|Physician Decision|0|||
94324522|NCT02648724|322969503|FG001|Overall Study|Physician Decision|0|||
94324523|NCT02648724|322969504|FG002|Overall Study|Physician Decision|0|||
94324524|NCT02648724|322969505|FG003|Overall Study|Physician Decision|0|||
94324525|NCT02648724|322969506|FG004|Overall Study|Physician Decision|1|||
94324526|NCT02648724|322969507|FG005|Overall Study|Physician Decision|0|||
94324527|NCT02648724|322969508|FG006|Overall Study|Physician Decision|1|||
94324528|NCT02648724|322969502|FG000|Overall Study|Transferred to named patient program|0|||
94324529|NCT02648724|322969503|FG001|Overall Study|Transferred to named patient program|0|||
94324530|NCT02648724|322969504|FG002|Overall Study|Transferred to named patient program|0|||
94324531|NCT02648724|322969505|FG003|Overall Study|Transferred to named patient program|0|||
94324532|NCT02648724|322969506|FG004|Overall Study|Transferred to named patient program|0|||
94324533|NCT02648724|322969507|FG005|Overall Study|Transferred to named patient program|1|||
94324534|NCT02648724|322969508|FG006|Overall Study|Transferred to named patient program|0|||
94324535|NCT05127421|322969509|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
94324536|NCT05127421|322969510|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
94324537|NCT05127421|322969511|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
94324538|NCT05127421|322969512|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
94324539|NCT05127421|322969509|FG000|4-Week Double-Blind Period|Physician Decision|1|||
94324540|NCT05127421|322969510|FG001|4-Week Double-Blind Period|Physician Decision|0|||
94324541|NCT05127421|322969511|FG002|4-Week Double-Blind Period|Physician Decision|0|||
94324542|NCT05127421|322969512|FG003|4-Week Double-Blind Period|Physician Decision|0|||
94324543|NCT05127421|322969509|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
94324544|NCT05127421|322969510|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
94324545|NCT05127421|322969511|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
94324546|NCT05127421|322969512|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
94324547|NCT05127421|322969509|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
94324548|NCT05127421|322969510|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
94324549|NCT05127421|322969511|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
94324550|NCT05127421|322969512|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
94324551|NCT05127421|322969509|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
94324552|NCT05127421|322969510|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
94324553|NCT05127421|322969511|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
94324554|NCT05127421|322969512|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
94324555|NCT05127421|322969509|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
94324556|NCT05127421|322969510|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
94324557|NCT05127421|322969511|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
94324558|NCT05127421|322969512|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
94324559|NCT05127421|322969509|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
94324560|NCT05127421|322969510|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
94324561|NCT05127421|322969511|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
94388198|NCT03450070|323209013|FG000|Overall Study|Withdrawal by Subject|8|||
94324562|NCT05127421|322969512|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
94324563|NCT05127421|322969509|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
94324564|NCT05127421|322969510|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
94324565|NCT05127421|322969511|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
94388199|NCT01126736|323209017|FG000|Overall Study|Death|2|||
94324566|NCT05127421|322969512|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
94324567|NCT03655717|322969519|FG000|Overall Study|Withdrawal by Subject|4|||
94324568|NCT03655717|322969520|FG001|Overall Study|Withdrawal by Subject|8|||
94324569|NCT03655717|322969521|FG002|Overall Study|Withdrawal by Subject|1|||
94324570|NCT03655717|322969522|FG003|Overall Study|Withdrawal by Subject|0|||
94324571|NCT03655717|322969523|FG004|Overall Study|Withdrawal by Subject|0|||
94324572|NCT03655717|322969524|FG005|Overall Study|Withdrawal by Subject|1|||
94388200|NCT01126736|323209018|FG001|Overall Study|Death|2|||
94388201|NCT01126736|323209019|FG002|Overall Study|Death|1|||
94388202|NCT01126736|323209020|FG003|Overall Study|Death|19|||
94388203|NCT01126736|323209021|FG004|Overall Study|Death|19|||
94388204|NCT01126736|323209017|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
94388205|NCT01126736|323209018|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
94388206|NCT01126736|323209019|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
94388207|NCT01126736|323209020|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
94388208|NCT01126736|323209021|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
94388209|NCT01126736|323209017|FG000|Overall Study|Lost to Follow-up|0|||
94388210|NCT01126736|323209018|FG001|Overall Study|Lost to Follow-up|0|||
94388211|NCT01126736|323209019|FG002|Overall Study|Lost to Follow-up|0|||
94388212|NCT01126736|323209020|FG003|Overall Study|Lost to Follow-up|1|||
94388213|NCT01126736|323209021|FG004|Overall Study|Lost to Follow-up|1|||
94388214|NCT01126736|323209017|FG000|Overall Study|Administrative reasons|0|||
94388215|NCT01126736|323209018|FG001|Overall Study|Administrative reasons|0|||
94388216|NCT01126736|323209019|FG002|Overall Study|Administrative reasons|0|||
94388217|NCT01126736|323209020|FG003|Overall Study|Administrative reasons|0|||
94388218|NCT01126736|323209021|FG004|Overall Study|Administrative reasons|1|||
94388219|NCT01126736|323209017|FG000|Overall Study|Progressive disease|0|||
94388220|NCT01126736|323209018|FG001|Overall Study|Progressive disease|0|||
94388221|NCT01126736|323209019|FG002|Overall Study|Progressive disease|0|||
94388222|NCT01126736|323209020|FG003|Overall Study|Progressive disease|2|||
94388223|NCT01126736|323209021|FG004|Overall Study|Progressive disease|1|||
94388224|NCT01126736|323209017|FG000|Overall Study|Withdrawal by Subject|0|||
94388225|NCT01126736|323209018|FG001|Overall Study|Withdrawal by Subject|0|||
94388226|NCT01126736|323209019|FG002|Overall Study|Withdrawal by Subject|0|||
94388227|NCT01126736|323209020|FG003|Overall Study|Withdrawal by Subject|1|||
94388228|NCT01126736|323209021|FG004|Overall Study|Withdrawal by Subject|1|||
94388229|NCT01126736|323209017|FG000|Overall Study|Other|2|||
94388230|NCT01126736|323209018|FG001|Overall Study|Other|4|||
94388231|NCT01126736|323209019|FG002|Overall Study|Other|4|||
94388232|NCT01126736|323209020|FG003|Overall Study|Other|16|||
94388233|NCT01126736|323209021|FG004|Overall Study|Other|15|||
94388234|NCT02193880|323209022|FG000|Overall Study|patients did not collect enough HPC|3|||
94388235|NCT02914600|323209027|FG000|Overall Study|Adverse Event|298|||
94388236|NCT02914600|323209028|FG001|Overall Study|Adverse Event|35|||
94388237|NCT02914600|323209029|FG002|Overall Study|Adverse Event|25|||
94388238|NCT02914600|323209027|FG000|Overall Study|Sponsors decision|287|||
94388239|NCT02914600|323209028|FG001|Overall Study|Sponsors decision|41|||
94388240|NCT02914600|323209029|FG002|Overall Study|Sponsors decision|12|||
94388241|NCT02914600|323209027|FG000|Overall Study|Withdrawal by Subject|158|||
94388242|NCT02914600|323209028|FG001|Overall Study|Withdrawal by Subject|20|||
94388243|NCT02914600|323209029|FG002|Overall Study|Withdrawal by Subject|18|||
94388244|NCT02914600|323209027|FG000|Overall Study|Investigators discretion|169|||
94388245|NCT02914600|323209028|FG001|Overall Study|Investigators discretion|14|||
94388246|NCT02914600|323209029|FG002|Overall Study|Investigators discretion|13|||
94388247|NCT02914600|323209027|FG000|Overall Study|Lost to Follow-up|10|||
94388248|NCT02914600|323209028|FG001|Overall Study|Lost to Follow-up|4|||
94388249|NCT02914600|323209029|FG002|Overall Study|Lost to Follow-up|0|||
94388250|NCT02914600|323209027|FG000|Overall Study|Pregnancy|8|||
94388251|NCT02914600|323209028|FG001|Overall Study|Pregnancy|0|||
94388252|NCT02914600|323209029|FG002|Overall Study|Pregnancy|0|||
94388253|NCT02914600|323209027|FG000|Overall Study|Protocol Violation|5|||
94388254|NCT02914600|323209028|FG001|Overall Study|Protocol Violation|3|||
94324573|NCT03655717|322969525|FG006|Overall Study|Withdrawal by Subject|3|||
94388255|NCT02914600|323209029|FG002|Overall Study|Protocol Violation|0|||
94388256|NCT02914600|323209027|FG000|Overall Study|Non-compliance with study drug|6|||
94388257|NCT02914600|323209028|FG001|Overall Study|Non-compliance with study drug|1|||
94324574|NCT03655717|322969526|FG007|Overall Study|Withdrawal by Subject|1|||
94324575|NCT03655717|322969527|FG008|Overall Study|Withdrawal by Subject|2|||
94324576|NCT03655717|322969528|FG009|Overall Study|Withdrawal by Subject|0|||
94388258|NCT02914600|323209029|FG002|Overall Study|Non-compliance with study drug|0|||
94388259|NCT02914600|323209027|FG000|Overall Study|Death|3|||
94388260|NCT02914600|323209028|FG001|Overall Study|Death|1|||
94388261|NCT02914600|323209029|FG002|Overall Study|Death|1|||
94388262|NCT02914600|323209027|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
94388263|NCT02914600|323209028|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
94388264|NCT02914600|323209029|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
94388265|NCT02914600|323209027|FG000|Overall Study|Enrolled but not treated|1|||
94324577|NCT03655717|322969529|FG010|Overall Study|Withdrawal by Subject|0|||
94324578|NCT03655717|322969530|FG011|Overall Study|Withdrawal by Subject|1|||
94324579|NCT03655717|322969531|FG012|Overall Study|Withdrawal by Subject|0|||
94324580|NCT03655717|322969532|FG013|Overall Study|Withdrawal by Subject|3|||
94324581|NCT03655717|322969533|FG014|Overall Study|Withdrawal by Subject|0|||
94324582|NCT03655717|322969534|FG015|Overall Study|Withdrawal by Subject|1|||
94324583|NCT03655717|322969535|FG016|Overall Study|Withdrawal by Subject|0|||
94324584|NCT03655717|322969536|FG017|Overall Study|Withdrawal by Subject|0|||
94324585|NCT03655717|322969537|FG018|Overall Study|Withdrawal by Subject|1|||
94324586|NCT03655717|322969538|FG019|Overall Study|Withdrawal by Subject|0|||
94324587|NCT03655717|322969539|FG020|Overall Study|Withdrawal by Subject|0|||
94324588|NCT03655717|322969540|FG021|Overall Study|Withdrawal by Subject|1|||
94324589|NCT03655717|322969541|FG022|Overall Study|Withdrawal by Subject|2|||
94324590|NCT03655717|322969542|FG023|Overall Study|Withdrawal by Subject|1|||
94324591|NCT03655717|322969543|FG024|Overall Study|Withdrawal by Subject|1|||
94324592|NCT03655717|322969544|FG025|Overall Study|Withdrawal by Subject|0|||
94324593|NCT03655717|322969519|FG000|Overall Study|Physician Decision|3|||
94324594|NCT03655717|322969520|FG001|Overall Study|Physician Decision|3|||
94324595|NCT03655717|322969521|FG002|Overall Study|Physician Decision|0|||
94324596|NCT03655717|322969522|FG003|Overall Study|Physician Decision|0|||
94324597|NCT03655717|322969523|FG004|Overall Study|Physician Decision|0|||
94324598|NCT03655717|322969524|FG005|Overall Study|Physician Decision|0|||
94324599|NCT03655717|322969525|FG006|Overall Study|Physician Decision|0|||
94324600|NCT03655717|322969526|FG007|Overall Study|Physician Decision|0|||
94324601|NCT03655717|322969527|FG008|Overall Study|Physician Decision|0|||
94324602|NCT03655717|322969528|FG009|Overall Study|Physician Decision|1|||
94324603|NCT03655717|322969529|FG010|Overall Study|Physician Decision|0|||
94324604|NCT03655717|322969530|FG011|Overall Study|Physician Decision|0|||
94324605|NCT03655717|322969531|FG012|Overall Study|Physician Decision|0|||
94324606|NCT03655717|322969532|FG013|Overall Study|Physician Decision|0|||
94324607|NCT03655717|322969533|FG014|Overall Study|Physician Decision|0|||
94324608|NCT03655717|322969534|FG015|Overall Study|Physician Decision|0|||
94324609|NCT03655717|322969535|FG016|Overall Study|Physician Decision|0|||
94324610|NCT03655717|322969536|FG017|Overall Study|Physician Decision|0|||
94324611|NCT03655717|322969537|FG018|Overall Study|Physician Decision|0|||
94324612|NCT03655717|322969538|FG019|Overall Study|Physician Decision|1|||
94324613|NCT03655717|322969539|FG020|Overall Study|Physician Decision|0|||
94324614|NCT03655717|322969540|FG021|Overall Study|Physician Decision|0|||
94324615|NCT03655717|322969541|FG022|Overall Study|Physician Decision|0|||
94324616|NCT03655717|322969542|FG023|Overall Study|Physician Decision|1|||
94324617|NCT03655717|322969543|FG024|Overall Study|Physician Decision|0|||
94324618|NCT03655717|322969544|FG025|Overall Study|Physician Decision|0|||
94324619|NCT03655717|322969519|FG000|Overall Study|Lost to Follow-up|3|||
94324620|NCT03655717|322969520|FG001|Overall Study|Lost to Follow-up|1|||
94324621|NCT03655717|322969521|FG002|Overall Study|Lost to Follow-up|0|||
94324622|NCT03655717|322969522|FG003|Overall Study|Lost to Follow-up|1|||
94324623|NCT03655717|322969523|FG004|Overall Study|Lost to Follow-up|0|||
94324624|NCT03655717|322969524|FG005|Overall Study|Lost to Follow-up|1|||
94324625|NCT03655717|322969525|FG006|Overall Study|Lost to Follow-up|0|||
94324626|NCT03655717|322969526|FG007|Overall Study|Lost to Follow-up|0|||
94324627|NCT03655717|322969527|FG008|Overall Study|Lost to Follow-up|0|||
94324628|NCT03655717|322969528|FG009|Overall Study|Lost to Follow-up|0|||
94324629|NCT03655717|322969529|FG010|Overall Study|Lost to Follow-up|0|||
94324630|NCT03655717|322969530|FG011|Overall Study|Lost to Follow-up|1|||
94324631|NCT03655717|322969531|FG012|Overall Study|Lost to Follow-up|0|||
94324632|NCT03655717|322969532|FG013|Overall Study|Lost to Follow-up|0|||
94324633|NCT03655717|322969533|FG014|Overall Study|Lost to Follow-up|0|||
94324634|NCT03655717|322969534|FG015|Overall Study|Lost to Follow-up|0|||
94324635|NCT03655717|322969535|FG016|Overall Study|Lost to Follow-up|0|||
94324636|NCT03655717|322969536|FG017|Overall Study|Lost to Follow-up|0|||
94324637|NCT03655717|322969537|FG018|Overall Study|Lost to Follow-up|0|||
94324638|NCT03655717|322969538|FG019|Overall Study|Lost to Follow-up|0|||
94324639|NCT03655717|322969539|FG020|Overall Study|Lost to Follow-up|0|||
94324640|NCT03655717|322969540|FG021|Overall Study|Lost to Follow-up|0|||
94324641|NCT03655717|322969541|FG022|Overall Study|Lost to Follow-up|0|||
94324642|NCT03655717|322969542|FG023|Overall Study|Lost to Follow-up|0|||
94324643|NCT03655717|322969543|FG024|Overall Study|Lost to Follow-up|0|||
94324644|NCT03655717|322969544|FG025|Overall Study|Lost to Follow-up|0|||
94324645|NCT01973452|322969545|FG000|Overall Study|Lack of Efficacy|0|||
94324646|NCT01973452|322969546|FG001|Overall Study|Lack of Efficacy|1|||
94324647|NCT01973452|322969545|FG000|Overall Study|Lost to Follow-up|1|||
94324648|NCT01973452|322969546|FG001|Overall Study|Lost to Follow-up|0|||
94324649|NCT01973452|322969545|FG000|Overall Study|Withdrawal by Subject|10|||
94324650|NCT01973452|322969546|FG001|Overall Study|Withdrawal by Subject|9|||
94324651|NCT01973452|322969545|FG000|Overall Study|Ineligible|1|||
94324652|NCT01973452|322969546|FG001|Overall Study|Ineligible|1|||
94324653|NCT01973452|322969545|FG000|Overall Study|Surgery canceled by participant|5|||
94324654|NCT01973452|322969546|FG001|Overall Study|Surgery canceled by participant|3|||
94324655|NCT00819585|322969547|FG000|Core Study|Adverse Event|2|||
94324656|NCT00819585|322969548|FG001|Core Study|Adverse Event|1|||
94388266|NCT02914600|323209028|FG001|Overall Study|Enrolled but not treated|0|||
94388267|NCT02914600|323209029|FG002|Overall Study|Enrolled but not treated|0|||
94388268|NCT00537030|323209030|FG000|Overall Study|Physician Decision|2|||
94388269|NCT00537030|323209030|FG000|Overall Study|Withdrawal by Subject|2|||
94388270|NCT00537030|323209030|FG000|Overall Study|≥ Grade 2 allergy|7|||
94388271|NCT00537030|323209030|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
94388272|NCT00537030|323209030|FG000|Overall Study|Ineligible|2|||
94388273|NCT00537030|323209030|FG000|Overall Study|Inevaluable|2|||
94388274|NCT01387022|323209031|FG000|Overall Study|Death|1|||
94388275|NCT01387022|323209032|FG001|Overall Study|Death|1|||
94388276|NCT01387022|323209031|FG000|Overall Study|Lost to Follow-up|0|||
94388277|NCT01387022|323209032|FG001|Overall Study|Lost to Follow-up|3|||
94388278|NCT02849652|323209042|FG000|Overall Study|Lost to Follow-up|104|||
94388279|NCT02849652|323209043|FG001|Overall Study|Lost to Follow-up|35|||
94388280|NCT02849652|323209044|FG002|Overall Study|Lost to Follow-up|116|||
94388281|NCT02849652|323209045|FG003|Overall Study|Lost to Follow-up|22|||
94388282|NCT02849652|323209042|FG000|Overall Study|Withdrawal by Subject|10|||
94388283|NCT02849652|323209043|FG001|Overall Study|Withdrawal by Subject|2|||
94388284|NCT02849652|323209044|FG002|Overall Study|Withdrawal by Subject|8|||
94388285|NCT02849652|323209045|FG003|Overall Study|Withdrawal by Subject|4|||
94388286|NCT00565448|323209046|FG000|Overall Study|Adverse Event|1|||
94388287|NCT00565448|323209047|FG001|Overall Study|Adverse Event|2|||
94388288|NCT00565448|323209046|FG000|Overall Study|Disease progression|1|||
94388289|NCT00565448|323209047|FG001|Overall Study|Disease progression|0|||
94388290|NCT00565448|323209046|FG000|Overall Study|Withdrawal by Subject|1|||
94388291|NCT00565448|323209047|FG001|Overall Study|Withdrawal by Subject|0|||
94324657|NCT00819585|322969549|FG002|Core Study|Adverse Event|1|||
94324658|NCT00819585|322969550|FG003|Core Study|Adverse Event|4|||
94324659|NCT00819585|322969551|FG004|Core Study|Adverse Event|1|||
94324660|NCT00819585|322969552|FG005|Core Study|Adverse Event|0|||
94324661|NCT00819585|322969553|FG006|Core Study|Adverse Event|2|||
94324662|NCT00819585|322969554|FG007|Core Study|Adverse Event|0|||
94324663|NCT00819585|322969555|FG008|Core Study|Adverse Event|0|||
94324664|NCT00819585|322969556|FG009|Core Study|Adverse Event|0|||
94324665|NCT00819585|322969557|FG010|Core Study|Adverse Event|0|||
94324666|NCT00819585|322969547|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
94324667|NCT00819585|322969548|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
94324668|NCT00819585|322969549|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
94324669|NCT00819585|322969550|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
94324670|NCT00819585|322969551|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
94324671|NCT00819585|322969552|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
94324672|NCT00819585|322969553|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
94324673|NCT00819585|322969554|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
94324674|NCT00819585|322969555|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
94324675|NCT00819585|322969556|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
94324676|NCT00819585|322969557|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
94324677|NCT00819585|322969547|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
94324678|NCT00819585|322969548|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
94324679|NCT00819585|322969549|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
94324680|NCT00819585|322969550|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
94324681|NCT00819585|322969551|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
94324682|NCT00819585|322969552|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
94324683|NCT00819585|322969553|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
94324684|NCT00819585|322969554|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
94324685|NCT00819585|322969555|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
94324686|NCT00819585|322969556|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
94324687|NCT00819585|322969557|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
94324688|NCT00819585|322969547|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
94324689|NCT00819585|322969548|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
94324690|NCT00819585|322969549|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
94324691|NCT00819585|322969550|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
94324692|NCT00819585|322969551|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
94324693|NCT00819585|322969552|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
94324694|NCT00819585|322969553|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
94324695|NCT00819585|322969554|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
94324696|NCT00819585|322969555|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
94324697|NCT00819585|322969556|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
94324698|NCT00819585|322969557|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
94324699|NCT00819585|322969547|FG000|Core Study|Subject Withdrew Consent|0|||
94324700|NCT00819585|322969548|FG001|Core Study|Subject Withdrew Consent|3|||
94388292|NCT00610363|323209049|FG000|Overall Study|Non-compliance with protocol|0|||
94388293|NCT00610363|323209050|FG001|Overall Study|Non-compliance with protocol|1|||
94388294|NCT00610363|323209049|FG000|Overall Study|Adverse Event|3|||
94324701|NCT00819585|322969549|FG002|Core Study|Subject Withdrew Consent|2|||
94482489|NCT05067972|323558121|FG005|Part 1: Treatment|Physician Decision|0|||
94388295|NCT00610363|323209050|FG001|Overall Study|Adverse Event|1|||
94388296|NCT00610363|323209049|FG000|Overall Study|Lack of Efficacy|2|||
94388297|NCT00610363|323209050|FG001|Overall Study|Lack of Efficacy|0|||
94388298|NCT00610363|323209049|FG000|Overall Study|Lost to Follow-up|4|||
94388299|NCT00610363|323209050|FG001|Overall Study|Lost to Follow-up|0|||
94388300|NCT00610363|323209049|FG000|Overall Study|Withdrawal by Subject|1|||
94388301|NCT00610363|323209050|FG001|Overall Study|Withdrawal by Subject|0|||
94388302|NCT00610363|323209049|FG000|Overall Study|Other than specified above|1|||
94388303|NCT00610363|323209050|FG001|Overall Study|Other than specified above|1|||
94388304|NCT03897088|323209055|FG000|Overall Study|Withdrawal by Subject|12|||
94388305|NCT03897088|323209056|FG001|Overall Study|Withdrawal by Subject|12|||
94388306|NCT03897088|323209055|FG000|Overall Study|Lost to Follow-up|7|||
94388307|NCT03897088|323209056|FG001|Overall Study|Lost to Follow-up|15|||
94388308|NCT03897088|323209055|FG000|Overall Study|Sponsor Decision|1|||
94388309|NCT03897088|323209056|FG001|Overall Study|Sponsor Decision|2|||
94388310|NCT03897088|323209055|FG000|Overall Study|COVID-19|2|||
94388311|NCT03897088|323209056|FG001|Overall Study|COVID-19|0|||
94388312|NCT03897088|323209055|FG000|Overall Study|Other|3|||
94388313|NCT03897088|323209056|FG001|Overall Study|Other|0|||
94388314|NCT03897088|323209055|FG000|Overall Study|Non-compliance with Study Drug|1|||
94388315|NCT03897088|323209056|FG001|Overall Study|Non-compliance with Study Drug|1|||
94388316|NCT03897088|323209055|FG000|Overall Study|Pregnancy|0|||
94388317|NCT03897088|323209056|FG001|Overall Study|Pregnancy|1|||
94388318|NCT01937390|323209065|FG000|Overall Study|Death|2|||
94388319|NCT01937390|323209065|FG000|Overall Study|Lost to Follow-up|7|||
94388320|NCT01937390|323209065|FG000|Overall Study|Withdrawal by Subject|5|||
94388321|NCT01937390|323209065|FG000|Overall Study|Fail to return|21|||
94388322|NCT02920996|323209068|FG000|Overall Study|Adverse Event|8|||
94388323|NCT02920996|323209069|FG001|Overall Study|Adverse Event|0|||
94388324|NCT02920996|323209068|FG000|Overall Study|Physician Decision|1|||
94388325|NCT02920996|323209069|FG001|Overall Study|Physician Decision|0|||
94388326|NCT02920996|323209068|FG000|Overall Study|Death|1|||
94388327|NCT02920996|323209069|FG001|Overall Study|Death|0|||
94388328|NCT02920996|323209068|FG000|Overall Study|Missing|1|||
94388329|NCT02920996|323209069|FG001|Overall Study|Missing|0|||
94388330|NCT02920996|323209068|FG000|Overall Study|Subject Non-Compliance|1|||
94388331|NCT02920996|323209069|FG001|Overall Study|Subject Non-Compliance|0|||
94388332|NCT01085045|323210624|FG000|Part A|Withdrawal by Subject|4|||
94388333|NCT01085045|323210624|FG000|Part A|Adverse Event|6|||
94388334|NCT01085045|323210624|FG000|Part A|Protocol Violation|1|||
94388335|NCT01085045|323210624|FG000|Part A|Protocol Specified Criteria|7|||
94388336|NCT01085045|323210624|FG000|Part B|Withdrawal by Subject|2|||
94388337|NCT01085045|323210624|FG000|Part B|Protocol Specified Criteria|6|||
94388338|NCT01085045|323210624|FG000|Part B|Lost to Follow-up|1|||
94388339|NCT01085045|323210624|FG000|Part B|Adverse Event|6|||
94388340|NCT02924038|323210625|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
94388341|NCT02924038|323210626|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
94388342|NCT01108094|323210634|FG000|Overall Study|Adverse Event|2|||
94388343|NCT01108094|323210635|FG001|Overall Study|Adverse Event|0|||
94388344|NCT01108094|323210636|FG002|Overall Study|Adverse Event|0|||
94388345|NCT01108094|323210637|FG003|Overall Study|Adverse Event|0|||
94388346|NCT01108094|323210634|FG000|Overall Study|Withdrawal by Subject|1|||
94388347|NCT01108094|323210635|FG001|Overall Study|Withdrawal by Subject|0|||
94388348|NCT01108094|323210636|FG002|Overall Study|Withdrawal by Subject|0|||
94388349|NCT01108094|323210637|FG003|Overall Study|Withdrawal by Subject|0|||
94388350|NCT03655106|323210640|FG000|Overall Study|Withdrawal by Subject|3|||
94388351|NCT03655106|323210641|FG001|Overall Study|Withdrawal by Subject|2|||
94388352|NCT03655106|323210640|FG000|Overall Study|Lost to Follow-up|2|||
94388353|NCT03655106|323210641|FG001|Overall Study|Lost to Follow-up|1|||
94388354|NCT03655106|323210640|FG000|Overall Study|Duplicate Enrollment|1|||
94388355|NCT03655106|323210641|FG001|Overall Study|Duplicate Enrollment|1|||
94388356|NCT03655106|323210640|FG000|Overall Study|Protocol Violation|3|||
94388357|NCT03655106|323210641|FG001|Overall Study|Protocol Violation|0|||
94388358|NCT02109042|323210642|FG000|Overall Study|Sponsor Decision|15|||
94388359|NCT01520909|323210644|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
94388360|NCT01520909|323210645|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
94388361|NCT01520909|323210646|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
94388362|NCT01520909|323210644|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
94388363|NCT01520909|323210645|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
94388364|NCT01520909|323210646|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
94388365|NCT01520909|323210644|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
94388366|NCT01520909|323210645|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
94388367|NCT01520909|323210646|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
94388368|NCT01520909|323210644|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
94388369|NCT01520909|323210645|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
94388370|NCT01520909|323210646|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
94388371|NCT01882257|323210647|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
94324702|NCT00819585|322969550|FG003|Core Study|Subject Withdrew Consent|1|||
94324703|NCT00819585|322969551|FG004|Core Study|Subject Withdrew Consent|0|||
94324704|NCT00819585|322969552|FG005|Core Study|Subject Withdrew Consent|0|||
94324705|NCT00819585|322969553|FG006|Core Study|Subject Withdrew Consent|3|||
94324706|NCT00819585|322969554|FG007|Core Study|Subject Withdrew Consent|0|||
94324707|NCT00819585|322969555|FG008|Core Study|Subject Withdrew Consent|0|||
94324708|NCT00819585|322969556|FG009|Core Study|Subject Withdrew Consent|0|||
94324709|NCT00819585|322969557|FG010|Core Study|Subject Withdrew Consent|0|||
94324710|NCT00819585|322969547|FG000|Core Study|Lost to Follow-up|2|||
94324711|NCT00819585|322969548|FG001|Core Study|Lost to Follow-up|1|||
94324712|NCT00819585|322969549|FG002|Core Study|Lost to Follow-up|2|||
94324713|NCT00819585|322969550|FG003|Core Study|Lost to Follow-up|0|||
94324714|NCT00819585|322969551|FG004|Core Study|Lost to Follow-up|1|||
94324715|NCT00819585|322969552|FG005|Core Study|Lost to Follow-up|1|||
94324716|NCT00819585|322969553|FG006|Core Study|Lost to Follow-up|1|||
94324717|NCT00819585|322969554|FG007|Core Study|Lost to Follow-up|0|||
94324718|NCT00819585|322969555|FG008|Core Study|Lost to Follow-up|0|||
94324719|NCT00819585|322969556|FG009|Core Study|Lost to Follow-up|0|||
94324720|NCT00819585|322969557|FG010|Core Study|Lost to Follow-up|0|||
94324721|NCT00819585|322969547|FG000|Core Study|Administrative Problems|0|||
94324722|NCT00819585|322969548|FG001|Core Study|Administrative Problems|0|||
94324723|NCT00819585|322969549|FG002|Core Study|Administrative Problems|0|||
94324724|NCT00819585|322969550|FG003|Core Study|Administrative Problems|0|||
94324725|NCT00819585|322969551|FG004|Core Study|Administrative Problems|0|||
94324726|NCT00819585|322969552|FG005|Core Study|Administrative Problems|0|||
94324727|NCT00819585|322969553|FG006|Core Study|Administrative Problems|2|||
94324728|NCT00819585|322969554|FG007|Core Study|Administrative Problems|0|||
94324729|NCT00819585|322969555|FG008|Core Study|Administrative Problems|0|||
94324730|NCT00819585|322969556|FG009|Core Study|Administrative Problems|0|||
94324731|NCT00819585|322969557|FG010|Core Study|Administrative Problems|0|||
94324732|NCT00819585|322969547|FG000|Core Study|Death|0|||
94324733|NCT00819585|322969548|FG001|Core Study|Death|0|||
94324734|NCT00819585|322969549|FG002|Core Study|Death|0|||
94324735|NCT00819585|322969550|FG003|Core Study|Death|0|||
94324736|NCT00819585|322969551|FG004|Core Study|Death|0|||
94324737|NCT00819585|322969552|FG005|Core Study|Death|0|||
94324738|NCT00819585|322969553|FG006|Core Study|Death|1|||
94324739|NCT00819585|322969554|FG007|Core Study|Death|0|||
94324740|NCT00819585|322969555|FG008|Core Study|Death|0|||
94324741|NCT00819585|322969556|FG009|Core Study|Death|0|||
94324742|NCT00819585|322969557|FG010|Core Study|Death|0|||
94324743|NCT00819585|322969547|FG000|Core Study|Protocol Violation|0|||
94324744|NCT00819585|322969548|FG001|Core Study|Protocol Violation|0|||
94324745|NCT00819585|322969549|FG002|Core Study|Protocol Violation|1|||
94324746|NCT00819585|322969550|FG003|Core Study|Protocol Violation|0|||
94324747|NCT00819585|322969551|FG004|Core Study|Protocol Violation|0|||
94324748|NCT00819585|322969552|FG005|Core Study|Protocol Violation|1|||
94324749|NCT00819585|322969553|FG006|Core Study|Protocol Violation|3|||
94324750|NCT00819585|322969554|FG007|Core Study|Protocol Violation|0|||
94324751|NCT00819585|322969555|FG008|Core Study|Protocol Violation|0|||
94324752|NCT00819585|322969556|FG009|Core Study|Protocol Violation|0|||
94324753|NCT00819585|322969557|FG010|Core Study|Protocol Violation|0|||
94324754|NCT00819585|322969547|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
94324755|NCT00819585|322969548|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
94324756|NCT00819585|322969549|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
94324757|NCT00819585|322969550|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
94324758|NCT00819585|322969551|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
94324759|NCT00819585|322969552|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
94324760|NCT00819585|322969553|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
94324761|NCT00819585|322969554|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
94324762|NCT00819585|322969555|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
94324763|NCT00819585|322969556|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
94324764|NCT00819585|322969557|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
94324765|NCT00819585|322969547|FG000|Extension Study|Subject Withdrew Consent|0|||
94324766|NCT00819585|322969548|FG001|Extension Study|Subject Withdrew Consent|0|||
94324767|NCT00819585|322969549|FG002|Extension Study|Subject Withdrew Consent|0|||
94324768|NCT00819585|322969550|FG003|Extension Study|Subject Withdrew Consent|0|||
94324769|NCT00819585|322969551|FG004|Extension Study|Subject Withdrew Consent|0|||
94324770|NCT00819585|322969552|FG005|Extension Study|Subject Withdrew Consent|0|||
94324771|NCT00819585|322969553|FG006|Extension Study|Subject Withdrew Consent|0|||
94324772|NCT00819585|322969554|FG007|Extension Study|Subject Withdrew Consent|0|||
94324773|NCT00819585|322969555|FG008|Extension Study|Subject Withdrew Consent|3|||
94324774|NCT00819585|322969556|FG009|Extension Study|Subject Withdrew Consent|0|||
94324775|NCT00819585|322969557|FG010|Extension Study|Subject Withdrew Consent|1|||
94324776|NCT00819585|322969547|FG000|Extension Study|Lost to Follow-up|0|||
94324777|NCT00819585|322969548|FG001|Extension Study|Lost to Follow-up|0|||
94324778|NCT00819585|322969549|FG002|Extension Study|Lost to Follow-up|0|||
94324779|NCT00819585|322969550|FG003|Extension Study|Lost to Follow-up|0|||
94324780|NCT00819585|322969551|FG004|Extension Study|Lost to Follow-up|0|||
94324781|NCT00819585|322969552|FG005|Extension Study|Lost to Follow-up|0|||
94324782|NCT00819585|322969553|FG006|Extension Study|Lost to Follow-up|0|||
94324783|NCT00819585|322969554|FG007|Extension Study|Lost to Follow-up|0|||
94324784|NCT00819585|322969555|FG008|Extension Study|Lost to Follow-up|2|||
94324785|NCT00819585|322969556|FG009|Extension Study|Lost to Follow-up|1|||
94324786|NCT00819585|322969557|FG010|Extension Study|Lost to Follow-up|1|||
94324787|NCT00819585|322969547|FG000|Extension Study|Death|0|||
94324788|NCT00819585|322969548|FG001|Extension Study|Death|0|||
94324789|NCT00819585|322969549|FG002|Extension Study|Death|0|||
94324790|NCT00819585|322969550|FG003|Extension Study|Death|0|||
94324791|NCT00819585|322969551|FG004|Extension Study|Death|0|||
94324792|NCT00819585|322969552|FG005|Extension Study|Death|0|||
94324793|NCT00819585|322969553|FG006|Extension Study|Death|0|||
94324794|NCT00819585|322969554|FG007|Extension Study|Death|0|||
94324795|NCT00819585|322969555|FG008|Extension Study|Death|2|||
94324796|NCT00819585|322969556|FG009|Extension Study|Death|0|||
94324797|NCT00819585|322969557|FG010|Extension Study|Death|0|||
94324798|NCT00349752|322969558|FG000|Overall Study|Adverse Event|8|||
94324799|NCT00349752|322969559|FG001|Overall Study|Adverse Event|12|||
94324800|NCT00349752|322969558|FG000|Overall Study|Lack of Efficacy|37|||
94324801|NCT00349752|322969559|FG001|Overall Study|Lack of Efficacy|42|||
94324802|NCT00349752|322969558|FG000|Overall Study|Lost to Follow-up|4|||
94324803|NCT00349752|322969559|FG001|Overall Study|Lost to Follow-up|2|||
94324804|NCT00349752|322969558|FG000|Overall Study|Personal reasons|6|||
94324805|NCT00349752|322969559|FG001|Overall Study|Personal reasons|5|||
94324806|NCT00349752|322969558|FG000|Overall Study|Other: Required exclusionary medication|0|||
94324807|NCT00349752|322969559|FG001|Overall Study|Other: Required exclusionary medication|1|||
94324808|NCT00349752|322969558|FG000|Overall Study|Other: Non compliance|0|||
94324809|NCT00349752|322969559|FG001|Overall Study|Other: Non compliance|1|||
94324810|NCT00349752|322969558|FG000|Overall Study|Other: Patient stopped steroids|0|||
94324811|NCT00349752|322969559|FG001|Overall Study|Other: Patient stopped steroids|1|||
94324812|NCT00349752|322969558|FG000|Overall Study|Other: Patient's steroid use|1|||
94324813|NCT00349752|322969559|FG001|Overall Study|Other: Patient's steroid use|0|||
94324814|NCT00349752|322969558|FG000|Overall Study|Other: Ineligible|1|||
94324815|NCT00349752|322969559|FG001|Overall Study|Other: Ineligible|0|||
94324816|NCT00349752|322969558|FG000|Overall Study|Other: Inadvertently unblinded|1|||
94324817|NCT00349752|322969559|FG001|Overall Study|Other: Inadvertently unblinded|0|||
94324818|NCT00349752|322969558|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
94324819|NCT00349752|322969559|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
94324820|NCT03521193|322969560|FG000|Overall Study|Withdrawal by Subject|8|||
94324821|NCT03521193|322969561|FG001|Overall Study|Withdrawal by Subject|0|||
94324822|NCT03521193|322969560|FG000|Overall Study|non compliant to ASA treatment|8|||
94324823|NCT03521193|322969561|FG001|Overall Study|non compliant to ASA treatment|0|||
94324824|NCT00406783|322969562|FG000|Overall Study|Adverse Event|4|||
94324825|NCT00406783|322969563|FG001|Overall Study|Adverse Event|4|||
94324826|NCT00406783|322969562|FG000|Overall Study|Treatment Failure|2|||
94324827|NCT00406783|322969563|FG001|Overall Study|Treatment Failure|3|||
94324828|NCT00406783|322969562|FG000|Overall Study|Lost to Follow-up|3|||
94324829|NCT00406783|322969563|FG001|Overall Study|Lost to Follow-up|0|||
94324830|NCT00406783|322969562|FG000|Overall Study|Withdrawal by Subject|1|||
94324831|NCT00406783|322969563|FG001|Overall Study|Withdrawal by Subject|4|||
94324832|NCT00406783|322969562|FG000|Overall Study|Protocol Violation|4|||
94324833|NCT00406783|322969563|FG001|Overall Study|Protocol Violation|4|||
94324834|NCT03334396|322969564|FG000|Overall Study|Adverse Event|1|||
94324835|NCT03334396|322969565|FG001|Overall Study|Adverse Event|0|||
94324836|NCT03334396|322969566|FG002|Overall Study|Adverse Event|1|||
94324837|NCT03334396|322969567|FG003|Overall Study|Adverse Event|0|||
94324838|NCT03334396|322969568|FG004|Overall Study|Adverse Event|0|||
94324839|NCT03334396|322969569|FG005|Overall Study|Adverse Event|0|||
94324840|NCT03334396|322969570|FG006|Overall Study|Adverse Event|0|||
94324841|NCT03334396|322969571|FG007|Overall Study|Adverse Event|0|||
94324842|NCT03334396|322969564|FG000|Overall Study|Lack of Efficacy|10|||
94324843|NCT03334396|322969565|FG001|Overall Study|Lack of Efficacy|4|||
94324844|NCT03334396|322969566|FG002|Overall Study|Lack of Efficacy|1|||
94324845|NCT03334396|322969567|FG003|Overall Study|Lack of Efficacy|3|||
94324846|NCT03334396|322969568|FG004|Overall Study|Lack of Efficacy|1|||
94324847|NCT03334396|322969569|FG005|Overall Study|Lack of Efficacy|0|||
94324848|NCT03334396|322969570|FG006|Overall Study|Lack of Efficacy|0|||
94324849|NCT03334396|322969571|FG007|Overall Study|Lack of Efficacy|1|||
94324850|NCT03334396|322969564|FG000|Overall Study|Lost to Follow-up|0|||
94324851|NCT03334396|322969565|FG001|Overall Study|Lost to Follow-up|0|||
94324852|NCT03334396|322969566|FG002|Overall Study|Lost to Follow-up|1|||
94324853|NCT03334396|322969567|FG003|Overall Study|Lost to Follow-up|0|||
94324854|NCT03334396|322969568|FG004|Overall Study|Lost to Follow-up|0|||
94324855|NCT03334396|322969569|FG005|Overall Study|Lost to Follow-up|0|||
94324856|NCT03334396|322969570|FG006|Overall Study|Lost to Follow-up|1|||
94324857|NCT03334396|322969571|FG007|Overall Study|Lost to Follow-up|0|||
94324858|NCT03334396|322969564|FG000|Overall Study|Physician Decision|1|||
94324859|NCT03334396|322969565|FG001|Overall Study|Physician Decision|0|||
94324860|NCT03334396|322969566|FG002|Overall Study|Physician Decision|0|||
94324861|NCT03334396|322969567|FG003|Overall Study|Physician Decision|0|||
94324862|NCT03334396|322969568|FG004|Overall Study|Physician Decision|0|||
94324863|NCT03334396|322969569|FG005|Overall Study|Physician Decision|0|||
94324864|NCT03334396|322969570|FG006|Overall Study|Physician Decision|0|||
94324865|NCT03334396|322969571|FG007|Overall Study|Physician Decision|0|||
94324866|NCT03334396|322969564|FG000|Overall Study|Withdrawal by Subject|10|||
94324867|NCT03334396|322969565|FG001|Overall Study|Withdrawal by Subject|5|||
94324868|NCT03334396|322969566|FG002|Overall Study|Withdrawal by Subject|7|||
94324869|NCT03334396|322969567|FG003|Overall Study|Withdrawal by Subject|2|||
94324870|NCT03334396|322969568|FG004|Overall Study|Withdrawal by Subject|2|||
94324871|NCT03334396|322969569|FG005|Overall Study|Withdrawal by Subject|1|||
94324872|NCT03334396|322969570|FG006|Overall Study|Withdrawal by Subject|2|||
94324873|NCT03334396|322969571|FG007|Overall Study|Withdrawal by Subject|0|||
94324874|NCT03334396|322969564|FG000|Overall Study|Pregnancy|0|||
94324875|NCT03334396|322969565|FG001|Overall Study|Pregnancy|1|||
94324876|NCT03334396|322969566|FG002|Overall Study|Pregnancy|0|||
94324877|NCT03334396|322969567|FG003|Overall Study|Pregnancy|0|||
94324878|NCT03334396|322969568|FG004|Overall Study|Pregnancy|0|||
94324879|NCT03334396|322969569|FG005|Overall Study|Pregnancy|0|||
94324880|NCT03334396|322969570|FG006|Overall Study|Pregnancy|0|||
94324881|NCT03334396|322969571|FG007|Overall Study|Pregnancy|0|||
94324882|NCT03334396|322969564|FG000|Overall Study|Ineligible|0|||
94324883|NCT03334396|322969565|FG001|Overall Study|Ineligible|1|||
94324884|NCT03334396|322969566|FG002|Overall Study|Ineligible|0|||
94324885|NCT03334396|322969567|FG003|Overall Study|Ineligible|0|||
94324886|NCT03334396|322969568|FG004|Overall Study|Ineligible|0|||
94324887|NCT03334396|322969569|FG005|Overall Study|Ineligible|0|||
94324888|NCT03334396|322969570|FG006|Overall Study|Ineligible|0|||
94324889|NCT03334396|322969571|FG007|Overall Study|Ineligible|0|||
94324890|NCT03334396|322969564|FG000|Overall Study|Started New Job|1|||
94324891|NCT03334396|322969565|FG001|Overall Study|Started New Job|0|||
94324892|NCT03334396|322969566|FG002|Overall Study|Started New Job|0|||
94324893|NCT03334396|322969567|FG003|Overall Study|Started New Job|0|||
94324894|NCT03334396|322969568|FG004|Overall Study|Started New Job|0|||
94324895|NCT03334396|322969569|FG005|Overall Study|Started New Job|0|||
94324896|NCT03334396|322969570|FG006|Overall Study|Started New Job|0|||
94324897|NCT03334396|322969571|FG007|Overall Study|Started New Job|0|||
94324898|NCT00838916|322969572|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
94324899|NCT00838916|322969573|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
94324900|NCT00838916|322969572|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
94324901|NCT00838916|322969573|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
94324902|NCT00838916|322969572|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
94324903|NCT00838916|322969573|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
94324904|NCT00838916|322969572|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
94324905|NCT00838916|322969573|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
94324906|NCT00838916|322969572|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
94324907|NCT00838916|322969573|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
94324908|NCT00838916|322969572|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
94324909|NCT00838916|322969573|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
94324910|NCT00838916|322969572|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
94324911|NCT00838916|322969573|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
94324912|NCT00838916|322969572|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
94324913|NCT00838916|322969573|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
94324914|NCT00838916|322969572|FG000|Treatment Period (156 Weeks)|Missing|3|||
94324915|NCT00838916|322969573|FG001|Treatment Period (156 Weeks)|Missing|1|||
94324916|NCT00838916|322969572|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
94324917|NCT00838916|322969573|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
94324918|NCT00838916|322969572|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
94324919|NCT00838916|322969573|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
94324920|NCT00838916|322969572|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
94324921|NCT00838916|322969573|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
94324922|NCT00838916|322969572|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
94324923|NCT00838916|322969573|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
94324924|NCT00838916|322969572|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
94324925|NCT00838916|322969573|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
94324926|NCT00838916|322969572|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
94324927|NCT00838916|322969573|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
94324928|NCT00838916|322969572|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
94324929|NCT00838916|322969573|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
94324930|NCT00838916|322969572|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
94324931|NCT00838916|322969573|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
94324932|NCT00838916|322969572|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
94324933|NCT00838916|322969573|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
94324934|NCT00838916|322969572|FG000|Follow-up Period (8 Weeks)|Missing|3|||
94324935|NCT00838916|322969573|FG001|Follow-up Period (8 Weeks)|Missing|0|||
94324936|NCT01969799|322969575|FG000|Overall Study|Adverse Event|0|||
94324937|NCT01969799|322969576|FG001|Overall Study|Adverse Event|1|||
94324938|NCT01969799|322969575|FG000|Overall Study|Death|16|||
94324939|NCT01969799|322969576|FG001|Overall Study|Death|11|||
94324940|NCT01969799|322969575|FG000|Overall Study|Lost to Follow-up|0|||
94324941|NCT01969799|322969576|FG001|Overall Study|Lost to Follow-up|2|||
94324942|NCT01969799|322969575|FG000|Overall Study|Physician Decision|1|||
94324943|NCT01969799|322969576|FG001|Overall Study|Physician Decision|0|||
94324944|NCT01842607|322969577|FG000|Overall Study|Adverse Event|11|||
94324945|NCT01842607|322969577|FG000|Overall Study|Lack of Efficacy|19|||
94324946|NCT01842607|322969577|FG000|Overall Study|Protocol Violation|8|||
94324947|NCT01842607|322969577|FG000|Overall Study|Protocol defined stopping criteria|2|||
94324948|NCT01842607|322969577|FG000|Overall Study|Lost to Follow-up|3|||
94324949|NCT01842607|322969577|FG000|Overall Study|Physician Decision|9|||
94324950|NCT01842607|322969577|FG000|Overall Study|Withdrawal by Subject|14|||
94324951|NCT00012012|322969580|FG000|Overall Study|Protocol Violation|1|||
94324952|NCT00012012|322969581|FG001|Overall Study|Protocol Violation|1|||
94324953|NCT00012012|322969580|FG000|Overall Study|Withdrawal by Subject|0|||
94324954|NCT00012012|322969581|FG001|Overall Study|Withdrawal by Subject|2|||
94324955|NCT02927873|322969582|FG000|Overall Study|Lost to Follow-up|0|||
94324956|NCT02927873|322969583|FG001|Overall Study|Lost to Follow-up|1|||
94324957|NCT02927873|322969584|FG002|Overall Study|Lost to Follow-up|0|||
94324958|NCT02927873|322969585|FG003|Overall Study|Lost to Follow-up|0|||
94324959|NCT02927873|322969586|FG004|Overall Study|Lost to Follow-up|0|||
94324960|NCT02927873|322969587|FG005|Overall Study|Lost to Follow-up|0|||
94324961|NCT02927873|322969582|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
94324962|NCT02927873|322969583|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
94324963|NCT02927873|322969584|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
94324964|NCT02927873|322969585|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
94324965|NCT02927873|322969586|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
94324966|NCT02927873|322969587|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
94324967|NCT02927873|322969582|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94324968|NCT02927873|322969583|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94324969|NCT02927873|322969584|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94324970|NCT02927873|322969585|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94324971|NCT02927873|322969586|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94324972|NCT02927873|322969587|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
94324973|NCT02927873|322969582|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
94324974|NCT02927873|322969583|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
94324975|NCT02927873|322969584|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
94324976|NCT02927873|322969585|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
94324977|NCT02927873|322969586|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
94324978|NCT02927873|322969587|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
94324979|NCT02927873|322969582|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
94324980|NCT02927873|322969583|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
94324981|NCT02927873|322969584|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
94324982|NCT02927873|322969585|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
94324983|NCT02927873|322969586|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
94330981|NCT01376245|322991783|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
94330982|NCT01376245|322991784|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
94330983|NCT01376245|322991780|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
94330984|NCT01376245|322991781|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
94330985|NCT01376245|322991782|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
94330986|NCT01376245|322991783|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
94330987|NCT01376245|322991784|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
94330988|NCT01376245|322991780|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
94330989|NCT01376245|322991781|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
94330990|NCT01376245|322991782|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
94330991|NCT01376245|322991783|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
94330992|NCT01376245|322991784|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
94330993|NCT00105560|322991785|FG000|Overall Study|Lost to Follow-up|1|||
94330994|NCT00405821|322991786|FG000|Overall Study|Death|5|||
94330995|NCT00405821|322991787|FG001|Overall Study|Death|7|||
94330996|NCT00405821|322991786|FG000|Overall Study|Lost to Follow-up|7|||
94330997|NCT00405821|322991787|FG001|Overall Study|Lost to Follow-up|7|||
94330998|NCT00405821|322991786|FG000|Overall Study|Protocol Violation|1|||
94330999|NCT00405821|322991787|FG001|Overall Study|Protocol Violation|0|||
94331000|NCT00405821|322991786|FG000|Overall Study|initiated ART|9|||
94331001|NCT00405821|322991787|FG001|Overall Study|initiated ART|8|||
94324984|NCT02927873|322969587|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
94324985|NCT02927873|322969582|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
94324986|NCT02927873|322969583|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
94324987|NCT02927873|322969584|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
94324988|NCT02927873|322969585|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
94324989|NCT02927873|322969586|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
94324990|NCT02927873|322969587|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
94324991|NCT02034474|322969588|FG000|Overall Study|Adverse Event|3|||
94324992|NCT02034474|322969589|FG001|Overall Study|Adverse Event|2|||
94324993|NCT02034474|322969588|FG000|Overall Study|Withdrawal by Subject|1|||
94324994|NCT02034474|322969589|FG001|Overall Study|Withdrawal by Subject|2|||
94324995|NCT01391819|322969595|FG000|Overall Study|Withdrawal by Subject|56|||
94324996|NCT01391819|322969595|FG000|Overall Study|Migrated/moved from study area|82|||
94324997|NCT01391819|322969595|FG000|Overall Study|Lost to Follow-up|252|||
94324998|NCT01391819|322969595|FG000|Overall Study|Death|3|||
94324999|NCT01391819|322969595|FG000|Overall Study|Other|9|||
94325000|NCT03629041|322969596|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
94325001|NCT03629041|322969597|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
94325002|NCT03629041|322969598|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
94325003|NCT03629041|322969599|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
94325004|NCT03488251|322969601|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
94325005|NCT03488251|322969602|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
94325006|NCT03488251|322969603|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
94325007|NCT03488251|322969604|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
94325008|NCT03488251|322969601|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
94325009|NCT03488251|322969602|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
94325010|NCT03488251|322969603|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
94325011|NCT03488251|322969604|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
94325012|NCT03488251|322969601|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
94325013|NCT03488251|322969602|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
94325014|NCT03488251|322969603|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
94325015|NCT03488251|322969604|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
94325016|NCT03488251|322969601|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
94325017|NCT03488251|322969602|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
94325018|NCT03488251|322969603|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
94325019|NCT03488251|322969604|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
94325020|NCT03488251|322969601|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
94325021|NCT03488251|322969602|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
94325022|NCT03488251|322969603|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
94325023|NCT03488251|322969604|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
94325024|NCT00675103|322969605|FG000|Overall Study|Lack of Efficacy|2|||
94325025|NCT00675103|322969605|FG000|Overall Study|Adverse Event|1|||
94325026|NCT03600714|322969606|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
94325027|NCT03814590|322969607|FG000|Overall Study|Adverse Event|0|||
94325028|NCT03814590|322969608|FG001|Overall Study|Adverse Event|0|||
94325029|NCT03814590|322969609|FG002|Overall Study|Adverse Event|0|||
94325030|NCT03814590|322969610|FG003|Overall Study|Adverse Event|0|||
94325031|NCT03814590|322969611|FG004|Overall Study|Adverse Event|0|||
94325032|NCT03814590|322969612|FG005|Overall Study|Adverse Event|1|||
94325033|NCT03814590|322969613|FG006|Overall Study|Adverse Event|1|||
94325034|NCT03814590|322969614|FG007|Overall Study|Adverse Event|1|||
94325035|NCT03814590|322969615|FG008|Overall Study|Adverse Event|0|||
94325036|NCT03814590|322969616|FG009|Overall Study|Adverse Event|0|||
94325037|NCT03814590|322969617|FG010|Overall Study|Adverse Event|1|||
94325038|NCT03814590|322969618|FG011|Overall Study|Adverse Event|0|||
94325039|NCT03814590|322969619|FG012|Overall Study|Adverse Event|3|||
94325040|NCT03814590|322969620|FG013|Overall Study|Adverse Event|0|||
94325041|NCT03814590|322969607|FG000|Overall Study|Lost to Follow-up|0|||
94325042|NCT03814590|322969608|FG001|Overall Study|Lost to Follow-up|2|||
94325043|NCT03814590|322969609|FG002|Overall Study|Lost to Follow-up|1|||
94325044|NCT03814590|322969610|FG003|Overall Study|Lost to Follow-up|0|||
94325045|NCT03814590|322969611|FG004|Overall Study|Lost to Follow-up|1|||
94325046|NCT03814590|322969612|FG005|Overall Study|Lost to Follow-up|1|||
94325047|NCT03814590|322969613|FG006|Overall Study|Lost to Follow-up|1|||
94325048|NCT03814590|322969614|FG007|Overall Study|Lost to Follow-up|1|||
94325049|NCT03814590|322969615|FG008|Overall Study|Lost to Follow-up|0|||
94325050|NCT03814590|322969616|FG009|Overall Study|Lost to Follow-up|0|||
94325051|NCT03814590|322969617|FG010|Overall Study|Lost to Follow-up|1|||
94325052|NCT03814590|322969618|FG011|Overall Study|Lost to Follow-up|0|||
94325053|NCT03814590|322969619|FG012|Overall Study|Lost to Follow-up|0|||
94325054|NCT03814590|322969620|FG013|Overall Study|Lost to Follow-up|1|||
94325055|NCT03814590|322969607|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
94325056|NCT03814590|322969608|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
94325057|NCT03814590|322969609|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
94325058|NCT03814590|322969610|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
94325059|NCT03814590|322969611|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
94325060|NCT03814590|322969612|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
94325061|NCT03814590|322969613|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
94325062|NCT03814590|322969614|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
94325063|NCT03814590|322969615|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
94325064|NCT03814590|322969616|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
94325065|NCT03814590|322969617|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
94325066|NCT03814590|322969618|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
94325067|NCT03814590|322969619|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
94325068|NCT03814590|322969620|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
94325069|NCT03814590|322969607|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
94325070|NCT03814590|322969608|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
94325071|NCT03814590|322969609|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
94325072|NCT03814590|322969610|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
94325073|NCT03814590|322969611|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
94325074|NCT03814590|322969612|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
94325075|NCT03814590|322969613|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
94325076|NCT03814590|322969614|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
94325077|NCT03814590|322969615|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
94325078|NCT03814590|322969616|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
94325079|NCT03814590|322969617|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
94325080|NCT03814590|322969618|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
94325081|NCT03814590|322969619|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
94325082|NCT03814590|322969620|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
94325083|NCT03814590|322969607|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94325084|NCT03814590|322969608|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94325085|NCT03814590|322969609|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94325086|NCT03814590|322969610|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94325087|NCT03814590|322969611|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94325088|NCT03814590|322969612|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94325089|NCT03814590|322969613|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94325090|NCT03814590|322969614|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
94325091|NCT03814590|322969615|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94325092|NCT03814590|322969616|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
94325093|NCT03814590|322969617|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94325094|NCT03814590|322969618|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94325095|NCT03814590|322969619|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94325096|NCT03814590|322969620|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94325097|NCT03814590|322969607|FG000|Overall Study|UNKNOWN REASON|0|||
94325098|NCT03814590|322969608|FG001|Overall Study|UNKNOWN REASON|0|||
94325099|NCT03814590|322969609|FG002|Overall Study|UNKNOWN REASON|0|||
94325100|NCT03814590|322969610|FG003|Overall Study|UNKNOWN REASON|0|||
94325101|NCT03814590|322969611|FG004|Overall Study|UNKNOWN REASON|0|||
94325102|NCT03814590|322969612|FG005|Overall Study|UNKNOWN REASON|0|||
94325103|NCT03814590|322969613|FG006|Overall Study|UNKNOWN REASON|0|||
94325104|NCT03814590|322969614|FG007|Overall Study|UNKNOWN REASON|1|||
94325105|NCT03814590|322969615|FG008|Overall Study|UNKNOWN REASON|0|||
94325106|NCT03814590|322969616|FG009|Overall Study|UNKNOWN REASON|0|||
94325107|NCT03814590|322969617|FG010|Overall Study|UNKNOWN REASON|0|||
94325108|NCT03814590|322969618|FG011|Overall Study|UNKNOWN REASON|0|||
94325109|NCT03814590|322969619|FG012|Overall Study|UNKNOWN REASON|0|||
94325110|NCT03814590|322969620|FG013|Overall Study|UNKNOWN REASON|0|||
94325111|NCT00592553|322969623|FG000|Overall Study|Protocol Noncompliance|1|||
94325112|NCT00592553|322969624|FG001|Overall Study|Protocol Noncompliance|0|||
94325113|NCT00592553|322969625|FG002|Overall Study|Protocol Noncompliance|0|||
94325114|NCT01115738|322969626|FG000|Overall Study|Death|1|||
94388372|NCT01882257|323210648|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
94388373|NCT01882257|323210649|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
94388374|NCT01882257|323210647|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
94388375|NCT01882257|323210648|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
94388376|NCT01882257|323210649|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
94388377|NCT01866319|323210652|FG000|Overall Study|Adverse Event|12|||
94388378|NCT01866319|323210653|FG001|Overall Study|Adverse Event|5|||
94388379|NCT01866319|323210654|FG002|Overall Study|Adverse Event|9|||
94388380|NCT01866319|323210652|FG000|Overall Study|Clinical progression|3|||
94388381|NCT01866319|323210653|FG001|Overall Study|Clinical progression|2|||
94388382|NCT01866319|323210654|FG002|Overall Study|Clinical progression|2|||
94388383|NCT01866319|323210652|FG000|Overall Study|Death|153|||
94325115|NCT01115738|322969627|FG001|Overall Study|Death|0|||
94325116|NCT01115738|322969628|FG002|Overall Study|Death|0|||
94325117|NCT01115738|322969626|FG000|Overall Study|Lost to Follow-up|0|||
94325118|NCT01115738|322969627|FG001|Overall Study|Lost to Follow-up|0|||
94325119|NCT01115738|322969628|FG002|Overall Study|Lost to Follow-up|1|||
94325120|NCT01115738|322969626|FG000|Overall Study|Physician Decision|18|||
94325121|NCT01115738|322969627|FG001|Overall Study|Physician Decision|15|||
94325122|NCT01115738|322969628|FG002|Overall Study|Physician Decision|17|||
94325123|NCT01115738|322969626|FG000|Overall Study|Withdrawal by Subject|6|||
94325124|NCT01115738|322969627|FG001|Overall Study|Withdrawal by Subject|6|||
94325125|NCT01115738|322969628|FG002|Overall Study|Withdrawal by Subject|9|||
94325126|NCT03245723|322969629|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
94325127|NCT03245723|322969630|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
94325128|NCT03245723|322969629|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
94325129|NCT03245723|322969630|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
94325130|NCT03245723|322969629|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
94325131|NCT03245723|322969630|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
94325132|NCT03245723|322969629|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
94325133|NCT03245723|322969630|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
94325134|NCT03337139|322969632|FG000|Phase I|Withdrawal by Subject|10|||
94325135|NCT03337139|322969633|FG001|Phase I|Withdrawal by Subject|0|||
94325136|NCT01871896|322969643|FG000|Overall Study|Lost to Follow-up|1|||
94325137|NCT04092816|322971123|FG000|Overall Study|Lost to Follow-up|1|||
94325138|NCT04092816|322971124|FG001|Overall Study|Lost to Follow-up|2|||
94325139|NCT00369967|322971126|FG000|Overall Study|Lost to Follow-up|23|||
94325140|NCT00369967|322971127|FG001|Overall Study|Lost to Follow-up|12|||
94325141|NCT01677624|322971128|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
94325142|NCT00967226|322971129|FG000|Overall Study|Adverse Event|0|||
94325143|NCT00967226|322971130|FG001|Overall Study|Adverse Event|5|||
94325144|NCT00967226|322971129|FG000|Overall Study|Protocol Violation|2|||
94325145|NCT00967226|322971130|FG001|Overall Study|Protocol Violation|0|||
94325146|NCT00967226|322971129|FG000|Overall Study|Physician Decision|0|||
94325147|NCT00967226|322971130|FG001|Overall Study|Physician Decision|1|||
94325148|NCT01263093|322971131|FG000|Washout|Physician Decision|1|||
94325149|NCT01263093|322971132|FG001|Washout|Physician Decision|0|||
94325150|NCT01263093|322971131|FG000|Period 2|Adverse Event|1|||
94325151|NCT01263093|322971132|FG001|Period 2|Adverse Event|0|||
94325152|NCT02174861|322971137|FG000|Overall Study|Decision by sponsor|8|||
94325153|NCT02174861|322971137|FG000|Overall Study|Withdrawal by Subject|124|||
94325154|NCT02174861|322971137|FG000|Overall Study|Lost to Follow-up|26|||
94325155|NCT00605722|322971138|FG000|Overall Study|Adverse Event|6|||
94325156|NCT00605722|322971138|FG000|Overall Study|Insufficient therapeutic response|44|||
94325157|NCT00605722|322971138|FG000|Overall Study|Failure to return|1|||
94325158|NCT00280150|322971139|FG000|Overall Study|Adverse Event|0|||
94325159|NCT00280150|322971140|FG001|Overall Study|Adverse Event|1|||
94325160|NCT00280150|322971141|FG002|Overall Study|Adverse Event|2|||
94325161|NCT00280150|322971142|FG003|Overall Study|Adverse Event|3|||
94325162|NCT00280150|322971139|FG000|Overall Study|Lack of Efficacy|0|||
94325163|NCT00280150|322971140|FG001|Overall Study|Lack of Efficacy|0|||
94325164|NCT00280150|322971141|FG002|Overall Study|Lack of Efficacy|0|||
94325165|NCT00280150|322971142|FG003|Overall Study|Lack of Efficacy|3|||
94325166|NCT00280150|322971139|FG000|Overall Study|Physician Decision|0|||
94325167|NCT00280150|322971140|FG001|Overall Study|Physician Decision|0|||
94325168|NCT00280150|322971141|FG002|Overall Study|Physician Decision|0|||
94325169|NCT00280150|322971142|FG003|Overall Study|Physician Decision|1|||
94325170|NCT00280150|322971139|FG000|Overall Study|Protocol Violation|0|||
94388384|NCT01866319|323210653|FG001|Overall Study|Death|154|||
94325171|NCT00280150|322971140|FG001|Overall Study|Protocol Violation|0|||
94325172|NCT00280150|322971141|FG002|Overall Study|Protocol Violation|0|||
94325173|NCT00280150|322971142|FG003|Overall Study|Protocol Violation|1|||
94325174|NCT00280150|322971139|FG000|Overall Study|Withdrawal by Subject|0|||
94325175|NCT00280150|322971140|FG001|Overall Study|Withdrawal by Subject|0|||
94325176|NCT00280150|322971141|FG002|Overall Study|Withdrawal by Subject|0|||
94325177|NCT00280150|322971142|FG003|Overall Study|Withdrawal by Subject|1|||
94325178|NCT00280150|322971139|FG000|Overall Study|Did not get consolidation therapy|3|||
94325179|NCT00280150|322971140|FG001|Overall Study|Did not get consolidation therapy|0|||
94325180|NCT00280150|322971141|FG002|Overall Study|Did not get consolidation therapy|3|||
94325181|NCT00280150|322971142|FG003|Overall Study|Did not get consolidation therapy|0|||
94325182|NCT00280150|322971139|FG000|Overall Study|Declining Performance Status|0|||
94325183|NCT00280150|322971140|FG001|Overall Study|Declining Performance Status|0|||
94325184|NCT00280150|322971141|FG002|Overall Study|Declining Performance Status|0|||
94388385|NCT01866319|323210654|FG002|Overall Study|Death|147|||
94388386|NCT01866319|323210652|FG000|Overall Study|Lost to Follow-up|6|||
94388387|NCT01866319|323210653|FG001|Overall Study|Lost to Follow-up|3|||
94388388|NCT01866319|323210654|FG002|Overall Study|Lost to Follow-up|8|||
94388389|NCT01866319|323210652|FG000|Overall Study|Physician Decision|1|||
94388390|NCT01866319|323210653|FG001|Overall Study|Physician Decision|0|||
94388391|NCT01866319|323210654|FG002|Overall Study|Physician Decision|1|||
94388392|NCT01866319|323210652|FG000|Overall Study|Protocol Violation|0|||
94388393|NCT01866319|323210653|FG001|Overall Study|Protocol Violation|0|||
94388394|NCT01866319|323210654|FG002|Overall Study|Protocol Violation|1|||
94388395|NCT01866319|323210652|FG000|Overall Study|Withdrawal by Subject|32|||
94388396|NCT01866319|323210653|FG001|Overall Study|Withdrawal by Subject|14|||
94388397|NCT01866319|323210654|FG002|Overall Study|Withdrawal by Subject|12|||
94388398|NCT01720264|323210667|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
94388399|NCT01720264|323210667|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
94388400|NCT01720264|323210667|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
94388401|NCT00877032|323210668|FG000|Overall Study|Did not meet entrance criteria|0|||
94388402|NCT00877032|323210669|FG001|Overall Study|Did not meet entrance criteria|0|||
94388403|NCT00877032|323210670|FG002|Overall Study|Did not meet entrance criteria|0|||
94388404|NCT00877032|323210671|FG003|Overall Study|Did not meet entrance criteria|1|||
94388405|NCT00877032|323210672|FG004|Overall Study|Did not meet entrance criteria|0|||
94388406|NCT00877032|323210673|FG005|Overall Study|Did not meet entrance criteria|0|||
94388407|NCT00877032|323210674|FG006|Overall Study|Did not meet entrance criteria|2|||
94388408|NCT00553280|323210675|FG000|Overall Study|Adverse Event|19|||
94388409|NCT00553280|323210675|FG000|Overall Study|Lack of Efficacy|3|||
94388410|NCT00553280|323210675|FG000|Overall Study|Withdrawal by Subject|3|||
94388411|NCT00553280|323210675|FG000|Overall Study|Physician Decision|1|||
94388412|NCT01544127|323210676|FG000|Overall Study|Lost to Follow-up|4|||
94388413|NCT01544127|323210677|FG001|Overall Study|Lost to Follow-up|2|||
94388414|NCT01544127|323210678|FG002|Overall Study|Lost to Follow-up|9|||
94388415|NCT01544127|323210676|FG000|Overall Study|Withdrawal by Subject|2|||
94388416|NCT01544127|323210677|FG001|Overall Study|Withdrawal by Subject|2|||
94388417|NCT01544127|323210678|FG002|Overall Study|Withdrawal by Subject|1|||
94388418|NCT01544127|323210676|FG000|Overall Study|Discharged out of catchment area|1|||
94325185|NCT00280150|322971142|FG003|Overall Study|Declining Performance Status|1|||
94325186|NCT02871401|322971145|FG000|Overall Study|Adverse Event|1|||
94325187|NCT02871401|322971146|FG001|Overall Study|Adverse Event|0|||
94325188|NCT01830816|322971157|FG000|Overall Study|Progressive Disease|12|||
94325189|NCT01830816|322971158|FG001|Overall Study|Progressive Disease|7|||
94325190|NCT01830816|322971159|FG002|Overall Study|Progressive Disease|7|||
94325191|NCT01830816|322971157|FG000|Overall Study|Adverse Event|3|||
94325192|NCT01830816|322971158|FG001|Overall Study|Adverse Event|4|||
94325193|NCT01830816|322971159|FG002|Overall Study|Adverse Event|0|||
94325194|NCT01830816|322971157|FG000|Overall Study|Study Terminated by Sponsor|1|||
94325195|NCT01830816|322971158|FG001|Overall Study|Study Terminated by Sponsor|1|||
94325196|NCT01830816|322971159|FG002|Overall Study|Study Terminated by Sponsor|0|||
94325197|NCT01830816|322971157|FG000|Overall Study|Withdrawal by Subject|1|||
94325198|NCT01830816|322971158|FG001|Overall Study|Withdrawal by Subject|1|||
94325199|NCT01830816|322971159|FG002|Overall Study|Withdrawal by Subject|0|||
94325200|NCT01830816|322971157|FG000|Overall Study|Lost to Follow-up|0|||
94325201|NCT01830816|322971158|FG001|Overall Study|Lost to Follow-up|1|||
94325202|NCT01830816|322971159|FG002|Overall Study|Lost to Follow-up|0|||
94325203|NCT01830816|322971157|FG000|Overall Study|Symptomatic Deterioration|1|||
94325204|NCT01830816|322971158|FG001|Overall Study|Symptomatic Deterioration|0|||
94325205|NCT01830816|322971159|FG002|Overall Study|Symptomatic Deterioration|0|||
94325206|NCT01830816|322971157|FG000|Overall Study|Reason not Specified|2|||
94388419|NCT01544127|323210677|FG001|Overall Study|Discharged out of catchment area|1|||
94388420|NCT01544127|323210678|FG002|Overall Study|Discharged out of catchment area|1|||
94388421|NCT01544127|323210676|FG000|Overall Study|Death|1|||
94325207|NCT01830816|322971158|FG001|Overall Study|Reason not Specified|0|||
94325208|NCT01830816|322971159|FG002|Overall Study|Reason not Specified|0|||
94325209|NCT00839423|322971162|FG000|Overall Study|Adverse Event|4|||
94325210|NCT00839423|322971163|FG001|Overall Study|Adverse Event|3|||
94325211|NCT00839423|322971164|FG002|Overall Study|Adverse Event|7|||
94325212|NCT00839423|322971165|FG003|Overall Study|Adverse Event|16|||
94388422|NCT01544127|323210677|FG001|Overall Study|Death|0|||
94388423|NCT01544127|323210678|FG002|Overall Study|Death|0|||
94388424|NCT01544127|323210676|FG000|Overall Study|Jail or Prison|1|||
94388425|NCT01544127|323210677|FG001|Overall Study|Jail or Prison|1|||
94388426|NCT01544127|323210678|FG002|Overall Study|Jail or Prison|2|||
94388427|NCT01544127|323210676|FG000|Overall Study|Became Psychotic|1|||
94325213|NCT00839423|322971162|FG000|Overall Study|Lack of Efficacy|6|||
94325214|NCT00839423|322971163|FG001|Overall Study|Lack of Efficacy|6|||
94388428|NCT01544127|323210677|FG001|Overall Study|Became Psychotic|0|||
94388429|NCT01544127|323210678|FG002|Overall Study|Became Psychotic|0|||
94388430|NCT01544127|323210676|FG000|Overall Study|Researcher withdrew|1|||
94388431|NCT01544127|323210677|FG001|Overall Study|Researcher withdrew|0|||
94388432|NCT01544127|323210678|FG002|Overall Study|Researcher withdrew|0|||
94388433|NCT01544127|323210676|FG000|Overall Study|Went active duty|0|||
94388434|NCT01544127|323210677|FG001|Overall Study|Went active duty|0|||
94388435|NCT01544127|323210678|FG002|Overall Study|Went active duty|1|||
94388436|NCT00615069|323210679|FG000|Overall Study|Death|10|||
94388437|NCT00615069|323210679|FG000|Overall Study|Physician Decision|2|||
94388438|NCT00615069|323210679|FG000|Overall Study|Withdrawal by Subject|4|||
94388439|NCT02107092|323210680|FG000|Overall Study|Miscellaneous|3|||
94388440|NCT02107092|323210680|FG000|Overall Study|Subject compliance|3|||
94388441|NCT02107092|323210680|FG000|Overall Study|Hypo-or hyperkalemia|2|||
94388442|NCT02107092|323210680|FG000|Overall Study|Met ECG withdrawal criteria|3|||
94388443|NCT02107092|323210680|FG000|Overall Study|Physician Decision|3|||
94388444|NCT02107092|323210680|FG000|Overall Study|Lost to Follow-up|2|||
94388445|NCT02107092|323210680|FG000|Overall Study|Withdrawal by Subject|9|||
94388446|NCT02107092|323210680|FG000|Overall Study|Adverse Event|7|||
94388447|NCT02107092|323210680|FG000|Overall Study|Expected progression of CKD|12|||
94388448|NCT00259012|323210681|FG000|Overall Study|Adverse Event|0|||
94388449|NCT00259012|323210682|FG001|Overall Study|Adverse Event|1|||
94388450|NCT00259012|323210681|FG000|Overall Study|Withdrawal by Subject|1|||
94388451|NCT00259012|323210682|FG001|Overall Study|Withdrawal by Subject|0|||
94325215|NCT00839423|322971164|FG002|Overall Study|Lack of Efficacy|3|||
94325216|NCT00839423|322971165|FG003|Overall Study|Lack of Efficacy|2|||
94325217|NCT00839423|322971162|FG000|Overall Study|Non-compliance|0|||
94325218|NCT00839423|322971163|FG001|Overall Study|Non-compliance|0|||
94325219|NCT00839423|322971164|FG002|Overall Study|Non-compliance|0|||
94325220|NCT00839423|322971165|FG003|Overall Study|Non-compliance|1|||
94325221|NCT00839423|322971162|FG000|Overall Study|Protocol Violation|0|||
94325222|NCT00839423|322971163|FG001|Overall Study|Protocol Violation|1|||
94325223|NCT00839423|322971164|FG002|Overall Study|Protocol Violation|2|||
94325224|NCT00839423|322971165|FG003|Overall Study|Protocol Violation|0|||
94325225|NCT00839423|322971162|FG000|Overall Study|Withdrawal of consent|4|||
94325226|NCT00839423|322971163|FG001|Overall Study|Withdrawal of consent|0|||
94325227|NCT00839423|322971164|FG002|Overall Study|Withdrawal of consent|4|||
94325228|NCT00839423|322971165|FG003|Overall Study|Withdrawal of consent|1|||
94325229|NCT00839423|322971162|FG000|Overall Study|Lost to Follow-up|1|||
94325230|NCT00839423|322971163|FG001|Overall Study|Lost to Follow-up|0|||
94325231|NCT00839423|322971164|FG002|Overall Study|Lost to Follow-up|1|||
94325232|NCT00839423|322971165|FG003|Overall Study|Lost to Follow-up|0|||
94325233|NCT00839423|322971162|FG000|Overall Study|Administrative or other reasons|3|||
94325234|NCT00839423|322971163|FG001|Overall Study|Administrative or other reasons|0|||
94325235|NCT00839423|322971164|FG002|Overall Study|Administrative or other reasons|1|||
94325236|NCT00839423|322971165|FG003|Overall Study|Administrative or other reasons|0|||
94325237|NCT01071096|322971166|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
94325238|NCT01071096|322971167|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
94325239|NCT02585999|322971168|FG000|Overall Study|Lost to Follow-up|1|||
94325240|NCT02585999|322971168|FG000|Overall Study|Protocol Violation|1|||
94325241|NCT00485589|322971169|FG000|Overall Study|Death|2|||
94325242|NCT00485589|322971170|FG001|Overall Study|Death|2|||
94325243|NCT00485589|322971171|FG002|Overall Study|Death|0|||
94325244|NCT00485589|322971169|FG000|Overall Study|Failure to return|6|||
94325245|NCT00485589|322971170|FG001|Overall Study|Failure to return|5|||
94325246|NCT00485589|322971171|FG002|Overall Study|Failure to return|1|||
94325247|NCT00485589|322971169|FG000|Overall Study|Protocol Violation|1|||
94325248|NCT00485589|322971170|FG001|Overall Study|Protocol Violation|0|||
94325249|NCT00485589|322971171|FG002|Overall Study|Protocol Violation|0|||
94325250|NCT00485589|322971169|FG000|Overall Study|Violation of selection criteria at entry|0|||
94325251|NCT00485589|322971170|FG001|Overall Study|Violation of selection criteria at entry|3|||
94325252|NCT00485589|322971171|FG002|Overall Study|Violation of selection criteria at entry|1|||
94325253|NCT00485589|322971169|FG000|Overall Study|Administrative/Other|1|||
94325254|NCT00485589|322971170|FG001|Overall Study|Administrative/Other|2|||
94325255|NCT00485589|322971171|FG002|Overall Study|Administrative/Other|1|||
94325256|NCT00485589|322971169|FG000|Overall Study|Insufficient therapeutic response|10|||
94325257|NCT00485589|322971170|FG001|Overall Study|Insufficient therapeutic response|3|||
94325258|NCT00485589|322971171|FG002|Overall Study|Insufficient therapeutic response|1|||
94325259|NCT00485589|322971169|FG000|Overall Study|Refused treatment/did not cooperate|1|||
94325260|NCT00485589|322971170|FG001|Overall Study|Refused treatment/did not cooperate|0|||
94388452|NCT00259012|323210681|FG000|Overall Study|Physician Decision|0|||
94388453|NCT00259012|323210682|FG001|Overall Study|Physician Decision|1|||
94388454|NCT00259012|323210681|FG000|Overall Study|Lost to Follow-up|0|||
94388455|NCT00259012|323210682|FG001|Overall Study|Lost to Follow-up|1|||
94388456|NCT00259012|323210681|FG000|Overall Study|Protocol Violation|1|||
94325261|NCT00485589|322971171|FG002|Overall Study|Refused treatment/did not cooperate|2|||
94388457|NCT00259012|323210682|FG001|Overall Study|Protocol Violation|1|||
94388458|NCT02458469|323210683|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
94325262|NCT00485589|322971169|FG000|Overall Study|Withdrawal by Subject|3|||
94325263|NCT00485589|322971170|FG001|Overall Study|Withdrawal by Subject|2|||
94325264|NCT00485589|322971171|FG002|Overall Study|Withdrawal by Subject|2|||
94325265|NCT00485589|322971169|FG000|Overall Study|Adverse Event|3|||
94325266|NCT00485589|322971170|FG001|Overall Study|Adverse Event|3|||
94325267|NCT00485589|322971171|FG002|Overall Study|Adverse Event|10|||
94325268|NCT00205699|322971172|FG000|Overall Study|Lost to Follow-up|1|||
94325269|NCT00205699|322971173|FG001|Overall Study|Lost to Follow-up|3|||
94325270|NCT00205699|322971174|FG002|Overall Study|Lost to Follow-up|5|||
94325271|NCT00205699|322971172|FG000|Overall Study|Adverse Event|1|||
94325272|NCT00205699|322971173|FG001|Overall Study|Adverse Event|0|||
94325273|NCT00205699|322971174|FG002|Overall Study|Adverse Event|0|||
94325274|NCT00205699|322971172|FG000|Overall Study|Withdrawal by Subject|1|||
94325275|NCT00205699|322971173|FG001|Overall Study|Withdrawal by Subject|2|||
94325276|NCT00205699|322971174|FG002|Overall Study|Withdrawal by Subject|1|||
94325277|NCT00205699|322971172|FG000|Overall Study|Lack of Efficacy|0|||
94325278|NCT00205699|322971173|FG001|Overall Study|Lack of Efficacy|1|||
94325279|NCT00205699|322971174|FG002|Overall Study|Lack of Efficacy|0|||
94325280|NCT00830115|322971175|FG000|Overall Study|Adverse Event|2|||
94325281|NCT00830115|322971175|FG000|Overall Study|Improvement/recovery|1|||
94325282|NCT01149343|322971180|FG000|Overall Study|Withdrawal by Subject|1|||
94325283|NCT01149343|322971181|FG001|Overall Study|Withdrawal by Subject|1|||
94325284|NCT01149343|322971182|FG002|Overall Study|Withdrawal by Subject|1|||
94325285|NCT01149343|322971183|FG003|Overall Study|Withdrawal by Subject|5|||
94325286|NCT01149343|322971180|FG000|Overall Study|Death|10|||
94325287|NCT01149343|322971181|FG001|Overall Study|Death|13|||
94325288|NCT01149343|322971182|FG002|Overall Study|Death|18|||
94325289|NCT01149343|322971183|FG003|Overall Study|Death|18|||
94325290|NCT01149343|322971180|FG000|Overall Study|Lost to Follow-up|1|||
94325291|NCT01149343|322971181|FG001|Overall Study|Lost to Follow-up|0|||
94325292|NCT01149343|322971182|FG002|Overall Study|Lost to Follow-up|0|||
94325293|NCT01149343|322971183|FG003|Overall Study|Lost to Follow-up|1|||
94325294|NCT01149343|322971180|FG000|Overall Study|Other|8|||
94325295|NCT01149343|322971181|FG001|Overall Study|Other|10|||
94325296|NCT01149343|322971182|FG002|Overall Study|Other|2|||
94325297|NCT01149343|322971183|FG003|Overall Study|Other|14|||
94325298|NCT01149343|322971180|FG000|Overall Study|Sponsor study termination|0|||
94325299|NCT01149343|322971181|FG001|Overall Study|Sponsor study termination|0|||
94325300|NCT01149343|322971182|FG002|Overall Study|Sponsor study termination|0|||
94325301|NCT01149343|322971183|FG003|Overall Study|Sponsor study termination|2|||
94325302|NCT01149343|322971180|FG000|Overall Study|Recurrence / Progressive disease|0|||
94325303|NCT01149343|322971181|FG001|Overall Study|Recurrence / Progressive disease|0|||
94325304|NCT01149343|322971182|FG002|Overall Study|Recurrence / Progressive disease|1|||
94325305|NCT01149343|322971183|FG003|Overall Study|Recurrence / Progressive disease|0|||
94325306|NCT01061736|322971184|FG000|Overall Study|Dose regimen not selected|0|||
94325307|NCT01061736|322971185|FG001|Overall Study|Dose regimen not selected|0|||
94325308|NCT01061736|322971186|FG002|Overall Study|Dose regimen not selected|0|||
94325309|NCT01061736|322971187|FG003|Overall Study|Dose regimen not selected|0|||
94325310|NCT01061736|322971188|FG004|Overall Study|Dose regimen not selected|0|||
94325311|NCT01061736|322971189|FG005|Overall Study|Dose regimen not selected|0|||
94325312|NCT01061736|322971190|FG006|Overall Study|Dose regimen not selected|79|||
94325313|NCT01061736|322971191|FG007|Overall Study|Dose regimen not selected|0|||
94388459|NCT02458469|323210684|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
94388460|NCT02458469|323210685|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
94325314|NCT01061736|322971192|FG008|Overall Study|Dose regimen not selected|0|||
94325315|NCT01061736|322971193|FG009|Overall Study|Dose regimen not selected|0|||
94325316|NCT01061736|322971184|FG000|Overall Study|Adverse Event|13|||
94325317|NCT01061736|322971185|FG001|Overall Study|Adverse Event|1|||
94325318|NCT01061736|322971186|FG002|Overall Study|Adverse Event|3|||
94325319|NCT01061736|322971187|FG003|Overall Study|Adverse Event|2|||
94325320|NCT01061736|322971188|FG004|Overall Study|Adverse Event|4|||
94325321|NCT01061736|322971189|FG005|Overall Study|Adverse Event|1|||
94325322|NCT01061736|322971190|FG006|Overall Study|Adverse Event|4|||
94325323|NCT01061736|322971191|FG007|Overall Study|Adverse Event|63|||
94325324|NCT01061736|322971192|FG008|Overall Study|Adverse Event|67|||
94325325|NCT01061736|322971193|FG009|Overall Study|Adverse Event|34|||
94325326|NCT01061736|322971184|FG000|Overall Study|Lack of Efficacy|0|||
94325327|NCT01061736|322971185|FG001|Overall Study|Lack of Efficacy|2|||
94325328|NCT01061736|322971186|FG002|Overall Study|Lack of Efficacy|1|||
94325329|NCT01061736|322971187|FG003|Overall Study|Lack of Efficacy|1|||
94325330|NCT01061736|322971188|FG004|Overall Study|Lack of Efficacy|1|||
94325331|NCT01061736|322971189|FG005|Overall Study|Lack of Efficacy|2|||
94325332|NCT01061736|322971190|FG006|Overall Study|Lack of Efficacy|1|||
94325333|NCT01061736|322971191|FG007|Overall Study|Lack of Efficacy|9|||
94325334|NCT01061736|322971192|FG008|Overall Study|Lack of Efficacy|9|||
94325335|NCT01061736|322971193|FG009|Overall Study|Lack of Efficacy|10|||
94325336|NCT01061736|322971184|FG000|Overall Study|Poor compliance to protocol|0|||
94325337|NCT01061736|322971185|FG001|Overall Study|Poor compliance to protocol|0|||
94325338|NCT01061736|322971186|FG002|Overall Study|Poor compliance to protocol|0|||
94325339|NCT01061736|322971187|FG003|Overall Study|Poor compliance to protocol|0|||
94325340|NCT01061736|322971188|FG004|Overall Study|Poor compliance to protocol|0|||
94325341|NCT01061736|322971189|FG005|Overall Study|Poor compliance to protocol|0|||
94325342|NCT01061736|322971190|FG006|Overall Study|Poor compliance to protocol|0|||
94325343|NCT01061736|322971191|FG007|Overall Study|Poor compliance to protocol|2|||
94325344|NCT01061736|322971192|FG008|Overall Study|Poor compliance to protocol|5|||
94325345|NCT01061736|322971193|FG009|Overall Study|Poor compliance to protocol|9|||
94325346|NCT01061736|322971184|FG000|Overall Study|Not treated|0|||
94325347|NCT01061736|322971185|FG001|Overall Study|Not treated|0|||
94325348|NCT01061736|322971186|FG002|Overall Study|Not treated|0|||
94325349|NCT01061736|322971187|FG003|Overall Study|Not treated|0|||
94325350|NCT01061736|322971188|FG004|Overall Study|Not treated|1|||
94325351|NCT01061736|322971189|FG005|Overall Study|Not treated|0|||
94325352|NCT01061736|322971190|FG006|Overall Study|Not treated|0|||
94325353|NCT01061736|322971191|FG007|Overall Study|Not treated|2|||
94325354|NCT01061736|322971192|FG008|Overall Study|Not treated|1|||
94325355|NCT01061736|322971193|FG009|Overall Study|Not treated|0|||
94325356|NCT01061736|322971184|FG000|Overall Study|Other than specified above|0|||
94325357|NCT01061736|322971185|FG001|Overall Study|Other than specified above|1|||
94325358|NCT01061736|322971186|FG002|Overall Study|Other than specified above|2|||
94325359|NCT01061736|322971187|FG003|Overall Study|Other than specified above|0|||
94325360|NCT01061736|322971188|FG004|Overall Study|Other than specified above|1|||
94325361|NCT01061736|322971189|FG005|Overall Study|Other than specified above|0|||
94325362|NCT01061736|322971190|FG006|Overall Study|Other than specified above|0|||
94325363|NCT01061736|322971191|FG007|Overall Study|Other than specified above|18|||
94325364|NCT01061736|322971192|FG008|Overall Study|Other than specified above|15|||
94325365|NCT01061736|322971193|FG009|Overall Study|Other than specified above|21|||
94325366|NCT01207388|322971194|FG000|Overall Study|Death|67|||
94325367|NCT01207388|322971194|FG000|Overall Study|Withdrawal by Subject|1|||
94325368|NCT01204697|322971196|FG000|Overall Study|Death|26|||
94325369|NCT01204697|322971197|FG001|Overall Study|Death|27|||
94325370|NCT01204697|322971196|FG000|Overall Study|Lost to Follow-up|3|||
94325371|NCT01204697|322971197|FG001|Overall Study|Lost to Follow-up|4|||
94325372|NCT01204697|322971196|FG000|Overall Study|Withdrawal by Subject|2|||
94325373|NCT01204697|322971197|FG001|Overall Study|Withdrawal by Subject|4|||
94325374|NCT01204697|322971196|FG000|Overall Study|Randomized, but not treated|0|||
94325375|NCT01204697|322971197|FG001|Overall Study|Randomized, but not treated|1|||
94325376|NCT01205451|322971198|FG000|Overall Study|Lost to Follow-up|1|||
94325377|NCT01205451|322971199|FG001|Overall Study|Lost to Follow-up|1|||
94325378|NCT01205451|322971198|FG000|Overall Study|Withdrawal by Subject|5|||
94325379|NCT01205451|322971199|FG001|Overall Study|Withdrawal by Subject|9|||
94325380|NCT02287402|322971200|FG000|Treatment Period|Adverse Event|17|||
94325381|NCT02287402|322971200|FG000|Treatment Period|Voluntary Withdrawal|10|||
94325382|NCT02287402|322971200|FG000|Follow-up|Lost to Follow-up|1|||
94325383|NCT02287402|322971200|FG000|Follow-up|Voluntary Withdrawal|2|||
94325384|NCT00589979|322971203|FG000|Run-In Period|Adverse Event|5|||
94325385|NCT00589979|322971204|FG001|Run-In Period|Adverse Event|0|||
94325386|NCT00589979|322971205|FG002|Run-In Period|Adverse Event|0|||
94325387|NCT00589979|322971203|FG000|Run-In Period|Protocol Violation|3|||
94325388|NCT00589979|322971204|FG001|Run-In Period|Protocol Violation|0|||
94325389|NCT00589979|322971205|FG002|Run-In Period|Protocol Violation|0|||
94325390|NCT00589979|322971203|FG000|Run-In Period|Did not qualify for randomization|54|||
94325391|NCT00589979|322971204|FG001|Run-In Period|Did not qualify for randomization|0|||
94325392|NCT00589979|322971205|FG002|Run-In Period|Did not qualify for randomization|0|||
94325393|NCT00589979|322971203|FG000|Run-In Period|Withdrawal by Subject|10|||
94325394|NCT00589979|322971204|FG001|Run-In Period|Withdrawal by Subject|0|||
94325395|NCT00589979|322971205|FG002|Run-In Period|Withdrawal by Subject|0|||
94325396|NCT00589979|322971203|FG000|Run-In Period|Informed Consent Withdrawn|4|||
94325397|NCT00589979|322971204|FG001|Run-In Period|Informed Consent Withdrawn|0|||
94325398|NCT00589979|322971205|FG002|Run-In Period|Informed Consent Withdrawn|0|||
94325399|NCT00589979|322971203|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
94325400|NCT00589979|322971204|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
94325401|NCT00589979|322971205|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
94325402|NCT00589979|322971203|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
94325403|NCT00589979|322971204|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
94325404|NCT00589979|322971205|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
94325405|NCT00589979|322971203|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
94325406|NCT00589979|322971204|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
94325407|NCT00589979|322971205|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
94325408|NCT00589979|322971203|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
94325409|NCT00589979|322971204|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
94325410|NCT00589979|322971205|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
94325411|NCT00589979|322971203|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
94325412|NCT00589979|322971204|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
94325413|NCT00589979|322971205|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
94325414|NCT00589979|322971203|FG000|Double-Blind Treatment Period 2|Other|0|||
94325415|NCT00589979|322971204|FG001|Double-Blind Treatment Period 2|Other|0|||
94325416|NCT00589979|322971205|FG002|Double-Blind Treatment Period 2|Other|1|||
94325417|NCT00589979|322971203|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
94325418|NCT00589979|322971204|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
94325419|NCT00589979|322971205|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
94325420|NCT00589979|322971203|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
94325421|NCT00589979|322971204|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
94325422|NCT00589979|322971205|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
94325423|NCT00976950|322971206|FG000|Overall Study|Adverse Event|3|||
94325424|NCT00976950|322971206|FG000|Overall Study|Events with no relationship to Aptivus|3|||
94325425|NCT00304915|322971207|FG000|Overall Study|Lost to Follow-up|11|||
94325426|NCT00304915|322971208|FG001|Overall Study|Lost to Follow-up|11|||
94325427|NCT00304915|322971207|FG000|Overall Study|Death|4|||
94325428|NCT00304915|322971208|FG001|Overall Study|Death|5|||
94325429|NCT00304915|322971207|FG000|Overall Study|Withdrawal by Subject|3|||
94325430|NCT00304915|322971208|FG001|Overall Study|Withdrawal by Subject|0|||
94325431|NCT01479374|322971215|FG000|Overall Study|Adverse Event|2|||
94325432|NCT01479374|322971216|FG001|Overall Study|Adverse Event|1|||
94325433|NCT01479374|322971217|FG002|Overall Study|Adverse Event|0|||
94325434|NCT01479374|322971215|FG000|Overall Study|Lost to Follow-up|1|||
94325435|NCT01479374|322971216|FG001|Overall Study|Lost to Follow-up|2|||
94325436|NCT01479374|322971217|FG002|Overall Study|Lost to Follow-up|0|||
94325437|NCT01479374|322971215|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
94325438|NCT01479374|322971216|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
94325439|NCT01479374|322971217|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
94325440|NCT01479374|322971215|FG000|Overall Study|Other|0|||
94325441|NCT01479374|322971216|FG001|Overall Study|Other|4|||
94325442|NCT01479374|322971217|FG002|Overall Study|Other|5|||
94325443|NCT01511107|322971218|FG000|Overall Study|Ineligible|3|||
94325444|NCT01511107|322971219|FG001|Overall Study|Ineligible|2|||
94325445|NCT01511107|322971218|FG000|Overall Study|Lost to Follow-up|10|||
94325446|NCT01511107|322971219|FG001|Overall Study|Lost to Follow-up|19|||
94325447|NCT01511107|322971218|FG000|Overall Study|Withdrawal by Subject|9|||
94325448|NCT01511107|322971219|FG001|Overall Study|Withdrawal by Subject|20|||
94325449|NCT04404010|322971222|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
94325450|NCT04404010|322971223|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
94325451|NCT02120157|322971224|FG000|Overall Study|Death|8|||
94325452|NCT00586924|322971228|FG000|Overall Study|Adverse event/serious adverse event|0|||
94325453|NCT00586924|322971229|FG001|Overall Study|Adverse event/serious adverse event|0|||
94325454|NCT00586924|322971230|FG002|Overall Study|Adverse event/serious adverse event|0|||
94325455|NCT00586924|322971231|FG003|Overall Study|Adverse event/serious adverse event|1|||
94325456|NCT00586924|322971232|FG004|Overall Study|Adverse event/serious adverse event|0|||
94325457|NCT00586924|322971233|FG005|Overall Study|Adverse event/serious adverse event|2|||
94325458|NCT00586924|322971228|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
94325459|NCT00586924|322971229|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
94325460|NCT00586924|322971230|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
94325461|NCT00586924|322971231|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
94325462|NCT00586924|322971232|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
94325463|NCT00586924|322971233|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
94325464|NCT00586924|322971228|FG000|Overall Study|Disease progression|0|||
94325465|NCT00586924|322971229|FG001|Overall Study|Disease progression|0|||
94325466|NCT00586924|322971230|FG002|Overall Study|Disease progression|0|||
94325467|NCT00586924|322971231|FG003|Overall Study|Disease progression|1|||
94325468|NCT00586924|322971232|FG004|Overall Study|Disease progression|1|||
94325469|NCT00586924|322971233|FG005|Overall Study|Disease progression|0|||
94325470|NCT00586924|322971228|FG000|Overall Study|Development of neutralizing antibodies|2|||
94325471|NCT00586924|322971229|FG001|Overall Study|Development of neutralizing antibodies|2|||
94325472|NCT00586924|322971230|FG002|Overall Study|Development of neutralizing antibodies|2|||
94325473|NCT00586924|322971231|FG003|Overall Study|Development of neutralizing antibodies|0|||
94325474|NCT00586924|322971232|FG004|Overall Study|Development of neutralizing antibodies|0|||
94325475|NCT00586924|322971233|FG005|Overall Study|Development of neutralizing antibodies|22|||
94325476|NCT00586924|322971228|FG000|Overall Study|Complete response|0|||
94325477|NCT00586924|322971229|FG001|Overall Study|Complete response|1|||
94325478|NCT00586924|322971230|FG002|Overall Study|Complete response|0|||
94325479|NCT00586924|322971231|FG003|Overall Study|Complete response|0|||
94325480|NCT00586924|322971232|FG004|Overall Study|Complete response|2|||
94325481|NCT00586924|322971233|FG005|Overall Study|Complete response|2|||
94325482|NCT00586924|322971228|FG000|Overall Study|Other|1|||
94325483|NCT00586924|322971229|FG001|Overall Study|Other|0|||
94325484|NCT00586924|322971230|FG002|Overall Study|Other|1|||
94325485|NCT00586924|322971231|FG003|Overall Study|Other|1|||
94325486|NCT00586924|322971232|FG004|Overall Study|Other|1|||
94325487|NCT00586924|322971233|FG005|Overall Study|Other|6|||
94325488|NCT00536978|322971234|FG000|Overall Study|Not eligible for Adback Infusion|22|||
94325489|NCT01737840|322971239|FG000|Overall Study|Diagnosed with an other pathology|2|||
94325490|NCT01737840|322971240|FG001|Overall Study|Diagnosed with an other pathology|2|||
94325491|NCT03666858|322971242|FG000|Cohort 1|Adverse Event|1|||
94325492|NCT03666858|322971243|FG001|Cohort 1|Adverse Event|0|||
94325493|NCT03666858|322971242|FG000|Cohort 2|Adverse Event|0|||
94325494|NCT03666858|322971243|FG001|Cohort 2|Adverse Event|1|||
94325495|NCT02768194|322971244|FG000|Period 1|Adverse Event|0|||
94325496|NCT02768194|322971245|FG001|Period 1|Adverse Event|0|||
94325497|NCT02768194|322971246|FG002|Period 1|Adverse Event|0|||
94325498|NCT02768194|322971247|FG003|Period 1|Adverse Event|1|||
94325499|NCT02768194|322971248|FG004|Period 1|Adverse Event|0|||
94325500|NCT02768194|322971249|FG005|Period 1|Adverse Event|0|||
94325501|NCT02768194|322971244|FG000|Period 2|Other (Reason not specified)|1|||
94325502|NCT02768194|322971245|FG001|Period 2|Other (Reason not specified)|0|||
94325503|NCT02768194|322971246|FG002|Period 2|Other (Reason not specified)|0|||
94325504|NCT02768194|322971247|FG003|Period 2|Other (Reason not specified)|0|||
94325505|NCT02768194|322971248|FG004|Period 2|Other (Reason not specified)|0|||
94325506|NCT02768194|322971249|FG005|Period 2|Other (Reason not specified)|0|||
94325507|NCT02768194|322971244|FG000|Period 3|Other (Reason not specified)|0|||
94325508|NCT02768194|322971245|FG001|Period 3|Other (Reason not specified)|1|||
94325509|NCT02768194|322971246|FG002|Period 3|Other (Reason not specified)|0|||
94325510|NCT02768194|322971247|FG003|Period 3|Other (Reason not specified)|0|||
94325511|NCT02768194|322971248|FG004|Period 3|Other (Reason not specified)|0|||
94325512|NCT02768194|322971249|FG005|Period 3|Other (Reason not specified)|0|||
94325513|NCT01029886|322971252|FG000|Overall Study|Adverse Event|12|||
94325514|NCT01029886|322971253|FG001|Overall Study|Adverse Event|25|||
94325515|NCT01029886|322971252|FG000|Overall Study|Lost to Follow-up|1|||
94325516|NCT01029886|322971253|FG001|Overall Study|Lost to Follow-up|0|||
94325517|NCT01029886|322971252|FG000|Overall Study|Physician Decision|2|||
94325518|NCT01029886|322971253|FG001|Overall Study|Physician Decision|6|||
94325519|NCT01029886|322971252|FG000|Overall Study|Protocol Violation|17|||
94325520|NCT01029886|322971253|FG001|Overall Study|Protocol Violation|5|||
94325521|NCT01029886|322971252|FG000|Overall Study|Withdrawal by Subject|8|||
94325522|NCT01029886|322971253|FG001|Overall Study|Withdrawal by Subject|18|||
94325523|NCT01029886|322971252|FG000|Overall Study|Entry Criteria Not Met|13|||
94325524|NCT01029886|322971253|FG001|Overall Study|Entry Criteria Not Met|5|||
94325525|NCT01029886|322971252|FG000|Overall Study|Sponsor Decision|1|||
94325526|NCT01029886|322971253|FG001|Overall Study|Sponsor Decision|0|||
94325527|NCT01029886|322971252|FG000|Overall Study|Loss Glucose Control|7|||
94325528|NCT01029886|322971253|FG001|Overall Study|Loss Glucose Control|1|||
94325529|NCT00255086|322971256|FG000|Overall Study|Adverse Event|1|||
94325530|NCT00255086|322971257|FG001|Overall Study|Adverse Event|1|||
94325531|NCT00255086|322971256|FG000|Overall Study|Protocol Violation|1|||
94325532|NCT00255086|322971257|FG001|Overall Study|Protocol Violation|1|||
94325533|NCT02365584|322971261|FG000|Overall Study|Adverse Event|2|||
94325534|NCT02365584|322971262|FG001|Overall Study|Adverse Event|2|||
94325535|NCT02365584|322971261|FG000|Overall Study|Withdrawal by Subject|1|||
94325536|NCT02365584|322971262|FG001|Overall Study|Withdrawal by Subject|0|||
94325537|NCT02365584|322971261|FG000|Overall Study|Disease Progression|9|||
94325538|NCT02365584|322971262|FG001|Overall Study|Disease Progression|12|||
94325539|NCT05294211|322971263|FG000|Overall Study|Withdrawal by Subject|3|||
94325540|NCT05294211|322971263|FG000|Overall Study|Physician Decision|2|||
94388461|NCT02458469|323210686|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
94388462|NCT02458469|323210687|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
94325541|NCT05294211|322971263|FG000|Overall Study|Progressed to active labor|1|||
94325542|NCT05294211|322971263|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
94325543|NCT05294211|322971263|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
94325544|NCT00964158|322971264|FG000|Overall Study|Lost to Follow-up|0|||
94325545|NCT00964158|322971265|FG001|Overall Study|Lost to Follow-up|1|||
94325546|NCT00964158|322971266|FG002|Overall Study|Lost to Follow-up|2|||
94325547|NCT00964158|322971264|FG000|Overall Study|Withdrawal by Subject|0|||
94325548|NCT00964158|322971265|FG001|Overall Study|Withdrawal by Subject|0|||
94325549|NCT00964158|322971266|FG002|Overall Study|Withdrawal by Subject|6|||
94325550|NCT02198651|322973069|FG000|Lead-in Period|Withdrew consent|13|||
94325551|NCT02198651|322973070|FG001|Lead-in Period|Withdrew consent|0|||
94325552|NCT02198651|322973071|FG002|Lead-in Period|Withdrew consent|0|||
94325553|NCT02198651|322973072|FG003|Lead-in Period|Withdrew consent|0|||
94325554|NCT02198651|322973073|FG004|Lead-in Period|Withdrew consent|0|||
94325555|NCT02198651|322973069|FG000|Lead-in Period|Adverse Event|2|||
94325556|NCT02198651|322973070|FG001|Lead-in Period|Adverse Event|0|||
94325557|NCT02198651|322973071|FG002|Lead-in Period|Adverse Event|0|||
94325558|NCT02198651|322973072|FG003|Lead-in Period|Adverse Event|0|||
94325559|NCT02198651|322973073|FG004|Lead-in Period|Adverse Event|0|||
94325560|NCT02198651|322973069|FG000|Lead-in Period|Other, not specified|22|||
94325561|NCT02198651|322973070|FG001|Lead-in Period|Other, not specified|0|||
94325562|NCT02198651|322973071|FG002|Lead-in Period|Other, not specified|0|||
94325563|NCT02198651|322973072|FG003|Lead-in Period|Other, not specified|0|||
94325564|NCT02198651|322973073|FG004|Lead-in Period|Other, not specified|0|||
94325565|NCT02198651|322973069|FG000|Double-blind Period|Withdrew consent|0|||
94325566|NCT02198651|322973070|FG001|Double-blind Period|Withdrew consent|4|||
94325567|NCT02198651|322973071|FG002|Double-blind Period|Withdrew consent|0|||
94325568|NCT02198651|322973072|FG003|Double-blind Period|Withdrew consent|0|||
94325569|NCT02198651|322973073|FG004|Double-blind Period|Withdrew consent|0|||
94325570|NCT02198651|322973069|FG000|Double-blind Period|Adverse Event|0|||
94325571|NCT02198651|322973070|FG001|Double-blind Period|Adverse Event|1|||
94325572|NCT02198651|322973071|FG002|Double-blind Period|Adverse Event|0|||
94325573|NCT02198651|322973072|FG003|Double-blind Period|Adverse Event|0|||
94325574|NCT02198651|322973073|FG004|Double-blind Period|Adverse Event|0|||
94325575|NCT02198651|322973069|FG000|Double-blind Period|Other, not specified|0|||
94325576|NCT02198651|322973070|FG001|Double-blind Period|Other, not specified|4|||
94325577|NCT02198651|322973071|FG002|Double-blind Period|Other, not specified|1|||
94325578|NCT02198651|322973072|FG003|Double-blind Period|Other, not specified|0|||
94325579|NCT02198651|322973073|FG004|Double-blind Period|Other, not specified|0|||
94325580|NCT02198651|322973069|FG000|Open-label Rescue Period|Withdrew consent|0|||
94325581|NCT02198651|322973070|FG001|Open-label Rescue Period|Withdrew consent|0|||
94325582|NCT02198651|322973071|FG002|Open-label Rescue Period|Withdrew consent|0|||
94325583|NCT02198651|322973072|FG003|Open-label Rescue Period|Withdrew consent|2|||
94325584|NCT02198651|322973073|FG004|Open-label Rescue Period|Withdrew consent|0|||
94325585|NCT02198651|322973069|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
94325586|NCT02198651|322973070|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
94325587|NCT02198651|322973071|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
94325588|NCT02198651|322973072|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
94325589|NCT02198651|322973073|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
94325590|NCT04095442|322973077|FG000|Overall Study|Lost to Follow-up|0|||
94325591|NCT04095442|322973078|FG001|Overall Study|Lost to Follow-up|1|||
94325592|NCT04095442|322973077|FG000|Overall Study|Screen failure|1|||
94325593|NCT04095442|322973078|FG001|Overall Study|Screen failure|0|||
94325594|NCT01747811|322973083|FG000|Overall Study|Lack of Efficacy|2|||
94325595|NCT01747811|322973084|FG001|Overall Study|Lack of Efficacy|4|||
94325596|NCT02690207|322973085|FG000|Overall Study|Lost to Follow-up|48|||
94325597|NCT02690207|322973085|FG000|Overall Study|Withdrawal by Subject|46|||
94325598|NCT02690207|322973085|FG000|Overall Study|Protocol Violation|2|||
94325599|NCT02690207|322973085|FG000|Overall Study|Serious adverse event|110|||
94325600|NCT02690207|322973085|FG000|Overall Study|Non-serious Adverse Event|18|||
94325601|NCT02690207|322973085|FG000|Overall Study|Migrated/moved from study area|5|||
94325602|NCT02690207|322973085|FG000|Overall Study|Suspected HZ Episode|1|||
94325603|NCT02690207|322973085|FG000|Overall Study|Other reasons for withdrawal|23|||
94325604|NCT01120379|322973086|FG000|One Year Timepoint|Withdrawal by Subject|41|||
94325605|NCT01120379|322973086|FG000|One Year Timepoint|Lost to Follow-up|115|||
94325606|NCT01120379|322973086|FG000|One Year Timepoint|Death|108|||
94325607|NCT01120379|322973086|FG000|One Year Timepoint|Physician Decision|9|||
94325608|NCT01120379|322973086|FG000|One Year Timepoint|Any other reason for early termination|5|||
94325609|NCT01120379|322973086|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
94325610|NCT01120379|322973086|FG000|Two Year Timepoint|Lost to Follow-up|87|||
94325611|NCT01120379|322973086|FG000|Two Year Timepoint|Death|123|||
94325612|NCT01120379|322973086|FG000|Two Year Timepoint|Physician Decision|12|||
94325613|NCT01120379|322973086|FG000|Two Year Timepoint|Any other reason for early termination|4|||
94325614|NCT01120379|322973086|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
94325615|NCT01120379|322973086|FG000|Three Year Timepoint|Lost to Follow-up|43|||
94325616|NCT01120379|322973086|FG000|Three Year Timepoint|Death|120|||
94325617|NCT01120379|322973086|FG000|Three Year Timepoint|Physician Decision|9|||
94325618|NCT01120379|322973086|FG000|Three Year Timepoint|Any other reason for early termination|17|||
94325619|NCT01120379|322973086|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
94325620|NCT01120379|322973086|FG000|Four Year Timepoint|Lost to Follow-up|10|||
94325621|NCT01120379|322973086|FG000|Four Year Timepoint|Death|131|||
94325622|NCT01120379|322973086|FG000|Four Year Timepoint|Physician Decision|5|||
94325623|NCT01120379|322973086|FG000|Four Year Timepoint|Any other reason for early termination|217|||
94325624|NCT03162055|322973087|FG000|Overall Study|Adverse Event|6|||
94325625|NCT03162055|322973088|FG001|Overall Study|Adverse Event|5|||
94325626|NCT03162055|322973087|FG000|Overall Study|Death|3|||
94325627|NCT03162055|322973088|FG001|Overall Study|Death|3|||
94325628|NCT03162055|322973087|FG000|Overall Study|Lost to Follow-up|0|||
94325629|NCT03162055|322973088|FG001|Overall Study|Lost to Follow-up|1|||
94325630|NCT03162055|322973087|FG000|Overall Study|Study-specific withdrawal criteria|22|||
94325631|NCT03162055|322973088|FG001|Overall Study|Study-specific withdrawal criteria|14|||
94325632|NCT03162055|322973087|FG000|Overall Study|Withdrawal by Subject|17|||
94325633|NCT03162055|322973088|FG001|Overall Study|Withdrawal by Subject|2|||
94325634|NCT03162055|322973087|FG000|Overall Study|Did not receive treatment|2|||
94325635|NCT03162055|322973088|FG001|Overall Study|Did not receive treatment|0|||
94325636|NCT03162055|322973087|FG000|Overall Study|Incorrect randomization|4|||
94325637|NCT03162055|322973088|FG001|Overall Study|Incorrect randomization|3|||
94325638|NCT03162055|322973087|FG000|Overall Study|Other|8|||
94325639|NCT03162055|322973088|FG001|Overall Study|Other|15|||
94325640|NCT04656418|322973089|FG000|Overall Study|Withdrawal by Subject|1|||
94325641|NCT04656418|322973090|FG001|Overall Study|Withdrawal by Subject|3|||
94325642|NCT03287245|322973091|FG000|Overall Study|Study terminated by sponsor|3|||
94325643|NCT03287245|322973092|FG001|Overall Study|Study terminated by sponsor|0|||
94325644|NCT03287245|322973093|FG002|Overall Study|Study terminated by sponsor|3|||
94325645|NCT03287245|322973094|FG003|Overall Study|Study terminated by sponsor|1|||
94325646|NCT03287245|322973091|FG000|Overall Study|Adverse Event|1|||
94325647|NCT03287245|322973092|FG001|Overall Study|Adverse Event|0|||
94325648|NCT03287245|322973093|FG002|Overall Study|Adverse Event|0|||
94325649|NCT03287245|322973094|FG003|Overall Study|Adverse Event|0|||
94325650|NCT03287245|322973091|FG000|Overall Study|Withdrawal by Subject|8|||
94325651|NCT03287245|322973092|FG001|Overall Study|Withdrawal by Subject|3|||
94325652|NCT03287245|322973093|FG002|Overall Study|Withdrawal by Subject|3|||
94325653|NCT03287245|322973094|FG003|Overall Study|Withdrawal by Subject|0|||
94325654|NCT03287245|322973091|FG000|Overall Study|Physician Decision|3|||
94325655|NCT03287245|322973092|FG001|Overall Study|Physician Decision|2|||
94325656|NCT03287245|322973093|FG002|Overall Study|Physician Decision|0|||
94325657|NCT03287245|322973094|FG003|Overall Study|Physician Decision|0|||
94325658|NCT02586077|322973095|FG000|Overall Study|Withdrawal by Subject|1|||
94325659|NCT02586077|322973095|FG000|Overall Study|Physician Decision|4|||
94325660|NCT02586077|322973095|FG000|Overall Study|Lost to Follow-up|3|||
94325661|NCT00781963|322973098|FG000|Overall Study|Death|3|||
94325662|NCT00781963|322973099|FG001|Overall Study|Death|0|||
94325663|NCT00781963|322973098|FG000|Overall Study|Lost to Follow-up|2|||
94325664|NCT00781963|322973099|FG001|Overall Study|Lost to Follow-up|1|||
94325665|NCT00781963|322973098|FG000|Overall Study|Withdrawal by Subject|3|||
94325666|NCT00781963|322973099|FG001|Overall Study|Withdrawal by Subject|1|||
94325667|NCT00781963|322973098|FG000|Overall Study|Refused follow-up|9|||
94325668|NCT00781963|322973099|FG001|Overall Study|Refused follow-up|0|||
94325669|NCT02062463|322973100|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
94325670|NCT02062463|322973101|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
94325671|NCT02062463|322973102|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
94325672|NCT02062463|322973103|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
94325673|NCT02062463|322973100|FG000|Stage 2|Adverse Event|0|||
94325674|NCT02062463|322973101|FG001|Stage 2|Adverse Event|0|||
94325675|NCT02062463|322973102|FG002|Stage 2|Adverse Event|12|||
94325676|NCT02062463|322973103|FG003|Stage 2|Adverse Event|20|||
94325677|NCT02062463|322973100|FG000|Stage 2|Lack of Efficacy|0|||
94325678|NCT02062463|322973101|FG001|Stage 2|Lack of Efficacy|0|||
94325679|NCT02062463|322973102|FG002|Stage 2|Lack of Efficacy|3|||
94325680|NCT02062463|322973103|FG003|Stage 2|Lack of Efficacy|4|||
94325681|NCT02062463|322973100|FG000|Stage 2|Lost to Follow-up|0|||
94325682|NCT02062463|322973101|FG001|Stage 2|Lost to Follow-up|0|||
94325683|NCT02062463|322973102|FG002|Stage 2|Lost to Follow-up|20|||
94325684|NCT02062463|322973103|FG003|Stage 2|Lost to Follow-up|20|||
94325685|NCT02062463|322973100|FG000|Stage 2|Non-Compliance|0|||
94325686|NCT02062463|322973101|FG001|Stage 2|Non-Compliance|0|||
94325687|NCT02062463|322973102|FG002|Stage 2|Non-Compliance|0|||
94325688|NCT02062463|322973103|FG003|Stage 2|Non-Compliance|1|||
94325689|NCT02062463|322973100|FG000|Stage 2|Other than specified|0|||
94325690|NCT02062463|322973101|FG001|Stage 2|Other than specified|0|||
94325691|NCT02062463|322973102|FG002|Stage 2|Other than specified|3|||
94325692|NCT02062463|322973103|FG003|Stage 2|Other than specified|1|||
94325693|NCT02062463|322973100|FG000|Stage 2|Withdrawal by Subject|0|||
94325694|NCT02062463|322973101|FG001|Stage 2|Withdrawal by Subject|0|||
94325695|NCT02062463|322973102|FG002|Stage 2|Withdrawal by Subject|15|||
94325696|NCT02062463|322973103|FG003|Stage 2|Withdrawal by Subject|10|||
94325697|NCT01956240|322973110|FG000|Overall Study|Lost to Follow-up|6|||
94325698|NCT01956240|322973111|FG001|Overall Study|Lost to Follow-up|20|||
94325699|NCT01956240|322973110|FG000|Overall Study|Adverse Event|17|||
94325700|NCT01956240|322973111|FG001|Overall Study|Adverse Event|4|||
94325701|NCT00600028|322973114|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
94325702|NCT00600028|322973115|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
94325703|NCT00600028|322973114|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
94325704|NCT00600028|322973115|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
94325705|NCT00600028|322973114|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
94325706|NCT00600028|322973115|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
94325707|NCT04124692|322973116|FG000|Overall Study|Medical reason|0|||
94325708|NCT04124692|322973117|FG001|Overall Study|Medical reason|1|||
94325709|NCT04124692|322973116|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
94325710|NCT04124692|322973117|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
94325711|NCT04124692|322973116|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
94325712|NCT04124692|322973117|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
94325713|NCT04124692|322973116|FG000|Overall Study|Lost to Follow-up|2|||
94325714|NCT04124692|322973117|FG001|Overall Study|Lost to Follow-up|4|||
94325715|NCT04124692|322973116|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
94388463|NCT02458469|323210688|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
94388464|NCT02458469|323210683|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
94325716|NCT04124692|322973117|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
94325717|NCT02716194|322973118|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
94325718|NCT02716194|322973119|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
94325719|NCT02716194|322973120|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
94325720|NCT00971425|322973121|FG000|Overall Study|Adverse Event|1|||
94325721|NCT00971425|322973122|FG001|Overall Study|Adverse Event|1|||
94325722|NCT00971425|322973121|FG000|Overall Study|Withdrawal by Subject|0|||
94325723|NCT00971425|322973122|FG001|Overall Study|Withdrawal by Subject|1|||
94325724|NCT00363051|322973126|FG000|Overall Study|Adminstrative problems|1|||
94325725|NCT00363051|322973127|FG001|Overall Study|Adminstrative problems|1|||
94325726|NCT00363051|322973126|FG000|Overall Study|Adverse Event|21|||
94325727|NCT00363051|322973127|FG001|Overall Study|Adverse Event|12|||
94325728|NCT00363051|322973126|FG000|Overall Study|New Cancer Therapy|2|||
94325729|NCT00363051|322973127|FG001|Overall Study|New Cancer Therapy|1|||
94325730|NCT00363051|322973126|FG000|Overall Study|Withdrawal by Subject|11|||
94325731|NCT00363051|322973127|FG001|Overall Study|Withdrawal by Subject|3|||
94325732|NCT00363051|322973126|FG000|Overall Study|Lost to Follow-up|0|||
94325733|NCT00363051|322973127|FG001|Overall Study|Lost to Follow-up|1|||
94325734|NCT00363051|322973126|FG000|Overall Study|Protocol Violation|0|||
94325735|NCT00363051|322973127|FG001|Overall Study|Protocol Violation|2|||
94325736|NCT00363051|322973126|FG000|Overall Study|Death|3|||
94325737|NCT00363051|322973127|FG001|Overall Study|Death|2|||
94325738|NCT01957709|322973130|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
94325739|NCT03587584|322973131|FG000|Overall Study|SOC deviations|4|||
94325740|NCT03587584|322973132|FG001|Overall Study|SOC deviations|6|||
94325741|NCT03587584|322973131|FG000|Overall Study|Incomplete data|0|||
94325742|NCT03587584|322973132|FG001|Overall Study|Incomplete data|3|||
94325743|NCT00120289|322973133|FG000|Overall Study|Death|96|||
94325744|NCT00120289|322973134|FG001|Overall Study|Death|82|||
94325745|NCT00120289|322973133|FG000|Overall Study|Lost to Follow-up|11|||
94325746|NCT00120289|322973134|FG001|Overall Study|Lost to Follow-up|14|||
94325747|NCT00120289|322973133|FG000|Overall Study|Withdrawal by Subject|14|||
94325748|NCT00120289|322973134|FG001|Overall Study|Withdrawal by Subject|13|||
94325749|NCT00387348|322973135|FG000|Overall Study|Death|1|||
94325750|NCT00387348|322973136|FG001|Overall Study|Death|1|||
94325751|NCT00387348|322973137|FG002|Overall Study|Death|0|||
94325752|NCT00387348|322973135|FG000|Overall Study|Physician Decision|1|||
94325753|NCT00387348|322973136|FG001|Overall Study|Physician Decision|0|||
94325754|NCT00387348|322973137|FG002|Overall Study|Physician Decision|1|||
94325755|NCT00387348|322973135|FG000|Overall Study|Withdrawal by Subject|0|||
94325756|NCT00387348|322973136|FG001|Overall Study|Withdrawal by Subject|2|||
94325757|NCT00387348|322973137|FG002|Overall Study|Withdrawal by Subject|2|||
94325758|NCT00387348|322973135|FG000|Overall Study|Adverse Event|1|||
94325759|NCT00387348|322973136|FG001|Overall Study|Adverse Event|0|||
94325760|NCT00387348|322973137|FG002|Overall Study|Adverse Event|1|||
94325761|NCT00650091|322973154|FG000|Amended Study Design|Withdrawal by Subject|12|||
94325762|NCT00650091|322973155|FG001|Amended Study Design|Withdrawal by Subject|11|||
94325763|NCT00650091|322973156|FG002|Amended Study Design|Withdrawal by Subject|0|||
94325764|NCT00650091|322973154|FG000|Amended Study Design|Physician Decision|5|||
94325765|NCT00650091|322973155|FG001|Amended Study Design|Physician Decision|0|||
94325766|NCT00650091|322973156|FG002|Amended Study Design|Physician Decision|0|||
94325767|NCT00650091|322973154|FG000|Amended Study Design|Adverse Event|1|||
94325768|NCT00650091|322973155|FG001|Amended Study Design|Adverse Event|4|||
94325769|NCT00650091|322973156|FG002|Amended Study Design|Adverse Event|0|||
94325770|NCT00650091|322973154|FG000|Amended Study Design|Lung transplantation|4|||
94325771|NCT00650091|322973155|FG001|Amended Study Design|Lung transplantation|2|||
94325772|NCT00650091|322973156|FG002|Amended Study Design|Lung transplantation|0|||
94325773|NCT00650091|322973154|FG000|Amended Study Design|Other|1|||
94325774|NCT00650091|322973155|FG001|Amended Study Design|Other|3|||
94325775|NCT00650091|322973156|FG002|Amended Study Design|Other|0|||
94325776|NCT01677507|322973158|FG000|Initial Assignment|Adverse Event|0|||
94325777|NCT01677507|322973159|FG001|Initial Assignment|Adverse Event|1|||
94325778|NCT01677507|322973158|FG000|Initial Assignment|Protocol Violation|0|||
94325779|NCT01677507|322973159|FG001|Initial Assignment|Protocol Violation|1|||
94325780|NCT01677507|322973158|FG000|Second Assigment|Withdrawal by Subject|2|||
94325781|NCT01677507|322973159|FG001|Second Assigment|Withdrawal by Subject|2|||
94325782|NCT01677507|322973158|FG000|Second Assigment|Adverse Event|1|||
94388465|NCT02458469|323210684|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
94325783|NCT01677507|322973159|FG001|Second Assigment|Adverse Event|3|||
94325784|NCT01194869|322973160|FG000|Overall Study|Disease Progression|2|||
94325785|NCT01194869|322973160|FG000|Overall Study|Toxicity|2|||
94325786|NCT01954251|322973161|FG000|Overall Study|Adverse Event|5|||
94325787|NCT01954251|322973162|FG001|Overall Study|Adverse Event|7|||
94325788|NCT01954251|322973161|FG000|Overall Study|Lost to Follow-up|6|||
94325789|NCT01954251|322973162|FG001|Overall Study|Lost to Follow-up|6|||
94325790|NCT01954251|322973161|FG000|Overall Study|Withdrawal by Subject|2|||
94325791|NCT01954251|322973162|FG001|Overall Study|Withdrawal by Subject|6|||
94325792|NCT00190983|322973165|FG000|Overall Study|Inevaluable (never treated)|2|||
94325793|NCT01844830|322973166|FG000|Overall Study|Withdrawal by Subject|1|||
94325794|NCT01844830|322973167|FG001|Overall Study|Withdrawal by Subject|0|||
94325795|NCT00502320|322973168|FG000|Overall Study|Lost to Follow-up|1|||
94325796|NCT00502320|322973169|FG001|Overall Study|Lost to Follow-up|1|||
94325797|NCT00502320|322973168|FG000|Overall Study|Withdrew Consent|1|||
94325798|NCT00502320|322973169|FG001|Overall Study|Withdrew Consent|0|||
94325799|NCT00502320|322973168|FG000|Overall Study|No longer met criteria|1|||
94325800|NCT00502320|322973169|FG001|Overall Study|No longer met criteria|0|||
94325801|NCT00502320|322973168|FG000|Overall Study|Screen Failure|0|||
94325802|NCT00502320|322973169|FG001|Overall Study|Screen Failure|1|||
94325803|NCT00502320|322973168|FG000|Overall Study|Adverse Event|3|||
94325804|NCT00502320|322973169|FG001|Overall Study|Adverse Event|5|||
94325805|NCT00098020|322973170|FG000|Overall Study|Adverse Event|2|||
94325806|NCT00098020|322973170|FG000|Overall Study|Lost to Follow-up|1|||
94325807|NCT00098020|322973170|FG000|Overall Study|elevated liver enzymes|1|||
94325808|NCT00098020|322973170|FG000|Overall Study|Low urine PCR|1|||
94325809|NCT00098020|322973170|FG000|Overall Study|Low epidermal growth factor receptor|1|||
94325810|NCT01453998|322973171|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
94325811|NCT01453998|322973172|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
94325812|NCT01453998|322973173|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
94325813|NCT02394808|322973176|FG000|Period 1|Unsatisfactory lens fitting|0|||
94325814|NCT02394808|322973177|FG001|Period 1|Unsatisfactory lens fitting|1|||
94325815|NCT02394808|322973176|FG000|Period 2|Lost to Follow-up|1|||
94325816|NCT02394808|322973177|FG001|Period 2|Lost to Follow-up|0|||
94325817|NCT00209170|322973179|FG000|Overall Study|Adverse Event|0|||
94325818|NCT00209170|322973180|FG001|Overall Study|Adverse Event|1|||
94325819|NCT00209170|322973179|FG000|Overall Study|Withdrawal by Subject|2|||
94325820|NCT00209170|322973180|FG001|Overall Study|Withdrawal by Subject|1|||
94325821|NCT00209170|322973179|FG000|Overall Study|Lack of Efficacy|0|||
94325822|NCT00209170|322973180|FG001|Overall Study|Lack of Efficacy|1|||
94325823|NCT00089479|322973181|FG000|Overall Study|Death|108|||
94325824|NCT00089479|322973182|FG001|Overall Study|Death|75|||
94325825|NCT00089479|322973181|FG000|Overall Study|Withdrawal by Subject|86|||
94325826|NCT00089479|322973182|FG001|Overall Study|Withdrawal by Subject|107|||
94325827|NCT00089479|322973181|FG000|Overall Study|Lost to Follow-up|137|||
94325828|NCT00089479|322973182|FG001|Overall Study|Lost to Follow-up|107|||
94325829|NCT01199055|322973185|FG000|Overall Study|Death|0|||
94325830|NCT01199055|322973186|FG001|Overall Study|Death|1|||
94325831|NCT01199055|322973187|FG002|Overall Study|Death|0|||
94325832|NCT01199055|322973185|FG000|Overall Study|Physician Decision|0|||
94325833|NCT01199055|322973186|FG001|Overall Study|Physician Decision|1|||
94325834|NCT01199055|322973187|FG002|Overall Study|Physician Decision|1|||
94325835|NCT01199055|322973185|FG000|Overall Study|Progressive disease|2|||
94325836|NCT01199055|322973186|FG001|Overall Study|Progressive disease|1|||
94325837|NCT01199055|322973187|FG002|Overall Study|Progressive disease|2|||
94325838|NCT01199055|322973185|FG000|Overall Study|Withdrawal by Subject|0|||
94325839|NCT01199055|322973186|FG001|Overall Study|Withdrawal by Subject|0|||
94325840|NCT01199055|322973187|FG002|Overall Study|Withdrawal by Subject|1|||
94325841|NCT01797965|322973188|FG000|Overall Study|Adverse Event|104|||
94325842|NCT01797965|322973189|FG001|Overall Study|Adverse Event|129|||
94325843|NCT01797965|322973190|FG002|Overall Study|Adverse Event|4|||
94325844|NCT01797965|322973191|FG003|Overall Study|Adverse Event|21|||
94325845|NCT01797965|322973188|FG000|Overall Study|Lost to Follow-up|9|||
94325846|NCT01797965|322973189|FG001|Overall Study|Lost to Follow-up|8|||
94325847|NCT01797965|322973190|FG002|Overall Study|Lost to Follow-up|1|||
94325848|NCT01797965|322973191|FG003|Overall Study|Lost to Follow-up|2|||
94325849|NCT01797965|322973188|FG000|Overall Study|Consent withdrawn|130|||
94325850|NCT01797965|322973189|FG001|Overall Study|Consent withdrawn|117|||
94325851|NCT01797965|322973190|FG002|Overall Study|Consent withdrawn|3|||
94325852|NCT01797965|322973191|FG003|Overall Study|Consent withdrawn|35|||
94325853|NCT01797965|322973188|FG000|Overall Study|Investigator decision|21|||
94325854|NCT01797965|322973189|FG001|Overall Study|Investigator decision|15|||
94325855|NCT01797965|322973190|FG002|Overall Study|Investigator decision|0|||
94325856|NCT01797965|322973191|FG003|Overall Study|Investigator decision|0|||
94325857|NCT01797965|322973188|FG000|Overall Study|Death|2|||
94325858|NCT01797965|322973189|FG001|Overall Study|Death|4|||
94325859|NCT01797965|322973190|FG002|Overall Study|Death|0|||
94325860|NCT01797965|322973191|FG003|Overall Study|Death|0|||
94325861|NCT01797965|322973188|FG000|Overall Study|Disease progression, defined by protocol|3|||
94325862|NCT01797965|322973189|FG001|Overall Study|Disease progression, defined by protocol|1|||
94325863|NCT01797965|322973190|FG002|Overall Study|Disease progression, defined by protocol|0|||
94325864|NCT01797965|322973191|FG003|Overall Study|Disease progression, defined by protocol|0|||
94325865|NCT01797965|322973188|FG000|Overall Study|Reason Not Specified|280|||
94325866|NCT01797965|322973189|FG001|Overall Study|Reason Not Specified|295|||
94325867|NCT01797965|322973190|FG002|Overall Study|Reason Not Specified|0|||
94325868|NCT01797965|322973191|FG003|Overall Study|Reason Not Specified|15|||
94325869|NCT02662985|322973192|FG000|Treatment Period 1|Adverse Event|0|||
94325870|NCT02662985|322973193|FG001|Treatment Period 1|Adverse Event|2|||
94325871|NCT02662985|322973192|FG000|Treatment Period 1|Protocol Violation|0|||
94325872|NCT02662985|322973193|FG001|Treatment Period 1|Protocol Violation|1|||
94325873|NCT02662985|322973192|FG000|Treatment Period 1|Physician Decision|1|||
94325874|NCT02662985|322973193|FG001|Treatment Period 1|Physician Decision|0|||
94325875|NCT02662985|322973192|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94325876|NCT02662985|322973193|FG001|Treatment Period 1|Withdrawal by Subject|1|||
94325877|NCT02662985|322973192|FG000|Treatment Period 2|Lack of Efficacy|0|||
94325878|NCT02662985|322973193|FG001|Treatment Period 2|Lack of Efficacy|1|||
94325879|NCT02662985|322973192|FG000|Treatment Period 2|Lost to Follow-up|1|||
94325880|NCT02662985|322973193|FG001|Treatment Period 2|Lost to Follow-up|0|||
94325881|NCT02662985|322973192|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
94325882|NCT02662985|322973193|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
94325883|NCT02662985|322973192|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
94325884|NCT02662985|322973193|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
94325885|NCT02662985|322973192|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
94325886|NCT02662985|322973193|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
94325887|NCT02662985|322973192|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
94325888|NCT02662985|322973193|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
94325889|NCT02662985|322973192|FG000|Treatment Period 3 (Extension Period)|Death|0|||
94325890|NCT02662985|322973193|FG001|Treatment Period 3 (Extension Period)|Death|1|||
94325891|NCT01736254|322973194|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
94325892|NCT01736254|322973194|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
94325893|NCT03491553|322973195|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
94325894|NCT03491553|322973196|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
94325895|NCT03491553|322973197|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
94325896|NCT03491553|322973198|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
94325897|NCT03491553|322973199|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
94325898|NCT03491553|322973200|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
94325899|NCT03491553|322973195|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
94325900|NCT03491553|322973196|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
94325901|NCT03491553|322973197|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
94325902|NCT03491553|322973198|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
94325903|NCT03491553|322973199|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
94325904|NCT03491553|322973200|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
94325905|NCT01397448|322973204|FG000|Overall Study|Adverse Event|4|||
94325906|NCT01397448|322973205|FG001|Overall Study|Adverse Event|4|||
94325907|NCT01397448|322973206|FG002|Overall Study|Adverse Event|6|||
94325908|NCT01397448|322973204|FG000|Overall Study|Withdrawal by Subject|4|||
94325909|NCT01397448|322973205|FG001|Overall Study|Withdrawal by Subject|4|||
94325910|NCT01397448|322973206|FG002|Overall Study|Withdrawal by Subject|3|||
94325911|NCT01397448|322973204|FG000|Overall Study|Lack of Efficacy|2|||
94325912|NCT01397448|322973205|FG001|Overall Study|Lack of Efficacy|0|||
94325913|NCT01397448|322973206|FG002|Overall Study|Lack of Efficacy|5|||
94325914|NCT01397448|322973204|FG000|Overall Study|Other|8|||
94325915|NCT01397448|322973205|FG001|Overall Study|Other|7|||
94325916|NCT01397448|322973206|FG002|Overall Study|Other|4|||
94325917|NCT01996904|322973211|FG000|Overall Study|Lost to Follow-up|38|||
94325918|NCT01996904|322973212|FG001|Overall Study|Lost to Follow-up|27|||
94325919|NCT00916370|322973213|FG000|Overall Study|Death|3|||
94325920|NCT00916370|322973214|FG001|Overall Study|Death|1|||
94325921|NCT00916370|322973213|FG000|Overall Study|Withdrawal by Subject|2|||
94325922|NCT00916370|322973214|FG001|Overall Study|Withdrawal by Subject|0|||
94325923|NCT00916370|322973213|FG000|Overall Study|Physician Decision|0|||
94325924|NCT00916370|322973214|FG001|Overall Study|Physician Decision|1|||
94325925|NCT00585923|322973216|FG000|Overall Study|Physician decided not to continue|31|||
94325926|NCT00585923|322973217|FG001|Overall Study|Physician decided not to continue|33|||
94325927|NCT01669811|322973218|FG000|Overall Study|Investigator decision|0|||
94325928|NCT01669811|322973219|FG001|Overall Study|Investigator decision|1|||
94325929|NCT01669811|322973218|FG000|Overall Study|Withdrawal by Subject|1|||
94325930|NCT01669811|322973219|FG001|Overall Study|Withdrawal by Subject|2|||
94325931|NCT01669811|322973218|FG000|Overall Study|Adverse Event|2|||
94325932|NCT01669811|322973219|FG001|Overall Study|Adverse Event|6|||
94325933|NCT01669811|322973218|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
94325934|NCT01669811|322973219|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
94325935|NCT01146951|322974602|FG000|Overall Study|Adverse Event|4|||
94325936|NCT01146951|322974603|FG001|Overall Study|Adverse Event|1|||
94325937|NCT00453180|322974604|FG000|Overall Study|Lost to Follow-up|2|||
94325938|NCT00453180|322974605|FG001|Overall Study|Lost to Follow-up|1|||
94325939|NCT00453180|322974604|FG000|Overall Study|Adverse Event|1|||
94325940|NCT00453180|322974605|FG001|Overall Study|Adverse Event|2|||
94325941|NCT00804843|322974606|FG000|Overall Study|Protocol Violation|1|||
94325942|NCT00804843|322974607|FG001|Overall Study|Protocol Violation|0|||
94325943|NCT00804843|322974606|FG000|Overall Study|Adverse Event|8|||
94325944|NCT00804843|322974607|FG001|Overall Study|Adverse Event|5|||
94325945|NCT00804843|322974606|FG000|Overall Study|Withdrawal by Subject|1|||
94325946|NCT00804843|322974607|FG001|Overall Study|Withdrawal by Subject|2|||
94325947|NCT00571688|322974614|FG000|Overall Study|Lost to Follow-up|3|||
94325948|NCT00571688|322974615|FG001|Overall Study|Lost to Follow-up|6|||
94325949|NCT00571688|322974614|FG000|Overall Study|subject did not tolerate Consta|1|||
94325950|NCT00571688|322974615|FG001|Overall Study|subject did not tolerate Consta|0|||
94325951|NCT00571688|322974614|FG000|Overall Study|subject moved out of the area|1|||
94325952|NCT00571688|322974615|FG001|Overall Study|subject moved out of the area|0|||
94325953|NCT00085917|322974622|FG000|Overall Study|Adverse Event|4|||
94325954|NCT00085917|322974623|FG001|Overall Study|Adverse Event|3|||
94325955|NCT02505542|322974629|FG000|Part A: Open-Label Period|Adverse Event|31|||
94325956|NCT02505542|322974630|FG001|Part A: Open-Label Period|Adverse Event|0|||
94325957|NCT02505542|322974631|FG002|Part A: Open-Label Period|Adverse Event|0|||
94325958|NCT02505542|322974632|FG003|Part A: Open-Label Period|Adverse Event|0|||
94325959|NCT02505542|322974629|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
94325960|NCT02505542|322974630|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
94325961|NCT02505542|322974631|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
94325962|NCT02505542|322974632|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
94325963|NCT02505542|322974629|FG000|Part A: Open-Label Period|Protocol Violation|1|||
94325964|NCT02505542|322974630|FG001|Part A: Open-Label Period|Protocol Violation|0|||
94325965|NCT02505542|322974631|FG002|Part A: Open-Label Period|Protocol Violation|0|||
94325966|NCT02505542|322974632|FG003|Part A: Open-Label Period|Protocol Violation|0|||
94325967|NCT02505542|322974629|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
94325968|NCT02505542|322974630|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
94325969|NCT02505542|322974631|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
94325970|NCT02505542|322974632|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
94325971|NCT02505542|322974629|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
94325972|NCT02505542|322974630|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
94325973|NCT02505542|322974631|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
94325974|NCT02505542|322974632|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
94325975|NCT02505542|322974629|FG000|Part A: Open-Label Period|New medical history available|1|||
94325976|NCT02505542|322974630|FG001|Part A: Open-Label Period|New medical history available|0|||
94325977|NCT02505542|322974631|FG002|Part A: Open-Label Period|New medical history available|0|||
94325978|NCT02505542|322974632|FG003|Part A: Open-Label Period|New medical history available|0|||
94325979|NCT02505542|322974629|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
94325980|NCT02505542|322974630|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
94325981|NCT02505542|322974631|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
94325982|NCT02505542|322974632|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
94325983|NCT02505542|322974629|FG000|Part A: Open-Label Period|Pregnancy|2|||
94325984|NCT02505542|322974630|FG001|Part A: Open-Label Period|Pregnancy|0|||
94325985|NCT02505542|322974631|FG002|Part A: Open-Label Period|Pregnancy|0|||
94325986|NCT02505542|322974632|FG003|Part A: Open-Label Period|Pregnancy|0|||
94325987|NCT02505542|322974629|FG000|Part A: Open-Label Period|Sponsor directive|1|||
94325988|NCT02505542|322974630|FG001|Part A: Open-Label Period|Sponsor directive|0|||
94325989|NCT02505542|322974631|FG002|Part A: Open-Label Period|Sponsor directive|0|||
94325990|NCT02505542|322974632|FG003|Part A: Open-Label Period|Sponsor directive|0|||
94325991|NCT02505542|322974629|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
94325992|NCT02505542|322974630|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
94325993|NCT02505542|322974631|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
94325994|NCT02505542|322974632|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
94325995|NCT02505542|322974629|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
94325996|NCT02505542|322974630|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
94325997|NCT02505542|322974631|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
94325998|NCT02505542|322974632|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
94325999|NCT02505542|322974629|FG000|Part A: Open-Label Period|Non-compliance|1|||
94326000|NCT02505542|322974630|FG001|Part A: Open-Label Period|Non-compliance|0|||
94326001|NCT02505542|322974631|FG002|Part A: Open-Label Period|Non-compliance|0|||
94326002|NCT02505542|322974632|FG003|Part A: Open-Label Period|Non-compliance|0|||
94326003|NCT02505542|322974629|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
94326004|NCT02505542|322974630|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
94326005|NCT02505542|322974631|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
94326006|NCT02505542|322974632|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
94326007|NCT02505542|322974629|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
94326008|NCT02505542|322974630|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
94326009|NCT02505542|322974631|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
94326010|NCT02505542|322974632|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
94326011|NCT02505542|322974629|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
94326012|NCT02505542|322974630|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
94326013|NCT02505542|322974631|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
94326014|NCT02505542|322974632|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
94326015|NCT02505542|322974629|FG000|Part B: Double-Blind Period|Adverse Event|0|||
94326016|NCT02505542|322974630|FG001|Part B: Double-Blind Period|Adverse Event|0|||
94326017|NCT02505542|322974631|FG002|Part B: Double-Blind Period|Adverse Event|1|||
94326018|NCT02505542|322974632|FG003|Part B: Double-Blind Period|Adverse Event|3|||
94326019|NCT02505542|322974629|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
94326020|NCT02505542|322974630|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
94326021|NCT02505542|322974631|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
94326022|NCT02505542|322974632|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
94326023|NCT02505542|322974629|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
94326024|NCT02505542|322974630|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
94326025|NCT02505542|322974631|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
94326026|NCT02505542|322974632|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
94326027|NCT02505542|322974629|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
94326028|NCT02505542|322974630|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
94326029|NCT02505542|322974631|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
94326030|NCT02505542|322974632|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
94326031|NCT02505542|322974629|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
94326032|NCT02505542|322974630|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
94326033|NCT02505542|322974631|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
94326034|NCT02505542|322974632|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
94326035|NCT02505542|322974629|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
94326036|NCT02505542|322974630|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
94326037|NCT02505542|322974631|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
94326038|NCT02505542|322974632|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
94326039|NCT02505542|322974629|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
94326040|NCT02505542|322974630|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
94326041|NCT02505542|322974631|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
94326042|NCT02505542|322974632|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
94326043|NCT02505542|322974629|FG000|Part B: Double-Blind Period|Miscalculation|0|||
94326044|NCT02505542|322974630|FG001|Part B: Double-Blind Period|Miscalculation|1|||
94326045|NCT02505542|322974631|FG002|Part B: Double-Blind Period|Miscalculation|0|||
94326046|NCT02505542|322974632|FG003|Part B: Double-Blind Period|Miscalculation|0|||
94326047|NCT02505542|322974629|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
94326048|NCT02505542|322974630|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
94326049|NCT02505542|322974631|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
94326050|NCT02505542|322974632|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
94326051|NCT01360762|322974633|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
94326052|NCT01360762|322974633|FG000|Main Study Period (12-month Treatment)|Death|5|||
94326053|NCT01360762|322974633|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
94326054|NCT01360762|322974633|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
94326055|NCT01360762|322974633|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
94326056|NCT01360762|322974633|FG000|Whole Study Period|Lost to Follow-up|10|||
94326057|NCT01360762|322974633|FG000|Whole Study Period|Death|7|||
94326058|NCT01360762|322974633|FG000|Whole Study Period|Patient relapsed|18|||
94326059|NCT01360762|322974633|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
94326060|NCT02806947|322974634|FG000|Overall Study|Withdrawal by Subject|5|||
94326061|NCT02806947|322974635|FG001|Overall Study|Withdrawal by Subject|1|||
94326062|NCT04511819|322974636|FG000|Overall Study|Non-compliance with study drug|5|||
94326063|NCT04511819|322974637|FG001|Overall Study|Non-compliance with study drug|1|||
94326064|NCT04511819|322974636|FG000|Overall Study|Withdrawal by Subject|0|||
94326065|NCT04511819|322974637|FG001|Overall Study|Withdrawal by Subject|3|||
94326066|NCT04511819|322974636|FG000|Overall Study|Adverse Event|0|||
94326067|NCT04511819|322974637|FG001|Overall Study|Adverse Event|1|||
94326068|NCT04511819|322974636|FG000|Overall Study|Protocol deviation|1|||
94326069|NCT04511819|322974637|FG001|Overall Study|Protocol deviation|0|||
94326070|NCT00664209|322974641|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
94326071|NCT00664209|322974641|FG000|Study Treatment Period|Physician Decision|4|||
94326072|NCT00664209|322974641|FG000|Study Treatment Period|Withdrawal by Subject|2|||
94326073|NCT02767856|322974645|FG000|Overall Study|Lost to Follow-up|9|||
94326074|NCT02767856|322974646|FG001|Overall Study|Lost to Follow-up|1|||
94326075|NCT02767856|322974645|FG000|Overall Study|Withdrawal by Subject|2|||
94326076|NCT02767856|322974646|FG001|Overall Study|Withdrawal by Subject|1|||
94326077|NCT01464788|322974649|FG000|Overall Study|Lost to Follow-up|0|||
94326078|NCT01464788|322974650|FG001|Overall Study|Lost to Follow-up|1|||
94326079|NCT01464788|322974651|FG002|Overall Study|Lost to Follow-up|0|||
94326080|NCT01464788|322974649|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
94326081|NCT01464788|322974650|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
94388466|NCT02458469|323210685|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
94388467|NCT02458469|323210686|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
94388468|NCT02458469|323210687|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
94388469|NCT02458469|323210688|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
94388470|NCT02458469|323210683|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
94388471|NCT02458469|323210684|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
94388472|NCT02458469|323210685|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
94388473|NCT02458469|323210686|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
94388474|NCT02458469|323210687|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
94388475|NCT02458469|323210688|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
94388476|NCT03522675|323210689|FG000|Overall Study|Screen fail|1|||
94388477|NCT03522675|323210689|FG000|Overall Study|Non-reactive to histamine|1|||
94388478|NCT02076022|323210690|FG000|Overall Study|Withdrawal by Subject|2|||
94388479|NCT02076022|323210691|FG001|Overall Study|Withdrawal by Subject|0|||
94388480|NCT01536405|323210692|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
94388481|NCT01536405|323210693|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
94388482|NCT01536405|323210692|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
94388483|NCT01536405|323210693|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
94388484|NCT01536405|323210692|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
94388485|NCT01536405|323210693|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
94388486|NCT01536405|323210692|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
94388487|NCT01536405|323210693|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
94388488|NCT01536405|323210692|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
94388489|NCT01536405|323210693|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
94388490|NCT01536405|323210692|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
94388491|NCT01536405|323210693|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
94388492|NCT01536405|323210692|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
94388493|NCT01536405|323210693|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
94388494|NCT01536405|323210692|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
94388495|NCT01536405|323210693|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
94388496|NCT01536405|323210692|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
94388497|NCT01536405|323210693|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
94388498|NCT01536405|323210692|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
94388499|NCT01536405|323210693|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
94388500|NCT01536405|323210692|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
94388501|NCT01536405|323210693|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
94388502|NCT01536405|323210692|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
94388503|NCT01536405|323210693|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
94388504|NCT01536405|323210692|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
94388505|NCT01536405|323210693|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
94388506|NCT01376167|323210694|FG000|Overall Study|Lost to Follow-up|2|||
94388507|NCT01376167|323210695|FG001|Overall Study|Lost to Follow-up|4|||
94388508|NCT01376167|323210696|FG002|Overall Study|Lost to Follow-up|2|||
94388509|NCT01376167|323210694|FG000|Overall Study|Physician Decision|1|||
94388510|NCT01376167|323210695|FG001|Overall Study|Physician Decision|1|||
94388511|NCT01376167|323210696|FG002|Overall Study|Physician Decision|0|||
94388512|NCT01376167|323210694|FG000|Overall Study|Withdrawal by Subject|1|||
94388513|NCT01376167|323210695|FG001|Overall Study|Withdrawal by Subject|5|||
94388514|NCT01376167|323210696|FG002|Overall Study|Withdrawal by Subject|4|||
94388515|NCT04786184|323210697|FG000|Overall Study|Adverse Event|4|||
94388516|NCT04786184|323210698|FG001|Overall Study|Adverse Event|0|||
94388517|NCT04786184|323210697|FG000|Overall Study|Withdrawal by Subject|3|||
94388518|NCT04786184|323210698|FG001|Overall Study|Withdrawal by Subject|1|||
94388519|NCT04786184|323210697|FG000|Overall Study|Lost to Follow-up|4|||
94388520|NCT04786184|323210698|FG001|Overall Study|Lost to Follow-up|2|||
94388521|NCT01173692|323210702|FG000|Overall Study|Adverse Event|1|||
94388522|NCT01173692|323210703|FG001|Overall Study|Adverse Event|2|||
94388523|NCT01173692|323210702|FG000|Overall Study|Withdrawal by Subject|1|||
94388524|NCT01173692|323210703|FG001|Overall Study|Withdrawal by Subject|3|||
94388525|NCT04625114|323210706|FG000|Overall Study|Adverse Event|3|||
94388526|NCT04625114|323210707|FG001|Overall Study|Adverse Event|1|||
94388527|NCT04625114|323210706|FG000|Overall Study|Withdrawal by Subject|2|||
94388528|NCT04625114|323210707|FG001|Overall Study|Withdrawal by Subject|0|||
94388529|NCT00193609|323210708|FG000|Overall Study|Lack of Efficacy|2|||
94388530|NCT00193609|323210708|FG000|Overall Study|Adverse Event|2|||
94388531|NCT01390844|323210710|FG000|Treatment Phase|Adverse Event|12|||
94388532|NCT01390844|323210711|FG001|Treatment Phase|Adverse Event|2|||
94388533|NCT01390844|323210712|FG002|Treatment Phase|Adverse Event|3|||
94388534|NCT01390844|323210713|FG003|Treatment Phase|Adverse Event|2|||
94388535|NCT01390844|323210710|FG000|Treatment Phase|Treatment Failure|23|||
94388536|NCT01390844|323210711|FG001|Treatment Phase|Treatment Failure|25|||
94388537|NCT01390844|323210712|FG002|Treatment Phase|Treatment Failure|10|||
94388538|NCT01390844|323210713|FG003|Treatment Phase|Treatment Failure|13|||
94388539|NCT01390844|323210710|FG000|Treatment Phase|Non-Medical Reasons|5|||
94388540|NCT01390844|323210711|FG001|Treatment Phase|Non-Medical Reasons|1|||
94388541|NCT01390844|323210712|FG002|Treatment Phase|Non-Medical Reasons|8|||
94388542|NCT01390844|323210713|FG003|Treatment Phase|Non-Medical Reasons|1|||
94388543|NCT01390844|323210710|FG000|Treatment Phase|Non-GCP Compliant|0|||
94388544|NCT01390844|323210711|FG001|Treatment Phase|Non-GCP Compliant|0|||
94388545|NCT01390844|323210712|FG002|Treatment Phase|Non-GCP Compliant|10|||
94388546|NCT01390844|323210713|FG003|Treatment Phase|Non-GCP Compliant|3|||
94388547|NCT01390844|323210710|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
94388548|NCT01390844|323210711|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
94388549|NCT01390844|323210712|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
94388550|NCT01390844|323210713|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
94388551|NCT03048500|323210716|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
94388552|NCT03048500|323210716|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
94388553|NCT03048500|323210716|FG000|Reached 1st Response/Continued Treatment|Death|1|||
94388554|NCT03048500|323210716|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
94388555|NCT03048500|323210716|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
94388556|NCT03048500|323210716|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
94388557|NCT03048500|323210716|FG000|Follow up for 3 Years|Death|12|||
94388558|NCT00302952|323210720|FG000|Overall Study|Physician Decision|1|||
94388559|NCT00302952|323210721|FG001|Overall Study|Physician Decision|1|||
94388560|NCT00302952|323210720|FG000|Overall Study|Withdrawal by Subject|2|||
94388561|NCT00302952|323210721|FG001|Overall Study|Withdrawal by Subject|3|||
94388562|NCT00302952|323210720|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
94388563|NCT00302952|323210721|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
94388564|NCT02979353|323210725|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
94388565|NCT02979353|323210726|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
94388566|NCT02979353|323210725|FG000|Overall Study|Withdrawal by Subject|16|||
94388567|NCT02979353|323210726|FG001|Overall Study|Withdrawal by Subject|12|||
94388568|NCT02979353|323210725|FG000|Overall Study|Death|10|||
94388569|NCT02979353|323210726|FG001|Overall Study|Death|11|||
94388570|NCT02979353|323210725|FG000|Overall Study|Transfer to Hospice Care|19|||
94388571|NCT02979353|323210726|FG001|Overall Study|Transfer to Hospice Care|14|||
94388572|NCT02979353|323210725|FG000|Overall Study|Lost to Follow-up|1|||
94388573|NCT02979353|323210726|FG001|Overall Study|Lost to Follow-up|5|||
94388574|NCT01318499|323210727|FG000|Overall Study|Adverse Event|16|||
94388575|NCT01318499|323210728|FG001|Overall Study|Adverse Event|11|||
94388576|NCT01318499|323210729|FG002|Overall Study|Adverse Event|6|||
94388577|NCT01318499|323210727|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
94388578|NCT01318499|323210728|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
94388579|NCT01318499|323210729|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
94388580|NCT01318499|323210727|FG000|Overall Study|Noncompliance|2|||
94388581|NCT01318499|323210728|FG001|Overall Study|Noncompliance|3|||
94388582|NCT01318499|323210729|FG002|Overall Study|Noncompliance|0|||
94388583|NCT01318499|323210727|FG000|Overall Study|Treatment Failure|19|||
94388584|NCT01318499|323210728|FG001|Overall Study|Treatment Failure|19|||
94388585|NCT01318499|323210729|FG002|Overall Study|Treatment Failure|101|||
94388586|NCT01318499|323210727|FG000|Overall Study|Protocol Violation|2|||
94388587|NCT01318499|323210728|FG001|Overall Study|Protocol Violation|4|||
94388588|NCT01318499|323210729|FG002|Overall Study|Protocol Violation|2|||
94388589|NCT01318499|323210727|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
94388590|NCT01318499|323210728|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
94388591|NCT01318499|323210729|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
94388592|NCT01318499|323210727|FG000|Overall Study|Other|7|||
94388593|NCT01318499|323210728|FG001|Overall Study|Other|10|||
94388594|NCT01318499|323210729|FG002|Overall Study|Other|22|||
94388595|NCT03693430|323210732|FG000|Overall Study|Lost to Follow-up|3|||
94388596|NCT03693430|323210733|FG001|Overall Study|Lost to Follow-up|14|||
94388597|NCT03693430|323210732|FG000|Overall Study|Death|1|||
94388598|NCT03693430|323210733|FG001|Overall Study|Death|0|||
94388599|NCT03693430|323210732|FG000|Overall Study|Withdrawal by Subject|0|||
94388600|NCT03693430|323210733|FG001|Overall Study|Withdrawal by Subject|4|||
94388601|NCT01059903|323210738|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
94388602|NCT01059903|323210739|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
94388603|NCT03639311|323210740|FG000|Maintenance Phase|Lost to Follow-up|1|||
94388604|NCT03639311|323210741|FG001|Maintenance Phase|Lost to Follow-up|0|||
94388605|NCT03639311|323210742|FG002|Maintenance Phase|Lost to Follow-up|0|||
94388606|NCT03639311|323210740|FG000|Maintenance Phase|Adverse Event|1|||
94388607|NCT03639311|323210741|FG001|Maintenance Phase|Adverse Event|0|||
94388608|NCT03639311|323210742|FG002|Maintenance Phase|Adverse Event|0|||
94388609|NCT03639311|323210740|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
94388610|NCT03639311|323210741|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
94388611|NCT03639311|323210742|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
94388612|NCT03639311|323210740|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
94388613|NCT03639311|323210741|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
94388614|NCT03639311|323210742|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
94388615|NCT03639311|323210740|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
94388616|NCT03639311|323210741|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
94388617|NCT03639311|323210742|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
94388618|NCT03639311|323210740|FG000|Maintenance Phase|Lack of Efficacy|1|||
94388619|NCT03639311|323210741|FG001|Maintenance Phase|Lack of Efficacy|0|||
94388620|NCT03639311|323210742|FG002|Maintenance Phase|Lack of Efficacy|0|||
94388621|NCT00855738|323210743|FG000|Overall Study|Lost to Follow-up|2|||
94388622|NCT00855738|323210743|FG000|Overall Study|Adverse Event|1|||
94388623|NCT00855738|323210743|FG000|Overall Study|Subject Defaulted|1|||
94388624|NCT00855738|323210743|FG000|Overall Study|Death|1|||
94388625|NCT00304083|323210747|FG000|Overall Study|Withdrawal by Subject|4|||
94388626|NCT00304083|323210748|FG001|Overall Study|Withdrawal by Subject|2|||
94388627|NCT00304083|323210747|FG000|Overall Study|Physician Decision|8|||
94388628|NCT00304083|323210748|FG001|Overall Study|Physician Decision|3|||
94388629|NCT00304083|323210747|FG000|Overall Study|Disease Progression|5|||
94388630|NCT00304083|323210748|FG001|Overall Study|Disease Progression|1|||
94388631|NCT00304083|323210747|FG000|Overall Study|Other|5|||
94388632|NCT00304083|323210748|FG001|Overall Study|Other|2|||
94388633|NCT00214422|323210755|FG000|Overall Study|Physician Decision|2|||
94388634|NCT00214422|323210756|FG001|Overall Study|Physician Decision|0|||
94388635|NCT00214422|323210757|FG002|Overall Study|Physician Decision|0|||
94388636|NCT00214422|323210755|FG000|Overall Study|Developed esophageal ca|1|||
94388637|NCT00214422|323210756|FG001|Overall Study|Developed esophageal ca|0|||
94388638|NCT00214422|323210757|FG002|Overall Study|Developed esophageal ca|0|||
94388639|NCT00214422|323210755|FG000|Overall Study|Pt taken off study|1|||
94388640|NCT00214422|323210756|FG001|Overall Study|Pt taken off study|1|||
94388641|NCT00214422|323210757|FG002|Overall Study|Pt taken off study|0|||
94388642|NCT00214422|323210755|FG000|Overall Study|Disease progression on study|1|||
94388643|NCT00214422|323210756|FG001|Overall Study|Disease progression on study|0|||
94388644|NCT00214422|323210757|FG002|Overall Study|Disease progression on study|0|||
94388645|NCT00214422|323210755|FG000|Overall Study|Unable to make a radiation treatment|0|||
94388646|NCT00214422|323210756|FG001|Overall Study|Unable to make a radiation treatment|0|||
94388647|NCT00214422|323210757|FG002|Overall Study|Unable to make a radiation treatment|1|||
94388648|NCT03991494|323210758|FG000|Overall Study|Progressive Disease|4|||
94388649|NCT01706536|323210759|FG000|Overall Study|Withdrawal by Subject|1|||
94388650|NCT01706536|323210760|FG001|Overall Study|Withdrawal by Subject|0|||
94388651|NCT01706536|323210761|FG002|Overall Study|Withdrawal by Subject|1|||
94388652|NCT01706536|323210762|FG003|Overall Study|Withdrawal by Subject|0|||
94388653|NCT01706536|323210763|FG004|Overall Study|Withdrawal by Subject|0|||
94388654|NCT01706536|323210759|FG000|Overall Study|Adverse Event|2|||
94388655|NCT01706536|323210760|FG001|Overall Study|Adverse Event|3|||
94388656|NCT01706536|323210761|FG002|Overall Study|Adverse Event|4|||
94388657|NCT01706536|323210762|FG003|Overall Study|Adverse Event|3|||
94388658|NCT01706536|323210763|FG004|Overall Study|Adverse Event|2|||
94388659|NCT01706536|323210759|FG000|Overall Study|Lack of Efficacy|1|||
94388660|NCT01706536|323210760|FG001|Overall Study|Lack of Efficacy|0|||
94388661|NCT01706536|323210761|FG002|Overall Study|Lack of Efficacy|0|||
94388662|NCT01706536|323210762|FG003|Overall Study|Lack of Efficacy|1|||
94388663|NCT01706536|323210763|FG004|Overall Study|Lack of Efficacy|0|||
94388664|NCT01706536|323210759|FG000|Overall Study|non compliance|0|||
94388665|NCT01706536|323210760|FG001|Overall Study|non compliance|1|||
94388666|NCT01706536|323210761|FG002|Overall Study|non compliance|0|||
94388667|NCT01706536|323210762|FG003|Overall Study|non compliance|0|||
94388668|NCT01706536|323210763|FG004|Overall Study|non compliance|0|||
94388669|NCT00385684|323210764|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
94388670|NCT00385684|323210765|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
94388671|NCT00385684|323210764|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
94388672|NCT00385684|323210765|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
94388673|NCT00385684|323210764|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
94388674|NCT00385684|323210765|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
94388675|NCT02272777|323210766|FG000|Overall Study|Adverse Event|0|||
94388676|NCT02272777|323210767|FG001|Overall Study|Adverse Event|1|||
94388677|NCT02272777|323210766|FG000|Overall Study|Withdrawal by Subject|0|||
94388678|NCT02272777|323210767|FG001|Overall Study|Withdrawal by Subject|3|||
94388679|NCT02272777|323210766|FG000|Overall Study|Lost to Follow-up|2|||
94388680|NCT02272777|323210767|FG001|Overall Study|Lost to Follow-up|0|||
94388681|NCT02272777|323210766|FG000|Overall Study|Other|2|||
94388682|NCT02272777|323210767|FG001|Overall Study|Other|0|||
94388683|NCT00440297|323210768|FG000|Overall Study|Adverse Event|8|||
94388684|NCT00440297|323210769|FG001|Overall Study|Adverse Event|5|||
94388685|NCT00440297|323210768|FG000|Overall Study|Lost to Follow-up|1|||
94388686|NCT00440297|323210769|FG001|Overall Study|Lost to Follow-up|0|||
94388687|NCT00440297|323210768|FG000|Overall Study|Physician Decision|1|||
94388688|NCT00440297|323210769|FG001|Overall Study|Physician Decision|0|||
94388689|NCT00440297|323210768|FG000|Overall Study|Protocol Violation|11|||
94388690|NCT00440297|323210769|FG001|Overall Study|Protocol Violation|7|||
94388691|NCT00440297|323210768|FG000|Overall Study|Withdrawal by Subject|1|||
94388692|NCT00440297|323210769|FG001|Overall Study|Withdrawal by Subject|6|||
94388693|NCT00440297|323210768|FG000|Overall Study|Randomized by mistake|1|||
94388694|NCT00440297|323210769|FG001|Overall Study|Randomized by mistake|0|||
94388695|NCT03243630|323210770|FG000|Overall Study|Protocol Violation|1|||
94388696|NCT03243630|323210770|FG000|Overall Study|Physician Decision|1|||
94388697|NCT02140060|323210771|FG000|Overall Study|Adverse Event|0|||
94388698|NCT02140060|323210772|FG001|Overall Study|Adverse Event|0|||
94388699|NCT02140060|323210773|FG002|Overall Study|Adverse Event|0|||
94388700|NCT02140060|323210774|FG003|Overall Study|Adverse Event|1|||
94388701|NCT02140060|323210775|FG004|Overall Study|Adverse Event|1|||
94388702|NCT02140060|323210776|FG005|Overall Study|Adverse Event|1|||
94388703|NCT02140060|323210771|FG000|Overall Study|Lack of Efficacy|0|||
94388704|NCT02140060|323210772|FG001|Overall Study|Lack of Efficacy|0|||
94388705|NCT02140060|323210773|FG002|Overall Study|Lack of Efficacy|0|||
94388706|NCT02140060|323210774|FG003|Overall Study|Lack of Efficacy|1|||
94388707|NCT02140060|323210775|FG004|Overall Study|Lack of Efficacy|0|||
94388708|NCT02140060|323210776|FG005|Overall Study|Lack of Efficacy|0|||
94388709|NCT02039908|323210778|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
94388710|NCT02039908|323210779|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
94388711|NCT02039908|323210780|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
94388712|NCT02039908|323210781|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
94388713|NCT02039908|323210778|FG000|Phase 1-Summer|Protocol Violation|6|||
94388714|NCT02039908|323210779|FG001|Phase 1-Summer|Protocol Violation|0|||
94388715|NCT02039908|323210780|FG002|Phase 1-Summer|Protocol Violation|0|||
94388716|NCT02039908|323210781|FG003|Phase 1-Summer|Protocol Violation|0|||
94388717|NCT02039908|323210778|FG000|Phase 2-School Year|Lost to Follow-up|0|||
94388718|NCT02039908|323210779|FG001|Phase 2-School Year|Lost to Follow-up|0|||
94388719|NCT02039908|323210780|FG002|Phase 2-School Year|Lost to Follow-up|1|||
94388720|NCT02039908|323210781|FG003|Phase 2-School Year|Lost to Follow-up|3|||
94388721|NCT02039908|323210778|FG000|Phase 2-School Year|Protocol Violation|0|||
94388722|NCT02039908|323210779|FG001|Phase 2-School Year|Protocol Violation|0|||
94388723|NCT02039908|323210780|FG002|Phase 2-School Year|Protocol Violation|3|||
94388724|NCT02039908|323210781|FG003|Phase 2-School Year|Protocol Violation|0|||
94388725|NCT02039908|323210778|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
94388726|NCT02039908|323210779|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
94388727|NCT02039908|323210780|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
94388728|NCT02039908|323210781|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
94388729|NCT00416520|323212288|FG000|Open-label Period|Adverse Event|28|||
94388730|NCT00416520|323212289|FG001|Open-label Period|Adverse Event|10|||
94326082|NCT01464788|322974651|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
94326083|NCT03337152|322974652|FG000|Overall Study|Physician Decision|1|||
94326084|NCT03337152|322974653|FG001|Overall Study|Physician Decision|0|||
94326085|NCT03337152|322974652|FG000|Overall Study|Lost to Follow-up|1|||
94326086|NCT03337152|322974653|FG001|Overall Study|Lost to Follow-up|3|||
94326087|NCT03337152|322974652|FG000|Overall Study|Adverse Event|3|||
94326088|NCT03337152|322974653|FG001|Overall Study|Adverse Event|1|||
94326089|NCT03337152|322974652|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
94326090|NCT03337152|322974653|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
94326091|NCT00418379|322974654|FG000|Year 1|Adverse Event|9|||
94326092|NCT00418379|322974655|FG001|Year 1|Adverse Event|15|||
94326093|NCT00418379|322974656|FG002|Year 1|Adverse Event|3|||
94326094|NCT00418379|322974654|FG000|Year 1|Withdrawal by Subject|7|||
94326095|NCT00418379|322974655|FG001|Year 1|Withdrawal by Subject|8|||
94326096|NCT00418379|322974656|FG002|Year 1|Withdrawal by Subject|5|||
94326097|NCT00418379|322974654|FG000|Year 1|Any other reason not above-mentioned|2|||
94326098|NCT00418379|322974655|FG001|Year 1|Any other reason not above-mentioned|5|||
94326099|NCT00418379|322974656|FG002|Year 1|Any other reason not above-mentioned|7|||
94326100|NCT00418379|322974654|FG000|Year 2|Adverse Event|5|||
94326101|NCT00418379|322974655|FG001|Year 2|Adverse Event|2|||
94326102|NCT00418379|322974656|FG002|Year 2|Adverse Event|1|||
94326103|NCT00418379|322974654|FG000|Year 2|Withdrawal by Subject|1|||
94326104|NCT00418379|322974655|FG001|Year 2|Withdrawal by Subject|1|||
94326105|NCT00418379|322974656|FG002|Year 2|Withdrawal by Subject|3|||
94326106|NCT00418379|322974654|FG000|Year 2|Any other reason not above-mentioned|2|||
94326107|NCT00418379|322974655|FG001|Year 2|Any other reason not above-mentioned|1|||
94326108|NCT00418379|322974656|FG002|Year 2|Any other reason not above-mentioned|6|||
94326109|NCT00418379|322974654|FG000|Year 3|Withdrawal by Subject|1|||
94326110|NCT00418379|322974655|FG001|Year 3|Withdrawal by Subject|1|||
94326111|NCT00418379|322974656|FG002|Year 3|Withdrawal by Subject|2|||
94388731|NCT00416520|323212290|FG002|Open-label Period|Adverse Event|0|||
94388732|NCT00416520|323212291|FG003|Open-label Period|Adverse Event|0|||
94388733|NCT00416520|323212288|FG000|Open-label Period|Death|2|||
94388734|NCT00416520|323212289|FG001|Open-label Period|Death|1|||
94388735|NCT00416520|323212290|FG002|Open-label Period|Death|0|||
94388736|NCT00416520|323212291|FG003|Open-label Period|Death|0|||
94388737|NCT00416520|323212288|FG000|Open-label Period|Lack of Efficacy|8|||
94388738|NCT00416520|323212289|FG001|Open-label Period|Lack of Efficacy|1|||
94326112|NCT00418379|322974654|FG000|Year 3|Any other reason not above-mentioned|2|||
94326113|NCT00418379|322974655|FG001|Year 3|Any other reason not above-mentioned|1|||
94326114|NCT00418379|322974656|FG002|Year 3|Any other reason not above-mentioned|1|||
94326115|NCT00418379|322974654|FG000|Year 4|Adverse Event|0|||
94326116|NCT00418379|322974655|FG001|Year 4|Adverse Event|1|||
94326117|NCT00418379|322974656|FG002|Year 4|Adverse Event|0|||
94326118|NCT00418379|322974654|FG000|Year 4|Withdrawal by Subject|2|||
94326119|NCT00418379|322974655|FG001|Year 4|Withdrawal by Subject|3|||
94326120|NCT00418379|322974656|FG002|Year 4|Withdrawal by Subject|2|||
94326121|NCT00418379|322974654|FG000|Year 4|Any other reason not above-mentioned|1|||
94326122|NCT00418379|322974655|FG001|Year 4|Any other reason not above-mentioned|1|||
94326123|NCT00418379|322974656|FG002|Year 4|Any other reason not above-mentioned|0|||
94326124|NCT00418379|322974654|FG000|Year 5|Adverse Event|0|||
94326125|NCT00418379|322974655|FG001|Year 5|Adverse Event|1|||
94326126|NCT00418379|322974656|FG002|Year 5|Adverse Event|0|||
94326127|NCT00418379|322974654|FG000|Year 5|Any other reason not above-mentioned|2|||
94326128|NCT00418379|322974655|FG001|Year 5|Any other reason not above-mentioned|4|||
94326129|NCT00418379|322974656|FG002|Year 5|Any other reason not above-mentioned|3|||
94326130|NCT00843843|322974657|FG000|Overall Study|Physician Decision|1|||
94326131|NCT00843843|322974658|FG001|Overall Study|Physician Decision|1|||
94326132|NCT00843843|322974657|FG000|Overall Study|Protocol Violation|1|||
94326133|NCT00843843|322974658|FG001|Overall Study|Protocol Violation|1|||
94326134|NCT01594333|322974659|FG000|Overall Study|Death|96|||
94326135|NCT01594333|322974660|FG001|Overall Study|Death|83|||
94326136|NCT01594333|322974659|FG000|Overall Study|Lost to Follow-up|5|||
94326137|NCT01594333|322974660|FG001|Overall Study|Lost to Follow-up|5|||
94326138|NCT01594333|322974659|FG000|Overall Study|Withdrawal by Subject|60|||
94326139|NCT01594333|322974660|FG001|Overall Study|Withdrawal by Subject|63|||
94326140|NCT01764256|322974661|FG000|Received All Vaccinations|Adverse Event|1|||
94326141|NCT01764256|322974662|FG001|Received All Vaccinations|Adverse Event|1|||
94326142|NCT01764256|322974663|FG002|Received All Vaccinations|Adverse Event|0|||
94326143|NCT01764256|322974664|FG003|Received All Vaccinations|Adverse Event|0|||
94326144|NCT01764256|322974661|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
94326145|NCT01764256|322974662|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
94326146|NCT01764256|322974663|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
94326147|NCT01764256|322974664|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
94326148|NCT01764256|322974661|FG000|Received All Vaccinations|Lost to Follow-up|1|||
94326149|NCT01764256|322974662|FG001|Received All Vaccinations|Lost to Follow-up|0|||
94326150|NCT01764256|322974663|FG002|Received All Vaccinations|Lost to Follow-up|0|||
94326151|NCT01764256|322974664|FG003|Received All Vaccinations|Lost to Follow-up|0|||
94326152|NCT01764256|322974661|FG000|Completed Study|Lost to Follow-up|0|||
94326153|NCT01764256|322974662|FG001|Completed Study|Lost to Follow-up|0|||
94326154|NCT01764256|322974663|FG002|Completed Study|Lost to Follow-up|0|||
94326155|NCT01764256|322974664|FG003|Completed Study|Lost to Follow-up|1|||
94326156|NCT01875367|322974668|FG000|Overall Study|Not complete at least 2 questionaries|4|||
94326157|NCT01875367|322974669|FG001|Overall Study|Not complete at least 2 questionaries|2|||
94326158|NCT01875367|322974668|FG000|Overall Study|Not receive study treatment|1|||
94326159|NCT01875367|322974669|FG001|Overall Study|Not receive study treatment|0|||
94326160|NCT00400712|322974670|FG000|Overall Study|Death|1|||
94326161|NCT00400712|322974671|FG001|Overall Study|Death|0|||
94326162|NCT00400712|322974670|FG000|Overall Study|Withdrawal by Subject|11|||
94326163|NCT00400712|322974671|FG001|Overall Study|Withdrawal by Subject|12|||
94326164|NCT00400712|322974670|FG000|Overall Study|Physician Decision|5|||
94326165|NCT00400712|322974671|FG001|Overall Study|Physician Decision|4|||
94326166|NCT02670330|322974672|FG000|Overall Study|Protocol Deviation|1|||
94326167|NCT02670330|322974673|FG001|Overall Study|Protocol Deviation|0|||
94326168|NCT02670330|322974672|FG000|Overall Study|Study Terminated By Sponsor|36|||
94326169|NCT02670330|322974673|FG001|Overall Study|Study Terminated By Sponsor|43|||
94326170|NCT02670330|322974672|FG000|Overall Study|Adverse Event|1|||
94326171|NCT02670330|322974673|FG001|Overall Study|Adverse Event|3|||
94326172|NCT02670330|322974672|FG000|Overall Study|Withdrawal by Subject|34|||
94326173|NCT02670330|322974673|FG001|Overall Study|Withdrawal by Subject|29|||
94326174|NCT02670330|322974672|FG000|Overall Study|Lost to Follow-up|3|||
94326175|NCT02670330|322974673|FG001|Overall Study|Lost to Follow-up|2|||
94326176|NCT00441103|322974680|FG000|Overall Study|Adverse Event|2|||
94326177|NCT00441103|322974681|FG001|Overall Study|Adverse Event|1|||
94326178|NCT00441103|322974680|FG000|Overall Study|Death|1|||
94326179|NCT00441103|322974681|FG001|Overall Study|Death|0|||
94326180|NCT00441103|322974680|FG000|Overall Study|Disease Progression|2|||
94326181|NCT00441103|322974681|FG001|Overall Study|Disease Progression|0|||
94326182|NCT00441103|322974680|FG000|Overall Study|Lost to Follow-up|1|||
94326183|NCT00441103|322974681|FG001|Overall Study|Lost to Follow-up|0|||
94326184|NCT00441103|322974680|FG000|Overall Study|Protocol Violation|1|||
94326185|NCT00441103|322974681|FG001|Overall Study|Protocol Violation|0|||
94326186|NCT00441103|322974680|FG000|Overall Study|Participant unable to use Rebiject II|1|||
94326187|NCT00441103|322974681|FG001|Overall Study|Participant unable to use Rebiject II|0|||
94326188|NCT00441103|322974680|FG000|Overall Study|Participant refused MRI|1|||
94326189|NCT00441103|322974681|FG001|Overall Study|Participant refused MRI|0|||
94326190|NCT00441103|322974680|FG000|Overall Study|Inclusion criteria absent|1|||
94326191|NCT00441103|322974681|FG001|Overall Study|Inclusion criteria absent|0|||
94326192|NCT00441103|322974680|FG000|Overall Study|Non-compliant|0|||
94326193|NCT00441103|322974681|FG001|Overall Study|Non-compliant|1|||
94326194|NCT00441103|322974680|FG000|Overall Study|Participant decided to withdraw|1|||
94326195|NCT00441103|322974681|FG001|Overall Study|Participant decided to withdraw|0|||
94326196|NCT00441103|322974680|FG000|Overall Study|Participant's reason|0|||
94326197|NCT00441103|322974681|FG001|Overall Study|Participant's reason|1|||
94326198|NCT00441103|322974680|FG000|Overall Study|Participant decided to stop|0|||
94326199|NCT00441103|322974681|FG001|Overall Study|Participant decided to stop|1|||
94326200|NCT01838590|322974682|FG000|Overall Study|Lack of Efficacy|12|||
94326201|NCT01838590|322974683|FG001|Overall Study|Lack of Efficacy|4|||
94326202|NCT01838590|322974682|FG000|Overall Study|Lost to Follow-up|0|||
94326203|NCT01838590|322974683|FG001|Overall Study|Lost to Follow-up|1|||
94326204|NCT02802878|322974684|FG000|Overall Study|Withdrawal by Subject|3|||
94326205|NCT02802878|322974685|FG001|Overall Study|Withdrawal by Subject|3|||
94326206|NCT02802878|322974684|FG000|Overall Study|Protocol Violation|1|||
94326207|NCT02802878|322974685|FG001|Overall Study|Protocol Violation|0|||
94326208|NCT03691610|322974687|FG000|Overall Study|Adverse Event|0|||
94326209|NCT03691610|322974688|FG001|Overall Study|Adverse Event|1|||
94326210|NCT03691610|322974689|FG002|Overall Study|Adverse Event|0|||
94326211|NCT03691610|322974690|FG003|Overall Study|Adverse Event|0|||
94326212|NCT03691610|322974687|FG000|Overall Study|Protocol Deviation|15|||
94326213|NCT03691610|322974688|FG001|Overall Study|Protocol Deviation|8|||
94326214|NCT03691610|322974689|FG002|Overall Study|Protocol Deviation|1|||
94326215|NCT03691610|322974690|FG003|Overall Study|Protocol Deviation|2|||
94326216|NCT03691610|322974687|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
94326217|NCT03691610|322974688|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
94326218|NCT03691610|322974689|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
94326219|NCT03691610|322974690|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
94326220|NCT03691610|322974687|FG000|Overall Study|Lost to Follow-up|20|||
94326221|NCT03691610|322974688|FG001|Overall Study|Lost to Follow-up|11|||
94326222|NCT03691610|322974689|FG002|Overall Study|Lost to Follow-up|5|||
94326223|NCT03691610|322974690|FG003|Overall Study|Lost to Follow-up|2|||
94326224|NCT03699631|322974693|FG000|Overall Study|Adverse Event|3|||
94326225|NCT02921919|322974694|FG000|Overall Study|Other|5|||
94326226|NCT02921919|322974695|FG001|Overall Study|Other|6|||
94326227|NCT02921919|322974694|FG000|Overall Study|Lost to Follow-up|0|||
94388739|NCT00416520|323212290|FG002|Open-label Period|Lack of Efficacy|0|||
94388740|NCT00416520|323212291|FG003|Open-label Period|Lack of Efficacy|0|||
94388741|NCT00416520|323212288|FG000|Open-label Period|Protocol Violation|3|||
94388742|NCT00416520|323212289|FG001|Open-label Period|Protocol Violation|3|||
94388743|NCT00416520|323212290|FG002|Open-label Period|Protocol Violation|0|||
94388744|NCT00416520|323212291|FG003|Open-label Period|Protocol Violation|0|||
94388745|NCT00416520|323212288|FG000|Open-label Period|Withdrawal by Subject|16|||
94388746|NCT00416520|323212289|FG001|Open-label Period|Withdrawal by Subject|5|||
94388747|NCT00416520|323212290|FG002|Open-label Period|Withdrawal by Subject|0|||
94388748|NCT00416520|323212291|FG003|Open-label Period|Withdrawal by Subject|0|||
94388749|NCT00416520|323212288|FG000|Open-label Period|Other Reasons|3|||
94388750|NCT00416520|323212289|FG001|Open-label Period|Other Reasons|12|||
94388751|NCT00416520|323212290|FG002|Open-label Period|Other Reasons|0|||
94326228|NCT02921919|322974695|FG001|Overall Study|Lost to Follow-up|1|||
94326229|NCT02921919|322974694|FG000|Overall Study|Withdrawal by Subject|5|||
94326230|NCT02921919|322974695|FG001|Overall Study|Withdrawal by Subject|1|||
94326231|NCT02921919|322974694|FG000|Overall Study|Disease Progression|47|||
94326232|NCT02921919|322974695|FG001|Overall Study|Disease Progression|38|||
94326233|NCT02921919|322974694|FG000|Overall Study|Physician Decision|3|||
94326234|NCT02921919|322974695|FG001|Overall Study|Physician Decision|2|||
94326235|NCT02921919|322974694|FG000|Overall Study|Adverse Event|6|||
94326236|NCT02921919|322974695|FG001|Overall Study|Adverse Event|4|||
94326237|NCT00121992|322974696|FG000|Overall Study|Treatment not received|2|||
94326238|NCT00121992|322974697|FG001|Overall Study|Treatment not received|11|||
94326239|NCT02121756|322974700|FG000|Overall Study|Adverse Event|3|||
94326240|NCT02121756|322974701|FG001|Overall Study|Adverse Event|0|||
94326241|NCT02121756|322974700|FG000|Overall Study|Protocol Violation|1|||
94326242|NCT02121756|322974701|FG001|Overall Study|Protocol Violation|1|||
94326243|NCT02121756|322974700|FG000|Overall Study|Physician Decision|2|||
94326244|NCT02121756|322974701|FG001|Overall Study|Physician Decision|1|||
94326245|NCT01324622|322974702|FG000|Overall Study|Lost to Follow-up|7|||
94326246|NCT01324622|322974703|FG001|Overall Study|Lost to Follow-up|7|||
94326247|NCT01324622|322974702|FG000|Overall Study|Death|1|||
94326248|NCT01324622|322974703|FG001|Overall Study|Death|0|||
94326249|NCT01324622|322974702|FG000|Overall Study|Lack of Efficacy|1|||
94326250|NCT01324622|322974703|FG001|Overall Study|Lack of Efficacy|0|||
94388752|NCT00416520|323212291|FG003|Open-label Period|Other Reasons|0|||
94388753|NCT00416520|323212288|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
94388754|NCT00416520|323212289|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
94326251|NCT00618449|322974704|FG000|Overall Study|Lost to Follow-up|98|||
94326252|NCT00618449|322974705|FG001|Overall Study|Lost to Follow-up|110|||
94326253|NCT01441115|322974706|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
94326254|NCT00438399|322974708|FG000|Overall Study|Lost to Follow-up|2|||
94326255|NCT00438399|322974709|FG001|Overall Study|Lost to Follow-up|2|||
94326256|NCT00438399|322974710|FG002|Overall Study|Lost to Follow-up|1|||
94326257|NCT00438399|322974711|FG003|Overall Study|Lost to Follow-up|1|||
94326258|NCT00438399|322974712|FG004|Overall Study|Lost to Follow-up|1|||
94326259|NCT00438399|322974713|FG005|Overall Study|Lost to Follow-up|1|||
94326260|NCT00438399|322974708|FG000|Overall Study|Adverse Event|0|||
94326261|NCT00438399|322974709|FG001|Overall Study|Adverse Event|0|||
94326262|NCT00438399|322974710|FG002|Overall Study|Adverse Event|1|||
94326263|NCT00438399|322974711|FG003|Overall Study|Adverse Event|1|||
94326264|NCT00438399|322974712|FG004|Overall Study|Adverse Event|0|||
94326265|NCT00438399|322974713|FG005|Overall Study|Adverse Event|1|||
94326266|NCT00438399|322974708|FG000|Overall Study|Withdrawal by Subject|5|||
94326267|NCT00438399|322974709|FG001|Overall Study|Withdrawal by Subject|6|||
94326268|NCT00438399|322974710|FG002|Overall Study|Withdrawal by Subject|3|||
94326269|NCT00438399|322974711|FG003|Overall Study|Withdrawal by Subject|2|||
94326270|NCT00438399|322974712|FG004|Overall Study|Withdrawal by Subject|2|||
94326271|NCT00438399|322974713|FG005|Overall Study|Withdrawal by Subject|2|||
94326272|NCT00438399|322974708|FG000|Overall Study|Protocol Violation|0|||
94326273|NCT00438399|322974709|FG001|Overall Study|Protocol Violation|0|||
94326274|NCT00438399|322974710|FG002|Overall Study|Protocol Violation|1|||
94326275|NCT00438399|322974711|FG003|Overall Study|Protocol Violation|0|||
94326276|NCT00438399|322974712|FG004|Overall Study|Protocol Violation|0|||
94326277|NCT00438399|322974713|FG005|Overall Study|Protocol Violation|1|||
94326278|NCT00438399|322974708|FG000|Overall Study|Subje stopped study|0|||
94326279|NCT00438399|322974709|FG001|Overall Study|Subje stopped study|0|||
94326280|NCT00438399|322974710|FG002|Overall Study|Subje stopped study|1|||
94326281|NCT00438399|322974711|FG003|Overall Study|Subje stopped study|0|||
94326282|NCT00438399|322974712|FG004|Overall Study|Subje stopped study|0|||
94326283|NCT00438399|322974713|FG005|Overall Study|Subje stopped study|0|||
94326284|NCT00438399|322974708|FG000|Overall Study|Pregnancy|0|||
94326285|NCT00438399|322974709|FG001|Overall Study|Pregnancy|0|||
94326286|NCT00438399|322974710|FG002|Overall Study|Pregnancy|0|||
94326287|NCT00438399|322974711|FG003|Overall Study|Pregnancy|0|||
94326288|NCT00438399|322974712|FG004|Overall Study|Pregnancy|0|||
94326289|NCT00438399|322974713|FG005|Overall Study|Pregnancy|1|||
94326290|NCT00438399|322974708|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
94326291|NCT00438399|322974709|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
94326292|NCT00438399|322974710|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
94326293|NCT00438399|322974711|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
94326294|NCT00438399|322974712|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
94326295|NCT00438399|322974713|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
94326296|NCT00878215|322974714|FG000|Overall Study|Determined to be ineligible|0|||
94326297|NCT00878215|322974715|FG001|Overall Study|Determined to be ineligible|10|||
94326298|NCT00878215|322974716|FG002|Overall Study|Determined to be ineligible|0|||
94326299|NCT00878215|322974717|FG003|Overall Study|Determined to be ineligible|0|||
94326300|NCT01364233|322974718|FG000|Overall Study|Lost to Follow-up|1|||
94326301|NCT00138424|322974721|FG000|Overall Study|Physician Decision|0|||
94326302|NCT00138424|322974722|FG001|Overall Study|Physician Decision|1|||
94326303|NCT00138424|322974723|FG002|Overall Study|Physician Decision|0|||
94326304|NCT00138424|322974724|FG003|Overall Study|Physician Decision|0|||
94326305|NCT04311177|322974727|FG000|Overall Study|Adverse Event|3|||
94326306|NCT04311177|322974728|FG001|Overall Study|Adverse Event|1|||
94326307|NCT04311177|322974727|FG000|Overall Study|Physician Decision|4|||
94326308|NCT04311177|322974728|FG001|Overall Study|Physician Decision|3|||
94326309|NCT04311177|322974727|FG000|Overall Study|Withdrawal by Subject|1|||
94326310|NCT04311177|322974728|FG001|Overall Study|Withdrawal by Subject|0|||
94326311|NCT01767519|322974733|FG000|Overall Study|Other Reasons|4|||
94326312|NCT01767519|322974734|FG001|Overall Study|Other Reasons|4|||
94326313|NCT01767519|322974735|FG002|Overall Study|Other Reasons|2|||
94326314|NCT01767519|322974733|FG000|Overall Study|Protocol Violation|0|||
94326315|NCT01767519|322974734|FG001|Overall Study|Protocol Violation|3|||
94326316|NCT01767519|322974735|FG002|Overall Study|Protocol Violation|0|||
94326317|NCT01767519|322974733|FG000|Overall Study|Personal Reasons|1|||
94326318|NCT01767519|322974734|FG001|Overall Study|Personal Reasons|0|||
94326319|NCT01767519|322974735|FG002|Overall Study|Personal Reasons|0|||
94326320|NCT01767519|322974733|FG000|Overall Study|Lost to Follow-up|3|||
94326321|NCT01767519|322974734|FG001|Overall Study|Lost to Follow-up|1|||
94326322|NCT01767519|322974735|FG002|Overall Study|Lost to Follow-up|2|||
94326323|NCT01767519|322974733|FG000|Overall Study|Lack of Efficacy|1|||
94326324|NCT01767519|322974734|FG001|Overall Study|Lack of Efficacy|0|||
94326325|NCT01767519|322974735|FG002|Overall Study|Lack of Efficacy|0|||
94326326|NCT01767519|322974733|FG000|Overall Study|Adverse Event|5|||
94326327|NCT01767519|322974734|FG001|Overall Study|Adverse Event|5|||
94326328|NCT01767519|322974735|FG002|Overall Study|Adverse Event|1|||
94326329|NCT01401465|322974736|FG000|Treatment Period 1|Adverse Event|4|||
94388755|NCT00416520|323212290|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
94388756|NCT00416520|323212291|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
94388757|NCT00416520|323212288|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
94388758|NCT00416520|323212289|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
94388759|NCT00416520|323212290|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
94388760|NCT00416520|323212291|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
94388761|NCT00416520|323212288|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
94388762|NCT00416520|323212289|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
94388763|NCT00416520|323212290|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
94388764|NCT00416520|323212291|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
94388765|NCT02106156|323212294|FG000|Overall Study|Patient Died|19|||
94388766|NCT02106156|323212295|FG001|Overall Study|Patient Died|0|||
94388767|NCT02106156|323212296|FG002|Overall Study|Patient Died|0|||
94388768|NCT02106156|323212294|FG000|Overall Study|Lack of Tolerability|305|||
94388769|NCT02106156|323212295|FG001|Overall Study|Lack of Tolerability|3|||
94388770|NCT02106156|323212296|FG002|Overall Study|Lack of Tolerability|0|||
94388771|NCT02106156|323212294|FG000|Overall Study|Lack of Virological Response|1044|||
94388772|NCT02106156|323212295|FG001|Overall Study|Lack of Virological Response|8|||
94388773|NCT02106156|323212296|FG002|Overall Study|Lack of Virological Response|0|||
94388774|NCT02106156|323212294|FG000|Overall Study|Concomitant Disease|74|||
94388775|NCT02106156|323212295|FG001|Overall Study|Concomitant Disease|2|||
94388776|NCT02106156|323212296|FG002|Overall Study|Concomitant Disease|0|||
94388777|NCT02106156|323212294|FG000|Overall Study|Lack of Compliance|211|||
94388778|NCT02106156|323212295|FG001|Overall Study|Lack of Compliance|7|||
94388779|NCT02106156|323212296|FG002|Overall Study|Lack of Compliance|0|||
94388780|NCT02106156|323212294|FG000|Overall Study|Patients Request|307|||
94388781|NCT02106156|323212295|FG001|Overall Study|Patients Request|9|||
94388782|NCT02106156|323212296|FG002|Overall Study|Patients Request|0|||
94388783|NCT02106156|323212294|FG000|Overall Study|Lost to Follow-up|451|||
94388784|NCT02106156|323212295|FG001|Overall Study|Lost to Follow-up|8|||
94388785|NCT02106156|323212296|FG002|Overall Study|Lost to Follow-up|0|||
94388786|NCT02106156|323212294|FG000|Overall Study|Unplanned Event|82|||
94388787|NCT02106156|323212295|FG001|Overall Study|Unplanned Event|2|||
94388788|NCT02106156|323212296|FG002|Overall Study|Unplanned Event|0|||
94388789|NCT02106156|323212294|FG000|Overall Study|Change of Laboratory Parameter|10|||
94388790|NCT02106156|323212295|FG001|Overall Study|Change of Laboratory Parameter|0|||
94388791|NCT02106156|323212296|FG002|Overall Study|Change of Laboratory Parameter|0|||
94388792|NCT02106156|323212294|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
94388793|NCT02106156|323212295|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
94388794|NCT02106156|323212296|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
94388795|NCT02106156|323212294|FG000|Overall Study|Relocation/Change of Physician|40|||
94388796|NCT02106156|323212295|FG001|Overall Study|Relocation/Change of Physician|1|||
94388797|NCT02106156|323212296|FG002|Overall Study|Relocation/Change of Physician|0|||
94388798|NCT04657770|323212299|FG000|Overall Study|Withdrawal by Subject|3|||
94388799|NCT04657770|323212299|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
94388800|NCT00746798|323212300|FG000|Overall Study|Protocol Violation|0|||
94388801|NCT00746798|323212301|FG001|Overall Study|Protocol Violation|1|||
94388802|NCT00746798|323212302|FG002|Overall Study|Protocol Violation|0|||
94388803|NCT00746798|323212303|FG003|Overall Study|Protocol Violation|0|||
94388804|NCT00746798|323212300|FG000|Overall Study|Withdrawal by Subject|0|||
94388805|NCT00746798|323212301|FG001|Overall Study|Withdrawal by Subject|1|||
94388806|NCT00746798|323212302|FG002|Overall Study|Withdrawal by Subject|1|||
94388807|NCT00746798|323212303|FG003|Overall Study|Withdrawal by Subject|0|||
94388808|NCT00746798|323212300|FG000|Overall Study|Death|0|||
94388809|NCT00746798|323212301|FG001|Overall Study|Death|0|||
94388810|NCT00746798|323212302|FG002|Overall Study|Death|2|||
94388811|NCT00746798|323212303|FG003|Overall Study|Death|0|||
94388812|NCT00746798|323212300|FG000|Overall Study|Participant unable to return for visit|1|||
94388813|NCT00746798|323212301|FG001|Overall Study|Participant unable to return for visit|0|||
94388814|NCT00746798|323212302|FG002|Overall Study|Participant unable to return for visit|0|||
94388815|NCT00746798|323212303|FG003|Overall Study|Participant unable to return for visit|0|||
94388816|NCT02262377|323212304|FG000|Overall Study|Lost to Follow-up|5|||
94388817|NCT02262377|323212305|FG001|Overall Study|Lost to Follow-up|6|||
94388818|NCT02262377|323212304|FG000|Overall Study|Found ineligible after enrollment|3|||
94388819|NCT02262377|323212305|FG001|Overall Study|Found ineligible after enrollment|0|||
94388820|NCT02262377|323212304|FG000|Overall Study|Withdrawal by Subject|4|||
94388821|NCT02262377|323212305|FG001|Overall Study|Withdrawal by Subject|0|||
94388822|NCT00088829|323212309|FG000|Overall Study|PI left institution and study was close|22|||
94388823|NCT01900730|323212326|FG000|Overall Study|Withdrawal by Subject|1|||
94388824|NCT01900730|323212327|FG001|Overall Study|Withdrawal by Subject|0|||
94388825|NCT01900730|323212326|FG000|Overall Study|Screen Failure|1|||
94388826|NCT01900730|323212327|FG001|Overall Study|Screen Failure|0|||
94388827|NCT01511939|323212328|FG000|Overall Study|Withdrawal by Subject|2|||
94388828|NCT01511939|323212329|FG001|Overall Study|Withdrawal by Subject|1|||
94388829|NCT01511939|323212330|FG002|Overall Study|Withdrawal by Subject|0|||
94388830|NCT02932878|323212336|FG000|Overall Study|Due to Lab Results|2|||
94388831|NCT02932878|323212337|FG001|Overall Study|Due to Lab Results|1|||
94388832|NCT00880568|323212338|FG000|Overall Study|Disease progression|3|||
94388833|NCT00880568|323212339|FG001|Overall Study|Disease progression|3|||
94388834|NCT00880568|323212340|FG002|Overall Study|Disease progression|3|||
94388835|NCT00880568|323212341|FG003|Overall Study|Disease progression|1|||
94388836|NCT00880568|323212342|FG004|Overall Study|Disease progression|3|||
94388837|NCT00880568|323212343|FG005|Overall Study|Disease progression|3|||
94388838|NCT00880568|323212344|FG006|Overall Study|Disease progression|5|||
94388839|NCT00880568|323212345|FG007|Overall Study|Disease progression|0|||
94388840|NCT00880568|323212346|FG008|Overall Study|Disease progression|3|||
94388841|NCT00880568|323212338|FG000|Overall Study|Adverse Event|0|||
94388842|NCT00880568|323212339|FG001|Overall Study|Adverse Event|0|||
94388843|NCT00880568|323212340|FG002|Overall Study|Adverse Event|0|||
94388844|NCT00880568|323212341|FG003|Overall Study|Adverse Event|0|||
94388845|NCT00880568|323212342|FG004|Overall Study|Adverse Event|0|||
94388846|NCT00880568|323212343|FG005|Overall Study|Adverse Event|0|||
94388847|NCT00880568|323212344|FG006|Overall Study|Adverse Event|1|||
94388848|NCT00880568|323212345|FG007|Overall Study|Adverse Event|1|||
94388849|NCT00880568|323212346|FG008|Overall Study|Adverse Event|0|||
94388850|NCT00880568|323212338|FG000|Overall Study|Withdrawal by Subject|0|||
94388851|NCT00880568|323212339|FG001|Overall Study|Withdrawal by Subject|0|||
94388852|NCT00880568|323212340|FG002|Overall Study|Withdrawal by Subject|0|||
94388853|NCT00880568|323212341|FG003|Overall Study|Withdrawal by Subject|0|||
94388854|NCT00880568|323212342|FG004|Overall Study|Withdrawal by Subject|0|||
94388855|NCT00880568|323212343|FG005|Overall Study|Withdrawal by Subject|0|||
94388856|NCT00880568|323212344|FG006|Overall Study|Withdrawal by Subject|0|||
94388857|NCT00880568|323212345|FG007|Overall Study|Withdrawal by Subject|1|||
94388858|NCT00880568|323212346|FG008|Overall Study|Withdrawal by Subject|0|||
94326330|NCT01401465|322974737|FG001|Treatment Period 1|Adverse Event|1|||
94326331|NCT01401465|322974736|FG000|Treatment Period 1|Pregnancy|0|||
94326332|NCT01401465|322974737|FG001|Treatment Period 1|Pregnancy|1|||
94326333|NCT01401465|322974736|FG000|Treatment Period 1|Protocol Violation|5|||
94326334|NCT01401465|322974737|FG001|Treatment Period 1|Protocol Violation|0|||
94326335|NCT01401465|322974736|FG000|Treatment Period 1|Withdrawal by Subject|1|||
94326336|NCT01401465|322974737|FG001|Treatment Period 1|Withdrawal by Subject|4|||
94326337|NCT01401465|322974736|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
94326338|NCT01401465|322974737|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
94326339|NCT01401465|322974736|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
94326340|NCT01401465|322974737|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
94326341|NCT01401465|322974736|FG000|Treatment Period 1|Scheduling Difficulties|1|||
94326342|NCT01401465|322974737|FG001|Treatment Period 1|Scheduling Difficulties|1|||
94326343|NCT01401465|322974736|FG000|Treatment Period 2|Lost to Follow-up|0|||
94326344|NCT01401465|322974737|FG001|Treatment Period 2|Lost to Follow-up|1|||
94326345|NCT01401465|322974736|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94326346|NCT01401465|322974737|FG001|Treatment Period 2|Withdrawal by Subject|1|||
94326347|NCT00986427|322974738|FG000|Overall Study|Lost to Follow-up|2|||
94326348|NCT00986427|322974739|FG001|Overall Study|Lost to Follow-up|0|||
94326349|NCT00986427|322974738|FG000|Overall Study|Lack of Efficacy|1|||
94326350|NCT00986427|322974739|FG001|Overall Study|Lack of Efficacy|0|||
94326351|NCT00986427|322974738|FG000|Overall Study|Withdrawal by Subject|1|||
94326352|NCT00986427|322974739|FG001|Overall Study|Withdrawal by Subject|0|||
94326353|NCT00171314|322974744|FG000|Overall Study|Adverse Event|44|||
94326354|NCT00171314|322974745|FG001|Overall Study|Adverse Event|41|||
94326355|NCT00171314|322974744|FG000|Overall Study|Lack of Efficacy|19|||
94326356|NCT00171314|322974745|FG001|Overall Study|Lack of Efficacy|14|||
94326357|NCT00171314|322974744|FG000|Overall Study|Withdrawal by Subject|9|||
94326358|NCT00171314|322974745|FG001|Overall Study|Withdrawal by Subject|6|||
94326359|NCT00171314|322974744|FG000|Overall Study|Abnormal Test Procedure Results|9|||
94326360|NCT00171314|322974745|FG001|Overall Study|Abnormal Test Procedure Results|3|||
94388859|NCT00437658|323212347|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
94388860|NCT00437658|323212348|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
94388861|NCT00437658|323212349|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
94388862|NCT00437658|323212347|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
94388863|NCT00437658|323212348|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
94326361|NCT00171314|322974744|FG000|Overall Study|Protocol Violation|3|||
94326362|NCT00171314|322974745|FG001|Overall Study|Protocol Violation|7|||
94326363|NCT00171314|322974744|FG000|Overall Study|Administrative Problems|4|||
94326364|NCT00171314|322974745|FG001|Overall Study|Administrative Problems|3|||
94326365|NCT00171314|322974744|FG000|Overall Study|Lost to Follow-up|1|||
94326366|NCT00171314|322974745|FG001|Overall Study|Lost to Follow-up|3|||
94326367|NCT00171314|322974744|FG000|Overall Study|Death|2|||
94326368|NCT00171314|322974745|FG001|Overall Study|Death|1|||
94326369|NCT00377429|322974746|FG000|Overall Study|Withdrawal by Subject|5|||
94388864|NCT00437658|323212349|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
94388865|NCT00437658|323212347|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
94326370|NCT00377429|322974746|FG000|Overall Study|Adverse Event|8|||
94326371|NCT00377429|322974746|FG000|Overall Study|Physician Decision|1|||
94326372|NCT00377429|322974746|FG000|Overall Study|Patient non-compliance|1|||
94326373|NCT01561560|322974747|FG000|First Two Weeks of Wear|Time/job conflict|0|||
94326374|NCT01561560|322974748|FG001|First Two Weeks of Wear|Time/job conflict|1|||
94326375|NCT01561560|322974747|FG000|First Two Weeks of Wear|Adverse Event|0|||
94326376|NCT01561560|322974748|FG001|First Two Weeks of Wear|Adverse Event|1|||
94326377|NCT01561560|322974747|FG000|Second Two Weeks of Wear|Adverse Event|0|||
94326378|NCT01561560|322974748|FG001|Second Two Weeks of Wear|Adverse Event|1|||
94326379|NCT01255306|322976214|FG000|Overall Study|Physician Decision|1|||
94326380|NCT01255306|322976215|FG001|Overall Study|Physician Decision|1|||
94326381|NCT02017899|322976216|FG000|Overall Study|Withdrawal by Subject|0|||
94326382|NCT02017899|322976217|FG001|Overall Study|Withdrawal by Subject|0|||
94326383|NCT02017899|322976218|FG002|Overall Study|Withdrawal by Subject|0|||
94326384|NCT02017899|322976219|FG003|Overall Study|Withdrawal by Subject|1|||
94326385|NCT02017899|322976220|FG004|Overall Study|Withdrawal by Subject|1|||
94326386|NCT02017899|322976221|FG005|Overall Study|Withdrawal by Subject|0|||
94326387|NCT01337167|322976222|FG000|Infant Series|Adverse Event|1|||
94326388|NCT01337167|322976223|FG001|Infant Series|Adverse Event|1|||
94326389|NCT01337167|322976222|FG000|Infant Series|Death|1|||
94326390|NCT01337167|322976223|FG001|Infant Series|Death|1|||
94326391|NCT01337167|322976222|FG000|Infant Series|Lost to Follow-up|13|||
94326392|NCT01337167|322976223|FG001|Infant Series|Lost to Follow-up|7|||
94326393|NCT01337167|322976222|FG000|Infant Series|Non-compliance with study drug|2|||
94326394|NCT01337167|322976223|FG001|Infant Series|Non-compliance with study drug|1|||
94326395|NCT01337167|322976222|FG000|Infant Series|Physician Decision|3|||
94326396|NCT01337167|322976223|FG001|Infant Series|Physician Decision|1|||
94326397|NCT01337167|322976222|FG000|Infant Series|Protocol Violation|22|||
94326398|NCT01337167|322976223|FG001|Infant Series|Protocol Violation|9|||
94326399|NCT01337167|322976222|FG000|Infant Series|Withdrawal by Subject|15|||
94326400|NCT01337167|322976223|FG001|Infant Series|Withdrawal by Subject|4|||
94326401|NCT01337167|322976222|FG000|Infant Series|Randomized but not vaccinated|5|||
94326402|NCT01337167|322976223|FG001|Infant Series|Randomized but not vaccinated|3|||
94326403|NCT01337167|322976222|FG000|Interim Period|Lost to Follow-up|51|||
94326404|NCT01337167|322976223|FG001|Interim Period|Lost to Follow-up|23|||
94326405|NCT01337167|322976222|FG000|Interim Period|Non-compliance with study drug|1|||
94326406|NCT01337167|322976223|FG001|Interim Period|Non-compliance with study drug|0|||
94326407|NCT01337167|322976222|FG000|Interim Period|Physician Decision|6|||
94326408|NCT01337167|322976223|FG001|Interim Period|Physician Decision|3|||
94326409|NCT01337167|322976222|FG000|Interim Period|Protocol Violation|5|||
94326410|NCT01337167|322976223|FG001|Interim Period|Protocol Violation|3|||
94326411|NCT01337167|322976222|FG000|Interim Period|Withdrawal by Subject|18|||
94326412|NCT01337167|322976223|FG001|Interim Period|Withdrawal by Subject|10|||
94326413|NCT01337167|322976222|FG000|Interim Period|Other protocol criterion not met|0|||
94326414|NCT01337167|322976223|FG001|Interim Period|Other protocol criterion not met|1|||
94326415|NCT01337167|322976222|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
94326416|NCT01337167|322976223|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
94326417|NCT01337167|322976222|FG000|Toddler Vaccinations|Protocol Violation|0|||
94326418|NCT01337167|322976223|FG001|Toddler Vaccinations|Protocol Violation|1|||
94326419|NCT01337167|322976222|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
94326420|NCT01337167|322976223|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
94326421|NCT03833817|322976224|FG000|Overall Study|Withdrawal by Subject|3|||
94326422|NCT03833817|322976225|FG001|Overall Study|Withdrawal by Subject|3|||
94326423|NCT03833817|322976224|FG000|Overall Study|Lost to Follow-up|3|||
94326424|NCT03833817|322976225|FG001|Overall Study|Lost to Follow-up|3|||
94326425|NCT00884221|322976232|FG000|Overall Study|Withdrawal by Subject|0|||
94326426|NCT00884221|322976233|FG001|Overall Study|Withdrawal by Subject|3|||
94326427|NCT00884221|322976232|FG000|Overall Study|Adverse Event|6|||
94326428|NCT00884221|322976233|FG001|Overall Study|Adverse Event|3|||
94326429|NCT00884221|322976232|FG000|Overall Study|Protocol Violation|16|||
94326430|NCT00884221|322976233|FG001|Overall Study|Protocol Violation|13|||
94326431|NCT00884221|322976232|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
94326432|NCT00884221|322976233|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
94326433|NCT02126670|322976236|FG000|Overall Study|Withdrawal by Subject|1|||
94326434|NCT02126670|322976237|FG001|Overall Study|Withdrawal by Subject|0|||
94326435|NCT02126670|322976238|FG002|Overall Study|Withdrawal by Subject|0|||
94326436|NCT02126670|322976239|FG003|Overall Study|Withdrawal by Subject|1|||
94326437|NCT03363919|322976242|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
94326438|NCT03363919|322976243|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
94326439|NCT03363919|322976242|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
94326440|NCT03363919|322976243|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
94326441|NCT03434418|322976248|FG000|Overall Study|Disease Progression|11|||
94326442|NCT03434418|322976248|FG000|Overall Study|Adverse Event|2|||
94326443|NCT03434418|322976248|FG000|Overall Study|Physician Decision|1|||
94326444|NCT03434418|322976248|FG000|Overall Study|Decline in Performance Status (PS)|1|||
94326445|NCT00213980|322976253|FG000|Overall Study|Withdrawal by Subject|3|||
94326446|NCT00213980|322976254|FG001|Overall Study|Withdrawal by Subject|1|||
94326447|NCT00213980|322976253|FG000|Overall Study|Adverse Event|1|||
94326448|NCT00213980|322976254|FG001|Overall Study|Adverse Event|1|||
94326449|NCT00213980|322976253|FG000|Overall Study|Disease progression|0|||
94326450|NCT00213980|322976254|FG001|Overall Study|Disease progression|2|||
94326451|NCT00213980|322976253|FG000|Overall Study|Developed ovarian cancer|1|||
94326452|NCT00213980|322976254|FG001|Overall Study|Developed ovarian cancer|0|||
94326453|NCT00213980|322976253|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
94326454|NCT00213980|322976254|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
94326455|NCT01840228|322976258|FG000|Overall Study|Lost to Follow-up|1|||
94326456|NCT01840228|322976259|FG001|Overall Study|Lost to Follow-up|1|||
94326457|NCT03495453|322976260|FG000|Overall Study|Withdrawal by Subject|0|||
94326458|NCT03495453|322976261|FG001|Overall Study|Withdrawal by Subject|1|||
94326459|NCT01103778|322976265|FG000|Overall Study|Lost to Follow-up|1|||
94326460|NCT01103778|322976265|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
94326461|NCT01103778|322976265|FG000|Overall Study|Screen failure|1|||
94326462|NCT00302718|322976266|FG000|Overall Study|Participant left the hospital|1|||
94326463|NCT00302718|322976267|FG001|Overall Study|Participant left the hospital|0|||
94326464|NCT00302718|322976268|FG002|Overall Study|Participant left the hospital|0|||
94326465|NCT00302718|322976269|FG003|Overall Study|Participant left the hospital|1|||
94326466|NCT00302718|322976266|FG000|Overall Study|Withdrawal by Subject|0|||
94326467|NCT00302718|322976267|FG001|Overall Study|Withdrawal by Subject|1|||
94326468|NCT00302718|322976268|FG002|Overall Study|Withdrawal by Subject|0|||
94326469|NCT00302718|322976269|FG003|Overall Study|Withdrawal by Subject|0|||
94326470|NCT00302718|322976266|FG000|Overall Study|Participant left primary care setting|0|||
94326471|NCT00302718|322976267|FG001|Overall Study|Participant left primary care setting|0|||
94326472|NCT00302718|322976268|FG002|Overall Study|Participant left primary care setting|2|||
94326473|NCT00302718|322976269|FG003|Overall Study|Participant left primary care setting|1|||
94326474|NCT00574496|322976270|FG000|Overall Study|Withdrawal by Subject|1|||
94326475|NCT00413062|322976271|FG000|Overall Study|Adverse event/serious adverse event|289|||
94326476|NCT00413062|322976272|FG001|Overall Study|Adverse event/serious adverse event|56|||
94326477|NCT00413062|322976271|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
94326478|NCT00413062|322976272|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
94326479|NCT00413062|322976271|FG000|Overall Study|Withdrawal of informed consent|111|||
94326480|NCT00413062|322976272|FG001|Overall Study|Withdrawal of informed consent|36|||
94326481|NCT00413062|322976271|FG000|Overall Study|Pregnancy|15|||
94326482|NCT00413062|322976272|FG001|Overall Study|Pregnancy|5|||
94326483|NCT00413062|322976271|FG000|Overall Study|Pregnancy wish|17|||
94326484|NCT00413062|322976272|FG001|Overall Study|Pregnancy wish|6|||
94326485|NCT00413062|322976271|FG000|Overall Study|Lost to Follow-up|175|||
94326486|NCT00413062|322976272|FG001|Overall Study|Lost to Follow-up|73|||
94326487|NCT00413062|322976271|FG000|Overall Study|Other reason|70|||
94326488|NCT00413062|322976272|FG001|Overall Study|Other reason|34|||
94326489|NCT02176291|322976273|FG000|Overall Study|Death|1|||
94326490|NCT02176291|322976274|FG001|Overall Study|Death|0|||
94326491|NCT02176291|322976273|FG000|Overall Study|non compliance with protocol|2|||
94326492|NCT02176291|322976274|FG001|Overall Study|non compliance with protocol|0|||
94326493|NCT02176291|322976273|FG000|Overall Study|Withdrawal by Subject|2|||
94326494|NCT02176291|322976274|FG001|Overall Study|Withdrawal by Subject|0|||
94326495|NCT00393913|322976278|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
94326496|NCT00393913|322976278|FG000|Initial Assessment|Withdrawal by Subject|16|||
94326497|NCT00393913|322976278|FG000|CPAP|Withdrawal by Subject|3|||
94326498|NCT00393913|322976278|FG000|CPAP|Physician Decision|1|||
94326499|NCT00393913|322976278|FG000|CPAP|TEchnical problem with CPAP|3|||
94326500|NCT01167582|322976279|FG000|Overall Study|Lost to Follow-up|0|||
94326501|NCT01167582|322976280|FG001|Overall Study|Lost to Follow-up|1|||
94326502|NCT01681576|322976281|FG000|Period 1|Adverse Event|1|||
94326503|NCT01681576|322976282|FG001|Period 1|Adverse Event|0|||
94326504|NCT01681576|322976281|FG000|Period 1|Protocol Deviation|1|||
94326505|NCT01681576|322976282|FG001|Period 1|Protocol Deviation|0|||
94326506|NCT01681576|322976281|FG000|Period 2|subject/guardian decision|3|||
94326507|NCT01681576|322976282|FG001|Period 2|subject/guardian decision|1|||
94326508|NCT01681576|322976281|FG000|Period 2|Non-compliance with study treatment|1|||
94326509|NCT01681576|322976282|FG001|Period 2|Non-compliance with study treatment|0|||
94326510|NCT00115765|322976285|FG000|Overall Study|Withdrawal by Subject|22|||
94326511|NCT00115765|322976286|FG001|Overall Study|Withdrawal by Subject|53|||
94326512|NCT00115765|322976287|FG002|Overall Study|Withdrawal by Subject|76|||
94326513|NCT00115765|322976288|FG003|Overall Study|Withdrawal by Subject|15|||
94326514|NCT00115765|322976285|FG000|Overall Study|Physician Decision|4|||
94326515|NCT00115765|322976286|FG001|Overall Study|Physician Decision|15|||
94326516|NCT00115765|322976287|FG002|Overall Study|Physician Decision|18|||
94326517|NCT00115765|322976288|FG003|Overall Study|Physician Decision|13|||
94326518|NCT00115765|322976285|FG000|Overall Study|Lost to Follow-up|3|||
94326519|NCT00115765|322976286|FG001|Overall Study|Lost to Follow-up|20|||
94326520|NCT00115765|322976287|FG002|Overall Study|Lost to Follow-up|18|||
94388866|NCT00437658|323212348|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
94388867|NCT00437658|323212349|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
94388868|NCT00437658|323212347|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
94388869|NCT00437658|323212348|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
94388870|NCT00437658|323212349|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
94388871|NCT00437658|323212347|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
94388872|NCT00437658|323212348|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
94388873|NCT00437658|323212349|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
94388874|NCT00437658|323212347|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
94388875|NCT00437658|323212348|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
94388876|NCT00437658|323212349|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
94388877|NCT00437658|323212347|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
94388878|NCT00437658|323212348|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
94388879|NCT00437658|323212349|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
94388880|NCT00437658|323212347|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
94388881|NCT00437658|323212348|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
94388882|NCT00437658|323212349|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
94388883|NCT00437658|323212347|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
94388884|NCT00437658|323212348|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
94388885|NCT00437658|323212349|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
94388886|NCT00437658|323212347|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
94388887|NCT00437658|323212348|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
94388888|NCT00437658|323212349|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
94388889|NCT00437658|323212347|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
94388890|NCT00437658|323212348|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
94388891|NCT00437658|323212349|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
94388892|NCT00437658|323212347|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
94388893|NCT00437658|323212348|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
94388894|NCT00437658|323212349|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
94388895|NCT02152566|323212350|FG000|Overall Study|Lost to Follow-up|1|||
94388896|NCT02152566|323212350|FG000|Overall Study|Withdrawal by Subject|2|||
94388897|NCT04091971|323212353|FG000|Overall Study|Withdrawal by Subject|1|||
94388898|NCT04091971|323212353|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
94388899|NCT04091971|323212353|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
94388900|NCT01391793|323212354|FG000|Overall Study|Ineligible|3|||
94388901|NCT01391793|323212355|FG001|Overall Study|Ineligible|0|||
94388902|NCT01391793|323212354|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
94388903|NCT01391793|323212355|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
94388904|NCT01391793|323212354|FG000|Overall Study|No DMSA|73|||
94388905|NCT01391793|323212355|FG001|Overall Study|No DMSA|57|||
94388906|NCT01449630|323212358|FG000|Period 1|Physician Decision|1|||
94326521|NCT00115765|322976288|FG003|Overall Study|Lost to Follow-up|1|||
94326522|NCT00115765|322976285|FG000|Overall Study|Other|6|||
94326523|NCT00115765|322976286|FG001|Overall Study|Other|12|||
94326524|NCT00115765|322976287|FG002|Overall Study|Other|9|||
94326525|NCT00115765|322976288|FG003|Overall Study|Other|2|||
94326526|NCT03543358|322976291|FG000|Overall Study|Death|1|||
94326527|NCT03543358|322976292|FG001|Overall Study|Death|0|||
94326528|NCT03543358|322976291|FG000|Overall Study|Disease Progression|1|||
94326529|NCT03543358|322976292|FG001|Overall Study|Disease Progression|0|||
94326530|NCT03543358|322976291|FG000|Overall Study|Parent Study Closure|1|||
94326531|NCT03543358|322976292|FG001|Overall Study|Parent Study Closure|0|||
94326532|NCT00178464|322976293|FG000|Overall Study|Withdrawal by Subject|1|||
94326533|NCT00178464|322976293|FG000|Overall Study|Physician Decision|1|||
94326534|NCT00870818|322976294|FG000|Overall Study|Lost to Follow-up|3|||
94326535|NCT00870818|322976295|FG001|Overall Study|Lost to Follow-up|2|||
94326536|NCT00870818|322976296|FG002|Overall Study|Lost to Follow-up|1|||
94326537|NCT00870818|322976297|FG003|Overall Study|Lost to Follow-up|0|||
94326538|NCT00870818|322976298|FG004|Overall Study|Lost to Follow-up|0|||
94326539|NCT00870818|322976294|FG000|Overall Study|Withdrawal by Subject|0|||
94388907|NCT01449630|323212359|FG001|Period 1|Physician Decision|0|||
94388908|NCT01449630|323212360|FG002|Period 1|Physician Decision|0|||
94388909|NCT01449630|323212361|FG003|Period 1|Physician Decision|1|||
94388910|NCT01449630|323212362|FG004|Period 1|Physician Decision|0|||
94388911|NCT01449630|323212363|FG005|Period 1|Physician Decision|0|||
94388912|NCT01449630|323212364|FG006|Period 1|Physician Decision|0|||
94388913|NCT01449630|323212365|FG007|Period 1|Physician Decision|0|||
94388914|NCT01449630|323212366|FG008|Period 1|Physician Decision|0|||
94388915|NCT01449630|323212358|FG000|Period 1|Sponsor Decision|0|||
94326540|NCT00870818|322976295|FG001|Overall Study|Withdrawal by Subject|0|||
94326541|NCT00870818|322976296|FG002|Overall Study|Withdrawal by Subject|1|||
94326542|NCT00870818|322976297|FG003|Overall Study|Withdrawal by Subject|2|||
94326543|NCT00870818|322976298|FG004|Overall Study|Withdrawal by Subject|0|||
94326544|NCT00870818|322976294|FG000|Overall Study|Terminated by sponsor|29|||
94388916|NCT01449630|323212359|FG001|Period 1|Sponsor Decision|0|||
94388917|NCT01449630|323212360|FG002|Period 1|Sponsor Decision|0|||
94388918|NCT01449630|323212361|FG003|Period 1|Sponsor Decision|0|||
94388919|NCT01449630|323212362|FG004|Period 1|Sponsor Decision|0|||
94388920|NCT01449630|323212363|FG005|Period 1|Sponsor Decision|1|||
94388921|NCT01449630|323212364|FG006|Period 1|Sponsor Decision|0|||
94388922|NCT01449630|323212365|FG007|Period 1|Sponsor Decision|0|||
94388923|NCT01449630|323212366|FG008|Period 1|Sponsor Decision|0|||
94388924|NCT01449630|323212358|FG000|Period 2|Sponsor Decision|0|||
94388925|NCT01449630|323212359|FG001|Period 2|Sponsor Decision|0|||
94388926|NCT01449630|323212360|FG002|Period 2|Sponsor Decision|0|||
94388927|NCT01449630|323212361|FG003|Period 2|Sponsor Decision|0|||
94388928|NCT01449630|323212362|FG004|Period 2|Sponsor Decision|0|||
94326545|NCT00870818|322976295|FG001|Overall Study|Terminated by sponsor|70|||
94326546|NCT00870818|322976296|FG002|Overall Study|Terminated by sponsor|36|||
94326547|NCT00870818|322976297|FG003|Overall Study|Terminated by sponsor|36|||
94388929|NCT01449630|323212363|FG005|Period 2|Sponsor Decision|0|||
94388930|NCT01449630|323212364|FG006|Period 2|Sponsor Decision|1|||
94388931|NCT01449630|323212365|FG007|Period 2|Sponsor Decision|0|||
94388932|NCT01449630|323212366|FG008|Period 2|Sponsor Decision|0|||
94388933|NCT02087904|323212369|FG000|Overall Study|Did Not Receive Study Drug|0|||
94388934|NCT02087904|323212370|FG001|Overall Study|Did Not Receive Study Drug|0|||
94326548|NCT00870818|322976298|FG004|Overall Study|Terminated by sponsor|38|||
94326549|NCT00870818|322976294|FG000|Overall Study|Other|0|||
94326550|NCT00870818|322976295|FG001|Overall Study|Other|1|||
94326551|NCT00870818|322976296|FG002|Overall Study|Other|0|||
94326552|NCT00870818|322976297|FG003|Overall Study|Other|0|||
94326553|NCT00870818|322976298|FG004|Overall Study|Other|0|||
94326554|NCT01766817|322976299|FG000|Overall Study|Drug-related adverse event|1|||
94326555|NCT01766817|322976300|FG001|Overall Study|Drug-related adverse event|2|||
94326556|NCT01766817|322976301|FG002|Overall Study|Drug-related adverse event|1|||
94326557|NCT01766817|322976299|FG000|Overall Study|Drug-unrelated adverse event|3|||
94326558|NCT01766817|322976300|FG001|Overall Study|Drug-unrelated adverse event|3|||
94326559|NCT01766817|322976301|FG002|Overall Study|Drug-unrelated adverse event|3|||
94326560|NCT01766817|322976299|FG000|Overall Study|Death|1|||
94326561|NCT01766817|322976300|FG001|Overall Study|Death|1|||
94326562|NCT01766817|322976301|FG002|Overall Study|Death|0|||
94326563|NCT01766817|322976299|FG000|Overall Study|Unable to take study drug|0|||
94326564|NCT01766817|322976300|FG001|Overall Study|Unable to take study drug|1|||
94326565|NCT01766817|322976301|FG002|Overall Study|Unable to take study drug|0|||
94326566|NCT01766817|322976299|FG000|Overall Study|Withdrawal by Subject|2|||
94326567|NCT01766817|322976300|FG001|Overall Study|Withdrawal by Subject|0|||
94326568|NCT01766817|322976301|FG002|Overall Study|Withdrawal by Subject|3|||
94326569|NCT01766817|322976299|FG000|Overall Study|Subject non-compliance|0|||
94326570|NCT01766817|322976300|FG001|Overall Study|Subject non-compliance|1|||
94326571|NCT01766817|322976301|FG002|Overall Study|Subject non-compliance|2|||
94326572|NCT01766817|322976299|FG000|Overall Study|Physician Decision|3|||
94326573|NCT01766817|322976300|FG001|Overall Study|Physician Decision|3|||
94326574|NCT01766817|322976301|FG002|Overall Study|Physician Decision|4|||
94326575|NCT01766817|322976299|FG000|Overall Study|Other|1|||
94326576|NCT01766817|322976300|FG001|Overall Study|Other|0|||
94326577|NCT01766817|322976301|FG002|Overall Study|Other|0|||
94326578|NCT04900038|322976302|FG000|Overall Study|Adverse Event|1|||
94326579|NCT04900038|322976303|FG001|Overall Study|Adverse Event|0|||
94326580|NCT04900038|322976304|FG002|Overall Study|Adverse Event|1|||
94326581|NCT04900038|322976305|FG003|Overall Study|Adverse Event|1|||
94326582|NCT04900038|322976302|FG000|Overall Study|Withdrawal by Subject|0|||
94388935|NCT02087904|323212371|FG002|Overall Study|Did Not Receive Study Drug|2|||
94388936|NCT02087904|323212372|FG003|Overall Study|Did Not Receive Study Drug|1|||
94388937|NCT02087904|323212369|FG000|Overall Study|Adverse Event|8|||
94388938|NCT02087904|323212370|FG001|Overall Study|Adverse Event|4|||
94388939|NCT02087904|323212371|FG002|Overall Study|Adverse Event|4|||
94388940|NCT02087904|323212372|FG003|Overall Study|Adverse Event|12|||
94388941|NCT02087904|323212369|FG000|Overall Study|Lack of Efficacy|3|||
94482490|NCT05067972|323558122|FG006|Part 1: Treatment|Physician Decision|0|||
94482491|NCT05067972|323558116|FG000|Part 1: Treatment|Death|0|||
94482492|NCT05067972|323558117|FG001|Part 1: Treatment|Death|0|||
94326583|NCT04900038|322976303|FG001|Overall Study|Withdrawal by Subject|1|||
94326584|NCT04900038|322976304|FG002|Overall Study|Withdrawal by Subject|0|||
94326585|NCT04900038|322976305|FG003|Overall Study|Withdrawal by Subject|0|||
94326586|NCT04900038|322976302|FG000|Overall Study|Study terminated by sponsor|18|||
94326587|NCT04900038|322976303|FG001|Overall Study|Study terminated by sponsor|15|||
94326588|NCT04900038|322976304|FG002|Overall Study|Study terminated by sponsor|17|||
94326589|NCT04900038|322976305|FG003|Overall Study|Study terminated by sponsor|14|||
94326590|NCT04900038|322976302|FG000|Overall Study|Protocol Deviation|1|||
94326591|NCT04900038|322976303|FG001|Overall Study|Protocol Deviation|1|||
94326592|NCT04900038|322976304|FG002|Overall Study|Protocol Deviation|0|||
94326593|NCT04900038|322976305|FG003|Overall Study|Protocol Deviation|0|||
94388942|NCT02087904|323212370|FG001|Overall Study|Lack of Efficacy|6|||
94388943|NCT02087904|323212371|FG002|Overall Study|Lack of Efficacy|3|||
94482493|NCT05067972|323558118|FG002|Part 1: Treatment|Death|0|||
94326594|NCT04900038|322976302|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
94326595|NCT04900038|322976303|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
94326596|NCT04900038|322976304|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
94326597|NCT04900038|322976305|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
94326598|NCT04900038|322976302|FG000|Overall Study|Lost to Follow-up|0|||
94326599|NCT04900038|322976303|FG001|Overall Study|Lost to Follow-up|0|||
94326600|NCT04900038|322976304|FG002|Overall Study|Lost to Follow-up|0|||
94326601|NCT04900038|322976305|FG003|Overall Study|Lost to Follow-up|1|||
94326602|NCT02227108|322976306|FG000|Overall Study|Did not receive treatment|2|||
94326603|NCT02227108|322976306|FG000|Overall Study|Other|3|||
94388944|NCT02087904|323212372|FG003|Overall Study|Lack of Efficacy|2|||
94388945|NCT02087904|323212369|FG000|Overall Study|Other|6|||
94388946|NCT02087904|323212370|FG001|Overall Study|Other|2|||
94388947|NCT02087904|323212371|FG002|Overall Study|Other|4|||
94388948|NCT02087904|323212372|FG003|Overall Study|Other|4|||
94388949|NCT02087904|323212369|FG000|Overall Study|Withdrawal by Subject|8|||
94388950|NCT02087904|323212370|FG001|Overall Study|Withdrawal by Subject|3|||
94388951|NCT02087904|323212371|FG002|Overall Study|Withdrawal by Subject|7|||
94388952|NCT02087904|323212372|FG003|Overall Study|Withdrawal by Subject|4|||
94388953|NCT02087904|323212369|FG000|Overall Study|Lost to Follow-up|0|||
94388954|NCT02087904|323212370|FG001|Overall Study|Lost to Follow-up|4|||
94388955|NCT02087904|323212371|FG002|Overall Study|Lost to Follow-up|2|||
94388956|NCT02087904|323212372|FG003|Overall Study|Lost to Follow-up|2|||
94388957|NCT01196052|323212373|FG000|Overall Study|Adverse Event|9|||
94388958|NCT01196052|323212373|FG000|Overall Study|Lost to Follow-up|1|||
94388959|NCT01196052|323212373|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
94388960|NCT01196052|323212373|FG000|Overall Study|Reason not Specified|5|||
94388961|NCT01196052|323212373|FG000|Overall Study|Withdrawal by Subject|6|||
94388962|NCT00893464|323212374|FG000|Overall Study|Did not complete therapy/experience PD|0|||
94388963|NCT00893464|323212375|FG001|Overall Study|Did not complete therapy/experience PD|0|||
94388964|NCT00893464|323212376|FG002|Overall Study|Did not complete therapy/experience PD|0|||
94388965|NCT00893464|323212377|FG003|Overall Study|Did not complete therapy/experience PD|0|||
94388966|NCT00893464|323212378|FG004|Overall Study|Did not complete therapy/experience PD|0|||
94388967|NCT00893464|323212379|FG005|Overall Study|Did not complete therapy/experience PD|0|||
94388968|NCT00893464|323212380|FG006|Overall Study|Did not complete therapy/experience PD|2|||
94388969|NCT00893464|323212381|FG007|Overall Study|Did not complete therapy/experience PD|2|||
94388970|NCT01389102|323212382|FG000|Overall Study|Adverse Event|1|||
94388971|NCT01389102|323212383|FG001|Overall Study|Adverse Event|3|||
94388972|NCT01389102|323212384|FG002|Overall Study|Adverse Event|2|||
94388973|NCT01389102|323212385|FG003|Overall Study|Adverse Event|2|||
94388974|NCT01389102|323212386|FG004|Overall Study|Adverse Event|2|||
94388975|NCT01389102|323212387|FG005|Overall Study|Adverse Event|2|||
94388976|NCT01389102|323212382|FG000|Overall Study|Hurricane Katrina|4|||
94388977|NCT01389102|323212383|FG001|Overall Study|Hurricane Katrina|2|||
94388978|NCT01389102|323212384|FG002|Overall Study|Hurricane Katrina|3|||
94388979|NCT01389102|323212385|FG003|Overall Study|Hurricane Katrina|0|||
94388980|NCT01389102|323212386|FG004|Overall Study|Hurricane Katrina|3|||
94388981|NCT01389102|323212387|FG005|Overall Study|Hurricane Katrina|1|||
94388982|NCT01389102|323212382|FG000|Overall Study|Lost to Follow-up|4|||
94388983|NCT01389102|323212383|FG001|Overall Study|Lost to Follow-up|1|||
94388984|NCT01389102|323212384|FG002|Overall Study|Lost to Follow-up|1|||
94388985|NCT01389102|323212385|FG003|Overall Study|Lost to Follow-up|2|||
94388986|NCT01389102|323212386|FG004|Overall Study|Lost to Follow-up|4|||
94388987|NCT01389102|323212387|FG005|Overall Study|Lost to Follow-up|1|||
94388988|NCT01389102|323212382|FG000|Overall Study|Protocol Violation|0|||
94388989|NCT01389102|323212383|FG001|Overall Study|Protocol Violation|0|||
94388990|NCT01389102|323212384|FG002|Overall Study|Protocol Violation|3|||
94388991|NCT01389102|323212385|FG003|Overall Study|Protocol Violation|0|||
94388992|NCT01389102|323212386|FG004|Overall Study|Protocol Violation|1|||
94388993|NCT01389102|323212387|FG005|Overall Study|Protocol Violation|1|||
94388994|NCT01389102|323212382|FG000|Overall Study|Withdrawal by Subject|7|||
94388995|NCT01389102|323212383|FG001|Overall Study|Withdrawal by Subject|4|||
94388996|NCT01389102|323212384|FG002|Overall Study|Withdrawal by Subject|9|||
94326604|NCT02227108|322976306|FG000|Overall Study|Progressive disease|17|||
94326605|NCT02227108|322976306|FG000|Overall Study|Initiation of alternative therapy|2|||
94388997|NCT01389102|323212385|FG003|Overall Study|Withdrawal by Subject|2|||
94388998|NCT01389102|323212386|FG004|Overall Study|Withdrawal by Subject|3|||
94388999|NCT01389102|323212387|FG005|Overall Study|Withdrawal by Subject|3|||
94389000|NCT01389102|323212382|FG000|Overall Study|Subject Traveling Out of Country|0|||
94389001|NCT01389102|323212383|FG001|Overall Study|Subject Traveling Out of Country|0|||
94389002|NCT01389102|323212384|FG002|Overall Study|Subject Traveling Out of Country|0|||
94389003|NCT01389102|323212385|FG003|Overall Study|Subject Traveling Out of Country|1|||
94389004|NCT01389102|323212386|FG004|Overall Study|Subject Traveling Out of Country|0|||
94389005|NCT01389102|323212387|FG005|Overall Study|Subject Traveling Out of Country|0|||
94389006|NCT01389102|323212382|FG000|Overall Study|Subject Moved|2|||
94389007|NCT01389102|323212383|FG001|Overall Study|Subject Moved|0|||
94482494|NCT05067972|323558119|FG003|Part 1: Treatment|Death|2|||
94482495|NCT05067972|323558120|FG004|Part 1: Treatment|Death|0|||
94482496|NCT05067972|323558121|FG005|Part 1: Treatment|Death|0|||
94482497|NCT05067972|323558122|FG006|Part 1: Treatment|Death|0|||
94482498|NCT05067972|323558116|FG000|Part 1: Treatment|Adverse Event|0|||
94482499|NCT05067972|323558117|FG001|Part 1: Treatment|Adverse Event|0|||
94482500|NCT05067972|323558118|FG002|Part 1: Treatment|Adverse Event|0|||
94482501|NCT05067972|323558119|FG003|Part 1: Treatment|Adverse Event|0|||
94482502|NCT05067972|323558120|FG004|Part 1: Treatment|Adverse Event|0|||
94482503|NCT05067972|323558121|FG005|Part 1: Treatment|Adverse Event|2|||
94482504|NCT05067972|323558122|FG006|Part 1: Treatment|Adverse Event|1|||
94482505|NCT05067972|323558116|FG000|Part 1: Follow-up|Adverse Event|0|||
94482506|NCT05067972|323558117|FG001|Part 1: Follow-up|Adverse Event|0|||
94482507|NCT05067972|323558118|FG002|Part 1: Follow-up|Adverse Event|0|||
94482508|NCT05067972|323558119|FG003|Part 1: Follow-up|Adverse Event|0|||
94482509|NCT05067972|323558120|FG004|Part 1: Follow-up|Adverse Event|0|||
94482510|NCT05067972|323558121|FG005|Part 1: Follow-up|Adverse Event|1|||
94482511|NCT05067972|323558122|FG006|Part 1: Follow-up|Adverse Event|0|||
94389008|NCT01389102|323212384|FG002|Overall Study|Subject Moved|1|||
94389009|NCT01389102|323212385|FG003|Overall Study|Subject Moved|0|||
94389010|NCT01389102|323212386|FG004|Overall Study|Subject Moved|0|||
94389011|NCT01389102|323212387|FG005|Overall Study|Subject Moved|0|||
94389012|NCT01389102|323212382|FG000|Overall Study|Unavailable due to husband's illness|0|||
94389013|NCT01389102|323212383|FG001|Overall Study|Unavailable due to husband's illness|1|||
94389014|NCT01389102|323212384|FG002|Overall Study|Unavailable due to husband's illness|0|||
94389015|NCT01389102|323212385|FG003|Overall Study|Unavailable due to husband's illness|0|||
94389016|NCT01389102|323212386|FG004|Overall Study|Unavailable due to husband's illness|0|||
94389017|NCT01389102|323212387|FG005|Overall Study|Unavailable due to husband's illness|0|||
94389018|NCT01389102|323212382|FG000|Overall Study|Investigator Judgement|0|||
94389019|NCT01389102|323212383|FG001|Overall Study|Investigator Judgement|1|||
94389020|NCT01389102|323212384|FG002|Overall Study|Investigator Judgement|0|||
94389021|NCT01389102|323212385|FG003|Overall Study|Investigator Judgement|0|||
94482512|NCT05067972|323558116|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
94482513|NCT05067972|323558117|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
94482514|NCT05067972|323558118|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
94482515|NCT05067972|323558119|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
94482516|NCT05067972|323558120|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
94482517|NCT05067972|323558121|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
94482518|NCT05067972|323558122|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
94482519|NCT05067972|323558116|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
94482520|NCT05067972|323558117|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
94482521|NCT05067972|323558118|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
94482522|NCT05067972|323558119|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
94482523|NCT05067972|323558120|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
94482524|NCT05067972|323558121|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
94389022|NCT01389102|323212386|FG004|Overall Study|Investigator Judgement|0|||
94389023|NCT01389102|323212387|FG005|Overall Study|Investigator Judgement|0|||
94389024|NCT00050778|323212388|FG000|Overall Study|Adverse Event|13|||
94389025|NCT00050778|323212389|FG001|Overall Study|Adverse Event|3|||
94389026|NCT00050778|323212390|FG002|Overall Study|Adverse Event|2|||
94389027|NCT00050778|323212388|FG000|Overall Study|Death|0|||
94389028|NCT00050778|323212389|FG001|Overall Study|Death|1|||
94389029|NCT00050778|323212390|FG002|Overall Study|Death|1|||
94389030|NCT00050778|323212388|FG000|Overall Study|Lack of Efficacy|16|||
94389031|NCT00050778|323212389|FG001|Overall Study|Lack of Efficacy|2|||
94389032|NCT00050778|323212390|FG002|Overall Study|Lack of Efficacy|2|||
94389033|NCT00050778|323212388|FG000|Overall Study|Lost to Follow-up|0|||
94389034|NCT00050778|323212389|FG001|Overall Study|Lost to Follow-up|2|||
94389035|NCT00050778|323212390|FG002|Overall Study|Lost to Follow-up|4|||
94389036|NCT00050778|323212388|FG000|Overall Study|Physician Decision|3|||
94389037|NCT00050778|323212389|FG001|Overall Study|Physician Decision|0|||
94389038|NCT00050778|323212390|FG002|Overall Study|Physician Decision|2|||
94389039|NCT00050778|323212388|FG000|Overall Study|Protocol Violation|2|||
94389040|NCT00050778|323212389|FG001|Overall Study|Protocol Violation|0|||
94389041|NCT00050778|323212390|FG002|Overall Study|Protocol Violation|1|||
94389042|NCT00050778|323212388|FG000|Overall Study|Withdrawal by Subject|6|||
94389043|NCT00050778|323212389|FG001|Overall Study|Withdrawal by Subject|8|||
94389044|NCT00050778|323212390|FG002|Overall Study|Withdrawal by Subject|4|||
94482525|NCT05067972|323558122|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
94389045|NCT00050778|323212388|FG000|Overall Study|Randomized but not treated|4|||
94389046|NCT00050778|323212389|FG001|Overall Study|Randomized but not treated|5|||
94482526|NCT05067972|323558116|FG000|Part 1: Follow-up|Physician Decision|0|||
94482527|NCT05067972|323558117|FG001|Part 1: Follow-up|Physician Decision|0|||
94482528|NCT05067972|323558118|FG002|Part 1: Follow-up|Physician Decision|0|||
94482529|NCT05067972|323558119|FG003|Part 1: Follow-up|Physician Decision|1|||
94482530|NCT05067972|323558120|FG004|Part 1: Follow-up|Physician Decision|0|||
94482531|NCT05067972|323558121|FG005|Part 1: Follow-up|Physician Decision|0|||
94326606|NCT02227108|322976306|FG000|Overall Study|Investigator discretion|1|||
94326607|NCT02227108|322976306|FG000|Overall Study|Adverse Event|6|||
94326608|NCT00995670|322976307|FG000|Overall Study|Failed arterial cannulation|1|||
94326609|NCT00995670|322976308|FG001|Overall Study|Failed arterial cannulation|0|||
94326610|NCT00995670|322976309|FG002|Overall Study|Failed arterial cannulation|3|||
94326611|NCT02486952|322976310|FG000|Overall Study|Not Started Induction Therapy|3|||
94326612|NCT02486952|322976310|FG000|Overall Study|Adverse Event|1|||
94326613|NCT02486952|322976310|FG000|Overall Study|Death|15|||
94326614|NCT02486952|322976310|FG000|Overall Study|Lack of Efficacy|3|||
94326615|NCT02486952|322976310|FG000|Overall Study|Lost to Follow-up|26|||
94326616|NCT02486952|322976310|FG000|Overall Study|Other|2|||
94326617|NCT04111107|322976311|FG000|Overall Study|Withdrawal by Subject|6|||
94326618|NCT04111107|322976311|FG000|Overall Study|Declining Health|5|||
94326619|NCT00383721|322976312|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
94326620|NCT00383721|322976313|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
94326621|NCT00383721|322976314|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
94326622|NCT00383721|322976315|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
94326623|NCT00383721|322976316|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
94326624|NCT00383721|322976312|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
94326625|NCT00383721|322976313|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
94326626|NCT00383721|322976314|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
94326627|NCT00383721|322976315|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
94326628|NCT00383721|322976316|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
94326629|NCT00383721|322976312|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
94326630|NCT00383721|322976313|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
94326631|NCT00383721|322976314|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
94326632|NCT00383721|322976315|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
94326633|NCT00383721|322976316|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
94326634|NCT00383721|322976312|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
94326635|NCT00383721|322976313|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
94326636|NCT00383721|322976314|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
94326637|NCT00383721|322976315|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
94326638|NCT00383721|322976316|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
94326639|NCT00383721|322976312|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
94326640|NCT00383721|322976313|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
94326641|NCT00383721|322976314|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
94326642|NCT00383721|322976315|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
94326643|NCT00383721|322976316|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
94326644|NCT00383721|322976312|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
94326645|NCT00383721|322976313|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
94326646|NCT00383721|322976314|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
94326647|NCT00383721|322976315|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
94326648|NCT00383721|322976316|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
94326649|NCT00383721|322976312|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
94326650|NCT00383721|322976313|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
94326651|NCT00383721|322976314|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
94326652|NCT00383721|322976315|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
94326653|NCT00383721|322976316|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
94326654|NCT00383721|322976312|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
94326655|NCT00383721|322976313|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
94326656|NCT00383721|322976314|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
94326657|NCT00383721|322976315|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
94326658|NCT00383721|322976316|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
94326659|NCT00383721|322976312|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
94326660|NCT00383721|322976313|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
94326661|NCT00383721|322976314|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
94326662|NCT00383721|322976315|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
94326663|NCT00383721|322976316|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
94326664|NCT00383721|322976312|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
94389047|NCT00050778|323212390|FG002|Overall Study|Randomized but not treated|2|||
94389048|NCT00050778|323212388|FG000|Overall Study|Familial and personal reasons|1|||
94389049|NCT00050778|323212389|FG001|Overall Study|Familial and personal reasons|0|||
94326665|NCT00383721|322976313|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
94326666|NCT00383721|322976314|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
94326667|NCT00383721|322976315|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
94389050|NCT00050778|323212390|FG002|Overall Study|Familial and personal reasons|0|||
94482532|NCT05067972|323558122|FG006|Part 1: Follow-up|Physician Decision|0|||
94482533|NCT05067972|323558116|FG000|Part 1: Follow-up|Death|1|||
94482534|NCT05067972|323558117|FG001|Part 1: Follow-up|Death|2|||
94482535|NCT05067972|323558118|FG002|Part 1: Follow-up|Death|1|||
94482536|NCT05067972|323558119|FG003|Part 1: Follow-up|Death|0|||
94482537|NCT05067972|323558120|FG004|Part 1: Follow-up|Death|1|||
94482538|NCT05067972|323558121|FG005|Part 1: Follow-up|Death|0|||
94326668|NCT00383721|322976316|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
94326669|NCT00383721|322976312|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
94326670|NCT00383721|322976313|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
94326671|NCT00383721|322976314|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
94326672|NCT00383721|322976315|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
94326673|NCT00383721|322976316|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
94326674|NCT00383721|322976312|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
94326675|NCT00383721|322976313|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
94326676|NCT00383721|322976314|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
94326677|NCT00383721|322976315|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
94326678|NCT00383721|322976316|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
94326679|NCT00383721|322976312|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
94326680|NCT00383721|322976313|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
94326681|NCT00383721|322976314|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
94326682|NCT00383721|322976315|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
94326683|NCT00383721|322976316|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
94326684|NCT00383721|322976312|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
94326685|NCT00383721|322976313|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
94326686|NCT00383721|322976314|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
94326687|NCT00383721|322976315|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
94326688|NCT00383721|322976316|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
94326689|NCT00383721|322976312|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
94326690|NCT00383721|322976313|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
94326691|NCT00383721|322976314|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
94326692|NCT00383721|322976315|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
94326693|NCT00383721|322976316|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
94326694|NCT00383721|322976312|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
94326695|NCT00383721|322976313|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
94326696|NCT00383721|322976314|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
94326697|NCT00383721|322976315|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
94326698|NCT00383721|322976316|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
94326699|NCT00383721|322976312|FG000|26-Week Treatment Safety Extension|Administrative|1|||
94326700|NCT00383721|322976313|FG001|26-Week Treatment Safety Extension|Administrative|2|||
94326701|NCT00383721|322976314|FG002|26-Week Treatment Safety Extension|Administrative|3|||
94326702|NCT00383721|322976315|FG003|26-Week Treatment Safety Extension|Administrative|1|||
94326703|NCT00383721|322976316|FG004|26-Week Treatment Safety Extension|Administrative|0|||
94326704|NCT04093258|322976317|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
94326705|NCT04093258|322976318|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
94326706|NCT00594204|322976319|FG000|Overall Study|Adverse Event|15|||
94326707|NCT00594204|322976320|FG001|Overall Study|Adverse Event|3|||
94326708|NCT00594204|322976319|FG000|Overall Study|Lost to Follow-up|9|||
94326709|NCT00594204|322976320|FG001|Overall Study|Lost to Follow-up|5|||
94326710|NCT00594204|322976319|FG000|Overall Study|Withdrawal by Subject|23|||
94326711|NCT00594204|322976320|FG001|Overall Study|Withdrawal by Subject|29|||
94326712|NCT00594204|322976319|FG000|Overall Study|Other|4|||
94326713|NCT00594204|322976320|FG001|Overall Study|Other|3|||
94326714|NCT00594204|322976319|FG000|Overall Study|Lack of Efficacy|3|||
94326715|NCT00594204|322976320|FG001|Overall Study|Lack of Efficacy|4|||
94326716|NCT00594204|322976319|FG000|Overall Study|Randomized but not treated|4|||
94326717|NCT00594204|322976320|FG001|Overall Study|Randomized but not treated|1|||
94326718|NCT00567541|322976322|FG000|Overall Study|Adverse Event|0|||
94326719|NCT00567541|322976323|FG001|Overall Study|Adverse Event|1|||
94326720|NCT01890512|322976324|FG000|Overall Study|Physician Decision|1|||
94326721|NCT01890512|322976324|FG000|Overall Study|Withdrawal by Subject|1|||
94326722|NCT01890512|322976324|FG000|Overall Study|Protocol Violation|1|||
94326723|NCT00946881|322976325|FG000|First Treatment|Withdrawal by Subject|1|||
94326724|NCT00946881|322976325|FG000|First Treatment|Patient relocated to another state|1|||
94326725|NCT00946881|322976325|FG000|Retreatment|Withdrawal by Subject|1|||
94326726|NCT00293423|322976326|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
94482539|NCT05067972|323558122|FG006|Part 1: Follow-up|Death|1|||
94482540|NCT04391842|323558123|FG000|Overall Study|Withdrawal by Subject|2|||
94482541|NCT01691378|323558127|FG000|Overall Study|Withdrawal by Subject|2|||
94482542|NCT01691378|323558128|FG001|Overall Study|Withdrawal by Subject|0|||
94389051|NCT02910037|323212391|FG000|Overall Study|Withdrawal by Subject|4|||
94389052|NCT02910037|323212391|FG000|Overall Study|Lost to Follow-up|6|||
94389053|NCT00436553|323212392|FG000|Overall Study|Adverse Event|4|||
94389054|NCT00436553|323212393|FG001|Overall Study|Adverse Event|3|||
94389055|NCT00436553|323212394|FG002|Overall Study|Adverse Event|4|||
94389056|NCT00436553|323212392|FG000|Overall Study|Death|3|||
94389057|NCT00436553|323212393|FG001|Overall Study|Death|1|||
94389058|NCT00436553|323212394|FG002|Overall Study|Death|3|||
94389059|NCT00436553|323212392|FG000|Overall Study|Lost to Follow-up|0|||
94389060|NCT00436553|323212393|FG001|Overall Study|Lost to Follow-up|2|||
94389061|NCT00436553|323212394|FG002|Overall Study|Lost to Follow-up|0|||
94389062|NCT00436553|323212392|FG000|Overall Study|Protocol Violation|1|||
94389063|NCT00436553|323212393|FG001|Overall Study|Protocol Violation|0|||
94389064|NCT00436553|323212394|FG002|Overall Study|Protocol Violation|0|||
94389065|NCT00436553|323212392|FG000|Overall Study|Withdrawal by Subject|5|||
94389066|NCT00436553|323212393|FG001|Overall Study|Withdrawal by Subject|6|||
94389067|NCT00436553|323212394|FG002|Overall Study|Withdrawal by Subject|3|||
94389068|NCT00625443|323212399|FG000|Overall Study|Adverse Event|1|||
94389069|NCT00625443|323212400|FG001|Overall Study|Adverse Event|4|||
94389070|NCT00625443|323212401|FG002|Overall Study|Adverse Event|0|||
94389071|NCT00625443|323212399|FG000|Overall Study|Non-compliance with protocol|0|||
94389072|NCT00625443|323212400|FG001|Overall Study|Non-compliance with protocol|1|||
94389073|NCT00625443|323212401|FG002|Overall Study|Non-compliance with protocol|0|||
94389074|NCT00625443|323212399|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
94389075|NCT00625443|323212400|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
94389076|NCT00625443|323212401|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
94326727|NCT00293423|322976327|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
94326728|NCT00293423|322976326|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
94326729|NCT00293423|322976327|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
94326730|NCT00293423|322976326|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
94326731|NCT00293423|322976327|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
94326732|NCT00293423|322976326|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
94389077|NCT00625443|323212399|FG000|Overall Study|Withdrawal by Subject|0|||
94389078|NCT00625443|323212400|FG001|Overall Study|Withdrawal by Subject|1|||
94389079|NCT00625443|323212401|FG002|Overall Study|Withdrawal by Subject|2|||
94389080|NCT00625443|323212399|FG000|Overall Study|Physician Decision|0|||
94389081|NCT00625443|323212400|FG001|Overall Study|Physician Decision|4|||
94389082|NCT00625443|323212401|FG002|Overall Study|Physician Decision|2|||
94389083|NCT00625443|323212399|FG000|Overall Study|Other|0|||
94389084|NCT00625443|323212400|FG001|Overall Study|Other|1|||
94389085|NCT00625443|323212401|FG002|Overall Study|Other|1|||
94389086|NCT00450190|323212404|FG000|Overall Study|Withdrawal by Subject|2|||
94482543|NCT01691378|323558127|FG000|Overall Study|Lost to Follow-up|5|||
94326733|NCT00293423|322976327|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
94326734|NCT00293423|322976326|FG000|Surgical Resection|processing error during surgical resection|1|||
94326735|NCT00293423|322976327|FG001|Surgical Resection|processing error during surgical resection|0|||
94326736|NCT00293423|322976326|FG000|Surgical Resection|Withdrawal by Subject|4|||
94326737|NCT00293423|322976327|FG001|Surgical Resection|Withdrawal by Subject|0|||
94326738|NCT00293423|322976326|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
94326739|NCT00293423|322976327|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
94326740|NCT01935336|322976328|FG000|Overall Study|Adverse Event|1|||
94482544|NCT01691378|323558128|FG001|Overall Study|Lost to Follow-up|2|||
94482545|NCT02573259|323558133|FG000|Overall Study|Death|1|||
94482546|NCT02573259|323558134|FG001|Overall Study|Death|6|||
94326741|NCT01935336|322976329|FG001|Overall Study|Adverse Event|0|||
94326742|NCT01935336|322976330|FG002|Overall Study|Adverse Event|0|||
94326743|NCT01935336|322976331|FG003|Overall Study|Adverse Event|0|||
94326744|NCT01935336|322976328|FG000|Overall Study|Progressive disease|5|||
94326745|NCT01935336|322976329|FG001|Overall Study|Progressive disease|3|||
94326746|NCT01935336|322976330|FG002|Overall Study|Progressive disease|47|||
94326747|NCT01935336|322976331|FG003|Overall Study|Progressive disease|66|||
94326748|NCT01529385|322976332|FG000|Overall Study|Lost to Follow-up|2|||
94326749|NCT01529385|322976333|FG001|Overall Study|Lost to Follow-up|1|||
94389087|NCT01185821|323212405|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94389088|NCT01185821|323212406|FG001|Overall Study|Abnormal laboratory value(s)|2|||
94389089|NCT01185821|323212407|FG002|Overall Study|Abnormal laboratory value(s)|1|||
94482547|NCT02573259|323558135|FG002|Overall Study|Death|5|||
94482548|NCT02573259|323558136|FG003|Overall Study|Death|6|||
94389090|NCT01185821|323212408|FG003|Overall Study|Abnormal laboratory value(s)|0|||
94326750|NCT00507416|322976336|FG000|Overall Study|Adverse Event|58|||
94326751|NCT00507416|322976337|FG001|Overall Study|Adverse Event|67|||
94326752|NCT00507416|322976338|FG002|Overall Study|Adverse Event|65|||
94389091|NCT01185821|323212409|FG004|Overall Study|Abnormal laboratory value(s)|0|||
94389092|NCT01185821|323212405|FG000|Overall Study|Protocol Violation|0|||
94389093|NCT01185821|323212406|FG001|Overall Study|Protocol Violation|0|||
94482549|NCT02573259|323558137|FG004|Overall Study|Death|9|||
94389094|NCT01185821|323212407|FG002|Overall Study|Protocol Violation|0|||
94389095|NCT01185821|323212408|FG003|Overall Study|Protocol Violation|1|||
94389096|NCT01185821|323212409|FG004|Overall Study|Protocol Violation|1|||
94389097|NCT01185821|323212405|FG000|Overall Study|Abnormal test procedure result|0|||
94389098|NCT01185821|323212406|FG001|Overall Study|Abnormal test procedure result|0|||
94389099|NCT01185821|323212407|FG002|Overall Study|Abnormal test procedure result|0|||
94389100|NCT01185821|323212408|FG003|Overall Study|Abnormal test procedure result|0|||
94389101|NCT01185821|323212409|FG004|Overall Study|Abnormal test procedure result|1|||
94389102|NCT01185821|323212405|FG000|Overall Study|Death|0|||
94389103|NCT01185821|323212406|FG001|Overall Study|Death|1|||
94389104|NCT01185821|323212407|FG002|Overall Study|Death|0|||
94389105|NCT01185821|323212408|FG003|Overall Study|Death|0|||
94389106|NCT01185821|323212409|FG004|Overall Study|Death|0|||
94389107|NCT01185821|323212405|FG000|Overall Study|Condition no longer required study drug|0|||
94389108|NCT01185821|323212406|FG001|Overall Study|Condition no longer required study drug|0|||
94389109|NCT01185821|323212407|FG002|Overall Study|Condition no longer required study drug|0|||
94389110|NCT01185821|323212408|FG003|Overall Study|Condition no longer required study drug|0|||
94389111|NCT01185821|323212409|FG004|Overall Study|Condition no longer required study drug|1|||
94389112|NCT01185821|323212405|FG000|Overall Study|Adverse Event|2|||
94389113|NCT01185821|323212406|FG001|Overall Study|Adverse Event|3|||
94389114|NCT01185821|323212407|FG002|Overall Study|Adverse Event|1|||
94389115|NCT01185821|323212408|FG003|Overall Study|Adverse Event|2|||
94389116|NCT01185821|323212409|FG004|Overall Study|Adverse Event|5|||
94389117|NCT01185821|323212405|FG000|Overall Study|Lack of Efficacy|0|||
94389118|NCT01185821|323212406|FG001|Overall Study|Lack of Efficacy|0|||
94389119|NCT01185821|323212407|FG002|Overall Study|Lack of Efficacy|3|||
94389120|NCT01185821|323212408|FG003|Overall Study|Lack of Efficacy|0|||
94389121|NCT01185821|323212409|FG004|Overall Study|Lack of Efficacy|9|||
94389122|NCT01185821|323212405|FG000|Overall Study|Withdrawal by Subject|3|||
94389123|NCT01185821|323212406|FG001|Overall Study|Withdrawal by Subject|2|||
94389124|NCT01185821|323212407|FG002|Overall Study|Withdrawal by Subject|2|||
94389125|NCT01185821|323212408|FG003|Overall Study|Withdrawal by Subject|1|||
94389126|NCT01185821|323212409|FG004|Overall Study|Withdrawal by Subject|3|||
94389127|NCT01185821|323212405|FG000|Overall Study|Lost to Follow-up|1|||
94389128|NCT01185821|323212406|FG001|Overall Study|Lost to Follow-up|1|||
94389129|NCT01185821|323212407|FG002|Overall Study|Lost to Follow-up|2|||
94389130|NCT01185821|323212408|FG003|Overall Study|Lost to Follow-up|1|||
94389131|NCT01185821|323212409|FG004|Overall Study|Lost to Follow-up|2|||
94389132|NCT01185821|323212405|FG000|Overall Study|Administrative problems|0|||
94389133|NCT01185821|323212406|FG001|Overall Study|Administrative problems|0|||
94389134|NCT01185821|323212407|FG002|Overall Study|Administrative problems|1|||
94389135|NCT01185821|323212408|FG003|Overall Study|Administrative problems|1|||
94389136|NCT01185821|323212409|FG004|Overall Study|Administrative problems|2|||
94482550|NCT02573259|323558138|FG005|Overall Study|Death|32|||
94482551|NCT02573259|323558139|FG006|Overall Study|Death|21|||
94482552|NCT02573259|323558133|FG000|Overall Study|Lost to Follow-up|0|||
94482553|NCT02573259|323558134|FG001|Overall Study|Lost to Follow-up|0|||
94482554|NCT02573259|323558135|FG002|Overall Study|Lost to Follow-up|0|||
94326753|NCT00507416|322976336|FG000|Overall Study|Protocol Violation|1|||
94326754|NCT00507416|322976337|FG001|Overall Study|Protocol Violation|2|||
94326755|NCT00507416|322976338|FG002|Overall Study|Protocol Violation|0|||
94326756|NCT00507416|322976336|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
94326757|NCT00507416|322976337|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
94326758|NCT00507416|322976338|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
94326759|NCT00507416|322976336|FG000|Overall Study|Progressive Disease|20|||
94326760|NCT00507416|322976337|FG001|Overall Study|Progressive Disease|10|||
94326761|NCT00507416|322976338|FG002|Overall Study|Progressive Disease|13|||
94326762|NCT00507416|322976336|FG000|Overall Study|Patient declined further treatment|18|||
94326763|NCT00507416|322976337|FG001|Overall Study|Patient declined further treatment|14|||
94326764|NCT00507416|322976338|FG002|Overall Study|Patient declined further treatment|11|||
94326765|NCT00507416|322976336|FG000|Overall Study|Other|11|||
94326766|NCT00507416|322976337|FG001|Overall Study|Other|16|||
94326767|NCT00507416|322976338|FG002|Overall Study|Other|13|||
94326768|NCT00507416|322976336|FG000|Overall Study|Did not Receive Study Treatment|3|||
94326769|NCT00507416|322976337|FG001|Overall Study|Did not Receive Study Treatment|9|||
94326770|NCT00507416|322976338|FG002|Overall Study|Did not Receive Study Treatment|4|||
94389137|NCT03929393|323212412|FG000|Overall Study|Death|1|||
94389138|NCT03929393|323212413|FG001|Overall Study|Death|0|||
94389139|NCT03929393|323212412|FG000|Overall Study|Time Commitment|2|||
94389140|NCT03929393|323212413|FG001|Overall Study|Time Commitment|5|||
94389141|NCT03929393|323212412|FG000|Overall Study|Motor Vehicle Accident|0|||
94389142|NCT03929393|323212413|FG001|Overall Study|Motor Vehicle Accident|1|||
94389143|NCT03929393|323212412|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
94326771|NCT02157506|322976341|FG000|Overall Study|Adverse Event|0|||
94326772|NCT02157506|322976342|FG001|Overall Study|Adverse Event|1|||
94389144|NCT03929393|323212413|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
94482555|NCT02573259|323558136|FG003|Overall Study|Lost to Follow-up|0|||
94326773|NCT02157506|322976343|FG002|Overall Study|Adverse Event|0|||
94326774|NCT02157506|322976344|FG003|Overall Study|Adverse Event|0|||
94326775|NCT02157506|322976345|FG004|Overall Study|Adverse Event|0|||
94326776|NCT02157506|322976341|FG000|Overall Study|Lost to Follow-up|0|||
94326777|NCT02157506|322976342|FG001|Overall Study|Lost to Follow-up|0|||
94326778|NCT02157506|322976343|FG002|Overall Study|Lost to Follow-up|1|||
94326779|NCT02157506|322976344|FG003|Overall Study|Lost to Follow-up|0|||
94326780|NCT02157506|322976345|FG004|Overall Study|Lost to Follow-up|0|||
94326781|NCT03101514|322976347|FG000|Overall Study|Withdrawal by Subject|4|||
94326782|NCT03101514|322976347|FG000|Overall Study|Protocol Violation|2|||
94326783|NCT03101514|322976347|FG000|Overall Study|patient's information was incomplete|1|||
94326784|NCT01740388|322976350|FG000|Overall Study|Withdrawal by Subject|1|||
94326785|NCT01740388|322976351|FG001|Overall Study|Withdrawal by Subject|2|||
94326786|NCT01740388|322976350|FG000|Overall Study|Lost to Follow-up|2|||
94326787|NCT01740388|322976351|FG001|Overall Study|Lost to Follow-up|0|||
94326788|NCT01740388|322976350|FG000|Overall Study|Physician Decision|2|||
94326789|NCT01740388|322976351|FG001|Overall Study|Physician Decision|6|||
94326790|NCT01740388|322976350|FG000|Overall Study|Subjects missing data, completed|41|||
94326791|NCT01740388|322976351|FG001|Overall Study|Subjects missing data, completed|36|||
94326792|NCT01244191|322976352|FG000|Overall Study|Progressive disease|295|||
94326793|NCT01244191|322976353|FG001|Overall Study|Progressive disease|350|||
94326794|NCT01244191|322976352|FG000|Overall Study|Clinical disease progression|54|||
94326795|NCT01244191|322976353|FG001|Overall Study|Clinical disease progression|36|||
94326796|NCT01244191|322976352|FG000|Overall Study|Adverse Event|65|||
94326797|NCT01244191|322976353|FG001|Overall Study|Adverse Event|48|||
94326798|NCT01244191|322976352|FG000|Overall Study|Death|22|||
94326799|NCT01244191|322976353|FG001|Overall Study|Death|29|||
94326800|NCT01244191|322976352|FG000|Overall Study|Lost to Follow-up|0|||
94326801|NCT01244191|322976353|FG001|Overall Study|Lost to Follow-up|2|||
94326802|NCT01244191|322976352|FG000|Overall Study|Protocol Violation|1|||
94326803|NCT01244191|322976353|FG001|Overall Study|Protocol Violation|2|||
94326804|NCT01244191|322976352|FG000|Overall Study|Withdrawal by Subject|31|||
94326805|NCT01244191|322976353|FG001|Overall Study|Withdrawal by Subject|23|||
94326806|NCT01244191|322976352|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
94326807|NCT01244191|322976353|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
94326808|NCT04142216|322976354|FG000|Overall Study|Hospitalization|0|||
94326809|NCT04142216|322976355|FG001|Overall Study|Hospitalization|2|||
94326810|NCT04142216|322976354|FG000|Overall Study|Death|3|||
94326811|NCT04142216|322976355|FG001|Overall Study|Death|1|||
94326812|NCT04142216|322976354|FG000|Overall Study|Referral to another hemodialysis unit|3|||
94326813|NCT04142216|322976355|FG001|Overall Study|Referral to another hemodialysis unit|2|||
94326814|NCT04142216|322976354|FG000|Overall Study|Use of clove|0|||
94326815|NCT04142216|322976355|FG001|Overall Study|Use of clove|1|||
94326816|NCT00475540|322976359|FG000|36 Months|Lost to Follow-up|4|||
94326817|NCT00475540|322976360|FG001|36 Months|Lost to Follow-up|4|||
94326818|NCT00475540|322976359|FG000|36 Months|Death|1|||
94326819|NCT00475540|322976360|FG001|36 Months|Death|2|||
94326820|NCT00475540|322976359|FG000|36 Months|Censored due to reoperation|3|||
94326821|NCT00475540|322976360|FG001|36 Months|Censored due to reoperation|0|||
94326822|NCT00424346|322978208|FG000|Core Study|Adverse Event|5|||
94326823|NCT00424346|322978209|FG001|Core Study|Adverse Event|3|||
94326824|NCT00424346|322978210|FG002|Core Study|Adverse Event|1|||
94326825|NCT00424346|322978211|FG003|Core Study|Adverse Event|1|||
94326826|NCT00424346|322978208|FG000|Core Study|Abnormal Laboratory Values|0|||
94326827|NCT00424346|322978209|FG001|Core Study|Abnormal Laboratory Values|1|||
94326828|NCT00424346|322978210|FG002|Core Study|Abnormal Laboratory Values|0|||
94326829|NCT00424346|322978211|FG003|Core Study|Abnormal Laboratory Values|0|||
94326830|NCT00424346|322978208|FG000|Core Study|Lack of Efficacy|1|||
94326831|NCT00424346|322978209|FG001|Core Study|Lack of Efficacy|3|||
94326832|NCT00424346|322978210|FG002|Core Study|Lack of Efficacy|0|||
94326833|NCT00424346|322978211|FG003|Core Study|Lack of Efficacy|4|||
94326834|NCT00424346|322978208|FG000|Core Study|Withdrawal by Subject|1|||
94326835|NCT00424346|322978209|FG001|Core Study|Withdrawal by Subject|0|||
94326836|NCT00424346|322978210|FG002|Core Study|Withdrawal by Subject|0|||
94326837|NCT00424346|322978211|FG003|Core Study|Withdrawal by Subject|2|||
94326838|NCT00424346|322978208|FG000|Core Study|Lost to Follow-up|1|||
94326839|NCT00424346|322978209|FG001|Core Study|Lost to Follow-up|1|||
94326840|NCT00424346|322978210|FG002|Core Study|Lost to Follow-up|0|||
94326841|NCT00424346|322978211|FG003|Core Study|Lost to Follow-up|0|||
94326842|NCT00424346|322978208|FG000|Core Study|Administrative Problems|1|||
94326843|NCT00424346|322978209|FG001|Core Study|Administrative Problems|0|||
94326844|NCT00424346|322978210|FG002|Core Study|Administrative Problems|1|||
94326845|NCT00424346|322978211|FG003|Core Study|Administrative Problems|0|||
94326846|NCT00424346|322978208|FG000|Core Study|Protocol Violation|0|||
94326847|NCT00424346|322978209|FG001|Core Study|Protocol Violation|0|||
94326848|NCT00424346|322978210|FG002|Core Study|Protocol Violation|2|||
94326849|NCT00424346|322978211|FG003|Core Study|Protocol Violation|0|||
94326850|NCT00424346|322978208|FG000|Extension Phase|Adverse Event|0|||
94326851|NCT00424346|322978209|FG001|Extension Phase|Adverse Event|9|||
94326852|NCT00424346|322978210|FG002|Extension Phase|Adverse Event|5|||
94326853|NCT00424346|322978211|FG003|Extension Phase|Adverse Event|4|||
94326854|NCT00424346|322978208|FG000|Extension Phase|Lack of Efficacy|0|||
94326855|NCT00424346|322978209|FG001|Extension Phase|Lack of Efficacy|16|||
94326856|NCT00424346|322978210|FG002|Extension Phase|Lack of Efficacy|14|||
94326857|NCT00424346|322978211|FG003|Extension Phase|Lack of Efficacy|11|||
94326858|NCT00424346|322978208|FG000|Extension Phase|Withdrawal by Subject|0|||
94326859|NCT00424346|322978209|FG001|Extension Phase|Withdrawal by Subject|5|||
94326860|NCT00424346|322978210|FG002|Extension Phase|Withdrawal by Subject|3|||
94326861|NCT00424346|322978211|FG003|Extension Phase|Withdrawal by Subject|4|||
94326862|NCT00424346|322978208|FG000|Extension Phase|Lost to Follow-up|0|||
94326863|NCT00424346|322978209|FG001|Extension Phase|Lost to Follow-up|2|||
94326864|NCT00424346|322978210|FG002|Extension Phase|Lost to Follow-up|0|||
94326865|NCT00424346|322978211|FG003|Extension Phase|Lost to Follow-up|0|||
94326866|NCT00424346|322978208|FG000|Extension Phase|Administrative Problems|0|||
94326867|NCT00424346|322978209|FG001|Extension Phase|Administrative Problems|69|||
94326868|NCT00424346|322978210|FG002|Extension Phase|Administrative Problems|32|||
94326869|NCT00424346|322978211|FG003|Extension Phase|Administrative Problems|35|||
94326870|NCT00424346|322978208|FG000|Extension Phase|Death|0|||
94326871|NCT00424346|322978209|FG001|Extension Phase|Death|0|||
94326872|NCT00424346|322978210|FG002|Extension Phase|Death|0|||
94326873|NCT00424346|322978211|FG003|Extension Phase|Death|1|||
94326874|NCT00424346|322978208|FG000|Extension Phase|Protocol Violation|0|||
94326875|NCT00424346|322978209|FG001|Extension Phase|Protocol Violation|1|||
94326876|NCT00424346|322978210|FG002|Extension Phase|Protocol Violation|1|||
94326877|NCT00424346|322978211|FG003|Extension Phase|Protocol Violation|0|||
94326878|NCT02310906|322978217|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
94326879|NCT02310906|322978218|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
94326880|NCT02310906|322978219|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
94326881|NCT02310906|322978220|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
94326882|NCT02310906|322978217|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
94326883|NCT02310906|322978218|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
94326884|NCT02310906|322978219|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
94326885|NCT02310906|322978220|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
94326886|NCT02310906|322978217|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
94326887|NCT02310906|322978218|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
94326888|NCT02310906|322978219|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
94326889|NCT02310906|322978220|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
94326890|NCT02310906|322978217|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
94326891|NCT02310906|322978218|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
94326892|NCT02310906|322978219|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
94326893|NCT02310906|322978220|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
94326894|NCT03654755|322978224|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
94326895|NCT03654755|322978225|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
94326896|NCT03654755|322978226|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
94326897|NCT03654755|322978224|FG000|Overall Study|Withdrawal by Subject|2|||
94326898|NCT03654755|322978225|FG001|Overall Study|Withdrawal by Subject|4|||
94326899|NCT03654755|322978226|FG002|Overall Study|Withdrawal by Subject|8|||
94326900|NCT03654755|322978224|FG000|Overall Study|Lost to Follow-up|1|||
94326901|NCT03654755|322978225|FG001|Overall Study|Lost to Follow-up|3|||
94326902|NCT03654755|322978226|FG002|Overall Study|Lost to Follow-up|7|||
94326903|NCT03654755|322978224|FG000|Overall Study|Physician Decision|0|||
94326904|NCT03654755|322978225|FG001|Overall Study|Physician Decision|1|||
94326905|NCT03654755|322978226|FG002|Overall Study|Physician Decision|0|||
94326906|NCT03654755|322978224|FG000|Overall Study|Adverse Event|0|||
94326907|NCT03654755|322978225|FG001|Overall Study|Adverse Event|0|||
94326908|NCT03654755|322978226|FG002|Overall Study|Adverse Event|4|||
94326909|NCT03654755|322978224|FG000|Overall Study|Lack of Efficacy|0|||
94326910|NCT03654755|322978225|FG001|Overall Study|Lack of Efficacy|0|||
94326911|NCT03654755|322978226|FG002|Overall Study|Lack of Efficacy|1|||
94326912|NCT01879319|322978231|FG000|Overall Study|Withdrawal by Subject|1|||
94326913|NCT01879319|322978232|FG001|Overall Study|Withdrawal by Subject|0|||
94326914|NCT01879319|322978231|FG000|Overall Study|Lost to Follow-up|1|||
94326915|NCT01879319|322978232|FG001|Overall Study|Lost to Follow-up|5|||
94326916|NCT04724733|322978233|FG000|Overall Study|Lost to Follow-up|1|||
94326917|NCT04724733|322978234|FG001|Overall Study|Lost to Follow-up|1|||
94326918|NCT04724733|322978235|FG002|Overall Study|Lost to Follow-up|1|||
94389145|NCT03929393|323212412|FG000|Overall Study|Other|1|||
94326919|NCT03067129|322978236|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
94326920|NCT03067129|322978237|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
94326921|NCT03067129|322978238|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
94326922|NCT03067129|322978239|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
94389146|NCT03929393|323212413|FG001|Overall Study|Other|3|||
94389147|NCT02612337|323212416|FG000|Overall Study|Lack of Efficacy|1|||
94389148|NCT02612337|323212417|FG001|Overall Study|Lack of Efficacy|0|||
94389149|NCT02612337|323212416|FG000|Overall Study|Withdrawal by Subject|2|||
94389150|NCT02612337|323212417|FG001|Overall Study|Withdrawal by Subject|2|||
94389151|NCT02612337|323212416|FG000|Overall Study|Did not receive study drug|0|||
94389152|NCT02612337|323212417|FG001|Overall Study|Did not receive study drug|1|||
94389153|NCT02089997|323212418|FG000|Overall Study|Case report forms uncollected|99|||
94389154|NCT02089997|323212418|FG000|Overall Study|Protocol Violation|147|||
94389155|NCT02441309|323212419|FG000|Overall Study|Disease progression|2|||
94389156|NCT02441309|323212420|FG001|Overall Study|Disease progression|1|||
94389157|NCT02441309|323212421|FG002|Overall Study|Disease progression|2|||
94389158|NCT02441309|323212419|FG000|Overall Study|Adverse Event|0|||
94389159|NCT02441309|323212420|FG001|Overall Study|Adverse Event|1|||
94389160|NCT02441309|323212421|FG002|Overall Study|Adverse Event|0|||
94389161|NCT02441309|323212419|FG000|Overall Study|Withdrawal by Subject|1|||
94389162|NCT02441309|323212420|FG001|Overall Study|Withdrawal by Subject|0|||
94389163|NCT02441309|323212421|FG002|Overall Study|Withdrawal by Subject|1|||
94389164|NCT00854100|323212422|FG000|Overall Study|Inability to complete the study visits|0|||
94389165|NCT00854100|323212423|FG001|Overall Study|Inability to complete the study visits|0|||
94389166|NCT00854100|323212424|FG002|Overall Study|Inability to complete the study visits|1|||
94389167|NCT00854100|323212422|FG000|Overall Study|Lost to Follow-up|2|||
94389168|NCT00854100|323212423|FG001|Overall Study|Lost to Follow-up|0|||
94389169|NCT00854100|323212424|FG002|Overall Study|Lost to Follow-up|3|||
94389170|NCT00854100|323212422|FG000|Overall Study|Withdrawal by Subject|3|||
94389171|NCT00854100|323212423|FG001|Overall Study|Withdrawal by Subject|1|||
94389172|NCT00854100|323212424|FG002|Overall Study|Withdrawal by Subject|2|||
94389173|NCT00854100|323212422|FG000|Overall Study|Protocol Violation|2|||
94389174|NCT00854100|323212423|FG001|Overall Study|Protocol Violation|4|||
94389175|NCT00854100|323212424|FG002|Overall Study|Protocol Violation|3|||
94389176|NCT00854100|323212422|FG000|Overall Study|Adverse Event|2|||
94389177|NCT00854100|323212423|FG001|Overall Study|Adverse Event|1|||
94389178|NCT00854100|323212424|FG002|Overall Study|Adverse Event|2|||
94389179|NCT02374853|323212428|FG000|Overall Study|Surgery Cancelled|5|||
94389180|NCT02374853|323212429|FG001|Overall Study|Surgery Cancelled|11|||
94389181|NCT05341622|323212434|FG000|Overall Study|Death|0|||
94389182|NCT05341622|323212435|FG001|Overall Study|Death|0|||
94389183|NCT05341622|323212436|FG002|Overall Study|Death|0|||
94389184|NCT05341622|323212437|FG003|Overall Study|Death|0|||
94389185|NCT05341622|323212438|FG004|Overall Study|Death|1|||
94389186|NCT05341622|323212439|FG005|Overall Study|Death|0|||
94389187|NCT05341622|323212440|FG006|Overall Study|Death|0|||
94389188|NCT05341622|323212441|FG007|Overall Study|Death|1|||
94389189|NCT05341622|323212434|FG000|Overall Study|Invalid Address|0|||
94389190|NCT05341622|323212435|FG001|Overall Study|Invalid Address|1|||
94389191|NCT05341622|323212436|FG002|Overall Study|Invalid Address|0|||
94389192|NCT05341622|323212437|FG003|Overall Study|Invalid Address|0|||
94389193|NCT05341622|323212438|FG004|Overall Study|Invalid Address|0|||
94389194|NCT05341622|323212439|FG005|Overall Study|Invalid Address|0|||
94389195|NCT05341622|323212440|FG006|Overall Study|Invalid Address|0|||
94389196|NCT05341622|323212441|FG007|Overall Study|Invalid Address|0|||
94389197|NCT05341622|323212434|FG000|Overall Study|Ineligible|26|||
94389198|NCT05341622|323212435|FG001|Overall Study|Ineligible|21|||
94389199|NCT05341622|323212436|FG002|Overall Study|Ineligible|28|||
94389200|NCT05341622|323212437|FG003|Overall Study|Ineligible|24|||
94389201|NCT05341622|323212438|FG004|Overall Study|Ineligible|29|||
94389202|NCT05341622|323212439|FG005|Overall Study|Ineligible|31|||
94389203|NCT05341622|323212440|FG006|Overall Study|Ineligible|28|||
94389204|NCT05341622|323212441|FG007|Overall Study|Ineligible|26|||
94389205|NCT02658084|323212442|FG000|Overall Study|Withdrawal by Subject|1|||
94389206|NCT02658084|323212443|FG001|Overall Study|Withdrawal by Subject|0|||
94389207|NCT02658084|323212442|FG000|Overall Study|Study Termination|1|||
94389208|NCT02658084|323212443|FG001|Overall Study|Study Termination|0|||
94389209|NCT04753437|323212444|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
94389210|NCT04753437|323212445|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
94389211|NCT04753437|323212444|FG000|Overall Study|Liver Function Test Abnormalities|2|||
94389212|NCT04753437|323212445|FG001|Overall Study|Liver Function Test Abnormalities|4|||
94389213|NCT02066922|323212448|FG000|Overall Study|Adverse Event|1|||
94389214|NCT03567174|323212450|FG000|Overall Study|Death|24|||
94389215|NCT03567174|323212451|FG001|Overall Study|Death|31|||
94389216|NCT03567174|323212450|FG000|Overall Study|Lost to Follow-up|165|||
94389217|NCT03567174|323212451|FG001|Overall Study|Lost to Follow-up|174|||
94389218|NCT02131129|323212453|FG000|Overall Study|Withdrawal by Subject|1|||
94389219|NCT02131129|323212454|FG001|Overall Study|Withdrawal by Subject|0|||
94389220|NCT03707912|323212455|FG000|Overall Study|Violation of inclusion criteria|1|||
94389221|NCT03707912|323212456|FG001|Overall Study|Violation of inclusion criteria|0|||
94389222|NCT00727961|323212457|FG000|Overall Study|Lost to Follow-up|1|||
94389223|NCT00727961|323212457|FG000|Overall Study|Adverse Event|4|||
94389224|NCT00727961|323212457|FG000|Overall Study|Patient's refusal|2|||
94389225|NCT00727961|323212457|FG000|Overall Study|Progression|30|||
94326923|NCT03067129|322978236|FG000|Overall Study|Withdrawal by Subject|0|||
94326924|NCT03067129|322978237|FG001|Overall Study|Withdrawal by Subject|0|||
94326925|NCT03067129|322978238|FG002|Overall Study|Withdrawal by Subject|1|||
94326926|NCT03067129|322978239|FG003|Overall Study|Withdrawal by Subject|2|||
94326927|NCT03067129|322978236|FG000|Overall Study|Lost to Follow-up|5|||
94326928|NCT03067129|322978237|FG001|Overall Study|Lost to Follow-up|5|||
94326929|NCT03067129|322978238|FG002|Overall Study|Lost to Follow-up|4|||
94326930|NCT03067129|322978239|FG003|Overall Study|Lost to Follow-up|3|||
94326931|NCT03084718|322978240|FG000|Overall Study|Withdrawal by Subject|4|||
94326932|NCT03084718|322978241|FG001|Overall Study|Withdrawal by Subject|3|||
94326933|NCT03084718|322978242|FG002|Overall Study|Withdrawal by Subject|4|||
94326934|NCT03084718|322978243|FG003|Overall Study|Withdrawal by Subject|0|||
94326935|NCT03084718|322978244|FG004|Overall Study|Withdrawal by Subject|0|||
94326936|NCT03084718|322978240|FG000|Overall Study|Physician Decision|1|||
94326937|NCT03084718|322978241|FG001|Overall Study|Physician Decision|0|||
94326938|NCT03084718|322978242|FG002|Overall Study|Physician Decision|0|||
94326939|NCT03084718|322978243|FG003|Overall Study|Physician Decision|0|||
94326940|NCT03084718|322978244|FG004|Overall Study|Physician Decision|0|||
94326941|NCT03084718|322978240|FG000|Overall Study|Adverse Event|3|||
94326942|NCT03084718|322978241|FG001|Overall Study|Adverse Event|5|||
94326943|NCT03084718|322978242|FG002|Overall Study|Adverse Event|5|||
94326944|NCT03084718|322978243|FG003|Overall Study|Adverse Event|8|||
94326945|NCT03084718|322978244|FG004|Overall Study|Adverse Event|2|||
94326946|NCT03084718|322978240|FG000|Overall Study|Lack of Efficacy|2|||
94326947|NCT03084718|322978241|FG001|Overall Study|Lack of Efficacy|0|||
94326948|NCT03084718|322978242|FG002|Overall Study|Lack of Efficacy|1|||
94326949|NCT03084718|322978243|FG003|Overall Study|Lack of Efficacy|4|||
94326950|NCT03084718|322978244|FG004|Overall Study|Lack of Efficacy|0|||
94326951|NCT03084718|322978240|FG000|Overall Study|Lost to Follow-up|0|||
94326952|NCT03084718|322978241|FG001|Overall Study|Lost to Follow-up|1|||
94326953|NCT03084718|322978242|FG002|Overall Study|Lost to Follow-up|0|||
94326954|NCT03084718|322978243|FG003|Overall Study|Lost to Follow-up|0|||
94326955|NCT03084718|322978244|FG004|Overall Study|Lost to Follow-up|2|||
94326956|NCT03084718|322978240|FG000|Overall Study|Protocol Violation|0|||
94326957|NCT03084718|322978241|FG001|Overall Study|Protocol Violation|0|||
94326958|NCT03084718|322978242|FG002|Overall Study|Protocol Violation|1|||
94326959|NCT03084718|322978243|FG003|Overall Study|Protocol Violation|0|||
94326960|NCT03084718|322978244|FG004|Overall Study|Protocol Violation|0|||
94326961|NCT03084718|322978240|FG000|Overall Study|Death|0|||
94326962|NCT03084718|322978241|FG001|Overall Study|Death|1|||
94326963|NCT03084718|322978242|FG002|Overall Study|Death|0|||
94326964|NCT03084718|322978243|FG003|Overall Study|Death|0|||
94326965|NCT03084718|322978244|FG004|Overall Study|Death|0|||
94326966|NCT03084718|322978240|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
94326967|NCT03084718|322978241|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
94326968|NCT03084718|322978242|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
94326969|NCT03084718|322978243|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
94326970|NCT03084718|322978244|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
94326971|NCT03986190|322978245|FG000|Overall Study|Withdrawal by Subject|12|||
94326972|NCT03986190|322978246|FG001|Overall Study|Withdrawal by Subject|0|||
94326973|NCT04929613|322978247|FG000|Overall Study|Withdrawal by Subject|12|||
94326974|NCT01742078|322978248|FG000|Overall Study|Withdrawal by Subject|0|||
94326975|NCT01742078|322978249|FG001|Overall Study|Withdrawal by Subject|0|||
94326976|NCT01742078|322978250|FG002|Overall Study|Withdrawal by Subject|0|||
94326977|NCT01742078|322978251|FG003|Overall Study|Withdrawal by Subject|1|||
94326978|NCT01742078|322978252|FG004|Overall Study|Withdrawal by Subject|0|||
94326979|NCT01742078|322978253|FG005|Overall Study|Withdrawal by Subject|0|||
94326980|NCT01742078|322978254|FG006|Overall Study|Withdrawal by Subject|0|||
94326981|NCT01742078|322978255|FG007|Overall Study|Withdrawal by Subject|0|||
94326982|NCT01742078|322978256|FG008|Overall Study|Withdrawal by Subject|0|||
94326983|NCT03247413|322978262|FG000|Overall Study|Lost to Follow-up|28|||
94326984|NCT00091026|322978273|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
94326985|NCT00091026|322978274|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
94326986|NCT00091026|322978273|FG000|Overall Study|Patient withdrew and never received trea|0|||
94326987|NCT00091026|322978274|FG001|Overall Study|Patient withdrew and never received trea|2|||
94326988|NCT00091026|322978273|FG000|Overall Study|Unknown-never received treatment|0|||
94326989|NCT00091026|322978274|FG001|Overall Study|Unknown-never received treatment|1|||
94326990|NCT00565058|322978277|FG000|Overall Study|Adverse Event|1|||
94326991|NCT00565058|322978278|FG001|Overall Study|Adverse Event|0|||
94326992|NCT03176277|322978279|FG000|Part A Dose Escalation Study|Adverse Event|1|||
94326993|NCT03176277|322978280|FG001|Part A Dose Escalation Study|Adverse Event|0|||
94326994|NCT03176277|322978281|FG002|Part A Dose Escalation Study|Adverse Event|1|||
94326995|NCT03176277|322978282|FG003|Part A Dose Escalation Study|Adverse Event|0|||
94326996|NCT03176277|322978279|FG000|Part A Dose Escalation Study|Physician Decision|1|||
94326997|NCT03176277|322978280|FG001|Part A Dose Escalation Study|Physician Decision|1|||
94389226|NCT02865122|323212458|FG000|Overall Study|Adverse Event|1|||
94389227|NCT02865122|323212459|FG001|Overall Study|Adverse Event|0|||
94389228|NCT02865122|323212460|FG002|Overall Study|Adverse Event|0|||
94389229|NCT00837486|323212463|FG000|Blinded-treatment Phase|Physician Decision|1|||
94389230|NCT00837486|323212464|FG001|Blinded-treatment Phase|Physician Decision|0|||
94389231|NCT00837486|323212463|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
94389232|NCT00837486|323212464|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
94389233|NCT00837486|323212463|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
94389234|NCT00837486|323212464|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
94389235|NCT00837486|323212463|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
94389236|NCT00837486|323212464|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
94389237|NCT03601637|323214324|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
94389238|NCT03601637|323214325|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
94389239|NCT03601637|323214324|FG000|Overall Study|Adverse Event|1|||
94389240|NCT03601637|323214325|FG001|Overall Study|Adverse Event|1|||
94389241|NCT03601637|323214324|FG000|Overall Study|Other|0|||
94389242|NCT03601637|323214325|FG001|Overall Study|Other|1|||
94389243|NCT01387737|323214326|FG000|Overall Study|Adverse Event|20|||
94389244|NCT01387737|323214327|FG001|Overall Study|Adverse Event|30|||
94389245|NCT01387737|323214326|FG000|Overall Study|Lack of Efficacy|1|||
94389246|NCT01387737|323214327|FG001|Overall Study|Lack of Efficacy|0|||
94389247|NCT01387737|323214326|FG000|Overall Study|Physician Decision|3|||
94389248|NCT01387737|323214327|FG001|Overall Study|Physician Decision|10|||
94389249|NCT01387737|323214326|FG000|Overall Study|Withdrawal by Subject|27|||
94389250|NCT01387737|323214327|FG001|Overall Study|Withdrawal by Subject|31|||
94389251|NCT01387737|323214326|FG000|Overall Study|Clearly not eligible for the study|1|||
94389252|NCT01387737|323214327|FG001|Overall Study|Clearly not eligible for the study|3|||
94389253|NCT04349917|323214337|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
94389254|NCT04349917|323214338|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
94389255|NCT04349917|323214337|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
94389256|NCT04349917|323214338|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
94389257|NCT00705536|323214339|FG000|Start Period 1|Withdrawal by Subject|0|||
94389258|NCT00705536|323214340|FG001|Start Period 1|Withdrawal by Subject|0|||
94389259|NCT00705536|323214341|FG002|Start Period 1|Withdrawal by Subject|0|||
94389260|NCT00705536|323214342|FG003|Start Period 1|Withdrawal by Subject|1|||
94389261|NCT04188106|323214343|FG000|Overall Study|Lost to Follow-up|5|||
94389262|NCT04188106|323214343|FG000|Overall Study|Non-Compliance|1|||
94389263|NCT00441467|323214347|FG000|Overall Study|Adverse Event|6|||
94389264|NCT00441467|323214347|FG000|Overall Study|Withdrawal by Subject|3|||
94389265|NCT00441467|323214347|FG000|Overall Study|Progressive disease|9|||
94389266|NCT02289963|323214348|FG000|Overall Study|Adverse Event|1|||
94389267|NCT02289963|323214349|FG001|Overall Study|Adverse Event|2|||
94389268|NCT02289963|323214348|FG000|Overall Study|Poor compliance to protocol|1|||
94389269|NCT02289963|323214349|FG001|Overall Study|Poor compliance to protocol|0|||
94389270|NCT02289963|323214348|FG000|Overall Study|Withdrawal by Subject|1|||
94389271|NCT02289963|323214349|FG001|Overall Study|Withdrawal by Subject|0|||
94389272|NCT02289963|323214348|FG000|Overall Study|Last injection missed|2|||
94389273|NCT02289963|323214349|FG001|Overall Study|Last injection missed|2|||
94389274|NCT02289963|323214348|FG000|Overall Study|End treatment visit outside visit window|0|||
94389275|NCT02289963|323214349|FG001|Overall Study|End treatment visit outside visit window|4|||
94389276|NCT02289963|323214348|FG000|Overall Study|Other than specified above|0|||
94389277|NCT02289963|323214349|FG001|Overall Study|Other than specified above|2|||
94389278|NCT01042522|323214352|FG000|Overall Study|Adverse Event|1|||
94389279|NCT01042522|323214353|FG001|Overall Study|Adverse Event|2|||
94389280|NCT01042522|323214352|FG000|Overall Study|Disease Progression|5|||
94389281|NCT01042522|323214353|FG001|Overall Study|Disease Progression|0|||
94389282|NCT01042522|323214352|FG000|Overall Study|Death|1|||
94389283|NCT01042522|323214353|FG001|Overall Study|Death|0|||
94389284|NCT01042522|323214352|FG000|Overall Study|Patient Refused|0|||
94389285|NCT01042522|323214353|FG001|Overall Study|Patient Refused|3|||
94389286|NCT01042522|323214352|FG000|Overall Study|Withdrawal by Subject|1|||
94389287|NCT01042522|323214353|FG001|Overall Study|Withdrawal by Subject|1|||
94389288|NCT00549718|323214354|FG000|Overall Study|Insufficient clinical response|20|||
94389289|NCT00549718|323214355|FG001|Overall Study|Insufficient clinical response|7|||
94389290|NCT00549718|323214356|FG002|Overall Study|Insufficient clinical response|18|||
94389291|NCT00549718|323214357|FG003|Overall Study|Insufficient clinical response|32|||
94389292|NCT00549718|323214354|FG000|Overall Study|Adverse Event|6|||
94389293|NCT00549718|323214355|FG001|Overall Study|Adverse Event|8|||
94389294|NCT00549718|323214356|FG002|Overall Study|Adverse Event|7|||
94389295|NCT00549718|323214357|FG003|Overall Study|Adverse Event|3|||
94389296|NCT00549718|323214354|FG000|Overall Study|Lost to Follow-up|4|||
94389297|NCT00549718|323214355|FG001|Overall Study|Lost to Follow-up|2|||
94389298|NCT00549718|323214356|FG002|Overall Study|Lost to Follow-up|0|||
94389299|NCT00549718|323214357|FG003|Overall Study|Lost to Follow-up|6|||
94389300|NCT00549718|323214354|FG000|Overall Study|Withdrawal by Subject|9|||
94389301|NCT00549718|323214355|FG001|Overall Study|Withdrawal by Subject|18|||
94389302|NCT00549718|323214356|FG002|Overall Study|Withdrawal by Subject|12|||
94389303|NCT00549718|323214357|FG003|Overall Study|Withdrawal by Subject|13|||
94389304|NCT00549718|323214354|FG000|Overall Study|Administrative|2|||
94389305|NCT00549718|323214355|FG001|Overall Study|Administrative|2|||
94389306|NCT00549718|323214356|FG002|Overall Study|Administrative|2|||
94389307|NCT00549718|323214357|FG003|Overall Study|Administrative|1|||
94389308|NCT01746017|323214358|FG000|Period 1|Withdrawal by Subject|0|||
94389309|NCT01746017|323214359|FG001|Period 1|Withdrawal by Subject|0|||
94389310|NCT01746017|323214360|FG002|Period 1|Withdrawal by Subject|0|||
94389311|NCT01746017|323214361|FG003|Period 1|Withdrawal by Subject|0|||
94389312|NCT01746017|323214362|FG004|Period 1|Withdrawal by Subject|0|||
94389313|NCT01746017|323214363|FG005|Period 1|Withdrawal by Subject|0|||
94389314|NCT01746017|323214364|FG006|Period 1|Withdrawal by Subject|1|||
94389315|NCT01746017|323214365|FG007|Period 1|Withdrawal by Subject|0|||
94389316|NCT01746017|323214366|FG008|Period 1|Withdrawal by Subject|0|||
94389317|NCT01746017|323214367|FG009|Period 1|Withdrawal by Subject|0|||
94389318|NCT01746017|323214368|FG010|Period 1|Withdrawal by Subject|0|||
94389319|NCT01746017|323214358|FG000|Period 3|Withdrawal by Subject|0|||
94389320|NCT01746017|323214359|FG001|Period 3|Withdrawal by Subject|0|||
94389321|NCT01746017|323214360|FG002|Period 3|Withdrawal by Subject|0|||
94389322|NCT01746017|323214361|FG003|Period 3|Withdrawal by Subject|0|||
94389323|NCT01746017|323214362|FG004|Period 3|Withdrawal by Subject|0|||
94389324|NCT01746017|323214363|FG005|Period 3|Withdrawal by Subject|1|||
94389325|NCT01746017|323214364|FG006|Period 3|Withdrawal by Subject|0|||
94389326|NCT01746017|323214365|FG007|Period 3|Withdrawal by Subject|0|||
94389327|NCT01746017|323214366|FG008|Period 3|Withdrawal by Subject|0|||
94389328|NCT01746017|323214367|FG009|Period 3|Withdrawal by Subject|0|||
94389329|NCT01746017|323214368|FG010|Period 3|Withdrawal by Subject|0|||
94389330|NCT03597256|323214372|FG000|Overall Study|Lost to Follow-up|3|||
94389331|NCT03597256|323214373|FG001|Overall Study|Lost to Follow-up|1|||
94389332|NCT03597256|323214372|FG000|Overall Study|Withdrawal by Subject|0|||
94389333|NCT03597256|323214373|FG001|Overall Study|Withdrawal by Subject|1|||
94389334|NCT03597256|323214372|FG000|Overall Study|Could not return for treatment|0|||
94389335|NCT03597256|323214373|FG001|Overall Study|Could not return for treatment|1|||
94389336|NCT03597256|323214372|FG000|Overall Study|Moved from location|0|||
94389337|NCT03597256|323214373|FG001|Overall Study|Moved from location|1|||
94389338|NCT03597256|323214372|FG000|Overall Study|Not accepted the treatment|0|||
94389339|NCT03597256|323214373|FG001|Overall Study|Not accepted the treatment|1|||
94389340|NCT01725529|323214374|FG000|Overall Study|Adverse Event|1|||
94389341|NCT01725529|323214375|FG001|Overall Study|Adverse Event|0|||
94389342|NCT01725529|323214376|FG002|Overall Study|Adverse Event|0|||
94389343|NCT01725529|323214374|FG000|Overall Study|Lost to Follow-up|2|||
94389344|NCT01725529|323214375|FG001|Overall Study|Lost to Follow-up|1|||
94389345|NCT01725529|323214376|FG002|Overall Study|Lost to Follow-up|1|||
94389346|NCT01725529|323214374|FG000|Overall Study|Protocol Violation|0|||
94389347|NCT01725529|323214375|FG001|Overall Study|Protocol Violation|1|||
94389348|NCT01725529|323214376|FG002|Overall Study|Protocol Violation|1|||
94389349|NCT01725529|323214374|FG000|Overall Study|Withdrawal by Subject|12|||
94389350|NCT01725529|323214375|FG001|Overall Study|Withdrawal by Subject|14|||
94389351|NCT01725529|323214376|FG002|Overall Study|Withdrawal by Subject|8|||
94389352|NCT00485472|323214377|FG000|Overall Study|Adverse Event|8|||
94389353|NCT00485472|323214378|FG001|Overall Study|Adverse Event|5|||
94326998|NCT03176277|322978281|FG002|Part A Dose Escalation Study|Physician Decision|2|||
94326999|NCT03176277|322978282|FG003|Part A Dose Escalation Study|Physician Decision|0|||
94327000|NCT03176277|322978279|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
94327001|NCT03176277|322978280|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
94327002|NCT03176277|322978281|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
94327003|NCT03176277|322978282|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
94327004|NCT03176277|322978279|FG000|Part A Dose Escalation Study|Progressive disease|3|||
94327005|NCT03176277|322978280|FG001|Part A Dose Escalation Study|Progressive disease|1|||
94327006|NCT03176277|322978281|FG002|Part A Dose Escalation Study|Progressive disease|3|||
94327007|NCT03176277|322978282|FG003|Part A Dose Escalation Study|Progressive disease|0|||
94327008|NCT02146248|322978283|FG000|Overall Study|Withdrawal by Subject|2|||
94327009|NCT00634114|322978284|FG000|Overall Study|Adverse Event|6|||
94389354|NCT00485472|323214377|FG000|Overall Study|Lack of Efficacy|5|||
94389355|NCT00485472|323214378|FG001|Overall Study|Lack of Efficacy|4|||
94389356|NCT00485472|323214377|FG000|Overall Study|Withdrawal by Subject|1|||
94327010|NCT00634114|322978285|FG001|Overall Study|Adverse Event|8|||
94327011|NCT00634114|322978286|FG002|Overall Study|Adverse Event|3|||
94389357|NCT00485472|323214378|FG001|Overall Study|Withdrawal by Subject|0|||
94389358|NCT00485472|323214377|FG000|Overall Study|Protocol Violation|0|||
94389359|NCT00485472|323214378|FG001|Overall Study|Protocol Violation|1|||
94389360|NCT00485472|323214377|FG000|Overall Study|Other|2|||
94389361|NCT00485472|323214378|FG001|Overall Study|Other|1|||
94389362|NCT00485472|323214377|FG000|Overall Study|Lost to Follow-up|0|||
94389363|NCT00485472|323214378|FG001|Overall Study|Lost to Follow-up|1|||
94389364|NCT00324168|323214380|FG000|Overall Study|Lost to Follow-up|19|||
94327012|NCT00634114|322978284|FG000|Overall Study|Withdrawal by Subject|9|||
94327013|NCT00634114|322978285|FG001|Overall Study|Withdrawal by Subject|6|||
94327014|NCT00634114|322978286|FG002|Overall Study|Withdrawal by Subject|11|||
94327015|NCT00634114|322978284|FG000|Overall Study|Lost to Follow-up|0|||
94327016|NCT00634114|322978285|FG001|Overall Study|Lost to Follow-up|0|||
94327017|NCT00634114|322978286|FG002|Overall Study|Lost to Follow-up|1|||
94327018|NCT00634114|322978284|FG000|Overall Study|Protocol Violation|3|||
94327019|NCT00634114|322978285|FG001|Overall Study|Protocol Violation|3|||
94327020|NCT00634114|322978286|FG002|Overall Study|Protocol Violation|1|||
94327021|NCT00634114|322978284|FG000|Overall Study|Pregnancy|1|||
94327022|NCT00634114|322978285|FG001|Overall Study|Pregnancy|0|||
94327023|NCT00634114|322978286|FG002|Overall Study|Pregnancy|0|||
94327024|NCT00634114|322978284|FG000|Overall Study|Incorrect enrolment|0|||
94327025|NCT00634114|322978285|FG001|Overall Study|Incorrect enrolment|1|||
94327026|NCT00634114|322978286|FG002|Overall Study|Incorrect enrolment|0|||
94327027|NCT00634114|322978284|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
94327028|NCT00634114|322978285|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
94327029|NCT00634114|322978286|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
94327030|NCT00634114|322978284|FG000|Overall Study|Difficult to continue|3|||
94327031|NCT00634114|322978285|FG001|Overall Study|Difficult to continue|1|||
94327032|NCT00634114|322978286|FG002|Overall Study|Difficult to continue|1|||
94327033|NCT00634114|322978284|FG000|Overall Study|Other reason|1|||
94327034|NCT00634114|322978285|FG001|Overall Study|Other reason|1|||
94327035|NCT00634114|322978286|FG002|Overall Study|Other reason|1|||
94327036|NCT02940626|322978287|FG000|Overall Study|Death|40|||
94327037|NCT02940626|322978288|FG001|Overall Study|Death|32|||
94327038|NCT02940626|322978287|FG000|Overall Study|Lost to Follow-up|5|||
94327039|NCT02940626|322978288|FG001|Overall Study|Lost to Follow-up|2|||
94327040|NCT02940626|322978287|FG000|Overall Study|Withdrawal by Subject|1|||
94327041|NCT02940626|322978288|FG001|Overall Study|Withdrawal by Subject|0|||
94327042|NCT02940626|322978287|FG000|Overall Study|Transfer to Hospice Care|1|||
94327043|NCT02940626|322978288|FG001|Overall Study|Transfer to Hospice Care|0|||
94327044|NCT02940626|322978287|FG000|Overall Study|Prohibited Concomitant Medication|0|||
94327045|NCT02940626|322978288|FG001|Overall Study|Prohibited Concomitant Medication|1|||
94327046|NCT02815293|322978293|FG000|Overall Study|Study termination by sponsor|10|||
94327047|NCT02815293|322978294|FG001|Overall Study|Study termination by sponsor|7|||
94327048|NCT02815293|322978295|FG002|Overall Study|Study termination by sponsor|0|||
94327049|NCT02815293|322978293|FG000|Overall Study|Participants not randomized|0|||
94327050|NCT02815293|322978294|FG001|Overall Study|Participants not randomized|0|||
94327051|NCT02815293|322978295|FG002|Overall Study|Participants not randomized|18|||
94327052|NCT02815293|322978293|FG000|Overall Study|Adverse Event|0|||
94327053|NCT02815293|322978294|FG001|Overall Study|Adverse Event|1|||
94327054|NCT02815293|322978295|FG002|Overall Study|Adverse Event|0|||
94327055|NCT02159469|322978296|FG000|Overall Study|Missing Completion status|1|||
94327056|NCT02159469|322978296|FG000|Overall Study|Adverse Event|5|||
94327057|NCT02159469|322978296|FG000|Overall Study|Non-compliance|2|||
94327058|NCT02159469|322978296|FG000|Overall Study|Withdrawal by Subject|9|||
94327059|NCT02159469|322978296|FG000|Overall Study|Lost to Follow-up|1|||
94327060|NCT02159469|322978296|FG000|Overall Study|Sponsor's request|2|||
94327061|NCT02159469|322978296|FG000|Overall Study|Met Stopping Criteria|3|||
94327062|NCT02159469|322978296|FG000|Overall Study|Other|1|||
94327063|NCT02159469|322978296|FG000|Overall Study|Multiple|29|||
94327064|NCT00006604|322978297|FG000|Overall Study|Met study objective - no further FU|1|||
94327065|NCT00006604|322978298|FG001|Overall Study|Met study objective - no further FU|0|||
94327066|NCT00006604|322978299|FG002|Overall Study|Met study objective - no further FU|0|||
94327067|NCT00006604|322978300|FG003|Overall Study|Met study objective - no further FU|0|||
94327068|NCT00006604|322978301|FG004|Overall Study|Met study objective - no further FU|0|||
94327069|NCT00006604|322978302|FG005|Overall Study|Met study objective - no further FU|0|||
94327070|NCT00006604|322978303|FG006|Overall Study|Met study objective - no further FU|0|||
94327071|NCT00006604|322978304|FG007|Overall Study|Met study objective - no further FU|0|||
94327072|NCT00006604|322978305|FG008|Overall Study|Met study objective - no further FU|0|||
94327073|NCT00006604|322978306|FG009|Overall Study|Met study objective - no further FU|0|||
94327074|NCT00006604|322978307|FG010|Overall Study|Met study objective - no further FU|0|||
94327075|NCT00006604|322978308|FG011|Overall Study|Met study objective - no further FU|0|||
94327076|NCT00006604|322978309|FG012|Overall Study|Met study objective - no further FU|0|||
94327077|NCT00006604|322978310|FG013|Overall Study|Met study objective - no further FU|0|||
94327078|NCT00006604|322978311|FG014|Overall Study|Met study objective - no further FU|1|||
94327079|NCT00006604|322978312|FG015|Overall Study|Met study objective - no further FU|1|||
94327080|NCT00006604|322978313|FG016|Overall Study|Met study objective - no further FU|0|||
94327081|NCT00006604|322978297|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
94327082|NCT00006604|322978298|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
94327083|NCT00006604|322978299|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
94327084|NCT00006604|322978300|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
94327085|NCT00006604|322978301|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
94327086|NCT00006604|322978302|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
94327087|NCT00006604|322978303|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
94327088|NCT00006604|322978304|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
94327089|NCT00006604|322978305|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
94327090|NCT00006604|322978306|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
94327091|NCT00006604|322978307|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
94327092|NCT00006604|322978308|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
94327093|NCT00006604|322978309|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
94327094|NCT00006604|322978310|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
94327095|NCT00006604|322978311|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
94327096|NCT00006604|322978312|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
94327097|NCT00006604|322978313|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
94327098|NCT00006604|322978297|FG000|Overall Study|Death|0|||
94327099|NCT00006604|322978298|FG001|Overall Study|Death|0|||
94327100|NCT00006604|322978299|FG002|Overall Study|Death|0|||
94327101|NCT00006604|322978300|FG003|Overall Study|Death|0|||
94327102|NCT00006604|322978301|FG004|Overall Study|Death|0|||
94327103|NCT00006604|322978302|FG005|Overall Study|Death|0|||
94327104|NCT00006604|322978303|FG006|Overall Study|Death|0|||
94327105|NCT00006604|322978304|FG007|Overall Study|Death|0|||
94327106|NCT00006604|322978305|FG008|Overall Study|Death|0|||
94327107|NCT00006604|322978306|FG009|Overall Study|Death|1|||
94327108|NCT00006604|322978307|FG010|Overall Study|Death|1|||
94327109|NCT00006604|322978308|FG011|Overall Study|Death|1|||
94327110|NCT00006604|322978309|FG012|Overall Study|Death|0|||
94327111|NCT00006604|322978310|FG013|Overall Study|Death|0|||
94327112|NCT00006604|322978311|FG014|Overall Study|Death|0|||
94327113|NCT00006604|322978312|FG015|Overall Study|Death|0|||
94327114|NCT00006604|322978313|FG016|Overall Study|Death|0|||
94327115|NCT00006604|322978297|FG000|Overall Study|Severe debilitation, unable to continue|0|||
94327116|NCT00006604|322978298|FG001|Overall Study|Severe debilitation, unable to continue|0|||
94327117|NCT00006604|322978299|FG002|Overall Study|Severe debilitation, unable to continue|0|||
94327118|NCT00006604|322978300|FG003|Overall Study|Severe debilitation, unable to continue|0|||
94327119|NCT00006604|322978301|FG004|Overall Study|Severe debilitation, unable to continue|0|||
94327120|NCT00006604|322978302|FG005|Overall Study|Severe debilitation, unable to continue|0|||
94327121|NCT00006604|322978303|FG006|Overall Study|Severe debilitation, unable to continue|3|||
94327122|NCT00006604|322978304|FG007|Overall Study|Severe debilitation, unable to continue|0|||
94327123|NCT00006604|322978305|FG008|Overall Study|Severe debilitation, unable to continue|0|||
94327124|NCT00006604|322978306|FG009|Overall Study|Severe debilitation, unable to continue|5|||
94327125|NCT00006604|322978307|FG010|Overall Study|Severe debilitation, unable to continue|0|||
94327126|NCT00006604|322978308|FG011|Overall Study|Severe debilitation, unable to continue|2|||
94327127|NCT00006604|322978309|FG012|Overall Study|Severe debilitation, unable to continue|1|||
94327128|NCT00006604|322978310|FG013|Overall Study|Severe debilitation, unable to continue|0|||
94327129|NCT00006604|322978311|FG014|Overall Study|Severe debilitation, unable to continue|2|||
94327130|NCT00006604|322978312|FG015|Overall Study|Severe debilitation, unable to continue|0|||
94327131|NCT00006604|322978313|FG016|Overall Study|Severe debilitation, unable to continue|0|||
94327132|NCT00006604|322978297|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
94327133|NCT00006604|322978298|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
94327134|NCT00006604|322978299|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
94327135|NCT00006604|322978300|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
94327136|NCT00006604|322978301|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
94327137|NCT00006604|322978302|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
94327138|NCT00006604|322978303|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
94327139|NCT00006604|322978304|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
94389365|NCT00324168|323214381|FG001|Overall Study|Lost to Follow-up|18|||
94389366|NCT00324168|323214380|FG000|Overall Study|Death|3|||
94389367|NCT00324168|323214381|FG001|Overall Study|Death|3|||
94389368|NCT00324168|323214380|FG000|Overall Study|Patient did not visit in f/u window|6|||
94389369|NCT00324168|323214381|FG001|Overall Study|Patient did not visit in f/u window|9|||
94389370|NCT00274937|323214382|FG000|Overall Study|Physician Decision|10|||
94389371|NCT00274937|323214382|FG000|Overall Study|Withdrawal by Subject|6|||
94389372|NCT00274937|323214382|FG000|Overall Study|Progressive Disease|4|||
94389373|NCT02189941|323214383|FG000|Overall Study|Non-compliance|0|||
94389374|NCT02189941|323214384|FG001|Overall Study|Non-compliance|0|||
94389375|NCT02189941|323214385|FG002|Overall Study|Non-compliance|1|||
94389376|NCT01682083|323214386|FG000|Overall Study|Lost to Follow-up|11|||
94389377|NCT01682083|323214387|FG001|Overall Study|Lost to Follow-up|18|||
94389378|NCT01682083|323214386|FG000|Overall Study|Withdrawal by Subject|31|||
94389379|NCT01682083|323214387|FG001|Overall Study|Withdrawal by Subject|40|||
94389380|NCT01682083|323214386|FG000|Overall Study|Death|60|||
94389381|NCT01682083|323214387|FG001|Overall Study|Death|93|||
94389382|NCT01682083|323214386|FG000|Overall Study|Physician Decision|5|||
94389383|NCT01682083|323214387|FG001|Overall Study|Physician Decision|4|||
94389384|NCT02475954|323214388|FG000|Overall Study|Withdrawal by Subject|2|||
94389385|NCT02475954|323214389|FG001|Overall Study|Withdrawal by Subject|2|||
94327140|NCT00006604|322978305|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
94327141|NCT00006604|322978306|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
94327142|NCT00006604|322978307|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
94327143|NCT00006604|322978308|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
94327144|NCT00006604|322978309|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
94327145|NCT00006604|322978310|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
94327146|NCT00006604|322978311|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
94327147|NCT00006604|322978312|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
94327148|NCT00006604|322978313|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
94327149|NCT00006604|322978297|FG000|Overall Study|Site closing|0|||
94327150|NCT00006604|322978298|FG001|Overall Study|Site closing|0|||
94327151|NCT00006604|322978299|FG002|Overall Study|Site closing|1|||
94327152|NCT00006604|322978300|FG003|Overall Study|Site closing|1|||
94327153|NCT00006604|322978301|FG004|Overall Study|Site closing|0|||
94327154|NCT00006604|322978302|FG005|Overall Study|Site closing|0|||
94327155|NCT00006604|322978303|FG006|Overall Study|Site closing|0|||
94327156|NCT00006604|322978304|FG007|Overall Study|Site closing|1|||
94327157|NCT00006604|322978305|FG008|Overall Study|Site closing|0|||
94327158|NCT00006604|322978306|FG009|Overall Study|Site closing|0|||
94327159|NCT00006604|322978307|FG010|Overall Study|Site closing|0|||
94327160|NCT00006604|322978308|FG011|Overall Study|Site closing|1|||
94327161|NCT00006604|322978309|FG012|Overall Study|Site closing|1|||
94327162|NCT00006604|322978310|FG013|Overall Study|Site closing|1|||
94327163|NCT00006604|322978311|FG014|Overall Study|Site closing|0|||
94327164|NCT00006604|322978312|FG015|Overall Study|Site closing|0|||
94327165|NCT00006604|322978313|FG016|Overall Study|Site closing|1|||
94327166|NCT00006604|322978297|FG000|Overall Study|Withdrawal by Subject|1|||
94327167|NCT00006604|322978298|FG001|Overall Study|Withdrawal by Subject|0|||
94327168|NCT00006604|322978299|FG002|Overall Study|Withdrawal by Subject|2|||
94327169|NCT00006604|322978300|FG003|Overall Study|Withdrawal by Subject|0|||
94327170|NCT00006604|322978301|FG004|Overall Study|Withdrawal by Subject|1|||
94327171|NCT00006604|322978302|FG005|Overall Study|Withdrawal by Subject|2|||
94327172|NCT00006604|322978303|FG006|Overall Study|Withdrawal by Subject|2|||
94327173|NCT00006604|322978304|FG007|Overall Study|Withdrawal by Subject|0|||
94327174|NCT00006604|322978305|FG008|Overall Study|Withdrawal by Subject|1|||
94327175|NCT00006604|322978306|FG009|Overall Study|Withdrawal by Subject|3|||
94327176|NCT00006604|322978307|FG010|Overall Study|Withdrawal by Subject|2|||
94327177|NCT00006604|322978308|FG011|Overall Study|Withdrawal by Subject|0|||
94327178|NCT00006604|322978309|FG012|Overall Study|Withdrawal by Subject|1|||
94327179|NCT00006604|322978310|FG013|Overall Study|Withdrawal by Subject|2|||
94327180|NCT00006604|322978311|FG014|Overall Study|Withdrawal by Subject|1|||
94327181|NCT00006604|322978312|FG015|Overall Study|Withdrawal by Subject|0|||
94327182|NCT00006604|322978313|FG016|Overall Study|Withdrawal by Subject|1|||
94327183|NCT00006604|322978297|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
94327184|NCT00006604|322978298|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
94327185|NCT00006604|322978299|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
94327186|NCT00006604|322978300|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
94327187|NCT00006604|322978301|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
94327188|NCT00006604|322978302|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
94327189|NCT00006604|322978303|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
94327190|NCT00006604|322978304|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
94327191|NCT00006604|322978305|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
94327192|NCT00006604|322978306|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
94327193|NCT00006604|322978307|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
94327194|NCT00006604|322978308|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
94327195|NCT00006604|322978309|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
94327196|NCT00006604|322978310|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
94327197|NCT00006604|322978311|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
94327198|NCT00006604|322978312|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
94327199|NCT00006604|322978313|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
94389386|NCT02475954|323214388|FG000|Overall Study|Lost to Follow-up|11|||
94389387|NCT02475954|323214389|FG001|Overall Study|Lost to Follow-up|9|||
94389388|NCT02475954|323214388|FG000|Overall Study|Death|1|||
94389389|NCT02475954|323214389|FG001|Overall Study|Death|1|||
94389390|NCT00849901|323214392|FG000|Acute Treatment Phase|Adverse Event|9|||
94389391|NCT00849901|323214393|FG001|Acute Treatment Phase|Adverse Event|1|||
94389392|NCT00849901|323214394|FG002|Acute Treatment Phase|Adverse Event|3|||
94327200|NCT00006604|322978297|FG000|Overall Study|Lost to Follow-up|0|||
94389393|NCT00849901|323214392|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
94327201|NCT00006604|322978298|FG001|Overall Study|Lost to Follow-up|0|||
94327202|NCT00006604|322978299|FG002|Overall Study|Lost to Follow-up|0|||
94389394|NCT00849901|323214393|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
94389395|NCT00849901|323214394|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
94327203|NCT00006604|322978300|FG003|Overall Study|Lost to Follow-up|0|||
94327204|NCT00006604|322978301|FG004|Overall Study|Lost to Follow-up|0|||
94327205|NCT00006604|322978302|FG005|Overall Study|Lost to Follow-up|0|||
94327206|NCT00006604|322978303|FG006|Overall Study|Lost to Follow-up|0|||
94327207|NCT00006604|322978304|FG007|Overall Study|Lost to Follow-up|1|||
94327208|NCT00006604|322978305|FG008|Overall Study|Lost to Follow-up|0|||
94327209|NCT00006604|322978306|FG009|Overall Study|Lost to Follow-up|2|||
94327210|NCT00006604|322978307|FG010|Overall Study|Lost to Follow-up|0|||
94327211|NCT00006604|322978308|FG011|Overall Study|Lost to Follow-up|0|||
94327212|NCT00006604|322978309|FG012|Overall Study|Lost to Follow-up|0|||
94327213|NCT00006604|322978310|FG013|Overall Study|Lost to Follow-up|0|||
94327214|NCT00006604|322978311|FG014|Overall Study|Lost to Follow-up|0|||
94327215|NCT00006604|322978312|FG015|Overall Study|Lost to Follow-up|1|||
94327216|NCT00006604|322978313|FG016|Overall Study|Lost to Follow-up|3|||
94327217|NCT00006604|322978297|FG000|Overall Study|Other Reason|0|||
94327218|NCT00006604|322978298|FG001|Overall Study|Other Reason|0|||
94327219|NCT00006604|322978299|FG002|Overall Study|Other Reason|0|||
94327220|NCT00006604|322978300|FG003|Overall Study|Other Reason|0|||
94327221|NCT00006604|322978301|FG004|Overall Study|Other Reason|0|||
94327222|NCT00006604|322978302|FG005|Overall Study|Other Reason|1|||
94327223|NCT00006604|322978303|FG006|Overall Study|Other Reason|0|||
94327224|NCT00006604|322978304|FG007|Overall Study|Other Reason|0|||
94327225|NCT00006604|322978305|FG008|Overall Study|Other Reason|0|||
94327226|NCT00006604|322978306|FG009|Overall Study|Other Reason|1|||
94327227|NCT00006604|322978307|FG010|Overall Study|Other Reason|0|||
94327228|NCT00006604|322978308|FG011|Overall Study|Other Reason|0|||
94327229|NCT00006604|322978309|FG012|Overall Study|Other Reason|0|||
94327230|NCT00006604|322978310|FG013|Overall Study|Other Reason|0|||
94327231|NCT00006604|322978311|FG014|Overall Study|Other Reason|0|||
94327232|NCT00006604|322978312|FG015|Overall Study|Other Reason|0|||
94327233|NCT00006604|322978313|FG016|Overall Study|Other Reason|0|||
94327234|NCT02431468|322978314|FG000|Overall Study|Adverse Event|2|||
94327235|NCT02431468|322978315|FG001|Overall Study|Adverse Event|4|||
94327236|NCT02431468|322978316|FG002|Overall Study|Adverse Event|5|||
94327237|NCT02431468|322978314|FG000|Overall Study|Withdrawal by Subject|4|||
94327238|NCT02431468|322978315|FG001|Overall Study|Withdrawal by Subject|12|||
94327239|NCT02431468|322978316|FG002|Overall Study|Withdrawal by Subject|2|||
94327240|NCT02431468|322978314|FG000|Overall Study|noncompliance, investigator termination,|2|||
94327241|NCT02431468|322978315|FG001|Overall Study|noncompliance, investigator termination,|2|||
94327242|NCT02431468|322978316|FG002|Overall Study|noncompliance, investigator termination,|2|||
94327243|NCT01056341|322978317|FG000|Overall Study|Treatment Intolerance|0|||
94327244|NCT01056341|322978318|FG001|Overall Study|Treatment Intolerance|2|||
94327245|NCT01056341|322978319|FG002|Overall Study|Treatment Intolerance|0|||
94327246|NCT01056341|322978320|FG003|Overall Study|Treatment Intolerance|2|||
94327247|NCT01056341|322978321|FG004|Overall Study|Treatment Intolerance|0|||
94327248|NCT01056341|322978317|FG000|Overall Study|Lack of Efficacy|32|||
94327249|NCT01056341|322978318|FG001|Overall Study|Lack of Efficacy|30|||
94327250|NCT01056341|322978319|FG002|Overall Study|Lack of Efficacy|7|||
94327251|NCT01056341|322978320|FG003|Overall Study|Lack of Efficacy|25|||
94327252|NCT01056341|322978321|FG004|Overall Study|Lack of Efficacy|9|||
94327253|NCT01056341|322978317|FG000|Overall Study|Other reasons|4|||
94327254|NCT01056341|322978318|FG001|Overall Study|Other reasons|4|||
94327255|NCT01056341|322978319|FG002|Overall Study|Other reasons|8|||
94327256|NCT01056341|322978320|FG003|Overall Study|Other reasons|9|||
94327257|NCT01056341|322978321|FG004|Overall Study|Other reasons|5|||
94327258|NCT02475395|322978322|FG000|Overall Study|Protocol Violation|30|||
94327259|NCT02475395|322978323|FG001|Overall Study|Protocol Violation|3|||
94327260|NCT01086150|322978324|FG000|Overall Study|Withdrawal by Subject|0|||
94327261|NCT01086150|322978325|FG001|Overall Study|Withdrawal by Subject|4|||
94327262|NCT01086150|322978326|FG002|Overall Study|Withdrawal by Subject|1|||
94327263|NCT01086150|322978324|FG000|Overall Study|Lost to Follow-up|0|||
94327264|NCT01086150|322978325|FG001|Overall Study|Lost to Follow-up|1|||
94327265|NCT01086150|322978326|FG002|Overall Study|Lost to Follow-up|0|||
94327266|NCT01086150|322978324|FG000|Overall Study|Screen Failure|0|||
94327267|NCT01086150|322978325|FG001|Overall Study|Screen Failure|1|||
94327268|NCT01086150|322978326|FG002|Overall Study|Screen Failure|0|||
94327269|NCT01927419|322978327|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
94327270|NCT01927419|322978328|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
94327271|NCT01927419|322978327|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
94327272|NCT01927419|322978328|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
94327273|NCT01927419|322978327|FG000|Treatment Period|Disease progression|17|||
94327274|NCT01927419|322978328|FG001|Treatment Period|Disease progression|20|||
94327275|NCT01927419|322978327|FG000|Treatment Period|Study drug toxicity|48|||
94327276|NCT01927419|322978328|FG001|Treatment Period|Study drug toxicity|10|||
94327277|NCT01927419|322978327|FG000|Treatment Period|Death|0|||
94327278|NCT01927419|322978328|FG001|Treatment Period|Death|1|||
94327279|NCT01927419|322978327|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
94327280|NCT01927419|322978328|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
94389396|NCT00849901|323214392|FG000|Acute Treatment Phase|Protocol Violation|0|||
94389397|NCT00849901|323214393|FG001|Acute Treatment Phase|Protocol Violation|2|||
94389398|NCT00849901|323214394|FG002|Acute Treatment Phase|Protocol Violation|1|||
94389399|NCT00849901|323214392|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
94389400|NCT00849901|323214393|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
94389401|NCT00849901|323214394|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
94389402|NCT00849901|323214392|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
94389403|NCT00849901|323214393|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
94389404|NCT00849901|323214394|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
94389405|NCT00849901|323214392|FG000|Acute Treatment Phase|Physician Decision|1|||
94389406|NCT00849901|323214393|FG001|Acute Treatment Phase|Physician Decision|1|||
94389407|NCT00849901|323214394|FG002|Acute Treatment Phase|Physician Decision|1|||
94389408|NCT00849901|323214392|FG000|Acute Treatment Phase|Sponsor Decision|1|||
94389409|NCT00849901|323214393|FG001|Acute Treatment Phase|Sponsor Decision|0|||
94389410|NCT00849901|323214394|FG002|Acute Treatment Phase|Sponsor Decision|0|||
94389411|NCT00849901|323214392|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
94389412|NCT00849901|323214393|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
94389413|NCT00849901|323214394|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
94389414|NCT00849901|323214392|FG000|Extension Phase|Adverse Event|2|||
94389415|NCT00849901|323214393|FG001|Extension Phase|Adverse Event|8|||
94389416|NCT00849901|323214394|FG002|Extension Phase|Adverse Event|4|||
94389417|NCT00849901|323214392|FG000|Extension Phase|Lost to Follow-up|3|||
94389418|NCT00849901|323214393|FG001|Extension Phase|Lost to Follow-up|0|||
94389419|NCT00849901|323214394|FG002|Extension Phase|Lost to Follow-up|1|||
94389420|NCT00849901|323214392|FG000|Extension Phase|Protocol Violation|2|||
94389421|NCT00849901|323214393|FG001|Extension Phase|Protocol Violation|2|||
94389422|NCT00849901|323214394|FG002|Extension Phase|Protocol Violation|4|||
94389423|NCT00849901|323214392|FG000|Extension Phase|Withdrawal by Subject|7|||
94389424|NCT00849901|323214393|FG001|Extension Phase|Withdrawal by Subject|6|||
94389425|NCT00849901|323214394|FG002|Extension Phase|Withdrawal by Subject|3|||
94389426|NCT00849901|323214392|FG000|Extension Phase|Parent or Caregiver Decision|10|||
94389427|NCT00849901|323214393|FG001|Extension Phase|Parent or Caregiver Decision|4|||
94389428|NCT00849901|323214394|FG002|Extension Phase|Parent or Caregiver Decision|4|||
94389429|NCT00849901|323214392|FG000|Extension Phase|Physician Decision|1|||
94389430|NCT00849901|323214393|FG001|Extension Phase|Physician Decision|2|||
94389431|NCT00849901|323214394|FG002|Extension Phase|Physician Decision|0|||
94389432|NCT00849901|323214392|FG000|Extension Phase|Lack of Efficacy|2|||
94389433|NCT00849901|323214393|FG001|Extension Phase|Lack of Efficacy|4|||
94389434|NCT00849901|323214394|FG002|Extension Phase|Lack of Efficacy|1|||
94389435|NCT00358449|323214397|FG000|Overall Study|Adverse Event|1|||
94389436|NCT00358449|323214398|FG001|Overall Study|Adverse Event|0|||
94389437|NCT00358449|323214399|FG002|Overall Study|Adverse Event|1|||
94389438|NCT00358449|323214397|FG000|Overall Study|Lost to Follow-up|1|||
94389439|NCT00358449|323214398|FG001|Overall Study|Lost to Follow-up|0|||
94389440|NCT00358449|323214399|FG002|Overall Study|Lost to Follow-up|0|||
94389441|NCT00358449|323214397|FG000|Overall Study|Withdrawal by Subject|2|||
94389442|NCT00358449|323214398|FG001|Overall Study|Withdrawal by Subject|0|||
94389443|NCT00358449|323214399|FG002|Overall Study|Withdrawal by Subject|0|||
94389444|NCT00358449|323214397|FG000|Overall Study|Lack of Efficacy|0|||
94389445|NCT00358449|323214398|FG001|Overall Study|Lack of Efficacy|1|||
94389446|NCT00358449|323214399|FG002|Overall Study|Lack of Efficacy|0|||
94389447|NCT00358449|323214397|FG000|Overall Study|Steriod Inhaler was Increased|0|||
94389448|NCT00358449|323214398|FG001|Overall Study|Steriod Inhaler was Increased|0|||
94327281|NCT01927419|322978327|FG000|Treatment Period|Participant request to discontinue|12|||
94327282|NCT01927419|322978328|FG001|Treatment Period|Participant request to discontinue|4|||
94327283|NCT01927419|322978327|FG000|Treatment Period|Withdrawal by Subject|1|||
94327284|NCT01927419|322978328|FG001|Treatment Period|Withdrawal by Subject|1|||
94327285|NCT01927419|322978327|FG000|Treatment Period|Maximum Clinical Benefit|6|||
94327286|NCT01927419|322978328|FG001|Treatment Period|Maximum Clinical Benefit|2|||
94327287|NCT01927419|322978327|FG000|Treatment Period|Other reasons|3|||
94327288|NCT01927419|322978328|FG001|Treatment Period|Other reasons|4|||
94327289|NCT01927419|322978327|FG000|Treatment Period|Not Reported|1|||
94327290|NCT01927419|322978328|FG001|Treatment Period|Not Reported|1|||
94327291|NCT01518244|322978334|FG000|Overall Study|Adverse Event|3|||
94327292|NCT01928485|322978341|FG000|Overall Study|Physician Decision|0|||
94327293|NCT01928485|322978342|FG001|Overall Study|Physician Decision|1|||
94389449|NCT00358449|323214399|FG002|Overall Study|Steriod Inhaler was Increased|1|||
94389450|NCT01804270|323214400|FG000|Overall Study|Withdrawal by Subject|1|||
94389451|NCT01804270|323214401|FG001|Overall Study|Withdrawal by Subject|1|||
94389452|NCT04407806|323214404|FG000|Overall Study|Withdrawal by Subject|1|||
94389453|NCT04407806|323214405|FG001|Overall Study|Withdrawal by Subject|2|||
94389454|NCT00496964|323214406|FG000|Overall Study|Withdrawal by Subject|0|||
94389455|NCT00496964|323214407|FG001|Overall Study|Withdrawal by Subject|1|||
94389456|NCT02188303|323214410|FG000|Overall Study|Adverse Event|0|||
94389457|NCT02188303|323214411|FG001|Overall Study|Adverse Event|0|||
94389458|NCT02188303|323214412|FG002|Overall Study|Adverse Event|0|||
94389459|NCT02188303|323214413|FG003|Overall Study|Adverse Event|0|||
94389460|NCT02188303|323214414|FG004|Overall Study|Adverse Event|0|||
94389461|NCT02188303|323214415|FG005|Overall Study|Adverse Event|2|||
94389462|NCT02188303|323214416|FG006|Overall Study|Adverse Event|0|||
94389463|NCT02188303|323214417|FG007|Overall Study|Adverse Event|2|||
94389464|NCT02188303|323214410|FG000|Overall Study|Dose Termination Criteria Met|0|||
94389465|NCT02188303|323214411|FG001|Overall Study|Dose Termination Criteria Met|0|||
94389466|NCT02188303|323214412|FG002|Overall Study|Dose Termination Criteria Met|0|||
94389467|NCT02188303|323214413|FG003|Overall Study|Dose Termination Criteria Met|0|||
94389468|NCT02188303|323214414|FG004|Overall Study|Dose Termination Criteria Met|0|||
94389469|NCT02188303|323214415|FG005|Overall Study|Dose Termination Criteria Met|0|||
94389470|NCT02188303|323214416|FG006|Overall Study|Dose Termination Criteria Met|2|||
94389471|NCT02188303|323214417|FG007|Overall Study|Dose Termination Criteria Met|4|||
94389472|NCT02334722|323214418|FG000|Overall Study|Lost to Follow-up|4|||
94389473|NCT02334722|323214419|FG001|Overall Study|Lost to Follow-up|0|||
94389474|NCT02334722|323214418|FG000|Overall Study|6 week questionnaire not completed|2|||
94389475|NCT02334722|323214419|FG001|Overall Study|6 week questionnaire not completed|0|||
94389476|NCT02334722|323214418|FG000|Overall Study|Unable to obtain medication|1|||
94389477|NCT02334722|323214419|FG001|Overall Study|Unable to obtain medication|1|||
94389478|NCT02334722|323214418|FG000|Overall Study|Withdrawal by Subject|0|||
94389479|NCT02334722|323214419|FG001|Overall Study|Withdrawal by Subject|3|||
94389480|NCT02334722|323214418|FG000|Overall Study|Adverse Event|0|||
94389481|NCT02334722|323214419|FG001|Overall Study|Adverse Event|2|||
94389482|NCT02334722|323214418|FG000|Overall Study|Physician Decision|0|||
94389483|NCT02334722|323214419|FG001|Overall Study|Physician Decision|1|||
94389484|NCT00418184|323214420|FG000|Double-blind Phase|Withdrawal by Subject|22|||
94389485|NCT00418184|323214421|FG001|Double-blind Phase|Withdrawal by Subject|9|||
94389486|NCT00418184|323214420|FG000|Double-blind Phase|Adverse Event|2|||
94389487|NCT00418184|323214421|FG001|Double-blind Phase|Adverse Event|1|||
94389488|NCT00418184|323214420|FG000|Double-blind Phase|Poor compliance|3|||
94389489|NCT00418184|323214421|FG001|Double-blind Phase|Poor compliance|1|||
94389490|NCT04088760|323214422|FG000|Overall Study|Physician Decision|1|||
94389491|NCT01035060|323214425|FG000|Overall Study|Lost to Follow-up|0|||
94389492|NCT01035060|323214426|FG001|Overall Study|Lost to Follow-up|7|||
94389493|NCT01035060|323214425|FG000|Overall Study|Did not quality after 2nd screening|14|||
94389494|NCT01035060|323214426|FG001|Overall Study|Did not quality after 2nd screening|1|||
94389495|NCT01035060|323214425|FG000|Overall Study|Withdrawal by Subject|8|||
94389496|NCT01035060|323214426|FG001|Overall Study|Withdrawal by Subject|6|||
94389497|NCT01035060|323214425|FG000|Overall Study|Physician Decision|2|||
94389498|NCT01035060|323214426|FG001|Overall Study|Physician Decision|0|||
94389499|NCT00064753|323214427|FG000|Overall Study|Death|251|||
94389500|NCT00064753|323214428|FG001|Overall Study|Death|242|||
94389501|NCT00064753|323214427|FG000|Overall Study|Withdrawal by Subject|198|||
94389502|NCT00064753|323214428|FG001|Overall Study|Withdrawal by Subject|171|||
94389503|NCT00064753|323214427|FG000|Overall Study|Lost to Follow-up|225|||
94389504|NCT00064753|323214428|FG001|Overall Study|Lost to Follow-up|235|||
94389505|NCT04869787|323214429|FG000|Screening|Physician Decision|1|||
94389506|NCT04869787|323214429|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
94389507|NCT00813293|323214430|FG000|Overall Study|Intercurrent illness|1|||
94389508|NCT00813293|323214431|FG001|Overall Study|Intercurrent illness|0|||
94389509|NCT00813293|323214430|FG000|Overall Study|Adverse Event|0|||
94389510|NCT00813293|323214431|FG001|Overall Study|Adverse Event|1|||
94389511|NCT01182415|323214433|FG000|Overall Study|Lost to Follow-up|1|||
94389512|NCT00533273|323214434|FG000|Double-blind|Withdrew consent|0|||
94389513|NCT00533273|323214435|FG001|Double-blind|Withdrew consent|2|||
94389514|NCT00533273|323214434|FG000|Open-label|Withdrawal by Subject|6|||
94389515|NCT00533273|323214435|FG001|Open-label|Withdrawal by Subject|0|||
94389516|NCT00669942|323214446|FG000|Parts 2 and 3|Adverse Event|0|||
94389517|NCT00669942|323214447|FG001|Parts 2 and 3|Adverse Event|0|||
94389518|NCT00669942|323214448|FG002|Parts 2 and 3|Adverse Event|0|||
94389519|NCT00669942|323214449|FG003|Parts 2 and 3|Adverse Event|0|||
94389520|NCT00669942|323214450|FG004|Parts 2 and 3|Adverse Event|0|||
94389521|NCT00669942|323214451|FG005|Parts 2 and 3|Adverse Event|0|||
94389522|NCT00669942|323214452|FG006|Parts 2 and 3|Adverse Event|0|||
94389523|NCT00669942|323214453|FG007|Parts 2 and 3|Adverse Event|2|||
94389524|NCT00669942|323214454|FG008|Parts 2 and 3|Adverse Event|1|||
94389525|NCT00669942|323214455|FG009|Parts 2 and 3|Adverse Event|0|||
94389526|NCT00669942|323214456|FG010|Parts 2 and 3|Adverse Event|0|||
94389527|NCT00669942|323214457|FG011|Parts 2 and 3|Adverse Event|0|||
94389528|NCT00669942|323214446|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
94389529|NCT00669942|323214447|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
94389530|NCT00669942|323214448|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
94389531|NCT00669942|323214449|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
94389532|NCT00669942|323214450|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
94389533|NCT00669942|323214451|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
94389534|NCT00669942|323214452|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
94482556|NCT02573259|323558137|FG004|Overall Study|Lost to Follow-up|0|||
94482557|NCT02573259|323558138|FG005|Overall Study|Lost to Follow-up|2|||
94389535|NCT00669942|323214453|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
94389536|NCT00669942|323214454|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
94389537|NCT00669942|323214455|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
94389538|NCT00669942|323214456|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
94389539|NCT00669942|323214457|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
94389540|NCT00669942|323214446|FG000|Parts 2 and 3|Protocol Violation|0|||
94389541|NCT00669942|323214447|FG001|Parts 2 and 3|Protocol Violation|0|||
94389542|NCT00669942|323214448|FG002|Parts 2 and 3|Protocol Violation|0|||
94389543|NCT00669942|323214449|FG003|Parts 2 and 3|Protocol Violation|0|||
94389544|NCT00669942|323214450|FG004|Parts 2 and 3|Protocol Violation|0|||
94389545|NCT00669942|323214451|FG005|Parts 2 and 3|Protocol Violation|1|||
94389546|NCT00669942|323214452|FG006|Parts 2 and 3|Protocol Violation|0|||
94389547|NCT00669942|323214453|FG007|Parts 2 and 3|Protocol Violation|0|||
94389548|NCT00669942|323214454|FG008|Parts 2 and 3|Protocol Violation|0|||
94389549|NCT00669942|323214455|FG009|Parts 2 and 3|Protocol Violation|0|||
94389550|NCT00669942|323214456|FG010|Parts 2 and 3|Protocol Violation|0|||
94389551|NCT00669942|323214457|FG011|Parts 2 and 3|Protocol Violation|0|||
94389552|NCT00454909|323214459|FG000|Overall Study|Withdrawal by Subject|1|||
94389553|NCT00454909|323214460|FG001|Overall Study|Withdrawal by Subject|0|||
94389554|NCT00454909|323214461|FG002|Overall Study|Withdrawal by Subject|0|||
94389555|NCT00454909|323214459|FG000|Overall Study|Migrated/moved from study area|0|||
94389556|NCT00454909|323214460|FG001|Overall Study|Migrated/moved from study area|0|||
94389557|NCT00454909|323214461|FG002|Overall Study|Migrated/moved from study area|1|||
94389558|NCT00454909|323214459|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
94389559|NCT00454909|323214460|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
94389560|NCT00454909|323214461|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
94389561|NCT00454909|323214459|FG000|Overall Study|Others|1|||
94389562|NCT00454909|323214460|FG001|Overall Study|Others|0|||
94389563|NCT00454909|323214461|FG002|Overall Study|Others|0|||
94389564|NCT02661295|323214464|FG000|Overall Study|Death|1|||
94389565|NCT02661295|323214464|FG000|Overall Study|Transferred Out|1|||
94389566|NCT02661295|323214464|FG000|Overall Study|Kidney Transplant|1|||
94389567|NCT02661295|323214464|FG000|Overall Study|Withdrawn due to side effects|8|||
94389568|NCT02661295|323214464|FG000|Overall Study|Withdrawn due to access type|1|||
94389569|NCT02661295|323214464|FG000|Overall Study|Withdrawn due to allergies|1|||
94389570|NCT02661295|323214464|FG000|Overall Study|Withdrawn due to non-compliance|1|||
94389571|NCT02661295|323214464|FG000|Overall Study|Withdrawal by Subject|3|||
94389572|NCT02661295|323214464|FG000|Overall Study|Failed screening|2|||
94389573|NCT02331394|323214465|FG000|Overall Study|Disease progression|1|||
94389574|NCT00301366|323214466|FG000|Overall Study|Adverse Event|1|||
94389575|NCT02549092|323214467|FG000|Treatment Period|Adverse Event|2|||
94389576|NCT02549092|323214468|FG001|Treatment Period|Adverse Event|2|||
94389577|NCT02549092|323214467|FG000|Treatment Period|Withdrawal by Subject|1|||
94389578|NCT02549092|323214468|FG001|Treatment Period|Withdrawal by Subject|3|||
94389579|NCT02549092|323214467|FG000|Treatment Period|Lack of Efficacy|0|||
94389580|NCT02549092|323214468|FG001|Treatment Period|Lack of Efficacy|2|||
94389581|NCT02549092|323214467|FG000|Extension/Transition Period|Adverse Event|1|||
94389582|NCT02549092|323214468|FG001|Extension/Transition Period|Adverse Event|1|||
94389583|NCT02549092|323214467|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
94389584|NCT02549092|323214468|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
94389585|NCT02549092|323214467|FG000|Extension/Transition Period|Other, Not Specified|4|||
94389586|NCT02549092|323214468|FG001|Extension/Transition Period|Other, Not Specified|2|||
94389587|NCT02511782|323214470|FG000|Overall Study|Withdrawal by Subject|1|||
94389588|NCT02511782|323214471|FG001|Overall Study|Withdrawal by Subject|0|||
94389589|NCT02511782|323214472|FG002|Overall Study|Withdrawal by Subject|0|||
94389590|NCT02255097|323214475|FG000|Overall Study|Death|151|||
94389591|NCT02255097|323214475|FG000|Overall Study|Lost to Follow-up|5|||
94389592|NCT02255097|323214475|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
94389593|NCT02255097|323214475|FG000|Overall Study|Withdrawal by Subject|7|||
94389594|NCT02255097|323214475|FG000|Overall Study|Allocated but not treated|1|||
94389595|NCT01546545|323214479|FG000|Overall Study|Withdrawal by Subject|1|||
94389596|NCT03361228|323214480|FG000|Overall Study|Other|1|||
94389597|NCT03361228|323214481|FG001|Overall Study|Other|1|||
94389598|NCT03361228|323214480|FG000|Overall Study|Death|3|||
94389599|NCT03361228|323214481|FG001|Overall Study|Death|0|||
94389600|NCT01079988|323214482|FG000|Overall Study|Lost to Follow-up|0|||
94389601|NCT01079988|323214483|FG001|Overall Study|Lost to Follow-up|0|||
94389602|NCT01079988|323214484|FG002|Overall Study|Lost to Follow-up|0|||
94389603|NCT01079988|323214485|FG003|Overall Study|Lost to Follow-up|1|||
94389604|NCT01079988|323214486|FG004|Overall Study|Lost to Follow-up|0|||
94389605|NCT01079988|323214482|FG000|Overall Study|Lack of Efficacy|1|||
94389606|NCT01079988|323214483|FG001|Overall Study|Lack of Efficacy|0|||
94389607|NCT01079988|323214484|FG002|Overall Study|Lack of Efficacy|0|||
94389608|NCT01079988|323214485|FG003|Overall Study|Lack of Efficacy|0|||
94389609|NCT01079988|323214486|FG004|Overall Study|Lack of Efficacy|0|||
94389610|NCT01079988|323214482|FG000|Overall Study|Other|0|||
94389611|NCT01079988|323214483|FG001|Overall Study|Other|0|||
94389612|NCT01079988|323214484|FG002|Overall Study|Other|0|||
94482558|NCT02573259|323558139|FG006|Overall Study|Lost to Follow-up|1|||
94482559|NCT02573259|323558133|FG000|Overall Study|Participant refused further follow-up|0|||
94482560|NCT02573259|323558134|FG001|Overall Study|Participant refused further follow-up|2|||
94482561|NCT02573259|323558135|FG002|Overall Study|Participant refused further follow-up|1|||
94482562|NCT02573259|323558136|FG003|Overall Study|Participant refused further follow-up|0|||
94482563|NCT02573259|323558137|FG004|Overall Study|Participant refused further follow-up|3|||
94482564|NCT02573259|323558138|FG005|Overall Study|Participant refused further follow-up|20|||
94482565|NCT02573259|323558139|FG006|Overall Study|Participant refused further follow-up|7|||
94482566|NCT02573259|323558133|FG000|Overall Study|Other|0|||
94482567|NCT02573259|323558134|FG001|Overall Study|Other|0|||
94482568|NCT02573259|323558135|FG002|Overall Study|Other|0|||
94482569|NCT02573259|323558136|FG003|Overall Study|Other|0|||
94482570|NCT02573259|323558137|FG004|Overall Study|Other|1|||
94482571|NCT02573259|323558138|FG005|Overall Study|Other|4|||
94482572|NCT02573259|323558139|FG006|Overall Study|Other|5|||
94482573|NCT00369343|323558142|FG000|Double-blind Phase|Adverse Event|19|||
94482574|NCT00369343|323558143|FG001|Double-blind Phase|Adverse Event|4|||
94482575|NCT00369343|323558142|FG000|Double-blind Phase|Failed to return|2|||
94482576|NCT00369343|323558143|FG001|Double-blind Phase|Failed to return|0|||
94482577|NCT00369343|323558142|FG000|Double-blind Phase|Lost to Follow-up|9|||
94482578|NCT00369343|323558143|FG001|Double-blind Phase|Lost to Follow-up|2|||
94482579|NCT00369343|323558142|FG000|Double-blind Phase|Protocol Violation|2|||
94482580|NCT00369343|323558143|FG001|Double-blind Phase|Protocol Violation|0|||
94482581|NCT00369343|323558142|FG000|Double-blind Phase|Withdrawal by Subject|8|||
94482582|NCT00369343|323558143|FG001|Double-blind Phase|Withdrawal by Subject|6|||
94482583|NCT00369343|323558142|FG000|Double-blind Phase|Lack of Efficacy|0|||
94482584|NCT00369343|323558143|FG001|Double-blind Phase|Lack of Efficacy|4|||
94482585|NCT00369343|323558142|FG000|Double-blind Phase|Protocol deviation|4|||
94482586|NCT00369343|323558143|FG001|Double-blind Phase|Protocol deviation|0|||
94482587|NCT00369343|323558142|FG000|Open-label Phase|Adverse Event|19|||
94482588|NCT00369343|323558143|FG001|Open-label Phase|Adverse Event|7|||
94482589|NCT00369343|323558142|FG000|Open-label Phase|Failed to return|4|||
94482590|NCT00369343|323558143|FG001|Open-label Phase|Failed to return|0|||
94482591|NCT00369343|323558142|FG000|Open-label Phase|Physician Decision|2|||
94482592|NCT00369343|323558143|FG001|Open-label Phase|Physician Decision|0|||
94482593|NCT00369343|323558142|FG000|Open-label Phase|Lost to Follow-up|5|||
94482594|NCT00369343|323558143|FG001|Open-label Phase|Lost to Follow-up|3|||
94482595|NCT00369343|323558142|FG000|Open-label Phase|inadvertently reported study completers|3|||
94482596|NCT00369343|323558143|FG001|Open-label Phase|inadvertently reported study completers|2|||
94482597|NCT00369343|323558142|FG000|Open-label Phase|Protocol Violation|1|||
94482598|NCT00369343|323558143|FG001|Open-label Phase|Protocol Violation|3|||
94482599|NCT00369343|323558142|FG000|Open-label Phase|Withdrawal by Subject|15|||
94482600|NCT00369343|323558143|FG001|Open-label Phase|Withdrawal by Subject|6|||
94482601|NCT00369343|323558142|FG000|Open-label Phase|Lack of Efficacy|4|||
94482602|NCT00369343|323558143|FG001|Open-label Phase|Lack of Efficacy|3|||
94482603|NCT00369343|323558142|FG000|Open-label Phase|Lack of continuance tolerability|3|||
94482604|NCT00369343|323558143|FG001|Open-label Phase|Lack of continuance tolerability|4|||
94482605|NCT00369343|323558142|FG000|Open-label Phase|did not take study drug|1|||
94482606|NCT00369343|323558143|FG001|Open-label Phase|did not take study drug|2|||
94482607|NCT02493517|323558144|FG000|Overall Study|Protocol Violation|1|||
94482608|NCT02493517|323558145|FG001|Overall Study|Protocol Violation|2|||
94482609|NCT02493517|323558144|FG000|Overall Study|Withdrawal by Subject|1|||
94482610|NCT02493517|323558145|FG001|Overall Study|Withdrawal by Subject|2|||
94482611|NCT02493517|323558144|FG000|Overall Study|Adverse Event|0|||
94482612|NCT02493517|323558145|FG001|Overall Study|Adverse Event|2|||
94327294|NCT03589885|322978343|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
94327295|NCT03589885|322978344|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
94327296|NCT03589885|322978345|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
94327297|NCT03589885|322978346|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
94327298|NCT03589885|322978347|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
94327299|NCT03589885|322978343|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
94327300|NCT03589885|322978344|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
94327301|NCT03589885|322978345|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
94327302|NCT03589885|322978346|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
94327303|NCT03589885|322978347|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
94327304|NCT03589885|322978343|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
94482613|NCT02493517|323558144|FG000|Overall Study|Missed study visit|0|||
94482614|NCT02493517|323558145|FG001|Overall Study|Missed study visit|1|||
94482615|NCT04632225|323558146|FG000|Overall Study|Withdrawal by Subject|2|||
94482616|NCT04632225|323558147|FG001|Overall Study|Withdrawal by Subject|2|||
94482617|NCT03811821|323558159|FG000|Overall Study|Adverse Event|1|||
94482618|NCT03811821|323558160|FG001|Overall Study|Adverse Event|1|||
94482619|NCT03811821|323558159|FG000|Overall Study|Withdrawal by Subject|5|||
94482620|NCT03811821|323558160|FG001|Overall Study|Withdrawal by Subject|4|||
94482621|NCT03811821|323558159|FG000|Overall Study|Lost to Follow-up|2|||
94389613|NCT01079988|323214485|FG003|Overall Study|Other|2|||
94389614|NCT01079988|323214486|FG004|Overall Study|Other|1|||
94389615|NCT00415363|323214489|FG000|Overall Study|Withdrawal by Subject|4|||
94389616|NCT00415363|323214490|FG001|Overall Study|Withdrawal by Subject|4|||
94389617|NCT00415363|323214489|FG000|Overall Study|Adverse Event|4|||
94389618|NCT00415363|323214490|FG001|Overall Study|Adverse Event|4|||
94389619|NCT00415363|323214489|FG000|Overall Study|Lost to Follow-up|2|||
94389620|NCT00415363|323214490|FG001|Overall Study|Lost to Follow-up|1|||
94389621|NCT00415363|323214489|FG000|Overall Study|Physician Decision|3|||
94389622|NCT00415363|323214490|FG001|Overall Study|Physician Decision|1|||
94389623|NCT00415363|323214489|FG000|Overall Study|Death|16|||
94389624|NCT00415363|323214490|FG001|Overall Study|Death|12|||
94389625|NCT00415363|323214489|FG000|Overall Study|Progressive disease|26|||
94389626|NCT00415363|323214490|FG001|Overall Study|Progressive disease|32|||
94389627|NCT00095212|323214494|FG000|Overall Study|Withdrawal by Subject|1|||
94389628|NCT00095212|323214495|FG001|Overall Study|Withdrawal by Subject|3|||
94389629|NCT02216071|323214505|FG000|Overall Study|Withdrawal by Subject|7|||
94389630|NCT02216071|323214506|FG001|Overall Study|Withdrawal by Subject|2|||
94389631|NCT02216071|323214505|FG000|Overall Study|Lost to Follow-up|3|||
94389632|NCT02216071|323214506|FG001|Overall Study|Lost to Follow-up|3|||
94389633|NCT02216071|323214505|FG000|Overall Study|Protocol Violation|3|||
94389634|NCT02216071|323214506|FG001|Overall Study|Protocol Violation|5|||
94389635|NCT02216071|323214505|FG000|Overall Study|Other|2|||
94389636|NCT02216071|323214506|FG001|Overall Study|Other|2|||
94389637|NCT00389064|323214507|FG000|Overall Study|Adverse Event|11|||
94389638|NCT00389064|323214508|FG001|Overall Study|Adverse Event|3|||
94389639|NCT00389064|323214507|FG000|Overall Study|Lack of Efficacy|3|||
94389640|NCT00389064|323214508|FG001|Overall Study|Lack of Efficacy|14|||
94389641|NCT00389064|323214507|FG000|Overall Study|Withdrawal by Subject|17|||
94389642|NCT00389064|323214508|FG001|Overall Study|Withdrawal by Subject|27|||
94389643|NCT00389064|323214507|FG000|Overall Study|Physician Decision|2|||
94389644|NCT00389064|323214508|FG001|Overall Study|Physician Decision|2|||
94389645|NCT00389064|323214507|FG000|Overall Study|Lost to Follow-up|1|||
94389646|NCT00389064|323214508|FG001|Overall Study|Lost to Follow-up|2|||
94389647|NCT00389064|323214507|FG000|Overall Study|Protocol Violation|2|||
94389648|NCT00389064|323214508|FG001|Overall Study|Protocol Violation|0|||
94389649|NCT00389064|323214507|FG000|Overall Study|Multiple Reasons|9|||
94389650|NCT00389064|323214508|FG001|Overall Study|Multiple Reasons|11|||
94389651|NCT00824265|323214509|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
94389652|NCT00824265|323214510|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
94389653|NCT00824265|323214509|FG000|Treatment Phase|Protocol Violation|1|||
94389654|NCT00824265|323214510|FG001|Treatment Phase|Protocol Violation|0|||
94389655|NCT00824265|323214509|FG000|Treatment Phase|Lost to Follow-up|1|||
94389656|NCT00824265|323214510|FG001|Treatment Phase|Lost to Follow-up|1|||
94389657|NCT00824265|323214509|FG000|Treatment Phase|Physician Decision|6|||
94389658|NCT00824265|323214510|FG001|Treatment Phase|Physician Decision|12|||
94389659|NCT00824265|323214509|FG000|Treatment Phase|Withdrawal by Subject|6|||
94389660|NCT00824265|323214510|FG001|Treatment Phase|Withdrawal by Subject|15|||
94389661|NCT00824265|323214509|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
94389662|NCT00824265|323214510|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
94389663|NCT00824265|323214509|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
94389664|NCT00824265|323214510|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
94389665|NCT02024932|323214512|FG000|Overall Study|Adverse Event|2|||
94389666|NCT02024932|323214513|FG001|Overall Study|Adverse Event|3|||
94389667|NCT02024932|323214514|FG002|Overall Study|Adverse Event|0|||
94389668|NCT02024932|323214515|FG003|Overall Study|Adverse Event|0|||
94389669|NCT02024932|323214516|FG004|Overall Study|Adverse Event|2|||
94389670|NCT02024932|323214517|FG005|Overall Study|Adverse Event|0|||
94389671|NCT02024932|323214512|FG000|Overall Study|Abnormal laboratory value|0|||
94389672|NCT02024932|323214513|FG001|Overall Study|Abnormal laboratory value|0|||
94389673|NCT02024932|323214514|FG002|Overall Study|Abnormal laboratory value|0|||
94389674|NCT02024932|323214515|FG003|Overall Study|Abnormal laboratory value|2|||
94389675|NCT02024932|323214516|FG004|Overall Study|Abnormal laboratory value|0|||
94389676|NCT02024932|323214517|FG005|Overall Study|Abnormal laboratory value|0|||
94389677|NCT01248247|323215928|FG000|Overall Study|Adverse Event|2|||
94389678|NCT01248247|323215929|FG001|Overall Study|Adverse Event|4|||
94389679|NCT01248247|323215930|FG002|Overall Study|Adverse Event|4|||
94389680|NCT01248247|323215931|FG003|Overall Study|Adverse Event|2|||
94389681|NCT01248247|323215928|FG000|Overall Study|Death|0|||
94389682|NCT01248247|323215929|FG001|Overall Study|Death|1|||
94389683|NCT01248247|323215930|FG002|Overall Study|Death|4|||
94389684|NCT01248247|323215931|FG003|Overall Study|Death|7|||
94389685|NCT01248247|323215928|FG000|Overall Study|Lost to Follow-up|0|||
94389686|NCT01248247|323215929|FG001|Overall Study|Lost to Follow-up|1|||
94389687|NCT01248247|323215930|FG002|Overall Study|Lost to Follow-up|1|||
94389688|NCT01248247|323215931|FG003|Overall Study|Lost to Follow-up|0|||
94389689|NCT01248247|323215928|FG000|Overall Study|Alternative treatment|0|||
94389690|NCT01248247|323215929|FG001|Overall Study|Alternative treatment|1|||
94389691|NCT01248247|323215930|FG002|Overall Study|Alternative treatment|0|||
94389692|NCT01248247|323215931|FG003|Overall Study|Alternative treatment|0|||
94389693|NCT01248247|323215928|FG000|Overall Study|Other|2|||
94389694|NCT01248247|323215929|FG001|Overall Study|Other|8|||
94389695|NCT01248247|323215930|FG002|Overall Study|Other|8|||
94389696|NCT01248247|323215931|FG003|Overall Study|Other|5|||
94389697|NCT01248247|323215928|FG000|Overall Study|Progression|18|||
94389698|NCT01248247|323215929|FG001|Overall Study|Progression|27|||
94389699|NCT01248247|323215930|FG002|Overall Study|Progression|56|||
94389700|NCT01248247|323215931|FG003|Overall Study|Progression|44|||
94389701|NCT01248247|323215928|FG000|Overall Study|Refuse further treatment|0|||
94389702|NCT01248247|323215929|FG001|Overall Study|Refuse further treatment|0|||
94389703|NCT01248247|323215930|FG002|Overall Study|Refuse further treatment|1|||
94389704|NCT01248247|323215931|FG003|Overall Study|Refuse further treatment|2|||
94389705|NCT01248247|323215928|FG000|Overall Study|Complicating disease|0|||
94389706|NCT01248247|323215929|FG001|Overall Study|Complicating disease|0|||
94389707|NCT01248247|323215930|FG002|Overall Study|Complicating disease|1|||
94389708|NCT01248247|323215931|FG003|Overall Study|Complicating disease|1|||
94389709|NCT03203447|323215932|FG000|Overall Study|Withdrawal by Subject|2|||
94389710|NCT03203447|323215933|FG001|Overall Study|Withdrawal by Subject|1|||
94389711|NCT03203447|323215932|FG000|Overall Study|Lost to Follow-up|1|||
94389712|NCT03203447|323215933|FG001|Overall Study|Lost to Follow-up|10|||
94389713|NCT03203447|323215932|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
94389714|NCT03203447|323215933|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
94389715|NCT03497897|323215934|FG000|Overall Study|Adverse Event|1|||
94389716|NCT03497897|323215935|FG001|Overall Study|Adverse Event|1|||
94389717|NCT03497897|323215936|FG002|Overall Study|Adverse Event|1|||
94389718|NCT03497897|323215934|FG000|Overall Study|Lost to Follow-up|2|||
94389719|NCT03497897|323215935|FG001|Overall Study|Lost to Follow-up|0|||
94389720|NCT03497897|323215936|FG002|Overall Study|Lost to Follow-up|2|||
94389721|NCT03497897|323215934|FG000|Overall Study|Physician Decision|1|||
94389722|NCT03497897|323215935|FG001|Overall Study|Physician Decision|0|||
94389723|NCT03497897|323215936|FG002|Overall Study|Physician Decision|0|||
94389724|NCT03497897|323215934|FG000|Overall Study|Subject/Guardian Decision|2|||
94389725|NCT03497897|323215935|FG001|Overall Study|Subject/Guardian Decision|1|||
94389726|NCT03497897|323215936|FG002|Overall Study|Subject/Guardian Decision|3|||
94389727|NCT00864097|323215938|FG000|Overall Study|Death|0|||
94389728|NCT00864097|323215939|FG001|Overall Study|Death|1|||
94389729|NCT00864097|323215940|FG002|Overall Study|Death|0|||
94389730|NCT00864097|323215941|FG003|Overall Study|Death|0|||
94389731|NCT00864097|323215938|FG000|Overall Study|Adverse Event|6|||
94389732|NCT00864097|323215939|FG001|Overall Study|Adverse Event|8|||
94389733|NCT00864097|323215940|FG002|Overall Study|Adverse Event|11|||
94389734|NCT00864097|323215941|FG003|Overall Study|Adverse Event|9|||
94389735|NCT00864097|323215938|FG000|Overall Study|Lack of Efficacy|9|||
94389736|NCT00864097|323215939|FG001|Overall Study|Lack of Efficacy|3|||
94389737|NCT00864097|323215940|FG002|Overall Study|Lack of Efficacy|7|||
94327305|NCT03589885|322978344|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
94389738|NCT00864097|323215941|FG003|Overall Study|Lack of Efficacy|2|||
94389739|NCT00864097|323215938|FG000|Overall Study|Lost to Follow-up|0|||
94389740|NCT00864097|323215939|FG001|Overall Study|Lost to Follow-up|1|||
94389741|NCT00864097|323215940|FG002|Overall Study|Lost to Follow-up|0|||
94482622|NCT03811821|323558160|FG001|Overall Study|Lost to Follow-up|2|||
94327306|NCT03589885|322978345|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
94327307|NCT03589885|322978346|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
94327308|NCT03589885|322978347|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
94327309|NCT03589885|322978343|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
94327310|NCT03589885|322978344|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
94327311|NCT03589885|322978345|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
94327312|NCT03589885|322978346|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
94327313|NCT03589885|322978347|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
94327314|NCT03589885|322978343|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
94327315|NCT03589885|322978344|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
94327316|NCT03589885|322978345|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
94327317|NCT03589885|322978346|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
94327318|NCT03589885|322978347|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
94327319|NCT03589885|322978343|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
94327320|NCT03589885|322978344|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
94327321|NCT03589885|322978345|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
94327322|NCT03589885|322978346|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
94389742|NCT00864097|323215941|FG003|Overall Study|Lost to Follow-up|1|||
94389743|NCT00864097|323215938|FG000|Overall Study|Withdrawal by Subject|15|||
94389744|NCT00864097|323215939|FG001|Overall Study|Withdrawal by Subject|11|||
94389745|NCT00864097|323215940|FG002|Overall Study|Withdrawal by Subject|11|||
94389746|NCT00864097|323215941|FG003|Overall Study|Withdrawal by Subject|12|||
94389747|NCT00864097|323215938|FG000|Overall Study|Protocol Violation|2|||
94389748|NCT00864097|323215939|FG001|Overall Study|Protocol Violation|1|||
94327323|NCT03589885|322978347|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
94327324|NCT03589885|322978343|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
94327325|NCT03589885|322978344|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
94327326|NCT03589885|322978345|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
94327327|NCT03589885|322978346|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
94327328|NCT03589885|322978347|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
94327329|NCT03589885|322978343|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
94327330|NCT03589885|322978344|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
94327331|NCT03589885|322978345|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
94327332|NCT03589885|322978346|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
94327333|NCT03589885|322978347|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
94327334|NCT03956225|322978353|FG000|Overall Study|Lack of Efficacy|1|||
94327335|NCT03956225|322978354|FG001|Overall Study|Lack of Efficacy|1|||
94327336|NCT03956225|322978353|FG000|Overall Study|Lost to Follow-up|0|||
94389749|NCT00864097|323215940|FG002|Overall Study|Protocol Violation|0|||
94389750|NCT00864097|323215941|FG003|Overall Study|Protocol Violation|1|||
94389751|NCT00864097|323215938|FG000|Overall Study|Terminated by sponsor|105|||
94389752|NCT00864097|323215939|FG001|Overall Study|Terminated by sponsor|112|||
94389753|NCT00864097|323215940|FG002|Overall Study|Terminated by sponsor|102|||
94389754|NCT00864097|323215941|FG003|Overall Study|Terminated by sponsor|99|||
94389755|NCT00864097|323215938|FG000|Overall Study|Randomized but not treated|2|||
94389756|NCT00864097|323215939|FG001|Overall Study|Randomized but not treated|0|||
94389757|NCT00864097|323215940|FG002|Overall Study|Randomized but not treated|1|||
94389758|NCT00864097|323215941|FG003|Overall Study|Randomized but not treated|0|||
94389759|NCT00864097|323215938|FG000|Overall Study|Other|0|||
94389760|NCT00864097|323215939|FG001|Overall Study|Other|0|||
94389761|NCT00864097|323215940|FG002|Overall Study|Other|0|||
94389762|NCT00864097|323215941|FG003|Overall Study|Other|1|||
94389763|NCT01591785|323215942|FG000|Overall Study|worsening condition|1|||
94389764|NCT01591785|323215943|FG001|Overall Study|worsening condition|2|||
94389765|NCT01591785|323215942|FG000|Overall Study|Protocol Violation|2|||
94389766|NCT01591785|323215943|FG001|Overall Study|Protocol Violation|0|||
94389767|NCT01591785|323215942|FG000|Overall Study|Lost to Follow-up|1|||
94389768|NCT01591785|323215943|FG001|Overall Study|Lost to Follow-up|0|||
94389769|NCT00262223|323215944|FG000|Treatment Phase|Withdrawal by Subject|3|||
94389770|NCT00262223|323215945|FG001|Treatment Phase|Withdrawal by Subject|6|||
94389771|NCT00262223|323215944|FG000|Treatment Phase|Adverse Event|1|||
94389772|NCT00262223|323215945|FG001|Treatment Phase|Adverse Event|2|||
94389773|NCT00262223|323215944|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
94389774|NCT00262223|323215945|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
94389775|NCT00262223|323215944|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
94389776|NCT00262223|323215945|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
94389777|NCT00262223|323215944|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
94389778|NCT00262223|323215945|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
94389779|NCT01367457|323215949|FG000|Overall Study|Death|2|||
94389780|NCT01367457|323215950|FG001|Overall Study|Death|0|||
94389781|NCT01367457|323215951|FG002|Overall Study|Death|0|||
94389782|NCT01367457|323215949|FG000|Overall Study|Investigator's decision|2|||
94389783|NCT01367457|323215950|FG001|Overall Study|Investigator's decision|0|||
94389784|NCT01367457|323215951|FG002|Overall Study|Investigator's decision|0|||
94389785|NCT01367457|323215949|FG000|Overall Study|Clinical decline (CD)|2|||
94389786|NCT01367457|323215950|FG001|Overall Study|Clinical decline (CD)|0|||
94389787|NCT01367457|323215951|FG002|Overall Study|Clinical decline (CD)|0|||
94389788|NCT01367457|323215949|FG000|Overall Study|Progression and death|8|||
94389789|NCT01367457|323215950|FG001|Overall Study|Progression and death|0|||
94389790|NCT01367457|323215951|FG002|Overall Study|Progression and death|0|||
94389791|NCT01367457|323215949|FG000|Overall Study|Toxicity|16|||
94389792|NCT01367457|323215950|FG001|Overall Study|Toxicity|0|||
94389793|NCT01367457|323215951|FG002|Overall Study|Toxicity|0|||
94327337|NCT03956225|322978354|FG001|Overall Study|Lost to Follow-up|1|||
94389794|NCT01367457|323215949|FG000|Overall Study|Progression|137|||
94389795|NCT01367457|323215950|FG001|Overall Study|Progression|0|||
94389796|NCT01367457|323215951|FG002|Overall Study|Progression|0|||
94389797|NCT01367457|323215949|FG000|Overall Study|Patient asks for rest + slow progression|1|||
94389798|NCT01367457|323215950|FG001|Overall Study|Patient asks for rest + slow progression|0|||
94389799|NCT01367457|323215951|FG002|Overall Study|Patient asks for rest + slow progression|0|||
94389800|NCT01367457|323215949|FG000|Overall Study|Investigator's opinion, stable disease|1|||
94389801|NCT01367457|323215950|FG001|Overall Study|Investigator's opinion, stable disease|0|||
94389802|NCT01367457|323215951|FG002|Overall Study|Investigator's opinion, stable disease|0|||
94389803|NCT01367457|323215949|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
94389804|NCT01367457|323215950|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
94327338|NCT03956225|322978353|FG000|Overall Study|Withdrawal by Subject|2|||
94327339|NCT03956225|322978354|FG001|Overall Study|Withdrawal by Subject|1|||
94327340|NCT03956225|322978353|FG000|Overall Study|Other Reasons|2|||
94389805|NCT01367457|323215951|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
94327341|NCT03956225|322978354|FG001|Overall Study|Other Reasons|1|||
94327342|NCT03519516|322978357|FG000|Overall Study|Adverse Event|0|||
94327343|NCT03519516|322978358|FG001|Overall Study|Adverse Event|1|||
94327344|NCT00805545|322978359|FG000|Overall Study|Protocol Violation|3|||
94327345|NCT00805545|322978360|FG001|Overall Study|Protocol Violation|2|||
94327346|NCT00805545|322978359|FG000|Overall Study|Protocol Violation|3|||
94327347|NCT00805545|322978360|FG001|Overall Study|Protocol Violation|1|||
94327348|NCT02379390|322978363|FG000|Overall Study|Adverse Event|1|||
94327349|NCT02379390|322978364|FG001|Overall Study|Adverse Event|1|||
94327350|NCT02379390|322978363|FG000|Overall Study|Investigator's decision|1|||
94327351|NCT02379390|322978364|FG001|Overall Study|Investigator's decision|0|||
94327352|NCT02379390|322978363|FG000|Overall Study|Study Termination|0|||
94327353|NCT02379390|322978364|FG001|Overall Study|Study Termination|1|||
94327354|NCT02721251|322978367|FG000|Overall Study|Withdrawal by Subject|8|||
94327355|NCT02721251|322978368|FG001|Overall Study|Withdrawal by Subject|7|||
94327356|NCT02721251|322978369|FG002|Overall Study|Withdrawal by Subject|9|||
94327357|NCT02721251|322978367|FG000|Overall Study|poor adherence|2|||
94327358|NCT02721251|322978368|FG001|Overall Study|poor adherence|2|||
94327359|NCT02721251|322978369|FG002|Overall Study|poor adherence|2|||
94327360|NCT01714817|322978370|FG000|Year 1 Period|Lack of Efficacy|11|||
94327361|NCT01714817|322978371|FG001|Year 1 Period|Lack of Efficacy|9|||
94327362|NCT01714817|322978370|FG000|Year 1 Period|Adverse Event|20|||
94327363|NCT01714817|322978371|FG001|Year 1 Period|Adverse Event|17|||
94327364|NCT01714817|322978370|FG000|Year 1 Period|Withdrawal by Subject|6|||
94327365|NCT01714817|322978371|FG001|Year 1 Period|Withdrawal by Subject|7|||
94327366|NCT01714817|322978370|FG000|Year 1 Period|Death|1|||
94327367|NCT01714817|322978371|FG001|Year 1 Period|Death|1|||
94327368|NCT01714817|322978370|FG000|Year 1 Period|Lost to Follow-up|0|||
94327369|NCT01714817|322978371|FG001|Year 1 Period|Lost to Follow-up|2|||
94327370|NCT01714817|322978370|FG000|Year 1 Period|Poor / non-compliance|0|||
94327371|NCT01714817|322978371|FG001|Year 1 Period|Poor / non-compliance|1|||
94327372|NCT01714817|322978370|FG000|Year 1 Period|Pregnancy|2|||
94327373|NCT01714817|322978371|FG001|Year 1 Period|Pregnancy|0|||
94327374|NCT01714817|322978370|FG000|Year 1 Period|Participant no longer meets criteria|6|||
94327375|NCT01714817|322978371|FG001|Year 1 Period|Participant no longer meets criteria|2|||
94327376|NCT01714817|322978370|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
94327377|NCT01714817|322978371|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
94327378|NCT01714817|322978370|FG000|Year 1 Period|Change in Concomitant Medication|0|||
94327379|NCT01714817|322978371|FG001|Year 1 Period|Change in Concomitant Medication|1|||
94327380|NCT01714817|322978370|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
94327381|NCT01714817|322978371|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
94327382|NCT01714817|322978370|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
94327383|NCT01714817|322978371|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
94327384|NCT01714817|322978370|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
94327385|NCT01714817|322978371|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
94327386|NCT01714817|322978370|FG000|Year 2 Period|Lack of Efficacy|4|||
94327387|NCT01714817|322978371|FG001|Year 2 Period|Lack of Efficacy|12|||
94327388|NCT01714817|322978370|FG000|Year 2 Period|Adverse Event|7|||
94327389|NCT01714817|322978371|FG001|Year 2 Period|Adverse Event|6|||
94327390|NCT01714817|322978370|FG000|Year 2 Period|Participant request to stop treatment|4|||
94327391|NCT01714817|322978371|FG001|Year 2 Period|Participant request to stop treatment|4|||
94327392|NCT01714817|322978370|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
94327393|NCT01714817|322978371|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
94327394|NCT01714817|322978370|FG000|Year 2 Period|Participant withdrew consent|1|||
94327395|NCT01714817|322978371|FG001|Year 2 Period|Participant withdrew consent|5|||
94327396|NCT01714817|322978370|FG000|Year 2 Period|Participant no longer meets criteria|1|||
94327397|NCT01714817|322978371|FG001|Year 2 Period|Participant no longer meets criteria|4|||
94327398|NCT01714817|322978370|FG000|Year 2 Period|Lost to Follow-up|2|||
94327399|NCT01714817|322978371|FG001|Year 2 Period|Lost to Follow-up|0|||
94327400|NCT01714817|322978370|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
94327401|NCT01714817|322978371|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
94327402|NCT01714817|322978370|FG000|Year 2 Period|Pregnancy|1|||
94327403|NCT01714817|322978371|FG001|Year 2 Period|Pregnancy|1|||
94327404|NCT01714817|322978370|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
94327405|NCT01714817|322978371|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
94327406|NCT01714817|322978370|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
94327407|NCT01714817|322978371|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
94327408|NCT01714817|322978370|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
94327409|NCT01714817|322978371|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
94327410|NCT01714817|322978370|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
94327411|NCT01714817|322978371|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
94327412|NCT01714817|322978370|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
94327413|NCT01714817|322978371|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
94327414|NCT01714817|322978370|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
94389806|NCT01367457|323215949|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
94389807|NCT01367457|323215950|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
94389808|NCT01367457|323215951|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
94389809|NCT01367457|323215949|FG000|Overall Study|low grade toxicities + stable disease|1|||
94389810|NCT01367457|323215950|FG001|Overall Study|low grade toxicities + stable disease|0|||
94389811|NCT01367457|323215951|FG002|Overall Study|low grade toxicities + stable disease|0|||
94389812|NCT01367457|323215949|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
94389813|NCT01367457|323215950|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
94389814|NCT01367457|323215951|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
94389815|NCT01367457|323215949|FG000|Overall Study|Withdrawal by Subject|1|||
94389816|NCT01367457|323215950|FG001|Overall Study|Withdrawal by Subject|0|||
94389817|NCT01367457|323215951|FG002|Overall Study|Withdrawal by Subject|0|||
94389818|NCT01367457|323215949|FG000|Overall Study|CD, associated leukaemia|1|||
94389819|NCT01367457|323215950|FG001|Overall Study|CD, associated leukaemia|0|||
94389820|NCT01367457|323215951|FG002|Overall Study|CD, associated leukaemia|0|||
94389821|NCT01367457|323215949|FG000|Overall Study|Uncontrolled pain|1|||
94389822|NCT01367457|323215950|FG001|Overall Study|Uncontrolled pain|0|||
94389823|NCT01367457|323215951|FG002|Overall Study|Uncontrolled pain|0|||
94389824|NCT01367457|323215949|FG000|Overall Study|Overall status worsens to grade 4|1|||
94389825|NCT01367457|323215950|FG001|Overall Study|Overall status worsens to grade 4|0|||
94389826|NCT01367457|323215951|FG002|Overall Study|Overall status worsens to grade 4|0|||
94389827|NCT01367457|323215949|FG000|Overall Study|Stabilisation + frequent infections|1|||
94389828|NCT01367457|323215950|FG001|Overall Study|Stabilisation + frequent infections|0|||
94389829|NCT01367457|323215951|FG002|Overall Study|Stabilisation + frequent infections|0|||
94389830|NCT01367457|323215949|FG000|Overall Study|No clinical benefit|1|||
94389831|NCT01367457|323215950|FG001|Overall Study|No clinical benefit|0|||
94389832|NCT01367457|323215951|FG002|Overall Study|No clinical benefit|0|||
94482623|NCT03811821|323558159|FG000|Overall Study|Contraindication for treatment|0|||
94482624|NCT03811821|323558160|FG001|Overall Study|Contraindication for treatment|1|||
94482625|NCT03811821|323558159|FG000|Overall Study|Tolerability|0|||
94482626|NCT03811821|323558160|FG001|Overall Study|Tolerability|3|||
94482627|NCT03811821|323558159|FG000|Overall Study|Comorbidities|0|||
94327415|NCT01714817|322978371|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
94327416|NCT01714817|322978370|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
94327417|NCT01714817|322978371|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
94327418|NCT01714817|322978370|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
94327419|NCT01714817|322978371|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
94327420|NCT01714817|322978370|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
94327421|NCT01714817|322978371|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
94327422|NCT01714817|322978370|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
94327423|NCT01714817|322978371|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
94327424|NCT01714817|322978370|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
94327425|NCT01714817|322978371|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
94327426|NCT01714817|322978370|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
94327427|NCT01714817|322978371|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
94327428|NCT01714817|322978370|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
94327429|NCT01714817|322978371|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
94327430|NCT01714817|322978370|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
94389833|NCT01367457|323215949|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
94389834|NCT01367457|323215950|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
94389835|NCT01367457|323215951|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
94482628|NCT03811821|323558160|FG001|Overall Study|Comorbidities|2|||
94482629|NCT00919633|323558161|FG000|Overall Study|Adverse Event|1|||
94482630|NCT00919633|323558162|FG001|Overall Study|Adverse Event|9|||
94482631|NCT00919633|323558163|FG002|Overall Study|Adverse Event|12|||
94482632|NCT00919633|323558164|FG003|Overall Study|Adverse Event|10|||
94482633|NCT00919633|323558161|FG000|Overall Study|Death|0|||
94482634|NCT00919633|323558162|FG001|Overall Study|Death|0|||
94482635|NCT00919633|323558163|FG002|Overall Study|Death|2|||
94482636|NCT00919633|323558164|FG003|Overall Study|Death|0|||
94482637|NCT00919633|323558161|FG000|Overall Study|Lack of Efficacy|17|||
94482638|NCT00919633|323558162|FG001|Overall Study|Lack of Efficacy|3|||
94482639|NCT00919633|323558163|FG002|Overall Study|Lack of Efficacy|2|||
94482640|NCT00919633|323558164|FG003|Overall Study|Lack of Efficacy|3|||
94482641|NCT00919633|323558161|FG000|Overall Study|Withdrawal by Subject|1|||
94389836|NCT01367457|323215949|FG000|Overall Study|Overall decline|1|||
94389837|NCT01367457|323215950|FG001|Overall Study|Overall decline|0|||
94482642|NCT00919633|323558162|FG001|Overall Study|Withdrawal by Subject|2|||
94482643|NCT00919633|323558163|FG002|Overall Study|Withdrawal by Subject|4|||
94482644|NCT00919633|323558164|FG003|Overall Study|Withdrawal by Subject|3|||
94482645|NCT00919633|323558161|FG000|Overall Study|Lost to Follow-up|3|||
94482646|NCT00919633|323558162|FG001|Overall Study|Lost to Follow-up|1|||
94389838|NCT01367457|323215951|FG002|Overall Study|Overall decline|0|||
94389839|NCT01367457|323215949|FG000|Overall Study|Rejection of treatment|1|||
94389840|NCT01367457|323215950|FG001|Overall Study|Rejection of treatment|0|||
94389841|NCT01367457|323215951|FG002|Overall Study|Rejection of treatment|0|||
94389842|NCT01367457|323215949|FG000|Overall Study|Lost to Follow-up|1|||
94389843|NCT01367457|323215950|FG001|Overall Study|Lost to Follow-up|0|||
94389844|NCT01367457|323215951|FG002|Overall Study|Lost to Follow-up|0|||
94389845|NCT01367457|323215949|FG000|Overall Study|Death from septic shock|1|||
94389846|NCT01367457|323215950|FG001|Overall Study|Death from septic shock|0|||
94389847|NCT01367457|323215951|FG002|Overall Study|Death from septic shock|0|||
94389848|NCT01367457|323215949|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
94389849|NCT01367457|323215950|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
94389850|NCT01367457|323215951|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
94389851|NCT01367457|323215949|FG000|Overall Study|Patient's Wish|1|||
94389852|NCT01367457|323215950|FG001|Overall Study|Patient's Wish|0|||
94389853|NCT01367457|323215951|FG002|Overall Study|Patient's Wish|0|||
94389854|NCT01367457|323215949|FG000|Overall Study|Palliative. Overall decline|1|||
94389855|NCT01367457|323215950|FG001|Overall Study|Palliative. Overall decline|0|||
94389856|NCT01367457|323215951|FG002|Overall Study|Palliative. Overall decline|0|||
94389857|NCT01367457|323215949|FG000|Overall Study|Suspected DP/suspected active infection|1|||
94389858|NCT01367457|323215950|FG001|Overall Study|Suspected DP/suspected active infection|0|||
94389859|NCT01367457|323215951|FG002|Overall Study|Suspected DP/suspected active infection|0|||
94389860|NCT02058498|323215956|FG000|Overall Study|Withdrawal by Subject|4|||
94389861|NCT03478397|323215957|FG000|Overall Study|Refused to participate|31|||
94389862|NCT03478397|323215958|FG001|Overall Study|Refused to participate|7|||
94389863|NCT05327491|323215959|FG000|Periods 1 & 2|Miscellaneous|0|||
94389864|NCT05327491|323215960|FG001|Periods 1 & 2|Miscellaneous|1|||
94389865|NCT05327491|323215961|FG002|Periods 1 & 2|Miscellaneous|0|||
94389866|NCT05327491|323215962|FG003|Periods 1 & 2|Miscellaneous|0|||
94389867|NCT05327491|323215959|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
94389868|NCT05327491|323215960|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
94389869|NCT05327491|323215961|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
94389870|NCT05327491|323215962|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
94389871|NCT00856388|323215963|FG000|Overall Study|Other|1|||
94389872|NCT05038293|323215964|FG000|Overall Study|device was not operating properly for one subject.|1|||
94389873|NCT05038293|323215965|FG001|Overall Study|device was not operating properly for one subject.|0|||
94389874|NCT05038293|323215964|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
94389875|NCT05038293|323215965|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
94389876|NCT02015390|323215969|FG000|Overall Study|Lost to Follow-up|1|||
94389877|NCT02015390|323215970|FG001|Overall Study|Lost to Follow-up|0|||
94389878|NCT02015390|323215969|FG000|Overall Study|Adverse Event|0|||
94389879|NCT02015390|323215970|FG001|Overall Study|Adverse Event|3|||
94389880|NCT02015390|323215969|FG000|Overall Study|Physician Decision|0|||
94389881|NCT02015390|323215970|FG001|Overall Study|Physician Decision|1|||
94389882|NCT02996682|323215971|FG000|Overall Study|Death|0|||
94389883|NCT02996682|323215972|FG001|Overall Study|Death|3|||
94389884|NCT02457520|323215973|FG000|Active Treatment Phase|Adverse Event|10|||
94389885|NCT02457520|323215973|FG000|Active Treatment Phase|Lost to Follow-up|8|||
94389886|NCT02457520|323215973|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
94389887|NCT02457520|323215973|FG000|Active Treatment Phase|other|4|||
94389888|NCT02457520|323215973|FG000|Active Treatment Phase|Physician Decision|1|||
94389889|NCT02457520|323215973|FG000|Active Treatment Phase|Protocol Violation|1|||
94389890|NCT02457520|323215973|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
94389891|NCT02457520|323215973|FG000|Post-treatment Period|Other: Retreatment Required|7|||
94389892|NCT02457520|323215973|FG000|Post-treatment Period|Lost to Follow-up|23|||
94389893|NCT02457520|323215973|FG000|Post-treatment Period|Other|3|||
94389894|NCT02457520|323215973|FG000|Post-treatment Period|Physician Decision|1|||
94389895|NCT02457520|323215973|FG000|Post-treatment Period|Withdrawal by Subject|14|||
94389896|NCT02587962|323215974|FG000|Overall Study|Adverse Event|0|||
94389897|NCT02587962|323215975|FG001|Overall Study|Adverse Event|0|||
94389898|NCT02587962|323215976|FG002|Overall Study|Adverse Event|1|||
94389899|NCT02587962|323215977|FG003|Overall Study|Adverse Event|0|||
94389900|NCT02587962|323215978|FG004|Overall Study|Adverse Event|0|||
94389901|NCT02587962|323215974|FG000|Overall Study|Withdrawal by Subject|0|||
94389902|NCT02587962|323215975|FG001|Overall Study|Withdrawal by Subject|0|||
94389903|NCT02587962|323215976|FG002|Overall Study|Withdrawal by Subject|1|||
94389904|NCT02587962|323215977|FG003|Overall Study|Withdrawal by Subject|1|||
94389905|NCT02587962|323215978|FG004|Overall Study|Withdrawal by Subject|4|||
94389906|NCT02587962|323215974|FG000|Overall Study|Radiological progression|2|||
94389907|NCT02587962|323215975|FG001|Overall Study|Radiological progression|2|||
94389908|NCT02587962|323215976|FG002|Overall Study|Radiological progression|2|||
94389909|NCT02587962|323215977|FG003|Overall Study|Radiological progression|5|||
94389910|NCT02587962|323215978|FG004|Overall Study|Radiological progression|10|||
94482647|NCT00919633|323558163|FG002|Overall Study|Lost to Follow-up|0|||
94389911|NCT02587962|323215974|FG000|Overall Study|Clinical progression|0|||
94327431|NCT01714817|322978371|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
94327432|NCT01714817|322978370|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
94327433|NCT01714817|322978371|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
94327434|NCT01714817|322978370|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
94327435|NCT01714817|322978371|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
94327436|NCT03495817|322978372|FG000|26 Week Open Label|Adverse Event|3|||
94327437|NCT03495817|322978372|FG000|26 Week Open Label|Withdrawal by Subject|4|||
94327438|NCT03495817|322978372|FG000|26 Week Open Label|Lost to Follow-up|1|||
94327439|NCT03495817|322978372|FG000|26 Week Extension|Lost to Follow-up|2|||
94327440|NCT01117012|322978373|FG000|Overall Study|Adverse Event|0|||
94327441|NCT01117012|322978374|FG001|Overall Study|Adverse Event|1|||
94327442|NCT01117012|322978373|FG000|Overall Study|Death|1|||
94327443|NCT01117012|322978374|FG001|Overall Study|Death|1|||
94327444|NCT01117012|322978373|FG000|Overall Study|Withdrawal by Subject|3|||
94327445|NCT01117012|322978374|FG001|Overall Study|Withdrawal by Subject|0|||
94327446|NCT01117012|322978373|FG000|Overall Study|Undefined|4|||
94327447|NCT01117012|322978374|FG001|Overall Study|Undefined|3|||
94327448|NCT01975246|322980342|FG000|Overall Study|Adverse Event|2|||
94327449|NCT01975246|322980343|FG001|Overall Study|Adverse Event|1|||
94327450|NCT01975246|322980342|FG000|Overall Study|Lack of Efficacy|1|||
94327451|NCT01975246|322980343|FG001|Overall Study|Lack of Efficacy|0|||
94327452|NCT01975246|322980342|FG000|Overall Study|Protocol Violation|1|||
94327453|NCT01975246|322980343|FG001|Overall Study|Protocol Violation|0|||
94327454|NCT01975246|322980342|FG000|Overall Study|Other than stated|0|||
94327455|NCT01975246|322980343|FG001|Overall Study|Other than stated|1|||
94327456|NCT01646398|322980350|FG000|Overall Study|Withdrawal by Subject|1|||
94327457|NCT01646398|322980351|FG001|Overall Study|Withdrawal by Subject|0|||
94327458|NCT00255034|322980352|FG000|Overall Study|Withdrawal by Subject|15|||
94327459|NCT00255034|322980353|FG001|Overall Study|Withdrawal by Subject|38|||
94327460|NCT02499575|322980354|FG000|Overall Study|Protocol Violation|0|||
94327461|NCT02499575|322980355|FG001|Overall Study|Protocol Violation|1|||
94327462|NCT00574119|322980356|FG000|Overall Study|Adverse Event|1|||
94327463|NCT00574119|322980356|FG000|Overall Study|Protocol Violation|1|||
94327464|NCT00574119|322980356|FG000|Overall Study|Withdrawal by Subject|1|||
94327465|NCT00574119|322980356|FG000|Overall Study|Physician Decision|1|||
94327466|NCT01617655|322980368|FG000|Overall Study|Adverse Event|2|||
94327467|NCT01617655|322980369|FG001|Overall Study|Adverse Event|3|||
94327468|NCT01617655|322980368|FG000|Overall Study|Poor compliance to protocol|1|||
94327469|NCT01617655|322980369|FG001|Overall Study|Poor compliance to protocol|4|||
94327470|NCT01617655|322980368|FG000|Overall Study|Participants moved|0|||
94327471|NCT01617655|322980369|FG001|Overall Study|Participants moved|4|||
94327472|NCT01617655|322980368|FG000|Overall Study|Consent withdrawn by participant|1|||
94327473|NCT01617655|322980369|FG001|Overall Study|Consent withdrawn by participant|1|||
94327474|NCT01617655|322980368|FG000|Overall Study|Last visit outside protocol visit window|1|||
94327475|NCT01617655|322980369|FG001|Overall Study|Last visit outside protocol visit window|10|||
94327476|NCT01617655|322980368|FG000|Overall Study|Site closure|3|||
94327477|NCT01617655|322980369|FG001|Overall Study|Site closure|5|||
94327478|NCT01617655|322980368|FG000|Overall Study|Other than specified above|1|||
94327479|NCT01617655|322980369|FG001|Overall Study|Other than specified above|2|||
94327480|NCT01175213|322980370|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
94327481|NCT01175213|322980371|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
94327482|NCT01175213|322980370|FG000|IGSC, 10%/rHuPH20|Death|1|||
94327483|NCT01175213|322980371|FG001|IGSC, 10%/rHuPH20|Death|0|||
94327484|NCT01175213|322980370|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
94327485|NCT01175213|322980371|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
94327486|NCT01175213|322980370|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
94327487|NCT01175213|322980371|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
94327488|NCT01175213|322980370|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
94327489|NCT01175213|322980371|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
94327490|NCT01175213|322980370|FG000|Safety Follow-up|Adverse Event|1|||
94327491|NCT01175213|322980371|FG001|Safety Follow-up|Adverse Event|0|||
94327492|NCT00949910|322980372|FG000|Overall Study|Progressive Disease|3750|||
94327493|NCT00949910|322980372|FG000|Overall Study|Symptomatic Deterioration|1088|||
94327494|NCT00949910|322980372|FG000|Overall Study|Lost to Follow-up|100|||
94327495|NCT00949910|322980372|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
94327496|NCT00949910|322980372|FG000|Overall Study|Participant Refusal|390|||
94327497|NCT00949910|322980372|FG000|Overall Study|Death Due to Malignant Disease|456|||
94327498|NCT00949910|322980372|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
94327499|NCT00949910|322980372|FG000|Overall Study|Death Due to Adverse Event|115|||
94327500|NCT00949910|322980372|FG000|Overall Study|Death Due to Toxicity|3|||
94327501|NCT00949910|322980372|FG000|Overall Study|Death from Unknown Cause|5|||
94327502|NCT00949910|322980372|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
94327503|NCT00949910|322980372|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
94327504|NCT00949910|322980372|FG000|Overall Study|Switched to Commercial Treatment|4|||
94327505|NCT00949910|322980372|FG000|Overall Study|Violation of Eligibility|23|||
94327506|NCT00949910|322980372|FG000|Overall Study|Logistical Reasons|13|||
94389912|NCT02587962|323215975|FG001|Overall Study|Clinical progression|1|||
94389913|NCT02587962|323215976|FG002|Overall Study|Clinical progression|2|||
94389914|NCT02587962|323215977|FG003|Overall Study|Clinical progression|0|||
94389915|NCT02587962|323215978|FG004|Overall Study|Clinical progression|1|||
94389916|NCT00282048|323215979|FG000|Overall Study|Lack of Efficacy|30|||
94389917|NCT00282048|323215979|FG000|Overall Study|Adverse Event|22|||
94389918|NCT00282048|323215979|FG000|Overall Study|Withdrawal by Subject|1|||
94389919|NCT00282048|323215979|FG000|Overall Study|Other|8|||
94389920|NCT00282048|323215979|FG000|Overall Study|Ongoing|1|||
94389921|NCT01185548|323215980|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
94389922|NCT02678286|323215981|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
94389923|NCT02678286|323215982|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
94389924|NCT02678286|323215981|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
94389925|NCT02678286|323215982|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
94389926|NCT02678286|323215981|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
94389927|NCT02678286|323215982|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
94389928|NCT02678286|323215981|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
94389929|NCT02678286|323215982|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
94389930|NCT02678286|323215981|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
94389931|NCT02678286|323215982|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
94389932|NCT00086996|323215984|FG000|Overall Study|Adverse Event|29|||
94389933|NCT00086996|323215984|FG000|Overall Study|Death|4|||
94389934|NCT00086996|323215984|FG000|Overall Study|progression/relapse|7|||
94389935|NCT00086996|323215984|FG000|Overall Study|Withdrawal by Subject|13|||
94389936|NCT00086996|323215984|FG000|Overall Study|Other|6|||
94389937|NCT00086996|323215984|FG000|Overall Study|not eligible|5|||
94389938|NCT01422538|323215987|FG000|Overall Study|Lost to Follow-up|0|||
94389939|NCT01422538|323215988|FG001|Overall Study|Lost to Follow-up|1|||
94389940|NCT01422538|323215989|FG002|Overall Study|Lost to Follow-up|1|||
94389941|NCT01422538|323215987|FG000|Overall Study|Missed visit|0|||
94389942|NCT01422538|323215988|FG001|Overall Study|Missed visit|1|||
94389943|NCT01422538|323215989|FG002|Overall Study|Missed visit|1|||
94389944|NCT00312663|323215992|FG000|Immunization Phase|Adverse Event|0|||
94389945|NCT00312663|323215993|FG001|Immunization Phase|Adverse Event|1|||
94389946|NCT00312663|323215994|FG002|Immunization Phase|Adverse Event|0|||
94389947|NCT00286754|323216002|FG000|Overall Study|Adverse Event|2|||
94389948|NCT00286754|323216003|FG001|Overall Study|Adverse Event|2|||
94389949|NCT00286754|323216004|FG002|Overall Study|Adverse Event|3|||
94389950|NCT00286754|323216002|FG000|Overall Study|Withdrawal by Subject|6|||
94389951|NCT00286754|323216003|FG001|Overall Study|Withdrawal by Subject|2|||
94389952|NCT00286754|323216004|FG002|Overall Study|Withdrawal by Subject|0|||
94389953|NCT00286754|323216002|FG000|Overall Study|Lost to Follow-up|12|||
94389954|NCT00286754|323216003|FG001|Overall Study|Lost to Follow-up|14|||
94389955|NCT00286754|323216004|FG002|Overall Study|Lost to Follow-up|6|||
94389956|NCT00286754|323216002|FG000|Overall Study|Moved out of state|0|||
94389957|NCT00286754|323216003|FG001|Overall Study|Moved out of state|0|||
94389958|NCT00286754|323216004|FG002|Overall Study|Moved out of state|1|||
94389959|NCT01772537|323216015|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
94389960|NCT01772537|323216016|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
94389961|NCT01772537|323216017|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
94389962|NCT02098876|323216018|FG000|Overall Study|Withdrawal by Subject|5|||
94389963|NCT02098876|323216019|FG001|Overall Study|Withdrawal by Subject|5|||
94389964|NCT01263704|323216020|FG000|Overall Study|Progressive disease|18|||
94389965|NCT01263704|323216020|FG000|Overall Study|Adverse Event|3|||
94389966|NCT01263704|323216020|FG000|Overall Study|Death|2|||
94389967|NCT01263704|323216020|FG000|Overall Study|Patient withdrew consent|2|||
94389968|NCT01263704|323216020|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
94389969|NCT01263704|323216020|FG000|Overall Study|Lost to Follow-up|1|||
94389970|NCT01263704|323216020|FG000|Overall Study|Colon metastases|1|||
94389971|NCT01263704|323216020|FG000|Overall Study|Principal Investigator (PI) decision|1|||
94389972|NCT01061866|323216021|FG000|Overall Study|Adverse Event|2|||
94389973|NCT01270503|323216022|FG000|Overall Study|Lost to Follow-up|1|||
94389974|NCT04384978|323216030|FG000|Overall Study|Withdrawal by Subject|4|||
94389975|NCT04384978|323216031|FG001|Overall Study|Withdrawal by Subject|0|||
94389976|NCT04419311|323216032|FG000|Overall Study|Lost to Follow-up|1|||
94389977|NCT04419311|323216033|FG001|Overall Study|Lost to Follow-up|0|||
94389978|NCT03555305|323216034|FG000|Period 1|Physician Decision|0|||
94389979|NCT03555305|323216035|FG001|Period 1|Physician Decision|1|||
94389980|NCT03555305|323216034|FG000|Period 1|Adverse Event|0|||
94389981|NCT03555305|323216035|FG001|Period 1|Adverse Event|1|||
94389982|NCT03966365|323216045|FG000|Overall Study|Protocol Violation|1|||
94389983|NCT03966365|323216046|FG001|Overall Study|Protocol Violation|0|||
94389984|NCT02100228|323216047|FG000|Overall Study|Other|19|||
94389985|NCT02100228|323216048|FG001|Overall Study|Other|19|||
94389986|NCT02100228|323216047|FG000|Overall Study|Administrative reason|0|||
94389987|NCT02100228|323216048|FG001|Overall Study|Administrative reason|1|||
94389988|NCT02100228|323216047|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
94327507|NCT00949910|322980372|FG000|Overall Study|Non-Compliance|10|||
94327508|NCT00949910|322980372|FG000|Overall Study|Prolonged Dosing Interruption|4|||
94327509|NCT00949910|322980372|FG000|Overall Study|Adverse Event|83|||
94327510|NCT00949910|322980372|FG000|Overall Study|Serious Adverse Event|6|||
94327511|NCT00949910|322980372|FG000|Overall Study|Physician/Participant Decision|7|||
94327512|NCT00949910|322980372|FG000|Overall Study|Other|4|||
94327513|NCT00949910|322980372|FG000|Overall Study|No Data|9|||
94327514|NCT01245764|322980377|FG000|Study Phase A|Other|3|||
94327515|NCT01245764|322980378|FG001|Study Phase A|Other|2|||
94327516|NCT01245764|322980379|FG002|Study Phase A|Other|3|||
94327517|NCT01245764|322980380|FG003|Study Phase A|Other|1|||
94327518|NCT01245764|322980377|FG000|Study Phase A|Protocol Violation|6|||
94327519|NCT01245764|322980378|FG001|Study Phase A|Protocol Violation|3|||
94327520|NCT01245764|322980379|FG002|Study Phase A|Protocol Violation|2|||
94327521|NCT01245764|322980380|FG003|Study Phase A|Protocol Violation|2|||
94327522|NCT01245764|322980377|FG000|Study Phase A|Lost to Follow-up|0|||
94327523|NCT01245764|322980378|FG001|Study Phase A|Lost to Follow-up|0|||
94327524|NCT01245764|322980379|FG002|Study Phase A|Lost to Follow-up|5|||
94327525|NCT01245764|322980380|FG003|Study Phase A|Lost to Follow-up|0|||
94327526|NCT03297216|322980381|FG000|Overall Study|Death|0|||
94327527|NCT03297216|322980382|FG001|Overall Study|Death|1|||
94327528|NCT03297216|322980381|FG000|Overall Study|Miscarriage|0|||
94327529|NCT03297216|322980382|FG001|Overall Study|Miscarriage|2|||
94327530|NCT03297216|322980381|FG000|Overall Study|Lost to Follow-up|3|||
94327531|NCT03297216|322980382|FG001|Overall Study|Lost to Follow-up|2|||
94327532|NCT03172481|322980383|FG000|Double-blind|Withdrawal by Subject|1|||
94327533|NCT03172481|322980384|FG001|Double-blind|Withdrawal by Subject|0|||
94327534|NCT01925612|322980386|FG000|Overall Study|Progressive Disease|1|||
94327535|NCT01925612|322980387|FG001|Overall Study|Progressive Disease|1|||
94327536|NCT01925612|322980388|FG002|Overall Study|Progressive Disease|1|||
94327537|NCT01925612|322980389|FG003|Overall Study|Progressive Disease|0|||
94327538|NCT01925612|322980390|FG004|Overall Study|Progressive Disease|0|||
94327539|NCT01925612|322980386|FG000|Overall Study|Adverse Event|3|||
94327540|NCT01925612|322980387|FG001|Overall Study|Adverse Event|3|||
94327541|NCT01925612|322980388|FG002|Overall Study|Adverse Event|0|||
94327542|NCT01925612|322980389|FG003|Overall Study|Adverse Event|1|||
94327543|NCT01925612|322980390|FG004|Overall Study|Adverse Event|2|||
94327544|NCT00225147|322980393|FG000|Open-label Phase|Lost to Follow-up|0|||
94327545|NCT00225147|322980394|FG001|Open-label Phase|Lost to Follow-up|0|||
94327546|NCT00225147|322980395|FG002|Open-label Phase|Lost to Follow-up|0|||
94327547|NCT00225147|322980396|FG003|Open-label Phase|Lost to Follow-up|4|||
94327548|NCT00225147|322980393|FG000|Open-label Phase|Withdrawal by Subject|0|||
94327549|NCT00225147|322980394|FG001|Open-label Phase|Withdrawal by Subject|0|||
94327550|NCT00225147|322980395|FG002|Open-label Phase|Withdrawal by Subject|0|||
94327551|NCT00225147|322980396|FG003|Open-label Phase|Withdrawal by Subject|6|||
94327552|NCT04019795|322980397|FG000|Overall Study|Withdrawal by Subject|1|||
94327553|NCT04019795|322980398|FG001|Overall Study|Withdrawal by Subject|2|||
94327554|NCT04019795|322980399|FG002|Overall Study|Withdrawal by Subject|2|||
94327555|NCT04019795|322980400|FG003|Overall Study|Withdrawal by Subject|1|||
94327556|NCT04019795|322980397|FG000|Overall Study|Lost to Follow-up|0|||
94327557|NCT04019795|322980398|FG001|Overall Study|Lost to Follow-up|1|||
94327558|NCT04019795|322980399|FG002|Overall Study|Lost to Follow-up|1|||
94327559|NCT04019795|322980400|FG003|Overall Study|Lost to Follow-up|2|||
94327560|NCT04019795|322980397|FG000|Overall Study|Treatment non-compliance|3|||
94327561|NCT04019795|322980398|FG001|Overall Study|Treatment non-compliance|1|||
94327562|NCT04019795|322980399|FG002|Overall Study|Treatment non-compliance|2|||
94327563|NCT04019795|322980400|FG003|Overall Study|Treatment non-compliance|0|||
94327564|NCT04019795|322980397|FG000|Overall Study|Physician Decision|0|||
94327565|NCT04019795|322980398|FG001|Overall Study|Physician Decision|0|||
94327566|NCT04019795|322980399|FG002|Overall Study|Physician Decision|1|||
94327567|NCT04019795|322980400|FG003|Overall Study|Physician Decision|0|||
94327568|NCT04019795|322980397|FG000|Overall Study|Adverse Event|1|||
94327569|NCT04019795|322980398|FG001|Overall Study|Adverse Event|0|||
94327570|NCT04019795|322980399|FG002|Overall Study|Adverse Event|0|||
94327571|NCT04019795|322980400|FG003|Overall Study|Adverse Event|0|||
94327572|NCT03024255|322980401|FG000|Overall Study|Adverse Event|1|||
94327573|NCT03024255|322980402|FG001|Overall Study|Adverse Event|4|||
94327574|NCT03024255|322980403|FG002|Overall Study|Adverse Event|8|||
94327575|NCT03024255|322980404|FG003|Overall Study|Adverse Event|0|||
94327576|NCT03024255|322980401|FG000|Overall Study|Withdrawal by Subject|3|||
94327577|NCT03024255|322980402|FG001|Overall Study|Withdrawal by Subject|1|||
94327578|NCT03024255|322980403|FG002|Overall Study|Withdrawal by Subject|0|||
94327579|NCT03024255|322980404|FG003|Overall Study|Withdrawal by Subject|3|||
94327580|NCT03024255|322980401|FG000|Overall Study|Protocol Violation|0|||
94327581|NCT03024255|322980402|FG001|Overall Study|Protocol Violation|0|||
94327582|NCT03024255|322980403|FG002|Overall Study|Protocol Violation|2|||
94327583|NCT03024255|322980404|FG003|Overall Study|Protocol Violation|0|||
94327584|NCT03024255|322980401|FG000|Overall Study|Lost to Follow-up|1|||
94327585|NCT03024255|322980402|FG001|Overall Study|Lost to Follow-up|2|||
94327586|NCT03024255|322980403|FG002|Overall Study|Lost to Follow-up|1|||
94389989|NCT02100228|323216048|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
94389990|NCT02100228|323216047|FG000|Overall Study|Non-compliance|0|||
94389991|NCT02100228|323216048|FG001|Overall Study|Non-compliance|3|||
94389992|NCT02100228|323216047|FG000|Overall Study|Lost to Follow-up|0|||
94389993|NCT02100228|323216048|FG001|Overall Study|Lost to Follow-up|1|||
94389994|NCT02100228|323216047|FG000|Overall Study|Withdrawal by Subject|27|||
94389995|NCT02100228|323216048|FG001|Overall Study|Withdrawal by Subject|37|||
94389996|NCT02100228|323216047|FG000|Overall Study|Adverse Event|16|||
94389997|NCT02100228|323216048|FG001|Overall Study|Adverse Event|12|||
94389998|NCT02100228|323216047|FG000|Overall Study|Death|1|||
94389999|NCT02100228|323216048|FG001|Overall Study|Death|1|||
94390000|NCT02335658|323216059|FG000|Overall Study|Adverse Event|18|||
94390001|NCT02335658|323216060|FG001|Overall Study|Adverse Event|12|||
94390002|NCT02335658|323216059|FG000|Overall Study|Lack of Efficacy|4|||
94390003|NCT02335658|323216060|FG001|Overall Study|Lack of Efficacy|5|||
94390004|NCT02335658|323216059|FG000|Overall Study|Pregnancy|1|||
94390005|NCT02335658|323216060|FG001|Overall Study|Pregnancy|0|||
94390006|NCT02335658|323216059|FG000|Overall Study|Withdrawal by Subject|13|||
94390007|NCT02335658|323216060|FG001|Overall Study|Withdrawal by Subject|21|||
94390008|NCT02335658|323216059|FG000|Overall Study|non-compliance|2|||
94390009|NCT02335658|323216060|FG001|Overall Study|non-compliance|3|||
94390010|NCT02335658|323216059|FG000|Overall Study|other reason|2|||
94390011|NCT02335658|323216060|FG001|Overall Study|other reason|3|||
94390012|NCT03500692|323216061|FG000|Overall Study|Death|163|||
94390013|NCT03500692|323216061|FG000|Overall Study|Lost to Follow-up|75|||
94390014|NCT03500692|323216061|FG000|Overall Study|Termination Reasons|3|||
94390015|NCT02305758|323216062|FG000|Overall Study|Death|27|||
94390016|NCT02305758|323216063|FG001|Overall Study|Death|27|||
94390017|NCT02305758|323216062|FG000|Overall Study|Withdrew consent|9|||
94390018|NCT02305758|323216063|FG001|Overall Study|Withdrew consent|2|||
94390019|NCT02305758|323216062|FG000|Overall Study|Lost to Follow-up|6|||
94390020|NCT02305758|323216063|FG001|Overall Study|Lost to Follow-up|1|||
94390021|NCT02305758|323216062|FG000|Overall Study|Study Terminated by Sponsor|21|||
94390022|NCT02305758|323216063|FG001|Overall Study|Study Terminated by Sponsor|34|||
94390023|NCT02305758|323216062|FG000|Overall Study|Other, not specified|2|||
94390024|NCT02305758|323216063|FG001|Overall Study|Other, not specified|1|||
94390025|NCT05593965|323216064|FG000|1st Intervention (1 Day)|Technical error|1|||
94390026|NCT05593965|323216065|FG001|1st Intervention (1 Day)|Technical error|0|||
94390027|NCT03020641|323216068|FG000|Overall Study|Lost to Follow-up|0|||
94390028|NCT03020641|323216069|FG001|Overall Study|Lost to Follow-up|1|||
94390029|NCT03020641|323216068|FG000|Overall Study|Converted to open surgery|2|||
94390030|NCT03020641|323216069|FG001|Overall Study|Converted to open surgery|1|||
94390031|NCT03020641|323216068|FG000|Overall Study|for surgery not performed|0|||
94390032|NCT03020641|323216069|FG001|Overall Study|for surgery not performed|1|||
94390033|NCT00939003|323216070|FG000|Double-blind Treatment Period|Adverse Event|1|||
94390034|NCT00939003|323216071|FG001|Double-blind Treatment Period|Adverse Event|1|||
94390035|NCT00939003|323216070|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
94390036|NCT00939003|323216071|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
94390037|NCT00939003|323216070|FG000|Double-blind Treatment Period|Pregnancy|0|||
94390038|NCT00939003|323216071|FG001|Double-blind Treatment Period|Pregnancy|1|||
94390039|NCT00939003|323216070|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
94390040|NCT00939003|323216071|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
94390041|NCT00939003|323216070|FG000|Open-label Treatment Period|Adverse Event|4|||
94390042|NCT00939003|323216071|FG001|Open-label Treatment Period|Adverse Event|8|||
94390043|NCT00939003|323216070|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
94390044|NCT00939003|323216071|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
94390045|NCT00939003|323216070|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
94390046|NCT00939003|323216071|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
94390047|NCT00939003|323216070|FG000|Open-label Treatment Period|Pregnancy|1|||
94390048|NCT00939003|323216071|FG001|Open-label Treatment Period|Pregnancy|1|||
94390049|NCT00939003|323216070|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
94390050|NCT00939003|323216071|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
94390051|NCT00939003|323216070|FG000|Open-label Treatment Period|Site Closure|3|||
94390052|NCT00939003|323216071|FG001|Open-label Treatment Period|Site Closure|4|||
94390053|NCT04611789|323216072|FG000|Overall Study|Lost to Follow-up|1|||
94390054|NCT04611789|323216073|FG001|Overall Study|Lost to Follow-up|0|||
94482648|NCT00919633|323558164|FG003|Overall Study|Lost to Follow-up|2|||
94482649|NCT00919633|323558161|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
94390055|NCT04611789|323216074|FG002|Overall Study|Lost to Follow-up|0|||
94390056|NCT00397488|323218036|FG000|Overall Study|Withdrawal by Subject|3|||
94390057|NCT00397488|323218036|FG000|Overall Study|Adverse Event|3|||
94390058|NCT00397488|323218036|FG000|Overall Study|Death|1|||
94390059|NCT02943447|323218039|FG000|Blinded Study Phase|Withdrew Consent|1|||
94390060|NCT02943447|323218040|FG001|Blinded Study Phase|Withdrew Consent|2|||
94390061|NCT02943447|323218041|FG002|Blinded Study Phase|Withdrew Consent|1|||
94390062|NCT02943447|323218039|FG000|Blinded Study Phase|Adverse Event|3|||
94390063|NCT02943447|323218040|FG001|Blinded Study Phase|Adverse Event|0|||
94390064|NCT02943447|323218041|FG002|Blinded Study Phase|Adverse Event|0|||
94390065|NCT02943447|323218039|FG000|Blinded Study Phase|Investigator's discretion|1|||
94390066|NCT02943447|323218040|FG001|Blinded Study Phase|Investigator's discretion|0|||
94327587|NCT03024255|322980404|FG003|Overall Study|Lost to Follow-up|1|||
94327588|NCT03024255|322980401|FG000|Overall Study|Lack of Efficacy|1|||
94327589|NCT03024255|322980402|FG001|Overall Study|Lack of Efficacy|0|||
94327590|NCT03024255|322980403|FG002|Overall Study|Lack of Efficacy|0|||
94327591|NCT03024255|322980404|FG003|Overall Study|Lack of Efficacy|0|||
94327592|NCT03024255|322980401|FG000|Overall Study|Protocol Noncompliance|1|||
94327593|NCT03024255|322980402|FG001|Overall Study|Protocol Noncompliance|1|||
94327594|NCT03024255|322980403|FG002|Overall Study|Protocol Noncompliance|0|||
94327595|NCT03024255|322980404|FG003|Overall Study|Protocol Noncompliance|1|||
94327596|NCT03819218|322980413|FG000|Overall Study|Protocol Violation|1|||
94327597|NCT02899377|322980414|FG000|Overall Study|Adverse Event|1|||
94327598|NCT02899377|322980415|FG001|Overall Study|Adverse Event|0|||
94327599|NCT01231607|322980416|FG000|Overall Study|Adverse Event|0|||
94327600|NCT01231607|322980417|FG001|Overall Study|Adverse Event|8|||
94327601|NCT01231607|322980418|FG002|Overall Study|Adverse Event|4|||
94327602|NCT01231607|322980419|FG003|Overall Study|Adverse Event|4|||
94327603|NCT01231607|322980420|FG004|Overall Study|Adverse Event|5|||
94327604|NCT01231607|322980416|FG000|Overall Study|Lost to Follow-up|13|||
94327605|NCT01231607|322980417|FG001|Overall Study|Lost to Follow-up|11|||
94327606|NCT01231607|322980418|FG002|Overall Study|Lost to Follow-up|10|||
94327607|NCT01231607|322980419|FG003|Overall Study|Lost to Follow-up|10|||
94327608|NCT01231607|322980420|FG004|Overall Study|Lost to Follow-up|4|||
94327609|NCT01231607|322980416|FG000|Overall Study|Physician Decision|4|||
94327610|NCT01231607|322980417|FG001|Overall Study|Physician Decision|4|||
94327611|NCT01231607|322980418|FG002|Overall Study|Physician Decision|3|||
94327612|NCT01231607|322980419|FG003|Overall Study|Physician Decision|5|||
94327613|NCT01231607|322980420|FG004|Overall Study|Physician Decision|4|||
94327614|NCT01231607|322980416|FG000|Overall Study|Protocol Violation|3|||
94327615|NCT01231607|322980417|FG001|Overall Study|Protocol Violation|2|||
94327616|NCT01231607|322980418|FG002|Overall Study|Protocol Violation|0|||
94327617|NCT01231607|322980419|FG003|Overall Study|Protocol Violation|2|||
94327618|NCT01231607|322980420|FG004|Overall Study|Protocol Violation|2|||
94327619|NCT01231607|322980416|FG000|Overall Study|Withdrawal by Subject|9|||
94327620|NCT01231607|322980417|FG001|Overall Study|Withdrawal by Subject|9|||
94327621|NCT01231607|322980418|FG002|Overall Study|Withdrawal by Subject|14|||
94327622|NCT01231607|322980419|FG003|Overall Study|Withdrawal by Subject|17|||
94327623|NCT01231607|322980420|FG004|Overall Study|Withdrawal by Subject|9|||
94327624|NCT03325556|322980421|FG000|Open-label Period|Lack of Response in OL period|70|||
94327625|NCT03325556|322980422|FG001|Open-label Period|Lack of Response in OL period|0|||
94327626|NCT03325556|322980423|FG002|Open-label Period|Lack of Response in OL period|0|||
94327627|NCT03325556|322980421|FG000|Open-label Period|Adverse Event|27|||
94327628|NCT03325556|322980422|FG001|Open-label Period|Adverse Event|0|||
94327629|NCT03325556|322980423|FG002|Open-label Period|Adverse Event|0|||
94327630|NCT03325556|322980421|FG000|Open-label Period|Death|1|||
94327631|NCT03325556|322980422|FG001|Open-label Period|Death|0|||
94327632|NCT03325556|322980423|FG002|Open-label Period|Death|0|||
94327633|NCT03325556|322980421|FG000|Open-label Period|Lost to Follow-up|1|||
94327634|NCT03325556|322980422|FG001|Open-label Period|Lost to Follow-up|0|||
94327635|NCT03325556|322980423|FG002|Open-label Period|Lost to Follow-up|0|||
94327636|NCT03325556|322980421|FG000|Open-label Period|Non-compliance with study drug|5|||
94327637|NCT03325556|322980422|FG001|Open-label Period|Non-compliance with study drug|0|||
94327638|NCT03325556|322980423|FG002|Open-label Period|Non-compliance with study drug|0|||
94327639|NCT03325556|322980421|FG000|Open-label Period|Use of prohibited medication|1|||
94327640|NCT03325556|322980422|FG001|Open-label Period|Use of prohibited medication|0|||
94327641|NCT03325556|322980423|FG002|Open-label Period|Use of prohibited medication|0|||
94327642|NCT03325556|322980421|FG000|Open-label Period|Protocol Violation|4|||
94327643|NCT03325556|322980422|FG001|Open-label Period|Protocol Violation|0|||
94327644|NCT03325556|322980423|FG002|Open-label Period|Protocol Violation|0|||
94327645|NCT03325556|322980421|FG000|Open-label Period|Withdrawal by Subject|17|||
94390067|NCT02943447|323218041|FG002|Blinded Study Phase|Investigator's discretion|0|||
94327646|NCT03325556|322980422|FG001|Open-label Period|Withdrawal by Subject|0|||
94327647|NCT03325556|322980423|FG002|Open-label Period|Withdrawal by Subject|0|||
94327648|NCT03325556|322980421|FG000|Open-label Period|Not otherwise specified|8|||
94327649|NCT03325556|322980422|FG001|Open-label Period|Not otherwise specified|0|||
94327650|NCT03325556|322980423|FG002|Open-label Period|Not otherwise specified|0|||
94327651|NCT03325556|322980421|FG000|Open-label Period|Administrative discont. at study termination|41|||
94327652|NCT03325556|322980422|FG001|Open-label Period|Administrative discont. at study termination|0|||
94327653|NCT03325556|322980423|FG002|Open-label Period|Administrative discont. at study termination|0|||
94327654|NCT03325556|322980421|FG000|Double-blind Period|Relapse|0|||
94327655|NCT03325556|322980422|FG001|Double-blind Period|Relapse|15|||
94327656|NCT03325556|322980423|FG002|Double-blind Period|Relapse|34|||
94327657|NCT03325556|322980421|FG000|Double-blind Period|Adverse Event|0|||
94327658|NCT03325556|322980422|FG001|Double-blind Period|Adverse Event|3|||
94327659|NCT03325556|322980423|FG002|Double-blind Period|Adverse Event|1|||
94390068|NCT02943447|323218039|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
94390069|NCT02943447|323218040|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
94390070|NCT02943447|323218041|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
94390071|NCT02943447|323218039|FG000|Open-Label Extension Phase|Adverse Event|4|||
94390072|NCT02943447|323218040|FG001|Open-Label Extension Phase|Adverse Event|7|||
94390073|NCT02943447|323218041|FG002|Open-Label Extension Phase|Adverse Event|3|||
94390074|NCT02943447|323218039|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
94390075|NCT02943447|323218040|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
94390076|NCT02943447|323218041|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
94390077|NCT02943447|323218039|FG000|Open-Label Extension Phase|Withdrew consent|1|||
94390078|NCT02943447|323218040|FG001|Open-Label Extension Phase|Withdrew consent|1|||
94390079|NCT02943447|323218041|FG002|Open-Label Extension Phase|Withdrew consent|1|||
94390080|NCT02943447|323218039|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
94390081|NCT02943447|323218040|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
94390082|NCT02943447|323218041|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
94390083|NCT00420303|323218042|FG000|Overall Study|Serious Adverse Event|1|||
94390084|NCT00420303|323218043|FG001|Overall Study|Serious Adverse Event|0|||
94390085|NCT00420303|323218042|FG000|Overall Study|Lack of Efficacy|0|||
94390086|NCT00420303|323218043|FG001|Overall Study|Lack of Efficacy|3|||
94390087|NCT00420303|323218042|FG000|Overall Study|Physician Decision|0|||
94390088|NCT00420303|323218043|FG001|Overall Study|Physician Decision|1|||
94390089|NCT01948258|323218050|FG000|Overall Study|Pregnancy|41|||
94390090|NCT01948258|323218050|FG000|Overall Study|Did not complete by cut-off date|35|||
94390091|NCT01948258|323218050|FG000|Overall Study|Lost to Follow-up|27|||
94390092|NCT01948258|323218050|FG000|Overall Study|Withdrawal by SPD|8|||
94390093|NCT01948258|323218050|FG000|Overall Study|Withdrawal by Subject|6|||
94390094|NCT01948258|323218050|FG000|Overall Study|Health Care Professional|43|||
94390095|NCT01948258|323218050|FG000|Overall Study|Removed from statistical analysis|2|||
94390096|NCT00905346|323218060|FG000|Period 1|Withdrawal by Subject|1|||
94390097|NCT00905346|323218061|FG001|Period 1|Withdrawal by Subject|0|||
94390098|NCT01149473|323218062|FG000|First Intervention|Adverse Event|1|||
94390099|NCT01149473|323218063|FG001|First Intervention|Adverse Event|1|||
94390100|NCT01149473|323218062|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
94390101|NCT01149473|323218063|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
94390102|NCT01328093|323218064|FG000|Double-Blind Phase|Adverse Event|78|||
94390103|NCT01328093|323218065|FG001|Double-Blind Phase|Adverse Event|15|||
94390104|NCT01328093|323218064|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
94390105|NCT01328093|323218065|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
94390106|NCT01328093|323218064|FG000|Double-Blind Phase|Lost to Follow-up|39|||
94390107|NCT01328093|323218065|FG001|Double-Blind Phase|Lost to Follow-up|14|||
94390108|NCT01328093|323218064|FG000|Double-Blind Phase|Protocol Violation|30|||
94390109|NCT01328093|323218065|FG001|Double-Blind Phase|Protocol Violation|10|||
94390110|NCT01328093|323218064|FG000|Double-Blind Phase|Lack of Efficacy|55|||
94390111|NCT01328093|323218065|FG001|Double-Blind Phase|Lack of Efficacy|13|||
94390112|NCT01328093|323218064|FG000|Double-Blind Phase|Sponsor Decision|17|||
94390113|NCT01328093|323218065|FG001|Double-Blind Phase|Sponsor Decision|3|||
94390114|NCT01328093|323218064|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
94390115|NCT01328093|323218065|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
94390116|NCT01328093|323218064|FG000|Double-Blind Phase|Scheduling conflict|8|||
94390117|NCT01328093|323218065|FG001|Double-Blind Phase|Scheduling conflict|3|||
94390118|NCT01328093|323218064|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
94390119|NCT01328093|323218065|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
94390120|NCT01328093|323218064|FG000|Double-Blind Phase|Death|1|||
94390121|NCT01328093|323218065|FG001|Double-Blind Phase|Death|0|||
94390122|NCT01328093|323218064|FG000|Open-Label Phase|Sponsor Decision|98|||
94390123|NCT01328093|323218065|FG001|Open-Label Phase|Sponsor Decision|34|||
94390124|NCT01328093|323218064|FG000|Open-Label Phase|Protocol Violation|8|||
94390125|NCT01328093|323218065|FG001|Open-Label Phase|Protocol Violation|3|||
94390126|NCT01328093|323218064|FG000|Open-Label Phase|Lost to Follow-up|10|||
94390127|NCT01328093|323218065|FG001|Open-Label Phase|Lost to Follow-up|1|||
94390128|NCT01328093|323218064|FG000|Open-Label Phase|Adverse Event|10|||
94390129|NCT01328093|323218065|FG001|Open-Label Phase|Adverse Event|4|||
94390130|NCT01328093|323218064|FG000|Open-Label Phase|Lack of Efficacy|5|||
94390131|NCT01328093|323218065|FG001|Open-Label Phase|Lack of Efficacy|6|||
94390132|NCT01328093|323218064|FG000|Open-Label Phase|Withdrawal by Subject|4|||
94390133|NCT01328093|323218065|FG001|Open-Label Phase|Withdrawal by Subject|1|||
94390134|NCT01328093|323218064|FG000|Open-Label Phase|Scheduling conflict|2|||
94390135|NCT01328093|323218065|FG001|Open-Label Phase|Scheduling conflict|1|||
94390136|NCT01328093|323218064|FG000|Open-Label Phase|Subject is moving or has moved|2|||
94482650|NCT00919633|323558162|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
94390137|NCT01328093|323218065|FG001|Open-Label Phase|Subject is moving or has moved|0|||
94390138|NCT01328093|323218064|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
94390139|NCT01328093|323218065|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
94390140|NCT00832377|323218066|FG000|Overall Study|Protocol Violation|1|||
94390141|NCT02924883|323218067|FG000|Overall Study|Death|39|||
94390142|NCT02924883|323218068|FG001|Overall Study|Death|20|||
94390143|NCT02924883|323218067|FG000|Overall Study|Lost to Follow-up|1|||
94390144|NCT02924883|323218068|FG001|Overall Study|Lost to Follow-up|0|||
94390145|NCT02924883|323218067|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
94390146|NCT02924883|323218068|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
94390147|NCT02924883|323218067|FG000|Overall Study|Protocol Violation|1|||
94390148|NCT02924883|323218068|FG001|Overall Study|Protocol Violation|0|||
94390149|NCT02924883|323218067|FG000|Overall Study|Withdrawal by Subject|22|||
94390150|NCT02924883|323218068|FG001|Overall Study|Withdrawal by Subject|16|||
94390151|NCT02924883|323218067|FG000|Overall Study|Progressive Disease|1|||
94390152|NCT02924883|323218068|FG001|Overall Study|Progressive Disease|0|||
94390153|NCT02924883|323218067|FG000|Overall Study|Study Terminated by Sponsor|69|||
94390154|NCT02924883|323218068|FG001|Overall Study|Study Terminated by Sponsor|32|||
94390155|NCT00376623|323218069|FG000|Overall Study|Progressive disease|35|||
94390156|NCT00376623|323218070|FG001|Overall Study|Progressive disease|22|||
94390157|NCT00376623|323218071|FG002|Overall Study|Progressive disease|17|||
94390158|NCT00376623|323218069|FG000|Overall Study|Lost to Follow-up|0|||
94390159|NCT00376623|323218070|FG001|Overall Study|Lost to Follow-up|1|||
94390160|NCT00376623|323218071|FG002|Overall Study|Lost to Follow-up|0|||
94390161|NCT00376623|323218069|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
94390162|NCT00376623|323218070|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
94390163|NCT00376623|323218071|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
94390164|NCT00376623|323218069|FG000|Overall Study|Not treated with BI 2536|1|||
94390165|NCT00376623|323218070|FG001|Overall Study|Not treated with BI 2536|0|||
94390166|NCT00376623|323218071|FG002|Overall Study|Not treated with BI 2536|0|||
94390167|NCT00376623|323218069|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
94390168|NCT00376623|323218070|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
94390169|NCT00376623|323218071|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
94390170|NCT00376623|323218069|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
94390171|NCT00376623|323218070|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
94390172|NCT00376623|323218071|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
94390173|NCT00376623|323218069|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
94390174|NCT00376623|323218070|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
94390175|NCT00376623|323218071|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
94390176|NCT00376623|323218069|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
94390177|NCT00376623|323218070|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
94390178|NCT00376623|323218071|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
94390179|NCT00376623|323218069|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
94390180|NCT00376623|323218070|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
94390181|NCT00376623|323218071|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
94390182|NCT00376623|323218069|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
94390183|NCT00376623|323218070|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
94390184|NCT00376623|323218071|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
94390185|NCT00376623|323218069|FG000|Overall Study|Increase of tumour markers|0|||
94390186|NCT00376623|323218070|FG001|Overall Study|Increase of tumour markers|1|||
94390187|NCT00376623|323218071|FG002|Overall Study|Increase of tumour markers|0|||
94390188|NCT00376623|323218069|FG000|Overall Study|Bone metastasis|1|||
94390189|NCT00376623|323218070|FG001|Overall Study|Bone metastasis|0|||
94390190|NCT00376623|323218071|FG002|Overall Study|Bone metastasis|0|||
94390191|NCT02865850|323218072|FG000|Overall Study|Death|15|||
94390192|NCT02865850|323218073|FG001|Overall Study|Death|19|||
94390193|NCT02865850|323218072|FG000|Overall Study|Withdrawal by Subject|3|||
94390194|NCT02865850|323218073|FG001|Overall Study|Withdrawal by Subject|2|||
94390195|NCT02865850|323218072|FG000|Overall Study|Lost to Follow-up|3|||
94390196|NCT02865850|323218073|FG001|Overall Study|Lost to Follow-up|2|||
94390197|NCT00552669|323218074|FG000|Overall Study|Death|3|||
94390198|NCT00552669|323218075|FG001|Overall Study|Death|7|||
94390199|NCT03687736|323218079|FG000|Overall Study|Lost to Follow-up|7|||
94390200|NCT03687736|323218079|FG000|Overall Study|Withdrawal by Subject|3|||
94390201|NCT01496183|323218081|FG000|Overall Study|Physician Decision|3|||
94390202|NCT01496183|323218082|FG001|Overall Study|Physician Decision|1|||
94390203|NCT01496183|323218081|FG000|Overall Study|Withdrawal by Subject|0|||
94390204|NCT01496183|323218082|FG001|Overall Study|Withdrawal by Subject|1|||
94390205|NCT00102440|323218083|FG000|Overall Study|Lost to Follow-up|25|||
94482651|NCT00919633|323558163|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
94482652|NCT00919633|323558164|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
94482653|NCT00919633|323558161|FG000|Overall Study|Protocol Violation|0|||
94482654|NCT00919633|323558162|FG001|Overall Study|Protocol Violation|0|||
94482655|NCT00919633|323558163|FG002|Overall Study|Protocol Violation|0|||
94390206|NCT00102440|323218084|FG001|Overall Study|Lost to Follow-up|18|||
94390207|NCT00102440|323218085|FG002|Overall Study|Lost to Follow-up|21|||
94390208|NCT00102440|323218083|FG000|Overall Study|Adverse Event|16|||
94390209|NCT00102440|323218084|FG001|Overall Study|Adverse Event|23|||
94390210|NCT00102440|323218085|FG002|Overall Study|Adverse Event|8|||
94390211|NCT00102440|323218083|FG000|Overall Study|Gout Flare|10|||
94390212|NCT00102440|323218084|FG001|Overall Study|Gout Flare|28|||
94390213|NCT00102440|323218085|FG002|Overall Study|Gout Flare|9|||
94390214|NCT00102440|323218083|FG000|Overall Study|Personal Reason(s)|19|||
94390215|NCT00102440|323218084|FG001|Overall Study|Personal Reason(s)|13|||
94390216|NCT00102440|323218085|FG002|Overall Study|Personal Reason(s)|13|||
94390217|NCT00102440|323218083|FG000|Overall Study|Other|11|||
94390218|NCT00102440|323218084|FG001|Overall Study|Other|14|||
94390219|NCT00102440|323218085|FG002|Overall Study|Other|14|||
94390220|NCT00102440|323218083|FG000|Overall Study|Protocol Violation|7|||
94390221|NCT00102440|323218084|FG001|Overall Study|Protocol Violation|2|||
94390222|NCT00102440|323218085|FG002|Overall Study|Protocol Violation|1|||
94390223|NCT04627038|323218086|FG000|Overall Study|Adverse Event|36|||
94390224|NCT04627038|323218087|FG001|Overall Study|Adverse Event|8|||
94390225|NCT04627038|323218086|FG000|Overall Study|Lost to Follow-up|1|||
94390226|NCT04627038|323218087|FG001|Overall Study|Lost to Follow-up|0|||
94390227|NCT04627038|323218086|FG000|Overall Study|Physician Decision|0|||
94390228|NCT04627038|323218087|FG001|Overall Study|Physician Decision|1|||
94390229|NCT04627038|323218086|FG000|Overall Study|Protocol Violation|3|||
94390230|NCT04627038|323218087|FG001|Overall Study|Protocol Violation|1|||
94390231|NCT04627038|323218086|FG000|Overall Study|Withdrawal by Subject|13|||
94390232|NCT04627038|323218087|FG001|Overall Study|Withdrawal by Subject|3|||
94390233|NCT04627038|323218086|FG000|Overall Study|Non-compliance with study drug|0|||
94390234|NCT04627038|323218087|FG001|Overall Study|Non-compliance with study drug|1|||
94390235|NCT04627038|323218086|FG000|Overall Study|Prohibited Concomitant Medication|1|||
94390236|NCT04627038|323218087|FG001|Overall Study|Prohibited Concomitant Medication|0|||
94390237|NCT02514122|323218090|FG000|Overall Study|Withdrawal by Subject|2|||
94390238|NCT02514122|323218091|FG001|Overall Study|Withdrawal by Subject|0|||
94390239|NCT04239872|323218092|FG000|Overall Study|Lost to Follow-up|0|||
94390240|NCT04239872|323218093|FG001|Overall Study|Lost to Follow-up|1|||
94390241|NCT00579670|323218098|FG000|Overall Study|Death|1|||
94390242|NCT00579670|323218099|FG001|Overall Study|Death|0|||
94390243|NCT00579670|323218100|FG002|Overall Study|Death|0|||
94390244|NCT00579670|323218101|FG003|Overall Study|Death|0|||
94390245|NCT00579670|323218102|FG004|Overall Study|Death|0|||
94390246|NCT00579670|323218098|FG000|Overall Study|Adverse Event|1|||
94390247|NCT00579670|323218099|FG001|Overall Study|Adverse Event|0|||
94390248|NCT00579670|323218100|FG002|Overall Study|Adverse Event|1|||
94390249|NCT00579670|323218101|FG003|Overall Study|Adverse Event|2|||
94390250|NCT00579670|323218102|FG004|Overall Study|Adverse Event|0|||
94390251|NCT00579670|323218098|FG000|Overall Study|Lack of Efficacy|0|||
94390252|NCT00579670|323218099|FG001|Overall Study|Lack of Efficacy|0|||
94390253|NCT00579670|323218100|FG002|Overall Study|Lack of Efficacy|1|||
94390254|NCT00579670|323218101|FG003|Overall Study|Lack of Efficacy|14|||
94390255|NCT00579670|323218102|FG004|Overall Study|Lack of Efficacy|0|||
94390256|NCT00579670|323218098|FG000|Overall Study|Lost to Follow-up|0|||
94390257|NCT00579670|323218099|FG001|Overall Study|Lost to Follow-up|1|||
94390258|NCT00579670|323218100|FG002|Overall Study|Lost to Follow-up|0|||
94390259|NCT00579670|323218101|FG003|Overall Study|Lost to Follow-up|4|||
94390260|NCT00579670|323218102|FG004|Overall Study|Lost to Follow-up|0|||
94390261|NCT00579670|323218098|FG000|Overall Study|Other|0|||
94390262|NCT00579670|323218099|FG001|Overall Study|Other|0|||
94390263|NCT00579670|323218100|FG002|Overall Study|Other|1|||
94390264|NCT00579670|323218101|FG003|Overall Study|Other|2|||
94390265|NCT00579670|323218102|FG004|Overall Study|Other|0|||
94390266|NCT00579670|323218098|FG000|Overall Study|Withdrawal by Subject|0|||
94390267|NCT00579670|323218099|FG001|Overall Study|Withdrawal by Subject|0|||
94390268|NCT00579670|323218100|FG002|Overall Study|Withdrawal by Subject|1|||
94390269|NCT00579670|323218101|FG003|Overall Study|Withdrawal by Subject|0|||
94390270|NCT00579670|323218102|FG004|Overall Study|Withdrawal by Subject|0|||
94390271|NCT01513174|323218108|FG000|Overall Study|Inclusion Error|1|||
94390272|NCT01513174|323218109|FG001|Overall Study|Inclusion Error|7|||
94390273|NCT01513174|323218108|FG000|Overall Study|Not receive study treatment|3|||
94390274|NCT01513174|323218109|FG001|Overall Study|Not receive study treatment|1|||
94390275|NCT00850174|323218110|FG000|Washout: One Week|Withdrawal by Subject|0|||
94390276|NCT00850174|323218111|FG001|Washout: One Week|Withdrawal by Subject|2|||
94390277|NCT00850174|323218110|FG000|Second Intervention|Withdrawal by Subject|1|||
94390278|NCT00850174|323218111|FG001|Second Intervention|Withdrawal by Subject|0|||
94390279|NCT01900626|323218112|FG000|Overall Study|study was closed due to low enrollment|1|||
94482656|NCT00919633|323558164|FG003|Overall Study|Protocol Violation|1|||
94390280|NCT01900626|323218113|FG001|Overall Study|study was closed due to low enrollment|1|||
94390281|NCT00635492|323218114|FG000|Overall Study|Death|12|||
94390282|NCT00635492|323218115|FG001|Overall Study|Death|40|||
94390283|NCT00635492|323218114|FG000|Overall Study|Lost to Follow-up|151|||
94390284|NCT00635492|323218115|FG001|Overall Study|Lost to Follow-up|172|||
94390285|NCT00635492|323218114|FG000|Overall Study|Physician Decision|32|||
94390286|NCT00635492|323218115|FG001|Overall Study|Physician Decision|22|||
94390287|NCT00635492|323218114|FG000|Overall Study|Sponsor decision|2|||
94390288|NCT00635492|323218115|FG001|Overall Study|Sponsor decision|3|||
94390289|NCT00635492|323218114|FG000|Overall Study|Withdrawal by Subject|82|||
94390290|NCT00635492|323218115|FG001|Overall Study|Withdrawal by Subject|45|||
94390291|NCT01702987|323218123|FG000|Overall Study|Withdrawal by Subject|1|||
94390292|NCT01702987|323218124|FG001|Overall Study|Withdrawal by Subject|0|||
94390293|NCT00112463|323218125|FG000|Overall Study|Physician Decision|1|||
94390294|NCT00112463|323218125|FG000|Overall Study|Progression|30|||
94390295|NCT00112463|323218125|FG000|Overall Study|Second Primary|1|||
94390296|NCT00112463|323218125|FG000|Overall Study|Toxicity|3|||
94390297|NCT00112463|323218125|FG000|Overall Study|Withdrawal by Subject|2|||
94390298|NCT00112463|323218125|FG000|Overall Study|Never started treatment|2|||
94390299|NCT00296647|323218133|FG000|Overall Study|Death|4|||
94390300|NCT00296647|323218134|FG001|Overall Study|Death|1|||
94390301|NCT00296647|323218135|FG002|Overall Study|Death|2|||
94390302|NCT00296647|323218136|FG003|Overall Study|Death|1|||
94390303|NCT00296647|323218137|FG004|Overall Study|Death|1|||
94390304|NCT00296647|323218133|FG000|Overall Study|Withdrawal by Subject|28|||
94390305|NCT00296647|323218134|FG001|Overall Study|Withdrawal by Subject|27|||
94390306|NCT00296647|323218135|FG002|Overall Study|Withdrawal by Subject|32|||
94390307|NCT00296647|323218136|FG003|Overall Study|Withdrawal by Subject|16|||
94390308|NCT00296647|323218137|FG004|Overall Study|Withdrawal by Subject|19|||
94390309|NCT02057458|323218141|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
94482657|NCT00919633|323558161|FG000|Overall Study|Physician Decision|0|||
94482658|NCT00919633|323558162|FG001|Overall Study|Physician Decision|0|||
94482659|NCT00919633|323558163|FG002|Overall Study|Physician Decision|0|||
94482660|NCT00919633|323558164|FG003|Overall Study|Physician Decision|1|||
94482661|NCT00919633|323558161|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
94482662|NCT00919633|323558162|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
94482663|NCT00919633|323558163|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
94482664|NCT00919633|323558164|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
94482665|NCT00919633|323558161|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
94482666|NCT00919633|323558162|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
94482667|NCT00919633|323558163|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
94482668|NCT00919633|323558164|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
94482669|NCT05079321|323558165|FG000|Overall Study|Withdrawal by Subject|2|||
94482670|NCT05079321|323558166|FG001|Overall Study|Withdrawal by Subject|2|||
94482671|NCT05079321|323558165|FG000|Overall Study|Lost to Follow-up|0|||
94482672|NCT05079321|323558166|FG001|Overall Study|Lost to Follow-up|1|||
94482673|NCT00960804|323558169|FG000|Overall Study|Adverse Event|1|||
94482674|NCT00960804|323558170|FG001|Overall Study|Adverse Event|0|||
94482675|NCT00960804|323558171|FG002|Overall Study|Adverse Event|0|||
94482676|NCT00960804|323558169|FG000|Overall Study|Withdrawal by Subject|1|||
94482677|NCT00960804|323558170|FG001|Overall Study|Withdrawal by Subject|0|||
94482678|NCT00960804|323558171|FG002|Overall Study|Withdrawal by Subject|0|||
94482679|NCT00960804|323558169|FG000|Overall Study|Study terminated by the sponsor|5|||
94482680|NCT00960804|323558170|FG001|Overall Study|Study terminated by the sponsor|4|||
94482681|NCT00960804|323558171|FG002|Overall Study|Study terminated by the sponsor|10|||
94482682|NCT00490919|323558172|FG000|Open-label Run-in Period|Adverse Event|239|||
94482683|NCT00490919|323558173|FG001|Open-label Run-in Period|Adverse Event|0|||
94482684|NCT00490919|323558174|FG002|Open-label Run-in Period|Adverse Event|0|||
94327660|NCT03325556|322980421|FG000|Double-blind Period|Noncompliance with study drug|0|||
94327661|NCT03325556|322980422|FG001|Double-blind Period|Noncompliance with study drug|0|||
94327662|NCT03325556|322980423|FG002|Double-blind Period|Noncompliance with study drug|1|||
94327663|NCT03325556|322980421|FG000|Double-blind Period|Use of prohibited medication|0|||
94327664|NCT03325556|322980422|FG001|Double-blind Period|Use of prohibited medication|1|||
94327665|NCT03325556|322980423|FG002|Double-blind Period|Use of prohibited medication|0|||
94327666|NCT03325556|322980421|FG000|Double-blind Period|Physician Decision|0|||
94327667|NCT03325556|322980422|FG001|Double-blind Period|Physician Decision|0|||
94327668|NCT03325556|322980423|FG002|Double-blind Period|Physician Decision|1|||
94327669|NCT03325556|322980421|FG000|Double-blind Period|Withdrawal by Subject|0|||
94390310|NCT02057458|323218142|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
94390311|NCT02057458|323218143|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
94482685|NCT00490919|323558172|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
94482686|NCT00490919|323558173|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
94482687|NCT00490919|323558174|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
94482688|NCT00490919|323558172|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
94327670|NCT03325556|322980422|FG001|Double-blind Period|Withdrawal by Subject|6|||
94390312|NCT02057458|323218141|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
94390313|NCT02057458|323218142|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
94390314|NCT02057458|323218143|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
94390315|NCT02057458|323218141|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
94390316|NCT02057458|323218142|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
94390317|NCT02057458|323218143|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
94390318|NCT01214850|323218144|FG000|Overall Study|Withdrawal by Subject|38|||
94390319|NCT01214850|323218145|FG001|Overall Study|Withdrawal by Subject|31|||
94390320|NCT01214850|323218146|FG002|Overall Study|Withdrawal by Subject|28|||
94390321|NCT01214850|323218144|FG000|Overall Study|Lost to Follow-up|124|||
94390322|NCT01214850|323218145|FG001|Overall Study|Lost to Follow-up|98|||
94390323|NCT01214850|323218146|FG002|Overall Study|Lost to Follow-up|123|||
94390324|NCT01214850|323218144|FG000|Overall Study|Protocol Violation|5|||
94390325|NCT01214850|323218145|FG001|Overall Study|Protocol Violation|5|||
94390326|NCT01214850|323218146|FG002|Overall Study|Protocol Violation|6|||
94390327|NCT01214850|323218144|FG000|Overall Study|Adverse event or death|11|||
94390328|NCT01214850|323218145|FG001|Overall Study|Adverse event or death|8|||
94390329|NCT01214850|323218146|FG002|Overall Study|Adverse event or death|3|||
94390330|NCT01214850|323218144|FG000|Overall Study|Inappropriate enrollment|2|||
94390331|NCT01214850|323218145|FG001|Overall Study|Inappropriate enrollment|1|||
94390332|NCT01214850|323218146|FG002|Overall Study|Inappropriate enrollment|0|||
94390333|NCT01214850|323218144|FG000|Overall Study|Administrative reason|1|||
94390334|NCT01214850|323218145|FG001|Overall Study|Administrative reason|0|||
94390335|NCT01214850|323218146|FG002|Overall Study|Administrative reason|0|||
94390336|NCT01214850|323218144|FG000|Overall Study|Unable to classify|2|||
94390337|NCT01214850|323218145|FG001|Overall Study|Unable to classify|1|||
94390338|NCT01214850|323218146|FG002|Overall Study|Unable to classify|1|||
94390339|NCT01863745|323218147|FG000|Overall Study|Disease Progression|9|||
94390340|NCT01863745|323218147|FG000|Overall Study|Adverse Event|2|||
94390341|NCT01863745|323218147|FG000|Overall Study|Death|1|||
94390342|NCT01863745|323218147|FG000|Overall Study|Withdrawal by Subject|1|||
94390343|NCT00735904|323218148|FG000|Overall Study|Adverse Event|3|||
94390344|NCT00735904|323218148|FG000|Overall Study|Death|20|||
94390345|NCT00735904|323218148|FG000|Overall Study|Protocol Violation|1|||
94390346|NCT00735904|323218148|FG000|Overall Study|Withdrawal by Subject|1|||
94390347|NCT00735904|323218148|FG000|Overall Study|Study Terminated by Sponsor|5|||
94390348|NCT00735904|323218148|FG000|Overall Study|Other|8|||
94390349|NCT00984126|323218149|FG000|Overall Study|Protocol Violation|0|||
94390350|NCT00984126|323218150|FG001|Overall Study|Protocol Violation|0|||
94390351|NCT00984126|323218151|FG002|Overall Study|Protocol Violation|1|||
94390352|NCT00984126|323218152|FG003|Overall Study|Protocol Violation|2|||
94390353|NCT00984126|323218149|FG000|Overall Study|Adverse Event|0|||
94390354|NCT00984126|323218150|FG001|Overall Study|Adverse Event|0|||
94390355|NCT00984126|323218151|FG002|Overall Study|Adverse Event|0|||
94390356|NCT00984126|323218152|FG003|Overall Study|Adverse Event|2|||
94390357|NCT00984126|323218149|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
94390358|NCT00984126|323218150|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
94390359|NCT00984126|323218151|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
94390360|NCT00984126|323218152|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
94327671|NCT03325556|322980423|FG002|Double-blind Period|Withdrawal by Subject|4|||
94327672|NCT03325556|322980421|FG000|Double-blind Period|Not otherwise specified|0|||
94327673|NCT03325556|322980422|FG001|Double-blind Period|Not otherwise specified|1|||
94327674|NCT03325556|322980423|FG002|Double-blind Period|Not otherwise specified|5|||
94327675|NCT03325556|322980421|FG000|Double-blind Period|Administrative discont. at study termination|0|||
94327676|NCT03325556|322980422|FG001|Double-blind Period|Administrative discont. at study termination|35|||
94327677|NCT03325556|322980423|FG002|Double-blind Period|Administrative discont. at study termination|31|||
94327678|NCT00340834|322980432|FG000|Core Phase of Study|Adverse Event|26|||
94327679|NCT00340834|322980433|FG001|Core Phase of Study|Adverse Event|9|||
94327680|NCT00340834|322980434|FG002|Core Phase of Study|Adverse Event|9|||
94327681|NCT00340834|322980435|FG003|Core Phase of Study|Adverse Event|0|||
94327682|NCT00340834|322980436|FG004|Core Phase of Study|Adverse Event|0|||
94327683|NCT00340834|322980432|FG000|Core Phase of Study|Withdrawal by Subject|11|||
94327684|NCT00340834|322980433|FG001|Core Phase of Study|Withdrawal by Subject|9|||
94327685|NCT00340834|322980434|FG002|Core Phase of Study|Withdrawal by Subject|16|||
94327686|NCT00340834|322980435|FG003|Core Phase of Study|Withdrawal by Subject|0|||
94327687|NCT00340834|322980436|FG004|Core Phase of Study|Withdrawal by Subject|0|||
94327688|NCT00340834|322980432|FG000|Core Phase of Study|Administrative Problems|6|||
94327689|NCT00340834|322980433|FG001|Core Phase of Study|Administrative Problems|2|||
94327690|NCT00340834|322980434|FG002|Core Phase of Study|Administrative Problems|7|||
94327691|NCT00340834|322980435|FG003|Core Phase of Study|Administrative Problems|0|||
94327692|NCT00340834|322980436|FG004|Core Phase of Study|Administrative Problems|0|||
94390361|NCT00984126|323218149|FG000|Overall Study|Withdrawal criteria|0|||
94390362|NCT00984126|323218150|FG001|Overall Study|Withdrawal criteria|1|||
94390363|NCT00984126|323218151|FG002|Overall Study|Withdrawal criteria|3|||
94390364|NCT00984126|323218152|FG003|Overall Study|Withdrawal criteria|9|||
94390365|NCT00468286|323218155|FG000|Overall Study|Adverse Event|1|||
94390366|NCT00468286|323218156|FG001|Overall Study|Adverse Event|6|||
94327693|NCT00340834|322980432|FG000|Core Phase of Study|Lack of Efficacy|3|||
94327694|NCT00340834|322980433|FG001|Core Phase of Study|Lack of Efficacy|3|||
94327695|NCT00340834|322980434|FG002|Core Phase of Study|Lack of Efficacy|7|||
94390367|NCT00468286|323218155|FG000|Overall Study|Protocol Violation|2|||
94390368|NCT00468286|323218156|FG001|Overall Study|Protocol Violation|2|||
94390369|NCT00468286|323218155|FG000|Overall Study|Withdrawal by Subject|4|||
94390370|NCT00468286|323218156|FG001|Overall Study|Withdrawal by Subject|3|||
94390371|NCT00468286|323218155|FG000|Overall Study|Physician Decision|0|||
94390372|NCT00468286|323218156|FG001|Overall Study|Physician Decision|1|||
94390373|NCT02196675|323218159|FG000|Overall Study|Withdrawal by Subject|1|||
94390374|NCT02196675|323218160|FG001|Overall Study|Withdrawal by Subject|0|||
94390375|NCT02196675|323218161|FG002|Overall Study|Withdrawal by Subject|0|||
94327696|NCT00340834|322980435|FG003|Core Phase of Study|Lack of Efficacy|0|||
94327697|NCT00340834|322980436|FG004|Core Phase of Study|Lack of Efficacy|0|||
94327698|NCT00340834|322980432|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
94327699|NCT00340834|322980433|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
94327700|NCT00340834|322980434|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
94327701|NCT00340834|322980435|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
94327702|NCT00340834|322980436|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
94327703|NCT00340834|322980432|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
94327704|NCT00340834|322980433|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
94327705|NCT00340834|322980434|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
94327706|NCT00340834|322980435|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
94327707|NCT00340834|322980436|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
94327708|NCT00340834|322980432|FG000|Core Phase of Study|Lost to Follow-up|1|||
94327709|NCT00340834|322980433|FG001|Core Phase of Study|Lost to Follow-up|1|||
94327710|NCT00340834|322980434|FG002|Core Phase of Study|Lost to Follow-up|4|||
94327711|NCT00340834|322980435|FG003|Core Phase of Study|Lost to Follow-up|0|||
94327712|NCT00340834|322980436|FG004|Core Phase of Study|Lost to Follow-up|0|||
94327713|NCT00340834|322980432|FG000|Core Phase of Study|Death|2|||
94327714|NCT00340834|322980433|FG001|Core Phase of Study|Death|0|||
94327715|NCT00340834|322980434|FG002|Core Phase of Study|Death|0|||
94327716|NCT00340834|322980435|FG003|Core Phase of Study|Death|0|||
94327717|NCT00340834|322980436|FG004|Core Phase of Study|Death|0|||
94327718|NCT00340834|322980432|FG000|Core Phase of Study|Protocol Violation|0|||
94327719|NCT00340834|322980433|FG001|Core Phase of Study|Protocol Violation|0|||
94327720|NCT00340834|322980434|FG002|Core Phase of Study|Protocol Violation|2|||
94327721|NCT00340834|322980435|FG003|Core Phase of Study|Protocol Violation|0|||
94327722|NCT00340834|322980436|FG004|Core Phase of Study|Protocol Violation|0|||
94327723|NCT00340834|322980432|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
94327724|NCT00340834|322980433|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
94327725|NCT00340834|322980434|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
94327726|NCT00340834|322980435|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
94327727|NCT00340834|322980436|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
94327728|NCT00340834|322980432|FG000|Extension Phase of Study|Subject withdrew consent|26|||
94327729|NCT00340834|322980433|FG001|Extension Phase of Study|Subject withdrew consent|31|||
94327730|NCT00340834|322980434|FG002|Extension Phase of Study|Subject withdrew consent|0|||
94327731|NCT00340834|322980435|FG003|Extension Phase of Study|Subject withdrew consent|12|||
94327732|NCT00340834|322980436|FG004|Extension Phase of Study|Subject withdrew consent|15|||
94327733|NCT00340834|322980432|FG000|Extension Phase of Study|Adverse Event|21|||
94327734|NCT00340834|322980433|FG001|Extension Phase of Study|Adverse Event|22|||
94327735|NCT00340834|322980434|FG002|Extension Phase of Study|Adverse Event|0|||
94327736|NCT00340834|322980435|FG003|Extension Phase of Study|Adverse Event|19|||
94327737|NCT00340834|322980436|FG004|Extension Phase of Study|Adverse Event|7|||
94327738|NCT00340834|322980432|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
94327739|NCT00340834|322980433|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
94327740|NCT00340834|322980434|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
94327741|NCT00340834|322980435|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
94327742|NCT00340834|322980436|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
94327743|NCT00340834|322980432|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
94327744|NCT00340834|322980433|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
94327745|NCT00340834|322980434|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
94327746|NCT00340834|322980435|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
94327747|NCT00340834|322980436|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
94327748|NCT00340834|322980432|FG000|Extension Phase of Study|Lost to Follow-up|1|||
94327749|NCT00340834|322980433|FG001|Extension Phase of Study|Lost to Follow-up|1|||
94327750|NCT00340834|322980434|FG002|Extension Phase of Study|Lost to Follow-up|0|||
94327751|NCT00340834|322980435|FG003|Extension Phase of Study|Lost to Follow-up|2|||
94327752|NCT00340834|322980436|FG004|Extension Phase of Study|Lost to Follow-up|3|||
94390376|NCT02196675|323218159|FG000|Overall Study|Intra-operative surgical exclusion|1|||
94390377|NCT02196675|323218160|FG001|Overall Study|Intra-operative surgical exclusion|1|||
94327753|NCT00340834|322980432|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
94327754|NCT00340834|322980433|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
94327755|NCT00340834|322980434|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
94327756|NCT00340834|322980435|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
94327757|NCT00340834|322980436|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
94327758|NCT00340834|322980432|FG000|Extension Phase of Study|Administrative problems|3|||
94327759|NCT00340834|322980433|FG001|Extension Phase of Study|Administrative problems|0|||
94327760|NCT00340834|322980434|FG002|Extension Phase of Study|Administrative problems|0|||
94327761|NCT00340834|322980435|FG003|Extension Phase of Study|Administrative problems|1|||
94327762|NCT00340834|322980436|FG004|Extension Phase of Study|Administrative problems|1|||
94327763|NCT00340834|322980432|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
94327764|NCT00340834|322980433|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
94327765|NCT00340834|322980434|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
94327766|NCT00340834|322980435|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
94327767|NCT00340834|322980436|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
94327768|NCT00340834|322980432|FG000|Extension Phase of Study|Protocol Violation|3|||
94327769|NCT00340834|322980433|FG001|Extension Phase of Study|Protocol Violation|0|||
94327770|NCT00340834|322980434|FG002|Extension Phase of Study|Protocol Violation|0|||
94327771|NCT00340834|322980435|FG003|Extension Phase of Study|Protocol Violation|0|||
94327772|NCT00340834|322980436|FG004|Extension Phase of Study|Protocol Violation|0|||
94327773|NCT00340834|322980432|FG000|Extension Phase of Study|Death|0|||
94327774|NCT00340834|322980433|FG001|Extension Phase of Study|Death|0|||
94327775|NCT00340834|322980434|FG002|Extension Phase of Study|Death|0|||
94327776|NCT00340834|322980435|FG003|Extension Phase of Study|Death|0|||
94327777|NCT00340834|322980436|FG004|Extension Phase of Study|Death|1|||
94327778|NCT03017846|322980445|FG000|Overall Study|Lost to Follow-up|3|||
94327779|NCT03017846|322980445|FG000|Overall Study|Adverse Event|2|||
94327780|NCT02022033|322980446|FG000|Overall Study|Physician Decision|1|||
94327781|NCT01429077|322980447|FG000|Overall Study|Lost to Follow-up|0|||
94327782|NCT01429077|322980448|FG001|Overall Study|Lost to Follow-up|3|||
94327783|NCT01413542|322980449|FG000|Overall Study|Physician Decision|1|||
94327784|NCT01413542|322980450|FG001|Overall Study|Physician Decision|0|||
94327785|NCT01413542|322980451|FG002|Overall Study|Physician Decision|3|||
94327786|NCT01413542|322980452|FG003|Overall Study|Physician Decision|0|||
94327787|NCT01413542|322980449|FG000|Overall Study|Adverse Event|0|||
94327788|NCT01413542|322980450|FG001|Overall Study|Adverse Event|0|||
94327789|NCT01413542|322980451|FG002|Overall Study|Adverse Event|0|||
94327790|NCT01413542|322980452|FG003|Overall Study|Adverse Event|1|||
94327791|NCT04603391|322980454|FG000|First Intervention (4 Days)|Adverse Event|1|||
94327792|NCT04603391|322980455|FG001|First Intervention (4 Days)|Adverse Event|0|||
94327793|NCT04603391|322980454|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
94327794|NCT04603391|322980455|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
94327795|NCT03372603|322980456|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
94327796|NCT03372603|322980457|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
94327797|NCT03372603|322980456|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
94327798|NCT03372603|322980457|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
94327799|NCT02759861|322980458|FG000|Overall Study|Death|1|||
94327800|NCT00865189|322980461|FG000|Overall Study|Other|1|||
94327801|NCT00865189|322980462|FG001|Overall Study|Other|2|||
94327802|NCT00865189|322980461|FG000|Overall Study|Death|4|||
94327803|NCT00865189|322980462|FG001|Overall Study|Death|11|||
94327804|NCT00865189|322980461|FG000|Overall Study|Lost to Follow-up|6|||
94327805|NCT00865189|322980462|FG001|Overall Study|Lost to Follow-up|6|||
94327806|NCT00865189|322980461|FG000|Overall Study|Withdrawal by Subject|1|||
94327807|NCT00865189|322980462|FG001|Overall Study|Withdrawal by Subject|0|||
94327808|NCT05590767|322980463|FG000|Overall Study|Protocol Violation|1|||
94327809|NCT05590767|322980463|FG000|Overall Study|surgery canceled|1|||
94327810|NCT05590767|322980463|FG000|Overall Study|interscalene brachial block not performed|1|||
94327811|NCT01153841|322980466|FG000|Overall Study|Adverse Event|1|||
94327812|NCT01153841|322980467|FG001|Overall Study|Adverse Event|0|||
94327813|NCT01153841|322980466|FG000|Overall Study|Withdrawal by Subject|1|||
94327814|NCT01153841|322980467|FG001|Overall Study|Withdrawal by Subject|0|||
94327815|NCT01153841|322980466|FG000|Overall Study|Protocol Violation|2|||
94327816|NCT01153841|322980467|FG001|Overall Study|Protocol Violation|0|||
94327817|NCT01153841|322980466|FG000|Overall Study|Lost to Follow-up|2|||
94327818|NCT01153841|322980467|FG001|Overall Study|Lost to Follow-up|0|||
94327819|NCT00830804|322980468|FG000|Overall Study|Lost to Follow-up|4|||
94327820|NCT00830804|322980468|FG000|Overall Study|Death|1|||
94327821|NCT00830804|322980468|FG000|Overall Study|Unable to get to clinic|7|||
94327822|NCT00830804|322980468|FG000|Overall Study|Consent withdrawn|2|||
94327823|NCT00830804|322980468|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
94327824|NCT03428997|322980476|FG000|Overall Study|Sponsor decision.|1|||
94327825|NCT03428997|322980476|FG000|Overall Study|Withdrawal by Subject|3|||
94327826|NCT03428997|322980476|FG000|Overall Study|Lost to Follow-up|4|||
94327827|NCT00270998|322980477|FG000|3 Month Follow-up|Adverse Event|1|||
94327828|NCT00270998|322980478|FG001|3 Month Follow-up|Adverse Event|0|||
94327829|NCT00270998|322980479|FG002|3 Month Follow-up|Adverse Event|0|||
94327830|NCT00270998|322980477|FG000|3 Month Follow-up|Lack of Efficacy|1|||
94390378|NCT02196675|323218161|FG002|Overall Study|Intra-operative surgical exclusion|0|||
94390379|NCT02196675|323218159|FG000|Overall Study|Protocol Violation|0|||
94390380|NCT02196675|323218160|FG001|Overall Study|Protocol Violation|1|||
94390381|NCT02196675|323218161|FG002|Overall Study|Protocol Violation|0|||
94390382|NCT02196675|323218159|FG000|Overall Study|Death|0|||
94390383|NCT02196675|323218160|FG001|Overall Study|Death|0|||
94390384|NCT02196675|323218161|FG002|Overall Study|Death|1|||
94390385|NCT00537979|323218163|FG000|Overall Study|Adverse Event|2|||
94390386|NCT00537979|323218164|FG001|Overall Study|Adverse Event|2|||
94390387|NCT00537979|323218163|FG000|Overall Study|Withdrawal by Subject|1|||
94390388|NCT00537979|323218164|FG001|Overall Study|Withdrawal by Subject|4|||
94390389|NCT00537979|323218163|FG000|Overall Study|Lost to Follow-up|1|||
94390390|NCT00537979|323218164|FG001|Overall Study|Lost to Follow-up|4|||
94390391|NCT00537979|323218163|FG000|Overall Study|Lack of Efficacy|0|||
94390392|NCT00537979|323218164|FG001|Overall Study|Lack of Efficacy|1|||
94390393|NCT00537979|323218163|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
94390394|NCT00537979|323218164|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
94390395|NCT00537979|323218163|FG000|Overall Study|Death|0|||
94390396|NCT00537979|323218164|FG001|Overall Study|Death|3|||
94390397|NCT00537979|323218163|FG000|Overall Study|Kidney transplant|0|||
94390398|NCT00537979|323218164|FG001|Overall Study|Kidney transplant|3|||
94390399|NCT00537979|323218163|FG000|Overall Study|Heart failure|0|||
94390400|NCT00537979|323218164|FG001|Overall Study|Heart failure|1|||
94390401|NCT03459807|323218165|FG000|Overall Study|Withdrawal due to transplant|0|||
94390402|NCT03459807|323218166|FG001|Overall Study|Withdrawal due to transplant|1|||
94390403|NCT03482882|323218169|FG000|Overall Study|Adverse Event|3|||
94390404|NCT03482882|323218169|FG000|Overall Study|Lost to Follow-up|1|||
94390405|NCT03482882|323218169|FG000|Overall Study|Protocol Violation|2|||
94390406|NCT03482882|323218169|FG000|Overall Study|Not further specified|1|||
94390407|NCT02032888|323218172|FG000|Treatment Period|Poor compliance/noncompliance|1|||
94390408|NCT02032888|323218173|FG001|Treatment Period|Poor compliance/noncompliance|1|||
94390409|NCT02032888|323218174|FG002|Treatment Period|Poor compliance/noncompliance|0|||
94390410|NCT02032888|323218172|FG000|Treatment Period|Other|1|||
94390411|NCT02032888|323218173|FG001|Treatment Period|Other|1|||
94390412|NCT02032888|323218174|FG002|Treatment Period|Other|0|||
94390413|NCT02032888|323218172|FG000|Follow-up Period|Lost to Follow-up|1|||
94390414|NCT02032888|323218173|FG001|Follow-up Period|Lost to Follow-up|1|||
94390415|NCT02032888|323218174|FG002|Follow-up Period|Lost to Follow-up|0|||
94390416|NCT02032888|323218172|FG000|Follow-up Period|Death|1|||
94390417|NCT02032888|323218173|FG001|Follow-up Period|Death|1|||
94390418|NCT02032888|323218174|FG002|Follow-up Period|Death|0|||
94390419|NCT02032888|323218172|FG000|Follow-up Period|Other|1|||
94390420|NCT02032888|323218173|FG001|Follow-up Period|Other|0|||
94390421|NCT02032888|323218174|FG002|Follow-up Period|Other|0|||
94390422|NCT01697696|323218175|FG000|Overall Study|Study terminated by sponsor|0|||
94390423|NCT01697696|323218176|FG001|Overall Study|Study terminated by sponsor|3|||
94390424|NCT01697696|323218175|FG000|Overall Study|Protocol deviation|1|||
94390425|NCT01697696|323218176|FG001|Overall Study|Protocol deviation|0|||
94390426|NCT01697696|323218175|FG000|Overall Study|Physician Decision|1|||
94390427|NCT01697696|323218176|FG001|Overall Study|Physician Decision|0|||
94390428|NCT01697696|323218175|FG000|Overall Study|Death|4|||
94390429|NCT01697696|323218176|FG001|Overall Study|Death|2|||
94390430|NCT01697696|323218175|FG000|Overall Study|Lost to Follow-up|10|||
94390431|NCT01697696|323218176|FG001|Overall Study|Lost to Follow-up|7|||
94390432|NCT01697696|323218175|FG000|Overall Study|Subject/guardian decision|31|||
94390433|NCT01697696|323218176|FG001|Overall Study|Subject/guardian decision|35|||
94390434|NCT01424644|323218177|FG000|Overall Study|Adverse Event|2|||
94390435|NCT01424644|323218178|FG001|Overall Study|Adverse Event|0|||
94390436|NCT01424644|323218177|FG000|Overall Study|Withdrawal by Subject|9|||
94390437|NCT01424644|323218178|FG001|Overall Study|Withdrawal by Subject|12|||
94390438|NCT01424644|323218177|FG000|Overall Study|Lost to Follow-up|16|||
94390439|NCT01424644|323218178|FG001|Overall Study|Lost to Follow-up|12|||
94390440|NCT01424644|323218177|FG000|Overall Study|Protocol Violation|4|||
94390441|NCT01424644|323218178|FG001|Overall Study|Protocol Violation|3|||
94390442|NCT01424644|323218177|FG000|Overall Study|Administrative Reason|1|||
94390443|NCT01424644|323218178|FG001|Overall Study|Administrative Reason|0|||
94390444|NCT01424644|323218177|FG000|Overall Study|Unable to Classify|1|||
94390445|NCT01424644|323218178|FG001|Overall Study|Unable to Classify|0|||
94390446|NCT03616106|323218193|FG000|Overall Study|Removed by PI|6|||
94390447|NCT03616106|323218194|FG001|Overall Study|Removed by PI|0|||
94390448|NCT03616106|323218193|FG000|Overall Study|Withdrawal by Subject|1|||
94390449|NCT03616106|323218194|FG001|Overall Study|Withdrawal by Subject|1|||
94390450|NCT03616106|323218193|FG000|Overall Study|Lost to Follow-up|7|||
94390451|NCT03616106|323218194|FG001|Overall Study|Lost to Follow-up|0|||
94390452|NCT01880593|323218197|FG000|Overall Study|Adverse Event|1|||
94390453|NCT01880593|323218198|FG001|Overall Study|Adverse Event|0|||
94390454|NCT01880593|323218197|FG000|Overall Study|Lack of Efficacy|1|||
94390455|NCT01880593|323218198|FG001|Overall Study|Lack of Efficacy|5|||
94390456|NCT01880593|323218197|FG000|Overall Study|Withdrawal by Subject|6|||
94327831|NCT00270998|322980478|FG001|3 Month Follow-up|Lack of Efficacy|2|||
94327832|NCT00270998|322980479|FG002|3 Month Follow-up|Lack of Efficacy|1|||
94327833|NCT00270998|322980477|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
94327834|NCT00270998|322980478|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
94327835|NCT00270998|322980479|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
94327836|NCT00270998|322980477|FG000|3 Month Follow-up|Pessary did not fit|12|||
94327837|NCT00270998|322980478|FG001|3 Month Follow-up|Pessary did not fit|0|||
94327838|NCT00270998|322980479|FG002|3 Month Follow-up|Pessary did not fit|0|||
94327839|NCT00270998|322980477|FG000|3 Month Follow-up|Personal/family health|1|||
94327840|NCT00270998|322980478|FG001|3 Month Follow-up|Personal/family health|1|||
94327841|NCT00270998|322980479|FG002|3 Month Follow-up|Personal/family health|0|||
94327842|NCT00270998|322980477|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
94327843|NCT00270998|322980478|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
94327844|NCT00270998|322980479|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
94327845|NCT00270998|322980477|FG000|12 Month Follow-up|Lack of Efficacy|5|||
94327846|NCT00270998|322980478|FG001|12 Month Follow-up|Lack of Efficacy|4|||
94327847|NCT00270998|322980479|FG002|12 Month Follow-up|Lack of Efficacy|3|||
94327848|NCT00270998|322980477|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
94327849|NCT00270998|322980478|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
94327850|NCT00270998|322980479|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
94327851|NCT00270998|322980477|FG000|12 Month Follow-up|Pessary did not fit|1|||
94327852|NCT00270998|322980478|FG001|12 Month Follow-up|Pessary did not fit|0|||
94327853|NCT00270998|322980479|FG002|12 Month Follow-up|Pessary did not fit|0|||
94327854|NCT00270998|322980477|FG000|12 Month Follow-up|Personal/family health|0|||
94327855|NCT00270998|322980478|FG001|12 Month Follow-up|Personal/family health|5|||
94327856|NCT00270998|322980479|FG002|12 Month Follow-up|Personal/family health|1|||
94327857|NCT00270998|322980477|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
94327858|NCT00270998|322980478|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
94327859|NCT00270998|322980479|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
94327860|NCT00510068|322980482|FG000|Double-blind Period|Disease progression|98|||
94327861|NCT00510068|322980483|FG001|Double-blind Period|Disease progression|169|||
94327862|NCT00510068|322980482|FG000|Double-blind Period|Final primary analysis|52|||
94327863|NCT00510068|322980483|FG001|Double-blind Period|Final primary analysis|18|||
94327864|NCT00510068|322980482|FG000|Double-blind Period|Adverse Event|37|||
94327865|NCT00510068|322980483|FG001|Double-blind Period|Adverse Event|7|||
94327866|NCT00510068|322980482|FG000|Double-blind Period|Withdrawal by Subject|8|||
94327867|NCT00510068|322980483|FG001|Double-blind Period|Withdrawal by Subject|6|||
94327868|NCT00510068|322980482|FG000|Double-blind Period|Death|4|||
94327869|NCT00510068|322980483|FG001|Double-blind Period|Death|3|||
94327870|NCT00510068|322980482|FG000|Double-blind Period|Abnormal test result (s)|1|||
94327871|NCT00510068|322980483|FG001|Double-blind Period|Abnormal test result (s)|0|||
94327872|NCT00510068|322980482|FG000|Double-blind Period|Lost to Follow-up|1|||
94327873|NCT00510068|322980483|FG001|Double-blind Period|Lost to Follow-up|0|||
94327874|NCT00510068|322980482|FG000|Double-blind Period|Protocol Violation|6|||
94327875|NCT00510068|322980483|FG001|Double-blind Period|Protocol Violation|0|||
94327876|NCT00510068|322980482|FG000|Open-label Period|Disease Progression|124|||
94327877|NCT00510068|322980483|FG001|Open-label Period|Disease Progression|0|||
94327878|NCT00510068|322980482|FG000|Open-label Period|Adverse Event|46|||
94327879|NCT00510068|322980483|FG001|Open-label Period|Adverse Event|0|||
94327880|NCT00510068|322980482|FG000|Open-label Period|Withdrawal by Subject|21|||
94327881|NCT00510068|322980483|FG001|Open-label Period|Withdrawal by Subject|0|||
94327882|NCT00510068|322980482|FG000|Open-label Period|Administrative problems|17|||
94327883|NCT00510068|322980483|FG001|Open-label Period|Administrative problems|0|||
94327884|NCT00510068|322980482|FG000|Open-label Period|Death|7|||
94327885|NCT00510068|322980483|FG001|Open-label Period|Death|0|||
94327886|NCT00510068|322980482|FG000|Open-label Period|New cancer therapy|7|||
94327887|NCT00510068|322980483|FG001|Open-label Period|New cancer therapy|0|||
94327888|NCT00510068|322980482|FG000|Open-label Period|Protocol Violation|2|||
94327889|NCT00510068|322980483|FG001|Open-label Period|Protocol Violation|0|||
94327890|NCT00510068|322980482|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
94327891|NCT00510068|322980483|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
94327892|NCT02180217|322980485|FG000|Overall Study|Adverse Event|3|||
94327893|NCT02180217|322980486|FG001|Overall Study|Adverse Event|2|||
94327894|NCT02180217|322980487|FG002|Overall Study|Adverse Event|22|||
94327895|NCT02180217|322980485|FG000|Overall Study|Death|1|||
94327896|NCT02180217|322980486|FG001|Overall Study|Death|1|||
94327897|NCT02180217|322980487|FG002|Overall Study|Death|0|||
94327898|NCT02180217|322980485|FG000|Overall Study|Withdrawal by Subject|1|||
94327899|NCT02180217|322980486|FG001|Overall Study|Withdrawal by Subject|1|||
94327900|NCT02180217|322980487|FG002|Overall Study|Withdrawal by Subject|4|||
94327901|NCT02180217|322980485|FG000|Overall Study|Subject/Guardian decision|5|||
94327902|NCT02180217|322980486|FG001|Overall Study|Subject/Guardian decision|3|||
94327903|NCT02180217|322980487|FG002|Overall Study|Subject/Guardian decision|6|||
94327904|NCT02180217|322980485|FG000|Overall Study|Physician Decision|1|||
94327905|NCT02180217|322980486|FG001|Overall Study|Physician Decision|1|||
94327906|NCT02180217|322980487|FG002|Overall Study|Physician Decision|6|||
94390457|NCT01880593|323218198|FG001|Overall Study|Withdrawal by Subject|1|||
94390458|NCT05275205|323218201|FG000|Overall Study|Adverse Event|1|||
94390459|NCT05275205|323218202|FG001|Overall Study|Adverse Event|2|||
94390460|NCT05275205|323218201|FG000|Overall Study|Physician Decision|1|||
94390461|NCT05275205|323218202|FG001|Overall Study|Physician Decision|1|||
94390462|NCT05275205|323218201|FG000|Overall Study|Withdrawal by Subject|2|||
94390463|NCT05275205|323218202|FG001|Overall Study|Withdrawal by Subject|3|||
94390464|NCT05275205|323218201|FG000|Overall Study|Death|1|||
94390465|NCT05275205|323218202|FG001|Overall Study|Death|0|||
94390466|NCT05275205|323218201|FG000|Overall Study|Patient unable to attend visits|1|||
94390467|NCT05275205|323218202|FG001|Overall Study|Patient unable to attend visits|0|||
94390468|NCT02445339|323218203|FG000|Overall Study|Physician Decision|1|||
94390469|NCT02445339|323218204|FG001|Overall Study|Physician Decision|0|||
94390470|NCT02445339|323218203|FG000|Overall Study|Lost to Follow-up|11|||
94390471|NCT02445339|323218204|FG001|Overall Study|Lost to Follow-up|15|||
94390472|NCT03041025|323218205|FG000|Overall Study|Adverse Event|0|||
94390473|NCT03041025|323218206|FG001|Overall Study|Adverse Event|0|||
94390474|NCT03041025|323218207|FG002|Overall Study|Adverse Event|1|||
94390475|NCT03041025|323218205|FG000|Overall Study|Lost to Follow-up|1|||
94390476|NCT03041025|323218206|FG001|Overall Study|Lost to Follow-up|0|||
94390477|NCT03041025|323218207|FG002|Overall Study|Lost to Follow-up|0|||
94390478|NCT03041025|323218205|FG000|Overall Study|Withdrawal by Subject|0|||
94390479|NCT03041025|323218206|FG001|Overall Study|Withdrawal by Subject|0|||
94390480|NCT03041025|323218207|FG002|Overall Study|Withdrawal by Subject|1|||
94390481|NCT00840632|323219649|FG000|First Intervention|Withdrawal by Subject|0|||
94390482|NCT00840632|323219650|FG001|First Intervention|Withdrawal by Subject|1|||
94390483|NCT00840632|323219649|FG000|Washout|Withdrawal by Subject|1|||
94390484|NCT00840632|323219650|FG001|Washout|Withdrawal by Subject|1|||
94390485|NCT01918397|323219651|FG000|Overall Study|Never started treatment|2|||
94390486|NCT01918397|323219652|FG001|Overall Study|Never started treatment|1|||
94390487|NCT01918397|323219653|FG002|Overall Study|Never started treatment|0|||
94390488|NCT01918397|323219654|FG003|Overall Study|Never started treatment|0|||
94390489|NCT01918397|323219651|FG000|Overall Study|Adverse Event|1|||
94390490|NCT01918397|323219652|FG001|Overall Study|Adverse Event|1|||
94390491|NCT01918397|323219653|FG002|Overall Study|Adverse Event|1|||
94390492|NCT01918397|323219654|FG003|Overall Study|Adverse Event|0|||
94390493|NCT01918397|323219651|FG000|Overall Study|Lack of compliance|2|||
94390494|NCT01918397|323219652|FG001|Overall Study|Lack of compliance|2|||
94327907|NCT02180217|322980485|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94327908|NCT02180217|322980486|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94327909|NCT02180217|322980487|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
94327910|NCT02855450|322980488|FG000|Overall Study|Adverse Event|1|||
94327911|NCT02855450|322980489|FG001|Overall Study|Adverse Event|0|||
94327912|NCT02855450|322980488|FG000|Overall Study|Lost to Follow-up|4|||
94327913|NCT02855450|322980489|FG001|Overall Study|Lost to Follow-up|0|||
94327914|NCT01181102|322980490|FG000|Overall Study|Adverse Event|28|||
94327915|NCT01181102|322980491|FG001|Overall Study|Adverse Event|26|||
94327916|NCT01181102|322980490|FG000|Overall Study|Lack of Efficacy|3|||
94327917|NCT01181102|322980491|FG001|Overall Study|Lack of Efficacy|1|||
94327918|NCT01181102|322980490|FG000|Overall Study|Lost to Follow-up|2|||
94327919|NCT01181102|322980491|FG001|Overall Study|Lost to Follow-up|0|||
94327920|NCT01181102|322980490|FG000|Overall Study|Physician Decision|3|||
94327921|NCT01181102|322980491|FG001|Overall Study|Physician Decision|1|||
94327922|NCT01181102|322980490|FG000|Overall Study|Protocol Violation|5|||
94327923|NCT01181102|322980491|FG001|Overall Study|Protocol Violation|6|||
94327924|NCT01181102|322980490|FG000|Overall Study|Withdrawal by Subject|10|||
94327925|NCT01181102|322980491|FG001|Overall Study|Withdrawal by Subject|12|||
94327926|NCT00239837|322980498|FG000|Overall Study|Lost to Follow-up|3|||
94327927|NCT00239837|322980499|FG001|Overall Study|Lost to Follow-up|7|||
94390495|NCT01918397|323219653|FG002|Overall Study|Lack of compliance|3|||
94390496|NCT01918397|323219654|FG003|Overall Study|Lack of compliance|0|||
94390497|NCT01918397|323219651|FG000|Overall Study|Pregnancy|0|||
94390498|NCT01918397|323219652|FG001|Overall Study|Pregnancy|1|||
94390499|NCT01918397|323219653|FG002|Overall Study|Pregnancy|0|||
94390500|NCT01918397|323219654|FG003|Overall Study|Pregnancy|0|||
94390501|NCT01918397|323219651|FG000|Overall Study|Rifampin susceptible|0|||
94390502|NCT01918397|323219652|FG001|Overall Study|Rifampin susceptible|0|||
94390503|NCT01918397|323219653|FG002|Overall Study|Rifampin susceptible|0|||
94390504|NCT01918397|323219654|FG003|Overall Study|Rifampin susceptible|2|||
94390505|NCT01918397|323219651|FG000|Overall Study|Treatment failure|0|||
94390506|NCT01918397|323219652|FG001|Overall Study|Treatment failure|0|||
94390507|NCT01918397|323219653|FG002|Overall Study|Treatment failure|0|||
94390508|NCT01918397|323219654|FG003|Overall Study|Treatment failure|1|||
94390509|NCT01918397|323219651|FG000|Overall Study|Withdrawal by Subject|3|||
94327928|NCT00764946|322980500|FG000|Overall Study|Lack of Efficacy|1|||
94327929|NCT00764946|322980501|FG001|Overall Study|Lack of Efficacy|0|||
94390510|NCT01918397|323219652|FG001|Overall Study|Withdrawal by Subject|2|||
94390511|NCT01918397|323219653|FG002|Overall Study|Withdrawal by Subject|1|||
94390512|NCT01918397|323219654|FG003|Overall Study|Withdrawal by Subject|1|||
94390513|NCT01918397|323219651|FG000|Overall Study|XDR at baseline|0|||
94390514|NCT01918397|323219652|FG001|Overall Study|XDR at baseline|0|||
94390515|NCT01918397|323219653|FG002|Overall Study|XDR at baseline|1|||
94390516|NCT01918397|323219654|FG003|Overall Study|XDR at baseline|0|||
94390517|NCT01918397|323219651|FG000|Overall Study|Lost to Follow-up|2|||
94390518|NCT01918397|323219652|FG001|Overall Study|Lost to Follow-up|1|||
94390519|NCT01918397|323219653|FG002|Overall Study|Lost to Follow-up|1|||
94390520|NCT01918397|323219654|FG003|Overall Study|Lost to Follow-up|1|||
94390521|NCT01918397|323219651|FG000|Overall Study|Increased QTc|1|||
94390522|NCT01918397|323219652|FG001|Overall Study|Increased QTc|0|||
94390523|NCT01918397|323219653|FG002|Overall Study|Increased QTc|0|||
94390524|NCT01918397|323219654|FG003|Overall Study|Increased QTc|1|||
94390525|NCT01918397|323219651|FG000|Overall Study|Death|0|||
94390526|NCT01918397|323219652|FG001|Overall Study|Death|0|||
94390527|NCT01918397|323219653|FG002|Overall Study|Death|1|||
94390528|NCT01918397|323219654|FG003|Overall Study|Death|0|||
94390529|NCT01918397|323219651|FG000|Overall Study|Involved in another investigative trial|0|||
94390530|NCT01918397|323219652|FG001|Overall Study|Involved in another investigative trial|0|||
94390531|NCT01918397|323219653|FG002|Overall Study|Involved in another investigative trial|0|||
94390532|NCT01918397|323219654|FG003|Overall Study|Involved in another investigative trial|1|||
94390533|NCT02942264|323219658|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
94390534|NCT02942264|323219659|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
94390535|NCT02942264|323219660|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
94390536|NCT02942264|323219661|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
94390537|NCT02942264|323219662|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
94390538|NCT02942264|323219663|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
94390539|NCT02942264|323219664|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
94390540|NCT02942264|323219665|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
94390541|NCT02942264|323219666|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
94390542|NCT02942264|323219658|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
94390543|NCT02942264|323219659|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
94390544|NCT02942264|323219660|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
94390545|NCT02942264|323219661|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
94390546|NCT02942264|323219662|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
94390547|NCT02942264|323219663|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
94390548|NCT02942264|323219664|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
94390549|NCT02942264|323219665|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
94390550|NCT02942264|323219666|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
94390551|NCT04206332|323219667|FG000|Part A|Lost to Follow-up|0|||
94390552|NCT04206332|323219668|FG001|Part A|Lost to Follow-up|1|||
94390553|NCT04206332|323219669|FG002|Part A|Lost to Follow-up|0|||
94390554|NCT04206332|323219670|FG003|Part A|Lost to Follow-up|0|||
94390555|NCT04206332|323219671|FG004|Part A|Lost to Follow-up|0|||
94390556|NCT04206332|323219672|FG005|Part A|Lost to Follow-up|0|||
94390557|NCT04206332|323219673|FG006|Part A|Lost to Follow-up|0|||
94390558|NCT04206332|323219674|FG007|Part A|Lost to Follow-up|0|||
94390559|NCT04206332|323219675|FG008|Part A|Lost to Follow-up|0|||
94390560|NCT04206332|323219676|FG009|Part A|Lost to Follow-up|0|||
94390561|NCT04206332|323219677|FG010|Part A|Lost to Follow-up|0|||
94390562|NCT04206332|323219678|FG011|Part A|Lost to Follow-up|0|||
94390563|NCT04206332|323219679|FG012|Part A|Lost to Follow-up|0|||
94390564|NCT04206332|323219680|FG013|Part A|Lost to Follow-up|0|||
94390565|NCT04206332|323219681|FG014|Part A|Lost to Follow-up|0|||
94390566|NCT04206332|323219682|FG015|Part A|Lost to Follow-up|0|||
94390567|NCT04206332|323219683|FG016|Part A|Lost to Follow-up|0|||
94390568|NCT04206332|323219667|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
94390569|NCT04206332|323219668|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
94390570|NCT04206332|323219669|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
94390571|NCT04206332|323219670|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
94390572|NCT04206332|323219671|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
94390573|NCT04206332|323219672|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
94390574|NCT04206332|323219673|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
94390575|NCT04206332|323219674|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
94390576|NCT04206332|323219675|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
94390577|NCT04206332|323219676|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
94390578|NCT04206332|323219677|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
94390579|NCT04206332|323219678|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
94390580|NCT04206332|323219679|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
94482689|NCT00490919|323558173|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
94482690|NCT00490919|323558174|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
94327930|NCT00764946|322980502|FG002|Overall Study|Lack of Efficacy|0|||
94327931|NCT00764946|322980500|FG000|Overall Study|Lost to Follow-up|3|||
94327932|NCT00764946|322980501|FG001|Overall Study|Lost to Follow-up|4|||
94482691|NCT00490919|323558172|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
94482692|NCT00490919|323558173|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
94482693|NCT00490919|323558174|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
94482694|NCT00490919|323558172|FG000|Open-label Run-in Period|Administrative|40|||
94482695|NCT00490919|323558173|FG001|Open-label Run-in Period|Administrative|0|||
94482696|NCT00490919|323558174|FG002|Open-label Run-in Period|Administrative|0|||
94482697|NCT00490919|323558172|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
94482698|NCT00490919|323558173|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
94482699|NCT00490919|323558174|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
94482700|NCT00490919|323558172|FG000|Double-blind Phase|Adverse Event|0|||
94482701|NCT00490919|323558173|FG001|Double-blind Phase|Adverse Event|40|||
94482702|NCT00490919|323558174|FG002|Double-blind Phase|Adverse Event|20|||
94482703|NCT00490919|323558172|FG000|Double-blind Phase|Withdrawal by Subject|0|||
94482704|NCT00490919|323558173|FG001|Double-blind Phase|Withdrawal by Subject|10|||
94482705|NCT00490919|323558174|FG002|Double-blind Phase|Withdrawal by Subject|11|||
94482706|NCT00490919|323558172|FG000|Double-blind Phase|Lost to Follow-up|0|||
94482707|NCT00490919|323558173|FG001|Double-blind Phase|Lost to Follow-up|8|||
94482708|NCT00490919|323558174|FG002|Double-blind Phase|Lost to Follow-up|11|||
94482709|NCT00490919|323558172|FG000|Double-blind Phase|Lack of Efficacy|0|||
94482710|NCT00490919|323558173|FG001|Double-blind Phase|Lack of Efficacy|22|||
94482711|NCT00490919|323558174|FG002|Double-blind Phase|Lack of Efficacy|36|||
94482712|NCT00490919|323558172|FG000|Double-blind Phase|Administrative|0|||
94482713|NCT00490919|323558173|FG001|Double-blind Phase|Administrative|6|||
94482714|NCT00490919|323558174|FG002|Double-blind Phase|Administrative|6|||
94482715|NCT03492437|323559655|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94482716|NCT03492437|323559656|FG001|Treatment Period 2|Withdrawal by Subject|1|||
94482717|NCT04534517|323559657|FG000|Overall Study|Adverse Event|1|||
94482718|NCT04534517|323559657|FG000|Overall Study|Withdrawal by Subject|1|||
94482719|NCT04534517|323559657|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
94482720|NCT04534517|323559657|FG000|Overall Study|COVID-19 Related|1|||
94482721|NCT02692586|323559660|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
94482722|NCT02692586|323559660|FG000|Overall Study|Received adjunctive thrombolytics|2|||
94482723|NCT03150082|323559663|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
94482724|NCT03150082|323559664|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
94482725|NCT02087774|323559666|FG000|Overall Study|Were absent day of data collection|8|||
94482726|NCT02087774|323559667|FG001|Overall Study|Were absent day of data collection|20|||
94482727|NCT02659943|323559668|FG000|Overall Study|Switched to alternative treatment|1|||
94482728|NCT02659943|323559669|FG001|Overall Study|Switched to alternative treatment|1|||
94482729|NCT02659943|323559670|FG002|Overall Study|Switched to alternative treatment|0|||
94482730|NCT02659943|323559671|FG003|Overall Study|Switched to alternative treatment|2|||
94482731|NCT02659943|323559672|FG004|Overall Study|Switched to alternative treatment|1|||
94482732|NCT02659943|323559673|FG005|Overall Study|Switched to alternative treatment|0|||
94482733|NCT02659943|323559674|FG006|Overall Study|Switched to alternative treatment|1|||
94482734|NCT02659943|323559668|FG000|Overall Study|Disease progression on study|0|||
94482735|NCT02659943|323559669|FG001|Overall Study|Disease progression on study|1|||
94482736|NCT02659943|323559670|FG002|Overall Study|Disease progression on study|1|||
94482737|NCT02659943|323559671|FG003|Overall Study|Disease progression on study|1|||
94482738|NCT02659943|323559672|FG004|Overall Study|Disease progression on study|1|||
94482739|NCT02659943|323559673|FG005|Overall Study|Disease progression on study|4|||
94482740|NCT02659943|323559674|FG006|Overall Study|Disease progression on study|0|||
94482741|NCT02659943|323559668|FG000|Overall Study|Patient's condition per principal investigator|0|||
94482742|NCT02659943|323559669|FG001|Overall Study|Patient's condition per principal investigator|0|||
94482743|NCT02659943|323559670|FG002|Overall Study|Patient's condition per principal investigator|0|||
94482744|NCT02659943|323559671|FG003|Overall Study|Patient's condition per principal investigator|0|||
94482745|NCT02659943|323559672|FG004|Overall Study|Patient's condition per principal investigator|0|||
94482746|NCT02659943|323559673|FG005|Overall Study|Patient's condition per principal investigator|1|||
94482747|NCT02659943|323559674|FG006|Overall Study|Patient's condition per principal investigator|0|||
94482748|NCT02659943|323559668|FG000|Overall Study|Ineligible|0|||
94482749|NCT02659943|323559669|FG001|Overall Study|Ineligible|0|||
94482750|NCT02659943|323559670|FG002|Overall Study|Ineligible|0|||
94482751|NCT02659943|323559671|FG003|Overall Study|Ineligible|0|||
94482752|NCT02659943|323559672|FG004|Overall Study|Ineligible|0|||
94482753|NCT02659943|323559673|FG005|Overall Study|Ineligible|0|||
94482754|NCT02659943|323559674|FG006|Overall Study|Ineligible|1|||
94482755|NCT02659943|323559668|FG000|Overall Study|No longer meets eligibility|0|||
94482756|NCT02659943|323559669|FG001|Overall Study|No longer meets eligibility|0|||
94482757|NCT02659943|323559670|FG002|Overall Study|No longer meets eligibility|0|||
94482758|NCT02659943|323559671|FG003|Overall Study|No longer meets eligibility|0|||
94482759|NCT02659943|323559672|FG004|Overall Study|No longer meets eligibility|0|||
94327933|NCT00764946|322980502|FG002|Overall Study|Lost to Follow-up|0|||
94482760|NCT02659943|323559673|FG005|Overall Study|No longer meets eligibility|0|||
94482761|NCT02659943|323559674|FG006|Overall Study|No longer meets eligibility|1|||
94482762|NCT02659943|323559668|FG000|Overall Study|No treatment, per protocol|0|||
94482763|NCT02659943|323559669|FG001|Overall Study|No treatment, per protocol|0|||
94482764|NCT02659943|323559670|FG002|Overall Study|No treatment, per protocol|0|||
94327934|NCT00764946|322980500|FG000|Overall Study|Physician Decision|2|||
94327935|NCT00764946|322980501|FG001|Overall Study|Physician Decision|4|||
94327936|NCT00764946|322980502|FG002|Overall Study|Physician Decision|0|||
94327937|NCT00764946|322980500|FG000|Overall Study|Adverse Event|3|||
94327938|NCT00764946|322980501|FG001|Overall Study|Adverse Event|2|||
94327939|NCT00764946|322980502|FG002|Overall Study|Adverse Event|1|||
94327940|NCT00764946|322980500|FG000|Overall Study|Withdrawal by Subject|3|||
94327941|NCT00764946|322980501|FG001|Overall Study|Withdrawal by Subject|6|||
94327942|NCT00764946|322980502|FG002|Overall Study|Withdrawal by Subject|2|||
94327943|NCT00764946|322980500|FG000|Overall Study|Never Treated|1|||
94327944|NCT00764946|322980501|FG001|Overall Study|Never Treated|1|||
94327945|NCT00764946|322980502|FG002|Overall Study|Never Treated|1|||
94327946|NCT01361919|322980503|FG000|Overall Study|technical issues|10|||
94327947|NCT01361919|322980504|FG001|Overall Study|technical issues|12|||
94327948|NCT01361919|322980505|FG002|Overall Study|technical issues|10|||
94327949|NCT03454412|322980506|FG000|Baseline Assesment|Physician Decision|12|||
94327950|NCT03730194|322980507|FG000|First Stage Treatment|Withdrawal by Subject|1|||
94327951|NCT03730194|322980508|FG001|First Stage Treatment|Withdrawal by Subject|1|||
94327952|NCT03730194|322980509|FG002|First Stage Treatment|Withdrawal by Subject|0|||
94327953|NCT03730194|322980510|FG003|First Stage Treatment|Withdrawal by Subject|0|||
94327954|NCT03730194|322980511|FG004|First Stage Treatment|Withdrawal by Subject|0|||
94327955|NCT03730194|322980512|FG005|First Stage Treatment|Withdrawal by Subject|0|||
94390581|NCT04206332|323219680|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
94390582|NCT04206332|323219681|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
94390583|NCT04206332|323219682|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
94390584|NCT04206332|323219683|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
94390585|NCT04206332|323219667|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390586|NCT04206332|323219668|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390587|NCT04206332|323219669|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390588|NCT04206332|323219670|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390589|NCT04206332|323219671|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390590|NCT04206332|323219672|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390591|NCT04206332|323219673|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390592|NCT04206332|323219674|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
94390593|NCT04206332|323219675|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390594|NCT04206332|323219676|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390595|NCT04206332|323219677|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
94390596|NCT04206332|323219678|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390597|NCT04206332|323219679|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390598|NCT04206332|323219680|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390599|NCT04206332|323219681|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390600|NCT04206332|323219682|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390601|NCT04206332|323219683|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390602|NCT04206332|323219667|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390603|NCT04206332|323219668|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390604|NCT04206332|323219669|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390605|NCT04206332|323219670|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390606|NCT04206332|323219671|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390607|NCT04206332|323219672|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390608|NCT04206332|323219673|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390609|NCT04206332|323219674|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94482765|NCT02659943|323559671|FG003|Overall Study|No treatment, per protocol|0|||
94327956|NCT03730194|322980507|FG000|First Stage Treatment|Protocol Violation|3|||
94327957|NCT03730194|322980508|FG001|First Stage Treatment|Protocol Violation|3|||
94327958|NCT03730194|322980509|FG002|First Stage Treatment|Protocol Violation|0|||
94327959|NCT03730194|322980510|FG003|First Stage Treatment|Protocol Violation|0|||
94327960|NCT03730194|322980511|FG004|First Stage Treatment|Protocol Violation|0|||
94482766|NCT02659943|323559672|FG004|Overall Study|No treatment, per protocol|0|||
94482767|NCT02659943|323559673|FG005|Overall Study|No treatment, per protocol|0|||
94327961|NCT03730194|322980512|FG005|First Stage Treatment|Protocol Violation|0|||
94327962|NCT02260648|322980513|FG000|Overall Study|Adverse Event|3|||
94327963|NCT02260648|322980514|FG001|Overall Study|Adverse Event|0|||
94327964|NCT02260648|322980515|FG002|Overall Study|Adverse Event|1|||
94327965|NCT02260648|322980513|FG000|Overall Study|Withdrawal by Subject|1|||
94327966|NCT02260648|322980514|FG001|Overall Study|Withdrawal by Subject|1|||
94327967|NCT02260648|322980515|FG002|Overall Study|Withdrawal by Subject|0|||
94327968|NCT02260648|322980513|FG000|Overall Study|Protocol Violation|1|||
94327969|NCT02260648|322980514|FG001|Overall Study|Protocol Violation|0|||
94327970|NCT02260648|322980515|FG002|Overall Study|Protocol Violation|0|||
94327971|NCT02260648|322980513|FG000|Overall Study|Discontinue Due to Study Termination|13|||
94327972|NCT02260648|322980514|FG001|Overall Study|Discontinue Due to Study Termination|12|||
94327973|NCT02260648|322980515|FG002|Overall Study|Discontinue Due to Study Termination|7|||
94327974|NCT00039741|322980516|FG000|Overall Study|Death|0|||
94327975|NCT00039741|322980517|FG001|Overall Study|Death|1|||
94327976|NCT00039741|322980518|FG002|Overall Study|Death|0|||
94327977|NCT00039741|322980519|FG003|Overall Study|Death|0|||
94327978|NCT00039741|322980516|FG000|Overall Study|Lost to Follow-up|3|||
94327979|NCT00039741|322980517|FG001|Overall Study|Lost to Follow-up|1|||
94327980|NCT00039741|322980518|FG002|Overall Study|Lost to Follow-up|5|||
94327981|NCT00039741|322980519|FG003|Overall Study|Lost to Follow-up|2|||
94327982|NCT00039741|322980516|FG000|Overall Study|Confounding medical condition|1|||
94327983|NCT00039741|322980517|FG001|Overall Study|Confounding medical condition|0|||
94327984|NCT00039741|322980518|FG002|Overall Study|Confounding medical condition|0|||
94327985|NCT00039741|322980519|FG003|Overall Study|Confounding medical condition|0|||
94327986|NCT00039741|322980516|FG000|Overall Study|Not able to get to clinic|5|||
94327987|NCT00039741|322980517|FG001|Overall Study|Not able to get to clinic|2|||
94327988|NCT00039741|322980518|FG002|Overall Study|Not able to get to clinic|0|||
94327989|NCT00039741|322980519|FG003|Overall Study|Not able to get to clinic|3|||
94327990|NCT00039741|322980516|FG000|Overall Study|Moved|3|||
94327991|NCT00039741|322980517|FG001|Overall Study|Moved|2|||
94327992|NCT00039741|322980518|FG002|Overall Study|Moved|3|||
94327993|NCT00039741|322980519|FG003|Overall Study|Moved|6|||
94327994|NCT00039741|322980516|FG000|Overall Study|Non-compliance with protocol|1|||
94327995|NCT00039741|322980517|FG001|Overall Study|Non-compliance with protocol|0|||
94327996|NCT00039741|322980518|FG002|Overall Study|Non-compliance with protocol|1|||
94327997|NCT00039741|322980519|FG003|Overall Study|Non-compliance with protocol|0|||
94390610|NCT04206332|323219675|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390611|NCT04206332|323219676|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390612|NCT04206332|323219677|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390613|NCT04206332|323219678|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390614|NCT04206332|323219679|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390615|NCT04206332|323219680|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390616|NCT04206332|323219681|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390617|NCT04206332|323219682|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
94390618|NCT04206332|323219683|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
94390619|NCT04206332|323219667|FG000|Part C|Withdrawal by Subject|0|||
94390620|NCT04206332|323219668|FG001|Part C|Withdrawal by Subject|0|||
94390621|NCT04206332|323219669|FG002|Part C|Withdrawal by Subject|0|||
94390622|NCT04206332|323219670|FG003|Part C|Withdrawal by Subject|0|||
94390623|NCT04206332|323219671|FG004|Part C|Withdrawal by Subject|0|||
94390624|NCT04206332|323219672|FG005|Part C|Withdrawal by Subject|0|||
94390625|NCT04206332|323219673|FG006|Part C|Withdrawal by Subject|0|||
94390626|NCT04206332|323219674|FG007|Part C|Withdrawal by Subject|0|||
94390627|NCT04206332|323219675|FG008|Part C|Withdrawal by Subject|0|||
94390628|NCT04206332|323219676|FG009|Part C|Withdrawal by Subject|0|||
94390629|NCT04206332|323219677|FG010|Part C|Withdrawal by Subject|0|||
94390630|NCT04206332|323219678|FG011|Part C|Withdrawal by Subject|0|||
94390631|NCT04206332|323219679|FG012|Part C|Withdrawal by Subject|0|||
94390632|NCT04206332|323219680|FG013|Part C|Withdrawal by Subject|0|||
94390633|NCT04206332|323219681|FG014|Part C|Withdrawal by Subject|2|||
94390634|NCT04206332|323219682|FG015|Part C|Withdrawal by Subject|0|||
94390635|NCT04206332|323219683|FG016|Part C|Withdrawal by Subject|0|||
94390636|NCT04000815|323219684|FG000|Overall Study|Lost to Follow-up|9|||
94390637|NCT04000815|323219685|FG001|Overall Study|Lost to Follow-up|2|||
94327998|NCT00039741|322980516|FG000|Overall Study|Withdrew consent|0|||
94327999|NCT00039741|322980517|FG001|Overall Study|Withdrew consent|5|||
94328000|NCT00039741|322980518|FG002|Overall Study|Withdrew consent|0|||
94328001|NCT00039741|322980519|FG003|Overall Study|Withdrew consent|1|||
94390638|NCT04000815|323219686|FG002|Overall Study|Lost to Follow-up|3|||
94390639|NCT04000815|323219684|FG000|Overall Study|Withdrawal by Subject|4|||
94390640|NCT04000815|323219685|FG001|Overall Study|Withdrawal by Subject|3|||
94390641|NCT04000815|323219686|FG002|Overall Study|Withdrawal by Subject|2|||
94390642|NCT04000815|323219684|FG000|Overall Study|Right ovarian cyst occured|1|||
94390643|NCT04000815|323219685|FG001|Overall Study|Right ovarian cyst occured|0|||
94390644|NCT04000815|323219686|FG002|Overall Study|Right ovarian cyst occured|0|||
94390645|NCT04000815|323219684|FG000|Overall Study|Hypertension occured on follow up|0|||
94390646|NCT04000815|323219685|FG001|Overall Study|Hypertension occured on follow up|0|||
94390647|NCT04000815|323219686|FG002|Overall Study|Hypertension occured on follow up|2|||
94390648|NCT01171989|323219687|FG000|Overall Study|Lost to Follow-up|0|||
94390649|NCT01171989|323219688|FG001|Overall Study|Lost to Follow-up|0|||
94390650|NCT01171989|323219689|FG002|Overall Study|Lost to Follow-up|1|||
94390651|NCT00150462|323219690|FG000|Overall Study|Disease Progression or Relapse|3|||
94390652|NCT00150462|323219691|FG001|Overall Study|Disease Progression or Relapse|1|||
94390653|NCT00150462|323219692|FG002|Overall Study|Disease Progression or Relapse|2|||
94390654|NCT00150462|323219693|FG003|Overall Study|Disease Progression or Relapse|1|||
94390655|NCT00150462|323219694|FG004|Overall Study|Disease Progression or Relapse|2|||
94390656|NCT00150462|323219695|FG005|Overall Study|Disease Progression or Relapse|2|||
94390657|NCT00150462|323219696|FG006|Overall Study|Disease Progression or Relapse|3|||
94390658|NCT00150462|323219697|FG007|Overall Study|Disease Progression or Relapse|5|||
94390659|NCT00150462|323219698|FG008|Overall Study|Disease Progression or Relapse|5|||
94390660|NCT00150462|323219699|FG009|Overall Study|Disease Progression or Relapse|3|||
94390661|NCT00150462|323219700|FG010|Overall Study|Disease Progression or Relapse|2|||
94390662|NCT00150462|323219690|FG000|Overall Study|Withdrawal by Subject|0|||
94390663|NCT00150462|323219691|FG001|Overall Study|Withdrawal by Subject|1|||
94390664|NCT00150462|323219692|FG002|Overall Study|Withdrawal by Subject|1|||
94390665|NCT00150462|323219693|FG003|Overall Study|Withdrawal by Subject|0|||
94390666|NCT00150462|323219694|FG004|Overall Study|Withdrawal by Subject|1|||
94390667|NCT00150462|323219695|FG005|Overall Study|Withdrawal by Subject|2|||
94390668|NCT00150462|323219696|FG006|Overall Study|Withdrawal by Subject|0|||
94390669|NCT00150462|323219697|FG007|Overall Study|Withdrawal by Subject|1|||
94390670|NCT00150462|323219698|FG008|Overall Study|Withdrawal by Subject|0|||
94390671|NCT00150462|323219699|FG009|Overall Study|Withdrawal by Subject|1|||
94390672|NCT00150462|323219700|FG010|Overall Study|Withdrawal by Subject|0|||
94390673|NCT00150462|323219690|FG000|Overall Study|Death|0|||
94390674|NCT00150462|323219691|FG001|Overall Study|Death|1|||
94390675|NCT00150462|323219692|FG002|Overall Study|Death|0|||
94390676|NCT00150462|323219693|FG003|Overall Study|Death|0|||
94390677|NCT00150462|323219694|FG004|Overall Study|Death|0|||
94390678|NCT00150462|323219695|FG005|Overall Study|Death|0|||
94390679|NCT00150462|323219696|FG006|Overall Study|Death|0|||
94390680|NCT00150462|323219697|FG007|Overall Study|Death|0|||
94390681|NCT00150462|323219698|FG008|Overall Study|Death|1|||
94390682|NCT00150462|323219699|FG009|Overall Study|Death|0|||
94390683|NCT00150462|323219700|FG010|Overall Study|Death|0|||
94390684|NCT00150462|323219690|FG000|Overall Study|Adverse Event|0|||
94390685|NCT00150462|323219691|FG001|Overall Study|Adverse Event|0|||
94390686|NCT00150462|323219692|FG002|Overall Study|Adverse Event|0|||
94390687|NCT00150462|323219693|FG003|Overall Study|Adverse Event|1|||
94390688|NCT00150462|323219694|FG004|Overall Study|Adverse Event|0|||
94390689|NCT00150462|323219695|FG005|Overall Study|Adverse Event|0|||
94390690|NCT00150462|323219696|FG006|Overall Study|Adverse Event|0|||
94390691|NCT00150462|323219697|FG007|Overall Study|Adverse Event|2|||
94390692|NCT00150462|323219698|FG008|Overall Study|Adverse Event|0|||
94390693|NCT00150462|323219699|FG009|Overall Study|Adverse Event|1|||
94390694|NCT00150462|323219700|FG010|Overall Study|Adverse Event|0|||
94390695|NCT00150462|323219690|FG000|Overall Study|Physician Decision|0|||
94390696|NCT00150462|323219691|FG001|Overall Study|Physician Decision|0|||
94390697|NCT00150462|323219692|FG002|Overall Study|Physician Decision|1|||
94390698|NCT00150462|323219693|FG003|Overall Study|Physician Decision|1|||
94390699|NCT00150462|323219694|FG004|Overall Study|Physician Decision|0|||
94390700|NCT00150462|323219695|FG005|Overall Study|Physician Decision|0|||
94390701|NCT00150462|323219696|FG006|Overall Study|Physician Decision|0|||
94390702|NCT00150462|323219697|FG007|Overall Study|Physician Decision|0|||
94390703|NCT00150462|323219698|FG008|Overall Study|Physician Decision|0|||
94390704|NCT00150462|323219699|FG009|Overall Study|Physician Decision|0|||
94390705|NCT00150462|323219700|FG010|Overall Study|Physician Decision|0|||
94390706|NCT00150462|323219690|FG000|Overall Study|Other|0|||
94390707|NCT00150462|323219691|FG001|Overall Study|Other|0|||
94390708|NCT00150462|323219692|FG002|Overall Study|Other|0|||
94390709|NCT00150462|323219693|FG003|Overall Study|Other|0|||
94390710|NCT00150462|323219694|FG004|Overall Study|Other|0|||
94390711|NCT00150462|323219695|FG005|Overall Study|Other|0|||
94390712|NCT00150462|323219696|FG006|Overall Study|Other|0|||
94390713|NCT00150462|323219697|FG007|Overall Study|Other|0|||
94390714|NCT00150462|323219698|FG008|Overall Study|Other|0|||
94390715|NCT00150462|323219699|FG009|Overall Study|Other|1|||
94390716|NCT00150462|323219700|FG010|Overall Study|Other|1|||
94390717|NCT04567186|323219701|FG000|Period 1|COVID-19 related|1|||
94390718|NCT04567186|323219702|FG001|Period 1|COVID-19 related|0|||
94390719|NCT04567186|323219701|FG000|Period 1|Protocol Violation|0|||
94390720|NCT04567186|323219702|FG001|Period 1|Protocol Violation|1|||
94390721|NCT04567186|323219701|FG000|Period 1|Adverse Event|0|||
94390722|NCT04567186|323219702|FG001|Period 1|Adverse Event|2|||
94390723|NCT04567186|323219701|FG000|Period 2|COVID-19 Related|0|||
94390724|NCT04567186|323219702|FG001|Period 2|COVID-19 Related|1|||
94390725|NCT04567186|323219701|FG000|Period 2|Protocol Violation|0|||
94390726|NCT04567186|323219702|FG001|Period 2|Protocol Violation|1|||
94390727|NCT04567186|323219701|FG000|Period 2|Lost to Follow-up|0|||
94390728|NCT04567186|323219702|FG001|Period 2|Lost to Follow-up|1|||
94390729|NCT04567186|323219701|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
94390730|NCT04567186|323219702|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
94390731|NCT03136380|323219703|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
94390732|NCT03136380|323219704|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
94390733|NCT03136380|323219705|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
94390734|NCT03136380|323219706|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
94390735|NCT03136380|323219707|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
94390736|NCT02728102|323219708|FG000|Overall Study|Death|3|||
94390737|NCT02728102|323219709|FG001|Overall Study|Death|0|||
94390738|NCT02728102|323219710|FG002|Overall Study|Death|1|||
94390739|NCT02728102|323219708|FG000|Overall Study|Withdrawal by Subject|0|||
94390740|NCT02728102|323219709|FG001|Overall Study|Withdrawal by Subject|2|||
94390741|NCT02728102|323219710|FG002|Overall Study|Withdrawal by Subject|3|||
94390742|NCT02728102|323219708|FG000|Overall Study|Physician Decision|1|||
94390743|NCT02728102|323219709|FG001|Overall Study|Physician Decision|1|||
94390744|NCT02728102|323219710|FG002|Overall Study|Physician Decision|0|||
94390745|NCT02728102|323219708|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
94390746|NCT02728102|323219709|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
94390747|NCT02728102|323219710|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
94390748|NCT02728102|323219708|FG000|Overall Study|Covid|0|||
94390749|NCT02728102|323219709|FG001|Overall Study|Covid|0|||
94390750|NCT02728102|323219710|FG002|Overall Study|Covid|1|||
94390751|NCT03699020|323219717|FG000|Overall Study|Withdrawal by Subject|3|||
94390752|NCT03699020|323219718|FG001|Overall Study|Withdrawal by Subject|2|||
94390753|NCT02202850|323219719|FG000|Overall Study|Other|2|||
94390754|NCT02202850|323219720|FG001|Overall Study|Other|2|||
94390755|NCT02202850|323219719|FG000|Overall Study|Enbrel treatment discontinued|15|||
94390756|NCT02202850|323219720|FG001|Overall Study|Enbrel treatment discontinued|3|||
94390757|NCT02202850|323219719|FG000|Overall Study|Lost to Follow-up|7|||
94390758|NCT02202850|323219720|FG001|Overall Study|Lost to Follow-up|1|||
94390759|NCT01873586|323219721|FG000|Overall Study|Lost to Follow-up|3|||
94390760|NCT01256684|323219722|FG000|Overall Study|Adverse Event|1|||
94390761|NCT01256684|323219723|FG001|Overall Study|Adverse Event|4|||
94390762|NCT01256684|323219724|FG002|Overall Study|Adverse Event|2|||
94390763|NCT01256684|323219722|FG000|Overall Study|Withdrawal by Subject|4|||
94390764|NCT01256684|323219723|FG001|Overall Study|Withdrawal by Subject|0|||
94390765|NCT01256684|323219724|FG002|Overall Study|Withdrawal by Subject|2|||
94390766|NCT01256684|323219722|FG000|Overall Study|Physician Decision|0|||
94390767|NCT01256684|323219723|FG001|Overall Study|Physician Decision|1|||
94390768|NCT01256684|323219724|FG002|Overall Study|Physician Decision|0|||
94390769|NCT01256684|323219722|FG000|Overall Study|Lack of Efficacy|0|||
94390770|NCT01256684|323219723|FG001|Overall Study|Lack of Efficacy|1|||
94390771|NCT01256684|323219724|FG002|Overall Study|Lack of Efficacy|1|||
94390772|NCT01256684|323219722|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
94390773|NCT01256684|323219723|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
94390774|NCT01256684|323219724|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
94390775|NCT02674477|323219725|FG000|Overall Study|Protocol Violation|8|||
94390776|NCT02674477|323219726|FG001|Overall Study|Protocol Violation|2|||
94390777|NCT00624065|323219727|FG000|Overall Study|Adverse Event|5|||
94390778|NCT00624065|323219728|FG001|Overall Study|Adverse Event|6|||
94390779|NCT00624065|323219727|FG000|Overall Study|Lost to Follow-up|4|||
94390780|NCT00624065|323219728|FG001|Overall Study|Lost to Follow-up|1|||
94390781|NCT00624065|323219727|FG000|Overall Study|Consent withdrawn|6|||
94390782|NCT00624065|323219728|FG001|Overall Study|Consent withdrawn|5|||
94390783|NCT00624065|323219727|FG000|Overall Study|Lack of Efficacy|0|||
94390784|NCT00624065|323219728|FG001|Overall Study|Lack of Efficacy|3|||
94390785|NCT00624065|323219727|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
94390786|NCT00624065|323219728|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
94390787|NCT04213326|323219730|FG000|Overall Study|Consent withdrawn|51|||
94390788|NCT04213326|323219731|FG001|Overall Study|Consent withdrawn|241|||
94390789|NCT04213326|323219730|FG000|Overall Study|Lost to Follow-up|50|||
94390790|NCT04213326|323219731|FG001|Overall Study|Lost to Follow-up|902|||
94390791|NCT04213326|323219730|FG000|Overall Study|Protocol Violation|3|||
94390792|NCT04213326|323219731|FG001|Overall Study|Protocol Violation|25|||
94390793|NCT04213326|323219730|FG000|Overall Study|Participant eligibility changed|106|||
94390794|NCT04213326|323219731|FG001|Overall Study|Participant eligibility changed|19|||
94390795|NCT04213326|323219730|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
94390796|NCT04213326|323219731|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
94390797|NCT04213326|323219730|FG000|Overall Study|Incomplete study visit|0|||
94390798|NCT04213326|323219731|FG001|Overall Study|Incomplete study visit|367|||
94390799|NCT01844375|323219732|FG000|Overall Study|Protocol Violation|1|||
94390800|NCT01844375|323219733|FG001|Overall Study|Protocol Violation|1|||
94390801|NCT01536574|323219738|FG000|Overall Study|Adverse Event|4|||
94390802|NCT01536574|323219739|FG001|Overall Study|Adverse Event|5|||
94390803|NCT01536574|323219738|FG000|Overall Study|Withdrawal by Subject|1|||
94390804|NCT01536574|323219739|FG001|Overall Study|Withdrawal by Subject|2|||
94390805|NCT01536574|323219738|FG000|Overall Study|Lack of Efficacy|1|||
94390806|NCT01536574|323219739|FG001|Overall Study|Lack of Efficacy|0|||
94390807|NCT02481830|323219740|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
94390808|NCT02481830|323219741|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
94390809|NCT02481830|323219740|FG000|Pre-treatment|Withdrawal by Subject|0|||
94390810|NCT02481830|323219741|FG001|Pre-treatment|Withdrawal by Subject|10|||
94390811|NCT02481830|323219740|FG000|Pre-treatment|Disease Progression|1|||
94390812|NCT02481830|323219741|FG001|Pre-treatment|Disease Progression|1|||
94390813|NCT02481830|323219740|FG000|Pre-treatment|Other reasons|0|||
94390814|NCT02481830|323219741|FG001|Pre-treatment|Other reasons|1|||
94390815|NCT02481830|323219740|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
94390816|NCT02481830|323219741|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
94390817|NCT02481830|323219740|FG000|Treatment|Disease Progression|233|||
94390818|NCT02481830|323219741|FG001|Treatment|Disease Progression|171|||
94390819|NCT02481830|323219740|FG000|Treatment|Study drug toxicity|18|||
94328002|NCT00039741|322980516|FG000|Overall Study|Missed final visit|2|||
94328003|NCT00039741|322980517|FG001|Overall Study|Missed final visit|1|||
94328004|NCT00039741|322980518|FG002|Overall Study|Missed final visit|2|||
94328005|NCT00039741|322980519|FG003|Overall Study|Missed final visit|2|||
94328006|NCT01182337|322980520|FG000|Overall Study|Withdrawal by Subject|3|||
94328007|NCT01182337|322980521|FG001|Overall Study|Withdrawal by Subject|1|||
94328008|NCT01182337|322980520|FG000|Overall Study|Lost to Follow-up|0|||
94328009|NCT01182337|322980521|FG001|Overall Study|Lost to Follow-up|1|||
94328010|NCT01021813|322980525|FG000|DB Treatment Phase|Adverse Event|60|||
94328011|NCT01021813|322980526|FG001|DB Treatment Phase|Adverse Event|22|||
94328012|NCT01021813|322980527|FG002|DB Treatment Phase|Adverse Event|0|||
94328013|NCT01021813|322980528|FG003|DB Treatment Phase|Adverse Event|0|||
94328014|NCT01021813|322980529|FG004|DB Treatment Phase|Adverse Event|0|||
94328015|NCT01021813|322980525|FG000|DB Treatment Phase|Lack of Efficacy|44|||
94328016|NCT01021813|322980526|FG001|DB Treatment Phase|Lack of Efficacy|28|||
94328017|NCT01021813|322980527|FG002|DB Treatment Phase|Lack of Efficacy|0|||
94328018|NCT01021813|322980528|FG003|DB Treatment Phase|Lack of Efficacy|0|||
94328019|NCT01021813|322980529|FG004|DB Treatment Phase|Lack of Efficacy|0|||
94328020|NCT01021813|322980525|FG000|DB Treatment Phase|Lost to Follow-up|14|||
94328021|NCT01021813|322980526|FG001|DB Treatment Phase|Lost to Follow-up|12|||
94328022|NCT01021813|322980527|FG002|DB Treatment Phase|Lost to Follow-up|0|||
94328023|NCT01021813|322980528|FG003|DB Treatment Phase|Lost to Follow-up|0|||
94328024|NCT01021813|322980529|FG004|DB Treatment Phase|Lost to Follow-up|0|||
94328025|NCT01021813|322980525|FG000|DB Treatment Phase|Physician Decision|17|||
94328026|NCT01021813|322980526|FG001|DB Treatment Phase|Physician Decision|8|||
94328027|NCT01021813|322980527|FG002|DB Treatment Phase|Physician Decision|0|||
94328028|NCT01021813|322980528|FG003|DB Treatment Phase|Physician Decision|0|||
94328029|NCT01021813|322980529|FG004|DB Treatment Phase|Physician Decision|0|||
94328030|NCT01021813|322980525|FG000|DB Treatment Phase|Pregnancy|1|||
94328031|NCT01021813|322980526|FG001|DB Treatment Phase|Pregnancy|0|||
94328032|NCT01021813|322980527|FG002|DB Treatment Phase|Pregnancy|0|||
94328033|NCT01021813|322980528|FG003|DB Treatment Phase|Pregnancy|0|||
94328034|NCT01021813|322980529|FG004|DB Treatment Phase|Pregnancy|0|||
94328035|NCT01021813|322980525|FG000|DB Treatment Phase|Protocol Violation|4|||
94328036|NCT01021813|322980526|FG001|DB Treatment Phase|Protocol Violation|3|||
94328037|NCT01021813|322980527|FG002|DB Treatment Phase|Protocol Violation|0|||
94328038|NCT01021813|322980528|FG003|DB Treatment Phase|Protocol Violation|0|||
94328039|NCT01021813|322980529|FG004|DB Treatment Phase|Protocol Violation|0|||
94328040|NCT01021813|322980525|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
94328041|NCT01021813|322980526|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
94390820|NCT02481830|323219741|FG001|Treatment|Study drug toxicity|38|||
94390821|NCT02481830|323219740|FG000|Treatment|Death|1|||
94390822|NCT02481830|323219741|FG001|Treatment|Death|1|||
94390823|NCT02481830|323219740|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
94390824|NCT02481830|323219741|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
94390825|NCT02481830|323219740|FG000|Treatment|Participants request to discontinue Study treatment|6|||
94390826|NCT02481830|323219741|FG001|Treatment|Participants request to discontinue Study treatment|34|||
94390827|NCT02481830|323219740|FG000|Treatment|Withdrawal by Subject|2|||
94328042|NCT01021813|322980527|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
94328043|NCT01021813|322980528|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
94328044|NCT01021813|322980529|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
94328045|NCT01021813|322980525|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
94328046|NCT01021813|322980526|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
94328047|NCT01021813|322980527|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
94328048|NCT01021813|322980528|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
94328049|NCT01021813|322980529|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
94328050|NCT01021813|322980525|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
94328051|NCT01021813|322980526|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
94328052|NCT01021813|322980527|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
94328053|NCT01021813|322980528|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
94328054|NCT01021813|322980529|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
94328055|NCT01021813|322980525|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
94328056|NCT01021813|322980526|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
94328057|NCT01021813|322980527|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
94328058|NCT01021813|322980528|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
94328059|NCT01021813|322980529|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
94328060|NCT01021813|322980525|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
94328061|NCT01021813|322980526|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
94328062|NCT01021813|322980527|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
94328063|NCT01021813|322980528|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
94328064|NCT01021813|322980529|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
94328065|NCT01021813|322980525|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
94328066|NCT01021813|322980526|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
94328067|NCT01021813|322980527|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
94328068|NCT01021813|322980528|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
94328069|NCT01021813|322980529|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
94328070|NCT03103906|322980530|FG000|Overall Study|Adverse Event|2|||
94328071|NCT03103906|322980531|FG001|Overall Study|Adverse Event|3|||
94328072|NCT03103906|322980530|FG000|Overall Study|Other|2|||
94328073|NCT03103906|322980531|FG001|Overall Study|Other|0|||
94328074|NCT00764478|322980532|FG000|Overall Study|Adverse Event|1|||
94328075|NCT00764478|322980533|FG001|Overall Study|Adverse Event|1|||
94328076|NCT00764478|322980534|FG002|Overall Study|Adverse Event|1|||
94328077|NCT00764478|322980532|FG000|Overall Study|Withdrawal by Subject|7|||
94328078|NCT00764478|322980533|FG001|Overall Study|Withdrawal by Subject|12|||
94328079|NCT00764478|322980534|FG002|Overall Study|Withdrawal by Subject|1|||
94328080|NCT00764478|322980532|FG000|Overall Study|Lost to Follow-up|7|||
94328081|NCT00764478|322980533|FG001|Overall Study|Lost to Follow-up|8|||
94328082|NCT00764478|322980534|FG002|Overall Study|Lost to Follow-up|5|||
94328083|NCT00764478|322980532|FG000|Overall Study|Protocol Violation|0|||
94328084|NCT00764478|322980533|FG001|Overall Study|Protocol Violation|1|||
94328085|NCT00764478|322980534|FG002|Overall Study|Protocol Violation|1|||
94328086|NCT02702011|322980539|FG000|Overall Study|Withdrawal by Subject|0|||
94328087|NCT02702011|322980540|FG001|Overall Study|Withdrawal by Subject|1|||
94328088|NCT02702011|322980541|FG002|Overall Study|Withdrawal by Subject|0|||
94328089|NCT02702011|322980542|FG003|Overall Study|Withdrawal by Subject|0|||
94328090|NCT02921763|322980546|FG000|Overall Study|Adverse Event|4|||
94328091|NCT02921763|322980546|FG000|Overall Study|Lost to Follow-up|4|||
94328092|NCT02921763|322980546|FG000|Overall Study|Lack of Efficacy|3|||
94328093|NCT02921763|322980546|FG000|Overall Study|Protocol Violation|2|||
94328094|NCT02921763|322980546|FG000|Overall Study|Withdrawal by Subject|2|||
94328095|NCT02921763|322980546|FG000|Overall Study|Physician Decision|1|||
94328096|NCT02921763|322980546|FG000|Overall Study|No data obtained|2|||
94328097|NCT00862121|322980549|FG000|Overall Study|Adverse Event|1|||
94328098|NCT00862121|322980550|FG001|Overall Study|Adverse Event|2|||
94328099|NCT00862121|322980549|FG000|Overall Study|Lack of Efficacy|0|||
94328100|NCT00862121|322980550|FG001|Overall Study|Lack of Efficacy|3|||
94328101|NCT00862121|322980549|FG000|Overall Study|Protocol Violation|0|||
94328102|NCT00862121|322980550|FG001|Overall Study|Protocol Violation|1|||
94328103|NCT00862121|322980549|FG000|Overall Study|Exclusion criterion violation|0|||
94328104|NCT00862121|322980550|FG001|Overall Study|Exclusion criterion violation|1|||
94390828|NCT02481830|323219741|FG001|Treatment|Withdrawal by Subject|3|||
94328105|NCT00862121|322980549|FG000|Overall Study|Incorrect randomisation|0|||
94328106|NCT00862121|322980550|FG001|Overall Study|Incorrect randomisation|1|||
94328107|NCT02554253|322980564|FG000|Overall Study|ineligible after enrollment|1|||
94328108|NCT02554253|322980565|FG001|Overall Study|ineligible after enrollment|0|||
94328109|NCT02554253|322980564|FG000|Overall Study|converted to transcatheter procedure|0|||
94328110|NCT02554253|322980565|FG001|Overall Study|converted to transcatheter procedure|1|||
94328111|NCT02554253|322980564|FG000|Overall Study|received both drugs|0|||
94328112|NCT02554253|322980565|FG001|Overall Study|received both drugs|1|||
94328113|NCT02559206|322980566|FG000|Overall Study|Adverse Event|0|||
94328114|NCT02559206|322980567|FG001|Overall Study|Adverse Event|4|||
94328115|NCT02559206|322980568|FG002|Overall Study|Adverse Event|1|||
94328116|NCT02559206|322980569|FG003|Overall Study|Adverse Event|5|||
94390829|NCT02481830|323219740|FG000|Treatment|Lost to Follow-up|1|||
94390830|NCT02481830|323219741|FG001|Treatment|Lost to Follow-up|0|||
94390831|NCT02481830|323219740|FG000|Treatment|Maximum Clinical Benefit|0|||
94390832|NCT02481830|323219741|FG001|Treatment|Maximum Clinical Benefit|5|||
94390833|NCT02481830|323219740|FG000|Treatment|Administrative reason by sponsor|1|||
94390834|NCT02481830|323219741|FG001|Treatment|Administrative reason by sponsor|1|||
94390835|NCT02481830|323219740|FG000|Treatment|Other reasons|6|||
94390836|NCT02481830|323219741|FG001|Treatment|Other reasons|1|||
94390837|NCT01498120|323219747|FG000|Overall Study|Lost to Follow-up|1|||
94390838|NCT01498120|323219747|FG000|Overall Study|Withdrawal by Subject|5|||
94390839|NCT01498120|323219747|FG000|Overall Study|AE, non-serious non-fatal|3|||
94390840|NCT01498120|323219747|FG000|Overall Study|Other|4|||
94390841|NCT02902211|323219748|FG000|First Three Months|Withdrawal by Subject|7|||
94390842|NCT02902211|323219749|FG001|First Three Months|Withdrawal by Subject|3|||
94390843|NCT01629381|323219755|FG000|Overall Study|Withdrawal by Subject|2|||
94390844|NCT01629381|323219756|FG001|Overall Study|Withdrawal by Subject|5|||
94390845|NCT03204539|323219761|FG000|Overall Study|Loss of funding|0|||
94390846|NCT03204539|323219762|FG001|Overall Study|Loss of funding|1|||
94390847|NCT01171963|323219765|FG000|Overall Study|Adverse Event|10|||
94390848|NCT01171963|323219766|FG001|Overall Study|Adverse Event|15|||
94390849|NCT01171963|323219765|FG000|Overall Study|Lost to Follow-up|23|||
94390850|NCT01171963|323219766|FG001|Overall Study|Lost to Follow-up|24|||
94390851|NCT01171963|323219765|FG000|Overall Study|Other - diarrhoea|1|||
94390852|NCT01171963|323219766|FG001|Overall Study|Other - diarrhoea|0|||
94390853|NCT01171963|323219765|FG000|Overall Study|Withdrawal by Subject|114|||
94390854|NCT01171963|323219766|FG001|Overall Study|Withdrawal by Subject|129|||
94390855|NCT00846495|323219772|FG000|Overall Study|Lost to Follow-up|1|||
94390856|NCT00846495|323219773|FG001|Overall Study|Lost to Follow-up|0|||
94390857|NCT00846495|323219772|FG000|Overall Study|Adverse Event|5|||
94390858|NCT00846495|323219773|FG001|Overall Study|Adverse Event|1|||
94390859|NCT00846495|323219772|FG000|Overall Study|Lack of Efficacy|1|||
94390860|NCT00846495|323219773|FG001|Overall Study|Lack of Efficacy|2|||
94390861|NCT00846495|323219772|FG000|Overall Study|Physician Decision|1|||
94390862|NCT00846495|323219773|FG001|Overall Study|Physician Decision|0|||
94390863|NCT02453386|323219775|FG000|Overall Study|Adverse Event|22|||
94390864|NCT02453386|323219776|FG001|Overall Study|Adverse Event|30|||
94390865|NCT02453386|323219777|FG002|Overall Study|Adverse Event|15|||
94390866|NCT02453386|323219775|FG000|Overall Study|Protocol Violation|1|||
94390867|NCT02453386|323219776|FG001|Overall Study|Protocol Violation|0|||
94390868|NCT02453386|323219777|FG002|Overall Study|Protocol Violation|1|||
94390869|NCT02453386|323219775|FG000|Overall Study|Withdrawal by Subject|10|||
94390870|NCT02453386|323219776|FG001|Overall Study|Withdrawal by Subject|9|||
94390871|NCT02453386|323219777|FG002|Overall Study|Withdrawal by Subject|9|||
94390872|NCT02453386|323219775|FG000|Overall Study|Sponsor Terminated Study|14|||
94390873|NCT02453386|323219776|FG001|Overall Study|Sponsor Terminated Study|8|||
94390874|NCT02453386|323219777|FG002|Overall Study|Sponsor Terminated Study|11|||
94390875|NCT02453386|323219775|FG000|Overall Study|Subject Terminated by Sponsor|1|||
94390876|NCT02453386|323219776|FG001|Overall Study|Subject Terminated by Sponsor|1|||
94390877|NCT02453386|323219777|FG002|Overall Study|Subject Terminated by Sponsor|1|||
94390878|NCT02453386|323219775|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
94390879|NCT02453386|323219776|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
94390880|NCT02453386|323219777|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
94390881|NCT02453386|323219775|FG000|Overall Study|Lost to Follow-up|0|||
94390882|NCT02453386|323219776|FG001|Overall Study|Lost to Follow-up|0|||
94390883|NCT02453386|323219777|FG002|Overall Study|Lost to Follow-up|1|||
94390884|NCT02453386|323219775|FG000|Overall Study|Other|1|||
94390885|NCT02453386|323219776|FG001|Overall Study|Other|0|||
94390886|NCT02453386|323219777|FG002|Overall Study|Other|1|||
94390887|NCT00359281|323219778|FG000|Overall Study|Adverse Event|1|||
94390888|NCT00359281|323219779|FG001|Overall Study|Adverse Event|0|||
94390889|NCT00359281|323219780|FG002|Overall Study|Adverse Event|0|||
94390890|NCT00359281|323219781|FG003|Overall Study|Adverse Event|0|||
94390891|NCT00359281|323219782|FG004|Overall Study|Adverse Event|0|||
94390892|NCT00359281|323219783|FG005|Overall Study|Adverse Event|0|||
94390893|NCT00359281|323219784|FG006|Overall Study|Adverse Event|1|||
94390894|NCT00359281|323219785|FG007|Overall Study|Adverse Event|0|||
94390895|NCT00359281|323219786|FG008|Overall Study|Adverse Event|0|||
94390896|NCT00359281|323219778|FG000|Overall Study|Withdrawal by Subject|0|||
94390897|NCT00359281|323219779|FG001|Overall Study|Withdrawal by Subject|0|||
94390898|NCT00359281|323219780|FG002|Overall Study|Withdrawal by Subject|0|||
94390899|NCT00359281|323219781|FG003|Overall Study|Withdrawal by Subject|0|||
94390900|NCT00359281|323219782|FG004|Overall Study|Withdrawal by Subject|0|||
94390901|NCT00359281|323219783|FG005|Overall Study|Withdrawal by Subject|0|||
94390902|NCT00359281|323219784|FG006|Overall Study|Withdrawal by Subject|1|||
94390903|NCT00359281|323219785|FG007|Overall Study|Withdrawal by Subject|0|||
94390904|NCT00359281|323219786|FG008|Overall Study|Withdrawal by Subject|0|||
94390905|NCT01474551|323219787|FG000|Overall Study|Death|1|||
94390906|NCT02392000|323219788|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
94390907|NCT02392000|323219788|FG000|Overall Study|Withdrawal by Subject|1|||
94390908|NCT02392000|323219788|FG000|Overall Study|Lost to Follow-up|8|||
94390909|NCT03586726|323219796|FG000|Overall Study|Withdrawal by Subject|1|||
94390910|NCT00965185|323219797|FG000|Overall Study|Lost to Follow-up|2|||
94390911|NCT00965185|323219798|FG001|Overall Study|Lost to Follow-up|0|||
94390912|NCT00965185|323219797|FG000|Overall Study|Withdrawal by Subject|0|||
94390913|NCT00965185|323219798|FG001|Overall Study|Withdrawal by Subject|1|||
94390914|NCT02820350|323219800|FG000|Overall Study|Withdrawal by Subject|3|||
94390915|NCT02820350|323219800|FG000|Overall Study|Death|4|||
94390916|NCT00819741|323219803|FG000|Overall Study|Adverse Event|5|||
94390917|NCT00819741|323219804|FG001|Overall Study|Adverse Event|2|||
94390918|NCT00819741|323219803|FG000|Overall Study|Lack of Efficacy|0|||
94390919|NCT00819741|323219804|FG001|Overall Study|Lack of Efficacy|2|||
94390920|NCT00819741|323219803|FG000|Overall Study|Lost to Follow-up|3|||
94390921|NCT00819741|323219804|FG001|Overall Study|Lost to Follow-up|1|||
94390922|NCT00819741|323219803|FG000|Overall Study|Protocol Violation|3|||
94390923|NCT00819741|323219804|FG001|Overall Study|Protocol Violation|4|||
94390924|NCT00819741|323219803|FG000|Overall Study|Withdrawal by Subject|2|||
94390925|NCT00819741|323219804|FG001|Overall Study|Withdrawal by Subject|2|||
94390926|NCT00819741|323219803|FG000|Overall Study|Unclassified|6|||
94390927|NCT00819741|323219804|FG001|Overall Study|Unclassified|0|||
94390928|NCT00819741|323219803|FG000|Overall Study|Reasons unknown|3|||
94390929|NCT00819741|323219804|FG001|Overall Study|Reasons unknown|3|||
94390930|NCT00119015|323219805|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
94390931|NCT00119015|323219806|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
94390932|NCT00119015|323219807|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
94390933|NCT01313780|323219808|FG000|Overall Study|Lack of Efficacy|4|||
94390934|NCT01313780|323219809|FG001|Overall Study|Lack of Efficacy|2|||
94390935|NCT01313780|323219808|FG000|Overall Study|Adverse Event|6|||
94390936|NCT01313780|323219809|FG001|Overall Study|Adverse Event|11|||
94390937|NCT01313780|323219808|FG000|Overall Study|Withdrawal by Subject|2|||
94390938|NCT01313780|323219809|FG001|Overall Study|Withdrawal by Subject|8|||
94390939|NCT01313780|323219808|FG000|Overall Study|Protocol Violation|10|||
94390940|NCT01313780|323219809|FG001|Overall Study|Protocol Violation|4|||
94390941|NCT01313780|323219808|FG000|Overall Study|missing data|3|||
94390942|NCT01313780|323219809|FG001|Overall Study|missing data|3|||
94390943|NCT02424097|323221354|FG000|Overall Study|Lost to Follow-up|1|||
94390944|NCT02424097|323221355|FG001|Overall Study|Lost to Follow-up|2|||
94390945|NCT01215981|323221356|FG000|Overall Study|Physician Decision|0|||
94390946|NCT01215981|323221357|FG001|Overall Study|Physician Decision|1|||
94390947|NCT01215981|323221356|FG000|Overall Study|Protocol Violation|1|||
94390948|NCT01215981|323221357|FG001|Overall Study|Protocol Violation|0|||
94390949|NCT01215981|323221356|FG000|Overall Study|Withdrawal by Subject|1|||
94390950|NCT01215981|323221357|FG001|Overall Study|Withdrawal by Subject|0|||
94390951|NCT01675622|323221358|FG000|Overall Study|Withdrawal by Subject|2|||
94390952|NCT01675622|323221359|FG001|Overall Study|Withdrawal by Subject|2|||
94390953|NCT01675622|323221358|FG000|Overall Study|Adverse Event|12|||
94390954|NCT01675622|323221359|FG001|Overall Study|Adverse Event|10|||
94390955|NCT01675622|323221358|FG000|Overall Study|Protocol Violation|4|||
94390956|NCT01675622|323221359|FG001|Overall Study|Protocol Violation|1|||
94390957|NCT01675622|323221358|FG000|Overall Study|Lack of Efficacy|2|||
94390958|NCT01675622|323221359|FG001|Overall Study|Lack of Efficacy|4|||
94390959|NCT01675622|323221358|FG000|Overall Study|Lost to Follow-up|1|||
94390960|NCT01675622|323221359|FG001|Overall Study|Lost to Follow-up|3|||
94390961|NCT01675622|323221358|FG000|Overall Study|Other|5|||
94390962|NCT01675622|323221359|FG001|Overall Study|Other|4|||
94390963|NCT04032977|323221360|FG000|Overall Study|Withdrawal by Subject|6|||
94390964|NCT04032977|323221361|FG001|Overall Study|Withdrawal by Subject|1|||
94390965|NCT04032977|323221360|FG000|Overall Study|Lost to Follow-up|2|||
94390966|NCT04032977|323221361|FG001|Overall Study|Lost to Follow-up|7|||
94390967|NCT04032977|323221360|FG000|Overall Study|Pregnancy|1|||
94390968|NCT04032977|323221361|FG001|Overall Study|Pregnancy|0|||
94390969|NCT01101022|323221363|FG000|Overall Study|Adverse Event|6|||
94390970|NCT01101022|323221364|FG001|Overall Study|Adverse Event|2|||
94390971|NCT01101022|323221363|FG000|Overall Study|Protocol Violation|4|||
94390972|NCT01101022|323221364|FG001|Overall Study|Protocol Violation|3|||
94390973|NCT01101022|323221363|FG000|Overall Study|Withdrawal by Subject|3|||
94390974|NCT01101022|323221364|FG001|Overall Study|Withdrawal by Subject|8|||
94390975|NCT01101022|323221363|FG000|Overall Study|Lost to Follow-up|1|||
94390976|NCT01101022|323221364|FG001|Overall Study|Lost to Follow-up|4|||
94390977|NCT01101022|323221363|FG000|Overall Study|Lack of Efficacy|0|||
94390978|NCT01101022|323221364|FG001|Overall Study|Lack of Efficacy|7|||
94390979|NCT01101022|323221363|FG000|Overall Study|Sponsor decision|1|||
94390980|NCT01101022|323221364|FG001|Overall Study|Sponsor decision|1|||
94390981|NCT01101022|323221363|FG000|Overall Study|Non-compliance|1|||
94390982|NCT01101022|323221364|FG001|Overall Study|Non-compliance|0|||
94390983|NCT01101022|323221363|FG000|Overall Study|Work schedule|1|||
94390984|NCT01101022|323221364|FG001|Overall Study|Work schedule|1|||
94390985|NCT01101022|323221363|FG000|Overall Study|Vacation|0|||
94390986|NCT01101022|323221364|FG001|Overall Study|Vacation|1|||
94328117|NCT02559206|322980570|FG004|Overall Study|Adverse Event|3|||
94328118|NCT02559206|322980571|FG005|Overall Study|Adverse Event|0|||
94328119|NCT02559206|322980572|FG006|Overall Study|Adverse Event|1|||
94328120|NCT02559206|322980573|FG007|Overall Study|Adverse Event|0|||
94328121|NCT02559206|322980566|FG000|Overall Study|Protocol Violation|1|||
94328122|NCT02559206|322980567|FG001|Overall Study|Protocol Violation|0|||
94328123|NCT02559206|322980568|FG002|Overall Study|Protocol Violation|1|||
94328124|NCT02559206|322980569|FG003|Overall Study|Protocol Violation|0|||
94328125|NCT02559206|322980570|FG004|Overall Study|Protocol Violation|0|||
94328126|NCT02559206|322980571|FG005|Overall Study|Protocol Violation|2|||
94328127|NCT02559206|322980572|FG006|Overall Study|Protocol Violation|0|||
94328128|NCT02559206|322980573|FG007|Overall Study|Protocol Violation|0|||
94328129|NCT02559206|322980566|FG000|Overall Study|Withdrawal by Subject|3|||
94328130|NCT02559206|322980567|FG001|Overall Study|Withdrawal by Subject|3|||
94328131|NCT02559206|322980568|FG002|Overall Study|Withdrawal by Subject|1|||
94328132|NCT02559206|322980569|FG003|Overall Study|Withdrawal by Subject|3|||
94328133|NCT02559206|322980570|FG004|Overall Study|Withdrawal by Subject|5|||
94328134|NCT02559206|322980571|FG005|Overall Study|Withdrawal by Subject|4|||
94328135|NCT02559206|322980572|FG006|Overall Study|Withdrawal by Subject|1|||
94328136|NCT02559206|322980573|FG007|Overall Study|Withdrawal by Subject|2|||
94328137|NCT02559206|322980566|FG000|Overall Study|Lost to Follow-up|3|||
94328138|NCT02559206|322980567|FG001|Overall Study|Lost to Follow-up|5|||
94328139|NCT02559206|322980568|FG002|Overall Study|Lost to Follow-up|3|||
94328140|NCT02559206|322980569|FG003|Overall Study|Lost to Follow-up|3|||
94328141|NCT02559206|322980570|FG004|Overall Study|Lost to Follow-up|2|||
94328142|NCT02559206|322980571|FG005|Overall Study|Lost to Follow-up|5|||
94328143|NCT02559206|322980572|FG006|Overall Study|Lost to Follow-up|1|||
94328144|NCT02559206|322980573|FG007|Overall Study|Lost to Follow-up|4|||
94328145|NCT02559206|322980566|FG000|Overall Study|Lack of Efficacy|1|||
94328146|NCT02559206|322980567|FG001|Overall Study|Lack of Efficacy|0|||
94328147|NCT02559206|322980568|FG002|Overall Study|Lack of Efficacy|3|||
94328148|NCT02559206|322980569|FG003|Overall Study|Lack of Efficacy|2|||
94328149|NCT02559206|322980570|FG004|Overall Study|Lack of Efficacy|2|||
94328150|NCT02559206|322980571|FG005|Overall Study|Lack of Efficacy|3|||
94328151|NCT02559206|322980572|FG006|Overall Study|Lack of Efficacy|3|||
94328152|NCT02559206|322980573|FG007|Overall Study|Lack of Efficacy|3|||
94328153|NCT02559206|322980566|FG000|Overall Study|Other Not Specified|0|||
94328154|NCT02559206|322980567|FG001|Overall Study|Other Not Specified|0|||
94328155|NCT02559206|322980568|FG002|Overall Study|Other Not Specified|0|||
94328156|NCT02559206|322980569|FG003|Overall Study|Other Not Specified|1|||
94328157|NCT02559206|322980570|FG004|Overall Study|Other Not Specified|0|||
94328158|NCT02559206|322980571|FG005|Overall Study|Other Not Specified|0|||
94328159|NCT02559206|322980572|FG006|Overall Study|Other Not Specified|0|||
94328160|NCT02559206|322980573|FG007|Overall Study|Other Not Specified|0|||
94328161|NCT02947022|322980574|FG000|Overall Study|Study Stopped|1|||
94328162|NCT00646113|322982585|FG000|Overall Study|Lost to Follow-up|5|||
94328163|NCT00646113|322982585|FG000|Overall Study|Adverse Event|3|||
94328164|NCT02862548|322982591|FG000|Randomized Phase (Up to Week 48)|Death|0|||
94328165|NCT02862548|322982592|FG001|Randomized Phase (Up to Week 48)|Death|1|||
94328166|NCT02862548|322982591|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
94328167|NCT02862548|322982592|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
94328168|NCT02862548|322982591|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
94328169|NCT02862548|322982592|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
94328170|NCT02862548|322982591|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
94328171|NCT02862548|322982592|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
94328172|NCT00880763|322982593|FG000|Extension Period (Part 2)|Adverse Event|0|||
94328173|NCT00880763|322982594|FG001|Extension Period (Part 2)|Adverse Event|0|||
94328174|NCT00880763|322982595|FG002|Extension Period (Part 2)|Adverse Event|1|||
94328175|NCT00880763|322982596|FG003|Extension Period (Part 2)|Adverse Event|1|||
94328176|NCT00880763|322982593|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
94328177|NCT00880763|322982594|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
94328178|NCT00880763|322982595|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
94328179|NCT00880763|322982596|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
94328180|NCT00880763|322982593|FG000|Extension Period (Part 2)|Physician Decision|0|||
94328181|NCT00880763|322982594|FG001|Extension Period (Part 2)|Physician Decision|1|||
94328182|NCT00880763|322982595|FG002|Extension Period (Part 2)|Physician Decision|1|||
94328183|NCT00880763|322982596|FG003|Extension Period (Part 2)|Physician Decision|0|||
94328184|NCT00880763|322982593|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
94328185|NCT00880763|322982594|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
94328186|NCT00880763|322982595|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
94328187|NCT00880763|322982596|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
94328188|NCT01993615|322982597|FG000|Overall Study|Death|1|||
94328189|NCT01993615|322982598|FG001|Overall Study|Death|0|||
94328190|NCT00003476|322982600|FG000|Overall Study|Not evaluable|1|||
94328191|NCT03097614|322982604|FG000|Overall Study|Adverse Event|3|||
94328192|NCT00603733|322982606|FG000|Active Phase ITT|Adverse Event|8|||
94328193|NCT00603733|322982607|FG001|Active Phase ITT|Adverse Event|7|||
94390987|NCT03075761|323221365|FG000|Overall Study|Lost to Follow-up|1|||
94328194|NCT00603733|322982606|FG000|Active Phase ITT|Withdrawal by Subject|0|||
94328195|NCT00603733|322982607|FG001|Active Phase ITT|Withdrawal by Subject|3|||
94328196|NCT00603733|322982606|FG000|Active Phase ITT|Lost to Follow-up|0|||
94328197|NCT00603733|322982607|FG001|Active Phase ITT|Lost to Follow-up|1|||
94328198|NCT00603733|322982606|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
94328199|NCT00603733|322982607|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
94328200|NCT00603733|322982606|FG000|Active Phase ITT|Lack of Efficacy|1|||
94328201|NCT00603733|322982607|FG001|Active Phase ITT|Lack of Efficacy|2|||
94328202|NCT00603733|322982606|FG000|Active Phase ITT|Subject moved, site closed|1|||
94328203|NCT00603733|322982607|FG001|Active Phase ITT|Subject moved, site closed|1|||
94328204|NCT00603733|322982606|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
94328205|NCT00603733|322982607|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
94328206|NCT00603733|322982606|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
94328207|NCT00603733|322982607|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
94328208|NCT00603733|322982606|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
94328209|NCT00603733|322982607|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
94328210|NCT00603733|322982606|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
94328211|NCT00603733|322982607|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
94328212|NCT00603733|322982606|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
94328213|NCT00603733|322982607|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
94328214|NCT00603733|322982606|FG000|Maintenance Phase ITT|Adverse Event|3|||
94328215|NCT00603733|322982607|FG001|Maintenance Phase ITT|Adverse Event|6|||
94328216|NCT00603733|322982606|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
94328217|NCT00603733|322982607|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
94328218|NCT00603733|322982606|FG000|Maintenance Phase ITT|Protocol Violation|1|||
94328219|NCT00603733|322982607|FG001|Maintenance Phase ITT|Protocol Violation|1|||
94328220|NCT00603733|322982606|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
94328221|NCT00603733|322982607|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
94328222|NCT00603733|322982606|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
94328223|NCT00603733|322982607|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
94328224|NCT00603733|322982606|FG000|Maintenance Phase ITT|Physician Decision|0|||
94328225|NCT00603733|322982607|FG001|Maintenance Phase ITT|Physician Decision|1|||
94328226|NCT00603733|322982606|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
94328227|NCT00603733|322982607|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
94328228|NCT02064205|322982608|FG000|Overall Study|Withdrawal by Subject|1|||
94328229|NCT03057951|322982609|FG000|Overall Study|Adverse Event|553|||
94328230|NCT03057951|322982610|FG001|Overall Study|Adverse Event|575|||
94328231|NCT03057951|322982609|FG000|Overall Study|Protocol Violation|30|||
94390988|NCT03075761|323221366|FG001|Overall Study|Lost to Follow-up|6|||
94390989|NCT01519661|323221367|FG000|Overall Study|Protocol deviation|6|||
94390990|NCT01519661|323221367|FG000|Overall Study|Lost to Follow-up|3|||
94390991|NCT01519661|323221367|FG000|Overall Study|Withdrawal by Subject|17|||
94390992|NCT01519661|323221367|FG000|Overall Study|Lack of Efficacy|6|||
94390993|NCT01519661|323221367|FG000|Overall Study|Adverse Event|29|||
94390994|NCT02880761|323221368|FG000|Overall Study|Death|6|||
94390995|NCT02880761|323221369|FG001|Overall Study|Death|8|||
94390996|NCT02880761|323221368|FG000|Overall Study|Withdrawal by Subject|3|||
94390997|NCT02880761|323221369|FG001|Overall Study|Withdrawal by Subject|6|||
94390998|NCT02880761|323221368|FG000|Overall Study|Protocol Violation|4|||
94390999|NCT02880761|323221369|FG001|Overall Study|Protocol Violation|3|||
94391000|NCT02880761|323221368|FG000|Overall Study|Lost to Follow-up|3|||
94391001|NCT02880761|323221369|FG001|Overall Study|Lost to Follow-up|4|||
94391002|NCT01139047|323221370|FG000|Overall Study|Withdrawal by Subject|1|||
94391003|NCT01294787|323221380|FG000|Period 1|Adverse Event|0|||
94391004|NCT01294787|323221381|FG001|Period 1|Adverse Event|0|||
94391005|NCT01294787|323221382|FG002|Period 1|Adverse Event|0|||
94391006|NCT01294787|323221383|FG003|Period 1|Adverse Event|0|||
94391007|NCT01294787|323221384|FG004|Period 1|Adverse Event|1|||
94391008|NCT01294787|323221385|FG005|Period 1|Adverse Event|0|||
94391009|NCT01294787|323221380|FG000|Period 1|Withdrawal by Subject|0|||
94391010|NCT01294787|323221381|FG001|Period 1|Withdrawal by Subject|0|||
94391011|NCT01294787|323221382|FG002|Period 1|Withdrawal by Subject|0|||
94391012|NCT01294787|323221383|FG003|Period 1|Withdrawal by Subject|1|||
94391013|NCT01294787|323221384|FG004|Period 1|Withdrawal by Subject|1|||
94391014|NCT01294787|323221385|FG005|Period 1|Withdrawal by Subject|1|||
94391015|NCT01294787|323221380|FG000|Period 1|Administrative problem|0|||
94391016|NCT01294787|323221381|FG001|Period 1|Administrative problem|0|||
94328232|NCT03057951|322982610|FG001|Overall Study|Protocol Violation|24|||
94328233|NCT03057951|322982609|FG000|Overall Study|Lost to Follow-up|6|||
94328234|NCT03057951|322982610|FG001|Overall Study|Lost to Follow-up|16|||
94328235|NCT03057951|322982609|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
94328236|NCT03057951|322982610|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
94328237|NCT03057951|322982609|FG000|Overall Study|Study drug stopped, reason missing|6|||
94328238|NCT03057951|322982610|FG001|Overall Study|Study drug stopped, reason missing|1|||
94391017|NCT01294787|323221382|FG002|Period 1|Administrative problem|1|||
94391018|NCT01294787|323221383|FG003|Period 1|Administrative problem|0|||
94391019|NCT01294787|323221384|FG004|Period 1|Administrative problem|0|||
94391020|NCT01294787|323221385|FG005|Period 1|Administrative problem|1|||
94391021|NCT01294787|323221380|FG000|Period 2|Adverse Event|0|||
94391022|NCT01294787|323221381|FG001|Period 2|Adverse Event|3|||
94391023|NCT01294787|323221382|FG002|Period 2|Adverse Event|0|||
94391024|NCT01294787|323221383|FG003|Period 2|Adverse Event|1|||
94391025|NCT01294787|323221384|FG004|Period 2|Adverse Event|0|||
94391026|NCT01294787|323221385|FG005|Period 2|Adverse Event|0|||
94391027|NCT01294787|323221380|FG000|Period 2|No longer needs study drug|0|||
94391028|NCT01294787|323221381|FG001|Period 2|No longer needs study drug|0|||
94391029|NCT01294787|323221382|FG002|Period 2|No longer needs study drug|0|||
94391030|NCT01294787|323221383|FG003|Period 2|No longer needs study drug|1|||
94391031|NCT01294787|323221384|FG004|Period 2|No longer needs study drug|0|||
94391032|NCT01294787|323221385|FG005|Period 2|No longer needs study drug|0|||
94391033|NCT01294787|323221380|FG000|Period 3|Adverse Event|0|||
94391034|NCT01294787|323221381|FG001|Period 3|Adverse Event|0|||
94391035|NCT01294787|323221382|FG002|Period 3|Adverse Event|0|||
94391036|NCT01294787|323221383|FG003|Period 3|Adverse Event|0|||
94391037|NCT01294787|323221384|FG004|Period 3|Adverse Event|1|||
94391038|NCT01294787|323221385|FG005|Period 3|Adverse Event|0|||
94391039|NCT05017480|323221386|FG000|Stage 1 Study|Withdrawal by Subject|8|||
94391040|NCT05017480|323221387|FG001|Stage 1 Study|Withdrawal by Subject|6|||
94391041|NCT05017480|323221388|FG002|Stage 1 Study|Withdrawal by Subject|0|||
94328239|NCT03057951|322982609|FG000|Overall Study|Medical advice|6|||
94328240|NCT03057951|322982610|FG001|Overall Study|Medical advice|2|||
94328241|NCT03057951|322982609|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
94328242|NCT03057951|322982610|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
94328243|NCT03057951|322982609|FG000|Overall Study|Investigator decision|2|||
94328244|NCT03057951|322982610|FG001|Overall Study|Investigator decision|0|||
94328245|NCT03057951|322982609|FG000|Overall Study|Patient decision|5|||
94328246|NCT03057951|322982610|FG001|Overall Study|Patient decision|2|||
94328247|NCT03057951|322982609|FG000|Overall Study|Not attending study visits|3|||
94328248|NCT03057951|322982610|FG001|Overall Study|Not attending study visits|0|||
94328249|NCT03057951|322982609|FG000|Overall Study|Patient moved away|3|||
94328250|NCT03057951|322982610|FG001|Overall Study|Patient moved away|4|||
94328251|NCT03057951|322982609|FG000|Overall Study|Other reason than stated above|23|||
94328252|NCT03057951|322982610|FG001|Overall Study|Other reason than stated above|29|||
94328253|NCT03057951|322982609|FG000|Overall Study|Not treated|2|||
94328254|NCT03057951|322982610|FG001|Overall Study|Not treated|1|||
94328255|NCT00696436|322982611|FG000|Overall Study|Adverse Event|7|||
94328256|NCT00696436|322982612|FG001|Overall Study|Adverse Event|9|||
94328257|NCT00696436|322982613|FG002|Overall Study|Adverse Event|8|||
94328258|NCT00696436|322982614|FG003|Overall Study|Adverse Event|6|||
94328259|NCT00696436|322982615|FG004|Overall Study|Adverse Event|4|||
94328260|NCT00696436|322982611|FG000|Overall Study|Protocol Violation|3|||
94328261|NCT00696436|322982612|FG001|Overall Study|Protocol Violation|2|||
94328262|NCT00696436|322982613|FG002|Overall Study|Protocol Violation|2|||
94328263|NCT00696436|322982614|FG003|Overall Study|Protocol Violation|0|||
94328264|NCT00696436|322982615|FG004|Overall Study|Protocol Violation|1|||
94328265|NCT00696436|322982611|FG000|Overall Study|Lost to Follow-up|1|||
94328266|NCT00696436|322982612|FG001|Overall Study|Lost to Follow-up|6|||
94328267|NCT00696436|322982613|FG002|Overall Study|Lost to Follow-up|2|||
94328268|NCT00696436|322982614|FG003|Overall Study|Lost to Follow-up|4|||
94391042|NCT05017480|323221389|FG003|Stage 1 Study|Withdrawal by Subject|0|||
94391043|NCT05017480|323221390|FG004|Stage 1 Study|Withdrawal by Subject|0|||
94391044|NCT05017480|323221386|FG000|Stage 1 Study|Adverse Event|1|||
94391045|NCT05017480|323221387|FG001|Stage 1 Study|Adverse Event|1|||
94391046|NCT05017480|323221388|FG002|Stage 1 Study|Adverse Event|0|||
94391047|NCT05017480|323221389|FG003|Stage 1 Study|Adverse Event|0|||
94391048|NCT05017480|323221390|FG004|Stage 1 Study|Adverse Event|0|||
94391049|NCT05017480|323221386|FG000|Stage 1 Study|Poor Compliance|1|||
94391050|NCT05017480|323221387|FG001|Stage 1 Study|Poor Compliance|1|||
94391051|NCT05017480|323221388|FG002|Stage 1 Study|Poor Compliance|0|||
94391052|NCT05017480|323221389|FG003|Stage 1 Study|Poor Compliance|0|||
94391053|NCT05017480|323221390|FG004|Stage 1 Study|Poor Compliance|0|||
94391054|NCT05017480|323221386|FG000|Stage 1 Study|Physician Decision|0|||
94391055|NCT05017480|323221387|FG001|Stage 1 Study|Physician Decision|1|||
94391056|NCT05017480|323221388|FG002|Stage 1 Study|Physician Decision|0|||
94391057|NCT05017480|323221389|FG003|Stage 1 Study|Physician Decision|0|||
94391058|NCT05017480|323221390|FG004|Stage 1 Study|Physician Decision|0|||
94391059|NCT05017480|323221386|FG000|Stage 2 Study|Withdrawal by Subject|0|||
94391060|NCT05017480|323221387|FG001|Stage 2 Study|Withdrawal by Subject|0|||
94391061|NCT05017480|323221388|FG002|Stage 2 Study|Withdrawal by Subject|6|||
94391062|NCT05017480|323221389|FG003|Stage 2 Study|Withdrawal by Subject|9|||
94391063|NCT05017480|323221390|FG004|Stage 2 Study|Withdrawal by Subject|11|||
94391064|NCT05017480|323221386|FG000|Stage 2 Study|Lost to Follow-up|0|||
94391065|NCT05017480|323221387|FG001|Stage 2 Study|Lost to Follow-up|0|||
94391066|NCT05017480|323221388|FG002|Stage 2 Study|Lost to Follow-up|0|||
94391067|NCT05017480|323221389|FG003|Stage 2 Study|Lost to Follow-up|2|||
94391068|NCT05017480|323221390|FG004|Stage 2 Study|Lost to Follow-up|1|||
94391069|NCT05017480|323221386|FG000|Stage 2 Study|Adverse Event|0|||
94328269|NCT00696436|322982615|FG004|Overall Study|Lost to Follow-up|3|||
94328270|NCT00696436|322982611|FG000|Overall Study|Withdrawal by Subject|4|||
94328271|NCT00696436|322982612|FG001|Overall Study|Withdrawal by Subject|11|||
94328272|NCT00696436|322982613|FG002|Overall Study|Withdrawal by Subject|5|||
94328273|NCT00696436|322982614|FG003|Overall Study|Withdrawal by Subject|7|||
94328274|NCT00696436|322982615|FG004|Overall Study|Withdrawal by Subject|1|||
94328275|NCT00696436|322982611|FG000|Overall Study|Lack of Efficacy|3|||
94328276|NCT00696436|322982612|FG001|Overall Study|Lack of Efficacy|1|||
94328277|NCT00696436|322982613|FG002|Overall Study|Lack of Efficacy|5|||
94328278|NCT00696436|322982614|FG003|Overall Study|Lack of Efficacy|2|||
94328279|NCT00696436|322982615|FG004|Overall Study|Lack of Efficacy|4|||
94328280|NCT00696436|322982611|FG000|Overall Study|Participant Unavailability|2|||
94328281|NCT00696436|322982612|FG001|Overall Study|Participant Unavailability|0|||
94328282|NCT00696436|322982613|FG002|Overall Study|Participant Unavailability|2|||
94328283|NCT00696436|322982614|FG003|Overall Study|Participant Unavailability|1|||
94328284|NCT00696436|322982615|FG004|Overall Study|Participant Unavailability|0|||
94328285|NCT00696436|322982611|FG000|Overall Study|Administrative Error|2|||
94328286|NCT00696436|322982612|FG001|Overall Study|Administrative Error|0|||
94328287|NCT00696436|322982613|FG002|Overall Study|Administrative Error|2|||
94328288|NCT00696436|322982614|FG003|Overall Study|Administrative Error|0|||
94328289|NCT00696436|322982615|FG004|Overall Study|Administrative Error|0|||
94328290|NCT00696436|322982611|FG000|Overall Study|Participant Non-compliance|0|||
94328291|NCT00696436|322982612|FG001|Overall Study|Participant Non-compliance|0|||
94328292|NCT00696436|322982613|FG002|Overall Study|Participant Non-compliance|1|||
94328293|NCT00696436|322982614|FG003|Overall Study|Participant Non-compliance|2|||
94328294|NCT00696436|322982615|FG004|Overall Study|Participant Non-compliance|0|||
94328295|NCT00696436|322982611|FG000|Overall Study|Administrative Decision|1|||
94328296|NCT00696436|322982612|FG001|Overall Study|Administrative Decision|0|||
94328297|NCT00696436|322982613|FG002|Overall Study|Administrative Decision|0|||
94328298|NCT00696436|322982614|FG003|Overall Study|Administrative Decision|0|||
94328299|NCT00696436|322982615|FG004|Overall Study|Administrative Decision|0|||
94328300|NCT00696436|322982611|FG000|Overall Study|Missing|0|||
94328301|NCT00696436|322982612|FG001|Overall Study|Missing|1|||
94328302|NCT00696436|322982613|FG002|Overall Study|Missing|1|||
94328303|NCT00696436|322982614|FG003|Overall Study|Missing|0|||
94328304|NCT00696436|322982615|FG004|Overall Study|Missing|0|||
94328305|NCT02670928|322982619|FG000|Overall Study|Adverse Event|3|||
94328306|NCT02670928|322982620|FG001|Overall Study|Adverse Event|1|||
94328307|NCT02670928|322982619|FG000|Overall Study|Withdrawal by Subject|4|||
94328308|NCT02670928|322982620|FG001|Overall Study|Withdrawal by Subject|0|||
94328309|NCT02670928|322982619|FG000|Overall Study|Lost to Follow-up|1|||
94328310|NCT02670928|322982620|FG001|Overall Study|Lost to Follow-up|0|||
94328311|NCT02670928|322982619|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
94328312|NCT02670928|322982620|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
94328313|NCT02678312|322982621|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
94328314|NCT02678312|322982622|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
94328315|NCT02678312|322982623|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
94328316|NCT02678312|322982624|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
94328317|NCT02678312|322982625|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
94328318|NCT02678312|322982621|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
94328319|NCT02678312|322982622|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
94328320|NCT02678312|322982623|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
94328321|NCT02678312|322982624|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
94328322|NCT02678312|322982625|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
94328323|NCT02678312|322982621|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
94328324|NCT02678312|322982622|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
94328325|NCT02678312|322982623|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
94328326|NCT02678312|322982624|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
94328327|NCT02678312|322982625|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
94328328|NCT02678312|322982621|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
94328329|NCT02678312|322982622|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
94328330|NCT02678312|322982623|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
94328331|NCT02678312|322982624|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
94328332|NCT02678312|322982625|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
94328333|NCT02678312|322982621|FG000|Part 2 Double Blind Epoch|Death|0|||
94328334|NCT02678312|322982622|FG001|Part 2 Double Blind Epoch|Death|0|||
94328335|NCT02678312|322982623|FG002|Part 2 Double Blind Epoch|Death|0|||
94328336|NCT02678312|322982624|FG003|Part 2 Double Blind Epoch|Death|8|||
94328337|NCT02678312|322982625|FG004|Part 2 Double Blind Epoch|Death|12|||
94328338|NCT02678312|322982621|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
94328339|NCT02678312|322982622|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
94328340|NCT02678312|322982623|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
94328341|NCT02678312|322982624|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
94328342|NCT02678312|322982625|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
94391070|NCT05017480|323221387|FG001|Stage 2 Study|Adverse Event|0|||
94391071|NCT05017480|323221388|FG002|Stage 2 Study|Adverse Event|0|||
94391072|NCT05017480|323221389|FG003|Stage 2 Study|Adverse Event|1|||
94391073|NCT05017480|323221390|FG004|Stage 2 Study|Adverse Event|0|||
94391074|NCT05017480|323221386|FG000|Stage 2 Study|COVID-19|0|||
94391075|NCT05017480|323221387|FG001|Stage 2 Study|COVID-19|0|||
94391076|NCT05017480|323221388|FG002|Stage 2 Study|COVID-19|0|||
94391077|NCT05017480|323221389|FG003|Stage 2 Study|COVID-19|1|||
94391078|NCT05017480|323221390|FG004|Stage 2 Study|COVID-19|0|||
94391079|NCT05017480|323221386|FG000|Stage 2 Study|Pregnancy|0|||
94391080|NCT05017480|323221387|FG001|Stage 2 Study|Pregnancy|0|||
94391081|NCT05017480|323221388|FG002|Stage 2 Study|Pregnancy|0|||
94391082|NCT05017480|323221389|FG003|Stage 2 Study|Pregnancy|0|||
94391083|NCT05017480|323221390|FG004|Stage 2 Study|Pregnancy|1|||
94391084|NCT01136382|323221393|FG000|Overall Study|Other|8|||
94391085|NCT01136382|323221394|FG001|Overall Study|Other|3|||
94391086|NCT01136382|323221393|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
94391087|NCT01136382|323221394|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
94391088|NCT01136382|323221393|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
94391089|NCT01136382|323221394|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
94391090|NCT01136382|323221393|FG000|Overall Study|Withdrawal by Subject|4|||
94391091|NCT01136382|323221394|FG001|Overall Study|Withdrawal by Subject|1|||
94391092|NCT00942968|323221397|FG000|Overall Study|Adverse Event|60|||
94391093|NCT00942968|323221397|FG000|Overall Study|Death|76|||
94391094|NCT00942968|323221397|FG000|Overall Study|Protocol Violation|9|||
94391095|NCT00942968|323221397|FG000|Overall Study|Lost to Follow-up|4|||
94391096|NCT00942968|323221397|FG000|Overall Study|Withdrawal by Subject|44|||
94391097|NCT00942968|323221397|FG000|Overall Study|Sponsor request|5|||
94391098|NCT00942968|323221397|FG000|Overall Study|Physician Decision|11|||
94391099|NCT00942968|323221397|FG000|Overall Study|Progression of disease|12|||
94391100|NCT00942968|323221397|FG000|Overall Study|Inferior vena cava filter placement|4|||
94391101|NCT00942968|323221397|FG000|Overall Study|Pulmonary embolism (PE)|1|||
94391102|NCT00942968|323221397|FG000|Overall Study|Participant required pancreatic biopsy|1|||
94391103|NCT00942968|323221397|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
94391104|NCT02653664|323221398|FG000|Post-Treatment|Withdrawal by Subject|6|||
94391105|NCT02653664|323221399|FG001|Post-Treatment|Withdrawal by Subject|5|||
94391106|NCT02653664|323221400|FG002|Post-Treatment|Withdrawal by Subject|7|||
94391107|NCT02653664|323221398|FG000|Post-Treatment|Lost to Follow-up|8|||
94391108|NCT02653664|323221399|FG001|Post-Treatment|Lost to Follow-up|1|||
94391109|NCT02653664|323221400|FG002|Post-Treatment|Lost to Follow-up|7|||
94391110|NCT02653664|323221398|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
94391111|NCT02653664|323221399|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
94391112|NCT02653664|323221400|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
94391113|NCT02653664|323221398|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
94391114|NCT02653664|323221399|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
94391115|NCT02653664|323221400|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
94391116|NCT02653664|323221398|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
94391117|NCT02653664|323221399|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
94391118|NCT02653664|323221400|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
94391119|NCT02653664|323221398|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
94391120|NCT02653664|323221399|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
94391121|NCT02653664|323221400|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
94391122|NCT02653664|323221398|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
94391123|NCT02653664|323221399|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
94391124|NCT02653664|323221400|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
94391125|NCT02653664|323221398|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
94391126|NCT02653664|323221399|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
94391127|NCT02653664|323221400|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
94391128|NCT02653664|323221398|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
94391129|NCT02653664|323221399|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
94391130|NCT02653664|323221400|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
94391131|NCT02653664|323221398|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
94391132|NCT02653664|323221399|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
94391133|NCT02653664|323221400|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
94391134|NCT00633594|323221401|FG000|Overall Study|Adverse Event|0|||
94391135|NCT00633594|323221402|FG001|Overall Study|Adverse Event|4|||
94391136|NCT00633594|323221403|FG002|Overall Study|Adverse Event|7|||
94391137|NCT00633594|323221401|FG000|Overall Study|Death|0|||
94391138|NCT00633594|323221402|FG001|Overall Study|Death|1|||
94391139|NCT00633594|323221403|FG002|Overall Study|Death|2|||
94391140|NCT00633594|323221401|FG000|Overall Study|Disease Progression|0|||
94391141|NCT00633594|323221402|FG001|Overall Study|Disease Progression|0|||
94391142|NCT00633594|323221403|FG002|Overall Study|Disease Progression|1|||
94391143|NCT00723528|323221408|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
94391144|NCT00723528|323221409|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
94391145|NCT00723528|323221410|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
94482768|NCT02659943|323559674|FG006|Overall Study|No treatment, per protocol|3|||
94482769|NCT02048722|323559685|FG000|2 Cycles of Treatment|Adverse Event|2|||
94482770|NCT02048722|323559685|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
94482771|NCT02048722|323559685|FG000|2 Cycles of Treatment|Progressive Disease|2|||
94482772|NCT02048722|323559685|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
94482773|NCT02048722|323559685|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
94482774|NCT02048722|323559685|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
94482775|NCT00661089|323559688|FG000|Overall Study|1 subject withdrawal|0|||
94482776|NCT00661089|323559689|FG001|Overall Study|1 subject withdrawal|1|||
94328343|NCT02678312|322982621|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
94328344|NCT02678312|322982622|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
94328345|NCT02678312|322982623|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
94328346|NCT02678312|322982624|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
94328347|NCT02678312|322982625|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
94328348|NCT02678312|322982621|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
94328349|NCT02678312|322982622|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
94328350|NCT02678312|322982623|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
94328351|NCT02678312|322982624|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
94328352|NCT02678312|322982625|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
94328353|NCT00912340|322982626|FG000|Overall Study|Adverse Event|2|||
94328354|NCT00912340|322982627|FG001|Overall Study|Adverse Event|4|||
94328355|NCT00912340|322982628|FG002|Overall Study|Adverse Event|0|||
94328356|NCT00912340|322982626|FG000|Overall Study|Protocol revised to remove arm|0|||
94328357|NCT00912340|322982627|FG001|Overall Study|Protocol revised to remove arm|0|||
94328358|NCT00912340|322982628|FG002|Overall Study|Protocol revised to remove arm|4|||
94328359|NCT01517412|322982629|FG000|Overall Study|Adverse Event|10|||
94328360|NCT01517412|322982630|FG001|Overall Study|Adverse Event|11|||
94328361|NCT01517412|322982629|FG000|Overall Study|Lack of Efficacy|10|||
94328362|NCT01517412|322982630|FG001|Overall Study|Lack of Efficacy|5|||
94328363|NCT01517412|322982629|FG000|Overall Study|Poor compliance to protocol|8|||
94328364|NCT01517412|322982630|FG001|Overall Study|Poor compliance to protocol|3|||
94328365|NCT01517412|322982629|FG000|Overall Study|Other than specified above|8|||
94328366|NCT01517412|322982630|FG001|Overall Study|Other than specified above|5|||
94328367|NCT01253187|322982633|FG000|Period 2|Withdrawal by Subject|0|||
94328368|NCT01253187|322982634|FG001|Period 2|Withdrawal by Subject|0|||
94328369|NCT01253187|322982635|FG002|Period 2|Withdrawal by Subject|0|||
94328370|NCT01253187|322982636|FG003|Period 2|Withdrawal by Subject|0|||
94328371|NCT01253187|322982637|FG004|Period 2|Withdrawal by Subject|1|||
94328372|NCT01253187|322982638|FG005|Period 2|Withdrawal by Subject|0|||
94328373|NCT01253187|322982633|FG000|Period 3|Pregnancy|1|||
94328374|NCT01253187|322982634|FG001|Period 3|Pregnancy|0|||
94328375|NCT01253187|322982635|FG002|Period 3|Pregnancy|0|||
94328376|NCT01253187|322982636|FG003|Period 3|Pregnancy|0|||
94328377|NCT01253187|322982637|FG004|Period 3|Pregnancy|0|||
94328378|NCT01253187|322982638|FG005|Period 3|Pregnancy|0|||
94328379|NCT01253187|322982633|FG000|Period 3|difficulty with blood sampling|0|||
94328380|NCT01253187|322982634|FG001|Period 3|difficulty with blood sampling|1|||
94328381|NCT01253187|322982635|FG002|Period 3|difficulty with blood sampling|0|||
94328382|NCT01253187|322982636|FG003|Period 3|difficulty with blood sampling|0|||
94328383|NCT01253187|322982637|FG004|Period 3|difficulty with blood sampling|0|||
94328384|NCT01253187|322982638|FG005|Period 3|difficulty with blood sampling|0|||
94328385|NCT01253187|322982633|FG000|Period 3|non-compliance|0|||
94328386|NCT01253187|322982634|FG001|Period 3|non-compliance|0|||
94328387|NCT01253187|322982635|FG002|Period 3|non-compliance|0|||
94482777|NCT00661089|323559688|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
94482778|NCT00661089|323559689|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
94482779|NCT01529606|323559690|FG000|Overall Study|Lost to Follow-up|21|||
94482780|NCT01529606|323559691|FG001|Overall Study|Lost to Follow-up|18|||
94482781|NCT03990051|323559695|FG000|Masked Period|Lost to Follow-up|1|||
94482782|NCT03990051|323559696|FG001|Masked Period|Lost to Follow-up|0|||
94482783|NCT03990051|323559695|FG000|Long Term Period|Death|1|||
94482784|NCT03990051|323559696|FG001|Long Term Period|Death|1|||
94482785|NCT03990051|323559695|FG000|Long Term Period|Lost to Follow-up|7|||
94482786|NCT03990051|323559696|FG001|Long Term Period|Lost to Follow-up|2|||
94482787|NCT04202497|323559697|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
94482788|NCT04202497|323559698|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
94482789|NCT04202497|323559699|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
94482790|NCT04202497|323559700|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
94482791|NCT04863872|323559707|FG000|Overall Study|Withdrawal by Subject|4|||
94482792|NCT04863872|323559708|FG001|Overall Study|Withdrawal by Subject|15|||
94328388|NCT01253187|322982636|FG003|Period 3|non-compliance|0|||
94328389|NCT01253187|322982637|FG004|Period 3|non-compliance|1|||
94328390|NCT01253187|322982638|FG005|Period 3|non-compliance|0|||
94328391|NCT00525785|322982639|FG000|Overall Study|Withdrawal by Subject|1|||
94328392|NCT00525785|322982639|FG000|Overall Study|Lack of Efficacy|1|||
94328393|NCT00525785|322982639|FG000|Overall Study|Physician Decision|1|||
94328394|NCT00505752|322982642|FG000|Overall Study|Adverse Event|1|||
94328395|NCT00505752|322982643|FG001|Overall Study|Adverse Event|0|||
94328396|NCT00505752|322982644|FG002|Overall Study|Adverse Event|1|||
94328397|NCT00505752|322982645|FG003|Overall Study|Adverse Event|0|||
94328398|NCT00505752|322982642|FG000|Overall Study|Lost to Follow-up|1|||
94328399|NCT00505752|322982643|FG001|Overall Study|Lost to Follow-up|0|||
94328400|NCT00505752|322982644|FG002|Overall Study|Lost to Follow-up|0|||
94328401|NCT00505752|322982645|FG003|Overall Study|Lost to Follow-up|0|||
94328402|NCT00505752|322982642|FG000|Overall Study|Lack of ovarian response|1|||
94328403|NCT00505752|322982643|FG001|Overall Study|Lack of ovarian response|3|||
94328404|NCT00505752|322982644|FG002|Overall Study|Lack of ovarian response|0|||
94328405|NCT00505752|322982645|FG003|Overall Study|Lack of ovarian response|0|||
94328406|NCT00505752|322982642|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
94328407|NCT00505752|322982643|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
94328408|NCT00505752|322982644|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
94328409|NCT00505752|322982645|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
94328410|NCT00505752|322982642|FG000|Overall Study|No oocytes retrieved|0|||
94328411|NCT00505752|322982643|FG001|Overall Study|No oocytes retrieved|2|||
94328412|NCT00505752|322982644|FG002|Overall Study|No oocytes retrieved|0|||
94328413|NCT00505752|322982645|FG003|Overall Study|No oocytes retrieved|1|||
94328414|NCT00505752|322982642|FG000|Overall Study|No Fertilization|1|||
94328415|NCT00505752|322982643|FG001|Overall Study|No Fertilization|1|||
94328416|NCT00505752|322982644|FG002|Overall Study|No Fertilization|2|||
94328417|NCT00505752|322982645|FG003|Overall Study|No Fertilization|1|||
94328418|NCT00505752|322982642|FG000|Overall Study|All embryos/blastocysts discarded|0|||
94328419|NCT00505752|322982643|FG001|Overall Study|All embryos/blastocysts discarded|0|||
94328420|NCT00505752|322982644|FG002|Overall Study|All embryos/blastocysts discarded|1|||
94328421|NCT00505752|322982645|FG003|Overall Study|All embryos/blastocysts discarded|1|||
94328422|NCT00505752|322982642|FG000|Overall Study|Other|1|||
94328423|NCT00505752|322982643|FG001|Overall Study|Other|2|||
94328424|NCT00505752|322982644|FG002|Overall Study|Other|1|||
94328425|NCT00505752|322982645|FG003|Overall Study|Other|2|||
94328426|NCT01624506|322982646|FG000|Overall Study|Lost to Follow-up|29|||
94328427|NCT01624506|322982647|FG001|Overall Study|Lost to Follow-up|15|||
94328428|NCT01624506|322982646|FG000|Overall Study|Withdrawal by Subject|9|||
94328429|NCT01624506|322982647|FG001|Overall Study|Withdrawal by Subject|2|||
94328430|NCT01624506|322982646|FG000|Overall Study|Death|1|||
94328431|NCT01624506|322982647|FG001|Overall Study|Death|0|||
94328432|NCT01624506|322982646|FG000|Overall Study|LINX explants|23|||
94328433|NCT01624506|322982647|FG001|Overall Study|LINX explants|0|||
94328434|NCT01624506|322982646|FG000|Overall Study|Adverse Event|3|||
94328435|NCT01624506|322982647|FG001|Overall Study|Adverse Event|0|||
94328436|NCT01281189|322982648|FG000|Overall Study|Adverse Event|7|||
94328437|NCT01281189|322982649|FG001|Overall Study|Adverse Event|9|||
94328438|NCT01281189|322982648|FG000|Overall Study|Lost to Follow-up|6|||
94328439|NCT01281189|322982649|FG001|Overall Study|Lost to Follow-up|4|||
94328440|NCT01281189|322982648|FG000|Overall Study|Withdrawal by Subject|21|||
94328441|NCT01281189|322982649|FG001|Overall Study|Withdrawal by Subject|24|||
94328442|NCT01281189|322982648|FG000|Overall Study|Physician Decision|2|||
94328443|NCT01281189|322982649|FG001|Overall Study|Physician Decision|3|||
94328444|NCT01281189|322982648|FG000|Overall Study|Death|103|||
94328445|NCT01281189|322982649|FG001|Overall Study|Death|91|||
94328446|NCT01281189|322982648|FG000|Overall Study|Other|8|||
94328447|NCT01281189|322982649|FG001|Overall Study|Other|12|||
94328448|NCT01019252|322982654|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
94328449|NCT01019252|322982655|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
94328450|NCT01019252|322982654|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
94328451|NCT01019252|322982655|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
94328452|NCT01019252|322982654|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
94328453|NCT01019252|322982655|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
94328454|NCT01019252|322982654|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
94328455|NCT01019252|322982655|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
94328456|NCT03625141|322982656|FG000|Overall Study|Adverse Event|0|||
94328457|NCT03625141|322982657|FG001|Overall Study|Adverse Event|2|||
94328458|NCT03625141|322982656|FG000|Overall Study|Study Terminated By Sponsor|1|||
94328459|NCT03625141|322982657|FG001|Overall Study|Study Terminated By Sponsor|13|||
94328460|NCT03625141|322982656|FG000|Overall Study|Withdrawal by Subject|3|||
94328461|NCT03625141|322982657|FG001|Overall Study|Withdrawal by Subject|0|||
94328462|NCT03625141|322982656|FG000|Overall Study|Withdrawal Of Consent|0|||
94328463|NCT03625141|322982657|FG001|Overall Study|Withdrawal Of Consent|1|||
94328464|NCT03625141|322982656|FG000|Overall Study|Death|11|||
94328465|NCT03625141|322982657|FG001|Overall Study|Death|47|||
94328466|NCT03625141|322982656|FG000|Overall Study|Progressive Disease|0|||
94328467|NCT03625141|322982657|FG001|Overall Study|Progressive Disease|2|||
94328468|NCT00868166|322982658|FG000|Overall Study|Death|58|||
94328469|NCT00868166|322982659|FG001|Overall Study|Death|65|||
94391146|NCT00723528|323221411|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
94391147|NCT00723528|323221412|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
94391148|NCT00723528|323221413|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
94391149|NCT00723528|323221414|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
94391150|NCT00723528|323221408|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
94391151|NCT00723528|323221409|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
94391152|NCT00723528|323221410|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
94391153|NCT00723528|323221411|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
94391154|NCT00723528|323221412|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
94391155|NCT00723528|323221413|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
94391156|NCT00723528|323221414|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
94391157|NCT00723528|323221408|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
94391158|NCT00723528|323221409|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
94391159|NCT00723528|323221410|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
94391160|NCT00723528|323221411|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
94391161|NCT00723528|323221412|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
94391162|NCT00723528|323221413|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
94391163|NCT00723528|323221414|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
94391164|NCT00723528|323221408|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
94391165|NCT00723528|323221409|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
94391166|NCT00723528|323221410|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
94391167|NCT00723528|323221411|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
94391168|NCT00723528|323221412|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
94391169|NCT00723528|323221413|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
94391170|NCT00723528|323221414|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
94391171|NCT00723528|323221408|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
94391172|NCT00723528|323221409|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
94391173|NCT00723528|323221410|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
94391174|NCT00723528|323221411|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
94391175|NCT00723528|323221412|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
94391176|NCT00723528|323221413|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
94391177|NCT00723528|323221414|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
94391178|NCT00723528|323221408|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
94391179|NCT00723528|323221409|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
94391180|NCT00723528|323221410|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
94391181|NCT00723528|323221411|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
94391182|NCT00723528|323221412|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
94391183|NCT00723528|323221413|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
94391184|NCT00723528|323221414|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
94391185|NCT00723528|323221408|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
94391186|NCT00723528|323221409|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
94391187|NCT00723528|323221410|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
94391188|NCT00723528|323221411|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
94391189|NCT00723528|323221412|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
94391190|NCT00723528|323221413|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
94391191|NCT00723528|323221414|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
94391192|NCT00723528|323221408|FG000|Period 2: After Controlled Period|Other|0|||
94391193|NCT00723528|323221409|FG001|Period 2: After Controlled Period|Other|0|||
94391194|NCT00723528|323221410|FG002|Period 2: After Controlled Period|Other|0|||
94391195|NCT00723528|323221411|FG003|Period 2: After Controlled Period|Other|0|||
94391196|NCT00723528|323221412|FG004|Period 2: After Controlled Period|Other|1|||
94391197|NCT00723528|323221413|FG005|Period 2: After Controlled Period|Other|4|||
94391198|NCT00723528|323221414|FG006|Period 2: After Controlled Period|Other|0|||
94391199|NCT00723528|323221408|FG000|Period 2: After Controlled Period|Adverse Event|0|||
94391200|NCT00723528|323221409|FG001|Period 2: After Controlled Period|Adverse Event|0|||
94391201|NCT00723528|323221410|FG002|Period 2: After Controlled Period|Adverse Event|0|||
94391202|NCT00723528|323221411|FG003|Period 2: After Controlled Period|Adverse Event|0|||
94391203|NCT00723528|323221412|FG004|Period 2: After Controlled Period|Adverse Event|1|||
94391204|NCT00723528|323221413|FG005|Period 2: After Controlled Period|Adverse Event|0|||
94391205|NCT00723528|323221414|FG006|Period 2: After Controlled Period|Adverse Event|1|||
94391206|NCT00723528|323221408|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
94391207|NCT00723528|323221409|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
94391208|NCT00723528|323221410|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
94391209|NCT00723528|323221411|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
94482793|NCT04863872|323559707|FG000|Overall Study|Death|5|||
94391210|NCT00723528|323221412|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
94391211|NCT00723528|323221413|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
94391212|NCT00723528|323221414|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
94391213|NCT00723528|323221408|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
94391214|NCT00723528|323221409|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
94391215|NCT00723528|323221410|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
94391216|NCT00723528|323221411|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
94391217|NCT00723528|323221412|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
94391218|NCT00723528|323221413|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
94391219|NCT00723528|323221414|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
94391220|NCT01993030|323221415|FG000|Overall Study|Adverse Event|0|||
94391221|NCT01993030|323221416|FG001|Overall Study|Adverse Event|4|||
94391222|NCT03785548|323221417|FG000|Overall Study|age > 80|1|||
94391223|NCT03785548|323221418|FG001|Overall Study|age > 80|0|||
94391224|NCT03785548|323221417|FG000|Overall Study|no Postop queries|1|||
94391225|NCT03785548|323221418|FG001|Overall Study|no Postop queries|0|||
94391226|NCT01710657|323221419|FG000|Overall Study|Lost to Follow-up|2|||
94391227|NCT01710657|323221420|FG001|Overall Study|Lost to Follow-up|0|||
94391228|NCT01710657|323221421|FG002|Overall Study|Lost to Follow-up|1|||
94391229|NCT01710657|323221419|FG000|Overall Study|Protocol Violation|2|||
94391230|NCT01710657|323221420|FG001|Overall Study|Protocol Violation|2|||
94391231|NCT01710657|323221421|FG002|Overall Study|Protocol Violation|0|||
94391232|NCT01710657|323221419|FG000|Overall Study|Adverse Event|14|||
94391233|NCT01710657|323221420|FG001|Overall Study|Adverse Event|8|||
94391234|NCT01710657|323221421|FG002|Overall Study|Adverse Event|28|||
94391235|NCT01710657|323221419|FG000|Overall Study|Withdrawal by Subject|0|||
94391236|NCT01710657|323221420|FG001|Overall Study|Withdrawal by Subject|1|||
94391237|NCT01710657|323221421|FG002|Overall Study|Withdrawal by Subject|2|||
94391238|NCT01710657|323221419|FG000|Overall Study|Lack of Efficacy|0|||
94391239|NCT01710657|323221420|FG001|Overall Study|Lack of Efficacy|1|||
94391240|NCT01710657|323221421|FG002|Overall Study|Lack of Efficacy|1|||
94391241|NCT00620022|323221424|FG000|Treatment Period 1|Adverse Event|4|||
94391242|NCT00620022|323221425|FG001|Treatment Period 1|Adverse Event|6|||
94391243|NCT00620022|323221424|FG000|Treatment Period 1|Subject withdrew consent|1|||
94391244|NCT00620022|323221425|FG001|Treatment Period 1|Subject withdrew consent|0|||
94391245|NCT00620022|323221424|FG000|Treatment Period 2|Adverse Event|2|||
94391246|NCT00620022|323221425|FG001|Treatment Period 2|Adverse Event|2|||
94391247|NCT00667095|323221434|FG000|Overall Study|Withdrawal by Subject|0|||
94391248|NCT00667095|323221435|FG001|Overall Study|Withdrawal by Subject|1|||
94391249|NCT03351335|323221437|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
94391250|NCT03351335|323221438|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
94391251|NCT03351335|323221439|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
94391252|NCT02440711|323221443|FG000|Second Intervention|Lost to Follow-up|1|||
94391253|NCT02440711|323221444|FG001|Second Intervention|Lost to Follow-up|0|||
94391254|NCT03450057|323221446|FG000|Overall Study|Death|17|||
94391255|NCT03450057|323221446|FG000|Overall Study|ICF withdrawal|4|||
94391256|NCT03450057|323221446|FG000|Overall Study|Lost to Follow-up|2|||
94391257|NCT02146105|323221447|FG000|Overall Study|Adverse Event|1|||
94391258|NCT02146105|323221447|FG000|Overall Study|Withdrawal by Subject|5|||
94391259|NCT00573066|323221448|FG000|Overall Study|Exclusion criteria|18|||
94391260|NCT00573066|323221448|FG000|Overall Study|IV malfunction|1|||
94391261|NCT00573066|323221448|FG000|Overall Study|Postoperative bleeding|1|||
94391262|NCT05755282|323221449|FG000|Overall Study|Protocol Violation|0|||
94391263|NCT05755282|323221450|FG001|Overall Study|Protocol Violation|1|||
94391264|NCT04129346|323221451|FG000|Overall Study|Death|1|||
94391265|NCT04129346|323221452|FG001|Overall Study|Death|0|||
94391266|NCT01034358|323221453|FG000|Overall Study|Withdrawal by Subject|1|||
94391267|NCT01034358|323221453|FG000|Overall Study|Protocol Violation|1|||
94391268|NCT01838941|323221455|FG000|Overall Study|Adverse Event|1|||
94391269|NCT01838941|323221455|FG000|Overall Study|Withdrawal by Subject|1|||
94391270|NCT00834743|323221456|FG000|Second Intervention|Withdrawal by Subject|1|||
94391271|NCT00834743|323221457|FG001|Second Intervention|Withdrawal by Subject|0|||
94391272|NCT03025880|323221458|FG000|Overall Study|Adverse Event|1|||
94391273|NCT03025880|323221459|FG001|Overall Study|Adverse Event|0|||
94391274|NCT03025880|323221458|FG000|Overall Study|Death|1|||
94391275|NCT03025880|323221459|FG001|Overall Study|Death|1|||
94391276|NCT03025880|323221458|FG000|Overall Study|Withdrawal by Subject|0|||
94391277|NCT03025880|323221459|FG001|Overall Study|Withdrawal by Subject|1|||
94391278|NCT03025880|323221458|FG000|Overall Study|Physician Decision|0|||
94391279|NCT03025880|323221459|FG001|Overall Study|Physician Decision|1|||
94391280|NCT03025880|323221458|FG000|Overall Study|Progressive Disease|12|||
94391281|NCT03025880|323221459|FG001|Overall Study|Progressive Disease|19|||
94391282|NCT01661686|323221460|FG000|Overall Study|Lost to Follow-up|2|||
94391283|NCT01661686|323221461|FG001|Overall Study|Lost to Follow-up|1|||
94391284|NCT01661686|323221460|FG000|Overall Study|did not receive allocated intervention|0|||
94391285|NCT01661686|323221461|FG001|Overall Study|did not receive allocated intervention|1|||
94391286|NCT02419937|323221462|FG000|Overall Study|Lost to Follow-up|1|||
94391287|NCT02419937|323221463|FG001|Overall Study|Lost to Follow-up|0|||
94391288|NCT02794974|323221464|FG000|Overall Study|Physician Decision|0|||
94391289|NCT02794974|323221465|FG001|Overall Study|Physician Decision|1|||
94391290|NCT02246920|323221466|FG000|Overall Study|Adverse Event|3|||
94391291|NCT02246920|323221467|FG001|Overall Study|Adverse Event|1|||
94391292|NCT02246920|323221468|FG002|Overall Study|Adverse Event|1|||
94391293|NCT02246920|323221466|FG000|Overall Study|Lost to Follow-up|2|||
94391294|NCT02246920|323221467|FG001|Overall Study|Lost to Follow-up|1|||
94391295|NCT02246920|323221468|FG002|Overall Study|Lost to Follow-up|0|||
94391296|NCT02246920|323221466|FG000|Overall Study|Protocol Violation|2|||
94391297|NCT02246920|323221467|FG001|Overall Study|Protocol Violation|5|||
94391298|NCT02246920|323221468|FG002|Overall Study|Protocol Violation|1|||
94391299|NCT02246920|323221466|FG000|Overall Study|Withdrawal by Subject|0|||
94391300|NCT02246920|323221467|FG001|Overall Study|Withdrawal by Subject|0|||
94391301|NCT02246920|323221468|FG002|Overall Study|Withdrawal by Subject|1|||
94391302|NCT00184600|323221470|FG000|Overall Study|Adverse Event|9|||
94391303|NCT00184600|323221471|FG001|Overall Study|Adverse Event|0|||
94391304|NCT00184600|323221472|FG002|Overall Study|Adverse Event|5|||
94391305|NCT00184600|323221470|FG000|Overall Study|Death|3|||
94391306|NCT00184600|323221471|FG001|Overall Study|Death|9|||
94391307|NCT00184600|323221472|FG002|Overall Study|Death|7|||
94391308|NCT00184600|323221470|FG000|Overall Study|Lack of Efficacy|3|||
94391309|NCT00184600|323221471|FG001|Overall Study|Lack of Efficacy|1|||
94391310|NCT00184600|323221472|FG002|Overall Study|Lack of Efficacy|3|||
94391311|NCT00184600|323221470|FG000|Overall Study|Lost to Follow-up|4|||
94391312|NCT00184600|323221471|FG001|Overall Study|Lost to Follow-up|6|||
94391313|NCT00184600|323221472|FG002|Overall Study|Lost to Follow-up|1|||
94391314|NCT00184600|323221470|FG000|Overall Study|Protocol Violation|2|||
94391315|NCT00184600|323221471|FG001|Overall Study|Protocol Violation|2|||
94391316|NCT00184600|323221472|FG002|Overall Study|Protocol Violation|3|||
94391317|NCT00184600|323221470|FG000|Overall Study|Withdrawal by Subject|20|||
94391318|NCT00184600|323221471|FG001|Overall Study|Withdrawal by Subject|28|||
94391319|NCT00184600|323221472|FG002|Overall Study|Withdrawal by Subject|12|||
94391320|NCT00184600|323221470|FG000|Overall Study|Unclassified|4|||
94391321|NCT00184600|323221471|FG001|Overall Study|Unclassified|5|||
94391322|NCT00184600|323221472|FG002|Overall Study|Unclassified|3|||
94391323|NCT02336165|323221473|FG000|Overall Study|Death|3|||
94391324|NCT02336165|323221474|FG001|Overall Study|Death|0|||
94391325|NCT02336165|323221475|FG002|Overall Study|Death|0|||
94391326|NCT02336165|323221476|FG003|Overall Study|Death|0|||
94391327|NCT02336165|323221477|FG004|Overall Study|Death|1|||
94391328|NCT02336165|323221473|FG000|Overall Study|Physician Decision|2|||
94391329|NCT02336165|323221474|FG001|Overall Study|Physician Decision|2|||
94391330|NCT02336165|323221475|FG002|Overall Study|Physician Decision|1|||
94391331|NCT02336165|323221476|FG003|Overall Study|Physician Decision|1|||
94391332|NCT02336165|323221477|FG004|Overall Study|Physician Decision|0|||
94391333|NCT02336165|323221473|FG000|Overall Study|Withdrawal by Subject|0|||
94391334|NCT02336165|323221474|FG001|Overall Study|Withdrawal by Subject|0|||
94391335|NCT02336165|323221475|FG002|Overall Study|Withdrawal by Subject|1|||
94391336|NCT02336165|323221476|FG003|Overall Study|Withdrawal by Subject|0|||
94391337|NCT02336165|323221477|FG004|Overall Study|Withdrawal by Subject|1|||
94391338|NCT02336165|323221473|FG000|Overall Study|Adverse Event|4|||
94391339|NCT02336165|323221474|FG001|Overall Study|Adverse Event|1|||
94391340|NCT02336165|323221475|FG002|Overall Study|Adverse Event|2|||
94391341|NCT02336165|323221476|FG003|Overall Study|Adverse Event|4|||
94391342|NCT02336165|323221477|FG004|Overall Study|Adverse Event|1|||
94391343|NCT02336165|323221473|FG000|Overall Study|Progressive disease|23|||
94391344|NCT02336165|323221474|FG001|Overall Study|Progressive disease|22|||
94391345|NCT02336165|323221475|FG002|Overall Study|Progressive disease|27|||
94391346|NCT02336165|323221476|FG003|Overall Study|Progressive disease|24|||
94391347|NCT02336165|323221477|FG004|Overall Study|Progressive disease|19|||
94391348|NCT02336165|323221473|FG000|Overall Study|Non-compliance|1|||
94391349|NCT02336165|323221474|FG001|Overall Study|Non-compliance|0|||
94391350|NCT02336165|323221475|FG002|Overall Study|Non-compliance|0|||
94391351|NCT02336165|323221476|FG003|Overall Study|Non-compliance|1|||
94391352|NCT02336165|323221477|FG004|Overall Study|Non-compliance|0|||
94391353|NCT02336165|323221473|FG000|Overall Study|Other|1|||
94391354|NCT02336165|323221474|FG001|Overall Study|Other|0|||
94391355|NCT02336165|323221475|FG002|Overall Study|Other|0|||
94391356|NCT02336165|323221476|FG003|Overall Study|Other|1|||
94391357|NCT02336165|323221477|FG004|Overall Study|Other|0|||
94391358|NCT01313273|323221478|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
94391359|NCT01313273|323221479|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
94391360|NCT01313273|323221478|FG000|Overall Study|Withdrawal by Subject|1|||
94391361|NCT01313273|323221479|FG001|Overall Study|Withdrawal by Subject|0|||
94391362|NCT01313273|323221478|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
94391363|NCT01313273|323221479|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
94391364|NCT00910663|323221480|FG000|Period 1|Withdrawal by Subject|0|||
94391365|NCT00910663|323221481|FG001|Period 1|Withdrawal by Subject|1|||
94391366|NCT02726581|323221482|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
94391367|NCT02726581|323221483|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
94391368|NCT02726581|323221484|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
94391369|NCT02726581|323221482|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
94391370|NCT02726581|323221483|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
94391371|NCT02726581|323221484|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
94391372|NCT02726581|323221482|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
94391373|NCT02726581|323221483|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94391374|NCT02726581|323221484|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94391375|NCT02726581|323221482|FG000|Treatment Period|Disease progression|47|||
94391376|NCT02726581|323221483|FG001|Treatment Period|Disease progression|50|||
94391377|NCT02726581|323221484|FG002|Treatment Period|Disease progression|16|||
94391378|NCT02726581|323221482|FG000|Treatment Period|Other reasons|9|||
94391379|NCT02726581|323221483|FG001|Treatment Period|Other reasons|8|||
94391380|NCT02726581|323221484|FG002|Treatment Period|Other reasons|2|||
94391381|NCT02726581|323221482|FG000|Treatment Period|Study drug toxicity|6|||
94391382|NCT02726581|323221483|FG001|Treatment Period|Study drug toxicity|3|||
94391383|NCT02726581|323221484|FG002|Treatment Period|Study drug toxicity|2|||
94391384|NCT02726581|323221482|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
94391385|NCT02726581|323221483|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
94391386|NCT02726581|323221484|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
94391387|NCT02726581|323221482|FG000|Treatment Period|Participant withdrew consent|3|||
94391388|NCT02726581|323221483|FG001|Treatment Period|Participant withdrew consent|1|||
94391389|NCT02726581|323221484|FG002|Treatment Period|Participant withdrew consent|1|||
94391390|NCT02726581|323221482|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
94391391|NCT02726581|323221483|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
94391392|NCT02726581|323221484|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
94391393|NCT02726581|323221482|FG000|Treatment Period|Maximum clinical benefit|0|||
94391394|NCT02726581|323221483|FG001|Treatment Period|Maximum clinical benefit|2|||
94391395|NCT02726581|323221484|FG002|Treatment Period|Maximum clinical benefit|0|||
94391396|NCT02726581|323221482|FG000|Treatment Period|Death|1|||
94391397|NCT02726581|323221483|FG001|Treatment Period|Death|0|||
94391398|NCT02726581|323221484|FG002|Treatment Period|Death|0|||
94391399|NCT02726581|323221482|FG000|Treatment Period|Poor/non-compliance|1|||
94391400|NCT02726581|323221483|FG001|Treatment Period|Poor/non-compliance|0|||
94391401|NCT02726581|323221484|FG002|Treatment Period|Poor/non-compliance|0|||
94391402|NCT02726581|323221482|FG000|Treatment Period|Participant no longer meets study criteria|0|||
94391403|NCT02726581|323221483|FG001|Treatment Period|Participant no longer meets study criteria|1|||
94391404|NCT02726581|323221484|FG002|Treatment Period|Participant no longer meets study criteria|0|||
94391405|NCT03195491|323221485|FG000|Overall Study|Study drug toxicity|25|||
94391406|NCT03195491|323221486|FG001|Overall Study|Study drug toxicity|3|||
94391407|NCT03195491|323221485|FG000|Overall Study|Maximum clinical benefit|5|||
94391408|NCT03195491|323221486|FG001|Overall Study|Maximum clinical benefit|0|||
94391409|NCT03195491|323221485|FG000|Overall Study|Lost to Follow-up|1|||
94391410|NCT03195491|323221486|FG001|Overall Study|Lost to Follow-up|0|||
94391411|NCT03195491|323221485|FG000|Overall Study|Death|3|||
94391412|NCT03195491|323221486|FG001|Overall Study|Death|0|||
94391413|NCT03195491|323221485|FG000|Overall Study|Adverse event unrelated to study drug|19|||
94391414|NCT03195491|323221486|FG001|Overall Study|Adverse event unrelated to study drug|2|||
94391415|NCT03195491|323221485|FG000|Overall Study|Disease progression|266|||
94391416|NCT03195491|323221486|FG001|Overall Study|Disease progression|8|||
94391417|NCT03195491|323221485|FG000|Overall Study|Other reasons|10|||
94391418|NCT03195491|323221486|FG001|Overall Study|Other reasons|0|||
94391419|NCT03195491|323221485|FG000|Overall Study|Participant withdrew consent|8|||
94391420|NCT03195491|323221486|FG001|Overall Study|Participant withdrew consent|1|||
94391421|NCT03195491|323221485|FG000|Overall Study|Participant no longer meets study criteria|0|||
94391422|NCT03195491|323221486|FG001|Overall Study|Participant no longer meets study criteria|1|||
94391423|NCT03195491|323221485|FG000|Overall Study|Participant request to discontinue study treatment|10|||
94391424|NCT03195491|323221486|FG001|Overall Study|Participant request to discontinue study treatment|0|||
94391425|NCT03020615|323221487|FG000|Overall Study|Physician Decision|3|||
94391426|NCT03020615|323221488|FG001|Overall Study|Physician Decision|1|||
94482794|NCT04863872|323559708|FG001|Overall Study|Death|2|||
94391427|NCT03020615|323221489|FG002|Overall Study|Physician Decision|2|||
94391428|NCT03020615|323221487|FG000|Overall Study|Parent/guardian/patient choice|3|||
94391429|NCT03020615|323221488|FG001|Overall Study|Parent/guardian/patient choice|0|||
94391430|NCT03020615|323221489|FG002|Overall Study|Parent/guardian/patient choice|4|||
94391431|NCT03020615|323221487|FG000|Overall Study|Screen failure|0|||
94391432|NCT03020615|323221488|FG001|Overall Study|Screen failure|0|||
94391433|NCT03020615|323221489|FG002|Overall Study|Screen failure|1|||
94391434|NCT03020615|323221487|FG000|Overall Study|Death|1|||
94391435|NCT03020615|323221488|FG001|Overall Study|Death|0|||
94391436|NCT03020615|323221489|FG002|Overall Study|Death|0|||
94391437|NCT03020615|323221487|FG000|Overall Study|Lost to Follow-up|0|||
94391438|NCT03020615|323221488|FG001|Overall Study|Lost to Follow-up|1|||
94391439|NCT03020615|323221489|FG002|Overall Study|Lost to Follow-up|0|||
94391440|NCT00772941|323221490|FG000|Overall Study|CRFs not available|195|||
94391441|NCT00772941|323221490|FG000|Overall Study|Study not completed|16|||
94391442|NCT00772941|323221490|FG000|Overall Study|Missed Visits|374|||
94391443|NCT00772941|323221490|FG000|Overall Study|Poor Compliance|7|||
94391444|NCT00772941|323221490|FG000|Overall Study|GPSP Violation|90|||
94391445|NCT04263649|323221491|FG000|Overall Study|Adverse Event|53|||
94391446|NCT04263649|323221491|FG000|Overall Study|Lost to Follow-up|3|||
94391447|NCT04263649|323221491|FG000|Overall Study|Death|29|||
94391448|NCT04263649|323221491|FG000|Overall Study|Device deficiency|19|||
94391449|NCT04263649|323221491|FG000|Overall Study|other reasons|11|||
94391450|NCT00550537|323221504|FG000|Overall Study|Death|18|||
94391451|NCT00550537|323221504|FG000|Overall Study|Adverse Event|20|||
94391452|NCT00550537|323221504|FG000|Overall Study|Disease progression before|46|||
94391453|NCT00550537|323221504|FG000|Overall Study|Withdrawal by Subject|7|||
94391454|NCT00550537|323221504|FG000|Overall Study|Change in treatment plan|4|||
94391455|NCT00550537|323221504|FG000|Overall Study|Other complicating ilness|3|||
94391456|NCT00550537|323221504|FG000|Overall Study|Declining performance status|2|||
94391457|NCT00550537|323221504|FG000|Overall Study|Treated closer to home|4|||
94391458|NCT03197883|323221505|FG000|Overall Study|Adverse Event|1|||
94391459|NCT03197883|323221506|FG001|Overall Study|Adverse Event|1|||
94391460|NCT03197883|323221505|FG000|Overall Study|Lost to Follow-up|1|||
94391461|NCT03197883|323221506|FG001|Overall Study|Lost to Follow-up|0|||
94391462|NCT03197883|323221505|FG000|Overall Study|Protocol Violation|1|||
94391463|NCT03197883|323221506|FG001|Overall Study|Protocol Violation|0|||
94391464|NCT03197883|323221505|FG000|Overall Study|Other (Not Specified)|0|||
94391465|NCT03197883|323221506|FG001|Overall Study|Other (Not Specified)|5|||
94391466|NCT02605928|323221507|FG000|Overall Study|Model tuning phase|28|||
94391467|NCT02605928|323221507|FG000|Overall Study|Lack of Efficacy|5|||
94391468|NCT01110005|323221508|FG000|Overall Study|ineligible|1|||
94391469|NCT01110005|323221509|FG001|Overall Study|ineligible|2|||
94391470|NCT01110005|323221508|FG000|Overall Study|missing consent|3|||
94391471|NCT01110005|323221509|FG001|Overall Study|missing consent|2|||
94391472|NCT01110005|323221508|FG000|Overall Study|Withdrawal by Subject|0|||
94391473|NCT01110005|323221509|FG001|Overall Study|Withdrawal by Subject|1|||
94391474|NCT02242201|323221512|FG000|Overall Study|preoperative identified neuropathy|2|||
94391475|NCT02242201|323221513|FG001|Overall Study|preoperative identified neuropathy|0|||
94391476|NCT02242201|323221514|FG002|Overall Study|preoperative identified neuropathy|0|||
94391477|NCT02242201|323221512|FG000|Overall Study|planned post-op anticoagulation|1|||
94391478|NCT02242201|323221513|FG001|Overall Study|planned post-op anticoagulation|0|||
94391479|NCT02242201|323221514|FG002|Overall Study|planned post-op anticoagulation|0|||
94391480|NCT02242201|323221512|FG000|Overall Study|changed surgical procedure|1|||
94391481|NCT02242201|323221513|FG001|Overall Study|changed surgical procedure|0|||
94391482|NCT02242201|323221514|FG002|Overall Study|changed surgical procedure|0|||
94391483|NCT02242201|323221512|FG000|Overall Study|postponed surgery|0|||
94391484|NCT02242201|323221513|FG001|Overall Study|postponed surgery|0|||
94391485|NCT02242201|323221514|FG002|Overall Study|postponed surgery|1|||
94391486|NCT02242201|323221512|FG000|Overall Study|preoperative opioid consumption|0|||
94391487|NCT02242201|323221513|FG001|Overall Study|preoperative opioid consumption|1|||
94391488|NCT02242201|323221514|FG002|Overall Study|preoperative opioid consumption|0|||
94391489|NCT01577381|323221517|FG000|Overall Study|Discontinued|2|||
94391490|NCT01577381|323221518|FG001|Overall Study|Discontinued|1|||
94391491|NCT01577381|323221519|FG002|Overall Study|Discontinued|2|||
94391492|NCT01577381|323221520|FG003|Overall Study|Discontinued|2|||
94391493|NCT01577381|323221517|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
94391494|NCT01577381|323221518|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
94391495|NCT01577381|323221519|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
94391496|NCT01577381|323221520|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
94391497|NCT00859430|323221521|FG000|First Intervention|Withdrawal by Subject|0|||
94391498|NCT00859430|323221522|FG001|First Intervention|Withdrawal by Subject|1|||
94391499|NCT01507051|323223691|FG000|Overall Study|Withdrawal by Subject|1|||
94391500|NCT01507051|323223692|FG001|Overall Study|Withdrawal by Subject|3|||
94391501|NCT01507051|323223693|FG002|Overall Study|Withdrawal by Subject|1|||
94391502|NCT01507051|323223694|FG003|Overall Study|Withdrawal by Subject|6|||
94391503|NCT01507051|323223691|FG000|Overall Study|Physician Decision|0|||
94391504|NCT01507051|323223692|FG001|Overall Study|Physician Decision|0|||
94391505|NCT01507051|323223693|FG002|Overall Study|Physician Decision|0|||
94391506|NCT01507051|323223694|FG003|Overall Study|Physician Decision|1|||
94391507|NCT01507051|323223691|FG000|Overall Study|Adverse Event|1|||
94391508|NCT01507051|323223692|FG001|Overall Study|Adverse Event|0|||
94391509|NCT01507051|323223693|FG002|Overall Study|Adverse Event|0|||
94391510|NCT01507051|323223694|FG003|Overall Study|Adverse Event|0|||
94391511|NCT01049334|323223695|FG000|Overall Study|Withdrawal by Subject|5|||
94391512|NCT01049334|323223696|FG001|Overall Study|Withdrawal by Subject|3|||
94391513|NCT01049334|323223695|FG000|Overall Study|Adverse Event|2|||
94391514|NCT01049334|323223696|FG001|Overall Study|Adverse Event|3|||
94391515|NCT01049334|323223695|FG000|Overall Study|Physician Decision|2|||
94391516|NCT01049334|323223696|FG001|Overall Study|Physician Decision|0|||
94391517|NCT01049334|323223695|FG000|Overall Study|Protocol Violation|0|||
94391518|NCT01049334|323223696|FG001|Overall Study|Protocol Violation|1|||
94328470|NCT00868166|322982658|FG000|Overall Study|Withdrawal by Subject|33|||
94328471|NCT00868166|322982659|FG001|Overall Study|Withdrawal by Subject|25|||
94328472|NCT00868166|322982658|FG000|Overall Study|Protocol Violation|1|||
94328473|NCT00868166|322982659|FG001|Overall Study|Protocol Violation|0|||
94328474|NCT00868166|322982658|FG000|Overall Study|Lost to Follow-up|1|||
94328475|NCT00868166|322982659|FG001|Overall Study|Lost to Follow-up|3|||
94328476|NCT00868166|322982658|FG000|Overall Study|Adverse Event|9|||
94328477|NCT00868166|322982659|FG001|Overall Study|Adverse Event|10|||
94328478|NCT00868166|322982658|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
94328479|NCT00868166|322982659|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
94328480|NCT00868166|322982658|FG000|Overall Study|Non-compliance with IMP|1|||
94328481|NCT00868166|322982659|FG001|Overall Study|Non-compliance with IMP|1|||
94328482|NCT00126581|322982660|FG000|Overall Study|Adverse Event|3|||
94328483|NCT00126581|322982661|FG001|Overall Study|Adverse Event|7|||
94328484|NCT00126581|322982660|FG000|Overall Study|Death|3|||
94328485|NCT00126581|322982661|FG001|Overall Study|Death|2|||
94328486|NCT00126581|322982660|FG000|Overall Study|Withdrawal by Subject|1|||
94328487|NCT00126581|322982661|FG001|Overall Study|Withdrawal by Subject|4|||
94328488|NCT00126581|322982660|FG000|Overall Study|Alternative therapy|3|||
94328489|NCT00126581|322982661|FG001|Overall Study|Alternative therapy|3|||
94328490|NCT00126581|322982660|FG000|Overall Study|Other illness/MD discretion|3|||
94328491|NCT00126581|322982661|FG001|Overall Study|Other illness/MD discretion|4|||
94328492|NCT00433446|322982664|FG000|Overall Study|Adverse Event|4|||
94328493|NCT00433446|322982664|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
94328494|NCT00433446|322982664|FG000|Overall Study|Progression|44|||
94328495|NCT00433446|322982664|FG000|Overall Study|Other - Not Protocol specified|3|||
94328496|NCT00433446|322982664|FG000|Overall Study|Ineligible|9|||
94328497|NCT02680587|322982665|FG000|Overall Study|Withdrawal by Subject|1|||
94328498|NCT02680587|322982666|FG001|Overall Study|Withdrawal by Subject|0|||
94328499|NCT01188538|322982667|FG000|Overall Study|Lost to Follow-up|0|||
94328500|NCT01188538|322982668|FG001|Overall Study|Lost to Follow-up|1|||
94328501|NCT00691093|322982675|FG000|Overall Study|Adverse Event|1|||
94328502|NCT00691093|322982675|FG000|Overall Study|Lost to Follow-up|1|||
94328503|NCT00691093|322982675|FG000|Overall Study|Lack of Efficacy|1|||
94328504|NCT00691093|322982675|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
94328505|NCT02677220|322982677|FG000|Overall Study|Adverse Event|1|||
94328506|NCT00965146|322982678|FG000|Overall Study|Death|7|||
94328507|NCT00965146|322982678|FG000|Overall Study|Lost to Follow-up|22|||
94328508|NCT00965146|322982678|FG000|Overall Study|Withdrawal by Subject|17|||
94328509|NCT00965146|322982678|FG000|Overall Study|Unable to return|1|||
94328510|NCT00965146|322982678|FG000|Overall Study|Unwilling to return|11|||
94328511|NCT00965146|322982678|FG000|Overall Study|Intercurrent illness|1|||
94328512|NCT00965146|322982678|FG000|Overall Study|Revision / Removal of Study Implant|6|||
94328513|NCT00965146|322982678|FG000|Overall Study|Overall Study Termination|145|||
94328514|NCT02553317|322982679|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
94328515|NCT02553317|322982680|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
94328516|NCT02553317|322982679|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
94328517|NCT02553317|322982680|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
94328518|NCT02553317|322982679|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
94328519|NCT02553317|322982680|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
94328520|NCT02553317|322982679|FG000|Overall Treatment Period + Follow-up|Death|1|||
94328521|NCT02553317|322982680|FG001|Overall Treatment Period + Follow-up|Death|3|||
94328522|NCT02553317|322982679|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
94328523|NCT02553317|322982680|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
94328524|NCT02553317|322982679|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
94328525|NCT02553317|322982680|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
94328526|NCT02553317|322982679|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
94328527|NCT02553317|322982680|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
94328528|NCT02553317|322982679|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
94328529|NCT02553317|322982680|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
94328530|NCT02553317|322982679|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
94328531|NCT02553317|322982680|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
94328532|NCT02553317|322982679|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
94328533|NCT02553317|322982680|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
94328534|NCT01309841|322982685|FG000|Overall Study|Other|0|||
94328535|NCT01309841|322982686|FG001|Overall Study|Other|1|||
94391519|NCT00396279|323223699|FG000|Overall Study|Ongoing in study|26|||
94391520|NCT00396279|323223699|FG000|Overall Study|Disease progression|2|||
94391521|NCT00396279|323223699|FG000|Overall Study|Withdrawal by Subject|1|||
94482795|NCT04863872|323559707|FG000|Overall Study|Lost to Follow-up|2|||
94482796|NCT04863872|323559708|FG001|Overall Study|Lost to Follow-up|1|||
94482797|NCT02155699|323559709|FG000|Overall Study|Withdrawal by Subject|0|||
94482798|NCT02155699|323559710|FG001|Overall Study|Withdrawal by Subject|3|||
94482799|NCT02155699|323559711|FG002|Overall Study|Withdrawal by Subject|6|||
94482800|NCT02155699|323559712|FG003|Overall Study|Withdrawal by Subject|1|||
94482801|NCT02155699|323559709|FG000|Overall Study|Lost to Follow-up|0|||
94482802|NCT02155699|323559710|FG001|Overall Study|Lost to Follow-up|0|||
94482803|NCT02155699|323559711|FG002|Overall Study|Lost to Follow-up|0|||
94482804|NCT02155699|323559712|FG003|Overall Study|Lost to Follow-up|3|||
94482805|NCT02155699|323559709|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
94482806|NCT02155699|323559710|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
94482807|NCT02155699|323559711|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
94482808|NCT02155699|323559712|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
94482809|NCT00485069|323559715|FG000|Overall Study|Adverse Event|10|||
94482810|NCT00485069|323559716|FG001|Overall Study|Adverse Event|4|||
94482811|NCT00485069|323559715|FG000|Overall Study|Lack of Efficacy|2|||
94482812|NCT00485069|323559716|FG001|Overall Study|Lack of Efficacy|1|||
94482813|NCT00485069|323559715|FG000|Overall Study|Protocol Violation|0|||
94482814|NCT00485069|323559716|FG001|Overall Study|Protocol Violation|1|||
94482815|NCT00485069|323559715|FG000|Overall Study|Withdrawal by Subject|6|||
94482816|NCT00485069|323559716|FG001|Overall Study|Withdrawal by Subject|6|||
94482817|NCT02989402|323559719|FG000|Overall Study|Adverse event, or serious adverse event|4|||
94482818|NCT02989402|323559719|FG000|Overall Study|Death|2|||
94482819|NCT02989402|323559719|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
94482820|NCT02989402|323559719|FG000|Overall Study|Lost to Follow-up|8|||
94482821|NCT02989402|323559719|FG000|Overall Study|Patient no longer on monotherapy|1|||
94482822|NCT02989402|323559719|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
94482823|NCT02989402|323559719|FG000|Overall Study|Withdrawal by Subject|7|||
94482824|NCT02989402|323559719|FG000|Overall Study|Other|2|||
94482825|NCT00828113|323559722|FG000|Overall Study|Withdrawal by Subject|27|||
94482826|NCT00828113|323559723|FG001|Overall Study|Withdrawal by Subject|26|||
94482827|NCT00828113|323559722|FG000|Overall Study|Lost to Follow-up|3|||
94482828|NCT00828113|323559723|FG001|Overall Study|Lost to Follow-up|5|||
94482829|NCT01275144|323559724|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
94482830|NCT01275144|323559725|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
94482831|NCT01365130|323559726|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
94482832|NCT04622969|323559730|FG000|Overall Study|Withdrawal by Subject|2|||
94482833|NCT04622969|323559731|FG001|Overall Study|Withdrawal by Subject|3|||
94482834|NCT02864407|323559734|FG000|Overall Study|Protocol Violation|3|||
94482835|NCT02864407|323559734|FG000|Overall Study|Lost to Follow-up|115|||
94482836|NCT02864407|323559734|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
94482837|NCT02864407|323559734|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
94482838|NCT02864407|323559734|FG000|Overall Study|Consent prior to the contract date|1|||
94482839|NCT01819727|323559748|FG000|Overall Study|Adverse Event|8|||
94482840|NCT01819727|323559749|FG001|Overall Study|Adverse Event|9|||
94482841|NCT01819727|323559748|FG000|Overall Study|Death|1|||
94482842|NCT01819727|323559749|FG001|Overall Study|Death|0|||
94482843|NCT01819727|323559748|FG000|Overall Study|Lost to Follow-up|1|||
94482844|NCT01819727|323559749|FG001|Overall Study|Lost to Follow-up|1|||
94482845|NCT01819727|323559748|FG000|Overall Study|Physician Decision|3|||
94482846|NCT01819727|323559749|FG001|Overall Study|Physician Decision|2|||
94482847|NCT01819727|323559748|FG000|Overall Study|Pregnancy|1|||
94482848|NCT01819727|323559749|FG001|Overall Study|Pregnancy|0|||
94482849|NCT01819727|323559748|FG000|Overall Study|Protocol Violation|0|||
94482850|NCT01819727|323559749|FG001|Overall Study|Protocol Violation|2|||
94482851|NCT01819727|323559748|FG000|Overall Study|Study Terminated by Sponsor|0|||
94482852|NCT01819727|323559749|FG001|Overall Study|Study Terminated by Sponsor|1|||
94482853|NCT01819727|323559748|FG000|Overall Study|Withdrawal by Subject|6|||
94482854|NCT01819727|323559749|FG001|Overall Study|Withdrawal by Subject|11|||
94482855|NCT01819727|323559748|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
94482856|NCT01819727|323559749|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
94482857|NCT01819727|323559748|FG000|Overall Study|Quit due to lack of health benifits|0|||
94482858|NCT01819727|323559749|FG001|Overall Study|Quit due to lack of health benifits|1|||
94482859|NCT00751140|323559757|FG000|Overall Study|benign angioma excluded from analysis|1|||
94482860|NCT01628848|323559758|FG000|Overall Study|Adverse Event|9|||
94482861|NCT01628848|323559759|FG001|Overall Study|Adverse Event|7|||
94482862|NCT01628848|323559758|FG000|Overall Study|Lack of Efficacy|0|||
94482863|NCT01628848|323559759|FG001|Overall Study|Lack of Efficacy|4|||
94482864|NCT01628848|323559758|FG000|Overall Study|Withdrawal by Subject|0|||
94482865|NCT01628848|323559759|FG001|Overall Study|Withdrawal by Subject|2|||
94482866|NCT01628848|323559758|FG000|Overall Study|Physician Decision|3|||
94482867|NCT01628848|323559759|FG001|Overall Study|Physician Decision|1|||
94482868|NCT02667301|323559764|FG000|Overall Study|Adverse Event|1|||
94482869|NCT02667301|323559764|FG000|Overall Study|Lack of Efficacy|1|||
94482870|NCT02283658|323559765|FG000|Overall Study|Withdrawal by Subject|1|||
94482871|NCT00003471|323559767|FG000|Overall Study|Not evaluable|4|||
94482872|NCT02340000|323559768|FG000|Time Period 1|Withdrawal by Subject|6|||
94482873|NCT02340000|323559769|FG001|Time Period 1|Withdrawal by Subject|8|||
94482874|NCT02340000|323559768|FG000|Time Period 1|Lost to Follow-up|6|||
94482875|NCT02340000|323559769|FG001|Time Period 1|Lost to Follow-up|7|||
94482876|NCT02340000|323559768|FG000|Time Period 2|Withdrawal by Subject|9|||
94482877|NCT02340000|323559769|FG001|Time Period 2|Withdrawal by Subject|7|||
94482878|NCT02340000|323559768|FG000|Time Period 2|Lost to Follow-up|10|||
94482879|NCT02340000|323559769|FG001|Time Period 2|Lost to Follow-up|8|||
94482880|NCT01619878|323559770|FG000|6 Week Follow-up Phase|Adverse Event|1|||
94482881|NCT01619878|323559770|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
94482882|NCT01619878|323559770|FG000|Follow-up at 12 Months of Age|Death|2|||
94482883|NCT02370511|323559775|FG000|Overall Study|Death|10|||
94482884|NCT02370511|323559776|FG001|Overall Study|Death|7|||
94482885|NCT02370511|323559777|FG002|Overall Study|Death|1|||
94482886|NCT02370511|323559775|FG000|Overall Study|Withdrawal by Subject|2|||
94482887|NCT02370511|323559776|FG001|Overall Study|Withdrawal by Subject|0|||
94482888|NCT02370511|323559777|FG002|Overall Study|Withdrawal by Subject|0|||
94482889|NCT02370511|323559775|FG000|Overall Study|Lost to Follow-up|0|||
94482890|NCT02370511|323559776|FG001|Overall Study|Lost to Follow-up|4|||
94482891|NCT02370511|323559777|FG002|Overall Study|Lost to Follow-up|0|||
94482892|NCT00807365|323559781|FG000|Overall Study|Study Terminated|5|||
94482893|NCT01526785|323559788|FG000|Overall Study|Study Terminated by Sponsor|8|||
94482894|NCT01526785|323559788|FG000|Overall Study|Death|2|||
94482895|NCT01526785|323559788|FG000|Overall Study|Physician Decision|1|||
94482896|NCT01526785|323559788|FG000|Overall Study|Withdrawal by Subject|2|||
94482897|NCT01121263|323559789|FG000|Overall Study|Death|3|||
94482898|NCT01121263|323559790|FG001|Overall Study|Death|2|||
94482899|NCT01121263|323559789|FG000|Overall Study|Lost to Follow-up|22|||
94482900|NCT01121263|323559790|FG001|Overall Study|Lost to Follow-up|12|||
94482901|NCT01121263|323559789|FG000|Overall Study|Withdrawal by Subject|0|||
94482902|NCT01121263|323559790|FG001|Overall Study|Withdrawal by Subject|1|||
94482903|NCT02007720|323559791|FG000|Overall Study|Withdrawal by Subject|9|||
94482904|NCT02007720|323559792|FG001|Overall Study|Withdrawal by Subject|11|||
94482905|NCT02007720|323559791|FG000|Overall Study|study terminated by sponsor|58|||
94482906|NCT02007720|323559792|FG001|Overall Study|study terminated by sponsor|54|||
94482907|NCT02007720|323559791|FG000|Overall Study|technical problem|4|||
94482908|NCT02007720|323559792|FG001|Overall Study|technical problem|2|||
94482909|NCT02007720|323559791|FG000|Overall Study|patient followd less than 165 days|11|||
94482910|NCT02007720|323559792|FG001|Overall Study|patient followd less than 165 days|5|||
94482911|NCT03810456|323559793|FG000|Treatment|Urgent Family Matters|3|||
94482912|NCT03810456|323559794|FG001|Treatment|Urgent Family Matters|0|||
94482913|NCT03810456|323559795|FG002|Treatment|Urgent Family Matters|0|||
94482914|NCT03810456|323559793|FG000|Treatment|Scheduling Conflicts|0|||
94482915|NCT03810456|323559794|FG001|Treatment|Scheduling Conflicts|11|||
94482916|NCT03810456|323559795|FG002|Treatment|Scheduling Conflicts|0|||
94482917|NCT03810456|323559793|FG000|Treatment|No Longer Interested|0|||
94482918|NCT03810456|323559794|FG001|Treatment|No Longer Interested|12|||
94482919|NCT03810456|323559795|FG002|Treatment|No Longer Interested|0|||
94482920|NCT03810456|323559793|FG000|Treatment|Transportation Issues|0|||
94482921|NCT03810456|323559794|FG001|Treatment|Transportation Issues|1|||
94482922|NCT03810456|323559795|FG002|Treatment|Transportation Issues|0|||
94482923|NCT03810456|323559793|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
94482924|NCT03810456|323559794|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
94482925|NCT03810456|323559795|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
94482926|NCT03810456|323559793|FG000|1 Month Follow-Up|Relocated to Different State|1|||
94482927|NCT03810456|323559794|FG001|1 Month Follow-Up|Relocated to Different State|0|||
94482928|NCT03810456|323559795|FG002|1 Month Follow-Up|Relocated to Different State|1|||
94482929|NCT03810456|323559793|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
94482930|NCT03810456|323559794|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
94482931|NCT03810456|323559795|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
94482932|NCT03810456|323559793|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
94482933|NCT03810456|323559794|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
94482934|NCT03810456|323559795|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
94482935|NCT03810456|323559793|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
94482936|NCT03810456|323559794|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
94482937|NCT03810456|323559795|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
94482938|NCT03810456|323559793|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
94482939|NCT03810456|323559794|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
94482940|NCT03810456|323559795|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
94482941|NCT03810456|323559793|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
94482942|NCT03810456|323559794|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
94482943|NCT03810456|323559795|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
94482944|NCT01419535|323559796|FG000|Overall Study|could not maintain iv line|1|||
94482945|NCT01419535|323559797|FG001|Overall Study|could not maintain iv line|1|||
94482946|NCT01419535|323559796|FG000|Overall Study|Withdrawal by Subject|0|||
94482947|NCT01419535|323559797|FG001|Overall Study|Withdrawal by Subject|1|||
94482948|NCT01381926|323561654|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
94482949|NCT01381926|323561655|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
94482950|NCT01381926|323561654|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
94482951|NCT01381926|323561655|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
94482952|NCT01484951|323561660|FG000|Overall Study|Adverse Event|3|||
94482953|NCT01484951|323561660|FG000|Overall Study|Personal Reasons|1|||
94482954|NCT01484951|323561660|FG000|Overall Study|Non-Compliance|1|||
94482955|NCT01249417|323561661|FG000|Randomised Population|Study treatment not received|0|||
94482956|NCT01249417|323561662|FG001|Randomised Population|Study treatment not received|0|||
94482957|NCT01249417|323561663|FG002|Randomised Population|Study treatment not received|2|||
94482958|NCT01249417|323561661|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
94482959|NCT01249417|323561662|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
94482960|NCT01249417|323561663|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
94482961|NCT01249417|323561661|FG000|Treatment Phase - ITT Population|Other|0|||
94482962|NCT01249417|323561662|FG001|Treatment Phase - ITT Population|Other|0|||
94482963|NCT01249417|323561663|FG002|Treatment Phase - ITT Population|Other|1|||
94482964|NCT01249417|323561661|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
94482965|NCT01249417|323561662|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
94482966|NCT01249417|323561663|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
94482967|NCT01249417|323561661|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
94482968|NCT01249417|323561662|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
94482969|NCT01249417|323561663|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
94482970|NCT01249417|323561661|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
94482971|NCT01249417|323561662|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
94482972|NCT01249417|323561663|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
94482973|NCT00048035|323561664|FG000|Core Period|Early Withdrawals|4|||
94482974|NCT00048035|323561665|FG001|Core Period|Early Withdrawals|2|||
94482975|NCT00048035|323561666|FG002|Core Period|Early Withdrawals|1|||
94482976|NCT00048035|323561667|FG003|Core Period|Early Withdrawals|1|||
94482977|NCT00048035|323561668|FG004|Core Period|Early Withdrawals|1|||
94482978|NCT00048035|323561669|FG005|Core Period|Early Withdrawals|1|||
94482979|NCT00048035|323561670|FG006|Core Period|Early Withdrawals|0|||
94482980|NCT00048035|323561671|FG007|Core Period|Early Withdrawals|0|||
94482981|NCT00048035|323561664|FG000|Extension Year 1|Early Withdrawals|0|||
94482982|NCT00048035|323561665|FG001|Extension Year 1|Early Withdrawals|0|||
94482983|NCT00048035|323561666|FG002|Extension Year 1|Early Withdrawals|0|||
94482984|NCT00048035|323561667|FG003|Extension Year 1|Early Withdrawals|0|||
94482985|NCT00048035|323561668|FG004|Extension Year 1|Early Withdrawals|0|||
94482986|NCT00048035|323561669|FG005|Extension Year 1|Early Withdrawals|0|||
94482987|NCT00048035|323561670|FG006|Extension Year 1|Early Withdrawals|11|||
94482988|NCT00048035|323561671|FG007|Extension Year 1|Early Withdrawals|11|||
94482989|NCT00048035|323561664|FG000|Extension Year 2|Early Withdrawals|0|||
94482990|NCT00048035|323561665|FG001|Extension Year 2|Early Withdrawals|0|||
94482991|NCT00048035|323561666|FG002|Extension Year 2|Early Withdrawals|0|||
94482992|NCT00048035|323561667|FG003|Extension Year 2|Early Withdrawals|0|||
94482993|NCT00048035|323561668|FG004|Extension Year 2|Early Withdrawals|0|||
94482994|NCT00048035|323561669|FG005|Extension Year 2|Early Withdrawals|0|||
94482995|NCT00048035|323561670|FG006|Extension Year 2|Early Withdrawals|3|||
94482996|NCT00048035|323561671|FG007|Extension Year 2|Early Withdrawals|3|||
94482997|NCT04110314|323561672|FG000|Overall Study|Did not meet inclusion criteria|35255|||
94482998|NCT04110314|323561673|FG001|Overall Study|Did not meet inclusion criteria|35104|||
94482999|NCT04110314|323561674|FG002|Overall Study|Did not meet inclusion criteria|35636|||
94483000|NCT04110314|323561675|FG003|Overall Study|Did not meet inclusion criteria|35135|||
94483001|NCT04110314|323561676|FG004|Overall Study|Did not meet inclusion criteria|35247|||
94483002|NCT04110314|323561677|FG005|Overall Study|Did not meet inclusion criteria|35727|||
94483003|NCT02619617|323561682|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
94483004|NCT02619617|323561683|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
94483005|NCT02619617|323561682|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
94483006|NCT02619617|323561683|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
94483007|NCT02735980|323561684|FG000|Overall Study|Adverse Event|0|||
94483008|NCT02735980|323561685|FG001|Overall Study|Adverse Event|4|||
94483009|NCT02735980|323561686|FG002|Overall Study|Adverse Event|1|||
94483010|NCT02735980|323561684|FG000|Overall Study|Death|5|||
94483011|NCT02735980|323561685|FG001|Overall Study|Death|4|||
94483012|NCT02735980|323561686|FG002|Overall Study|Death|0|||
94483013|NCT02735980|323561684|FG000|Overall Study|Physician Decision|3|||
94483014|NCT02735980|323561685|FG001|Overall Study|Physician Decision|1|||
94483015|NCT02735980|323561686|FG002|Overall Study|Physician Decision|0|||
94483016|NCT02735980|323561684|FG000|Overall Study|Screen failure|1|||
94483017|NCT02735980|323561685|FG001|Overall Study|Screen failure|0|||
94483018|NCT02735980|323561686|FG002|Overall Study|Screen failure|0|||
94483019|NCT02735980|323561684|FG000|Overall Study|Withdrawal by Subject|1|||
94483020|NCT02735980|323561685|FG001|Overall Study|Withdrawal by Subject|2|||
94391522|NCT00396279|323223699|FG000|Overall Study|Physician Decision|1|||
94391523|NCT03447262|323223700|FG000|Overall Study|Adverse Event|7|||
94391524|NCT03447262|323223700|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
94391525|NCT03447262|323223700|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
94391526|NCT03447262|323223700|FG000|Overall Study|Death|2|||
94391527|NCT03447262|323223700|FG000|Overall Study|Study Termination by Sponsor|455|||
94391528|NCT03447262|323223700|FG000|Overall Study|Other|4|||
94391529|NCT00830206|323223701|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
94391530|NCT00830206|323223702|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
94391531|NCT04605094|323223705|FG000|Overall Study|Adverse Event|2|||
94391532|NCT04605094|323223706|FG001|Overall Study|Adverse Event|2|||
94391533|NCT04605094|323223705|FG000|Overall Study|Lost to Follow-up|1|||
94391534|NCT04605094|323223706|FG001|Overall Study|Lost to Follow-up|4|||
94391535|NCT04605094|323223705|FG000|Overall Study|Physician Decision|2|||
94391536|NCT04605094|323223706|FG001|Overall Study|Physician Decision|2|||
94391537|NCT04605094|323223705|FG000|Overall Study|Study terminated by Sponsor|31|||
94391538|NCT04605094|323223706|FG001|Overall Study|Study terminated by Sponsor|33|||
94391539|NCT04605094|323223705|FG000|Overall Study|Withdrawal by Subject|22|||
94391540|NCT04605094|323223706|FG001|Overall Study|Withdrawal by Subject|19|||
94391541|NCT04605094|323223705|FG000|Overall Study|Other|1|||
94391542|NCT04605094|323223706|FG001|Overall Study|Other|1|||
94391543|NCT00469417|323223709|FG000|Overall Study|Treatment failure all lesions|18|||
94391544|NCT00469417|323223710|FG001|Overall Study|Treatment failure all lesions|11|||
94391545|NCT00469417|323223709|FG000|Overall Study|Consent withdrawn|1|||
94391546|NCT00469417|323223710|FG001|Overall Study|Consent withdrawn|1|||
94391547|NCT00469417|323223709|FG000|Overall Study|Adverse Event|8|||
94391548|NCT00469417|323223710|FG001|Overall Study|Adverse Event|2|||
94391549|NCT00469417|323223709|FG000|Overall Study|Lost to Follow-up|1|||
94391550|NCT00469417|323223710|FG001|Overall Study|Lost to Follow-up|2|||
94391551|NCT00469417|323223709|FG000|Overall Study|Intercurrent disease|0|||
94391552|NCT00469417|323223710|FG001|Overall Study|Intercurrent disease|1|||
94391553|NCT00469417|323223709|FG000|Overall Study|Randomized but not treated|2|||
94391554|NCT00469417|323223710|FG001|Overall Study|Randomized but not treated|0|||
94391555|NCT01954394|323223713|FG000|Overall Study|Enrolled but not treated|1|||
94391556|NCT01954394|323223714|FG001|Overall Study|Enrolled but not treated|0|||
94391557|NCT01954394|323223713|FG000|Overall Study|Adverse Event|10|||
94391558|NCT01954394|323223714|FG001|Overall Study|Adverse Event|23|||
94391559|NCT01954394|323223713|FG000|Overall Study|Poor compliance to protocol|7|||
94391560|NCT01954394|323223714|FG001|Overall Study|Poor compliance to protocol|7|||
94391561|NCT01954394|323223713|FG000|Overall Study|Participant Moved|0|||
94391562|NCT01954394|323223714|FG001|Overall Study|Participant Moved|4|||
94391563|NCT01954394|323223713|FG000|Overall Study|Related to Study Drug administration|2|||
94391564|NCT01954394|323223714|FG001|Overall Study|Related to Study Drug administration|2|||
94391565|NCT01954394|323223713|FG000|Overall Study|Other than specified above|10|||
94391566|NCT01954394|323223714|FG001|Overall Study|Other than specified above|21|||
94391567|NCT00909610|323223715|FG000|Period: First Intervention|Adverse Event|0|||
94391568|NCT00909610|323223716|FG001|Period: First Intervention|Adverse Event|1|||
94391569|NCT00909610|323223715|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
94391570|NCT00909610|323223716|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
94391571|NCT00909610|323223715|FG000|Period: Second Intervention|Adverse Event|1|||
94391572|NCT00909610|323223716|FG001|Period: Second Intervention|Adverse Event|0|||
94391573|NCT03874715|323223717|FG000|Overall Study|Adverse Event|2|||
94391574|NCT03874715|323223718|FG001|Overall Study|Adverse Event|0|||
94391575|NCT03874715|323223717|FG000|Overall Study|Poor compliance to protocol|5|||
94391576|NCT03874715|323223718|FG001|Overall Study|Poor compliance to protocol|1|||
94391577|NCT03874715|323223717|FG000|Overall Study|Withdrawal by Subject|1|||
94391578|NCT03874715|323223718|FG001|Overall Study|Withdrawal by Subject|0|||
94391579|NCT03874715|323223717|FG000|Overall Study|Other-unspecified|1|||
94391580|NCT03874715|323223718|FG001|Overall Study|Other-unspecified|0|||
94391581|NCT04123548|323223721|FG000|Overall Study|Withdrawal by Subject|1|||
94391582|NCT04123548|323223721|FG000|Overall Study|Lost to Follow-up|8|||
94391583|NCT04123548|323223721|FG000|Overall Study|Death|4|||
94391584|NCT04123548|323223721|FG000|Overall Study|Reason Not Specified|1|||
94391585|NCT02269657|323223722|FG000|Overall Study|Protocol Violation|3|||
94391586|NCT00851877|323223725|FG000|Phase I-1|Death|1|||
94391587|NCT00851877|323223726|FG001|Phase I-1|Death|0|||
94391588|NCT00851877|323223727|FG002|Phase I-1|Death|0|||
94391589|NCT00851877|323223725|FG000|Phase II|Withdrawal by Subject|0|||
94391590|NCT00851877|323223726|FG001|Phase II|Withdrawal by Subject|0|||
94391591|NCT00851877|323223727|FG002|Phase II|Withdrawal by Subject|3|||
94391592|NCT02822235|323223730|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
94391593|NCT02822235|323223731|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
94391594|NCT02822235|323223730|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
94391595|NCT02822235|323223731|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
94391596|NCT02822235|323223730|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
94391597|NCT02822235|323223731|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
94483021|NCT02735980|323561686|FG002|Overall Study|Withdrawal by Subject|0|||
94483022|NCT00509899|323561687|FG000|Overall Study|Progressive disease|1|||
94483023|NCT00509899|323561688|FG001|Overall Study|Progressive disease|3|||
94483024|NCT00509899|323561689|FG002|Overall Study|Progressive disease|5|||
94483025|NCT00509899|323561690|FG003|Overall Study|Progressive disease|1|||
94483026|NCT00509899|323561691|FG004|Overall Study|Progressive disease|0|||
94483027|NCT00509899|323561692|FG005|Overall Study|Progressive disease|1|||
94483028|NCT00509899|323561693|FG006|Overall Study|Progressive disease|0|||
94483029|NCT00509899|323561694|FG007|Overall Study|Progressive disease|0|||
94483030|NCT00509899|323561687|FG000|Overall Study|Unacceptable Toxicity|1|||
94483031|NCT00509899|323561688|FG001|Overall Study|Unacceptable Toxicity|0|||
94483032|NCT00509899|323561689|FG002|Overall Study|Unacceptable Toxicity|0|||
94483033|NCT00509899|323561690|FG003|Overall Study|Unacceptable Toxicity|2|||
94483034|NCT00509899|323561691|FG004|Overall Study|Unacceptable Toxicity|0|||
94483035|NCT00509899|323561692|FG005|Overall Study|Unacceptable Toxicity|0|||
94483036|NCT00509899|323561693|FG006|Overall Study|Unacceptable Toxicity|0|||
94483037|NCT00509899|323561694|FG007|Overall Study|Unacceptable Toxicity|0|||
94483038|NCT00509899|323561687|FG000|Overall Study|Withdrawal by Subject|6|||
94483039|NCT00509899|323561688|FG001|Overall Study|Withdrawal by Subject|2|||
94483040|NCT00509899|323561689|FG002|Overall Study|Withdrawal by Subject|3|||
94483041|NCT00509899|323561690|FG003|Overall Study|Withdrawal by Subject|0|||
94483042|NCT00509899|323561691|FG004|Overall Study|Withdrawal by Subject|3|||
94483043|NCT00509899|323561692|FG005|Overall Study|Withdrawal by Subject|2|||
94483044|NCT00509899|323561693|FG006|Overall Study|Withdrawal by Subject|0|||
94483045|NCT00509899|323561694|FG007|Overall Study|Withdrawal by Subject|0|||
94483046|NCT00509899|323561687|FG000|Overall Study|Physician Decision|4|||
94483047|NCT00509899|323561688|FG001|Overall Study|Physician Decision|2|||
94483048|NCT00509899|323561689|FG002|Overall Study|Physician Decision|7|||
94483049|NCT00509899|323561690|FG003|Overall Study|Physician Decision|0|||
94483050|NCT00509899|323561691|FG004|Overall Study|Physician Decision|1|||
94483051|NCT00509899|323561692|FG005|Overall Study|Physician Decision|4|||
94483052|NCT00509899|323561693|FG006|Overall Study|Physician Decision|0|||
94483053|NCT00509899|323561694|FG007|Overall Study|Physician Decision|0|||
94483054|NCT00509899|323561687|FG000|Overall Study|Intercurrent Illness|1|||
94483055|NCT00509899|323561688|FG001|Overall Study|Intercurrent Illness|0|||
94483056|NCT00509899|323561689|FG002|Overall Study|Intercurrent Illness|0|||
94483057|NCT00509899|323561690|FG003|Overall Study|Intercurrent Illness|1|||
94483058|NCT00509899|323561691|FG004|Overall Study|Intercurrent Illness|0|||
94483059|NCT00509899|323561692|FG005|Overall Study|Intercurrent Illness|1|||
94483060|NCT00509899|323561693|FG006|Overall Study|Intercurrent Illness|0|||
94483061|NCT00509899|323561694|FG007|Overall Study|Intercurrent Illness|0|||
94483062|NCT00509899|323561687|FG000|Overall Study|Death|2|||
94483063|NCT00509899|323561688|FG001|Overall Study|Death|2|||
94483064|NCT00509899|323561689|FG002|Overall Study|Death|3|||
94483065|NCT00509899|323561690|FG003|Overall Study|Death|0|||
94483066|NCT00509899|323561691|FG004|Overall Study|Death|1|||
94483067|NCT00509899|323561692|FG005|Overall Study|Death|1|||
94483068|NCT00509899|323561693|FG006|Overall Study|Death|1|||
94483069|NCT00509899|323561694|FG007|Overall Study|Death|1|||
94483070|NCT00509899|323561687|FG000|Overall Study|Lack of Efficacy|1|||
94483071|NCT00509899|323561688|FG001|Overall Study|Lack of Efficacy|0|||
94483072|NCT00509899|323561689|FG002|Overall Study|Lack of Efficacy|2|||
94483073|NCT00509899|323561690|FG003|Overall Study|Lack of Efficacy|0|||
94483074|NCT00509899|323561691|FG004|Overall Study|Lack of Efficacy|0|||
94483075|NCT00509899|323561692|FG005|Overall Study|Lack of Efficacy|1|||
94483076|NCT00509899|323561693|FG006|Overall Study|Lack of Efficacy|0|||
94483077|NCT00509899|323561694|FG007|Overall Study|Lack of Efficacy|0|||
94483078|NCT02948829|323561697|FG000|Overall Study|Lost to Follow-up|2|||
94483079|NCT02948829|323561697|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
94483080|NCT02948829|323561697|FG000|Overall Study|Pregnancy|1|||
94483081|NCT02948829|323561697|FG000|Overall Study|Other: Reason not Specified|8|||
94483082|NCT02515630|323561706|FG000|Overall Study|Withdrawal by Subject|5|||
94483083|NCT02515630|323561706|FG000|Overall Study|Adverse Event|4|||
94483084|NCT02515630|323561706|FG000|Overall Study|Physician Decision|4|||
94483085|NCT02515630|323561706|FG000|Overall Study|Death|2|||
94483086|NCT02515630|323561706|FG000|Overall Study|Disease Progression|1|||
94483087|NCT01001910|323561707|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
94483088|NCT03669549|323561712|FG000|Overall Study|Adverse Event|4|||
94483089|NCT03669549|323561712|FG000|Overall Study|Withdrawal by Subject|1|||
94483090|NCT03669549|323561712|FG000|Overall Study|Study terminated by the Sponsor|1|||
94483091|NCT02219685|323561713|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
94483092|NCT02219685|323561714|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
94483093|NCT02219685|323561713|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
94483094|NCT02219685|323561714|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
94483095|NCT00698815|323561715|FG000|Overall Study|Death|1|||
94483096|NCT00698815|323561716|FG001|Overall Study|Death|2|||
94483097|NCT00698815|323561717|FG002|Overall Study|Death|4|||
94483098|NCT00698815|323561715|FG000|Overall Study|Withdrawal by Subject|6|||
94483099|NCT00698815|323561716|FG001|Overall Study|Withdrawal by Subject|3|||
94483100|NCT00698815|323561717|FG002|Overall Study|Withdrawal by Subject|2|||
94483101|NCT00698815|323561715|FG000|Overall Study|MD discretion|2|||
94483102|NCT00698815|323561716|FG001|Overall Study|MD discretion|7|||
94483103|NCT00698815|323561717|FG002|Overall Study|MD discretion|2|||
94483104|NCT00698815|323561715|FG000|Overall Study|Did not receive protocol treatment|1|||
94483105|NCT00698815|323561716|FG001|Overall Study|Did not receive protocol treatment|2|||
94483106|NCT00698815|323561717|FG002|Overall Study|Did not receive protocol treatment|2|||
94483107|NCT01701245|323561723|FG000|Overall Study|Protocol Violation|1|||
94483108|NCT01701245|323561724|FG001|Overall Study|Protocol Violation|3|||
94483109|NCT01701245|323561723|FG000|Overall Study|Did not complete the open label period|11|||
94483110|NCT01701245|323561724|FG001|Overall Study|Did not complete the open label period|12|||
94483111|NCT02567188|323561725|FG000|Overall Study|Death|10|||
94483112|NCT02567188|323561725|FG000|Overall Study|Terminated Mircera Treatment|9|||
94483113|NCT02567188|323561725|FG000|Overall Study|Lost to Follow-up|5|||
94483114|NCT02567188|323561725|FG000|Overall Study|Adverse Event|1|||
94483115|NCT02567188|323561725|FG000|Overall Study|Withdrawal by Subject|1|||
94483116|NCT02567188|323561725|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
94483117|NCT02567188|323561725|FG000|Overall Study|Moved and Changed Clinic|1|||
94328536|NCT01309841|322982687|FG002|Overall Study|Other|1|||
94328537|NCT01309841|322982685|FG000|Overall Study|Lost to Follow-up|7|||
94328538|NCT01309841|322982686|FG001|Overall Study|Lost to Follow-up|6|||
94328539|NCT01309841|322982687|FG002|Overall Study|Lost to Follow-up|4|||
94328540|NCT01309841|322982685|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
94328541|NCT01309841|322982686|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
94328542|NCT01309841|322982687|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
94328543|NCT01309841|322982685|FG000|Overall Study|Lack of Efficacy|0|||
94328544|NCT01309841|322982686|FG001|Overall Study|Lack of Efficacy|0|||
94328545|NCT01309841|322982687|FG002|Overall Study|Lack of Efficacy|2|||
94328546|NCT01309841|322982685|FG000|Overall Study|Adverse Event|9|||
94328547|NCT01309841|322982686|FG001|Overall Study|Adverse Event|22|||
94328548|NCT01309841|322982687|FG002|Overall Study|Adverse Event|11|||
94328549|NCT01309841|322982685|FG000|Overall Study|Death|1|||
94328550|NCT01309841|322982686|FG001|Overall Study|Death|0|||
94328551|NCT01309841|322982687|FG002|Overall Study|Death|0|||
94328552|NCT01309841|322982685|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
94328553|NCT01309841|322982686|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
94328554|NCT01309841|322982687|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
94328555|NCT01309841|322982685|FG000|Overall Study|Withdrawal by Subject|17|||
94328556|NCT01309841|322982686|FG001|Overall Study|Withdrawal by Subject|6|||
94328557|NCT01309841|322982687|FG002|Overall Study|Withdrawal by Subject|13|||
94328558|NCT01309841|322982685|FG000|Overall Study|Did Not Receive Treatment|2|||
94328559|NCT01309841|322982686|FG001|Overall Study|Did Not Receive Treatment|0|||
94328560|NCT01309841|322982687|FG002|Overall Study|Did Not Receive Treatment|1|||
94328561|NCT01309841|322982685|FG000|Overall Study|Severe non-compliance with protocol|0|||
94328562|NCT01309841|322982686|FG001|Overall Study|Severe non-compliance with protocol|5|||
94328563|NCT01309841|322982687|FG002|Overall Study|Severe non-compliance with protocol|2|||
94328564|NCT01153893|322982688|FG000|Overall Study|Adverse Event|1|||
94328565|NCT01153893|322982689|FG001|Overall Study|Adverse Event|0|||
94328566|NCT00050960|322982690|FG000|Overall Study|Progressive Disease|137|||
94328567|NCT00050960|322982691|FG001|Overall Study|Progressive Disease|93|||
94328568|NCT00050960|322982690|FG000|Overall Study|Stable Disease|19|||
94328569|NCT00050960|322982691|FG001|Overall Study|Stable Disease|48|||
94328570|NCT00050960|322982690|FG000|Overall Study|Partial Response|14|||
94328571|NCT00050960|322982691|FG001|Overall Study|Partial Response|19|||
94328572|NCT00050960|322982690|FG000|Overall Study|Complete Response|0|||
94328573|NCT00050960|322982691|FG001|Overall Study|Complete Response|2|||
94328574|NCT00050960|322982690|FG000|Overall Study|Adverse Event|62|||
94328575|NCT00050960|322982691|FG001|Overall Study|Adverse Event|61|||
94328576|NCT00050960|322982690|FG000|Overall Study|Lost to Follow-up|0|||
94328577|NCT00050960|322982691|FG001|Overall Study|Lost to Follow-up|1|||
94328578|NCT00050960|322982690|FG000|Overall Study|Withdrawal by Subject|23|||
94328579|NCT00050960|322982691|FG001|Overall Study|Withdrawal by Subject|18|||
94328580|NCT00050960|322982690|FG000|Overall Study|Administrative|31|||
94328581|NCT00050960|322982691|FG001|Overall Study|Administrative|46|||
94328582|NCT00050960|322982690|FG000|Overall Study|Non-compliance|3|||
94328583|NCT00050960|322982691|FG001|Overall Study|Non-compliance|1|||
94328584|NCT00050960|322982690|FG000|Overall Study|Death|13|||
94328585|NCT00050960|322982691|FG001|Overall Study|Death|15|||
94328586|NCT00305604|322982692|FG000|Overall Study|Adverse Event|6|||
94328587|NCT00305604|322982693|FG001|Overall Study|Adverse Event|3|||
94328588|NCT00305604|322982692|FG000|Overall Study|Lack of Efficacy|11|||
94328589|NCT00305604|322982693|FG001|Overall Study|Lack of Efficacy|18|||
94328590|NCT00305604|322982692|FG000|Overall Study|Lost to Follow-up|0|||
94328591|NCT00305604|322982693|FG001|Overall Study|Lost to Follow-up|4|||
94328592|NCT00305604|322982692|FG000|Overall Study|Protocol Violation|2|||
94328593|NCT00305604|322982693|FG001|Overall Study|Protocol Violation|1|||
94328594|NCT00305604|322982692|FG000|Overall Study|Withdrawal by Subject|12|||
94483118|NCT02567188|323561725|FG000|Overall Study|Started Hemodialysis|2|||
94483119|NCT02567188|323561725|FG000|Overall Study|Protocol Violation|5|||
94483120|NCT02718911|323561733|FG000|Overall Study|Adverse Event|0|||
94483121|NCT02718911|323561734|FG001|Overall Study|Adverse Event|0|||
94483122|NCT02718911|323561735|FG002|Overall Study|Adverse Event|0|||
94483123|NCT02718911|323561736|FG003|Overall Study|Adverse Event|0|||
94483124|NCT02718911|323561737|FG004|Overall Study|Adverse Event|0|||
94483125|NCT02718911|323561738|FG005|Overall Study|Adverse Event|0|||
94483126|NCT02718911|323561739|FG006|Overall Study|Adverse Event|0|||
94483127|NCT02718911|323561740|FG007|Overall Study|Adverse Event|0|||
94483128|NCT02718911|323561741|FG008|Overall Study|Adverse Event|0|||
94483129|NCT02718911|323561742|FG009|Overall Study|Adverse Event|2|||
94483130|NCT02718911|323561733|FG000|Overall Study|Death|2|||
94483131|NCT02718911|323561734|FG001|Overall Study|Death|3|||
94483132|NCT02718911|323561735|FG002|Overall Study|Death|1|||
94483133|NCT02718911|323561736|FG003|Overall Study|Death|0|||
94483134|NCT02718911|323561737|FG004|Overall Study|Death|1|||
94483135|NCT02718911|323561738|FG005|Overall Study|Death|3|||
94483136|NCT02718911|323561739|FG006|Overall Study|Death|1|||
94483137|NCT02718911|323561740|FG007|Overall Study|Death|1|||
94483138|NCT02718911|323561741|FG008|Overall Study|Death|4|||
94483139|NCT02718911|323561742|FG009|Overall Study|Death|3|||
94483140|NCT02718911|323561733|FG000|Overall Study|Lost to Follow-up|0|||
94483141|NCT02718911|323561734|FG001|Overall Study|Lost to Follow-up|0|||
94483142|NCT02718911|323561735|FG002|Overall Study|Lost to Follow-up|0|||
94483143|NCT02718911|323561736|FG003|Overall Study|Lost to Follow-up|0|||
94483144|NCT02718911|323561737|FG004|Overall Study|Lost to Follow-up|0|||
94483145|NCT02718911|323561738|FG005|Overall Study|Lost to Follow-up|0|||
94483146|NCT02718911|323561739|FG006|Overall Study|Lost to Follow-up|0|||
94483147|NCT02718911|323561740|FG007|Overall Study|Lost to Follow-up|0|||
94483148|NCT02718911|323561741|FG008|Overall Study|Lost to Follow-up|1|||
94483149|NCT02718911|323561742|FG009|Overall Study|Lost to Follow-up|0|||
94483150|NCT02718911|323561733|FG000|Overall Study|Physician Decision|2|||
94483151|NCT02718911|323561734|FG001|Overall Study|Physician Decision|0|||
94483152|NCT02718911|323561735|FG002|Overall Study|Physician Decision|1|||
94483153|NCT02718911|323561736|FG003|Overall Study|Physician Decision|1|||
94483154|NCT02718911|323561737|FG004|Overall Study|Physician Decision|0|||
94483155|NCT02718911|323561738|FG005|Overall Study|Physician Decision|0|||
94483156|NCT02718911|323561739|FG006|Overall Study|Physician Decision|0|||
94483157|NCT02718911|323561740|FG007|Overall Study|Physician Decision|1|||
94483158|NCT02718911|323561741|FG008|Overall Study|Physician Decision|2|||
94483159|NCT02718911|323561742|FG009|Overall Study|Physician Decision|1|||
94483160|NCT02718911|323561733|FG000|Overall Study|Withdrawal by Subject|0|||
94483161|NCT02718911|323561734|FG001|Overall Study|Withdrawal by Subject|0|||
94483162|NCT02718911|323561735|FG002|Overall Study|Withdrawal by Subject|0|||
94483163|NCT02718911|323561736|FG003|Overall Study|Withdrawal by Subject|0|||
94483164|NCT02718911|323561737|FG004|Overall Study|Withdrawal by Subject|1|||
94483165|NCT02718911|323561738|FG005|Overall Study|Withdrawal by Subject|0|||
94483166|NCT02718911|323561739|FG006|Overall Study|Withdrawal by Subject|0|||
94483167|NCT02718911|323561740|FG007|Overall Study|Withdrawal by Subject|0|||
94483168|NCT02718911|323561741|FG008|Overall Study|Withdrawal by Subject|1|||
94483169|NCT02718911|323561742|FG009|Overall Study|Withdrawal by Subject|4|||
94483170|NCT02718911|323561733|FG000|Overall Study|Reason Not Collected|0|||
94483171|NCT02718911|323561734|FG001|Overall Study|Reason Not Collected|0|||
94483172|NCT02718911|323561735|FG002|Overall Study|Reason Not Collected|1|||
94483173|NCT02718911|323561736|FG003|Overall Study|Reason Not Collected|0|||
94483174|NCT02718911|323561737|FG004|Overall Study|Reason Not Collected|0|||
94483175|NCT02718911|323561738|FG005|Overall Study|Reason Not Collected|0|||
94483176|NCT02718911|323561739|FG006|Overall Study|Reason Not Collected|2|||
94483177|NCT02718911|323561740|FG007|Overall Study|Reason Not Collected|1|||
94483178|NCT02718911|323561741|FG008|Overall Study|Reason Not Collected|4|||
94483179|NCT02718911|323561742|FG009|Overall Study|Reason Not Collected|9|||
94483180|NCT04817332|323561743|FG000|Overall Study|Lost to Follow-up|3|||
94483181|NCT04817332|323561744|FG001|Overall Study|Lost to Follow-up|3|||
94483182|NCT04817332|323561743|FG000|Overall Study|Protocol Violation|2|||
94483183|NCT04817332|323561744|FG001|Overall Study|Protocol Violation|0|||
94483184|NCT01172873|323561747|FG000|Overall Study|Withdrawal by Subject|3|||
94483185|NCT01172873|323561748|FG001|Overall Study|Withdrawal by Subject|2|||
94483186|NCT04795466|323561749|FG000|Overall Study|Adverse Event|3|||
94483187|NCT04795466|323561750|FG001|Overall Study|Adverse Event|1|||
94483188|NCT04795466|323561749|FG000|Overall Study|Physician Decision|1|||
94483189|NCT04795466|323561750|FG001|Overall Study|Physician Decision|0|||
94483190|NCT04795466|323561749|FG000|Overall Study|Withdrawal by Subject|2|||
94483191|NCT04795466|323561750|FG001|Overall Study|Withdrawal by Subject|1|||
94483192|NCT01038687|323561753|FG000|Overall Study|Adverse Event|0|||
94483193|NCT01038687|323561754|FG001|Overall Study|Adverse Event|2|||
94483194|NCT01038687|323561755|FG002|Overall Study|Adverse Event|1|||
94483195|NCT03589807|323561756|FG000|Overall Study|Lost to Follow-up|0|||
94483196|NCT03589807|323561757|FG001|Overall Study|Lost to Follow-up|2|||
94483197|NCT03589807|323561758|FG002|Overall Study|Lost to Follow-up|2|||
94483198|NCT03589807|323561759|FG003|Overall Study|Lost to Follow-up|3|||
94483199|NCT03589807|323561760|FG004|Overall Study|Lost to Follow-up|1|||
94483200|NCT03589807|323561761|FG005|Overall Study|Lost to Follow-up|1|||
94483201|NCT03589807|323561756|FG000|Overall Study|Withdrawal by Subject|0|||
94483202|NCT03589807|323561757|FG001|Overall Study|Withdrawal by Subject|5|||
94483203|NCT03589807|323561758|FG002|Overall Study|Withdrawal by Subject|0|||
94483204|NCT03589807|323561759|FG003|Overall Study|Withdrawal by Subject|0|||
94483205|NCT03589807|323561760|FG004|Overall Study|Withdrawal by Subject|0|||
94483206|NCT03589807|323561761|FG005|Overall Study|Withdrawal by Subject|0|||
94483207|NCT03589807|323561756|FG000|Overall Study|Protocol Violation|0|||
94483208|NCT03589807|323561757|FG001|Overall Study|Protocol Violation|0|||
94483209|NCT03589807|323561758|FG002|Overall Study|Protocol Violation|0|||
94483210|NCT03589807|323561759|FG003|Overall Study|Protocol Violation|1|||
94483211|NCT03589807|323561760|FG004|Overall Study|Protocol Violation|0|||
94483212|NCT03589807|323561761|FG005|Overall Study|Protocol Violation|0|||
94483213|NCT03589807|323561756|FG000|Overall Study|Enrolled but treatment not administered|0|||
94483214|NCT03589807|323561757|FG001|Overall Study|Enrolled but treatment not administered|0|||
94483215|NCT03589807|323561758|FG002|Overall Study|Enrolled but treatment not administered|0|||
94483216|NCT03589807|323561759|FG003|Overall Study|Enrolled but treatment not administered|0|||
94483217|NCT03589807|323561760|FG004|Overall Study|Enrolled but treatment not administered|1|||
94483218|NCT03589807|323561761|FG005|Overall Study|Enrolled but treatment not administered|0|||
94483219|NCT01076543|323561762|FG000|Overall Study|Withdrawal by Subject|2|||
94483220|NCT01076543|323561763|FG001|Overall Study|Withdrawal by Subject|0|||
94483221|NCT01076543|323561764|FG002|Overall Study|Withdrawal by Subject|0|||
94483222|NCT01076543|323561765|FG003|Overall Study|Withdrawal by Subject|0|||
94483223|NCT01076543|323561766|FG004|Overall Study|Withdrawal by Subject|0|||
94483224|NCT01076543|323561767|FG005|Overall Study|Withdrawal by Subject|0|||
94483225|NCT04396626|323561770|FG000|Overall Study|Premature termination of study|975|||
94483226|NCT02616783|323561783|FG000|Overall Study|Randomized but Not Treated|1|||
94483227|NCT02616783|323561784|FG001|Overall Study|Randomized but Not Treated|0|||
94483228|NCT02616783|323561783|FG000|Overall Study|Adverse Event|1|||
94483229|NCT02616783|323561784|FG001|Overall Study|Adverse Event|0|||
94483230|NCT02616783|323561783|FG000|Overall Study|Death|1|||
94483231|NCT02616783|323561784|FG001|Overall Study|Death|0|||
94483232|NCT02616783|323561783|FG000|Overall Study|Non-Compliance with Study Drug|1|||
94483233|NCT02616783|323561784|FG001|Overall Study|Non-Compliance with Study Drug|0|||
94483234|NCT02616783|323561783|FG000|Overall Study|Protocol Violation|1|||
94483235|NCT02616783|323561784|FG001|Overall Study|Protocol Violation|1|||
94483236|NCT02616783|323561783|FG000|Overall Study|Withdrew Consent|1|||
94483237|NCT02616783|323561784|FG001|Overall Study|Withdrew Consent|1|||
94483238|NCT00072410|323561785|FG000|Overall Study|Progressive disease|0|||
94483239|NCT00072410|323561786|FG001|Overall Study|Progressive disease|3|||
94483240|NCT01091246|323561787|FG000|Overall Study|Lost to Follow-up|23|||
94483241|NCT01091246|323561788|FG001|Overall Study|Lost to Follow-up|11|||
94483242|NCT01091246|323561789|FG002|Overall Study|Lost to Follow-up|7|||
94483243|NCT01091246|323561787|FG000|Overall Study|Adverse Event|1|||
94483244|NCT01091246|323561788|FG001|Overall Study|Adverse Event|0|||
94483245|NCT01091246|323561789|FG002|Overall Study|Adverse Event|1|||
94483246|NCT01091246|323561787|FG000|Overall Study|Withdrawal by Subject|9|||
94483247|NCT01091246|323561788|FG001|Overall Study|Withdrawal by Subject|5|||
94483248|NCT01091246|323561789|FG002|Overall Study|Withdrawal by Subject|4|||
94483249|NCT01091246|323561787|FG000|Overall Study|Subject not dosed|2|||
94483250|NCT01091246|323561788|FG001|Overall Study|Subject not dosed|0|||
94483251|NCT01091246|323561789|FG002|Overall Study|Subject not dosed|1|||
94483252|NCT00931632|323561797|FG000|Overall Study|Withdrawal by Subject|2|||
94483253|NCT00931632|323561798|FG001|Overall Study|Withdrawal by Subject|3|||
94483254|NCT00931632|323561797|FG000|Overall Study|Adverse Event|19|||
94483255|NCT00931632|323561798|FG001|Overall Study|Adverse Event|15|||
94483256|NCT01419314|323561799|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
94483257|NCT01419314|323561800|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
94483258|NCT01419314|323561799|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
94483259|NCT01419314|323561800|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
94483260|NCT01419314|323561799|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
94483261|NCT01419314|323561800|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
94483262|NCT03528551|323561804|FG000|Overall Study|Lost to Follow-up|0|||
94483263|NCT03528551|323561805|FG001|Overall Study|Lost to Follow-up|1|||
94483264|NCT03528551|323561806|FG002|Overall Study|Lost to Follow-up|0|||
94483265|NCT03528551|323561804|FG000|Overall Study|Transferred to other arm/group|2|||
94483266|NCT03528551|323561805|FG001|Overall Study|Transferred to other arm/group|3|||
94483267|NCT03528551|323561806|FG002|Overall Study|Transferred to other arm/group|0|||
94483268|NCT03528551|323561804|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94483269|NCT03528551|323561805|FG001|Overall Study|Withdrawal by parent/guardian|5|||
94483270|NCT03528551|323561806|FG002|Overall Study|Withdrawal by parent/guardian|0|||
94483271|NCT03528551|323561804|FG000|Overall Study|Protocol Violation|0|||
94483272|NCT03528551|323561805|FG001|Overall Study|Protocol Violation|3|||
94483273|NCT03528551|323561806|FG002|Overall Study|Protocol Violation|0|||
94483274|NCT03528551|323561804|FG000|Overall Study|Withdrawal by Subject|0|||
94483275|NCT03528551|323561805|FG001|Overall Study|Withdrawal by Subject|7|||
94483276|NCT03528551|323561806|FG002|Overall Study|Withdrawal by Subject|0|||
94483277|NCT00808067|323561807|FG000|Overall Study|Major/minor bleed|30|||
94483278|NCT00808067|323561808|FG001|Overall Study|Major/minor bleed|44|||
94483279|NCT00808067|323561807|FG000|Overall Study|Outcome event - other|33|||
94483280|NCT00808067|323561808|FG001|Overall Study|Outcome event - other|25|||
94483281|NCT00808067|323561807|FG000|Overall Study|Adverse Event|111|||
94483282|NCT00808067|323561808|FG001|Overall Study|Adverse Event|121|||
94483283|NCT00808067|323561807|FG000|Overall Study|Hospitalization (not including surgery)|18|||
94483284|NCT00808067|323561808|FG001|Overall Study|Hospitalization (not including surgery)|17|||
94483285|NCT00808067|323561807|FG000|Overall Study|Hospitalization due to surgery|37|||
94483286|NCT00808067|323561808|FG001|Overall Study|Hospitalization due to surgery|40|||
94483287|NCT00808067|323561807|FG000|Overall Study|Reduced creatinine clearance|53|||
94483288|NCT00808067|323561808|FG001|Overall Study|Reduced creatinine clearance|55|||
94483289|NCT00808067|323561807|FG000|Overall Study|Elevated LFT results|7|||
94483290|NCT00808067|323561808|FG001|Overall Study|Elevated LFT results|3|||
94483291|NCT00808067|323561807|FG000|Overall Study|Patient refused to take study medication|65|||
94483292|NCT00808067|323561808|FG001|Overall Study|Patient refused to take study medication|76|||
94483293|NCT00808067|323561807|FG000|Overall Study|Missing|1|||
94483294|NCT00808067|323561808|FG001|Overall Study|Missing|0|||
94483295|NCT00808067|323561807|FG000|Overall Study|Death|1|||
94483296|NCT00808067|323561808|FG001|Overall Study|Death|1|||
94483297|NCT00808067|323561807|FG000|Overall Study|Procedure|6|||
94483298|NCT00808067|323561808|FG001|Overall Study|Procedure|7|||
94483299|NCT00808067|323561807|FG000|Overall Study|Withdrawal by Subject|21|||
94483300|NCT00808067|323561808|FG001|Overall Study|Withdrawal by Subject|25|||
94483301|NCT00808067|323561807|FG000|Overall Study|Site closed|4|||
94483302|NCT00808067|323561808|FG001|Overall Study|Site closed|3|||
94483303|NCT00808067|323561807|FG000|Overall Study|Physician Decision|47|||
94483304|NCT00808067|323561808|FG001|Overall Study|Physician Decision|38|||
94391598|NCT02822235|323223730|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
94391599|NCT02822235|323223731|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
94391600|NCT02822235|323223730|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
94391601|NCT02822235|323223731|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
94391602|NCT02822235|323223730|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
94391603|NCT02822235|323223731|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
94391604|NCT02246166|323223737|FG000|Overall Study|Protocol Violation|1|||
94391605|NCT02246166|323223738|FG001|Overall Study|Protocol Violation|0|||
94391606|NCT00707161|323223746|FG000|Overall Study|Physician Decision|6|||
94391607|NCT00004562|323223747|FG000|Overall Study|Lost to Follow-up|102|||
94391608|NCT00004562|323223748|FG001|Overall Study|Lost to Follow-up|91|||
94391609|NCT02770820|323223749|FG000|Overall Study|Death|1|||
94391610|NCT02770820|323223749|FG000|Overall Study|Physician Decision|2|||
94391611|NCT00696020|323223750|FG000|Overall Study|Adverse Event|3|||
94391612|NCT00696020|323223751|FG001|Overall Study|Adverse Event|1|||
94391613|NCT00696020|323223752|FG002|Overall Study|Adverse Event|2|||
94391614|NCT00696020|323223753|FG003|Overall Study|Adverse Event|1|||
94391615|NCT00696020|323223750|FG000|Overall Study|Lack of Efficacy|1|||
94391616|NCT00696020|323223751|FG001|Overall Study|Lack of Efficacy|0|||
94391617|NCT00696020|323223752|FG002|Overall Study|Lack of Efficacy|0|||
94391618|NCT00696020|323223753|FG003|Overall Study|Lack of Efficacy|0|||
94391619|NCT00696020|323223750|FG000|Overall Study|Protocol Violation|0|||
94391620|NCT00696020|323223751|FG001|Overall Study|Protocol Violation|0|||
94391621|NCT00696020|323223752|FG002|Overall Study|Protocol Violation|0|||
94391622|NCT00696020|323223753|FG003|Overall Study|Protocol Violation|1|||
94391623|NCT00696020|323223750|FG000|Overall Study|Withdrawal by Subject|0|||
94391624|NCT00696020|323223751|FG001|Overall Study|Withdrawal by Subject|1|||
94391625|NCT00696020|323223752|FG002|Overall Study|Withdrawal by Subject|0|||
94483305|NCT00808067|323561807|FG000|Overall Study|Protocol Violation|3|||
94483306|NCT00808067|323561808|FG001|Overall Study|Protocol Violation|11|||
94483307|NCT00808067|323561807|FG000|Overall Study|Patient elected|7|||
94391626|NCT00696020|323223753|FG003|Overall Study|Withdrawal by Subject|1|||
94391627|NCT00696020|323223750|FG000|Overall Study|Other not stated above|0|||
94391628|NCT00696020|323223751|FG001|Overall Study|Other not stated above|0|||
94391629|NCT00696020|323223752|FG002|Overall Study|Other not stated above|1|||
94391630|NCT00696020|323223753|FG003|Overall Study|Other not stated above|1|||
94391631|NCT04274686|323223756|FG000|Overall Study|Physician Decision|1|||
94391632|NCT04274686|323223757|FG001|Overall Study|Physician Decision|0|||
94391633|NCT03627091|323223758|FG000|Overall Study|Adverse Event|0|||
94391634|NCT03627091|323223759|FG001|Overall Study|Adverse Event|0|||
94391635|NCT03627091|323223760|FG002|Overall Study|Adverse Event|2|||
94391636|NCT03627091|323223758|FG000|Overall Study|Withdrawal by Subject|2|||
94483308|NCT00808067|323561808|FG001|Overall Study|Patient elected|9|||
94483309|NCT00808067|323561807|FG000|Overall Study|Site closed for cause|19|||
94483310|NCT00808067|323561808|FG001|Overall Study|Site closed for cause|19|||
94483311|NCT00808067|323561807|FG000|Overall Study|Other reason not defined above|5|||
94483312|NCT00808067|323561808|FG001|Overall Study|Other reason not defined above|5|||
94483313|NCT00808067|323561807|FG000|Overall Study|Excluded from analysis|13|||
94483314|NCT00808067|323561808|FG001|Overall Study|Excluded from analysis|19|||
94483315|NCT00689338|323561809|FG000|Overall Study|Death|65|||
94483316|NCT00689338|323561809|FG000|Overall Study|Adverse Event|13|||
94483317|NCT00689338|323561809|FG000|Overall Study|Insufficient Clinical Response|1|||
94483318|NCT00689338|323561809|FG000|Overall Study|Lack of Efficacy|6|||
94483319|NCT00689338|323561809|FG000|Overall Study|Other|8|||
94483320|NCT00689338|323561809|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
94483321|NCT00689338|323561809|FG000|Overall Study|Lost to Follow-up|5|||
94483322|NCT00689338|323561809|FG000|Overall Study|Withdrawal by Subject|3|||
94483323|NCT00689338|323561809|FG000|Overall Study|Protocol Violation|15|||
94483324|NCT03644017|323561810|FG000|Overall Study|Access Abandonment|5|||
94483325|NCT03644017|323561810|FG000|Overall Study|Kidney Transplant|2|||
94391637|NCT03627091|323223759|FG001|Overall Study|Withdrawal by Subject|0|||
94483326|NCT01107925|323561812|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
94391638|NCT03627091|323223760|FG002|Overall Study|Withdrawal by Subject|2|||
94391639|NCT03627091|323223758|FG000|Overall Study|Physician Decision|2|||
94391640|NCT03627091|323223759|FG001|Overall Study|Physician Decision|0|||
94391641|NCT03627091|323223760|FG002|Overall Study|Physician Decision|0|||
94391642|NCT03627091|323223758|FG000|Overall Study|Site terminated by sponsor|0|||
94391643|NCT03627091|323223759|FG001|Overall Study|Site terminated by sponsor|1|||
94391644|NCT03627091|323223760|FG002|Overall Study|Site terminated by sponsor|0|||
94391645|NCT03627091|323223758|FG000|Overall Study|Disease relapse|7|||
94391646|NCT03627091|323223759|FG001|Overall Study|Disease relapse|5|||
94391647|NCT03627091|323223760|FG002|Overall Study|Disease relapse|1|||
94391648|NCT03627091|323223758|FG000|Overall Study|Other|1|||
94391649|NCT03627091|323223759|FG001|Overall Study|Other|0|||
94391650|NCT03627091|323223760|FG002|Overall Study|Other|0|||
94391651|NCT02193165|323223763|FG000|4 Week Product Use|Lost to Follow-up|1|||
94391652|NCT02193165|323223764|FG001|4 Week Product Use|Lost to Follow-up|1|||
94391653|NCT02193165|323223765|FG002|4 Week Product Use|Lost to Follow-up|1|||
94391654|NCT02193165|323223763|FG000|6 Week Product Use|Lost to Follow-up|0|||
94391655|NCT02193165|323223764|FG001|6 Week Product Use|Lost to Follow-up|1|||
94391656|NCT02193165|323223765|FG002|6 Week Product Use|Lost to Follow-up|0|||
94391657|NCT01745120|323223766|FG000|Overall Study|Investigator decision|1|||
94391658|NCT01745120|323223767|FG001|Overall Study|Investigator decision|0|||
94391659|NCT01118312|323223768|FG000|Overall Study|Lost to Follow-up|33|||
94391660|NCT01118312|323223769|FG001|Overall Study|Lost to Follow-up|32|||
94391661|NCT01118312|323223768|FG000|Overall Study|Withdrawal by Subject|1|||
94391662|NCT01118312|323223769|FG001|Overall Study|Withdrawal by Subject|3|||
94391663|NCT01667679|323223771|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
94391664|NCT01667679|323223772|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
94391665|NCT01667679|323223771|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
94391666|NCT01667679|323223772|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
94391667|NCT01667679|323223771|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
94391668|NCT01667679|323223772|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
94391669|NCT01667679|323223771|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
94391670|NCT01667679|323223772|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
94391671|NCT01667679|323223771|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
94391672|NCT01667679|323223772|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
94391673|NCT01667679|323223771|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
94391674|NCT01667679|323223772|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
94391675|NCT01667679|323223771|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
94391676|NCT01667679|323223772|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
94391677|NCT01667679|323223771|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
94391678|NCT01667679|323223772|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
94391679|NCT01667679|323223771|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
94391680|NCT01667679|323223772|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
94391681|NCT01667679|323223771|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
94391682|NCT01667679|323223772|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
94391683|NCT01667679|323223771|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
94391684|NCT01667679|323223772|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
94391685|NCT01667679|323223771|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
94391686|NCT01667679|323223772|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
94391687|NCT01667679|323223771|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
94391688|NCT01667679|323223772|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
94391689|NCT01667679|323223771|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
94391690|NCT01667679|323223772|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
94391691|NCT01667679|323223771|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
94391692|NCT01667679|323223772|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
94483327|NCT01107925|323561813|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
94391693|NCT01667679|323223771|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
94391694|NCT01667679|323223772|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
94391695|NCT01667679|323223771|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
94391696|NCT01667679|323223772|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
94391697|NCT01667679|323223771|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
94391698|NCT01667679|323223772|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
94391699|NCT01667679|323223771|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
94391700|NCT01667679|323223772|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
94391701|NCT01667679|323223771|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
94391702|NCT01667679|323223772|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
94391703|NCT01667679|323223771|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
94391704|NCT01667679|323223772|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
94391705|NCT00986245|323223773|FG000|First Intervention|Poor compliance|8|||
94391706|NCT00986245|323223774|FG001|First Intervention|Poor compliance|4|||
94391707|NCT00986245|323223773|FG000|First Intervention|Lack of Efficacy|1|||
94391708|NCT00986245|323223774|FG001|First Intervention|Lack of Efficacy|2|||
94391709|NCT00986245|323223773|FG000|First Intervention|Withdrawal by Subject|0|||
94391710|NCT00986245|323223774|FG001|First Intervention|Withdrawal by Subject|1|||
94391711|NCT00986245|323223773|FG000|First Intervention|Protocol Violation|0|||
94391712|NCT00986245|323223774|FG001|First Intervention|Protocol Violation|1|||
94391713|NCT00986245|323223773|FG000|First Intervention|Out of indication|1|||
94391714|NCT00986245|323223774|FG001|First Intervention|Out of indication|0|||
94391715|NCT00986245|323223773|FG000|Second Intervention|Poor compliance|1|||
94391716|NCT00986245|323223774|FG001|Second Intervention|Poor compliance|0|||
94391717|NCT00986245|323223773|FG000|Second Intervention|Lost to Follow-up|1|||
94391718|NCT00986245|323223774|FG001|Second Intervention|Lost to Follow-up|0|||
94391719|NCT00986245|323223773|FG000|Second Intervention|Protocol Violation|0|||
94391720|NCT00986245|323223774|FG001|Second Intervention|Protocol Violation|1|||
94391721|NCT01534520|323223775|FG000|Overall Study|Adverse Event|0|||
94391722|NCT01534520|323223776|FG001|Overall Study|Adverse Event|1|||
94391723|NCT03017885|323223777|FG000|Overall Study|Adverse Event|2|||
94391724|NCT03017885|323223778|FG001|Overall Study|Adverse Event|0|||
94391725|NCT03017885|323223779|FG002|Overall Study|Adverse Event|0|||
94391726|NCT03017885|323223780|FG003|Overall Study|Adverse Event|0|||
94391727|NCT03017885|323223781|FG004|Overall Study|Adverse Event|0|||
94391728|NCT03017885|323223782|FG005|Overall Study|Adverse Event|0|||
94391729|NCT03017885|323223777|FG000|Overall Study|Progression of disease|4|||
94391730|NCT03017885|323223778|FG001|Overall Study|Progression of disease|3|||
94391731|NCT03017885|323223779|FG002|Overall Study|Progression of disease|4|||
94391732|NCT03017885|323223780|FG003|Overall Study|Progression of disease|0|||
94391733|NCT03017885|323223781|FG004|Overall Study|Progression of disease|0|||
94391734|NCT03017885|323223782|FG005|Overall Study|Progression of disease|0|||
94391735|NCT03017885|323223777|FG000|Overall Study|Other than listed|1|||
94391736|NCT03017885|323223778|FG001|Overall Study|Other than listed|2|||
94391737|NCT03017885|323223779|FG002|Overall Study|Other than listed|1|||
94391738|NCT03017885|323223780|FG003|Overall Study|Other than listed|0|||
94391739|NCT03017885|323223781|FG004|Overall Study|Other than listed|0|||
94391740|NCT03017885|323223782|FG005|Overall Study|Other than listed|0|||
94391741|NCT03017885|323223777|FG000|Overall Study|Lost to Follow-up|2|||
94391742|NCT03017885|323223778|FG001|Overall Study|Lost to Follow-up|0|||
94391743|NCT03017885|323223779|FG002|Overall Study|Lost to Follow-up|3|||
94391744|NCT03017885|323223780|FG003|Overall Study|Lost to Follow-up|0|||
94391745|NCT03017885|323223781|FG004|Overall Study|Lost to Follow-up|0|||
94391746|NCT03017885|323223782|FG005|Overall Study|Lost to Follow-up|0|||
94391747|NCT03017885|323223777|FG000|Overall Study|Change to other anti-cancer therapy|0|||
94391748|NCT03017885|323223778|FG001|Overall Study|Change to other anti-cancer therapy|0|||
94391749|NCT03017885|323223779|FG002|Overall Study|Change to other anti-cancer therapy|1|||
94391750|NCT03017885|323223780|FG003|Overall Study|Change to other anti-cancer therapy|0|||
94391751|NCT03017885|323223781|FG004|Overall Study|Change to other anti-cancer therapy|0|||
94391752|NCT03017885|323223782|FG005|Overall Study|Change to other anti-cancer therapy|0|||
94391753|NCT05093205|323223784|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
94391754|NCT05093205|323223785|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
94391755|NCT05093205|323223786|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
94391756|NCT05093205|323223787|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
94391757|NCT05093205|323223788|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
94391758|NCT05093205|323223789|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
94391759|NCT05093205|323223790|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
94391760|NCT05093205|323223791|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
94391761|NCT05093205|323223792|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
94391762|NCT05093205|323223793|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
94391763|NCT05093205|323223794|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
94391764|NCT05093205|323223795|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
94391765|NCT05093205|323223796|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
94391766|NCT05093205|323223784|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
94391767|NCT05093205|323223785|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
94391768|NCT05093205|323223786|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
94391769|NCT05093205|323223787|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
94391770|NCT05093205|323223788|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
94391771|NCT05093205|323223789|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
94391772|NCT05093205|323223790|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
94391773|NCT05093205|323223791|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
94391774|NCT05093205|323223792|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
94391775|NCT05093205|323223793|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
94391776|NCT05093205|323223794|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
94391777|NCT05093205|323223795|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
94391778|NCT05093205|323223796|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
94391779|NCT05093205|323223784|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
94391780|NCT05093205|323223785|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
94391781|NCT05093205|323223786|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
94391782|NCT05093205|323223787|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
94391783|NCT05093205|323223788|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
94391784|NCT05093205|323223789|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
94391785|NCT05093205|323223790|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
94391786|NCT05093205|323223791|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
94391787|NCT05093205|323223792|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
94391788|NCT05093205|323223793|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
94391789|NCT05093205|323223794|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
94391790|NCT05093205|323223795|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
94391791|NCT05093205|323223796|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
94391792|NCT05093205|323223784|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
94391793|NCT05093205|323223785|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
94391794|NCT05093205|323223786|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
94391795|NCT05093205|323223787|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
94391796|NCT05093205|323223788|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
94391797|NCT05093205|323223789|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
94391798|NCT05093205|323223790|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
94391799|NCT05093205|323223791|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
94391800|NCT05093205|323223792|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
94391801|NCT05093205|323223793|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
94391802|NCT05093205|323223794|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
94391803|NCT05093205|323223795|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
94391804|NCT05093205|323223796|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
94391805|NCT05093205|323223784|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
94391806|NCT05093205|323223785|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
94391807|NCT05093205|323223786|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
94391808|NCT05093205|323223787|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
94391809|NCT05093205|323223788|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
94391810|NCT05093205|323223789|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
94391811|NCT05093205|323223790|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
94391812|NCT05093205|323223791|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
94391813|NCT05093205|323223792|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
94391814|NCT05093205|323223793|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
94391815|NCT05093205|323223794|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
94391816|NCT05093205|323223795|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
94391817|NCT05093205|323223796|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
94391818|NCT05093205|323223784|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
94391819|NCT05093205|323223785|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
94391820|NCT05093205|323223786|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
94391821|NCT05093205|323223787|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
94391822|NCT05093205|323223788|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
94391823|NCT05093205|323223789|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
94391824|NCT05093205|323223790|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
94391825|NCT05093205|323223791|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
94391826|NCT05093205|323223792|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
94391827|NCT05093205|323223793|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
94391828|NCT05093205|323223794|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
94391829|NCT05093205|323223795|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
94391830|NCT05093205|323223796|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
94391831|NCT05093205|323223784|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
94391832|NCT05093205|323223785|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
94391833|NCT05093205|323223786|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
94391834|NCT05093205|323223787|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
94391835|NCT05093205|323223788|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
94391836|NCT05093205|323223789|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
94391837|NCT05093205|323223790|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
94391838|NCT05093205|323223791|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
94483328|NCT01107925|323561814|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
94483329|NCT01107925|323561815|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
94483330|NCT01107925|323561816|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
94483331|NCT01107925|323561817|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
94483332|NCT01107925|323561812|FG000|Period 2|Withdrawal by Subject|0|||
94483333|NCT01107925|323561813|FG001|Period 2|Withdrawal by Subject|1|||
94483334|NCT01107925|323561814|FG002|Period 2|Withdrawal by Subject|0|||
94483335|NCT01107925|323561815|FG003|Period 2|Withdrawal by Subject|0|||
94483336|NCT01107925|323561816|FG004|Period 2|Withdrawal by Subject|0|||
94483337|NCT01107925|323561817|FG005|Period 2|Withdrawal by Subject|1|||
94483338|NCT03718429|323561820|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
94483339|NCT03718429|323561821|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
94483340|NCT03718429|323561822|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
94483341|NCT03718429|323561823|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
94483342|NCT00103285|323563327|FG000|Induction|Adverse Event|14|||
94483343|NCT00103285|323563328|FG001|Induction|Adverse Event|0|||
94483344|NCT00103285|323563329|FG002|Induction|Adverse Event|0|||
94483345|NCT00103285|323563330|FG003|Induction|Adverse Event|0|||
94483346|NCT00103285|323563331|FG004|Induction|Adverse Event|0|||
94483347|NCT00103285|323563332|FG005|Induction|Adverse Event|0|||
94483348|NCT00103285|323563333|FG006|Induction|Adverse Event|0|||
94483349|NCT00103285|323563334|FG007|Induction|Adverse Event|0|||
94483350|NCT00103285|323563327|FG000|Induction|Death|24|||
94483351|NCT00103285|323563328|FG001|Induction|Death|0|||
94483352|NCT00103285|323563329|FG002|Induction|Death|0|||
94483353|NCT00103285|323563330|FG003|Induction|Death|0|||
94483354|NCT00103285|323563331|FG004|Induction|Death|0|||
94483355|NCT00103285|323563332|FG005|Induction|Death|0|||
94483356|NCT00103285|323563333|FG006|Induction|Death|0|||
94483357|NCT00103285|323563334|FG007|Induction|Death|0|||
94483358|NCT00103285|323563327|FG000|Induction|Physician Decision|103|||
94483359|NCT00103285|323563328|FG001|Induction|Physician Decision|0|||
94483360|NCT00103285|323563329|FG002|Induction|Physician Decision|0|||
94483361|NCT00103285|323563330|FG003|Induction|Physician Decision|0|||
94483362|NCT00103285|323563331|FG004|Induction|Physician Decision|0|||
94483363|NCT00103285|323563332|FG005|Induction|Physician Decision|0|||
94483364|NCT00103285|323563333|FG006|Induction|Physician Decision|0|||
94483365|NCT00103285|323563334|FG007|Induction|Physician Decision|0|||
94483366|NCT00103285|323563327|FG000|Induction|Withdrawal by Subject|1|||
94483367|NCT00103285|323563328|FG001|Induction|Withdrawal by Subject|0|||
94483368|NCT00103285|323563329|FG002|Induction|Withdrawal by Subject|0|||
94483369|NCT00103285|323563330|FG003|Induction|Withdrawal by Subject|0|||
94483370|NCT00103285|323563331|FG004|Induction|Withdrawal by Subject|0|||
94483371|NCT00103285|323563332|FG005|Induction|Withdrawal by Subject|0|||
94483372|NCT00103285|323563333|FG006|Induction|Withdrawal by Subject|0|||
94483373|NCT00103285|323563334|FG007|Induction|Withdrawal by Subject|0|||
94483374|NCT00103285|323563327|FG000|Induction|Ineligible|43|||
94483375|NCT00103285|323563328|FG001|Induction|Ineligible|0|||
94483376|NCT00103285|323563329|FG002|Induction|Ineligible|0|||
94483377|NCT00103285|323563330|FG003|Induction|Ineligible|0|||
94483378|NCT00103285|323563331|FG004|Induction|Ineligible|0|||
94483379|NCT00103285|323563332|FG005|Induction|Ineligible|0|||
94483380|NCT00103285|323563333|FG006|Induction|Ineligible|0|||
94483381|NCT00103285|323563334|FG007|Induction|Ineligible|0|||
94391839|NCT05093205|323223792|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
94391840|NCT05093205|323223793|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
94391841|NCT05093205|323223794|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
94391842|NCT05093205|323223795|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
94391843|NCT05093205|323223796|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
94391844|NCT05093205|323223784|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
94391845|NCT05093205|323223785|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
94391846|NCT05093205|323223786|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
94391847|NCT05093205|323223787|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
94391848|NCT05093205|323223788|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
94391849|NCT05093205|323223789|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
94483382|NCT00103285|323563327|FG000|Induction|Refusal|906|||
94483383|NCT00103285|323563328|FG001|Induction|Refusal|0|||
94391850|NCT05093205|323223790|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
94391851|NCT05093205|323223791|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
94483384|NCT00103285|323563329|FG002|Induction|Refusal|0|||
94483385|NCT00103285|323563330|FG003|Induction|Refusal|0|||
94483386|NCT00103285|323563331|FG004|Induction|Refusal|0|||
94483387|NCT00103285|323563332|FG005|Induction|Refusal|0|||
94483388|NCT00103285|323563333|FG006|Induction|Refusal|0|||
94483389|NCT00103285|323563334|FG007|Induction|Refusal|0|||
94391852|NCT05093205|323223792|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
94483390|NCT00103285|323563327|FG000|Induction|Other|258|||
94483391|NCT00103285|323563328|FG001|Induction|Other|0|||
94483392|NCT00103285|323563329|FG002|Induction|Other|0|||
94483393|NCT00103285|323563330|FG003|Induction|Other|0|||
94483394|NCT00103285|323563331|FG004|Induction|Other|0|||
94483395|NCT00103285|323563332|FG005|Induction|Other|0|||
94391853|NCT05093205|323223793|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
94391854|NCT05093205|323223794|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
94391855|NCT05093205|323223795|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
94391856|NCT05093205|323223796|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
94391857|NCT05093205|323223784|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
94391858|NCT05093205|323223785|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
94391859|NCT05093205|323223786|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
94391860|NCT05093205|323223787|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
94391861|NCT05093205|323223788|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
94391862|NCT05093205|323223789|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
94391863|NCT05093205|323223790|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
94391864|NCT05093205|323223791|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
94391865|NCT05093205|323223792|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
94391866|NCT05093205|323223793|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
94391867|NCT05093205|323223794|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
94391868|NCT05093205|323223795|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
94391869|NCT05093205|323223796|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
94391870|NCT05093205|323223784|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
94391871|NCT05093205|323223785|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
94391872|NCT05093205|323223786|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
94391873|NCT05093205|323223787|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
94391874|NCT05093205|323223788|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
94391875|NCT05093205|323223789|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
94391876|NCT05093205|323223790|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
94391877|NCT05093205|323223791|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
94391878|NCT05093205|323223792|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
94391879|NCT05093205|323223793|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
94391880|NCT05093205|323223794|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
94391881|NCT05093205|323223795|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
94391882|NCT05093205|323223796|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
94391883|NCT05093205|323223784|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
94391884|NCT05093205|323223785|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
94391885|NCT05093205|323223786|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
94391886|NCT05093205|323223787|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
94391887|NCT05093205|323223788|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
94391888|NCT05093205|323223789|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
94391889|NCT05093205|323223790|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
94391890|NCT05093205|323223791|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
94391891|NCT05093205|323223792|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
94391892|NCT05093205|323223793|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
94391893|NCT05093205|323223794|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
94391894|NCT05093205|323223795|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
94391895|NCT05093205|323223796|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
94391896|NCT05093205|323223784|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
94391897|NCT05093205|323223785|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
94391898|NCT05093205|323223786|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
94391899|NCT05093205|323223787|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
94391900|NCT05093205|323223788|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
94391901|NCT05093205|323223789|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
94391902|NCT05093205|323223790|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
94391903|NCT05093205|323223791|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
94391904|NCT05093205|323223792|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
94391905|NCT05093205|323223793|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
94391906|NCT05093205|323223794|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
94391907|NCT05093205|323223795|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
94391908|NCT05093205|323223796|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
94391909|NCT05093205|323223784|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
94391910|NCT05093205|323223785|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
94391911|NCT05093205|323223786|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
94391912|NCT05093205|323223787|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
94391913|NCT05093205|323223788|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
94391914|NCT05093205|323223789|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
94483396|NCT00103285|323563333|FG006|Induction|Other|0|||
94391915|NCT05093205|323223790|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
94391916|NCT05093205|323223791|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
94391917|NCT05093205|323223792|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
94391918|NCT05093205|323223793|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
94391919|NCT05093205|323223794|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
94483397|NCT00103285|323563334|FG007|Induction|Other|0|||
94483398|NCT00103285|323563327|FG000|Response Assignment|Adverse Event|0|||
94483399|NCT00103285|323563328|FG001|Response Assignment|Adverse Event|8|||
94391920|NCT05093205|323223795|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
94391921|NCT05093205|323223796|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
94391922|NCT05093205|323223784|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
94391923|NCT05093205|323223785|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
94391924|NCT05093205|323223786|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
94391925|NCT05093205|323223787|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
94391926|NCT05093205|323223788|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
94391927|NCT05093205|323223789|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
94391928|NCT05093205|323223790|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
94391929|NCT05093205|323223791|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
94391930|NCT05093205|323223792|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
94391931|NCT05093205|323223793|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
94391932|NCT05093205|323223794|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
94391933|NCT05093205|323223795|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
94391934|NCT05093205|323223796|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
94391935|NCT03663179|323223797|FG000|Overall Study|Withdrawal by Subject|2|||
94391936|NCT03663179|323223798|FG001|Overall Study|Withdrawal by Subject|0|||
94391937|NCT03663179|323223797|FG000|Overall Study|Lost to Follow-up|1|||
94391938|NCT03663179|323223798|FG001|Overall Study|Lost to Follow-up|1|||
94391939|NCT03663179|323223797|FG000|Overall Study|Revealed exclusionary condition|1|||
94391940|NCT03663179|323223798|FG001|Overall Study|Revealed exclusionary condition|0|||
94391941|NCT01686438|323223799|FG000|Overall Study|Lost to Follow-up|8|||
94391942|NCT01686438|323223800|FG001|Overall Study|Lost to Follow-up|9|||
94391943|NCT01686438|323223801|FG002|Overall Study|Lost to Follow-up|10|||
94391944|NCT01686438|323223799|FG000|Overall Study|Adverse Event|0|||
94391945|NCT01686438|323223800|FG001|Overall Study|Adverse Event|0|||
94391946|NCT01686438|323223801|FG002|Overall Study|Adverse Event|1|||
94391947|NCT01686438|323223799|FG000|Overall Study|Protocol Violation|0|||
94391948|NCT01686438|323223800|FG001|Overall Study|Protocol Violation|0|||
94391949|NCT01686438|323223801|FG002|Overall Study|Protocol Violation|1|||
94391950|NCT01686438|323223799|FG000|Overall Study|Withdrawal by Subject|0|||
94391951|NCT01686438|323223800|FG001|Overall Study|Withdrawal by Subject|0|||
94391952|NCT01686438|323223801|FG002|Overall Study|Withdrawal by Subject|1|||
94391953|NCT00585689|323223802|FG000|Overall Study|Received different ABI-007 schedule|3|||
94391954|NCT00585689|323223802|FG000|Overall Study|Adverse Event|1|||
94391955|NCT00585689|323223802|FG000|Overall Study|Patient Declined Surgery|1|||
94391956|NCT00585689|323223802|FG000|Overall Study|Patient had unresectable disease|1|||
94391957|NCT00585689|323223802|FG000|Overall Study|Death|1|||
94391958|NCT00318461|323223803|FG000|Double-Blind, 6 Months|Adverse Event|11|||
94391959|NCT00318461|323223804|FG001|Double-Blind, 6 Months|Adverse Event|23|||
94391960|NCT00318461|323223805|FG002|Double-Blind, 6 Months|Adverse Event|29|||
94391961|NCT00318461|323223806|FG003|Double-Blind, 6 Months|Adverse Event|2|||
94391962|NCT00318461|323223807|FG004|Double-Blind, 6 Months|Adverse Event|8|||
94391963|NCT00318461|323223803|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
94391964|NCT00318461|323223804|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
94391965|NCT00318461|323223805|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
94391966|NCT00318461|323223806|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
94391967|NCT00318461|323223807|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
94391968|NCT00318461|323223803|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
94391969|NCT00318461|323223804|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
94391970|NCT00318461|323223805|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
94391971|NCT00318461|323223806|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
94391972|NCT00318461|323223807|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
94391973|NCT00318461|323223803|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
94391974|NCT00318461|323223804|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
94391975|NCT00318461|323223805|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
94391976|NCT00318461|323223806|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
94391977|NCT00318461|323223807|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
94391978|NCT00318461|323223803|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
94391979|NCT00318461|323223804|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
94391980|NCT00318461|323223805|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
94391981|NCT00318461|323223806|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
94391982|NCT00318461|323223807|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
94391983|NCT00318461|323223803|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
94391984|NCT00318461|323223804|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
94391985|NCT00318461|323223805|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
94391986|NCT00318461|323223806|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
94391987|NCT00318461|323223807|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
94391988|NCT00318461|323223803|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
94391989|NCT00318461|323223804|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
94391990|NCT00318461|323223805|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
94391991|NCT00318461|323223806|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
94391992|NCT00318461|323223807|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
94391993|NCT00318461|323223803|FG000|Double-Blind, 6 Months|Move|0|||
94391994|NCT00318461|323223804|FG001|Double-Blind, 6 Months|Move|1|||
94391995|NCT00318461|323223805|FG002|Double-Blind, 6 Months|Move|0|||
94391996|NCT00318461|323223806|FG003|Double-Blind, 6 Months|Move|0|||
94391997|NCT00318461|323223807|FG004|Double-Blind, 6 Months|Move|0|||
94391998|NCT00318461|323223803|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
94391999|NCT00318461|323223804|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
94392000|NCT00318461|323223805|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
94392001|NCT00318461|323223806|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
94392002|NCT00318461|323223807|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
94392003|NCT00318461|323223803|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
94392004|NCT00318461|323223804|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
94392005|NCT00318461|323223805|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
94392006|NCT00318461|323223806|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
94392007|NCT00318461|323223807|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
94392008|NCT00318461|323223803|FG000|Double-Blind, 6 Months|Work commitment|0|||
94392009|NCT00318461|323223804|FG001|Double-Blind, 6 Months|Work commitment|0|||
94392010|NCT00318461|323223805|FG002|Double-Blind, 6 Months|Work commitment|0|||
94392011|NCT00318461|323223806|FG003|Double-Blind, 6 Months|Work commitment|0|||
94392012|NCT00318461|323223807|FG004|Double-Blind, 6 Months|Work commitment|1|||
94392013|NCT00318461|323223803|FG000|Double-Blind, 6 Months|Investigator decision|0|||
94392014|NCT00318461|323223804|FG001|Double-Blind, 6 Months|Investigator decision|0|||
94392015|NCT00318461|323223805|FG002|Double-Blind, 6 Months|Investigator decision|0|||
94392016|NCT00318461|323223806|FG003|Double-Blind, 6 Months|Investigator decision|0|||
94392017|NCT00318461|323223807|FG004|Double-Blind, 6 Months|Investigator decision|1|||
94392018|NCT00318461|323223803|FG000|Double-Blind, 6 Months|Lack of time|1|||
94392019|NCT00318461|323223804|FG001|Double-Blind, 6 Months|Lack of time|0|||
94392020|NCT00318461|323223805|FG002|Double-Blind, 6 Months|Lack of time|0|||
94392021|NCT00318461|323223806|FG003|Double-Blind, 6 Months|Lack of time|0|||
94392022|NCT00318461|323223807|FG004|Double-Blind, 6 Months|Lack of time|0|||
94392023|NCT00318461|323223803|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
94392024|NCT00318461|323223804|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
94392025|NCT00318461|323223805|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
94392026|NCT00318461|323223806|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
94392027|NCT00318461|323223807|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
94392028|NCT00318461|323223803|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
94392029|NCT00318461|323223804|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
94392030|NCT00318461|323223805|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
94392031|NCT00318461|323223806|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
94392032|NCT00318461|323223807|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
94392033|NCT00318461|323223803|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
94392034|NCT00318461|323223804|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
94392035|NCT00318461|323223805|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
94392036|NCT00318461|323223806|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
94392037|NCT00318461|323223807|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
94392038|NCT00318461|323223803|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
94392039|NCT00318461|323223804|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
94392040|NCT00318461|323223805|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
94392041|NCT00318461|323223806|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
94392042|NCT00318461|323223807|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
94392043|NCT00318461|323223803|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
94392044|NCT00318461|323223804|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
94392045|NCT00318461|323223805|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
94392046|NCT00318461|323223806|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
94392047|NCT00318461|323223807|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
94392048|NCT00318461|323223803|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
94392049|NCT00318461|323223804|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
94392050|NCT00318461|323223805|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
94392051|NCT00318461|323223806|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
94392052|NCT00318461|323223807|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
94392053|NCT00318461|323223803|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
94392054|NCT00318461|323223804|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
94392055|NCT00318461|323223805|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
94483400|NCT00103285|323563329|FG002|Response Assignment|Adverse Event|3|||
94483401|NCT00103285|323563330|FG003|Response Assignment|Adverse Event|2|||
94483402|NCT00103285|323563331|FG004|Response Assignment|Adverse Event|3|||
94483403|NCT00103285|323563332|FG005|Response Assignment|Adverse Event|1|||
94392056|NCT00318461|323223806|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
94392057|NCT00318461|323223807|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
94392058|NCT00318461|323223803|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
94392059|NCT00318461|323223804|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
94392060|NCT00318461|323223805|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
94392061|NCT00318461|323223806|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
94392062|NCT00318461|323223807|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
94392063|NCT01029340|323223808|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
94392064|NCT01029340|323223809|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
94392065|NCT01029340|323223810|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
94392066|NCT01029340|323223811|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
94392067|NCT01029340|323223812|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
94392068|NCT01029340|323223813|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
94392069|NCT01029340|323223808|FG000|Part B Treatment Period|Protocol Violation|0|||
94392070|NCT01029340|323223809|FG001|Part B Treatment Period|Protocol Violation|0|||
94392071|NCT01029340|323223810|FG002|Part B Treatment Period|Protocol Violation|1|||
94392072|NCT01029340|323223811|FG003|Part B Treatment Period|Protocol Violation|0|||
94392073|NCT01029340|323223812|FG004|Part B Treatment Period|Protocol Violation|0|||
94392074|NCT01029340|323223813|FG005|Part B Treatment Period|Protocol Violation|0|||
94392075|NCT01029340|323223808|FG000|Extension Period|Adverse Event|0|||
94392076|NCT01029340|323223809|FG001|Extension Period|Adverse Event|0|||
94392077|NCT01029340|323223810|FG002|Extension Period|Adverse Event|0|||
94392078|NCT01029340|323223811|FG003|Extension Period|Adverse Event|0|||
94392079|NCT01029340|323223812|FG004|Extension Period|Adverse Event|0|||
94392080|NCT01029340|323223813|FG005|Extension Period|Adverse Event|1|||
94392081|NCT01029340|323223808|FG000|Extension Period|starting another study|0|||
94392082|NCT01029340|323223809|FG001|Extension Period|starting another study|0|||
94392083|NCT01029340|323223810|FG002|Extension Period|starting another study|0|||
94392084|NCT01029340|323223811|FG003|Extension Period|starting another study|0|||
94392085|NCT01029340|323223812|FG004|Extension Period|starting another study|0|||
94392086|NCT01029340|323223813|FG005|Extension Period|starting another study|8|||
94392087|NCT01029340|323223808|FG000|Extension Period|non-compliance|0|||
94392088|NCT01029340|323223809|FG001|Extension Period|non-compliance|0|||
94392089|NCT01029340|323223810|FG002|Extension Period|non-compliance|0|||
94392090|NCT01029340|323223811|FG003|Extension Period|non-compliance|0|||
94392091|NCT01029340|323223812|FG004|Extension Period|non-compliance|0|||
94392092|NCT01029340|323223813|FG005|Extension Period|non-compliance|1|||
94392093|NCT01029340|323223808|FG000|Extension Period|Withdrawal by Subject|0|||
94392094|NCT01029340|323223809|FG001|Extension Period|Withdrawal by Subject|0|||
94392095|NCT01029340|323223810|FG002|Extension Period|Withdrawal by Subject|0|||
94392096|NCT01029340|323223811|FG003|Extension Period|Withdrawal by Subject|0|||
94392097|NCT01029340|323223812|FG004|Extension Period|Withdrawal by Subject|0|||
94392098|NCT01029340|323223813|FG005|Extension Period|Withdrawal by Subject|1|||
94392099|NCT01029340|323223808|FG000|Extension Period|Physician Decision|0|||
94392100|NCT01029340|323223809|FG001|Extension Period|Physician Decision|0|||
94392101|NCT01029340|323223810|FG002|Extension Period|Physician Decision|0|||
94392102|NCT01029340|323223811|FG003|Extension Period|Physician Decision|0|||
94392103|NCT01029340|323223812|FG004|Extension Period|Physician Decision|0|||
94392104|NCT01029340|323223813|FG005|Extension Period|Physician Decision|1|||
94392105|NCT00268905|323223814|FG000|Overall Study|Adverse Event|3|||
94392106|NCT00268905|323223815|FG001|Overall Study|Adverse Event|0|||
94392107|NCT00268905|323223816|FG002|Overall Study|Adverse Event|4|||
94392108|NCT00268905|323223814|FG000|Overall Study|Lost to Follow-up|0|||
94392109|NCT00268905|323223815|FG001|Overall Study|Lost to Follow-up|1|||
94392110|NCT00268905|323223816|FG002|Overall Study|Lost to Follow-up|0|||
94392111|NCT00268905|323223814|FG000|Overall Study|Withdrawal by Subject|0|||
94392112|NCT00268905|323223815|FG001|Overall Study|Withdrawal by Subject|0|||
94392113|NCT00268905|323223816|FG002|Overall Study|Withdrawal by Subject|3|||
94392114|NCT00268905|323223814|FG000|Overall Study|Progressive Disease|28|||
94392115|NCT00268905|323223815|FG001|Overall Study|Progressive Disease|4|||
94392116|NCT00268905|323223816|FG002|Overall Study|Progressive Disease|3|||
94392117|NCT00268905|323223814|FG000|Overall Study|Physician Decision|3|||
94392118|NCT00268905|323223815|FG001|Overall Study|Physician Decision|0|||
94392119|NCT00268905|323223816|FG002|Overall Study|Physician Decision|1|||
94392120|NCT00268905|323223814|FG000|Overall Study|Clinical Progression|9|||
94392121|NCT00268905|323223815|FG001|Overall Study|Clinical Progression|4|||
94392122|NCT00268905|323223816|FG002|Overall Study|Clinical Progression|1|||
94392123|NCT01864174|323223817|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
94392124|NCT01864174|323223818|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
94392125|NCT01864174|323223817|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
94392126|NCT01864174|323223818|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
94392127|NCT01864174|323223817|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
94392128|NCT01864174|323223818|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
94392129|NCT01864174|323223817|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
94392130|NCT01864174|323223818|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
94392131|NCT01864174|323223817|FG000|Double Blind - Compliant Randomized|Death|1|||
94392132|NCT01864174|323223818|FG001|Double Blind - Compliant Randomized|Death|0|||
94392133|NCT01864174|323223817|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
94483404|NCT00103285|323563333|FG006|Response Assignment|Adverse Event|1|||
94483405|NCT00103285|323563334|FG007|Response Assignment|Adverse Event|2|||
94483406|NCT00103285|323563327|FG000|Response Assignment|Death|0|||
94483407|NCT00103285|323563328|FG001|Response Assignment|Death|5|||
94483408|NCT00103285|323563329|FG002|Response Assignment|Death|2|||
94483409|NCT00103285|323563330|FG003|Response Assignment|Death|2|||
94483410|NCT00103285|323563331|FG004|Response Assignment|Death|3|||
94483411|NCT00103285|323563332|FG005|Response Assignment|Death|1|||
94483412|NCT00103285|323563333|FG006|Response Assignment|Death|0|||
94483413|NCT00103285|323563334|FG007|Response Assignment|Death|8|||
94483414|NCT00103285|323563327|FG000|Response Assignment|Lost to Follow-up|0|||
94483415|NCT00103285|323563328|FG001|Response Assignment|Lost to Follow-up|9|||
94483416|NCT00103285|323563329|FG002|Response Assignment|Lost to Follow-up|5|||
94483417|NCT00103285|323563330|FG003|Response Assignment|Lost to Follow-up|5|||
94483418|NCT00103285|323563331|FG004|Response Assignment|Lost to Follow-up|1|||
94483419|NCT00103285|323563332|FG005|Response Assignment|Lost to Follow-up|2|||
94483420|NCT00103285|323563333|FG006|Response Assignment|Lost to Follow-up|2|||
94483421|NCT00103285|323563334|FG007|Response Assignment|Lost to Follow-up|5|||
94483422|NCT00103285|323563327|FG000|Response Assignment|Physician Decision|0|||
94483423|NCT00103285|323563328|FG001|Response Assignment|Physician Decision|13|||
94483424|NCT00103285|323563329|FG002|Response Assignment|Physician Decision|14|||
94483425|NCT00103285|323563330|FG003|Response Assignment|Physician Decision|9|||
94483426|NCT00103285|323563331|FG004|Response Assignment|Physician Decision|13|||
94483427|NCT00103285|323563332|FG005|Response Assignment|Physician Decision|7|||
94483428|NCT00103285|323563333|FG006|Response Assignment|Physician Decision|4|||
94392134|NCT01864174|323223818|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
94392135|NCT01864174|323223817|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
94392136|NCT01864174|323223818|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
94392137|NCT01864174|323223817|FG000|Double Blind - Compliant Randomized|Other|6|||
94392138|NCT01864174|323223818|FG001|Double Blind - Compliant Randomized|Other|10|||
94392139|NCT01864174|323223817|FG000|Off Treatment Follow-Up|Other|2|||
94392140|NCT01864174|323223818|FG001|Off Treatment Follow-Up|Other|0|||
94392141|NCT01864174|323223817|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
94392142|NCT01864174|323223818|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
94392143|NCT02648347|323223822|FG000|Overall Study|Death|174|||
94392144|NCT02648347|323223823|FG001|Overall Study|Death|167|||
94392145|NCT02648347|323223822|FG000|Overall Study|Withdrawal by Subject|16|||
94392146|NCT02648347|323223823|FG001|Overall Study|Withdrawal by Subject|9|||
94392147|NCT02648347|323223822|FG000|Overall Study|Lost to Follow-up|18|||
94392148|NCT02648347|323223823|FG001|Overall Study|Lost to Follow-up|21|||
94392149|NCT02648347|323223822|FG000|Overall Study|Missing|1|||
94392150|NCT02648347|323223823|FG001|Overall Study|Missing|0|||
94392151|NCT03546842|323223825|FG000|Overall Study|Protocol Violation|1|||
94392152|NCT03546842|323223825|FG000|Overall Study|Withdrawal by Subject|2|||
94392153|NCT02739997|323223826|FG000|Overall Study|Death|1|||
94392154|NCT02739997|323223826|FG000|Overall Study|Withdrawal by Subject|1|||
94392155|NCT00617305|323223830|FG000|Overall Study|Adverse Event|4|||
94392156|NCT00617305|323223831|FG001|Overall Study|Adverse Event|0|||
94392157|NCT00617305|323223832|FG002|Overall Study|Adverse Event|0|||
94392158|NCT00617305|323223830|FG000|Overall Study|Death|1|||
94392159|NCT00617305|323223831|FG001|Overall Study|Death|0|||
94392160|NCT00617305|323223832|FG002|Overall Study|Death|0|||
94392161|NCT00617305|323223830|FG000|Overall Study|Physician Decision|1|||
94392162|NCT00617305|323223831|FG001|Overall Study|Physician Decision|0|||
94392163|NCT00617305|323223832|FG002|Overall Study|Physician Decision|0|||
94392164|NCT00617305|323223830|FG000|Overall Study|Protocol Violation|1|||
94392165|NCT00617305|323223831|FG001|Overall Study|Protocol Violation|0|||
94392166|NCT00617305|323223832|FG002|Overall Study|Protocol Violation|1|||
94392167|NCT00617305|323223830|FG000|Overall Study|Withdrawal by Subject|1|||
94392168|NCT00617305|323223831|FG001|Overall Study|Withdrawal by Subject|0|||
94392169|NCT00617305|323223832|FG002|Overall Study|Withdrawal by Subject|0|||
94392170|NCT02158663|323223833|FG000|Overall Study|Withdrawal by Subject|5|||
94392171|NCT02158663|323223834|FG001|Overall Study|Withdrawal by Subject|4|||
94392172|NCT01265056|323223835|FG000|Initial Study Period|Withdrawal by Subject|1|||
94483429|NCT00103285|323563334|FG007|Response Assignment|Physician Decision|35|||
94483430|NCT00103285|323563327|FG000|Response Assignment|Protocol Violation|0|||
94392173|NCT01265056|323223836|FG001|Initial Study Period|Withdrawal by Subject|1|||
94392174|NCT01265056|323223835|FG000|Initial Study Period|Withdrawal by Subject|1|||
94392175|NCT01265056|323223836|FG001|Initial Study Period|Withdrawal by Subject|1|||
94392176|NCT01265056|323223835|FG000|Follow up|Lost to Follow-up|7|||
94392177|NCT01265056|323223836|FG001|Follow up|Lost to Follow-up|3|||
94392178|NCT02711852|323223841|FG000|Overall Study|Death|5|||
94392179|NCT02711852|323223841|FG000|Overall Study|Lost to Follow-up|1|||
94392180|NCT02711852|323223841|FG000|Overall Study|Completed follow-up|3|||
94392181|NCT02711852|323223841|FG000|Overall Study|Withdrawal by Subject|1|||
94483431|NCT00103285|323563328|FG001|Response Assignment|Protocol Violation|2|||
94483432|NCT00103285|323563329|FG002|Response Assignment|Protocol Violation|0|||
94483433|NCT00103285|323563330|FG003|Response Assignment|Protocol Violation|0|||
94392182|NCT02009163|323223847|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
94392183|NCT02009163|323223848|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
94392184|NCT02009163|323223849|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
94392185|NCT02009163|323223847|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
94392186|NCT02009163|323223848|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
94392187|NCT02009163|323223849|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
94392188|NCT02009163|323223847|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
94392189|NCT02009163|323223848|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
94392190|NCT02009163|323223849|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
94392191|NCT02009163|323223847|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
94392192|NCT02009163|323223848|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
94392193|NCT02009163|323223849|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
94392194|NCT02009163|323223847|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
94392195|NCT02009163|323223848|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
94392196|NCT02009163|323223849|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
94392197|NCT02009163|323223847|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
94392198|NCT02009163|323223848|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
94392199|NCT02009163|323223849|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
94392200|NCT02009163|323223847|FG000|Open-label Period (Non-randomized)|Other|13|||
94392201|NCT02009163|323223848|FG001|Open-label Period (Non-randomized)|Other|0|||
94392202|NCT02009163|323223849|FG002|Open-label Period (Non-randomized)|Other|0|||
94392203|NCT02009163|323223847|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
94392204|NCT02009163|323223848|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
94392205|NCT02009163|323223849|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
94392206|NCT02009163|323223847|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
94392207|NCT02009163|323223848|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
94392208|NCT02009163|323223849|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
94392209|NCT02009163|323223847|FG000|Randomized-withdrawal Period|Adverse Event|0|||
94392210|NCT02009163|323223848|FG001|Randomized-withdrawal Period|Adverse Event|0|||
94392211|NCT02009163|323223849|FG002|Randomized-withdrawal Period|Adverse Event|6|||
94392212|NCT02009163|323223847|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
94392213|NCT02009163|323223848|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
94392214|NCT02009163|323223849|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
94392215|NCT02009163|323223847|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
94392216|NCT02009163|323223848|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
94392217|NCT02009163|323223849|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
94392218|NCT02009163|323223847|FG000|Randomized-withdrawal Period|Pregnancy|0|||
94392219|NCT02009163|323223848|FG001|Randomized-withdrawal Period|Pregnancy|0|||
94392220|NCT02009163|323223849|FG002|Randomized-withdrawal Period|Pregnancy|2|||
94392221|NCT02009163|323223847|FG000|Randomized-withdrawal Period|Other|0|||
94392222|NCT02009163|323223848|FG001|Randomized-withdrawal Period|Other|9|||
94392223|NCT02009163|323223849|FG002|Randomized-withdrawal Period|Other|5|||
94392224|NCT02414152|323223852|FG000|Overall Study|Withdrawal by Subject|1|||
94392225|NCT02414152|323223852|FG000|Overall Study|Lack of Efficacy|1|||
94392226|NCT03233724|323223866|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
94392227|NCT03233724|323223867|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
94392228|NCT03233724|323223868|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
94392229|NCT03233724|323223869|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
94392230|NCT03233724|323223870|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
94392231|NCT03233724|323223866|FG000|Phase I Dose Escalation|Best interest of participant|1|||
94392232|NCT03233724|323223867|FG001|Phase I Dose Escalation|Best interest of participant|1|||
94392233|NCT03233724|323223868|FG002|Phase I Dose Escalation|Best interest of participant|1|||
94392234|NCT03233724|323223869|FG003|Phase I Dose Escalation|Best interest of participant|0|||
94392235|NCT03233724|323223870|FG004|Phase I Dose Escalation|Best interest of participant|0|||
94392236|NCT03233724|323223866|FG000|Phase I Dose Escalation|Physician Decision|0|||
94392237|NCT03233724|323223867|FG001|Phase I Dose Escalation|Physician Decision|0|||
94392238|NCT03233724|323223868|FG002|Phase I Dose Escalation|Physician Decision|1|||
94392239|NCT03233724|323223869|FG003|Phase I Dose Escalation|Physician Decision|0|||
94392240|NCT03233724|323223870|FG004|Phase I Dose Escalation|Physician Decision|0|||
94392241|NCT03233724|323223866|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
94392242|NCT03233724|323223867|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
94392243|NCT03233724|323223868|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
94392244|NCT03233724|323223869|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
94392245|NCT03233724|323223870|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
94392246|NCT03135834|323223871|FG000|Stage 1|Adverse Event|1|||
94392247|NCT03135834|323223872|FG001|Stage 1|Adverse Event|2|||
94483434|NCT00103285|323563331|FG004|Response Assignment|Protocol Violation|0|||
94483435|NCT00103285|323563332|FG005|Response Assignment|Protocol Violation|0|||
94483436|NCT00103285|323563333|FG006|Response Assignment|Protocol Violation|0|||
94483437|NCT00103285|323563334|FG007|Response Assignment|Protocol Violation|0|||
94483438|NCT00103285|323563327|FG000|Response Assignment|Withdrawal by Subject|0|||
94483439|NCT00103285|323563328|FG001|Response Assignment|Withdrawal by Subject|4|||
94483440|NCT00103285|323563329|FG002|Response Assignment|Withdrawal by Subject|1|||
94483441|NCT00103285|323563330|FG003|Response Assignment|Withdrawal by Subject|1|||
94483442|NCT00103285|323563331|FG004|Response Assignment|Withdrawal by Subject|2|||
94483443|NCT00103285|323563332|FG005|Response Assignment|Withdrawal by Subject|2|||
94483444|NCT00103285|323563333|FG006|Response Assignment|Withdrawal by Subject|0|||
94483445|NCT00103285|323563334|FG007|Response Assignment|Withdrawal by Subject|2|||
94483446|NCT00103285|323563327|FG000|Response Assignment|Ineligible|0|||
94483447|NCT00103285|323563328|FG001|Response Assignment|Ineligible|8|||
94483448|NCT00103285|323563329|FG002|Response Assignment|Ineligible|6|||
94483449|NCT00103285|323563330|FG003|Response Assignment|Ineligible|2|||
94483450|NCT00103285|323563331|FG004|Response Assignment|Ineligible|0|||
94483451|NCT00103285|323563332|FG005|Response Assignment|Ineligible|3|||
94483452|NCT00103285|323563333|FG006|Response Assignment|Ineligible|1|||
94483453|NCT00103285|323563334|FG007|Response Assignment|Ineligible|5|||
94483454|NCT00103285|323563327|FG000|Response Assignment|Refusal|0|||
94483455|NCT00103285|323563328|FG001|Response Assignment|Refusal|53|||
94483456|NCT00103285|323563329|FG002|Response Assignment|Refusal|5|||
94483457|NCT00103285|323563330|FG003|Response Assignment|Refusal|3|||
94483458|NCT00103285|323563331|FG004|Response Assignment|Refusal|25|||
94483459|NCT00103285|323563332|FG005|Response Assignment|Refusal|15|||
94483460|NCT00103285|323563333|FG006|Response Assignment|Refusal|30|||
94483461|NCT00103285|323563334|FG007|Response Assignment|Refusal|10|||
94483462|NCT00103285|323563327|FG000|Response Assignment|Other|0|||
94392248|NCT03135834|323223873|FG002|Stage 1|Adverse Event|2|||
94392249|NCT03135834|323223874|FG003|Stage 1|Adverse Event|1|||
94392250|NCT03135834|323223871|FG000|Stage 1|Death|1|||
94392251|NCT03135834|323223872|FG001|Stage 1|Death|0|||
94392252|NCT03135834|323223873|FG002|Stage 1|Death|0|||
94392253|NCT03135834|323223874|FG003|Stage 1|Death|0|||
94392254|NCT03135834|323223871|FG000|Stage 1|Lost to Follow-up|17|||
94392255|NCT03135834|323223872|FG001|Stage 1|Lost to Follow-up|24|||
94392256|NCT03135834|323223873|FG002|Stage 1|Lost to Follow-up|21|||
94392257|NCT03135834|323223874|FG003|Stage 1|Lost to Follow-up|38|||
94392258|NCT03135834|323223871|FG000|Stage 1|No longer met eligibility criteria|1|||
94392259|NCT03135834|323223872|FG001|Stage 1|No longer met eligibility criteria|6|||
94392260|NCT03135834|323223873|FG002|Stage 1|No longer met eligibility criteria|2|||
94392261|NCT03135834|323223874|FG003|Stage 1|No longer met eligibility criteria|5|||
94392262|NCT03135834|323223871|FG000|Stage 1|Other|0|||
94392263|NCT03135834|323223872|FG001|Stage 1|Other|2|||
94392264|NCT03135834|323223873|FG002|Stage 1|Other|1|||
94392265|NCT03135834|323223874|FG003|Stage 1|Other|0|||
94392266|NCT03135834|323223871|FG000|Stage 1|Physician Decision|0|||
94392267|NCT03135834|323223872|FG001|Stage 1|Physician Decision|1|||
94392268|NCT03135834|323223873|FG002|Stage 1|Physician Decision|0|||
94392269|NCT03135834|323223874|FG003|Stage 1|Physician Decision|0|||
94392270|NCT03135834|323223871|FG000|Stage 1|Pregnancy|0|||
94392271|NCT03135834|323223872|FG001|Stage 1|Pregnancy|4|||
94392272|NCT03135834|323223873|FG002|Stage 1|Pregnancy|2|||
94392273|NCT03135834|323223874|FG003|Stage 1|Pregnancy|4|||
94392274|NCT03135834|323223871|FG000|Stage 1|Protocol Violation|1|||
94392275|NCT03135834|323223872|FG001|Stage 1|Protocol Violation|1|||
94392276|NCT03135834|323223873|FG002|Stage 1|Protocol Violation|2|||
94392277|NCT03135834|323223874|FG003|Stage 1|Protocol Violation|1|||
94392278|NCT03135834|323223871|FG000|Stage 1|Withdrawal by parent/guardian|2|||
94392279|NCT03135834|323223872|FG001|Stage 1|Withdrawal by parent/guardian|10|||
94392280|NCT03135834|323223873|FG002|Stage 1|Withdrawal by parent/guardian|2|||
94392281|NCT03135834|323223874|FG003|Stage 1|Withdrawal by parent/guardian|1|||
94392282|NCT03135834|323223871|FG000|Stage 1|Withdrawal by Subject|16|||
94392283|NCT03135834|323223872|FG001|Stage 1|Withdrawal by Subject|22|||
94392284|NCT03135834|323223873|FG002|Stage 1|Withdrawal by Subject|7|||
94392285|NCT03135834|323223874|FG003|Stage 1|Withdrawal by Subject|10|||
94483463|NCT00103285|323563328|FG001|Response Assignment|Other|30|||
94483464|NCT00103285|323563329|FG002|Response Assignment|Other|48|||
94392286|NCT03135834|323223871|FG000|Stage 1|Randomized but not Vaccinated|0|||
94392287|NCT03135834|323223872|FG001|Stage 1|Randomized but not Vaccinated|3|||
94392288|NCT03135834|323223873|FG002|Stage 1|Randomized but not Vaccinated|1|||
94392289|NCT03135834|323223874|FG003|Stage 1|Randomized but not Vaccinated|6|||
94392290|NCT03135834|323223871|FG000|Stage 2|Lost to Follow-up|0|||
94392291|NCT03135834|323223872|FG001|Stage 2|Lost to Follow-up|1|||
94392292|NCT03135834|323223873|FG002|Stage 2|Lost to Follow-up|0|||
94392293|NCT03135834|323223874|FG003|Stage 2|Lost to Follow-up|0|||
94392294|NCT03135834|323223871|FG000|Stage 2|Withdrawal by Subject|0|||
94392295|NCT03135834|323223872|FG001|Stage 2|Withdrawal by Subject|1|||
94483465|NCT00103285|323563330|FG003|Response Assignment|Other|38|||
94483466|NCT00103285|323563331|FG004|Response Assignment|Other|37|||
94483467|NCT00103285|323563332|FG005|Response Assignment|Other|17|||
94483468|NCT00103285|323563333|FG006|Response Assignment|Other|11|||
94483469|NCT00103285|323563334|FG007|Response Assignment|Other|53|||
94483470|NCT00452439|323563335|FG000|Overall Study|Lost to Follow-up|1|||
94483471|NCT00452439|323563336|FG001|Overall Study|Lost to Follow-up|1|||
94483472|NCT00452439|323563335|FG000|Overall Study|Refused Treatment|4|||
94483473|NCT00452439|323563336|FG001|Overall Study|Refused Treatment|3|||
94483474|NCT00452439|323563335|FG000|Overall Study|Death|3|||
94483475|NCT00452439|323563336|FG001|Overall Study|Death|1|||
94483476|NCT00452439|323563335|FG000|Overall Study|Bone Marrow Transplant|0|||
94483477|NCT00452439|323563336|FG001|Overall Study|Bone Marrow Transplant|1|||
94483478|NCT00452439|323563335|FG000|Overall Study|Too Ill to Continue|0|||
94483479|NCT00452439|323563336|FG001|Overall Study|Too Ill to Continue|1|||
94483480|NCT00452439|323563335|FG000|Overall Study|Failed to achieve complete response|2|||
94483481|NCT00452439|323563336|FG001|Overall Study|Failed to achieve complete response|0|||
94483482|NCT00452439|323563335|FG000|Overall Study|Relapse|3|||
94483483|NCT00452439|323563336|FG001|Overall Study|Relapse|0|||
94483484|NCT00452439|323563335|FG000|Overall Study|Fracture|1|||
94483485|NCT00452439|323563336|FG001|Overall Study|Fracture|0|||
94483486|NCT03101150|323563341|FG000|Overall Study|Lost to Follow-up|2|||
94483487|NCT03101150|323563342|FG001|Overall Study|Lost to Follow-up|4|||
94483488|NCT03101150|323563341|FG000|Overall Study|Miscarriage|3|||
94483489|NCT03101150|323563342|FG001|Overall Study|Miscarriage|6|||
94483490|NCT01022203|323563343|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
94483491|NCT01022203|323563344|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
94483492|NCT01022203|323563343|FG000|Post Treatment Assessment|Physician Decision|2|||
94483493|NCT01022203|323563344|FG001|Post Treatment Assessment|Physician Decision|0|||
94483494|NCT01022203|323563343|FG000|Post Treatment Assessment|Adverse Event|0|||
94392296|NCT03135834|323223873|FG002|Stage 2|Withdrawal by Subject|0|||
94392297|NCT03135834|323223874|FG003|Stage 2|Withdrawal by Subject|0|||
94392298|NCT03135834|323223871|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
94392299|NCT03135834|323223872|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
94392300|NCT03135834|323223873|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
94392301|NCT03135834|323223874|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
94392302|NCT03135834|323223871|FG000|Stage 2|Did not receive Booster Vaccination|1|||
94392303|NCT03135834|323223872|FG001|Stage 2|Did not receive Booster Vaccination|1|||
94392304|NCT03135834|323223873|FG002|Stage 2|Did not receive Booster Vaccination|0|||
94392305|NCT03135834|323223874|FG003|Stage 2|Did not receive Booster Vaccination|0|||
94392306|NCT00576056|323223875|FG000|Overall Study|Adverse Event|1|||
94392307|NCT00576056|323223875|FG000|Overall Study|Death|1|||
94392308|NCT00576056|323223875|FG000|Overall Study|Lack of Efficacy|1|||
94392309|NCT00576056|323223875|FG000|Overall Study|Withdrawal by Subject|2|||
94392310|NCT00576056|323223875|FG000|Overall Study|did not meet eligibility criteria|8|||
94392311|NCT00576056|323223875|FG000|Overall Study|Physician Decision|1|||
94392312|NCT01854047|323223876|FG000|Overall Study|Lack of Efficacy|1|||
94392313|NCT01854047|323223877|FG001|Overall Study|Lack of Efficacy|0|||
94392314|NCT01854047|323223878|FG002|Overall Study|Lack of Efficacy|0|||
94392315|NCT01854047|323223879|FG003|Overall Study|Lack of Efficacy|0|||
94392316|NCT01854047|323223880|FG004|Overall Study|Lack of Efficacy|0|||
94392317|NCT01854047|323223876|FG000|Overall Study|Poor compliance to protocol|3|||
94392318|NCT01854047|323223877|FG001|Overall Study|Poor compliance to protocol|0|||
94392319|NCT01854047|323223878|FG002|Overall Study|Poor compliance to protocol|2|||
94392320|NCT01854047|323223879|FG003|Overall Study|Poor compliance to protocol|0|||
94392321|NCT01854047|323223880|FG004|Overall Study|Poor compliance to protocol|0|||
94392322|NCT01854047|323223876|FG000|Overall Study|Adverse Event|5|||
94392323|NCT01854047|323223877|FG001|Overall Study|Adverse Event|4|||
94392324|NCT01854047|323223878|FG002|Overall Study|Adverse Event|6|||
94392325|NCT01854047|323223879|FG003|Overall Study|Adverse Event|10|||
94392326|NCT01854047|323223880|FG004|Overall Study|Adverse Event|7|||
94392327|NCT01854047|323223876|FG000|Overall Study|Randomized but not treated|0|||
94392328|NCT01854047|323223877|FG001|Overall Study|Randomized but not treated|1|||
94392329|NCT01854047|323223878|FG002|Overall Study|Randomized but not treated|2|||
94392330|NCT01854047|323223879|FG003|Overall Study|Randomized but not treated|0|||
94392331|NCT01854047|323223880|FG004|Overall Study|Randomized but not treated|4|||
94392332|NCT01854047|323223876|FG000|Overall Study|Other than specified above|3|||
94392333|NCT01854047|323223877|FG001|Overall Study|Other than specified above|3|||
94483495|NCT01022203|323563344|FG001|Post Treatment Assessment|Adverse Event|2|||
94483496|NCT01022203|323563343|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
94483497|NCT01022203|323563344|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
94483498|NCT02699996|323563351|FG000|Overall Study|Withdrawal by Subject|5|||
94392334|NCT01854047|323223878|FG002|Overall Study|Other than specified above|3|||
94483499|NCT02699996|323563352|FG001|Overall Study|Withdrawal by Subject|2|||
94483500|NCT00823134|323563353|FG000|Overall Study|Invalid measurement|1|||
94392335|NCT01854047|323223879|FG003|Overall Study|Other than specified above|5|||
94392336|NCT01854047|323223880|FG004|Overall Study|Other than specified above|8|||
94392337|NCT03161405|323223881|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
94483501|NCT01095835|323563357|FG000|Overall Study|Adverse Event|8|||
94483502|NCT01095835|323563358|FG001|Overall Study|Adverse Event|6|||
94392338|NCT00731783|323223882|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
94392339|NCT00731783|323223883|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
94392340|NCT00731783|323223882|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
94392341|NCT00731783|323223883|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
94392342|NCT00731783|323223882|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
94392343|NCT00731783|323223883|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
94392344|NCT00731783|323223882|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
94392345|NCT00731783|323223883|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
94392346|NCT02311361|323225235|FG000|Overall Study|Did not receive treatment|0|||
94392347|NCT02311361|323225236|FG001|Overall Study|Did not receive treatment|1|||
94392348|NCT02311361|323225237|FG002|Overall Study|Did not receive treatment|0|||
94392349|NCT02311361|323225238|FG003|Overall Study|Did not receive treatment|1|||
94392350|NCT00745420|323225239|FG000|Overall Study|Ineligible|1|||
94392351|NCT00667862|323225241|FG000|Overall Study|Adverse Event|9|||
94392352|NCT00667862|323225241|FG000|Overall Study|Death|1|||
94392353|NCT00667862|323225241|FG000|Overall Study|Disease Progression|22|||
94392354|NCT00667862|323225241|FG000|Overall Study|Withdrawal by Subject|3|||
94392355|NCT00239577|323225258|FG000|Primary Phase|Adverse Event|0|||
94392356|NCT00239577|323225259|FG001|Primary Phase|Adverse Event|0|||
94392357|NCT00239577|323225260|FG002|Primary Phase|Adverse Event|1|||
94392358|NCT00239577|323225261|FG003|Primary Phase|Adverse Event|0|||
94392359|NCT00239577|323225258|FG000|Primary Phase|Other|5|||
94392360|NCT00239577|323225259|FG001|Primary Phase|Other|3|||
94392361|NCT00239577|323225260|FG002|Primary Phase|Other|2|||
94392362|NCT00239577|323225261|FG003|Primary Phase|Other|0|||
94392363|NCT00328926|323225264|FG000|Overall Study|Pregnancy|2|||
94392364|NCT00328926|323225265|FG001|Overall Study|Pregnancy|1|||
94392365|NCT00328926|323225266|FG002|Overall Study|Pregnancy|0|||
94392366|NCT00328926|323225264|FG000|Overall Study|Lost to Follow-up|0|||
94392367|NCT00328926|323225265|FG001|Overall Study|Lost to Follow-up|1|||
94392368|NCT00328926|323225266|FG002|Overall Study|Lost to Follow-up|0|||
94392369|NCT00328926|323225264|FG000|Overall Study|Death|0|||
94392370|NCT00328926|323225265|FG001|Overall Study|Death|0|||
94392371|NCT00328926|323225266|FG002|Overall Study|Death|1|||
94392372|NCT00328926|323225264|FG000|Overall Study|In vitro fertilization treatment|0|||
94392373|NCT00328926|323225265|FG001|Overall Study|In vitro fertilization treatment|0|||
94392374|NCT00328926|323225266|FG002|Overall Study|In vitro fertilization treatment|1|||
94392375|NCT00328926|323225264|FG000|Overall Study|Lack of ovarian response|0|||
94392376|NCT00328926|323225265|FG001|Overall Study|Lack of ovarian response|1|||
94392377|NCT00328926|323225266|FG002|Overall Study|Lack of ovarian response|0|||
94392378|NCT04466111|323225269|FG000|Prior to Trial Phase|Physician Decision|1|||
94392379|NCT00105196|323225271|FG000|Overall Study|Lack of Efficacy|2|||
94328595|NCT00305604|322982693|FG001|Overall Study|Withdrawal by Subject|21|||
94328596|NCT00305604|322982692|FG000|Overall Study|Patient moved|1|||
94328597|NCT00305604|322982693|FG001|Overall Study|Patient moved|0|||
94328598|NCT00643604|322982694|FG000|Overall Study|Death|1|||
94328599|NCT03498287|322982701|FG000|Overall Study|Withdrawal by Subject|3|||
94328600|NCT03498287|322982702|FG001|Overall Study|Withdrawal by Subject|0|||
94328601|NCT03498287|322982701|FG000|Overall Study|Protocol Violation|0|||
94328602|NCT03498287|322982702|FG001|Overall Study|Protocol Violation|4|||
94328603|NCT03498287|322982701|FG000|Overall Study|Adverse Event|0|||
94328604|NCT03498287|322982702|FG001|Overall Study|Adverse Event|1|||
94328605|NCT01374217|322982703|FG000|Overall Study|Lack of Efficacy|13|||
94328606|NCT01641991|322982704|FG000|Overall Study|Physician Decision|0|||
94328607|NCT01641991|322982705|FG001|Overall Study|Physician Decision|1|||
94328608|NCT01641991|322982706|FG002|Overall Study|Physician Decision|7|||
94328609|NCT01641991|322982707|FG003|Overall Study|Physician Decision|5|||
94328610|NCT01641991|322982704|FG000|Overall Study|Withdrawal by Subject|4|||
94328611|NCT01641991|322982705|FG001|Overall Study|Withdrawal by Subject|2|||
94328612|NCT01641991|322982706|FG002|Overall Study|Withdrawal by Subject|1|||
94328613|NCT01641991|322982707|FG003|Overall Study|Withdrawal by Subject|5|||
94328614|NCT01641991|322982704|FG000|Overall Study|Adverse Event|2|||
94328615|NCT01641991|322982705|FG001|Overall Study|Adverse Event|1|||
94328616|NCT01641991|322982706|FG002|Overall Study|Adverse Event|2|||
94328617|NCT01641991|322982707|FG003|Overall Study|Adverse Event|1|||
94328618|NCT01641991|322982704|FG000|Overall Study|Lost to Follow-up|0|||
94328619|NCT01641991|322982705|FG001|Overall Study|Lost to Follow-up|2|||
94328620|NCT01641991|322982706|FG002|Overall Study|Lost to Follow-up|3|||
94328621|NCT01641991|322982707|FG003|Overall Study|Lost to Follow-up|1|||
94328622|NCT01641991|322982704|FG000|Overall Study|Protocol Violation|1|||
94328623|NCT01641991|322982705|FG001|Overall Study|Protocol Violation|1|||
94328624|NCT01641991|322982706|FG002|Overall Study|Protocol Violation|3|||
94328625|NCT01641991|322982707|FG003|Overall Study|Protocol Violation|0|||
94328626|NCT01641991|322982704|FG000|Overall Study|Pregnancy|0|||
94328627|NCT01641991|322982705|FG001|Overall Study|Pregnancy|0|||
94328628|NCT01641991|322982706|FG002|Overall Study|Pregnancy|1|||
94328629|NCT01641991|322982707|FG003|Overall Study|Pregnancy|0|||
94392380|NCT00105196|323225272|FG001|Overall Study|Lack of Efficacy|3|||
94392381|NCT00105196|323225271|FG000|Overall Study|Adverse Event|11|||
94392382|NCT00105196|323225272|FG001|Overall Study|Adverse Event|3|||
94483503|NCT01095835|323563359|FG002|Overall Study|Adverse Event|6|||
94483504|NCT01095835|323563357|FG000|Overall Study|Lack of Efficacy|0|||
94483505|NCT01095835|323563358|FG001|Overall Study|Lack of Efficacy|1|||
94483506|NCT01095835|323563359|FG002|Overall Study|Lack of Efficacy|0|||
94483507|NCT01095835|323563357|FG000|Overall Study|Physician Decision|0|||
94483508|NCT01095835|323563358|FG001|Overall Study|Physician Decision|0|||
94483509|NCT01095835|323563359|FG002|Overall Study|Physician Decision|1|||
94483510|NCT01095835|323563357|FG000|Overall Study|Withdrawal by Subject|1|||
94483511|NCT01095835|323563358|FG001|Overall Study|Withdrawal by Subject|3|||
94483512|NCT01095835|323563359|FG002|Overall Study|Withdrawal by Subject|0|||
94483513|NCT01095835|323563357|FG000|Overall Study|Non study compliance|0|||
94483514|NCT01095835|323563358|FG001|Overall Study|Non study compliance|0|||
94483515|NCT01095835|323563359|FG002|Overall Study|Non study compliance|1|||
94483516|NCT01095835|323563357|FG000|Overall Study|Protocol Violation|1|||
94483517|NCT01095835|323563358|FG001|Overall Study|Protocol Violation|2|||
94483518|NCT01095835|323563359|FG002|Overall Study|Protocol Violation|0|||
94483519|NCT00419757|323563363|FG000|Overall Study|Adverse Event|1|||
94483520|NCT00419757|323563364|FG001|Overall Study|Adverse Event|4|||
94483521|NCT00419757|323563363|FG000|Overall Study|Lost to Follow-up|1|||
94483522|NCT00419757|323563364|FG001|Overall Study|Lost to Follow-up|4|||
94483523|NCT00419757|323563363|FG000|Overall Study|Withdrawal by Subject|7|||
94483524|NCT00419757|323563364|FG001|Overall Study|Withdrawal by Subject|1|||
94483525|NCT00419757|323563363|FG000|Overall Study|Protocol Violation|2|||
94483526|NCT00419757|323563364|FG001|Overall Study|Protocol Violation|3|||
94483527|NCT00419757|323563363|FG000|Overall Study|Study specific discontinuation criteria|4|||
94483528|NCT00419757|323563364|FG001|Overall Study|Study specific discontinuation criteria|8|||
94483529|NCT00419757|323563363|FG000|Overall Study|Multiple reasons|3|||
94483530|NCT00419757|323563364|FG001|Overall Study|Multiple reasons|1|||
94483531|NCT01051921|323563365|FG000|Overall Study|Physician Decision|9|||
94483532|NCT01051921|323563365|FG000|Overall Study|Adverse Event|8|||
94483533|NCT01051921|323563365|FG000|Overall Study|Withdrawal by Subject|7|||
94483534|NCT01051921|323563365|FG000|Overall Study|Lost to Follow-up|4|||
94483535|NCT01051921|323563365|FG000|Overall Study|virological failure|1|||
94483536|NCT01051921|323563365|FG000|Overall Study|patient moved|1|||
94483537|NCT02486692|323563370|FG000|Overall Study|did not login for randomization|4|||
94483538|NCT02486692|323563371|FG001|Overall Study|did not login for randomization|7|||
94483539|NCT01716806|323563376|FG000|Overall Study|Patient withdrawal of consent|4|||
94483540|NCT01716806|323563377|FG001|Overall Study|Patient withdrawal of consent|2|||
94483541|NCT01716806|323563378|FG002|Overall Study|Patient withdrawal of consent|4|||
94483542|NCT01716806|323563379|FG003|Overall Study|Patient withdrawal of consent|3|||
94483543|NCT01716806|323563380|FG004|Overall Study|Patient withdrawal of consent|2|||
94483544|NCT01716806|323563381|FG005|Overall Study|Patient withdrawal of consent|0|||
94483545|NCT01716806|323563376|FG000|Overall Study|Lost to Follow-up|3|||
94483546|NCT01716806|323563377|FG001|Overall Study|Lost to Follow-up|3|||
94483547|NCT01716806|323563378|FG002|Overall Study|Lost to Follow-up|0|||
94483548|NCT01716806|323563379|FG003|Overall Study|Lost to Follow-up|2|||
94483549|NCT01716806|323563380|FG004|Overall Study|Lost to Follow-up|1|||
94483550|NCT01716806|323563381|FG005|Overall Study|Lost to Follow-up|0|||
94483551|NCT01716806|323563376|FG000|Overall Study|Death|13|||
94483552|NCT01716806|323563377|FG001|Overall Study|Death|9|||
94483553|NCT01716806|323563378|FG002|Overall Study|Death|12|||
94483554|NCT01716806|323563379|FG003|Overall Study|Death|4|||
94483555|NCT01716806|323563380|FG004|Overall Study|Death|10|||
94483556|NCT01716806|323563381|FG005|Overall Study|Death|5|||
94483557|NCT01716806|323563376|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
94483558|NCT01716806|323563377|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
94483559|NCT01716806|323563378|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
94483560|NCT01716806|323563379|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
94483561|NCT01716806|323563380|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
94483562|NCT01716806|323563381|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
94483563|NCT01716806|323563376|FG000|Overall Study|PI decision|0|||
94483564|NCT01716806|323563377|FG001|Overall Study|PI decision|0|||
94483565|NCT01716806|323563378|FG002|Overall Study|PI decision|0|||
94483566|NCT01716806|323563379|FG003|Overall Study|PI decision|0|||
94483567|NCT01716806|323563380|FG004|Overall Study|PI decision|1|||
94483568|NCT01716806|323563381|FG005|Overall Study|PI decision|0|||
94328630|NCT01641991|322982704|FG000|Overall Study|no longer eligible|2|||
94483569|NCT01716806|323563376|FG000|Overall Study|Change in performance status|1|||
94483570|NCT01716806|323563377|FG001|Overall Study|Change in performance status|0|||
94483571|NCT01716806|323563378|FG002|Overall Study|Change in performance status|0|||
94483572|NCT01716806|323563379|FG003|Overall Study|Change in performance status|0|||
94483573|NCT01716806|323563380|FG004|Overall Study|Change in performance status|0|||
94483574|NCT01716806|323563381|FG005|Overall Study|Change in performance status|0|||
94483575|NCT01716806|323563376|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
94483576|NCT01716806|323563377|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
94483577|NCT01716806|323563378|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
94483578|NCT01716806|323563379|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
94483579|NCT01716806|323563380|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
94483580|NCT01716806|323563381|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
94483581|NCT01716806|323563376|FG000|Overall Study|Sponsor direction|7|||
94483582|NCT01716806|323563377|FG001|Overall Study|Sponsor direction|8|||
94483583|NCT01716806|323563378|FG002|Overall Study|Sponsor direction|5|||
94483584|NCT01716806|323563379|FG003|Overall Study|Sponsor direction|12|||
94483585|NCT01716806|323563380|FG004|Overall Study|Sponsor direction|16|||
94483586|NCT01716806|323563381|FG005|Overall Study|Sponsor direction|1|||
94483587|NCT01128296|323563382|FG000|Overall Study|Physician Decision|0|||
94483588|NCT01128296|323563383|FG001|Overall Study|Physician Decision|0|||
94483589|NCT01128296|323563384|FG002|Overall Study|Physician Decision|0|||
94483590|NCT01128296|323563385|FG003|Overall Study|Physician Decision|0|||
94483591|NCT01128296|323563386|FG004|Overall Study|Physician Decision|0|||
94483592|NCT01128296|323563387|FG005|Overall Study|Physician Decision|3|||
94483593|NCT01128296|323563382|FG000|Overall Study|Withdrawal by Subject|0|||
94483594|NCT01128296|323563383|FG001|Overall Study|Withdrawal by Subject|0|||
94483595|NCT01128296|323563384|FG002|Overall Study|Withdrawal by Subject|0|||
94483596|NCT01128296|323563385|FG003|Overall Study|Withdrawal by Subject|0|||
94483597|NCT01128296|323563386|FG004|Overall Study|Withdrawal by Subject|0|||
94483598|NCT01128296|323563387|FG005|Overall Study|Withdrawal by Subject|2|||
94483599|NCT03316586|323563388|FG000|Overall Study|Adverse Event|2|||
94483600|NCT03316586|323563388|FG000|Overall Study|Physician Decision|3|||
94483601|NCT03316586|323563388|FG000|Overall Study|Lack of Efficacy|10|||
94483602|NCT03316586|323563388|FG000|Overall Study|still on treatment|1|||
94483603|NCT03316586|323563388|FG000|Overall Study|Patient needed radiation therapy|1|||
94483604|NCT03316586|323563388|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
94483605|NCT03934216|323563389|FG000|Overall Study|Other Reasons|5|||
94483606|NCT03934216|323563390|FG001|Overall Study|Other Reasons|5|||
94483607|NCT03934216|323563389|FG000|Overall Study|Adverse Event|22|||
94483608|NCT03934216|323563390|FG001|Overall Study|Adverse Event|11|||
94483609|NCT03934216|323563389|FG000|Overall Study|Lack of Efficacy|8|||
94483610|NCT03934216|323563390|FG001|Overall Study|Lack of Efficacy|7|||
94483611|NCT03934216|323563389|FG000|Overall Study|Lost to Follow-up|2|||
94483612|NCT03934216|323563390|FG001|Overall Study|Lost to Follow-up|0|||
94483613|NCT03934216|323563389|FG000|Overall Study|Non-Compliance with Study Drug|1|||
94483614|NCT03934216|323563390|FG001|Overall Study|Non-Compliance with Study Drug|1|||
94483615|NCT03934216|323563389|FG000|Overall Study|Pregnancy|1|||
94483616|NCT03934216|323563390|FG001|Overall Study|Pregnancy|0|||
94483617|NCT03934216|323563389|FG000|Overall Study|Withdrawal by Subject|18|||
94392383|NCT00105196|323225271|FG000|Overall Study|Withdrawal by Subject|6|||
94392384|NCT00105196|323225272|FG001|Overall Study|Withdrawal by Subject|6|||
94392385|NCT00105196|323225271|FG000|Overall Study|Lost to Follow-up|3|||
94392386|NCT00105196|323225272|FG001|Overall Study|Lost to Follow-up|2|||
94392387|NCT00105196|323225271|FG000|Overall Study|Poor/noncompliance|3|||
94392388|NCT00105196|323225272|FG001|Overall Study|Poor/noncompliance|4|||
94392389|NCT00105196|323225271|FG000|Overall Study|Protocol Violation|5|||
94392390|NCT00105196|323225272|FG001|Overall Study|Protocol Violation|2|||
94392391|NCT00105196|323225271|FG000|Overall Study|pending surgery|0|||
94392392|NCT00105196|323225272|FG001|Overall Study|pending surgery|1|||
94392393|NCT00105196|323225271|FG000|Overall Study|marijuana use|0|||
94392394|NCT00105196|323225272|FG001|Overall Study|marijuana use|1|||
94392395|NCT00105196|323225271|FG000|Overall Study|Subject became unblinded|0|||
94392396|NCT00105196|323225272|FG001|Overall Study|Subject became unblinded|1|||
94392397|NCT02472366|323225275|FG000|Overall Study|Lost to Follow-up|1|||
94392398|NCT02472366|323225276|FG001|Overall Study|Lost to Follow-up|0|||
94392399|NCT01981720|323225279|FG000|Overall Study|Adverse Event|1|||
94392400|NCT01981720|323225279|FG000|Overall Study|Withdrawal by Subject|3|||
94392401|NCT01981720|323225279|FG000|Overall Study|Pregnancy|1|||
94392402|NCT03956862|323225280|FG000|Overall Study|Lost to Follow-up|1|||
94483618|NCT03934216|323563390|FG001|Overall Study|Withdrawal by Subject|6|||
94392403|NCT03956862|323225281|FG001|Overall Study|Lost to Follow-up|1|||
94392404|NCT03956862|323225280|FG000|Overall Study|Withdrawal by Subject|1|||
94392405|NCT03956862|323225281|FG001|Overall Study|Withdrawal by Subject|1|||
94392406|NCT00467363|323225284|FG000|Overall Study|Lost to Follow-up|80|||
94392407|NCT00467363|323225285|FG001|Overall Study|Lost to Follow-up|70|||
94483619|NCT03934216|323563389|FG000|Overall Study|Randomized but not treated|1|||
94392408|NCT04060147|323225293|FG000|Overall Study|Withdrew consent|1|||
94483620|NCT03934216|323563390|FG001|Overall Study|Randomized but not treated|1|||
94483621|NCT02063672|323563391|FG000|Overall Study|Ongoing Follow-up|27|||
94483622|NCT02063672|323563392|FG001|Overall Study|Ongoing Follow-up|14|||
94483623|NCT02063672|323563391|FG000|Overall Study|Death|5|||
94483624|NCT02063672|323563392|FG001|Overall Study|Death|3|||
94483625|NCT02063672|323563391|FG000|Overall Study|Lost to Follow-up|1|||
94483626|NCT02063672|323563392|FG001|Overall Study|Lost to Follow-up|3|||
94483627|NCT02063672|323563391|FG000|Overall Study|Withdrawal by Subject|2|||
94483628|NCT02063672|323563392|FG001|Overall Study|Withdrawal by Subject|2|||
94483629|NCT01914393|323563399|FG000|Overall Study|Protocol Violation|11|||
94483630|NCT01914393|323563400|FG001|Overall Study|Protocol Violation|3|||
94483631|NCT01914393|323563401|FG002|Overall Study|Protocol Violation|19|||
94483632|NCT01914393|323563399|FG000|Overall Study|Lack of Efficacy|11|||
94483633|NCT01914393|323563400|FG001|Overall Study|Lack of Efficacy|16|||
94483634|NCT01914393|323563401|FG002|Overall Study|Lack of Efficacy|5|||
94483635|NCT01914393|323563399|FG000|Overall Study|no reason given|14|||
94483636|NCT01914393|323563400|FG001|Overall Study|no reason given|8|||
94483637|NCT01914393|323563401|FG002|Overall Study|no reason given|16|||
94483638|NCT01914393|323563399|FG000|Overall Study|Adverse Event|29|||
94483639|NCT01914393|323563400|FG001|Overall Study|Adverse Event|18|||
94483640|NCT01914393|323563401|FG002|Overall Study|Adverse Event|31|||
94483641|NCT01914393|323563399|FG000|Overall Study|Withdrawal by Subject|38|||
94483642|NCT01914393|323563400|FG001|Overall Study|Withdrawal by Subject|20|||
94483643|NCT01914393|323563401|FG002|Overall Study|Withdrawal by Subject|47|||
94483644|NCT01914393|323563399|FG000|Overall Study|Lost to Follow-up|12|||
94483645|NCT01914393|323563400|FG001|Overall Study|Lost to Follow-up|6|||
94483646|NCT01914393|323563401|FG002|Overall Study|Lost to Follow-up|19|||
94483647|NCT01914393|323563399|FG000|Overall Study|subject never dosed|0|||
94483648|NCT01914393|323563400|FG001|Overall Study|subject never dosed|0|||
94483649|NCT01914393|323563401|FG002|Overall Study|subject never dosed|1|||
94483650|NCT01396083|323563402|FG000|Overall Study|Adverse Event|2|||
94483651|NCT01396083|323563403|FG001|Overall Study|Adverse Event|28|||
94483652|NCT01396083|323563402|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
94483653|NCT01396083|323563403|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
94483654|NCT01396083|323563402|FG000|Overall Study|Consent withdrawn|4|||
94483655|NCT01396083|323563403|FG001|Overall Study|Consent withdrawn|5|||
94483656|NCT01396083|323563402|FG000|Overall Study|Protocol deviation(s)|0|||
94483657|NCT01396083|323563403|FG001|Overall Study|Protocol deviation(s)|1|||
94483658|NCT01396083|323563402|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94483659|NCT01396083|323563403|FG001|Overall Study|Abnormal laboratory value(s)|0|||
94483660|NCT01396083|323563402|FG000|Overall Study|Administrative problems|1|||
94483661|NCT01396083|323563403|FG001|Overall Study|Administrative problems|0|||
94483662|NCT01396083|323563402|FG000|Overall Study|Lost to Follow-up|1|||
94483663|NCT01396083|323563403|FG001|Overall Study|Lost to Follow-up|0|||
94483664|NCT01063855|323563404|FG000|Overall Study|Adverse Event|4|||
94483665|NCT01063855|323563405|FG001|Overall Study|Adverse Event|4|||
94483666|NCT01063855|323563404|FG000|Overall Study|Death|0|||
94483667|NCT01063855|323563405|FG001|Overall Study|Death|1|||
94483668|NCT01063855|323563404|FG000|Overall Study|Lost to Follow-up|8|||
94483669|NCT01063855|323563405|FG001|Overall Study|Lost to Follow-up|4|||
94483670|NCT01063855|323563404|FG000|Overall Study|Pregnancy|1|||
94483671|NCT01063855|323563405|FG001|Overall Study|Pregnancy|0|||
94483672|NCT01063855|323563404|FG000|Overall Study|Lack of Efficacy|0|||
94483673|NCT01063855|323563405|FG001|Overall Study|Lack of Efficacy|1|||
94483674|NCT01063855|323563404|FG000|Overall Study|Withdrawal by Subject|11|||
94483675|NCT01063855|323563405|FG001|Overall Study|Withdrawal by Subject|8|||
94483676|NCT01063855|323563404|FG000|Overall Study|Reason not specified|13|||
94483677|NCT01063855|323563405|FG001|Overall Study|Reason not specified|11|||
94483678|NCT02806713|323563406|FG000|Overall Study|Urethral injury during procedure|1|||
94483679|NCT02806713|323563407|FG001|Overall Study|Urethral injury during procedure|0|||
94483680|NCT02806713|323563406|FG000|Overall Study|cancelled surgery|1|||
94483681|NCT02806713|323563407|FG001|Overall Study|cancelled surgery|2|||
94483682|NCT01165307|323563408|FG000|Overall Study|Lost to Follow-up|11|||
94483683|NCT01165307|323563409|FG001|Overall Study|Lost to Follow-up|3|||
94483684|NCT01165307|323563408|FG000|Overall Study|Withdrawal by Subject|2|||
94483685|NCT01165307|323563409|FG001|Overall Study|Withdrawal by Subject|0|||
94483686|NCT01165307|323563408|FG000|Overall Study|Subject not available for contact|1|||
94483687|NCT01165307|323563409|FG001|Overall Study|Subject not available for contact|0|||
94483688|NCT02999789|323563413|FG000|Overall Study|Withdrawal by Subject|0|||
94483689|NCT02999789|323563414|FG001|Overall Study|Withdrawal by Subject|1|||
94483690|NCT02999789|323563413|FG000|Overall Study|Became ineligible|1|||
94483691|NCT02999789|323563414|FG001|Overall Study|Became ineligible|2|||
94483692|NCT01111565|323563415|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
94483693|NCT01111565|323563416|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
94483694|NCT01111565|323563417|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
94483695|NCT01111565|323563418|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
94483696|NCT01111565|323563419|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
94483697|NCT01111565|323563415|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
94483698|NCT01111565|323563416|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
94483699|NCT01111565|323563417|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
94483700|NCT01111565|323563418|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
94483701|NCT01111565|323563419|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
94483702|NCT01111565|323563415|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
94483703|NCT01111565|323563416|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
94483704|NCT01111565|323563417|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
94483705|NCT01111565|323563418|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
94392409|NCT02159183|323225294|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
94392410|NCT02159183|323225295|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
94392411|NCT02159183|323225294|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
94392412|NCT02159183|323225295|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
94392413|NCT02159183|323225294|FG000|Analysis After the 36 Months Follow-up|Death|0|||
94392414|NCT02159183|323225295|FG001|Analysis After the 36 Months Follow-up|Death|1|||
94392415|NCT02159183|323225294|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
94392416|NCT02159183|323225295|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
94392417|NCT02159183|323225294|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
94392418|NCT02159183|323225295|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
94392419|NCT05169710|323225299|FG000|Overall Study|Adverse Event|1|||
94392420|NCT05169710|323225300|FG001|Overall Study|Adverse Event|2|||
94392421|NCT05169710|323225301|FG002|Overall Study|Adverse Event|2|||
94392422|NCT05169710|323225299|FG000|Overall Study|Lost to Follow-up|0|||
94392423|NCT05169710|323225300|FG001|Overall Study|Lost to Follow-up|0|||
94392424|NCT05169710|323225301|FG002|Overall Study|Lost to Follow-up|1|||
94392425|NCT05169710|323225299|FG000|Overall Study|Withdrawal by Subject|2|||
94392426|NCT05169710|323225300|FG001|Overall Study|Withdrawal by Subject|1|||
94392427|NCT05169710|323225301|FG002|Overall Study|Withdrawal by Subject|0|||
94392428|NCT05169710|323225299|FG000|Overall Study|Other Study Discontinuation Reason|0|||
94392429|NCT05169710|323225300|FG001|Overall Study|Other Study Discontinuation Reason|2|||
94392430|NCT05169710|323225301|FG002|Overall Study|Other Study Discontinuation Reason|0|||
94392431|NCT00836056|323225302|FG000|First Intervention|Adverse Event|1|||
94392432|NCT00836056|323225303|FG001|First Intervention|Adverse Event|0|||
94392433|NCT02645409|323225304|FG000|Overall Study|Withdrawal by Subject|3|||
94392434|NCT02645409|323225305|FG001|Overall Study|Withdrawal by Subject|0|||
94392435|NCT02645409|323225304|FG000|Overall Study|Physician Decision|1|||
94392436|NCT02645409|323225305|FG001|Overall Study|Physician Decision|0|||
94392437|NCT02601560|323225307|FG000|Overall Study|Other|0|||
94392438|NCT02601560|323225308|FG001|Overall Study|Other|0|||
94392439|NCT02601560|323225309|FG002|Overall Study|Other|0|||
94392440|NCT02601560|323225310|FG003|Overall Study|Other|0|||
94392441|NCT02601560|323225311|FG004|Overall Study|Other|0|||
94392442|NCT02601560|323225312|FG005|Overall Study|Other|0|||
94392443|NCT02601560|323225313|FG006|Overall Study|Other|1|||
94392444|NCT02601560|323225314|FG007|Overall Study|Other|0|||
94392445|NCT01576042|323225317|FG000|Overall Study|Physician Decision|2|||
94392446|NCT01576042|323225318|FG001|Overall Study|Physician Decision|0|||
94392447|NCT01302548|323225322|FG000|Overall Study|Lost to Follow-up|2|||
94392448|NCT01302548|323225323|FG001|Overall Study|Lost to Follow-up|1|||
94392449|NCT04646213|323225324|FG000|Overall Study|Physician Decision|3|||
94392450|NCT04646213|323225324|FG000|Overall Study|Withdrawal by Subject|2|||
94392451|NCT03600376|323225325|FG000|Overall Study|Adverse Event|1|||
94392452|NCT03600376|323225326|FG001|Overall Study|Adverse Event|1|||
94392453|NCT03600376|323225325|FG000|Overall Study|Transferred to other facility|1|||
94392454|NCT03600376|323225326|FG001|Overall Study|Transferred to other facility|0|||
94392455|NCT03600376|323225325|FG000|Overall Study|Investigator Decision|0|||
94392456|NCT03600376|323225326|FG001|Overall Study|Investigator Decision|4|||
94392457|NCT03600376|323225325|FG000|Overall Study|Determined to be ineligible for study|0|||
94392458|NCT03600376|323225326|FG001|Overall Study|Determined to be ineligible for study|1|||
94392459|NCT00424047|323225329|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
94392460|NCT00424047|323225330|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
94392461|NCT00424047|323225329|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
94392462|NCT00424047|323225330|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
94392463|NCT00424047|323225329|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
94392464|NCT00424047|323225330|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
94392465|NCT00424047|323225329|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
94392466|NCT00424047|323225330|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
94392467|NCT00424047|323225329|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
94392468|NCT00424047|323225330|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
94392469|NCT00424047|323225329|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
94392470|NCT00424047|323225330|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
94392471|NCT00424047|323225329|FG000|On Study at Time of Unblinding|Adverse Event|22|||
94392472|NCT00424047|323225330|FG001|On Study at Time of Unblinding|Adverse Event|12|||
94392473|NCT00424047|323225329|FG000|On Study at Time of Unblinding|Progression of disease|92|||
94392474|NCT00424047|323225330|FG001|On Study at Time of Unblinding|Progression of disease|128|||
94392475|NCT00424047|323225329|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
94392476|NCT00424047|323225330|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
94392477|NCT00424047|323225329|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
94392478|NCT00424047|323225330|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
94392479|NCT00424047|323225329|FG000|On Study at Time of Unblinding|Death|11|||
94392480|NCT00424047|323225330|FG001|On Study at Time of Unblinding|Death|11|||
94392481|NCT00424047|323225329|FG000|On Study at Time of Unblinding|Other|5|||
94483706|NCT01111565|323563419|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
94483707|NCT01111565|323563415|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
94483708|NCT01111565|323563416|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
94483709|NCT01111565|323563417|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
94483710|NCT01111565|323563418|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
94483711|NCT01111565|323563419|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
94483712|NCT01111565|323563415|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
94483713|NCT01111565|323563416|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
94483714|NCT01111565|323563417|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
94483715|NCT01111565|323563418|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
94483716|NCT01111565|323563419|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
94483717|NCT01111565|323563415|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
94483718|NCT01111565|323563416|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
94483719|NCT01111565|323563417|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
94483720|NCT01111565|323563418|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
94483721|NCT01111565|323563419|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
94483722|NCT01111565|323563415|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
94483723|NCT01111565|323563416|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
94483724|NCT01111565|323563417|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
94483725|NCT01111565|323563418|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
94483726|NCT01111565|323563419|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
94483727|NCT01111565|323563415|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
94483728|NCT01111565|323563416|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
94483729|NCT01111565|323563417|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
94483730|NCT01111565|323563418|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
94483731|NCT01111565|323563419|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
94483732|NCT01111565|323563415|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
94483733|NCT01111565|323563416|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
94483734|NCT01111565|323563417|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
94483735|NCT01111565|323563418|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
94483736|NCT01111565|323563419|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
94483737|NCT01111565|323563415|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
94483738|NCT01111565|323563416|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
94483739|NCT01111565|323563417|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
94483740|NCT01111565|323563418|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
94483741|NCT01111565|323563419|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
94483742|NCT01111565|323563415|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
94483743|NCT01111565|323563416|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
94483744|NCT01111565|323563417|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
94483745|NCT01111565|323563418|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
94483746|NCT01111565|323563419|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
94483747|NCT01111565|323563415|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
94483748|NCT01111565|323563416|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
94483749|NCT01111565|323563417|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
94483750|NCT01111565|323563418|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
94483751|NCT01111565|323563419|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
94483752|NCT00521365|323563424|FG000|Overall Study|Adverse Event|3|||
94483753|NCT00521365|323563424|FG000|Overall Study|Lost to Follow-up|6|||
94483754|NCT00521365|323563424|FG000|Overall Study|Protocol deviation|2|||
94483755|NCT00521365|323563424|FG000|Overall Study|Drug compliance|3|||
94483756|NCT00521365|323563424|FG000|Overall Study|Usage of not allowed drugs|6|||
94483757|NCT01718483|323563425|FG000|Overall Study|Withdrawal by Subject|14|||
94483758|NCT01718483|323563426|FG001|Overall Study|Withdrawal by Subject|12|||
94483759|NCT01718483|323563425|FG000|Overall Study|Adverse Event|5|||
94483760|NCT01718483|323563426|FG001|Overall Study|Adverse Event|12|||
94483761|NCT01718483|323563425|FG000|Overall Study|Lost to Follow-up|8|||
94483762|NCT01718483|323563426|FG001|Overall Study|Lost to Follow-up|3|||
94483763|NCT01718483|323563425|FG000|Overall Study|Protocol Violation|4|||
94483764|NCT01718483|323563426|FG001|Overall Study|Protocol Violation|2|||
94483765|NCT01718483|323563425|FG000|Overall Study|Other|1|||
94483766|NCT01718483|323563426|FG001|Overall Study|Other|4|||
94483767|NCT01718483|323563425|FG000|Overall Study|Pregnancy|1|||
94483768|NCT01718483|323563426|FG001|Overall Study|Pregnancy|1|||
94483769|NCT01718483|323563425|FG000|Overall Study|Lack of Efficacy|1|||
94483770|NCT01718483|323563426|FG001|Overall Study|Lack of Efficacy|0|||
94483771|NCT02974868|323563436|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
94483772|NCT02974868|323563437|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
94483773|NCT02974868|323563438|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
94392482|NCT00424047|323225330|FG001|On Study at Time of Unblinding|Other|4|||
94392483|NCT00424047|323225329|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
94392484|NCT00424047|323225330|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
94392485|NCT00424047|323225329|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
94392486|NCT00424047|323225330|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
94392487|NCT00424047|323225329|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
94392488|NCT00424047|323225330|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
94392489|NCT00424047|323225329|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
94392490|NCT00424047|323225330|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
94392491|NCT00424047|323225329|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
94392492|NCT00424047|323225330|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
94392493|NCT01686477|323225335|FG000|Feeding Intervention|Death|1|||
94392494|NCT01686477|323225336|FG001|Feeding Intervention|Death|0|||
94392495|NCT01686477|323225337|FG002|Feeding Intervention|Death|1|||
94392496|NCT01686477|323225335|FG000|Feeding Intervention|Withdrawal by Subject|0|||
94392497|NCT01686477|323225336|FG001|Feeding Intervention|Withdrawal by Subject|6|||
94392498|NCT01686477|323225337|FG002|Feeding Intervention|Withdrawal by Subject|0|||
94392499|NCT01686477|323225335|FG000|Feeding Intervention|Physician Decision|1|||
94392500|NCT01686477|323225336|FG001|Feeding Intervention|Physician Decision|2|||
94392501|NCT01686477|323225337|FG002|Feeding Intervention|Physician Decision|0|||
94392502|NCT01686477|323225335|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
94392503|NCT01686477|323225336|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
94392504|NCT01686477|323225337|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
94392505|NCT01686477|323225335|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
94392506|NCT01686477|323225336|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
94392507|NCT01686477|323225337|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
94392508|NCT01686477|323225335|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
94392509|NCT01686477|323225336|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
94392510|NCT01686477|323225337|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
94392511|NCT01686477|323225335|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
94392512|NCT01686477|323225336|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
94392513|NCT01686477|323225337|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
94392514|NCT01686477|323225335|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
94392515|NCT01686477|323225336|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
94392516|NCT01686477|323225337|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
94392517|NCT01686477|323225335|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
94392518|NCT01686477|323225336|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
94392519|NCT01686477|323225337|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
94392520|NCT01686477|323225335|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
94392521|NCT01686477|323225336|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
94392522|NCT01686477|323225337|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
94392523|NCT03238781|323225338|FG000|Overall Study|Adverse Event|1|||
94392524|NCT03238781|323225339|FG001|Overall Study|Adverse Event|1|||
94392525|NCT03238781|323225340|FG002|Overall Study|Adverse Event|2|||
94392526|NCT03238781|323225338|FG000|Overall Study|Lost to Follow-up|2|||
94392527|NCT03238781|323225339|FG001|Overall Study|Lost to Follow-up|1|||
94392528|NCT03238781|323225340|FG002|Overall Study|Lost to Follow-up|2|||
94392529|NCT03238781|323225338|FG000|Overall Study|Withdrawal by Subject|23|||
94392530|NCT03238781|323225339|FG001|Overall Study|Withdrawal by Subject|14|||
94392531|NCT03238781|323225340|FG002|Overall Study|Withdrawal by Subject|16|||
94392532|NCT03238781|323225338|FG000|Overall Study|Decision by sponsor|0|||
94392533|NCT03238781|323225339|FG001|Overall Study|Decision by sponsor|1|||
94392534|NCT03238781|323225340|FG002|Overall Study|Decision by sponsor|0|||
94392535|NCT03880266|323225341|FG000|Overall Study|Withdrawal by Subject|0|||
94392536|NCT03880266|323225342|FG001|Overall Study|Withdrawal by Subject|1|||
94392537|NCT03880266|323225343|FG002|Overall Study|Withdrawal by Subject|1|||
94392538|NCT03880266|323225344|FG003|Overall Study|Withdrawal by Subject|0|||
94392539|NCT03880266|323225345|FG004|Overall Study|Withdrawal by Subject|0|||
94392540|NCT03880266|323225346|FG005|Overall Study|Withdrawal by Subject|0|||
94392541|NCT03880266|323225347|FG006|Overall Study|Withdrawal by Subject|0|||
94392542|NCT03880266|323225348|FG007|Overall Study|Withdrawal by Subject|0|||
94392543|NCT02186821|323225353|FG000|Overall Study|Adverse Event|9|||
94392544|NCT02186821|323225353|FG000|Overall Study|Death|2|||
94392545|NCT02186821|323225353|FG000|Overall Study|Disease progression|32|||
94392546|NCT02186821|323225353|FG000|Overall Study|Protocol Violation|1|||
94392547|NCT02186821|323225353|FG000|Overall Study|Physician Decision|1|||
94392548|NCT02186821|323225353|FG000|Overall Study|Study terminated by sponsor|2|||
94392549|NCT01421277|323225354|FG000|Overall Study|Lack of qualifying event|0|||
94392550|NCT01421277|323225355|FG001|Overall Study|Lack of qualifying event|61|||
94392551|NCT01421277|323225354|FG000|Overall Study|Incomplete baseline data|0|||
94392552|NCT01421277|323225355|FG001|Overall Study|Incomplete baseline data|31|||
94392553|NCT00813592|323225356|FG000|Overall Study|Disease assessment was not completed per|2|||
94392554|NCT00787254|323225357|FG000|Overall Study|Adverse Event|24|||
94392555|NCT00787254|323225358|FG001|Overall Study|Adverse Event|23|||
94392556|NCT00787254|323225357|FG000|Overall Study|Protocol Violation|26|||
94392557|NCT00787254|323225358|FG001|Overall Study|Protocol Violation|23|||
94392558|NCT00787254|323225357|FG000|Overall Study|Withdrawal by Subject|16|||
94392559|NCT00787254|323225358|FG001|Overall Study|Withdrawal by Subject|11|||
94392560|NCT00787254|323225357|FG000|Overall Study|Lack of Efficacy|4|||
94392561|NCT00787254|323225358|FG001|Overall Study|Lack of Efficacy|15|||
94392562|NCT00787254|323225357|FG000|Overall Study|NSAIDs discontinuation|1|||
94392563|NCT00787254|323225358|FG001|Overall Study|NSAIDs discontinuation|2|||
94392564|NCT00787254|323225357|FG000|Overall Study|Institution closed|1|||
94392565|NCT00787254|323225358|FG001|Overall Study|Institution closed|0|||
94392566|NCT00787254|323225357|FG000|Overall Study|Physician Decision|4|||
94392567|NCT00787254|323225358|FG001|Overall Study|Physician Decision|8|||
94392568|NCT03649477|323225359|FG000|Overall Study|Adverse Event|2|||
94392569|NCT03649477|323225360|FG001|Overall Study|Adverse Event|0|||
94392570|NCT03649477|323225361|FG002|Overall Study|Adverse Event|0|||
94392571|NCT02128997|323226403|FG000|Overall Study|Lost to Follow-up|6|||
94392572|NCT02128997|323226404|FG001|Overall Study|Lost to Follow-up|11|||
94392573|NCT03988803|323226405|FG000|Period 2|Prematurely discontinued from medication|2|||
94392574|NCT03988803|323226405|FG000|Period 2|Adverse Event|1|||
94392575|NCT03021018|323226409|FG000|Overall Study|Adverse Event|1|||
94392576|NCT03021018|323226410|FG001|Overall Study|Adverse Event|0|||
94392577|NCT03021018|323226411|FG002|Overall Study|Adverse Event|0|||
94392578|NCT03021018|323226409|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
94392579|NCT03021018|323226410|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
94392580|NCT03021018|323226411|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
94392581|NCT01802320|323226413|FG000|Overall Study|Death|1|||
94392582|NCT01802320|323226413|FG000|Overall Study|Withdrawal by Subject|1|||
94392583|NCT00620074|323226415|FG000|Overall Study|Adverse Event|1|||
94392584|NCT01247701|323226418|FG000|Overall Study|Death|2|||
94392585|NCT01247701|323226418|FG000|Overall Study|Relapsed|8|||
94392586|NCT00829790|323226419|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
94392587|NCT00829790|323226420|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
94392588|NCT00829530|323226421|FG000|First Intervention|Adverse Event|0|||
94392589|NCT00829530|323226422|FG001|First Intervention|Adverse Event|1|||
94392590|NCT00829530|323226421|FG000|First Intervention|Intolerance to Venopuncture|0|||
94392591|NCT00829530|323226422|FG001|First Intervention|Intolerance to Venopuncture|1|||
94392592|NCT00829530|323226421|FG000|Second Intervention|Intolerance to Venopuncture|1|||
94392593|NCT00829530|323226422|FG001|Second Intervention|Intolerance to Venopuncture|0|||
94392594|NCT00834756|323226430|FG000|First Intervention|Adverse Event|1|||
94392595|NCT00834756|323226431|FG001|First Intervention|Adverse Event|0|||
94392596|NCT00834756|323226430|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
94392597|NCT00834756|323226431|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
94392598|NCT03620747|323226432|FG000|Overall Study|Participant decision|7|||
94392599|NCT03620747|323226432|FG000|Overall Study|Adverse Event|6|||
94392600|NCT03620747|323226432|FG000|Overall Study|Lack of Efficacy|1|||
94392601|NCT03620747|323226432|FG000|Overall Study|Poor compliance to protocol|2|||
94392602|NCT03620747|323226432|FG000|Overall Study|Other-unspecified|3|||
94392603|NCT01010542|323226435|FG000|Overall Study|Adverse Event|0|||
94392604|NCT01010542|323226436|FG001|Overall Study|Adverse Event|1|||
94392605|NCT01010542|323226437|FG002|Overall Study|Adverse Event|0|||
94392606|NCT01010542|323226435|FG000|Overall Study|Lost to Follow-up|0|||
94392607|NCT01010542|323226436|FG001|Overall Study|Lost to Follow-up|1|||
94392608|NCT01010542|323226437|FG002|Overall Study|Lost to Follow-up|0|||
94392609|NCT01010542|323226435|FG000|Overall Study|Withdrawal by Subject|0|||
94392610|NCT01010542|323226436|FG001|Overall Study|Withdrawal by Subject|3|||
94392611|NCT01010542|323226437|FG002|Overall Study|Withdrawal by Subject|2|||
94392612|NCT02294604|323226438|FG000|Overall Study|Did not provide samples for culture|0|||
94392613|NCT02294604|323226439|FG001|Overall Study|Did not provide samples for culture|1|||
94392614|NCT02294604|323226440|FG002|Overall Study|Did not provide samples for culture|0|||
94392615|NCT02294604|323226438|FG000|Overall Study|Culture contamination|1|||
94392616|NCT02294604|323226439|FG001|Overall Study|Culture contamination|2|||
94392617|NCT02294604|323226440|FG002|Overall Study|Culture contamination|0|||
94392618|NCT01472341|323226441|FG000|Overall Study|Started insulin therapy|55|||
94392619|NCT01472341|323226441|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
94392620|NCT01472341|323226441|FG000|Overall Study|Withdrawal by Subject|39|||
94392621|NCT01472341|323226441|FG000|Overall Study|Lost to Follow-up|52|||
94392622|NCT01472341|323226441|FG000|Overall Study|Laboratory parameters unavailable|25|||
94392623|NCT01472341|323226441|FG000|Overall Study|Death|9|||
94392624|NCT01363765|323226445|FG000|Overall Study|non-diagnostic|2621|||
94392625|NCT01363765|323226446|FG001|Overall Study|non-diagnostic|1124|||
94392626|NCT01363765|323226445|FG000|Overall Study|duplicate records|736|||
94392627|NCT01363765|323226446|FG001|Overall Study|duplicate records|3177|||
94392628|NCT01363765|323226445|FG000|Overall Study|non-resident|156|||
94392629|NCT01363765|323226446|FG001|Overall Study|non-resident|76|||
94392630|NCT01363765|323226445|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
94483774|NCT02974868|323563439|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
94328631|NCT01641991|322982705|FG001|Overall Study|no longer eligible|1|||
94328632|NCT01641991|322982706|FG002|Overall Study|no longer eligible|0|||
94328633|NCT01641991|322982707|FG003|Overall Study|no longer eligible|4|||
94328634|NCT01195363|322982708|FG000|Overall Study|Lost to Follow-up|7|||
94328635|NCT01195363|322982709|FG001|Overall Study|Lost to Follow-up|4|||
94328636|NCT01195363|322982708|FG000|Overall Study|Adverse Event|3|||
94328637|NCT01195363|322982709|FG001|Overall Study|Adverse Event|1|||
94328638|NCT01195363|322982708|FG000|Overall Study|Lack of Efficacy|0|||
94328639|NCT01195363|322982709|FG001|Overall Study|Lack of Efficacy|4|||
94328640|NCT01195363|322982708|FG000|Overall Study|incarceration|1|||
94328641|NCT01195363|322982709|FG001|Overall Study|incarceration|0|||
94328642|NCT01763866|322982710|FG000|Overall Study|Withdrawal by Subject|2|||
94328643|NCT01763866|322982711|FG001|Overall Study|Withdrawal by Subject|1|||
94328644|NCT01763866|322982712|FG002|Overall Study|Withdrawal by Subject|4|||
94328645|NCT01763866|322982713|FG003|Overall Study|Withdrawal by Subject|0|||
94328646|NCT01763866|322982714|FG004|Overall Study|Withdrawal by Subject|0|||
94328647|NCT01763866|322982715|FG005|Overall Study|Withdrawal by Subject|3|||
94328648|NCT01763866|322982716|FG006|Overall Study|Withdrawal by Subject|4|||
94328649|NCT01763866|322982717|FG007|Overall Study|Withdrawal by Subject|0|||
94328650|NCT01763866|322982718|FG008|Overall Study|Withdrawal by Subject|1|||
94328651|NCT01763866|322982719|FG009|Overall Study|Withdrawal by Subject|1|||
94328652|NCT01763866|322982720|FG010|Overall Study|Withdrawal by Subject|2|||
94328653|NCT01763866|322982721|FG011|Overall Study|Withdrawal by Subject|2|||
94328654|NCT01763866|322982722|FG012|Overall Study|Withdrawal by Subject|2|||
94328655|NCT01763866|322982723|FG013|Overall Study|Withdrawal by Subject|0|||
94328656|NCT01763866|322982724|FG014|Overall Study|Withdrawal by Subject|6|||
94328657|NCT01763866|322982725|FG015|Overall Study|Withdrawal by Subject|3|||
94328658|NCT01763866|322982726|FG016|Overall Study|Withdrawal by Subject|0|||
94328659|NCT01763866|322982727|FG017|Overall Study|Withdrawal by Subject|1|||
94328660|NCT01763866|322982728|FG018|Overall Study|Withdrawal by Subject|1|||
94328661|NCT01763866|322982729|FG019|Overall Study|Withdrawal by Subject|1|||
94328662|NCT01763866|322982730|FG020|Overall Study|Withdrawal by Subject|2|||
94328663|NCT01763866|322982731|FG021|Overall Study|Withdrawal by Subject|1|||
94328664|NCT01763866|322982732|FG022|Overall Study|Withdrawal by Subject|2|||
94328665|NCT01763866|322982733|FG023|Overall Study|Withdrawal by Subject|1|||
94328666|NCT01763866|322982710|FG000|Overall Study|Decision by sponsor|0|||
94328667|NCT01763866|322982711|FG001|Overall Study|Decision by sponsor|0|||
94328668|NCT01763866|322982712|FG002|Overall Study|Decision by sponsor|1|||
94328669|NCT01763866|322982713|FG003|Overall Study|Decision by sponsor|0|||
94328670|NCT01763866|322982714|FG004|Overall Study|Decision by sponsor|2|||
94328671|NCT01763866|322982715|FG005|Overall Study|Decision by sponsor|0|||
94328672|NCT01763866|322982716|FG006|Overall Study|Decision by sponsor|2|||
94328673|NCT01763866|322982717|FG007|Overall Study|Decision by sponsor|0|||
94328674|NCT01763866|322982718|FG008|Overall Study|Decision by sponsor|2|||
94328675|NCT01763866|322982719|FG009|Overall Study|Decision by sponsor|0|||
94328676|NCT01763866|322982720|FG010|Overall Study|Decision by sponsor|6|||
94328677|NCT01763866|322982721|FG011|Overall Study|Decision by sponsor|0|||
94328678|NCT01763866|322982722|FG012|Overall Study|Decision by sponsor|1|||
94328679|NCT01763866|322982723|FG013|Overall Study|Decision by sponsor|0|||
94328680|NCT01763866|322982724|FG014|Overall Study|Decision by sponsor|5|||
94328681|NCT01763866|322982725|FG015|Overall Study|Decision by sponsor|0|||
94328682|NCT01763866|322982726|FG016|Overall Study|Decision by sponsor|0|||
94328683|NCT01763866|322982727|FG017|Overall Study|Decision by sponsor|0|||
94328684|NCT01763866|322982728|FG018|Overall Study|Decision by sponsor|4|||
94328685|NCT01763866|322982729|FG019|Overall Study|Decision by sponsor|0|||
94328686|NCT01763866|322982730|FG020|Overall Study|Decision by sponsor|2|||
94328687|NCT01763866|322982731|FG021|Overall Study|Decision by sponsor|0|||
94328688|NCT01763866|322982732|FG022|Overall Study|Decision by sponsor|1|||
94328689|NCT01763866|322982733|FG023|Overall Study|Decision by sponsor|0|||
94328690|NCT01763866|322982710|FG000|Overall Study|Lost to Follow-up|0|||
94328691|NCT01763866|322982711|FG001|Overall Study|Lost to Follow-up|0|||
94328692|NCT01763866|322982712|FG002|Overall Study|Lost to Follow-up|0|||
94328693|NCT01763866|322982713|FG003|Overall Study|Lost to Follow-up|0|||
94328694|NCT01763866|322982714|FG004|Overall Study|Lost to Follow-up|0|||
94328695|NCT01763866|322982715|FG005|Overall Study|Lost to Follow-up|0|||
94328696|NCT01763866|322982716|FG006|Overall Study|Lost to Follow-up|1|||
94328697|NCT01763866|322982717|FG007|Overall Study|Lost to Follow-up|0|||
94328698|NCT01763866|322982718|FG008|Overall Study|Lost to Follow-up|0|||
94328699|NCT01763866|322982719|FG009|Overall Study|Lost to Follow-up|0|||
94328700|NCT01763866|322982720|FG010|Overall Study|Lost to Follow-up|0|||
94328701|NCT01763866|322982721|FG011|Overall Study|Lost to Follow-up|0|||
94328702|NCT01763866|322982722|FG012|Overall Study|Lost to Follow-up|1|||
94328703|NCT01763866|322982723|FG013|Overall Study|Lost to Follow-up|0|||
94328704|NCT01763866|322982724|FG014|Overall Study|Lost to Follow-up|1|||
94328705|NCT01763866|322982725|FG015|Overall Study|Lost to Follow-up|0|||
94328706|NCT01763866|322982726|FG016|Overall Study|Lost to Follow-up|0|||
94328707|NCT01763866|322982727|FG017|Overall Study|Lost to Follow-up|0|||
94328708|NCT01763866|322982728|FG018|Overall Study|Lost to Follow-up|1|||
94392631|NCT01363765|323226446|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
94392632|NCT01363765|323226445|FG000|Overall Study|smear during intervention|2170|||
94392633|NCT01363765|323226446|FG001|Overall Study|smear during intervention|0|||
94392634|NCT02682784|323226447|FG000|Overall Study|Withdrawal by Subject|0|||
94392635|NCT02682784|323226448|FG001|Overall Study|Withdrawal by Subject|2|||
94392636|NCT02682784|323226449|FG002|Overall Study|Withdrawal by Subject|1|||
94392637|NCT02682784|323226450|FG003|Overall Study|Withdrawal by Subject|2|||
94392638|NCT02682784|323226447|FG000|Overall Study|Physician Decision|1|||
94392639|NCT02682784|323226448|FG001|Overall Study|Physician Decision|0|||
94392640|NCT02682784|323226449|FG002|Overall Study|Physician Decision|1|||
94392641|NCT02682784|323226450|FG003|Overall Study|Physician Decision|1|||
94392642|NCT02017223|323226451|FG000|Overall Study|Algorithm problems|2|||
94392643|NCT01401647|323226455|FG000|Overall Study|Withdrawal by Subject|1|||
94392644|NCT01401647|323226456|FG001|Overall Study|Withdrawal by Subject|5|||
94392645|NCT01401647|323226457|FG002|Overall Study|Withdrawal by Subject|2|||
94392646|NCT01401647|323226455|FG000|Overall Study|Lost to Follow-up|3|||
94392647|NCT01401647|323226456|FG001|Overall Study|Lost to Follow-up|3|||
94392648|NCT01401647|323226457|FG002|Overall Study|Lost to Follow-up|1|||
94392649|NCT01975948|323226462|FG000|Overall Study|Withdrawal by Subject|17|||
94392650|NCT01975948|323226463|FG001|Overall Study|Withdrawal by Subject|21|||
94392651|NCT01975948|323226464|FG002|Overall Study|Withdrawal by Subject|7|||
94392652|NCT01975948|323226465|FG003|Overall Study|Withdrawal by Subject|6|||
94392653|NCT00678639|323226466|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
94392654|NCT00678639|323226467|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
94392655|NCT01200810|323226469|FG000|Overall Study|Physician Decision|1|||
94392656|NCT01200810|323226470|FG001|Overall Study|Physician Decision|0|||
94392657|NCT01200810|323226469|FG000|Overall Study|Withdrawal by Subject|1|||
94392658|NCT01200810|323226470|FG001|Overall Study|Withdrawal by Subject|2|||
94392659|NCT01200810|323226469|FG000|Overall Study|Sponsor stopped making study drug|3|||
94392660|NCT01200810|323226470|FG001|Overall Study|Sponsor stopped making study drug|3|||
94392661|NCT00365846|323226471|FG000|Overall Study|Lost to Follow-up|1|||
94392662|NCT01527006|323226472|FG000|Core Study|Adverse Event|0|||
94392663|NCT01527006|323226473|FG001|Core Study|Adverse Event|2|||
94392664|NCT01527006|323226472|FG000|Core Study|Lost to Follow-up|0|||
94392665|NCT01527006|323226473|FG001|Core Study|Lost to Follow-up|1|||
94392666|NCT01527006|323226472|FG000|Core Study|Subject Choice|1|||
94392667|NCT01527006|323226473|FG001|Core Study|Subject Choice|0|||
94392668|NCT01527006|323226472|FG000|Core Study|Inadequate Therapeutic Effect|1|||
94392669|NCT01527006|323226473|FG001|Core Study|Inadequate Therapeutic Effect|0|||
94392670|NCT01527006|323226472|FG000|Core Study|Withdrawal by Subject|0|||
94392671|NCT01527006|323226473|FG001|Core Study|Withdrawal by Subject|1|||
94392672|NCT01527006|323226472|FG000|Core Study|Other|0|||
94392673|NCT01527006|323226473|FG001|Core Study|Other|2|||
94392674|NCT01527006|323226472|FG000|Extension Phase|Adverse Event|4|||
94392675|NCT01527006|323226473|FG001|Extension Phase|Adverse Event|2|||
94392676|NCT01527006|323226472|FG000|Extension Phase|Lost to Follow-up|0|||
94392677|NCT01527006|323226473|FG001|Extension Phase|Lost to Follow-up|1|||
94392678|NCT01527006|323226472|FG000|Extension Phase|Subject Choice|1|||
94392679|NCT01527006|323226473|FG001|Extension Phase|Subject Choice|1|||
94392680|NCT01527006|323226472|FG000|Extension Phase|Inadequate therapeutic effect|1|||
94392681|NCT01527006|323226473|FG001|Extension Phase|Inadequate therapeutic effect|1|||
94392682|NCT01527006|323226472|FG000|Extension Phase|Other|0|||
94392683|NCT01527006|323226473|FG001|Extension Phase|Other|3|||
94392684|NCT00904215|323226474|FG000|Overall Study|Adverse Event|25|||
94392685|NCT00904215|323226474|FG000|Overall Study|Protocol Violation|10|||
94392686|NCT00904215|323226474|FG000|Overall Study|Lost to Follow-up|63|||
94392687|NCT00904215|323226474|FG000|Overall Study|Withdrawal by Subject|9|||
94392688|NCT00904215|323226474|FG000|Overall Study|Other|28|||
94392689|NCT00960297|323226475|FG000|Overall Study|Physician Decision|1|||
94392690|NCT00960297|323226475|FG000|Overall Study|Venous port infection|1|||
94392691|NCT00960297|323226475|FG000|Overall Study|Disease progression|1|||
94392692|NCT03247972|323226476|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
94392693|NCT03247972|323226476|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
94392694|NCT02576938|323226477|FG000|Overall Study|Adverse Event|5|||
94392695|NCT02576938|323226478|FG001|Overall Study|Adverse Event|3|||
94392696|NCT02576938|323226479|FG002|Overall Study|Adverse Event|6|||
94392697|NCT02576938|323226477|FG000|Overall Study|Protocol Violation|1|||
94392698|NCT02576938|323226478|FG001|Overall Study|Protocol Violation|1|||
94392699|NCT02576938|323226479|FG002|Overall Study|Protocol Violation|1|||
94483775|NCT02974868|323563436|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
94392700|NCT02576938|323226477|FG000|Overall Study|Withdrawal by Subject|3|||
94483776|NCT02974868|323563437|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
94392701|NCT02576938|323226478|FG001|Overall Study|Withdrawal by Subject|2|||
94392702|NCT02576938|323226479|FG002|Overall Study|Withdrawal by Subject|4|||
94392703|NCT02576938|323226477|FG000|Overall Study|Lack of Efficacy|9|||
94392704|NCT02576938|323226478|FG001|Overall Study|Lack of Efficacy|4|||
94392705|NCT02576938|323226479|FG002|Overall Study|Lack of Efficacy|0|||
94392706|NCT02576938|323226477|FG000|Overall Study|Lost to Follow-up|2|||
94392707|NCT02576938|323226478|FG001|Overall Study|Lost to Follow-up|0|||
94392708|NCT02576938|323226479|FG002|Overall Study|Lost to Follow-up|1|||
94392709|NCT02576938|323226477|FG000|Overall Study|Physician Decision|0|||
94392710|NCT02576938|323226478|FG001|Overall Study|Physician Decision|1|||
94392711|NCT02576938|323226479|FG002|Overall Study|Physician Decision|0|||
94392712|NCT02576938|323226477|FG000|Overall Study|Met Exclusion Criteria|0|||
94392713|NCT02576938|323226478|FG001|Overall Study|Met Exclusion Criteria|1|||
94392714|NCT02576938|323226479|FG002|Overall Study|Met Exclusion Criteria|0|||
94392715|NCT00838630|323226481|FG000|First Intervention|Adverse Event|1|||
94392716|NCT00838630|323226482|FG001|First Intervention|Adverse Event|0|||
94392717|NCT00838630|323226481|FG000|Washout: 7 Days|Protocol Violation|1|||
94392718|NCT00838630|323226482|FG001|Washout: 7 Days|Protocol Violation|0|||
94392719|NCT00123734|323226483|FG000|Overall Study|Death|3|||
94392720|NCT00123734|323226483|FG000|Overall Study|Lost to Follow-up|3|||
94392721|NCT00123734|323226483|FG000|Overall Study|Dropout|1|||
94392722|NCT00123734|323226483|FG000|Overall Study|Withdrawal by Subject|1|||
94392723|NCT00113386|323226484|FG000|Overall Study|Withdrawal by Subject|1|||
94392724|NCT00113386|323226485|FG001|Overall Study|Withdrawal by Subject|0|||
94392725|NCT00113386|323226484|FG000|Overall Study|Physician Decision|0|||
94392726|NCT00113386|323226485|FG001|Overall Study|Physician Decision|1|||
94392727|NCT00113386|323226484|FG000|Overall Study|Toxicity|3|||
94392728|NCT00113386|323226485|FG001|Overall Study|Toxicity|0|||
94392729|NCT00113386|323226484|FG000|Overall Study|Ineligible|1|||
94392730|NCT00113386|323226485|FG001|Overall Study|Ineligible|2|||
94392731|NCT00113386|323226484|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
94392732|NCT00113386|323226485|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
94392733|NCT02937870|323226486|FG000|Overall Study|Adverse Event|1|||
94392734|NCT02937870|323226486|FG000|Overall Study|Protocol Deviation|2|||
94392735|NCT03673670|323226487|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
94392736|NCT03673670|323226488|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
94392737|NCT03673670|323226489|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
94392738|NCT03673670|323226490|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
94392739|NCT03673670|323226491|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
94392740|NCT03673670|323226492|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
94392741|NCT03673670|323226487|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
94392742|NCT03673670|323226488|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
94392743|NCT03673670|323226489|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
94392744|NCT03673670|323226490|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
94392745|NCT03673670|323226491|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
94392746|NCT03673670|323226492|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
94392747|NCT03673670|323226487|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
94392748|NCT03673670|323226488|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
94392749|NCT03673670|323226489|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
94392750|NCT03673670|323226490|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
94392751|NCT03673670|323226491|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
94392752|NCT03673670|323226492|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
94392753|NCT03673670|323226487|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
94392754|NCT03673670|323226488|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
94392755|NCT03673670|323226489|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
94392756|NCT03673670|323226490|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
94392757|NCT03673670|323226491|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
94392758|NCT03673670|323226492|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
94392759|NCT03673670|323226487|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
94392760|NCT03673670|323226488|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
94392761|NCT03673670|323226489|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
94392762|NCT03673670|323226490|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
94392763|NCT03673670|323226491|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
94392764|NCT03673670|323226492|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
94392765|NCT03673670|323226487|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
94392766|NCT03673670|323226488|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
94392767|NCT03673670|323226489|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
94392768|NCT03673670|323226490|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
94392769|NCT03673670|323226491|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
94392770|NCT03673670|323226492|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
94392771|NCT03673670|323226487|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
94392772|NCT03673670|323226488|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
94392773|NCT03673670|323226489|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
94392774|NCT03673670|323226490|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
94392775|NCT03673670|323226491|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
94392776|NCT03673670|323226492|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
94392777|NCT00571064|323226495|FG000|Overall Study|Adverse Event|13|||
94392778|NCT00571064|323226495|FG000|Overall Study|Protocol Violation|4|||
94392779|NCT00571064|323226495|FG000|Overall Study|Withdrawal by Subject|2|||
94392780|NCT00571064|323226495|FG000|Overall Study|Other|2|||
94392781|NCT04238754|323226496|FG000|Washout - 1 Week|Lost to Follow-up|1|||
94392782|NCT04238754|323226497|FG001|Washout - 1 Week|Lost to Follow-up|0|||
94392783|NCT03138967|323226500|FG000|Overall Study|Death|0|||
94392784|NCT03138967|323226501|FG001|Overall Study|Death|1|||
94392785|NCT03138967|323226500|FG000|Overall Study|Physician Decision|1|||
94392786|NCT03138967|323226501|FG001|Overall Study|Physician Decision|3|||
94392787|NCT03925532|323226504|FG000|Overall Study|Lost to Follow-up|1|||
94392788|NCT00723710|323226505|FG000|Overall Study|Disease progression|48|||
94392789|NCT00723710|323226505|FG000|Overall Study|Adverse Event|88|||
94392790|NCT00723710|323226505|FG000|Overall Study|Withdrawal by Subject|36|||
94392791|NCT00723710|323226505|FG000|Overall Study|Physician Decision|2|||
94392792|NCT04499963|323226506|FG000|Overall Study|Adverse Event|3|||
94392793|NCT04499963|323226507|FG001|Overall Study|Adverse Event|0|||
94392794|NCT04499963|323226506|FG000|Overall Study|Death|3|||
94392795|NCT04499963|323226507|FG001|Overall Study|Death|0|||
94392796|NCT04499963|323226506|FG000|Overall Study|Lack of Efficacy|7|||
94392797|NCT04499963|323226507|FG001|Overall Study|Lack of Efficacy|0|||
94392798|NCT04499963|323226506|FG000|Overall Study|Lost to Follow-up|2|||
94392799|NCT04499963|323226507|FG001|Overall Study|Lost to Follow-up|0|||
94392800|NCT01615198|323226508|FG000|Overall Study|Withdrawal by Subject|5|||
94392801|NCT01615198|323226509|FG001|Overall Study|Withdrawal by Subject|5|||
94392802|NCT01615198|323226508|FG000|Overall Study|Protocol deviation|1|||
94392803|NCT01615198|323226509|FG001|Overall Study|Protocol deviation|1|||
94392804|NCT01615198|323226508|FG000|Overall Study|Physician Decision|5|||
94392805|NCT01615198|323226509|FG001|Overall Study|Physician Decision|1|||
94392806|NCT01615198|323226508|FG000|Overall Study|Lost to Follow-up|1|||
94392807|NCT01615198|323226509|FG001|Overall Study|Lost to Follow-up|1|||
94392808|NCT01615198|323226508|FG000|Overall Study|Lack of Efficacy|1|||
94392809|NCT01615198|323226509|FG001|Overall Study|Lack of Efficacy|6|||
94392810|NCT01615198|323226508|FG000|Overall Study|Adverse Event|11|||
94392811|NCT01615198|323226509|FG001|Overall Study|Adverse Event|5|||
94392812|NCT01097577|323226510|FG000|Overall Study|Adverse Event|0|||
94392813|NCT01097577|323226511|FG001|Overall Study|Adverse Event|1|||
94392814|NCT00316186|323226512|FG000|Overall Study|Adverse Event|6|||
94392815|NCT00316186|323226512|FG000|Overall Study|Disease Progression|4|||
94392816|NCT00316186|323226512|FG000|Overall Study|Lost to Follow-up|1|||
94392817|NCT00316186|323226512|FG000|Overall Study|Other|1|||
94392818|NCT03235739|323228007|FG000|Overall Study|Withdrawal by Subject|2|||
94392819|NCT03235739|323228008|FG001|Overall Study|Withdrawal by Subject|2|||
94392820|NCT03235739|323228007|FG000|Overall Study|Physician Decision|0|||
94392821|NCT03235739|323228008|FG001|Overall Study|Physician Decision|1|||
94392822|NCT02847650|323228010|FG000|Overall Study|Adverse Event|2|||
94392823|NCT02847650|323228011|FG001|Overall Study|Adverse Event|4|||
94392824|NCT02847650|323228010|FG000|Overall Study|Lost to Follow-up|1|||
94392825|NCT02847650|323228011|FG001|Overall Study|Lost to Follow-up|0|||
94392826|NCT02847650|323228010|FG000|Overall Study|Protocol Violation|0|||
94392827|NCT02847650|323228011|FG001|Overall Study|Protocol Violation|1|||
94392828|NCT02847650|323228010|FG000|Overall Study|Withdrawal by Subject|1|||
94392829|NCT02847650|323228011|FG001|Overall Study|Withdrawal by Subject|1|||
94392830|NCT03772522|323228015|FG000|Pre-intervention|Withdrawal by Subject|3|||
94392831|NCT03772522|323228016|FG001|Pre-intervention|Withdrawal by Subject|4|||
94392832|NCT03772522|323228015|FG000|Intervention|Withdrawal by Subject|1|||
94392833|NCT03772522|323228016|FG001|Intervention|Withdrawal by Subject|0|||
94392834|NCT03772522|323228015|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
94392835|NCT03772522|323228016|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
94392836|NCT05376319|323228017|FG000|Overall Study|Funding termination|2|||
94392837|NCT05376319|323228018|FG001|Overall Study|Funding termination|4|||
94392838|NCT01124175|323228019|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
94392839|NCT01124175|323228020|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
94392840|NCT01466166|323228030|FG000|Overall Study|Death|1|||
94392841|NCT01466166|323228030|FG000|Overall Study|Lost to Follow-up|7|||
94392842|NCT01466166|323228030|FG000|Overall Study|Infusion Reaction (IR)|27|||
94392843|NCT01466166|323228030|FG000|Overall Study|Adverse Event (Other than IR)|11|||
94392844|NCT01466166|323228030|FG000|Overall Study|Elevated Serum Uric Acid|78|||
94392845|NCT01466166|323228030|FG000|Overall Study|Withdrawal by Subject|13|||
94392846|NCT01466166|323228030|FG000|Overall Study|Sponsor Decision|4|||
94392847|NCT01466166|323228030|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
94392848|NCT01466166|323228030|FG000|Overall Study|Other|20|||
94392849|NCT02175095|323228033|FG000|Overall Study|Withdrawal by Subject|3|||
94392850|NCT02495857|323228034|FG000|Overall Study|Adverse Event|5|||
94392851|NCT02495857|323228035|FG001|Overall Study|Adverse Event|0|||
94392852|NCT02495857|323228036|FG002|Overall Study|Adverse Event|1|||
94392853|NCT02495857|323228034|FG000|Overall Study|Withdrawal by Subject|9|||
94392854|NCT02495857|323228035|FG001|Overall Study|Withdrawal by Subject|6|||
94392855|NCT02495857|323228036|FG002|Overall Study|Withdrawal by Subject|10|||
94392856|NCT02495857|323228034|FG000|Overall Study|Physician Decision|0|||
94392857|NCT02495857|323228035|FG001|Overall Study|Physician Decision|1|||
94392858|NCT02495857|323228036|FG002|Overall Study|Physician Decision|0|||
94392859|NCT02495857|323228034|FG000|Overall Study|Protocol Violation|1|||
94392860|NCT02495857|323228035|FG001|Overall Study|Protocol Violation|1|||
94392861|NCT02495857|323228036|FG002|Overall Study|Protocol Violation|2|||
94392862|NCT02495857|323228034|FG000|Overall Study|Lost to Follow-up|4|||
94392863|NCT02495857|323228035|FG001|Overall Study|Lost to Follow-up|5|||
94392864|NCT02495857|323228036|FG002|Overall Study|Lost to Follow-up|3|||
94392865|NCT02495857|323228034|FG000|Overall Study|Other|3|||
94392866|NCT02495857|323228035|FG001|Overall Study|Other|3|||
94392867|NCT02495857|323228036|FG002|Overall Study|Other|2|||
94392868|NCT02883452|323228037|FG000|Overall Study|Withdrawal by Subject|1|||
94392869|NCT02883452|323228038|FG001|Overall Study|Withdrawal by Subject|1|||
94392870|NCT02883452|323228039|FG002|Overall Study|Withdrawal by Subject|3|||
94392871|NCT02883452|323228040|FG003|Overall Study|Withdrawal by Subject|0|||
94392872|NCT02883452|323228041|FG004|Overall Study|Withdrawal by Subject|2|||
94392873|NCT02883452|323228042|FG005|Overall Study|Withdrawal by Subject|5|||
94392874|NCT02883452|323228037|FG000|Overall Study|Disease progression|1|||
94392875|NCT02883452|323228038|FG001|Overall Study|Disease progression|0|||
94392876|NCT02883452|323228039|FG002|Overall Study|Disease progression|0|||
94392877|NCT02883452|323228040|FG003|Overall Study|Disease progression|1|||
94392878|NCT02883452|323228041|FG004|Overall Study|Disease progression|4|||
94392879|NCT02883452|323228042|FG005|Overall Study|Disease progression|5|||
94392880|NCT02883452|323228037|FG000|Overall Study|Adverse Event|2|||
94392881|NCT02883452|323228038|FG001|Overall Study|Adverse Event|1|||
94392882|NCT02883452|323228039|FG002|Overall Study|Adverse Event|1|||
94392883|NCT02883452|323228040|FG003|Overall Study|Adverse Event|1|||
94392884|NCT02883452|323228041|FG004|Overall Study|Adverse Event|1|||
94392885|NCT02883452|323228042|FG005|Overall Study|Adverse Event|3|||
94392886|NCT02883452|323228037|FG000|Overall Study|Physician Decision|0|||
94392887|NCT02883452|323228038|FG001|Overall Study|Physician Decision|0|||
94392888|NCT02883452|323228039|FG002|Overall Study|Physician Decision|0|||
94392889|NCT02883452|323228040|FG003|Overall Study|Physician Decision|0|||
94392890|NCT02883452|323228041|FG004|Overall Study|Physician Decision|4|||
94392891|NCT02883452|323228042|FG005|Overall Study|Physician Decision|1|||
94392892|NCT02883452|323228037|FG000|Overall Study|Death|1|||
94392893|NCT02883452|323228038|FG001|Overall Study|Death|0|||
94392894|NCT02883452|323228039|FG002|Overall Study|Death|1|||
94392895|NCT02883452|323228040|FG003|Overall Study|Death|0|||
94392896|NCT02883452|323228041|FG004|Overall Study|Death|0|||
94392897|NCT02883452|323228042|FG005|Overall Study|Death|0|||
94392898|NCT02883452|323228037|FG000|Overall Study|Other|0|||
94392899|NCT02883452|323228038|FG001|Overall Study|Other|0|||
94392900|NCT02883452|323228039|FG002|Overall Study|Other|0|||
94392901|NCT02883452|323228040|FG003|Overall Study|Other|0|||
94392902|NCT02883452|323228041|FG004|Overall Study|Other|0|||
94392903|NCT02883452|323228042|FG005|Overall Study|Other|1|||
94392904|NCT00834249|323228047|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
94392905|NCT00834249|323228048|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
94392906|NCT00834249|323228047|FG000|Second Intervention|Adverse Event|1|||
94392907|NCT00834249|323228048|FG001|Second Intervention|Adverse Event|0|||
94392908|NCT01015625|323228051|FG000|Overall Study|Lost to Follow-up|3|||
94392909|NCT01015625|323228052|FG001|Overall Study|Lost to Follow-up|1|||
94392910|NCT01015625|323228051|FG000|Overall Study|Withdrawal by Subject|2|||
94392911|NCT01015625|323228052|FG001|Overall Study|Withdrawal by Subject|3|||
94392912|NCT01015625|323228051|FG000|Overall Study|Physician Decision|2|||
94392913|NCT01015625|323228052|FG001|Overall Study|Physician Decision|0|||
94392914|NCT01015625|323228051|FG000|Overall Study|Death|30|||
94392915|NCT01015625|323228052|FG001|Overall Study|Death|22|||
94392916|NCT04112823|323228053|FG000|Overall Study|Lost to Follow-up|2|||
94392917|NCT04112823|323228054|FG001|Overall Study|Lost to Follow-up|3|||
94392918|NCT00905840|323228060|FG000|Overall Study|Lost to Follow-up|11|||
94392919|NCT00905840|323228060|FG000|Overall Study|Death|3|||
94392920|NCT00905840|323228060|FG000|Overall Study|Withdrawal by Subject|1|||
94392921|NCT00905840|323228060|FG000|Overall Study|Adverse Event|1|||
94392922|NCT00089661|323228061|FG000|Overall Study|Adverse Event|0|||
94392923|NCT00089661|323228062|FG001|Overall Study|Adverse Event|2|||
94392924|NCT00089661|323228061|FG000|Overall Study|Death|1|||
94392925|NCT00089661|323228062|FG001|Overall Study|Death|0|||
94392926|NCT00089661|323228061|FG000|Overall Study|Lost to Follow-up|0|||
94392927|NCT00089661|323228062|FG001|Overall Study|Lost to Follow-up|3|||
94392928|NCT00089661|323228061|FG000|Overall Study|Withdrawal by Subject|11|||
94392929|NCT00089661|323228062|FG001|Overall Study|Withdrawal by Subject|9|||
94392930|NCT00089661|323228061|FG000|Overall Study|Disease progression|1|||
94392931|NCT00089661|323228062|FG001|Overall Study|Disease progression|3|||
94392932|NCT00089661|323228061|FG000|Overall Study|Ineligibility determined|4|||
94392933|NCT00089661|323228062|FG001|Overall Study|Ineligibility determined|4|||
94392934|NCT00089661|323228061|FG000|Overall Study|Noncompliance|2|||
94392935|NCT00089661|323228062|FG001|Overall Study|Noncompliance|4|||
94392936|NCT00089661|323228061|FG000|Overall Study|Other|2|||
94392937|NCT00089661|323228062|FG001|Overall Study|Other|1|||
94392938|NCT02459951|323228063|FG000|Overall Study|Unable to meet holding requirement|1|||
94392939|NCT01273805|323228064|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
94392940|NCT01273805|323228065|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
94483777|NCT02974868|323563438|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
94483778|NCT02974868|323563439|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
94483779|NCT02974868|323563436|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
94483780|NCT02974868|323563437|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
94483781|NCT02974868|323563438|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
94483782|NCT02974868|323563439|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
94483783|NCT02974868|323563436|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
94483784|NCT02974868|323563437|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
94483785|NCT02974868|323563438|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
94483786|NCT02974868|323563439|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
94483787|NCT03903172|323563448|FG000|Overall Study|screen fail|4|||
94483788|NCT03903172|323563449|FG001|Overall Study|screen fail|1|||
94483789|NCT01746862|323563454|FG000|Overall Study|Withdrawal by Subject|1|||
94483790|NCT01746862|323563455|FG001|Overall Study|Withdrawal by Subject|1|||
94483791|NCT01746862|323563454|FG000|Overall Study|Protocol Violation|1|||
94483792|NCT01746862|323563455|FG001|Overall Study|Protocol Violation|0|||
94483793|NCT01746862|323563454|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
94483794|NCT01746862|323563455|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
94483795|NCT01746862|323563454|FG000|Overall Study|Entered puberty during the study|1|||
94483796|NCT01746862|323563455|FG001|Overall Study|Entered puberty during the study|0|||
94483797|NCT04742673|323563456|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
94483798|NCT04742673|323563457|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
94483799|NCT01900444|323563458|FG000|Overall Study|Protocol Violation|2|||
94483800|NCT01900444|323563458|FG000|Overall Study|Lost to Follow-up|1|||
94483801|NCT01825200|323563459|FG000|Overall Study|Lost to Follow-up|5|||
94483802|NCT01825200|323563460|FG001|Overall Study|Lost to Follow-up|6|||
94483803|NCT01825200|323563459|FG000|Overall Study|Withdrawal by Subject|0|||
94483804|NCT01825200|323563460|FG001|Overall Study|Withdrawal by Subject|1|||
94483805|NCT00490035|323563461|FG000|Overall Study|AE, non-serious non-fatal|3|||
94483806|NCT00490035|323563462|FG001|Overall Study|AE, non-serious non-fatal|4|||
94483807|NCT00490035|323563463|FG002|Overall Study|AE, non-serious non-fatal|4|||
94483808|NCT00490035|323563464|FG003|Overall Study|AE, non-serious non-fatal|5|||
94483809|NCT00490035|323563461|FG000|Overall Study|Lost to Follow-up|2|||
94483810|NCT00490035|323563462|FG001|Overall Study|Lost to Follow-up|0|||
94483811|NCT00490035|323563463|FG002|Overall Study|Lost to Follow-up|1|||
94483812|NCT00490035|323563464|FG003|Overall Study|Lost to Follow-up|0|||
94483813|NCT00490035|323563461|FG000|Overall Study|Withdrawal by Subject|2|||
94483814|NCT00490035|323563462|FG001|Overall Study|Withdrawal by Subject|1|||
94328709|NCT01763866|322982729|FG019|Overall Study|Lost to Follow-up|1|||
94328710|NCT01763866|322982730|FG020|Overall Study|Lost to Follow-up|0|||
94328711|NCT01763866|322982731|FG021|Overall Study|Lost to Follow-up|0|||
94328712|NCT01763866|322982732|FG022|Overall Study|Lost to Follow-up|0|||
94328713|NCT01763866|322982733|FG023|Overall Study|Lost to Follow-up|1|||
94328714|NCT01763866|322982710|FG000|Overall Study|Death|0|||
94328715|NCT01763866|322982711|FG001|Overall Study|Death|0|||
94328716|NCT01763866|322982712|FG002|Overall Study|Death|0|||
94328717|NCT01763866|322982713|FG003|Overall Study|Death|0|||
94328718|NCT01763866|322982714|FG004|Overall Study|Death|0|||
94328719|NCT01763866|322982715|FG005|Overall Study|Death|0|||
94328720|NCT01763866|322982716|FG006|Overall Study|Death|0|||
94328721|NCT01763866|322982717|FG007|Overall Study|Death|0|||
94328722|NCT01763866|322982718|FG008|Overall Study|Death|0|||
94328723|NCT01763866|322982719|FG009|Overall Study|Death|0|||
94328724|NCT01763866|322982720|FG010|Overall Study|Death|0|||
94328725|NCT01763866|322982721|FG011|Overall Study|Death|0|||
94328726|NCT01763866|322982722|FG012|Overall Study|Death|0|||
94328727|NCT01763866|322982723|FG013|Overall Study|Death|0|||
94328728|NCT01763866|322982724|FG014|Overall Study|Death|0|||
94328729|NCT01763866|322982725|FG015|Overall Study|Death|0|||
94328730|NCT01763866|322982726|FG016|Overall Study|Death|1|||
94328731|NCT01763866|322982727|FG017|Overall Study|Death|0|||
94328732|NCT01763866|322982728|FG018|Overall Study|Death|0|||
94328733|NCT01763866|322982729|FG019|Overall Study|Death|0|||
94328734|NCT01763866|322982730|FG020|Overall Study|Death|0|||
94328735|NCT01763866|322982731|FG021|Overall Study|Death|0|||
94328736|NCT01763866|322982732|FG022|Overall Study|Death|0|||
94483815|NCT00490035|323563463|FG002|Overall Study|Withdrawal by Subject|1|||
94328737|NCT01763866|322982733|FG023|Overall Study|Death|0|||
94328738|NCT01578785|322982738|FG000|Overall Study|Withdrawal by Subject|0|||
94328739|NCT01578785|322982739|FG001|Overall Study|Withdrawal by Subject|1|||
94328740|NCT01578785|322982738|FG000|Overall Study|Study terminated by sponsor|59|||
94328741|NCT01578785|322982739|FG001|Overall Study|Study terminated by sponsor|118|||
94328742|NCT00844285|322982740|FG000|Overall Study|Other|0|||
94328743|NCT00844285|322982741|FG001|Overall Study|Other|1|||
94328744|NCT00844285|322982742|FG002|Overall Study|Other|0|||
94483816|NCT00490035|323563464|FG003|Overall Study|Withdrawal by Subject|0|||
94483817|NCT00490035|323563461|FG000|Overall Study|Other reason|0|||
94483818|NCT00490035|323563462|FG001|Overall Study|Other reason|1|||
94392941|NCT00252720|323228066|FG000|Overall Study|Withdrawal by Subject|95|||
94392942|NCT00252720|323228067|FG001|Overall Study|Withdrawal by Subject|97|||
94392943|NCT00252720|323228066|FG000|Overall Study|Death|7|||
94392944|NCT00252720|323228067|FG001|Overall Study|Death|8|||
94392945|NCT00252720|323228066|FG000|Overall Study|Moving|23|||
94392946|NCT00252720|323228067|FG001|Overall Study|Moving|42|||
94392947|NCT00252720|323228066|FG000|Overall Study|Mainly patients lost to follow-up|7|||
94392948|NCT00252720|323228067|FG001|Overall Study|Mainly patients lost to follow-up|18|||
94392949|NCT02647944|323228068|FG000|Overall Study|Withdrawal by Subject|0|||
94392950|NCT02647944|323228069|FG001|Overall Study|Withdrawal by Subject|3|||
94392951|NCT02647944|323228068|FG000|Overall Study|Adverse Event|2|||
94392952|NCT02647944|323228069|FG001|Overall Study|Adverse Event|0|||
94392953|NCT02077465|323228072|FG000|Overall Study|Withdrew Consent|0|||
94392954|NCT02077465|323228073|FG001|Overall Study|Withdrew Consent|1|||
94392955|NCT02077465|323228072|FG000|Overall Study|Lost to Follow-up|1|||
94392956|NCT02077465|323228073|FG001|Overall Study|Lost to Follow-up|0|||
94392957|NCT03375463|323228077|FG000|Period 1|Lost to Follow-up|0|||
94392958|NCT03375463|323228078|FG001|Period 1|Lost to Follow-up|0|||
94392959|NCT03375463|323228079|FG002|Period 1|Lost to Follow-up|1|||
94392960|NCT03375463|323228080|FG003|Period 1|Lost to Follow-up|0|||
94392961|NCT03375463|323228081|FG004|Period 1|Lost to Follow-up|0|||
94392962|NCT03375463|323228082|FG005|Period 1|Lost to Follow-up|0|||
94392963|NCT03375463|323228077|FG000|Period 1|Adverse Event|0|||
94392964|NCT03375463|323228078|FG001|Period 1|Adverse Event|0|||
94392965|NCT03375463|323228079|FG002|Period 1|Adverse Event|0|||
94392966|NCT03375463|323228080|FG003|Period 1|Adverse Event|0|||
94392967|NCT03375463|323228081|FG004|Period 1|Adverse Event|1|||
94392968|NCT03375463|323228082|FG005|Period 1|Adverse Event|0|||
94392969|NCT03375463|323228077|FG000|Period 2|Lost to Follow-up|1|||
94392970|NCT03375463|323228078|FG001|Period 2|Lost to Follow-up|1|||
94392971|NCT03375463|323228079|FG002|Period 2|Lost to Follow-up|0|||
94392972|NCT03375463|323228080|FG003|Period 2|Lost to Follow-up|0|||
94392973|NCT03375463|323228081|FG004|Period 2|Lost to Follow-up|0|||
94392974|NCT03375463|323228082|FG005|Period 2|Lost to Follow-up|0|||
94392975|NCT01037114|323228083|FG000|Year 20|Others|1|||
94392976|NCT01602419|323228084|FG000|Overall Study|Not treated with Wilate|9|||
94392977|NCT01602419|323228084|FG000|Overall Study|Adverse Drug Reaction|4|||
94392978|NCT01602419|323228084|FG000|Overall Study|Insurance issues|3|||
94392979|NCT01602419|323228084|FG000|Overall Study|Changed treatment centre|1|||
94392980|NCT01602419|323228084|FG000|Overall Study|Treatment centre closed|1|||
94392981|NCT01602419|323228084|FG000|Overall Study|Withdrawal by Subject|5|||
94392982|NCT01602419|323228084|FG000|Overall Study|Lost to Follow-up|6|||
94392983|NCT01792635|323228085|FG000|Part B|Adverse Event|0|||
94392984|NCT01792635|323228086|FG001|Part B|Adverse Event|0|||
94392985|NCT01792635|323228087|FG002|Part B|Adverse Event|1|||
94392986|NCT01792635|323228085|FG000|Part B|Study terminated|0|||
94392987|NCT01792635|323228086|FG001|Part B|Study terminated|4|||
94392988|NCT01792635|323228087|FG002|Part B|Study terminated|3|||
94392989|NCT02714062|323228091|FG000|Overall Study|Adverse Event|0|||
94392990|NCT02714062|323228092|FG001|Overall Study|Adverse Event|0|||
94392991|NCT02714062|323228093|FG002|Overall Study|Adverse Event|2|||
94392992|NCT02714062|323228091|FG000|Overall Study|Withdrawal by Subject|1|||
94392993|NCT02714062|323228092|FG001|Overall Study|Withdrawal by Subject|0|||
94392994|NCT02714062|323228093|FG002|Overall Study|Withdrawal by Subject|1|||
94392995|NCT02714062|323228091|FG000|Overall Study|Protocol Violation|0|||
94392996|NCT02714062|323228092|FG001|Overall Study|Protocol Violation|1|||
94392997|NCT02714062|323228093|FG002|Overall Study|Protocol Violation|0|||
94392998|NCT00473330|323228096|FG000|Core Study|Adverse Event|4|||
94392999|NCT00473330|323228097|FG001|Core Study|Adverse Event|4|||
94393000|NCT00473330|323228098|FG002|Core Study|Adverse Event|1|||
94393001|NCT00473330|323228096|FG000|Core Study|Death|6|||
94393002|NCT00473330|323228097|FG001|Core Study|Death|4|||
94393003|NCT00473330|323228098|FG002|Core Study|Death|4|||
94393004|NCT00473330|323228096|FG000|Core Study|Lost to Follow-up|5|||
94393005|NCT00473330|323228097|FG001|Core Study|Lost to Follow-up|5|||
94393006|NCT00473330|323228098|FG002|Core Study|Lost to Follow-up|10|||
94393007|NCT00473330|323228096|FG000|Core Study|Physician Decision|2|||
94393008|NCT00473330|323228097|FG001|Core Study|Physician Decision|1|||
94393009|NCT00473330|323228098|FG002|Core Study|Physician Decision|3|||
94393010|NCT00473330|323228096|FG000|Core Study|Subject Non-compliance|1|||
94393011|NCT00473330|323228097|FG001|Core Study|Subject Non-compliance|2|||
94393012|NCT00473330|323228098|FG002|Core Study|Subject Non-compliance|1|||
94393013|NCT00473330|323228096|FG000|Core Study|Subject Required Other Therapy|0|||
94393014|NCT00473330|323228097|FG001|Core Study|Subject Required Other Therapy|1|||
94393015|NCT00473330|323228098|FG002|Core Study|Subject Required Other Therapy|3|||
94393016|NCT00473330|323228096|FG000|Core Study|Subject's Decision|9|||
94393017|NCT00473330|323228097|FG001|Core Study|Subject's Decision|8|||
94393018|NCT00473330|323228098|FG002|Core Study|Subject's Decision|19|||
94393019|NCT00473330|323228096|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
94393020|NCT00473330|323228097|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
94393021|NCT00473330|323228098|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
94328745|NCT00844285|322982740|FG000|Overall Study|Other than specified|95|||
94328746|NCT00844285|322982741|FG001|Overall Study|Other than specified|129|||
94328747|NCT00844285|322982742|FG002|Overall Study|Other than specified|12|||
94328748|NCT00844285|322982740|FG000|Overall Study|Site closure|256|||
94328749|NCT00844285|322982741|FG001|Overall Study|Site closure|450|||
94328750|NCT00844285|322982742|FG002|Overall Study|Site closure|50|||
94328751|NCT00844285|322982740|FG000|Overall Study|Follow-up < 8 years|16|||
94328752|NCT00844285|322982741|FG001|Overall Study|Follow-up < 8 years|23|||
94328753|NCT00844285|322982742|FG002|Overall Study|Follow-up < 8 years|4|||
94328754|NCT00844285|322982740|FG000|Overall Study|Protocol Violation|26|||
94328755|NCT00844285|322982741|FG001|Overall Study|Protocol Violation|28|||
94328756|NCT00844285|322982742|FG002|Overall Study|Protocol Violation|54|||
94328757|NCT00844285|322982740|FG000|Overall Study|Death|22|||
94328758|NCT00844285|322982741|FG001|Overall Study|Death|21|||
94328759|NCT00844285|322982742|FG002|Overall Study|Death|8|||
94328760|NCT00844285|322982740|FG000|Overall Study|Withdrew Consent|344|||
94328761|NCT00844285|322982741|FG001|Overall Study|Withdrew Consent|466|||
94328762|NCT00844285|322982742|FG002|Overall Study|Withdrew Consent|70|||
94328763|NCT00844285|322982740|FG000|Overall Study|Lost to Follow-up|330|||
94328764|NCT00844285|322982741|FG001|Overall Study|Lost to Follow-up|486|||
94328765|NCT00844285|322982742|FG002|Overall Study|Lost to Follow-up|74|||
94328766|NCT00966693|322982743|FG000|Overall Study|Adverse Event|0|||
94328767|NCT00966693|322982744|FG001|Overall Study|Adverse Event|0|||
94328768|NCT00966693|322982745|FG002|Overall Study|Adverse Event|1|||
94328769|NCT00966693|322982746|FG003|Overall Study|Adverse Event|2|||
94328770|NCT00966693|322982743|FG000|Overall Study|Death|0|||
94328771|NCT00966693|322982744|FG001|Overall Study|Death|0|||
94328772|NCT00966693|322982745|FG002|Overall Study|Death|1|||
94328773|NCT00966693|322982746|FG003|Overall Study|Death|0|||
94328774|NCT00966693|322982743|FG000|Overall Study|Withdrawal by Subject|1|||
94328775|NCT00966693|322982744|FG001|Overall Study|Withdrawal by Subject|0|||
94328776|NCT00966693|322982745|FG002|Overall Study|Withdrawal by Subject|0|||
94328777|NCT00966693|322982746|FG003|Overall Study|Withdrawal by Subject|5|||
94328778|NCT00966693|322982743|FG000|Overall Study|Disease Progression|0|||
94328779|NCT00966693|322982744|FG001|Overall Study|Disease Progression|0|||
94328780|NCT00966693|322982745|FG002|Overall Study|Disease Progression|1|||
94328781|NCT00966693|322982746|FG003|Overall Study|Disease Progression|16|||
94328782|NCT01033487|322982747|FG000|Fourth Intervention Period|Adverse Event|0|||
94328783|NCT01033487|322982748|FG001|Fourth Intervention Period|Adverse Event|0|||
94328784|NCT01033487|322982749|FG002|Fourth Intervention Period|Adverse Event|0|||
94328785|NCT01033487|322982750|FG003|Fourth Intervention Period|Adverse Event|0|||
94328786|NCT01033487|322982751|FG004|Fourth Intervention Period|Adverse Event|0|||
94328787|NCT01033487|322982752|FG005|Fourth Intervention Period|Adverse Event|0|||
94328788|NCT01033487|322982753|FG006|Fourth Intervention Period|Adverse Event|0|||
94328789|NCT01033487|322982754|FG007|Fourth Intervention Period|Adverse Event|0|||
94328790|NCT01033487|322982755|FG008|Fourth Intervention Period|Adverse Event|1|||
94328791|NCT01033487|322982756|FG009|Fourth Intervention Period|Adverse Event|0|||
94328792|NCT01617187|322982758|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
94328793|NCT01617187|322982759|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
94328794|NCT01617187|322982760|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
94328795|NCT01617187|322982761|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
94328796|NCT01617187|322982758|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
94328797|NCT01617187|322982759|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
94328798|NCT01617187|322982760|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
94328799|NCT01617187|322982761|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
94328800|NCT01617187|322982758|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
94328801|NCT01617187|322982759|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
94328802|NCT01617187|322982760|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
94328803|NCT01617187|322982761|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
94328804|NCT01617187|322982758|FG000|Treatment Through Study Completion|Adverse Event|1|||
94328805|NCT01617187|322982759|FG001|Treatment Through Study Completion|Adverse Event|1|||
94328806|NCT01617187|322982760|FG002|Treatment Through Study Completion|Adverse Event|0|||
94328807|NCT01617187|322982761|FG003|Treatment Through Study Completion|Adverse Event|1|||
94328808|NCT01617187|322982758|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
94328809|NCT01617187|322982759|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
94328810|NCT01617187|322982760|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
94328811|NCT01617187|322982761|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
94328812|NCT01617187|322982758|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
94328813|NCT01617187|322982759|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
94328814|NCT01617187|322982760|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
94328815|NCT01617187|322982761|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
94328816|NCT01617187|322982758|FG000|Treatment Through Study Completion|Protocol Violation|1|||
94328817|NCT01617187|322982759|FG001|Treatment Through Study Completion|Protocol Violation|0|||
94393022|NCT00473330|323228096|FG000|Open-label Extension Through Month 48|Death|2|||
94393023|NCT00473330|323228097|FG001|Open-label Extension Through Month 48|Death|0|||
94393024|NCT00473330|323228098|FG002|Open-label Extension Through Month 48|Death|0|||
94393025|NCT00473330|323228096|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
94393026|NCT00473330|323228097|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
94393027|NCT00473330|323228098|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
94393028|NCT00473330|323228096|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
94393029|NCT00473330|323228097|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
94393030|NCT00473330|323228098|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
94393031|NCT00473330|323228096|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
94393032|NCT00473330|323228097|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
94393033|NCT00473330|323228098|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
94393034|NCT00473330|323228096|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
94393035|NCT00473330|323228097|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
94393036|NCT00473330|323228098|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
94393037|NCT00473330|323228096|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
94393038|NCT00473330|323228097|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
94393039|NCT00473330|323228098|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
94393040|NCT00473330|323228096|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
94393041|NCT00473330|323228097|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
94393042|NCT00473330|323228098|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
94393043|NCT00473330|323228096|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
94393044|NCT00473330|323228097|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
94393045|NCT00473330|323228098|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
94393046|NCT00473330|323228096|FG000|Open-label Extension Through Month 60|Death|2|||
94393047|NCT00473330|323228097|FG001|Open-label Extension Through Month 60|Death|2|||
94393048|NCT00473330|323228098|FG002|Open-label Extension Through Month 60|Death|1|||
94393049|NCT00473330|323228096|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
94393050|NCT00473330|323228097|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
94393051|NCT00473330|323228098|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
94393052|NCT00473330|323228096|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
94393053|NCT00473330|323228097|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
94393054|NCT00473330|323228098|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
94328818|NCT01617187|322982760|FG002|Treatment Through Study Completion|Protocol Violation|0|||
94328819|NCT01617187|322982761|FG003|Treatment Through Study Completion|Protocol Violation|1|||
94328820|NCT01512108|322984163|FG000|Overall Study|Adverse Event|9|||
94328821|NCT01512108|322984164|FG001|Overall Study|Adverse Event|4|||
94328822|NCT01512108|322984163|FG000|Overall Study|Protocol Violation|1|||
94328823|NCT01512108|322984164|FG001|Overall Study|Protocol Violation|2|||
94328824|NCT01512108|322984163|FG000|Overall Study|Withdrawal Criteria|1|||
94328825|NCT01512108|322984164|FG001|Overall Study|Withdrawal Criteria|0|||
94328826|NCT01512108|322984163|FG000|Overall Study|Unclassified|11|||
94328827|NCT01512108|322984164|FG001|Overall Study|Unclassified|3|||
94328828|NCT02843178|322984170|FG000|Overall Study|Lost to Follow-up|8|||
94328829|NCT02843178|322984171|FG001|Overall Study|Lost to Follow-up|8|||
94328830|NCT02843178|322984172|FG002|Overall Study|Lost to Follow-up|6|||
94328831|NCT02843178|322984173|FG003|Overall Study|Lost to Follow-up|3|||
94328832|NCT02843178|322984170|FG000|Overall Study|Withdrawal by Subject|0|||
94328833|NCT02843178|322984171|FG001|Overall Study|Withdrawal by Subject|0|||
94328834|NCT02843178|322984172|FG002|Overall Study|Withdrawal by Subject|1|||
94328835|NCT02843178|322984173|FG003|Overall Study|Withdrawal by Subject|1|||
94328836|NCT02701192|322984183|FG000|Overall Study|Protocol Violation|2|||
94328837|NCT02701192|322984183|FG000|Overall Study|Lost to Follow-up|4|||
94328838|NCT03287869|322984190|FG000|Overall Study|Adverse Event|14|||
94328839|NCT03287869|322984191|FG001|Overall Study|Adverse Event|12|||
94328840|NCT03287869|322984190|FG000|Overall Study|Lack of Efficacy|1|||
94328841|NCT03287869|322984191|FG001|Overall Study|Lack of Efficacy|0|||
94328842|NCT03287869|322984190|FG000|Overall Study|Lost to Follow-up|13|||
94328843|NCT03287869|322984191|FG001|Overall Study|Lost to Follow-up|19|||
94328844|NCT03287869|322984190|FG000|Overall Study|Non-Compliance With Study Drug|5|||
94328845|NCT03287869|322984191|FG001|Overall Study|Non-Compliance With Study Drug|9|||
94328846|NCT03287869|322984190|FG000|Overall Study|Progressive Disease|1|||
94328847|NCT03287869|322984191|FG001|Overall Study|Progressive Disease|0|||
94328848|NCT03287869|322984190|FG000|Overall Study|Protocol Deviation|2|||
94328849|NCT03287869|322984191|FG001|Overall Study|Protocol Deviation|1|||
94328850|NCT03287869|322984190|FG000|Overall Study|Withdrawal by Subject|36|||
94328851|NCT03287869|322984191|FG001|Overall Study|Withdrawal by Subject|43|||
94328852|NCT03287869|322984190|FG000|Overall Study|Early Closure of the Site|0|||
94328853|NCT03287869|322984191|FG001|Overall Study|Early Closure of the Site|1|||
94328854|NCT03287869|322984190|FG000|Overall Study|Physician Decision|5|||
94393055|NCT00473330|323228096|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
94393056|NCT00473330|323228097|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
94393057|NCT00473330|323228098|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
94393058|NCT00473330|323228096|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
94393059|NCT00473330|323228097|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
94393060|NCT00473330|323228098|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
94393061|NCT00473330|323228096|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
94393062|NCT00473330|323228097|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
94393063|NCT00473330|323228098|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
94393064|NCT00473330|323228096|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
94393065|NCT00473330|323228097|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
94483819|NCT00490035|323563463|FG002|Overall Study|Other reason|3|||
94483820|NCT00490035|323563464|FG003|Overall Study|Other reason|1|||
94393066|NCT00473330|323228098|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
94393067|NCT02911792|323228102|FG000|Overall Study|Lost to Follow-up|3|||
94393068|NCT02911792|323228103|FG001|Overall Study|Lost to Follow-up|3|||
94393069|NCT02911792|323228104|FG002|Overall Study|Lost to Follow-up|3|||
94393070|NCT02911792|323228105|FG003|Overall Study|Lost to Follow-up|3|||
94393071|NCT03872128|323228106|FG000|Overall Study|Dropped out before treatment|1|||
94393072|NCT03872128|323228107|FG001|Overall Study|Dropped out before treatment|0|||
94393073|NCT03872128|323228108|FG002|Overall Study|Dropped out before treatment|4|||
94393074|NCT03872128|323228106|FG000|Overall Study|Lost to Follow-up|2|||
94393075|NCT03872128|323228107|FG001|Overall Study|Lost to Follow-up|5|||
94393076|NCT03872128|323228108|FG002|Overall Study|Lost to Follow-up|8|||
94393077|NCT00840073|323228109|FG000|Second Intervention|Missed 72 hour blood draw|1|||
94393078|NCT00840073|323228110|FG001|Second Intervention|Missed 72 hour blood draw|1|||
94393079|NCT03285594|323228113|FG000|Overall Study|At the Participant's Own Request|10|||
94393080|NCT03285594|323228114|FG001|Overall Study|At the Participant's Own Request|5|||
94393081|NCT03285594|323228115|FG002|Overall Study|At the Participant's Own Request|21|||
94393082|NCT03285594|323228113|FG000|Overall Study|Adverse Event|2|||
94393083|NCT03285594|323228114|FG001|Overall Study|Adverse Event|2|||
94393084|NCT03285594|323228115|FG002|Overall Study|Adverse Event|6|||
94393085|NCT03285594|323228113|FG000|Overall Study|Poor Compliance to Protocol|0|||
94393086|NCT03285594|323228114|FG001|Overall Study|Poor Compliance to Protocol|0|||
94393087|NCT03285594|323228115|FG002|Overall Study|Poor Compliance to Protocol|1|||
94393088|NCT03285594|323228113|FG000|Overall Study|Lost to Follow-up|0|||
94393089|NCT03285594|323228114|FG001|Overall Study|Lost to Follow-up|0|||
94393090|NCT03285594|323228115|FG002|Overall Study|Lost to Follow-up|1|||
94393091|NCT03285594|323228113|FG000|Overall Study|Reason Not Specified|3|||
94393092|NCT03285594|323228114|FG001|Overall Study|Reason Not Specified|4|||
94393093|NCT03285594|323228115|FG002|Overall Study|Reason Not Specified|8|||
94393094|NCT00556322|323228119|FG000|Overall Study|Insufficient therapeutic response|158|||
94393095|NCT00556322|323228120|FG001|Overall Study|Insufficient therapeutic response|168|||
94393096|NCT00556322|323228119|FG000|Overall Study|Adverse Event|7|||
94393097|NCT00556322|323228120|FG001|Overall Study|Adverse Event|4|||
94393098|NCT00556322|323228119|FG000|Overall Study|Other|4|||
94393099|NCT00556322|323228120|FG001|Overall Study|Other|1|||
94393100|NCT00556322|323228119|FG000|Overall Study|Lost to Follow-up|5|||
94393101|NCT00556322|323228120|FG001|Overall Study|Lost to Follow-up|3|||
94393102|NCT00556322|323228119|FG000|Overall Study|Withdrawal by Subject|19|||
94393103|NCT00556322|323228120|FG001|Overall Study|Withdrawal by Subject|7|||
94393104|NCT00556322|323228119|FG000|Overall Study|Protocol Violation|5|||
94393105|NCT00556322|323228120|FG001|Overall Study|Protocol Violation|1|||
94393106|NCT00556322|323228119|FG000|Overall Study|Ongoing at data cutoff|3|||
94393107|NCT00556322|323228120|FG001|Overall Study|Ongoing at data cutoff|5|||
94393108|NCT00556322|323228119|FG000|Overall Study|Death|20|||
94393109|NCT00556322|323228120|FG001|Overall Study|Death|14|||
94393110|NCT03733444|323228121|FG000|Overall Study|Adverse Event|8|||
94393111|NCT03733444|323228122|FG001|Overall Study|Adverse Event|10|||
94393112|NCT03733444|323228123|FG002|Overall Study|Adverse Event|5|||
94393113|NCT03733444|323228121|FG000|Overall Study|Death|20|||
94393114|NCT03733444|323228122|FG001|Overall Study|Death|19|||
94483821|NCT00490035|323563461|FG000|Overall Study|AE, serious fatal|1|||
94483822|NCT00490035|323563462|FG001|Overall Study|AE, serious fatal|0|||
94483823|NCT00490035|323563463|FG002|Overall Study|AE, serious fatal|0|||
94393115|NCT03733444|323228123|FG002|Overall Study|Death|11|||
94393116|NCT03733444|323228121|FG000|Overall Study|Lost to Follow-up|3|||
94393117|NCT03733444|323228122|FG001|Overall Study|Lost to Follow-up|0|||
94393118|NCT03733444|323228123|FG002|Overall Study|Lost to Follow-up|1|||
94393119|NCT03733444|323228121|FG000|Overall Study|Lack of Efficacy|0|||
94483824|NCT00490035|323563464|FG003|Overall Study|AE, serious fatal|0|||
94483825|NCT00490035|323563461|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
94393120|NCT03733444|323228122|FG001|Overall Study|Lack of Efficacy|1|||
94393121|NCT03733444|323228123|FG002|Overall Study|Lack of Efficacy|1|||
94483826|NCT00490035|323563462|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
94483827|NCT00490035|323563463|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
94483828|NCT00490035|323563464|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
94483829|NCT00490035|323563461|FG000|Overall Study|AE of unknown type|0|||
94483830|NCT00490035|323563462|FG001|Overall Study|AE of unknown type|0|||
94483831|NCT00490035|323563463|FG002|Overall Study|AE of unknown type|2|||
94483832|NCT00490035|323563464|FG003|Overall Study|AE of unknown type|0|||
94483833|NCT02277028|323563466|FG000|Overall Study|Lost to Follow-up|1|||
94483834|NCT02277028|323563467|FG001|Overall Study|Lost to Follow-up|0|||
94483835|NCT02277028|323563466|FG000|Overall Study|Withdrawal by Subject|0|||
94483836|NCT02277028|323563467|FG001|Overall Study|Withdrawal by Subject|1|||
94483837|NCT02115607|323563475|FG000|Overall Study|Withdrawal by Subject|1|||
94483838|NCT03797898|323563476|FG000|Overall Study|Lost to Follow-up|60|||
94483839|NCT03797898|323563477|FG001|Overall Study|Lost to Follow-up|69|||
94483840|NCT03797898|323563476|FG000|Overall Study|Withdrawal by Subject|9|||
94483841|NCT03797898|323563477|FG001|Overall Study|Withdrawal by Subject|7|||
94483842|NCT03797898|323563476|FG000|Overall Study|Became ineligible|5|||
94483843|NCT03797898|323563477|FG001|Overall Study|Became ineligible|2|||
94483844|NCT00732069|323563479|FG000|Washout After First Study Drug|Adverse Event|1|||
94483845|NCT00732069|323563480|FG001|Washout After First Study Drug|Adverse Event|0|||
94483846|NCT00732069|323563481|FG002|Washout After First Study Drug|Adverse Event|0|||
94483847|NCT00732069|323563482|FG003|Washout After First Study Drug|Adverse Event|0|||
94483848|NCT00732069|323563483|FG004|Washout After First Study Drug|Adverse Event|0|||
94483849|NCT00732069|323563484|FG005|Washout After First Study Drug|Adverse Event|0|||
94483850|NCT04386902|323563485|FG000|Overall Study|Withdrawal by Subject|5|||
94483851|NCT04386902|323563485|FG000|Overall Study|Technical problems in the recording|5|||
94483852|NCT01100502|323563486|FG000|Overall Study|Withdrawal by Subject|18|||
94483853|NCT01100502|323563487|FG001|Overall Study|Withdrawal by Subject|25|||
94483854|NCT01100502|323563486|FG000|Overall Study|Lost to Follow-up|13|||
94483855|NCT01100502|323563487|FG001|Overall Study|Lost to Follow-up|28|||
94483856|NCT01100502|323563486|FG000|Overall Study|Site request to end participation in study|0|||
94483857|NCT01100502|323563487|FG001|Overall Study|Site request to end participation in study|1|||
94483858|NCT01100502|323563486|FG000|Overall Study|Death|45|||
94483859|NCT01100502|323563487|FG001|Overall Study|Death|40|||
94483860|NCT01618968|323563488|FG000|Overall Study|Adverse Event|1|||
94483861|NCT01618968|323563489|FG001|Overall Study|Adverse Event|0|||
94483862|NCT01618968|323563490|FG002|Overall Study|Adverse Event|0|||
94483863|NCT01618968|323563491|FG003|Overall Study|Adverse Event|0|||
94483864|NCT01618968|323563488|FG000|Overall Study|Death|0|||
94483865|NCT01618968|323563489|FG001|Overall Study|Death|0|||
94483866|NCT01618968|323563490|FG002|Overall Study|Death|0|||
94483867|NCT01618968|323563491|FG003|Overall Study|Death|1|||
94483868|NCT03163446|323565381|FG000|Overall Study|Unable to return for Day 180 visit|2|||
94483869|NCT03163446|323565382|FG001|Overall Study|Unable to return for Day 180 visit|0|||
94483870|NCT03163446|323565381|FG000|Overall Study|Withdrawal by Subject|2|||
94483871|NCT03163446|323565382|FG001|Overall Study|Withdrawal by Subject|6|||
94483872|NCT03163446|323565381|FG000|Overall Study|Death|16|||
94483873|NCT03163446|323565382|FG001|Overall Study|Death|5|||
94483874|NCT03163446|323565381|FG000|Overall Study|Lost to Follow-up|6|||
94393122|NCT03733444|323228121|FG000|Overall Study|Physician Decision|2|||
94393123|NCT03733444|323228122|FG001|Overall Study|Physician Decision|1|||
94393124|NCT03733444|323228123|FG002|Overall Study|Physician Decision|0|||
94393125|NCT03733444|323228121|FG000|Overall Study|Protocol Violation|2|||
94393126|NCT03733444|323228122|FG001|Overall Study|Protocol Violation|1|||
94393127|NCT03733444|323228123|FG002|Overall Study|Protocol Violation|0|||
94393128|NCT03733444|323228121|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
94393129|NCT03733444|323228122|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
94393130|NCT03733444|323228123|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
94393131|NCT03733444|323228121|FG000|Overall Study|Study Terminated by Sponsor|203|||
94393132|NCT03733444|323228122|FG001|Overall Study|Study Terminated by Sponsor|209|||
94393133|NCT03733444|323228123|FG002|Overall Study|Study Terminated by Sponsor|221|||
94393134|NCT03733444|323228121|FG000|Overall Study|Withdrawal by Subject|19|||
94393135|NCT03733444|323228122|FG001|Overall Study|Withdrawal by Subject|18|||
94393136|NCT03733444|323228123|FG002|Overall Study|Withdrawal by Subject|16|||
94393137|NCT03733444|323228121|FG000|Overall Study|Miscellaneous|1|||
94393138|NCT03733444|323228122|FG001|Overall Study|Miscellaneous|0|||
94393139|NCT03733444|323228123|FG002|Overall Study|Miscellaneous|1|||
94393140|NCT03733444|323228121|FG000|Overall Study|Not Treated|1|||
94393141|NCT03733444|323228122|FG001|Overall Study|Not Treated|2|||
94393142|NCT03733444|323228123|FG002|Overall Study|Not Treated|1|||
94393143|NCT01723397|323228129|FG000|Study Period 1|Protocol Violation|0|||
94393144|NCT01723397|323228130|FG001|Study Period 1|Protocol Violation|1|||
94483875|NCT03163446|323565382|FG001|Overall Study|Lost to Follow-up|5|||
94483876|NCT03163446|323565381|FG000|Overall Study|Physician Decision|1|||
94483877|NCT03163446|323565382|FG001|Overall Study|Physician Decision|1|||
94483878|NCT03163446|323565381|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
94483879|NCT03163446|323565382|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
94393145|NCT01723397|323228129|FG000|Study Period 2|Protocol Violation|0|||
94393146|NCT01723397|323228130|FG001|Study Period 2|Protocol Violation|1|||
94393147|NCT00833937|323228135|FG000|Washout|Withdrawal by Subject|1|||
94393148|NCT00833937|323228136|FG001|Washout|Withdrawal by Subject|0|||
94393149|NCT00465270|323228139|FG000|Overall Study|Death|7|||
94393150|NCT00465270|323228140|FG001|Overall Study|Death|11|||
94393151|NCT00465270|323228139|FG000|Overall Study|Withdrawal by Subject|34|||
94393152|NCT00465270|323228140|FG001|Overall Study|Withdrawal by Subject|78|||
94393153|NCT00465270|323228139|FG000|Overall Study|Lost to Follow-up|60|||
94393154|NCT00465270|323228140|FG001|Overall Study|Lost to Follow-up|67|||
94393155|NCT00465270|323228139|FG000|Overall Study|Investigator request|3|||
94393156|NCT00465270|323228140|FG001|Overall Study|Investigator request|4|||
94393157|NCT02388191|323228141|FG000|Overall Study|Patient did not receive IUD|1|||
94393158|NCT02388191|323228142|FG001|Overall Study|Patient did not receive IUD|0|||
94393159|NCT01045161|323228143|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
94393160|NCT01045161|323228144|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
94393161|NCT01045161|323228145|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
94393162|NCT01045161|323228143|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
94393163|NCT01045161|323228144|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
94393164|NCT01045161|323228145|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
94393165|NCT01045161|323228143|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
94393166|NCT01045161|323228144|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
94393167|NCT01045161|323228145|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
94393168|NCT01045161|323228143|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
94393169|NCT01045161|323228144|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
94393170|NCT01045161|323228145|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
94393171|NCT01045161|323228143|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
94393172|NCT01045161|323228144|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
94393173|NCT01045161|323228145|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
94393174|NCT01045161|323228143|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
94393175|NCT01045161|323228144|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
94393176|NCT01045161|323228145|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
94393177|NCT01045161|323228143|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
94393178|NCT01045161|323228144|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
94393179|NCT01045161|323228145|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
94393180|NCT01045161|323228143|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
94393181|NCT01045161|323228144|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
94393182|NCT01045161|323228145|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
94393183|NCT01045161|323228143|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
94393184|NCT01045161|323228144|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
94393185|NCT01045161|323228145|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
94393186|NCT01045161|323228143|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
94393187|NCT01045161|323228144|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
94393188|NCT01045161|323228145|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
94393189|NCT01045161|323228143|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
94393190|NCT01045161|323228144|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
94393191|NCT01045161|323228145|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
94393192|NCT01045161|323228143|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
94393193|NCT01045161|323228144|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
94393194|NCT01045161|323228145|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
94393195|NCT01045161|323228143|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
94393196|NCT01045161|323228144|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
94393197|NCT01045161|323228145|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
94393198|NCT01045161|323228143|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
94393199|NCT01045161|323228144|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
94393200|NCT01045161|323228145|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
94393201|NCT03686033|323228146|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
94393202|NCT03686033|323228147|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
94393203|NCT03686033|323228148|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
94393204|NCT03686033|323228149|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
94393205|NCT03686033|323228150|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
94393206|NCT03686033|323228151|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
94393207|NCT00773253|323228152|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
94393208|NCT00773253|323228153|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
94393209|NCT03173547|323228154|FG000|Overall Study|Adverse Event|2|||
94393210|NCT03173547|323228155|FG001|Overall Study|Adverse Event|0|||
94393211|NCT03173547|323228154|FG000|Overall Study|Withdrawal by Subject|2|||
94393212|NCT03173547|323228155|FG001|Overall Study|Withdrawal by Subject|2|||
94393213|NCT00657553|323228157|FG000|Overall Study|low accrual, no analysis run|5|||
94393214|NCT00657553|323228158|FG001|Overall Study|low accrual, no analysis run|5|||
94393215|NCT03031847|323228159|FG000|Overall Study|Death|1|||
94393216|NCT03031847|323228160|FG001|Overall Study|Death|1|||
94393217|NCT03031847|323228161|FG002|Overall Study|Death|2|||
94393218|NCT03031847|323228162|FG003|Overall Study|Death|3|||
94393219|NCT03031847|323228159|FG000|Overall Study|Lost to Follow-up|1|||
94393220|NCT03031847|323228160|FG001|Overall Study|Lost to Follow-up|1|||
94393221|NCT03031847|323228161|FG002|Overall Study|Lost to Follow-up|2|||
94393222|NCT03031847|323228162|FG003|Overall Study|Lost to Follow-up|3|||
94393223|NCT00858845|323228163|FG000|Overall Study|Patient underwent heart transplant.|0|||
94393224|NCT00858845|323228164|FG001|Overall Study|Patient underwent heart transplant.|1|||
94393225|NCT01353664|323228166|FG000|Overall Study|Other|3|||
94393226|NCT01353664|323228166|FG000|Overall Study|Disease Progression|16|||
94393227|NCT00446563|323228167|FG000|Overall Study|Adverse Event|4|||
94393228|NCT00446563|323228168|FG001|Overall Study|Adverse Event|3|||
94393229|NCT00446563|323228167|FG000|Overall Study|Abnormal laboratory value(s)|0|||
94393230|NCT00446563|323228168|FG001|Overall Study|Abnormal laboratory value(s)|1|||
94393231|NCT00446563|323228167|FG000|Overall Study|Abnormal test procedure result(s)|1|||
94393232|NCT00446563|323228168|FG001|Overall Study|Abnormal test procedure result(s)|0|||
94393233|NCT00446563|323228167|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94393234|NCT00446563|323228168|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
94393235|NCT00446563|323228167|FG000|Overall Study|Withdrawal by Subject|2|||
94393236|NCT00446563|323228168|FG001|Overall Study|Withdrawal by Subject|1|||
94393237|NCT00446563|323228167|FG000|Overall Study|Administrative problems|0|||
94393238|NCT00446563|323228168|FG001|Overall Study|Administrative problems|1|||
94393239|NCT03769025|323228169|FG000|Overall Study|Withdrawal by Subject|1|||
94393240|NCT03769025|323228170|FG001|Overall Study|Withdrawal by Subject|1|||
94393241|NCT03769025|323228169|FG000|Overall Study|Lost to Follow-up|4|||
94393242|NCT03769025|323228170|FG001|Overall Study|Lost to Follow-up|3|||
94393243|NCT01066143|323230336|FG000|Overall Study|ineligible for the study|8|||
94393244|NCT01340495|323230337|FG000|Overall Study|Withdrawal by Subject|1|||
94393245|NCT01811953|323230338|FG000|Overall Study|Adverse Event|0|||
94393246|NCT01811953|323230339|FG001|Overall Study|Adverse Event|0|||
94393247|NCT01811953|323230340|FG002|Overall Study|Adverse Event|0|||
94393248|NCT01811953|323230341|FG003|Overall Study|Adverse Event|1|||
94393249|NCT01811953|323230342|FG004|Overall Study|Adverse Event|0|||
94393250|NCT01811953|323230343|FG005|Overall Study|Adverse Event|1|||
94393251|NCT01811953|323230338|FG000|Overall Study|Protocol Violation|0|||
94393252|NCT01811953|323230339|FG001|Overall Study|Protocol Violation|0|||
94393253|NCT01811953|323230340|FG002|Overall Study|Protocol Violation|0|||
94393254|NCT01811953|323230341|FG003|Overall Study|Protocol Violation|0|||
94393255|NCT01811953|323230342|FG004|Overall Study|Protocol Violation|1|||
94393256|NCT01811953|323230343|FG005|Overall Study|Protocol Violation|0|||
94393257|NCT00834522|323230346|FG000|Washout|Adverse Event|1|||
94393258|NCT00834522|323230347|FG001|Washout|Adverse Event|0|||
94393259|NCT00834522|323230346|FG000|Washout|Withdrawal by Subject|2|||
94393260|NCT00834522|323230347|FG001|Washout|Withdrawal by Subject|1|||
94393261|NCT02956460|323230356|FG000|Lens 1|Lost to Follow-up|1|||
94393262|NCT02956460|323230357|FG001|Lens 1|Lost to Follow-up|0|||
94393263|NCT00163657|323230358|FG000|Overall Study|Death|12|||
94393264|NCT00163657|323230359|FG001|Overall Study|Death|14|||
94393265|NCT00163657|323230360|FG002|Overall Study|Death|19|||
94393266|NCT00163657|323230358|FG000|Overall Study|graft loss|4|||
94393267|NCT00163657|323230359|FG001|Overall Study|graft loss|1|||
94393268|NCT00163657|323230360|FG002|Overall Study|graft loss|2|||
94393269|NCT00163657|323230358|FG000|Overall Study|Withdrawal by Subject|2|||
94393270|NCT00163657|323230359|FG001|Overall Study|Withdrawal by Subject|3|||
94393271|NCT00163657|323230360|FG002|Overall Study|Withdrawal by Subject|2|||
94393272|NCT00163657|323230358|FG000|Overall Study|Physician Decision|0|||
94393273|NCT00163657|323230359|FG001|Overall Study|Physician Decision|1|||
94393274|NCT00163657|323230360|FG002|Overall Study|Physician Decision|1|||
94393275|NCT00163657|323230358|FG000|Overall Study|Non Compliance|1|||
94393276|NCT00163657|323230359|FG001|Overall Study|Non Compliance|0|||
94393277|NCT00163657|323230360|FG002|Overall Study|Non Compliance|0|||
94393278|NCT00163657|323230358|FG000|Overall Study|Lost to Follow-up|1|||
94393279|NCT00163657|323230359|FG001|Overall Study|Lost to Follow-up|3|||
94393280|NCT00163657|323230360|FG002|Overall Study|Lost to Follow-up|10|||
94393281|NCT00163657|323230358|FG000|Overall Study|Other reason|0|||
94393282|NCT00163657|323230359|FG001|Overall Study|Other reason|1|||
94393283|NCT00163657|323230360|FG002|Overall Study|Other reason|3|||
94393284|NCT00984022|323230361|FG000|Overall Study|Lost to Follow-up|10|||
94393285|NCT00984022|323230362|FG001|Overall Study|Lost to Follow-up|14|||
94393286|NCT02543203|323230363|FG000|Overall Study|Unpalatable Fragrance|2|||
94393287|NCT02543203|323230364|FG001|Overall Study|Unpalatable Fragrance|2|||
94393288|NCT02543203|323230363|FG000|Overall Study|Lost to Follow-up|1|||
94393289|NCT02543203|323230364|FG001|Overall Study|Lost to Follow-up|0|||
94393290|NCT02543203|323230363|FG000|Overall Study|Increased Irritability|1|||
94393291|NCT02543203|323230364|FG001|Overall Study|Increased Irritability|0|||
94393292|NCT02543203|323230363|FG000|Overall Study|Family|1|||
94393293|NCT02543203|323230364|FG001|Overall Study|Family|2|||
94393294|NCT02543203|323230363|FG000|Overall Study|Negative Behavior|1|||
94393295|NCT02543203|323230364|FG001|Overall Study|Negative Behavior|0|||
94393296|NCT02543203|323230363|FG000|Overall Study|Withdrawal by Subject|0|||
94393297|NCT02543203|323230364|FG001|Overall Study|Withdrawal by Subject|1|||
94393298|NCT02909907|323230367|FG000|Overall Study|Withdrawal by Subject|0|||
94393299|NCT02909907|323230368|FG001|Overall Study|Withdrawal by Subject|1|||
94393300|NCT04533594|323230371|FG000|Overall Study|Death|26|||
94393301|NCT03500341|323230383|FG000|Overall Study|Withdrawn prior to Completion|2|||
94393302|NCT01294917|323230388|FG000|Overall Study|Relocation|5|||
94393303|NCT01294917|323230388|FG000|Overall Study|Inconvenience|1|||
94393304|NCT02159950|323230389|FG000|Overall Study|Adverse Event|0|||
94393305|NCT02159950|323230390|FG001|Overall Study|Adverse Event|1|||
94393306|NCT02159950|323230389|FG000|Overall Study|Progression|0|||
94393307|NCT02159950|323230390|FG001|Overall Study|Progression|1|||
94393308|NCT01175018|323230391|FG000|Overall Study|Adverse Event|3|||
94393309|NCT01175018|323230392|FG001|Overall Study|Adverse Event|1|||
94393310|NCT01244620|323230393|FG000|Overall Study|Study terminated|4|||
94393311|NCT01244620|323230394|FG001|Overall Study|Study terminated|4|||
94393312|NCT01244620|323230395|FG002|Overall Study|Study terminated|4|||
94393313|NCT01244620|323230396|FG003|Overall Study|Study terminated|4|||
94393314|NCT02648438|323230401|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
94393315|NCT02648438|323230402|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
94393316|NCT02648438|323230403|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
94393317|NCT02648438|323230401|FG000|Overall Study|Protocol Violation|2|||
94393318|NCT02648438|323230402|FG001|Overall Study|Protocol Violation|0|||
94393319|NCT02648438|323230403|FG002|Overall Study|Protocol Violation|0|||
94393320|NCT02648438|323230401|FG000|Overall Study|Withdrawal by Subject|1|||
94393321|NCT02648438|323230402|FG001|Overall Study|Withdrawal by Subject|1|||
94393322|NCT02648438|323230403|FG002|Overall Study|Withdrawal by Subject|0|||
94393323|NCT04400890|323230404|FG000|Overall Study|Withdrawal by Subject|3|||
94393324|NCT04400890|323230405|FG001|Overall Study|Withdrawal by Subject|2|||
94393325|NCT02258074|323230410|FG000|Overall Study|Withdrawal by Subject|1|||
94393326|NCT02258074|323230411|FG001|Overall Study|Withdrawal by Subject|0|||
94393327|NCT02258074|323230412|FG002|Overall Study|Withdrawal by Subject|0|||
94393328|NCT02258074|323230413|FG003|Overall Study|Withdrawal by Subject|0|||
94393329|NCT04405570|323230414|FG000|Overall Study|Adverse Event|0|||
94393330|NCT04405570|323230415|FG001|Overall Study|Adverse Event|1|||
94393331|NCT04405570|323230416|FG002|Overall Study|Adverse Event|1|||
94393332|NCT04405570|323230417|FG003|Overall Study|Adverse Event|1|||
94393333|NCT04405570|323230414|FG000|Overall Study|Lost to Follow-up|0|||
94393334|NCT04405570|323230415|FG001|Overall Study|Lost to Follow-up|1|||
94393335|NCT04405570|323230416|FG002|Overall Study|Lost to Follow-up|0|||
94393336|NCT04405570|323230417|FG003|Overall Study|Lost to Follow-up|0|||
94393337|NCT04405570|323230414|FG000|Overall Study|Physician Decision|0|||
94393338|NCT04405570|323230415|FG001|Overall Study|Physician Decision|0|||
94393339|NCT04405570|323230416|FG002|Overall Study|Physician Decision|1|||
94393340|NCT04405570|323230417|FG003|Overall Study|Physician Decision|0|||
94393341|NCT04405570|323230414|FG000|Overall Study|Withdrawal by Subject|0|||
94393342|NCT04405570|323230415|FG001|Overall Study|Withdrawal by Subject|1|||
94393343|NCT04405570|323230416|FG002|Overall Study|Withdrawal by Subject|1|||
94393344|NCT04405570|323230417|FG003|Overall Study|Withdrawal by Subject|0|||
94393345|NCT04405570|323230414|FG000|Overall Study|Randomized not dosed|0|||
94393346|NCT04405570|323230415|FG001|Overall Study|Randomized not dosed|2|||
94393347|NCT04405570|323230416|FG002|Overall Study|Randomized not dosed|0|||
94393348|NCT04405570|323230417|FG003|Overall Study|Randomized not dosed|0|||
94393349|NCT01208337|323230418|FG000|Overall Study|Death|3|||
94393350|NCT01848938|323230423|FG000|Overall Study|Lost to Follow-up|1|||
94393351|NCT01848938|323230424|FG001|Overall Study|Lost to Follow-up|1|||
94393352|NCT03552393|323230425|FG000|Core Period|Kidney Transplant|1|||
94393353|NCT03552393|323230425|FG000|Core Period|Prohibited Medication|1|||
94393354|NCT03552393|323230425|FG000|Safety Extension Period|Kidney Transplant|4|||
94393355|NCT02601625|323230426|FG000|Overall Study|Lost to Follow-up|0|||
94393356|NCT02601625|323230427|FG001|Overall Study|Lost to Follow-up|0|||
94393357|NCT02601625|323230428|FG002|Overall Study|Lost to Follow-up|1|||
94393358|NCT02601625|323230429|FG003|Overall Study|Lost to Follow-up|1|||
94393359|NCT01757392|323230431|FG000|Overall Study|Withdrawal by Subject|1|||
94393360|NCT01757392|323230431|FG000|Overall Study|Screen Fail|3|||
94393361|NCT01289262|323230434|FG000|Overall Study|Lost to Follow-up|29|||
94393362|NCT01289262|323230435|FG001|Overall Study|Lost to Follow-up|16|||
94393363|NCT01289262|323230434|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
94393364|NCT01289262|323230435|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
94393365|NCT00838279|323230438|FG000|Washout|Protocol Violation|1|||
94393366|NCT00838279|323230439|FG001|Washout|Protocol Violation|0|||
94393367|NCT00838279|323230438|FG000|Washout|Withdrawal by Subject|0|||
94393368|NCT00838279|323230439|FG001|Washout|Withdrawal by Subject|1|||
94393369|NCT01250912|323230440|FG000|Overall Study|Lost to Follow-up|1|||
94393370|NCT00463684|323230441|FG000|Overall Study|Withdrawal by Subject|1|||
94393371|NCT00463684|323230441|FG000|Overall Study|Lost to Follow-up|3|||
94393372|NCT01316055|323230443|FG000|Overall Study|Lost to Follow-up|1|||
94393373|NCT01316055|323230444|FG001|Overall Study|Lost to Follow-up|0|||
94393374|NCT01316055|323230445|FG002|Overall Study|Lost to Follow-up|0|||
94393375|NCT01929863|323230446|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
94393376|NCT01929863|323230447|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
94393377|NCT01929863|323230446|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
94393378|NCT01929863|323230447|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
94393379|NCT01929863|323230446|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
94393380|NCT01929863|323230447|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
94393381|NCT00003470|323230448|FG000|Overall Study|Not evaluable|6|||
94393382|NCT01218867|323230449|FG000|Overall Study|Death during treatment|0|||
94393383|NCT01218867|323230450|FG001|Overall Study|Death during treatment|0|||
94393384|NCT01218867|323230451|FG002|Overall Study|Death during treatment|0|||
94393385|NCT01218867|323230452|FG003|Overall Study|Death during treatment|0|||
94393386|NCT01218867|323230453|FG004|Overall Study|Death during treatment|0|||
94393387|NCT01218867|323230454|FG005|Overall Study|Death during treatment|0|||
94393388|NCT01218867|323230455|FG006|Overall Study|Death during treatment|1|||
94393389|NCT01218867|323230456|FG007|Overall Study|Death during treatment|0|||
94393390|NCT01218867|323230457|FG008|Overall Study|Death during treatment|0|||
94393391|NCT01218867|323230458|FG009|Overall Study|Death during treatment|0|||
94393392|NCT01218867|323230459|FG010|Overall Study|Death during treatment|0|||
94393393|NCT03792477|323230460|FG000|Overall Study|Adverse Event|0|||
94393394|NCT03792477|323230461|FG001|Overall Study|Adverse Event|0|||
94393395|NCT03792477|323230462|FG002|Overall Study|Adverse Event|0|||
94393396|NCT03792477|323230463|FG003|Overall Study|Adverse Event|1|||
94393397|NCT03792477|323230464|FG004|Overall Study|Adverse Event|0|||
94393398|NCT03792477|323230460|FG000|Overall Study|Lost to Follow-up|0|||
94393399|NCT03792477|323230461|FG001|Overall Study|Lost to Follow-up|0|||
94393400|NCT03792477|323230462|FG002|Overall Study|Lost to Follow-up|2|||
94393401|NCT03792477|323230463|FG003|Overall Study|Lost to Follow-up|0|||
94393402|NCT03792477|323230464|FG004|Overall Study|Lost to Follow-up|0|||
94393403|NCT03792477|323230460|FG000|Overall Study|Other|0|||
94393404|NCT03792477|323230461|FG001|Overall Study|Other|0|||
94393405|NCT03792477|323230462|FG002|Overall Study|Other|0|||
94393406|NCT03792477|323230463|FG003|Overall Study|Other|0|||
94393407|NCT03792477|323230464|FG004|Overall Study|Other|1|||
94393408|NCT00840411|323230465|FG000|First Intervention|Adverse Event|1|||
94393409|NCT00840411|323230466|FG001|First Intervention|Adverse Event|0|||
94393410|NCT00840411|323230465|FG000|Washout|Withdrawal by Subject|1|||
94393411|NCT00840411|323230466|FG001|Washout|Withdrawal by Subject|0|||
94393412|NCT03122457|323230467|FG000|Overall Study|Withdrawal by Subject|6|||
94393413|NCT00651820|323230472|FG000|Overall Study|Lost to Follow-up|2|||
94393414|NCT01921062|323230473|FG000|Overall Study|Withdrawal by Subject|0|||
94393415|NCT01921062|323230474|FG001|Overall Study|Withdrawal by Subject|7|||
94393416|NCT01921062|323230473|FG000|Overall Study|Adverse Event|5|||
94393417|NCT01921062|323230474|FG001|Overall Study|Adverse Event|6|||
94393418|NCT01921062|323230473|FG000|Overall Study|Protocol Violation|0|||
94393419|NCT01921062|323230474|FG001|Overall Study|Protocol Violation|1|||
94393420|NCT01921062|323230473|FG000|Overall Study|VMIQ score > 72|4|||
94393421|NCT01921062|323230474|FG001|Overall Study|VMIQ score > 72|1|||
94393422|NCT01921062|323230473|FG000|Overall Study|Logistic error|0|||
94393423|NCT01921062|323230474|FG001|Overall Study|Logistic error|1|||
94393424|NCT01911676|323230475|FG000|Period 1 of Study|Withdrawal by Subject|4|||
94393425|NCT01911676|323230476|FG001|Period 1 of Study|Withdrawal by Subject|2|||
94393426|NCT01911676|323230477|FG002|Period 1 of Study|Withdrawal by Subject|1|||
94393427|NCT01911676|323230478|FG003|Period 1 of Study|Withdrawal by Subject|2|||
94393428|NCT01911676|323230475|FG000|Period 1 of Study|Physician Decision|2|||
94393429|NCT01911676|323230476|FG001|Period 1 of Study|Physician Decision|0|||
94393430|NCT01911676|323230477|FG002|Period 1 of Study|Physician Decision|0|||
94393431|NCT01911676|323230478|FG003|Period 1 of Study|Physician Decision|1|||
94393432|NCT01911676|323230475|FG000|Period 2 of Study|Physician Decision|2|||
94393433|NCT01911676|323230476|FG001|Period 2 of Study|Physician Decision|0|||
94393434|NCT01911676|323230477|FG002|Period 2 of Study|Physician Decision|0|||
94393435|NCT01911676|323230478|FG003|Period 2 of Study|Physician Decision|1|||
94393436|NCT01911676|323230475|FG000|Period 2 of Study|Lost to Follow-up|0|||
94393437|NCT01911676|323230476|FG001|Period 2 of Study|Lost to Follow-up|0|||
94393438|NCT01911676|323230477|FG002|Period 2 of Study|Lost to Follow-up|0|||
94393439|NCT01911676|323230478|FG003|Period 2 of Study|Lost to Follow-up|1|||
94393440|NCT01878292|323230480|FG000|Randomized|Protocol Violation|1|||
94393441|NCT01878292|323230481|FG001|Randomized|Protocol Violation|0|||
94393442|NCT01878292|323230482|FG002|Randomized|Protocol Violation|0|||
94393443|NCT01878292|323230480|FG000|Randomized|Lost to Follow-up|1|||
94393444|NCT01878292|323230481|FG001|Randomized|Lost to Follow-up|0|||
94393445|NCT01878292|323230482|FG002|Randomized|Lost to Follow-up|0|||
94393446|NCT01878292|323230480|FG000|Randomized|Adverse Event|1|||
94393447|NCT01878292|323230481|FG001|Randomized|Adverse Event|0|||
94393448|NCT01878292|323230482|FG002|Randomized|Adverse Event|0|||
94393449|NCT01878292|323230480|FG000|Double-blind Treatment Period|Other Reasons|2|||
94393450|NCT01878292|323230481|FG001|Double-blind Treatment Period|Other Reasons|0|||
94328855|NCT03287869|322984191|FG001|Overall Study|Physician Decision|5|||
94328856|NCT03287869|322984190|FG000|Overall Study|Reason not Specified|6|||
94328857|NCT03287869|322984191|FG001|Overall Study|Reason not Specified|3|||
94393451|NCT01878292|323230482|FG002|Double-blind Treatment Period|Other Reasons|0|||
94393452|NCT01878292|323230480|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
94393453|NCT01878292|323230481|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
94328858|NCT03488238|322984192|FG000|Overall Study|Equipment malfunction|1|||
94328859|NCT03488238|322984192|FG000|Overall Study|Adverse Event|1|||
94328860|NCT02282982|322984193|FG000|Overall Study|Lost to Follow-up|15|||
94328861|NCT02282982|322984193|FG000|Overall Study|Withdrew consent|2|||
94328862|NCT02282982|322984193|FG000|Overall Study|Death|4|||
94328863|NCT02282982|322984193|FG000|Overall Study|Lack of product|156|||
94328864|NCT02282982|322984193|FG000|Overall Study|Palivizumab is ended|11|||
94328865|NCT02282982|322984193|FG000|Overall Study|Other, not specified|18|||
94328866|NCT03039738|322984194|FG000|Overall Study|Incomplete data sets|54|||
94328867|NCT03039738|322984195|FG001|Overall Study|Incomplete data sets|0|||
94328868|NCT04681729|322984196|FG000|Overall Study|Lack of Efficacy|2|||
94328869|NCT04681729|322984197|FG001|Overall Study|Lack of Efficacy|2|||
94328870|NCT04681729|322984196|FG000|Overall Study|Withdrawal by Subject|8|||
94328871|NCT04681729|322984197|FG001|Overall Study|Withdrawal by Subject|9|||
94328872|NCT03728140|322984208|FG000|Overall Study|Abnormal embryo transfer operation|10|||
94328873|NCT03728140|322984209|FG001|Overall Study|Abnormal embryo transfer operation|7|||
94328874|NCT02384395|322984213|FG000|Overall Study|Physician Decision|4|||
94328875|NCT02384395|322984213|FG000|Overall Study|Withdrawal by Subject|3|||
94328876|NCT02384395|322984213|FG000|Overall Study|Lost to Follow-up|3|||
94328877|NCT01280266|322984214|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
94328878|NCT01280266|322984215|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
94328879|NCT01280266|322984214|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
94328880|NCT01280266|322984215|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
94328881|NCT00448760|322984223|FG000|Overall Study|Death|3|||
94328882|NCT01295580|322984224|FG000|Overall Study|Protocol Violation|4|||
94328883|NCT01295580|322984225|FG001|Overall Study|Protocol Violation|2|||
94328884|NCT01295580|322984224|FG000|Overall Study|Withdrawal by Subject|1|||
94328885|NCT01295580|322984225|FG001|Overall Study|Withdrawal by Subject|4|||
94328886|NCT01295580|322984224|FG000|Overall Study|Adverse Event|2|||
94328887|NCT01295580|322984225|FG001|Overall Study|Adverse Event|1|||
94328888|NCT01295580|322984224|FG000|Overall Study|Lost to Follow-up|1|||
94328889|NCT01295580|322984225|FG001|Overall Study|Lost to Follow-up|0|||
94328890|NCT01295580|322984224|FG000|Overall Study|Lack of Efficacy|1|||
94328891|NCT01295580|322984225|FG001|Overall Study|Lack of Efficacy|0|||
94328892|NCT01295580|322984224|FG000|Overall Study|Other: inconvenience|1|||
94328893|NCT01295580|322984225|FG001|Overall Study|Other: inconvenience|0|||
94328894|NCT01295580|322984224|FG000|Overall Study|Other: family objection|0|||
94328895|NCT01295580|322984225|FG001|Overall Study|Other: family objection|1|||
94328896|NCT00065442|322984228|FG000|Overall Study|Lost to Follow-up|1|||
94328897|NCT00065442|322984229|FG001|Overall Study|Lost to Follow-up|1|||
94328898|NCT00065442|322984228|FG000|Overall Study|Death|121|||
94328899|NCT00065442|322984229|FG001|Overall Study|Death|210|||
94328900|NCT00065442|322984228|FG000|Overall Study|Withdrawal by Subject|3|||
94328901|NCT00065442|322984229|FG001|Overall Study|Withdrawal by Subject|9|||
94328902|NCT00282867|322984237|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
94328903|NCT00282867|322984238|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
94328904|NCT00282867|322984239|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
94328905|NCT00830960|322984240|FG000|Overall Study|Death|5|||
94328906|NCT00830960|322984241|FG001|Overall Study|Death|4|||
94328907|NCT00830960|322984242|FG002|Overall Study|Death|3|||
94328908|NCT00830960|322984243|FG003|Overall Study|Death|2|||
94328909|NCT00830960|322984244|FG004|Overall Study|Death|6|||
94328910|NCT00830960|322984245|FG005|Overall Study|Death|1|||
94328911|NCT00830960|322984240|FG000|Overall Study|Lost to Follow-up|1|||
94328912|NCT00830960|322984241|FG001|Overall Study|Lost to Follow-up|1|||
94328913|NCT00830960|322984242|FG002|Overall Study|Lost to Follow-up|1|||
94328914|NCT00830960|322984243|FG003|Overall Study|Lost to Follow-up|0|||
94328915|NCT00830960|322984244|FG004|Overall Study|Lost to Follow-up|0|||
94328916|NCT00830960|322984245|FG005|Overall Study|Lost to Follow-up|1|||
94328917|NCT00830960|322984240|FG000|Overall Study|Withdrawal by Subject|19|||
94328918|NCT00830960|322984241|FG001|Overall Study|Withdrawal by Subject|19|||
94328919|NCT00830960|322984242|FG002|Overall Study|Withdrawal by Subject|18|||
94328920|NCT00830960|322984243|FG003|Overall Study|Withdrawal by Subject|23|||
94328921|NCT00830960|322984244|FG004|Overall Study|Withdrawal by Subject|16|||
94328922|NCT00830960|322984245|FG005|Overall Study|Withdrawal by Subject|21|||
94328923|NCT00830960|322984240|FG000|Overall Study|Sponsor Decision|1|||
94328924|NCT00830960|322984241|FG001|Overall Study|Sponsor Decision|2|||
94328925|NCT00830960|322984242|FG002|Overall Study|Sponsor Decision|3|||
94328926|NCT00830960|322984243|FG003|Overall Study|Sponsor Decision|4|||
94328927|NCT00830960|322984244|FG004|Overall Study|Sponsor Decision|5|||
94328928|NCT00830960|322984245|FG005|Overall Study|Sponsor Decision|7|||
94393454|NCT01878292|323230482|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
94393455|NCT01878292|323230480|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
94393456|NCT01878292|323230481|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
94393457|NCT01878292|323230482|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
94393458|NCT01878292|323230480|FG000|Double-blind Treatment Period|Protocol Violation|3|||
94393459|NCT01878292|323230481|FG001|Double-blind Treatment Period|Protocol Violation|4|||
94393460|NCT01878292|323230482|FG002|Double-blind Treatment Period|Protocol Violation|2|||
94393461|NCT01878292|323230480|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
94393462|NCT01878292|323230481|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
94393463|NCT01878292|323230482|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
94393464|NCT01878292|323230480|FG000|Double-blind Treatment Period|Adverse Event|4|||
94393465|NCT01878292|323230481|FG001|Double-blind Treatment Period|Adverse Event|9|||
94393466|NCT01878292|323230482|FG002|Double-blind Treatment Period|Adverse Event|8|||
94393467|NCT01878292|323230480|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
94393468|NCT01878292|323230481|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
94393469|NCT01878292|323230482|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
94393470|NCT00323882|323230483|FG000|Overall Study|Adverse Event|2|||
94393471|NCT00323882|323230484|FG001|Overall Study|Adverse Event|1|||
94393472|NCT00323882|323230485|FG002|Overall Study|Adverse Event|1|||
94393473|NCT00323882|323230486|FG003|Overall Study|Adverse Event|1|||
94393474|NCT00323882|323230487|FG004|Overall Study|Adverse Event|3|||
94393475|NCT00323882|323230483|FG000|Overall Study|Disease Progression|6|||
94393476|NCT00323882|323230484|FG001|Overall Study|Disease Progression|4|||
94393477|NCT00323882|323230485|FG002|Overall Study|Disease Progression|10|||
94393478|NCT00323882|323230486|FG003|Overall Study|Disease Progression|5|||
94393479|NCT00323882|323230487|FG004|Overall Study|Disease Progression|22|||
94393480|NCT00323882|323230483|FG000|Overall Study|Death|0|||
94393481|NCT00323882|323230484|FG001|Overall Study|Death|1|||
94393482|NCT00323882|323230485|FG002|Overall Study|Death|1|||
94393483|NCT00323882|323230486|FG003|Overall Study|Death|0|||
94393484|NCT00323882|323230487|FG004|Overall Study|Death|5|||
94393485|NCT00323882|323230483|FG000|Overall Study|Lost to Follow-up|0|||
94393486|NCT00323882|323230484|FG001|Overall Study|Lost to Follow-up|0|||
94393487|NCT00323882|323230485|FG002|Overall Study|Lost to Follow-up|1|||
94393488|NCT00323882|323230486|FG003|Overall Study|Lost to Follow-up|0|||
94393489|NCT00323882|323230487|FG004|Overall Study|Lost to Follow-up|1|||
94393490|NCT00323882|323230483|FG000|Overall Study|Other|0|||
94393491|NCT00323882|323230484|FG001|Overall Study|Other|0|||
94393492|NCT00323882|323230485|FG002|Overall Study|Other|0|||
94393493|NCT00323882|323230486|FG003|Overall Study|Other|1|||
94393494|NCT00323882|323230487|FG004|Overall Study|Other|1|||
94393495|NCT00835536|323230491|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
94393496|NCT00835536|323230492|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
94393497|NCT03134222|323230493|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
94393498|NCT03134222|323230494|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
94393499|NCT03134222|323230495|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
94393500|NCT03134222|323230496|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
94393501|NCT03134222|323230497|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
94393502|NCT03134222|323230493|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
94393503|NCT03134222|323230494|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
94393504|NCT03134222|323230495|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
94393505|NCT03134222|323230496|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
94393506|NCT03134222|323230497|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
94393507|NCT03134222|323230493|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
94393508|NCT03134222|323230494|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
94393509|NCT03134222|323230495|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
94393510|NCT03134222|323230496|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
94393511|NCT03134222|323230497|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
94393512|NCT03134222|323230493|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
94393513|NCT03134222|323230494|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
94393514|NCT03134222|323230495|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
94393515|NCT03134222|323230496|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
94393516|NCT03134222|323230497|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
94393517|NCT03134222|323230493|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
94393518|NCT03134222|323230494|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
94393519|NCT03134222|323230495|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
94393520|NCT03134222|323230496|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
94393521|NCT03134222|323230497|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
94393522|NCT03134222|323230493|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
94393523|NCT03134222|323230494|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
94393524|NCT03134222|323230495|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
94393525|NCT03134222|323230496|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
94393526|NCT03134222|323230497|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
94483880|NCT00611806|323565383|FG000|Overall Study|Withdrawal by Subject|8|||
94393527|NCT03134222|323230493|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
94393528|NCT03134222|323230494|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
94393529|NCT03134222|323230495|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
94393530|NCT03134222|323230496|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
94393531|NCT03134222|323230497|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
94393532|NCT03134222|323230493|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
94393533|NCT03134222|323230494|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
94393534|NCT03134222|323230495|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
94393535|NCT03134222|323230496|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
94393536|NCT03134222|323230497|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
94393537|NCT00950989|323230498|FG000|Overall Study|Death|0|||
94393538|NCT00950989|323230499|FG001|Overall Study|Death|0|||
94393539|NCT00950989|323230500|FG002|Overall Study|Death|1|||
94393540|NCT00950989|323230501|FG003|Overall Study|Death|0|||
94393541|NCT00950989|323230498|FG000|Overall Study|Administrative Decision|0|||
94393542|NCT00950989|323230499|FG001|Overall Study|Administrative Decision|1|||
94393543|NCT00950989|323230500|FG002|Overall Study|Administrative Decision|0|||
94393544|NCT00950989|323230501|FG003|Overall Study|Administrative Decision|0|||
94393545|NCT00950989|323230498|FG000|Overall Study|Disease Progression|0|||
94393546|NCT00950989|323230499|FG001|Overall Study|Disease Progression|0|||
94393547|NCT00950989|323230500|FG002|Overall Study|Disease Progression|1|||
94393548|NCT00950989|323230501|FG003|Overall Study|Disease Progression|0|||
94393549|NCT00950989|323230498|FG000|Overall Study|Withdrawal by Subject|2|||
94393550|NCT00950989|323230499|FG001|Overall Study|Withdrawal by Subject|1|||
94393551|NCT00950989|323230500|FG002|Overall Study|Withdrawal by Subject|0|||
94393552|NCT00950989|323230501|FG003|Overall Study|Withdrawal by Subject|0|||
94393553|NCT00950989|323230498|FG000|Overall Study|Adverse Event|2|||
94393554|NCT00950989|323230499|FG001|Overall Study|Adverse Event|1|||
94393555|NCT00950989|323230500|FG002|Overall Study|Adverse Event|1|||
94393556|NCT00950989|323230501|FG003|Overall Study|Adverse Event|0|||
94393557|NCT01841554|323230502|FG000|Overall Study|Death|7|||
94393558|NCT01841554|323230502|FG000|Overall Study|No Implantation|1|||
94393559|NCT01841554|323230502|FG000|Overall Study|Discontinued Follow Up|5|||
94393560|NCT01841554|323230502|FG000|Overall Study|Study exit due to secondary intervention|6|||
94393561|NCT03804983|323230506|FG000|Overall Study|Adverse Event|0|||
94393562|NCT03804983|323230507|FG001|Overall Study|Adverse Event|1|||
94393563|NCT03804983|323230506|FG000|Overall Study|Family Obligation|1|||
94393564|NCT03804983|323230507|FG001|Overall Study|Family Obligation|0|||
94393565|NCT03123471|323230510|FG000|Placebo-controlled Phase|Adverse Event|3|||
94393566|NCT03123471|323230511|FG001|Placebo-controlled Phase|Adverse Event|8|||
94393567|NCT03123471|323230510|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
94393568|NCT03123471|323230511|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
94393569|NCT03123471|323230510|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
94393570|NCT03123471|323230511|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
94393571|NCT03123471|323230510|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
94393572|NCT03123471|323230511|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
94393573|NCT03123471|323230510|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
94393574|NCT03123471|323230511|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
94393575|NCT03123471|323230510|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
94393576|NCT03123471|323230511|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
94393577|NCT03123471|323230510|FG000|Placebo-controlled Phase|Miscellaneous|0|||
94393578|NCT03123471|323230511|FG001|Placebo-controlled Phase|Miscellaneous|1|||
94393579|NCT03123471|323230510|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
94393580|NCT03123471|323230511|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
94393581|NCT03123471|323230510|FG000|Apremilast Extension Phase|Adverse Event|1|||
94393582|NCT03123471|323230511|FG001|Apremilast Extension Phase|Adverse Event|5|||
94393583|NCT03123471|323230510|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
94393584|NCT03123471|323230511|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
94393585|NCT03123471|323230510|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
94393586|NCT03123471|323230511|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
94393587|NCT01473953|323230512|FG000|Overall Study|Other|1|||
94393588|NCT01473953|323230513|FG001|Overall Study|Other|0|||
94393589|NCT01473953|323230514|FG002|Overall Study|Other|0|||
94393590|NCT01473953|323230515|FG003|Overall Study|Other|0|||
94393591|NCT01473953|323230516|FG004|Overall Study|Other|0|||
94393592|NCT00312897|323230517|FG000|Overall Study|Adverse Event|1|||
94393593|NCT00312897|323230518|FG001|Overall Study|Adverse Event|0|||
94393594|NCT00312897|323230517|FG000|Overall Study|Lost to Follow-up|2|||
94393595|NCT00312897|323230518|FG001|Overall Study|Lost to Follow-up|0|||
94393596|NCT00312897|323230517|FG000|Overall Study|Physician Decision|1|||
94393597|NCT00312897|323230518|FG001|Overall Study|Physician Decision|0|||
94393598|NCT00312897|323230517|FG000|Overall Study|Withdrawal by Subject|1|||
94393599|NCT00312897|323230518|FG001|Overall Study|Withdrawal by Subject|3|||
94393600|NCT00312897|323230517|FG000|Overall Study|Pregnancy|1|||
94393601|NCT00312897|323230518|FG001|Overall Study|Pregnancy|0|||
94483881|NCT00611806|323565384|FG001|Overall Study|Withdrawal by Subject|2|||
94483882|NCT00611806|323565383|FG000|Overall Study|Adverse Event|2|||
94483883|NCT00611806|323565384|FG001|Overall Study|Adverse Event|1|||
94483884|NCT00611806|323565383|FG000|Overall Study|Lost to Follow-up|6|||
94393602|NCT00312897|323230517|FG000|Overall Study|discontinued prior to getting treatment|0|||
94393603|NCT00312897|323230518|FG001|Overall Study|discontinued prior to getting treatment|3|||
94393604|NCT02281084|323230521|FG000|Overall Study|Death|21|||
94393605|NCT02281084|323230522|FG001|Overall Study|Death|18|||
94393606|NCT02281084|323230523|FG002|Overall Study|Death|3|||
94393607|NCT02281084|323230524|FG003|Overall Study|Death|5|||
94393608|NCT02281084|323230521|FG000|Overall Study|Adverse Event|1|||
94393609|NCT02281084|323230522|FG001|Overall Study|Adverse Event|0|||
94393610|NCT02281084|323230523|FG002|Overall Study|Adverse Event|0|||
94393611|NCT02281084|323230524|FG003|Overall Study|Adverse Event|0|||
94393612|NCT02281084|323230521|FG000|Overall Study|Withdrawal by Subject|2|||
94393613|NCT02281084|323230522|FG001|Overall Study|Withdrawal by Subject|2|||
94393614|NCT02281084|323230523|FG002|Overall Study|Withdrawal by Subject|0|||
94393615|NCT02281084|323230524|FG003|Overall Study|Withdrawal by Subject|0|||
94393616|NCT02281084|323230521|FG000|Overall Study|Site Closure by Sponsor|5|||
94393617|NCT02281084|323230522|FG001|Overall Study|Site Closure by Sponsor|1|||
94393618|NCT02281084|323230523|FG002|Overall Study|Site Closure by Sponsor|2|||
94393619|NCT02281084|323230524|FG003|Overall Study|Site Closure by Sponsor|0|||
94393620|NCT03290781|323230528|FG000|Overall Study|Adverse Event|5|||
94393621|NCT03290781|323230529|FG001|Overall Study|Adverse Event|7|||
94393622|NCT03290781|323230530|FG002|Overall Study|Adverse Event|4|||
94393623|NCT03290781|323230531|FG003|Overall Study|Adverse Event|1|||
94393624|NCT03290781|323230532|FG004|Overall Study|Adverse Event|0|||
94393625|NCT03290781|323230533|FG005|Overall Study|Adverse Event|0|||
94393626|NCT03290781|323230534|FG006|Overall Study|Adverse Event|0|||
94393627|NCT03290781|323230528|FG000|Overall Study|Death|0|||
94393628|NCT03290781|323230529|FG001|Overall Study|Death|0|||
94393629|NCT03290781|323230530|FG002|Overall Study|Death|1|||
94393630|NCT03290781|323230531|FG003|Overall Study|Death|0|||
94393631|NCT03290781|323230532|FG004|Overall Study|Death|1|||
94393632|NCT03290781|323230533|FG005|Overall Study|Death|0|||
94393633|NCT03290781|323230534|FG006|Overall Study|Death|0|||
94393634|NCT03290781|323230528|FG000|Overall Study|Withdrawal by Subject|6|||
94393635|NCT03290781|323230529|FG001|Overall Study|Withdrawal by Subject|5|||
94393636|NCT03290781|323230530|FG002|Overall Study|Withdrawal by Subject|9|||
94393637|NCT03290781|323230531|FG003|Overall Study|Withdrawal by Subject|10|||
94393638|NCT03290781|323230532|FG004|Overall Study|Withdrawal by Subject|1|||
94393639|NCT03290781|323230533|FG005|Overall Study|Withdrawal by Subject|2|||
94393640|NCT03290781|323230534|FG006|Overall Study|Withdrawal by Subject|0|||
94393641|NCT03290781|323230528|FG000|Overall Study|Physician Decision|0|||
94393642|NCT03290781|323230529|FG001|Overall Study|Physician Decision|1|||
94393643|NCT03290781|323230530|FG002|Overall Study|Physician Decision|0|||
94393644|NCT03290781|323230531|FG003|Overall Study|Physician Decision|0|||
94393645|NCT03290781|323230532|FG004|Overall Study|Physician Decision|0|||
94393646|NCT03290781|323230533|FG005|Overall Study|Physician Decision|0|||
94393647|NCT03290781|323230534|FG006|Overall Study|Physician Decision|0|||
94393648|NCT03290781|323230528|FG000|Overall Study|Site Terminated by Sponsor|1|||
94393649|NCT03290781|323230529|FG001|Overall Study|Site Terminated by Sponsor|0|||
94393650|NCT03290781|323230530|FG002|Overall Study|Site Terminated by Sponsor|2|||
94393651|NCT03290781|323230531|FG003|Overall Study|Site Terminated by Sponsor|1|||
94393652|NCT03290781|323230532|FG004|Overall Study|Site Terminated by Sponsor|0|||
94393653|NCT03290781|323230533|FG005|Overall Study|Site Terminated by Sponsor|0|||
94393654|NCT03290781|323230534|FG006|Overall Study|Site Terminated by Sponsor|0|||
94393655|NCT03290781|323230528|FG000|Overall Study|Lost to Follow-up|0|||
94393656|NCT03290781|323230529|FG001|Overall Study|Lost to Follow-up|0|||
94393657|NCT03290781|323230530|FG002|Overall Study|Lost to Follow-up|0|||
94393658|NCT03290781|323230531|FG003|Overall Study|Lost to Follow-up|1|||
94393659|NCT03290781|323230532|FG004|Overall Study|Lost to Follow-up|0|||
94393660|NCT03290781|323230533|FG005|Overall Study|Lost to Follow-up|0|||
94483885|NCT00611806|323565384|FG001|Overall Study|Lost to Follow-up|0|||
94483886|NCT01228591|323565385|FG000|Baseline|Lack of Efficacy|1|||
94393661|NCT03290781|323230534|FG006|Overall Study|Lost to Follow-up|0|||
94393662|NCT03290781|323230528|FG000|Overall Study|Protocol Deviation|2|||
94393663|NCT03290781|323230529|FG001|Overall Study|Protocol Deviation|0|||
94393664|NCT03290781|323230530|FG002|Overall Study|Protocol Deviation|0|||
94393665|NCT03290781|323230531|FG003|Overall Study|Protocol Deviation|1|||
94393666|NCT03290781|323230532|FG004|Overall Study|Protocol Deviation|0|||
94393667|NCT03290781|323230533|FG005|Overall Study|Protocol Deviation|0|||
94393668|NCT03290781|323230534|FG006|Overall Study|Protocol Deviation|0|||
94393669|NCT03290781|323230528|FG000|Overall Study|Disease Relapse|32|||
94393670|NCT03290781|323230529|FG001|Overall Study|Disease Relapse|5|||
94393671|NCT03290781|323230530|FG002|Overall Study|Disease Relapse|38|||
94393672|NCT03290781|323230531|FG003|Overall Study|Disease Relapse|7|||
94393673|NCT03290781|323230532|FG004|Overall Study|Disease Relapse|3|||
94393674|NCT03290781|323230533|FG005|Overall Study|Disease Relapse|1|||
94393675|NCT03290781|323230534|FG006|Overall Study|Disease Relapse|4|||
94393676|NCT03290781|323230528|FG000|Overall Study|Other|3|||
94393677|NCT03290781|323230529|FG001|Overall Study|Other|0|||
94393678|NCT03290781|323230530|FG002|Overall Study|Other|2|||
94393679|NCT03290781|323230531|FG003|Overall Study|Other|2|||
94393680|NCT03290781|323230532|FG004|Overall Study|Other|0|||
94393681|NCT03290781|323230533|FG005|Overall Study|Other|0|||
94393682|NCT03290781|323230534|FG006|Overall Study|Other|0|||
94393683|NCT02178787|323230535|FG000|Overall Study|Lost to Follow-up|1|||
94393684|NCT02178787|323230536|FG001|Overall Study|Lost to Follow-up|0|||
94393685|NCT02178787|323230535|FG000|Overall Study|Withdrawal by Subject|0|||
94393686|NCT02178787|323230536|FG001|Overall Study|Withdrawal by Subject|2|||
94393687|NCT02178787|323230535|FG000|Overall Study|No TCD window|3|||
94393688|NCT02178787|323230536|FG001|Overall Study|No TCD window|7|||
94393689|NCT02178787|323230535|FG000|Overall Study|Physician Decision|1|||
94393690|NCT02178787|323230536|FG001|Overall Study|Physician Decision|0|||
94393691|NCT03873272|323230537|FG000|Overall Study|Withdrawal by Subject|2|||
94393692|NCT03873272|323230538|FG001|Overall Study|Withdrawal by Subject|0|||
94393693|NCT03873272|323230539|FG002|Overall Study|Withdrawal by Subject|1|||
94393694|NCT03873272|323230537|FG000|Overall Study|Death|0|||
94393695|NCT03873272|323230538|FG001|Overall Study|Death|2|||
94393696|NCT03873272|323230539|FG002|Overall Study|Death|1|||
94393697|NCT01597245|323230542|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
94393698|NCT01597245|323230543|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
94393699|NCT01597245|323230544|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
94393700|NCT01597245|323230545|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
94393701|NCT01597245|323230546|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
94393702|NCT01597245|323230547|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
94393703|NCT01597245|323230548|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
94393704|NCT01597245|323230549|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
94393705|NCT01597245|323230550|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
94393706|NCT01597245|323230551|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
94393707|NCT01597245|323230552|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
94393708|NCT01597245|323230553|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
94393709|NCT01597245|323230554|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
94393710|NCT01597245|323230555|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
94393711|NCT01597245|323230556|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
94393712|NCT01597245|323230557|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
94393713|NCT01597245|323230558|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
94393714|NCT01597245|323230559|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
94393715|NCT01597245|323230560|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
94393716|NCT01597245|323230561|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
94393717|NCT01597245|323230562|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
94393718|NCT01597245|323230542|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
94393719|NCT01597245|323230543|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
94393720|NCT01597245|323230544|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
94393721|NCT01597245|323230545|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
94393722|NCT01597245|323230546|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
94393723|NCT01597245|323230547|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
94393724|NCT01597245|323230548|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
94393725|NCT01597245|323230549|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
94393726|NCT01597245|323230550|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
94393727|NCT01597245|323230551|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
94393728|NCT01597245|323230552|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
94393729|NCT01597245|323230553|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
94393730|NCT01597245|323230554|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
94393731|NCT01597245|323230555|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
94393732|NCT01597245|323230556|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
94393733|NCT01597245|323230557|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
94393734|NCT01597245|323230558|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
94393735|NCT01597245|323230559|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
94393736|NCT01597245|323230560|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
94393737|NCT01597245|323230561|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
94393738|NCT01597245|323230562|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
94393739|NCT01597245|323230542|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
94393740|NCT01597245|323230543|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
94393741|NCT01597245|323230544|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
94393742|NCT01597245|323230545|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
94483887|NCT01228591|323565386|FG001|Baseline|Lack of Efficacy|2|||
94393743|NCT01597245|323230546|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
94393744|NCT01597245|323230547|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
94393745|NCT01597245|323230548|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
94483888|NCT01317940|323565387|FG000|Overall Study|Death|1|||
94483889|NCT01317940|323565388|FG001|Overall Study|Death|0|||
94483890|NCT01317940|323565389|FG002|Overall Study|Death|1|||
94483891|NCT01317940|323565390|FG003|Overall Study|Death|0|||
94483892|NCT01317940|323565391|FG004|Overall Study|Death|0|||
94483893|NCT01317940|323565392|FG005|Overall Study|Death|0|||
94483894|NCT01317940|323565387|FG000|Overall Study|Lost to Follow-up|0|||
94483895|NCT01317940|323565388|FG001|Overall Study|Lost to Follow-up|0|||
94483896|NCT01317940|323565389|FG002|Overall Study|Lost to Follow-up|1|||
94483897|NCT01317940|323565390|FG003|Overall Study|Lost to Follow-up|1|||
94483898|NCT01317940|323565391|FG004|Overall Study|Lost to Follow-up|1|||
94483899|NCT01317940|323565392|FG005|Overall Study|Lost to Follow-up|0|||
94483900|NCT01317940|323565387|FG000|Overall Study|Change in therapy plan|0|||
94483901|NCT01317940|323565388|FG001|Overall Study|Change in therapy plan|0|||
94483902|NCT01317940|323565389|FG002|Overall Study|Change in therapy plan|3|||
94483903|NCT01317940|323565390|FG003|Overall Study|Change in therapy plan|0|||
94483904|NCT01317940|323565391|FG004|Overall Study|Change in therapy plan|0|||
94483905|NCT01317940|323565392|FG005|Overall Study|Change in therapy plan|0|||
94483906|NCT00715559|323565393|FG000|Overall Study|medication not tolerated - nausea|1|||
94483907|NCT01921517|323565394|FG000|Overall Study|Lost to Follow-up|5|||
94483908|NCT01921517|323565395|FG001|Overall Study|Lost to Follow-up|0|||
94483909|NCT01921517|323565394|FG000|Overall Study|Newly diagnosed health concern|2|||
94483910|NCT01921517|323565395|FG001|Overall Study|Newly diagnosed health concern|0|||
94483911|NCT01921517|323565394|FG000|Overall Study|Physician Decision|0|||
94483912|NCT01921517|323565395|FG001|Overall Study|Physician Decision|2|||
94483913|NCT01921517|323565394|FG000|Overall Study|Withdrawal by Subject|7|||
94483914|NCT01921517|323565395|FG001|Overall Study|Withdrawal by Subject|3|||
94483915|NCT01921517|323565394|FG000|Overall Study|Subject missed final imaging|1|||
94483916|NCT01921517|323565395|FG001|Overall Study|Subject missed final imaging|4|||
94483917|NCT04069715|323565398|FG000|Overall Study|Lost to Follow-up|1|||
94483918|NCT04069715|323565399|FG001|Overall Study|Lost to Follow-up|1|||
94483919|NCT04069715|323565398|FG000|Overall Study|Physician Decision|1|||
94483920|NCT04069715|323565399|FG001|Overall Study|Physician Decision|1|||
94483921|NCT04069715|323565398|FG000|Overall Study|Withdrawal by Subject|3|||
94483922|NCT04069715|323565399|FG001|Overall Study|Withdrawal by Subject|3|||
94483923|NCT02922153|323565404|FG000|Overall Study|Death|8|||
94483924|NCT02922153|323565405|FG001|Overall Study|Death|1|||
94483925|NCT02922153|323565404|FG000|Overall Study|Lost to Follow-up|1|||
94483926|NCT02922153|323565405|FG001|Overall Study|Lost to Follow-up|0|||
94393746|NCT01597245|323230549|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
94393747|NCT01597245|323230550|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
94393748|NCT01597245|323230551|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
94393749|NCT01597245|323230552|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
94393750|NCT01597245|323230553|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
94393751|NCT01597245|323230554|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
94393752|NCT01597245|323230555|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
94393753|NCT01597245|323230556|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
94393754|NCT01597245|323230557|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
94393755|NCT01597245|323230558|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
94393756|NCT01597245|323230559|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
94393757|NCT01597245|323230560|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
94393758|NCT01597245|323230561|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
94393759|NCT01597245|323230562|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
94393760|NCT01597245|323230542|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
94393761|NCT01597245|323230543|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
94393762|NCT01597245|323230544|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
94393763|NCT01597245|323230545|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
94393764|NCT01597245|323230546|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
94393765|NCT01597245|323230547|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
94393766|NCT01597245|323230548|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
94393767|NCT01597245|323230549|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
94393768|NCT01597245|323230550|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
94483927|NCT02922153|323565404|FG000|Overall Study|Physician Decision|1|||
94483928|NCT02922153|323565405|FG001|Overall Study|Physician Decision|1|||
94483929|NCT00327340|323565410|FG000|Overall Study|Withdrawal by Subject|1|||
94483930|NCT00327340|323565411|FG001|Overall Study|Withdrawal by Subject|5|||
94483931|NCT00327340|323565410|FG000|Overall Study|Physician Decision|1|||
94483932|NCT00327340|323565411|FG001|Overall Study|Physician Decision|1|||
94483933|NCT00327340|323565410|FG000|Overall Study|Disease Progression|10|||
94483934|NCT00327340|323565411|FG001|Overall Study|Disease Progression|19|||
94483935|NCT00327340|323565410|FG000|Overall Study|Symptomatic Disease|0|||
94393769|NCT01597245|323230551|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
94483936|NCT00327340|323565411|FG001|Overall Study|Symptomatic Disease|2|||
94483937|NCT00327340|323565410|FG000|Overall Study|Adverse Event|3|||
94483938|NCT00327340|323565411|FG001|Overall Study|Adverse Event|3|||
94393770|NCT01597245|323230552|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
94393771|NCT01597245|323230553|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
94393772|NCT01597245|323230554|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
94393773|NCT01597245|323230555|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
94393774|NCT01597245|323230556|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
94393775|NCT01597245|323230557|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
94393776|NCT01597245|323230558|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
94393777|NCT01597245|323230559|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
94393778|NCT01597245|323230560|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
94393779|NCT01597245|323230561|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
94393780|NCT01597245|323230562|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
94393781|NCT01597245|323230542|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
94393782|NCT01597245|323230543|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393783|NCT01597245|323230544|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393784|NCT01597245|323230545|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
94393785|NCT01597245|323230546|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393786|NCT01597245|323230547|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393787|NCT01597245|323230548|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393788|NCT01597245|323230549|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393789|NCT01597245|323230550|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393790|NCT01597245|323230551|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393791|NCT01597245|323230552|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393792|NCT01597245|323230553|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393793|NCT01597245|323230554|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393794|NCT01597245|323230555|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393795|NCT01597245|323230556|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393796|NCT01597245|323230557|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393797|NCT01597245|323230558|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393798|NCT01597245|323230559|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393799|NCT01597245|323230560|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393800|NCT01597245|323230561|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393801|NCT01597245|323230562|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
94393802|NCT01597245|323230542|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
94393803|NCT01597245|323230543|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
94393804|NCT01597245|323230544|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
94393805|NCT01597245|323230545|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
94393806|NCT01597245|323230546|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
94393807|NCT01597245|323230547|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
94393808|NCT01597245|323230548|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
94393809|NCT01597245|323230549|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
94393810|NCT01597245|323230550|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
94393811|NCT01597245|323230551|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
94393812|NCT01597245|323230552|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
94393813|NCT01597245|323230553|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
94393814|NCT01597245|323230554|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
94393815|NCT01597245|323230555|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
94393816|NCT01597245|323230556|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
94393817|NCT01597245|323230557|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
94393818|NCT01597245|323230558|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
94393819|NCT01597245|323230559|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
94393820|NCT01597245|323230560|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
94393821|NCT01597245|323230561|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
94393822|NCT01597245|323230562|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
94393823|NCT01597245|323230542|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94393824|NCT01597245|323230543|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94393825|NCT01597245|323230544|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94393826|NCT01597245|323230545|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94393827|NCT01597245|323230546|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94393828|NCT01597245|323230547|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
94393829|NCT01597245|323230548|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
94393830|NCT01597245|323230549|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94393831|NCT01597245|323230550|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94393832|NCT01597245|323230551|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94393833|NCT01597245|323230552|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94393834|NCT01597245|323230553|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94483939|NCT01325350|323565414|FG000|Overall Study|Adverse Event|3|||
94483940|NCT01325350|323565415|FG001|Overall Study|Adverse Event|3|||
94483941|NCT01325350|323565416|FG002|Overall Study|Adverse Event|3|||
94483942|NCT01325350|323565417|FG003|Overall Study|Adverse Event|1|||
94483943|NCT01325350|323565418|FG004|Overall Study|Adverse Event|2|||
94483944|NCT01325350|323565414|FG000|Overall Study|Pregnancy|0|||
94483945|NCT01325350|323565415|FG001|Overall Study|Pregnancy|0|||
94483946|NCT01325350|323565416|FG002|Overall Study|Pregnancy|1|||
94483947|NCT01325350|323565417|FG003|Overall Study|Pregnancy|0|||
94483948|NCT01325350|323565418|FG004|Overall Study|Pregnancy|1|||
94483949|NCT01325350|323565414|FG000|Overall Study|Lost to Follow-up|1|||
94483950|NCT01325350|323565415|FG001|Overall Study|Lost to Follow-up|0|||
94483951|NCT01325350|323565416|FG002|Overall Study|Lost to Follow-up|5|||
94483952|NCT01325350|323565417|FG003|Overall Study|Lost to Follow-up|1|||
94483953|NCT01325350|323565418|FG004|Overall Study|Lost to Follow-up|5|||
94483954|NCT01325350|323565414|FG000|Overall Study|Personal Reasons|2|||
94483955|NCT01325350|323565415|FG001|Overall Study|Personal Reasons|1|||
94483956|NCT01325350|323565416|FG002|Overall Study|Personal Reasons|6|||
94483957|NCT01325350|323565417|FG003|Overall Study|Personal Reasons|5|||
94483958|NCT01325350|323565418|FG004|Overall Study|Personal Reasons|3|||
94483959|NCT01325350|323565414|FG000|Overall Study|Protocol Violation|0|||
94483960|NCT01325350|323565415|FG001|Overall Study|Protocol Violation|0|||
94483961|NCT01325350|323565416|FG002|Overall Study|Protocol Violation|0|||
94483962|NCT01325350|323565417|FG003|Overall Study|Protocol Violation|1|||
94483963|NCT01325350|323565418|FG004|Overall Study|Protocol Violation|0|||
94483964|NCT01325350|323565414|FG000|Overall Study|Withdrawal by Subject|0|||
94483965|NCT01325350|323565415|FG001|Overall Study|Withdrawal by Subject|0|||
94483966|NCT01325350|323565416|FG002|Overall Study|Withdrawal by Subject|1|||
94483967|NCT01325350|323565417|FG003|Overall Study|Withdrawal by Subject|1|||
94483968|NCT01325350|323565418|FG004|Overall Study|Withdrawal by Subject|0|||
94483969|NCT01325350|323565414|FG000|Overall Study|Did Not Receive Treatment|0|||
94483970|NCT01325350|323565415|FG001|Overall Study|Did Not Receive Treatment|1|||
94483971|NCT01325350|323565416|FG002|Overall Study|Did Not Receive Treatment|1|||
94483972|NCT01325350|323565417|FG003|Overall Study|Did Not Receive Treatment|0|||
94483973|NCT01325350|323565418|FG004|Overall Study|Did Not Receive Treatment|1|||
94483974|NCT02224625|323565419|FG000|Irritation|Adverse Event|6|||
94483975|NCT02224625|323565419|FG000|Sensitization|Adverse Event|55|||
94483976|NCT01775670|323565421|FG000|Overall Study|Lost to Follow-up|1|||
94483977|NCT01775670|323565422|FG001|Overall Study|Lost to Follow-up|1|||
94483978|NCT00956839|323565424|FG000|Overall Study|Lost to Follow-up|3|||
94483979|NCT00956839|323565425|FG001|Overall Study|Lost to Follow-up|0|||
94483980|NCT00956839|323565426|FG002|Overall Study|Lost to Follow-up|3|||
94483981|NCT00010257|323565431|FG000|Overall Study|Withdrawal by Subject|1|||
94483982|NCT00010257|323565432|FG001|Overall Study|Withdrawal by Subject|0|||
94483983|NCT00643760|323565435|FG000|Overall Study|Adverse Event|11|||
94483984|NCT00643760|323565436|FG001|Overall Study|Adverse Event|5|||
94483985|NCT00643760|323565437|FG002|Overall Study|Adverse Event|12|||
94483986|NCT00643760|323565438|FG003|Overall Study|Adverse Event|21|||
94483987|NCT00643760|323565439|FG004|Overall Study|Adverse Event|6|||
94483988|NCT00643760|323565435|FG000|Overall Study|Lack of Efficacy|3|||
94483989|NCT00643760|323565436|FG001|Overall Study|Lack of Efficacy|1|||
94483990|NCT00643760|323565437|FG002|Overall Study|Lack of Efficacy|0|||
94483991|NCT00643760|323565438|FG003|Overall Study|Lack of Efficacy|4|||
94483992|NCT00643760|323565439|FG004|Overall Study|Lack of Efficacy|3|||
94483993|NCT00643760|323565435|FG000|Overall Study|Protocol Violation|7|||
94483994|NCT00643760|323565436|FG001|Overall Study|Protocol Violation|6|||
94483995|NCT00643760|323565437|FG002|Overall Study|Protocol Violation|4|||
94483996|NCT00643760|323565438|FG003|Overall Study|Protocol Violation|4|||
94483997|NCT00643760|323565439|FG004|Overall Study|Protocol Violation|6|||
94483998|NCT00643760|323565435|FG000|Overall Study|Lost to Follow-up|6|||
94483999|NCT00643760|323565436|FG001|Overall Study|Lost to Follow-up|2|||
94484000|NCT00643760|323565437|FG002|Overall Study|Lost to Follow-up|1|||
94484001|NCT00643760|323565438|FG003|Overall Study|Lost to Follow-up|3|||
94484002|NCT00643760|323565439|FG004|Overall Study|Lost to Follow-up|3|||
94484003|NCT00643760|323565435|FG000|Overall Study|Investigator Discretion|0|||
94484004|NCT00643760|323565436|FG001|Overall Study|Investigator Discretion|0|||
94484005|NCT00643760|323565437|FG002|Overall Study|Investigator Discretion|0|||
94484006|NCT00643760|323565438|FG003|Overall Study|Investigator Discretion|2|||
94484007|NCT00643760|323565439|FG004|Overall Study|Investigator Discretion|0|||
94484008|NCT00643760|323565435|FG000|Overall Study|Withdrawal by Subject|3|||
94484009|NCT00643760|323565436|FG001|Overall Study|Withdrawal by Subject|1|||
94484010|NCT00643760|323565437|FG002|Overall Study|Withdrawal by Subject|2|||
94484011|NCT00643760|323565438|FG003|Overall Study|Withdrawal by Subject|4|||
94484012|NCT00643760|323565439|FG004|Overall Study|Withdrawal by Subject|1|||
94484013|NCT00735709|323565442|FG000|Overall Study|Adverse Event|2|||
94484014|NCT00735709|323565443|FG001|Overall Study|Adverse Event|3|||
94484015|NCT00735709|323565444|FG002|Overall Study|Adverse Event|1|||
94484016|NCT00735709|323565445|FG003|Overall Study|Adverse Event|5|||
94484017|NCT00735709|323565442|FG000|Overall Study|Lack of Efficacy|8|||
94484018|NCT00735709|323565443|FG001|Overall Study|Lack of Efficacy|4|||
94484019|NCT00735709|323565444|FG002|Overall Study|Lack of Efficacy|2|||
94484020|NCT00735709|323565445|FG003|Overall Study|Lack of Efficacy|3|||
94484021|NCT00735709|323565442|FG000|Overall Study|Noncompliance|0|||
94484022|NCT00735709|323565443|FG001|Overall Study|Noncompliance|0|||
94484023|NCT00735709|323565444|FG002|Overall Study|Noncompliance|1|||
94484024|NCT00735709|323565445|FG003|Overall Study|Noncompliance|0|||
94484025|NCT00735709|323565442|FG000|Overall Study|Protocol deviations|1|||
94484026|NCT00735709|323565443|FG001|Overall Study|Protocol deviations|2|||
94484027|NCT00735709|323565444|FG002|Overall Study|Protocol deviations|1|||
94484028|NCT00735709|323565445|FG003|Overall Study|Protocol deviations|1|||
94484029|NCT00735709|323565442|FG000|Overall Study|Voluntary Withdrawal|1|||
94484030|NCT00735709|323565443|FG001|Overall Study|Voluntary Withdrawal|3|||
94484031|NCT00735709|323565444|FG002|Overall Study|Voluntary Withdrawal|5|||
94484032|NCT00735709|323565445|FG003|Overall Study|Voluntary Withdrawal|7|||
94484033|NCT00735709|323565442|FG000|Overall Study|Lost to Follow-up|0|||
94484034|NCT00735709|323565443|FG001|Overall Study|Lost to Follow-up|1|||
94484035|NCT00735709|323565444|FG002|Overall Study|Lost to Follow-up|1|||
94484036|NCT00735709|323565445|FG003|Overall Study|Lost to Follow-up|1|||
94484037|NCT00735709|323565442|FG000|Overall Study|Excluded medication|1|||
94484038|NCT00735709|323565443|FG001|Overall Study|Excluded medication|0|||
94484039|NCT00735709|323565444|FG002|Overall Study|Excluded medication|0|||
94484040|NCT00735709|323565445|FG003|Overall Study|Excluded medication|1|||
94484041|NCT04635839|323565461|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
94484042|NCT04635839|323565462|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
94393835|NCT01597245|323230554|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94393836|NCT01597245|323230555|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94393837|NCT01597245|323230556|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94393838|NCT01597245|323230557|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94393839|NCT01597245|323230558|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94393840|NCT01597245|323230559|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94393841|NCT01597245|323230560|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94393842|NCT01597245|323230561|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94393843|NCT01597245|323230562|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
94393844|NCT01597245|323230542|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
94393845|NCT01597245|323230543|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
94393846|NCT01597245|323230544|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
94393847|NCT01597245|323230545|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
94393848|NCT01597245|323230546|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
94393849|NCT01597245|323230547|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
94393850|NCT01597245|323230548|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
94393851|NCT01597245|323230549|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
94393852|NCT01597245|323230550|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
94393853|NCT01597245|323230551|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
94393854|NCT01597245|323230552|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
94393855|NCT01597245|323230553|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
94393856|NCT01597245|323230554|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
94393857|NCT01597245|323230555|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
94393858|NCT01597245|323230556|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
94393859|NCT01597245|323230557|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
94393860|NCT01597245|323230558|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
94393861|NCT01597245|323230559|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
94393862|NCT01597245|323230560|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
94393863|NCT01597245|323230561|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
94393864|NCT01597245|323230562|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
94393865|NCT01597245|323230542|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
94393866|NCT01597245|323230543|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
94393867|NCT01597245|323230544|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
94393868|NCT01597245|323230545|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
94393869|NCT01597245|323230546|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
94393870|NCT01597245|323230547|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
94393871|NCT01597245|323230548|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
94393872|NCT01597245|323230549|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
94484043|NCT00744939|323565464|FG000|Overall Study|Withdrawal by Subject|9|||
94484044|NCT00744939|323565464|FG000|Overall Study|Protocol Violation|13|||
94484045|NCT00744939|323565464|FG000|Overall Study|Death|24|||
94484046|NCT00744939|323565464|FG000|Overall Study|distance|4|||
94484047|NCT00744939|323565464|FG000|Overall Study|Lost to Follow-up|12|||
94484048|NCT00744939|323565464|FG000|Overall Study|Medical history exclusionary|1|||
94484049|NCT00744939|323565464|FG000|Overall Study|Did not receive Magnevist|7|||
94484050|NCT00744939|323565464|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
94484051|NCT00744939|323565464|FG000|Overall Study|coma|1|||
94484052|NCT00744939|323565464|FG000|Overall Study|incorrect race|1|||
94393873|NCT01597245|323230550|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
94393874|NCT01597245|323230551|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
94393875|NCT01597245|323230552|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
94393876|NCT01597245|323230553|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
94393877|NCT01597245|323230554|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
94393878|NCT01597245|323230555|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
94393879|NCT01597245|323230556|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
94393880|NCT01597245|323230557|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
94393881|NCT01597245|323230558|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
94393882|NCT01597245|323230559|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
94393883|NCT01597245|323230560|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
94393884|NCT01597245|323230561|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
94393885|NCT01597245|323230562|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
94393886|NCT01597245|323230542|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
94393887|NCT01597245|323230543|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
94393888|NCT01597245|323230544|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
94393889|NCT01597245|323230545|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
94393890|NCT01597245|323230546|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
94393891|NCT01597245|323230547|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
94393892|NCT01597245|323230548|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
94393893|NCT01597245|323230549|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
94393894|NCT01597245|323230550|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
94393895|NCT01597245|323230551|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
94393896|NCT01597245|323230552|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
94393897|NCT01597245|323230553|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
94393898|NCT01597245|323230554|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
94393899|NCT01597245|323230555|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
94393900|NCT01597245|323230556|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
94393901|NCT01597245|323230557|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
94393902|NCT01597245|323230558|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
94393903|NCT01597245|323230559|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
94393904|NCT01597245|323230560|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
94393905|NCT01597245|323230561|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
94393906|NCT01597245|323230562|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
94393907|NCT01597245|323230542|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
94393908|NCT01597245|323230543|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
94393909|NCT01597245|323230544|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
94393910|NCT01597245|323230545|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
94393911|NCT01597245|323230546|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
94393912|NCT01597245|323230547|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
94393913|NCT01597245|323230548|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
94393914|NCT01597245|323230549|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
94393915|NCT01597245|323230550|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
94393916|NCT01597245|323230551|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
94393917|NCT01597245|323230552|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
94393918|NCT01597245|323230553|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
94393919|NCT01597245|323230554|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
94393920|NCT01597245|323230555|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
94393921|NCT01597245|323230556|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
94393922|NCT01597245|323230557|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
94393923|NCT01597245|323230558|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
94393924|NCT01597245|323230559|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
94393925|NCT01597245|323230560|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
94393926|NCT01597245|323230561|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
94393927|NCT01597245|323230562|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
94393928|NCT01597245|323230542|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
94393929|NCT01597245|323230543|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
94393930|NCT01597245|323230544|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
94393931|NCT01597245|323230545|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
94393932|NCT01597245|323230546|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
94393933|NCT01597245|323230547|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
94393934|NCT01597245|323230548|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
94393935|NCT01597245|323230549|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
94484053|NCT01447407|323565467|FG000|Overall Study|Withdrawal by Subject|2|||
94484054|NCT01447407|323565468|FG001|Overall Study|Withdrawal by Subject|0|||
94484055|NCT01447407|323565469|FG002|Overall Study|Withdrawal by Subject|0|||
94484056|NCT01447407|323565470|FG003|Overall Study|Withdrawal by Subject|1|||
94484057|NCT01447407|323565467|FG000|Overall Study|Physician Decision|0|||
94484058|NCT01447407|323565468|FG001|Overall Study|Physician Decision|0|||
94484059|NCT01447407|323565469|FG002|Overall Study|Physician Decision|1|||
94484060|NCT01447407|323565470|FG003|Overall Study|Physician Decision|1|||
94484061|NCT00528424|323565473|FG000|Overall Study|Lost to Follow-up|13|||
94484062|NCT00528424|323565473|FG000|Overall Study|Withdrew consent|2|||
94484063|NCT00528424|323565473|FG000|Overall Study|Administrative reason|2|||
94484064|NCT00528424|323565473|FG000|Overall Study|Other|12|||
94484065|NCT02771275|323565474|FG000|Overall Study|Reoperation|3|||
94484066|NCT02771275|323565474|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
94484067|NCT02254772|323565475|FG000|Overall Study|Ineligible|1|||
94484068|NCT02254772|323565475|FG000|Overall Study|Withdrawal by Subject|1|||
94484069|NCT00643201|323565476|FG000|Randomized, Completed 6 Months of Study|Death|20|||
94484070|NCT00643201|323565477|FG001|Randomized, Completed 6 Months of Study|Death|26|||
94484071|NCT00643201|323565476|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
94484072|NCT00643201|323565477|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
94484073|NCT00643201|323565476|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
94484074|NCT00643201|323565477|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
94484075|NCT00643201|323565476|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
94484076|NCT00643201|323565477|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
94484077|NCT00643201|323565476|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
94484078|NCT00643201|323565477|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
94484079|NCT00643201|323565476|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
94484080|NCT00643201|323565477|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
94484081|NCT00643201|323565476|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
94484082|NCT00643201|323565477|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
94484083|NCT00643201|323565476|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
94484084|NCT00643201|323565477|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
94484085|NCT00643201|323565476|FG000|Randomized, Completed 6 Months of Study|Other|107|||
94484086|NCT00643201|323565477|FG001|Randomized, Completed 6 Months of Study|Other|107|||
94484087|NCT00643201|323565476|FG000|Completed Study Follow Up|Death|28|||
94484088|NCT00643201|323565477|FG001|Completed Study Follow Up|Death|34|||
94484089|NCT00643201|323565476|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
94484090|NCT00643201|323565477|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
94484091|NCT00643201|323565476|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
94484092|NCT00643201|323565477|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
94484093|NCT00643201|323565476|FG000|Completed Study Follow Up|non-specified|1|||
94484094|NCT00643201|323565477|FG001|Completed Study Follow Up|non-specified|0|||
94484095|NCT03102762|323565478|FG000|Overall Study|Lost to Follow-up|1|||
94484096|NCT03102762|323565479|FG001|Overall Study|Lost to Follow-up|0|||
94484097|NCT00483652|323565480|FG000|Double-blind Treatment Period|Protocol Violation|2|||
94484098|NCT00483652|323565481|FG001|Double-blind Treatment Period|Protocol Violation|1|||
94484099|NCT00483652|323565480|FG000|Double-blind Treatment Period|Adverse Event|3|||
94484100|NCT00483652|323565481|FG001|Double-blind Treatment Period|Adverse Event|4|||
94484101|NCT00483652|323565480|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
94484102|NCT00483652|323565481|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
94484103|NCT00483652|323565480|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
94484104|NCT00483652|323565481|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
94484105|NCT00928434|323565482|FG000|Overall Study|Adverse Event|14|||
94484106|NCT00928434|323565483|FG001|Overall Study|Adverse Event|5|||
94484107|NCT00928434|323565484|FG002|Overall Study|Adverse Event|18|||
94484108|NCT00928434|323565482|FG000|Overall Study|Protocol Violation|5|||
94484109|NCT00928434|323565483|FG001|Overall Study|Protocol Violation|0|||
94484110|NCT00928434|323565484|FG002|Overall Study|Protocol Violation|8|||
94484111|NCT00928434|323565482|FG000|Overall Study|Physician Decision|2|||
94484112|NCT00928434|323565483|FG001|Overall Study|Physician Decision|0|||
94484113|NCT00928434|323565484|FG002|Overall Study|Physician Decision|3|||
94484114|NCT00928434|323565482|FG000|Overall Study|Lost to Follow-up|1|||
94484115|NCT00928434|323565483|FG001|Overall Study|Lost to Follow-up|0|||
94484116|NCT00928434|323565484|FG002|Overall Study|Lost to Follow-up|3|||
94484117|NCT00928434|323565482|FG000|Overall Study|Withdrawal by Subject|5|||
94484118|NCT00928434|323565483|FG001|Overall Study|Withdrawal by Subject|3|||
94484119|NCT00928434|323565484|FG002|Overall Study|Withdrawal by Subject|2|||
94484120|NCT00928434|323565482|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
94484121|NCT00928434|323565483|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
94484122|NCT00928434|323565484|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
94484123|NCT00928434|323565482|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
94484124|NCT00928434|323565483|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
94393936|NCT01597245|323230550|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
94393937|NCT01597245|323230551|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
94393938|NCT01597245|323230552|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
94393939|NCT01597245|323230553|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
94393940|NCT01597245|323230554|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
94393941|NCT01597245|323230555|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
94393942|NCT01597245|323230556|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
94393943|NCT01597245|323230557|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
94393944|NCT01597245|323230558|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
94393945|NCT01597245|323230559|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
94393946|NCT01597245|323230560|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
94393947|NCT01597245|323230561|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
94393948|NCT01597245|323230562|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
94393949|NCT01597245|323230542|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
94393950|NCT01597245|323230543|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
94393951|NCT01597245|323230544|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
94393952|NCT01597245|323230545|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
94393953|NCT01597245|323230546|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
94393954|NCT01597245|323230547|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
94393955|NCT01597245|323230548|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
94393956|NCT01597245|323230549|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
94393957|NCT01597245|323230550|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
94393958|NCT01597245|323230551|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
94393959|NCT01597245|323230552|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
94393960|NCT01597245|323230553|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
94393961|NCT01597245|323230554|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
94393962|NCT01597245|323230555|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
94393963|NCT01597245|323230556|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
94393964|NCT01597245|323230557|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
94393965|NCT01597245|323230558|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
94393966|NCT01597245|323230559|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
94393967|NCT01597245|323230560|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
94393968|NCT01597245|323230561|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
94393969|NCT01597245|323230562|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
94393970|NCT01597245|323230542|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
94393971|NCT01597245|323230543|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
94393972|NCT01597245|323230544|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
94393973|NCT01597245|323230545|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
94393974|NCT01597245|323230546|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
94393975|NCT01597245|323230547|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
94393976|NCT01597245|323230548|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
94393977|NCT01597245|323230549|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
94393978|NCT01597245|323230550|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
94393979|NCT01597245|323230551|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
94393980|NCT01597245|323230552|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
94393981|NCT01597245|323230553|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
94393982|NCT01597245|323230554|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
94393983|NCT01597245|323230555|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
94393984|NCT01597245|323230556|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
94393985|NCT01597245|323230557|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
94393986|NCT01597245|323230558|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
94393987|NCT01597245|323230559|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
94393988|NCT01597245|323230560|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
94393989|NCT01597245|323230561|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
94393990|NCT01597245|323230562|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
94393991|NCT01597245|323230542|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94393992|NCT01597245|323230543|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94393993|NCT01597245|323230544|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94393994|NCT01597245|323230545|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94393995|NCT01597245|323230546|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94393996|NCT01597245|323230547|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94393997|NCT01597245|323230548|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94484125|NCT00928434|323565484|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
94484126|NCT00928434|323565482|FG000|Overall Study|Other (not meeting above criteria)|5|||
94484127|NCT00928434|323565483|FG001|Overall Study|Other (not meeting above criteria)|1|||
94484128|NCT00928434|323565484|FG002|Overall Study|Other (not meeting above criteria)|2|||
94484129|NCT00728494|323565485|FG000|Overall Study|Adverse Event|7|||
94484130|NCT00728494|323565486|FG001|Overall Study|Adverse Event|0|||
94484131|NCT00728494|323565485|FG000|Overall Study|Withdrawal by Subject|0|||
94484132|NCT00728494|323565486|FG001|Overall Study|Withdrawal by Subject|2|||
94484133|NCT00728494|323565485|FG000|Overall Study|Lack of Efficacy|2|||
94484134|NCT00728494|323565486|FG001|Overall Study|Lack of Efficacy|4|||
94484135|NCT00728494|323565485|FG000|Overall Study|No data available|0|||
94484136|NCT00728494|323565486|FG001|Overall Study|No data available|1|||
94484137|NCT01232790|323565487|FG000|Randomization|Withdrawal by Subject|2|||
94484138|NCT01232790|323565488|FG001|Randomization|Withdrawal by Subject|0|||
94484139|NCT01232790|323565487|FG000|Randomization|Protocol Violation|0|||
94484140|NCT01232790|323565488|FG001|Randomization|Protocol Violation|1|||
94484141|NCT01232790|323565487|FG000|Randomization|Physician Decision|0|||
94484142|NCT01232790|323565488|FG001|Randomization|Physician Decision|1|||
94484143|NCT01232790|323565487|FG000|Initial Assessment|Withdrawal by Subject|0|||
94484144|NCT01232790|323565488|FG001|Initial Assessment|Withdrawal by Subject|1|||
94484145|NCT01232790|323565487|FG000|First Crossover|Withdrawal by Subject|1|||
94484146|NCT01232790|323565488|FG001|First Crossover|Withdrawal by Subject|0|||
94484147|NCT01232790|323565487|FG000|Second Crossover|Withdrawal by Subject|1|||
94484148|NCT01232790|323565488|FG001|Second Crossover|Withdrawal by Subject|2|||
94484149|NCT03769649|323565489|FG000|Overall Study|Lost to Follow-up|4|||
94484150|NCT01290718|323565494|FG000|Overall Study|Early termination of the study|4|||
94484151|NCT01249131|323565495|FG000|Washout Period of 10 Days|Adverse Event|0|||
94484152|NCT01249131|323565496|FG001|Washout Period of 10 Days|Adverse Event|0|||
94484153|NCT01249131|323565497|FG002|Washout Period of 10 Days|Adverse Event|0|||
94484154|NCT01249131|323565498|FG003|Washout Period of 10 Days|Adverse Event|0|||
94484155|NCT01249131|323565499|FG004|Washout Period of 10 Days|Adverse Event|1|||
94484156|NCT01249131|323565500|FG005|Washout Period of 10 Days|Adverse Event|0|||
94484157|NCT02059239|323565503|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
94484158|NCT02059239|323565504|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
94484159|NCT02059239|323565503|FG000|Overall Study|Physician Decision|1|||
94484160|NCT02059239|323565504|FG001|Overall Study|Physician Decision|0|||
94484161|NCT01408706|323565505|FG000|Overall Study|Physician Decision|1|||
94484162|NCT01408706|323565506|FG001|Overall Study|Physician Decision|0|||
94484163|NCT01566604|323565508|FG000|Overall Study|Patient's inability to use the device|1|||
94484164|NCT01566604|323565509|FG001|Overall Study|Patient's inability to use the device|0|||
94484165|NCT01566604|323565508|FG000|Overall Study|Administrative problems|1|||
94484166|NCT01566604|323565509|FG001|Overall Study|Administrative problems|0|||
94484167|NCT01566604|323565508|FG000|Overall Study|Lack of Efficacy|1|||
94484168|NCT01566604|323565509|FG001|Overall Study|Lack of Efficacy|2|||
94484169|NCT01566604|323565508|FG000|Overall Study|Protocol deviation|2|||
94393998|NCT01597245|323230549|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94393999|NCT01597245|323230550|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94394000|NCT01597245|323230551|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94394001|NCT01597245|323230552|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
94394002|NCT01597245|323230553|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94394003|NCT01597245|323230554|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94394004|NCT01597245|323230555|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94484170|NCT01566604|323565509|FG001|Overall Study|Protocol deviation|0|||
94484171|NCT01566604|323565508|FG000|Overall Study|Abnormal laboratory value|2|||
94484172|NCT01566604|323565509|FG001|Overall Study|Abnormal laboratory value|0|||
94484173|NCT01566604|323565508|FG000|Overall Study|Death|4|||
94484174|NCT01566604|323565509|FG001|Overall Study|Death|1|||
94484175|NCT01566604|323565508|FG000|Overall Study|Adverse Event|4|||
94484176|NCT01566604|323565509|FG001|Overall Study|Adverse Event|2|||
94484177|NCT01566604|323565508|FG000|Overall Study|Withdrawal by Subject|9|||
94484178|NCT01566604|323565509|FG001|Overall Study|Withdrawal by Subject|6|||
94484179|NCT02983045|323565516|FG000|Overall Study|Withdrawal by Subject|0|||
94484180|NCT02983045|323565517|FG001|Overall Study|Withdrawal by Subject|1|||
94394005|NCT01597245|323230556|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94394006|NCT01597245|323230557|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94484181|NCT02983045|323565518|FG002|Overall Study|Withdrawal by Subject|0|||
94484182|NCT02983045|323565519|FG003|Overall Study|Withdrawal by Subject|5|||
94484183|NCT02983045|323565520|FG004|Overall Study|Withdrawal by Subject|0|||
94484184|NCT02983045|323565521|FG005|Overall Study|Withdrawal by Subject|72|||
94484185|NCT02983045|323565522|FG006|Overall Study|Withdrawal by Subject|0|||
94484186|NCT02983045|323565523|FG007|Overall Study|Withdrawal by Subject|0|||
94484187|NCT02983045|323565524|FG008|Overall Study|Withdrawal by Subject|0|||
94484188|NCT02983045|323565525|FG009|Overall Study|Withdrawal by Subject|2|||
94484189|NCT02983045|323565516|FG000|Overall Study|Lost to Follow-up|0|||
94484190|NCT02983045|323565517|FG001|Overall Study|Lost to Follow-up|0|||
94484191|NCT02983045|323565518|FG002|Overall Study|Lost to Follow-up|0|||
94394007|NCT01597245|323230558|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94394008|NCT01597245|323230559|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94394009|NCT01597245|323230560|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94394010|NCT01597245|323230561|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94394011|NCT01597245|323230562|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
94394012|NCT01597245|323230542|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
94394013|NCT01597245|323230543|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
94394014|NCT01597245|323230544|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
94394015|NCT01597245|323230545|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
94394016|NCT01597245|323230546|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
94394017|NCT01597245|323230547|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
94394018|NCT01597245|323230548|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
94394019|NCT01597245|323230549|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
94394020|NCT01597245|323230550|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
94394021|NCT01597245|323230551|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
94394022|NCT01597245|323230552|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
94394023|NCT01597245|323230553|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
94394024|NCT01597245|323230554|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
94394025|NCT01597245|323230555|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
94394026|NCT01597245|323230556|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
94394027|NCT01597245|323230557|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
94394028|NCT01597245|323230558|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
94394029|NCT01597245|323230559|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
94394030|NCT01597245|323230560|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
94394031|NCT01597245|323230561|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
94394032|NCT01597245|323230562|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
94394033|NCT01597245|323230542|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
94394034|NCT01597245|323230543|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
94394035|NCT01597245|323230544|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
94394036|NCT01597245|323230545|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
94394037|NCT01597245|323230546|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
94394038|NCT01597245|323230547|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
94394039|NCT01597245|323230548|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
94394040|NCT01597245|323230549|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
94394041|NCT01597245|323230550|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
94394042|NCT01597245|323230551|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
94394043|NCT01597245|323230552|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
94484192|NCT02983045|323565519|FG003|Overall Study|Lost to Follow-up|0|||
94484193|NCT02983045|323565520|FG004|Overall Study|Lost to Follow-up|0|||
94484194|NCT02983045|323565521|FG005|Overall Study|Lost to Follow-up|10|||
94484195|NCT02983045|323565522|FG006|Overall Study|Lost to Follow-up|0|||
94484196|NCT02983045|323565523|FG007|Overall Study|Lost to Follow-up|0|||
94484197|NCT02983045|323565524|FG008|Overall Study|Lost to Follow-up|0|||
94484198|NCT02983045|323565525|FG009|Overall Study|Lost to Follow-up|0|||
94484199|NCT04010461|323565531|FG000|Overall Study|COVID based withdrawal|5|||
94484200|NCT04010461|323565531|FG000|Overall Study|Withdrawal by Subject|5|||
94484201|NCT04010461|323565531|FG000|Overall Study|Adverse Event|1|||
94484202|NCT04010461|323565531|FG000|Overall Study|No Motor Threshold obtainable|1|||
94484203|NCT04010461|323565531|FG000|Overall Study|Physician Decision|1|||
94484204|NCT02314728|323565535|FG000|Overall Study|Protocol Violation|1|||
94484205|NCT02314728|323565536|FG001|Overall Study|Protocol Violation|0|||
94484206|NCT02314728|323565535|FG000|Overall Study|Lost to Follow-up|0|||
94484207|NCT02314728|323565536|FG001|Overall Study|Lost to Follow-up|1|||
94484208|NCT02895347|323565537|FG000|Overall Study|Withdrawal by Subject|3|||
94484209|NCT02895347|323565538|FG001|Overall Study|Withdrawal by Subject|1|||
94484210|NCT02287038|323565539|FG000|Overall Study|Stopped attending appointments|3|||
94484211|NCT02287038|323565540|FG001|Overall Study|Stopped attending appointments|2|||
94484212|NCT02287038|323565539|FG000|Overall Study|Anxiety after starting medication|0|||
94484213|NCT02287038|323565540|FG001|Overall Study|Anxiety after starting medication|1|||
94484214|NCT02287038|323565539|FG000|Overall Study|Nausea after starting medication|1|||
94484215|NCT02287038|323565540|FG001|Overall Study|Nausea after starting medication|0|||
94484216|NCT02287038|323565539|FG000|Overall Study|Abnormal ECG after starting medication|1|||
94484217|NCT02287038|323565540|FG001|Overall Study|Abnormal ECG after starting medication|0|||
94484218|NCT01673178|323565541|FG000|Overall Study|Lost to Follow-up|0|||
94484219|NCT01673178|323565542|FG001|Overall Study|Lost to Follow-up|1|||
94484220|NCT01673178|323565543|FG002|Overall Study|Lost to Follow-up|0|||
94484221|NCT01673178|323565544|FG003|Overall Study|Lost to Follow-up|0|||
94484222|NCT01673178|323565545|FG004|Overall Study|Lost to Follow-up|0|||
94484223|NCT01673178|323565541|FG000|Overall Study|Withdrawal by Subject|0|||
94484224|NCT01673178|323565542|FG001|Overall Study|Withdrawal by Subject|0|||
94484225|NCT01673178|323565543|FG002|Overall Study|Withdrawal by Subject|1|||
94484226|NCT01673178|323565544|FG003|Overall Study|Withdrawal by Subject|4|||
94484227|NCT01673178|323565545|FG004|Overall Study|Withdrawal by Subject|2|||
94484228|NCT01673178|323565541|FG000|Overall Study|Protocol Violation|1|||
94484229|NCT01673178|323565542|FG001|Overall Study|Protocol Violation|1|||
94484230|NCT01673178|323565543|FG002|Overall Study|Protocol Violation|0|||
94484231|NCT01673178|323565544|FG003|Overall Study|Protocol Violation|1|||
94484232|NCT01673178|323565545|FG004|Overall Study|Protocol Violation|0|||
94484233|NCT01673178|323565541|FG000|Overall Study|Adverse Event|1|||
94484234|NCT01673178|323565542|FG001|Overall Study|Adverse Event|0|||
94484235|NCT01673178|323565543|FG002|Overall Study|Adverse Event|0|||
94484236|NCT01673178|323565544|FG003|Overall Study|Adverse Event|2|||
94484237|NCT01673178|323565545|FG004|Overall Study|Adverse Event|0|||
94484238|NCT01673178|323565541|FG000|Overall Study|Other|1|||
94484239|NCT01673178|323565542|FG001|Overall Study|Other|0|||
94484240|NCT01673178|323565543|FG002|Overall Study|Other|2|||
94484241|NCT01673178|323565544|FG003|Overall Study|Other|1|||
94484242|NCT01673178|323565545|FG004|Overall Study|Other|0|||
94484243|NCT02322749|323565546|FG000|Period 2|Adverse Event|0|||
94484244|NCT02322749|323565547|FG001|Period 2|Adverse Event|0|||
94484245|NCT02322749|323565548|FG002|Period 2|Adverse Event|0|||
94484246|NCT02322749|323565549|FG003|Period 2|Adverse Event|1|||
94484247|NCT02322749|323565550|FG004|Period 2|Adverse Event|0|||
94484248|NCT02322749|323565551|FG005|Period 2|Adverse Event|0|||
94484249|NCT02322749|323565546|FG000|Period 2|Withdrawal by Subject|0|||
94484250|NCT02322749|323565547|FG001|Period 2|Withdrawal by Subject|0|||
94484251|NCT02322749|323565548|FG002|Period 2|Withdrawal by Subject|0|||
94484252|NCT02322749|323565549|FG003|Period 2|Withdrawal by Subject|1|||
94484253|NCT02322749|323565550|FG004|Period 2|Withdrawal by Subject|0|||
94484254|NCT02322749|323565551|FG005|Period 2|Withdrawal by Subject|0|||
94484255|NCT02322749|323565546|FG000|Period 3|Withdrawal by Subject|0|||
94484256|NCT02322749|323565547|FG001|Period 3|Withdrawal by Subject|0|||
94484257|NCT02322749|323565548|FG002|Period 3|Withdrawal by Subject|1|||
94484258|NCT02322749|323565549|FG003|Period 3|Withdrawal by Subject|0|||
94484259|NCT02322749|323565550|FG004|Period 3|Withdrawal by Subject|0|||
94484260|NCT02322749|323565551|FG005|Period 3|Withdrawal by Subject|0|||
94484261|NCT03641508|323565552|FG000|First Injection|Lost to Follow-up|2|||
94484262|NCT03641508|323565553|FG001|First Injection|Lost to Follow-up|0|||
94484263|NCT03638128|323567444|FG000|Overall Study|Withdrawal by Subject|1|||
94484264|NCT03638128|323567445|FG001|Overall Study|Withdrawal by Subject|7|||
94484265|NCT03638128|323567446|FG002|Overall Study|Withdrawal by Subject|6|||
94484266|NCT03638128|323567444|FG000|Overall Study|Sponsor Decision|15|||
94484267|NCT03638128|323567445|FG001|Overall Study|Sponsor Decision|12|||
94484268|NCT03638128|323567446|FG002|Overall Study|Sponsor Decision|19|||
94484269|NCT03638128|323567444|FG000|Overall Study|Lost to Follow-up|0|||
94484270|NCT03638128|323567445|FG001|Overall Study|Lost to Follow-up|0|||
94484271|NCT03638128|323567446|FG002|Overall Study|Lost to Follow-up|1|||
94484272|NCT02611882|323567447|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
94484273|NCT02611882|323567448|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
94484274|NCT02611882|323567449|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
94484275|NCT04980014|323567452|FG000|Overall Study|Participants who are Duplicated|1|||
94484276|NCT04980014|323567452|FG000|Overall Study|Follow-up Failure|13|||
94484277|NCT04980014|323567452|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
94484278|NCT04980014|323567452|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
94484279|NCT04980014|323567452|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
94484280|NCT02291029|323567453|FG000|Overall Study|Withdrawal by Subject|0|||
94484281|NCT02291029|323567454|FG001|Overall Study|Withdrawal by Subject|0|||
94484282|NCT02291029|323567455|FG002|Overall Study|Withdrawal by Subject|1|||
94484283|NCT02291029|323567456|FG003|Overall Study|Withdrawal by Subject|0|||
94484284|NCT02291029|323567457|FG004|Overall Study|Withdrawal by Subject|0|||
94484285|NCT02291029|323567458|FG005|Overall Study|Withdrawal by Subject|0|||
94484286|NCT02291029|323567453|FG000|Overall Study|Adverse Event|0|||
94484287|NCT02291029|323567454|FG001|Overall Study|Adverse Event|1|||
94484288|NCT02291029|323567455|FG002|Overall Study|Adverse Event|0|||
94484289|NCT02291029|323567456|FG003|Overall Study|Adverse Event|0|||
94484290|NCT02291029|323567457|FG004|Overall Study|Adverse Event|0|||
94484291|NCT02291029|323567458|FG005|Overall Study|Adverse Event|0|||
94484292|NCT02783170|323567459|FG000|Overall Study|Randomized but not Vaccinated|1|||
94484293|NCT02783170|323567460|FG001|Overall Study|Randomized but not Vaccinated|0|||
94484294|NCT03110354|323567461|FG000|Overall Study|Death|1|||
94484295|NCT03110354|323567462|FG001|Overall Study|Death|0|||
94484296|NCT03110354|323567463|FG002|Overall Study|Death|0|||
94484297|NCT03110354|323567464|FG003|Overall Study|Death|1|||
94484298|NCT03110354|323567465|FG004|Overall Study|Death|0|||
94484299|NCT03110354|323567461|FG000|Overall Study|Start of new therapy|0|||
94484300|NCT03110354|323567462|FG001|Overall Study|Start of new therapy|0|||
94484301|NCT03110354|323567463|FG002|Overall Study|Start of new therapy|0|||
94394044|NCT01597245|323230553|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
94394045|NCT01597245|323230554|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
94394046|NCT01597245|323230555|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
94394047|NCT01597245|323230556|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
94394048|NCT01597245|323230557|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
94394049|NCT01597245|323230558|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
94394050|NCT01597245|323230559|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
94394051|NCT01597245|323230560|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
94394052|NCT01597245|323230561|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
94394053|NCT01597245|323230562|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
94394054|NCT01597245|323230542|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94394055|NCT01597245|323230543|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94328929|NCT00830960|322984240|FG000|Overall Study|No study drug received|7|||
94328930|NCT00830960|322984241|FG001|Overall Study|No study drug received|2|||
94328931|NCT00830960|322984242|FG002|Overall Study|No study drug received|4|||
94328932|NCT00830960|322984243|FG003|Overall Study|No study drug received|3|||
94328933|NCT00830960|322984244|FG004|Overall Study|No study drug received|5|||
94328934|NCT00830960|322984245|FG005|Overall Study|No study drug received|7|||
94328935|NCT00425113|322984246|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
94328936|NCT00425113|322984247|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
94328937|NCT00425113|322984246|FG000|Overall Study|diagnosis of abdominal TB|0|||
94328938|NCT00425113|322984247|FG001|Overall Study|diagnosis of abdominal TB|1|||
94328939|NCT00425113|322984246|FG000|Overall Study|missing study drug more than 14 days|0|||
94328940|NCT00425113|322984247|FG001|Overall Study|missing study drug more than 14 days|1|||
94328941|NCT00425113|322984246|FG000|Overall Study|Withdrawal by Subject|1|||
94328942|NCT00425113|322984247|FG001|Overall Study|Withdrawal by Subject|0|||
94328943|NCT00776555|322984248|FG000|Overall Study|Study terminated|3|||
94328944|NCT00776555|322984249|FG001|Overall Study|Study terminated|0|||
94328945|NCT01504971|322984250|FG000|Overall Study|Physician Decision|13|||
94328946|NCT03483116|322984251|FG000|Overall Study|Adverse Event|0|||
94328947|NCT03483116|322984252|FG001|Overall Study|Adverse Event|1|||
94328948|NCT03483116|322984253|FG002|Overall Study|Adverse Event|0|||
94328949|NCT03483116|322984254|FG003|Overall Study|Adverse Event|1|||
94328950|NCT03483116|322984251|FG000|Overall Study|Protocol Violation|1|||
94328951|NCT03483116|322984252|FG001|Overall Study|Protocol Violation|0|||
94328952|NCT03483116|322984253|FG002|Overall Study|Protocol Violation|0|||
94328953|NCT03483116|322984254|FG003|Overall Study|Protocol Violation|7|||
94328954|NCT03483116|322984251|FG000|Overall Study|Lost to Follow-up|9|||
94328955|NCT03483116|322984252|FG001|Overall Study|Lost to Follow-up|4|||
94328956|NCT03483116|322984253|FG002|Overall Study|Lost to Follow-up|9|||
94328957|NCT03483116|322984254|FG003|Overall Study|Lost to Follow-up|5|||
94328958|NCT03483116|322984251|FG000|Overall Study|Death|1|||
94328959|NCT03483116|322984252|FG001|Overall Study|Death|0|||
94328960|NCT03483116|322984253|FG002|Overall Study|Death|2|||
94328961|NCT03483116|322984254|FG003|Overall Study|Death|1|||
94328962|NCT03483116|322984251|FG000|Overall Study|Withdrawal by Subject|14|||
94328963|NCT03483116|322984252|FG001|Overall Study|Withdrawal by Subject|16|||
94328964|NCT03483116|322984253|FG002|Overall Study|Withdrawal by Subject|14|||
94328965|NCT03483116|322984254|FG003|Overall Study|Withdrawal by Subject|16|||
94328966|NCT03483116|322984251|FG000|Overall Study|Unknown other reason|3|||
94328967|NCT03483116|322984252|FG001|Overall Study|Unknown other reason|2|||
94328968|NCT03483116|322984253|FG002|Overall Study|Unknown other reason|1|||
94328969|NCT03483116|322984254|FG003|Overall Study|Unknown other reason|1|||
94328970|NCT00936117|322984257|FG000|Overall Study|Adverse Event|7|||
94328971|NCT00936117|322984257|FG000|Overall Study|Unable to continue oral medication|3|||
94328972|NCT04685499|322984258|FG000|Overall Study|Study Terminated Early|1|||
94328973|NCT02559713|322984259|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
94328974|NCT03448224|322984261|FG000|Overall Study|Provided same answer to every question|1|||
94328975|NCT03448224|322984262|FG001|Overall Study|Provided same answer to every question|0|||
94328976|NCT03571256|322984265|FG000|Overall Study|Adverse Event|3|||
94328977|NCT03571256|322984266|FG001|Overall Study|Adverse Event|0|||
94328978|NCT03571256|322984267|FG002|Overall Study|Adverse Event|1|||
94328979|NCT03571256|322984265|FG000|Overall Study|Withdrawal by Subject|3|||
94328980|NCT03571256|322984266|FG001|Overall Study|Withdrawal by Subject|1|||
94328981|NCT03571256|322984267|FG002|Overall Study|Withdrawal by Subject|1|||
94328982|NCT03571256|322984265|FG000|Overall Study|Other than specified|0|||
94328983|NCT03571256|322984266|FG001|Overall Study|Other than specified|1|||
94328984|NCT03571256|322984267|FG002|Overall Study|Other than specified|1|||
94328985|NCT03571256|322984265|FG000|Overall Study|Protocol Violation|0|||
94328986|NCT03571256|322984266|FG001|Overall Study|Protocol Violation|1|||
94328987|NCT03571256|322984267|FG002|Overall Study|Protocol Violation|1|||
94328988|NCT00575094|322984268|FG000|Overall Study|Adverse Event|2|||
94328989|NCT00575094|322984268|FG000|Overall Study|Withdrawal by Subject|1|||
94328990|NCT01054976|322984273|FG000|Overall Study|Adverse Event|16|||
94394056|NCT01597245|323230544|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94394057|NCT01597245|323230545|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94394058|NCT01597245|323230546|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94394059|NCT01597245|323230547|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94394060|NCT01597245|323230548|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94394061|NCT01597245|323230549|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94394062|NCT01597245|323230550|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94394063|NCT01597245|323230551|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94394064|NCT01597245|323230552|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94394065|NCT01597245|323230553|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94394066|NCT01597245|323230554|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94394067|NCT01597245|323230555|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94394068|NCT01597245|323230556|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
94394069|NCT01597245|323230557|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
94394070|NCT01597245|323230558|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94394071|NCT01597245|323230559|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94394072|NCT01597245|323230560|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94394073|NCT01597245|323230561|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94484302|NCT03110354|323567464|FG003|Overall Study|Start of new therapy|0|||
94394074|NCT01597245|323230562|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
94394075|NCT01597245|323230542|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394076|NCT01597245|323230543|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394077|NCT01597245|323230544|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394078|NCT01597245|323230545|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394079|NCT01597245|323230546|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394080|NCT01597245|323230547|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394081|NCT01597245|323230548|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394082|NCT01597245|323230549|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394083|NCT01597245|323230550|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394084|NCT01597245|323230551|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394085|NCT01597245|323230552|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394086|NCT01597245|323230553|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394087|NCT01597245|323230554|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394088|NCT01597245|323230555|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394089|NCT01597245|323230556|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
94394090|NCT01597245|323230557|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
94394091|NCT01597245|323230558|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394092|NCT01597245|323230559|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394093|NCT01597245|323230560|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394094|NCT01597245|323230561|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394095|NCT01597245|323230562|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
94394096|NCT01597245|323230542|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
94394097|NCT01597245|323230543|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
94394098|NCT01597245|323230544|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
94394099|NCT01597245|323230545|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
94394100|NCT01597245|323230546|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
94394101|NCT01597245|323230547|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
94394102|NCT01597245|323230548|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
94394103|NCT01597245|323230549|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
94394104|NCT01597245|323230550|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
94394105|NCT01597245|323230551|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
94394106|NCT01597245|323230552|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
94394107|NCT01597245|323230553|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
94394108|NCT01597245|323230554|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
94394109|NCT01597245|323230555|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
94394110|NCT01597245|323230556|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
94394111|NCT01597245|323230557|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
94394112|NCT01597245|323230558|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
94394113|NCT01597245|323230559|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
94394114|NCT01597245|323230560|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
94394115|NCT01597245|323230561|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
94394116|NCT01597245|323230562|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
94394117|NCT01597245|323230542|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394118|NCT01597245|323230543|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394119|NCT01597245|323230544|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394120|NCT01597245|323230545|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394121|NCT01597245|323230546|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394122|NCT01597245|323230547|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394123|NCT01597245|323230548|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394124|NCT01597245|323230549|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394125|NCT01597245|323230550|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394126|NCT01597245|323230551|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394127|NCT01597245|323230552|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394128|NCT01597245|323230553|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394129|NCT01597245|323230554|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394130|NCT01597245|323230555|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394131|NCT01597245|323230556|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
94394132|NCT01597245|323230557|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
94394133|NCT01597245|323230558|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394134|NCT01597245|323230559|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394135|NCT01597245|323230560|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394136|NCT01597245|323230561|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394137|NCT01597245|323230562|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
94394138|NCT01597245|323230542|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394139|NCT01597245|323230543|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394140|NCT01597245|323230544|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394141|NCT01597245|323230545|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394142|NCT01597245|323230546|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394143|NCT01597245|323230547|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394144|NCT01597245|323230548|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394145|NCT01597245|323230549|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394146|NCT01597245|323230550|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394147|NCT01597245|323230551|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394148|NCT01597245|323230552|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394149|NCT01597245|323230553|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394150|NCT01597245|323230554|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394151|NCT01597245|323230555|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394152|NCT01597245|323230556|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
94394153|NCT01597245|323230557|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
94394154|NCT01597245|323230558|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394155|NCT01597245|323230559|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394156|NCT01597245|323230560|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394157|NCT01597245|323230561|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394158|NCT01597245|323230562|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
94394159|NCT01597245|323230542|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394160|NCT01597245|323230543|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394161|NCT01597245|323230544|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394162|NCT01597245|323230545|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394163|NCT01597245|323230546|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394164|NCT01597245|323230547|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394165|NCT01597245|323230548|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394166|NCT01597245|323230549|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394167|NCT01597245|323230550|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394168|NCT01597245|323230551|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394169|NCT01597245|323230552|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394170|NCT01597245|323230553|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394171|NCT01597245|323230554|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394172|NCT01597245|323230555|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394173|NCT01597245|323230556|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
94394174|NCT01597245|323230557|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
94394175|NCT01597245|323230558|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394176|NCT01597245|323230559|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394177|NCT01597245|323230560|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394178|NCT01597245|323230561|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394179|NCT01597245|323230562|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
94394180|NCT01597245|323230542|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394181|NCT01597245|323230543|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394182|NCT01597245|323230544|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394183|NCT01597245|323230545|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394184|NCT01597245|323230546|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394185|NCT01597245|323230547|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394186|NCT01597245|323230548|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394187|NCT01597245|323230549|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394188|NCT01597245|323230550|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394189|NCT01597245|323230551|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394190|NCT01597245|323230552|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394191|NCT01597245|323230553|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394192|NCT01597245|323230554|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394193|NCT01597245|323230555|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394194|NCT01597245|323230556|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
94394195|NCT01597245|323230557|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
94394196|NCT01597245|323230558|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394197|NCT01597245|323230559|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394198|NCT01597245|323230560|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394199|NCT01597245|323230561|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394200|NCT01597245|323230562|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
94394201|NCT01597245|323230542|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394202|NCT01597245|323230543|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394203|NCT01597245|323230544|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394204|NCT01597245|323230545|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394205|NCT01597245|323230546|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394206|NCT01597245|323230547|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394207|NCT01597245|323230548|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394208|NCT01597245|323230549|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394209|NCT01597245|323230550|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394210|NCT01597245|323230551|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394211|NCT01597245|323230552|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394212|NCT01597245|323230553|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394213|NCT01597245|323230554|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394214|NCT01597245|323230555|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
94394215|NCT01597245|323230556|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394216|NCT01597245|323230557|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394217|NCT01597245|323230558|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394218|NCT01597245|323230559|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394219|NCT01597245|323230560|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394220|NCT01597245|323230561|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394221|NCT01597245|323230562|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
94394222|NCT01597245|323230542|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
94394223|NCT01597245|323230543|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
94394224|NCT01597245|323230544|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
94394225|NCT01597245|323230545|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
94394226|NCT01597245|323230546|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
94394227|NCT01597245|323230547|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
94394228|NCT01597245|323230548|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
94394229|NCT01597245|323230549|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
94394230|NCT01597245|323230550|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
94394231|NCT01597245|323230551|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
94394232|NCT01597245|323230552|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
94394233|NCT01597245|323230553|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
94394234|NCT01597245|323230554|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
94394235|NCT01597245|323230555|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
94394236|NCT01597245|323230556|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
94394237|NCT01597245|323230557|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
94394238|NCT01597245|323230558|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
94394239|NCT01597245|323230559|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
94394240|NCT01597245|323230560|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
94394241|NCT01597245|323230561|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
94394242|NCT01597245|323230562|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
94394243|NCT01597245|323230542|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
94394244|NCT01597245|323230543|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
94394245|NCT01597245|323230544|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
94394246|NCT01597245|323230545|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
94394247|NCT01597245|323230546|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
94394248|NCT01597245|323230547|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
94394249|NCT01597245|323230548|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
94394250|NCT01597245|323230549|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
94394251|NCT01597245|323230550|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
94394252|NCT01597245|323230551|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
94394253|NCT01597245|323230552|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
94394254|NCT01597245|323230553|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
94394255|NCT01597245|323230554|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
94394256|NCT01597245|323230555|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
94394257|NCT01597245|323230556|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
94394258|NCT01597245|323230557|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
94394259|NCT01597245|323230558|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
94394260|NCT01597245|323230559|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
94394261|NCT01597245|323230560|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
94394262|NCT01597245|323230561|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
94394263|NCT01597245|323230562|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
94394264|NCT01597245|323230542|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
94394265|NCT01597245|323230543|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
94394266|NCT01597245|323230544|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
94394267|NCT01597245|323230545|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
94394268|NCT01597245|323230546|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
94394269|NCT01597245|323230547|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
94394270|NCT01597245|323230548|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
94394271|NCT01597245|323230549|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
94394272|NCT01597245|323230550|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
94394273|NCT01597245|323230551|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
94394274|NCT01597245|323230552|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
94394275|NCT01597245|323230553|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
94394276|NCT01597245|323230554|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
94394277|NCT01597245|323230555|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
94394278|NCT01597245|323230556|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
94394279|NCT01597245|323230557|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
94394280|NCT01597245|323230558|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
94394281|NCT01597245|323230559|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
94394282|NCT01597245|323230560|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
94394283|NCT01597245|323230561|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
94394284|NCT01597245|323230562|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
94394285|NCT01597245|323230542|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
94394286|NCT01597245|323230543|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
94394287|NCT01597245|323230544|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
94394288|NCT01597245|323230545|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
94394289|NCT01597245|323230546|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
94394290|NCT01597245|323230547|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
94394291|NCT01597245|323230548|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
94394292|NCT01597245|323230549|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
94394293|NCT01597245|323230550|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
94394294|NCT01597245|323230551|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
94394295|NCT01597245|323230552|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
94394296|NCT01597245|323230553|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
94394297|NCT01597245|323230554|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
94394298|NCT01597245|323230555|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
94394299|NCT01597245|323230556|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
94394300|NCT01597245|323230557|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
94394301|NCT01597245|323230558|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
94394302|NCT01597245|323230559|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
94394303|NCT01597245|323230560|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
94394304|NCT01597245|323230561|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
94394305|NCT01597245|323230562|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
94394306|NCT01597245|323230542|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
94394307|NCT01597245|323230543|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
94394308|NCT01597245|323230544|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
94394309|NCT01597245|323230545|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
94484303|NCT03110354|323567465|FG004|Overall Study|Start of new therapy|1|||
94484304|NCT03110354|323567461|FG000|Overall Study|Failure to achieve response|2|||
94484305|NCT03110354|323567462|FG001|Overall Study|Failure to achieve response|3|||
94394310|NCT01597245|323230546|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
94394311|NCT01597245|323230547|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
94394312|NCT01597245|323230548|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
94394313|NCT01597245|323230549|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
94394314|NCT01597245|323230550|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
94394315|NCT01597245|323230551|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
94394316|NCT01597245|323230552|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
94394317|NCT01597245|323230553|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
94394318|NCT01597245|323230554|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
94394319|NCT01597245|323230555|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
94394320|NCT01597245|323230556|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
94394321|NCT01597245|323230557|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
94394322|NCT01597245|323230558|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
94394323|NCT01597245|323230559|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
94394324|NCT01597245|323230560|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
94394325|NCT01597245|323230561|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
94394326|NCT01597245|323230562|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
94394327|NCT01597245|323230542|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
94394328|NCT01597245|323230543|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
94394329|NCT01597245|323230544|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
94394330|NCT01597245|323230545|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
94394331|NCT01597245|323230546|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
94394332|NCT01597245|323230547|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
94394333|NCT01597245|323230548|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
94394334|NCT01597245|323230549|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
94394335|NCT01597245|323230550|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
94394336|NCT01597245|323230551|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
94394337|NCT01597245|323230552|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
94394338|NCT01597245|323230553|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
94394339|NCT01597245|323230554|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
94394340|NCT01597245|323230555|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
94394341|NCT01597245|323230556|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
94394342|NCT01597245|323230557|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
94394343|NCT01597245|323230558|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
94394344|NCT01597245|323230559|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
94394345|NCT01597245|323230560|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
94394346|NCT01597245|323230561|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
94394347|NCT01597245|323230562|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
94394348|NCT01597245|323230542|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94394349|NCT01597245|323230543|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94394350|NCT01597245|323230544|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94394351|NCT01597245|323230545|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94394352|NCT01597245|323230546|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94394353|NCT01597245|323230547|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94394354|NCT01597245|323230548|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94394355|NCT01597245|323230549|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94394356|NCT01597245|323230550|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94394357|NCT01597245|323230551|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94394358|NCT01597245|323230552|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94394359|NCT01597245|323230553|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94394360|NCT01597245|323230554|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94394361|NCT01597245|323230555|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94394362|NCT01597245|323230556|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94394363|NCT01597245|323230557|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94394364|NCT01597245|323230558|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
94394365|NCT01597245|323230559|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94484306|NCT03110354|323567463|FG002|Overall Study|Failure to achieve response|0|||
94484307|NCT03110354|323567464|FG003|Overall Study|Failure to achieve response|2|||
94484308|NCT03110354|323567465|FG004|Overall Study|Failure to achieve response|1|||
94484309|NCT03110354|323567461|FG000|Overall Study|Progressive disease|1|||
94484310|NCT03110354|323567462|FG001|Overall Study|Progressive disease|1|||
94484311|NCT03110354|323567463|FG002|Overall Study|Progressive disease|3|||
94484312|NCT03110354|323567464|FG003|Overall Study|Progressive disease|4|||
94484313|NCT03110354|323567465|FG004|Overall Study|Progressive disease|2|||
94484314|NCT03110354|323567461|FG000|Overall Study|Adverse Event|0|||
94484315|NCT03110354|323567462|FG001|Overall Study|Adverse Event|0|||
94484316|NCT03110354|323567463|FG002|Overall Study|Adverse Event|0|||
94484317|NCT03110354|323567464|FG003|Overall Study|Adverse Event|2|||
94484318|NCT03110354|323567465|FG004|Overall Study|Adverse Event|2|||
94484319|NCT03110354|323567461|FG000|Overall Study|Other|0|||
94484320|NCT03110354|323567462|FG001|Overall Study|Other|0|||
94484321|NCT03110354|323567463|FG002|Overall Study|Other|0|||
94484322|NCT03110354|323567464|FG003|Overall Study|Other|1|||
94484323|NCT03110354|323567465|FG004|Overall Study|Other|1|||
94484324|NCT00379834|323567466|FG000|Overall Study|Time constraints|2|||
94484325|NCT03028142|323567467|FG000|Overall Study|Adverse Event|1|||
94484326|NCT03028142|323567468|FG001|Overall Study|Adverse Event|1|||
94484327|NCT03028142|323567469|FG002|Overall Study|Adverse Event|0|||
94484328|NCT03028142|323567470|FG003|Overall Study|Adverse Event|0|||
94484329|NCT03028142|323567471|FG004|Overall Study|Adverse Event|0|||
94484330|NCT03028142|323567472|FG005|Overall Study|Adverse Event|1|||
94484331|NCT03028142|323567467|FG000|Overall Study|Withdrawal by Subject|0|||
94484332|NCT03028142|323567468|FG001|Overall Study|Withdrawal by Subject|0|||
94484333|NCT03028142|323567469|FG002|Overall Study|Withdrawal by Subject|0|||
94484334|NCT03028142|323567470|FG003|Overall Study|Withdrawal by Subject|0|||
94484335|NCT03028142|323567471|FG004|Overall Study|Withdrawal by Subject|1|||
94484336|NCT03028142|323567472|FG005|Overall Study|Withdrawal by Subject|0|||
94484337|NCT01298700|323567473|FG000|Overall Study|Adverse Event|50|||
94484338|NCT01298700|323567474|FG001|Overall Study|Adverse Event|51|||
94484339|NCT01298700|323567473|FG000|Overall Study|Lack of Efficacy|9|||
94484340|NCT01298700|323567474|FG001|Overall Study|Lack of Efficacy|14|||
94484341|NCT01298700|323567473|FG000|Overall Study|Lost to Follow-up|5|||
94484342|NCT01298700|323567474|FG001|Overall Study|Lost to Follow-up|2|||
94484343|NCT01298700|323567473|FG000|Overall Study|Withdrawal by Subject|12|||
94484344|NCT01298700|323567474|FG001|Overall Study|Withdrawal by Subject|9|||
94484345|NCT01298700|323567473|FG000|Overall Study|Protocol Violation|6|||
94484346|NCT01298700|323567474|FG001|Overall Study|Protocol Violation|4|||
94484347|NCT01298700|323567473|FG000|Overall Study|Other Miscellaneous Reasons|16|||
94484348|NCT01298700|323567474|FG001|Overall Study|Other Miscellaneous Reasons|15|||
94484349|NCT01298700|323567473|FG000|Overall Study|Did not Receive Study Drug|3|||
94484350|NCT01298700|323567474|FG001|Overall Study|Did not Receive Study Drug|5|||
94484351|NCT02163395|323567475|FG000|Overall Study|Withdrawal by Subject|1|||
94484352|NCT02163395|323567475|FG000|Overall Study|Lost to Follow-up|3|||
94484353|NCT02163395|323567475|FG000|Overall Study|Adverse Event|1|||
94484354|NCT00104052|323567476|FG000|Overall Study|Adverse Event|1|||
94484355|NCT00104052|323567476|FG000|Overall Study|Lack of Efficacy|26|||
94484356|NCT00104052|323567476|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
94484357|NCT01241279|323567479|FG000|Overall Study|Lost to Follow-up|0|||
94484358|NCT01241279|323567480|FG001|Overall Study|Lost to Follow-up|1|||
94484359|NCT01811732|323567481|FG000|Overall Study|Lost to Follow-up|24|||
94484360|NCT01811732|323567482|FG001|Overall Study|Lost to Follow-up|30|||
94484361|NCT01811732|323567481|FG000|Overall Study|Withdrawal by Subject|16|||
94484362|NCT01811732|323567482|FG001|Overall Study|Withdrawal by Subject|10|||
94484363|NCT01811732|323567481|FG000|Overall Study|Adverse Event|3|||
94484364|NCT01811732|323567482|FG001|Overall Study|Adverse Event|9|||
94484365|NCT01811732|323567481|FG000|Overall Study|Lack of Efficacy|3|||
94484366|NCT01811732|323567482|FG001|Overall Study|Lack of Efficacy|1|||
94484367|NCT01811732|323567481|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
94484368|NCT01811732|323567482|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
94484369|NCT01811732|323567481|FG000|Overall Study|Physician Decision|2|||
94484370|NCT01811732|323567482|FG001|Overall Study|Physician Decision|0|||
94484371|NCT01811732|323567481|FG000|Overall Study|Death|1|||
94484372|NCT01811732|323567482|FG001|Overall Study|Death|1|||
94484373|NCT01811732|323567481|FG000|Overall Study|Insufficient venous access|0|||
94484374|NCT01811732|323567482|FG001|Overall Study|Insufficient venous access|1|||
94484375|NCT01811732|323567481|FG000|Overall Study|Protocol Violation|0|||
94484376|NCT01811732|323567482|FG001|Overall Study|Protocol Violation|1|||
94484377|NCT01811732|323567481|FG000|Overall Study|Subject incarcerated|1|||
94484378|NCT01811732|323567482|FG001|Overall Study|Subject incarcerated|2|||
94484379|NCT01811732|323567481|FG000|Overall Study|Admitted to another facility|1|||
94484380|NCT01811732|323567482|FG001|Overall Study|Admitted to another facility|0|||
94484381|NCT01811732|323567481|FG000|Overall Study|Correct study drug not available on site|1|||
94484382|NCT01811732|323567482|FG001|Overall Study|Correct study drug not available on site|0|||
94484383|NCT00126594|323567483|FG000|Overall Study|Ineligible|2|||
94484384|NCT00126594|323567484|FG001|Overall Study|Ineligible|0|||
94484385|NCT00126594|323567483|FG000|Overall Study|Withdrawal by Subject|0|||
94484386|NCT00126594|323567484|FG001|Overall Study|Withdrawal by Subject|4|||
94484387|NCT00126594|323567483|FG000|Overall Study|Physician Decision|1|||
94484388|NCT00126594|323567484|FG001|Overall Study|Physician Decision|3|||
94394366|NCT01597245|323230560|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94394367|NCT01597245|323230561|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
94394368|NCT01597245|323230562|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
94394369|NCT01597245|323230542|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394370|NCT01597245|323230543|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394371|NCT01597245|323230544|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394372|NCT01597245|323230545|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394373|NCT01597245|323230546|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394374|NCT01597245|323230547|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394375|NCT01597245|323230548|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394376|NCT01597245|323230549|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394377|NCT01597245|323230550|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394378|NCT01597245|323230551|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394379|NCT01597245|323230552|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394380|NCT01597245|323230553|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394381|NCT01597245|323230554|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394382|NCT01597245|323230555|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394383|NCT01597245|323230556|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394384|NCT01597245|323230557|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394385|NCT01597245|323230558|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
94394386|NCT01597245|323230559|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394387|NCT01597245|323230560|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394388|NCT01597245|323230561|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
94394389|NCT01597245|323230562|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
94394390|NCT01597245|323230542|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394391|NCT01597245|323230543|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394392|NCT01597245|323230544|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394393|NCT01597245|323230545|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394394|NCT01597245|323230546|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394395|NCT01597245|323230547|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394396|NCT01597245|323230548|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394397|NCT01597245|323230549|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394398|NCT01597245|323230550|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394399|NCT01597245|323230551|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394400|NCT01597245|323230552|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394401|NCT01597245|323230553|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394402|NCT01597245|323230554|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394403|NCT01597245|323230555|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394404|NCT01597245|323230556|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394405|NCT01597245|323230557|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394406|NCT01597245|323230558|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394407|NCT01597245|323230559|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394408|NCT01597245|323230560|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394409|NCT01597245|323230561|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
94394410|NCT01597245|323230562|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
94394411|NCT01404988|323230563|FG000|Overall Study|Death|2|||
94394412|NCT01404988|323230564|FG001|Overall Study|Death|0|||
94394413|NCT01404988|323230565|FG002|Overall Study|Death|2|||
94394414|NCT01404988|323230563|FG000|Overall Study|Adverse Event|1|||
94394415|NCT01404988|323230564|FG001|Overall Study|Adverse Event|0|||
94394416|NCT01404988|323230565|FG002|Overall Study|Adverse Event|0|||
94394417|NCT01404988|323230563|FG000|Overall Study|Withdrawal by Subject|2|||
94394418|NCT01404988|323230564|FG001|Overall Study|Withdrawal by Subject|2|||
94394419|NCT01404988|323230565|FG002|Overall Study|Withdrawal by Subject|0|||
94394420|NCT01404988|323230563|FG000|Overall Study|Lost to Follow-up|1|||
94394421|NCT01404988|323230564|FG001|Overall Study|Lost to Follow-up|2|||
94394422|NCT01404988|323230565|FG002|Overall Study|Lost to Follow-up|1|||
94394423|NCT04852978|323230570|FG000|Overall Study|Physician Decision|0|||
94394424|NCT04852978|323230571|FG001|Overall Study|Physician Decision|1|||
94394425|NCT04852978|323230572|FG002|Overall Study|Physician Decision|0|||
94394426|NCT04852978|323230573|FG003|Overall Study|Physician Decision|0|||
94394427|NCT04852978|323230574|FG004|Overall Study|Physician Decision|0|||
94394428|NCT04852978|323230575|FG005|Overall Study|Physician Decision|0|||
94394429|NCT04852978|323230576|FG006|Overall Study|Physician Decision|0|||
94394430|NCT04852978|323230577|FG007|Overall Study|Physician Decision|2|||
94394431|NCT04852978|323230578|FG008|Overall Study|Physician Decision|0|||
94394432|NCT04852978|323230570|FG000|Overall Study|Sponsor request|0|||
94394433|NCT04852978|323230571|FG001|Overall Study|Sponsor request|0|||
94394434|NCT04852978|323230572|FG002|Overall Study|Sponsor request|1|||
94394435|NCT04852978|323230573|FG003|Overall Study|Sponsor request|0|||
94328991|NCT01054976|322984273|FG000|Overall Study|Uncooperative participations to study|7|||
94328992|NCT01054976|322984273|FG000|Overall Study|Withdrawal by Subject|4|||
94328993|NCT01054976|322984273|FG000|Overall Study|Other|8|||
94328994|NCT02555657|322984274|FG000|Overall Study|Death|274|||
94328995|NCT02555657|322984275|FG001|Overall Study|Death|262|||
94328996|NCT02555657|322984274|FG000|Overall Study|Physician Decision|0|||
94328997|NCT02555657|322984275|FG001|Overall Study|Physician Decision|1|||
94328998|NCT02555657|322984274|FG000|Overall Study|Sponsor Decision|27|||
94328999|NCT02555657|322984275|FG001|Overall Study|Sponsor Decision|15|||
94329000|NCT02555657|322984274|FG000|Overall Study|Withdrawal by Subject|11|||
94329001|NCT02555657|322984275|FG001|Overall Study|Withdrawal by Subject|32|||
94329002|NCT00493974|322984276|FG000|Overall Study|Death|1|||
94329003|NCT00493974|322984277|FG001|Overall Study|Death|2|||
94329004|NCT00493974|322984276|FG000|Overall Study|Withdrawal by Subject|8|||
94329005|NCT00493974|322984277|FG001|Overall Study|Withdrawal by Subject|6|||
94329006|NCT00493974|322984276|FG000|Overall Study|Lost to Follow-up|4|||
94329007|NCT00493974|322984277|FG001|Overall Study|Lost to Follow-up|6|||
94329008|NCT02807363|322984279|FG000|Dosing Period|Adverse Event|0|||
94329009|NCT02807363|322984280|FG001|Dosing Period|Adverse Event|1|||
94329010|NCT02807363|322984281|FG002|Dosing Period|Adverse Event|0|||
94329011|NCT02807363|322984282|FG003|Dosing Period|Adverse Event|0|||
94329012|NCT02188719|322984283|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
94329013|NCT02188719|322984284|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
94329014|NCT02188719|322984285|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
94329015|NCT02188719|322984286|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
94329016|NCT03371732|322984287|FG000|Overall Study|Withdrawal by Subject|9|||
94329017|NCT03371732|322984288|FG001|Overall Study|Withdrawal by Subject|3|||
94329018|NCT03371732|322984287|FG000|Overall Study|Refusal to continue|3|||
94329019|NCT03371732|322984288|FG001|Overall Study|Refusal to continue|4|||
94329020|NCT02581982|322984289|FG000|Overall Study|Lack of Efficacy|12|||
94329021|NCT02581982|322984289|FG000|Overall Study|Adverse Event|3|||
94329022|NCT02581982|322984289|FG000|Overall Study|Physician Decision|1|||
94329023|NCT00599027|322984290|FG000|Overall Study|Withdrawal by Subject|1|||
94329024|NCT00599027|322984291|FG001|Overall Study|Withdrawal by Subject|1|||
94329025|NCT00599027|322984290|FG000|Overall Study|Adverse Event|0|||
94329026|NCT00599027|322984291|FG001|Overall Study|Adverse Event|1|||
94329027|NCT00599027|322984290|FG000|Overall Study|Treatment Failure|0|||
94329028|NCT00599027|322984291|FG001|Overall Study|Treatment Failure|1|||
94329029|NCT02031432|322984298|FG000|Overall Study|Protocol Violation|1|||
94329030|NCT02031432|322984298|FG000|Overall Study|Lack of Efficacy|5|||
94329031|NCT02031432|322984298|FG000|Overall Study|Cancer Progression|2|||
94329032|NCT02031432|322984298|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
94329033|NCT02031432|322984298|FG000|Overall Study|Adverse Event|8|||
94329034|NCT02031432|322984298|FG000|Overall Study|Withdrawal by Subject|5|||
94329035|NCT02031432|322984298|FG000|Overall Study|Lost to Follow-up|1|||
94329036|NCT02031432|322984298|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
94329037|NCT02031432|322984298|FG000|Overall Study|Death|10|||
94329038|NCT02726113|322984299|FG000|Total Enrollment|Physician Decision|0|||
94329039|NCT02726113|322984300|FG001|Total Enrollment|Physician Decision|1|||
94329040|NCT02726113|322984299|FG000|Total Enrollment|Protocol Violation|1|||
94329041|NCT02726113|322984300|FG001|Total Enrollment|Protocol Violation|0|||
94329042|NCT02726113|322984299|FG000|Total Enrollment|Withdrawal by Subject|2|||
94329043|NCT02726113|322984300|FG001|Total Enrollment|Withdrawal by Subject|1|||
94329044|NCT02726113|322984299|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
94329045|NCT02726113|322984300|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
94329046|NCT02726113|322984299|FG000|Genomic Analysis|Protocol Violation|1|||
94329047|NCT02726113|322984300|FG001|Genomic Analysis|Protocol Violation|0|||
94329048|NCT02726113|322984299|FG000|Genomic Analysis|Withdrawal by Subject|2|||
94329049|NCT02726113|322984300|FG001|Genomic Analysis|Withdrawal by Subject|1|||
94329050|NCT02726113|322984299|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
94329051|NCT02726113|322984300|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
94329052|NCT01999946|322984303|FG000|Overall Study|Participant not released from jail|2|||
94329053|NCT01999946|322984304|FG001|Overall Study|Participant not released from jail|2|||
94329054|NCT01999946|322984305|FG002|Overall Study|Participant not released from jail|0|||
94329055|NCT01999946|322984303|FG000|Overall Study|Not included in primary outcome analysis|0|||
94329056|NCT01999946|322984304|FG001|Overall Study|Not included in primary outcome analysis|0|||
94329057|NCT01999946|322984305|FG002|Overall Study|Not included in primary outcome analysis|79|||
94484389|NCT00126594|323567483|FG000|Overall Study|Adverse Event|7|||
94329058|NCT01265420|322984306|FG000|Overall Study|Lost to Follow-up|1|||
94329059|NCT02293902|322984309|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
94329060|NCT02293902|322984310|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
94329061|NCT02293902|322984311|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
94329062|NCT02293902|322984312|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
94329063|NCT02293902|322984313|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
94329064|NCT02293902|322984309|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
94484390|NCT00126594|323567484|FG001|Overall Study|Adverse Event|5|||
94484391|NCT00126594|323567483|FG000|Overall Study|Non-compliance|0|||
94484392|NCT00126594|323567484|FG001|Overall Study|Non-compliance|1|||
94484393|NCT00126594|323567483|FG000|Overall Study|Disease Progression|29|||
94484394|NCT00126594|323567484|FG001|Overall Study|Disease Progression|24|||
94484395|NCT02456727|323567485|FG000|Overall Study|Lost to Follow-up|63|||
94484396|NCT02456727|323567486|FG001|Overall Study|Lost to Follow-up|65|||
94484397|NCT02456727|323567485|FG000|Overall Study|Death|2|||
94484398|NCT02456727|323567486|FG001|Overall Study|Death|1|||
94484399|NCT02456727|323567485|FG000|Overall Study|Withdrawal by Subject|1|||
94484400|NCT02456727|323567486|FG001|Overall Study|Withdrawal by Subject|10|||
94484401|NCT02456727|323567485|FG000|Overall Study|Never Initiated Treatment|43|||
94484402|NCT02456727|323567486|FG001|Overall Study|Never Initiated Treatment|30|||
94484403|NCT00243919|323567487|FG000|Overall Study|Death|3|||
94484404|NCT00243919|323567488|FG001|Overall Study|Death|4|||
94484405|NCT00243919|323567489|FG002|Overall Study|Death|6|||
94484406|NCT00243919|323567487|FG000|Overall Study|Withdrawal by Subject|6|||
94484407|NCT00243919|323567488|FG001|Overall Study|Withdrawal by Subject|6|||
94484408|NCT00243919|323567489|FG002|Overall Study|Withdrawal by Subject|2|||
94484409|NCT00243919|323567487|FG000|Overall Study|Lost to Follow-up|6|||
94484410|NCT00243919|323567488|FG001|Overall Study|Lost to Follow-up|7|||
94484411|NCT00243919|323567489|FG002|Overall Study|Lost to Follow-up|3|||
94484412|NCT00243919|323567487|FG000|Overall Study|Administrative Error|1|||
94484413|NCT00243919|323567488|FG001|Overall Study|Administrative Error|0|||
94484414|NCT00243919|323567489|FG002|Overall Study|Administrative Error|0|||
94484415|NCT00243919|323567487|FG000|Overall Study|Physician Decision|1|||
94484416|NCT00243919|323567488|FG001|Overall Study|Physician Decision|1|||
94484417|NCT00243919|323567489|FG002|Overall Study|Physician Decision|0|||
94484418|NCT04919317|323567490|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
94484419|NCT04919317|323567491|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
94484420|NCT04919317|323567490|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
94484421|NCT04919317|323567491|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
94484422|NCT00297648|323567496|FG000|Overall Study|Adverse Event|13|||
94484423|NCT00297648|323567496|FG000|Overall Study|Lack of Efficacy|18|||
94484424|NCT00297648|323567496|FG000|Overall Study|Lost to Follow-up|1|||
94484425|NCT00297648|323567496|FG000|Overall Study|Withdrawal by Subject|3|||
94484426|NCT00297648|323567496|FG000|Overall Study|Other: Incompliance|1|||
94484427|NCT02053493|323567497|FG000|Overall Study|Withdrawal by Subject|1|||
94484428|NCT02053493|323567498|FG001|Overall Study|Withdrawal by Subject|1|||
94484429|NCT01747499|323567500|FG000|Overall Study|Steroid refractory aGvHD|1|||
94484430|NCT01747499|323567501|FG001|Overall Study|Steroid refractory aGvHD|0|||
94484431|NCT01747499|323567502|FG002|Overall Study|Steroid refractory aGvHD|0|||
94484432|NCT01747499|323567503|FG003|Overall Study|Steroid refractory aGvHD|1|||
94484433|NCT01747499|323567504|FG004|Overall Study|Steroid refractory aGvHD|4|||
94484434|NCT01747499|323567500|FG000|Overall Study|Physician Decision|0|||
94484435|NCT01747499|323567501|FG001|Overall Study|Physician Decision|1|||
94484436|NCT01747499|323567502|FG002|Overall Study|Physician Decision|0|||
94484437|NCT01747499|323567503|FG003|Overall Study|Physician Decision|0|||
94484438|NCT01747499|323567504|FG004|Overall Study|Physician Decision|2|||
94484439|NCT01747499|323567500|FG000|Overall Study|Death|0|||
94484440|NCT01747499|323567501|FG001|Overall Study|Death|0|||
94484441|NCT01747499|323567502|FG002|Overall Study|Death|0|||
94484442|NCT01747499|323567503|FG003|Overall Study|Death|1|||
94484443|NCT01747499|323567504|FG004|Overall Study|Death|1|||
94484444|NCT01747499|323567500|FG000|Overall Study|Withdrawal by Subject|0|||
94484445|NCT01747499|323567501|FG001|Overall Study|Withdrawal by Subject|0|||
94484446|NCT01747499|323567502|FG002|Overall Study|Withdrawal by Subject|0|||
94484447|NCT01747499|323567503|FG003|Overall Study|Withdrawal by Subject|0|||
94484448|NCT01747499|323567504|FG004|Overall Study|Withdrawal by Subject|6|||
94484449|NCT01747499|323567500|FG000|Overall Study|Developed AML and death|0|||
94484450|NCT01747499|323567501|FG001|Overall Study|Developed AML and death|0|||
94484451|NCT01747499|323567502|FG002|Overall Study|Developed AML and death|0|||
94484452|NCT01747499|323567503|FG003|Overall Study|Developed AML and death|0|||
94484453|NCT01747499|323567504|FG004|Overall Study|Developed AML and death|1|||
94484454|NCT01747499|323567500|FG000|Overall Study|Determined not to be eligible|0|||
94484455|NCT01747499|323567501|FG001|Overall Study|Determined not to be eligible|0|||
94484456|NCT01747499|323567502|FG002|Overall Study|Determined not to be eligible|0|||
94484457|NCT01747499|323567503|FG003|Overall Study|Determined not to be eligible|0|||
94329065|NCT02293902|322984310|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
94484458|NCT01747499|323567504|FG004|Overall Study|Determined not to be eligible|1|||
94484459|NCT00102596|323567505|FG000|Part A|Screen failures|6|||
94484460|NCT00102596|323567506|FG001|Part A|Screen failures|0|||
94484461|NCT00102596|323567505|FG000|Part A|Adverse Event|1|||
94484462|NCT00102596|323567506|FG001|Part A|Adverse Event|0|||
94484463|NCT01791595|323567507|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
94484464|NCT01791595|323567508|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
94484465|NCT01791595|323567509|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
94484466|NCT01791595|323567510|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
94394436|NCT04852978|323230574|FG004|Overall Study|Sponsor request|0|||
94394437|NCT04852978|323230575|FG005|Overall Study|Sponsor request|0|||
94394438|NCT04852978|323230576|FG006|Overall Study|Sponsor request|0|||
94394439|NCT04852978|323230577|FG007|Overall Study|Sponsor request|0|||
94394440|NCT04852978|323230578|FG008|Overall Study|Sponsor request|0|||
94394441|NCT04852978|323230570|FG000|Overall Study|Death|0|||
94394442|NCT04852978|323230571|FG001|Overall Study|Death|0|||
94394443|NCT04852978|323230572|FG002|Overall Study|Death|0|||
94394444|NCT04852978|323230573|FG003|Overall Study|Death|0|||
94394445|NCT04852978|323230574|FG004|Overall Study|Death|0|||
94394446|NCT04852978|323230575|FG005|Overall Study|Death|0|||
94394447|NCT04852978|323230576|FG006|Overall Study|Death|1|||
94394448|NCT04852978|323230577|FG007|Overall Study|Death|0|||
94394449|NCT04852978|323230578|FG008|Overall Study|Death|0|||
94394450|NCT04852978|323230570|FG000|Overall Study|Lost to Follow-up|3|||
94394451|NCT04852978|323230571|FG001|Overall Study|Lost to Follow-up|2|||
94394452|NCT04852978|323230572|FG002|Overall Study|Lost to Follow-up|2|||
94394453|NCT04852978|323230573|FG003|Overall Study|Lost to Follow-up|0|||
94394454|NCT04852978|323230574|FG004|Overall Study|Lost to Follow-up|2|||
94394455|NCT04852978|323230575|FG005|Overall Study|Lost to Follow-up|4|||
94394456|NCT04852978|323230576|FG006|Overall Study|Lost to Follow-up|1|||
94394457|NCT04852978|323230577|FG007|Overall Study|Lost to Follow-up|2|||
94394458|NCT04852978|323230578|FG008|Overall Study|Lost to Follow-up|2|||
94394459|NCT04852978|323230570|FG000|Overall Study|Withdrawal by Subject|4|||
94394460|NCT04852978|323230571|FG001|Overall Study|Withdrawal by Subject|2|||
94394461|NCT04852978|323230572|FG002|Overall Study|Withdrawal by Subject|2|||
94394462|NCT04852978|323230573|FG003|Overall Study|Withdrawal by Subject|1|||
94394463|NCT04852978|323230574|FG004|Overall Study|Withdrawal by Subject|5|||
94394464|NCT04852978|323230575|FG005|Overall Study|Withdrawal by Subject|3|||
94394465|NCT04852978|323230576|FG006|Overall Study|Withdrawal by Subject|2|||
94394466|NCT04852978|323230577|FG007|Overall Study|Withdrawal by Subject|2|||
94394467|NCT04852978|323230578|FG008|Overall Study|Withdrawal by Subject|1|||
94394468|NCT00218257|323232096|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
94394469|NCT00218257|323232097|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
94394470|NCT00579345|323232098|FG000|Overall Study|Withdrawal by Subject|2|||
94394471|NCT00579345|323232099|FG001|Overall Study|Withdrawal by Subject|0|||
94394472|NCT00579345|323232100|FG002|Overall Study|Withdrawal by Subject|0|||
94394473|NCT00579345|323232101|FG003|Overall Study|Withdrawal by Subject|0|||
94394474|NCT00579345|323232102|FG004|Overall Study|Withdrawal by Subject|0|||
94394475|NCT00579345|323232103|FG005|Overall Study|Withdrawal by Subject|0|||
94394476|NCT00579345|323232104|FG006|Overall Study|Withdrawal by Subject|0|||
94394477|NCT00579345|323232105|FG007|Overall Study|Withdrawal by Subject|1|||
94394478|NCT00579345|323232098|FG000|Overall Study|Lost to Follow-up|1|||
94394479|NCT00579345|323232099|FG001|Overall Study|Lost to Follow-up|0|||
94394480|NCT00579345|323232100|FG002|Overall Study|Lost to Follow-up|0|||
94394481|NCT00579345|323232101|FG003|Overall Study|Lost to Follow-up|0|||
94394482|NCT00579345|323232102|FG004|Overall Study|Lost to Follow-up|0|||
94394483|NCT00579345|323232103|FG005|Overall Study|Lost to Follow-up|0|||
94394484|NCT00579345|323232104|FG006|Overall Study|Lost to Follow-up|0|||
94394485|NCT00579345|323232105|FG007|Overall Study|Lost to Follow-up|0|||
94394486|NCT00579345|323232098|FG000|Overall Study|Adverse Event|0|||
94394487|NCT00579345|323232099|FG001|Overall Study|Adverse Event|0|||
94394488|NCT00579345|323232100|FG002|Overall Study|Adverse Event|1|||
94394489|NCT00579345|323232101|FG003|Overall Study|Adverse Event|0|||
94394490|NCT00579345|323232102|FG004|Overall Study|Adverse Event|0|||
94394491|NCT00579345|323232103|FG005|Overall Study|Adverse Event|0|||
94394492|NCT00579345|323232104|FG006|Overall Study|Adverse Event|0|||
94394493|NCT00579345|323232105|FG007|Overall Study|Adverse Event|0|||
94394494|NCT00579345|323232098|FG000|Overall Study|Protocol Violation|1|||
94394495|NCT00579345|323232099|FG001|Overall Study|Protocol Violation|0|||
94394496|NCT00579345|323232100|FG002|Overall Study|Protocol Violation|0|||
94394497|NCT00579345|323232101|FG003|Overall Study|Protocol Violation|0|||
94394498|NCT00579345|323232102|FG004|Overall Study|Protocol Violation|0|||
94394499|NCT00579345|323232103|FG005|Overall Study|Protocol Violation|0|||
94394500|NCT00579345|323232104|FG006|Overall Study|Protocol Violation|0|||
94394501|NCT00579345|323232105|FG007|Overall Study|Protocol Violation|1|||
94394502|NCT00579345|323232098|FG000|Overall Study|Death|1|||
94394503|NCT00579345|323232099|FG001|Overall Study|Death|1|||
94394504|NCT00579345|323232100|FG002|Overall Study|Death|1|||
94394505|NCT00579345|323232101|FG003|Overall Study|Death|1|||
94394506|NCT00579345|323232102|FG004|Overall Study|Death|0|||
94394507|NCT00579345|323232103|FG005|Overall Study|Death|0|||
94394508|NCT00579345|323232104|FG006|Overall Study|Death|0|||
94394509|NCT00579345|323232105|FG007|Overall Study|Death|0|||
94394510|NCT00371839|323232109|FG000|Overall Study|Death|4|||
94394511|NCT00371839|323232110|FG001|Overall Study|Death|0|||
94394512|NCT00371839|323232111|FG002|Overall Study|Death|0|||
94394513|NCT00371839|323232109|FG000|Overall Study|Withdrawal by Subject|7|||
94394514|NCT00371839|323232110|FG001|Overall Study|Withdrawal by Subject|4|||
94394515|NCT00371839|323232111|FG002|Overall Study|Withdrawal by Subject|0|||
94394516|NCT00371839|323232109|FG000|Overall Study|Lost to Follow-up|6|||
94394517|NCT00371839|323232110|FG001|Overall Study|Lost to Follow-up|3|||
94394518|NCT00371839|323232111|FG002|Overall Study|Lost to Follow-up|2|||
94394519|NCT02724462|323232114|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
94394520|NCT02724462|323232115|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
94394521|NCT02724462|323232114|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
94394522|NCT02724462|323232115|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
94394523|NCT02724462|323232114|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
94394524|NCT02724462|323232115|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
94394525|NCT02724462|323232114|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
94394526|NCT02724462|323232115|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
94394527|NCT02724462|323232114|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
94394528|NCT02724462|323232115|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
94394529|NCT02724462|323232114|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
94394530|NCT02724462|323232115|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
94394531|NCT05612724|323232116|FG000|Overall Study|Lost to Follow-up|4|||
94394532|NCT00934050|323232121|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
94394533|NCT00934050|323232122|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
94394534|NCT00934050|323232123|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
94394535|NCT00934050|323232124|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
94394536|NCT00934050|323232125|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
94394537|NCT00934050|323232126|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
94394538|NCT00934050|323232121|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
94394539|NCT00934050|323232122|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
94394540|NCT00934050|323232123|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
94484467|NCT01791595|323567511|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
94329066|NCT02293902|322984311|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
94329067|NCT02293902|322984312|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
94329068|NCT02293902|322984313|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
94329069|NCT02293902|322984309|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
94329070|NCT02293902|322984310|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
94329071|NCT02293902|322984311|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
94329072|NCT02293902|322984312|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
94329073|NCT02293902|322984313|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
94329074|NCT02293902|322984309|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
94329075|NCT02293902|322984310|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
94329076|NCT02293902|322984311|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
94329077|NCT02293902|322984312|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
94329078|NCT02293902|322984313|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
94329079|NCT02293902|322984309|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
94329080|NCT02293902|322984310|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
94329081|NCT02293902|322984311|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
94329082|NCT02293902|322984312|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
94329083|NCT02293902|322984313|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
94329084|NCT03927911|322986050|FG000|Overall Study|problems with eDiary|0|||
94329085|NCT03927911|322986051|FG001|Overall Study|problems with eDiary|1|||
94329086|NCT03927911|322986052|FG002|Overall Study|problems with eDiary|0|||
94329087|NCT03927911|322986053|FG003|Overall Study|problems with eDiary|1|||
94329088|NCT03927911|322986054|FG004|Overall Study|problems with eDiary|0|||
94329089|NCT03927911|322986055|FG005|Overall Study|problems with eDiary|4|||
94329090|NCT03927911|322986050|FG000|Overall Study|Adverse Event|0|||
94329091|NCT03927911|322986051|FG001|Overall Study|Adverse Event|0|||
94329092|NCT03927911|322986052|FG002|Overall Study|Adverse Event|0|||
94329093|NCT03927911|322986053|FG003|Overall Study|Adverse Event|0|||
94329094|NCT03927911|322986054|FG004|Overall Study|Adverse Event|0|||
94329095|NCT03927911|322986055|FG005|Overall Study|Adverse Event|1|||
94329096|NCT03927911|322986050|FG000|Overall Study|not treated -study terminated by sponsor|0|||
94329097|NCT03927911|322986051|FG001|Overall Study|not treated -study terminated by sponsor|1|||
94329098|NCT03927911|322986052|FG002|Overall Study|not treated -study terminated by sponsor|0|||
94329099|NCT03927911|322986053|FG003|Overall Study|not treated -study terminated by sponsor|0|||
94329100|NCT03927911|322986054|FG004|Overall Study|not treated -study terminated by sponsor|0|||
94329101|NCT03927911|322986055|FG005|Overall Study|not treated -study terminated by sponsor|0|||
94329102|NCT03927911|322986050|FG000|Overall Study|Surgery cancelled|0|||
94329103|NCT03927911|322986051|FG001|Overall Study|Surgery cancelled|0|||
94329104|NCT03927911|322986052|FG002|Overall Study|Surgery cancelled|0|||
94329105|NCT03927911|322986053|FG003|Overall Study|Surgery cancelled|1|||
94329106|NCT03927911|322986054|FG004|Overall Study|Surgery cancelled|0|||
94484468|NCT01791595|323567512|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
94329107|NCT03927911|322986055|FG005|Overall Study|Surgery cancelled|1|||
94329108|NCT03927911|322986050|FG000|Overall Study|Protocol Violation|0|||
94394541|NCT00934050|323232124|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
94394542|NCT00934050|323232125|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
94394543|NCT00934050|323232126|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
94394544|NCT00934050|323232121|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
94394545|NCT00934050|323232122|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
94394546|NCT00934050|323232123|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
94394547|NCT00934050|323232124|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
94394548|NCT00934050|323232125|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
94394549|NCT00934050|323232126|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
94394550|NCT00934050|323232121|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
94394551|NCT00934050|323232122|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
94394552|NCT00934050|323232123|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
94394553|NCT00934050|323232124|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
94394554|NCT00934050|323232125|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
94394555|NCT00934050|323232126|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
94394556|NCT00934050|323232121|FG000|Enrolled After 15 Dec 2009|Death|0|||
94394557|NCT00934050|323232122|FG001|Enrolled After 15 Dec 2009|Death|0|||
94394558|NCT00934050|323232123|FG002|Enrolled After 15 Dec 2009|Death|0|||
94394559|NCT00934050|323232124|FG003|Enrolled After 15 Dec 2009|Death|0|||
94394560|NCT00934050|323232125|FG004|Enrolled After 15 Dec 2009|Death|0|||
94394561|NCT00934050|323232126|FG005|Enrolled After 15 Dec 2009|Death|1|||
94394562|NCT00934050|323232121|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
94394563|NCT00934050|323232122|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
94394564|NCT00934050|323232123|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
94394565|NCT00934050|323232124|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
94394566|NCT00934050|323232125|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
94394567|NCT00934050|323232126|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
94394568|NCT00934050|323232121|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
94394569|NCT00934050|323232122|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
94394570|NCT00934050|323232123|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
94394571|NCT00934050|323232124|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
94394572|NCT00934050|323232125|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
94394573|NCT00934050|323232126|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
94394574|NCT00834067|323232127|FG000|Washout of 21 Days|Protocol Violation|0|||
94394575|NCT00834067|323232128|FG001|Washout of 21 Days|Protocol Violation|1|||
94394576|NCT00272779|323232130|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
94394577|NCT00272779|323232131|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
94394578|NCT00272779|323232130|FG000|Baseline Through Week 48|Death before Week 48|4|||
94394579|NCT00272779|323232131|FG001|Baseline Through Week 48|Death before Week 48|4|||
94394580|NCT00272779|323232130|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
94394581|NCT00272779|323232131|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
94394582|NCT00272779|323232130|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
94394583|NCT00272779|323232131|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
94394584|NCT00272779|323232130|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
94394585|NCT00272779|323232131|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
94394586|NCT00272779|323232130|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
94394587|NCT00272779|323232131|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
94394588|NCT00272779|323232130|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
94394589|NCT00272779|323232131|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
94394590|NCT00272779|323232130|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
94394591|NCT00272779|323232131|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
94394592|NCT00272779|323232130|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
94394593|NCT00272779|323232131|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
94394594|NCT00272779|323232130|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
94394595|NCT00272779|323232131|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
94394596|NCT00272779|323232130|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
94394597|NCT00272779|323232131|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
94394598|NCT00272779|323232130|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
94394599|NCT00272779|323232131|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
94394600|NCT00272779|323232130|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
94394601|NCT00272779|323232131|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
94394602|NCT00272779|323232130|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
94394603|NCT00272779|323232131|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
94394604|NCT00272779|323232130|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
94394605|NCT00272779|323232131|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
94394606|NCT00272779|323232130|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
94394607|NCT00272779|323232131|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
94394608|NCT00272779|323232130|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
94394609|NCT00272779|323232131|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
94394610|NCT00272779|323232130|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
94394611|NCT00272779|323232131|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
94394612|NCT00272779|323232130|FG000|Baseline Through Week 48|Continuing treatment|385|||
94394613|NCT00272779|323232131|FG001|Baseline Through Week 48|Continuing treatment|368|||
94394614|NCT00272779|323232130|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
94394615|NCT00272779|323232131|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
94394616|NCT00272779|323232130|FG000|Baseline Through Week 48|Never treated|2|||
94394617|NCT00272779|323232131|FG001|Baseline Through Week 48|Never treated|3|||
94394618|NCT00272779|323232130|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
94394619|NCT00272779|323232131|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
94394620|NCT00272779|323232130|FG000|Baseline Through Week 96|Death before Week 96|6|||
94394621|NCT00272779|323232131|FG001|Baseline Through Week 96|Death before Week 96|5|||
94394622|NCT00272779|323232130|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
94394623|NCT00272779|323232131|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
94394624|NCT00272779|323232130|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
94394625|NCT00272779|323232131|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
94394626|NCT00272779|323232130|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
94394627|NCT00272779|323232131|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
94394628|NCT00272779|323232130|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
94394629|NCT00272779|323232131|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
94394630|NCT00272779|323232130|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
94394631|NCT00272779|323232131|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
94394632|NCT00272779|323232130|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
94394633|NCT00272779|323232131|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
94394634|NCT00272779|323232130|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
94394635|NCT00272779|323232131|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
94394636|NCT00272779|323232130|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
94394637|NCT00272779|323232131|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
94394638|NCT00272779|323232130|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
94394639|NCT00272779|323232131|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
94394640|NCT00272779|323232130|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
94394641|NCT00272779|323232131|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
94394642|NCT00272779|323232130|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
94394643|NCT00272779|323232131|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
94394644|NCT00272779|323232130|FG000|Baseline Through Week 96|Never treated|2|||
94394645|NCT00272779|323232131|FG001|Baseline Through Week 96|Never treated|3|||
94394646|NCT00272779|323232130|FG000|Baseline Through Week 96|Continuing on treatment|61|||
94394647|NCT00272779|323232131|FG001|Baseline Through Week 96|Continuing on treatment|38|||
94394648|NCT00561015|323232132|FG000|Overall Study|Adverse Event|0|||
94394649|NCT00561015|323232133|FG001|Overall Study|Adverse Event|0|||
94394650|NCT00561015|323232134|FG002|Overall Study|Adverse Event|0|||
94394651|NCT00561015|323232135|FG003|Overall Study|Adverse Event|0|||
94394652|NCT00561015|323232136|FG004|Overall Study|Adverse Event|1|||
94394653|NCT00561015|323232137|FG005|Overall Study|Adverse Event|0|||
94394654|NCT00561015|323232132|FG000|Overall Study|Lost to Follow-up|2|||
94394655|NCT00561015|323232133|FG001|Overall Study|Lost to Follow-up|0|||
94394656|NCT00561015|323232134|FG002|Overall Study|Lost to Follow-up|0|||
94394657|NCT00561015|323232135|FG003|Overall Study|Lost to Follow-up|1|||
94394658|NCT00561015|323232136|FG004|Overall Study|Lost to Follow-up|0|||
94394659|NCT00561015|323232137|FG005|Overall Study|Lost to Follow-up|3|||
94394660|NCT00561015|323232132|FG000|Overall Study|Participant non-compliance|2|||
94394661|NCT00561015|323232133|FG001|Overall Study|Participant non-compliance|0|||
94394662|NCT00561015|323232134|FG002|Overall Study|Participant non-compliance|0|||
94394663|NCT00561015|323232135|FG003|Overall Study|Participant non-compliance|0|||
94394664|NCT00561015|323232136|FG004|Overall Study|Participant non-compliance|0|||
94394665|NCT00561015|323232137|FG005|Overall Study|Participant non-compliance|0|||
94394666|NCT00096447|323232138|FG000|Overall Study|Never treated|1|||
94394667|NCT03733730|323232140|FG000|Overall Study|Lost to Follow-up|1|||
94484469|NCT01791595|323567513|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
94484470|NCT01791595|323567507|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
94484471|NCT01791595|323567508|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
94394668|NCT03733730|323232141|FG001|Overall Study|Lost to Follow-up|32|||
94394669|NCT03733730|323232140|FG000|Overall Study|Other|1|||
94394670|NCT03733730|323232141|FG001|Overall Study|Other|0|||
94394671|NCT03733730|323232140|FG000|Overall Study|Adverse Event|0|||
94394672|NCT03733730|323232141|FG001|Overall Study|Adverse Event|4|||
94394673|NCT03733730|323232140|FG000|Overall Study|Death|0|||
94394674|NCT03733730|323232141|FG001|Overall Study|Death|5|||
94394675|NCT03733730|323232140|FG000|Overall Study|Withdrawal by Subject|0|||
94394676|NCT03733730|323232141|FG001|Overall Study|Withdrawal by Subject|8|||
94394677|NCT03214952|323232144|FG000|Overall Study|Protocol Deviation|45|||
94394678|NCT03214952|323232144|FG000|Overall Study|Case Report Forms Uncollected|13|||
94394679|NCT02476994|323232145|FG000|Overall Study|Based on feedback from FDA|1|||
94394680|NCT02476994|323232146|FG001|Overall Study|Based on feedback from FDA|0|||
94394681|NCT03769896|323232147|FG000|Open-label Phase|Lack of Efficacy|5|||
94394682|NCT03769896|323232148|FG001|Open-label Phase|Lack of Efficacy|0|||
94394683|NCT03769896|323232147|FG000|Open-label Phase|Adverse Event|3|||
94394684|NCT03769896|323232148|FG001|Open-label Phase|Adverse Event|0|||
94394685|NCT03769896|323232147|FG000|Open-label Phase|Withdrawal by Subject|1|||
94394686|NCT03769896|323232148|FG001|Open-label Phase|Withdrawal by Subject|0|||
94394687|NCT01015703|323232151|FG000|Overall Study|Withdrawal by Subject|0|||
94394688|NCT01015703|323232152|FG001|Overall Study|Withdrawal by Subject|1|||
94394689|NCT01015703|323232153|FG002|Overall Study|Withdrawal by Subject|0|||
94394690|NCT01015703|323232154|FG003|Overall Study|Withdrawal by Subject|0|||
94394691|NCT01015703|323232155|FG004|Overall Study|Withdrawal by Subject|0|||
94394692|NCT01015703|323232151|FG000|Overall Study|Adverse Event|1|||
94394693|NCT01015703|323232152|FG001|Overall Study|Adverse Event|0|||
94394694|NCT01015703|323232153|FG002|Overall Study|Adverse Event|0|||
94394695|NCT01015703|323232154|FG003|Overall Study|Adverse Event|0|||
94394696|NCT01015703|323232155|FG004|Overall Study|Adverse Event|0|||
94394697|NCT01015703|323232151|FG000|Overall Study|Protocol Violation|1|||
94394698|NCT01015703|323232152|FG001|Overall Study|Protocol Violation|0|||
94394699|NCT01015703|323232153|FG002|Overall Study|Protocol Violation|0|||
94394700|NCT01015703|323232154|FG003|Overall Study|Protocol Violation|0|||
94394701|NCT01015703|323232155|FG004|Overall Study|Protocol Violation|0|||
94394702|NCT02718326|323232156|FG000|Overall Study|Adverse Event|4|||
94394703|NCT02718326|323232157|FG001|Overall Study|Adverse Event|9|||
94394704|NCT02718326|323232158|FG002|Overall Study|Adverse Event|0|||
94394705|NCT02718326|323232156|FG000|Overall Study|Death|8|||
94394706|NCT02718326|323232157|FG001|Overall Study|Death|1|||
94394707|NCT02718326|323232158|FG002|Overall Study|Death|2|||
94394708|NCT02718326|323232156|FG000|Overall Study|Withdrawal by Subject|4|||
94394709|NCT02718326|323232157|FG001|Overall Study|Withdrawal by Subject|9|||
94394710|NCT02718326|323232158|FG002|Overall Study|Withdrawal by Subject|6|||
94394711|NCT02718326|323232156|FG000|Overall Study|Lost to Follow-up|18|||
94394712|NCT02718326|323232157|FG001|Overall Study|Lost to Follow-up|5|||
94394713|NCT02718326|323232158|FG002|Overall Study|Lost to Follow-up|14|||
94394714|NCT02718326|323232156|FG000|Overall Study|Protocol Deviation|1|||
94394715|NCT02718326|323232157|FG001|Overall Study|Protocol Deviation|0|||
94394716|NCT02718326|323232158|FG002|Overall Study|Protocol Deviation|0|||
94394717|NCT02718326|323232156|FG000|Overall Study|Pregnancy|1|||
94394718|NCT02718326|323232157|FG001|Overall Study|Pregnancy|0|||
94394719|NCT02718326|323232158|FG002|Overall Study|Pregnancy|0|||
94394720|NCT00627016|323232159|FG000|Overall Study|Adverse Event|1|||
94394721|NCT00627016|323232160|FG001|Overall Study|Adverse Event|1|||
94394722|NCT00627016|323232159|FG000|Overall Study|Protocol Violation|0|||
94394723|NCT00627016|323232160|FG001|Overall Study|Protocol Violation|2|||
94394724|NCT00627016|323232159|FG000|Overall Study|Lost to Follow-up|0|||
94394725|NCT00627016|323232160|FG001|Overall Study|Lost to Follow-up|1|||
94394726|NCT00627016|323232159|FG000|Overall Study|Withdrawal by Subject|2|||
94394727|NCT00627016|323232160|FG001|Overall Study|Withdrawal by Subject|1|||
94394728|NCT00627016|323232159|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
94394729|NCT00627016|323232160|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
94394730|NCT00627016|323232159|FG000|Overall Study|Lack of Efficacy|1|||
94394731|NCT00627016|323232160|FG001|Overall Study|Lack of Efficacy|0|||
94394732|NCT00627016|323232159|FG000|Overall Study|Placed on Excluded Drugs|1|||
94394733|NCT00627016|323232160|FG001|Overall Study|Placed on Excluded Drugs|0|||
94394734|NCT00627016|323232159|FG000|Overall Study|Pregnancy|1|||
94394735|NCT00627016|323232160|FG001|Overall Study|Pregnancy|0|||
94394736|NCT03154047|323232161|FG000|Overall Study|Death|1|||
94394737|NCT03154047|323232161|FG000|Overall Study|Study terminated by sponsor|76|||
94394738|NCT03154047|323232161|FG000|Overall Study|Withdrawal by Subject|3|||
94394739|NCT00583453|323232162|FG000|Overall Study|discontinued intervention|0|||
94394740|NCT00583453|323232163|FG001|Overall Study|discontinued intervention|2|||
94394741|NCT02436005|323232164|FG000|Second Intervention|Adverse Event|0|||
94394742|NCT02436005|323232165|FG001|Second Intervention|Adverse Event|1|||
94394743|NCT00365365|323232166|FG000|Overall Study|Randomized but not treated|0|||
94394744|NCT00365365|323232167|FG001|Overall Study|Randomized but not treated|2|||
94394745|NCT00365365|323232168|FG002|Overall Study|Randomized but not treated|0|||
94394746|NCT00365365|323232166|FG000|Overall Study|Poor compliance to protocol|0|||
94394747|NCT00365365|323232167|FG001|Overall Study|Poor compliance to protocol|1|||
94394748|NCT00365365|323232168|FG002|Overall Study|Poor compliance to protocol|0|||
94394749|NCT00365365|323232166|FG000|Overall Study|Lost to Follow-up|3|||
94394750|NCT00365365|323232167|FG001|Overall Study|Lost to Follow-up|3|||
94394751|NCT00365365|323232168|FG002|Overall Study|Lost to Follow-up|3|||
94394752|NCT00365365|323232166|FG000|Overall Study|Death|1|||
94394753|NCT00365365|323232167|FG001|Overall Study|Death|3|||
94394754|NCT00365365|323232168|FG002|Overall Study|Death|0|||
94394755|NCT00365365|323232166|FG000|Overall Study|Subject's request|11|||
94394756|NCT00365365|323232167|FG001|Overall Study|Subject's request|13|||
94394757|NCT00365365|323232168|FG002|Overall Study|Subject's request|1|||
94394758|NCT00365365|323232166|FG000|Overall Study|Disease progression/relapse|9|||
94394759|NCT00365365|323232167|FG001|Overall Study|Disease progression/relapse|6|||
94394760|NCT00365365|323232168|FG002|Overall Study|Disease progression/relapse|7|||
94394761|NCT00365365|323232166|FG000|Overall Study|Adverse Event|6|||
94394762|NCT00365365|323232167|FG001|Overall Study|Adverse Event|6|||
94394763|NCT00365365|323232168|FG002|Overall Study|Adverse Event|3|||
94394764|NCT00365365|323232166|FG000|Overall Study|Moved|2|||
94394765|NCT00365365|323232167|FG001|Overall Study|Moved|0|||
94394766|NCT00365365|323232168|FG002|Overall Study|Moved|0|||
94394767|NCT00365365|323232166|FG000|Overall Study|New cancer|1|||
94394768|NCT00365365|323232167|FG001|Overall Study|New cancer|0|||
94394769|NCT00365365|323232168|FG002|Overall Study|New cancer|0|||
94394770|NCT00365365|323232166|FG000|Overall Study|Withdrew consent|1|||
94394771|NCT00365365|323232167|FG001|Overall Study|Withdrew consent|1|||
94394772|NCT00365365|323232168|FG002|Overall Study|Withdrew consent|0|||
94394773|NCT00365365|323232166|FG000|Overall Study|Second malignancy|0|||
94394774|NCT00365365|323232167|FG001|Overall Study|Second malignancy|1|||
94394775|NCT00365365|323232168|FG002|Overall Study|Second malignancy|0|||
94394776|NCT00365365|323232166|FG000|Overall Study|Patient/physician decision|0|||
94394777|NCT00365365|323232167|FG001|Overall Study|Patient/physician decision|0|||
94394778|NCT00365365|323232168|FG002|Overall Study|Patient/physician decision|1|||
94394779|NCT02300103|323232169|FG000|Overall Study|Lack of Efficacy|3|||
94394780|NCT02300103|323232169|FG000|Overall Study|Protocol Violation|1|||
94394781|NCT02300103|323232169|FG000|Overall Study|Withdrew Consent|2|||
94394782|NCT01083693|323232178|FG000|Overall Study|Adverse Event|1|||
94394783|NCT01083693|323232179|FG001|Overall Study|Adverse Event|1|||
94394784|NCT01083693|323232180|FG002|Overall Study|Adverse Event|0|||
94394785|NCT01083693|323232178|FG000|Overall Study|Lost to Follow-up|2|||
94394786|NCT01083693|323232179|FG001|Overall Study|Lost to Follow-up|0|||
94394787|NCT01083693|323232180|FG002|Overall Study|Lost to Follow-up|2|||
94394788|NCT01083693|323232178|FG000|Overall Study|Lack of effectiveness|13|||
94394789|NCT01083693|323232179|FG001|Overall Study|Lack of effectiveness|2|||
94394790|NCT01083693|323232180|FG002|Overall Study|Lack of effectiveness|2|||
94394791|NCT01083693|323232178|FG000|Overall Study|Patient Moved|0|||
94394792|NCT01083693|323232179|FG001|Overall Study|Patient Moved|1|||
94394793|NCT01083693|323232180|FG002|Overall Study|Patient Moved|0|||
94394794|NCT01083693|323232178|FG000|Overall Study|Complete remission|0|||
94394795|NCT01083693|323232179|FG001|Overall Study|Complete remission|1|||
94394796|NCT01083693|323232180|FG002|Overall Study|Complete remission|0|||
94394797|NCT01083693|323232178|FG000|Overall Study|Other medical condition/surgery|1|||
94394798|NCT01083693|323232179|FG001|Overall Study|Other medical condition/surgery|1|||
94394799|NCT01083693|323232180|FG002|Overall Study|Other medical condition/surgery|0|||
94394800|NCT01083693|323232178|FG000|Overall Study|Withdrawal by Subject|3|||
94394801|NCT01083693|323232179|FG001|Overall Study|Withdrawal by Subject|0|||
94394802|NCT01083693|323232180|FG002|Overall Study|Withdrawal by Subject|2|||
94394803|NCT01083693|323232178|FG000|Overall Study|Reason unknown|0|||
94394804|NCT01083693|323232179|FG001|Overall Study|Reason unknown|0|||
94394805|NCT01083693|323232180|FG002|Overall Study|Reason unknown|1|||
94394806|NCT03107091|323232181|FG000|Overall Study|Physician Decision|1|||
94394807|NCT00834418|323232182|FG000|Overall Study|Adverse Event|0|||
94394808|NCT00834418|323232183|FG001|Overall Study|Adverse Event|2|||
94394809|NCT03496623|323232189|FG000|Run-In Period (2 Weeks)|Death|1|||
94394810|NCT03496623|323232190|FG001|Run-In Period (2 Weeks)|Death|0|||
94394811|NCT03496623|323232191|FG002|Run-In Period (2 Weeks)|Death|0|||
94394812|NCT03496623|323232192|FG003|Run-In Period (2 Weeks)|Death|0|||
94394813|NCT03496623|323232193|FG004|Run-In Period (2 Weeks)|Death|0|||
94394814|NCT03496623|323232189|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
94394815|NCT03496623|323232190|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
94394816|NCT03496623|323232191|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
94394817|NCT03496623|323232192|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
94394818|NCT03496623|323232193|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
94394819|NCT03496623|323232189|FG000|Period 1 (12 Weeks)|Death|0|||
94394820|NCT03496623|323232190|FG001|Period 1 (12 Weeks)|Death|3|||
94394821|NCT03496623|323232191|FG002|Period 1 (12 Weeks)|Death|0|||
94394822|NCT03496623|323232192|FG003|Period 1 (12 Weeks)|Death|0|||
94394823|NCT03496623|323232193|FG004|Period 1 (12 Weeks)|Death|0|||
94394824|NCT03496623|323232189|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
94394825|NCT03496623|323232190|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
94394826|NCT03496623|323232191|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
94394827|NCT03496623|323232192|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
94394828|NCT03496623|323232193|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
94394829|NCT03496623|323232189|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
94394830|NCT03496623|323232190|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
94394831|NCT03496623|323232191|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
94394832|NCT03496623|323232192|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
94394833|NCT03496623|323232193|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
94394834|NCT03496623|323232189|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
94484472|NCT01791595|323567509|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
94484473|NCT01791595|323567510|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
94484474|NCT01791595|323567511|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
94484475|NCT01791595|323567512|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
94484476|NCT01791595|323567513|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
94484477|NCT01791595|323567507|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
94484478|NCT01791595|323567508|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
94484479|NCT01791595|323567509|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
94484480|NCT01791595|323567510|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
94484481|NCT01791595|323567511|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
94484482|NCT01791595|323567512|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
94484483|NCT01791595|323567513|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
94484484|NCT01791595|323567507|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
94484485|NCT01791595|323567508|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
94484486|NCT01791595|323567509|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
94484487|NCT01791595|323567510|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
94484488|NCT01791595|323567511|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
94484489|NCT01791595|323567512|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
94484490|NCT01791595|323567513|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
94484491|NCT01791595|323567507|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
94484492|NCT01791595|323567508|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
94484493|NCT01791595|323567509|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
94484494|NCT01791595|323567510|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
94484495|NCT01791595|323567511|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
94484496|NCT01791595|323567512|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
94484497|NCT01791595|323567513|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
94484498|NCT01791595|323567507|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
94484499|NCT01791595|323567508|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
94484500|NCT01791595|323567509|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
94484501|NCT01791595|323567510|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
94394835|NCT03496623|323232190|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
94394836|NCT03496623|323232191|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
94394837|NCT03496623|323232192|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
94394838|NCT03496623|323232193|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
94394839|NCT03496623|323232189|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
94394840|NCT03496623|323232190|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
94394841|NCT03496623|323232191|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
94394842|NCT03496623|323232192|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
94394843|NCT03496623|323232193|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
94394844|NCT03496623|323232189|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
94394845|NCT03496623|323232190|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
94394846|NCT03496623|323232191|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
94394847|NCT03496623|323232192|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
94394848|NCT03496623|323232193|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
94394849|NCT03496623|323232189|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
94394850|NCT03496623|323232190|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
94394851|NCT03496623|323232191|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
94394852|NCT03496623|323232192|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
94394853|NCT03496623|323232193|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
94394854|NCT00448019|323232194|FG000|Overall Study|Withdrawal by Subject|3|||
94394855|NCT00448019|323232194|FG000|Overall Study|Disease progression|1|||
94394856|NCT00448019|323232194|FG000|Overall Study|Death|2|||
94394857|NCT00448019|323232194|FG000|Overall Study|Insurance Issues|1|||
94394858|NCT02760368|323232195|FG000|Overall Study|Withdrawal by Subject|8|||
94394859|NCT02760368|323232196|FG001|Overall Study|Withdrawal by Subject|12|||
94394860|NCT02760368|323232197|FG002|Overall Study|Withdrawal by Subject|9|||
94394861|NCT02760368|323232195|FG000|Overall Study|Screen Failure|0|||
94394862|NCT02760368|323232196|FG001|Overall Study|Screen Failure|0|||
94394863|NCT02760368|323232197|FG002|Overall Study|Screen Failure|1|||
94394864|NCT02760368|323232195|FG000|Overall Study|Death|0|||
94484502|NCT01791595|323567511|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
94484503|NCT01791595|323567512|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
94394865|NCT02760368|323232196|FG001|Overall Study|Death|1|||
94394866|NCT02760368|323232197|FG002|Overall Study|Death|0|||
94394867|NCT02760368|323232195|FG000|Overall Study|Withdrawal by Sponsor|0|||
94394868|NCT02760368|323232196|FG001|Overall Study|Withdrawal by Sponsor|0|||
94394869|NCT02760368|323232197|FG002|Overall Study|Withdrawal by Sponsor|1|||
94394870|NCT01827163|323232198|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
94394871|NCT01827163|323232198|FG000|Overall Study|Adverse Event|9|||
94394872|NCT01370317|323232199|FG000|Overall Study|Participant withdrew consent|1|||
94394873|NCT01370317|323232200|FG001|Overall Study|Participant withdrew consent|0|||
94394874|NCT01370317|323232199|FG000|Overall Study|Protocol deviation|0|||
94394875|NCT01370317|323232200|FG001|Overall Study|Protocol deviation|1|||
94394876|NCT03098394|323232208|FG000|Overall Study|Pregnancy|0|||
94394877|NCT03098394|323232209|FG001|Overall Study|Pregnancy|1|||
94394878|NCT00609674|323232210|FG000|Overall Study|Adverse Event|1|||
94394879|NCT00609674|323232211|FG001|Overall Study|Adverse Event|1|||
94394880|NCT00609674|323232210|FG000|Overall Study|Protocol Violation|3|||
94394881|NCT00609674|323232211|FG001|Overall Study|Protocol Violation|5|||
94394882|NCT00609674|323232210|FG000|Overall Study|Lost to Follow-up|1|||
94394883|NCT00609674|323232211|FG001|Overall Study|Lost to Follow-up|0|||
94394884|NCT00609674|323232210|FG000|Overall Study|Withdrew consent|2|||
94394885|NCT00609674|323232211|FG001|Overall Study|Withdrew consent|1|||
94394886|NCT00244764|323232212|FG000|Overall Study|Adverse Event|37|||
94394887|NCT00244764|323232212|FG000|Overall Study|Lost to Follow-up|23|||
94394888|NCT00244764|323232212|FG000|Overall Study|Withdrawal by Subject|12|||
94394889|NCT00244764|323232212|FG000|Overall Study|Disease Progression|13|||
94394890|NCT00244764|323232212|FG000|Overall Study|Protocol Violation|2|||
94394891|NCT00244764|323232212|FG000|Overall Study|Death|1|||
94394892|NCT00244764|323232212|FG000|Overall Study|Off Study Medication for >21 Days|1|||
94394893|NCT00244764|323232212|FG000|Overall Study|Declining Performance Status|1|||
94394894|NCT00244764|323232212|FG000|Overall Study|Participant was Hospitalized until Death|1|||
94394895|NCT00244764|323232212|FG000|Overall Study|Primary Investigator Discretion|2|||
94394896|NCT00244764|323232212|FG000|Overall Study|Sponsor Terminated Study|2|||
94394897|NCT00244764|323232212|FG000|Overall Study|Developed Secondary Malignancy|1|||
94394898|NCT03637764|323232215|FG000|Overall Study|Adverse Event|2|||
94394899|NCT03637764|323232216|FG001|Overall Study|Adverse Event|0|||
94394900|NCT03637764|323232217|FG002|Overall Study|Adverse Event|0|||
94394901|NCT03637764|323232218|FG003|Overall Study|Adverse Event|1|||
94394902|NCT03637764|323232215|FG000|Overall Study|Progressive Disease|23|||
94394903|NCT03637764|323232216|FG001|Overall Study|Progressive Disease|23|||
94394904|NCT03637764|323232217|FG002|Overall Study|Progressive Disease|18|||
94394905|NCT03637764|323232218|FG003|Overall Study|Progressive Disease|31|||
94394906|NCT03637764|323232215|FG000|Overall Study|Withdrawal by Subject|1|||
94394907|NCT03637764|323232216|FG001|Overall Study|Withdrawal by Subject|3|||
94394908|NCT03637764|323232217|FG002|Overall Study|Withdrawal by Subject|0|||
94394909|NCT03637764|323232218|FG003|Overall Study|Withdrawal by Subject|1|||
94394910|NCT01103713|323232219|FG000|Overall Study|Lost to Follow-up|2|||
94394911|NCT01103713|323232219|FG000|Overall Study|Withdrawal by Subject|8|||
94394912|NCT01103713|323232219|FG000|Overall Study|Study terminated by sponsor|2|||
94394913|NCT01103713|323232219|FG000|Overall Study|Other|1|||
94394914|NCT01940341|323232222|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
94394915|NCT01940341|323232223|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
94394916|NCT01940341|323232224|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
94394917|NCT01940341|323232225|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
94394918|NCT01940341|323232222|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
94394919|NCT01940341|323232223|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
94394920|NCT01940341|323232224|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
94394921|NCT01940341|323232225|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
94394922|NCT01940341|323232222|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
94394923|NCT01940341|323232223|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
94394924|NCT01940341|323232224|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
94394925|NCT01940341|323232225|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
94394926|NCT01940341|323232222|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
94394927|NCT01940341|323232223|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
94394928|NCT01940341|323232224|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
94394929|NCT01940341|323232225|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
94394930|NCT01940341|323232222|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
94394931|NCT01940341|323232223|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
94394932|NCT01940341|323232224|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
94394933|NCT01940341|323232225|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
94394934|NCT01940341|323232222|FG000|Period 1: Double-blind Phase|Death|0|||
94394935|NCT01940341|323232223|FG001|Period 1: Double-blind Phase|Death|1|||
94394936|NCT01940341|323232224|FG002|Period 1: Double-blind Phase|Death|0|||
94394937|NCT01940341|323232225|FG003|Period 1: Double-blind Phase|Death|0|||
94394938|NCT01940341|323232222|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
94394939|NCT01940341|323232223|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
94394940|NCT01940341|323232224|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
94394941|NCT01940341|323232225|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
94394942|NCT01940341|323232222|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
94394943|NCT01940341|323232223|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
94394944|NCT01940341|323232224|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
94394945|NCT01940341|323232225|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
94394946|NCT01940341|323232222|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
94394947|NCT01940341|323232223|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
94394948|NCT01940341|323232224|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
94394949|NCT01940341|323232225|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
94394950|NCT01940341|323232222|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
94394951|NCT01940341|323232223|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
94394952|NCT01940341|323232224|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
94394953|NCT01940341|323232225|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
94394954|NCT01940341|323232222|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
94394955|NCT01940341|323232223|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
94394956|NCT01940341|323232224|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
94394957|NCT01940341|323232225|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
94394958|NCT01940341|323232222|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
94394959|NCT01940341|323232223|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
94394960|NCT01940341|323232224|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
94394961|NCT01940341|323232225|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
94394962|NCT01940341|323232222|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
94394963|NCT01940341|323232223|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
94394964|NCT01940341|323232224|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
94394965|NCT01940341|323232225|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
94394966|NCT01940341|323232222|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
94394967|NCT01940341|323232223|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
94394968|NCT01940341|323232224|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
94394969|NCT01940341|323232225|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
94394970|NCT01940341|323232222|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
94394971|NCT01940341|323232223|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
94394972|NCT01940341|323232224|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
94394973|NCT01940341|323232225|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
94394974|NCT01940341|323232222|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
94394975|NCT01940341|323232223|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
94394976|NCT01940341|323232224|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
94394977|NCT01940341|323232225|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
94394978|NCT01940341|323232222|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
94394979|NCT01940341|323232223|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
94394980|NCT01940341|323232224|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
94394981|NCT01940341|323232225|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
94394982|NCT01940341|323232222|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
94394983|NCT01940341|323232223|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
94394984|NCT01940341|323232224|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
94394985|NCT01940341|323232225|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
94394986|NCT01940341|323232222|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
94394987|NCT01940341|323232223|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
94394988|NCT01940341|323232224|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
94394989|NCT01940341|323232225|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
94394990|NCT00207090|323232228|FG000|Overall Study|Study drug toxicity|3|||
94394991|NCT00207090|323232228|FG000|Overall Study|Chest wall mass larger|1|||
94394992|NCT00207090|323232228|FG000|Overall Study|Disease progression/relapse|2|||
94394993|NCT00207090|323232228|FG000|Overall Study|Physician Decision|1|||
94394994|NCT04887415|323232229|FG000|Overall Study|Lost to Follow-up|2|||
94394995|NCT00841698|323232230|FG000|First Intervention|Withdrawal by Subject|1|||
94394996|NCT00841698|323232231|FG001|First Intervention|Withdrawal by Subject|0|||
94394997|NCT01348789|323232232|FG000|Overall Study|Protocol Violation|2|||
94394998|NCT01348789|323232232|FG000|Overall Study|Withdrawal by Subject|2|||
94394999|NCT04633564|323232233|FG000|Period 1|Adverse Event|28|||
94395000|NCT04633564|323232234|FG001|Period 1|Adverse Event|19|||
94395001|NCT04633564|323232233|FG000|Period 1|Death|8|||
94395002|NCT04633564|323232234|FG001|Period 1|Death|7|||
94395003|NCT04633564|323232233|FG000|Period 1|Lost to Follow-up|3|||
94395004|NCT04633564|323232234|FG001|Period 1|Lost to Follow-up|5|||
94395005|NCT04633564|323232233|FG000|Period 1|Physician Decision|4|||
94395006|NCT04633564|323232234|FG001|Period 1|Physician Decision|12|||
94395007|NCT04633564|323232233|FG000|Period 1|Protocol Violation|0|||
94395008|NCT04633564|323232234|FG001|Period 1|Protocol Violation|1|||
94395009|NCT04633564|323232233|FG000|Period 1|Withdrawal by Subject|10|||
94395010|NCT04633564|323232234|FG001|Period 1|Withdrawal by Subject|8|||
94395011|NCT04633564|323232233|FG000|Period 1|Progressive disease|47|||
94395012|NCT04633564|323232234|FG001|Period 1|Progressive disease|51|||
94395013|NCT04633564|323232233|FG000|Period 1|Terminated by Sponsor|8|||
94395014|NCT04633564|323232234|FG001|Period 1|Terminated by Sponsor|6|||
94395015|NCT04633564|323232233|FG000|Period 2|Adverse Event|3|||
94395016|NCT04633564|323232234|FG001|Period 2|Adverse Event|4|||
94395017|NCT04633564|323232233|FG000|Period 2|Death|0|||
94395018|NCT04633564|323232234|FG001|Period 2|Death|2|||
94395019|NCT04633564|323232233|FG000|Period 2|Lost to Follow-up|0|||
94395020|NCT04633564|323232234|FG001|Period 2|Lost to Follow-up|1|||
94395021|NCT04633564|323232233|FG000|Period 2|Physician Decision|2|||
94395022|NCT04633564|323232234|FG001|Period 2|Physician Decision|4|||
94395023|NCT04633564|323232233|FG000|Period 2|Withdrawal by Subject|5|||
94395024|NCT04633564|323232234|FG001|Period 2|Withdrawal by Subject|1|||
94395025|NCT04633564|323232233|FG000|Period 2|Progressive Disease|74|||
94395026|NCT04633564|323232234|FG001|Period 2|Progressive Disease|82|||
94395027|NCT04633564|323232233|FG000|Period 2|Terminated by Sponsor|9|||
94395028|NCT04633564|323232234|FG001|Period 2|Terminated by Sponsor|3|||
94395029|NCT03206177|323232235|FG000|Overall Study|Withdrawal by Subject|1|||
94395030|NCT02963259|323232236|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
94395031|NCT02963259|323232236|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
94395032|NCT02963259|323232236|FG000|Overall Study|Death|1|||
94395033|NCT02963259|323232236|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
94395034|NCT01279486|323232237|FG000|Overall Study|Lost to Follow-up|1|||
94395035|NCT02655679|323232238|FG000|Overall Study|Adverse Event|0|||
94395036|NCT02655679|323232239|FG001|Overall Study|Adverse Event|1|||
94395037|NCT02655679|323232240|FG002|Overall Study|Adverse Event|0|||
94395038|NCT02655679|323232241|FG003|Overall Study|Adverse Event|0|||
94395039|NCT02655679|323232242|FG004|Overall Study|Adverse Event|0|||
94395040|NCT02655679|323232238|FG000|Overall Study|Withdrawal by Subject|1|||
94395041|NCT02655679|323232239|FG001|Overall Study|Withdrawal by Subject|1|||
94395042|NCT02655679|323232240|FG002|Overall Study|Withdrawal by Subject|0|||
94395043|NCT02655679|323232241|FG003|Overall Study|Withdrawal by Subject|3|||
94395044|NCT02655679|323232242|FG004|Overall Study|Withdrawal by Subject|1|||
94395045|NCT02655679|323232238|FG000|Overall Study|Inability to Comply with the Protocol|1|||
94395046|NCT02655679|323232239|FG001|Overall Study|Inability to Comply with the Protocol|0|||
94395047|NCT02655679|323232240|FG002|Overall Study|Inability to Comply with the Protocol|0|||
94395048|NCT02655679|323232241|FG003|Overall Study|Inability to Comply with the Protocol|0|||
94395049|NCT02655679|323232242|FG004|Overall Study|Inability to Comply with the Protocol|0|||
94395050|NCT02655679|323232238|FG000|Overall Study|Lost to Follow-up|0|||
94395051|NCT02655679|323232239|FG001|Overall Study|Lost to Follow-up|1|||
94395052|NCT02655679|323232240|FG002|Overall Study|Lost to Follow-up|1|||
94395053|NCT02655679|323232241|FG003|Overall Study|Lost to Follow-up|1|||
94395054|NCT02655679|323232242|FG004|Overall Study|Lost to Follow-up|0|||
94395055|NCT02655679|323232238|FG000|Overall Study|Other Miscellaneous Reasons|1|||
94395056|NCT02655679|323232239|FG001|Overall Study|Other Miscellaneous Reasons|0|||
94395057|NCT02655679|323232240|FG002|Overall Study|Other Miscellaneous Reasons|0|||
94395058|NCT02655679|323232241|FG003|Overall Study|Other Miscellaneous Reasons|0|||
94395059|NCT02655679|323232242|FG004|Overall Study|Other Miscellaneous Reasons|0|||
94395060|NCT01963728|323232245|FG000|Overall Study|Study terminated early|0|||
94395061|NCT01963728|323232246|FG001|Overall Study|Study terminated early|1|||
94395062|NCT00467896|323233975|FG000|Overall Study|Consent Withdrawal|18|||
94395063|NCT00467896|323233975|FG000|Overall Study|Adverse Event|7|||
94395064|NCT00467896|323233975|FG000|Overall Study|Serious Adverse Event|13|||
94395065|NCT00467896|323233975|FG000|Overall Study|Non-compliance|3|||
94395066|NCT00467896|323233975|FG000|Overall Study|Changed therapy|2|||
94395067|NCT00467896|323233975|FG000|Overall Study|Patient received transplant|2|||
94395068|NCT00467896|323233975|FG000|Overall Study|Patient had atrial septostomy|1|||
94395069|NCT00467896|323233975|FG000|Overall Study|Patient weaned off iloprost|1|||
94395070|NCT00467896|323233975|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
94395071|NCT00467896|323233975|FG000|Overall Study|Started intravenous prostacyclin|1|||
94395072|NCT00467896|323233975|FG000|Overall Study|Started inhaled Remodulin|1|||
94395073|NCT00467896|323233975|FG000|Overall Study|Patient had no improvement|1|||
94395074|NCT00001703|323233976|FG000|Overall Study|progressed disease|2|||
94395075|NCT00001703|323233976|FG000|Overall Study|No evidence of disease|1|||
94395076|NCT00001703|323233976|FG000|Overall Study|recurrent disease|2|||
94395077|NCT00834795|323233979|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
94395078|NCT00834795|323233980|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
94395079|NCT00834795|323233979|FG000|Second Intervention|Adverse Event|1|||
94395080|NCT00834795|323233980|FG001|Second Intervention|Adverse Event|0|||
94395081|NCT03818581|323233981|FG000|Overall Study|Adverse Event|1|||
94395082|NCT03818581|323233982|FG001|Overall Study|Adverse Event|0|||
94395083|NCT03818581|323233983|FG002|Overall Study|Adverse Event|0|||
94395084|NCT03818581|323233984|FG003|Overall Study|Adverse Event|0|||
94395085|NCT03818581|323233985|FG004|Overall Study|Adverse Event|0|||
94395086|NCT03818581|323233981|FG000|Overall Study|Covid-19|2|||
94395087|NCT03818581|323233982|FG001|Overall Study|Covid-19|0|||
94395088|NCT03818581|323233983|FG002|Overall Study|Covid-19|0|||
94395089|NCT03818581|323233984|FG003|Overall Study|Covid-19|0|||
94395090|NCT03818581|323233985|FG004|Overall Study|Covid-19|1|||
94395091|NCT03818581|323233981|FG000|Overall Study|Withdrawal by Subject|0|||
94329109|NCT03927911|322986051|FG001|Overall Study|Protocol Violation|0|||
94329110|NCT03927911|322986052|FG002|Overall Study|Protocol Violation|0|||
94329111|NCT03927911|322986053|FG003|Overall Study|Protocol Violation|0|||
94329112|NCT03927911|322986054|FG004|Overall Study|Protocol Violation|0|||
94329113|NCT03927911|322986055|FG005|Overall Study|Protocol Violation|1|||
94329114|NCT00562640|322986056|FG000|Overall Study|Death|0|||
94329115|NCT00562640|322986057|FG001|Overall Study|Death|1|||
94329116|NCT00562640|322986058|FG002|Overall Study|Death|1|||
94329117|NCT00562640|322986059|FG003|Overall Study|Death|0|||
94329118|NCT05263921|322986060|FG000|Overall Study|Other: family emergency.|0|||
94329119|NCT05263921|322986061|FG001|Overall Study|Other: family emergency.|0|||
94329120|NCT05263921|322986062|FG002|Overall Study|Other: family emergency.|1|||
94329121|NCT05263921|322986063|FG003|Overall Study|Other: family emergency.|0|||
94329122|NCT03073213|322986064|FG000|Multiple Dose Period|Protocol Violation|0|||
94329123|NCT03073213|322986065|FG001|Multiple Dose Period|Protocol Violation|0|||
94329124|NCT03073213|322986066|FG002|Multiple Dose Period|Protocol Violation|1|||
94329125|NCT01357980|322986076|FG000|Overall Study|Lack of Efficacy|0|||
94329126|NCT01357980|322986077|FG001|Overall Study|Lack of Efficacy|1|||
94329127|NCT01357980|322986078|FG002|Overall Study|Lack of Efficacy|0|||
94329128|NCT01357980|322986079|FG003|Overall Study|Lack of Efficacy|0|||
94329129|NCT01357980|322986076|FG000|Overall Study|Consent withdrawn|0|||
94329130|NCT01357980|322986077|FG001|Overall Study|Consent withdrawn|0|||
94329131|NCT01357980|322986078|FG002|Overall Study|Consent withdrawn|1|||
94329132|NCT01357980|322986079|FG003|Overall Study|Consent withdrawn|0|||
94329133|NCT04507776|322986080|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
94329134|NCT00438464|322986088|FG000|Overall Study|Terminated Early|14|||
94329135|NCT00438464|322986089|FG001|Overall Study|Terminated Early|5|||
94329136|NCT00438464|322986088|FG000|Overall Study|Incomplete data submission|0|||
94329137|NCT00438464|322986089|FG001|Overall Study|Incomplete data submission|2|||
94329138|NCT00132314|322986090|FG000|Overall Study|Lost to Follow-up|70|||
94329139|NCT00132314|322986091|FG001|Overall Study|Lost to Follow-up|62|||
94329140|NCT00132314|322986090|FG000|Overall Study|Lacked SSN|1|||
94329141|NCT00132314|322986091|FG001|Overall Study|Lacked SSN|3|||
94329142|NCT00132314|322986090|FG000|Overall Study|Refused intervention at baseline|2|||
94329143|NCT00132314|322986091|FG001|Overall Study|Refused intervention at baseline|7|||
94329144|NCT02685995|322986092|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
94329145|NCT02685995|322986093|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
94329146|NCT00817206|322986094|FG000|Overall Study|Adverse Event|10|||
94329147|NCT00817206|322986095|FG001|Overall Study|Adverse Event|3|||
94329148|NCT00817206|322986094|FG000|Overall Study|Protocol Violation|0|||
94329149|NCT00817206|322986095|FG001|Overall Study|Protocol Violation|2|||
94329150|NCT00817206|322986094|FG000|Overall Study|Lost to Follow-up|0|||
94329151|NCT00817206|322986095|FG001|Overall Study|Lost to Follow-up|1|||
94329152|NCT00817206|322986094|FG000|Overall Study|Death|2|||
94329153|NCT00817206|322986095|FG001|Overall Study|Death|0|||
94329154|NCT00817206|322986094|FG000|Overall Study|Withdrawal by Subject|7|||
94329155|NCT00817206|322986095|FG001|Overall Study|Withdrawal by Subject|3|||
94329156|NCT00817206|322986094|FG000|Overall Study|Physician Decision|2|||
94329157|NCT00817206|322986095|FG001|Overall Study|Physician Decision|0|||
94329158|NCT02501902|322986096|FG000|Overall Study|Subject Refused Further Follow-up|0|||
94329159|NCT02501902|322986097|FG001|Overall Study|Subject Refused Further Follow-up|0|||
94329160|NCT02501902|322986098|FG002|Overall Study|Subject Refused Further Follow-up|0|||
94329161|NCT02501902|322986099|FG003|Overall Study|Subject Refused Further Follow-up|0|||
94329162|NCT02501902|322986100|FG004|Overall Study|Subject Refused Further Follow-up|0|||
94329163|NCT02501902|322986101|FG005|Overall Study|Subject Refused Further Follow-up|0|||
94329164|NCT02501902|322986102|FG006|Overall Study|Subject Refused Further Follow-up|0|||
94329165|NCT02501902|322986103|FG007|Overall Study|Subject Refused Further Follow-up|1|||
94329166|NCT02501902|322986096|FG000|Overall Study|Study Terminated by Sponsor|0|||
94329167|NCT02501902|322986097|FG001|Overall Study|Study Terminated by Sponsor|3|||
94329168|NCT02501902|322986098|FG002|Overall Study|Study Terminated by Sponsor|0|||
94329169|NCT02501902|322986099|FG003|Overall Study|Study Terminated by Sponsor|1|||
94329170|NCT02501902|322986100|FG004|Overall Study|Study Terminated by Sponsor|1|||
94329171|NCT02501902|322986101|FG005|Overall Study|Study Terminated by Sponsor|0|||
94329172|NCT02501902|322986102|FG006|Overall Study|Study Terminated by Sponsor|2|||
94329173|NCT02501902|322986103|FG007|Overall Study|Study Terminated by Sponsor|4|||
94329174|NCT02501902|322986096|FG000|Overall Study|Death|3|||
94329175|NCT02501902|322986097|FG001|Overall Study|Death|4|||
94329176|NCT02501902|322986098|FG002|Overall Study|Death|4|||
94329177|NCT02501902|322986099|FG003|Overall Study|Death|10|||
94329178|NCT02501902|322986100|FG004|Overall Study|Death|10|||
94329179|NCT02501902|322986101|FG005|Overall Study|Death|11|||
94329180|NCT02501902|322986102|FG006|Overall Study|Death|7|||
94329181|NCT02501902|322986103|FG007|Overall Study|Death|15|||
94329182|NCT01700985|322986104|FG000|Overall Study|Incarcerated|0|||
94329183|NCT01700985|322986105|FG001|Overall Study|Incarcerated|1|||
94329184|NCT01315847|322986110|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
94395092|NCT03818581|323233982|FG001|Overall Study|Withdrawal by Subject|0|||
94395093|NCT03818581|323233983|FG002|Overall Study|Withdrawal by Subject|0|||
94395094|NCT03818581|323233984|FG003|Overall Study|Withdrawal by Subject|0|||
94395095|NCT03818581|323233985|FG004|Overall Study|Withdrawal by Subject|1|||
94395096|NCT03818581|323233981|FG000|Overall Study|No longer met study criteria|0|||
94395097|NCT03818581|323233982|FG001|Overall Study|No longer met study criteria|0|||
94395098|NCT03818581|323233983|FG002|Overall Study|No longer met study criteria|0|||
94395099|NCT03818581|323233984|FG003|Overall Study|No longer met study criteria|0|||
94395100|NCT03818581|323233985|FG004|Overall Study|No longer met study criteria|1|||
94395101|NCT00462345|323233993|FG000|Overall Study|Withdrawal by Subject|2|||
94395102|NCT00462345|323233993|FG000|Overall Study|Did not complete second course|1|||
94395103|NCT00070291|323233996|FG000|Step 1|Withdrawal by Subject|1|||
94395104|NCT00070291|323233996|FG000|Step 1|Adverse Event|1|||
94395105|NCT00070291|323233996|FG000|Step 2|Adverse Event|1|||
94395106|NCT03255733|323233997|FG000|Overall Study|Lost to Follow-up|4|||
94395107|NCT00520130|323233998|FG000|Overall Study|Disease progression on study|4|||
94395108|NCT00520130|323233999|FG001|Overall Study|Disease progression on study|0|||
94395109|NCT00520130|323233998|FG000|Overall Study|Physician Decision|1|||
94395110|NCT00520130|323233999|FG001|Overall Study|Physician Decision|1|||
94395111|NCT02028715|323234002|FG000|Overall Study|Adverse Event|2|||
94395112|NCT02028715|323234003|FG001|Overall Study|Adverse Event|2|||
94395113|NCT02028715|323234002|FG000|Overall Study|Physician Decision|1|||
94395114|NCT02028715|323234003|FG001|Overall Study|Physician Decision|0|||
94395115|NCT02028715|323234002|FG000|Overall Study|Did not complete satisfaction surveys|2|||
94395116|NCT02028715|323234003|FG001|Overall Study|Did not complete satisfaction surveys|2|||
94395117|NCT01435265|323234007|FG000|Overall Study|Lost to Follow-up|0|||
94395118|NCT01435265|323234008|FG001|Overall Study|Lost to Follow-up|1|||
94395119|NCT01900691|323234009|FG000|Overall Study|Death|7|||
94395120|NCT01900691|323234009|FG000|Overall Study|Lost to Follow-up|4|||
94395121|NCT01900691|323234009|FG000|Overall Study|Study Device Not Placed|3|||
94395122|NCT01900691|323234009|FG000|Overall Study|Non study stent placed|2|||
94395123|NCT01900691|323234009|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
94395124|NCT01900691|323234009|FG000|Overall Study|Complete stent migration through digestive tract|1|||
94395125|NCT04089735|323234010|FG000|Overall Study|Adverse Event|1|||
94395126|NCT04089735|323234011|FG001|Overall Study|Adverse Event|0|||
94395127|NCT04089735|323234012|FG002|Overall Study|Adverse Event|1|||
94395128|NCT04089735|323234013|FG003|Overall Study|Adverse Event|1|||
94395129|NCT04089735|323234014|FG004|Overall Study|Adverse Event|0|||
94395130|NCT04089735|323234015|FG005|Overall Study|Adverse Event|0|||
94395131|NCT04089735|323234010|FG000|Overall Study|Physician Decision|0|||
94395132|NCT04089735|323234011|FG001|Overall Study|Physician Decision|3|||
94395133|NCT04089735|323234012|FG002|Overall Study|Physician Decision|0|||
94395134|NCT04089735|323234013|FG003|Overall Study|Physician Decision|0|||
94395135|NCT04089735|323234014|FG004|Overall Study|Physician Decision|0|||
94395136|NCT04089735|323234015|FG005|Overall Study|Physician Decision|0|||
94395137|NCT04089735|323234010|FG000|Overall Study|Withdrawal by Subject|0|||
94395138|NCT04089735|323234011|FG001|Overall Study|Withdrawal by Subject|0|||
94395139|NCT04089735|323234012|FG002|Overall Study|Withdrawal by Subject|1|||
94395140|NCT04089735|323234013|FG003|Overall Study|Withdrawal by Subject|0|||
94395141|NCT04089735|323234014|FG004|Overall Study|Withdrawal by Subject|0|||
94395142|NCT04089735|323234015|FG005|Overall Study|Withdrawal by Subject|0|||
94395143|NCT04089735|323234010|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
94395144|NCT04089735|323234011|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
94395145|NCT04089735|323234012|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
94395146|NCT04089735|323234013|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
94395147|NCT04089735|323234014|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
94395148|NCT04089735|323234015|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
94395149|NCT00519194|323234016|FG000|Overall Study|Withdrawal by Subject|9|||
94395150|NCT00519194|323234016|FG000|Overall Study|Death|9|||
94395151|NCT00519194|323234016|FG000|Overall Study|Lost to Follow-up|3|||
94395152|NCT03165994|323234017|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
94395153|NCT03165994|323234017|FG000|Overall Study|Death|2|||
94395154|NCT03165994|323234017|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
94395155|NCT03165994|323234017|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
94395156|NCT03165994|323234017|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
94395157|NCT03165994|323234017|FG000|Overall Study|Miscellaneous|1|||
94395158|NCT02736721|323234018|FG000|Overall Study|Adverse Event|8|||
94395159|NCT02736721|323234018|FG000|Overall Study|Lost to Follow-up|3|||
94395160|NCT02736721|323234018|FG000|Overall Study|Other|5|||
94395161|NCT02422264|323234019|FG000|Overall Study|Serious Adverse Event|1|||
94484504|NCT01791595|323567513|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
94395162|NCT02422264|323234020|FG001|Overall Study|Serious Adverse Event|0|||
94395163|NCT02422264|323234019|FG000|Overall Study|Withdrawal by Subject|1|||
94395164|NCT02422264|323234020|FG001|Overall Study|Withdrawal by Subject|2|||
94395165|NCT02422264|323234019|FG000|Overall Study|Migrated/moved from study area|3|||
94395166|NCT02422264|323234020|FG001|Overall Study|Migrated/moved from study area|1|||
94395167|NCT02422264|323234019|FG000|Overall Study|Subject vaccinated outside of the study|0|||
94395168|NCT02422264|323234020|FG001|Overall Study|Subject vaccinated outside of the study|1|||
94395169|NCT01439880|323234025|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
94395170|NCT01439880|323234026|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
94395171|NCT01439880|323234025|FG000|SOC-controlled Period (Year 1)|Death|2|||
94395172|NCT01439880|323234026|FG001|SOC-controlled Period (Year 1)|Death|1|||
94395173|NCT01439880|323234025|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
94395174|NCT01439880|323234026|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
94395175|NCT01439880|323234025|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
94395176|NCT01439880|323234026|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
94395177|NCT01439880|323234025|FG000|SOC-controlled Period (Year 1)|Other|8|||
94395178|NCT01439880|323234026|FG001|SOC-controlled Period (Year 1)|Other|13|||
94395179|NCT01439880|323234025|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
94395180|NCT01439880|323234026|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
94395181|NCT01439880|323234025|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
94395182|NCT01439880|323234026|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
94395183|NCT01439880|323234025|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
94395184|NCT01439880|323234026|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
94395185|NCT01439880|323234025|FG000|All-IP Period (Years 2 to 5)|Death|3|||
94395186|NCT01439880|323234026|FG001|All-IP Period (Years 2 to 5)|Death|13|||
94395187|NCT01439880|323234025|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
94395188|NCT01439880|323234026|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
94395189|NCT01439880|323234025|FG000|All-IP Period (Years 2 to 5)|Other|14|||
94395190|NCT01439880|323234026|FG001|All-IP Period (Years 2 to 5)|Other|31|||
94395191|NCT01439880|323234025|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
94395192|NCT01439880|323234026|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
94395193|NCT00461786|323234030|FG000|Overall Study|Entry Criteria Not Met|2|||
94395194|NCT00461786|323234030|FG000|Overall Study|Inevaluable (Never Treated)|1|||
94395195|NCT00835991|323234031|FG000|First Intervention|Adverse Event|0|||
94395196|NCT00835991|323234032|FG001|First Intervention|Adverse Event|1|||
94395197|NCT00835991|323234031|FG000|Washout|Protocol Violation|0|||
94395198|NCT00835991|323234032|FG001|Washout|Protocol Violation|2|||
94395199|NCT00835991|323234031|FG000|Washout|Withdrawal by Subject|3|||
94395200|NCT00835991|323234032|FG001|Washout|Withdrawal by Subject|1|||
94395201|NCT01111461|323234033|FG000|Overall Study|Adverse Event|32|||
94395202|NCT01111461|323234033|FG000|Overall Study|Participant choice|11|||
94395203|NCT01111461|323234033|FG000|Overall Study|Lost to Follow-up|1|||
94395204|NCT01111461|323234033|FG000|Overall Study|Withdrawal by Subject|1|||
94395205|NCT01111461|323234033|FG000|Overall Study|Other|6|||
94395206|NCT04278560|323234034|FG000|Overall Study|Adverse Event|1|||
94395207|NCT04278560|323234035|FG001|Overall Study|Adverse Event|2|||
94395208|NCT04278560|323234034|FG000|Overall Study|Withdrawal by Subject|0|||
94395209|NCT04278560|323234035|FG001|Overall Study|Withdrawal by Subject|1|||
94395210|NCT00829673|323234036|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
94395211|NCT00829673|323234037|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
94395212|NCT04166630|323234038|FG000|Overall Study|Withdrawal by Subject|0|||
94395213|NCT04166630|323234039|FG001|Overall Study|Withdrawal by Subject|1|||
94395214|NCT02378935|323234040|FG000|Overall Study|Lack of Efficacy|10|||
94395215|NCT02378935|323234041|FG001|Overall Study|Lack of Efficacy|0|||
94395216|NCT02378935|323234042|FG002|Overall Study|Lack of Efficacy|2|||
94395217|NCT02378935|323234043|FG003|Overall Study|Lack of Efficacy|6|||
94395218|NCT02378935|323234044|FG004|Overall Study|Lack of Efficacy|0|||
94395219|NCT02378935|323234045|FG005|Overall Study|Lack of Efficacy|0|||
94395220|NCT02378935|323234046|FG006|Overall Study|Lack of Efficacy|0|||
94395221|NCT02378935|323234040|FG000|Overall Study|Death|0|||
94395222|NCT02378935|323234041|FG001|Overall Study|Death|0|||
94395223|NCT02378935|323234042|FG002|Overall Study|Death|1|||
94395224|NCT02378935|323234043|FG003|Overall Study|Death|0|||
94395225|NCT02378935|323234044|FG004|Overall Study|Death|0|||
94395226|NCT02378935|323234045|FG005|Overall Study|Death|0|||
94395227|NCT02378935|323234046|FG006|Overall Study|Death|0|||
94395228|NCT03935880|323234049|FG000|Overall Study|Lost to Follow-up|0|||
94395229|NCT03935880|323234050|FG001|Overall Study|Lost to Follow-up|1|||
94395230|NCT01534663|323234051|FG000|Overall Study|Lost to Follow-up|0|||
94395231|NCT01534663|323234052|FG001|Overall Study|Lost to Follow-up|2|||
94395232|NCT01534663|323234051|FG000|Overall Study|Adverse Event|2|||
94395233|NCT01534663|323234052|FG001|Overall Study|Adverse Event|1|||
94395234|NCT02646124|323234053|FG000|Overall Study|Lost to Follow-up|0|||
94395235|NCT02646124|323234054|FG001|Overall Study|Lost to Follow-up|2|||
94395236|NCT01796171|323234058|FG000|Enrolled|Death|0|||
94395237|NCT01796171|323234059|FG001|Enrolled|Death|0|||
94484505|NCT01791595|323567507|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
94395238|NCT01796171|323234060|FG002|Enrolled|Death|0|||
94395239|NCT01796171|323234061|FG003|Enrolled|Death|0|||
94395240|NCT01796171|323234062|FG004|Enrolled|Death|0|||
94395241|NCT01796171|323234063|FG005|Enrolled|Death|0|||
94395242|NCT01796171|323234064|FG006|Enrolled|Death|0|||
94395243|NCT01796171|323234065|FG007|Enrolled|Death|0|||
94395244|NCT01796171|323234066|FG008|Enrolled|Death|0|||
94395245|NCT01796171|323234067|FG009|Enrolled|Death|0|||
94395246|NCT01796171|323234068|FG010|Enrolled|Death|0|||
94395247|NCT01796171|323234069|FG011|Enrolled|Death|0|||
94395248|NCT01796171|323234070|FG012|Enrolled|Death|0|||
94395249|NCT01796171|323234071|FG013|Enrolled|Death|0|||
94395250|NCT01796171|323234072|FG014|Enrolled|Death|1|||
94395251|NCT01796171|323234058|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
94395252|NCT01796171|323234059|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
94395253|NCT01796171|323234060|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
94395254|NCT01796171|323234061|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
94395255|NCT01796171|323234062|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
94395256|NCT01796171|323234063|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
94395257|NCT01796171|323234064|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
94395258|NCT01796171|323234065|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
94395259|NCT01796171|323234066|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
94395260|NCT01796171|323234067|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
94395261|NCT01796171|323234068|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
94395262|NCT01796171|323234069|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
94395263|NCT01796171|323234070|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
94395264|NCT01796171|323234071|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
94395265|NCT01796171|323234072|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
94395266|NCT01796171|323234058|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
94395267|NCT01796171|323234059|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
94395268|NCT01796171|323234060|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
94395269|NCT01796171|323234061|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
94395270|NCT01796171|323234062|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
94395271|NCT01796171|323234063|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
94395272|NCT01796171|323234064|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
94395273|NCT01796171|323234065|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
94395274|NCT01796171|323234066|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
94395275|NCT01796171|323234067|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
94395276|NCT01796171|323234068|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
94395277|NCT01796171|323234069|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
94395278|NCT01796171|323234070|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
94395279|NCT01796171|323234071|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
94395280|NCT01796171|323234072|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
94395281|NCT01796171|323234058|FG000|Treatment Period With Betalutin|Progressive disease|0|||
94395282|NCT01796171|323234059|FG001|Treatment Period With Betalutin|Progressive disease|1|||
94395283|NCT01796171|323234060|FG002|Treatment Period With Betalutin|Progressive disease|0|||
94395284|NCT01796171|323234061|FG003|Treatment Period With Betalutin|Progressive disease|0|||
94395285|NCT01796171|323234062|FG004|Treatment Period With Betalutin|Progressive disease|0|||
94395286|NCT01796171|323234063|FG005|Treatment Period With Betalutin|Progressive disease|0|||
94395287|NCT01796171|323234064|FG006|Treatment Period With Betalutin|Progressive disease|0|||
94395288|NCT01796171|323234065|FG007|Treatment Period With Betalutin|Progressive disease|0|||
94395289|NCT01796171|323234066|FG008|Treatment Period With Betalutin|Progressive disease|0|||
94395290|NCT01796171|323234067|FG009|Treatment Period With Betalutin|Progressive disease|0|||
94395291|NCT01796171|323234068|FG010|Treatment Period With Betalutin|Progressive disease|0|||
94395292|NCT01796171|323234069|FG011|Treatment Period With Betalutin|Progressive disease|0|||
94395293|NCT01796171|323234070|FG012|Treatment Period With Betalutin|Progressive disease|0|||
94395294|NCT01796171|323234071|FG013|Treatment Period With Betalutin|Progressive disease|0|||
94395295|NCT01796171|323234072|FG014|Treatment Period With Betalutin|Progressive disease|0|||
94395296|NCT01796171|323234058|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
94395297|NCT01796171|323234059|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
94395298|NCT01796171|323234060|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
94395299|NCT01796171|323234061|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
94395300|NCT01796171|323234062|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
94395301|NCT01796171|323234063|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
94395302|NCT01796171|323234064|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
94395303|NCT01796171|323234065|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
94395304|NCT01796171|323234066|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
94395305|NCT01796171|323234067|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
94395306|NCT01796171|323234068|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
94395307|NCT01796171|323234069|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
94395308|NCT01796171|323234070|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
94395309|NCT01796171|323234071|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
94395310|NCT01796171|323234072|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
94395311|NCT01796171|323234058|FG000|Treatment Period With Betalutin|Physician Decision|0|||
94395312|NCT01796171|323234059|FG001|Treatment Period With Betalutin|Physician Decision|0|||
94395313|NCT01796171|323234060|FG002|Treatment Period With Betalutin|Physician Decision|0|||
94395314|NCT01796171|323234061|FG003|Treatment Period With Betalutin|Physician Decision|0|||
94395315|NCT01796171|323234062|FG004|Treatment Period With Betalutin|Physician Decision|0|||
94395316|NCT01796171|323234063|FG005|Treatment Period With Betalutin|Physician Decision|0|||
94395317|NCT01796171|323234064|FG006|Treatment Period With Betalutin|Physician Decision|0|||
94395318|NCT01796171|323234065|FG007|Treatment Period With Betalutin|Physician Decision|0|||
94395319|NCT01796171|323234066|FG008|Treatment Period With Betalutin|Physician Decision|0|||
94395320|NCT01796171|323234067|FG009|Treatment Period With Betalutin|Physician Decision|0|||
94395321|NCT01796171|323234068|FG010|Treatment Period With Betalutin|Physician Decision|5|||
94395322|NCT01796171|323234069|FG011|Treatment Period With Betalutin|Physician Decision|1|||
94395323|NCT01796171|323234070|FG012|Treatment Period With Betalutin|Physician Decision|1|||
94395324|NCT01796171|323234071|FG013|Treatment Period With Betalutin|Physician Decision|0|||
94395325|NCT01796171|323234072|FG014|Treatment Period With Betalutin|Physician Decision|0|||
94395326|NCT01796171|323234058|FG000|Treatment Period With Betalutin|Death|0|||
94395327|NCT01796171|323234059|FG001|Treatment Period With Betalutin|Death|0|||
94395328|NCT01796171|323234060|FG002|Treatment Period With Betalutin|Death|0|||
94395329|NCT01796171|323234061|FG003|Treatment Period With Betalutin|Death|0|||
94395330|NCT01796171|323234062|FG004|Treatment Period With Betalutin|Death|0|||
94395331|NCT01796171|323234063|FG005|Treatment Period With Betalutin|Death|0|||
94395332|NCT01796171|323234064|FG006|Treatment Period With Betalutin|Death|0|||
94395333|NCT01796171|323234065|FG007|Treatment Period With Betalutin|Death|0|||
94395334|NCT01796171|323234066|FG008|Treatment Period With Betalutin|Death|0|||
94395335|NCT01796171|323234067|FG009|Treatment Period With Betalutin|Death|0|||
94395336|NCT01796171|323234068|FG010|Treatment Period With Betalutin|Death|2|||
94395337|NCT01796171|323234069|FG011|Treatment Period With Betalutin|Death|0|||
94395338|NCT01796171|323234070|FG012|Treatment Period With Betalutin|Death|0|||
94395339|NCT01796171|323234071|FG013|Treatment Period With Betalutin|Death|0|||
94395340|NCT01796171|323234072|FG014|Treatment Period With Betalutin|Death|0|||
94395341|NCT01796171|323234058|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
94395342|NCT01796171|323234059|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
94395343|NCT01796171|323234060|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
94395344|NCT01796171|323234061|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
94395345|NCT01796171|323234062|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
94395346|NCT01796171|323234063|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
94395347|NCT01796171|323234064|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
94395348|NCT01796171|323234065|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
94395349|NCT01796171|323234066|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
94395350|NCT01796171|323234067|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
94395351|NCT01796171|323234068|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
94395352|NCT01796171|323234069|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
94395353|NCT01796171|323234070|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
94395354|NCT01796171|323234071|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
94395355|NCT01796171|323234072|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
94395356|NCT01796171|323234058|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
94395357|NCT01796171|323234059|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
94395358|NCT01796171|323234060|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
94395359|NCT01796171|323234061|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
94395360|NCT01796171|323234062|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
94395361|NCT01796171|323234063|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
94395362|NCT01796171|323234064|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
94395363|NCT01796171|323234065|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
94395364|NCT01796171|323234066|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
94395365|NCT01796171|323234067|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
94395366|NCT01796171|323234068|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
94395367|NCT01796171|323234069|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
94395368|NCT01796171|323234070|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
94395369|NCT01796171|323234071|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
94395370|NCT01796171|323234072|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
94395371|NCT01796171|323234058|FG000|Follow-up Period|Start of further anticancer therapy|4|||
94395372|NCT01796171|323234059|FG001|Follow-up Period|Start of further anticancer therapy|25|||
94395373|NCT01796171|323234060|FG002|Follow-up Period|Start of further anticancer therapy|2|||
94395374|NCT01796171|323234061|FG003|Follow-up Period|Start of further anticancer therapy|1|||
94395375|NCT01796171|323234062|FG004|Follow-up Period|Start of further anticancer therapy|2|||
94395376|NCT01796171|323234063|FG005|Follow-up Period|Start of further anticancer therapy|2|||
94484506|NCT01791595|323567508|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
94484507|NCT01791595|323567509|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
94484508|NCT01791595|323567510|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
94484509|NCT01791595|323567511|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
94484510|NCT01791595|323567512|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
94484511|NCT01791595|323567513|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
94484512|NCT01791595|323567507|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
94484513|NCT01791595|323567508|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
94484514|NCT01791595|323567509|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
94484515|NCT01791595|323567510|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
94484516|NCT01791595|323567511|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
94395377|NCT01796171|323234064|FG006|Follow-up Period|Start of further anticancer therapy|1|||
94395378|NCT01796171|323234065|FG007|Follow-up Period|Start of further anticancer therapy|15|||
94395379|NCT01796171|323234066|FG008|Follow-up Period|Start of further anticancer therapy|2|||
94395380|NCT01796171|323234067|FG009|Follow-up Period|Start of further anticancer therapy|0|||
94395381|NCT01796171|323234068|FG010|Follow-up Period|Start of further anticancer therapy|0|||
94395382|NCT01796171|323234069|FG011|Follow-up Period|Start of further anticancer therapy|0|||
94395383|NCT01796171|323234070|FG012|Follow-up Period|Start of further anticancer therapy|0|||
94395384|NCT01796171|323234071|FG013|Follow-up Period|Start of further anticancer therapy|0|||
94395385|NCT01796171|323234072|FG014|Follow-up Period|Start of further anticancer therapy|0|||
94395386|NCT01796171|323234058|FG000|Follow-up Period|Progressive disease|0|||
94395387|NCT01796171|323234059|FG001|Follow-up Period|Progressive disease|1|||
94395388|NCT01796171|323234060|FG002|Follow-up Period|Progressive disease|0|||
94395389|NCT01796171|323234061|FG003|Follow-up Period|Progressive disease|0|||
94395390|NCT01796171|323234062|FG004|Follow-up Period|Progressive disease|0|||
94395391|NCT01796171|323234063|FG005|Follow-up Period|Progressive disease|0|||
94395392|NCT01796171|323234064|FG006|Follow-up Period|Progressive disease|0|||
94395393|NCT01796171|323234065|FG007|Follow-up Period|Progressive disease|3|||
94395394|NCT01796171|323234066|FG008|Follow-up Period|Progressive disease|0|||
94395395|NCT01796171|323234067|FG009|Follow-up Period|Progressive disease|0|||
94395396|NCT01796171|323234068|FG010|Follow-up Period|Progressive disease|0|||
94395397|NCT01796171|323234069|FG011|Follow-up Period|Progressive disease|0|||
94395398|NCT01796171|323234070|FG012|Follow-up Period|Progressive disease|0|||
94395399|NCT01796171|323234071|FG013|Follow-up Period|Progressive disease|0|||
94395400|NCT01796171|323234072|FG014|Follow-up Period|Progressive disease|0|||
94395401|NCT01796171|323234058|FG000|Follow-up Period|Physician Decision|0|||
94395402|NCT01796171|323234059|FG001|Follow-up Period|Physician Decision|2|||
94395403|NCT01796171|323234060|FG002|Follow-up Period|Physician Decision|0|||
94395404|NCT01796171|323234061|FG003|Follow-up Period|Physician Decision|0|||
94395405|NCT01796171|323234062|FG004|Follow-up Period|Physician Decision|0|||
94395406|NCT01796171|323234063|FG005|Follow-up Period|Physician Decision|0|||
94395407|NCT01796171|323234064|FG006|Follow-up Period|Physician Decision|0|||
94395408|NCT01796171|323234065|FG007|Follow-up Period|Physician Decision|0|||
94395409|NCT01796171|323234066|FG008|Follow-up Period|Physician Decision|0|||
94395410|NCT01796171|323234067|FG009|Follow-up Period|Physician Decision|0|||
94395411|NCT01796171|323234068|FG010|Follow-up Period|Physician Decision|5|||
94395412|NCT01796171|323234069|FG011|Follow-up Period|Physician Decision|0|||
94395413|NCT01796171|323234070|FG012|Follow-up Period|Physician Decision|0|||
94395414|NCT01796171|323234071|FG013|Follow-up Period|Physician Decision|0|||
94395415|NCT01796171|323234072|FG014|Follow-up Period|Physician Decision|0|||
94395416|NCT01796171|323234058|FG000|Follow-up Period|Withdrawal by Subject|0|||
94484517|NCT01791595|323567512|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
94484518|NCT01791595|323567513|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
94484519|NCT01791595|323567507|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
94329185|NCT01315847|322986111|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
94329186|NCT01315847|322986110|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
94329187|NCT01315847|322986111|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
94329188|NCT02270684|322986112|FG000|Overall Study|Lost to Follow-up|0|||
94329189|NCT02270684|322986113|FG001|Overall Study|Lost to Follow-up|3|||
94329190|NCT02270684|322986112|FG000|Overall Study|Study terminated|1|||
94329191|NCT02270684|322986113|FG001|Overall Study|Study terminated|0|||
94329192|NCT00772382|322986114|FG000|Overall Study|Adverse Event|19|||
94329193|NCT00772382|322986114|FG000|Overall Study|Death|6|||
94329194|NCT00772382|322986114|FG000|Overall Study|Lack of Efficacy|4|||
94329195|NCT00772382|322986114|FG000|Overall Study|Physician Decision|5|||
94329196|NCT00772382|322986114|FG000|Overall Study|Protocol Violation|1|||
94329197|NCT00772382|322986114|FG000|Overall Study|Withdrawal by Subject|10|||
94329198|NCT00772382|322986114|FG000|Overall Study|Other Reasons|10|||
94329199|NCT03695393|322986118|FG000|Overall Study|Death|3|||
94329200|NCT03695393|322986119|FG001|Overall Study|Death|1|||
94329201|NCT03695393|322986118|FG000|Overall Study|Lost to Follow-up|0|||
94395417|NCT01796171|323234059|FG001|Follow-up Period|Withdrawal by Subject|1|||
94395418|NCT01796171|323234060|FG002|Follow-up Period|Withdrawal by Subject|0|||
94395419|NCT01796171|323234061|FG003|Follow-up Period|Withdrawal by Subject|0|||
94395420|NCT01796171|323234062|FG004|Follow-up Period|Withdrawal by Subject|0|||
94395421|NCT01796171|323234063|FG005|Follow-up Period|Withdrawal by Subject|1|||
94395422|NCT01796171|323234064|FG006|Follow-up Period|Withdrawal by Subject|0|||
94395423|NCT01796171|323234065|FG007|Follow-up Period|Withdrawal by Subject|0|||
94395424|NCT01796171|323234066|FG008|Follow-up Period|Withdrawal by Subject|0|||
94395425|NCT01796171|323234067|FG009|Follow-up Period|Withdrawal by Subject|0|||
94395426|NCT01796171|323234068|FG010|Follow-up Period|Withdrawal by Subject|3|||
94395427|NCT01796171|323234069|FG011|Follow-up Period|Withdrawal by Subject|1|||
94395428|NCT01796171|323234070|FG012|Follow-up Period|Withdrawal by Subject|0|||
94395429|NCT01796171|323234071|FG013|Follow-up Period|Withdrawal by Subject|0|||
94395430|NCT01796171|323234072|FG014|Follow-up Period|Withdrawal by Subject|0|||
94395431|NCT01796171|323234058|FG000|Follow-up Period|Death|0|||
94395432|NCT01796171|323234059|FG001|Follow-up Period|Death|0|||
94395433|NCT01796171|323234060|FG002|Follow-up Period|Death|0|||
94395434|NCT01796171|323234061|FG003|Follow-up Period|Death|0|||
94395435|NCT01796171|323234062|FG004|Follow-up Period|Death|0|||
94395436|NCT01796171|323234063|FG005|Follow-up Period|Death|0|||
94395437|NCT01796171|323234064|FG006|Follow-up Period|Death|1|||
94395438|NCT01796171|323234065|FG007|Follow-up Period|Death|0|||
94395439|NCT01796171|323234066|FG008|Follow-up Period|Death|0|||
94395440|NCT01796171|323234067|FG009|Follow-up Period|Death|0|||
94395441|NCT01796171|323234068|FG010|Follow-up Period|Death|17|||
94395442|NCT01796171|323234069|FG011|Follow-up Period|Death|9|||
94395443|NCT01796171|323234070|FG012|Follow-up Period|Death|1|||
94395444|NCT01796171|323234071|FG013|Follow-up Period|Death|0|||
94395445|NCT01796171|323234072|FG014|Follow-up Period|Death|0|||
94395446|NCT01796171|323234058|FG000|Follow-up Period|Patient transferred to other hospital|0|||
94395447|NCT01796171|323234059|FG001|Follow-up Period|Patient transferred to other hospital|1|||
94395448|NCT01796171|323234060|FG002|Follow-up Period|Patient transferred to other hospital|0|||
94395449|NCT01796171|323234061|FG003|Follow-up Period|Patient transferred to other hospital|0|||
94395450|NCT01796171|323234062|FG004|Follow-up Period|Patient transferred to other hospital|0|||
94395451|NCT01796171|323234063|FG005|Follow-up Period|Patient transferred to other hospital|0|||
94395452|NCT01796171|323234064|FG006|Follow-up Period|Patient transferred to other hospital|0|||
94395453|NCT01796171|323234065|FG007|Follow-up Period|Patient transferred to other hospital|0|||
94395454|NCT01796171|323234066|FG008|Follow-up Period|Patient transferred to other hospital|0|||
94395455|NCT01796171|323234067|FG009|Follow-up Period|Patient transferred to other hospital|0|||
94395456|NCT01796171|323234068|FG010|Follow-up Period|Patient transferred to other hospital|0|||
94395457|NCT01796171|323234069|FG011|Follow-up Period|Patient transferred to other hospital|0|||
94395458|NCT01796171|323234070|FG012|Follow-up Period|Patient transferred to other hospital|0|||
94395459|NCT01796171|323234071|FG013|Follow-up Period|Patient transferred to other hospital|0|||
94395460|NCT01796171|323234072|FG014|Follow-up Period|Patient transferred to other hospital|0|||
94395461|NCT01796171|323234058|FG000|Follow-up Period|Sponsor Decision|0|||
94395462|NCT01796171|323234059|FG001|Follow-up Period|Sponsor Decision|0|||
94395463|NCT01796171|323234060|FG002|Follow-up Period|Sponsor Decision|0|||
94395464|NCT01796171|323234061|FG003|Follow-up Period|Sponsor Decision|0|||
94395465|NCT01796171|323234062|FG004|Follow-up Period|Sponsor Decision|0|||
94395466|NCT01796171|323234063|FG005|Follow-up Period|Sponsor Decision|0|||
94395467|NCT01796171|323234064|FG006|Follow-up Period|Sponsor Decision|0|||
94395468|NCT01796171|323234065|FG007|Follow-up Period|Sponsor Decision|0|||
94395469|NCT01796171|323234066|FG008|Follow-up Period|Sponsor Decision|0|||
94395470|NCT01796171|323234067|FG009|Follow-up Period|Sponsor Decision|0|||
94395471|NCT01796171|323234068|FG010|Follow-up Period|Sponsor Decision|40|||
94395472|NCT01796171|323234069|FG011|Follow-up Period|Sponsor Decision|15|||
94395473|NCT01796171|323234070|FG012|Follow-up Period|Sponsor Decision|7|||
94395474|NCT01796171|323234071|FG013|Follow-up Period|Sponsor Decision|0|||
94395475|NCT01796171|323234072|FG014|Follow-up Period|Sponsor Decision|0|||
94395476|NCT00455312|323234073|FG000|Overall Study|Death|0|||
94395477|NCT00455312|323234074|FG001|Overall Study|Death|1|||
94395478|NCT01693523|323234077|FG000|Overall Study|Adverse Event|2|||
94395479|NCT01693523|323234078|FG001|Overall Study|Adverse Event|1|||
94395480|NCT01693523|323234079|FG002|Overall Study|Adverse Event|0|||
94395481|NCT01693523|323234077|FG000|Overall Study|Death|0|||
94395482|NCT01693523|323234078|FG001|Overall Study|Death|1|||
94395483|NCT01693523|323234079|FG002|Overall Study|Death|1|||
94395484|NCT01693523|323234077|FG000|Overall Study|Lost to Follow-up|0|||
94395485|NCT01693523|323234078|FG001|Overall Study|Lost to Follow-up|0|||
94395486|NCT01693523|323234079|FG002|Overall Study|Lost to Follow-up|4|||
94395487|NCT01693523|323234077|FG000|Overall Study|Physician Decision|0|||
94395488|NCT01693523|323234078|FG001|Overall Study|Physician Decision|0|||
94395489|NCT01693523|323234079|FG002|Overall Study|Physician Decision|1|||
94395490|NCT01693523|323234077|FG000|Overall Study|Withdrawal by Subject|1|||
94395491|NCT01693523|323234078|FG001|Overall Study|Withdrawal by Subject|2|||
94395492|NCT01693523|323234079|FG002|Overall Study|Withdrawal by Subject|2|||
94395493|NCT01693523|323234077|FG000|Overall Study|Lack of compliance study medication|1|||
94395494|NCT01693523|323234078|FG001|Overall Study|Lack of compliance study medication|2|||
94395495|NCT01693523|323234079|FG002|Overall Study|Lack of compliance study medication|0|||
94395496|NCT01693523|323234077|FG000|Overall Study|Chemotherapy was held|1|||
94395497|NCT01693523|323234078|FG001|Overall Study|Chemotherapy was held|2|||
94395498|NCT01693523|323234079|FG002|Overall Study|Chemotherapy was held|0|||
94395499|NCT03343535|323234080|FG000|Overall Study|Lost to Follow-up|1|||
94395500|NCT03343535|323234080|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
94395501|NCT03343535|323234080|FG000|Overall Study|Death|12|||
94395502|NCT00777023|323234081|FG000|Overall Study|Adverse Event|15|||
94395503|NCT00777023|323234082|FG001|Overall Study|Adverse Event|21|||
94395504|NCT00777023|323234083|FG002|Overall Study|Adverse Event|8|||
94395505|NCT00777023|323234081|FG000|Overall Study|Lack of Efficacy|1|||
94395506|NCT00777023|323234082|FG001|Overall Study|Lack of Efficacy|0|||
94395507|NCT00777023|323234083|FG002|Overall Study|Lack of Efficacy|14|||
94395508|NCT00777023|323234081|FG000|Overall Study|Protocol Violation|2|||
94395509|NCT00777023|323234082|FG001|Overall Study|Protocol Violation|1|||
94395510|NCT00777023|323234083|FG002|Overall Study|Protocol Violation|1|||
94395511|NCT00777023|323234081|FG000|Overall Study|Lost to Follow-up|2|||
94395512|NCT00777023|323234082|FG001|Overall Study|Lost to Follow-up|3|||
94395513|NCT00777023|323234083|FG002|Overall Study|Lost to Follow-up|3|||
94395514|NCT00777023|323234081|FG000|Overall Study|Death|0|||
94395515|NCT00777023|323234082|FG001|Overall Study|Death|1|||
94395516|NCT00777023|323234083|FG002|Overall Study|Death|0|||
94395517|NCT00777023|323234081|FG000|Overall Study|Withdrawal by Subject|7|||
94395518|NCT00777023|323234082|FG001|Overall Study|Withdrawal by Subject|7|||
94395519|NCT00777023|323234083|FG002|Overall Study|Withdrawal by Subject|8|||
94395520|NCT00777023|323234081|FG000|Overall Study|Missing data|1|||
94395521|NCT00777023|323234082|FG001|Overall Study|Missing data|1|||
94395522|NCT00777023|323234083|FG002|Overall Study|Missing data|0|||
94395523|NCT00777023|323234081|FG000|Overall Study|Reasons not specified|4|||
94395524|NCT00777023|323234082|FG001|Overall Study|Reasons not specified|4|||
94395525|NCT00777023|323234083|FG002|Overall Study|Reasons not specified|2|||
94395526|NCT00777023|323234081|FG000|Overall Study|Last dose date unknown|3|||
94395527|NCT00777023|323234082|FG001|Overall Study|Last dose date unknown|3|||
94395528|NCT00777023|323234083|FG002|Overall Study|Last dose date unknown|1|||
94395529|NCT00604162|323234086|FG000|Overall Study|Physician Decision|3|||
94395530|NCT00604162|323234086|FG000|Overall Study|Withdrawal by Subject|1|||
94395531|NCT02241551|323234087|FG000|Overall Study|Adverse Event|1|||
94395532|NCT02241551|323234088|FG001|Overall Study|Adverse Event|0|||
94395533|NCT00794963|323234093|FG000|Overall Study|Withdrawal by Subject|1|||
94395534|NCT00794963|323234094|FG001|Overall Study|Withdrawal by Subject|4|||
94395535|NCT03181594|323234104|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
94395536|NCT03181594|323234104|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
94395537|NCT03181594|323234104|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
94395538|NCT03181594|323234104|FG000|Initial Study Protocol (12-month FU)|Death|1|||
94395539|NCT03181594|323234104|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
94395540|NCT03181594|323234104|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
94395541|NCT01675765|323234105|FG000|Overall Study|Progressive disease|4|||
94395542|NCT01675765|323234106|FG001|Overall Study|Progressive disease|4|||
94395543|NCT01675765|323234105|FG000|Overall Study|Adverse Event|1|||
94395544|NCT01675765|323234106|FG001|Overall Study|Adverse Event|2|||
94395545|NCT01675765|323234105|FG000|Overall Study|Withdrawal by Subject|2|||
94395546|NCT01675765|323234106|FG001|Overall Study|Withdrawal by Subject|0|||
94395547|NCT01675765|323234105|FG000|Overall Study|Death|1|||
94395548|NCT01675765|323234106|FG001|Overall Study|Death|0|||
94395549|NCT01675765|323234105|FG000|Overall Study|Clinical progression|3|||
94395550|NCT01675765|323234106|FG001|Overall Study|Clinical progression|2|||
94395551|NCT03965091|323234109|FG000|Overall Study|Adverse Event|0|||
94395552|NCT03965091|323234110|FG001|Overall Study|Adverse Event|2|||
94395553|NCT03965091|323234111|FG002|Overall Study|Adverse Event|3|||
94395554|NCT03965091|323234109|FG000|Overall Study|Withdrawal by Subject|11|||
94395555|NCT03965091|323234110|FG001|Overall Study|Withdrawal by Subject|3|||
94395556|NCT03965091|323234111|FG002|Overall Study|Withdrawal by Subject|5|||
94395557|NCT03965091|323234109|FG000|Overall Study|Non-compliance with study drug|0|||
94395558|NCT03965091|323234110|FG001|Overall Study|Non-compliance with study drug|0|||
94395559|NCT03965091|323234111|FG002|Overall Study|Non-compliance with study drug|1|||
94395560|NCT03965091|323234109|FG000|Overall Study|Lost to Follow-up|1|||
94395561|NCT03965091|323234110|FG001|Overall Study|Lost to Follow-up|1|||
94395562|NCT03965091|323234111|FG002|Overall Study|Lost to Follow-up|1|||
94395563|NCT03965091|323234109|FG000|Overall Study|Lack of Efficacy|2|||
94395564|NCT03965091|323234110|FG001|Overall Study|Lack of Efficacy|0|||
94395565|NCT03965091|323234111|FG002|Overall Study|Lack of Efficacy|0|||
94395566|NCT03965091|323234109|FG000|Overall Study|Other than specified|9|||
94395567|NCT03965091|323234110|FG001|Overall Study|Other than specified|11|||
94395568|NCT03965091|323234111|FG002|Overall Study|Other than specified|8|||
94395569|NCT00968812|323234115|FG000|Overall Study|Adverse Event|30|||
94395570|NCT00968812|323234116|FG001|Overall Study|Adverse Event|46|||
94395571|NCT00968812|323234117|FG002|Overall Study|Adverse Event|33|||
94395572|NCT00968812|323234115|FG000|Overall Study|Death|2|||
94484520|NCT01791595|323567508|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
94484521|NCT01791595|323567509|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
94484522|NCT01791595|323567510|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
94329202|NCT03695393|322986119|FG001|Overall Study|Lost to Follow-up|1|||
94329203|NCT01582971|322986120|FG000|Overall Study|Death|2|||
94329204|NCT01582971|322986121|FG001|Overall Study|Death|1|||
94329205|NCT01582971|322986120|FG000|Overall Study|Lost to Follow-up|18|||
94329206|NCT01582971|322986121|FG001|Overall Study|Lost to Follow-up|21|||
94329207|NCT01582971|322986120|FG000|Overall Study|Withdrawal by Subject|4|||
94329208|NCT01582971|322986121|FG001|Overall Study|Withdrawal by Subject|2|||
94329209|NCT01582971|322986120|FG000|Overall Study|Other|15|||
94329210|NCT01582971|322986121|FG001|Overall Study|Other|13|||
94329211|NCT02007954|322986122|FG000|Overall Study|Received liver transplant|3|||
94329212|NCT02007954|322986122|FG000|Overall Study|Switch in treatment modality|2|||
94329213|NCT02007954|322986122|FG000|Overall Study|Disease progression and unrelated AE|1|||
94329214|NCT02007954|322986122|FG000|Overall Study|Death|1|||
94329215|NCT04585451|322986126|FG000|Overall Study|Withdrawal by Subject|26|||
94329216|NCT04585451|322986127|FG001|Overall Study|Withdrawal by Subject|0|||
94329217|NCT00673894|322986128|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
94329218|NCT00673894|322986129|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
94329219|NCT00673894|322986128|FG000|First Intervention 4 Weeks|Adverse Event|1|||
94329220|NCT00673894|322986129|FG001|First Intervention 4 Weeks|Adverse Event|0|||
94329221|NCT00326417|322986130|FG000|Overall Study|Withdrawal by Subject|0|||
94329222|NCT00326417|322986131|FG001|Overall Study|Withdrawal by Subject|0|||
94329223|NCT00326417|322986132|FG002|Overall Study|Withdrawal by Subject|1|||
94329224|NCT00326417|322986133|FG003|Overall Study|Withdrawal by Subject|0|||
94329225|NCT00326417|322986130|FG000|Overall Study|Arm Closed|7|||
94329226|NCT00326417|322986131|FG001|Overall Study|Arm Closed|0|||
94329227|NCT00326417|322986132|FG002|Overall Study|Arm Closed|0|||
94329228|NCT00326417|322986133|FG003|Overall Study|Arm Closed|3|||
94329229|NCT00326417|322986130|FG000|Overall Study|Death|7|||
94329230|NCT00326417|322986131|FG001|Overall Study|Death|0|||
94329231|NCT00326417|322986132|FG002|Overall Study|Death|0|||
94329232|NCT00326417|322986133|FG003|Overall Study|Death|0|||
94329233|NCT01164865|322986137|FG000|Overall Study|Lost to Follow-up|2|||
94329234|NCT01164865|322986138|FG001|Overall Study|Lost to Follow-up|1|||
94329235|NCT04682353|322986142|FG000|Overall Study|Lost to Follow-up|0|||
94329236|NCT04682353|322986143|FG001|Overall Study|Lost to Follow-up|1|||
94329237|NCT04682353|322986144|FG002|Overall Study|Lost to Follow-up|0|||
94329238|NCT04682353|322986145|FG003|Overall Study|Lost to Follow-up|1|||
94329239|NCT04682353|322986142|FG000|Overall Study|Personal reasons|0|||
94329240|NCT04682353|322986143|FG001|Overall Study|Personal reasons|1|||
94329241|NCT04682353|322986144|FG002|Overall Study|Personal reasons|0|||
94329242|NCT04682353|322986145|FG003|Overall Study|Personal reasons|0|||
94329243|NCT00476996|322986148|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
94329244|NCT00476996|322986149|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
94329245|NCT00476996|322986150|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
94329246|NCT00476996|322986151|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
94329247|NCT00476996|322986148|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
94329248|NCT00476996|322986149|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
94329249|NCT00476996|322986150|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
94329250|NCT00476996|322986151|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
94329251|NCT00476996|322986148|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
94329252|NCT00476996|322986149|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
94329253|NCT00476996|322986150|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
94329254|NCT00476996|322986151|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
94329255|NCT00476996|322986148|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
94329256|NCT00476996|322986149|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
94329257|NCT00476996|322986150|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
94329258|NCT00476996|322986151|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
94329259|NCT00476996|322986148|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
94329260|NCT00476996|322986149|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
94329261|NCT00476996|322986150|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
94329262|NCT00476996|322986151|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
94329263|NCT00476996|322986148|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
94329264|NCT00476996|322986149|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
94329265|NCT00476996|322986150|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
94329266|NCT00476996|322986151|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
94329267|NCT00476996|322986148|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
94329268|NCT00476996|322986149|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
94329269|NCT00476996|322986150|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
94329270|NCT00476996|322986151|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
94395573|NCT00968812|323234116|FG001|Overall Study|Death|2|||
94395574|NCT00968812|323234117|FG002|Overall Study|Death|1|||
94395575|NCT00968812|323234115|FG000|Overall Study|Lack of Efficacy|9|||
94395576|NCT00968812|323234116|FG001|Overall Study|Lack of Efficacy|7|||
94395577|NCT00968812|323234117|FG002|Overall Study|Lack of Efficacy|16|||
94395578|NCT00968812|323234115|FG000|Overall Study|Lost to Follow-up|17|||
94395579|NCT00968812|323234116|FG001|Overall Study|Lost to Follow-up|12|||
94395580|NCT00968812|323234117|FG002|Overall Study|Lost to Follow-up|11|||
94395581|NCT00968812|323234115|FG000|Overall Study|Physician Decision|8|||
94395582|NCT00968812|323234116|FG001|Overall Study|Physician Decision|5|||
94395583|NCT00968812|323234117|FG002|Overall Study|Physician Decision|9|||
94395584|NCT00968812|323234115|FG000|Overall Study|Protocol Violation|7|||
94395585|NCT00968812|323234116|FG001|Overall Study|Protocol Violation|4|||
94395586|NCT00968812|323234117|FG002|Overall Study|Protocol Violation|3|||
94395587|NCT00968812|323234115|FG000|Overall Study|Withdrawal by Subject|17|||
94395588|NCT00968812|323234116|FG001|Overall Study|Withdrawal by Subject|23|||
94395589|NCT00968812|323234117|FG002|Overall Study|Withdrawal by Subject|25|||
94395590|NCT00968812|323234115|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
94395591|NCT00968812|323234116|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
94395592|NCT00968812|323234117|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
94395593|NCT00968812|323234115|FG000|Overall Study|Noncompliance with study drug|4|||
94395594|NCT00968812|323234116|FG001|Overall Study|Noncompliance with study drug|1|||
94395595|NCT00968812|323234117|FG002|Overall Study|Noncompliance with study drug|6|||
94395596|NCT00968812|323234115|FG000|Overall Study|Unable to take rescue therapy|12|||
94395597|NCT00968812|323234116|FG001|Overall Study|Unable to take rescue therapy|12|||
94395598|NCT00968812|323234117|FG002|Overall Study|Unable to take rescue therapy|17|||
94395599|NCT00968812|323234115|FG000|Overall Study|Other|25|||
94395600|NCT00968812|323234116|FG001|Overall Study|Other|37|||
94395601|NCT00968812|323234117|FG002|Overall Study|Other|40|||
94395602|NCT00834340|323234121|FG000|Washout|Adverse Event|1|||
94395603|NCT00834340|323234122|FG001|Washout|Adverse Event|0|||
94395604|NCT00834340|323234121|FG000|Washout|Withdrawal by Subject|1|||
94395605|NCT00834340|323234122|FG001|Washout|Withdrawal by Subject|0|||
94395606|NCT01648582|323234123|FG000|Overall Study|Adverse Event|6|||
94395607|NCT01648582|323234124|FG001|Overall Study|Adverse Event|11|||
94395608|NCT01648582|323234125|FG002|Overall Study|Adverse Event|2|||
94395609|NCT01648582|323234123|FG000|Overall Study|Lost to Follow-up|9|||
94395610|NCT01648582|323234124|FG001|Overall Study|Lost to Follow-up|6|||
94395611|NCT01648582|323234125|FG002|Overall Study|Lost to Follow-up|8|||
94395612|NCT01648582|323234123|FG000|Overall Study|Protocol Violation|1|||
94395613|NCT01648582|323234124|FG001|Overall Study|Protocol Violation|2|||
94395614|NCT01648582|323234125|FG002|Overall Study|Protocol Violation|1|||
94395615|NCT01648582|323234123|FG000|Overall Study|Withdrawal by Subject|15|||
94395616|NCT01648582|323234124|FG001|Overall Study|Withdrawal by Subject|17|||
94395617|NCT01648582|323234125|FG002|Overall Study|Withdrawal by Subject|17|||
94395618|NCT01648582|323234123|FG000|Overall Study|Physician Decision|0|||
94395619|NCT01648582|323234124|FG001|Overall Study|Physician Decision|1|||
94395620|NCT01648582|323234125|FG002|Overall Study|Physician Decision|3|||
94395621|NCT01648582|323234123|FG000|Overall Study|Death|1|||
94395622|NCT01648582|323234124|FG001|Overall Study|Death|0|||
94395623|NCT01648582|323234125|FG002|Overall Study|Death|0|||
94395624|NCT01648582|323234123|FG000|Overall Study|Sponsor Decision|0|||
94395625|NCT01648582|323234124|FG001|Overall Study|Sponsor Decision|1|||
94395626|NCT01648582|323234125|FG002|Overall Study|Sponsor Decision|1|||
94395627|NCT00640562|323234126|FG000|Overall Study|Adverse Event|8|||
94395628|NCT00640562|323234127|FG001|Overall Study|Adverse Event|5|||
94395629|NCT00640562|323234126|FG000|Overall Study|Lack of Efficacy|1|||
94395630|NCT00640562|323234127|FG001|Overall Study|Lack of Efficacy|4|||
94395631|NCT00640562|323234126|FG000|Overall Study|Protocol Violation|2|||
94395632|NCT00640562|323234127|FG001|Overall Study|Protocol Violation|4|||
94395633|NCT00640562|323234126|FG000|Overall Study|Withdrawal by Subject|6|||
94395634|NCT00640562|323234127|FG001|Overall Study|Withdrawal by Subject|10|||
94395635|NCT00640562|323234126|FG000|Overall Study|Known risperidone intolerance|0|||
94395636|NCT00640562|323234127|FG001|Overall Study|Known risperidone intolerance|1|||
94395637|NCT00640562|323234126|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
94395638|NCT00640562|323234127|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
94395639|NCT00640562|323234126|FG000|Overall Study|Low study drug dose|0|||
94395640|NCT00640562|323234127|FG001|Overall Study|Low study drug dose|1|||
94395641|NCT00640562|323234126|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
94395642|NCT00640562|323234127|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
94395643|NCT00448591|323234128|FG000|Overall Study|Withdrawal by Subject|178|||
94395644|NCT00448591|323234128|FG000|Overall Study|Progressive Disease|1382|||
94395645|NCT00448591|323234128|FG000|Overall Study|Adverse Event|382|||
94395646|NCT00448591|323234128|FG000|Overall Study|Protocol Violation|41|||
94395647|NCT00448591|323234128|FG000|Overall Study|Lost to Follow-up|19|||
94395648|NCT00448591|323234128|FG000|Overall Study|Treatment Regimen Completed|70|||
94395649|NCT00448591|323234128|FG000|Overall Study|Other|154|||
94395650|NCT00448591|323234128|FG000|Overall Study|Termination of Study|70|||
94395651|NCT02849457|323234129|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
94395652|NCT02849457|323234130|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
94395653|NCT02849457|323234131|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
94395654|NCT02849457|323234132|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
94395655|NCT01136174|323234135|FG000|Overall Study|Adverse Event|0|||
94395656|NCT01136174|323234136|FG001|Overall Study|Adverse Event|0|||
94395657|NCT01136174|323234137|FG002|Overall Study|Adverse Event|0|||
94395658|NCT01136174|323234138|FG003|Overall Study|Adverse Event|4|||
94395659|NCT01249651|323234139|FG000|Overall Study|Withdrawal by Subject|4|||
94395660|NCT01249651|323234139|FG000|Overall Study|Adverse Event|1|||
94395661|NCT01249651|323234139|FG000|Overall Study|Protocol Violation|1|||
94395662|NCT01249651|323234139|FG000|Overall Study|Sponsor Decision|1|||
94395663|NCT02554890|323234144|FG000|Double-blind|Adverse Event|45|||
94395664|NCT02554890|323234145|FG001|Double-blind|Adverse Event|51|||
94395665|NCT02554890|323234144|FG000|Double-blind|Death|6|||
94395666|NCT02554890|323234145|FG001|Double-blind|Death|4|||
94395667|NCT02554890|323234144|FG000|Double-blind|Protocol Violation|1|||
94395668|NCT02554890|323234145|FG001|Double-blind|Protocol Violation|1|||
94395669|NCT02554890|323234144|FG000|Double-blind|Physician Decision|4|||
94395670|NCT02554890|323234145|FG001|Double-blind|Physician Decision|3|||
94395671|NCT02554890|323234144|FG000|Double-blind|Subject/Guardian decision|21|||
94395672|NCT02554890|323234145|FG001|Double-blind|Subject/Guardian decision|16|||
94395673|NCT02554890|323234144|FG000|Double-blind|Lost to Follow-up|7|||
94395674|NCT02554890|323234145|FG001|Double-blind|Lost to Follow-up|5|||
94395675|NCT02554890|323234144|FG000|Double-blind|Technical problems|1|||
94395676|NCT02554890|323234145|FG001|Double-blind|Technical problems|0|||
94395677|NCT02554890|323234144|FG000|Double-blind|Withdrawal by Subject|5|||
94395678|NCT02554890|323234145|FG001|Double-blind|Withdrawal by Subject|6|||
94395679|NCT02554890|323234144|FG000|Double-blind|Noncompliance with study treatment|6|||
94395680|NCT02554890|323234145|FG001|Double-blind|Noncompliance with study treatment|5|||
94395681|NCT02554890|323234144|FG000|Open-label|Adverse Event|0|||
94395682|NCT02554890|323234145|FG001|Open-label|Adverse Event|30|||
94395683|NCT02554890|323234144|FG000|Open-label|Death|0|||
94395684|NCT02554890|323234145|FG001|Open-label|Death|1|||
94395685|NCT02554890|323234144|FG000|Open-label|Physician Decision|0|||
94395686|NCT02554890|323234145|FG001|Open-label|Physician Decision|1|||
94395687|NCT02554890|323234144|FG000|Open-label|Subject/Guardian decision|0|||
94395688|NCT02554890|323234145|FG001|Open-label|Subject/Guardian decision|11|||
94395689|NCT02554890|323234144|FG000|Open-label|Lost to Follow-up|0|||
94395690|NCT02554890|323234145|FG001|Open-label|Lost to Follow-up|7|||
94395691|NCT02554890|323234144|FG000|Open-label|Technical problems|0|||
94395692|NCT02554890|323234145|FG001|Open-label|Technical problems|1|||
94395693|NCT02554890|323234144|FG000|Open-label|Withdrawal by Subject|0|||
94395694|NCT02554890|323234145|FG001|Open-label|Withdrawal by Subject|1|||
94395695|NCT02392195|323236475|FG000|Overall Study|Lost to Follow-up|4|||
94395696|NCT02392195|323236475|FG000|Overall Study|Withdrawal by Subject|4|||
94395697|NCT04408794|323236478|FG000|Overall Study|Adverse Event|43|||
94395698|NCT04408794|323236478|FG000|Overall Study|Infrequent study drug usage|43|||
94395699|NCT04408794|323236478|FG000|Overall Study|Lack of Efficacy|61|||
94395700|NCT04408794|323236478|FG000|Overall Study|Lost to Follow-up|33|||
94395701|NCT04408794|323236478|FG000|Overall Study|Non-compliance|6|||
94395702|NCT04408794|323236478|FG000|Overall Study|Physician Decision|1|||
94395703|NCT04408794|323236478|FG000|Overall Study|Pregnancy|6|||
94395704|NCT04408794|323236478|FG000|Overall Study|Protocol Deviation|9|||
94395705|NCT04408794|323236478|FG000|Overall Study|Sheehan-STS Result|1|||
94395706|NCT04408794|323236478|FG000|Overall Study|Withdrawal by Subject|57|||
94395707|NCT04408794|323236478|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
94395708|NCT04408794|323236478|FG000|Overall Study|Never Treated Migraine|5|||
94395709|NCT03679598|323236481|FG000|Overall Study|Adverse Event|2|||
94395710|NCT03679598|323236482|FG001|Overall Study|Adverse Event|0|||
94395711|NCT01518972|323236483|FG000|Overall Study|Lost to Follow-up|2|||
94395712|NCT01518972|323236484|FG001|Overall Study|Lost to Follow-up|1|||
94395713|NCT01518972|323236483|FG000|Overall Study|Withdrawal by Subject|1|||
94395714|NCT01518972|323236484|FG001|Overall Study|Withdrawal by Subject|0|||
94395715|NCT01518972|323236483|FG000|Overall Study|Moved from area|1|||
94484523|NCT01791595|323567511|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
94395716|NCT01518972|323236484|FG001|Overall Study|Moved from area|0|||
94395717|NCT01518972|323236483|FG000|Overall Study|Transportation problems|1|||
94484524|NCT01791595|323567512|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
94395718|NCT01518972|323236484|FG001|Overall Study|Transportation problems|0|||
94395719|NCT01518972|323236483|FG000|Overall Study|Exclusionary medical condition|1|||
94395720|NCT01518972|323236484|FG001|Overall Study|Exclusionary medical condition|0|||
94395721|NCT01518972|323236483|FG000|Overall Study|Missed safety visits|0|||
94395722|NCT01518972|323236484|FG001|Overall Study|Missed safety visits|1|||
94395723|NCT01518972|323236483|FG000|Overall Study|Exclusionary medication|0|||
94329271|NCT00476996|322986148|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
94329272|NCT00476996|322986149|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
94329273|NCT00476996|322986150|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
94329274|NCT00476996|322986151|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
94329275|NCT00476996|322986148|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
94329276|NCT00476996|322986149|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
94329277|NCT00476996|322986150|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
94329278|NCT00476996|322986151|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
94329279|NCT00476996|322986148|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
94329280|NCT00476996|322986149|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
94329281|NCT00476996|322986150|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
94329282|NCT00476996|322986151|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
94329283|NCT00476996|322986148|FG000|OLE Phase (From Week 48)|Death|0|||
94329284|NCT00476996|322986149|FG001|OLE Phase (From Week 48)|Death|0|||
94329285|NCT00476996|322986150|FG002|OLE Phase (From Week 48)|Death|0|||
94329286|NCT00476996|322986151|FG003|OLE Phase (From Week 48)|Death|7|||
94329287|NCT00476996|322986148|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
94329288|NCT00476996|322986149|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
94329289|NCT00476996|322986150|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
94329290|NCT00476996|322986151|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
94329291|NCT00476996|322986148|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
94329292|NCT00476996|322986149|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
94329293|NCT00476996|322986150|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
94329294|NCT00476996|322986151|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
94329295|NCT00476996|322986148|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
94329296|NCT00476996|322986149|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
94329297|NCT00476996|322986150|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
94329298|NCT00476996|322986151|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
94329299|NCT00476996|322986148|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
94329300|NCT00476996|322986149|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
94329301|NCT00476996|322986150|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
94329302|NCT00476996|322986151|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
94329303|NCT00862654|322986152|FG000|Overall Study|Lack of Efficacy|1|||
94329304|NCT00862654|322986153|FG001|Overall Study|Lack of Efficacy|0|||
94329305|NCT00862654|322986154|FG002|Overall Study|Lack of Efficacy|1|||
94329306|NCT00862654|322986155|FG003|Overall Study|Lack of Efficacy|0|||
94329307|NCT00862654|322986152|FG000|Overall Study|Lost to Follow-up|1|||
94329308|NCT00862654|322986153|FG001|Overall Study|Lost to Follow-up|2|||
94329309|NCT00862654|322986154|FG002|Overall Study|Lost to Follow-up|1|||
94329310|NCT00862654|322986155|FG003|Overall Study|Lost to Follow-up|3|||
94329311|NCT00862654|322986152|FG000|Overall Study|Adverse Event|0|||
94329312|NCT00862654|322986153|FG001|Overall Study|Adverse Event|1|||
94329313|NCT00862654|322986154|FG002|Overall Study|Adverse Event|1|||
94329314|NCT00862654|322986155|FG003|Overall Study|Adverse Event|0|||
94329315|NCT00862654|322986152|FG000|Overall Study|Pregnancy|1|||
94329316|NCT00862654|322986153|FG001|Overall Study|Pregnancy|1|||
94329317|NCT00862654|322986154|FG002|Overall Study|Pregnancy|0|||
94329318|NCT00862654|322986155|FG003|Overall Study|Pregnancy|0|||
94329319|NCT00862654|322986152|FG000|Overall Study|Withdrawal by Subject|2|||
94329320|NCT00862654|322986153|FG001|Overall Study|Withdrawal by Subject|2|||
94329321|NCT00862654|322986154|FG002|Overall Study|Withdrawal by Subject|2|||
94329322|NCT00862654|322986155|FG003|Overall Study|Withdrawal by Subject|3|||
94329323|NCT00862654|322986152|FG000|Overall Study|Subject mistake|0|||
94329324|NCT00862654|322986153|FG001|Overall Study|Subject mistake|1|||
94329325|NCT00862654|322986154|FG002|Overall Study|Subject mistake|0|||
94329326|NCT00862654|322986155|FG003|Overall Study|Subject mistake|0|||
94329327|NCT00862654|322986152|FG000|Overall Study|Familly constraint|0|||
94329328|NCT00862654|322986153|FG001|Overall Study|Familly constraint|1|||
94329329|NCT00862654|322986154|FG002|Overall Study|Familly constraint|0|||
94329330|NCT00862654|322986155|FG003|Overall Study|Familly constraint|0|||
94329331|NCT00862654|322986152|FG000|Overall Study|Never used study drugs|1|||
94329332|NCT00862654|322986153|FG001|Overall Study|Never used study drugs|0|||
94329333|NCT00862654|322986154|FG002|Overall Study|Never used study drugs|0|||
94329334|NCT00862654|322986155|FG003|Overall Study|Never used study drugs|0|||
94329335|NCT00862654|322986152|FG000|Overall Study|Included after end of inclusions|0|||
94329336|NCT00862654|322986153|FG001|Overall Study|Included after end of inclusions|0|||
94329337|NCT00862654|322986154|FG002|Overall Study|Included after end of inclusions|1|||
94329338|NCT00862654|322986155|FG003|Overall Study|Included after end of inclusions|0|||
94329339|NCT00889681|322986161|FG000|Overall Study|Not meeting qualification Criteria|2|||
94329340|NCT00889681|322986161|FG000|Overall Study|Insurance disapproval|1|||
94329341|NCT01957787|322986167|FG000|Overall Study|Death|18|||
94329342|NCT01957787|322986167|FG000|Overall Study|Lost to Follow-up|3|||
94329343|NCT01957787|322986167|FG000|Overall Study|Withdrawal by Subject|3|||
94329344|NCT01957787|322986167|FG000|Overall Study|Entered Hospice or Similar Program|2|||
94329345|NCT01957787|322986167|FG000|Overall Study|Index Tumor(s) Resected|2|||
94395724|NCT01518972|323236484|FG001|Overall Study|Exclusionary medication|1|||
94395725|NCT01518972|323236483|FG000|Overall Study|Declined medication starting on day 12|0|||
94395726|NCT01518972|323236484|FG001|Overall Study|Declined medication starting on day 12|1|||
94395727|NCT00835263|323236487|FG000|Second Intervention|Adverse Event|1|||
94395728|NCT00835263|323236488|FG001|Second Intervention|Adverse Event|0|||
94395729|NCT00466167|323236489|FG000|Overall Study|Adverse Event|8|||
94395730|NCT00466167|323236490|FG001|Overall Study|Adverse Event|8|||
94395731|NCT00466167|323236491|FG002|Overall Study|Adverse Event|7|||
94395732|NCT00466167|323236489|FG000|Overall Study|Lack of Efficacy|2|||
94395733|NCT00466167|323236490|FG001|Overall Study|Lack of Efficacy|0|||
94395734|NCT00466167|323236491|FG002|Overall Study|Lack of Efficacy|3|||
94395735|NCT00466167|323236489|FG000|Overall Study|Protocol Violation|1|||
94395736|NCT00466167|323236490|FG001|Overall Study|Protocol Violation|1|||
94395737|NCT00466167|323236491|FG002|Overall Study|Protocol Violation|2|||
94395738|NCT00466167|323236489|FG000|Overall Study|Lost to Follow-up|3|||
94395739|NCT00466167|323236490|FG001|Overall Study|Lost to Follow-up|2|||
94395740|NCT00466167|323236491|FG002|Overall Study|Lost to Follow-up|2|||
94395741|NCT00466167|323236489|FG000|Overall Study|Withdrawal by Subject|4|||
94395742|NCT00466167|323236490|FG001|Overall Study|Withdrawal by Subject|1|||
94395743|NCT00466167|323236491|FG002|Overall Study|Withdrawal by Subject|6|||
94395744|NCT00466167|323236489|FG000|Overall Study|patient did not meet inclusion criteria|1|||
94395745|NCT00466167|323236490|FG001|Overall Study|patient did not meet inclusion criteria|0|||
94395746|NCT00466167|323236491|FG002|Overall Study|patient did not meet inclusion criteria|1|||
94395747|NCT00466167|323236489|FG000|Overall Study|Not treated|1|||
94395748|NCT00466167|323236490|FG001|Overall Study|Not treated|0|||
94395749|NCT00466167|323236491|FG002|Overall Study|Not treated|0|||
94395750|NCT02964039|323236492|FG000|Overall Study|Medical reason unrelated to study participation|1|||
94395751|NCT02964039|323236493|FG001|Overall Study|Medical reason unrelated to study participation|0|||
94395752|NCT02964039|323236494|FG002|Overall Study|Medical reason unrelated to study participation|3|||
94395753|NCT02964039|323236492|FG000|Overall Study|Research shutdown due to pandemic|2|||
94395754|NCT02964039|323236493|FG001|Overall Study|Research shutdown due to pandemic|0|||
94395755|NCT02964039|323236494|FG002|Overall Study|Research shutdown due to pandemic|1|||
94395756|NCT02964039|323236492|FG000|Overall Study|Withdrawal by Subject|0|||
94395757|NCT02964039|323236493|FG001|Overall Study|Withdrawal by Subject|1|||
94395758|NCT02964039|323236494|FG002|Overall Study|Withdrawal by Subject|0|||
94395759|NCT02964039|323236492|FG000|Overall Study|Lost to Follow-up|1|||
94395760|NCT02964039|323236493|FG001|Overall Study|Lost to Follow-up|0|||
94395761|NCT02964039|323236494|FG002|Overall Study|Lost to Follow-up|1|||
94395762|NCT01370733|323236495|FG000|Overall Study|Withdrawal by Subject|8|||
94395763|NCT01370733|323236496|FG001|Overall Study|Withdrawal by Subject|8|||
94395764|NCT01370733|323236495|FG000|Overall Study|Lost to Follow-up|3|||
94395765|NCT01370733|323236496|FG001|Overall Study|Lost to Follow-up|0|||
94395766|NCT01370733|323236495|FG000|Overall Study|Adverse Event|2|||
94395767|NCT01370733|323236496|FG001|Overall Study|Adverse Event|4|||
94395768|NCT01370733|323236495|FG000|Overall Study|Lack of Efficacy|3|||
94395769|NCT01370733|323236496|FG001|Overall Study|Lack of Efficacy|5|||
94395770|NCT01370733|323236495|FG000|Overall Study|Physician Decision|0|||
94395771|NCT01370733|323236496|FG001|Overall Study|Physician Decision|2|||
94395772|NCT01370733|323236495|FG000|Overall Study|Protocol Violation|1|||
94395773|NCT01370733|323236496|FG001|Overall Study|Protocol Violation|3|||
94395774|NCT01188681|323236497|FG000|Overall Study|bladder cancer|0|||
94395775|NCT01188681|323236498|FG001|Overall Study|bladder cancer|0|||
94395776|NCT01188681|323236499|FG002|Overall Study|bladder cancer|1|||
94395777|NCT01188681|323236500|FG003|Overall Study|bladder cancer|0|||
94484525|NCT01791595|323567513|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
94484526|NCT01791595|323567507|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
94484527|NCT01791595|323567508|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
94484528|NCT01791595|323567509|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
94484529|NCT01791595|323567510|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
94484530|NCT01791595|323567511|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
94484531|NCT01791595|323567512|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
94484532|NCT01791595|323567513|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
94484533|NCT01791595|323567507|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
94484534|NCT01791595|323567508|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
94484535|NCT01791595|323567509|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
94484536|NCT01791595|323567510|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
94484537|NCT01791595|323567511|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
94484538|NCT01791595|323567512|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
94484539|NCT01791595|323567513|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
94395778|NCT01188681|323236497|FG000|Overall Study|Withdrawal by Subject|0|||
94395779|NCT01188681|323236498|FG001|Overall Study|Withdrawal by Subject|0|||
94395780|NCT01188681|323236499|FG002|Overall Study|Withdrawal by Subject|0|||
94395781|NCT01188681|323236500|FG003|Overall Study|Withdrawal by Subject|1|||
94395782|NCT03419403|323236501|FG000|Overall Study|Withdrawal by Subject|5|||
94395783|NCT03419403|323236502|FG001|Overall Study|Withdrawal by Subject|2|||
94395784|NCT03419403|323236503|FG002|Overall Study|Withdrawal by Subject|5|||
94395785|NCT03419403|323236504|FG003|Overall Study|Withdrawal by Subject|1|||
94395786|NCT03419403|323236501|FG000|Overall Study|Progressive disease (per protocol)|0|||
94395787|NCT03419403|323236502|FG001|Overall Study|Progressive disease (per protocol)|2|||
94395788|NCT03419403|323236503|FG002|Overall Study|Progressive disease (per protocol)|2|||
94395789|NCT03419403|323236504|FG003|Overall Study|Progressive disease (per protocol)|0|||
94395790|NCT03419403|323236501|FG000|Overall Study|Other, not specified|6|||
94395791|NCT03419403|323236502|FG001|Overall Study|Other, not specified|4|||
94395792|NCT03419403|323236503|FG002|Overall Study|Other, not specified|5|||
94395793|NCT03419403|323236504|FG003|Overall Study|Other, not specified|1|||
94395794|NCT03419403|323236501|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
94395795|NCT03419403|323236502|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
94484540|NCT01791595|323567507|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
94484541|NCT01791595|323567508|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
94484542|NCT01791595|323567509|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
94484543|NCT01791595|323567510|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
94484544|NCT01791595|323567511|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
94484545|NCT01791595|323567512|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
94484546|NCT01791595|323567513|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
94484547|NCT01791595|323567507|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
94484548|NCT01791595|323567508|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
94484549|NCT01791595|323567509|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
94484550|NCT01791595|323567510|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
94395796|NCT03419403|323236503|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
94395797|NCT03419403|323236504|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
94395798|NCT02089685|323236507|FG000|Overall Study|Adverse Event|1|||
94395799|NCT02089685|323236508|FG001|Overall Study|Adverse Event|0|||
94395800|NCT02089685|323236509|FG002|Overall Study|Adverse Event|0|||
94395801|NCT02089685|323236510|FG003|Overall Study|Adverse Event|0|||
94395802|NCT02089685|323236511|FG004|Overall Study|Adverse Event|1|||
94395803|NCT02089685|323236512|FG005|Overall Study|Adverse Event|0|||
94395804|NCT02089685|323236507|FG000|Overall Study|Clinical Progression|4|||
94395805|NCT02089685|323236508|FG001|Overall Study|Clinical Progression|0|||
94395806|NCT02089685|323236509|FG002|Overall Study|Clinical Progression|0|||
94395807|NCT02089685|323236510|FG003|Overall Study|Clinical Progression|5|||
94395808|NCT02089685|323236511|FG004|Overall Study|Clinical Progression|1|||
94395809|NCT02089685|323236512|FG005|Overall Study|Clinical Progression|2|||
94395810|NCT02089685|323236507|FG000|Overall Study|Excluded Medication|1|||
94395811|NCT02089685|323236508|FG001|Overall Study|Excluded Medication|0|||
94395812|NCT02089685|323236509|FG002|Overall Study|Excluded Medication|0|||
94395813|NCT02089685|323236510|FG003|Overall Study|Excluded Medication|11|||
94395814|NCT02089685|323236511|FG004|Overall Study|Excluded Medication|2|||
94395815|NCT02089685|323236512|FG005|Overall Study|Excluded Medication|1|||
94395816|NCT02089685|323236507|FG000|Overall Study|Progressive disease|13|||
94395817|NCT02089685|323236508|FG001|Overall Study|Progressive disease|10|||
94395818|NCT02089685|323236509|FG002|Overall Study|Progressive disease|3|||
94395819|NCT02089685|323236510|FG003|Overall Study|Progressive disease|51|||
94395820|NCT02089685|323236511|FG004|Overall Study|Progressive disease|17|||
94395821|NCT02089685|323236512|FG005|Overall Study|Progressive disease|12|||
94395822|NCT02089685|323236507|FG000|Overall Study|Follow up ended by sponsor|2|||
94395823|NCT02089685|323236508|FG001|Overall Study|Follow up ended by sponsor|2|||
94395824|NCT02089685|323236509|FG002|Overall Study|Follow up ended by sponsor|0|||
94395825|NCT02089685|323236510|FG003|Overall Study|Follow up ended by sponsor|70|||
94395826|NCT02089685|323236511|FG004|Overall Study|Follow up ended by sponsor|26|||
94395827|NCT02089685|323236512|FG005|Overall Study|Follow up ended by sponsor|26|||
94395828|NCT02089685|323236507|FG000|Overall Study|Withdrawal by Subject|0|||
94395829|NCT02089685|323236508|FG001|Overall Study|Withdrawal by Subject|2|||
94395830|NCT02089685|323236509|FG002|Overall Study|Withdrawal by Subject|0|||
94395831|NCT02089685|323236510|FG003|Overall Study|Withdrawal by Subject|8|||
94395832|NCT02089685|323236511|FG004|Overall Study|Withdrawal by Subject|1|||
94395833|NCT02089685|323236512|FG005|Overall Study|Withdrawal by Subject|1|||
94395834|NCT02089685|323236507|FG000|Overall Study|Status not recorded|1|||
94395835|NCT02089685|323236508|FG001|Overall Study|Status not recorded|0|||
94395836|NCT02089685|323236509|FG002|Overall Study|Status not recorded|0|||
94395837|NCT02089685|323236510|FG003|Overall Study|Status not recorded|0|||
94484551|NCT01791595|323567511|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
94395838|NCT02089685|323236511|FG004|Overall Study|Status not recorded|1|||
94484552|NCT01791595|323567512|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
94395839|NCT02089685|323236512|FG005|Overall Study|Status not recorded|0|||
94395840|NCT02089685|323236507|FG000|Overall Study|Death|0|||
94395841|NCT02089685|323236508|FG001|Overall Study|Death|0|||
94395842|NCT02089685|323236509|FG002|Overall Study|Death|0|||
94395843|NCT02089685|323236510|FG003|Overall Study|Death|7|||
94395844|NCT02089685|323236511|FG004|Overall Study|Death|2|||
94395845|NCT02089685|323236512|FG005|Overall Study|Death|5|||
94395846|NCT02089685|323236507|FG000|Overall Study|Lost to Follow-up|0|||
94395847|NCT02089685|323236508|FG001|Overall Study|Lost to Follow-up|0|||
94395848|NCT02089685|323236509|FG002|Overall Study|Lost to Follow-up|0|||
94395849|NCT02089685|323236510|FG003|Overall Study|Lost to Follow-up|1|||
94395850|NCT02089685|323236511|FG004|Overall Study|Lost to Follow-up|0|||
94395851|NCT02089685|323236512|FG005|Overall Study|Lost to Follow-up|0|||
94395852|NCT02089685|323236507|FG000|Overall Study|Physician Decision|0|||
94395853|NCT02089685|323236508|FG001|Overall Study|Physician Decision|0|||
94395854|NCT02089685|323236509|FG002|Overall Study|Physician Decision|0|||
94395855|NCT02089685|323236510|FG003|Overall Study|Physician Decision|0|||
94395856|NCT02089685|323236511|FG004|Overall Study|Physician Decision|0|||
94395857|NCT02089685|323236512|FG005|Overall Study|Physician Decision|4|||
94395858|NCT02089685|323236507|FG000|Overall Study|Screen failure|1|||
94395859|NCT02089685|323236508|FG001|Overall Study|Screen failure|0|||
94395860|NCT02089685|323236509|FG002|Overall Study|Screen failure|0|||
94395861|NCT02089685|323236510|FG003|Overall Study|Screen failure|0|||
94395862|NCT02089685|323236511|FG004|Overall Study|Screen failure|0|||
94395863|NCT02089685|323236512|FG005|Overall Study|Screen failure|0|||
94395864|NCT02890992|323236513|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
94395865|NCT02890992|323236514|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
94395866|NCT02890992|323236515|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
94395867|NCT02890992|323236516|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
94395868|NCT02890992|323236517|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
94395869|NCT02890992|323236518|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
94395870|NCT02890992|323236519|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
94395871|NCT02890992|323236520|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
94395872|NCT02890992|323236513|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
94395873|NCT02890992|323236514|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
94395874|NCT02890992|323236515|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
94395875|NCT02890992|323236516|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
94395876|NCT02890992|323236517|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
94395877|NCT02890992|323236518|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
94395878|NCT02890992|323236519|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
94395879|NCT02890992|323236520|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
94395880|NCT02890992|323236513|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
94395881|NCT02890992|323236514|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
94395882|NCT02890992|323236515|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
94395883|NCT02890992|323236516|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
94395884|NCT02890992|323236517|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
94395885|NCT02890992|323236518|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
94395886|NCT02890992|323236519|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
94395887|NCT02890992|323236520|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
94395888|NCT03236311|323236521|FG000|Overall Study|Study terminated by sponsor|0|||
94395889|NCT03236311|323236522|FG001|Overall Study|Study terminated by sponsor|2|||
94395890|NCT03236311|323236521|FG000|Overall Study|Adverse Event|0|||
94395891|NCT03236311|323236522|FG001|Overall Study|Adverse Event|1|||
94395892|NCT00505622|323236525|FG000|Overall Study|Adverse Event|5|||
94395893|NCT00505622|323236526|FG001|Overall Study|Adverse Event|6|||
94395894|NCT00505622|323236527|FG002|Overall Study|Adverse Event|4|||
94395895|NCT00505622|323236525|FG000|Overall Study|Protocol Violation|1|||
94395896|NCT00505622|323236526|FG001|Overall Study|Protocol Violation|1|||
94395897|NCT00505622|323236527|FG002|Overall Study|Protocol Violation|0|||
94395898|NCT00505622|323236525|FG000|Overall Study|Withdrawal by Subject|0|||
94395899|NCT00505622|323236526|FG001|Overall Study|Withdrawal by Subject|3|||
94395900|NCT00505622|323236527|FG002|Overall Study|Withdrawal by Subject|2|||
94395901|NCT00505622|323236525|FG000|Overall Study|Study termination by sponsor|115|||
94395902|NCT00505622|323236526|FG001|Overall Study|Study termination by sponsor|98|||
94395903|NCT00505622|323236527|FG002|Overall Study|Study termination by sponsor|90|||
94395904|NCT03084471|323236528|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
94395905|NCT03084471|323236528|FG000|Overall Study|Condition under investigation worsened|84|||
94395906|NCT03084471|323236528|FG000|Overall Study|Lack of therapeutic response|2|||
94395907|NCT03084471|323236528|FG000|Overall Study|Protocol Violation|1|||
94395908|NCT03084471|323236528|FG000|Overall Study|Adverse Event|73|||
94395909|NCT03084471|323236528|FG000|Overall Study|Withdrawal by Subject|12|||
94395910|NCT03084471|323236528|FG000|Overall Study|Disease relapse|181|||
94395911|NCT03084471|323236528|FG000|Overall Study|Subjective disease progression|359|||
94395912|NCT03084471|323236528|FG000|Overall Study|Other (as recorded)|33|||
94395913|NCT03084471|323236528|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
94395914|NCT00796653|323236529|FG000|Overall Study|Adverse Event|19|||
94395915|NCT00796653|323236530|FG001|Overall Study|Adverse Event|16|||
94484553|NCT01791595|323567513|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
94484554|NCT01791595|323567507|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
94484555|NCT01791595|323567508|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
94484556|NCT01791595|323567509|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
94484557|NCT01791595|323567510|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
94484558|NCT01791595|323567511|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
94395916|NCT00796653|323236531|FG002|Overall Study|Adverse Event|16|||
94395917|NCT00796653|323236532|FG003|Overall Study|Adverse Event|16|||
94395918|NCT00796653|323236529|FG000|Overall Study|Lost to Follow-up|2|||
94395919|NCT00796653|323236530|FG001|Overall Study|Lost to Follow-up|1|||
94395920|NCT00796653|323236531|FG002|Overall Study|Lost to Follow-up|2|||
94395921|NCT00796653|323236532|FG003|Overall Study|Lost to Follow-up|3|||
94395922|NCT00796653|323236529|FG000|Overall Study|Withdrawal by Subject|16|||
94395923|NCT00796653|323236530|FG001|Overall Study|Withdrawal by Subject|8|||
94395924|NCT00796653|323236531|FG002|Overall Study|Withdrawal by Subject|8|||
94395925|NCT00796653|323236532|FG003|Overall Study|Withdrawal by Subject|13|||
94395926|NCT00796653|323236529|FG000|Overall Study|Lack of Efficacy|8|||
94395927|NCT00796653|323236530|FG001|Overall Study|Lack of Efficacy|1|||
94395928|NCT00796653|323236531|FG002|Overall Study|Lack of Efficacy|3|||
94395929|NCT00796653|323236532|FG003|Overall Study|Lack of Efficacy|2|||
94395930|NCT00796653|323236529|FG000|Overall Study|Non compliance with protocol|2|||
94395931|NCT00796653|323236530|FG001|Overall Study|Non compliance with protocol|2|||
94395932|NCT00796653|323236531|FG002|Overall Study|Non compliance with protocol|0|||
94395933|NCT00796653|323236532|FG003|Overall Study|Non compliance with protocol|2|||
94395934|NCT00796653|323236529|FG000|Overall Study|Other reason not described above|4|||
94395935|NCT00796653|323236530|FG001|Overall Study|Other reason not described above|9|||
94395936|NCT00796653|323236531|FG002|Overall Study|Other reason not described above|7|||
94395937|NCT00796653|323236532|FG003|Overall Study|Other reason not described above|4|||
94395938|NCT04608188|323236539|FG000|Overall Study|Withdrawal by Subject|4|||
94395939|NCT04608188|323236540|FG001|Overall Study|Withdrawal by Subject|8|||
94395940|NCT01415986|323236545|FG000|Overall Study|Lost to Follow-up|1|||
94395941|NCT04078022|323236547|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
94395942|NCT04078022|323236548|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
94395943|NCT01075282|323236555|FG000|Overall Study|Withdrawal by Subject|11|||
94395944|NCT01075282|323236556|FG001|Overall Study|Withdrawal by Subject|7|||
94395945|NCT01075282|323236557|FG002|Overall Study|Withdrawal by Subject|11|||
94395946|NCT01075282|323236555|FG000|Overall Study|Adverse Event|9|||
94395947|NCT01075282|323236556|FG001|Overall Study|Adverse Event|8|||
94395948|NCT01075282|323236557|FG002|Overall Study|Adverse Event|5|||
94395949|NCT01075282|323236555|FG000|Overall Study|Entry Criteria Not Met|3|||
94395950|NCT01075282|323236556|FG001|Overall Study|Entry Criteria Not Met|2|||
94395951|NCT01075282|323236557|FG002|Overall Study|Entry Criteria Not Met|0|||
94395952|NCT01075282|323236555|FG000|Overall Study|Lost to Follow-up|3|||
94395953|NCT01075282|323236556|FG001|Overall Study|Lost to Follow-up|3|||
94395954|NCT01075282|323236557|FG002|Overall Study|Lost to Follow-up|3|||
94395955|NCT01075282|323236555|FG000|Overall Study|Physician Decision|3|||
94395956|NCT01075282|323236556|FG001|Overall Study|Physician Decision|3|||
94395957|NCT01075282|323236557|FG002|Overall Study|Physician Decision|3|||
94395958|NCT01075282|323236555|FG000|Overall Study|Lack of Efficacy|1|||
94395959|NCT01075282|323236556|FG001|Overall Study|Lack of Efficacy|1|||
94395960|NCT01075282|323236557|FG002|Overall Study|Lack of Efficacy|0|||
94395961|NCT01075282|323236555|FG000|Overall Study|Treatment Non-compliance|1|||
94395962|NCT01075282|323236556|FG001|Overall Study|Treatment Non-compliance|2|||
94395963|NCT01075282|323236557|FG002|Overall Study|Treatment Non-compliance|2|||
94395964|NCT01075282|323236555|FG000|Overall Study|Protocol Violation|0|||
94395965|NCT01075282|323236556|FG001|Overall Study|Protocol Violation|2|||
94395966|NCT01075282|323236557|FG002|Overall Study|Protocol Violation|1|||
94395967|NCT01075282|323236555|FG000|Overall Study|Death|0|||
94395968|NCT01075282|323236556|FG001|Overall Study|Death|1|||
94395969|NCT01075282|323236557|FG002|Overall Study|Death|2|||
94395970|NCT00185458|323236563|FG000|Contraception Phase|Adverse Event|37|||
94395971|NCT00185458|323236563|FG000|Contraception Phase|Lost to Follow-up|10|||
94395972|NCT00185458|323236563|FG000|Contraception Phase|Protocol Violation|2|||
94395973|NCT00185458|323236563|FG000|Contraception Phase|Physician Decision|2|||
94395974|NCT00185458|323236563|FG000|Contraception Phase|Withdrawal by Subject|7|||
94395975|NCT00185458|323236563|FG000|HRT Phase|Adverse Event|18|||
94395976|NCT00185458|323236563|FG000|HRT Phase|Lost to Follow-up|4|||
94484559|NCT01791595|323567512|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
94395977|NCT00185458|323236563|FG000|HRT Phase|Protocol Violation|2|||
94395978|NCT00185458|323236563|FG000|HRT Phase|Withdrawal by Subject|3|||
94395979|NCT02139826|323236577|FG000|Overall Study|Adverse Event|1|||
94395980|NCT02911701|323236580|FG000|Overall Study|Withdrawal by Subject|2|||
94395981|NCT02911701|323236581|FG001|Overall Study|Withdrawal by Subject|4|||
94395982|NCT02911701|323236580|FG000|Overall Study|Adverse Event|1|||
94395983|NCT02911701|323236581|FG001|Overall Study|Adverse Event|0|||
94395984|NCT01983969|323236584|FG000|Overall Study|Disease Progression|0|||
94484560|NCT01791595|323567513|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
94484561|NCT01791595|323567507|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
94484562|NCT01791595|323567508|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
94484563|NCT01791595|323567509|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
94484564|NCT01791595|323567510|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
94484565|NCT01791595|323567511|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
94484566|NCT01791595|323567512|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
94484567|NCT01791595|323567513|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
94484568|NCT01791595|323567507|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
94484569|NCT01791595|323567508|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
94484570|NCT01791595|323567509|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
94484571|NCT01791595|323567510|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
94484572|NCT01791595|323567511|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
94484573|NCT01791595|323567512|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
94484574|NCT01791595|323567513|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
94484575|NCT01791595|323567507|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
94484576|NCT01791595|323567508|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
94484577|NCT01791595|323567509|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
94484578|NCT01791595|323567510|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
94484579|NCT01791595|323567511|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
94484580|NCT01791595|323567512|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
94484581|NCT01791595|323567513|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
94484582|NCT01791595|323567507|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
94484583|NCT01791595|323567508|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
94484584|NCT01791595|323567509|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
94484585|NCT01791595|323567510|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
94484586|NCT01791595|323567511|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
94484587|NCT01791595|323567512|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
94484588|NCT01791595|323567513|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
94395985|NCT01983969|323236585|FG001|Overall Study|Disease Progression|1|||
94395986|NCT01983969|323236586|FG002|Overall Study|Disease Progression|0|||
94395987|NCT00436163|323236591|FG000|Overall Study|Lost to Follow-up|2|||
94395988|NCT00436163|323236591|FG000|Overall Study|Adverse Event|1|||
94395989|NCT00268203|323236592|FG000|Overall Study|Lost to Follow-up|92|||
94395990|NCT00268203|323236592|FG000|Overall Study|Withdrawal by Subject|9|||
94395991|NCT00268203|323236592|FG000|Overall Study|Received Other NHL Therapy|7|||
94395992|NCT00268203|323236592|FG000|Overall Study|Progressive Disease|359|||
94395993|NCT00268203|323236592|FG000|Overall Study|Death|84|||
94395994|NCT00268203|323236592|FG000|Overall Study|Reason Not Specified|34|||
94395995|NCT00268203|323236592|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
94395996|NCT02530905|323236595|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
94395997|NCT02530905|323236596|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
94395998|NCT02530905|323236597|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
94395999|NCT00147498|323236602|FG000|Overall Study|Adverse Event|1|||
94396000|NCT00147498|323236603|FG001|Overall Study|Adverse Event|6|||
94396001|NCT00147498|323236604|FG002|Overall Study|Adverse Event|7|||
94396002|NCT00147498|323236605|FG003|Overall Study|Adverse Event|3|||
94396003|NCT00147498|323236602|FG000|Overall Study|Lack of Efficacy|1|||
94396004|NCT00147498|323236603|FG001|Overall Study|Lack of Efficacy|1|||
94396005|NCT00147498|323236604|FG002|Overall Study|Lack of Efficacy|1|||
94396006|NCT00147498|323236605|FG003|Overall Study|Lack of Efficacy|8|||
94396007|NCT00147498|323236602|FG000|Overall Study|Laboratory abnormality|0|||
94396008|NCT00147498|323236603|FG001|Overall Study|Laboratory abnormality|0|||
94396009|NCT00147498|323236604|FG002|Overall Study|Laboratory abnormality|2|||
94396010|NCT00147498|323236605|FG003|Overall Study|Laboratory abnormality|0|||
94396011|NCT00147498|323236602|FG000|Overall Study|Participant defaulted|0|||
94396012|NCT00147498|323236603|FG001|Overall Study|Participant defaulted|1|||
94396013|NCT00147498|323236604|FG002|Overall Study|Participant defaulted|4|||
94396014|NCT00147498|323236605|FG003|Overall Study|Participant defaulted|3|||
94396015|NCT00147498|323236602|FG000|Overall Study|Other|1|||
94396016|NCT00147498|323236603|FG001|Overall Study|Other|1|||
94396017|NCT00147498|323236604|FG002|Overall Study|Other|3|||
94396018|NCT00147498|323236605|FG003|Overall Study|Other|3|||
94396019|NCT02152163|323236606|FG000|Overall Study|Physician Decision|12|||
94396020|NCT02152163|323236607|FG001|Overall Study|Physician Decision|13|||
94396021|NCT00796562|323236611|FG000|Overall Study|Death|49|||
94396022|NCT01229150|323236614|FG000|Overall Study|Toxicity|2|||
94396023|NCT01229150|323236615|FG001|Overall Study|Toxicity|2|||
94396024|NCT01229150|323236616|FG002|Overall Study|Toxicity|0|||
94396025|NCT01229150|323236617|FG003|Overall Study|Toxicity|0|||
94396026|NCT03100344|323236618|FG000|Overall Study|Adverse Event|0|||
94396027|NCT03100344|323236619|FG001|Overall Study|Adverse Event|3|||
94396028|NCT03100344|323236620|FG002|Overall Study|Adverse Event|2|||
94396029|NCT03100344|323236621|FG003|Overall Study|Adverse Event|3|||
94396030|NCT03100344|323236618|FG000|Overall Study|Lack of Efficacy|2|||
94396031|NCT03100344|323236619|FG001|Overall Study|Lack of Efficacy|0|||
94396032|NCT03100344|323236620|FG002|Overall Study|Lack of Efficacy|0|||
94396033|NCT03100344|323236621|FG003|Overall Study|Lack of Efficacy|0|||
94396034|NCT03100344|323236618|FG000|Overall Study|Protocol Violation|1|||
94396035|NCT03100344|323236619|FG001|Overall Study|Protocol Violation|0|||
94396036|NCT03100344|323236620|FG002|Overall Study|Protocol Violation|0|||
94484589|NCT03118934|323567514|FG000|Overall Study|Adverse Event|0|||
94484590|NCT03118934|323567515|FG001|Overall Study|Adverse Event|0|||
94484591|NCT03118934|323567516|FG002|Overall Study|Adverse Event|0|||
94484592|NCT03118934|323567517|FG003|Overall Study|Adverse Event|0|||
94396037|NCT03100344|323236621|FG003|Overall Study|Protocol Violation|0|||
94396038|NCT03100344|323236618|FG000|Overall Study|Withdrawal by Subject|10|||
94396039|NCT03100344|323236619|FG001|Overall Study|Withdrawal by Subject|7|||
94396040|NCT03100344|323236620|FG002|Overall Study|Withdrawal by Subject|4|||
94396041|NCT03100344|323236621|FG003|Overall Study|Withdrawal by Subject|8|||
94396042|NCT03100344|323236618|FG000|Overall Study|Lost to Follow-up|1|||
94396043|NCT03100344|323236619|FG001|Overall Study|Lost to Follow-up|1|||
94396044|NCT03100344|323236620|FG002|Overall Study|Lost to Follow-up|1|||
94396045|NCT03100344|323236621|FG003|Overall Study|Lost to Follow-up|1|||
94396046|NCT03114891|323236622|FG000|First Treatment Round|Lost to Follow-up|0|||
94396047|NCT03114891|323236623|FG001|First Treatment Round|Lost to Follow-up|1|||
94396048|NCT03114891|323236624|FG002|First Treatment Round|Lost to Follow-up|1|||
94396049|NCT03114891|323236625|FG003|First Treatment Round|Lost to Follow-up|0|||
94396050|NCT03114891|323236622|FG000|First Treatment Round|Withdrawal by Subject|0|||
94396051|NCT03114891|323236623|FG001|First Treatment Round|Withdrawal by Subject|2|||
94396052|NCT03114891|323236624|FG002|First Treatment Round|Withdrawal by Subject|0|||
94396053|NCT03114891|323236625|FG003|First Treatment Round|Withdrawal by Subject|1|||
94396054|NCT03114891|323236622|FG000|3 Week Break|Lost to Follow-up|1|||
94396055|NCT03114891|323236623|FG001|3 Week Break|Lost to Follow-up|0|||
94484593|NCT03118934|323567518|FG004|Overall Study|Adverse Event|0|||
94484594|NCT03118934|323567519|FG005|Overall Study|Adverse Event|1|||
94484595|NCT03118934|323567514|FG000|Overall Study|Physician Decision|0|||
94484596|NCT03118934|323567515|FG001|Overall Study|Physician Decision|0|||
94484597|NCT03118934|323567516|FG002|Overall Study|Physician Decision|0|||
94484598|NCT03118934|323567517|FG003|Overall Study|Physician Decision|0|||
94484599|NCT03118934|323567518|FG004|Overall Study|Physician Decision|0|||
94484600|NCT03118934|323567519|FG005|Overall Study|Physician Decision|1|||
94396056|NCT03114891|323236624|FG002|3 Week Break|Lost to Follow-up|0|||
94396057|NCT03114891|323236625|FG003|3 Week Break|Lost to Follow-up|1|||
94396058|NCT03114891|323236622|FG000|3 Week Break|Withdrawal by Subject|0|||
94396059|NCT03114891|323236623|FG001|3 Week Break|Withdrawal by Subject|1|||
94396060|NCT03114891|323236624|FG002|3 Week Break|Withdrawal by Subject|0|||
94396061|NCT03114891|323236625|FG003|3 Week Break|Withdrawal by Subject|0|||
94396062|NCT03114891|323236622|FG000|Second Treatment Round|Lost to Follow-up|1|||
94396063|NCT03114891|323236623|FG001|Second Treatment Round|Lost to Follow-up|0|||
94396064|NCT03114891|323236624|FG002|Second Treatment Round|Lost to Follow-up|0|||
94396065|NCT03114891|323236625|FG003|Second Treatment Round|Lost to Follow-up|0|||
94396066|NCT03114891|323236622|FG000|Second Treatment Round|Physician Decision|1|||
94396067|NCT03114891|323236623|FG001|Second Treatment Round|Physician Decision|0|||
94396068|NCT03114891|323236624|FG002|Second Treatment Round|Physician Decision|0|||
94396069|NCT03114891|323236625|FG003|Second Treatment Round|Physician Decision|0|||
94396070|NCT02358538|323236626|FG000|Through Week 26|Adverse Event|0|||
94396071|NCT02358538|323236627|FG001|Through Week 26|Adverse Event|1|||
94396072|NCT02358538|323236628|FG002|Through Week 26|Adverse Event|1|||
94396073|NCT02358538|323236629|FG003|Through Week 26|Adverse Event|2|||
94396074|NCT02358538|323236626|FG000|Through Week 26|Lack of Efficacy|1|||
94396075|NCT02358538|323236627|FG001|Through Week 26|Lack of Efficacy|1|||
94396076|NCT02358538|323236628|FG002|Through Week 26|Lack of Efficacy|3|||
94396077|NCT02358538|323236629|FG003|Through Week 26|Lack of Efficacy|3|||
94396078|NCT02358538|323236626|FG000|Through Week 26|Withdrawal by Subject|1|||
94396079|NCT02358538|323236627|FG001|Through Week 26|Withdrawal by Subject|0|||
94396080|NCT02358538|323236628|FG002|Through Week 26|Withdrawal by Subject|0|||
94396081|NCT02358538|323236629|FG003|Through Week 26|Withdrawal by Subject|0|||
94396082|NCT02358538|323236626|FG000|Through Week 26|Non-Compliance|0|||
94396083|NCT02358538|323236627|FG001|Through Week 26|Non-Compliance|0|||
94396084|NCT02358538|323236628|FG002|Through Week 26|Non-Compliance|1|||
94396085|NCT02358538|323236629|FG003|Through Week 26|Non-Compliance|0|||
94396086|NCT02358538|323236626|FG000|Through Week 26|Family did not see benefit from IP|1|||
94396087|NCT02358538|323236627|FG001|Through Week 26|Family did not see benefit from IP|0|||
94396088|NCT02358538|323236628|FG002|Through Week 26|Family did not see benefit from IP|0|||
94396089|NCT02358538|323236629|FG003|Through Week 26|Family did not see benefit from IP|0|||
94484601|NCT03118934|323567514|FG000|Overall Study|Discontinued prior to exposure|0|||
94484602|NCT03118934|323567515|FG001|Overall Study|Discontinued prior to exposure|1|||
94484603|NCT03118934|323567516|FG002|Overall Study|Discontinued prior to exposure|1|||
94329346|NCT01957787|322986167|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
94329347|NCT01957787|322986167|FG000|Overall Study|Local therapy, not cryoablation|6|||
94329348|NCT04176445|322986168|FG000|Overall Study|Adverse Event|0|||
94329349|NCT04176445|322986169|FG001|Overall Study|Adverse Event|1|||
94329350|NCT04176445|322986168|FG000|Overall Study|change plans weaning after first intervention|0|||
94329351|NCT04176445|322986169|FG001|Overall Study|change plans weaning after first intervention|1|||
94329352|NCT04046341|322986172|FG000|Overall Study|Lost to Follow-up|2|||
94329353|NCT04046341|322986172|FG000|Overall Study|Withdrawal by Subject|1|||
94329354|NCT04377672|322986175|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
94329355|NCT03479216|322986176|FG000|Overall Study|Withdrawal by Subject|3|||
94329356|NCT03479216|322986177|FG001|Overall Study|Withdrawal by Subject|2|||
94329357|NCT03479216|322986176|FG000|Overall Study|Physician Decision|2|||
94396090|NCT02358538|323236626|FG000|52 Week Extension Period|Lack of Efficacy|0|||
94396091|NCT02358538|323236627|FG001|52 Week Extension Period|Lack of Efficacy|0|||
94396092|NCT02358538|323236628|FG002|52 Week Extension Period|Lack of Efficacy|2|||
94396093|NCT02358538|323236629|FG003|52 Week Extension Period|Lack of Efficacy|4|||
94396094|NCT01010503|323236630|FG000|Overall Study|Adverse Event|1|||
94396095|NCT01010503|323236630|FG000|Overall Study|Death|1|||
94396096|NCT03681470|323236631|FG000|Overall Study|Lack of Efficacy|3|||
94396097|NCT03681470|323236631|FG000|Overall Study|Lost to Follow-up|1|||
94396098|NCT03681470|323236631|FG000|Overall Study|Protocol Violation|3|||
94396099|NCT03681470|323236631|FG000|Overall Study|Withdrawal by Subject|1|||
94396100|NCT01494532|323236632|FG000|Overall Study|Adverse Event|4|||
94396101|NCT01494532|323236633|FG001|Overall Study|Adverse Event|1|||
94396102|NCT01494532|323236634|FG002|Overall Study|Adverse Event|8|||
94396103|NCT01494532|323236635|FG003|Overall Study|Adverse Event|6|||
94396104|NCT01494532|323236636|FG004|Overall Study|Adverse Event|5|||
94396105|NCT01494532|323236637|FG005|Overall Study|Adverse Event|0|||
94396106|NCT01494532|323236632|FG000|Overall Study|Lack of Efficacy|0|||
94396107|NCT01494532|323236633|FG001|Overall Study|Lack of Efficacy|0|||
94396108|NCT01494532|323236634|FG002|Overall Study|Lack of Efficacy|0|||
94396109|NCT01494532|323236635|FG003|Overall Study|Lack of Efficacy|0|||
94396110|NCT01494532|323236636|FG004|Overall Study|Lack of Efficacy|2|||
94396111|NCT01494532|323236637|FG005|Overall Study|Lack of Efficacy|0|||
94396112|NCT01494532|323236632|FG000|Overall Study|Protocol deviation|2|||
94396113|NCT01494532|323236633|FG001|Overall Study|Protocol deviation|1|||
94396114|NCT01494532|323236634|FG002|Overall Study|Protocol deviation|3|||
94396115|NCT01494532|323236635|FG003|Overall Study|Protocol deviation|2|||
94396116|NCT01494532|323236636|FG004|Overall Study|Protocol deviation|3|||
94396117|NCT01494532|323236637|FG005|Overall Study|Protocol deviation|0|||
94396118|NCT01494532|323236632|FG000|Overall Study|Protocol-defined stopping criteria|0|||
94396119|NCT01494532|323236633|FG001|Overall Study|Protocol-defined stopping criteria|0|||
94396120|NCT01494532|323236634|FG002|Overall Study|Protocol-defined stopping criteria|1|||
94396121|NCT01494532|323236635|FG003|Overall Study|Protocol-defined stopping criteria|0|||
94396122|NCT01494532|323236636|FG004|Overall Study|Protocol-defined stopping criteria|0|||
94396123|NCT01494532|323236637|FG005|Overall Study|Protocol-defined stopping criteria|0|||
94396124|NCT01494532|323236632|FG000|Overall Study|Lost to Follow-up|1|||
94396125|NCT01494532|323236633|FG001|Overall Study|Lost to Follow-up|0|||
94396126|NCT01494532|323236634|FG002|Overall Study|Lost to Follow-up|0|||
94396127|NCT01494532|323236635|FG003|Overall Study|Lost to Follow-up|2|||
94396128|NCT01494532|323236636|FG004|Overall Study|Lost to Follow-up|0|||
94396129|NCT01494532|323236637|FG005|Overall Study|Lost to Follow-up|0|||
94396130|NCT01494532|323236632|FG000|Overall Study|Physician Decision|0|||
94396131|NCT01494532|323236633|FG001|Overall Study|Physician Decision|1|||
94396132|NCT01494532|323236634|FG002|Overall Study|Physician Decision|1|||
94396133|NCT01494532|323236635|FG003|Overall Study|Physician Decision|2|||
94396134|NCT01494532|323236636|FG004|Overall Study|Physician Decision|0|||
94396135|NCT01494532|323236637|FG005|Overall Study|Physician Decision|0|||
94396136|NCT01494532|323236632|FG000|Overall Study|Withdrawal by Subject|3|||
94396137|NCT01494532|323236633|FG001|Overall Study|Withdrawal by Subject|1|||
94396138|NCT01494532|323236634|FG002|Overall Study|Withdrawal by Subject|4|||
94396139|NCT01494532|323236635|FG003|Overall Study|Withdrawal by Subject|3|||
94396140|NCT01494532|323236636|FG004|Overall Study|Withdrawal by Subject|2|||
94396141|NCT01494532|323236637|FG005|Overall Study|Withdrawal by Subject|0|||
94329358|NCT03479216|322986177|FG001|Overall Study|Physician Decision|3|||
94396142|NCT00849797|323236638|FG000|First Intervention|bad veins|1|||
94396143|NCT00849797|323236639|FG001|First Intervention|bad veins|0|||
94396144|NCT00849797|323236638|FG000|First Intervention|Adverse Event|0|||
94396145|NCT00849797|323236639|FG001|First Intervention|Adverse Event|1|||
94396146|NCT00849797|323236638|FG000|Washout: One Week|Withdrawal by Subject|0|||
94329359|NCT03846219|322986178|FG000|Overall Study|Withdrawal by Subject|3|||
94396147|NCT00849797|323236639|FG001|Washout: One Week|Withdrawal by Subject|2|||
94396148|NCT02957942|323236640|FG000|Overall Study|Withdrawal by Subject|0|||
94396149|NCT02957942|323236641|FG001|Overall Study|Withdrawal by Subject|1|||
94396150|NCT02957942|323236640|FG000|Overall Study|Practicing experiment protocol|0|||
94396151|NCT02957942|323236641|FG001|Overall Study|Practicing experiment protocol|6|||
94396152|NCT00730691|323236643|FG000|Overall Study|Adverse Event|4|||
94396153|NCT00730691|323236644|FG001|Overall Study|Adverse Event|8|||
94396154|NCT00730691|323236645|FG002|Overall Study|Adverse Event|11|||
94396155|NCT00730691|323236646|FG003|Overall Study|Adverse Event|11|||
94396156|NCT00730691|323236647|FG004|Overall Study|Adverse Event|23|||
94396157|NCT00730691|323236643|FG000|Overall Study|Lack of Efficacy|4|||
94396158|NCT00730691|323236644|FG001|Overall Study|Lack of Efficacy|4|||
94396159|NCT00730691|323236645|FG002|Overall Study|Lack of Efficacy|2|||
94396160|NCT00730691|323236646|FG003|Overall Study|Lack of Efficacy|1|||
94396161|NCT00730691|323236647|FG004|Overall Study|Lack of Efficacy|1|||
94396162|NCT00730691|323236643|FG000|Overall Study|Non-compliance with Study Drug|6|||
94396163|NCT00730691|323236644|FG001|Overall Study|Non-compliance with Study Drug|1|||
94396164|NCT00730691|323236645|FG002|Overall Study|Non-compliance with Study Drug|6|||
94396165|NCT00730691|323236646|FG003|Overall Study|Non-compliance with Study Drug|3|||
94396166|NCT00730691|323236647|FG004|Overall Study|Non-compliance with Study Drug|3|||
94396167|NCT00730691|323236643|FG000|Overall Study|Protocol Deviations|3|||
94396168|NCT00730691|323236644|FG001|Overall Study|Protocol Deviations|5|||
94396169|NCT00730691|323236645|FG002|Overall Study|Protocol Deviations|3|||
94396170|NCT00730691|323236646|FG003|Overall Study|Protocol Deviations|7|||
94396171|NCT00730691|323236647|FG004|Overall Study|Protocol Deviations|5|||
94396172|NCT00730691|323236643|FG000|Overall Study|Withdrawal of Consent|7|||
94396173|NCT00730691|323236644|FG001|Overall Study|Withdrawal of Consent|9|||
94396174|NCT00730691|323236645|FG002|Overall Study|Withdrawal of Consent|3|||
94396175|NCT00730691|323236646|FG003|Overall Study|Withdrawal of Consent|6|||
94396176|NCT00730691|323236647|FG004|Overall Study|Withdrawal of Consent|3|||
94396177|NCT00730691|323236643|FG000|Overall Study|Lost to Follow-up|11|||
94396178|NCT00730691|323236644|FG001|Overall Study|Lost to Follow-up|8|||
94396179|NCT00730691|323236645|FG002|Overall Study|Lost to Follow-up|13|||
94396180|NCT00730691|323236646|FG003|Overall Study|Lost to Follow-up|15|||
94396181|NCT00730691|323236647|FG004|Overall Study|Lost to Follow-up|13|||
94396182|NCT00730691|323236643|FG000|Overall Study|Other|1|||
94396183|NCT00730691|323236644|FG001|Overall Study|Other|1|||
94396184|NCT00730691|323236645|FG002|Overall Study|Other|1|||
94396185|NCT00730691|323236646|FG003|Overall Study|Other|2|||
94396186|NCT00730691|323236647|FG004|Overall Study|Other|2|||
94396187|NCT00811655|323236649|FG000|Overall Study|Physician Decision|1|||
94396188|NCT04198363|323236657|FG000|Overall Study|Adverse Event|1|||
94396189|NCT04198363|323236658|FG001|Overall Study|Adverse Event|1|||
94396190|NCT04198363|323236657|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
94396191|NCT04198363|323236658|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
94396192|NCT04198363|323236657|FG000|Overall Study|Reason not Specified|1|||
94396193|NCT04198363|323236658|FG001|Overall Study|Reason not Specified|0|||
94396194|NCT01030133|323236659|FG000|Overall Study|failed to experience pain at level 7/10|2|||
94396195|NCT01030133|323236660|FG001|Overall Study|failed to experience pain at level 7/10|2|||
94396196|NCT00829764|323236661|FG000|First Intervention|Adverse Event|1|||
94396197|NCT00829764|323236662|FG001|First Intervention|Adverse Event|0|||
94396198|NCT00829764|323236661|FG000|First Intervention|Withdrawal by Subject|1|||
94396199|NCT00829764|323236662|FG001|First Intervention|Withdrawal by Subject|1|||
94396200|NCT00477594|323236663|FG000|Year 1 and Year 2|Adverse Event|4|||
94396201|NCT00477594|323236664|FG001|Year 1 and Year 2|Adverse Event|2|||
94396202|NCT00477594|323236663|FG000|Year 1 and Year 2|Physician Decision|2|||
94396203|NCT00477594|323236664|FG001|Year 1 and Year 2|Physician Decision|1|||
94396204|NCT00477594|323236663|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
94396205|NCT00477594|323236664|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
94396206|NCT00477594|323236663|FG000|Year 1 and Year 2|Other|1|||
94396207|NCT00477594|323236664|FG001|Year 1 and Year 2|Other|0|||
94396208|NCT00477594|323236663|FG000|Year 3|Adverse Event|1|||
94396209|NCT00477594|323236664|FG001|Year 3|Adverse Event|0|||
94396210|NCT00477594|323236663|FG000|Year 3|Withdrawal by Subject|1|||
94396211|NCT00477594|323236664|FG001|Year 3|Withdrawal by Subject|0|||
94396212|NCT00477594|323236663|FG000|Follow-up Period|Withdrawal by Subject|2|||
94396213|NCT00477594|323236664|FG001|Follow-up Period|Withdrawal by Subject|1|||
94396214|NCT00477594|323236663|FG000|Follow-up Period|Other|1|||
94396215|NCT00477594|323236664|FG001|Follow-up Period|Other|0|||
94396216|NCT02588339|323236665|FG000|Overall Study|Withdrawal by Subject|1|||
94396217|NCT02588339|323236665|FG000|Overall Study|GVHD Progression prior to treatment|2|||
94396218|NCT03122535|323238175|FG000|Overall Study|Lost to Follow-up|68|||
94396219|NCT03122535|323238176|FG001|Overall Study|Lost to Follow-up|68|||
94396220|NCT03122535|323238175|FG000|Overall Study|Physician Decision|3|||
94396221|NCT03122535|323238176|FG001|Overall Study|Physician Decision|3|||
94396222|NCT03122535|323238175|FG000|Overall Study|Withdrawal by Subject|2|||
94396223|NCT03122535|323238176|FG001|Overall Study|Withdrawal by Subject|2|||
94396224|NCT00377260|323238177|FG000|Overall Study|Lost to Follow-up|0|||
94396225|NCT00377260|323238178|FG001|Overall Study|Lost to Follow-up|1|||
94396226|NCT00377260|323238177|FG000|Overall Study|Withdrawal by Subject|2|||
94396227|NCT00377260|323238178|FG001|Overall Study|Withdrawal by Subject|4|||
94396228|NCT00857454|323238179|FG000|Overall Study|Withdrawal by Subject|2|||
94396229|NCT00857454|323238179|FG000|Overall Study|Lost to Follow-up|1|||
94396230|NCT00857454|323238179|FG000|Overall Study|Adverse Event|2|||
94396231|NCT00857454|323238179|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
94396232|NCT00857454|323238179|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
94396233|NCT00857454|323238179|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
94396234|NCT00418561|323238182|FG000|Overall Study|Participant's (guardian's) decision|0|||
94396235|NCT00418561|323238183|FG001|Overall Study|Participant's (guardian's) decision|1|||
94396236|NCT00418561|323238184|FG002|Overall Study|Participant's (guardian's) decision|0|||
94396237|NCT00829309|323238185|FG000|Washout: 7 Days|Protocol Violation|1|||
94396238|NCT00829309|323238186|FG001|Washout: 7 Days|Protocol Violation|0|||
94396239|NCT01558635|323238187|FG000|Overall Study|Death|1|||
94396240|NCT01558635|323238187|FG000|Overall Study|Withdrawal by Subject|2|||
94396241|NCT01558635|323238187|FG000|Overall Study|Physician Decision|1|||
94396242|NCT01558635|323238187|FG000|Overall Study|Subject received other treatment|1|||
94396243|NCT01558635|323238187|FG000|Overall Study|Reveal XT was explanted|1|||
94396244|NCT01705574|323238188|FG000|Double-Blind Phase|Lost to Follow-up|12|||
94396245|NCT01705574|323238189|FG001|Double-Blind Phase|Lost to Follow-up|16|||
94396246|NCT01705574|323238190|FG002|Double-Blind Phase|Lost to Follow-up|0|||
94396247|NCT01705574|323238191|FG003|Double-Blind Phase|Lost to Follow-up|0|||
94396248|NCT01705574|323238188|FG000|Double-Blind Phase|Adverse Event|3|||
94396249|NCT01705574|323238189|FG001|Double-Blind Phase|Adverse Event|10|||
94396250|NCT01705574|323238190|FG002|Double-Blind Phase|Adverse Event|0|||
94396251|NCT01705574|323238191|FG003|Double-Blind Phase|Adverse Event|0|||
94396252|NCT01705574|323238188|FG000|Double-Blind Phase|Withdrew Consent|8|||
94396253|NCT01705574|323238189|FG001|Double-Blind Phase|Withdrew Consent|5|||
94396254|NCT01705574|323238190|FG002|Double-Blind Phase|Withdrew Consent|0|||
94396255|NCT01705574|323238191|FG003|Double-Blind Phase|Withdrew Consent|0|||
94396256|NCT01705574|323238188|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
94396257|NCT01705574|323238189|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
94396258|NCT01705574|323238190|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
94396259|NCT01705574|323238191|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
94396260|NCT01705574|323238188|FG000|Double-Blind Phase|Pregnancy|1|||
94396261|NCT01705574|323238189|FG001|Double-Blind Phase|Pregnancy|1|||
94396262|NCT01705574|323238190|FG002|Double-Blind Phase|Pregnancy|0|||
94396263|NCT01705574|323238191|FG003|Double-Blind Phase|Pregnancy|0|||
94396264|NCT01705574|323238188|FG000|Double-Blind Phase|Protocol Violation|1|||
94396265|NCT01705574|323238189|FG001|Double-Blind Phase|Protocol Violation|0|||
94396266|NCT01705574|323238190|FG002|Double-Blind Phase|Protocol Violation|0|||
94396267|NCT01705574|323238191|FG003|Double-Blind Phase|Protocol Violation|0|||
94396268|NCT01705574|323238188|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
94396269|NCT01705574|323238189|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
94396270|NCT01705574|323238190|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
94396271|NCT01705574|323238191|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
94396272|NCT01705574|323238188|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
94396273|NCT01705574|323238189|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
94396274|NCT01705574|323238190|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
94396275|NCT01705574|323238191|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
94396276|NCT01705574|323238188|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
94396277|NCT01705574|323238189|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
94396278|NCT01705574|323238190|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
94396279|NCT01705574|323238191|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
94396280|NCT01705574|323238188|FG000|Open-Label Extension Phase|Adverse Event|3|||
94396281|NCT01705574|323238189|FG001|Open-Label Extension Phase|Adverse Event|0|||
94396282|NCT01705574|323238190|FG002|Open-Label Extension Phase|Adverse Event|0|||
94396283|NCT01705574|323238191|FG003|Open-Label Extension Phase|Adverse Event|1|||
94396284|NCT01705574|323238188|FG000|Open-Label Extension Phase|Death|2|||
94396285|NCT01705574|323238189|FG001|Open-Label Extension Phase|Death|0|||
94396286|NCT01705574|323238190|FG002|Open-Label Extension Phase|Death|1|||
94396287|NCT01705574|323238191|FG003|Open-Label Extension Phase|Death|0|||
94396288|NCT01705574|323238188|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
94396289|NCT01705574|323238189|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
94396290|NCT01705574|323238190|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
94396291|NCT01705574|323238191|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
94396292|NCT01705574|323238188|FG000|Open-Label Extension Phase|Physician Decision|0|||
94396293|NCT01705574|323238189|FG001|Open-Label Extension Phase|Physician Decision|0|||
94396294|NCT01705574|323238190|FG002|Open-Label Extension Phase|Physician Decision|2|||
94396295|NCT01705574|323238191|FG003|Open-Label Extension Phase|Physician Decision|0|||
94396296|NCT01705574|323238188|FG000|Open-Label Extension Phase|Pregnancy|0|||
94396297|NCT01705574|323238189|FG001|Open-Label Extension Phase|Pregnancy|0|||
94396298|NCT01705574|323238190|FG002|Open-Label Extension Phase|Pregnancy|1|||
94396299|NCT01705574|323238191|FG003|Open-Label Extension Phase|Pregnancy|1|||
94396300|NCT03606174|323238192|FG000|Overall Study|Death|37|||
94396301|NCT03606174|323238193|FG001|Overall Study|Death|15|||
94396302|NCT03606174|323238194|FG002|Overall Study|Death|15|||
94396303|NCT03606174|323238195|FG003|Overall Study|Death|7|||
94396304|NCT03606174|323238196|FG004|Overall Study|Death|35|||
94396305|NCT03606174|323238197|FG005|Overall Study|Death|12|||
94396306|NCT03606174|323238198|FG006|Overall Study|Death|35|||
94396307|NCT03606174|323238199|FG007|Overall Study|Death|8|||
94396308|NCT03606174|323238200|FG008|Overall Study|Death|5|||
94396309|NCT03606174|323238201|FG009|Overall Study|Death|3|||
94396310|NCT03606174|323238202|FG010|Overall Study|Death|0|||
94396311|NCT03606174|323238192|FG000|Overall Study|Lost to Follow-up|0|||
94396312|NCT03606174|323238193|FG001|Overall Study|Lost to Follow-up|0|||
94396313|NCT03606174|323238194|FG002|Overall Study|Lost to Follow-up|0|||
94396314|NCT03606174|323238195|FG003|Overall Study|Lost to Follow-up|0|||
94396315|NCT03606174|323238196|FG004|Overall Study|Lost to Follow-up|1|||
94396316|NCT03606174|323238197|FG005|Overall Study|Lost to Follow-up|1|||
94396317|NCT03606174|323238198|FG006|Overall Study|Lost to Follow-up|0|||
94396318|NCT03606174|323238199|FG007|Overall Study|Lost to Follow-up|0|||
94396319|NCT03606174|323238200|FG008|Overall Study|Lost to Follow-up|0|||
94396320|NCT03606174|323238201|FG009|Overall Study|Lost to Follow-up|0|||
94396321|NCT03606174|323238202|FG010|Overall Study|Lost to Follow-up|0|||
94396322|NCT03606174|323238192|FG000|Overall Study|Withdrawal by Subject|6|||
94396323|NCT03606174|323238193|FG001|Overall Study|Withdrawal by Subject|0|||
94396324|NCT03606174|323238194|FG002|Overall Study|Withdrawal by Subject|0|||
94396325|NCT03606174|323238195|FG003|Overall Study|Withdrawal by Subject|1|||
94396326|NCT03606174|323238196|FG004|Overall Study|Withdrawal by Subject|2|||
94396327|NCT03606174|323238197|FG005|Overall Study|Withdrawal by Subject|1|||
94396328|NCT03606174|323238198|FG006|Overall Study|Withdrawal by Subject|4|||
94396329|NCT03606174|323238199|FG007|Overall Study|Withdrawal by Subject|0|||
94396330|NCT03606174|323238200|FG008|Overall Study|Withdrawal by Subject|0|||
94396331|NCT03606174|323238201|FG009|Overall Study|Withdrawal by Subject|0|||
94396332|NCT03606174|323238202|FG010|Overall Study|Withdrawal by Subject|1|||
94396333|NCT03606174|323238192|FG000|Overall Study|Study Terminated by Sponsor|5|||
94396334|NCT03606174|323238193|FG001|Overall Study|Study Terminated by Sponsor|7|||
94396335|NCT03606174|323238194|FG002|Overall Study|Study Terminated by Sponsor|3|||
94396336|NCT03606174|323238195|FG003|Overall Study|Study Terminated by Sponsor|0|||
94396337|NCT03606174|323238196|FG004|Overall Study|Study Terminated by Sponsor|11|||
94396338|NCT03606174|323238197|FG005|Overall Study|Study Terminated by Sponsor|6|||
94396339|NCT03606174|323238198|FG006|Overall Study|Study Terminated by Sponsor|12|||
94396340|NCT03606174|323238199|FG007|Overall Study|Study Terminated by Sponsor|1|||
94396341|NCT03606174|323238200|FG008|Overall Study|Study Terminated by Sponsor|3|||
94396342|NCT03606174|323238201|FG009|Overall Study|Study Terminated by Sponsor|1|||
94396343|NCT03606174|323238202|FG010|Overall Study|Study Terminated by Sponsor|2|||
94396344|NCT03606174|323238192|FG000|Overall Study|Miscellaneous|1|||
94396345|NCT03606174|323238193|FG001|Overall Study|Miscellaneous|1|||
94396346|NCT03606174|323238194|FG002|Overall Study|Miscellaneous|0|||
94396347|NCT03606174|323238195|FG003|Overall Study|Miscellaneous|1|||
94396348|NCT03606174|323238196|FG004|Overall Study|Miscellaneous|4|||
94396349|NCT03606174|323238197|FG005|Overall Study|Miscellaneous|7|||
94396350|NCT03606174|323238198|FG006|Overall Study|Miscellaneous|5|||
94396351|NCT03606174|323238199|FG007|Overall Study|Miscellaneous|0|||
94396352|NCT03606174|323238200|FG008|Overall Study|Miscellaneous|0|||
94396353|NCT03606174|323238201|FG009|Overall Study|Miscellaneous|0|||
94396354|NCT03606174|323238202|FG010|Overall Study|Miscellaneous|1|||
94396355|NCT02888756|323238205|FG000|Analytical Treatment Interruption|Physician Decision|10|||
94396356|NCT02888756|323238206|FG001|Analytical Treatment Interruption|Physician Decision|6|||
94396357|NCT02888756|323238207|FG002|Analytical Treatment Interruption|Physician Decision|5|||
94396358|NCT01158118|323238211|FG000|Overall Study|Screen failure|1|||
94396359|NCT01158118|323238212|FG001|Overall Study|Screen failure|0|||
94396360|NCT01158118|323238211|FG000|Overall Study|Donor match was a screen failure|0|||
94396361|NCT01158118|323238212|FG001|Overall Study|Donor match was a screen failure|1|||
94396362|NCT01158118|323238211|FG000|Overall Study|Suffered stroke prior to transplant|0|||
94396363|NCT01158118|323238212|FG001|Overall Study|Suffered stroke prior to transplant|1|||
94396364|NCT01158118|323238211|FG000|Overall Study|Death|0|||
94396365|NCT01158118|323238212|FG001|Overall Study|Death|1|||
94396366|NCT01204294|323238213|FG000|Overall Study|Adverse Event|2|||
94396367|NCT01204294|323238214|FG001|Overall Study|Adverse Event|6|||
94396368|NCT01204294|323238215|FG002|Overall Study|Adverse Event|0|||
94396369|NCT01204294|323238216|FG003|Overall Study|Adverse Event|7|||
94396370|NCT01204294|323238217|FG004|Overall Study|Adverse Event|1|||
94396371|NCT01204294|323238218|FG005|Overall Study|Adverse Event|4|||
94396372|NCT01204294|323238219|FG006|Overall Study|Adverse Event|0|||
94396373|NCT01204294|323238213|FG000|Overall Study|Protocol Violation|1|||
94396374|NCT01204294|323238214|FG001|Overall Study|Protocol Violation|0|||
94396375|NCT01204294|323238215|FG002|Overall Study|Protocol Violation|2|||
94396376|NCT01204294|323238216|FG003|Overall Study|Protocol Violation|1|||
94396377|NCT01204294|323238217|FG004|Overall Study|Protocol Violation|0|||
94396378|NCT01204294|323238218|FG005|Overall Study|Protocol Violation|0|||
94396379|NCT01204294|323238219|FG006|Overall Study|Protocol Violation|0|||
94396380|NCT01204294|323238213|FG000|Overall Study|Withdrawal by Subject|0|||
94396381|NCT01204294|323238214|FG001|Overall Study|Withdrawal by Subject|2|||
94396382|NCT01204294|323238215|FG002|Overall Study|Withdrawal by Subject|2|||
94396383|NCT01204294|323238216|FG003|Overall Study|Withdrawal by Subject|1|||
94396384|NCT01204294|323238217|FG004|Overall Study|Withdrawal by Subject|1|||
94396385|NCT01204294|323238218|FG005|Overall Study|Withdrawal by Subject|1|||
94396386|NCT01204294|323238219|FG006|Overall Study|Withdrawal by Subject|2|||
94396387|NCT01204294|323238213|FG000|Overall Study|Lack of Efficacy|0|||
94396388|NCT01204294|323238214|FG001|Overall Study|Lack of Efficacy|0|||
94396389|NCT01204294|323238215|FG002|Overall Study|Lack of Efficacy|0|||
94396390|NCT01204294|323238216|FG003|Overall Study|Lack of Efficacy|2|||
94396391|NCT01204294|323238217|FG004|Overall Study|Lack of Efficacy|0|||
94396392|NCT01204294|323238218|FG005|Overall Study|Lack of Efficacy|0|||
94396393|NCT01204294|323238219|FG006|Overall Study|Lack of Efficacy|0|||
94396394|NCT01204294|323238213|FG000|Overall Study|Other (house moving)|0|||
94396395|NCT01204294|323238214|FG001|Overall Study|Other (house moving)|0|||
94396396|NCT01204294|323238215|FG002|Overall Study|Other (house moving)|1|||
94396397|NCT01204294|323238216|FG003|Overall Study|Other (house moving)|0|||
94396398|NCT01204294|323238217|FG004|Overall Study|Other (house moving)|0|||
94396399|NCT01204294|323238218|FG005|Overall Study|Other (house moving)|0|||
94396400|NCT01204294|323238219|FG006|Overall Study|Other (house moving)|0|||
94396401|NCT02682238|323238220|FG000|Overall Study|Lost to Follow-up|0|||
94396402|NCT02682238|323238221|FG001|Overall Study|Lost to Follow-up|2|||
94396403|NCT02682238|323238220|FG000|Overall Study|Withdrawal by Subject|1|||
94396404|NCT02682238|323238221|FG001|Overall Study|Withdrawal by Subject|0|||
94396405|NCT02682238|323238220|FG000|Overall Study|Adverse Event|1|||
94396406|NCT02682238|323238221|FG001|Overall Study|Adverse Event|0|||
94396407|NCT02682238|323238220|FG000|Overall Study|Non-compliance with Study Drug|1|||
94396408|NCT02682238|323238221|FG001|Overall Study|Non-compliance with Study Drug|0|||
94396409|NCT02682238|323238220|FG000|Overall Study|Non-compliance with Protocol|0|||
94396410|NCT02682238|323238221|FG001|Overall Study|Non-compliance with Protocol|2|||
94396411|NCT00075478|323238222|FG000|Overall Study|not eligible|1|||
94396412|NCT00075478|323238223|FG001|Overall Study|not eligible|0|||
94396413|NCT00075478|323238222|FG000|Overall Study|Physician Decision|0|||
94396414|NCT00075478|323238223|FG001|Overall Study|Physician Decision|1|||
94396415|NCT02075463|323238224|FG000|Overall Study|Adverse Event|3|||
94396416|NCT02075463|323238224|FG000|Overall Study|Par. reached stopping criteria|4|||
94396417|NCT02075463|323238224|FG000|Overall Study|Withdrawal by Subject|1|||
94396418|NCT00824291|323238225|FG000|Overall Study|Adverse Event|15|||
94396419|NCT00824291|323238226|FG001|Overall Study|Adverse Event|6|||
94396420|NCT00824291|323238225|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
94396421|NCT00824291|323238226|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
94396422|NCT00824291|323238225|FG000|Overall Study|Lost to Follow-up|11|||
94396423|NCT00824291|323238226|FG001|Overall Study|Lost to Follow-up|9|||
94396424|NCT00824291|323238225|FG000|Overall Study|Non-compliance|1|||
94396425|NCT00824291|323238226|FG001|Overall Study|Non-compliance|1|||
94396426|NCT00824291|323238225|FG000|Overall Study|Protocol Violation|4|||
94396427|NCT00824291|323238226|FG001|Overall Study|Protocol Violation|1|||
94396428|NCT00824291|323238225|FG000|Overall Study|Withdrawal by Subject|14|||
94396429|NCT00824291|323238226|FG001|Overall Study|Withdrawal by Subject|8|||
94396430|NCT00824291|323238225|FG000|Overall Study|Lack of Efficacy|7|||
94396431|NCT00824291|323238226|FG001|Overall Study|Lack of Efficacy|8|||
94396432|NCT00824291|323238225|FG000|Overall Study|Participant on prohibited medication|1|||
94396433|NCT00824291|323238226|FG001|Overall Study|Participant on prohibited medication|0|||
94396434|NCT01383486|323238227|FG000|Overall Study|Lost to Follow-up|10|||
94396435|NCT01383486|323238227|FG000|Overall Study|Incomplete information for analysis|2|||
94396436|NCT01383486|323238227|FG000|Overall Study|Did not take any product|6|||
94396437|NCT03276754|323238231|FG000|Overall Study|Withdrawal of informed consent|4|||
94396438|NCT03276754|323238231|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
94396439|NCT03276754|323238231|FG000|Overall Study|Lost to Follow-up|27|||
94396440|NCT03276754|323238231|FG000|Overall Study|No data reported at Month 24|31|||
94396441|NCT03276754|323238231|FG000|Overall Study|Death|39|||
94396442|NCT03437265|323238233|FG000|Overall Study|Protocol Violation|6|||
94396443|NCT02294786|323238234|FG000|Overall Study|Withdrawal by Subject|0|||
94396444|NCT02294786|323238235|FG001|Overall Study|Withdrawal by Subject|1|||
94396445|NCT02294786|323238234|FG000|Overall Study|Physician Decision|6|||
94396446|NCT02294786|323238235|FG001|Overall Study|Physician Decision|7|||
94396447|NCT02294786|323238234|FG000|Overall Study|Lost to Follow-up|1|||
94396448|NCT02294786|323238235|FG001|Overall Study|Lost to Follow-up|2|||
94396449|NCT02294786|323238234|FG000|Overall Study|Protocol Violation|1|||
94396450|NCT02294786|323238235|FG001|Overall Study|Protocol Violation|0|||
94396451|NCT02294786|323238234|FG000|Overall Study|Adverse Event|1|||
94396452|NCT02294786|323238235|FG001|Overall Study|Adverse Event|1|||
94396453|NCT02294786|323238234|FG000|Overall Study|Death|2|||
94396454|NCT02294786|323238235|FG001|Overall Study|Death|3|||
94396455|NCT05041361|323238236|FG000|Overall Study|Lost to Follow-up|1|||
94396456|NCT05041361|323238237|FG001|Overall Study|Lost to Follow-up|3|||
94396457|NCT01788423|323238238|FG000|Overall Study|See Comments in Completed (above)|0|||
94396458|NCT01788423|323238239|FG001|Overall Study|See Comments in Completed (above)|4|||
94396459|NCT01788423|323238240|FG002|Overall Study|See Comments in Completed (above)|5|||
94396460|NCT01913405|323238241|FG000|Overall Study|Withdrawal by Subject|1|||
94396461|NCT01913405|323238241|FG000|Overall Study|Adverse Event|1|||
94396462|NCT01380782|323238242|FG000|Overall Study|Adverse Event|0|||
94396463|NCT01380782|323238243|FG001|Overall Study|Adverse Event|1|||
94396464|NCT01380782|323238244|FG002|Overall Study|Adverse Event|0|||
94396465|NCT01380782|323238245|FG003|Overall Study|Adverse Event|0|||
94396466|NCT01380782|323238242|FG000|Overall Study|Death|1|||
94396467|NCT01380782|323238243|FG001|Overall Study|Death|0|||
94396468|NCT01380782|323238244|FG002|Overall Study|Death|0|||
94396469|NCT01380782|323238245|FG003|Overall Study|Death|0|||
94396470|NCT01380782|323238242|FG000|Overall Study|Lack of Efficacy|10|||
94396471|NCT01380782|323238243|FG001|Overall Study|Lack of Efficacy|9|||
94396472|NCT01380782|323238244|FG002|Overall Study|Lack of Efficacy|10|||
94396473|NCT01380782|323238245|FG003|Overall Study|Lack of Efficacy|3|||
94396474|NCT01380782|323238242|FG000|Overall Study|Physician Decision|1|||
94396475|NCT01380782|323238243|FG001|Overall Study|Physician Decision|0|||
94396476|NCT01380782|323238244|FG002|Overall Study|Physician Decision|0|||
94396477|NCT01380782|323238245|FG003|Overall Study|Physician Decision|0|||
94396478|NCT01380782|323238242|FG000|Overall Study|Withdrawal by Subject|0|||
94396479|NCT01380782|323238243|FG001|Overall Study|Withdrawal by Subject|0|||
94396480|NCT01380782|323238244|FG002|Overall Study|Withdrawal by Subject|1|||
94396481|NCT01380782|323238245|FG003|Overall Study|Withdrawal by Subject|1|||
94396482|NCT01403194|323238246|FG000|Overall Study|Screen Failure|2|||
94396483|NCT01403194|323238246|FG000|Overall Study|Lost to Follow-up|8|||
94396484|NCT01535222|323238247|FG000|Overall Study|Inclusion/exclusion|0|||
94396485|NCT01535222|323238248|FG001|Overall Study|Inclusion/exclusion|0|||
94396486|NCT01535222|323238249|FG002|Overall Study|Inclusion/exclusion|1|||
94396487|NCT01535222|323238250|FG003|Overall Study|Inclusion/exclusion|0|||
94396488|NCT01535222|323238251|FG004|Overall Study|Inclusion/exclusion|0|||
94396489|NCT01535222|323238252|FG005|Overall Study|Inclusion/exclusion|0|||
94396490|NCT03325881|323238257|FG000|Overall Study|Protocol Violation|0|||
94396491|NCT03325881|323238258|FG001|Overall Study|Protocol Violation|1|||
94396492|NCT03325881|323238257|FG000|Overall Study|Withdrawal by Subject|0|||
94396493|NCT03325881|323238258|FG001|Overall Study|Withdrawal by Subject|2|||
94396494|NCT03325881|323238257|FG000|Overall Study|Lack of Efficacy|2|||
94396495|NCT03325881|323238258|FG001|Overall Study|Lack of Efficacy|0|||
94396496|NCT03325881|323238257|FG000|Overall Study|Not treated|1|||
94396497|NCT03325881|323238258|FG001|Overall Study|Not treated|0|||
94396498|NCT00606281|323238261|FG000|Overall Study|Adverse Event|11|||
94396499|NCT00606281|323238262|FG001|Overall Study|Adverse Event|12|||
94396500|NCT00606281|323238261|FG000|Overall Study|Death|1|||
94396501|NCT00606281|323238262|FG001|Overall Study|Death|0|||
94396502|NCT00606281|323238261|FG000|Overall Study|Lack of Efficacy|28|||
94396503|NCT00606281|323238262|FG001|Overall Study|Lack of Efficacy|35|||
94396504|NCT00606281|323238261|FG000|Overall Study|Physician Decision|0|||
94396505|NCT00606281|323238262|FG001|Overall Study|Physician Decision|1|||
94396506|NCT00606281|323238261|FG000|Overall Study|Protocol Violation|3|||
94396507|NCT00606281|323238262|FG001|Overall Study|Protocol Violation|3|||
94396508|NCT00606281|323238261|FG000|Overall Study|Withdrawal by Subject|11|||
94396509|NCT00606281|323238262|FG001|Overall Study|Withdrawal by Subject|13|||
94396510|NCT00606281|323238261|FG000|Overall Study|Progression to depressive phase|1|||
94396511|NCT00606281|323238262|FG001|Overall Study|Progression to depressive phase|1|||
94396512|NCT00606281|323238261|FG000|Overall Study|Change of residence or other commitments|1|||
94396513|NCT00606281|323238262|FG001|Overall Study|Change of residence or other commitments|1|||
94396514|NCT02213263|323238265|FG000|Overall Study|Insufficient clinical response|4|||
94396515|NCT02213263|323238266|FG001|Overall Study|Insufficient clinical response|3|||
94396516|NCT02213263|323238265|FG000|Overall Study|Lost to Follow-up|0|||
94396517|NCT02213263|323238266|FG001|Overall Study|Lost to Follow-up|1|||
94396518|NCT02213263|323238265|FG000|Overall Study|No longer willing to participate|3|||
94396519|NCT02213263|323238266|FG001|Overall Study|No longer willing to participate|4|||
94396520|NCT02213263|323238265|FG000|Overall Study|Progressive disease|20|||
94396521|NCT02213263|323238266|FG001|Overall Study|Progressive disease|14|||
94396522|NCT02213263|323238265|FG000|Overall Study|Protocol Violation|0|||
94396523|NCT02213263|323238266|FG001|Overall Study|Protocol Violation|1|||
94396524|NCT02213263|323238265|FG000|Overall Study|Adverse Event|1|||
94396525|NCT02213263|323238266|FG001|Overall Study|Adverse Event|3|||
94396526|NCT02622386|323238267|FG000|First Assignment|Withdrawal by Subject|3|||
94396527|NCT02622386|323238268|FG001|First Assignment|Withdrawal by Subject|2|||
94396528|NCT02622386|323238267|FG000|Washout|Withdrawal by Subject|4|||
94396529|NCT02622386|323238268|FG001|Washout|Withdrawal by Subject|4|||
94396530|NCT02622386|323238267|FG000|Second Assignment|Withdrawal by Subject|0|||
94396531|NCT02622386|323238268|FG001|Second Assignment|Withdrawal by Subject|2|||
94396532|NCT02412852|323238269|FG000|Overall Study|Withdrawal by Subject|0|||
94396533|NCT02412852|323238270|FG001|Overall Study|Withdrawal by Subject|1|||
94396534|NCT02412852|323238271|FG002|Overall Study|Withdrawal by Subject|0|||
94396535|NCT02412852|323238272|FG003|Overall Study|Withdrawal by Subject|0|||
94396536|NCT02412852|323238269|FG000|Overall Study|Physician Decision|0|||
94396537|NCT02412852|323238270|FG001|Overall Study|Physician Decision|0|||
94396538|NCT02412852|323238271|FG002|Overall Study|Physician Decision|0|||
94396539|NCT02412852|323238272|FG003|Overall Study|Physician Decision|1|||
94396540|NCT00909753|323238281|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
94396541|NCT00909753|323238282|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
94396542|NCT00909753|323238281|FG000|Period: Second Intervention|Protocol Violation|1|||
94396543|NCT00909753|323238282|FG001|Period: Second Intervention|Protocol Violation|0|||
94396544|NCT00418145|323238285|FG000|Overall Study|study terminated|6|||
94396545|NCT00924638|323238288|FG000|Overall Study|Death|3|||
94396546|NCT00924638|323238289|FG001|Overall Study|Death|2|||
94396547|NCT00924638|323238288|FG000|Overall Study|Lost to Follow-up|1|||
94396548|NCT00924638|323238289|FG001|Overall Study|Lost to Follow-up|1|||
94396549|NCT00924638|323238288|FG000|Overall Study|Withdrawal by Subject|5|||
94396550|NCT00924638|323238289|FG001|Overall Study|Withdrawal by Subject|7|||
94396551|NCT00924638|323238288|FG000|Overall Study|Physician Decision|3|||
94396552|NCT00924638|323238289|FG001|Overall Study|Physician Decision|3|||
94396553|NCT00847535|323238290|FG000|Overall Study|Withdrawal by Subject|2|||
94396554|NCT00847535|323238291|FG001|Overall Study|Withdrawal by Subject|1|||
94396555|NCT00847535|323238292|FG002|Overall Study|Withdrawal by Subject|1|||
94396556|NCT00847535|323238290|FG000|Overall Study|Lost to Follow-up|0|||
94396557|NCT00847535|323238291|FG001|Overall Study|Lost to Follow-up|1|||
94396558|NCT00847535|323238292|FG002|Overall Study|Lost to Follow-up|0|||
94396559|NCT00906399|323238295|FG000|Year 1|Randomized But Not Treated|0|||
94396560|NCT00906399|323238296|FG001|Year 1|Randomized But Not Treated|1|||
94396561|NCT00906399|323238297|FG002|Year 1|Randomized But Not Treated|3|||
94396562|NCT00906399|323238298|FG003|Year 1|Randomized But Not Treated|0|||
94396563|NCT00906399|323238299|FG004|Year 1|Randomized But Not Treated|0|||
94396564|NCT00906399|323238300|FG005|Year 1|Randomized But Not Treated|0|||
94396565|NCT00906399|323238301|FG006|Year 1|Randomized But Not Treated|0|||
94396566|NCT00906399|323238295|FG000|Year 1|Adverse Event|4|||
94396567|NCT00906399|323238296|FG001|Year 1|Adverse Event|22|||
94396568|NCT00906399|323238297|FG002|Year 1|Adverse Event|24|||
94396569|NCT00906399|323238298|FG003|Year 1|Adverse Event|0|||
94396570|NCT00906399|323238299|FG004|Year 1|Adverse Event|0|||
94396571|NCT00906399|323238300|FG005|Year 1|Adverse Event|0|||
94396572|NCT00906399|323238301|FG006|Year 1|Adverse Event|0|||
94396573|NCT00906399|323238295|FG000|Year 1|Lost to Follow-up|4|||
94396574|NCT00906399|323238296|FG001|Year 1|Lost to Follow-up|4|||
94396575|NCT00906399|323238297|FG002|Year 1|Lost to Follow-up|2|||
94396576|NCT00906399|323238298|FG003|Year 1|Lost to Follow-up|0|||
94396577|NCT00906399|323238299|FG004|Year 1|Lost to Follow-up|0|||
94396578|NCT00906399|323238300|FG005|Year 1|Lost to Follow-up|0|||
94396579|NCT00906399|323238301|FG006|Year 1|Lost to Follow-up|0|||
94396580|NCT00906399|323238295|FG000|Year 1|Withdrawal by Subject|30|||
94396581|NCT00906399|323238296|FG001|Year 1|Withdrawal by Subject|32|||
94396582|NCT00906399|323238297|FG002|Year 1|Withdrawal by Subject|36|||
94396583|NCT00906399|323238298|FG003|Year 1|Withdrawal by Subject|0|||
94396584|NCT00906399|323238299|FG004|Year 1|Withdrawal by Subject|0|||
94396585|NCT00906399|323238300|FG005|Year 1|Withdrawal by Subject|0|||
94396586|NCT00906399|323238301|FG006|Year 1|Withdrawal by Subject|0|||
94396587|NCT00906399|323238295|FG000|Year 1|Physician Decision|0|||
94396588|NCT00906399|323238296|FG001|Year 1|Physician Decision|1|||
94396589|NCT00906399|323238297|FG002|Year 1|Physician Decision|3|||
94396590|NCT00906399|323238298|FG003|Year 1|Physician Decision|0|||
94396591|NCT00906399|323238299|FG004|Year 1|Physician Decision|0|||
94396592|NCT00906399|323238300|FG005|Year 1|Physician Decision|0|||
94396593|NCT00906399|323238301|FG006|Year 1|Physician Decision|0|||
94396594|NCT00906399|323238295|FG000|Year 1|Death|2|||
94396595|NCT00906399|323238296|FG001|Year 1|Death|1|||
94396596|NCT00906399|323238297|FG002|Year 1|Death|1|||
94396597|NCT00906399|323238298|FG003|Year 1|Death|0|||
94396598|NCT00906399|323238299|FG004|Year 1|Death|0|||
94396599|NCT00906399|323238300|FG005|Year 1|Death|0|||
94396600|NCT00906399|323238301|FG006|Year 1|Death|0|||
94396601|NCT00906399|323238295|FG000|Year 1|Other|4|||
94396602|NCT00906399|323238296|FG001|Year 1|Other|2|||
94396603|NCT00906399|323238297|FG002|Year 1|Other|7|||
94396604|NCT00906399|323238298|FG003|Year 1|Other|0|||
94396605|NCT00906399|323238299|FG004|Year 1|Other|0|||
94396606|NCT00906399|323238300|FG005|Year 1|Other|0|||
94396607|NCT00906399|323238301|FG006|Year 1|Other|0|||
94396608|NCT00906399|323238295|FG000|Year 2|Adverse Event|0|||
94396609|NCT00906399|323238296|FG001|Year 2|Adverse Event|0|||
94396610|NCT00906399|323238297|FG002|Year 2|Adverse Event|0|||
94396611|NCT00906399|323238298|FG003|Year 2|Adverse Event|9|||
94396612|NCT00906399|323238299|FG004|Year 2|Adverse Event|8|||
94396613|NCT00906399|323238300|FG005|Year 2|Adverse Event|11|||
94396614|NCT00906399|323238301|FG006|Year 2|Adverse Event|6|||
94396615|NCT00906399|323238295|FG000|Year 2|Lost to Follow-up|0|||
94396616|NCT00906399|323238296|FG001|Year 2|Lost to Follow-up|0|||
94396617|NCT00906399|323238297|FG002|Year 2|Lost to Follow-up|0|||
94396618|NCT00906399|323238298|FG003|Year 2|Lost to Follow-up|1|||
94396619|NCT00906399|323238299|FG004|Year 2|Lost to Follow-up|4|||
94396620|NCT00906399|323238300|FG005|Year 2|Lost to Follow-up|2|||
94396621|NCT00906399|323238301|FG006|Year 2|Lost to Follow-up|4|||
94396622|NCT00906399|323238295|FG000|Year 2|Withdrawal by Subject|0|||
94396623|NCT00906399|323238296|FG001|Year 2|Withdrawal by Subject|0|||
94396624|NCT00906399|323238297|FG002|Year 2|Withdrawal by Subject|0|||
94396625|NCT00906399|323238298|FG003|Year 2|Withdrawal by Subject|17|||
94396626|NCT00906399|323238299|FG004|Year 2|Withdrawal by Subject|18|||
94396627|NCT00906399|323238300|FG005|Year 2|Withdrawal by Subject|27|||
94396628|NCT00906399|323238301|FG006|Year 2|Withdrawal by Subject|13|||
94396629|NCT00906399|323238295|FG000|Year 2|Physician Decision|0|||
94396630|NCT00906399|323238296|FG001|Year 2|Physician Decision|0|||
94396631|NCT00906399|323238297|FG002|Year 2|Physician Decision|0|||
94396632|NCT00906399|323238298|FG003|Year 2|Physician Decision|0|||
94396633|NCT00906399|323238299|FG004|Year 2|Physician Decision|2|||
94396634|NCT00906399|323238300|FG005|Year 2|Physician Decision|6|||
94396635|NCT00906399|323238301|FG006|Year 2|Physician Decision|3|||
94396636|NCT00906399|323238295|FG000|Year 2|Death|0|||
94396637|NCT00906399|323238296|FG001|Year 2|Death|0|||
94396638|NCT00906399|323238297|FG002|Year 2|Death|0|||
94396639|NCT00906399|323238298|FG003|Year 2|Death|1|||
94396640|NCT00906399|323238299|FG004|Year 2|Death|0|||
94396641|NCT00906399|323238300|FG005|Year 2|Death|0|||
94396642|NCT00906399|323238301|FG006|Year 2|Death|3|||
94396643|NCT00906399|323238295|FG000|Year 2|Other|0|||
94396644|NCT00906399|323238296|FG001|Year 2|Other|0|||
94396645|NCT00906399|323238297|FG002|Year 2|Other|0|||
94396646|NCT00906399|323238298|FG003|Year 2|Other|2|||
94396647|NCT00906399|323238299|FG004|Year 2|Other|3|||
94396648|NCT00906399|323238300|FG005|Year 2|Other|1|||
94396649|NCT00906399|323238301|FG006|Year 2|Other|0|||
94396650|NCT00251979|323238303|FG000|Overall Study|Protocol Violation|3|||
94396651|NCT00251979|323238304|FG001|Overall Study|Protocol Violation|5|||
94396652|NCT00251979|323238303|FG000|Overall Study|Adverse Event|11|||
94396653|NCT00251979|323238304|FG001|Overall Study|Adverse Event|17|||
94396654|NCT00251979|323238303|FG000|Overall Study|Withdrawal by Subject|13|||
94396655|NCT00251979|323238304|FG001|Overall Study|Withdrawal by Subject|7|||
94396656|NCT00251979|323238303|FG000|Overall Study|Lost to Follow-up|8|||
94396657|NCT00251979|323238304|FG001|Overall Study|Lost to Follow-up|6|||
94396658|NCT00251979|323238303|FG000|Overall Study|Death|3|||
94396659|NCT00251979|323238304|FG001|Overall Study|Death|5|||
94396660|NCT01566721|323238309|FG000|Treatment Period|Withdrawal by Subject|35|||
94396661|NCT01566721|323238310|FG001|Treatment Period|Withdrawal by Subject|9|||
94396662|NCT01566721|323238309|FG000|Treatment Period|Disease Progression/Recurrence|37|||
94396663|NCT01566721|323238310|FG001|Treatment Period|Disease Progression/Recurrence|13|||
94396664|NCT01566721|323238309|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
94396665|NCT01566721|323238310|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
94396666|NCT01566721|323238309|FG000|Treatment Period|Other|13|||
94396667|NCT01566721|323238310|FG001|Treatment Period|Other|2|||
94396668|NCT01566721|323238309|FG000|Treatment Period|Lack of Compliance|5|||
94396669|NCT01566721|323238310|FG001|Treatment Period|Lack of Compliance|1|||
94396670|NCT01566721|323238309|FG000|Treatment Period|Adverse Event|100|||
94396671|NCT01566721|323238310|FG001|Treatment Period|Adverse Event|30|||
94396672|NCT01566721|323238309|FG000|Treatment Period|Pregnancy|1|||
94396673|NCT01566721|323238310|FG001|Treatment Period|Pregnancy|0|||
94396674|NCT01566721|323238309|FG000|Safety Follow-up|Physician Decision|6|||
94396675|NCT01566721|323238310|FG001|Safety Follow-up|Physician Decision|4|||
94396676|NCT01566721|323238309|FG000|Safety Follow-up|Lost to Follow-up|101|||
94396677|NCT01566721|323238310|FG001|Safety Follow-up|Lost to Follow-up|48|||
94396678|NCT01566721|323238309|FG000|Safety Follow-up|Withdrawal by Subject|155|||
94396679|NCT01566721|323238310|FG001|Safety Follow-up|Withdrawal by Subject|49|||
94396680|NCT01566721|323238309|FG000|Safety Follow-up|Death|28|||
94396681|NCT01566721|323238310|FG001|Safety Follow-up|Death|4|||
94396682|NCT01566721|323238309|FG000|Safety Follow-up|Non-compliance|7|||
94396683|NCT01566721|323238310|FG001|Safety Follow-up|Non-compliance|3|||
94396684|NCT01566721|323238309|FG000|Safety Follow-up|Protocol Violation|7|||
94396685|NCT01566721|323238310|FG001|Safety Follow-up|Protocol Violation|0|||
94396686|NCT01566721|323238309|FG000|Safety Follow-up|Site closure|2|||
94396687|NCT01566721|323238310|FG001|Safety Follow-up|Site closure|3|||
94396688|NCT01566721|323238309|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
94396689|NCT01566721|323238310|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
94396690|NCT01566721|323238309|FG000|Safety Follow-up|Missing|7|||
94396691|NCT01566721|323238310|FG001|Safety Follow-up|Missing|2|||
94396692|NCT01566721|323238309|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
94396693|NCT01566721|323238310|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
94396694|NCT01566721|323238309|FG000|Safety Follow-up|Sponsor decision|1|||
94396695|NCT01566721|323238310|FG001|Safety Follow-up|Sponsor decision|0|||
94396696|NCT01566721|323238309|FG000|Safety Follow-up|Adverse Event|8|||
94396697|NCT01566721|323238310|FG001|Safety Follow-up|Adverse Event|4|||
94396698|NCT01794845|323238314|FG000|Overall Study|Withdrawal by Subject|1|||
94396699|NCT01169558|323238315|FG000|Overall Study|Disease progression|98|||
94396700|NCT01169558|323238315|FG000|Overall Study|Adverse Event|25|||
94396701|NCT01169558|323238315|FG000|Overall Study|Withdrawal of Consent|8|||
94396702|NCT01169558|323238315|FG000|Overall Study|Medical Decision|7|||
94396703|NCT01169558|323238315|FG000|Overall Study|Stable Disease|4|||
94396704|NCT01169558|323238315|FG000|Overall Study|Lost to Follow-up|4|||
94396705|NCT01169558|323238315|FG000|Overall Study|Need for Surgery|4|||
94396706|NCT01169558|323238315|FG000|Overall Study|Non-compliance|2|||
94329360|NCT03846219|322986179|FG001|Overall Study|Withdrawal by Subject|2|||
94329361|NCT03846219|322986180|FG002|Overall Study|Withdrawal by Subject|2|||
94329362|NCT03846219|322986178|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
94396707|NCT01169558|323238315|FG000|Overall Study|Protocol Violation|2|||
94396708|NCT01169558|323238315|FG000|Overall Study|Partial response|2|||
94396709|NCT00429416|323238316|FG000|Overall Study|Death|1|||
94396710|NCT00830024|323238317|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
94396711|NCT00830024|323238318|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
94396712|NCT03273153|323238320|FG000|Overall Study|Adverse Event|1|||
94396713|NCT03273153|323238321|FG001|Overall Study|Adverse Event|2|||
94396714|NCT03273153|323238320|FG000|Overall Study|Missing|0|||
94329363|NCT03846219|322986179|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
94329364|NCT03846219|322986180|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
94329365|NCT03846219|322986178|FG000|Overall Study|Physician Decision|0|||
94329366|NCT03846219|322986179|FG001|Overall Study|Physician Decision|0|||
94329367|NCT03846219|322986180|FG002|Overall Study|Physician Decision|2|||
94329368|NCT02671461|322986181|FG000|Treatment|Adverse Event|0|||
94329369|NCT02671461|322986182|FG001|Treatment|Adverse Event|0|||
94329370|NCT02671461|322986183|FG002|Treatment|Adverse Event|1|||
94329371|NCT02671461|322986181|FG000|Treatment|Administrative Reason by Sponsor|1|||
94329372|NCT02671461|322986182|FG001|Treatment|Administrative Reason by Sponsor|3|||
94329373|NCT02671461|322986183|FG002|Treatment|Administrative Reason by Sponsor|4|||
94329374|NCT02671461|322986181|FG000|Treatment|Randomized, not treated|1|||
94329375|NCT02671461|322986182|FG001|Treatment|Randomized, not treated|0|||
94329376|NCT02671461|322986183|FG002|Treatment|Randomized, not treated|0|||
94329377|NCT02671461|322986181|FG000|Follow-up|Withdrawal by Subject|1|||
94329378|NCT02671461|322986182|FG001|Follow-up|Withdrawal by Subject|0|||
94329379|NCT02671461|322986183|FG002|Follow-up|Withdrawal by Subject|0|||
94329380|NCT02671461|322986181|FG000|Follow-up|Lost to Follow-up|0|||
94329381|NCT02671461|322986182|FG001|Follow-up|Lost to Follow-up|0|||
94329382|NCT02671461|322986183|FG002|Follow-up|Lost to Follow-up|1|||
94329383|NCT02671461|322986181|FG000|Follow-up|Administrative Reason by Sponsor|0|||
94329384|NCT02671461|322986182|FG001|Follow-up|Administrative Reason by Sponsor|1|||
94329385|NCT02671461|322986183|FG002|Follow-up|Administrative Reason by Sponsor|0|||
94329386|NCT01688635|322986186|FG000|Washout 1|Withdrawal by Subject|1|||
94329387|NCT01688635|322986187|FG001|Washout 1|Withdrawal by Subject|0|||
94329388|NCT01688635|322986186|FG000|Washout 1|Adverse Event|0|||
94396715|NCT03273153|323238321|FG001|Overall Study|Missing|2|||
94396716|NCT03273153|323238320|FG000|Overall Study|Other|3|||
94396717|NCT03273153|323238321|FG001|Overall Study|Other|2|||
94396718|NCT03273153|323238320|FG000|Overall Study|Symptomatic Deterioration|0|||
94396719|NCT03273153|323238321|FG001|Overall Study|Symptomatic Deterioration|1|||
94396720|NCT03273153|323238320|FG000|Overall Study|Progressive Disease|6|||
94396721|NCT03273153|323238321|FG001|Overall Study|Progressive Disease|5|||
94396722|NCT03273153|323238320|FG000|Overall Study|Physician Decision|1|||
94396723|NCT03273153|323238321|FG001|Overall Study|Physician Decision|3|||
94396724|NCT03273153|323238320|FG000|Overall Study|Study Terminated by Sponsor|112|||
94396725|NCT03273153|323238321|FG001|Overall Study|Study Terminated by Sponsor|102|||
94396726|NCT03273153|323238320|FG000|Overall Study|Withdrawal by Subject|26|||
94396727|NCT03273153|323238321|FG001|Overall Study|Withdrawal by Subject|25|||
94396728|NCT03273153|323238320|FG000|Overall Study|Protocol Deviation|3|||
94396729|NCT03273153|323238321|FG001|Overall Study|Protocol Deviation|0|||
94396730|NCT03273153|323238320|FG000|Overall Study|Lost to Follow-up|6|||
94396731|NCT03273153|323238321|FG001|Overall Study|Lost to Follow-up|11|||
94396732|NCT03273153|323238320|FG000|Overall Study|Death|66|||
94396733|NCT03273153|323238321|FG001|Overall Study|Death|69|||
94396734|NCT01456221|323238324|FG000|Overall Study|Withdrawal by Subject|56|||
94396735|NCT01456221|323238325|FG001|Overall Study|Withdrawal by Subject|49|||
94396736|NCT01456221|323238324|FG000|Overall Study|Lost to Follow-up|1|||
94329389|NCT01688635|322986187|FG001|Washout 1|Adverse Event|1|||
94329390|NCT01688635|322986186|FG000|Washout 1|Physician Decision|0|||
94329391|NCT01688635|322986187|FG001|Washout 1|Physician Decision|1|||
94329392|NCT01688635|322986186|FG000|Washout 2|Physician Decision|1|||
94329393|NCT01688635|322986187|FG001|Washout 2|Physician Decision|0|||
94396737|NCT01456221|323238325|FG001|Overall Study|Lost to Follow-up|4|||
94396738|NCT01456221|323238324|FG000|Overall Study|Received medication|3|||
94396739|NCT01456221|323238325|FG001|Overall Study|Received medication|2|||
94396740|NCT01456221|323238324|FG000|Overall Study|Incomplete data|4|||
94396741|NCT01456221|323238325|FG001|Overall Study|Incomplete data|2|||
94329394|NCT01688635|322986186|FG000|Washout 2|Withdrawal by Subject|1|||
94329395|NCT01688635|322986187|FG001|Washout 2|Withdrawal by Subject|0|||
94329396|NCT01688635|322986186|FG000|Washout 2|Sponsor Decision|1|||
94329397|NCT01688635|322986187|FG001|Washout 2|Sponsor Decision|2|||
94329398|NCT01688635|322986186|FG000|Washout 3|Withdrawal by Subject|1|||
94329399|NCT01688635|322986187|FG001|Washout 3|Withdrawal by Subject|0|||
94329400|NCT01924299|322986192|FG000|Period 2|Withdrawal by Subject|1|||
94329401|NCT01924299|322986193|FG001|Period 2|Withdrawal by Subject|0|||
94329402|NCT01924299|322986192|FG000|Period 2|Adverse Event|0|||
94396742|NCT02409355|323238326|FG000|Overall Study|Withdrawal by Subject|1|||
94396743|NCT02409355|323238327|FG001|Overall Study|Withdrawal by Subject|0|||
94396744|NCT02409355|323238326|FG000|Overall Study|Death|1|||
94396745|NCT02409355|323238327|FG001|Overall Study|Death|1|||
94396746|NCT02409355|323238326|FG000|Overall Study|Study terminated by Sponsor|2|||
94396747|NCT02409355|323238327|FG001|Overall Study|Study terminated by Sponsor|3|||
94396748|NCT01237054|323238328|FG000|Overall Study|imaging 10C0096|1|||
94396749|NCT02301975|323239987|FG000|Overall Study|Adverse Event|8|||
94396750|NCT02301975|323239988|FG001|Overall Study|Adverse Event|3|||
94396751|NCT02301975|323239989|FG002|Overall Study|Adverse Event|2|||
94396752|NCT02301975|323239987|FG000|Overall Study|Lack of Efficacy|1|||
94396753|NCT02301975|323239988|FG001|Overall Study|Lack of Efficacy|1|||
94396754|NCT02301975|323239989|FG002|Overall Study|Lack of Efficacy|1|||
94396755|NCT02301975|323239987|FG000|Overall Study|Protocol Violation|3|||
94396756|NCT02301975|323239988|FG001|Overall Study|Protocol Violation|5|||
94396757|NCT02301975|323239989|FG002|Overall Study|Protocol Violation|3|||
94396758|NCT02301975|323239987|FG000|Overall Study|Lost to Follow-up|0|||
94396759|NCT02301975|323239988|FG001|Overall Study|Lost to Follow-up|2|||
94396760|NCT02301975|323239989|FG002|Overall Study|Lost to Follow-up|2|||
94396761|NCT02301975|323239987|FG000|Overall Study|Physician Decision|4|||
94396762|NCT02301975|323239988|FG001|Overall Study|Physician Decision|2|||
94396763|NCT02301975|323239989|FG002|Overall Study|Physician Decision|3|||
94396764|NCT02301975|323239987|FG000|Overall Study|Withdrawal by Subject|15|||
94396765|NCT02301975|323239988|FG001|Overall Study|Withdrawal by Subject|12|||
94396766|NCT02301975|323239989|FG002|Overall Study|Withdrawal by Subject|11|||
94396767|NCT02149420|323239990|FG000|Core Study|Administrative problems|0|||
94396768|NCT02149420|323239991|FG001|Core Study|Administrative problems|1|||
94396769|NCT02149420|323239992|FG002|Core Study|Administrative problems|2|||
94396770|NCT02149420|323239990|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
94396771|NCT02149420|323239991|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
94396772|NCT02149420|323239992|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
94396773|NCT00440518|323239996|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
94396774|NCT00440518|323239997|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
94396775|NCT00440518|323239998|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
94396776|NCT00440518|323239996|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
94396777|NCT00440518|323239997|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
94396778|NCT00440518|323239998|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
94396779|NCT00440518|323239996|FG000|Randomized /Titration Period|Protocol Deviation|1|||
94396780|NCT00440518|323239997|FG001|Randomized /Titration Period|Protocol Deviation|0|||
94396781|NCT00440518|323239998|FG002|Randomized /Titration Period|Protocol Deviation|0|||
94396782|NCT00440518|323239996|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
94396783|NCT00440518|323239997|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
94396784|NCT00440518|323239998|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
94396785|NCT00440518|323239996|FG000|Randomized /Titration Period|Other|1|||
94396786|NCT00440518|323239997|FG001|Randomized /Titration Period|Other|0|||
94396787|NCT00440518|323239998|FG002|Randomized /Titration Period|Other|0|||
94396788|NCT00440518|323239996|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
94396789|NCT00440518|323239997|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
94396790|NCT00440518|323239998|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
94396791|NCT00440518|323239996|FG000|Randomized /Titration Period|Adverse Event|2|||
94396792|NCT00440518|323239997|FG001|Randomized /Titration Period|Adverse Event|3|||
94396793|NCT00440518|323239998|FG002|Randomized /Titration Period|Adverse Event|0|||
94396794|NCT00440518|323239996|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
94396795|NCT00440518|323239997|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
94396796|NCT00440518|323239998|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
94396797|NCT00440518|323239996|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
94396798|NCT00440518|323239997|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
94396799|NCT00440518|323239998|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
94396800|NCT00440518|323239996|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
94396801|NCT00440518|323239997|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
94396802|NCT00440518|323239998|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
94396803|NCT00440518|323239996|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
94396804|NCT00440518|323239997|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
94396805|NCT00440518|323239998|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
94396806|NCT00440518|323239996|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
94396807|NCT00440518|323239997|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
94396808|NCT00440518|323239998|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
94396809|NCT00440518|323239996|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
94396810|NCT00440518|323239997|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
94396811|NCT00440518|323239998|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
94396812|NCT06195579|323240003|FG000|Overall Study|Withdrawal by Subject|1|||
94396813|NCT00573443|323240004|FG000|Double-Blind Phase|Lost to Follow-up|1|||
94396814|NCT00573443|323240005|FG001|Double-Blind Phase|Lost to Follow-up|3|||
94396815|NCT00573443|323240006|FG002|Double-Blind Phase|Lost to Follow-up|2|||
94396816|NCT00573443|323240004|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
94396817|NCT00573443|323240005|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
94396818|NCT00573443|323240006|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
94396819|NCT00573443|323240004|FG000|Double-Blind Phase|Adverse Event|1|||
94396820|NCT00573443|323240005|FG001|Double-Blind Phase|Adverse Event|5|||
94396821|NCT00573443|323240006|FG002|Double-Blind Phase|Adverse Event|0|||
94396822|NCT00573443|323240004|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
94396823|NCT00573443|323240005|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
94396824|NCT00573443|323240006|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
94396825|NCT00573443|323240004|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
94396826|NCT00573443|323240005|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
94396827|NCT00573443|323240006|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
94396828|NCT00573443|323240004|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
94396829|NCT00573443|323240005|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
94396830|NCT00573443|323240006|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
94396831|NCT00573443|323240004|FG000|Double-Blind Phase|Protocol Violation|0|||
94396832|NCT00573443|323240005|FG001|Double-Blind Phase|Protocol Violation|2|||
94396833|NCT00573443|323240006|FG002|Double-Blind Phase|Protocol Violation|1|||
94396834|NCT00573443|323240004|FG000|Double-Blind Phase|Other|0|||
94396835|NCT00573443|323240005|FG001|Double-Blind Phase|Other|2|||
94396836|NCT00573443|323240006|FG002|Double-Blind Phase|Other|3|||
94396837|NCT00573443|323240004|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
94396838|NCT00573443|323240005|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
94396839|NCT00573443|323240006|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
94396840|NCT00573443|323240004|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
94396841|NCT00573443|323240005|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
94396842|NCT00573443|323240006|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
94396843|NCT00573443|323240004|FG000|Open-Label Extension Phase|Adverse Event|3|||
94396844|NCT00573443|323240005|FG001|Open-Label Extension Phase|Adverse Event|0|||
94396845|NCT00573443|323240006|FG002|Open-Label Extension Phase|Adverse Event|0|||
94396846|NCT00573443|323240004|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
94396847|NCT00573443|323240005|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
94396848|NCT00573443|323240006|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
94396849|NCT00573443|323240004|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
94396850|NCT00573443|323240005|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
94396851|NCT00573443|323240006|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
94396852|NCT00573443|323240004|FG000|Open-Label Extension Phase|Protocol Violation|2|||
94396853|NCT00573443|323240005|FG001|Open-Label Extension Phase|Protocol Violation|0|||
94396854|NCT00573443|323240006|FG002|Open-Label Extension Phase|Protocol Violation|0|||
94396855|NCT00573443|323240004|FG000|Open-Label Extension Phase|Other|2|||
94396856|NCT00573443|323240005|FG001|Open-Label Extension Phase|Other|0|||
94396857|NCT00573443|323240006|FG002|Open-Label Extension Phase|Other|0|||
94396858|NCT00905606|323240007|FG000|Period 1|Adverse Event|0|||
94396859|NCT00905606|323240008|FG001|Period 1|Adverse Event|1|||
94396860|NCT00905606|323240007|FG000|Washout|Withdrawal by Subject|1|||
94396861|NCT00905606|323240008|FG001|Washout|Withdrawal by Subject|0|||
94396862|NCT00804856|323240010|FG000|Overall Study|Progressive Disease|3|||
94396863|NCT00804856|323240011|FG001|Overall Study|Progressive Disease|2|||
94396864|NCT00804856|323240012|FG002|Overall Study|Progressive Disease|4|||
94396865|NCT00804856|323240013|FG003|Overall Study|Progressive Disease|6|||
94396866|NCT00804856|323240014|FG004|Overall Study|Progressive Disease|4|||
94396867|NCT00804856|323240015|FG005|Overall Study|Progressive Disease|1|||
94396868|NCT00804856|323240016|FG006|Overall Study|Progressive Disease|8|||
94396869|NCT00804856|323240017|FG007|Overall Study|Progressive Disease|2|||
94396870|NCT00804856|323240018|FG008|Overall Study|Progressive Disease|4|||
94396871|NCT00804856|323240019|FG009|Overall Study|Progressive Disease|5|||
94396872|NCT00804856|323240020|FG010|Overall Study|Progressive Disease|12|||
94396873|NCT00804856|323240021|FG011|Overall Study|Progressive Disease|2|||
94396874|NCT00804856|323240022|FG012|Overall Study|Progressive Disease|2|||
94396875|NCT00804856|323240023|FG013|Overall Study|Progressive Disease|26|||
94396876|NCT00804856|323240024|FG014|Overall Study|Progressive Disease|20|||
94396877|NCT00804856|323240010|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94396878|NCT00804856|323240011|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94396879|NCT00804856|323240012|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94396880|NCT00804856|323240013|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94396881|NCT00804856|323240014|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
94396882|NCT00804856|323240015|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94396883|NCT00804856|323240016|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94396884|NCT00804856|323240017|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94396885|NCT00804856|323240018|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94396886|NCT00804856|323240019|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94396887|NCT00804856|323240020|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94396888|NCT00804856|323240021|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94396889|NCT00804856|323240022|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94396890|NCT00804856|323240023|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
94396891|NCT00804856|323240024|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
94396892|NCT00804856|323240010|FG000|Overall Study|Other Adverse Event|1|||
94396893|NCT00804856|323240011|FG001|Overall Study|Other Adverse Event|1|||
94396894|NCT00804856|323240012|FG002|Overall Study|Other Adverse Event|1|||
94396895|NCT00804856|323240013|FG003|Overall Study|Other Adverse Event|2|||
94396896|NCT00804856|323240014|FG004|Overall Study|Other Adverse Event|2|||
94396897|NCT00804856|323240015|FG005|Overall Study|Other Adverse Event|1|||
94396898|NCT00804856|323240016|FG006|Overall Study|Other Adverse Event|3|||
94396899|NCT00804856|323240017|FG007|Overall Study|Other Adverse Event|0|||
94396900|NCT00804856|323240018|FG008|Overall Study|Other Adverse Event|0|||
94396901|NCT00804856|323240019|FG009|Overall Study|Other Adverse Event|1|||
94396902|NCT00804856|323240020|FG010|Overall Study|Other Adverse Event|5|||
94396903|NCT00804856|323240021|FG011|Overall Study|Other Adverse Event|2|||
94396904|NCT00804856|323240022|FG012|Overall Study|Other Adverse Event|0|||
94396905|NCT00804856|323240023|FG013|Overall Study|Other Adverse Event|6|||
94396906|NCT00804856|323240024|FG014|Overall Study|Other Adverse Event|13|||
94396907|NCT00804856|323240010|FG000|Overall Study|Non compliance with protocol|0|||
94396908|NCT00804856|323240011|FG001|Overall Study|Non compliance with protocol|0|||
94396909|NCT00804856|323240012|FG002|Overall Study|Non compliance with protocol|0|||
94396910|NCT00804856|323240013|FG003|Overall Study|Non compliance with protocol|0|||
94396911|NCT00804856|323240014|FG004|Overall Study|Non compliance with protocol|0|||
94396912|NCT00804856|323240015|FG005|Overall Study|Non compliance with protocol|0|||
94396913|NCT00804856|323240016|FG006|Overall Study|Non compliance with protocol|0|||
94396914|NCT00804856|323240017|FG007|Overall Study|Non compliance with protocol|0|||
94396915|NCT00804856|323240018|FG008|Overall Study|Non compliance with protocol|0|||
94396916|NCT00804856|323240019|FG009|Overall Study|Non compliance with protocol|0|||
94396917|NCT00804856|323240020|FG010|Overall Study|Non compliance with protocol|0|||
94396918|NCT00804856|323240021|FG011|Overall Study|Non compliance with protocol|0|||
94396919|NCT00804856|323240022|FG012|Overall Study|Non compliance with protocol|0|||
94396920|NCT00804856|323240023|FG013|Overall Study|Non compliance with protocol|2|||
94396921|NCT00804856|323240024|FG014|Overall Study|Non compliance with protocol|0|||
94396922|NCT00804856|323240010|FG000|Overall Study|Refused to continue medication|0|||
94396923|NCT00804856|323240011|FG001|Overall Study|Refused to continue medication|0|||
94396924|NCT00804856|323240012|FG002|Overall Study|Refused to continue medication|0|||
94396925|NCT00804856|323240013|FG003|Overall Study|Refused to continue medication|1|||
94396926|NCT00804856|323240014|FG004|Overall Study|Refused to continue medication|1|||
94396927|NCT00804856|323240015|FG005|Overall Study|Refused to continue medication|0|||
94396928|NCT00804856|323240016|FG006|Overall Study|Refused to continue medication|0|||
94396929|NCT00804856|323240017|FG007|Overall Study|Refused to continue medication|0|||
94396930|NCT00804856|323240018|FG008|Overall Study|Refused to continue medication|0|||
94396931|NCT00804856|323240019|FG009|Overall Study|Refused to continue medication|0|||
94396932|NCT00804856|323240020|FG010|Overall Study|Refused to continue medication|3|||
94396933|NCT00804856|323240021|FG011|Overall Study|Refused to continue medication|0|||
94396934|NCT00804856|323240022|FG012|Overall Study|Refused to continue medication|1|||
94396935|NCT00804856|323240023|FG013|Overall Study|Refused to continue medication|1|||
94396936|NCT00804856|323240024|FG014|Overall Study|Refused to continue medication|5|||
94396937|NCT00804856|323240010|FG000|Overall Study|Other reason than listed above|0|||
94396938|NCT00804856|323240011|FG001|Overall Study|Other reason than listed above|0|||
94396939|NCT00804856|323240012|FG002|Overall Study|Other reason than listed above|0|||
94396940|NCT00804856|323240013|FG003|Overall Study|Other reason than listed above|0|||
94396941|NCT00804856|323240014|FG004|Overall Study|Other reason than listed above|0|||
94396942|NCT00804856|323240015|FG005|Overall Study|Other reason than listed above|1|||
94396943|NCT00804856|323240016|FG006|Overall Study|Other reason than listed above|0|||
94396944|NCT00804856|323240017|FG007|Overall Study|Other reason than listed above|0|||
94396945|NCT00804856|323240018|FG008|Overall Study|Other reason than listed above|1|||
94396946|NCT00804856|323240019|FG009|Overall Study|Other reason than listed above|0|||
94396947|NCT00804856|323240020|FG010|Overall Study|Other reason than listed above|3|||
94396948|NCT00804856|323240021|FG011|Overall Study|Other reason than listed above|1|||
94396949|NCT00804856|323240022|FG012|Overall Study|Other reason than listed above|1|||
94396950|NCT00804856|323240023|FG013|Overall Study|Other reason than listed above|10|||
94396951|NCT00804856|323240024|FG014|Overall Study|Other reason than listed above|3|||
94396952|NCT00835575|323240025|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
94396953|NCT00835575|323240026|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
94396954|NCT01440803|323240027|FG000|Overall Study|Met study stopping rule|2|||
94396955|NCT01440803|323240028|FG001|Overall Study|Met study stopping rule|1|||
94396956|NCT01440803|323240027|FG000|Overall Study|Lost to Follow-up|0|||
94396957|NCT01440803|323240028|FG001|Overall Study|Lost to Follow-up|2|||
94396958|NCT01440803|323240027|FG000|Overall Study|Withdrawal by Subject|0|||
94396959|NCT01440803|323240028|FG001|Overall Study|Withdrawal by Subject|1|||
94396960|NCT03868891|323240029|FG000|Overall Study|Adverse Event|1|||
94396961|NCT03868891|323240030|FG001|Overall Study|Adverse Event|0|||
94484604|NCT03118934|323567517|FG003|Overall Study|Discontinued prior to exposure|1|||
94484605|NCT03118934|323567518|FG004|Overall Study|Discontinued prior to exposure|2|||
94329403|NCT01924299|322986193|FG001|Period 2|Adverse Event|1|||
94329404|NCT00617656|322986198|FG000|Overall Study|Inclusion error|4|||
94329405|NCT00617656|322986199|FG001|Overall Study|Inclusion error|4|||
94329406|NCT00617656|322986200|FG002|Overall Study|Inclusion error|0|||
94329407|NCT00617656|322986201|FG003|Overall Study|Inclusion error|0|||
94329408|NCT00617656|322986198|FG000|Overall Study|Missing data|44|||
94329409|NCT00617656|322986199|FG001|Overall Study|Missing data|30|||
94329410|NCT00617656|322986200|FG002|Overall Study|Missing data|13|||
94329411|NCT00617656|322986201|FG003|Overall Study|Missing data|6|||
94329412|NCT00617656|322986198|FG000|Overall Study|Withdrawal by Subject|0|||
94329413|NCT00617656|322986199|FG001|Overall Study|Withdrawal by Subject|2|||
94329414|NCT00617656|322986200|FG002|Overall Study|Withdrawal by Subject|0|||
94329415|NCT00617656|322986201|FG003|Overall Study|Withdrawal by Subject|0|||
94329416|NCT00719953|322986204|FG000|Overall Study|Adverse Event|4|||
94329417|NCT00642018|322986205|FG000|Overall Study|Adverse Event|11|||
94329418|NCT00642018|322986206|FG001|Overall Study|Adverse Event|36|||
94329419|NCT00642018|322986205|FG000|Overall Study|Withdrawal by Subject|4|||
94329420|NCT00642018|322986206|FG001|Overall Study|Withdrawal by Subject|10|||
94329421|NCT00642018|322986205|FG000|Overall Study|Progressive Disease|13|||
94329422|NCT00642018|322986206|FG001|Overall Study|Progressive Disease|18|||
94329423|NCT00642018|322986205|FG000|Overall Study|Physician Decision|0|||
94329424|NCT00642018|322986206|FG001|Overall Study|Physician Decision|10|||
94329425|NCT00642018|322986205|FG000|Overall Study|Protocol Violation|0|||
94329426|NCT00642018|322986206|FG001|Overall Study|Protocol Violation|1|||
94329427|NCT00642018|322986205|FG000|Overall Study|Death|0|||
94329428|NCT00642018|322986206|FG001|Overall Study|Death|3|||
94329429|NCT00642018|322986205|FG000|Overall Study|Entry Criteria Not Met|0|||
94329430|NCT00642018|322986206|FG001|Overall Study|Entry Criteria Not Met|1|||
94329431|NCT02109744|322987979|FG000|Overall Study|Death|1|||
94329432|NCT02109744|322987980|FG001|Overall Study|Death|1|||
94329433|NCT02109744|322987979|FG000|Overall Study|no marrow exam|1|||
94329434|NCT02109744|322987980|FG001|Overall Study|no marrow exam|0|||
94329435|NCT02658968|322987981|FG000|Received Rituximab|Adverse Event|0|||
94329436|NCT02658968|322987982|FG001|Received Rituximab|Adverse Event|0|||
94329437|NCT02658968|322987983|FG002|Received Rituximab|Adverse Event|0|||
94329438|NCT02658968|322987984|FG003|Received Rituximab|Adverse Event|0|||
94329439|NCT02658968|322987985|FG004|Received Rituximab|Adverse Event|1|||
94329440|NCT02658968|322987981|FG000|Received Rituximab|Progressive disease|0|||
94329441|NCT02658968|322987982|FG001|Received Rituximab|Progressive disease|0|||
94329442|NCT02658968|322987983|FG002|Received Rituximab|Progressive disease|0|||
94329443|NCT02658968|322987984|FG003|Received Rituximab|Progressive disease|0|||
94329444|NCT02658968|322987985|FG004|Received Rituximab|Progressive disease|1|||
94329445|NCT02658968|322987981|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
94329446|NCT02658968|322987982|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
94329447|NCT02658968|322987983|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
94329448|NCT02658968|322987984|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
94329449|NCT02658968|322987985|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
94329450|NCT02658968|322987981|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
94329451|NCT02658968|322987982|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
94329452|NCT02658968|322987983|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
94329453|NCT02658968|322987984|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
94329454|NCT02658968|322987985|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
94329455|NCT02658968|322987981|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
94329456|NCT02658968|322987982|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
94329457|NCT02658968|322987983|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
94329458|NCT02658968|322987984|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
94329459|NCT02658968|322987985|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
94329460|NCT02658968|322987981|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
94329461|NCT02658968|322987982|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
94329462|NCT02658968|322987983|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
94329463|NCT02658968|322987984|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
94329464|NCT02658968|322987985|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
94329465|NCT02658968|322987981|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
94329466|NCT02658968|322987982|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
94329467|NCT02658968|322987983|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
94329468|NCT02658968|322987984|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
94329469|NCT02658968|322987985|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
94329470|NCT02667457|322987986|FG000|Overall Study|Withdrawal by Subject|1|||
94329471|NCT02667457|322987987|FG001|Overall Study|Withdrawal by Subject|0|||
94484606|NCT03118934|323567519|FG005|Overall Study|Discontinued prior to exposure|0|||
94329472|NCT02667457|322987986|FG000|Overall Study|Other Reason|0|||
94329473|NCT02667457|322987987|FG001|Overall Study|Other Reason|2|||
94329474|NCT02475850|322987988|FG000|Overall Study|Death|155|||
94329475|NCT02475850|322987989|FG001|Overall Study|Death|141|||
94329476|NCT02475850|322987988|FG000|Overall Study|Lost to Follow-up|217|||
94329477|NCT02475850|322987989|FG001|Overall Study|Lost to Follow-up|188|||
94329478|NCT02475850|322987988|FG000|Overall Study|Withdrawal by Subject|221|||
94329479|NCT02475850|322987989|FG001|Overall Study|Withdrawal by Subject|155|||
94329480|NCT02700919|322987990|FG000|Overall Study|Physician Decision|1|||
94329481|NCT02700919|322987991|FG001|Overall Study|Physician Decision|0|||
94329482|NCT02700919|322987992|FG002|Overall Study|Physician Decision|0|||
94329483|NCT02700919|322987990|FG000|Overall Study|Protocol Violation|1|||
94329484|NCT02700919|322987991|FG001|Overall Study|Protocol Violation|0|||
94329485|NCT02700919|322987992|FG002|Overall Study|Protocol Violation|0|||
94329486|NCT02700919|322987990|FG000|Overall Study|Adverse Event|1|||
94329487|NCT02700919|322987991|FG001|Overall Study|Adverse Event|3|||
94329488|NCT02700919|322987992|FG002|Overall Study|Adverse Event|1|||
94329489|NCT02700919|322987990|FG000|Overall Study|Withdrawal by Subject|5|||
94329490|NCT02700919|322987991|FG001|Overall Study|Withdrawal by Subject|8|||
94329491|NCT02700919|322987992|FG002|Overall Study|Withdrawal by Subject|2|||
94329492|NCT02700919|322987990|FG000|Overall Study|Lost to Follow-up|2|||
94329493|NCT02700919|322987991|FG001|Overall Study|Lost to Follow-up|0|||
94329494|NCT02700919|322987992|FG002|Overall Study|Lost to Follow-up|0|||
94329495|NCT02700919|322987990|FG000|Overall Study|Other|2|||
94329496|NCT02700919|322987991|FG001|Overall Study|Other|1|||
94329497|NCT02700919|322987992|FG002|Overall Study|Other|1|||
94329498|NCT02528253|322987999|FG000|Overall Study|Adverse Event|3|||
94329499|NCT02528253|322988000|FG001|Overall Study|Adverse Event|4|||
94329500|NCT02528253|322988001|FG002|Overall Study|Adverse Event|4|||
94329501|NCT02528253|322988002|FG003|Overall Study|Adverse Event|8|||
94329502|NCT02528253|322988003|FG004|Overall Study|Adverse Event|18|||
94329503|NCT02528253|322987999|FG000|Overall Study|Death|2|||
94329504|NCT02528253|322988000|FG001|Overall Study|Death|2|||
94329505|NCT02528253|322988001|FG002|Overall Study|Death|1|||
94329506|NCT02528253|322988002|FG003|Overall Study|Death|0|||
94329507|NCT02528253|322988003|FG004|Overall Study|Death|1|||
94329508|NCT02528253|322987999|FG000|Overall Study|Insufficient clinical response|7|||
94329509|NCT02528253|322988000|FG001|Overall Study|Insufficient clinical response|10|||
94329510|NCT02528253|322988001|FG002|Overall Study|Insufficient clinical response|13|||
94329511|NCT02528253|322988002|FG003|Overall Study|Insufficient clinical response|12|||
94329512|NCT02528253|322988003|FG004|Overall Study|Insufficient clinical response|16|||
94329513|NCT02528253|322987999|FG000|Overall Study|Lost to Follow-up|16|||
94329514|NCT02528253|322988000|FG001|Overall Study|Lost to Follow-up|9|||
94329515|NCT02528253|322988001|FG002|Overall Study|Lost to Follow-up|31|||
94329516|NCT02528253|322988002|FG003|Overall Study|Lost to Follow-up|16|||
94329517|NCT02528253|322988003|FG004|Overall Study|Lost to Follow-up|34|||
94329518|NCT02528253|322987999|FG000|Overall Study|Other|21|||
94329519|NCT02528253|322988000|FG001|Overall Study|Other|22|||
94329520|NCT02528253|322988001|FG002|Overall Study|Other|58|||
94329521|NCT02528253|322988002|FG003|Overall Study|Other|52|||
94329522|NCT02528253|322988003|FG004|Overall Study|Other|76|||
94329523|NCT02528253|322987999|FG000|Overall Study|Withdrawal by Subject|25|||
94329524|NCT02528253|322988000|FG001|Overall Study|Withdrawal by Subject|20|||
94329525|NCT02528253|322988001|FG002|Overall Study|Withdrawal by Subject|29|||
94329526|NCT02528253|322988002|FG003|Overall Study|Withdrawal by Subject|48|||
94329527|NCT02528253|322988003|FG004|Overall Study|Withdrawal by Subject|73|||
94329528|NCT02528253|322987999|FG000|Overall Study|Protocol Violation|1|||
94329529|NCT02528253|322988000|FG001|Overall Study|Protocol Violation|2|||
94329530|NCT02528253|322988001|FG002|Overall Study|Protocol Violation|4|||
94329531|NCT02528253|322988002|FG003|Overall Study|Protocol Violation|0|||
94329532|NCT02528253|322988003|FG004|Overall Study|Protocol Violation|4|||
94329533|NCT02528253|322987999|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
94329534|NCT02528253|322988000|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
94329535|NCT02528253|322988001|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
94329536|NCT02528253|322988002|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
94329537|NCT02528253|322988003|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
94329538|NCT01711541|322988007|FG000|Overall Study|Cancel prior to treatment|0|||
94329539|NCT01711541|322988008|FG001|Overall Study|Cancel prior to treatment|0|||
94329540|NCT01711541|322988009|FG002|Overall Study|Cancel prior to treatment|0|||
94329541|NCT01711541|322988010|FG003|Overall Study|Cancel prior to treatment|1|||
94329542|NCT01711541|322988011|FG004|Overall Study|Cancel prior to treatment|0|||
94329543|NCT01711541|322988007|FG000|Overall Study|Ineligible|0|||
94329544|NCT01711541|322988008|FG001|Overall Study|Ineligible|1|||
94329545|NCT01711541|322988009|FG002|Overall Study|Ineligible|0|||
94329546|NCT01711541|322988010|FG003|Overall Study|Ineligible|0|||
94329547|NCT01711541|322988011|FG004|Overall Study|Ineligible|0|||
94329548|NCT00728936|322988012|FG000|Overall Study|Withdrawal by Subject|0|||
94329549|NCT00728936|322988013|FG001|Overall Study|Withdrawal by Subject|0|||
94329550|NCT00728936|322988014|FG002|Overall Study|Withdrawal by Subject|0|||
94396962|NCT03868891|323240029|FG000|Overall Study|Lost to Follow-up|2|||
94396963|NCT03868891|323240030|FG001|Overall Study|Lost to Follow-up|1|||
94396964|NCT03868891|323240029|FG000|Overall Study|COVID-19 Restrictions|1|||
94396965|NCT03868891|323240030|FG001|Overall Study|COVID-19 Restrictions|2|||
94396966|NCT02125461|323240031|FG000|Overall Study|Withdrawal by Subject|30|||
94396967|NCT02125461|323240032|FG001|Overall Study|Withdrawal by Subject|16|||
94396968|NCT02125461|323240031|FG000|Overall Study|Lost to Follow-up|8|||
94396969|NCT02125461|323240032|FG001|Overall Study|Lost to Follow-up|3|||
94396970|NCT02125461|323240031|FG000|Overall Study|Death|260|||
94396971|NCT02125461|323240032|FG001|Overall Study|Death|149|||
94396972|NCT02125461|323240031|FG000|Overall Study|Missing Termination Reason|0|||
94396973|NCT02125461|323240032|FG001|Overall Study|Missing Termination Reason|1|||
94396974|NCT03049748|323240040|FG000|Overall Study|Lost to Follow-up|1|||
94396975|NCT03049748|323240041|FG001|Overall Study|Lost to Follow-up|0|||
94396976|NCT03049748|323240040|FG000|Overall Study|Death|3|||
94396977|NCT03049748|323240041|FG001|Overall Study|Death|0|||
94396978|NCT03049748|323240040|FG000|Overall Study|Withdrawal by Subject|0|||
94396979|NCT03049748|323240041|FG001|Overall Study|Withdrawal by Subject|3|||
94396980|NCT03049748|323240040|FG000|Overall Study|Protocol Violation|0|||
94396981|NCT03049748|323240041|FG001|Overall Study|Protocol Violation|2|||
94396982|NCT03049748|323240040|FG000|Overall Study|Moved out of state (relocation)|0|||
94396983|NCT03049748|323240041|FG001|Overall Study|Moved out of state (relocation)|1|||
94396984|NCT02659150|323240042|FG000|Subject Enrollment|Physician Decision|3|||
94396985|NCT02659150|323240042|FG000|Subject Enrollment|Withdrawal by Subject|2|||
94396986|NCT02659150|323240042|FG000|Baseline Imaging|Withdrawal by Subject|1|||
94396987|NCT02659150|323240042|FG000|Baseline Imaging|Physician Decision|1|||
94396988|NCT02659150|323240042|FG000|Study Drug Dosing|Adverse Event|1|||
94396989|NCT01471353|323240048|FG000|Overall Study|remain on study|3|||
94396990|NCT03502811|323240050|FG000|Overall Study|Death|157|||
94396991|NCT03502811|323240050|FG000|Overall Study|Withdrawal by Subject|105|||
94396992|NCT03502811|323240050|FG000|Overall Study|Lost to Follow-up|26|||
94396993|NCT03502811|323240050|FG000|Overall Study|No Visits (Missed)|31|||
94396994|NCT03913377|323240051|FG000|Period 1|Test Article no longer available|0|||
94396995|NCT03913377|323240052|FG001|Period 1|Test Article no longer available|1|||
94396996|NCT03913377|323240053|FG002|Period 1|Test Article no longer available|0|||
94396997|NCT03913377|323240051|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
94396998|NCT03913377|323240052|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
94396999|NCT03913377|323240053|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
94397000|NCT03123094|323240054|FG000|Overall Study|Withdrawal by Subject|0|||
94397001|NCT03123094|323240055|FG001|Overall Study|Withdrawal by Subject|2|||
94397002|NCT03123094|323240056|FG002|Overall Study|Withdrawal by Subject|1|||
94397003|NCT03123094|323240057|FG003|Overall Study|Withdrawal by Subject|0|||
94397004|NCT03123094|323240058|FG004|Overall Study|Withdrawal by Subject|1|||
94397005|NCT05239195|323240059|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
94397006|NCT05239195|323240060|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
94397007|NCT04994535|323240061|FG000|Overall Study|Lost to Follow-up|7|||
94397008|NCT04994535|323240062|FG001|Overall Study|Lost to Follow-up|7|||
94397009|NCT04994535|323240061|FG000|Overall Study|Withdrawal by Subject|10|||
94397010|NCT04994535|323240062|FG001|Overall Study|Withdrawal by Subject|7|||
94397011|NCT04994535|323240061|FG000|Overall Study|Other|1|||
94397012|NCT04994535|323240062|FG001|Overall Study|Other|1|||
94397013|NCT03128723|323240065|FG000|Overall Study|Withdrawal by Subject|2|||
94397014|NCT01839279|323240068|FG000|Overall Study|Adverse Event|4|||
94397015|NCT01839279|323240069|FG001|Overall Study|Adverse Event|1|||
94397016|NCT01839279|323240070|FG002|Overall Study|Adverse Event|1|||
94397017|NCT01839279|323240068|FG000|Overall Study|Withdrawal by Subject|4|||
94397018|NCT01839279|323240069|FG001|Overall Study|Withdrawal by Subject|1|||
94397019|NCT01839279|323240070|FG002|Overall Study|Withdrawal by Subject|1|||
94397020|NCT01839279|323240068|FG000|Overall Study|Classified as 'Other'|5|||
94397021|NCT01839279|323240069|FG001|Overall Study|Classified as 'Other'|0|||
94397022|NCT01839279|323240070|FG002|Overall Study|Classified as 'Other'|0|||
94397023|NCT00003659|323240072|FG000|Overall Study|Withdrawal by Subject|3|||
94397024|NCT00927069|323240073|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
94397025|NCT00927069|323240074|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
94397026|NCT00927069|323240075|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
94397027|NCT00927069|323240076|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
94397028|NCT00927069|323240073|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
94397029|NCT00927069|323240074|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
94397030|NCT00927069|323240075|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
94397031|NCT00927069|323240076|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
94397032|NCT00927069|323240073|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
94397033|NCT00927069|323240074|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
94397034|NCT00927069|323240075|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
94397035|NCT00927069|323240076|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
94397036|NCT00927069|323240073|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
94397037|NCT00927069|323240074|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
94397038|NCT00927069|323240075|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
94397039|NCT00927069|323240076|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
94397040|NCT00927069|323240073|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
94397041|NCT00927069|323240074|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
94397042|NCT00927069|323240075|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
94397043|NCT00927069|323240076|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
94397044|NCT04022954|323240077|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
94397045|NCT04022954|323240077|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
94397046|NCT04022954|323240077|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
94397047|NCT02321098|323240078|FG000|12 Weeks Treament|Lost to Follow-up|1|||
94397048|NCT02321098|323240079|FG001|12 Weeks Treament|Lost to Follow-up|1|||
94397049|NCT02321098|323240080|FG002|12 Weeks Treament|Lost to Follow-up|0|||
94397050|NCT02321098|323240078|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
94397051|NCT02321098|323240079|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
94397052|NCT02321098|323240080|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
94397053|NCT02321098|323240078|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
94397054|NCT02321098|323240079|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
94397055|NCT02321098|323240080|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
94397056|NCT02321098|323240078|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
94397057|NCT02321098|323240079|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
94397058|NCT02321098|323240080|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
94397059|NCT00796328|323240085|FG000|Overall Study|experienced hypotension requiring tx|6|||
94397060|NCT02842853|323240088|FG000|Overall Study|Non-compliance with the protocol|3|||
94397061|NCT02842853|323240089|FG001|Overall Study|Non-compliance with the protocol|7|||
94397062|NCT02842853|323240090|FG002|Overall Study|Non-compliance with the protocol|2|||
94397063|NCT02842853|323240091|FG003|Overall Study|Non-compliance with the protocol|5|||
94397064|NCT02842853|323240088|FG000|Overall Study|Subject met exclusion criteria|0|||
94397065|NCT02842853|323240089|FG001|Overall Study|Subject met exclusion criteria|1|||
94397066|NCT02842853|323240090|FG002|Overall Study|Subject met exclusion criteria|0|||
94397067|NCT02842853|323240091|FG003|Overall Study|Subject met exclusion criteria|0|||
94397068|NCT02842853|323240088|FG000|Overall Study|Withdrawal by Subject|11|||
94397069|NCT02842853|323240089|FG001|Overall Study|Withdrawal by Subject|13|||
94397070|NCT02842853|323240090|FG002|Overall Study|Withdrawal by Subject|9|||
94397071|NCT02842853|323240091|FG003|Overall Study|Withdrawal by Subject|8|||
94397072|NCT02842853|323240088|FG000|Overall Study|Lost to Follow-up|9|||
94397073|NCT02842853|323240089|FG001|Overall Study|Lost to Follow-up|13|||
94397074|NCT02842853|323240090|FG002|Overall Study|Lost to Follow-up|10|||
94397075|NCT02842853|323240091|FG003|Overall Study|Lost to Follow-up|11|||
94397076|NCT03987191|323240094|FG000|Overall Study|COVID-19 related research disruption|0|||
94397077|NCT03987191|323240095|FG001|Overall Study|COVID-19 related research disruption|2|||
94397078|NCT03261167|323240096|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
94397079|NCT03261167|323240097|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
94397080|NCT03261167|323240096|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
94397081|NCT03261167|323240097|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
94397082|NCT03261167|323240096|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
94397083|NCT03261167|323240097|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
94397084|NCT03261167|323240096|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
94397085|NCT03261167|323240097|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
94397086|NCT03261167|323240096|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
94397087|NCT03261167|323240097|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
94397088|NCT03199963|323240098|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
94397089|NCT03199963|323240099|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
94397090|NCT03199963|323240098|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
94397091|NCT03199963|323240099|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
94397092|NCT03199963|323240098|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
94397093|NCT03199963|323240099|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
94397094|NCT03199963|323240098|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
94397095|NCT03199963|323240099|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
94397096|NCT03199963|323240098|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
94397097|NCT03199963|323240099|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
94397098|NCT03199963|323240098|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
94397099|NCT03199963|323240099|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
94397100|NCT03446768|323240100|FG000|Overall Study|Withdrawal by Subject|0|||
94397101|NCT03446768|323240101|FG001|Overall Study|Withdrawal by Subject|1|||
94397102|NCT03889639|323240102|FG000|Overall Study|Withdrawal by Subject|0|||
94397103|NCT03889639|323240103|FG001|Overall Study|Withdrawal by Subject|0|||
94397104|NCT03889639|323240104|FG002|Overall Study|Withdrawal by Subject|0|||
94484607|NCT03080935|323567520|FG000|Overall Study|Death|34|||
94397105|NCT03889639|323240105|FG003|Overall Study|Withdrawal by Subject|0|||
94397106|NCT03889639|323240106|FG004|Overall Study|Withdrawal by Subject|0|||
94397107|NCT03889639|323240107|FG005|Overall Study|Withdrawal by Subject|0|||
94397108|NCT03889639|323240108|FG006|Overall Study|Withdrawal by Subject|0|||
94397109|NCT03889639|323240109|FG007|Overall Study|Withdrawal by Subject|1|||
94397110|NCT02760927|323240110|FG000|Overall Study|Tube Slippage from Device|1|||
94397111|NCT02105272|323240111|FG000|Overall Study|Adverse Event|1|||
94397112|NCT02105272|323240112|FG001|Overall Study|Adverse Event|2|||
94397113|NCT02105272|323240111|FG000|Overall Study|Physician Decision|0|||
94397114|NCT02105272|323240112|FG001|Overall Study|Physician Decision|1|||
94397115|NCT02105272|323240111|FG000|Overall Study|Protocol Violation|2|||
94397116|NCT02105272|323240112|FG001|Overall Study|Protocol Violation|0|||
94397117|NCT02105272|323240111|FG000|Overall Study|Withdrawal by Subject|2|||
94397118|NCT02105272|323240112|FG001|Overall Study|Withdrawal by Subject|0|||
94397119|NCT03366792|323240113|FG000|Overall Study|Withdrawal by Subject|7|||
94397120|NCT03366792|323240113|FG000|Overall Study|Lost to Follow-up|2|||
94397121|NCT03366792|323240113|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
94397122|NCT03366792|323240113|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
94397123|NCT02699463|323240114|FG000|Overall Study|Lost to Follow-up|11|||
94397124|NCT02699463|323240115|FG001|Overall Study|Lost to Follow-up|8|||
94397125|NCT02699463|323240114|FG000|Overall Study|Withdrawal by Subject|4|||
94397126|NCT02699463|323240115|FG001|Overall Study|Withdrawal by Subject|1|||
94397127|NCT01808651|323240116|FG000|Study Period 1|Lost to Follow-up|1|||
94397128|NCT01808651|323240117|FG001|Study Period 1|Lost to Follow-up|3|||
94397129|NCT01808651|323240118|FG002|Study Period 1|Lost to Follow-up|0|||
94397130|NCT01808651|323240116|FG000|Study Period 1|Protocol Violation|1|||
94397131|NCT01808651|323240117|FG001|Study Period 1|Protocol Violation|0|||
94397132|NCT01808651|323240118|FG002|Study Period 1|Protocol Violation|1|||
94397133|NCT01808651|323240116|FG000|Study Period 1|Physician Decision|3|||
94397134|NCT01808651|323240117|FG001|Study Period 1|Physician Decision|2|||
94397135|NCT01808651|323240118|FG002|Study Period 1|Physician Decision|0|||
94397136|NCT01808651|323240116|FG000|Study Period 1|Lack of Efficacy|2|||
94397137|NCT01808651|323240117|FG001|Study Period 1|Lack of Efficacy|1|||
94397138|NCT01808651|323240118|FG002|Study Period 1|Lack of Efficacy|0|||
94397139|NCT01808651|323240116|FG000|Study Period 1|Adverse Event|10|||
94397140|NCT01808651|323240117|FG001|Study Period 1|Adverse Event|4|||
94397141|NCT01808651|323240118|FG002|Study Period 1|Adverse Event|1|||
94397142|NCT01808651|323240116|FG000|Study Period 1|Participant Decision|9|||
94397143|NCT01808651|323240117|FG001|Study Period 1|Participant Decision|7|||
94397144|NCT01808651|323240118|FG002|Study Period 1|Participant Decision|3|||
94397145|NCT02294981|323240127|FG000|Overall Study|Lost to Follow-up|1|||
94397146|NCT01484912|323240128|FG000|Overall Study|Withdrawal by Subject|1|||
94397147|NCT01484912|323240129|FG001|Overall Study|Withdrawal by Subject|0|||
94397148|NCT01484912|323240128|FG000|Overall Study|Physician Decision|0|||
94397149|NCT01484912|323240129|FG001|Overall Study|Physician Decision|1|||
94397150|NCT05752721|323240130|FG000|Overall Study|Lost to Follow-up|22|||
94397151|NCT05752721|323240131|FG001|Overall Study|Lost to Follow-up|20|||
94397152|NCT05752721|323240130|FG000|Overall Study|Withdrawal by Subject|15|||
94397153|NCT05752721|323240131|FG001|Overall Study|Withdrawal by Subject|12|||
94397154|NCT00073307|323240138|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
94397155|NCT00073307|323240139|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
94397156|NCT00073307|323240140|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
94397157|NCT00073307|323240138|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
94397158|NCT00073307|323240139|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
94397159|NCT00073307|323240140|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
94397160|NCT00073307|323240138|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
94397161|NCT00073307|323240139|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
94397162|NCT00073307|323240140|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
94397163|NCT00073307|323240138|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
94397164|NCT00073307|323240139|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
94397165|NCT00073307|323240140|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
94397166|NCT00073307|323240138|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
94397167|NCT00073307|323240139|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
94397168|NCT00073307|323240140|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
94397169|NCT00073307|323240138|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
94397170|NCT00073307|323240139|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
94397171|NCT00073307|323240140|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
94397172|NCT00073307|323240138|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
94397173|NCT00073307|323240139|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
94397174|NCT00073307|323240140|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
94397175|NCT00073307|323240138|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
94397176|NCT00073307|323240139|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
94397177|NCT00073307|323240140|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
94397178|NCT00073307|323240138|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
94397179|NCT00073307|323240139|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
94397180|NCT00073307|323240140|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
94397181|NCT00073307|323240138|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
94397182|NCT00073307|323240139|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
94397183|NCT00073307|323240140|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
94397184|NCT00073307|323240138|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
94397185|NCT00073307|323240139|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
94397186|NCT00073307|323240140|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
94397187|NCT00073307|323240138|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
94397188|NCT00073307|323240139|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
94397189|NCT00073307|323240140|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
94397190|NCT00073307|323240138|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
94397191|NCT00073307|323240139|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
94397192|NCT00073307|323240140|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
94397193|NCT00073307|323240138|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
94397194|NCT00073307|323240139|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
94397195|NCT00073307|323240140|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
94397196|NCT00073307|323240138|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
94397197|NCT00073307|323240139|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
94397198|NCT00073307|323240140|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
94397199|NCT00073307|323240138|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
94397200|NCT00073307|323240139|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
94397201|NCT00073307|323240140|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
94397202|NCT00073307|323240138|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
94397203|NCT00073307|323240139|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
94397204|NCT00073307|323240140|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
94397205|NCT00073307|323240138|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
94397206|NCT00073307|323240139|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
94397207|NCT00073307|323240140|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
94397208|NCT00073307|323240138|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
94397209|NCT00073307|323240139|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
94397210|NCT00073307|323240140|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
94397211|NCT01075516|323240141|FG000|Overall Study|Death|5|||
94397212|NCT01075516|323240142|FG001|Overall Study|Death|9|||
94397213|NCT01075516|323240141|FG000|Overall Study|Lost to Follow-up|10|||
94397214|NCT01075516|323240142|FG001|Overall Study|Lost to Follow-up|2|||
94397215|NCT01075516|323240141|FG000|Overall Study|Withdrawal by Subject|3|||
94397216|NCT01075516|323240142|FG001|Overall Study|Withdrawal by Subject|5|||
94397217|NCT03503318|323240145|FG000|Overall Study|Death|1|||
94397218|NCT03503318|323240146|FG001|Overall Study|Death|0|||
94397219|NCT03503318|323240147|FG002|Overall Study|Death|4|||
94397220|NCT03503318|323240145|FG000|Overall Study|Adverse Event|3|||
94397221|NCT03503318|323240146|FG001|Overall Study|Adverse Event|4|||
94397222|NCT03503318|323240147|FG002|Overall Study|Adverse Event|2|||
94397223|NCT03503318|323240145|FG000|Overall Study|Withdrawal by Subject|12|||
94397224|NCT03503318|323240146|FG001|Overall Study|Withdrawal by Subject|17|||
94397225|NCT03503318|323240147|FG002|Overall Study|Withdrawal by Subject|16|||
94397226|NCT03503318|323240145|FG000|Overall Study|Protocol Violation|5|||
94397227|NCT03503318|323240146|FG001|Overall Study|Protocol Violation|0|||
94397228|NCT03503318|323240147|FG002|Overall Study|Protocol Violation|3|||
94397229|NCT03503318|323240145|FG000|Overall Study|Lost to Follow-up|17|||
94397230|NCT03503318|323240146|FG001|Overall Study|Lost to Follow-up|15|||
94397231|NCT03503318|323240147|FG002|Overall Study|Lost to Follow-up|12|||
94397232|NCT03503318|323240145|FG000|Overall Study|Other than specified|1|||
94397233|NCT03503318|323240146|FG001|Overall Study|Other than specified|3|||
94484608|NCT03080935|323567521|FG001|Overall Study|Death|50|||
94397234|NCT03503318|323240147|FG002|Overall Study|Other than specified|3|||
94397235|NCT00838539|323240150|FG000|Overall Study|Disease Progression|2|||
94397236|NCT00838539|323240151|FG001|Overall Study|Disease Progression|4|||
94397237|NCT00838539|323240152|FG002|Overall Study|Disease Progression|3|||
94397238|NCT00838539|323240153|FG003|Overall Study|Disease Progression|2|||
94397239|NCT00838539|323240154|FG004|Overall Study|Disease Progression|4|||
94397240|NCT00838539|323240155|FG005|Overall Study|Disease Progression|2|||
94397241|NCT00838539|323240156|FG006|Overall Study|Disease Progression|3|||
94397242|NCT00838539|323240157|FG007|Overall Study|Disease Progression|4|||
94397243|NCT00838539|323240158|FG008|Overall Study|Disease Progression|4|||
94484609|NCT03080935|323567520|FG000|Overall Study|Lost to Follow-up|5|||
94484610|NCT03080935|323567521|FG001|Overall Study|Lost to Follow-up|4|||
94484611|NCT03080935|323567520|FG000|Overall Study|Withdrawal by Subject|11|||
94484612|NCT03080935|323567521|FG001|Overall Study|Withdrawal by Subject|15|||
94484613|NCT01614470|323567522|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
94484614|NCT01614470|323567523|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
94484615|NCT01614470|323567524|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
94484616|NCT01614470|323567522|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
94484617|NCT01614470|323567523|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
94484618|NCT01614470|323567524|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
94484619|NCT02175121|323567525|FG000|Overall Study|Lack of Efficacy|1|||
94484620|NCT02175121|323567526|FG001|Overall Study|Lack of Efficacy|0|||
94484621|NCT02175121|323567527|FG002|Overall Study|Lack of Efficacy|0|||
94484622|NCT02175121|323567528|FG003|Overall Study|Lack of Efficacy|0|||
94484623|NCT02175121|323567529|FG004|Overall Study|Lack of Efficacy|0|||
94484624|NCT02175121|323567525|FG000|Overall Study|Lost to Follow-up|0|||
94484625|NCT02175121|323567526|FG001|Overall Study|Lost to Follow-up|1|||
94484626|NCT02175121|323567527|FG002|Overall Study|Lost to Follow-up|0|||
94484627|NCT02175121|323567528|FG003|Overall Study|Lost to Follow-up|1|||
94484628|NCT02175121|323567529|FG004|Overall Study|Lost to Follow-up|0|||
94484629|NCT02175121|323567525|FG000|Overall Study|Personal emergency|0|||
94484630|NCT02175121|323567526|FG001|Overall Study|Personal emergency|0|||
94484631|NCT02175121|323567527|FG002|Overall Study|Personal emergency|0|||
94484632|NCT02175121|323567528|FG003|Overall Study|Personal emergency|0|||
94484633|NCT02175121|323567529|FG004|Overall Study|Personal emergency|1|||
94484634|NCT02175121|323567525|FG000|Overall Study|Schedule conflict|0|||
94484635|NCT02175121|323567526|FG001|Overall Study|Schedule conflict|0|||
94484636|NCT02175121|323567527|FG002|Overall Study|Schedule conflict|1|||
94484637|NCT02175121|323567528|FG003|Overall Study|Schedule conflict|0|||
94484638|NCT02175121|323567529|FG004|Overall Study|Schedule conflict|0|||
94484639|NCT02175121|323567525|FG000|Overall Study|Time issues|0|||
94484640|NCT02175121|323567526|FG001|Overall Study|Time issues|0|||
94484641|NCT02175121|323567527|FG002|Overall Study|Time issues|1|||
94484642|NCT02175121|323567528|FG003|Overall Study|Time issues|0|||
94484643|NCT02175121|323567529|FG004|Overall Study|Time issues|0|||
94484644|NCT00248651|323567530|FG000|Overall Study|Withdrawal by Subject|28|||
94484645|NCT00248651|323567531|FG001|Overall Study|Withdrawal by Subject|40|||
94484646|NCT00248651|323567532|FG002|Overall Study|Withdrawal by Subject|32|||
94484647|NCT03177148|323567543|FG000|Overall Study|Lost to Follow-up|50|||
94484648|NCT03177148|323567544|FG001|Overall Study|Lost to Follow-up|1|||
94484649|NCT03177148|323567543|FG000|Overall Study|Death|1|||
94484650|NCT03177148|323567544|FG001|Overall Study|Death|0|||
94484651|NCT02557399|323567545|FG000|Overall Study|Adverse Event|6|||
94484652|NCT02557399|323567546|FG001|Overall Study|Adverse Event|5|||
94484653|NCT02557399|323567545|FG000|Overall Study|Protocol Violation|0|||
94484654|NCT02557399|323567546|FG001|Overall Study|Protocol Violation|1|||
94484655|NCT02557399|323567545|FG000|Overall Study|Protocol-defined stopping criteria|0|||
94397244|NCT00838539|323240159|FG009|Overall Study|Disease Progression|5|||
94397245|NCT00838539|323240160|FG010|Overall Study|Disease Progression|1|||
94397246|NCT00838539|323240161|FG011|Overall Study|Disease Progression|4|||
94397247|NCT00838539|323240150|FG000|Overall Study|Adverse Event|1|||
94397248|NCT00838539|323240151|FG001|Overall Study|Adverse Event|1|||
94397249|NCT00838539|323240152|FG002|Overall Study|Adverse Event|1|||
94397250|NCT00838539|323240153|FG003|Overall Study|Adverse Event|1|||
94397251|NCT00838539|323240154|FG004|Overall Study|Adverse Event|2|||
94397252|NCT00838539|323240155|FG005|Overall Study|Adverse Event|1|||
94397253|NCT00838539|323240156|FG006|Overall Study|Adverse Event|0|||
94397254|NCT00838539|323240157|FG007|Overall Study|Adverse Event|2|||
94397255|NCT00838539|323240158|FG008|Overall Study|Adverse Event|0|||
94397256|NCT00838539|323240159|FG009|Overall Study|Adverse Event|1|||
94397257|NCT00838539|323240160|FG010|Overall Study|Adverse Event|2|||
94397258|NCT00838539|323240161|FG011|Overall Study|Adverse Event|0|||
94397259|NCT00838539|323240150|FG000|Overall Study|Withdrawal by Subject|0|||
94397260|NCT00838539|323240151|FG001|Overall Study|Withdrawal by Subject|1|||
94397261|NCT00838539|323240152|FG002|Overall Study|Withdrawal by Subject|0|||
94397262|NCT00838539|323240153|FG003|Overall Study|Withdrawal by Subject|0|||
94397263|NCT00838539|323240154|FG004|Overall Study|Withdrawal by Subject|0|||
94397264|NCT00838539|323240155|FG005|Overall Study|Withdrawal by Subject|0|||
94484656|NCT02557399|323567546|FG001|Overall Study|Protocol-defined stopping criteria|1|||
94484657|NCT02557399|323567545|FG000|Overall Study|Withdrawal by Subject|1|||
94484658|NCT02557399|323567546|FG001|Overall Study|Withdrawal by Subject|1|||
94484659|NCT02848664|323567548|FG000|Overall Study|Withdrawal by Subject|2|||
94484660|NCT02848664|323567548|FG000|Overall Study|Adverse Event|1|||
94484661|NCT02848664|323567548|FG000|Overall Study|no assistance for device training|1|||
94484662|NCT00577317|323567549|FG000|Overall Study|Study Terminated|0|||
94484663|NCT00577317|323567550|FG001|Overall Study|Study Terminated|2|||
94484664|NCT00846586|323567558|FG000|Overall Study|Adverse Event|20|||
94484665|NCT00846586|323567559|FG001|Overall Study|Adverse Event|10|||
94484666|NCT00846586|323567558|FG000|Overall Study|Subject withdrew consent|8|||
94329551|NCT00728936|322988015|FG003|Overall Study|Withdrawal by Subject|0|||
94329552|NCT00728936|322988016|FG004|Overall Study|Withdrawal by Subject|0|||
94329553|NCT00728936|322988017|FG005|Overall Study|Withdrawal by Subject|1|||
94329554|NCT00728936|322988018|FG006|Overall Study|Withdrawal by Subject|0|||
94329555|NCT03472040|322988035|FG000|Overall Study|Physician Decision|0|||
94329556|NCT03472040|322988036|FG001|Overall Study|Physician Decision|3|||
94329557|NCT03472040|322988035|FG000|Overall Study|Withdrawal by Subject|10|||
94329558|NCT03472040|322988036|FG001|Overall Study|Withdrawal by Subject|23|||
94329559|NCT03472040|322988035|FG000|Overall Study|Perceived Lack of Efficacy|29|||
94329560|NCT03472040|322988036|FG001|Overall Study|Perceived Lack of Efficacy|30|||
94329561|NCT03472040|322988035|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
94329562|NCT03472040|322988036|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
94329563|NCT03472040|322988035|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
94329564|NCT03472040|322988036|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
94329565|NCT03472040|322988035|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
94329566|NCT03472040|322988036|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
94329567|NCT03472040|322988035|FG000|Overall Study|Subject Non-compliance|2|||
94329568|NCT03472040|322988036|FG001|Overall Study|Subject Non-compliance|5|||
94329569|NCT03472040|322988035|FG000|Overall Study|Discontinuation due to Rash|0|||
94329570|NCT03472040|322988036|FG001|Overall Study|Discontinuation due to Rash|1|||
94329571|NCT03472040|322988035|FG000|Overall Study|Subsequent Ineligibility|0|||
94329572|NCT03472040|322988036|FG001|Overall Study|Subsequent Ineligibility|2|||
94329573|NCT03472040|322988035|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
94329574|NCT03472040|322988036|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
94329575|NCT00793182|322988044|FG000|Overall Study|Adverse Event|0|||
94329576|NCT00793182|322988045|FG001|Overall Study|Adverse Event|1|||
94329577|NCT02034552|322988046|FG000|Overall Study|Never treated|3|||
94329578|NCT02034552|322988047|FG001|Overall Study|Never treated|2|||
94329579|NCT02034552|322988048|FG002|Overall Study|Never treated|0|||
94329580|NCT02034552|322988046|FG000|Overall Study|Radiological progression|3|||
94329581|NCT02034552|322988047|FG001|Overall Study|Radiological progression|5|||
94329582|NCT02034552|322988048|FG002|Overall Study|Radiological progression|4|||
94329583|NCT02034552|322988046|FG000|Overall Study|AE not assoc. with disease progression|1|||
94329584|NCT02034552|322988047|FG001|Overall Study|AE not assoc. with disease progression|4|||
94329585|NCT02034552|322988048|FG002|Overall Study|AE not assoc. with disease progression|2|||
94329586|NCT02034552|322988046|FG000|Overall Study|AE associated with disease progression|0|||
94329587|NCT02034552|322988047|FG001|Overall Study|AE associated with disease progression|1|||
94329588|NCT02034552|322988048|FG002|Overall Study|AE associated with disease progression|0|||
94329589|NCT02034552|322988046|FG000|Overall Study|Withdrawal by Subject|2|||
94329590|NCT02034552|322988047|FG001|Overall Study|Withdrawal by Subject|1|||
94329591|NCT02034552|322988048|FG002|Overall Study|Withdrawal by Subject|1|||
94329592|NCT02034552|322988046|FG000|Overall Study|Non-compliance with study drug|0|||
94329593|NCT02034552|322988047|FG001|Overall Study|Non-compliance with study drug|0|||
94329594|NCT02034552|322988048|FG002|Overall Study|Non-compliance with study drug|1|||
94329595|NCT02034552|322988046|FG000|Overall Study|Clinical progression|5|||
94329596|NCT02034552|322988047|FG001|Overall Study|Clinical progression|7|||
94329597|NCT02034552|322988048|FG002|Overall Study|Clinical progression|9|||
94329598|NCT04209530|322988049|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
94329599|NCT04209530|322988050|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
94329600|NCT04209530|322988049|FG000|Overall Study|Withdrawal by Subject|0|||
94329601|NCT04209530|322988050|FG001|Overall Study|Withdrawal by Subject|1|||
94329602|NCT02273037|322988051|FG000|Overall Study|Lost to Follow-up|1|||
94329603|NCT02273037|322988052|FG001|Overall Study|Lost to Follow-up|0|||
94329604|NCT02273037|322988051|FG000|Overall Study|Delivered before monitoring initiated|1|||
94329605|NCT02273037|322988052|FG001|Overall Study|Delivered before monitoring initiated|3|||
94329606|NCT02273037|322988051|FG000|Overall Study|Breech delivery|2|||
94329607|NCT02273037|322988052|FG001|Overall Study|Breech delivery|3|||
94329608|NCT02273037|322988051|FG000|Overall Study|Multiple delivery|2|||
94329609|NCT02273037|322988052|FG001|Overall Study|Multiple delivery|2|||
94329610|NCT02273037|322988051|FG000|Overall Study|Other complication|2|||
94329611|NCT02273037|322988052|FG001|Overall Study|Other complication|0|||
94329612|NCT00851253|322988053|FG000|Overall Study|Disease Progression|1|||
94329613|NCT00851253|322988054|FG001|Overall Study|Disease Progression|0|||
94329614|NCT04154943|322988055|FG000|Overall Study|Study Ongoing|68|||
94329615|NCT04154943|322988055|FG000|Overall Study|Lost to Follow-up|1|||
94329616|NCT04154943|322988055|FG000|Overall Study|Decision by the Investigator|1|||
94329617|NCT04154943|322988055|FG000|Overall Study|Death|5|||
94329618|NCT04154943|322988055|FG000|Overall Study|Withdrawal by Subject|4|||
94329619|NCT02062398|322988056|FG000|Overall Study|Implant removal|1|||
94329620|NCT02197897|322988057|FG000|Overall Study|not eligible|1|||
94329621|NCT02513771|322988058|FG000|Overall Study|Lost to Follow-up|1|||
94329622|NCT02513771|322988059|FG001|Overall Study|Lost to Follow-up|1|||
94329623|NCT02513771|322988058|FG000|Overall Study|Not being able to get to clinic|1|||
94329624|NCT02513771|322988059|FG001|Overall Study|Not being able to get to clinic|0|||
94329625|NCT00415519|322988062|FG000|Overall Study|Adverse Event|1|||
94329626|NCT00415519|322988063|FG001|Overall Study|Adverse Event|0|||
94329627|NCT00415519|322988062|FG000|Overall Study|Withdrawal by Subject|2|||
94397265|NCT00838539|323240156|FG006|Overall Study|Withdrawal by Subject|0|||
94397266|NCT00838539|323240157|FG007|Overall Study|Withdrawal by Subject|0|||
94397267|NCT00838539|323240158|FG008|Overall Study|Withdrawal by Subject|0|||
94397268|NCT00838539|323240159|FG009|Overall Study|Withdrawal by Subject|1|||
94329628|NCT00415519|322988063|FG001|Overall Study|Withdrawal by Subject|0|||
94329629|NCT00415519|322988062|FG000|Overall Study|Patient's convenience|1|||
94329630|NCT00415519|322988063|FG001|Overall Study|Patient's convenience|0|||
94329631|NCT01595438|322988066|FG000|Overall Study|Lost to Follow-up|20|||
94329632|NCT01595438|322988067|FG001|Overall Study|Lost to Follow-up|20|||
94329633|NCT01595438|322988066|FG000|Overall Study|Withdrawal by Subject|12|||
94397269|NCT00838539|323240160|FG010|Overall Study|Withdrawal by Subject|2|||
94397270|NCT00838539|323240161|FG011|Overall Study|Withdrawal by Subject|0|||
94397271|NCT00838539|323240150|FG000|Overall Study|Death|0|||
94397272|NCT00838539|323240151|FG001|Overall Study|Death|0|||
94397273|NCT00838539|323240152|FG002|Overall Study|Death|0|||
94397274|NCT00838539|323240153|FG003|Overall Study|Death|0|||
94397275|NCT00838539|323240154|FG004|Overall Study|Death|0|||
94329634|NCT01595438|322988067|FG001|Overall Study|Withdrawal by Subject|12|||
94329635|NCT01595438|322988066|FG000|Overall Study|Other Eligibility criteria|11|||
94329636|NCT01595438|322988067|FG001|Overall Study|Other Eligibility criteria|9|||
94329637|NCT00367341|322988068|FG000|Overall Study|Physician Decision|1|||
94329638|NCT00367341|322988069|FG001|Overall Study|Physician Decision|0|||
94329639|NCT00367341|322988068|FG000|Overall Study|Protocol Violation|1|||
94329640|NCT00367341|322988069|FG001|Overall Study|Protocol Violation|0|||
94329641|NCT02119026|322988072|FG000|1st-line Treatment|Adverse Event|9|||
94329642|NCT02119026|322988073|FG001|1st-line Treatment|Adverse Event|14|||
94329643|NCT02119026|322988072|FG000|1st-line Treatment|Physician Decision|3|||
94329644|NCT02119026|322988073|FG001|1st-line Treatment|Physician Decision|8|||
94329645|NCT02119026|322988072|FG000|1st-line Treatment|Withdrawal by Subject|4|||
94329646|NCT02119026|322988073|FG001|1st-line Treatment|Withdrawal by Subject|10|||
94329647|NCT02119026|322988072|FG000|1st-line Treatment|Patient condition or compliance|6|||
94329648|NCT02119026|322988073|FG001|1st-line Treatment|Patient condition or compliance|4|||
94329649|NCT02119026|322988072|FG000|1st-line Treatment|Surgery of metastases|2|||
94329650|NCT02119026|322988073|FG001|1st-line Treatment|Surgery of metastases|1|||
94329651|NCT02119026|322988072|FG000|1st-line Treatment|Death|2|||
94329652|NCT02119026|322988073|FG001|1st-line Treatment|Death|1|||
94329653|NCT02119026|322988072|FG000|2nd-line Treatment|Lost to Follow-up|2|||
94329654|NCT02119026|322988073|FG001|2nd-line Treatment|Lost to Follow-up|0|||
94329655|NCT02119026|322988072|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
94329656|NCT02119026|322988073|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
94329657|NCT02119026|322988072|FG000|2nd-line Treatment|Adverse Event|4|||
94329658|NCT02119026|322988073|FG001|2nd-line Treatment|Adverse Event|1|||
94329659|NCT01381718|322988076|FG000|Overall Study|Withdrawal by Subject|2|||
94329660|NCT01381718|322988077|FG001|Overall Study|Withdrawal by Subject|5|||
94329661|NCT01381718|322988076|FG000|Overall Study|Lost to Follow-up|3|||
94329662|NCT01381718|322988077|FG001|Overall Study|Lost to Follow-up|5|||
94329663|NCT01381718|322988076|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
94329664|NCT01381718|322988077|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
94329665|NCT00618995|322988080|FG000|Period 1|Adverse Event|0|||
94329666|NCT00618995|322988081|FG001|Period 1|Adverse Event|0|||
94329667|NCT00618995|322988082|FG002|Period 1|Adverse Event|1|||
94329668|NCT00618995|322988083|FG003|Period 1|Adverse Event|0|||
94329669|NCT00618995|322988080|FG000|Period 1|Protocol Violation|0|||
94329670|NCT00618995|322988081|FG001|Period 1|Protocol Violation|1|||
94329671|NCT00618995|322988082|FG002|Period 1|Protocol Violation|1|||
94329672|NCT00618995|322988083|FG003|Period 1|Protocol Violation|0|||
94329673|NCT00618995|322988080|FG000|Period 2|Protocol Violation|0|||
94329674|NCT00618995|322988081|FG001|Period 2|Protocol Violation|0|||
94329675|NCT00618995|322988082|FG002|Period 2|Protocol Violation|1|||
94329676|NCT00618995|322988083|FG003|Period 2|Protocol Violation|0|||
94329677|NCT00618995|322988080|FG000|Period 4|Adverse Event|1|||
94329678|NCT00618995|322988081|FG001|Period 4|Adverse Event|0|||
94329679|NCT00618995|322988082|FG002|Period 4|Adverse Event|0|||
94329680|NCT00618995|322988083|FG003|Period 4|Adverse Event|0|||
94329681|NCT00992186|322988087|FG000|Overall Study|Withdrawal by Subject|2|||
94397276|NCT00838539|323240155|FG005|Overall Study|Death|0|||
94397277|NCT00838539|323240156|FG006|Overall Study|Death|1|||
94397278|NCT00838539|323240157|FG007|Overall Study|Death|0|||
94397279|NCT00838539|323240158|FG008|Overall Study|Death|0|||
94397280|NCT00838539|323240159|FG009|Overall Study|Death|0|||
94397281|NCT00838539|323240160|FG010|Overall Study|Death|0|||
94397282|NCT00838539|323240161|FG011|Overall Study|Death|0|||
94397283|NCT00838539|323240150|FG000|Overall Study|Physician Decision|0|||
94397284|NCT00838539|323240151|FG001|Overall Study|Physician Decision|0|||
94397285|NCT00838539|323240152|FG002|Overall Study|Physician Decision|0|||
94397286|NCT00838539|323240153|FG003|Overall Study|Physician Decision|0|||
94397287|NCT00838539|323240154|FG004|Overall Study|Physician Decision|0|||
94397288|NCT00838539|323240155|FG005|Overall Study|Physician Decision|0|||
94397289|NCT00838539|323240156|FG006|Overall Study|Physician Decision|0|||
94397290|NCT00838539|323240157|FG007|Overall Study|Physician Decision|0|||
94397291|NCT00838539|323240158|FG008|Overall Study|Physician Decision|1|||
94397292|NCT00838539|323240159|FG009|Overall Study|Physician Decision|0|||
94397293|NCT00838539|323240160|FG010|Overall Study|Physician Decision|0|||
94397294|NCT00838539|323240161|FG011|Overall Study|Physician Decision|0|||
94329682|NCT00992186|322988087|FG000|Overall Study|Protocol Violation|1|||
94329683|NCT00992186|322988087|FG000|Overall Study|Physician Decision|1|||
94329684|NCT00992186|322988087|FG000|Overall Study|Adverse Event|9|||
94329685|NCT00992186|322988087|FG000|Overall Study|Progressive Disease|30|||
94329686|NCT00992186|322988087|FG000|Overall Study|Refusal To Receive Study Agent|3|||
94329687|NCT04992546|322988089|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
94329688|NCT04992546|322988089|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
94329689|NCT04992546|322988089|FG000|Open-Label Treatment Period|Adverse Event|3|||
94329690|NCT04992546|322988089|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
94329691|NCT02029638|322988090|FG000|Overall Study|Death|0|||
94329692|NCT02029638|322988091|FG001|Overall Study|Death|0|||
94329693|NCT02029638|322988092|FG002|Overall Study|Death|1|||
94329694|NCT02029638|322988090|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
94329695|NCT02029638|322988091|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
94329696|NCT02029638|322988092|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
94329697|NCT02378883|322988093|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
94329698|NCT02378883|322988093|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
94329699|NCT02378883|322988093|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
94329700|NCT02378883|322988093|FG000|30 Day Follow-Up|Physician Decision|2|||
94329701|NCT02378883|322988093|FG000|30 Day Follow-Up|Missed Visit|2|||
94329702|NCT02378883|322988093|FG000|30 Day Follow-Up|Death|1|||
94329703|NCT02378883|322988093|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
94329704|NCT02378883|322988093|FG000|12 Months Follow-Up|Death|2|||
94329705|NCT00318565|322988094|FG000|Overall Study|Excluded per protocol|24|||
94329706|NCT03037307|322988095|FG000|Period 1|Did Not Meet Study Criteria|0|||
94329707|NCT03037307|322988096|FG001|Period 1|Did Not Meet Study Criteria|0|||
94329708|NCT03037307|322988097|FG002|Period 1|Did Not Meet Study Criteria|0|||
94329709|NCT03037307|322988098|FG003|Period 1|Did Not Meet Study Criteria|1|||
94329710|NCT03037307|322988099|FG004|Period 1|Did Not Meet Study Criteria|0|||
94329711|NCT03037307|322988100|FG005|Period 1|Did Not Meet Study Criteria|0|||
94329712|NCT01588353|322988101|FG000|Step2|Withdrawal by Subject|0|||
94329713|NCT01588353|322988102|FG001|Step2|Withdrawal by Subject|1|||
94329714|NCT01588353|322988103|FG002|Step2|Withdrawal by Subject|0|||
94329715|NCT01588353|322988101|FG000|Step3|Adverse Event|0|||
94329716|NCT01588353|322988102|FG001|Step3|Adverse Event|0|||
94329717|NCT01588353|322988103|FG002|Step3|Adverse Event|2|||
94329718|NCT03395223|322988106|FG000|Overall Study|Lost to Follow-up|3|||
94329719|NCT03395223|322988106|FG000|Overall Study|Other|1|||
94329720|NCT01896856|322988107|FG000|Overall Study|Transportation issues / Non-compliance|0|||
94329721|NCT01896856|322988108|FG001|Overall Study|Transportation issues / Non-compliance|0|||
94329722|NCT01896856|322988109|FG002|Overall Study|Transportation issues / Non-compliance|1|||
94329723|NCT01896856|322988110|FG003|Overall Study|Transportation issues / Non-compliance|0|||
94329724|NCT01896856|322988111|FG004|Overall Study|Transportation issues / Non-compliance|0|||
94329725|NCT01896856|322988112|FG005|Overall Study|Transportation issues / Non-compliance|0|||
94329726|NCT02563925|322988113|FG000|Overall Study|Withdrawal by Subject|2|||
94329727|NCT00067470|322988114|FG000|Overall Study|Withdrawal by Subject|0|||
94329728|NCT00067470|322988115|FG001|Overall Study|Withdrawal by Subject|1|||
94329729|NCT02727660|322988117|FG000|Overall Study|Lack of Efficacy|40|||
94329730|NCT02727660|322988118|FG001|Overall Study|Lack of Efficacy|40|||
94329731|NCT02727660|322988119|FG002|Overall Study|Lack of Efficacy|70|||
94329732|NCT02727660|322988117|FG000|Overall Study|Adverse Event|28|||
94329733|NCT02727660|322988118|FG001|Overall Study|Adverse Event|21|||
94329734|NCT02727660|322988119|FG002|Overall Study|Adverse Event|32|||
94329735|NCT02727660|322988117|FG000|Overall Study|Withdrawal by Subject|26|||
94329736|NCT02727660|322988118|FG001|Overall Study|Withdrawal by Subject|25|||
94329737|NCT02727660|322988119|FG002|Overall Study|Withdrawal by Subject|30|||
94329738|NCT02727660|322988117|FG000|Overall Study|Physician Decision|3|||
94329739|NCT02727660|322988118|FG001|Overall Study|Physician Decision|8|||
94329740|NCT02727660|322988119|FG002|Overall Study|Physician Decision|14|||
94329741|NCT02727660|322988117|FG000|Overall Study|Lost to Follow-up|5|||
94397295|NCT00838539|323240150|FG000|Overall Study|Clinical Progression|0|||
94397296|NCT00838539|323240151|FG001|Overall Study|Clinical Progression|0|||
94397297|NCT00838539|323240152|FG002|Overall Study|Clinical Progression|0|||
94329742|NCT02727660|322988118|FG001|Overall Study|Lost to Follow-up|9|||
94329743|NCT02727660|322988119|FG002|Overall Study|Lost to Follow-up|8|||
94329744|NCT02727660|322988117|FG000|Overall Study|Protocol Violation|7|||
94397298|NCT00838539|323240153|FG003|Overall Study|Clinical Progression|0|||
94397299|NCT00838539|323240154|FG004|Overall Study|Clinical Progression|0|||
94397300|NCT00838539|323240155|FG005|Overall Study|Clinical Progression|0|||
94397301|NCT00838539|323240156|FG006|Overall Study|Clinical Progression|1|||
94397302|NCT00838539|323240157|FG007|Overall Study|Clinical Progression|0|||
94397303|NCT00838539|323240158|FG008|Overall Study|Clinical Progression|0|||
94397304|NCT00838539|323240159|FG009|Overall Study|Clinical Progression|0|||
94397305|NCT00838539|323240160|FG010|Overall Study|Clinical Progression|0|||
94397306|NCT00838539|323240161|FG011|Overall Study|Clinical Progression|0|||
94397307|NCT00838539|323240150|FG000|Overall Study|Symptomatic Deterioration|0|||
94397308|NCT00838539|323240151|FG001|Overall Study|Symptomatic Deterioration|0|||
94397309|NCT00838539|323240152|FG002|Overall Study|Symptomatic Deterioration|1|||
94397310|NCT00838539|323240153|FG003|Overall Study|Symptomatic Deterioration|1|||
94397311|NCT00838539|323240154|FG004|Overall Study|Symptomatic Deterioration|0|||
94397312|NCT00838539|323240155|FG005|Overall Study|Symptomatic Deterioration|1|||
94397313|NCT00838539|323240156|FG006|Overall Study|Symptomatic Deterioration|0|||
94397314|NCT00838539|323240157|FG007|Overall Study|Symptomatic Deterioration|0|||
94397315|NCT00838539|323240158|FG008|Overall Study|Symptomatic Deterioration|0|||
94397316|NCT00838539|323240159|FG009|Overall Study|Symptomatic Deterioration|1|||
94397317|NCT00838539|323240160|FG010|Overall Study|Symptomatic Deterioration|0|||
94397318|NCT00838539|323240161|FG011|Overall Study|Symptomatic Deterioration|0|||
94397319|NCT02286739|323242105|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
94397320|NCT02286739|323242106|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
94397321|NCT02286739|323242105|FG000|Overall Study|No Verasense type documented|0|||
94397322|NCT02286739|323242106|FG001|Overall Study|No Verasense type documented|23|||
94397323|NCT02286739|323242105|FG000|Overall Study|Adverse Event|1|||
94397324|NCT02286739|323242106|FG001|Overall Study|Adverse Event|2|||
94397325|NCT02286739|323242105|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
94397326|NCT02286739|323242106|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
94397327|NCT03447353|323242107|FG000|Overall Study|Failure at Screening Visit|2|||
94397328|NCT03447353|323242107|FG000|Overall Study|Lost to Follow-up|4|||
94397329|NCT03447353|323242107|FG000|Overall Study|Scheduling Conflicts|3|||
94397330|NCT03447353|323242107|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
94397331|NCT02222818|323242108|FG000|Period 1|Eligibility criteria not met|0|||
94397332|NCT02222818|323242109|FG001|Period 1|Eligibility criteria not met|3|||
94397333|NCT04183335|323242110|FG000|Overall Study|Adverse Event|1|||
94397334|NCT04183335|323242111|FG001|Overall Study|Adverse Event|0|||
94397335|NCT04183335|323242110|FG000|Overall Study|Withdrawal by Subject|12|||
94397336|NCT04183335|323242111|FG001|Overall Study|Withdrawal by Subject|3|||
94397337|NCT01660243|323242112|FG000|Overall Study|Adverse Event|1|||
94397338|NCT01660243|323242113|FG001|Overall Study|Adverse Event|0|||
94397339|NCT01660243|323242114|FG002|Overall Study|Adverse Event|1|||
94397340|NCT01660243|323242115|FG003|Overall Study|Adverse Event|0|||
94397341|NCT01660243|323242112|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
94397342|NCT01660243|323242113|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
94397343|NCT01660243|323242114|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
94397344|NCT01660243|323242115|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
94397345|NCT01660243|323242112|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
94397346|NCT01660243|323242113|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
94397347|NCT01660243|323242114|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
94397348|NCT01660243|323242115|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
94397349|NCT01660243|323242112|FG000|Overall Study|Randomization error|0|||
94397350|NCT01660243|323242113|FG001|Overall Study|Randomization error|0|||
94397351|NCT01660243|323242114|FG002|Overall Study|Randomization error|0|||
94397352|NCT01660243|323242115|FG003|Overall Study|Randomization error|1|||
94397353|NCT00795821|323242116|FG000|Acute Treatment Phase|Adverse Event|23|||
94397354|NCT00795821|323242117|FG001|Acute Treatment Phase|Adverse Event|4|||
94397355|NCT00795821|323242116|FG000|Acute Treatment Phase|Death|1|||
94397356|NCT00795821|323242117|FG001|Acute Treatment Phase|Death|0|||
94397357|NCT00795821|323242116|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
94397358|NCT00795821|323242117|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
94397359|NCT00795821|323242116|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
94397360|NCT00795821|323242117|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
94397361|NCT00795821|323242116|FG000|Acute Treatment Phase|Physician Decision|1|||
94397362|NCT00795821|323242117|FG001|Acute Treatment Phase|Physician Decision|1|||
94397363|NCT00795821|323242116|FG000|Acute Treatment Phase|Protocol Violation|1|||
94397364|NCT00795821|323242117|FG001|Acute Treatment Phase|Protocol Violation|2|||
94397365|NCT00795821|323242116|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
94397366|NCT00795821|323242117|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
94397367|NCT00795821|323242116|FG000|Long-term Extension Phase|Adverse Event|25|||
94484667|NCT00846586|323567559|FG001|Overall Study|Subject withdrew consent|10|||
94484668|NCT00846586|323567558|FG000|Overall Study|Administrative problems|5|||
94484669|NCT00846586|323567559|FG001|Overall Study|Administrative problems|4|||
94484670|NCT00846586|323567558|FG000|Overall Study|Death|2|||
94484671|NCT00846586|323567559|FG001|Overall Study|Death|0|||
94484672|NCT00846586|323567558|FG000|Overall Study|Protocol deviation|2|||
94329745|NCT02727660|322988118|FG001|Overall Study|Protocol Violation|5|||
94329746|NCT02727660|322988119|FG002|Overall Study|Protocol Violation|5|||
94329747|NCT02727660|322988117|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
94329748|NCT02727660|322988118|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
94329749|NCT02727660|322988119|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
94329750|NCT02727660|322988117|FG000|Overall Study|Administrative Reasons|2|||
94329751|NCT02727660|322988118|FG001|Overall Study|Administrative Reasons|3|||
94329752|NCT02727660|322988119|FG002|Overall Study|Administrative Reasons|4|||
94329753|NCT00192036|322988120|FG000|Overall Study|Protocol Violation|3|||
94329754|NCT00192036|322988120|FG000|Overall Study|Adverse Event|6|||
94329755|NCT00192036|322988120|FG000|Overall Study|Patient/Physician Perception|1|||
94329756|NCT00192036|322988120|FG000|Overall Study|Objective Tumor Progression|4|||
94329757|NCT00192036|322988120|FG000|Overall Study|Clinical Disease Progression|1|||
94329758|NCT00192036|322988120|FG000|Overall Study|Death|1|||
94329759|NCT00192036|322988120|FG000|Overall Study|Unknown or Not Specified|5|||
94329760|NCT00871572|322988122|FG000|Overall Study|Adverse Event|0|||
94329761|NCT00871572|322988123|FG001|Overall Study|Adverse Event|2|||
94329762|NCT00871572|322988124|FG002|Overall Study|Adverse Event|0|||
94329763|NCT00871572|322988125|FG003|Overall Study|Adverse Event|3|||
94329764|NCT00871572|322988122|FG000|Overall Study|Investigator Decision|0|||
94329765|NCT00871572|322988123|FG001|Overall Study|Investigator Decision|1|||
94329766|NCT00871572|322988124|FG002|Overall Study|Investigator Decision|0|||
94329767|NCT00871572|322988125|FG003|Overall Study|Investigator Decision|1|||
94329768|NCT00871572|322988122|FG000|Overall Study|Lost to Follow-up|0|||
94329769|NCT00871572|322988123|FG001|Overall Study|Lost to Follow-up|1|||
94329770|NCT00871572|322988124|FG002|Overall Study|Lost to Follow-up|0|||
94329771|NCT00871572|322988125|FG003|Overall Study|Lost to Follow-up|1|||
94329772|NCT00871572|322988122|FG000|Overall Study|Protocol Violation|0|||
94329773|NCT00871572|322988123|FG001|Overall Study|Protocol Violation|0|||
94329774|NCT00871572|322988124|FG002|Overall Study|Protocol Violation|1|||
94329775|NCT00871572|322988125|FG003|Overall Study|Protocol Violation|1|||
94329776|NCT00871572|322988122|FG000|Overall Study|Sponsor Decision|1|||
94329777|NCT00871572|322988123|FG001|Overall Study|Sponsor Decision|0|||
94329778|NCT00871572|322988124|FG002|Overall Study|Sponsor Decision|0|||
94329779|NCT00871572|322988125|FG003|Overall Study|Sponsor Decision|0|||
94329780|NCT00871572|322988122|FG000|Overall Study|Withdrawal by Subject|1|||
94329781|NCT00871572|322988123|FG001|Overall Study|Withdrawal by Subject|2|||
94329782|NCT00871572|322988124|FG002|Overall Study|Withdrawal by Subject|3|||
94329783|NCT00871572|322988125|FG003|Overall Study|Withdrawal by Subject|1|||
94329784|NCT00108953|322988132|FG000|Follow-up|Death|18|||
94329785|NCT00108953|322988133|FG001|Follow-up|Death|26|||
94329786|NCT00108953|322988132|FG000|Follow-up|Lost to Follow-up|1|||
94329787|NCT00108953|322988133|FG001|Follow-up|Lost to Follow-up|1|||
94329788|NCT00108953|322988132|FG000|Follow-up|Study terminated by sponsor|10|||
94329789|NCT00108953|322988133|FG001|Follow-up|Study terminated by sponsor|6|||
94329790|NCT01181778|322988134|FG000|Overall Study|Physician Decision|48|||
94329791|NCT02148211|322988135|FG000|Overall Study|Lost to Follow-up|352|||
94329792|NCT00367432|322988139|FG000|First Period (16 Weeks)|Adverse Event|6|||
94329793|NCT00367432|322988140|FG001|First Period (16 Weeks)|Adverse Event|0|||
94329794|NCT00367432|322988139|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
94329795|NCT00367432|322988140|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
94329796|NCT00367432|322988139|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
94329797|NCT00367432|322988140|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
94329798|NCT00367432|322988139|FG000|First Period (16 Weeks)|Other Reason|2|||
94329799|NCT00367432|322988140|FG001|First Period (16 Weeks)|Other Reason|0|||
94329800|NCT00367432|322988139|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
94329801|NCT00367432|322988140|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
94329802|NCT00367432|322988139|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
94329803|NCT00367432|322988140|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
94329804|NCT00367432|322988139|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
94329805|NCT00367432|322988140|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
94329806|NCT00367432|322988139|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
94329807|NCT00367432|322988140|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
94329808|NCT00367432|322988139|FG000|Second Period (up to 54 Months)|Other Reason|6|||
94329809|NCT00367432|322988140|FG001|Second Period (up to 54 Months)|Other Reason|2|||
94329810|NCT05200455|322988141|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
94329811|NCT00892957|322988142|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
94484673|NCT00846586|323567559|FG001|Overall Study|Protocol deviation|6|||
94484674|NCT00846586|323567558|FG000|Overall Study|Abnormal test procedure result(s)|1|||
94484675|NCT00846586|323567559|FG001|Overall Study|Abnormal test procedure result(s)|0|||
94397368|NCT00795821|323242117|FG001|Long-term Extension Phase|Adverse Event|32|||
94397369|NCT00795821|323242116|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
94397370|NCT00795821|323242117|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
94397371|NCT00795821|323242116|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
94397372|NCT00795821|323242117|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
94397373|NCT00795821|323242116|FG000|Long-term Extension Phase|Physician Decision|1|||
94397374|NCT00795821|323242117|FG001|Long-term Extension Phase|Physician Decision|2|||
94397375|NCT00795821|323242116|FG000|Long-term Extension Phase|Protocol Violation|3|||
94397376|NCT00795821|323242117|FG001|Long-term Extension Phase|Protocol Violation|5|||
94397377|NCT00795821|323242116|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
94397378|NCT00795821|323242117|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
94397379|NCT00795821|323242116|FG000|Taper Phase|Adverse Event|2|||
94397380|NCT00795821|323242117|FG001|Taper Phase|Adverse Event|0|||
94397381|NCT00795821|323242116|FG000|Taper Phase|Lost to Follow-up|1|||
94397382|NCT00795821|323242117|FG001|Taper Phase|Lost to Follow-up|0|||
94397383|NCT00795821|323242116|FG000|Taper Phase|Physician Decision|2|||
94397384|NCT00795821|323242117|FG001|Taper Phase|Physician Decision|0|||
94397385|NCT00795821|323242116|FG000|Taper Phase|Withdrawal by Subject|4|||
94397386|NCT00795821|323242117|FG001|Taper Phase|Withdrawal by Subject|0|||
94397387|NCT00712959|323242122|FG000|Overall Study|Protocol Violation|3|||
94397388|NCT00712959|323242123|FG001|Overall Study|Protocol Violation|1|||
94397389|NCT00712959|323242122|FG000|Overall Study|Lost to Follow-up|13|||
94397390|NCT00712959|323242123|FG001|Overall Study|Lost to Follow-up|2|||
94397391|NCT00712959|323242122|FG000|Overall Study|Withdrawal by Subject|3|||
94397392|NCT00712959|323242123|FG001|Overall Study|Withdrawal by Subject|0|||
94397393|NCT01319383|323242132|FG000|Overall Study|No ex vivo or in vivo response|4|||
94397394|NCT01319383|323242133|FG001|Overall Study|No ex vivo or in vivo response|0|||
94397395|NCT01319383|323242132|FG000|Overall Study|Physician Decision|3|||
94397396|NCT01319383|323242133|FG001|Overall Study|Physician Decision|0|||
94397397|NCT01319383|323242132|FG000|Overall Study|Lack of Efficacy|5|||
94397398|NCT01319383|323242133|FG001|Overall Study|Lack of Efficacy|9|||
94397399|NCT01319383|323242132|FG000|Overall Study|No in vivo response to interval doses|0|||
94397400|NCT01319383|323242133|FG001|Overall Study|No in vivo response to interval doses|1|||
94397401|NCT02563561|323242134|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
94397402|NCT02563561|323242135|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
94397403|NCT02563561|323242136|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
94397404|NCT02563561|323242134|FG000|Overall Study|Withdrew of Consent|1|||
94397405|NCT02563561|323242135|FG001|Overall Study|Withdrew of Consent|1|||
94397406|NCT02563561|323242136|FG002|Overall Study|Withdrew of Consent|2|||
94397407|NCT02563561|323242134|FG000|Overall Study|Lost to Follow-up|1|||
94397408|NCT02563561|323242135|FG001|Overall Study|Lost to Follow-up|1|||
94397409|NCT02563561|323242136|FG002|Overall Study|Lost to Follow-up|0|||
94397410|NCT02563561|323242134|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
94397411|NCT02563561|323242135|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
94397412|NCT02563561|323242136|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
94397413|NCT02563561|323242134|FG000|Overall Study|Investigator Decision|3|||
94397414|NCT02563561|323242135|FG001|Overall Study|Investigator Decision|4|||
94397415|NCT02563561|323242136|FG002|Overall Study|Investigator Decision|2|||
94397416|NCT02563561|323242134|FG000|Overall Study|Sponsor Decision|5|||
94397417|NCT02563561|323242135|FG001|Overall Study|Sponsor Decision|2|||
94397418|NCT02563561|323242136|FG002|Overall Study|Sponsor Decision|4|||
94397419|NCT02563561|323242134|FG000|Overall Study|Other|1|||
94397420|NCT02563561|323242135|FG001|Overall Study|Other|5|||
94397421|NCT02563561|323242136|FG002|Overall Study|Other|2|||
94397422|NCT03600805|323242145|FG000|Overall Study|Adverse Event|2|||
94397423|NCT03600805|323242146|FG001|Overall Study|Adverse Event|1|||
94397424|NCT03600805|323242147|FG002|Overall Study|Adverse Event|1|||
94484676|NCT00846586|323567558|FG000|Overall Study|Lost to Follow-up|1|||
94484677|NCT00846586|323567559|FG001|Overall Study|Lost to Follow-up|4|||
94484678|NCT00846586|323567558|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94397425|NCT03600805|323242148|FG003|Overall Study|Adverse Event|7|||
94397426|NCT03600805|323242145|FG000|Overall Study|Lack of Efficacy|2|||
94397427|NCT03600805|323242146|FG001|Overall Study|Lack of Efficacy|1|||
94397428|NCT03600805|323242147|FG002|Overall Study|Lack of Efficacy|0|||
94397429|NCT03600805|323242148|FG003|Overall Study|Lack of Efficacy|0|||
94397430|NCT03600805|323242145|FG000|Overall Study|Withdrawal by Subject|1|||
94397431|NCT03600805|323242146|FG001|Overall Study|Withdrawal by Subject|0|||
94397432|NCT03600805|323242147|FG002|Overall Study|Withdrawal by Subject|0|||
94397433|NCT03600805|323242148|FG003|Overall Study|Withdrawal by Subject|1|||
94397434|NCT03600805|323242145|FG000|Overall Study|Other unspecified|14|||
94397435|NCT03600805|323242146|FG001|Overall Study|Other unspecified|6|||
94397436|NCT03600805|323242147|FG002|Overall Study|Other unspecified|7|||
94397437|NCT03600805|323242148|FG003|Overall Study|Other unspecified|11|||
94397438|NCT01056484|323242149|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
94397439|NCT01056484|323242150|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
94397440|NCT01056484|323242149|FG000|Randomized Controlled Trial|Physician Decision|1|||
94397441|NCT01056484|323242150|FG001|Randomized Controlled Trial|Physician Decision|0|||
94397442|NCT01056484|323242149|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
94397443|NCT01056484|323242150|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
94397444|NCT02545283|323242151|FG000|Overall Study|Lost to Follow-up|2|||
94397445|NCT02545283|323242152|FG001|Overall Study|Lost to Follow-up|4|||
94397446|NCT02545283|323242151|FG000|Overall Study|Withdrawal by Subject|5|||
94397447|NCT02545283|323242152|FG001|Overall Study|Withdrawal by Subject|9|||
94397448|NCT02545283|323242151|FG000|Overall Study|Death|109|||
94397449|NCT02545283|323242152|FG001|Overall Study|Death|211|||
94397450|NCT02545283|323242151|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
94397451|NCT02545283|323242152|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
94397452|NCT02545283|323242151|FG000|Overall Study|Study Terminated By Sponsor|33|||
94397453|NCT02545283|323242152|FG001|Overall Study|Study Terminated By Sponsor|71|||
94397454|NCT03635320|323242153|FG000|Overall Study|not implanted the device|1|||
94397455|NCT03635320|323242154|FG001|Overall Study|not implanted the device|2|||
94397456|NCT03635320|323242153|FG000|Overall Study|Withdrawal by Subject|11|||
94397457|NCT03635320|323242154|FG001|Overall Study|Withdrawal by Subject|6|||
94397458|NCT00933686|323242158|FG000|Overall Study|Protocol Violation|0|||
94397459|NCT00933686|323242159|FG001|Overall Study|Protocol Violation|1|||
94397460|NCT00933686|323242158|FG000|Overall Study|Lost to Follow-up|2|||
94397461|NCT00933686|323242159|FG001|Overall Study|Lost to Follow-up|2|||
94397462|NCT00933686|323242158|FG000|Overall Study|Withdrawal by Subject|6|||
94397463|NCT00933686|323242159|FG001|Overall Study|Withdrawal by Subject|5|||
94397464|NCT00933686|323242158|FG000|Overall Study|Adverse Event|1|||
94397465|NCT00933686|323242159|FG001|Overall Study|Adverse Event|1|||
94397466|NCT00933686|323242158|FG000|Overall Study|Physician Decision|1|||
94397467|NCT00933686|323242159|FG001|Overall Study|Physician Decision|0|||
94397468|NCT00933686|323242158|FG000|Overall Study|Failure to show up at endpoint visits|0|||
94397469|NCT00933686|323242159|FG001|Overall Study|Failure to show up at endpoint visits|2|||
94397470|NCT00395694|323242162|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
94397471|NCT00395694|323242163|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
94397472|NCT00395694|323242162|FG000|Continuation Phase|Adverse Event|1|||
94397473|NCT00395694|323242163|FG001|Continuation Phase|Adverse Event|0|||
94397474|NCT00395694|323242162|FG000|Continuation Phase|Lack of Efficacy|12|||
94397475|NCT00395694|323242163|FG001|Continuation Phase|Lack of Efficacy|11|||
94397476|NCT00395694|323242162|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
94397477|NCT00395694|323242163|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
94397478|NCT00395694|323242162|FG000|Continuation Phase|Poor Compliance|1|||
94397479|NCT00395694|323242163|FG001|Continuation Phase|Poor Compliance|0|||
94397480|NCT00395694|323242162|FG000|Continuation Phase|Withdrawal by Subject|0|||
94397481|NCT00395694|323242163|FG001|Continuation Phase|Withdrawal by Subject|2|||
94397482|NCT00392665|323242164|FG000|Overall Study|Death|16|||
94397483|NCT00392665|323242165|FG001|Overall Study|Death|14|||
94397484|NCT00392665|323242164|FG000|Overall Study|Lost to Follow-up|1|||
94397485|NCT00392665|323242165|FG001|Overall Study|Lost to Follow-up|1|||
94397486|NCT01959672|323242169|FG000|Overall Study|Death|1|||
94397487|NCT00840216|323242170|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
94397488|NCT00840216|323242171|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
94397489|NCT01058668|323242172|FG000|Double-blind Treatment Phase|Adverse Event|8|||
94397490|NCT01058668|323242173|FG001|Double-blind Treatment Phase|Adverse Event|15|||
94397491|NCT01058668|323242174|FG002|Double-blind Treatment Phase|Adverse Event|25|||
94397492|NCT01058668|323242172|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
94397493|NCT01058668|323242173|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
94397494|NCT01058668|323242174|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
94397495|NCT01058668|323242172|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
94397496|NCT01058668|323242173|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
94397497|NCT01058668|323242174|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
94397498|NCT01058668|323242172|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
94397499|NCT01058668|323242173|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
94397500|NCT01058668|323242174|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
94484679|NCT00846586|323567559|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
94397501|NCT01058668|323242172|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
94397502|NCT01058668|323242173|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
94397503|NCT01058668|323242174|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
94397504|NCT01058668|323242172|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
94397505|NCT01058668|323242173|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
94397506|NCT01058668|323242174|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
94397507|NCT00545792|323242175|FG000|Overall Study|Withdrawal by Subject|1|||
94397508|NCT01778010|323242179|FG000|Overall Study|Withdrawal by Subject|2|||
94397509|NCT01778010|323242179|FG000|Overall Study|abnormal ECG before meds|1|||
94397510|NCT01778010|323242179|FG000|Overall Study|Arrested|1|||
94397511|NCT01778010|323242179|FG000|Overall Study|rash while on placebo|1|||
94397512|NCT01642277|323242181|FG000|Overall Study|Adverse Event|10|||
94397513|NCT01642277|323242182|FG001|Overall Study|Adverse Event|0|||
94397514|NCT01642277|323242181|FG000|Overall Study|Physician Decision|2|||
94397515|NCT01642277|323242182|FG001|Overall Study|Physician Decision|0|||
94397516|NCT01642277|323242181|FG000|Overall Study|Protocol Violation|1|||
94397517|NCT01642277|323242182|FG001|Overall Study|Protocol Violation|0|||
94397518|NCT01642277|323242181|FG000|Overall Study|Withdrawal by Subject|11|||
94397519|NCT01642277|323242182|FG001|Overall Study|Withdrawal by Subject|0|||
94397520|NCT00316277|323242183|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
94397521|NCT00316277|323242184|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
94397522|NCT00316277|323242183|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
94397523|NCT00316277|323242184|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
94397524|NCT00316277|323242183|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
94397525|NCT00316277|323242184|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
94397526|NCT00316277|323242183|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
94397527|NCT00316277|323242184|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
94397528|NCT00316277|323242183|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
94397529|NCT00316277|323242184|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
94397530|NCT03605342|323242188|FG000|Overall Study|Withdrawal by Subject|9|||
94397531|NCT03605342|323242189|FG001|Overall Study|Withdrawal by Subject|7|||
94397532|NCT03605342|323242188|FG000|Overall Study|Lost to Follow-up|1|||
94397533|NCT03605342|323242189|FG001|Overall Study|Lost to Follow-up|1|||
94397534|NCT01444378|323242190|FG000|Overall Study|Lost to Follow-up|1|||
94397535|NCT01444378|323242190|FG000|Overall Study|Withdrawal by Subject|1|||
94397536|NCT01444378|323242190|FG000|Overall Study|Death|3|||
94397537|NCT01444378|323242190|FG000|Overall Study|Administrative Closure Of The Study|2|||
94397538|NCT01444378|323242190|FG000|Overall Study|Missed Visits|10|||
94397539|NCT01663233|323242191|FG000|Overall Study|Withdrawal by Subject|3|||
94397540|NCT01663233|323242192|FG001|Overall Study|Withdrawal by Subject|2|||
94397541|NCT01663233|323242191|FG000|Overall Study|Protocol Deviation|1|||
94397542|NCT01663233|323242192|FG001|Overall Study|Protocol Deviation|4|||
94397543|NCT01663233|323242191|FG000|Overall Study|Lost to Follow-up|0|||
94397544|NCT01663233|323242192|FG001|Overall Study|Lost to Follow-up|1|||
94397545|NCT00834431|323242193|FG000|First Intervention|Adverse Event|0|||
94397546|NCT00834431|323242194|FG001|First Intervention|Adverse Event|1|||
94397547|NCT00834431|323242193|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
94397548|NCT00834431|323242194|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
94397549|NCT03249454|323242195|FG000|Overall Study|Withdrawal by Subject|0|||
94397550|NCT03249454|323242196|FG001|Overall Study|Withdrawal by Subject|0|||
94397551|NCT03249454|323242197|FG002|Overall Study|Withdrawal by Subject|0|||
94397552|NCT03249454|323242198|FG003|Overall Study|Withdrawal by Subject|0|||
94397553|NCT03249454|323242199|FG004|Overall Study|Withdrawal by Subject|0|||
94397554|NCT03249454|323242200|FG005|Overall Study|Withdrawal by Subject|0|||
94397555|NCT03249454|323242201|FG006|Overall Study|Withdrawal by Subject|0|||
94397556|NCT03249454|323242202|FG007|Overall Study|Withdrawal by Subject|0|||
94397557|NCT03249454|323242203|FG008|Overall Study|Withdrawal by Subject|0|||
94397558|NCT03249454|323242204|FG009|Overall Study|Withdrawal by Subject|1|||
94397559|NCT03249454|323242205|FG010|Overall Study|Withdrawal by Subject|1|||
94397560|NCT01701063|323242206|FG000|Overall Study|Lost to Follow-up|0|||
94397561|NCT01701063|323242207|FG001|Overall Study|Lost to Follow-up|1|||
94397562|NCT01701063|323242208|FG002|Overall Study|Lost to Follow-up|0|||
94397563|NCT01701063|323242206|FG000|Overall Study|Withdrawal by Subject|0|||
94397564|NCT01701063|323242207|FG001|Overall Study|Withdrawal by Subject|0|||
94397565|NCT01701063|323242208|FG002|Overall Study|Withdrawal by Subject|1|||
94397566|NCT01701063|323242206|FG000|Overall Study|Other|0|||
94397567|NCT01701063|323242207|FG001|Overall Study|Other|0|||
94397568|NCT01701063|323242208|FG002|Overall Study|Other|1|||
94397569|NCT05387408|323242211|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
94397570|NCT01919112|323242217|FG000|Secondary Analysis-day 30|Death|1|||
94397571|NCT01919112|323242218|FG001|Secondary Analysis-day 30|Death|1|||
94397572|NCT01919112|323242219|FG002|Secondary Analysis-day 30|Death|1|||
94397573|NCT01919112|323242217|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
94484680|NCT01939314|323567563|FG000|Overall Study|Withdrawal by Subject|3|||
94397574|NCT01919112|323242218|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
94397575|NCT01919112|323242219|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
94397576|NCT04692155|323242222|FG000|Overall Study|Death|1|||
94397577|NCT00835666|323242223|FG000|Washout|Protocol Violation|1|||
94397578|NCT00835666|323242224|FG001|Washout|Protocol Violation|0|||
94397579|NCT00835666|323242223|FG000|Washout|Withdrawal by Subject|1|||
94397580|NCT00835666|323242224|FG001|Washout|Withdrawal by Subject|0|||
94397581|NCT05133180|323242225|FG000|Overall Study|Withdrawal of consent|1|||
94397582|NCT05133180|323242226|FG001|Overall Study|Withdrawal of consent|1|||
94397583|NCT05133180|323242225|FG000|Overall Study|Lost to Follow-up|1|||
94397584|NCT05133180|323242226|FG001|Overall Study|Lost to Follow-up|1|||
94397585|NCT05133180|323242225|FG000|Overall Study|Documented disease progression|0|||
94397586|NCT05133180|323242226|FG001|Overall Study|Documented disease progression|1|||
94397587|NCT00935012|323242230|FG000|Overall Study|Death|19|||
94397588|NCT00935012|323242230|FG000|Overall Study|Withdrawal by Subject|3|||
94397589|NCT00935012|323242230|FG000|Overall Study|Other|5|||
94397590|NCT00935012|323242230|FG000|Overall Study|Adverse Event|2|||
94397591|NCT01442155|323242231|FG000|Overall Study|Complete remission|35|||
94397592|NCT01442155|323242231|FG000|Overall Study|Recurrence|26|||
94397593|NCT01442155|323242231|FG000|Overall Study|Adverse Event|2|||
94397594|NCT01442155|323242231|FG000|Overall Study|Lost to Follow-up|2|||
94397595|NCT02488239|323242232|FG000|Overall Study|Death|3|||
94397596|NCT02488239|323242232|FG000|Overall Study|Withdrawal by Subject|3|||
94397597|NCT02488239|323242232|FG000|Overall Study|Physician Decision|2|||
94397598|NCT02488239|323242232|FG000|Overall Study|Consent ineligible|1|||
94397599|NCT02488239|323242232|FG000|Overall Study|Did not undergo implant procedure|1|||
94397600|NCT03480763|323242234|FG000|Overall Study|Withdrawal by Subject|18|||
94397601|NCT03480763|323242235|FG001|Overall Study|Withdrawal by Subject|10|||
94397602|NCT03480763|323242234|FG000|Overall Study|Lost to Follow-up|4|||
94397603|NCT03480763|323242235|FG001|Overall Study|Lost to Follow-up|7|||
94397604|NCT03480763|323242234|FG000|Overall Study|non-study pneumococcal vaccine|1|||
94397605|NCT03480763|323242235|FG001|Overall Study|non-study pneumococcal vaccine|0|||
94397606|NCT03480763|323242234|FG000|Overall Study|oncological treatment|0|||
94397607|NCT03480763|323242235|FG001|Overall Study|oncological treatment|2|||
94397608|NCT03480763|323242234|FG000|Overall Study|pain with vaccination|1|||
94397609|NCT03480763|323242235|FG001|Overall Study|pain with vaccination|0|||
94397610|NCT01895335|323242236|FG000|Overall Study|Adverse Event|106|||
94397611|NCT01895335|323242236|FG000|Overall Study|Lack of Efficacy|53|||
94397612|NCT01895335|323242236|FG000|Overall Study|Poor Compliance to Protocol|11|||
94397613|NCT01895335|323242236|FG000|Overall Study|Included But Not treated|1|||
94397614|NCT01895335|323242236|FG000|Overall Study|Other than Specified Above|44|||
94397615|NCT01906372|323242237|FG000|Overall Study|Withdrawal by Subject|2|||
94397616|NCT00191815|323242238|FG000|Overall Study|Adverse Event|2|||
94397617|NCT00191815|323242238|FG000|Overall Study|Disease progression or relapse|24|||
94397618|NCT00191815|323242238|FG000|Overall Study|Death|2|||
94397619|NCT00191815|323242238|FG000|Overall Study|Protocol Violation|3|||
94397620|NCT00191815|323242238|FG000|Overall Study|Physician Decision|2|||
94397621|NCT00191815|323242238|FG000|Overall Study|Withdrawal by Subject|7|||
94397622|NCT03644550|323242239|FG000|Overall Study|Withdrawal by Subject|3|||
94397623|NCT03644550|323242239|FG000|Overall Study|Progressive disease|15|||
94397624|NCT00700739|323242240|FG000|Overall Study|Lost to Follow-up|4|||
94397625|NCT00700739|323242241|FG001|Overall Study|Lost to Follow-up|4|||
94397626|NCT01252953|323242242|FG000|Overall Study|Withdrawal by Subject|16|||
94397627|NCT01252953|323242243|FG001|Overall Study|Withdrawal by Subject|17|||
94397628|NCT01252953|323242242|FG000|Overall Study|Lost to Follow-up|22|||
94397629|NCT01252953|323242243|FG001|Overall Study|Lost to Follow-up|21|||
94397630|NCT02426918|323242250|FG000|Overall Study|Adverse Event|2|||
94397631|NCT02426918|323242251|FG001|Overall Study|Adverse Event|2|||
94397632|NCT02426918|323242252|FG002|Overall Study|Adverse Event|0|||
94397633|NCT02426918|323242250|FG000|Overall Study|Physician Decision|1|||
94397634|NCT02426918|323242251|FG001|Overall Study|Physician Decision|1|||
94397635|NCT02426918|323242252|FG002|Overall Study|Physician Decision|1|||
94397636|NCT02426918|323242250|FG000|Overall Study|Withdrawal by Subject|5|||
94397637|NCT02426918|323242251|FG001|Overall Study|Withdrawal by Subject|5|||
94397638|NCT02426918|323242252|FG002|Overall Study|Withdrawal by Subject|4|||
94397639|NCT02426918|323242250|FG000|Overall Study|Other|9|||
94397640|NCT02426918|323242251|FG001|Overall Study|Other|11|||
94397641|NCT02426918|323242252|FG002|Overall Study|Other|9|||
94397642|NCT03488108|323242253|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
94397643|NCT03488108|323242254|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
94397644|NCT03488108|323242253|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
94397645|NCT03488108|323242254|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
94397646|NCT04631562|323242264|FG000|Overall Study|Withdrawal by Subject|0|||
94397647|NCT04631562|323242265|FG001|Overall Study|Withdrawal by Subject|0|||
94397648|NCT04631562|323242266|FG002|Overall Study|Withdrawal by Subject|0|||
94397649|NCT04631562|323242267|FG003|Overall Study|Withdrawal by Subject|0|||
94397650|NCT04631562|323242268|FG004|Overall Study|Withdrawal by Subject|0|||
94397651|NCT04631562|323242269|FG005|Overall Study|Withdrawal by Subject|0|||
94397652|NCT04631562|323242270|FG006|Overall Study|Withdrawal by Subject|0|||
94397653|NCT04631562|323242271|FG007|Overall Study|Withdrawal by Subject|1|||
94397654|NCT04631562|323242272|FG008|Overall Study|Withdrawal by Subject|0|||
94397655|NCT04631562|323242264|FG000|Overall Study|Other|0|||
94397656|NCT04631562|323242265|FG001|Overall Study|Other|0|||
94397657|NCT04631562|323242266|FG002|Overall Study|Other|0|||
94397658|NCT04631562|323242267|FG003|Overall Study|Other|0|||
94397659|NCT04631562|323242268|FG004|Overall Study|Other|0|||
94397660|NCT04631562|323242269|FG005|Overall Study|Other|0|||
94397661|NCT04631562|323242270|FG006|Overall Study|Other|0|||
94397662|NCT04631562|323242271|FG007|Overall Study|Other|0|||
94397663|NCT04631562|323242272|FG008|Overall Study|Other|1|||
94397664|NCT04631562|323242264|FG000|Overall Study|Lost to Follow-up|0|||
94397665|NCT04631562|323242265|FG001|Overall Study|Lost to Follow-up|0|||
94397666|NCT04631562|323242266|FG002|Overall Study|Lost to Follow-up|0|||
94397667|NCT04631562|323242267|FG003|Overall Study|Lost to Follow-up|1|||
94397668|NCT04631562|323242268|FG004|Overall Study|Lost to Follow-up|0|||
94397669|NCT04631562|323242269|FG005|Overall Study|Lost to Follow-up|0|||
94397670|NCT04631562|323242270|FG006|Overall Study|Lost to Follow-up|0|||
94397671|NCT04631562|323242271|FG007|Overall Study|Lost to Follow-up|0|||
94397672|NCT04631562|323242272|FG008|Overall Study|Lost to Follow-up|0|||
94397673|NCT04631562|323242264|FG000|Overall Study|Adverse Event|0|||
94397674|NCT04631562|323242265|FG001|Overall Study|Adverse Event|0|||
94397675|NCT04631562|323242266|FG002|Overall Study|Adverse Event|0|||
94397676|NCT04631562|323242267|FG003|Overall Study|Adverse Event|0|||
94397677|NCT04631562|323242268|FG004|Overall Study|Adverse Event|0|||
94397678|NCT04631562|323242269|FG005|Overall Study|Adverse Event|0|||
94397679|NCT04631562|323242270|FG006|Overall Study|Adverse Event|1|||
94397680|NCT04631562|323242271|FG007|Overall Study|Adverse Event|0|||
94397681|NCT04631562|323242272|FG008|Overall Study|Adverse Event|0|||
94397682|NCT00829452|323242273|FG000|First Intervention|Withdrawal by Subject|0|||
94397683|NCT00829452|323242274|FG001|First Intervention|Withdrawal by Subject|1|||
94397684|NCT00829452|323242273|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
94397685|NCT00829452|323242274|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
94397686|NCT00829452|323242273|FG000|Second Intervention|Physician Decision|0|||
94397687|NCT00829452|323242274|FG001|Second Intervention|Physician Decision|1|||
94397688|NCT00834873|323242275|FG000|First Intervention|Adverse Event|0|||
94397689|NCT00834873|323242276|FG001|First Intervention|Adverse Event|1|||
94397690|NCT02055547|323242277|FG000|Overall Study|Protocol Violation|0|||
94397691|NCT02055547|323242278|FG001|Overall Study|Protocol Violation|0|||
94397692|NCT02055547|323242279|FG002|Overall Study|Protocol Violation|1|||
94397693|NCT02055547|323242280|FG003|Overall Study|Protocol Violation|0|||
94397694|NCT02055547|323242281|FG004|Overall Study|Protocol Violation|0|||
94397695|NCT02055547|323242282|FG005|Overall Study|Protocol Violation|0|||
94397696|NCT02055547|323242283|FG006|Overall Study|Protocol Violation|1|||
94397697|NCT02055547|323242284|FG007|Overall Study|Protocol Violation|0|||
94397698|NCT02055547|323242285|FG008|Overall Study|Protocol Violation|0|||
94397699|NCT02055547|323242286|FG009|Overall Study|Protocol Violation|0|||
94397700|NCT02055547|323242287|FG010|Overall Study|Protocol Violation|0|||
94397701|NCT02055547|323242288|FG011|Overall Study|Protocol Violation|0|||
94397702|NCT02055547|323242289|FG012|Overall Study|Protocol Violation|0|||
94397703|NCT02055547|323242290|FG013|Overall Study|Protocol Violation|0|||
94397704|NCT02055547|323242291|FG014|Overall Study|Protocol Violation|0|||
94397705|NCT02055547|323242292|FG015|Overall Study|Protocol Violation|0|||
94397706|NCT02055547|323242293|FG016|Overall Study|Protocol Violation|0|||
94397707|NCT02055547|323242294|FG017|Overall Study|Protocol Violation|0|||
94397708|NCT02055547|323242295|FG018|Overall Study|Protocol Violation|0|||
94397709|NCT02055547|323242277|FG000|Overall Study|Physician Decision|0|||
94397710|NCT02055547|323242278|FG001|Overall Study|Physician Decision|1|||
94397711|NCT02055547|323242279|FG002|Overall Study|Physician Decision|1|||
94397712|NCT02055547|323242280|FG003|Overall Study|Physician Decision|0|||
94397713|NCT02055547|323242281|FG004|Overall Study|Physician Decision|1|||
94397714|NCT02055547|323242282|FG005|Overall Study|Physician Decision|0|||
94397715|NCT02055547|323242283|FG006|Overall Study|Physician Decision|0|||
94397716|NCT02055547|323242284|FG007|Overall Study|Physician Decision|0|||
94397717|NCT02055547|323242285|FG008|Overall Study|Physician Decision|0|||
94397718|NCT02055547|323242286|FG009|Overall Study|Physician Decision|1|||
94397719|NCT02055547|323242287|FG010|Overall Study|Physician Decision|1|||
94397720|NCT02055547|323242288|FG011|Overall Study|Physician Decision|0|||
94397721|NCT02055547|323242289|FG012|Overall Study|Physician Decision|0|||
94397722|NCT02055547|323242290|FG013|Overall Study|Physician Decision|0|||
94397723|NCT02055547|323242291|FG014|Overall Study|Physician Decision|0|||
94397724|NCT02055547|323242292|FG015|Overall Study|Physician Decision|0|||
94397725|NCT02055547|323242293|FG016|Overall Study|Physician Decision|0|||
94397726|NCT02055547|323242294|FG017|Overall Study|Physician Decision|0|||
94397727|NCT02055547|323242295|FG018|Overall Study|Physician Decision|0|||
94397728|NCT02055547|323242277|FG000|Overall Study|Adverse Event|0|||
94397729|NCT02055547|323242278|FG001|Overall Study|Adverse Event|0|||
94397730|NCT02055547|323242279|FG002|Overall Study|Adverse Event|0|||
94397731|NCT02055547|323242280|FG003|Overall Study|Adverse Event|0|||
94397732|NCT02055547|323242281|FG004|Overall Study|Adverse Event|0|||
94397733|NCT02055547|323242282|FG005|Overall Study|Adverse Event|0|||
94397734|NCT02055547|323242283|FG006|Overall Study|Adverse Event|1|||
94397735|NCT02055547|323242284|FG007|Overall Study|Adverse Event|0|||
94397736|NCT02055547|323242285|FG008|Overall Study|Adverse Event|1|||
94397737|NCT02055547|323242286|FG009|Overall Study|Adverse Event|0|||
94397738|NCT02055547|323242287|FG010|Overall Study|Adverse Event|0|||
94397739|NCT02055547|323242288|FG011|Overall Study|Adverse Event|0|||
94397740|NCT02055547|323242289|FG012|Overall Study|Adverse Event|0|||
94397741|NCT02055547|323242290|FG013|Overall Study|Adverse Event|0|||
94397742|NCT02055547|323242291|FG014|Overall Study|Adverse Event|0|||
94397743|NCT02055547|323242292|FG015|Overall Study|Adverse Event|0|||
94397744|NCT02055547|323242293|FG016|Overall Study|Adverse Event|0|||
94397745|NCT02055547|323242294|FG017|Overall Study|Adverse Event|0|||
94397746|NCT02055547|323242295|FG018|Overall Study|Adverse Event|0|||
94397747|NCT02055547|323242277|FG000|Overall Study|Withdrawal by Subject|0|||
94397748|NCT02055547|323242278|FG001|Overall Study|Withdrawal by Subject|0|||
94397749|NCT02055547|323242279|FG002|Overall Study|Withdrawal by Subject|0|||
94397750|NCT02055547|323242280|FG003|Overall Study|Withdrawal by Subject|0|||
94397751|NCT02055547|323242281|FG004|Overall Study|Withdrawal by Subject|0|||
94397752|NCT02055547|323242282|FG005|Overall Study|Withdrawal by Subject|1|||
94397753|NCT02055547|323242283|FG006|Overall Study|Withdrawal by Subject|0|||
94397754|NCT02055547|323242284|FG007|Overall Study|Withdrawal by Subject|0|||
94397755|NCT02055547|323242285|FG008|Overall Study|Withdrawal by Subject|1|||
94397756|NCT02055547|323242286|FG009|Overall Study|Withdrawal by Subject|0|||
94397757|NCT02055547|323242287|FG010|Overall Study|Withdrawal by Subject|0|||
94397758|NCT02055547|323242288|FG011|Overall Study|Withdrawal by Subject|0|||
94397759|NCT02055547|323242289|FG012|Overall Study|Withdrawal by Subject|0|||
94397760|NCT02055547|323242290|FG013|Overall Study|Withdrawal by Subject|1|||
94397761|NCT02055547|323242291|FG014|Overall Study|Withdrawal by Subject|0|||
94397762|NCT02055547|323242292|FG015|Overall Study|Withdrawal by Subject|1|||
94397763|NCT02055547|323242293|FG016|Overall Study|Withdrawal by Subject|0|||
94397764|NCT02055547|323242294|FG017|Overall Study|Withdrawal by Subject|0|||
94397765|NCT02055547|323242295|FG018|Overall Study|Withdrawal by Subject|0|||
94397766|NCT02055547|323242277|FG000|Overall Study|Lost to Follow-up|0|||
94397767|NCT02055547|323242278|FG001|Overall Study|Lost to Follow-up|0|||
94397768|NCT02055547|323242279|FG002|Overall Study|Lost to Follow-up|1|||
94397769|NCT02055547|323242280|FG003|Overall Study|Lost to Follow-up|0|||
94397770|NCT02055547|323242281|FG004|Overall Study|Lost to Follow-up|0|||
94397771|NCT02055547|323242282|FG005|Overall Study|Lost to Follow-up|0|||
94397772|NCT02055547|323242283|FG006|Overall Study|Lost to Follow-up|0|||
94397773|NCT02055547|323242284|FG007|Overall Study|Lost to Follow-up|0|||
94397774|NCT02055547|323242285|FG008|Overall Study|Lost to Follow-up|0|||
94397775|NCT02055547|323242286|FG009|Overall Study|Lost to Follow-up|0|||
94329812|NCT00892957|322988143|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
94329813|NCT00892957|322988142|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
94329814|NCT00892957|322988143|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
94329815|NCT02146833|322988144|FG000|Overall Study|Death|10|||
94329816|NCT02146833|322988144|FG000|Overall Study|No longer consented to study treatment|1|||
94329817|NCT02420795|322990018|FG000|Overall Study|Withdrawal by Subject|1|||
94329818|NCT02420795|322990019|FG001|Overall Study|Withdrawal by Subject|0|||
94329819|NCT02420795|322990020|FG002|Overall Study|Withdrawal by Subject|0|||
94329820|NCT02420795|322990018|FG000|Overall Study|Adverse Event|1|||
94329821|NCT02420795|322990019|FG001|Overall Study|Adverse Event|0|||
94329822|NCT02420795|322990020|FG002|Overall Study|Adverse Event|0|||
94329823|NCT02420795|322990018|FG000|Overall Study|Progressive disease|2|||
94329824|NCT02420795|322990019|FG001|Overall Study|Progressive disease|2|||
94329825|NCT02420795|322990020|FG002|Overall Study|Progressive disease|4|||
94329826|NCT02420795|322990018|FG000|Overall Study|Death|0|||
94329827|NCT02420795|322990019|FG001|Overall Study|Death|0|||
94329828|NCT02420795|322990020|FG002|Overall Study|Death|1|||
94329829|NCT00571519|322990023|FG000|Overall Study|Subject withdrew consent|0|||
94329830|NCT00571519|322990024|FG001|Overall Study|Subject withdrew consent|1|||
94329831|NCT00571519|322990025|FG002|Overall Study|Subject withdrew consent|0|||
94329832|NCT00571519|322990026|FG003|Overall Study|Subject withdrew consent|2|||
94329833|NCT00571519|322990027|FG004|Overall Study|Subject withdrew consent|1|||
94329834|NCT00571519|322990028|FG005|Overall Study|Subject withdrew consent|1|||
94329835|NCT00571519|322990029|FG006|Overall Study|Subject withdrew consent|2|||
94329836|NCT00571519|322990023|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
94329837|NCT00571519|322990024|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
94329838|NCT00571519|322990025|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
94329839|NCT00571519|322990026|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
94329840|NCT00571519|322990027|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
94329841|NCT00571519|322990028|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
94329842|NCT00571519|322990029|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
94329843|NCT00571519|322990023|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
94329844|NCT00571519|322990024|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
94329845|NCT00571519|322990025|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
94329846|NCT00571519|322990026|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
94329847|NCT00571519|322990027|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
94329848|NCT00571519|322990028|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
94329849|NCT00571519|322990029|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
94397776|NCT02055547|323242287|FG010|Overall Study|Lost to Follow-up|0|||
94397777|NCT02055547|323242288|FG011|Overall Study|Lost to Follow-up|0|||
94397778|NCT02055547|323242289|FG012|Overall Study|Lost to Follow-up|0|||
94397779|NCT02055547|323242290|FG013|Overall Study|Lost to Follow-up|0|||
94397780|NCT02055547|323242291|FG014|Overall Study|Lost to Follow-up|0|||
94397781|NCT02055547|323242292|FG015|Overall Study|Lost to Follow-up|0|||
94397782|NCT02055547|323242293|FG016|Overall Study|Lost to Follow-up|0|||
94397783|NCT02055547|323242294|FG017|Overall Study|Lost to Follow-up|0|||
94397784|NCT02055547|323242295|FG018|Overall Study|Lost to Follow-up|0|||
94397785|NCT05098743|323242296|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
94397786|NCT05098743|323242297|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
94397787|NCT05098743|323242296|FG000|Overall Study|Lost to Follow-up|1|||
94397788|NCT05098743|323242297|FG001|Overall Study|Lost to Follow-up|2|||
94397789|NCT03500094|323242298|FG000|Overall Study|Withdrawal by Subject|1|||
94397790|NCT03500094|323242298|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
94397791|NCT03500094|323242298|FG000|Overall Study|Lost to Follow-up|1|||
94397792|NCT00835705|323243880|FG000|First Intervention|Difficulty with vein|1|||
94397793|NCT00835705|323243881|FG001|First Intervention|Difficulty with vein|0|||
94397794|NCT00835705|323243880|FG000|Second Intervention|Difficulty with vein|1|||
94397795|NCT00835705|323243881|FG001|Second Intervention|Difficulty with vein|0|||
94397796|NCT00594035|323243882|FG000|Overall Study|Lost to Follow-up|1|||
94397797|NCT00594035|323243883|FG001|Overall Study|Lost to Follow-up|1|||
94397798|NCT00594035|323243882|FG000|Overall Study|Withdrawal by Subject|1|||
94397799|NCT00594035|323243883|FG001|Overall Study|Withdrawal by Subject|0|||
94397800|NCT00594035|323243882|FG000|Overall Study|Subject transferred to nursing home|0|||
94397801|NCT00594035|323243883|FG001|Overall Study|Subject transferred to nursing home|1|||
94397802|NCT00594035|323243882|FG000|Overall Study|Subject couldn't return due to job|0|||
94397803|NCT00594035|323243883|FG001|Overall Study|Subject couldn't return due to job|1|||
94397804|NCT04035187|323243884|FG000|Overall Study|Withdrawal by Subject|2|||
94397805|NCT04035187|323243885|FG001|Overall Study|Withdrawal by Subject|1|||
94397806|NCT04035187|323243886|FG002|Overall Study|Withdrawal by Subject|0|||
94397807|NCT04035187|323243887|FG003|Overall Study|Withdrawal by Subject|0|||
94397808|NCT04035187|323243884|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
94397809|NCT04035187|323243885|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
94397810|NCT04035187|323243886|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
94397811|NCT04035187|323243887|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
94397812|NCT00508651|323243890|FG000|Overall Study|Lost to Follow-up|3|||
94397813|NCT00508651|323243891|FG001|Overall Study|Lost to Follow-up|1|||
94397814|NCT00508651|323243890|FG000|Overall Study|Withdrawal by Subject|1|||
94397815|NCT00508651|323243891|FG001|Overall Study|Withdrawal by Subject|1|||
94397816|NCT01528696|323243895|FG000|Overall Study|See detailed description|18|||
94397817|NCT01528696|323243896|FG001|Overall Study|See detailed description|19|||
94397818|NCT00446966|323243897|FG000|Overall Study|Lost to Follow-up|10|||
94397819|NCT00446966|323243898|FG001|Overall Study|Lost to Follow-up|7|||
94397820|NCT00836472|323243899|FG000|Washout|Adverse Event|1|||
94397821|NCT00836472|323243900|FG001|Washout|Adverse Event|2|||
94397822|NCT00836472|323243899|FG000|Washout|Withdrawal by Subject|1|||
94397823|NCT00836472|323243900|FG001|Washout|Withdrawal by Subject|1|||
94397824|NCT01695239|323243901|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
94397825|NCT01695239|323243902|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
94397826|NCT01695239|323243903|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
94397827|NCT01695239|323243904|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
94397828|NCT01695239|323243905|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
94397829|NCT01695239|323243906|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
94397830|NCT01695239|323243907|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
94397831|NCT01695239|323243908|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
94397832|NCT01695239|323243909|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
94397833|NCT01695239|323243910|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
94397834|NCT01695239|323243911|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
94397835|NCT01695239|323243912|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
94397836|NCT01695239|323243913|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
94397837|NCT01695239|323243914|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
94397838|NCT01695239|323243901|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
94397839|NCT01695239|323243902|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
94397840|NCT01695239|323243903|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
94397841|NCT01695239|323243904|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
94397842|NCT01695239|323243905|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
94397843|NCT01695239|323243906|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
94397844|NCT01695239|323243907|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
94397845|NCT01695239|323243908|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
94397846|NCT01695239|323243909|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
94397847|NCT01695239|323243910|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
94397848|NCT01695239|323243911|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
94484681|NCT01939314|323567564|FG001|Overall Study|Withdrawal by Subject|1|||
94484682|NCT01939314|323567563|FG000|Overall Study|Protocol Violation|1|||
94484683|NCT01939314|323567564|FG001|Overall Study|Protocol Violation|0|||
94484684|NCT01939314|323567563|FG000|Overall Study|Pregnancy|0|||
94484685|NCT01939314|323567564|FG001|Overall Study|Pregnancy|1|||
94484686|NCT01939314|323567563|FG000|Overall Study|Lost to Follow-up|5|||
94484687|NCT01939314|323567564|FG001|Overall Study|Lost to Follow-up|6|||
94484688|NCT01061606|323567565|FG000|Overall Study|Adverse Event|1|||
94484689|NCT01061606|323567565|FG000|Overall Study|Death|1|||
94484690|NCT01061606|323567565|FG000|Overall Study|Disease Progression|4|||
94484691|NCT01061606|323567565|FG000|Overall Study|alternative therapy|2|||
94484692|NCT01789047|323567566|FG000|Overall Study|Adverse Event|3|||
94484693|NCT01789047|323567567|FG001|Overall Study|Adverse Event|2|||
94484694|NCT01789047|323567566|FG000|Overall Study|Withdrawal by Subject|1|||
94484695|NCT01789047|323567567|FG001|Overall Study|Withdrawal by Subject|2|||
94484696|NCT02175225|323567568|FG000|Overall Study|Withdrawal by Subject|1|||
94484697|NCT02175225|323567569|FG001|Overall Study|Withdrawal by Subject|2|||
94484698|NCT02175225|323567568|FG000|Overall Study|Lost to Follow-up|6|||
94484699|NCT02175225|323567569|FG001|Overall Study|Lost to Follow-up|7|||
94484700|NCT02175225|323567568|FG000|Overall Study|Study drug not administered|1|||
94484701|NCT02175225|323567569|FG001|Overall Study|Study drug not administered|2|||
94484702|NCT00606307|323567576|FG000|Overall Study|Adverse Event|2|||
94484703|NCT00606307|323567576|FG000|Overall Study|Withdrawal by Subject|2|||
94484704|NCT00606307|323567576|FG000|Overall Study|Disease progression|6|||
94484705|NCT00606307|323567576|FG000|Overall Study|QTc prolongation|1|||
94484706|NCT02563899|323567577|FG000|Overall Study|Protocol Violation|1|||
94484707|NCT02563899|323567578|FG001|Overall Study|Protocol Violation|0|||
94484708|NCT02563899|323567579|FG002|Overall Study|Protocol Violation|0|||
94484709|NCT02563899|323567580|FG003|Overall Study|Protocol Violation|0|||
94484710|NCT02563899|323567577|FG000|Overall Study|Withdrawal by Subject|0|||
94484711|NCT02563899|323567578|FG001|Overall Study|Withdrawal by Subject|0|||
94484712|NCT02563899|323567579|FG002|Overall Study|Withdrawal by Subject|1|||
94484713|NCT02563899|323567580|FG003|Overall Study|Withdrawal by Subject|0|||
94484714|NCT02949947|323567586|FG000|Overall Study|Non Compliance|0|||
94484715|NCT02949947|323567587|FG001|Overall Study|Non Compliance|1|||
94484716|NCT02949947|323567586|FG000|Overall Study|Insurance change|1|||
94484717|NCT02949947|323567587|FG001|Overall Study|Insurance change|0|||
94484718|NCT02247466|323567590|FG000|Overall Study|Procedure changed to open surgery|0|||
94484719|NCT02247466|323567591|FG001|Overall Study|Procedure changed to open surgery|3|||
94484720|NCT01883895|323567592|FG000|Overall Study|Lost to Follow-up|2|||
94484721|NCT00492726|323567594|FG000|Overall Study|Adverse Event|10|||
94484722|NCT00492726|323567595|FG001|Overall Study|Adverse Event|6|||
94484723|NCT00492726|323567594|FG000|Overall Study|Death|7|||
94484724|NCT00492726|323567595|FG001|Overall Study|Death|2|||
94484725|NCT00492726|323567594|FG000|Overall Study|Lack of Efficacy|0|||
94484726|NCT00492726|323567595|FG001|Overall Study|Lack of Efficacy|2|||
94484727|NCT00492726|323567594|FG000|Overall Study|Lost to Follow-up|27|||
94484728|NCT00492726|323567595|FG001|Overall Study|Lost to Follow-up|19|||
94484729|NCT00492726|323567594|FG000|Overall Study|Physician Decision|0|||
94484730|NCT00492726|323567595|FG001|Overall Study|Physician Decision|1|||
94484731|NCT00492726|323567594|FG000|Overall Study|Withdrawal by Subject|6|||
94484732|NCT00492726|323567595|FG001|Overall Study|Withdrawal by Subject|3|||
94484733|NCT00492726|323567594|FG000|Overall Study|Non compliant with study medication|0|||
94484734|NCT00492726|323567595|FG001|Overall Study|Non compliant with study medication|3|||
94484735|NCT02230891|323567596|FG000|Baseline|Did not meet inclusion|0|||
94484736|NCT02230891|323567597|FG001|Baseline|Did not meet inclusion|1|||
94484737|NCT02230891|323567598|FG002|Baseline|Did not meet inclusion|1|||
94484738|NCT02230891|323567596|FG000|2 Week|Withdrawal by Subject|2|||
94484739|NCT02230891|323567597|FG001|2 Week|Withdrawal by Subject|2|||
94484740|NCT02230891|323567598|FG002|2 Week|Withdrawal by Subject|0|||
94484741|NCT02230891|323567596|FG000|2 Week|Consent withdrawn|1|||
94484742|NCT02230891|323567597|FG001|2 Week|Consent withdrawn|0|||
94484743|NCT02230891|323567598|FG002|2 Week|Consent withdrawn|0|||
94484744|NCT02230891|323567596|FG000|6 Month|Withdrawal by Subject|1|||
94484745|NCT02230891|323567597|FG001|6 Month|Withdrawal by Subject|1|||
94484746|NCT02230891|323567598|FG002|6 Month|Withdrawal by Subject|1|||
94484747|NCT02230891|323567596|FG000|6 Month|Physician Decision|0|||
94484748|NCT02230891|323567597|FG001|6 Month|Physician Decision|2|||
94484749|NCT02230891|323567598|FG002|6 Month|Physician Decision|0|||
94484750|NCT02230891|323567596|FG000|12 Month|Death|1|||
94484751|NCT02230891|323567597|FG001|12 Month|Death|0|||
94484752|NCT02230891|323567598|FG002|12 Month|Death|0|||
94484753|NCT02230891|323567596|FG000|12 Month|Lost to Follow-up|0|||
94484754|NCT02230891|323567597|FG001|12 Month|Lost to Follow-up|1|||
94484755|NCT02230891|323567598|FG002|12 Month|Lost to Follow-up|0|||
94484756|NCT02230891|323567596|FG000|12 Month|Withdrawal by Subject|0|||
94484757|NCT02230891|323567597|FG001|12 Month|Withdrawal by Subject|2|||
94484758|NCT02230891|323567598|FG002|12 Month|Withdrawal by Subject|0|||
94484759|NCT02230891|323567596|FG000|18 Month End of Study|Death|0|||
94484760|NCT02230891|323567597|FG001|18 Month End of Study|Death|0|||
94484761|NCT02230891|323567598|FG002|18 Month End of Study|Death|1|||
94397849|NCT01695239|323243912|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
94397850|NCT01695239|323243913|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
94397851|NCT01695239|323243914|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
94397852|NCT01695239|323243901|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
94397853|NCT01695239|323243902|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
94397854|NCT01695239|323243903|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
94397855|NCT01695239|323243904|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
94397856|NCT01695239|323243905|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
94397857|NCT01695239|323243906|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
94397858|NCT01695239|323243907|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
94397859|NCT01695239|323243908|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
94397860|NCT01695239|323243909|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
94397861|NCT01695239|323243910|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
94397862|NCT01695239|323243911|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
94397863|NCT01695239|323243912|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
94397864|NCT01695239|323243913|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
94397865|NCT01695239|323243914|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
94397866|NCT01695239|323243901|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
94397867|NCT01695239|323243902|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
94397868|NCT01695239|323243903|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
94397869|NCT01695239|323243904|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
94397870|NCT01695239|323243905|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
94397871|NCT01695239|323243906|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
94397872|NCT01695239|323243907|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
94397873|NCT01695239|323243908|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
94397874|NCT01695239|323243909|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
94397875|NCT01695239|323243910|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
94397876|NCT01695239|323243911|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
94397877|NCT01695239|323243912|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
94397878|NCT01695239|323243913|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
94397879|NCT01695239|323243914|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
94397880|NCT01695239|323243901|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
94397881|NCT01695239|323243902|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
94397882|NCT01695239|323243903|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
94397883|NCT01695239|323243904|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
94397884|NCT01695239|323243905|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
94397885|NCT01695239|323243906|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
94397886|NCT01695239|323243907|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
94397887|NCT01695239|323243908|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
94397888|NCT01695239|323243909|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
94397889|NCT01695239|323243910|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
94397890|NCT01695239|323243911|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
94397891|NCT01695239|323243912|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
94397892|NCT01695239|323243913|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
94397893|NCT01695239|323243914|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
94397894|NCT01695239|323243901|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
94397895|NCT01695239|323243902|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
94397896|NCT01695239|323243903|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
94397897|NCT01695239|323243904|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
94397898|NCT01695239|323243905|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
94397899|NCT01695239|323243906|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
94397900|NCT01695239|323243907|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
94397901|NCT01695239|323243908|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
94397902|NCT01695239|323243909|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
94397903|NCT01695239|323243910|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
94397904|NCT01695239|323243911|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
94397905|NCT01695239|323243912|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
94397906|NCT01695239|323243913|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
94397907|NCT01695239|323243914|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
94397908|NCT01695239|323243901|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
94397909|NCT01695239|323243902|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
94397910|NCT01695239|323243903|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
94397911|NCT01695239|323243904|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
94397912|NCT01695239|323243905|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
94397913|NCT01695239|323243906|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
94397914|NCT01695239|323243907|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
94484762|NCT02230891|323567596|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
94484763|NCT02230891|323567597|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
94484764|NCT02230891|323567598|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
94484765|NCT02404545|323567599|FG000|Overall Study|Sponsor Termination|6|||
94484766|NCT02404545|323567600|FG001|Overall Study|Sponsor Termination|6|||
94484767|NCT00073918|323567601|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
94484768|NCT00073918|323567601|FG000|Overall Study|Rapid disease progression|2|||
94484769|NCT00073918|323567601|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
94484770|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
94484771|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
94484772|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
94484773|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
94484774|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
94484775|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
94397915|NCT01695239|323243908|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
94397916|NCT01695239|323243909|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
94397917|NCT01695239|323243910|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
94397918|NCT01695239|323243911|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
94397919|NCT01695239|323243912|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
94397920|NCT01695239|323243913|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
94397921|NCT01695239|323243914|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
94397922|NCT01695239|323243901|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
94397923|NCT01695239|323243902|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
94397924|NCT01695239|323243903|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
94397925|NCT01695239|323243904|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
94397926|NCT01695239|323243905|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
94397927|NCT01695239|323243906|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
94397928|NCT01695239|323243907|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
94397929|NCT01695239|323243908|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
94397930|NCT01695239|323243909|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
94397931|NCT01695239|323243910|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
94397932|NCT01695239|323243911|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
94397933|NCT01695239|323243912|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
94397934|NCT01695239|323243913|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
94397935|NCT01695239|323243914|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
94397936|NCT01695239|323243901|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
94397937|NCT01695239|323243902|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
94397938|NCT01695239|323243903|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
94397939|NCT01695239|323243904|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
94397940|NCT01695239|323243905|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
94397941|NCT01695239|323243906|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
94397942|NCT01695239|323243907|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
94397943|NCT01695239|323243908|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
94397944|NCT01695239|323243909|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
94397945|NCT01695239|323243910|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
94397946|NCT01695239|323243911|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
94397947|NCT01695239|323243912|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
94397948|NCT01695239|323243913|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
94397949|NCT01695239|323243914|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
94397950|NCT01695239|323243901|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
94397951|NCT01695239|323243902|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
94397952|NCT01695239|323243903|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
94397953|NCT01695239|323243904|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
94397954|NCT01695239|323243905|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
94397955|NCT01695239|323243906|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
94397956|NCT01695239|323243907|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
94397957|NCT01695239|323243908|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
94397958|NCT01695239|323243909|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
94397959|NCT01695239|323243910|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
94397960|NCT01695239|323243911|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
94397961|NCT01695239|323243912|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
94484776|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
94484777|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
94484778|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
94397962|NCT01695239|323243913|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
94484779|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
94484780|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
94484781|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
94484782|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
94484783|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
94484784|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
94484785|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
94484786|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
94484787|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
94484788|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
94484789|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
94484790|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
94484791|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
94484792|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
94484793|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
94484794|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
94484795|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
94484796|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
94484797|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
94329850|NCT00571519|322990023|FG000|Overall Study|Termination of study by Sponsor|2|||
94329851|NCT00571519|322990024|FG001|Overall Study|Termination of study by Sponsor|7|||
94329852|NCT00571519|322990025|FG002|Overall Study|Termination of study by Sponsor|10|||
94329853|NCT00571519|322990026|FG003|Overall Study|Termination of study by Sponsor|24|||
94329854|NCT00571519|322990027|FG004|Overall Study|Termination of study by Sponsor|8|||
94329855|NCT00571519|322990028|FG005|Overall Study|Termination of study by Sponsor|9|||
94329856|NCT00571519|322990029|FG006|Overall Study|Termination of study by Sponsor|22|||
94329857|NCT00571519|322990023|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
94329858|NCT00571519|322990024|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
94329859|NCT00571519|322990025|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
94329860|NCT00571519|322990026|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
94329861|NCT00571519|322990027|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
94329862|NCT00571519|322990028|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
94329863|NCT00571519|322990029|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
94329864|NCT01002742|322990032|FG000|Overall Study|Determined to be ineligible|0|||
94329865|NCT01002742|322990033|FG001|Overall Study|Determined to be ineligible|1|||
94329866|NCT02150213|322990034|FG000|Overall Study|Lost to Follow-up|1|||
94329867|NCT02150213|322990034|FG000|Overall Study|Withdrawal by Subject|1|||
94329868|NCT01297309|322990035|FG000|Overall Study|Eligibility failure|2|||
94329869|NCT01297309|322990035|FG000|Overall Study|Screen failure|2|||
94329870|NCT01297309|322990035|FG000|Overall Study|Withdrawal by Subject|5|||
94329871|NCT01297309|322990035|FG000|Overall Study|Adverse Event|1|||
94329872|NCT01297309|322990035|FG000|Overall Study|Investigator Decision|2|||
94329873|NCT01297309|322990035|FG000|Overall Study|Death|1|||
94329874|NCT01297309|322990035|FG000|Overall Study|Participant not entering extensionperiod|1|||
94329875|NCT00520299|322990038|FG000|Overall Study|Withdrawal by Subject|0|||
94329876|NCT00520299|322990039|FG001|Overall Study|Withdrawal by Subject|0|||
94329877|NCT00520299|322990040|FG002|Overall Study|Withdrawal by Subject|2|||
94329878|NCT00520299|322990038|FG000|Overall Study|Progressive disease|0|||
94329879|NCT00520299|322990039|FG001|Overall Study|Progressive disease|3|||
94329880|NCT00520299|322990040|FG002|Overall Study|Progressive disease|4|||
94329881|NCT02759562|322990043|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
94329882|NCT02759562|322990044|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
94329883|NCT02759562|322990043|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
94329884|NCT02759562|322990044|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
94329885|NCT02293993|322990045|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
94329886|NCT02293993|322990046|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
94329887|NCT02293993|322990047|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
94329888|NCT02293993|322990048|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
94329889|NCT02293993|322990045|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
94329890|NCT02293993|322990046|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
94329891|NCT02293993|322990047|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
94329892|NCT02293993|322990048|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
94329893|NCT02293993|322990045|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
94329894|NCT02293993|322990046|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
94329895|NCT02293993|322990047|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
94329896|NCT02293993|322990048|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
94329897|NCT02293993|322990045|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
94329898|NCT02293993|322990046|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
94329899|NCT02293993|322990047|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
94329900|NCT02293993|322990048|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
94329901|NCT02293993|322990045|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
94329902|NCT02293993|322990046|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
94329903|NCT02293993|322990047|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
94329904|NCT02293993|322990048|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
94329905|NCT00092677|322990049|FG000|Overall Study|Lost to Follow-up|0|||
94329906|NCT00092677|322990050|FG001|Overall Study|Lost to Follow-up|2|||
94329907|NCT00092677|322990049|FG000|Overall Study|Adminstrative|5|||
94329908|NCT00092677|322990050|FG001|Overall Study|Adminstrative|9|||
94329909|NCT04624672|322990051|FG000|Overall Study|Early Study Closure|2|||
94329910|NCT04624672|322990052|FG001|Overall Study|Early Study Closure|1|||
94329911|NCT01419015|322990053|FG000|Overall Study|Death|2|||
94329912|NCT01188096|322990054|FG000|Overall Study|progression of disease|4|||
94329913|NCT01188096|322990054|FG000|Overall Study|Withdrawal by Subject|2|||
94329914|NCT01797445|322990055|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
94329915|NCT01797445|322990056|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
94329916|NCT01797445|322990055|FG000|Double-Blind Phase|Adverse Event|3|||
94329917|NCT01797445|322990056|FG001|Double-Blind Phase|Adverse Event|0|||
94329918|NCT01797445|322990055|FG000|Double-Blind Phase|Death|5|||
94329919|NCT01797445|322990056|FG001|Double-Blind Phase|Death|4|||
94329920|NCT01797445|322990055|FG000|Double-Blind Phase|Pregnancy|0|||
94329921|NCT01797445|322990056|FG001|Double-Blind Phase|Pregnancy|1|||
94329922|NCT01797445|322990055|FG000|Double-Blind Phase|Lack of Efficacy|1|||
94329923|NCT01797445|322990056|FG001|Double-Blind Phase|Lack of Efficacy|2|||
94329924|NCT01797445|322990055|FG000|Double-Blind Phase|Investigator's Discretion|15|||
94329925|NCT01797445|322990056|FG001|Double-Blind Phase|Investigator's Discretion|17|||
94329926|NCT01797445|322990055|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
94329927|NCT01797445|322990056|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
94329928|NCT01797445|322990055|FG000|Double-Blind Phase|Protocol Violation|0|||
94329929|NCT01797445|322990056|FG001|Double-Blind Phase|Protocol Violation|1|||
94329930|NCT01797445|322990055|FG000|Double-Blind Phase|Withdrew Consent|20|||
94329931|NCT01797445|322990056|FG001|Double-Blind Phase|Withdrew Consent|35|||
94329932|NCT01797445|322990055|FG000|Double-Blind Phase|Lost to Follow-up|34|||
94329933|NCT01797445|322990056|FG001|Double-Blind Phase|Lost to Follow-up|26|||
94329934|NCT01797445|322990055|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
94329935|NCT01797445|322990056|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
94329936|NCT03892707|322990059|FG000|Overall Study|Screen failure|6|||
94329937|NCT03892707|322990060|FG001|Overall Study|Screen failure|0|||
94329938|NCT03892707|322990059|FG000|Overall Study|Pain resolution|0|||
94329939|NCT03892707|322990060|FG001|Overall Study|Pain resolution|4|||
94329940|NCT03892707|322990059|FG000|Overall Study|Withdrawal by Subject|0|||
94329941|NCT03892707|322990060|FG001|Overall Study|Withdrawal by Subject|1|||
94329942|NCT03892707|322990059|FG000|Overall Study|Other (long business trip)|0|||
94329943|NCT03892707|322990060|FG001|Overall Study|Other (long business trip)|1|||
94329944|NCT01409993|322990066|FG000|Overall Study|Adverse Event|4|||
94329945|NCT01409993|322990067|FG001|Overall Study|Adverse Event|4|||
94329946|NCT01409993|322990068|FG002|Overall Study|Adverse Event|3|||
94329947|NCT01409993|322990069|FG003|Overall Study|Adverse Event|1|||
94329948|NCT01409993|322990066|FG000|Overall Study|Withdrawal by Subject|0|||
94329949|NCT01409993|322990067|FG001|Overall Study|Withdrawal by Subject|0|||
94329950|NCT01409993|322990068|FG002|Overall Study|Withdrawal by Subject|0|||
94329951|NCT01409993|322990069|FG003|Overall Study|Withdrawal by Subject|4|||
94329952|NCT01409993|322990066|FG000|Overall Study|Lost to Follow-up|0|||
94329953|NCT01409993|322990067|FG001|Overall Study|Lost to Follow-up|1|||
94329954|NCT01409993|322990068|FG002|Overall Study|Lost to Follow-up|0|||
94329955|NCT01409993|322990069|FG003|Overall Study|Lost to Follow-up|0|||
94329956|NCT03074149|322990072|FG000|Overall Study|Reason unknown|22|||
94329957|NCT03074149|322990073|FG001|Overall Study|Reason unknown|35|||
94329958|NCT03074149|322990072|FG000|Overall Study|Death|10|||
94329959|NCT03074149|322990073|FG001|Overall Study|Death|45|||
94329960|NCT00879437|322990075|FG000|Overall Study|Protocol Violation|0|||
94329961|NCT00879437|322990076|FG001|Overall Study|Protocol Violation|1|||
94397963|NCT01695239|323243914|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
94329962|NCT00879437|322990075|FG000|Overall Study|Death|1|||
94329963|NCT00879437|322990076|FG001|Overall Study|Death|0|||
94329964|NCT00426556|322990077|FG000|Phase I - Core Phase|Disease Progression|0|||
94329965|NCT00426556|322990078|FG001|Phase I - Core Phase|Disease Progression|6|||
94329966|NCT00426556|322990079|FG002|Phase I - Core Phase|Disease Progression|2|||
94397964|NCT01695239|323243901|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
94397965|NCT01695239|323243902|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
94397966|NCT01695239|323243903|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
94397967|NCT01695239|323243904|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
94397968|NCT01695239|323243905|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
94397969|NCT01695239|323243906|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
94397970|NCT01695239|323243907|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
94397971|NCT01695239|323243908|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
94397972|NCT01695239|323243909|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
94397973|NCT01695239|323243910|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
94397974|NCT01695239|323243911|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
94397975|NCT01695239|323243912|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
94397976|NCT01695239|323243913|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
94397977|NCT01695239|323243914|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
94397978|NCT01695239|323243901|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
94397979|NCT01695239|323243902|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
94397980|NCT01695239|323243903|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
94397981|NCT01695239|323243904|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
94397982|NCT01695239|323243905|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
94397983|NCT01695239|323243906|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
94397984|NCT01695239|323243907|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
94397985|NCT01695239|323243908|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
94397986|NCT01695239|323243909|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
94397987|NCT01695239|323243910|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
94397988|NCT01695239|323243911|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
94397989|NCT01695239|323243912|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
94397990|NCT01695239|323243913|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
94397991|NCT01695239|323243914|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
94397992|NCT01695239|323243901|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
94397993|NCT01695239|323243902|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
94397994|NCT01695239|323243903|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
94397995|NCT01695239|323243904|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
94397996|NCT01695239|323243905|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
94397997|NCT01695239|323243906|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
94397998|NCT01695239|323243907|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
94397999|NCT01695239|323243908|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
94398000|NCT01695239|323243909|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
94398001|NCT01695239|323243910|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
94398002|NCT01695239|323243911|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
94398003|NCT01695239|323243912|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
94398004|NCT01695239|323243913|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
94398005|NCT01695239|323243914|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
94398006|NCT01695239|323243901|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
94398007|NCT01695239|323243902|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
94398008|NCT01695239|323243903|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
94398009|NCT01695239|323243904|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
94398010|NCT01695239|323243905|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
94398011|NCT01695239|323243906|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
94398012|NCT01695239|323243907|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
94398013|NCT01695239|323243908|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
94398014|NCT01695239|323243909|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
94398015|NCT01695239|323243910|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
94398016|NCT01695239|323243911|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
94398017|NCT01695239|323243912|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
94398018|NCT01695239|323243913|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
94398019|NCT01695239|323243914|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
94398020|NCT01695239|323243901|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
94398021|NCT01695239|323243902|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
94398022|NCT01695239|323243903|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
94398023|NCT01695239|323243904|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
94398024|NCT01695239|323243905|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
94398025|NCT01695239|323243906|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
94398026|NCT01695239|323243907|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
94398027|NCT01695239|323243908|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
94398028|NCT01695239|323243909|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
94398029|NCT01695239|323243910|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
94398030|NCT01695239|323243911|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
94398031|NCT01695239|323243912|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
94398032|NCT01695239|323243913|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
94398033|NCT01695239|323243914|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
94398034|NCT01695239|323243901|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
94398035|NCT01695239|323243902|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
94398036|NCT01695239|323243903|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
94398037|NCT01695239|323243904|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
94398038|NCT01695239|323243905|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
94398039|NCT01695239|323243906|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
94398040|NCT01695239|323243907|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
94398041|NCT01695239|323243908|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
94398042|NCT01695239|323243909|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
94398043|NCT01695239|323243910|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
94398044|NCT01695239|323243911|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
94398045|NCT01695239|323243912|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
94398046|NCT01695239|323243913|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
94398047|NCT01695239|323243914|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
94398048|NCT01695239|323243901|FG000|Extension Long-Term Extension Periods|Death|0|||
94398049|NCT01695239|323243902|FG001|Extension Long-Term Extension Periods|Death|0|||
94398050|NCT01695239|323243903|FG002|Extension Long-Term Extension Periods|Death|0|||
94398051|NCT01695239|323243904|FG003|Extension Long-Term Extension Periods|Death|0|||
94398052|NCT01695239|323243905|FG004|Extension Long-Term Extension Periods|Death|0|||
94398053|NCT01695239|323243906|FG005|Extension Long-Term Extension Periods|Death|0|||
94398054|NCT01695239|323243907|FG006|Extension Long-Term Extension Periods|Death|0|||
94398055|NCT01695239|323243908|FG007|Extension Long-Term Extension Periods|Death|0|||
94398056|NCT01695239|323243909|FG008|Extension Long-Term Extension Periods|Death|1|||
94398057|NCT01695239|323243910|FG009|Extension Long-Term Extension Periods|Death|0|||
94398058|NCT01695239|323243911|FG010|Extension Long-Term Extension Periods|Death|0|||
94398059|NCT01695239|323243912|FG011|Extension Long-Term Extension Periods|Death|0|||
94398060|NCT01695239|323243913|FG012|Extension Long-Term Extension Periods|Death|0|||
94398061|NCT01695239|323243914|FG013|Extension Long-Term Extension Periods|Death|0|||
94398062|NCT01695239|323243901|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94398063|NCT01695239|323243902|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94398064|NCT01695239|323243903|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94398065|NCT01695239|323243904|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94398066|NCT01695239|323243905|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94398067|NCT01695239|323243906|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94398068|NCT01695239|323243907|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94398069|NCT01695239|323243908|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94398070|NCT01695239|323243909|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94398071|NCT01695239|323243910|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94398072|NCT01695239|323243911|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
94398073|NCT01695239|323243912|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
94398074|NCT01695239|323243913|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
94484798|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
94398075|NCT01695239|323243914|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
94398076|NCT01695239|323243901|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94398077|NCT01695239|323243902|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94398078|NCT01695239|323243903|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94398079|NCT01695239|323243904|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94398080|NCT01695239|323243905|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94398081|NCT01695239|323243906|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94398082|NCT01695239|323243907|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94398083|NCT01695239|323243908|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94398084|NCT01695239|323243909|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94398085|NCT01695239|323243910|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94398086|NCT01695239|323243911|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94398087|NCT01695239|323243912|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
94398088|NCT01695239|323243913|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
94398089|NCT01695239|323243914|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
94398090|NCT01695239|323243901|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
94398091|NCT01695239|323243902|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
94398092|NCT01695239|323243903|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
94398093|NCT01695239|323243904|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
94398094|NCT01695239|323243905|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
94398095|NCT01695239|323243906|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
94398096|NCT01695239|323243907|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
94398097|NCT01695239|323243908|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
94398098|NCT01695239|323243909|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
94398099|NCT01695239|323243910|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
94398100|NCT01695239|323243911|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
94398101|NCT01695239|323243912|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
94398102|NCT01695239|323243913|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
94398103|NCT01695239|323243914|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
94398104|NCT01695239|323243901|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94398105|NCT01695239|323243902|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94398106|NCT01695239|323243903|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94398107|NCT01695239|323243904|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94398108|NCT01695239|323243905|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94398109|NCT01695239|323243906|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94398110|NCT01695239|323243907|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94398111|NCT01695239|323243908|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94398112|NCT01695239|323243909|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94398113|NCT01695239|323243910|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94398114|NCT01695239|323243911|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94398115|NCT01695239|323243912|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94398116|NCT01695239|323243913|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
94398117|NCT01695239|323243914|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
94398118|NCT03552484|323243915|FG000|Overall Study|Death|6|||
94398119|NCT03552484|323243916|FG001|Overall Study|Death|4|||
94398120|NCT03552484|323243915|FG000|Overall Study|Lost to Follow-up|0|||
94398121|NCT03552484|323243916|FG001|Overall Study|Lost to Follow-up|16|||
94398122|NCT00245063|323243919|FG000|Overall Study|Adverse Event|6|||
94398123|NCT00245063|323243920|FG001|Overall Study|Adverse Event|5|||
94398124|NCT00245063|323243919|FG000|Overall Study|Death|1|||
94398125|NCT00245063|323243920|FG001|Overall Study|Death|0|||
94398126|NCT04194801|323243927|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
94398127|NCT04194801|323243928|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
94398128|NCT04194801|323243929|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
94398129|NCT04194801|323243927|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
94398130|NCT04194801|323243928|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
94398131|NCT04194801|323243929|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
94398132|NCT04194801|323243927|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
94398133|NCT04194801|323243928|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
94398134|NCT04194801|323243929|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
94398135|NCT04194801|323243927|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
94398136|NCT04194801|323243928|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
94398137|NCT04194801|323243929|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
94398138|NCT04194801|323243927|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
94398139|NCT04194801|323243928|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
94398140|NCT04194801|323243929|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
94398141|NCT04194801|323243927|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
94398142|NCT04194801|323243928|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
94398143|NCT04194801|323243929|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
94398144|NCT04194801|323243927|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
94398145|NCT04194801|323243928|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
94398146|NCT04194801|323243929|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
94398147|NCT04194801|323243927|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
94398148|NCT04194801|323243928|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
94398149|NCT04194801|323243929|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
94398150|NCT04194801|323243927|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
94398151|NCT04194801|323243928|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
94398152|NCT04194801|323243929|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
94398153|NCT04194801|323243927|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
94398154|NCT04194801|323243928|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
94398155|NCT04194801|323243929|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
94398156|NCT04194801|323243927|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
94398157|NCT04194801|323243928|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
94398158|NCT04194801|323243929|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
94398159|NCT04194801|323243927|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
94398160|NCT04194801|323243928|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
94398161|NCT04194801|323243929|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
94398162|NCT04194801|323243927|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
94398163|NCT04194801|323243928|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
94398164|NCT04194801|323243929|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
94398165|NCT04194801|323243927|FG000|Part Ib/II End of Study|Death|2|||
94398166|NCT04194801|323243928|FG001|Part Ib/II End of Study|Death|3|||
94398167|NCT04194801|323243929|FG002|Part Ib/II End of Study|Death|3|||
94398168|NCT04194801|323243927|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
94398169|NCT04194801|323243928|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
94398170|NCT04194801|323243929|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
94398171|NCT04194801|323243927|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
94398172|NCT04194801|323243928|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
94398173|NCT04194801|323243929|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
94398174|NCT04194801|323243927|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
94398175|NCT04194801|323243928|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
94398176|NCT04194801|323243929|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
94398177|NCT04194801|323243927|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
94398178|NCT04194801|323243928|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
94398179|NCT04194801|323243929|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
94398180|NCT01923740|323243930|FG000|Overall Study|Lost to Follow-up|4|||
94398181|NCT01923740|323243931|FG001|Overall Study|Lost to Follow-up|9|||
94398182|NCT01923740|323243930|FG000|Overall Study|Withdrawal by Subject|2|||
94398183|NCT01923740|323243931|FG001|Overall Study|Withdrawal by Subject|0|||
94398184|NCT04723693|323243932|FG000|Overall Study|Withdrawal by Subject|2|||
94398185|NCT00705666|323243933|FG000|Overall Study|No post-treatment questionnaire|279|||
94398186|NCT00705666|323243933|FG000|Overall Study|Withdrawal by Subject|21|||
94398187|NCT00705666|323243933|FG000|Overall Study|Physician Decision|7|||
94398188|NCT00705666|323243933|FG000|Overall Study|Lost to Follow-up|5|||
94398189|NCT00705666|323243933|FG000|Overall Study|Death|1|||
94398190|NCT00705666|323243933|FG000|Overall Study|Adverse Event|4|||
94398191|NCT00705666|323243933|FG000|Overall Study|Other|12|||
94398192|NCT00705666|323243933|FG000|Overall Study|Other|2|||
94398193|NCT00705666|323243933|FG000|Overall Study|Lack of data|3|||
94398194|NCT00705666|323243933|FG000|Overall Study|Untreated|5|||
94398195|NCT00506831|323243934|FG000|Overall Study|Death|1|||
94398196|NCT00506831|323243934|FG000|Overall Study|Withdrawal by Subject|1|||
94398197|NCT01590563|323243943|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
94398198|NCT03256695|323243948|FG000|Overall Study|Adverse Event|8|||
94398199|NCT03256695|323243948|FG000|Overall Study|Death|2|||
94398200|NCT03256695|323243948|FG000|Overall Study|Withdrawal by Subject|14|||
94398201|NCT03256695|323243948|FG000|Overall Study|Non-compliance with study drug|1|||
94398202|NCT03256695|323243948|FG000|Overall Study|Lost to Follow-up|3|||
94398203|NCT03256695|323243948|FG000|Overall Study|Lack of Efficacy|3|||
94398204|NCT03256695|323243948|FG000|Overall Study|Protocol Violation|5|||
94398205|NCT03256695|323243948|FG000|Overall Study|Other than specified|3|||
94398206|NCT01604941|323243949|FG000|Overall Study|Adverse Event|1|||
94398207|NCT01604941|323243950|FG001|Overall Study|Adverse Event|2|||
94398208|NCT01604941|323243951|FG002|Overall Study|Adverse Event|0|||
94398209|NCT01604941|323243952|FG003|Overall Study|Adverse Event|0|||
94398210|NCT01604941|323243953|FG004|Overall Study|Adverse Event|1|||
94398211|NCT01604941|323243954|FG005|Overall Study|Adverse Event|5|||
94398212|NCT01604941|323243949|FG000|Overall Study|Non-compliance|1|||
94398213|NCT01604941|323243950|FG001|Overall Study|Non-compliance|0|||
94398214|NCT01604941|323243951|FG002|Overall Study|Non-compliance|0|||
94398215|NCT01604941|323243952|FG003|Overall Study|Non-compliance|0|||
94398216|NCT01604941|323243953|FG004|Overall Study|Non-compliance|0|||
94398217|NCT01604941|323243954|FG005|Overall Study|Non-compliance|0|||
94398218|NCT01604941|323243949|FG000|Overall Study|Participant Decision|0|||
94398219|NCT01604941|323243950|FG001|Overall Study|Participant Decision|0|||
94398220|NCT01604941|323243951|FG002|Overall Study|Participant Decision|0|||
94398221|NCT01604941|323243952|FG003|Overall Study|Participant Decision|0|||
94398222|NCT01604941|323243953|FG004|Overall Study|Participant Decision|0|||
94398223|NCT01604941|323243954|FG005|Overall Study|Participant Decision|2|||
94398224|NCT01604941|323243949|FG000|Overall Study|Early Study Termination|9|||
94398225|NCT01604941|323243950|FG001|Overall Study|Early Study Termination|2|||
94398226|NCT01604941|323243951|FG002|Overall Study|Early Study Termination|3|||
94398227|NCT01604941|323243952|FG003|Overall Study|Early Study Termination|3|||
94398228|NCT01604941|323243953|FG004|Overall Study|Early Study Termination|0|||
94398229|NCT01604941|323243954|FG005|Overall Study|Early Study Termination|0|||
94398230|NCT03930732|323243958|FG000|Overall Study|Adverse Event|9|||
94398231|NCT03930732|323243959|FG001|Overall Study|Adverse Event|7|||
94398232|NCT03930732|323243958|FG000|Overall Study|Poor compliance to protocol|0|||
94398233|NCT03930732|323243959|FG001|Overall Study|Poor compliance to protocol|1|||
94398234|NCT03930732|323243958|FG000|Overall Study|Withdrawal by Subject|23|||
94398235|NCT03930732|323243959|FG001|Overall Study|Withdrawal by Subject|11|||
94398236|NCT03930732|323243958|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
94398237|NCT03930732|323243959|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
94398238|NCT03930732|323243958|FG000|Overall Study|Other reason not related to COVID-19|5|||
94398239|NCT03930732|323243959|FG001|Overall Study|Other reason not related to COVID-19|8|||
94398240|NCT03406156|323243960|FG000|Overall Study|Death|9|||
94398241|NCT03406156|323243961|FG001|Overall Study|Death|3|||
94398242|NCT03406156|323243960|FG000|Overall Study|Withdrawal by Subject|1|||
94398243|NCT03406156|323243961|FG001|Overall Study|Withdrawal by Subject|2|||
94398244|NCT03406156|323243960|FG000|Overall Study|COVID-19 infection|1|||
94398245|NCT03406156|323243961|FG001|Overall Study|COVID-19 infection|0|||
94484799|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
94484800|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
94484801|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
94484802|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
94484803|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
94484804|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
94398246|NCT03406156|323243960|FG000|Overall Study|Non-compliance with study procedures|1|||
94398247|NCT03406156|323243961|FG001|Overall Study|Non-compliance with study procedures|1|||
94398248|NCT03406156|323243960|FG000|Overall Study|Lost to Follow-up|0|||
94398249|NCT03406156|323243961|FG001|Overall Study|Lost to Follow-up|2|||
94398250|NCT03406156|323243960|FG000|Overall Study|Other, not specified|72|||
94398251|NCT03406156|323243961|FG001|Overall Study|Other, not specified|28|||
94398252|NCT01410227|323243962|FG000|Overall Study|Adverse Event|1|||
94398253|NCT01410227|323243963|FG001|Overall Study|Adverse Event|0|||
94398254|NCT01410227|323243964|FG002|Overall Study|Adverse Event|0|||
94398255|NCT01410227|323243965|FG003|Overall Study|Adverse Event|0|||
94398256|NCT01410227|323243962|FG000|Overall Study|Withdrawal by Subject|3|||
94398257|NCT01410227|323243963|FG001|Overall Study|Withdrawal by Subject|0|||
94398258|NCT01410227|323243964|FG002|Overall Study|Withdrawal by Subject|1|||
94398259|NCT01410227|323243965|FG003|Overall Study|Withdrawal by Subject|0|||
94398260|NCT01410227|323243962|FG000|Overall Study|Pregnancy|0|||
94398261|NCT01410227|323243963|FG001|Overall Study|Pregnancy|0|||
94398262|NCT01410227|323243964|FG002|Overall Study|Pregnancy|0|||
94398263|NCT01410227|323243965|FG003|Overall Study|Pregnancy|1|||
94398264|NCT01410227|323243962|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
94398265|NCT01410227|323243963|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
94398266|NCT01410227|323243964|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
94398267|NCT01410227|323243965|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
94398268|NCT00834444|323243966|FG000|First Intervention|Adverse Event|1|||
94398269|NCT00834444|323243967|FG001|First Intervention|Adverse Event|0|||
94398270|NCT00834444|323243966|FG000|First Intervention|Intolerance to Venopuncture|0|||
94398271|NCT00834444|323243967|FG001|First Intervention|Intolerance to Venopuncture|1|||
94398272|NCT00834444|323243966|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
94398273|NCT00834444|323243967|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
94398274|NCT00834444|323243966|FG000|Second Intervention|Adverse Event|1|||
94398275|NCT00834444|323243967|FG001|Second Intervention|Adverse Event|0|||
94398276|NCT03676634|323243968|FG000|Overall Study|Red blood cell loss|1|||
94398277|NCT03676634|323243968|FG000|Overall Study|Out-of-limit pulse|2|||
94398278|NCT00829712|323243970|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
94398279|NCT00829712|323243971|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
94398280|NCT01174186|323243975|FG000|Overall Study|Lost to Follow-up|0|||
94398281|NCT01174186|323243976|FG001|Overall Study|Lost to Follow-up|1|||
94398282|NCT01174186|323243975|FG000|Overall Study|Withdrawal by Subject|0|||
94398283|NCT01174186|323243976|FG001|Overall Study|Withdrawal by Subject|2|||
94398284|NCT00918684|323243978|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
94398285|NCT00918684|323243978|FG000|Treatment Phase|Lack of Efficacy|6|||
94398286|NCT00918684|323243978|FG000|Treatment Phase|Lost to Follow-up|2|||
94398287|NCT00918684|323243978|FG000|Treatment Phase|Physician Decision|8|||
94398288|NCT00918684|323243978|FG000|Treatment Phase|Protocol Violation|1|||
94398289|NCT00918684|323243978|FG000|Treatment Phase|Withdrawal by Subject|8|||
94398290|NCT00909038|323243979|FG000|Overall Study|Protocol Violation|187|||
94398291|NCT00909038|323243979|FG000|Overall Study|Non-evaluable Subjects|230|||
94398292|NCT01051349|323243980|FG000|Overall Study|Adverse Event|88|||
94398293|NCT01051349|323243980|FG000|Overall Study|Consent Withdrawn|54|||
94398294|NCT01051349|323243980|FG000|Overall Study|Investigator Decision|6|||
94398295|NCT01051349|323243980|FG000|Overall Study|Lost to Follow-up|6|||
94398296|NCT01051349|323243980|FG000|Overall Study|Subject non-compliance|7|||
94398297|NCT01051349|323243980|FG000|Overall Study|Reason not Specified|12|||
94398298|NCT00484679|323243981|FG000|Overall Study|Withdrawal by Subject|3|||
94398299|NCT00835692|323243982|FG000|First Intervention|Withdrawal by Subject|1|||
94398300|NCT00835692|323243983|FG001|First Intervention|Withdrawal by Subject|0|||
94398301|NCT00841542|323243986|FG000|Period 1|Adverse Event|1|||
94398302|NCT00841542|323243987|FG001|Period 1|Adverse Event|0|||
94398303|NCT00115063|323243992|FG000|Overall Study|Lost to Follow-up|98|||
94398304|NCT00115063|323243993|FG001|Overall Study|Lost to Follow-up|104|||
94398305|NCT00115063|323243992|FG000|Overall Study|Death|1|||
94398306|NCT00115063|323243993|FG001|Overall Study|Death|0|||
94398307|NCT01438060|323243996|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
94398308|NCT01438060|323243997|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
94398309|NCT01438060|323243996|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
94398310|NCT01438060|323243997|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
94398311|NCT01438060|323243996|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
94398312|NCT01438060|323243997|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
94398313|NCT01438060|323243996|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
94398314|NCT01438060|323243997|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
94398315|NCT01438060|323243996|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
94398316|NCT01438060|323243997|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
94398317|NCT01438060|323243996|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
94398318|NCT01438060|323243997|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
94398319|NCT01438060|323243996|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
94398320|NCT01438060|323243997|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
94398321|NCT01438060|323243996|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
94398322|NCT01438060|323243997|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
94398323|NCT01438060|323243996|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
94398324|NCT01438060|323243997|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
94398325|NCT01438060|323243996|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
94398326|NCT01438060|323243997|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
94398327|NCT01438060|323243996|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
94398328|NCT01438060|323243997|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
94398329|NCT01438060|323243996|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
94398330|NCT01438060|323243997|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
94398331|NCT01438060|323243996|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
94398332|NCT01438060|323243997|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
94398333|NCT01438060|323243996|FG000|On Study Beyond Week 140|Adverse Event|0|||
94398334|NCT01438060|323243997|FG001|On Study Beyond Week 140|Adverse Event|2|||
94398335|NCT01438060|323243996|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
94398336|NCT01438060|323243997|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
94398337|NCT01438060|323243996|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
94398338|NCT01438060|323243997|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
94398339|NCT01438060|323243996|FG000|On Study Beyond Week 140|Death|0|||
94398340|NCT01438060|323243997|FG001|On Study Beyond Week 140|Death|1|||
94398341|NCT01438060|323243996|FG000|On Study Beyond Week 140|Other Reason|0|||
94398342|NCT01438060|323243997|FG001|On Study Beyond Week 140|Other Reason|3|||
94398343|NCT01190865|323244002|FG000|Overall Study|Withdrawal by Subject|1|||
94398344|NCT01190865|323244002|FG000|Overall Study|Non-compliance|2|||
94398345|NCT02436200|323244004|FG000|Overall Study|Significant outlier|1|||
94398346|NCT02911025|323244008|FG000|Overall Study|Lost to Follow-up|3|||
94398347|NCT02272803|323244009|FG000|Overall Study|Disease progression|16|||
94398348|NCT02272803|323244010|FG001|Overall Study|Disease progression|8|||
94398349|NCT02272803|323244009|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
94398350|NCT02272803|323244010|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
94398351|NCT02272803|323244009|FG000|Overall Study|Study drug toxicity|4|||
94398352|NCT02272803|323244010|FG001|Overall Study|Study drug toxicity|9|||
94398353|NCT02272803|323244009|FG000|Overall Study|Participant request to discontinue study treatment|3|||
94398354|NCT02272803|323244010|FG001|Overall Study|Participant request to discontinue study treatment|7|||
94398355|NCT02272803|323244009|FG000|Overall Study|Maximum clinical benefit|4|||
94398356|NCT02272803|323244010|FG001|Overall Study|Maximum clinical benefit|2|||
94398357|NCT02272803|323244009|FG000|Overall Study|Poor/non-compliance|2|||
94398358|NCT02272803|323244010|FG001|Overall Study|Poor/non-compliance|2|||
94398359|NCT02272803|323244009|FG000|Overall Study|Withdrawal by Subject|2|||
94398360|NCT02272803|323244010|FG001|Overall Study|Withdrawal by Subject|1|||
94398361|NCT02272803|323244009|FG000|Overall Study|Death|0|||
94398362|NCT02272803|323244010|FG001|Overall Study|Death|1|||
94398363|NCT02272803|323244009|FG000|Overall Study|Other reasons|1|||
94398364|NCT02272803|323244010|FG001|Overall Study|Other reasons|3|||
94398365|NCT02272803|323244009|FG000|Overall Study|Administrative reason by sponsor|5|||
94398366|NCT02272803|323244010|FG001|Overall Study|Administrative reason by sponsor|4|||
94398367|NCT02264977|323244011|FG000|Overall Study|Death|3|||
94398368|NCT02264977|323244011|FG000|Overall Study|Physician Decision|1|||
94398369|NCT02264977|323244011|FG000|Overall Study|Refuse to return|1|||
94398370|NCT03067987|323244012|FG000|Overall Study|Lost to Follow-up|7|||
94398371|NCT03067987|323244013|FG001|Overall Study|Lost to Follow-up|10|||
94398372|NCT03067987|323244012|FG000|Overall Study|Protocol Violation|1|||
94398373|NCT03067987|323244013|FG001|Overall Study|Protocol Violation|2|||
94398374|NCT03067987|323244012|FG000|Overall Study|Withdrawal by Subject|2|||
94398375|NCT03067987|323244013|FG001|Overall Study|Withdrawal by Subject|1|||
94398376|NCT04827394|323244017|FG000|Overall Study|Physician Decision|0|||
94398377|NCT04827394|323244018|FG001|Overall Study|Physician Decision|2|||
94398378|NCT03801707|323244019|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
94398379|NCT04236596|323244022|FG000|Overall Study|Withdrawal by Subject|1|||
94398380|NCT04236596|323244022|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
94398381|NCT04236596|323244022|FG000|Overall Study|Participants did not receive implant at all|4|||
94398382|NCT04594252|323244023|FG000|Overall Study|Adverse Event|0|||
94398383|NCT04594252|323244024|FG001|Overall Study|Adverse Event|2|||
94398384|NCT02566850|323245221|FG000|Overall Study|Protocol Violation|1|||
94398385|NCT02642653|323245225|FG000|Overall Study|Adverse Event|2|||
94398386|NCT02642653|323245226|FG001|Overall Study|Adverse Event|0|||
94398387|NCT02267187|323245227|FG000|Overall Study|Physician Decision|2|||
94398388|NCT02267187|323245227|FG000|Overall Study|Screen fail|3|||
94398389|NCT02875392|323245228|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
94398390|NCT02875392|323245229|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
94398391|NCT03025087|323245232|FG000|Overall Study|Physician Decision|3|||
94398392|NCT03025087|323245233|FG001|Overall Study|Physician Decision|3|||
94398393|NCT03025087|323245234|FG002|Overall Study|Physician Decision|0|||
94398394|NCT03025087|323245235|FG003|Overall Study|Physician Decision|0|||
94398395|NCT03025087|323245236|FG004|Overall Study|Physician Decision|0|||
94398396|NCT03025087|323245232|FG000|Overall Study|Withdrawal by Subject|1|||
94398397|NCT03025087|323245233|FG001|Overall Study|Withdrawal by Subject|1|||
94398398|NCT03025087|323245234|FG002|Overall Study|Withdrawal by Subject|0|||
94398399|NCT03025087|323245235|FG003|Overall Study|Withdrawal by Subject|0|||
94398400|NCT03025087|323245236|FG004|Overall Study|Withdrawal by Subject|0|||
94398401|NCT03025087|323245232|FG000|Overall Study|Unable to complete MRI|2|||
94398402|NCT03025087|323245233|FG001|Overall Study|Unable to complete MRI|2|||
94398403|NCT03025087|323245234|FG002|Overall Study|Unable to complete MRI|0|||
94398404|NCT03025087|323245235|FG003|Overall Study|Unable to complete MRI|0|||
94398405|NCT03025087|323245236|FG004|Overall Study|Unable to complete MRI|0|||
94398406|NCT01750294|323245237|FG000|Overall Study|Withdrawal by Subject|1|||
94398407|NCT01750294|323245237|FG000|Overall Study|Safety Endpoint|1|||
94398408|NCT02316223|323245240|FG000|Overall Study|Lack of Efficacy|0|||
94398409|NCT02316223|323245241|FG001|Overall Study|Lack of Efficacy|1|||
94398410|NCT02316223|323245242|FG002|Overall Study|Lack of Efficacy|1|||
94398411|NCT02316223|323245240|FG000|Overall Study|Lost to Follow-up|27|||
94398412|NCT02316223|323245241|FG001|Overall Study|Lost to Follow-up|34|||
94398413|NCT02316223|323245242|FG002|Overall Study|Lost to Follow-up|36|||
94398414|NCT02316223|323245240|FG000|Overall Study|COPD Diagnosis|3|||
94398415|NCT02316223|323245241|FG001|Overall Study|COPD Diagnosis|2|||
94398416|NCT02316223|323245242|FG002|Overall Study|COPD Diagnosis|3|||
94398417|NCT02316223|323245240|FG000|Overall Study|Reside outside study area|1|||
94398418|NCT02316223|323245241|FG001|Overall Study|Reside outside study area|1|||
94398419|NCT02316223|323245242|FG002|Overall Study|Reside outside study area|1|||
94398420|NCT02316223|323245240|FG000|Overall Study|No asthma|2|||
94398421|NCT02316223|323245241|FG001|Overall Study|No asthma|0|||
94398422|NCT02316223|323245242|FG002|Overall Study|No asthma|0|||
94398423|NCT02316223|323245240|FG000|Overall Study|Discontinued by PI|11|||
94398424|NCT02316223|323245241|FG001|Overall Study|Discontinued by PI|19|||
94398425|NCT02316223|323245242|FG002|Overall Study|Discontinued by PI|3|||
94398426|NCT03669250|323245243|FG000|Overall Study|Adverse Event|0|||
94398427|NCT03669250|323245244|FG001|Overall Study|Adverse Event|0|||
94398428|NCT03669250|323245245|FG002|Overall Study|Adverse Event|0|||
94398429|NCT03669250|323245246|FG003|Overall Study|Adverse Event|0|||
94398430|NCT03669250|323245247|FG004|Overall Study|Adverse Event|1|||
94398431|NCT03669250|323245248|FG005|Overall Study|Adverse Event|0|||
94398432|NCT03669250|323245243|FG000|Overall Study|Withdrawal by Subject|0|||
94398433|NCT03669250|323245244|FG001|Overall Study|Withdrawal by Subject|1|||
94398434|NCT03669250|323245245|FG002|Overall Study|Withdrawal by Subject|0|||
94398435|NCT03669250|323245246|FG003|Overall Study|Withdrawal by Subject|1|||
94398436|NCT03669250|323245247|FG004|Overall Study|Withdrawal by Subject|0|||
94398437|NCT03669250|323245248|FG005|Overall Study|Withdrawal by Subject|0|||
94398438|NCT05511935|323245251|FG000|Overall Study|Lost to Follow-up|9|||
94398439|NCT05511935|323245252|FG001|Overall Study|Lost to Follow-up|27|||
94398440|NCT02328040|323245258|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
94398441|NCT02328040|323245259|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
94398442|NCT01987765|323245261|FG000|Overall Study|Protocol Violation|65|||
94398443|NCT01987765|323245261|FG000|Overall Study|Lost to Follow-up|37|||
94398444|NCT00772603|323245262|FG000|Overall Study|Withdrawal by Subject|11|||
94398445|NCT00772603|323245263|FG001|Overall Study|Withdrawal by Subject|10|||
94398446|NCT00772603|323245264|FG002|Overall Study|Withdrawal by Subject|6|||
94398447|NCT00772603|323245262|FG000|Overall Study|Adverse Event|37|||
94398448|NCT00772603|323245263|FG001|Overall Study|Adverse Event|18|||
94398449|NCT00772603|323245264|FG002|Overall Study|Adverse Event|10|||
94398450|NCT00772603|323245262|FG000|Overall Study|Subject Non-compliance|1|||
94398451|NCT00772603|323245263|FG001|Overall Study|Subject Non-compliance|6|||
94398452|NCT00772603|323245264|FG002|Overall Study|Subject Non-compliance|4|||
94398453|NCT00772603|323245262|FG000|Overall Study|Protocol Violation|0|||
94398454|NCT00772603|323245263|FG001|Overall Study|Protocol Violation|1|||
94398455|NCT00772603|323245264|FG002|Overall Study|Protocol Violation|1|||
94398456|NCT00772603|323245262|FG000|Overall Study|Lost to Follow-up|1|||
94398457|NCT00772603|323245263|FG001|Overall Study|Lost to Follow-up|5|||
94398458|NCT00772603|323245264|FG002|Overall Study|Lost to Follow-up|2|||
94398459|NCT00772603|323245262|FG000|Overall Study|Physician Decision|0|||
94398460|NCT00772603|323245263|FG001|Overall Study|Physician Decision|0|||
94398461|NCT00772603|323245264|FG002|Overall Study|Physician Decision|1|||
94398462|NCT00772603|323245262|FG000|Overall Study|Other|2|||
94398463|NCT00772603|323245263|FG001|Overall Study|Other|0|||
94398464|NCT00772603|323245264|FG002|Overall Study|Other|2|||
94398465|NCT01547286|323245265|FG000|Overall Study|Did not meet all eligibility criteria|1|||
94398466|NCT01547286|323245265|FG000|Overall Study|Physician Decision|1|||
94398467|NCT03415308|323245266|FG000|Overall Study|Lost to Follow-up|0|||
94398468|NCT03415308|323245267|FG001|Overall Study|Lost to Follow-up|0|||
94398469|NCT03415308|323245268|FG002|Overall Study|Lost to Follow-up|1|||
94398470|NCT03415308|323245266|FG000|Overall Study|Scheduling Conflicts|0|||
94398471|NCT03415308|323245267|FG001|Overall Study|Scheduling Conflicts|0|||
94398472|NCT03415308|323245268|FG002|Overall Study|Scheduling Conflicts|7|||
94398473|NCT00081653|323245269|FG000|Overall Study|Adverse Event|23|||
94398474|NCT00081653|323245270|FG001|Overall Study|Adverse Event|17|||
94398475|NCT00081653|323245269|FG000|Overall Study|Lost to Follow-up|2|||
94398476|NCT00081653|323245270|FG001|Overall Study|Lost to Follow-up|4|||
94398477|NCT00081653|323245269|FG000|Overall Study|Refused Treatment|18|||
94398478|NCT00081653|323245270|FG001|Overall Study|Refused Treatment|14|||
94398479|NCT00081653|323245269|FG000|Overall Study|Low bone mineral density|1|||
94398480|NCT00081653|323245270|FG001|Overall Study|Low bone mineral density|0|||
94398481|NCT00081653|323245269|FG000|Overall Study|Bone loss|2|||
94398482|NCT00081653|323245270|FG001|Overall Study|Bone loss|0|||
94398483|NCT00081653|323245269|FG000|Overall Study|Participant leaving country|1|||
94398484|NCT00081653|323245270|FG001|Overall Study|Participant leaving country|0|||
94398485|NCT00081653|323245269|FG000|Overall Study|Loss of bone mass|0|||
94398486|NCT00081653|323245270|FG001|Overall Study|Loss of bone mass|2|||
94398487|NCT01592240|323245271|FG000|Overall Study|Adverse Event|1|||
94398488|NCT01592240|323245272|FG001|Overall Study|Adverse Event|0|||
94398489|NCT01592240|323245273|FG002|Overall Study|Adverse Event|0|||
94398490|NCT01592240|323245274|FG003|Overall Study|Adverse Event|1|||
94398491|NCT01592240|323245275|FG004|Overall Study|Adverse Event|1|||
94398492|NCT01592240|323245276|FG005|Overall Study|Adverse Event|0|||
94398493|NCT01592240|323245277|FG006|Overall Study|Adverse Event|0|||
94398494|NCT01592240|323245271|FG000|Overall Study|Death|0|||
94398495|NCT01592240|323245272|FG001|Overall Study|Death|1|||
94398496|NCT01592240|323245273|FG002|Overall Study|Death|0|||
94398497|NCT01592240|323245274|FG003|Overall Study|Death|0|||
94398498|NCT01592240|323245275|FG004|Overall Study|Death|0|||
94398499|NCT01592240|323245276|FG005|Overall Study|Death|0|||
94398500|NCT01592240|323245277|FG006|Overall Study|Death|0|||
94398501|NCT01592240|323245271|FG000|Overall Study|Lost to Follow-up|1|||
94398502|NCT01592240|323245272|FG001|Overall Study|Lost to Follow-up|3|||
94398503|NCT01592240|323245273|FG002|Overall Study|Lost to Follow-up|1|||
94398504|NCT01592240|323245274|FG003|Overall Study|Lost to Follow-up|0|||
94398505|NCT01592240|323245275|FG004|Overall Study|Lost to Follow-up|3|||
94398506|NCT01592240|323245276|FG005|Overall Study|Lost to Follow-up|2|||
94398507|NCT01592240|323245277|FG006|Overall Study|Lost to Follow-up|0|||
94398508|NCT01592240|323245271|FG000|Overall Study|Protocol Violation|0|||
94398509|NCT01592240|323245272|FG001|Overall Study|Protocol Violation|0|||
94398510|NCT01592240|323245273|FG002|Overall Study|Protocol Violation|0|||
94398511|NCT01592240|323245274|FG003|Overall Study|Protocol Violation|0|||
94398512|NCT01592240|323245275|FG004|Overall Study|Protocol Violation|0|||
94398513|NCT01592240|323245276|FG005|Overall Study|Protocol Violation|1|||
94398514|NCT01592240|323245277|FG006|Overall Study|Protocol Violation|0|||
94398515|NCT01592240|323245271|FG000|Overall Study|Withdrawal by Subject|0|||
94398516|NCT01592240|323245272|FG001|Overall Study|Withdrawal by Subject|4|||
94398517|NCT01592240|323245273|FG002|Overall Study|Withdrawal by Subject|4|||
94398518|NCT01592240|323245274|FG003|Overall Study|Withdrawal by Subject|1|||
94484805|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
94398519|NCT01592240|323245275|FG004|Overall Study|Withdrawal by Subject|3|||
94484806|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
94484807|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
94484808|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
94398520|NCT01592240|323245276|FG005|Overall Study|Withdrawal by Subject|0|||
94398521|NCT01592240|323245277|FG006|Overall Study|Withdrawal by Subject|2|||
94398522|NCT01592240|323245271|FG000|Overall Study|Other|0|||
94398523|NCT01592240|323245272|FG001|Overall Study|Other|3|||
94398524|NCT01592240|323245273|FG002|Overall Study|Other|1|||
94398525|NCT01592240|323245274|FG003|Overall Study|Other|1|||
94398526|NCT01592240|323245275|FG004|Overall Study|Other|0|||
94398527|NCT01592240|323245276|FG005|Overall Study|Other|0|||
94398528|NCT01592240|323245277|FG006|Overall Study|Other|1|||
94398529|NCT01592240|323245271|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
94398530|NCT01592240|323245272|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
94398531|NCT01592240|323245273|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
94398532|NCT01592240|323245274|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
94398533|NCT01592240|323245275|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
94398534|NCT01592240|323245276|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
94398535|NCT01592240|323245277|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
94398536|NCT01205035|323245281|FG000|Overall Study|Withdrawal by Subject|1|||
94398537|NCT01205035|323245282|FG001|Overall Study|Withdrawal by Subject|0|||
94398538|NCT01205035|323245281|FG000|Overall Study|Physician Decision|1|||
94398539|NCT01205035|323245282|FG001|Overall Study|Physician Decision|0|||
94398540|NCT02663349|323245284|FG000|Overall Study|Withdrawal by Subject|6|||
94398541|NCT00488774|323245286|FG000|Overall Study|Withdrawal of consent|2|||
94398542|NCT00488774|323245287|FG001|Overall Study|Withdrawal of consent|2|||
94398543|NCT00488774|323245288|FG002|Overall Study|Withdrawal of consent|2|||
94398544|NCT00488774|323245289|FG003|Overall Study|Withdrawal of consent|0|||
94398545|NCT00488774|323245286|FG000|Overall Study|Other|6|||
94398546|NCT00488774|323245287|FG001|Overall Study|Other|3|||
94398547|NCT00488774|323245288|FG002|Overall Study|Other|2|||
94398548|NCT00488774|323245289|FG003|Overall Study|Other|2|||
94398549|NCT00488774|323245286|FG000|Overall Study|Lost to Follow-up|0|||
94398550|NCT00488774|323245287|FG001|Overall Study|Lost to Follow-up|0|||
94398551|NCT00488774|323245288|FG002|Overall Study|Lost to Follow-up|1|||
94398552|NCT00488774|323245289|FG003|Overall Study|Lost to Follow-up|1|||
94398553|NCT00673660|323245291|FG000|Overall Study|Lost to Follow-up|107|||
94398554|NCT05099380|323245292|FG000|Overall Study|Subject enrolled in error|1|||
94398555|NCT05099380|323245293|FG001|Overall Study|Subject enrolled in error|0|||
94398556|NCT05099380|323245292|FG000|Overall Study|Study Procedure|1|||
94398557|NCT05099380|323245293|FG001|Overall Study|Study Procedure|0|||
94398558|NCT05099380|323245292|FG000|Overall Study|Protocol Violation|1|||
94398559|NCT05099380|323245293|FG001|Overall Study|Protocol Violation|0|||
94398560|NCT05099380|323245292|FG000|Overall Study|Adverse Event|1|||
94398561|NCT05099380|323245293|FG001|Overall Study|Adverse Event|1|||
94398562|NCT05099380|323245292|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
94398563|NCT05099380|323245293|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
94398564|NCT04089553|323245302|FG000|Overall Study|Death|1|||
94398565|NCT04089553|323245303|FG001|Overall Study|Death|1|||
94398566|NCT04089553|323245302|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
94398567|NCT04089553|323245303|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
94398568|NCT04089553|323245302|FG000|Overall Study|Withdrawal by Subject|3|||
94398569|NCT04089553|323245303|FG001|Overall Study|Withdrawal by Subject|3|||
94398570|NCT04089553|323245302|FG000|Overall Study|Physician Decision|1|||
94398571|NCT04089553|323245303|FG001|Overall Study|Physician Decision|0|||
94398572|NCT04089553|323245302|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
94398573|NCT04089553|323245303|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
94398574|NCT04089553|323245302|FG000|Overall Study|Other|1|||
94398575|NCT04089553|323245303|FG001|Overall Study|Other|0|||
94398576|NCT04089553|323245302|FG000|Overall Study|Adverse Event|1|||
94398577|NCT04089553|323245303|FG001|Overall Study|Adverse Event|1|||
94398578|NCT01020474|323245307|FG000|Overall Study|Adverse Event|4|||
94398579|NCT01020474|323245308|FG001|Overall Study|Adverse Event|4|||
94398580|NCT01020474|323245307|FG000|Overall Study|Protocol Violation|0|||
94398581|NCT01020474|323245308|FG001|Overall Study|Protocol Violation|2|||
94398582|NCT01020474|323245307|FG000|Overall Study|Withdrawal by Subject|5|||
94398583|NCT01020474|323245308|FG001|Overall Study|Withdrawal by Subject|7|||
94398584|NCT01020474|323245307|FG000|Overall Study|Other Reasons|1|||
94398585|NCT01020474|323245308|FG001|Overall Study|Other Reasons|1|||
94398586|NCT01020474|323245307|FG000|Overall Study|Insufficient Clinical Response|0|||
94398587|NCT01020474|323245308|FG001|Overall Study|Insufficient Clinical Response|3|||
94398588|NCT00107991|323245309|FG000|Eligibility Assessment|Disease not severe enough|7|||
94398589|NCT00107991|323245309|FG000|Eligibility Assessment|Unwilling to participate|7|||
94398590|NCT00107991|323245309|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
94398591|NCT00107991|323245309|FG000|Eligibility Assessment|Abnormal labs|2|||
94398592|NCT00107991|323245309|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
94398593|NCT00107991|323245309|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
94398594|NCT00107991|323245309|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
94398595|NCT00107991|323245309|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
94398596|NCT00107991|323245309|FG000|12 Week Treatment Period|Adverse Event|1|||
94398597|NCT00107991|323245309|FG000|12 Week Treatment Period|Protocol Violation|1|||
94398598|NCT00107991|323245309|FG000|12 Week Treatment Period|Incarcerated|1|||
94398599|NCT00107991|323245309|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
94398600|NCT00585286|323245310|FG000|Overall Study|Lost to Follow-up|1|||
94398601|NCT00608322|323245312|FG000|Overall Study|Death|2|||
94398602|NCT00608322|323245313|FG001|Overall Study|Death|1|||
94398603|NCT05479058|323245314|FG000|Overall Study|Withdrawal by Subject|1|||
94398604|NCT05479058|323245315|FG001|Overall Study|Withdrawal by Subject|1|||
94398605|NCT05479058|323245314|FG000|Overall Study|Study terminated by sponsor|10|||
94484809|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
94484810|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
94484811|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
94484812|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
94484813|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
94484814|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
94484815|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
94329967|NCT00426556|322990080|FG003|Phase I - Core Phase|Disease Progression|0|||
94329968|NCT00426556|322990077|FG000|Phase I - Core Phase|Adverse Event|1|||
94329969|NCT00426556|322990078|FG001|Phase I - Core Phase|Adverse Event|3|||
94329970|NCT00426556|322990079|FG002|Phase I - Core Phase|Adverse Event|1|||
94329971|NCT00426556|322990080|FG003|Phase I - Core Phase|Adverse Event|0|||
94329972|NCT00426556|322990077|FG000|Phase I - Core Phase|Death|0|||
94329973|NCT00426556|322990078|FG001|Phase I - Core Phase|Death|1|||
94329974|NCT00426556|322990079|FG002|Phase I - Core Phase|Death|0|||
94329975|NCT00426556|322990080|FG003|Phase I - Core Phase|Death|0|||
94329976|NCT00426556|322990077|FG000|Phase I - Extension Phase|Adverse Event|0|||
94329977|NCT00426556|322990078|FG001|Phase I - Extension Phase|Adverse Event|1|||
94329978|NCT00426556|322990079|FG002|Phase I - Extension Phase|Adverse Event|1|||
94329979|NCT00426556|322990080|FG003|Phase I - Extension Phase|Adverse Event|0|||
94329980|NCT00426556|322990077|FG000|Phase I - Extension Phase|Disease Progression|5|||
94329981|NCT00426556|322990078|FG001|Phase I - Extension Phase|Disease Progression|5|||
94329982|NCT00426556|322990079|FG002|Phase I - Extension Phase|Disease Progression|6|||
94398606|NCT05479058|323245315|FG001|Overall Study|Study terminated by sponsor|10|||
94398607|NCT02280863|323245318|FG000|Integrated Platform|Met stopping criteria|0|||
94398608|NCT02280863|323245319|FG001|Integrated Platform|Met stopping criteria|1|||
94398609|NCT00807495|323245322|FG000|Overall Study|Adverse Event|6|||
94398610|NCT00807495|323245323|FG001|Overall Study|Adverse Event|3|||
94398611|NCT00807495|323245324|FG002|Overall Study|Adverse Event|1|||
94398612|NCT00807495|323245325|FG003|Overall Study|Adverse Event|1|||
94398613|NCT00807495|323245326|FG004|Overall Study|Adverse Event|2|||
94398614|NCT00807495|323245322|FG000|Overall Study|Withdrawal by Patient|2|||
94398615|NCT00807495|323245323|FG001|Overall Study|Withdrawal by Patient|0|||
94398616|NCT00807495|323245324|FG002|Overall Study|Withdrawal by Patient|1|||
94398617|NCT00807495|323245325|FG003|Overall Study|Withdrawal by Patient|0|||
94398618|NCT00807495|323245326|FG004|Overall Study|Withdrawal by Patient|0|||
94398619|NCT00807495|323245322|FG000|Overall Study|Reason Not Specified|0|||
94398620|NCT00807495|323245323|FG001|Overall Study|Reason Not Specified|3|||
94398621|NCT00807495|323245324|FG002|Overall Study|Reason Not Specified|2|||
94398622|NCT00807495|323245325|FG003|Overall Study|Reason Not Specified|0|||
94398623|NCT00807495|323245326|FG004|Overall Study|Reason Not Specified|3|||
94398624|NCT00402103|323245328|FG000|Overall Study|Adverse Event|60|||
94398625|NCT00402103|323245329|FG001|Overall Study|Adverse Event|7|||
94398626|NCT00402103|323245328|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94398627|NCT00402103|323245329|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
94398628|NCT00402103|323245328|FG000|Overall Study|Condition no longer requires study drug|2|||
94398629|NCT00402103|323245329|FG001|Overall Study|Condition no longer requires study drug|0|||
94398630|NCT00402103|323245328|FG000|Overall Study|Protocol Deviation|8|||
94398631|NCT00402103|323245329|FG001|Overall Study|Protocol Deviation|0|||
94398632|NCT00402103|323245328|FG000|Overall Study|Patient withdrew consent|12|||
94398633|NCT00402103|323245329|FG001|Overall Study|Patient withdrew consent|1|||
94398634|NCT00402103|323245328|FG000|Overall Study|Lost to Follow-up|6|||
94398635|NCT00402103|323245329|FG001|Overall Study|Lost to Follow-up|3|||
94398636|NCT00402103|323245328|FG000|Overall Study|Administrative problems|2|||
94398637|NCT00402103|323245329|FG001|Overall Study|Administrative problems|0|||
94398638|NCT04345653|323245330|FG000|Overall Study|Withdrawal by Subject|2|||
94398639|NCT01168856|323245333|FG000|Overall Study|Lost to Follow-up|4|||
94398640|NCT01168856|323245334|FG001|Overall Study|Lost to Follow-up|34|||
94398641|NCT01168856|323245333|FG000|Overall Study|Withdrawal by Subject|6|||
94398642|NCT01168856|323245334|FG001|Overall Study|Withdrawal by Subject|8|||
94398643|NCT01168856|323245333|FG000|Overall Study|Physician Decision|2|||
94398644|NCT01168856|323245334|FG001|Overall Study|Physician Decision|1|||
94398645|NCT01168856|323245333|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
94398646|NCT01168856|323245334|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
94398647|NCT01168856|323245333|FG000|Overall Study|Participant received anti-HCV treatment|1|||
94398648|NCT01168856|323245334|FG001|Overall Study|Participant received anti-HCV treatment|0|||
94398649|NCT01168856|323245333|FG000|Overall Study|Death|0|||
94398650|NCT01168856|323245334|FG001|Overall Study|Death|2|||
94398651|NCT01168856|323245333|FG000|Overall Study|Other|1|||
94398652|NCT01168856|323245334|FG001|Overall Study|Other|291|||
94398653|NCT01168856|323245333|FG000|Overall Study|Protocol Violation|4|||
94398654|NCT01168856|323245334|FG001|Overall Study|Protocol Violation|6|||
94398655|NCT00679081|323245339|FG000|Overall Study|Lost to Follow-up|1|||
94398656|NCT00725322|323245340|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
94329983|NCT00426556|322990080|FG003|Phase I - Extension Phase|Disease Progression|0|||
94329984|NCT00426556|322990077|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
94329985|NCT00426556|322990078|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
94329986|NCT00426556|322990079|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
94329987|NCT00426556|322990080|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
94329988|NCT00426556|322990077|FG000|Phase II - Core Phase|Disease Progression|0|||
94329989|NCT00426556|322990078|FG001|Phase II - Core Phase|Disease Progression|0|||
94329990|NCT00426556|322990079|FG002|Phase II - Core Phase|Disease Progression|0|||
94329991|NCT00426556|322990080|FG003|Phase II - Core Phase|Disease Progression|16|||
94329992|NCT00426556|322990077|FG000|Phase II - Core Phase|Adverse Event|0|||
94329993|NCT00426556|322990078|FG001|Phase II - Core Phase|Adverse Event|0|||
94329994|NCT00426556|322990079|FG002|Phase II - Core Phase|Adverse Event|0|||
94329995|NCT00426556|322990080|FG003|Phase II - Core Phase|Adverse Event|8|||
94329996|NCT00426556|322990077|FG000|Phase II - Extension Phase|Disease Progression|0|||
94329997|NCT00426556|322990078|FG001|Phase II - Extension Phase|Disease Progression|0|||
94329998|NCT00426556|322990079|FG002|Phase II - Extension Phase|Disease Progression|0|||
94329999|NCT00426556|322990080|FG003|Phase II - Extension Phase|Disease Progression|21|||
94330000|NCT00426556|322990077|FG000|Phase II - Extension Phase|Adverse Event|0|||
94398657|NCT00725322|323245341|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
94398658|NCT00725322|323245340|FG000|Washout (28 Days)|Protocol Violation|0|||
94398659|NCT00725322|323245341|FG001|Washout (28 Days)|Protocol Violation|1|||
94398660|NCT01958294|323247026|FG000|Overall Study|Clinical Circumstances|2|||
94398661|NCT02635750|323247028|FG000|Part 1, Period 2|Adverse Event|1|||
94398662|NCT02635750|323247029|FG001|Part 1, Period 2|Adverse Event|0|||
94398663|NCT02635750|323247030|FG002|Part 1, Period 2|Adverse Event|0|||
94398664|NCT02057835|323247031|FG000|Overall Study|Withdrawal by Subject|0|||
94398665|NCT02057835|323247032|FG001|Overall Study|Withdrawal by Subject|2|||
94398666|NCT02057835|323247033|FG002|Overall Study|Withdrawal by Subject|0|||
94398667|NCT02057835|323247034|FG003|Overall Study|Withdrawal by Subject|0|||
94398668|NCT02057835|323247035|FG004|Overall Study|Withdrawal by Subject|0|||
94398669|NCT02057835|323247036|FG005|Overall Study|Withdrawal by Subject|0|||
94398670|NCT02057835|323247037|FG006|Overall Study|Withdrawal by Subject|0|||
94398671|NCT02057835|323247038|FG007|Overall Study|Withdrawal by Subject|0|||
94398672|NCT02057835|323247039|FG008|Overall Study|Withdrawal by Subject|0|||
94398673|NCT02057835|323247040|FG009|Overall Study|Withdrawal by Subject|0|||
94398674|NCT00830258|323247041|FG000|First Intervention|Adverse Event|1|||
94398675|NCT00830258|323247042|FG001|First Intervention|Adverse Event|0|||
94398676|NCT00830258|323247041|FG000|Washout: 7 Days|Protocol Violation|1|||
94398677|NCT00830258|323247042|FG001|Washout: 7 Days|Protocol Violation|0|||
94398678|NCT00682461|323247043|FG000|Overall Study|Adverse Event|5|||
94398679|NCT00682461|323247044|FG001|Overall Study|Adverse Event|7|||
94398680|NCT00682461|323247043|FG000|Overall Study|Lost to Follow-up|8|||
94398681|NCT00682461|323247044|FG001|Overall Study|Lost to Follow-up|5|||
94398682|NCT00682461|323247043|FG000|Overall Study|Withdrawal by Subject|12|||
94398683|NCT00682461|323247044|FG001|Overall Study|Withdrawal by Subject|19|||
94398684|NCT00834717|323247048|FG000|First Intervention|Adverse Event|1|||
94398685|NCT00834717|323247049|FG001|First Intervention|Adverse Event|0|||
94398686|NCT00834717|323247048|FG000|First Intervention|Withdrawal by Subject|0|||
94398687|NCT00834717|323247049|FG001|First Intervention|Withdrawal by Subject|1|||
94398688|NCT04299087|323247050|FG000|Overall Study|Lost to Follow-up|2|||
94398689|NCT04299087|323247051|FG001|Overall Study|Lost to Follow-up|1|||
94398690|NCT00660660|323247052|FG000|Overall Study|Adverse Event|1|||
94398691|NCT00660660|323247053|FG001|Overall Study|Adverse Event|0|||
94398692|NCT00660660|323247052|FG000|Overall Study|Lost to Follow-up|0|||
94398693|NCT00660660|323247053|FG001|Overall Study|Lost to Follow-up|6|||
94398694|NCT00660660|323247052|FG000|Overall Study|Lack of Efficacy|0|||
94398695|NCT00660660|323247053|FG001|Overall Study|Lack of Efficacy|2|||
94398696|NCT00660660|323247052|FG000|Overall Study|Withdrawal by Subject|3|||
94398697|NCT00660660|323247053|FG001|Overall Study|Withdrawal by Subject|0|||
94398698|NCT00660660|323247052|FG000|Overall Study|Incorrect enrollment and other|0|||
94398699|NCT00660660|323247053|FG001|Overall Study|Incorrect enrollment and other|1|||
94398700|NCT00660660|323247052|FG000|Overall Study|New medication after randomization|1|||
94398701|NCT00660660|323247053|FG001|Overall Study|New medication after randomization|0|||
94398702|NCT02832063|323247054|FG000|Overall Study|Adverse Event|2|||
94398703|NCT02832063|323247055|FG001|Overall Study|Adverse Event|1|||
94398704|NCT02832063|323247054|FG000|Overall Study|Physician Decision|5|||
94398705|NCT02832063|323247055|FG001|Overall Study|Physician Decision|7|||
94398706|NCT02832063|323247054|FG000|Overall Study|Lost to Follow-up|15|||
94398707|NCT02832063|323247055|FG001|Overall Study|Lost to Follow-up|8|||
94484816|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
94330001|NCT00426556|322990078|FG001|Phase II - Extension Phase|Adverse Event|0|||
94330002|NCT00426556|322990079|FG002|Phase II - Extension Phase|Adverse Event|0|||
94398708|NCT02832063|323247054|FG000|Overall Study|Withdrawal by Subject|10|||
94330003|NCT00426556|322990080|FG003|Phase II - Extension Phase|Adverse Event|2|||
94398709|NCT02832063|323247055|FG001|Overall Study|Withdrawal by Subject|21|||
94398710|NCT02832063|323247054|FG000|Overall Study|Other|2|||
94398711|NCT02832063|323247055|FG001|Overall Study|Other|1|||
94398712|NCT01531894|323247056|FG000|Overall Study|Physician Decision|8|||
94398713|NCT01531894|323247056|FG000|Overall Study|Death|1|||
94398714|NCT01564394|323247065|FG000|Overall Study|Withdrawal by Subject|6|||
94398715|NCT01564394|323247066|FG001|Overall Study|Withdrawal by Subject|10|||
94398716|NCT00443651|323247069|FG000|Overall Study|Death|1|||
94398717|NCT00443651|323247070|FG001|Overall Study|Death|5|||
94398718|NCT00443651|323247069|FG000|Overall Study|Adverse Event|5|||
94398719|NCT00443651|323247070|FG001|Overall Study|Adverse Event|6|||
94398720|NCT00443651|323247069|FG000|Overall Study|Lost to Follow-up|18|||
94398721|NCT00443651|323247070|FG001|Overall Study|Lost to Follow-up|12|||
94398722|NCT00443651|323247069|FG000|Overall Study|Patient's/Guardian's Decision|58|||
94398723|NCT00443651|323247070|FG001|Overall Study|Patient's/Guardian's Decision|30|||
94398724|NCT00443651|323247069|FG000|Overall Study|Physician Decision|13|||
94398725|NCT00443651|323247070|FG001|Overall Study|Physician Decision|4|||
94398726|NCT00443651|323247069|FG000|Overall Study|Pregnancy|0|||
94398727|NCT00443651|323247070|FG001|Overall Study|Pregnancy|1|||
94398728|NCT00859521|323247071|FG000|Washout|Withdrawal by Subject|0|||
94398729|NCT00859521|323247072|FG001|Washout|Withdrawal by Subject|1|||
94398730|NCT01609257|323247073|FG000|Overall Study|Lost to Follow-up|2|||
94398731|NCT01609257|323247074|FG001|Overall Study|Lost to Follow-up|1|||
94398732|NCT01609257|323247073|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
94398733|NCT01609257|323247074|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
94398734|NCT01609257|323247073|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
94398735|NCT01609257|323247074|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
94398736|NCT01735994|323247076|FG000|Overall Study|Withdrawal by Subject|6|||
94398737|NCT01735994|323247077|FG001|Overall Study|Withdrawal by Subject|4|||
94398738|NCT01735994|323247076|FG000|Overall Study|Injury|2|||
94398739|NCT01735994|323247077|FG001|Overall Study|Injury|0|||
94398740|NCT01735994|323247076|FG000|Overall Study|Kicked off team|5|||
94398741|NCT01735994|323247077|FG001|Overall Study|Kicked off team|0|||
94398742|NCT01735994|323247076|FG000|Overall Study|Lost to Follow-up|50|||
94398743|NCT01735994|323247077|FG001|Overall Study|Lost to Follow-up|62|||
94398744|NCT03499353|323247080|FG000|Treatment|Adverse Event|3|||
94398745|NCT03499353|323247080|FG000|Treatment|Progressive Disease|10|||
94398746|NCT03499353|323247080|FG000|Treatment|Other|1|||
94398747|NCT03499353|323247080|FG000|Treatment|Withdrawal by Subject|2|||
94398748|NCT03499353|323247080|FG000|Long-Term Follow-up|Death|2|||
94398749|NCT03499353|323247080|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
94398750|NCT03499353|323247080|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
94398751|NCT01015287|323247081|FG000|Overall Study|Death|21|||
94398752|NCT01015287|323247082|FG001|Overall Study|Death|16|||
94398753|NCT01015287|323247081|FG000|Overall Study|Adverse Event|1|||
94398754|NCT01015287|323247082|FG001|Overall Study|Adverse Event|0|||
94398755|NCT01015287|323247081|FG000|Overall Study|Sponsor Decision|3|||
94398756|NCT01015287|323247082|FG001|Overall Study|Sponsor Decision|7|||
94398757|NCT01015287|323247081|FG000|Overall Study|Physician Decision|19|||
94398758|NCT01015287|323247082|FG001|Overall Study|Physician Decision|21|||
94398759|NCT01015287|323247081|FG000|Overall Study|Withdrawal by Subject|14|||
94398760|NCT01015287|323247082|FG001|Overall Study|Withdrawal by Subject|19|||
94398761|NCT01015287|323247081|FG000|Overall Study|Entry Criteria not Met|11|||
94398762|NCT01015287|323247082|FG001|Overall Study|Entry Criteria not Met|14|||
94398763|NCT01015287|323247081|FG000|Overall Study|Lost to Follow-up|2|||
94398764|NCT01015287|323247082|FG001|Overall Study|Lost to Follow-up|1|||
94398765|NCT01015287|323247081|FG000|Overall Study|Protocol Violation|1|||
94398766|NCT01015287|323247082|FG001|Overall Study|Protocol Violation|1|||
94398767|NCT00469898|323247086|FG000|Overall Study|Adverse Event|7|||
94398768|NCT00469898|323247086|FG000|Overall Study|Withdrawal by Subject|4|||
94398769|NCT00469898|323247086|FG000|Overall Study|Death|4|||
94398770|NCT00469898|323247086|FG000|Overall Study|Disease progression|9|||
94398771|NCT00469898|323247086|FG000|Overall Study|Decreased performance status|1|||
94398772|NCT00736190|323247089|FG000|Overall Study|Pregnancy|1|||
94398773|NCT00736190|323247089|FG000|Overall Study|Withdrawal by Subject|1|||
94398774|NCT00736190|323247089|FG000|Overall Study|Adverse Event|1|||
94398775|NCT02197416|323247091|FG000|Overall Study|Other reasons|0|||
94398776|NCT02197416|323247092|FG001|Overall Study|Other reasons|2|||
94398777|NCT02197416|323247093|FG002|Overall Study|Other reasons|5|||
94398778|NCT02197416|323247091|FG000|Overall Study|Withdrawal by Subject|0|||
94398779|NCT02197416|323247092|FG001|Overall Study|Withdrawal by Subject|2|||
94398780|NCT02197416|323247093|FG002|Overall Study|Withdrawal by Subject|1|||
94398781|NCT02197416|323247091|FG000|Overall Study|Protocol Violation|1|||
94398782|NCT02197416|323247092|FG001|Overall Study|Protocol Violation|0|||
94398783|NCT02197416|323247093|FG002|Overall Study|Protocol Violation|1|||
94398784|NCT02197416|323247091|FG000|Overall Study|Adverse Event|0|||
94398785|NCT02197416|323247092|FG001|Overall Study|Adverse Event|0|||
94398786|NCT02197416|323247093|FG002|Overall Study|Adverse Event|1|||
94398787|NCT00716625|323247094|FG000|Overall Study|Safety was not Assessable|1|||
94398788|NCT01492439|323247095|FG000|Overall Study|Withdrew from RTE|4|||
94398789|NCT01492439|323247096|FG001|Overall Study|Withdrew from RTE|9|||
94398790|NCT02558491|323247101|FG000|First Invention|Withdrawal by Subject|3|||
94398791|NCT02558491|323247102|FG001|First Invention|Withdrawal by Subject|1|||
94398792|NCT02558491|323247101|FG000|First Invention|Data collection issues|1|||
94398793|NCT02558491|323247102|FG001|First Invention|Data collection issues|0|||
94398794|NCT02558491|323247101|FG000|First Invention|Stopping criteria|0|||
94398795|NCT02558491|323247102|FG001|First Invention|Stopping criteria|1|||
94398796|NCT02558491|323247101|FG000|First Invention|Changed parameters during trial|1|||
94398797|NCT02558491|323247102|FG001|First Invention|Changed parameters during trial|0|||
94398798|NCT02558491|323247101|FG000|Second Intervention|Withdrawal by Subject|1|||
94398799|NCT02558491|323247102|FG001|Second Intervention|Withdrawal by Subject|0|||
94398800|NCT02558491|323247101|FG000|Second Intervention|Stopping Criteria|1|||
94398801|NCT02558491|323247102|FG001|Second Intervention|Stopping Criteria|0|||
94398802|NCT00848536|323247105|FG000|Overall Study|Adverse Event|2|||
94398803|NCT00848536|323247106|FG001|Overall Study|Adverse Event|2|||
94398804|NCT00848536|323247105|FG000|Overall Study|Withdrawal by Subject|0|||
94398805|NCT00848536|323247106|FG001|Overall Study|Withdrawal by Subject|1|||
94398806|NCT00848536|323247105|FG000|Overall Study|Protocol Violation|0|||
94398807|NCT00848536|323247106|FG001|Overall Study|Protocol Violation|1|||
94398808|NCT00848536|323247105|FG000|Overall Study|Noncompliance|1|||
94398809|NCT00848536|323247106|FG001|Overall Study|Noncompliance|0|||
94398810|NCT00848536|323247105|FG000|Overall Study|Inadequate Control of IOP|1|||
94398811|NCT00848536|323247106|FG001|Overall Study|Inadequate Control of IOP|1|||
94398812|NCT00848536|323247105|FG000|Overall Study|Patient Moved|0|||
94398813|NCT00848536|323247106|FG001|Overall Study|Patient Moved|2|||
94398814|NCT01175135|323247109|FG000|Overall Study|Adverse Event|2|||
94398815|NCT01175135|323247110|FG001|Overall Study|Adverse Event|5|||
94398816|NCT01175135|323247111|FG002|Overall Study|Adverse Event|3|||
94398817|NCT01175135|323247112|FG003|Overall Study|Adverse Event|4|||
94398818|NCT01175135|323247109|FG000|Overall Study|Death|1|||
94398819|NCT01175135|323247110|FG001|Overall Study|Death|0|||
94398820|NCT01175135|323247111|FG002|Overall Study|Death|0|||
94398821|NCT01175135|323247112|FG003|Overall Study|Death|0|||
94398822|NCT01175135|323247109|FG000|Overall Study|Lack of Efficacy|4|||
94398823|NCT01175135|323247110|FG001|Overall Study|Lack of Efficacy|5|||
94398824|NCT01175135|323247111|FG002|Overall Study|Lack of Efficacy|0|||
94398825|NCT01175135|323247112|FG003|Overall Study|Lack of Efficacy|5|||
94398826|NCT01175135|323247109|FG000|Overall Study|Lost to Follow-up|1|||
94398827|NCT01175135|323247110|FG001|Overall Study|Lost to Follow-up|2|||
94398828|NCT01175135|323247111|FG002|Overall Study|Lost to Follow-up|0|||
94398829|NCT01175135|323247112|FG003|Overall Study|Lost to Follow-up|0|||
94398830|NCT01175135|323247109|FG000|Overall Study|Protocol Violation|1|||
94398831|NCT01175135|323247110|FG001|Overall Study|Protocol Violation|1|||
94398832|NCT01175135|323247111|FG002|Overall Study|Protocol Violation|0|||
94398833|NCT01175135|323247112|FG003|Overall Study|Protocol Violation|0|||
94398834|NCT01175135|323247109|FG000|Overall Study|Withdrawal by Subject|4|||
94398835|NCT01175135|323247110|FG001|Overall Study|Withdrawal by Subject|8|||
94398836|NCT01175135|323247111|FG002|Overall Study|Withdrawal by Subject|5|||
94398837|NCT01175135|323247112|FG003|Overall Study|Withdrawal by Subject|5|||
94398838|NCT01175135|323247109|FG000|Overall Study|Other|3|||
94398839|NCT01175135|323247110|FG001|Overall Study|Other|1|||
94398840|NCT01175135|323247111|FG002|Overall Study|Other|3|||
94398841|NCT01175135|323247112|FG003|Overall Study|Other|0|||
94398842|NCT01175135|323247109|FG000|Overall Study|Randomized But Not Treated|0|||
94398843|NCT01175135|323247110|FG001|Overall Study|Randomized But Not Treated|0|||
94398844|NCT01175135|323247111|FG002|Overall Study|Randomized But Not Treated|1|||
94398845|NCT01175135|323247112|FG003|Overall Study|Randomized But Not Treated|0|||
94398846|NCT03428750|323247115|FG000|Overall Study|Withdrawal by Subject|11|||
94398847|NCT03428750|323247116|FG001|Overall Study|Withdrawal by Subject|10|||
94398848|NCT03428750|323247115|FG000|Overall Study|Lost to Follow-up|3|||
94398849|NCT03428750|323247116|FG001|Overall Study|Lost to Follow-up|9|||
94484817|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
94398850|NCT03428750|323247115|FG000|Overall Study|Adverse Event|9|||
94484818|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
94398851|NCT03428750|323247116|FG001|Overall Study|Adverse Event|1|||
94398852|NCT03428750|323247115|FG000|Overall Study|Protocol Violation|1|||
94398853|NCT03428750|323247116|FG001|Overall Study|Protocol Violation|0|||
94398854|NCT03428750|323247115|FG000|Overall Study|Administrative|0|||
94398855|NCT03428750|323247116|FG001|Overall Study|Administrative|1|||
94398856|NCT03364192|323247119|FG000|Overall Study|Ineligible|10|||
94398857|NCT03364192|323247119|FG000|Overall Study|Withdrawal by Subject|5|||
94398858|NCT03364192|323247119|FG000|Overall Study|Lost to Follow-up|1|||
94398859|NCT02554877|323247120|FG000|Overall Study|Adverse Event|2|||
94484819|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
94398860|NCT02554877|323247121|FG001|Overall Study|Adverse Event|0|||
94398861|NCT02554877|323247122|FG002|Overall Study|Adverse Event|0|||
94398862|NCT02554877|323247123|FG003|Overall Study|Adverse Event|1|||
94398863|NCT02554877|323247120|FG000|Overall Study|Lost to Follow-up|1|||
94398864|NCT02554877|323247121|FG001|Overall Study|Lost to Follow-up|1|||
94398865|NCT02554877|323247122|FG002|Overall Study|Lost to Follow-up|1|||
94398866|NCT02554877|323247123|FG003|Overall Study|Lost to Follow-up|2|||
94398867|NCT02554877|323247120|FG000|Overall Study|Did not meet entrance criteria|0|||
94398868|NCT02554877|323247121|FG001|Overall Study|Did not meet entrance criteria|0|||
94398869|NCT02554877|323247122|FG002|Overall Study|Did not meet entrance criteria|1|||
94398870|NCT02554877|323247123|FG003|Overall Study|Did not meet entrance criteria|0|||
94398871|NCT02554877|323247120|FG000|Overall Study|No longer met eligibility criteria|1|||
94398872|NCT02554877|323247121|FG001|Overall Study|No longer met eligibility criteria|0|||
94398873|NCT02554877|323247122|FG002|Overall Study|No longer met eligibility criteria|1|||
94330004|NCT05159362|322990082|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
94330005|NCT05159362|322990083|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
94330006|NCT05159362|322990084|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
94330007|NCT01357889|322990088|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
94330008|NCT01357889|322990089|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
94330009|NCT01357889|322990088|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
94330010|NCT01357889|322990089|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
94330011|NCT01357889|322990088|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
94330012|NCT01357889|322990089|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
94330013|NCT01357889|322990088|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
94330014|NCT01357889|322990089|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
94330015|NCT01357889|322990088|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
94330016|NCT01357889|322990089|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
94330017|NCT01357889|322990088|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
94330018|NCT01357889|322990089|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
94330019|NCT01357889|322990088|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
94330020|NCT01357889|322990089|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
94330021|NCT01357889|322990088|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
94330022|NCT01357889|322990089|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
94330023|NCT01357889|322990088|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
94330024|NCT01357889|322990089|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
94330025|NCT01357889|322990088|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
94330026|NCT01357889|322990089|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
94330027|NCT01357889|322990088|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
94330028|NCT01357889|322990089|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
94330029|NCT01357889|322990088|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
94330030|NCT01357889|322990089|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
94330031|NCT01357889|322990088|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
94330032|NCT01357889|322990089|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
94398874|NCT02554877|323247123|FG003|Overall Study|No longer met eligibility criteria|1|||
94398875|NCT02554877|323247120|FG000|Overall Study|Protocol Violation|3|||
94398876|NCT02554877|323247121|FG001|Overall Study|Protocol Violation|1|||
94398877|NCT02554877|323247122|FG002|Overall Study|Protocol Violation|1|||
94398878|NCT02554877|323247123|FG003|Overall Study|Protocol Violation|0|||
94398879|NCT02554877|323247120|FG000|Overall Study|Other|1|||
94398880|NCT02554877|323247121|FG001|Overall Study|Other|3|||
94398881|NCT02554877|323247122|FG002|Overall Study|Other|0|||
94398882|NCT02554877|323247123|FG003|Overall Study|Other|3|||
94398883|NCT02554877|323247120|FG000|Overall Study|Insufficient clinical response|4|||
94398884|NCT02554877|323247121|FG001|Overall Study|Insufficient clinical response|0|||
94398885|NCT02554877|323247122|FG002|Overall Study|Insufficient clinical response|0|||
94398886|NCT02554877|323247123|FG003|Overall Study|Insufficient clinical response|0|||
94398887|NCT02554877|323247120|FG000|Overall Study|No longer willing to participate|0|||
94398888|NCT02554877|323247121|FG001|Overall Study|No longer willing to participate|2|||
94398889|NCT02554877|323247122|FG002|Overall Study|No longer willing to participate|2|||
94398890|NCT02554877|323247123|FG003|Overall Study|No longer willing to participate|0|||
94398891|NCT00274651|323247124|FG000|Overall Study|Adverse Event|6|||
94398892|NCT00274651|323247125|FG001|Overall Study|Adverse Event|3|||
94398893|NCT00274651|323247124|FG000|Overall Study|Lack of Efficacy|13|||
94398894|NCT00274651|323247125|FG001|Overall Study|Lack of Efficacy|6|||
94398895|NCT00274651|323247124|FG000|Overall Study|Death|1|||
94398896|NCT00274651|323247125|FG001|Overall Study|Death|3|||
94398897|NCT00274651|323247124|FG000|Overall Study|Withdrawal by Subject|0|||
94398898|NCT00274651|323247125|FG001|Overall Study|Withdrawal by Subject|1|||
94398899|NCT00274651|323247124|FG000|Overall Study|Physician Decision|8|||
94398900|NCT00274651|323247125|FG001|Overall Study|Physician Decision|7|||
94398901|NCT00918645|323247126|FG000|Overall Study|Withdrawal by Subject|1|||
94398902|NCT03669861|323247129|FG000|Overall Study|Disease Flare|5|||
94398903|NCT03669861|323247129|FG000|Overall Study|Lack of Efficacy|2|||
94398904|NCT00294047|323247130|FG000|Month 48|Adverse Event|28|||
94398905|NCT00294047|323247131|FG001|Month 48|Adverse Event|13|||
94398906|NCT00294047|323247130|FG000|Month 48|Protocol Violation|4|||
94398907|NCT00294047|323247131|FG001|Month 48|Protocol Violation|4|||
94398908|NCT00294047|323247130|FG000|Month 48|Withdrawal by Subject|111|||
94398909|NCT00294047|323247131|FG001|Month 48|Withdrawal by Subject|115|||
94398910|NCT00294047|323247130|FG000|Month 48|Lost to Follow-up|272|||
94398911|NCT00294047|323247131|FG001|Month 48|Lost to Follow-up|287|||
94398912|NCT00294047|323247130|FG000|Month 48|Other|10|||
94398913|NCT00294047|323247131|FG001|Month 48|Other|14|||
94398914|NCT00294047|323247130|FG000|Month 84|Adverse Event|4|||
94398915|NCT00294047|323247131|FG001|Month 84|Adverse Event|2|||
94398916|NCT00294047|323247130|FG000|Month 84|Protocol Violation|1|||
94398917|NCT00294047|323247131|FG001|Month 84|Protocol Violation|1|||
94398918|NCT00294047|323247130|FG000|Month 84|Withdrawal by Subject|33|||
94398919|NCT00294047|323247131|FG001|Month 84|Withdrawal by Subject|31|||
94398920|NCT00294047|323247130|FG000|Month 84|Lost to Follow-up|187|||
94398921|NCT00294047|323247131|FG001|Month 84|Lost to Follow-up|190|||
94398922|NCT00294047|323247130|FG000|Month 84|Absent Cervix|2|||
94398923|NCT00294047|323247131|FG001|Month 84|Absent Cervix|0|||
94398924|NCT00294047|323247130|FG000|Month 84|Work related reasons|4|||
94398925|NCT00294047|323247131|FG001|Month 84|Work related reasons|2|||
94398926|NCT00294047|323247130|FG000|Month 84|Center closed, subject did not transfer|1|||
94398927|NCT00294047|323247131|FG001|Month 84|Center closed, subject did not transfer|0|||
94398928|NCT00294047|323247130|FG000|Month 84|Family problems|2|||
94398929|NCT00294047|323247131|FG001|Month 84|Family problems|2|||
94398930|NCT00294047|323247130|FG000|Month 84|Lack of time|3|||
94398931|NCT00294047|323247131|FG001|Month 84|Lack of time|1|||
94398932|NCT00294047|323247130|FG000|Month 84|Personal reason|2|||
94398933|NCT00294047|323247131|FG001|Month 84|Personal reason|4|||
94398934|NCT00294047|323247130|FG000|Month 84|Subject does not want male physician|1|||
94398935|NCT00294047|323247131|FG001|Month 84|Subject does not want male physician|0|||
94398936|NCT00294047|323247130|FG000|Month 84|Transport reimbursement delayed|0|||
94398937|NCT00294047|323247131|FG001|Month 84|Transport reimbursement delayed|1|||
94398938|NCT00294047|323247130|FG000|Month 84|Unable to reach study site|1|||
94398939|NCT00294047|323247131|FG001|Month 84|Unable to reach study site|0|||
94398940|NCT00294047|323247130|FG000|Month 84|Under investigation locally|1|||
94398941|NCT00294047|323247131|FG001|Month 84|Under investigation locally|0|||
94398942|NCT00294047|323247130|FG000|Month 84|Visit missed|0|||
94398943|NCT00294047|323247131|FG001|Month 84|Visit missed|1|||
94398944|NCT00294047|323247130|FG000|Month 84|No consent for Month 84 Follow-up|731|||
94398945|NCT00294047|323247131|FG001|Month 84|No consent for Month 84 Follow-up|754|||
94398946|NCT02157974|323247132|FG000|Overall Study|Withdrawal by Subject|0|||
94398947|NCT02157974|323247133|FG001|Overall Study|Withdrawal by Subject|1|||
94398948|NCT02157974|323247134|FG002|Overall Study|Withdrawal by Subject|0|||
94398949|NCT02157974|323247135|FG003|Overall Study|Withdrawal by Subject|0|||
94398950|NCT02157974|323247136|FG004|Overall Study|Withdrawal by Subject|0|||
94398951|NCT02157974|323247132|FG000|Overall Study|Screen Failure|0|||
94398952|NCT02157974|323247133|FG001|Overall Study|Screen Failure|1|||
94398953|NCT02157974|323247134|FG002|Overall Study|Screen Failure|0|||
94398954|NCT02157974|323247135|FG003|Overall Study|Screen Failure|0|||
94398955|NCT02157974|323247136|FG004|Overall Study|Screen Failure|0|||
94398956|NCT02157974|323247132|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
94398957|NCT02157974|323247133|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
94398958|NCT02157974|323247134|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
94398959|NCT02157974|323247135|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
94398960|NCT02157974|323247136|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
94398961|NCT02450539|323247144|FG000|Overall Study|Withdrawal by Subject|12|||
94398962|NCT02450539|323247145|FG001|Overall Study|Withdrawal by Subject|6|||
94398963|NCT02450539|323247144|FG000|Overall Study|Lost to Follow-up|4|||
94398964|NCT02450539|323247145|FG001|Overall Study|Lost to Follow-up|1|||
94398965|NCT04583423|323247146|FG000|Overall Study|Lost to Follow-up|0|||
94398966|NCT04583423|323247147|FG001|Overall Study|Lost to Follow-up|1|||
94398967|NCT04583423|323247148|FG002|Overall Study|Lost to Follow-up|0|||
94398968|NCT04583423|323247149|FG003|Overall Study|Lost to Follow-up|2|||
94398969|NCT04583423|323247146|FG000|Overall Study|Study Terminated by Sponsor|32|||
94398970|NCT04583423|323247147|FG001|Overall Study|Study Terminated by Sponsor|35|||
94398971|NCT04583423|323247148|FG002|Overall Study|Study Terminated by Sponsor|36|||
94398972|NCT04583423|323247149|FG003|Overall Study|Study Terminated by Sponsor|33|||
94398973|NCT04583423|323247146|FG000|Overall Study|Withdrawal by Subject|3|||
94398974|NCT04583423|323247147|FG001|Overall Study|Withdrawal by Subject|1|||
94398975|NCT04583423|323247148|FG002|Overall Study|Withdrawal by Subject|2|||
94398976|NCT04583423|323247149|FG003|Overall Study|Withdrawal by Subject|1|||
94398977|NCT03131895|323247161|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
94398978|NCT03131895|323247162|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
94398979|NCT03131895|323247163|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
94398980|NCT03131895|323247164|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
94398981|NCT03131895|323247161|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
94398982|NCT03131895|323247162|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
94398983|NCT03131895|323247163|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
94398984|NCT03131895|323247164|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
94398985|NCT03131895|323247161|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
94398986|NCT03131895|323247162|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
94398987|NCT03131895|323247163|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
94398988|NCT03131895|323247164|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
94398989|NCT03131895|323247161|FG000|Washout Period (at Least 5 Days)|Other|0|||
94398990|NCT03131895|323247162|FG001|Washout Period (at Least 5 Days)|Other|0|||
94398991|NCT03131895|323247163|FG002|Washout Period (at Least 5 Days)|Other|2|||
94398992|NCT03131895|323247164|FG003|Washout Period (at Least 5 Days)|Other|0|||
94398993|NCT03131895|323247161|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
94398994|NCT03131895|323247162|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
94398995|NCT03131895|323247163|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
94398996|NCT03131895|323247164|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
94398997|NCT03131895|323247161|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
94398998|NCT03131895|323247162|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
94398999|NCT03131895|323247163|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
94399000|NCT03131895|323247164|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
94399001|NCT00263588|323247165|FG000|Overall Study|Death|54|||
94399002|NCT00263588|323247166|FG001|Overall Study|Death|90|||
94399003|NCT00263588|323247165|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
94399004|NCT00263588|323247166|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
94399005|NCT00263588|323247165|FG000|Overall Study|Lost to Follow-up|7|||
94399006|NCT00263588|323247166|FG001|Overall Study|Lost to Follow-up|10|||
94399007|NCT00263588|323247165|FG000|Overall Study|Withdrawal by Subject|3|||
94399008|NCT00263588|323247166|FG001|Overall Study|Withdrawal by Subject|4|||
94399009|NCT00263588|323247165|FG000|Overall Study|Protocol Violation|0|||
94399010|NCT00263588|323247166|FG001|Overall Study|Protocol Violation|1|||
94399011|NCT00263588|323247165|FG000|Overall Study|Investigator decision|7|||
94399012|NCT00263588|323247166|FG001|Overall Study|Investigator decision|15|||
94399013|NCT00263588|323247165|FG000|Overall Study|Sponsor terminated study|0|||
94399014|NCT00263588|323247166|FG001|Overall Study|Sponsor terminated study|1|||
94399015|NCT00216736|323247169|FG000|Overall Study|Lost to Follow-up|1|||
94399016|NCT00216736|323247170|FG001|Overall Study|Lost to Follow-up|1|||
94399017|NCT02704091|323247171|FG000|Overall Study|Adverse Event|4|||
94399018|NCT02704091|323247172|FG001|Overall Study|Adverse Event|3|||
94399019|NCT02704091|323247171|FG000|Overall Study|Protocol Violation|5|||
94399020|NCT02704091|323247172|FG001|Overall Study|Protocol Violation|3|||
94399021|NCT02704091|323247171|FG000|Overall Study|Consent withdrawn|4|||
94399022|NCT02704091|323247172|FG001|Overall Study|Consent withdrawn|4|||
94399023|NCT02704091|323247171|FG000|Overall Study|Lost to Follow-up|13|||
94399024|NCT02704091|323247172|FG001|Overall Study|Lost to Follow-up|5|||
94399025|NCT02704091|323247171|FG000|Overall Study|Other|2|||
94399026|NCT02704091|323247172|FG001|Overall Study|Other|8|||
94399027|NCT00985439|323247173|FG000|Overall Study|Adverse Event|0|||
94399028|NCT00985439|323247174|FG001|Overall Study|Adverse Event|0|||
94399029|NCT00985439|323247175|FG002|Overall Study|Adverse Event|1|||
94399030|NCT00985439|323247176|FG003|Overall Study|Adverse Event|0|||
94399031|NCT00472212|323247177|FG000|Overall Study|Lost to Follow-up|6|||
94399032|NCT00472212|323247178|FG001|Overall Study|Lost to Follow-up|4|||
94399033|NCT00858780|323247183|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
94399034|NCT00858780|323247184|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
94399035|NCT00858780|323247185|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
94399036|NCT00858780|323247186|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
94399037|NCT00858780|323247187|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
94399038|NCT00858780|323247183|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
94399039|NCT00858780|323247184|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
94399040|NCT00858780|323247185|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
94399041|NCT00858780|323247186|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
94399042|NCT00858780|323247187|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
94399043|NCT00858780|323247183|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
94399044|NCT00858780|323247184|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
94399045|NCT00858780|323247185|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
94399046|NCT00858780|323247186|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
94399047|NCT00858780|323247187|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
94399048|NCT00858780|323247183|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
94399049|NCT00858780|323247184|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
94399050|NCT00858780|323247185|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
94399051|NCT00858780|323247186|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
94399052|NCT00858780|323247187|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
94399053|NCT00858780|323247183|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
94399054|NCT00858780|323247184|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
94399055|NCT00858780|323247185|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
94399056|NCT00858780|323247186|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
94399057|NCT00858780|323247187|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
94399058|NCT00858780|323247183|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
94399059|NCT00858780|323247184|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
94399060|NCT00858780|323247185|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
94399061|NCT00858780|323247186|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
94399062|NCT00858780|323247187|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
94399063|NCT00863330|323247188|FG000|Overall Study|study terminated early due to administra|6|||
94399064|NCT01297504|323247189|FG000|Overall Study|Invalid Consent|1|||
94399065|NCT01297504|323247189|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
94399066|NCT01297504|323247189|FG000|Overall Study|No Study Visits|4|||
94399067|NCT01297504|323247189|FG000|Overall Study|Death|3|||
94399068|NCT01297504|323247189|FG000|Overall Study|Lost to Follow-up|43|||
94399069|NCT01297504|323247189|FG000|Overall Study|Withdrawal by Subject|9|||
94399070|NCT01297504|323247189|FG000|Overall Study|Site Closure|3|||
94399071|NCT01297504|323247189|FG000|Overall Study|Protocol Violation|3|||
94399072|NCT00669162|323248557|FG000|Overall Study|Withdrawal by Subject|1|||
94399073|NCT02441686|323248558|FG000|Induction|Adverse Event|4|||
94399074|NCT02441686|323248558|FG000|Induction|Complicating disease|1|||
94399075|NCT02441686|323248558|FG000|Induction|Physician Decision|1|||
94399076|NCT02441686|323248558|FG000|Induction|Withdrawal by Subject|1|||
94399077|NCT02441686|323248558|FG000|Induction|Did not receive treatment|1|||
94399078|NCT02441686|323248558|FG000|Maintenance|Remaining on Treatment|23|||
94399079|NCT02441686|323248558|FG000|Maintenance|Physician Decision|1|||
94399080|NCT02441686|323248558|FG000|Maintenance|Adverse Event|3|||
94399081|NCT02441686|323248558|FG000|Maintenance|Progressive Disease|10|||
94399082|NCT02441686|323248558|FG000|Maintenance|Withdrawal by Subject|1|||
94399083|NCT01634139|323248559|FG000|Overall Study|Non compliant with protocol|1|||
94399084|NCT01634139|323248560|FG001|Overall Study|Non compliant with protocol|0|||
94399085|NCT01634139|323248561|FG002|Overall Study|Non compliant with protocol|0|||
94399086|NCT01634139|323248559|FG000|Overall Study|Consent withdrawn not due to AE|4|||
94399087|NCT01634139|323248560|FG001|Overall Study|Consent withdrawn not due to AE|3|||
94399088|NCT01634139|323248561|FG002|Overall Study|Consent withdrawn not due to AE|2|||
94399089|NCT01634139|323248559|FG000|Overall Study|Other|4|||
94399090|NCT01634139|323248560|FG001|Overall Study|Other|0|||
94399091|NCT01634139|323248561|FG002|Overall Study|Other|3|||
94399092|NCT01634139|323248559|FG000|Overall Study|Lost to Follow-up|0|||
94399093|NCT01634139|323248560|FG001|Overall Study|Lost to Follow-up|2|||
94399094|NCT01634139|323248561|FG002|Overall Study|Lost to Follow-up|0|||
94399095|NCT01634139|323248559|FG000|Overall Study|Not treated|1|||
94399096|NCT01634139|323248560|FG001|Overall Study|Not treated|1|||
94399097|NCT01634139|323248561|FG002|Overall Study|Not treated|0|||
94399098|NCT00425308|323248562|FG000|Overall Study|Adverse Event|2|||
94399099|NCT00425308|323248563|FG001|Overall Study|Adverse Event|1|||
94399100|NCT00425308|323248562|FG000|Overall Study|Withdrawal by Subject|1|||
94399101|NCT00425308|323248563|FG001|Overall Study|Withdrawal by Subject|0|||
94399102|NCT00425308|323248562|FG000|Overall Study|Death|1|||
94399103|NCT00425308|323248563|FG001|Overall Study|Death|0|||
94399104|NCT00418938|323248568|FG000|Overall Study|Reimbursement|1|||
94399105|NCT00418938|323248569|FG001|Overall Study|Reimbursement|0|||
94399106|NCT00418938|323248568|FG000|Overall Study|Administrative decision|3|||
94399107|NCT00418938|323248569|FG001|Overall Study|Administrative decision|3|||
94399108|NCT00418938|323248568|FG000|Overall Study|Withdrawal by Subject|16|||
94399109|NCT00418938|323248569|FG001|Overall Study|Withdrawal by Subject|15|||
94399110|NCT00418938|323248568|FG000|Overall Study|Lost to Follow-up|1|||
94399111|NCT00418938|323248569|FG001|Overall Study|Lost to Follow-up|3|||
94399112|NCT00418938|323248568|FG000|Overall Study|Adverse Event|1|||
94399113|NCT00418938|323248569|FG001|Overall Study|Adverse Event|1|||
94399114|NCT00418938|323248568|FG000|Overall Study|On-going|1|||
94399115|NCT00418938|323248569|FG001|Overall Study|On-going|1|||
94399116|NCT00418938|323248568|FG000|Overall Study|Ineligibility Determined|1|||
94399117|NCT00418938|323248569|FG001|Overall Study|Ineligibility Determined|0|||
94399118|NCT01647828|323248570|FG000|Overall Study|Death|3|||
94399119|NCT01647828|323248571|FG001|Overall Study|Death|4|||
94399120|NCT01647828|323248572|FG002|Overall Study|Death|4|||
94399121|NCT01647828|323248573|FG003|Overall Study|Death|5|||
94399122|NCT01647828|323248574|FG004|Overall Study|Death|6|||
94484820|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
94399123|NCT01647828|323248575|FG005|Overall Study|Death|3|||
94399124|NCT01647828|323248576|FG006|Overall Study|Death|10|||
94399125|NCT01647828|323248577|FG007|Overall Study|Death|60|||
94399126|NCT01647828|323248578|FG008|Overall Study|Death|71|||
94399127|NCT01647828|323248570|FG000|Overall Study|Withdrawal by Subject|2|||
94399128|NCT01647828|323248571|FG001|Overall Study|Withdrawal by Subject|0|||
94399129|NCT01647828|323248572|FG002|Overall Study|Withdrawal by Subject|0|||
94484821|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
94399130|NCT01647828|323248573|FG003|Overall Study|Withdrawal by Subject|1|||
94399131|NCT01647828|323248574|FG004|Overall Study|Withdrawal by Subject|0|||
94399132|NCT01647828|323248575|FG005|Overall Study|Withdrawal by Subject|0|||
94484822|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
94484823|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
94484824|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
94484825|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
94484826|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
94484827|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
94484828|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
94484829|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
94484830|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
94484831|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
94484832|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
94484833|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
94484834|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
94484835|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
94484836|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
94484837|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
94484838|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
94484839|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
94484840|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
94484841|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
94484842|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
94399133|NCT01647828|323248576|FG006|Overall Study|Withdrawal by Subject|1|||
94399134|NCT01647828|323248577|FG007|Overall Study|Withdrawal by Subject|0|||
94399135|NCT01647828|323248578|FG008|Overall Study|Withdrawal by Subject|2|||
94399136|NCT01647828|323248570|FG000|Overall Study|Study terminated by Sponsor|0|||
94399137|NCT01647828|323248571|FG001|Overall Study|Study terminated by Sponsor|0|||
94399138|NCT01647828|323248572|FG002|Overall Study|Study terminated by Sponsor|0|||
94399139|NCT01647828|323248573|FG003|Overall Study|Study terminated by Sponsor|0|||
94399140|NCT01647828|323248574|FG004|Overall Study|Study terminated by Sponsor|0|||
94399141|NCT01647828|323248575|FG005|Overall Study|Study terminated by Sponsor|0|||
94399142|NCT01647828|323248576|FG006|Overall Study|Study terminated by Sponsor|1|||
94484843|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
94484844|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
94484845|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
94484846|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
94484847|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
94484848|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
94484849|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
94484850|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
94484851|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
94484852|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
94484853|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
94484854|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
94484855|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
94484856|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
94484857|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
94484858|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
94399143|NCT01647828|323248577|FG007|Overall Study|Study terminated by Sponsor|26|||
94399144|NCT01647828|323248578|FG008|Overall Study|Study terminated by Sponsor|16|||
94399145|NCT01647828|323248570|FG000|Overall Study|Lost to Follow-up|0|||
94399146|NCT01647828|323248571|FG001|Overall Study|Lost to Follow-up|0|||
94399147|NCT01647828|323248572|FG002|Overall Study|Lost to Follow-up|0|||
94399148|NCT01647828|323248573|FG003|Overall Study|Lost to Follow-up|0|||
94399149|NCT01647828|323248574|FG004|Overall Study|Lost to Follow-up|0|||
94399150|NCT01647828|323248575|FG005|Overall Study|Lost to Follow-up|0|||
94399151|NCT01647828|323248576|FG006|Overall Study|Lost to Follow-up|0|||
94399152|NCT01647828|323248577|FG007|Overall Study|Lost to Follow-up|2|||
94399153|NCT01647828|323248578|FG008|Overall Study|Lost to Follow-up|0|||
94399154|NCT03629054|323248579|FG000|Period 2 (4 Days)|Not treated|0|||
94399155|NCT03629054|323248580|FG001|Period 2 (4 Days)|Not treated|1|||
94399156|NCT03808376|323248581|FG000|Overall Study|Withdrawal by Subject|10|||
94399157|NCT00367133|323248582|FG000|2 Years|Death|20|||
94399158|NCT00367133|323248583|FG001|2 Years|Death|12|||
94399159|NCT00367133|323248584|FG002|2 Years|Death|12|||
94399160|NCT00367133|323248582|FG000|2 Years|Dropped|34|||
94399161|NCT00367133|323248583|FG001|2 Years|Dropped|19|||
94399162|NCT00367133|323248584|FG002|2 Years|Dropped|33|||
94399163|NCT00367133|323248582|FG000|2 Years|Missed visit|4|||
94484859|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
94484860|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
94484861|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
94484862|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
94484863|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
94484864|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
94484865|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
94484866|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
94484867|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
94484868|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
94484869|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
94484870|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
94484871|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
94484872|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
94484873|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
94484874|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
94484875|NCT02717195|323567602|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
94484876|NCT02717195|323567603|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
94484877|NCT02717195|323567604|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
94484878|NCT02717195|323567605|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
94484879|NCT02717195|323567606|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
94484880|NCT02717195|323567602|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
94484881|NCT02717195|323567603|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
94484882|NCT02717195|323567604|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
94484883|NCT02717195|323567605|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
94484884|NCT02717195|323567606|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
94484885|NCT02717195|323567602|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
94484886|NCT02717195|323567603|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
94484887|NCT02717195|323567604|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
94484888|NCT02717195|323567605|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
94484889|NCT02717195|323567606|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
94484890|NCT02717195|323567602|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
94484891|NCT02717195|323567603|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
94484892|NCT02717195|323567604|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
94399164|NCT00367133|323248583|FG001|2 Years|Missed visit|5|||
94399165|NCT00367133|323248584|FG002|2 Years|Missed visit|4|||
94399166|NCT00958724|323248585|FG000|Overall Study|Disease Progression|6|||
94399167|NCT03694197|323248593|FG000|Overall Study|Adverse Event|9|||
94399168|NCT03694197|323248593|FG000|Overall Study|Protocol became inconvenient to participate|1|||
94399169|NCT03694197|323248593|FG000|Overall Study|Physician Decision|4|||
94399170|NCT03694197|323248593|FG000|Overall Study|Study terminated by sponsor|1350|||
94399171|NCT03694197|323248593|FG000|Overall Study|Participant moved|5|||
94399172|NCT03694197|323248593|FG000|Overall Study|Participant withdrew consent|10|||
94399173|NCT03694197|323248593|FG000|Overall Study|Related to IMP administration|1|||
94399174|NCT03694197|323248593|FG000|Overall Study|Not disclosed|5|||
94399175|NCT01867658|323248596|FG000|Overall Study|Withdrawal by Subject|6|||
94399176|NCT01867658|323248596|FG000|Overall Study|Death|2|||
94399177|NCT01867658|323248596|FG000|Overall Study|Subject could not be contacted|1|||
94399178|NCT00474058|323248599|FG000|Overall Study|Adverse Event|11|||
94399179|NCT00474058|323248600|FG001|Overall Study|Adverse Event|6|||
94399180|NCT00474058|323248599|FG000|Overall Study|Lack of Efficacy|0|||
94399181|NCT00474058|323248600|FG001|Overall Study|Lack of Efficacy|4|||
94399182|NCT00474058|323248599|FG000|Overall Study|Withdrawal by Subject|11|||
94399183|NCT00474058|323248600|FG001|Overall Study|Withdrawal by Subject|7|||
94399184|NCT00474058|323248599|FG000|Overall Study|Other|2|||
94399185|NCT00474058|323248600|FG001|Overall Study|Other|0|||
94399186|NCT01442376|323248602|FG000|Overall Study|Adverse Event|0|||
94399187|NCT01442376|323248603|FG001|Overall Study|Adverse Event|3|||
94399188|NCT01442376|323248604|FG002|Overall Study|Adverse Event|2|||
94399189|NCT01442376|323248602|FG000|Overall Study|Death|0|||
94399190|NCT01442376|323248603|FG001|Overall Study|Death|1|||
94399191|NCT01442376|323248604|FG002|Overall Study|Death|1|||
94399192|NCT01442376|323248602|FG000|Overall Study|Withdrawal of consent|0|||
94484893|NCT02717195|323567605|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
94399193|NCT01442376|323248603|FG001|Overall Study|Withdrawal of consent|0|||
94399194|NCT01442376|323248604|FG002|Overall Study|Withdrawal of consent|1|||
94399195|NCT01442376|323248602|FG000|Overall Study|Patients not treated|2|||
94399196|NCT01442376|323248603|FG001|Overall Study|Patients not treated|3|||
94399197|NCT01442376|323248604|FG002|Overall Study|Patients not treated|1|||
94399198|NCT01442376|323248602|FG000|Overall Study|Not eligible for subsequent cycles|1|||
94399199|NCT01442376|323248603|FG001|Overall Study|Not eligible for subsequent cycles|2|||
94399200|NCT01442376|323248604|FG002|Overall Study|Not eligible for subsequent cycles|0|||
94399201|NCT04404725|323248605|FG000|First Intervention|Withdrawal by Subject|0|||
94399202|NCT04404725|323248606|FG001|First Intervention|Withdrawal by Subject|2|||
94399203|NCT04404725|323248605|FG000|Second Intervention|Adverse Event|1|||
94399204|NCT04404725|323248606|FG001|Second Intervention|Adverse Event|1|||
94399205|NCT04404725|323248605|FG000|Second Intervention|Withdrawal by Subject|0|||
94399206|NCT04404725|323248606|FG001|Second Intervention|Withdrawal by Subject|1|||
94399207|NCT03602339|323248607|FG000|Overall Study|Withdrawal by Subject|9|||
94399208|NCT03602339|323248607|FG000|Overall Study|Physician Decision|2|||
94399209|NCT03602339|323248607|FG000|Overall Study|Other reason|4|||
94399210|NCT02252016|323248608|FG000|Overall Study|Lost to Follow-up|2|||
94399211|NCT02252016|323248609|FG001|Overall Study|Lost to Follow-up|1|||
94399212|NCT02252016|323248608|FG000|Overall Study|Physician Decision|1|||
94399213|NCT02252016|323248609|FG001|Overall Study|Physician Decision|0|||
94399214|NCT02252016|323248608|FG000|Overall Study|Withdrawal by Subject|0|||
94399215|NCT02252016|323248609|FG001|Overall Study|Withdrawal by Subject|2|||
94399216|NCT02615249|323248615|FG000|Overall Study|Withdrawal by Subject|1|||
94399217|NCT00957021|323248622|FG000|Overall Study|Death|5|||
94399218|NCT00957021|323248622|FG000|Overall Study|Lost to Follow-up|8|||
94399219|NCT00957021|323248622|FG000|Overall Study|Withdrawal by Subject|34|||
94399220|NCT00957021|323248622|FG000|Overall Study|No 2 yr ROM data|35|||
94399221|NCT00957021|323248622|FG000|Overall Study|Revised study component by 2 yr visit|8|||
94399222|NCT00957021|323248622|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
94399223|NCT00957021|323248622|FG000|Overall Study|Surgery Cancelled|9|||
94399224|NCT00957021|323248622|FG000|Overall Study|Termination due to language issue|2|||
94399225|NCT00672984|323248625|FG000|First Intervention|Adverse Event|5|||
94399226|NCT00672984|323248626|FG001|First Intervention|Adverse Event|0|||
94399227|NCT00672984|323248627|FG002|First Intervention|Adverse Event|0|||
94399228|NCT00672984|323248625|FG000|First Intervention|Withdrawal by Subject|1|||
94399229|NCT00672984|323248626|FG001|First Intervention|Withdrawal by Subject|2|||
94399230|NCT00672984|323248627|FG002|First Intervention|Withdrawal by Subject|2|||
94399231|NCT00672984|323248625|FG000|First Intervention|Sponsor decision|3|||
94399232|NCT00672984|323248626|FG001|First Intervention|Sponsor decision|0|||
94399233|NCT00672984|323248627|FG002|First Intervention|Sponsor decision|0|||
94399234|NCT00672984|323248625|FG000|Second Intervention|Non-compliance with facility policies|0|||
94399235|NCT00672984|323248626|FG001|Second Intervention|Non-compliance with facility policies|2|||
94399236|NCT00672984|323248627|FG002|Second Intervention|Non-compliance with facility policies|0|||
94399237|NCT00672984|323248625|FG000|Second Intervention|Withdrawal by Subject|0|||
94399238|NCT00672984|323248626|FG001|Second Intervention|Withdrawal by Subject|3|||
94399239|NCT00672984|323248627|FG002|Second Intervention|Withdrawal by Subject|0|||
94399240|NCT00672984|323248625|FG000|Second Intervention|Protocol Violation|0|||
94399241|NCT00672984|323248626|FG001|Second Intervention|Protocol Violation|1|||
94399242|NCT00672984|323248627|FG002|Second Intervention|Protocol Violation|1|||
94399243|NCT00672984|323248625|FG000|Third Intervention|Adverse Event|1|||
94399244|NCT00672984|323248626|FG001|Third Intervention|Adverse Event|0|||
94399245|NCT00672984|323248627|FG002|Third Intervention|Adverse Event|1|||
94399246|NCT00354835|323248632|FG000|Overall Study|Death|1|||
94399247|NCT00354835|323248633|FG001|Overall Study|Death|1|||
94399248|NCT00354835|323248632|FG000|Overall Study|Physician Decision|8|||
94399249|NCT00354835|323248633|FG001|Overall Study|Physician Decision|13|||
94399250|NCT00354835|323248632|FG000|Overall Study|Withdrawal by Subject|2|||
94399251|NCT00354835|323248633|FG001|Overall Study|Withdrawal by Subject|1|||
94399252|NCT00354835|323248632|FG000|Overall Study|Ineligible|17|||
94399253|NCT00354835|323248633|FG001|Overall Study|Ineligible|16|||
94399254|NCT00354835|323248632|FG000|Overall Study|Disease progression or relapse|15|||
94399255|NCT00354835|323248633|FG001|Overall Study|Disease progression or relapse|22|||
94399256|NCT00354835|323248632|FG000|Overall Study|Adverse Event|6|||
94399257|NCT00354835|323248633|FG001|Overall Study|Adverse Event|0|||
94399258|NCT00354835|323248632|FG000|Overall Study|Refusal of further therapy|3|||
94399259|NCT00354835|323248633|FG001|Overall Study|Refusal of further therapy|8|||
94399260|NCT01507662|323248638|FG000|Overall Study|Death|26|||
94399261|NCT01507662|323248639|FG001|Overall Study|Death|18|||
94399262|NCT01507662|323248638|FG000|Overall Study|Withdrawal by Subject|290|||
94399263|NCT01507662|323248639|FG001|Overall Study|Withdrawal by Subject|287|||
94399264|NCT01507662|323248638|FG000|Overall Study|Lost to Follow-up|498|||
94399265|NCT01507662|323248639|FG001|Overall Study|Lost to Follow-up|523|||
94399266|NCT01507662|323248638|FG000|Overall Study|Proxy interview done|2|||
94399267|NCT01507662|323248639|FG001|Overall Study|Proxy interview done|3|||
94399268|NCT01395017|323248640|FG000|Overall Study|Lost to Follow-up|1|||
94399269|NCT01395017|323248641|FG001|Overall Study|Lost to Follow-up|0|||
94399270|NCT01395017|323248640|FG000|Overall Study|Adverse Event|26|||
94399271|NCT01395017|323248641|FG001|Overall Study|Adverse Event|12|||
94399272|NCT01395017|323248640|FG000|Overall Study|Physician Decision|11|||
94399273|NCT01395017|323248641|FG001|Overall Study|Physician Decision|15|||
94399274|NCT01395017|323248640|FG000|Overall Study|Withdrawal by Subject|14|||
94399275|NCT01395017|323248641|FG001|Overall Study|Withdrawal by Subject|8|||
94399276|NCT01395017|323248640|FG000|Overall Study|Protocol deviation|1|||
94399277|NCT01395017|323248641|FG001|Overall Study|Protocol deviation|2|||
94399278|NCT01395017|323248640|FG000|Overall Study|Death|4|||
94399279|NCT01395017|323248641|FG001|Overall Study|Death|3|||
94399280|NCT01395017|323248640|FG000|Overall Study|Disease progression|42|||
94399281|NCT01395017|323248641|FG001|Overall Study|Disease progression|58|||
94399282|NCT01395017|323248640|FG000|Overall Study|Sponsor discontinued study|1|||
94399283|NCT01395017|323248641|FG001|Overall Study|Sponsor discontinued study|4|||
94399284|NCT01663896|323248642|FG000|Overall Study|Various reasons|43|||
94399285|NCT01451541|323248643|FG000|Overall Study|Adverse Event|4|||
94399286|NCT01451541|323248644|FG001|Overall Study|Adverse Event|3|||
94399287|NCT01451541|323248645|FG002|Overall Study|Adverse Event|6|||
94399288|NCT01451541|323248643|FG000|Overall Study|Lack of Efficacy|2|||
94399289|NCT01451541|323248644|FG001|Overall Study|Lack of Efficacy|0|||
94399290|NCT01451541|323248645|FG002|Overall Study|Lack of Efficacy|0|||
94399291|NCT01451541|323248643|FG000|Overall Study|Lost to Follow-up|4|||
94399292|NCT01451541|323248644|FG001|Overall Study|Lost to Follow-up|4|||
94399293|NCT01451541|323248645|FG002|Overall Study|Lost to Follow-up|7|||
94399294|NCT01451541|323248643|FG000|Overall Study|Withdrawal by Subject|15|||
94399295|NCT01451541|323248644|FG001|Overall Study|Withdrawal by Subject|8|||
94399296|NCT01451541|323248645|FG002|Overall Study|Withdrawal by Subject|6|||
94399297|NCT01451541|323248643|FG000|Overall Study|randomization error, noncompliance|11|||
94399298|NCT01451541|323248644|FG001|Overall Study|randomization error, noncompliance|10|||
94399299|NCT01451541|323248645|FG002|Overall Study|randomization error, noncompliance|8|||
94399300|NCT01004510|323248647|FG000|Overall Study|Adverse Event|1|||
94399301|NCT03541252|323248650|FG000|Overall Study|Withdrawal by Subject|1|||
94399302|NCT03218787|323248660|FG000|Overall Study|Lost to Follow-up|12|||
94399303|NCT03218787|323248660|FG000|Overall Study|Withdrawal by Subject|72|||
94399304|NCT03218787|323248660|FG000|Overall Study|Physician Decision|11|||
94399305|NCT03218787|323248660|FG000|Overall Study|Death|111|||
94399306|NCT03719040|323248661|FG000|Overall Study|Withdrawal by Subject|177|||
94399307|NCT03719040|323248661|FG000|Overall Study|Lost to Follow-up|26|||
94399308|NCT00227370|323248662|FG000|Overall Study|Withdrawal by Subject|1|||
94399309|NCT00227370|323248663|FG001|Overall Study|Withdrawal by Subject|2|||
94399310|NCT00227370|323248662|FG000|Overall Study|Death|3|||
94399311|NCT00227370|323248663|FG001|Overall Study|Death|4|||
94399312|NCT00227370|323248662|FG000|Overall Study|Adverse Event|6|||
94399313|NCT00227370|323248663|FG001|Overall Study|Adverse Event|11|||
94399314|NCT00227370|323248662|FG000|Overall Study|Physician Decision|9|||
94399315|NCT00227370|323248663|FG001|Overall Study|Physician Decision|6|||
94399316|NCT00227370|323248662|FG000|Overall Study|Other reasons|2|||
94399317|NCT00227370|323248663|FG001|Overall Study|Other reasons|1|||
94399318|NCT05315713|323248666|FG000|Overall Study|Death|5|||
94399319|NCT05315713|323248666|FG000|Overall Study|Progressive disease|1|||
94399320|NCT05315713|323248666|FG000|Overall Study|Withdrawal by Subject|1|||
94399321|NCT05315713|323248666|FG000|Overall Study|Study terminated by sponsor|1|||
94399322|NCT03961204|323248667|FG000|Overall Study|Withdrawal by Subject|2|||
94399323|NCT03961204|323248667|FG000|Overall Study|Lost to Follow-up|3|||
94399324|NCT03961204|323248667|FG000|Overall Study|Other|1|||
94399325|NCT03961204|323248667|FG000|Overall Study|Missing|1|||
94399326|NCT01838681|323248668|FG000|Period A|Adverse Event|39|||
94399327|NCT01838681|323248669|FG001|Period A|Adverse Event|0|||
94399328|NCT01838681|323248670|FG002|Period A|Adverse Event|0|||
94399329|NCT01838681|323248671|FG003|Period A|Adverse Event|0|||
94399330|NCT01838681|323248668|FG000|Period A|Lack of Efficacy|21|||
94399331|NCT01838681|323248669|FG001|Period A|Lack of Efficacy|0|||
94399332|NCT01838681|323248670|FG002|Period A|Lack of Efficacy|0|||
94399333|NCT01838681|323248671|FG003|Period A|Lack of Efficacy|0|||
94399334|NCT01838681|323248668|FG000|Period A|Early response|148|||
94399335|NCT01838681|323248669|FG001|Period A|Early response|0|||
94399336|NCT01838681|323248670|FG002|Period A|Early response|0|||
94399337|NCT01838681|323248671|FG003|Period A|Early response|0|||
94399338|NCT01838681|323248668|FG000|Period A|Withdrawal by Subject|70|||
94399339|NCT01838681|323248669|FG001|Period A|Withdrawal by Subject|0|||
94399340|NCT01838681|323248670|FG002|Period A|Withdrawal by Subject|0|||
94399341|NCT01838681|323248671|FG003|Period A|Withdrawal by Subject|0|||
94399342|NCT01838681|323248668|FG000|Period A|Protocol Violation|16|||
94399343|NCT01838681|323248669|FG001|Period A|Protocol Violation|0|||
94399344|NCT01838681|323248670|FG002|Period A|Protocol Violation|0|||
94399345|NCT01838681|323248671|FG003|Period A|Protocol Violation|0|||
94399346|NCT01838681|323248668|FG000|Period A|Non-compliance with IMP|6|||
94399347|NCT01838681|323248669|FG001|Period A|Non-compliance with IMP|0|||
94399348|NCT01838681|323248670|FG002|Period A|Non-compliance with IMP|0|||
94399349|NCT01838681|323248671|FG003|Period A|Non-compliance with IMP|0|||
94399350|NCT01838681|323248668|FG000|Period A|Lost to Follow-up|4|||
94399351|NCT01838681|323248669|FG001|Period A|Lost to Follow-up|0|||
94399352|NCT01838681|323248670|FG002|Period A|Lost to Follow-up|0|||
94399353|NCT01838681|323248671|FG003|Period A|Lost to Follow-up|0|||
94399354|NCT01838681|323248668|FG000|Period A|Withdrawal before treatment|4|||
94399355|NCT01838681|323248669|FG001|Period A|Withdrawal before treatment|0|||
94399356|NCT01838681|323248670|FG002|Period A|Withdrawal before treatment|0|||
94484894|NCT02717195|323567606|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
94484895|NCT02717195|323567602|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
94484896|NCT02717195|323567603|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
94484897|NCT02717195|323567604|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
94484898|NCT02717195|323567605|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
94484899|NCT02717195|323567606|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
94484900|NCT02717195|323567602|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
94484901|NCT02717195|323567603|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
94484902|NCT02717195|323567604|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
94484903|NCT02717195|323567605|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
94484904|NCT02717195|323567606|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
94484905|NCT02717195|323567602|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
94484906|NCT02717195|323567603|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
94484907|NCT02717195|323567604|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
94484908|NCT02717195|323567605|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
94484909|NCT02717195|323567606|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
94484910|NCT02717195|323567602|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
94484911|NCT02717195|323567603|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
94484912|NCT02717195|323567604|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
94484913|NCT02717195|323567605|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
94484914|NCT02717195|323567606|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
94484915|NCT02717195|323567602|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
94484916|NCT02717195|323567603|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
94484917|NCT02717195|323567604|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
94484918|NCT02717195|323567605|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
94484919|NCT02717195|323567606|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
94484920|NCT02717195|323567602|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
94484921|NCT02717195|323567603|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
94484922|NCT02717195|323567604|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
94399357|NCT01838681|323248671|FG003|Period A|Withdrawal before treatment|0|||
94399358|NCT01838681|323248668|FG000|Period A|Administrative or other reasons|17|||
94399359|NCT01838681|323248669|FG001|Period A|Administrative or other reasons|0|||
94399360|NCT01838681|323248670|FG002|Period A|Administrative or other reasons|0|||
94399361|NCT01838681|323248671|FG003|Period A|Administrative or other reasons|0|||
94399362|NCT01838681|323248668|FG000|Period B/A+|Adverse Event|0|||
94399363|NCT01838681|323248669|FG001|Period B/A+|Adverse Event|13|||
94399364|NCT01838681|323248670|FG002|Period B/A+|Adverse Event|27|||
94399365|NCT01838681|323248671|FG003|Period B/A+|Adverse Event|16|||
94399366|NCT01838681|323248668|FG000|Period B/A+|Lack of Efficacy|0|||
94399367|NCT01838681|323248669|FG001|Period B/A+|Lack of Efficacy|9|||
94399368|NCT01838681|323248670|FG002|Period B/A+|Lack of Efficacy|11|||
94399369|NCT01838681|323248671|FG003|Period B/A+|Lack of Efficacy|6|||
94399370|NCT01838681|323248668|FG000|Period B/A+|Withdrawal by Subject|0|||
94399371|NCT01838681|323248669|FG001|Period B/A+|Withdrawal by Subject|28|||
94399372|NCT01838681|323248670|FG002|Period B/A+|Withdrawal by Subject|35|||
94399373|NCT01838681|323248671|FG003|Period B/A+|Withdrawal by Subject|47|||
94399374|NCT01838681|323248668|FG000|Period B/A+|Protocol Violation|0|||
94399375|NCT01838681|323248669|FG001|Period B/A+|Protocol Violation|1|||
94399376|NCT01838681|323248670|FG002|Period B/A+|Protocol Violation|4|||
94399377|NCT01838681|323248671|FG003|Period B/A+|Protocol Violation|6|||
94399378|NCT01838681|323248668|FG000|Period B/A+|Non-compliance with IMP|0|||
94399379|NCT01838681|323248669|FG001|Period B/A+|Non-compliance with IMP|2|||
94399380|NCT01838681|323248670|FG002|Period B/A+|Non-compliance with IMP|3|||
94399381|NCT01838681|323248671|FG003|Period B/A+|Non-compliance with IMP|3|||
94399382|NCT01838681|323248668|FG000|Period B/A+|Lost to Follow-up|0|||
94399383|NCT01838681|323248669|FG001|Period B/A+|Lost to Follow-up|2|||
94399384|NCT01838681|323248670|FG002|Period B/A+|Lost to Follow-up|5|||
94399385|NCT01838681|323248671|FG003|Period B/A+|Lost to Follow-up|11|||
94399386|NCT01838681|323248668|FG000|Period B/A+|Withdrawal before treatment|0|||
94399387|NCT01838681|323248669|FG001|Period B/A+|Withdrawal before treatment|1|||
94399388|NCT01838681|323248670|FG002|Period B/A+|Withdrawal before treatment|0|||
94399389|NCT01838681|323248671|FG003|Period B/A+|Withdrawal before treatment|0|||
94484923|NCT02717195|323567605|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
94399390|NCT01838681|323248668|FG000|Period B/A+|Administrative or other reasons|0|||
94399391|NCT01838681|323248669|FG001|Period B/A+|Administrative or other reasons|6|||
94399392|NCT01838681|323248670|FG002|Period B/A+|Administrative or other reasons|10|||
94399393|NCT01838681|323248671|FG003|Period B/A+|Administrative or other reasons|28|||
94399394|NCT03867760|323248674|FG000|Overall Study|Lost to Follow-up|2|||
94399395|NCT03867760|323248675|FG001|Overall Study|Lost to Follow-up|3|||
94399396|NCT03867760|323248674|FG000|Overall Study|Withdrawal by Subject|1|||
94399397|NCT03867760|323248675|FG001|Overall Study|Withdrawal by Subject|2|||
94399398|NCT03867760|323248674|FG000|Overall Study|subject could not meet study logistics|3|||
94484924|NCT02717195|323567606|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
94399399|NCT03867760|323248675|FG001|Overall Study|subject could not meet study logistics|3|||
94399400|NCT01528735|323248677|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
94399401|NCT01528735|323248678|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
94399402|NCT01528735|323248677|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
94399403|NCT01528735|323248678|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
94399404|NCT02011945|323248681|FG000|Overall Study|Participant requested to Discontinue|0|||
94399405|NCT02011945|323248682|FG001|Overall Study|Participant requested to Discontinue|1|||
94399406|NCT02011945|323248683|FG002|Overall Study|Participant requested to Discontinue|1|||
94399407|NCT02011945|323248681|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
94399408|NCT02011945|323248682|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
94399409|NCT02011945|323248683|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
94399410|NCT02011945|323248681|FG000|Overall Study|Study Drug Toxicity|0|||
94399411|NCT02011945|323248682|FG001|Overall Study|Study Drug Toxicity|0|||
94399412|NCT02011945|323248683|FG002|Overall Study|Study Drug Toxicity|1|||
94399413|NCT02011945|323248681|FG000|Overall Study|Treatment Failure|0|||
94399414|NCT02011945|323248682|FG001|Overall Study|Treatment Failure|7|||
94399415|NCT02011945|323248683|FG002|Overall Study|Treatment Failure|6|||
94399416|NCT02011945|323248681|FG000|Overall Study|No Longer Meets Study Criteria|1|||
94399417|NCT02011945|323248682|FG001|Overall Study|No Longer Meets Study Criteria|0|||
94399418|NCT02011945|323248683|FG002|Overall Study|No Longer Meets Study Criteria|0|||
94399419|NCT02011945|323248681|FG000|Overall Study|Proceeded to stem cell transplant|0|||
94399420|NCT02011945|323248682|FG001|Overall Study|Proceeded to stem cell transplant|0|||
94399421|NCT02011945|323248683|FG002|Overall Study|Proceeded to stem cell transplant|1|||
94399422|NCT02011945|323248681|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
94399423|NCT02011945|323248682|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
94399424|NCT02011945|323248683|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
94399425|NCT01566435|323248684|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
94399426|NCT02286466|323248685|FG000|Overall Study|Death|1|||
94399427|NCT02286466|323248686|FG001|Overall Study|Death|3|||
94399428|NCT02286466|323248685|FG000|Overall Study|Withdrawal by Subject|5|||
94399429|NCT02286466|323248686|FG001|Overall Study|Withdrawal by Subject|2|||
94399430|NCT02286466|323248685|FG000|Overall Study|Lost to Follow-up|1|||
94399431|NCT02286466|323248686|FG001|Overall Study|Lost to Follow-up|4|||
94399432|NCT02286466|323248685|FG000|Overall Study|Declined Clinician Assessment|0|||
94399433|NCT02286466|323248686|FG001|Overall Study|Declined Clinician Assessment|1|||
94399434|NCT03599193|323250689|FG000|Overall Study|Adverse Event|0|||
94399435|NCT03599193|323250690|FG001|Overall Study|Adverse Event|2|||
94399436|NCT03599193|323250689|FG000|Overall Study|Withdrawal by Subject|1|||
94399437|NCT03599193|323250690|FG001|Overall Study|Withdrawal by Subject|0|||
94399438|NCT03599193|323250689|FG000|Overall Study|Protocol Violation|1|||
94399439|NCT03599193|323250690|FG001|Overall Study|Protocol Violation|0|||
94399440|NCT03599193|323250689|FG000|Overall Study|Lost to Follow-up|0|||
94399441|NCT03599193|323250690|FG001|Overall Study|Lost to Follow-up|1|||
94399442|NCT00516295|323250691|FG000|Overall Study|Lack of Efficacy|2|||
94399443|NCT00516295|323250692|FG001|Overall Study|Lack of Efficacy|0|||
94399444|NCT00516295|323250693|FG002|Overall Study|Lack of Efficacy|0|||
94399445|NCT00516295|323250691|FG000|Overall Study|Ineligible|1|||
94399446|NCT00516295|323250692|FG001|Overall Study|Ineligible|0|||
94399447|NCT00516295|323250693|FG002|Overall Study|Ineligible|0|||
94399448|NCT02034513|323250694|FG000|Overall Study|Adverse Event|11|||
94399449|NCT02034513|323250695|FG001|Overall Study|Adverse Event|10|||
94399450|NCT02034513|323250694|FG000|Overall Study|Lack of Efficacy|0|||
94399451|NCT02034513|323250695|FG001|Overall Study|Lack of Efficacy|1|||
94399452|NCT02034513|323250694|FG000|Overall Study|Lost to Follow-up|6|||
94399453|NCT02034513|323250695|FG001|Overall Study|Lost to Follow-up|7|||
94399454|NCT02034513|323250694|FG000|Overall Study|Pregnancy|0|||
94399455|NCT02034513|323250695|FG001|Overall Study|Pregnancy|3|||
94399456|NCT02034513|323250694|FG000|Overall Study|Protocol Violation|7|||
94399457|NCT02034513|323250695|FG001|Overall Study|Protocol Violation|10|||
94399458|NCT02034513|323250694|FG000|Overall Study|Withdrawal by Subject|25|||
94399459|NCT02034513|323250695|FG001|Overall Study|Withdrawal by Subject|25|||
94399460|NCT02034513|323250694|FG000|Overall Study|Unclassified|0|||
94399461|NCT02034513|323250695|FG001|Overall Study|Unclassified|1|||
94484925|NCT02717195|323567602|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
94399462|NCT01243151|323250696|FG000|Overall Study|Adverse Event|0|||
94399463|NCT01243151|323250697|FG001|Overall Study|Adverse Event|1|||
94484926|NCT02717195|323567603|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
94399464|NCT01243151|323250698|FG002|Overall Study|Adverse Event|0|||
94399465|NCT01243151|323250699|FG003|Overall Study|Adverse Event|0|||
94399466|NCT01243151|323250700|FG004|Overall Study|Adverse Event|0|||
94399467|NCT01243151|323250696|FG000|Overall Study|Protocol Violation|0|||
94399468|NCT01243151|323250697|FG001|Overall Study|Protocol Violation|0|||
94399469|NCT01243151|323250698|FG002|Overall Study|Protocol Violation|1|||
94399470|NCT01243151|323250699|FG003|Overall Study|Protocol Violation|0|||
94399471|NCT01243151|323250700|FG004|Overall Study|Protocol Violation|0|||
94484927|NCT02717195|323567604|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
94484928|NCT02717195|323567605|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
94484929|NCT02717195|323567606|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
94484930|NCT02717195|323567602|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
94484931|NCT02717195|323567603|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
94484932|NCT02717195|323567604|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
94484933|NCT02717195|323567605|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
94484934|NCT02717195|323567606|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
94484935|NCT02717195|323567602|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
94484936|NCT02717195|323567603|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
94484937|NCT02717195|323567604|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
94484938|NCT02717195|323567605|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
94484939|NCT02717195|323567606|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
94484940|NCT02717195|323567602|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
94484941|NCT02717195|323567603|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
94484942|NCT02717195|323567604|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
94484943|NCT02717195|323567605|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
94484944|NCT02717195|323567606|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
94484945|NCT02717195|323567602|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
94484946|NCT02717195|323567603|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
94399472|NCT01243151|323250696|FG000|Overall Study|Other|0|||
94399473|NCT01243151|323250697|FG001|Overall Study|Other|0|||
94399474|NCT01243151|323250698|FG002|Overall Study|Other|0|||
94399475|NCT01243151|323250699|FG003|Overall Study|Other|1|||
94399476|NCT01243151|323250700|FG004|Overall Study|Other|0|||
94399477|NCT01243151|323250696|FG000|Overall Study|Randomized but not treated|0|||
94399478|NCT01243151|323250697|FG001|Overall Study|Randomized but not treated|0|||
94399479|NCT01243151|323250698|FG002|Overall Study|Randomized but not treated|0|||
94399480|NCT01243151|323250699|FG003|Overall Study|Randomized but not treated|1|||
94399481|NCT01243151|323250700|FG004|Overall Study|Randomized but not treated|0|||
94399482|NCT03086460|323250701|FG000|Study Participants|Lost to Follow-up|2|||
94399483|NCT03086460|323250701|FG000|Study Participants|Protocol Violation|1|||
94399484|NCT03086460|323250701|FG000|Study Participants|Withdrawal by Subject|6|||
94399485|NCT03086460|323250701|FG000|Treatment A|Lost to Follow-up|1|||
94399486|NCT03086460|323250701|FG000|Treatment A|Protocol Violation|1|||
94399487|NCT03086460|323250701|FG000|Treatment A|Withdrawal by Subject|2|||
94399488|NCT03086460|323250701|FG000|Treatment C|Withdrawal by Subject|2|||
94399489|NCT03086460|323250701|FG000|Treatment E|Lost to Follow-up|1|||
94399490|NCT03086460|323250701|FG000|Treatment E|Withdrawal by Subject|3|||
94399491|NCT03246503|323250711|FG000|Overall Study|Lost to Follow-up|23|||
94399492|NCT03246503|323250711|FG000|Overall Study|Withdrawal by Subject|20|||
94399493|NCT03246503|323250711|FG000|Overall Study|Physician Decision|5|||
94399494|NCT03246503|323250711|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
94399495|NCT01896934|323250712|FG000|Overall Study|Adverse Event|1|||
94399496|NCT01896934|323250712|FG000|Overall Study|Withdrawal by Subject|1|||
94399497|NCT03206749|323250713|FG000|Overall Study|Withdrawal of consent|5|||
94399498|NCT03206749|323250714|FG001|Overall Study|Withdrawal of consent|3|||
94399499|NCT03206749|323250715|FG002|Overall Study|Withdrawal of consent|6|||
94399500|NCT03206749|323250713|FG000|Overall Study|Lost to Follow-up|0|||
94399501|NCT03206749|323250714|FG001|Overall Study|Lost to Follow-up|0|||
94399502|NCT03206749|323250715|FG002|Overall Study|Lost to Follow-up|1|||
94399503|NCT04590027|323250716|FG000|Overall Study|Lost to Follow-up|17|||
94399504|NCT04590027|323250717|FG001|Overall Study|Lost to Follow-up|14|||
94399505|NCT04590027|323250716|FG000|Overall Study|Protocol Violation|0|||
94399506|NCT04590027|323250717|FG001|Overall Study|Protocol Violation|3|||
94399507|NCT02699866|323250718|FG000|Overall Study|Withdrawal by Subject|3|||
94399508|NCT02699866|323250718|FG000|Overall Study|Physician Decision|2|||
94399509|NCT02699866|323250718|FG000|Overall Study|Adverse Event|3|||
94399510|NCT01572662|323250719|FG000|Overall Study|Withdrawal by Subject|1|||
94399511|NCT01572662|323250720|FG001|Overall Study|Withdrawal by Subject|0|||
94399512|NCT01572662|323250719|FG000|Overall Study|Physician Decision|0|||
94399513|NCT01572662|323250720|FG001|Overall Study|Physician Decision|1|||
94399514|NCT02043132|323250724|FG000|Overall Study|Lost to Follow-up|1|||
94399515|NCT02043132|323250725|FG001|Overall Study|Lost to Follow-up|1|||
94399516|NCT02043132|323250724|FG000|Overall Study|screen failures|4|||
94399517|NCT02043132|323250725|FG001|Overall Study|screen failures|8|||
94399518|NCT04474405|323250726|FG000|Overall Study|Withdrawal by Subject|0|||
94399519|NCT04474405|323250727|FG001|Overall Study|Withdrawal by Subject|0|||
94399520|NCT04474405|323250728|FG002|Overall Study|Withdrawal by Subject|1|||
94399521|NCT04474405|323250729|FG003|Overall Study|Withdrawal by Subject|0|||
94399522|NCT04474405|323250730|FG004|Overall Study|Withdrawal by Subject|1|||
94399523|NCT04474405|323250731|FG005|Overall Study|Withdrawal by Subject|0|||
94399524|NCT04474405|323250726|FG000|Overall Study|Other|0|||
94399525|NCT04474405|323250727|FG001|Overall Study|Other|0|||
94399526|NCT04474405|323250728|FG002|Overall Study|Other|0|||
94399527|NCT04474405|323250729|FG003|Overall Study|Other|0|||
94399528|NCT04474405|323250730|FG004|Overall Study|Other|3|||
94399529|NCT04474405|323250731|FG005|Overall Study|Other|0|||
94399530|NCT03599362|323250732|FG000|Overall Study|Screen Failure|3|||
94399531|NCT04547192|323250733|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
94484947|NCT02717195|323567604|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
94399532|NCT04547192|323250734|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
94399533|NCT04547192|323250735|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
94399534|NCT04547192|323250736|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
94399535|NCT04547192|323250733|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
94399536|NCT04547192|323250734|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
94399537|NCT04547192|323250735|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
94399538|NCT04547192|323250736|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
94399539|NCT04547192|323250733|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
94399540|NCT04547192|323250734|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
94399541|NCT04547192|323250735|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
94399542|NCT04547192|323250736|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
94399543|NCT04547192|323250733|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
94399544|NCT04547192|323250734|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
94399545|NCT04547192|323250735|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
94399546|NCT04547192|323250736|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
94399547|NCT04547192|323250733|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
94399548|NCT04547192|323250734|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
94399549|NCT04547192|323250735|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
94399550|NCT04547192|323250736|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
94399551|NCT03827395|323250737|FG000|Overall Study|Lost to Follow-up|1|||
94399552|NCT03827395|323250738|FG001|Overall Study|Lost to Follow-up|0|||
94399553|NCT03827395|323250737|FG000|Overall Study|Protocol Violation|1|||
94399554|NCT03827395|323250738|FG001|Overall Study|Protocol Violation|0|||
94399555|NCT03827395|323250737|FG000|Overall Study|Became ineligible after enrollment|1|||
94399556|NCT03827395|323250738|FG001|Overall Study|Became ineligible after enrollment|2|||
94399557|NCT01370083|323250740|FG000|Overall Study|Lost to Follow-up|2|||
94399558|NCT01370083|323250741|FG001|Overall Study|Lost to Follow-up|0|||
94484948|NCT02717195|323567605|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
94484949|NCT02717195|323567606|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
94484950|NCT02033759|323567607|FG000|Overall Study|Withdrawal by Subject|2|||
94484951|NCT02033759|323567608|FG001|Overall Study|Withdrawal by Subject|1|||
94484952|NCT02033759|323567607|FG000|Overall Study|Protocol Violation|1|||
94484953|NCT02033759|323567608|FG001|Overall Study|Protocol Violation|1|||
94484954|NCT00764790|323567610|FG000|Overall Study|Protocol Violation|0|||
94484955|NCT00764790|323567611|FG001|Overall Study|Protocol Violation|0|||
94484956|NCT00764790|323567612|FG002|Overall Study|Protocol Violation|1|||
94484957|NCT00764790|323567610|FG000|Overall Study|Withdrawal by Subject|10|||
94484958|NCT00764790|323567611|FG001|Overall Study|Withdrawal by Subject|12|||
94484959|NCT00764790|323567612|FG002|Overall Study|Withdrawal by Subject|6|||
94399559|NCT01370083|323250740|FG000|Overall Study|Adverse Event|0|||
94399560|NCT01370083|323250741|FG001|Overall Study|Adverse Event|1|||
94399561|NCT00731939|323250747|FG000|Overall Study|Adverse Event|6|||
94399562|NCT00731939|323250747|FG000|Overall Study|Lost to Follow-up|15|||
94399563|NCT00731939|323250747|FG000|Overall Study|Not implanted with study device|9|||
94399564|NCT00731939|323250747|FG000|Overall Study|Withdrawal by Subject|2|||
94399565|NCT00731939|323250747|FG000|Overall Study|Did not meet enrollment criteria|2|||
94399566|NCT00574847|323250771|FG000|Overall Study|Adverse Event|2|||
94399567|NCT00574847|323250772|FG001|Overall Study|Adverse Event|0|||
94399568|NCT00574847|323250771|FG000|Overall Study|Death|1|||
94399569|NCT00574847|323250772|FG001|Overall Study|Death|0|||
94399570|NCT00574847|323250771|FG000|Overall Study|Withdrawal by Subject|2|||
94399571|NCT00574847|323250772|FG001|Overall Study|Withdrawal by Subject|2|||
94399572|NCT00574847|323250771|FG000|Overall Study|Physician Decision|1|||
94399573|NCT00574847|323250772|FG001|Overall Study|Physician Decision|0|||
94399574|NCT00574847|323250771|FG000|Overall Study|Did not receive medication (declined)|2|||
94399575|NCT00574847|323250772|FG001|Overall Study|Did not receive medication (declined)|5|||
94399576|NCT00881751|323250775|FG000|Overall Study|Physician Decision|0|||
94484960|NCT00764790|323567610|FG000|Overall Study|Lost to Follow-up|28|||
94484961|NCT00764790|323567611|FG001|Overall Study|Lost to Follow-up|29|||
94484962|NCT00764790|323567612|FG002|Overall Study|Lost to Follow-up|23|||
94399577|NCT00881751|323250776|FG001|Overall Study|Physician Decision|1|||
94399578|NCT00881751|323250775|FG000|Overall Study|Adverse Event|0|||
94399579|NCT00881751|323250776|FG001|Overall Study|Adverse Event|2|||
94399580|NCT00881751|323250775|FG000|Overall Study|Withdrawal by Subject|0|||
94399581|NCT00881751|323250776|FG001|Overall Study|Withdrawal by Subject|2|||
94399582|NCT02385708|323250777|FG000|Overall Study|Withdrawal by Subject|0|||
94399583|NCT02385708|323250778|FG001|Overall Study|Withdrawal by Subject|2|||
94484963|NCT03533751|323567616|FG000|Overall Study|Withdrawal by Subject|12|||
94484964|NCT03533751|323567617|FG001|Overall Study|Withdrawal by Subject|6|||
94399584|NCT02385708|323250777|FG000|Overall Study|Withdrawn - surgery canceled|2|||
94399585|NCT02385708|323250778|FG001|Overall Study|Withdrawn - surgery canceled|5|||
94399586|NCT02385708|323250777|FG000|Overall Study|Investigator decision|5|||
94399587|NCT02385708|323250778|FG001|Overall Study|Investigator decision|7|||
94399588|NCT02385708|323250777|FG000|Overall Study|Protocol Violation|1|||
94399589|NCT02385708|323250778|FG001|Overall Study|Protocol Violation|1|||
94399590|NCT01143337|323250779|FG000|Overall Study|Adverse Event|3|||
94399591|NCT01143337|323250780|FG001|Overall Study|Adverse Event|9|||
94399592|NCT01143337|323250781|FG002|Overall Study|Adverse Event|5|||
94399593|NCT01143337|323250779|FG000|Overall Study|Lack of Efficacy|6|||
94399594|NCT01143337|323250780|FG001|Overall Study|Lack of Efficacy|2|||
94399595|NCT01143337|323250781|FG002|Overall Study|Lack of Efficacy|1|||
94399596|NCT01143337|323250779|FG000|Overall Study|Protocol Violation|1|||
94399597|NCT01143337|323250780|FG001|Overall Study|Protocol Violation|0|||
94399598|NCT01143337|323250781|FG002|Overall Study|Protocol Violation|0|||
94399599|NCT01143337|323250779|FG000|Overall Study|Withdrawal by Subject|0|||
94399600|NCT01143337|323250780|FG001|Overall Study|Withdrawal by Subject|0|||
94399601|NCT01143337|323250781|FG002|Overall Study|Withdrawal by Subject|1|||
94399602|NCT01143337|323250779|FG000|Overall Study|Other reason|0|||
94399603|NCT01143337|323250780|FG001|Overall Study|Other reason|0|||
94399604|NCT01143337|323250781|FG002|Overall Study|Other reason|5|||
94399605|NCT02471807|323250787|FG000|Overall Study|Death|14|||
94399606|NCT02471807|323250787|FG000|Overall Study|Withdrawal by Subject|2|||
94399607|NCT02471807|323250787|FG000|Overall Study|Explant|5|||
94399608|NCT02471807|323250787|FG000|Overall Study|Lost to Follow-up|1|||
94399609|NCT00487435|323250788|FG000|Overall Study|Adverse Event|146|||
94399610|NCT00487435|323250788|FG000|Overall Study|Death|2|||
94399611|NCT00487435|323250788|FG000|Overall Study|Lack of Efficacy|33|||
94399612|NCT00487435|323250788|FG000|Overall Study|Lost to Follow-up|54|||
94399613|NCT00487435|323250788|FG000|Overall Study|Pregnancy|2|||
94399614|NCT00487435|323250788|FG000|Overall Study|Withdrawal by Subject|132|||
94399615|NCT00487435|323250788|FG000|Overall Study|Resolution Of Pain|1|||
94399616|NCT00487435|323250788|FG000|Overall Study|Study Medication Non-Compliant|32|||
94399617|NCT00487435|323250788|FG000|Overall Study|Other|83|||
94399618|NCT03255980|323250789|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
94399619|NCT03255980|323250790|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
94399620|NCT03255980|323250791|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
94399621|NCT03255980|323250792|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
94399622|NCT03255980|323250789|FG000|Overall Study|Adverse Event|1|||
94399623|NCT03255980|323250790|FG001|Overall Study|Adverse Event|1|||
94399624|NCT03255980|323250791|FG002|Overall Study|Adverse Event|0|||
94399625|NCT03255980|323250792|FG003|Overall Study|Adverse Event|1|||
94399626|NCT03255980|323250789|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
94399627|NCT03255980|323250790|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
94399628|NCT03255980|323250791|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
94399629|NCT03255980|323250792|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
94399630|NCT03255980|323250789|FG000|Overall Study|Lost to Follow-up|1|||
94399631|NCT03255980|323250790|FG001|Overall Study|Lost to Follow-up|1|||
94399632|NCT03255980|323250791|FG002|Overall Study|Lost to Follow-up|0|||
94399633|NCT03255980|323250792|FG003|Overall Study|Lost to Follow-up|3|||
94399634|NCT03255980|323250789|FG000|Overall Study|Withdrawal by Subject|0|||
94399635|NCT03255980|323250790|FG001|Overall Study|Withdrawal by Subject|1|||
94399636|NCT03255980|323250791|FG002|Overall Study|Withdrawal by Subject|0|||
94399637|NCT03255980|323250792|FG003|Overall Study|Withdrawal by Subject|3|||
94399638|NCT04025021|323250793|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
94399639|NCT04025021|323250794|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
94399640|NCT01986647|323250795|FG000|Overall Study|Lost to Follow-up|4|||
94399641|NCT01986647|323250796|FG001|Overall Study|Lost to Follow-up|1|||
94399642|NCT01986647|323250797|FG002|Overall Study|Lost to Follow-up|4|||
94399643|NCT01986647|323250798|FG003|Overall Study|Lost to Follow-up|4|||
94399644|NCT01986647|323250795|FG000|Overall Study|Withdrawal by Subject|1|||
94399645|NCT01986647|323250796|FG001|Overall Study|Withdrawal by Subject|3|||
94399646|NCT01986647|323250797|FG002|Overall Study|Withdrawal by Subject|2|||
94399647|NCT01986647|323250798|FG003|Overall Study|Withdrawal by Subject|3|||
94399648|NCT01986647|323250795|FG000|Overall Study|Health|5|||
94399649|NCT01986647|323250796|FG001|Overall Study|Health|3|||
94399650|NCT01986647|323250797|FG002|Overall Study|Health|6|||
94399651|NCT01986647|323250798|FG003|Overall Study|Health|4|||
94399652|NCT00868998|323250799|FG000|Overall Study|Screen Failure|1|||
94399653|NCT00868998|323250799|FG000|Overall Study|Withdrawal by Subject|1|||
94399654|NCT00868998|323250799|FG000|Overall Study|Progression of disease|2|||
94399655|NCT00868998|323250799|FG000|Overall Study|Death|1|||
94399656|NCT00533507|323250801|FG000|Overall Study|Withdrawal by Subject|1|||
94399657|NCT01960296|323250802|FG000|Overall Study|Postponed surgery|1|||
94399658|NCT01960296|323250803|FG001|Overall Study|Postponed surgery|0|||
94399659|NCT01960296|323250802|FG000|Overall Study|Received different procedure|1|||
94399660|NCT01960296|323250803|FG001|Overall Study|Received different procedure|3|||
94399661|NCT02003391|323250804|FG000|Overall Study|Withdrawal by Subject|2|||
94399662|NCT02003391|323250805|FG001|Overall Study|Withdrawal by Subject|1|||
94399663|NCT02003391|323250804|FG000|Overall Study|Protocol Violation|0|||
94399664|NCT02003391|323250805|FG001|Overall Study|Protocol Violation|1|||
94399665|NCT02003391|323250804|FG000|Overall Study|Adverse Event|1|||
94399666|NCT02003391|323250805|FG001|Overall Study|Adverse Event|0|||
94399667|NCT01120028|323250809|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
94399668|NCT01120028|323250810|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
94399669|NCT01120028|323250811|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
94399670|NCT01120028|323250812|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
94399671|NCT01120028|323250809|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
94399672|NCT01120028|323250810|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
94399673|NCT01120028|323250811|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
94399674|NCT01120028|323250812|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
94399675|NCT02452463|323250815|FG000|Overall Study|Death|1|||
94399676|NCT02452463|323250816|FG001|Overall Study|Death|0|||
94399677|NCT02452463|323250817|FG002|Overall Study|Death|0|||
94399678|NCT02452463|323250815|FG000|Overall Study|Study Suspended|1|||
94399679|NCT02452463|323250816|FG001|Overall Study|Study Suspended|0|||
94399680|NCT02452463|323250817|FG002|Overall Study|Study Suspended|0|||
94399681|NCT02452463|323250815|FG000|Overall Study|Recommended by DSMB|0|||
94399682|NCT02452463|323250816|FG001|Overall Study|Recommended by DSMB|1|||
94399683|NCT02452463|323250817|FG002|Overall Study|Recommended by DSMB|0|||
94399684|NCT02452463|323250815|FG000|Overall Study|Withdrawal by Subject|0|||
94399685|NCT02452463|323250816|FG001|Overall Study|Withdrawal by Subject|1|||
94399686|NCT02452463|323250817|FG002|Overall Study|Withdrawal by Subject|0|||
94399687|NCT05740098|323250818|FG000|Overall Study|Lost to Follow-up|26|||
94399688|NCT05740098|323250819|FG001|Overall Study|Lost to Follow-up|17|||
94399689|NCT05740098|323250820|FG002|Overall Study|Lost to Follow-up|21|||
94399690|NCT00556673|323250821|FG000|Overall Study|Protocol deviation|3|||
94399691|NCT00556673|323250822|FG001|Overall Study|Protocol deviation|2|||
94399692|NCT01401062|323250823|FG000|Overall Study|Death|9|||
94399693|NCT01401062|323250824|FG001|Overall Study|Death|7|||
94399694|NCT01401062|323250823|FG000|Overall Study|Physician Decision|1|||
94399695|NCT01401062|323250824|FG001|Overall Study|Physician Decision|0|||
94399696|NCT01401062|323250823|FG000|Overall Study|Withdrawal by Subject|1|||
94399697|NCT01401062|323250824|FG001|Overall Study|Withdrawal by Subject|1|||
94399698|NCT01131260|323250825|FG000|Overall Study|Randomization error|5|||
94399699|NCT01131260|323250826|FG001|Overall Study|Randomization error|1|||
94399700|NCT01131260|323250825|FG000|Overall Study|Declined to continue participation|8|||
94399701|NCT01131260|323250826|FG001|Overall Study|Declined to continue participation|13|||
94399702|NCT01131260|323250825|FG000|Overall Study|Physician Decision|22|||
94399703|NCT01131260|323250826|FG001|Overall Study|Physician Decision|24|||
94399704|NCT01131260|323250825|FG000|Overall Study|Technical problems|7|||
94399705|NCT01131260|323250826|FG001|Overall Study|Technical problems|6|||
94399706|NCT01131260|323250825|FG000|Overall Study|Staff error|2|||
94399707|NCT01131260|323250826|FG001|Overall Study|Staff error|1|||
94399708|NCT01131260|323250825|FG000|Overall Study|Ineligible|0|||
94399709|NCT01131260|323250826|FG001|Overall Study|Ineligible|2|||
94399710|NCT01426854|323250827|FG000|Overall Study|Adverse Event|1|||
94399711|NCT01426854|323250828|FG001|Overall Study|Adverse Event|5|||
94399712|NCT01426854|323250827|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
94399713|NCT01426854|323250828|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
94399714|NCT01426854|323250827|FG000|Overall Study|Lost to Follow-up|3|||
94399715|NCT01426854|323250828|FG001|Overall Study|Lost to Follow-up|0|||
94399716|NCT01426854|323250827|FG000|Overall Study|Noncompliance|0|||
94399717|NCT01426854|323250828|FG001|Overall Study|Noncompliance|1|||
94399718|NCT01426854|323250827|FG000|Overall Study|Treatment Failure|0|||
94399719|NCT01426854|323250828|FG001|Overall Study|Treatment Failure|16|||
94399720|NCT01426854|323250827|FG000|Overall Study|Protocol Deviation|0|||
94399721|NCT01426854|323250828|FG001|Overall Study|Protocol Deviation|1|||
94399722|NCT01426854|323250827|FG000|Overall Study|Other|3|||
94399723|NCT01426854|323250828|FG001|Overall Study|Other|2|||
94399724|NCT01942135|323250832|FG000|Overall Study|Adverse Event|21|||
94399725|NCT01942135|323250833|FG001|Overall Study|Adverse Event|7|||
94399726|NCT01942135|323250832|FG000|Overall Study|Global Deterioration of Health Status|9|||
94399727|NCT01942135|323250833|FG001|Overall Study|Global Deterioration of Health Status|6|||
94399728|NCT01942135|323250832|FG000|Overall Study|Randomized Not Treated|2|||
94399729|NCT01942135|323250833|FG001|Overall Study|Randomized Not Treated|2|||
94399730|NCT01942135|323250832|FG000|Overall Study|Death|2|||
94399731|NCT01942135|323250833|FG001|Overall Study|Death|1|||
94399732|NCT01942135|323250832|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
94399733|NCT01942135|323250833|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
94399734|NCT01942135|323250832|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
94399735|NCT01942135|323250833|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
94399736|NCT01942135|323250832|FG000|Overall Study|Withdrawal by Subject|4|||
94399737|NCT01942135|323250833|FG001|Overall Study|Withdrawal by Subject|3|||
94399738|NCT01942135|323250832|FG000|Overall Study|Protocol Violation|1|||
94399739|NCT01942135|323250833|FG001|Overall Study|Protocol Violation|0|||
94399740|NCT01942135|323250832|FG000|Overall Study|Other|19|||
94399741|NCT01942135|323250833|FG001|Overall Study|Other|4|||
94399742|NCT03578809|323253051|FG000|Overall Study|Death|0|||
94399743|NCT03578809|323253052|FG001|Overall Study|Death|2|||
94399744|NCT03578809|323253053|FG002|Overall Study|Death|0|||
94399745|NCT03578809|323253054|FG003|Overall Study|Death|1|||
94399746|NCT03578809|323253051|FG000|Overall Study|Lost to Follow-up|0|||
94399747|NCT03578809|323253052|FG001|Overall Study|Lost to Follow-up|1|||
94399748|NCT03578809|323253053|FG002|Overall Study|Lost to Follow-up|0|||
94399749|NCT03578809|323253054|FG003|Overall Study|Lost to Follow-up|0|||
94399750|NCT03578809|323253051|FG000|Overall Study|Withdrawal by Subject|3|||
94399751|NCT03578809|323253052|FG001|Overall Study|Withdrawal by Subject|5|||
94399752|NCT03578809|323253053|FG002|Overall Study|Withdrawal by Subject|2|||
94399753|NCT03578809|323253054|FG003|Overall Study|Withdrawal by Subject|0|||
94399754|NCT03578809|323253051|FG000|Overall Study|Other|3|||
94399755|NCT03578809|323253052|FG001|Overall Study|Other|6|||
94399756|NCT03578809|323253053|FG002|Overall Study|Other|2|||
94399757|NCT03578809|323253054|FG003|Overall Study|Other|8|||
94399758|NCT00665925|323253055|FG000|Overall Study|Lack of Efficacy|10|||
94399759|NCT00665925|323253056|FG001|Overall Study|Lack of Efficacy|8|||
94399760|NCT00665925|323253057|FG002|Overall Study|Lack of Efficacy|9|||
94399761|NCT00665925|323253058|FG003|Overall Study|Lack of Efficacy|8|||
94399762|NCT00665925|323253055|FG000|Overall Study|Lost to Follow-up|1|||
94399763|NCT00665925|323253056|FG001|Overall Study|Lost to Follow-up|2|||
94399764|NCT00665925|323253057|FG002|Overall Study|Lost to Follow-up|2|||
94399765|NCT00665925|323253058|FG003|Overall Study|Lost to Follow-up|2|||
94399766|NCT00665925|323253055|FG000|Overall Study|Withdrawal by Subject|2|||
94399767|NCT00665925|323253056|FG001|Overall Study|Withdrawal by Subject|2|||
94399768|NCT00665925|323253057|FG002|Overall Study|Withdrawal by Subject|3|||
94399769|NCT00665925|323253058|FG003|Overall Study|Withdrawal by Subject|2|||
94399770|NCT00665925|323253055|FG000|Overall Study|Physician Decision|0|||
94399771|NCT00665925|323253056|FG001|Overall Study|Physician Decision|0|||
94399772|NCT00665925|323253057|FG002|Overall Study|Physician Decision|1|||
94399773|NCT00665925|323253058|FG003|Overall Study|Physician Decision|2|||
94399774|NCT00665925|323253055|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
94399775|NCT00665925|323253056|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
94399776|NCT00665925|323253057|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
94399777|NCT00665925|323253058|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
94399778|NCT00665925|323253055|FG000|Overall Study|Adverse Event|1|||
94399779|NCT00665925|323253056|FG001|Overall Study|Adverse Event|5|||
94399780|NCT00665925|323253057|FG002|Overall Study|Adverse Event|10|||
94399781|NCT00665925|323253058|FG003|Overall Study|Adverse Event|5|||
94399782|NCT00665925|323253055|FG000|Overall Study|Enrolled by mistake|0|||
94399783|NCT00665925|323253056|FG001|Overall Study|Enrolled by mistake|0|||
94399784|NCT00665925|323253057|FG002|Overall Study|Enrolled by mistake|0|||
94399785|NCT00665925|323253058|FG003|Overall Study|Enrolled by mistake|1|||
94399786|NCT00665925|323253055|FG000|Overall Study|Due to exclusion criteria|1|||
94399787|NCT00665925|323253056|FG001|Overall Study|Due to exclusion criteria|0|||
94399788|NCT00665925|323253057|FG002|Overall Study|Due to exclusion criteria|0|||
94399789|NCT00665925|323253058|FG003|Overall Study|Due to exclusion criteria|0|||
94399790|NCT01490190|323253061|FG000|Overall Study|Withdrawal by Subject|9|||
94399791|NCT01490190|323253061|FG000|Overall Study|Adverse Event|17|||
94399792|NCT01490190|323253061|FG000|Overall Study|Protocol Violation|5|||
94399793|NCT01490190|323253061|FG000|Overall Study|Lost to Follow-up|13|||
94399794|NCT01490190|323253061|FG000|Overall Study|Relocation|1|||
94399795|NCT01490190|323253061|FG000|Overall Study|Inconvenience|1|||
94399796|NCT01490190|323253061|FG000|Overall Study|Ring expulsion|2|||
94399797|NCT03234907|323253062|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
94399798|NCT03234907|323253063|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
94399799|NCT03234907|323253064|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
94399800|NCT03234907|323253065|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
94399801|NCT03234907|323253066|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
94399802|NCT03234907|323253067|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
94399803|NCT03234907|323253062|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
94399804|NCT03234907|323253063|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
94399805|NCT03234907|323253064|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
94399806|NCT03234907|323253065|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
94399807|NCT03234907|323253066|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
94399808|NCT03234907|323253067|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
94399809|NCT03234907|323253062|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
94399810|NCT03234907|323253063|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
94399811|NCT03234907|323253064|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
94399812|NCT03234907|323253065|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
94399813|NCT03234907|323253066|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
94399814|NCT03234907|323253067|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
94399815|NCT03234907|323253062|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
94399816|NCT03234907|323253063|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
94399817|NCT03234907|323253064|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
94399818|NCT03234907|323253065|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
94399819|NCT03234907|323253066|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
94399820|NCT03234907|323253067|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
94399821|NCT03234907|323253062|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
94399822|NCT03234907|323253063|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
94399823|NCT03234907|323253064|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
94399824|NCT03234907|323253065|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
94399825|NCT03234907|323253066|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
94399826|NCT03234907|323253067|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
94399827|NCT03234907|323253062|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
94399828|NCT03234907|323253063|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
94399829|NCT03234907|323253064|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
94399830|NCT03234907|323253065|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
94399831|NCT03234907|323253066|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
94399832|NCT03234907|323253067|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
94399833|NCT03234907|323253062|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
94399834|NCT03234907|323253063|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
94399835|NCT03234907|323253064|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
94399836|NCT03234907|323253065|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
94399837|NCT03234907|323253066|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
94399838|NCT03234907|323253067|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
94399839|NCT01376037|323253070|FG000|Overall Study|Lost to Follow-up|0|||
94399840|NCT01376037|323253071|FG001|Overall Study|Lost to Follow-up|2|||
94399841|NCT02664415|323253072|FG000|Overall Study|Adverse Event|1|||
94399842|NCT02664415|323253073|FG001|Overall Study|Adverse Event|0|||
94399843|NCT00642993|323253074|FG000|Overall Study|Adverse Event|85|||
94399844|NCT00642993|323253075|FG001|Overall Study|Adverse Event|4|||
94399845|NCT00642993|323253074|FG000|Overall Study|Lost to Follow-up|8|||
94399846|NCT00642993|323253075|FG001|Overall Study|Lost to Follow-up|4|||
94399847|NCT00642993|323253074|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
94399848|NCT00642993|323253075|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
94399849|NCT00642993|323253074|FG000|Overall Study|Protocol Violation|1|||
94399850|NCT00642993|323253075|FG001|Overall Study|Protocol Violation|4|||
94399851|NCT00642993|323253074|FG000|Overall Study|Did not meet protocol eligibility|0|||
94399852|NCT00642993|323253075|FG001|Overall Study|Did not meet protocol eligibility|1|||
94399853|NCT00642993|323253074|FG000|Overall Study|Administrative|1|||
94399854|NCT00642993|323253075|FG001|Overall Study|Administrative|0|||
94399855|NCT01624233|323253080|FG000|Period 2 - Induction|Adverse Event|1|||
94399856|NCT01624233|323253080|FG000|Period 3 - Maintenance|Adverse Event|2|||
94399857|NCT01624233|323253080|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
94399858|NCT01624233|323253080|FG000|Period 3 - Maintenance|Physician Decision|2|||
94399859|NCT01624233|323253080|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
94399860|NCT01624233|323253080|FG000|Period 4 - Drug Free Period|Relapsed|61|||
94399861|NCT01624233|323253080|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
94399862|NCT01624233|323253080|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
94399863|NCT01624233|323253080|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
94399864|NCT01624233|323253080|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
94399865|NCT01624233|323253080|FG000|Period 6: Follow-up|Adverse Event|3|||
94399866|NCT01624233|323253080|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
94399867|NCT01624233|323253080|FG000|Period 6: Follow-up|Physician Decision|1|||
94399868|NCT01624233|323253080|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
94399869|NCT02986139|323253084|FG000|Overall Study|Sponsor Decision|1|||
94399870|NCT02986139|323253085|FG001|Overall Study|Sponsor Decision|2|||
94399871|NCT02986139|323253084|FG000|Overall Study|Withdrawal by Subject|0|||
94399872|NCT02986139|323253085|FG001|Overall Study|Withdrawal by Subject|1|||
94399873|NCT02986139|323253084|FG000|Overall Study|Lost to Follow-up|0|||
94399874|NCT02986139|323253085|FG001|Overall Study|Lost to Follow-up|1|||
94399875|NCT02583048|323253086|FG000|Overall Study|Withdrawal by Subject|0|||
94399876|NCT02583048|323253087|FG001|Overall Study|Withdrawal by Subject|1|||
94399877|NCT02583048|323253088|FG002|Overall Study|Withdrawal by Subject|0|||
94399878|NCT02583048|323253086|FG000|Overall Study|Failed to meet eligibility criterion|0|||
94484965|NCT03533751|323567618|FG002|Overall Study|Withdrawal by Subject|11|||
94399879|NCT02583048|323253087|FG001|Overall Study|Failed to meet eligibility criterion|0|||
94399880|NCT02583048|323253088|FG002|Overall Study|Failed to meet eligibility criterion|1|||
94399881|NCT00414726|323253089|FG000|Overall Study|Withdrawal by Subject|0|||
94399882|NCT00414726|323253090|FG001|Overall Study|Withdrawal by Subject|1|||
94399883|NCT00757705|323253091|FG000|Overall Study|Adverse Event|19|||
94399884|NCT00757705|323253091|FG000|Overall Study|Lost to Follow-up|16|||
94399885|NCT00757705|323253091|FG000|Overall Study|Withdrawal by Subject|25|||
94399886|NCT00757705|323253091|FG000|Overall Study|Insufficient Response|26|||
94399887|NCT00757705|323253091|FG000|Overall Study|Ineligible to continue|8|||
94399888|NCT00757705|323253091|FG000|Overall Study|Non-compliant|9|||
94399889|NCT00757705|323253091|FG000|Overall Study|Other|18|||
94399890|NCT02751424|323253097|FG000|Part 2|Adverse Event|0|||
94399891|NCT02751424|323253098|FG001|Part 2|Adverse Event|0|||
94399892|NCT02751424|323253099|FG002|Part 2|Adverse Event|0|||
94399893|NCT02751424|323253100|FG003|Part 2|Adverse Event|0|||
94399894|NCT02751424|323253101|FG004|Part 2|Adverse Event|0|||
94399895|NCT02751424|323253102|FG005|Part 2|Adverse Event|0|||
94399896|NCT02751424|323253103|FG006|Part 2|Adverse Event|0|||
94399897|NCT02751424|323253104|FG007|Part 2|Adverse Event|5|||
94399898|NCT02751424|323253105|FG008|Part 2|Adverse Event|0|||
94399899|NCT00635648|323253109|FG000|Overall Study|Adverse Event|12|||
94399900|NCT00635648|323253109|FG000|Overall Study|Withdrawal by Subject|9|||
94399901|NCT00635648|323253109|FG000|Overall Study|Physician Decision|4|||
94399902|NCT00635648|323253109|FG000|Overall Study|Rapid progression of baseline disease|4|||
94399903|NCT00635648|323253109|FG000|Overall Study|Use of other antifungal agent needed|1|||
94399904|NCT00635648|323253109|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
94399905|NCT00635648|323253109|FG000|Overall Study|Noncompliance with protocol|1|||
94399906|NCT00635648|323253109|FG000|Overall Study|Other reason|2|||
94399907|NCT03707587|323253110|FG000|Overall Study|Death|0|||
94399908|NCT03707587|323253111|FG001|Overall Study|Death|1|||
94399909|NCT01537887|323253112|FG000|Period 1|Physician Decision|0|||
94399910|NCT01537887|323253113|FG001|Period 1|Physician Decision|0|||
94399911|NCT01537887|323253114|FG002|Period 1|Physician Decision|0|||
94399912|NCT01537887|323253115|FG003|Period 1|Physician Decision|0|||
94399913|NCT01537887|323253116|FG004|Period 1|Physician Decision|1|||
94399914|NCT01537887|323253117|FG005|Period 1|Physician Decision|1|||
94399915|NCT01537887|323253112|FG000|Period 1|Did not receive treatment|0|||
94399916|NCT01537887|323253113|FG001|Period 1|Did not receive treatment|0|||
94399917|NCT01537887|323253114|FG002|Period 1|Did not receive treatment|1|||
94399918|NCT01537887|323253115|FG003|Period 1|Did not receive treatment|0|||
94399919|NCT01537887|323253116|FG004|Period 1|Did not receive treatment|0|||
94399920|NCT01537887|323253117|FG005|Period 1|Did not receive treatment|0|||
94399921|NCT01537887|323253112|FG000|Period 2|Withdrawal by Subject|0|||
94399922|NCT01537887|323253113|FG001|Period 2|Withdrawal by Subject|1|||
94399923|NCT01537887|323253114|FG002|Period 2|Withdrawal by Subject|0|||
94399924|NCT01537887|323253115|FG003|Period 2|Withdrawal by Subject|0|||
94399925|NCT01537887|323253116|FG004|Period 2|Withdrawal by Subject|0|||
94399926|NCT01537887|323253117|FG005|Period 2|Withdrawal by Subject|0|||
94399927|NCT01537887|323253112|FG000|Period 3|Adverse Event|0|||
94399928|NCT01537887|323253113|FG001|Period 3|Adverse Event|0|||
94399929|NCT01537887|323253114|FG002|Period 3|Adverse Event|1|||
94399930|NCT01537887|323253115|FG003|Period 3|Adverse Event|0|||
94399931|NCT01537887|323253116|FG004|Period 3|Adverse Event|0|||
94399932|NCT01537887|323253117|FG005|Period 3|Adverse Event|0|||
94399933|NCT01537887|323253112|FG000|Period 3|Withdrawal by Subject|0|||
94399934|NCT01537887|323253113|FG001|Period 3|Withdrawal by Subject|1|||
94399935|NCT01537887|323253114|FG002|Period 3|Withdrawal by Subject|0|||
94399936|NCT01537887|323253115|FG003|Period 3|Withdrawal by Subject|0|||
94399937|NCT01537887|323253116|FG004|Period 3|Withdrawal by Subject|0|||
94399938|NCT01537887|323253117|FG005|Period 3|Withdrawal by Subject|0|||
94399939|NCT00540423|323253120|FG000|Double-Blind Treatment Period|Adverse Event|0|||
94399940|NCT00540423|323253121|FG001|Double-Blind Treatment Period|Adverse Event|1|||
94399941|NCT00540423|323253122|FG002|Double-Blind Treatment Period|Adverse Event|0|||
94399942|NCT00540423|323253120|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
94399943|NCT00540423|323253121|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
94399944|NCT00540423|323253122|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
94399945|NCT03158727|323253127|FG000|Overall Study|Withdrawal by Subject|2|||
94399946|NCT03158727|323253128|FG001|Overall Study|Withdrawal by Subject|6|||
94399947|NCT03158727|323253127|FG000|Overall Study|Death|11|||
94399948|NCT03158727|323253128|FG001|Overall Study|Death|12|||
94399949|NCT03158727|323253127|FG000|Overall Study|Lost to Follow-up|1|||
94399950|NCT03158727|323253128|FG001|Overall Study|Lost to Follow-up|0|||
94399951|NCT03158727|323253127|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
94399952|NCT03158727|323253128|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
94399953|NCT03158727|323253127|FG000|Overall Study|Visit 11 not done by mistake|0|||
94399954|NCT03158727|323253128|FG001|Overall Study|Visit 11 not done by mistake|1|||
94399955|NCT03158727|323253127|FG000|Overall Study|Enrolled, not treated|1|||
94399956|NCT03158727|323253128|FG001|Overall Study|Enrolled, not treated|0|||
94399957|NCT00205777|323253129|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
94399958|NCT00205777|323253130|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
94399959|NCT00205777|323253131|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
94399960|NCT00205777|323253132|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
94399961|NCT00205777|323253133|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
94399962|NCT00205777|323253134|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
94399963|NCT00205777|323253129|FG000|Core Study (Up to 3 Years)|Death|9|||
94399964|NCT00205777|323253130|FG001|Core Study (Up to 3 Years)|Death|7|||
94399965|NCT00205777|323253131|FG002|Core Study (Up to 3 Years)|Death|14|||
94399966|NCT00205777|323253132|FG003|Core Study (Up to 3 Years)|Death|7|||
94399967|NCT00205777|323253133|FG004|Core Study (Up to 3 Years)|Death|0|||
94399968|NCT00205777|323253134|FG005|Core Study (Up to 3 Years)|Death|0|||
94399969|NCT00205777|323253129|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
94399970|NCT00205777|323253130|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
94399971|NCT00205777|323253131|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
94399972|NCT00205777|323253132|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
94399973|NCT00205777|323253133|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
94399974|NCT00205777|323253134|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
94399975|NCT00205777|323253129|FG000|Core Study (Up to 3 Years)|Other Event|49|||
94399976|NCT00205777|323253130|FG001|Core Study (Up to 3 Years)|Other Event|52|||
94399977|NCT00205777|323253131|FG002|Core Study (Up to 3 Years)|Other Event|41|||
94399978|NCT00205777|323253132|FG003|Core Study (Up to 3 Years)|Other Event|58|||
94399979|NCT00205777|323253133|FG004|Core Study (Up to 3 Years)|Other Event|0|||
94399980|NCT00205777|323253134|FG005|Core Study (Up to 3 Years)|Other Event|0|||
94399981|NCT00205777|323253129|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
94399982|NCT00205777|323253130|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
94399983|NCT00205777|323253131|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
94399984|NCT00205777|323253132|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
94399985|NCT00205777|323253133|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
94399986|NCT00205777|323253134|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
94399987|NCT00205777|323253129|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
94399988|NCT00205777|323253130|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
94399989|NCT00205777|323253131|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
94399990|NCT00205777|323253132|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
94399991|NCT00205777|323253133|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
94399992|NCT00205777|323253134|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
94399993|NCT00205777|323253129|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
94399994|NCT00205777|323253130|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
94399995|NCT00205777|323253131|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
94399996|NCT00205777|323253132|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
94399997|NCT00205777|323253133|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
94399998|NCT00205777|323253134|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
94399999|NCT00205777|323253129|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
94400000|NCT00205777|323253130|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
94400001|NCT00205777|323253131|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
94400002|NCT00205777|323253132|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
94400003|NCT00205777|323253133|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
94400004|NCT00205777|323253134|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
94400005|NCT00205777|323253129|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
94400006|NCT00205777|323253130|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
94400007|NCT00205777|323253131|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
94400008|NCT00205777|323253132|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
94400009|NCT00205777|323253133|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
94400010|NCT00205777|323253134|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
94400011|NCT00205777|323253129|FG000|Completed Core Study, Entered SE I|Other Event|52|||
94400012|NCT00205777|323253130|FG001|Completed Core Study, Entered SE I|Other Event|46|||
94400013|NCT00205777|323253131|FG002|Completed Core Study, Entered SE I|Other Event|47|||
94400014|NCT00205777|323253132|FG003|Completed Core Study, Entered SE I|Other Event|50|||
94400015|NCT00205777|323253133|FG004|Completed Core Study, Entered SE I|Other Event|0|||
94400016|NCT00205777|323253134|FG005|Completed Core Study, Entered SE I|Other Event|0|||
94400017|NCT00205777|323253129|FG000|Study Extension I|Adverse Event|57|||
94400018|NCT00205777|323253130|FG001|Study Extension I|Adverse Event|0|||
94400019|NCT00205777|323253131|FG002|Study Extension I|Adverse Event|0|||
94400020|NCT00205777|323253132|FG003|Study Extension I|Adverse Event|61|||
94400021|NCT00205777|323253133|FG004|Study Extension I|Adverse Event|58|||
94400022|NCT00205777|323253134|FG005|Study Extension I|Adverse Event|0|||
94400023|NCT00205777|323253129|FG000|Study Extension I|Death|5|||
94400024|NCT00205777|323253130|FG001|Study Extension I|Death|0|||
94400025|NCT00205777|323253131|FG002|Study Extension I|Death|0|||
94400026|NCT00205777|323253132|FG003|Study Extension I|Death|1|||
94400027|NCT00205777|323253133|FG004|Study Extension I|Death|2|||
94400028|NCT00205777|323253134|FG005|Study Extension I|Death|0|||
94400029|NCT00205777|323253129|FG000|Study Extension I|Withdrawal by Subject|99|||
94400030|NCT00205777|323253130|FG001|Study Extension I|Withdrawal by Subject|0|||
94400031|NCT00205777|323253131|FG002|Study Extension I|Withdrawal by Subject|0|||
94400032|NCT00205777|323253132|FG003|Study Extension I|Withdrawal by Subject|106|||
94400033|NCT00205777|323253133|FG004|Study Extension I|Withdrawal by Subject|89|||
94484966|NCT03533751|323567619|FG003|Overall Study|Withdrawal by Subject|9|||
94484967|NCT03533751|323567620|FG004|Overall Study|Withdrawal by Subject|10|||
94484968|NCT03533751|323567616|FG000|Overall Study|Adverse Event|4|||
94484969|NCT03533751|323567617|FG001|Overall Study|Adverse Event|7|||
94330033|NCT01335698|322990090|FG000|Treatment Stage 1|Lack of Efficacy|3|||
94330034|NCT01335698|322990091|FG001|Treatment Stage 1|Lack of Efficacy|1|||
94330035|NCT01335698|322990092|FG002|Treatment Stage 1|Lack of Efficacy|3|||
94330036|NCT01335698|322990093|FG003|Treatment Stage 1|Lack of Efficacy|3|||
94330037|NCT01335698|322990094|FG004|Treatment Stage 1|Lack of Efficacy|1|||
94330038|NCT01335698|322990090|FG000|Treatment Stage 1|Adverse Event|1|||
94330039|NCT01335698|322990091|FG001|Treatment Stage 1|Adverse Event|2|||
94330040|NCT01335698|322990092|FG002|Treatment Stage 1|Adverse Event|2|||
94330041|NCT01335698|322990093|FG003|Treatment Stage 1|Adverse Event|1|||
94330042|NCT01335698|322990094|FG004|Treatment Stage 1|Adverse Event|1|||
94330043|NCT01335698|322990090|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
94330044|NCT01335698|322990091|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
94330045|NCT01335698|322990092|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
94330046|NCT01335698|322990093|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
94330047|NCT01335698|322990094|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
94330048|NCT01335698|322990090|FG000|Treatment Stage 1|Lost to Follow-up|1|||
94330049|NCT01335698|322990091|FG001|Treatment Stage 1|Lost to Follow-up|1|||
94330050|NCT01335698|322990092|FG002|Treatment Stage 1|Lost to Follow-up|0|||
94330051|NCT01335698|322990093|FG003|Treatment Stage 1|Lost to Follow-up|0|||
94330052|NCT01335698|322990094|FG004|Treatment Stage 1|Lost to Follow-up|0|||
94330053|NCT01335698|322990090|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
94330054|NCT01335698|322990091|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
94330055|NCT01335698|322990092|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
94330056|NCT01335698|322990093|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
94330057|NCT01335698|322990094|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
94330058|NCT01335698|322990090|FG000|Treatment Stage 1|No longer meets study criteria|1|||
94330059|NCT01335698|322990091|FG001|Treatment Stage 1|No longer meets study criteria|1|||
94330060|NCT01335698|322990092|FG002|Treatment Stage 1|No longer meets study criteria|0|||
94330061|NCT01335698|322990093|FG003|Treatment Stage 1|No longer meets study criteria|1|||
94330062|NCT01335698|322990094|FG004|Treatment Stage 1|No longer meets study criteria|0|||
94330063|NCT01335698|322990090|FG000|Treatment Stage 1|Other|1|||
94330064|NCT01335698|322990091|FG001|Treatment Stage 1|Other|0|||
94330065|NCT01335698|322990092|FG002|Treatment Stage 1|Other|0|||
94330066|NCT01335698|322990093|FG003|Treatment Stage 1|Other|1|||
94330067|NCT01335698|322990094|FG004|Treatment Stage 1|Other|0|||
94330068|NCT01335698|322990090|FG000|Treatment Stage 2|Lack of Efficacy|2|||
94330069|NCT01335698|322990091|FG001|Treatment Stage 2|Lack of Efficacy|1|||
94330070|NCT01335698|322990092|FG002|Treatment Stage 2|Lack of Efficacy|3|||
94330071|NCT01335698|322990093|FG003|Treatment Stage 2|Lack of Efficacy|1|||
94330072|NCT01335698|322990094|FG004|Treatment Stage 2|Lack of Efficacy|0|||
94330073|NCT01335698|322990090|FG000|Treatment Stage 2|Adverse Event|2|||
94330074|NCT01335698|322990091|FG001|Treatment Stage 2|Adverse Event|0|||
94330075|NCT01335698|322990092|FG002|Treatment Stage 2|Adverse Event|0|||
94330076|NCT01335698|322990093|FG003|Treatment Stage 2|Adverse Event|3|||
94330077|NCT01335698|322990094|FG004|Treatment Stage 2|Adverse Event|0|||
94330078|NCT01335698|322990090|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
94330079|NCT01335698|322990091|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
94330080|NCT01335698|322990092|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
94330081|NCT01335698|322990093|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
94330082|NCT01335698|322990094|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
94330083|NCT01335698|322990090|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
94330084|NCT01335698|322990091|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
94330085|NCT01335698|322990092|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
94330086|NCT01335698|322990093|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
94330087|NCT01335698|322990094|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
94330088|NCT01335698|322990090|FG000|Treatment Stage 2|Lost to Follow-up|1|||
94330089|NCT01335698|322990091|FG001|Treatment Stage 2|Lost to Follow-up|0|||
94330090|NCT01335698|322990092|FG002|Treatment Stage 2|Lost to Follow-up|0|||
94330091|NCT01335698|322990093|FG003|Treatment Stage 2|Lost to Follow-up|0|||
94330092|NCT01335698|322990094|FG004|Treatment Stage 2|Lost to Follow-up|0|||
94330093|NCT01335698|322990090|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
94330094|NCT01335698|322990091|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
94330095|NCT01335698|322990092|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
94330096|NCT01335698|322990093|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
94330097|NCT01335698|322990094|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
94330098|NCT01335698|322990090|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
94330099|NCT01335698|322990091|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
94330100|NCT01335698|322990092|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
94330101|NCT01335698|322990093|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
94330102|NCT01335698|322990094|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
94400034|NCT00205777|323253134|FG005|Study Extension I|Withdrawal by Subject|0|||
94400035|NCT00205777|323253129|FG000|Study Extension I|Protocol Violation|4|||
94400036|NCT00205777|323253130|FG001|Study Extension I|Protocol Violation|0|||
94400037|NCT00205777|323253131|FG002|Study Extension I|Protocol Violation|0|||
94400038|NCT00205777|323253132|FG003|Study Extension I|Protocol Violation|8|||
94400039|NCT00205777|323253133|FG004|Study Extension I|Protocol Violation|8|||
94400040|NCT00205777|323253134|FG005|Study Extension I|Protocol Violation|0|||
94400041|NCT00205777|323253129|FG000|Study Extension I|Lack of Efficacy|0|||
94400042|NCT00205777|323253130|FG001|Study Extension I|Lack of Efficacy|0|||
94400043|NCT00205777|323253131|FG002|Study Extension I|Lack of Efficacy|0|||
94400044|NCT00205777|323253132|FG003|Study Extension I|Lack of Efficacy|1|||
94400045|NCT00205777|323253133|FG004|Study Extension I|Lack of Efficacy|2|||
94400046|NCT00205777|323253134|FG005|Study Extension I|Lack of Efficacy|0|||
94400047|NCT00205777|323253129|FG000|Study Extension I|Failed to return|15|||
94400048|NCT00205777|323253130|FG001|Study Extension I|Failed to return|0|||
94400049|NCT00205777|323253131|FG002|Study Extension I|Failed to return|0|||
94400050|NCT00205777|323253132|FG003|Study Extension I|Failed to return|17|||
94400051|NCT00205777|323253133|FG004|Study Extension I|Failed to return|13|||
94400052|NCT00205777|323253134|FG005|Study Extension I|Failed to return|0|||
94400053|NCT00205777|323253129|FG000|Study Extension I|Other Event|34|||
94400054|NCT00205777|323253130|FG001|Study Extension I|Other Event|0|||
94400055|NCT00205777|323253131|FG002|Study Extension I|Other Event|0|||
94400056|NCT00205777|323253132|FG003|Study Extension I|Other Event|34|||
94400057|NCT00205777|323253133|FG004|Study Extension I|Other Event|29|||
94400058|NCT00205777|323253134|FG005|Study Extension I|Other Event|0|||
94400059|NCT00205777|323253129|FG000|Study Extension I|Withdrawn as per protocol|0|||
94400060|NCT00205777|323253130|FG001|Study Extension I|Withdrawn as per protocol|0|||
94400061|NCT00205777|323253131|FG002|Study Extension I|Withdrawn as per protocol|1070|||
94400062|NCT00205777|323253132|FG003|Study Extension I|Withdrawn as per protocol|0|||
94400063|NCT00205777|323253133|FG004|Study Extension I|Withdrawn as per protocol|0|||
94400064|NCT00205777|323253134|FG005|Study Extension I|Withdrawn as per protocol|0|||
94400065|NCT00205777|323253129|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
94400066|NCT00205777|323253130|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
94400067|NCT00205777|323253131|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
94400068|NCT00205777|323253132|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
94400069|NCT00205777|323253133|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
94400070|NCT00205777|323253134|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
94400071|NCT00205777|323253129|FG000|Study Extension II|Adverse Event|0|||
94400072|NCT00205777|323253130|FG001|Study Extension II|Adverse Event|0|||
94400073|NCT00205777|323253131|FG002|Study Extension II|Adverse Event|0|||
94400074|NCT00205777|323253132|FG003|Study Extension II|Adverse Event|14|||
94400075|NCT00205777|323253133|FG004|Study Extension II|Adverse Event|0|||
94400076|NCT00205777|323253134|FG005|Study Extension II|Adverse Event|30|||
94400077|NCT00205777|323253129|FG000|Study Extension II|Death|0|||
94400078|NCT00205777|323253130|FG001|Study Extension II|Death|0|||
94400079|NCT00205777|323253131|FG002|Study Extension II|Death|0|||
94400080|NCT00205777|323253132|FG003|Study Extension II|Death|2|||
94400081|NCT00205777|323253133|FG004|Study Extension II|Death|0|||
94400082|NCT00205777|323253134|FG005|Study Extension II|Death|5|||
94400083|NCT00205777|323253129|FG000|Study Extension II|Withdrawal by Subject|0|||
94400084|NCT00205777|323253130|FG001|Study Extension II|Withdrawal by Subject|0|||
94400085|NCT00205777|323253131|FG002|Study Extension II|Withdrawal by Subject|0|||
94400086|NCT00205777|323253132|FG003|Study Extension II|Withdrawal by Subject|35|||
94400087|NCT00205777|323253133|FG004|Study Extension II|Withdrawal by Subject|0|||
94400088|NCT00205777|323253134|FG005|Study Extension II|Withdrawal by Subject|59|||
94400089|NCT00205777|323253129|FG000|Study Extension II|Protocol Violation|0|||
94400090|NCT00205777|323253130|FG001|Study Extension II|Protocol Violation|0|||
94400091|NCT00205777|323253131|FG002|Study Extension II|Protocol Violation|0|||
94400092|NCT00205777|323253132|FG003|Study Extension II|Protocol Violation|1|||
94400093|NCT00205777|323253133|FG004|Study Extension II|Protocol Violation|0|||
94400094|NCT00205777|323253134|FG005|Study Extension II|Protocol Violation|10|||
94400095|NCT00205777|323253129|FG000|Study Extension II|Lack of Efficacy|0|||
94400096|NCT00205777|323253130|FG001|Study Extension II|Lack of Efficacy|0|||
94400097|NCT00205777|323253131|FG002|Study Extension II|Lack of Efficacy|0|||
94400098|NCT00205777|323253132|FG003|Study Extension II|Lack of Efficacy|0|||
94400099|NCT00205777|323253133|FG004|Study Extension II|Lack of Efficacy|0|||
94400100|NCT00205777|323253134|FG005|Study Extension II|Lack of Efficacy|1|||
94400101|NCT00205777|323253129|FG000|Study Extension II|Failed to return|0|||
94400102|NCT00205777|323253130|FG001|Study Extension II|Failed to return|0|||
94400103|NCT00205777|323253131|FG002|Study Extension II|Failed to return|0|||
94400104|NCT00205777|323253132|FG003|Study Extension II|Failed to return|14|||
94400105|NCT00205777|323253133|FG004|Study Extension II|Failed to return|0|||
94400106|NCT00205777|323253134|FG005|Study Extension II|Failed to return|26|||
94400107|NCT00205777|323253129|FG000|Study Extension II|Other Event|0|||
94400108|NCT00205777|323253130|FG001|Study Extension II|Other Event|0|||
94400109|NCT00205777|323253131|FG002|Study Extension II|Other Event|0|||
94400110|NCT00205777|323253132|FG003|Study Extension II|Other Event|12|||
94400111|NCT00205777|323253133|FG004|Study Extension II|Other Event|0|||
94400112|NCT00205777|323253134|FG005|Study Extension II|Other Event|20|||
94400113|NCT00205777|323253129|FG000|Study Extension II|Enrolled but not treated|0|||
94400114|NCT00205777|323253130|FG001|Study Extension II|Enrolled but not treated|0|||
94400115|NCT00205777|323253131|FG002|Study Extension II|Enrolled but not treated|0|||
94400116|NCT00205777|323253132|FG003|Study Extension II|Enrolled but not treated|71|||
94400117|NCT00205777|323253133|FG004|Study Extension II|Enrolled but not treated|0|||
94400118|NCT00205777|323253134|FG005|Study Extension II|Enrolled but not treated|131|||
94400119|NCT02462837|323253135|FG000|Overall Study|pt developed hives|1|||
94400120|NCT02462837|323253136|FG001|Overall Study|pt developed hives|0|||
94400121|NCT02462837|323253135|FG000|Overall Study|Withdrawal by Subject|1|||
94400122|NCT02462837|323253136|FG001|Overall Study|Withdrawal by Subject|0|||
94400123|NCT02336074|323253140|FG000|Overall Study|Adverse Event|0|||
94400124|NCT02336074|323253141|FG001|Overall Study|Adverse Event|2|||
94400125|NCT02679729|323253142|FG000|Overall Study|Lost to Follow-up|0|||
94400126|NCT02679729|323253143|FG001|Overall Study|Lost to Follow-up|1|||
94400127|NCT02679729|323253144|FG002|Overall Study|Lost to Follow-up|0|||
94400128|NCT02679729|323253145|FG003|Overall Study|Lost to Follow-up|0|||
94400129|NCT02679729|323253146|FG004|Overall Study|Lost to Follow-up|1|||
94400130|NCT02679729|323253147|FG005|Overall Study|Lost to Follow-up|0|||
94400131|NCT02679729|323253148|FG006|Overall Study|Lost to Follow-up|0|||
94400132|NCT02679729|323253149|FG007|Overall Study|Lost to Follow-up|0|||
94400133|NCT02679729|323253150|FG008|Overall Study|Lost to Follow-up|0|||
94400134|NCT02679729|323253142|FG000|Overall Study|Participant decision|0|||
94400135|NCT02679729|323253143|FG001|Overall Study|Participant decision|1|||
94400136|NCT02679729|323253144|FG002|Overall Study|Participant decision|0|||
94400137|NCT02679729|323253145|FG003|Overall Study|Participant decision|0|||
94400138|NCT02679729|323253146|FG004|Overall Study|Participant decision|0|||
94400139|NCT02679729|323253147|FG005|Overall Study|Participant decision|0|||
94400140|NCT02679729|323253148|FG006|Overall Study|Participant decision|1|||
94400141|NCT02679729|323253149|FG007|Overall Study|Participant decision|0|||
94400142|NCT02679729|323253150|FG008|Overall Study|Participant decision|0|||
94400143|NCT05604014|323253153|FG000|Overall Study|Lost to Follow-up|13|||
94400144|NCT01266902|323253154|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
94400145|NCT01266902|323253155|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
94400146|NCT01266902|323253156|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
94400147|NCT01266902|323253154|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
94400148|NCT01266902|323253155|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
94400149|NCT01266902|323253156|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
94400150|NCT01266902|323253154|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
94400151|NCT01266902|323253155|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
94400152|NCT01266902|323253156|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
94400153|NCT01266902|323253154|FG000|Period 1 (Main Study)|Adverse Event|3|||
94400154|NCT01266902|323253155|FG001|Period 1 (Main Study)|Adverse Event|11|||
94400155|NCT01266902|323253156|FG002|Period 1 (Main Study)|Adverse Event|0|||
94400156|NCT01266902|323253154|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
94400157|NCT01266902|323253155|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
94400158|NCT01266902|323253156|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
94400159|NCT01266902|323253154|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
94400160|NCT01266902|323253155|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
94400161|NCT01266902|323253156|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
94400162|NCT01266902|323253154|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
94400163|NCT01266902|323253155|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
94400164|NCT01266902|323253156|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
94400165|NCT01266902|323253154|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
94400166|NCT01266902|323253155|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
94400167|NCT01266902|323253156|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
94400168|NCT01266902|323253154|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
94400169|NCT01266902|323253155|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
94400170|NCT01266902|323253156|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
94400171|NCT01266902|323253154|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
94400172|NCT01266902|323253155|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
94400173|NCT01266902|323253156|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
94400174|NCT02121184|323253157|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
94400175|NCT02121184|323253158|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
94484970|NCT03533751|323567618|FG002|Overall Study|Adverse Event|2|||
94484971|NCT03533751|323567619|FG003|Overall Study|Adverse Event|4|||
94400176|NCT02121184|323253157|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
94484972|NCT03533751|323567620|FG004|Overall Study|Adverse Event|5|||
94400177|NCT02121184|323253158|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
94400178|NCT02121184|323253157|FG000|Overall Study|Emergency cesarean section required|0|||
94400179|NCT02121184|323253158|FG001|Overall Study|Emergency cesarean section required|2|||
94400180|NCT02121184|323253157|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
94400181|NCT02121184|323253158|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
94400182|NCT05562011|323253165|FG000|Overall Study|Withdrawal by Subject|3|||
94400183|NCT05562011|323253165|FG000|Overall Study|Lost to Follow-up|1|||
94400184|NCT05562011|323253165|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
94400185|NCT05562011|323253165|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
94400186|NCT05562011|323253165|FG000|Overall Study|Device malfunction|13|||
94400187|NCT00387153|323253168|FG000|Overall Study|Adverse Event|1|||
94400188|NCT00387153|323253168|FG000|Overall Study|Disease Progression|3|||
94400189|NCT00387153|323253168|FG000|Overall Study|Lack of Response|4|||
94400190|NCT01186458|323253172|FG000|Overall Study|Adverse Event|1|||
94400191|NCT00748566|323253173|FG000|Overall Study|Adverse Event|49|||
94400192|NCT00748566|323253173|FG000|Overall Study|Death|1|||
94400193|NCT00748566|323253173|FG000|Overall Study|Lack of Efficacy|12|||
94400194|NCT00748566|323253173|FG000|Overall Study|Lost to Follow-up|1|||
94400195|NCT00748566|323253173|FG000|Overall Study|Protocol Violation|13|||
94400196|NCT00748566|323253173|FG000|Overall Study|Withdrawal by Subject|22|||
94400197|NCT00748566|323253173|FG000|Overall Study|Study terminated by sponsor|5|||
94400198|NCT00748566|323253173|FG000|Overall Study|Other|9|||
94400199|NCT00989950|323253174|FG000|Randomized Phase|Protocol Violation|1|||
94400200|NCT00989950|323253175|FG001|Randomized Phase|Protocol Violation|0|||
94400201|NCT00989950|323253176|FG002|Randomized Phase|Protocol Violation|0|||
94400202|NCT00989950|323253177|FG003|Randomized Phase|Protocol Violation|0|||
94400203|NCT00989950|323253174|FG000|Randomized Phase|Adverse Event|0|||
94400204|NCT00989950|323253175|FG001|Randomized Phase|Adverse Event|1|||
94400205|NCT00989950|323253176|FG002|Randomized Phase|Adverse Event|0|||
94400206|NCT00989950|323253177|FG003|Randomized Phase|Adverse Event|0|||
94400207|NCT00840658|323253178|FG000|Overall Study|Death|2|||
94400208|NCT00840658|323253179|FG001|Overall Study|Death|2|||
94400209|NCT00840658|323253180|FG002|Overall Study|Death|3|||
94400210|NCT00840658|323253181|FG003|Overall Study|Death|3|||
94400211|NCT00840658|323253178|FG000|Overall Study|Lost to Follow-up|3|||
94400212|NCT00840658|323253179|FG001|Overall Study|Lost to Follow-up|1|||
94400213|NCT00840658|323253180|FG002|Overall Study|Lost to Follow-up|2|||
94400214|NCT00840658|323253181|FG003|Overall Study|Lost to Follow-up|1|||
94400215|NCT03101358|323253182|FG000|Overall Study|Non-compliance with study schedule|1|||
94400216|NCT03101358|323253183|FG001|Overall Study|Non-compliance with study schedule|0|||
94400217|NCT03101358|323253184|FG002|Overall Study|Non-compliance with study schedule|0|||
94400218|NCT03101358|323253185|FG003|Overall Study|Non-compliance with study schedule|1|||
94400219|NCT03101358|323253182|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
94400220|NCT03101358|323253183|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
94400221|NCT03101358|323253184|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
94400222|NCT03101358|323253185|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
94400223|NCT03101358|323253182|FG000|Overall Study|Physician Decision|1|||
94400224|NCT03101358|323253183|FG001|Overall Study|Physician Decision|0|||
94400225|NCT03101358|323253184|FG002|Overall Study|Physician Decision|0|||
94400226|NCT03101358|323253185|FG003|Overall Study|Physician Decision|3|||
94400227|NCT03101358|323253182|FG000|Overall Study|Adverse Event|0|||
94400228|NCT03101358|323253183|FG001|Overall Study|Adverse Event|0|||
94400229|NCT03101358|323253184|FG002|Overall Study|Adverse Event|1|||
94400230|NCT03101358|323253185|FG003|Overall Study|Adverse Event|0|||
94400231|NCT03101358|323253182|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
94400232|NCT03101358|323253183|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
94400233|NCT03101358|323253184|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
94400234|NCT03101358|323253185|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
94400235|NCT03101358|323253182|FG000|Overall Study|Lost to Follow-up|1|||
94400236|NCT03101358|323253183|FG001|Overall Study|Lost to Follow-up|0|||
94400237|NCT03101358|323253184|FG002|Overall Study|Lost to Follow-up|0|||
94400238|NCT03101358|323253185|FG003|Overall Study|Lost to Follow-up|1|||
94400239|NCT00624286|323253186|FG000|Overall Study|Protocol Deviation|7|||
94400240|NCT00624286|323253187|FG001|Overall Study|Protocol Deviation|9|||
94400241|NCT00624286|323253186|FG000|Overall Study|Adverse Event|6|||
94400242|NCT00624286|323253187|FG001|Overall Study|Adverse Event|3|||
94484973|NCT03533751|323567616|FG000|Overall Study|Physician Decision|0|||
94484974|NCT03533751|323567617|FG001|Overall Study|Physician Decision|2|||
94400243|NCT00624286|323253186|FG000|Overall Study|Withdrawal by Subject|5|||
94400244|NCT00624286|323253187|FG001|Overall Study|Withdrawal by Subject|4|||
94400245|NCT00624286|323253186|FG000|Overall Study|Lost to Follow-up|3|||
94484975|NCT03533751|323567618|FG002|Overall Study|Physician Decision|1|||
94484976|NCT03533751|323567619|FG003|Overall Study|Physician Decision|2|||
94330103|NCT01335698|322990090|FG000|Treatment Stage 2|Switched to another formulation|1|||
94330104|NCT01335698|322990091|FG001|Treatment Stage 2|Switched to another formulation|1|||
94330105|NCT01335698|322990092|FG002|Treatment Stage 2|Switched to another formulation|0|||
94330106|NCT01335698|322990093|FG003|Treatment Stage 2|Switched to another formulation|0|||
94330107|NCT01335698|322990094|FG004|Treatment Stage 2|Switched to another formulation|0|||
94330108|NCT01170221|322990095|FG000|Overall Study|Lost to Follow-up|22|||
94330109|NCT01170221|322990096|FG001|Overall Study|Lost to Follow-up|21|||
94330110|NCT01170221|322990095|FG000|Overall Study|Withdrawal by Subject|9|||
94330111|NCT01170221|322990096|FG001|Overall Study|Withdrawal by Subject|7|||
94330112|NCT01170221|322990095|FG000|Overall Study|Subject completed only screening and LFU|1|||
94330113|NCT01170221|322990096|FG001|Overall Study|Subject completed only screening and LFU|0|||
94330114|NCT01170221|322990095|FG000|Overall Study|Randomized but not treated|1|||
94330115|NCT01170221|322990096|FG001|Overall Study|Randomized but not treated|0|||
94330116|NCT02693691|322990097|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
94330117|NCT02693691|322990097|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
94330118|NCT02693691|322990097|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
94330119|NCT02693691|322990097|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
94330120|NCT02693691|322990097|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
94330121|NCT02693691|322990097|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
94330122|NCT02693691|322990097|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
94330123|NCT03970824|322990098|FG000|Overall Study|Withdrawal by Subject|1|||
94330124|NCT03970824|322990099|FG001|Overall Study|Withdrawal by Subject|1|||
94330125|NCT03970824|322990100|FG002|Overall Study|Withdrawal by Subject|3|||
94330126|NCT03970824|322990098|FG000|Overall Study|Lost to Follow-up|0|||
94330127|NCT03970824|322990099|FG001|Overall Study|Lost to Follow-up|2|||
94330128|NCT03970824|322990100|FG002|Overall Study|Lost to Follow-up|1|||
94330129|NCT03970824|322990098|FG000|Overall Study|Adverse Event|1|||
94330130|NCT03970824|322990099|FG001|Overall Study|Adverse Event|0|||
94330131|NCT03970824|322990100|FG002|Overall Study|Adverse Event|0|||
94330132|NCT00416312|322990101|FG000|Overall Study|tumors not visible on imaging|2|||
94330133|NCT01248364|322990107|FG000|Overall Study|Adverse Event|0|||
94330134|NCT01248364|322990108|FG001|Overall Study|Adverse Event|1|||
94330135|NCT01248364|322990109|FG002|Overall Study|Adverse Event|0|||
94330136|NCT01248364|322990110|FG003|Overall Study|Adverse Event|0|||
94330137|NCT01354431|322990115|FG000|Pre-Treatment Period|Not reported|1|||
94330138|NCT01354431|322990116|FG001|Pre-Treatment Period|Not reported|0|||
94330139|NCT01354431|322990117|FG002|Pre-Treatment Period|Not reported|0|||
94330140|NCT01354431|322990115|FG000|Treatment Period|Disease Progression|50|||
94330141|NCT01354431|322990116|FG001|Treatment Period|Disease Progression|40|||
94330142|NCT01354431|322990117|FG002|Treatment Period|Disease Progression|44|||
94330143|NCT01354431|322990115|FG000|Treatment Period|Study Drug Toxicity|5|||
94330144|NCT01354431|322990116|FG001|Treatment Period|Study Drug Toxicity|8|||
94330145|NCT01354431|322990117|FG002|Treatment Period|Study Drug Toxicity|4|||
94330146|NCT01354431|322990115|FG000|Treatment Period|Death|0|||
94330147|NCT01354431|322990116|FG001|Treatment Period|Death|1|||
94330148|NCT01354431|322990117|FG002|Treatment Period|Death|0|||
94330149|NCT01354431|322990115|FG000|Treatment Period|AE unrelated to study drug|1|||
94330150|NCT01354431|322990116|FG001|Treatment Period|AE unrelated to study drug|2|||
94330151|NCT01354431|322990117|FG002|Treatment Period|AE unrelated to study drug|5|||
94330152|NCT01354431|322990115|FG000|Treatment Period|Participant request to discontinue|2|||
94330153|NCT01354431|322990116|FG001|Treatment Period|Participant request to discontinue|2|||
94330154|NCT01354431|322990117|FG002|Treatment Period|Participant request to discontinue|1|||
94330155|NCT01354431|322990115|FG000|Treatment Period|Participant withdrew consent|0|||
94330156|NCT01354431|322990116|FG001|Treatment Period|Participant withdrew consent|1|||
94330157|NCT01354431|322990117|FG002|Treatment Period|Participant withdrew consent|0|||
94330158|NCT01354431|322990115|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
94330159|NCT01354431|322990116|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
94330160|NCT01354431|322990117|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
94330161|NCT03219567|322990118|FG000|Overall Study|Withdrawal by Subject|0|||
94330162|NCT03219567|322990119|FG001|Overall Study|Withdrawal by Subject|1|||
94330163|NCT01412060|322990122|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
94330164|NCT01412060|322990123|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
94330165|NCT01412060|322990124|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
94330166|NCT01412060|322990122|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
94330167|NCT01412060|322990123|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
94330168|NCT01412060|322990124|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
94330169|NCT01412060|322990122|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
94330170|NCT01412060|322990123|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
94330171|NCT01412060|322990124|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
94330172|NCT01412060|322990122|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
94484977|NCT03533751|323567620|FG004|Overall Study|Physician Decision|1|||
94400246|NCT00624286|323253187|FG001|Overall Study|Lost to Follow-up|2|||
94400247|NCT00624286|323253186|FG000|Overall Study|Administrative problems|3|||
94400248|NCT00624286|323253187|FG001|Overall Study|Administrative problems|0|||
94400249|NCT00624286|323253186|FG000|Overall Study|Lack of Efficacy|1|||
94400250|NCT00624286|323253187|FG001|Overall Study|Lack of Efficacy|6|||
94400251|NCT00624286|323253186|FG000|Overall Study|Not stated|0|||
94400252|NCT00624286|323253187|FG001|Overall Study|Not stated|1|||
94400253|NCT00624286|323253186|FG000|Overall Study|Abnormal test procedure result(s)|0|||
94400254|NCT00624286|323253187|FG001|Overall Study|Abnormal test procedure result(s)|1|||
94400255|NCT00624286|323253186|FG000|Overall Study|Death|0|||
94400256|NCT00624286|323253187|FG001|Overall Study|Death|1|||
94400257|NCT01496118|323253188|FG000|Overall Study|Disease progression|3|||
94400258|NCT01496118|323253189|FG001|Overall Study|Disease progression|2|||
94400259|NCT01496118|323253190|FG002|Overall Study|Disease progression|3|||
94400260|NCT01496118|323253191|FG003|Overall Study|Disease progression|1|||
94400261|NCT01496118|323253192|FG004|Overall Study|Disease progression|2|||
94400262|NCT01496118|323253193|FG005|Overall Study|Disease progression|2|||
94400263|NCT01496118|323253194|FG006|Overall Study|Disease progression|14|||
94400264|NCT01496118|323253195|FG007|Overall Study|Disease progression|10|||
94400265|NCT01496118|323253188|FG000|Overall Study|Physician Decision|0|||
94400266|NCT01496118|323253189|FG001|Overall Study|Physician Decision|0|||
94400267|NCT01496118|323253190|FG002|Overall Study|Physician Decision|0|||
94400268|NCT01496118|323253191|FG003|Overall Study|Physician Decision|0|||
94400269|NCT01496118|323253192|FG004|Overall Study|Physician Decision|1|||
94400270|NCT01496118|323253193|FG005|Overall Study|Physician Decision|0|||
94400271|NCT01496118|323253194|FG006|Overall Study|Physician Decision|3|||
94400272|NCT01496118|323253195|FG007|Overall Study|Physician Decision|6|||
94400273|NCT01496118|323253188|FG000|Overall Study|Adverse Event|1|||
94400274|NCT01496118|323253189|FG001|Overall Study|Adverse Event|1|||
94400275|NCT01496118|323253190|FG002|Overall Study|Adverse Event|0|||
94400276|NCT01496118|323253191|FG003|Overall Study|Adverse Event|0|||
94400277|NCT01496118|323253192|FG004|Overall Study|Adverse Event|0|||
94400278|NCT01496118|323253193|FG005|Overall Study|Adverse Event|0|||
94400279|NCT01496118|323253194|FG006|Overall Study|Adverse Event|6|||
94400280|NCT01496118|323253195|FG007|Overall Study|Adverse Event|10|||
94400281|NCT01496118|323253188|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
94400282|NCT01496118|323253189|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
94400283|NCT01496118|323253190|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
94400284|NCT01496118|323253191|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
94400285|NCT01496118|323253192|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
94400286|NCT01496118|323253193|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
94400287|NCT01496118|323253194|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
94400288|NCT01496118|323253195|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
94400289|NCT01496118|323253188|FG000|Overall Study|Death|0|||
94400290|NCT01496118|323253189|FG001|Overall Study|Death|0|||
94400291|NCT01496118|323253190|FG002|Overall Study|Death|0|||
94400292|NCT01496118|323253191|FG003|Overall Study|Death|0|||
94400293|NCT01496118|323253192|FG004|Overall Study|Death|0|||
94400294|NCT01496118|323253193|FG005|Overall Study|Death|0|||
94400295|NCT01496118|323253194|FG006|Overall Study|Death|1|||
94400296|NCT01496118|323253195|FG007|Overall Study|Death|1|||
94400297|NCT01496118|323253188|FG000|Overall Study|Withdrawal by Subject|0|||
94400298|NCT01496118|323253189|FG001|Overall Study|Withdrawal by Subject|0|||
94400299|NCT01496118|323253190|FG002|Overall Study|Withdrawal by Subject|0|||
94400300|NCT01496118|323253191|FG003|Overall Study|Withdrawal by Subject|2|||
94400301|NCT01496118|323253192|FG004|Overall Study|Withdrawal by Subject|0|||
94400302|NCT01496118|323253193|FG005|Overall Study|Withdrawal by Subject|1|||
94400303|NCT01496118|323253194|FG006|Overall Study|Withdrawal by Subject|6|||
94400304|NCT01496118|323253195|FG007|Overall Study|Withdrawal by Subject|3|||
94400305|NCT00654186|323253200|FG000|Overall Study|Withdrawal by Subject|5|||
94400306|NCT00875524|323253202|FG000|Overall Study|Serious adverse event|0|||
94400307|NCT00875524|323253203|FG001|Overall Study|Serious adverse event|1|||
94400308|NCT00875524|323253202|FG000|Overall Study|Protocol Violation|4|||
94400309|NCT00875524|323253203|FG001|Overall Study|Protocol Violation|0|||
94400310|NCT00875524|323253202|FG000|Overall Study|Lost to Follow-up|1|||
94400311|NCT00875524|323253203|FG001|Overall Study|Lost to Follow-up|0|||
94400312|NCT00875524|323253202|FG000|Overall Study|Withdrawal by Subject|3|||
94400313|NCT00875524|323253203|FG001|Overall Study|Withdrawal by Subject|5|||
94400314|NCT03366428|323253210|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
94400315|NCT03366428|323253210|FG000|Overall Study|Adverse Event|12|||
94400316|NCT03366428|323253210|FG000|Overall Study|Clinical progression|2|||
94400317|NCT03366428|323253210|FG000|Overall Study|Withdrawal by Subject|4|||
94400318|NCT03573544|323253211|FG000|Overall Study|Adverse Event|0|||
94400319|NCT03573544|323253212|FG001|Overall Study|Adverse Event|0|||
94400320|NCT03573544|323253213|FG002|Overall Study|Adverse Event|0|||
94400321|NCT03573544|323253214|FG003|Overall Study|Adverse Event|3|||
94400322|NCT03573544|323253215|FG004|Overall Study|Adverse Event|1|||
94400323|NCT03573544|323253216|FG005|Overall Study|Adverse Event|0|||
94400324|NCT03573544|323253217|FG006|Overall Study|Adverse Event|2|||
94400325|NCT03573544|323253218|FG007|Overall Study|Adverse Event|0|||
94400326|NCT03573544|323253211|FG000|Overall Study|Physician Decision|0|||
94400327|NCT03573544|323253212|FG001|Overall Study|Physician Decision|0|||
94400328|NCT03573544|323253213|FG002|Overall Study|Physician Decision|0|||
94400329|NCT03573544|323253214|FG003|Overall Study|Physician Decision|0|||
94400330|NCT03573544|323253215|FG004|Overall Study|Physician Decision|0|||
94400331|NCT03573544|323253216|FG005|Overall Study|Physician Decision|0|||
94400332|NCT03573544|323253217|FG006|Overall Study|Physician Decision|1|||
94400333|NCT03573544|323253218|FG007|Overall Study|Physician Decision|0|||
94400334|NCT03573544|323253211|FG000|Overall Study|Withdrawal by Subject|2|||
94400335|NCT03573544|323253212|FG001|Overall Study|Withdrawal by Subject|0|||
94400336|NCT03573544|323253213|FG002|Overall Study|Withdrawal by Subject|0|||
94400337|NCT03573544|323253214|FG003|Overall Study|Withdrawal by Subject|1|||
94400338|NCT03573544|323253215|FG004|Overall Study|Withdrawal by Subject|1|||
94400339|NCT03573544|323253216|FG005|Overall Study|Withdrawal by Subject|1|||
94400340|NCT03573544|323253217|FG006|Overall Study|Withdrawal by Subject|0|||
94400341|NCT03573544|323253218|FG007|Overall Study|Withdrawal by Subject|1|||
94400342|NCT03573544|323253211|FG000|Overall Study|Disease progression|3|||
94400343|NCT03573544|323253212|FG001|Overall Study|Disease progression|3|||
94400344|NCT03573544|323253213|FG002|Overall Study|Disease progression|6|||
94400345|NCT03573544|323253214|FG003|Overall Study|Disease progression|4|||
94400346|NCT03573544|323253215|FG004|Overall Study|Disease progression|5|||
94400347|NCT03573544|323253216|FG005|Overall Study|Disease progression|7|||
94400348|NCT03573544|323253217|FG006|Overall Study|Disease progression|6|||
94400349|NCT03573544|323253218|FG007|Overall Study|Disease progression|7|||
94400350|NCT00950300|323253219|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
94400351|NCT00950300|323253220|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
94400352|NCT00950300|323253219|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
94400353|NCT00950300|323253220|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
94400354|NCT00950300|323253219|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
94400355|NCT00950300|323253220|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
94400356|NCT00950300|323253219|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
94400357|NCT00950300|323253220|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
94400358|NCT00950300|323253219|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
94400359|NCT00950300|323253220|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
94400360|NCT00950300|323253219|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
94400361|NCT00950300|323253220|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
94400362|NCT00950300|323253219|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
94400363|NCT00950300|323253220|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
94400364|NCT00950300|323253219|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
94400365|NCT00950300|323253220|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
94400366|NCT00950300|323253219|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
94400367|NCT00950300|323253220|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
94400368|NCT00950300|323253219|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
94400369|NCT00950300|323253220|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
94400370|NCT00950300|323253219|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
94400371|NCT00950300|323253220|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
94400372|NCT00950300|323253219|FG000|TFFU Period|Death|4|||
94400373|NCT00950300|323253220|FG001|TFFU Period|Death|1|||
94400374|NCT00950300|323253219|FG000|TFFU Period|Refused Treatment|10|||
94400375|NCT00950300|323253220|FG001|TFFU Period|Refused Treatment|11|||
94400376|NCT00950300|323253219|FG000|TFFU Period|Failure to Return|16|||
94400377|NCT00950300|323253220|FG001|TFFU Period|Failure to Return|16|||
94400378|NCT00950300|323253219|FG000|TFFU Period|Recurrence of Disease|63|||
94400379|NCT00950300|323253220|FG001|TFFU Period|Recurrence of Disease|72|||
94400380|NCT00950300|323253219|FG000|TFFU Period|Other|4|||
94400381|NCT00950300|323253220|FG001|TFFU Period|Other|3|||
94400382|NCT00950300|323253219|FG000|SFU Period|Death|44|||
94400383|NCT00950300|323253220|FG001|SFU Period|Death|42|||
94400384|NCT00950300|323253219|FG000|SFU Period|Lost to Follow-up|30|||
94400385|NCT00950300|323253220|FG001|SFU Period|Lost to Follow-up|28|||
94400386|NCT00950300|323253219|FG000|SFU Period|Withdrawal by Subject|4|||
94400387|NCT00950300|323253220|FG001|SFU Period|Withdrawal by Subject|8|||
94400388|NCT00902538|323253221|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
94400389|NCT00902538|323253222|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
94400390|NCT00902538|323253223|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
94400391|NCT00902538|323253224|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
94400392|NCT00902538|323253225|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
94400393|NCT00902538|323253226|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
94400394|NCT00902538|323253221|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
94400395|NCT00902538|323253222|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
94400396|NCT00902538|323253223|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
94400397|NCT00902538|323253224|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
94400398|NCT00902538|323253225|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
94400399|NCT00902538|323253226|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
94400400|NCT00902538|323253221|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
94400401|NCT00902538|323253222|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
94400402|NCT00902538|323253223|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
94400403|NCT00902538|323253224|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
94400404|NCT00902538|323253225|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
94400405|NCT00902538|323253226|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
94400406|NCT00902538|323253221|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
94400407|NCT00902538|323253222|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
94400408|NCT00902538|323253223|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
94400409|NCT00902538|323253224|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
94400410|NCT00902538|323253225|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
94400411|NCT00902538|323253226|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
94400412|NCT00902538|323253221|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
94400413|NCT00902538|323253222|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
94400414|NCT00902538|323253223|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
94400415|NCT00902538|323253224|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
94400416|NCT00902538|323253225|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
94400417|NCT00902538|323253226|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
94400418|NCT00902538|323253221|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
94400419|NCT00902538|323253222|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
94400420|NCT00902538|323253223|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
94400421|NCT00902538|323253224|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
94400422|NCT00902538|323253225|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
94400423|NCT00902538|323253226|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
94400424|NCT00902538|323253221|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
94400425|NCT00902538|323253222|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
94400426|NCT00902538|323253223|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
94400427|NCT00902538|323253224|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
94400428|NCT00902538|323253225|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
94400429|NCT00902538|323253226|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
94400430|NCT00902538|323253221|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
94400431|NCT00902538|323253222|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
94400432|NCT00902538|323253223|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
94400433|NCT00902538|323253224|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
94400434|NCT00902538|323253225|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
94400435|NCT00902538|323253226|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
94400436|NCT00902538|323253221|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
94400437|NCT00902538|323253222|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
94400438|NCT00902538|323253223|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
94400439|NCT00902538|323253224|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
94400440|NCT00902538|323253225|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
94400441|NCT00902538|323253226|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
94400442|NCT00902538|323253221|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
94400443|NCT00902538|323253222|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
94400444|NCT00902538|323253223|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
94400445|NCT00902538|323253224|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
94400446|NCT00902538|323253225|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
94400447|NCT00902538|323253226|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
94400448|NCT00902538|323253221|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
94400449|NCT00902538|323253222|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
94400450|NCT00902538|323253223|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
94400451|NCT00902538|323253224|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
94400452|NCT00902538|323253225|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
94400453|NCT00902538|323253226|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
94400454|NCT00902538|323253221|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
94400455|NCT00902538|323253222|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
94400456|NCT00902538|323253223|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
94400457|NCT00902538|323253224|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
94400458|NCT00902538|323253225|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
94400459|NCT00902538|323253226|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
94330173|NCT01412060|322990123|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
94400460|NCT00902538|323253221|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
94330174|NCT01412060|322990124|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
94330175|NCT01412060|322990122|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
94330176|NCT01412060|322990123|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
94330177|NCT01412060|322990124|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
94330178|NCT01412060|322990122|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
94330179|NCT01412060|322990123|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
94330180|NCT01412060|322990124|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
94330181|NCT01412060|322990122|FG000|Period Between RIP and SP|Adverse Event|4|||
94330182|NCT01412060|322990123|FG001|Period Between RIP and SP|Adverse Event|0|||
94330183|NCT01412060|322990124|FG002|Period Between RIP and SP|Adverse Event|0|||
94330184|NCT01412060|322990122|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
94330185|NCT01412060|322990123|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
94330186|NCT01412060|322990124|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
94330187|NCT01412060|322990122|FG000|Period Between RIP and SP|Protocol Violation|2|||
94330188|NCT01412060|322990123|FG001|Period Between RIP and SP|Protocol Violation|0|||
94330189|NCT01412060|322990124|FG002|Period Between RIP and SP|Protocol Violation|0|||
94330190|NCT01412060|322990122|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
94330191|NCT01412060|322990123|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
94330192|NCT01412060|322990124|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
94330193|NCT01412060|322990122|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
94330194|NCT01412060|322990123|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
94330195|NCT01412060|322990124|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
94330196|NCT01412060|322990122|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
94330197|NCT01412060|322990123|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
94330198|NCT01412060|322990124|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
94330199|NCT01412060|322990122|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
94330200|NCT01412060|322990123|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
94330201|NCT01412060|322990124|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
94330202|NCT01412060|322990122|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
94330203|NCT01412060|322990123|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
94330204|NCT01412060|322990124|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
94330205|NCT01412060|322990122|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
94330206|NCT01412060|322990123|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
94330207|NCT01412060|322990124|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
94330208|NCT01412060|322990122|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
94330209|NCT01412060|322990123|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
94330210|NCT01412060|322990124|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
94330211|NCT01412060|322990122|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
94330212|NCT01412060|322990123|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
94330213|NCT01412060|322990124|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
94330214|NCT01412060|322990122|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
94330215|NCT01412060|322990123|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
94330216|NCT01412060|322990124|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
94330217|NCT01412060|322990122|FG000|Period Between SP and DBP|Protocol Violation|2|||
94330218|NCT01412060|322990123|FG001|Period Between SP and DBP|Protocol Violation|0|||
94330219|NCT01412060|322990124|FG002|Period Between SP and DBP|Protocol Violation|0|||
94330220|NCT01412060|322990122|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
94330221|NCT01412060|322990123|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
94330222|NCT01412060|322990124|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
94330223|NCT01412060|322990122|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
94330224|NCT01412060|322990123|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
94330225|NCT01412060|322990124|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
94330226|NCT01412060|322990122|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
94330227|NCT01412060|322990123|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
94330228|NCT01412060|322990124|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
94330229|NCT01412060|322990122|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
94330230|NCT01412060|322990123|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
94330231|NCT01412060|322990124|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
94330232|NCT01412060|322990122|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
94330233|NCT01412060|322990123|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
94330234|NCT01412060|322990124|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
94330235|NCT01412060|322990122|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
94400461|NCT00902538|323253222|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
94400462|NCT00902538|323253223|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
94400463|NCT00902538|323253224|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
94400464|NCT00902538|323253225|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
94400465|NCT00902538|323253226|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
94400466|NCT00902538|323253221|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
94400467|NCT00902538|323253222|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
94400468|NCT00902538|323253223|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
94400469|NCT00902538|323253224|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
94400470|NCT00902538|323253225|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
94400471|NCT00902538|323253226|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
94400472|NCT00902538|323253221|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
94400473|NCT00902538|323253222|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
94400474|NCT00902538|323253223|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
94400475|NCT00902538|323253224|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
94400476|NCT00902538|323253225|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
94400477|NCT00902538|323253226|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
94400478|NCT00902538|323253221|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
94400479|NCT00902538|323253222|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
94400480|NCT00902538|323253223|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
94400481|NCT00902538|323253224|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
94400482|NCT00902538|323253225|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
94400483|NCT00902538|323253226|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
94400484|NCT00902538|323253221|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
94400485|NCT00902538|323253222|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
94400486|NCT00902538|323253223|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
94400487|NCT00902538|323253224|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
94400488|NCT00902538|323253225|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
94400489|NCT00902538|323253226|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
94400490|NCT03531827|323253227|FG000|Overall Study|Adverse Event|2|||
94400491|NCT03531827|323253228|FG001|Overall Study|Adverse Event|0|||
94400492|NCT03531827|323253227|FG000|Overall Study|Progressive disease|1|||
94400493|NCT03531827|323253228|FG001|Overall Study|Progressive disease|0|||
94400494|NCT03684928|323253229|FG000|First Intervention|Lost to Follow-up|0|||
94400495|NCT03684928|323253230|FG001|First Intervention|Lost to Follow-up|1|||
94400496|NCT03684928|323253229|FG000|First Intervention|Withdrawal by Subject|0|||
94400497|NCT03684928|323253230|FG001|First Intervention|Withdrawal by Subject|2|||
94400498|NCT03684928|323253229|FG000|Second Intervention|Soft Tissue Injury|1|||
94400499|NCT03684928|323253230|FG001|Second Intervention|Soft Tissue Injury|0|||
94400500|NCT04750239|323253234|FG000|Overall Study|Withdrawal by Subject|2|||
94400501|NCT04750239|323253234|FG000|Overall Study|Trial terminated by sponsor|1|||
94400502|NCT01912807|323253235|FG000|Overall Study|Did not meet elegibility criteria|6|||
94400503|NCT01912807|323253236|FG001|Overall Study|Did not meet elegibility criteria|4|||
94400504|NCT01912807|323253235|FG000|Overall Study|Lost to Follow-up|36|||
94400505|NCT01912807|323253236|FG001|Overall Study|Lost to Follow-up|37|||
94400506|NCT00919711|323253239|FG000|Overall Study|Withdrawal by Subject|15|||
94400507|NCT00919711|323253240|FG001|Overall Study|Withdrawal by Subject|7|||
94400508|NCT00919711|323253239|FG000|Overall Study|Adverse Event|13|||
94400509|NCT00919711|323253240|FG001|Overall Study|Adverse Event|3|||
94400510|NCT00919711|323253239|FG000|Overall Study|Other|1|||
94400511|NCT00919711|323253240|FG001|Overall Study|Other|2|||
94400512|NCT00919711|323253239|FG000|Overall Study|Administrative Decision|0|||
94400513|NCT00919711|323253240|FG001|Overall Study|Administrative Decision|1|||
94400514|NCT00919711|323253239|FG000|Overall Study|Lost to Follow-up|2|||
94400515|NCT00919711|323253240|FG001|Overall Study|Lost to Follow-up|0|||
94400516|NCT00919711|323253239|FG000|Overall Study|Death|1|||
94400517|NCT00919711|323253240|FG001|Overall Study|Death|0|||
94400518|NCT00919711|323253239|FG000|Overall Study|Noncompliance|1|||
94400519|NCT00919711|323253240|FG001|Overall Study|Noncompliance|0|||
94400520|NCT00903877|323253241|FG000|Overall Study|Did not meet study criteria|33|||
94400521|NCT00903877|323253241|FG000|Overall Study|Withdrawal by Subject|3|||
94400522|NCT00903877|323253241|FG000|Overall Study|Adverse Event|2|||
94400523|NCT00903877|323253241|FG000|Overall Study|Lost to Follow-up|1|||
94400524|NCT00903877|323253241|FG000|Overall Study|Participation put on hold|4|||
94400525|NCT02535923|323253243|FG000|Overall Study|Lost to Follow-up|5|||
94400526|NCT02535923|323253244|FG001|Overall Study|Lost to Follow-up|5|||
94400527|NCT02535923|323253243|FG000|Overall Study|Withdrawal by Subject|4|||
94400528|NCT02535923|323253244|FG001|Overall Study|Withdrawal by Subject|3|||
94400529|NCT01018862|323253247|FG000|Overall Study|Adverse Event|2|||
94400530|NCT01018862|323253248|FG001|Overall Study|Adverse Event|0|||
94400531|NCT01018862|323253249|FG002|Overall Study|Adverse Event|6|||
94484978|NCT03533751|323567616|FG000|Overall Study|Sponsor Decision|0|||
94400532|NCT01018862|323253247|FG000|Overall Study|Lack of Efficacy|1|||
94400533|NCT01018862|323253248|FG001|Overall Study|Lack of Efficacy|0|||
94400534|NCT01018862|323253249|FG002|Overall Study|Lack of Efficacy|2|||
94484979|NCT03533751|323567617|FG001|Overall Study|Sponsor Decision|0|||
94484980|NCT03533751|323567618|FG002|Overall Study|Sponsor Decision|1|||
94484981|NCT03533751|323567619|FG003|Overall Study|Sponsor Decision|1|||
94484982|NCT03533751|323567620|FG004|Overall Study|Sponsor Decision|0|||
94484983|NCT03533751|323567616|FG000|Overall Study|Lost to Follow-up|3|||
94484984|NCT03533751|323567617|FG001|Overall Study|Lost to Follow-up|7|||
94484985|NCT03533751|323567618|FG002|Overall Study|Lost to Follow-up|6|||
94484986|NCT03533751|323567619|FG003|Overall Study|Lost to Follow-up|4|||
94484987|NCT03533751|323567620|FG004|Overall Study|Lost to Follow-up|3|||
94484988|NCT03533751|323567616|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
94484989|NCT03533751|323567617|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
94484990|NCT03533751|323567618|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
94484991|NCT03533751|323567619|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
94484992|NCT03533751|323567620|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
94484993|NCT03533751|323567616|FG000|Overall Study|Other|0|||
94484994|NCT03533751|323567617|FG001|Overall Study|Other|2|||
94484995|NCT03533751|323567618|FG002|Overall Study|Other|1|||
94484996|NCT03533751|323567619|FG003|Overall Study|Other|0|||
94484997|NCT03533751|323567620|FG004|Overall Study|Other|3|||
94484998|NCT01884597|323567621|FG000|Overall Study|Adverse Event|0|||
94484999|NCT01884597|323567622|FG001|Overall Study|Adverse Event|0|||
94485000|NCT01884597|323567623|FG002|Overall Study|Adverse Event|1|||
94485001|NCT01884597|323567621|FG000|Overall Study|Lack of Efficacy|1|||
94485002|NCT01884597|323567622|FG001|Overall Study|Lack of Efficacy|0|||
94485003|NCT01884597|323567623|FG002|Overall Study|Lack of Efficacy|0|||
94485004|NCT01884597|323567621|FG000|Overall Study|Death|0|||
94485005|NCT01884597|323567622|FG001|Overall Study|Death|1|||
94485006|NCT01884597|323567623|FG002|Overall Study|Death|0|||
94485007|NCT01081626|323567624|FG000|Overall Study|Dosing error|1|||
94485008|NCT01081626|323567625|FG001|Overall Study|Dosing error|1|||
94485009|NCT01081626|323567624|FG000|Overall Study|Missing Estradiol|25|||
94485010|NCT01081626|323567625|FG001|Overall Study|Missing Estradiol|28|||
94485011|NCT01081626|323567624|FG000|Overall Study|Low antral follicle count|1|||
94485012|NCT01081626|323567625|FG001|Overall Study|Low antral follicle count|0|||
94485013|NCT01081626|323567624|FG000|Overall Study|Overstimulation|0|||
94485014|NCT01081626|323567625|FG001|Overall Study|Overstimulation|1|||
94485015|NCT01081626|323567624|FG000|Overall Study|Lost to Follow-up|0|||
94330236|NCT01412060|322990123|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
94330237|NCT01412060|322990124|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
94330238|NCT01412060|322990122|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
94330239|NCT01412060|322990123|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
94330240|NCT01412060|322990124|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
94330241|NCT01412060|322990122|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
94330242|NCT01412060|322990123|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
94330243|NCT01412060|322990124|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
94330244|NCT01412060|322990122|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
94330245|NCT01412060|322990123|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
94330246|NCT01412060|322990124|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
94330247|NCT01412060|322990122|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
94330248|NCT01412060|322990123|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
94330249|NCT01412060|322990124|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
94330250|NCT02807844|322990125|FG000|Overall Study|Physician Decision|0|||
94330251|NCT02807844|322990126|FG001|Overall Study|Physician Decision|0|||
94330252|NCT02807844|322990127|FG002|Overall Study|Physician Decision|0|||
94330253|NCT02807844|322990128|FG003|Overall Study|Physician Decision|0|||
94330254|NCT02807844|322990129|FG004|Overall Study|Physician Decision|0|||
94330255|NCT02807844|322990130|FG005|Overall Study|Physician Decision|0|||
94330256|NCT02807844|322990131|FG006|Overall Study|Physician Decision|3|||
94330257|NCT02807844|322990132|FG007|Overall Study|Physician Decision|0|||
94330258|NCT02807844|322990133|FG008|Overall Study|Physician Decision|1|||
94400535|NCT01018862|323253247|FG000|Overall Study|Lost to Follow-up|3|||
94400536|NCT01018862|323253248|FG001|Overall Study|Lost to Follow-up|1|||
94400537|NCT01018862|323253249|FG002|Overall Study|Lost to Follow-up|0|||
94400538|NCT01018862|323253247|FG000|Overall Study|Protocol Violation|1|||
94400539|NCT01018862|323253248|FG001|Overall Study|Protocol Violation|3|||
94400540|NCT01018862|323253249|FG002|Overall Study|Protocol Violation|3|||
94400541|NCT01018862|323253247|FG000|Overall Study|Withdrawal by Subject|1|||
94400542|NCT01018862|323253248|FG001|Overall Study|Withdrawal by Subject|2|||
94400543|NCT01018862|323253249|FG002|Overall Study|Withdrawal by Subject|1|||
94400544|NCT01018862|323253247|FG000|Overall Study|administrative problems|5|||
94400545|NCT01018862|323253248|FG001|Overall Study|administrative problems|4|||
94400546|NCT01018862|323253249|FG002|Overall Study|administrative problems|4|||
94400547|NCT01253564|323253250|FG000|Overall Study|Disease Progression|22|||
94485016|NCT01081626|323567625|FG001|Overall Study|Lost to Follow-up|1|||
94485017|NCT01081626|323567624|FG000|Overall Study|Other|33|||
94485018|NCT01081626|323567625|FG001|Overall Study|Other|30|||
94485019|NCT01324947|323567626|FG000|Overall Study|Adverse Event|7|||
94485020|NCT01324947|323567626|FG000|Overall Study|Death|10|||
94485021|NCT01324947|323567626|FG000|Overall Study|Other|3|||
94485022|NCT01324947|323567626|FG000|Overall Study|Progressive Disease|50|||
94485023|NCT01324947|323567626|FG000|Overall Study|Withdrawal by Subject|3|||
94485024|NCT01324947|323567626|FG000|Overall Study|1 discontinued before starting drug|1|||
94485025|NCT01274351|323567627|FG000|Overall Study|Lost to Follow-up|1|||
94485026|NCT01274351|323567627|FG000|Overall Study|patient not compliant with the protocol|1|||
94485027|NCT01274351|323567627|FG000|Overall Study|Pregnancy|1|||
94485028|NCT01274351|323567627|FG000|Overall Study|Death|2|||
94485029|NCT01274351|323567627|FG000|Overall Study|Withdrawal by Subject|3|||
94485030|NCT01274351|323567627|FG000|Overall Study|Adverse Event|8|||
94485031|NCT01274351|323567627|FG000|Overall Study|progression of disease|3|||
94485032|NCT01274351|323567627|FG000|Overall Study|hospitalization|1|||
94485033|NCT01296412|323567628|FG000|Overall Study|Adverse Event|8|||
94485034|NCT01296412|323567629|FG001|Overall Study|Adverse Event|29|||
94485035|NCT01296412|323567628|FG000|Overall Study|Lack of Efficacy|1|||
94485036|NCT01296412|323567629|FG001|Overall Study|Lack of Efficacy|0|||
94485037|NCT01296412|323567628|FG000|Overall Study|Lost to Follow-up|10|||
94485038|NCT01296412|323567629|FG001|Overall Study|Lost to Follow-up|7|||
94485039|NCT01296412|323567628|FG000|Overall Study|Non-compliance with study drug|1|||
94485040|NCT01296412|323567629|FG001|Overall Study|Non-compliance with study drug|2|||
94485041|NCT01296412|323567628|FG000|Overall Study|Other reason not specified|20|||
94485042|NCT01296412|323567629|FG001|Overall Study|Other reason not specified|15|||
94485043|NCT01296412|323567628|FG000|Overall Study|Physician Decision|1|||
94485044|NCT01296412|323567629|FG001|Overall Study|Physician Decision|3|||
94485045|NCT01296412|323567628|FG000|Overall Study|Pregnancy|0|||
94485046|NCT01296412|323567629|FG001|Overall Study|Pregnancy|1|||
94485047|NCT01296412|323567628|FG000|Overall Study|Withdrawal by Subject|10|||
94485048|NCT01296412|323567629|FG001|Overall Study|Withdrawal by Subject|13|||
94485049|NCT02100124|323567631|FG000|Overall Study|Lost to Follow-up|5|||
94485050|NCT02100124|323567632|FG001|Overall Study|Lost to Follow-up|11|||
94485051|NCT02100124|323567633|FG002|Overall Study|Lost to Follow-up|3|||
94485052|NCT02100124|323567631|FG000|Overall Study|Withdrawal by Subject|1|||
94485053|NCT02100124|323567632|FG001|Overall Study|Withdrawal by Subject|0|||
94485054|NCT02100124|323567633|FG002|Overall Study|Withdrawal by Subject|0|||
94485055|NCT01317641|323569996|FG000|Overall Study|Not treated|0|||
94485056|NCT01317641|323569997|FG001|Overall Study|Not treated|0|||
94485057|NCT01317641|323569998|FG002|Overall Study|Not treated|0|||
94485058|NCT01317641|323569999|FG003|Overall Study|Not treated|0|||
94485059|NCT01317641|323570000|FG004|Overall Study|Not treated|0|||
94485060|NCT01317641|323570001|FG005|Overall Study|Not treated|0|||
94485061|NCT01317641|323570002|FG006|Overall Study|Not treated|0|||
94485062|NCT01317641|323570003|FG007|Overall Study|Not treated|1|||
94485063|NCT01317641|323570004|FG008|Overall Study|Not treated|1|||
94485064|NCT01317641|323569996|FG000|Overall Study|Adverse Event|0|||
94485065|NCT01317641|323569997|FG001|Overall Study|Adverse Event|1|||
94485066|NCT01317641|323569998|FG002|Overall Study|Adverse Event|0|||
94485067|NCT01317641|323569999|FG003|Overall Study|Adverse Event|1|||
94485068|NCT01317641|323570000|FG004|Overall Study|Adverse Event|0|||
94485069|NCT01317641|323570001|FG005|Overall Study|Adverse Event|0|||
94485070|NCT01317641|323570002|FG006|Overall Study|Adverse Event|2|||
94485071|NCT01317641|323570003|FG007|Overall Study|Adverse Event|1|||
94485072|NCT01317641|323570004|FG008|Overall Study|Adverse Event|0|||
94485073|NCT01317641|323569996|FG000|Overall Study|Protocol Violation|1|||
94485074|NCT01317641|323569997|FG001|Overall Study|Protocol Violation|0|||
94485075|NCT01317641|323569998|FG002|Overall Study|Protocol Violation|0|||
94485076|NCT01317641|323569999|FG003|Overall Study|Protocol Violation|0|||
94485077|NCT01317641|323570000|FG004|Overall Study|Protocol Violation|0|||
94485078|NCT01317641|323570001|FG005|Overall Study|Protocol Violation|0|||
94485079|NCT01317641|323570002|FG006|Overall Study|Protocol Violation|0|||
94485080|NCT01317641|323570003|FG007|Overall Study|Protocol Violation|0|||
94485081|NCT01317641|323570004|FG008|Overall Study|Protocol Violation|0|||
94485082|NCT01317641|323569996|FG000|Overall Study|Disease progression|0|||
94485083|NCT01317641|323569997|FG001|Overall Study|Disease progression|0|||
94485084|NCT01317641|323569998|FG002|Overall Study|Disease progression|0|||
94485085|NCT01317641|323569999|FG003|Overall Study|Disease progression|0|||
94485086|NCT01317641|323570000|FG004|Overall Study|Disease progression|0|||
94485087|NCT01317641|323570001|FG005|Overall Study|Disease progression|0|||
94485088|NCT01317641|323570002|FG006|Overall Study|Disease progression|0|||
94485089|NCT01317641|323570003|FG007|Overall Study|Disease progression|3|||
94485090|NCT01317641|323570004|FG008|Overall Study|Disease progression|4|||
94485091|NCT01317641|323569996|FG000|Overall Study|Withdrawal by Subject|0|||
94485092|NCT01317641|323569997|FG001|Overall Study|Withdrawal by Subject|0|||
94485093|NCT01317641|323569998|FG002|Overall Study|Withdrawal by Subject|0|||
94485094|NCT01317641|323569999|FG003|Overall Study|Withdrawal by Subject|0|||
94485095|NCT01317641|323570000|FG004|Overall Study|Withdrawal by Subject|0|||
94485096|NCT01317641|323570001|FG005|Overall Study|Withdrawal by Subject|0|||
94485097|NCT01317641|323570002|FG006|Overall Study|Withdrawal by Subject|1|||
94485098|NCT01317641|323570003|FG007|Overall Study|Withdrawal by Subject|0|||
94485099|NCT01317641|323570004|FG008|Overall Study|Withdrawal by Subject|0|||
94485100|NCT01094288|323570005|FG000|Overall Study|Adverse Event|0|||
94485101|NCT01094288|323570006|FG001|Overall Study|Adverse Event|3|||
94400548|NCT01253564|323253250|FG000|Overall Study|Withdrawal by Subject|1|||
94400549|NCT01253564|323253250|FG000|Overall Study|Serious Adverse Event|1|||
94400550|NCT00798603|323255101|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
94485102|NCT01094288|323570007|FG002|Overall Study|Adverse Event|1|||
94485103|NCT01094288|323570008|FG003|Overall Study|Adverse Event|1|||
94485104|NCT01094288|323570009|FG004|Overall Study|Adverse Event|0|||
94485105|NCT01094288|323570010|FG005|Overall Study|Adverse Event|0|||
94485106|NCT01094288|323570011|FG006|Overall Study|Adverse Event|0|||
94485107|NCT01094288|323570012|FG007|Overall Study|Adverse Event|0|||
94485108|NCT01094288|323570005|FG000|Overall Study|Withdrawal by Subject|0|||
94485109|NCT01094288|323570006|FG001|Overall Study|Withdrawal by Subject|1|||
94485110|NCT01094288|323570007|FG002|Overall Study|Withdrawal by Subject|2|||
94485111|NCT01094288|323570008|FG003|Overall Study|Withdrawal by Subject|0|||
94485112|NCT01094288|323570009|FG004|Overall Study|Withdrawal by Subject|0|||
94485113|NCT01094288|323570010|FG005|Overall Study|Withdrawal by Subject|0|||
94400551|NCT00798603|323255101|FG000|Overall Study|Withdrawal by Subject|10|||
94400552|NCT00798603|323255101|FG000|Overall Study|Adverse Event|22|||
94400553|NCT00798603|323255101|FG000|Overall Study|Physician Decision|1|||
94400554|NCT00798603|323255101|FG000|Overall Study|Lack of insurance coverage|1|||
94400555|NCT00521586|323255108|FG000|Initial Vaccination (Year 0)|Subject request|8|||
94400556|NCT00521586|323255109|FG001|Initial Vaccination (Year 0)|Subject request|11|||
94400557|NCT00521586|323255108|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
94400558|NCT00521586|323255109|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
94400559|NCT00521586|323255108|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
94400560|NCT00521586|323255109|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
94400561|NCT00521586|323255108|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
94400562|NCT00521586|323255109|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
94400563|NCT00521586|323255108|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
94400564|NCT00521586|323255109|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
94400565|NCT00521586|323255108|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
94400566|NCT00521586|323255109|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
94400567|NCT00521586|323255108|FG000|Initial Vaccination (Year 0)|Death|1|||
94400568|NCT00521586|323255109|FG001|Initial Vaccination (Year 0)|Death|0|||
94400569|NCT00521586|323255108|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
94400570|NCT00521586|323255109|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
94400571|NCT00521586|323255108|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
94400572|NCT00521586|323255109|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
94400573|NCT00521586|323255108|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
94400574|NCT00521586|323255109|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
94400575|NCT00521586|323255108|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
94400576|NCT00521586|323255109|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
94400577|NCT00521586|323255108|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
94400578|NCT00521586|323255109|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
94400579|NCT00521586|323255108|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
94400580|NCT00521586|323255109|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
94400581|NCT00521586|323255108|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
94400582|NCT00521586|323255109|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
94400583|NCT00521586|323255108|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
94400584|NCT00521586|323255109|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
94400585|NCT00521586|323255108|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
94400586|NCT00521586|323255109|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
94400587|NCT00521586|323255108|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
94400588|NCT00521586|323255109|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
94400589|NCT00521586|323255108|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
94400590|NCT00521586|323255109|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
94400591|NCT00521586|323255108|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
94400592|NCT00521586|323255109|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
94400593|NCT02997176|323255110|FG000|Overall Study|Adverse Event|0|||
94400594|NCT02997176|323255111|FG001|Overall Study|Adverse Event|0|||
94400595|NCT02997176|323255112|FG002|Overall Study|Adverse Event|0|||
94400596|NCT02997176|323255113|FG003|Overall Study|Adverse Event|8|||
94400597|NCT02997176|323255110|FG000|Overall Study|Progressive Disease|1|||
94400598|NCT02997176|323255111|FG001|Overall Study|Progressive Disease|0|||
94400599|NCT02997176|323255112|FG002|Overall Study|Progressive Disease|1|||
94400600|NCT02997176|323255113|FG003|Overall Study|Progressive Disease|1|||
94400601|NCT02997176|323255110|FG000|Overall Study|Death|0|||
94400602|NCT02997176|323255111|FG001|Overall Study|Death|0|||
94485114|NCT01094288|323570011|FG006|Overall Study|Withdrawal by Subject|0|||
94485115|NCT01094288|323570012|FG007|Overall Study|Withdrawal by Subject|2|||
94485116|NCT01094288|323570005|FG000|Overall Study|Initiation of Alternative Therapy|0|||
94400603|NCT02997176|323255112|FG002|Overall Study|Death|1|||
94400604|NCT02997176|323255113|FG003|Overall Study|Death|1|||
94400605|NCT02997176|323255110|FG000|Overall Study|Withdrawal by Subject|0|||
94400606|NCT02997176|323255111|FG001|Overall Study|Withdrawal by Subject|2|||
94400607|NCT02997176|323255112|FG002|Overall Study|Withdrawal by Subject|0|||
94400608|NCT02997176|323255113|FG003|Overall Study|Withdrawal by Subject|1|||
94400609|NCT02107196|323255117|FG000|12-week Treatment Period|Adverse Event|6|||
94400610|NCT02107196|323255118|FG001|12-week Treatment Period|Adverse Event|3|||
94400611|NCT02107196|323255117|FG000|12-week Treatment Period|Lack of Efficacy|2|||
94400612|NCT02107196|323255118|FG001|12-week Treatment Period|Lack of Efficacy|1|||
94400613|NCT02107196|323255117|FG000|12-week Treatment Period|Lost to Follow-up|3|||
94400614|NCT02107196|323255118|FG001|12-week Treatment Period|Lost to Follow-up|6|||
94400615|NCT02107196|323255117|FG000|12-week Treatment Period|Physician Decision|0|||
94400616|NCT02107196|323255118|FG001|12-week Treatment Period|Physician Decision|1|||
94400617|NCT02107196|323255117|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
94400618|NCT02107196|323255118|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
94400619|NCT02107196|323255117|FG000|12-week Treatment Period|Protocol Violation|7|||
94400620|NCT02107196|323255118|FG001|12-week Treatment Period|Protocol Violation|8|||
94400621|NCT02107196|323255117|FG000|12-week Treatment Period|Reason Missing|11|||
94400622|NCT02107196|323255118|FG001|12-week Treatment Period|Reason Missing|8|||
94400623|NCT02107196|323255117|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
94400624|NCT02107196|323255118|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
94400625|NCT02107196|323255117|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
94400626|NCT02107196|323255118|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
94400627|NCT02107196|323255117|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
94400628|NCT02107196|323255118|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
94400629|NCT02107196|323255117|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
94400630|NCT02107196|323255118|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
94400631|NCT01117623|323255124|FG000|Overall Study|Adverse Event|0|||
94400632|NCT01117623|323255125|FG001|Overall Study|Adverse Event|2|||
94400633|NCT01117623|323255126|FG002|Overall Study|Adverse Event|4|||
94400634|NCT01117623|323255127|FG003|Overall Study|Adverse Event|0|||
94400635|NCT01117623|323255128|FG004|Overall Study|Adverse Event|2|||
94400636|NCT01117623|323255129|FG005|Overall Study|Adverse Event|0|||
94400637|NCT01117623|323255130|FG006|Overall Study|Adverse Event|0|||
94400638|NCT01117623|323255131|FG007|Overall Study|Adverse Event|2|||
94400639|NCT01117623|323255124|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
94400640|NCT01117623|323255125|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
94400641|NCT01117623|323255126|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
94400642|NCT01117623|323255127|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
94400643|NCT01117623|323255128|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
94400644|NCT01117623|323255129|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
94400645|NCT01117623|323255130|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
94400646|NCT01117623|323255131|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
94400647|NCT01117623|323255124|FG000|Overall Study|Withdrawal by Subject|0|||
94400648|NCT01117623|323255125|FG001|Overall Study|Withdrawal by Subject|0|||
94400649|NCT01117623|323255126|FG002|Overall Study|Withdrawal by Subject|2|||
94400650|NCT01117623|323255127|FG003|Overall Study|Withdrawal by Subject|0|||
94400651|NCT01117623|323255128|FG004|Overall Study|Withdrawal by Subject|0|||
94400652|NCT01117623|323255129|FG005|Overall Study|Withdrawal by Subject|1|||
94400653|NCT01117623|323255130|FG006|Overall Study|Withdrawal by Subject|1|||
94400654|NCT01117623|323255131|FG007|Overall Study|Withdrawal by Subject|1|||
94400655|NCT01117623|323255124|FG000|Overall Study|Non-compliance with study medication|0|||
94400656|NCT01117623|323255125|FG001|Overall Study|Non-compliance with study medication|0|||
94400657|NCT01117623|323255126|FG002|Overall Study|Non-compliance with study medication|0|||
94400658|NCT01117623|323255127|FG003|Overall Study|Non-compliance with study medication|0|||
94400659|NCT01117623|323255128|FG004|Overall Study|Non-compliance with study medication|0|||
94400660|NCT01117623|323255129|FG005|Overall Study|Non-compliance with study medication|0|||
94400661|NCT01117623|323255130|FG006|Overall Study|Non-compliance with study medication|0|||
94400662|NCT01117623|323255131|FG007|Overall Study|Non-compliance with study medication|1|||
94400663|NCT01117623|323255124|FG000|Overall Study|Invest. text: completed all planned txs|0|||
94400664|NCT01117623|323255125|FG001|Overall Study|Invest. text: completed all planned txs|0|||
94400665|NCT01117623|323255126|FG002|Overall Study|Invest. text: completed all planned txs|0|||
94400666|NCT01117623|323255127|FG003|Overall Study|Invest. text: completed all planned txs|0|||
94400667|NCT01117623|323255128|FG004|Overall Study|Invest. text: completed all planned txs|0|||
94400668|NCT01117623|323255129|FG005|Overall Study|Invest. text: completed all planned txs|1|||
94400669|NCT01117623|323255130|FG006|Overall Study|Invest. text: completed all planned txs|0|||
94400670|NCT01117623|323255131|FG007|Overall Study|Invest. text: completed all planned txs|0|||
94400671|NCT02727192|323255132|FG000|Overall Study|Lost to Follow-up|1|||
94400672|NCT02727192|323255133|FG001|Overall Study|Lost to Follow-up|0|||
94400673|NCT02727192|323255134|FG002|Overall Study|Lost to Follow-up|0|||
94485117|NCT01094288|323570006|FG001|Overall Study|Initiation of Alternative Therapy|0|||
94485118|NCT01094288|323570007|FG002|Overall Study|Initiation of Alternative Therapy|1|||
94485119|NCT01094288|323570008|FG003|Overall Study|Initiation of Alternative Therapy|0|||
94485120|NCT01094288|323570009|FG004|Overall Study|Initiation of Alternative Therapy|0|||
94485121|NCT01094288|323570010|FG005|Overall Study|Initiation of Alternative Therapy|0|||
94485122|NCT01094288|323570011|FG006|Overall Study|Initiation of Alternative Therapy|0|||
94485123|NCT01094288|323570012|FG007|Overall Study|Initiation of Alternative Therapy|0|||
94485124|NCT01094288|323570005|FG000|Overall Study|Reason not Specified|2|||
94485125|NCT01094288|323570006|FG001|Overall Study|Reason not Specified|3|||
94485126|NCT01094288|323570007|FG002|Overall Study|Reason not Specified|0|||
94485127|NCT01094288|323570008|FG003|Overall Study|Reason not Specified|1|||
94485128|NCT01094288|323570009|FG004|Overall Study|Reason not Specified|0|||
94485129|NCT01094288|323570010|FG005|Overall Study|Reason not Specified|0|||
94485130|NCT01094288|323570011|FG006|Overall Study|Reason not Specified|0|||
94485131|NCT01094288|323570012|FG007|Overall Study|Reason not Specified|0|||
94485132|NCT01094288|323570005|FG000|Overall Study|Ongoing Participants|0|||
94485133|NCT01094288|323570006|FG001|Overall Study|Ongoing Participants|3|||
94485134|NCT01094288|323570007|FG002|Overall Study|Ongoing Participants|0|||
94485135|NCT01094288|323570008|FG003|Overall Study|Ongoing Participants|0|||
94485136|NCT01094288|323570009|FG004|Overall Study|Ongoing Participants|0|||
94485137|NCT01094288|323570010|FG005|Overall Study|Ongoing Participants|0|||
94485138|NCT01094288|323570011|FG006|Overall Study|Ongoing Participants|0|||
94485139|NCT01094288|323570012|FG007|Overall Study|Ongoing Participants|0|||
94485140|NCT03205150|323570015|FG000|Overall Study|Protocol deviation|1|||
94485141|NCT03205150|323570016|FG001|Overall Study|Protocol deviation|3|||
94485142|NCT03205150|323570017|FG002|Overall Study|Protocol deviation|0|||
94485143|NCT03205150|323570015|FG000|Overall Study|Patient/guardian decision|0|||
94485144|NCT03205150|323570016|FG001|Overall Study|Patient/guardian decision|3|||
94485145|NCT03205150|323570017|FG002|Overall Study|Patient/guardian decision|0|||
94485146|NCT03205150|323570015|FG000|Overall Study|Adverse Event|1|||
94485147|NCT03205150|323570016|FG001|Overall Study|Adverse Event|1|||
94485148|NCT03205150|323570017|FG002|Overall Study|Adverse Event|1|||
94485149|NCT03205150|323570015|FG000|Overall Study|Lost to Follow-up|0|||
94485150|NCT03205150|323570016|FG001|Overall Study|Lost to Follow-up|0|||
94485151|NCT03205150|323570017|FG002|Overall Study|Lost to Follow-up|1|||
94485152|NCT01251952|323570018|FG000|Overall Study|Adverse Event|1|||
94485153|NCT02812186|323570022|FG000|Period 1|Post randomization screen failure|5|||
94485154|NCT02812186|323570023|FG001|Period 1|Post randomization screen failure|9|||
94485155|NCT02812186|323570022|FG000|Period 1|nonevaluable data sets|6|||
94485156|NCT02812186|323570023|FG001|Period 1|nonevaluable data sets|6|||
94485157|NCT01053741|323570028|FG000|2nd Study Intervention|Physician Decision|0|||
94485158|NCT01053741|323570029|FG001|2nd Study Intervention|Physician Decision|1|||
94485159|NCT01307787|323570030|FG000|Overall Study|Withdrawal by Subject|2|||
94485160|NCT01307787|323570031|FG001|Overall Study|Withdrawal by Subject|0|||
94485161|NCT03353792|323570035|FG000|Overall Study|Lost to Follow-up|1|||
94485162|NCT03353792|323570036|FG001|Overall Study|Lost to Follow-up|0|||
94485163|NCT03353792|323570035|FG000|Overall Study|Participant Unable to Manage Device|1|||
94485164|NCT03353792|323570036|FG001|Overall Study|Participant Unable to Manage Device|0|||
94485165|NCT02498678|323570037|FG000|Overall Study|interference from the surgical team|0|||
94485166|NCT02498678|323570038|FG001|Overall Study|interference from the surgical team|2|||
94485167|NCT01405560|323570049|FG000|Overall Study|Physician Decision|1|||
94485168|NCT02683109|323570050|FG000|Overall Study|Adverse Event|1|||
94485169|NCT02683109|323570051|FG001|Overall Study|Adverse Event|0|||
94485170|NCT00896493|323570054|FG000|Overall Study|Early disease relapse|3|||
94485171|NCT01868646|323570055|FG000|Overall Study|Do not meet inclusion criteria|3|||
94485172|NCT01868646|323570056|FG001|Overall Study|Do not meet inclusion criteria|5|||
94485173|NCT01450813|323570058|FG000|Overall Study|Physician Decision|1|||
94485174|NCT01450813|323570059|FG001|Overall Study|Physician Decision|1|||
94485175|NCT01450813|323570060|FG002|Overall Study|Physician Decision|0|||
94485176|NCT01450813|323570061|FG003|Overall Study|Physician Decision|3|||
94485177|NCT00960193|323570074|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
94485178|NCT03322293|323570081|FG000|Overall Study|Lost to Follow-up|0|||
94485179|NCT03322293|323570082|FG001|Overall Study|Lost to Follow-up|0|||
94485180|NCT03322293|323570083|FG002|Overall Study|Lost to Follow-up|1|||
94485181|NCT00473655|323570086|FG000|Overall Study|Lost to Follow-up|9|||
94485182|NCT00473655|323570087|FG001|Overall Study|Lost to Follow-up|5|||
94485183|NCT00473655|323570088|FG002|Overall Study|Lost to Follow-up|8|||
94485184|NCT03439137|323570089|FG000|Overall Study|Adverse Event|16|||
94485185|NCT03439137|323570090|FG001|Overall Study|Adverse Event|12|||
94485186|NCT03439137|323570089|FG000|Overall Study|Physician Decision|0|||
94485187|NCT03439137|323570090|FG001|Overall Study|Physician Decision|5|||
94485188|NCT03439137|323570089|FG000|Overall Study|Withdrawal by Subject|14|||
94485189|NCT03439137|323570090|FG001|Overall Study|Withdrawal by Subject|4|||
94485190|NCT03439137|323570089|FG000|Overall Study|Conducting rescue therapy|2|||
94485191|NCT03439137|323570090|FG001|Overall Study|Conducting rescue therapy|1|||
94485192|NCT03439137|323570089|FG000|Overall Study|Difficult to control Hb|10|||
94485193|NCT03439137|323570090|FG001|Overall Study|Difficult to control Hb|2|||
94485194|NCT03439137|323570089|FG000|Overall Study|Initiation of a renal transplant|0|||
94485195|NCT03439137|323570090|FG001|Overall Study|Initiation of a renal transplant|2|||
94485196|NCT01240382|323570091|FG000|Overall Study|Adverse Event|2|||
94400674|NCT02451696|323255139|FG000|Overall Study|Surgery postponed|1|||
94400675|NCT02451696|323255140|FG001|Overall Study|Surgery postponed|0|||
94400676|NCT02854800|323255145|FG000|Overall Study|Protocol Violation|16|||
94400677|NCT02854800|323255146|FG001|Overall Study|Protocol Violation|11|||
94400678|NCT02854800|323255147|FG002|Overall Study|Protocol Violation|3|||
94400679|NCT02854800|323255145|FG000|Overall Study|Withdrawal by Subject|4|||
94400680|NCT02854800|323255146|FG001|Overall Study|Withdrawal by Subject|2|||
94400681|NCT02854800|323255147|FG002|Overall Study|Withdrawal by Subject|3|||
94400682|NCT05274763|323255148|FG000|Overall Study|Lost to Follow-up|1|||
94400683|NCT03073798|323255154|FG000|Overall Study|Adverse Event|1|||
94400684|NCT03073798|323255154|FG000|Overall Study|Withdrawal by Subject|1|||
94400685|NCT04567329|323255155|FG000|Overall Study|Withdrawal by Subject|5|||
94400686|NCT04567329|323255156|FG001|Overall Study|Withdrawal by Subject|6|||
94400687|NCT04567329|323255155|FG000|Overall Study|Protocol Violation|2|||
94400688|NCT04567329|323255156|FG001|Overall Study|Protocol Violation|3|||
94400689|NCT04567329|323255155|FG000|Overall Study|Discontinued|2|||
94400690|NCT04567329|323255156|FG001|Overall Study|Discontinued|2|||
94400691|NCT04567329|323255155|FG000|Overall Study|Lost to Follow-up|0|||
94400692|NCT04567329|323255156|FG001|Overall Study|Lost to Follow-up|1|||
94400693|NCT04567329|323255155|FG000|Overall Study|Lack of Efficacy|0|||
94400694|NCT04567329|323255156|FG001|Overall Study|Lack of Efficacy|1|||
94400695|NCT01945580|323255157|FG000|Overall Study|Withdrawal by Subject|13|||
94400696|NCT01945580|323255158|FG001|Overall Study|Withdrawal by Subject|35|||
94400697|NCT01945580|323255157|FG000|Overall Study|Physician Decision|3|||
94400698|NCT01945580|323255158|FG001|Overall Study|Physician Decision|2|||
94400699|NCT01945580|323255157|FG000|Overall Study|Lost to Follow-up|26|||
94400700|NCT01945580|323255158|FG001|Overall Study|Lost to Follow-up|39|||
94400701|NCT01945580|323255157|FG000|Overall Study|Death|7|||
94400702|NCT01945580|323255158|FG001|Overall Study|Death|2|||
94400703|NCT01945580|323255157|FG000|Overall Study|Patient moved out of state|0|||
94400704|NCT01945580|323255158|FG001|Overall Study|Patient moved out of state|1|||
94400705|NCT01945580|323255157|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
94400706|NCT01945580|323255158|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
94400707|NCT01945580|323255157|FG000|Overall Study|Family illness - unable to return|0|||
94400708|NCT01945580|323255158|FG001|Overall Study|Family illness - unable to return|1|||
94400709|NCT01945580|323255157|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
94400710|NCT01945580|323255158|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
94400711|NCT01945580|323255157|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
94400712|NCT01945580|323255158|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
94400713|NCT01945580|323255157|FG000|Overall Study|Noncompliance with 36 month visit|1|||
94400714|NCT01945580|323255158|FG001|Overall Study|Noncompliance with 36 month visit|0|||
94400715|NCT01945580|323255157|FG000|Overall Study|The patient moved.|1|||
94400716|NCT01945580|323255158|FG001|Overall Study|The patient moved.|0|||
94400717|NCT01945580|323255157|FG000|Overall Study|No data available|0|||
94400718|NCT01945580|323255158|FG001|Overall Study|No data available|2|||
94400719|NCT02933060|323255159|FG000|Overall Study|Withdrawal by Subject|0|||
94400720|NCT02933060|323255160|FG001|Overall Study|Withdrawal by Subject|1|||
94400721|NCT04411680|323255163|FG000|Treatment Period|Adverse Event|3|||
94400722|NCT04411680|323255164|FG001|Treatment Period|Adverse Event|0|||
94400723|NCT04411680|323255163|FG000|Treatment Period|Discharged from hospital|18|||
94400724|NCT04411680|323255164|FG001|Treatment Period|Discharged from hospital|7|||
94400725|NCT04411680|323255163|FG000|Treatment Period|Missed 1 or more doses|8|||
94400726|NCT04411680|323255164|FG001|Treatment Period|Missed 1 or more doses|0|||
94400727|NCT04411680|323255163|FG000|Treatment Period|Transferred to another hospital|0|||
94485197|NCT01240382|323570092|FG001|Overall Study|Adverse Event|1|||
94400728|NCT04411680|323255164|FG001|Treatment Period|Transferred to another hospital|1|||
94400729|NCT04411680|323255163|FG000|Follow up Period|Withdrawal by Subject|2|||
94400730|NCT04411680|323255164|FG001|Follow up Period|Withdrawal by Subject|0|||
94400731|NCT04411680|323255163|FG000|Follow up Period|Lost to Follow-up|5|||
94400732|NCT04411680|323255164|FG001|Follow up Period|Lost to Follow-up|6|||
94400733|NCT04411680|323255163|FG000|Follow up Period|Death|11|||
94400734|NCT04411680|323255164|FG001|Follow up Period|Death|8|||
94400735|NCT05034874|323255165|FG000|Overall Study|Withdrawal by Subject|6|||
94400736|NCT05034874|323255166|FG001|Overall Study|Withdrawal by Subject|6|||
94400737|NCT05034874|323255165|FG000|Overall Study|Lost to Follow-up|18|||
94400738|NCT05034874|323255166|FG001|Overall Study|Lost to Follow-up|8|||
94400739|NCT05034874|323255165|FG000|Overall Study|Physician Decision|0|||
94400740|NCT05034874|323255166|FG001|Overall Study|Physician Decision|1|||
94400741|NCT05034874|323255165|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
94485198|NCT01240382|323570091|FG000|Overall Study|Lack of Efficacy|0|||
94400742|NCT05034874|323255166|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
94400743|NCT02957331|323255167|FG000|Overall Study|Protocol Violation|1|||
94400744|NCT02957331|323255168|FG001|Overall Study|Protocol Violation|0|||
94400745|NCT00101439|323255169|FG000|Period 2|Withdrawal by Subject|0|||
94400746|NCT00101439|323255170|FG001|Period 2|Withdrawal by Subject|2|||
94400747|NCT02845336|323255177|FG000|Overall Study|Lost to Follow-up|3|||
94400748|NCT02845336|323255178|FG001|Overall Study|Lost to Follow-up|1|||
94400749|NCT02845336|323255177|FG000|Overall Study|Inability to get medication|2|||
94400750|NCT02845336|323255178|FG001|Overall Study|Inability to get medication|0|||
94400751|NCT00841659|323255180|FG000|Washout: 2 Weeks|Protocol Violation|1|||
94400752|NCT00841659|323255181|FG001|Washout: 2 Weeks|Protocol Violation|0|||
94400753|NCT02054715|323255188|FG000|Baseline/Follow-up 1|Refused|1|||
94400754|NCT02054715|323255189|FG001|Baseline/Follow-up 1|Refused|3|||
94400755|NCT02054715|323255188|FG000|Baseline/Follow-up 1|Medical|0|||
94400756|NCT02054715|323255189|FG001|Baseline/Follow-up 1|Medical|1|||
94400757|NCT02054715|323255188|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
94400758|NCT02054715|323255189|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
94400759|NCT02054715|323255188|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
94400760|NCT02054715|323255189|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
94400761|NCT02054715|323255188|FG000|Baseline/Follow-up 1|No Reason|0|||
94400762|NCT02054715|323255189|FG001|Baseline/Follow-up 1|No Reason|1|||
94400763|NCT02054715|323255188|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
94400764|NCT02054715|323255189|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
94400765|NCT02054715|323255188|FG000|Baseline/Follow-up 1|Ineligible|3|||
94400766|NCT02054715|323255189|FG001|Baseline/Follow-up 1|Ineligible|0|||
94400767|NCT02054715|323255188|FG000|Baseline/Follow-up 1|Hospitalization|1|||
94400768|NCT02054715|323255189|FG001|Baseline/Follow-up 1|Hospitalization|0|||
94400769|NCT02054715|323255188|FG000|Baseline/Follow-up 1|Changed Mind|1|||
94400770|NCT02054715|323255189|FG001|Baseline/Follow-up 1|Changed Mind|0|||
94400771|NCT02054715|323255188|FG000|Follow-up 2|Lost to Followup|3|||
94400772|NCT02054715|323255189|FG001|Follow-up 2|Lost to Followup|1|||
94400773|NCT02054715|323255188|FG000|Follow-up 2|Refused|3|||
94400774|NCT02054715|323255189|FG001|Follow-up 2|Refused|2|||
94400775|NCT02054715|323255188|FG000|Follow-up 2|Followup Not Completed|3|||
94400776|NCT02054715|323255189|FG001|Follow-up 2|Followup Not Completed|4|||
94400777|NCT02054715|323255188|FG000|Follow-up 2|Ineligible|4|||
94400778|NCT02054715|323255189|FG001|Follow-up 2|Ineligible|5|||
94400779|NCT02054715|323255188|FG000|Follow-up 2|Death|3|||
94400780|NCT02054715|323255189|FG001|Follow-up 2|Death|3|||
94400781|NCT02054715|323255188|FG000|Follow-up 2|Hospitalization|0|||
94400782|NCT02054715|323255189|FG001|Follow-up 2|Hospitalization|2|||
94400783|NCT02054715|323255188|FG000|Follow-up 2|Changed MD/Facility|0|||
94400784|NCT02054715|323255189|FG001|Follow-up 2|Changed MD/Facility|1|||
94400785|NCT02054715|323255188|FG000|Follow-up 2|Changed Mind|0|||
94400786|NCT02054715|323255189|FG001|Follow-up 2|Changed Mind|1|||
94400787|NCT02054715|323255188|FG000|Follow-up 2|No Reason|2|||
94400788|NCT02054715|323255189|FG001|Follow-up 2|No Reason|0|||
94400789|NCT02054715|323255188|FG000|Follow-up 2|Treatment Change or Delay|1|||
94400790|NCT02054715|323255189|FG001|Follow-up 2|Treatment Change or Delay|0|||
94400791|NCT03499873|323255193|FG000|Overall Study|Withdrawal by Subject|4|||
94400792|NCT03499873|323255194|FG001|Overall Study|Withdrawal by Subject|6|||
94485199|NCT01240382|323570092|FG001|Overall Study|Lack of Efficacy|2|||
94485200|NCT01240382|323570091|FG000|Overall Study|Fear of adverse events|0|||
94485201|NCT01240382|323570092|FG001|Overall Study|Fear of adverse events|1|||
94485202|NCT05081388|323570093|FG000|Overall Study|Adverse Event|1|||
94400793|NCT03499873|323255195|FG002|Overall Study|Withdrawal by Subject|1|||
94400794|NCT03499873|323255193|FG000|Overall Study|Subjects condition worsened|0|||
94400795|NCT03499873|323255194|FG001|Overall Study|Subjects condition worsened|3|||
94400796|NCT03499873|323255195|FG002|Overall Study|Subjects condition worsened|11|||
94400797|NCT03499873|323255193|FG000|Overall Study|Adverse Event|8|||
94400798|NCT03499873|323255194|FG001|Overall Study|Adverse Event|3|||
94400799|NCT03499873|323255195|FG002|Overall Study|Adverse Event|6|||
94400800|NCT03499873|323255193|FG000|Overall Study|Physician Decision|1|||
94400801|NCT03499873|323255194|FG001|Overall Study|Physician Decision|0|||
94400802|NCT03499873|323255195|FG002|Overall Study|Physician Decision|0|||
94400803|NCT03499873|323255193|FG000|Overall Study|Administrative reasons|0|||
94400804|NCT03499873|323255194|FG001|Overall Study|Administrative reasons|1|||
94400805|NCT03499873|323255195|FG002|Overall Study|Administrative reasons|0|||
94400806|NCT03499873|323255193|FG000|Overall Study|Concomitant therapy|5|||
94400807|NCT03499873|323255194|FG001|Overall Study|Concomitant therapy|4|||
94400808|NCT03499873|323255195|FG002|Overall Study|Concomitant therapy|7|||
94400809|NCT03499873|323255193|FG000|Overall Study|Miscellaneous|1|||
94400810|NCT03499873|323255194|FG001|Overall Study|Miscellaneous|2|||
94485203|NCT05081388|323570094|FG001|Overall Study|Adverse Event|0|||
94400811|NCT03499873|323255195|FG002|Overall Study|Miscellaneous|2|||
94400812|NCT03499873|323255193|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
94400813|NCT03499873|323255194|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
94400814|NCT03499873|323255195|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
94485204|NCT05081388|323570095|FG002|Overall Study|Adverse Event|0|||
94485205|NCT05081388|323570096|FG003|Overall Study|Adverse Event|0|||
94485206|NCT05081388|323570097|FG004|Overall Study|Adverse Event|0|||
94485207|NCT05081388|323570093|FG000|Overall Study|Lost to Follow-up|0|||
94485208|NCT05081388|323570094|FG001|Overall Study|Lost to Follow-up|1|||
94485209|NCT05081388|323570095|FG002|Overall Study|Lost to Follow-up|0|||
94485210|NCT05081388|323570096|FG003|Overall Study|Lost to Follow-up|0|||
94485211|NCT05081388|323570097|FG004|Overall Study|Lost to Follow-up|0|||
94485212|NCT05081388|323570093|FG000|Overall Study|Subject decision|0|||
94485213|NCT05081388|323570094|FG001|Overall Study|Subject decision|0|||
94485214|NCT05081388|323570095|FG002|Overall Study|Subject decision|0|||
94485215|NCT05081388|323570096|FG003|Overall Study|Subject decision|1|||
94485216|NCT05081388|323570097|FG004|Overall Study|Subject decision|0|||
94485217|NCT00192114|323570098|FG000|Overall Study|Objective Tumor Progression|19|||
94485218|NCT00192114|323570098|FG000|Overall Study|Adverse Event|2|||
94485219|NCT00192114|323570098|FG000|Overall Study|Clinical Progression|2|||
94485220|NCT00192114|323570098|FG000|Overall Study|Death|1|||
94485221|NCT01222104|323570099|FG000|Overall Study|Lost to Follow-up|37|||
94485222|NCT01222104|323570099|FG000|Overall Study|Death|10|||
94485223|NCT00230048|323570101|FG000|Overall Study|Lost to Follow-up|13|||
94485224|NCT00230048|323570102|FG001|Overall Study|Lost to Follow-up|18|||
94485225|NCT02869789|323570103|FG000|Overall Study|Disease progression|184|||
94485226|NCT02869789|323570104|FG001|Overall Study|Disease progression|109|||
94485227|NCT02869789|323570105|FG002|Overall Study|Disease progression|260|||
94485228|NCT02869789|323570106|FG003|Overall Study|Disease progression|19|||
94485229|NCT02869789|323570103|FG000|Overall Study|Study drug toxicity|90|||
94485230|NCT02869789|323570104|FG001|Overall Study|Study drug toxicity|32|||
94485231|NCT02869789|323570105|FG002|Overall Study|Study drug toxicity|55|||
94485232|NCT02869789|323570106|FG003|Overall Study|Study drug toxicity|14|||
94330259|NCT02807844|322990134|FG009|Overall Study|Physician Decision|2|||
94330260|NCT02807844|322990125|FG000|Overall Study|Death|0|||
94330261|NCT02807844|322990126|FG001|Overall Study|Death|0|||
94330262|NCT02807844|322990127|FG002|Overall Study|Death|2|||
94330263|NCT02807844|322990128|FG003|Overall Study|Death|4|||
94330264|NCT02807844|322990129|FG004|Overall Study|Death|1|||
94330265|NCT02807844|322990130|FG005|Overall Study|Death|2|||
94330266|NCT02807844|322990131|FG006|Overall Study|Death|1|||
94330267|NCT02807844|322990132|FG007|Overall Study|Death|2|||
94330268|NCT02807844|322990133|FG008|Overall Study|Death|0|||
94330269|NCT02807844|322990134|FG009|Overall Study|Death|1|||
94330270|NCT02807844|322990125|FG000|Overall Study|Withdrawal by Subject|0|||
94330271|NCT02807844|322990126|FG001|Overall Study|Withdrawal by Subject|0|||
94330272|NCT02807844|322990127|FG002|Overall Study|Withdrawal by Subject|2|||
94330273|NCT02807844|322990128|FG003|Overall Study|Withdrawal by Subject|1|||
94330274|NCT02807844|322990129|FG004|Overall Study|Withdrawal by Subject|1|||
94330275|NCT02807844|322990130|FG005|Overall Study|Withdrawal by Subject|0|||
94330276|NCT02807844|322990131|FG006|Overall Study|Withdrawal by Subject|1|||
94330277|NCT02807844|322990132|FG007|Overall Study|Withdrawal by Subject|0|||
94330278|NCT02807844|322990133|FG008|Overall Study|Withdrawal by Subject|0|||
94330279|NCT02807844|322990134|FG009|Overall Study|Withdrawal by Subject|0|||
94330280|NCT02807844|322990125|FG000|Overall Study|Progressive disease|5|||
94330281|NCT02807844|322990126|FG001|Overall Study|Progressive disease|12|||
94330282|NCT02807844|322990127|FG002|Overall Study|Progressive disease|8|||
94330283|NCT02807844|322990128|FG003|Overall Study|Progressive disease|8|||
94330284|NCT02807844|322990129|FG004|Overall Study|Progressive disease|3|||
94330285|NCT02807844|322990130|FG005|Overall Study|Progressive disease|8|||
94330286|NCT02807844|322990131|FG006|Overall Study|Progressive disease|14|||
94330287|NCT02807844|322990132|FG007|Overall Study|Progressive disease|17|||
94330288|NCT02807844|322990133|FG008|Overall Study|Progressive disease|19|||
94330289|NCT02807844|322990134|FG009|Overall Study|Progressive disease|15|||
94330290|NCT02807844|322990125|FG000|Overall Study|Adverse Event|1|||
94330291|NCT02807844|322990126|FG001|Overall Study|Adverse Event|0|||
94330292|NCT02807844|322990127|FG002|Overall Study|Adverse Event|0|||
94330293|NCT02807844|322990128|FG003|Overall Study|Adverse Event|0|||
94330294|NCT02807844|322990129|FG004|Overall Study|Adverse Event|1|||
94330295|NCT02807844|322990130|FG005|Overall Study|Adverse Event|1|||
94330296|NCT02807844|322990131|FG006|Overall Study|Adverse Event|1|||
94330297|NCT02807844|322990132|FG007|Overall Study|Adverse Event|1|||
94330298|NCT02807844|322990133|FG008|Overall Study|Adverse Event|1|||
94330299|NCT02807844|322990134|FG009|Overall Study|Adverse Event|2|||
94330300|NCT03097029|322990135|FG000|Overall Study|Withdrawal by Subject|1|||
94485233|NCT02869789|323570103|FG000|Overall Study|Death|7|||
94485234|NCT02869789|323570104|FG001|Overall Study|Death|3|||
94485235|NCT02869789|323570105|FG002|Overall Study|Death|5|||
94485236|NCT02869789|323570106|FG003|Overall Study|Death|1|||
94330301|NCT00373490|322990137|FG000|Overall Study|Adverse Event|0|||
94330302|NCT00373490|322990138|FG001|Overall Study|Adverse Event|1|||
94330303|NCT00373490|322990137|FG000|Overall Study|Lack of Efficacy|9|||
94330304|NCT00373490|322990138|FG001|Overall Study|Lack of Efficacy|4|||
94330305|NCT00373490|322990137|FG000|Overall Study|Withdrawal by Subject|0|||
94485237|NCT02869789|323570103|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
94330306|NCT00373490|322990138|FG001|Overall Study|Withdrawal by Subject|1|||
94400815|NCT01964950|323255196|FG000|Overall Study|Protocol Violation|25|||
94400816|NCT03306277|323255197|FG000|Overall Study|Death|1|||
94400817|NCT03306277|323255197|FG000|Overall Study|Adverse Event|1|||
94400818|NCT03306277|323255197|FG000|Overall Study|Withdrawal by Subject|1|||
94400819|NCT00301964|323255198|FG000|Overall Study|Second primary|2|||
94400820|NCT00301964|323255198|FG000|Overall Study|Wrong primary|1|||
94400821|NCT00301964|323255198|FG000|Overall Study|Inadequate pathology|1|||
94400822|NCT00728754|323255205|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
94400823|NCT00728754|323255206|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
94400824|NCT00728754|323255205|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
94400825|NCT00728754|323255206|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
94400826|NCT00728754|323255205|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
94400827|NCT00728754|323255206|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
94400828|NCT01559363|323255207|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
94400829|NCT01559363|323255208|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
94400830|NCT01559363|323255209|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
94400831|NCT01559363|323255210|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
94400832|NCT01559363|323255211|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
94400833|NCT01559363|323255212|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
94400834|NCT01559363|323255207|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
94400835|NCT01559363|323255208|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
94400836|NCT01559363|323255209|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
94400837|NCT01559363|323255210|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
94400838|NCT01559363|323255211|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
94400839|NCT01559363|323255212|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
94400840|NCT01559363|323255207|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
94400841|NCT01559363|323255208|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
94400842|NCT01559363|323255209|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
94400843|NCT01559363|323255210|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
94400844|NCT01559363|323255211|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
94400845|NCT01559363|323255212|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
94400846|NCT01559363|323255207|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
94400847|NCT01559363|323255208|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
94400848|NCT01559363|323255209|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
94400849|NCT01559363|323255210|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
94400850|NCT01559363|323255211|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
94400851|NCT01559363|323255212|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
94400852|NCT01559363|323255207|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
94400853|NCT01559363|323255208|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
94400854|NCT01559363|323255209|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
94400855|NCT01559363|323255210|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
94330307|NCT00753688|322990145|FG000|Overall Study|Death|102|||
94330308|NCT00753688|322990146|FG001|Overall Study|Death|203|||
94330309|NCT00753688|322990145|FG000|Overall Study|Missing|4|||
94330310|NCT00753688|322990146|FG001|Overall Study|Missing|9|||
94330311|NCT00753688|322990145|FG000|Overall Study|Participant Withdrew Consent|2|||
94330312|NCT00753688|322990146|FG001|Overall Study|Participant Withdrew Consent|2|||
94330313|NCT00753688|322990145|FG000|Overall Study|Ongoing - in Follow-up|15|||
94330314|NCT00753688|322990146|FG001|Overall Study|Ongoing - in Follow-up|31|||
94330315|NCT00753688|322990145|FG000|Overall Study|Adverse Event|0|||
94330316|NCT00753688|322990146|FG001|Overall Study|Adverse Event|1|||
94330317|NCT00004732|322990147|FG000|Overall Study|Withdrawal by Subject|36|||
94330318|NCT00004732|322990148|FG001|Overall Study|Withdrawal by Subject|64|||
94330319|NCT00004732|322990147|FG000|Overall Study|Lost to Follow-up|33|||
94330320|NCT00004732|322990148|FG001|Overall Study|Lost to Follow-up|47|||
94330321|NCT04294095|322990152|FG000|Overall Study|Adverse Event|1|||
94330322|NCT04294095|322990153|FG001|Overall Study|Adverse Event|0|||
94330323|NCT02661464|322990155|FG000|Overall Study|Lost to Follow-up|28|||
94330324|NCT02661464|322990156|FG001|Overall Study|Lost to Follow-up|0|||
94330325|NCT02661464|322990157|FG002|Overall Study|Lost to Follow-up|0|||
94330326|NCT02661464|322990158|FG003|Overall Study|Lost to Follow-up|0|||
94330327|NCT02661464|322990155|FG000|Overall Study|Withdrawal by Subject|3|||
94330328|NCT02661464|322990156|FG001|Overall Study|Withdrawal by Subject|1|||
94330329|NCT02661464|322990157|FG002|Overall Study|Withdrawal by Subject|0|||
94400856|NCT01559363|323255211|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
94400857|NCT01559363|323255212|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
94330330|NCT02661464|322990158|FG003|Overall Study|Withdrawal by Subject|0|||
94330331|NCT02661464|322990155|FG000|Overall Study|Participants terminated prematurely|288|||
94330332|NCT02661464|322990156|FG001|Overall Study|Participants terminated prematurely|52|||
94330333|NCT02661464|322990157|FG002|Overall Study|Participants terminated prematurely|1|||
94330334|NCT02661464|322990158|FG003|Overall Study|Participants terminated prematurely|1|||
94330335|NCT02661464|322990155|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
94400858|NCT01559363|323255207|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
94400859|NCT01559363|323255208|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
94400860|NCT01559363|323255209|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
94400861|NCT01559363|323255210|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
94400862|NCT01559363|323255211|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
94400863|NCT01559363|323255212|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
94400864|NCT01559363|323255207|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
94400865|NCT01559363|323255208|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
94400866|NCT01559363|323255209|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
94400867|NCT01559363|323255210|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
94400868|NCT01559363|323255211|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
94400869|NCT01559363|323255212|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
94400870|NCT01926119|323255216|FG000|Overall Study|Withdrawal by Subject|1|||
94400871|NCT00645853|323255217|FG000|Overall Study|Adverse Event|18|||
94400872|NCT00645853|323255218|FG001|Overall Study|Adverse Event|7|||
94400873|NCT00645853|323255217|FG000|Overall Study|AZ study closure in Hungary|60|||
94400874|NCT00645853|323255218|FG001|Overall Study|AZ study closure in Hungary|40|||
94400875|NCT00645853|323255217|FG000|Overall Study|Withdrawal by Subject|5|||
94400876|NCT00645853|323255218|FG001|Overall Study|Withdrawal by Subject|2|||
94400877|NCT00645853|323255217|FG000|Overall Study|Protocol Violation|0|||
94400878|NCT00645853|323255218|FG001|Overall Study|Protocol Violation|2|||
94400879|NCT00645853|323255217|FG000|Overall Study|Discontinuation criteria|2|||
94400880|NCT00645853|323255218|FG001|Overall Study|Discontinuation criteria|2|||
94400881|NCT00645853|323255217|FG000|Overall Study|recall of ICF, planned operation, death|7|||
94400882|NCT00645853|323255218|FG001|Overall Study|recall of ICF, planned operation, death|4|||
94400883|NCT00406393|323255227|FG000|Overall Study|Did not undergo transplantation|2|||
94400884|NCT00406393|323255228|FG001|Overall Study|Did not undergo transplantation|1|||
94400885|NCT01559116|323255231|FG000|Overall Study|Adverse Event|10|||
94400886|NCT01559116|323255231|FG000|Overall Study|Lack of Efficacy|1|||
94400887|NCT01559116|323255231|FG000|Overall Study|Lost to Follow-up|1|||
94400888|NCT01559116|323255231|FG000|Overall Study|Protocol Violation|1|||
94400889|NCT01559116|323255231|FG000|Overall Study|Withdrawal by Subject|4|||
94400890|NCT01559116|323255231|FG000|Overall Study|other than stated above|9|||
94400891|NCT00562718|323255232|FG000|Overall Study|Death|1|||
94400892|NCT00562718|323255232|FG000|Overall Study|Withdrawal by Subject|3|||
94400893|NCT00562718|323255232|FG000|Overall Study|Adverse Event|4|||
94400894|NCT00562718|323255232|FG000|Overall Study|Lack of Efficacy|2|||
94400895|NCT00562718|323255232|FG000|Overall Study|not stated|1|||
94400896|NCT01151618|323255233|FG000|Overall Study|Adverse Event|2|||
94400897|NCT01151618|323255233|FG000|Overall Study|Withdrawal by Subject|7|||
94400898|NCT01868243|323255234|FG000|Overall Study|Death|0|||
94400899|NCT01868243|323255235|FG001|Overall Study|Death|1|||
94400900|NCT02227238|323255236|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
94400901|NCT02227238|323255237|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
94400902|NCT02227238|323255238|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
94400903|NCT02227238|323255236|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
94400904|NCT02227238|323255237|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
94400905|NCT02227238|323255238|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
94400906|NCT02227238|323255236|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
94400907|NCT02227238|323255237|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
94400908|NCT02227238|323255238|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
94400909|NCT02227238|323255236|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
94400910|NCT02227238|323255237|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
94400911|NCT02227238|323255238|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
94400912|NCT02227238|323255236|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
94400913|NCT02227238|323255237|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
94400914|NCT02227238|323255238|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
94400915|NCT02227238|323255236|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
94400916|NCT02227238|323255237|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
94400917|NCT02227238|323255238|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
94400918|NCT02227238|323255236|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
94400919|NCT02227238|323255237|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
94400920|NCT02227238|323255238|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
94400921|NCT02227238|323255236|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
94400922|NCT02227238|323255237|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
94400923|NCT02227238|323255238|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
94400924|NCT02227238|323255236|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
94400925|NCT02227238|323255237|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
94400926|NCT02227238|323255238|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
94400927|NCT02227238|323255236|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
94400928|NCT02227238|323255237|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
94400929|NCT02227238|323255238|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
94400930|NCT02227238|323255236|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
94400931|NCT02227238|323255237|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
94400932|NCT02227238|323255238|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
94400933|NCT02227238|323255236|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
94400934|NCT02227238|323255237|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
94400935|NCT02227238|323255238|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
94400936|NCT02227238|323255236|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
94400937|NCT02227238|323255237|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
94400938|NCT02227238|323255238|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
94400939|NCT02227238|323255236|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
94400940|NCT02227238|323255237|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
94400941|NCT02227238|323255238|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
94400942|NCT01632306|323255239|FG000|Overall Study|Protocol Violation|1|||
94400943|NCT01632306|323255240|FG001|Overall Study|Protocol Violation|0|||
94400944|NCT01632306|323255241|FG002|Overall Study|Protocol Violation|0|||
94400945|NCT00985751|323255242|FG000|Overall Study|Adverse Event|0|||
94400946|NCT00985751|323255243|FG001|Overall Study|Adverse Event|0|||
94400947|NCT00985751|323255244|FG002|Overall Study|Adverse Event|0|||
94400948|NCT00985751|323255245|FG003|Overall Study|Adverse Event|0|||
94400949|NCT00985751|323255246|FG004|Overall Study|Adverse Event|1|||
94400950|NCT03277248|323255247|FG000|Overall Study|Adverse Event|3|||
94400951|NCT03277248|323255248|FG001|Overall Study|Adverse Event|1|||
94400952|NCT03277248|323255247|FG000|Overall Study|Subject Withdrawal of Consent|6|||
94400953|NCT03277248|323255248|FG001|Overall Study|Subject Withdrawal of Consent|23|||
94400954|NCT03277248|323255247|FG000|Overall Study|Investigator/Sponsor Decision|2|||
94400955|NCT03277248|323255248|FG001|Overall Study|Investigator/Sponsor Decision|2|||
94400956|NCT03277248|323255247|FG000|Overall Study|Pregnancy|4|||
94400957|NCT03277248|323255248|FG001|Overall Study|Pregnancy|1|||
94400958|NCT03277248|323255247|FG000|Overall Study|Lost to Follow-up|0|||
94400959|NCT03277248|323255248|FG001|Overall Study|Lost to Follow-up|2|||
94400960|NCT03277248|323255247|FG000|Overall Study|Lack of Efficacy|0|||
94400961|NCT03277248|323255248|FG001|Overall Study|Lack of Efficacy|2|||
94400962|NCT03277248|323255247|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
94400963|NCT03277248|323255248|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
94400964|NCT01046084|323255251|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
94400965|NCT01046084|323255252|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
94400966|NCT00999687|323255253|FG000|First Intervention|Withdrawal by Subject|1|||
94400967|NCT00999687|323255253|FG000|Second Intervention|Withdrawal by Subject|2|||
94400968|NCT00999687|323255253|FG000|Second Intervention|Lack of Efficacy|1|||
94400969|NCT03614728|323255255|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
94400970|NCT03614728|323255256|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
94400971|NCT03614728|323255257|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
94400972|NCT03614728|323255258|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
94400973|NCT03614728|323255255|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
94400974|NCT03614728|323255256|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
94400975|NCT03614728|323255257|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
94400976|NCT03614728|323255258|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
94400977|NCT01116739|323256752|FG000|Overall Study|Child had 2 years of HS|110|||
94400978|NCT01116739|323256753|FG001|Overall Study|Child had 2 years of HS|128|||
94400979|NCT01116739|323256752|FG000|Overall Study|Withdrawal by Subject|6|||
94400980|NCT01116739|323256753|FG001|Overall Study|Withdrawal by Subject|0|||
94400981|NCT01116739|323256752|FG000|Overall Study|child too young|2|||
94400982|NCT01116739|323256753|FG001|Overall Study|child too young|6|||
94400983|NCT01116739|323256752|FG000|Overall Study|child not enrolled in head start|10|||
94400984|NCT01116739|323256753|FG001|Overall Study|child not enrolled in head start|2|||
94400985|NCT01116739|323256752|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
94400986|NCT01116739|323256753|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
94400987|NCT02255149|323256754|FG000|Overall Study|Lost to Follow-up|2|||
94400988|NCT02255149|323256754|FG000|Overall Study|Withdrawal by Subject|1|||
94400989|NCT02255149|323256754|FG000|Overall Study|Withdrawal by PI|1|||
94400990|NCT02255149|323256754|FG000|Overall Study|Implant Failure|1|||
94400991|NCT00529763|323256755|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
94400992|NCT00529763|323256756|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
94400993|NCT00529763|323256757|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
94485238|NCT02869789|323570104|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
94400994|NCT00529763|323256755|FG000|Overall Study|Death|1|||
94400995|NCT00529763|323256756|FG001|Overall Study|Death|1|||
94400996|NCT00529763|323256757|FG002|Overall Study|Death|1|||
94400997|NCT00529763|323256755|FG000|Overall Study|Disease Progression|10|||
94400998|NCT00529763|323256756|FG001|Overall Study|Disease Progression|16|||
94400999|NCT00529763|323256757|FG002|Overall Study|Disease Progression|11|||
94401000|NCT00529763|323256755|FG000|Overall Study|Lost to Follow-up|1|||
94401001|NCT00529763|323256756|FG001|Overall Study|Lost to Follow-up|2|||
94401002|NCT00529763|323256757|FG002|Overall Study|Lost to Follow-up|3|||
94401003|NCT00529763|323256755|FG000|Overall Study|Stem Cell Transplant|0|||
94401004|NCT00529763|323256756|FG001|Overall Study|Stem Cell Transplant|3|||
94401005|NCT00529763|323256757|FG002|Overall Study|Stem Cell Transplant|1|||
94401006|NCT00529763|323256755|FG000|Overall Study|Study Drug Toxicity|3|||
94401007|NCT00529763|323256756|FG001|Overall Study|Study Drug Toxicity|6|||
94401008|NCT00529763|323256757|FG002|Overall Study|Study Drug Toxicity|4|||
94401009|NCT00529763|323256755|FG000|Overall Study|Participant Withdrew Consent|2|||
94401010|NCT00529763|323256756|FG001|Overall Study|Participant Withdrew Consent|3|||
94401011|NCT00529763|323256757|FG002|Overall Study|Participant Withdrew Consent|4|||
94401012|NCT00529763|323256755|FG000|Overall Study|Other reasons|2|||
94401013|NCT00529763|323256756|FG001|Overall Study|Other reasons|0|||
94401014|NCT00529763|323256757|FG002|Overall Study|Other reasons|2|||
94401015|NCT00529763|323256755|FG000|Overall Study|Participant request to discontinue treatment|1|||
94401016|NCT00529763|323256756|FG001|Overall Study|Participant request to discontinue treatment|1|||
94401017|NCT00529763|323256757|FG002|Overall Study|Participant request to discontinue treatment|3|||
94401018|NCT00373256|323256758|FG000|Overall Study|Adverse Event (AE)|1|||
94401019|NCT00373256|323256759|FG001|Overall Study|Adverse Event (AE)|5|||
94401020|NCT00373256|323256758|FG000|Overall Study|Lost to Follow-up|2|||
94401021|NCT00373256|323256759|FG001|Overall Study|Lost to Follow-up|1|||
94401022|NCT00373256|323256758|FG000|Overall Study|Death|9|||
94401023|NCT00373256|323256759|FG001|Overall Study|Death|8|||
94401024|NCT00373256|323256758|FG000|Overall Study|Objective Progression or Relapse|111|||
94401025|NCT00373256|323256759|FG001|Overall Study|Objective Progression or Relapse|104|||
94401026|NCT00373256|323256758|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
94401027|NCT00373256|323256759|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
94401028|NCT00373256|323256758|FG000|Overall Study|Other|73|||
94401029|NCT00373256|323256759|FG001|Overall Study|Other|107|||
94401030|NCT00373256|323256758|FG000|Overall Study|Protocol Violation|0|||
94401031|NCT00373256|323256759|FG001|Overall Study|Protocol Violation|2|||
94401032|NCT00373256|323256758|FG000|Overall Study|Study Terminated by Sponsor|41|||
94401033|NCT00373256|323256759|FG001|Overall Study|Study Terminated by Sponsor|13|||
94401034|NCT01151280|323256760|FG000|Overall Study|Adverse Event|1|||
94401035|NCT01151280|323256760|FG000|Overall Study|Lack of Efficacy|3|||
94401036|NCT02308241|323256761|FG000|Overall Study|Withdrawal by Subject|3|||
94401037|NCT01993186|323256762|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
94401038|NCT01993186|323256763|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
94401039|NCT01993186|323256762|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
94401040|NCT01993186|323256763|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
94401041|NCT01993186|323256762|FG000|Open-Label Extension Period|Other, Not Specified|0|||
94401042|NCT01993186|323256763|FG001|Open-Label Extension Period|Other, Not Specified|1|||
94401043|NCT01993186|323256762|FG000|Open-Label Extension Period|Adverse Event|1|||
94401044|NCT01993186|323256763|FG001|Open-Label Extension Period|Adverse Event|0|||
94401045|NCT01993186|323256762|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
94401046|NCT01993186|323256763|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
94401047|NCT01993186|323256762|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
94401048|NCT01993186|323256763|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
94401049|NCT01993186|323256762|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
94401050|NCT01993186|323256763|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
94401051|NCT00928057|323256764|FG000|Overall Study|Adverse Event|1|||
94401052|NCT00928057|323256765|FG001|Overall Study|Adverse Event|2|||
94401053|NCT00928057|323256764|FG000|Overall Study|Withdrawal by Subject|1|||
94401054|NCT00928057|323256765|FG001|Overall Study|Withdrawal by Subject|0|||
94401055|NCT00928057|323256764|FG000|Overall Study|Lost to Follow-up|0|||
94401056|NCT00928057|323256765|FG001|Overall Study|Lost to Follow-up|1|||
94401057|NCT00928057|323256764|FG000|Overall Study|Protocol Violation|0|||
94401058|NCT00928057|323256765|FG001|Overall Study|Protocol Violation|1|||
94401059|NCT05497557|323256766|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
94401060|NCT05497557|323256767|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
94401061|NCT05497557|323256768|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
94401062|NCT03387462|323256769|FG000|Overall Study|Lost to Follow-up|1|||
94401063|NCT01557751|323256771|FG000|Overall Study|Physician Decision|3|||
94401064|NCT00210639|323256772|FG000|Overall Study|Lost to Follow-up|37|||
94401065|NCT00210639|323256773|FG001|Overall Study|Lost to Follow-up|29|||
94401066|NCT00210639|323256772|FG000|Overall Study|Withdrawal by Subject|8|||
94401067|NCT00210639|323256773|FG001|Overall Study|Withdrawal by Subject|1|||
94401068|NCT00210639|323256772|FG000|Overall Study|Other|18|||
94401069|NCT00210639|323256773|FG001|Overall Study|Other|12|||
94401070|NCT00397254|323256774|FG000|Overall Study|Lost to Follow-up|2|||
94401071|NCT00397254|323256775|FG001|Overall Study|Lost to Follow-up|2|||
94485239|NCT02869789|323570105|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
94401072|NCT04002648|323256776|FG000|Overall Study|Lost to Follow-up|2|||
94401073|NCT04002648|323256777|FG001|Overall Study|Lost to Follow-up|0|||
94401074|NCT03358147|323256778|FG000|Overall Study|Withdrawal by Subject|13|||
94401075|NCT03358147|323256779|FG001|Overall Study|Withdrawal by Subject|19|||
94401076|NCT03358147|323256780|FG002|Overall Study|Withdrawal by Subject|16|||
94401077|NCT03358147|323256781|FG003|Overall Study|Withdrawal by Subject|10|||
94401078|NCT03358147|323256782|FG004|Overall Study|Withdrawal by Subject|5|||
94401079|NCT03358147|323256778|FG000|Overall Study|Adverse Event|3|||
94401080|NCT03358147|323256779|FG001|Overall Study|Adverse Event|9|||
94401081|NCT03358147|323256780|FG002|Overall Study|Adverse Event|7|||
94401082|NCT03358147|323256781|FG003|Overall Study|Adverse Event|5|||
94401083|NCT03358147|323256782|FG004|Overall Study|Adverse Event|2|||
94401084|NCT03358147|323256778|FG000|Overall Study|Lost to Follow-up|4|||
94401085|NCT03358147|323256779|FG001|Overall Study|Lost to Follow-up|3|||
94401086|NCT03358147|323256780|FG002|Overall Study|Lost to Follow-up|7|||
94401087|NCT03358147|323256781|FG003|Overall Study|Lost to Follow-up|6|||
94401088|NCT03358147|323256782|FG004|Overall Study|Lost to Follow-up|4|||
94401089|NCT03358147|323256778|FG000|Overall Study|Major Protocol Deviation|11|||
94401090|NCT03358147|323256779|FG001|Overall Study|Major Protocol Deviation|3|||
94401091|NCT03358147|323256780|FG002|Overall Study|Major Protocol Deviation|2|||
94401092|NCT03358147|323256781|FG003|Overall Study|Major Protocol Deviation|3|||
94401093|NCT03358147|323256782|FG004|Overall Study|Major Protocol Deviation|1|||
94401094|NCT03358147|323256778|FG000|Overall Study|Protocol specified criteria|2|||
94401095|NCT03358147|323256779|FG001|Overall Study|Protocol specified criteria|3|||
94401096|NCT03358147|323256780|FG002|Overall Study|Protocol specified criteria|0|||
94401097|NCT03358147|323256781|FG003|Overall Study|Protocol specified criteria|3|||
94401098|NCT03358147|323256782|FG004|Overall Study|Protocol specified criteria|1|||
94401099|NCT03358147|323256778|FG000|Overall Study|Physician Decision|1|||
94401100|NCT03358147|323256779|FG001|Overall Study|Physician Decision|0|||
94401101|NCT03358147|323256780|FG002|Overall Study|Physician Decision|1|||
94401102|NCT03358147|323256781|FG003|Overall Study|Physician Decision|6|||
94401103|NCT03358147|323256782|FG004|Overall Study|Physician Decision|1|||
94401104|NCT03358147|323256778|FG000|Overall Study|Administrative reasons|0|||
94401105|NCT03358147|323256779|FG001|Overall Study|Administrative reasons|1|||
94401106|NCT03358147|323256780|FG002|Overall Study|Administrative reasons|0|||
94401107|NCT03358147|323256781|FG003|Overall Study|Administrative reasons|3|||
94401108|NCT03358147|323256782|FG004|Overall Study|Administrative reasons|0|||
94401109|NCT03358147|323256778|FG000|Overall Study|Lack of Efficacy|0|||
94401110|NCT03358147|323256779|FG001|Overall Study|Lack of Efficacy|1|||
94401111|NCT03358147|323256780|FG002|Overall Study|Lack of Efficacy|1|||
94401112|NCT03358147|323256781|FG003|Overall Study|Lack of Efficacy|0|||
94401113|NCT03358147|323256782|FG004|Overall Study|Lack of Efficacy|0|||
94401114|NCT02072096|323256783|FG000|Overall Study|Lack of Efficacy|18|||
94401115|NCT02072096|323256784|FG001|Overall Study|Lack of Efficacy|29|||
94401116|NCT02072096|323256783|FG000|Overall Study|Protocol Violation|7|||
94485240|NCT02869789|323570106|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
94485241|NCT02869789|323570103|FG000|Overall Study|Participant request to discontinue study treatment|10|||
94485242|NCT02869789|323570104|FG001|Overall Study|Participant request to discontinue study treatment|5|||
94485243|NCT02869789|323570105|FG002|Overall Study|Participant request to discontinue study treatment|5|||
94485244|NCT02869789|323570106|FG003|Overall Study|Participant request to discontinue study treatment|3|||
94485245|NCT02869789|323570103|FG000|Overall Study|Withdrawal by Subject|5|||
94485246|NCT02869789|323570104|FG001|Overall Study|Withdrawal by Subject|2|||
94485247|NCT02869789|323570105|FG002|Overall Study|Withdrawal by Subject|7|||
94485248|NCT02869789|323570106|FG003|Overall Study|Withdrawal by Subject|2|||
94485249|NCT02869789|323570103|FG000|Overall Study|Lost to Follow-up|0|||
94485250|NCT02869789|323570104|FG001|Overall Study|Lost to Follow-up|0|||
94485251|NCT02869789|323570105|FG002|Overall Study|Lost to Follow-up|2|||
94485252|NCT02869789|323570106|FG003|Overall Study|Lost to Follow-up|0|||
94485253|NCT02869789|323570103|FG000|Overall Study|Maximum clinical benefit|5|||
94485254|NCT02869789|323570104|FG001|Overall Study|Maximum clinical benefit|2|||
94485255|NCT02869789|323570105|FG002|Overall Study|Maximum clinical benefit|1|||
94485256|NCT02869789|323570106|FG003|Overall Study|Maximum clinical benefit|0|||
94485257|NCT02869789|323570103|FG000|Overall Study|Poor/Non-compliance|0|||
94485258|NCT02869789|323570104|FG001|Overall Study|Poor/Non-compliance|2|||
94401117|NCT02072096|323256784|FG001|Overall Study|Protocol Violation|7|||
94401118|NCT02072096|323256783|FG000|Overall Study|Withdrawal by Subject|5|||
94401119|NCT02072096|323256784|FG001|Overall Study|Withdrawal by Subject|7|||
94401120|NCT02072096|323256783|FG000|Overall Study|Adverse Event|5|||
94401121|NCT02072096|323256784|FG001|Overall Study|Adverse Event|2|||
94401122|NCT02072096|323256783|FG000|Overall Study|No Reason Provided|4|||
94401123|NCT02072096|323256784|FG001|Overall Study|No Reason Provided|2|||
94485259|NCT02869789|323570105|FG002|Overall Study|Poor/Non-compliance|1|||
94485260|NCT02869789|323570106|FG003|Overall Study|Poor/Non-compliance|0|||
94401124|NCT02072096|323256783|FG000|Overall Study|Death|2|||
94401125|NCT02072096|323256784|FG001|Overall Study|Death|0|||
94401126|NCT02072096|323256783|FG000|Overall Study|Physician Decision|0|||
94401127|NCT02072096|323256784|FG001|Overall Study|Physician Decision|1|||
94401128|NCT02072096|323256783|FG000|Overall Study|Study Terminated by Sponsor|43|||
94401129|NCT02072096|323256784|FG001|Overall Study|Study Terminated by Sponsor|30|||
94401130|NCT02072096|323256783|FG000|Overall Study|Lost to Follow-up|1|||
94401131|NCT02072096|323256784|FG001|Overall Study|Lost to Follow-up|0|||
94401132|NCT00674128|323256792|FG000|Overall Study|Withdrawal by Subject|25|||
94401133|NCT00674128|323256793|FG001|Overall Study|Withdrawal by Subject|23|||
94401134|NCT04133311|323256795|FG000|Period 1 Double Masked Treatment Period|Death|1|||
94401135|NCT04133311|323256796|FG001|Period 1 Double Masked Treatment Period|Death|0|||
94401136|NCT04133311|323256797|FG002|Period 1 Double Masked Treatment Period|Death|0|||
94401137|NCT04133311|323256798|FG003|Period 1 Double Masked Treatment Period|Death|0|||
94401138|NCT04133311|323256795|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
94401139|NCT04133311|323256796|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
94401140|NCT04133311|323256797|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
94401141|NCT04133311|323256798|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
94401142|NCT04133311|323256795|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
94401143|NCT04133311|323256796|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
94401144|NCT04133311|323256797|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
94401145|NCT04133311|323256798|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
94401146|NCT04133311|323256795|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
94330336|NCT02661464|322990156|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
94330337|NCT02661464|322990157|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
94330338|NCT02661464|322990158|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
94330339|NCT00903370|322990159|FG000|Overall Study|Death|13|||
94330340|NCT00903370|322990160|FG001|Overall Study|Death|10|||
94330341|NCT00903370|322990159|FG000|Overall Study|Withdrawal by Subject|9|||
94330342|NCT00903370|322990160|FG001|Overall Study|Withdrawal by Subject|6|||
94330343|NCT00903370|322990159|FG000|Overall Study|Lost to Follow-up|6|||
94330344|NCT00903370|322990160|FG001|Overall Study|Lost to Follow-up|8|||
94330345|NCT00014911|322990161|FG000|Overall Study|Adverse Event|1|||
94330346|NCT00014911|322990161|FG000|Overall Study|Lost to Follow-up|1|||
94330347|NCT00014911|322990161|FG000|Overall Study|Withdrawal by Subject|6|||
94330348|NCT00014911|322990161|FG000|Overall Study|Unknown Reasons|2|||
94330349|NCT00014911|322990161|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
94330350|NCT00676208|322990162|FG000|Overall Study|Lost to Follow-up|0|||
94330351|NCT00676208|322990163|FG001|Overall Study|Lost to Follow-up|2|||
94330352|NCT00676208|322990162|FG000|Overall Study|Incomplete data|2|||
94330353|NCT00676208|322990163|FG001|Overall Study|Incomplete data|4|||
94330354|NCT02177175|322990164|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
94330355|NCT02177175|322990165|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
94330356|NCT00628758|322990169|FG000|Overall Study|Adverse Event|2|||
94330357|NCT00628758|322990170|FG001|Overall Study|Adverse Event|3|||
94330358|NCT00628758|322990169|FG000|Overall Study|Withdrawal by Subject|6|||
94330359|NCT00628758|322990170|FG001|Overall Study|Withdrawal by Subject|3|||
94330360|NCT00628758|322990169|FG000|Overall Study|Death|1|||
94330361|NCT00628758|322990170|FG001|Overall Study|Death|0|||
94330362|NCT00628758|322990169|FG000|Overall Study|Protocol Violation|5|||
94330363|NCT00628758|322990170|FG001|Overall Study|Protocol Violation|1|||
94330364|NCT00628758|322990169|FG000|Overall Study|Lost to Follow-up|25|||
94330365|NCT00628758|322990170|FG001|Overall Study|Lost to Follow-up|31|||
94330366|NCT00628758|322990169|FG000|Overall Study|Pregnancy|2|||
94330367|NCT00628758|322990170|FG001|Overall Study|Pregnancy|2|||
94330368|NCT00628758|322990169|FG000|Overall Study|Investigator Moved|3|||
94330369|NCT00628758|322990170|FG001|Overall Study|Investigator Moved|0|||
94330370|NCT00628758|322990169|FG000|Overall Study|Treatment Failure|0|||
94330371|NCT00628758|322990170|FG001|Overall Study|Treatment Failure|2|||
94330372|NCT01938001|322990171|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
94330373|NCT01938001|322990172|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
94330374|NCT01938001|322990171|FG000|Pre-Treatment|Death|1|||
94330375|NCT01938001|322990172|FG001|Pre-Treatment|Death|0|||
94330376|NCT01938001|322990171|FG000|Treatment|Death|2|||
94330377|NCT01938001|322990172|FG001|Treatment|Death|0|||
94330378|NCT01938001|322990171|FG000|Treatment|Adverse Event|14|||
94330379|NCT01938001|322990172|FG001|Treatment|Adverse Event|8|||
94330380|NCT01938001|322990171|FG000|Treatment|Progressive Disease|21|||
94330381|NCT01938001|322990172|FG001|Treatment|Progressive Disease|54|||
94330382|NCT01938001|322990171|FG000|Treatment|Withdrawal by Subject|13|||
94330383|NCT01938001|322990172|FG001|Treatment|Withdrawal by Subject|7|||
94330384|NCT01938001|322990171|FG000|Treatment|Other reasons|2|||
94330385|NCT01938001|322990172|FG001|Treatment|Other reasons|1|||
94330386|NCT00631540|322990173|FG000|Overall Study|Withdrawal by Subject|5|||
94330387|NCT00631540|322990173|FG000|Overall Study|Death|4|||
94330388|NCT00631540|322990173|FG000|Overall Study|Lost to Follow-up|2|||
94330389|NCT00631540|322990173|FG000|Overall Study|Core Lab Data Unavailable|3|||
94330390|NCT00131664|322990174|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
94330391|NCT00131664|322990175|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
94330392|NCT00131664|322990176|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
94330393|NCT00131664|322990177|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
94330394|NCT00131664|322990178|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
94330395|NCT00131664|322990179|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
94330396|NCT00131664|322990174|FG000|First Period (First 6 Months)|Death|0|||
94330397|NCT00131664|322990175|FG001|First Period (First 6 Months)|Death|1|||
94330398|NCT00131664|322990176|FG002|First Period (First 6 Months)|Death|0|||
94330399|NCT00131664|322990177|FG003|First Period (First 6 Months)|Death|0|||
94330400|NCT00131664|322990178|FG004|First Period (First 6 Months)|Death|0|||
94330401|NCT00131664|322990179|FG005|First Period (First 6 Months)|Death|0|||
94330402|NCT00131664|322990174|FG000|First Period (First 6 Months)|Protocol Violation|2|||
94330403|NCT00131664|322990175|FG001|First Period (First 6 Months)|Protocol Violation|2|||
94401147|NCT04133311|323256796|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
94401148|NCT04133311|323256797|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
94401149|NCT04133311|323256798|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
94401150|NCT04133311|323256795|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
94401151|NCT04133311|323256796|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
94401152|NCT04133311|323256797|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
94401153|NCT04133311|323256798|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
94401154|NCT04133311|323256795|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
94401155|NCT04133311|323256796|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
94401156|NCT04133311|323256797|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
94401157|NCT04133311|323256798|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
94401158|NCT04133311|323256795|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
94401159|NCT04133311|323256796|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
94401160|NCT04133311|323256797|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
94401161|NCT04133311|323256798|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
94401162|NCT04133311|323256795|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
94401163|NCT04133311|323256796|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
94401164|NCT04133311|323256797|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
94401165|NCT04133311|323256798|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
94401166|NCT01968551|323256799|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
94401167|NCT01968551|323256800|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
94401168|NCT01968551|323256801|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
94401169|NCT01968551|323256799|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
94401170|NCT01968551|323256800|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
94401171|NCT01968551|323256801|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
94401172|NCT01968551|323256799|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
94401173|NCT01968551|323256800|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
94401174|NCT01968551|323256801|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
94401175|NCT01968551|323256799|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
94401176|NCT01968551|323256800|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
94401177|NCT01968551|323256801|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
94401178|NCT01968551|323256799|FG000|Extension Phase|Adverse Event|0|||
94401179|NCT01968551|323256800|FG001|Extension Phase|Adverse Event|0|||
94401180|NCT01968551|323256801|FG002|Extension Phase|Adverse Event|2|||
94401181|NCT01968551|323256799|FG000|Extension Phase|Death|0|||
94401182|NCT01968551|323256800|FG001|Extension Phase|Death|1|||
94401183|NCT01968551|323256801|FG002|Extension Phase|Death|0|||
94401184|NCT01968551|323256799|FG000|Extension Phase|Withdrew Consent|0|||
94401185|NCT01968551|323256800|FG001|Extension Phase|Withdrew Consent|0|||
94401186|NCT01968551|323256801|FG002|Extension Phase|Withdrew Consent|1|||
94401187|NCT01968551|323256799|FG000|Extension Phase|Lost to Follow-up|1|||
94401188|NCT01968551|323256800|FG001|Extension Phase|Lost to Follow-up|0|||
94401189|NCT01968551|323256801|FG002|Extension Phase|Lost to Follow-up|1|||
94401190|NCT00819169|323256802|FG000|Overall Study|Withdrawal by Subject|2|||
94401191|NCT00819169|323256803|FG001|Overall Study|Withdrawal by Subject|0|||
94401192|NCT00819169|323256804|FG002|Overall Study|Withdrawal by Subject|0|||
94401193|NCT00819169|323256805|FG003|Overall Study|Withdrawal by Subject|1|||
94401194|NCT00819169|323256806|FG004|Overall Study|Withdrawal by Subject|1|||
94401195|NCT00819169|323256807|FG005|Overall Study|Withdrawal by Subject|1|||
94401196|NCT00819169|323256808|FG006|Overall Study|Withdrawal by Subject|5|||
94485261|NCT02869789|323570103|FG000|Overall Study|Participant no longer meets study criteria|0|||
94485262|NCT02869789|323570104|FG001|Overall Study|Participant no longer meets study criteria|1|||
94330404|NCT00131664|322990176|FG002|First Period (First 6 Months)|Protocol Violation|1|||
94401197|NCT00819169|323256809|FG007|Overall Study|Withdrawal by Subject|1|||
94401198|NCT00819169|323256810|FG008|Overall Study|Withdrawal by Subject|4|||
94401199|NCT00819169|323256802|FG000|Overall Study|Lost to Follow-up|0|||
94401200|NCT00819169|323256803|FG001|Overall Study|Lost to Follow-up|2|||
94401201|NCT00819169|323256804|FG002|Overall Study|Lost to Follow-up|0|||
94401202|NCT00819169|323256805|FG003|Overall Study|Lost to Follow-up|1|||
94485263|NCT02869789|323570105|FG002|Overall Study|Participant no longer meets study criteria|1|||
94401203|NCT00819169|323256806|FG004|Overall Study|Lost to Follow-up|0|||
94401204|NCT00819169|323256807|FG005|Overall Study|Lost to Follow-up|6|||
94401205|NCT00819169|323256808|FG006|Overall Study|Lost to Follow-up|2|||
94401206|NCT00819169|323256809|FG007|Overall Study|Lost to Follow-up|2|||
94401207|NCT00819169|323256810|FG008|Overall Study|Lost to Follow-up|1|||
94485264|NCT02869789|323570106|FG003|Overall Study|Participant no longer meets study criteria|0|||
94485265|NCT02869789|323570103|FG000|Overall Study|Administrative reason by sponsor|0|||
94485266|NCT02869789|323570104|FG001|Overall Study|Administrative reason by sponsor|0|||
94485267|NCT02869789|323570105|FG002|Overall Study|Administrative reason by sponsor|1|||
94485268|NCT02869789|323570106|FG003|Overall Study|Administrative reason by sponsor|0|||
94485269|NCT02869789|323570103|FG000|Overall Study|Other reasons|4|||
94485270|NCT02869789|323570104|FG001|Overall Study|Other reasons|8|||
94485271|NCT02869789|323570105|FG002|Overall Study|Other reasons|6|||
94485272|NCT02869789|323570106|FG003|Overall Study|Other reasons|0|||
94485273|NCT00706004|323570107|FG000|Overall Study|Did not meet eligibility criteria|2|||
94485274|NCT00749398|323570108|FG000|Overall Study|Lack of Efficacy|7|||
94485275|NCT00749398|323570108|FG000|Overall Study|Adverse Event|4|||
94485276|NCT00749398|323570108|FG000|Overall Study|Serious adverse event|11|||
94485277|NCT00749398|323570108|FG000|Overall Study|Withdrawal by Subject|17|||
94401208|NCT00819169|323256802|FG000|Overall Study|Death|1|||
94401209|NCT00819169|323256803|FG001|Overall Study|Death|1|||
94401210|NCT00819169|323256804|FG002|Overall Study|Death|3|||
94401211|NCT00819169|323256805|FG003|Overall Study|Death|8|||
94401212|NCT00819169|323256806|FG004|Overall Study|Death|5|||
94401213|NCT00819169|323256807|FG005|Overall Study|Death|7|||
94401214|NCT00819169|323256808|FG006|Overall Study|Death|9|||
94401215|NCT00819169|323256809|FG007|Overall Study|Death|4|||
94401216|NCT00819169|323256810|FG008|Overall Study|Death|7|||
94401217|NCT00819169|323256802|FG000|Overall Study|Ineligibility determined|0|||
94401218|NCT00819169|323256803|FG001|Overall Study|Ineligibility determined|0|||
94401219|NCT00819169|323256804|FG002|Overall Study|Ineligibility determined|0|||
94401220|NCT00819169|323256805|FG003|Overall Study|Ineligibility determined|2|||
94401221|NCT00819169|323256806|FG004|Overall Study|Ineligibility determined|0|||
94401222|NCT00819169|323256807|FG005|Overall Study|Ineligibility determined|0|||
94401223|NCT00819169|323256808|FG006|Overall Study|Ineligibility determined|0|||
94401224|NCT00819169|323256809|FG007|Overall Study|Ineligibility determined|0|||
94401225|NCT00819169|323256810|FG008|Overall Study|Ineligibility determined|1|||
94401226|NCT00819169|323256802|FG000|Overall Study|Adverse Event|0|||
94401227|NCT00819169|323256803|FG001|Overall Study|Adverse Event|0|||
94401228|NCT00819169|323256804|FG002|Overall Study|Adverse Event|0|||
94401229|NCT00819169|323256805|FG003|Overall Study|Adverse Event|0|||
94401230|NCT00819169|323256806|FG004|Overall Study|Adverse Event|1|||
94401231|NCT00819169|323256807|FG005|Overall Study|Adverse Event|0|||
94401232|NCT00819169|323256808|FG006|Overall Study|Adverse Event|0|||
94401233|NCT00819169|323256809|FG007|Overall Study|Adverse Event|0|||
94401234|NCT00819169|323256810|FG008|Overall Study|Adverse Event|0|||
94401235|NCT00819169|323256802|FG000|Overall Study|Administrative Decision|0|||
94401236|NCT00819169|323256803|FG001|Overall Study|Administrative Decision|0|||
94401237|NCT00819169|323256804|FG002|Overall Study|Administrative Decision|0|||
94401238|NCT00819169|323256805|FG003|Overall Study|Administrative Decision|0|||
94401239|NCT00819169|323256806|FG004|Overall Study|Administrative Decision|1|||
94401240|NCT00819169|323256807|FG005|Overall Study|Administrative Decision|2|||
94401241|NCT00819169|323256808|FG006|Overall Study|Administrative Decision|0|||
94401242|NCT00819169|323256809|FG007|Overall Study|Administrative Decision|2|||
94401243|NCT00819169|323256810|FG008|Overall Study|Administrative Decision|0|||
94401244|NCT04060251|323256811|FG000|Overall Study|Study terminated due to low enrollment.|7|||
94401245|NCT04060251|323256812|FG001|Overall Study|Study terminated due to low enrollment.|5|||
94401246|NCT04060251|323256813|FG002|Overall Study|Study terminated due to low enrollment.|7|||
94485278|NCT00749398|323570108|FG000|Overall Study|Lost to Follow-up|11|||
94485279|NCT00749398|323570108|FG000|Overall Study|Reason not specified|2|||
94485280|NCT00749398|323570108|FG000|Overall Study|Unknown reason|1|||
94485281|NCT03225170|323570109|FG000|Overall Study|Lost to Follow-up|4|||
94485282|NCT03225170|323570110|FG001|Overall Study|Lost to Follow-up|4|||
94485283|NCT03225170|323570111|FG002|Overall Study|Lost to Follow-up|0|||
94401247|NCT04060251|323256811|FG000|Overall Study|Adverse Event|1|||
94401248|NCT04060251|323256812|FG001|Overall Study|Adverse Event|1|||
94401249|NCT04060251|323256813|FG002|Overall Study|Adverse Event|0|||
94401250|NCT01617096|323256814|FG000|Overall Study|Withdrawal by Subject|96|||
94401251|NCT01617096|323256815|FG001|Overall Study|Withdrawal by Subject|81|||
94401252|NCT01617096|323256814|FG000|Overall Study|Lost to Follow-up|37|||
94401253|NCT01617096|323256815|FG001|Overall Study|Lost to Follow-up|32|||
94401254|NCT01617096|323256814|FG000|Overall Study|Physician Decision|10|||
94401255|NCT01617096|323256815|FG001|Overall Study|Physician Decision|18|||
94401256|NCT01617096|323256814|FG000|Overall Study|Death|4|||
94401257|NCT01617096|323256815|FG001|Overall Study|Death|3|||
94401258|NCT01617096|323256814|FG000|Overall Study|Other|1|||
94401259|NCT01617096|323256815|FG001|Overall Study|Other|3|||
94401260|NCT02905435|323256821|FG000|Overall Study|Death|2|||
94401261|NCT02905435|323256821|FG000|Overall Study|Physician Decision|1|||
94401262|NCT02905435|323256821|FG000|Overall Study|Lost to Follow-up|4|||
94401263|NCT03498560|323256822|FG000|Overall Study|Found Ineligible|2|||
94401264|NCT03498560|323256822|FG000|Overall Study|Withdrawal by Subject|14|||
94401265|NCT03498560|323256822|FG000|Overall Study|Lost to Follow-up|4|||
94401266|NCT03498560|323256822|FG000|Overall Study|Death|1|||
94401267|NCT01483820|323256823|FG000|Overall Study|Lack of Efficacy|6|||
94401268|NCT01483820|323256823|FG000|Overall Study|Adverse Event|1|||
94401269|NCT01483820|323256823|FG000|Overall Study|Death|1|||
94401270|NCT00112437|323256837|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
94401271|NCT00112437|323256838|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
94401272|NCT00112437|323256839|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
94401273|NCT00112437|323256840|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
94401274|NCT00112437|323256841|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
94401275|NCT00112437|323256842|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401276|NCT00112437|323256843|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401277|NCT00112437|323256844|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401278|NCT00112437|323256845|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401279|NCT00112437|323256846|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401280|NCT00112437|323256847|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401281|NCT00112437|323256848|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401282|NCT00112437|323256849|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401283|NCT00112437|323256850|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401284|NCT00112437|323256851|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401285|NCT00112437|323256852|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401286|NCT00112437|323256853|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401287|NCT00112437|323256854|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401288|NCT00112437|323256855|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401289|NCT00112437|323256856|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401290|NCT00112437|323256857|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401291|NCT00112437|323256858|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401292|NCT00112437|323256859|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401293|NCT00112437|323256860|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401294|NCT00112437|323256861|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401295|NCT00112437|323256862|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
94401296|NCT00112437|323256837|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401297|NCT00112437|323256838|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
94401298|NCT00112437|323256839|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401299|NCT00112437|323256840|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401300|NCT00112437|323256841|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401301|NCT00112437|323256842|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401302|NCT00112437|323256843|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401303|NCT00112437|323256844|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401304|NCT00112437|323256845|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401305|NCT00112437|323256846|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401306|NCT00112437|323256847|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401307|NCT00112437|323256848|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401308|NCT00112437|323256849|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401309|NCT00112437|323256850|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401310|NCT00112437|323256851|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401311|NCT00112437|323256852|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401312|NCT00112437|323256853|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401313|NCT00112437|323256854|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401314|NCT00112437|323256855|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401315|NCT00112437|323256856|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401316|NCT00112437|323256857|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401317|NCT00112437|323256858|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401318|NCT00112437|323256859|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401319|NCT00112437|323256860|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401320|NCT00112437|323256861|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401321|NCT00112437|323256862|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
94401322|NCT00112437|323256837|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401323|NCT00112437|323256838|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
94401324|NCT00112437|323256839|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401325|NCT00112437|323256840|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401326|NCT00112437|323256841|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401327|NCT00112437|323256842|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401328|NCT00112437|323256843|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401329|NCT00112437|323256844|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401330|NCT00112437|323256845|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401331|NCT00112437|323256846|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401332|NCT00112437|323256847|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401333|NCT00112437|323256848|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401334|NCT00112437|323256849|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401335|NCT00112437|323256850|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401336|NCT00112437|323256851|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401337|NCT00112437|323256852|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401338|NCT00112437|323256853|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401339|NCT00112437|323256854|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401340|NCT00112437|323256855|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401341|NCT00112437|323256856|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401342|NCT00112437|323256857|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401343|NCT00112437|323256858|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401344|NCT00112437|323256859|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401345|NCT00112437|323256860|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401346|NCT00112437|323256861|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401347|NCT00112437|323256862|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
94401348|NCT00112437|323256837|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
94401349|NCT00112437|323256838|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401350|NCT00112437|323256839|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
94401351|NCT00112437|323256840|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
94401352|NCT00112437|323256841|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
94401353|NCT00112437|323256842|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401354|NCT00112437|323256843|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401355|NCT00112437|323256844|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401356|NCT00112437|323256845|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401357|NCT00112437|323256846|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401358|NCT00112437|323256847|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401359|NCT00112437|323256848|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401360|NCT00112437|323256849|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401361|NCT00112437|323256850|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401362|NCT00112437|323256851|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401363|NCT00112437|323256852|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401364|NCT00112437|323256853|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401365|NCT00112437|323256854|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401366|NCT00112437|323256855|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401367|NCT00112437|323256856|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401368|NCT00112437|323256857|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401369|NCT00112437|323256858|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401370|NCT00112437|323256859|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401371|NCT00112437|323256860|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401372|NCT00112437|323256861|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401373|NCT00112437|323256862|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
94401374|NCT00112437|323256837|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
94401375|NCT00112437|323256838|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
94401376|NCT00112437|323256839|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
94401377|NCT00112437|323256840|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
94401378|NCT00112437|323256841|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
94401379|NCT00112437|323256842|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401380|NCT00112437|323256843|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401381|NCT00112437|323256844|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401382|NCT00112437|323256845|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401383|NCT00112437|323256846|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401384|NCT00112437|323256847|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401385|NCT00112437|323256848|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401386|NCT00112437|323256849|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401387|NCT00112437|323256850|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401388|NCT00112437|323256851|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401389|NCT00112437|323256852|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401390|NCT00112437|323256853|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401391|NCT00112437|323256854|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401392|NCT00112437|323256855|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401393|NCT00112437|323256856|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94485284|NCT03225170|323570109|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
94485285|NCT03225170|323570110|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
94401394|NCT00112437|323256857|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401395|NCT00112437|323256858|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401396|NCT00112437|323256859|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401397|NCT00112437|323256860|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401398|NCT00112437|323256861|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401399|NCT00112437|323256862|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
94401400|NCT00112437|323256837|FG000|Year 1 (12-Month Base Study)|moved|0|||
94401401|NCT00112437|323256838|FG001|Year 1 (12-Month Base Study)|moved|1|||
94401402|NCT00112437|323256839|FG002|Year 1 (12-Month Base Study)|moved|1|||
94401403|NCT00112437|323256840|FG003|Year 1 (12-Month Base Study)|moved|0|||
94401404|NCT00112437|323256841|FG004|Year 1 (12-Month Base Study)|moved|0|||
94401405|NCT00112437|323256842|FG005|Year 1 (12-Month Base Study)|moved|0|||
94401406|NCT00112437|323256843|FG006|Year 1 (12-Month Base Study)|moved|0|||
94401407|NCT00112437|323256844|FG007|Year 1 (12-Month Base Study)|moved|0|||
94401408|NCT00112437|323256845|FG008|Year 1 (12-Month Base Study)|moved|0|||
94401409|NCT00112437|323256846|FG009|Year 1 (12-Month Base Study)|moved|0|||
94401410|NCT00112437|323256847|FG010|Year 1 (12-Month Base Study)|moved|0|||
94401411|NCT00112437|323256848|FG011|Year 1 (12-Month Base Study)|moved|0|||
94401412|NCT00112437|323256849|FG012|Year 1 (12-Month Base Study)|moved|0|||
94401413|NCT00112437|323256850|FG013|Year 1 (12-Month Base Study)|moved|0|||
94485286|NCT03225170|323570111|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
94485287|NCT01663402|323570112|FG000|Overall Study|Randomized but not treated|19|||
94485288|NCT01663402|323570113|FG001|Overall Study|Randomized but not treated|11|||
94485289|NCT01663402|323570112|FG000|Overall Study|Adverse Event|347|||
94485290|NCT01663402|323570113|FG001|Overall Study|Adverse Event|362|||
94485291|NCT01663402|323570112|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
94485292|NCT01663402|323570113|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
94485293|NCT01663402|323570112|FG000|Overall Study|Poor compliance to protocol|529|||
94485294|NCT01663402|323570113|FG001|Overall Study|Poor compliance to protocol|454|||
94485295|NCT01663402|323570112|FG000|Overall Study|Physician Decision|77|||
94485296|NCT01663402|323570113|FG001|Overall Study|Physician Decision|62|||
94485297|NCT01663402|323570112|FG000|Overall Study|Site terminated by sponsor|1|||
94485298|NCT01663402|323570113|FG001|Overall Study|Site terminated by sponsor|3|||
94485299|NCT01663402|323570112|FG000|Overall Study|Participant moved|139|||
94485300|NCT01663402|323570113|FG001|Overall Study|Participant moved|104|||
94485301|NCT01663402|323570112|FG000|Overall Study|Withdrawal by Subject|118|||
94485302|NCT01663402|323570113|FG001|Overall Study|Withdrawal by Subject|91|||
94485303|NCT01663402|323570112|FG000|Overall Study|Related to study drug administration|96|||
94485304|NCT01663402|323570113|FG001|Overall Study|Related to study drug administration|105|||
94485305|NCT01663402|323570112|FG000|Overall Study|Lost to Follow-up|17|||
94485306|NCT01663402|323570113|FG001|Overall Study|Lost to Follow-up|15|||
94485307|NCT01663402|323570112|FG000|Overall Study|Other than specified above|172|||
94485308|NCT01663402|323570113|FG001|Overall Study|Other than specified above|147|||
94485309|NCT01545388|323570116|FG000|Overall Study|Adverse Event|2|||
94485310|NCT01545388|323570117|FG001|Overall Study|Adverse Event|4|||
94485311|NCT01545388|323570118|FG002|Overall Study|Adverse Event|1|||
94485312|NCT01545388|323570116|FG000|Overall Study|Lack of Efficacy|3|||
94485313|NCT01545388|323570117|FG001|Overall Study|Lack of Efficacy|2|||
94485314|NCT01545388|323570118|FG002|Overall Study|Lack of Efficacy|5|||
94485315|NCT01545388|323570116|FG000|Overall Study|Participant moved or relocated|1|||
94485316|NCT01545388|323570117|FG001|Overall Study|Participant moved or relocated|0|||
94485317|NCT01545388|323570118|FG002|Overall Study|Participant moved or relocated|0|||
94485318|NCT01545388|323570116|FG000|Overall Study|Withdrawal by Subject|1|||
94485319|NCT01545388|323570117|FG001|Overall Study|Withdrawal by Subject|4|||
94485320|NCT01545388|323570118|FG002|Overall Study|Withdrawal by Subject|2|||
94485321|NCT01545388|323570116|FG000|Overall Study|Other|1|||
94485322|NCT01545388|323570117|FG001|Overall Study|Other|1|||
94485323|NCT01545388|323570118|FG002|Overall Study|Other|0|||
94485324|NCT00274742|323570119|FG000|Overall Study|Adverse Event|0|||
94485325|NCT00274742|323570120|FG001|Overall Study|Adverse Event|4|||
94485326|NCT00274742|323570121|FG002|Overall Study|Adverse Event|1|||
94485327|NCT00274742|323570122|FG003|Overall Study|Adverse Event|4|||
94485328|NCT00274742|323570123|FG004|Overall Study|Adverse Event|12|||
94485329|NCT00274742|323570124|FG005|Overall Study|Adverse Event|3|||
94485330|NCT00274742|323570119|FG000|Overall Study|Lost to Follow-up|0|||
94485331|NCT00274742|323570120|FG001|Overall Study|Lost to Follow-up|0|||
94485332|NCT00274742|323570121|FG002|Overall Study|Lost to Follow-up|0|||
94485333|NCT00274742|323570122|FG003|Overall Study|Lost to Follow-up|0|||
94485334|NCT00274742|323570123|FG004|Overall Study|Lost to Follow-up|1|||
94485335|NCT00274742|323570124|FG005|Overall Study|Lost to Follow-up|0|||
94401414|NCT00112437|323256851|FG014|Year 1 (12-Month Base Study)|moved|0|||
94401415|NCT00112437|323256852|FG015|Year 1 (12-Month Base Study)|moved|0|||
94401416|NCT00112437|323256853|FG016|Year 1 (12-Month Base Study)|moved|0|||
94485336|NCT00274742|323570119|FG000|Overall Study|End of Study|0|||
94485337|NCT00274742|323570120|FG001|Overall Study|End of Study|0|||
94485338|NCT00274742|323570121|FG002|Overall Study|End of Study|0|||
94485339|NCT00274742|323570122|FG003|Overall Study|End of Study|1|||
94485340|NCT00274742|323570123|FG004|Overall Study|End of Study|0|||
94401417|NCT00112437|323256854|FG017|Year 1 (12-Month Base Study)|moved|0|||
94401418|NCT00112437|323256855|FG018|Year 1 (12-Month Base Study)|moved|0|||
94485341|NCT00274742|323570124|FG005|Overall Study|End of Study|0|||
94485342|NCT00274742|323570119|FG000|Overall Study|Disease Progression|0|||
94485343|NCT00274742|323570120|FG001|Overall Study|Disease Progression|1|||
94485344|NCT00274742|323570121|FG002|Overall Study|Disease Progression|1|||
94485345|NCT00274742|323570122|FG003|Overall Study|Disease Progression|0|||
94485346|NCT00274742|323570123|FG004|Overall Study|Disease Progression|1|||
94485347|NCT00274742|323570124|FG005|Overall Study|Disease Progression|0|||
94485348|NCT00274742|323570119|FG000|Overall Study|Other|0|||
94485349|NCT00274742|323570120|FG001|Overall Study|Other|3|||
94485350|NCT00274742|323570121|FG002|Overall Study|Other|0|||
94485351|NCT00274742|323570122|FG003|Overall Study|Other|0|||
94485352|NCT00274742|323570123|FG004|Overall Study|Other|2|||
94485353|NCT00274742|323570124|FG005|Overall Study|Other|0|||
94485354|NCT03555149|323570129|FG000|Overall Study|Death|18|||
94485355|NCT03555149|323570130|FG001|Overall Study|Death|15|||
94485356|NCT03555149|323570131|FG002|Overall Study|Death|15|||
94485357|NCT03555149|323570132|FG003|Overall Study|Death|4|||
94485358|NCT03555149|323570133|FG004|Overall Study|Death|4|||
94485359|NCT03555149|323570134|FG005|Overall Study|Death|11|||
94485360|NCT03555149|323570135|FG006|Overall Study|Death|12|||
94485361|NCT03555149|323570136|FG007|Overall Study|Death|1|||
94485362|NCT03555149|323570129|FG000|Overall Study|Lost to Follow-up|1|||
94485363|NCT03555149|323570130|FG001|Overall Study|Lost to Follow-up|0|||
94485364|NCT03555149|323570131|FG002|Overall Study|Lost to Follow-up|0|||
94485365|NCT03555149|323570132|FG003|Overall Study|Lost to Follow-up|0|||
94485366|NCT03555149|323570133|FG004|Overall Study|Lost to Follow-up|0|||
94485367|NCT03555149|323570134|FG005|Overall Study|Lost to Follow-up|1|||
94485368|NCT03555149|323570135|FG006|Overall Study|Lost to Follow-up|0|||
94485369|NCT03555149|323570136|FG007|Overall Study|Lost to Follow-up|0|||
94485370|NCT03555149|323570129|FG000|Overall Study|Physician Decision|1|||
94485371|NCT03555149|323570130|FG001|Overall Study|Physician Decision|0|||
94485372|NCT03555149|323570131|FG002|Overall Study|Physician Decision|0|||
94485373|NCT03555149|323570132|FG003|Overall Study|Physician Decision|0|||
94485374|NCT03555149|323570133|FG004|Overall Study|Physician Decision|0|||
94485375|NCT03555149|323570134|FG005|Overall Study|Physician Decision|0|||
94485376|NCT03555149|323570135|FG006|Overall Study|Physician Decision|0|||
94485377|NCT03555149|323570136|FG007|Overall Study|Physician Decision|0|||
94485378|NCT03555149|323570129|FG000|Overall Study|Study Terminated By Sponsor|1|||
94485379|NCT03555149|323570130|FG001|Overall Study|Study Terminated By Sponsor|0|||
94485380|NCT03555149|323570131|FG002|Overall Study|Study Terminated By Sponsor|0|||
94485381|NCT03555149|323570132|FG003|Overall Study|Study Terminated By Sponsor|0|||
94485382|NCT03555149|323570133|FG004|Overall Study|Study Terminated By Sponsor|0|||
94485383|NCT03555149|323570134|FG005|Overall Study|Study Terminated By Sponsor|2|||
94485384|NCT03555149|323570135|FG006|Overall Study|Study Terminated By Sponsor|3|||
94485385|NCT03555149|323570136|FG007|Overall Study|Study Terminated By Sponsor|1|||
94485386|NCT03555149|323570129|FG000|Overall Study|Withdrawal by Subject|3|||
94485387|NCT03555149|323570130|FG001|Overall Study|Withdrawal by Subject|0|||
94485388|NCT03555149|323570131|FG002|Overall Study|Withdrawal by Subject|0|||
94485389|NCT03555149|323570132|FG003|Overall Study|Withdrawal by Subject|2|||
94485390|NCT03555149|323570133|FG004|Overall Study|Withdrawal by Subject|0|||
94485391|NCT03555149|323570134|FG005|Overall Study|Withdrawal by Subject|1|||
94485392|NCT03555149|323570135|FG006|Overall Study|Withdrawal by Subject|0|||
94485393|NCT03555149|323570136|FG007|Overall Study|Withdrawal by Subject|0|||
94485394|NCT00072384|323570139|FG000|Overall Study|Physician Decision|1|||
94485395|NCT00072384|323570139|FG000|Overall Study|Ineligible|8|||
94485396|NCT01255163|323570140|FG000|Overall Study|Withdrawal by Subject|1|||
94485397|NCT01255163|323570141|FG001|Overall Study|Withdrawal by Subject|0|||
94485398|NCT01255163|323570140|FG000|Overall Study|Lost to Follow-up|2|||
94485399|NCT01255163|323570141|FG001|Overall Study|Lost to Follow-up|0|||
94485400|NCT01255163|323570140|FG000|Overall Study|Adverse Event|0|||
94485401|NCT01255163|323570141|FG001|Overall Study|Adverse Event|2|||
94485402|NCT01255163|323570140|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
94485403|NCT01255163|323570141|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
94485404|NCT00731822|323570142|FG000|Overall Study|Adverse Event|2|||
94485405|NCT00731822|323570143|FG001|Overall Study|Adverse Event|1|||
94485406|NCT00731822|323570142|FG000|Overall Study|Protocol Violation|1|||
94485407|NCT00731822|323570143|FG001|Overall Study|Protocol Violation|0|||
94485408|NCT00731822|323570142|FG000|Overall Study|Lost to Follow-up|1|||
94485409|NCT00731822|323570143|FG001|Overall Study|Lost to Follow-up|0|||
94485410|NCT03863353|323570147|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
94485411|NCT03863353|323570148|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
94485412|NCT02495389|323570149|FG000|Overall Study|Withdrawal by Subject|40|||
94485413|NCT02127658|323570150|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
94485414|NCT02127658|323570151|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
94485415|NCT02127658|323570150|FG000|Overall Study|Withdrawal by Subject|0|||
94485416|NCT02127658|323570151|FG001|Overall Study|Withdrawal by Subject|2|||
94485417|NCT02127658|323570150|FG000|Overall Study|Physician Decision|0|||
94485418|NCT02127658|323570151|FG001|Overall Study|Physician Decision|1|||
94485419|NCT03585270|323570152|FG000|Overall Study|Withdrawal by Subject|2|||
94485420|NCT03585270|323570153|FG001|Overall Study|Withdrawal by Subject|6|||
94485421|NCT03585270|323570152|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
94485422|NCT03585270|323570153|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
94485423|NCT03585270|323570152|FG000|Overall Study|Adverse Event|5|||
94485424|NCT03585270|323570153|FG001|Overall Study|Adverse Event|2|||
94485425|NCT03585270|323570152|FG000|Overall Study|Lost to Follow-up|1|||
94485426|NCT03585270|323570153|FG001|Overall Study|Lost to Follow-up|4|||
94485427|NCT03585270|323570152|FG000|Overall Study|Death|5|||
94485428|NCT03585270|323570153|FG001|Overall Study|Death|3|||
94485429|NCT03585270|323570152|FG000|Overall Study|Other reasons|2|||
94485430|NCT03585270|323570153|FG001|Overall Study|Other reasons|2|||
94485431|NCT00570401|323570154|FG000|Overall Study|Adverse Event|2|||
94485432|NCT02849587|323570155|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
94485433|NCT02849587|323570156|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
94485434|NCT02849587|323570157|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
94485435|NCT02849587|323570155|FG000|Overall Study|Withdrawal by Subject|0|||
94485436|NCT02849587|323570156|FG001|Overall Study|Withdrawal by Subject|1|||
94485437|NCT02849587|323570157|FG002|Overall Study|Withdrawal by Subject|0|||
94485438|NCT00617357|323570158|FG000|Overall Study|Lost to Follow-up|7|||
94485439|NCT00617357|323570158|FG000|Overall Study|Death|5|||
94485440|NCT00617357|323570158|FG000|Overall Study|insurance concerns|2|||
94485441|NCT00617357|323570158|FG000|Overall Study|Withdrawal by Subject|1|||
94485442|NCT00617357|323570158|FG000|Overall Study|Physician Decision|1|||
94485443|NCT01710020|323570159|FG000|Period 1|Protocol Violation|1|||
94485444|NCT00427908|323570160|FG000|Primary Phase|Lost to Follow-up|4|||
94485445|NCT00427908|323570161|FG001|Primary Phase|Lost to Follow-up|0|||
94485446|NCT00427908|323570162|FG002|Primary Phase|Lost to Follow-up|2|||
94485447|NCT00427908|323570163|FG003|Primary Phase|Lost to Follow-up|0|||
94485448|NCT00427908|323570160|FG000|Primary Phase|Withdrawal by Subject|1|||
94401419|NCT00112437|323256856|FG019|Year 1 (12-Month Base Study)|moved|0|||
94401420|NCT00112437|323256857|FG020|Year 1 (12-Month Base Study)|moved|0|||
94401421|NCT00112437|323256858|FG021|Year 1 (12-Month Base Study)|moved|0|||
94401422|NCT00112437|323256859|FG022|Year 1 (12-Month Base Study)|moved|0|||
94401423|NCT00112437|323256860|FG023|Year 1 (12-Month Base Study)|moved|0|||
94401424|NCT00112437|323256861|FG024|Year 1 (12-Month Base Study)|moved|0|||
94401425|NCT00112437|323256862|FG025|Year 1 (12-Month Base Study)|moved|0|||
94401426|NCT00112437|323256837|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401427|NCT00112437|323256838|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401428|NCT00112437|323256839|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401429|NCT00112437|323256840|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
94401430|NCT00112437|323256841|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401431|NCT00112437|323256842|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401432|NCT00112437|323256843|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401433|NCT00112437|323256844|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401434|NCT00112437|323256845|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401435|NCT00112437|323256846|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401436|NCT00112437|323256847|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401437|NCT00112437|323256848|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401438|NCT00112437|323256849|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401439|NCT00112437|323256850|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401440|NCT00112437|323256851|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401441|NCT00112437|323256852|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401442|NCT00112437|323256853|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401443|NCT00112437|323256854|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401444|NCT00112437|323256855|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401445|NCT00112437|323256856|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401446|NCT00112437|323256857|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401447|NCT00112437|323256858|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401448|NCT00112437|323256859|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401449|NCT00112437|323256860|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94485449|NCT00427908|323570161|FG001|Primary Phase|Withdrawal by Subject|2|||
94485450|NCT00427908|323570162|FG002|Primary Phase|Withdrawal by Subject|1|||
94485451|NCT00427908|323570163|FG003|Primary Phase|Withdrawal by Subject|0|||
94485452|NCT00427908|323570160|FG000|Primary Phase|Adverse Event|0|||
94485453|NCT00427908|323570161|FG001|Primary Phase|Adverse Event|1|||
94485454|NCT00427908|323570162|FG002|Primary Phase|Adverse Event|0|||
94485455|NCT00427908|323570163|FG003|Primary Phase|Adverse Event|0|||
94485456|NCT02984982|323570164|FG000|Overall Study|Adverse Event|2|||
94485457|NCT02984982|323570165|FG001|Overall Study|Adverse Event|5|||
94485458|NCT02984982|323570164|FG000|Overall Study|Poor Compliance to Protocol|4|||
94485459|NCT02984982|323570165|FG001|Overall Study|Poor Compliance to Protocol|4|||
94485460|NCT02984982|323570164|FG000|Overall Study|Withdrawal by Subject|2|||
94485461|NCT02984982|323570165|FG001|Overall Study|Withdrawal by Subject|0|||
94485462|NCT02984982|323570164|FG000|Overall Study|Randomized but not treated|0|||
94485463|NCT02984982|323570165|FG001|Overall Study|Randomized but not treated|1|||
94485464|NCT00372424|323570166|FG000|Overall Study|Adverse Event|2|||
94485465|NCT00372424|323570166|FG000|Overall Study|Withdrawal by Subject|1|||
94485466|NCT00372424|323570166|FG000|Overall Study|Death|1|||
94485467|NCT00372424|323570166|FG000|Overall Study|Objective Progression or Relapse|14|||
94485468|NCT00372424|323570166|FG000|Overall Study|Other|7|||
94485469|NCT00372424|323570166|FG000|Overall Study|Enrolled, Not Treated|1|||
94485470|NCT01405898|323570170|FG000|Overall Study|Withdrawal by Subject|2|||
94485471|NCT01405898|323570171|FG001|Overall Study|Withdrawal by Subject|2|||
94401450|NCT00112437|323256861|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401451|NCT00112437|323256862|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
94401452|NCT00112437|323256837|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401453|NCT00112437|323256838|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401454|NCT00112437|323256839|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401455|NCT00112437|323256840|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401456|NCT00112437|323256841|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
94401457|NCT00112437|323256842|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401458|NCT00112437|323256843|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401459|NCT00112437|323256844|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401460|NCT00112437|323256845|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401461|NCT00112437|323256846|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401462|NCT00112437|323256847|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401463|NCT00112437|323256848|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401464|NCT00112437|323256849|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401465|NCT00112437|323256850|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401466|NCT00112437|323256851|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401467|NCT00112437|323256852|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401468|NCT00112437|323256853|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401469|NCT00112437|323256854|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401470|NCT00112437|323256855|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401471|NCT00112437|323256856|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401472|NCT00112437|323256857|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401473|NCT00112437|323256858|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401474|NCT00112437|323256859|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401475|NCT00112437|323256860|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401476|NCT00112437|323256861|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401477|NCT00112437|323256862|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
94401478|NCT00112437|323256837|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
94401479|NCT00112437|323256838|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
94401480|NCT00112437|323256839|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
94401481|NCT00112437|323256840|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
94401482|NCT00112437|323256841|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
94401483|NCT00112437|323256842|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
94401484|NCT00112437|323256843|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
94401485|NCT00112437|323256844|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
94401486|NCT00112437|323256845|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
94401487|NCT00112437|323256846|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
94401488|NCT00112437|323256847|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
94401489|NCT00112437|323256848|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
94401490|NCT00112437|323256849|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
94401491|NCT00112437|323256850|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
94401492|NCT00112437|323256851|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
94401493|NCT00112437|323256852|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
94401494|NCT00112437|323256853|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
94401495|NCT00112437|323256854|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
94401496|NCT00112437|323256855|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
94401497|NCT00112437|323256856|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
94485472|NCT03139552|323570180|FG000|Overall Study|unable to attend tasting due to schedule|3|||
94485473|NCT00780975|323570183|FG000|Overall Study|Progressive disease|3|||
94401498|NCT00112437|323256857|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
94401499|NCT00112437|323256858|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
94485474|NCT00780975|323570183|FG000|Overall Study|Toxicity|5|||
94485475|NCT00887484|323570186|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
94485476|NCT00887484|323570186|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
94485477|NCT00887484|323570186|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
94485478|NCT00735007|323570188|FG000|Overall Study|Adverse Event|4|||
94485479|NCT00735007|323570188|FG000|Overall Study|Protocol Violation|1|||
94485480|NCT03044314|323570189|FG000|Overall Study|Physician Decision|2|||
94485481|NCT03044314|323570189|FG000|Overall Study|Withdrawal by Subject|1|||
94485482|NCT03044314|323570189|FG000|Overall Study|Connector tubing not available|1|||
94485483|NCT00715403|323570190|FG000|Overall Study|Progressive disease|0|||
94485484|NCT00715403|323570191|FG001|Overall Study|Progressive disease|1|||
94485485|NCT00715403|323570192|FG002|Overall Study|Progressive disease|3|||
94485486|NCT00715403|323570193|FG003|Overall Study|Progressive disease|9|||
94485487|NCT00715403|323570194|FG004|Overall Study|Progressive disease|5|||
94485488|NCT00715403|323570195|FG005|Overall Study|Progressive disease|14|||
94485489|NCT00715403|323570196|FG006|Overall Study|Progressive disease|1|||
94485490|NCT00715403|323570190|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
94485491|NCT00715403|323570191|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
94485492|NCT00715403|323570192|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
94401500|NCT00112437|323256859|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
94485493|NCT00715403|323570193|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
94485494|NCT00715403|323570194|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
94485495|NCT00715403|323570195|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
94485496|NCT00715403|323570196|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
94485497|NCT00715403|323570190|FG000|Overall Study|Other Adverse Event than DLT|1|||
94485498|NCT00715403|323570191|FG001|Overall Study|Other Adverse Event than DLT|0|||
94485499|NCT00715403|323570192|FG002|Overall Study|Other Adverse Event than DLT|0|||
94485500|NCT00715403|323570193|FG003|Overall Study|Other Adverse Event than DLT|0|||
94485501|NCT00715403|323570194|FG004|Overall Study|Other Adverse Event than DLT|0|||
94485502|NCT00715403|323570195|FG005|Overall Study|Other Adverse Event than DLT|2|||
94485503|NCT00715403|323570196|FG006|Overall Study|Other Adverse Event than DLT|0|||
94485504|NCT00715403|323570190|FG000|Overall Study|Protocol Violation|0|||
94485505|NCT00715403|323570191|FG001|Overall Study|Protocol Violation|0|||
94485506|NCT00715403|323570192|FG002|Overall Study|Protocol Violation|0|||
94485507|NCT00715403|323570193|FG003|Overall Study|Protocol Violation|0|||
94485508|NCT00715403|323570194|FG004|Overall Study|Protocol Violation|0|||
94485509|NCT00715403|323570195|FG005|Overall Study|Protocol Violation|1|||
94485510|NCT00715403|323570196|FG006|Overall Study|Protocol Violation|0|||
94485511|NCT00715403|323570190|FG000|Overall Study|Other reason not defined above|0|||
94485512|NCT00715403|323570191|FG001|Overall Study|Other reason not defined above|0|||
94485513|NCT00715403|323570192|FG002|Overall Study|Other reason not defined above|1|||
94485514|NCT00715403|323570193|FG003|Overall Study|Other reason not defined above|0|||
94485515|NCT00715403|323570194|FG004|Overall Study|Other reason not defined above|1|||
94485516|NCT00715403|323570195|FG005|Overall Study|Other reason not defined above|1|||
94485517|NCT00715403|323570196|FG006|Overall Study|Other reason not defined above|0|||
94485518|NCT02700048|323570197|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
94485519|NCT02700048|323570198|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
94401501|NCT00112437|323256860|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
94401502|NCT00112437|323256861|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
94401503|NCT00112437|323256862|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
94401504|NCT00112437|323256837|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401505|NCT00112437|323256838|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401506|NCT00112437|323256839|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401507|NCT00112437|323256840|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401508|NCT00112437|323256841|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401509|NCT00112437|323256842|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
94401510|NCT00112437|323256843|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
94401511|NCT00112437|323256844|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401512|NCT00112437|323256845|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401513|NCT00112437|323256846|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
94401514|NCT00112437|323256847|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401515|NCT00112437|323256848|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401516|NCT00112437|323256849|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401517|NCT00112437|323256850|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401518|NCT00112437|323256851|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401519|NCT00112437|323256852|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401520|NCT00112437|323256853|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401521|NCT00112437|323256854|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401522|NCT00112437|323256855|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401523|NCT00112437|323256856|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401524|NCT00112437|323256857|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401525|NCT00112437|323256858|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94485520|NCT00449163|323570199|FG000|Overall Study|Physician Decision|3|||
94485521|NCT00794664|323570200|FG000|Treatment Period|Withdrawal by Subject|0|||
94485522|NCT00794664|323570201|FG001|Treatment Period|Withdrawal by Subject|2|||
94485523|NCT00794664|323570200|FG000|Treatment Period|Protocol non-compliance|0|||
94401526|NCT00112437|323256859|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401527|NCT00112437|323256860|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401528|NCT00112437|323256861|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401529|NCT00112437|323256862|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
94401530|NCT00112437|323256837|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401531|NCT00112437|323256838|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401532|NCT00112437|323256839|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401533|NCT00112437|323256840|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401534|NCT00112437|323256841|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401535|NCT00112437|323256842|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401536|NCT00112437|323256843|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401537|NCT00112437|323256844|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401538|NCT00112437|323256845|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
94401539|NCT00112437|323256846|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401540|NCT00112437|323256847|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401541|NCT00112437|323256848|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401542|NCT00112437|323256849|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401543|NCT00112437|323256850|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401544|NCT00112437|323256851|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401545|NCT00112437|323256852|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401546|NCT00112437|323256853|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401547|NCT00112437|323256854|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401548|NCT00112437|323256855|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401549|NCT00112437|323256856|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401550|NCT00112437|323256857|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401551|NCT00112437|323256858|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401552|NCT00112437|323256859|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401553|NCT00112437|323256860|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401554|NCT00112437|323256861|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401555|NCT00112437|323256862|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
94401556|NCT00112437|323256837|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401557|NCT00112437|323256838|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401558|NCT00112437|323256839|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401559|NCT00112437|323256840|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401560|NCT00112437|323256841|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401561|NCT00112437|323256842|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401562|NCT00112437|323256843|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401563|NCT00112437|323256844|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401564|NCT00112437|323256845|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
94401565|NCT00112437|323256846|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401566|NCT00112437|323256847|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401567|NCT00112437|323256848|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401568|NCT00112437|323256849|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401569|NCT00112437|323256850|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401570|NCT00112437|323256851|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401571|NCT00112437|323256852|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401572|NCT00112437|323256853|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401573|NCT00112437|323256854|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401574|NCT00112437|323256855|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401575|NCT00112437|323256856|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401576|NCT00112437|323256857|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401577|NCT00112437|323256858|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401578|NCT00112437|323256859|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401579|NCT00112437|323256860|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401580|NCT00112437|323256861|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401581|NCT00112437|323256862|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
94401582|NCT00112437|323256837|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401583|NCT00112437|323256838|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401584|NCT00112437|323256839|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401585|NCT00112437|323256840|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401586|NCT00112437|323256841|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401587|NCT00112437|323256842|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
94401588|NCT00112437|323256843|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
94401589|NCT00112437|323256844|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
94401590|NCT00112437|323256845|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
94401591|NCT00112437|323256846|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
94401592|NCT00112437|323256847|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401593|NCT00112437|323256848|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401594|NCT00112437|323256849|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401595|NCT00112437|323256850|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401596|NCT00112437|323256851|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401597|NCT00112437|323256852|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401598|NCT00112437|323256853|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401599|NCT00112437|323256854|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401600|NCT00112437|323256855|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401601|NCT00112437|323256856|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401602|NCT00112437|323256857|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401603|NCT00112437|323256858|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401604|NCT00112437|323256859|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401605|NCT00112437|323256860|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401606|NCT00112437|323256861|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401607|NCT00112437|323256862|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
94401608|NCT00112437|323256837|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401609|NCT00112437|323256838|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401610|NCT00112437|323256839|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401611|NCT00112437|323256840|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401612|NCT00112437|323256841|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401613|NCT00112437|323256842|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401614|NCT00112437|323256843|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401615|NCT00112437|323256844|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401616|NCT00112437|323256845|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401617|NCT00112437|323256846|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
94401618|NCT00112437|323256847|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401619|NCT00112437|323256848|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401620|NCT00112437|323256849|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401621|NCT00112437|323256850|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401622|NCT00112437|323256851|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401623|NCT00112437|323256852|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401624|NCT00112437|323256853|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401625|NCT00112437|323256854|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401626|NCT00112437|323256855|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401627|NCT00112437|323256856|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401628|NCT00112437|323256857|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401629|NCT00112437|323256858|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401630|NCT00112437|323256859|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401631|NCT00112437|323256860|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401632|NCT00112437|323256861|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401633|NCT00112437|323256862|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
94401634|NCT00112437|323256837|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401635|NCT00112437|323256838|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401636|NCT00112437|323256839|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401637|NCT00112437|323256840|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401638|NCT00112437|323256841|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401639|NCT00112437|323256842|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401640|NCT00112437|323256843|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401641|NCT00112437|323256844|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401642|NCT00112437|323256845|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401643|NCT00112437|323256846|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
94401644|NCT00112437|323256847|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401645|NCT00112437|323256848|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401646|NCT00112437|323256849|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401647|NCT00112437|323256850|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401648|NCT00112437|323256851|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401649|NCT00112437|323256852|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401650|NCT00112437|323256853|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401651|NCT00112437|323256854|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401652|NCT00112437|323256855|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401653|NCT00112437|323256856|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401654|NCT00112437|323256857|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401655|NCT00112437|323256858|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401656|NCT00112437|323256859|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401657|NCT00112437|323256860|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401658|NCT00112437|323256861|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401659|NCT00112437|323256862|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
94401660|NCT00112437|323256837|FG000|Year 2 (12-Month Extension)|Moved|0|||
94401661|NCT00112437|323256838|FG001|Year 2 (12-Month Extension)|Moved|0|||
94401662|NCT00112437|323256839|FG002|Year 2 (12-Month Extension)|Moved|0|||
94401663|NCT00112437|323256840|FG003|Year 2 (12-Month Extension)|Moved|0|||
94401664|NCT00112437|323256841|FG004|Year 2 (12-Month Extension)|Moved|0|||
94401665|NCT00112437|323256842|FG005|Year 2 (12-Month Extension)|Moved|0|||
94401666|NCT00112437|323256843|FG006|Year 2 (12-Month Extension)|Moved|0|||
94401667|NCT00112437|323256844|FG007|Year 2 (12-Month Extension)|Moved|0|||
94401668|NCT00112437|323256845|FG008|Year 2 (12-Month Extension)|Moved|0|||
94401669|NCT00112437|323256846|FG009|Year 2 (12-Month Extension)|Moved|1|||
94401670|NCT00112437|323256847|FG010|Year 2 (12-Month Extension)|Moved|0|||
94401671|NCT00112437|323256848|FG011|Year 2 (12-Month Extension)|Moved|0|||
94401672|NCT00112437|323256849|FG012|Year 2 (12-Month Extension)|Moved|0|||
94401673|NCT00112437|323256850|FG013|Year 2 (12-Month Extension)|Moved|0|||
94401674|NCT00112437|323256851|FG014|Year 2 (12-Month Extension)|Moved|0|||
94401675|NCT00112437|323256852|FG015|Year 2 (12-Month Extension)|Moved|0|||
94401676|NCT00112437|323256853|FG016|Year 2 (12-Month Extension)|Moved|0|||
94401677|NCT00112437|323256854|FG017|Year 2 (12-Month Extension)|Moved|0|||
94401678|NCT00112437|323256855|FG018|Year 2 (12-Month Extension)|Moved|0|||
94401679|NCT00112437|323256856|FG019|Year 2 (12-Month Extension)|Moved|0|||
94401680|NCT00112437|323256857|FG020|Year 2 (12-Month Extension)|Moved|0|||
94401681|NCT00112437|323256858|FG021|Year 2 (12-Month Extension)|Moved|0|||
94401682|NCT00112437|323256859|FG022|Year 2 (12-Month Extension)|Moved|0|||
94401683|NCT00112437|323256860|FG023|Year 2 (12-Month Extension)|Moved|0|||
94401684|NCT00112437|323256861|FG024|Year 2 (12-Month Extension)|Moved|0|||
94401685|NCT00112437|323256862|FG025|Year 2 (12-Month Extension)|Moved|0|||
94401686|NCT00112437|323256837|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
94401687|NCT00112437|323256838|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
94401688|NCT00112437|323256839|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
94401689|NCT00112437|323256840|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
94401690|NCT00112437|323256841|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
94401691|NCT00112437|323256842|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
94401692|NCT00112437|323256843|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
94401693|NCT00112437|323256844|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
94401694|NCT00112437|323256845|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
94401695|NCT00112437|323256846|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
94401696|NCT00112437|323256847|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
94401697|NCT00112437|323256848|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
94401698|NCT00112437|323256849|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
94401699|NCT00112437|323256850|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
94401700|NCT00112437|323256851|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
94401701|NCT00112437|323256852|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
94401702|NCT00112437|323256853|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
94401703|NCT00112437|323256854|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
94401704|NCT00112437|323256855|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
94401705|NCT00112437|323256856|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
94401706|NCT00112437|323256857|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
94401707|NCT00112437|323256858|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
94401708|NCT00112437|323256859|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
94401709|NCT00112437|323256860|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
94401710|NCT00112437|323256861|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
94401711|NCT00112437|323256862|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
94401712|NCT00112437|323256837|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401713|NCT00112437|323256838|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401714|NCT00112437|323256839|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401715|NCT00112437|323256840|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401716|NCT00112437|323256841|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401717|NCT00112437|323256842|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401718|NCT00112437|323256843|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401719|NCT00112437|323256844|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401720|NCT00112437|323256845|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401721|NCT00112437|323256846|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401722|NCT00112437|323256847|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401723|NCT00112437|323256848|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
94401724|NCT00112437|323256849|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401725|NCT00112437|323256850|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
94401726|NCT00112437|323256851|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94485524|NCT00794664|323570201|FG001|Treatment Period|Protocol non-compliance|1|||
94485525|NCT00794664|323570200|FG000|Treatment Period|Other|0|||
94401727|NCT00112437|323256852|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
94401728|NCT00112437|323256853|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401729|NCT00112437|323256854|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401730|NCT00112437|323256855|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
94401731|NCT00112437|323256856|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401732|NCT00112437|323256857|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401733|NCT00112437|323256858|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94485526|NCT00794664|323570201|FG001|Treatment Period|Other|1|||
94401734|NCT00112437|323256859|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401735|NCT00112437|323256860|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401736|NCT00112437|323256861|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401737|NCT00112437|323256862|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
94401738|NCT00112437|323256837|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401739|NCT00112437|323256838|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401740|NCT00112437|323256839|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401741|NCT00112437|323256840|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401742|NCT00112437|323256841|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401743|NCT00112437|323256842|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401744|NCT00112437|323256843|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401745|NCT00112437|323256844|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401746|NCT00112437|323256845|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401747|NCT00112437|323256846|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401748|NCT00112437|323256847|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401749|NCT00112437|323256848|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401750|NCT00112437|323256849|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401751|NCT00112437|323256850|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401752|NCT00112437|323256851|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401753|NCT00112437|323256852|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
94401754|NCT00112437|323256853|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401755|NCT00112437|323256854|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401756|NCT00112437|323256855|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401757|NCT00112437|323256856|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401758|NCT00112437|323256857|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401759|NCT00112437|323256858|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401760|NCT00112437|323256859|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401761|NCT00112437|323256860|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401762|NCT00112437|323256861|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401763|NCT00112437|323256862|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
94401764|NCT00112437|323256837|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401765|NCT00112437|323256838|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401766|NCT00112437|323256839|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401767|NCT00112437|323256840|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401768|NCT00112437|323256841|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401769|NCT00112437|323256842|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401770|NCT00112437|323256843|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401771|NCT00112437|323256844|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401772|NCT00112437|323256845|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401773|NCT00112437|323256846|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401774|NCT00112437|323256847|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401775|NCT00112437|323256848|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401776|NCT00112437|323256849|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401777|NCT00112437|323256850|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401778|NCT00112437|323256851|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401779|NCT00112437|323256852|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
94401780|NCT00112437|323256853|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401781|NCT00112437|323256854|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401782|NCT00112437|323256855|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401783|NCT00112437|323256856|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401784|NCT00112437|323256857|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401785|NCT00112437|323256858|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401786|NCT00112437|323256859|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401787|NCT00112437|323256860|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401788|NCT00112437|323256861|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401789|NCT00112437|323256862|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
94401790|NCT00112437|323256837|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401791|NCT00112437|323256838|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401792|NCT00112437|323256839|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401793|NCT00112437|323256840|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401794|NCT00112437|323256841|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401795|NCT00112437|323256842|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401796|NCT00112437|323256843|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401797|NCT00112437|323256844|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401798|NCT00112437|323256845|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401799|NCT00112437|323256846|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401800|NCT00112437|323256847|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401801|NCT00112437|323256848|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
94401802|NCT00112437|323256849|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401803|NCT00112437|323256850|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401804|NCT00112437|323256851|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
94401805|NCT00112437|323256852|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401806|NCT00112437|323256853|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401807|NCT00112437|323256854|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401808|NCT00112437|323256855|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401809|NCT00112437|323256856|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401810|NCT00112437|323256857|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401811|NCT00112437|323256858|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401812|NCT00112437|323256859|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401813|NCT00112437|323256860|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401814|NCT00112437|323256861|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401815|NCT00112437|323256862|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
94401816|NCT00112437|323256837|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401817|NCT00112437|323256838|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401818|NCT00112437|323256839|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401819|NCT00112437|323256840|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401820|NCT00112437|323256841|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401821|NCT00112437|323256842|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401822|NCT00112437|323256843|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401823|NCT00112437|323256844|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401824|NCT00112437|323256845|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401825|NCT00112437|323256846|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401826|NCT00112437|323256847|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
94401827|NCT00112437|323256848|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
94401828|NCT00112437|323256849|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401829|NCT00112437|323256850|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401830|NCT00112437|323256851|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401831|NCT00112437|323256852|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401832|NCT00112437|323256853|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401833|NCT00112437|323256854|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401834|NCT00112437|323256855|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401835|NCT00112437|323256856|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401836|NCT00112437|323256857|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401837|NCT00112437|323256858|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401838|NCT00112437|323256859|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401839|NCT00112437|323256860|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401840|NCT00112437|323256861|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401841|NCT00112437|323256862|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
94401842|NCT00112437|323256837|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401843|NCT00112437|323256838|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401844|NCT00112437|323256839|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401845|NCT00112437|323256840|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401846|NCT00112437|323256841|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401847|NCT00112437|323256842|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401848|NCT00112437|323256843|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401849|NCT00112437|323256844|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401850|NCT00112437|323256845|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401851|NCT00112437|323256846|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401852|NCT00112437|323256847|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401853|NCT00112437|323256848|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401854|NCT00112437|323256849|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401855|NCT00112437|323256850|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401856|NCT00112437|323256851|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401857|NCT00112437|323256852|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401858|NCT00112437|323256853|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401859|NCT00112437|323256854|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401860|NCT00112437|323256855|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401861|NCT00112437|323256856|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401862|NCT00112437|323256857|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
94401863|NCT00112437|323256858|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
94401864|NCT00112437|323256859|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401865|NCT00112437|323256860|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401866|NCT00112437|323256861|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401867|NCT00112437|323256862|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
94401868|NCT00112437|323256837|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401869|NCT00112437|323256838|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94330405|NCT00131664|322990177|FG003|First Period (First 6 Months)|Protocol Violation|0|||
94330406|NCT00131664|322990178|FG004|First Period (First 6 Months)|Protocol Violation|0|||
94330407|NCT00131664|322990179|FG005|First Period (First 6 Months)|Protocol Violation|0|||
94330408|NCT00131664|322990174|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
94330409|NCT00131664|322990175|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
94330410|NCT00131664|322990176|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
94330411|NCT00131664|322990177|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
94330412|NCT00131664|322990178|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
94330413|NCT00131664|322990179|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
94330414|NCT00131664|322990174|FG000|First Period (First 6 Months)|Adverse Event|9|||
94330415|NCT00131664|322990175|FG001|First Period (First 6 Months)|Adverse Event|4|||
94330416|NCT00131664|322990176|FG002|First Period (First 6 Months)|Adverse Event|5|||
94330417|NCT00131664|322990177|FG003|First Period (First 6 Months)|Adverse Event|0|||
94330418|NCT00131664|322990178|FG004|First Period (First 6 Months)|Adverse Event|0|||
94330419|NCT00131664|322990179|FG005|First Period (First 6 Months)|Adverse Event|0|||
94330420|NCT00131664|322990174|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
94330421|NCT00131664|322990175|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
94330422|NCT00131664|322990176|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
94330423|NCT00131664|322990177|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
94330424|NCT00131664|322990178|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
94330425|NCT00131664|322990179|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
94330426|NCT00131664|322990174|FG000|First Period (First 6 Months)|Administrative reasons|2|||
94330427|NCT00131664|322990175|FG001|First Period (First 6 Months)|Administrative reasons|0|||
94330428|NCT00131664|322990176|FG002|First Period (First 6 Months)|Administrative reasons|5|||
94330429|NCT00131664|322990177|FG003|First Period (First 6 Months)|Administrative reasons|0|||
94330430|NCT00131664|322990178|FG004|First Period (First 6 Months)|Administrative reasons|0|||
94330431|NCT00131664|322990179|FG005|First Period (First 6 Months)|Administrative reasons|0|||
94330432|NCT00131664|322990174|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
94330433|NCT00131664|322990175|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
94330434|NCT00131664|322990176|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
94330435|NCT00131664|322990177|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
94330436|NCT00131664|322990178|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
94330437|NCT00131664|322990179|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
94330438|NCT00131664|322990174|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
94330439|NCT00131664|322990175|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
94330440|NCT00131664|322990176|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
94330441|NCT00131664|322990177|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
94330442|NCT00131664|322990178|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
94330443|NCT00131664|322990179|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
94330444|NCT00131664|322990174|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
94330445|NCT00131664|322990175|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
94330446|NCT00131664|322990176|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
94330447|NCT00131664|322990177|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
94330448|NCT00131664|322990178|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
94330449|NCT00131664|322990179|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
94330450|NCT00131664|322990174|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
94330451|NCT00131664|322990175|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
94330452|NCT00131664|322990176|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
94330453|NCT00131664|322990177|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
94330454|NCT00131664|322990178|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
94330455|NCT00131664|322990179|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
94330456|NCT00131664|322990174|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
94330457|NCT00131664|322990175|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
94330458|NCT00131664|322990176|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
94330459|NCT00131664|322990177|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
94330460|NCT00131664|322990178|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
94330461|NCT00131664|322990179|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
94330462|NCT00131664|322990174|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
94330463|NCT00131664|322990175|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
94330464|NCT00131664|322990176|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
94330465|NCT00131664|322990177|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
94330466|NCT00131664|322990178|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
94330467|NCT00131664|322990179|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
94401870|NCT00112437|323256839|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401871|NCT00112437|323256840|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401872|NCT00112437|323256841|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401873|NCT00112437|323256842|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401874|NCT00112437|323256843|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401875|NCT00112437|323256844|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401876|NCT00112437|323256845|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401877|NCT00112437|323256846|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401878|NCT00112437|323256847|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401879|NCT00112437|323256848|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401880|NCT00112437|323256849|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401881|NCT00112437|323256850|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401882|NCT00112437|323256851|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401883|NCT00112437|323256852|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401884|NCT00112437|323256853|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401885|NCT00112437|323256854|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401886|NCT00112437|323256855|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401887|NCT00112437|323256856|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401888|NCT00112437|323256857|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
94401889|NCT00112437|323256858|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401890|NCT00112437|323256859|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401891|NCT00112437|323256860|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401892|NCT00112437|323256861|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401893|NCT00112437|323256862|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
94401894|NCT00112437|323256837|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401895|NCT00112437|323256838|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401896|NCT00112437|323256839|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401897|NCT00112437|323256840|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401898|NCT00112437|323256841|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401899|NCT00112437|323256842|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401900|NCT00112437|323256843|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401901|NCT00112437|323256844|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401902|NCT00112437|323256845|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401903|NCT00112437|323256846|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401904|NCT00112437|323256847|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401905|NCT00112437|323256848|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401906|NCT00112437|323256849|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401907|NCT00112437|323256850|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401908|NCT00112437|323256851|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401909|NCT00112437|323256852|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401910|NCT00112437|323256853|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401911|NCT00112437|323256854|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401912|NCT00112437|323256855|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401913|NCT00112437|323256856|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401914|NCT00112437|323256857|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401915|NCT00112437|323256858|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
94401916|NCT00112437|323256859|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401917|NCT00112437|323256860|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401918|NCT00112437|323256861|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401919|NCT00112437|323256862|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
94401920|NCT00112437|323256837|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401921|NCT00112437|323256838|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401922|NCT00112437|323256839|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401923|NCT00112437|323256840|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401924|NCT00112437|323256841|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401925|NCT00112437|323256842|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401926|NCT00112437|323256843|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401927|NCT00112437|323256844|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401928|NCT00112437|323256845|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401929|NCT00112437|323256846|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401930|NCT00112437|323256847|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
94485527|NCT00794664|323570200|FG000|Treatment Period|Adverse Event|1|||
94401931|NCT00112437|323256848|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401932|NCT00112437|323256849|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401933|NCT00112437|323256850|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401934|NCT00112437|323256851|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401935|NCT00112437|323256852|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401936|NCT00112437|323256853|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401937|NCT00112437|323256854|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401938|NCT00112437|323256855|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401939|NCT00112437|323256856|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401940|NCT00112437|323256857|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401941|NCT00112437|323256858|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
94401942|NCT00112437|323256859|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401943|NCT00112437|323256860|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401944|NCT00112437|323256861|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401945|NCT00112437|323256862|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
94401946|NCT00112437|323256837|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401947|NCT00112437|323256838|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401948|NCT00112437|323256839|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401949|NCT00112437|323256840|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401950|NCT00112437|323256841|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401951|NCT00112437|323256842|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401952|NCT00112437|323256843|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401953|NCT00112437|323256844|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401954|NCT00112437|323256845|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401955|NCT00112437|323256846|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401956|NCT00112437|323256847|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401957|NCT00112437|323256848|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401958|NCT00112437|323256849|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401959|NCT00112437|323256850|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401960|NCT00112437|323256851|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401961|NCT00112437|323256852|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401962|NCT00112437|323256853|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401963|NCT00112437|323256854|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401964|NCT00112437|323256855|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401965|NCT00112437|323256856|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401966|NCT00112437|323256857|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
94401967|NCT00112437|323256858|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
94401968|NCT00112437|323256859|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401969|NCT00112437|323256860|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401970|NCT00112437|323256861|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401971|NCT00112437|323256862|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
94401972|NCT00112437|323256837|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401973|NCT00112437|323256838|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401974|NCT00112437|323256839|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401975|NCT00112437|323256840|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401976|NCT00112437|323256841|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401977|NCT00112437|323256842|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401978|NCT00112437|323256843|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401979|NCT00112437|323256844|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401980|NCT00112437|323256845|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401981|NCT00112437|323256846|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401982|NCT00112437|323256847|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401983|NCT00112437|323256848|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401984|NCT00112437|323256849|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401985|NCT00112437|323256850|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401986|NCT00112437|323256851|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401987|NCT00112437|323256852|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401988|NCT00112437|323256853|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401989|NCT00112437|323256854|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401990|NCT00112437|323256855|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401991|NCT00112437|323256856|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401992|NCT00112437|323256857|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401993|NCT00112437|323256858|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401994|NCT00112437|323256859|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
94401995|NCT00112437|323256860|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
94401996|NCT00112437|323256861|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
94401997|NCT00112437|323256862|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
94401998|NCT00112437|323256837|FG000|Years 6-10 (60-Month Extension)|Death|0|||
94401999|NCT00112437|323256838|FG001|Years 6-10 (60-Month Extension)|Death|0|||
94402000|NCT00112437|323256839|FG002|Years 6-10 (60-Month Extension)|Death|0|||
94402001|NCT00112437|323256840|FG003|Years 6-10 (60-Month Extension)|Death|0|||
94402002|NCT00112437|323256841|FG004|Years 6-10 (60-Month Extension)|Death|0|||
94485528|NCT00794664|323570201|FG001|Treatment Period|Adverse Event|8|||
94485529|NCT00794664|323570200|FG000|Follow-up Period|Other|1|||
94402003|NCT00112437|323256842|FG005|Years 6-10 (60-Month Extension)|Death|0|||
94402004|NCT00112437|323256843|FG006|Years 6-10 (60-Month Extension)|Death|0|||
94402005|NCT00112437|323256844|FG007|Years 6-10 (60-Month Extension)|Death|0|||
94402006|NCT00112437|323256845|FG008|Years 6-10 (60-Month Extension)|Death|0|||
94402007|NCT00112437|323256846|FG009|Years 6-10 (60-Month Extension)|Death|0|||
94402008|NCT00112437|323256847|FG010|Years 6-10 (60-Month Extension)|Death|0|||
94402009|NCT00112437|323256848|FG011|Years 6-10 (60-Month Extension)|Death|0|||
94402010|NCT00112437|323256849|FG012|Years 6-10 (60-Month Extension)|Death|0|||
94402011|NCT00112437|323256850|FG013|Years 6-10 (60-Month Extension)|Death|0|||
94402012|NCT00112437|323256851|FG014|Years 6-10 (60-Month Extension)|Death|0|||
94402013|NCT00112437|323256852|FG015|Years 6-10 (60-Month Extension)|Death|0|||
94402014|NCT00112437|323256853|FG016|Years 6-10 (60-Month Extension)|Death|0|||
94402015|NCT00112437|323256854|FG017|Years 6-10 (60-Month Extension)|Death|0|||
94402016|NCT00112437|323256855|FG018|Years 6-10 (60-Month Extension)|Death|0|||
94402017|NCT00112437|323256856|FG019|Years 6-10 (60-Month Extension)|Death|0|||
94402018|NCT00112437|323256857|FG020|Years 6-10 (60-Month Extension)|Death|0|||
94402019|NCT00112437|323256858|FG021|Years 6-10 (60-Month Extension)|Death|0|||
94402020|NCT00112437|323256859|FG022|Years 6-10 (60-Month Extension)|Death|0|||
94402021|NCT00112437|323256860|FG023|Years 6-10 (60-Month Extension)|Death|2|||
94402022|NCT00112437|323256861|FG024|Years 6-10 (60-Month Extension)|Death|0|||
94402023|NCT00112437|323256862|FG025|Years 6-10 (60-Month Extension)|Death|0|||
94402024|NCT00112437|323256837|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402025|NCT00112437|323256838|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402026|NCT00112437|323256839|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402027|NCT00112437|323256840|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402028|NCT00112437|323256841|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402029|NCT00112437|323256842|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402030|NCT00112437|323256843|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402031|NCT00112437|323256844|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402032|NCT00112437|323256845|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402033|NCT00112437|323256846|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402034|NCT00112437|323256847|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402035|NCT00112437|323256848|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402036|NCT00112437|323256849|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402037|NCT00112437|323256850|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402038|NCT00112437|323256851|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402039|NCT00112437|323256852|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402040|NCT00112437|323256853|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402041|NCT00112437|323256854|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402042|NCT00112437|323256855|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402043|NCT00112437|323256856|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402044|NCT00112437|323256857|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402045|NCT00112437|323256858|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402046|NCT00112437|323256859|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402047|NCT00112437|323256860|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402048|NCT00112437|323256861|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
94402049|NCT00112437|323256862|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
94402050|NCT00112437|323256837|FG000|Years 6-10 (60-Month Extension)|Other|0|||
94402051|NCT00112437|323256838|FG001|Years 6-10 (60-Month Extension)|Other|0|||
94402052|NCT00112437|323256839|FG002|Years 6-10 (60-Month Extension)|Other|0|||
94402053|NCT00112437|323256840|FG003|Years 6-10 (60-Month Extension)|Other|0|||
94402054|NCT00112437|323256841|FG004|Years 6-10 (60-Month Extension)|Other|0|||
94402055|NCT00112437|323256842|FG005|Years 6-10 (60-Month Extension)|Other|0|||
94402056|NCT00112437|323256843|FG006|Years 6-10 (60-Month Extension)|Other|0|||
94402057|NCT00112437|323256844|FG007|Years 6-10 (60-Month Extension)|Other|0|||
94402058|NCT00112437|323256845|FG008|Years 6-10 (60-Month Extension)|Other|0|||
94402059|NCT00112437|323256846|FG009|Years 6-10 (60-Month Extension)|Other|0|||
94402060|NCT00112437|323256847|FG010|Years 6-10 (60-Month Extension)|Other|0|||
94402061|NCT00112437|323256848|FG011|Years 6-10 (60-Month Extension)|Other|0|||
94402062|NCT00112437|323256849|FG012|Years 6-10 (60-Month Extension)|Other|0|||
94402063|NCT00112437|323256850|FG013|Years 6-10 (60-Month Extension)|Other|0|||
94402064|NCT00112437|323256851|FG014|Years 6-10 (60-Month Extension)|Other|0|||
94402065|NCT00112437|323256852|FG015|Years 6-10 (60-Month Extension)|Other|0|||
94402066|NCT00112437|323256853|FG016|Years 6-10 (60-Month Extension)|Other|0|||
94402067|NCT00112437|323256854|FG017|Years 6-10 (60-Month Extension)|Other|0|||
94402068|NCT00112437|323256855|FG018|Years 6-10 (60-Month Extension)|Other|0|||
94402069|NCT00112437|323256856|FG019|Years 6-10 (60-Month Extension)|Other|0|||
94402070|NCT00112437|323256857|FG020|Years 6-10 (60-Month Extension)|Other|0|||
94402071|NCT00112437|323256858|FG021|Years 6-10 (60-Month Extension)|Other|0|||
94402072|NCT00112437|323256859|FG022|Years 6-10 (60-Month Extension)|Other|0|||
94485530|NCT00794664|323570201|FG001|Follow-up Period|Other|2|||
94402073|NCT00112437|323256860|FG023|Years 6-10 (60-Month Extension)|Other|0|||
94402074|NCT00112437|323256861|FG024|Years 6-10 (60-Month Extension)|Other|1|||
94402075|NCT00112437|323256862|FG025|Years 6-10 (60-Month Extension)|Other|0|||
94402076|NCT00112437|323256837|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402077|NCT00112437|323256838|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402078|NCT00112437|323256839|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402079|NCT00112437|323256840|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402080|NCT00112437|323256841|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402081|NCT00112437|323256842|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402082|NCT00112437|323256843|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402083|NCT00112437|323256844|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402084|NCT00112437|323256845|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402085|NCT00112437|323256846|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402086|NCT00112437|323256847|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402087|NCT00112437|323256848|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402088|NCT00112437|323256849|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402089|NCT00112437|323256850|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402090|NCT00112437|323256851|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402091|NCT00112437|323256852|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402092|NCT00112437|323256853|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402093|NCT00112437|323256854|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402094|NCT00112437|323256855|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402095|NCT00112437|323256856|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402096|NCT00112437|323256857|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402097|NCT00112437|323256858|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402098|NCT00112437|323256859|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402099|NCT00112437|323256860|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
94402100|NCT00112437|323256861|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402101|NCT00112437|323256862|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
94402102|NCT00112437|323256837|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402103|NCT00112437|323256838|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402104|NCT00112437|323256839|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402105|NCT00112437|323256840|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402106|NCT00112437|323256841|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402107|NCT00112437|323256842|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402108|NCT00112437|323256843|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402109|NCT00112437|323256844|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402110|NCT00112437|323256845|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402111|NCT00112437|323256846|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402112|NCT00112437|323256847|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402113|NCT00112437|323256848|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402114|NCT00112437|323256849|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402115|NCT00112437|323256850|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402116|NCT00112437|323256851|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402117|NCT00112437|323256852|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402118|NCT00112437|323256853|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402119|NCT00112437|323256854|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402120|NCT00112437|323256855|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402121|NCT00112437|323256856|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402122|NCT00112437|323256857|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402123|NCT00112437|323256858|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402124|NCT00112437|323256859|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
94402125|NCT00112437|323256860|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
94402126|NCT00112437|323256861|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
94402127|NCT00112437|323256862|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
94402128|NCT05665387|323256863|FG000|Overall Study|Withdrawal by Subject|1|||
94402129|NCT05665387|323256864|FG001|Overall Study|Withdrawal by Subject|0|||
94402130|NCT05665387|323256865|FG002|Overall Study|Withdrawal by Subject|1|||
94402131|NCT00842309|323256869|FG000|Overall Study|Withdrawal by Subject|3|||
94402132|NCT00842309|323256870|FG001|Overall Study|Withdrawal by Subject|1|||
94402133|NCT01576705|323256871|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
94402134|NCT01576705|323256872|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
94402135|NCT01576705|323256873|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
94402136|NCT01576705|323256874|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
94402137|NCT01576705|323256871|FG000|Overall Study|invalid ICF|0|||
94402138|NCT01576705|323256872|FG001|Overall Study|invalid ICF|1|||
94402139|NCT01576705|323256873|FG002|Overall Study|invalid ICF|0|||
94402140|NCT01576705|323256874|FG003|Overall Study|invalid ICF|0|||
94402141|NCT03727139|323256875|FG000|Overall Study|Protocol Violation|60|||
94402142|NCT00566722|323256876|FG000|Overall Study|Adverse Event|0|||
94402143|NCT00566722|323256877|FG001|Overall Study|Adverse Event|1|||
94402144|NCT00566722|323256878|FG002|Overall Study|Adverse Event|0|||
94402145|NCT00566722|323256876|FG000|Overall Study|Withdrawal by Subject|0|||
94402146|NCT00566722|323256877|FG001|Overall Study|Withdrawal by Subject|0|||
94402147|NCT00566722|323256878|FG002|Overall Study|Withdrawal by Subject|1|||
94402148|NCT00566722|323256876|FG000|Overall Study|Lost to Follow-up|1|||
94402149|NCT00566722|323256877|FG001|Overall Study|Lost to Follow-up|1|||
94402150|NCT00566722|323256878|FG002|Overall Study|Lost to Follow-up|1|||
94402151|NCT00566722|323256876|FG000|Overall Study|Lack of Efficacy|1|||
94402152|NCT00566722|323256877|FG001|Overall Study|Lack of Efficacy|2|||
94402153|NCT00566722|323256878|FG002|Overall Study|Lack of Efficacy|4|||
94402154|NCT00566722|323256876|FG000|Overall Study|Did not meet exclusion criteria|0|||
94402155|NCT00566722|323256877|FG001|Overall Study|Did not meet exclusion criteria|0|||
94402156|NCT00566722|323256878|FG002|Overall Study|Did not meet exclusion criteria|2|||
94402157|NCT00566722|323256876|FG000|Overall Study|Serious adverse event|0|||
94402158|NCT00566722|323256877|FG001|Overall Study|Serious adverse event|1|||
94402159|NCT00566722|323256878|FG002|Overall Study|Serious adverse event|0|||
94402160|NCT00566722|323256876|FG000|Overall Study|Noncompliant with drug administration|0|||
94402161|NCT00566722|323256877|FG001|Overall Study|Noncompliant with drug administration|0|||
94402162|NCT00566722|323256878|FG002|Overall Study|Noncompliant with drug administration|1|||
94402163|NCT00757172|323256881|FG000|Overall Study|Withdrawal by Subject|4|||
94402164|NCT00757172|323256881|FG000|Overall Study|Physician Decision|3|||
94402165|NCT00757172|323256881|FG000|Overall Study|Progression|4|||
94402166|NCT01717040|323256884|FG000|Overall Study|Lost to Follow-up|2|||
94402167|NCT01717040|323256885|FG001|Overall Study|Lost to Follow-up|3|||
94402168|NCT01717040|323256884|FG000|Overall Study|Lack of Efficacy|1|||
94402169|NCT01717040|323256885|FG001|Overall Study|Lack of Efficacy|1|||
94402170|NCT01717040|323256884|FG000|Overall Study|Adverse Event|1|||
94402171|NCT01717040|323256885|FG001|Overall Study|Adverse Event|0|||
94402172|NCT01717040|323256884|FG000|Overall Study|Required Medication Change|0|||
94402173|NCT01717040|323256885|FG001|Overall Study|Required Medication Change|1|||
94402174|NCT01717040|323256884|FG000|Overall Study|New Substance Use Disorder|1|||
94402175|NCT01717040|323256885|FG001|Overall Study|New Substance Use Disorder|0|||
94402176|NCT00835081|323256887|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
94402177|NCT00835081|323256888|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
94402178|NCT00421304|323256889|FG000|Overall Study|Lost to Follow-up|5|||
94402179|NCT00421304|323256890|FG001|Overall Study|Lost to Follow-up|2|||
94402180|NCT00421304|323256891|FG002|Overall Study|Lost to Follow-up|5|||
94402181|NCT00421304|323256889|FG000|Overall Study|Withdrawal by Subject|2|||
94402182|NCT00421304|323256890|FG001|Overall Study|Withdrawal by Subject|2|||
94402183|NCT00421304|323256891|FG002|Overall Study|Withdrawal by Subject|2|||
94402184|NCT00421304|323256889|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
94402185|NCT00421304|323256890|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
94402186|NCT00421304|323256891|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
94402187|NCT00421304|323256889|FG000|Overall Study|Did not attend Day 360 visit|0|||
94402188|NCT00421304|323256890|FG001|Overall Study|Did not attend Day 360 visit|0|||
94402189|NCT00421304|323256891|FG002|Overall Study|Did not attend Day 360 visit|1|||
94402190|NCT01539239|323256892|FG000|Overall Study|Death|5|||
94402191|NCT01539239|323256893|FG001|Overall Study|Death|5|||
94402192|NCT01539239|323256892|FG000|Overall Study|Lost to Follow-up|7|||
94402193|NCT01539239|323256893|FG001|Overall Study|Lost to Follow-up|12|||
94402194|NCT00840879|323256897|FG000|Second Intervention|Withdrawal by Subject|1|||
94402195|NCT00840879|323256898|FG001|Second Intervention|Withdrawal by Subject|0|||
94402196|NCT00874276|323256899|FG000|Overall Study|Withdrawal by Subject|1|||
94402197|NCT00874276|323256900|FG001|Overall Study|Withdrawal by Subject|1|||
94402198|NCT02061280|323256903|FG000|Overall Study|Protocol Violation|12|||
94402199|NCT02061280|323256904|FG001|Overall Study|Protocol Violation|8|||
94402200|NCT02061280|323256903|FG000|Overall Study|moved out of state|0|||
94402201|NCT02061280|323256904|FG001|Overall Study|moved out of state|1|||
94402202|NCT02061280|323256903|FG000|Overall Study|Withdrawal by Subject|1|||
94402203|NCT02061280|323256904|FG001|Overall Study|Withdrawal by Subject|2|||
94402204|NCT02061280|323256903|FG000|Overall Study|Lost to Follow-up|5|||
94402205|NCT02061280|323256904|FG001|Overall Study|Lost to Follow-up|1|||
94402206|NCT00659815|323258721|FG000|Overall Study|Study related symptoms and complaints|2|||
94402207|NCT00659815|323258722|FG001|Overall Study|Study related symptoms and complaints|1|||
94402208|NCT00659815|323258721|FG000|Overall Study|Inability to maintain wearing schedule|1|||
94402209|NCT00659815|323258722|FG001|Overall Study|Inability to maintain wearing schedule|2|||
94402210|NCT00659815|323258721|FG000|Overall Study|Withdrawal by Subject|1|||
94402211|NCT00659815|323258722|FG001|Overall Study|Withdrawal by Subject|1|||
94402212|NCT02651987|323258723|FG000|Overall Study|Adverse Event|2|||
94402213|NCT02651987|323258724|FG001|Overall Study|Adverse Event|2|||
94402214|NCT02651987|323258723|FG000|Overall Study|Consent Withdrawn|2|||
94402215|NCT02651987|323258724|FG001|Overall Study|Consent Withdrawn|0|||
94402216|NCT02651987|323258723|FG000|Overall Study|Local PD|0|||
94402217|NCT02651987|323258724|FG001|Overall Study|Local PD|2|||
94402218|NCT02651987|323258723|FG000|Overall Study|Investigator Decision|1|||
94402219|NCT02651987|323258724|FG001|Overall Study|Investigator Decision|1|||
94402220|NCT01630616|323258725|FG000|Overall Study|Adverse Event|0|||
94402221|NCT01630616|323258726|FG001|Overall Study|Adverse Event|0|||
94402222|NCT01630616|323258727|FG002|Overall Study|Adverse Event|0|||
94402223|NCT01630616|323258728|FG003|Overall Study|Adverse Event|1|||
94402224|NCT01630616|323258729|FG004|Overall Study|Adverse Event|0|||
94402225|NCT01630616|323258730|FG005|Overall Study|Adverse Event|0|||
94402226|NCT01630616|323258725|FG000|Overall Study|Withdrawal by Subject|0|||
94402227|NCT01630616|323258726|FG001|Overall Study|Withdrawal by Subject|0|||
94402228|NCT01630616|323258727|FG002|Overall Study|Withdrawal by Subject|0|||
94402229|NCT01630616|323258728|FG003|Overall Study|Withdrawal by Subject|2|||
94402230|NCT01630616|323258729|FG004|Overall Study|Withdrawal by Subject|0|||
94402231|NCT01630616|323258730|FG005|Overall Study|Withdrawal by Subject|0|||
94402232|NCT02725515|323258731|FG000|Overall Study|Refused infusion (no study treatment)|1|||
94402233|NCT02725515|323258732|FG001|Overall Study|Refused infusion (no study treatment)|0|||
94402234|NCT02725515|323258731|FG000|Overall Study|Loss of Improvement per Protocol|14|||
94402235|NCT02725515|323258732|FG001|Overall Study|Loss of Improvement per Protocol|25|||
94402236|NCT02725515|323258731|FG000|Overall Study|Withdrawal by Subject|2|||
94402237|NCT02725515|323258732|FG001|Overall Study|Withdrawal by Subject|1|||
94402238|NCT02725515|323258731|FG000|Overall Study|Non-Compliance With Study Drug|0|||
94402239|NCT02725515|323258732|FG001|Overall Study|Non-Compliance With Study Drug|3|||
94402240|NCT02725515|323258731|FG000|Overall Study|Lost to Follow-up|1|||
94402241|NCT02725515|323258732|FG001|Overall Study|Lost to Follow-up|1|||
94402242|NCT02725515|323258731|FG000|Overall Study|Adverse Event|7|||
94402243|NCT02725515|323258732|FG001|Overall Study|Adverse Event|2|||
94402244|NCT02725515|323258731|FG000|Overall Study|No Documented Disease Improvement|0|||
94402245|NCT02725515|323258732|FG001|Overall Study|No Documented Disease Improvement|1|||
94402246|NCT02725515|323258731|FG000|Overall Study|Completed Study Under Original Protocol|0|||
94402247|NCT02725515|323258732|FG001|Overall Study|Completed Study Under Original Protocol|1|||
94402248|NCT02725515|323258731|FG000|Overall Study|Lack of Response|0|||
94402249|NCT02725515|323258732|FG001|Overall Study|Lack of Response|1|||
94402250|NCT00084864|323258737|FG000|Overall Study|Adverse Event|1|||
94402251|NCT00084864|323258738|FG001|Overall Study|Adverse Event|0|||
94402252|NCT00084864|323258739|FG002|Overall Study|Adverse Event|0|||
94402253|NCT00084864|323258740|FG003|Overall Study|Adverse Event|0|||
94402254|NCT02694536|323258747|FG000|Overall Study|Progressive Disease|40|||
94402255|NCT02694536|323258747|FG000|Overall Study|Lost to Follow-up|1|||
94402256|NCT02694536|323258747|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
94402257|NCT02694536|323258747|FG000|Overall Study|Withdrawal by Subject|8|||
94402258|NCT02694536|323258747|FG000|Overall Study|Death|8|||
94402259|NCT02694536|323258747|FG000|Overall Study|Other|22|||
94402260|NCT00059332|323258748|FG000|Overall Study|Withdrawal by Subject|2|||
94402261|NCT00059332|323258749|FG001|Overall Study|Withdrawal by Subject|1|||
94402262|NCT00059332|323258748|FG000|Overall Study|Lost to Follow-up|1|||
94402263|NCT00059332|323258749|FG001|Overall Study|Lost to Follow-up|1|||
94402264|NCT01911429|323258750|FG000|Overall Study|Adverse Event|5|||
94402265|NCT01911429|323258751|FG001|Overall Study|Adverse Event|3|||
94402266|NCT01911429|323258752|FG002|Overall Study|Adverse Event|9|||
94402267|NCT01911429|323258750|FG000|Overall Study|Lack of Efficacy|1|||
94402268|NCT01911429|323258751|FG001|Overall Study|Lack of Efficacy|2|||
94402269|NCT01911429|323258752|FG002|Overall Study|Lack of Efficacy|4|||
94402270|NCT01911429|323258750|FG000|Overall Study|Lost to Follow-up|0|||
94402271|NCT01911429|323258751|FG001|Overall Study|Lost to Follow-up|0|||
94402272|NCT01911429|323258752|FG002|Overall Study|Lost to Follow-up|1|||
94402273|NCT01911429|323258750|FG000|Overall Study|Protocol Violation|0|||
94402274|NCT01911429|323258751|FG001|Overall Study|Protocol Violation|0|||
94402275|NCT01911429|323258752|FG002|Overall Study|Protocol Violation|1|||
94402276|NCT01911429|323258750|FG000|Overall Study|Withdrawal by Subject|5|||
94402277|NCT01911429|323258751|FG001|Overall Study|Withdrawal by Subject|5|||
94402278|NCT01911429|323258752|FG002|Overall Study|Withdrawal by Subject|4|||
94402279|NCT01911429|323258750|FG000|Overall Study|Accidental randomization|0|||
94402280|NCT01911429|323258751|FG001|Overall Study|Accidental randomization|0|||
94402281|NCT01911429|323258752|FG002|Overall Study|Accidental randomization|1|||
94402282|NCT01911429|323258750|FG000|Overall Study|subject left study|1|||
94402283|NCT01911429|323258751|FG001|Overall Study|subject left study|0|||
94402284|NCT01911429|323258752|FG002|Overall Study|subject left study|0|||
94402285|NCT01853176|323258763|FG000|Overall Study|Study terminated|4|||
94402286|NCT01853176|323258764|FG001|Overall Study|Study terminated|0|||
94402287|NCT00198133|323258765|FG000|Overall Study|Disease progression|2|||
94402288|NCT00198133|323258766|FG001|Overall Study|Disease progression|5|||
94402289|NCT00198133|323258765|FG000|Overall Study|Adverse Event|1|||
94402290|NCT00198133|323258766|FG001|Overall Study|Adverse Event|3|||
94402291|NCT00198133|323258765|FG000|Overall Study|Withdrawal by Subject|1|||
94402292|NCT00198133|323258766|FG001|Overall Study|Withdrawal by Subject|0|||
94402293|NCT00198133|323258765|FG000|Overall Study|Physician Decision|1|||
94402294|NCT00198133|323258766|FG001|Overall Study|Physician Decision|0|||
94402295|NCT02906917|323258769|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
94330468|NCT03136367|322990180|FG000|T1 Consultation|discontinued mistakenly included|2|||
94330469|NCT03136367|322990181|FG001|T1 Consultation|discontinued mistakenly included|6|||
94330470|NCT03136367|322990182|FG002|T1 Consultation|discontinued mistakenly included|1|||
94330471|NCT03136367|322990180|FG000|T1 Consultation|Discontinued other|0|||
94330472|NCT03136367|322990181|FG001|T1 Consultation|Discontinued other|1|||
94330473|NCT03136367|322990182|FG002|T1 Consultation|Discontinued other|0|||
94330474|NCT03136367|322990180|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
94330475|NCT03136367|322990181|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
94330476|NCT03136367|322990182|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
94330477|NCT03136367|322990180|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
94330478|NCT03136367|322990181|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
94330479|NCT03136367|322990182|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
94330480|NCT03136367|322990180|FG000|T2 Post-consultation|Discontinued other|0|||
94330481|NCT03136367|322990181|FG001|T2 Post-consultation|Discontinued other|2|||
94330482|NCT03136367|322990182|FG002|T2 Post-consultation|Discontinued other|6|||
94330483|NCT03136367|322990180|FG000|T2 Post-consultation|Discontinued transferred care|0|||
94330484|NCT03136367|322990181|FG001|T2 Post-consultation|Discontinued transferred care|0|||
94330485|NCT03136367|322990182|FG002|T2 Post-consultation|Discontinued transferred care|3|||
94330486|NCT03136367|322990180|FG000|T2 Post-consultation|Discontinued lost contact|0|||
94330487|NCT03136367|322990181|FG001|T2 Post-consultation|Discontinued lost contact|1|||
94330488|NCT03136367|322990182|FG002|T2 Post-consultation|Discontinued lost contact|0|||
94330489|NCT03136367|322990180|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
94330490|NCT03136367|322990181|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
94330491|NCT03136367|322990182|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
94330492|NCT03136367|322990180|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
94330493|NCT03136367|322990181|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
94330494|NCT03136367|322990182|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
94330495|NCT03136367|322990180|FG000|T3 1 Week After Surgery|other discontinued|2|||
94330496|NCT03136367|322990181|FG001|T3 1 Week After Surgery|other discontinued|4|||
94330497|NCT03136367|322990182|FG002|T3 1 Week After Surgery|other discontinued|3|||
94330498|NCT03136367|322990180|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
94330499|NCT03136367|322990181|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
94330500|NCT03136367|322990182|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
94330501|NCT03136367|322990180|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
94330502|NCT03136367|322990181|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
94330503|NCT03136367|322990182|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
94330504|NCT03136367|322990180|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
94330505|NCT03136367|322990181|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
94330506|NCT03136367|322990182|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
94330507|NCT03136367|322990180|FG000|T4 12 Weeks After Surgery|Death|0|||
94330508|NCT03136367|322990181|FG001|T4 12 Weeks After Surgery|Death|1|||
94330509|NCT03136367|322990182|FG002|T4 12 Weeks After Surgery|Death|3|||
94330510|NCT03136367|322990180|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
94330511|NCT03136367|322990181|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
94330512|NCT03136367|322990182|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
94330513|NCT03136367|322990180|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
94330514|NCT03136367|322990181|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
94330515|NCT03136367|322990182|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
94330516|NCT03136367|322990180|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
94330517|NCT03136367|322990181|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
94330518|NCT03136367|322990182|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
94330519|NCT03136367|322990180|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
94330520|NCT03136367|322990181|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
94330521|NCT03136367|322990182|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
94330522|NCT03136367|322990180|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
94330523|NCT03136367|322990181|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
94330524|NCT03136367|322990182|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
94330525|NCT03136367|322990180|FG000|T5 1 Year After Surgery|Death|0|||
94330526|NCT03136367|322990181|FG001|T5 1 Year After Surgery|Death|0|||
94330527|NCT03136367|322990182|FG002|T5 1 Year After Surgery|Death|1|||
94330528|NCT03136367|322990180|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
94330529|NCT03136367|322990181|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
94330530|NCT03136367|322990182|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
94330531|NCT03136367|322990180|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
94330532|NCT03136367|322990181|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
94330533|NCT03136367|322990182|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
94330534|NCT03136367|322990180|FG000|T5 1 Year After Surgery|study ended before due|31|||
94330535|NCT03136367|322990181|FG001|T5 1 Year After Surgery|study ended before due|103|||
94330536|NCT03136367|322990182|FG002|T5 1 Year After Surgery|study ended before due|110|||
94402296|NCT02906917|323258770|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
94402297|NCT02906917|323258769|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
94402298|NCT02906917|323258770|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
94402299|NCT02906917|323258769|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
94402300|NCT02906917|323258770|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
94402301|NCT02906917|323258769|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
94402302|NCT02906917|323258770|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
94402303|NCT02906917|323258769|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
94402304|NCT02906917|323258770|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
94402305|NCT02906917|323258769|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
94402306|NCT02906917|323258770|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
94402307|NCT02906917|323258769|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
94402308|NCT02906917|323258770|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
94402309|NCT02906917|323258769|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
94402310|NCT02906917|323258770|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
94402311|NCT03497130|323258774|FG000|Overall Study|Lost to Follow-up|1|||
94402312|NCT03497130|323258775|FG001|Overall Study|Lost to Follow-up|1|||
94402313|NCT00874822|323258777|FG000|Overall Study|excluded by criteria|8|||
94402314|NCT03214588|323258778|FG000|Overall Study|Adverse Event|1|||
94402315|NCT03214588|323258779|FG001|Overall Study|Adverse Event|0|||
94402316|NCT03214588|323258780|FG002|Overall Study|Adverse Event|2|||
94402317|NCT03214588|323258778|FG000|Overall Study|Reason Not Specified|0|||
94402318|NCT03214588|323258779|FG001|Overall Study|Reason Not Specified|1|||
94402319|NCT03214588|323258780|FG002|Overall Study|Reason Not Specified|0|||
94402320|NCT02627963|323258783|FG000|Overall Study|Randomized but not treated|2|||
94402321|NCT02627963|323258784|FG001|Overall Study|Randomized but not treated|6|||
94402322|NCT00840203|323258785|FG000|First Intervention|Protocol Violation|1|||
94402323|NCT00840203|323258786|FG001|First Intervention|Protocol Violation|1|||
94402324|NCT00840203|323258785|FG000|Washout|Protocol Violation|1|||
94402325|NCT00840203|323258786|FG001|Washout|Protocol Violation|0|||
94402326|NCT02420353|323258787|FG000|Overall Study|Withdrawal by Subject|0|||
94402327|NCT02420353|323258788|FG001|Overall Study|Withdrawal by Subject|1|||
94402328|NCT00152451|323258789|FG000|Overall Study|Adverse Event|4|||
94402329|NCT00503867|323258791|FG000|Overall Study|Lost to Follow-up|1|||
94402330|NCT00503867|323258791|FG000|Overall Study|Adverse Event|1|||
94402331|NCT04697173|323258794|FG000|Overall Study|Withdrawal by Subject|34|||
94402332|NCT04697173|323258795|FG001|Overall Study|Withdrawal by Subject|38|||
94402333|NCT03807440|323258796|FG000|Overall Study|No documentation of index date 2|320|||
94402334|NCT03807440|323258796|FG000|Overall Study|No informed consent for index date 2|117|||
94402335|NCT04608448|323258797|FG000|Overall Study|Withdrawal by Subject|1|||
94402336|NCT04608448|323258797|FG000|Overall Study|Adverse Event|1|||
94402337|NCT01149057|323258798|FG000|Overall Study|Lack of Efficacy|16|||
94402338|NCT01149057|323258798|FG000|Overall Study|Adverse Event|13|||
94402339|NCT01149057|323258798|FG000|Overall Study|Withdrawal by Subject|9|||
94402340|NCT01149057|323258798|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
94402341|NCT01149057|323258798|FG000|Overall Study|B Cell Depletion|4|||
94402342|NCT01149057|323258798|FG000|Overall Study|Participant Non-Compliance|2|||
94402343|NCT01149057|323258798|FG000|Overall Study|Lost to Follow-up|1|||
94402344|NCT01149057|323258798|FG000|Overall Study|High Parathyroid Hormone Value|1|||
94402345|NCT01149057|323258798|FG000|Overall Study|Other|6|||
94402346|NCT00323258|323258799|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
94402347|NCT00323258|323258800|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
94402348|NCT00323258|323258799|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
94402349|NCT00323258|323258800|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
94402350|NCT00323258|323258799|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
94402351|NCT00323258|323258800|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
94402352|NCT00323258|323258799|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
94402353|NCT00323258|323258800|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
94402354|NCT00323258|323258799|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
94402355|NCT00323258|323258800|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
94402356|NCT00323258|323258799|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
94402357|NCT00323258|323258800|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
94402358|NCT00323258|323258799|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
94402359|NCT00323258|323258800|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
94402360|NCT05616728|323258806|FG000|Overall Study|Lost to Follow-up|0|||
94402361|NCT05616728|323258807|FG001|Overall Study|Lost to Follow-up|0|||
94402362|NCT05616728|323258808|FG002|Overall Study|Lost to Follow-up|1|||
94402363|NCT05616728|323258806|FG000|Overall Study|Withdrawal by Subject|1|||
94402364|NCT05616728|323258807|FG001|Overall Study|Withdrawal by Subject|1|||
94402365|NCT05616728|323258808|FG002|Overall Study|Withdrawal by Subject|0|||
94402366|NCT05616728|323258806|FG000|Overall Study|Physician Decision|1|||
94402367|NCT05616728|323258807|FG001|Overall Study|Physician Decision|1|||
94402368|NCT05616728|323258808|FG002|Overall Study|Physician Decision|1|||
94402369|NCT05616728|323258806|FG000|Overall Study|Other|0|||
94402370|NCT05616728|323258807|FG001|Overall Study|Other|2|||
94402371|NCT05616728|323258808|FG002|Overall Study|Other|0|||
94402372|NCT00577655|323258811|FG000|Overall Study|Patient Request|0|||
94402373|NCT00577655|323258812|FG001|Overall Study|Patient Request|2|||
94402374|NCT00577655|323258811|FG000|Overall Study|Protocol Violation|0|||
94402375|NCT00577655|323258812|FG001|Overall Study|Protocol Violation|1|||
94402376|NCT00577655|323258811|FG000|Overall Study|Lost to Follow-up|1|||
94402377|NCT00577655|323258812|FG001|Overall Study|Lost to Follow-up|1|||
94402378|NCT01024855|323258813|FG000|Overall Study|Inclusion/exclusion criteria|1|||
94402379|NCT02372006|323258816|FG000|Overall Study|Progressive disease|8|||
94402380|NCT02372006|323258817|FG001|Overall Study|Progressive disease|7|||
94402381|NCT02372006|323258818|FG002|Overall Study|Progressive disease|34|||
94402382|NCT02372006|323258816|FG000|Overall Study|Dose limiting toxicity|0|||
94402383|NCT02372006|323258817|FG001|Overall Study|Dose limiting toxicity|1|||
94402384|NCT02372006|323258818|FG002|Overall Study|Dose limiting toxicity|0|||
94402385|NCT02372006|323258816|FG000|Overall Study|Adverse Event|0|||
94402386|NCT02372006|323258817|FG001|Overall Study|Adverse Event|0|||
94402387|NCT02372006|323258818|FG002|Overall Study|Adverse Event|3|||
94402388|NCT02372006|323258816|FG000|Overall Study|Withdrawal by Subject|0|||
94402389|NCT02372006|323258817|FG001|Overall Study|Withdrawal by Subject|1|||
94402390|NCT02372006|323258818|FG002|Overall Study|Withdrawal by Subject|1|||
94402391|NCT02372006|323258816|FG000|Overall Study|Other reason for not completing|0|||
94402392|NCT02372006|323258817|FG001|Overall Study|Other reason for not completing|0|||
94402393|NCT02372006|323258818|FG002|Overall Study|Other reason for not completing|1|||
94402394|NCT01055834|323258823|FG000|Treatment Period I|Adverse Event|1|||
94402395|NCT01055834|323258824|FG001|Treatment Period I|Adverse Event|0|||
94402396|NCT01370863|323258825|FG000|Overall Study|Adverse Event|1|||
94402397|NCT01370863|323258826|FG001|Overall Study|Adverse Event|1|||
94402398|NCT01370863|323258825|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
94402399|NCT01370863|323258826|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
94402400|NCT01370863|323258825|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
94402401|NCT01370863|323258826|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
94402402|NCT01717313|323258829|FG000|Phase A (Weeks 0 to 24)|Death|0|||
94402403|NCT01717313|323258830|FG001|Phase A (Weeks 0 to 24)|Death|1|||
94402404|NCT01717313|323258829|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
94402405|NCT01717313|323258830|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
94402406|NCT01717313|323258829|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
94402407|NCT01717313|323258830|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
94402408|NCT01717313|323258829|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
94402409|NCT01717313|323258830|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
94402410|NCT01717313|323258829|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
94402411|NCT01717313|323258830|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
94402412|NCT01717313|323258829|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
94402413|NCT01717313|323258830|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
94402414|NCT01717313|323258829|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
94402415|NCT01717313|323258830|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
94402416|NCT01717313|323258829|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
94402417|NCT01717313|323258830|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
94402418|NCT01717313|323258829|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
94402419|NCT01717313|323258830|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
94402420|NCT01859598|323258831|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
94402421|NCT00573313|323258834|FG000|Overall Study|Protocol Violation|5|||
94402422|NCT00573313|323258835|FG001|Overall Study|Protocol Violation|0|||
94402423|NCT00573313|323258836|FG002|Overall Study|Protocol Violation|6|||
94402424|NCT00573313|323258837|FG003|Overall Study|Protocol Violation|0|||
94402425|NCT04473326|323258838|FG000|Overall Study|Death|0|||
94402426|NCT04473326|323258839|FG001|Overall Study|Death|1|||
94402427|NCT04473326|323258838|FG000|Overall Study|Withdrawal by Subject|1|||
94402428|NCT04473326|323258839|FG001|Overall Study|Withdrawal by Subject|2|||
94485531|NCT00794664|323570200|FG000|Follow-up Period|Withdrawal by Subject|0|||
94402429|NCT01087502|323258846|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
94402430|NCT01087502|323258847|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
94402431|NCT01087502|323258846|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
94402432|NCT01087502|323258847|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
94402433|NCT01087502|323258846|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
94402434|NCT01087502|323258847|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
94402435|NCT01087502|323258846|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
94402436|NCT01087502|323258847|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
94402437|NCT01087502|323258846|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
94402438|NCT01087502|323258847|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
94402439|NCT01087502|323258846|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
94402440|NCT01087502|323258847|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
94402441|NCT01087502|323258846|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
94402442|NCT01087502|323258847|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
94402443|NCT01087502|323258846|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
94402444|NCT01087502|323258847|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
94402445|NCT01087502|323258846|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
94402446|NCT01087502|323258847|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
94402447|NCT01087502|323258846|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
94402448|NCT01087502|323258847|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
94402449|NCT01087502|323258846|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
94402450|NCT01087502|323258847|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
94402451|NCT01087502|323258846|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
94402452|NCT01087502|323258847|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
94402453|NCT01653704|323258848|FG000|Overall Study|Technical failure during recording|1|||
94402454|NCT01653704|323258849|FG001|Overall Study|Technical failure during recording|1|||
94402455|NCT01653704|323258848|FG000|Overall Study|Performance not reflective of training|1|||
94402456|NCT01653704|323258849|FG001|Overall Study|Performance not reflective of training|0|||
94402457|NCT01728116|323258852|FG000|Overall Study|Sponsor Terminated Study|106|||
94402458|NCT01728116|323258853|FG001|Overall Study|Sponsor Terminated Study|35|||
94402459|NCT01728116|323258852|FG000|Overall Study|Withdrawal by Subject|16|||
94402460|NCT01728116|323258853|FG001|Overall Study|Withdrawal by Subject|9|||
94402461|NCT01728116|323258852|FG000|Overall Study|Adverse Event|13|||
94402462|NCT01728116|323258853|FG001|Overall Study|Adverse Event|0|||
94402463|NCT01728116|323258852|FG000|Overall Study|Procedure/device failure|7|||
94402464|NCT01728116|323258853|FG001|Overall Study|Procedure/device failure|0|||
94402465|NCT01728116|323258852|FG000|Overall Study|Lost to Follow-up|9|||
94402466|NCT01728116|323258853|FG001|Overall Study|Lost to Follow-up|2|||
94402467|NCT01728116|323258852|FG000|Overall Study|Physician Decision|2|||
94402468|NCT01728116|323258853|FG001|Overall Study|Physician Decision|0|||
94402469|NCT01728116|323258852|FG000|Overall Study|Subject Non-Compliance|2|||
94402470|NCT01728116|323258853|FG001|Overall Study|Subject Non-Compliance|0|||
94402471|NCT01728116|323258852|FG000|Overall Study|Inter-current finding at procedure|1|||
94402472|NCT01728116|323258853|FG001|Overall Study|Inter-current finding at procedure|0|||
94402473|NCT01728116|323258852|FG000|Overall Study|Incorrectly enrolled in Study|0|||
94402474|NCT01728116|323258853|FG001|Overall Study|Incorrectly enrolled in Study|1|||
94402475|NCT01728116|323258852|FG000|Overall Study|various not noted previously|5|||
94402476|NCT01728116|323258853|FG001|Overall Study|various not noted previously|0|||
94402477|NCT01532908|323258854|FG000|Overall Study|Not Transplanted|1|||
94402478|NCT01532908|323258855|FG001|Overall Study|Not Transplanted|0|||
94402479|NCT01196390|323258856|FG000|Overall Study|Protocol Violation|4|||
94402480|NCT01196390|323258857|FG001|Overall Study|Protocol Violation|5|||
94402481|NCT03966911|323258859|FG000|Overall Study|Adverse Event|1|||
94402482|NCT03966911|323258860|FG001|Overall Study|Adverse Event|1|||
94402483|NCT03966911|323258859|FG000|Overall Study|Withdrawal by Subject|8|||
94402484|NCT03966911|323258860|FG001|Overall Study|Withdrawal by Subject|2|||
94402485|NCT03966911|323258859|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
94402486|NCT03966911|323258860|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
94402487|NCT00467597|323258861|FG000|Overall Study|Withdrawal by Subject|2|||
94402488|NCT00467597|323258862|FG001|Overall Study|Withdrawal by Subject|0|||
94402489|NCT00380588|323258871|FG000|Overall Study|Unequivocal Disease Progression|25|||
94402490|NCT00380588|323258872|FG001|Overall Study|Unequivocal Disease Progression|34|||
94402491|NCT00380588|323258871|FG000|Overall Study|Next Cycle Not Started|4|||
94402492|NCT00380588|323258872|FG001|Overall Study|Next Cycle Not Started|0|||
94402493|NCT00380588|323258871|FG000|Overall Study|Adverse Event|7|||
94402494|NCT00380588|323258872|FG001|Overall Study|Adverse Event|3|||
94402495|NCT00380588|323258871|FG000|Overall Study|Withdrawal by Subject|1|||
94402496|NCT00380588|323258872|FG001|Overall Study|Withdrawal by Subject|3|||
94402497|NCT00380588|323258871|FG000|Overall Study|Physician Decision|2|||
94402498|NCT00380588|323258872|FG001|Overall Study|Physician Decision|0|||
94402499|NCT00867360|323258873|FG000|Overall Study|Withdrawal by Subject|1|||
94402500|NCT00867360|323258874|FG001|Overall Study|Withdrawal by Subject|0|||
94402501|NCT00867360|323258873|FG000|Overall Study|Physician Decision|0|||
94402502|NCT00867360|323258874|FG001|Overall Study|Physician Decision|1|||
94402503|NCT03259165|323258876|FG000|Overall Study|COVID 19 pandemic|1|||
94402504|NCT03259165|323258877|FG001|Overall Study|COVID 19 pandemic|1|||
94402505|NCT00474188|323258878|FG000|Overall Study|Withdrawal by Subject|1|||
94402506|NCT00474188|323258878|FG000|Overall Study|Study discontinued by sponsor|5|||
94402507|NCT00379353|323258879|FG000|Overall Study|Hospitalization|3|||
94402508|NCT00379353|323258880|FG001|Overall Study|Hospitalization|3|||
94402509|NCT00379353|323258879|FG000|Overall Study|Withdrawal by Subject|5|||
94402510|NCT00379353|323258880|FG001|Overall Study|Withdrawal by Subject|2|||
94402511|NCT00379353|323258879|FG000|Overall Study|Death|1|||
94402512|NCT00379353|323258880|FG001|Overall Study|Death|0|||
94402513|NCT00379353|323258879|FG000|Overall Study|Cardiac Tamponade|1|||
94402514|NCT00379353|323258880|FG001|Overall Study|Cardiac Tamponade|0|||
94402515|NCT00379353|323258879|FG000|Overall Study|Non-compliance|1|||
94402516|NCT00379353|323258880|FG001|Overall Study|Non-compliance|0|||
94402517|NCT00379353|323258879|FG000|Overall Study|Conflicting drug treatment|0|||
94402518|NCT00379353|323258880|FG001|Overall Study|Conflicting drug treatment|1|||
94402519|NCT00884390|323258884|FG000|Overall Study|Adverse Event|0|||
94402520|NCT00884390|323258885|FG001|Overall Study|Adverse Event|1|||
94402521|NCT00884390|323258884|FG000|Overall Study|Lost to Follow-up|0|||
94402522|NCT00884390|323258885|FG001|Overall Study|Lost to Follow-up|1|||
94402523|NCT00884390|323258884|FG000|Overall Study|Physician Decision|2|||
94402524|NCT00884390|323258885|FG001|Overall Study|Physician Decision|1|||
94402525|NCT00884390|323258884|FG000|Overall Study|Protocol Violation|4|||
94402526|NCT00884390|323258885|FG001|Overall Study|Protocol Violation|1|||
94402527|NCT00884390|323258884|FG000|Overall Study|Withdrawal by Subject|4|||
94402528|NCT00884390|323258885|FG001|Overall Study|Withdrawal by Subject|1|||
94402529|NCT00884390|323258884|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
94402530|NCT00884390|323258885|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
94402531|NCT00884390|323258884|FG000|Overall Study|Other|11|||
94402532|NCT00884390|323258885|FG001|Overall Study|Other|1|||
94402533|NCT00751023|323258886|FG000|Overall Study|Lost to Follow-up|11|||
94402534|NCT00751023|323258887|FG001|Overall Study|Lost to Follow-up|7|||
94402535|NCT02623218|323258888|FG000|Overall Study|Lost to Follow-up|0|||
94402536|NCT02623218|323258889|FG001|Overall Study|Lost to Follow-up|1|||
94402537|NCT02623218|323258890|FG002|Overall Study|Lost to Follow-up|0|||
94402538|NCT02623218|323258891|FG003|Overall Study|Lost to Follow-up|0|||
94402539|NCT02623218|323258892|FG004|Overall Study|Lost to Follow-up|0|||
94402540|NCT03555695|323258896|FG000|Overall Study|Withdrawal by Subject|1|||
94402541|NCT03555695|323258896|FG000|Overall Study|Lost to Follow-up|1|||
94402542|NCT03555695|323258896|FG000|Overall Study|appendicitis (unrelated)|1|||
94402543|NCT03555695|323258896|FG000|Overall Study|pre-existing sciatica|1|||
94402544|NCT00526162|323260336|FG000|Overall Study|Device not implanted|3|||
94402545|NCT01952691|323260337|FG000|Overall Study|Lost to Follow-up|2|||
94402546|NCT00762411|323260338|FG000|Initial Treatment|Death|7|||
94402547|NCT00762411|323260339|FG001|Initial Treatment|Death|6|||
94402548|NCT00762411|323260338|FG000|Initial Treatment|Adverse Event|132|||
94402549|NCT00762411|323260339|FG001|Initial Treatment|Adverse Event|40|||
94402550|NCT00762411|323260338|FG000|Initial Treatment|Protocol Violation|4|||
94402551|NCT00762411|323260339|FG001|Initial Treatment|Protocol Violation|1|||
94402552|NCT00762411|323260338|FG000|Initial Treatment|Withdrawal by Subject|65|||
94402553|NCT00762411|323260339|FG001|Initial Treatment|Withdrawal by Subject|52|||
94402554|NCT00762411|323260338|FG000|Initial Treatment|Physician Decision|1|||
94402555|NCT00762411|323260339|FG001|Initial Treatment|Physician Decision|0|||
94402556|NCT00762411|323260338|FG000|Initial Treatment|Sponsor Decision|293|||
94402557|NCT00762411|323260339|FG001|Initial Treatment|Sponsor Decision|401|||
94402558|NCT00762411|323260338|FG000|Initial Treatment|Lost to Follow-up|5|||
94402559|NCT00762411|323260339|FG001|Initial Treatment|Lost to Follow-up|0|||
94402560|NCT00762411|323260338|FG000|Initial Treatment|Caregiver Decision|21|||
94402561|NCT00762411|323260339|FG001|Initial Treatment|Caregiver Decision|16|||
94402562|NCT00762411|323260338|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
94402563|NCT00762411|323260339|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
94402564|NCT00762411|323260338|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
94402565|NCT00762411|323260339|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
94402566|NCT00762411|323260338|FG000|Delayed Start|Adverse Event|0|||
94402567|NCT00762411|323260339|FG001|Delayed Start|Adverse Event|4|||
94402568|NCT00762411|323260338|FG000|Delayed Start|Protocol Violation|0|||
94402569|NCT00762411|323260339|FG001|Delayed Start|Protocol Violation|1|||
94402570|NCT00762411|323260338|FG000|Delayed Start|Sponsor Decision|16|||
94402571|NCT00762411|323260339|FG001|Delayed Start|Sponsor Decision|20|||
94402572|NCT00762411|323260338|FG000|Delayed Start|Caregiver Decision|1|||
94402573|NCT00762411|323260339|FG001|Delayed Start|Caregiver Decision|1|||
94402574|NCT00762411|323260338|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
94402575|NCT00762411|323260339|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
94402576|NCT00762411|323260338|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
94402577|NCT00762411|323260339|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
94402578|NCT00762411|323260338|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
94402579|NCT00762411|323260339|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
94402580|NCT00762411|323260338|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
94402581|NCT00762411|323260339|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
94402582|NCT00762411|323260338|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
94402583|NCT00762411|323260339|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
94402584|NCT00762411|323260338|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
94402585|NCT00762411|323260339|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
94402586|NCT00452348|323260340|FG000|Overall Study|Adverse Event|6|||
94485532|NCT00794664|323570201|FG001|Follow-up Period|Withdrawal by Subject|2|||
94402587|NCT00452348|323260341|FG001|Overall Study|Adverse Event|9|||
94402588|NCT00452348|323260340|FG000|Overall Study|Lack of Efficacy|10|||
94402589|NCT00452348|323260341|FG001|Overall Study|Lack of Efficacy|9|||
94402590|NCT00452348|323260340|FG000|Overall Study|Lost to Follow-up|14|||
94402591|NCT00452348|323260341|FG001|Overall Study|Lost to Follow-up|8|||
94402592|NCT00452348|323260340|FG000|Overall Study|Protocol Violation|22|||
94402593|NCT00452348|323260341|FG001|Overall Study|Protocol Violation|28|||
94402594|NCT00452348|323260340|FG000|Overall Study|Withdrawal by Subject|18|||
94402595|NCT00452348|323260341|FG001|Overall Study|Withdrawal by Subject|21|||
94402596|NCT00452348|323260340|FG000|Overall Study|Other|9|||
94402597|NCT00452348|323260341|FG001|Overall Study|Other|9|||
94402598|NCT00828321|323260342|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
94402599|NCT00828321|323260343|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
94402600|NCT00828321|323260342|FG000|Second Intervention|Protocol Violation|0|||
94402601|NCT00828321|323260343|FG001|Second Intervention|Protocol Violation|1|||
94402602|NCT04408924|323260350|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
94402603|NCT04408924|323260350|FG000|Overall Study|Lost to Follow-up|3|||
94402604|NCT04408924|323260350|FG000|Overall Study|Withdrawal by Subject|5|||
94402605|NCT04408924|323260350|FG000|Overall Study|Sponsor Decision|2|||
94402606|NCT00396162|323260356|FG000|Overall Study|Withdrawal by Subject|2|||
94402607|NCT00396162|323260357|FG001|Overall Study|Withdrawal by Subject|3|||
94402608|NCT03167606|323260358|FG000|Overall Study|Lost to Follow-up|73|||
94402609|NCT03167606|323260359|FG001|Overall Study|Lost to Follow-up|64|||
94402610|NCT03167606|323260358|FG000|Overall Study|Withdrawal by Subject|6|||
94402611|NCT03167606|323260359|FG001|Overall Study|Withdrawal by Subject|5|||
94402612|NCT03167606|323260358|FG000|Overall Study|Withdrawal by Investigator|0|||
94402613|NCT03167606|323260359|FG001|Overall Study|Withdrawal by Investigator|2|||
94402614|NCT00385736|323260363|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
94402615|NCT00385736|323260364|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
94402616|NCT00385736|323260365|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
94402617|NCT00385736|323260363|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
94402618|NCT00385736|323260364|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
94402619|NCT00385736|323260365|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
94402620|NCT00385736|323260363|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
94402621|NCT00385736|323260364|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
94402622|NCT00385736|323260365|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
94402623|NCT00385736|323260363|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
94402624|NCT00385736|323260364|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
94402625|NCT00385736|323260365|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
94402626|NCT00385736|323260363|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
94402627|NCT00385736|323260364|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
94402628|NCT00385736|323260365|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
94402629|NCT00385736|323260363|FG000|Efficacy Analysis Set - Induction|Other|0|||
94402630|NCT00385736|323260364|FG001|Efficacy Analysis Set - Induction|Other|0|||
94402631|NCT00385736|323260365|FG002|Efficacy Analysis Set - Induction|Other|1|||
94402632|NCT00385736|323260363|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
94402633|NCT00385736|323260364|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
94402634|NCT00385736|323260365|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
94402635|NCT00385736|323260363|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
94402636|NCT00385736|323260364|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
94402637|NCT00385736|323260365|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
94402638|NCT00385736|323260363|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
94402639|NCT00385736|323260364|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
94402640|NCT00385736|323260365|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
94402641|NCT00385736|323260363|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
94402642|NCT00385736|323260364|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
94402643|NCT00385736|323260365|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
94402644|NCT00385736|323260363|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
94402645|NCT00385736|323260364|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
94402646|NCT00385736|323260365|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
94402647|NCT00385736|323260363|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
94402648|NCT00385736|323260364|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
94402649|NCT00385736|323260365|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
94402650|NCT00385736|323260363|FG000|Safety Analysis Set|Adverse Event|23|||
94402651|NCT00385736|323260364|FG001|Safety Analysis Set|Adverse Event|15|||
94402652|NCT00385736|323260365|FG002|Safety Analysis Set|Adverse Event|23|||
94402653|NCT00385736|323260363|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
94402654|NCT00385736|323260364|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
94402655|NCT00385736|323260365|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
94402656|NCT00385736|323260363|FG000|Safety Analysis Set|Lost to Follow-up|0|||
94402657|NCT00385736|323260364|FG001|Safety Analysis Set|Lost to Follow-up|2|||
94402658|NCT00385736|323260365|FG002|Safety Analysis Set|Lost to Follow-up|2|||
94402659|NCT00385736|323260363|FG000|Safety Analysis Set|Lack of Efficacy|38|||
94402660|NCT00385736|323260364|FG001|Safety Analysis Set|Lack of Efficacy|16|||
94402661|NCT00385736|323260365|FG002|Safety Analysis Set|Lack of Efficacy|31|||
94402662|NCT00385736|323260363|FG000|Safety Analysis Set|Protocol Violation|2|||
94402663|NCT00385736|323260364|FG001|Safety Analysis Set|Protocol Violation|1|||
94402664|NCT00385736|323260365|FG002|Safety Analysis Set|Protocol Violation|6|||
94402665|NCT00385736|323260363|FG000|Safety Analysis Set|Other|1|||
94402666|NCT00385736|323260364|FG001|Safety Analysis Set|Other|4|||
94402667|NCT00385736|323260365|FG002|Safety Analysis Set|Other|4|||
94402668|NCT01741545|323260366|FG000|Treatment Period|Lack of Efficacy|0|||
94402669|NCT01741545|323260367|FG001|Treatment Period|Lack of Efficacy|1|||
94402670|NCT01741545|323260366|FG000|Treatment Period|Adverse event, non-fatal|1|||
94402671|NCT01741545|323260367|FG001|Treatment Period|Adverse event, non-fatal|3|||
94402672|NCT01741545|323260366|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
94402673|NCT01741545|323260367|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
94402674|NCT01741545|323260366|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
94402675|NCT01741545|323260367|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
94402676|NCT04442503|323260371|FG000|Overall Study|Adverse Event|1|||
94402677|NCT04442503|323260372|FG001|Overall Study|Adverse Event|1|||
94402678|NCT04442503|323260371|FG000|Overall Study|Lost to Follow-up|8|||
94402679|NCT04442503|323260372|FG001|Overall Study|Lost to Follow-up|6|||
94402680|NCT04442503|323260371|FG000|Overall Study|Physician Decision|0|||
94402681|NCT04442503|323260372|FG001|Overall Study|Physician Decision|2|||
94402682|NCT04442503|323260371|FG000|Overall Study|Withdrawal by Subject|3|||
94402683|NCT04442503|323260372|FG001|Overall Study|Withdrawal by Subject|4|||
94402684|NCT04442503|323260371|FG000|Overall Study|Reason not Specified|0|||
94402685|NCT04442503|323260372|FG001|Overall Study|Reason not Specified|1|||
94402686|NCT04442503|323260371|FG000|Overall Study|Randomized but not Treated|3|||
94402687|NCT04442503|323260372|FG001|Overall Study|Randomized but not Treated|1|||
94402688|NCT05278858|323260374|FG000|Overall Study|Withdrawal by Subject|1|||
94402689|NCT02858037|323260377|FG000|Overall Study|Death|1|||
94402690|NCT02858037|323260377|FG000|Overall Study|Withdrawal by Subject|18|||
94402691|NCT02858037|323260377|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
94402692|NCT02858037|323260377|FG000|Overall Study|Lost to Follow-up|3|||
94402693|NCT02858037|323260377|FG000|Overall Study|Other|4|||
94402694|NCT04320745|323260378|FG000|Overall Study|Adverse Event|26|||
94402695|NCT04320745|323260378|FG000|Overall Study|Withdrawal by Subject|4|||
94402696|NCT04320745|323260378|FG000|Overall Study|Lost to Follow-up|12|||
94402697|NCT04320745|323260378|FG000|Overall Study|Protocol Deviation|2|||
94402698|NCT04320745|323260378|FG000|Overall Study|Non-compliance With Study Drug|2|||
94402699|NCT04320745|323260378|FG000|Overall Study|Reason Not Specified|1|||
94402700|NCT01567527|323260379|FG000|Conversion Phase.|Protocol deviation|3|||
94402701|NCT01567527|323260380|FG001|Conversion Phase.|Protocol deviation|0|||
94402702|NCT01567527|323260381|FG002|Conversion Phase.|Protocol deviation|0|||
94402703|NCT01567527|323260382|FG003|Conversion Phase.|Protocol deviation|0|||
94402704|NCT01567527|323260383|FG004|Conversion Phase.|Protocol deviation|0|||
94402705|NCT01567527|323260379|FG000|Conversion Phase.|Met withdrawal criteria|10|||
94402706|NCT01567527|323260380|FG001|Conversion Phase.|Met withdrawal criteria|0|||
94402707|NCT01567527|323260381|FG002|Conversion Phase.|Met withdrawal criteria|0|||
94402708|NCT01567527|323260382|FG003|Conversion Phase.|Met withdrawal criteria|0|||
94402709|NCT01567527|323260383|FG004|Conversion Phase.|Met withdrawal criteria|0|||
94402710|NCT01567527|323260379|FG000|Conversion Phase.|Withdrawal by Subject|32|||
94402711|NCT01567527|323260380|FG001|Conversion Phase.|Withdrawal by Subject|0|||
94402712|NCT01567527|323260381|FG002|Conversion Phase.|Withdrawal by Subject|0|||
94402713|NCT01567527|323260382|FG003|Conversion Phase.|Withdrawal by Subject|0|||
94402714|NCT01567527|323260383|FG004|Conversion Phase.|Withdrawal by Subject|0|||
94402715|NCT01567527|323260379|FG000|Conversion Phase.|Lost to Follow-up|16|||
94402716|NCT01567527|323260380|FG001|Conversion Phase.|Lost to Follow-up|0|||
94402717|NCT01567527|323260381|FG002|Conversion Phase.|Lost to Follow-up|0|||
94402718|NCT01567527|323260382|FG003|Conversion Phase.|Lost to Follow-up|0|||
94402719|NCT01567527|323260383|FG004|Conversion Phase.|Lost to Follow-up|0|||
94402720|NCT01567527|323260379|FG000|Conversion Phase.|Lack of Efficacy|2|||
94402721|NCT01567527|323260380|FG001|Conversion Phase.|Lack of Efficacy|0|||
94402722|NCT01567527|323260381|FG002|Conversion Phase.|Lack of Efficacy|0|||
94402723|NCT01567527|323260382|FG003|Conversion Phase.|Lack of Efficacy|0|||
94402724|NCT01567527|323260383|FG004|Conversion Phase.|Lack of Efficacy|0|||
94402725|NCT01567527|323260379|FG000|Conversion Phase.|Adverse Event|33|||
94402726|NCT01567527|323260380|FG001|Conversion Phase.|Adverse Event|0|||
94402727|NCT01567527|323260381|FG002|Conversion Phase.|Adverse Event|0|||
94402728|NCT01567527|323260382|FG003|Conversion Phase.|Adverse Event|0|||
94402729|NCT01567527|323260383|FG004|Conversion Phase.|Adverse Event|0|||
94402730|NCT01567527|323260379|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
94402731|NCT01567527|323260380|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
94402732|NCT01567527|323260381|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
94402733|NCT01567527|323260382|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
94402734|NCT01567527|323260383|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
94402735|NCT01567527|323260379|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
94402736|NCT01567527|323260380|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
94402737|NCT01567527|323260381|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
94402738|NCT01567527|323260382|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
94402739|NCT01567527|323260383|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
94402740|NCT01567527|323260379|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
94402741|NCT01567527|323260380|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
94402742|NCT01567527|323260381|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
94402743|NCT01567527|323260382|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
94402744|NCT01567527|323260383|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
94402745|NCT01567527|323260379|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
94402746|NCT01567527|323260380|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
94402747|NCT01567527|323260381|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
94402748|NCT01567527|323260382|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
94402749|NCT01567527|323260383|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
94402750|NCT01567527|323260379|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
94402751|NCT01567527|323260380|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
94402752|NCT01567527|323260381|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
94402753|NCT01567527|323260382|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
94402754|NCT01567527|323260383|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
94402755|NCT01567527|323260379|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
94402756|NCT01567527|323260380|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
94402757|NCT01567527|323260381|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
94402758|NCT01567527|323260382|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
94402759|NCT01567527|323260383|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
94402760|NCT01567527|323260379|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
94402761|NCT01567527|323260380|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
94402762|NCT01567527|323260381|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
94402763|NCT01567527|323260382|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
94402764|NCT01567527|323260383|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
94402765|NCT01567527|323260379|FG000|IM Depot Stabilization.|Protocol deviation|0|||
94402766|NCT01567527|323260380|FG001|IM Depot Stabilization.|Protocol deviation|0|||
94402767|NCT01567527|323260381|FG002|IM Depot Stabilization.|Protocol deviation|5|||
94402768|NCT01567527|323260382|FG003|IM Depot Stabilization.|Protocol deviation|0|||
94402769|NCT01567527|323260383|FG004|IM Depot Stabilization.|Protocol deviation|0|||
94402770|NCT01567527|323260379|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
94402771|NCT01567527|323260380|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
94402772|NCT01567527|323260381|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
94402773|NCT01567527|323260382|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
94402774|NCT01567527|323260383|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
94402775|NCT01567527|323260379|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
94402776|NCT01567527|323260380|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
94402777|NCT01567527|323260381|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
94402778|NCT01567527|323260382|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
94402779|NCT01567527|323260383|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
94402780|NCT01567527|323260379|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
94402781|NCT01567527|323260380|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
94402782|NCT01567527|323260381|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
94402783|NCT01567527|323260382|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
94402784|NCT01567527|323260383|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
94402785|NCT01567527|323260379|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
94402786|NCT01567527|323260380|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
94402787|NCT01567527|323260381|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
94402788|NCT01567527|323260382|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
94402789|NCT01567527|323260383|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
94402790|NCT01567527|323260379|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
94402791|NCT01567527|323260380|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
94402792|NCT01567527|323260381|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
94402793|NCT01567527|323260382|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
94402794|NCT01567527|323260383|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
94402795|NCT01567527|323260379|FG000|IM Depot Stabilization.|Adverse Event|0|||
94402796|NCT01567527|323260380|FG001|IM Depot Stabilization.|Adverse Event|0|||
94402797|NCT01567527|323260381|FG002|IM Depot Stabilization.|Adverse Event|37|||
94402798|NCT01567527|323260382|FG003|IM Depot Stabilization.|Adverse Event|0|||
94402799|NCT01567527|323260383|FG004|IM Depot Stabilization.|Adverse Event|0|||
94402800|NCT01567527|323260379|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
94402801|NCT01567527|323260380|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
94402802|NCT01567527|323260381|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
94402803|NCT01567527|323260382|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
94485533|NCT00794664|323570200|FG000|Follow-up Period|Protocol non-compliance|0|||
94485534|NCT00794664|323570201|FG001|Follow-up Period|Protocol non-compliance|1|||
94485535|NCT01305564|323570204|FG000|Overall Study|Death|21|||
94330537|NCT03136367|322990180|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
94330538|NCT03136367|322990181|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
94330539|NCT03136367|322990182|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
94330540|NCT02483078|322990185|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
94330541|NCT02483078|322990186|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
94330542|NCT02483078|322990185|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
94330543|NCT02483078|322990186|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
94330544|NCT02483078|322990185|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
94330545|NCT02483078|322990186|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
94330546|NCT02483078|322990185|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
94330547|NCT02483078|322990186|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
94330548|NCT02483078|322990185|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
94330549|NCT02483078|322990186|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
94330550|NCT02483078|322990185|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
94330551|NCT02483078|322990186|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
94330552|NCT04876599|322990187|FG000|Overall Study|Missed|2|||
94330553|NCT04876599|322990188|FG001|Overall Study|Missed|0|||
94330554|NCT04876599|322990187|FG000|Overall Study|Declined|2|||
94330555|NCT04876599|322990188|FG001|Overall Study|Declined|3|||
94330556|NCT03947255|322991638|FG000|Overall Study|Study Closure by Sponsor|2|||
94330557|NCT03947255|322991639|FG001|Overall Study|Study Closure by Sponsor|2|||
94330558|NCT03947255|322991638|FG000|Overall Study|Withdrawal by Subject|2|||
94330559|NCT03947255|322991639|FG001|Overall Study|Withdrawal by Subject|2|||
94330560|NCT03947255|322991638|FG000|Overall Study|Lost to Follow-up|2|||
94330561|NCT03947255|322991639|FG001|Overall Study|Lost to Follow-up|0|||
94330562|NCT03947255|322991638|FG000|Overall Study|Death|0|||
94330563|NCT03947255|322991639|FG001|Overall Study|Death|2|||
94330564|NCT02591238|322991640|FG000|Overall Study|Pregnancy|1|||
94330565|NCT02591238|322991641|FG001|Overall Study|Pregnancy|0|||
94330566|NCT02591238|322991642|FG002|Overall Study|Pregnancy|0|||
94330567|NCT02591238|322991643|FG003|Overall Study|Pregnancy|0|||
94330568|NCT02591238|322991640|FG000|Overall Study|Withdrawal by Subject|0|||
94330569|NCT02591238|322991641|FG001|Overall Study|Withdrawal by Subject|0|||
94330570|NCT02591238|322991642|FG002|Overall Study|Withdrawal by Subject|0|||
94330571|NCT02591238|322991643|FG003|Overall Study|Withdrawal by Subject|1|||
94330572|NCT02591238|322991640|FG000|Overall Study|influenza|0|||
94330573|NCT02591238|322991641|FG001|Overall Study|influenza|0|||
94330574|NCT02591238|322991642|FG002|Overall Study|influenza|0|||
94330575|NCT02591238|322991643|FG003|Overall Study|influenza|1|||
94330576|NCT02591238|322991640|FG000|Overall Study|personal circumstances|0|||
94330577|NCT02591238|322991641|FG001|Overall Study|personal circumstances|0|||
94330578|NCT02591238|322991642|FG002|Overall Study|personal circumstances|0|||
94330579|NCT02591238|322991643|FG003|Overall Study|personal circumstances|1|||
94330580|NCT02591238|322991640|FG000|Overall Study|personal circumstances|0|||
94330581|NCT02591238|322991641|FG001|Overall Study|personal circumstances|1|||
94330582|NCT02591238|322991642|FG002|Overall Study|personal circumstances|0|||
94330583|NCT02591238|322991643|FG003|Overall Study|personal circumstances|0|||
94330584|NCT01494987|322991644|FG000|Overall Study|Adverse Event|6|||
94330585|NCT01494987|322991645|FG001|Overall Study|Adverse Event|5|||
94330586|NCT01494987|322991644|FG000|Overall Study|Hyperglycemia|6|||
94330587|NCT01494987|322991645|FG001|Overall Study|Hyperglycemia|4|||
94330588|NCT01494987|322991644|FG000|Overall Study|Investigator's Discretion|1|||
94330589|NCT01494987|322991645|FG001|Overall Study|Investigator's Discretion|2|||
94330590|NCT01494987|322991644|FG000|Overall Study|Lost to Follow-up|1|||
94330591|NCT01494987|322991645|FG001|Overall Study|Lost to Follow-up|1|||
94330592|NCT01494987|322991644|FG000|Overall Study|Protocol Violation|3|||
94330593|NCT01494987|322991645|FG001|Overall Study|Protocol Violation|3|||
94330594|NCT01494987|322991644|FG000|Overall Study|Subject Non-Compliance|9|||
94330595|NCT01494987|322991645|FG001|Overall Study|Subject Non-Compliance|10|||
94330596|NCT01494987|322991644|FG000|Overall Study|Subject Withdrew Consent|2|||
94330597|NCT01494987|322991645|FG001|Overall Study|Subject Withdrew Consent|3|||
94330598|NCT02215616|322991648|FG000|Overall Study|Sponsor requested to stop study drug|0|||
94330599|NCT02215616|322991649|FG001|Overall Study|Sponsor requested to stop study drug|0|||
94330600|NCT02215616|322991650|FG002|Overall Study|Sponsor requested to stop study drug|1|||
94330601|NCT02215616|322991651|FG003|Overall Study|Sponsor requested to stop study drug|4|||
94330602|NCT02215616|322991648|FG000|Overall Study|Death|1|||
94330603|NCT02215616|322991649|FG001|Overall Study|Death|0|||
94330604|NCT02215616|322991650|FG002|Overall Study|Death|0|||
94330605|NCT02215616|322991651|FG003|Overall Study|Death|0|||
94330606|NCT02215616|322991648|FG000|Overall Study|Adverse Event|7|||
94330607|NCT02215616|322991649|FG001|Overall Study|Adverse Event|4|||
94330608|NCT02215616|322991650|FG002|Overall Study|Adverse Event|9|||
94330609|NCT02215616|322991651|FG003|Overall Study|Adverse Event|2|||
94330610|NCT02215616|322991648|FG000|Overall Study|Withdrawal by Subject|1|||
94402804|NCT01567527|323260383|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
94402805|NCT01567527|323260379|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
94402806|NCT01567527|323260380|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
94402807|NCT01567527|323260381|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
94402808|NCT01567527|323260382|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
94402809|NCT01567527|323260383|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
94402810|NCT01567527|323260379|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
94402811|NCT01567527|323260380|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
94402812|NCT01567527|323260381|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
94402813|NCT01567527|323260382|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
94402814|NCT01567527|323260383|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
94402815|NCT01567527|323260379|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
94402816|NCT01567527|323260380|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
94402817|NCT01567527|323260381|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
94402818|NCT01567527|323260382|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
94402819|NCT01567527|323260383|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
94402820|NCT01567527|323260379|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
94402821|NCT01567527|323260380|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
94402822|NCT01567527|323260381|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
94402823|NCT01567527|323260382|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
94402824|NCT01567527|323260383|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
94402825|NCT01567527|323260379|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
94402826|NCT01567527|323260380|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
94402827|NCT01567527|323260381|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
94402828|NCT01567527|323260382|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
94402829|NCT01567527|323260383|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
94402830|NCT01567527|323260379|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
94402831|NCT01567527|323260380|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
94402832|NCT01567527|323260381|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
94402833|NCT01567527|323260382|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
94402834|NCT01567527|323260383|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
94402835|NCT01567527|323260379|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
94485536|NCT01305564|323570204|FG000|Overall Study|Lost to Follow-up|12|||
94330611|NCT02215616|322991649|FG001|Overall Study|Withdrawal by Subject|8|||
94330612|NCT02215616|322991650|FG002|Overall Study|Withdrawal by Subject|2|||
94330613|NCT02215616|322991651|FG003|Overall Study|Withdrawal by Subject|5|||
94330614|NCT02215616|322991648|FG000|Overall Study|Non-compliance|0|||
94330615|NCT02215616|322991649|FG001|Overall Study|Non-compliance|2|||
94330616|NCT02215616|322991650|FG002|Overall Study|Non-compliance|1|||
94330617|NCT02215616|322991651|FG003|Overall Study|Non-compliance|0|||
94330618|NCT02215616|322991648|FG000|Overall Study|Protocol Violation|0|||
94330619|NCT02215616|322991649|FG001|Overall Study|Protocol Violation|2|||
94330620|NCT02215616|322991650|FG002|Overall Study|Protocol Violation|0|||
94330621|NCT02215616|322991651|FG003|Overall Study|Protocol Violation|0|||
94330622|NCT02215616|322991648|FG000|Overall Study|Lost to Follow-up|1|||
94330623|NCT02215616|322991649|FG001|Overall Study|Lost to Follow-up|1|||
94330624|NCT02215616|322991650|FG002|Overall Study|Lost to Follow-up|0|||
94330625|NCT02215616|322991651|FG003|Overall Study|Lost to Follow-up|1|||
94330626|NCT02215616|322991648|FG000|Overall Study|Other than specified|1|||
94330627|NCT02215616|322991649|FG001|Overall Study|Other than specified|0|||
94330628|NCT02215616|322991650|FG002|Overall Study|Other than specified|1|||
94330629|NCT02215616|322991651|FG003|Overall Study|Other than specified|1|||
94330630|NCT00801892|322991659|FG000|Main Study Period|Withdrawal by Subject|0|||
94330631|NCT00801892|322991660|FG001|Main Study Period|Withdrawal by Subject|1|||
94330632|NCT00801892|322991659|FG000|Sham Crossover Period|Lost to Follow-up|0|||
94330633|NCT00801892|322991660|FG001|Sham Crossover Period|Lost to Follow-up|2|||
94330634|NCT01136746|322991664|FG000|Overall Study|Lost to Follow-up|0|||
94330635|NCT01136746|322991665|FG001|Overall Study|Lost to Follow-up|2|||
94330636|NCT01136746|322991664|FG000|Overall Study|Protocol Violation|2|||
94330637|NCT01136746|322991665|FG001|Overall Study|Protocol Violation|1|||
94330638|NCT01136746|322991664|FG000|Overall Study|Death|1|||
94330639|NCT01136746|322991665|FG001|Overall Study|Death|0|||
94330640|NCT02966353|322991671|FG000|Overall Study|Withdrawal by Subject|7|||
94330641|NCT02966353|322991671|FG000|Overall Study|Adverse Event|4|||
94330642|NCT02966353|322991671|FG000|Overall Study|Death|4|||
94330643|NCT02966353|322991671|FG000|Overall Study|Physician Decision|3|||
94330644|NCT02966353|322991671|FG000|Overall Study|Progressive disease|2|||
94330645|NCT02966353|322991671|FG000|Overall Study|Protocol deviation|2|||
94330646|NCT01601704|322991672|FG000|Overall Study|Randomized but not dispensed study med|1|||
94402836|NCT01567527|323260380|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
94402837|NCT01567527|323260381|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
94402838|NCT01567527|323260382|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
94402839|NCT01567527|323260383|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
94402840|NCT01567527|323260379|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
94402841|NCT01567527|323260380|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
94402842|NCT01567527|323260381|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
94402843|NCT01567527|323260382|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
94402844|NCT01567527|323260383|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
94402845|NCT01824576|323260384|FG000|Overall Study|Device deficiency|2|||
94402846|NCT01958476|323260387|FG000|Overall Study|Parent requested exclusion from analysis|1|||
94402847|NCT01958476|323260388|FG001|Overall Study|Parent requested exclusion from analysis|0|||
94402848|NCT02004691|323260389|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
94402849|NCT02004691|323260390|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
94402850|NCT02004691|323260389|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
94402851|NCT02004691|323260390|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
94402852|NCT02004691|323260389|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
94402853|NCT02004691|323260390|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
94402854|NCT02004691|323260389|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
94402855|NCT02004691|323260390|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
94402856|NCT02004691|323260389|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
94402857|NCT02004691|323260390|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
94402858|NCT02004691|323260389|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
94402859|NCT02004691|323260390|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
94402860|NCT00702507|323260393|FG000|Initial Treatment Phase|Adverse Event|2|||
94402861|NCT00702507|323260393|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
94402862|NCT00702507|323260393|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
94402863|NCT00702507|323260393|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
94402864|NCT00702507|323260393|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
94402865|NCT00702507|323260393|FG000|Follow-up Phase|Protocol Violation|2|||
94402866|NCT00702507|323260393|FG000|Follow-up Phase|Lost to Follow-up|23|||
94402867|NCT00702507|323260393|FG000|Follow-up Phase|Late Enrollment|1|||
94402868|NCT05412121|323260395|FG000|Overall Study|Withdrawal by Subject|4|||
94402869|NCT05412121|323260395|FG000|Overall Study|Physician Decision|1|||
94402870|NCT05412121|323260395|FG000|Overall Study|Lost to Follow-up|5|||
94402871|NCT02670551|323260398|FG000|Overall Study|Adverse Event|4|||
94402872|NCT02670551|323260399|FG001|Overall Study|Adverse Event|7|||
94402873|NCT02670551|323260400|FG002|Overall Study|Adverse Event|9|||
94402874|NCT02670551|323260398|FG000|Overall Study|Lack of Efficacy|2|||
94402875|NCT02670551|323260399|FG001|Overall Study|Lack of Efficacy|0|||
94402876|NCT02670551|323260400|FG002|Overall Study|Lack of Efficacy|3|||
94402877|NCT02670551|323260398|FG000|Overall Study|Withdrawal of Consent|6|||
94402878|NCT02670551|323260399|FG001|Overall Study|Withdrawal of Consent|3|||
94402879|NCT02670551|323260400|FG002|Overall Study|Withdrawal of Consent|8|||
94402880|NCT02670551|323260398|FG000|Overall Study|Lost to Follow-up|5|||
94402881|NCT02670551|323260399|FG001|Overall Study|Lost to Follow-up|7|||
94402882|NCT02670551|323260400|FG002|Overall Study|Lost to Follow-up|6|||
94402883|NCT02670551|323260398|FG000|Overall Study|Protocol Violation|1|||
94402884|NCT02670551|323260399|FG001|Overall Study|Protocol Violation|0|||
94402885|NCT02670551|323260400|FG002|Overall Study|Protocol Violation|0|||
94402886|NCT02670551|323260398|FG000|Overall Study|Noncompliance with study drug|3|||
94402887|NCT02670551|323260399|FG001|Overall Study|Noncompliance with study drug|3|||
94402888|NCT02670551|323260400|FG002|Overall Study|Noncompliance with study drug|2|||
94402889|NCT02670551|323260398|FG000|Overall Study|Other Miscellaneous Reasons|2|||
94402890|NCT02670551|323260399|FG001|Overall Study|Other Miscellaneous Reasons|3|||
94402891|NCT02670551|323260400|FG002|Overall Study|Other Miscellaneous Reasons|3|||
94402892|NCT02670551|323260398|FG000|Overall Study|Did Not Receive Treatment|5|||
94402893|NCT02670551|323260399|FG001|Overall Study|Did Not Receive Treatment|3|||
94402894|NCT02670551|323260400|FG002|Overall Study|Did Not Receive Treatment|0|||
94402895|NCT01962298|323260401|FG000|Overall Study|Protocol Violation|1|||
94402896|NCT01962298|323260402|FG001|Overall Study|Protocol Violation|0|||
94402897|NCT01962298|323260403|FG002|Overall Study|Protocol Violation|1|||
94402898|NCT01962298|323260404|FG003|Overall Study|Protocol Violation|1|||
94402899|NCT01962298|323260405|FG004|Overall Study|Protocol Violation|0|||
94402900|NCT01962298|323260401|FG000|Overall Study|Data quality insufficient|2|||
94402901|NCT01962298|323260402|FG001|Overall Study|Data quality insufficient|0|||
94402902|NCT01962298|323260403|FG002|Overall Study|Data quality insufficient|3|||
94402903|NCT01962298|323260404|FG003|Overall Study|Data quality insufficient|1|||
94402904|NCT01962298|323260405|FG004|Overall Study|Data quality insufficient|4|||
94402905|NCT01962298|323260401|FG000|Overall Study|Insufficient data|0|||
94402906|NCT01962298|323260402|FG001|Overall Study|Insufficient data|2|||
94402907|NCT01962298|323260403|FG002|Overall Study|Insufficient data|1|||
94402908|NCT01962298|323260404|FG003|Overall Study|Insufficient data|0|||
94402909|NCT01962298|323260405|FG004|Overall Study|Insufficient data|1|||
94402910|NCT01962298|323260401|FG000|Overall Study|Incorrect data recorded|0|||
94402911|NCT01962298|323260402|FG001|Overall Study|Incorrect data recorded|1|||
94402912|NCT01962298|323260403|FG002|Overall Study|Incorrect data recorded|0|||
94402913|NCT01962298|323260404|FG003|Overall Study|Incorrect data recorded|0|||
94402914|NCT01962298|323260405|FG004|Overall Study|Incorrect data recorded|0|||
94402915|NCT01962298|323260401|FG000|Overall Study|Physician Decision|0|||
94402916|NCT01962298|323260402|FG001|Overall Study|Physician Decision|1|||
94402917|NCT01962298|323260403|FG002|Overall Study|Physician Decision|0|||
94402918|NCT01962298|323260404|FG003|Overall Study|Physician Decision|0|||
94402919|NCT01962298|323260405|FG004|Overall Study|Physician Decision|1|||
94402920|NCT00021541|323260408|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
94402921|NCT00021541|323260409|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
94402922|NCT00021541|323260408|FG000|Period 1-First Treatment|Adverse Event|2|||
94402923|NCT00021541|323260409|FG001|Period 1-First Treatment|Adverse Event|1|||
94402924|NCT00021541|323260408|FG000|Period 1-First Treatment|non-adherence|3|||
94402925|NCT00021541|323260409|FG001|Period 1-First Treatment|non-adherence|0|||
94402926|NCT00021541|323260408|FG000|Period 1-First Treatment|Death|1|||
94402927|NCT00021541|323260409|FG001|Period 1-First Treatment|Death|0|||
94402928|NCT00021541|323260408|FG000|Period 1-First Treatment|Pts that did not progress|2|||
94402929|NCT00021541|323260409|FG001|Period 1-First Treatment|Pts that did not progress|2|||
94402930|NCT00021541|323260408|FG000|Period 1-First Treatment|Ineligible|0|||
94402931|NCT00021541|323260409|FG001|Period 1-First Treatment|Ineligible|2|||
94402932|NCT00021541|323260408|FG000|Period 2-crossover|refused phase B|2|||
94402933|NCT00021541|323260409|FG001|Period 2-crossover|refused phase B|2|||
94402934|NCT00021541|323260408|FG000|Period 2-crossover|Withdrawal by Subject|3|||
94402935|NCT00021541|323260409|FG001|Period 2-crossover|Withdrawal by Subject|4|||
94402936|NCT00021541|323260408|FG000|Period 2-crossover|Adverse Event|2|||
94402937|NCT00021541|323260409|FG001|Period 2-crossover|Adverse Event|2|||
94402938|NCT00021541|323260408|FG000|Period 2-crossover|non-adherence|1|||
94402939|NCT00021541|323260409|FG001|Period 2-crossover|non-adherence|0|||
94402940|NCT00021541|323260408|FG000|Period 2-crossover|Pts that did not progress|2|||
94402941|NCT00021541|323260409|FG001|Period 2-crossover|Pts that did not progress|3|||
94402942|NCT01874535|323260410|FG000|Overall Study|Lost to Follow-up|10|||
94402943|NCT01874535|323260411|FG001|Overall Study|Lost to Follow-up|9|||
94402944|NCT01874535|323260410|FG000|Overall Study|incomplete symptom resolution|45|||
94402945|NCT01874535|323260411|FG001|Overall Study|incomplete symptom resolution|35|||
94402946|NCT02611323|323260412|FG000|Overall Study|Death|3|||
94402947|NCT02611323|323260413|FG001|Overall Study|Death|1|||
94402948|NCT02611323|323260414|FG002|Overall Study|Death|0|||
94402949|NCT02611323|323260415|FG003|Overall Study|Death|0|||
94402950|NCT02611323|323260416|FG004|Overall Study|Death|1|||
94402951|NCT02611323|323260417|FG005|Overall Study|Death|1|||
94402952|NCT02611323|323260418|FG006|Overall Study|Death|8|||
94402953|NCT02611323|323260419|FG007|Overall Study|Death|0|||
94402954|NCT02611323|323260420|FG008|Overall Study|Death|4|||
94402955|NCT02611323|323260421|FG009|Overall Study|Death|6|||
94402956|NCT02611323|323260422|FG010|Overall Study|Death|26|||
94402957|NCT02611323|323260412|FG000|Overall Study|Lost to Follow-up|1|||
94402958|NCT02611323|323260413|FG001|Overall Study|Lost to Follow-up|0|||
94402959|NCT02611323|323260414|FG002|Overall Study|Lost to Follow-up|0|||
94402960|NCT02611323|323260415|FG003|Overall Study|Lost to Follow-up|0|||
94402961|NCT02611323|323260416|FG004|Overall Study|Lost to Follow-up|0|||
94402962|NCT02611323|323260417|FG005|Overall Study|Lost to Follow-up|0|||
94402963|NCT02611323|323260418|FG006|Overall Study|Lost to Follow-up|3|||
94402964|NCT02611323|323260419|FG007|Overall Study|Lost to Follow-up|0|||
94402965|NCT02611323|323260420|FG008|Overall Study|Lost to Follow-up|0|||
94402966|NCT02611323|323260421|FG009|Overall Study|Lost to Follow-up|0|||
94402967|NCT02611323|323260422|FG010|Overall Study|Lost to Follow-up|2|||
94402968|NCT02611323|323260412|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
94402969|NCT02611323|323260413|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
94402970|NCT02611323|323260414|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
94402971|NCT02611323|323260415|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
94402972|NCT02611323|323260416|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
94402973|NCT02611323|323260417|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
94402974|NCT02611323|323260418|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
94402975|NCT02611323|323260419|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
94402976|NCT02611323|323260420|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
94402977|NCT02611323|323260421|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
94402978|NCT02611323|323260422|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
94402979|NCT02611323|323260412|FG000|Overall Study|Progressive Disease|0|||
94402980|NCT02611323|323260413|FG001|Overall Study|Progressive Disease|0|||
94402981|NCT02611323|323260414|FG002|Overall Study|Progressive Disease|0|||
94402982|NCT02611323|323260415|FG003|Overall Study|Progressive Disease|0|||
94402983|NCT02611323|323260416|FG004|Overall Study|Progressive Disease|0|||
94402984|NCT02611323|323260417|FG005|Overall Study|Progressive Disease|0|||
94402985|NCT02611323|323260418|FG006|Overall Study|Progressive Disease|0|||
94402986|NCT02611323|323260419|FG007|Overall Study|Progressive Disease|0|||
94402987|NCT02611323|323260420|FG008|Overall Study|Progressive Disease|0|||
94402988|NCT02611323|323260421|FG009|Overall Study|Progressive Disease|0|||
94402989|NCT02611323|323260422|FG010|Overall Study|Progressive Disease|1|||
94402990|NCT02611323|323260412|FG000|Overall Study|Withdrawal by Subject|1|||
94402991|NCT02611323|323260413|FG001|Overall Study|Withdrawal by Subject|0|||
94402992|NCT02611323|323260414|FG002|Overall Study|Withdrawal by Subject|0|||
94402993|NCT02611323|323260415|FG003|Overall Study|Withdrawal by Subject|0|||
94402994|NCT02611323|323260416|FG004|Overall Study|Withdrawal by Subject|0|||
94402995|NCT02611323|323260417|FG005|Overall Study|Withdrawal by Subject|0|||
94402996|NCT02611323|323260418|FG006|Overall Study|Withdrawal by Subject|0|||
94402997|NCT02611323|323260419|FG007|Overall Study|Withdrawal by Subject|1|||
94402998|NCT02611323|323260420|FG008|Overall Study|Withdrawal by Subject|0|||
94402999|NCT02611323|323260421|FG009|Overall Study|Withdrawal by Subject|1|||
94403000|NCT02611323|323260422|FG010|Overall Study|Withdrawal by Subject|0|||
94403001|NCT00858403|323260423|FG000|Overall Study|Withdrawal by Subject|1|||
94403002|NCT00858403|323260423|FG000|Overall Study|Death|3|||
94403003|NCT00858403|323260423|FG000|Overall Study|Disease Progression|1|||
94403004|NCT02597049|323260424|FG000|Overall Study|Lost to Follow-up|0|||
94403005|NCT02597049|323260425|FG001|Overall Study|Lost to Follow-up|3|||
94403006|NCT02597049|323260426|FG002|Overall Study|Lost to Follow-up|2|||
94403007|NCT02597049|323260424|FG000|Overall Study|Withdrawal by Subject|2|||
94403008|NCT02597049|323260425|FG001|Overall Study|Withdrawal by Subject|2|||
94403009|NCT02597049|323260426|FG002|Overall Study|Withdrawal by Subject|1|||
94403010|NCT02597049|323260424|FG000|Overall Study|Adverse Event|2|||
94403011|NCT02597049|323260425|FG001|Overall Study|Adverse Event|0|||
94403012|NCT02597049|323260426|FG002|Overall Study|Adverse Event|0|||
94403013|NCT02597049|323260424|FG000|Overall Study|Death|2|||
94403014|NCT02597049|323260425|FG001|Overall Study|Death|0|||
94403015|NCT02597049|323260426|FG002|Overall Study|Death|0|||
94403016|NCT02597049|323260424|FG000|Overall Study|Noncompliant with Study Visits|1|||
94403017|NCT02597049|323260425|FG001|Overall Study|Noncompliant with Study Visits|0|||
94403018|NCT02597049|323260426|FG002|Overall Study|Noncompliant with Study Visits|0|||
94403019|NCT01215721|323260429|FG000|Overall Study|Adverse Event|2|||
94403020|NCT00243347|323260430|FG000|Overall Study|Lack of Efficacy|4|||
94403021|NCT00243347|323260430|FG000|Overall Study|Adverse Event|2|||
94403022|NCT00243347|323260430|FG000|Overall Study|Death|1|||
94403023|NCT00243347|323260430|FG000|Overall Study|Withdrawal by Subject|5|||
94403024|NCT00243347|323260430|FG000|Overall Study|Condition worsened|7|||
94403025|NCT00045162|323260431|FG000|Overall Study|Ineligible|12|||
94403026|NCT00045162|323260432|FG001|Overall Study|Ineligible|8|||
94403027|NCT00045162|323260431|FG000|Overall Study|Not treated|7|||
94403028|NCT00045162|323260432|FG001|Overall Study|Not treated|2|||
94403029|NCT00045162|323260431|FG000|Overall Study|Adverse Event|55|||
94403030|NCT00045162|323260432|FG001|Overall Study|Adverse Event|50|||
94403031|NCT00045162|323260431|FG000|Overall Study|Lack of Efficacy|32|||
94403032|NCT00045162|323260432|FG001|Overall Study|Lack of Efficacy|29|||
94403033|NCT00045162|323260431|FG000|Overall Study|Death|10|||
94403034|NCT00045162|323260432|FG001|Overall Study|Death|10|||
94403035|NCT00045162|323260431|FG000|Overall Study|Withdrawal by Subject|5|||
94403036|NCT00045162|323260432|FG001|Overall Study|Withdrawal by Subject|3|||
94403037|NCT00045162|323260431|FG000|Overall Study|Other|21|||
94403038|NCT00045162|323260432|FG001|Overall Study|Other|16|||
94403039|NCT01044433|323260433|FG000|Overall Study|Lost to Follow-up|3|||
94403040|NCT01044433|323260433|FG000|Overall Study|Withdrawal by Subject|3|||
94403041|NCT03105297|323260435|FG000|Baseline Phase (Day 1)|Other|21|||
94403042|NCT03105297|323260435|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
94403043|NCT03105297|323260435|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
94403044|NCT05065619|323260436|FG000|Up to Day 42|Lost to Follow-up|1|||
94403045|NCT05065619|323260437|FG001|Up to Day 42|Lost to Follow-up|0|||
94403046|NCT05065619|323260436|FG000|Up to Day 42|Withdrawal by Subject|1|||
94403047|NCT05065619|323260437|FG001|Up to Day 42|Withdrawal by Subject|0|||
94403048|NCT05065619|323260436|FG000|After Day 43|Lost to Follow-up|1|||
94403049|NCT05065619|323260437|FG001|After Day 43|Lost to Follow-up|0|||
94403050|NCT05065619|323260436|FG000|After Day 43|Physician Decision|3|||
94403051|NCT05065619|323260437|FG001|After Day 43|Physician Decision|0|||
94403052|NCT05065619|323260436|FG000|After Day 43|Withdrawal by Subject|1|||
94403053|NCT05065619|323260437|FG001|After Day 43|Withdrawal by Subject|2|||
94403054|NCT05065619|323260436|FG000|After Day 43|Public vaccination|6|||
94403055|NCT05065619|323260437|FG001|After Day 43|Public vaccination|8|||
94403056|NCT05065619|323260436|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
94403057|NCT05065619|323260437|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
94403058|NCT05065619|323260436|FG000|After Day 43|Study Terminated by Sponsor|88|||
94403059|NCT05065619|323260437|FG001|After Day 43|Study Terminated by Sponsor|16|||
94403060|NCT01390948|323260445|FG000|Overall Study|End of Study|1|||
94403061|NCT01390948|323260446|FG001|Overall Study|End of Study|0|||
94403062|NCT01390948|323260447|FG002|Overall Study|End of Study|0|||
94403063|NCT01390948|323260445|FG000|Overall Study|Withdrew consent|2|||
94403064|NCT01390948|323260446|FG001|Overall Study|Withdrew consent|2|||
94403065|NCT01390948|323260447|FG002|Overall Study|Withdrew consent|0|||
94403066|NCT01390948|323260445|FG000|Overall Study|Progressive Disease|2|||
94403067|NCT01390948|323260446|FG001|Overall Study|Progressive Disease|5|||
94403068|NCT01390948|323260447|FG002|Overall Study|Progressive Disease|0|||
94403069|NCT01390948|323260445|FG000|Overall Study|Death during follow-up|10|||
94403070|NCT01390948|323260446|FG001|Overall Study|Death during follow-up|11|||
94403071|NCT01390948|323260447|FG002|Overall Study|Death during follow-up|1|||
94403072|NCT05692154|323260448|FG000|Overall Study|Adverse Event|0|||
94403073|NCT05692154|323260449|FG001|Overall Study|Adverse Event|1|||
94403074|NCT02416934|323260450|FG000|Overall Study|given steroids|1|||
94403075|NCT02416934|323260451|FG001|Overall Study|given steroids|2|||
94403076|NCT02416934|323260450|FG000|Overall Study|Lost to Follow-up|0|||
94403077|NCT02416934|323260451|FG001|Overall Study|Lost to Follow-up|2|||
94403078|NCT02416934|323260450|FG000|Overall Study|Withdrawal by Subject|1|||
94403079|NCT02416934|323260451|FG001|Overall Study|Withdrawal by Subject|0|||
94403080|NCT02416934|323260450|FG000|Overall Study|recruited during continuing renewal proc|0|||
94403081|NCT02416934|323260451|FG001|Overall Study|recruited during continuing renewal proc|1|||
94403082|NCT02416934|323260450|FG000|Overall Study|Protocol Violation|0|||
94403083|NCT02416934|323260451|FG001|Overall Study|Protocol Violation|1|||
94403084|NCT02416934|323260450|FG000|Overall Study|surgery started late|0|||
94403085|NCT02416934|323260451|FG001|Overall Study|surgery started late|1|||
94403086|NCT02416934|323260450|FG000|Overall Study|re-operation|1|||
94403087|NCT02416934|323260451|FG001|Overall Study|re-operation|0|||
94403088|NCT00860262|323260452|FG000|Overall Study|Adverse Event|9|||
94403089|NCT00860262|323260453|FG001|Overall Study|Adverse Event|6|||
94403090|NCT00860262|323260454|FG002|Overall Study|Adverse Event|7|||
94403091|NCT00860262|323260452|FG000|Overall Study|Protocol Violation|0|||
94403092|NCT00860262|323260453|FG001|Overall Study|Protocol Violation|1|||
94403093|NCT00860262|323260454|FG002|Overall Study|Protocol Violation|0|||
94403094|NCT00860262|323260452|FG000|Overall Study|Lost to Follow-up|2|||
94403095|NCT00860262|323260453|FG001|Overall Study|Lost to Follow-up|0|||
94403096|NCT00860262|323260454|FG002|Overall Study|Lost to Follow-up|1|||
94403097|NCT00860262|323260452|FG000|Overall Study|Withdrawal by Subject|4|||
94403098|NCT00860262|323260453|FG001|Overall Study|Withdrawal by Subject|8|||
94403099|NCT00860262|323260454|FG002|Overall Study|Withdrawal by Subject|6|||
94403100|NCT00860262|323260452|FG000|Overall Study|Lack of Efficacy|0|||
94403101|NCT00860262|323260453|FG001|Overall Study|Lack of Efficacy|4|||
94403102|NCT00860262|323260454|FG002|Overall Study|Lack of Efficacy|3|||
94403103|NCT00860262|323260452|FG000|Overall Study|Other|5|||
94403104|NCT00860262|323260453|FG001|Overall Study|Other|3|||
94403105|NCT00860262|323260454|FG002|Overall Study|Other|1|||
94403106|NCT00124618|323260458|FG000|Overall Study|Ineligible|1|||
94403107|NCT02387762|323260459|FG000|Overall Study|Withdrawal by Subject|1|||
94403108|NCT02387762|323260460|FG001|Overall Study|Withdrawal by Subject|0|||
94403109|NCT04203823|323260464|FG000|Overall Study|Withdrawal by Subject|2|||
94403110|NCT04203823|323260465|FG001|Overall Study|Withdrawal by Subject|2|||
94403111|NCT04203823|323260464|FG000|Overall Study|Adverse Event|1|||
94403112|NCT04203823|323260465|FG001|Overall Study|Adverse Event|1|||
94403113|NCT04203823|323260464|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94403114|NCT04203823|323260465|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
94403115|NCT01499043|323260466|FG000|Overall Study|Progressive disease (radiographic)|2|||
94403116|NCT01499043|323260466|FG000|Overall Study|Progressive disease (clinical)|1|||
94403117|NCT01499043|323260466|FG000|Overall Study|Withdrawal by Subject|2|||
94403118|NCT01499043|323260466|FG000|Overall Study|Adverse Event|1|||
94403119|NCT01598896|323260468|FG000|Overall Study|Withdrawal by Subject|0|||
94403120|NCT01598896|323260469|FG001|Overall Study|Withdrawal by Subject|1|||
94403121|NCT01598896|323260468|FG000|Overall Study|Lack of Efficacy|0|||
94403122|NCT01598896|323260469|FG001|Overall Study|Lack of Efficacy|1|||
94403123|NCT01223027|323260470|FG000|Overall Study|Adverse Event|20|||
94403124|NCT01223027|323260471|FG001|Overall Study|Adverse Event|10|||
94403125|NCT01223027|323260470|FG000|Overall Study|Death|42|||
94403126|NCT01223027|323260471|FG001|Overall Study|Death|42|||
94403127|NCT01223027|323260470|FG000|Overall Study|Lost to Follow-up|2|||
94403128|NCT01223027|323260471|FG001|Overall Study|Lost to Follow-up|1|||
94403129|NCT01223027|323260470|FG000|Overall Study|Physician Decision|4|||
94403130|NCT01223027|323260471|FG001|Overall Study|Physician Decision|8|||
94403131|NCT01223027|323260470|FG000|Overall Study|Progressive Disease|167|||
94403132|NCT01223027|323260471|FG001|Overall Study|Progressive Disease|183|||
94403133|NCT01223027|323260470|FG000|Overall Study|Protocol Violation|2|||
94403134|NCT01223027|323260471|FG001|Overall Study|Protocol Violation|1|||
94403135|NCT01223027|323260470|FG000|Overall Study|Subject/guardian decicion|18|||
94403136|NCT01223027|323260471|FG001|Overall Study|Subject/guardian decicion|16|||
94403137|NCT01223027|323260470|FG000|Overall Study|New therapy for study indication|17|||
94403138|NCT01223027|323260471|FG001|Overall Study|New therapy for study indication|8|||
94403139|NCT01223027|323260470|FG000|Overall Study|Study terminated by sponsor|2|||
94403140|NCT01223027|323260471|FG001|Overall Study|Study terminated by sponsor|8|||
94403141|NCT00199901|323261750|FG000|Overall Study|Protocol Violation|2|||
94330647|NCT01601704|322991673|FG001|Overall Study|Randomized but not dispensed study med|4|||
94330648|NCT01090102|322991674|FG000|First 12 Weeks|Withdrawal by Subject|1|||
94330649|NCT01090102|322991675|FG001|First 12 Weeks|Withdrawal by Subject|1|||
94330650|NCT01090102|322991674|FG000|First 12 Weeks|Adverse Event|2|||
94330651|NCT01090102|322991675|FG001|First 12 Weeks|Adverse Event|0|||
94330652|NCT01090102|322991674|FG000|First 12 Weeks|Death|1|||
94330653|NCT01090102|322991675|FG001|First 12 Weeks|Death|1|||
94330654|NCT01090102|322991674|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
94330655|NCT01090102|322991675|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
94330656|NCT00877006|322991678|FG000|Treatment Period|Death|2|||
94330657|NCT00877006|322991679|FG001|Treatment Period|Death|1|||
94330658|NCT00877006|322991678|FG000|Treatment Period|Adverse Event|10|||
94330659|NCT00877006|322991679|FG001|Treatment Period|Adverse Event|3|||
94330660|NCT00877006|322991678|FG000|Treatment Period|Withdrawal by Subject|2|||
94330661|NCT00877006|322991679|FG001|Treatment Period|Withdrawal by Subject|3|||
94330662|NCT00877006|322991678|FG000|Treatment Period|Protocol Violation|1|||
94330663|NCT00877006|322991679|FG001|Treatment Period|Protocol Violation|0|||
94330664|NCT00877006|322991678|FG000|Treatment Period|Lost to Follow-up|0|||
94330665|NCT00877006|322991679|FG001|Treatment Period|Lost to Follow-up|1|||
94330666|NCT00877006|322991678|FG000|Treatment Period|Disease Progression|1|||
94330667|NCT00877006|322991679|FG001|Treatment Period|Disease Progression|2|||
94330668|NCT00877006|322991678|FG000|Treatment Period|Started New Treatment Regimen|2|||
94330669|NCT00877006|322991679|FG001|Treatment Period|Started New Treatment Regimen|5|||
94330670|NCT00877006|322991678|FG000|Treatment Period|Other|4|||
94330671|NCT00877006|322991679|FG001|Treatment Period|Other|4|||
94330672|NCT00877006|322991678|FG000|Treatment Period|Randomized but Not Treated|3|||
94330673|NCT00877006|322991679|FG001|Treatment Period|Randomized but Not Treated|8|||
94330674|NCT00877006|322991678|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
94330675|NCT00877006|322991679|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
94330676|NCT00877006|322991678|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
94330677|NCT00877006|322991679|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
94330678|NCT00877006|322991678|FG000|Long-Term Follow-up Period|Death|26|||
94330679|NCT00877006|322991679|FG001|Long-Term Follow-up Period|Death|18|||
94330680|NCT00877006|322991678|FG000|Long-Term Follow-up Period|Other|7|||
94330681|NCT00877006|322991679|FG001|Long-Term Follow-up Period|Other|9|||
94330682|NCT04067011|322991680|FG000|Overall Study|Not Treated|8|||
94330683|NCT04067011|322991681|FG001|Overall Study|Not Treated|7|||
94330684|NCT04067011|322991682|FG002|Overall Study|Not Treated|5|||
94330685|NCT04067011|322991680|FG000|Overall Study|Adverse Event|2|||
94330686|NCT04067011|322991681|FG001|Overall Study|Adverse Event|1|||
94330687|NCT04067011|322991682|FG002|Overall Study|Adverse Event|0|||
94330688|NCT04067011|322991680|FG000|Overall Study|Withdrawal by Subject|6|||
94330689|NCT04067011|322991681|FG001|Overall Study|Withdrawal by Subject|2|||
94330690|NCT04067011|322991682|FG002|Overall Study|Withdrawal by Subject|1|||
94330691|NCT04067011|322991680|FG000|Overall Study|Lost to Follow-up|0|||
94330692|NCT04067011|322991681|FG001|Overall Study|Lost to Follow-up|0|||
94330693|NCT04067011|322991682|FG002|Overall Study|Lost to Follow-up|1|||
94330694|NCT04067011|322991680|FG000|Overall Study|Physician Decision|1|||
94330695|NCT04067011|322991681|FG001|Overall Study|Physician Decision|1|||
94330696|NCT04067011|322991682|FG002|Overall Study|Physician Decision|0|||
94330697|NCT04067011|322991680|FG000|Overall Study|Other Reasons|2|||
94330698|NCT04067011|322991681|FG001|Overall Study|Other Reasons|0|||
94330699|NCT04067011|322991682|FG002|Overall Study|Other Reasons|1|||
94330700|NCT04067011|322991680|FG000|Overall Study|Missing|0|||
94330701|NCT04067011|322991681|FG001|Overall Study|Missing|2|||
94330702|NCT04067011|322991682|FG002|Overall Study|Missing|0|||
94330703|NCT01779648|322991686|FG000|Overall Study|Protocol Violation|1|||
94330704|NCT01779648|322991687|FG001|Overall Study|Protocol Violation|0|||
94330705|NCT02267278|322991689|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
94330706|NCT02267278|322991689|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
94330707|NCT02267278|322991689|FG000|Overall Study|Developed new cancer diagnoses|2|||
94330708|NCT02267278|322991689|FG000|Overall Study|prescribed prohibited medication|1|||
94330709|NCT03351478|322991692|FG000|Overall Study|At the subject's own request|11|||
94330710|NCT03351478|322991693|FG001|Overall Study|At the subject's own request|12|||
94330711|NCT03351478|322991694|FG002|Overall Study|At the subject's own request|5|||
94330712|NCT03351478|322991692|FG000|Overall Study|Adverse Event|1|||
94330713|NCT03351478|322991693|FG001|Overall Study|Adverse Event|2|||
94330714|NCT03351478|322991694|FG002|Overall Study|Adverse Event|1|||
94330715|NCT03351478|322991692|FG000|Overall Study|Poor compliance to protocol|1|||
94330716|NCT03351478|322991693|FG001|Overall Study|Poor compliance to protocol|0|||
94330717|NCT03351478|322991694|FG002|Overall Study|Poor compliance to protocol|0|||
94330718|NCT03351478|322991692|FG000|Overall Study|Reason not Specified|1|||
94330719|NCT03351478|322991693|FG001|Overall Study|Reason not Specified|3|||
94330720|NCT03351478|322991694|FG002|Overall Study|Reason not Specified|0|||
94330721|NCT03351478|322991692|FG000|Overall Study|Lost to Follow-up|0|||
94330722|NCT03351478|322991693|FG001|Overall Study|Lost to Follow-up|0|||
94330723|NCT03351478|322991694|FG002|Overall Study|Lost to Follow-up|1|||
94330724|NCT03485222|322991699|FG000|Overall Study|Death|0|||
94403142|NCT00199901|323261751|FG001|Overall Study|Protocol Violation|0|||
94403143|NCT00199901|323261750|FG000|Overall Study|Withdrawal by Subject|1|||
94330725|NCT03485222|322991700|FG001|Overall Study|Death|1|||
94330726|NCT03485222|322991699|FG000|Overall Study|Lost to Follow-up|2|||
94330727|NCT03485222|322991700|FG001|Overall Study|Lost to Follow-up|1|||
94330728|NCT03657810|322991701|FG000|Overall Study|Adverse Event|0|||
94330729|NCT03657810|322991702|FG001|Overall Study|Adverse Event|1|||
94330730|NCT03657810|322991703|FG002|Overall Study|Adverse Event|0|||
94330731|NCT03657810|322991701|FG000|Overall Study|Lack of Efficacy|4|||
94330732|NCT03657810|322991702|FG001|Overall Study|Lack of Efficacy|1|||
94330733|NCT03657810|322991703|FG002|Overall Study|Lack of Efficacy|3|||
94330734|NCT03657810|322991701|FG000|Overall Study|Protocol Violation|1|||
94330735|NCT03657810|322991702|FG001|Overall Study|Protocol Violation|0|||
94330736|NCT03657810|322991703|FG002|Overall Study|Protocol Violation|0|||
94330737|NCT03657810|322991701|FG000|Overall Study|Lost to Follow-up|0|||
94330738|NCT03657810|322991702|FG001|Overall Study|Lost to Follow-up|1|||
94330739|NCT03657810|322991703|FG002|Overall Study|Lost to Follow-up|0|||
94330740|NCT03657810|322991701|FG000|Overall Study|Not provided|0|||
94330741|NCT03657810|322991702|FG001|Overall Study|Not provided|1|||
94330742|NCT03657810|322991703|FG002|Overall Study|Not provided|0|||
94330743|NCT03911869|322991704|FG000|Safety Lead-in Phase|Death|7|||
94330744|NCT03911869|322991705|FG001|Safety Lead-in Phase|Death|0|||
94330745|NCT03911869|322991706|FG002|Safety Lead-in Phase|Death|0|||
94330746|NCT03911869|322991704|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
94330747|NCT03911869|322991705|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
94330748|NCT03911869|322991706|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
94330749|NCT03911869|322991704|FG000|Safety Lead-in Phase|Other|1|||
94330750|NCT03911869|322991705|FG001|Safety Lead-in Phase|Other|0|||
94330751|NCT03911869|322991706|FG002|Safety Lead-in Phase|Other|0|||
94330752|NCT03911869|322991704|FG000|Phase 2|Death|0|||
94330753|NCT03911869|322991705|FG001|Phase 2|Death|3|||
94330754|NCT03911869|322991706|FG002|Phase 2|Death|0|||
94330755|NCT00527072|322991709|FG000|Overall Study|Adverse Event|13|||
94330756|NCT00527072|322991709|FG000|Overall Study|Lack of Efficacy|11|||
94330757|NCT00527072|322991709|FG000|Overall Study|Lost to Follow-up|3|||
94330758|NCT00527072|322991709|FG000|Overall Study|Protocol Violation|2|||
94330759|NCT00527072|322991709|FG000|Overall Study|Withdrawal by Subject|7|||
94330760|NCT00985738|322991710|FG000|Overall Study|Study closed prematurely|8|||
94330761|NCT00985738|322991711|FG001|Overall Study|Study closed prematurely|8|||
94330762|NCT01705587|322991712|FG000|Overall Study|Withdrawal by Subject|0|||
94330763|NCT01705587|322991713|FG001|Overall Study|Withdrawal by Subject|1|||
94330764|NCT02227849|322991714|FG000|Overall Study|Adverse Event|4|||
94330765|NCT02227849|322991714|FG000|Overall Study|Physician Decision|1|||
94330766|NCT02227849|322991714|FG000|Overall Study|Withdrawal by Subject|3|||
94330767|NCT04295356|322991715|FG000|Overall Study|Physician Decision|1|||
94330768|NCT04295356|322991716|FG001|Overall Study|Physician Decision|0|||
94330769|NCT04295356|322991715|FG000|Overall Study|Lost to Follow-up|0|||
94330770|NCT04295356|322991716|FG001|Overall Study|Lost to Follow-up|3|||
94330771|NCT04295356|322991715|FG000|Overall Study|Protocol Violation|0|||
94330772|NCT04295356|322991716|FG001|Overall Study|Protocol Violation|1|||
94330773|NCT00510484|322991717|FG000|Wash-out Period|Adverse Event|0|||
94330774|NCT00510484|322991718|FG001|Wash-out Period|Adverse Event|1|||
94330775|NCT03004976|322991725|FG000|Overall Study|Lost to Follow-up|7|||
94330776|NCT03004976|322991726|FG001|Overall Study|Lost to Follow-up|5|||
94330777|NCT03004976|322991725|FG000|Overall Study|Physician Decision|1|||
94330778|NCT03004976|322991726|FG001|Overall Study|Physician Decision|0|||
94330779|NCT03004976|322991725|FG000|Overall Study|Withdrawal by Subject|1|||
94330780|NCT03004976|322991726|FG001|Overall Study|Withdrawal by Subject|0|||
94330781|NCT03004976|322991725|FG000|Overall Study|Death|4|||
94330782|NCT03004976|322991726|FG001|Overall Study|Death|1|||
94330783|NCT00291499|322991729|FG000|Overall Study|Adverse Event|3|||
94330784|NCT00291499|322991730|FG001|Overall Study|Adverse Event|8|||
94330785|NCT00291499|322991729|FG000|Overall Study|Change to other therapy|2|||
94330786|NCT00291499|322991730|FG001|Overall Study|Change to other therapy|1|||
94330787|NCT00291499|322991729|FG000|Overall Study|Intercurrent illness|1|||
94330788|NCT00291499|322991730|FG001|Overall Study|Intercurrent illness|0|||
94330789|NCT00291499|322991729|FG000|Overall Study|Protocol Violation|2|||
94330790|NCT00291499|322991730|FG001|Overall Study|Protocol Violation|2|||
94330791|NCT00291499|322991729|FG000|Overall Study|Other reasons|1|||
94330792|NCT00291499|322991730|FG001|Overall Study|Other reasons|4|||
94330793|NCT02786836|322991733|FG000|Overall Study|Death|1|||
94330794|NCT02786836|322991733|FG000|Overall Study|Lack of Efficacy|2|||
94330795|NCT02786836|322991733|FG000|Overall Study|Protocol Violation|3|||
94330796|NCT02786836|322991733|FG000|Overall Study|Withdrawal by Subject|3|||
94330797|NCT02786836|322991733|FG000|Overall Study|Liver Transplantation|2|||
94330798|NCT02786836|322991733|FG000|Overall Study|Device or Pharmacy Issues|3|||
94330799|NCT01082367|322991734|FG000|Double-blind Period|Administrative problems|0|||
94403144|NCT00199901|323261751|FG001|Overall Study|Withdrawal by Subject|0|||
94403145|NCT00199901|323261750|FG000|Overall Study|Progressive Disease|24|||
94403146|NCT00199901|323261751|FG001|Overall Study|Progressive Disease|24|||
94403147|NCT01691430|323261752|FG000|Overall Study|Death|17|||
94403148|NCT01691430|323261753|FG001|Overall Study|Death|16|||
94403149|NCT01691430|323261752|FG000|Overall Study|Withdrawal by Subject|5|||
94403150|NCT01691430|323261753|FG001|Overall Study|Withdrawal by Subject|1|||
94403151|NCT01691430|323261752|FG000|Overall Study|Lost to Follow-up|0|||
94403152|NCT01691430|323261753|FG001|Overall Study|Lost to Follow-up|3|||
94403153|NCT03119662|323261759|FG000|Overall Study|Withdrawal by Subject|0|||
94403154|NCT03119662|323261760|FG001|Overall Study|Withdrawal by Subject|1|||
94403155|NCT04158687|323261764|FG000|Overall Study|Adverse Event|2|||
94403156|NCT04158687|323261765|FG001|Overall Study|Adverse Event|3|||
94403157|NCT04158687|323261766|FG002|Overall Study|Adverse Event|0|||
94403158|NCT04158687|323261767|FG003|Overall Study|Adverse Event|3|||
94403159|NCT04158687|323261764|FG000|Overall Study|Lost to Follow-up|5|||
94403160|NCT04158687|323261765|FG001|Overall Study|Lost to Follow-up|12|||
94403161|NCT04158687|323261766|FG002|Overall Study|Lost to Follow-up|4|||
94403162|NCT04158687|323261767|FG003|Overall Study|Lost to Follow-up|5|||
94403163|NCT04158687|323261764|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
94403164|NCT04158687|323261765|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
94403165|NCT04158687|323261766|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
94403166|NCT04158687|323261767|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
94403167|NCT04158687|323261764|FG000|Overall Study|Non-Compliance with Study Medication|2|||
94403168|NCT04158687|323261765|FG001|Overall Study|Non-Compliance with Study Medication|2|||
94403169|NCT04158687|323261766|FG002|Overall Study|Non-Compliance with Study Medication|3|||
94403170|NCT04158687|323261767|FG003|Overall Study|Non-Compliance with Study Medication|0|||
94330800|NCT01082367|322991735|FG001|Double-blind Period|Administrative problems|1|||
94330801|NCT01082367|322991734|FG000|Double-blind Period|Lack of Efficacy|5|||
94330802|NCT01082367|322991735|FG001|Double-blind Period|Lack of Efficacy|11|||
94330803|NCT01082367|322991734|FG000|Double-blind Period|Adverse Event|0|||
94330804|NCT01082367|322991735|FG001|Double-blind Period|Adverse Event|1|||
94330805|NCT01082367|322991734|FG000|Follow-up (F-U) Period|Administrative problems|1|||
94330806|NCT01082367|322991735|FG001|Follow-up (F-U) Period|Administrative problems|0|||
94330807|NCT01082367|322991734|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
94330808|NCT01082367|322991735|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
94330809|NCT01082367|322991734|FG000|Follow-up (F-U) Period|Adverse Event|0|||
94330810|NCT01082367|322991735|FG001|Follow-up (F-U) Period|Adverse Event|1|||
94330811|NCT00881361|322991736|FG000|Overall Study|Terminated prior to surgery|27|||
94330812|NCT00881361|322991737|FG001|Overall Study|Terminated prior to surgery|7|||
94330813|NCT00881361|322991738|FG002|Overall Study|Terminated prior to surgery|0|||
94330814|NCT00881361|322991736|FG000|Overall Study|Ineligible|17|||
94330815|NCT00881361|322991737|FG001|Overall Study|Ineligible|2|||
94330816|NCT00881361|322991738|FG002|Overall Study|Ineligible|2|||
94330817|NCT02016898|322991739|FG000|Overall Study|Death|1|||
94330818|NCT02016898|322991740|FG001|Overall Study|Death|1|||
94330819|NCT02016898|322991739|FG000|Overall Study|Lost to Follow-up|4|||
94330820|NCT02016898|322991740|FG001|Overall Study|Lost to Follow-up|4|||
94330821|NCT00712933|322991741|FG000|Overall Study|Adverse Event|69|||
94330822|NCT00712933|322991741|FG000|Overall Study|Lack of Efficacy|6|||
94330823|NCT00712933|322991741|FG000|Overall Study|Lost to Follow-up|22|||
94330824|NCT00712933|322991741|FG000|Overall Study|Non-compliance with study drug|13|||
94330825|NCT00712933|322991741|FG000|Overall Study|Other Pregnancy|37|||
94330826|NCT00712933|322991741|FG000|Overall Study|Sponsor decision|14|||
94330827|NCT00712933|322991741|FG000|Overall Study|Withdrew consent|4|||
94330828|NCT00712933|322991741|FG000|Overall Study|Hip replacement surgery|1|||
94330829|NCT00712933|322991741|FG000|Overall Study|Involved in Clinical research|3|||
94330830|NCT00712933|322991741|FG000|Overall Study|Participant hospitalized|1|||
94330831|NCT00712933|322991741|FG000|Overall Study|Participant travelled overseas|2|||
94330832|NCT00712933|322991741|FG000|Overall Study|Death of patient|1|||
94330833|NCT00712933|322991741|FG000|Overall Study|Other Physician decision|1|||
94330834|NCT00712933|322991741|FG000|Overall Study|Not committed to contraception|1|||
94330835|NCT00712933|322991741|FG000|Overall Study|Participant received medication|1|||
94330836|NCT00712933|322991741|FG000|Overall Study|Physician Decision|36|||
94330837|NCT00712933|322991741|FG000|Overall Study|Protocol Violation|4|||
94330838|NCT00712933|322991741|FG000|Overall Study|Withdrawal by Subject|151|||
94330839|NCT01306032|322991742|FG000|First Intervention|Adverse Event|1|||
94330840|NCT01306032|322991743|FG001|First Intervention|Adverse Event|0|||
94330841|NCT01306032|322991744|FG002|First Intervention|Adverse Event|1|||
94330842|NCT01306032|322991745|FG003|First Intervention|Adverse Event|0|||
94330843|NCT01306032|322991746|FG004|First Intervention|Adverse Event|0|||
94330844|NCT01306032|322991747|FG005|First Intervention|Adverse Event|1|||
94330845|NCT01306032|322991742|FG000|First Intervention|Withdrawal by Subject|0|||
94403171|NCT04158687|323261764|FG000|Overall Study|Investigator Decision|0|||
94403172|NCT04158687|323261765|FG001|Overall Study|Investigator Decision|0|||
94403173|NCT04158687|323261766|FG002|Overall Study|Investigator Decision|2|||
94330846|NCT01306032|322991743|FG001|First Intervention|Withdrawal by Subject|2|||
94330847|NCT01306032|322991744|FG002|First Intervention|Withdrawal by Subject|0|||
94330848|NCT01306032|322991745|FG003|First Intervention|Withdrawal by Subject|1|||
94330849|NCT01306032|322991746|FG004|First Intervention|Withdrawal by Subject|0|||
94330850|NCT01306032|322991747|FG005|First Intervention|Withdrawal by Subject|0|||
94330851|NCT01306032|322991742|FG000|First Intervention|Death|0|||
94330852|NCT01306032|322991743|FG001|First Intervention|Death|0|||
94330853|NCT01306032|322991744|FG002|First Intervention|Death|1|||
94330854|NCT01306032|322991745|FG003|First Intervention|Death|0|||
94330855|NCT01306032|322991746|FG004|First Intervention|Death|0|||
94330856|NCT01306032|322991747|FG005|First Intervention|Death|0|||
94330857|NCT01306032|322991742|FG000|First Intervention|Ineligible|0|||
94330858|NCT01306032|322991743|FG001|First Intervention|Ineligible|0|||
94330859|NCT01306032|322991744|FG002|First Intervention|Ineligible|0|||
94330860|NCT01306032|322991745|FG003|First Intervention|Ineligible|0|||
94330861|NCT01306032|322991746|FG004|First Intervention|Ineligible|0|||
94330862|NCT01306032|322991747|FG005|First Intervention|Ineligible|1|||
94330863|NCT01306032|322991742|FG000|First Intervention|Progressive disease|0|||
94330864|NCT01306032|322991743|FG001|First Intervention|Progressive disease|0|||
94330865|NCT01306032|322991744|FG002|First Intervention|Progressive disease|0|||
94330866|NCT01306032|322991745|FG003|First Intervention|Progressive disease|0|||
94330867|NCT01306032|322991746|FG004|First Intervention|Progressive disease|2|||
94330868|NCT01306032|322991747|FG005|First Intervention|Progressive disease|0|||
94330869|NCT01306032|322991742|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
94330870|NCT01306032|322991743|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
94330871|NCT01306032|322991744|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
94330872|NCT01306032|322991745|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
94330873|NCT01306032|322991746|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
94330874|NCT01306032|322991747|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
94330875|NCT01306032|322991742|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
94330876|NCT01306032|322991743|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
94330877|NCT01306032|322991744|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
94330878|NCT01306032|322991745|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
94330879|NCT01306032|322991746|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
94330880|NCT01306032|322991747|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
94330881|NCT02988219|322991748|FG000|Overall Study|Lack of Efficacy|1|||
94330882|NCT02988219|322991749|FG001|Overall Study|Lack of Efficacy|1|||
94330883|NCT02988219|322991748|FG000|Overall Study|Withdrawal by Subject|0|||
94330884|NCT02988219|322991749|FG001|Overall Study|Withdrawal by Subject|2|||
94403174|NCT04158687|323261767|FG003|Overall Study|Investigator Decision|0|||
94403175|NCT04158687|323261764|FG000|Overall Study|Protocol Violation|0|||
94403176|NCT04158687|323261765|FG001|Overall Study|Protocol Violation|2|||
94403177|NCT04158687|323261766|FG002|Overall Study|Protocol Violation|1|||
94403178|NCT04158687|323261767|FG003|Overall Study|Protocol Violation|0|||
94403179|NCT04158687|323261764|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
94403180|NCT04158687|323261765|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
94403181|NCT04158687|323261766|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
94403182|NCT04158687|323261767|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
94403183|NCT04158687|323261764|FG000|Overall Study|Reason not Specified|3|||
94403184|NCT04158687|323261765|FG001|Overall Study|Reason not Specified|2|||
94403185|NCT04158687|323261766|FG002|Overall Study|Reason not Specified|4|||
94403186|NCT04158687|323261767|FG003|Overall Study|Reason not Specified|4|||
94403187|NCT05061992|323261770|FG000|Overall Study|Excess bowel movements|1|||
94403188|NCT05061992|323261771|FG001|Overall Study|Excess bowel movements|0|||
94403189|NCT05061992|323261770|FG000|Overall Study|Complications of Medical Care|1|||
94403190|NCT05061992|323261771|FG001|Overall Study|Complications of Medical Care|0|||
94403191|NCT05061992|323261770|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
94403192|NCT05061992|323261771|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
94403193|NCT05061992|323261770|FG000|Overall Study|Withdrawal by Subject|0|||
94403194|NCT05061992|323261771|FG001|Overall Study|Withdrawal by Subject|1|||
94403195|NCT04523480|323261774|FG000|Overall Study|Lost to Follow-up|30|||
94403196|NCT04523480|323261775|FG001|Overall Study|Lost to Follow-up|35|||
94403197|NCT04523480|323261776|FG002|Overall Study|Lost to Follow-up|0|||
94403198|NCT00735696|323261779|FG000|Overall Study|Withdrawal by Subject|1|||
94403199|NCT00735696|323261779|FG000|Overall Study|Enrolled but never Treated|1|||
94403200|NCT04102345|323261783|FG000|Overall Study|Withdrawal by Subject|1|||
94403201|NCT04102345|323261784|FG001|Overall Study|Withdrawal by Subject|0|||
94403202|NCT01513239|323261785|FG000|Period 1: Main Phase|Adverse Event|1|||
94403203|NCT01513239|323261786|FG001|Period 1: Main Phase|Adverse Event|1|||
94403204|NCT01513239|323261787|FG002|Period 1: Main Phase|Adverse Event|2|||
94403205|NCT01513239|323261788|FG003|Period 1: Main Phase|Adverse Event|0|||
94403206|NCT01513239|323261789|FG004|Period 1: Main Phase|Adverse Event|0|||
94403207|NCT01513239|323261790|FG005|Period 1: Main Phase|Adverse Event|0|||
94403208|NCT01513239|323261785|FG000|Period 1: Main Phase|Death|29|||
94403209|NCT01513239|323261786|FG001|Period 1: Main Phase|Death|22|||
94403210|NCT01513239|323261787|FG002|Period 1: Main Phase|Death|32|||
94403211|NCT01513239|323261788|FG003|Period 1: Main Phase|Death|0|||
94403212|NCT01513239|323261789|FG004|Period 1: Main Phase|Death|0|||
94403213|NCT01513239|323261790|FG005|Period 1: Main Phase|Death|0|||
94403214|NCT01513239|323261785|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
94403215|NCT01513239|323261786|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
94403216|NCT01513239|323261787|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
94403217|NCT01513239|323261788|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
94403218|NCT01513239|323261789|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
94403219|NCT01513239|323261790|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
94403220|NCT01513239|323261785|FG000|Period 1: Main Phase|Physician Decision|4|||
94403221|NCT01513239|323261786|FG001|Period 1: Main Phase|Physician Decision|4|||
94403222|NCT01513239|323261787|FG002|Period 1: Main Phase|Physician Decision|4|||
94403223|NCT01513239|323261788|FG003|Period 1: Main Phase|Physician Decision|0|||
94403224|NCT01513239|323261789|FG004|Period 1: Main Phase|Physician Decision|0|||
94403225|NCT01513239|323261790|FG005|Period 1: Main Phase|Physician Decision|0|||
94403226|NCT01513239|323261785|FG000|Period 1: Main Phase|Protocol Violation|2|||
94403227|NCT01513239|323261786|FG001|Period 1: Main Phase|Protocol Violation|2|||
94403228|NCT01513239|323261787|FG002|Period 1: Main Phase|Protocol Violation|2|||
94403229|NCT01513239|323261788|FG003|Period 1: Main Phase|Protocol Violation|0|||
94403230|NCT01513239|323261789|FG004|Period 1: Main Phase|Protocol Violation|0|||
94403231|NCT01513239|323261790|FG005|Period 1: Main Phase|Protocol Violation|0|||
94403232|NCT01513239|323261785|FG000|Period 1: Main Phase|Technical Problems|1|||
94403233|NCT01513239|323261786|FG001|Period 1: Main Phase|Technical Problems|2|||
94403234|NCT01513239|323261787|FG002|Period 1: Main Phase|Technical Problems|0|||
94403235|NCT01513239|323261788|FG003|Period 1: Main Phase|Technical Problems|0|||
94403236|NCT01513239|323261789|FG004|Period 1: Main Phase|Technical Problems|0|||
94403237|NCT01513239|323261790|FG005|Period 1: Main Phase|Technical Problems|0|||
94403238|NCT01513239|323261785|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
94403239|NCT01513239|323261786|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
94403240|NCT01513239|323261787|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
94403241|NCT01513239|323261788|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
94403242|NCT01513239|323261789|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
94403243|NCT01513239|323261790|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
94403244|NCT01513239|323261785|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
94403245|NCT01513239|323261786|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
94403246|NCT01513239|323261787|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
94403247|NCT01513239|323261788|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
94403248|NCT01513239|323261789|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
94403249|NCT01513239|323261790|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
94403250|NCT01513239|323261785|FG000|Period 2: 9 Month Extension Phase|Death|0|||
94403251|NCT01513239|323261786|FG001|Period 2: 9 Month Extension Phase|Death|0|||
94403252|NCT01513239|323261787|FG002|Period 2: 9 Month Extension Phase|Death|0|||
94403253|NCT01513239|323261788|FG003|Period 2: 9 Month Extension Phase|Death|2|||
94403254|NCT01513239|323261789|FG004|Period 2: 9 Month Extension Phase|Death|5|||
94403255|NCT01513239|323261790|FG005|Period 2: 9 Month Extension Phase|Death|2|||
94403256|NCT01513239|323261785|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
94403257|NCT01513239|323261786|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
94403258|NCT01513239|323261787|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
94403259|NCT01513239|323261788|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
94403260|NCT01513239|323261789|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
94403261|NCT01513239|323261790|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
94403262|NCT01513239|323261785|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
94403263|NCT01513239|323261786|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
94403264|NCT01513239|323261787|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
94403265|NCT01513239|323261788|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
94403266|NCT01513239|323261789|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
94403267|NCT01513239|323261790|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
94403268|NCT01513239|323261785|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
94403269|NCT01513239|323261786|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
94403270|NCT01513239|323261787|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
94403271|NCT01513239|323261788|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
94403272|NCT01513239|323261789|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
94403273|NCT01513239|323261790|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
94403274|NCT03540160|323261800|FG000|Overall Study|Protocol Violation|1|||
94403275|NCT03540160|323261800|FG000|Overall Study|Physician Decision|8|||
94403276|NCT03540160|323261800|FG000|Overall Study|Lack of Efficacy|60|||
94403277|NCT03540160|323261800|FG000|Overall Study|Pregnancy|1|||
94403278|NCT03540160|323261800|FG000|Overall Study|Adverse Event|20|||
94403279|NCT03540160|323261800|FG000|Overall Study|Withdrawal by Subject|68|||
94403280|NCT03540160|323261800|FG000|Overall Study|COVID-19|2|||
94403281|NCT03540160|323261800|FG000|Overall Study|Study Closure|10|||
94403282|NCT03540160|323261800|FG000|Overall Study|Lost to Follow-up|18|||
94403283|NCT03540160|323261800|FG000|Overall Study|Sponsor decision|191|||
94403284|NCT01664039|323261802|FG000|Overall Study|Adverse Event|3|||
94403285|NCT01664039|323261803|FG001|Overall Study|Adverse Event|4|||
94403286|NCT01664039|323261802|FG000|Overall Study|Lost to Follow-up|1|||
94403287|NCT01664039|323261803|FG001|Overall Study|Lost to Follow-up|1|||
94403288|NCT01664039|323261802|FG000|Overall Study|Withdrawal by Subject|1|||
94403289|NCT01664039|323261803|FG001|Overall Study|Withdrawal by Subject|3|||
94403290|NCT01664039|323261802|FG000|Overall Study|Noncompliance|1|||
94403291|NCT01664039|323261803|FG001|Overall Study|Noncompliance|1|||
94403292|NCT03314857|323261804|FG000|Overall Study|Death|4|||
94403293|NCT03314857|323261804|FG000|Overall Study|Physician Decision|1|||
94403294|NCT04281472|323261811|FG000|Stage A|Lack of Efficacy|8|||
94403295|NCT04281472|323261812|FG001|Stage A|Lack of Efficacy|0|||
94403296|NCT04281472|323261813|FG002|Stage A|Lack of Efficacy|0|||
94403297|NCT04281472|323261811|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
94403298|NCT04281472|323261812|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
94403299|NCT04281472|323261813|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
94403300|NCT04281472|323261811|FG000|Stage A|Adverse Event|20|||
94403301|NCT04281472|323261812|FG001|Stage A|Adverse Event|0|||
94403302|NCT04281472|323261813|FG002|Stage A|Adverse Event|0|||
94403303|NCT04281472|323261811|FG000|Stage A|Death|1|||
94403304|NCT04281472|323261812|FG001|Stage A|Death|0|||
94403305|NCT04281472|323261813|FG002|Stage A|Death|0|||
94403306|NCT04281472|323261811|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
94403307|NCT04281472|323261812|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
94403308|NCT04281472|323261813|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
94403309|NCT04281472|323261811|FG000|Stage A|Lost to Follow-up|2|||
94403310|NCT04281472|323261812|FG001|Stage A|Lost to Follow-up|0|||
94403311|NCT04281472|323261813|FG002|Stage A|Lost to Follow-up|0|||
94403312|NCT04281472|323261811|FG000|Stage A|Non-compliance with study drug|1|||
94403313|NCT04281472|323261812|FG001|Stage A|Non-compliance with study drug|0|||
94403314|NCT04281472|323261813|FG002|Stage A|Non-compliance with study drug|0|||
94403315|NCT04281472|323261811|FG000|Stage A|Physician Decision|1|||
94403316|NCT04281472|323261812|FG001|Stage A|Physician Decision|0|||
94403317|NCT04281472|323261813|FG002|Stage A|Physician Decision|0|||
94403318|NCT04281472|323261811|FG000|Stage A|Prohibited medications|2|||
94403319|NCT04281472|323261812|FG001|Stage A|Prohibited medications|0|||
94403320|NCT04281472|323261813|FG002|Stage A|Prohibited medications|0|||
94403321|NCT04281472|323261811|FG000|Stage A|Withdrawal by Subject|11|||
94403322|NCT04281472|323261812|FG001|Stage A|Withdrawal by Subject|0|||
94403323|NCT04281472|323261813|FG002|Stage A|Withdrawal by Subject|0|||
94403324|NCT04281472|323261811|FG000|Stage A|Other|5|||
94403325|NCT04281472|323261812|FG001|Stage A|Other|0|||
94403326|NCT04281472|323261813|FG002|Stage A|Other|0|||
94403327|NCT04281472|323261811|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
94403328|NCT04281472|323261812|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
94403329|NCT04281472|323261813|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
94403330|NCT04281472|323261811|FG000|Stage B|Adverse Event|0|||
94403331|NCT04281472|323261812|FG001|Stage B|Adverse Event|3|||
94403332|NCT04281472|323261813|FG002|Stage B|Adverse Event|0|||
94403333|NCT04281472|323261811|FG000|Stage B|Death|0|||
94403334|NCT04281472|323261812|FG001|Stage B|Death|0|||
94403335|NCT04281472|323261813|FG002|Stage B|Death|1|||
94403336|NCT04281472|323261811|FG000|Stage B|Lack of Efficacy|0|||
94403337|NCT04281472|323261812|FG001|Stage B|Lack of Efficacy|0|||
94403338|NCT04281472|323261813|FG002|Stage B|Lack of Efficacy|1|||
94403339|NCT04281472|323261811|FG000|Stage B|Lost to Follow-up|0|||
94403340|NCT04281472|323261812|FG001|Stage B|Lost to Follow-up|0|||
94403341|NCT04281472|323261813|FG002|Stage B|Lost to Follow-up|2|||
94403342|NCT04281472|323261811|FG000|Stage B|Prohibited medications|0|||
94403343|NCT04281472|323261812|FG001|Stage B|Prohibited medications|2|||
94403344|NCT04281472|323261813|FG002|Stage B|Prohibited medications|1|||
94403345|NCT04281472|323261811|FG000|Stage B|Protocol Violation|0|||
94403346|NCT04281472|323261812|FG001|Stage B|Protocol Violation|1|||
94403347|NCT04281472|323261813|FG002|Stage B|Protocol Violation|1|||
94403348|NCT04281472|323261811|FG000|Stage B|Sponsor decision|0|||
94403349|NCT04281472|323261812|FG001|Stage B|Sponsor decision|0|||
94403350|NCT04281472|323261813|FG002|Stage B|Sponsor decision|1|||
94485537|NCT01305564|323570204|FG000|Overall Study|Withdrawal by Subject|1|||
94485538|NCT01305564|323570204|FG000|Overall Study|Physician Decision|3|||
94403351|NCT04281472|323261811|FG000|Stage B|Withdrawal by Subject|0|||
94403352|NCT04281472|323261812|FG001|Stage B|Withdrawal by Subject|3|||
94403353|NCT04281472|323261813|FG002|Stage B|Withdrawal by Subject|3|||
94403354|NCT04281472|323261811|FG000|Stage B|Other|0|||
94403355|NCT04281472|323261812|FG001|Stage B|Other|3|||
94403356|NCT04281472|323261813|FG002|Stage B|Other|0|||
94403357|NCT02640235|323261814|FG000|Overall Study|Withdrawal by Subject|7|||
94403358|NCT02640235|323261815|FG001|Overall Study|Withdrawal by Subject|6|||
94403359|NCT02640235|323261814|FG000|Overall Study|Lost to Follow-up|4|||
94403360|NCT02640235|323261815|FG001|Overall Study|Lost to Follow-up|3|||
94403361|NCT02640235|323261814|FG000|Overall Study|Death|2|||
94403362|NCT02640235|323261815|FG001|Overall Study|Death|3|||
94403363|NCT02640235|323261814|FG000|Overall Study|Other|1|||
94403364|NCT02640235|323261815|FG001|Overall Study|Other|2|||
94403365|NCT02451358|323261816|FG000|Overall Study|Withdrawal by Subject|1|||
94403366|NCT02451358|323261817|FG001|Overall Study|Withdrawal by Subject|1|||
94403367|NCT02451358|323261818|FG002|Overall Study|Withdrawal by Subject|0|||
94403368|NCT02451358|323261819|FG003|Overall Study|Withdrawal by Subject|0|||
94403369|NCT02451358|323261816|FG000|Overall Study|Protocol Violation|0|||
94403370|NCT02451358|323261817|FG001|Overall Study|Protocol Violation|1|||
94403371|NCT02451358|323261818|FG002|Overall Study|Protocol Violation|1|||
94403372|NCT02451358|323261819|FG003|Overall Study|Protocol Violation|0|||
94403373|NCT02761915|323261829|FG000|Overall Study|Death|3|||
94403374|NCT02761915|323261830|FG001|Overall Study|Death|1|||
94403375|NCT02761915|323261831|FG002|Overall Study|Death|1|||
94403376|NCT02761915|323261832|FG003|Overall Study|Death|1|||
94403377|NCT02761915|323261833|FG004|Overall Study|Death|0|||
94403378|NCT02761915|323261834|FG005|Overall Study|Death|1|||
94403379|NCT02761915|323261829|FG000|Overall Study|Withdrawal by Subject|1|||
94403380|NCT02761915|323261830|FG001|Overall Study|Withdrawal by Subject|0|||
94403381|NCT02761915|323261831|FG002|Overall Study|Withdrawal by Subject|0|||
94403382|NCT02761915|323261832|FG003|Overall Study|Withdrawal by Subject|0|||
94403383|NCT02761915|323261833|FG004|Overall Study|Withdrawal by Subject|1|||
94403384|NCT02761915|323261834|FG005|Overall Study|Withdrawal by Subject|2|||
94403385|NCT02761915|323261829|FG000|Overall Study|Disease Progression|0|||
94403386|NCT02761915|323261830|FG001|Overall Study|Disease Progression|0|||
94403387|NCT02761915|323261831|FG002|Overall Study|Disease Progression|0|||
94403388|NCT02761915|323261832|FG003|Overall Study|Disease Progression|2|||
94403389|NCT02761915|323261833|FG004|Overall Study|Disease Progression|2|||
94403390|NCT02761915|323261834|FG005|Overall Study|Disease Progression|2|||
94403391|NCT02611362|323261836|FG000|Overall Study|Withdrawal by Subject|7|||
94403392|NCT02611362|323261837|FG001|Overall Study|Withdrawal by Subject|2|||
94403393|NCT02611362|323261836|FG000|Overall Study|Lost to Follow-up|2|||
94403394|NCT02611362|323261837|FG001|Overall Study|Lost to Follow-up|4|||
94403395|NCT00354159|323261838|FG000|Randomized Study Period|Withdrawal by Subject|5|||
94403396|NCT00354159|323261839|FG001|Randomized Study Period|Withdrawal by Subject|3|||
94403397|NCT00354159|323261838|FG000|Randomized Study Period|Physician Decision|6|||
94403398|NCT00354159|323261839|FG001|Randomized Study Period|Physician Decision|10|||
94403399|NCT00354159|323261838|FG000|Randomized Study Period|Lost to Follow-up|4|||
94403400|NCT00354159|323261839|FG001|Randomized Study Period|Lost to Follow-up|0|||
94403401|NCT00354159|323261838|FG000|Randomized Study Period|Death|7|||
94403402|NCT00354159|323261839|FG001|Randomized Study Period|Death|9|||
94403403|NCT00354159|323261838|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
94403404|NCT00354159|323261839|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
94403405|NCT00354159|323261838|FG000|Long-term Follow-up|Physician Decision|127|||
94403406|NCT00354159|323261839|FG001|Long-term Follow-up|Physician Decision|122|||
94403407|NCT00354159|323261838|FG000|Long-term Follow-up|Lost to Follow-up|1|||
94403408|NCT00354159|323261839|FG001|Long-term Follow-up|Lost to Follow-up|0|||
94403409|NCT00354159|323261838|FG000|Long-term Follow-up|Death|14|||
94403410|NCT00354159|323261839|FG001|Long-term Follow-up|Death|11|||
94403411|NCT00354159|323261838|FG000|Long-term Follow-up|Study Closed|29|||
94403412|NCT00354159|323261839|FG001|Long-term Follow-up|Study Closed|34|||
94403413|NCT02046122|323261840|FG000|Overall Study|Physician Decision|8|||
94403414|NCT02046122|323261840|FG000|Overall Study|Withdrawal by Subject|1|||
94403415|NCT02229084|323261841|FG000|Overall Study|Adverse Event|1|||
94403416|NCT02229084|323261842|FG001|Overall Study|Adverse Event|0|||
94403417|NCT02229084|323261843|FG002|Overall Study|Adverse Event|0|||
94403418|NCT02229084|323261844|FG003|Overall Study|Adverse Event|0|||
94403419|NCT02229084|323261845|FG004|Overall Study|Adverse Event|0|||
94403420|NCT02229084|323261846|FG005|Overall Study|Adverse Event|0|||
94403421|NCT02229084|323261847|FG006|Overall Study|Adverse Event|0|||
94403422|NCT02229084|323261841|FG000|Overall Study|Lost to Follow-up|0|||
94403423|NCT02229084|323261842|FG001|Overall Study|Lost to Follow-up|0|||
94403424|NCT02229084|323261843|FG002|Overall Study|Lost to Follow-up|1|||
94403425|NCT02229084|323261844|FG003|Overall Study|Lost to Follow-up|1|||
94403426|NCT02229084|323261845|FG004|Overall Study|Lost to Follow-up|0|||
94403427|NCT02229084|323261846|FG005|Overall Study|Lost to Follow-up|0|||
94403428|NCT02229084|323261847|FG006|Overall Study|Lost to Follow-up|1|||
94485539|NCT00828711|323570205|FG000|Overall Study|Lost to Follow-up|1|||
94403429|NCT02229084|323261841|FG000|Overall Study|Physician Decision|0|||
94403430|NCT02229084|323261842|FG001|Overall Study|Physician Decision|0|||
94403431|NCT02229084|323261843|FG002|Overall Study|Physician Decision|0|||
94403432|NCT02229084|323261844|FG003|Overall Study|Physician Decision|1|||
94403433|NCT02229084|323261845|FG004|Overall Study|Physician Decision|3|||
94403434|NCT02229084|323261846|FG005|Overall Study|Physician Decision|0|||
94403435|NCT02229084|323261847|FG006|Overall Study|Physician Decision|1|||
94403436|NCT02229084|323261841|FG000|Overall Study|Withdrawal by Subject|0|||
94485540|NCT00828711|323570206|FG001|Overall Study|Lost to Follow-up|0|||
94403437|NCT02229084|323261842|FG001|Overall Study|Withdrawal by Subject|0|||
94403438|NCT02229084|323261843|FG002|Overall Study|Withdrawal by Subject|1|||
94403439|NCT02229084|323261844|FG003|Overall Study|Withdrawal by Subject|0|||
94403440|NCT02229084|323261845|FG004|Overall Study|Withdrawal by Subject|1|||
94403441|NCT02229084|323261846|FG005|Overall Study|Withdrawal by Subject|1|||
94403442|NCT02229084|323261847|FG006|Overall Study|Withdrawal by Subject|1|||
94403443|NCT02229084|323261841|FG000|Overall Study|Death|0|||
94403444|NCT02229084|323261842|FG001|Overall Study|Death|0|||
94403445|NCT02229084|323261843|FG002|Overall Study|Death|0|||
94403446|NCT02229084|323261844|FG003|Overall Study|Death|0|||
94403447|NCT02229084|323261845|FG004|Overall Study|Death|0|||
94403448|NCT02229084|323261846|FG005|Overall Study|Death|0|||
94403449|NCT02229084|323261847|FG006|Overall Study|Death|1|||
94403450|NCT02705716|323261850|FG000|Overall Study|Adverse Event|0|||
94403451|NCT02705716|323261851|FG001|Overall Study|Adverse Event|1|||
94403452|NCT02705716|323261850|FG000|Overall Study|Protocol Violation|3|||
94403453|NCT02705716|323261851|FG001|Overall Study|Protocol Violation|0|||
94403454|NCT02705716|323261850|FG000|Overall Study|Withdrawal of Consent|1|||
94403455|NCT02705716|323261851|FG001|Overall Study|Withdrawal of Consent|1|||
94403456|NCT04535986|323261854|FG000|Overall Study|Death|4|||
94403457|NCT04535986|323261855|FG001|Overall Study|Death|5|||
94403458|NCT04535986|323261854|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
94403459|NCT04535986|323261855|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
94403460|NCT04535986|323261854|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
94403461|NCT04535986|323261855|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
94403462|NCT04535986|323261854|FG000|Overall Study|Adverse Event|10|||
94403463|NCT04535986|323261855|FG001|Overall Study|Adverse Event|1|||
94403464|NCT04535986|323261854|FG000|Overall Study|Lack of Efficacy|3|||
94403465|NCT04535986|323261855|FG001|Overall Study|Lack of Efficacy|2|||
94403466|NCT04535986|323261854|FG000|Overall Study|Investigator discretion|3|||
94403467|NCT04535986|323261855|FG001|Overall Study|Investigator discretion|0|||
94403468|NCT04535986|323261854|FG000|Overall Study|Withdrawal by Subject|32|||
94403469|NCT04535986|323261855|FG001|Overall Study|Withdrawal by Subject|14|||
94403470|NCT04535986|323261854|FG000|Overall Study|Lost to Follow-up|5|||
94403471|NCT04535986|323261855|FG001|Overall Study|Lost to Follow-up|3|||
94403472|NCT04535986|323261854|FG000|Overall Study|Other|7|||
94403473|NCT04535986|323261855|FG001|Overall Study|Other|3|||
94403474|NCT05070754|323261856|FG000|Overall Study|Withdrawal by Subject|0|||
94403475|NCT05070754|323261857|FG001|Overall Study|Withdrawal by Subject|0|||
94403476|NCT05070754|323261858|FG002|Overall Study|Withdrawal by Subject|0|||
94403477|NCT05070754|323261859|FG003|Overall Study|Withdrawal by Subject|1|||
94403478|NCT05070754|323261856|FG000|Overall Study|Protocol Violation|0|||
94403479|NCT05070754|323261857|FG001|Overall Study|Protocol Violation|0|||
94403480|NCT05070754|323261858|FG002|Overall Study|Protocol Violation|0|||
94403481|NCT05070754|323261859|FG003|Overall Study|Protocol Violation|1|||
94403482|NCT00252564|323261860|FG000|Overall Study|Adverse Event|17|||
94403483|NCT00252564|323261861|FG001|Overall Study|Adverse Event|13|||
94403484|NCT00252564|323261860|FG000|Overall Study|Unrelated Complication|2|||
94403485|NCT00252564|323261861|FG001|Overall Study|Unrelated Complication|1|||
94403486|NCT00252564|323261860|FG000|Overall Study|Disease Progression|14|||
94403487|NCT00252564|323261861|FG001|Overall Study|Disease Progression|20|||
94403488|NCT00252564|323261860|FG000|Overall Study|Death|0|||
94403489|NCT00252564|323261861|FG001|Overall Study|Death|3|||
94403490|NCT00252564|323261860|FG000|Overall Study|Physician Decision|1|||
94403491|NCT00252564|323261861|FG001|Overall Study|Physician Decision|0|||
94403492|NCT00252564|323261860|FG000|Overall Study|Lost to Follow-up|1|||
94403493|NCT00252564|323261861|FG001|Overall Study|Lost to Follow-up|0|||
94403494|NCT00252564|323261860|FG000|Overall Study|Patient Request|4|||
94403495|NCT00252564|323261861|FG001|Overall Study|Patient Request|5|||
94403496|NCT00252564|323261860|FG000|Overall Study|Withdrawal by Subject|0|||
94403497|NCT00252564|323261861|FG001|Overall Study|Withdrawal by Subject|2|||
94403498|NCT02096705|323261862|FG000|Treatment|Adverse Event|6|||
94403499|NCT02096705|323261863|FG001|Treatment|Adverse Event|3|||
94403500|NCT02096705|323261862|FG000|Treatment|Subject request to discontinue treatment|1|||
94403501|NCT02096705|323261863|FG001|Treatment|Subject request to discontinue treatment|1|||
94403502|NCT02096705|323261862|FG000|Treatment|Withdrawal by Subject|1|||
94403503|NCT02096705|323261863|FG001|Treatment|Withdrawal by Subject|0|||
94403504|NCT02096705|323261862|FG000|Treatment|Other|1|||
94403505|NCT02096705|323261863|FG001|Treatment|Other|1|||
94403506|NCT02096705|323261862|FG000|Follow-up|Withdrawal by Subject|1|||
94403507|NCT02096705|323261863|FG001|Follow-up|Withdrawal by Subject|0|||
94403508|NCT02096705|323261862|FG000|Follow-up|Adverse Event|2|||
94403509|NCT02096705|323261863|FG001|Follow-up|Adverse Event|2|||
94403510|NCT02096705|323261862|FG000|Follow-up|Subjects not reporting status|1|||
94403511|NCT02096705|323261863|FG001|Follow-up|Subjects not reporting status|2|||
94403512|NCT01993940|323261864|FG000|Overall Study|Adverse Event|16|||
94403513|NCT01993940|323261865|FG001|Overall Study|Adverse Event|11|||
94403514|NCT01993940|323261864|FG000|Overall Study|Withdrawal by Subject|15|||
94403515|NCT01993940|323261865|FG001|Overall Study|Withdrawal by Subject|19|||
94403516|NCT01993940|323261864|FG000|Overall Study|Lost to Follow-up|2|||
94403517|NCT01993940|323261865|FG001|Overall Study|Lost to Follow-up|5|||
94403518|NCT01993940|323261864|FG000|Overall Study|Protocol Violation|5|||
94403519|NCT01993940|323261865|FG001|Overall Study|Protocol Violation|8|||
94403520|NCT01993940|323261864|FG000|Overall Study|Death|1|||
94403521|NCT01993940|323261865|FG001|Overall Study|Death|0|||
94403522|NCT01993940|323261864|FG000|Overall Study|Other - Miscellaneous|1|||
94403523|NCT01993940|323261865|FG001|Overall Study|Other - Miscellaneous|1|||
94403524|NCT03732833|323261866|FG000|Overall Study|Adverse Event|0|||
94403525|NCT03732833|323261867|FG001|Overall Study|Adverse Event|3|||
94403526|NCT03732833|323261868|FG002|Overall Study|Adverse Event|1|||
94403527|NCT03732833|323261866|FG000|Overall Study|Withdrawal by Subject|11|||
94403528|NCT03732833|323261867|FG001|Overall Study|Withdrawal by Subject|13|||
94403529|NCT03732833|323261868|FG002|Overall Study|Withdrawal by Subject|8|||
94403530|NCT03732833|323261866|FG000|Overall Study|Lost to Follow-up|3|||
94403531|NCT03732833|323261867|FG001|Overall Study|Lost to Follow-up|5|||
94403532|NCT03732833|323261868|FG002|Overall Study|Lost to Follow-up|4|||
94403533|NCT03732833|323261866|FG000|Overall Study|Pregnancy|0|||
94403534|NCT03732833|323261867|FG001|Overall Study|Pregnancy|2|||
94403535|NCT03732833|323261868|FG002|Overall Study|Pregnancy|0|||
94403536|NCT03732833|323261866|FG000|Overall Study|Physician Decision|2|||
94403537|NCT03732833|323261867|FG001|Overall Study|Physician Decision|3|||
94403538|NCT03732833|323261868|FG002|Overall Study|Physician Decision|1|||
94403539|NCT03732833|323261866|FG000|Overall Study|Covid-19 related and other reasons|2|||
94403540|NCT03732833|323261867|FG001|Overall Study|Covid-19 related and other reasons|7|||
94403541|NCT03732833|323261868|FG002|Overall Study|Covid-19 related and other reasons|3|||
94403542|NCT04049097|323261870|FG000|Overall Study|Adverse Event|18|||
94403543|NCT04049097|323261870|FG000|Overall Study|Death|2|||
94403544|NCT04049097|323261870|FG000|Overall Study|Lost to Follow-up|1|||
94403545|NCT04049097|323261870|FG000|Overall Study|Physician Decision|2|||
94403546|NCT04049097|323261870|FG000|Overall Study|Withdrawal by Subject|9|||
94403547|NCT04049097|323261870|FG000|Overall Study|Protocol Violation|2|||
94403548|NCT04049097|323261870|FG000|Overall Study|Other|1|||
94403549|NCT04049097|323261870|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
94403550|NCT00537095|323261871|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
94403551|NCT00537095|323261872|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
94403552|NCT00537095|323261871|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
94403553|NCT00537095|323261872|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
94403554|NCT00537095|323261871|FG000|Randomized Treatment Period (433 Days)|Death|3|||
94403555|NCT00537095|323261872|FG001|Randomized Treatment Period (433 Days)|Death|1|||
94403556|NCT00537095|323261871|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
94403557|NCT00537095|323261872|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
94403558|NCT00537095|323261871|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
94403559|NCT00537095|323261872|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
94403560|NCT00537095|323261871|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
94403561|NCT00537095|323261872|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
94403562|NCT00537095|323261871|FG000|Open-label Period (590 Days)|Adverse Event|2|||
94403563|NCT00537095|323261872|FG001|Open-label Period (590 Days)|Adverse Event|11|||
94403564|NCT00537095|323261871|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
94403565|NCT00537095|323261872|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
94403566|NCT00537095|323261871|FG000|Open-label Period (590 Days)|Death|2|||
94403567|NCT00537095|323261872|FG001|Open-label Period (590 Days)|Death|2|||
94403568|NCT00537095|323261871|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
94403569|NCT00537095|323261872|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
94403570|NCT00537095|323261871|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
94403571|NCT00537095|323261872|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
94403572|NCT03193021|323261873|FG000|Overall Study|Lost to Follow-up|1|||
94403573|NCT03193021|323261874|FG001|Overall Study|Lost to Follow-up|1|||
94403574|NCT03196284|323261877|FG000|Main Part|Withdrawal by Subject|0|||
94403575|NCT03196284|323261878|FG001|Main Part|Withdrawal by Subject|1|||
94403576|NCT03196284|323261879|FG002|Main Part|Withdrawal by Subject|0|||
94403577|NCT03196284|323261877|FG000|Extension Part|Lack of Efficacy|0|||
94403578|NCT03196284|323261878|FG001|Extension Part|Lack of Efficacy|0|||
94403579|NCT03196284|323261879|FG002|Extension Part|Lack of Efficacy|1|||
94403580|NCT03196284|323261877|FG000|Extension Part|Withdrawal by Subject|0|||
94403581|NCT03196284|323261878|FG001|Extension Part|Withdrawal by Subject|0|||
94403582|NCT03196284|323261879|FG002|Extension Part|Withdrawal by Subject|1|||
94403583|NCT03196284|323261877|FG000|Extension Part|Physician Decision|0|||
94403584|NCT03196284|323261878|FG001|Extension Part|Physician Decision|0|||
94403585|NCT03196284|323261879|FG002|Extension Part|Physician Decision|1|||
94403586|NCT01675596|323261880|FG000|Overall Study|Death|6|||
94403587|NCT01675596|323261880|FG000|Overall Study|Exit with other reason|1|||
94403588|NCT01675596|323261880|FG000|Overall Study|Missed Visit|1|||
94403589|NCT00087529|323261881|FG000|Overall Study|Death|1|||
94403590|NCT00087529|323261882|FG001|Overall Study|Death|0|||
94403591|NCT00087529|323261881|FG000|Overall Study|Adverse Event|0|||
94403592|NCT00087529|323261882|FG001|Overall Study|Adverse Event|8|||
94403593|NCT00087529|323261881|FG000|Overall Study|Pregnancy|0|||
94403594|NCT00087529|323261882|FG001|Overall Study|Pregnancy|1|||
94403595|NCT00087529|323261881|FG000|Overall Study|Lost to Follow-up|2|||
94403596|NCT00087529|323261882|FG001|Overall Study|Lost to Follow-up|3|||
94403597|NCT00087529|323261881|FG000|Overall Study|Participant Decision|14|||
94403598|NCT00087529|323261882|FG001|Overall Study|Participant Decision|37|||
94403599|NCT00087529|323261881|FG000|Overall Study|Physician Decision|4|||
94403600|NCT00087529|323261882|FG001|Overall Study|Physician Decision|8|||
94403601|NCT00087529|323261881|FG000|Overall Study|Initiation of Excluded Therapy|0|||
94403602|NCT00087529|323261882|FG001|Overall Study|Initiation of Excluded Therapy|1|||
94403603|NCT00087529|323261881|FG000|Overall Study|Participant Noncompliance|0|||
94403604|NCT00087529|323261882|FG001|Overall Study|Participant Noncompliance|1|||
94403605|NCT00087529|323261881|FG000|Overall Study|Disease Progression|5|||
94403606|NCT00087529|323261882|FG001|Overall Study|Disease Progression|4|||
94403607|NCT00087529|323261881|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
94403608|NCT00087529|323261882|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
94403609|NCT01968031|323261888|FG000|Overall Study|Adverse Event|13|||
94403610|NCT01968031|323261889|FG001|Overall Study|Adverse Event|10|||
94403611|NCT01968031|323261890|FG002|Overall Study|Adverse Event|22|||
94403612|NCT01968031|323261888|FG000|Overall Study|Withdrawal by Subject|3|||
94403613|NCT01968031|323261889|FG001|Overall Study|Withdrawal by Subject|7|||
94403614|NCT01968031|323261890|FG002|Overall Study|Withdrawal by Subject|3|||
94403615|NCT01968031|323261888|FG000|Overall Study|Did not meet entry criteria|1|||
94403616|NCT01968031|323261889|FG001|Overall Study|Did not meet entry criteria|1|||
94403617|NCT01968031|323261890|FG002|Overall Study|Did not meet entry criteria|1|||
94403618|NCT01968031|323261888|FG000|Overall Study|Noncompliance|0|||
94403619|NCT01968031|323261889|FG001|Overall Study|Noncompliance|0|||
94403620|NCT01968031|323261890|FG002|Overall Study|Noncompliance|2|||
94403621|NCT01968031|323261888|FG000|Overall Study|Failed inclusion criteria|0|||
94403622|NCT01968031|323261889|FG001|Overall Study|Failed inclusion criteria|2|||
94403623|NCT01968031|323261890|FG002|Overall Study|Failed inclusion criteria|0|||
94403624|NCT01968031|323261888|FG000|Overall Study|Death|0|||
94403625|NCT01968031|323261889|FG001|Overall Study|Death|0|||
94403626|NCT01968031|323261890|FG002|Overall Study|Death|1|||
94403627|NCT01968031|323261888|FG000|Overall Study|Prohibited concomitant medication|1|||
94403628|NCT01968031|323261889|FG001|Overall Study|Prohibited concomitant medication|0|||
94403629|NCT01968031|323261890|FG002|Overall Study|Prohibited concomitant medication|0|||
94403630|NCT00685334|323261895|FG000|Overall Study|Withdrawal by Subject|5|||
94403631|NCT00685334|323261896|FG001|Overall Study|Withdrawal by Subject|6|||
94403632|NCT00685334|323261895|FG000|Overall Study|Lost to Follow-up|4|||
94403633|NCT00685334|323261896|FG001|Overall Study|Lost to Follow-up|0|||
94403634|NCT00685334|323261895|FG000|Overall Study|Chose to enter hospital|1|||
94403635|NCT00685334|323261896|FG001|Overall Study|Chose to enter hospital|1|||
94403636|NCT00724958|323261901|FG000|Overall Study|Adverse Event|28|||
94403637|NCT00724958|323261901|FG000|Overall Study|Loss of Response|40|||
94403638|NCT00724958|323261901|FG000|Overall Study|No Response|18|||
94403639|NCT00724958|323261901|FG000|Overall Study|Remission|7|||
94403640|NCT00724958|323261901|FG000|Overall Study|Other Reason|76|||
94403641|NCT00724958|323261901|FG000|Overall Study|No documentation for end of therapy|13|||
94403642|NCT01109849|323263375|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
94403643|NCT01109849|323263376|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
94403644|NCT01109849|323263377|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
94403645|NCT01109849|323263378|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
94403646|NCT01109849|323263379|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
94403647|NCT01109849|323263375|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
94403648|NCT01109849|323263376|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
94403649|NCT01109849|323263377|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
94403650|NCT01109849|323263378|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
94403651|NCT01109849|323263379|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
94403652|NCT01109849|323263375|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
94403653|NCT01109849|323263376|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
94403654|NCT01109849|323263377|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
94403655|NCT01109849|323263378|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
94403656|NCT01109849|323263379|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
94403657|NCT01109849|323263375|FG000|Initial Randomization: ADHD Treatment|move away|2|||
94403658|NCT01109849|323263376|FG001|Initial Randomization: ADHD Treatment|move away|7|||
94403659|NCT01109849|323263377|FG002|Initial Randomization: ADHD Treatment|move away|0|||
94403660|NCT01109849|323263378|FG003|Initial Randomization: ADHD Treatment|move away|0|||
94403661|NCT01109849|323263379|FG004|Initial Randomization: ADHD Treatment|move away|0|||
94403662|NCT01109849|323263375|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
94403663|NCT01109849|323263376|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
94403664|NCT01109849|323263377|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
94403665|NCT01109849|323263378|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
94403666|NCT01109849|323263379|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
94403667|NCT01109849|323263375|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
94403668|NCT01109849|323263376|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
94403669|NCT01109849|323263377|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
94403670|NCT01109849|323263378|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
94403671|NCT01109849|323263379|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
94403672|NCT00640393|323263389|FG000|Part 1|Lost to Follow-up|2|||
94403673|NCT00640393|323263390|FG001|Part 1|Lost to Follow-up|0|||
94403674|NCT00640393|323263391|FG002|Part 1|Lost to Follow-up|0|||
94403675|NCT00640393|323263389|FG000|Part 1|Withdrawal by Subject|3|||
94403676|NCT00640393|323263390|FG001|Part 1|Withdrawal by Subject|0|||
94403677|NCT00640393|323263391|FG002|Part 1|Withdrawal by Subject|0|||
94403678|NCT00640393|323263389|FG000|Randomization|Withdrawn per protocol|17|||
94403679|NCT00640393|323263390|FG001|Randomization|Withdrawn per protocol|0|||
94403680|NCT00640393|323263391|FG002|Randomization|Withdrawn per protocol|0|||
94403681|NCT00640393|323263389|FG000|Randomization|Never randomized by site|2|||
94403682|NCT00640393|323263390|FG001|Randomization|Never randomized by site|0|||
94403683|NCT00640393|323263391|FG002|Randomization|Never randomized by site|0|||
94403684|NCT00640393|323263389|FG000|Part 2|Lost to Follow-up|0|||
94403685|NCT00640393|323263390|FG001|Part 2|Lost to Follow-up|2|||
94403686|NCT00640393|323263391|FG002|Part 2|Lost to Follow-up|2|||
94403687|NCT00640393|323263389|FG000|Part 2|Withdrawal by Subject|0|||
94403688|NCT00640393|323263390|FG001|Part 2|Withdrawal by Subject|6|||
94403689|NCT00640393|323263391|FG002|Part 2|Withdrawal by Subject|1|||
94403690|NCT00640393|323263389|FG000|Part 2|Non-adherence|0|||
94403691|NCT00640393|323263390|FG001|Part 2|Non-adherence|1|||
94403692|NCT00640393|323263391|FG002|Part 2|Non-adherence|0|||
94403693|NCT00640393|323263389|FG000|Part 2|Adverse Event|0|||
94403694|NCT00640393|323263390|FG001|Part 2|Adverse Event|1|||
94403695|NCT00640393|323263391|FG002|Part 2|Adverse Event|0|||
94403696|NCT02587143|323263395|FG000|Overall Study|Adverse Event|1|||
94403697|NCT02587143|323263396|FG001|Overall Study|Adverse Event|0|||
94403698|NCT05004649|323263397|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
94403699|NCT05004649|323263397|FG000|Overall Study|Lost to Follow-up|1|||
94403700|NCT05004649|323263397|FG000|Overall Study|Withdrawal by Subject|2|||
94403701|NCT05004649|323263397|FG000|Overall Study|COVID-19|1|||
94403702|NCT03504085|323263399|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
94403703|NCT03504085|323263400|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
94403704|NCT03504085|323263399|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
94403705|NCT03504085|323263400|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
94403706|NCT02654145|323263407|FG000|Overall Study|Lack of Efficacy|1|||
94403707|NCT02654145|323263407|FG000|Overall Study|Protocol Violation|1|||
94403708|NCT02654145|323263407|FG000|Overall Study|Withdrawal by Subject|5|||
94403709|NCT00009945|323263408|FG000|Overall Study|no follow up data|7|||
94403710|NCT00009945|323263409|FG001|Overall Study|no follow up data|5|||
94403711|NCT01943435|323263412|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
94403712|NCT01943435|323263413|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
94403713|NCT01943435|323263414|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
94403714|NCT01943435|323263412|FG000|Intervention Period|Withdrawal by Subject|3|||
94403715|NCT01943435|323263413|FG001|Intervention Period|Withdrawal by Subject|3|||
94403716|NCT01943435|323263414|FG002|Intervention Period|Withdrawal by Subject|4|||
94403717|NCT01943435|323263412|FG000|2 Month Follow up|Lost to Follow-up|2|||
94403718|NCT01943435|323263413|FG001|2 Month Follow up|Lost to Follow-up|3|||
94403719|NCT01943435|323263414|FG002|2 Month Follow up|Lost to Follow-up|0|||
94403720|NCT01943435|323263412|FG000|6 Month Follow up|Lost to Follow-up|12|||
94403721|NCT01943435|323263413|FG001|6 Month Follow up|Lost to Follow-up|7|||
94403722|NCT01943435|323263414|FG002|6 Month Follow up|Lost to Follow-up|15|||
94403723|NCT00295490|323263415|FG000|Overall Study|Protocol Violation|0|||
94403724|NCT00295490|323263416|FG001|Overall Study|Protocol Violation|0|||
94403725|NCT00295490|323263417|FG002|Overall Study|Protocol Violation|3|||
94403726|NCT00295490|323263418|FG003|Overall Study|Protocol Violation|3|||
94403727|NCT00295490|323263415|FG000|Overall Study|Withdrawal by Subject|0|||
94403728|NCT00295490|323263416|FG001|Overall Study|Withdrawal by Subject|2|||
94403729|NCT00295490|323263417|FG002|Overall Study|Withdrawal by Subject|0|||
94403730|NCT00295490|323263418|FG003|Overall Study|Withdrawal by Subject|1|||
94403731|NCT00295490|323263415|FG000|Overall Study|Lost to Follow-up|0|||
94403732|NCT00295490|323263416|FG001|Overall Study|Lost to Follow-up|0|||
94403733|NCT00295490|323263417|FG002|Overall Study|Lost to Follow-up|1|||
94403734|NCT00295490|323263418|FG003|Overall Study|Lost to Follow-up|0|||
94403735|NCT00295490|323263415|FG000|Overall Study|Adverse Event|1|||
94403736|NCT00295490|323263416|FG001|Overall Study|Adverse Event|0|||
94403737|NCT00295490|323263417|FG002|Overall Study|Adverse Event|0|||
94403738|NCT00295490|323263418|FG003|Overall Study|Adverse Event|0|||
94403739|NCT00295490|323263415|FG000|Overall Study|Other|0|||
94403740|NCT00295490|323263416|FG001|Overall Study|Other|2|||
94403741|NCT00295490|323263417|FG002|Overall Study|Other|0|||
94403742|NCT00295490|323263418|FG003|Overall Study|Other|1|||
94403743|NCT01597791|323263423|FG000|Overall Study|Physician Decision|2|||
94403744|NCT01597791|323263424|FG001|Overall Study|Physician Decision|1|||
94403745|NCT01597791|323263423|FG000|Overall Study|Cesarean Section|6|||
94403746|NCT01597791|323263424|FG001|Overall Study|Cesarean Section|7|||
94403747|NCT01597791|323263423|FG000|Overall Study|Subject withdrawal|0|||
94403748|NCT01597791|323263424|FG001|Overall Study|Subject withdrawal|1|||
94403749|NCT01597791|323263423|FG000|Overall Study|Protocol Violation|0|||
94403750|NCT01597791|323263424|FG001|Overall Study|Protocol Violation|1|||
94403751|NCT01155531|323263425|FG000|Overall Study|Adverse Event|0|||
94403752|NCT01155531|323263426|FG001|Overall Study|Adverse Event|0|||
94403753|NCT01155531|323263427|FG002|Overall Study|Adverse Event|1|||
94403754|NCT01155531|323263428|FG003|Overall Study|Adverse Event|0|||
94403755|NCT01155531|323263425|FG000|Overall Study|Lost to Follow-up|0|||
94403756|NCT01155531|323263426|FG001|Overall Study|Lost to Follow-up|0|||
94403757|NCT01155531|323263427|FG002|Overall Study|Lost to Follow-up|0|||
94403758|NCT01155531|323263428|FG003|Overall Study|Lost to Follow-up|1|||
94403759|NCT01155531|323263425|FG000|Overall Study|Withdrawal by Subject|1|||
94403760|NCT01155531|323263426|FG001|Overall Study|Withdrawal by Subject|0|||
94403761|NCT01155531|323263427|FG002|Overall Study|Withdrawal by Subject|1|||
94403762|NCT01155531|323263428|FG003|Overall Study|Withdrawal by Subject|0|||
94403763|NCT01344018|323263429|FG000|Overall Study|Death|22|||
94403764|NCT01344018|323263430|FG001|Overall Study|Death|25|||
94403765|NCT01344018|323263429|FG000|Overall Study|Lost to Follow-up|4|||
94403766|NCT01344018|323263430|FG001|Overall Study|Lost to Follow-up|7|||
94403767|NCT03141151|323263438|FG000|Overall Study|Lost to Follow-up|3|||
94403768|NCT03141151|323263439|FG001|Overall Study|Lost to Follow-up|2|||
94403769|NCT03141151|323263438|FG000|Overall Study|Withdrawal by Subject|3|||
94403770|NCT03141151|323263439|FG001|Overall Study|Withdrawal by Subject|2|||
94403771|NCT01670097|323263442|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
94403772|NCT01670097|323263443|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
94403773|NCT01670097|323263442|FG000|Overall Study|Study burden|1|||
94403774|NCT01670097|323263443|FG001|Overall Study|Study burden|0|||
94403775|NCT01670097|323263442|FG000|Overall Study|COPD exacerbation|0|||
94403776|NCT01670097|323263443|FG001|Overall Study|COPD exacerbation|1|||
94403777|NCT01670097|323263442|FG000|Overall Study|Neutropenia|0|||
94403778|NCT01670097|323263443|FG001|Overall Study|Neutropenia|1|||
94403779|NCT01670097|323263442|FG000|Overall Study|Clinical deterioration|0|||
94403780|NCT01670097|323263443|FG001|Overall Study|Clinical deterioration|1|||
94403781|NCT01670097|323263442|FG000|Overall Study|Disease progression|0|||
94403782|NCT01670097|323263443|FG001|Overall Study|Disease progression|1|||
94403783|NCT00697827|323263444|FG000|Overall Study|enrolled but not treated|2|||
94403784|NCT00697827|323263445|FG001|Overall Study|enrolled but not treated|1|||
94403785|NCT02166606|323263446|FG000|Overall Study|Adverse Event|3|||
94403786|NCT02166606|323263446|FG000|Overall Study|Death|31|||
94403787|NCT02166606|323263446|FG000|Overall Study|Protocol Violation|7|||
94403788|NCT02166606|323263446|FG000|Overall Study|Lost to Follow-up|30|||
94403789|NCT02166606|323263446|FG000|Overall Study|Withdrawal by Subject|1|||
94403790|NCT02166606|323263446|FG000|Overall Study|Physician Decision|1|||
94403791|NCT02166606|323263446|FG000|Overall Study|Device upgrade|1|||
94403792|NCT02166606|323263446|FG000|Overall Study|Enrolled after End of Enrollment|4|||
94403793|NCT02311894|323263447|FG000|Overall Study|Discontinued in error|1|||
94403794|NCT02311894|323263447|FG000|Overall Study|Lost to Follow-up|1|||
94403795|NCT02311894|323263447|FG000|Overall Study|Adverse Event|1|||
94403796|NCT02311894|323263447|FG000|Overall Study|Withdrawal by Subject|1|||
94403797|NCT02472639|323263448|FG000|Overall Study|Physician Decision|4|||
94403798|NCT02472639|323263449|FG001|Overall Study|Physician Decision|3|||
94403799|NCT01691612|323263450|FG000|Overall Study|deemed ineligible after 1st visit|6|||
94403800|NCT01691612|323263450|FG000|Overall Study|Adverse Event|1|||
94403801|NCT01726803|323263451|FG000|Overall Study|Lost to Follow-up|6|||
94403802|NCT01726803|323263452|FG001|Overall Study|Lost to Follow-up|1|||
94403803|NCT01726803|323263451|FG000|Overall Study|Withdrawal by Subject|1|||
94403804|NCT01726803|323263452|FG001|Overall Study|Withdrawal by Subject|0|||
94403805|NCT01685008|323263453|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
94403806|NCT01685008|323263454|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
94403807|NCT01685008|323263455|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
94403808|NCT01685008|323263456|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
94403809|NCT01685008|323263453|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
94403810|NCT01685008|323263454|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
94403811|NCT01685008|323263455|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
94403812|NCT01685008|323263456|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
94403813|NCT01685008|323263453|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
94403814|NCT01685008|323263454|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
94403815|NCT01685008|323263455|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
94403816|NCT01685008|323263456|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
94403817|NCT01685008|323263453|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
94403818|NCT01685008|323263454|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
94403819|NCT01685008|323263455|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
94403820|NCT01685008|323263456|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
94403821|NCT01685008|323263453|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
94403822|NCT01685008|323263454|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
94403823|NCT01685008|323263455|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
94403824|NCT01685008|323263456|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
94403825|NCT01971645|323263457|FG000|Overall Study|Adverse Event|1|||
94403826|NCT01971645|323263458|FG001|Overall Study|Adverse Event|0|||
94485541|NCT00828711|323570207|FG002|Overall Study|Lost to Follow-up|0|||
94485542|NCT03191552|323570209|FG000|Overall Study|Lost to Follow-up|1|||
94403827|NCT01971645|323263459|FG002|Overall Study|Adverse Event|0|||
94403828|NCT01971645|323263457|FG000|Overall Study|Lost to Follow-up|1|||
94403829|NCT01971645|323263458|FG001|Overall Study|Lost to Follow-up|0|||
94403830|NCT01971645|323263459|FG002|Overall Study|Lost to Follow-up|1|||
94403831|NCT01971645|323263457|FG000|Overall Study|Protocol Violation|0|||
94403832|NCT01971645|323263458|FG001|Overall Study|Protocol Violation|0|||
94403833|NCT01971645|323263459|FG002|Overall Study|Protocol Violation|1|||
94403834|NCT00715676|323263468|FG000|Overall Study|Adverse Event|3|||
94403835|NCT00715676|323263469|FG001|Overall Study|Adverse Event|5|||
94403836|NCT00715676|323263470|FG002|Overall Study|Adverse Event|21|||
94403837|NCT00715676|323263468|FG000|Overall Study|Withdrawal by Subject|1|||
94403838|NCT00715676|323263469|FG001|Overall Study|Withdrawal by Subject|3|||
94403839|NCT00715676|323263470|FG002|Overall Study|Withdrawal by Subject|8|||
94403840|NCT00715676|323263468|FG000|Overall Study|Lost to Follow-up|1|||
94403841|NCT00715676|323263469|FG001|Overall Study|Lost to Follow-up|2|||
94403842|NCT00715676|323263470|FG002|Overall Study|Lost to Follow-up|1|||
94403843|NCT00715676|323263468|FG000|Overall Study|Terminated by Sponsor|1|||
94403844|NCT00715676|323263469|FG001|Overall Study|Terminated by Sponsor|0|||
94403845|NCT00715676|323263470|FG002|Overall Study|Terminated by Sponsor|0|||
94403846|NCT00715676|323263468|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
94403847|NCT00715676|323263469|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
94403848|NCT00715676|323263470|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
94403849|NCT00715676|323263468|FG000|Overall Study|Use of Exclusionary Medication|0|||
94403850|NCT00715676|323263469|FG001|Overall Study|Use of Exclusionary Medication|0|||
94403851|NCT00715676|323263470|FG002|Overall Study|Use of Exclusionary Medication|1|||
94403852|NCT00715676|323263468|FG000|Overall Study|Elevated Blood Glucose|0|||
94403853|NCT00715676|323263469|FG001|Overall Study|Elevated Blood Glucose|1|||
94403854|NCT00715676|323263470|FG002|Overall Study|Elevated Blood Glucose|0|||
94403855|NCT01970592|323263471|FG000|Overall Study|Withdrawal by Subject|4|||
94403856|NCT01970592|323263471|FG000|Overall Study|Physician Decision|1|||
94403857|NCT01970592|323263471|FG000|Overall Study|Adverse Event|1|||
94403858|NCT01320722|323263472|FG000|Overall Study|Did not Receive Intervention|3|||
94403859|NCT01320722|323263473|FG001|Overall Study|Did not Receive Intervention|2|||
94403860|NCT01320722|323263474|FG002|Overall Study|Did not Receive Intervention|1|||
94403861|NCT01320722|323263475|FG003|Overall Study|Did not Receive Intervention|1|||
94403862|NCT01320722|323263476|FG004|Overall Study|Did not Receive Intervention|2|||
94403863|NCT01320722|323263472|FG000|Overall Study|Lost to Follow-up|0|||
94403864|NCT01320722|323263473|FG001|Overall Study|Lost to Follow-up|1|||
94403865|NCT01320722|323263474|FG002|Overall Study|Lost to Follow-up|0|||
94403866|NCT01320722|323263475|FG003|Overall Study|Lost to Follow-up|1|||
94403867|NCT01320722|323263476|FG004|Overall Study|Lost to Follow-up|3|||
94403868|NCT01320722|323263472|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
94403869|NCT01320722|323263473|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
94403870|NCT01320722|323263474|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
94403871|NCT01320722|323263475|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
94403872|NCT01320722|323263476|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
94403873|NCT01320722|323263472|FG000|Overall Study|Participant Developed a Rash|0|||
94403874|NCT01320722|323263473|FG001|Overall Study|Participant Developed a Rash|0|||
94403875|NCT01320722|323263474|FG002|Overall Study|Participant Developed a Rash|2|||
94403876|NCT01320722|323263475|FG003|Overall Study|Participant Developed a Rash|1|||
94403877|NCT01320722|323263476|FG004|Overall Study|Participant Developed a Rash|1|||
94403878|NCT01320722|323263472|FG000|Overall Study|Non-compliant with Medication|0|||
94403879|NCT01320722|323263473|FG001|Overall Study|Non-compliant with Medication|0|||
94403880|NCT01320722|323263474|FG002|Overall Study|Non-compliant with Medication|1|||
94403881|NCT01320722|323263475|FG003|Overall Study|Non-compliant with Medication|0|||
94403882|NCT01320722|323263476|FG004|Overall Study|Non-compliant with Medication|0|||
94403883|NCT01320722|323263472|FG000|Overall Study|Adverse Event|0|||
94403884|NCT01320722|323263473|FG001|Overall Study|Adverse Event|0|||
94403885|NCT01320722|323263474|FG002|Overall Study|Adverse Event|3|||
94403886|NCT01320722|323263475|FG003|Overall Study|Adverse Event|6|||
94403887|NCT01320722|323263476|FG004|Overall Study|Adverse Event|0|||
94403888|NCT01320722|323263472|FG000|Overall Study|Not Compliant with Study Procedures|0|||
94403889|NCT01320722|323263473|FG001|Overall Study|Not Compliant with Study Procedures|0|||
94485543|NCT03191552|323570210|FG001|Overall Study|Lost to Follow-up|0|||
94403890|NCT01320722|323263474|FG002|Overall Study|Not Compliant with Study Procedures|0|||
94403891|NCT01320722|323263475|FG003|Overall Study|Not Compliant with Study Procedures|4|||
94403892|NCT01320722|323263476|FG004|Overall Study|Not Compliant with Study Procedures|0|||
94403893|NCT01320722|323263472|FG000|Overall Study|Pregnancy|0|||
94403894|NCT01320722|323263473|FG001|Overall Study|Pregnancy|0|||
94403895|NCT01320722|323263474|FG002|Overall Study|Pregnancy|0|||
94403896|NCT01320722|323263475|FG003|Overall Study|Pregnancy|1|||
94403897|NCT01320722|323263476|FG004|Overall Study|Pregnancy|0|||
94403898|NCT01320722|323263472|FG000|Overall Study|Started an Exclusionary Medication|0|||
94403899|NCT01320722|323263473|FG001|Overall Study|Started an Exclusionary Medication|0|||
94403900|NCT01320722|323263474|FG002|Overall Study|Started an Exclusionary Medication|0|||
94403901|NCT01320722|323263475|FG003|Overall Study|Started an Exclusionary Medication|0|||
94403902|NCT01320722|323263476|FG004|Overall Study|Started an Exclusionary Medication|1|||
94403903|NCT01320722|323263472|FG000|Overall Study|Withdrew due to Health Condition|0|||
94403904|NCT01320722|323263473|FG001|Overall Study|Withdrew due to Health Condition|0|||
94403905|NCT01320722|323263474|FG002|Overall Study|Withdrew due to Health Condition|0|||
94403906|NCT01320722|323263475|FG003|Overall Study|Withdrew due to Health Condition|0|||
94403907|NCT01320722|323263476|FG004|Overall Study|Withdrew due to Health Condition|1|||
94403908|NCT03980522|323263477|FG000|Treatment Period|Adverse Event|1|||
94403909|NCT03980522|323263478|FG001|Treatment Period|Adverse Event|0|||
94403910|NCT03980522|323263479|FG002|Treatment Period|Adverse Event|0|||
94403911|NCT03980522|323263480|FG003|Treatment Period|Adverse Event|0|||
94403912|NCT03980522|323263481|FG004|Treatment Period|Adverse Event|0|||
94403913|NCT02896296|323263482|FG000|Overall Study|Adverse Event|1|||
94403914|NCT02896296|323263482|FG000|Overall Study|Lost to Follow-up|19|||
94403915|NCT02896296|323263482|FG000|Overall Study|Pregnancy|1|||
94403916|NCT02896296|323263482|FG000|Overall Study|Physician Decision|2|||
94403917|NCT02896296|323263482|FG000|Overall Study|Withdrawal by Subject|10|||
94403918|NCT02896296|323263482|FG000|Overall Study|Site closing|7|||
94403919|NCT02896296|323263482|FG000|Overall Study|Incarceration|1|||
94403920|NCT02896296|323263482|FG000|Overall Study|Relocation|1|||
94403921|NCT02616380|323263486|FG000|Overall Study|Lost to Follow-up|1|||
94403922|NCT02616380|323263486|FG000|Overall Study|Other|2|||
94403923|NCT00024258|323263487|FG000|Overall Study|Withdrawal by Subject|1|||
94403924|NCT00024258|323263487|FG000|Overall Study|Disease Progression|8|||
94403925|NCT01929681|323263495|FG000|Overall Study|Withdrawal by Subject|1|||
94403926|NCT01929681|323263496|FG001|Overall Study|Withdrawal by Subject|0|||
94403927|NCT01929681|323263495|FG000|Overall Study|Physician Decision|1|||
94403928|NCT01929681|323263496|FG001|Overall Study|Physician Decision|1|||
94403929|NCT00494013|323263499|FG000|Overall Study|Adverse Event|0|||
94403930|NCT00494013|323263500|FG001|Overall Study|Adverse Event|1|||
94403931|NCT00494013|323263499|FG000|Overall Study|Entry Criteria Not Met|1|||
94403932|NCT00494013|323263500|FG001|Overall Study|Entry Criteria Not Met|4|||
94403933|NCT00494013|323263499|FG000|Overall Study|Lost to Follow-up|5|||
94403934|NCT00494013|323263500|FG001|Overall Study|Lost to Follow-up|6|||
94403935|NCT00494013|323263499|FG000|Overall Study|Physician Decision|3|||
94403936|NCT00494013|323263500|FG001|Overall Study|Physician Decision|5|||
94403937|NCT00494013|323263499|FG000|Overall Study|Protocol Violation|8|||
94403938|NCT00494013|323263500|FG001|Overall Study|Protocol Violation|5|||
94403939|NCT00494013|323263499|FG000|Overall Study|Withdrawal by Subject|13|||
94403940|NCT00494013|323263500|FG001|Overall Study|Withdrawal by Subject|14|||
94403941|NCT00494013|323263499|FG000|Overall Study|Sponsor Decision|0|||
94403942|NCT00494013|323263500|FG001|Overall Study|Sponsor Decision|1|||
94403943|NCT04553406|323263501|FG000|Overall Study|Study Discontinuation|0|||
94403944|NCT04553406|323263502|FG001|Overall Study|Study Discontinuation|1|||
94403945|NCT01374451|323263503|FG000|Overall Study|Administrative problems|1|||
94403946|NCT01374451|323263504|FG001|Overall Study|Administrative problems|0|||
94403947|NCT01992094|323263505|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
94403948|NCT01992094|323263506|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
94403949|NCT01992094|323263507|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
94403950|NCT01992094|323263505|FG000|Overall Study|Adverse Event|1|||
94485544|NCT03191552|323570211|FG002|Overall Study|Lost to Follow-up|0|||
94485545|NCT03191552|323570209|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
94485546|NCT03191552|323570210|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
94485547|NCT03191552|323570211|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
94403951|NCT01992094|323263506|FG001|Overall Study|Adverse Event|0|||
94403952|NCT01992094|323263507|FG002|Overall Study|Adverse Event|0|||
94403953|NCT01992094|323263505|FG000|Overall Study|Death|5|||
94403954|NCT01992094|323263506|FG001|Overall Study|Death|5|||
94403955|NCT01992094|323263507|FG002|Overall Study|Death|2|||
94403956|NCT01992094|323263505|FG000|Overall Study|Lost to Follow-up|26|||
94403957|NCT01992094|323263506|FG001|Overall Study|Lost to Follow-up|9|||
94403958|NCT01992094|323263507|FG002|Overall Study|Lost to Follow-up|13|||
94403959|NCT01992094|323263505|FG000|Overall Study|OTHER|4|||
94403960|NCT01992094|323263506|FG001|Overall Study|OTHER|0|||
94403961|NCT01992094|323263507|FG002|Overall Study|OTHER|0|||
94403962|NCT01992094|323263505|FG000|Overall Study|Protocol Violation|1|||
94403963|NCT01992094|323263506|FG001|Overall Study|Protocol Violation|0|||
94403964|NCT01992094|323263507|FG002|Overall Study|Protocol Violation|1|||
94403965|NCT01992094|323263505|FG000|Overall Study|Withdrawal by Subject|7|||
94403966|NCT01992094|323263506|FG001|Overall Study|Withdrawal by Subject|3|||
94403967|NCT01992094|323263507|FG002|Overall Study|Withdrawal by Subject|4|||
94403968|NCT04428645|323263508|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
94403969|NCT01891357|323263509|FG000|Overall Study|Protocol Violation|3|||
94403970|NCT03201003|323263513|FG000|Overall Study|Adverse Event|14|||
94403971|NCT03201003|323263514|FG001|Overall Study|Adverse Event|1|||
94403972|NCT03201003|323263513|FG000|Overall Study|Other reasons|5|||
94403973|NCT03201003|323263514|FG001|Overall Study|Other reasons|1|||
94403974|NCT03201003|323263513|FG000|Overall Study|Withdrawal by Subject|4|||
94403975|NCT03201003|323263514|FG001|Overall Study|Withdrawal by Subject|1|||
94403976|NCT03201003|323263513|FG000|Overall Study|Lost to Follow-up|2|||
94403977|NCT03201003|323263514|FG001|Overall Study|Lost to Follow-up|0|||
94403978|NCT03201003|323263513|FG000|Overall Study|Protocol Violation|1|||
94403979|NCT03201003|323263514|FG001|Overall Study|Protocol Violation|0|||
94403980|NCT00834613|323263515|FG000|First Intervention|Protocol Violation|1|||
94403981|NCT00834613|323263516|FG001|First Intervention|Protocol Violation|0|||
94403982|NCT00663234|323263517|FG000|Overall Study|Not willing to adhere to requirements|1|||
94403983|NCT01751087|323263520|FG000|Overall Study|Withdrawal by Subject|1|||
94403984|NCT01751087|323263521|FG001|Overall Study|Withdrawal by Subject|0|||
94403985|NCT01751087|323263522|FG002|Overall Study|Withdrawal by Subject|0|||
94403986|NCT01751087|323263520|FG000|Overall Study|Physician Decision|0|||
94403987|NCT01751087|323263521|FG001|Overall Study|Physician Decision|0|||
94403988|NCT01751087|323263522|FG002|Overall Study|Physician Decision|1|||
94403989|NCT00697619|323263523|FG000|Overall Study|Lack of Efficacy|2|||
94403990|NCT00697619|323263524|FG001|Overall Study|Lack of Efficacy|2|||
94403991|NCT00697619|323263523|FG000|Overall Study|Adverse Event|4|||
94403992|NCT00697619|323263524|FG001|Overall Study|Adverse Event|6|||
94403993|NCT00640341|323265683|FG000|Overall Study|Adverse Event|0|||
94403994|NCT00640341|323265684|FG001|Overall Study|Adverse Event|0|||
94403995|NCT00640341|323265685|FG002|Overall Study|Adverse Event|1|||
94403996|NCT00640341|323265683|FG000|Overall Study|Positive Slit Lamp Findings|0|||
94403997|NCT00640341|323265684|FG001|Overall Study|Positive Slit Lamp Findings|0|||
94403998|NCT00640341|323265685|FG002|Overall Study|Positive Slit Lamp Findings|1|||
94403999|NCT00640341|323265683|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
94404000|NCT00640341|323265684|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
94404001|NCT00640341|323265685|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
94404002|NCT00640341|323265683|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
94404003|NCT00640341|323265684|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
94404004|NCT00640341|323265685|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
94404005|NCT00640341|323265683|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
94404006|NCT00640341|323265684|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
94404007|NCT00640341|323265685|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
94404008|NCT00640341|323265683|FG000|Overall Study|Lost to Follow-up|2|||
94404009|NCT00640341|323265684|FG001|Overall Study|Lost to Follow-up|0|||
94404010|NCT00640341|323265685|FG002|Overall Study|Lost to Follow-up|0|||
94404011|NCT00640341|323265683|FG000|Overall Study|Withdrawal by Subject|4|||
94404012|NCT00640341|323265684|FG001|Overall Study|Withdrawal by Subject|0|||
94404013|NCT00640341|323265685|FG002|Overall Study|Withdrawal by Subject|1|||
94404014|NCT00640341|323265683|FG000|Overall Study|Unacceptable Lens Movement|1|||
94404015|NCT00640341|323265684|FG001|Overall Study|Unacceptable Lens Movement|0|||
94404016|NCT00640341|323265685|FG002|Overall Study|Unacceptable Lens Movement|0|||
94404017|NCT00640341|323265683|FG000|Overall Study|Poor fit/Uncomfortable|4|||
94404018|NCT00640341|323265684|FG001|Overall Study|Poor fit/Uncomfortable|0|||
94404019|NCT00640341|323265685|FG002|Overall Study|Poor fit/Uncomfortable|0|||
94404020|NCT00640341|323265683|FG000|Overall Study|Ineligable at Baseline|5|||
94404021|NCT00640341|323265684|FG001|Overall Study|Ineligable at Baseline|3|||
94404022|NCT00640341|323265685|FG002|Overall Study|Ineligable at Baseline|2|||
94404023|NCT00640341|323265683|FG000|Overall Study|Adverse event and positive slit lamp|1|||
94404024|NCT00640341|323265684|FG001|Overall Study|Adverse event and positive slit lamp|0|||
94404025|NCT00640341|323265685|FG002|Overall Study|Adverse event and positive slit lamp|0|||
94404026|NCT01894230|323265687|FG000|Overall Study|Lost to Follow-up|2|||
94404027|NCT01894230|323265688|FG001|Overall Study|Lost to Follow-up|2|||
94404028|NCT01894230|323265687|FG000|Overall Study|Withdrawal by Subject|4|||
94404029|NCT01894230|323265688|FG001|Overall Study|Withdrawal by Subject|4|||
94404030|NCT01894230|323265687|FG000|Overall Study|Non-adherent|0|||
94404031|NCT01894230|323265688|FG001|Overall Study|Non-adherent|1|||
94404032|NCT01894230|323265687|FG000|Overall Study|Death|1|||
94404033|NCT01894230|323265688|FG001|Overall Study|Death|0|||
94404034|NCT00660387|323265695|FG000|Overall Study|Adverse Event|1|||
94404035|NCT00660387|323265696|FG001|Overall Study|Adverse Event|2|||
94404036|NCT00660387|323265695|FG000|Overall Study|Lack of Efficacy|0|||
94404037|NCT00660387|323265696|FG001|Overall Study|Lack of Efficacy|1|||
94404038|NCT00660387|323265695|FG000|Overall Study|Protocol Violation|1|||
94404039|NCT00660387|323265696|FG001|Overall Study|Protocol Violation|0|||
94404040|NCT04729101|323265697|FG000|Overall Study|Adverse Event|1|||
94404041|NCT04729101|323265698|FG001|Overall Study|Adverse Event|0|||
94404042|NCT04729101|323265697|FG000|Overall Study|Physician Decision|1|||
94404043|NCT04729101|323265698|FG001|Overall Study|Physician Decision|0|||
94404044|NCT04729101|323265697|FG000|Overall Study|Withdrawal by Subject|1|||
94404045|NCT04729101|323265698|FG001|Overall Study|Withdrawal by Subject|0|||
94404046|NCT02302716|323265701|FG000|Overall Study|Adverse Event|1|||
94404047|NCT02302716|323265702|FG001|Overall Study|Adverse Event|1|||
94404048|NCT02302716|323265701|FG000|Overall Study|Death|0|||
94404049|NCT02302716|323265702|FG001|Overall Study|Death|1|||
94404050|NCT02302716|323265701|FG000|Overall Study|Lack of Efficacy|0|||
94404051|NCT02302716|323265702|FG001|Overall Study|Lack of Efficacy|1|||
94404052|NCT02302716|323265701|FG000|Overall Study|Lost to Follow-up|2|||
94404053|NCT02302716|323265702|FG001|Overall Study|Lost to Follow-up|4|||
94404054|NCT02302716|323265701|FG000|Overall Study|Physician Decision|3|||
94404055|NCT02302716|323265702|FG001|Overall Study|Physician Decision|4|||
94404056|NCT02302716|323265701|FG000|Overall Study|Withdrawal by Subject|13|||
94404057|NCT02302716|323265702|FG001|Overall Study|Withdrawal by Subject|7|||
94404058|NCT02302716|323265701|FG000|Overall Study|Protocol Violation|0|||
94404059|NCT02302716|323265702|FG001|Overall Study|Protocol Violation|1|||
94404060|NCT01662024|323265703|FG000|Overall Study|Pregnancy|2|||
94404061|NCT01662024|323265703|FG000|Overall Study|Withdrawal by Subject|3|||
94404062|NCT04364854|323265704|FG000|Overall Study|Withdrawal by Subject|1|||
94404063|NCT04364854|323265705|FG001|Overall Study|Withdrawal by Subject|0|||
94404064|NCT04364854|323265706|FG002|Overall Study|Withdrawal by Subject|1|||
94404065|NCT04364854|323265707|FG003|Overall Study|Withdrawal by Subject|3|||
94404066|NCT04364854|323265704|FG000|Overall Study|Death|1|||
94404067|NCT04364854|323265705|FG001|Overall Study|Death|0|||
94404068|NCT04364854|323265706|FG002|Overall Study|Death|0|||
94404069|NCT04364854|323265707|FG003|Overall Study|Death|0|||
94404070|NCT04364854|323265704|FG000|Overall Study|Lost to Follow-up|0|||
94404071|NCT04364854|323265705|FG001|Overall Study|Lost to Follow-up|0|||
94404072|NCT04364854|323265706|FG002|Overall Study|Lost to Follow-up|0|||
94404073|NCT04364854|323265707|FG003|Overall Study|Lost to Follow-up|1|||
94404074|NCT00522041|323265710|FG000|Overall Study|Adverse Event|9|||
94404075|NCT00522041|323265711|FG001|Overall Study|Adverse Event|3|||
94404076|NCT00522041|323265710|FG000|Overall Study|Protocol Violation|2|||
94404077|NCT00522041|323265711|FG001|Overall Study|Protocol Violation|0|||
94404078|NCT00522041|323265710|FG000|Overall Study|Lost to Follow-up|1|||
94404079|NCT00522041|323265711|FG001|Overall Study|Lost to Follow-up|4|||
94404080|NCT00522041|323265710|FG000|Overall Study|Voluntary withdrawal|5|||
94404081|NCT00522041|323265711|FG001|Overall Study|Voluntary withdrawal|4|||
94404082|NCT00522041|323265710|FG000|Overall Study|Did not receive treatment|0|||
94404083|NCT00522041|323265711|FG001|Overall Study|Did not receive treatment|1|||
94404084|NCT00691704|323265713|FG000|Induction Therapy|Disease Progression|1|||
94404085|NCT00691704|323265713|FG000|Induction Therapy|Active Hepatitis|1|||
94404086|NCT00691704|323265713|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
94404087|NCT00691704|323265713|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
94404088|NCT00691704|323265713|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
94404089|NCT00874549|323265715|FG000|Overall Study|Adverse Event|0|||
94404090|NCT00874549|323265716|FG001|Overall Study|Adverse Event|0|||
94404091|NCT00874549|323265717|FG002|Overall Study|Adverse Event|1|||
94404092|NCT00874549|323265718|FG003|Overall Study|Adverse Event|0|||
94404093|NCT00874549|323265715|FG000|Overall Study|Protocol Violation|1|||
94404094|NCT00874549|323265716|FG001|Overall Study|Protocol Violation|0|||
94404095|NCT00874549|323265717|FG002|Overall Study|Protocol Violation|2|||
94404096|NCT00874549|323265718|FG003|Overall Study|Protocol Violation|1|||
94404097|NCT00874549|323265715|FG000|Overall Study|Lost to Follow-up|0|||
94404098|NCT00874549|323265716|FG001|Overall Study|Lost to Follow-up|0|||
94404099|NCT00874549|323265717|FG002|Overall Study|Lost to Follow-up|1|||
94404100|NCT00874549|323265718|FG003|Overall Study|Lost to Follow-up|0|||
94404101|NCT00874549|323265715|FG000|Overall Study|Withdrawal by Subject|0|||
94404102|NCT00874549|323265716|FG001|Overall Study|Withdrawal by Subject|1|||
94404103|NCT00874549|323265717|FG002|Overall Study|Withdrawal by Subject|0|||
94404104|NCT00874549|323265718|FG003|Overall Study|Withdrawal by Subject|1|||
94404105|NCT01710358|323265719|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
94404106|NCT01710358|323265720|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
94404107|NCT01710358|323265721|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
94404108|NCT01710358|323265719|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
94404109|NCT01710358|323265720|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
94404110|NCT01710358|323265721|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
94404111|NCT01710358|323265719|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
94404112|NCT01710358|323265720|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
94404113|NCT01710358|323265721|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
94404114|NCT01710358|323265719|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
94404115|NCT01710358|323265720|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
94404116|NCT01710358|323265721|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
94404117|NCT01710358|323265719|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
94404118|NCT01710358|323265720|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
94404119|NCT01710358|323265721|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
94404120|NCT01710358|323265719|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
94404121|NCT01710358|323265720|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
94404122|NCT01710358|323265721|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
94404123|NCT01710358|323265719|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
94404124|NCT01710358|323265720|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
94404125|NCT01710358|323265721|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
94404126|NCT01710358|323265719|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
94404127|NCT01710358|323265720|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
94404128|NCT01710358|323265721|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
94404129|NCT01710358|323265719|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
94404130|NCT01710358|323265720|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
94404131|NCT01710358|323265721|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
94404132|NCT01710358|323265719|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
94404133|NCT01710358|323265720|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
94404134|NCT01710358|323265721|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
94404135|NCT01710358|323265719|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
94404136|NCT01710358|323265720|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
94404137|NCT01710358|323265721|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
94404138|NCT01710358|323265719|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
94404139|NCT01710358|323265720|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
94404140|NCT01710358|323265721|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
94404141|NCT01710358|323265719|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
94404142|NCT01710358|323265720|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
94404143|NCT01710358|323265721|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
94404144|NCT01710358|323265719|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
94404145|NCT01710358|323265720|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
94404146|NCT01710358|323265721|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
94404147|NCT01710358|323265719|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
94404148|NCT01710358|323265720|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
94404149|NCT01710358|323265721|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
94404150|NCT01710358|323265719|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
94404151|NCT01710358|323265720|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
94404152|NCT01710358|323265721|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
94404153|NCT01710358|323265719|FG000|Rescue Period|Adverse Event|0|||
94404154|NCT01710358|323265720|FG001|Rescue Period|Adverse Event|15|||
94404155|NCT01710358|323265721|FG002|Rescue Period|Adverse Event|0|||
94404156|NCT01710358|323265719|FG000|Rescue Period|Death|0|||
94404157|NCT01710358|323265720|FG001|Rescue Period|Death|1|||
94404158|NCT01710358|323265721|FG002|Rescue Period|Death|0|||
94404159|NCT01710358|323265719|FG000|Rescue Period|Lack of Efficacy|0|||
94404160|NCT01710358|323265720|FG001|Rescue Period|Lack of Efficacy|7|||
94404161|NCT01710358|323265721|FG002|Rescue Period|Lack of Efficacy|0|||
94404162|NCT01710358|323265719|FG000|Rescue Period|Withdrawal by Subject|0|||
94404163|NCT01710358|323265720|FG001|Rescue Period|Withdrawal by Subject|8|||
94404164|NCT01710358|323265721|FG002|Rescue Period|Withdrawal by Subject|0|||
94404165|NCT02473393|323265722|FG000|Overall Study|Adverse Event|0|||
94404166|NCT02473393|323265723|FG001|Overall Study|Adverse Event|0|||
94404167|NCT02473393|323265724|FG002|Overall Study|Adverse Event|1|||
94404168|NCT02473393|323265725|FG003|Overall Study|Adverse Event|0|||
94404169|NCT02473393|323265722|FG000|Overall Study|Withdrawal by Subject|0|||
94404170|NCT02473393|323265723|FG001|Overall Study|Withdrawal by Subject|0|||
94404171|NCT02473393|323265724|FG002|Overall Study|Withdrawal by Subject|1|||
94404172|NCT02473393|323265725|FG003|Overall Study|Withdrawal by Subject|1|||
94404173|NCT04406194|323265726|FG000|Period 1|Withdrawal by Subject|0|||
94404174|NCT04406194|323265727|FG001|Period 1|Withdrawal by Subject|1|||
94404175|NCT01398787|323265744|FG000|Overall Study|Adverse Event|1|||
94404176|NCT04561115|323265745|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
94404177|NCT04561115|323265746|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
94404178|NCT04561115|323265745|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
94404179|NCT04561115|323265746|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
94404180|NCT04561115|323265745|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
94485548|NCT04030598|323570212|FG000|Overall Study|Voluntary Withdrawal|0|||
94485549|NCT04030598|323570213|FG001|Overall Study|Voluntary Withdrawal|1|||
94485550|NCT04030598|323570214|FG002|Overall Study|Voluntary Withdrawal|0|||
94404181|NCT04561115|323265746|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
94404182|NCT01097694|323265747|FG000|Overall Study|Adverse Event|5|||
94404183|NCT01097694|323265748|FG001|Overall Study|Adverse Event|0|||
94404184|NCT01097694|323265747|FG000|Overall Study|Lost to Follow-up|0|||
94404185|NCT01097694|323265748|FG001|Overall Study|Lost to Follow-up|3|||
94404186|NCT01097694|323265747|FG000|Overall Study|Withdrawal by Subject|3|||
94404187|NCT01097694|323265748|FG001|Overall Study|Withdrawal by Subject|1|||
94404188|NCT03922750|323265755|FG000|Overall Study|Unclassified|0|||
94404189|NCT03922750|323265756|FG001|Overall Study|Unclassified|0|||
94404190|NCT03922750|323265757|FG002|Overall Study|Unclassified|1|||
94404191|NCT03922750|323265755|FG000|Overall Study|Adverse Event|0|||
94404192|NCT03922750|323265756|FG001|Overall Study|Adverse Event|1|||
94404193|NCT03922750|323265757|FG002|Overall Study|Adverse Event|0|||
94404194|NCT01949532|323265770|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
94404195|NCT01949532|323265771|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
94404196|NCT02308696|323265774|FG000|Overall Study|Lost to Follow-up|28|||
94404197|NCT02308696|323265775|FG001|Overall Study|Lost to Follow-up|21|||
94404198|NCT02308696|323265774|FG000|Overall Study|Death|8|||
94404199|NCT02308696|323265775|FG001|Overall Study|Death|4|||
94404200|NCT02308696|323265774|FG000|Overall Study|Moved to a Higher Level of Care|17|||
94404201|NCT02308696|323265775|FG001|Overall Study|Moved to a Higher Level of Care|6|||
94404202|NCT01211262|323265776|FG000|Overall Study|Progressive Disease|18|||
94404203|NCT01211262|323265777|FG001|Overall Study|Progressive Disease|9|||
94404204|NCT01211262|323265776|FG000|Overall Study|Adverse Event|4|||
94404205|NCT01211262|323265777|FG001|Overall Study|Adverse Event|0|||
94404206|NCT01211262|323265776|FG000|Overall Study|Withdrawal of Consent|1|||
94404207|NCT01211262|323265777|FG001|Overall Study|Withdrawal of Consent|0|||
94404208|NCT01211262|323265776|FG000|Overall Study|Other|0|||
94404209|NCT01211262|323265777|FG001|Overall Study|Other|1|||
94404210|NCT01277510|323265778|FG000|Double-blind Phase|Non-compliance|0|||
94404211|NCT01277510|323265779|FG001|Double-blind Phase|Non-compliance|1|||
94404212|NCT01277510|323265778|FG000|Double-blind Phase|Adverse Event|1|||
94404213|NCT01277510|323265779|FG001|Double-blind Phase|Adverse Event|0|||
94404214|NCT01277510|323265778|FG000|Double-blind Phase|Withdrawal by Subject|2|||
94404215|NCT01277510|323265779|FG001|Double-blind Phase|Withdrawal by Subject|0|||
94404216|NCT01277510|323265778|FG000|Double-blind Phase|Administrative decision|7|||
94404217|NCT01277510|323265779|FG001|Double-blind Phase|Administrative decision|9|||
94404218|NCT01277510|323265778|FG000|Double-blind Phase|Death|0|||
94404219|NCT01277510|323265779|FG001|Double-blind Phase|Death|1|||
94404220|NCT01277510|323265778|FG000|Double-blind Phase|Protocol-specified criteria|2|||
94404221|NCT01277510|323265779|FG001|Double-blind Phase|Protocol-specified criteria|6|||
94404222|NCT01277510|323265778|FG000|Double-blind Phase|Other|1|||
94404223|NCT01277510|323265779|FG001|Double-blind Phase|Other|1|||
94404224|NCT01277510|323265778|FG000|Open-label Phase|Administrative decision|4|||
94404225|NCT01277510|323265779|FG001|Open-label Phase|Administrative decision|3|||
94404226|NCT01277510|323265778|FG000|Open-label Phase|Protocol-specified criteria|1|||
94404227|NCT01277510|323265779|FG001|Open-label Phase|Protocol-specified criteria|0|||
94404228|NCT01277510|323265778|FG000|Open-label Phase|Never received investigational product|2|||
94404229|NCT01277510|323265779|FG001|Open-label Phase|Never received investigational product|0|||
94404230|NCT04892147|323265780|FG000|Overall Study|Withdrawal by Subject|2|||
94404231|NCT04892147|323265781|FG001|Overall Study|Withdrawal by Subject|0|||
94404232|NCT01341405|323265783|FG000|Overall Study|Adverse Event|0|||
94404233|NCT01341405|323265784|FG001|Overall Study|Adverse Event|1|||
94404234|NCT01341405|323265785|FG002|Overall Study|Adverse Event|1|||
94404235|NCT01341405|323265783|FG000|Overall Study|Withdrawal by Subject|3|||
94404236|NCT01341405|323265784|FG001|Overall Study|Withdrawal by Subject|2|||
94404237|NCT01341405|323265785|FG002|Overall Study|Withdrawal by Subject|1|||
94404238|NCT00057941|323265786|FG000|Overall Study|Death|1|||
94404239|NCT00057941|323265787|FG001|Overall Study|Death|2|||
94404240|NCT00057941|323265786|FG000|Overall Study|Adverse Event|7|||
94404241|NCT00057941|323265787|FG001|Overall Study|Adverse Event|9|||
94404242|NCT00057941|323265786|FG000|Overall Study|Lack of Efficacy|54|||
94404243|NCT00057941|323265787|FG001|Overall Study|Lack of Efficacy|53|||
94404244|NCT00057941|323265786|FG000|Overall Study|Withdrawal by Subject|6|||
94404245|NCT00057941|323265787|FG001|Overall Study|Withdrawal by Subject|1|||
94404246|NCT00057941|323265786|FG000|Overall Study|still on treatment|3|||
94404247|NCT00057941|323265787|FG001|Overall Study|still on treatment|1|||
94404248|NCT00057941|323265786|FG000|Overall Study|insurance, symptomatic deterioration|1|||
94404249|NCT00057941|323265787|FG001|Overall Study|insurance, symptomatic deterioration|3|||
94404250|NCT00057941|323265786|FG000|Overall Study|Ineligible|2|||
94404251|NCT00057941|323265787|FG001|Overall Study|Ineligible|5|||
94404252|NCT01098539|323265790|FG000|Overall Study|Adverse Event|26|||
94404253|NCT01098539|323265791|FG001|Overall Study|Adverse Event|26|||
94404254|NCT01098539|323265790|FG000|Overall Study|Protocol Violation|1|||
94485551|NCT02810418|323571899|FG000|Arm A Dose Escalation|Adverse Event|2|||
94404255|NCT01098539|323265791|FG001|Overall Study|Protocol Violation|4|||
94404256|NCT01098539|323265790|FG000|Overall Study|Noncompliance|3|||
94404257|NCT01098539|323265791|FG001|Overall Study|Noncompliance|5|||
94404258|NCT01098539|323265790|FG000|Overall Study|Lost to Follow-up|4|||
94404259|NCT01098539|323265791|FG001|Overall Study|Lost to Follow-up|4|||
94404260|NCT01098539|323265790|FG000|Overall Study|Withdrawal by Subject|12|||
94404261|NCT01098539|323265791|FG001|Overall Study|Withdrawal by Subject|26|||
94404262|NCT01098539|323265790|FG000|Overall Study|Physician Decision|5|||
94404263|NCT01098539|323265791|FG001|Overall Study|Physician Decision|3|||
94404264|NCT00939523|323265792|FG000|Overall Study|Lack of Efficacy|1|||
94404265|NCT00939523|323265792|FG000|Overall Study|Physician Decision|2|||
94404266|NCT00714051|323265793|FG000|Overall Study|Withdrawal by Subject|1|||
94404267|NCT00714051|323265794|FG001|Overall Study|Withdrawal by Subject|0|||
94404268|NCT00714051|323265793|FG000|Overall Study|Death|0|||
94404269|NCT00714051|323265794|FG001|Overall Study|Death|1|||
94404270|NCT00609154|323265799|FG000|Overall Study|Protocol Violation|1|||
94404271|NCT00609154|323265800|FG001|Overall Study|Protocol Violation|2|||
94404272|NCT00609154|323265799|FG000|Overall Study|Unable to establish IV access|0|||
94404273|NCT00609154|323265800|FG001|Overall Study|Unable to establish IV access|4|||
94404274|NCT00609154|323265799|FG000|Overall Study|Adverse Event|0|||
94404275|NCT00609154|323265800|FG001|Overall Study|Adverse Event|2|||
94404276|NCT01073631|323265801|FG000|Overall Study|Death|82|||
94404277|NCT01073631|323265801|FG000|Overall Study|Adverse Event|24|||
94404278|NCT01073631|323265801|FG000|Overall Study|Other|63|||
94404279|NCT04194151|323265802|FG000|Overall Study|Physician Decision|1|||
94404280|NCT04194151|323265803|FG001|Overall Study|Physician Decision|1|||
94404281|NCT04194151|323265804|FG002|Overall Study|Physician Decision|1|||
94404282|NCT04194151|323265805|FG003|Overall Study|Physician Decision|1|||
94404283|NCT04194151|323265806|FG004|Overall Study|Physician Decision|0|||
94404284|NCT04194151|323265807|FG005|Overall Study|Physician Decision|1|||
94404285|NCT04194151|323265802|FG000|Overall Study|Monitorization problem|0|||
94404286|NCT04194151|323265803|FG001|Overall Study|Monitorization problem|1|||
94404287|NCT04194151|323265804|FG002|Overall Study|Monitorization problem|0|||
94404288|NCT04194151|323265805|FG003|Overall Study|Monitorization problem|0|||
94404289|NCT04194151|323265806|FG004|Overall Study|Monitorization problem|0|||
94404290|NCT04194151|323265807|FG005|Overall Study|Monitorization problem|0|||
94404291|NCT00593827|323265808|FG000|Overall Study|On Active Treatment/Pending|0|||
94404292|NCT00593827|323265809|FG001|Overall Study|On Active Treatment/Pending|2|||
94404293|NCT00438633|323265810|FG000|Overall Study|Withdrawal by Subject|1|||
94404294|NCT00438633|323265811|FG001|Overall Study|Withdrawal by Subject|0|||
94404295|NCT00438633|323265810|FG000|Overall Study|Lost to Follow-up|15|||
94404296|NCT00438633|323265811|FG001|Overall Study|Lost to Follow-up|17|||
94404297|NCT01139762|323265812|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
94404298|NCT01139762|323265813|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
94404299|NCT01139762|323265814|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
94404300|NCT01139762|323265812|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
94404301|NCT01139762|323265813|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
94404302|NCT01139762|323265814|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
94404303|NCT01139762|323265812|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
94404304|NCT01139762|323265813|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
94404305|NCT01139762|323265814|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
94404306|NCT01139762|323265812|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
94404307|NCT01139762|323265813|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
94404308|NCT01139762|323265814|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
94404309|NCT01139762|323265812|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
94404310|NCT01139762|323265813|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
94404311|NCT01139762|323265814|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
94404312|NCT01139762|323265812|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
94404313|NCT01139762|323265813|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
94404314|NCT01139762|323265814|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
94404315|NCT01139762|323265812|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
94404316|NCT01139762|323265813|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
94404317|NCT01139762|323265814|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
94404318|NCT01139762|323265812|FG000|Double-Blind Randomized Active Treatment|Death|0|||
94404319|NCT01139762|323265813|FG001|Double-Blind Randomized Active Treatment|Death|1|||
94404320|NCT01139762|323265814|FG002|Double-Blind Randomized Active Treatment|Death|1|||
94404321|NCT01139762|323265812|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
94404322|NCT01139762|323265813|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
94404323|NCT01139762|323265814|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
94404324|NCT01139762|323265812|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
94404325|NCT01139762|323265813|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
94404326|NCT01139762|323265814|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
94404327|NCT01139762|323265812|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
94404328|NCT01139762|323265813|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
94404329|NCT01139762|323265814|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
94404330|NCT01139762|323265812|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
94404331|NCT01139762|323265813|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
94404332|NCT01139762|323265814|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
94404333|NCT01139762|323265812|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
94404334|NCT01139762|323265813|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
94404335|NCT01139762|323265814|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
94404336|NCT01139762|323265812|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
94404337|NCT01139762|323265813|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
94404338|NCT01139762|323265814|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
94404339|NCT01139762|323265812|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
94404340|NCT01139762|323265813|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
94404341|NCT01139762|323265814|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
94404342|NCT02614196|323265815|FG000|Double Blind Treatment Phase|Adverse Event|8|||
94404343|NCT02614196|323265816|FG001|Double Blind Treatment Phase|Adverse Event|5|||
94404344|NCT02614196|323265817|FG002|Double Blind Treatment Phase|Adverse Event|9|||
94404345|NCT02614196|323265818|FG003|Double Blind Treatment Phase|Adverse Event|0|||
94404346|NCT02614196|323265819|FG004|Double Blind Treatment Phase|Adverse Event|0|||
94404347|NCT02614196|323265820|FG005|Double Blind Treatment Phase|Adverse Event|0|||
94404348|NCT02614196|323265815|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
94404349|NCT02614196|323265816|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
94404350|NCT02614196|323265817|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
94404351|NCT02614196|323265818|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
94404352|NCT02614196|323265819|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
94404353|NCT02614196|323265820|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
94404354|NCT02614196|323265815|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
94404355|NCT02614196|323265816|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
94404356|NCT02614196|323265817|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
94404357|NCT02614196|323265818|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
94404358|NCT02614196|323265819|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
94404359|NCT02614196|323265820|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
94404360|NCT02614196|323265815|FG000|Double Blind Treatment Phase|Physician Decision|4|||
94404361|NCT02614196|323265816|FG001|Double Blind Treatment Phase|Physician Decision|0|||
94404362|NCT02614196|323265817|FG002|Double Blind Treatment Phase|Physician Decision|2|||
94404363|NCT02614196|323265818|FG003|Double Blind Treatment Phase|Physician Decision|0|||
94404364|NCT02614196|323265819|FG004|Double Blind Treatment Phase|Physician Decision|0|||
94404365|NCT02614196|323265820|FG005|Double Blind Treatment Phase|Physician Decision|0|||
94404366|NCT02614196|323265815|FG000|Double Blind Treatment Phase|Pregnancy|1|||
94404367|NCT02614196|323265816|FG001|Double Blind Treatment Phase|Pregnancy|2|||
94404368|NCT02614196|323265817|FG002|Double Blind Treatment Phase|Pregnancy|0|||
94404369|NCT02614196|323265818|FG003|Double Blind Treatment Phase|Pregnancy|0|||
94404370|NCT02614196|323265819|FG004|Double Blind Treatment Phase|Pregnancy|0|||
94404371|NCT02614196|323265820|FG005|Double Blind Treatment Phase|Pregnancy|0|||
94404372|NCT02614196|323265815|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
94404373|NCT02614196|323265816|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
94404374|NCT02614196|323265817|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
94404375|NCT02614196|323265818|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
94404376|NCT02614196|323265819|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
94404377|NCT02614196|323265820|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
94404378|NCT02614196|323265815|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
94404379|NCT02614196|323265816|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
94404380|NCT02614196|323265817|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
94404381|NCT02614196|323265818|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
94404382|NCT02614196|323265819|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
94404383|NCT02614196|323265820|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
94404384|NCT02614196|323265815|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
94404385|NCT02614196|323265816|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
94404386|NCT02614196|323265817|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
94404387|NCT02614196|323265818|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
94404388|NCT02614196|323265819|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
94404389|NCT02614196|323265820|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
94404390|NCT02614196|323265815|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
94404391|NCT02614196|323265816|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
94404392|NCT02614196|323265817|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
94404393|NCT02614196|323265818|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
94404394|NCT02614196|323265819|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
94404395|NCT02614196|323265820|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
94404396|NCT02614196|323265815|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
94404397|NCT02614196|323265816|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
94404398|NCT02614196|323265817|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
94404399|NCT02614196|323265818|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
94404400|NCT02614196|323265819|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
94404401|NCT02614196|323265820|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
94404402|NCT02614196|323265815|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
94404403|NCT02614196|323265816|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
94404404|NCT02614196|323265817|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
94404405|NCT02614196|323265818|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
94404406|NCT02614196|323265819|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
94404407|NCT02614196|323265820|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
94404408|NCT02614196|323265815|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
94404409|NCT02614196|323265816|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
94404410|NCT02614196|323265817|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
94404411|NCT02614196|323265818|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
94404412|NCT02614196|323265819|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
94404413|NCT02614196|323265820|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
94404414|NCT02614196|323265815|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
94404415|NCT02614196|323265816|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
94404416|NCT02614196|323265817|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
94404417|NCT02614196|323265818|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
94404418|NCT02614196|323265819|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
94404419|NCT02614196|323265820|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
94404420|NCT00642811|323265821|FG000|Overall Study|Adverse Event|2|||
94404421|NCT00642811|323265822|FG001|Overall Study|Adverse Event|3|||
94404422|NCT00642811|323265823|FG002|Overall Study|Adverse Event|0|||
94404423|NCT00642811|323265824|FG003|Overall Study|Adverse Event|0|||
94404424|NCT00642811|323265825|FG004|Overall Study|Adverse Event|0|||
94404425|NCT00642811|323265826|FG005|Overall Study|Adverse Event|1|||
94404426|NCT00642811|323265821|FG000|Overall Study|Developement of discontinuation criteria|0|||
94404427|NCT00642811|323265822|FG001|Overall Study|Developement of discontinuation criteria|0|||
94404428|NCT00642811|323265823|FG002|Overall Study|Developement of discontinuation criteria|0|||
94404429|NCT00642811|323265824|FG003|Overall Study|Developement of discontinuation criteria|0|||
94404430|NCT00642811|323265825|FG004|Overall Study|Developement of discontinuation criteria|1|||
94404431|NCT00642811|323265826|FG005|Overall Study|Developement of discontinuation criteria|0|||
94404432|NCT00642811|323265821|FG000|Overall Study|Severe Non-compliance to protocol|1|||
94404433|NCT00642811|323265822|FG001|Overall Study|Severe Non-compliance to protocol|0|||
94404434|NCT00642811|323265823|FG002|Overall Study|Severe Non-compliance to protocol|0|||
94404435|NCT00642811|323265824|FG003|Overall Study|Severe Non-compliance to protocol|0|||
94404436|NCT00642811|323265825|FG004|Overall Study|Severe Non-compliance to protocol|0|||
94404437|NCT00642811|323265826|FG005|Overall Study|Severe Non-compliance to protocol|0|||
94404438|NCT00642811|323265821|FG000|Overall Study|Other|0|||
94404439|NCT00642811|323265822|FG001|Overall Study|Other|1|||
94404440|NCT00642811|323265823|FG002|Overall Study|Other|0|||
94404441|NCT00642811|323265824|FG003|Overall Study|Other|1|||
94404442|NCT00642811|323265825|FG004|Overall Study|Other|0|||
94404443|NCT00642811|323265826|FG005|Overall Study|Other|0|||
94404444|NCT03370510|323265828|FG000|Overall Study|COVID-19|2|||
94404445|NCT03370510|323265829|FG001|Overall Study|COVID-19|0|||
94404446|NCT00772148|323265830|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
94404447|NCT00772148|323265831|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
94404448|NCT00772148|323265830|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
94404449|NCT00772148|323265831|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
94404450|NCT00772148|323265830|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
94404451|NCT00772148|323265831|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
94404452|NCT00772148|323265830|FG000|Maintenance Phase (Week 52)|Death|2|||
94404453|NCT00772148|323265831|FG001|Maintenance Phase (Week 52)|Death|2|||
94404454|NCT00772148|323265830|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
94404455|NCT00772148|323265831|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
94404456|NCT00772148|323265830|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
94404457|NCT00772148|323265831|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
94404458|NCT00772148|323265830|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
94404459|NCT00772148|323265831|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
94404460|NCT01562613|323265832|FG000|Overall Study|Lost to Follow-up|2|||
94404461|NCT01562613|323265832|FG000|Overall Study|Withdrawal by Subject|2|||
94404462|NCT00633022|323265833|FG000|Overall Study|Adverse Event|1|||
94404463|NCT00633022|323265834|FG001|Overall Study|Adverse Event|0|||
94404464|NCT00633022|323265835|FG002|Overall Study|Adverse Event|5|||
94404465|NCT00633022|323265833|FG000|Overall Study|Physician Decision|0|||
94404466|NCT00633022|323265834|FG001|Overall Study|Physician Decision|1|||
94404467|NCT00633022|323265835|FG002|Overall Study|Physician Decision|0|||
94404468|NCT01525628|323265837|FG000|Overall Study|Adverse Event|1|||
94404469|NCT01525628|323265838|FG001|Overall Study|Adverse Event|1|||
94404470|NCT01525628|323265839|FG002|Overall Study|Adverse Event|2|||
94404471|NCT01525628|323265840|FG003|Overall Study|Adverse Event|0|||
94404472|NCT01525628|323265841|FG004|Overall Study|Adverse Event|1|||
94404473|NCT01525628|323265837|FG000|Overall Study|Lack of Efficacy|0|||
94404474|NCT01525628|323265838|FG001|Overall Study|Lack of Efficacy|2|||
94404475|NCT01525628|323265839|FG002|Overall Study|Lack of Efficacy|2|||
94404476|NCT01525628|323265840|FG003|Overall Study|Lack of Efficacy|1|||
94404477|NCT01525628|323265841|FG004|Overall Study|Lack of Efficacy|2|||
94404478|NCT01525628|323265837|FG000|Overall Study|Protocol Violation|0|||
94404479|NCT01525628|323265838|FG001|Overall Study|Protocol Violation|0|||
94404480|NCT01525628|323265839|FG002|Overall Study|Protocol Violation|1|||
94404481|NCT01525628|323265840|FG003|Overall Study|Protocol Violation|0|||
94404482|NCT01525628|323265841|FG004|Overall Study|Protocol Violation|0|||
94404483|NCT01525628|323265837|FG000|Overall Study|Lost to Follow-up|1|||
94404484|NCT01525628|323265838|FG001|Overall Study|Lost to Follow-up|1|||
94404485|NCT01525628|323265839|FG002|Overall Study|Lost to Follow-up|0|||
94404486|NCT01525628|323265840|FG003|Overall Study|Lost to Follow-up|0|||
94404487|NCT01525628|323265841|FG004|Overall Study|Lost to Follow-up|0|||
94404488|NCT01525628|323265837|FG000|Overall Study|Withdrawal by Subject|0|||
94404489|NCT01525628|323265838|FG001|Overall Study|Withdrawal by Subject|1|||
94404490|NCT01525628|323265839|FG002|Overall Study|Withdrawal by Subject|0|||
94404491|NCT01525628|323265840|FG003|Overall Study|Withdrawal by Subject|0|||
94404492|NCT01525628|323265841|FG004|Overall Study|Withdrawal by Subject|0|||
94404493|NCT01525628|323265837|FG000|Overall Study|Other reason not defined above|0|||
94404494|NCT01525628|323265838|FG001|Overall Study|Other reason not defined above|0|||
94404495|NCT01525628|323265839|FG002|Overall Study|Other reason not defined above|0|||
94404496|NCT01525628|323265840|FG003|Overall Study|Other reason not defined above|3|||
94404497|NCT01525628|323265841|FG004|Overall Study|Other reason not defined above|0|||
94404498|NCT03573336|323265842|FG000|Overall Study|Study terminated|2|||
94404499|NCT03573336|323265843|FG001|Overall Study|Study terminated|4|||
94404500|NCT03573336|323265844|FG002|Overall Study|Study terminated|2|||
94404501|NCT02614898|323265845|FG000|Overall Study|Participated until study termination|10|||
94404502|NCT02614898|323265846|FG001|Overall Study|Participated until study termination|26|||
94404503|NCT02614898|323265845|FG000|Overall Study|Lost to Follow-up|0|||
94404504|NCT02614898|323265846|FG001|Overall Study|Lost to Follow-up|2|||
94404505|NCT02614898|323265845|FG000|Overall Study|Physician Decision|1|||
94404506|NCT02614898|323265846|FG001|Overall Study|Physician Decision|8|||
94404507|NCT02614898|323265845|FG000|Overall Study|Study Terminated by Sponsor|3|||
94404508|NCT02614898|323265846|FG001|Overall Study|Study Terminated by Sponsor|0|||
94404509|NCT02614898|323265845|FG000|Overall Study|Withdrawal by Subject|0|||
94404510|NCT02614898|323265846|FG001|Overall Study|Withdrawal by Subject|2|||
94404511|NCT02614898|323265845|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
94404512|NCT02614898|323265846|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
94404513|NCT02614898|323265845|FG000|Overall Study|Other-Additional Information Unavailable|0|||
94404514|NCT02614898|323265846|FG001|Overall Study|Other-Additional Information Unavailable|11|||
94404515|NCT02614898|323265845|FG000|Overall Study|Missing|0|||
94404516|NCT02614898|323265846|FG001|Overall Study|Missing|1|||
94404517|NCT04388787|323265847|FG000|Blinded Period|Patient could not follow instructions|1|||
94404518|NCT04388787|323265847|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
94404519|NCT03382041|323265848|FG000|Overall Study|Consent Form Lost|2|||
94404520|NCT03382041|323265849|FG001|Overall Study|Consent Form Lost|1|||
94404521|NCT03382041|323265848|FG000|Overall Study|Withdrawal by Subject|1|||
94404522|NCT03382041|323265849|FG001|Overall Study|Withdrawal by Subject|4|||
94404523|NCT03382041|323265848|FG000|Overall Study|Lost to Follow-up|1|||
94404524|NCT03382041|323265849|FG001|Overall Study|Lost to Follow-up|4|||
94404525|NCT00787605|323265850|FG000|Overall Study|Administrative Problems|3|||
94404526|NCT00787605|323265851|FG001|Overall Study|Administrative Problems|0|||
94404527|NCT00787605|323265850|FG000|Overall Study|Adverse Event|14|||
94404528|NCT00787605|323265851|FG001|Overall Study|Adverse Event|25|||
94404529|NCT00787605|323265850|FG000|Overall Study|Lost to Follow-up|3|||
94404530|NCT00787605|323265851|FG001|Overall Study|Lost to Follow-up|6|||
94404531|NCT00787605|323265850|FG000|Overall Study|Protocol Violation|7|||
94404532|NCT00787605|323265851|FG001|Overall Study|Protocol Violation|3|||
94404533|NCT00787605|323265850|FG000|Overall Study|Withdrawal by Subject|6|||
94404534|NCT00787605|323265851|FG001|Overall Study|Withdrawal by Subject|13|||
94404535|NCT00787605|323265850|FG000|Overall Study|Lack of Efficacy|13|||
94404536|NCT00787605|323265851|FG001|Overall Study|Lack of Efficacy|9|||
94404537|NCT02490800|323265856|FG000|Overall Study|Adverse Event|0|||
94485552|NCT02810418|323571900|FG001|Arm A Dose Escalation|Adverse Event|1|||
94485553|NCT02810418|323571901|FG002|Arm A Dose Escalation|Adverse Event|0|||
94404538|NCT02490800|323265857|FG001|Overall Study|Adverse Event|0|||
94404539|NCT02490800|323265858|FG002|Overall Study|Adverse Event|0|||
94404540|NCT02490800|323265859|FG003|Overall Study|Adverse Event|2|||
94404541|NCT02490800|323265860|FG004|Overall Study|Adverse Event|3|||
94404542|NCT02490800|323265861|FG005|Overall Study|Adverse Event|2|||
94404543|NCT02490800|323265862|FG006|Overall Study|Adverse Event|0|||
94404544|NCT02490800|323265863|FG007|Overall Study|Adverse Event|0|||
94485554|NCT02810418|323571902|FG003|Arm A Dose Escalation|Adverse Event|0|||
94404545|NCT02490800|323265864|FG008|Overall Study|Adverse Event|0|||
94404546|NCT02490800|323265865|FG009|Overall Study|Adverse Event|0|||
94404547|NCT02490800|323265866|FG010|Overall Study|Adverse Event|0|||
94404548|NCT02490800|323265867|FG011|Overall Study|Adverse Event|2|||
94404549|NCT02490800|323265868|FG012|Overall Study|Adverse Event|2|||
94404550|NCT02490800|323265856|FG000|Overall Study|Withdrawal by Subject|0|||
94404551|NCT02490800|323265857|FG001|Overall Study|Withdrawal by Subject|0|||
94404552|NCT02490800|323265858|FG002|Overall Study|Withdrawal by Subject|0|||
94404553|NCT02490800|323265859|FG003|Overall Study|Withdrawal by Subject|1|||
94404554|NCT02490800|323265860|FG004|Overall Study|Withdrawal by Subject|0|||
94404555|NCT02490800|323265861|FG005|Overall Study|Withdrawal by Subject|0|||
94404556|NCT02490800|323265862|FG006|Overall Study|Withdrawal by Subject|0|||
94404557|NCT02490800|323265863|FG007|Overall Study|Withdrawal by Subject|0|||
94404558|NCT02490800|323265864|FG008|Overall Study|Withdrawal by Subject|1|||
94404559|NCT02490800|323265865|FG009|Overall Study|Withdrawal by Subject|0|||
94404560|NCT02490800|323265866|FG010|Overall Study|Withdrawal by Subject|0|||
94404561|NCT02490800|323265867|FG011|Overall Study|Withdrawal by Subject|0|||
94404562|NCT02490800|323265868|FG012|Overall Study|Withdrawal by Subject|0|||
94404563|NCT02490800|323265856|FG000|Overall Study|Progressive disease|3|||
94404564|NCT02490800|323265857|FG001|Overall Study|Progressive disease|3|||
94404565|NCT02490800|323265858|FG002|Overall Study|Progressive disease|3|||
94404566|NCT02490800|323265859|FG003|Overall Study|Progressive disease|4|||
94404567|NCT02490800|323265860|FG004|Overall Study|Progressive disease|4|||
94404568|NCT02490800|323265861|FG005|Overall Study|Progressive disease|1|||
94404569|NCT02490800|323265862|FG006|Overall Study|Progressive disease|4|||
94404570|NCT02490800|323265863|FG007|Overall Study|Progressive disease|3|||
94404571|NCT02490800|323265864|FG008|Overall Study|Progressive disease|6|||
94404572|NCT02490800|323265865|FG009|Overall Study|Progressive disease|2|||
94404573|NCT02490800|323265866|FG010|Overall Study|Progressive disease|7|||
94404574|NCT02490800|323265867|FG011|Overall Study|Progressive disease|1|||
94404575|NCT02490800|323265868|FG012|Overall Study|Progressive disease|10|||
94404576|NCT02490800|323265856|FG000|Overall Study|Patient enrolled in post-trial access|0|||
94404577|NCT02490800|323265857|FG001|Overall Study|Patient enrolled in post-trial access|0|||
94404578|NCT02490800|323265858|FG002|Overall Study|Patient enrolled in post-trial access|0|||
94404579|NCT02490800|323265859|FG003|Overall Study|Patient enrolled in post-trial access|0|||
94404580|NCT02490800|323265860|FG004|Overall Study|Patient enrolled in post-trial access|0|||
94404581|NCT02490800|323265861|FG005|Overall Study|Patient enrolled in post-trial access|0|||
94404582|NCT02490800|323265862|FG006|Overall Study|Patient enrolled in post-trial access|0|||
94404583|NCT02490800|323265863|FG007|Overall Study|Patient enrolled in post-trial access|0|||
94404584|NCT02490800|323265864|FG008|Overall Study|Patient enrolled in post-trial access|0|||
94404585|NCT02490800|323265865|FG009|Overall Study|Patient enrolled in post-trial access|1|||
94404586|NCT02490800|323265866|FG010|Overall Study|Patient enrolled in post-trial access|1|||
94404587|NCT02490800|323265867|FG011|Overall Study|Patient enrolled in post-trial access|0|||
94404588|NCT02490800|323265868|FG012|Overall Study|Patient enrolled in post-trial access|6|||
94404589|NCT03493919|323265869|FG000|Overall Study|Other|2|||
94404590|NCT03493919|323265870|FG001|Overall Study|Other|0|||
94404591|NCT03493919|323265871|FG002|Overall Study|Other|1|||
94404592|NCT03493919|323265872|FG003|Overall Study|Other|0|||
94404593|NCT03493919|323265869|FG000|Overall Study|Withdrawal by Subject|9|||
94404594|NCT03493919|323265870|FG001|Overall Study|Withdrawal by Subject|3|||
94404595|NCT03493919|323265871|FG002|Overall Study|Withdrawal by Subject|1|||
94404596|NCT03493919|323265872|FG003|Overall Study|Withdrawal by Subject|1|||
94404597|NCT03493919|323265869|FG000|Overall Study|Lost to Follow-up|5|||
94404598|NCT03493919|323265870|FG001|Overall Study|Lost to Follow-up|0|||
94404599|NCT03493919|323265871|FG002|Overall Study|Lost to Follow-up|0|||
94404600|NCT03493919|323265872|FG003|Overall Study|Lost to Follow-up|3|||
94404601|NCT03493919|323265869|FG000|Overall Study|Adverse Event|0|||
94404602|NCT03493919|323265870|FG001|Overall Study|Adverse Event|1|||
94404603|NCT03493919|323265871|FG002|Overall Study|Adverse Event|0|||
94404604|NCT03493919|323265872|FG003|Overall Study|Adverse Event|0|||
94404605|NCT04640194|323265873|FG000|Overall Study|Adverse Event|3|||
94404606|NCT04640194|323265874|FG001|Overall Study|Adverse Event|7|||
94404607|NCT04640194|323265875|FG002|Overall Study|Adverse Event|0|||
94404608|NCT04640194|323265876|FG003|Overall Study|Adverse Event|5|||
94404609|NCT04640194|323265877|FG004|Overall Study|Adverse Event|0|||
94404610|NCT04640194|323265878|FG005|Overall Study|Adverse Event|4|||
94404611|NCT04640194|323265879|FG006|Overall Study|Adverse Event|0|||
94404612|NCT04640194|323265873|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
94404613|NCT04640194|323265874|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
94404614|NCT04640194|323265875|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
94404615|NCT04640194|323265876|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
94404616|NCT04640194|323265877|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
94404617|NCT04640194|323265878|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
94404618|NCT04640194|323265879|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
94404619|NCT04640194|323265873|FG000|Overall Study|fibrinogen level too low|0|||
94404620|NCT04640194|323265874|FG001|Overall Study|fibrinogen level too low|0|||
94404621|NCT04640194|323265875|FG002|Overall Study|fibrinogen level too low|0|||
94404622|NCT04640194|323265876|FG003|Overall Study|fibrinogen level too low|1|||
94404623|NCT04640194|323265877|FG004|Overall Study|fibrinogen level too low|0|||
94404624|NCT04640194|323265878|FG005|Overall Study|fibrinogen level too low|0|||
94404625|NCT04640194|323265879|FG006|Overall Study|fibrinogen level too low|0|||
94404626|NCT04640194|323265873|FG000|Overall Study|mild bleeding|0|||
94404627|NCT04640194|323265874|FG001|Overall Study|mild bleeding|0|||
94404628|NCT04640194|323265875|FG002|Overall Study|mild bleeding|0|||
94404629|NCT04640194|323265876|FG003|Overall Study|mild bleeding|1|||
94404630|NCT04640194|323265877|FG004|Overall Study|mild bleeding|0|||
94404631|NCT04640194|323265878|FG005|Overall Study|mild bleeding|0|||
94404632|NCT04640194|323265879|FG006|Overall Study|mild bleeding|0|||
94404633|NCT04640194|323265873|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
94404634|NCT04640194|323265874|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
94404635|NCT04640194|323265875|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
94404636|NCT04640194|323265876|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
94404637|NCT04640194|323265877|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
94404638|NCT04640194|323265878|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
94404639|NCT04640194|323265879|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
94404640|NCT04773600|323265897|FG000|Overall Study|Withdrawal by Subject|15|||
94404641|NCT04773600|323265898|FG001|Overall Study|Withdrawal by Subject|9|||
94404642|NCT04773600|323265897|FG000|Overall Study|Lost to Follow-up|10|||
94404643|NCT04773600|323265898|FG001|Overall Study|Lost to Follow-up|6|||
94404644|NCT04773600|323265897|FG000|Overall Study|Adverse Event|8|||
94404645|NCT04773600|323265898|FG001|Overall Study|Adverse Event|2|||
94404646|NCT04773600|323265897|FG000|Overall Study|Lack of Efficacy|2|||
94404647|NCT04773600|323265898|FG001|Overall Study|Lack of Efficacy|3|||
94404648|NCT04773600|323265897|FG000|Overall Study|Noncompliance|2|||
94404649|NCT04773600|323265898|FG001|Overall Study|Noncompliance|0|||
94404650|NCT04773600|323265897|FG000|Overall Study|Protocol Violation|2|||
94404651|NCT04773600|323265898|FG001|Overall Study|Protocol Violation|0|||
94404652|NCT04773600|323265897|FG000|Overall Study|Physician Decision|0|||
94404653|NCT04773600|323265898|FG001|Overall Study|Physician Decision|1|||
94404654|NCT04773600|323265897|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
94404655|NCT04773600|323265898|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
94404656|NCT04773600|323265897|FG000|Overall Study|Emergency Travel Out of Country|1|||
94404657|NCT04773600|323265898|FG001|Overall Study|Emergency Travel Out of Country|0|||
94404658|NCT03506633|323267630|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
94404659|NCT03506633|323267631|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
94404660|NCT00258856|323267639|FG000|Overall Study|Lost to Follow-up|1|||
94404661|NCT00258856|323267640|FG001|Overall Study|Lost to Follow-up|0|||
94404662|NCT00258856|323267641|FG002|Overall Study|Lost to Follow-up|2|||
94404663|NCT00258856|323267642|FG003|Overall Study|Lost to Follow-up|0|||
94404664|NCT00258856|323267639|FG000|Overall Study|Non-compliance|2|||
94404665|NCT00258856|323267640|FG001|Overall Study|Non-compliance|0|||
94404666|NCT00258856|323267641|FG002|Overall Study|Non-compliance|0|||
94404667|NCT00258856|323267642|FG003|Overall Study|Non-compliance|1|||
94404668|NCT04573309|323267643|FG000|Overall Study|Protocol Violation|1|||
94404669|NCT04573309|323267644|FG001|Overall Study|Protocol Violation|0|||
94404670|NCT03247686|323267645|FG000|Overall Study|Withdrawal by Subject|1|||
94404671|NCT03247686|323267646|FG001|Overall Study|Withdrawal by Subject|2|||
94404672|NCT02488109|323267652|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
94404673|NCT02488109|323267653|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
94404674|NCT02488109|323267652|FG000|12-month Follow-Up|Lost to Follow-up|4|||
94404675|NCT02488109|323267653|FG001|12-month Follow-Up|Lost to Follow-up|7|||
94404676|NCT05776901|323267656|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
94404677|NCT00274625|323267657|FG000|Overall Study|Lost to Follow-up|46|||
94404678|NCT00274625|323267658|FG001|Overall Study|Lost to Follow-up|54|||
94404679|NCT00274625|323267657|FG000|Overall Study|Excluded from analysis|14|||
94404680|NCT00274625|323267658|FG001|Overall Study|Excluded from analysis|8|||
94404681|NCT03086135|323267661|FG000|Overall Study|Adverse Event|1|||
94404682|NCT03086135|323267661|FG000|Overall Study|Lost to Follow-up|2|||
94404683|NCT03969641|323267662|FG000|Overall Study|Lost to Follow-up|5|||
94404684|NCT03969641|323267663|FG001|Overall Study|Lost to Follow-up|3|||
94404685|NCT03969641|323267662|FG000|Overall Study|Withdrawal by Subject|1|||
94404686|NCT03969641|323267663|FG001|Overall Study|Withdrawal by Subject|2|||
94404687|NCT03969641|323267662|FG000|Overall Study|Found to be ineligible|1|||
94404688|NCT03969641|323267663|FG001|Overall Study|Found to be ineligible|1|||
94404689|NCT03969641|323267662|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
94404690|NCT03969641|323267663|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
94404691|NCT03969641|323267662|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
94404692|NCT03969641|323267663|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
94404693|NCT03969641|323267662|FG000|Overall Study|Elective termination|0|||
94404694|NCT03969641|323267663|FG001|Overall Study|Elective termination|1|||
94404695|NCT01023061|323267666|FG000|Overall Study|Withdrawal prior to treatment|2|||
94404696|NCT02966340|323267667|FG000|Overall Study|Adverse Event|0|||
94404697|NCT02966340|323267668|FG001|Overall Study|Adverse Event|1|||
94404698|NCT02966340|323267667|FG000|Overall Study|Lost to Follow-up|0|||
94404699|NCT02966340|323267668|FG001|Overall Study|Lost to Follow-up|1|||
94404700|NCT02966340|323267667|FG000|Overall Study|Withdrawal by Subject|1|||
94404701|NCT02966340|323267668|FG001|Overall Study|Withdrawal by Subject|0|||
94404702|NCT02966340|323267667|FG000|Overall Study|data acquisition error|1|||
94404703|NCT02966340|323267668|FG001|Overall Study|data acquisition error|0|||
94404704|NCT02966340|323267667|FG000|Overall Study|startle non-responder|1|||
94404705|NCT02966340|323267668|FG001|Overall Study|startle non-responder|1|||
94404706|NCT01541215|323267672|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
94404707|NCT01541215|323267673|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
94404708|NCT01541215|323267672|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
94404709|NCT01541215|323267673|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
94404710|NCT01541215|323267672|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
94404711|NCT01541215|323267673|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
94404712|NCT01541215|323267672|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
94404713|NCT01541215|323267673|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
94404714|NCT01541215|323267672|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
94404715|NCT01541215|323267673|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
94404716|NCT01541215|323267672|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
94404717|NCT01541215|323267673|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
94404718|NCT02259348|323267674|FG000|Overall Study|Donors|6|||
94404719|NCT02259348|323267674|FG000|Overall Study|Death|4|||
94404720|NCT04211766|323267675|FG000|Overall Study|Withdrawal by Subject|5|||
94404721|NCT04211766|323267676|FG001|Overall Study|Withdrawal by Subject|1|||
94404722|NCT02710214|323267677|FG000|Overall Study|Lost to Follow-up|1|||
94404723|NCT02710214|323267678|FG001|Overall Study|Lost to Follow-up|0|||
94404724|NCT02710214|323267677|FG000|Overall Study|Lack of Efficacy|0|||
94404725|NCT02710214|323267678|FG001|Overall Study|Lack of Efficacy|1|||
94404726|NCT02710214|323267677|FG000|Overall Study|Death|0|||
94404727|NCT02710214|323267678|FG001|Overall Study|Death|1|||
94404728|NCT04264819|323267679|FG000|Overall Study|Physician Decision|19|||
94404729|NCT04264819|323267679|FG000|Overall Study|Adverse Event|12|||
94404730|NCT04264819|323267679|FG000|Overall Study|Withdrawal by Subject|11|||
94404731|NCT04264819|323267679|FG000|Overall Study|Lost to Follow-up|2|||
94404732|NCT04264819|323267679|FG000|Overall Study|Death|2|||
94404733|NCT00557245|323267680|FG000|Overall Study|Lost to Follow-up|7|||
94404734|NCT00557245|323267681|FG001|Overall Study|Lost to Follow-up|8|||
94404735|NCT00557245|323267682|FG002|Overall Study|Lost to Follow-up|10|||
94404736|NCT00557245|323267680|FG000|Overall Study|Ineligible|5|||
94404737|NCT00557245|323267681|FG001|Overall Study|Ineligible|4|||
94404738|NCT00557245|323267682|FG002|Overall Study|Ineligible|2|||
94404739|NCT00202839|323267685|FG000|Overall Study|Adverse Event|1|||
94404740|NCT00202839|323267686|FG001|Overall Study|Adverse Event|5|||
94404741|NCT00202839|323267685|FG000|Overall Study|Physician Decision|12|||
94404742|NCT00202839|323267686|FG001|Overall Study|Physician Decision|0|||
94404743|NCT00202839|323267685|FG000|Overall Study|Withdrawal by Subject|6|||
94404744|NCT00202839|323267686|FG001|Overall Study|Withdrawal by Subject|2|||
94404745|NCT00202839|323267685|FG000|Overall Study|Protocol Violation|2|||
94404746|NCT00202839|323267686|FG001|Overall Study|Protocol Violation|1|||
94404747|NCT00202839|323267685|FG000|Overall Study|Lost to Follow-up|3|||
94404748|NCT00202839|323267686|FG001|Overall Study|Lost to Follow-up|2|||
94404749|NCT01098851|323267687|FG000|Overall Study|Equipment failure|1|||
94404750|NCT01098851|323267688|FG001|Overall Study|Equipment failure|0|||
94404751|NCT01453153|323267690|FG000|Overall Study|Physician Decision|0|||
94404752|NCT01453153|323267691|FG001|Overall Study|Physician Decision|0|||
94404753|NCT01453153|323267692|FG002|Overall Study|Physician Decision|1|||
94404754|NCT01453153|323267690|FG000|Overall Study|Progressive Disease|3|||
94404755|NCT01453153|323267691|FG001|Overall Study|Progressive Disease|2|||
94404756|NCT01453153|323267692|FG002|Overall Study|Progressive Disease|16|||
94404757|NCT01453153|323267690|FG000|Overall Study|Withdrawal by Subject|0|||
94485555|NCT02810418|323571903|FG004|Arm A Dose Escalation|Adverse Event|0|||
94404758|NCT01453153|323267691|FG001|Overall Study|Withdrawal by Subject|1|||
94404759|NCT01453153|323267692|FG002|Overall Study|Withdrawal by Subject|2|||
94404760|NCT01453153|323267690|FG000|Overall Study|Adverse Event|1|||
94404761|NCT01453153|323267691|FG001|Overall Study|Adverse Event|1|||
94404762|NCT01453153|323267692|FG002|Overall Study|Adverse Event|1|||
94404763|NCT02435433|323267694|FG000|Overall Study|Withdrawal by Subject|2|||
94404764|NCT02435433|323267695|FG001|Overall Study|Withdrawal by Subject|3|||
94404765|NCT02435433|323267696|FG002|Overall Study|Withdrawal by Subject|1|||
94404766|NCT02435433|323267697|FG003|Overall Study|Withdrawal by Subject|0|||
94404767|NCT02435433|323267698|FG004|Overall Study|Withdrawal by Subject|0|||
94404768|NCT02435433|323267694|FG000|Overall Study|Lost to Follow-up|2|||
94404769|NCT02435433|323267695|FG001|Overall Study|Lost to Follow-up|2|||
94404770|NCT02435433|323267696|FG002|Overall Study|Lost to Follow-up|4|||
94404771|NCT02435433|323267697|FG003|Overall Study|Lost to Follow-up|1|||
94404772|NCT02435433|323267698|FG004|Overall Study|Lost to Follow-up|0|||
94485556|NCT02810418|323571904|FG005|Arm A Dose Escalation|Adverse Event|0|||
94404773|NCT02817828|323267699|FG000|Overall Study|Lost to Follow-up|41|||
94404774|NCT02817828|323267699|FG000|Overall Study|Adverse event not related to bleeding|104|||
94404775|NCT02817828|323267699|FG000|Overall Study|Adverse event related to bleeding|53|||
94404776|NCT02817828|323267699|FG000|Overall Study|Protocol Violation|11|||
94404777|NCT02817828|323267699|FG000|Overall Study|Pregnancy|7|||
94404778|NCT02817828|323267699|FG000|Overall Study|Pregnancy wish|15|||
94404779|NCT02817828|323267699|FG000|Overall Study|Withdrawal by Subject|78|||
94404780|NCT02817828|323267699|FG000|Overall Study|Other|26|||
94404781|NCT02218541|323267702|FG000|Overall Study|Lost to Follow-up|2|||
94404782|NCT02218541|323267703|FG001|Overall Study|Lost to Follow-up|1|||
94404783|NCT02218541|323267702|FG000|Overall Study|Implant Failure|4|||
94404784|NCT02218541|323267703|FG001|Overall Study|Implant Failure|1|||
94404785|NCT02313558|323267704|FG000|Overall Study|Withdrawal by Subject|2|||
94404786|NCT02313558|323267705|FG001|Overall Study|Withdrawal by Subject|0|||
94404787|NCT02313558|323267704|FG000|Overall Study|Lost to Follow-up|4|||
94404788|NCT02313558|323267705|FG001|Overall Study|Lost to Follow-up|4|||
94404789|NCT01157234|323267709|FG000|Overall Study|Withdrawal by Subject|1|||
94404790|NCT01157234|323267710|FG001|Overall Study|Withdrawal by Subject|0|||
94404791|NCT02998541|323267711|FG000|Overall Study|Adverse Event|4|||
94404792|NCT02998541|323267712|FG001|Overall Study|Adverse Event|5|||
94404793|NCT02998541|323267713|FG002|Overall Study|Adverse Event|1|||
94404794|NCT02998541|323267711|FG000|Overall Study|Protocol Violation|1|||
94404795|NCT02998541|323267712|FG001|Overall Study|Protocol Violation|0|||
94404796|NCT02998541|323267713|FG002|Overall Study|Protocol Violation|0|||
94404797|NCT02998541|323267711|FG000|Overall Study|Withdrawal by Subject|3|||
94404798|NCT02998541|323267712|FG001|Overall Study|Withdrawal by Subject|1|||
94404799|NCT02998541|323267713|FG002|Overall Study|Withdrawal by Subject|0|||
94404800|NCT02998541|323267711|FG000|Overall Study|Lost to Follow-up|0|||
94404801|NCT02998541|323267712|FG001|Overall Study|Lost to Follow-up|3|||
94404802|NCT02998541|323267713|FG002|Overall Study|Lost to Follow-up|1|||
94404803|NCT02998541|323267711|FG000|Overall Study|Physician Decision|0|||
94404804|NCT02998541|323267712|FG001|Overall Study|Physician Decision|0|||
94404805|NCT02998541|323267713|FG002|Overall Study|Physician Decision|3|||
94404806|NCT02998541|323267711|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94404807|NCT02998541|323267712|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94404808|NCT02998541|323267713|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
94404809|NCT01765270|323267714|FG000|Overall Study|Physician Decision|1|||
94404810|NCT01765270|323267715|FG001|Overall Study|Physician Decision|0|||
94404811|NCT01765270|323267714|FG000|Overall Study|Withdrawal by Subject|0|||
94404812|NCT01765270|323267715|FG001|Overall Study|Withdrawal by Subject|1|||
94404813|NCT02419573|323267716|FG000|Overall Study|Lost to Follow-up|3|||
94404814|NCT02419573|323267717|FG001|Overall Study|Lost to Follow-up|0|||
94404815|NCT02419573|323267716|FG000|Overall Study|Withdrawal by Subject|1|||
94404816|NCT02419573|323267717|FG001|Overall Study|Withdrawal by Subject|0|||
94404817|NCT01456962|323267719|FG000|Overall Study|Lost to Follow-up|2|||
94404818|NCT01456962|323267720|FG001|Overall Study|Lost to Follow-up|1|||
94404819|NCT00413049|323267721|FG000|Overall Study|Adverse Event|10|||
94404820|NCT00413049|323267722|FG001|Overall Study|Adverse Event|8|||
94404821|NCT00413049|323267721|FG000|Overall Study|Withdrawal by Subject|7|||
94404822|NCT00413049|323267722|FG001|Overall Study|Withdrawal by Subject|5|||
94404823|NCT00413049|323267721|FG000|Overall Study|Lost to Follow-up|2|||
94404824|NCT00413049|323267722|FG001|Overall Study|Lost to Follow-up|3|||
94404825|NCT00413049|323267721|FG000|Overall Study|Protocol Violation|3|||
94404826|NCT00413049|323267722|FG001|Overall Study|Protocol Violation|1|||
94404827|NCT00413049|323267721|FG000|Overall Study|Subject no longer requires study drug|0|||
94404828|NCT00413049|323267722|FG001|Overall Study|Subject no longer requires study drug|1|||
94404829|NCT00413049|323267721|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94404830|NCT00413049|323267722|FG001|Overall Study|Abnormal laboratory value(s)|0|||
94404831|NCT00413049|323267721|FG000|Overall Study|Lack of Efficacy|1|||
94404832|NCT00413049|323267722|FG001|Overall Study|Lack of Efficacy|0|||
94404833|NCT01460628|323267723|FG000|Overall Study|Adverse Event|3|||
94404834|NCT01460628|323267723|FG000|Overall Study|Withdrawal by Subject|2|||
94404835|NCT02179190|323267724|FG000|Enrollment|Exit Prior to Device Attempt|11|||
94485557|NCT02810418|323571905|FG006|Arm A Dose Escalation|Adverse Event|0|||
94404836|NCT02179190|323267724|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
94404837|NCT02179190|323267724|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
94404838|NCT02179190|323267724|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
94404839|NCT02179190|323267724|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
94404840|NCT02179190|323267724|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
94404841|NCT04476277|323267725|FG000|Overall Study|Withdrawal by Subject|0|||
94404842|NCT04476277|323267726|FG001|Overall Study|Withdrawal by Subject|0|||
94404843|NCT04476277|323267727|FG002|Overall Study|Withdrawal by Subject|1|||
94404844|NCT04476277|323267728|FG003|Overall Study|Withdrawal by Subject|0|||
94404845|NCT01899053|323267729|FG000|Overall Study|Progressive Disease|4|||
94404846|NCT01899053|323267730|FG001|Overall Study|Progressive Disease|0|||
94404847|NCT01899053|323267731|FG002|Overall Study|Progressive Disease|3|||
94485558|NCT02810418|323571899|FG000|Dose Expansion|Adverse Event|0|||
94404848|NCT01899053|323267732|FG003|Overall Study|Progressive Disease|0|||
94404849|NCT01899053|323267733|FG004|Overall Study|Progressive Disease|3|||
94404850|NCT01899053|323267734|FG005|Overall Study|Progressive Disease|1|||
94404851|NCT01899053|323267735|FG006|Overall Study|Progressive Disease|1|||
94404852|NCT01899053|323267736|FG007|Overall Study|Progressive Disease|1|||
94404853|NCT01899053|323267737|FG008|Overall Study|Progressive Disease|4|||
94404854|NCT01899053|323267738|FG009|Overall Study|Progressive Disease|3|||
94404855|NCT01899053|323267739|FG010|Overall Study|Progressive Disease|12|||
94404856|NCT01899053|323267740|FG011|Overall Study|Progressive Disease|5|||
94404857|NCT01899053|323267741|FG012|Overall Study|Progressive Disease|8|||
94404858|NCT01899053|323267742|FG013|Overall Study|Progressive Disease|17|||
94404859|NCT01899053|323267729|FG000|Overall Study|Adverse Event|1|||
94404860|NCT01899053|323267730|FG001|Overall Study|Adverse Event|1|||
94404861|NCT01899053|323267731|FG002|Overall Study|Adverse Event|1|||
94404862|NCT01899053|323267732|FG003|Overall Study|Adverse Event|3|||
94404863|NCT01899053|323267733|FG004|Overall Study|Adverse Event|1|||
94404864|NCT01899053|323267734|FG005|Overall Study|Adverse Event|1|||
94404865|NCT01899053|323267735|FG006|Overall Study|Adverse Event|1|||
94404866|NCT01899053|323267736|FG007|Overall Study|Adverse Event|0|||
94404867|NCT01899053|323267737|FG008|Overall Study|Adverse Event|2|||
94404868|NCT01899053|323267738|FG009|Overall Study|Adverse Event|0|||
94404869|NCT01899053|323267739|FG010|Overall Study|Adverse Event|3|||
94404870|NCT01899053|323267740|FG011|Overall Study|Adverse Event|1|||
94404871|NCT01899053|323267741|FG012|Overall Study|Adverse Event|2|||
94404872|NCT01899053|323267742|FG013|Overall Study|Adverse Event|2|||
94404873|NCT01899053|323267729|FG000|Overall Study|Reason Not Specified|0|||
94404874|NCT01899053|323267730|FG001|Overall Study|Reason Not Specified|0|||
94404875|NCT01899053|323267731|FG002|Overall Study|Reason Not Specified|0|||
94404876|NCT01899053|323267732|FG003|Overall Study|Reason Not Specified|0|||
94404877|NCT01899053|323267733|FG004|Overall Study|Reason Not Specified|0|||
94404878|NCT01899053|323267734|FG005|Overall Study|Reason Not Specified|0|||
94404879|NCT01899053|323267735|FG006|Overall Study|Reason Not Specified|1|||
94404880|NCT01899053|323267736|FG007|Overall Study|Reason Not Specified|0|||
94404881|NCT01899053|323267737|FG008|Overall Study|Reason Not Specified|0|||
94404882|NCT01899053|323267738|FG009|Overall Study|Reason Not Specified|0|||
94404883|NCT01899053|323267739|FG010|Overall Study|Reason Not Specified|0|||
94404884|NCT01899053|323267740|FG011|Overall Study|Reason Not Specified|0|||
94404885|NCT01899053|323267741|FG012|Overall Study|Reason Not Specified|1|||
94404886|NCT01899053|323267742|FG013|Overall Study|Reason Not Specified|0|||
94404887|NCT01899053|323267729|FG000|Overall Study|Withdrawal by Subject|1|||
94404888|NCT01899053|323267730|FG001|Overall Study|Withdrawal by Subject|1|||
94404889|NCT01899053|323267731|FG002|Overall Study|Withdrawal by Subject|2|||
94404890|NCT01899053|323267732|FG003|Overall Study|Withdrawal by Subject|0|||
94404891|NCT01899053|323267733|FG004|Overall Study|Withdrawal by Subject|2|||
94404892|NCT01899053|323267734|FG005|Overall Study|Withdrawal by Subject|0|||
94404893|NCT01899053|323267735|FG006|Overall Study|Withdrawal by Subject|0|||
94404894|NCT01899053|323267736|FG007|Overall Study|Withdrawal by Subject|1|||
94404895|NCT01899053|323267737|FG008|Overall Study|Withdrawal by Subject|0|||
94404896|NCT01899053|323267738|FG009|Overall Study|Withdrawal by Subject|0|||
94404897|NCT01899053|323267739|FG010|Overall Study|Withdrawal by Subject|0|||
94404898|NCT01899053|323267740|FG011|Overall Study|Withdrawal by Subject|0|||
94404899|NCT01899053|323267741|FG012|Overall Study|Withdrawal by Subject|1|||
94404900|NCT01899053|323267742|FG013|Overall Study|Withdrawal by Subject|1|||
94404901|NCT01899053|323267729|FG000|Overall Study|Protocol Violation|0|||
94404902|NCT01899053|323267730|FG001|Overall Study|Protocol Violation|0|||
94404903|NCT01899053|323267731|FG002|Overall Study|Protocol Violation|1|||
94404904|NCT01899053|323267732|FG003|Overall Study|Protocol Violation|0|||
94404905|NCT01899053|323267733|FG004|Overall Study|Protocol Violation|0|||
94404906|NCT01899053|323267734|FG005|Overall Study|Protocol Violation|0|||
94404907|NCT01899053|323267735|FG006|Overall Study|Protocol Violation|0|||
94404908|NCT01899053|323267736|FG007|Overall Study|Protocol Violation|0|||
94404909|NCT01899053|323267737|FG008|Overall Study|Protocol Violation|0|||
94404910|NCT01899053|323267738|FG009|Overall Study|Protocol Violation|0|||
94404911|NCT01899053|323267739|FG010|Overall Study|Protocol Violation|0|||
94404912|NCT01899053|323267740|FG011|Overall Study|Protocol Violation|0|||
94404913|NCT01899053|323267741|FG012|Overall Study|Protocol Violation|0|||
94404914|NCT01899053|323267742|FG013|Overall Study|Protocol Violation|0|||
94404915|NCT01899053|323267729|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
94404916|NCT01899053|323267730|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
94404917|NCT01899053|323267731|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
94404918|NCT01899053|323267732|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
94404919|NCT01899053|323267733|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
94404920|NCT01899053|323267734|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
94404921|NCT01899053|323267735|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
94404922|NCT01899053|323267736|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
94404923|NCT01899053|323267737|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
94404924|NCT01899053|323267738|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
94404925|NCT01899053|323267739|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
94404926|NCT01899053|323267740|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
94404927|NCT01899053|323267741|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
94404928|NCT01899053|323267742|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
94404929|NCT01899053|323267729|FG000|Overall Study|Symptomatic Deterioration|0|||
94404930|NCT01899053|323267730|FG001|Overall Study|Symptomatic Deterioration|0|||
94404931|NCT01899053|323267731|FG002|Overall Study|Symptomatic Deterioration|0|||
94404932|NCT01899053|323267732|FG003|Overall Study|Symptomatic Deterioration|0|||
94404933|NCT01899053|323267733|FG004|Overall Study|Symptomatic Deterioration|0|||
94404934|NCT01899053|323267734|FG005|Overall Study|Symptomatic Deterioration|1|||
94404935|NCT01899053|323267735|FG006|Overall Study|Symptomatic Deterioration|0|||
94404936|NCT01899053|323267736|FG007|Overall Study|Symptomatic Deterioration|1|||
94404937|NCT01899053|323267737|FG008|Overall Study|Symptomatic Deterioration|0|||
94404938|NCT01899053|323267738|FG009|Overall Study|Symptomatic Deterioration|0|||
94404939|NCT01899053|323267739|FG010|Overall Study|Symptomatic Deterioration|0|||
94404940|NCT01899053|323267740|FG011|Overall Study|Symptomatic Deterioration|1|||
94404941|NCT01899053|323267741|FG012|Overall Study|Symptomatic Deterioration|2|||
94404942|NCT01899053|323267742|FG013|Overall Study|Symptomatic Deterioration|0|||
94404943|NCT02760433|323267743|FG000|Overall Study|Lost to Follow-up|1|||
94404944|NCT02760433|323267744|FG001|Overall Study|Lost to Follow-up|0|||
94404945|NCT02760433|323267745|FG002|Overall Study|Lost to Follow-up|1|||
94404946|NCT02760433|323267746|FG003|Overall Study|Lost to Follow-up|0|||
94404947|NCT02760433|323267747|FG004|Overall Study|Lost to Follow-up|0|||
94404948|NCT02760433|323267743|FG000|Overall Study|Withdrawal by Subject|23|||
94404949|NCT02760433|323267744|FG001|Overall Study|Withdrawal by Subject|9|||
94404950|NCT02760433|323267745|FG002|Overall Study|Withdrawal by Subject|0|||
94404951|NCT02760433|323267746|FG003|Overall Study|Withdrawal by Subject|2|||
94404952|NCT02760433|323267747|FG004|Overall Study|Withdrawal by Subject|9|||
94404953|NCT02760433|323267743|FG000|Overall Study|Lack of Response At Week 14|0|||
94404954|NCT02760433|323267744|FG001|Overall Study|Lack of Response At Week 14|0|||
94404955|NCT02760433|323267745|FG002|Overall Study|Lack of Response At Week 14|0|||
94404956|NCT02760433|323267746|FG003|Overall Study|Lack of Response At Week 14|0|||
94404957|NCT02760433|323267747|FG004|Overall Study|Lack of Response At Week 14|1|||
94404958|NCT02760433|323267743|FG000|Overall Study|Subject refused to continue the study|1|||
94404959|NCT02760433|323267744|FG001|Overall Study|Subject refused to continue the study|0|||
94404960|NCT02760433|323267745|FG002|Overall Study|Subject refused to continue the study|0|||
94404961|NCT02760433|323267746|FG003|Overall Study|Subject refused to continue the study|0|||
94404962|NCT02760433|323267747|FG004|Overall Study|Subject refused to continue the study|0|||
94404963|NCT02760433|323267743|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
94404964|NCT02760433|323267744|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
94404965|NCT02760433|323267745|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
94404966|NCT02760433|323267746|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
94404967|NCT02760433|323267747|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
94404968|NCT02760433|323267743|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
94404969|NCT02760433|323267744|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
94404970|NCT02760433|323267745|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
94404971|NCT02760433|323267746|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
94404972|NCT02760433|323267747|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
94404973|NCT00826241|323267748|FG000|Overall Study|Withdrawal from Follow-up|1|||
94404974|NCT00826241|323267748|FG000|Overall Study|Withdrew consent|2|||
94404975|NCT00826241|323267748|FG000|Overall Study|Death|4|||
94404976|NCT00826241|323267748|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
94404977|NCT00826241|323267748|FG000|Overall Study|Non-compliance|1|||
94404978|NCT00826241|323267748|FG000|Overall Study|Progression of disease|1|||
94404979|NCT00826241|323267748|FG000|Overall Study|Patient refused follow-up|3|||
94404980|NCT00826241|323267748|FG000|Overall Study|Lost to Follow-up|9|||
94404981|NCT00826241|323267748|FG000|Overall Study|Could not obtain records|1|||
94404982|NCT00826241|323267748|FG000|Overall Study|Screen failure|2|||
94404983|NCT00826241|323267748|FG000|Overall Study|Pt unable to proceed to registration|1|||
94404984|NCT00826241|323267748|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
94404985|NCT03407729|323267749|FG000|Overall Study|Lost to Follow-up|2|||
94404986|NCT03407729|323267750|FG001|Overall Study|Lost to Follow-up|0|||
94404987|NCT03407729|323267749|FG000|Overall Study|Unable to schedule|0|||
94404988|NCT03407729|323267750|FG001|Overall Study|Unable to schedule|3|||
94404989|NCT04142658|323267751|FG000|Overall Study|Death|2|||
94404990|NCT04142658|323267752|FG001|Overall Study|Death|1|||
94404991|NCT04142658|323267751|FG000|Overall Study|Lost to Follow-up|4|||
94404992|NCT04142658|323267752|FG001|Overall Study|Lost to Follow-up|13|||
94404993|NCT04142658|323267751|FG000|Overall Study|Withdrawal by Subject|9|||
94404994|NCT04142658|323267752|FG001|Overall Study|Withdrawal by Subject|16|||
94404995|NCT01050764|323267753|FG000|Overall Study|Death, before HSCT|1|||
94404996|NCT01050764|323267753|FG000|Overall Study|Donor mobilization failure, death|1|||
94404997|NCT01050764|323267753|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
94404998|NCT03439085|323267754|FG000|Overall Study|Death|2|||
94404999|NCT03439085|323267754|FG000|Overall Study|Screen Failure|20|||
94405000|NCT01863433|323267755|FG000|Overall Study|Protocol Violation|1|||
94405001|NCT01292837|323267756|FG000|Overall Study|Adverse Event|1|||
94405002|NCT01292837|323267756|FG000|Overall Study|Further treatment determined|1|||
94405003|NCT02119936|323267757|FG000|Overall Study|Lost to Follow-up|10|||
94405004|NCT03868631|323267758|FG000|Baseline to Week 6|Adverse Event|0|||
94405005|NCT03868631|323267759|FG001|Baseline to Week 6|Adverse Event|3|||
94405006|NCT03868631|323267758|FG000|Baseline to Week 6|Protocol Violation|1|||
94405007|NCT03868631|323267759|FG001|Baseline to Week 6|Protocol Violation|1|||
94405008|NCT03868631|323267758|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
94405009|NCT03868631|323267759|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
94405010|NCT03868631|323267758|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
94405011|NCT03868631|323267759|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
94405012|NCT03868631|323267758|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
94405013|NCT03868631|323267759|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
94405014|NCT03868631|323267758|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
94405015|NCT03868631|323267759|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
94405016|NCT01785615|323267760|FG000|Dietary Phase|Lost to Follow-up|0|||
94405017|NCT01785615|323267761|FG001|Dietary Phase|Lost to Follow-up|0|||
94405018|NCT01785615|323267762|FG002|Dietary Phase|Lost to Follow-up|0|||
94405019|NCT01785615|323267763|FG003|Dietary Phase|Lost to Follow-up|24|||
94405020|NCT01450800|323267764|FG000|Overall Study|Protocol Violation|1|||
94405021|NCT01450800|323267765|FG001|Overall Study|Protocol Violation|3|||
94405022|NCT03250117|323267768|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
94405023|NCT03250117|323267769|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
94405024|NCT03250117|323267770|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
94405025|NCT03250117|323267771|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
94405026|NCT01971554|323267772|FG000|Overall Study|Lost to Follow-up|1|||
94405027|NCT01971554|323267773|FG001|Overall Study|Lost to Follow-up|0|||
94405028|NCT01971554|323267774|FG002|Overall Study|Lost to Follow-up|0|||
94405029|NCT01971554|323267775|FG003|Overall Study|Lost to Follow-up|0|||
94405030|NCT02625974|323267776|FG000|Part 1|Lost to Follow-up|9|||
94405031|NCT02625974|323267777|FG001|Part 1|Lost to Follow-up|3|||
94405032|NCT02625974|323267776|FG000|Part 2|Lost to Follow-up|4|||
94405033|NCT02625974|323267777|FG001|Part 2|Lost to Follow-up|6|||
94405034|NCT02625974|323267776|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
94405035|NCT02625974|323267777|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
94405036|NCT05068284|323267778|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
94405037|NCT05068284|323267779|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
94405038|NCT05068284|323267780|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
94405039|NCT05068284|323267781|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
94405040|NCT05068284|323267782|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
94405041|NCT05068284|323267783|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
94405042|NCT05068284|323267784|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
94405043|NCT05068284|323267785|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
94405044|NCT05068284|323267778|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
94405045|NCT05068284|323267779|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
94405046|NCT05068284|323267780|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
94405047|NCT05068284|323267781|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
94405048|NCT05068284|323267782|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
94405049|NCT05068284|323267783|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
94405050|NCT05068284|323267784|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
94405051|NCT05068284|323267785|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
94405052|NCT05068284|323267778|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
94405053|NCT05068284|323267779|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
94405054|NCT05068284|323267780|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
94405055|NCT05068284|323267781|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
94405056|NCT05068284|323267782|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
94405057|NCT05068284|323267783|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
94405058|NCT05068284|323267784|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
94405059|NCT05068284|323267785|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
94405060|NCT05068284|323267778|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
94405061|NCT05068284|323267779|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
94405062|NCT05068284|323267780|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
94405063|NCT05068284|323267781|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
94485559|NCT02810418|323571900|FG001|Dose Expansion|Adverse Event|1|||
94405064|NCT05068284|323267782|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
94405065|NCT05068284|323267783|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
94405066|NCT05068284|323267784|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
94405067|NCT05068284|323267785|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
94405068|NCT05068284|323267778|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
94405069|NCT05068284|323267779|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
94405070|NCT05068284|323267780|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
94405071|NCT05068284|323267781|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
94405072|NCT05068284|323267782|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
94405073|NCT05068284|323267783|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
94405074|NCT05068284|323267784|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
94405075|NCT05068284|323267785|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
94405076|NCT05068284|323267778|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
94405077|NCT05068284|323267779|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
94405078|NCT05068284|323267780|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
94405079|NCT05068284|323267781|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
94405080|NCT05068284|323267782|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
94405081|NCT05068284|323267783|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
94405082|NCT05068284|323267784|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
94405083|NCT05068284|323267785|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
94405084|NCT05068284|323267778|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
94405085|NCT05068284|323267779|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
94405086|NCT05068284|323267780|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
94405087|NCT05068284|323267781|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
94405088|NCT05068284|323267782|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
94405089|NCT05068284|323267783|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
94405090|NCT05068284|323267784|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
94405091|NCT05068284|323267785|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
94405092|NCT05068284|323267778|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
94405093|NCT05068284|323267779|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
94405094|NCT05068284|323267780|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
94405095|NCT05068284|323267781|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
94405096|NCT05068284|323267782|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
94405097|NCT05068284|323267783|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
94405098|NCT05068284|323267784|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
94405099|NCT05068284|323267785|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
94405100|NCT05068284|323267778|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
94405101|NCT05068284|323267779|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
94405102|NCT05068284|323267780|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
94405103|NCT05068284|323267781|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
94405104|NCT05068284|323267782|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
94405105|NCT05068284|323267783|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
94405106|NCT05068284|323267784|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
94405107|NCT05068284|323267785|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
94405108|NCT05068284|323267778|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
94405109|NCT05068284|323267779|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
94405110|NCT05068284|323267780|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
94405111|NCT05068284|323267781|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
94405112|NCT05068284|323267782|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
94405113|NCT05068284|323267783|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
94405114|NCT05068284|323267784|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
94405115|NCT05068284|323267785|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
94405116|NCT05068284|323267778|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
94405117|NCT05068284|323267779|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
94405118|NCT05068284|323267780|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
94405119|NCT05068284|323267781|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
94405120|NCT05068284|323267782|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
94405121|NCT05068284|323267783|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
94405122|NCT05068284|323267784|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
94405123|NCT05068284|323267785|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
94405124|NCT05068284|323267778|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
94405125|NCT05068284|323267779|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
94405126|NCT05068284|323267780|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
94405127|NCT05068284|323267781|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
94405128|NCT05068284|323267782|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
94405129|NCT05068284|323267783|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
94405130|NCT05068284|323267784|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
94405131|NCT05068284|323267785|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
94405132|NCT05068284|323267778|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
94405133|NCT05068284|323267779|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
94405134|NCT05068284|323267780|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
94405135|NCT05068284|323267781|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
94405136|NCT05068284|323267782|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
94405137|NCT05068284|323267783|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
94405138|NCT05068284|323267784|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
94405139|NCT05068284|323267785|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
94405140|NCT05068284|323267778|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
94405141|NCT05068284|323267779|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
94405142|NCT05068284|323267780|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
94405143|NCT05068284|323267781|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
94405144|NCT05068284|323267782|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
94405145|NCT05068284|323267783|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
94405146|NCT05068284|323267784|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
94405147|NCT05068284|323267785|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
94405148|NCT01520987|323269536|FG000|Overall Study|Withdrawal by Subject|1|||
94405149|NCT01520987|323269537|FG001|Overall Study|Withdrawal by Subject|0|||
94405150|NCT01520987|323269538|FG002|Overall Study|Withdrawal by Subject|0|||
94405151|NCT01520987|323269539|FG003|Overall Study|Withdrawal by Subject|0|||
94405152|NCT01520987|323269540|FG004|Overall Study|Withdrawal by Subject|0|||
94405153|NCT01520987|323269541|FG005|Overall Study|Withdrawal by Subject|1|||
94405154|NCT01520987|323269542|FG006|Overall Study|Withdrawal by Subject|0|||
94405155|NCT01520987|323269543|FG007|Overall Study|Withdrawal by Subject|0|||
94405156|NCT00486434|323269544|FG000|Overall Study|Withdrawal by Subject|34|||
94405157|NCT00486434|323269545|FG001|Overall Study|Withdrawal by Subject|39|||
94405158|NCT00486434|323269544|FG000|Overall Study|Adverse Event|118|||
94405159|NCT00486434|323269545|FG001|Overall Study|Adverse Event|44|||
94405160|NCT00486434|323269544|FG000|Overall Study|Protocol Violation|22|||
94405161|NCT00486434|323269545|FG001|Overall Study|Protocol Violation|21|||
94405162|NCT00486434|323269544|FG000|Overall Study|Lack of Efficacy|12|||
94405163|NCT00486434|323269545|FG001|Overall Study|Lack of Efficacy|19|||
94405164|NCT00486434|323269544|FG000|Overall Study|Lost to Follow-up|2|||
94405165|NCT00486434|323269545|FG001|Overall Study|Lost to Follow-up|3|||
94405166|NCT00486434|323269544|FG000|Overall Study|Death|1|||
94405167|NCT00486434|323269545|FG001|Overall Study|Death|2|||
94405168|NCT00486434|323269544|FG000|Overall Study|Personal reasons|5|||
94405169|NCT00486434|323269545|FG001|Overall Study|Personal reasons|6|||
94405170|NCT00288704|323269546|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
94405171|NCT00288704|323269547|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
94405172|NCT00288704|323269548|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
94405173|NCT00288704|323269546|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
94405174|NCT00288704|323269547|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
94405175|NCT00288704|323269548|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
94405176|NCT00288704|323269546|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
94405177|NCT00288704|323269547|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
94405178|NCT00288704|323269548|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
94405179|NCT00288704|323269546|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
94405180|NCT00288704|323269547|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
94405181|NCT00288704|323269548|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
94405182|NCT00288704|323269546|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
94405183|NCT00288704|323269547|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
94405184|NCT00288704|323269548|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
94405185|NCT00288704|323269546|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
94405186|NCT00288704|323269547|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
94405187|NCT00288704|323269548|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
94485560|NCT02810418|323571901|FG002|Dose Expansion|Adverse Event|1|||
94405188|NCT00288704|323269546|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
94405189|NCT00288704|323269547|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
94405190|NCT00288704|323269548|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
94405191|NCT04661202|323269549|FG000|Overall Study|Withdrawal by Subject|1|||
94405192|NCT04661202|323269550|FG001|Overall Study|Withdrawal by Subject|1|||
94405193|NCT04661202|323269549|FG000|Overall Study|Lack of Efficacy|2|||
94405194|NCT04661202|323269550|FG001|Overall Study|Lack of Efficacy|0|||
94405195|NCT00544167|323269551|FG000|Overall Study|Adverse Event|21|||
94405196|NCT00544167|323269551|FG000|Overall Study|Physician Decision|8|||
94405197|NCT02578641|323269552|FG000|Overall Study|Adverse Event|5|||
94405198|NCT02578641|323269553|FG001|Overall Study|Adverse Event|15|||
94405199|NCT02578641|323269552|FG000|Overall Study|Death|16|||
94405200|NCT02578641|323269553|FG001|Overall Study|Death|8|||
94405201|NCT02578641|323269552|FG000|Overall Study|Lost to Follow-up|0|||
94405202|NCT02578641|323269553|FG001|Overall Study|Lost to Follow-up|1|||
94405203|NCT02578641|323269552|FG000|Overall Study|Withdrawal by Subject|14|||
94405204|NCT02578641|323269553|FG001|Overall Study|Withdrawal by Subject|7|||
94405205|NCT02578641|323269552|FG000|Overall Study|Progressive Disease|69|||
94405206|NCT02578641|323269553|FG001|Overall Study|Progressive Disease|21|||
94405207|NCT02578641|323269552|FG000|Overall Study|No Study Drug|2|||
94405208|NCT02578641|323269553|FG001|Overall Study|No Study Drug|0|||
94405209|NCT02578641|323269552|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
94405210|NCT02578641|323269553|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
94405211|NCT02578641|323269552|FG000|Overall Study|Non-compliance with Study Schedule|1|||
94405212|NCT02578641|323269553|FG001|Overall Study|Non-compliance with Study Schedule|0|||
94405213|NCT02578641|323269552|FG000|Overall Study|Other|1|||
94405214|NCT02578641|323269553|FG001|Overall Study|Other|10|||
94405215|NCT02578641|323269552|FG000|Overall Study|Not treated|1|||
94405216|NCT02578641|323269553|FG001|Overall Study|Not treated|4|||
94405217|NCT00856349|323269554|FG000|Overall Study|Death|418|||
94405218|NCT00856349|323269554|FG000|Overall Study|Withdrawal by Subject|116|||
94405219|NCT00856349|323269554|FG000|Overall Study|Lost to Follow-up|91|||
94405220|NCT00856349|323269554|FG000|Overall Study|Protocol Violation|38|||
94405221|NCT00856349|323269554|FG000|Overall Study|Physician Decision|13|||
94405222|NCT00856349|323269554|FG000|Overall Study|Subject relocation|104|||
94405223|NCT00856349|323269554|FG000|Overall Study|Device explant|33|||
94405224|NCT00856349|323269554|FG000|Overall Study|Site closure|78|||
94405225|NCT00856349|323269554|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
94405226|NCT01802216|323269555|FG000|4 Month Visit|Participant did not show to visit|3|||
94405227|NCT01802216|323269556|FG001|4 Month Visit|Participant did not show to visit|4|||
94405228|NCT01802216|323269555|FG000|8 Month Visit|Participant did not show to visit|3|||
94405229|NCT01802216|323269556|FG001|8 Month Visit|Participant did not show to visit|5|||
94405230|NCT01802216|323269555|FG000|12 Month Visit|Participant did not show to visit|3|||
94405231|NCT01802216|323269556|FG001|12 Month Visit|Participant did not show to visit|4|||
94405232|NCT01257581|323269561|FG000|Overall Study|Early Termination|3|||
94405233|NCT01257581|323269562|FG001|Overall Study|Early Termination|1|||
94405234|NCT01257581|323269563|FG002|Overall Study|Early Termination|2|||
94405235|NCT01257581|323269561|FG000|Overall Study|Death|2|||
94405236|NCT01257581|323269562|FG001|Overall Study|Death|2|||
94405237|NCT01257581|323269563|FG002|Overall Study|Death|4|||
94405238|NCT04982445|323269565|FG000|Overall Study|Protocol Violation|1|||
94405239|NCT04982445|323269565|FG000|Overall Study|Withdrawal by Subject|4|||
94405240|NCT04982445|323269565|FG000|Overall Study|Lost to Follow-up|1|||
94405241|NCT02483416|323269567|FG000|Overall Study|Other reason|0|||
94405242|NCT02483416|323269568|FG001|Overall Study|Other reason|1|||
94405243|NCT02483416|323269567|FG000|Overall Study|Treatment stop|3|||
94405244|NCT02483416|323269568|FG001|Overall Study|Treatment stop|0|||
94405245|NCT04968925|323269569|FG000|Phase I- Period 1|COVID-19 related|0|||
94405246|NCT04968925|323269570|FG001|Phase I- Period 1|COVID-19 related|1|||
94405247|NCT04968925|323269571|FG002|Phase I- Period 1|COVID-19 related|0|||
94405248|NCT04968925|323269572|FG003|Phase I- Period 1|COVID-19 related|0|||
94405249|NCT04968925|323269569|FG000|Phase I- Period 1|Subject enrolled in error|1|||
94405250|NCT04968925|323269570|FG001|Phase I- Period 1|Subject enrolled in error|1|||
94405251|NCT04968925|323269571|FG002|Phase I- Period 1|Subject enrolled in error|0|||
94405252|NCT04968925|323269572|FG003|Phase I- Period 1|Subject enrolled in error|0|||
94405253|NCT04968925|323269569|FG000|Phase II- Period 1|COVID-19 Related|0|||
94405254|NCT04968925|323269570|FG001|Phase II- Period 1|COVID-19 Related|0|||
94405255|NCT04968925|323269571|FG002|Phase II- Period 1|COVID-19 Related|6|||
94405256|NCT04968925|323269572|FG003|Phase II- Period 1|COVID-19 Related|6|||
94405257|NCT04968925|323269569|FG000|Phase II- Period 1|Subject enrolled in error|0|||
94405258|NCT04968925|323269570|FG001|Phase II- Period 1|Subject enrolled in error|0|||
94405259|NCT04968925|323269571|FG002|Phase II- Period 1|Subject enrolled in error|1|||
94405260|NCT04968925|323269572|FG003|Phase II- Period 1|Subject enrolled in error|0|||
94405261|NCT04968925|323269569|FG000|Phase II -Period 2|COVID-19 related|0|||
94405262|NCT04968925|323269570|FG001|Phase II -Period 2|COVID-19 related|0|||
94405263|NCT04968925|323269571|FG002|Phase II -Period 2|COVID-19 related|4|||
94405264|NCT04968925|323269572|FG003|Phase II -Period 2|COVID-19 related|3|||
94405265|NCT04968925|323269569|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
94405266|NCT04968925|323269570|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
94405267|NCT04968925|323269571|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
94405268|NCT04968925|323269572|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
94405269|NCT01944722|323269573|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
94405270|NCT01944722|323269573|FG000|Overall Study|Specimen Shipping Issues|34|||
94405271|NCT01944722|323269573|FG000|Overall Study|Improper Storage/Transport|5|||
94405272|NCT01944722|323269573|FG000|Overall Study|Insufficient Volume for Test|1|||
94405273|NCT01944722|323269573|FG000|Overall Study|Missing Specimens|3|||
94405274|NCT01944722|323269573|FG000|Overall Study|Specimens Mislabeled|2|||
94405275|NCT01944722|323269573|FG000|Overall Study|Withdrawal by Subject|8|||
94405276|NCT01944722|323269573|FG000|Overall Study|NILM Subjects <30 years old|8106|||
94405277|NCT01944722|323269573|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
94405278|NCT01944722|323269573|FG000|Overall Study|>ASCUS Cytology|1122|||
94405279|NCT00487695|323269576|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
94405280|NCT00487695|323269577|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
94405281|NCT00487695|323269576|FG000|First Procedure|active wheezing (did not have procedure)|1|||
94405282|NCT00487695|323269577|FG001|First Procedure|active wheezing (did not have procedure)|0|||
94405283|NCT00487695|323269576|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
94405284|NCT00487695|323269577|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
94405285|NCT00487695|323269576|FG000|Second Procedure|active wheezing|0|||
94405286|NCT00487695|323269577|FG001|Second Procedure|active wheezing|1|||
94405287|NCT00487695|323269576|FG000|Second Procedure|Withdrawal by Subject|1|||
94405288|NCT00487695|323269577|FG001|Second Procedure|Withdrawal by Subject|2|||
94405289|NCT02167594|323269578|FG000|Overall Study|Withdrawal by Subject|2|||
94405290|NCT02167594|323269579|FG001|Overall Study|Withdrawal by Subject|0|||
94405291|NCT02167594|323269580|FG002|Overall Study|Withdrawal by Subject|0|||
94405292|NCT02167594|323269578|FG000|Overall Study|Death|0|||
94405293|NCT02167594|323269579|FG001|Overall Study|Death|1|||
94405294|NCT02167594|323269580|FG002|Overall Study|Death|0|||
94405295|NCT02161549|323269581|FG000|Overall Study|Physician Decision|6|||
94405296|NCT02161549|323269582|FG001|Overall Study|Physician Decision|2|||
94405297|NCT02340780|323269583|FG000|Overall Study|Ineligible|1|||
94405298|NCT02786953|323269584|FG000|Overall Study|Withdrawal by Subject|3|||
94405299|NCT02786953|323269585|FG001|Overall Study|Withdrawal by Subject|0|||
94405300|NCT02786953|323269584|FG000|Overall Study|Physician Decision|0|||
94405301|NCT02786953|323269585|FG001|Overall Study|Physician Decision|1|||
94405302|NCT01628549|323269586|FG000|Overall Study|Adverse Event|1|||
94405303|NCT01628549|323269587|FG001|Overall Study|Adverse Event|1|||
94405304|NCT01628549|323269588|FG002|Overall Study|Adverse Event|0|||
94405305|NCT01628549|323269589|FG003|Overall Study|Adverse Event|4|||
94405306|NCT01628549|323269586|FG000|Overall Study|Lost to Follow-up|3|||
94405307|NCT01628549|323269587|FG001|Overall Study|Lost to Follow-up|4|||
94405308|NCT01628549|323269588|FG002|Overall Study|Lost to Follow-up|3|||
94405309|NCT01628549|323269589|FG003|Overall Study|Lost to Follow-up|3|||
94405310|NCT01628549|323269586|FG000|Overall Study|Withdrawal by Subject|3|||
94405311|NCT01628549|323269587|FG001|Overall Study|Withdrawal by Subject|4|||
94405312|NCT01628549|323269588|FG002|Overall Study|Withdrawal by Subject|4|||
94405313|NCT01628549|323269589|FG003|Overall Study|Withdrawal by Subject|1|||
94405314|NCT01628549|323269586|FG000|Overall Study|Protocol Violation|2|||
94405315|NCT01628549|323269587|FG001|Overall Study|Protocol Violation|1|||
94405316|NCT01628549|323269588|FG002|Overall Study|Protocol Violation|1|||
94405317|NCT01628549|323269589|FG003|Overall Study|Protocol Violation|0|||
94405318|NCT01628549|323269586|FG000|Overall Study|withdrawn for noncompliance|0|||
94405319|NCT01628549|323269587|FG001|Overall Study|withdrawn for noncompliance|2|||
94405320|NCT01628549|323269588|FG002|Overall Study|withdrawn for noncompliance|1|||
94405321|NCT01628549|323269589|FG003|Overall Study|withdrawn for noncompliance|0|||
94405322|NCT01628549|323269586|FG000|Overall Study|abnormal laboratory test results|0|||
94405323|NCT01628549|323269587|FG001|Overall Study|abnormal laboratory test results|0|||
94405324|NCT01628549|323269588|FG002|Overall Study|abnormal laboratory test results|1|||
94405325|NCT01628549|323269589|FG003|Overall Study|abnormal laboratory test results|0|||
94405326|NCT01628549|323269586|FG000|Overall Study|positive pregnancy test|0|||
94405327|NCT01628549|323269587|FG001|Overall Study|positive pregnancy test|0|||
94405328|NCT01628549|323269588|FG002|Overall Study|positive pregnancy test|0|||
94405329|NCT01628549|323269589|FG003|Overall Study|positive pregnancy test|1|||
94405330|NCT00177164|323269590|FG000|Overall Study|Protocol Violation|0|||
94405331|NCT00177164|323269591|FG001|Overall Study|Protocol Violation|7|||
94405332|NCT00177164|323269590|FG000|Overall Study|Lost to Follow-up|4|||
94405333|NCT00177164|323269591|FG001|Overall Study|Lost to Follow-up|5|||
94405334|NCT00177164|323269590|FG000|Overall Study|increase in alcohol and drug use|1|||
94405335|NCT00177164|323269591|FG001|Overall Study|increase in alcohol and drug use|2|||
94405336|NCT00177164|323269590|FG000|Overall Study|Adverse Event|1|||
94405337|NCT00177164|323269591|FG001|Overall Study|Adverse Event|0|||
94405338|NCT00177164|323269590|FG000|Overall Study|discharge from hospital|1|||
94405339|NCT00177164|323269591|FG001|Overall Study|discharge from hospital|0|||
94485561|NCT02810418|323571902|FG003|Dose Expansion|Adverse Event|0|||
94405340|NCT00177164|323269590|FG000|Overall Study|Lack of Efficacy|2|||
94405341|NCT00177164|323269591|FG001|Overall Study|Lack of Efficacy|1|||
94405342|NCT00177164|323269590|FG000|Overall Study|Pregnancy|0|||
94405343|NCT00177164|323269591|FG001|Overall Study|Pregnancy|1|||
94405344|NCT00965757|323269592|FG000|Double-blind Phase|Progression of concomitant disease|1|||
94405345|NCT00965757|323269593|FG001|Double-blind Phase|Progression of concomitant disease|2|||
94405346|NCT00965757|323269594|FG002|Double-blind Phase|Progression of concomitant disease|0|||
94405347|NCT00965757|323269595|FG003|Double-blind Phase|Progression of concomitant disease|0|||
94405348|NCT00965757|323269592|FG000|Double-blind Phase|Adverse drug reaction|2|||
94405349|NCT00965757|323269593|FG001|Double-blind Phase|Adverse drug reaction|1|||
94405350|NCT00965757|323269594|FG002|Double-blind Phase|Adverse drug reaction|0|||
94405351|NCT00965757|323269595|FG003|Double-blind Phase|Adverse drug reaction|0|||
94405352|NCT00965757|323269592|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
94405353|NCT00965757|323269593|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
94405354|NCT00965757|323269594|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
94405355|NCT00965757|323269595|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
94405356|NCT00965757|323269592|FG000|Double-blind Phase|Lack of Efficacy|7|||
94405357|NCT00965757|323269593|FG001|Double-blind Phase|Lack of Efficacy|11|||
94405358|NCT00965757|323269594|FG002|Double-blind Phase|Lack of Efficacy|0|||
94405359|NCT00965757|323269595|FG003|Double-blind Phase|Lack of Efficacy|0|||
94405360|NCT00965757|323269592|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
94405361|NCT00965757|323269593|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
94405362|NCT00965757|323269594|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
94405363|NCT00965757|323269595|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
94405364|NCT00965757|323269592|FG000|Double-blind Phase|Lost to Follow-up|0|||
94405365|NCT00965757|323269593|FG001|Double-blind Phase|Lost to Follow-up|1|||
94405366|NCT00965757|323269594|FG002|Double-blind Phase|Lost to Follow-up|0|||
94405367|NCT00965757|323269595|FG003|Double-blind Phase|Lost to Follow-up|0|||
94405368|NCT00965757|323269592|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
94405369|NCT00965757|323269593|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
94405370|NCT00965757|323269594|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
94405371|NCT00965757|323269595|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
94405372|NCT00965757|323269592|FG000|Double-blind Phase|Other|1|||
94405373|NCT00965757|323269593|FG001|Double-blind Phase|Other|0|||
94405374|NCT00965757|323269594|FG002|Double-blind Phase|Other|0|||
94405375|NCT00965757|323269595|FG003|Double-blind Phase|Other|0|||
94405376|NCT00965757|323269592|FG000|Extension Phase|Progression of concomitant disease|0|||
94405377|NCT00965757|323269593|FG001|Extension Phase|Progression of concomitant disease|0|||
94405378|NCT00965757|323269594|FG002|Extension Phase|Progression of concomitant disease|4|||
94405379|NCT00965757|323269595|FG003|Extension Phase|Progression of concomitant disease|2|||
94405380|NCT00965757|323269592|FG000|Extension Phase|Adverse drug reaction|0|||
94405381|NCT00965757|323269593|FG001|Extension Phase|Adverse drug reaction|0|||
94405382|NCT00965757|323269594|FG002|Extension Phase|Adverse drug reaction|6|||
94405383|NCT00965757|323269595|FG003|Extension Phase|Adverse drug reaction|3|||
94405384|NCT00965757|323269592|FG000|Extension Phase|Abnormal Laboratory Value|0|||
94405385|NCT00965757|323269593|FG001|Extension Phase|Abnormal Laboratory Value|0|||
94405386|NCT00965757|323269594|FG002|Extension Phase|Abnormal Laboratory Value|6|||
94405387|NCT00965757|323269595|FG003|Extension Phase|Abnormal Laboratory Value|1|||
94405388|NCT00965757|323269592|FG000|Extension Phase|Lack of Efficacy|0|||
94405389|NCT00965757|323269593|FG001|Extension Phase|Lack of Efficacy|0|||
94405390|NCT00965757|323269594|FG002|Extension Phase|Lack of Efficacy|8|||
94405391|NCT00965757|323269595|FG003|Extension Phase|Lack of Efficacy|12|||
94405392|NCT00965757|323269592|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
94405393|NCT00965757|323269593|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
94405394|NCT00965757|323269594|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
94405395|NCT00965757|323269595|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
94405396|NCT00965757|323269592|FG000|Extension Phase|Lost to Follow-up|0|||
94485562|NCT02810418|323571903|FG004|Dose Expansion|Adverse Event|0|||
94485563|NCT02810418|323571904|FG005|Dose Expansion|Adverse Event|0|||
94485564|NCT02810418|323571905|FG006|Dose Expansion|Adverse Event|0|||
94485565|NCT02810418|323571899|FG000|Dose Expansion|Physician Decision|0|||
94485566|NCT02810418|323571900|FG001|Dose Expansion|Physician Decision|0|||
94485567|NCT02810418|323571901|FG002|Dose Expansion|Physician Decision|2|||
94485568|NCT02810418|323571902|FG003|Dose Expansion|Physician Decision|0|||
94405397|NCT00965757|323269593|FG001|Extension Phase|Lost to Follow-up|0|||
94405398|NCT00965757|323269594|FG002|Extension Phase|Lost to Follow-up|0|||
94405399|NCT00965757|323269595|FG003|Extension Phase|Lost to Follow-up|1|||
94405400|NCT00965757|323269592|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
94405401|NCT00965757|323269593|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
94405402|NCT00965757|323269594|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
94405403|NCT00965757|323269595|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
94485569|NCT02810418|323571903|FG004|Dose Expansion|Physician Decision|0|||
94485570|NCT02810418|323571904|FG005|Dose Expansion|Physician Decision|0|||
94485571|NCT02810418|323571905|FG006|Dose Expansion|Physician Decision|0|||
94405404|NCT00965757|323269592|FG000|Extension Phase|Protocol Violation|0|||
94405405|NCT00965757|323269593|FG001|Extension Phase|Protocol Violation|0|||
94405406|NCT00965757|323269594|FG002|Extension Phase|Protocol Violation|0|||
94405407|NCT00965757|323269595|FG003|Extension Phase|Protocol Violation|1|||
94405408|NCT00965757|323269592|FG000|Extension Phase|Other|0|||
94405409|NCT00965757|323269593|FG001|Extension Phase|Other|0|||
94405410|NCT00965757|323269594|FG002|Extension Phase|Other|2|||
94405411|NCT00965757|323269595|FG003|Extension Phase|Other|1|||
94405412|NCT01745094|323269596|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
94405413|NCT01745094|323269597|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
94405414|NCT01745094|323269598|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
94405415|NCT01745094|323269599|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
94405416|NCT01745094|323269596|FG000|Overall Study|Adverse Event|0|||
94405417|NCT01745094|323269597|FG001|Overall Study|Adverse Event|0|||
94405418|NCT01745094|323269598|FG002|Overall Study|Adverse Event|3|||
94405419|NCT01745094|323269599|FG003|Overall Study|Adverse Event|0|||
94405420|NCT01745094|323269596|FG000|Overall Study|Withdrawal by Subject|2|||
94405421|NCT01745094|323269597|FG001|Overall Study|Withdrawal by Subject|0|||
94405422|NCT01745094|323269598|FG002|Overall Study|Withdrawal by Subject|1|||
94405423|NCT01745094|323269599|FG003|Overall Study|Withdrawal by Subject|2|||
94405424|NCT01745094|323269596|FG000|Overall Study|Protocol Violation|1|||
94405425|NCT01745094|323269597|FG001|Overall Study|Protocol Violation|0|||
94405426|NCT01745094|323269598|FG002|Overall Study|Protocol Violation|3|||
94405427|NCT01745094|323269599|FG003|Overall Study|Protocol Violation|1|||
94405428|NCT01745094|323269596|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
94405429|NCT01745094|323269597|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
94405430|NCT01745094|323269598|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
94405431|NCT01745094|323269599|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
94405432|NCT01745094|323269596|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
94405433|NCT01745094|323269597|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
94405434|NCT01745094|323269598|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
94405435|NCT01745094|323269599|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
94405436|NCT01745094|323269596|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
94405437|NCT01745094|323269597|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
94405438|NCT01745094|323269598|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
94405439|NCT01745094|323269599|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
94405440|NCT00640926|323269604|FG000|Overall Study|Adverse Event|2|||
94405441|NCT00640926|323269605|FG001|Overall Study|Adverse Event|3|||
94405442|NCT00640926|323269606|FG002|Overall Study|Adverse Event|2|||
94405443|NCT00640926|323269604|FG000|Overall Study|Lack of Efficacy|0|||
94405444|NCT00640926|323269605|FG001|Overall Study|Lack of Efficacy|2|||
94405445|NCT00640926|323269606|FG002|Overall Study|Lack of Efficacy|1|||
94405446|NCT00640926|323269604|FG000|Overall Study|Protocol Violation|2|||
94405447|NCT00640926|323269605|FG001|Overall Study|Protocol Violation|0|||
94405448|NCT00640926|323269606|FG002|Overall Study|Protocol Violation|2|||
94405449|NCT00640926|323269604|FG000|Overall Study|Lost to Follow-up|3|||
94405450|NCT00640926|323269605|FG001|Overall Study|Lost to Follow-up|1|||
94405451|NCT00640926|323269606|FG002|Overall Study|Lost to Follow-up|2|||
94405452|NCT00640926|323269604|FG000|Overall Study|Withdrawal by Subject|1|||
94405453|NCT00640926|323269605|FG001|Overall Study|Withdrawal by Subject|0|||
94405454|NCT00640926|323269606|FG002|Overall Study|Withdrawal by Subject|1|||
94405455|NCT00550147|323269607|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
94405456|NCT00550147|323269607|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
94405457|NCT00550147|323269607|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
94405458|NCT00550147|323269607|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
94405459|NCT00550147|323269607|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
94405460|NCT01067521|323269612|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
94405461|NCT01067521|323269613|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
94405462|NCT01067521|323269612|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
94405463|NCT01067521|323269613|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
94405464|NCT01067521|323269612|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
94405465|NCT01067521|323269613|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
94405466|NCT01067521|323269612|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
94405467|NCT01067521|323269613|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
94405468|NCT01067521|323269612|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
94405469|NCT01067521|323269613|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
94485572|NCT02810418|323571899|FG000|Arm B Dose Escalation|Adverse Event|0|||
94485573|NCT02810418|323571900|FG001|Arm B Dose Escalation|Adverse Event|0|||
94405470|NCT01067521|323269612|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
94405471|NCT01067521|323269613|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
94405472|NCT01067521|323269612|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
94405473|NCT01067521|323269613|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
94405474|NCT01067521|323269612|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
94405475|NCT01067521|323269613|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
94405476|NCT01067521|323269612|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
94405477|NCT01067521|323269613|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
94405478|NCT01067521|323269612|FG000|Open-Label Period|Death|3|||
94405479|NCT01067521|323269613|FG001|Open-Label Period|Death|1|||
94405480|NCT01067521|323269612|FG000|Open-Label Period|Adverse Event|30|||
94405481|NCT01067521|323269613|FG001|Open-Label Period|Adverse Event|28|||
94405482|NCT01067521|323269612|FG000|Open-Label Period|Withdrawal by Subject|160|||
94405483|NCT01067521|323269613|FG001|Open-Label Period|Withdrawal by Subject|88|||
94405484|NCT01067521|323269612|FG000|Open-Label Period|Physician Decision|13|||
94405485|NCT01067521|323269613|FG001|Open-Label Period|Physician Decision|11|||
94405486|NCT01067521|323269612|FG000|Open-Label Period|Non-compliance with study drug|5|||
94405487|NCT01067521|323269613|FG001|Open-Label Period|Non-compliance with study drug|0|||
94405488|NCT01067521|323269612|FG000|Open-Label Period|Protocol Violation|3|||
94405489|NCT01067521|323269613|FG001|Open-Label Period|Protocol Violation|0|||
94405490|NCT01067521|323269612|FG000|Open-Label Period|Pregnancy|14|||
94405491|NCT01067521|323269613|FG001|Open-Label Period|Pregnancy|8|||
94405492|NCT01067521|323269612|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
94405493|NCT01067521|323269613|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
94405494|NCT01067521|323269612|FG000|Open-Label Period|Lost to Follow-up|21|||
94405495|NCT01067521|323269613|FG001|Open-Label Period|Lost to Follow-up|20|||
94405496|NCT01547728|323269618|FG000|Overall Study|Change in procedure and equipment|1|||
94405497|NCT01547728|323269618|FG000|Overall Study|Drug not ready for subject|1|||
94405498|NCT01547728|323269618|FG000|Overall Study|Screen failure|39|||
94405499|NCT03828539|323269619|FG000|Overall Study|Adverse Event|3|||
94405500|NCT03828539|323269620|FG001|Overall Study|Adverse Event|12|||
94405501|NCT03828539|323269619|FG000|Overall Study|Patient's/guardian's decision|3|||
94405502|NCT03828539|323269620|FG001|Overall Study|Patient's/guardian's decision|5|||
94405503|NCT03828539|323269619|FG000|Overall Study|Lost to Follow-up|4|||
94405504|NCT03828539|323269620|FG001|Overall Study|Lost to Follow-up|2|||
94405505|NCT03828539|323269619|FG000|Overall Study|Protocol Violation|3|||
94405506|NCT03828539|323269620|FG001|Overall Study|Protocol Violation|2|||
94405507|NCT03828539|323269619|FG000|Overall Study|Withdrawal of informed consent|2|||
94405508|NCT03828539|323269620|FG001|Overall Study|Withdrawal of informed consent|1|||
94405509|NCT03828539|323269619|FG000|Overall Study|New therapy for study indication|1|||
94405510|NCT03828539|323269620|FG001|Overall Study|New therapy for study indication|0|||
94405511|NCT05263505|323269621|FG000|Overall Study|Adverse Event|0|||
94405512|NCT05263505|323269622|FG001|Overall Study|Adverse Event|1|||
94405513|NCT00766493|323269623|FG000|30 Days Post-Procedure|Discontinued|7|||
94405514|NCT00766493|323269623|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
94405515|NCT00766493|323269623|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
94405516|NCT00965731|323269625|FG000|Overall Study|Death|0|||
94405517|NCT00965731|323269626|FG001|Overall Study|Death|4|||
94405518|NCT00965731|323269625|FG000|Overall Study|Withdrawal by Subject|0|||
94405519|NCT00965731|323269626|FG001|Overall Study|Withdrawal by Subject|1|||
94405520|NCT00965731|323269625|FG000|Overall Study|Other|7|||
94405521|NCT00965731|323269626|FG001|Overall Study|Other|15|||
94405522|NCT02914457|323269627|FG000|Overall Study|Withdrawal by Subject|1|||
94405523|NCT02914457|323269627|FG000|Overall Study|Physician Decision|1|||
94405524|NCT02914457|323269627|FG000|Overall Study|No veins available for lead placement|1|||
94405525|NCT02914457|323269627|FG000|Overall Study|Electrical instability of patient|1|||
94405526|NCT02914457|323269627|FG000|Overall Study|ECG acquisition error due to sweating|1|||
94405527|NCT02914457|323269627|FG000|Overall Study|Protocol Violation|1|||
94405528|NCT03843125|323269628|FG000|Overall Study|Adverse Event|17|||
94405529|NCT03843125|323269629|FG001|Overall Study|Adverse Event|13|||
94405530|NCT03843125|323269630|FG002|Overall Study|Adverse Event|5|||
94405531|NCT03843125|323269631|FG003|Overall Study|Adverse Event|9|||
94405532|NCT03843125|323269628|FG000|Overall Study|Death|0|||
94405533|NCT03843125|323269629|FG001|Overall Study|Death|6|||
94405534|NCT03843125|323269630|FG002|Overall Study|Death|2|||
94405535|NCT03843125|323269631|FG003|Overall Study|Death|0|||
94405536|NCT03843125|323269628|FG000|Overall Study|Lack of Efficacy|14|||
94405537|NCT03843125|323269629|FG001|Overall Study|Lack of Efficacy|11|||
94405538|NCT03843125|323269630|FG002|Overall Study|Lack of Efficacy|9|||
94405539|NCT03843125|323269631|FG003|Overall Study|Lack of Efficacy|4|||
94405540|NCT03843125|323269628|FG000|Overall Study|Lost to Follow-up|3|||
94405541|NCT03843125|323269629|FG001|Overall Study|Lost to Follow-up|4|||
94405542|NCT03843125|323269630|FG002|Overall Study|Lost to Follow-up|0|||
94405543|NCT03843125|323269631|FG003|Overall Study|Lost to Follow-up|2|||
94405544|NCT03843125|323269628|FG000|Overall Study|Other|12|||
94405545|NCT03843125|323269629|FG001|Overall Study|Other|14|||
94405546|NCT03843125|323269630|FG002|Overall Study|Other|3|||
94405547|NCT03843125|323269631|FG003|Overall Study|Other|4|||
94405548|NCT03843125|323269628|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
94405549|NCT03843125|323269629|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
94405550|NCT03843125|323269630|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
94405551|NCT03843125|323269631|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
94405552|NCT03843125|323269628|FG000|Overall Study|Study Terminated by Sponsor|318|||
94405553|NCT03843125|323269629|FG001|Overall Study|Study Terminated by Sponsor|318|||
94405554|NCT03843125|323269630|FG002|Overall Study|Study Terminated by Sponsor|163|||
94405555|NCT03843125|323269631|FG003|Overall Study|Study Terminated by Sponsor|163|||
94405556|NCT03843125|323269628|FG000|Overall Study|Withdrawal by Subject|23|||
94405557|NCT03843125|323269629|FG001|Overall Study|Withdrawal by Subject|12|||
94405558|NCT03843125|323269630|FG002|Overall Study|Withdrawal by Subject|6|||
94405559|NCT03843125|323269631|FG003|Overall Study|Withdrawal by Subject|9|||
94405560|NCT03843125|323269628|FG000|Overall Study|Missing data|0|||
94405561|NCT03843125|323269629|FG001|Overall Study|Missing data|1|||
94405562|NCT03843125|323269630|FG002|Overall Study|Missing data|1|||
94405563|NCT03843125|323269631|FG003|Overall Study|Missing data|0|||
94405564|NCT02943096|323269637|FG000|Overall Study|Lack of Efficacy|0|||
94405565|NCT02943096|323269638|FG001|Overall Study|Lack of Efficacy|1|||
94405566|NCT03950674|323269639|FG000|Overall Study|Death|16|||
94405567|NCT03950674|323269640|FG001|Overall Study|Death|15|||
94405568|NCT03950674|323269639|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
94405569|NCT03950674|323269640|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
94405570|NCT02174276|323269641|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
94405571|NCT02174276|323269642|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
94405572|NCT02174276|323269643|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
94405573|NCT02174276|323269644|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
94405574|NCT02174276|323269641|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
94405575|NCT02174276|323269642|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
94405576|NCT02174276|323269643|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
94405577|NCT02174276|323269644|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
94405578|NCT02174276|323269641|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
94405579|NCT02174276|323269642|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
94405580|NCT02174276|323269643|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
94405581|NCT02174276|323269644|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
94405582|NCT02174276|323269641|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
94405583|NCT02174276|323269642|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
94405584|NCT02174276|323269643|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
94405585|NCT02174276|323269644|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
94405586|NCT02174276|323269641|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
94405587|NCT02174276|323269642|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
94405588|NCT02174276|323269643|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
94405589|NCT02174276|323269644|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
94405590|NCT02174276|323269641|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
94405591|NCT02174276|323269642|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
94405592|NCT02174276|323269643|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
94405593|NCT02174276|323269644|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
94405594|NCT02661022|323269645|FG000|Overall Study|Withdrawal by Subject|3|||
94405595|NCT02661022|323269646|FG001|Overall Study|Withdrawal by Subject|0|||
94405596|NCT02661022|323269645|FG000|Overall Study|Adverse Event|1|||
94405597|NCT02661022|323269646|FG001|Overall Study|Adverse Event|1|||
94405598|NCT02661022|323269645|FG000|Overall Study|Physician Decision|1|||
94405599|NCT02661022|323269646|FG001|Overall Study|Physician Decision|0|||
94405600|NCT02661022|323269645|FG000|Overall Study|Progressive Disease|2|||
94405601|NCT02661022|323269646|FG001|Overall Study|Progressive Disease|1|||
94405602|NCT00570128|323269649|FG000|Overall Study|Adverse Event|1|||
94405603|NCT00570128|323269650|FG001|Overall Study|Adverse Event|0|||
94405604|NCT00570128|323269649|FG000|Overall Study|Lost to Follow-up|1|||
94405605|NCT00570128|323269650|FG001|Overall Study|Lost to Follow-up|0|||
94405606|NCT00570128|323269649|FG000|Overall Study|Withdrawal by Subject|2|||
94405607|NCT00570128|323269650|FG001|Overall Study|Withdrawal by Subject|0|||
94405608|NCT01898598|323269651|FG000|Overall Study|Adverse Event|1|||
94405609|NCT01898598|323269652|FG001|Overall Study|Adverse Event|0|||
94405610|NCT01898598|323269651|FG000|Overall Study|Withdrawal by Subject|3|||
94405611|NCT01898598|323269652|FG001|Overall Study|Withdrawal by Subject|0|||
94405612|NCT01898598|323269651|FG000|Overall Study|Lost to Follow-up|0|||
94405613|NCT01898598|323269652|FG001|Overall Study|Lost to Follow-up|1|||
94405614|NCT01898598|323269651|FG000|Overall Study|Other|0|||
94405615|NCT01898598|323269652|FG001|Overall Study|Other|1|||
94405616|NCT03833427|323269653|FG000|Overall Study|Death|4|||
94405617|NCT03833427|323269654|FG001|Overall Study|Death|2|||
94405618|NCT03833427|323269655|FG002|Overall Study|Death|9|||
94405619|NCT03833427|323269656|FG003|Overall Study|Death|11|||
94405620|NCT03833427|323269657|FG004|Overall Study|Death|0|||
94405621|NCT03833427|323269658|FG005|Overall Study|Death|0|||
94405622|NCT03833427|323269659|FG006|Overall Study|Death|0|||
94405623|NCT03833427|323269653|FG000|Overall Study|Withdrawal by Subject|0|||
94405624|NCT03833427|323269654|FG001|Overall Study|Withdrawal by Subject|1|||
94405625|NCT03833427|323269655|FG002|Overall Study|Withdrawal by Subject|1|||
94405626|NCT03833427|323269656|FG003|Overall Study|Withdrawal by Subject|0|||
94405627|NCT03833427|323269657|FG004|Overall Study|Withdrawal by Subject|0|||
94405628|NCT03833427|323269658|FG005|Overall Study|Withdrawal by Subject|0|||
94405629|NCT03833427|323269659|FG006|Overall Study|Withdrawal by Subject|0|||
94405630|NCT03833427|323269653|FG000|Overall Study|Sponsor Decision|0|||
94405631|NCT03833427|323269654|FG001|Overall Study|Sponsor Decision|0|||
94405632|NCT03833427|323269655|FG002|Overall Study|Sponsor Decision|1|||
94405633|NCT03833427|323269656|FG003|Overall Study|Sponsor Decision|3|||
94405634|NCT03833427|323269657|FG004|Overall Study|Sponsor Decision|0|||
94405635|NCT03833427|323269658|FG005|Overall Study|Sponsor Decision|0|||
94405636|NCT03833427|323269659|FG006|Overall Study|Sponsor Decision|0|||
94405637|NCT04531527|323269660|FG000|Overall Study|Found to be Ineligible|3|||
94405638|NCT03448692|323269662|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
94405639|NCT03448692|323269663|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
94405640|NCT03448692|323269662|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
94405641|NCT03448692|323269663|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
94405642|NCT03448692|323269662|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
94405643|NCT03448692|323269663|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
94405644|NCT03448692|323269662|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
94405645|NCT03448692|323269663|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
94405646|NCT03448692|323269662|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
94405647|NCT03448692|323269663|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
94405648|NCT00515216|323269664|FG000|Overall Study|Withdrawal by Subject|1|||
94405649|NCT03310619|323269670|FG000|Pre-Treatment Period|Death|1|||
94405650|NCT03310619|323269671|FG001|Pre-Treatment Period|Death|0|||
94405651|NCT03310619|323269672|FG002|Pre-Treatment Period|Death|0|||
94405652|NCT03310619|323269673|FG003|Pre-Treatment Period|Death|0|||
94405653|NCT03310619|323269674|FG004|Pre-Treatment Period|Death|1|||
94405654|NCT03310619|323269675|FG005|Pre-Treatment Period|Death|0|||
94405655|NCT03310619|323269676|FG006|Pre-Treatment Period|Death|0|||
94405656|NCT03310619|323269677|FG007|Pre-Treatment Period|Death|0|||
94405657|NCT03310619|323269670|FG000|Pre-Treatment Period|Other reasons|2|||
94405658|NCT03310619|323269671|FG001|Pre-Treatment Period|Other reasons|1|||
94405659|NCT03310619|323269672|FG002|Pre-Treatment Period|Other reasons|2|||
94405660|NCT03310619|323269673|FG003|Pre-Treatment Period|Other reasons|0|||
94405661|NCT03310619|323269674|FG004|Pre-Treatment Period|Other reasons|0|||
94405662|NCT03310619|323269675|FG005|Pre-Treatment Period|Other reasons|0|||
94405663|NCT03310619|323269676|FG006|Pre-Treatment Period|Other reasons|2|||
94405664|NCT03310619|323269677|FG007|Pre-Treatment Period|Other reasons|0|||
94405665|NCT03310619|323269670|FG000|Treatment Period|Death|1|||
94405666|NCT03310619|323269671|FG001|Treatment Period|Death|2|||
94405667|NCT03310619|323269672|FG002|Treatment Period|Death|0|||
94405668|NCT03310619|323269673|FG003|Treatment Period|Death|0|||
94405669|NCT03310619|323269674|FG004|Treatment Period|Death|1|||
94405670|NCT03310619|323269675|FG005|Treatment Period|Death|0|||
94405671|NCT03310619|323269676|FG006|Treatment Period|Death|2|||
94405672|NCT03310619|323269677|FG007|Treatment Period|Death|0|||
94405673|NCT03310619|323269670|FG000|Treatment Period|Adverse Event|0|||
94405674|NCT03310619|323269671|FG001|Treatment Period|Adverse Event|1|||
94405675|NCT03310619|323269672|FG002|Treatment Period|Adverse Event|4|||
94405676|NCT03310619|323269673|FG003|Treatment Period|Adverse Event|1|||
94405677|NCT03310619|323269674|FG004|Treatment Period|Adverse Event|0|||
94405678|NCT03310619|323269675|FG005|Treatment Period|Adverse Event|0|||
94405679|NCT03310619|323269676|FG006|Treatment Period|Adverse Event|0|||
94405680|NCT03310619|323269677|FG007|Treatment Period|Adverse Event|0|||
94405681|NCT03310619|323269670|FG000|Treatment Period|Withdrawal by participant|0|||
94405682|NCT03310619|323269671|FG001|Treatment Period|Withdrawal by participant|0|||
94405683|NCT03310619|323269672|FG002|Treatment Period|Withdrawal by participant|1|||
94405684|NCT03310619|323269673|FG003|Treatment Period|Withdrawal by participant|0|||
94405685|NCT03310619|323269674|FG004|Treatment Period|Withdrawal by participant|0|||
94405686|NCT03310619|323269675|FG005|Treatment Period|Withdrawal by participant|0|||
94405687|NCT03310619|323269676|FG006|Treatment Period|Withdrawal by participant|0|||
94405688|NCT03310619|323269677|FG007|Treatment Period|Withdrawal by participant|0|||
94405689|NCT03310619|323269670|FG000|Treatment Period|Lost to Follow-up|0|||
94405690|NCT03310619|323269671|FG001|Treatment Period|Lost to Follow-up|0|||
94405691|NCT03310619|323269672|FG002|Treatment Period|Lost to Follow-up|0|||
94405692|NCT03310619|323269673|FG003|Treatment Period|Lost to Follow-up|0|||
94405693|NCT03310619|323269674|FG004|Treatment Period|Lost to Follow-up|0|||
94405694|NCT03310619|323269675|FG005|Treatment Period|Lost to Follow-up|0|||
94405695|NCT03310619|323269676|FG006|Treatment Period|Lost to Follow-up|0|||
94405696|NCT03310619|323269677|FG007|Treatment Period|Lost to Follow-up|1|||
94405697|NCT03310619|323269670|FG000|Treatment Period|Study terminated by sponsor|0|||
94405698|NCT03310619|323269671|FG001|Treatment Period|Study terminated by sponsor|0|||
94405699|NCT03310619|323269672|FG002|Treatment Period|Study terminated by sponsor|0|||
94405700|NCT03310619|323269673|FG003|Treatment Period|Study terminated by sponsor|0|||
94405701|NCT03310619|323269674|FG004|Treatment Period|Study terminated by sponsor|0|||
94405702|NCT03310619|323269675|FG005|Treatment Period|Study terminated by sponsor|0|||
94405703|NCT03310619|323269676|FG006|Treatment Period|Study terminated by sponsor|0|||
94405704|NCT03310619|323269677|FG007|Treatment Period|Study terminated by sponsor|1|||
94405705|NCT03310619|323269670|FG000|Treatment Period|Physician Decision|0|||
94405706|NCT03310619|323269671|FG001|Treatment Period|Physician Decision|0|||
94405707|NCT03310619|323269672|FG002|Treatment Period|Physician Decision|0|||
94405708|NCT03310619|323269673|FG003|Treatment Period|Physician Decision|0|||
94405709|NCT03310619|323269674|FG004|Treatment Period|Physician Decision|3|||
94405710|NCT03310619|323269675|FG005|Treatment Period|Physician Decision|0|||
94405711|NCT03310619|323269676|FG006|Treatment Period|Physician Decision|0|||
94405712|NCT03310619|323269677|FG007|Treatment Period|Physician Decision|0|||
94405713|NCT03310619|323269670|FG000|Treatment Period|Other reasons|1|||
94405714|NCT03310619|323269671|FG001|Treatment Period|Other reasons|0|||
94405715|NCT03310619|323269672|FG002|Treatment Period|Other reasons|2|||
94405716|NCT03310619|323269673|FG003|Treatment Period|Other reasons|0|||
94405717|NCT03310619|323269674|FG004|Treatment Period|Other reasons|0|||
94405718|NCT03310619|323269675|FG005|Treatment Period|Other reasons|0|||
94405719|NCT03310619|323269676|FG006|Treatment Period|Other reasons|0|||
94405720|NCT03310619|323269677|FG007|Treatment Period|Other reasons|0|||
94405721|NCT04974580|323269678|FG000|Overall Study|Lost to Follow-up|33|||
94405722|NCT04974580|323269679|FG001|Overall Study|Lost to Follow-up|39|||
94405723|NCT04974580|323269680|FG002|Overall Study|Lost to Follow-up|30|||
94405724|NCT04974580|323269681|FG003|Overall Study|Lost to Follow-up|29|||
94405725|NCT02218216|323269682|FG000|Overall Study|Study terminated before completed|6|||
94405726|NCT02218216|323269683|FG001|Overall Study|Study terminated before completed|0|||
94405727|NCT02218216|323269684|FG002|Overall Study|Study terminated before completed|0|||
94405728|NCT00398073|323269687|FG000|Overall Study|Withdrawal by Subject|1|||
94405729|NCT00398073|323269688|FG001|Overall Study|Withdrawal by Subject|0|||
94405730|NCT01596127|323269689|FG000|Overall Study|Patient Ineligible|1|||
94405731|NCT04148287|323269690|FG000|Overall Study|Death|2|||
94405732|NCT00239005|323269691|FG000|Overall Study|Adverse Event|6|||
94405733|NCT00239005|323269692|FG001|Overall Study|Adverse Event|6|||
94405734|NCT00239005|323269691|FG000|Overall Study|Withdrawal by Subject|3|||
94405735|NCT00239005|323269692|FG001|Overall Study|Withdrawal by Subject|4|||
94405736|NCT00239005|323269691|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
94405737|NCT00239005|323269692|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
94405738|NCT00239005|323269691|FG000|Overall Study|Protocol Violation|1|||
94405739|NCT00239005|323269692|FG001|Overall Study|Protocol Violation|0|||
94405740|NCT00239005|323269691|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
94405741|NCT00239005|323269692|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
94405742|NCT00239005|323269691|FG000|Overall Study|Lost to Follow-up|0|||
94405743|NCT00239005|323269692|FG001|Overall Study|Lost to Follow-up|1|||
94405744|NCT03108820|323269693|FG000|Overall Study|Lost to Follow-up|30|||
94405745|NCT03108820|323269694|FG001|Overall Study|Lost to Follow-up|28|||
94405746|NCT03108820|323269693|FG000|Overall Study|Withdrawal by Subject|32|||
94405747|NCT03108820|323269694|FG001|Overall Study|Withdrawal by Subject|24|||
94405748|NCT03108820|323269693|FG000|Overall Study|Death|6|||
94405749|NCT03108820|323269694|FG001|Overall Study|Death|11|||
94405750|NCT00688844|323269695|FG000|Overall Study|Lost to Follow-up|10|||
94405751|NCT01214239|323269700|FG000|Overall Study|Adverse Event|3|||
94405752|NCT01214239|323269701|FG001|Overall Study|Adverse Event|4|||
94405753|NCT01214239|323269700|FG000|Overall Study|Protocol Violation|2|||
94405754|NCT01214239|323269701|FG001|Overall Study|Protocol Violation|1|||
94405755|NCT01214239|323269700|FG000|Overall Study|Lost to Follow-up|1|||
94405756|NCT01214239|323269701|FG001|Overall Study|Lost to Follow-up|1|||
94405757|NCT01214239|323269700|FG000|Overall Study|Withdrawal by Subject|4|||
94405758|NCT01214239|323269701|FG001|Overall Study|Withdrawal by Subject|9|||
94405759|NCT01214239|323269700|FG000|Overall Study|Lack of Efficacy|1|||
94405760|NCT01214239|323269701|FG001|Overall Study|Lack of Efficacy|2|||
94405761|NCT01214239|323269700|FG000|Overall Study|patient's private reason|1|||
94405762|NCT01214239|323269701|FG001|Overall Study|patient's private reason|1|||
94405763|NCT01049581|323269702|FG000|Overall Study|Lost to Follow-up|2|||
94405764|NCT01049581|323269703|FG001|Overall Study|Lost to Follow-up|1|||
94405765|NCT02219009|323271290|FG000|Overall Study|Withdrawal by Subject|5|||
94405766|NCT02219009|323271291|FG001|Overall Study|Withdrawal by Subject|1|||
94405767|NCT02219009|323271290|FG000|Overall Study|Adverse Event|2|||
94405768|NCT02219009|323271291|FG001|Overall Study|Adverse Event|4|||
94405769|NCT02219009|323271290|FG000|Overall Study|Lost to Follow-up|2|||
94405770|NCT02219009|323271291|FG001|Overall Study|Lost to Follow-up|2|||
94405771|NCT02219009|323271290|FG000|Overall Study|Protocol deviation|1|||
94405772|NCT02219009|323271291|FG001|Overall Study|Protocol deviation|0|||
94405773|NCT02219009|323271290|FG000|Overall Study|Physician Decision|0|||
94405774|NCT02219009|323271291|FG001|Overall Study|Physician Decision|1|||
94405775|NCT04832971|323271292|FG000|Overall Study|Death|1|||
94405776|NCT04832971|323271293|FG001|Overall Study|Death|0|||
94405777|NCT04832971|323271294|FG002|Overall Study|Death|0|||
94405778|NCT04832971|323271295|FG003|Overall Study|Death|0|||
94405779|NCT04832971|323271292|FG000|Overall Study|Lost to Follow-up|1|||
94405780|NCT04832971|323271293|FG001|Overall Study|Lost to Follow-up|1|||
94405781|NCT04832971|323271294|FG002|Overall Study|Lost to Follow-up|1|||
94405782|NCT04832971|323271295|FG003|Overall Study|Lost to Follow-up|0|||
94405783|NCT04832971|323271292|FG000|Overall Study|Withdrawal by Subject|1|||
94405784|NCT04832971|323271293|FG001|Overall Study|Withdrawal by Subject|3|||
94405785|NCT04832971|323271294|FG002|Overall Study|Withdrawal by Subject|2|||
94405786|NCT04832971|323271295|FG003|Overall Study|Withdrawal by Subject|2|||
94405787|NCT04832971|323271292|FG000|Overall Study|Other, Not Specified|0|||
94405788|NCT04832971|323271293|FG001|Overall Study|Other, Not Specified|0|||
94405789|NCT04832971|323271294|FG002|Overall Study|Other, Not Specified|1|||
94405790|NCT04832971|323271295|FG003|Overall Study|Other, Not Specified|0|||
94405791|NCT01579006|323271296|FG000|Overall Study|Lack of Efficacy|10|||
94405792|NCT01579006|323271296|FG000|Overall Study|Adverse Event|13|||
94405793|NCT01579006|323271296|FG000|Overall Study|Withdrawal by Subject|5|||
94405794|NCT01579006|323271296|FG000|Overall Study|Non-compliance|3|||
94405795|NCT01579006|323271296|FG000|Overall Study|Due to participant's health fund|1|||
94405796|NCT01579006|323271296|FG000|Overall Study|Scheduled surgery|1|||
94405797|NCT05393271|323271297|FG000|Overall Study|Physician Decision|0|||
94405798|NCT05393271|323271298|FG001|Overall Study|Physician Decision|0|||
94405799|NCT05393271|323271299|FG002|Overall Study|Physician Decision|0|||
94405800|NCT05393271|323271300|FG003|Overall Study|Physician Decision|0|||
94405801|NCT05393271|323271301|FG004|Overall Study|Physician Decision|0|||
94405802|NCT05393271|323271302|FG005|Overall Study|Physician Decision|0|||
94405803|NCT05393271|323271303|FG006|Overall Study|Physician Decision|1|||
94405804|NCT05393271|323271304|FG007|Overall Study|Physician Decision|0|||
94405805|NCT05393271|323271305|FG008|Overall Study|Physician Decision|0|||
94405806|NCT05393271|323271306|FG009|Overall Study|Physician Decision|0|||
94405807|NCT05393271|323271307|FG010|Overall Study|Physician Decision|0|||
94405808|NCT01721772|323271316|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
94405809|NCT01721772|323271317|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
94405810|NCT01721772|323271316|FG000|Pre-Treatment|Poor/non-compliance|0|||
94405811|NCT01721772|323271317|FG001|Pre-Treatment|Poor/non-compliance|1|||
94405812|NCT01721772|323271316|FG000|Pre-Treatment|Participant withdrew consent|0|||
94405813|NCT01721772|323271317|FG001|Pre-Treatment|Participant withdrew consent|1|||
94405814|NCT01721772|323271316|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
94405815|NCT01721772|323271317|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
94405816|NCT01721772|323271316|FG000|Treatment|Disease progression|119|||
94405817|NCT01721772|323271317|FG001|Treatment|Disease progression|168|||
94405818|NCT01721772|323271316|FG000|Treatment|Study drug toxicity|19|||
94405819|NCT01721772|323271317|FG001|Treatment|Study drug toxicity|10|||
94405820|NCT01721772|323271316|FG000|Treatment|Adverse event unrelated to study drug|7|||
94405821|NCT01721772|323271317|FG001|Treatment|Adverse event unrelated to study drug|7|||
94405822|NCT01721772|323271316|FG000|Treatment|Maximum clinical benefit|16|||
94405823|NCT01721772|323271317|FG001|Treatment|Maximum clinical benefit|4|||
94405824|NCT01721772|323271316|FG000|Treatment|Other|19|||
94405825|NCT01721772|323271317|FG001|Treatment|Other|2|||
94405826|NCT01721772|323271316|FG000|Treatment|Participant withdrew consent|2|||
94405827|NCT01721772|323271317|FG001|Treatment|Participant withdrew consent|5|||
94405828|NCT01721772|323271316|FG000|Treatment|Participant request to discontinue study treatment|21|||
94405829|NCT01721772|323271317|FG001|Treatment|Participant request to discontinue study treatment|8|||
94405830|NCT01721772|323271316|FG000|Treatment|Death|1|||
94405831|NCT01721772|323271317|FG001|Treatment|Death|0|||
94405832|NCT01721772|323271316|FG000|Treatment|Not reported|1|||
94405833|NCT01721772|323271317|FG001|Treatment|Not reported|0|||
94485574|NCT02810418|323571901|FG002|Arm B Dose Escalation|Adverse Event|0|||
94405834|NCT01721772|323271316|FG000|Treatment|Poor/non-compliance|1|||
94405835|NCT01721772|323271317|FG001|Treatment|Poor/non-compliance|0|||
94405836|NCT01721772|323271316|FG000|Treatment|Lost to Follow-up|0|||
94405837|NCT01721772|323271317|FG001|Treatment|Lost to Follow-up|1|||
94405838|NCT02754492|323271318|FG000|Overall Study|Protocol Violation|2|||
94405839|NCT02754492|323271319|FG001|Overall Study|Protocol Violation|2|||
94405840|NCT02754492|323271320|FG002|Overall Study|Protocol Violation|0|||
94405841|NCT02754492|323271321|FG003|Overall Study|Protocol Violation|1|||
94405842|NCT02754492|323271318|FG000|Overall Study|Withdrawal by Subject|2|||
94405843|NCT02754492|323271319|FG001|Overall Study|Withdrawal by Subject|0|||
94405844|NCT02754492|323271320|FG002|Overall Study|Withdrawal by Subject|0|||
94405845|NCT02754492|323271321|FG003|Overall Study|Withdrawal by Subject|0|||
94405846|NCT02754492|323271318|FG000|Overall Study|Equipment malfuntion|0|||
94405847|NCT02754492|323271319|FG001|Overall Study|Equipment malfuntion|0|||
94405848|NCT02754492|323271320|FG002|Overall Study|Equipment malfuntion|2|||
94405849|NCT02754492|323271321|FG003|Overall Study|Equipment malfuntion|5|||
94405850|NCT02754492|323271318|FG000|Overall Study|Adverse Event|0|||
94485575|NCT02810418|323571902|FG003|Arm B Dose Escalation|Adverse Event|0|||
94405851|NCT02754492|323271319|FG001|Overall Study|Adverse Event|0|||
94405852|NCT02754492|323271320|FG002|Overall Study|Adverse Event|0|||
94405853|NCT02754492|323271321|FG003|Overall Study|Adverse Event|13|||
94405854|NCT02754492|323271318|FG000|Overall Study|Venous access issues not resulting in AE|0|||
94405855|NCT02754492|323271319|FG001|Overall Study|Venous access issues not resulting in AE|0|||
94405856|NCT02754492|323271320|FG002|Overall Study|Venous access issues not resulting in AE|0|||
94405857|NCT02754492|323271321|FG003|Overall Study|Venous access issues not resulting in AE|4|||
94405858|NCT01408888|323271322|FG000|First Intervention|Adverse Event|0|||
94405859|NCT01408888|323271323|FG001|First Intervention|Adverse Event|1|||
94405860|NCT01408888|323271322|FG000|First Intervention|Withdrawal by Subject|0|||
94405861|NCT01408888|323271323|FG001|First Intervention|Withdrawal by Subject|2|||
94405862|NCT01408888|323271322|FG000|Second Intervention|Withdrawal by Subject|1|||
94405863|NCT01408888|323271323|FG001|Second Intervention|Withdrawal by Subject|0|||
94405864|NCT01408888|323271322|FG000|Second Intervention|Adverse Event|1|||
94405865|NCT01408888|323271323|FG001|Second Intervention|Adverse Event|0|||
94405866|NCT00687739|323271328|FG000|Overall Study|Lost to Follow-up|2|||
94405867|NCT00687739|323271329|FG001|Overall Study|Lost to Follow-up|2|||
94405868|NCT00687739|323271330|FG002|Overall Study|Lost to Follow-up|1|||
94405869|NCT00687739|323271331|FG003|Overall Study|Lost to Follow-up|2|||
94405870|NCT00687739|323271328|FG000|Overall Study|Adverse Event|0|||
94405871|NCT00687739|323271329|FG001|Overall Study|Adverse Event|1|||
94405872|NCT00687739|323271330|FG002|Overall Study|Adverse Event|1|||
94405873|NCT00687739|323271331|FG003|Overall Study|Adverse Event|0|||
94405874|NCT01698554|323271337|FG000|Overall Study|Adverse Event|2|||
94405875|NCT01698554|323271338|FG001|Overall Study|Adverse Event|5|||
94405876|NCT01698554|323271339|FG002|Overall Study|Adverse Event|0|||
94405877|NCT01698554|323271340|FG003|Overall Study|Adverse Event|1|||
94405878|NCT01698554|323271337|FG000|Overall Study|Lost to Follow-up|1|||
94405879|NCT01698554|323271338|FG001|Overall Study|Lost to Follow-up|0|||
94405880|NCT01698554|323271339|FG002|Overall Study|Lost to Follow-up|0|||
94405881|NCT01698554|323271340|FG003|Overall Study|Lost to Follow-up|0|||
94405882|NCT01698554|323271337|FG000|Overall Study|Personal Reasons|0|||
94405883|NCT01698554|323271338|FG001|Overall Study|Personal Reasons|5|||
94405884|NCT01698554|323271339|FG002|Overall Study|Personal Reasons|1|||
94405885|NCT01698554|323271340|FG003|Overall Study|Personal Reasons|1|||
94405886|NCT01698554|323271337|FG000|Overall Study|Protocol Violation|2|||
94405887|NCT01698554|323271338|FG001|Overall Study|Protocol Violation|0|||
94405888|NCT01698554|323271339|FG002|Overall Study|Protocol Violation|1|||
94405889|NCT01698554|323271340|FG003|Overall Study|Protocol Violation|0|||
94405890|NCT01698554|323271337|FG000|Overall Study|Other Miscellaneous Reasons|1|||
94405891|NCT01698554|323271338|FG001|Overall Study|Other Miscellaneous Reasons|0|||
94405892|NCT01698554|323271339|FG002|Overall Study|Other Miscellaneous Reasons|0|||
94405893|NCT01698554|323271340|FG003|Overall Study|Other Miscellaneous Reasons|0|||
94405894|NCT02637141|323271347|FG000|Overall Study|Adverse Event|1|||
94405895|NCT02637141|323271348|FG001|Overall Study|Adverse Event|1|||
94405896|NCT02637141|323271349|FG002|Overall Study|Adverse Event|0|||
94405897|NCT02637141|323271347|FG000|Overall Study|Withdrawal by Subject|1|||
94405898|NCT02637141|323271348|FG001|Overall Study|Withdrawal by Subject|1|||
94405899|NCT02637141|323271349|FG002|Overall Study|Withdrawal by Subject|1|||
94405900|NCT03885934|323271350|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
94405901|NCT03885934|323271351|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
94405902|NCT03885934|323271352|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
94405903|NCT03885934|323271353|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
94405904|NCT03885934|323271354|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
94405905|NCT03885934|323271355|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
94405906|NCT02416180|323271362|FG000|Overall Study|Withdrawal by Subject|1|||
94405907|NCT04610580|323271363|FG000|Two-way Crossover Period|Adverse Event|1|||
94405908|NCT04610580|323271364|FG001|Two-way Crossover Period|Adverse Event|0|||
94405909|NCT04610580|323271365|FG002|Two-way Crossover Period|Adverse Event|0|||
94405910|NCT04610580|323271366|FG003|Two-way Crossover Period|Adverse Event|0|||
94405911|NCT04610580|323271367|FG004|Two-way Crossover Period|Adverse Event|0|||
94405912|NCT04610580|323271368|FG005|Two-way Crossover Period|Adverse Event|0|||
94405913|NCT04610580|323271363|FG000|Two-way Crossover Period|Physician Decision|1|||
94405914|NCT04610580|323271364|FG001|Two-way Crossover Period|Physician Decision|0|||
94405915|NCT04610580|323271365|FG002|Two-way Crossover Period|Physician Decision|0|||
94405916|NCT04610580|323271366|FG003|Two-way Crossover Period|Physician Decision|0|||
94405917|NCT04610580|323271367|FG004|Two-way Crossover Period|Physician Decision|0|||
94405918|NCT04610580|323271368|FG005|Two-way Crossover Period|Physician Decision|0|||
94405919|NCT04610580|323271363|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
94405920|NCT04610580|323271364|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
94405921|NCT04610580|323271365|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
94405922|NCT04610580|323271366|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
94405923|NCT04610580|323271367|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
94405924|NCT04610580|323271368|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
94405925|NCT04610580|323271363|FG000|Two-way Crossover Period|Other than specified|0|||
94405926|NCT04610580|323271364|FG001|Two-way Crossover Period|Other than specified|1|||
94405927|NCT04610580|323271365|FG002|Two-way Crossover Period|Other than specified|0|||
94405928|NCT04610580|323271366|FG003|Two-way Crossover Period|Other than specified|0|||
94405929|NCT04610580|323271367|FG004|Two-way Crossover Period|Other than specified|0|||
94405930|NCT04610580|323271368|FG005|Two-way Crossover Period|Other than specified|0|||
94405931|NCT04610580|323271363|FG000|Washout Before Extension Period|Other than specified|0|||
94405932|NCT04610580|323271364|FG001|Washout Before Extension Period|Other than specified|1|||
94405933|NCT04610580|323271365|FG002|Washout Before Extension Period|Other than specified|0|||
94405934|NCT04610580|323271366|FG003|Washout Before Extension Period|Other than specified|0|||
94405935|NCT04610580|323271367|FG004|Washout Before Extension Period|Other than specified|0|||
94405936|NCT04610580|323271368|FG005|Washout Before Extension Period|Other than specified|0|||
94405937|NCT04610580|323271363|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
94405938|NCT04610580|323271364|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
94405939|NCT04610580|323271365|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
94405940|NCT04610580|323271366|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
94405941|NCT04610580|323271367|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
94405942|NCT04610580|323271368|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
94405943|NCT04610580|323271363|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
94405944|NCT04610580|323271364|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
94405945|NCT04610580|323271365|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
94405946|NCT04610580|323271366|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
94405947|NCT04610580|323271367|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
94405948|NCT04610580|323271368|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
94405949|NCT02377349|323271370|FG000|Overall Study|Serious Adverse Event|1|||
94405950|NCT02377349|323271371|FG001|Overall Study|Serious Adverse Event|0|||
94405951|NCT02377349|323271370|FG000|Overall Study|Protocol Violation|3|||
94405952|NCT02377349|323271371|FG001|Overall Study|Protocol Violation|2|||
94405953|NCT02377349|323271370|FG000|Overall Study|Withdrawal by Subject|5|||
94405954|NCT02377349|323271371|FG001|Overall Study|Withdrawal by Subject|3|||
94405955|NCT02377349|323271370|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
94405956|NCT02377349|323271371|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
94405957|NCT02377349|323271370|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
94405958|NCT02377349|323271371|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
94405959|NCT02377349|323271370|FG000|Overall Study|Other|0|||
94405960|NCT02377349|323271371|FG001|Overall Study|Other|1|||
94405961|NCT04010227|323271372|FG000|Overall Study|Death|1|||
94405962|NCT04010227|323271373|FG001|Overall Study|Death|2|||
94405963|NCT04010227|323271372|FG000|Overall Study|Medical Reasons|4|||
94405964|NCT04010227|323271373|FG001|Overall Study|Medical Reasons|3|||
94405965|NCT04010227|323271372|FG000|Overall Study|Withdrawal by Subject|2|||
94405966|NCT04010227|323271373|FG001|Overall Study|Withdrawal by Subject|0|||
94405967|NCT04010227|323271372|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
94405968|NCT04010227|323271373|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
94405969|NCT00881569|323271374|FG000|Overall Study|Disease progression|1|||
94405970|NCT00881569|323271375|FG001|Overall Study|Disease progression|1|||
94405971|NCT02985398|323271376|FG000|Overall Study|Adverse Event|1|||
94405972|NCT02985398|323271376|FG000|Overall Study|Lost to Follow-up|4|||
94405973|NCT02985398|323271376|FG000|Overall Study|Withdrawal by Subject|8|||
94405974|NCT02985398|323271376|FG000|Overall Study|Study Burden|9|||
94405975|NCT01841073|323271379|FG000|Overall Study|Adverse Event|1|||
94405976|NCT01841073|323271380|FG001|Overall Study|Adverse Event|1|||
94405977|NCT01841073|323271379|FG000|Overall Study|Physician Decision|1|||
94405978|NCT01841073|323271380|FG001|Overall Study|Physician Decision|0|||
94405979|NCT01841073|323271379|FG000|Overall Study|Lost to Follow-up|0|||
94405980|NCT01841073|323271380|FG001|Overall Study|Lost to Follow-up|2|||
94405981|NCT00668395|323271381|FG000|Overall Study|Withdrawal by Subject|4|||
94405982|NCT00668395|323271382|FG001|Overall Study|Withdrawal by Subject|4|||
94405983|NCT00668395|323271383|FG002|Overall Study|Withdrawal by Subject|1|||
94405984|NCT00668395|323271381|FG000|Overall Study|Adverse Event|1|||
94405985|NCT00668395|323271382|FG001|Overall Study|Adverse Event|1|||
94405986|NCT00668395|323271383|FG002|Overall Study|Adverse Event|0|||
94405987|NCT00668395|323271381|FG000|Overall Study|Physician Decision|1|||
94405988|NCT00668395|323271382|FG001|Overall Study|Physician Decision|1|||
94405989|NCT00668395|323271383|FG002|Overall Study|Physician Decision|0|||
94405990|NCT00283842|323271384|FG000|Overall Study|Adverse Event|8|||
94405991|NCT00283842|323271385|FG001|Overall Study|Adverse Event|7|||
94405992|NCT00283842|323271386|FG002|Overall Study|Adverse Event|21|||
94405993|NCT00283842|323271387|FG003|Overall Study|Adverse Event|21|||
94405994|NCT00283842|323271388|FG004|Overall Study|Adverse Event|5|||
94405995|NCT00283842|323271384|FG000|Overall Study|Protocol Violation|1|||
94405996|NCT00283842|323271385|FG001|Overall Study|Protocol Violation|5|||
94405997|NCT00283842|323271386|FG002|Overall Study|Protocol Violation|4|||
94405998|NCT00283842|323271387|FG003|Overall Study|Protocol Violation|0|||
94405999|NCT00283842|323271388|FG004|Overall Study|Protocol Violation|0|||
94406000|NCT00283842|323271384|FG000|Overall Study|Protocol deviation|0|||
94406001|NCT00283842|323271385|FG001|Overall Study|Protocol deviation|0|||
94406002|NCT00283842|323271386|FG002|Overall Study|Protocol deviation|0|||
94406003|NCT00283842|323271387|FG003|Overall Study|Protocol deviation|0|||
94406004|NCT00283842|323271388|FG004|Overall Study|Protocol deviation|2|||
94406005|NCT00283842|323271384|FG000|Overall Study|Withdrawal by Subject|2|||
94406006|NCT00283842|323271385|FG001|Overall Study|Withdrawal by Subject|1|||
94406007|NCT00283842|323271386|FG002|Overall Study|Withdrawal by Subject|1|||
94406008|NCT00283842|323271387|FG003|Overall Study|Withdrawal by Subject|5|||
94406009|NCT00283842|323271388|FG004|Overall Study|Withdrawal by Subject|4|||
94406010|NCT00283842|323271384|FG000|Overall Study|Lack of Efficacy|1|||
94406011|NCT00283842|323271385|FG001|Overall Study|Lack of Efficacy|3|||
94406012|NCT00283842|323271386|FG002|Overall Study|Lack of Efficacy|1|||
94406013|NCT00283842|323271387|FG003|Overall Study|Lack of Efficacy|0|||
94406014|NCT00283842|323271388|FG004|Overall Study|Lack of Efficacy|3|||
94406015|NCT00283842|323271384|FG000|Overall Study|Lost to Follow-up|0|||
94406016|NCT00283842|323271385|FG001|Overall Study|Lost to Follow-up|2|||
94406017|NCT00283842|323271386|FG002|Overall Study|Lost to Follow-up|4|||
94406018|NCT00283842|323271387|FG003|Overall Study|Lost to Follow-up|1|||
94406019|NCT00283842|323271388|FG004|Overall Study|Lost to Follow-up|1|||
94406020|NCT01824498|323271391|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
94406021|NCT01824498|323271392|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
94406022|NCT01824498|323271393|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
94406023|NCT01824498|323271394|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
94406024|NCT01824498|323271395|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
94406025|NCT01824498|323271396|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
94406026|NCT00046839|323271397|FG000|Overall Study|Ineligible / No protocol treatment|0|||
94406027|NCT00046839|323271398|FG001|Overall Study|Ineligible / No protocol treatment|2|||
94406028|NCT00046839|323271397|FG000|Overall Study|Withdrawal of consent|1|||
94406029|NCT00046839|323271398|FG001|Overall Study|Withdrawal of consent|0|||
94406030|NCT02448563|323271401|FG000|Overall Study|Lost to Follow-up|16|||
94406031|NCT02448563|323271402|FG001|Overall Study|Lost to Follow-up|10|||
94406032|NCT02448563|323271401|FG000|Overall Study|Withdrawal by Subject|0|||
94406033|NCT02448563|323271402|FG001|Overall Study|Withdrawal by Subject|1|||
94406034|NCT02972515|323271407|FG000|Overall Study|Lost to Follow-up|78|||
94406035|NCT02224053|323271408|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
94406036|NCT02224053|323271408|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
94406037|NCT02224053|323271408|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
94406038|NCT02224053|323271408|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
94406039|NCT02224053|323271408|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
94406040|NCT01499160|323271416|FG000|Overall Study|Adverse Event|1|||
94406041|NCT01499160|323271416|FG000|Overall Study|Withdrawal by Subject|1|||
94406042|NCT01077258|323271422|FG000|Overall Study|Lost to Follow-up|1390|||
94406043|NCT01077258|323271422|FG000|Overall Study|Adverse drug reaction|218|||
94406044|NCT01077258|323271422|FG000|Overall Study|Lack of Efficacy|663|||
94406045|NCT01077258|323271422|FG000|Overall Study|Clinical remission|37|||
94406046|NCT01077258|323271422|FG000|Overall Study|Other reasons|260|||
94406047|NCT00726895|323271423|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
94406048|NCT00726895|323271424|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
94406049|NCT04194008|323271425|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
94406050|NCT04194008|323271425|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
94406051|NCT04194008|323271425|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
94406052|NCT04194008|323271425|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
94406053|NCT04194008|323271425|FG000|Treatment Phase With Nerivio|Missing data|4|||
94406054|NCT04194008|323271425|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
94406055|NCT00982228|323271439|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
94406056|NCT00982228|323271440|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
94406057|NCT00982228|323271439|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
94406058|NCT00982228|323271440|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
94406059|NCT00982228|323271439|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
94406060|NCT00982228|323271440|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
94406061|NCT00982228|323271439|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
94406062|NCT00982228|323271440|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
94406063|NCT00982228|323271439|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
94406064|NCT00982228|323271440|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
94406065|NCT00982228|323271439|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
94406066|NCT00982228|323271440|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
94406067|NCT00982228|323271439|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
94406068|NCT00982228|323271440|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
94406069|NCT00982228|323271439|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
94406070|NCT00982228|323271440|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
94406071|NCT00982228|323271439|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
94406072|NCT00982228|323271440|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
94406073|NCT00982228|323271439|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
94406074|NCT00982228|323271440|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
94406075|NCT01203917|323271441|FG000|Overall Study|Death|29|||
94406076|NCT01203917|323271441|FG000|Overall Study|Lost to Follow-up|2|||
94406077|NCT01203917|323271441|FG000|Overall Study|Withdrawal by Subject|3|||
94406078|NCT01203917|323271441|FG000|Overall Study|Due to objective disease progression|1|||
94406079|NCT01203917|323271441|FG000|Overall Study|Due to EGFR M+I patient|1|||
94406080|NCT01115933|323271442|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
94406081|NCT03294317|323271443|FG000|Overall Study|Physician Decision|1|||
94406082|NCT03294317|323271443|FG000|Overall Study|Withdrawal by Subject|6|||
94406083|NCT03294317|323271443|FG000|Overall Study|Lost to Follow-up|1|||
94406084|NCT03294317|323271443|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
94406085|NCT03294317|323271443|FG000|Overall Study|Failed HB lead implant|8|||
94406086|NCT03294317|323271443|FG000|Overall Study|Received CRT instead|1|||
94406087|NCT03294317|323271443|FG000|Overall Study|Exited after lead revision|2|||
94406088|NCT04979858|323271446|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
94406089|NCT04979858|323271447|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
94406090|NCT01896505|323271448|FG000|Overall Study|Adverse Event|1|||
94406091|NCT01896505|323271449|FG001|Overall Study|Adverse Event|0|||
94406092|NCT01896505|323271450|FG002|Overall Study|Adverse Event|2|||
94406093|NCT01896505|323271451|FG003|Overall Study|Adverse Event|1|||
94406094|NCT01896505|323271452|FG004|Overall Study|Adverse Event|1|||
94406095|NCT01896505|323271453|FG005|Overall Study|Adverse Event|0|||
94406096|NCT01896505|323271448|FG000|Overall Study|Physician Decision|1|||
94406097|NCT01896505|323271449|FG001|Overall Study|Physician Decision|3|||
94406098|NCT01896505|323271450|FG002|Overall Study|Physician Decision|2|||
94406099|NCT01896505|323271451|FG003|Overall Study|Physician Decision|0|||
94406100|NCT01896505|323271452|FG004|Overall Study|Physician Decision|0|||
94406101|NCT01896505|323271453|FG005|Overall Study|Physician Decision|1|||
94406102|NCT01896505|323271448|FG000|Overall Study|Withdrawal by Subject|1|||
94406103|NCT01896505|323271449|FG001|Overall Study|Withdrawal by Subject|0|||
94406104|NCT01896505|323271450|FG002|Overall Study|Withdrawal by Subject|3|||
94406105|NCT01896505|323271451|FG003|Overall Study|Withdrawal by Subject|1|||
94406106|NCT01896505|323271452|FG004|Overall Study|Withdrawal by Subject|0|||
94406107|NCT01896505|323271453|FG005|Overall Study|Withdrawal by Subject|0|||
94406108|NCT01896505|323271448|FG000|Overall Study|Disease Progression|7|||
94406109|NCT01896505|323271449|FG001|Overall Study|Disease Progression|5|||
94406110|NCT01896505|323271450|FG002|Overall Study|Disease Progression|8|||
94406111|NCT01896505|323271451|FG003|Overall Study|Disease Progression|4|||
94406112|NCT01896505|323271452|FG004|Overall Study|Disease Progression|4|||
94406113|NCT01896505|323271453|FG005|Overall Study|Disease Progression|4|||
94406114|NCT01896505|323271448|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
94406115|NCT01896505|323271449|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
94406116|NCT01896505|323271450|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
94406117|NCT01896505|323271451|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
94406118|NCT01896505|323271452|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
94406119|NCT01896505|323271453|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
94406120|NCT01896505|323271448|FG000|Overall Study|Intercurrent illness|0|||
94406121|NCT01896505|323271449|FG001|Overall Study|Intercurrent illness|1|||
94406122|NCT01896505|323271450|FG002|Overall Study|Intercurrent illness|0|||
94406123|NCT01896505|323271451|FG003|Overall Study|Intercurrent illness|0|||
94406124|NCT01896505|323271452|FG004|Overall Study|Intercurrent illness|0|||
94406125|NCT01896505|323271453|FG005|Overall Study|Intercurrent illness|0|||
94406126|NCT01896505|323271448|FG000|Overall Study|Death|0|||
94406127|NCT01896505|323271449|FG001|Overall Study|Death|0|||
94406128|NCT01896505|323271450|FG002|Overall Study|Death|1|||
94406129|NCT01896505|323271451|FG003|Overall Study|Death|1|||
94406130|NCT01896505|323271452|FG004|Overall Study|Death|0|||
94406131|NCT01896505|323271453|FG005|Overall Study|Death|1|||
94406132|NCT01709903|323271458|FG000|Overall Study|administrative problems|2|||
94406133|NCT01709903|323271459|FG001|Overall Study|administrative problems|6|||
94406134|NCT01709903|323271458|FG000|Overall Study|Abnormal test procedure results|1|||
94406135|NCT01709903|323271459|FG001|Overall Study|Abnormal test procedure results|0|||
94406136|NCT01709903|323271458|FG000|Overall Study|In ability to use device|1|||
94406137|NCT01709903|323271459|FG001|Overall Study|In ability to use device|1|||
94406138|NCT01709903|323271458|FG000|Overall Study|no longer needed study drug|0|||
94406139|NCT01709903|323271459|FG001|Overall Study|no longer needed study drug|1|||
94406140|NCT01709903|323271458|FG000|Overall Study|Lost to Follow-up|0|||
94406141|NCT01709903|323271459|FG001|Overall Study|Lost to Follow-up|2|||
94406142|NCT01709903|323271458|FG000|Overall Study|Death|2|||
94406143|NCT01709903|323271459|FG001|Overall Study|Death|0|||
94406144|NCT01709903|323271458|FG000|Overall Study|Protocol Violation|3|||
94406145|NCT01709903|323271459|FG001|Overall Study|Protocol Violation|2|||
94406146|NCT01709903|323271458|FG000|Overall Study|Lack of Efficacy|3|||
94406147|NCT01709903|323271459|FG001|Overall Study|Lack of Efficacy|3|||
94406148|NCT01709903|323271458|FG000|Overall Study|Withdrawal by Subject|6|||
94406149|NCT01709903|323271459|FG001|Overall Study|Withdrawal by Subject|6|||
94406150|NCT01709903|323271458|FG000|Overall Study|Adverse Event|11|||
94406151|NCT01709903|323271459|FG001|Overall Study|Adverse Event|18|||
94406152|NCT02005562|323272983|FG000|Overall Study|Death|2|||
94406153|NCT02005562|323272984|FG001|Overall Study|Death|2|||
94406154|NCT02005562|323272983|FG000|Overall Study|Graft loss|7|||
94406155|NCT02005562|323272984|FG001|Overall Study|Graft loss|6|||
94406156|NCT02005562|323272983|FG000|Overall Study|Withdrawal by Subject|2|||
94406157|NCT02005562|323272984|FG001|Overall Study|Withdrawal by Subject|2|||
94406158|NCT02005562|323272983|FG000|Overall Study|No transplant|1|||
94406159|NCT02005562|323272984|FG001|Overall Study|No transplant|4|||
94406160|NCT02005562|323272983|FG000|Overall Study|Physician Decision|0|||
94406161|NCT02005562|323272984|FG001|Overall Study|Physician Decision|1|||
94406162|NCT01622660|323272985|FG000|Overall Study|Adverse Event|1|||
94406163|NCT04812548|323272986|FG000|Overall Study|Adverse Event|2|||
94406164|NCT04812548|323272987|FG001|Overall Study|Adverse Event|7|||
94406165|NCT04812548|323272986|FG000|Overall Study|HSCT Planned|2|||
94406166|NCT04812548|323272987|FG001|Overall Study|HSCT Planned|3|||
94406167|NCT04812548|323272986|FG000|Overall Study|Progressive Disease|0|||
94406168|NCT04812548|323272987|FG001|Overall Study|Progressive Disease|2|||
94406169|NCT04812548|323272986|FG000|Overall Study|Death|0|||
94406170|NCT04812548|323272987|FG001|Overall Study|Death|1|||
94406171|NCT04812548|323272986|FG000|Overall Study|Post Study Access to Treatment|0|||
94406172|NCT04812548|323272987|FG001|Overall Study|Post Study Access to Treatment|1|||
94406173|NCT04812548|323272986|FG000|Overall Study|Withdrawal by Subject|0|||
94406174|NCT04812548|323272987|FG001|Overall Study|Withdrawal by Subject|1|||
94406175|NCT04812548|323272986|FG000|Overall Study|Physician Decision|1|||
94406176|NCT04812548|323272987|FG001|Overall Study|Physician Decision|0|||
94406177|NCT00754052|323272993|FG000|Overall Study|Study terminated by Sponsor|5|||
94406178|NCT00754052|323272994|FG001|Overall Study|Study terminated by Sponsor|3|||
94406179|NCT03686215|323272999|FG000|Overall Study|Adverse Event|0|||
94406180|NCT03686215|323273000|FG001|Overall Study|Adverse Event|0|||
94406181|NCT03686215|323273001|FG002|Overall Study|Adverse Event|7|||
94406182|NCT03686215|323272999|FG000|Overall Study|Physician Decision|0|||
94406183|NCT03686215|323273000|FG001|Overall Study|Physician Decision|0|||
94406184|NCT03686215|323273001|FG002|Overall Study|Physician Decision|1|||
94406185|NCT03686215|323272999|FG000|Overall Study|Protocol Violation|0|||
94406186|NCT03686215|323273000|FG001|Overall Study|Protocol Violation|0|||
94406187|NCT03686215|323273001|FG002|Overall Study|Protocol Violation|4|||
94406188|NCT03686215|323272999|FG000|Overall Study|Device issue|1|||
94406189|NCT03686215|323273000|FG001|Overall Study|Device issue|0|||
94406190|NCT03686215|323273001|FG002|Overall Study|Device issue|2|||
94406191|NCT02485158|323273005|FG000|Overall Study|Withdrawal by Subject|3|||
94406192|NCT02485158|323273005|FG000|Overall Study|expected drug side effect|1|||
94406193|NCT01188226|323273006|FG000|Overall Study|Withdrawal by Subject|4|||
94406194|NCT04980456|323273009|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
94406195|NCT04980456|323273010|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
94406196|NCT04980456|323273009|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
94406197|NCT04980456|323273010|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
94406198|NCT04980456|323273009|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
94406199|NCT04980456|323273010|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
94406200|NCT04980456|323273009|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
94406201|NCT04980456|323273010|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
94406202|NCT02846883|323273011|FG000|Overall Study|Death|0|||
94406203|NCT02846883|323273012|FG001|Overall Study|Death|1|||
94406204|NCT02846883|323273013|FG002|Overall Study|Death|1|||
94406205|NCT02846883|323273011|FG000|Overall Study|Lost to Follow-up|0|||
94406206|NCT02846883|323273012|FG001|Overall Study|Lost to Follow-up|0|||
94406207|NCT02846883|323273013|FG002|Overall Study|Lost to Follow-up|1|||
94406208|NCT02846883|323273011|FG000|Overall Study|Withdrawal by Subject|1|||
94406209|NCT02846883|323273012|FG001|Overall Study|Withdrawal by Subject|0|||
94406210|NCT02846883|323273013|FG002|Overall Study|Withdrawal by Subject|0|||
94406211|NCT02846883|323273011|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
94406212|NCT02846883|323273012|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
94406213|NCT02846883|323273013|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
94406214|NCT02846883|323273011|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
94406215|NCT02846883|323273012|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
94406216|NCT02846883|323273013|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
94406217|NCT04768296|323273014|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
94406218|NCT04768296|323273015|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
94406219|NCT00442351|323273016|FG000|Overall Study|Administrative|6|||
94406220|NCT00442351|323273017|FG001|Overall Study|Administrative|5|||
94406221|NCT00442351|323273016|FG000|Overall Study|Did not meet protocol eligibility|1|||
94406222|NCT00442351|323273017|FG001|Overall Study|Did not meet protocol eligibility|0|||
94406223|NCT00442351|323273016|FG000|Overall Study|Other|0|||
94406224|NCT00442351|323273017|FG001|Overall Study|Other|1|||
94406225|NCT03087786|323273022|FG000|Overall Study|Withdrawal by Subject|2|||
94406226|NCT03087786|323273023|FG001|Overall Study|Withdrawal by Subject|0|||
94406227|NCT03035890|323273025|FG000|Overall Study|Death|1|||
94406228|NCT03243396|323273026|FG000|Overall Study|Lost to Follow-up|2|||
94406229|NCT03243396|323273027|FG001|Overall Study|Lost to Follow-up|3|||
94406230|NCT03243396|323273028|FG002|Overall Study|Lost to Follow-up|15|||
94406231|NCT03243396|323273029|FG003|Overall Study|Lost to Follow-up|8|||
94406232|NCT03243396|323273030|FG004|Overall Study|Lost to Follow-up|1|||
94406233|NCT03243396|323273031|FG005|Overall Study|Lost to Follow-up|4|||
94406234|NCT03243396|323273032|FG006|Overall Study|Lost to Follow-up|9|||
94406235|NCT03687242|323273033|FG000|Overall Study|Adverse Event|1|||
94406236|NCT00960154|323273034|FG000|Overall Study|Study termination|25|||
94406237|NCT00960154|323273035|FG001|Overall Study|Study termination|25|||
94406238|NCT00377156|323273036|FG000|Overall Study|Death|23|||
94406239|NCT00377156|323273037|FG001|Overall Study|Death|19|||
94406240|NCT00377156|323273036|FG000|Overall Study|Withdrawal by Subject|16|||
94406241|NCT00377156|323273037|FG001|Overall Study|Withdrawal by Subject|24|||
94406242|NCT00377156|323273036|FG000|Overall Study|Had follow-up <90 d|3|||
94406243|NCT00377156|323273037|FG001|Overall Study|Had follow-up <90 d|6|||
94406244|NCT00377156|323273036|FG000|Overall Study|Cancellation|1|||
94406245|NCT00377156|323273037|FG001|Overall Study|Cancellation|0|||
94406246|NCT00377156|323273036|FG000|Overall Study|Refused testing|0|||
94406247|NCT00377156|323273037|FG001|Overall Study|Refused testing|1|||
94406248|NCT00377156|323273036|FG000|Overall Study|Ineligible|0|||
94406249|NCT00377156|323273037|FG001|Overall Study|Ineligible|1|||
94406250|NCT00377156|323273036|FG000|Overall Study|Disability or language problem|0|||
94406251|NCT00377156|323273037|FG001|Overall Study|Disability or language problem|1|||
94406252|NCT00377156|323273036|FG000|Overall Study|Other|5|||
94406253|NCT00377156|323273037|FG001|Overall Study|Other|2|||
94406254|NCT00799708|323273038|FG000|Overall Study|non-compliance|1|||
94406255|NCT00799708|323273039|FG001|Overall Study|non-compliance|0|||
94406256|NCT00799708|323273040|FG002|Overall Study|non-compliance|0|||
94406257|NCT02655224|323273045|FG000|Overall Study|Adverse Event|1|||
94406258|NCT02655224|323273046|FG001|Overall Study|Adverse Event|1|||
94406259|NCT02327325|323273057|FG000|Overall Study|Withdrawal by Subject|1|||
94406260|NCT02327325|323273058|FG001|Overall Study|Withdrawal by Subject|4|||
94406261|NCT02327325|323273059|FG002|Overall Study|Withdrawal by Subject|4|||
94406262|NCT02327325|323273057|FG000|Overall Study|Excluded by Study Team|0|||
94406263|NCT02327325|323273058|FG001|Overall Study|Excluded by Study Team|0|||
94406264|NCT02327325|323273059|FG002|Overall Study|Excluded by Study Team|1|||
94406265|NCT00695110|323273060|FG000|Treatment Period 1|Adverse Event|1|||
94406266|NCT00695110|323273060|FG000|Treatment Period 1|Withdrawal by Subject|2|||
94406267|NCT00695110|323273060|FG000|Treatment Period 3|Withdrawal by Subject|1|||
94406268|NCT00695110|323273060|FG000|Treatment Period 4|Adverse Event|1|||
94406269|NCT00348816|323273061|FG000|Overall Study|Noncompliance with radiation treatment|1|||
94406270|NCT03008005|323273067|FG000|Overall Study|Physician Decision|1|||
94406271|NCT03008005|323273068|FG001|Overall Study|Physician Decision|0|||
94406272|NCT03008005|323273069|FG002|Overall Study|Physician Decision|0|||
94406273|NCT03008005|323273067|FG000|Overall Study|Withdrawal by Subject|1|||
94406274|NCT03008005|323273068|FG001|Overall Study|Withdrawal by Subject|0|||
94406275|NCT03008005|323273069|FG002|Overall Study|Withdrawal by Subject|0|||
94406276|NCT03008005|323273067|FG000|Overall Study|Ineligible|0|||
94406277|NCT03008005|323273068|FG001|Overall Study|Ineligible|1|||
94406278|NCT03008005|323273069|FG002|Overall Study|Ineligible|0|||
94406279|NCT00743145|323273072|FG000|Overall Study|Withdrawal by Subject|1|||
94406280|NCT00743145|323273072|FG000|Overall Study|Adverse Event|2|||
94406281|NCT00743145|323273072|FG000|Overall Study|Pregnancy|1|||
94406282|NCT01583530|323273073|FG000|Overall Study|Adverse Event|0|||
94406283|NCT01583530|323273074|FG001|Overall Study|Adverse Event|0|||
94406284|NCT01583530|323273075|FG002|Overall Study|Adverse Event|0|||
94406285|NCT01583530|323273076|FG003|Overall Study|Adverse Event|0|||
94406286|NCT01583530|323273077|FG004|Overall Study|Adverse Event|0|||
94406287|NCT01583530|323273078|FG005|Overall Study|Adverse Event|1|||
94406288|NCT01583530|323273073|FG000|Overall Study|Withdrawal by Subject|0|||
94406289|NCT01583530|323273074|FG001|Overall Study|Withdrawal by Subject|3|||
94406290|NCT01583530|323273075|FG002|Overall Study|Withdrawal by Subject|0|||
94406291|NCT01583530|323273076|FG003|Overall Study|Withdrawal by Subject|1|||
94406292|NCT01583530|323273077|FG004|Overall Study|Withdrawal by Subject|1|||
94406293|NCT01583530|323273078|FG005|Overall Study|Withdrawal by Subject|2|||
94406294|NCT01583530|323273073|FG000|Overall Study|Lost to Follow-up|0|||
94406295|NCT01583530|323273074|FG001|Overall Study|Lost to Follow-up|0|||
94406296|NCT01583530|323273075|FG002|Overall Study|Lost to Follow-up|0|||
94406297|NCT01583530|323273076|FG003|Overall Study|Lost to Follow-up|0|||
94406298|NCT01583530|323273077|FG004|Overall Study|Lost to Follow-up|3|||
94406299|NCT01583530|323273078|FG005|Overall Study|Lost to Follow-up|0|||
94406300|NCT01583530|323273073|FG000|Overall Study|Lack of compliance|0|||
94406301|NCT01583530|323273074|FG001|Overall Study|Lack of compliance|0|||
94406302|NCT01583530|323273075|FG002|Overall Study|Lack of compliance|0|||
94406303|NCT01583530|323273076|FG003|Overall Study|Lack of compliance|0|||
94406304|NCT01583530|323273077|FG004|Overall Study|Lack of compliance|1|||
94406305|NCT01583530|323273078|FG005|Overall Study|Lack of compliance|0|||
94406306|NCT02351167|323273079|FG000|Overall Study|Withdrawal by Subject|19|||
94406307|NCT02351167|323273080|FG001|Overall Study|Withdrawal by Subject|18|||
94406308|NCT02351167|323273081|FG002|Overall Study|Withdrawal by Subject|21|||
94406309|NCT03750695|323273088|FG000|Overall Study|Lost to Follow-up|0|||
94406310|NCT03750695|323273089|FG001|Overall Study|Lost to Follow-up|1|||
94406311|NCT02250651|323273090|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
94406312|NCT02250651|323273091|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
94406313|NCT02250651|323273092|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
94406314|NCT02250651|323273090|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
94406315|NCT02250651|323273091|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
94406316|NCT02250651|323273092|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
94406317|NCT02250651|323273090|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
94406318|NCT02250651|323273091|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
94406319|NCT02250651|323273092|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
94406320|NCT02250651|323273090|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
94406321|NCT02250651|323273091|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
94406322|NCT02250651|323273092|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
94406323|NCT02250651|323273090|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
94406324|NCT02250651|323273091|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
94406325|NCT02250651|323273092|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
94406326|NCT02250651|323273090|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
94406327|NCT02250651|323273091|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
94406328|NCT02250651|323273092|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
94406329|NCT02250651|323273090|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
94406330|NCT02250651|323273091|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
94406331|NCT02250651|323273092|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
94406332|NCT02250651|323273090|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
94406333|NCT02250651|323273091|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
94406334|NCT02250651|323273092|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
94406335|NCT02250651|323273090|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
94406336|NCT02250651|323273091|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
94406337|NCT02250651|323273092|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
94406338|NCT02250651|323273090|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
94406339|NCT02250651|323273091|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
94406340|NCT02250651|323273092|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
94406341|NCT02250651|323273090|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
94406342|NCT02250651|323273091|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
94406343|NCT02250651|323273092|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
94406344|NCT02250651|323273090|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
94406345|NCT02250651|323273091|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
94406346|NCT02250651|323273092|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
94406347|NCT02250651|323273090|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
94406348|NCT02250651|323273091|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
94406349|NCT02250651|323273092|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
94406350|NCT02250651|323273090|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
94406351|NCT02250651|323273091|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
94406352|NCT02250651|323273092|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
94406353|NCT02250651|323273090|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
94406354|NCT02250651|323273091|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
94406355|NCT02250651|323273092|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
94406356|NCT01685216|323273095|FG000|Overall Study|Did not receive study drug|1|||
94406357|NCT00756717|323273096|FG000|Overall Study|Withdrawal by Subject|2|||
94406358|NCT02654015|323273097|FG000|Overall Study|Death|12|||
94406359|NCT02654015|323273097|FG000|Overall Study|Lost to Follow-up|3|||
94406360|NCT00879684|323273101|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
94406361|NCT00879684|323273102|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
94406362|NCT00879684|323273103|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
94406363|NCT00879684|323273104|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
94406364|NCT00879684|323273105|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
94406365|NCT00879684|323273106|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
94485576|NCT02810418|323571903|FG004|Arm B Dose Escalation|Adverse Event|1|||
94485577|NCT02810418|323571904|FG005|Arm B Dose Escalation|Adverse Event|2|||
94485578|NCT02810418|323571905|FG006|Arm B Dose Escalation|Adverse Event|0|||
94485579|NCT00116688|323571906|FG000|Overall Study|Protocol deviation|1|||
94485580|NCT00116688|323571907|FG001|Overall Study|Protocol deviation|0|||
94485581|NCT00116688|323571906|FG000|Overall Study|Noncompliance|3|||
94485582|NCT00116688|323571907|FG001|Overall Study|Noncompliance|1|||
94485583|NCT00116688|323571906|FG000|Overall Study|Adverse Event|11|||
94485584|NCT00116688|323571907|FG001|Overall Study|Adverse Event|0|||
94485585|NCT00116688|323571906|FG000|Overall Study|Withdrawal by Subject|26|||
94406366|NCT00879684|323273107|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
94406367|NCT00879684|323273101|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
94406368|NCT00879684|323273102|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
94406369|NCT00879684|323273103|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
94406370|NCT00879684|323273104|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
94406371|NCT00879684|323273105|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
94406372|NCT00879684|323273106|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
94406373|NCT00879684|323273107|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
94406374|NCT00879684|323273101|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
94406375|NCT00879684|323273102|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
94406376|NCT00879684|323273103|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
94406377|NCT00879684|323273104|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
94406378|NCT00879684|323273105|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
94406379|NCT00879684|323273106|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
94406380|NCT00879684|323273107|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
94406381|NCT00879684|323273101|FG000|Stage 1: Dose Escalation|Death|0|||
94406382|NCT00879684|323273102|FG001|Stage 1: Dose Escalation|Death|0|||
94406383|NCT00879684|323273103|FG002|Stage 1: Dose Escalation|Death|1|||
94406384|NCT00879684|323273104|FG003|Stage 1: Dose Escalation|Death|0|||
94406385|NCT00879684|323273105|FG004|Stage 1: Dose Escalation|Death|0|||
94406386|NCT00879684|323273106|FG005|Stage 1: Dose Escalation|Death|0|||
94406387|NCT00879684|323273107|FG006|Stage 1: Dose Escalation|Death|0|||
94406388|NCT00879684|323273101|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
94406389|NCT00879684|323273102|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
94406390|NCT00879684|323273103|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
94406391|NCT00879684|323273104|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
94406392|NCT00879684|323273105|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
94406393|NCT00879684|323273106|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
94406394|NCT00879684|323273107|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
94406395|NCT00879684|323273101|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
94406396|NCT00879684|323273102|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
94406397|NCT00879684|323273103|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
94406398|NCT00879684|323273104|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
94406399|NCT00879684|323273105|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
94406400|NCT00879684|323273106|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
94406401|NCT00879684|323273107|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
94406402|NCT00879684|323273101|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
94406403|NCT00879684|323273102|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
94406404|NCT00879684|323273103|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
94406405|NCT00879684|323273104|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
94406406|NCT00879684|323273105|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
94406407|NCT00879684|323273106|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
94406408|NCT00879684|323273107|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
94406409|NCT00127166|323273108|FG000|Period I|Protocol Violation|0|||
94406410|NCT00127166|323273109|FG001|Period I|Protocol Violation|2|||
94406411|NCT00127166|323273108|FG000|Period I|Withdrawal by Subject|2|||
94406412|NCT00127166|323273109|FG001|Period I|Withdrawal by Subject|0|||
94406413|NCT00127166|323273108|FG000|Period I|Patient did not meet inclusion criteria|1|||
94406414|NCT00127166|323273109|FG001|Period I|Patient did not meet inclusion criteria|0|||
94406415|NCT00127166|323273108|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
94406416|NCT00127166|323273109|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
94406417|NCT00127166|323273108|FG000|Period II|Withdrawal by Subject|2|||
94406418|NCT00127166|323273109|FG001|Period II|Withdrawal by Subject|0|||
94406419|NCT00127166|323273108|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
94406420|NCT00127166|323273109|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
94406421|NCT00105157|323273110|FG000|Double-Blind (DB)|Never Treated|1|||
94406422|NCT00105157|323273111|FG001|Double-Blind (DB)|Never Treated|0|||
94406423|NCT00105157|323273112|FG002|Double-Blind (DB)|Never Treated|0|||
94485586|NCT00116688|323571907|FG001|Overall Study|Withdrawal by Subject|2|||
94406424|NCT00105157|323273113|FG003|Double-Blind (DB)|Never Treated|0|||
94406425|NCT00105157|323273110|FG000|Double-Blind (DB)|Adverse Event|2|||
94406426|NCT00105157|323273111|FG001|Double-Blind (DB)|Adverse Event|0|||
94406427|NCT00105157|323273112|FG002|Double-Blind (DB)|Adverse Event|1|||
94406428|NCT00105157|323273113|FG003|Double-Blind (DB)|Adverse Event|1|||
94406429|NCT00105157|323273110|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
94406430|NCT00105157|323273111|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
94406431|NCT00105157|323273112|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
94406432|NCT00105157|323273113|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
94406433|NCT00105157|323273110|FG000|Open-Label Continuation of DB|Adverse Event|3|||
94406434|NCT00105157|323273111|FG001|Open-Label Continuation of DB|Adverse Event|1|||
94406435|NCT00105157|323273112|FG002|Open-Label Continuation of DB|Adverse Event|0|||
94485587|NCT00116688|323571906|FG000|Overall Study|Requirement for alternative therapy|11|||
94485588|NCT00116688|323571907|FG001|Overall Study|Requirement for alternative therapy|1|||
94485589|NCT00116688|323571906|FG000|Overall Study|Physician Decision|7|||
94485590|NCT00116688|323571907|FG001|Overall Study|Physician Decision|0|||
94485591|NCT00116688|323571906|FG000|Overall Study|Lost to Follow-up|3|||
94485592|NCT00116688|323571907|FG001|Overall Study|Lost to Follow-up|0|||
94485593|NCT00116688|323571906|FG000|Overall Study|Death|15|||
94485594|NCT00116688|323571907|FG001|Overall Study|Death|0|||
94485595|NCT00116688|323571906|FG000|Overall Study|Protocol-specified criteria|3|||
94485596|NCT00116688|323571907|FG001|Overall Study|Protocol-specified criteria|0|||
94485597|NCT00116688|323571906|FG000|Overall Study|Pregnancy|1|||
94485598|NCT00116688|323571907|FG001|Overall Study|Pregnancy|0|||
94485599|NCT00116688|323571906|FG000|Overall Study|Other|11|||
94485600|NCT00116688|323571907|FG001|Overall Study|Other|0|||
94485601|NCT04006145|323571908|FG000|Overall Study|Lost to Follow-up|0|||
94485602|NCT04006145|323571909|FG001|Overall Study|Lost to Follow-up|1|||
94485603|NCT04006145|323571908|FG000|Overall Study|Other|1|||
94485604|NCT04006145|323571909|FG001|Overall Study|Other|2|||
94485605|NCT01573000|323571912|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
94485606|NCT01573000|323571913|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
94485607|NCT01573000|323571912|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
94485608|NCT01573000|323571913|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
94485609|NCT01573000|323571912|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
94485610|NCT01573000|323571913|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
94485611|NCT01573000|323571912|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
94485612|NCT01573000|323571913|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
94485613|NCT01573000|323571912|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
94485614|NCT01573000|323571913|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
94485615|NCT01573000|323571912|FG000|Crossover Phase|Lack of Efficacy|0|||
94485616|NCT01573000|323571913|FG001|Crossover Phase|Lack of Efficacy|13|||
94485617|NCT01573000|323571912|FG000|Crossover Phase|Lost to Follow-up|0|||
94485618|NCT01573000|323571913|FG001|Crossover Phase|Lost to Follow-up|2|||
94485619|NCT01573000|323571912|FG000|Crossover Phase|Death|0|||
94485620|NCT01573000|323571913|FG001|Crossover Phase|Death|3|||
94485621|NCT01573000|323571912|FG000|Long-Term Follow-Up|Death|3|||
94485622|NCT01573000|323571913|FG001|Long-Term Follow-Up|Death|0|||
94485623|NCT01573000|323571912|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
94485624|NCT01573000|323571913|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
94485625|NCT00619827|323571917|FG000|Overall Study|Adverse Event|1|||
94485626|NCT00619827|323571918|FG001|Overall Study|Adverse Event|2|||
94485627|NCT00619827|323571917|FG000|Overall Study|Withdrawal by Subject|2|||
94485628|NCT00619827|323571918|FG001|Overall Study|Withdrawal by Subject|2|||
94485629|NCT00789321|323571919|FG000|Overall Study|Adverse Event|0|||
94485630|NCT00789321|323571920|FG001|Overall Study|Adverse Event|1|||
94485631|NCT03964207|323571928|FG000|First Treatment|Withdrawal by Subject|1|||
94485632|NCT03964207|323571929|FG001|First Treatment|Withdrawal by Subject|2|||
94485633|NCT03964207|323571928|FG000|First Treatment|Protocol Violation|1|||
94485634|NCT03964207|323571929|FG001|First Treatment|Protocol Violation|0|||
94485635|NCT03964207|323571928|FG000|First Treatment|Lost to Follow-up|1|||
94485636|NCT03964207|323571929|FG001|First Treatment|Lost to Follow-up|0|||
94485637|NCT03964207|323571928|FG000|Second Treatment|Lost to Follow-up|0|||
94485638|NCT03964207|323571929|FG001|Second Treatment|Lost to Follow-up|1|||
94485639|NCT03964207|323571928|FG000|Second Treatment|Adverse Event|1|||
94485640|NCT03964207|323571929|FG001|Second Treatment|Adverse Event|2|||
94485641|NCT01930539|323571930|FG000|Overall Study|Withdrawal by Subject|2|||
94485642|NCT01930539|323571931|FG001|Overall Study|Withdrawal by Subject|2|||
94485643|NCT01190891|323571936|FG000|Overall Study|Protocol Violation|1|||
94485644|NCT01190891|323571937|FG001|Overall Study|Protocol Violation|0|||
94485645|NCT01190891|323571936|FG000|Overall Study|Withdrawal by Subject|5|||
94485646|NCT01190891|323571937|FG001|Overall Study|Withdrawal by Subject|0|||
94485647|NCT01218308|323571942|FG000|Overall Study|Adverse Event|1|||
94485648|NCT01218308|323571943|FG001|Overall Study|Adverse Event|2|||
94485649|NCT01218308|323571942|FG000|Overall Study|Protocol Violation|0|||
94485650|NCT01218308|323571943|FG001|Overall Study|Protocol Violation|2|||
94485651|NCT01218308|323571942|FG000|Overall Study|Withdrawal by Subject|61|||
94485652|NCT01218308|323571943|FG001|Overall Study|Withdrawal by Subject|64|||
94485653|NCT01218308|323571942|FG000|Overall Study|Lost to Follow-up|27|||
94485654|NCT01218308|323571943|FG001|Overall Study|Lost to Follow-up|31|||
94485655|NCT01218308|323571942|FG000|Overall Study|Other|14|||
94485656|NCT01218308|323571943|FG001|Overall Study|Other|21|||
94485657|NCT01587885|323571944|FG000|Treatment Period 1|Failure to Return|0|||
94485658|NCT01587885|323571945|FG001|Treatment Period 1|Failure to Return|1|||
94485659|NCT01587885|323571944|FG000|Treatment Period 1|Protocol Violation|0|||
94485660|NCT01587885|323571945|FG001|Treatment Period 1|Protocol Violation|2|||
94485661|NCT03885908|323571946|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
94485662|NCT03885908|323571947|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
94512831|NCT00725985|323676429|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
94406436|NCT00105157|323273113|FG003|Open-Label Continuation of DB|Adverse Event|0|||
94406437|NCT00105157|323273110|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
94406438|NCT00105157|323273111|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
94406439|NCT00105157|323273112|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
94406440|NCT00105157|323273113|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
94406441|NCT00105157|323273110|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
94406442|NCT00105157|323273111|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
94406443|NCT00105157|323273112|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
94406444|NCT00105157|323273113|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
94406445|NCT00105157|323273110|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
94406446|NCT00105157|323273111|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
94406447|NCT00105157|323273112|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
94406448|NCT00105157|323273113|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
94406449|NCT00105157|323273110|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
94406450|NCT00105157|323273111|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
94406451|NCT00105157|323273112|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
94406452|NCT00105157|323273113|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
94406453|NCT00105157|323273110|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
94406454|NCT00105157|323273111|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
94406455|NCT00105157|323273112|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
94406456|NCT00105157|323273113|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
94406457|NCT00105157|323273110|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
94406458|NCT00105157|323273111|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
94406459|NCT00105157|323273112|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
94406460|NCT00105157|323273113|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
94406461|NCT00105157|323273110|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
94406462|NCT00105157|323273111|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
94406463|NCT00105157|323273112|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
94406464|NCT00105157|323273113|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
94406465|NCT00105157|323273110|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
94406466|NCT00105157|323273111|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
94406467|NCT00105157|323273112|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
94406468|NCT00105157|323273113|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
94406469|NCT00105157|323273110|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
94406470|NCT00105157|323273111|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
94406471|NCT00105157|323273112|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
94406472|NCT00105157|323273113|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
94406473|NCT00105157|323273110|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
94406474|NCT00105157|323273111|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
94406475|NCT00105157|323273112|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
94406476|NCT00105157|323273113|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
94406477|NCT01160640|323273114|FG000|Overall Study|Physician Decision|3|||
94406478|NCT01160640|323273115|FG001|Overall Study|Physician Decision|3|||
94406479|NCT01160640|323273114|FG000|Overall Study|Incarceration|1|||
94406480|NCT01160640|323273115|FG001|Overall Study|Incarceration|0|||
94406481|NCT01160640|323273114|FG000|Overall Study|Withdrawal by Subject|0|||
94406482|NCT01160640|323273115|FG001|Overall Study|Withdrawal by Subject|3|||
94406483|NCT00708682|323273118|FG000|Infant Series|Adverse Event|1|||
94406484|NCT00708682|323273118|FG000|Infant Series|Lost to Follow-up|4|||
94406485|NCT00708682|323273118|FG000|Infant Series|Protocol Violation|1|||
94406486|NCT00708682|323273118|FG000|Infant Series|Parent/legal guardian request|6|||
94406487|NCT00708682|323273118|FG000|Infant Series|Failed to return|2|||
94406488|NCT00708682|323273118|FG000|Infant Series|Other|19|||
94406489|NCT00708682|323273118|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
94406490|NCT00708682|323273118|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
94406491|NCT00708682|323273118|FG000|Toddler Dose|Lost to Follow-up|3|||
94406492|NCT00708682|323273118|FG000|Toddler Dose|Failed to Return|4|||
94406493|NCT01148225|323273125|FG000|Overall Study|Other|185|||
94406494|NCT00420095|323273131|FG000|Overall Study|Adverse Event|1|||
94406495|NCT00420095|323273132|FG001|Overall Study|Adverse Event|0|||
94406496|NCT00420095|323273131|FG000|Overall Study|Protocol Violation|1|||
94406497|NCT00420095|323273132|FG001|Overall Study|Protocol Violation|1|||
94406498|NCT00420095|323273131|FG000|Overall Study|Lost to Follow-up|1|||
94406499|NCT00420095|323273132|FG001|Overall Study|Lost to Follow-up|0|||
94485663|NCT03885908|323571946|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
94406500|NCT01378962|323273133|FG000|Overall Study|Death|14|||
94406501|NCT01378962|323273133|FG000|Overall Study|Lost to Follow-up|1|||
94406502|NCT01378962|323273133|FG000|Overall Study|Other|2|||
94406503|NCT00393705|323273134|FG000|Overall Study|Adverse Event|0|||
94406504|NCT00393705|323273135|FG001|Overall Study|Adverse Event|2|||
94406505|NCT00393705|323273134|FG000|Overall Study|Death|0|||
94406506|NCT00393705|323273135|FG001|Overall Study|Death|1|||
94406507|NCT00393705|323273134|FG000|Overall Study|Lost to Follow-up|2|||
94406508|NCT00393705|323273135|FG001|Overall Study|Lost to Follow-up|2|||
94406509|NCT00393705|323273134|FG000|Overall Study|Entry Criteria Not Met|10|||
94406510|NCT00393705|323273135|FG001|Overall Study|Entry Criteria Not Met|10|||
94406511|NCT00393705|323273134|FG000|Overall Study|Protocol Violation|4|||
94406512|NCT00393705|323273135|FG001|Overall Study|Protocol Violation|3|||
94406513|NCT00393705|323273134|FG000|Overall Study|Withdrawal by Subject|5|||
94406514|NCT00393705|323273135|FG001|Overall Study|Withdrawal by Subject|3|||
94406515|NCT00393705|323273134|FG000|Overall Study|Physician Decision|2|||
94406516|NCT00393705|323273135|FG001|Overall Study|Physician Decision|2|||
94406517|NCT01754376|323274983|FG000|Overall Study|Adverse Event|1|||
94406518|NCT01754376|323274983|FG000|Overall Study|Lack of Efficacy|2|||
94406519|NCT04590781|323274984|FG000|Overall Study|Death|0|||
94406520|NCT04590781|323274985|FG001|Overall Study|Death|2|||
94406521|NCT04590781|323274984|FG000|Overall Study|Withdrawal by Subject|2|||
94406522|NCT04590781|323274985|FG001|Overall Study|Withdrawal by Subject|0|||
94406523|NCT04556734|323274986|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
94406524|NCT04556734|323274987|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
94406525|NCT04556734|323274988|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
94406526|NCT04556734|323274989|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94406527|NCT04556734|323274990|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94406528|NCT04556734|323274991|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94406529|NCT04556734|323274992|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94406530|NCT04556734|323274993|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
94406531|NCT04556734|323274986|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
94406532|NCT04556734|323274987|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
94406533|NCT04556734|323274988|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
94406534|NCT04556734|323274989|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
94406535|NCT04556734|323274990|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
94406536|NCT04556734|323274991|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
94406537|NCT04556734|323274992|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
94406538|NCT04556734|323274993|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
94406539|NCT04556734|323274986|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
94406540|NCT04556734|323274987|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94406541|NCT04556734|323274988|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
94406542|NCT04556734|323274989|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94406543|NCT04556734|323274990|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94406544|NCT04556734|323274991|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94406545|NCT04556734|323274992|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94406546|NCT04556734|323274993|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
94406547|NCT04556734|323274986|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
94406548|NCT04556734|323274987|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
94406549|NCT04556734|323274988|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
94406550|NCT04556734|323274989|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
94406551|NCT04556734|323274990|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
94406552|NCT04556734|323274991|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
94406553|NCT04556734|323274992|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
94406554|NCT04556734|323274993|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
94406555|NCT04556734|323274986|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
94406556|NCT04556734|323274987|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
94406557|NCT04556734|323274988|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
94406558|NCT04556734|323274989|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
94406559|NCT04556734|323274990|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
94406560|NCT04556734|323274991|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
94406561|NCT04556734|323274992|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
94406562|NCT04556734|323274993|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
94406563|NCT04556734|323274986|FG000|OLE Period (28 Weeks)|Not reported|0|||
94406564|NCT04556734|323274987|FG001|OLE Period (28 Weeks)|Not reported|0|||
94406565|NCT04556734|323274988|FG002|OLE Period (28 Weeks)|Not reported|0|||
94406566|NCT04556734|323274989|FG003|OLE Period (28 Weeks)|Not reported|0|||
94406567|NCT04556734|323274990|FG004|OLE Period (28 Weeks)|Not reported|0|||
94406568|NCT04556734|323274991|FG005|OLE Period (28 Weeks)|Not reported|1|||
94406569|NCT04556734|323274992|FG006|OLE Period (28 Weeks)|Not reported|0|||
94406570|NCT04556734|323274993|FG007|OLE Period (28 Weeks)|Not reported|0|||
94406571|NCT04556734|323274986|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
94406572|NCT04556734|323274987|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
94406573|NCT04556734|323274988|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
94406574|NCT04556734|323274989|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
94485664|NCT03885908|323571947|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
94485665|NCT03885908|323571946|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
94485666|NCT03885908|323571947|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
94485667|NCT03885908|323571946|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
94485668|NCT03885908|323571947|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
94485669|NCT01159574|323571948|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
94485670|NCT01159574|323571948|FG000|Treatment Phase|Adverse Event|3|||
94485671|NCT01159574|323571948|FG000|Treatment Phase|Death|6|||
94485672|NCT01159574|323571948|FG000|Treatment Phase|Physician Decision|2|||
94485673|NCT01159574|323571948|FG000|Treatment Phase|Withdrawal by Subject|7|||
94485674|NCT01159574|323571948|FG000|Treatment Phase|still on treatment|2|||
94485675|NCT01159574|323571948|FG000|Follow Up Phase|Lost to Follow-up|2|||
94485676|NCT01159574|323571948|FG000|Follow Up Phase|still being followed for overall surviva|18|||
94485677|NCT02666222|323571949|FG000|Overall Study|Death|2|||
94485678|NCT03292016|323571962|FG000|Second Washout|Adverse Event|0|||
94485679|NCT03292016|323571963|FG001|Second Washout|Adverse Event|1|||
94485680|NCT03292016|323571964|FG002|Second Washout|Adverse Event|0|||
94485681|NCT03292016|323571965|FG003|Second Washout|Adverse Event|0|||
94485682|NCT03292016|323571966|FG004|Second Washout|Adverse Event|0|||
94485683|NCT03292016|323571967|FG005|Second Washout|Adverse Event|0|||
94485684|NCT01802385|323571968|FG000|Overall Study|Death|106|||
94485685|NCT01802385|323571969|FG001|Overall Study|Death|120|||
94485686|NCT03810183|323571971|FG000|Overall Study|Study terminated by Sponsor|2|||
94485687|NCT03810183|323571972|FG001|Overall Study|Study terminated by Sponsor|1|||
94485688|NCT01443858|323571973|FG000|Overall Study|Withdrawal by Subject|9|||
94485689|NCT01443858|323571974|FG001|Overall Study|Withdrawal by Subject|8|||
94485690|NCT01443858|323571975|FG002|Overall Study|Withdrawal by Subject|5|||
94485691|NCT01443858|323571973|FG000|Overall Study|Lack of Efficacy|1|||
94485692|NCT01443858|323571974|FG001|Overall Study|Lack of Efficacy|0|||
94485693|NCT01443858|323571975|FG002|Overall Study|Lack of Efficacy|0|||
94485694|NCT01443858|323571973|FG000|Overall Study|Lost to Follow-up|5|||
94485695|NCT01443858|323571974|FG001|Overall Study|Lost to Follow-up|5|||
94485696|NCT01443858|323571975|FG002|Overall Study|Lost to Follow-up|2|||
94485697|NCT03167242|323571976|FG000|Overall Study|Patient/Guardian Decision|0|||
94485698|NCT03167242|323571977|FG001|Overall Study|Patient/Guardian Decision|1|||
94485699|NCT03167242|323571978|FG002|Overall Study|Patient/Guardian Decision|2|||
94485700|NCT03167242|323571979|FG003|Overall Study|Patient/Guardian Decision|1|||
94485701|NCT03167242|323571980|FG004|Overall Study|Patient/Guardian Decision|1|||
94485702|NCT03167242|323571981|FG005|Overall Study|Patient/Guardian Decision|1|||
94485703|NCT03167242|323571982|FG006|Overall Study|Patient/Guardian Decision|0|||
94485704|NCT03167242|323571983|FG007|Overall Study|Patient/Guardian Decision|0|||
94485705|NCT03167242|323571984|FG008|Overall Study|Patient/Guardian Decision|0|||
94485706|NCT03167242|323571985|FG009|Overall Study|Patient/Guardian Decision|0|||
94485707|NCT03167242|323571986|FG010|Overall Study|Patient/Guardian Decision|1|||
94485708|NCT03167242|323571987|FG011|Overall Study|Patient/Guardian Decision|0|||
94485709|NCT03167242|323571976|FG000|Overall Study|Lost to Follow-up|0|||
94485710|NCT03167242|323571977|FG001|Overall Study|Lost to Follow-up|0|||
94485711|NCT03167242|323571978|FG002|Overall Study|Lost to Follow-up|1|||
94485712|NCT03167242|323571979|FG003|Overall Study|Lost to Follow-up|0|||
94485713|NCT03167242|323571980|FG004|Overall Study|Lost to Follow-up|0|||
94485714|NCT03167242|323571981|FG005|Overall Study|Lost to Follow-up|1|||
94406575|NCT04556734|323274990|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
94406576|NCT04556734|323274991|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
94406577|NCT04556734|323274992|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
94406578|NCT04556734|323274993|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
94406579|NCT04556734|323274986|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
94406580|NCT04556734|323274987|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
94406581|NCT04556734|323274988|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
94406582|NCT04556734|323274989|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
94406583|NCT04556734|323274990|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
94406584|NCT04556734|323274991|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
94406585|NCT04556734|323274992|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
94485715|NCT03167242|323571982|FG006|Overall Study|Lost to Follow-up|2|||
94406586|NCT04556734|323274993|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
94406587|NCT04556734|323274986|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
94485716|NCT03167242|323571983|FG007|Overall Study|Lost to Follow-up|1|||
94485717|NCT03167242|323571984|FG008|Overall Study|Lost to Follow-up|0|||
94485718|NCT03167242|323571985|FG009|Overall Study|Lost to Follow-up|0|||
94485719|NCT03167242|323571986|FG010|Overall Study|Lost to Follow-up|1|||
94485720|NCT03167242|323571987|FG011|Overall Study|Lost to Follow-up|1|||
94406588|NCT04556734|323274987|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
94406589|NCT04556734|323274988|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
94406590|NCT04556734|323274989|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
94406591|NCT04556734|323274990|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
94406592|NCT04556734|323274991|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
94485721|NCT03167242|323571976|FG000|Overall Study|Reason not provided|0|||
94485722|NCT03167242|323571977|FG001|Overall Study|Reason not provided|0|||
94485723|NCT03167242|323571978|FG002|Overall Study|Reason not provided|0|||
94485724|NCT03167242|323571979|FG003|Overall Study|Reason not provided|0|||
94485725|NCT03167242|323571980|FG004|Overall Study|Reason not provided|0|||
94485726|NCT03167242|323571981|FG005|Overall Study|Reason not provided|0|||
94485727|NCT03167242|323571982|FG006|Overall Study|Reason not provided|0|||
94485728|NCT03167242|323571983|FG007|Overall Study|Reason not provided|0|||
94485729|NCT03167242|323571984|FG008|Overall Study|Reason not provided|1|||
94485730|NCT03167242|323571985|FG009|Overall Study|Reason not provided|0|||
94485731|NCT03167242|323571986|FG010|Overall Study|Reason not provided|0|||
94485732|NCT03167242|323571987|FG011|Overall Study|Reason not provided|0|||
94485733|NCT03786380|323571988|FG000|Overall Study|Adverse Event|1|||
94485734|NCT03786380|323571989|FG001|Overall Study|Adverse Event|0|||
94485735|NCT03786380|323571990|FG002|Overall Study|Adverse Event|0|||
94485736|NCT03786380|323571991|FG003|Overall Study|Adverse Event|3|||
94485737|NCT03786380|323571992|FG004|Overall Study|Adverse Event|1|||
94485738|NCT03786380|323571988|FG000|Overall Study|Lack of Efficacy|0|||
94485739|NCT03786380|323571989|FG001|Overall Study|Lack of Efficacy|0|||
94485740|NCT03786380|323571990|FG002|Overall Study|Lack of Efficacy|0|||
94485741|NCT03786380|323571991|FG003|Overall Study|Lack of Efficacy|0|||
94485742|NCT03786380|323571992|FG004|Overall Study|Lack of Efficacy|1|||
94485743|NCT03786380|323571988|FG000|Overall Study|Withdrawal by Subject|1|||
94485744|NCT03786380|323571989|FG001|Overall Study|Withdrawal by Subject|2|||
94485745|NCT03786380|323571990|FG002|Overall Study|Withdrawal by Subject|2|||
94485746|NCT03786380|323571991|FG003|Overall Study|Withdrawal by Subject|1|||
94485747|NCT03786380|323571992|FG004|Overall Study|Withdrawal by Subject|2|||
94485748|NCT03786380|323571988|FG000|Overall Study|Lost to Follow-up|3|||
94485749|NCT03786380|323571989|FG001|Overall Study|Lost to Follow-up|0|||
94485750|NCT03786380|323571990|FG002|Overall Study|Lost to Follow-up|1|||
94485751|NCT03786380|323571991|FG003|Overall Study|Lost to Follow-up|2|||
94485752|NCT03786380|323571992|FG004|Overall Study|Lost to Follow-up|0|||
94485753|NCT03786380|323571988|FG000|Overall Study|Physician Decision|0|||
94485754|NCT03786380|323571989|FG001|Overall Study|Physician Decision|0|||
94485755|NCT03786380|323571990|FG002|Overall Study|Physician Decision|1|||
94485756|NCT03786380|323571991|FG003|Overall Study|Physician Decision|0|||
94485757|NCT03786380|323571992|FG004|Overall Study|Physician Decision|0|||
94485758|NCT03786380|323571988|FG000|Overall Study|Study Terminated by the Sponsor|30|||
94485759|NCT03786380|323571989|FG001|Overall Study|Study Terminated by the Sponsor|20|||
94485760|NCT03786380|323571990|FG002|Overall Study|Study Terminated by the Sponsor|50|||
94485761|NCT03786380|323571991|FG003|Overall Study|Study Terminated by the Sponsor|57|||
94485762|NCT03786380|323571992|FG004|Overall Study|Study Terminated by the Sponsor|23|||
94485763|NCT03786380|323571988|FG000|Overall Study|Reason Not Specified|0|||
94485764|NCT03786380|323571989|FG001|Overall Study|Reason Not Specified|0|||
94485765|NCT03786380|323571990|FG002|Overall Study|Reason Not Specified|0|||
94485766|NCT03786380|323571991|FG003|Overall Study|Reason Not Specified|0|||
94485767|NCT03786380|323571992|FG004|Overall Study|Reason Not Specified|1|||
94485768|NCT05002972|323571993|FG000|Overall Study|Withdrawal by Subject|2|||
94485769|NCT01867008|323571995|FG000|Overall Study|Withdrawal by Subject|1|||
94485770|NCT00983372|323572000|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
94485771|NCT00983372|323572000|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
94485772|NCT00983372|323572000|FG000|Diltiazem ER Alone|Adverse Event|1|||
94485773|NCT01909804|323572003|FG000|Overall Study|Randomized but Never Treated|0|||
94485774|NCT01909804|323572004|FG001|Overall Study|Randomized but Never Treated|0|||
94485775|NCT01909804|323572005|FG002|Overall Study|Randomized but Never Treated|0|||
94485776|NCT01909804|323572006|FG003|Overall Study|Randomized but Never Treated|0|||
94485777|NCT01909804|323572007|FG004|Overall Study|Randomized but Never Treated|0|||
94485778|NCT01909804|323572008|FG005|Overall Study|Randomized but Never Treated|0|||
94485779|NCT01909804|323572009|FG006|Overall Study|Randomized but Never Treated|1|||
94485780|NCT01909804|323572010|FG007|Overall Study|Randomized but Never Treated|0|||
94485781|NCT01909804|323572011|FG008|Overall Study|Randomized but Never Treated|0|||
94485782|NCT01909804|323572012|FG009|Overall Study|Randomized but Never Treated|0|||
94485783|NCT01909804|323572013|FG010|Overall Study|Randomized but Never Treated|0|||
94485784|NCT01909804|323572014|FG011|Overall Study|Randomized but Never Treated|1|||
94485785|NCT01909804|323572003|FG000|Overall Study|Death|0|||
94485786|NCT01909804|323572004|FG001|Overall Study|Death|0|||
94485787|NCT01909804|323572005|FG002|Overall Study|Death|0|||
94485788|NCT01909804|323572006|FG003|Overall Study|Death|0|||
94485789|NCT01909804|323572007|FG004|Overall Study|Death|0|||
94485790|NCT01909804|323572008|FG005|Overall Study|Death|0|||
94485791|NCT01909804|323572009|FG006|Overall Study|Death|0|||
94485792|NCT01909804|323572010|FG007|Overall Study|Death|0|||
94485793|NCT01909804|323572011|FG008|Overall Study|Death|0|||
94485794|NCT01909804|323572012|FG009|Overall Study|Death|0|||
94485795|NCT01909804|323572013|FG010|Overall Study|Death|1|||
94485796|NCT01909804|323572014|FG011|Overall Study|Death|0|||
94485797|NCT01909804|323572003|FG000|Overall Study|Lack of Efficacy|4|||
94485798|NCT01909804|323572004|FG001|Overall Study|Lack of Efficacy|1|||
94485799|NCT01909804|323572005|FG002|Overall Study|Lack of Efficacy|0|||
94485800|NCT01909804|323572006|FG003|Overall Study|Lack of Efficacy|0|||
94485801|NCT01909804|323572007|FG004|Overall Study|Lack of Efficacy|7|||
94485802|NCT01909804|323572008|FG005|Overall Study|Lack of Efficacy|3|||
94485803|NCT01909804|323572009|FG006|Overall Study|Lack of Efficacy|1|||
94485804|NCT01909804|323572010|FG007|Overall Study|Lack of Efficacy|1|||
94406593|NCT04556734|323274992|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
94406594|NCT04556734|323274993|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
94406595|NCT01680016|323275000|FG000|Overall Study|Adverse Event|0|||
94406596|NCT01680016|323275001|FG001|Overall Study|Adverse Event|0|||
94406597|NCT01680016|323275002|FG002|Overall Study|Adverse Event|1|||
94406598|NCT01680016|323275003|FG003|Overall Study|Adverse Event|4|||
94406599|NCT01680016|323275000|FG000|Overall Study|The Subject went out of The Trial|1|||
94406600|NCT01680016|323275001|FG001|Overall Study|The Subject went out of The Trial|0|||
94406601|NCT01680016|323275002|FG002|Overall Study|The Subject went out of The Trial|3|||
94406602|NCT01680016|323275003|FG003|Overall Study|The Subject went out of The Trial|0|||
94406603|NCT01680016|323275000|FG000|Overall Study|Protocol Violation|0|||
94406604|NCT01680016|323275001|FG001|Overall Study|Protocol Violation|1|||
94406605|NCT01680016|323275002|FG002|Overall Study|Protocol Violation|0|||
94406606|NCT01680016|323275003|FG003|Overall Study|Protocol Violation|0|||
94406607|NCT01680016|323275000|FG000|Overall Study|Withdrawal by Subject|5|||
94406608|NCT01680016|323275001|FG001|Overall Study|Withdrawal by Subject|7|||
94406609|NCT01680016|323275002|FG002|Overall Study|Withdrawal by Subject|1|||
94406610|NCT01680016|323275003|FG003|Overall Study|Withdrawal by Subject|1|||
94406611|NCT02658019|323275004|FG000|Overall Study|Adverse Event|1|||
94406612|NCT02722616|323275005|FG000|Overall Study|Sponsor closed study after one month|2|||
94406613|NCT02722616|323275006|FG001|Overall Study|Sponsor closed study after one month|0|||
94406614|NCT02722616|323275007|FG002|Overall Study|Sponsor closed study after one month|0|||
94406615|NCT01120899|323275008|FG000|Overall Study|Withdrawal by Subject|3|||
94406616|NCT02697617|323275014|FG000|Overall Study|Withdrawal by Subject|0|||
94406617|NCT02697617|323275015|FG001|Overall Study|Withdrawal by Subject|2|||
94406618|NCT02697617|323275014|FG000|Overall Study|Pregnancy|1|||
94406619|NCT02697617|323275015|FG001|Overall Study|Pregnancy|0|||
94406620|NCT00517192|323275018|FG000|Overall Study|Adverse Event|1|||
94406621|NCT00517192|323275019|FG001|Overall Study|Adverse Event|1|||
94406622|NCT00517192|323275018|FG000|Overall Study|Lost to Follow-up|1|||
94406623|NCT00517192|323275019|FG001|Overall Study|Lost to Follow-up|1|||
94406624|NCT00517192|323275018|FG000|Overall Study|Withdrawal by Subject|1|||
94406625|NCT00517192|323275019|FG001|Overall Study|Withdrawal by Subject|0|||
94406626|NCT00517192|323275018|FG000|Overall Study|Early termination of the trial|16|||
94406627|NCT00517192|323275019|FG001|Overall Study|Early termination of the trial|18|||
94406628|NCT04129944|323275020|FG000|Overall Study|Death|0|||
94406629|NCT04129944|323275021|FG001|Overall Study|Death|0|||
94406630|NCT04129944|323275022|FG002|Overall Study|Death|0|||
94406631|NCT04129944|323275023|FG003|Overall Study|Death|1|||
94406632|NCT04129944|323275020|FG000|Overall Study|Lost to Follow-up|1|||
94406633|NCT04129944|323275021|FG001|Overall Study|Lost to Follow-up|0|||
94406634|NCT04129944|323275022|FG002|Overall Study|Lost to Follow-up|0|||
94406635|NCT04129944|323275023|FG003|Overall Study|Lost to Follow-up|0|||
94406636|NCT04129944|323275020|FG000|Overall Study|Withdrawal by Subject|1|||
94406637|NCT04129944|323275021|FG001|Overall Study|Withdrawal by Subject|0|||
94406638|NCT04129944|323275022|FG002|Overall Study|Withdrawal by Subject|1|||
94406639|NCT04129944|323275023|FG003|Overall Study|Withdrawal by Subject|2|||
94406640|NCT02943993|323275024|FG000|Overall Study|Withdrawal by Subject|52|||
94406641|NCT02943993|323275024|FG000|Overall Study|Transfer to another institution|6|||
94406642|NCT02943993|323275024|FG000|Overall Study|Lost to Follow-up|135|||
94406643|NCT02943993|323275024|FG000|Overall Study|Death|98|||
94406644|NCT02943993|323275024|FG000|Overall Study|Other reason for premature termination|32|||
94406645|NCT02943993|323275024|FG000|Overall Study|Missing reason for termination|7|||
94406646|NCT03433703|323275028|FG000|Overall Study|Study terminated by Sponsor|2|||
94406647|NCT01957150|323275029|FG000|Overall Study|Adverse Event|23|||
94406648|NCT01957150|323275030|FG001|Overall Study|Adverse Event|20|||
94406649|NCT01957150|323275029|FG000|Overall Study|Withdrawal by Subject|13|||
94406650|NCT01957150|323275030|FG001|Overall Study|Withdrawal by Subject|17|||
94406651|NCT01957150|323275029|FG000|Overall Study|Physician Decision|3|||
94406652|NCT01957150|323275030|FG001|Overall Study|Physician Decision|6|||
94406653|NCT01957150|323275029|FG000|Overall Study|Lost to Follow-up|4|||
94406654|NCT01957150|323275030|FG001|Overall Study|Lost to Follow-up|4|||
94406655|NCT01957150|323275029|FG000|Overall Study|Protocol Violation|1|||
94406656|NCT01957150|323275030|FG001|Overall Study|Protocol Violation|0|||
94406657|NCT01957150|323275029|FG000|Overall Study|Lack of Efficacy|11|||
94406658|NCT01957150|323275030|FG001|Overall Study|Lack of Efficacy|11|||
94406659|NCT02050321|323275031|FG000|Overall Study|Withdrawal by Subject|1|||
94406660|NCT02050321|323275031|FG000|Overall Study|Adverse Event|1|||
94406661|NCT04768114|323275032|FG000|Overall Study|Lost to Follow-up|5|||
94406662|NCT04768114|323275033|FG001|Overall Study|Lost to Follow-up|10|||
94406663|NCT04768114|323275032|FG000|Overall Study|Withdrawal by Subject|0|||
94485805|NCT01909804|323572011|FG008|Overall Study|Lack of Efficacy|0|||
94485806|NCT01909804|323572012|FG009|Overall Study|Lack of Efficacy|1|||
94485807|NCT01909804|323572013|FG010|Overall Study|Lack of Efficacy|0|||
94485808|NCT01909804|323572014|FG011|Overall Study|Lack of Efficacy|1|||
94485809|NCT01909804|323572003|FG000|Overall Study|Withdrew Consent|0|||
94485810|NCT01909804|323572004|FG001|Overall Study|Withdrew Consent|0|||
94485811|NCT01909804|323572005|FG002|Overall Study|Withdrew Consent|0|||
94485812|NCT01909804|323572006|FG003|Overall Study|Withdrew Consent|0|||
94485813|NCT01909804|323572007|FG004|Overall Study|Withdrew Consent|1|||
94485814|NCT01909804|323572008|FG005|Overall Study|Withdrew Consent|1|||
94485815|NCT01909804|323572009|FG006|Overall Study|Withdrew Consent|0|||
94485816|NCT01909804|323572010|FG007|Overall Study|Withdrew Consent|0|||
94485817|NCT01909804|323572011|FG008|Overall Study|Withdrew Consent|0|||
94485818|NCT01909804|323572012|FG009|Overall Study|Withdrew Consent|0|||
94485819|NCT01909804|323572013|FG010|Overall Study|Withdrew Consent|0|||
94485820|NCT01909804|323572014|FG011|Overall Study|Withdrew Consent|0|||
94485821|NCT01909804|323572003|FG000|Overall Study|Protocol Violation|0|||
94485822|NCT01909804|323572004|FG001|Overall Study|Protocol Violation|0|||
94485823|NCT01909804|323572005|FG002|Overall Study|Protocol Violation|0|||
94485824|NCT01909804|323572006|FG003|Overall Study|Protocol Violation|0|||
94485825|NCT01909804|323572007|FG004|Overall Study|Protocol Violation|0|||
94485826|NCT01909804|323572008|FG005|Overall Study|Protocol Violation|0|||
94485827|NCT01909804|323572009|FG006|Overall Study|Protocol Violation|0|||
94406664|NCT04768114|323275033|FG001|Overall Study|Withdrawal by Subject|1|||
94406665|NCT00113919|323275035|FG000|Overall Study|Physician Decision|8|||
94406666|NCT00113919|323275035|FG000|Overall Study|Death|6|||
94406667|NCT02005276|323275036|FG000|Overall Study|No longer interested|5|||
94406668|NCT02005276|323275037|FG001|Overall Study|No longer interested|2|||
94406669|NCT02005276|323275038|FG002|Overall Study|No longer interested|3|||
94406670|NCT02005276|323275039|FG003|Overall Study|No longer interested|3|||
94406671|NCT01963260|323275040|FG000|Overall Study|Withdrawal by Subject|2|||
94406672|NCT01963260|323275041|FG001|Overall Study|Withdrawal by Subject|0|||
94406673|NCT01963260|323275042|FG002|Overall Study|Withdrawal by Subject|0|||
94406674|NCT01963260|323275043|FG003|Overall Study|Withdrawal by Subject|1|||
94406675|NCT01963260|323275044|FG004|Overall Study|Withdrawal by Subject|2|||
94406676|NCT01963260|323275045|FG005|Overall Study|Withdrawal by Subject|0|||
94406677|NCT01963260|323275046|FG006|Overall Study|Withdrawal by Subject|0|||
94406678|NCT01963260|323275047|FG007|Overall Study|Withdrawal by Subject|0|||
94406679|NCT01963260|323275048|FG008|Overall Study|Withdrawal by Subject|0|||
94406680|NCT01963260|323275049|FG009|Overall Study|Withdrawal by Subject|0|||
94406681|NCT00530348|323275050|FG000|Overall Study|Adverse Event|5|||
94406682|NCT00530348|323275051|FG001|Overall Study|Adverse Event|1|||
94406683|NCT00530348|323275050|FG000|Overall Study|Death|0|||
94406684|NCT00530348|323275051|FG001|Overall Study|Death|1|||
94406685|NCT00530348|323275050|FG000|Overall Study|Lack of Efficacy|2|||
94406686|NCT00530348|323275051|FG001|Overall Study|Lack of Efficacy|0|||
94406687|NCT00530348|323275050|FG000|Overall Study|Lost to Follow-up|0|||
94406688|NCT00530348|323275051|FG001|Overall Study|Lost to Follow-up|2|||
94406689|NCT00530348|323275050|FG000|Overall Study|Physician Decision|1|||
94406690|NCT00530348|323275051|FG001|Overall Study|Physician Decision|2|||
94406691|NCT00530348|323275050|FG000|Overall Study|Pregnancy|1|||
94406692|NCT00530348|323275051|FG001|Overall Study|Pregnancy|0|||
94406693|NCT00530348|323275050|FG000|Overall Study|Withdrawal by Subject|12|||
94406694|NCT00530348|323275051|FG001|Overall Study|Withdrawal by Subject|12|||
94406695|NCT00530348|323275050|FG000|Overall Study|Randomised in error|1|||
94406696|NCT00530348|323275051|FG001|Overall Study|Randomised in error|0|||
94406697|NCT00530348|323275050|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
94406698|NCT00530348|323275051|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
94406699|NCT01186016|323275052|FG000|Overall Study|Withdrawal by Subject|46|||
94406700|NCT01186016|323275053|FG001|Overall Study|Withdrawal by Subject|29|||
94485828|NCT01909804|323572010|FG007|Overall Study|Protocol Violation|0|||
94485829|NCT01909804|323572011|FG008|Overall Study|Protocol Violation|0|||
94485830|NCT01909804|323572012|FG009|Overall Study|Protocol Violation|0|||
94485831|NCT01909804|323572013|FG010|Overall Study|Protocol Violation|0|||
94485832|NCT01909804|323572014|FG011|Overall Study|Protocol Violation|1|||
94485833|NCT00338741|323572017|FG000|Overall Study|Lost to Follow-up|2|||
94485834|NCT00338741|323572018|FG001|Overall Study|Lost to Follow-up|0|||
94485835|NCT05222880|323572019|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
94485836|NCT05222880|323572019|FG000|Overall Study|Withdrew Consent during Study|1|||
94485837|NCT05222880|323572019|FG000|Overall Study|COVID-19 Related|1|||
94485838|NCT00791999|323572020|FG000|Overall Study|Protocol planed withdrawal|14|||
94485839|NCT00791999|323572021|FG001|Overall Study|Protocol planed withdrawal|11|||
94485840|NCT00791999|323572022|FG002|Overall Study|Protocol planed withdrawal|11|||
94485841|NCT00791999|323572023|FG003|Overall Study|Protocol planed withdrawal|45|||
94406701|NCT01091363|323275054|FG000|Overall Study|Withdrawal by Subject|11|||
94406702|NCT01091363|323275055|FG001|Overall Study|Withdrawal by Subject|15|||
94406703|NCT01091363|323275054|FG000|Overall Study|Lost to Follow-up|2|||
94406704|NCT01091363|323275055|FG001|Overall Study|Lost to Follow-up|2|||
94406705|NCT00160524|323275056|FG000|Overall Study|Adverse Event|119|||
94406706|NCT00160524|323275056|FG000|Overall Study|Adverse Event and Other|94|||
94406707|NCT00160524|323275056|FG000|Overall Study|Protocol Violation|16|||
94406708|NCT00160524|323275056|FG000|Overall Study|Protocol Violation and Other|2|||
94406709|NCT00160524|323275056|FG000|Overall Study|Withdrawal by Subject|141|||
94406710|NCT00160524|323275056|FG000|Overall Study|Withdrawal by Subject and Other|17|||
94406711|NCT00160524|323275056|FG000|Overall Study|Physician Decision|27|||
94406712|NCT00160524|323275056|FG000|Overall Study|Physician Decision and Other|6|||
94406713|NCT00160524|323275056|FG000|Overall Study|Lost to Follow-up|13|||
94406714|NCT00160524|323275056|FG000|Overall Study|Lost to Follow-up and Other|1|||
94406715|NCT00160524|323275056|FG000|Overall Study|Lack of Efficacy|21|||
94406716|NCT00160524|323275056|FG000|Overall Study|Lack of Efficacy and Other|1|||
94406717|NCT00160524|323275056|FG000|Overall Study|Other|20|||
94406718|NCT02151149|323275058|FG000|Treatment Period|Death|2|||
94406719|NCT02151149|323275059|FG001|Treatment Period|Death|3|||
94406720|NCT02151149|323275058|FG000|Treatment Period|Adverse Event|17|||
94406721|NCT02151149|323275059|FG001|Treatment Period|Adverse Event|14|||
94406722|NCT02151149|323275058|FG000|Treatment Period|Progressive Disease|25|||
94406723|NCT02151149|323275059|FG001|Treatment Period|Progressive Disease|24|||
94406724|NCT02151149|323275058|FG000|Treatment Period|Symptomatic Deterioration|2|||
94406725|NCT02151149|323275059|FG001|Treatment Period|Symptomatic Deterioration|10|||
94406726|NCT02151149|323275058|FG000|Treatment Period|Withdrawal by Subject|13|||
94406727|NCT02151149|323275059|FG001|Treatment Period|Withdrawal by Subject|11|||
94406728|NCT02151149|323275058|FG000|Treatment Period|Miscellaneous|8|||
94406729|NCT02151149|323275059|FG001|Treatment Period|Miscellaneous|7|||
94406730|NCT02151149|323275058|FG000|Treatment Period|Participants randomized but not treated|3|||
94406731|NCT02151149|323275059|FG001|Treatment Period|Participants randomized but not treated|2|||
94406732|NCT02151149|323275058|FG000|Follow-Up Period|Lost to Follow-up|2|||
94406733|NCT02151149|323275059|FG001|Follow-Up Period|Lost to Follow-up|3|||
94406734|NCT02151149|323275058|FG000|Follow-Up Period|Death|37|||
94406735|NCT02151149|323275059|FG001|Follow-Up Period|Death|34|||
94406736|NCT01781234|323275062|FG000|Overall Study|Adverse Event|2|||
94406737|NCT01781234|323275063|FG001|Overall Study|Adverse Event|0|||
94406738|NCT01781234|323275062|FG000|Overall Study|Protocol Violation|3|||
94406739|NCT01781234|323275063|FG001|Overall Study|Protocol Violation|0|||
94406740|NCT01781234|323275062|FG000|Overall Study|Withdrawal by Subject|4|||
94406741|NCT01781234|323275063|FG001|Overall Study|Withdrawal by Subject|3|||
94406742|NCT00721955|323275064|FG000|Overall Study|Adverse Event|0|||
94406743|NCT00721955|323275065|FG001|Overall Study|Adverse Event|0|||
94406744|NCT00721955|323275066|FG002|Overall Study|Adverse Event|2|||
94406745|NCT03173560|323275067|FG000|Overall Study|Death|70|||
94406746|NCT03173560|323275068|FG001|Overall Study|Death|60|||
94406747|NCT03173560|323275067|FG000|Overall Study|Lost to Follow-up|1|||
94406748|NCT03173560|323275068|FG001|Overall Study|Lost to Follow-up|4|||
94406749|NCT03173560|323275067|FG000|Overall Study|Withdrawal by Subject|10|||
94406750|NCT03173560|323275068|FG001|Overall Study|Withdrawal by Subject|5|||
94406751|NCT03173560|323275067|FG000|Overall Study|Other|0|||
94406752|NCT03173560|323275068|FG001|Overall Study|Other|1|||
94406753|NCT00830167|323275079|FG000|Overall Study|Lack of Efficacy|26|||
94406754|NCT00830167|323275080|FG001|Overall Study|Lack of Efficacy|10|||
94406755|NCT00830167|323275079|FG000|Overall Study|Adverse Event|8|||
94406756|NCT00830167|323275080|FG001|Overall Study|Adverse Event|24|||
94406757|NCT00830167|323275079|FG000|Overall Study|Not meeting entrance criteria|2|||
94406758|NCT00830167|323275080|FG001|Overall Study|Not meeting entrance criteria|5|||
94406759|NCT00830167|323275079|FG000|Overall Study|Withdrawal by Subject|2|||
94406760|NCT00830167|323275080|FG001|Overall Study|Withdrawal by Subject|0|||
94406761|NCT00830167|323275079|FG000|Overall Study|Lost to Follow-up|0|||
94406762|NCT00830167|323275080|FG001|Overall Study|Lost to Follow-up|1|||
94406763|NCT00830167|323275079|FG000|Overall Study|Protocol Violation|0|||
94406764|NCT00830167|323275080|FG001|Overall Study|Protocol Violation|1|||
94406765|NCT00830167|323275079|FG000|Overall Study|Other|2|||
94406766|NCT00830167|323275080|FG001|Overall Study|Other|2|||
94406767|NCT02359864|323275083|FG000|Overall Study|Withdrawal by Subject|1|||
94406768|NCT02359864|323275084|FG001|Overall Study|Withdrawal by Subject|0|||
94406769|NCT00725764|323275085|FG000|Overall Study|Withdrawal by Subject|2|||
94406770|NCT00725764|323275085|FG000|Overall Study|Physician Decision|1|||
94406771|NCT00725764|323275085|FG000|Overall Study|Progressive Disease|7|||
94406772|NCT00725764|323275085|FG000|Overall Study|Lost to Follow-up|1|||
94406773|NCT00725764|323275085|FG000|Overall Study|Death|1|||
94406774|NCT00725764|323275085|FG000|Overall Study|Participant non compliant with protocol|1|||
94406775|NCT00725764|323275085|FG000|Overall Study|Decline in performance status|1|||
94406776|NCT04254809|323275089|FG000|Overall Study|Lost to Follow-up|5|||
94406777|NCT04254809|323275090|FG001|Overall Study|Lost to Follow-up|10|||
94406778|NCT04480307|323275091|FG000|Overall Study|Withdrawal by Subject|0|||
94406779|NCT04480307|323275092|FG001|Overall Study|Withdrawal by Subject|1|||
94406780|NCT04480307|323275093|FG002|Overall Study|Withdrawal by Subject|0|||
94406781|NCT04480307|323275094|FG003|Overall Study|Withdrawal by Subject|0|||
94406782|NCT04480307|323275091|FG000|Overall Study|Adverse Event|0|||
94406783|NCT04480307|323275092|FG001|Overall Study|Adverse Event|0|||
94406784|NCT04480307|323275093|FG002|Overall Study|Adverse Event|0|||
94406785|NCT04480307|323275094|FG003|Overall Study|Adverse Event|1|||
94406786|NCT01928615|323275095|FG000|Overall Study|Study Terminated by Sponsor|2|||
94406787|NCT01438476|323275100|FG000|Overall Study|Protocol Violation|1|||
94406788|NCT01438476|323275101|FG001|Overall Study|Protocol Violation|0|||
94406789|NCT01438476|323275100|FG000|Overall Study|Withdrawal by Subject|1|||
94406790|NCT01438476|323275101|FG001|Overall Study|Withdrawal by Subject|0|||
94406791|NCT01438476|323275100|FG000|Overall Study|No Surgery- Disease|8|||
94406792|NCT01438476|323275101|FG001|Overall Study|No Surgery- Disease|10|||
94406793|NCT01438476|323275100|FG000|Overall Study|Communication barrier|0|||
94406794|NCT01438476|323275101|FG001|Overall Study|Communication barrier|1|||
94406795|NCT02522780|323275104|FG000|Overall Study|Consent withdrawn by subject|5|||
94406796|NCT02522780|323275105|FG001|Overall Study|Consent withdrawn by subject|7|||
94406797|NCT02522780|323275104|FG000|Overall Study|Protocol deviation|1|||
94406798|NCT02522780|323275105|FG001|Overall Study|Protocol deviation|3|||
94406799|NCT02522780|323275104|FG000|Overall Study|Subject refused endoscopic procedure|0|||
94406800|NCT02522780|323275105|FG001|Overall Study|Subject refused endoscopic procedure|1|||
94406801|NCT02522780|323275104|FG000|Overall Study|Adverse event, non-fatal|11|||
94406802|NCT02522780|323275105|FG001|Overall Study|Adverse event, non-fatal|16|||
94406803|NCT02058160|323275106|FG000|Overall Study|Randomized but not treated|2|||
94406804|NCT02058160|323275107|FG001|Overall Study|Randomized but not treated|4|||
94406805|NCT02058160|323275106|FG000|Overall Study|Poor compliance to protocol|4|||
94406806|NCT02058160|323275107|FG001|Overall Study|Poor compliance to protocol|1|||
94406807|NCT02058160|323275106|FG000|Overall Study|Adverse Event|12|||
94406808|NCT02058160|323275107|FG001|Overall Study|Adverse Event|3|||
94406809|NCT02058160|323275106|FG000|Overall Study|Lost to Follow-up|1|||
94406810|NCT02058160|323275107|FG001|Overall Study|Lost to Follow-up|0|||
94406811|NCT02058160|323275106|FG000|Overall Study|Other than specified above|12|||
94406812|NCT02058160|323275107|FG001|Overall Study|Other than specified above|6|||
94406813|NCT04106817|323275110|FG000|Overall Study|Lost to Follow-up|1|||
94406814|NCT04106817|323275111|FG001|Overall Study|Lost to Follow-up|0|||
94406815|NCT04106817|323275112|FG002|Overall Study|Lost to Follow-up|0|||
94406816|NCT01266603|323275114|FG000|Overall Study|Adverse Event|1|||
94406817|NCT01266603|323275114|FG000|Overall Study|Lack of Efficacy|14|||
94406818|NCT01266603|323275114|FG000|Overall Study|Withdrawal by Subject|1|||
94406819|NCT01266603|323275114|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
94406820|NCT02911935|323275115|FG000|Overall Study|Lost to Follow-up|5|||
94406821|NCT02911935|323275116|FG001|Overall Study|Lost to Follow-up|7|||
94406822|NCT02418754|323275120|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
94406823|NCT02418754|323275121|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
94406824|NCT02418754|323275122|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
94406825|NCT02418754|323275123|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
94406826|NCT02418754|323275124|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
94406827|NCT02418754|323275120|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
94406828|NCT02418754|323275121|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
94406829|NCT02418754|323275122|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
94406830|NCT02418754|323275123|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
94406831|NCT02418754|323275124|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
94406832|NCT02418754|323275120|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
94406833|NCT02418754|323275121|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
94406834|NCT02418754|323275122|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
94406835|NCT02418754|323275123|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
94406836|NCT02418754|323275124|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
94406837|NCT02418754|323275120|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
94406838|NCT02418754|323275121|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
94406839|NCT02418754|323275122|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
94406840|NCT02418754|323275123|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
94406841|NCT02418754|323275124|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
94406842|NCT02418754|323275120|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
94406843|NCT02418754|323275121|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
94406844|NCT02418754|323275122|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
94406845|NCT02418754|323275123|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
94406846|NCT02418754|323275124|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
94406847|NCT02418754|323275120|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
94406848|NCT02418754|323275121|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
94406849|NCT02418754|323275122|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
94406850|NCT02418754|323275123|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
94406851|NCT02418754|323275124|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
94406852|NCT02418754|323275120|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
94406853|NCT02418754|323275121|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
94406854|NCT02418754|323275122|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
94406855|NCT02418754|323275123|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
94406856|NCT02418754|323275124|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
94406857|NCT02418754|323275120|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
94406858|NCT02418754|323275121|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
94485842|NCT00791999|323572020|FG000|Overall Study|Withdrawal by Subject|0|||
94485843|NCT00791999|323572021|FG001|Overall Study|Withdrawal by Subject|1|||
94485844|NCT00791999|323572022|FG002|Overall Study|Withdrawal by Subject|0|||
94485845|NCT00791999|323572023|FG003|Overall Study|Withdrawal by Subject|2|||
94485846|NCT00791999|323572020|FG000|Overall Study|Protocol Violation|3|||
94485847|NCT00791999|323572021|FG001|Overall Study|Protocol Violation|0|||
94485848|NCT00791999|323572022|FG002|Overall Study|Protocol Violation|1|||
94485849|NCT00791999|323572023|FG003|Overall Study|Protocol Violation|0|||
94485850|NCT00791999|323572020|FG000|Overall Study|Adverse Event|3|||
94485851|NCT00791999|323572021|FG001|Overall Study|Adverse Event|3|||
94485852|NCT00791999|323572022|FG002|Overall Study|Adverse Event|7|||
94485853|NCT00791999|323572023|FG003|Overall Study|Adverse Event|3|||
94485854|NCT00791999|323572020|FG000|Overall Study|Lack of Efficacy|0|||
94485855|NCT00791999|323572021|FG001|Overall Study|Lack of Efficacy|1|||
94485856|NCT00791999|323572022|FG002|Overall Study|Lack of Efficacy|0|||
94485857|NCT00791999|323572023|FG003|Overall Study|Lack of Efficacy|2|||
94485858|NCT00791999|323572020|FG000|Overall Study|Reason other than those above|1|||
94485859|NCT00791999|323572021|FG001|Overall Study|Reason other than those above|0|||
94485860|NCT00791999|323572022|FG002|Overall Study|Reason other than those above|1|||
94485861|NCT00791999|323572023|FG003|Overall Study|Reason other than those above|0|||
94485862|NCT02153918|323572031|FG000|Overall Study|Refused further treatment|1|||
94485863|NCT01764841|323572032|FG000|Overall Study|Logistical Difficulties|0|||
94485864|NCT01764841|323572033|FG001|Overall Study|Logistical Difficulties|1|||
94485865|NCT01764841|323572034|FG002|Overall Study|Logistical Difficulties|0|||
94485866|NCT01764841|323572035|FG003|Overall Study|Logistical Difficulties|0|||
94485867|NCT01764841|323572032|FG000|Overall Study|Death|3|||
94485868|NCT01764841|323572033|FG001|Overall Study|Death|0|||
94485869|NCT01764841|323572034|FG002|Overall Study|Death|1|||
94485870|NCT01764841|323572035|FG003|Overall Study|Death|4|||
94485871|NCT01764841|323572032|FG000|Overall Study|No Follow Up|1|||
94485872|NCT01764841|323572033|FG001|Overall Study|No Follow Up|0|||
94485873|NCT01764841|323572034|FG002|Overall Study|No Follow Up|1|||
94485874|NCT01764841|323572035|FG003|Overall Study|No Follow Up|0|||
94485875|NCT01764841|323572032|FG000|Overall Study|Protocol Violation|0|||
94485876|NCT01764841|323572033|FG001|Overall Study|Protocol Violation|1|||
94485877|NCT01764841|323572034|FG002|Overall Study|Protocol Violation|0|||
94485878|NCT01764841|323572035|FG003|Overall Study|Protocol Violation|0|||
94485879|NCT01764841|323572032|FG000|Overall Study|Withdrawal by Subject|16|||
94485880|NCT01764841|323572033|FG001|Overall Study|Withdrawal by Subject|24|||
94485881|NCT01764841|323572034|FG002|Overall Study|Withdrawal by Subject|11|||
94485882|NCT01764841|323572035|FG003|Overall Study|Withdrawal by Subject|15|||
94485883|NCT01764841|323572032|FG000|Overall Study|Lost to Follow-up|3|||
94485884|NCT01764841|323572033|FG001|Overall Study|Lost to Follow-up|0|||
94485885|NCT01764841|323572034|FG002|Overall Study|Lost to Follow-up|1|||
94485886|NCT01764841|323572035|FG003|Overall Study|Lost to Follow-up|0|||
94485887|NCT00086190|323572037|FG000|Overall Study|Adverse Event|6|||
94485888|NCT00086190|323572038|FG001|Overall Study|Adverse Event|2|||
94485889|NCT00086190|323572039|FG002|Overall Study|Adverse Event|2|||
94485890|NCT00086190|323572037|FG000|Overall Study|Withdrawal by Subject|0|||
94485891|NCT00086190|323572038|FG001|Overall Study|Withdrawal by Subject|2|||
94485892|NCT00086190|323572039|FG002|Overall Study|Withdrawal by Subject|2|||
94485893|NCT00086190|323572037|FG000|Overall Study|Protocol Violation|1|||
94485894|NCT00086190|323572038|FG001|Overall Study|Protocol Violation|0|||
94485895|NCT00086190|323572039|FG002|Overall Study|Protocol Violation|0|||
94485896|NCT00086190|323572037|FG000|Overall Study|Moved|1|||
94485897|NCT00086190|323572038|FG001|Overall Study|Moved|0|||
94485898|NCT00086190|323572039|FG002|Overall Study|Moved|0|||
94485899|NCT00086190|323572037|FG000|Overall Study|Worsening depression|0|||
94485900|NCT00086190|323572038|FG001|Overall Study|Worsening depression|0|||
94485901|NCT00086190|323572039|FG002|Overall Study|Worsening depression|2|||
94485902|NCT02027025|323572040|FG000|Overall Study|Adverse Event|0|||
94485903|NCT02027025|323572041|FG001|Overall Study|Adverse Event|1|||
94485904|NCT02027025|323572042|FG002|Overall Study|Adverse Event|1|||
94485905|NCT02027025|323572040|FG000|Overall Study|Protocol Violation|1|||
94485906|NCT02027025|323572041|FG001|Overall Study|Protocol Violation|0|||
94485907|NCT02027025|323572042|FG002|Overall Study|Protocol Violation|0|||
94485908|NCT02027025|323572040|FG000|Overall Study|Lost to Follow-up|0|||
94485909|NCT02027025|323572041|FG001|Overall Study|Lost to Follow-up|2|||
94485910|NCT02027025|323572042|FG002|Overall Study|Lost to Follow-up|0|||
94485911|NCT02027025|323572040|FG000|Overall Study|Withdrawal by Subject|0|||
94485912|NCT02027025|323572041|FG001|Overall Study|Withdrawal by Subject|1|||
94485913|NCT02027025|323572042|FG002|Overall Study|Withdrawal by Subject|0|||
94485914|NCT02027025|323572040|FG000|Overall Study|Sponsor's decision|0|||
94485915|NCT02027025|323572041|FG001|Overall Study|Sponsor's decision|1|||
94485916|NCT02027025|323572042|FG002|Overall Study|Sponsor's decision|0|||
94485917|NCT00402727|323572050|FG000|Overall Study|Adverse Event|10|||
94485918|NCT00402727|323572051|FG001|Overall Study|Adverse Event|6|||
94485919|NCT00402727|323572050|FG000|Overall Study|Death|1|||
94485920|NCT00402727|323572051|FG001|Overall Study|Death|0|||
94485921|NCT00402727|323572050|FG000|Overall Study|Lack of Efficacy|1|||
94406859|NCT02418754|323275122|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
94406860|NCT02418754|323275123|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
94406861|NCT02418754|323275124|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
94406862|NCT02418754|323275120|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
94406863|NCT02418754|323275121|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
94406864|NCT02418754|323275122|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
94406865|NCT02418754|323275123|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
94406866|NCT02418754|323275124|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
94406867|NCT02418754|323275120|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
94406868|NCT02418754|323275121|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
94406869|NCT02418754|323275122|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
94406870|NCT02418754|323275123|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
94406871|NCT02418754|323275124|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
94406872|NCT02418754|323275120|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
94406873|NCT02418754|323275121|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
94406874|NCT02418754|323275122|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
94406875|NCT02418754|323275123|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
94406876|NCT02418754|323275124|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
94406877|NCT00613730|323275128|FG000|Overall Study|Disease progression|2|||
94406878|NCT00613730|323275128|FG000|Overall Study|Administrative decision|1|||
94406879|NCT02030535|323275129|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
94406880|NCT03185741|323275134|FG000|Baseline|Withdrawal by Subject|1|||
94406881|NCT03185741|323275135|FG001|Baseline|Withdrawal by Subject|3|||
94406882|NCT03185741|323275136|FG002|Baseline|Withdrawal by Subject|2|||
94406883|NCT03185741|323275134|FG000|Baseline|Lost to Follow-up|1|||
94406884|NCT03185741|323275135|FG001|Baseline|Lost to Follow-up|2|||
94406885|NCT03185741|323275136|FG002|Baseline|Lost to Follow-up|3|||
94406886|NCT03185741|323275134|FG000|3Month|Death|1|||
94406887|NCT03185741|323275135|FG001|3Month|Death|1|||
94406888|NCT03185741|323275136|FG002|3Month|Death|2|||
94406889|NCT03185741|323275134|FG000|3Month|Withdrawal by Subject|1|||
94406890|NCT03185741|323275135|FG001|3Month|Withdrawal by Subject|5|||
94406891|NCT03185741|323275136|FG002|3Month|Withdrawal by Subject|1|||
94406892|NCT03185741|323275134|FG000|3Month|Lost to Follow-up|7|||
94406893|NCT03185741|323275135|FG001|3Month|Lost to Follow-up|9|||
94406894|NCT03185741|323275136|FG002|3Month|Lost to Follow-up|8|||
94406895|NCT03185741|323275134|FG000|3Month|Unavailable for 3Month|11|||
94406896|NCT03185741|323275135|FG001|3Month|Unavailable for 3Month|10|||
94406897|NCT03185741|323275136|FG002|3Month|Unavailable for 3Month|11|||
94406898|NCT03185741|323275134|FG000|3Month|Protocol Violation|0|||
94406899|NCT03185741|323275135|FG001|3Month|Protocol Violation|0|||
94406900|NCT03185741|323275136|FG002|3Month|Protocol Violation|3|||
94406901|NCT03185741|323275134|FG000|6Month|Death|1|||
94406902|NCT03185741|323275135|FG001|6Month|Death|1|||
94406903|NCT03185741|323275136|FG002|6Month|Death|2|||
94406904|NCT03185741|323275134|FG000|6Month|Withdrawal by Subject|2|||
94406905|NCT03185741|323275135|FG001|6Month|Withdrawal by Subject|3|||
94406906|NCT03185741|323275136|FG002|6Month|Withdrawal by Subject|1|||
94406907|NCT03185741|323275134|FG000|6Month|Lost to Follow-up|16|||
94406908|NCT03185741|323275135|FG001|6Month|Lost to Follow-up|15|||
94406909|NCT03185741|323275136|FG002|6Month|Lost to Follow-up|16|||
94406910|NCT01588548|323275137|FG000|Overall Study|Withdrawal by Subject|0|||
94406911|NCT01588548|323275138|FG001|Overall Study|Withdrawal by Subject|1|||
94406912|NCT01588548|323275139|FG002|Overall Study|Withdrawal by Subject|1|||
94406913|NCT01588548|323275140|FG003|Overall Study|Withdrawal by Subject|1|||
94406914|NCT01588548|323275141|FG004|Overall Study|Withdrawal by Subject|2|||
94406915|NCT01588548|323275142|FG005|Overall Study|Withdrawal by Subject|3|||
94406916|NCT01588548|323275137|FG000|Overall Study|Adverse Event|0|||
94406917|NCT01588548|323275138|FG001|Overall Study|Adverse Event|0|||
94406918|NCT01588548|323275139|FG002|Overall Study|Adverse Event|1|||
94406919|NCT01588548|323275140|FG003|Overall Study|Adverse Event|2|||
94485922|NCT00402727|323572051|FG001|Overall Study|Lack of Efficacy|3|||
94406920|NCT01588548|323275141|FG004|Overall Study|Adverse Event|1|||
94406921|NCT01588548|323275142|FG005|Overall Study|Adverse Event|0|||
94406922|NCT01588548|323275137|FG000|Overall Study|Condition Under Investigation Worsened|3|||
94406923|NCT01588548|323275138|FG001|Overall Study|Condition Under Investigation Worsened|6|||
94485923|NCT00402727|323572050|FG000|Overall Study|Lost to Follow-up|24|||
94406924|NCT01588548|323275139|FG002|Overall Study|Condition Under Investigation Worsened|4|||
94406925|NCT01588548|323275140|FG003|Overall Study|Condition Under Investigation Worsened|4|||
94406926|NCT01588548|323275141|FG004|Overall Study|Condition Under Investigation Worsened|3|||
94406927|NCT01588548|323275142|FG005|Overall Study|Condition Under Investigation Worsened|3|||
94406928|NCT03693950|323275148|FG000|Overall Study|Withdrawal by Subject|1|||
94406929|NCT03693950|323275149|FG001|Overall Study|Withdrawal by Subject|0|||
94406930|NCT01321697|323275154|FG000|Overall Study|Study Terminated|7|||
94406931|NCT00434590|323275155|FG000|Overall Study|Administrative problems|5|||
94406932|NCT00434590|323275156|FG001|Overall Study|Administrative problems|5|||
94406933|NCT02028455|323275157|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
94406934|NCT02028455|323275158|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
94406935|NCT02028455|323275159|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
94406936|NCT02028455|323275160|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
94406937|NCT02028455|323275161|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
94406938|NCT02028455|323275162|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
94406939|NCT02028455|323275163|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
94406940|NCT02028455|323275164|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
94406941|NCT02028455|323275157|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
94406942|NCT02028455|323275158|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
94406943|NCT02028455|323275159|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
94406944|NCT02028455|323275160|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
94406945|NCT02028455|323275161|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
94406946|NCT02028455|323275162|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
94406947|NCT02028455|323275163|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
94406948|NCT02028455|323275164|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
94406949|NCT02028455|323275157|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
94406950|NCT02028455|323275158|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
94406951|NCT02028455|323275159|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
94406952|NCT02028455|323275160|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
94406953|NCT02028455|323275161|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
94406954|NCT02028455|323275162|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
94406955|NCT02028455|323275163|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
94406956|NCT02028455|323275164|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
94406957|NCT02028455|323275157|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
94406958|NCT02028455|323275158|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
94406959|NCT02028455|323275159|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
94406960|NCT02028455|323275160|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
94406961|NCT02028455|323275161|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
94406962|NCT02028455|323275162|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
94406963|NCT02028455|323275163|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
94406964|NCT02028455|323275164|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
94406965|NCT02300987|323276348|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
94406966|NCT02300987|323276349|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
94406967|NCT02300987|323276348|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
94406968|NCT02300987|323276349|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
94406969|NCT02300987|323276348|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
94406970|NCT02300987|323276349|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
94406971|NCT02300987|323276348|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
94406972|NCT02300987|323276349|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
94406973|NCT02300987|323276348|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
94406974|NCT02300987|323276349|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
94406975|NCT02129062|323276350|FG000|Overall Study|Death|1|||
94406976|NCT02129062|323276350|FG000|Overall Study|Disease Progression|2|||
94406977|NCT02940522|323276351|FG000|Overall Study|Lost to Follow-up|1|||
94406978|NCT02940522|323276352|FG001|Overall Study|Lost to Follow-up|2|||
94406979|NCT02940522|323276351|FG000|Overall Study|Withdrawal by Subject|1|||
94406980|NCT02940522|323276352|FG001|Overall Study|Withdrawal by Subject|0|||
94406981|NCT00559637|323276354|FG000|Overall Study|Adverse Event|22|||
94406982|NCT00559637|323276354|FG000|Overall Study|Withdrawal by Subject|4|||
94406983|NCT00559637|323276354|FG000|Overall Study|Protocol Violation|6|||
94406984|NCT00559637|323276354|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
94406985|NCT00559637|323276354|FG000|Overall Study|Failure to return|6|||
94406986|NCT00559637|323276354|FG000|Overall Study|Insufficient response|3|||
94406987|NCT00559637|323276354|FG000|Overall Study|Started requiring dialysis after month 7|2|||
94406988|NCT00559637|323276354|FG000|Overall Study|Suspected lung cancer|1|||
94406989|NCT00559637|323276354|FG000|Overall Study|Participation in another study|1|||
94406990|NCT00559637|323276354|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
94406991|NCT00559637|323276354|FG000|Overall Study|Change of center|1|||
94406992|NCT00559637|323276354|FG000|Overall Study|Change of home|1|||
94485924|NCT00402727|323572051|FG001|Overall Study|Lost to Follow-up|11|||
94406993|NCT00559637|323276354|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
94485925|NCT00402727|323572050|FG000|Overall Study|Physician Decision|1|||
94485926|NCT00402727|323572051|FG001|Overall Study|Physician Decision|1|||
94406994|NCT02832167|323276355|FG000|Treatment Period 1|Disease progression|90|||
94406995|NCT02832167|323276355|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
94406996|NCT02832167|323276355|FG000|Treatment Period 1|Death|2|||
94406997|NCT02832167|323276355|FG000|Treatment Period 1|Study Drug Toxicity|6|||
94406998|NCT02832167|323276355|FG000|Treatment Period 1|Participant request to discontinue|9|||
94406999|NCT02832167|323276355|FG000|Treatment Period 1|No longer meet study criteria|1|||
94407000|NCT02832167|323276355|FG000|Treatment Period 1|Participant withdrew consent|3|||
94407001|NCT02832167|323276355|FG000|Treatment Period 1|Other reasons|6|||
94407002|NCT02832167|323276355|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
94407003|NCT02832167|323276355|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
94407004|NCT02832167|323276355|FG000|Transition From Period 1 to Period 2|Death|2|||
94407005|NCT02832167|323276355|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
94407006|NCT02832167|323276355|FG000|Treatment Period 2|Disease progression|69|||
94407007|NCT02832167|323276355|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
94407008|NCT02832167|323276355|FG000|Treatment Period 2|Maximum clinical benefit|1|||
94407009|NCT02832167|323276355|FG000|Treatment Period 2|Study Drug Toxicity|5|||
94407010|NCT02832167|323276355|FG000|Treatment Period 2|Participant request to discontinue|2|||
94407011|NCT02832167|323276355|FG000|Treatment Period 2|Participant withdrew consent|3|||
94407012|NCT02832167|323276355|FG000|Treatment Period 2|Other reasons|3|||
94407013|NCT01705717|323276356|FG000|Overall Study|Adverse Event|2|||
94407014|NCT01705717|323276357|FG001|Overall Study|Adverse Event|2|||
94407015|NCT01705717|323276356|FG000|Overall Study|Lack of Efficacy|0|||
94407016|NCT01705717|323276357|FG001|Overall Study|Lack of Efficacy|1|||
94407017|NCT01705717|323276356|FG000|Overall Study|Other|0|||
94407018|NCT01705717|323276357|FG001|Overall Study|Other|2|||
94407019|NCT00820599|323276358|FG000|Overall Study|Death|129|||
94407020|NCT00820599|323276358|FG000|Overall Study|Withdrawal by Subject|2|||
94407021|NCT01813435|323276364|FG000|Overall Study|did not finish experimental regimen|1902|||
94407022|NCT01813435|323276365|FG001|Overall Study|did not finish experimental regimen|770|||
94407023|NCT01813435|323276364|FG000|Overall Study|Lost to Follow-up|268|||
94407024|NCT01813435|323276365|FG001|Overall Study|Lost to Follow-up|237|||
94407025|NCT00880334|323276368|FG000|Randomized Phase|Physician Decision|1|||
94407026|NCT00880334|323276369|FG001|Randomized Phase|Physician Decision|0|||
94407027|NCT00880334|323276368|FG000|Randomized Phase|Withdrawal by Subject|2|||
94407028|NCT00880334|323276369|FG001|Randomized Phase|Withdrawal by Subject|1|||
94407029|NCT00880334|323276368|FG000|Randomized Phase|Inadequate Labs|1|||
94407030|NCT00880334|323276369|FG001|Randomized Phase|Inadequate Labs|1|||
94407031|NCT00880334|323276368|FG000|Randomized Phase|Brain Metastasis|0|||
94407032|NCT00880334|323276369|FG001|Randomized Phase|Brain Metastasis|1|||
94407033|NCT00880334|323276368|FG000|Randomized Phase|Crossover Participants|0|||
94407034|NCT00880334|323276369|FG001|Randomized Phase|Crossover Participants|37|||
94407035|NCT03343639|323276370|FG000|Overall Study|Withdrawal by Subject|10|||
94407036|NCT03343639|323276371|FG001|Overall Study|Withdrawal by Subject|6|||
94407037|NCT03343639|323276370|FG000|Overall Study|Lost to Follow-up|4|||
94407038|NCT03343639|323276371|FG001|Overall Study|Lost to Follow-up|5|||
94407039|NCT03343639|323276370|FG000|Overall Study|Protocol Violation|0|||
94407040|NCT03343639|323276371|FG001|Overall Study|Protocol Violation|1|||
94407041|NCT02274558|323276372|FG000|Overall Study|Adverse Event|2|||
94407042|NCT02274558|323276373|FG001|Overall Study|Adverse Event|4|||
94407043|NCT02274558|323276374|FG002|Overall Study|Adverse Event|2|||
94407044|NCT02274558|323276372|FG000|Overall Study|Non-compliance|2|||
94407045|NCT02274558|323276373|FG001|Overall Study|Non-compliance|1|||
94407046|NCT02274558|323276374|FG002|Overall Study|Non-compliance|0|||
94407047|NCT02274558|323276372|FG000|Overall Study|Withdrawal by Subject|1|||
94407048|NCT02274558|323276373|FG001|Overall Study|Withdrawal by Subject|5|||
94407049|NCT02274558|323276374|FG002|Overall Study|Withdrawal by Subject|4|||
94485927|NCT00402727|323572050|FG000|Overall Study|Protocol Violation|0|||
94407050|NCT02274558|323276372|FG000|Overall Study|Death|0|||
94407051|NCT02274558|323276373|FG001|Overall Study|Death|0|||
94407052|NCT02274558|323276374|FG002|Overall Study|Death|1|||
94407053|NCT02274558|323276372|FG000|Overall Study|Lost to Follow-up|2|||
94407054|NCT02274558|323276373|FG001|Overall Study|Lost to Follow-up|1|||
94407055|NCT02274558|323276374|FG002|Overall Study|Lost to Follow-up|1|||
94407056|NCT02274558|323276372|FG000|Overall Study|Physician Decision|0|||
94407057|NCT02274558|323276373|FG001|Overall Study|Physician Decision|2|||
94407058|NCT02274558|323276374|FG002|Overall Study|Physician Decision|1|||
94407059|NCT04592419|323276375|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
94407060|NCT04592419|323276376|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
94407061|NCT04592419|323276375|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
94407062|NCT04592419|323276376|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
94407063|NCT04592419|323276375|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
94407064|NCT04592419|323276376|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
94407065|NCT04592419|323276375|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
94407066|NCT04592419|323276376|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
94407067|NCT04592419|323276375|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
94485928|NCT00402727|323572051|FG001|Overall Study|Protocol Violation|4|||
94407068|NCT04592419|323276376|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
94407069|NCT04592419|323276375|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
94407070|NCT04592419|323276376|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
94407071|NCT04592419|323276375|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
94407072|NCT04592419|323276376|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
94407073|NCT04592419|323276375|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
94407074|NCT04592419|323276376|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
94407075|NCT04592419|323276375|FG000|Open-Label Extension Period|Adverse Event|1|||
94407076|NCT04592419|323276376|FG001|Open-Label Extension Period|Adverse Event|2|||
94407077|NCT04592419|323276375|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
94407078|NCT04592419|323276376|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
94407079|NCT04592419|323276375|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
94407080|NCT04592419|323276376|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
94407081|NCT04592419|323276375|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
94407082|NCT04592419|323276376|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
94407083|NCT04592419|323276375|FG000|Open-Label Extension Period|Sponsor Request|73|||
94407084|NCT04592419|323276376|FG001|Open-Label Extension Period|Sponsor Request|84|||
94407085|NCT00685035|323276381|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
94407086|NCT00685035|323276382|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
94407087|NCT05996198|323276385|FG000|Overall Study|Withdrawal by Subject|1|||
94407088|NCT05996198|323276386|FG001|Overall Study|Withdrawal by Subject|0|||
94407089|NCT00835796|323276388|FG000|First Intervention|Withdrawal by Subject|0|||
94407090|NCT00835796|323276389|FG001|First Intervention|Withdrawal by Subject|1|||
94407091|NCT00396630|323276390|FG000|Overall Study|Lost to Follow-up|1|||
94407092|NCT00396630|323276391|FG001|Overall Study|Lost to Follow-up|1|||
94407093|NCT00396630|323276390|FG000|Overall Study|Withdrawal by Subject|1|||
94407094|NCT00396630|323276391|FG001|Overall Study|Withdrawal by Subject|1|||
94407095|NCT00396630|323276390|FG000|Overall Study|Not vaccinated at Visit 3|3|||
94407096|NCT00396630|323276391|FG001|Overall Study|Not vaccinated at Visit 3|3|||
94407097|NCT01119625|323276392|FG000|Overall Study|Lost to Follow-up|1|||
94407098|NCT01119625|323276393|FG001|Overall Study|Lost to Follow-up|2|||
94407099|NCT01119625|323276392|FG000|Overall Study|Withdrawal by Subject|2|||
94407100|NCT01119625|323276393|FG001|Overall Study|Withdrawal by Subject|1|||
94407101|NCT01119625|323276392|FG000|Overall Study|Other|0|||
94407102|NCT01119625|323276393|FG001|Overall Study|Other|1|||
94407103|NCT00876265|323276394|FG000|Overall Study|Miscellaneous reasons|4|||
94407104|NCT00876265|323276394|FG000|Overall Study|Lost to Follow-up|6|||
94407105|NCT00876265|323276394|FG000|Overall Study|Withdrawal by Subject|2|||
94407106|NCT00651183|323276399|FG000|Overall Study|Lack of Efficacy|1|||
94407107|NCT00651183|323276400|FG001|Overall Study|Lack of Efficacy|0|||
94407108|NCT00651183|323276399|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
94407109|NCT00651183|323276400|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
94407110|NCT00651183|323276399|FG000|Overall Study|Tolerability insufficient|5|||
94407111|NCT00651183|323276400|FG001|Overall Study|Tolerability insufficient|2|||
94407112|NCT00651183|323276399|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
94407113|NCT00651183|323276400|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
94407114|NCT00651183|323276399|FG000|Overall Study|Withdrawal by Subject|6|||
94407115|NCT00651183|323276400|FG001|Overall Study|Withdrawal by Subject|3|||
94407116|NCT00651183|323276399|FG000|Overall Study|Lost to Follow-up|3|||
94407117|NCT00651183|323276400|FG001|Overall Study|Lost to Follow-up|1|||
94407118|NCT00651183|323276399|FG000|Overall Study|Other reasons|4|||
94407119|NCT00651183|323276400|FG001|Overall Study|Other reasons|2|||
94407120|NCT00651183|323276399|FG000|Overall Study|missing|1|||
94407121|NCT00651183|323276400|FG001|Overall Study|missing|0|||
94407122|NCT03414034|323276404|FG000|Overall Study|Adverse Event|6|||
94407123|NCT03414034|323276405|FG001|Overall Study|Adverse Event|1|||
94407124|NCT03414034|323276406|FG002|Overall Study|Adverse Event|1|||
94407125|NCT03414034|323276404|FG000|Overall Study|Death|0|||
94407126|NCT03414034|323276405|FG001|Overall Study|Death|0|||
94407127|NCT03414034|323276406|FG002|Overall Study|Death|1|||
94407128|NCT03414034|323276404|FG000|Overall Study|Non-compliance With Study Drug|0|||
94407129|NCT03414034|323276405|FG001|Overall Study|Non-compliance With Study Drug|0|||
94407130|NCT03414034|323276406|FG002|Overall Study|Non-compliance With Study Drug|1|||
94407131|NCT03414034|323276404|FG000|Overall Study|Physician Decision|1|||
94407132|NCT03414034|323276405|FG001|Overall Study|Physician Decision|3|||
94407133|NCT03414034|323276406|FG002|Overall Study|Physician Decision|2|||
94407134|NCT03414034|323276404|FG000|Overall Study|Withdrawal of Informed Consent|2|||
94407135|NCT03414034|323276405|FG001|Overall Study|Withdrawal of Informed Consent|1|||
94407136|NCT03414034|323276406|FG002|Overall Study|Withdrawal of Informed Consent|4|||
94407137|NCT03414034|323276404|FG000|Overall Study|Progressive Disease|15|||
94407138|NCT03414034|323276405|FG001|Overall Study|Progressive Disease|15|||
94407139|NCT03414034|323276406|FG002|Overall Study|Progressive Disease|17|||
94407140|NCT03414034|323276404|FG000|Overall Study|Miscellaneous|0|||
94407141|NCT03414034|323276405|FG001|Overall Study|Miscellaneous|0|||
94407142|NCT03414034|323276406|FG002|Overall Study|Miscellaneous|2|||
94407143|NCT01332968|323276408|FG000|Induction Period|Adverse Event|23|||
94407144|NCT01332968|323276409|FG001|Induction Period|Adverse Event|26|||
94407145|NCT01332968|323276410|FG002|Induction Period|Adverse Event|0|||
94407146|NCT01332968|323276411|FG003|Induction Period|Adverse Event|0|||
94407147|NCT01332968|323276412|FG004|Induction Period|Adverse Event|0|||
94407148|NCT01332968|323276413|FG005|Induction Period|Adverse Event|0|||
94407149|NCT01332968|323276414|FG006|Induction Period|Adverse Event|0|||
94407150|NCT01332968|323276415|FG007|Induction Period|Adverse Event|0|||
94407151|NCT01332968|323276408|FG000|Induction Period|Death|1|||
94407152|NCT01332968|323276409|FG001|Induction Period|Death|4|||
94407153|NCT01332968|323276410|FG002|Induction Period|Death|0|||
94407154|NCT01332968|323276411|FG003|Induction Period|Death|0|||
94407155|NCT01332968|323276412|FG004|Induction Period|Death|0|||
94407156|NCT01332968|323276413|FG005|Induction Period|Death|0|||
94407157|NCT01332968|323276414|FG006|Induction Period|Death|0|||
94407158|NCT01332968|323276415|FG007|Induction Period|Death|0|||
94407159|NCT01332968|323276408|FG000|Induction Period|Non-compliance|1|||
94407160|NCT01332968|323276409|FG001|Induction Period|Non-compliance|0|||
94407161|NCT01332968|323276410|FG002|Induction Period|Non-compliance|0|||
94407162|NCT01332968|323276411|FG003|Induction Period|Non-compliance|0|||
94407163|NCT01332968|323276412|FG004|Induction Period|Non-compliance|0|||
94407164|NCT01332968|323276413|FG005|Induction Period|Non-compliance|0|||
94407165|NCT01332968|323276414|FG006|Induction Period|Non-compliance|0|||
94407166|NCT01332968|323276415|FG007|Induction Period|Non-compliance|0|||
94407167|NCT01332968|323276408|FG000|Induction Period|Other|2|||
94407168|NCT01332968|323276409|FG001|Induction Period|Other|2|||
94407169|NCT01332968|323276410|FG002|Induction Period|Other|0|||
94407170|NCT01332968|323276411|FG003|Induction Period|Other|0|||
94407171|NCT01332968|323276412|FG004|Induction Period|Other|0|||
94407172|NCT01332968|323276413|FG005|Induction Period|Other|0|||
94407173|NCT01332968|323276414|FG006|Induction Period|Other|0|||
94407174|NCT01332968|323276415|FG007|Induction Period|Other|0|||
94407175|NCT01332968|323276408|FG000|Induction Period|Physician Decision|6|||
94407176|NCT01332968|323276409|FG001|Induction Period|Physician Decision|1|||
94407177|NCT01332968|323276410|FG002|Induction Period|Physician Decision|0|||
94407178|NCT01332968|323276411|FG003|Induction Period|Physician Decision|0|||
94407179|NCT01332968|323276412|FG004|Induction Period|Physician Decision|0|||
94407180|NCT01332968|323276413|FG005|Induction Period|Physician Decision|0|||
94407181|NCT01332968|323276414|FG006|Induction Period|Physician Decision|0|||
94407182|NCT01332968|323276415|FG007|Induction Period|Physician Decision|0|||
94407183|NCT01332968|323276408|FG000|Induction Period|Progressive Disease|15|||
94407184|NCT01332968|323276409|FG001|Induction Period|Progressive Disease|7|||
94407185|NCT01332968|323276410|FG002|Induction Period|Progressive Disease|0|||
94407186|NCT01332968|323276411|FG003|Induction Period|Progressive Disease|0|||
94407187|NCT01332968|323276412|FG004|Induction Period|Progressive Disease|0|||
94407188|NCT01332968|323276413|FG005|Induction Period|Progressive Disease|0|||
94407189|NCT01332968|323276414|FG006|Induction Period|Progressive Disease|0|||
94407190|NCT01332968|323276415|FG007|Induction Period|Progressive Disease|0|||
94407191|NCT01332968|323276408|FG000|Induction Period|Protocol Violation|3|||
94407192|NCT01332968|323276409|FG001|Induction Period|Protocol Violation|4|||
94407193|NCT01332968|323276410|FG002|Induction Period|Protocol Violation|0|||
94407194|NCT01332968|323276411|FG003|Induction Period|Protocol Violation|0|||
94407195|NCT01332968|323276412|FG004|Induction Period|Protocol Violation|0|||
94407196|NCT01332968|323276413|FG005|Induction Period|Protocol Violation|0|||
94407197|NCT01332968|323276414|FG006|Induction Period|Protocol Violation|0|||
94407198|NCT01332968|323276415|FG007|Induction Period|Protocol Violation|0|||
94407199|NCT01332968|323276408|FG000|Induction Period|Withdrawal by Subject|3|||
94407200|NCT01332968|323276409|FG001|Induction Period|Withdrawal by Subject|5|||
94407201|NCT01332968|323276410|FG002|Induction Period|Withdrawal by Subject|0|||
94407202|NCT01332968|323276411|FG003|Induction Period|Withdrawal by Subject|0|||
94407203|NCT01332968|323276412|FG004|Induction Period|Withdrawal by Subject|0|||
94407204|NCT01332968|323276413|FG005|Induction Period|Withdrawal by Subject|0|||
94407205|NCT01332968|323276414|FG006|Induction Period|Withdrawal by Subject|0|||
94407206|NCT01332968|323276415|FG007|Induction Period|Withdrawal by Subject|0|||
94407207|NCT01332968|323276408|FG000|Induction Period|Randomised but not treated|4|||
94407208|NCT01332968|323276409|FG001|Induction Period|Randomised but not treated|7|||
94407209|NCT01332968|323276410|FG002|Induction Period|Randomised but not treated|0|||
94407210|NCT01332968|323276411|FG003|Induction Period|Randomised but not treated|0|||
94407211|NCT01332968|323276412|FG004|Induction Period|Randomised but not treated|0|||
94407212|NCT01332968|323276413|FG005|Induction Period|Randomised but not treated|0|||
94407213|NCT01332968|323276414|FG006|Induction Period|Randomised but not treated|0|||
94407214|NCT01332968|323276415|FG007|Induction Period|Randomised but not treated|0|||
94407215|NCT01332968|323276408|FG000|Maintenance/Observation Period|Adverse Event|0|||
94407216|NCT01332968|323276409|FG001|Maintenance/Observation Period|Adverse Event|0|||
94407217|NCT01332968|323276410|FG002|Maintenance/Observation Period|Adverse Event|53|||
94407218|NCT01332968|323276411|FG003|Maintenance/Observation Period|Adverse Event|66|||
94407219|NCT01332968|323276412|FG004|Maintenance/Observation Period|Adverse Event|0|||
94485929|NCT00402727|323572050|FG000|Overall Study|Withdrawal by Subject|3|||
94485930|NCT00402727|323572051|FG001|Overall Study|Withdrawal by Subject|7|||
94485931|NCT00402727|323572050|FG000|Overall Study|supply problems|2|||
94485932|NCT00402727|323572051|FG001|Overall Study|supply problems|1|||
94485933|NCT00402727|323572050|FG000|Overall Study|non-compliance|0|||
94485934|NCT00402727|323572051|FG001|Overall Study|non-compliance|1|||
94485935|NCT04460326|323572052|FG000|Completed at Least 4 Meals|Early discharge|5|||
94485936|NCT04460326|323572053|FG001|Completed at Least 4 Meals|Early discharge|5|||
94485937|NCT04460326|323572052|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
94485938|NCT04460326|323572053|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
94485939|NCT04460326|323572052|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
94485940|NCT04460326|323572053|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
94485941|NCT04460326|323572052|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
94485942|NCT04460326|323572053|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
94485943|NCT04460326|323572052|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
94485944|NCT04460326|323572053|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
94485945|NCT04460326|323572052|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
94485946|NCT04460326|323572053|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
94485947|NCT03372798|323572054|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
94485948|NCT03372798|323572055|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
94485949|NCT03372798|323572054|FG000|Overall Study|Failure of imaging probe|0|||
94485950|NCT03372798|323572055|FG001|Overall Study|Failure of imaging probe|1|||
94485951|NCT03160716|323572056|FG000|Overall Study|Lost to Follow-up|1|||
94485952|NCT04794751|323572058|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
94485953|NCT04794751|323572059|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
94485954|NCT04794751|323572058|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
94485955|NCT04794751|323572059|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
94485956|NCT04794751|323572058|FG000|Period 1|Protocol Violation|0|||
94485957|NCT04794751|323572059|FG001|Period 1|Protocol Violation|2|||
94485958|NCT04794751|323572058|FG000|Period 1|Withdrawal by Subject|0|||
94485959|NCT04794751|323572059|FG001|Period 1|Withdrawal by Subject|1|||
94485960|NCT04794751|323572058|FG000|Period 2|Withdrawal by Subject|0|||
94485961|NCT04794751|323572059|FG001|Period 2|Withdrawal by Subject|1|||
94485962|NCT04794751|323572058|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
94485963|NCT04794751|323572059|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
94485964|NCT04794751|323572058|FG000|Period 2|Protocol Violation|1|||
94485965|NCT04794751|323572059|FG001|Period 2|Protocol Violation|0|||
94485966|NCT01204671|323572060|FG000|Overall Study|Adverse Event|4|||
94485967|NCT01204671|323572061|FG001|Overall Study|Adverse Event|3|||
94485968|NCT01204671|323572062|FG002|Overall Study|Adverse Event|3|||
94485969|NCT01204671|323572063|FG003|Overall Study|Adverse Event|3|||
94485970|NCT01204671|323572064|FG004|Overall Study|Adverse Event|1|||
94485971|NCT01204671|323572060|FG000|Overall Study|Withdrawal by Subject|2|||
94485972|NCT01204671|323572061|FG001|Overall Study|Withdrawal by Subject|3|||
94485973|NCT01204671|323572062|FG002|Overall Study|Withdrawal by Subject|4|||
94485974|NCT01204671|323572063|FG003|Overall Study|Withdrawal by Subject|5|||
94485975|NCT01204671|323572064|FG004|Overall Study|Withdrawal by Subject|3|||
94485976|NCT01204671|323572060|FG000|Overall Study|Lost to Follow-up|7|||
94485977|NCT01204671|323572061|FG001|Overall Study|Lost to Follow-up|8|||
94485978|NCT01204671|323572062|FG002|Overall Study|Lost to Follow-up|6|||
94485979|NCT01204671|323572063|FG003|Overall Study|Lost to Follow-up|4|||
94485980|NCT01204671|323572064|FG004|Overall Study|Lost to Follow-up|0|||
94485981|NCT01204671|323572060|FG000|Overall Study|Unknown Completion Status|1|||
94485982|NCT01204671|323572061|FG001|Overall Study|Unknown Completion Status|1|||
94485983|NCT01204671|323572062|FG002|Overall Study|Unknown Completion Status|0|||
94485984|NCT01204671|323572063|FG003|Overall Study|Unknown Completion Status|0|||
94485985|NCT01204671|323572064|FG004|Overall Study|Unknown Completion Status|0|||
94485986|NCT01204671|323572060|FG000|Overall Study|Physician Decision|0|||
94485987|NCT01204671|323572061|FG001|Overall Study|Physician Decision|0|||
94485988|NCT01204671|323572062|FG002|Overall Study|Physician Decision|0|||
94485989|NCT01204671|323572063|FG003|Overall Study|Physician Decision|1|||
94485990|NCT01204671|323572064|FG004|Overall Study|Physician Decision|0|||
94485991|NCT03234465|323572065|FG000|Overall Study|Adverse Event|4|||
94485992|NCT03234465|323572066|FG001|Overall Study|Adverse Event|2|||
94485993|NCT03234465|323572065|FG000|Overall Study|Death|0|||
94485994|NCT03234465|323572066|FG001|Overall Study|Death|1|||
94485995|NCT03234465|323572065|FG000|Overall Study|Lost to Follow-up|1|||
94485996|NCT03234465|323572066|FG001|Overall Study|Lost to Follow-up|1|||
94485997|NCT03234465|323572065|FG000|Overall Study|Withdrawal by Subject|12|||
94485998|NCT03234465|323572066|FG001|Overall Study|Withdrawal by Subject|27|||
94485999|NCT03234465|323572065|FG000|Overall Study|Symptomatic deterioration|0|||
94486000|NCT03234465|323572066|FG001|Overall Study|Symptomatic deterioration|1|||
94486001|NCT03234465|323572065|FG000|Overall Study|Non-compliance|2|||
94486002|NCT03234465|323572066|FG001|Overall Study|Non-compliance|0|||
94486003|NCT03234465|323572065|FG000|Overall Study|Other|14|||
94407220|NCT01332968|323276413|FG005|Maintenance/Observation Period|Adverse Event|0|||
94407221|NCT01332968|323276414|FG006|Maintenance/Observation Period|Adverse Event|0|||
94407222|NCT01332968|323276415|FG007|Maintenance/Observation Period|Adverse Event|0|||
94407223|NCT01332968|323276408|FG000|Maintenance/Observation Period|Death|0|||
94407224|NCT01332968|323276409|FG001|Maintenance/Observation Period|Death|0|||
94407225|NCT01332968|323276410|FG002|Maintenance/Observation Period|Death|5|||
94407226|NCT01332968|323276411|FG003|Maintenance/Observation Period|Death|6|||
94407227|NCT01332968|323276412|FG004|Maintenance/Observation Period|Death|0|||
94407228|NCT01332968|323276413|FG005|Maintenance/Observation Period|Death|0|||
94407229|NCT01332968|323276414|FG006|Maintenance/Observation Period|Death|0|||
94407230|NCT01332968|323276415|FG007|Maintenance/Observation Period|Death|0|||
94407231|NCT01332968|323276408|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
94407232|NCT01332968|323276409|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
94407233|NCT01332968|323276410|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
94407234|NCT01332968|323276411|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
94407235|NCT01332968|323276412|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
94407236|NCT01332968|323276413|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
94407237|NCT01332968|323276414|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
94407238|NCT01332968|323276415|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
94407239|NCT01332968|323276408|FG000|Maintenance/Observation Period|Non-compliance|0|||
94407240|NCT01332968|323276409|FG001|Maintenance/Observation Period|Non-compliance|0|||
94407241|NCT01332968|323276410|FG002|Maintenance/Observation Period|Non-compliance|4|||
94407242|NCT01332968|323276411|FG003|Maintenance/Observation Period|Non-compliance|3|||
94407243|NCT01332968|323276412|FG004|Maintenance/Observation Period|Non-compliance|0|||
94407244|NCT01332968|323276413|FG005|Maintenance/Observation Period|Non-compliance|0|||
94407245|NCT01332968|323276414|FG006|Maintenance/Observation Period|Non-compliance|0|||
94407246|NCT01332968|323276415|FG007|Maintenance/Observation Period|Non-compliance|0|||
94407247|NCT01332968|323276408|FG000|Maintenance/Observation Period|Other|0|||
94407248|NCT01332968|323276409|FG001|Maintenance/Observation Period|Other|0|||
94407249|NCT01332968|323276410|FG002|Maintenance/Observation Period|Other|4|||
94407250|NCT01332968|323276411|FG003|Maintenance/Observation Period|Other|7|||
94407251|NCT01332968|323276412|FG004|Maintenance/Observation Period|Other|0|||
94407252|NCT01332968|323276413|FG005|Maintenance/Observation Period|Other|0|||
94407253|NCT01332968|323276414|FG006|Maintenance/Observation Period|Other|0|||
94407254|NCT01332968|323276415|FG007|Maintenance/Observation Period|Other|0|||
94407255|NCT01332968|323276408|FG000|Maintenance/Observation Period|Physician Decision|0|||
94407256|NCT01332968|323276409|FG001|Maintenance/Observation Period|Physician Decision|0|||
94407257|NCT01332968|323276410|FG002|Maintenance/Observation Period|Physician Decision|14|||
94407258|NCT01332968|323276411|FG003|Maintenance/Observation Period|Physician Decision|19|||
94407259|NCT01332968|323276412|FG004|Maintenance/Observation Period|Physician Decision|0|||
94407260|NCT01332968|323276413|FG005|Maintenance/Observation Period|Physician Decision|1|||
94407261|NCT01332968|323276414|FG006|Maintenance/Observation Period|Physician Decision|0|||
94407262|NCT01332968|323276415|FG007|Maintenance/Observation Period|Physician Decision|0|||
94407263|NCT01332968|323276408|FG000|Maintenance/Observation Period|Progressive Disease|0|||
94407264|NCT01332968|323276409|FG001|Maintenance/Observation Period|Progressive Disease|0|||
94407265|NCT01332968|323276410|FG002|Maintenance/Observation Period|Progressive Disease|72|||
94407266|NCT01332968|323276411|FG003|Maintenance/Observation Period|Progressive Disease|40|||
94407267|NCT01332968|323276412|FG004|Maintenance/Observation Period|Progressive Disease|0|||
94407268|NCT01332968|323276413|FG005|Maintenance/Observation Period|Progressive Disease|0|||
94407269|NCT01332968|323276414|FG006|Maintenance/Observation Period|Progressive Disease|0|||
94407270|NCT01332968|323276415|FG007|Maintenance/Observation Period|Progressive Disease|0|||
94407271|NCT01332968|323276408|FG000|Maintenance/Observation Period|Protocol Violation|0|||
94407272|NCT01332968|323276409|FG001|Maintenance/Observation Period|Protocol Violation|0|||
94407273|NCT01332968|323276410|FG002|Maintenance/Observation Period|Protocol Violation|1|||
94407274|NCT01332968|323276411|FG003|Maintenance/Observation Period|Protocol Violation|1|||
94407275|NCT01332968|323276412|FG004|Maintenance/Observation Period|Protocol Violation|0|||
94407276|NCT01332968|323276413|FG005|Maintenance/Observation Period|Protocol Violation|0|||
94407277|NCT01332968|323276414|FG006|Maintenance/Observation Period|Protocol Violation|0|||
94407278|NCT01332968|323276415|FG007|Maintenance/Observation Period|Protocol Violation|0|||
94407279|NCT01332968|323276408|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
94407280|NCT01332968|323276409|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
94407281|NCT01332968|323276410|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
94407282|NCT01332968|323276411|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
94407283|NCT01332968|323276412|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
94407284|NCT01332968|323276413|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
94407285|NCT01332968|323276414|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
94407286|NCT01332968|323276415|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
94407287|NCT01332968|323276408|FG000|Follow-Up Period|Adverse Event|0|||
94407288|NCT01332968|323276409|FG001|Follow-Up Period|Adverse Event|0|||
94407289|NCT01332968|323276410|FG002|Follow-Up Period|Adverse Event|0|||
94486004|NCT03234465|323572066|FG001|Overall Study|Other|8|||
94486005|NCT03106077|323572067|FG000|Overall Study|Screen Failure|94|||
94486006|NCT03106077|323572068|FG001|Overall Study|Screen Failure|0|||
94486007|NCT01274533|323572069|FG000|Overall Study|Withdrawal by Subject|1|||
94486008|NCT01274533|323572069|FG000|Overall Study|Non-compliance|1|||
94486009|NCT01274533|323572069|FG000|Overall Study|Disease progression|2|||
94486010|NCT02668640|323572070|FG000|Overall Study|Lost to Follow-up|13|||
94486011|NCT02668640|323572070|FG000|Overall Study|Other, not specified|1|||
94486012|NCT03368664|323572079|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
94486013|NCT03368664|323572079|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
94486014|NCT03368664|323572079|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
94486015|NCT03368664|323572079|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
94486016|NCT03669588|323572080|FG000|Overall Study|Adverse Event|1|||
94486017|NCT03669588|323572081|FG001|Overall Study|Adverse Event|0|||
94486018|NCT03669588|323572080|FG000|Overall Study|Physician Decision|0|||
94486019|NCT03669588|323572081|FG001|Overall Study|Physician Decision|1|||
94486020|NCT03669588|323572080|FG000|Overall Study|Protocol Violation|1|||
94486021|NCT03669588|323572081|FG001|Overall Study|Protocol Violation|0|||
94486022|NCT03669588|323572080|FG000|Overall Study|Sponsor Decision|1|||
94486023|NCT03669588|323572081|FG001|Overall Study|Sponsor Decision|1|||
94486024|NCT03669588|323572080|FG000|Overall Study|Withdrawal by Subject|1|||
94486025|NCT03669588|323572081|FG001|Overall Study|Withdrawal by Subject|4|||
94486026|NCT03669588|323572080|FG000|Overall Study|Rescue Therapy Needed|0|||
94486027|NCT03669588|323572081|FG001|Overall Study|Rescue Therapy Needed|1|||
94486028|NCT02008526|323572082|FG000|Overall Study|Death|0|||
94486029|NCT02008526|323572083|FG001|Overall Study|Death|2|||
94486030|NCT02008526|323572084|FG002|Overall Study|Death|1|||
94486031|NCT02008526|323572082|FG000|Overall Study|Withdrawal by Subject|3|||
94486032|NCT02008526|323572083|FG001|Overall Study|Withdrawal by Subject|3|||
94486033|NCT02008526|323572084|FG002|Overall Study|Withdrawal by Subject|2|||
94486034|NCT02008526|323572082|FG000|Overall Study|Lost to Follow-up|5|||
94486035|NCT02008526|323572083|FG001|Overall Study|Lost to Follow-up|9|||
94486036|NCT02008526|323572084|FG002|Overall Study|Lost to Follow-up|6|||
94486037|NCT01118052|323572085|FG000|Overall Study|Never treated|2|||
94486038|NCT04158219|323572088|FG000|Overall Study|Lost to Follow-up|1|||
94486039|NCT04113694|323573489|FG000|Overall Study|Adverse Event|2|||
94486040|NCT04113694|323573489|FG000|Overall Study|Lost to Follow-up|2|||
94486041|NCT04113694|323573489|FG000|Overall Study|Withdrawal by Subject|6|||
94486042|NCT04113694|323573489|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
94486043|NCT01389232|323573492|FG000|Overall Study|Had scaffold removed|15|||
94486044|NCT01389232|323573492|FG000|Overall Study|Personal reasons|2|||
94486045|NCT01389232|323573492|FG000|Overall Study|Adverse Event|1|||
94486046|NCT01389232|323573492|FG000|Overall Study|Death|1|||
94486047|NCT02723188|323573493|FG000|Overall Study|Withdrawal by Subject|1|||
94486048|NCT02723188|323573494|FG001|Overall Study|Withdrawal by Subject|0|||
94486049|NCT02723188|323573495|FG002|Overall Study|Withdrawal by Subject|0|||
94486050|NCT00496769|323573496|FG000|Double Blind|>=1 reason assigned per patient|558|||
94486051|NCT00496769|323573497|FG001|Double Blind|>=1 reason assigned per patient|649|||
94407290|NCT01332968|323276411|FG003|Follow-Up Period|Adverse Event|0|||
94407291|NCT01332968|323276412|FG004|Follow-Up Period|Adverse Event|0|||
94407292|NCT01332968|323276413|FG005|Follow-Up Period|Adverse Event|0|||
94407293|NCT01332968|323276414|FG006|Follow-Up Period|Adverse Event|0|||
94407294|NCT01332968|323276415|FG007|Follow-Up Period|Adverse Event|4|||
94407295|NCT01332968|323276408|FG000|Follow-Up Period|Death|0|||
94407296|NCT01332968|323276409|FG001|Follow-Up Period|Death|0|||
94407297|NCT01332968|323276410|FG002|Follow-Up Period|Death|0|||
94407298|NCT01332968|323276411|FG003|Follow-Up Period|Death|0|||
94407299|NCT01332968|323276412|FG004|Follow-Up Period|Death|0|||
94407300|NCT01332968|323276413|FG005|Follow-Up Period|Death|0|||
94407301|NCT01332968|323276414|FG006|Follow-Up Period|Death|27|||
94407302|NCT01332968|323276415|FG007|Follow-Up Period|Death|30|||
94407303|NCT01332968|323276408|FG000|Follow-Up Period|Lost to Follow-up|0|||
94407304|NCT01332968|323276409|FG001|Follow-Up Period|Lost to Follow-up|0|||
94407305|NCT01332968|323276410|FG002|Follow-Up Period|Lost to Follow-up|0|||
94407306|NCT01332968|323276411|FG003|Follow-Up Period|Lost to Follow-up|0|||
94407307|NCT01332968|323276412|FG004|Follow-Up Period|Lost to Follow-up|0|||
94407308|NCT01332968|323276413|FG005|Follow-Up Period|Lost to Follow-up|0|||
94407309|NCT01332968|323276414|FG006|Follow-Up Period|Lost to Follow-up|11|||
94407310|NCT01332968|323276415|FG007|Follow-Up Period|Lost to Follow-up|15|||
94407311|NCT01332968|323276408|FG000|Follow-Up Period|Non-compliance|0|||
94407312|NCT01332968|323276409|FG001|Follow-Up Period|Non-compliance|0|||
94486052|NCT00496769|323573498|FG002|Double Blind|>=1 reason assigned per patient|0|||
94407313|NCT01332968|323276410|FG002|Follow-Up Period|Non-compliance|0|||
94407314|NCT01332968|323276411|FG003|Follow-Up Period|Non-compliance|0|||
94407315|NCT01332968|323276412|FG004|Follow-Up Period|Non-compliance|0|||
94407316|NCT01332968|323276413|FG005|Follow-Up Period|Non-compliance|0|||
94407317|NCT01332968|323276414|FG006|Follow-Up Period|Non-compliance|4|||
94486053|NCT00496769|323573496|FG000|Open Label|>=1 reason assigned per patient|0|||
94486054|NCT00496769|323573497|FG001|Open Label|>=1 reason assigned per patient|0|||
94486055|NCT00496769|323573498|FG002|Open Label|>=1 reason assigned per patient|1011|||
94486056|NCT01001429|323573499|FG000|Overall Study|surgery cancelled|0|||
94486057|NCT01001429|323573500|FG001|Overall Study|surgery cancelled|1|||
94486058|NCT04161391|323573505|FG000|Overall Study|Adverse Event|0|||
94486059|NCT04161391|323573506|FG001|Overall Study|Adverse Event|1|||
94486060|NCT04161391|323573507|FG002|Overall Study|Adverse Event|0|||
94486061|NCT04161391|323573508|FG003|Overall Study|Adverse Event|1|||
94486062|NCT04161391|323573509|FG004|Overall Study|Adverse Event|0|||
94486063|NCT04161391|323573510|FG005|Overall Study|Adverse Event|0|||
94486064|NCT04161391|323573511|FG006|Overall Study|Adverse Event|0|||
94486065|NCT04161391|323573512|FG007|Overall Study|Adverse Event|3|||
94486066|NCT04161391|323573513|FG008|Overall Study|Adverse Event|0|||
94486067|NCT04161391|323573505|FG000|Overall Study|Death|0|||
94486068|NCT04161391|323573506|FG001|Overall Study|Death|0|||
94486069|NCT04161391|323573507|FG002|Overall Study|Death|0|||
94486070|NCT04161391|323573508|FG003|Overall Study|Death|0|||
94486071|NCT04161391|323573509|FG004|Overall Study|Death|0|||
94486072|NCT04161391|323573510|FG005|Overall Study|Death|0|||
94486073|NCT04161391|323573511|FG006|Overall Study|Death|0|||
94486074|NCT04161391|323573512|FG007|Overall Study|Death|1|||
94486075|NCT04161391|323573513|FG008|Overall Study|Death|0|||
94486076|NCT04161391|323573505|FG000|Overall Study|Physician Decision|0|||
94486077|NCT04161391|323573506|FG001|Overall Study|Physician Decision|0|||
94486078|NCT04161391|323573507|FG002|Overall Study|Physician Decision|1|||
94486079|NCT04161391|323573508|FG003|Overall Study|Physician Decision|2|||
94486080|NCT04161391|323573509|FG004|Overall Study|Physician Decision|0|||
94486081|NCT04161391|323573510|FG005|Overall Study|Physician Decision|0|||
94486082|NCT04161391|323573511|FG006|Overall Study|Physician Decision|2|||
94486083|NCT04161391|323573512|FG007|Overall Study|Physician Decision|0|||
94486084|NCT04161391|323573513|FG008|Overall Study|Physician Decision|0|||
94486085|NCT04161391|323573505|FG000|Overall Study|Progressive Disease|4|||
94486086|NCT04161391|323573506|FG001|Overall Study|Progressive Disease|3|||
94486087|NCT04161391|323573507|FG002|Overall Study|Progressive Disease|3|||
94486088|NCT04161391|323573508|FG003|Overall Study|Progressive Disease|5|||
94486089|NCT04161391|323573509|FG004|Overall Study|Progressive Disease|3|||
94486090|NCT04161391|323573510|FG005|Overall Study|Progressive Disease|3|||
94486091|NCT04161391|323573511|FG006|Overall Study|Progressive Disease|5|||
94486092|NCT04161391|323573512|FG007|Overall Study|Progressive Disease|2|||
94486093|NCT04161391|323573513|FG008|Overall Study|Progressive Disease|2|||
94486094|NCT01162343|323573515|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
94486095|NCT01162343|323573515|FG000|Overall Study|Refused psychiatrist assessment|12|||
94486096|NCT02579629|323573526|FG000|Overall Study|Withdrawal by Subject|0|||
94486097|NCT02579629|323573527|FG001|Overall Study|Withdrawal by Subject|1|||
94486098|NCT02579629|323573528|FG002|Overall Study|Withdrawal by Subject|0|||
94486099|NCT02579629|323573526|FG000|Overall Study|Screen Failure|2|||
94486100|NCT02579629|323573527|FG001|Overall Study|Screen Failure|0|||
94486101|NCT02579629|323573528|FG002|Overall Study|Screen Failure|2|||
94486102|NCT01294423|323573529|FG000|Overall Study|Adverse Event|1|||
94486103|NCT01294423|323573530|FG001|Overall Study|Adverse Event|2|||
94486104|NCT01294423|323573531|FG002|Overall Study|Adverse Event|3|||
94486105|NCT01294423|323573529|FG000|Overall Study|Withdrawal by Subject|1|||
94486106|NCT01294423|323573530|FG001|Overall Study|Withdrawal by Subject|2|||
94486107|NCT01294423|323573531|FG002|Overall Study|Withdrawal by Subject|2|||
94486108|NCT01294423|323573529|FG000|Overall Study|subject no longer meets study criteria|2|||
94486109|NCT01294423|323573530|FG001|Overall Study|subject no longer meets study criteria|5|||
94486110|NCT01294423|323573531|FG002|Overall Study|subject no longer meets study criteria|2|||
94486111|NCT01294423|323573529|FG000|Overall Study|poor/non-compliance|1|||
94486112|NCT01294423|323573530|FG001|Overall Study|poor/non-compliance|0|||
94486113|NCT01294423|323573531|FG002|Overall Study|poor/non-compliance|1|||
94486114|NCT01324102|323573536|FG000|Overall Study|illness|1|||
94486115|NCT01324102|323573537|FG001|Overall Study|illness|6|||
94486116|NCT00902577|323573538|FG000|Overall Study|Withdrawal by Subject|6|||
94486117|NCT00902577|323573538|FG000|Overall Study|FMISO production failure|2|||
94486118|NCT00785356|323573541|FG000|Overall Study|Study prematurely terminated|8|||
94486119|NCT03238417|323573542|FG000|Overall|non-response|955|||
94486120|NCT03238417|323573543|FG001|Overall|non-response|1920|||
94486121|NCT03238417|323573542|FG000|Overall|partial completion|48|||
94486122|NCT03238417|323573543|FG001|Overall|partial completion|68|||
94486123|NCT03238417|323573542|FG000|Baseline|Partial completion|17|||
94486124|NCT03238417|323573543|FG001|Baseline|Partial completion|48|||
94486125|NCT03238417|323573542|FG000|Baseline|non-response|372|||
94486126|NCT03238417|323573543|FG001|Baseline|non-response|669|||
94486127|NCT03238417|323573542|FG000|12-month|non-response|296|||
94486128|NCT03238417|323573543|FG001|12-month|non-response|669|||
94486129|NCT03238417|323573542|FG000|12-month|partial completion|23|||
94486130|NCT03238417|323573543|FG001|12-month|partial completion|37|||
94486131|NCT03238417|323573542|FG000|24-month|non-response|287|||
94486132|NCT03238417|323573543|FG001|24-month|non-response|594|||
94486133|NCT03238417|323573542|FG000|24-month|partial completion|8|||
94486134|NCT03238417|323573543|FG001|24-month|partial completion|31|||
94486135|NCT03712280|323573544|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
94486136|NCT03712280|323573545|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
94486137|NCT03712280|323573546|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
94486138|NCT03712280|323573547|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
94486139|NCT03712280|323573544|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
94486140|NCT03712280|323573545|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
94486141|NCT03712280|323573546|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
94486142|NCT03712280|323573547|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
94486143|NCT03712280|323573544|FG000|Overall Study|Adverse Event|0|||
94486144|NCT03712280|323573545|FG001|Overall Study|Adverse Event|0|||
94486145|NCT03712280|323573546|FG002|Overall Study|Adverse Event|1|||
94486146|NCT03712280|323573547|FG003|Overall Study|Adverse Event|0|||
94486147|NCT00106002|323573548|FG000|Overall Study|Did not take any study drug|1|||
94486148|NCT00106002|323573548|FG000|Overall Study|Ineligible after Registration|1|||
94486149|NCT02631941|323573549|FG000|Overall Study|Physician Decision|0|||
94486150|NCT02631941|323573550|FG001|Overall Study|Physician Decision|1|||
94486151|NCT02631941|323573551|FG002|Overall Study|Physician Decision|0|||
94486152|NCT02631941|323573552|FG003|Overall Study|Physician Decision|0|||
94486153|NCT02631941|323573553|FG004|Overall Study|Physician Decision|0|||
94486154|NCT02631941|323573554|FG005|Overall Study|Physician Decision|0|||
94486155|NCT02631941|323573555|FG006|Overall Study|Physician Decision|0|||
94486156|NCT02631941|323573556|FG007|Overall Study|Physician Decision|0|||
94486157|NCT02631941|323573557|FG008|Overall Study|Physician Decision|0|||
94486158|NCT02631941|323573558|FG009|Overall Study|Physician Decision|0|||
94486159|NCT02631941|323573549|FG000|Overall Study|Adverse Event|0|||
94486160|NCT02631941|323573550|FG001|Overall Study|Adverse Event|1|||
94486161|NCT02631941|323573551|FG002|Overall Study|Adverse Event|0|||
94486162|NCT02631941|323573552|FG003|Overall Study|Adverse Event|0|||
94486163|NCT02631941|323573553|FG004|Overall Study|Adverse Event|0|||
94486164|NCT02631941|323573554|FG005|Overall Study|Adverse Event|0|||
94486165|NCT02631941|323573555|FG006|Overall Study|Adverse Event|0|||
94486166|NCT02631941|323573556|FG007|Overall Study|Adverse Event|0|||
94486167|NCT02631941|323573557|FG008|Overall Study|Adverse Event|0|||
94486168|NCT02631941|323573558|FG009|Overall Study|Adverse Event|0|||
94486169|NCT02631941|323573549|FG000|Overall Study|Withdrawal by Subject|0|||
94486170|NCT02631941|323573550|FG001|Overall Study|Withdrawal by Subject|0|||
94486171|NCT02631941|323573551|FG002|Overall Study|Withdrawal by Subject|0|||
94486172|NCT02631941|323573552|FG003|Overall Study|Withdrawal by Subject|0|||
94486173|NCT02631941|323573553|FG004|Overall Study|Withdrawal by Subject|1|||
94486174|NCT02631941|323573554|FG005|Overall Study|Withdrawal by Subject|0|||
94486175|NCT02631941|323573555|FG006|Overall Study|Withdrawal by Subject|0|||
94486176|NCT02631941|323573556|FG007|Overall Study|Withdrawal by Subject|1|||
94486177|NCT02631941|323573557|FG008|Overall Study|Withdrawal by Subject|0|||
94486178|NCT02631941|323573558|FG009|Overall Study|Withdrawal by Subject|0|||
94486179|NCT02631941|323573549|FG000|Overall Study|Lost to Follow-up|0|||
94486180|NCT02631941|323573550|FG001|Overall Study|Lost to Follow-up|0|||
94486181|NCT02631941|323573551|FG002|Overall Study|Lost to Follow-up|0|||
94486182|NCT02631941|323573552|FG003|Overall Study|Lost to Follow-up|0|||
94486183|NCT02631941|323573553|FG004|Overall Study|Lost to Follow-up|0|||
94486184|NCT02631941|323573554|FG005|Overall Study|Lost to Follow-up|0|||
94486185|NCT02631941|323573555|FG006|Overall Study|Lost to Follow-up|0|||
94486186|NCT02631941|323573556|FG007|Overall Study|Lost to Follow-up|0|||
94486187|NCT02631941|323573557|FG008|Overall Study|Lost to Follow-up|1|||
94486188|NCT02631941|323573558|FG009|Overall Study|Lost to Follow-up|0|||
94486189|NCT01245101|323573560|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
94486190|NCT01245101|323573561|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
94486191|NCT01245101|323573560|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
94486192|NCT01245101|323573561|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
94486193|NCT01245101|323573560|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
94486194|NCT01245101|323573561|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
94486195|NCT01225549|323573564|FG000|Period 4 - Washout|Disallowed medication|0|||
94486196|NCT01225549|323573565|FG001|Period 4 - Washout|Disallowed medication|1|||
94486197|NCT01225549|323573566|FG002|Period 4 - Washout|Disallowed medication|0|||
94486198|NCT01225549|323573567|FG003|Period 4 - Washout|Disallowed medication|0|||
94486199|NCT01225549|323573568|FG004|Period 4 - Washout|Disallowed medication|0|||
94486200|NCT01225549|323573569|FG005|Period 4 - Washout|Disallowed medication|0|||
94486201|NCT01225549|323573570|FG006|Period 4 - Washout|Disallowed medication|0|||
94486202|NCT01225549|323573571|FG007|Period 4 - Washout|Disallowed medication|0|||
94486203|NCT01225549|323573572|FG008|Period 4 - Washout|Disallowed medication|0|||
94486204|NCT01225549|323573573|FG009|Period 4 - Washout|Disallowed medication|0|||
94486205|NCT01225549|323573564|FG000|Period 6 - Washout|Disallowed medication|0|||
94486206|NCT01225549|323573565|FG001|Period 6 - Washout|Disallowed medication|0|||
94486207|NCT01225549|323573566|FG002|Period 6 - Washout|Disallowed medication|0|||
94486208|NCT01225549|323573567|FG003|Period 6 - Washout|Disallowed medication|1|||
94486209|NCT01225549|323573568|FG004|Period 6 - Washout|Disallowed medication|0|||
94407318|NCT01332968|323276415|FG007|Follow-Up Period|Non-compliance|9|||
94407319|NCT01332968|323276408|FG000|Follow-Up Period|Other|0|||
94407320|NCT01332968|323276409|FG001|Follow-Up Period|Other|0|||
94407321|NCT01332968|323276410|FG002|Follow-Up Period|Other|0|||
94407322|NCT01332968|323276411|FG003|Follow-Up Period|Other|0|||
94407323|NCT01332968|323276412|FG004|Follow-Up Period|Other|0|||
94407324|NCT01332968|323276413|FG005|Follow-Up Period|Other|0|||
94407325|NCT01332968|323276414|FG006|Follow-Up Period|Other|18|||
94407326|NCT01332968|323276415|FG007|Follow-Up Period|Other|21|||
94407327|NCT01332968|323276408|FG000|Follow-Up Period|Physician Decision|0|||
94407328|NCT01332968|323276409|FG001|Follow-Up Period|Physician Decision|0|||
94407329|NCT01332968|323276410|FG002|Follow-Up Period|Physician Decision|0|||
94407330|NCT01332968|323276411|FG003|Follow-Up Period|Physician Decision|0|||
94407331|NCT01332968|323276412|FG004|Follow-Up Period|Physician Decision|0|||
94407332|NCT01332968|323276413|FG005|Follow-Up Period|Physician Decision|0|||
94407333|NCT01332968|323276414|FG006|Follow-Up Period|Physician Decision|12|||
94407334|NCT01332968|323276415|FG007|Follow-Up Period|Physician Decision|15|||
94407335|NCT01332968|323276408|FG000|Follow-Up Period|Progressive Disease|0|||
94407336|NCT01332968|323276409|FG001|Follow-Up Period|Progressive Disease|0|||
94407337|NCT01332968|323276410|FG002|Follow-Up Period|Progressive Disease|0|||
94407338|NCT01332968|323276411|FG003|Follow-Up Period|Progressive Disease|0|||
94407339|NCT01332968|323276412|FG004|Follow-Up Period|Progressive Disease|0|||
94407340|NCT01332968|323276413|FG005|Follow-Up Period|Progressive Disease|0|||
94407341|NCT01332968|323276414|FG006|Follow-Up Period|Progressive Disease|126|||
94407342|NCT01332968|323276415|FG007|Follow-Up Period|Progressive Disease|106|||
94407343|NCT01332968|323276408|FG000|Follow-Up Period|Protocol Violation|0|||
94407344|NCT01332968|323276409|FG001|Follow-Up Period|Protocol Violation|0|||
94407345|NCT01332968|323276410|FG002|Follow-Up Period|Protocol Violation|0|||
94407346|NCT01332968|323276411|FG003|Follow-Up Period|Protocol Violation|0|||
94407347|NCT01332968|323276412|FG004|Follow-Up Period|Protocol Violation|0|||
94407348|NCT01332968|323276413|FG005|Follow-Up Period|Protocol Violation|0|||
94407349|NCT01332968|323276414|FG006|Follow-Up Period|Protocol Violation|1|||
94407350|NCT01332968|323276415|FG007|Follow-Up Period|Protocol Violation|0|||
94407351|NCT01332968|323276408|FG000|Follow-Up Period|Withdrawal by Subject|0|||
94407352|NCT01332968|323276409|FG001|Follow-Up Period|Withdrawal by Subject|0|||
94407353|NCT01332968|323276410|FG002|Follow-Up Period|Withdrawal by Subject|0|||
94407354|NCT01332968|323276411|FG003|Follow-Up Period|Withdrawal by Subject|0|||
94407355|NCT01332968|323276412|FG004|Follow-Up Period|Withdrawal by Subject|0|||
94407356|NCT01332968|323276413|FG005|Follow-Up Period|Withdrawal by Subject|0|||
94407357|NCT01332968|323276414|FG006|Follow-Up Period|Withdrawal by Subject|29|||
94407358|NCT01332968|323276415|FG007|Follow-Up Period|Withdrawal by Subject|32|||
94407359|NCT01332968|323276408|FG000|Follow-Up Period|No reason provided|0|||
94407360|NCT01332968|323276409|FG001|Follow-Up Period|No reason provided|0|||
94407361|NCT01332968|323276410|FG002|Follow-Up Period|No reason provided|0|||
94407362|NCT01332968|323276411|FG003|Follow-Up Period|No reason provided|0|||
94407363|NCT01332968|323276412|FG004|Follow-Up Period|No reason provided|0|||
94407364|NCT01332968|323276413|FG005|Follow-Up Period|No reason provided|0|||
94407365|NCT01332968|323276414|FG006|Follow-Up Period|No reason provided|2|||
94407366|NCT01332968|323276415|FG007|Follow-Up Period|No reason provided|3|||
94407367|NCT04164758|323276420|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
94407368|NCT04164758|323276421|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
94407369|NCT04164758|323276422|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
94407370|NCT04164758|323276420|FG000|Overall Study|Adverse Event|0|||
94407371|NCT04164758|323276421|FG001|Overall Study|Adverse Event|1|||
94407372|NCT04164758|323276422|FG002|Overall Study|Adverse Event|0|||
94407373|NCT02340962|323276425|FG000|Overall Study|Lost to Follow-up|1|||
94407374|NCT02340962|323276426|FG001|Overall Study|Lost to Follow-up|0|||
94407375|NCT00372996|323276427|FG000|Overall Study|Death|11|||
94407376|NCT00372996|323276428|FG001|Overall Study|Death|4|||
94407377|NCT00372996|323276429|FG002|Overall Study|Death|8|||
94407378|NCT00372996|323276430|FG003|Overall Study|Death|7|||
94407379|NCT00372996|323276427|FG000|Overall Study|Lost to Follow-up|0|||
94407380|NCT00372996|323276428|FG001|Overall Study|Lost to Follow-up|2|||
94407381|NCT00372996|323276429|FG002|Overall Study|Lost to Follow-up|0|||
94407382|NCT00372996|323276430|FG003|Overall Study|Lost to Follow-up|1|||
94407383|NCT00372996|323276427|FG000|Overall Study|Withdrawal by Subject|12|||
94407384|NCT00372996|323276428|FG001|Overall Study|Withdrawal by Subject|6|||
94407385|NCT00372996|323276429|FG002|Overall Study|Withdrawal by Subject|9|||
94407386|NCT00372996|323276430|FG003|Overall Study|Withdrawal by Subject|5|||
94407387|NCT00372996|323276427|FG000|Overall Study|Study Terminated by Sponsor|4|||
94407388|NCT00372996|323276428|FG001|Overall Study|Study Terminated by Sponsor|0|||
94407389|NCT00372996|323276429|FG002|Overall Study|Study Terminated by Sponsor|4|||
94407390|NCT00372996|323276430|FG003|Overall Study|Study Terminated by Sponsor|0|||
94407391|NCT00372996|323276427|FG000|Overall Study|Other|10|||
94407392|NCT00372996|323276428|FG001|Overall Study|Other|2|||
94407393|NCT00372996|323276429|FG002|Overall Study|Other|7|||
94407394|NCT00372996|323276430|FG003|Overall Study|Other|7|||
94407395|NCT04625413|323276431|FG000|Overall Study|Hospice|2|||
94407396|NCT04625413|323276431|FG000|Overall Study|Distress|1|||
94407397|NCT04625413|323276431|FG000|Overall Study|Not feeling well|1|||
94407398|NCT01206439|323276432|FG000|Overall Study|subject did not meet inclusion criteria|1|||
94407399|NCT05889039|323276433|FG000|Overall Study|error in completing survey|0|||
94407400|NCT05889039|323276434|FG001|Overall Study|error in completing survey|2|||
94407401|NCT05889039|323276435|FG002|Overall Study|error in completing survey|0|||
94407402|NCT05889039|323276436|FG003|Overall Study|error in completing survey|0|||
94407403|NCT05889039|323276433|FG000|Overall Study|Lost to Follow-up|4|||
94407404|NCT05889039|323276434|FG001|Overall Study|Lost to Follow-up|0|||
94407405|NCT05889039|323276435|FG002|Overall Study|Lost to Follow-up|0|||
94407406|NCT05889039|323276436|FG003|Overall Study|Lost to Follow-up|0|||
94407407|NCT01055886|323276437|FG000|Overall Study|Withdrawal by Subject|4|||
94407408|NCT01055886|323276438|FG001|Overall Study|Withdrawal by Subject|9|||
94407409|NCT01055886|323276437|FG000|Overall Study|Lost to Follow-up|1|||
94407410|NCT01055886|323276438|FG001|Overall Study|Lost to Follow-up|1|||
94407411|NCT01055886|323276437|FG000|Overall Study|Withdrawal by PI|0|||
94407412|NCT01055886|323276438|FG001|Overall Study|Withdrawal by PI|1|||
94407413|NCT00434837|323276440|FG000|Overall Study|Lost to Follow-up|20|||
94407414|NCT00434837|323276441|FG001|Overall Study|Lost to Follow-up|23|||
94407415|NCT00434837|323276442|FG002|Overall Study|Lost to Follow-up|30|||
94407416|NCT03428945|323276443|FG000|Overall Study|Lost to Follow-up|5|||
94407417|NCT03428945|323276444|FG001|Overall Study|Lost to Follow-up|3|||
94407418|NCT03428945|323276443|FG000|Overall Study|Withdrawal by Subject|10|||
94407419|NCT03428945|323276444|FG001|Overall Study|Withdrawal by Subject|10|||
94407420|NCT02795676|323276445|FG000|Overall Study|Adverse Event|2|||
94407421|NCT02795676|323276446|FG001|Overall Study|Adverse Event|0|||
94407422|NCT02795676|323276445|FG000|Overall Study|Withdrawal by Subject|3|||
94407423|NCT02795676|323276446|FG001|Overall Study|Withdrawal by Subject|1|||
94407424|NCT01264835|323276450|FG000|Overall Study|Lost to Follow-up|1|||
94407425|NCT02260635|323276451|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
94407426|NCT02260635|323276452|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
94407427|NCT02260635|323276451|FG000|Open-Label Extension|Study Termination|25|||
94407428|NCT02260635|323276452|FG001|Open-Label Extension|Study Termination|25|||
94407429|NCT02260635|323276451|FG000|Open-Label Extension|Withdrawal by Subject|1|||
94407430|NCT02260635|323276452|FG001|Open-Label Extension|Withdrawal by Subject|0|||
94407431|NCT00152516|323276454|FG000|Overall Study|Adverse Event|18|||
94407432|NCT00152516|323276454|FG000|Overall Study|Lack and Loss of Efficacy|30|||
94407433|NCT00152516|323276454|FG000|Overall Study|Lost to Follow-up|5|||
94407434|NCT00152516|323276454|FG000|Overall Study|Withdrawal by Subject|8|||
94407435|NCT00152516|323276454|FG000|Overall Study|Protocol Violation|3|||
94407436|NCT00152516|323276454|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
94407437|NCT00152516|323276454|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
94407438|NCT00152516|323276454|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
94407439|NCT00152516|323276454|FG000|Overall Study|Other: Non-Compliance|2|||
94407440|NCT00152516|323276454|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
94407441|NCT00152516|323276454|FG000|Overall Study|Other: Moved Out Of State|1|||
94407442|NCT00152516|323276454|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
94407443|NCT00152516|323276454|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
94407444|NCT00250705|323276458|FG000|Overall Study|Lack of Efficacy|2|||
94407445|NCT01235442|323276460|FG000|Overall Study|Lost to Follow-up|12|||
94407446|NCT01235442|323276461|FG001|Overall Study|Lost to Follow-up|10|||
94407447|NCT01235442|323276460|FG000|Overall Study|Death|0|||
94407448|NCT01235442|323276461|FG001|Overall Study|Death|2|||
94407449|NCT01235442|323276460|FG000|Overall Study|Pregnancy|1|||
94407450|NCT01235442|323276461|FG001|Overall Study|Pregnancy|1|||
94407451|NCT01235442|323276460|FG000|Overall Study|Ineligibility determined|5|||
94407452|NCT01235442|323276461|FG001|Overall Study|Ineligibility determined|4|||
94407453|NCT01235442|323276460|FG000|Overall Study|Protocol Violation|3|||
94407454|NCT01235442|323276461|FG001|Overall Study|Protocol Violation|3|||
94407455|NCT01235442|323276460|FG000|Overall Study|Adverse Event|4|||
94407456|NCT01235442|323276461|FG001|Overall Study|Adverse Event|6|||
94407457|NCT01235442|323276460|FG000|Overall Study|Withdrawal by Subject|15|||
94407458|NCT01235442|323276461|FG001|Overall Study|Withdrawal by Subject|9|||
94407459|NCT01235442|323276460|FG000|Overall Study|Lack of Efficacy|1|||
94407460|NCT01235442|323276461|FG001|Overall Study|Lack of Efficacy|3|||
94407461|NCT01235442|323276460|FG000|Overall Study|Noncompliance|1|||
94407462|NCT01235442|323276461|FG001|Overall Study|Noncompliance|2|||
94407463|NCT01235442|323276460|FG000|Overall Study|Administrative decision|1|||
94407464|NCT01235442|323276461|FG001|Overall Study|Administrative decision|2|||
94407465|NCT01235442|323276460|FG000|Overall Study|Other unspecified|1|||
94407466|NCT01235442|323276461|FG001|Overall Study|Other unspecified|2|||
94407467|NCT04449341|323276464|FG000|Overall Study|Protocol Violation|1|||
94407468|NCT04449341|323276465|FG001|Overall Study|Protocol Violation|0|||
94407469|NCT04499482|323276466|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
94407470|NCT01020526|323276468|FG000|Overall Study|Withdrawal by Subject|5|||
94407471|NCT01020526|323276468|FG000|Overall Study|Other reasons|3|||
94407472|NCT01020526|323276468|FG000|Overall Study|Insufficient clinical response|3|||
94407473|NCT01020526|323276468|FG000|Overall Study|Lost to Follow-up|1|||
94407474|NCT01020526|323276468|FG000|Overall Study|Adverse Event|2|||
94407475|NCT01263561|323276469|FG000|Overall Study|Death|1|||
94407476|NCT01263561|323276470|FG001|Overall Study|Death|2|||
94407477|NCT04203667|323276471|FG000|Overall Study|Withdrawal by Subject|1|||
94407478|NCT04203667|323276471|FG000|Overall Study|Lost to Follow-up|1|||
94407479|NCT04203667|323276471|FG000|Overall Study|Death|1|||
94407480|NCT04203667|323276471|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
94407481|NCT03942211|323276472|FG000|Overall Study|Death|1|||
94407482|NCT03942211|323276473|FG001|Overall Study|Death|0|||
94407483|NCT03942211|323276472|FG000|Overall Study|Study terminated by sponsor|5|||
94407484|NCT03942211|323276473|FG001|Overall Study|Study terminated by sponsor|3|||
94407485|NCT03942211|323276472|FG000|Overall Study|Adverse Event|0|||
94407486|NCT03942211|323276473|FG001|Overall Study|Adverse Event|1|||
94407487|NCT01833169|323276474|FG000|Overall Study|Disease Progression|99|||
94407488|NCT01833169|323276474|FG000|Overall Study|Adverse Event|33|||
94407489|NCT01833169|323276474|FG000|Overall Study|Withdrawal by Subject|9|||
94407490|NCT01833169|323276474|FG000|Overall Study|Death|3|||
94407491|NCT01833169|323276474|FG000|Overall Study|Physician Decision|2|||
94407492|NCT01958060|323278344|FG000|Overall Study|Not treated|2|||
94407493|NCT01958060|323278345|FG001|Overall Study|Not treated|0|||
94407494|NCT01958060|323278346|FG002|Overall Study|Not treated|0|||
94407495|NCT01958060|323278347|FG003|Overall Study|Not treated|0|||
94407496|NCT01958060|323278348|FG004|Overall Study|Not treated|1|||
94407497|NCT01958060|323278349|FG005|Overall Study|Not treated|0|||
94407498|NCT02460835|323278354|FG000|Overall Study|Disease progression prior to treatment|3|||
94407499|NCT02460835|323278354|FG000|Overall Study|Unable to complete planning scans|2|||
94407500|NCT02460835|323278354|FG000|Overall Study|Decrease in performance status|1|||
94407501|NCT02460835|323278354|FG000|Overall Study|Withdrawal by Subject|3|||
94407502|NCT02460835|323278354|FG000|Overall Study|Underwent fractionated RT|10|||
94407503|NCT02460835|323278354|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
94407504|NCT00381849|323278355|FG000|Wash Out|Withdrawal by Subject|0|||
94407505|NCT00381849|323278356|FG001|Wash Out|Withdrawal by Subject|1|||
94407506|NCT01235715|323278357|FG000|Overall Study|Physician Decision|0|||
94407507|NCT01235715|323278358|FG001|Overall Study|Physician Decision|2|||
94407508|NCT02733627|323278359|FG000|Overall Study|Adverse Event|0|||
94407509|NCT02733627|323278360|FG001|Overall Study|Adverse Event|1|||
94407510|NCT02733627|323278361|FG002|Overall Study|Adverse Event|1|||
94407511|NCT02733627|323278362|FG003|Overall Study|Adverse Event|0|||
94407512|NCT02733627|323278359|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
94407513|NCT02733627|323278360|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
94407514|NCT02733627|323278361|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
94407515|NCT02733627|323278362|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
94407516|NCT02246764|323278363|FG000|Overall Study|Adverse Event|15|||
94407517|NCT02246764|323278364|FG001|Overall Study|Adverse Event|29|||
94407518|NCT02246764|323278365|FG002|Overall Study|Adverse Event|1|||
94407519|NCT02246764|323278363|FG000|Overall Study|Withdrawal by Subject|0|||
94407520|NCT02246764|323278364|FG001|Overall Study|Withdrawal by Subject|0|||
94407521|NCT02246764|323278365|FG002|Overall Study|Withdrawal by Subject|1|||
94407522|NCT02246764|323278363|FG000|Overall Study|Disallowed Concomitant Medication|1|||
94407523|NCT02246764|323278364|FG001|Overall Study|Disallowed Concomitant Medication|0|||
94407524|NCT02246764|323278365|FG002|Overall Study|Disallowed Concomitant Medication|0|||
94407525|NCT02246764|323278363|FG000|Overall Study|Physician Decision|0|||
94407526|NCT02246764|323278364|FG001|Overall Study|Physician Decision|2|||
94407527|NCT02246764|323278365|FG002|Overall Study|Physician Decision|1|||
94407528|NCT02246764|323278363|FG000|Overall Study|Protocol Violation|2|||
94407529|NCT02246764|323278364|FG001|Overall Study|Protocol Violation|1|||
94407530|NCT02246764|323278365|FG002|Overall Study|Protocol Violation|1|||
94407531|NCT02576717|323278367|FG000|Overall Study|Other Reasons|16|||
94407532|NCT02576717|323278368|FG001|Overall Study|Other Reasons|18|||
94407533|NCT02576717|323278369|FG002|Overall Study|Other Reasons|15|||
94407534|NCT02576717|323278367|FG000|Overall Study|Covid-19 Pandemic|0|||
94407535|NCT02576717|323278368|FG001|Overall Study|Covid-19 Pandemic|1|||
94407536|NCT02576717|323278369|FG002|Overall Study|Covid-19 Pandemic|1|||
94407537|NCT02576717|323278367|FG000|Overall Study|Sponsor Decision|0|||
94407538|NCT02576717|323278368|FG001|Overall Study|Sponsor Decision|0|||
94407539|NCT02576717|323278369|FG002|Overall Study|Sponsor Decision|1|||
94407540|NCT02576717|323278367|FG000|Overall Study|Physician Decision|3|||
94407541|NCT02576717|323278368|FG001|Overall Study|Physician Decision|8|||
94407542|NCT02576717|323278369|FG002|Overall Study|Physician Decision|9|||
94407543|NCT02576717|323278367|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
94407544|NCT02576717|323278368|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
94407545|NCT02576717|323278369|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
94407546|NCT02576717|323278367|FG000|Overall Study|Death|3|||
94407547|NCT02576717|323278368|FG001|Overall Study|Death|5|||
94486210|NCT01225549|323573569|FG005|Period 6 - Washout|Disallowed medication|0|||
94486211|NCT01225549|323573570|FG006|Period 6 - Washout|Disallowed medication|0|||
94486212|NCT01225549|323573571|FG007|Period 6 - Washout|Disallowed medication|0|||
94486213|NCT01225549|323573572|FG008|Period 6 - Washout|Disallowed medication|0|||
94486214|NCT01225549|323573573|FG009|Period 6 - Washout|Disallowed medication|0|||
94486215|NCT00473083|323573575|FG000|Overall Study|Adverse Event|1|||
94486216|NCT00473083|323573576|FG001|Overall Study|Adverse Event|0|||
94486217|NCT00473083|323573577|FG002|Overall Study|Adverse Event|0|||
94486218|NCT02643693|323573583|FG000|Overall Study|Physician Decision|0|||
94486219|NCT02643693|323573584|FG001|Overall Study|Physician Decision|1|||
94486220|NCT02643693|323573585|FG002|Overall Study|Physician Decision|0|||
94486221|NCT02643693|323573586|FG003|Overall Study|Physician Decision|0|||
94486222|NCT02643693|323573587|FG004|Overall Study|Physician Decision|0|||
94486223|NCT02643693|323573588|FG005|Overall Study|Physician Decision|0|||
94486224|NCT02643693|323573583|FG000|Overall Study|Withdrawal by Subject|0|||
94486225|NCT02643693|323573584|FG001|Overall Study|Withdrawal by Subject|1|||
94486226|NCT02643693|323573585|FG002|Overall Study|Withdrawal by Subject|0|||
94486227|NCT02643693|323573586|FG003|Overall Study|Withdrawal by Subject|0|||
94486228|NCT02643693|323573587|FG004|Overall Study|Withdrawal by Subject|0|||
94486229|NCT02643693|323573588|FG005|Overall Study|Withdrawal by Subject|0|||
94486230|NCT02643693|323573583|FG000|Overall Study|Protocol Adherence Issues|2|||
94486231|NCT02643693|323573584|FG001|Overall Study|Protocol Adherence Issues|0|||
94486232|NCT02643693|323573585|FG002|Overall Study|Protocol Adherence Issues|1|||
94486233|NCT02643693|323573586|FG003|Overall Study|Protocol Adherence Issues|0|||
94486234|NCT02643693|323573587|FG004|Overall Study|Protocol Adherence Issues|0|||
94486235|NCT02643693|323573588|FG005|Overall Study|Protocol Adherence Issues|1|||
94486236|NCT00492297|323573589|FG000|Treatment|Death|2|||
94486237|NCT00492297|323573589|FG000|Treatment|Study terminated by sponsor|3|||
94486238|NCT00492297|323573589|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
94486239|NCT00492297|323573589|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
94486240|NCT00492297|323573589|FG000|Survival Only Follow-up|Death|46|||
94486241|NCT00492297|323573589|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
94486242|NCT00492297|323573589|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
94486243|NCT01268267|323573590|FG000|Overall Study|Protocol Violation|1|||
94486244|NCT00113607|323573591|FG000|Overall Study|Adverse Event|40|||
94486245|NCT00113607|323573592|FG001|Overall Study|Adverse Event|71|||
94486246|NCT00113607|323573591|FG000|Overall Study|Death|8|||
94486247|NCT00113607|323573592|FG001|Overall Study|Death|8|||
94486248|NCT00113607|323573591|FG000|Overall Study|Withdrawal by Subject|50|||
94486249|NCT00113607|323573592|FG001|Overall Study|Withdrawal by Subject|58|||
94486250|NCT00113607|323573591|FG000|Overall Study|Lost to Follow-up|0|||
94486251|NCT00113607|323573592|FG001|Overall Study|Lost to Follow-up|2|||
94486252|NCT00113607|323573591|FG000|Overall Study|Disease Progression|180|||
94486253|NCT00113607|323573592|FG001|Overall Study|Disease Progression|142|||
94486254|NCT00113607|323573591|FG000|Overall Study|Complete Response (Confirmed)|14|||
94486255|NCT00113607|323573592|FG001|Overall Study|Complete Response (Confirmed)|24|||
94486256|NCT00113607|323573591|FG000|Overall Study|Other|43|||
94486257|NCT00113607|323573592|FG001|Overall Study|Other|32|||
94486258|NCT01418339|323573593|FG000|Overall Study|Adverse Event|5|||
94486259|NCT01418339|323573594|FG001|Overall Study|Adverse Event|2|||
94486260|NCT01418339|323573593|FG000|Overall Study|Subject Withdrew Consent|1|||
94486261|NCT01418339|323573594|FG001|Overall Study|Subject Withdrew Consent|2|||
94486262|NCT01418339|323573593|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
94486263|NCT01418339|323573594|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
94486264|NCT02204917|323573595|FG000|Overall Study|Protocol Violation|1|||
94486265|NCT00909844|323573596|FG000|Overall Study|Adverse Event|1|||
94486266|NCT00909844|323573596|FG000|Overall Study|Withdrawal by Subject|1|||
94486267|NCT00909844|323573596|FG000|Overall Study|Lost to Follow-up|2|||
94486268|NCT03093181|323573597|FG000|Overall Study|Withdrawal by Subject|2|||
94486269|NCT03093181|323573598|FG001|Overall Study|Withdrawal by Subject|1|||
94486270|NCT03093181|323573599|FG002|Overall Study|Withdrawal by Subject|2|||
94486271|NCT03093181|323573597|FG000|Overall Study|Other (Not specified)|1|||
94486272|NCT03093181|323573598|FG001|Overall Study|Other (Not specified)|0|||
94486273|NCT03093181|323573599|FG002|Overall Study|Other (Not specified)|0|||
94486274|NCT03093181|323573597|FG000|Overall Study|Adverse Event|0|||
94486275|NCT03093181|323573598|FG001|Overall Study|Adverse Event|1|||
94486276|NCT03093181|323573599|FG002|Overall Study|Adverse Event|0|||
94486277|NCT03093181|323573597|FG000|Overall Study|Other (Protocol violation)|0|||
94486278|NCT03093181|323573598|FG001|Overall Study|Other (Protocol violation)|0|||
94486279|NCT03093181|323573599|FG002|Overall Study|Other (Protocol violation)|1|||
94486280|NCT01664091|323573601|FG000|Overall Study|Death|1|||
94486281|NCT01664091|323573601|FG000|Overall Study|Disease Progression|2|||
94486282|NCT01664091|323573601|FG000|Overall Study|Lost to Follow-up|2|||
94486283|NCT01664091|323573601|FG000|Overall Study|Withdrawal by Subject|1|||
94486284|NCT01494818|323573604|FG000|Overall Study|Relocation|1|||
94486285|NCT01494818|323573605|FG001|Overall Study|Relocation|2|||
94486286|NCT01494818|323573604|FG000|Overall Study|Lost to Follow-up|1|||
94486287|NCT01494818|323573605|FG001|Overall Study|Lost to Follow-up|0|||
94486288|NCT00846053|323573608|FG000|Overall Study|Physician Decision|3|||
94486289|NCT00846053|323573609|FG001|Overall Study|Physician Decision|0|||
94486290|NCT01077323|323573610|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
94486291|NCT01077323|323573611|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
94486292|NCT01077323|323573612|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
94486293|NCT01077323|323573610|FG000|Overall Study|Dispensing of drug in baseline period|0|||
94486294|NCT01077323|323573611|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
94486295|NCT01077323|323573612|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
94486296|NCT01077323|323573610|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
94486297|NCT01077323|323573611|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
94486298|NCT01077323|323573612|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
94486299|NCT01791985|323573613|FG000|Overall Study|Adverse Event|7|||
94486300|NCT01791985|323573613|FG000|Overall Study|Withdrawal by Subject|1|||
94486301|NCT01103323|323573616|FG000|Without/Before Drug Switch|Adverse Event|50|||
94486302|NCT01103323|323573617|FG001|Without/Before Drug Switch|Adverse Event|7|||
94486303|NCT01103323|323573616|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
94486304|NCT01103323|323573617|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
94486305|NCT01103323|323573616|FG000|Without/Before Drug Switch|Protocol Violation|2|||
94486306|NCT01103323|323573617|FG001|Without/Before Drug Switch|Protocol Violation|0|||
94486307|NCT01103323|323573616|FG000|Without/Before Drug Switch|Physician Decision|2|||
94486308|NCT01103323|323573617|FG001|Without/Before Drug Switch|Physician Decision|0|||
94486309|NCT01103323|323573616|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
94486310|NCT01103323|323573617|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
94486311|NCT01103323|323573616|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
94486312|NCT01103323|323573617|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
94486313|NCT01103323|323573616|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
94486314|NCT01103323|323573617|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
94486315|NCT03217591|323573628|FG000|Overall Study|Adverse Event|1|||
94486316|NCT03217591|323573629|FG001|Overall Study|Adverse Event|2|||
94486317|NCT03217591|323573630|FG002|Overall Study|Adverse Event|6|||
94486318|NCT03217591|323573628|FG000|Overall Study|Withdrawal by Subject|0|||
94486319|NCT03217591|323573629|FG001|Overall Study|Withdrawal by Subject|1|||
94486320|NCT03217591|323573630|FG002|Overall Study|Withdrawal by Subject|3|||
94486321|NCT03217591|323573628|FG000|Overall Study|Lost to Follow-up|1|||
94486322|NCT03217591|323573629|FG001|Overall Study|Lost to Follow-up|0|||
94486323|NCT03217591|323573630|FG002|Overall Study|Lost to Follow-up|0|||
94486324|NCT03217591|323573628|FG000|Overall Study|Protocol Violation|1|||
94486325|NCT03217591|323573629|FG001|Overall Study|Protocol Violation|0|||
94486326|NCT03217591|323573630|FG002|Overall Study|Protocol Violation|1|||
94486327|NCT01041859|323573631|FG000|Open-Label Titration|Adverse Event|69|||
94486328|NCT01041859|323573632|FG001|Open-Label Titration|Adverse Event|0|||
94486329|NCT01041859|323573633|FG002|Open-Label Titration|Adverse Event|0|||
94486330|NCT01041859|323573631|FG000|Open-Label Titration|Lack of Efficacy|3|||
94486331|NCT01041859|323573632|FG001|Open-Label Titration|Lack of Efficacy|0|||
94486332|NCT01041859|323573633|FG002|Open-Label Titration|Lack of Efficacy|0|||
94486333|NCT01041859|323573631|FG000|Open-Label Titration|Lost to Follow-up|1|||
94486334|NCT01041859|323573632|FG001|Open-Label Titration|Lost to Follow-up|0|||
94486335|NCT01041859|323573633|FG002|Open-Label Titration|Lost to Follow-up|0|||
94486336|NCT01041859|323573631|FG000|Open-Label Titration|Physician Decision|1|||
94486337|NCT01041859|323573632|FG001|Open-Label Titration|Physician Decision|0|||
94486338|NCT01041859|323573633|FG002|Open-Label Titration|Physician Decision|0|||
94486339|NCT01041859|323573631|FG000|Open-Label Titration|Protocol Violation|1|||
94486340|NCT01041859|323573632|FG001|Open-Label Titration|Protocol Violation|0|||
94486341|NCT01041859|323573633|FG002|Open-Label Titration|Protocol Violation|0|||
94486342|NCT01041859|323573631|FG000|Open-Label Titration|Other|7|||
94486343|NCT01041859|323573632|FG001|Open-Label Titration|Other|0|||
94486344|NCT01041859|323573633|FG002|Open-Label Titration|Other|0|||
94486345|NCT01041859|323573631|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
94407548|NCT02576717|323278369|FG002|Overall Study|Death|3|||
94407549|NCT02576717|323278367|FG000|Overall Study|Lost to Follow-up|9|||
94407550|NCT02576717|323278368|FG001|Overall Study|Lost to Follow-up|10|||
94407551|NCT02576717|323278369|FG002|Overall Study|Lost to Follow-up|19|||
94407552|NCT02576717|323278367|FG000|Overall Study|Protocol Violation|4|||
94407553|NCT02576717|323278368|FG001|Overall Study|Protocol Violation|0|||
94407554|NCT02576717|323278369|FG002|Overall Study|Protocol Violation|5|||
94407555|NCT02576717|323278367|FG000|Overall Study|Lack of Efficacy|24|||
94407556|NCT02576717|323278368|FG001|Overall Study|Lack of Efficacy|28|||
94407557|NCT02576717|323278369|FG002|Overall Study|Lack of Efficacy|20|||
94407558|NCT02576717|323278367|FG000|Overall Study|Adverse Event|26|||
94407559|NCT02576717|323278368|FG001|Overall Study|Adverse Event|32|||
94407560|NCT02576717|323278369|FG002|Overall Study|Adverse Event|26|||
94407561|NCT04412057|323278370|FG000|Overall Study|Death|3|||
94407562|NCT04412057|323278371|FG001|Overall Study|Death|7|||
94407563|NCT04412057|323278370|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
94407564|NCT04412057|323278371|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
94407565|NCT02575339|323278372|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
94407566|NCT02575339|323278373|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
94407567|NCT02575339|323278374|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
94407568|NCT02575339|323278372|FG000|Study Treatment|Disease Progression|5|||
94407569|NCT02575339|323278373|FG001|Study Treatment|Disease Progression|2|||
94407570|NCT02575339|323278374|FG002|Study Treatment|Disease Progression|0|||
94407571|NCT02575339|323278372|FG000|Study Treatment|Adverse Event|1|||
94407572|NCT02575339|323278373|FG001|Study Treatment|Adverse Event|2|||
94407573|NCT02575339|323278374|FG002|Study Treatment|Adverse Event|0|||
94407574|NCT02575339|323278372|FG000|Follow up|Death|6|||
94407575|NCT02575339|323278373|FG001|Follow up|Death|2|||
94407576|NCT02575339|323278374|FG002|Follow up|Death|0|||
94407577|NCT02575339|323278372|FG000|Follow up|Study Terminated|0|||
94407578|NCT02575339|323278373|FG001|Follow up|Study Terminated|2|||
94407579|NCT02575339|323278374|FG002|Follow up|Study Terminated|0|||
94407580|NCT02575339|323278372|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
94407581|NCT02575339|323278373|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
94407582|NCT02575339|323278374|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
94407583|NCT01190930|323278375|FG000|Induction|Adverse Event|17|||
94407584|NCT01190930|323278376|FG001|Induction|Adverse Event|0|||
94407585|NCT01190930|323278377|FG002|Induction|Adverse Event|0|||
94407586|NCT01190930|323278378|FG003|Induction|Adverse Event|0|||
94407587|NCT01190930|323278379|FG004|Induction|Adverse Event|0|||
94407588|NCT01190930|323278380|FG005|Induction|Adverse Event|0|||
94407589|NCT01190930|323278381|FG006|Induction|Adverse Event|0|||
94407590|NCT01190930|323278382|FG007|Induction|Adverse Event|0|||
94407591|NCT01190930|323278383|FG008|Induction|Adverse Event|0|||
94407592|NCT01190930|323278384|FG009|Induction|Adverse Event|0|||
94407593|NCT01190930|323278375|FG000|Induction|Death|34|||
94407594|NCT01190930|323278376|FG001|Induction|Death|0|||
94407595|NCT01190930|323278377|FG002|Induction|Death|0|||
94407596|NCT01190930|323278378|FG003|Induction|Death|0|||
94407597|NCT01190930|323278379|FG004|Induction|Death|0|||
94407598|NCT01190930|323278380|FG005|Induction|Death|0|||
94407599|NCT01190930|323278381|FG006|Induction|Death|0|||
94407600|NCT01190930|323278382|FG007|Induction|Death|0|||
94407601|NCT01190930|323278383|FG008|Induction|Death|0|||
94407602|NCT01190930|323278384|FG009|Induction|Death|0|||
94407603|NCT01190930|323278375|FG000|Induction|Lost to Follow-up|1|||
94407604|NCT01190930|323278376|FG001|Induction|Lost to Follow-up|0|||
94407605|NCT01190930|323278377|FG002|Induction|Lost to Follow-up|0|||
94407606|NCT01190930|323278378|FG003|Induction|Lost to Follow-up|0|||
94407607|NCT01190930|323278379|FG004|Induction|Lost to Follow-up|0|||
94407608|NCT01190930|323278380|FG005|Induction|Lost to Follow-up|0|||
94407609|NCT01190930|323278381|FG006|Induction|Lost to Follow-up|0|||
94407610|NCT01190930|323278382|FG007|Induction|Lost to Follow-up|0|||
94407611|NCT01190930|323278383|FG008|Induction|Lost to Follow-up|0|||
94407612|NCT01190930|323278384|FG009|Induction|Lost to Follow-up|0|||
94407613|NCT01190930|323278375|FG000|Induction|Physician Decision|125|||
94407614|NCT01190930|323278376|FG001|Induction|Physician Decision|3|||
94407615|NCT01190930|323278377|FG002|Induction|Physician Decision|0|||
94407616|NCT01190930|323278378|FG003|Induction|Physician Decision|0|||
94407617|NCT01190930|323278379|FG004|Induction|Physician Decision|0|||
94407618|NCT01190930|323278380|FG005|Induction|Physician Decision|0|||
94407619|NCT01190930|323278381|FG006|Induction|Physician Decision|0|||
94407620|NCT01190930|323278382|FG007|Induction|Physician Decision|0|||
94407621|NCT01190930|323278383|FG008|Induction|Physician Decision|0|||
94407622|NCT01190930|323278384|FG009|Induction|Physician Decision|0|||
94407623|NCT01190930|323278375|FG000|Induction|Withdrawal by Subject|9|||
94407624|NCT01190930|323278376|FG001|Induction|Withdrawal by Subject|0|||
94407625|NCT01190930|323278377|FG002|Induction|Withdrawal by Subject|0|||
94407626|NCT01190930|323278378|FG003|Induction|Withdrawal by Subject|0|||
94407627|NCT01190930|323278379|FG004|Induction|Withdrawal by Subject|0|||
94407628|NCT01190930|323278380|FG005|Induction|Withdrawal by Subject|0|||
94407629|NCT01190930|323278381|FG006|Induction|Withdrawal by Subject|0|||
94407630|NCT01190930|323278382|FG007|Induction|Withdrawal by Subject|0|||
94407631|NCT01190930|323278383|FG008|Induction|Withdrawal by Subject|0|||
94407632|NCT01190930|323278384|FG009|Induction|Withdrawal by Subject|0|||
94407633|NCT01190930|323278375|FG000|Induction|Refusal|235|||
94407634|NCT01190930|323278376|FG001|Induction|Refusal|0|||
94407635|NCT01190930|323278377|FG002|Induction|Refusal|0|||
94407636|NCT01190930|323278378|FG003|Induction|Refusal|0|||
94407637|NCT01190930|323278379|FG004|Induction|Refusal|0|||
94407638|NCT01190930|323278380|FG005|Induction|Refusal|0|||
94407639|NCT01190930|323278381|FG006|Induction|Refusal|0|||
94407640|NCT01190930|323278382|FG007|Induction|Refusal|0|||
94407641|NCT01190930|323278383|FG008|Induction|Refusal|0|||
94407642|NCT01190930|323278384|FG009|Induction|Refusal|0|||
94407643|NCT01190930|323278375|FG000|Induction|Inevaluable|23|||
94407644|NCT01190930|323278376|FG001|Induction|Inevaluable|1|||
94407645|NCT01190930|323278377|FG002|Induction|Inevaluable|0|||
94407646|NCT01190930|323278378|FG003|Induction|Inevaluable|0|||
94407647|NCT01190930|323278379|FG004|Induction|Inevaluable|0|||
94407648|NCT01190930|323278380|FG005|Induction|Inevaluable|0|||
94407649|NCT01190930|323278381|FG006|Induction|Inevaluable|0|||
94407650|NCT01190930|323278382|FG007|Induction|Inevaluable|0|||
94407651|NCT01190930|323278383|FG008|Induction|Inevaluable|0|||
94407652|NCT01190930|323278384|FG009|Induction|Inevaluable|0|||
94407653|NCT01190930|323278375|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
94407654|NCT01190930|323278376|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
94407655|NCT01190930|323278377|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
94407656|NCT01190930|323278378|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
94407657|NCT01190930|323278379|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
94407658|NCT01190930|323278380|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
94407659|NCT01190930|323278381|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
94407660|NCT01190930|323278382|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
94407661|NCT01190930|323278383|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
94407662|NCT01190930|323278384|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
94407663|NCT01190930|323278375|FG000|Induction|High Risk Downs|80|||
94407664|NCT01190930|323278376|FG001|Induction|High Risk Downs|0|||
94407665|NCT01190930|323278377|FG002|Induction|High Risk Downs|0|||
94407666|NCT01190930|323278378|FG003|Induction|High Risk Downs|0|||
94407667|NCT01190930|323278379|FG004|Induction|High Risk Downs|0|||
94407668|NCT01190930|323278380|FG005|Induction|High Risk Downs|0|||
94407669|NCT01190930|323278381|FG006|Induction|High Risk Downs|0|||
94407670|NCT01190930|323278382|FG007|Induction|High Risk Downs|0|||
94407671|NCT01190930|323278383|FG008|Induction|High Risk Downs|0|||
94407672|NCT01190930|323278384|FG009|Induction|High Risk Downs|0|||
94407673|NCT01190930|323278375|FG000|Induction|Enrollment onto another COG Protocol|1|||
94407674|NCT01190930|323278376|FG001|Induction|Enrollment onto another COG Protocol|0|||
94407675|NCT01190930|323278377|FG002|Induction|Enrollment onto another COG Protocol|0|||
94407676|NCT01190930|323278378|FG003|Induction|Enrollment onto another COG Protocol|0|||
94407677|NCT01190930|323278379|FG004|Induction|Enrollment onto another COG Protocol|0|||
94407678|NCT01190930|323278380|FG005|Induction|Enrollment onto another COG Protocol|0|||
94407679|NCT01190930|323278381|FG006|Induction|Enrollment onto another COG Protocol|0|||
94407680|NCT01190930|323278382|FG007|Induction|Enrollment onto another COG Protocol|0|||
94407681|NCT01190930|323278383|FG008|Induction|Enrollment onto another COG Protocol|0|||
94407682|NCT01190930|323278384|FG009|Induction|Enrollment onto another COG Protocol|0|||
94407683|NCT01190930|323278375|FG000|Induction|Average Risk|1847|||
94407684|NCT01190930|323278376|FG001|Induction|Average Risk|0|||
94407685|NCT01190930|323278377|FG002|Induction|Average Risk|0|||
94407686|NCT01190930|323278378|FG003|Induction|Average Risk|0|||
94407687|NCT01190930|323278379|FG004|Induction|Average Risk|0|||
94407688|NCT01190930|323278380|FG005|Induction|Average Risk|0|||
94407689|NCT01190930|323278381|FG006|Induction|Average Risk|0|||
94407690|NCT01190930|323278382|FG007|Induction|Average Risk|0|||
94407691|NCT01190930|323278383|FG008|Induction|Average Risk|0|||
94407692|NCT01190930|323278384|FG009|Induction|Average Risk|0|||
94407693|NCT01190930|323278375|FG000|Induction|High Risk|1227|||
94407694|NCT01190930|323278376|FG001|Induction|High Risk|0|||
94407695|NCT01190930|323278377|FG002|Induction|High Risk|0|||
94407696|NCT01190930|323278378|FG003|Induction|High Risk|0|||
94407697|NCT01190930|323278379|FG004|Induction|High Risk|0|||
94407698|NCT01190930|323278380|FG005|Induction|High Risk|0|||
94407699|NCT01190930|323278381|FG006|Induction|High Risk|0|||
94407700|NCT01190930|323278382|FG007|Induction|High Risk|0|||
94407701|NCT01190930|323278383|FG008|Induction|High Risk|0|||
94407702|NCT01190930|323278384|FG009|Induction|High Risk|0|||
94407703|NCT01190930|323278375|FG000|Induction|Low Risk|443|||
94407704|NCT01190930|323278376|FG001|Induction|Low Risk|0|||
94407705|NCT01190930|323278377|FG002|Induction|Low Risk|0|||
94407706|NCT01190930|323278378|FG003|Induction|Low Risk|0|||
94407707|NCT01190930|323278379|FG004|Induction|Low Risk|0|||
94407708|NCT01190930|323278380|FG005|Induction|Low Risk|0|||
94407709|NCT01190930|323278381|FG006|Induction|Low Risk|0|||
94407710|NCT01190930|323278382|FG007|Induction|Low Risk|0|||
94407711|NCT01190930|323278383|FG008|Induction|Low Risk|0|||
94407712|NCT01190930|323278384|FG009|Induction|Low Risk|0|||
94407713|NCT01190930|323278375|FG000|Induction|Very High Risk|1012|||
94407714|NCT01190930|323278376|FG001|Induction|Very High Risk|0|||
94407715|NCT01190930|323278377|FG002|Induction|Very High Risk|0|||
94407716|NCT01190930|323278378|FG003|Induction|Very High Risk|0|||
94407717|NCT01190930|323278379|FG004|Induction|Very High Risk|0|||
94407718|NCT01190930|323278380|FG005|Induction|Very High Risk|0|||
94407719|NCT01190930|323278381|FG006|Induction|Very High Risk|0|||
94407720|NCT01190930|323278382|FG007|Induction|Very High Risk|0|||
94407721|NCT01190930|323278383|FG008|Induction|Very High Risk|0|||
94407722|NCT01190930|323278384|FG009|Induction|Very High Risk|0|||
94407723|NCT01190930|323278375|FG000|Induction|Philadelphia chromosome-positive|99|||
94407724|NCT01190930|323278376|FG001|Induction|Philadelphia chromosome-positive|0|||
94407725|NCT01190930|323278377|FG002|Induction|Philadelphia chromosome-positive|0|||
94407726|NCT01190930|323278378|FG003|Induction|Philadelphia chromosome-positive|0|||
94407727|NCT01190930|323278379|FG004|Induction|Philadelphia chromosome-positive|0|||
94407728|NCT01190930|323278380|FG005|Induction|Philadelphia chromosome-positive|0|||
94407729|NCT01190930|323278381|FG006|Induction|Philadelphia chromosome-positive|0|||
94407730|NCT01190930|323278382|FG007|Induction|Philadelphia chromosome-positive|0|||
94407731|NCT01190930|323278383|FG008|Induction|Philadelphia chromosome-positive|0|||
94407732|NCT01190930|323278384|FG009|Induction|Philadelphia chromosome-positive|0|||
94407733|NCT01190930|323278375|FG000|Induction|Incomplete Induction data|63|||
94407734|NCT01190930|323278376|FG001|Induction|Incomplete Induction data|0|||
94407735|NCT01190930|323278377|FG002|Induction|Incomplete Induction data|0|||
94407736|NCT01190930|323278378|FG003|Induction|Incomplete Induction data|0|||
94407737|NCT01190930|323278379|FG004|Induction|Incomplete Induction data|0|||
94407738|NCT01190930|323278380|FG005|Induction|Incomplete Induction data|0|||
94407739|NCT01190930|323278381|FG006|Induction|Incomplete Induction data|0|||
94407740|NCT01190930|323278382|FG007|Induction|Incomplete Induction data|0|||
94407741|NCT01190930|323278383|FG008|Induction|Incomplete Induction data|0|||
94407742|NCT01190930|323278384|FG009|Induction|Incomplete Induction data|0|||
94407743|NCT01190930|323278375|FG000|Induction|Progressive disease|0|||
94407744|NCT01190930|323278376|FG001|Induction|Progressive disease|1|||
94407745|NCT01190930|323278377|FG002|Induction|Progressive disease|0|||
94407746|NCT01190930|323278378|FG003|Induction|Progressive disease|0|||
94407747|NCT01190930|323278379|FG004|Induction|Progressive disease|0|||
94407748|NCT01190930|323278380|FG005|Induction|Progressive disease|0|||
94407749|NCT01190930|323278381|FG006|Induction|Progressive disease|0|||
94407750|NCT01190930|323278382|FG007|Induction|Progressive disease|0|||
94407751|NCT01190930|323278383|FG008|Induction|Progressive disease|0|||
94407752|NCT01190930|323278384|FG009|Induction|Progressive disease|0|||
94407753|NCT01190930|323278375|FG000|Induction|No treatment|3|||
94407754|NCT01190930|323278376|FG001|Induction|No treatment|0|||
94407755|NCT01190930|323278377|FG002|Induction|No treatment|0|||
94407756|NCT01190930|323278378|FG003|Induction|No treatment|0|||
94407757|NCT01190930|323278379|FG004|Induction|No treatment|0|||
94407758|NCT01190930|323278380|FG005|Induction|No treatment|0|||
94407759|NCT01190930|323278381|FG006|Induction|No treatment|0|||
94407760|NCT01190930|323278382|FG007|Induction|No treatment|0|||
94407761|NCT01190930|323278383|FG008|Induction|No treatment|0|||
94407762|NCT01190930|323278384|FG009|Induction|No treatment|0|||
94407763|NCT01190930|323278375|FG000|Induction|Ineligible|69|||
94407764|NCT01190930|323278376|FG001|Induction|Ineligible|4|||
94407765|NCT01190930|323278377|FG002|Induction|Ineligible|0|||
94407766|NCT01190930|323278378|FG003|Induction|Ineligible|0|||
94407767|NCT01190930|323278379|FG004|Induction|Ineligible|0|||
94407768|NCT01190930|323278380|FG005|Induction|Ineligible|0|||
94407769|NCT01190930|323278381|FG006|Induction|Ineligible|0|||
94407770|NCT01190930|323278382|FG007|Induction|Ineligible|0|||
94407771|NCT01190930|323278383|FG008|Induction|Ineligible|0|||
94407772|NCT01190930|323278384|FG009|Induction|Ineligible|0|||
94407773|NCT01190930|323278375|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
94407774|NCT01190930|323278376|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
94407775|NCT01190930|323278377|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
94407776|NCT01190930|323278378|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
94407777|NCT01190930|323278379|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
94407778|NCT01190930|323278380|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
94407779|NCT01190930|323278381|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
94407780|NCT01190930|323278382|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
94407781|NCT01190930|323278383|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
94407782|NCT01190930|323278384|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
94407783|NCT01190930|323278375|FG000|Post Induction Pre-Maintenance|Death|0|||
94407784|NCT01190930|323278376|FG001|Post Induction Pre-Maintenance|Death|0|||
94407785|NCT01190930|323278377|FG002|Post Induction Pre-Maintenance|Death|8|||
94407786|NCT01190930|323278378|FG003|Post Induction Pre-Maintenance|Death|4|||
94407787|NCT01190930|323278379|FG004|Post Induction Pre-Maintenance|Death|0|||
94407788|NCT01190930|323278380|FG005|Post Induction Pre-Maintenance|Death|0|||
94407789|NCT01190930|323278381|FG006|Post Induction Pre-Maintenance|Death|0|||
94407790|NCT01190930|323278382|FG007|Post Induction Pre-Maintenance|Death|0|||
94407791|NCT01190930|323278383|FG008|Post Induction Pre-Maintenance|Death|0|||
94407792|NCT01190930|323278384|FG009|Post Induction Pre-Maintenance|Death|0|||
94407793|NCT01190930|323278375|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
94407794|NCT01190930|323278376|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
94407795|NCT01190930|323278377|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
94407796|NCT01190930|323278378|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
94407797|NCT01190930|323278379|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
94407798|NCT01190930|323278380|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
94407799|NCT01190930|323278381|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
94407800|NCT01190930|323278382|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
94407801|NCT01190930|323278383|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
94407802|NCT01190930|323278384|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
94407803|NCT01190930|323278375|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
94407804|NCT01190930|323278376|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
94407805|NCT01190930|323278377|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
94486346|NCT01041859|323573632|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
94486347|NCT01041859|323573633|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
94486348|NCT01041859|323573631|FG000|Open-Label Titration|Withdrawal by Subject|11|||
94486349|NCT01041859|323573632|FG001|Open-Label Titration|Withdrawal by Subject|0|||
94407806|NCT01190930|323278378|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
94407807|NCT01190930|323278379|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
94407808|NCT01190930|323278380|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
94407809|NCT01190930|323278381|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
94407810|NCT01190930|323278382|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
94407811|NCT01190930|323278383|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
94407812|NCT01190930|323278384|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
94407813|NCT01190930|323278375|FG000|Post Induction Pre-Maintenance|Refusal|0|||
94407814|NCT01190930|323278376|FG001|Post Induction Pre-Maintenance|Refusal|2|||
94407815|NCT01190930|323278377|FG002|Post Induction Pre-Maintenance|Refusal|694|||
94407816|NCT01190930|323278378|FG003|Post Induction Pre-Maintenance|Refusal|4|||
94407817|NCT01190930|323278379|FG004|Post Induction Pre-Maintenance|Refusal|0|||
94407818|NCT01190930|323278380|FG005|Post Induction Pre-Maintenance|Refusal|3|||
94407819|NCT01190930|323278381|FG006|Post Induction Pre-Maintenance|Refusal|0|||
94407820|NCT01190930|323278382|FG007|Post Induction Pre-Maintenance|Refusal|0|||
94407821|NCT01190930|323278383|FG008|Post Induction Pre-Maintenance|Refusal|0|||
94407822|NCT01190930|323278384|FG009|Post Induction Pre-Maintenance|Refusal|0|||
94407823|NCT01190930|323278375|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
94407824|NCT01190930|323278376|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
94407825|NCT01190930|323278377|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
94407826|NCT01190930|323278378|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
94407827|NCT01190930|323278379|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
94407828|NCT01190930|323278380|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
94407829|NCT01190930|323278381|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
94407830|NCT01190930|323278382|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
94407831|NCT01190930|323278383|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
94407832|NCT01190930|323278384|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
94407833|NCT01190930|323278375|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
94407834|NCT01190930|323278376|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
94407835|NCT01190930|323278377|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
94407836|NCT01190930|323278378|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
94407837|NCT01190930|323278379|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
94407838|NCT01190930|323278380|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
94407839|NCT01190930|323278381|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
94407840|NCT01190930|323278382|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
94407841|NCT01190930|323278383|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
94407842|NCT01190930|323278384|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
94407843|NCT01190930|323278375|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
94407844|NCT01190930|323278376|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
94407845|NCT01190930|323278377|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
94407846|NCT01190930|323278378|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
94407847|NCT01190930|323278379|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
94407848|NCT01190930|323278380|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
94407849|NCT01190930|323278381|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
94407850|NCT01190930|323278382|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
94407851|NCT01190930|323278383|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
94407852|NCT01190930|323278384|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
94407853|NCT01190930|323278375|FG000|Post Induction Pre-Maintenance|Relapse|0|||
94407854|NCT01190930|323278376|FG001|Post Induction Pre-Maintenance|Relapse|0|||
94407855|NCT01190930|323278377|FG002|Post Induction Pre-Maintenance|Relapse|1|||
94407856|NCT01190930|323278378|FG003|Post Induction Pre-Maintenance|Relapse|0|||
94407857|NCT01190930|323278379|FG004|Post Induction Pre-Maintenance|Relapse|0|||
94407858|NCT01190930|323278380|FG005|Post Induction Pre-Maintenance|Relapse|0|||
94407859|NCT01190930|323278381|FG006|Post Induction Pre-Maintenance|Relapse|0|||
94407860|NCT01190930|323278382|FG007|Post Induction Pre-Maintenance|Relapse|0|||
94407861|NCT01190930|323278383|FG008|Post Induction Pre-Maintenance|Relapse|0|||
94486350|NCT01041859|323573633|FG002|Open-Label Titration|Withdrawal by Subject|0|||
94486351|NCT01041859|323573631|FG000|Double-Blind Maintenance|Adverse Event|0|||
94407862|NCT01190930|323278384|FG009|Post Induction Pre-Maintenance|Relapse|0|||
94407863|NCT01190930|323278375|FG000|Maintenance|Adverse Event|0|||
94407864|NCT01190930|323278376|FG001|Maintenance|Adverse Event|0|||
94407865|NCT01190930|323278377|FG002|Maintenance|Adverse Event|0|||
94407866|NCT01190930|323278378|FG003|Maintenance|Adverse Event|0|||
94407867|NCT01190930|323278379|FG004|Maintenance|Adverse Event|0|||
94486352|NCT01041859|323573632|FG001|Double-Blind Maintenance|Adverse Event|23|||
94407868|NCT01190930|323278380|FG005|Maintenance|Adverse Event|1|||
94407869|NCT01190930|323278381|FG006|Maintenance|Adverse Event|1|||
94407870|NCT01190930|323278382|FG007|Maintenance|Adverse Event|3|||
94407871|NCT01190930|323278383|FG008|Maintenance|Adverse Event|3|||
94407872|NCT01190930|323278384|FG009|Maintenance|Adverse Event|0|||
94407873|NCT01190930|323278375|FG000|Maintenance|Death|0|||
94407874|NCT01190930|323278376|FG001|Maintenance|Death|0|||
94407875|NCT01190930|323278377|FG002|Maintenance|Death|0|||
94407876|NCT01190930|323278378|FG003|Maintenance|Death|1|||
94407877|NCT01190930|323278379|FG004|Maintenance|Death|0|||
94407878|NCT01190930|323278380|FG005|Maintenance|Death|0|||
94407879|NCT01190930|323278381|FG006|Maintenance|Death|2|||
94407880|NCT01190930|323278382|FG007|Maintenance|Death|2|||
94407881|NCT01190930|323278383|FG008|Maintenance|Death|2|||
94407882|NCT01190930|323278384|FG009|Maintenance|Death|2|||
94407883|NCT01190930|323278375|FG000|Maintenance|Lost to Follow-up|0|||
94407884|NCT01190930|323278376|FG001|Maintenance|Lost to Follow-up|0|||
94407885|NCT01190930|323278377|FG002|Maintenance|Lost to Follow-up|0|||
94407886|NCT01190930|323278378|FG003|Maintenance|Lost to Follow-up|0|||
94407887|NCT01190930|323278379|FG004|Maintenance|Lost to Follow-up|0|||
94407888|NCT01190930|323278380|FG005|Maintenance|Lost to Follow-up|0|||
94407889|NCT01190930|323278381|FG006|Maintenance|Lost to Follow-up|1|||
94407890|NCT01190930|323278382|FG007|Maintenance|Lost to Follow-up|1|||
94407891|NCT01190930|323278383|FG008|Maintenance|Lost to Follow-up|1|||
94407892|NCT01190930|323278384|FG009|Maintenance|Lost to Follow-up|0|||
94407893|NCT01190930|323278375|FG000|Maintenance|Physician Decision|0|||
94407894|NCT01190930|323278376|FG001|Maintenance|Physician Decision|1|||
94407895|NCT01190930|323278377|FG002|Maintenance|Physician Decision|0|||
94407896|NCT01190930|323278378|FG003|Maintenance|Physician Decision|5|||
94407897|NCT01190930|323278379|FG004|Maintenance|Physician Decision|9|||
94407898|NCT01190930|323278380|FG005|Maintenance|Physician Decision|4|||
94407899|NCT01190930|323278381|FG006|Maintenance|Physician Decision|8|||
94407900|NCT01190930|323278382|FG007|Maintenance|Physician Decision|8|||
94407901|NCT01190930|323278383|FG008|Maintenance|Physician Decision|10|||
94407902|NCT01190930|323278384|FG009|Maintenance|Physician Decision|17|||
94407903|NCT01190930|323278375|FG000|Maintenance|Withdrawal by Subject|0|||
94407904|NCT01190930|323278376|FG001|Maintenance|Withdrawal by Subject|0|||
94407905|NCT01190930|323278377|FG002|Maintenance|Withdrawal by Subject|0|||
94407906|NCT01190930|323278378|FG003|Maintenance|Withdrawal by Subject|0|||
94407907|NCT01190930|323278379|FG004|Maintenance|Withdrawal by Subject|0|||
94407908|NCT01190930|323278380|FG005|Maintenance|Withdrawal by Subject|0|||
94407909|NCT01190930|323278381|FG006|Maintenance|Withdrawal by Subject|2|||
94407910|NCT01190930|323278382|FG007|Maintenance|Withdrawal by Subject|1|||
94407911|NCT01190930|323278383|FG008|Maintenance|Withdrawal by Subject|4|||
94407912|NCT01190930|323278384|FG009|Maintenance|Withdrawal by Subject|1|||
94407913|NCT01190930|323278375|FG000|Maintenance|Refusal|0|||
94407914|NCT01190930|323278376|FG001|Maintenance|Refusal|1|||
94407915|NCT01190930|323278377|FG002|Maintenance|Refusal|0|||
94407916|NCT01190930|323278378|FG003|Maintenance|Refusal|2|||
94407917|NCT01190930|323278379|FG004|Maintenance|Refusal|0|||
94407918|NCT01190930|323278380|FG005|Maintenance|Refusal|4|||
94407919|NCT01190930|323278381|FG006|Maintenance|Refusal|5|||
94407920|NCT01190930|323278382|FG007|Maintenance|Refusal|17|||
94407921|NCT01190930|323278383|FG008|Maintenance|Refusal|13|||
94407922|NCT01190930|323278384|FG009|Maintenance|Refusal|6|||
94407923|NCT01190930|323278375|FG000|Maintenance|second malignant neoplasm|0|||
94407924|NCT01190930|323278376|FG001|Maintenance|second malignant neoplasm|0|||
94407925|NCT01190930|323278377|FG002|Maintenance|second malignant neoplasm|0|||
94407926|NCT01190930|323278378|FG003|Maintenance|second malignant neoplasm|1|||
94407927|NCT01190930|323278379|FG004|Maintenance|second malignant neoplasm|0|||
94407928|NCT01190930|323278380|FG005|Maintenance|second malignant neoplasm|1|||
94407929|NCT01190930|323278381|FG006|Maintenance|second malignant neoplasm|0|||
94407930|NCT01190930|323278382|FG007|Maintenance|second malignant neoplasm|0|||
94407931|NCT01190930|323278383|FG008|Maintenance|second malignant neoplasm|1|||
94407932|NCT01190930|323278384|FG009|Maintenance|second malignant neoplasm|0|||
94407933|NCT01190930|323278375|FG000|Maintenance|Inevaluable|0|||
94407934|NCT01190930|323278376|FG001|Maintenance|Inevaluable|0|||
94407935|NCT01190930|323278377|FG002|Maintenance|Inevaluable|0|||
94407936|NCT01190930|323278378|FG003|Maintenance|Inevaluable|0|||
94407937|NCT01190930|323278379|FG004|Maintenance|Inevaluable|0|||
94407938|NCT01190930|323278380|FG005|Maintenance|Inevaluable|1|||
94407939|NCT01190930|323278381|FG006|Maintenance|Inevaluable|1|||
94407940|NCT01190930|323278382|FG007|Maintenance|Inevaluable|1|||
94407941|NCT01190930|323278383|FG008|Maintenance|Inevaluable|0|||
94407942|NCT01190930|323278384|FG009|Maintenance|Inevaluable|0|||
94407943|NCT01190930|323278375|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
94407944|NCT01190930|323278376|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
94407945|NCT01190930|323278377|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
94407946|NCT01190930|323278378|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
94407947|NCT01190930|323278379|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
94407948|NCT01190930|323278380|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
94407949|NCT01190930|323278381|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
94407950|NCT01190930|323278382|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
94486353|NCT01041859|323573633|FG002|Double-Blind Maintenance|Adverse Event|13|||
94486354|NCT01041859|323573631|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
94486355|NCT01041859|323573632|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
94486356|NCT01041859|323573633|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
94486357|NCT01041859|323573631|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
94486358|NCT01041859|323573632|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
94486359|NCT01041859|323573633|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
94486360|NCT01041859|323573631|FG000|Double-Blind Maintenance|Physician Decision|0|||
94486361|NCT01041859|323573632|FG001|Double-Blind Maintenance|Physician Decision|2|||
94486362|NCT01041859|323573633|FG002|Double-Blind Maintenance|Physician Decision|1|||
94486363|NCT01041859|323573631|FG000|Double-Blind Maintenance|Protocol Violation|0|||
94486364|NCT01041859|323573632|FG001|Double-Blind Maintenance|Protocol Violation|1|||
94486365|NCT01041859|323573633|FG002|Double-Blind Maintenance|Protocol Violation|3|||
94486366|NCT01041859|323573631|FG000|Double-Blind Maintenance|Other|0|||
94486367|NCT01041859|323573632|FG001|Double-Blind Maintenance|Other|6|||
94486368|NCT01041859|323573633|FG002|Double-Blind Maintenance|Other|2|||
94486369|NCT01041859|323573631|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
94486370|NCT01041859|323573632|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
94486371|NCT01041859|323573633|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
94486372|NCT01041859|323573631|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
94486373|NCT01041859|323573632|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
94486374|NCT01041859|323573633|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
94486375|NCT03902613|323573634|FG000|Overall Study|Physician Decision|1|||
94486376|NCT00069264|323573635|FG000|Overall Study|Adverse Event|3|||
94486377|NCT00069264|323573635|FG000|Overall Study|Progressive Disease|23|||
94486378|NCT00069264|323573635|FG000|Overall Study|Withdrawal by Subject|3|||
94486379|NCT00069264|323573635|FG000|Overall Study|Discon Therapy|3|||
94486380|NCT00269152|323573638|FG000|Overall Study|Adverse Event|9|||
94486381|NCT00269152|323573639|FG001|Overall Study|Adverse Event|3|||
94486382|NCT00269152|323573638|FG000|Overall Study|Withdrawal by Subject|7|||
94486383|NCT00269152|323573639|FG001|Overall Study|Withdrawal by Subject|3|||
94486384|NCT00269152|323573638|FG000|Overall Study|Physician Decision|2|||
94486385|NCT00269152|323573639|FG001|Overall Study|Physician Decision|3|||
94486386|NCT00269152|323573638|FG000|Overall Study|Protocol Violation|0|||
94486387|NCT00269152|323573639|FG001|Overall Study|Protocol Violation|1|||
94486388|NCT04249427|323573640|FG000|Overall Study|Adverse Event|3|||
94486389|NCT04249427|323573641|FG001|Overall Study|Adverse Event|1|||
94486390|NCT04249427|323573640|FG000|Overall Study|Lack of Efficacy|0|||
94486391|NCT04249427|323573641|FG001|Overall Study|Lack of Efficacy|1|||
94486392|NCT04249427|323573640|FG000|Overall Study|Withdrawal by Subject|1|||
94486393|NCT04249427|323573641|FG001|Overall Study|Withdrawal by Subject|2|||
94486394|NCT03188055|323573642|FG000|Overall Study|Unavailable for training|0|||
94486395|NCT03188055|323573643|FG001|Overall Study|Unavailable for training|0|||
94486396|NCT03188055|323573644|FG002|Overall Study|Unavailable for training|19|||
94486397|NCT03188055|323573645|FG003|Overall Study|Unavailable for training|0|||
94486398|NCT03188055|323573646|FG004|Overall Study|Unavailable for training|0|||
94486399|NCT03188055|323573647|FG005|Overall Study|Unavailable for training|0|||
94486400|NCT03188055|323573642|FG000|Overall Study|Lost to Follow-up|0|||
94486401|NCT03188055|323573643|FG001|Overall Study|Lost to Follow-up|18|||
94486402|NCT03188055|323573644|FG002|Overall Study|Lost to Follow-up|0|||
94486403|NCT03188055|323573645|FG003|Overall Study|Lost to Follow-up|11|||
94486404|NCT03188055|323573646|FG004|Overall Study|Lost to Follow-up|0|||
94486405|NCT03188055|323573647|FG005|Overall Study|Lost to Follow-up|0|||
94486406|NCT03188055|323573642|FG000|Overall Study|Withdrawal by Subject|0|||
94486407|NCT03188055|323573643|FG001|Overall Study|Withdrawal by Subject|1|||
94486408|NCT03188055|323573644|FG002|Overall Study|Withdrawal by Subject|0|||
94486409|NCT03188055|323573645|FG003|Overall Study|Withdrawal by Subject|1|||
94486410|NCT03188055|323573646|FG004|Overall Study|Withdrawal by Subject|0|||
94486411|NCT03188055|323573647|FG005|Overall Study|Withdrawal by Subject|0|||
94486412|NCT01687218|323573648|FG000|Overall Study|Withdrawal by Subject|2|||
94486413|NCT01687218|323573649|FG001|Overall Study|Withdrawal by Subject|3|||
94486414|NCT01687218|323573650|FG002|Overall Study|Withdrawal by Subject|0|||
94486415|NCT01687218|323573651|FG003|Overall Study|Withdrawal by Subject|1|||
94486416|NCT01687218|323573652|FG004|Overall Study|Withdrawal by Subject|1|||
94486417|NCT01687218|323573653|FG005|Overall Study|Withdrawal by Subject|0|||
94486418|NCT01687218|323573648|FG000|Overall Study|Relocated, no follow-up planned|1|||
94486419|NCT01687218|323573649|FG001|Overall Study|Relocated, no follow-up planned|0|||
94486420|NCT01687218|323573650|FG002|Overall Study|Relocated, no follow-up planned|1|||
94486421|NCT01687218|323573651|FG003|Overall Study|Relocated, no follow-up planned|1|||
94486422|NCT01687218|323573652|FG004|Overall Study|Relocated, no follow-up planned|0|||
94486423|NCT01687218|323573653|FG005|Overall Study|Relocated, no follow-up planned|0|||
94486424|NCT01316224|323573654|FG000|Overall Study|Protocol Violation|3|||
94486425|NCT01316224|323573654|FG000|Overall Study|Adverse Event|3|||
94486426|NCT01316224|323573654|FG000|Overall Study|Lack of Efficacy|1|||
94486427|NCT01316224|323573654|FG000|Overall Study|Withdrawal by Subject|1|||
94407951|NCT01190930|323278383|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
94407952|NCT01190930|323278384|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
94407953|NCT01190930|323278375|FG000|Maintenance|Relapse|0|||
94407954|NCT01190930|323278376|FG001|Maintenance|Relapse|0|||
94407955|NCT01190930|323278377|FG002|Maintenance|Relapse|0|||
94407956|NCT01190930|323278378|FG003|Maintenance|Relapse|2|||
94407957|NCT01190930|323278379|FG004|Maintenance|Relapse|0|||
94407958|NCT01190930|323278380|FG005|Maintenance|Relapse|1|||
94407959|NCT01190930|323278381|FG006|Maintenance|Relapse|6|||
94407960|NCT01190930|323278382|FG007|Maintenance|Relapse|13|||
94407961|NCT01190930|323278383|FG008|Maintenance|Relapse|11|||
94407962|NCT01190930|323278384|FG009|Maintenance|Relapse|11|||
94407963|NCT01190930|323278375|FG000|Maintenance|Still on therapy|0|||
94407964|NCT01190930|323278376|FG001|Maintenance|Still on therapy|8|||
94407965|NCT01190930|323278377|FG002|Maintenance|Still on therapy|0|||
94407966|NCT01190930|323278378|FG003|Maintenance|Still on therapy|29|||
94407967|NCT01190930|323278379|FG004|Maintenance|Still on therapy|0|||
94407968|NCT01190930|323278380|FG005|Maintenance|Still on therapy|0|||
94407969|NCT01190930|323278381|FG006|Maintenance|Still on therapy|0|||
94407970|NCT01190930|323278382|FG007|Maintenance|Still on therapy|0|||
94407971|NCT01190930|323278383|FG008|Maintenance|Still on therapy|0|||
94407972|NCT01190930|323278384|FG009|Maintenance|Still on therapy|0|||
94407973|NCT00979212|323278385|FG000|Overall Study|Protocol Violation|1|||
94407974|NCT00979212|323278386|FG001|Overall Study|Protocol Violation|8|||
94407975|NCT00979212|323278385|FG000|Overall Study|No protocol therapy received|1|||
94407976|NCT00979212|323278386|FG001|Overall Study|No protocol therapy received|0|||
94407977|NCT03480022|323278392|FG000|Overall Study|Pregnancy|2|||
94407978|NCT03480022|323278393|FG001|Overall Study|Pregnancy|0|||
94407979|NCT03480022|323278392|FG000|Overall Study|Adverse Event|6|||
94407980|NCT03480022|323278393|FG001|Overall Study|Adverse Event|0|||
94407981|NCT03480022|323278392|FG000|Overall Study|Lack of Efficacy|0|||
94407982|NCT03480022|323278393|FG001|Overall Study|Lack of Efficacy|2|||
94407983|NCT03480022|323278392|FG000|Overall Study|Physician Decision|0|||
94407984|NCT03480022|323278393|FG001|Overall Study|Physician Decision|1|||
94407985|NCT03480022|323278392|FG000|Overall Study|Withdrawal by Subject|2|||
94407986|NCT03480022|323278393|FG001|Overall Study|Withdrawal by Subject|0|||
94407987|NCT03480022|323278392|FG000|Overall Study|Medication concerns|1|||
94407988|NCT03480022|323278393|FG001|Overall Study|Medication concerns|0|||
94407989|NCT03480022|323278392|FG000|Overall Study|Family member COVID exposure|0|||
94407990|NCT03480022|323278393|FG001|Overall Study|Family member COVID exposure|1|||
94407991|NCT01908205|323278394|FG000|Overall Study|Lost to Follow-up|2|||
94407992|NCT01908205|323278395|FG001|Overall Study|Lost to Follow-up|0|||
94407993|NCT01908205|323278394|FG000|Overall Study|Withdrawal by Subject|3|||
94407994|NCT01908205|323278395|FG001|Overall Study|Withdrawal by Subject|1|||
94407995|NCT03419962|323278396|FG000|Overall Study|Change to other medication|1|||
94407996|NCT03419962|323278396|FG000|Overall Study|Refusal of continuing with trial drug|1|||
94407997|NCT03419962|323278396|FG000|Overall Study|Lost to Follow-up|3|||
94407998|NCT03419962|323278396|FG000|Overall Study|Difficulty in inhaling the doses|1|||
94407999|NCT03419962|323278396|FG000|Overall Study|Missing completion data|31|||
94408000|NCT01881737|323278399|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
94408001|NCT01881737|323278399|FG000|Overall Study|Withdrawal by Subject|1|||
94408002|NCT01881737|323278399|FG000|Overall Study|Worsening of baseline behavior|1|||
94408003|NCT03023137|323278400|FG000|Overall Study|Multiple pregnancy|2|||
94408004|NCT03023137|323278401|FG001|Overall Study|Multiple pregnancy|4|||
94408005|NCT03023137|323278400|FG000|Overall Study|Lost to Follow-up|1|||
94408006|NCT03023137|323278401|FG001|Overall Study|Lost to Follow-up|1|||
94408007|NCT03023137|323278400|FG000|Overall Study|Protocol Violation|0|||
94408008|NCT03023137|323278401|FG001|Overall Study|Protocol Violation|4|||
94408009|NCT03023137|323278400|FG000|Overall Study|Lost the baby in a car accident|1|||
94408010|NCT03023137|323278401|FG001|Overall Study|Lost the baby in a car accident|0|||
94408011|NCT02608476|323278402|FG000|Overall Study|Withdrawal by Subject|30|||
94408012|NCT02608476|323278403|FG001|Overall Study|Withdrawal by Subject|37|||
94408013|NCT02608476|323278402|FG000|Overall Study|Lost to Follow-up|24|||
94408014|NCT02608476|323278403|FG001|Overall Study|Lost to Follow-up|24|||
94408015|NCT02608476|323278402|FG000|Overall Study|Adverse Event|2|||
94408016|NCT02608476|323278403|FG001|Overall Study|Adverse Event|8|||
94408017|NCT02608476|323278402|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
94408018|NCT02608476|323278403|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
94408019|NCT02608476|323278402|FG000|Overall Study|Noncompliance with treatment|1|||
94408020|NCT02608476|323278403|FG001|Overall Study|Noncompliance with treatment|5|||
94408021|NCT02608476|323278402|FG000|Overall Study|Lack of Efficacy|3|||
94408022|NCT02608476|323278403|FG001|Overall Study|Lack of Efficacy|1|||
94408023|NCT02608476|323278402|FG000|Overall Study|Other|0|||
94408024|NCT02608476|323278403|FG001|Overall Study|Other|1|||
94408025|NCT02608476|323278402|FG000|Overall Study|Physician Decision|1|||
94408026|NCT02608476|323278403|FG001|Overall Study|Physician Decision|0|||
94408027|NCT02608476|323278402|FG000|Overall Study|Pregnancy|0|||
94408028|NCT02608476|323278403|FG001|Overall Study|Pregnancy|1|||
94408029|NCT02608476|323278402|FG000|Overall Study|Progressive disease|1|||
94486428|NCT01316224|323573654|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
94486429|NCT01316224|323573654|FG000|Overall Study|Other|1|||
94486430|NCT00264147|323573655|FG000|Treatment I Period|Adverse Event|3|||
94486431|NCT00264147|323573656|FG001|Treatment I Period|Adverse Event|6|||
94486432|NCT00264147|323573657|FG002|Treatment I Period|Adverse Event|3|||
94486433|NCT00264147|323573658|FG003|Treatment I Period|Adverse Event|5|||
94486434|NCT00264147|323573659|FG004|Treatment I Period|Adverse Event|7|||
94486435|NCT00264147|323573660|FG005|Treatment I Period|Adverse Event|0|||
94486436|NCT00264147|323573655|FG000|Treatment I Period|Laboratory Adverse Event|0|||
94486437|NCT00264147|323573656|FG001|Treatment I Period|Laboratory Adverse Event|0|||
94486438|NCT00264147|323573657|FG002|Treatment I Period|Laboratory Adverse Event|0|||
94486439|NCT00264147|323573658|FG003|Treatment I Period|Laboratory Adverse Event|1|||
94486440|NCT00264147|323573659|FG004|Treatment I Period|Laboratory Adverse Event|0|||
94486441|NCT00264147|323573660|FG005|Treatment I Period|Laboratory Adverse Event|0|||
94486442|NCT00264147|323573655|FG000|Treatment I Period|Lack of Efficacy|6|||
94486443|NCT00264147|323573656|FG001|Treatment I Period|Lack of Efficacy|2|||
94486444|NCT00264147|323573657|FG002|Treatment I Period|Lack of Efficacy|8|||
94486445|NCT00264147|323573658|FG003|Treatment I Period|Lack of Efficacy|0|||
94486446|NCT00264147|323573659|FG004|Treatment I Period|Lack of Efficacy|1|||
94486447|NCT00264147|323573660|FG005|Treatment I Period|Lack of Efficacy|0|||
94486448|NCT00264147|323573655|FG000|Treatment I Period|Lost to Follow-up|1|||
94486449|NCT00264147|323573656|FG001|Treatment I Period|Lost to Follow-up|0|||
94486450|NCT00264147|323573657|FG002|Treatment I Period|Lost to Follow-up|0|||
94486451|NCT00264147|323573658|FG003|Treatment I Period|Lost to Follow-up|1|||
94486452|NCT00264147|323573659|FG004|Treatment I Period|Lost to Follow-up|1|||
94486453|NCT00264147|323573660|FG005|Treatment I Period|Lost to Follow-up|0|||
94486454|NCT00264147|323573655|FG000|Treatment I Period|Protocol Violation|2|||
94486455|NCT00264147|323573656|FG001|Treatment I Period|Protocol Violation|2|||
94486456|NCT00264147|323573657|FG002|Treatment I Period|Protocol Violation|0|||
94486457|NCT00264147|323573658|FG003|Treatment I Period|Protocol Violation|0|||
94486458|NCT00264147|323573659|FG004|Treatment I Period|Protocol Violation|0|||
94486459|NCT00264147|323573660|FG005|Treatment I Period|Protocol Violation|0|||
94486460|NCT00264147|323573655|FG000|Treatment I Period|Withdrawal by Subject|2|||
94486461|NCT00264147|323573656|FG001|Treatment I Period|Withdrawal by Subject|0|||
94486462|NCT00264147|323573657|FG002|Treatment I Period|Withdrawal by Subject|0|||
94486463|NCT00264147|323573658|FG003|Treatment I Period|Withdrawal by Subject|2|||
94486464|NCT00264147|323573659|FG004|Treatment I Period|Withdrawal by Subject|2|||
94486465|NCT00264147|323573660|FG005|Treatment I Period|Withdrawal by Subject|0|||
94486466|NCT00264147|323573655|FG000|Treatment I Period|Patient out of town for an extended time|0|||
94486467|NCT00264147|323573656|FG001|Treatment I Period|Patient out of town for an extended time|1|||
94486468|NCT00264147|323573657|FG002|Treatment I Period|Patient out of town for an extended time|0|||
94486469|NCT00264147|323573658|FG003|Treatment I Period|Patient out of town for an extended time|0|||
94486470|NCT00264147|323573659|FG004|Treatment I Period|Patient out of town for an extended time|0|||
94486471|NCT00264147|323573660|FG005|Treatment I Period|Patient out of town for an extended time|0|||
94486472|NCT00264147|323573655|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
94486473|NCT00264147|323573656|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
94486474|NCT00264147|323573657|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
94486475|NCT00264147|323573658|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
94486476|NCT00264147|323573659|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
94486477|NCT00264147|323573660|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
94486478|NCT00264147|323573655|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
94486479|NCT00264147|323573656|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
94486480|NCT00264147|323573657|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
94486481|NCT00264147|323573658|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
94486482|NCT00264147|323573659|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
94486483|NCT00264147|323573660|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
94486484|NCT00264147|323573655|FG000|Treatment II Period|Adverse Event|0|||
94486485|NCT00264147|323573656|FG001|Treatment II Period|Adverse Event|0|||
94486486|NCT00264147|323573657|FG002|Treatment II Period|Adverse Event|0|||
94486487|NCT00264147|323573658|FG003|Treatment II Period|Adverse Event|0|||
94486488|NCT00264147|323573659|FG004|Treatment II Period|Adverse Event|9|||
94486489|NCT00264147|323573660|FG005|Treatment II Period|Adverse Event|9|||
94486490|NCT00264147|323573655|FG000|Treatment II Period|Laboratory Adverse Event|0|||
94486491|NCT00264147|323573656|FG001|Treatment II Period|Laboratory Adverse Event|0|||
94486492|NCT00264147|323573657|FG002|Treatment II Period|Laboratory Adverse Event|0|||
94486493|NCT00264147|323573658|FG003|Treatment II Period|Laboratory Adverse Event|0|||
94486494|NCT00264147|323573659|FG004|Treatment II Period|Laboratory Adverse Event|0|||
94486495|NCT00264147|323573660|FG005|Treatment II Period|Laboratory Adverse Event|1|||
94486496|NCT00264147|323573655|FG000|Treatment II Period|Lack of Efficacy|0|||
94486497|NCT00264147|323573656|FG001|Treatment II Period|Lack of Efficacy|0|||
94486498|NCT00264147|323573657|FG002|Treatment II Period|Lack of Efficacy|0|||
94486499|NCT00264147|323573658|FG003|Treatment II Period|Lack of Efficacy|0|||
94486500|NCT00264147|323573659|FG004|Treatment II Period|Lack of Efficacy|20|||
94486501|NCT00264147|323573660|FG005|Treatment II Period|Lack of Efficacy|19|||
94486502|NCT00264147|323573655|FG000|Treatment II Period|Lost to Follow-up|0|||
94486503|NCT00264147|323573656|FG001|Treatment II Period|Lost to Follow-up|0|||
94486504|NCT00264147|323573657|FG002|Treatment II Period|Lost to Follow-up|0|||
94486505|NCT00264147|323573658|FG003|Treatment II Period|Lost to Follow-up|0|||
94486506|NCT00264147|323573659|FG004|Treatment II Period|Lost to Follow-up|1|||
94486507|NCT00264147|323573660|FG005|Treatment II Period|Lost to Follow-up|1|||
94486508|NCT00264147|323573655|FG000|Treatment II Period|Withdrawal by Subject|0|||
94486509|NCT00264147|323573656|FG001|Treatment II Period|Withdrawal by Subject|0|||
94486510|NCT00264147|323573657|FG002|Treatment II Period|Withdrawal by Subject|0|||
94486511|NCT00264147|323573658|FG003|Treatment II Period|Withdrawal by Subject|0|||
94486512|NCT00264147|323573659|FG004|Treatment II Period|Withdrawal by Subject|3|||
94486513|NCT00264147|323573660|FG005|Treatment II Period|Withdrawal by Subject|2|||
94486514|NCT00264147|323573655|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
94486515|NCT00264147|323573656|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
94486516|NCT00264147|323573657|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
94486517|NCT00264147|323573658|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
94486518|NCT00264147|323573659|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
94486519|NCT00264147|323573660|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
94486520|NCT00969228|323573661|FG000|Overall Study|Adverse Event|1|||
94486521|NCT00969228|323573662|FG001|Overall Study|Adverse Event|0|||
94486522|NCT00969228|323573661|FG000|Overall Study|Withdrawal by Subject|4|||
94486523|NCT00969228|323573662|FG001|Overall Study|Withdrawal by Subject|0|||
94486524|NCT00969228|323573661|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
94486525|NCT00969228|323573662|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
94486526|NCT01499810|323573663|FG000|Overall Study|Lost to Follow-up|10|||
94486527|NCT01499810|323573663|FG000|Overall Study|Protocol Violation|1|||
94486528|NCT01499810|323573663|FG000|Overall Study|Withdrawal by Subject|1|||
94486529|NCT05117060|323573664|FG000|Overall Study|Adverse Event|3|||
94486530|NCT05117060|323573665|FG001|Overall Study|Adverse Event|5|||
94486531|NCT05117060|323573666|FG002|Overall Study|Adverse Event|6|||
94486532|NCT05117060|323573667|FG003|Overall Study|Adverse Event|1|||
94486533|NCT05117060|323573664|FG000|Overall Study|Lost to Follow-up|0|||
94486534|NCT05117060|323573665|FG001|Overall Study|Lost to Follow-up|0|||
94486535|NCT05117060|323573666|FG002|Overall Study|Lost to Follow-up|0|||
94486536|NCT05117060|323573667|FG003|Overall Study|Lost to Follow-up|1|||
94486537|NCT05117060|323573664|FG000|Overall Study|Lack of Efficacy|4|||
94486538|NCT05117060|323573665|FG001|Overall Study|Lack of Efficacy|5|||
94486539|NCT05117060|323573666|FG002|Overall Study|Lack of Efficacy|2|||
94486540|NCT05117060|323573667|FG003|Overall Study|Lack of Efficacy|6|||
94486541|NCT05117060|323573664|FG000|Overall Study|Withdrawal by Subject|8|||
94486542|NCT05117060|323573665|FG001|Overall Study|Withdrawal by Subject|5|||
94486543|NCT05117060|323573666|FG002|Overall Study|Withdrawal by Subject|5|||
94486544|NCT05117060|323573667|FG003|Overall Study|Withdrawal by Subject|6|||
94486545|NCT05117060|323573664|FG000|Overall Study|Other|2|||
94486546|NCT05117060|323573665|FG001|Overall Study|Other|1|||
94486547|NCT05117060|323573666|FG002|Overall Study|Other|3|||
94486548|NCT05117060|323573667|FG003|Overall Study|Other|1|||
94486549|NCT02003144|323573668|FG000|Open Label Maintenance Phase|Other than specified|2|||
94486550|NCT02003144|323573669|FG001|Open Label Maintenance Phase|Other than specified|4|||
94486551|NCT02003144|323573668|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
94486552|NCT02003144|323573669|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
94486553|NCT02003144|323573668|FG000|Open Label Maintenance Phase|Pregnancy|0|||
94486554|NCT02003144|323573669|FG001|Open Label Maintenance Phase|Pregnancy|2|||
94486555|NCT02003144|323573668|FG000|Open Label Maintenance Phase|Physician Decision|1|||
94486556|NCT02003144|323573669|FG001|Open Label Maintenance Phase|Physician Decision|1|||
94486557|NCT02003144|323573668|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
94486558|NCT02003144|323573669|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
94486559|NCT02003144|323573668|FG000|Open Label Maintenance Phase|Adverse Event|2|||
94486560|NCT02003144|323573669|FG001|Open Label Maintenance Phase|Adverse Event|1|||
94486561|NCT01814007|323573670|FG000|Overall Study|Withdrawal by Subject|1|||
94486562|NCT04350827|323573673|FG000|Overall Study|Lost to Follow-up|1|||
94486563|NCT04350827|323573674|FG001|Overall Study|Lost to Follow-up|2|||
94486564|NCT01386606|323575258|FG000|Overall Study|Adverse Event|0|||
94486565|NCT01386606|323575259|FG001|Overall Study|Adverse Event|1|||
94486566|NCT01386606|323575260|FG002|Overall Study|Adverse Event|0|||
94486567|NCT01386606|323575261|FG003|Overall Study|Adverse Event|0|||
94486568|NCT01386606|323575258|FG000|Overall Study|Withdrawal by Subject|0|||
94486569|NCT01386606|323575259|FG001|Overall Study|Withdrawal by Subject|1|||
94486570|NCT01386606|323575260|FG002|Overall Study|Withdrawal by Subject|1|||
94486571|NCT01386606|323575261|FG003|Overall Study|Withdrawal by Subject|0|||
94486572|NCT01386606|323575258|FG000|Overall Study|Protocol Violation|1|||
94486573|NCT01386606|323575259|FG001|Overall Study|Protocol Violation|0|||
94486574|NCT01386606|323575260|FG002|Overall Study|Protocol Violation|1|||
94486575|NCT01386606|323575261|FG003|Overall Study|Protocol Violation|1|||
94408030|NCT02608476|323278403|FG001|Overall Study|Progressive disease|0|||
94408031|NCT00360490|323278404|FG000|Overall Study|Adverse Event|4|||
94408032|NCT00360490|323278405|FG001|Overall Study|Adverse Event|2|||
94408033|NCT00360490|323278404|FG000|Overall Study|Lost to Follow-up|2|||
94408034|NCT00360490|323278405|FG001|Overall Study|Lost to Follow-up|1|||
94408035|NCT00360490|323278404|FG000|Overall Study|Physician Decision|2|||
94408036|NCT00360490|323278405|FG001|Overall Study|Physician Decision|1|||
94408037|NCT00360490|323278404|FG000|Overall Study|Protocol Violation|0|||
94408038|NCT00360490|323278405|FG001|Overall Study|Protocol Violation|4|||
94408039|NCT00360490|323278404|FG000|Overall Study|Withdrawal by Subject|1|||
94408040|NCT00360490|323278405|FG001|Overall Study|Withdrawal by Subject|3|||
94408041|NCT02427399|323278406|FG000|Overall Study|Protocol Violation|14|||
94408042|NCT02427399|323278407|FG001|Overall Study|Protocol Violation|16|||
94408043|NCT02427399|323278408|FG002|Overall Study|Protocol Violation|12|||
94408044|NCT02427399|323278409|FG003|Overall Study|Protocol Violation|18|||
94408045|NCT02427399|323278410|FG004|Overall Study|Protocol Violation|15|||
94408046|NCT01256060|323278413|FG000|Overall Study|Lost to Follow-up|0|||
94408047|NCT01256060|323278414|FG001|Overall Study|Lost to Follow-up|1|||
94408048|NCT01256060|323278415|FG002|Overall Study|Lost to Follow-up|0|||
94408049|NCT01256060|323278416|FG003|Overall Study|Lost to Follow-up|0|||
94408050|NCT00926367|323278419|FG000|Overall Study|Withdrawal by Subject|0|||
94408051|NCT00926367|323278420|FG001|Overall Study|Withdrawal by Subject|1|||
94408052|NCT00926367|323278419|FG000|Overall Study|Lost to Follow-up|1|||
94408053|NCT00926367|323278420|FG001|Overall Study|Lost to Follow-up|0|||
94408054|NCT00926367|323278419|FG000|Overall Study|Skin Irritation|1|||
94408055|NCT00926367|323278420|FG001|Overall Study|Skin Irritation|2|||
94408056|NCT01517867|323278421|FG000|Overall Study|never started treatment|29|||
94408057|NCT01517867|323278422|FG001|Overall Study|never started treatment|32|||
94408058|NCT01517867|323278421|FG000|Overall Study|Withdrawal by Subject|34|||
94408059|NCT01517867|323278422|FG001|Overall Study|Withdrawal by Subject|30|||
94408060|NCT01517867|323278421|FG000|Overall Study|Still in treatment at study end|0|||
94408061|NCT01517867|323278422|FG001|Overall Study|Still in treatment at study end|3|||
94408062|NCT01801917|323278423|FG000|Period 1 - Randomized|Adverse Event|1|||
94408063|NCT01801917|323278424|FG001|Period 1 - Randomized|Adverse Event|0|||
94408064|NCT01801917|323278425|FG002|Period 1 - Randomized|Adverse Event|1|||
94408065|NCT01801917|323278426|FG003|Period 1 - Randomized|Adverse Event|0|||
94408066|NCT04307849|323278427|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
94408067|NCT04307849|323278428|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
94408068|NCT04307849|323278429|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
94408069|NCT04307849|323278430|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
94408070|NCT04307849|323278431|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
94408071|NCT04307849|323278432|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
94408072|NCT04307849|323278427|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
94408073|NCT04307849|323278428|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
94408074|NCT04307849|323278429|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
94408075|NCT04307849|323278430|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
94408076|NCT04307849|323278431|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
94408077|NCT04307849|323278432|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
94408078|NCT04307849|323278427|FG000|Overall Study|Family member did not want them to continue|0|||
94408079|NCT04307849|323278428|FG001|Overall Study|Family member did not want them to continue|0|||
94408080|NCT04307849|323278429|FG002|Overall Study|Family member did not want them to continue|1|||
94408081|NCT04307849|323278430|FG003|Overall Study|Family member did not want them to continue|0|||
94408082|NCT04307849|323278431|FG004|Overall Study|Family member did not want them to continue|0|||
94408083|NCT04307849|323278432|FG005|Overall Study|Family member did not want them to continue|0|||
94408084|NCT04307849|323278427|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
94408085|NCT04307849|323278428|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
94408086|NCT04307849|323278429|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
94408087|NCT04307849|323278430|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
94408088|NCT04307849|323278431|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
94408089|NCT04307849|323278432|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
94408090|NCT01294449|323278435|FG000|Overall Study|Death|11|||
94408091|NCT01294449|323278436|FG001|Overall Study|Death|12|||
94408092|NCT01294449|323278435|FG000|Overall Study|Withdrawal by Subject|1|||
94486576|NCT01386606|323575258|FG000|Overall Study|Lost to Follow-up|2|||
94408093|NCT01294449|323278436|FG001|Overall Study|Withdrawal by Subject|3|||
94408094|NCT00603512|323278437|FG000|Overall Study|Adverse Event|0|||
94408095|NCT00603512|323278438|FG001|Overall Study|Adverse Event|2|||
94408096|NCT00603512|323278439|FG002|Overall Study|Adverse Event|4|||
94408097|NCT00603512|323278440|FG003|Overall Study|Adverse Event|4|||
94408098|NCT00603512|323278441|FG004|Overall Study|Adverse Event|2|||
94486577|NCT01386606|323575259|FG001|Overall Study|Lost to Follow-up|0|||
94486578|NCT01386606|323575260|FG002|Overall Study|Lost to Follow-up|0|||
94486579|NCT01386606|323575261|FG003|Overall Study|Lost to Follow-up|0|||
94486580|NCT01386606|323575258|FG000|Overall Study|Subject incarcerated|0|||
94486581|NCT01386606|323575259|FG001|Overall Study|Subject incarcerated|1|||
94486582|NCT01386606|323575260|FG002|Overall Study|Subject incarcerated|0|||
94486583|NCT01386606|323575261|FG003|Overall Study|Subject incarcerated|0|||
94486584|NCT01386606|323575258|FG000|Overall Study|Unable to draw PK|1|||
94486585|NCT01386606|323575259|FG001|Overall Study|Unable to draw PK|0|||
94486586|NCT01386606|323575260|FG002|Overall Study|Unable to draw PK|0|||
94486587|NCT01386606|323575261|FG003|Overall Study|Unable to draw PK|0|||
94486588|NCT01386606|323575258|FG000|Overall Study|T levels too high|0|||
94486589|NCT01386606|323575259|FG001|Overall Study|T levels too high|1|||
94486590|NCT01386606|323575260|FG002|Overall Study|T levels too high|1|||
94486591|NCT01386606|323575261|FG003|Overall Study|T levels too high|0|||
94486592|NCT02873689|323575262|FG000|Overall Study|Lack of Efficacy|1|||
94486593|NCT02873689|323575263|FG001|Overall Study|Lack of Efficacy|0|||
94486594|NCT02873689|323575262|FG000|Overall Study|Withdrawal by Subject|2|||
94486595|NCT02873689|323575263|FG001|Overall Study|Withdrawal by Subject|2|||
94486596|NCT02873689|323575262|FG000|Overall Study|Protocol Violation|1|||
94486597|NCT02873689|323575263|FG001|Overall Study|Protocol Violation|0|||
94486598|NCT02873689|323575262|FG000|Overall Study|Adverse Event|2|||
94486599|NCT02873689|323575263|FG001|Overall Study|Adverse Event|2|||
94486600|NCT02873689|323575262|FG000|Overall Study|Randomized but not Treated|1|||
94486601|NCT02873689|323575263|FG001|Overall Study|Randomized but not Treated|1|||
94486602|NCT02990000|323575264|FG000|Overall Study|Failed to provide data beyond baseline|36|||
94486603|NCT02990000|323575265|FG001|Overall Study|Failed to provide data beyond baseline|34|||
94486604|NCT02787304|323575266|FG000|Overall Study|Adverse Event|9|||
94486605|NCT02787304|323575267|FG001|Overall Study|Adverse Event|3|||
94486606|NCT02787304|323575268|FG002|Overall Study|Adverse Event|8|||
94486607|NCT02787304|323575269|FG003|Overall Study|Adverse Event|1|||
94486608|NCT02787304|323575266|FG000|Overall Study|Withdrawal by Subject|1|||
94486609|NCT02787304|323575267|FG001|Overall Study|Withdrawal by Subject|4|||
94486610|NCT02787304|323575268|FG002|Overall Study|Withdrawal by Subject|0|||
94486611|NCT02787304|323575269|FG003|Overall Study|Withdrawal by Subject|0|||
94486612|NCT02787304|323575266|FG000|Overall Study|Lost to Follow-up|1|||
94486613|NCT02787304|323575267|FG001|Overall Study|Lost to Follow-up|0|||
94486614|NCT02787304|323575268|FG002|Overall Study|Lost to Follow-up|0|||
94486615|NCT02787304|323575269|FG003|Overall Study|Lost to Follow-up|1|||
94486616|NCT02787304|323575266|FG000|Overall Study|Noncompliance with study drug|0|||
94486617|NCT02787304|323575267|FG001|Overall Study|Noncompliance with study drug|0|||
94486618|NCT02787304|323575268|FG002|Overall Study|Noncompliance with study drug|1|||
94486619|NCT02787304|323575269|FG003|Overall Study|Noncompliance with study drug|0|||
94486620|NCT02787304|323575266|FG000|Overall Study|Physician Decision|0|||
94486621|NCT02787304|323575267|FG001|Overall Study|Physician Decision|0|||
94486622|NCT02787304|323575268|FG002|Overall Study|Physician Decision|1|||
94486623|NCT02787304|323575269|FG003|Overall Study|Physician Decision|0|||
94486624|NCT02787304|323575266|FG000|Overall Study|Study terminated by sponsor|25|||
94486625|NCT02787304|323575267|FG001|Overall Study|Study terminated by sponsor|31|||
94408099|NCT00603512|323278437|FG000|Overall Study|Lack of Efficacy|0|||
94408100|NCT00603512|323278438|FG001|Overall Study|Lack of Efficacy|1|||
94408101|NCT00603512|323278439|FG002|Overall Study|Lack of Efficacy|0|||
94408102|NCT00603512|323278440|FG003|Overall Study|Lack of Efficacy|0|||
94408103|NCT00603512|323278441|FG004|Overall Study|Lack of Efficacy|1|||
94408104|NCT00603512|323278437|FG000|Overall Study|Other|2|||
94408105|NCT00603512|323278438|FG001|Overall Study|Other|1|||
94408106|NCT00603512|323278439|FG002|Overall Study|Other|0|||
94408107|NCT00603512|323278440|FG003|Overall Study|Other|1|||
94408108|NCT00603512|323278441|FG004|Overall Study|Other|1|||
94408109|NCT00603512|323278437|FG000|Overall Study|Withdrawal by Subject|0|||
94408110|NCT00603512|323278438|FG001|Overall Study|Withdrawal by Subject|0|||
94486626|NCT02787304|323575268|FG002|Overall Study|Study terminated by sponsor|31|||
94486627|NCT02787304|323575269|FG003|Overall Study|Study terminated by sponsor|32|||
94408111|NCT00603512|323278439|FG002|Overall Study|Withdrawal by Subject|0|||
94408112|NCT00603512|323278440|FG003|Overall Study|Withdrawal by Subject|0|||
94408113|NCT00603512|323278441|FG004|Overall Study|Withdrawal by Subject|1|||
94408114|NCT00603512|323278437|FG000|Overall Study|Randomized but not treated|0|||
94486628|NCT01965327|323575274|FG000|Overall Study|Physician Decision|2|||
94486629|NCT03342001|323575275|FG000|Overall Study|Adverse Event|1|||
94408115|NCT00603512|323278438|FG001|Overall Study|Randomized but not treated|1|||
94408116|NCT00603512|323278439|FG002|Overall Study|Randomized but not treated|1|||
94408117|NCT00603512|323278440|FG003|Overall Study|Randomized but not treated|2|||
94486630|NCT03342001|323575275|FG000|Overall Study|Lost to Follow-up|1|||
94486631|NCT01100853|323575276|FG000|Overall Study|Lost to Follow-up|11|||
94486632|NCT01100853|323575277|FG001|Overall Study|Lost to Follow-up|6|||
94486633|NCT01100853|323575276|FG000|Overall Study|Received <4 study injections|10|||
94486634|NCT01100853|323575277|FG001|Overall Study|Received <4 study injections|13|||
94486635|NCT01100853|323575276|FG000|Overall Study|Withdrawal by Subject|6|||
94486636|NCT01100853|323575277|FG001|Overall Study|Withdrawal by Subject|4|||
94408118|NCT00603512|323278441|FG004|Overall Study|Randomized but not treated|0|||
94408119|NCT04220775|323278442|FG000|Overall Study|Adverse Event|1|||
94408120|NCT04220775|323278443|FG001|Overall Study|Adverse Event|0|||
94408121|NCT04220775|323278442|FG000|Overall Study|Disease Progression|1|||
94408122|NCT04220775|323278443|FG001|Overall Study|Disease Progression|0|||
94408123|NCT04253236|323278444|FG000|Overall Study|Adverse Event|1|||
94408124|NCT04253236|323278445|FG001|Overall Study|Adverse Event|0|||
94408125|NCT04253236|323278444|FG000|Overall Study|Safety Concerns|1|||
94408126|NCT04253236|323278445|FG001|Overall Study|Safety Concerns|0|||
94408127|NCT04253236|323278444|FG000|Overall Study|Study Terminated by Sponsor|1|||
94408128|NCT04253236|323278445|FG001|Overall Study|Study Terminated by Sponsor|0|||
94408129|NCT05467982|323278448|FG000|Overall Study|Death|0|||
94408130|NCT05467982|323278449|FG001|Overall Study|Death|1|||
94408131|NCT05467982|323278448|FG000|Overall Study|Lost to Follow-up|3|||
94408132|NCT05467982|323278449|FG001|Overall Study|Lost to Follow-up|1|||
94408133|NCT05103657|323278463|FG000|Overall Study|Other reasons than listed|9|||
94408134|NCT05103657|323278464|FG001|Overall Study|Other reasons than listed|8|||
94408135|NCT05103657|323278463|FG000|Overall Study|Protocol deviation|2|||
94408136|NCT05103657|323278464|FG001|Overall Study|Protocol deviation|2|||
94408137|NCT05103657|323278463|FG000|Overall Study|No reason available|5|||
94408138|NCT05103657|323278464|FG001|Overall Study|No reason available|4|||
94408139|NCT05103657|323278463|FG000|Overall Study|Burden of study procedures|3|||
94408140|NCT05103657|323278464|FG001|Overall Study|Burden of study procedures|1|||
94408141|NCT05103657|323278463|FG000|Overall Study|Perceived lack of efficacy|1|||
94408142|NCT05103657|323278464|FG001|Overall Study|Perceived lack of efficacy|1|||
94408143|NCT05103657|323278463|FG000|Overall Study|Adverse Event|6|||
94408144|NCT05103657|323278464|FG001|Overall Study|Adverse Event|14|||
94408145|NCT05103657|323278463|FG000|Overall Study|Not Treated|1|||
94408146|NCT05103657|323278464|FG001|Overall Study|Not Treated|1|||
94408147|NCT03635983|323278467|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
94408148|NCT03635983|323278468|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
94408149|NCT03635983|323278467|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
94408150|NCT03635983|323278468|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94408151|NCT03635983|323278467|FG000|Pre-Treatment Period|Other reasons|0|||
94408152|NCT03635983|323278468|FG001|Pre-Treatment Period|Other reasons|1|||
94408153|NCT03635983|323278467|FG000|Pre-Treatment Period|Disease Progression|0|||
94408154|NCT03635983|323278468|FG001|Pre-Treatment Period|Disease Progression|1|||
94408155|NCT03635983|323278467|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
94408156|NCT03635983|323278468|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
94408157|NCT03635983|323278467|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
94408158|NCT03635983|323278468|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
94408159|NCT03635983|323278467|FG000|Treatment Period|Withdrawal by Subject|3|||
94408160|NCT03635983|323278468|FG001|Treatment Period|Withdrawal by Subject|5|||
94408161|NCT03635983|323278467|FG000|Treatment Period|Death|3|||
94408162|NCT03635983|323278468|FG001|Treatment Period|Death|5|||
94408163|NCT03635983|323278467|FG000|Treatment Period|Poor/Non-compliance|2|||
94408164|NCT03635983|323278468|FG001|Treatment Period|Poor/Non-compliance|1|||
94408165|NCT03635983|323278467|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
94408166|NCT03635983|323278468|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
94408167|NCT03635983|323278467|FG000|Treatment Period|Other reasons|7|||
94408168|NCT03635983|323278468|FG001|Treatment Period|Other reasons|4|||
94408169|NCT03635983|323278467|FG000|Treatment Period|Disease progression|230|||
94408170|NCT03635983|323278468|FG001|Treatment Period|Disease progression|201|||
94408171|NCT03635983|323278467|FG000|Treatment Period|Study drug toxicity|35|||
94408172|NCT03635983|323278468|FG001|Treatment Period|Study drug toxicity|36|||
94408173|NCT03635983|323278467|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
94408174|NCT03635983|323278468|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
94408175|NCT03635983|323278467|FG000|Treatment Period|Maximum clinical benefit|3|||
94408176|NCT03635983|323278468|FG001|Treatment Period|Maximum clinical benefit|5|||
94408177|NCT03635983|323278467|FG000|Treatment Period|Administrative reason by the sponsor|1|||
94408178|NCT03635983|323278468|FG001|Treatment Period|Administrative reason by the sponsor|2|||
94408179|NCT03635983|323278467|FG000|Treatment Period|Lost to Follow-up|0|||
94408180|NCT03635983|323278468|FG001|Treatment Period|Lost to Follow-up|1|||
94408181|NCT00889252|323278469|FG000|Overall Study|Adverse Event|2|||
94408182|NCT00889252|323278470|FG001|Overall Study|Adverse Event|4|||
94408183|NCT00889252|323278469|FG000|Overall Study|Withdrawal by Subject|3|||
94408184|NCT00889252|323278470|FG001|Overall Study|Withdrawal by Subject|0|||
94408185|NCT00889252|323278469|FG000|Overall Study|Protocol Violation|2|||
94408186|NCT00889252|323278470|FG001|Overall Study|Protocol Violation|0|||
94408187|NCT01701973|323278471|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
94408188|NCT01701973|323278472|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
94408189|NCT01701973|323278473|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
94408190|NCT01701973|323278474|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
94408191|NCT01701973|323278475|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
94408192|NCT01701973|323278476|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
94486637|NCT03652818|323575278|FG000|Overall Study|Adverse Event|1|||
94486638|NCT03652818|323575279|FG001|Overall Study|Adverse Event|0|||
94486639|NCT03652818|323575280|FG002|Overall Study|Adverse Event|0|||
94486640|NCT03652818|323575281|FG003|Overall Study|Adverse Event|0|||
94486641|NCT03652818|323575282|FG004|Overall Study|Adverse Event|0|||
94486642|NCT03652818|323575278|FG000|Overall Study|Physician Decision|1|||
94486643|NCT03652818|323575279|FG001|Overall Study|Physician Decision|0|||
94486644|NCT03652818|323575280|FG002|Overall Study|Physician Decision|0|||
94486645|NCT03652818|323575281|FG003|Overall Study|Physician Decision|0|||
94486646|NCT03652818|323575282|FG004|Overall Study|Physician Decision|0|||
94486647|NCT03652818|323575278|FG000|Overall Study|Lost to Follow-up|0|||
94408193|NCT01701973|323278477|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
94408194|NCT01701973|323278478|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
94408195|NCT02169336|323278483|FG000|Overall Study|Lack of Efficacy|1|||
94408196|NCT02169336|323278484|FG001|Overall Study|Lack of Efficacy|1|||
94408197|NCT02169336|323278485|FG002|Overall Study|Lack of Efficacy|0|||
94408198|NCT02169336|323278483|FG000|Overall Study|Adverse Event|2|||
94408199|NCT02169336|323278484|FG001|Overall Study|Adverse Event|3|||
94408200|NCT02169336|323278485|FG002|Overall Study|Adverse Event|1|||
94408201|NCT02169336|323278483|FG000|Overall Study|Withdrawal by Subject|1|||
94408202|NCT02169336|323278484|FG001|Overall Study|Withdrawal by Subject|0|||
94408203|NCT02169336|323278485|FG002|Overall Study|Withdrawal by Subject|0|||
94408204|NCT02169336|323278483|FG000|Overall Study|Physician Decision|0|||
94408205|NCT02169336|323278484|FG001|Overall Study|Physician Decision|0|||
94408206|NCT02169336|323278485|FG002|Overall Study|Physician Decision|1|||
94408207|NCT02169336|323278483|FG000|Overall Study|Subject declined to continue dosing|0|||
94408208|NCT02169336|323278484|FG001|Overall Study|Subject declined to continue dosing|0|||
94408209|NCT02169336|323278485|FG002|Overall Study|Subject declined to continue dosing|1|||
94408210|NCT02212457|323278488|FG000|Overall Study|Adverse Event|1|||
94408211|NCT02212457|323278489|FG001|Overall Study|Adverse Event|2|||
94408212|NCT02212457|323278490|FG002|Overall Study|Adverse Event|2|||
94408213|NCT02212457|323278491|FG003|Overall Study|Adverse Event|2|||
94408214|NCT02212457|323278492|FG004|Overall Study|Adverse Event|0|||
94408215|NCT02212457|323278493|FG005|Overall Study|Adverse Event|1|||
94408216|NCT02212457|323278488|FG000|Overall Study|Withdrawal by Subject|8|||
94408217|NCT02212457|323278489|FG001|Overall Study|Withdrawal by Subject|10|||
94408218|NCT02212457|323278490|FG002|Overall Study|Withdrawal by Subject|8|||
94408219|NCT02212457|323278491|FG003|Overall Study|Withdrawal by Subject|6|||
94408220|NCT02212457|323278492|FG004|Overall Study|Withdrawal by Subject|5|||
94408221|NCT02212457|323278493|FG005|Overall Study|Withdrawal by Subject|4|||
94408222|NCT02212457|323278488|FG000|Overall Study|Lost to Follow-up|6|||
94408223|NCT02212457|323278489|FG001|Overall Study|Lost to Follow-up|7|||
94408224|NCT02212457|323278490|FG002|Overall Study|Lost to Follow-up|4|||
94408225|NCT02212457|323278491|FG003|Overall Study|Lost to Follow-up|1|||
94408226|NCT02212457|323278492|FG004|Overall Study|Lost to Follow-up|8|||
94408227|NCT02212457|323278493|FG005|Overall Study|Lost to Follow-up|4|||
94408228|NCT02212457|323278488|FG000|Overall Study|Protocol Violation|2|||
94408229|NCT02212457|323278489|FG001|Overall Study|Protocol Violation|1|||
94408230|NCT02212457|323278490|FG002|Overall Study|Protocol Violation|0|||
94408231|NCT02212457|323278491|FG003|Overall Study|Protocol Violation|1|||
94408232|NCT02212457|323278492|FG004|Overall Study|Protocol Violation|2|||
94408233|NCT02212457|323278493|FG005|Overall Study|Protocol Violation|3|||
94408234|NCT02212457|323278488|FG000|Overall Study|Other|2|||
94408235|NCT02212457|323278489|FG001|Overall Study|Other|1|||
94408236|NCT02212457|323278490|FG002|Overall Study|Other|2|||
94408237|NCT02212457|323278491|FG003|Overall Study|Other|1|||
94408238|NCT02212457|323278492|FG004|Overall Study|Other|0|||
94408239|NCT02212457|323278493|FG005|Overall Study|Other|1|||
94408240|NCT01117987|323278495|FG000|Overall Study|Protocol deviation|0|||
94408241|NCT01117987|323278496|FG001|Overall Study|Protocol deviation|1|||
94408242|NCT01117987|323278495|FG000|Overall Study|Subject no longer requires study drug|1|||
94408243|NCT01117987|323278496|FG001|Overall Study|Subject no longer requires study drug|0|||
94408244|NCT01117987|323278495|FG000|Overall Study|Lost to Follow-up|1|||
94408245|NCT01117987|323278496|FG001|Overall Study|Lost to Follow-up|1|||
94408246|NCT01117987|323278495|FG000|Overall Study|Abnormal test procedure result|2|||
94408247|NCT01117987|323278496|FG001|Overall Study|Abnormal test procedure result|0|||
94408248|NCT01117987|323278495|FG000|Overall Study|Lack of Efficacy|3|||
94408249|NCT01117987|323278496|FG001|Overall Study|Lack of Efficacy|4|||
94486648|NCT03652818|323575279|FG001|Overall Study|Lost to Follow-up|1|||
94486649|NCT03652818|323575280|FG002|Overall Study|Lost to Follow-up|2|||
94486650|NCT03652818|323575281|FG003|Overall Study|Lost to Follow-up|1|||
94486651|NCT03652818|323575282|FG004|Overall Study|Lost to Follow-up|1|||
94486652|NCT00830219|323575283|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
94408250|NCT01117987|323278495|FG000|Overall Study|Death|5|||
94408251|NCT01117987|323278496|FG001|Overall Study|Death|10|||
94408252|NCT01117987|323278495|FG000|Overall Study|Withdrawal by Subject|5|||
94408253|NCT01117987|323278496|FG001|Overall Study|Withdrawal by Subject|10|||
94408254|NCT01117987|323278495|FG000|Overall Study|Adverse Event|19|||
94408255|NCT01117987|323278496|FG001|Overall Study|Adverse Event|26|||
94486653|NCT00830219|323575284|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
94408256|NCT01117987|323278495|FG000|Overall Study|Administrative problems|25|||
94408257|NCT01117987|323278496|FG001|Overall Study|Administrative problems|22|||
94408258|NCT01120691|323278497|FG000|Overall Study|Adverse Event|59|||
94408259|NCT01120691|323278498|FG001|Overall Study|Adverse Event|67|||
94408260|NCT01120691|323278499|FG002|Overall Study|Adverse Event|47|||
94408261|NCT01120691|323278497|FG000|Overall Study|Subject withdrew consent|33|||
94408262|NCT01120691|323278498|FG001|Overall Study|Subject withdrew consent|50|||
94408263|NCT01120691|323278499|FG002|Overall Study|Subject withdrew consent|44|||
94408264|NCT01120691|323278497|FG000|Overall Study|Death|21|||
94408265|NCT01120691|323278498|FG001|Overall Study|Death|22|||
94408266|NCT01120691|323278499|FG002|Overall Study|Death|24|||
94408267|NCT01120691|323278497|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
94408268|NCT01120691|323278498|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
94408269|NCT01120691|323278499|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
94408270|NCT01120691|323278497|FG000|Overall Study|Administrative problems|15|||
94408271|NCT01120691|323278498|FG001|Overall Study|Administrative problems|8|||
94408272|NCT01120691|323278499|FG002|Overall Study|Administrative problems|9|||
94408273|NCT01120691|323278497|FG000|Overall Study|Protocol deviation|13|||
94408274|NCT01120691|323278498|FG001|Overall Study|Protocol deviation|12|||
94408275|NCT01120691|323278499|FG002|Overall Study|Protocol deviation|12|||
94408276|NCT01120691|323278497|FG000|Overall Study|Lost to Follow-up|5|||
94408277|NCT01120691|323278498|FG001|Overall Study|Lost to Follow-up|6|||
94408278|NCT01120691|323278499|FG002|Overall Study|Lost to Follow-up|4|||
94408279|NCT01120691|323278497|FG000|Overall Study|Abnormal test procedure result(s)|3|||
94408280|NCT01120691|323278498|FG001|Overall Study|Abnormal test procedure result(s)|2|||
94408281|NCT01120691|323278499|FG002|Overall Study|Abnormal test procedure result(s)|1|||
94408282|NCT01120691|323278497|FG000|Overall Study|Patient's inability to use the device|3|||
94408283|NCT01120691|323278498|FG001|Overall Study|Patient's inability to use the device|1|||
94408284|NCT01120691|323278499|FG002|Overall Study|Patient's inability to use the device|0|||
94408285|NCT01120691|323278497|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94408286|NCT01120691|323278498|FG001|Overall Study|Abnormal laboratory value(s)|3|||
94408287|NCT01120691|323278499|FG002|Overall Study|Abnormal laboratory value(s)|4|||
94408288|NCT00292227|323278502|FG000|Patch Period|Adverse Event|1|||
94408289|NCT00292227|323278503|FG001|Patch Period|Adverse Event|0|||
94408290|NCT00292227|323278504|FG002|Patch Period|Adverse Event|2|||
94408291|NCT00292227|323278502|FG000|Patch Period|Withdrawal by Subject|0|||
94408292|NCT00292227|323278503|FG001|Patch Period|Withdrawal by Subject|0|||
94408293|NCT00292227|323278504|FG002|Patch Period|Withdrawal by Subject|1|||
94408294|NCT00089973|323278505|FG000|Overall Study|Adverse Event|3|||
94408295|NCT00089973|323278505|FG000|Overall Study|Withdrawal by Subject|1|||
94408296|NCT00089973|323278505|FG000|Overall Study|Disease progression|45|||
94408297|NCT00089973|323278505|FG000|Overall Study|Death|1|||
94408298|NCT01835548|323278506|FG000|Dose Optimization Period|Adverse Event|0|||
94408299|NCT01835548|323278507|FG001|Dose Optimization Period|Adverse Event|0|||
94408300|NCT01835548|323278508|FG002|Dose Optimization Period|Adverse Event|1|||
94408301|NCT01835548|323278506|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
94408302|NCT01835548|323278507|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
94408303|NCT01835548|323278508|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
94408304|NCT01835548|323278506|FG000|Double-Blind Treatment Period|Adverse Event|0|||
94408305|NCT01835548|323278507|FG001|Double-Blind Treatment Period|Adverse Event|1|||
94408306|NCT01835548|323278508|FG002|Double-Blind Treatment Period|Adverse Event|0|||
94408307|NCT01835548|323278506|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
94408308|NCT01835548|323278507|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
94408309|NCT01835548|323278508|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
94408310|NCT01634854|323278509|FG000|Overall Study|Cesarean delivery|2|||
94408311|NCT01634854|323278510|FG001|Overall Study|Cesarean delivery|7|||
94408312|NCT01488448|323278511|FG000|Overall Study|Withdrawal by Subject|3|||
94408313|NCT01488448|323278512|FG001|Overall Study|Withdrawal by Subject|1|||
94408314|NCT01488448|323278511|FG000|Overall Study|Adverse Event|9|||
94408315|NCT01488448|323278512|FG001|Overall Study|Adverse Event|4|||
94408316|NCT01488448|323278511|FG000|Overall Study|Physician Decision|4|||
94408317|NCT01488448|323278512|FG001|Overall Study|Physician Decision|9|||
94408318|NCT01488448|323278511|FG000|Overall Study|Protocol Violation|4|||
94408319|NCT01488448|323278512|FG001|Overall Study|Protocol Violation|3|||
94408320|NCT03257254|323278513|FG000|Overall Study|Withdrawal by Subject|7|||
94408321|NCT03257254|323278513|FG000|Overall Study|Lost to Follow-up|9|||
94486654|NCT01130272|323575285|FG000|Overall Study|Adverse Event|2|||
94408322|NCT03257254|323278513|FG000|Overall Study|Study discontinued by sponsor|5|||
94408323|NCT03234608|323278514|FG000|Overall Study|Lost to Follow-up|23|||
94408324|NCT03234608|323278515|FG001|Overall Study|Lost to Follow-up|21|||
94408325|NCT00654641|323278516|FG000|Overall Study|Lost to Follow-up|2|||
94408326|NCT00654641|323278517|FG001|Overall Study|Lost to Follow-up|3|||
94408327|NCT01337596|323278518|FG000|Overall Study|Withdrawal by Subject|0|||
94408328|NCT01337596|323278519|FG001|Overall Study|Withdrawal by Subject|0|||
94408329|NCT01337596|323278520|FG002|Overall Study|Withdrawal by Subject|0|||
94408330|NCT01337596|323278521|FG003|Overall Study|Withdrawal by Subject|0|||
94408331|NCT01337596|323278522|FG004|Overall Study|Withdrawal by Subject|2|||
94408332|NCT01337596|323278523|FG005|Overall Study|Withdrawal by Subject|0|||
94408333|NCT01337596|323278524|FG006|Overall Study|Withdrawal by Subject|0|||
94408334|NCT01337596|323278525|FG007|Overall Study|Withdrawal by Subject|0|||
94408335|NCT01337596|323278526|FG008|Overall Study|Withdrawal by Subject|0|||
94408336|NCT03365791|323278527|FG000|Overall Study|Adverse Event|5|||
94408337|NCT03365791|323278527|FG000|Overall Study|Death|1|||
94408338|NCT03365791|323278527|FG000|Overall Study|Lost to Follow-up|1|||
94408339|NCT03365791|323278527|FG000|Overall Study|Physician Decision|9|||
94408340|NCT03365791|323278527|FG000|Overall Study|Progressive disease|51|||
94408341|NCT03365791|323278527|FG000|Overall Study|Subject/guardian decision|5|||
94408342|NCT01475487|323278528|FG000|Overall Study|had to leave early for personal reasons|2|||
94408343|NCT01475487|323278529|FG001|Overall Study|had to leave early for personal reasons|1|||
94408344|NCT00857818|323278530|FG000|Overall Study|Lack of Efficacy|1|||
94408345|NCT00857818|323278531|FG001|Overall Study|Lack of Efficacy|0|||
94408346|NCT00857818|323278530|FG000|Overall Study|Adverse Event|3|||
94408347|NCT00857818|323278531|FG001|Overall Study|Adverse Event|0|||
94408348|NCT00857818|323278530|FG000|Overall Study|Withdrawal by Subject|0|||
94408349|NCT00857818|323278531|FG001|Overall Study|Withdrawal by Subject|4|||
94408350|NCT00857818|323278530|FG000|Overall Study|Sponsor terminated study|6|||
94408351|NCT00857818|323278531|FG001|Overall Study|Sponsor terminated study|4|||
94408352|NCT00857818|323278530|FG000|Overall Study|Investigator decision|1|||
94408353|NCT00857818|323278531|FG001|Overall Study|Investigator decision|0|||
94408354|NCT01841060|323279878|FG000|Overall Study|Protocol Violation|10|||
94408355|NCT03303417|323279879|FG000|Overall Study|Withdrawal by Subject|1|||
94408356|NCT03303417|323279880|FG001|Overall Study|Withdrawal by Subject|1|||
94408357|NCT00493792|323279885|FG000|Overall Study|Death|55|||
94408358|NCT00493792|323279886|FG001|Overall Study|Death|50|||
94408359|NCT00493792|323279885|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
94408360|NCT00493792|323279886|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
94408361|NCT00683787|323279888|FG000|Overall Study|Progression|3|||
94408362|NCT00683787|323279889|FG001|Overall Study|Progression|3|||
94408363|NCT00683787|323279890|FG002|Overall Study|Progression|0|||
94408364|NCT00683787|323279888|FG000|Overall Study|Adverse Event|0|||
94408365|NCT00683787|323279889|FG001|Overall Study|Adverse Event|0|||
94408366|NCT00683787|323279890|FG002|Overall Study|Adverse Event|2|||
94408367|NCT00183196|323279891|FG000|Overall Study|Withdrawal by Subject|18|||
94408368|NCT00183196|323279892|FG001|Overall Study|Withdrawal by Subject|11|||
94408369|NCT00183196|323279893|FG002|Overall Study|Withdrawal by Subject|13|||
94408370|NCT00183196|323279891|FG000|Overall Study|Adverse Event|1|||
94408371|NCT00183196|323279892|FG001|Overall Study|Adverse Event|2|||
94408372|NCT00183196|323279893|FG002|Overall Study|Adverse Event|2|||
94408373|NCT00183196|323279891|FG000|Overall Study|Legal event|1|||
94408374|NCT00183196|323279892|FG001|Overall Study|Legal event|1|||
94408375|NCT00183196|323279893|FG002|Overall Study|Legal event|1|||
94408376|NCT00183196|323279891|FG000|Overall Study|Required more intensive care|0|||
94408377|NCT00183196|323279892|FG001|Overall Study|Required more intensive care|1|||
94408378|NCT00183196|323279893|FG002|Overall Study|Required more intensive care|2|||
94408379|NCT01755975|323279894|FG000|Overall Study|Adverse Event|0|||
94408380|NCT01755975|323279895|FG001|Overall Study|Adverse Event|0|||
94408381|NCT01755975|323279896|FG002|Overall Study|Adverse Event|1|||
94408382|NCT01755975|323279897|FG003|Overall Study|Adverse Event|0|||
94408383|NCT01755975|323279898|FG004|Overall Study|Adverse Event|2|||
94408384|NCT04675775|323279899|FG000|Overall Study|Withdrawal by Subject|7|||
94408385|NCT04633642|323279900|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
94486655|NCT01130272|323575286|FG001|Overall Study|Adverse Event|5|||
94486656|NCT01130272|323575287|FG002|Overall Study|Adverse Event|6|||
94408386|NCT04633642|323279901|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
94408387|NCT05966090|323279902|FG000|Overall Study|Lost to Follow-up|6|||
94408388|NCT05966090|323279903|FG001|Overall Study|Lost to Follow-up|6|||
94408389|NCT05966090|323279902|FG000|Overall Study|Adverse Event|1|||
94408390|NCT05966090|323279903|FG001|Overall Study|Adverse Event|1|||
94408391|NCT05966090|323279902|FG000|Overall Study|Withdrawal by Subject|1|||
94408392|NCT05966090|323279903|FG001|Overall Study|Withdrawal by Subject|1|||
94408393|NCT05966090|323279902|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
94486657|NCT01130272|323575288|FG003|Overall Study|Adverse Event|22|||
94486658|NCT01130272|323575289|FG004|Overall Study|Adverse Event|7|||
94408394|NCT05966090|323279903|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
94408395|NCT05966090|323279902|FG000|Overall Study|Other|1|||
94408396|NCT05966090|323279903|FG001|Overall Study|Other|1|||
94408397|NCT04886063|323279904|FG000|Overall Study|Adverse Event|50|||
94408398|NCT04886063|323279904|FG000|Overall Study|Lack of Efficacy|31|||
94408399|NCT04886063|323279904|FG000|Overall Study|Withdrawal by Subject|45|||
94408400|NCT04886063|323279904|FG000|Overall Study|Physician Decision|3|||
94408401|NCT04886063|323279904|FG000|Overall Study|Protocol Violation|3|||
94408402|NCT04886063|323279904|FG000|Overall Study|Site closure|4|||
94486659|NCT01130272|323575285|FG000|Overall Study|IVRS-confirmed constipation|0|||
94408403|NCT04886063|323279904|FG000|Overall Study|Nursing home replacement|3|||
94408404|NCT04886063|323279904|FG000|Overall Study|Lost to Follow-up|5|||
94408405|NCT04886063|323279904|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
94408406|NCT04886063|323279904|FG000|Overall Study|>1 reason|20|||
94408407|NCT04205162|323279919|FG000|Overall Study|Lost to Follow-up|1|||
94408408|NCT04205162|323279920|FG001|Overall Study|Lost to Follow-up|0|||
94408409|NCT04205162|323279919|FG000|Overall Study|Withdrawal by Subject|2|||
94408410|NCT04205162|323279920|FG001|Overall Study|Withdrawal by Subject|0|||
94408411|NCT04205162|323279919|FG000|Overall Study|University closure due to COVID-19|1|||
94408412|NCT04205162|323279920|FG001|Overall Study|University closure due to COVID-19|0|||
94408413|NCT02531594|323279923|FG000|Overall Study|Withdrawal by Subject|7|||
94408414|NCT02531594|323279924|FG001|Overall Study|Withdrawal by Subject|8|||
94408415|NCT04994431|323279925|FG000|Overall Study|Adverse Event|1|||
94408416|NCT04994431|323279926|FG001|Overall Study|Adverse Event|0|||
94408417|NCT01386125|323279927|FG000|Overall Study|Lost to Follow-up|3|||
94408418|NCT01386125|323279928|FG001|Overall Study|Lost to Follow-up|9|||
94408419|NCT01386125|323279927|FG000|Overall Study|Physician Decision|0|||
94408420|NCT01386125|323279928|FG001|Overall Study|Physician Decision|1|||
94408421|NCT01386125|323279927|FG000|Overall Study|Protocol Violation|5|||
94408422|NCT01386125|323279928|FG001|Overall Study|Protocol Violation|7|||
94408423|NCT01386125|323279927|FG000|Overall Study|Disease Progress|1|||
94408424|NCT01386125|323279928|FG001|Overall Study|Disease Progress|2|||
94408425|NCT01386125|323279927|FG000|Overall Study|Withdrawal by Subject|13|||
94408426|NCT01386125|323279928|FG001|Overall Study|Withdrawal by Subject|12|||
94408427|NCT01386125|323279927|FG000|Overall Study|Adverse Event|2|||
94408428|NCT01386125|323279928|FG001|Overall Study|Adverse Event|5|||
94408429|NCT01386125|323279927|FG000|Overall Study|Lack of Efficacy|0|||
94408430|NCT01386125|323279928|FG001|Overall Study|Lack of Efficacy|1|||
94408431|NCT01386125|323279927|FG000|Overall Study|Participant Leaving Country|1|||
94408432|NCT01386125|323279928|FG001|Overall Study|Participant Leaving Country|0|||
94408433|NCT03496298|323279931|FG000|Overall Study|Adverse Event|49|||
94408434|NCT03496298|323279932|FG001|Overall Study|Adverse Event|68|||
94408435|NCT03496298|323279933|FG002|Overall Study|Adverse Event|79|||
94408436|NCT03496298|323279931|FG000|Overall Study|Study terminated by Sponsor|1050|||
94408437|NCT03496298|323279932|FG001|Overall Study|Study terminated by Sponsor|1063|||
94408438|NCT03496298|323279933|FG002|Overall Study|Study terminated by Sponsor|1071|||
94408439|NCT03496298|323279931|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
94408440|NCT03496298|323279932|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
94408441|NCT03496298|323279933|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
94408442|NCT03496298|323279931|FG000|Overall Study|Withdrawal by Subject|176|||
94408443|NCT03496298|323279932|FG001|Overall Study|Withdrawal by Subject|154|||
94408444|NCT03496298|323279933|FG002|Overall Study|Withdrawal by Subject|151|||
94408445|NCT03496298|323279931|FG000|Overall Study|Other|29|||
94408446|NCT03496298|323279932|FG001|Overall Study|Other|20|||
94408447|NCT03496298|323279933|FG002|Overall Study|Other|23|||
94408448|NCT03496298|323279931|FG000|Overall Study|Randomized and not treated|1|||
94408449|NCT03496298|323279932|FG001|Overall Study|Randomized and not treated|1|||
94408450|NCT03496298|323279933|FG002|Overall Study|Randomized and not treated|1|||
94408451|NCT00605176|323279943|FG000|Overall Study|Adverse Event|2|||
94408452|NCT00605176|323279944|FG001|Overall Study|Adverse Event|1|||
94408453|NCT00605176|323279945|FG002|Overall Study|Adverse Event|3|||
94408454|NCT00605176|323279943|FG000|Overall Study|Withdrawal by Subject|4|||
94408455|NCT00605176|323279944|FG001|Overall Study|Withdrawal by Subject|2|||
94408456|NCT00605176|323279945|FG002|Overall Study|Withdrawal by Subject|4|||
94408457|NCT00605176|323279943|FG000|Overall Study|Lost to Follow-up|2|||
94408458|NCT00605176|323279944|FG001|Overall Study|Lost to Follow-up|2|||
94408459|NCT00605176|323279945|FG002|Overall Study|Lost to Follow-up|1|||
94408460|NCT00605176|323279943|FG000|Overall Study|Non-complicance with study procedures|1|||
94408461|NCT00605176|323279944|FG001|Overall Study|Non-complicance with study procedures|0|||
94408462|NCT00605176|323279945|FG002|Overall Study|Non-complicance with study procedures|0|||
94408463|NCT00605176|323279943|FG000|Overall Study|Use of concomitant therapy|1|||
94408464|NCT00605176|323279944|FG001|Overall Study|Use of concomitant therapy|0|||
94486660|NCT01130272|323575286|FG001|Overall Study|IVRS-confirmed constipation|1|||
94408465|NCT00605176|323279945|FG002|Overall Study|Use of concomitant therapy|1|||
94408466|NCT00605176|323279943|FG000|Overall Study|Other (not due to AE)|1|||
94408467|NCT00605176|323279944|FG001|Overall Study|Other (not due to AE)|1|||
94408468|NCT00605176|323279945|FG002|Overall Study|Other (not due to AE)|0|||
94408469|NCT02289820|323279953|FG000|Overall Study|Withdrawal by Subject|2|||
94408470|NCT02289820|323279954|FG001|Overall Study|Withdrawal by Subject|1|||
94408471|NCT02289820|323279955|FG002|Overall Study|Withdrawal by Subject|2|||
94408472|NCT02289820|323279956|FG003|Overall Study|Withdrawal by Subject|1|||
94486661|NCT01130272|323575287|FG002|Overall Study|IVRS-confirmed constipation|1|||
94408473|NCT02289820|323279957|FG004|Overall Study|Withdrawal by Subject|0|||
94408474|NCT02289820|323279958|FG005|Overall Study|Withdrawal by Subject|0|||
94408475|NCT02289820|323279959|FG006|Overall Study|Withdrawal by Subject|1|||
94408476|NCT02289820|323279953|FG000|Overall Study|Death|0|||
94408477|NCT02289820|323279954|FG001|Overall Study|Death|0|||
94408478|NCT02289820|323279955|FG002|Overall Study|Death|1|||
94408479|NCT02289820|323279956|FG003|Overall Study|Death|0|||
94408480|NCT02289820|323279957|FG004|Overall Study|Death|0|||
94408481|NCT02289820|323279958|FG005|Overall Study|Death|0|||
94408482|NCT02289820|323279959|FG006|Overall Study|Death|0|||
94408483|NCT02289820|323279953|FG000|Overall Study|Lost to Follow-up|0|||
94408484|NCT02289820|323279954|FG001|Overall Study|Lost to Follow-up|0|||
94408485|NCT02289820|323279955|FG002|Overall Study|Lost to Follow-up|3|||
94408486|NCT02289820|323279956|FG003|Overall Study|Lost to Follow-up|1|||
94408487|NCT02289820|323279957|FG004|Overall Study|Lost to Follow-up|0|||
94408488|NCT02289820|323279958|FG005|Overall Study|Lost to Follow-up|1|||
94408489|NCT02289820|323279959|FG006|Overall Study|Lost to Follow-up|1|||
94408490|NCT02289820|323279953|FG000|Overall Study|withdrawal of consent|0|||
94408491|NCT02289820|323279954|FG001|Overall Study|withdrawal of consent|1|||
94408492|NCT02289820|323279955|FG002|Overall Study|withdrawal of consent|0|||
94408493|NCT02289820|323279956|FG003|Overall Study|withdrawal of consent|0|||
94408494|NCT02289820|323279957|FG004|Overall Study|withdrawal of consent|0|||
94408495|NCT02289820|323279958|FG005|Overall Study|withdrawal of consent|0|||
94408496|NCT02289820|323279959|FG006|Overall Study|withdrawal of consent|0|||
94408497|NCT02725411|323279968|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
94408498|NCT02725411|323279969|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
94408499|NCT02725411|323279970|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
94408500|NCT02725411|323279968|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
94408501|NCT02725411|323279969|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
94408502|NCT02725411|323279970|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
94408503|NCT02725411|323279968|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
94408504|NCT02725411|323279969|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
94408505|NCT02725411|323279970|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
94408506|NCT02725411|323279968|FG000|Treatment Period (56 Weeks)|Other|1|||
94408507|NCT02725411|323279969|FG001|Treatment Period (56 Weeks)|Other|4|||
94408508|NCT02725411|323279970|FG002|Treatment Period (56 Weeks)|Other|5|||
94408509|NCT02725411|323279968|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
94408510|NCT02725411|323279969|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
94408511|NCT02725411|323279970|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
94408512|NCT02725411|323279968|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
94408513|NCT02725411|323279969|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
94408514|NCT02725411|323279970|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
94408515|NCT02725411|323279968|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
94408516|NCT02725411|323279969|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
94408517|NCT02725411|323279970|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
94408518|NCT02725411|323279968|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
94408519|NCT02725411|323279969|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
94408520|NCT02725411|323279970|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
94408521|NCT02725411|323279968|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
94408522|NCT02725411|323279969|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
94408523|NCT02725411|323279970|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
94408524|NCT02725411|323279968|FG000|Follow-up Period (24 Weeks)|Other|1|||
94408525|NCT02725411|323279969|FG001|Follow-up Period (24 Weeks)|Other|4|||
94408526|NCT02725411|323279970|FG002|Follow-up Period (24 Weeks)|Other|2|||
94408527|NCT02725411|323279968|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
94408528|NCT02725411|323279969|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
94408529|NCT02725411|323279970|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
94408530|NCT02786927|323279971|FG000|Overall Study|Adverse Event|1|||
94408531|NCT02786927|323279971|FG000|Overall Study|Protocol Violation|4|||
94408532|NCT00587431|323279972|FG000|Overall Study|Adverse Event|1|||
94408533|NCT00587431|323279973|FG001|Overall Study|Adverse Event|0|||
94408534|NCT00587431|323279972|FG000|Overall Study|Withdrawal by Subject|0|||
94408535|NCT00587431|323279973|FG001|Overall Study|Withdrawal by Subject|1|||
94408536|NCT03259789|323279983|FG000|Overall Study|Adverse Event|3|||
94408537|NCT03259789|323279984|FG001|Overall Study|Adverse Event|2|||
94408538|NCT03259789|323279985|FG002|Overall Study|Adverse Event|1|||
94408539|NCT03259789|323279983|FG000|Overall Study|Withdrawal by Subject|9|||
94408540|NCT03259789|323279984|FG001|Overall Study|Withdrawal by Subject|5|||
94408541|NCT03259789|323279985|FG002|Overall Study|Withdrawal by Subject|1|||
94408542|NCT03259789|323279983|FG000|Overall Study|Lost to Follow-up|5|||
94408543|NCT03259789|323279984|FG001|Overall Study|Lost to Follow-up|9|||
94408544|NCT03259789|323279985|FG002|Overall Study|Lost to Follow-up|4|||
94408545|NCT03259789|323279983|FG000|Overall Study|Physician Decision|0|||
94408546|NCT03259789|323279984|FG001|Overall Study|Physician Decision|1|||
94408547|NCT03259789|323279985|FG002|Overall Study|Physician Decision|0|||
94408548|NCT02063217|323279987|FG000|Overall Study|Withdrawal by Subject|1|||
94408549|NCT02063217|323279988|FG001|Overall Study|Withdrawal by Subject|0|||
94408550|NCT02063217|323279989|FG002|Overall Study|Withdrawal by Subject|0|||
94408551|NCT04314843|323279990|FG000|Overall Study|Death|2|||
94408552|NCT04314843|323279991|FG001|Overall Study|Death|2|||
94408553|NCT04314843|323279990|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
94408554|NCT04314843|323279991|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
94408555|NCT00551616|323279992|FG000|Overall Study|Lost to Follow-up|48|||
94408556|NCT00551616|323279993|FG001|Overall Study|Lost to Follow-up|40|||
94408557|NCT01183884|323279994|FG000|Overall Study|Progressive Disease|26|||
94408558|NCT01183884|323279994|FG000|Overall Study|Adverse Event|3|||
94408559|NCT01183884|323279994|FG000|Overall Study|Withdrawal by Subject|1|||
94408560|NCT01183884|323279994|FG000|Overall Study|Other Complicating Disease|3|||
94408561|NCT01183884|323279994|FG000|Overall Study|Not Treated|1|||
94408562|NCT01183884|323279994|FG000|Overall Study|Other|4|||
94408563|NCT01396421|323279995|FG000|Overall Study|Lost to Follow-up|0|||
94408564|NCT01396421|323279996|FG001|Overall Study|Lost to Follow-up|0|||
94408565|NCT01396421|323279997|FG002|Overall Study|Lost to Follow-up|0|||
94408566|NCT01396421|323279998|FG003|Overall Study|Lost to Follow-up|1|||
94408567|NCT01396421|323279995|FG000|Overall Study|Adverse Event|17|||
94408568|NCT01396421|323279996|FG001|Overall Study|Adverse Event|15|||
94408569|NCT01396421|323279997|FG002|Overall Study|Adverse Event|12|||
94408570|NCT01396421|323279998|FG003|Overall Study|Adverse Event|32|||
94408571|NCT01396421|323279995|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
94408572|NCT01396421|323279996|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
94408573|NCT01396421|323279997|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
94408574|NCT01396421|323279998|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
94408575|NCT01396421|323279995|FG000|Overall Study|Physician Decision|1|||
94408576|NCT01396421|323279996|FG001|Overall Study|Physician Decision|1|||
94408577|NCT01396421|323279997|FG002|Overall Study|Physician Decision|0|||
94408578|NCT01396421|323279998|FG003|Overall Study|Physician Decision|3|||
94408579|NCT01396421|323279995|FG000|Overall Study|Withdrawal by Subject|31|||
94408580|NCT01396421|323279996|FG001|Overall Study|Withdrawal by Subject|24|||
94408581|NCT01396421|323279997|FG002|Overall Study|Withdrawal by Subject|13|||
94408582|NCT01396421|323279998|FG003|Overall Study|Withdrawal by Subject|21|||
94408583|NCT01396421|323279995|FG000|Overall Study|Protocol Deviation|2|||
94408584|NCT01396421|323279996|FG001|Overall Study|Protocol Deviation|1|||
94408585|NCT01396421|323279997|FG002|Overall Study|Protocol Deviation|1|||
94408586|NCT01396421|323279998|FG003|Overall Study|Protocol Deviation|0|||
94408587|NCT01396421|323279995|FG000|Overall Study|Lack of Efficacy|7|||
94408588|NCT01396421|323279996|FG001|Overall Study|Lack of Efficacy|17|||
94408589|NCT01396421|323279997|FG002|Overall Study|Lack of Efficacy|7|||
94408590|NCT01396421|323279998|FG003|Overall Study|Lack of Efficacy|18|||
94408591|NCT01142661|323280000|FG000|Overall Study|Adverse Event|2|||
94408592|NCT01142661|323280000|FG000|Overall Study|Withdrawal by Subject|1|||
94408593|NCT01142661|323280000|FG000|Overall Study|Physician Decision|1|||
94408594|NCT05766787|323280001|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
94408595|NCT05766787|323280002|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
94408596|NCT05766787|323280001|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
94408597|NCT05766787|323280002|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
94408598|NCT05766787|323280001|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
94408599|NCT05766787|323280002|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
94408600|NCT01169038|323280003|FG000|Overall Study|Death|1|||
94408601|NCT01169038|323280003|FG000|Overall Study|Adverse Event|5|||
94408602|NCT01169038|323280003|FG000|Overall Study|Required antibiotic administration|1|||
94408603|NCT00537017|323280004|FG000|Treatment Phase|Adverse Event|19|||
94408604|NCT00537017|323280004|FG000|Treatment Phase|Withdrawal by Subject|13|||
94408605|NCT00537017|323280004|FG000|Treatment Phase|Protocol Violation|2|||
94408606|NCT00537017|323280004|FG000|Follow-up Phase|Withdrawal by Subject|9|||
94408607|NCT01362296|323280005|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
94408608|NCT01362296|323280006|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
94408609|NCT01362296|323280007|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
94408610|NCT01362296|323280008|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
94408611|NCT01362296|323280005|FG000|Randomized Phase (RP)|Physician Decision|1|||
94408612|NCT01362296|323280006|FG001|Randomized Phase (RP)|Physician Decision|9|||
94408613|NCT01362296|323280007|FG002|Randomized Phase (RP)|Physician Decision|0|||
94408614|NCT01362296|323280008|FG003|Randomized Phase (RP)|Physician Decision|0|||
94408615|NCT01362296|323280005|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
94408616|NCT01362296|323280006|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
94408617|NCT01362296|323280007|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
94408618|NCT01362296|323280008|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
94408619|NCT01362296|323280005|FG000|Randomized Phase (RP)|Adverse Event|20|||
94408620|NCT01362296|323280006|FG001|Randomized Phase (RP)|Adverse Event|4|||
94408621|NCT01362296|323280007|FG002|Randomized Phase (RP)|Adverse Event|0|||
94408622|NCT01362296|323280008|FG003|Randomized Phase (RP)|Adverse Event|0|||
94408623|NCT01362296|323280005|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
94408624|NCT01362296|323280006|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
94408625|NCT01362296|323280007|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
94408626|NCT01362296|323280008|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
94408627|NCT01362296|323280005|FG000|Crossover Phase|PD including Death due to PD|0|||
94408628|NCT01362296|323280006|FG001|Crossover Phase|PD including Death due to PD|0|||
94408629|NCT01362296|323280007|FG002|Crossover Phase|PD including Death due to PD|16|||
94408630|NCT01362296|323280008|FG003|Crossover Phase|PD including Death due to PD|1|||
94408631|NCT01362296|323280005|FG000|Crossover Phase|Withdrawal by Subject|0|||
94408632|NCT01362296|323280006|FG001|Crossover Phase|Withdrawal by Subject|0|||
94408633|NCT01362296|323280007|FG002|Crossover Phase|Withdrawal by Subject|2|||
94408634|NCT01362296|323280008|FG003|Crossover Phase|Withdrawal by Subject|1|||
94408635|NCT01362296|323280005|FG000|Crossover Phase|Adverse Event|0|||
94408636|NCT01362296|323280006|FG001|Crossover Phase|Adverse Event|0|||
94408637|NCT01362296|323280007|FG002|Crossover Phase|Adverse Event|4|||
94408638|NCT01362296|323280008|FG003|Crossover Phase|Adverse Event|0|||
94408639|NCT01362296|323280005|FG000|Crossover Phase|Study Closed/Terminated|0|||
94408640|NCT01362296|323280006|FG001|Crossover Phase|Study Closed/Terminated|0|||
94408641|NCT01362296|323280007|FG002|Crossover Phase|Study Closed/Terminated|1|||
94408642|NCT01362296|323280008|FG003|Crossover Phase|Study Closed/Terminated|0|||
94408643|NCT02219308|323280011|FG000|Overall Study|Withdrawal by Subject|1|||
94408644|NCT02219308|323280012|FG001|Overall Study|Withdrawal by Subject|2|||
94408645|NCT03203642|323280013|FG000|Overall Study|Adverse Event|3|||
94408646|NCT03203642|323280014|FG001|Overall Study|Adverse Event|1|||
94408647|NCT03203642|323280013|FG000|Overall Study|Withdrawal by Subject|6|||
94408648|NCT03203642|323280014|FG001|Overall Study|Withdrawal by Subject|6|||
94408649|NCT03203642|323280013|FG000|Overall Study|Lost to Follow-up|2|||
94408650|NCT03203642|323280014|FG001|Overall Study|Lost to Follow-up|1|||
94408651|NCT03203642|323280013|FG000|Overall Study|Termination of the study by sponsor|1|||
94408652|NCT03203642|323280014|FG001|Overall Study|Termination of the study by sponsor|1|||
94408653|NCT03203642|323280013|FG000|Overall Study|Participant moved|0|||
94408654|NCT03203642|323280014|FG001|Overall Study|Participant moved|1|||
94408655|NCT03203642|323280013|FG000|Overall Study|Investigator's decision|3|||
94408656|NCT03203642|323280014|FG001|Overall Study|Investigator's decision|0|||
94408657|NCT03203642|323280013|FG000|Overall Study|Other than above specified|0|||
94408658|NCT03203642|323280014|FG001|Overall Study|Other than above specified|1|||
94408659|NCT01977456|323280015|FG000|Overall Study|Death|5|||
94408660|NCT00927251|323281489|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
94408661|NCT03547635|323281512|FG000|Overall Study|Adverse Event|5|||
94408662|NCT03547635|323281513|FG001|Overall Study|Adverse Event|2|||
94408663|NCT03547635|323281514|FG002|Overall Study|Adverse Event|3|||
94408664|NCT03547635|323281512|FG000|Overall Study|Lost to Follow-up|1|||
94408665|NCT03547635|323281513|FG001|Overall Study|Lost to Follow-up|3|||
94408666|NCT03547635|323281514|FG002|Overall Study|Lost to Follow-up|4|||
94408667|NCT03547635|323281512|FG000|Overall Study|Withdrawal by Subject|1|||
94408668|NCT03547635|323281513|FG001|Overall Study|Withdrawal by Subject|0|||
94408669|NCT03547635|323281514|FG002|Overall Study|Withdrawal by Subject|0|||
94408670|NCT03547635|323281512|FG000|Overall Study|Withdrawal By PI|0|||
94408671|NCT03547635|323281513|FG001|Overall Study|Withdrawal By PI|1|||
94408672|NCT03547635|323281514|FG002|Overall Study|Withdrawal By PI|0|||
94408673|NCT03547635|323281512|FG000|Overall Study|Withdrawal by Sponsor|0|||
94408674|NCT03547635|323281513|FG001|Overall Study|Withdrawal by Sponsor|0|||
94408675|NCT03547635|323281514|FG002|Overall Study|Withdrawal by Sponsor|1|||
94408676|NCT03547635|323281512|FG000|Overall Study|Errant Randomization before Treatment|0|||
94408677|NCT03547635|323281513|FG001|Overall Study|Errant Randomization before Treatment|1|||
94408678|NCT03547635|323281514|FG002|Overall Study|Errant Randomization before Treatment|0|||
94408679|NCT03547635|323281512|FG000|Overall Study|Withdrawal by Subject|1|||
94408680|NCT03547635|323281513|FG001|Overall Study|Withdrawal by Subject|0|||
94408681|NCT03547635|323281514|FG002|Overall Study|Withdrawal by Subject|0|||
94408682|NCT02297841|323281520|FG000|Overall Study|Withdrawal by Subject|1|||
94408683|NCT02297841|323281520|FG000|Overall Study|Protocol Violation|7|||
94486662|NCT01130272|323575288|FG003|Overall Study|IVRS-confirmed constipation|2|||
94486663|NCT01130272|323575289|FG004|Overall Study|IVRS-confirmed constipation|0|||
94486664|NCT01130272|323575285|FG000|Overall Study|Rescue medications due to diarrhea|3|||
94486665|NCT01130272|323575286|FG001|Overall Study|Rescue medications due to diarrhea|5|||
94486666|NCT01130272|323575287|FG002|Overall Study|Rescue medications due to diarrhea|8|||
94408684|NCT03429049|323281521|FG000|Overall Study|Adverse Event|2|||
94408685|NCT03429049|323281522|FG001|Overall Study|Adverse Event|3|||
94408686|NCT03429049|323281521|FG000|Overall Study|Death|0|||
94408687|NCT03429049|323281522|FG001|Overall Study|Death|1|||
94408688|NCT03429049|323281521|FG000|Overall Study|Lack of Efficacy|4|||
94408689|NCT03429049|323281522|FG001|Overall Study|Lack of Efficacy|2|||
94408690|NCT03429049|323281521|FG000|Overall Study|Lost to Follow-up|9|||
94408691|NCT03429049|323281522|FG001|Overall Study|Lost to Follow-up|8|||
94408692|NCT03429049|323281521|FG000|Overall Study|Physician Decision|1|||
94408693|NCT03429049|323281522|FG001|Overall Study|Physician Decision|0|||
94408694|NCT03429049|323281521|FG000|Overall Study|Protocol Violation|3|||
94408695|NCT03429049|323281522|FG001|Overall Study|Protocol Violation|0|||
94408696|NCT03429049|323281521|FG000|Overall Study|Sponsor Decision|2|||
94408697|NCT03429049|323281522|FG001|Overall Study|Sponsor Decision|0|||
94486667|NCT01130272|323575288|FG003|Overall Study|Rescue medications due to diarrhea|8|||
94486668|NCT01130272|323575289|FG004|Overall Study|Rescue medications due to diarrhea|6|||
94486669|NCT01130272|323575285|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
94408698|NCT03429049|323281521|FG000|Overall Study|Withdrawal by Subject|4|||
94408699|NCT03429049|323281522|FG001|Overall Study|Withdrawal by Subject|20|||
94408700|NCT03429049|323281521|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
94408701|NCT03429049|323281522|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
94408702|NCT01872715|323281526|FG000|Overall Study|Adverse Event|1|||
94408703|NCT01872715|323281526|FG000|Overall Study|Protocol Violation|1|||
94408704|NCT01872715|323281526|FG000|Overall Study|Withdrawal by Subject|2|||
94408705|NCT05258630|323281527|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
94408706|NCT05258630|323281528|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
94408707|NCT05258630|323281527|FG000|Overall Study|Lost to Follow-up|0|||
94408708|NCT05258630|323281528|FG001|Overall Study|Lost to Follow-up|2|||
94408709|NCT00683592|323281529|FG000|Overall Study|Adverse Event|12|||
94408710|NCT00683592|323281530|FG001|Overall Study|Adverse Event|4|||
94408711|NCT00683592|323281529|FG000|Overall Study|Withdrawal by Subject|11|||
94408712|NCT00683592|323281530|FG001|Overall Study|Withdrawal by Subject|11|||
94408713|NCT00683592|323281529|FG000|Overall Study|Lost to Follow-up|17|||
94408714|NCT00683592|323281530|FG001|Overall Study|Lost to Follow-up|17|||
94408715|NCT00683592|323281529|FG000|Overall Study|Lack of Efficacy|3|||
94408716|NCT00683592|323281530|FG001|Overall Study|Lack of Efficacy|7|||
94408717|NCT00683592|323281529|FG000|Overall Study|Physician Decision|0|||
94408718|NCT00683592|323281530|FG001|Overall Study|Physician Decision|1|||
94408719|NCT00683592|323281529|FG000|Overall Study|Non-compliance|3|||
94408720|NCT00683592|323281530|FG001|Overall Study|Non-compliance|5|||
94408721|NCT00683592|323281529|FG000|Overall Study|Other|1|||
94408722|NCT00683592|323281530|FG001|Overall Study|Other|1|||
94408723|NCT01848210|323281538|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
94408724|NCT01848210|323281539|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
94408725|NCT01848210|323281538|FG000|Overall Study|Lost to Follow-up|24|||
94408726|NCT01848210|323281539|FG001|Overall Study|Lost to Follow-up|12|||
94408727|NCT01848210|323281538|FG000|Overall Study|Protocol Violation|3|||
94408728|NCT01848210|323281539|FG001|Overall Study|Protocol Violation|5|||
94408729|NCT01848210|323281538|FG000|Overall Study|Use of Forbidden Drugs|9|||
94408730|NCT01848210|323281539|FG001|Overall Study|Use of Forbidden Drugs|10|||
94408731|NCT01848210|323281538|FG000|Overall Study|Impedition Condition|5|||
94408732|NCT01848210|323281539|FG001|Overall Study|Impedition Condition|9|||
94408733|NCT01848210|323281538|FG000|Overall Study|Adverse Event|7|||
94408734|NCT01848210|323281539|FG001|Overall Study|Adverse Event|9|||
94408735|NCT01848210|323281538|FG000|Overall Study|Discontinuation Criterion|5|||
94408736|NCT01848210|323281539|FG001|Overall Study|Discontinuation Criterion|7|||
94408737|NCT01848210|323281538|FG000|Overall Study|Hypesensitivity|1|||
94408738|NCT01848210|323281539|FG001|Overall Study|Hypesensitivity|0|||
94408739|NCT01848210|323281538|FG000|Overall Study|Hepatic Function Alteration|4|||
94408740|NCT01848210|323281539|FG001|Overall Study|Hepatic Function Alteration|0|||
94408741|NCT01848210|323281538|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
94408742|NCT01848210|323281539|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
94408743|NCT01848210|323281538|FG000|Overall Study|Administrative|1|||
94408744|NCT01848210|323281539|FG001|Overall Study|Administrative|0|||
94408745|NCT00784979|323281540|FG000|Overall Study|incomplete data|6|||
94408746|NCT02674633|323281543|FG000|Overall Study|Lost to Follow-up|3|||
94408747|NCT02674633|323281544|FG001|Overall Study|Lost to Follow-up|2|||
94408748|NCT02674633|323281543|FG000|Overall Study|Physician Decision|1|||
94408749|NCT02674633|323281544|FG001|Overall Study|Physician Decision|0|||
94408750|NCT02674633|323281543|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
94408751|NCT02674633|323281544|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
94408752|NCT03619876|323281545|FG000|Overall Study|Withdrawal by Subject|1|||
94408753|NCT03619876|323281546|FG001|Overall Study|Withdrawal by Subject|2|||
94408754|NCT03619876|323281545|FG000|Overall Study|Withdrawal due to incidental finding|0|||
94408755|NCT03619876|323281546|FG001|Overall Study|Withdrawal due to incidental finding|2|||
94408756|NCT00996437|323281547|FG000|Overall Study|Death|1|||
94408757|NCT00996437|323281548|FG001|Overall Study|Death|0|||
94486670|NCT01130272|323575286|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
94408758|NCT00996437|323281547|FG000|Overall Study|Dropped|2|||
94408759|NCT00996437|323281548|FG001|Overall Study|Dropped|2|||
94408760|NCT00996437|323281547|FG000|Overall Study|Missed|2|||
94408761|NCT00996437|323281548|FG001|Overall Study|Missed|5|||
94408762|NCT03653026|323281549|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
94408763|NCT03653026|323281550|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
94408764|NCT03653026|323281551|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
94408765|NCT03653026|323281552|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
94408766|NCT03653026|323281549|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
94408767|NCT03653026|323281550|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
94408768|NCT03653026|323281551|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
94408769|NCT03653026|323281552|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
94408770|NCT03653026|323281549|FG000|Part 1: Placebo-controlled Period|Other|0|||
94408771|NCT03653026|323281550|FG001|Part 1: Placebo-controlled Period|Other|3|||
94408772|NCT03653026|323281551|FG002|Part 1: Placebo-controlled Period|Other|0|||
94408773|NCT03653026|323281552|FG003|Part 1: Placebo-controlled Period|Other|0|||
94408774|NCT03653026|323281549|FG000|Part 2: Open-label Extension|Adverse Event|0|||
94408775|NCT03653026|323281550|FG001|Part 2: Open-label Extension|Adverse Event|0|||
94408776|NCT03653026|323281551|FG002|Part 2: Open-label Extension|Adverse Event|1|||
94408777|NCT03653026|323281552|FG003|Part 2: Open-label Extension|Adverse Event|1|||
94408778|NCT03653026|323281549|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
94408779|NCT03653026|323281550|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
94408780|NCT03653026|323281551|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
94408781|NCT03653026|323281552|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
94408782|NCT03653026|323281549|FG000|Part 2: Open-label Extension|Other|0|||
94408783|NCT03653026|323281550|FG001|Part 2: Open-label Extension|Other|0|||
94408784|NCT03653026|323281551|FG002|Part 2: Open-label Extension|Other|1|||
94408785|NCT03653026|323281552|FG003|Part 2: Open-label Extension|Other|2|||
94408786|NCT02104817|323281553|FG000|Overall Study|Death|363|||
94408787|NCT02104817|323281554|FG001|Overall Study|Death|330|||
94408788|NCT02104817|323281553|FG000|Overall Study|Lost to Follow-up|3|||
94408789|NCT02104817|323281554|FG001|Overall Study|Lost to Follow-up|2|||
94408790|NCT02104817|323281553|FG000|Overall Study|Protocol Violation|0|||
94408791|NCT02104817|323281554|FG001|Overall Study|Protocol Violation|1|||
94408792|NCT02104817|323281553|FG000|Overall Study|Study terminated by sponsor|5854|||
94408793|NCT02104817|323281554|FG001|Overall Study|Study terminated by sponsor|5901|||
94408794|NCT02104817|323281553|FG000|Overall Study|Withdrawal by Subject|111|||
94408795|NCT02104817|323281554|FG001|Overall Study|Withdrawal by Subject|78|||
94408796|NCT02104817|323281553|FG000|Overall Study|Other reasons|128|||
94408797|NCT02104817|323281554|FG001|Overall Study|Other reasons|135|||
94408798|NCT00969124|323281559|FG000|Overall Study|Protocol Violation|2|||
94408799|NCT00969124|323281559|FG000|Overall Study|Inadequate bowel preparation|15|||
94408800|NCT00969124|323281559|FG000|Overall Study|Inability to reach cecum|9|||
94408801|NCT00969124|323281559|FG000|Overall Study|Previously unrecognized disease|3|||
94408802|NCT00969124|323281559|FG000|Overall Study|Technical error|1|||
94408803|NCT01976728|323281565|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
94408804|NCT01976728|323281566|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
94408805|NCT01976728|323281567|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
94408806|NCT01976728|323281568|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
94408807|NCT02734004|323281570|FG000|Overall Study|Death|36|||
94408808|NCT02734004|323281571|FG001|Overall Study|Death|24|||
94408809|NCT02734004|323281572|FG002|Overall Study|Death|26|||
94408810|NCT02734004|323281573|FG003|Overall Study|Death|35|||
94408811|NCT02734004|323281574|FG004|Overall Study|Death|13|||
94408812|NCT02734004|323281575|FG005|Overall Study|Death|17|||
94408813|NCT02734004|323281576|FG006|Overall Study|Death|20|||
94408814|NCT02734004|323281570|FG000|Overall Study|Lost to Follow-up|1|||
94408815|NCT02734004|323281571|FG001|Overall Study|Lost to Follow-up|1|||
94408816|NCT02734004|323281572|FG002|Overall Study|Lost to Follow-up|0|||
94408817|NCT02734004|323281573|FG003|Overall Study|Lost to Follow-up|0|||
94408818|NCT02734004|323281574|FG004|Overall Study|Lost to Follow-up|1|||
94408819|NCT02734004|323281575|FG005|Overall Study|Lost to Follow-up|0|||
94408820|NCT02734004|323281576|FG006|Overall Study|Lost to Follow-up|0|||
94408821|NCT02734004|323281570|FG000|Overall Study|Withdrawal by Subject|3|||
94408822|NCT02734004|323281571|FG001|Overall Study|Withdrawal by Subject|1|||
94408823|NCT02734004|323281572|FG002|Overall Study|Withdrawal by Subject|1|||
94408824|NCT02734004|323281573|FG003|Overall Study|Withdrawal by Subject|1|||
94408825|NCT02734004|323281574|FG004|Overall Study|Withdrawal by Subject|3|||
94408826|NCT02734004|323281575|FG005|Overall Study|Withdrawal by Subject|0|||
94408827|NCT02734004|323281576|FG006|Overall Study|Withdrawal by Subject|2|||
94408828|NCT02734004|323281570|FG000|Overall Study|Other|0|||
94486671|NCT01130272|323575287|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
94486672|NCT01130272|323575288|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
94486673|NCT01130272|323575289|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
94486674|NCT01130272|323575285|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
94408829|NCT02734004|323281571|FG001|Overall Study|Other|8|||
94408830|NCT02734004|323281572|FG002|Overall Study|Other|7|||
94408831|NCT02734004|323281573|FG003|Overall Study|Other|4|||
94408832|NCT02734004|323281574|FG004|Overall Study|Other|34|||
94408833|NCT02734004|323281575|FG005|Overall Study|Other|14|||
94408834|NCT02734004|323281576|FG006|Overall Study|Other|10|||
94408835|NCT03223909|323281580|FG000|Overall Study|Protocol Violation|48|||
94408836|NCT03223909|323281581|FG001|Overall Study|Protocol Violation|45|||
94408837|NCT03223909|323281582|FG002|Overall Study|Protocol Violation|16|||
94408838|NCT01011556|323281597|FG000|Overall Study|Adverse Event|1|||
94408839|NCT01011556|323281598|FG001|Overall Study|Adverse Event|3|||
94408840|NCT01011556|323281599|FG002|Overall Study|Adverse Event|2|||
94408841|NCT01011556|323281600|FG003|Overall Study|Adverse Event|1|||
94408842|NCT01011556|323281597|FG000|Overall Study|Lost to Follow-up|1|||
94408843|NCT01011556|323281598|FG001|Overall Study|Lost to Follow-up|0|||
94408844|NCT01011556|323281599|FG002|Overall Study|Lost to Follow-up|0|||
94408845|NCT01011556|323281600|FG003|Overall Study|Lost to Follow-up|0|||
94408846|NCT01011556|323281597|FG000|Overall Study|Physician Decision|1|||
94408847|NCT01011556|323281598|FG001|Overall Study|Physician Decision|0|||
94408848|NCT01011556|323281599|FG002|Overall Study|Physician Decision|0|||
94408849|NCT01011556|323281600|FG003|Overall Study|Physician Decision|1|||
94408850|NCT01011556|323281597|FG000|Overall Study|Protocol Violation|0|||
94408851|NCT01011556|323281598|FG001|Overall Study|Protocol Violation|1|||
94408852|NCT01011556|323281599|FG002|Overall Study|Protocol Violation|0|||
94408853|NCT01011556|323281600|FG003|Overall Study|Protocol Violation|0|||
94408854|NCT01011556|323281597|FG000|Overall Study|Withdrawal by Subject|1|||
94408855|NCT01011556|323281598|FG001|Overall Study|Withdrawal by Subject|2|||
94408856|NCT01011556|323281599|FG002|Overall Study|Withdrawal by Subject|4|||
94408857|NCT01011556|323281600|FG003|Overall Study|Withdrawal by Subject|4|||
94408858|NCT01011556|323281597|FG000|Overall Study|Sponsor decision|0|||
94408859|NCT01011556|323281598|FG001|Overall Study|Sponsor decision|1|||
94408860|NCT01011556|323281599|FG002|Overall Study|Sponsor decision|1|||
94408861|NCT01011556|323281600|FG003|Overall Study|Sponsor decision|2|||
94408862|NCT01011556|323281597|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
94408863|NCT01011556|323281598|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
94408864|NCT01011556|323281599|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
94408865|NCT01011556|323281600|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
94408866|NCT01098110|323281604|FG000|Overall Study|Withdrawal by Subject|14|||
94408867|NCT01098110|323281605|FG001|Overall Study|Withdrawal by Subject|24|||
94408868|NCT01098110|323281606|FG002|Overall Study|Withdrawal by Subject|19|||
94408869|NCT01098110|323281604|FG000|Overall Study|Adverse Event|30|||
94408870|NCT01098110|323281605|FG001|Overall Study|Adverse Event|32|||
94408871|NCT01098110|323281606|FG002|Overall Study|Adverse Event|43|||
94408872|NCT01098110|323281604|FG000|Overall Study|Lack of Efficacy|13|||
94408873|NCT01098110|323281605|FG001|Overall Study|Lack of Efficacy|9|||
94408874|NCT01098110|323281606|FG002|Overall Study|Lack of Efficacy|27|||
94408875|NCT01098110|323281604|FG000|Overall Study|Other|4|||
94408876|NCT01098110|323281605|FG001|Overall Study|Other|7|||
94408877|NCT01098110|323281606|FG002|Overall Study|Other|5|||
94408878|NCT01098110|323281604|FG000|Overall Study|Untreated|1|||
94408879|NCT01098110|323281605|FG001|Overall Study|Untreated|1|||
94408880|NCT01098110|323281606|FG002|Overall Study|Untreated|0|||
94408881|NCT02147587|323281607|FG000|Overall Study|Adverse Event|9|||
94408882|NCT02147587|323281608|FG001|Overall Study|Adverse Event|4|||
94408883|NCT02147587|323281607|FG000|Overall Study|Lack of Efficacy|2|||
94408884|NCT02147587|323281608|FG001|Overall Study|Lack of Efficacy|1|||
94408885|NCT01355302|323281609|FG000|Phase 1b|Death|4|||
94408886|NCT01355302|323281610|FG001|Phase 1b|Death|0|||
94408887|NCT01355302|323281611|FG002|Phase 1b|Death|0|||
94408888|NCT01355302|323281609|FG000|Phase 1b|Study terminated by sponsor|2|||
94408889|NCT01355302|323281610|FG001|Phase 1b|Study terminated by sponsor|0|||
94408890|NCT01355302|323281611|FG002|Phase 1b|Study terminated by sponsor|0|||
94408891|NCT01519947|323281612|FG000|Overall Study|Death|0|||
94408892|NCT01519947|323281613|FG001|Overall Study|Death|0|||
94408893|NCT01519947|323281614|FG002|Overall Study|Death|0|||
94408894|NCT01519947|323281615|FG003|Overall Study|Death|1|||
94408895|NCT01519947|323281612|FG000|Overall Study|Protocol Violation|0|||
94408896|NCT01519947|323281613|FG001|Overall Study|Protocol Violation|0|||
94408897|NCT01519947|323281614|FG002|Overall Study|Protocol Violation|2|||
94408898|NCT01519947|323281615|FG003|Overall Study|Protocol Violation|1|||
94486675|NCT01130272|323575286|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
94486676|NCT01130272|323575287|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
94486677|NCT01130272|323575288|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
94486678|NCT01130272|323575289|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
94486679|NCT01130272|323575285|FG000|Overall Study|Protocol Violation|0|||
94408899|NCT01519947|323281612|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
94408900|NCT01519947|323281613|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
94408901|NCT01519947|323281614|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
94408902|NCT01519947|323281615|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
94408903|NCT01519947|323281612|FG000|Overall Study|Development of Anemia|0|||
94408904|NCT01519947|323281613|FG001|Overall Study|Development of Anemia|1|||
94408905|NCT01519947|323281614|FG002|Overall Study|Development of Anemia|0|||
94408906|NCT01519947|323281615|FG003|Overall Study|Development of Anemia|1|||
94408907|NCT01519947|323281612|FG000|Overall Study|Blood Transfusion|0|||
94408908|NCT01519947|323281613|FG001|Overall Study|Blood Transfusion|1|||
94408909|NCT01519947|323281614|FG002|Overall Study|Blood Transfusion|1|||
94408910|NCT01519947|323281615|FG003|Overall Study|Blood Transfusion|0|||
94408911|NCT01519947|323281612|FG000|Overall Study|Withdrawal by Subject|0|||
94408912|NCT01519947|323281613|FG001|Overall Study|Withdrawal by Subject|1|||
94408913|NCT01519947|323281614|FG002|Overall Study|Withdrawal by Subject|0|||
94408914|NCT01519947|323281615|FG003|Overall Study|Withdrawal by Subject|1|||
94408915|NCT01519947|323281612|FG000|Overall Study|Lost to Follow-up|0|||
94408916|NCT01519947|323281613|FG001|Overall Study|Lost to Follow-up|0|||
94408917|NCT01519947|323281614|FG002|Overall Study|Lost to Follow-up|3|||
94408918|NCT01519947|323281615|FG003|Overall Study|Lost to Follow-up|2|||
94408919|NCT01519947|323281612|FG000|Overall Study|Poor Response|1|||
94408920|NCT01519947|323281613|FG001|Overall Study|Poor Response|0|||
94408921|NCT01519947|323281614|FG002|Overall Study|Poor Response|0|||
94408922|NCT01519947|323281615|FG003|Overall Study|Poor Response|1|||
94408923|NCT01519947|323281612|FG000|Overall Study|Adverse Event|1|||
94408924|NCT01519947|323281613|FG001|Overall Study|Adverse Event|0|||
94408925|NCT01519947|323281614|FG002|Overall Study|Adverse Event|1|||
94408926|NCT01519947|323281615|FG003|Overall Study|Adverse Event|1|||
94408927|NCT00931463|323281617|FG000|Overall Study|Death|8|||
94408928|NCT00931463|323281618|FG001|Overall Study|Death|4|||
94408929|NCT00931463|323281617|FG000|Overall Study|Withdrawal by Subject|5|||
94408930|NCT00931463|323281618|FG001|Overall Study|Withdrawal by Subject|0|||
94408931|NCT00931463|323281617|FG000|Overall Study|Lost to Follow-up|4|||
94408932|NCT00931463|323281618|FG001|Overall Study|Lost to Follow-up|1|||
94408933|NCT00585312|323281634|FG000|Overall Study|Adverse Event|3|||
94408934|NCT00585312|323281635|FG001|Overall Study|Adverse Event|0|||
94408935|NCT00585312|323281634|FG000|Overall Study|Lack of Efficacy|6|||
94408936|NCT00585312|323281635|FG001|Overall Study|Lack of Efficacy|11|||
94408937|NCT00585312|323281634|FG000|Overall Study|Lost to Follow-up|1|||
94408938|NCT00585312|323281635|FG001|Overall Study|Lost to Follow-up|1|||
94408939|NCT00585312|323281634|FG000|Overall Study|Reason not specified|2|||
94408940|NCT00585312|323281635|FG001|Overall Study|Reason not specified|0|||
94408941|NCT00585312|323281634|FG000|Overall Study|Withdrawal by Subject|5|||
94408942|NCT00585312|323281635|FG001|Overall Study|Withdrawal by Subject|1|||
94408943|NCT00585312|323281634|FG000|Overall Study|Study terminated by the sponsor|34|||
94408944|NCT00585312|323281635|FG001|Overall Study|Study terminated by the sponsor|31|||
94408945|NCT04291508|323281636|FG000|Overall Study|Withdrawal by Subject|1|||
94408946|NCT04291508|323281637|FG001|Overall Study|Withdrawal by Subject|0|||
94408947|NCT04291508|323281638|FG002|Overall Study|Withdrawal by Subject|1|||
94408948|NCT04291508|323281639|FG003|Overall Study|Withdrawal by Subject|0|||
94408949|NCT04291508|323281636|FG000|Overall Study|lost to follow up|4|||
94408950|NCT04291508|323281637|FG001|Overall Study|lost to follow up|0|||
94408951|NCT04291508|323281638|FG002|Overall Study|lost to follow up|1|||
94408952|NCT04291508|323281639|FG003|Overall Study|lost to follow up|0|||
94408953|NCT00388037|323281640|FG000|Overall Study|Protocol Violation|1|||
94408954|NCT00869440|323281641|FG000|Overall Study|Withdrawal by Subject|1|||
94408955|NCT00869440|323281642|FG001|Overall Study|Withdrawal by Subject|0|||
94408956|NCT00869440|323281643|FG002|Overall Study|Withdrawal by Subject|0|||
94408957|NCT00869440|323281644|FG003|Overall Study|Withdrawal by Subject|0|||
94408958|NCT00869440|323281641|FG000|Overall Study|Physician Decision|1|||
94408959|NCT00869440|323281642|FG001|Overall Study|Physician Decision|1|||
94408960|NCT00869440|323281643|FG002|Overall Study|Physician Decision|0|||
94408961|NCT00869440|323281644|FG003|Overall Study|Physician Decision|0|||
94408962|NCT01899326|323281645|FG000|Overall Study|Withdrawal by Subject|1|||
94408963|NCT01899326|323281645|FG000|Overall Study|Adverse Event|2|||
94408964|NCT01899326|323281645|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
94408965|NCT00569777|323281649|FG000|Overall Study|Withdrawal by Subject|4|||
94408966|NCT00569777|323281650|FG001|Overall Study|Withdrawal by Subject|0|||
94408967|NCT00569777|323281649|FG000|Overall Study|Adverse Event|3|||
94408968|NCT00569777|323281650|FG001|Overall Study|Adverse Event|0|||
94408969|NCT00569777|323281649|FG000|Overall Study|Lost to Follow-up|1|||
94408970|NCT00569777|323281650|FG001|Overall Study|Lost to Follow-up|0|||
94408971|NCT00569777|323281649|FG000|Overall Study|scheduled eye surgery|0|||
94408972|NCT00569777|323281650|FG001|Overall Study|scheduled eye surgery|1|||
94408973|NCT00569777|323281649|FG000|Overall Study|did not meet exclusion criteria|1|||
94408974|NCT00569777|323281650|FG001|Overall Study|did not meet exclusion criteria|2|||
94408975|NCT00569777|323281649|FG000|Overall Study|pregnant|1|||
94408976|NCT00569777|323281650|FG001|Overall Study|pregnant|0|||
94408977|NCT04230876|323281652|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
94408978|NCT04230876|323281653|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
94408979|NCT03840382|323281654|FG000|Overall Study|Lost to Follow-up|11|||
94408980|NCT02175368|323281656|FG000|Overall Study|Lost to Follow-up|1|||
94408981|NCT04034355|323281657|FG000|Overall Study|Study terminated by Sponsor|10|||
94408982|NCT04034355|323281658|FG001|Overall Study|Study terminated by Sponsor|17|||
94408983|NCT04034355|323281657|FG000|Overall Study|Withdrawal by Subject|12|||
94408984|NCT04034355|323281658|FG001|Overall Study|Withdrawal by Subject|11|||
94408985|NCT04034355|323281657|FG000|Overall Study|Site terminated by Sponsor|4|||
94408986|NCT04034355|323281658|FG001|Overall Study|Site terminated by Sponsor|5|||
94408987|NCT04034355|323281657|FG000|Overall Study|Adverse Event|2|||
94408988|NCT04034355|323281658|FG001|Overall Study|Adverse Event|0|||
94408989|NCT04034355|323281657|FG000|Overall Study|Death|1|||
94408990|NCT04034355|323281658|FG001|Overall Study|Death|1|||
94408991|NCT04034355|323281657|FG000|Overall Study|Not reported|2|||
94408992|NCT04034355|323281658|FG001|Overall Study|Not reported|0|||
94408993|NCT04034355|323281657|FG000|Overall Study|Lost to Follow-up|1|||
94408994|NCT04034355|323281658|FG001|Overall Study|Lost to Follow-up|0|||
94408995|NCT04034355|323281657|FG000|Overall Study|Physician Decision|1|||
94408996|NCT04034355|323281658|FG001|Overall Study|Physician Decision|0|||
94408997|NCT04034355|323281657|FG000|Overall Study|Protocol Violation|0|||
94408998|NCT04034355|323281658|FG001|Overall Study|Protocol Violation|1|||
94408999|NCT04034355|323281657|FG000|Overall Study|Progressive disease|1|||
94409000|NCT04034355|323281658|FG001|Overall Study|Progressive disease|0|||
94409001|NCT05135273|323283008|FG000|Overall Study|Recruited into the army|0|||
94409002|NCT05135273|323283009|FG001|Overall Study|Recruited into the army|0|||
94409003|NCT05135273|323283010|FG002|Overall Study|Recruited into the army|0|||
94409004|NCT05135273|323283011|FG003|Overall Study|Recruited into the army|0|||
94409005|NCT05135273|323283012|FG004|Overall Study|Recruited into the army|1|||
94409006|NCT05135273|323283013|FG005|Overall Study|Recruited into the army|0|||
94409007|NCT05135273|323283014|FG006|Overall Study|Recruited into the army|0|||
94409008|NCT05135273|323283015|FG007|Overall Study|Recruited into the army|0|||
94409009|NCT05135273|323283008|FG000|Overall Study|Moved away from study site|0|||
94409010|NCT05135273|323283009|FG001|Overall Study|Moved away from study site|0|||
94409011|NCT05135273|323283010|FG002|Overall Study|Moved away from study site|0|||
94409012|NCT05135273|323283011|FG003|Overall Study|Moved away from study site|0|||
94409013|NCT05135273|323283012|FG004|Overall Study|Moved away from study site|0|||
94409014|NCT05135273|323283013|FG005|Overall Study|Moved away from study site|1|||
94409015|NCT05135273|323283014|FG006|Overall Study|Moved away from study site|1|||
94409016|NCT05135273|323283015|FG007|Overall Study|Moved away from study site|0|||
94409017|NCT05135273|323283008|FG000|Overall Study|Travel|0|||
94409018|NCT05135273|323283009|FG001|Overall Study|Travel|0|||
94409019|NCT05135273|323283010|FG002|Overall Study|Travel|0|||
94409020|NCT05135273|323283011|FG003|Overall Study|Travel|0|||
94409021|NCT05135273|323283012|FG004|Overall Study|Travel|0|||
94409022|NCT05135273|323283013|FG005|Overall Study|Travel|0|||
94409023|NCT05135273|323283014|FG006|Overall Study|Travel|0|||
94409024|NCT05135273|323283015|FG007|Overall Study|Travel|1|||
94409025|NCT00676650|323283016|FG000|Overall Study|Death|45|||
94409026|NCT00676650|323283017|FG001|Overall Study|Death|14|||
94409027|NCT00676650|323283016|FG000|Overall Study|Adverse Event|159|||
94409028|NCT00676650|323283017|FG001|Overall Study|Adverse Event|21|||
94409029|NCT00676650|323283016|FG000|Overall Study|Global deterioration of health status|66|||
94409030|NCT00676650|323283017|FG001|Overall Study|Global deterioration of health status|31|||
94409031|NCT00676650|323283016|FG000|Overall Study|Lost to Follow-up|0|||
94409032|NCT00676650|323283017|FG001|Overall Study|Lost to Follow-up|1|||
94409033|NCT00676650|323283016|FG000|Overall Study|Objective progression or relapse|189|||
94409034|NCT00676650|323283017|FG001|Overall Study|Objective progression or relapse|140|||
94409035|NCT00676650|323283016|FG000|Overall Study|Other|14|||
94409036|NCT00676650|323283017|FG001|Overall Study|Other|10|||
94409037|NCT00676650|323283016|FG000|Overall Study|Protocol Violation|3|||
94409038|NCT00676650|323283017|FG001|Overall Study|Protocol Violation|1|||
94409039|NCT00676650|323283016|FG000|Overall Study|Study terminated by sponsor|57|||
94409040|NCT00676650|323283017|FG001|Overall Study|Study terminated by sponsor|43|||
94409041|NCT00676650|323283016|FG000|Overall Study|Withdrawal by Subject|48|||
94409042|NCT00676650|323283017|FG001|Overall Study|Withdrawal by Subject|24|||
94409043|NCT00676650|323283016|FG000|Overall Study|Randomized but not treated|3|||
94409044|NCT00676650|323283017|FG001|Overall Study|Randomized but not treated|4|||
94409045|NCT00399893|323283018|FG000|Overall Study|Withdrawal by Subject|1|||
94409046|NCT00399893|323283019|FG001|Overall Study|Withdrawal by Subject|0|||
94409047|NCT00263887|323283022|FG000|Overall Study|Withdrawal by Subject|1|||
94409048|NCT00263887|323283023|FG001|Overall Study|Withdrawal by Subject|1|||
94409049|NCT00263887|323283022|FG000|Overall Study|Lung transplantation|1|||
94409050|NCT00263887|323283023|FG001|Overall Study|Lung transplantation|2|||
94409051|NCT00263887|323283022|FG000|Overall Study|Too ill to attend visit|1|||
94409052|NCT00263887|323283023|FG001|Overall Study|Too ill to attend visit|0|||
94409053|NCT00263887|323283022|FG000|Overall Study|Adverse Event|0|||
94409054|NCT00263887|323283023|FG001|Overall Study|Adverse Event|2|||
94409055|NCT00263887|323283022|FG000|Overall Study|Disease progression|0|||
94409056|NCT00263887|323283023|FG001|Overall Study|Disease progression|1|||
94409057|NCT00263887|323283022|FG000|Overall Study|Lack of Efficacy|0|||
94409058|NCT00263887|323283023|FG001|Overall Study|Lack of Efficacy|1|||
94409059|NCT01849458|323283024|FG000|Overall Study|Lost to Follow-up|4|||
94409060|NCT00732160|323283028|FG000|Overall Study|Adverse Event|1|||
94409061|NCT00732160|323283029|FG001|Overall Study|Adverse Event|0|||
94409062|NCT00732160|323283030|FG002|Overall Study|Adverse Event|1|||
94409063|NCT00732160|323283031|FG003|Overall Study|Adverse Event|1|||
94409064|NCT00732160|323283028|FG000|Overall Study|scheduling|4|||
94409065|NCT00732160|323283029|FG001|Overall Study|scheduling|4|||
94409066|NCT00732160|323283030|FG002|Overall Study|scheduling|2|||
94409067|NCT00732160|323283031|FG003|Overall Study|scheduling|1|||
94409068|NCT04660032|323283032|FG000|Overall Study|Protocol Violation|1|||
94409069|NCT04660032|323283033|FG001|Overall Study|Protocol Violation|1|||
94409070|NCT03847974|323283036|FG000|Overall Study|relocated out of region|3|||
94409071|NCT03847974|323283036|FG000|Overall Study|Withdrawal by Subject|2|||
94409072|NCT03847974|323283036|FG000|Overall Study|Adverse Event|1|||
94409073|NCT01924364|323283037|FG000|Overall Study|Physician Decision|3|||
94409074|NCT00265785|323283040|FG000|Overall Study|Adverse Event|4|||
94409075|NCT00265785|323283040|FG000|Overall Study|Withdrawal by Subject|3|||
94409076|NCT00265785|323283040|FG000|Overall Study|Progression/Relapse|15|||
94409077|NCT00265785|323283040|FG000|Overall Study|Not protocol specified|2|||
94409078|NCT00265785|323283040|FG000|Overall Study|Ineligible|1|||
94409079|NCT00265785|323283040|FG000|Overall Study|Did not receive protocol treatment|2|||
94409080|NCT01609582|323283041|FG000|Overall Study|Adverse Event|20|||
94409081|NCT01609582|323283042|FG001|Overall Study|Adverse Event|18|||
94409082|NCT01609582|323283041|FG000|Overall Study|Lost to Follow-up|10|||
94409083|NCT01609582|323283042|FG001|Overall Study|Lost to Follow-up|10|||
94409084|NCT01609582|323283041|FG000|Overall Study|Withdrawal by Subject|21|||
94409085|NCT01609582|323283042|FG001|Overall Study|Withdrawal by Subject|15|||
94409086|NCT01609582|323283041|FG000|Overall Study|Study Terminated by Sponsor|1543|||
94409087|NCT01609582|323283042|FG001|Overall Study|Study Terminated by Sponsor|1548|||
94409088|NCT01609582|323283041|FG000|Overall Study|Other|9|||
94409089|NCT01609582|323283042|FG001|Overall Study|Other|10|||
94409090|NCT01609582|323283041|FG000|Overall Study|Randomized, but not treated|0|||
94409091|NCT01609582|323283042|FG001|Overall Study|Randomized, but not treated|3|||
94409092|NCT00685750|323283049|FG000|Overall Study|Tumor sampling failure|0|||
94409093|NCT00685750|323283050|FG001|Overall Study|Tumor sampling failure|0|||
94409094|NCT00685750|323283051|FG002|Overall Study|Tumor sampling failure|1|||
94409095|NCT00685750|323283052|FG003|Overall Study|Tumor sampling failure|0|||
94409096|NCT00685750|323283053|FG004|Overall Study|Tumor sampling failure|0|||
94409097|NCT00685750|323283054|FG005|Overall Study|Tumor sampling failure|0|||
94409098|NCT00685750|323283055|FG006|Overall Study|Tumor sampling failure|0|||
94409099|NCT00685750|323283049|FG000|Overall Study|Patient didn't receive the treatment|0|||
94409100|NCT00685750|323283050|FG001|Overall Study|Patient didn't receive the treatment|0|||
94409101|NCT00685750|323283051|FG002|Overall Study|Patient didn't receive the treatment|0|||
94409102|NCT00685750|323283052|FG003|Overall Study|Patient didn't receive the treatment|0|||
94409103|NCT00685750|323283053|FG004|Overall Study|Patient didn't receive the treatment|0|||
94409104|NCT00685750|323283054|FG005|Overall Study|Patient didn't receive the treatment|0|||
94409105|NCT00685750|323283055|FG006|Overall Study|Patient didn't receive the treatment|1|||
94409106|NCT00685750|323283049|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
94409107|NCT00685750|323283050|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
94409108|NCT00685750|323283051|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
94409109|NCT00685750|323283052|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
94409110|NCT00685750|323283053|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
94409111|NCT00685750|323283054|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
94409112|NCT00685750|323283055|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
94409113|NCT00808509|323283058|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
94409114|NCT00808509|323283059|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
94409115|NCT00808509|323283058|FG000|Randomized Phase|Reduced methotrexate dose|1|||
94409116|NCT00808509|323283059|FG001|Randomized Phase|Reduced methotrexate dose|2|||
94409117|NCT00808509|323283058|FG000|Randomized Phase|Patient refused rescue therapy|0|||
94409118|NCT00808509|323283059|FG001|Randomized Phase|Patient refused rescue therapy|3|||
94409119|NCT00436917|323283060|FG000|Overall Study|Withdrawal by Subject|13|||
94409120|NCT00436917|323283060|FG000|Overall Study|Adverse Event|2|||
94409121|NCT00436917|323283060|FG000|Overall Study|Physician Decision|1|||
94409122|NCT00436917|323283060|FG000|Overall Study|Death|1|||
94409123|NCT00436917|323283060|FG000|Overall Study|Lost to Follow-up|1|||
94409124|NCT00436917|323283060|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
94409125|NCT00436917|323283060|FG000|Overall Study|Increased creatinine|1|||
94409126|NCT00436917|323283060|FG000|Overall Study|Personal conflicts of patient|1|||
94409127|NCT02466386|323283063|FG000|Overall Study|Adverse Event|5|||
94409128|NCT02466386|323283063|FG000|Overall Study|Protocol Violation|2|||
94409129|NCT02466386|323283063|FG000|Overall Study|Withdrawal by Subject|14|||
94409130|NCT02466386|323283063|FG000|Overall Study|Lost to Follow-up|5|||
94409131|NCT02466386|323283063|FG000|Overall Study|Lack of Efficacy|8|||
94409132|NCT02466386|323283063|FG000|Overall Study|Other|10|||
94409133|NCT05317195|323283064|FG000|Randomization|Withdrawal by Subject|1|||
94409134|NCT05317195|323283064|FG000|Randomization|Discontinued|6|||
94409135|NCT05317195|323283064|FG000|Admission|Withdrawal by Subject|2|||
94409136|NCT00220727|323283065|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
94409137|NCT00220727|323283066|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
94409138|NCT00476593|323283071|FG000|Overall Study|Lost to Follow-up|10|||
94409139|NCT00476593|323283072|FG001|Overall Study|Lost to Follow-up|2|||
94409140|NCT00476593|323283073|FG002|Overall Study|Lost to Follow-up|8|||
94409141|NCT00476593|323283074|FG003|Overall Study|Lost to Follow-up|22|||
94409142|NCT03919695|323283075|FG000|3-month Follow-up|Death|1|||
94409143|NCT03919695|323283076|FG001|3-month Follow-up|Death|1|||
94409144|NCT03919695|323283075|FG000|3-month Follow-up|unable to contact|0|||
94409145|NCT03919695|323283076|FG001|3-month Follow-up|unable to contact|3|||
94409146|NCT03919695|323283075|FG000|3-month Follow-up|in prison|0|||
94409147|NCT03919695|323283076|FG001|3-month Follow-up|in prison|1|||
94409148|NCT03919695|323283075|FG000|6-month Follow-up|Death|0|||
94409149|NCT03919695|323283076|FG001|6-month Follow-up|Death|1|||
94409150|NCT03919695|323283075|FG000|6-month Follow-up|Lost to Follow-up|1|||
94409151|NCT03919695|323283076|FG001|6-month Follow-up|Lost to Follow-up|2|||
94409152|NCT03919695|323283075|FG000|6-month Follow-up|in prison|0|||
94409153|NCT03919695|323283076|FG001|6-month Follow-up|in prison|2|||
94409154|NCT03919695|323283075|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
94409155|NCT03919695|323283076|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
94409156|NCT03919695|323283075|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
94409157|NCT03919695|323283076|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
94409158|NCT04531982|323283078|FG000|Overall Study|Withdrawal by Subject|10|||
94409159|NCT04531982|323283079|FG001|Overall Study|Withdrawal by Subject|11|||
94409160|NCT04531982|323283078|FG000|Overall Study|Adverse Event|6|||
94409161|NCT04531982|323283079|FG001|Overall Study|Adverse Event|14|||
94409162|NCT04531982|323283078|FG000|Overall Study|Protocol Violation|6|||
94409163|NCT04531982|323283079|FG001|Overall Study|Protocol Violation|9|||
94409164|NCT04531982|323283078|FG000|Overall Study|Non-compliance with study drug|3|||
94409165|NCT04531982|323283079|FG001|Overall Study|Non-compliance with study drug|2|||
94409166|NCT04531982|323283078|FG000|Overall Study|Use of prohibited medication|2|||
94409167|NCT04531982|323283079|FG001|Overall Study|Use of prohibited medication|0|||
94409168|NCT04531982|323283078|FG000|Overall Study|Lost to Follow-up|0|||
94409169|NCT04531982|323283079|FG001|Overall Study|Lost to Follow-up|1|||
94409170|NCT04531982|323283078|FG000|Overall Study|Geopolitical conflict|2|||
94409171|NCT04531982|323283079|FG001|Overall Study|Geopolitical conflict|0|||
94409172|NCT04531982|323283078|FG000|Overall Study|Lack of Efficacy|3|||
94409173|NCT04531982|323283079|FG001|Overall Study|Lack of Efficacy|1|||
94409174|NCT01688882|323283080|FG000|Overall Study|Adverse Event|1|||
94409175|NCT01688882|323283081|FG001|Overall Study|Adverse Event|0|||
94409176|NCT01688882|323283080|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94409177|NCT01688882|323283081|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
94409178|NCT01688882|323283080|FG000|Overall Study|Administrative problems|1|||
94409179|NCT01688882|323283081|FG001|Overall Study|Administrative problems|0|||
94409180|NCT04126343|323283082|FG000|Overall Study|Adverse Event|0|||
94409181|NCT04126343|323283083|FG001|Overall Study|Adverse Event|0|||
94409182|NCT04126343|323283084|FG002|Overall Study|Adverse Event|0|||
94409183|NCT04126343|323283085|FG003|Overall Study|Adverse Event|0|||
94409184|NCT04126343|323283086|FG004|Overall Study|Adverse Event|0|||
94409185|NCT04126343|323283087|FG005|Overall Study|Adverse Event|1|||
94409186|NCT04126343|323283082|FG000|Overall Study|Withdrawal by Subject|0|||
94409187|NCT04126343|323283083|FG001|Overall Study|Withdrawal by Subject|0|||
94409188|NCT04126343|323283084|FG002|Overall Study|Withdrawal by Subject|0|||
94409189|NCT04126343|323283085|FG003|Overall Study|Withdrawal by Subject|1|||
94409190|NCT04126343|323283086|FG004|Overall Study|Withdrawal by Subject|0|||
94409191|NCT04126343|323283087|FG005|Overall Study|Withdrawal by Subject|0|||
94409192|NCT04126343|323283082|FG000|Overall Study|Related to COVID-19 pandemic|3|||
94409193|NCT04126343|323283083|FG001|Overall Study|Related to COVID-19 pandemic|4|||
94409194|NCT04126343|323283084|FG002|Overall Study|Related to COVID-19 pandemic|3|||
94409195|NCT04126343|323283085|FG003|Overall Study|Related to COVID-19 pandemic|3|||
94409196|NCT04126343|323283086|FG004|Overall Study|Related to COVID-19 pandemic|3|||
94409197|NCT04126343|323283087|FG005|Overall Study|Related to COVID-19 pandemic|3|||
94409198|NCT04019054|323283090|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
94409199|NCT04019054|323283091|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
94409200|NCT04019054|323283090|FG000|Overall Study|Withdrawal by Subject|3|||
94409201|NCT04019054|323283091|FG001|Overall Study|Withdrawal by Subject|1|||
94409202|NCT01731886|323283095|FG000|Overall Study|Death|1|||
94409203|NCT01731886|323283096|FG001|Overall Study|Death|0|||
94409204|NCT01731886|323283095|FG000|Overall Study|Never started treatment|0|||
94409205|NCT01731886|323283096|FG001|Overall Study|Never started treatment|1|||
94409206|NCT01731886|323283095|FG000|Overall Study|Non-compliant|1|||
94409207|NCT01731886|323283096|FG001|Overall Study|Non-compliant|0|||
94409208|NCT00129116|323283097|FG000|Primary Phase|Lost to Follow-up|1|||
94409209|NCT00129116|323283098|FG001|Primary Phase|Lost to Follow-up|1|||
94409210|NCT00129116|323283099|FG002|Primary Phase|Lost to Follow-up|0|||
94409211|NCT00129116|323283100|FG003|Primary Phase|Lost to Follow-up|1|||
94409212|NCT00129116|323283101|FG004|Primary Phase|Lost to Follow-up|1|||
94409213|NCT00129116|323283097|FG000|Primary Phase|Protocol Violation|0|||
94409214|NCT00129116|323283098|FG001|Primary Phase|Protocol Violation|1|||
94409215|NCT00129116|323283099|FG002|Primary Phase|Protocol Violation|0|||
94409216|NCT00129116|323283100|FG003|Primary Phase|Protocol Violation|0|||
94409217|NCT00129116|323283101|FG004|Primary Phase|Protocol Violation|0|||
94409218|NCT00129116|323283097|FG000|Primary Phase|Adverse Event|1|||
94409219|NCT00129116|323283098|FG001|Primary Phase|Adverse Event|1|||
94409220|NCT00129116|323283099|FG002|Primary Phase|Adverse Event|0|||
94409221|NCT00129116|323283100|FG003|Primary Phase|Adverse Event|0|||
94409222|NCT00129116|323283101|FG004|Primary Phase|Adverse Event|0|||
94409223|NCT00129116|323283097|FG000|Primary Phase|Withdrawal by Subject|0|||
94409224|NCT00129116|323283098|FG001|Primary Phase|Withdrawal by Subject|1|||
94409225|NCT00129116|323283099|FG002|Primary Phase|Withdrawal by Subject|0|||
94409226|NCT00129116|323283100|FG003|Primary Phase|Withdrawal by Subject|0|||
94409227|NCT00129116|323283101|FG004|Primary Phase|Withdrawal by Subject|0|||
94409228|NCT00129116|323283097|FG000|Primary Phase|Other|0|||
94409229|NCT00129116|323283098|FG001|Primary Phase|Other|0|||
94409230|NCT00129116|323283099|FG002|Primary Phase|Other|1|||
94409231|NCT00129116|323283100|FG003|Primary Phase|Other|0|||
94409232|NCT00129116|323283101|FG004|Primary Phase|Other|0|||
94409233|NCT00129116|323283097|FG000|Booster Phase|Lost to Follow-up|2|||
94409234|NCT00129116|323283098|FG001|Booster Phase|Lost to Follow-up|0|||
94409235|NCT00129116|323283099|FG002|Booster Phase|Lost to Follow-up|0|||
94409236|NCT00129116|323283100|FG003|Booster Phase|Lost to Follow-up|0|||
94409237|NCT00129116|323283101|FG004|Booster Phase|Lost to Follow-up|1|||
94409238|NCT03566238|323283102|FG000|Overall Study|Adverse Event|0|||
94409239|NCT03566238|323283103|FG001|Overall Study|Adverse Event|1|||
94409240|NCT03566238|323283104|FG002|Overall Study|Adverse Event|0|||
94409241|NCT03566238|323283102|FG000|Overall Study|Lack of Efficacy|4|||
94409242|NCT03566238|323283103|FG001|Overall Study|Lack of Efficacy|2|||
94409243|NCT03566238|323283104|FG002|Overall Study|Lack of Efficacy|5|||
94409244|NCT03566238|323283102|FG000|Overall Study|Other|1|||
94409245|NCT03566238|323283103|FG001|Overall Study|Other|0|||
94409246|NCT03566238|323283104|FG002|Overall Study|Other|0|||
94409247|NCT02941523|323283109|FG000|Monotherapy|Withdrawal by Subject|0|||
94409248|NCT02941523|323283110|FG001|Monotherapy|Withdrawal by Subject|1|||
94409249|NCT02941523|323283109|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
94409250|NCT02941523|323283110|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
94409251|NCT02941523|323283109|FG000|Carboplatin Combination Therapy|Death|1|||
94409252|NCT02941523|323283110|FG001|Carboplatin Combination Therapy|Death|2|||
94409253|NCT02941523|323283109|FG000|Carboplatin Combination Therapy|Disease progression|2|||
94409254|NCT02941523|323283110|FG001|Carboplatin Combination Therapy|Disease progression|0|||
94409255|NCT02941523|323283109|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
94409256|NCT02941523|323283110|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
94409257|NCT04330157|323283111|FG000|Overall Study|Protocol Violation|4|||
94409258|NCT04330157|323283111|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
94409259|NCT00373425|323283113|FG000|Overall Study|Relapse of NSCLC|116|||
94409260|NCT00373425|323283114|FG001|Overall Study|Relapse of NSCLC|104|||
94409261|NCT00373425|323283115|FG002|Overall Study|Relapse of NSCLC|19|||
94409262|NCT00373425|323283116|FG003|Overall Study|Relapse of NSCLC|2|||
94409263|NCT00373425|323283117|FG004|Overall Study|Relapse of NSCLC|26|||
94409264|NCT00373425|323283113|FG000|Overall Study|Adverse Event|191|||
94409265|NCT00373425|323283114|FG001|Overall Study|Adverse Event|22|||
94409266|NCT00373425|323283115|FG002|Overall Study|Adverse Event|59|||
94409267|NCT00373425|323283116|FG003|Overall Study|Adverse Event|0|||
94409268|NCT00373425|323283117|FG004|Overall Study|Adverse Event|34|||
94409269|NCT00373425|323283113|FG000|Overall Study|Patient request|35|||
94409270|NCT00373425|323283114|FG001|Overall Study|Patient request|18|||
94409271|NCT00373425|323283115|FG002|Overall Study|Patient request|43|||
94409272|NCT00373425|323283116|FG003|Overall Study|Patient request|6|||
94409273|NCT00373425|323283117|FG004|Overall Study|Patient request|7|||
94409274|NCT00373425|323283113|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
94409275|NCT00373425|323283114|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
94409276|NCT00373425|323283115|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
94409277|NCT00373425|323283116|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
94409278|NCT00373425|323283117|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
94409279|NCT00373425|323283113|FG000|Overall Study|Death|7|||
94409280|NCT00373425|323283114|FG001|Overall Study|Death|0|||
94409281|NCT00373425|323283115|FG002|Overall Study|Death|3|||
94409282|NCT00373425|323283116|FG003|Overall Study|Death|1|||
94409283|NCT00373425|323283117|FG004|Overall Study|Death|0|||
94409284|NCT02808819|323283118|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
94409285|NCT02808819|323283119|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
94409286|NCT02808819|323283118|FG000|Overall Study|Withdrawal by Subject|10|||
94409287|NCT02808819|323283119|FG001|Overall Study|Withdrawal by Subject|13|||
94409288|NCT02808819|323283118|FG000|Overall Study|Site terminated by sponsor|2|||
94409289|NCT02808819|323283119|FG001|Overall Study|Site terminated by sponsor|0|||
94409290|NCT02808819|323283118|FG000|Overall Study|Pregnancy|1|||
94409291|NCT02808819|323283119|FG001|Overall Study|Pregnancy|0|||
94409292|NCT02808819|323283118|FG000|Overall Study|Lost to Follow-up|1|||
94409293|NCT02808819|323283119|FG001|Overall Study|Lost to Follow-up|6|||
94409294|NCT02808819|323283118|FG000|Overall Study|Protocol Violation|0|||
94409295|NCT02808819|323283119|FG001|Overall Study|Protocol Violation|1|||
94409296|NCT02808819|323283118|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
94409297|NCT02808819|323283119|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
94409298|NCT02808819|323283118|FG000|Overall Study|Death|1|||
94409299|NCT02808819|323283119|FG001|Overall Study|Death|0|||
94409300|NCT02808819|323283118|FG000|Overall Study|Adverse Event|3|||
94409301|NCT02808819|323283119|FG001|Overall Study|Adverse Event|4|||
94409302|NCT03573817|323283120|FG000|Overall Study|Adverse Event|0|||
94409303|NCT03573817|323283121|FG001|Overall Study|Adverse Event|2|||
94409304|NCT03573817|323283120|FG000|Overall Study|Protocol Violation|0|||
94409305|NCT03573817|323283121|FG001|Overall Study|Protocol Violation|1|||
94409306|NCT03573817|323283120|FG000|Overall Study|Withdrawal by Subject|1|||
94409307|NCT03573817|323283121|FG001|Overall Study|Withdrawal by Subject|1|||
94409308|NCT01083680|323283122|FG000|Overall Study|Lost to Follow-up|2758|||
94409309|NCT01083680|323283122|FG000|Overall Study|Withdrawal by Subject|1086|||
94409310|NCT03546647|323283123|FG000|Overall Study|Adverse Event|1|||
94409311|NCT03546647|323283124|FG001|Overall Study|Adverse Event|0|||
94409312|NCT02260258|323283129|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
94409313|NCT02260258|323283130|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
94409314|NCT03689894|323283131|FG000|Overall Study|Adverse Event|1|||
94409315|NCT01644149|323283136|FG000|Overall Study|Withdrawal by Subject|1|||
94409316|NCT01644149|323283137|FG001|Overall Study|Withdrawal by Subject|0|||
94409317|NCT01644149|323283136|FG000|Overall Study|Lost to Follow-up|3|||
94409318|NCT01644149|323283137|FG001|Overall Study|Lost to Follow-up|1|||
94409319|NCT04718129|323283138|FG000|Overall Study|Lost to Follow-up|6|||
94409320|NCT04718129|323283139|FG001|Overall Study|Lost to Follow-up|7|||
94409321|NCT01436643|323283140|FG000|2-week Pre-treatment|Abnormal test result|0|||
94409322|NCT01436643|323283141|FG001|2-week Pre-treatment|Abnormal test result|0|||
94409323|NCT01436643|323283142|FG002|2-week Pre-treatment|Abnormal test result|0|||
94409324|NCT01436643|323283143|FG003|2-week Pre-treatment|Abnormal test result|1|||
94409325|NCT01436643|323283140|FG000|2-week Pre-treatment|Adverse Event|0|||
94409326|NCT01436643|323283141|FG001|2-week Pre-treatment|Adverse Event|0|||
94409327|NCT01436643|323283142|FG002|2-week Pre-treatment|Adverse Event|0|||
94409328|NCT01436643|323283143|FG003|2-week Pre-treatment|Adverse Event|5|||
94409329|NCT01436643|323283140|FG000|2-week Pre-treatment|Protocol Violation|0|||
94409330|NCT01436643|323283141|FG001|2-week Pre-treatment|Protocol Violation|0|||
94409331|NCT01436643|323283142|FG002|2-week Pre-treatment|Protocol Violation|0|||
94409332|NCT01436643|323283143|FG003|2-week Pre-treatment|Protocol Violation|4|||
94409333|NCT01436643|323283140|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
94409334|NCT01436643|323283141|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
94409335|NCT01436643|323283142|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
94409336|NCT01436643|323283143|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
94409337|NCT01436643|323283140|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
94409338|NCT01436643|323283141|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
94486680|NCT01130272|323575286|FG001|Overall Study|Protocol Violation|0|||
94486681|NCT01130272|323575287|FG002|Overall Study|Protocol Violation|3|||
94486682|NCT01130272|323575288|FG003|Overall Study|Protocol Violation|5|||
94486683|NCT01130272|323575289|FG004|Overall Study|Protocol Violation|5|||
94486684|NCT01130272|323575285|FG000|Overall Study|Lost to Follow-up|4|||
94486685|NCT01130272|323575286|FG001|Overall Study|Lost to Follow-up|3|||
94486686|NCT01130272|323575287|FG002|Overall Study|Lost to Follow-up|4|||
94486687|NCT01130272|323575288|FG003|Overall Study|Lost to Follow-up|7|||
94409339|NCT01436643|323283142|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
94409340|NCT01436643|323283143|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
94409341|NCT01436643|323283140|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
94409342|NCT01436643|323283141|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
94409343|NCT01436643|323283142|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
94409344|NCT01436643|323283143|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
94409345|NCT02875028|323283146|FG000|Washout Period|Withdrawal by Subject|0|||
94409346|NCT02875028|323283147|FG001|Washout Period|Withdrawal by Subject|1|||
94409347|NCT02031237|323284751|FG000|Overall Study|Death|1|||
94409348|NCT02031237|323284752|FG001|Overall Study|Death|5|||
94409349|NCT02031237|323284753|FG002|Overall Study|Death|0|||
94409350|NCT02031237|323284751|FG000|Overall Study|Physician Decision|0|||
94409351|NCT02031237|323284752|FG001|Overall Study|Physician Decision|1|||
94409352|NCT02031237|323284753|FG002|Overall Study|Physician Decision|0|||
94409353|NCT02031237|323284751|FG000|Overall Study|Withdrawal by Subject|2|||
94409354|NCT02031237|323284752|FG001|Overall Study|Withdrawal by Subject|2|||
94409355|NCT02031237|323284753|FG002|Overall Study|Withdrawal by Subject|0|||
94409356|NCT02031237|323284751|FG000|Overall Study|Protocol Violation|2|||
94409357|NCT02031237|323284752|FG001|Overall Study|Protocol Violation|6|||
94409358|NCT02031237|323284753|FG002|Overall Study|Protocol Violation|0|||
94409359|NCT02031237|323284751|FG000|Overall Study|Alternate Treatment Given|0|||
94409360|NCT02031237|323284752|FG001|Overall Study|Alternate Treatment Given|0|||
94409361|NCT02031237|323284753|FG002|Overall Study|Alternate Treatment Given|3|||
94409362|NCT01074008|323284757|FG000|Overall Study|Adverse Event|0|||
94409363|NCT01074008|323284758|FG001|Overall Study|Adverse Event|1|||
94409364|NCT01074008|323284759|FG002|Overall Study|Adverse Event|0|||
94409365|NCT01074008|323284760|FG003|Overall Study|Adverse Event|0|||
94409366|NCT01074008|323284761|FG004|Overall Study|Adverse Event|0|||
94409367|NCT01074008|323284762|FG005|Overall Study|Adverse Event|0|||
94409368|NCT01074008|323284763|FG006|Overall Study|Adverse Event|0|||
94409369|NCT01074008|323284764|FG007|Overall Study|Adverse Event|0|||
94486688|NCT01130272|323575289|FG004|Overall Study|Lost to Follow-up|6|||
94409370|NCT01074008|323284765|FG008|Overall Study|Adverse Event|0|||
94409371|NCT01074008|323284757|FG000|Overall Study|Withdrawal by Subject|1|||
94409372|NCT01074008|323284758|FG001|Overall Study|Withdrawal by Subject|1|||
94409373|NCT01074008|323284759|FG002|Overall Study|Withdrawal by Subject|1|||
94409374|NCT01074008|323284760|FG003|Overall Study|Withdrawal by Subject|0|||
94409375|NCT01074008|323284761|FG004|Overall Study|Withdrawal by Subject|1|||
94409376|NCT01074008|323284762|FG005|Overall Study|Withdrawal by Subject|0|||
94409377|NCT01074008|323284763|FG006|Overall Study|Withdrawal by Subject|0|||
94409378|NCT01074008|323284764|FG007|Overall Study|Withdrawal by Subject|0|||
94409379|NCT01074008|323284765|FG008|Overall Study|Withdrawal by Subject|0|||
94409380|NCT01074008|323284757|FG000|Overall Study|Lost to Follow-up|0|||
94409381|NCT01074008|323284758|FG001|Overall Study|Lost to Follow-up|1|||
94409382|NCT01074008|323284759|FG002|Overall Study|Lost to Follow-up|1|||
94409383|NCT01074008|323284760|FG003|Overall Study|Lost to Follow-up|1|||
94409384|NCT01074008|323284761|FG004|Overall Study|Lost to Follow-up|1|||
94409385|NCT01074008|323284762|FG005|Overall Study|Lost to Follow-up|0|||
94409386|NCT01074008|323284763|FG006|Overall Study|Lost to Follow-up|1|||
94409387|NCT01074008|323284764|FG007|Overall Study|Lost to Follow-up|0|||
94409388|NCT01074008|323284765|FG008|Overall Study|Lost to Follow-up|4|||
94409389|NCT00224484|323284766|FG000|Overall Study|Serious Adverse Event|1|||
94409390|NCT00224484|323284767|FG001|Overall Study|Serious Adverse Event|1|||
94409391|NCT00224484|323284768|FG002|Overall Study|Serious Adverse Event|0|||
94409392|NCT00224484|323284766|FG000|Overall Study|Non-Serious Adverse Event|5|||
94409393|NCT00224484|323284767|FG001|Overall Study|Non-Serious Adverse Event|7|||
94409394|NCT00224484|323284768|FG002|Overall Study|Non-Serious Adverse Event|3|||
94409395|NCT00224484|323284766|FG000|Overall Study|Protocol Violation|2|||
94409396|NCT00224484|323284767|FG001|Overall Study|Protocol Violation|2|||
94409397|NCT00224484|323284768|FG002|Overall Study|Protocol Violation|0|||
94409398|NCT00224484|323284766|FG000|Overall Study|Withdrawal by Subject|49|||
94409399|NCT00224484|323284767|FG001|Overall Study|Withdrawal by Subject|18|||
94409400|NCT00224484|323284768|FG002|Overall Study|Withdrawal by Subject|16|||
94409401|NCT00224484|323284766|FG000|Overall Study|Migrated/moved from study area|18|||
94409402|NCT00224484|323284767|FG001|Overall Study|Migrated/moved from study area|5|||
94409403|NCT00224484|323284768|FG002|Overall Study|Migrated/moved from study area|5|||
94409404|NCT00224484|323284766|FG000|Overall Study|Lost to Follow-up|66|||
94409405|NCT00224484|323284767|FG001|Overall Study|Lost to Follow-up|28|||
94409406|NCT00224484|323284768|FG002|Overall Study|Lost to Follow-up|36|||
94409407|NCT00224484|323284766|FG000|Overall Study|Reason not specified|5|||
94409408|NCT00224484|323284767|FG001|Overall Study|Reason not specified|4|||
94409409|NCT00224484|323284768|FG002|Overall Study|Reason not specified|2|||
94409410|NCT02805309|323284771|FG000|Overall Study|Lost to Follow-up|2|||
94409411|NCT02805309|323284772|FG001|Overall Study|Lost to Follow-up|2|||
94409412|NCT02805309|323284773|FG002|Overall Study|Lost to Follow-up|2|||
94409413|NCT02805309|323284771|FG000|Overall Study|Post-Randomization Exclusion|0|||
94409414|NCT02805309|323284772|FG001|Overall Study|Post-Randomization Exclusion|2|||
94409415|NCT02805309|323284773|FG002|Overall Study|Post-Randomization Exclusion|1|||
94409416|NCT00108628|323284781|FG000|Overall Study|Withdrawal by Subject|17|||
94409417|NCT00108628|323284782|FG001|Overall Study|Withdrawal by Subject|9|||
94409418|NCT00108628|323284781|FG000|Overall Study|Lack of Efficacy|2|||
94409419|NCT00108628|323284782|FG001|Overall Study|Lack of Efficacy|1|||
94409420|NCT00108628|323284781|FG000|Overall Study|Death|1|||
94409421|NCT00108628|323284782|FG001|Overall Study|Death|0|||
94409422|NCT01350934|323284785|FG000|Base Study|Adverse Event|6|||
94409423|NCT01350934|323284786|FG001|Base Study|Adverse Event|0|||
94409424|NCT01350934|323284785|FG000|Base Study|Lost to Follow-up|1|||
94409425|NCT01350934|323284786|FG001|Base Study|Lost to Follow-up|0|||
94409426|NCT01350934|323284785|FG000|Base Study|Protocol Violation|1|||
94409427|NCT01350934|323284786|FG001|Base Study|Protocol Violation|1|||
94409428|NCT01350934|323284785|FG000|Base Study|Withdrawal by Subject|1|||
94409429|NCT01350934|323284786|FG001|Base Study|Withdrawal by Subject|2|||
94409430|NCT01350934|323284785|FG000|Base Study|Non-Compliance With Study Drug|2|||
94409431|NCT01350934|323284786|FG001|Base Study|Non-Compliance With Study Drug|0|||
94409432|NCT01350934|323284785|FG000|Extension Study|Adverse Event|2|||
94409433|NCT01350934|323284786|FG001|Extension Study|Adverse Event|1|||
94409434|NCT01350934|323284785|FG000|Extension Study|Lost to Follow-up|2|||
94409435|NCT01350934|323284786|FG001|Extension Study|Lost to Follow-up|0|||
94409436|NCT01350934|323284785|FG000|Extension Study|Protocol Violation|1|||
94409437|NCT01350934|323284786|FG001|Extension Study|Protocol Violation|1|||
94409438|NCT01350934|323284785|FG000|Extension Study|Lack of Efficacy|0|||
94409439|NCT01350934|323284786|FG001|Extension Study|Lack of Efficacy|1|||
94409440|NCT01350934|323284785|FG000|Extension Study|Withdrawal by Subject|0|||
94409441|NCT01350934|323284786|FG001|Extension Study|Withdrawal by Subject|1|||
94409442|NCT01011335|323284787|FG000|Overall Study|Lost to Follow-up|0|||
94409443|NCT01011335|323284788|FG001|Overall Study|Lost to Follow-up|0|||
94409444|NCT01011335|323284789|FG002|Overall Study|Lost to Follow-up|1|||
94409445|NCT01011335|323284790|FG003|Overall Study|Lost to Follow-up|1|||
94409446|NCT01011335|323284791|FG004|Overall Study|Lost to Follow-up|1|||
94409447|NCT01011335|323284792|FG005|Overall Study|Lost to Follow-up|1|||
94409448|NCT01011335|323284793|FG006|Overall Study|Lost to Follow-up|2|||
94409449|NCT01011335|323284794|FG007|Overall Study|Lost to Follow-up|2|||
94409450|NCT01011335|323284795|FG008|Overall Study|Lost to Follow-up|1|||
94409451|NCT01011335|323284796|FG009|Overall Study|Lost to Follow-up|0|||
94409452|NCT01011335|323284797|FG010|Overall Study|Lost to Follow-up|0|||
94409453|NCT01011335|323284798|FG011|Overall Study|Lost to Follow-up|1|||
94409454|NCT01011335|323284799|FG012|Overall Study|Lost to Follow-up|2|||
94409455|NCT01011335|323284787|FG000|Overall Study|Protocol Violation|0|||
94409456|NCT01011335|323284788|FG001|Overall Study|Protocol Violation|1|||
94409457|NCT01011335|323284789|FG002|Overall Study|Protocol Violation|0|||
94409458|NCT01011335|323284790|FG003|Overall Study|Protocol Violation|0|||
94409459|NCT01011335|323284791|FG004|Overall Study|Protocol Violation|0|||
94409460|NCT01011335|323284792|FG005|Overall Study|Protocol Violation|0|||
94409461|NCT01011335|323284793|FG006|Overall Study|Protocol Violation|0|||
94409462|NCT01011335|323284794|FG007|Overall Study|Protocol Violation|0|||
94409463|NCT01011335|323284795|FG008|Overall Study|Protocol Violation|0|||
94409464|NCT01011335|323284796|FG009|Overall Study|Protocol Violation|0|||
94409465|NCT01011335|323284797|FG010|Overall Study|Protocol Violation|0|||
94409466|NCT01011335|323284798|FG011|Overall Study|Protocol Violation|0|||
94409467|NCT01011335|323284799|FG012|Overall Study|Protocol Violation|0|||
94409468|NCT01011335|323284787|FG000|Overall Study|Moved/deployed or no booster|1|||
94409469|NCT01011335|323284788|FG001|Overall Study|Moved/deployed or no booster|0|||
94409470|NCT01011335|323284789|FG002|Overall Study|Moved/deployed or no booster|0|||
94409471|NCT01011335|323284790|FG003|Overall Study|Moved/deployed or no booster|1|||
94409472|NCT01011335|323284791|FG004|Overall Study|Moved/deployed or no booster|0|||
94409473|NCT01011335|323284792|FG005|Overall Study|Moved/deployed or no booster|0|||
94409474|NCT01011335|323284793|FG006|Overall Study|Moved/deployed or no booster|1|||
94409475|NCT01011335|323284794|FG007|Overall Study|Moved/deployed or no booster|0|||
94409476|NCT01011335|323284795|FG008|Overall Study|Moved/deployed or no booster|1|||
94409477|NCT01011335|323284796|FG009|Overall Study|Moved/deployed or no booster|0|||
94409478|NCT01011335|323284797|FG010|Overall Study|Moved/deployed or no booster|2|||
94409479|NCT01011335|323284798|FG011|Overall Study|Moved/deployed or no booster|0|||
94409480|NCT01011335|323284799|FG012|Overall Study|Moved/deployed or no booster|0|||
94409481|NCT01011335|323284787|FG000|Overall Study|Adverse Event|0|||
94409482|NCT01011335|323284788|FG001|Overall Study|Adverse Event|0|||
94409483|NCT01011335|323284789|FG002|Overall Study|Adverse Event|0|||
94409484|NCT01011335|323284790|FG003|Overall Study|Adverse Event|0|||
94409485|NCT01011335|323284791|FG004|Overall Study|Adverse Event|0|||
94409486|NCT01011335|323284792|FG005|Overall Study|Adverse Event|0|||
94409487|NCT01011335|323284793|FG006|Overall Study|Adverse Event|0|||
94409488|NCT01011335|323284794|FG007|Overall Study|Adverse Event|0|||
94409489|NCT01011335|323284795|FG008|Overall Study|Adverse Event|0|||
94409490|NCT01011335|323284796|FG009|Overall Study|Adverse Event|0|||
94409491|NCT01011335|323284797|FG010|Overall Study|Adverse Event|4|||
94409492|NCT01011335|323284798|FG011|Overall Study|Adverse Event|0|||
94409493|NCT01011335|323284799|FG012|Overall Study|Adverse Event|1|||
94409494|NCT01636934|323284802|FG000|Overall Study|Withdrawal by Subject|3|||
94409495|NCT01636934|323284803|FG001|Overall Study|Withdrawal by Subject|2|||
94409496|NCT01636934|323284802|FG000|Overall Study|Chemo cancel|1|||
94409497|NCT01636934|323284803|FG001|Overall Study|Chemo cancel|0|||
94409498|NCT01636934|323284802|FG000|Overall Study|Too ill to continue|1|||
94409499|NCT01636934|323284803|FG001|Overall Study|Too ill to continue|0|||
94409500|NCT01636934|323284802|FG000|Overall Study|Never started study medication|1|||
94409501|NCT01636934|323284803|FG001|Overall Study|Never started study medication|1|||
94409502|NCT04167618|323284809|FG000|Overall Study|Trial terminated by sponsor|1|||
94409503|NCT04167618|323284810|FG001|Overall Study|Trial terminated by sponsor|1|||
94409504|NCT04542694|323284811|FG000|Overall Study|The need for prohibited therapy|2|||
94409505|NCT04542694|323284812|FG001|Overall Study|The need for prohibited therapy|0|||
94409506|NCT04542694|323284811|FG000|Overall Study|Adverse Event|1|||
94409507|NCT04542694|323284812|FG001|Overall Study|Adverse Event|0|||
94409508|NCT04542694|323284811|FG000|Overall Study|Protocol Violation|1|||
94409509|NCT04542694|323284812|FG001|Overall Study|Protocol Violation|0|||
94409510|NCT00991510|323284813|FG000|Period I (Days 1-14)|Adverse Event|1|||
94409511|NCT00991510|323284814|FG001|Period I (Days 1-14)|Adverse Event|0|||
94409512|NCT00991510|323284813|FG000|Period III (Days 29-112)|Adverse Event|1|||
94409513|NCT00991510|323284814|FG001|Period III (Days 29-112)|Adverse Event|1|||
94409514|NCT00763555|323284815|FG000|Overall Study|Adverse Event|2|||
94409515|NCT00763555|323284816|FG001|Overall Study|Adverse Event|1|||
94409516|NCT00763555|323284815|FG000|Overall Study|Withdrawal by Subject|2|||
94409517|NCT00763555|323284816|FG001|Overall Study|Withdrawal by Subject|6|||
94409518|NCT00763555|323284815|FG000|Overall Study|Lost to Follow-up|0|||
94409519|NCT00763555|323284816|FG001|Overall Study|Lost to Follow-up|3|||
94409520|NCT01729026|323284817|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
94409521|NCT01729026|323284818|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
94409522|NCT01729026|323284817|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
94409523|NCT01729026|323284818|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
94409524|NCT03710590|323284819|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
94409525|NCT03710590|323284820|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
94409526|NCT00852917|323284821|FG000|Overall Study|Adverse Event|13|||
94409527|NCT00852917|323284822|FG001|Overall Study|Adverse Event|20|||
94409528|NCT00852917|323284823|FG002|Overall Study|Adverse Event|35|||
94409529|NCT00852917|323284824|FG003|Overall Study|Adverse Event|17|||
94409530|NCT00852917|323284821|FG000|Overall Study|Lack of Efficacy|21|||
94409531|NCT00852917|323284822|FG001|Overall Study|Lack of Efficacy|11|||
94409532|NCT00852917|323284823|FG002|Overall Study|Lack of Efficacy|11|||
94409533|NCT00852917|323284824|FG003|Overall Study|Lack of Efficacy|47|||
94409534|NCT00852917|323284821|FG000|Overall Study|Withdrawal by Subject|4|||
94409535|NCT00852917|323284822|FG001|Overall Study|Withdrawal by Subject|8|||
94409536|NCT00852917|323284823|FG002|Overall Study|Withdrawal by Subject|10|||
94409537|NCT00852917|323284824|FG003|Overall Study|Withdrawal by Subject|9|||
94409538|NCT00852917|323284821|FG000|Overall Study|Physician Decision|6|||
94409539|NCT00852917|323284822|FG001|Overall Study|Physician Decision|7|||
94409540|NCT00852917|323284823|FG002|Overall Study|Physician Decision|2|||
94409541|NCT00852917|323284824|FG003|Overall Study|Physician Decision|19|||
94409542|NCT00852917|323284821|FG000|Overall Study|Death|0|||
94409543|NCT00852917|323284822|FG001|Overall Study|Death|0|||
94409544|NCT00852917|323284823|FG002|Overall Study|Death|0|||
94409545|NCT00852917|323284824|FG003|Overall Study|Death|1|||
94409546|NCT04823130|323284825|FG000|Overall Study|Withdrawal by Subject|2|||
94409547|NCT04823130|323284826|FG001|Overall Study|Withdrawal by Subject|3|||
94409548|NCT04823130|323284825|FG000|Overall Study|Failure to meet inclusion criteria|6|||
94409549|NCT04823130|323284826|FG001|Overall Study|Failure to meet inclusion criteria|4|||
94409550|NCT04823130|323284825|FG000|Overall Study|Other-unspecified|1|||
94409551|NCT04823130|323284826|FG001|Overall Study|Other-unspecified|0|||
94409552|NCT02488824|323284827|FG000|Overall Study|Adverse Event|1|||
94409553|NCT02488824|323284828|FG001|Overall Study|Adverse Event|1|||
94409554|NCT02356211|323284830|FG000|Overall Study|Withdrawal by Subject|2|||
94409555|NCT02356211|323284831|FG001|Overall Study|Withdrawal by Subject|2|||
94409556|NCT02356211|323284830|FG000|Overall Study|ineligible|1|||
94409557|NCT02356211|323284831|FG001|Overall Study|ineligible|8|||
94409558|NCT02510261|323284834|FG000|Overall Study|Adverse Event|5|||
94409559|NCT02510261|323284835|FG001|Overall Study|Adverse Event|8|||
94409560|NCT02510261|323284836|FG002|Overall Study|Adverse Event|0|||
94409561|NCT02510261|323284834|FG000|Overall Study|Physician Decision|1|||
94409562|NCT02510261|323284835|FG001|Overall Study|Physician Decision|5|||
94409563|NCT02510261|323284836|FG002|Overall Study|Physician Decision|0|||
94409564|NCT02510261|323284834|FG000|Overall Study|Death|19|||
94409565|NCT02510261|323284835|FG001|Overall Study|Death|19|||
94409566|NCT02510261|323284836|FG002|Overall Study|Death|0|||
94409567|NCT02510261|323284834|FG000|Overall Study|Withdrawal by Subject|3|||
94409568|NCT02510261|323284835|FG001|Overall Study|Withdrawal by Subject|10|||
94409569|NCT02510261|323284836|FG002|Overall Study|Withdrawal by Subject|3|||
94409570|NCT00108082|323284837|FG000|Overall Study|Adverse Event|14|||
94409571|NCT00108082|323284838|FG001|Overall Study|Adverse Event|12|||
94409572|NCT00108082|323284839|FG002|Overall Study|Adverse Event|17|||
94409573|NCT00108082|323284837|FG000|Overall Study|Lost to Follow-up|6|||
94409574|NCT00108082|323284838|FG001|Overall Study|Lost to Follow-up|3|||
94409575|NCT00108082|323284839|FG002|Overall Study|Lost to Follow-up|7|||
94409576|NCT00108082|323284837|FG000|Overall Study|Consent Withdrawn|3|||
94409577|NCT00108082|323284838|FG001|Overall Study|Consent Withdrawn|3|||
94409578|NCT00108082|323284839|FG002|Overall Study|Consent Withdrawn|5|||
94409579|NCT00108082|323284837|FG000|Overall Study|Protocol Violation|1|||
94409580|NCT00108082|323284838|FG001|Overall Study|Protocol Violation|2|||
94409581|NCT00108082|323284839|FG002|Overall Study|Protocol Violation|0|||
94409582|NCT00108082|323284837|FG000|Overall Study|Lack of Efficacy|3|||
94409583|NCT00108082|323284838|FG001|Overall Study|Lack of Efficacy|1|||
94409584|NCT00108082|323284839|FG002|Overall Study|Lack of Efficacy|2|||
94409585|NCT00108082|323284837|FG000|Overall Study|Amendment 4: > Month 12|5|||
94409586|NCT00108082|323284838|FG001|Overall Study|Amendment 4: > Month 12|7|||
94409587|NCT00108082|323284839|FG002|Overall Study|Amendment 4: > Month 12|5|||
94409588|NCT00108082|323284837|FG000|Overall Study|Woman of Child-bearing Potential|2|||
94409589|NCT00108082|323284838|FG001|Overall Study|Woman of Child-bearing Potential|0|||
94409590|NCT00108082|323284839|FG002|Overall Study|Woman of Child-bearing Potential|2|||
94409591|NCT00108082|323284837|FG000|Overall Study|Incorrectly Randomized|0|||
94409592|NCT00108082|323284838|FG001|Overall Study|Incorrectly Randomized|0|||
94409593|NCT00108082|323284839|FG002|Overall Study|Incorrectly Randomized|2|||
94409594|NCT00108082|323284837|FG000|Overall Study|Non-compliance|1|||
94409595|NCT00108082|323284838|FG001|Overall Study|Non-compliance|0|||
94409596|NCT00108082|323284839|FG002|Overall Study|Non-compliance|2|||
94409597|NCT00108082|323284837|FG000|Overall Study|Stopped Study Medication|0|||
94409598|NCT00108082|323284838|FG001|Overall Study|Stopped Study Medication|0|||
94409599|NCT00108082|323284839|FG002|Overall Study|Stopped Study Medication|1|||
94409600|NCT00108082|323284837|FG000|Overall Study|Site Closed Study|0|||
94409601|NCT00108082|323284838|FG001|Overall Study|Site Closed Study|2|||
94409602|NCT00108082|323284839|FG002|Overall Study|Site Closed Study|0|||
94409603|NCT00108082|323284837|FG000|Overall Study|Protocol Amendment|0|||
94409604|NCT00108082|323284838|FG001|Overall Study|Protocol Amendment|1|||
94409605|NCT00108082|323284839|FG002|Overall Study|Protocol Amendment|0|||
94409606|NCT00108082|323284837|FG000|Overall Study|Study Medication Not Tapered|0|||
94409607|NCT00108082|323284838|FG001|Overall Study|Study Medication Not Tapered|1|||
94409608|NCT00108082|323284839|FG002|Overall Study|Study Medication Not Tapered|0|||
94409609|NCT00108082|323284837|FG000|Overall Study|Subject Left Site Location|1|||
94409610|NCT00108082|323284838|FG001|Overall Study|Subject Left Site Location|0|||
94409611|NCT00108082|323284839|FG002|Overall Study|Subject Left Site Location|0|||
94409612|NCT00108082|323284837|FG000|Overall Study|Investigator Not at Site|1|||
94409613|NCT00108082|323284838|FG001|Overall Study|Investigator Not at Site|0|||
94409614|NCT00108082|323284839|FG002|Overall Study|Investigator Not at Site|0|||
94409615|NCT00108082|323284837|FG000|Overall Study|Blood Pressure Not Controlled|1|||
94409616|NCT00108082|323284838|FG001|Overall Study|Blood Pressure Not Controlled|0|||
94409617|NCT00108082|323284839|FG002|Overall Study|Blood Pressure Not Controlled|0|||
94409618|NCT03449199|323284844|FG000|Overall Study|Lost to Follow-up|1|||
94409619|NCT03449199|323284845|FG001|Overall Study|Lost to Follow-up|1|||
94409620|NCT03449199|323284846|FG002|Overall Study|Lost to Follow-up|0|||
94409621|NCT03449199|323284844|FG000|Overall Study|Protocol Deviation|0|||
94409622|NCT03449199|323284845|FG001|Overall Study|Protocol Deviation|0|||
94409623|NCT03449199|323284846|FG002|Overall Study|Protocol Deviation|1|||
94409624|NCT03449199|323284844|FG000|Overall Study|Withdrawal by Subject|0|||
94409625|NCT03449199|323284845|FG001|Overall Study|Withdrawal by Subject|0|||
94409626|NCT03449199|323284846|FG002|Overall Study|Withdrawal by Subject|1|||
94409627|NCT01091103|323284847|FG000|Overall Study|Adverse Event|1|||
94409628|NCT01091103|323284847|FG000|Overall Study|Progressive Disease|3|||
94409629|NCT01270620|323284848|FG000|Overall Study|Withdrawal by Subject|1|||
94409630|NCT01270620|323284849|FG001|Overall Study|Withdrawal by Subject|3|||
94409631|NCT02744755|323284852|FG000|Study Period 1|Protocol Violation|2|||
94409632|NCT02744755|323284853|FG001|Study Period 1|Protocol Violation|1|||
94409633|NCT02744755|323284852|FG000|Study Period 1|not defined|0|||
94409634|NCT02744755|323284853|FG001|Study Period 1|not defined|1|||
94409635|NCT02744755|323284852|FG000|Study Period 1|Pregnancy|1|||
94409636|NCT02744755|323284853|FG001|Study Period 1|Pregnancy|0|||
94409637|NCT02744755|323284852|FG000|Study Period 1|Adverse Event|1|||
94409638|NCT02744755|323284853|FG001|Study Period 1|Adverse Event|1|||
94409639|NCT02744755|323284852|FG000|Study Period 1|Lost to Follow-up|1|||
94409640|NCT02744755|323284853|FG001|Study Period 1|Lost to Follow-up|1|||
94409641|NCT02744755|323284852|FG000|Study Period 1|Lack of Efficacy|1|||
94409642|NCT02744755|323284853|FG001|Study Period 1|Lack of Efficacy|0|||
94409643|NCT02744755|323284852|FG000|Study Period 1|Withdrawal by Subject|8|||
94409644|NCT02744755|323284853|FG001|Study Period 1|Withdrawal by Subject|4|||
94409645|NCT02744755|323284852|FG000|Study Period 2|Adverse Event|5|||
94409646|NCT02744755|323284853|FG001|Study Period 2|Adverse Event|0|||
94409647|NCT02744755|323284852|FG000|Study Period 2|Protocol Violation|1|||
94409648|NCT02744755|323284853|FG001|Study Period 2|Protocol Violation|0|||
94409649|NCT02744755|323284852|FG000|Study Period 2|not defined|3|||
94409650|NCT02744755|323284853|FG001|Study Period 2|not defined|2|||
94409651|NCT02744755|323284852|FG000|Study Period 2|Lost to Follow-up|0|||
94409652|NCT02744755|323284853|FG001|Study Period 2|Lost to Follow-up|2|||
94409653|NCT02744755|323284852|FG000|Study Period 2|Withdrawal by Subject|2|||
94409654|NCT02744755|323284853|FG001|Study Period 2|Withdrawal by Subject|2|||
94409655|NCT02744755|323284852|FG000|Study Period 2|Lack of Efficacy|3|||
94409656|NCT02744755|323284853|FG001|Study Period 2|Lack of Efficacy|2|||
94409657|NCT01142908|323284854|FG000|Overall Study|Lost to Follow-up|19|||
94409658|NCT01142908|323284855|FG001|Overall Study|Lost to Follow-up|13|||
94409659|NCT01142908|323284854|FG000|Overall Study|Death|1|||
94409660|NCT01142908|323284855|FG001|Overall Study|Death|4|||
94409661|NCT01142908|323284854|FG000|Overall Study|Excluded - did not meet criteria|9|||
94409662|NCT01142908|323284855|FG001|Overall Study|Excluded - did not meet criteria|5|||
94409663|NCT01142908|323284854|FG000|Overall Study|Withdrawal by Subject|3|||
94409664|NCT01142908|323284855|FG001|Overall Study|Withdrawal by Subject|0|||
94409665|NCT00035555|323284858|FG000|Overall Study|Adverse Event|5|||
94409666|NCT00035555|323284859|FG001|Overall Study|Adverse Event|8|||
94409667|NCT00035555|323284860|FG002|Overall Study|Adverse Event|9|||
94409668|NCT00035555|323284858|FG000|Overall Study|Allograft loss|1|||
94409669|NCT00035555|323284859|FG001|Overall Study|Allograft loss|1|||
94409670|NCT00035555|323284860|FG002|Overall Study|Allograft loss|2|||
94409671|NCT00035555|323284858|FG000|Overall Study|Death|0|||
94409672|NCT00035555|323284859|FG001|Overall Study|Death|0|||
94409673|NCT00035555|323284860|FG002|Overall Study|Death|2|||
94409674|NCT00035555|323284858|FG000|Overall Study|Lost to Follow-up|0|||
94409675|NCT00035555|323284859|FG001|Overall Study|Lost to Follow-up|0|||
94409676|NCT00035555|323284860|FG002|Overall Study|Lost to Follow-up|1|||
94409677|NCT00035555|323284858|FG000|Overall Study|Noncompliance|0|||
94409678|NCT00035555|323284859|FG001|Overall Study|Noncompliance|1|||
94409679|NCT00035555|323284860|FG002|Overall Study|Noncompliance|1|||
94409680|NCT00035555|323284858|FG000|Overall Study|Prohibited medication|1|||
94409681|NCT00035555|323284859|FG001|Overall Study|Prohibited medication|1|||
94409682|NCT00035555|323284860|FG002|Overall Study|Prohibited medication|0|||
94409683|NCT00035555|323284858|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
94409684|NCT00035555|323284859|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
94409685|NCT00035555|323284860|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
94409686|NCT00035555|323284858|FG000|Overall Study|Withdrawal by Subject|2|||
94409687|NCT00035555|323284859|FG001|Overall Study|Withdrawal by Subject|0|||
94409688|NCT00035555|323284860|FG002|Overall Study|Withdrawal by Subject|2|||
94409689|NCT00035555|323284858|FG000|Overall Study|Investigator deemed not a good candidate|0|||
94409690|NCT00035555|323284859|FG001|Overall Study|Investigator deemed not a good candidate|0|||
94409691|NCT00035555|323284860|FG002|Overall Study|Investigator deemed not a good candidate|1|||
94409692|NCT00035555|323284858|FG000|Overall Study|Received cyclosporin in error|0|||
94409693|NCT00035555|323284859|FG001|Overall Study|Received cyclosporin in error|0|||
94409694|NCT00035555|323284860|FG002|Overall Study|Received cyclosporin in error|1|||
94409695|NCT00309985|323284863|FG000|Overall Study|Disease progression|12|||
94409696|NCT00309985|323284864|FG001|Overall Study|Disease progression|0|||
94409697|NCT00309985|323284863|FG000|Overall Study|Adverse Event|30|||
94409698|NCT00309985|323284864|FG001|Overall Study|Adverse Event|0|||
94409699|NCT00309985|323284863|FG000|Overall Study|Death|2|||
94409700|NCT00309985|323284864|FG001|Overall Study|Death|0|||
94409701|NCT00309985|323284863|FG000|Overall Study|Withdrawal by Subject|5|||
94409702|NCT00309985|323284864|FG001|Overall Study|Withdrawal by Subject|1|||
94409703|NCT00309985|323284863|FG000|Overall Study|Physician Decision|3|||
94409704|NCT00309985|323284864|FG001|Overall Study|Physician Decision|0|||
94409705|NCT00309985|323284863|FG000|Overall Study|Never started treatment|7|||
94409706|NCT00309985|323284864|FG001|Overall Study|Never started treatment|0|||
94409707|NCT00309985|323284863|FG000|Overall Study|Complicating disease|1|||
94409708|NCT00309985|323284864|FG001|Overall Study|Complicating disease|0|||
94409709|NCT00309985|323284863|FG000|Overall Study|Non-compliance|1|||
94409710|NCT00309985|323284864|FG001|Overall Study|Non-compliance|0|||
94409711|NCT00309985|323284863|FG000|Overall Study|Chemotherapy discontinued only|1|||
94409712|NCT00309985|323284864|FG001|Overall Study|Chemotherapy discontinued only|0|||
94409713|NCT01546519|323284865|FG000|Overall Study|Adverse Event|0|||
94409714|NCT01546519|323284866|FG001|Overall Study|Adverse Event|0|||
94409715|NCT01546519|323284867|FG002|Overall Study|Adverse Event|1|||
94409716|NCT01546519|323284868|FG003|Overall Study|Adverse Event|1|||
94409717|NCT01546519|323284865|FG000|Overall Study|Death|0|||
94409718|NCT01546519|323284866|FG001|Overall Study|Death|1|||
94409719|NCT01546519|323284867|FG002|Overall Study|Death|3|||
94409720|NCT01546519|323284868|FG003|Overall Study|Death|1|||
94409721|NCT01546519|323284865|FG000|Overall Study|related to disease progression|2|||
94409722|NCT01546519|323284866|FG001|Overall Study|related to disease progression|2|||
94409723|NCT01546519|323284867|FG002|Overall Study|related to disease progression|2|||
94409724|NCT01546519|323284868|FG003|Overall Study|related to disease progression|1|||
94409725|NCT01546519|323284865|FG000|Overall Study|Physician Decision|6|||
94409726|NCT01546519|323284866|FG001|Overall Study|Physician Decision|5|||
94409727|NCT01546519|323284867|FG002|Overall Study|Physician Decision|2|||
94409728|NCT01546519|323284868|FG003|Overall Study|Physician Decision|3|||
94409729|NCT01546519|323284865|FG000|Overall Study|Withdrawal by Subject|1|||
94409730|NCT01546519|323284866|FG001|Overall Study|Withdrawal by Subject|0|||
94409731|NCT01546519|323284867|FG002|Overall Study|Withdrawal by Subject|0|||
94409732|NCT01546519|323284868|FG003|Overall Study|Withdrawal by Subject|0|||
94409733|NCT00779402|323284871|FG000|Treatment Phase 1|Disease Progression|1|||
94409734|NCT00779402|323284872|FG001|Treatment Phase 1|Disease Progression|0|||
94409735|NCT00779402|323284871|FG000|Treatment Phase 1|Adverse Event|2|||
94409736|NCT00779402|323284872|FG001|Treatment Phase 1|Adverse Event|0|||
94409737|NCT00779402|323284871|FG000|Treatment Phase 1|Protocol Violation|1|||
94409738|NCT00779402|323284872|FG001|Treatment Phase 1|Protocol Violation|0|||
94409739|NCT00779402|323284871|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
94409740|NCT00779402|323284872|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
94409741|NCT00779402|323284871|FG000|Treatment Phase 1|Lost to Follow-up|0|||
94409742|NCT00779402|323284872|FG001|Treatment Phase 1|Lost to Follow-up|1|||
94409743|NCT00779402|323284871|FG000|Treatment Phase 1|Death|0|||
94409744|NCT00779402|323284872|FG001|Treatment Phase 1|Death|1|||
94409745|NCT00779402|323284871|FG000|Treatment Phase 1|Intercurrent Illness|1|||
94409746|NCT00779402|323284872|FG001|Treatment Phase 1|Intercurrent Illness|1|||
94409747|NCT00779402|323284871|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
94409748|NCT00779402|323284872|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
94409749|NCT00779402|323284871|FG000|Treatment Phase 1|Other|4|||
94409750|NCT00779402|323284872|FG001|Treatment Phase 1|Other|2|||
94409751|NCT00779402|323284871|FG000|Treatment Phase 1|Closure of Study|3|||
94409752|NCT00779402|323284872|FG001|Treatment Phase 1|Closure of Study|2|||
94409753|NCT00779402|323284871|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
94409754|NCT00779402|323284872|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
94409755|NCT00779402|323284871|FG000|Surveillance Phase|Protocol Violation|0|||
94409756|NCT00779402|323284872|FG001|Surveillance Phase|Protocol Violation|1|||
94409757|NCT00779402|323284871|FG000|Surveillance Phase|Patient refused to continue|22|||
94409758|NCT00779402|323284872|FG001|Surveillance Phase|Patient refused to continue|14|||
94409759|NCT00779402|323284871|FG000|Surveillance Phase|Lost to Follow-up|2|||
94409760|NCT00779402|323284872|FG001|Surveillance Phase|Lost to Follow-up|1|||
94409761|NCT00779402|323284871|FG000|Surveillance Phase|Death|0|||
94409762|NCT00779402|323284872|FG001|Surveillance Phase|Death|1|||
94409763|NCT00779402|323284871|FG000|Surveillance Phase|Intercurrent Illness|2|||
94409764|NCT00779402|323284872|FG001|Surveillance Phase|Intercurrent Illness|0|||
94409765|NCT00779402|323284871|FG000|Surveillance Phase|Other|5|||
94409766|NCT00779402|323284872|FG001|Surveillance Phase|Other|5|||
94409767|NCT00779402|323284871|FG000|Surveillance Phase|Withdrawal by Subject|4|||
94409768|NCT00779402|323284872|FG001|Surveillance Phase|Withdrawal by Subject|1|||
94409769|NCT00779402|323284871|FG000|Surveillance Phase|Closure of study|5|||
94409770|NCT00779402|323284872|FG001|Surveillance Phase|Closure of study|6|||
94409771|NCT00779402|323284871|FG000|Surveillance Phase|Completed Protocol Visits|3|||
94409772|NCT00779402|323284872|FG001|Surveillance Phase|Completed Protocol Visits|2|||
94409773|NCT00779402|323284871|FG000|Long-term Follow-up|Patient refused to continue|2|||
94409774|NCT00779402|323284872|FG001|Long-term Follow-up|Patient refused to continue|0|||
94409775|NCT00779402|323284871|FG000|Long-term Follow-up|Other|5|||
94409776|NCT00779402|323284872|FG001|Long-term Follow-up|Other|0|||
94409777|NCT00779402|323284871|FG000|Long-term Follow-up|Closure of Study|8|||
94409778|NCT00779402|323284872|FG001|Long-term Follow-up|Closure of Study|4|||
94409779|NCT00779402|323284871|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
94409780|NCT00779402|323284872|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
94409781|NCT00693225|323284873|FG000|Overall Study|Lost to Follow-up|1|||
94409782|NCT00693225|323284874|FG001|Overall Study|Lost to Follow-up|2|||
94409783|NCT00693225|323284873|FG000|Overall Study|Adverse Event|1|||
94409784|NCT00693225|323284874|FG001|Overall Study|Adverse Event|3|||
94409785|NCT01740791|323284875|FG000|Overall Study|Randomized but never treated|5|||
94409786|NCT01740791|323284876|FG001|Overall Study|Randomized but never treated|3|||
94409787|NCT01740791|323284877|FG002|Overall Study|Randomized but never treated|2|||
94409788|NCT01740791|323284878|FG003|Overall Study|Randomized but never treated|2|||
94409789|NCT01740791|323284879|FG004|Overall Study|Randomized but never treated|1|||
94409790|NCT01740791|323284880|FG005|Overall Study|Randomized but never treated|3|||
94409791|NCT01740791|323284875|FG000|Overall Study|Lost to Follow-up|2|||
94409792|NCT01740791|323284876|FG001|Overall Study|Lost to Follow-up|0|||
94409793|NCT01740791|323284877|FG002|Overall Study|Lost to Follow-up|2|||
94409794|NCT01740791|323284878|FG003|Overall Study|Lost to Follow-up|3|||
94409795|NCT01740791|323284879|FG004|Overall Study|Lost to Follow-up|2|||
94409796|NCT01740791|323284880|FG005|Overall Study|Lost to Follow-up|3|||
94409797|NCT01740791|323284875|FG000|Overall Study|Withdrew Consent|4|||
94409798|NCT01740791|323284876|FG001|Overall Study|Withdrew Consent|0|||
94409799|NCT01740791|323284877|FG002|Overall Study|Withdrew Consent|1|||
94409800|NCT01740791|323284878|FG003|Overall Study|Withdrew Consent|2|||
94409801|NCT01740791|323284879|FG004|Overall Study|Withdrew Consent|0|||
94409802|NCT01740791|323284880|FG005|Overall Study|Withdrew Consent|3|||
94409803|NCT01740791|323284875|FG000|Overall Study|Investigator's discretion|1|||
94409804|NCT01740791|323284876|FG001|Overall Study|Investigator's discretion|0|||
94409805|NCT01740791|323284877|FG002|Overall Study|Investigator's discretion|1|||
94409806|NCT01740791|323284878|FG003|Overall Study|Investigator's discretion|0|||
94409807|NCT01740791|323284879|FG004|Overall Study|Investigator's discretion|0|||
94409808|NCT01740791|323284880|FG005|Overall Study|Investigator's discretion|1|||
94409809|NCT01740791|323284875|FG000|Overall Study|Adverse Event|0|||
94409810|NCT01740791|323284876|FG001|Overall Study|Adverse Event|0|||
94409811|NCT01740791|323284877|FG002|Overall Study|Adverse Event|0|||
94409812|NCT01740791|323284878|FG003|Overall Study|Adverse Event|0|||
94409813|NCT01740791|323284879|FG004|Overall Study|Adverse Event|0|||
94409814|NCT01740791|323284880|FG005|Overall Study|Adverse Event|1|||
94409815|NCT00985231|323284881|FG000|Overall Study|ineligible|1|||
94409816|NCT00985231|323284882|FG001|Overall Study|ineligible|0|||
94409817|NCT00985231|323284881|FG000|Overall Study|Protocol Violation|1|||
94486689|NCT01130272|323575285|FG000|Overall Study|Withdrawal by Subject|4|||
94486690|NCT01130272|323575286|FG001|Overall Study|Withdrawal by Subject|11|||
94486691|NCT01130272|323575287|FG002|Overall Study|Withdrawal by Subject|10|||
94409818|NCT00985231|323284882|FG001|Overall Study|Protocol Violation|0|||
94409819|NCT00985231|323284881|FG000|Overall Study|Withdrawal by Subject|1|||
94409820|NCT00985231|323284882|FG001|Overall Study|Withdrawal by Subject|0|||
94409821|NCT00985231|323284881|FG000|Overall Study|Lost to Follow-up|0|||
94409822|NCT00985231|323284882|FG001|Overall Study|Lost to Follow-up|1|||
94486692|NCT01130272|323575288|FG003|Overall Study|Withdrawal by Subject|9|||
94409823|NCT00985231|323284881|FG000|Overall Study|Study related symptoms & complaints|0|||
94409824|NCT00985231|323284882|FG001|Overall Study|Study related symptoms & complaints|2|||
94486693|NCT01130272|323575289|FG004|Overall Study|Withdrawal by Subject|8|||
94486694|NCT01130272|323575285|FG000|Overall Study|Physician Decision|1|||
94409825|NCT00089076|323284889|FG000|Overall Study|Alternate Therapy|1|||
94409826|NCT00089076|323284889|FG000|Overall Study|Withdrawal by Subject|2|||
94409827|NCT00089076|323284889|FG000|Overall Study|Progression|7|||
94409828|NCT02169791|323284892|FG000|Overall Study|Death|6|||
94409829|NCT02169791|323284892|FG000|Overall Study|patient withdrew consent|1|||
94409830|NCT03069417|323284895|FG000|Overall Study|Lost to Follow-up|2|||
94409831|NCT03069417|323284896|FG001|Overall Study|Lost to Follow-up|0|||
94409832|NCT03069417|323284895|FG000|Overall Study|Reason Unknown|4|||
94409833|NCT03069417|323284896|FG001|Overall Study|Reason Unknown|7|||
94409834|NCT02329431|323284897|FG000|Overall Study|Lost to Follow-up|20|||
94409835|NCT02329431|323284898|FG001|Overall Study|Lost to Follow-up|13|||
94409836|NCT02105701|323284899|FG000|Overall Study|Lost to Follow-up|1|||
94409837|NCT02105701|323284900|FG001|Overall Study|Lost to Follow-up|0|||
94409838|NCT02105701|323284901|FG002|Overall Study|Lost to Follow-up|2|||
94409839|NCT02105701|323284902|FG003|Overall Study|Lost to Follow-up|1|||
94409840|NCT02105701|323284899|FG000|Overall Study|Protocol Violation|0|||
94409841|NCT02105701|323284900|FG001|Overall Study|Protocol Violation|0|||
94409842|NCT02105701|323284901|FG002|Overall Study|Protocol Violation|1|||
94409843|NCT02105701|323284902|FG003|Overall Study|Protocol Violation|0|||
94409844|NCT02105701|323284899|FG000|Overall Study|Withdrawal by Subject|2|||
94409845|NCT02105701|323284900|FG001|Overall Study|Withdrawal by Subject|1|||
94409846|NCT02105701|323284901|FG002|Overall Study|Withdrawal by Subject|0|||
94409847|NCT02105701|323284902|FG003|Overall Study|Withdrawal by Subject|1|||
94409848|NCT02105701|323284899|FG000|Overall Study|Death|1|||
94409849|NCT02105701|323284900|FG001|Overall Study|Death|0|||
94409850|NCT02105701|323284901|FG002|Overall Study|Death|0|||
94409851|NCT02105701|323284902|FG003|Overall Study|Death|0|||
94409852|NCT03168906|323284903|FG000|Overall Study|Lack of Efficacy|6|||
94409853|NCT03168906|323284904|FG001|Overall Study|Lack of Efficacy|6|||
94409854|NCT00810602|323284905|FG000|Overall Study|Withdrawal by Subject|8|||
94409855|NCT00810602|323284906|FG001|Overall Study|Withdrawal by Subject|3|||
94409856|NCT02413294|323284907|FG000|Overall Study|Withdrawal by Subject|1|||
94409857|NCT04149535|323284908|FG000|Overall Study|Death|11|||
94409858|NCT04149535|323284909|FG001|Overall Study|Death|7|||
94409859|NCT04149535|323284908|FG000|Overall Study|Physician Decision|10|||
94409860|NCT04149535|323284909|FG001|Overall Study|Physician Decision|4|||
94409861|NCT04149535|323284908|FG000|Overall Study|Withdrawal by Subject|6|||
94409862|NCT04149535|323284909|FG001|Overall Study|Withdrawal by Subject|7|||
94409863|NCT04149535|323284908|FG000|Overall Study|Not described|2|||
94409864|NCT04149535|323284909|FG001|Overall Study|Not described|0|||
94409865|NCT02293460|323286177|FG000|Overall Study|Protocol Violation|1|||
94409866|NCT02293460|323286177|FG000|Overall Study|Lack of Efficacy|2|||
94409867|NCT02293460|323286177|FG000|Overall Study|Adverse Event|2|||
94409868|NCT02293460|323286177|FG000|Overall Study|Withdrawal by Subject|1|||
94409869|NCT00500318|323286178|FG000|Overall Study|Adverse Event|3|||
94409870|NCT00500318|323286179|FG001|Overall Study|Adverse Event|8|||
94409871|NCT00500318|323286178|FG000|Overall Study|Protocol Violation|1|||
94409872|NCT00500318|323286179|FG001|Overall Study|Protocol Violation|3|||
94409873|NCT00500318|323286178|FG000|Overall Study|Withdrawal by Subject|1|||
94409874|NCT00500318|323286179|FG001|Overall Study|Withdrawal by Subject|2|||
94409875|NCT00500318|323286178|FG000|Overall Study|Lack of Efficacy|0|||
94409876|NCT00500318|323286179|FG001|Overall Study|Lack of Efficacy|3|||
94409877|NCT00500318|323286178|FG000|Overall Study|Other Reason|0|||
94409878|NCT00500318|323286179|FG001|Overall Study|Other Reason|1|||
94409879|NCT02415387|323286189|FG000|Overall Study|Withdrawal by Subject|6|||
94409880|NCT02415387|323286190|FG001|Overall Study|Withdrawal by Subject|1|||
94409881|NCT02415387|323286189|FG000|Overall Study|blood draw problem|0|||
94409882|NCT02415387|323286190|FG001|Overall Study|blood draw problem|1|||
94409883|NCT02415387|323286189|FG000|Overall Study|Protocol Violation|1|||
94409884|NCT02415387|323286190|FG001|Overall Study|Protocol Violation|0|||
94409885|NCT01765751|323286195|FG000|Overall Study|Lost to Follow-up|0|||
94409886|NCT01765751|323286196|FG001|Overall Study|Lost to Follow-up|2|||
94409887|NCT01765751|323286197|FG002|Overall Study|Lost to Follow-up|1|||
94409888|NCT02839798|323286198|FG000|Overall Study|Withdrawal by Subject|2|||
94409889|NCT02447887|323286199|FG000|Overall Study|Study was terminated|3|||
94409890|NCT00653159|323286201|FG000|Overall Study|Adverse Event|4|||
94409891|NCT00653159|323286202|FG001|Overall Study|Adverse Event|1|||
94409892|NCT00653159|323286201|FG000|Overall Study|Lost to Follow-up|1|||
94409893|NCT00653159|323286202|FG001|Overall Study|Lost to Follow-up|2|||
94409894|NCT00109837|323286203|FG000|Overall Study|Adverse Event|2|||
94409895|NCT00109837|323286203|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
94409896|NCT00109837|323286203|FG000|Overall Study|Death|1|||
94409897|NCT00109837|323286203|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
94409898|NCT00109837|323286203|FG000|Overall Study|Not treated|1|||
94409899|NCT00109837|323286203|FG000|Overall Study|Ineligible|1|||
94409900|NCT03431337|323286204|FG000|Overall Study|Lost to Follow-up|21|||
94409901|NCT03431337|323286205|FG001|Overall Study|Lost to Follow-up|19|||
94409902|NCT03431337|323286204|FG000|Overall Study|Withdrawal by Subject|8|||
94409903|NCT03431337|323286205|FG001|Overall Study|Withdrawal by Subject|3|||
94409904|NCT00329160|323286208|FG000|Overall Study|Adverse Event|27|||
94409905|NCT00329160|323286208|FG000|Overall Study|Withdrawal by Subject|13|||
94409906|NCT00329160|323286208|FG000|Overall Study|Protocol Violation|2|||
94409907|NCT00329160|323286208|FG000|Overall Study|Did not Receive Study Drug|1|||
94409908|NCT00329160|323286208|FG000|Overall Study|Incomplete IVUS|45|||
94409909|NCT04501094|323286209|FG000|Overall Study|Death (unrelated to research)|1|||
94409910|NCT04501094|323286210|FG001|Overall Study|Death (unrelated to research)|0|||
94409911|NCT00063258|323286213|FG000|Overall Study|Physician Decision|2|||
94409912|NCT00063258|323286214|FG001|Overall Study|Physician Decision|0|||
94409913|NCT00063258|323286213|FG000|Overall Study|Lack of Efficacy|2|||
94409914|NCT00063258|323286214|FG001|Overall Study|Lack of Efficacy|0|||
94409915|NCT03941834|323286215|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
94409916|NCT03941834|323286216|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
94409917|NCT03941834|323286217|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
94409918|NCT03941834|323286215|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
94409919|NCT03941834|323286216|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
94409920|NCT03941834|323286217|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
94409921|NCT03941834|323286215|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
94409922|NCT03941834|323286216|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
94409923|NCT03941834|323286217|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
94409924|NCT03941834|323286215|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
94409925|NCT03941834|323286216|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
94409926|NCT03941834|323286217|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
94409927|NCT03941834|323286215|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
94409928|NCT03941834|323286216|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
94409929|NCT03941834|323286217|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
94409930|NCT03941834|323286215|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
94409931|NCT03941834|323286216|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
94409932|NCT03941834|323286217|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
94409933|NCT02426541|323286220|FG000|Overall Study|Protocol Violation|1|||
94409934|NCT02426541|323286221|FG001|Overall Study|Protocol Violation|0|||
94409935|NCT04241133|323286223|FG000|Overall Study|COVID19 Precautions|14|||
94409936|NCT04241133|323286224|FG001|Overall Study|COVID19 Precautions|34|||
94409937|NCT00631007|323286226|FG000|Overall Study|Adverse Event|0|||
94409938|NCT00631007|323286227|FG001|Overall Study|Adverse Event|2|||
94409939|NCT00631007|323286228|FG002|Overall Study|Adverse Event|0|||
94409940|NCT00631007|323286229|FG003|Overall Study|Adverse Event|2|||
94409941|NCT00631007|323286230|FG004|Overall Study|Adverse Event|3|||
94409942|NCT00631007|323286231|FG005|Overall Study|Adverse Event|2|||
94409943|NCT00631007|323286226|FG000|Overall Study|Lost to Follow-up|2|||
94409944|NCT00631007|323286227|FG001|Overall Study|Lost to Follow-up|1|||
94409945|NCT00631007|323286228|FG002|Overall Study|Lost to Follow-up|2|||
94409946|NCT00631007|323286229|FG003|Overall Study|Lost to Follow-up|4|||
94409947|NCT00631007|323286230|FG004|Overall Study|Lost to Follow-up|5|||
94409948|NCT00631007|323286231|FG005|Overall Study|Lost to Follow-up|3|||
94409949|NCT00631007|323286226|FG000|Overall Study|Physician Decision|1|||
94409950|NCT00631007|323286227|FG001|Overall Study|Physician Decision|0|||
94409951|NCT00631007|323286228|FG002|Overall Study|Physician Decision|1|||
94409952|NCT00631007|323286229|FG003|Overall Study|Physician Decision|0|||
94409953|NCT00631007|323286230|FG004|Overall Study|Physician Decision|0|||
94409954|NCT00631007|323286231|FG005|Overall Study|Physician Decision|2|||
94409955|NCT00631007|323286226|FG000|Overall Study|Persistent Hyperglycemia|2|||
94409956|NCT00631007|323286227|FG001|Overall Study|Persistent Hyperglycemia|2|||
94409957|NCT00631007|323286228|FG002|Overall Study|Persistent Hyperglycemia|5|||
94409958|NCT00631007|323286229|FG003|Overall Study|Persistent Hyperglycemia|1|||
94409959|NCT00631007|323286230|FG004|Overall Study|Persistent Hyperglycemia|2|||
94409960|NCT00631007|323286231|FG005|Overall Study|Persistent Hyperglycemia|5|||
94409961|NCT00631007|323286226|FG000|Overall Study|Withdrawal by Subject|4|||
94409962|NCT00631007|323286227|FG001|Overall Study|Withdrawal by Subject|5|||
94409963|NCT00631007|323286228|FG002|Overall Study|Withdrawal by Subject|2|||
94409964|NCT00631007|323286229|FG003|Overall Study|Withdrawal by Subject|2|||
94409965|NCT00631007|323286230|FG004|Overall Study|Withdrawal by Subject|1|||
94409966|NCT00631007|323286231|FG005|Overall Study|Withdrawal by Subject|3|||
94409967|NCT00631007|323286226|FG000|Overall Study|Other|2|||
94409968|NCT00631007|323286227|FG001|Overall Study|Other|1|||
94409969|NCT00631007|323286228|FG002|Overall Study|Other|0|||
94409970|NCT00631007|323286229|FG003|Overall Study|Other|0|||
94409971|NCT00631007|323286230|FG004|Overall Study|Other|1|||
94409972|NCT00631007|323286231|FG005|Overall Study|Other|0|||
94409973|NCT00460109|323286232|FG000|Overall Study|Death|1|||
94409974|NCT00412737|323286235|FG000|Overall Study|Death|1|||
94409975|NCT00412737|323286236|FG001|Overall Study|Death|0|||
94409976|NCT00412737|323286235|FG000|Overall Study|Adverse Event|3|||
94409977|NCT00412737|323286236|FG001|Overall Study|Adverse Event|2|||
94409978|NCT00412737|323286235|FG000|Overall Study|Refused Treatment|6|||
94409979|NCT00412737|323286236|FG001|Overall Study|Refused Treatment|2|||
94409980|NCT00412737|323286235|FG000|Overall Study|Failure to Return|6|||
94409981|NCT00412737|323286236|FG001|Overall Study|Failure to Return|2|||
94409982|NCT01064531|323286237|FG000|Overall Study|Lost to Follow-up|0|||
94409983|NCT01064531|323286238|FG001|Overall Study|Lost to Follow-up|2|||
94409984|NCT01064531|323286237|FG000|Overall Study|Physician Decision|0|||
94409985|NCT01064531|323286238|FG001|Overall Study|Physician Decision|1|||
94409986|NCT01064531|323286237|FG000|Overall Study|Withdrawal by Subject|2|||
94486695|NCT01130272|323575286|FG001|Overall Study|Physician Decision|1|||
94486696|NCT01130272|323575287|FG002|Overall Study|Physician Decision|0|||
94486697|NCT01130272|323575288|FG003|Overall Study|Physician Decision|1|||
94486698|NCT01130272|323575289|FG004|Overall Study|Physician Decision|2|||
94486699|NCT01130272|323575285|FG000|Overall Study|Sponsor decision|6|||
94486700|NCT01130272|323575286|FG001|Overall Study|Sponsor decision|15|||
94486701|NCT01130272|323575287|FG002|Overall Study|Sponsor decision|16|||
94486702|NCT01130272|323575288|FG003|Overall Study|Sponsor decision|13|||
94486703|NCT01130272|323575289|FG004|Overall Study|Sponsor decision|16|||
94486704|NCT01130272|323575285|FG000|Overall Study|Study arm discontinued|38|||
94486705|NCT01130272|323575286|FG001|Overall Study|Study arm discontinued|0|||
94486706|NCT01130272|323575287|FG002|Overall Study|Study arm discontinued|0|||
94486707|NCT01130272|323575288|FG003|Overall Study|Study arm discontinued|0|||
94486708|NCT01130272|323575289|FG004|Overall Study|Study arm discontinued|0|||
94486709|NCT01548404|323575290|FG000|Overall Study|Adverse Event|3|||
94486710|NCT01548404|323575291|FG001|Overall Study|Adverse Event|1|||
94486711|NCT01548404|323575290|FG000|Overall Study|Physician Decision|2|||
94486712|NCT01548404|323575291|FG001|Overall Study|Physician Decision|1|||
94486713|NCT01548404|323575290|FG000|Overall Study|Inadequate response to study treatment|23|||
94486714|NCT01548404|323575291|FG001|Overall Study|Inadequate response to study treatment|7|||
94486715|NCT01548404|323575290|FG000|Overall Study|Lost to Follow-up|2|||
94486716|NCT01548404|323575291|FG001|Overall Study|Lost to Follow-up|0|||
94486717|NCT01548404|323575290|FG000|Overall Study|Withdrawal by Subject|0|||
94486718|NCT01548404|323575291|FG001|Overall Study|Withdrawal by Subject|3|||
94486719|NCT01548404|323575290|FG000|Overall Study|Other than specified above|0|||
94486720|NCT01548404|323575291|FG001|Overall Study|Other than specified above|2|||
94486721|NCT00641056|323575292|FG000|Overall Study|Adverse Event|12|||
94486722|NCT00641056|323575293|FG001|Overall Study|Adverse Event|2|||
94486723|NCT00641056|323575292|FG000|Overall Study|Lost to Follow-up|2|||
94486724|NCT00641056|323575293|FG001|Overall Study|Lost to Follow-up|1|||
94486725|NCT00641056|323575292|FG000|Overall Study|Physician Decision|3|||
94486726|NCT00641056|323575293|FG001|Overall Study|Physician Decision|1|||
94486727|NCT00641056|323575292|FG000|Overall Study|Protocol Violation|2|||
94486728|NCT00641056|323575293|FG001|Overall Study|Protocol Violation|0|||
94486729|NCT00641056|323575292|FG000|Overall Study|Entry Criteria Not Met|3|||
94486730|NCT00641056|323575293|FG001|Overall Study|Entry Criteria Not Met|0|||
94486731|NCT00641056|323575292|FG000|Overall Study|Subject Decision|6|||
94486732|NCT00641056|323575293|FG001|Overall Study|Subject Decision|19|||
94486733|NCT00641056|323575292|FG000|Overall Study|Sponsor Decision|1|||
94486734|NCT00641056|323575293|FG001|Overall Study|Sponsor Decision|2|||
94486735|NCT00239720|323575294|FG000|Overall Study|Adverse Event|1|||
94486736|NCT00239720|323575295|FG001|Overall Study|Adverse Event|0|||
94486737|NCT00239720|323575294|FG000|Overall Study|Lost to Follow-up|0|||
94486738|NCT00239720|323575295|FG001|Overall Study|Lost to Follow-up|1|||
94486739|NCT00368251|323575296|FG000|Overall Study|SAE, non-fatal|1|||
94486740|NCT00368251|323575297|FG001|Overall Study|SAE, non-fatal|0|||
94486741|NCT00368251|323575298|FG002|Overall Study|SAE, non-fatal|0|||
94486742|NCT00368251|323575296|FG000|Overall Study|AE, non-serious non-fatal|0|||
94486743|NCT00368251|323575297|FG001|Overall Study|AE, non-serious non-fatal|0|||
94486744|NCT00368251|323575298|FG002|Overall Study|AE, non-serious non-fatal|1|||
94486745|NCT01699750|323575300|FG000|Overall Study|Withdrew Consent|0|||
94486746|NCT01699750|323575301|FG001|Overall Study|Withdrew Consent|1|||
94486747|NCT01699750|323575300|FG000|Overall Study|Other|0|||
94486748|NCT01699750|323575301|FG001|Overall Study|Other|2|||
94486749|NCT02452047|323575302|FG000|Overall Study|Adverse Event|0|||
94486750|NCT02452047|323575303|FG001|Overall Study|Adverse Event|1|||
94486751|NCT02452047|323575304|FG002|Overall Study|Adverse Event|1|||
94486752|NCT02452047|323575302|FG000|Overall Study|Death|1|||
94486753|NCT02452047|323575303|FG001|Overall Study|Death|3|||
94486754|NCT02452047|323575304|FG002|Overall Study|Death|1|||
94486755|NCT02452047|323575302|FG000|Overall Study|Physician Decision|1|||
94486756|NCT02452047|323575303|FG001|Overall Study|Physician Decision|0|||
94486757|NCT02452047|323575304|FG002|Overall Study|Physician Decision|0|||
94486758|NCT02452047|323575302|FG000|Overall Study|Lost to Follow-up|1|||
94486759|NCT02452047|323575303|FG001|Overall Study|Lost to Follow-up|1|||
94486760|NCT02452047|323575304|FG002|Overall Study|Lost to Follow-up|0|||
94486761|NCT02452047|323575302|FG000|Overall Study|Withdrawal by Subject|1|||
94486762|NCT02452047|323575303|FG001|Overall Study|Withdrawal by Subject|0|||
94486763|NCT02452047|323575304|FG002|Overall Study|Withdrawal by Subject|0|||
94486764|NCT01739335|323575305|FG000|Overall Study|Lost to Follow-up|7|||
94486765|NCT01739335|323575306|FG001|Overall Study|Lost to Follow-up|4|||
94486766|NCT01739335|323575305|FG000|Overall Study|Ineligible patient randomized|0|||
94486767|NCT01739335|323575306|FG001|Overall Study|Ineligible patient randomized|1|||
94486768|NCT00288912|323575308|FG000|Overall Study|Developed exclusion criterion|4|||
94486769|NCT00288912|323575309|FG001|Overall Study|Developed exclusion criterion|6|||
94486770|NCT00288912|323575310|FG002|Overall Study|Developed exclusion criterion|7|||
94486771|NCT00288912|323575308|FG000|Overall Study|Lost to Follow-up|9|||
94486772|NCT00288912|323575309|FG001|Overall Study|Lost to Follow-up|6|||
94486773|NCT00288912|323575310|FG002|Overall Study|Lost to Follow-up|9|||
94486774|NCT00288912|323575308|FG000|Overall Study|Withdrawal by Subject|4|||
94486775|NCT00288912|323575309|FG001|Overall Study|Withdrawal by Subject|5|||
94486776|NCT00288912|323575310|FG002|Overall Study|Withdrawal by Subject|12|||
94486777|NCT03312738|323575312|FG000|Overall Study|Progressive disease|58|||
94486778|NCT03312738|323575313|FG001|Overall Study|Progressive disease|67|||
94486779|NCT03312738|323575312|FG000|Overall Study|Patient/guardian decision|13|||
94486780|NCT03312738|323575313|FG001|Overall Study|Patient/guardian decision|5|||
94486781|NCT03312738|323575312|FG000|Overall Study|Adverse Event|5|||
94486782|NCT03312738|323575313|FG001|Overall Study|Adverse Event|3|||
94486783|NCT03312738|323575312|FG000|Overall Study|Protocol deviation|2|||
94486784|NCT03312738|323575313|FG001|Overall Study|Protocol deviation|0|||
94486785|NCT03312738|323575312|FG000|Overall Study|Technical problems|0|||
94486786|NCT03312738|323575313|FG001|Overall Study|Technical problems|1|||
94486787|NCT03312738|323575312|FG000|Overall Study|Physician Decision|2|||
94486788|NCT03312738|323575313|FG001|Overall Study|Physician Decision|3|||
94486789|NCT02026141|323575317|FG000|Overall Study|Protocol Violation|0|||
94486790|NCT02026141|323575318|FG001|Overall Study|Protocol Violation|1|||
94486791|NCT01248455|323575319|FG000|Overall Study|switched to alternate treatment|1|||
94486792|NCT01309386|323575320|FG000|Overall Study|Other|2|||
94486793|NCT01309386|323575321|FG001|Overall Study|Other|0|||
94486794|NCT01309386|323575320|FG000|Overall Study|Withdrawal by Subject|2|||
94486795|NCT01309386|323575321|FG001|Overall Study|Withdrawal by Subject|0|||
94486796|NCT01309386|323575320|FG000|Overall Study|Progressive disease|9|||
94486797|NCT01309386|323575321|FG001|Overall Study|Progressive disease|11|||
94486798|NCT01309386|323575320|FG000|Overall Study|Physician Decision|1|||
94486799|NCT01309386|323575321|FG001|Overall Study|Physician Decision|1|||
94486800|NCT01309386|323575320|FG000|Overall Study|Lack of Efficacy|3|||
94486801|NCT01309386|323575321|FG001|Overall Study|Lack of Efficacy|1|||
94486802|NCT01309386|323575320|FG000|Overall Study|Adverse Event|5|||
94486803|NCT01309386|323575321|FG001|Overall Study|Adverse Event|8|||
94486804|NCT01783743|323575322|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
94486805|NCT01783743|323575323|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
94486806|NCT01783743|323575322|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
94486807|NCT01783743|323575323|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
94486808|NCT01783743|323575322|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
94486809|NCT01783743|323575323|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
94486810|NCT01607593|323575324|FG000|Overall Study|Adverse Event|15|||
94486811|NCT01607593|323575324|FG000|Overall Study|Lack of Efficacy|16|||
94486812|NCT01607593|323575324|FG000|Overall Study|Lost to Follow-up|25|||
94409987|NCT01064531|323286238|FG001|Overall Study|Withdrawal by Subject|2|||
94409988|NCT01064531|323286237|FG000|Overall Study|Revision due to femoral stem loosening|1|||
94409989|NCT01064531|323286238|FG001|Overall Study|Revision due to femoral stem loosening|0|||
94409990|NCT01064531|323286237|FG000|Overall Study|Revision due to dislocation|0|||
94409991|NCT01064531|323286238|FG001|Overall Study|Revision due to dislocation|1|||
94409992|NCT01064531|323286237|FG000|Overall Study|Death|0|||
94409993|NCT01064531|323286238|FG001|Overall Study|Death|1|||
94409994|NCT00981799|323286239|FG000|Overall Study|Adverse Event|1|||
94409995|NCT00981799|323286240|FG001|Overall Study|Adverse Event|1|||
94409996|NCT00981799|323286241|FG002|Overall Study|Adverse Event|0|||
94409997|NCT00981799|323286242|FG003|Overall Study|Adverse Event|0|||
94409998|NCT04745676|323286245|FG000|Overall Study|Death|1|||
94409999|NCT04745676|323286246|FG001|Overall Study|Death|0|||
94410000|NCT04745676|323286247|FG002|Overall Study|Death|0|||
94410001|NCT04364763|323286248|FG000|Overall Study|Death|1|||
94410002|NCT04364763|323286249|FG001|Overall Study|Death|2|||
94410003|NCT04364763|323286248|FG000|Overall Study|Lost to Follow-up|1|||
94410004|NCT04364763|323286249|FG001|Overall Study|Lost to Follow-up|0|||
94410005|NCT00090753|323286250|FG000|First Treatment Period|Adverse Event|20|||
94410006|NCT00090753|323286251|FG001|First Treatment Period|Adverse Event|8|||
94410007|NCT00090753|323286250|FG000|First Treatment Period|Death|88|||
94410008|NCT00090753|323286251|FG001|First Treatment Period|Death|62|||
94410009|NCT00090753|323286250|FG000|First Treatment Period|Lack of Efficacy|2|||
94486813|NCT01607593|323575324|FG000|Overall Study|Continuation|33|||
94410010|NCT00090753|323286251|FG001|First Treatment Period|Lack of Efficacy|1|||
94410011|NCT00090753|323286250|FG000|First Treatment Period|Refused Treatment|32|||
94410012|NCT00090753|323286251|FG001|First Treatment Period|Refused Treatment|25|||
94410013|NCT00090753|323286250|FG000|First Treatment Period|Lost to Follow-up|4|||
94410014|NCT00090753|323286251|FG001|First Treatment Period|Lost to Follow-up|4|||
94410015|NCT00090753|323286250|FG000|First Treatment Period|Renal Transplant|70|||
94410016|NCT00090753|323286251|FG001|First Treatment Period|Renal Transplant|50|||
94410017|NCT00090753|323286250|FG000|First Treatment Period|Mircera Commercialization|1|||
94410018|NCT00090753|323286251|FG001|First Treatment Period|Mircera Commercialization|0|||
94410019|NCT00090753|323286250|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
94410020|NCT00090753|323286251|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
94486814|NCT01607593|323575324|FG000|Overall Study|Other|4|||
94486815|NCT02062437|323575325|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
94410021|NCT00090753|323286250|FG000|Extended Treatment Period|Adverse Event|11|||
94410022|NCT00090753|323286251|FG001|Extended Treatment Period|Adverse Event|0|||
94410023|NCT00090753|323286250|FG000|Extended Treatment Period|Death|58|||
94410024|NCT00090753|323286251|FG001|Extended Treatment Period|Death|30|||
94410025|NCT00090753|323286250|FG000|Extended Treatment Period|Lack of Efficacy|1|||
94410026|NCT00090753|323286251|FG001|Extended Treatment Period|Lack of Efficacy|0|||
94410027|NCT00090753|323286250|FG000|Extended Treatment Period|Refused Treatment|18|||
94410028|NCT00090753|323286251|FG001|Extended Treatment Period|Refused Treatment|12|||
94410029|NCT00090753|323286250|FG000|Extended Treatment Period|Lost to Follow-up|3|||
94410030|NCT00090753|323286251|FG001|Extended Treatment Period|Lost to Follow-up|1|||
94410031|NCT00090753|323286250|FG000|Extended Treatment Period|Renal Transplant|15|||
94410032|NCT00090753|323286251|FG001|Extended Treatment Period|Renal Transplant|12|||
94410033|NCT00090753|323286250|FG000|Extended Treatment Period|Mircera Commercialization|188|||
94410034|NCT00090753|323286251|FG001|Extended Treatment Period|Mircera Commercialization|93|||
94410035|NCT00090753|323286250|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
94410036|NCT00090753|323286251|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
94410037|NCT01086969|323286252|FG000|Overall Study|Withdrawal by Subject|1|||
94410038|NCT01086969|323286253|FG001|Overall Study|Withdrawal by Subject|2|||
94410039|NCT01086969|323286254|FG002|Overall Study|Withdrawal by Subject|0|||
94410040|NCT01808248|323286257|FG000|Overall Study|Lack of Efficacy|3|||
94410041|NCT01808248|323286257|FG000|Overall Study|Withdrawal by Subject|1|||
94410042|NCT01808248|323286257|FG000|Overall Study|Lost to Follow-up|1|||
94410043|NCT01009515|323286259|FG000|Overall Study|Withdrawal by Subject|3|||
94410044|NCT01175473|323286260|FG000|Overall Study|Adverse Event|2|||
94410045|NCT01175473|323286261|FG001|Overall Study|Adverse Event|2|||
94410046|NCT02020967|323286264|FG000|Overall Study|Withdrawal by Subject|51|||
94410047|NCT00109850|323286265|FG000|Overall Study|Adverse Event|1|||
94410048|NCT00109850|323286265|FG000|Overall Study|Death|2|||
94410049|NCT00109850|323286265|FG000|Overall Study|Ineligible|1|||
94410050|NCT03430011|323286267|FG000|Pre-Treatment|Death|1|||
94410051|NCT03430011|323286268|FG001|Pre-Treatment|Death|0|||
94410052|NCT03430011|323286269|FG002|Pre-Treatment|Death|0|||
94410053|NCT03430011|323286270|FG003|Pre-Treatment|Death|0|||
94410054|NCT03430011|323286271|FG004|Pre-Treatment|Death|1|||
94410055|NCT03430011|323286272|FG005|Pre-Treatment|Death|0|||
94410056|NCT03430011|323286273|FG006|Pre-Treatment|Death|1|||
94410057|NCT03430011|323286274|FG007|Pre-Treatment|Death|0|||
94410058|NCT03430011|323286267|FG000|Pre-Treatment|Screen Fail|0|||
94410059|NCT03430011|323286268|FG001|Pre-Treatment|Screen Fail|0|||
94410060|NCT03430011|323286269|FG002|Pre-Treatment|Screen Fail|0|||
94410061|NCT03430011|323286270|FG003|Pre-Treatment|Screen Fail|0|||
94410062|NCT03430011|323286271|FG004|Pre-Treatment|Screen Fail|1|||
94410063|NCT03430011|323286272|FG005|Pre-Treatment|Screen Fail|0|||
94410064|NCT03430011|323286273|FG006|Pre-Treatment|Screen Fail|0|||
94410065|NCT03430011|323286274|FG007|Pre-Treatment|Screen Fail|0|||
94410066|NCT03430011|323286267|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
94410067|NCT03430011|323286268|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
94410068|NCT03430011|323286269|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
94410069|NCT03430011|323286270|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
94410070|NCT03430011|323286271|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
94410071|NCT03430011|323286272|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
94410072|NCT03430011|323286273|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
94410073|NCT03430011|323286274|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
94410074|NCT03430011|323286267|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
94410075|NCT03430011|323286268|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
94410076|NCT03430011|323286269|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
94410077|NCT03430011|323286270|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
94410078|NCT03430011|323286271|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
94410079|NCT03430011|323286272|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
94410080|NCT03430011|323286273|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
94410081|NCT03430011|323286274|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
94410082|NCT03430011|323286267|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
94410083|NCT03430011|323286268|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
94410084|NCT03430011|323286269|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
94410085|NCT03430011|323286270|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
94410086|NCT03430011|323286271|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
94410087|NCT03430011|323286272|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
94410088|NCT03430011|323286273|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
94410089|NCT03430011|323286274|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
94410090|NCT03430011|323286267|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
94410091|NCT03430011|323286268|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
94410092|NCT03430011|323286269|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
94410093|NCT03430011|323286270|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
94410094|NCT03430011|323286271|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
94410095|NCT03430011|323286272|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
94410096|NCT03430011|323286273|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
94410097|NCT03430011|323286274|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
94410098|NCT03430011|323286267|FG000|JCARH125 Treatment|Death|4|||
94410099|NCT03430011|323286268|FG001|JCARH125 Treatment|Death|19|||
94410100|NCT03430011|323286269|FG002|JCARH125 Treatment|Death|10|||
94410101|NCT03430011|323286270|FG003|JCARH125 Treatment|Death|8|||
94410102|NCT03430011|323286271|FG004|JCARH125 Treatment|Death|5|||
94410103|NCT03430011|323286272|FG005|JCARH125 Treatment|Death|3|||
94410104|NCT03430011|323286273|FG006|JCARH125 Treatment|Death|4|||
94410105|NCT03430011|323286274|FG007|JCARH125 Treatment|Death|2|||
94410106|NCT03430011|323286267|FG000|JCARH125 Treatment|Other reasons|1|||
94410107|NCT03430011|323286268|FG001|JCARH125 Treatment|Other reasons|0|||
94410108|NCT03430011|323286269|FG002|JCARH125 Treatment|Other reasons|4|||
94410109|NCT03430011|323286270|FG003|JCARH125 Treatment|Other reasons|2|||
94410110|NCT03430011|323286271|FG004|JCARH125 Treatment|Other reasons|2|||
94410111|NCT03430011|323286272|FG005|JCARH125 Treatment|Other reasons|1|||
94410112|NCT03430011|323286273|FG006|JCARH125 Treatment|Other reasons|3|||
94410113|NCT03430011|323286274|FG007|JCARH125 Treatment|Other reasons|2|||
94410114|NCT00575380|323286275|FG000|Overall Study|Withdrawal by Subject|1|||
94410115|NCT00575380|323286276|FG001|Overall Study|Withdrawal by Subject|0|||
94410116|NCT00575380|323286275|FG000|Overall Study|Adverse Event|0|||
94410117|NCT00575380|323286276|FG001|Overall Study|Adverse Event|1|||
94410118|NCT00575380|323286275|FG000|Overall Study|Various|0|||
94410119|NCT00575380|323286276|FG001|Overall Study|Various|2|||
94410120|NCT00559364|323286277|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
94410121|NCT00559364|323286278|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
94410122|NCT01857973|323286279|FG000|Overall Study|Subject did not meet required BG range|3|||
94410123|NCT01857973|323286279|FG000|Overall Study|drop out after 3 failed attempts|1|||
94410124|NCT01857973|323286279|FG000|Overall Study|Physician Decision|1|||
94410125|NCT02663882|323286280|FG000|Overall Study|Lost to Follow-up|4|||
94410126|NCT02663882|323286281|FG001|Overall Study|Lost to Follow-up|2|||
94410127|NCT00271024|323286288|FG000|Overall Study|Lost Interest|3|||
94410128|NCT00271024|323286289|FG001|Overall Study|Lost Interest|4|||
94410129|NCT00271024|323286290|FG002|Overall Study|Lost Interest|2|||
94410130|NCT00271024|323286291|FG003|Overall Study|Lost Interest|3|||
94410131|NCT00271024|323286288|FG000|Overall Study|Unknown/Unspecified|11|||
94410132|NCT00271024|323286289|FG001|Overall Study|Unknown/Unspecified|11|||
94410133|NCT00271024|323286290|FG002|Overall Study|Unknown/Unspecified|8|||
94410134|NCT00271024|323286291|FG003|Overall Study|Unknown/Unspecified|4|||
94410135|NCT00271024|323286288|FG000|Overall Study|Protocol Violation|1|||
94410136|NCT00271024|323286289|FG001|Overall Study|Protocol Violation|6|||
94410137|NCT00271024|323286290|FG002|Overall Study|Protocol Violation|5|||
94410138|NCT00271024|323286291|FG003|Overall Study|Protocol Violation|11|||
94410139|NCT00271024|323286288|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
94410140|NCT00271024|323286289|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
94410141|NCT00271024|323286290|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
94410142|NCT00271024|323286291|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
94410143|NCT00271024|323286288|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
94410144|NCT00271024|323286289|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
94410145|NCT00271024|323286290|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
94410146|NCT00271024|323286291|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
94410147|NCT00602537|323286292|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
94410148|NCT00602537|323286293|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
94410149|NCT00602537|323286292|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
94410150|NCT00602537|323286293|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
94410151|NCT00602537|323286292|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
94410152|NCT00602537|323286293|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
94410153|NCT00602537|323286292|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
94410154|NCT00602537|323286293|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
94410155|NCT00602537|323286292|FG000|Follow Up Study Comparison|Adverse Event|1|||
94410156|NCT00602537|323286293|FG001|Follow Up Study Comparison|Adverse Event|0|||
94410157|NCT00602537|323286292|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
94410158|NCT00602537|323286293|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
94410159|NCT00602537|323286292|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
94410160|NCT00602537|323286293|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
94410161|NCT02539368|323286294|FG000|Overall Study|Death|4|||
94410162|NCT02539368|323286295|FG001|Overall Study|Death|2|||
94410163|NCT02539368|323286296|FG002|Overall Study|Death|1|||
94410164|NCT02539368|323286297|FG003|Overall Study|Death|0|||
94410165|NCT02539368|323286298|FG004|Overall Study|Death|0|||
94410166|NCT02539368|323286294|FG000|Overall Study|Withdrawal by Subject|44|||
94410167|NCT02539368|323286295|FG001|Overall Study|Withdrawal by Subject|35|||
94410168|NCT02539368|323286296|FG002|Overall Study|Withdrawal by Subject|9|||
94410169|NCT02539368|323286297|FG003|Overall Study|Withdrawal by Subject|1|||
94410170|NCT02539368|323286298|FG004|Overall Study|Withdrawal by Subject|3|||
94410171|NCT02539368|323286294|FG000|Overall Study|Physician Decision|49|||
94410172|NCT02539368|323286295|FG001|Overall Study|Physician Decision|15|||
94486816|NCT02062437|323575325|FG000|Overall Study|Patient not available for the 2y visit|18|||
94486817|NCT02062437|323575325|FG000|Overall Study|Death|2|||
94486818|NCT02062437|323575325|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
94486819|NCT02900352|323575328|FG000|Overall Study|Lost to Follow-up|28|||
94486820|NCT02900352|323575329|FG001|Overall Study|Lost to Follow-up|17|||
94486821|NCT00752089|323575330|FG000|Overall Study|Adverse Event|1|||
94486822|NCT00752089|323575330|FG000|Overall Study|Protocol Deviation|2|||
94486823|NCT00752089|323575330|FG000|Overall Study|Could not attend visit 9|1|||
94486824|NCT00752089|323575330|FG000|Overall Study|Not capable of wearing partial denture|1|||
94486825|NCT00752089|323575330|FG000|Overall Study|Cannot continue the study|1|||
94486826|NCT01774981|323575331|FG000|Overall Study|Adverse Event|0|||
94486827|NCT01774981|323575332|FG001|Overall Study|Adverse Event|0|||
94486828|NCT01774981|323575333|FG002|Overall Study|Adverse Event|0|||
94486829|NCT01774981|323575334|FG003|Overall Study|Adverse Event|0|||
94486830|NCT01774981|323575335|FG004|Overall Study|Adverse Event|0|||
94486831|NCT01774981|323575336|FG005|Overall Study|Adverse Event|1|||
94486832|NCT01774981|323575337|FG006|Overall Study|Adverse Event|0|||
94486833|NCT01774981|323575338|FG007|Overall Study|Adverse Event|0|||
94486834|NCT01774981|323575331|FG000|Overall Study|Withdrawal by Subject|0|||
94486835|NCT01774981|323575332|FG001|Overall Study|Withdrawal by Subject|0|||
94486836|NCT01774981|323575333|FG002|Overall Study|Withdrawal by Subject|0|||
94486837|NCT01774981|323575334|FG003|Overall Study|Withdrawal by Subject|0|||
94486838|NCT01774981|323575335|FG004|Overall Study|Withdrawal by Subject|0|||
94486839|NCT01774981|323575336|FG005|Overall Study|Withdrawal by Subject|0|||
94486840|NCT01774981|323575337|FG006|Overall Study|Withdrawal by Subject|0|||
94486841|NCT01774981|323575338|FG007|Overall Study|Withdrawal by Subject|1|||
94486842|NCT01774981|323575331|FG000|Overall Study|Death|0|||
94486843|NCT01774981|323575332|FG001|Overall Study|Death|0|||
94486844|NCT01774981|323575333|FG002|Overall Study|Death|0|||
94486845|NCT01774981|323575334|FG003|Overall Study|Death|0|||
94486846|NCT01774981|323575335|FG004|Overall Study|Death|1|||
94486847|NCT01774981|323575336|FG005|Overall Study|Death|0|||
94486848|NCT01774981|323575337|FG006|Overall Study|Death|0|||
94486849|NCT01774981|323575338|FG007|Overall Study|Death|0|||
94486850|NCT00386334|323575339|FG000|Double Blind Period|Adverse Event|9|||
94486851|NCT00386334|323575340|FG001|Double Blind Period|Adverse Event|14|||
94486852|NCT00386334|323575339|FG000|Double Blind Period|Protocol Violation|1|||
94486853|NCT00386334|323575340|FG001|Double Blind Period|Protocol Violation|1|||
94486854|NCT00386334|323575339|FG000|Double Blind Period|Withdrawal by Subject|9|||
94486855|NCT00386334|323575340|FG001|Double Blind Period|Withdrawal by Subject|13|||
94486856|NCT00386334|323575339|FG000|Double Blind Period|Lack of Efficacy|20|||
94486857|NCT00386334|323575340|FG001|Double Blind Period|Lack of Efficacy|11|||
94486858|NCT00386334|323575339|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
94486859|NCT00386334|323575340|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
94486860|NCT00386334|323575339|FG000|Double Blind Period|Other|3|||
94486861|NCT00386334|323575340|FG001|Double Blind Period|Other|3|||
94486862|NCT00386334|323575339|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
94486863|NCT00386334|323575340|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
94486864|NCT01079780|323575341|FG000|Overall Study|Disease progression|43|||
94486865|NCT01079780|323575342|FG001|Overall Study|Disease progression|7|||
94486866|NCT01079780|323575343|FG002|Overall Study|Disease progression|31|||
94486867|NCT01079780|323575341|FG000|Overall Study|Adverse Event|13|||
94486868|NCT01079780|323575342|FG001|Overall Study|Adverse Event|5|||
94486869|NCT01079780|323575343|FG002|Overall Study|Adverse Event|7|||
94486870|NCT01079780|323575341|FG000|Overall Study|Death|2|||
94486871|NCT01079780|323575342|FG001|Overall Study|Death|0|||
94486872|NCT01079780|323575343|FG002|Overall Study|Death|2|||
94486873|NCT01079780|323575341|FG000|Overall Study|Withdrawal by Subject|6|||
94486874|NCT01079780|323575342|FG001|Overall Study|Withdrawal by Subject|4|||
94486875|NCT01079780|323575343|FG002|Overall Study|Withdrawal by Subject|4|||
94486876|NCT01079780|323575341|FG000|Overall Study|Alternative therapy|2|||
94486877|NCT01079780|323575342|FG001|Overall Study|Alternative therapy|0|||
94486878|NCT01079780|323575343|FG002|Overall Study|Alternative therapy|2|||
94486879|NCT01079780|323575341|FG000|Overall Study|Physician Decision|1|||
94486880|NCT01079780|323575342|FG001|Overall Study|Physician Decision|0|||
94486881|NCT01079780|323575343|FG002|Overall Study|Physician Decision|1|||
94486882|NCT01079780|323575341|FG000|Overall Study|Error made in lesion measurement|1|||
94486883|NCT01079780|323575342|FG001|Overall Study|Error made in lesion measurement|0|||
94486884|NCT01079780|323575343|FG002|Overall Study|Error made in lesion measurement|0|||
94486885|NCT01079780|323575341|FG000|Overall Study|Patient had surgery|1|||
94486886|NCT01079780|323575342|FG001|Overall Study|Patient had surgery|0|||
94486887|NCT01079780|323575343|FG002|Overall Study|Patient had surgery|0|||
94486888|NCT01079780|323575341|FG000|Overall Study|Treatment cycle delay|0|||
94486889|NCT01079780|323575342|FG001|Overall Study|Treatment cycle delay|0|||
94486890|NCT01079780|323575343|FG002|Overall Study|Treatment cycle delay|1|||
94486891|NCT01079780|323575341|FG000|Overall Study|Never started treatment|1|||
94486892|NCT01079780|323575342|FG001|Overall Study|Never started treatment|0|||
94486893|NCT01079780|323575343|FG002|Overall Study|Never started treatment|2|||
94486894|NCT00083915|323575344|FG000|Overall Study|Death|6|||
94486895|NCT00083915|323575345|FG001|Overall Study|Death|3|||
94486896|NCT00083915|323575344|FG000|Overall Study|Physician Decision|11|||
94486897|NCT00083915|323575345|FG001|Overall Study|Physician Decision|6|||
94486898|NCT00083915|323575344|FG000|Overall Study|Withdrawal by Subject|8|||
94486899|NCT00083915|323575345|FG001|Overall Study|Withdrawal by Subject|3|||
94486900|NCT00083915|323575344|FG000|Overall Study|disease progression|18|||
94486901|NCT00083915|323575345|FG001|Overall Study|disease progression|23|||
94486902|NCT00083915|323575344|FG000|Overall Study|Failure to collect|3|||
94486903|NCT00083915|323575345|FG001|Overall Study|Failure to collect|0|||
94486904|NCT00083915|323575344|FG000|Overall Study|No response|3|||
94486905|NCT00083915|323575345|FG001|Overall Study|No response|1|||
94486906|NCT00083915|323575344|FG000|Overall Study|Insurance issues|1|||
94486907|NCT00083915|323575345|FG001|Overall Study|Insurance issues|1|||
94486908|NCT00001566|323575346|FG000|Overall Study|patients' choice to discontinue protocol|3|||
94486909|NCT00001566|323575346|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
94486910|NCT00001566|323575346|FG000|Overall Study|Death|13|||
94486911|NCT00001566|323575346|FG000|Overall Study|Lost to Follow-up|1|||
94486912|NCT00001566|323575346|FG000|Overall Study|unable to complete initial apheresis|1|||
94486913|NCT00853762|323575350|FG000|Overall Study|Premature Termination|16|||
94486914|NCT00853762|323575351|FG001|Overall Study|Premature Termination|15|||
94486915|NCT00853762|323575352|FG002|Overall Study|Premature Termination|14|||
94486916|NCT00853762|323575353|FG003|Overall Study|Premature Termination|21|||
94486917|NCT00853762|323575350|FG000|Overall Study|Protocol Violation|0|||
94486918|NCT00853762|323575351|FG001|Overall Study|Protocol Violation|0|||
94486919|NCT00853762|323575352|FG002|Overall Study|Protocol Violation|0|||
94486920|NCT00853762|323575353|FG003|Overall Study|Protocol Violation|1|||
94486921|NCT00853762|323575350|FG000|Overall Study|Withdrawal by Subject|0|||
94486922|NCT00853762|323575351|FG001|Overall Study|Withdrawal by Subject|0|||
94486923|NCT00853762|323575352|FG002|Overall Study|Withdrawal by Subject|1|||
94486924|NCT00853762|323575353|FG003|Overall Study|Withdrawal by Subject|0|||
94486925|NCT00853762|323575350|FG000|Overall Study|Other|0|||
94486926|NCT00853762|323575351|FG001|Overall Study|Other|2|||
94486927|NCT00853762|323575352|FG002|Overall Study|Other|0|||
94486928|NCT00853762|323575353|FG003|Overall Study|Other|0|||
94486929|NCT00853762|323575350|FG000|Overall Study|Randomised but not Treated|0|||
94486930|NCT00853762|323575351|FG001|Overall Study|Randomised but not Treated|2|||
94486931|NCT00853762|323575352|FG002|Overall Study|Randomised but not Treated|2|||
94486932|NCT00853762|323575353|FG003|Overall Study|Randomised but not Treated|0|||
94486933|NCT02000921|323575356|FG000|Overall Study|Withdrawal by Subject|3|||
94486934|NCT02000921|323575357|FG001|Overall Study|Withdrawal by Subject|10|||
94486935|NCT02000921|323575358|FG002|Overall Study|Withdrawal by Subject|5|||
94486936|NCT02000921|323575356|FG000|Overall Study|Lost to Follow-up|2|||
94486937|NCT02000921|323575357|FG001|Overall Study|Lost to Follow-up|4|||
94486938|NCT02000921|323575358|FG002|Overall Study|Lost to Follow-up|5|||
94486939|NCT02000921|323575356|FG000|Overall Study|Physician Decision|0|||
94486940|NCT02000921|323575357|FG001|Overall Study|Physician Decision|2|||
94410173|NCT02539368|323286296|FG002|Overall Study|Physician Decision|7|||
94410174|NCT02539368|323286297|FG003|Overall Study|Physician Decision|0|||
94410175|NCT02539368|323286298|FG004|Overall Study|Physician Decision|2|||
94410176|NCT02539368|323286294|FG000|Overall Study|Lost to Follow-up|96|||
94410177|NCT02539368|323286295|FG001|Overall Study|Lost to Follow-up|21|||
94486941|NCT02000921|323575358|FG002|Overall Study|Physician Decision|0|||
94410178|NCT02539368|323286296|FG002|Overall Study|Lost to Follow-up|16|||
94410179|NCT02539368|323286297|FG003|Overall Study|Lost to Follow-up|4|||
94410180|NCT02539368|323286298|FG004|Overall Study|Lost to Follow-up|3|||
94410181|NCT02539368|323286294|FG000|Overall Study|Adverse Event|44|||
94410182|NCT02539368|323286295|FG001|Overall Study|Adverse Event|5|||
94410183|NCT02539368|323286296|FG002|Overall Study|Adverse Event|9|||
94410184|NCT02539368|323286297|FG003|Overall Study|Adverse Event|0|||
94410185|NCT02539368|323286298|FG004|Overall Study|Adverse Event|3|||
94410186|NCT02539368|323286294|FG000|Overall Study|Participant Non-compliant|13|||
94410187|NCT02539368|323286295|FG001|Overall Study|Participant Non-compliant|2|||
94410188|NCT02539368|323286296|FG002|Overall Study|Participant Non-compliant|1|||
94410189|NCT02539368|323286297|FG003|Overall Study|Participant Non-compliant|1|||
94410190|NCT02539368|323286298|FG004|Overall Study|Participant Non-compliant|0|||
94410191|NCT02539368|323286294|FG000|Overall Study|Other|145|||
94486942|NCT01663623|323575367|FG000|Overall Study|Adverse Event|3|||
94410192|NCT02539368|323286295|FG001|Overall Study|Other|18|||
94410193|NCT02539368|323286296|FG002|Overall Study|Other|24|||
94410194|NCT02539368|323286297|FG003|Overall Study|Other|1|||
94410195|NCT02539368|323286298|FG004|Overall Study|Other|3|||
94486943|NCT01663623|323575368|FG001|Overall Study|Adverse Event|7|||
94486944|NCT01663623|323575367|FG000|Overall Study|Lack of Efficacy|5|||
94486945|NCT01663623|323575368|FG001|Overall Study|Lack of Efficacy|6|||
94486946|NCT01663623|323575367|FG000|Overall Study|Protocol Violation|0|||
94486947|NCT01663623|323575368|FG001|Overall Study|Protocol Violation|1|||
94486948|NCT01663623|323575367|FG000|Overall Study|Other-Study closed/terminated|1|||
94486949|NCT01663623|323575368|FG001|Overall Study|Other-Study closed/terminated|1|||
94486950|NCT01663623|323575367|FG000|Overall Study|Physician Decision|1|||
94410196|NCT02539368|323286294|FG000|Overall Study|Missing|10|||
94410197|NCT02539368|323286295|FG001|Overall Study|Missing|3|||
94410198|NCT02539368|323286296|FG002|Overall Study|Missing|0|||
94410199|NCT02539368|323286297|FG003|Overall Study|Missing|0|||
94410200|NCT02539368|323286298|FG004|Overall Study|Missing|0|||
94410201|NCT04405739|323286304|FG000|Overall Study|Adverse Event|0|||
94410202|NCT04405739|323286305|FG001|Overall Study|Adverse Event|1|||
94410203|NCT04405739|323286306|FG002|Overall Study|Adverse Event|0|||
94410204|NCT04405739|323286307|FG003|Overall Study|Adverse Event|0|||
94410205|NCT04405739|323286304|FG000|Overall Study|Lost to Follow-up|0|||
94410206|NCT04405739|323286305|FG001|Overall Study|Lost to Follow-up|2|||
94410207|NCT04405739|323286306|FG002|Overall Study|Lost to Follow-up|1|||
94410208|NCT04405739|323286307|FG003|Overall Study|Lost to Follow-up|3|||
94410209|NCT04405739|323286304|FG000|Overall Study|Withdrawal by Subject|0|||
94410210|NCT04405739|323286305|FG001|Overall Study|Withdrawal by Subject|2|||
94410211|NCT04405739|323286306|FG002|Overall Study|Withdrawal by Subject|1|||
94410212|NCT04405739|323286307|FG003|Overall Study|Withdrawal by Subject|1|||
94410213|NCT04405739|323286304|FG000|Overall Study|Death|0|||
94410214|NCT04405739|323286305|FG001|Overall Study|Death|0|||
94410215|NCT04405739|323286306|FG002|Overall Study|Death|1|||
94410216|NCT04405739|323286307|FG003|Overall Study|Death|0|||
94410217|NCT04405739|323286304|FG000|Overall Study|Transferred to rehab|0|||
94410218|NCT04405739|323286305|FG001|Overall Study|Transferred to rehab|0|||
94410219|NCT04405739|323286306|FG002|Overall Study|Transferred to rehab|0|||
94410220|NCT04405739|323286307|FG003|Overall Study|Transferred to rehab|1|||
94410221|NCT04405739|323286304|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
94410222|NCT04405739|323286305|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
94410223|NCT04405739|323286306|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
94410224|NCT04405739|323286307|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
94410225|NCT01435928|323286309|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
94410226|NCT01435928|323286310|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
94410227|NCT01435928|323286311|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
94410228|NCT01435928|323286309|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
94410229|NCT01435928|323286310|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
94410230|NCT01435928|323286311|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
94410231|NCT01435928|323286309|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
94410232|NCT01435928|323286310|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
94410233|NCT01435928|323286311|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
94410234|NCT01435928|323286309|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
94410235|NCT01435928|323286310|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
94410236|NCT01435928|323286311|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
94410237|NCT01435928|323286309|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
94410238|NCT01435928|323286310|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
94410239|NCT01435928|323286311|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
94410240|NCT01435928|323286309|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
94410241|NCT01435928|323286310|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
94410242|NCT01435928|323286311|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
94410243|NCT01435928|323286309|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
94410244|NCT01435928|323286310|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
94410245|NCT01435928|323286311|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
94410246|NCT01435928|323286309|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
94410247|NCT01435928|323286310|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
94410248|NCT01435928|323286311|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
94410249|NCT01435928|323286309|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
94410250|NCT01435928|323286310|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
94410251|NCT01435928|323286311|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
94410252|NCT01435928|323286309|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
94410253|NCT01435928|323286310|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
94410254|NCT01435928|323286311|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
94410255|NCT01435928|323286309|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
94410256|NCT01435928|323286310|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
94410257|NCT01435928|323286311|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
94410258|NCT01435928|323286309|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
94410259|NCT01435928|323286310|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
94410260|NCT01435928|323286311|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
94410261|NCT01435928|323286309|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
94410262|NCT01435928|323286310|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
94410263|NCT01435928|323286311|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
94410264|NCT01435928|323286309|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
94410265|NCT01435928|323286310|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
94410266|NCT01435928|323286311|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
94486951|NCT01663623|323575368|FG001|Overall Study|Physician Decision|4|||
94410267|NCT01435928|323286309|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
94410268|NCT01435928|323286310|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
94410269|NCT01435928|323286311|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
94410270|NCT01435928|323286309|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
94410271|NCT01435928|323286310|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
94410272|NCT01435928|323286311|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
94410273|NCT04232540|323286315|FG000|Overall Study|Lost to Follow-up|1|||
94410274|NCT04232540|323286316|FG001|Overall Study|Lost to Follow-up|0|||
94410275|NCT03078478|323286321|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
94410276|NCT03078478|323286322|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
94410277|NCT03078478|323286321|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
94410278|NCT03078478|323286322|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
94410279|NCT03078478|323286321|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
94410280|NCT03078478|323286322|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
94410281|NCT03078478|323286321|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
94410282|NCT03078478|323286322|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
94410283|NCT03078478|323286321|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
94410284|NCT03078478|323286322|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
94410285|NCT03078478|323286321|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
94410286|NCT03078478|323286322|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
94410287|NCT03078478|323286321|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
94410288|NCT03078478|323286322|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
94410289|NCT03078478|323286321|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
94410290|NCT03078478|323286322|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
94410291|NCT01989676|323287891|FG000|Overall Study|Death|52|||
94410292|NCT01989676|323287892|FG001|Overall Study|Death|60|||
94410293|NCT01989676|323287891|FG000|Overall Study|Protocol Violation|2|||
94410294|NCT01989676|323287892|FG001|Overall Study|Protocol Violation|1|||
94410295|NCT01989676|323287891|FG000|Overall Study|Lost to Follow-up|8|||
94410296|NCT01989676|323287892|FG001|Overall Study|Lost to Follow-up|18|||
94410297|NCT01989676|323287891|FG000|Overall Study|No longer willing to participate in study|26|||
94410298|NCT01989676|323287892|FG001|Overall Study|No longer willing to participate in study|26|||
94410299|NCT01989676|323287891|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
94410300|NCT01989676|323287892|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
94410301|NCT01989676|323287891|FG000|Overall Study|Other|4|||
94410302|NCT01989676|323287892|FG001|Overall Study|Other|3|||
94410303|NCT00894933|323287893|FG000|Overall Study|Lost to Follow-up|2|||
94410304|NCT00894933|323287893|FG000|Overall Study|Cancelled Procedure|1|||
94410305|NCT00894933|323287893|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
94410306|NCT04403399|323287895|FG000|Period 2|Physician Decision|0|||
94410307|NCT04403399|323287896|FG001|Period 2|Physician Decision|1|||
94410308|NCT02014441|323287897|FG000|Overall Study|Withdrawal by Subject|12|||
94410309|NCT01363011|323287898|FG000|Main Study|Adverse Event|2|||
94410310|NCT01363011|323287899|FG001|Main Study|Adverse Event|3|||
94410311|NCT01363011|323287898|FG000|Main Study|Investigator's Discretion|1|||
94410312|NCT01363011|323287899|FG001|Main Study|Investigator's Discretion|1|||
94410313|NCT01363011|323287898|FG000|Main Study|Withdrew Consent|1|||
94410314|NCT01363011|323287899|FG001|Main Study|Withdrew Consent|4|||
94410315|NCT01363011|323287898|FG000|Main Study|Protocol Violation|0|||
94410316|NCT01363011|323287899|FG001|Main Study|Protocol Violation|1|||
94410317|NCT01363011|323287898|FG000|Extension Phase|Adverse Event|1|||
94410318|NCT01363011|323287899|FG001|Extension Phase|Adverse Event|1|||
94410319|NCT01363011|323287898|FG000|Extension Phase|Lack of Efficacy|0|||
94410320|NCT01363011|323287899|FG001|Extension Phase|Lack of Efficacy|1|||
94410321|NCT01363011|323287898|FG000|Extension Phase|Investigator's Discretion|2|||
94410322|NCT01363011|323287899|FG001|Extension Phase|Investigator's Discretion|2|||
94410323|NCT01363011|323287898|FG000|Extension Phase|Withdrew Consent|0|||
94410324|NCT01363011|323287899|FG001|Extension Phase|Withdrew Consent|1|||
94410325|NCT01363011|323287898|FG000|Extension Phase|Lost to Follow-up|0|||
94410326|NCT01363011|323287899|FG001|Extension Phase|Lost to Follow-up|2|||
94410327|NCT01363011|323287898|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
94410328|NCT01363011|323287899|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
94410329|NCT01901848|323287900|FG000|Randomized and Treated|Lost to Follow-up|3|||
94410330|NCT01901848|323287901|FG001|Randomized and Treated|Lost to Follow-up|6|||
94410331|NCT01901848|323287900|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
94410332|NCT01901848|323287901|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
94410333|NCT02668822|323287903|FG000|Overall Study|Protocol Violation|2|||
94410334|NCT02668822|323287904|FG001|Overall Study|Protocol Violation|0|||
94410335|NCT02668822|323287903|FG000|Overall Study|Study Terminated by Sponsor|7|||
94410336|NCT02668822|323287904|FG001|Overall Study|Study Terminated by Sponsor|9|||
94410337|NCT03042468|323287905|FG000|Overall Study|Death|0|||
94410338|NCT03042468|323287906|FG001|Overall Study|Death|1|||
94410339|NCT03042468|323287907|FG002|Overall Study|Death|1|||
94410340|NCT03042468|323287908|FG003|Overall Study|Death|0|||
94410341|NCT03042468|323287909|FG004|Overall Study|Death|0|||
94410342|NCT03042468|323287910|FG005|Overall Study|Death|0|||
94410343|NCT03042468|323287905|FG000|Overall Study|Withdrawal by Subject|0|||
94410344|NCT03042468|323287906|FG001|Overall Study|Withdrawal by Subject|0|||
94410345|NCT03042468|323287907|FG002|Overall Study|Withdrawal by Subject|0|||
94410346|NCT03042468|323287908|FG003|Overall Study|Withdrawal by Subject|0|||
94410347|NCT03042468|323287909|FG004|Overall Study|Withdrawal by Subject|0|||
94410348|NCT03042468|323287910|FG005|Overall Study|Withdrawal by Subject|1|||
94410349|NCT03042468|323287905|FG000|Overall Study|Lost to Follow-up|0|||
94410350|NCT03042468|323287906|FG001|Overall Study|Lost to Follow-up|0|||
94410351|NCT03042468|323287907|FG002|Overall Study|Lost to Follow-up|0|||
94410352|NCT03042468|323287908|FG003|Overall Study|Lost to Follow-up|0|||
94410353|NCT03042468|323287909|FG004|Overall Study|Lost to Follow-up|1|||
94410354|NCT03042468|323287910|FG005|Overall Study|Lost to Follow-up|1|||
94410355|NCT00684567|323287911|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
94410356|NCT00684567|323287911|FG000|Monotherapy Period|Adverse Event|2|||
94410357|NCT00684567|323287911|FG000|Monotherapy Period|Death|1|||
94410358|NCT00684567|323287911|FG000|Monotherapy Period|Progression of primary disease|11|||
94410359|NCT03136406|323287914|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
94410360|NCT00988208|323287917|FG000|Overall Study|Adverse Event|71|||
94410361|NCT00988208|323287918|FG001|Overall Study|Adverse Event|122|||
94410362|NCT00988208|323287917|FG000|Overall Study|Disease Progression|103|||
94410363|NCT00988208|323287918|FG001|Overall Study|Disease Progression|89|||
94410364|NCT00988208|323287917|FG000|Overall Study|Withdrawal by Subject|50|||
94410365|NCT00988208|323287918|FG001|Overall Study|Withdrawal by Subject|57|||
94410366|NCT00988208|323287917|FG000|Overall Study|Death|9|||
94410367|NCT00988208|323287918|FG001|Overall Study|Death|15|||
94410368|NCT00988208|323287917|FG000|Overall Study|Lost to Follow-up|2|||
94410369|NCT00988208|323287918|FG001|Overall Study|Lost to Follow-up|3|||
94410370|NCT00988208|323287917|FG000|Overall Study|Protocol Violation|9|||
94410371|NCT00988208|323287918|FG001|Overall Study|Protocol Violation|2|||
94410372|NCT00988208|323287917|FG000|Overall Study|Sponsor Decision|102|||
94410373|NCT00988208|323287918|FG001|Overall Study|Sponsor Decision|78|||
94410374|NCT00988208|323287917|FG000|Overall Study|Clinical Progression|17|||
94410375|NCT00988208|323287918|FG001|Overall Study|Clinical Progression|16|||
94410376|NCT00988208|323287917|FG000|Overall Study|Biochemical Progression|21|||
94410377|NCT00988208|323287918|FG001|Overall Study|Biochemical Progression|7|||
94410378|NCT00988208|323287917|FG000|Overall Study|Clinical Deterioration|7|||
94410379|NCT00988208|323287918|FG001|Overall Study|Clinical Deterioration|14|||
94410380|NCT00988208|323287917|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
94410381|NCT00988208|323287918|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
94410382|NCT00988208|323287917|FG000|Overall Study|Other|8|||
94410383|NCT00988208|323287918|FG001|Overall Study|Other|3|||
94410384|NCT04025684|323287921|FG000|Overall Study|Withdrawal by Subject|1|||
94410385|NCT04025684|323287922|FG001|Overall Study|Withdrawal by Subject|1|||
94410386|NCT04025684|323287923|FG002|Overall Study|Withdrawal by Subject|0|||
94410387|NCT04025684|323287924|FG003|Overall Study|Withdrawal by Subject|0|||
94410388|NCT04025684|323287921|FG000|Overall Study|Multiple reasons|1|||
94410389|NCT04025684|323287922|FG001|Overall Study|Multiple reasons|3|||
94410390|NCT04025684|323287923|FG002|Overall Study|Multiple reasons|0|||
94410391|NCT04025684|323287924|FG003|Overall Study|Multiple reasons|1|||
94410392|NCT00611884|323287925|FG000|Overall Study|Adverse Event|1|||
94410393|NCT00611884|323287926|FG001|Overall Study|Adverse Event|0|||
94410394|NCT00611884|323287927|FG002|Overall Study|Adverse Event|0|||
94410395|NCT00611884|323287928|FG003|Overall Study|Adverse Event|1|||
94410396|NCT00611884|323287925|FG000|Overall Study|Non-Compliance|1|||
94410397|NCT00611884|323287926|FG001|Overall Study|Non-Compliance|4|||
94410398|NCT00611884|323287927|FG002|Overall Study|Non-Compliance|2|||
94410399|NCT00611884|323287928|FG003|Overall Study|Non-Compliance|2|||
94410400|NCT00611884|323287925|FG000|Overall Study|Lack of Efficacy|0|||
94410401|NCT00611884|323287926|FG001|Overall Study|Lack of Efficacy|1|||
94410402|NCT00611884|323287927|FG002|Overall Study|Lack of Efficacy|0|||
94410403|NCT00611884|323287928|FG003|Overall Study|Lack of Efficacy|0|||
94410404|NCT00611884|323287925|FG000|Overall Study|Unclassified|7|||
94410405|NCT00611884|323287926|FG001|Overall Study|Unclassified|4|||
94410406|NCT00611884|323287927|FG002|Overall Study|Unclassified|2|||
94410407|NCT00611884|323287928|FG003|Overall Study|Unclassified|3|||
94410408|NCT01201759|323287929|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
94410409|NCT01201759|323287930|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
94410410|NCT01201759|323287929|FG000|Visit 3 - Washout|Adverse Event|0|||
94410411|NCT01201759|323287930|FG001|Visit 3 - Washout|Adverse Event|3|||
94410412|NCT01201759|323287929|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
94410413|NCT01201759|323287930|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
94410414|NCT01201759|323287929|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
94410415|NCT01201759|323287930|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
94410416|NCT00906373|323287931|FG000|Overall Study|Withdrawal by Subject|0|||
94410417|NCT00906373|323287932|FG001|Overall Study|Withdrawal by Subject|5|||
94410418|NCT00906373|323287931|FG000|Overall Study|Other|0|||
94410419|NCT00906373|323287932|FG001|Overall Study|Other|1|||
94410420|NCT00906373|323287931|FG000|Overall Study|Still on treatment at cutoff date|0|||
94410421|NCT00906373|323287932|FG001|Overall Study|Still on treatment at cutoff date|2|||
94410422|NCT01844531|323287933|FG000|Overall Study|Withdrawal by Subject|0|||
94410423|NCT01844531|323287934|FG001|Overall Study|Withdrawal by Subject|1|||
94410424|NCT01844531|323287935|FG002|Overall Study|Withdrawal by Subject|0|||
94410425|NCT01844531|323287936|FG003|Overall Study|Withdrawal by Subject|0|||
94410426|NCT01597479|323287937|FG000|Overall Study|Protocol Violation|1|||
94410427|NCT01597479|323287938|FG001|Overall Study|Protocol Violation|0|||
94410428|NCT01597479|323287937|FG000|Overall Study|Lost to Follow-up|1|||
94410429|NCT01597479|323287938|FG001|Overall Study|Lost to Follow-up|0|||
94410430|NCT01045707|323287943|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
94410431|NCT01045707|323287944|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
94410432|NCT01045707|323287943|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
94410433|NCT01045707|323287944|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
94410434|NCT01045707|323287943|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
94410435|NCT01045707|323287944|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
94410436|NCT01045707|323287943|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
94410437|NCT01045707|323287944|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
94410438|NCT01045707|323287943|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
94410439|NCT01045707|323287944|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
94410440|NCT01045707|323287943|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
94410441|NCT01045707|323287944|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
94410442|NCT01045707|323287943|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
94410443|NCT01045707|323287944|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
94410444|NCT01045707|323287943|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
94410445|NCT01045707|323287944|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
94410446|NCT01045707|323287943|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
94410447|NCT01045707|323287944|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
94410448|NCT00317642|323287959|FG000|Overall Study|Not Received Either Study Drug|1|||
94410449|NCT00317642|323287960|FG001|Overall Study|Not Received Either Study Drug|3|||
94410450|NCT00317642|323287959|FG000|Overall Study|Physician Decision|15|||
94410451|NCT00317642|323287960|FG001|Overall Study|Physician Decision|7|||
94410452|NCT00317642|323287959|FG000|Overall Study|Participant declined treatment|14|||
94410453|NCT00317642|323287960|FG001|Overall Study|Participant declined treatment|3|||
94410454|NCT00317642|323287959|FG000|Overall Study|Adverse Event|17|||
94410455|NCT00317642|323287960|FG001|Overall Study|Adverse Event|5|||
94410456|NCT00317642|323287959|FG000|Overall Study|Treatment Failure|56|||
94410457|NCT00317642|323287960|FG001|Overall Study|Treatment Failure|102|||
94410458|NCT00317642|323287959|FG000|Overall Study|Disease Recurrence|1|||
94410459|NCT00317642|323287960|FG001|Overall Study|Disease Recurrence|2|||
94410460|NCT00317642|323287959|FG000|Overall Study|Death|14|||
94410461|NCT00317642|323287960|FG001|Overall Study|Death|7|||
94410462|NCT00317642|323287959|FG000|Overall Study|Not Continue to Consolidation|2|||
94410463|NCT00317642|323287960|FG001|Overall Study|Not Continue to Consolidation|0|||
94410464|NCT00317642|323287959|FG000|Overall Study|Withdrawal by Subject|0|||
94410465|NCT00317642|323287960|FG001|Overall Study|Withdrawal by Subject|1|||
94410466|NCT00317642|323287959|FG000|Overall Study|Referred For Transplantation|1|||
94410467|NCT00317642|323287960|FG001|Overall Study|Referred For Transplantation|0|||
94410468|NCT00317642|323287959|FG000|Overall Study|AML Not Centrally Confirmed|1|||
94410469|NCT00317642|323287960|FG001|Overall Study|AML Not Centrally Confirmed|5|||
94410470|NCT00848042|323287961|FG000|Overall Study|Death|1|||
94410471|NCT00848042|323287962|FG001|Overall Study|Death|2|||
94410472|NCT00848042|323287963|FG002|Overall Study|Death|0|||
94410473|NCT00848042|323287961|FG000|Overall Study|Other Therapy|3|||
94410474|NCT00848042|323287962|FG001|Overall Study|Other Therapy|0|||
94410475|NCT00848042|323287963|FG002|Overall Study|Other Therapy|0|||
94410476|NCT04317599|323287964|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
94410477|NCT04317599|323287964|FG000|Overall Study|treatment outside standard of care|4|||
94410478|NCT02916693|323287966|FG000|Overall Study|Lost to Follow-up|7|||
94410479|NCT01999894|323287967|FG000|Overall Study|Adverse Event|9|||
94410480|NCT01999894|323287967|FG000|Overall Study|Lack of Efficacy|5|||
94410481|NCT01999894|323287967|FG000|Overall Study|Protocol Violation|1|||
94410482|NCT01999894|323287967|FG000|Overall Study|Withdrawal by Subject|7|||
94410483|NCT01999894|323287967|FG000|Overall Study|Lost to Follow-up|10|||
94410484|NCT01999894|323287967|FG000|Overall Study|Other Reason|3|||
94410485|NCT01999894|323287967|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
94410486|NCT00676494|323287971|FG000|Overall Study|Missed Visit|8|||
94410487|NCT00676494|323287971|FG000|Overall Study|Withdrawal by Subject|6|||
94410488|NCT01466036|323287980|FG000|Overall Study|Death|1|||
94410489|NCT01466036|323287981|FG001|Overall Study|Death|1|||
94410490|NCT01466036|323287980|FG000|Overall Study|Physician Decision|0|||
94410491|NCT01466036|323287981|FG001|Overall Study|Physician Decision|4|||
94410492|NCT01466036|323287980|FG000|Overall Study|Adverse Event|2|||
94410493|NCT01466036|323287981|FG001|Overall Study|Adverse Event|6|||
94410494|NCT01466036|323287980|FG000|Overall Study|Withdrawal by Subject|2|||
94410495|NCT01466036|323287981|FG001|Overall Study|Withdrawal by Subject|8|||
94410496|NCT01466036|323287980|FG000|Overall Study|progression/relapse|14|||
94410497|NCT01466036|323287981|FG001|Overall Study|progression/relapse|21|||
94410498|NCT01466036|323287980|FG000|Overall Study|prolonged treatment delay|1|||
94410499|NCT01466036|323287981|FG001|Overall Study|prolonged treatment delay|1|||
94410500|NCT01463982|323287982|FG000|Overall Study|Withdrawal by Subject|0|||
94410501|NCT01463982|323287983|FG001|Overall Study|Withdrawal by Subject|1|||
94410502|NCT01463982|323287984|FG002|Overall Study|Withdrawal by Subject|1|||
94410503|NCT01463982|323287985|FG003|Overall Study|Withdrawal by Subject|0|||
94410504|NCT01463982|323287982|FG000|Overall Study|Treatment delay over 5 week|0|||
94410505|NCT01463982|323287983|FG001|Overall Study|Treatment delay over 5 week|0|||
94410506|NCT01463982|323287984|FG002|Overall Study|Treatment delay over 5 week|1|||
94410507|NCT01463982|323287985|FG003|Overall Study|Treatment delay over 5 week|0|||
94410508|NCT00819767|323287987|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94410509|NCT00819767|323287988|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
94410510|NCT04234464|323287989|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
94410511|NCT04234464|323287990|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
94410512|NCT00983528|323287991|FG000|Overall Study|Death|4|||
94410513|NCT00983528|323287991|FG000|Overall Study|Lost to Follow-up|1|||
94410514|NCT00983528|323287991|FG000|Overall Study|Study Terminated|1|||
94410515|NCT00084799|323287992|FG000|Overall Study|Disease Progression|1|||
94410516|NCT00084799|323287993|FG001|Overall Study|Disease Progression|0|||
94410517|NCT03712124|323287994|FG000|Overall Study|Protocol Violation|1|||
94410518|NCT03712124|323287995|FG001|Overall Study|Protocol Violation|0|||
94410519|NCT01040793|323287998|FG000|Overall Study|Adverse Event|5|||
94410520|NCT01040793|323287999|FG001|Overall Study|Adverse Event|3|||
94410521|NCT01040793|323288000|FG002|Overall Study|Adverse Event|0|||
94410522|NCT01040793|323288001|FG003|Overall Study|Adverse Event|2|||
94410523|NCT01040793|323288002|FG004|Overall Study|Adverse Event|2|||
94410524|NCT01040793|323288003|FG005|Overall Study|Adverse Event|1|||
94410525|NCT01040793|323287998|FG000|Overall Study|Protocol Violation|1|||
94410526|NCT01040793|323287999|FG001|Overall Study|Protocol Violation|1|||
94410527|NCT01040793|323288000|FG002|Overall Study|Protocol Violation|1|||
94410528|NCT01040793|323288001|FG003|Overall Study|Protocol Violation|0|||
94410529|NCT01040793|323288002|FG004|Overall Study|Protocol Violation|1|||
94410530|NCT01040793|323288003|FG005|Overall Study|Protocol Violation|0|||
94410531|NCT01040793|323287998|FG000|Overall Study|Lost to Follow-up|0|||
94410532|NCT01040793|323287999|FG001|Overall Study|Lost to Follow-up|1|||
94410533|NCT01040793|323288000|FG002|Overall Study|Lost to Follow-up|1|||
94410534|NCT01040793|323288001|FG003|Overall Study|Lost to Follow-up|0|||
94410535|NCT01040793|323288002|FG004|Overall Study|Lost to Follow-up|0|||
94410536|NCT01040793|323288003|FG005|Overall Study|Lost to Follow-up|0|||
94410537|NCT01040793|323287998|FG000|Overall Study|Withdrawal by Subject|0|||
94410538|NCT01040793|323287999|FG001|Overall Study|Withdrawal by Subject|0|||
94410539|NCT01040793|323288000|FG002|Overall Study|Withdrawal by Subject|0|||
94410540|NCT01040793|323288001|FG003|Overall Study|Withdrawal by Subject|2|||
94410541|NCT01040793|323288002|FG004|Overall Study|Withdrawal by Subject|0|||
94410542|NCT01040793|323288003|FG005|Overall Study|Withdrawal by Subject|0|||
94410543|NCT01040793|323287998|FG000|Overall Study|Other reasons not listed above|0|||
94410544|NCT01040793|323287999|FG001|Overall Study|Other reasons not listed above|0|||
94410545|NCT01040793|323288000|FG002|Overall Study|Other reasons not listed above|1|||
94410546|NCT01040793|323288001|FG003|Overall Study|Other reasons not listed above|0|||
94410547|NCT01040793|323288002|FG004|Overall Study|Other reasons not listed above|1|||
94410548|NCT01040793|323288003|FG005|Overall Study|Other reasons not listed above|0|||
94410549|NCT02412722|323288004|FG000|Overall Study|Adverse Event|0|||
94410550|NCT02412722|323288005|FG001|Overall Study|Adverse Event|2|||
94410551|NCT02412722|323288006|FG002|Overall Study|Adverse Event|0|||
94410552|NCT02412722|323288007|FG003|Overall Study|Adverse Event|3|||
94410553|NCT02412722|323288008|FG004|Overall Study|Adverse Event|0|||
94410554|NCT02412722|323288009|FG005|Overall Study|Adverse Event|3|||
94410555|NCT02412722|323288004|FG000|Overall Study|Progressive Disease|6|||
94410556|NCT02412722|323288005|FG001|Overall Study|Progressive Disease|4|||
94410557|NCT02412722|323288006|FG002|Overall Study|Progressive Disease|4|||
94410558|NCT02412722|323288007|FG003|Overall Study|Progressive Disease|9|||
94410559|NCT02412722|323288008|FG004|Overall Study|Progressive Disease|3|||
94410560|NCT02412722|323288009|FG005|Overall Study|Progressive Disease|3|||
94486952|NCT01663623|323575367|FG000|Overall Study|Withdrawal by Subject|2|||
94410561|NCT02412722|323288004|FG000|Overall Study|Withdrawal by Subject|2|||
94410562|NCT02412722|323288005|FG001|Overall Study|Withdrawal by Subject|0|||
94410563|NCT02412722|323288006|FG002|Overall Study|Withdrawal by Subject|1|||
94410564|NCT02412722|323288007|FG003|Overall Study|Withdrawal by Subject|2|||
94410565|NCT02412722|323288008|FG004|Overall Study|Withdrawal by Subject|1|||
94410566|NCT02412722|323288009|FG005|Overall Study|Withdrawal by Subject|1|||
94410567|NCT02412722|323288004|FG000|Overall Study|Lost to Follow-up|0|||
94410568|NCT02412722|323288005|FG001|Overall Study|Lost to Follow-up|0|||
94410569|NCT02412722|323288006|FG002|Overall Study|Lost to Follow-up|0|||
94410570|NCT02412722|323288007|FG003|Overall Study|Lost to Follow-up|0|||
94410571|NCT02412722|323288008|FG004|Overall Study|Lost to Follow-up|1|||
94410572|NCT02412722|323288009|FG005|Overall Study|Lost to Follow-up|0|||
94410573|NCT02412722|323288004|FG000|Overall Study|Received drug in run-in and discontinued|0|||
94410574|NCT02412722|323288005|FG001|Overall Study|Received drug in run-in and discontinued|2|||
94410575|NCT02412722|323288006|FG002|Overall Study|Received drug in run-in and discontinued|0|||
94410576|NCT02412722|323288007|FG003|Overall Study|Received drug in run-in and discontinued|0|||
94410577|NCT02412722|323288008|FG004|Overall Study|Received drug in run-in and discontinued|0|||
94410578|NCT02412722|323288009|FG005|Overall Study|Received drug in run-in and discontinued|0|||
94410579|NCT02412722|323288004|FG000|Overall Study|Reason not Specified|3|||
94410580|NCT02412722|323288005|FG001|Overall Study|Reason not Specified|0|||
94410581|NCT02412722|323288006|FG002|Overall Study|Reason not Specified|2|||
94410582|NCT02412722|323288007|FG003|Overall Study|Reason not Specified|1|||
94410583|NCT02412722|323288008|FG004|Overall Study|Reason not Specified|2|||
94410584|NCT02412722|323288009|FG005|Overall Study|Reason not Specified|6|||
94410585|NCT03554317|323288012|FG000|Overall Study|Withdrawal by Subject|1|||
94410586|NCT03554317|323288012|FG000|Overall Study|PSA Progression|3|||
94410587|NCT03554317|323288012|FG000|Overall Study|Radiographic Progression|4|||
94410588|NCT00645944|323288013|FG000|Randomized|Withdrawal by Subject|1|||
94410589|NCT00645944|323288014|FG001|Randomized|Withdrawal by Subject|2|||
94410590|NCT00645944|323288013|FG000|Received Medication|Adverse Event|2|||
94410591|NCT00645944|323288014|FG001|Received Medication|Adverse Event|1|||
94410592|NCT00645944|323288013|FG000|Received Medication|Withdrawal by Subject|1|||
94410593|NCT00645944|323288014|FG001|Received Medication|Withdrawal by Subject|1|||
94410594|NCT00645944|323288013|FG000|Received Medication|Lost to Follow-up|1|||
94410595|NCT00645944|323288014|FG001|Received Medication|Lost to Follow-up|0|||
94410596|NCT00645944|323288013|FG000|Received Medication|Protocol Violation|2|||
94410597|NCT00645944|323288014|FG001|Received Medication|Protocol Violation|1|||
94410598|NCT00104247|323288015|FG000|Overall Study|Withdrawal by Subject|1|||
94410599|NCT00104247|323288016|FG001|Overall Study|Withdrawal by Subject|0|||
94410600|NCT00104247|323288015|FG000|Overall Study|Noncompliant with dosing|0|||
94410601|NCT00104247|323288016|FG001|Overall Study|Noncompliant with dosing|1|||
94410602|NCT01425528|323288018|FG000|Overall Study|Withdrawal by Subject|1|||
94410603|NCT01425528|323288019|FG001|Overall Study|Withdrawal by Subject|1|||
94410604|NCT03450629|323288020|FG000|Overall Study|Adverse Event|15|||
94410605|NCT03450629|323288021|FG001|Overall Study|Adverse Event|14|||
94410606|NCT03450629|323288020|FG000|Overall Study|Physician Decision|2|||
94410607|NCT03450629|323288021|FG001|Overall Study|Physician Decision|2|||
94410608|NCT03450629|323288020|FG000|Overall Study|Lack of Efficacy|2|||
94410609|NCT03450629|323288021|FG001|Overall Study|Lack of Efficacy|0|||
94410610|NCT03450629|323288020|FG000|Overall Study|Lost to Follow-up|4|||
94410611|NCT03450629|323288021|FG001|Overall Study|Lost to Follow-up|2|||
94410612|NCT03450629|323288020|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
94410613|NCT03450629|323288021|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
94410614|NCT03450629|323288020|FG000|Overall Study|Non-Compliance With Study Drug|2|||
94410615|NCT03450629|323288021|FG001|Overall Study|Non-Compliance With Study Drug|1|||
94410616|NCT03450629|323288020|FG000|Overall Study|Protocol Violation|11|||
94410617|NCT03450629|323288021|FG001|Overall Study|Protocol Violation|8|||
94410618|NCT03450629|323288020|FG000|Overall Study|Withdrawal by Subject|12|||
94410619|NCT03450629|323288021|FG001|Overall Study|Withdrawal by Subject|6|||
94410620|NCT02339090|323288034|FG000|Overall Study|Adverse Event|1|||
94410621|NCT02339090|323288035|FG001|Overall Study|Adverse Event|0|||
94410622|NCT02339090|323288034|FG000|Overall Study|Lost to Follow-up|0|||
94410623|NCT02339090|323288035|FG001|Overall Study|Lost to Follow-up|1|||
94410624|NCT02339090|323288034|FG000|Overall Study|Non-compliance With Study Drug|0|||
94410625|NCT02339090|323288035|FG001|Overall Study|Non-compliance With Study Drug|1|||
94410626|NCT02339090|323288034|FG000|Overall Study|Withdrawal by Subject|2|||
94410627|NCT02339090|323288035|FG001|Overall Study|Withdrawal by Subject|1|||
94410628|NCT02339090|323288034|FG000|Overall Study|Poor Growth|3|||
94410629|NCT02339090|323288035|FG001|Overall Study|Poor Growth|0|||
94410630|NCT02339090|323288034|FG000|Overall Study|Randomized but not treated|0|||
94410631|NCT02339090|323288035|FG001|Overall Study|Randomized but not treated|2|||
94410632|NCT01557582|323288036|FG000|Overall Study|Protocol Violation|4|||
94410633|NCT01557582|323288036|FG000|Overall Study|Operator error|2|||
94410634|NCT02994394|323290458|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
94410635|NCT02994394|323290459|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
94410636|NCT02994394|323290460|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
94410637|NCT02994394|323290461|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
94410638|NCT02994394|323290462|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
94410639|NCT02994394|323290463|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
94410640|NCT02994394|323290458|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
94410641|NCT02994394|323290459|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
94410642|NCT02994394|323290460|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
94410643|NCT02994394|323290461|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
94410644|NCT02994394|323290462|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
94410645|NCT02994394|323290463|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
94410646|NCT00802178|323290464|FG000|Overall Study|Lack of Efficacy|36|||
94410647|NCT00802178|323290464|FG000|Overall Study|Insufficient tolerability (IT)|17|||
94410648|NCT00802178|323290464|FG000|Overall Study|Withdrawal by Subject|18|||
94410649|NCT00802178|323290464|FG000|Overall Study|Other|32|||
94410650|NCT00802178|323290464|FG000|Overall Study|Lack of efficacy and patient wish|1|||
94410651|NCT00802178|323290464|FG000|Overall Study|IT and patient wish|8|||
94410652|NCT00802178|323290464|FG000|Overall Study|Patients wish and other reason|1|||
94410653|NCT01933919|323290465|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
94410654|NCT01933919|323290466|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
94410655|NCT01933919|323290465|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
94410656|NCT01933919|323290466|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
94410657|NCT01933919|323290465|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
94410658|NCT01933919|323290466|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
94410659|NCT01933919|323290465|FG000|Open-label Long-term Phase|Adverse Event|2|||
94410660|NCT01933919|323290466|FG001|Open-label Long-term Phase|Adverse Event|0|||
94410661|NCT01933919|323290465|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
94410662|NCT01933919|323290466|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
94410663|NCT01933919|323290465|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
94410664|NCT01933919|323290466|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
94410665|NCT01933919|323290465|FG000|Open-label Long-term Phase|Other|1|||
94410666|NCT01933919|323290466|FG001|Open-label Long-term Phase|Other|2|||
94410667|NCT01961882|323290468|FG000|Overall Study|Adverse Event|3|||
94410668|NCT01961882|323290469|FG001|Overall Study|Adverse Event|2|||
94410669|NCT01961882|323290468|FG000|Overall Study|Physician Decision|1|||
94410670|NCT01961882|323290469|FG001|Overall Study|Physician Decision|0|||
94410671|NCT01961882|323290468|FG000|Overall Study|Withdrawal by Subject|4|||
94410672|NCT01961882|323290469|FG001|Overall Study|Withdrawal by Subject|1|||
94410673|NCT01961882|323290468|FG000|Overall Study|Relapse of AML|39|||
94410674|NCT01961882|323290469|FG001|Overall Study|Relapse of AML|37|||
94410675|NCT01961882|323290468|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
94410676|NCT01961882|323290469|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
94410677|NCT01961882|323290468|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
94410678|NCT01961882|323290469|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
94410679|NCT01522950|323290480|FG000|Overall Study|Withdrawal by Subject|3|||
94410680|NCT01522950|323290481|FG001|Overall Study|Withdrawal by Subject|2|||
94410681|NCT01522950|323290482|FG002|Overall Study|Withdrawal by Subject|1|||
94410682|NCT01522950|323290480|FG000|Overall Study|Adverse Event|3|||
94410683|NCT01522950|323290481|FG001|Overall Study|Adverse Event|1|||
94410684|NCT01522950|323290482|FG002|Overall Study|Adverse Event|1|||
94410685|NCT01522950|323290480|FG000|Overall Study|Protocol Violation|0|||
94410686|NCT01522950|323290481|FG001|Overall Study|Protocol Violation|0|||
94410687|NCT01522950|323290482|FG002|Overall Study|Protocol Violation|2|||
94410688|NCT01522950|323290480|FG000|Overall Study|Death|0|||
94410689|NCT01522950|323290481|FG001|Overall Study|Death|1|||
94410690|NCT01522950|323290482|FG002|Overall Study|Death|1|||
94410691|NCT01522950|323290480|FG000|Overall Study|Study Medication Sensitivity|0|||
94410692|NCT01522950|323290481|FG001|Overall Study|Study Medication Sensitivity|1|||
94410693|NCT01522950|323290482|FG002|Overall Study|Study Medication Sensitivity|0|||
94410694|NCT02443324|323290484|FG000|Overall Study|Death|4|||
94410695|NCT02443324|323290485|FG001|Overall Study|Death|1|||
94410696|NCT02443324|323290486|FG002|Overall Study|Death|0|||
94410697|NCT02443324|323290487|FG003|Overall Study|Death|3|||
94410698|NCT02443324|323290488|FG004|Overall Study|Death|1|||
94410699|NCT02443324|323290489|FG005|Overall Study|Death|3|||
94410700|NCT02443324|323290490|FG006|Overall Study|Death|2|||
94410701|NCT02443324|323290484|FG000|Overall Study|Lost to Follow-up|0|||
94410702|NCT02443324|323290485|FG001|Overall Study|Lost to Follow-up|0|||
94410703|NCT02443324|323290486|FG002|Overall Study|Lost to Follow-up|0|||
94410704|NCT02443324|323290487|FG003|Overall Study|Lost to Follow-up|1|||
94410705|NCT02443324|323290488|FG004|Overall Study|Lost to Follow-up|0|||
94410706|NCT02443324|323290489|FG005|Overall Study|Lost to Follow-up|1|||
94410707|NCT02443324|323290490|FG006|Overall Study|Lost to Follow-up|0|||
94410708|NCT02443324|323290484|FG000|Overall Study|Physician Decision|0|||
94410709|NCT02443324|323290485|FG001|Overall Study|Physician Decision|3|||
94410710|NCT02443324|323290486|FG002|Overall Study|Physician Decision|5|||
94410711|NCT02443324|323290487|FG003|Overall Study|Physician Decision|1|||
94410712|NCT02443324|323290488|FG004|Overall Study|Physician Decision|1|||
94410713|NCT02443324|323290489|FG005|Overall Study|Physician Decision|0|||
94410714|NCT02443324|323290490|FG006|Overall Study|Physician Decision|2|||
94410715|NCT02443324|323290484|FG000|Overall Study|Progressive Disease|20|||
94410716|NCT02443324|323290485|FG001|Overall Study|Progressive Disease|20|||
94410717|NCT02443324|323290486|FG002|Overall Study|Progressive Disease|13|||
94410718|NCT02443324|323290487|FG003|Overall Study|Progressive Disease|10|||
94410719|NCT02443324|323290488|FG004|Overall Study|Progressive Disease|13|||
94410720|NCT02443324|323290489|FG005|Overall Study|Progressive Disease|17|||
94410721|NCT02443324|323290490|FG006|Overall Study|Progressive Disease|10|||
94410722|NCT02443324|323290484|FG000|Overall Study|Withdrawal by Subject|0|||
94410723|NCT02443324|323290485|FG001|Overall Study|Withdrawal by Subject|0|||
94410724|NCT02443324|323290486|FG002|Overall Study|Withdrawal by Subject|3|||
94410725|NCT02443324|323290487|FG003|Overall Study|Withdrawal by Subject|1|||
94410726|NCT02443324|323290488|FG004|Overall Study|Withdrawal by Subject|1|||
94410727|NCT02443324|323290489|FG005|Overall Study|Withdrawal by Subject|0|||
94410728|NCT02443324|323290490|FG006|Overall Study|Withdrawal by Subject|1|||
94410729|NCT02443324|323290484|FG000|Overall Study|Adverse Event|0|||
94410730|NCT02443324|323290485|FG001|Overall Study|Adverse Event|1|||
94410731|NCT02443324|323290486|FG002|Overall Study|Adverse Event|3|||
94410732|NCT02443324|323290487|FG003|Overall Study|Adverse Event|0|||
94410733|NCT02443324|323290488|FG004|Overall Study|Adverse Event|4|||
94410734|NCT02443324|323290489|FG005|Overall Study|Adverse Event|3|||
94410735|NCT02443324|323290490|FG006|Overall Study|Adverse Event|3|||
94410736|NCT02443324|323290484|FG000|Overall Study|Enrolled but Never Treated|0|||
94410737|NCT02443324|323290485|FG001|Overall Study|Enrolled but Never Treated|0|||
94410738|NCT02443324|323290486|FG002|Overall Study|Enrolled but Never Treated|1|||
94410739|NCT02443324|323290487|FG003|Overall Study|Enrolled but Never Treated|0|||
94410740|NCT02443324|323290488|FG004|Overall Study|Enrolled but Never Treated|1|||
94410741|NCT02443324|323290489|FG005|Overall Study|Enrolled but Never Treated|0|||
94410742|NCT02443324|323290490|FG006|Overall Study|Enrolled but Never Treated|1|||
94410743|NCT01647711|323290491|FG000|Overall Study|Progressive disease|6|||
94410744|NCT01647711|323290492|FG001|Overall Study|Progressive disease|2|||
94410745|NCT01647711|323290493|FG002|Overall Study|Progressive disease|6|||
94410746|NCT01647711|323290494|FG003|Overall Study|Progressive disease|8|||
94410747|NCT01647711|323290495|FG004|Overall Study|Progressive disease|2|||
94410748|NCT01647711|323290491|FG000|Overall Study|Other adverse event|0|||
94410749|NCT01647711|323290492|FG001|Overall Study|Other adverse event|0|||
94410750|NCT01647711|323290493|FG002|Overall Study|Other adverse event|2|||
94410751|NCT01647711|323290494|FG003|Overall Study|Other adverse event|0|||
94410752|NCT01647711|323290495|FG004|Overall Study|Other adverse event|2|||
94410753|NCT01647711|323290491|FG000|Overall Study|Protocol Violation|0|||
94410754|NCT01647711|323290492|FG001|Overall Study|Protocol Violation|0|||
94410755|NCT01647711|323290493|FG002|Overall Study|Protocol Violation|0|||
94410756|NCT01647711|323290494|FG003|Overall Study|Protocol Violation|0|||
94410757|NCT01647711|323290495|FG004|Overall Study|Protocol Violation|1|||
94410758|NCT01647711|323290491|FG000|Overall Study|Refused to continue taking medication|0|||
94410759|NCT01647711|323290492|FG001|Overall Study|Refused to continue taking medication|0|||
94410760|NCT01647711|323290493|FG002|Overall Study|Refused to continue taking medication|0|||
94410761|NCT01647711|323290494|FG003|Overall Study|Refused to continue taking medication|2|||
94410762|NCT01647711|323290495|FG004|Overall Study|Refused to continue taking medication|1|||
94410763|NCT01647711|323290491|FG000|Overall Study|Other reason not defined|0|||
94410764|NCT01647711|323290492|FG001|Overall Study|Other reason not defined|1|||
94410765|NCT01647711|323290493|FG002|Overall Study|Other reason not defined|1|||
94410766|NCT01647711|323290494|FG003|Overall Study|Other reason not defined|1|||
94410767|NCT01647711|323290495|FG004|Overall Study|Other reason not defined|0|||
94410768|NCT03036839|323290496|FG000|Overall Study|Adverse Event|0|||
94410769|NCT03036839|323290497|FG001|Overall Study|Adverse Event|0|||
94410770|NCT03036839|323290498|FG002|Overall Study|Adverse Event|1|||
94410771|NCT03036839|323290496|FG000|Overall Study|Death|3|||
94410772|NCT03036839|323290497|FG001|Overall Study|Death|0|||
94410773|NCT03036839|323290498|FG002|Overall Study|Death|3|||
94410774|NCT03036839|323290496|FG000|Overall Study|Withdrew Consent|0|||
94410775|NCT03036839|323290497|FG001|Overall Study|Withdrew Consent|0|||
94410776|NCT03036839|323290498|FG002|Overall Study|Withdrew Consent|1|||
94410777|NCT01796964|323290511|FG000|Overall Study|Adverse Event|1|||
94410778|NCT01796964|323290512|FG001|Overall Study|Adverse Event|1|||
94410779|NCT01796964|323290511|FG000|Overall Study|Death|1|||
94410780|NCT01796964|323290512|FG001|Overall Study|Death|0|||
94410781|NCT01796964|323290511|FG000|Overall Study|Protocol Violation|0|||
94410782|NCT01796964|323290512|FG001|Overall Study|Protocol Violation|1|||
94410783|NCT01796964|323290511|FG000|Overall Study|Withdrawal by Subject|1|||
94410784|NCT01796964|323290512|FG001|Overall Study|Withdrawal by Subject|1|||
94410785|NCT01239472|323290515|FG000|Overall Study|Withdrawal by Subject|5|||
94410786|NCT01239472|323290516|FG001|Overall Study|Withdrawal by Subject|1|||
94410787|NCT01239472|323290515|FG000|Overall Study|Adverse Event|0|||
94410788|NCT01239472|323290516|FG001|Overall Study|Adverse Event|1|||
94410789|NCT01239472|323290515|FG000|Overall Study|Lack of Efficacy|0|||
94410790|NCT01239472|323290516|FG001|Overall Study|Lack of Efficacy|1|||
94410791|NCT02780167|323290517|FG000|Overall Study|Adverse Event|9|||
94410792|NCT02780167|323290518|FG001|Overall Study|Adverse Event|8|||
94410793|NCT02780167|323290519|FG002|Overall Study|Adverse Event|8|||
94410794|NCT02780167|323290520|FG003|Overall Study|Adverse Event|12|||
94410795|NCT02780167|323290521|FG004|Overall Study|Adverse Event|8|||
94410796|NCT02780167|323290517|FG000|Overall Study|Lack of Efficacy|6|||
94410797|NCT02780167|323290518|FG001|Overall Study|Lack of Efficacy|5|||
94410798|NCT02780167|323290519|FG002|Overall Study|Lack of Efficacy|6|||
94410799|NCT02780167|323290520|FG003|Overall Study|Lack of Efficacy|1|||
94410800|NCT02780167|323290521|FG004|Overall Study|Lack of Efficacy|0|||
94410801|NCT02780167|323290517|FG000|Overall Study|Lost to Follow-up|2|||
94410802|NCT02780167|323290518|FG001|Overall Study|Lost to Follow-up|0|||
94410803|NCT02780167|323290519|FG002|Overall Study|Lost to Follow-up|1|||
94410804|NCT02780167|323290520|FG003|Overall Study|Lost to Follow-up|0|||
94410805|NCT02780167|323290521|FG004|Overall Study|Lost to Follow-up|0|||
94410806|NCT02780167|323290517|FG000|Overall Study|Does not meet entrance criteria|0|||
94410807|NCT02780167|323290518|FG001|Overall Study|Does not meet entrance criteria|0|||
94410808|NCT02780167|323290519|FG002|Overall Study|Does not meet entrance criteria|1|||
94410809|NCT02780167|323290520|FG003|Overall Study|Does not meet entrance criteria|0|||
94410810|NCT02780167|323290521|FG004|Overall Study|Does not meet entrance criteria|0|||
94410811|NCT02780167|323290517|FG000|Overall Study|No longer meets eligibility criteria|0|||
94410812|NCT02780167|323290518|FG001|Overall Study|No longer meets eligibility criteria|0|||
94410813|NCT02780167|323290519|FG002|Overall Study|No longer meets eligibility criteria|0|||
94410814|NCT02780167|323290520|FG003|Overall Study|No longer meets eligibility criteria|1|||
94410815|NCT02780167|323290521|FG004|Overall Study|No longer meets eligibility criteria|1|||
94410816|NCT02780167|323290517|FG000|Overall Study|Protocol Violation|5|||
94410817|NCT02780167|323290518|FG001|Overall Study|Protocol Violation|5|||
94410818|NCT02780167|323290519|FG002|Overall Study|Protocol Violation|1|||
94410819|NCT02780167|323290520|FG003|Overall Study|Protocol Violation|1|||
94410820|NCT02780167|323290521|FG004|Overall Study|Protocol Violation|2|||
94410821|NCT02780167|323290517|FG000|Overall Study|Withdrawal by Subject|6|||
94410822|NCT02780167|323290518|FG001|Overall Study|Withdrawal by Subject|4|||
94410823|NCT02780167|323290519|FG002|Overall Study|Withdrawal by Subject|4|||
94410824|NCT02780167|323290520|FG003|Overall Study|Withdrawal by Subject|3|||
94410825|NCT02780167|323290521|FG004|Overall Study|Withdrawal by Subject|4|||
94410826|NCT02780167|323290517|FG000|Overall Study|Other|0|||
94410827|NCT02780167|323290518|FG001|Overall Study|Other|0|||
94410828|NCT02780167|323290519|FG002|Overall Study|Other|3|||
94410829|NCT02780167|323290520|FG003|Overall Study|Other|1|||
94410830|NCT02780167|323290521|FG004|Overall Study|Other|2|||
94410831|NCT02315066|323290522|FG000|Overall Study|Lost to Follow-up|0|||
94410832|NCT02315066|323290523|FG001|Overall Study|Lost to Follow-up|1|||
94410833|NCT02315066|323290524|FG002|Overall Study|Lost to Follow-up|1|||
94410834|NCT02315066|323290525|FG003|Overall Study|Lost to Follow-up|0|||
94410835|NCT02315066|323290526|FG004|Overall Study|Lost to Follow-up|1|||
94410836|NCT02315066|323290527|FG005|Overall Study|Lost to Follow-up|0|||
94410837|NCT02315066|323290528|FG006|Overall Study|Lost to Follow-up|2|||
94410838|NCT02315066|323290529|FG007|Overall Study|Lost to Follow-up|1|||
94410839|NCT02315066|323290530|FG008|Overall Study|Lost to Follow-up|0|||
94410840|NCT02315066|323290531|FG009|Overall Study|Lost to Follow-up|0|||
94410841|NCT02315066|323290532|FG010|Overall Study|Lost to Follow-up|1|||
94410842|NCT02315066|323290533|FG011|Overall Study|Lost to Follow-up|2|||
94410843|NCT02315066|323290534|FG012|Overall Study|Lost to Follow-up|0|||
94410844|NCT02315066|323290535|FG013|Overall Study|Lost to Follow-up|4|||
94410845|NCT02315066|323290522|FG000|Overall Study|Death|2|||
94410846|NCT02315066|323290523|FG001|Overall Study|Death|7|||
94410847|NCT02315066|323290524|FG002|Overall Study|Death|6|||
94410848|NCT02315066|323290525|FG003|Overall Study|Death|11|||
94410849|NCT02315066|323290526|FG004|Overall Study|Death|10|||
94410850|NCT02315066|323290527|FG005|Overall Study|Death|3|||
94410851|NCT02315066|323290528|FG006|Overall Study|Death|9|||
94410852|NCT02315066|323290529|FG007|Overall Study|Death|9|||
94410853|NCT02315066|323290530|FG008|Overall Study|Death|10|||
94410854|NCT02315066|323290531|FG009|Overall Study|Death|8|||
94410855|NCT02315066|323290532|FG010|Overall Study|Death|10|||
94410856|NCT02315066|323290533|FG011|Overall Study|Death|7|||
94410857|NCT02315066|323290534|FG012|Overall Study|Death|8|||
94410858|NCT02315066|323290535|FG013|Overall Study|Death|21|||
94410859|NCT02315066|323290522|FG000|Overall Study|Other|0|||
94410860|NCT02315066|323290523|FG001|Overall Study|Other|0|||
94410861|NCT02315066|323290524|FG002|Overall Study|Other|0|||
94410862|NCT02315066|323290525|FG003|Overall Study|Other|0|||
94410863|NCT02315066|323290526|FG004|Overall Study|Other|0|||
94410864|NCT02315066|323290527|FG005|Overall Study|Other|0|||
94410865|NCT02315066|323290528|FG006|Overall Study|Other|0|||
94410866|NCT02315066|323290529|FG007|Overall Study|Other|1|||
94410867|NCT02315066|323290530|FG008|Overall Study|Other|1|||
94410868|NCT02315066|323290531|FG009|Overall Study|Other|2|||
94410869|NCT02315066|323290532|FG010|Overall Study|Other|0|||
94410870|NCT02315066|323290533|FG011|Overall Study|Other|0|||
94410871|NCT02315066|323290534|FG012|Overall Study|Other|0|||
94410872|NCT02315066|323290535|FG013|Overall Study|Other|0|||
94410873|NCT02315066|323290522|FG000|Overall Study|Subject refused further follow-up|0|||
94410874|NCT02315066|323290523|FG001|Overall Study|Subject refused further follow-up|2|||
94410875|NCT02315066|323290524|FG002|Overall Study|Subject refused further follow-up|2|||
94410876|NCT02315066|323290525|FG003|Overall Study|Subject refused further follow-up|0|||
94410877|NCT02315066|323290526|FG004|Overall Study|Subject refused further follow-up|0|||
94410878|NCT02315066|323290527|FG005|Overall Study|Subject refused further follow-up|0|||
94410879|NCT02315066|323290528|FG006|Overall Study|Subject refused further follow-up|2|||
94410880|NCT02315066|323290529|FG007|Overall Study|Subject refused further follow-up|3|||
94410881|NCT02315066|323290530|FG008|Overall Study|Subject refused further follow-up|0|||
94410882|NCT02315066|323290531|FG009|Overall Study|Subject refused further follow-up|1|||
94410883|NCT02315066|323290532|FG010|Overall Study|Subject refused further follow-up|1|||
94410884|NCT02315066|323290533|FG011|Overall Study|Subject refused further follow-up|2|||
94410885|NCT02315066|323290534|FG012|Overall Study|Subject refused further follow-up|2|||
94410886|NCT02315066|323290535|FG013|Overall Study|Subject refused further follow-up|4|||
94410887|NCT02315066|323290522|FG000|Overall Study|Study ongoing at date of cut-off|0|||
94410888|NCT02315066|323290523|FG001|Overall Study|Study ongoing at date of cut-off|0|||
94410889|NCT02315066|323290524|FG002|Overall Study|Study ongoing at date of cut-off|0|||
94410890|NCT02315066|323290525|FG003|Overall Study|Study ongoing at date of cut-off|0|||
94410891|NCT02315066|323290526|FG004|Overall Study|Study ongoing at date of cut-off|0|||
94410892|NCT02315066|323290527|FG005|Overall Study|Study ongoing at date of cut-off|0|||
94410893|NCT02315066|323290528|FG006|Overall Study|Study ongoing at date of cut-off|0|||
94410894|NCT02315066|323290529|FG007|Overall Study|Study ongoing at date of cut-off|0|||
94410895|NCT02315066|323290530|FG008|Overall Study|Study ongoing at date of cut-off|0|||
94410896|NCT02315066|323290531|FG009|Overall Study|Study ongoing at date of cut-off|0|||
94410897|NCT02315066|323290532|FG010|Overall Study|Study ongoing at date of cut-off|0|||
94410898|NCT02315066|323290533|FG011|Overall Study|Study ongoing at date of cut-off|0|||
94410899|NCT02315066|323290534|FG012|Overall Study|Study ongoing at date of cut-off|0|||
94410900|NCT02315066|323290535|FG013|Overall Study|Study ongoing at date of cut-off|1|||
94410901|NCT03180801|323290536|FG000|Overall Study|Physician Decision|3|||
94410902|NCT03180801|323290537|FG001|Overall Study|Physician Decision|3|||
94410903|NCT03180801|323290538|FG002|Overall Study|Physician Decision|1|||
94410904|NCT03180801|323290536|FG000|Overall Study|Non-compliance|1|||
94410905|NCT03180801|323290537|FG001|Overall Study|Non-compliance|4|||
94410906|NCT03180801|323290538|FG002|Overall Study|Non-compliance|0|||
94410907|NCT03180801|323290536|FG000|Overall Study|Inoculation Target Reached|1|||
94410908|NCT03180801|323290537|FG001|Overall Study|Inoculation Target Reached|1|||
94410909|NCT03180801|323290538|FG002|Overall Study|Inoculation Target Reached|3|||
94410910|NCT03180801|323290536|FG000|Overall Study|Adverse Event|1|||
94410911|NCT03180801|323290537|FG001|Overall Study|Adverse Event|0|||
94410912|NCT03180801|323290538|FG002|Overall Study|Adverse Event|2|||
94410913|NCT03180801|323290536|FG000|Overall Study|Withdrawal by Subject|2|||
94410914|NCT03180801|323290537|FG001|Overall Study|Withdrawal by Subject|2|||
94410915|NCT03180801|323290538|FG002|Overall Study|Withdrawal by Subject|1|||
94410916|NCT03180801|323290536|FG000|Overall Study|Lost to Follow-up|0|||
94410917|NCT03180801|323290537|FG001|Overall Study|Lost to Follow-up|2|||
94410918|NCT03180801|323290538|FG002|Overall Study|Lost to Follow-up|3|||
94410919|NCT01049412|323290539|FG000|Period I|Withdrawal by Subject|4|||
94410920|NCT01049412|323290540|FG001|Period I|Withdrawal by Subject|6|||
94410921|NCT01049412|323290539|FG000|Period I|Lost to Follow-up|2|||
94410922|NCT01049412|323290540|FG001|Period I|Lost to Follow-up|2|||
94410923|NCT01049412|323290539|FG000|Period I|Physician Decision|0|||
94410924|NCT01049412|323290540|FG001|Period I|Physician Decision|3|||
94410925|NCT01049412|323290539|FG000|Period I|Protocol Violation|1|||
94410926|NCT01049412|323290540|FG001|Period I|Protocol Violation|2|||
94410927|NCT01049412|323290539|FG000|Period I|Adverse Event|1|||
94410928|NCT01049412|323290540|FG001|Period I|Adverse Event|0|||
94410929|NCT01049412|323290539|FG000|Period II|Withdrawal by Subject|2|||
94410930|NCT01049412|323290540|FG001|Period II|Withdrawal by Subject|3|||
94410931|NCT01049412|323290539|FG000|Period II|Adverse Event|1|||
94410932|NCT01049412|323290540|FG001|Period II|Adverse Event|0|||
94410933|NCT01049412|323290539|FG000|Period II|Lost to Follow-up|1|||
94410934|NCT01049412|323290540|FG001|Period II|Lost to Follow-up|0|||
94410935|NCT01223235|323290541|FG000|Overall Study|Withdrawal by Subject|1|||
94410936|NCT00112294|323290542|FG000|Overall Study|Still on study|5|||
94410937|NCT00112294|323290543|FG001|Overall Study|Still on study|0|||
94410938|NCT02618382|323290544|FG000|Overall Study|Physician Decision|1|||
94410939|NCT02618382|323290544|FG000|Overall Study|Withdrawal by Subject|1|||
94410940|NCT02618382|323290544|FG000|Overall Study|Protocol Violation|1|||
94410941|NCT03235479|323290547|FG000|Overall Study|Lost to Follow-up|8|||
94410942|NCT03235479|323290548|FG001|Overall Study|Lost to Follow-up|11|||
94410943|NCT03235479|323290547|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
94410944|NCT03235479|323290548|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
94410945|NCT03235479|323290547|FG000|Overall Study|Pregnancy|1|||
94410946|NCT03235479|323290548|FG001|Overall Study|Pregnancy|0|||
94410947|NCT03235479|323290547|FG000|Overall Study|Protocol Deviation|1|||
94410948|NCT03235479|323290548|FG001|Overall Study|Protocol Deviation|3|||
94410949|NCT03235479|323290547|FG000|Overall Study|Technical Problems|3|||
94410950|NCT03235479|323290548|FG001|Overall Study|Technical Problems|2|||
94410951|NCT03235479|323290547|FG000|Overall Study|Withdrawal by Subject|2|||
94410952|NCT03235479|323290548|FG001|Overall Study|Withdrawal by Subject|2|||
94410953|NCT03235479|323290547|FG000|Overall Study|Other Reasons|3|||
94410954|NCT03235479|323290548|FG001|Overall Study|Other Reasons|5|||
94410955|NCT02001051|323290549|FG000|Overall Study|Deemed not eligible following enrollment|0|||
94410956|NCT02001051|323290550|FG001|Overall Study|Deemed not eligible following enrollment|1|||
94410957|NCT03110380|323290551|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
94410958|NCT03110380|323290552|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
94410959|NCT03110380|323290553|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
94410960|NCT03110380|323290554|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
94410961|NCT03110380|323290551|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
94410962|NCT03110380|323290552|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
94410963|NCT03110380|323290553|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
94410964|NCT03110380|323290554|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
94410965|NCT03110380|323290551|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
94410966|NCT03110380|323290552|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
94410967|NCT03110380|323290553|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
94410968|NCT03110380|323290554|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
94410969|NCT03110380|323290551|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
94410970|NCT03110380|323290552|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
94410971|NCT03110380|323290553|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
94410972|NCT03110380|323290554|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
94410973|NCT03110380|323290551|FG000|Double-Blind Treatment Phase|Death|2|||
94410974|NCT03110380|323290552|FG001|Double-Blind Treatment Phase|Death|1|||
94410975|NCT03110380|323290553|FG002|Double-Blind Treatment Phase|Death|0|||
94410976|NCT03110380|323290554|FG003|Double-Blind Treatment Phase|Death|0|||
94410977|NCT03110380|323290551|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
94410978|NCT03110380|323290552|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
94410979|NCT03110380|323290553|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
94410980|NCT03110380|323290554|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
94410981|NCT03110380|323290551|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
94410982|NCT03110380|323290552|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
94410983|NCT03110380|323290553|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
94410984|NCT03110380|323290554|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
94410985|NCT03110380|323290551|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
94410986|NCT03110380|323290552|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
94410987|NCT03110380|323290553|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
94410988|NCT03110380|323290554|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
94410989|NCT03110380|323290551|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
94410990|NCT03110380|323290552|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
94410991|NCT03110380|323290553|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
94410992|NCT03110380|323290554|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
94410993|NCT03110380|323290551|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
94410994|NCT03110380|323290552|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
94410995|NCT03110380|323290553|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
94410996|NCT03110380|323290554|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
94410997|NCT03110380|323290551|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
94410998|NCT03110380|323290552|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
94410999|NCT03110380|323290553|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
94411000|NCT03110380|323290554|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
94411001|NCT00707434|323290560|FG000|Overall Study|Adverse Event|1|||
94411002|NCT00983476|323290565|FG000|Overall Study|Did not receive intervention|17|||
94411003|NCT00983476|323290566|FG001|Overall Study|Did not receive intervention|22|||
94411004|NCT00983476|323290567|FG002|Overall Study|Did not receive intervention|0|||
94411005|NCT02762994|323290568|FG000|Overall Study|Withdrawal by Subject|0|||
94411006|NCT02762994|323290569|FG001|Overall Study|Withdrawal by Subject|1|||
94411007|NCT02762994|323290570|FG002|Overall Study|Withdrawal by Subject|2|||
94411008|NCT02762994|323290571|FG003|Overall Study|Withdrawal by Subject|0|||
94411009|NCT02762994|323290568|FG000|Overall Study|Protocol Violation|1|||
94411010|NCT02762994|323290569|FG001|Overall Study|Protocol Violation|0|||
94411011|NCT02762994|323290570|FG002|Overall Study|Protocol Violation|0|||
94411012|NCT02762994|323290571|FG003|Overall Study|Protocol Violation|2|||
94411013|NCT03507686|323290573|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
94411014|NCT03507686|323290574|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
94411015|NCT03507686|323290573|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
94411016|NCT03507686|323290574|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
94411017|NCT03507686|323290573|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
94411018|NCT03507686|323290574|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
94411019|NCT03507686|323290573|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
94411020|NCT03507686|323290574|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
94486953|NCT01663623|323575368|FG001|Overall Study|Withdrawal by Subject|1|||
94411021|NCT03507686|323290573|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
94411022|NCT03507686|323290574|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
94411023|NCT03507686|323290573|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
94486954|NCT00719901|323575370|FG000|Overall Study|Adverse Event|5|||
94411024|NCT03507686|323290574|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
94411025|NCT01857206|323290575|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
94411026|NCT01857206|323290576|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
94411027|NCT01857206|323290575|FG000|Overall Study|Lost to Follow-up|9|||
94411028|NCT01857206|323290576|FG001|Overall Study|Lost to Follow-up|6|||
94411029|NCT01857206|323290575|FG000|Overall Study|Unclassified|3|||
94411030|NCT01857206|323290576|FG001|Overall Study|Unclassified|3|||
94411031|NCT01857206|323290575|FG000|Overall Study|Withdrawal by Subject|1|||
94411032|NCT01857206|323290576|FG001|Overall Study|Withdrawal by Subject|0|||
94411033|NCT02752802|323290587|FG000|Overall Study|Contrast Volume Not Collected|1|||
94411034|NCT02752802|323290588|FG001|Overall Study|Contrast Volume Not Collected|0|||
94411035|NCT02400476|323290589|FG000|Overall Study|Adverse Event|57|||
94411036|NCT02400476|323290590|FG001|Overall Study|Adverse Event|10|||
94411037|NCT02400476|323290591|FG002|Overall Study|Adverse Event|22|||
94411038|NCT02400476|323290592|FG003|Overall Study|Adverse Event|19|||
94411039|NCT02400476|323290593|FG004|Overall Study|Adverse Event|5|||
94411040|NCT02400476|323290594|FG005|Overall Study|Adverse Event|8|||
94411041|NCT02400476|323290589|FG000|Overall Study|Withdrawal by Subject|4|||
94411042|NCT02400476|323290590|FG001|Overall Study|Withdrawal by Subject|1|||
94411043|NCT02400476|323290591|FG002|Overall Study|Withdrawal by Subject|12|||
94411044|NCT02400476|323290592|FG003|Overall Study|Withdrawal by Subject|7|||
94411045|NCT02400476|323290593|FG004|Overall Study|Withdrawal by Subject|5|||
94411046|NCT02400476|323290594|FG005|Overall Study|Withdrawal by Subject|5|||
94411047|NCT02400476|323290589|FG000|Overall Study|Lost to Follow-up|0|||
94411048|NCT02400476|323290590|FG001|Overall Study|Lost to Follow-up|0|||
94411049|NCT02400476|323290591|FG002|Overall Study|Lost to Follow-up|0|||
94411050|NCT02400476|323290592|FG003|Overall Study|Lost to Follow-up|1|||
94411051|NCT02400476|323290593|FG004|Overall Study|Lost to Follow-up|3|||
94411052|NCT02400476|323290594|FG005|Overall Study|Lost to Follow-up|1|||
94411053|NCT02400476|323290589|FG000|Overall Study|Physician Decision|0|||
94411054|NCT02400476|323290590|FG001|Overall Study|Physician Decision|0|||
94411055|NCT02400476|323290591|FG002|Overall Study|Physician Decision|1|||
94411056|NCT02400476|323290592|FG003|Overall Study|Physician Decision|1|||
94411057|NCT02400476|323290593|FG004|Overall Study|Physician Decision|0|||
94411058|NCT02400476|323290594|FG005|Overall Study|Physician Decision|1|||
94411059|NCT02400476|323290589|FG000|Overall Study|Other, Disease Progression|0|||
94411060|NCT02400476|323290590|FG001|Overall Study|Other, Disease Progression|1|||
94411061|NCT02400476|323290591|FG002|Overall Study|Other, Disease Progression|2|||
94411062|NCT02400476|323290592|FG003|Overall Study|Other, Disease Progression|1|||
94411063|NCT02400476|323290593|FG004|Overall Study|Other, Disease Progression|2|||
94411064|NCT02400476|323290594|FG005|Overall Study|Other, Disease Progression|1|||
94411065|NCT02400476|323290589|FG000|Overall Study|Other, Decreased Quality of Life|0|||
94411066|NCT02400476|323290590|FG001|Overall Study|Other, Decreased Quality of Life|0|||
94411067|NCT02400476|323290591|FG002|Overall Study|Other, Decreased Quality of Life|2|||
94411068|NCT02400476|323290592|FG003|Overall Study|Other, Decreased Quality of Life|0|||
94411069|NCT02400476|323290593|FG004|Overall Study|Other, Decreased Quality of Life|0|||
94411070|NCT02400476|323290594|FG005|Overall Study|Other, Decreased Quality of Life|0|||
94411071|NCT02400476|323290589|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
94411072|NCT02400476|323290590|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
94411073|NCT02400476|323290591|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
94411074|NCT02400476|323290592|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
94411075|NCT02400476|323290593|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
94411076|NCT02400476|323290594|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
94411077|NCT01198873|323290595|FG000|Overall Study|Adverse Event|4|||
94411078|NCT01198873|323290596|FG001|Overall Study|Adverse Event|7|||
94411079|NCT01198873|323290595|FG000|Overall Study|Study closure|29|||
94411080|NCT01198873|323290596|FG001|Overall Study|Study closure|23|||
94411081|NCT01198873|323290595|FG000|Overall Study|Other than above|4|||
94411082|NCT01198873|323290596|FG001|Overall Study|Other than above|2|||
94411083|NCT00885677|323290597|FG000|Overall Study|Death|40|||
94411084|NCT00885677|323290598|FG001|Overall Study|Death|34|||
94411085|NCT00885677|323290597|FG000|Overall Study|Lost to Follow-up|15|||
94411086|NCT00885677|323290598|FG001|Overall Study|Lost to Follow-up|13|||
94411087|NCT00885677|323290597|FG000|Overall Study|Protocol Violation|54|||
94411088|NCT00885677|323290598|FG001|Overall Study|Protocol Violation|54|||
94411089|NCT00885677|323290597|FG000|Overall Study|premature study closure|41|||
94411090|NCT00885677|323290598|FG001|Overall Study|premature study closure|44|||
94411091|NCT00885677|323290597|FG000|Overall Study|device/lead revision or replacement|7|||
94411092|NCT00885677|323290598|FG001|Overall Study|device/lead revision or replacement|6|||
94411093|NCT00885677|323290597|FG000|Overall Study|Heart transplantation|1|||
94411094|NCT00885677|323290598|FG001|Overall Study|Heart transplantation|0|||
94411095|NCT00885677|323290597|FG000|Overall Study|Inclusion/exclusion not met|25|||
94411096|NCT00885677|323290598|FG001|Overall Study|Inclusion/exclusion not met|27|||
94411097|NCT02339740|323290599|FG000|Overall Study|Death|1|||
94411098|NCT02339740|323290600|FG001|Overall Study|Death|0|||
94411099|NCT02339740|323290599|FG000|Overall Study|Physician Decision|0|||
94411100|NCT02339740|323290600|FG001|Overall Study|Physician Decision|2|||
94411101|NCT02339740|323290599|FG000|Overall Study|Withdrawal by Subject|5|||
94411102|NCT02339740|323290600|FG001|Overall Study|Withdrawal by Subject|1|||
94411103|NCT02339740|323290599|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
94411104|NCT02339740|323290600|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
94411105|NCT00063882|323290601|FG000|Overall Study|Protocol Violation|3|||
94411106|NCT00063882|323290602|FG001|Overall Study|Protocol Violation|3|||
94411107|NCT00063882|323290601|FG000|Overall Study|Withdrawal by Subject|2|||
94411108|NCT00063882|323290602|FG001|Overall Study|Withdrawal by Subject|1|||
94411109|NCT00438659|323290603|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
94411110|NCT00438659|323290604|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
94411111|NCT00438659|323290603|FG000|Overall Study|Cancel|5|||
94411112|NCT00438659|323290604|FG001|Overall Study|Cancel|2|||
94411113|NCT03718117|323290605|FG000|Overall Study|Death|12|||
94411114|NCT03718117|323290606|FG001|Overall Study|Death|11|||
94411115|NCT03718117|323290607|FG002|Overall Study|Death|0|||
94411116|NCT03718117|323290605|FG000|Overall Study|Other|0|||
94411117|NCT03718117|323290606|FG001|Overall Study|Other|1|||
94411118|NCT03718117|323290607|FG002|Overall Study|Other|0|||
94411119|NCT03718117|323290605|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
94411120|NCT03718117|323290606|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
94411121|NCT03718117|323290607|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
94411122|NCT03718117|323290605|FG000|Overall Study|Participant not met eligibility criteria|0|||
94411123|NCT03718117|323290606|FG001|Overall Study|Participant not met eligibility criteria|0|||
94411124|NCT03718117|323290607|FG002|Overall Study|Participant not met eligibility criteria|2|||
94411125|NCT03823287|323290608|FG000|Overall Study|Withdrawal by Subject|25|||
94411126|NCT03823287|323290609|FG001|Overall Study|Withdrawal by Subject|17|||
94411127|NCT03823287|323290608|FG000|Overall Study|Death|13|||
94411128|NCT03823287|323290609|FG001|Overall Study|Death|7|||
94411129|NCT03823287|323290608|FG000|Overall Study|Lost to Follow-up|7|||
94411130|NCT03823287|323290609|FG001|Overall Study|Lost to Follow-up|8|||
94411131|NCT03823287|323290608|FG000|Overall Study|Adverse Event|6|||
94411132|NCT03823287|323290609|FG001|Overall Study|Adverse Event|8|||
94411133|NCT03823287|323290608|FG000|Overall Study|Physician Decision|5|||
94411134|NCT03823287|323290609|FG001|Overall Study|Physician Decision|2|||
94411135|NCT03823287|323290608|FG000|Overall Study|Lack of Efficacy|2|||
94411136|NCT03823287|323290609|FG001|Overall Study|Lack of Efficacy|0|||
94411137|NCT03823287|323290608|FG000|Overall Study|Other|2|||
94411138|NCT03823287|323290609|FG001|Overall Study|Other|4|||
94411139|NCT01867606|323290610|FG000|Overall Study|Withdrawal by Subject|10|||
94411140|NCT01867606|323290611|FG001|Overall Study|Withdrawal by Subject|14|||
94411141|NCT01867606|323290610|FG000|Overall Study|Protocol Violation|0|||
94411142|NCT01867606|323290611|FG001|Overall Study|Protocol Violation|1|||
94411143|NCT04117945|323290613|FG000|Overall Study|Death|1|||
94411144|NCT04117945|323290614|FG001|Overall Study|Death|0|||
94411145|NCT04117945|323290613|FG000|Overall Study|Withdrawal by Subject|3|||
94411146|NCT04117945|323290614|FG001|Overall Study|Withdrawal by Subject|1|||
94411147|NCT04117945|323290613|FG000|Overall Study|Disease Progression|0|||
94411148|NCT04117945|323290614|FG001|Overall Study|Disease Progression|2|||
94411149|NCT04117945|323290613|FG000|Overall Study|Ineligible|8|||
94411150|NCT04117945|323290614|FG001|Overall Study|Ineligible|7|||
94411151|NCT03366194|323290620|FG000|Overall Study|Lost to Follow-up|2|||
94411152|NCT00442546|323290621|FG000|Overall Study|Adverse Event|11|||
94411153|NCT00442546|323290622|FG001|Overall Study|Adverse Event|17|||
94411154|NCT00442546|323290623|FG002|Overall Study|Adverse Event|13|||
94411155|NCT00442546|323290621|FG000|Overall Study|Lost to Follow-up|1|||
94411156|NCT00442546|323290622|FG001|Overall Study|Lost to Follow-up|2|||
94411157|NCT00442546|323290623|FG002|Overall Study|Lost to Follow-up|1|||
94411158|NCT00442546|323290621|FG000|Overall Study|Other|4|||
94411159|NCT00442546|323290622|FG001|Overall Study|Other|9|||
94411160|NCT00442546|323290623|FG002|Overall Study|Other|6|||
94411161|NCT00442546|323290621|FG000|Overall Study|Withdrawal by Subject|5|||
94411162|NCT00442546|323290622|FG001|Overall Study|Withdrawal by Subject|5|||
94411163|NCT00442546|323290623|FG002|Overall Study|Withdrawal by Subject|7|||
94411164|NCT00442546|323290621|FG000|Overall Study|Randomized But Not Treated|5|||
94411165|NCT00442546|323290622|FG001|Overall Study|Randomized But Not Treated|4|||
94411166|NCT00442546|323290623|FG002|Overall Study|Randomized But Not Treated|6|||
94411167|NCT02843659|323290627|FG000|Overall Study|Subject Withdrew Consent|0|||
94411168|NCT02843659|323290628|FG001|Overall Study|Subject Withdrew Consent|0|||
94411169|NCT02843659|323290629|FG002|Overall Study|Subject Withdrew Consent|1|||
94411170|NCT02843659|323290627|FG000|Overall Study|Administrative Reason by Sponsor|4|||
94411171|NCT02843659|323290628|FG001|Overall Study|Administrative Reason by Sponsor|5|||
94411172|NCT02843659|323290629|FG002|Overall Study|Administrative Reason by Sponsor|4|||
94411173|NCT02843659|323290627|FG000|Overall Study|Adverse Event|0|||
94411174|NCT02843659|323290628|FG001|Overall Study|Adverse Event|1|||
94411175|NCT02843659|323290629|FG002|Overall Study|Adverse Event|0|||
94411176|NCT01253317|323290639|FG000|Overall Study|Adverse Event|2|||
94411177|NCT02756637|323290640|FG000|Overall Study|Not eligible for initial SWOG study|10|||
94411178|NCT02756637|323290641|FG001|Overall Study|Not eligible for initial SWOG study|10|||
94411179|NCT02756637|323290640|FG000|Overall Study|No available NLR value|44|||
94411180|NCT02756637|323290641|FG001|Overall Study|No available NLR value|44|||
94411181|NCT02756637|323290640|FG000|Overall Study|Did not complete curative therapy|33|||
94411182|NCT02756637|323290641|FG001|Overall Study|Did not complete curative therapy|0|||
94411183|NCT00749411|323290642|FG000|Overall Study|Adverse Event|0|||
94411184|NCT00749411|323290643|FG001|Overall Study|Adverse Event|2|||
94411185|NCT00749411|323290642|FG000|Overall Study|Lack of Efficacy|0|||
94411186|NCT00749411|323290643|FG001|Overall Study|Lack of Efficacy|1|||
94411187|NCT00749411|323290642|FG000|Overall Study|Protocol Violation|1|||
94411188|NCT00749411|323290643|FG001|Overall Study|Protocol Violation|1|||
94411189|NCT00749411|323290642|FG000|Overall Study|Protocol-defined stopping criteria|0|||
94411190|NCT00749411|323290643|FG001|Overall Study|Protocol-defined stopping criteria|1|||
94411191|NCT03183141|323290644|FG000|Overall Study|Withdrawal by Subject|2|||
94411192|NCT03183141|323290645|FG001|Overall Study|Withdrawal by Subject|4|||
94411193|NCT03183141|323290644|FG000|Overall Study|Death|0|||
94411194|NCT03183141|323290645|FG001|Overall Study|Death|8|||
94411195|NCT01923311|323292578|FG000|Overall Study|Pregnancy|1|||
94411196|NCT01923311|323292579|FG001|Overall Study|Pregnancy|0|||
94411197|NCT01923311|323292578|FG000|Overall Study|Investigator's Discretion|1|||
94411198|NCT01923311|323292579|FG001|Overall Study|Investigator's Discretion|0|||
94411199|NCT01923311|323292578|FG000|Overall Study|Non-Compliance with Study Drug|2|||
94411200|NCT01923311|323292579|FG001|Overall Study|Non-Compliance with Study Drug|1|||
94411201|NCT01923311|323292578|FG000|Overall Study|Withdrew Consent|1|||
94411202|NCT01923311|323292579|FG001|Overall Study|Withdrew Consent|0|||
94411203|NCT01923311|323292578|FG000|Overall Study|Study Terminated by Sponsor|12|||
94411204|NCT01923311|323292579|FG001|Overall Study|Study Terminated by Sponsor|0|||
94411205|NCT00401245|323292580|FG000|Double Blind Titration Phase|Adverse Event|3|||
94411206|NCT00401245|323292581|FG001|Double Blind Titration Phase|Adverse Event|2|||
94411207|NCT00401245|323292582|FG002|Double Blind Titration Phase|Adverse Event|5|||
94411208|NCT00401245|323292583|FG003|Double Blind Titration Phase|Adverse Event|12|||
94411209|NCT00401245|323292584|FG004|Double Blind Titration Phase|Adverse Event|0|||
94411210|NCT00401245|323292585|FG005|Double Blind Titration Phase|Adverse Event|0|||
94411211|NCT00401245|323292586|FG006|Double Blind Titration Phase|Adverse Event|0|||
94411212|NCT00401245|323292587|FG007|Double Blind Titration Phase|Adverse Event|0|||
94411213|NCT00401245|323292580|FG000|Double Blind Titration Phase|Other|0|||
94411214|NCT00401245|323292581|FG001|Double Blind Titration Phase|Other|0|||
94411215|NCT00401245|323292582|FG002|Double Blind Titration Phase|Other|1|||
94411216|NCT00401245|323292583|FG003|Double Blind Titration Phase|Other|0|||
94411217|NCT00401245|323292584|FG004|Double Blind Titration Phase|Other|0|||
94411218|NCT00401245|323292585|FG005|Double Blind Titration Phase|Other|0|||
94411219|NCT00401245|323292586|FG006|Double Blind Titration Phase|Other|0|||
94411220|NCT00401245|323292587|FG007|Double Blind Titration Phase|Other|0|||
94411221|NCT00401245|323292580|FG000|Double Blind Titration Phase|Protocol Violation|0|||
94411222|NCT00401245|323292581|FG001|Double Blind Titration Phase|Protocol Violation|0|||
94411223|NCT00401245|323292582|FG002|Double Blind Titration Phase|Protocol Violation|0|||
94411224|NCT00401245|323292583|FG003|Double Blind Titration Phase|Protocol Violation|1|||
94411225|NCT00401245|323292584|FG004|Double Blind Titration Phase|Protocol Violation|0|||
94411226|NCT00401245|323292585|FG005|Double Blind Titration Phase|Protocol Violation|0|||
94411227|NCT00401245|323292586|FG006|Double Blind Titration Phase|Protocol Violation|0|||
94411228|NCT00401245|323292587|FG007|Double Blind Titration Phase|Protocol Violation|0|||
94411229|NCT00401245|323292580|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
94411230|NCT00401245|323292581|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
94411231|NCT00401245|323292582|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
94411232|NCT00401245|323292583|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
94411233|NCT00401245|323292584|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
94411234|NCT00401245|323292585|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
94411235|NCT00401245|323292586|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
94411236|NCT00401245|323292587|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
94411237|NCT00401245|323292580|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
94411238|NCT00401245|323292581|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
94411239|NCT00401245|323292582|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
94411240|NCT00401245|323292583|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
94411241|NCT00401245|323292584|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
94411242|NCT00401245|323292585|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
94411243|NCT00401245|323292586|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
94411244|NCT00401245|323292587|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
94411245|NCT00401245|323292580|FG000|Open Label Phase|Adverse Event|5|||
94411246|NCT00401245|323292581|FG001|Open Label Phase|Adverse Event|14|||
94411247|NCT00401245|323292582|FG002|Open Label Phase|Adverse Event|6|||
94411248|NCT00401245|323292583|FG003|Open Label Phase|Adverse Event|7|||
94411249|NCT00401245|323292584|FG004|Open Label Phase|Adverse Event|0|||
94411250|NCT00401245|323292585|FG005|Open Label Phase|Adverse Event|0|||
94411251|NCT00401245|323292586|FG006|Open Label Phase|Adverse Event|0|||
94411252|NCT00401245|323292587|FG007|Open Label Phase|Adverse Event|0|||
94411253|NCT00401245|323292580|FG000|Open Label Phase|Lost to Follow-up|5|||
94411254|NCT00401245|323292581|FG001|Open Label Phase|Lost to Follow-up|7|||
94411255|NCT00401245|323292582|FG002|Open Label Phase|Lost to Follow-up|5|||
94411256|NCT00401245|323292583|FG003|Open Label Phase|Lost to Follow-up|4|||
94411257|NCT00401245|323292584|FG004|Open Label Phase|Lost to Follow-up|0|||
94411258|NCT00401245|323292585|FG005|Open Label Phase|Lost to Follow-up|0|||
94411259|NCT00401245|323292586|FG006|Open Label Phase|Lost to Follow-up|0|||
94411260|NCT00401245|323292587|FG007|Open Label Phase|Lost to Follow-up|0|||
94411261|NCT00401245|323292580|FG000|Open Label Phase|Other|4|||
94411262|NCT00401245|323292581|FG001|Open Label Phase|Other|8|||
94411263|NCT00401245|323292582|FG002|Open Label Phase|Other|7|||
94411264|NCT00401245|323292583|FG003|Open Label Phase|Other|8|||
94411265|NCT00401245|323292584|FG004|Open Label Phase|Other|0|||
94411266|NCT00401245|323292585|FG005|Open Label Phase|Other|0|||
94411267|NCT00401245|323292586|FG006|Open Label Phase|Other|0|||
94411268|NCT00401245|323292587|FG007|Open Label Phase|Other|0|||
94411269|NCT00401245|323292580|FG000|Open Label Phase|Protocol Violation|0|||
94411270|NCT00401245|323292581|FG001|Open Label Phase|Protocol Violation|1|||
94411271|NCT00401245|323292582|FG002|Open Label Phase|Protocol Violation|0|||
94411272|NCT00401245|323292583|FG003|Open Label Phase|Protocol Violation|1|||
94411273|NCT00401245|323292584|FG004|Open Label Phase|Protocol Violation|0|||
94411274|NCT00401245|323292585|FG005|Open Label Phase|Protocol Violation|0|||
94411275|NCT00401245|323292586|FG006|Open Label Phase|Protocol Violation|0|||
94411276|NCT00401245|323292587|FG007|Open Label Phase|Protocol Violation|0|||
94411277|NCT00401245|323292580|FG000|Open Label Phase|Withdrawal by Subject|3|||
94411278|NCT00401245|323292581|FG001|Open Label Phase|Withdrawal by Subject|3|||
94411279|NCT00401245|323292582|FG002|Open Label Phase|Withdrawal by Subject|2|||
94411280|NCT00401245|323292583|FG003|Open Label Phase|Withdrawal by Subject|1|||
94411281|NCT00401245|323292584|FG004|Open Label Phase|Withdrawal by Subject|0|||
94411282|NCT00401245|323292585|FG005|Open Label Phase|Withdrawal by Subject|0|||
94411283|NCT00401245|323292586|FG006|Open Label Phase|Withdrawal by Subject|0|||
94411284|NCT00401245|323292587|FG007|Open Label Phase|Withdrawal by Subject|0|||
94411285|NCT00401245|323292580|FG000|Open Label Phase|Lack of Efficacy|4|||
94411286|NCT00401245|323292581|FG001|Open Label Phase|Lack of Efficacy|2|||
94411287|NCT00401245|323292582|FG002|Open Label Phase|Lack of Efficacy|3|||
94411288|NCT00401245|323292583|FG003|Open Label Phase|Lack of Efficacy|0|||
94411289|NCT00401245|323292584|FG004|Open Label Phase|Lack of Efficacy|0|||
94411290|NCT00401245|323292585|FG005|Open Label Phase|Lack of Efficacy|0|||
94411291|NCT00401245|323292586|FG006|Open Label Phase|Lack of Efficacy|0|||
94411292|NCT00401245|323292587|FG007|Open Label Phase|Lack of Efficacy|0|||
94411293|NCT00401245|323292580|FG000|Double Blind Tapering Phase|Adverse Event|0|||
94411294|NCT00401245|323292581|FG001|Double Blind Tapering Phase|Adverse Event|0|||
94411295|NCT00401245|323292582|FG002|Double Blind Tapering Phase|Adverse Event|0|||
94411296|NCT00401245|323292583|FG003|Double Blind Tapering Phase|Adverse Event|0|||
94411297|NCT00401245|323292584|FG004|Double Blind Tapering Phase|Adverse Event|1|||
94411298|NCT00401245|323292585|FG005|Double Blind Tapering Phase|Adverse Event|1|||
94411299|NCT00401245|323292586|FG006|Double Blind Tapering Phase|Adverse Event|2|||
94411300|NCT00401245|323292587|FG007|Double Blind Tapering Phase|Adverse Event|4|||
94411301|NCT00401245|323292580|FG000|Double Blind Tapering Phase|Investigator request|0|||
94411302|NCT00401245|323292581|FG001|Double Blind Tapering Phase|Investigator request|0|||
94411303|NCT00401245|323292582|FG002|Double Blind Tapering Phase|Investigator request|0|||
94411304|NCT00401245|323292583|FG003|Double Blind Tapering Phase|Investigator request|0|||
94411305|NCT00401245|323292584|FG004|Double Blind Tapering Phase|Investigator request|0|||
94411306|NCT00401245|323292585|FG005|Double Blind Tapering Phase|Investigator request|0|||
94411307|NCT00401245|323292586|FG006|Double Blind Tapering Phase|Investigator request|0|||
94411308|NCT00401245|323292587|FG007|Double Blind Tapering Phase|Investigator request|1|||
94411309|NCT00401245|323292580|FG000|Double Blind Tapering Phase|Other|0|||
94411310|NCT00401245|323292581|FG001|Double Blind Tapering Phase|Other|0|||
94411311|NCT00401245|323292582|FG002|Double Blind Tapering Phase|Other|0|||
94411312|NCT00401245|323292583|FG003|Double Blind Tapering Phase|Other|0|||
94411313|NCT00401245|323292584|FG004|Double Blind Tapering Phase|Other|1|||
94411314|NCT00401245|323292585|FG005|Double Blind Tapering Phase|Other|0|||
94411315|NCT00401245|323292586|FG006|Double Blind Tapering Phase|Other|2|||
94411316|NCT00401245|323292587|FG007|Double Blind Tapering Phase|Other|2|||
94411317|NCT00401245|323292580|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
94411318|NCT00401245|323292581|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
94411319|NCT00401245|323292582|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
94411320|NCT00401245|323292583|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
94411321|NCT00401245|323292584|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
94411322|NCT00401245|323292585|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
94411323|NCT00401245|323292586|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
94411324|NCT00401245|323292587|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
94411325|NCT00401245|323292580|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
94486955|NCT00719901|323575370|FG000|Overall Study|Withdrawal by Subject|1|||
94486956|NCT00719901|323575370|FG000|Overall Study|Alternate Treatment|1|||
94486957|NCT00719901|323575370|FG000|Overall Study|Disease Progression|3|||
94486958|NCT00719901|323575370|FG000|Overall Study|Availability of Study Drug|1|||
94486959|NCT04456686|323575371|FG000|Overall Study|Adverse Event|2|||
94486960|NCT04456686|323575372|FG001|Overall Study|Adverse Event|1|||
94486961|NCT04456686|323575371|FG000|Overall Study|Lack of Efficacy|3|||
94486962|NCT04456686|323575372|FG001|Overall Study|Lack of Efficacy|1|||
94486963|NCT04456686|323575371|FG000|Overall Study|Withdrew consent|3|||
94486964|NCT04456686|323575372|FG001|Overall Study|Withdrew consent|1|||
94486965|NCT04456686|323575371|FG000|Overall Study|Physician Decision|2|||
94486966|NCT04456686|323575372|FG001|Overall Study|Physician Decision|2|||
94486967|NCT04456686|323575371|FG000|Overall Study|Withdrawal by Subject|5|||
94486968|NCT04456686|323575372|FG001|Overall Study|Withdrawal by Subject|1|||
94486969|NCT04456686|323575371|FG000|Overall Study|Protocol Violation|0|||
94486970|NCT04456686|323575372|FG001|Overall Study|Protocol Violation|1|||
94486971|NCT02732639|323575379|FG000|Overall Study|Lost to Follow-up|1|||
94486972|NCT00748241|323575380|FG000|Overall Study|Implant failure|1|||
94486973|NCT00748241|323575380|FG000|Overall Study|Lost to Follow-up|5|||
94486974|NCT00748241|323575380|FG000|Overall Study|Death|2|||
94486975|NCT03575702|323575381|FG000|Overall Study|Withdrawal by Subject|1|||
94486976|NCT03575702|323575382|FG001|Overall Study|Withdrawal by Subject|1|||
94486977|NCT03575702|323575381|FG000|Overall Study|Lost to Follow-up|1|||
94486978|NCT03575702|323575382|FG001|Overall Study|Lost to Follow-up|2|||
94486979|NCT03575702|323575381|FG000|Overall Study|Protocol Violation|0|||
94486980|NCT03575702|323575382|FG001|Overall Study|Protocol Violation|1|||
94486981|NCT03575702|323575381|FG000|Overall Study|Patient non compliance|4|||
94486982|NCT03575702|323575382|FG001|Overall Study|Patient non compliance|0|||
94486983|NCT04210986|323575383|FG000|Overall Study|Lost to Follow-up|5|||
94486984|NCT04210986|323575384|FG001|Overall Study|Lost to Follow-up|2|||
94486985|NCT04210986|323575383|FG000|Overall Study|Withdrawal by Subject|3|||
94486986|NCT04210986|323575384|FG001|Overall Study|Withdrawal by Subject|1|||
94486987|NCT04210986|323575383|FG000|Overall Study|Protocol Violation|1|||
94486988|NCT04210986|323575384|FG001|Overall Study|Protocol Violation|1|||
94486989|NCT04210986|323575383|FG000|Overall Study|Physician Decision|0|||
94486990|NCT04210986|323575384|FG001|Overall Study|Physician Decision|1|||
94486991|NCT05401565|323575385|FG000|Overall Study|Lost to Follow-up|1|||
94486992|NCT05401565|323575386|FG001|Overall Study|Lost to Follow-up|0|||
94486993|NCT05401565|323575385|FG000|Overall Study|Adverse Event|2|||
94486994|NCT05401565|323575386|FG001|Overall Study|Adverse Event|0|||
94486995|NCT02144701|323575387|FG000|Overall Study|development of relapse, GVHD or death|9|||
94486996|NCT02144701|323575388|FG001|Overall Study|development of relapse, GVHD or death|3|||
94486997|NCT02475369|323575389|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
94486998|NCT02475369|323575390|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
94486999|NCT03368807|323575397|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
94487000|NCT03368807|323575397|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
94487001|NCT03368807|323575397|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
94487002|NCT03368807|323575397|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
94487003|NCT01677741|323575402|FG000|Overall Study|Death|0|||
94487004|NCT01677741|323575403|FG001|Overall Study|Death|0|||
94487005|NCT01677741|323575404|FG002|Overall Study|Death|0|||
94487006|NCT01677741|323575405|FG003|Overall Study|Death|1|||
94487007|NCT01677741|323575406|FG004|Overall Study|Death|0|||
94487008|NCT01677741|323575407|FG005|Overall Study|Death|1|||
94487009|NCT01677741|323575408|FG006|Overall Study|Death|0|||
94487010|NCT01677741|323575409|FG007|Overall Study|Death|0|||
94487011|NCT01677741|323575402|FG000|Overall Study|Withdrawal by Subject|2|||
94487012|NCT01677741|323575403|FG001|Overall Study|Withdrawal by Subject|7|||
94487013|NCT01677741|323575404|FG002|Overall Study|Withdrawal by Subject|5|||
94487014|NCT01677741|323575405|FG003|Overall Study|Withdrawal by Subject|4|||
94487015|NCT01677741|323575406|FG004|Overall Study|Withdrawal by Subject|11|||
94487016|NCT01677741|323575407|FG005|Overall Study|Withdrawal by Subject|20|||
94487017|NCT01677741|323575408|FG006|Overall Study|Withdrawal by Subject|4|||
94487018|NCT01677741|323575409|FG007|Overall Study|Withdrawal by Subject|2|||
94487019|NCT01677741|323575402|FG000|Overall Study|Enrolled in a rollover study|0|||
94487020|NCT01677741|323575403|FG001|Overall Study|Enrolled in a rollover study|3|||
94487021|NCT01677741|323575404|FG002|Overall Study|Enrolled in a rollover study|2|||
94487022|NCT01677741|323575405|FG003|Overall Study|Enrolled in a rollover study|1|||
94487023|NCT01677741|323575406|FG004|Overall Study|Enrolled in a rollover study|6|||
94487024|NCT01677741|323575407|FG005|Overall Study|Enrolled in a rollover study|6|||
94487025|NCT01677741|323575408|FG006|Overall Study|Enrolled in a rollover study|7|||
94487026|NCT01677741|323575409|FG007|Overall Study|Enrolled in a rollover study|0|||
94487027|NCT01677741|323575402|FG000|Overall Study|Progressive disease|1|||
94487028|NCT01677741|323575403|FG001|Overall Study|Progressive disease|0|||
94487029|NCT01677741|323575404|FG002|Overall Study|Progressive disease|1|||
94487030|NCT01677741|323575405|FG003|Overall Study|Progressive disease|0|||
94487031|NCT01677741|323575406|FG004|Overall Study|Progressive disease|0|||
94487032|NCT01677741|323575407|FG005|Overall Study|Progressive disease|1|||
94487033|NCT01677741|323575408|FG006|Overall Study|Progressive disease|0|||
94487034|NCT01677741|323575409|FG007|Overall Study|Progressive disease|0|||
94487035|NCT00617279|323575411|FG000|Overall Study|Study terminated by Sponsor|10|||
94487036|NCT00617279|323575412|FG001|Overall Study|Study terminated by Sponsor|15|||
94487037|NCT00617279|323575411|FG000|Overall Study|Graft abandonment|2|||
94487038|NCT00617279|323575412|FG001|Overall Study|Graft abandonment|0|||
94487039|NCT00617279|323575411|FG000|Overall Study|Lost to Follow-up|1|||
94487040|NCT00617279|323575412|FG001|Overall Study|Lost to Follow-up|0|||
94487041|NCT00617279|323575411|FG000|Overall Study|Death|1|||
94487042|NCT00617279|323575412|FG001|Overall Study|Death|2|||
94487043|NCT01548599|323577424|FG000|Overall Study|Lost to Follow-up|0|||
94487044|NCT01548599|323577425|FG001|Overall Study|Lost to Follow-up|1|||
94487045|NCT01548599|323577424|FG000|Overall Study|Withdrawal by Subject|4|||
94487046|NCT01548599|323577425|FG001|Overall Study|Withdrawal by Subject|0|||
94487047|NCT01548599|323577424|FG000|Overall Study|Death|2|||
94487048|NCT01548599|323577425|FG001|Overall Study|Death|1|||
94487049|NCT05630196|323577426|FG000|Overall Study|Adverse Event|2|||
94487050|NCT05630196|323577427|FG001|Overall Study|Adverse Event|1|||
94487051|NCT05630196|323577426|FG000|Overall Study|Lost to Follow-up|1|||
94487052|NCT05630196|323577427|FG001|Overall Study|Lost to Follow-up|1|||
94487053|NCT05630196|323577426|FG000|Overall Study|Protocol Violation|2|||
94487054|NCT05630196|323577427|FG001|Overall Study|Protocol Violation|3|||
94411326|NCT00401245|323292581|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
94411327|NCT00401245|323292582|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
94411328|NCT00401245|323292583|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
94411329|NCT00401245|323292584|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
94411330|NCT00401245|323292585|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
94411331|NCT00401245|323292586|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
94411332|NCT00401245|323292587|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
94411333|NCT01560819|323292591|FG000|Overall Study|Physician Decision|1|||
94411334|NCT01560819|323292592|FG001|Overall Study|Physician Decision|0|||
94411335|NCT02938442|323292593|FG000|Overall Study|Death|0|||
94411336|NCT02938442|323292594|FG001|Overall Study|Death|1|||
94411337|NCT02938442|323292593|FG000|Overall Study|Lost to Follow-up|0|||
94411338|NCT02938442|323292594|FG001|Overall Study|Lost to Follow-up|1|||
94411339|NCT02938442|323292593|FG000|Overall Study|Physician Decision|0|||
94411340|NCT02938442|323292594|FG001|Overall Study|Physician Decision|1|||
94411341|NCT02938442|323292593|FG000|Overall Study|Withdrawal by Subject|2|||
94411342|NCT02938442|323292594|FG001|Overall Study|Withdrawal by Subject|0|||
94411343|NCT00546910|323292597|FG000|Overall Study|Adverse Event|2|||
94411344|NCT00546910|323292598|FG001|Overall Study|Adverse Event|3|||
94411345|NCT00546910|323292597|FG000|Overall Study|Lack of Efficacy|5|||
94411346|NCT00546910|323292598|FG001|Overall Study|Lack of Efficacy|7|||
94411347|NCT00546910|323292597|FG000|Overall Study|Physician Decision|0|||
94411348|NCT00546910|323292598|FG001|Overall Study|Physician Decision|1|||
94411349|NCT00546910|323292597|FG000|Overall Study|Withdrawal by Subject|2|||
94411350|NCT00546910|323292598|FG001|Overall Study|Withdrawal by Subject|0|||
94411351|NCT01115855|323292599|FG000|Overall Study|Adverse Event|16|||
94411352|NCT01115855|323292600|FG001|Overall Study|Adverse Event|18|||
94411353|NCT01115855|323292599|FG000|Overall Study|Death|6|||
94411354|NCT01115855|323292600|FG001|Overall Study|Death|5|||
94411355|NCT01115855|323292599|FG000|Overall Study|Lab Abnormality|1|||
94411356|NCT01115855|323292600|FG001|Overall Study|Lab Abnormality|1|||
94411357|NCT01115855|323292599|FG000|Overall Study|Protocol Violation|0|||
94411358|NCT01115855|323292600|FG001|Overall Study|Protocol Violation|1|||
94411359|NCT01115855|323292599|FG000|Overall Study|Withdrawal by Subject|5|||
94411360|NCT01115855|323292600|FG001|Overall Study|Withdrawal by Subject|5|||
94411361|NCT01115855|323292599|FG000|Overall Study|Other|8|||
94411362|NCT01115855|323292600|FG001|Overall Study|Other|6|||
94411363|NCT01467479|323292601|FG000|Overall Study|No Study Medication|1|||
94487055|NCT05630196|323577426|FG000|Overall Study|Physician Decision|1|||
94487056|NCT05630196|323577427|FG001|Overall Study|Physician Decision|0|||
94411364|NCT01467479|323292602|FG001|Overall Study|No Study Medication|0|||
94411365|NCT01467479|323292603|FG002|Overall Study|No Study Medication|2|||
94487057|NCT05630196|323577426|FG000|Overall Study|Withdrawal by Subject|3|||
94487058|NCT05630196|323577427|FG001|Overall Study|Withdrawal by Subject|4|||
94487059|NCT02997163|323577428|FG000|Overall Study|Adverse Event|1|||
94487060|NCT02997163|323577429|FG001|Overall Study|Adverse Event|0|||
94411366|NCT01467479|323292601|FG000|Overall Study|Adverse Event|1|||
94411367|NCT01467479|323292602|FG001|Overall Study|Adverse Event|2|||
94487061|NCT02997163|323577430|FG002|Overall Study|Adverse Event|0|||
94487062|NCT02997163|323577431|FG003|Overall Study|Adverse Event|1|||
94487063|NCT00945243|323577432|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
94487064|NCT00922636|323577433|FG000|Overall Study|Adverse Event|3|||
94487065|NCT00922636|323577434|FG001|Overall Study|Adverse Event|3|||
94411368|NCT01467479|323292603|FG002|Overall Study|Adverse Event|0|||
94411369|NCT01467479|323292601|FG000|Overall Study|Death|0|||
94411370|NCT01467479|323292602|FG001|Overall Study|Death|0|||
94411371|NCT01467479|323292603|FG002|Overall Study|Death|1|||
94411372|NCT01467479|323292601|FG000|Overall Study|Lost to Follow-up|2|||
94411373|NCT01467479|323292602|FG001|Overall Study|Lost to Follow-up|5|||
94411374|NCT01467479|323292603|FG002|Overall Study|Lost to Follow-up|3|||
94411375|NCT01467479|323292601|FG000|Overall Study|Withdrawal of Consent|3|||
94411376|NCT01467479|323292602|FG001|Overall Study|Withdrawal of Consent|7|||
94411377|NCT01467479|323292603|FG002|Overall Study|Withdrawal of Consent|7|||
94411378|NCT01467479|323292601|FG000|Overall Study|Study Terminated by Sponsor|1|||
94411379|NCT01467479|323292602|FG001|Overall Study|Study Terminated by Sponsor|3|||
94411380|NCT01467479|323292603|FG002|Overall Study|Study Terminated by Sponsor|3|||
94411381|NCT01467479|323292601|FG000|Overall Study|Other|1|||
94411382|NCT01467479|323292602|FG001|Overall Study|Other|0|||
94411383|NCT01467479|323292603|FG002|Overall Study|Other|0|||
94411384|NCT02457819|323292607|FG000|Overall Study|reason not given|8|||
94411385|NCT02457819|323292607|FG000|Overall Study|Withdrawal by Subject|24|||
94411386|NCT02457819|323292607|FG000|Overall Study|Protocol Violation|1|||
94411387|NCT02457819|323292607|FG000|Overall Study|non compliance with study drug|4|||
94411388|NCT02457819|323292607|FG000|Overall Study|Lost to Follow-up|10|||
94411389|NCT02457819|323292607|FG000|Overall Study|Lack of Efficacy|19|||
94411390|NCT02457819|323292607|FG000|Overall Study|Adverse Event|33|||
94411391|NCT03330236|323292609|FG000|Overall Study|Death|2|||
94411392|NCT03330236|323292610|FG001|Overall Study|Death|1|||
94411393|NCT03330236|323292609|FG000|Overall Study|Withdrawal by Subject|2|||
94411394|NCT03330236|323292610|FG001|Overall Study|Withdrawal by Subject|4|||
94411395|NCT03330236|323292609|FG000|Overall Study|Lost to Follow-up|0|||
94411396|NCT03330236|323292610|FG001|Overall Study|Lost to Follow-up|2|||
94411397|NCT03330236|323292609|FG000|Overall Study|Physician Decision|2|||
94411398|NCT03330236|323292610|FG001|Overall Study|Physician Decision|0|||
94411399|NCT03330236|323292609|FG000|Overall Study|Protocol Violation|4|||
94411400|NCT03330236|323292610|FG001|Overall Study|Protocol Violation|3|||
94411401|NCT03330236|323292609|FG000|Overall Study|SedLine malfunction/blinding|19|||
94411402|NCT03330236|323292610|FG001|Overall Study|SedLine malfunction/blinding|14|||
94411403|NCT03330236|323292609|FG000|Overall Study|Volatile anesthetics used|11|||
94411404|NCT03330236|323292610|FG001|Overall Study|Volatile anesthetics used|8|||
94411405|NCT03330236|323292609|FG000|Overall Study|Surgery aborted/converted to open|60|||
94411406|NCT03330236|323292610|FG001|Overall Study|Surgery aborted/converted to open|52|||
94411407|NCT01684215|323292611|FG000|Phase 1, Part 1|Adverse Event|1|||
94411408|NCT01684215|323292612|FG001|Phase 1, Part 1|Adverse Event|0|||
94411409|NCT01684215|323292613|FG002|Phase 1, Part 1|Adverse Event|0|||
94411410|NCT01684215|323292614|FG003|Phase 1, Part 1|Adverse Event|0|||
94411411|NCT01684215|323292611|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
94411412|NCT01684215|323292612|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
94411413|NCT01684215|323292613|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
94411414|NCT01684215|323292614|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
94411415|NCT01684215|323292611|FG000|Phase 1, Part 2|Adverse Event|0|||
94411416|NCT01684215|323292612|FG001|Phase 1, Part 2|Adverse Event|0|||
94411417|NCT01684215|323292613|FG002|Phase 1, Part 2|Adverse Event|1|||
94411418|NCT01684215|323292614|FG003|Phase 1, Part 2|Adverse Event|0|||
94411419|NCT01684215|323292611|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
94411420|NCT01684215|323292612|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
94411421|NCT01684215|323292613|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
94411422|NCT01684215|323292614|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
94411423|NCT01684215|323292611|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
94411424|NCT01684215|323292612|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
94411425|NCT01684215|323292613|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
94411426|NCT01684215|323292614|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
94411427|NCT01684215|323292611|FG000|Phase 2|Death|0|||
94411428|NCT01684215|323292612|FG001|Phase 2|Death|0|||
94411429|NCT01684215|323292613|FG002|Phase 2|Death|0|||
94411430|NCT01684215|323292614|FG003|Phase 2|Death|8|||
94411431|NCT01684215|323292611|FG000|Phase 2|Study terminated by sponsor|0|||
94411432|NCT01684215|323292612|FG001|Phase 2|Study terminated by sponsor|0|||
94411433|NCT01684215|323292613|FG002|Phase 2|Study terminated by sponsor|0|||
94411434|NCT01684215|323292614|FG003|Phase 2|Study terminated by sponsor|30|||
94411435|NCT01684215|323292611|FG000|Phase 2|Enrolled but not treated|0|||
94411436|NCT01684215|323292612|FG001|Phase 2|Enrolled but not treated|0|||
94411437|NCT01684215|323292613|FG002|Phase 2|Enrolled but not treated|0|||
94411438|NCT01684215|323292614|FG003|Phase 2|Enrolled but not treated|1|||
94411439|NCT01684215|323292611|FG000|Phase 2|Lost to Follow-up|0|||
94411440|NCT01684215|323292612|FG001|Phase 2|Lost to Follow-up|0|||
94411441|NCT01684215|323292613|FG002|Phase 2|Lost to Follow-up|0|||
94411442|NCT01684215|323292614|FG003|Phase 2|Lost to Follow-up|4|||
94411443|NCT00407745|323292619|FG000|Overall Study|Lack of Efficacy|1|||
94411444|NCT00407745|323292620|FG001|Overall Study|Lack of Efficacy|2|||
94411445|NCT00407745|323292619|FG000|Overall Study|Withdrawal by Subject|3|||
94411446|NCT00407745|323292620|FG001|Overall Study|Withdrawal by Subject|3|||
94411447|NCT00407745|323292619|FG000|Overall Study|Protocol Violation|5|||
94411448|NCT00407745|323292620|FG001|Overall Study|Protocol Violation|3|||
94411449|NCT00407745|323292619|FG000|Overall Study|Adverse Event|8|||
94411450|NCT00407745|323292620|FG001|Overall Study|Adverse Event|8|||
94411451|NCT00407745|323292619|FG000|Overall Study|Other|2|||
94411452|NCT00407745|323292620|FG001|Overall Study|Other|0|||
94411453|NCT00407745|323292619|FG000|Overall Study|Randomized, unknown if treated|0|||
94411454|NCT00407745|323292620|FG001|Overall Study|Randomized, unknown if treated|1|||
94411455|NCT01563237|323292621|FG000|Overall Study|Lost to Follow-up|6|||
94411456|NCT01563237|323292622|FG001|Overall Study|Lost to Follow-up|0|||
94411457|NCT01563237|323292621|FG000|Overall Study|Withdrawal by Subject|1|||
94411458|NCT01563237|323292622|FG001|Overall Study|Withdrawal by Subject|0|||
94411459|NCT01563237|323292621|FG000|Overall Study|Adverse Event|1|||
94411460|NCT01563237|323292622|FG001|Overall Study|Adverse Event|0|||
94411461|NCT01563237|323292621|FG000|Overall Study|Medical Reasons|1|||
94411462|NCT01563237|323292622|FG001|Overall Study|Medical Reasons|0|||
94411463|NCT01563237|323292621|FG000|Overall Study|Death|1|||
94411464|NCT01563237|323292622|FG001|Overall Study|Death|0|||
94411465|NCT01552369|323292623|FG000|Overall Study|Did not consent to extended follow up|8|||
94411466|NCT01552369|323292624|FG001|Overall Study|Did not consent to extended follow up|9|||
94411467|NCT00097786|323292632|FG000|Overall Study|lost to follow-up for all-cause death|296|||
94411468|NCT00097786|323292633|FG001|Overall Study|lost to follow-up for all-cause death|292|||
94411469|NCT00097786|323292634|FG002|Overall Study|lost to follow-up for all-cause death|313|||
94411470|NCT00097786|323292635|FG003|Overall Study|lost to follow-up for all-cause death|310|||
94411471|NCT02940730|323292636|FG000|Intervention 2|Physician Decision|7|||
94411472|NCT02940730|323292637|FG001|Intervention 2|Physician Decision|0|||
94411473|NCT00298740|323292639|FG000|Overall Study|Lack of Efficacy|6|||
94411474|NCT00298740|323292639|FG000|Overall Study|Withdrawal by Subject|3|||
94411475|NCT05132569|323292640|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
94411476|NCT05132569|323292641|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
94411477|NCT05132569|323292640|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
94411478|NCT05132569|323292641|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
94411479|NCT05132569|323292640|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
94411480|NCT05132569|323292641|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
94411481|NCT00977548|323292643|FG000|Overall Study|Ineligible|4|||
94411482|NCT00977548|323292643|FG000|Overall Study|Adverse Event|8|||
94411483|NCT00977548|323292643|FG000|Overall Study|Withdrawal by Subject|1|||
94411484|NCT04142242|323292644|FG000|Stage I|Non-compliance with the protocol|1|||
94411485|NCT04142242|323292645|FG001|Stage I|Non-compliance with the protocol|0|||
94411486|NCT04142242|323292646|FG002|Stage I|Non-compliance with the protocol|0|||
94411487|NCT04142242|323292647|FG003|Stage I|Non-compliance with the protocol|0|||
94411488|NCT04142242|323292648|FG004|Stage I|Non-compliance with the protocol|0|||
94411489|NCT04142242|323292649|FG005|Stage I|Non-compliance with the protocol|1|||
94411490|NCT04142242|323292644|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
94411491|NCT04142242|323292645|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
94411492|NCT04142242|323292646|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
94411493|NCT04142242|323292647|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
94411494|NCT04142242|323292648|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
94411495|NCT04142242|323292649|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
94411496|NCT04142242|323292644|FG000|Stage II|Non-compliance with the protocol|0|||
94411497|NCT04142242|323292645|FG001|Stage II|Non-compliance with the protocol|0|||
94411498|NCT04142242|323292646|FG002|Stage II|Non-compliance with the protocol|0|||
94411499|NCT04142242|323292647|FG003|Stage II|Non-compliance with the protocol|2|||
94411500|NCT04142242|323292648|FG004|Stage II|Non-compliance with the protocol|0|||
94411501|NCT04142242|323292649|FG005|Stage II|Non-compliance with the protocol|0|||
94411502|NCT04142242|323292644|FG000|Stage II|Lost to Follow-up|0|||
94411503|NCT04142242|323292645|FG001|Stage II|Lost to Follow-up|0|||
94411504|NCT04142242|323292646|FG002|Stage II|Lost to Follow-up|1|||
94411505|NCT04142242|323292647|FG003|Stage II|Lost to Follow-up|2|||
94411506|NCT04142242|323292648|FG004|Stage II|Lost to Follow-up|0|||
94411507|NCT04142242|323292649|FG005|Stage II|Lost to Follow-up|0|||
94411508|NCT04142242|323292644|FG000|Stage II|Withdrawal by Subject|0|||
94411509|NCT04142242|323292645|FG001|Stage II|Withdrawal by Subject|0|||
94411510|NCT04142242|323292646|FG002|Stage II|Withdrawal by Subject|5|||
94411511|NCT04142242|323292647|FG003|Stage II|Withdrawal by Subject|9|||
94411512|NCT04142242|323292648|FG004|Stage II|Withdrawal by Subject|0|||
94411513|NCT04142242|323292649|FG005|Stage II|Withdrawal by Subject|0|||
94411514|NCT02070757|323292650|FG000|Overall Study|Adverse Event|107|||
94411515|NCT02070757|323292651|FG001|Overall Study|Adverse Event|99|||
94411516|NCT02070757|323292650|FG000|Overall Study|Lost to Follow-up|7|||
94411517|NCT02070757|323292651|FG001|Overall Study|Lost to Follow-up|4|||
94411518|NCT02070757|323292650|FG000|Overall Study|Protocol Violation|0|||
94411519|NCT02070757|323292651|FG001|Overall Study|Protocol Violation|4|||
94411520|NCT02070757|323292650|FG000|Overall Study|Withdrawal by Subject|1|||
94411521|NCT02070757|323292651|FG001|Overall Study|Withdrawal by Subject|3|||
94411522|NCT02070757|323292650|FG000|Overall Study|Investigator Decision|0|||
94411523|NCT02070757|323292651|FG001|Overall Study|Investigator Decision|2|||
94411524|NCT02070757|323292650|FG000|Overall Study|Discharged from Study Hospital|2|||
94411525|NCT02070757|323292651|FG001|Overall Study|Discharged from Study Hospital|2|||
94487066|NCT00922636|323577435|FG002|Overall Study|Adverse Event|2|||
94411526|NCT01546922|323292652|FG000|First Period of 10 Weeks|Protocol Violation|3|||
94411527|NCT01546922|323292653|FG001|First Period of 10 Weeks|Protocol Violation|1|||
94411528|NCT01546922|323292652|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
94411529|NCT01546922|323292653|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
94411530|NCT01546922|323292652|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
94411531|NCT01546922|323292653|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
94411532|NCT01546922|323292652|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
94411533|NCT01546922|323292653|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
94411534|NCT01546922|323292652|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
94411535|NCT01546922|323292653|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
94411536|NCT01613378|323292656|FG000|Overall Study|Lack of Efficacy|13|||
94411537|NCT01613378|323292656|FG000|Overall Study|Adverse Event|11|||
94411538|NCT01613378|323292656|FG000|Overall Study|Withdrawal by Subject|8|||
94411539|NCT01613378|323292656|FG000|Overall Study|Death|2|||
94411540|NCT01613378|323292656|FG000|Overall Study|Lost to Follow-up|1|||
94411541|NCT01613378|323292656|FG000|Overall Study|Other Reason|4|||
94411542|NCT01546142|323292657|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
94411543|NCT01546142|323292658|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
94411544|NCT01546142|323292657|FG000|Overall Study|Subject Noncompliance|1|||
94411545|NCT01546142|323292658|FG001|Overall Study|Subject Noncompliance|1|||
94411546|NCT01546142|323292657|FG000|Overall Study|Adverse Event|6|||
94411547|NCT01546142|323292658|FG001|Overall Study|Adverse Event|3|||
94411548|NCT01546142|323292657|FG000|Overall Study|Lost to Follow-up|20|||
94411549|NCT01546142|323292658|FG001|Overall Study|Lost to Follow-up|15|||
94411550|NCT01546142|323292657|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
94411551|NCT01546142|323292658|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
94411552|NCT01546142|323292657|FG000|Overall Study|Subject Randomized but Not Treated|1|||
94411553|NCT01546142|323292658|FG001|Overall Study|Subject Randomized but Not Treated|0|||
94411554|NCT00255151|323292659|FG000|Overall Study|Adverse Event|10|||
94411555|NCT00255151|323292660|FG001|Overall Study|Adverse Event|6|||
94411556|NCT00255151|323292661|FG002|Overall Study|Adverse Event|9|||
94411557|NCT00255151|323292659|FG000|Overall Study|Lost to Follow-up|4|||
94411558|NCT00255151|323292660|FG001|Overall Study|Lost to Follow-up|3|||
94411559|NCT00255151|323292661|FG002|Overall Study|Lost to Follow-up|4|||
94411560|NCT00255151|323292659|FG000|Overall Study|Withdrawal by Subject|18|||
94411561|NCT00255151|323292660|FG001|Overall Study|Withdrawal by Subject|17|||
94411562|NCT00255151|323292661|FG002|Overall Study|Withdrawal by Subject|8|||
94411563|NCT00255151|323292659|FG000|Overall Study|Noncompliance|0|||
94411564|NCT00255151|323292660|FG001|Overall Study|Noncompliance|1|||
94411565|NCT00255151|323292661|FG002|Overall Study|Noncompliance|2|||
94411566|NCT00255151|323292659|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
94411567|NCT00255151|323292660|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
94411568|NCT00255151|323292661|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
94411569|NCT00255151|323292659|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
94411570|NCT00255151|323292660|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
94411571|NCT00255151|323292661|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
94411572|NCT00255151|323292659|FG000|Overall Study|Possible Barrett's Esophagus|1|||
94411573|NCT00255151|323292660|FG001|Overall Study|Possible Barrett's Esophagus|3|||
94411574|NCT00255151|323292661|FG002|Overall Study|Possible Barrett's Esophagus|8|||
94411575|NCT00255151|323292659|FG000|Overall Study|Esophageal Stricture|0|||
94411576|NCT00255151|323292660|FG001|Overall Study|Esophageal Stricture|0|||
94411577|NCT00255151|323292661|FG002|Overall Study|Esophageal Stricture|1|||
94411578|NCT00255151|323292659|FG000|Overall Study|Therapeutic Failure|11|||
94411579|NCT00255151|323292660|FG001|Overall Study|Therapeutic Failure|2|||
94411580|NCT00255151|323292661|FG002|Overall Study|Therapeutic Failure|3|||
94411581|NCT00107042|323292664|FG000|Overall Study|Lost to Follow-up|9|||
94411582|NCT00107042|323292665|FG001|Overall Study|Lost to Follow-up|7|||
94411583|NCT00107042|323292664|FG000|Overall Study|Withdrawal by Subject|6|||
94411584|NCT00107042|323292665|FG001|Overall Study|Withdrawal by Subject|1|||
94411585|NCT00107042|323292664|FG000|Overall Study|Moved out of area|5|||
94411586|NCT00107042|323292665|FG001|Overall Study|Moved out of area|3|||
94411587|NCT00107042|323292664|FG000|Overall Study|Pregnancy|1|||
94411588|NCT00107042|323292665|FG001|Overall Study|Pregnancy|1|||
94411589|NCT00107042|323292664|FG000|Overall Study|Inadvertent enrollment|0|||
94411590|NCT00107042|323292665|FG001|Overall Study|Inadvertent enrollment|1|||
94411591|NCT00107042|323292664|FG000|Overall Study|vaccinated outside window|1|||
94411592|NCT00107042|323292665|FG001|Overall Study|vaccinated outside window|1|||
94411593|NCT00107042|323292664|FG000|Overall Study|Disallowed medications|0|||
94411594|NCT00107042|323292665|FG001|Overall Study|Disallowed medications|2|||
94411595|NCT03438539|323292668|FG000|Overall Study|Lost to Follow-up|8|||
94411596|NCT03438539|323292669|FG001|Overall Study|Lost to Follow-up|4|||
94411597|NCT03438539|323292670|FG002|Overall Study|Lost to Follow-up|10|||
94411598|NCT03438539|323292671|FG003|Overall Study|Lost to Follow-up|9|||
94411599|NCT03438539|323292672|FG004|Overall Study|Lost to Follow-up|3|||
94411600|NCT03438539|323292673|FG005|Overall Study|Lost to Follow-up|8|||
94411601|NCT04213209|323292674|FG000|Overall Study|Protocol Violation|1|||
94411602|NCT04213209|323292675|FG001|Overall Study|Protocol Violation|0|||
94411603|NCT04213209|323292676|FG002|Overall Study|Protocol Violation|0|||
94411604|NCT04213209|323292677|FG003|Overall Study|Protocol Violation|0|||
94411605|NCT04213209|323292678|FG004|Overall Study|Protocol Violation|0|||
94411606|NCT04213209|323292679|FG005|Overall Study|Protocol Violation|0|||
94411607|NCT00809965|323292681|FG000|Overall Study|Death|194|||
94411608|NCT00809965|323292682|FG001|Overall Study|Death|147|||
94411609|NCT00809965|323292683|FG002|Overall Study|Death|196|||
94411610|NCT00809965|323292681|FG000|Overall Study|Lost to Follow-up|17|||
94411611|NCT00809965|323292682|FG001|Overall Study|Lost to Follow-up|10|||
94411612|NCT00809965|323292683|FG002|Overall Study|Lost to Follow-up|18|||
94411613|NCT00809965|323292681|FG000|Overall Study|Withdrawal by Subject|405|||
94411614|NCT00809965|323292682|FG001|Overall Study|Withdrawal by Subject|448|||
94411615|NCT00809965|323292683|FG002|Overall Study|Withdrawal by Subject|441|||
94411616|NCT00809965|323292681|FG000|Overall Study|Other Reason|167|||
94411617|NCT00809965|323292682|FG001|Overall Study|Other Reason|170|||
94411618|NCT00809965|323292683|FG002|Overall Study|Other Reason|189|||
94411619|NCT02065713|323292684|FG000|Overall Study|Adverse Event|0|||
94411620|NCT02065713|323292685|FG001|Overall Study|Adverse Event|1|||
94411621|NCT02065713|323292684|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94411622|NCT02065713|323292685|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94411623|NCT01534078|323292688|FG000|Overall Study|Death|1|||
94411624|NCT01534078|323292688|FG000|Overall Study|Withdrawal by Subject|1|||
94411625|NCT02274948|323292691|FG000|Overall Study|Lost to Follow-up|28|||
94411626|NCT02274948|323292692|FG001|Overall Study|Lost to Follow-up|25|||
94411627|NCT02274948|323292691|FG000|Overall Study|Withdrawal by Subject|64|||
94411628|NCT02274948|323292692|FG001|Overall Study|Withdrawal by Subject|58|||
94411629|NCT02274948|323292691|FG000|Overall Study|Stopped on family Practitioner advice|2|||
94411630|NCT02274948|323292692|FG001|Overall Study|Stopped on family Practitioner advice|5|||
94411631|NCT02274948|323292691|FG000|Overall Study|Left the area|4|||
94411632|NCT02274948|323292692|FG001|Overall Study|Left the area|3|||
94411633|NCT03920280|323292693|FG000|Overall Study|Adverse Event|2|||
94411634|NCT03920280|323292694|FG001|Overall Study|Adverse Event|3|||
94411635|NCT03920280|323292693|FG000|Overall Study|Lost to Follow-up|0|||
94411636|NCT03920280|323292694|FG001|Overall Study|Lost to Follow-up|1|||
94411637|NCT03920280|323292693|FG000|Overall Study|Withdrawal by Subject|1|||
94411638|NCT03920280|323292694|FG001|Overall Study|Withdrawal by Subject|1|||
94411639|NCT03920280|323292693|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
94411640|NCT03920280|323292694|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
94411641|NCT01557920|323292695|FG000|Overall Study|Withdrawal by Subject|2|||
94411642|NCT01557920|323292696|FG001|Overall Study|Withdrawal by Subject|3|||
94411643|NCT01557920|323292695|FG000|Overall Study|Lack of Efficacy|1|||
94411644|NCT01557920|323292696|FG001|Overall Study|Lack of Efficacy|0|||
94411645|NCT03170869|323292697|FG000|Overall Study|Protocol Violation|5|||
94411646|NCT03170869|323292697|FG000|Overall Study|Early study termination|3|||
94411647|NCT02462486|323292698|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
94411648|NCT02462486|323292699|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
94411649|NCT02462486|323292700|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
94411650|NCT02462486|323292698|FG000|Overall Study|Adverse Event|53|||
94411651|NCT02462486|323292699|FG001|Overall Study|Adverse Event|48|||
94411652|NCT02462486|323292700|FG002|Overall Study|Adverse Event|21|||
94411653|NCT02462486|323292698|FG000|Overall Study|Lack of Efficacy|6|||
94411654|NCT02462486|323292699|FG001|Overall Study|Lack of Efficacy|12|||
94411655|NCT02462486|323292700|FG002|Overall Study|Lack of Efficacy|3|||
94411656|NCT02462486|323292698|FG000|Overall Study|Lost to Follow-up|3|||
94411657|NCT02462486|323292699|FG001|Overall Study|Lost to Follow-up|4|||
94411658|NCT02462486|323292700|FG002|Overall Study|Lost to Follow-up|2|||
94411659|NCT02462486|323292698|FG000|Overall Study|Withdrawal by Subject|25|||
94411660|NCT02462486|323292699|FG001|Overall Study|Withdrawal by Subject|22|||
94411661|NCT02462486|323292700|FG002|Overall Study|Withdrawal by Subject|19|||
94411662|NCT02462486|323292698|FG000|Overall Study|Protocol Violation|3|||
94411663|NCT02462486|323292699|FG001|Overall Study|Protocol Violation|1|||
94411664|NCT02462486|323292700|FG002|Overall Study|Protocol Violation|1|||
94411665|NCT02462486|323292698|FG000|Overall Study|Reason not Specified|3|||
94411666|NCT02462486|323292699|FG001|Overall Study|Reason not Specified|4|||
94411667|NCT02462486|323292700|FG002|Overall Study|Reason not Specified|3|||
94411668|NCT01483625|323292701|FG000|Overall Study|Adverse Event|1|||
94411669|NCT01483625|323292702|FG001|Overall Study|Adverse Event|1|||
94411670|NCT01483625|323292701|FG000|Overall Study|Refused to continue medication|2|||
94411671|NCT01483625|323292702|FG001|Overall Study|Refused to continue medication|1|||
94411672|NCT01483625|323292701|FG000|Overall Study|Due to other reason|1|||
94411673|NCT01483625|323292702|FG001|Overall Study|Due to other reason|0|||
94411674|NCT02310763|323292703|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
94411675|NCT02310763|323292704|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
94411676|NCT02310763|323292705|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
94411677|NCT02310763|323292703|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
94411678|NCT02310763|323292704|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
94411679|NCT02310763|323292705|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
94411680|NCT02310763|323292703|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
94411681|NCT02310763|323292704|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
94411682|NCT02310763|323292705|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
94411683|NCT02310763|323292703|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
94411684|NCT02310763|323292704|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
94411685|NCT02310763|323292705|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
94411686|NCT02310763|323292703|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
94411687|NCT02310763|323292704|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
94411688|NCT02310763|323292705|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
94411689|NCT02013531|323292710|FG000|Overall Study|Lost to Follow-up|3|||
94411690|NCT02013531|323292710|FG000|Overall Study|Met Withdrawal Criteria|1|||
94411691|NCT02013531|323292710|FG000|Overall Study|Withdrawal by Subject|1|||
94411692|NCT00588731|323292711|FG000|Overall Study|Withdrawal by Subject|3|||
94411693|NCT00588731|323292712|FG001|Overall Study|Withdrawal by Subject|2|||
94411694|NCT03297294|323292713|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
94411695|NCT03297294|323292714|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
94411696|NCT03297294|323292715|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
94411697|NCT03297294|323292716|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
94411698|NCT03297294|323292717|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
94411699|NCT03297294|323292713|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
94411700|NCT03297294|323292714|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
94411701|NCT03297294|323292715|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
94411702|NCT03297294|323292716|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
94411703|NCT03297294|323292717|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
94411704|NCT03297294|323292713|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
94411705|NCT03297294|323292714|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
94411706|NCT03297294|323292715|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
94411707|NCT03297294|323292716|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
94411708|NCT03297294|323292717|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
94411709|NCT03297294|323292713|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
94411710|NCT03297294|323292714|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
94411711|NCT03297294|323292715|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
94411712|NCT03297294|323292716|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
94411713|NCT03297294|323292717|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
94411714|NCT03297294|323292713|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
94411715|NCT03297294|323292714|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
94411716|NCT03297294|323292715|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
94411717|NCT03297294|323292716|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
94411718|NCT03297294|323292717|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
94411719|NCT00612677|323292718|FG000|Overall Study|study closed before treatment started|1|||
94411720|NCT03417830|323292719|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
94411721|NCT03417830|323292720|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
94411722|NCT01825837|323292721|FG000|PART I|Withdrawal by Subject|0|||
94411723|NCT01825837|323292722|FG001|PART I|Withdrawal by Subject|0|||
94411724|NCT01825837|323292723|FG002|PART I|Withdrawal by Subject|0|||
94411725|NCT01825837|323292724|FG003|PART I|Withdrawal by Subject|6|||
94411726|NCT01825837|323292721|FG000|PART I|Patient non-compliance|0|||
94411727|NCT01825837|323292722|FG001|PART I|Patient non-compliance|0|||
94411728|NCT01825837|323292723|FG002|PART I|Patient non-compliance|0|||
94411729|NCT01825837|323292724|FG003|PART I|Patient non-compliance|1|||
94411730|NCT01825837|323292721|FG000|PART I|Treatment failure|0|||
94411731|NCT01825837|323292722|FG001|PART I|Treatment failure|0|||
94411732|NCT01825837|323292723|FG002|PART I|Treatment failure|0|||
94411733|NCT01825837|323292724|FG003|PART I|Treatment failure|7|||
94411734|NCT01825837|323292721|FG000|PART I|reason unspecified|0|||
94411735|NCT01825837|323292722|FG001|PART I|reason unspecified|0|||
94411736|NCT01825837|323292723|FG002|PART I|reason unspecified|0|||
94411737|NCT01825837|323292724|FG003|PART I|reason unspecified|3|||
94411738|NCT01825837|323292721|FG000|PART II|Withdrawal by Subject|3|||
94411739|NCT01825837|323292722|FG001|PART II|Withdrawal by Subject|3|||
94411740|NCT01825837|323292723|FG002|PART II|Withdrawal by Subject|7|||
94411741|NCT01825837|323292724|FG003|PART II|Withdrawal by Subject|0|||
94411742|NCT01825837|323292721|FG000|PART II|Patient non-compliance|5|||
94411743|NCT01825837|323292722|FG001|PART II|Patient non-compliance|2|||
94411744|NCT01825837|323292723|FG002|PART II|Patient non-compliance|4|||
94411745|NCT01825837|323292724|FG003|PART II|Patient non-compliance|0|||
94411746|NCT01825837|323292721|FG000|PART II|Adverse Event|3|||
94411747|NCT01825837|323292722|FG001|PART II|Adverse Event|3|||
94411748|NCT01825837|323292723|FG002|PART II|Adverse Event|1|||
94411749|NCT01825837|323292724|FG003|PART II|Adverse Event|0|||
94411750|NCT01825837|323292721|FG000|PART II|Treatment failure|6|||
94411751|NCT01825837|323292722|FG001|PART II|Treatment failure|4|||
94411752|NCT01825837|323292723|FG002|PART II|Treatment failure|5|||
94411753|NCT01825837|323292724|FG003|PART II|Treatment failure|0|||
94411754|NCT01825837|323292721|FG000|PART II|reason unspecified|2|||
94411755|NCT01825837|323292722|FG001|PART II|reason unspecified|2|||
94411756|NCT01825837|323292723|FG002|PART II|reason unspecified|2|||
94411757|NCT01825837|323292724|FG003|PART II|reason unspecified|0|||
94411758|NCT00171340|323292725|FG000|Overall Study|Adverse Event|46|||
94411759|NCT00171340|323292726|FG001|Overall Study|Adverse Event|42|||
94411760|NCT00171340|323292725|FG000|Overall Study|Lack of Efficacy|29|||
94411761|NCT00171340|323292726|FG001|Overall Study|Lack of Efficacy|41|||
94411762|NCT00171340|323292725|FG000|Overall Study|Protocol Violation|7|||
94411763|NCT00171340|323292726|FG001|Overall Study|Protocol Violation|8|||
94411764|NCT00171340|323292725|FG000|Overall Study|Withdrawal by Subject|22|||
94411765|NCT00171340|323292726|FG001|Overall Study|Withdrawal by Subject|19|||
94411766|NCT00171340|323292725|FG000|Overall Study|Lost to Follow-up|0|||
94411767|NCT00171340|323292726|FG001|Overall Study|Lost to Follow-up|5|||
94411768|NCT00171340|323292725|FG000|Overall Study|Abnormal Laboratory Results|2|||
94411769|NCT00171340|323292726|FG001|Overall Study|Abnormal Laboratory Results|0|||
94411770|NCT00171340|323292725|FG000|Overall Study|Abnormal Test Procedure Results|6|||
94411771|NCT00171340|323292726|FG001|Overall Study|Abnormal Test Procedure Results|11|||
94411772|NCT00171340|323292725|FG000|Overall Study|No Longer Required Study Drug|1|||
94411773|NCT00171340|323292726|FG001|Overall Study|No Longer Required Study Drug|1|||
94411774|NCT00171340|323292725|FG000|Overall Study|Administrative Problems|5|||
94411775|NCT00171340|323292726|FG001|Overall Study|Administrative Problems|2|||
94411776|NCT00171340|323292725|FG000|Overall Study|Death|6|||
94411777|NCT00171340|323292726|FG001|Overall Study|Death|6|||
94411778|NCT01930175|323292736|FG000|Core Study|Lost to Follow-up|0|||
94411779|NCT01930175|323292737|FG001|Core Study|Lost to Follow-up|1|||
94411780|NCT01930175|323292738|FG002|Core Study|Lost to Follow-up|0|||
94411781|NCT01930175|323292736|FG000|Core Study|Adverse Event|0|||
94411782|NCT01930175|323292737|FG001|Core Study|Adverse Event|0|||
94411783|NCT01930175|323292738|FG002|Core Study|Adverse Event|1|||
94411784|NCT02820740|323292739|FG000|Overall Study|Did not have procedure|2|||
94411785|NCT02056652|323292742|FG000|Overall Study|Withdrawal by Subject|1|||
94411786|NCT02056652|323292743|FG001|Overall Study|Withdrawal by Subject|0|||
94411787|NCT02056652|323292742|FG000|Overall Study|Lost to Follow-up|0|||
94411788|NCT02056652|323292743|FG001|Overall Study|Lost to Follow-up|3|||
94411789|NCT01662362|323292744|FG000|Overall Study|Lost to Follow-up|38|||
94411790|NCT03253094|323292745|FG000|Overall Study|Adverse Event|2|||
94411791|NCT03253094|323292746|FG001|Overall Study|Adverse Event|0|||
94411792|NCT03253094|323292747|FG002|Overall Study|Adverse Event|0|||
94411793|NCT03253094|323292748|FG003|Overall Study|Adverse Event|0|||
94411794|NCT03253094|323292749|FG004|Overall Study|Adverse Event|0|||
94411795|NCT03253094|323292750|FG005|Overall Study|Adverse Event|0|||
94411796|NCT03253094|323292745|FG000|Overall Study|Lack of Efficacy|0|||
94411797|NCT03253094|323292746|FG001|Overall Study|Lack of Efficacy|0|||
94411798|NCT03253094|323292747|FG002|Overall Study|Lack of Efficacy|2|||
94411799|NCT03253094|323292748|FG003|Overall Study|Lack of Efficacy|1|||
94411800|NCT03253094|323292749|FG004|Overall Study|Lack of Efficacy|2|||
94411801|NCT03253094|323292750|FG005|Overall Study|Lack of Efficacy|1|||
94411802|NCT03253094|323292745|FG000|Overall Study|Lost to Follow-up|0|||
94411803|NCT03253094|323292746|FG001|Overall Study|Lost to Follow-up|0|||
94411804|NCT03253094|323292747|FG002|Overall Study|Lost to Follow-up|1|||
94411805|NCT03253094|323292748|FG003|Overall Study|Lost to Follow-up|1|||
94411806|NCT03253094|323292749|FG004|Overall Study|Lost to Follow-up|0|||
94411807|NCT03253094|323292750|FG005|Overall Study|Lost to Follow-up|1|||
94411808|NCT03253094|323292745|FG000|Overall Study|Physician Decision|1|||
94411809|NCT03253094|323292746|FG001|Overall Study|Physician Decision|0|||
94411810|NCT03253094|323292747|FG002|Overall Study|Physician Decision|0|||
94411811|NCT03253094|323292748|FG003|Overall Study|Physician Decision|1|||
94411812|NCT03253094|323292749|FG004|Overall Study|Physician Decision|0|||
94411813|NCT03253094|323292750|FG005|Overall Study|Physician Decision|2|||
94411814|NCT03253094|323292745|FG000|Overall Study|Withdrawal by Subject|1|||
94487067|NCT00922636|323577436|FG003|Overall Study|Adverse Event|3|||
94411815|NCT03253094|323292746|FG001|Overall Study|Withdrawal by Subject|2|||
94411816|NCT03253094|323292747|FG002|Overall Study|Withdrawal by Subject|1|||
94487068|NCT00922636|323577437|FG004|Overall Study|Adverse Event|2|||
94411817|NCT03253094|323292748|FG003|Overall Study|Withdrawal by Subject|0|||
94411818|NCT03253094|323292749|FG004|Overall Study|Withdrawal by Subject|3|||
94411819|NCT03253094|323292750|FG005|Overall Study|Withdrawal by Subject|0|||
94411820|NCT03253094|323292745|FG000|Overall Study|Other|0|||
94411821|NCT03253094|323292746|FG001|Overall Study|Other|1|||
94411822|NCT03253094|323292747|FG002|Overall Study|Other|2|||
94411823|NCT03253094|323292748|FG003|Overall Study|Other|1|||
94411824|NCT03253094|323292749|FG004|Overall Study|Other|0|||
94411825|NCT03253094|323292750|FG005|Overall Study|Other|0|||
94411826|NCT03123783|323292751|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
94411827|NCT03123783|323292752|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
94411828|NCT03123783|323292753|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
94487069|NCT00922636|323577433|FG000|Overall Study|Lack of Efficacy|1|||
94487070|NCT00922636|323577434|FG001|Overall Study|Lack of Efficacy|7|||
94487071|NCT00922636|323577435|FG002|Overall Study|Lack of Efficacy|3|||
94411829|NCT03123783|323292754|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
94411830|NCT03123783|323292755|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
94411831|NCT03123783|323292756|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
94411832|NCT03123783|323292757|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
94411833|NCT03123783|323292751|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
94411834|NCT03123783|323292752|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
94411835|NCT03123783|323292753|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
94411836|NCT03123783|323292754|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
94411837|NCT03123783|323292755|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
94411838|NCT03123783|323292756|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
94411839|NCT03123783|323292757|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
94411840|NCT03123783|323292751|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
94411841|NCT03123783|323292752|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
94411842|NCT03123783|323292753|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
94411843|NCT03123783|323292754|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
94411844|NCT03123783|323292755|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
94411845|NCT03123783|323292756|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
94411846|NCT03123783|323292757|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
94411847|NCT03123783|323292751|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
94411848|NCT03123783|323292752|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
94411849|NCT03123783|323292753|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
94411850|NCT03123783|323292754|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
94411851|NCT03123783|323292755|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
94411852|NCT03123783|323292756|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
94411853|NCT03123783|323292757|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
94411854|NCT00952276|323292762|FG000|Overall Study|Withdrawal by Subject|1|||
94411855|NCT00952276|323292763|FG001|Overall Study|Withdrawal by Subject|0|||
94411856|NCT00952276|323292764|FG002|Overall Study|Withdrawal by Subject|0|||
94411857|NCT00952276|323292765|FG003|Overall Study|Withdrawal by Subject|1|||
94411858|NCT00952276|323292766|FG004|Overall Study|Withdrawal by Subject|0|||
94411859|NCT01619579|323294548|FG000|Overall Study|Withdrawal by Subject|0|||
94411860|NCT01619579|323294549|FG001|Overall Study|Withdrawal by Subject|3|||
94411861|NCT02344745|323294550|FG000|Overall Study|Data collection sheets were lost|2|||
94411862|NCT02344745|323294551|FG001|Overall Study|Data collection sheets were lost|0|||
94411863|NCT02788513|323294552|FG000|Overall Study|Withdrawal by Subject|3|||
94411864|NCT02788513|323294553|FG001|Overall Study|Withdrawal by Subject|0|||
94411865|NCT02788513|323294554|FG002|Overall Study|Withdrawal by Subject|2|||
94411866|NCT02788513|323294555|FG003|Overall Study|Withdrawal by Subject|3|||
94411867|NCT02788513|323294556|FG004|Overall Study|Withdrawal by Subject|1|||
94411868|NCT02788513|323294552|FG000|Overall Study|Lost to Follow-up|1|||
94411869|NCT02788513|323294553|FG001|Overall Study|Lost to Follow-up|0|||
94411870|NCT02788513|323294554|FG002|Overall Study|Lost to Follow-up|0|||
94411871|NCT02788513|323294555|FG003|Overall Study|Lost to Follow-up|0|||
94411872|NCT02788513|323294556|FG004|Overall Study|Lost to Follow-up|1|||
94411873|NCT02788513|323294552|FG000|Overall Study|Adverse Event|5|||
94411874|NCT02788513|323294553|FG001|Overall Study|Adverse Event|8|||
94411875|NCT02788513|323294554|FG002|Overall Study|Adverse Event|4|||
94411876|NCT02788513|323294555|FG003|Overall Study|Adverse Event|2|||
94411877|NCT02788513|323294556|FG004|Overall Study|Adverse Event|2|||
94411878|NCT02788513|323294552|FG000|Overall Study|Protocol Violation|0|||
94411879|NCT02788513|323294553|FG001|Overall Study|Protocol Violation|0|||
94411880|NCT02788513|323294554|FG002|Overall Study|Protocol Violation|1|||
94411881|NCT02788513|323294555|FG003|Overall Study|Protocol Violation|1|||
94411882|NCT02788513|323294556|FG004|Overall Study|Protocol Violation|0|||
94487072|NCT00922636|323577436|FG003|Overall Study|Lack of Efficacy|2|||
94487073|NCT00922636|323577437|FG004|Overall Study|Lack of Efficacy|4|||
94487074|NCT00922636|323577433|FG000|Overall Study|Sponsor Decision|0|||
94487075|NCT00922636|323577434|FG001|Overall Study|Sponsor Decision|0|||
94487076|NCT00922636|323577435|FG002|Overall Study|Sponsor Decision|2|||
94487077|NCT00922636|323577436|FG003|Overall Study|Sponsor Decision|0|||
94411883|NCT02788513|323294552|FG000|Overall Study|Subject decided to stop taking treatment|0|||
94411884|NCT02788513|323294553|FG001|Overall Study|Subject decided to stop taking treatment|0|||
94411885|NCT02788513|323294554|FG002|Overall Study|Subject decided to stop taking treatment|1|||
94411886|NCT02788513|323294555|FG003|Overall Study|Subject decided to stop taking treatment|0|||
94411887|NCT02788513|323294556|FG004|Overall Study|Subject decided to stop taking treatment|0|||
94487078|NCT00922636|323577437|FG004|Overall Study|Sponsor Decision|0|||
94411888|NCT02788513|323294552|FG000|Overall Study|Decision by the study team|0|||
94411889|NCT02788513|323294553|FG001|Overall Study|Decision by the study team|0|||
94411890|NCT02788513|323294554|FG002|Overall Study|Decision by the study team|0|||
94411891|NCT02788513|323294555|FG003|Overall Study|Decision by the study team|0|||
94411892|NCT02788513|323294556|FG004|Overall Study|Decision by the study team|1|||
94411893|NCT02124902|323294557|FG000|Overall Study|Adverse Event|7|||
94411894|NCT02124902|323294558|FG001|Overall Study|Adverse Event|2|||
94411895|NCT02124902|323294557|FG000|Overall Study|Went to alternative treatment|4|||
94411896|NCT02124902|323294558|FG001|Overall Study|Went to alternative treatment|0|||
94411897|NCT02124902|323294557|FG000|Overall Study|Withdrawal by Subject|2|||
94411898|NCT02124902|323294558|FG001|Overall Study|Withdrawal by Subject|1|||
94411899|NCT02124902|323294557|FG000|Overall Study|Physician Decision|2|||
94411900|NCT02124902|323294558|FG001|Overall Study|Physician Decision|0|||
94411901|NCT02124902|323294557|FG000|Overall Study|Not eligible|1|||
94411902|NCT02124902|323294558|FG001|Overall Study|Not eligible|0|||
94411903|NCT02124902|323294557|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
94411904|NCT02124902|323294558|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
94411905|NCT01937351|323294559|FG000|Overall Study|Withdrawal by Subject|4|||
94411906|NCT01937351|323294560|FG001|Overall Study|Withdrawal by Subject|2|||
94411907|NCT01937351|323294559|FG000|Overall Study|Death|1|||
94411908|NCT01937351|323294560|FG001|Overall Study|Death|0|||
94411909|NCT01937351|323294559|FG000|Overall Study|Not treated w device, per protocol fail|4|||
94411910|NCT01937351|323294560|FG001|Overall Study|Not treated w device, per protocol fail|0|||
94411911|NCT01961687|323294561|FG000|Overall Study|Lost to Follow-up|19|||
94411912|NCT01961687|323294561|FG000|Overall Study|Re-operation|17|||
94411913|NCT01961687|323294561|FG000|Overall Study|Death|7|||
94411914|NCT01961687|323294561|FG000|Overall Study|Withdrawal by Subject|6|||
94411915|NCT01961687|323294561|FG000|Overall Study|Adverse Event|6|||
94411916|NCT01961687|323294561|FG000|Overall Study|Moved to area without study site|2|||
94411917|NCT01961687|323294561|FG000|Overall Study|Sponsor decision|2|||
94411918|NCT01961687|323294561|FG000|Overall Study|Physician Decision|1|||
94411919|NCT01961687|323294561|FG000|Overall Study|Unable to meet follow-up requirements|1|||
94411920|NCT02012452|323294564|FG000|Overall Study|Lost to Follow-up|2|||
94411921|NCT02012452|323294565|FG001|Overall Study|Lost to Follow-up|1|||
94411922|NCT02012452|323294564|FG000|Overall Study|Withdrawal by Subject|4|||
94411923|NCT02012452|323294565|FG001|Overall Study|Withdrawal by Subject|0|||
94411924|NCT02688387|323294566|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411925|NCT02688387|323294567|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411926|NCT02688387|323294568|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
94411927|NCT02688387|323294569|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411928|NCT02688387|323294570|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411929|NCT02688387|323294571|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411930|NCT02688387|323294572|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411931|NCT02688387|323294573|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411932|NCT02688387|323294574|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411933|NCT02688387|323294575|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411934|NCT02688387|323294576|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411935|NCT02688387|323294577|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411936|NCT02688387|323294578|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411937|NCT02688387|323294579|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411938|NCT02688387|323294580|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411939|NCT02688387|323294581|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411940|NCT02688387|323294582|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411941|NCT02688387|323294583|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411942|NCT02688387|323294584|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411943|NCT02688387|323294585|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411944|NCT02688387|323294586|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411945|NCT02688387|323294587|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
94411946|NCT02688387|323294566|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411947|NCT02688387|323294567|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411948|NCT02688387|323294568|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411949|NCT02688387|323294569|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
94411950|NCT02688387|323294570|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411951|NCT02688387|323294571|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411952|NCT02688387|323294572|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411953|NCT02688387|323294573|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411954|NCT02688387|323294574|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411955|NCT02688387|323294575|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411956|NCT02688387|323294576|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411957|NCT02688387|323294577|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411958|NCT02688387|323294578|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411959|NCT02688387|323294579|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94487079|NCT00922636|323577433|FG000|Overall Study|Withdrawal by Subject|0|||
94487080|NCT00922636|323577434|FG001|Overall Study|Withdrawal by Subject|0|||
94487081|NCT00922636|323577435|FG002|Overall Study|Withdrawal by Subject|5|||
94487082|NCT00922636|323577436|FG003|Overall Study|Withdrawal by Subject|2|||
94487083|NCT00922636|323577437|FG004|Overall Study|Withdrawal by Subject|4|||
94487084|NCT00922636|323577433|FG000|Overall Study|Protocol Violation|0|||
94487085|NCT00922636|323577434|FG001|Overall Study|Protocol Violation|0|||
94487086|NCT00922636|323577435|FG002|Overall Study|Protocol Violation|2|||
94487087|NCT00922636|323577436|FG003|Overall Study|Protocol Violation|2|||
94487088|NCT00922636|323577437|FG004|Overall Study|Protocol Violation|0|||
94487089|NCT00922636|323577433|FG000|Overall Study|Entry Criteria Not Met|0|||
94487090|NCT00922636|323577434|FG001|Overall Study|Entry Criteria Not Met|0|||
94487091|NCT00922636|323577435|FG002|Overall Study|Entry Criteria Not Met|1|||
94487092|NCT00922636|323577436|FG003|Overall Study|Entry Criteria Not Met|1|||
94487093|NCT00922636|323577437|FG004|Overall Study|Entry Criteria Not Met|0|||
94487094|NCT00922636|323577433|FG000|Overall Study|Parent/Caregiver Decision|2|||
94487095|NCT00922636|323577434|FG001|Overall Study|Parent/Caregiver Decision|4|||
94411960|NCT02688387|323294580|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411961|NCT02688387|323294581|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411962|NCT02688387|323294582|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411963|NCT02688387|323294583|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411964|NCT02688387|323294584|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411965|NCT02688387|323294585|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411966|NCT02688387|323294586|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411967|NCT02688387|323294587|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94411968|NCT02688387|323294566|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411969|NCT02688387|323294567|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
94411970|NCT02688387|323294568|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411971|NCT02688387|323294569|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411972|NCT02688387|323294570|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411973|NCT02688387|323294571|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411974|NCT02688387|323294572|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411975|NCT02688387|323294573|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411976|NCT02688387|323294574|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411977|NCT02688387|323294575|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411978|NCT02688387|323294576|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411979|NCT02688387|323294577|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411980|NCT02688387|323294578|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411981|NCT02688387|323294579|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411982|NCT02688387|323294580|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411983|NCT02688387|323294581|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411984|NCT02688387|323294582|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411985|NCT02688387|323294583|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411986|NCT02688387|323294584|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411987|NCT02688387|323294585|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411988|NCT02688387|323294586|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411989|NCT02688387|323294587|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
94411990|NCT02688387|323294566|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94411991|NCT02688387|323294567|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94411992|NCT02688387|323294568|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
94411993|NCT02688387|323294569|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94411994|NCT02688387|323294570|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
94411995|NCT02688387|323294571|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94411996|NCT02688387|323294572|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94411997|NCT02688387|323294573|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94411998|NCT02688387|323294574|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94411999|NCT02688387|323294575|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94412000|NCT02688387|323294576|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94412001|NCT02688387|323294577|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94487096|NCT00922636|323577435|FG002|Overall Study|Parent/Caregiver Decision|3|||
94487097|NCT00922636|323577436|FG003|Overall Study|Parent/Caregiver Decision|5|||
94487098|NCT00922636|323577437|FG004|Overall Study|Parent/Caregiver Decision|2|||
94487099|NCT00922636|323577433|FG000|Overall Study|Lost to Follow-up|1|||
94487100|NCT00922636|323577434|FG001|Overall Study|Lost to Follow-up|2|||
94412002|NCT02688387|323294578|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94412003|NCT02688387|323294579|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94412004|NCT02688387|323294580|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94412005|NCT02688387|323294581|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94412006|NCT02688387|323294582|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94412007|NCT02688387|323294583|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94412008|NCT02688387|323294584|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94412009|NCT02688387|323294585|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94412010|NCT02688387|323294586|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94412011|NCT02688387|323294587|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
94412012|NCT02688387|323294566|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
94412013|NCT02688387|323294567|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412014|NCT02688387|323294568|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412015|NCT02688387|323294569|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412016|NCT02688387|323294570|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412017|NCT02688387|323294571|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412018|NCT02688387|323294572|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412019|NCT02688387|323294573|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412020|NCT02688387|323294574|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412021|NCT02688387|323294575|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412022|NCT02688387|323294576|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412023|NCT02688387|323294577|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412024|NCT02688387|323294578|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412025|NCT02688387|323294579|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412026|NCT02688387|323294580|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412027|NCT02688387|323294581|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412028|NCT02688387|323294582|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412029|NCT02688387|323294583|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412030|NCT02688387|323294584|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412031|NCT02688387|323294585|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412032|NCT02688387|323294586|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412033|NCT02688387|323294587|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
94412034|NCT02688387|323294566|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412035|NCT02688387|323294567|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412036|NCT02688387|323294568|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412037|NCT02688387|323294569|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412038|NCT02688387|323294570|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412039|NCT02688387|323294571|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412040|NCT02688387|323294572|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412041|NCT02688387|323294573|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412042|NCT02688387|323294574|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412043|NCT02688387|323294575|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412044|NCT02688387|323294576|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
94412045|NCT02688387|323294577|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412046|NCT02688387|323294578|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412047|NCT02688387|323294579|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412048|NCT02688387|323294580|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412049|NCT02688387|323294581|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412050|NCT02688387|323294582|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412051|NCT02688387|323294583|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412052|NCT02688387|323294584|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412053|NCT02688387|323294585|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412054|NCT02688387|323294586|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412055|NCT02688387|323294587|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
94412056|NCT02688387|323294566|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412057|NCT02688387|323294567|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412058|NCT02688387|323294568|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412059|NCT02688387|323294569|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412060|NCT02688387|323294570|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94487101|NCT00922636|323577435|FG002|Overall Study|Lost to Follow-up|2|||
94487102|NCT00922636|323577436|FG003|Overall Study|Lost to Follow-up|2|||
94412061|NCT02688387|323294571|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412062|NCT02688387|323294572|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412063|NCT02688387|323294573|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412064|NCT02688387|323294574|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412065|NCT02688387|323294575|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412066|NCT02688387|323294576|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412067|NCT02688387|323294577|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412068|NCT02688387|323294578|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412069|NCT02688387|323294579|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412070|NCT02688387|323294580|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
94412071|NCT02688387|323294581|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412072|NCT02688387|323294582|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412073|NCT02688387|323294583|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412074|NCT02688387|323294584|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412075|NCT02688387|323294585|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412076|NCT02688387|323294586|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412077|NCT02688387|323294587|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
94412078|NCT02688387|323294566|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412079|NCT02688387|323294567|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412080|NCT02688387|323294568|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412081|NCT02688387|323294569|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412082|NCT02688387|323294570|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94487103|NCT00922636|323577437|FG004|Overall Study|Lost to Follow-up|4|||
94487104|NCT04969289|323577438|FG000|Overall Study|Lost to Follow-up|13|||
94487105|NCT04969289|323577439|FG001|Overall Study|Lost to Follow-up|9|||
94487106|NCT00557466|323577440|FG000|Overall Study|Adverse Event|3|||
94487107|NCT00557466|323577441|FG001|Overall Study|Adverse Event|1|||
94487108|NCT00557466|323577442|FG002|Overall Study|Adverse Event|4|||
94487109|NCT00557466|323577443|FG003|Overall Study|Adverse Event|1|||
94487110|NCT00557466|323577444|FG004|Overall Study|Adverse Event|2|||
94487111|NCT00557466|323577445|FG005|Overall Study|Adverse Event|4|||
94487112|NCT00557466|323577440|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94487113|NCT00557466|323577441|FG001|Overall Study|Abnormal laboratory value(s)|2|||
94487114|NCT00557466|323577442|FG002|Overall Study|Abnormal laboratory value(s)|0|||
94487115|NCT00557466|323577443|FG003|Overall Study|Abnormal laboratory value(s)|0|||
94487116|NCT00557466|323577444|FG004|Overall Study|Abnormal laboratory value(s)|0|||
94487117|NCT00557466|323577445|FG005|Overall Study|Abnormal laboratory value(s)|0|||
94487118|NCT00557466|323577440|FG000|Overall Study|Protocol deviation|0|||
94487119|NCT00557466|323577441|FG001|Overall Study|Protocol deviation|1|||
94487120|NCT00557466|323577442|FG002|Overall Study|Protocol deviation|0|||
94487121|NCT00557466|323577443|FG003|Overall Study|Protocol deviation|2|||
94487122|NCT00557466|323577444|FG004|Overall Study|Protocol deviation|0|||
94487123|NCT00557466|323577445|FG005|Overall Study|Protocol deviation|0|||
94487124|NCT00557466|323577440|FG000|Overall Study|Subject withdrew consent|0|||
94487125|NCT00557466|323577441|FG001|Overall Study|Subject withdrew consent|0|||
94487126|NCT00557466|323577442|FG002|Overall Study|Subject withdrew consent|0|||
94487127|NCT00557466|323577443|FG003|Overall Study|Subject withdrew consent|0|||
94487128|NCT00557466|323577444|FG004|Overall Study|Subject withdrew consent|1|||
94487129|NCT00557466|323577445|FG005|Overall Study|Subject withdrew consent|2|||
94487130|NCT00557466|323577440|FG000|Overall Study|Administrative problems|0|||
94487131|NCT00557466|323577441|FG001|Overall Study|Administrative problems|1|||
94487132|NCT00557466|323577442|FG002|Overall Study|Administrative problems|1|||
94487133|NCT00557466|323577443|FG003|Overall Study|Administrative problems|0|||
94487134|NCT00557466|323577444|FG004|Overall Study|Administrative problems|0|||
94487135|NCT00557466|323577445|FG005|Overall Study|Administrative problems|0|||
94487136|NCT00557466|323577440|FG000|Overall Study|Abnormal test procedure results|0|||
94487137|NCT00557466|323577441|FG001|Overall Study|Abnormal test procedure results|0|||
94487138|NCT00557466|323577442|FG002|Overall Study|Abnormal test procedure results|1|||
94487139|NCT00557466|323577443|FG003|Overall Study|Abnormal test procedure results|0|||
94487140|NCT00557466|323577444|FG004|Overall Study|Abnormal test procedure results|0|||
94487141|NCT00557466|323577445|FG005|Overall Study|Abnormal test procedure results|0|||
94487142|NCT00557466|323577440|FG000|Overall Study|Lost to Follow-up|0|||
94487143|NCT00557466|323577441|FG001|Overall Study|Lost to Follow-up|0|||
94487144|NCT00557466|323577442|FG002|Overall Study|Lost to Follow-up|0|||
94487145|NCT00557466|323577443|FG003|Overall Study|Lost to Follow-up|1|||
94487146|NCT00557466|323577444|FG004|Overall Study|Lost to Follow-up|0|||
94487147|NCT00557466|323577445|FG005|Overall Study|Lost to Follow-up|0|||
94487148|NCT02308046|323577450|FG000|Overall Study|Negative yeast culture at Baseline|32|||
94487149|NCT02308046|323577451|FG001|Overall Study|Negative yeast culture at Baseline|33|||
94487150|NCT02308046|323577450|FG000|Overall Study|Positive for STD at Baseline|1|||
94487151|NCT02308046|323577451|FG001|Overall Study|Positive for STD at Baseline|2|||
94487152|NCT02308046|323577450|FG000|Overall Study|Lost to Follow-up|1|||
94487153|NCT02308046|323577451|FG001|Overall Study|Lost to Follow-up|3|||
94487154|NCT00161213|323577452|FG000|Overall Study|Withdrawal by Subject|1|||
94487155|NCT00161213|323577452|FG000|Overall Study|Evaluable for toxicity but not response|1|||
94487156|NCT01926028|323577456|FG000|Overall Study|Lost to Follow-up|7|||
94487157|NCT01926028|323577457|FG001|Overall Study|Lost to Follow-up|6|||
94487158|NCT01926028|323577458|FG002|Overall Study|Lost to Follow-up|0|||
94412083|NCT02688387|323294571|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412084|NCT02688387|323294572|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412085|NCT02688387|323294573|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412086|NCT02688387|323294574|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412087|NCT02688387|323294575|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412088|NCT02688387|323294576|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412089|NCT02688387|323294577|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412090|NCT02688387|323294578|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412091|NCT02688387|323294579|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412092|NCT02688387|323294580|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412093|NCT02688387|323294581|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412094|NCT02688387|323294582|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412095|NCT02688387|323294583|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412096|NCT02688387|323294584|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412097|NCT02688387|323294585|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412098|NCT02688387|323294586|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
94412099|NCT02688387|323294587|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
94412100|NCT02688387|323294566|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412101|NCT02688387|323294567|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412102|NCT02688387|323294568|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412103|NCT02688387|323294569|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412104|NCT02688387|323294570|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412105|NCT02688387|323294571|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412106|NCT02688387|323294572|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412107|NCT02688387|323294573|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412108|NCT02688387|323294574|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412109|NCT02688387|323294575|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412110|NCT02688387|323294576|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412111|NCT02688387|323294577|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412112|NCT02688387|323294578|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412113|NCT02688387|323294579|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412114|NCT02688387|323294580|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412115|NCT02688387|323294581|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412116|NCT02688387|323294582|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412117|NCT02688387|323294583|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412118|NCT02688387|323294584|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
94412119|NCT02688387|323294585|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412120|NCT02688387|323294586|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
94412121|NCT02688387|323294587|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
94412122|NCT02688387|323294566|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412123|NCT02688387|323294567|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412124|NCT02688387|323294568|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412125|NCT02688387|323294569|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412126|NCT02688387|323294570|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412127|NCT02688387|323294571|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412128|NCT02688387|323294572|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412129|NCT02688387|323294573|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412130|NCT02688387|323294574|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412131|NCT02688387|323294575|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412132|NCT02688387|323294576|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412133|NCT02688387|323294577|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412134|NCT02688387|323294578|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412135|NCT02688387|323294579|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412136|NCT02688387|323294580|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412137|NCT02688387|323294581|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412138|NCT02688387|323294582|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412139|NCT02688387|323294583|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412140|NCT02688387|323294584|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412141|NCT02688387|323294585|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
94412142|NCT02688387|323294586|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412143|NCT02688387|323294587|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
94412144|NCT00831233|323294588|FG000|Overall Study|Adverse Event|0|||
94412145|NCT00831233|323294589|FG001|Overall Study|Adverse Event|1|||
94412146|NCT00831233|323294588|FG000|Overall Study|Protocol Violation|1|||
94412147|NCT00831233|323294589|FG001|Overall Study|Protocol Violation|0|||
94412148|NCT00831233|323294588|FG000|Overall Study|Selection Criteria Not Met|2|||
94412149|NCT00831233|323294589|FG001|Overall Study|Selection Criteria Not Met|0|||
94412150|NCT01647958|323294590|FG000|Initial Study|Lost to Follow-up|2|||
94487159|NCT01926028|323577456|FG000|Overall Study|Physician Decision|1|||
94487160|NCT01926028|323577457|FG001|Overall Study|Physician Decision|5|||
94487161|NCT01926028|323577458|FG002|Overall Study|Physician Decision|0|||
94487162|NCT01926028|323577456|FG000|Overall Study|Withdrawal by Subject|9|||
94487163|NCT01926028|323577457|FG001|Overall Study|Withdrawal by Subject|9|||
94487164|NCT01926028|323577458|FG002|Overall Study|Withdrawal by Subject|2|||
94487165|NCT01926028|323577456|FG000|Overall Study|Non compliance or other reasons|4|||
94487166|NCT01926028|323577457|FG001|Overall Study|Non compliance or other reasons|2|||
94487167|NCT01926028|323577458|FG002|Overall Study|Non compliance or other reasons|0|||
94487168|NCT00737048|323577459|FG000|Overall Study|Physician Decision|0|||
94487169|NCT00737048|323577460|FG001|Overall Study|Physician Decision|0|||
94487170|NCT00737048|323577461|FG002|Overall Study|Physician Decision|1|||
94487171|NCT00737048|323577459|FG000|Overall Study|Adverse Event|0|||
94487172|NCT00737048|323577460|FG001|Overall Study|Adverse Event|1|||
94487173|NCT00737048|323577461|FG002|Overall Study|Adverse Event|0|||
94487174|NCT00737048|323577459|FG000|Overall Study|Worsening of the symptoms|3|||
94487175|NCT00737048|323577460|FG001|Overall Study|Worsening of the symptoms|5|||
94487176|NCT00737048|323577461|FG002|Overall Study|Worsening of the symptoms|3|||
94487177|NCT00301834|323577464|FG000|Overall Study|Death|1|||
94487178|NCT01145482|323577465|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
94487179|NCT01145482|323577466|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
94487180|NCT02351934|323577467|FG000|Allocation|POD weight<pre-op weight|3|||
94487181|NCT02351934|323577468|FG001|Allocation|POD weight<pre-op weight|0|||
94487182|NCT02351934|323577467|FG000|Allocation|Hypotension preventing administration|2|||
94487183|NCT02351934|323577468|FG001|Allocation|Hypotension preventing administration|0|||
94487184|NCT02351934|323577467|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
94487185|NCT02351934|323577468|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
94487186|NCT02351934|323577467|FG000|Follow-Up|POD weight<pre-op weight|3|||
94487187|NCT02351934|323577468|FG001|Follow-Up|POD weight<pre-op weight|0|||
94487188|NCT02351934|323577467|FG000|Follow-Up|Acute Kidney Injury|1|||
94487189|NCT02351934|323577468|FG001|Follow-Up|Acute Kidney Injury|0|||
94487190|NCT02351934|323577467|FG000|Follow-Up|Early dismissal|3|||
94487191|NCT02351934|323577468|FG001|Follow-Up|Early dismissal|0|||
94487192|NCT02351934|323577467|FG000|Follow-Up|Hypotension|3|||
94487193|NCT02351934|323577468|FG001|Follow-Up|Hypotension|0|||
94487194|NCT02351934|323577467|FG000|Follow-Up|No documentation|2|||
94487195|NCT02351934|323577468|FG001|Follow-Up|No documentation|0|||
94487196|NCT02351934|323577467|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
94487197|NCT02351934|323577468|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
94487198|NCT02351934|323577467|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
94487199|NCT02351934|323577468|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
94487200|NCT02737358|323577469|FG000|Overall Study|Withdrawal by Subject|7|||
94412151|NCT01647958|323294591|FG001|Initial Study|Lost to Follow-up|3|||
94412152|NCT01647958|323294590|FG000|Continuation Phase|treatment received during Overall Study|39|||
94412153|NCT01647958|323294591|FG001|Continuation Phase|treatment received during Overall Study|0|||
94412154|NCT01647958|323294590|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
94412155|NCT01647958|323294591|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
94412156|NCT00983918|323294594|FG000|Overall Study|conversion to open cholecystectomy|0|||
94412157|NCT00983918|323294595|FG001|Overall Study|conversion to open cholecystectomy|2|||
94412158|NCT00983918|323294596|FG002|Overall Study|conversion to open cholecystectomy|2|||
94412159|NCT00983918|323294597|FG003|Overall Study|conversion to open cholecystectomy|2|||
94412160|NCT02000531|323294598|FG000|Overall Study|Lost to Follow-up|1|||
94412161|NCT02000531|323294599|FG001|Overall Study|Lost to Follow-up|0|||
94412162|NCT02000531|323294598|FG000|Overall Study|Discontinued due to data cut-off|3|||
94412163|NCT02000531|323294599|FG001|Overall Study|Discontinued due to data cut-off|8|||
94412164|NCT03756883|323294607|FG000|Overall Study|Adverse Event|2|||
94412165|NCT03756883|323294608|FG001|Overall Study|Adverse Event|2|||
94412166|NCT03756883|323294609|FG002|Overall Study|Adverse Event|2|||
94412167|NCT03756883|323294607|FG000|Overall Study|Lack of Efficacy|0|||
94412168|NCT03756883|323294608|FG001|Overall Study|Lack of Efficacy|1|||
94412169|NCT03756883|323294609|FG002|Overall Study|Lack of Efficacy|2|||
94412170|NCT03756883|323294607|FG000|Overall Study|Lost to Follow-up|3|||
94412171|NCT03756883|323294608|FG001|Overall Study|Lost to Follow-up|3|||
94412172|NCT03756883|323294609|FG002|Overall Study|Lost to Follow-up|0|||
94412173|NCT03756883|323294607|FG000|Overall Study|Protocol Violation|2|||
94487201|NCT02737358|323577470|FG001|Overall Study|Withdrawal by Subject|12|||
94487202|NCT02737358|323577469|FG000|Overall Study|Lost to Follow-up|2|||
94487203|NCT02737358|323577470|FG001|Overall Study|Lost to Follow-up|3|||
94487204|NCT03499795|323577478|FG000|Overall Study|Adverse Event|1|||
94487205|NCT03499795|323577478|FG000|Overall Study|Lost to Follow-up|1|||
94487206|NCT00547339|323577479|FG000|Overall Study|Physician Decision|0|||
94487207|NCT00547339|323577480|FG001|Overall Study|Physician Decision|0|||
94487208|NCT00547339|323577481|FG002|Overall Study|Physician Decision|1|||
94487209|NCT00547339|323577482|FG003|Overall Study|Physician Decision|0|||
94487210|NCT01569022|323577487|FG000|First Intervention|Lost to Follow-up|2|||
94487211|NCT01569022|323577488|FG001|First Intervention|Lost to Follow-up|1|||
94412174|NCT03756883|323294608|FG001|Overall Study|Protocol Violation|0|||
94412175|NCT03756883|323294609|FG002|Overall Study|Protocol Violation|1|||
94412176|NCT03756883|323294607|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
94412177|NCT03756883|323294608|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
94412178|NCT03756883|323294609|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
94412179|NCT03756883|323294607|FG000|Overall Study|Withdrawal by Subject|4|||
94412180|NCT03756883|323294608|FG001|Overall Study|Withdrawal by Subject|1|||
94412181|NCT03756883|323294609|FG002|Overall Study|Withdrawal by Subject|0|||
94412182|NCT03756883|323294607|FG000|Overall Study|Other Reasons|2|||
94412183|NCT03756883|323294608|FG001|Overall Study|Other Reasons|4|||
94412184|NCT03756883|323294609|FG002|Overall Study|Other Reasons|0|||
94412185|NCT01470417|323294610|FG000|Overall Study|Disease progression|0|||
94412186|NCT01470417|323294611|FG001|Overall Study|Disease progression|2|||
94412187|NCT02457611|323294614|FG000|Overall Study|Lost to Follow-up|3|||
94412188|NCT00529217|323294615|FG000|Overall Study|Lack of Efficacy|2|||
94412189|NCT00529217|323294615|FG000|Overall Study|Unable to adhere to study schedule|2|||
94412190|NCT01790113|323294616|FG000|Overall Study|Adverse Event|2|||
94412191|NCT01790113|323294617|FG001|Overall Study|Adverse Event|7|||
94412192|NCT01790113|323294616|FG000|Overall Study|Study ended due to FDA clearance|1|||
94412193|NCT01790113|323294617|FG001|Overall Study|Study ended due to FDA clearance|68|||
94412194|NCT01315028|323294618|FG000|Overall Study|Lost to Follow-up|1|||
94412195|NCT01315028|323294619|FG001|Overall Study|Lost to Follow-up|0|||
94412196|NCT01315028|323294618|FG000|Overall Study|Death|0|||
94412197|NCT01315028|323294619|FG001|Overall Study|Death|1|||
94412198|NCT00761176|323294623|FG000|Overall Study|Death|1|||
94412199|NCT00761176|323294624|FG001|Overall Study|Death|0|||
94412200|NCT00761176|323294623|FG000|Overall Study|Withdrawal by Subject|1|||
94412201|NCT00761176|323294624|FG001|Overall Study|Withdrawal by Subject|1|||
94412202|NCT02674386|323294625|FG000|Overall Study|Lost to Follow-up|0|||
94412203|NCT02674386|323294626|FG001|Overall Study|Lost to Follow-up|1|||
94412204|NCT02674386|323294627|FG002|Overall Study|Lost to Follow-up|1|||
94412205|NCT02674386|323294625|FG000|Overall Study|Withdrawal by Subject|0|||
94412206|NCT02674386|323294626|FG001|Overall Study|Withdrawal by Subject|4|||
94412207|NCT02674386|323294627|FG002|Overall Study|Withdrawal by Subject|0|||
94412208|NCT02674386|323294625|FG000|Overall Study|Other|0|||
94412209|NCT02674386|323294626|FG001|Overall Study|Other|1|||
94412210|NCT02674386|323294627|FG002|Overall Study|Other|0|||
94412211|NCT02674386|323294625|FG000|Overall Study|Enrolled but not evaluated|0|||
94412212|NCT02674386|323294626|FG001|Overall Study|Enrolled but not evaluated|4|||
94412213|NCT02674386|323294627|FG002|Overall Study|Enrolled but not evaluated|0|||
94412214|NCT02508116|323294630|FG000|Overall Study|Lost to Follow-up|2|||
94412215|NCT02508116|323294631|FG001|Overall Study|Lost to Follow-up|3|||
94412216|NCT02508116|323294630|FG000|Overall Study|Withdrawal by Subject|3|||
94412217|NCT02508116|323294631|FG001|Overall Study|Withdrawal by Subject|2|||
94412218|NCT02508116|323294630|FG000|Overall Study|Protocol Violation|1|||
94412219|NCT02508116|323294631|FG001|Overall Study|Protocol Violation|2|||
94412220|NCT02508116|323294630|FG000|Overall Study|Physician Decision|2|||
94412221|NCT02508116|323294631|FG001|Overall Study|Physician Decision|0|||
94412222|NCT00330460|323294636|FG000|Overall Study|Physician Decision|1|||
94412223|NCT00330460|323294637|FG001|Overall Study|Physician Decision|0|||
94412224|NCT00330460|323294636|FG000|Overall Study|Adverse Event|10|||
94412225|NCT00330460|323294637|FG001|Overall Study|Adverse Event|8|||
94412226|NCT00330460|323294636|FG000|Overall Study|Withdrawal by Subject|18|||
94412227|NCT00330460|323294637|FG001|Overall Study|Withdrawal by Subject|17|||
94412228|NCT00330460|323294636|FG000|Overall Study|Death|1|||
94412229|NCT00330460|323294637|FG001|Overall Study|Death|1|||
94412230|NCT00330460|323294636|FG000|Overall Study|Ineligibility determined|1|||
94412231|NCT00330460|323294637|FG001|Overall Study|Ineligibility determined|3|||
94412232|NCT00330460|323294636|FG000|Overall Study|Lost to Follow-up|8|||
94412233|NCT00330460|323294637|FG001|Overall Study|Lost to Follow-up|3|||
94412234|NCT00330460|323294636|FG000|Overall Study|Noncompliance|2|||
94412235|NCT00330460|323294637|FG001|Overall Study|Noncompliance|1|||
94412236|NCT00330460|323294636|FG000|Overall Study|Other|1|||
94412237|NCT00330460|323294637|FG001|Overall Study|Other|0|||
94412238|NCT02280187|323294640|FG000|Overall Study|Lost to Follow-up|218|||
94412239|NCT02094261|323294643|FG000|Overall Study|Death|24|||
94412240|NCT02094261|323294643|FG000|Overall Study|Lost to Follow-up|1|||
94412241|NCT02094261|323294643|FG000|Overall Study|Withdrawal by Subject|4|||
94412242|NCT02094261|323294643|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
94412243|NCT03558139|323294652|FG000|Overall Study|Consent Withdrawn|1|||
94412244|NCT03558139|323294653|FG001|Overall Study|Consent Withdrawn|1|||
94412245|NCT03558139|323294654|FG002|Overall Study|Consent Withdrawn|4|||
94412246|NCT03558139|323294652|FG000|Overall Study|Death|5|||
94412247|NCT03558139|323294653|FG001|Overall Study|Death|3|||
94412248|NCT03558139|323294654|FG002|Overall Study|Death|8|||
94412249|NCT03558139|323294652|FG000|Overall Study|Lost to Follow-up|0|||
94412250|NCT03558139|323294653|FG001|Overall Study|Lost to Follow-up|0|||
94412251|NCT03558139|323294654|FG002|Overall Study|Lost to Follow-up|3|||
94412252|NCT03558139|323294652|FG000|Overall Study|Study Ended Per Protocol|0|||
94412253|NCT03558139|323294653|FG001|Overall Study|Study Ended Per Protocol|3|||
94412254|NCT03558139|323294654|FG002|Overall Study|Study Ended Per Protocol|6|||
94412255|NCT03139240|323294659|FG000|Overall Study|Lost to Follow-up|0|||
94412256|NCT03139240|323294660|FG001|Overall Study|Lost to Follow-up|1|||
94412257|NCT03139240|323294661|FG002|Overall Study|Lost to Follow-up|1|||
94412258|NCT03139240|323294662|FG003|Overall Study|Lost to Follow-up|0|||
94412259|NCT01876368|323294666|FG000|Overall Study|Adverse Event|2|||
94412260|NCT01876368|323294667|FG001|Overall Study|Adverse Event|5|||
94412261|NCT01876368|323294666|FG000|Overall Study|Lack of Efficacy|1|||
94412262|NCT01876368|323294667|FG001|Overall Study|Lack of Efficacy|0|||
94412263|NCT01876368|323294666|FG000|Overall Study|Lost to Follow-up|0|||
94412264|NCT01876368|323294667|FG001|Overall Study|Lost to Follow-up|1|||
94412265|NCT01876368|323294666|FG000|Overall Study|Non-compliance with study treatment|0|||
94412266|NCT01876368|323294667|FG001|Overall Study|Non-compliance with study treatment|1|||
94412267|NCT01876368|323294666|FG000|Overall Study|Physician Decision|0|||
94412268|NCT01876368|323294667|FG001|Overall Study|Physician Decision|2|||
94412269|NCT01876368|323294666|FG000|Overall Study|Protocol deviation|3|||
94412270|NCT01876368|323294667|FG001|Overall Study|Protocol deviation|3|||
94412271|NCT01876368|323294666|FG000|Overall Study|Subject/guardian decision|3|||
94412272|NCT01876368|323294667|FG001|Overall Study|Subject/guardian decision|1|||
94412273|NCT04099641|323294668|FG000|Overall Study|Death|46|||
94412274|NCT04099641|323294669|FG001|Overall Study|Death|12|||
94412275|NCT04099641|323294668|FG000|Overall Study|Lost to Follow-up|1|||
94412276|NCT04099641|323294669|FG001|Overall Study|Lost to Follow-up|0|||
94412277|NCT04099641|323294668|FG000|Overall Study|Withdrawal by Subject|2|||
94412278|NCT04099641|323294669|FG001|Overall Study|Withdrawal by Subject|0|||
94412279|NCT03314662|323294672|FG000|Overall Study|Withdrawal by Subject|1|||
94412280|NCT03314662|323294673|FG001|Overall Study|Withdrawal by Subject|1|||
94412281|NCT03314662|323294674|FG002|Overall Study|Withdrawal by Subject|1|||
94412282|NCT03314662|323294672|FG000|Overall Study|Lost to Follow-up|5|||
94412283|NCT03314662|323294673|FG001|Overall Study|Lost to Follow-up|4|||
94412284|NCT03314662|323294674|FG002|Overall Study|Lost to Follow-up|4|||
94412285|NCT03314662|323294672|FG000|Overall Study|Death|2|||
94412286|NCT03314662|323294673|FG001|Overall Study|Death|0|||
94412287|NCT03314662|323294674|FG002|Overall Study|Death|0|||
94412288|NCT03043560|323294677|FG000|Overall Study|Discontinued Intervention|1|||
94412289|NCT03043560|323294678|FG001|Overall Study|Discontinued Intervention|2|||
94412290|NCT03043560|323294677|FG000|Overall Study|Lost to Follow-up|0|||
94412291|NCT03043560|323294678|FG001|Overall Study|Lost to Follow-up|1|||
94412292|NCT01117766|323294679|FG000|First Intervention|Adverse Event|0|||
94412293|NCT01117766|323294680|FG001|First Intervention|Adverse Event|1|||
94412294|NCT01117766|323294679|FG000|First Intervention|Protocol Violation|1|||
94412295|NCT01117766|323294680|FG001|First Intervention|Protocol Violation|0|||
94412296|NCT01117766|323294679|FG000|Washout Period|Protocol Violation|0|||
94412297|NCT01117766|323294680|FG001|Washout Period|Protocol Violation|2|||
94412298|NCT01117766|323294679|FG000|Second Intervention|Lost to Follow-up|1|||
94412299|NCT01117766|323294680|FG001|Second Intervention|Lost to Follow-up|0|||
94412300|NCT01117766|323294679|FG000|Second Intervention|Other|1|||
94412301|NCT01117766|323294680|FG001|Second Intervention|Other|2|||
94412302|NCT01117766|323294679|FG000|Second Intervention|Adverse Event|0|||
94412303|NCT01117766|323294680|FG001|Second Intervention|Adverse Event|2|||
94412304|NCT01117766|323294679|FG000|Second Intervention|Withdrawal by Subject|0|||
94412305|NCT01117766|323294680|FG001|Second Intervention|Withdrawal by Subject|1|||
94412306|NCT00440115|323294681|FG000|Overall Study|Death|7|||
94412307|NCT00440115|323294682|FG001|Overall Study|Death|9|||
94412308|NCT00440115|323294683|FG002|Overall Study|Death|5|||
94412309|NCT00440115|323294681|FG000|Overall Study|Incarceration|0|||
94412310|NCT00440115|323294682|FG001|Overall Study|Incarceration|2|||
94412311|NCT00440115|323294683|FG002|Overall Study|Incarceration|1|||
94412312|NCT02244424|323294686|FG000|Overall Study|Lost to Follow-up|20|||
94412313|NCT02244424|323294687|FG001|Overall Study|Lost to Follow-up|10|||
94412314|NCT00206102|323294688|FG000|Overall Study|Adverse Event|119|||
94412315|NCT00206102|323294689|FG001|Overall Study|Adverse Event|82|||
94412316|NCT00206102|323294688|FG000|Overall Study|Protocol Violation|0|||
94412317|NCT00206102|323294689|FG001|Overall Study|Protocol Violation|2|||
94412318|NCT00206102|323294688|FG000|Overall Study|Lack of therapeutic response|16|||
94412319|NCT00206102|323294689|FG001|Overall Study|Lack of therapeutic response|11|||
94412320|NCT00206102|323294688|FG000|Overall Study|Lost to Follow-up|95|||
94412321|NCT00206102|323294689|FG001|Overall Study|Lost to Follow-up|66|||
94412322|NCT00206102|323294688|FG000|Overall Study|Withdrawal by Subject|118|||
94412323|NCT00206102|323294689|FG001|Overall Study|Withdrawal by Subject|101|||
94412324|NCT00206102|323294688|FG000|Overall Study|Study-specific discontinuation criteria|18|||
94412325|NCT00206102|323294689|FG001|Overall Study|Study-specific discontinuation criteria|17|||
94412326|NCT00206102|323294688|FG000|Overall Study|None of those categories|42|||
94412327|NCT00206102|323294689|FG001|Overall Study|None of those categories|36|||
94412328|NCT00402025|323294693|FG000|Overall Study|Adverse Event|0|||
94412329|NCT00402025|323294694|FG001|Overall Study|Adverse Event|0|||
94412330|NCT00402025|323294695|FG002|Overall Study|Adverse Event|2|||
94412331|NCT00402025|323294693|FG000|Overall Study|Death|0|||
94487212|NCT01569022|323577487|FG000|Second Intervention|Lost to Follow-up|2|||
94412332|NCT00402025|323294694|FG001|Overall Study|Death|1|||
94412333|NCT00402025|323294695|FG002|Overall Study|Death|5|||
94412334|NCT00402025|323294693|FG000|Overall Study|Disease Progression|1|||
94412335|NCT00402025|323294694|FG001|Overall Study|Disease Progression|1|||
94412336|NCT00402025|323294695|FG002|Overall Study|Disease Progression|2|||
94412337|NCT00402025|323294693|FG000|Overall Study|Physician Decision|1|||
94412338|NCT00402025|323294694|FG001|Overall Study|Physician Decision|1|||
94412339|NCT00402025|323294695|FG002|Overall Study|Physician Decision|0|||
94412340|NCT00402025|323294693|FG000|Overall Study|Participant Decision|0|||
94412341|NCT00402025|323294694|FG001|Overall Study|Participant Decision|0|||
94412342|NCT00402025|323294695|FG002|Overall Study|Participant Decision|1|||
94412343|NCT01917968|323294699|FG000|Overall Study|Death|3|||
94412344|NCT01917968|323294700|FG001|Overall Study|Death|2|||
94412345|NCT01917968|323294699|FG000|Overall Study|Lost to Follow-up|21|||
94412346|NCT01917968|323294700|FG001|Overall Study|Lost to Follow-up|39|||
94412347|NCT01917968|323294699|FG000|Overall Study|Physician Decision|1|||
94412348|NCT01917968|323294700|FG001|Overall Study|Physician Decision|2|||
94412349|NCT01917968|323294699|FG000|Overall Study|Withdrawal by Subject|20|||
94412350|NCT01917968|323294700|FG001|Overall Study|Withdrawal by Subject|35|||
94412351|NCT01917968|323294699|FG000|Overall Study|Subject Relocation|5|||
94412352|NCT01917968|323294700|FG001|Overall Study|Subject Relocation|1|||
94412353|NCT01917968|323294699|FG000|Overall Study|36M Missed Visit|3|||
94412354|NCT01917968|323294700|FG001|Overall Study|36M Missed Visit|2|||
94412355|NCT01917968|323294699|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
94412356|NCT01917968|323294700|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
94412357|NCT01917968|323294699|FG000|Overall Study|Change in Family Circumstances|0|||
94412358|NCT01917968|323294700|FG001|Overall Study|Change in Family Circumstances|1|||
94412359|NCT01917968|323294699|FG000|Overall Study|No Data Available|0|||
94412360|NCT01917968|323294700|FG001|Overall Study|No Data Available|2|||
94412361|NCT00562120|323294703|FG000|First Intervention Period|Adverse Event|1|||
94412362|NCT00562120|323294704|FG001|First Intervention Period|Adverse Event|0|||
94412363|NCT00562120|323294705|FG002|First Intervention Period|Adverse Event|0|||
94412364|NCT00562120|323294706|FG003|First Intervention Period|Adverse Event|0|||
94412365|NCT00562120|323294703|FG000|First Intervention Period|Randomized but not Treated|1|||
94412366|NCT00562120|323294704|FG001|First Intervention Period|Randomized but not Treated|0|||
94412367|NCT00562120|323294705|FG002|First Intervention Period|Randomized but not Treated|0|||
94412368|NCT00562120|323294706|FG003|First Intervention Period|Randomized but not Treated|0|||
94412369|NCT02148445|323294707|FG000|Overall Study|Death|1|||
94412370|NCT02148445|323294708|FG001|Overall Study|Death|3|||
94412371|NCT02093923|323294710|FG000|Overall Study|Lost to Follow-up|0|||
94412372|NCT02093923|323294711|FG001|Overall Study|Lost to Follow-up|0|||
94412373|NCT02093923|323294712|FG002|Overall Study|Lost to Follow-up|0|||
94412374|NCT02093923|323294713|FG003|Overall Study|Lost to Follow-up|1|||
94412375|NCT02093923|323294714|FG004|Overall Study|Lost to Follow-up|0|||
94412376|NCT02093923|323294710|FG000|Overall Study|Screen failure after randomization|0|||
94412377|NCT02093923|323294711|FG001|Overall Study|Screen failure after randomization|0|||
94412378|NCT02093923|323294712|FG002|Overall Study|Screen failure after randomization|0|||
94412379|NCT02093923|323294713|FG003|Overall Study|Screen failure after randomization|1|||
94412380|NCT02093923|323294714|FG004|Overall Study|Screen failure after randomization|0|||
94412381|NCT00739973|323294715|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
94412382|NCT00739973|323294716|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
94412383|NCT00739973|323294717|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
94412384|NCT00739973|323294718|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
94412385|NCT00739973|323294719|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
94412386|NCT00739973|323294720|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
94412387|NCT00739973|323294721|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
94412388|NCT00739973|323294722|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
94412389|NCT00739973|323294723|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
94412390|NCT00739973|323294715|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
94412391|NCT00739973|323294716|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
94412392|NCT00739973|323294717|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
94412393|NCT00739973|323294718|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
94412394|NCT00739973|323294719|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
94412395|NCT00739973|323294720|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
94412396|NCT00739973|323294721|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
94412397|NCT00739973|323294722|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
94412398|NCT00739973|323294723|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
94412399|NCT00739973|323294715|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
94412400|NCT00739973|323294716|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
94412401|NCT00739973|323294717|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
94412402|NCT00739973|323294718|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
94412403|NCT00739973|323294719|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
94412404|NCT00739973|323294720|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
94412405|NCT00739973|323294721|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
94412406|NCT00739973|323294722|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
94412407|NCT00739973|323294723|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
94412408|NCT00739973|323294715|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
94412409|NCT00739973|323294716|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
94412410|NCT00739973|323294717|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
94412411|NCT00739973|323294718|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
94412412|NCT00739973|323294719|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
94412413|NCT00739973|323294720|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
94412414|NCT00739973|323294721|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
94412415|NCT00739973|323294722|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
94412416|NCT00739973|323294723|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
94412417|NCT00739973|323294715|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
94412418|NCT00739973|323294716|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
94412419|NCT00739973|323294717|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
94412420|NCT00739973|323294718|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
94412421|NCT00739973|323294719|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
94412422|NCT00739973|323294720|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
94412423|NCT00739973|323294721|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
94412424|NCT00739973|323294722|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
94412425|NCT00739973|323294723|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
94412426|NCT00739973|323294715|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
94412427|NCT00739973|323294716|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
94412428|NCT00739973|323294717|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
94412429|NCT00739973|323294718|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
94412430|NCT00739973|323294719|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
94412431|NCT00739973|323294720|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
94412432|NCT00739973|323294721|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
94412433|NCT00739973|323294722|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
94412434|NCT00739973|323294723|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
94412435|NCT00739973|323294715|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
94412436|NCT00739973|323294716|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
94412437|NCT00739973|323294717|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
94412438|NCT00739973|323294718|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
94412439|NCT00739973|323294719|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
94412440|NCT00739973|323294720|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
94412441|NCT00739973|323294721|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
94412442|NCT00739973|323294722|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
94412443|NCT00739973|323294723|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
94412444|NCT00739973|323294715|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
94412445|NCT00739973|323294716|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
94412446|NCT00739973|323294717|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
94412447|NCT00739973|323294718|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
94412448|NCT00739973|323294719|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
94412449|NCT00739973|323294720|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
94412450|NCT00739973|323294721|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
94412451|NCT00739973|323294722|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
94412452|NCT00739973|323294723|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
94412453|NCT00739973|323294715|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
94412454|NCT00739973|323294716|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
94412455|NCT00739973|323294717|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
94412456|NCT00739973|323294718|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
94412457|NCT00739973|323294719|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
94412458|NCT00739973|323294720|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
94412459|NCT00739973|323294721|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
94412460|NCT00739973|323294722|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
94412461|NCT00739973|323294723|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
94412462|NCT00739973|323294715|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
94412463|NCT00739973|323294716|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
94412464|NCT00739973|323294717|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
94412465|NCT00739973|323294718|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
94412466|NCT00739973|323294719|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
94487213|NCT01569022|323577488|FG001|Second Intervention|Lost to Follow-up|2|||
94487214|NCT03426345|323577493|FG000|Overall Study|Adverse Event|4|||
94412467|NCT00739973|323294720|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
94412468|NCT00739973|323294721|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
94412469|NCT00739973|323294722|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
94412470|NCT00739973|323294723|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
94412471|NCT00739973|323294715|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
94412472|NCT00739973|323294716|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
94412473|NCT00739973|323294717|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
94412474|NCT00739973|323294718|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
94412475|NCT00739973|323294719|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
94412476|NCT00739973|323294720|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
94412477|NCT00739973|323294721|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
94412478|NCT00739973|323294722|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
94412479|NCT00739973|323294723|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
94412480|NCT00739973|323294715|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
94412481|NCT00739973|323294716|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
94412482|NCT00739973|323294717|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
94412483|NCT00739973|323294718|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
94412484|NCT00739973|323294719|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
94412485|NCT00739973|323294720|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
94412486|NCT00739973|323294721|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
94412487|NCT00739973|323294722|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
94412488|NCT00739973|323294723|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
94412489|NCT00739973|323294715|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
94412490|NCT00739973|323294716|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
94412491|NCT00739973|323294717|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
94412492|NCT00739973|323294718|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
94412493|NCT00739973|323294719|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
94412494|NCT00739973|323294720|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
94412495|NCT00739973|323294721|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
94412496|NCT00739973|323294722|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
94412497|NCT00739973|323294723|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
94412498|NCT00739973|323294715|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
94412499|NCT00739973|323294716|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
94412500|NCT00739973|323294717|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
94412501|NCT00739973|323294718|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
94412502|NCT00739973|323294719|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
94412503|NCT00739973|323294720|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
94412504|NCT00739973|323294721|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
94412505|NCT00739973|323294722|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
94412506|NCT00739973|323294723|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
94412507|NCT00739973|323294715|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
94412508|NCT00739973|323294716|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
94487215|NCT03426345|323577494|FG001|Overall Study|Adverse Event|4|||
94487216|NCT03426345|323577493|FG000|Overall Study|Lack of Efficacy|1|||
94487217|NCT03426345|323577494|FG001|Overall Study|Lack of Efficacy|0|||
94487218|NCT03426345|323577493|FG000|Overall Study|Withdrawal by Subject|5|||
94487219|NCT03426345|323577494|FG001|Overall Study|Withdrawal by Subject|6|||
94487220|NCT03426345|323577493|FG000|Overall Study|Lost to Follow-up|3|||
94487221|NCT03426345|323577494|FG001|Overall Study|Lost to Follow-up|1|||
94487222|NCT03426345|323577493|FG000|Overall Study|Protocol Deviation|3|||
94487223|NCT03426345|323577494|FG001|Overall Study|Protocol Deviation|4|||
94487224|NCT03426345|323577493|FG000|Overall Study|Reason Not Specified|1|||
94487225|NCT03426345|323577494|FG001|Overall Study|Reason Not Specified|2|||
94487226|NCT03426345|323577493|FG000|Overall Study|Missing Completion Status|1|||
94487227|NCT03426345|323577494|FG001|Overall Study|Missing Completion Status|0|||
94487228|NCT00888654|323577502|FG000|Overall Study|Problems swallowing oral meds.|1|||
94487229|NCT00888654|323577502|FG000|Overall Study|Not enough oral meds before surgery|3|||
94487230|NCT00888654|323577502|FG000|Overall Study|Surgery aborted|2|||
94487231|NCT00888654|323577502|FG000|Overall Study|Withdrawal by Subject|1|||
94487232|NCT00888654|323577502|FG000|Overall Study|Inelig. due to contraindication of med|1|||
94412509|NCT00739973|323294717|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
94412510|NCT00739973|323294718|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
94412511|NCT00739973|323294719|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
94412512|NCT00739973|323294720|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
94412513|NCT00739973|323294721|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
94412514|NCT00739973|323294722|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
94412515|NCT00739973|323294723|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
94412516|NCT00739973|323294715|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
94412517|NCT00739973|323294716|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
94412518|NCT00739973|323294717|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
94412519|NCT00739973|323294718|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
94412520|NCT00739973|323294719|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
94412521|NCT00739973|323294720|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
94412522|NCT00739973|323294721|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
94412523|NCT00739973|323294722|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
94412524|NCT00739973|323294723|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
94412525|NCT00739973|323294715|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
94412526|NCT00739973|323294716|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
94412527|NCT00739973|323294717|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
94412528|NCT00739973|323294718|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
94412529|NCT00739973|323294719|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
94412530|NCT00739973|323294720|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
94412531|NCT00739973|323294721|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
94412532|NCT00739973|323294722|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
94412533|NCT00739973|323294723|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
94412534|NCT02792218|323294725|FG000|Overall Study|Patient/guardian decision|15|||
94412535|NCT02792218|323294726|FG001|Overall Study|Patient/guardian decision|42|||
94412536|NCT02792218|323294725|FG000|Overall Study|Adverse Event|15|||
94412537|NCT02792218|323294726|FG001|Overall Study|Adverse Event|14|||
94412538|NCT02792218|323294725|FG000|Overall Study|Lost to Follow-up|10|||
94412539|NCT02792218|323294726|FG001|Overall Study|Lost to Follow-up|5|||
94412540|NCT02792218|323294725|FG000|Overall Study|Lack of Efficacy|1|||
94412541|NCT02792218|323294726|FG001|Overall Study|Lack of Efficacy|12|||
94412542|NCT02792218|323294725|FG000|Overall Study|Physician Decision|4|||
94412543|NCT02792218|323294726|FG001|Overall Study|Physician Decision|4|||
94412544|NCT02792218|323294725|FG000|Overall Study|Protocol deviation|3|||
94412545|NCT02792218|323294726|FG001|Overall Study|Protocol deviation|2|||
94412546|NCT02792218|323294725|FG000|Overall Study|New therapy for study indication|0|||
94412547|NCT02792218|323294726|FG001|Overall Study|New therapy for study indication|1|||
94412548|NCT02792218|323294725|FG000|Overall Study|Non-compliance with study treatment|0|||
94412549|NCT02792218|323294726|FG001|Overall Study|Non-compliance with study treatment|1|||
94412550|NCT02792218|323294725|FG000|Overall Study|Pregnancy|1|||
94412551|NCT02792218|323294726|FG001|Overall Study|Pregnancy|0|||
94412552|NCT00824369|323294727|FG000|Overall Study|Nolonger willing to participate in study|1|||
94412553|NCT00824369|323294728|FG001|Overall Study|Nolonger willing to participate in study|0|||
94412554|NCT00824369|323294729|FG002|Overall Study|Nolonger willing to participate in study|1|||
94412555|NCT00824369|323294730|FG003|Overall Study|Nolonger willing to participate in study|2|||
94412556|NCT00824369|323294731|FG004|Overall Study|Nolonger willing to participate in study|0|||
94412557|NCT00824369|323294732|FG005|Overall Study|Nolonger willing to participate in study|1|||
94412558|NCT00824369|323294727|FG000|Overall Study|Lost to Follow-up|0|||
94412559|NCT00824369|323294728|FG001|Overall Study|Lost to Follow-up|0|||
94412560|NCT00824369|323294729|FG002|Overall Study|Lost to Follow-up|0|||
94412561|NCT00824369|323294730|FG003|Overall Study|Lost to Follow-up|0|||
94412562|NCT00824369|323294731|FG004|Overall Study|Lost to Follow-up|1|||
94412563|NCT00824369|323294732|FG005|Overall Study|Lost to Follow-up|0|||
94412564|NCT02985879|323294733|FG000|Overall Study|Adverse Event|7|||
94412565|NCT02985879|323294734|FG001|Overall Study|Adverse Event|9|||
94412566|NCT02985879|323294735|FG002|Overall Study|Adverse Event|7|||
94412567|NCT02985879|323294733|FG000|Overall Study|Withdrew consent|6|||
94412568|NCT02985879|323294734|FG001|Overall Study|Withdrew consent|8|||
94487233|NCT00888654|323577502|FG000|Overall Study|Change in surg date|1|||
94487234|NCT00888654|323577502|FG000|Overall Study|Stopped meds due to headaches|1|||
94487235|NCT01064479|323577505|FG000|Overall Study|Death|10|||
94412569|NCT02985879|323294735|FG002|Overall Study|Withdrew consent|10|||
94412570|NCT02985879|323294733|FG000|Overall Study|Lost to Follow-up|1|||
94487236|NCT01064479|323577506|FG001|Overall Study|Death|11|||
94487237|NCT01064479|323577505|FG000|Overall Study|Withdrawal by Subject|2|||
94487238|NCT01064479|323577506|FG001|Overall Study|Withdrawal by Subject|2|||
94487239|NCT01064479|323577505|FG000|Overall Study|Disease progression|1|||
94487240|NCT01064479|323577506|FG001|Overall Study|Disease progression|1|||
94487241|NCT01064479|323577505|FG000|Overall Study|Toxicity|1|||
94487242|NCT01064479|323577506|FG001|Overall Study|Toxicity|1|||
94487243|NCT01064479|323577505|FG000|Overall Study|Other|1|||
94487244|NCT01064479|323577506|FG001|Overall Study|Other|2|||
94487245|NCT00423046|323577509|FG000|Overall Study|Other|340|||
94487246|NCT00423046|323577510|FG001|Overall Study|Other|345|||
94487247|NCT00726609|323577513|FG000|Overall Study|Adverse Event|10|||
94487248|NCT00726609|323577513|FG000|Overall Study|Withdrawal by Subject|2|||
94487249|NCT00726609|323577513|FG000|Overall Study|Lack of Efficacy|25|||
94487250|NCT00726609|323577513|FG000|Overall Study|Other|16|||
94487251|NCT00726609|323577513|FG000|Overall Study|Missing|42|||
94487252|NCT00726609|323577513|FG000|Overall Study|Other|3|||
94487253|NCT00746551|323577514|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
94487254|NCT00746551|323577515|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
94487255|NCT00746551|323577514|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
94487256|NCT00746551|323577515|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
94487257|NCT00746551|323577514|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
94487258|NCT00746551|323577515|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
94487259|NCT02783911|323577522|FG000|Overall Study|Lost to Follow-up|3|||
94487260|NCT02783911|323577523|FG001|Overall Study|Lost to Follow-up|32|||
94487261|NCT00467519|323577524|FG000|Overall Study|Protocol Violation|8|||
94487262|NCT00467519|323577525|FG001|Overall Study|Protocol Violation|4|||
94487263|NCT00467519|323577524|FG000|Overall Study|Lost to Follow-up|2|||
94487264|NCT00467519|323577525|FG001|Overall Study|Lost to Follow-up|9|||
94487265|NCT00467519|323577524|FG000|Overall Study|Withdrawal by Subject|4|||
94487266|NCT00467519|323577525|FG001|Overall Study|Withdrawal by Subject|10|||
94487267|NCT03327324|323577527|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
94487268|NCT03327324|323577528|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
94487269|NCT03327324|323577529|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
94412571|NCT02985879|323294734|FG001|Overall Study|Lost to Follow-up|0|||
94412572|NCT02985879|323294735|FG002|Overall Study|Lost to Follow-up|2|||
94412573|NCT02985879|323294733|FG000|Overall Study|Other, not specified|62|||
94412574|NCT02985879|323294734|FG001|Overall Study|Other, not specified|58|||
94412575|NCT02985879|323294735|FG002|Overall Study|Other, not specified|58|||
94412576|NCT04974619|323296380|FG000|Overall Study|Lost to Follow-up|0|||
94412577|NCT04974619|323296381|FG001|Overall Study|Lost to Follow-up|0|||
94412578|NCT04974619|323296382|FG002|Overall Study|Lost to Follow-up|1|||
94412579|NCT04974619|323296380|FG000|Overall Study|Withdrawal by Subject|0|||
94412580|NCT04974619|323296381|FG001|Overall Study|Withdrawal by Subject|0|||
94412581|NCT04974619|323296382|FG002|Overall Study|Withdrawal by Subject|1|||
94412582|NCT04974619|323296380|FG000|Overall Study|Protocol Violation|0|||
94412583|NCT04974619|323296381|FG001|Overall Study|Protocol Violation|1|||
94412584|NCT04974619|323296382|FG002|Overall Study|Protocol Violation|0|||
94412585|NCT03180528|323296385|FG000|Overall Study|Adverse Event|1|||
94412586|NCT03180528|323296385|FG000|Overall Study|Withdrawal by Subject|1|||
94412587|NCT03180528|323296385|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
94412588|NCT04703855|323296386|FG000|Overall Study|Heart Transplant|1|||
94412589|NCT02459418|323296389|FG000|Overall Study|Exclusion Criteria|4|||
94412590|NCT02459418|323296390|FG001|Overall Study|Exclusion Criteria|0|||
94412591|NCT02459418|323296389|FG000|Overall Study|Protocol Violation|0|||
94412592|NCT02459418|323296390|FG001|Overall Study|Protocol Violation|2|||
94412593|NCT02459418|323296389|FG000|Overall Study|Physician Decision|0|||
94412594|NCT02459418|323296390|FG001|Overall Study|Physician Decision|2|||
94412595|NCT02459418|323296389|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
94412596|NCT02459418|323296390|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
94412597|NCT02459418|323296389|FG000|Overall Study|Adverse Event|0|||
94412598|NCT02459418|323296390|FG001|Overall Study|Adverse Event|1|||
94412599|NCT02459418|323296389|FG000|Overall Study|Withdrawal by Subject|1|||
94412600|NCT02459418|323296390|FG001|Overall Study|Withdrawal by Subject|1|||
94412601|NCT02459418|323296389|FG000|Overall Study|Elevated Creatine Kinase|1|||
94412602|NCT02459418|323296390|FG001|Overall Study|Elevated Creatine Kinase|0|||
94412603|NCT02459418|323296389|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
94412604|NCT02459418|323296390|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
94412605|NCT01010126|323296392|FG000|Overall Study|Withdrawal by Subject|1|||
94487270|NCT03327324|323577530|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
94487271|NCT03327324|323577531|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
94412606|NCT01010126|323296393|FG001|Overall Study|Withdrawal by Subject|0|||
94412607|NCT01010126|323296394|FG002|Overall Study|Withdrawal by Subject|1|||
94412608|NCT01010126|323296395|FG003|Overall Study|Withdrawal by Subject|0|||
94412609|NCT01010126|323296396|FG004|Overall Study|Withdrawal by Subject|3|||
94412610|NCT01010126|323296397|FG005|Overall Study|Withdrawal by Subject|0|||
94412611|NCT02190279|323296402|FG000|Overall Study|Withdrawal consent|1|||
94412612|NCT02190279|323296403|FG001|Overall Study|Withdrawal consent|0|||
94487272|NCT03327324|323577532|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
94487273|NCT03327324|323577527|FG000|Baseline (Month 0-Month 3)|Refused|0|||
94487274|NCT03327324|323577528|FG001|Baseline (Month 0-Month 3)|Refused|0|||
94487275|NCT03327324|323577529|FG002|Baseline (Month 0-Month 3)|Refused|0|||
94487276|NCT03327324|323577530|FG003|Baseline (Month 0-Month 3)|Refused|0|||
94487277|NCT03327324|323577531|FG004|Baseline (Month 0-Month 3)|Refused|1|||
94487278|NCT03327324|323577532|FG005|Baseline (Month 0-Month 3)|Refused|0|||
94487279|NCT03327324|323577527|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
94487280|NCT03327324|323577528|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
94487281|NCT03327324|323577529|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
94412613|NCT02190279|323296404|FG002|Overall Study|Withdrawal consent|1|||
94412614|NCT02190279|323296402|FG000|Overall Study|Lost to Follow-up|2|||
94412615|NCT02190279|323296403|FG001|Overall Study|Lost to Follow-up|0|||
94412616|NCT02190279|323296404|FG002|Overall Study|Lost to Follow-up|0|||
94412617|NCT02190279|323296402|FG000|Overall Study|Refused further treatment|0|||
94412618|NCT02190279|323296403|FG001|Overall Study|Refused further treatment|0|||
94412619|NCT02190279|323296404|FG002|Overall Study|Refused further treatment|1|||
94412620|NCT02190279|323296402|FG000|Overall Study|Screening failure|0|||
94412621|NCT02190279|323296403|FG001|Overall Study|Screening failure|0|||
94412622|NCT02190279|323296404|FG002|Overall Study|Screening failure|1|||
94412623|NCT01606228|323296405|FG000|Overall Study|Lost to Follow-up|20|||
94412624|NCT01606228|323296405|FG000|Overall Study|Withdrawal by Subject|3|||
94412625|NCT01606228|323296405|FG000|Overall Study|Non-compliant|3|||
94412626|NCT01606228|323296405|FG000|Overall Study|Lack of Efficacy|2|||
94412627|NCT01606228|323296405|FG000|Overall Study|Adverse Event|1|||
94412628|NCT00114231|323296416|FG000|Overall Study|No consent|2|||
94412629|NCT00114231|323296417|FG001|Overall Study|No consent|0|||
94412630|NCT00114231|323296416|FG000|Overall Study|QARC requirement not met|1|||
94412631|NCT00114231|323296417|FG001|Overall Study|QARC requirement not met|0|||
94412632|NCT00114231|323296416|FG000|Overall Study|Suspected metastatic disease|1|||
94412633|NCT00114231|323296417|FG001|Overall Study|Suspected metastatic disease|0|||
94412634|NCT00114231|323296416|FG000|Overall Study|No adenocarcinoma|1|||
94412635|NCT00114231|323296417|FG001|Overall Study|No adenocarcinoma|0|||
94412636|NCT00114231|323296416|FG000|Overall Study|Low creatinine clearance|0|||
94412637|NCT00114231|323296417|FG001|Overall Study|Low creatinine clearance|1|||
94412638|NCT00114231|323296416|FG000|Overall Study|Tumor size > 4cm|1|||
94412639|NCT00114231|323296417|FG001|Overall Study|Tumor size > 4cm|0|||
94412640|NCT00114231|323296416|FG000|Overall Study|Tumor fixed on digital exam|0|||
94412641|NCT00114231|323296417|FG001|Overall Study|Tumor fixed on digital exam|1|||
94412642|NCT00114231|323296416|FG000|Overall Study|No Absolute Neutrophil Count|2|||
94412643|NCT00114231|323296417|FG001|Overall Study|No Absolute Neutrophil Count|0|||
94412644|NCT00114231|323296416|FG000|Overall Study|Biopsy done after registration|1|||
94412645|NCT00114231|323296417|FG001|Overall Study|Biopsy done after registration|0|||
94412646|NCT01301482|323296421|FG000|Overall Study|Withdrawal by Subject|1|||
94412647|NCT00480324|323296422|FG000|Overall Study|Adverse Event|1|||
94412648|NCT00480324|323296423|FG001|Overall Study|Adverse Event|1|||
94412649|NCT00480324|323296422|FG000|Overall Study|Protocol Violation|0|||
94412650|NCT00480324|323296423|FG001|Overall Study|Protocol Violation|1|||
94487282|NCT03327324|323577530|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
94487283|NCT03327324|323577531|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
94487284|NCT03327324|323577532|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
94487285|NCT03327324|323577527|FG000|Baseline (Month 0-Month 3)|Death|0|||
94487286|NCT03327324|323577528|FG001|Baseline (Month 0-Month 3)|Death|0|||
94487287|NCT03327324|323577529|FG002|Baseline (Month 0-Month 3)|Death|0|||
94487288|NCT03327324|323577530|FG003|Baseline (Month 0-Month 3)|Death|0|||
94487289|NCT03327324|323577531|FG004|Baseline (Month 0-Month 3)|Death|1|||
94487290|NCT03327324|323577532|FG005|Baseline (Month 0-Month 3)|Death|0|||
94487291|NCT03327324|323577527|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
94487292|NCT03327324|323577528|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
94487293|NCT03327324|323577529|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
94487294|NCT03327324|323577530|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
94487295|NCT03327324|323577531|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
94487296|NCT03327324|323577532|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
94412651|NCT00480324|323296422|FG000|Overall Study|Withdrawal by Subject|14|||
94412652|NCT00480324|323296423|FG001|Overall Study|Withdrawal by Subject|5|||
94412653|NCT00480324|323296422|FG000|Overall Study|Lost to Follow-up|17|||
94412654|NCT00480324|323296423|FG001|Overall Study|Lost to Follow-up|8|||
94412655|NCT00480324|323296422|FG000|Overall Study|Subject's mother pregnant|0|||
94412656|NCT00480324|323296423|FG001|Overall Study|Subject's mother pregnant|1|||
94412657|NCT01131299|323296424|FG000|Overall Study|Withdrawal by Subject|4|||
94412658|NCT01131299|323296425|FG001|Overall Study|Withdrawal by Subject|7|||
94412659|NCT03785145|323296426|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
94412660|NCT03785145|323296427|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
94412661|NCT03785145|323296426|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
94412662|NCT03785145|323296427|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
94412663|NCT03785145|323296426|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
94412664|NCT03785145|323296427|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
94412665|NCT03785145|323296426|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
94412666|NCT03785145|323296427|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
94412667|NCT03785145|323296426|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
94412668|NCT03785145|323296427|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
94412669|NCT03785145|323296426|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
94412670|NCT03785145|323296427|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
94412671|NCT03785145|323296426|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
94412672|NCT03785145|323296427|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
94412673|NCT03785145|323296426|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
94412674|NCT03785145|323296427|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
94412675|NCT03785145|323296426|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
94412676|NCT03785145|323296427|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
94412677|NCT03785145|323296426|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
94412678|NCT03785145|323296427|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
94412679|NCT03785145|323296426|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
94412680|NCT03785145|323296427|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
94412681|NCT02999984|323296437|FG000|Overall Study|Treatment Failure|1|||
94412682|NCT01316419|323296438|FG000|Overall Study|Not treated|103|||
94412683|NCT01316419|323296438|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
94412684|NCT01316419|323296438|FG000|Overall Study|Lost to Follow-up|19|||
94412685|NCT04039919|323296445|FG000|Treatment Period 1|Withdrawal by Subject|1|||
94412686|NCT04039919|323296446|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94412687|NCT04039919|323296447|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94412688|NCT04039919|323296448|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94412689|NCT04039919|323296449|FG004|Treatment Period 1|Withdrawal by Subject|0|||
94412690|NCT04039919|323296445|FG000|Treatment Period 1|Sponsor's decision|0|||
94412691|NCT04039919|323296446|FG001|Treatment Period 1|Sponsor's decision|0|||
94412692|NCT04039919|323296447|FG002|Treatment Period 1|Sponsor's decision|0|||
94412693|NCT04039919|323296448|FG003|Treatment Period 1|Sponsor's decision|0|||
94412694|NCT04039919|323296449|FG004|Treatment Period 1|Sponsor's decision|16|||
94412695|NCT04039919|323296445|FG000|Treatment Period 5|Withdrawal by Subject|1|||
94412696|NCT04039919|323296446|FG001|Treatment Period 5|Withdrawal by Subject|0|||
94412697|NCT04039919|323296447|FG002|Treatment Period 5|Withdrawal by Subject|0|||
94412698|NCT04039919|323296448|FG003|Treatment Period 5|Withdrawal by Subject|0|||
94412699|NCT04039919|323296449|FG004|Treatment Period 5|Withdrawal by Subject|0|||
94412700|NCT01042535|323296450|FG000|Overall Study|disease progression prior to treatment|3|||
94412701|NCT01042535|323296450|FG000|Overall Study|disease progression during treatment|3|||
94412702|NCT01042535|323296450|FG000|Overall Study|complications from other disease|2|||
94412703|NCT01311557|323296453|FG000|Overall Study|Serious adverse event|0|||
94412704|NCT01311557|323296454|FG001|Overall Study|Serious adverse event|1|||
94412705|NCT01311557|323296453|FG000|Overall Study|Protocol Violation|4|||
94412706|NCT01311557|323296454|FG001|Overall Study|Protocol Violation|2|||
94412707|NCT01311557|323296453|FG000|Overall Study|Lost to Follow-up|0|||
94412708|NCT01311557|323296454|FG001|Overall Study|Lost to Follow-up|1|||
94412709|NCT01311557|323296453|FG000|Overall Study|Withdrawal by Subject|1|||
94412710|NCT01311557|323296454|FG001|Overall Study|Withdrawal by Subject|2|||
94412711|NCT00337428|323296455|FG000|Overall Study|Withdrawal by Subject|1|||
94412712|NCT00337428|323296456|FG001|Overall Study|Withdrawal by Subject|2|||
94412713|NCT00337428|323296455|FG000|Overall Study|Lack of Time|1|||
94412714|NCT00337428|323296456|FG001|Overall Study|Lack of Time|1|||
94412715|NCT00337428|323296455|FG000|Overall Study|Unwilling to Continue|1|||
94412716|NCT00337428|323296456|FG001|Overall Study|Unwilling to Continue|0|||
94412717|NCT00337428|323296455|FG000|Overall Study|Anorexia|1|||
94412718|NCT00337428|323296456|FG001|Overall Study|Anorexia|0|||
94412719|NCT02973321|323296457|FG000|Overall Study|Other than specified|0|||
94412720|NCT02973321|323296458|FG001|Overall Study|Other than specified|5|||
94412721|NCT02973321|323296459|FG002|Overall Study|Other than specified|3|||
94412722|NCT02973321|323296460|FG003|Overall Study|Other than specified|3|||
94412723|NCT02973321|323296461|FG004|Overall Study|Other than specified|1|||
94412724|NCT02973321|323296457|FG000|Overall Study|Lack of Efficacy|0|||
94412725|NCT02973321|323296458|FG001|Overall Study|Lack of Efficacy|0|||
94412726|NCT02973321|323296459|FG002|Overall Study|Lack of Efficacy|0|||
94412727|NCT02973321|323296460|FG003|Overall Study|Lack of Efficacy|0|||
94412728|NCT02973321|323296461|FG004|Overall Study|Lack of Efficacy|1|||
94412729|NCT02973321|323296457|FG000|Overall Study|Adverse Event|1|||
94487297|NCT03327324|323577527|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
94487298|NCT03327324|323577528|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
94487299|NCT03327324|323577529|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
94487300|NCT03327324|323577530|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
94487301|NCT03327324|323577531|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
94487302|NCT03327324|323577532|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
94487303|NCT03327324|323577527|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
94487304|NCT03327324|323577528|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
94487305|NCT03327324|323577529|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
94487306|NCT03327324|323577530|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
94487307|NCT03327324|323577531|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
94487308|NCT03327324|323577532|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
94487309|NCT03327324|323577527|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
94487310|NCT03327324|323577528|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
94487311|NCT03327324|323577529|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
94487312|NCT03327324|323577530|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
94487313|NCT03327324|323577531|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
94487314|NCT03327324|323577532|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
94487315|NCT03327324|323577527|FG000|Intervention (Month 3-Month 6)|Death|1|||
94487316|NCT03327324|323577528|FG001|Intervention (Month 3-Month 6)|Death|0|||
94487317|NCT03327324|323577529|FG002|Intervention (Month 3-Month 6)|Death|1|||
94487318|NCT03327324|323577530|FG003|Intervention (Month 3-Month 6)|Death|1|||
94487319|NCT03327324|323577531|FG004|Intervention (Month 3-Month 6)|Death|1|||
94487320|NCT03327324|323577532|FG005|Intervention (Month 3-Month 6)|Death|0|||
94487321|NCT03327324|323577527|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
94487322|NCT03327324|323577528|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
94487323|NCT03327324|323577529|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
94512832|NCT00725985|323676430|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
94412730|NCT02973321|323296458|FG001|Overall Study|Adverse Event|10|||
94412731|NCT02973321|323296459|FG002|Overall Study|Adverse Event|11|||
94412732|NCT02973321|323296460|FG003|Overall Study|Adverse Event|13|||
94412733|NCT02973321|323296461|FG004|Overall Study|Adverse Event|3|||
94412734|NCT00384293|323296463|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
94412735|NCT00384293|323296464|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
94412736|NCT00384293|323296465|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
94412737|NCT00384293|323296463|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
94412738|NCT00384293|323296464|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
94412739|NCT00384293|323296465|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
94412740|NCT00384293|323296463|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
94412741|NCT00384293|323296464|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
94412742|NCT00384293|323296465|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
94412743|NCT00384293|323296463|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
94412744|NCT00384293|323296464|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
94412745|NCT00384293|323296465|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
94412746|NCT00384293|323296463|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
94412747|NCT00384293|323296464|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
94412748|NCT00384293|323296465|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
94412749|NCT00384293|323296463|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
94412750|NCT00384293|323296464|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
94412751|NCT00384293|323296465|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
94412752|NCT00384293|323296463|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
94412753|NCT00384293|323296464|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
94412754|NCT00384293|323296465|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
94412755|NCT00384293|323296463|FG000|Post-randomization Period|Adverse Event|0|||
94412756|NCT00384293|323296464|FG001|Post-randomization Period|Adverse Event|23|||
94412757|NCT00384293|323296465|FG002|Post-randomization Period|Adverse Event|7|||
94412758|NCT00384293|323296463|FG000|Post-randomization Period|Lost to Follow-up|0|||
94412759|NCT00384293|323296464|FG001|Post-randomization Period|Lost to Follow-up|2|||
94412760|NCT00384293|323296465|FG002|Post-randomization Period|Lost to Follow-up|1|||
94412761|NCT00384293|323296463|FG000|Post-randomization Period|Protocol Violation|0|||
94412762|NCT00384293|323296464|FG001|Post-randomization Period|Protocol Violation|1|||
94412763|NCT00384293|323296465|FG002|Post-randomization Period|Protocol Violation|0|||
94412764|NCT00384293|323296463|FG000|Post-randomization Period|Withdrawal by Subject|0|||
94412765|NCT00384293|323296464|FG001|Post-randomization Period|Withdrawal by Subject|8|||
94412766|NCT00384293|323296465|FG002|Post-randomization Period|Withdrawal by Subject|6|||
94412767|NCT00384293|323296463|FG000|Post-randomization Period|Trial Termination|0|||
94412768|NCT00384293|323296464|FG001|Post-randomization Period|Trial Termination|180|||
94412769|NCT00384293|323296465|FG002|Post-randomization Period|Trial Termination|204|||
94412770|NCT00384293|323296463|FG000|Post-randomization Period|Patient Randomized in Error|0|||
94412771|NCT00384293|323296464|FG001|Post-randomization Period|Patient Randomized in Error|0|||
94412772|NCT00384293|323296465|FG002|Post-randomization Period|Patient Randomized in Error|1|||
94412773|NCT01501110|323296472|FG000|Overall Study|Death|0|||
94412774|NCT01501110|323296473|FG001|Overall Study|Death|1|||
94412775|NCT01439724|323296478|FG000|Overall Study|missing consultation|9|||
94412776|NCT01439724|323296479|FG001|Overall Study|missing consultation|8|||
94412777|NCT05444543|323296480|FG000|Overall Study|Withdrawal by Subject|1|||
94412778|NCT05444543|323296481|FG001|Overall Study|Withdrawal by Subject|0|||
94412779|NCT05444543|323296480|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
94412780|NCT05444543|323296481|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
94412781|NCT05444543|323296480|FG000|Overall Study|Adverse Event|0|||
94412782|NCT05444543|323296481|FG001|Overall Study|Adverse Event|1|||
94412783|NCT05444543|323296480|FG000|Overall Study|Family relocating at a distance from study site|0|||
94412784|NCT05444543|323296481|FG001|Overall Study|Family relocating at a distance from study site|1|||
94412785|NCT04668274|323296482|FG000|Part 1 Study Period 1|Adverse Event|3|||
94412786|NCT04668274|323296483|FG001|Part 1 Study Period 1|Adverse Event|0|||
94412787|NCT04668274|323296484|FG002|Part 1 Study Period 1|Adverse Event|0|||
94412788|NCT04668274|323296485|FG003|Part 1 Study Period 1|Adverse Event|0|||
94412789|NCT04668274|323296482|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
94412790|NCT04668274|323296483|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
94412791|NCT04668274|323296484|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
94412792|NCT04668274|323296485|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
94412793|NCT04668274|323296482|FG000|Part 1 Study Period 2|Other|0|||
94412794|NCT04668274|323296483|FG001|Part 1 Study Period 2|Other|1|||
94412795|NCT04668274|323296484|FG002|Part 1 Study Period 2|Other|0|||
94412796|NCT04668274|323296485|FG003|Part 1 Study Period 2|Other|0|||
94412797|NCT04668274|323296482|FG000|Part 1 Study Period 3|Adverse Event|0|||
94412798|NCT04668274|323296483|FG001|Part 1 Study Period 3|Adverse Event|0|||
94412799|NCT04668274|323296484|FG002|Part 1 Study Period 3|Adverse Event|1|||
94412800|NCT04668274|323296485|FG003|Part 1 Study Period 3|Adverse Event|0|||
94412801|NCT04668274|323296482|FG000|Part 1 Study Period 3|Other|0|||
94412802|NCT04668274|323296483|FG001|Part 1 Study Period 3|Other|0|||
94412803|NCT04668274|323296484|FG002|Part 1 Study Period 3|Other|2|||
94412804|NCT04668274|323296485|FG003|Part 1 Study Period 3|Other|0|||
94412805|NCT04668274|323296482|FG000|Part 2 Study Period 4|Other|0|||
94412806|NCT04668274|323296483|FG001|Part 2 Study Period 4|Other|0|||
94412807|NCT04668274|323296484|FG002|Part 2 Study Period 4|Other|0|||
94412808|NCT04668274|323296485|FG003|Part 2 Study Period 4|Other|1|||
94412809|NCT02363439|323296486|FG000|Overall Study|Lack of Efficacy|4|||
94412810|NCT01719562|323296489|FG000|Overall Study|Lost to Follow-up|1|||
94412811|NCT01719562|323296490|FG001|Overall Study|Lost to Follow-up|0|||
94412812|NCT01719562|323296489|FG000|Overall Study|Death|1|||
94412813|NCT01719562|323296490|FG001|Overall Study|Death|0|||
94412814|NCT01719562|323296489|FG000|Overall Study|New cancer diagnosis|1|||
94412815|NCT01719562|323296490|FG001|Overall Study|New cancer diagnosis|0|||
94412816|NCT00003531|323296494|FG000|Overall Study|Not evaluable|10|||
94412817|NCT02487082|323296497|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
94412818|NCT02487082|323296498|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
94412819|NCT02487082|323296497|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
94412820|NCT02487082|323296498|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
94412821|NCT01832402|323296500|FG000|Overall Study|Lost to Follow-up|2|||
94412822|NCT01832402|323296501|FG001|Overall Study|Lost to Follow-up|0|||
94412823|NCT01832402|323296500|FG000|Overall Study|Withdrawal by Subject|3|||
94412824|NCT01832402|323296501|FG001|Overall Study|Withdrawal by Subject|3|||
94412825|NCT01832402|323296500|FG000|Overall Study|Declining Performance status|2|||
94412826|NCT01832402|323296501|FG001|Overall Study|Declining Performance status|1|||
94412827|NCT02776553|323296502|FG000|Overall Study|Lost to Follow-up|1|||
94412828|NCT02776553|323296503|FG001|Overall Study|Lost to Follow-up|0|||
94412829|NCT02776553|323296502|FG000|Overall Study|got liver transplant|1|||
94412830|NCT02776553|323296503|FG001|Overall Study|got liver transplant|2|||
94412831|NCT02776553|323296502|FG000|Overall Study|had other surgery|1|||
94412832|NCT02776553|323296503|FG001|Overall Study|had other surgery|0|||
94412833|NCT02776553|323296502|FG000|Overall Study|Protocol Violation|0|||
94412834|NCT02776553|323296503|FG001|Overall Study|Protocol Violation|1|||
94412835|NCT01998243|323296504|FG000|Overall Study|Pregnancy|0|||
94412836|NCT01998243|323296505|FG001|Overall Study|Pregnancy|1|||
94412837|NCT01998243|323296504|FG000|Overall Study|Protocol Violation|5|||
94412838|NCT01998243|323296505|FG001|Overall Study|Protocol Violation|2|||
94412839|NCT01998243|323296504|FG000|Overall Study|Withdrawal by Subject|3|||
94412840|NCT01998243|323296505|FG001|Overall Study|Withdrawal by Subject|4|||
94412841|NCT01056640|323296506|FG000|Overall Study|Withdrawal by Subject|11|||
94412842|NCT01056640|323296507|FG001|Overall Study|Withdrawal by Subject|8|||
94412843|NCT01056640|323296506|FG000|Overall Study|Death|15|||
94412844|NCT01056640|323296507|FG001|Overall Study|Death|4|||
94412845|NCT02492841|323296514|FG000|Overall Study|Lost to Follow-up|34|||
94412846|NCT02492841|323296515|FG001|Overall Study|Lost to Follow-up|31|||
94412847|NCT02492841|323296516|FG002|Overall Study|Lost to Follow-up|35|||
94412848|NCT00895037|323296517|FG000|Overall Study|Death|0|||
94412849|NCT00895037|323296518|FG001|Overall Study|Death|2|||
94412850|NCT00895037|323296519|FG002|Overall Study|Death|1|||
94412851|NCT02096588|323296520|FG000|Overall Study|Lack of Efficacy|2|||
94412852|NCT02096588|323296521|FG001|Overall Study|Lack of Efficacy|0|||
94412853|NCT02096588|323296520|FG000|Overall Study|Withdrawal by Subject|0|||
94412854|NCT02096588|323296521|FG001|Overall Study|Withdrawal by Subject|1|||
94412855|NCT01192399|323296525|FG000|Overall Study|Lack of Efficacy|2|||
94412856|NCT00890552|323296527|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
94412857|NCT00890552|323296527|FG000|On-treatment|Early prog disease/ death|10|||
94412858|NCT02377921|323296528|FG000|Overall Study|Subject non-compliance|1|||
94412859|NCT02377921|323296529|FG001|Overall Study|Subject non-compliance|1|||
94412860|NCT02443545|323296530|FG000|Overall Study|Adverse Event|1|||
94412861|NCT02443545|323296531|FG001|Overall Study|Adverse Event|1|||
94412862|NCT02443545|323296530|FG000|Overall Study|Lost to Follow-up|0|||
94412863|NCT02443545|323296531|FG001|Overall Study|Lost to Follow-up|2|||
94412864|NCT02443545|323296530|FG000|Overall Study|Physician Decision|3|||
94412865|NCT02443545|323296531|FG001|Overall Study|Physician Decision|0|||
94412866|NCT02443545|323296530|FG000|Overall Study|Protocol Violation|8|||
94412867|NCT02443545|323296531|FG001|Overall Study|Protocol Violation|1|||
94412868|NCT02443545|323296530|FG000|Overall Study|Pregnancy|1|||
94412869|NCT02443545|323296531|FG001|Overall Study|Pregnancy|1|||
94412870|NCT02443545|323296530|FG000|Overall Study|Withdrawal by Subject|6|||
94412871|NCT02443545|323296531|FG001|Overall Study|Withdrawal by Subject|3|||
94412872|NCT02443545|323296530|FG000|Overall Study|Termination of study|20|||
94412873|NCT02443545|323296531|FG001|Overall Study|Termination of study|11|||
94412874|NCT01181531|323296544|FG000|Overall Study|Other|17|||
94412875|NCT01181531|323296545|FG001|Overall Study|Other|12|||
94412876|NCT01181531|323296544|FG000|Overall Study|Partial consent by subject withdrawn|0|||
94412877|NCT01181531|323296545|FG001|Overall Study|Partial consent by subject withdrawn|1|||
94412878|NCT01181531|323296544|FG000|Overall Study|Physician Decision|3|||
94412879|NCT01181531|323296545|FG001|Overall Study|Physician Decision|1|||
94412880|NCT01181531|323296544|FG000|Overall Study|Noncompliance|2|||
94412881|NCT01181531|323296545|FG001|Overall Study|Noncompliance|2|||
94412882|NCT01181531|323296544|FG000|Overall Study|Ineligibility determined|1|||
94412883|NCT01181531|323296545|FG001|Overall Study|Ineligibility determined|2|||
94412884|NCT01181531|323296544|FG000|Overall Study|Protocol Specified Criteria|15|||
94412885|NCT01181531|323296545|FG001|Overall Study|Protocol Specified Criteria|8|||
94412886|NCT01181531|323296544|FG000|Overall Study|Pregnancy|0|||
94412887|NCT01181531|323296545|FG001|Overall Study|Pregnancy|1|||
94412888|NCT01181531|323296544|FG000|Overall Study|Withdrawal by Subject|8|||
94412889|NCT01181531|323296545|FG001|Overall Study|Withdrawal by Subject|7|||
94412890|NCT01181531|323296544|FG000|Overall Study|Protocol Violation|6|||
94412891|NCT01181531|323296545|FG001|Overall Study|Protocol Violation|6|||
94412892|NCT01181531|323296544|FG000|Overall Study|Death|9|||
94412893|NCT01181531|323296545|FG001|Overall Study|Death|12|||
94412894|NCT01181531|323296544|FG000|Overall Study|Adverse Event|0|||
94412895|NCT01181531|323296545|FG001|Overall Study|Adverse Event|1|||
94412896|NCT00987831|323296546|FG000|Overall Study|Never flared in 12 months|1|||
94412897|NCT00987831|323296547|FG001|Overall Study|Never flared in 12 months|0|||
94412898|NCT00987831|323296548|FG002|Overall Study|Never flared in 12 months|0|||
94412899|NCT00987831|323296546|FG000|Overall Study|Lost to Follow-up|0|||
94412900|NCT00987831|323296547|FG001|Overall Study|Lost to Follow-up|3|||
94412901|NCT00987831|323296548|FG002|Overall Study|Lost to Follow-up|0|||
94412902|NCT00955721|323296549|FG000|Overall Study|Physician Decision|1|||
94412903|NCT00955721|323296550|FG001|Overall Study|Physician Decision|0|||
94412904|NCT00955721|323296549|FG000|Overall Study|Death|1|||
94412905|NCT00955721|323296550|FG001|Overall Study|Death|0|||
94412906|NCT00955721|323296549|FG000|Overall Study|Withdrawal by Subject|1|||
94412907|NCT00955721|323296550|FG001|Overall Study|Withdrawal by Subject|0|||
94412908|NCT01507090|323296551|FG000|Overall Study|incomplete dataset|18|||
94412909|NCT00493779|323298300|FG000|Overall Study|Logistical issue at site|1|||
94412910|NCT04100096|323298301|FG000|Overall Study|Adverse Event|19|||
94412911|NCT04100096|323298302|FG001|Overall Study|Adverse Event|7|||
94412912|NCT04100096|323298301|FG000|Overall Study|Lack of Efficacy|0|||
94412913|NCT04100096|323298302|FG001|Overall Study|Lack of Efficacy|1|||
94412914|NCT04100096|323298301|FG000|Overall Study|Lost to Follow-up|13|||
94412915|NCT04100096|323298302|FG001|Overall Study|Lost to Follow-up|11|||
94412916|NCT04100096|323298301|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94412917|NCT04100096|323298302|FG001|Overall Study|Non-Compliance With Study Drug|3|||
94412918|NCT04100096|323298301|FG000|Overall Study|Protocol Deviation|1|||
94412919|NCT04100096|323298302|FG001|Overall Study|Protocol Deviation|1|||
94412920|NCT04100096|323298301|FG000|Overall Study|Withdrawal by Participant|13|||
94412921|NCT04100096|323298302|FG001|Overall Study|Withdrawal by Participant|15|||
94412922|NCT02284347|323298307|FG000|Overall Study|Lost to Follow-up|2|||
94412923|NCT02284347|323298307|FG000|Overall Study|Withdrawn prior to treatment|1|||
94412924|NCT01730040|323298308|FG000|Overall Study|Randomized but not treated|0|||
94412925|NCT01730040|323298309|FG001|Overall Study|Randomized but not treated|0|||
94412926|NCT01730040|323298310|FG002|Overall Study|Randomized but not treated|0|||
94412927|NCT01730040|323298311|FG003|Overall Study|Randomized but not treated|0|||
94412928|NCT01730040|323298312|FG004|Overall Study|Randomized but not treated|0|||
94412929|NCT01730040|323298313|FG005|Overall Study|Randomized but not treated|1|||
94412930|NCT01730040|323298314|FG006|Overall Study|Randomized but not treated|0|||
94412931|NCT01730040|323298308|FG000|Overall Study|Subject moved|0|||
94412932|NCT01730040|323298309|FG001|Overall Study|Subject moved|0|||
94412933|NCT01730040|323298310|FG002|Overall Study|Subject moved|1|||
94412934|NCT01730040|323298311|FG003|Overall Study|Subject moved|0|||
94412935|NCT01730040|323298312|FG004|Overall Study|Subject moved|0|||
94412936|NCT01730040|323298313|FG005|Overall Study|Subject moved|0|||
94412937|NCT01730040|323298314|FG006|Overall Study|Subject moved|1|||
94412938|NCT01730040|323298308|FG000|Overall Study|Physician Decision|0|||
94412939|NCT01730040|323298309|FG001|Overall Study|Physician Decision|0|||
94412940|NCT01730040|323298310|FG002|Overall Study|Physician Decision|0|||
94412941|NCT01730040|323298311|FG003|Overall Study|Physician Decision|0|||
94412942|NCT01730040|323298312|FG004|Overall Study|Physician Decision|0|||
94412943|NCT01730040|323298313|FG005|Overall Study|Physician Decision|1|||
94412944|NCT01730040|323298314|FG006|Overall Study|Physician Decision|1|||
94412945|NCT01730040|323298308|FG000|Overall Study|Other than specified|7|||
94412946|NCT01730040|323298309|FG001|Overall Study|Other than specified|8|||
94412947|NCT01730040|323298310|FG002|Overall Study|Other than specified|5|||
94412948|NCT01730040|323298311|FG003|Overall Study|Other than specified|5|||
94412949|NCT01730040|323298312|FG004|Overall Study|Other than specified|5|||
94412950|NCT01730040|323298313|FG005|Overall Study|Other than specified|4|||
94412951|NCT01730040|323298314|FG006|Overall Study|Other than specified|4|||
94412952|NCT01730040|323298308|FG000|Overall Study|Adverse Event|4|||
94412953|NCT01730040|323298309|FG001|Overall Study|Adverse Event|3|||
94412954|NCT01730040|323298310|FG002|Overall Study|Adverse Event|5|||
94412955|NCT01730040|323298311|FG003|Overall Study|Adverse Event|3|||
94412956|NCT01730040|323298312|FG004|Overall Study|Adverse Event|1|||
94412957|NCT01730040|323298313|FG005|Overall Study|Adverse Event|1|||
94412958|NCT01730040|323298314|FG006|Overall Study|Adverse Event|2|||
94412959|NCT01730040|323298308|FG000|Overall Study|Poor compliance to protocol|2|||
94412960|NCT01730040|323298309|FG001|Overall Study|Poor compliance to protocol|4|||
94412961|NCT01730040|323298310|FG002|Overall Study|Poor compliance to protocol|0|||
94412962|NCT01730040|323298311|FG003|Overall Study|Poor compliance to protocol|0|||
94412963|NCT01730040|323298312|FG004|Overall Study|Poor compliance to protocol|0|||
94412964|NCT01730040|323298313|FG005|Overall Study|Poor compliance to protocol|0|||
94412965|NCT01730040|323298314|FG006|Overall Study|Poor compliance to protocol|1|||
94412966|NCT01915940|323298316|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
94412967|NCT01915940|323298317|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
94412968|NCT01915940|323298318|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
94412969|NCT01915940|323298316|FG000|Treatment Period|Decision of Participant|0|||
94412970|NCT01915940|323298317|FG001|Treatment Period|Decision of Participant|1|||
94412971|NCT01915940|323298318|FG002|Treatment Period|Decision of Participant|3|||
94412972|NCT01915940|323298316|FG000|Treatment Period|Adverse Event|0|||
94412973|NCT01915940|323298317|FG001|Treatment Period|Adverse Event|9|||
94412974|NCT01915940|323298318|FG002|Treatment Period|Adverse Event|1|||
94412975|NCT01915940|323298316|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
94412976|NCT01915940|323298317|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
94412977|NCT01915940|323298318|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
94412978|NCT02960438|323298320|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
94412979|NCT02960438|323298321|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
94412980|NCT02960438|323298322|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
94412981|NCT02960438|323298323|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
94412982|NCT02960438|323298320|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
94412983|NCT02960438|323298321|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
94412984|NCT02960438|323298322|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
94412985|NCT02960438|323298323|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
94412986|NCT02960438|323298320|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
94412987|NCT02960438|323298321|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
94412988|NCT02960438|323298322|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
94412989|NCT02960438|323298323|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
94412990|NCT02960438|323298320|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
94412991|NCT02960438|323298321|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
94412992|NCT02960438|323298322|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
94412993|NCT02960438|323298323|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
94412994|NCT02960438|323298320|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
94412995|NCT02960438|323298321|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
94412996|NCT02960438|323298322|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
94412997|NCT02960438|323298323|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
94412998|NCT02960438|323298320|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
94412999|NCT02960438|323298321|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
94413000|NCT02960438|323298322|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
94413001|NCT02960438|323298323|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
94413002|NCT02960438|323298320|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
94413003|NCT02960438|323298321|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
94413004|NCT02960438|323298322|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
94413005|NCT02960438|323298323|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
94413006|NCT02960438|323298320|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
94413007|NCT02960438|323298321|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
94413008|NCT02960438|323298322|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
94413009|NCT02960438|323298323|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
94413010|NCT02960438|323298320|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
94413011|NCT02960438|323298321|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
94413012|NCT02960438|323298322|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
94413013|NCT02960438|323298323|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
94413014|NCT02960438|323298320|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
94413015|NCT02960438|323298321|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
94413016|NCT02960438|323298322|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
94413017|NCT02960438|323298323|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
94413018|NCT02960438|323298320|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
94413019|NCT02960438|323298321|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
94413020|NCT02960438|323298322|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
94413021|NCT02960438|323298323|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
94413022|NCT02960438|323298320|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
94413023|NCT02960438|323298321|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
94413024|NCT02960438|323298322|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
94413025|NCT02960438|323298323|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
94413026|NCT00614926|323298326|FG000|Overall Study|Burden of travel|1|||
94413027|NCT00614926|323298327|FG001|Overall Study|Burden of travel|0|||
94413028|NCT00614926|323298326|FG000|Overall Study|Adverse Event|3|||
94413029|NCT00614926|323298327|FG001|Overall Study|Adverse Event|0|||
94413030|NCT01207440|323298328|FG000|Overall Study|Adverse Event|46|||
94413031|NCT01207440|323298329|FG001|Overall Study|Adverse Event|11|||
94413032|NCT01207440|323298330|FG002|Overall Study|Adverse Event|7|||
94413033|NCT01207440|323298331|FG003|Overall Study|Adverse Event|2|||
94413034|NCT01207440|323298332|FG004|Overall Study|Adverse Event|6|||
94413035|NCT01207440|323298333|FG005|Overall Study|Adverse Event|6|||
94413036|NCT01207440|323298334|FG006|Overall Study|Adverse Event|2|||
94413037|NCT01207440|323298328|FG000|Overall Study|Death|6|||
94413038|NCT01207440|323298329|FG001|Overall Study|Death|3|||
94413039|NCT01207440|323298330|FG002|Overall Study|Death|2|||
94413040|NCT01207440|323298331|FG003|Overall Study|Death|2|||
94413041|NCT01207440|323298332|FG004|Overall Study|Death|7|||
94413042|NCT01207440|323298333|FG005|Overall Study|Death|5|||
94413043|NCT01207440|323298334|FG006|Overall Study|Death|1|||
94413044|NCT01207440|323298328|FG000|Overall Study|Lack of Efficacy|13|||
94413045|NCT01207440|323298329|FG001|Overall Study|Lack of Efficacy|2|||
94413046|NCT01207440|323298330|FG002|Overall Study|Lack of Efficacy|5|||
94413047|NCT01207440|323298331|FG003|Overall Study|Lack of Efficacy|1|||
94487324|NCT03327324|323577530|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
94487325|NCT03327324|323577531|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
94487326|NCT03327324|323577532|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
94487327|NCT03327324|323577527|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
94487328|NCT03327324|323577528|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
94487329|NCT03327324|323577529|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
94487330|NCT03327324|323577530|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
94413048|NCT01207440|323298332|FG004|Overall Study|Lack of Efficacy|2|||
94413049|NCT01207440|323298333|FG005|Overall Study|Lack of Efficacy|3|||
94413050|NCT01207440|323298334|FG006|Overall Study|Lack of Efficacy|0|||
94413051|NCT01207440|323298328|FG000|Overall Study|Lost to Follow-up|0|||
94413052|NCT01207440|323298329|FG001|Overall Study|Lost to Follow-up|0|||
94413053|NCT01207440|323298330|FG002|Overall Study|Lost to Follow-up|2|||
94413054|NCT01207440|323298331|FG003|Overall Study|Lost to Follow-up|1|||
94413055|NCT01207440|323298332|FG004|Overall Study|Lost to Follow-up|0|||
94413056|NCT01207440|323298333|FG005|Overall Study|Lost to Follow-up|0|||
94413057|NCT01207440|323298334|FG006|Overall Study|Lost to Follow-up|0|||
94413058|NCT01207440|323298328|FG000|Overall Study|Non-compliance with Study Drug|3|||
94413059|NCT01207440|323298329|FG001|Overall Study|Non-compliance with Study Drug|0|||
94413060|NCT01207440|323298330|FG002|Overall Study|Non-compliance with Study Drug|1|||
94413061|NCT01207440|323298331|FG003|Overall Study|Non-compliance with Study Drug|0|||
94413062|NCT01207440|323298332|FG004|Overall Study|Non-compliance with Study Drug|0|||
94413063|NCT01207440|323298333|FG005|Overall Study|Non-compliance with Study Drug|0|||
94413064|NCT01207440|323298334|FG006|Overall Study|Non-compliance with Study Drug|0|||
94413065|NCT01207440|323298328|FG000|Overall Study|Physician Decision|6|||
94413066|NCT01207440|323298329|FG001|Overall Study|Physician Decision|5|||
94413067|NCT01207440|323298330|FG002|Overall Study|Physician Decision|5|||
94413068|NCT01207440|323298331|FG003|Overall Study|Physician Decision|0|||
94413069|NCT01207440|323298332|FG004|Overall Study|Physician Decision|1|||
94413070|NCT01207440|323298333|FG005|Overall Study|Physician Decision|0|||
94413071|NCT01207440|323298334|FG006|Overall Study|Physician Decision|0|||
94413072|NCT01207440|323298328|FG000|Overall Study|Progressive Disease|19|||
94413073|NCT01207440|323298329|FG001|Overall Study|Progressive Disease|10|||
94413074|NCT01207440|323298330|FG002|Overall Study|Progressive Disease|19|||
94413075|NCT01207440|323298331|FG003|Overall Study|Progressive Disease|7|||
94413076|NCT01207440|323298332|FG004|Overall Study|Progressive Disease|23|||
94413077|NCT01207440|323298333|FG005|Overall Study|Progressive Disease|27|||
94413078|NCT01207440|323298334|FG006|Overall Study|Progressive Disease|0|||
94413079|NCT01207440|323298328|FG000|Overall Study|Protocol Violation|2|||
94413080|NCT01207440|323298329|FG001|Overall Study|Protocol Violation|0|||
94413081|NCT01207440|323298330|FG002|Overall Study|Protocol Violation|0|||
94413082|NCT01207440|323298331|FG003|Overall Study|Protocol Violation|0|||
94413083|NCT01207440|323298332|FG004|Overall Study|Protocol Violation|0|||
94413084|NCT01207440|323298333|FG005|Overall Study|Protocol Violation|0|||
94413085|NCT01207440|323298334|FG006|Overall Study|Protocol Violation|0|||
94413086|NCT01207440|323298328|FG000|Overall Study|Site Terminated by Sponsor|69|||
94413087|NCT01207440|323298329|FG001|Overall Study|Site Terminated by Sponsor|19|||
94413088|NCT01207440|323298330|FG002|Overall Study|Site Terminated by Sponsor|12|||
94413089|NCT01207440|323298331|FG003|Overall Study|Site Terminated by Sponsor|2|||
94413090|NCT01207440|323298332|FG004|Overall Study|Site Terminated by Sponsor|3|||
94413091|NCT01207440|323298333|FG005|Overall Study|Site Terminated by Sponsor|0|||
94413092|NCT01207440|323298334|FG006|Overall Study|Site Terminated by Sponsor|2|||
94413093|NCT01207440|323298328|FG000|Overall Study|Withdrawal by Subject|29|||
94413094|NCT01207440|323298329|FG001|Overall Study|Withdrawal by Subject|4|||
94413095|NCT01207440|323298330|FG002|Overall Study|Withdrawal by Subject|5|||
94413096|NCT01207440|323298331|FG003|Overall Study|Withdrawal by Subject|3|||
94413097|NCT01207440|323298332|FG004|Overall Study|Withdrawal by Subject|2|||
94413098|NCT01207440|323298333|FG005|Overall Study|Withdrawal by Subject|2|||
94413099|NCT01207440|323298334|FG006|Overall Study|Withdrawal by Subject|0|||
94413100|NCT01207440|323298328|FG000|Overall Study|Reason Not Specified|10|||
94413101|NCT01207440|323298329|FG001|Overall Study|Reason Not Specified|10|||
94413102|NCT01207440|323298330|FG002|Overall Study|Reason Not Specified|7|||
94413103|NCT01207440|323298331|FG003|Overall Study|Reason Not Specified|0|||
94413104|NCT01207440|323298332|FG004|Overall Study|Reason Not Specified|4|||
94413105|NCT01207440|323298333|FG005|Overall Study|Reason Not Specified|3|||
94413106|NCT01207440|323298334|FG006|Overall Study|Reason Not Specified|0|||
94413107|NCT01197417|323298339|FG000|Overall Study|Physician Decision|3|||
94413108|NCT01197417|323298340|FG001|Overall Study|Physician Decision|2|||
94413109|NCT01197417|323298339|FG000|Overall Study|Withdrawal by Subject|2|||
94413110|NCT01197417|323298340|FG001|Overall Study|Withdrawal by Subject|4|||
94413111|NCT01197417|323298339|FG000|Overall Study|Site miscommunication|0|||
94413112|NCT01197417|323298340|FG001|Overall Study|Site miscommunication|1|||
94413113|NCT01197417|323298339|FG000|Overall Study|Subject transferred to intensive care|0|||
94413114|NCT01197417|323298340|FG001|Overall Study|Subject transferred to intensive care|1|||
94413115|NCT01197417|323298339|FG000|Overall Study|Not consented in time to receive drug|0|||
94413116|NCT01197417|323298340|FG001|Overall Study|Not consented in time to receive drug|1|||
94413117|NCT01197417|323298339|FG000|Overall Study|Hypotension|1|||
94413118|NCT01197417|323298340|FG001|Overall Study|Hypotension|2|||
94413119|NCT01197417|323298339|FG000|Overall Study|Found to be ineligible|2|||
94413120|NCT01197417|323298340|FG001|Overall Study|Found to be ineligible|5|||
94413121|NCT01197417|323298339|FG000|Overall Study|No 25-hour magnesium level|0|||
94413122|NCT01197417|323298340|FG001|Overall Study|No 25-hour magnesium level|2|||
94413123|NCT00792623|323298341|FG000|Overall Study|Adverse Event|2|||
94413124|NCT00792623|323298341|FG000|Overall Study|Withdrawal by Subject|5|||
94413125|NCT04776746|323298342|FG000|Overall Study|Study terminated by sponsor|61|||
94413126|NCT04776746|323298342|FG000|Overall Study|Adverse Event|5|||
94413127|NCT04776746|323298342|FG000|Overall Study|Death|4|||
94413128|NCT04776746|323298342|FG000|Overall Study|Lack of Efficacy|3|||
94413129|NCT04776746|323298342|FG000|Overall Study|Noncompliance with study drug|2|||
94413130|NCT04776746|323298342|FG000|Overall Study|Not related to COVID-19|2|||
94413131|NCT00892281|323298345|FG000|Overall Study|Adverse Event|65|||
94413132|NCT00892281|323298346|FG001|Overall Study|Adverse Event|8|||
94413133|NCT00892281|323298345|FG000|Overall Study|Lost to Follow-up|81|||
94413134|NCT00892281|323298346|FG001|Overall Study|Lost to Follow-up|8|||
94413135|NCT00892281|323298345|FG000|Overall Study|Pregnancy|1|||
94413136|NCT00892281|323298346|FG001|Overall Study|Pregnancy|0|||
94413137|NCT00892281|323298345|FG000|Overall Study|Protocol Violation|7|||
94413138|NCT00892281|323298346|FG001|Overall Study|Protocol Violation|2|||
94413139|NCT00892281|323298345|FG000|Overall Study|Withdrawal by Subject|86|||
94413140|NCT00892281|323298346|FG001|Overall Study|Withdrawal by Subject|14|||
94413141|NCT00892281|323298345|FG000|Overall Study|Subject failed to return for final visit|2|||
94413142|NCT00892281|323298346|FG001|Overall Study|Subject failed to return for final visit|0|||
94413143|NCT00892281|323298345|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
94413144|NCT00892281|323298346|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
94413145|NCT00892281|323298345|FG000|Overall Study|Final visit completed 4 weeks late|0|||
94413146|NCT00892281|323298346|FG001|Overall Study|Final visit completed 4 weeks late|1|||
94413147|NCT00892281|323298345|FG000|Overall Study|Subject completed day after study closed|1|||
94413148|NCT00892281|323298346|FG001|Overall Study|Subject completed day after study closed|0|||
94413149|NCT00892281|323298345|FG000|Overall Study|Family emergency|1|||
94413150|NCT00892281|323298346|FG001|Overall Study|Family emergency|0|||
94413151|NCT00892281|323298345|FG000|Overall Study|Last visit not done - death in family|1|||
94413152|NCT00892281|323298346|FG001|Overall Study|Last visit not done - death in family|0|||
94413153|NCT00892281|323298345|FG000|Overall Study|Did not meet incl/excl criteria|1|||
94413154|NCT00892281|323298346|FG001|Overall Study|Did not meet incl/excl criteria|0|||
94413155|NCT00892281|323298345|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
94413156|NCT00892281|323298346|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
94413157|NCT00892281|323298345|FG000|Overall Study|Unable to redeem the drug voucher|1|||
94413158|NCT00892281|323298346|FG001|Overall Study|Unable to redeem the drug voucher|0|||
94413159|NCT00892281|323298345|FG000|Overall Study|Subject not good candidate for study|1|||
94413160|NCT00892281|323298346|FG001|Overall Study|Subject not good candidate for study|0|||
94413161|NCT00892281|323298345|FG000|Overall Study|Subject did not return for any visits|1|||
94413162|NCT00892281|323298346|FG001|Overall Study|Subject did not return for any visits|0|||
94413163|NCT00892281|323298345|FG000|Overall Study|Subject missed several visits/lost meds|1|||
94413164|NCT00892281|323298346|FG001|Overall Study|Subject missed several visits/lost meds|0|||
94413165|NCT00892281|323298345|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
94413166|NCT00892281|323298346|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
94413167|NCT00892281|323298345|FG000|Overall Study|Scheduled for knee replacement|0|||
94413168|NCT00892281|323298346|FG001|Overall Study|Scheduled for knee replacement|1|||
94413169|NCT00892281|323298345|FG000|Overall Study|PI complained of inadequate compensation|3|||
94413170|NCT00892281|323298346|FG001|Overall Study|PI complained of inadequate compensation|0|||
94413171|NCT00892281|323298345|FG000|Overall Study|Subject lost interest in program|0|||
94413172|NCT00892281|323298346|FG001|Overall Study|Subject lost interest in program|1|||
94413173|NCT00892281|323298345|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
94413174|NCT00892281|323298346|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
94413175|NCT00892281|323298345|FG000|Overall Study|Death in family|1|||
94413176|NCT00892281|323298346|FG001|Overall Study|Death in family|0|||
94413177|NCT00892281|323298345|FG000|Overall Study|Lack of efficacy of study product|2|||
94413178|NCT00892281|323298346|FG001|Overall Study|Lack of efficacy of study product|0|||
94413179|NCT00892281|323298345|FG000|Overall Study|Subject not seen by PI at final visit|1|||
94413180|NCT00892281|323298346|FG001|Overall Study|Subject not seen by PI at final visit|0|||
94413181|NCT00892281|323298345|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
94413182|NCT00892281|323298346|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
94413183|NCT00892281|323298345|FG000|Overall Study|Missed multiple visits|1|||
94413184|NCT00892281|323298346|FG001|Overall Study|Missed multiple visits|0|||
94413185|NCT00892281|323298345|FG000|Overall Study|Missed visits rescheduled out of window|1|||
94413186|NCT00892281|323298346|FG001|Overall Study|Missed visits rescheduled out of window|0|||
94413187|NCT00892281|323298345|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
94413188|NCT00892281|323298346|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
94413189|NCT00892281|323298345|FG000|Overall Study|Subject had history of drug abuse|1|||
94413190|NCT00892281|323298346|FG001|Overall Study|Subject had history of drug abuse|0|||
94413191|NCT00892281|323298345|FG000|Overall Study|Rash on hand|1|||
94413192|NCT00892281|323298346|FG001|Overall Study|Rash on hand|0|||
94413193|NCT00892281|323298345|FG000|Overall Study|Visit 4 date out of window|1|||
94413194|NCT00892281|323298346|FG001|Overall Study|Visit 4 date out of window|0|||
94413195|NCT01134627|323298353|FG000|Overall Study|Adverse Event|47|||
94413196|NCT01134627|323298354|FG001|Overall Study|Adverse Event|31|||
94487331|NCT03327324|323577531|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
94487332|NCT03327324|323577532|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
94487333|NCT03327324|323577527|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
94487334|NCT03327324|323577528|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
94487335|NCT03327324|323577529|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
94487336|NCT03327324|323577530|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
94487337|NCT03327324|323577531|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
94487338|NCT03327324|323577532|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
94487339|NCT03327324|323577527|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
94487340|NCT03327324|323577528|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
94413197|NCT01134627|323298353|FG000|Overall Study|Lost to Follow-up|1|||
94413198|NCT01134627|323298354|FG001|Overall Study|Lost to Follow-up|2|||
94413199|NCT01134627|323298353|FG000|Overall Study|Protocol Violation|3|||
94413200|NCT01134627|323298354|FG001|Overall Study|Protocol Violation|5|||
94413201|NCT01134627|323298353|FG000|Overall Study|Lack of Efficacy|2|||
94413202|NCT01134627|323298354|FG001|Overall Study|Lack of Efficacy|12|||
94413203|NCT01134627|323298353|FG000|Overall Study|Withdrawal by Subject|4|||
94413204|NCT01134627|323298354|FG001|Overall Study|Withdrawal by Subject|3|||
94413205|NCT01134627|323298353|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
94413206|NCT01134627|323298354|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
94413207|NCT01134627|323298353|FG000|Overall Study|Other|11|||
94413208|NCT01134627|323298354|FG001|Overall Study|Other|14|||
94413209|NCT01341587|323298355|FG000|Overall Study|Lost to Follow-up|2|||
94413210|NCT01341587|323298356|FG001|Overall Study|Lost to Follow-up|0|||
94413211|NCT01341587|323298355|FG000|Overall Study|stopped using the meters|2|||
94413212|NCT01341587|323298356|FG001|Overall Study|stopped using the meters|10|||
94413213|NCT00351351|323298357|FG000|Overall Study|surgical access pbs; device issues|9|||
94413214|NCT00351351|323298358|FG001|Overall Study|surgical access pbs; device issues|4|||
94413215|NCT00508027|323298359|FG000|Dose Level 1|Lost to Follow-up|4|||
94413216|NCT00508027|323298359|FG000|Dose Level 1|Withdrawal by Subject|2|||
94413217|NCT00508027|323298359|FG000|Dose Level 1|Physician Decision|2|||
94413218|NCT00508027|323298359|FG000|Dose Level 2|Lost to Follow-up|2|||
94413219|NCT00508027|323298359|FG000|Dose Level 2|Withdrawal by Subject|2|||
94413220|NCT00939627|323298362|FG000|Overall Study|Disease Progression|16|||
94413221|NCT00939627|323298363|FG001|Overall Study|Disease Progression|12|||
94413222|NCT00939627|323298364|FG002|Overall Study|Disease Progression|0|||
94413223|NCT00939627|323298362|FG000|Overall Study|Adverse Event|6|||
94413224|NCT00939627|323298363|FG001|Overall Study|Adverse Event|7|||
94413225|NCT00939627|323298364|FG002|Overall Study|Adverse Event|0|||
94413226|NCT00939627|323298362|FG000|Overall Study|Death|0|||
94413227|NCT00939627|323298363|FG001|Overall Study|Death|2|||
94413228|NCT00939627|323298364|FG002|Overall Study|Death|0|||
94413229|NCT00939627|323298362|FG000|Overall Study|Withdrawal by Subject|2|||
94413230|NCT00939627|323298363|FG001|Overall Study|Withdrawal by Subject|4|||
94413231|NCT00939627|323298364|FG002|Overall Study|Withdrawal by Subject|0|||
94413232|NCT00939627|323298362|FG000|Overall Study|Other complicating disease|1|||
94413233|NCT00939627|323298363|FG001|Overall Study|Other complicating disease|1|||
94413234|NCT00939627|323298364|FG002|Overall Study|Other complicating disease|0|||
94413235|NCT00939627|323298362|FG000|Overall Study|Not compliant|2|||
94413236|NCT00939627|323298363|FG001|Overall Study|Not compliant|0|||
94413237|NCT00939627|323298364|FG002|Overall Study|Not compliant|0|||
94413238|NCT00939627|323298362|FG000|Overall Study|No off-tx reason given|0|||
94413239|NCT00939627|323298363|FG001|Overall Study|No off-tx reason given|2|||
94413240|NCT00939627|323298364|FG002|Overall Study|No off-tx reason given|0|||
94413241|NCT00251316|323298365|FG000|Overall Study|Physician Decision|2|||
94487341|NCT03327324|323577529|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
94487342|NCT03327324|323577530|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
94487343|NCT03327324|323577531|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
94413242|NCT00251316|323298366|FG001|Overall Study|Physician Decision|3|||
94413243|NCT00346164|323298369|FG000|Overall Study|Adverse Event|0|||
94413244|NCT00346164|323298370|FG001|Overall Study|Adverse Event|0|||
94413245|NCT00346164|323298371|FG002|Overall Study|Adverse Event|0|||
94413246|NCT00346164|323298372|FG003|Overall Study|Adverse Event|1|||
94413247|NCT00346164|323298369|FG000|Overall Study|Lack of Efficacy|0|||
94413248|NCT00346164|323298370|FG001|Overall Study|Lack of Efficacy|1|||
94413249|NCT00346164|323298371|FG002|Overall Study|Lack of Efficacy|7|||
94413250|NCT00346164|323298372|FG003|Overall Study|Lack of Efficacy|25|||
94413251|NCT00346164|323298369|FG000|Overall Study|Physician Decision|0|||
94413252|NCT00346164|323298370|FG001|Overall Study|Physician Decision|1|||
94413253|NCT00346164|323298371|FG002|Overall Study|Physician Decision|2|||
94413254|NCT00346164|323298372|FG003|Overall Study|Physician Decision|27|||
94413255|NCT00346164|323298369|FG000|Overall Study|Protocol Violation|6|||
94413256|NCT00346164|323298370|FG001|Overall Study|Protocol Violation|2|||
94413257|NCT00346164|323298371|FG002|Overall Study|Protocol Violation|10|||
94413258|NCT00346164|323298372|FG003|Overall Study|Protocol Violation|4|||
94413259|NCT00346164|323298369|FG000|Overall Study|Withdrawal by Subject|0|||
94413260|NCT00346164|323298370|FG001|Overall Study|Withdrawal by Subject|0|||
94413261|NCT00346164|323298371|FG002|Overall Study|Withdrawal by Subject|2|||
94413262|NCT00346164|323298372|FG003|Overall Study|Withdrawal by Subject|0|||
94413263|NCT00346164|323298369|FG000|Overall Study|Ineligible|11|||
94413264|NCT00346164|323298370|FG001|Overall Study|Ineligible|2|||
94413265|NCT00346164|323298371|FG002|Overall Study|Ineligible|2|||
94413266|NCT00346164|323298372|FG003|Overall Study|Ineligible|23|||
94413267|NCT00346164|323298369|FG000|Overall Study|Refusal of further protocol therapy|0|||
94413268|NCT00346164|323298370|FG001|Overall Study|Refusal of further protocol therapy|1|||
94413269|NCT00346164|323298371|FG002|Overall Study|Refusal of further protocol therapy|3|||
94413270|NCT00346164|323298372|FG003|Overall Study|Refusal of further protocol therapy|15|||
94413271|NCT00346164|323298369|FG000|Overall Study|Inability to start week 16 tx on time|0|||
94413272|NCT00346164|323298370|FG001|Overall Study|Inability to start week 16 tx on time|0|||
94413273|NCT00346164|323298371|FG002|Overall Study|Inability to start week 16 tx on time|0|||
94413274|NCT00346164|323298372|FG003|Overall Study|Inability to start week 16 tx on time|11|||
94413275|NCT00823199|323298373|FG000|Overall Study|Withdrawal by Subject|2|||
94413276|NCT00904748|323298375|FG000|Overall Study|Withdrawal by Subject|1|||
94413277|NCT00904748|323298376|FG001|Overall Study|Withdrawal by Subject|1|||
94413278|NCT00904748|323298377|FG002|Overall Study|Withdrawal by Subject|1|||
94413279|NCT00904748|323298378|FG003|Overall Study|Withdrawal by Subject|2|||
94413280|NCT00904748|323298379|FG004|Overall Study|Withdrawal by Subject|0|||
94413281|NCT00904748|323298380|FG005|Overall Study|Withdrawal by Subject|0|||
94413282|NCT00904748|323298375|FG000|Overall Study|Adverse Event|0|||
94413283|NCT00904748|323298376|FG001|Overall Study|Adverse Event|0|||
94413284|NCT00904748|323298377|FG002|Overall Study|Adverse Event|0|||
94413285|NCT00904748|323298378|FG003|Overall Study|Adverse Event|0|||
94413286|NCT00904748|323298379|FG004|Overall Study|Adverse Event|1|||
94413287|NCT00904748|323298380|FG005|Overall Study|Adverse Event|0|||
94413288|NCT00941720|323298381|FG000|Overall Study|Withdrawal by Subject|1|||
94413289|NCT00941720|323298381|FG000|Overall Study|Insurance denied participation|11|||
94413290|NCT00941720|323298381|FG000|Overall Study|ineligible|2|||
94413291|NCT04569786|323298382|FG000|Overall Study|Lost to Follow-up|1|||
94413292|NCT04569786|323298383|FG001|Overall Study|Lost to Follow-up|0|||
94413293|NCT04569786|323298384|FG002|Overall Study|Lost to Follow-up|4|||
94413294|NCT04569786|323298385|FG003|Overall Study|Lost to Follow-up|1|||
94413295|NCT04569786|323298386|FG004|Overall Study|Lost to Follow-up|0|||
94413296|NCT04569786|323298382|FG000|Overall Study|Withdrawal by Subject|0|||
94413297|NCT04569786|323298383|FG001|Overall Study|Withdrawal by Subject|0|||
94413298|NCT04569786|323298384|FG002|Overall Study|Withdrawal by Subject|0|||
94413299|NCT04569786|323298385|FG003|Overall Study|Withdrawal by Subject|5|||
94413300|NCT04569786|323298386|FG004|Overall Study|Withdrawal by Subject|1|||
94413301|NCT04569786|323298382|FG000|Overall Study|Physician Decision|0|||
94413302|NCT04569786|323298383|FG001|Overall Study|Physician Decision|0|||
94413303|NCT04569786|323298384|FG002|Overall Study|Physician Decision|0|||
94413304|NCT04569786|323298385|FG003|Overall Study|Physician Decision|1|||
94413305|NCT04569786|323298386|FG004|Overall Study|Physician Decision|0|||
94413306|NCT01640184|323298387|FG000|Overall Study|Death|1|||
94413307|NCT01640184|323298388|FG001|Overall Study|Death|0|||
94413308|NCT01640184|323298389|FG002|Overall Study|Death|0|||
94413309|NCT01640184|323298387|FG000|Overall Study|Lost to Follow-up|4|||
94413310|NCT01640184|323298388|FG001|Overall Study|Lost to Follow-up|1|||
94413311|NCT01640184|323298389|FG002|Overall Study|Lost to Follow-up|0|||
94413312|NCT01640184|323298387|FG000|Overall Study|Physician Decision|3|||
94413313|NCT01640184|323298388|FG001|Overall Study|Physician Decision|0|||
94413314|NCT01640184|323298389|FG002|Overall Study|Physician Decision|0|||
94413315|NCT01640184|323298387|FG000|Overall Study|Withdrawal by Subject|0|||
94413316|NCT01640184|323298388|FG001|Overall Study|Withdrawal by Subject|1|||
94413317|NCT01640184|323298389|FG002|Overall Study|Withdrawal by Subject|1|||
94413318|NCT01640184|323298387|FG000|Overall Study|Protocol Violation|0|||
94413319|NCT01640184|323298388|FG001|Overall Study|Protocol Violation|0|||
94413320|NCT01640184|323298389|FG002|Overall Study|Protocol Violation|1|||
94413321|NCT01684878|323298395|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
94413322|NCT01684878|323298396|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
94413323|NCT01684878|323298397|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
94413324|NCT01684878|323298398|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
94413325|NCT01684878|323298395|FG000|Part 1: Safety Run in Phase|Death|15|||
94413326|NCT01684878|323298396|FG001|Part 1: Safety Run in Phase|Death|20|||
94413327|NCT01684878|323298397|FG002|Part 1: Safety Run in Phase|Death|0|||
94413328|NCT01684878|323298398|FG003|Part 1: Safety Run in Phase|Death|0|||
94413329|NCT01684878|323298395|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
94413330|NCT01684878|323298396|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
94413331|NCT01684878|323298397|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
94413332|NCT01684878|323298398|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
94413333|NCT01684878|323298395|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
94413334|NCT01684878|323298396|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
94413335|NCT01684878|323298397|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
94413336|NCT01684878|323298398|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
94413337|NCT01684878|323298395|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
94413338|NCT01684878|323298396|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
94413339|NCT01684878|323298397|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
94413340|NCT01684878|323298398|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
94413341|NCT01684878|323298395|FG000|Part 2: Randomized Phase|Death|0|||
94413342|NCT01684878|323298396|FG001|Part 2: Randomized Phase|Death|0|||
94413343|NCT01684878|323298397|FG002|Part 2: Randomized Phase|Death|62|||
94413344|NCT01684878|323298398|FG003|Part 2: Randomized Phase|Death|68|||
94413345|NCT01684878|323298395|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
94413346|NCT01684878|323298396|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
94413347|NCT01684878|323298397|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
94413348|NCT01684878|323298398|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
94413349|NCT01684878|323298395|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
94413350|NCT01684878|323298396|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
94413351|NCT01684878|323298397|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
94413352|NCT01684878|323298398|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
94413353|NCT00775528|323298399|FG000|Overall Study|Protocol Violation|1|||
94413354|NCT04647383|323298400|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
94413355|NCT04647383|323298401|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
94413356|NCT04647383|323298402|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
94413357|NCT04647383|323298403|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
94413358|NCT00479388|323298407|FG000|Overall Study|Adverse Event|90|||
94413359|NCT00479388|323298408|FG001|Overall Study|Adverse Event|45|||
94413360|NCT00479388|323298407|FG000|Overall Study|Lost to Follow-up|0|||
94413361|NCT00479388|323298408|FG001|Overall Study|Lost to Follow-up|2|||
94413362|NCT00479388|323298407|FG000|Overall Study|Protocol Violation|10|||
94413363|NCT00479388|323298408|FG001|Overall Study|Protocol Violation|9|||
94413364|NCT00479388|323298407|FG000|Overall Study|Withdrawal by Subject|32|||
94413365|NCT00479388|323298408|FG001|Overall Study|Withdrawal by Subject|17|||
94413366|NCT01884688|323298409|FG000|Overall Study|Screen Failure|2|||
94413367|NCT01955044|323298413|FG000|Overall Study|Death|1|||
94413368|NCT01955044|323298414|FG001|Overall Study|Death|1|||
94413369|NCT01955044|323298415|FG002|Overall Study|Death|0|||
94413370|NCT02563769|323298416|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
94413371|NCT02563769|323298417|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
94413372|NCT02563769|323298418|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
94413373|NCT01029392|323298429|FG000|Overall Study|Withdrawal by Subject|18|||
94413374|NCT01029392|323298430|FG001|Overall Study|Withdrawal by Subject|11|||
94413375|NCT01029392|323298429|FG000|Overall Study|Physician Decision|2|||
94413376|NCT01029392|323298430|FG001|Overall Study|Physician Decision|0|||
94413377|NCT00767520|323298432|FG000|Overall Study|Participants still on treatment|11|||
94413378|NCT00767520|323298433|FG001|Overall Study|Participants still on treatment|15|||
94413379|NCT00767520|323298432|FG000|Overall Study|Randomized in error and Never treated|0|||
94413380|NCT00767520|323298433|FG001|Overall Study|Randomized in error and Never treated|2|||
94413381|NCT02709486|323298434|FG000|Overall Study|Adverse Event|2|||
94413382|NCT02709486|323298435|FG001|Overall Study|Adverse Event|5|||
94413383|NCT02709486|323298436|FG002|Overall Study|Adverse Event|3|||
94413384|NCT02709486|323298434|FG000|Overall Study|Death|0|||
94413385|NCT02709486|323298435|FG001|Overall Study|Death|0|||
94413386|NCT02709486|323298436|FG002|Overall Study|Death|2|||
94413387|NCT02709486|323298434|FG000|Overall Study|Insufficient clinical response|7|||
94413388|NCT02709486|323298435|FG001|Overall Study|Insufficient clinical response|3|||
94413389|NCT02709486|323298436|FG002|Overall Study|Insufficient clinical response|3|||
94413390|NCT02709486|323298434|FG000|Overall Study|Lost to Follow-up|3|||
94413391|NCT02709486|323298435|FG001|Overall Study|Lost to Follow-up|2|||
94413392|NCT02709486|323298436|FG002|Overall Study|Lost to Follow-up|2|||
94413393|NCT02709486|323298434|FG000|Overall Study|Other|0|||
94413394|NCT02709486|323298435|FG001|Overall Study|Other|2|||
94413395|NCT02709486|323298436|FG002|Overall Study|Other|3|||
94413396|NCT02709486|323298434|FG000|Overall Study|Withdrawal by Subject|32|||
94413397|NCT02709486|323298435|FG001|Overall Study|Withdrawal by Subject|22|||
94413398|NCT02709486|323298436|FG002|Overall Study|Withdrawal by Subject|32|||
94413399|NCT00545688|323298441|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
94413400|NCT00545688|323298442|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
94413401|NCT00545688|323298443|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
94413402|NCT00545688|323298444|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
94413403|NCT00545688|323298441|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
94413404|NCT00545688|323298442|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
94413405|NCT00545688|323298443|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
94413406|NCT00545688|323298444|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
94413407|NCT00545688|323298441|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
94413408|NCT00545688|323298442|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
94413409|NCT00545688|323298443|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
94413410|NCT00545688|323298444|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
94413411|NCT00545688|323298441|FG000|Neo-Adjuvant Treatment Period|Death|0|||
94413412|NCT00545688|323298442|FG001|Neo-Adjuvant Treatment Period|Death|1|||
94413413|NCT00545688|323298443|FG002|Neo-Adjuvant Treatment Period|Death|0|||
94413414|NCT00545688|323298444|FG003|Neo-Adjuvant Treatment Period|Death|0|||
94413415|NCT00545688|323298441|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
94413416|NCT00545688|323298442|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
94413417|NCT00545688|323298443|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
94413418|NCT00545688|323298444|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
94413419|NCT00545688|323298441|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
94413420|NCT00545688|323298442|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
94413421|NCT00545688|323298443|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
94413422|NCT00545688|323298444|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
94413423|NCT00545688|323298441|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
94413424|NCT00545688|323298442|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
94413425|NCT00545688|323298443|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
94413426|NCT00545688|323298444|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
94413427|NCT00545688|323298441|FG000|Adjuvant Treatment Period|Disease Progression|3|||
94413428|NCT00545688|323298442|FG001|Adjuvant Treatment Period|Disease Progression|3|||
94413429|NCT00545688|323298443|FG002|Adjuvant Treatment Period|Disease Progression|0|||
94413430|NCT00545688|323298444|FG003|Adjuvant Treatment Period|Disease Progression|7|||
94413431|NCT00545688|323298441|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
94413432|NCT00545688|323298442|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
94413433|NCT00545688|323298443|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
94413434|NCT00545688|323298444|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
94413435|NCT00545688|323298441|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
94413436|NCT00545688|323298442|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
94413437|NCT00545688|323298443|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
94413438|NCT00545688|323298444|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
94413439|NCT00545688|323298441|FG000|Adjuvant Treatment Period|Adverse Event|0|||
94413440|NCT00545688|323298442|FG001|Adjuvant Treatment Period|Adverse Event|3|||
94413441|NCT00545688|323298443|FG002|Adjuvant Treatment Period|Adverse Event|2|||
94413442|NCT00545688|323298444|FG003|Adjuvant Treatment Period|Adverse Event|2|||
94413443|NCT00545688|323298441|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
94413444|NCT00545688|323298442|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
94413445|NCT00545688|323298443|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
94413446|NCT00545688|323298444|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
94413447|NCT00545688|323298441|FG000|Follow-Up Period|Death|4|||
94413448|NCT00545688|323298442|FG001|Follow-Up Period|Death|2|||
94413449|NCT00545688|323298443|FG002|Follow-Up Period|Death|2|||
94413450|NCT00545688|323298444|FG003|Follow-Up Period|Death|6|||
94413451|NCT00545688|323298441|FG000|Follow-Up Period|Disease Progression|6|||
94413452|NCT00545688|323298442|FG001|Follow-Up Period|Disease Progression|5|||
94413453|NCT00545688|323298443|FG002|Follow-Up Period|Disease Progression|9|||
94413454|NCT00545688|323298444|FG003|Follow-Up Period|Disease Progression|9|||
94413455|NCT00545688|323298441|FG000|Follow-Up Period|Refused Treatment|6|||
94413456|NCT00545688|323298442|FG001|Follow-Up Period|Refused Treatment|2|||
94413457|NCT00545688|323298443|FG002|Follow-Up Period|Refused Treatment|0|||
94413458|NCT00545688|323298444|FG003|Follow-Up Period|Refused Treatment|2|||
94413459|NCT00545688|323298441|FG000|Follow-Up Period|Lost to Follow-up|3|||
94413460|NCT00545688|323298442|FG001|Follow-Up Period|Lost to Follow-up|3|||
94413461|NCT00545688|323298443|FG002|Follow-Up Period|Lost to Follow-up|3|||
94413462|NCT00545688|323298444|FG003|Follow-Up Period|Lost to Follow-up|1|||
94413463|NCT00545688|323298441|FG000|Follow-Up Period|Unspecified Reason|2|||
94413464|NCT00545688|323298442|FG001|Follow-Up Period|Unspecified Reason|5|||
94413465|NCT00545688|323298443|FG002|Follow-Up Period|Unspecified Reason|6|||
94413466|NCT00545688|323298444|FG003|Follow-Up Period|Unspecified Reason|8|||
94413467|NCT00545688|323298441|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
94413468|NCT00545688|323298442|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
94413469|NCT00545688|323298443|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
94413470|NCT00545688|323298444|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
94413471|NCT00233987|323298445|FG000|Overall Study|Withdrawal by Subject|1|||
94413472|NCT00233987|323298445|FG000|Overall Study|Lack of Efficacy|2|||
94413473|NCT00233987|323298445|FG000|Overall Study|Reason Under Review|1|||
94413474|NCT00233987|323298445|FG000|Overall Study|Other - Not Protocol Specified|5|||
94413475|NCT00233987|323298445|FG000|Overall Study|Eligible but No Treatment Received|2|||
94413476|NCT00233987|323298445|FG000|Overall Study|Ineligible|4|||
94487344|NCT03327324|323577532|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
94487345|NCT03327324|323577527|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
94487346|NCT03327324|323577528|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
94487347|NCT03327324|323577529|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
94512833|NCT00725985|323676431|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
94413477|NCT00544817|323299722|FG000|Combined Modality|Lack of Efficacy|2|||
94413478|NCT00544817|323299722|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
94413479|NCT00544817|323299722|FG000|Combined Modality|Adverse Event|2|||
94413480|NCT00544817|323299722|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
94413481|NCT00544817|323299722|FG000|No Treatment Interval|Lack of Efficacy|8|||
94413482|NCT00544817|323299722|FG000|No Treatment Interval|Physician Decision|3|||
94413483|NCT00544817|323299722|FG000|No Treatment Interval|Adverse Event|1|||
94413484|NCT00544817|323299722|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
94413485|NCT00544817|323299722|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
94413486|NCT00544817|323299722|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
94413487|NCT01885182|323299723|FG000|Overall Study|Adverse Event|11|||
94413488|NCT01885182|323299724|FG001|Overall Study|Adverse Event|13|||
94413489|NCT01885182|323299723|FG000|Overall Study|Withdrawal by Subject|13|||
94413490|NCT01885182|323299724|FG001|Overall Study|Withdrawal by Subject|6|||
94413491|NCT01885182|323299723|FG000|Overall Study|Lost to Follow-up|2|||
94413492|NCT01885182|323299724|FG001|Overall Study|Lost to Follow-up|2|||
94413493|NCT01885182|323299723|FG000|Overall Study|Lack of Efficacy|8|||
94413494|NCT01885182|323299724|FG001|Overall Study|Lack of Efficacy|1|||
94413495|NCT02211014|323299725|FG000|Overall Study|Adverse Event|0|||
94413496|NCT02211014|323299726|FG001|Overall Study|Adverse Event|2|||
94413497|NCT02211014|323299725|FG000|Overall Study|Physician Decision|1|||
94413498|NCT02211014|323299726|FG001|Overall Study|Physician Decision|2|||
94413499|NCT02211014|323299725|FG000|Overall Study|Started another cancer therapy|1|||
94413500|NCT02211014|323299726|FG001|Overall Study|Started another cancer therapy|0|||
94413501|NCT02211014|323299725|FG000|Overall Study|Withdrawal by Subject|0|||
94413502|NCT02211014|323299726|FG001|Overall Study|Withdrawal by Subject|1|||
94413503|NCT02211014|323299725|FG000|Overall Study|In agreement with patient, no benefit|0|||
94413504|NCT02211014|323299726|FG001|Overall Study|In agreement with patient, no benefit|1|||
94413505|NCT00966381|323299727|FG000|Overall Study|Withdrawal by Subject|2|||
94413506|NCT00966381|323299728|FG001|Overall Study|Withdrawal by Subject|2|||
94413507|NCT01124695|323299729|FG000|Overall Study|Disease progression|77|||
94413508|NCT01124695|323299729|FG000|Overall Study|Adverse Event|11|||
94413509|NCT01124695|323299729|FG000|Overall Study|Death|1|||
94413510|NCT01124695|323299729|FG000|Overall Study|Withdrawal by Subject|7|||
94413511|NCT01124695|323299729|FG000|Overall Study|Physician Decision|3|||
94413512|NCT01124695|323299729|FG000|Overall Study|Alternative therapy|9|||
94413513|NCT01124695|323299729|FG000|Overall Study|No documentation that patient went off treatment|4|||
94413514|NCT01124695|323299729|FG000|Overall Study|Ineligible|9|||
94413515|NCT01124695|323299729|FG000|Overall Study|Ineligible and never start treatment|2|||
94413516|NCT03686150|323299730|FG000|Overall Study|Withdrawal by Subject|1|||
94413517|NCT03686150|323299731|FG001|Overall Study|Withdrawal by Subject|1|||
94413518|NCT03686150|323299732|FG002|Overall Study|Withdrawal by Subject|1|||
94413519|NCT03686150|323299733|FG003|Overall Study|Withdrawal by Subject|0|||
94413520|NCT03686150|323299734|FG004|Overall Study|Withdrawal by Subject|1|||
94413521|NCT03686150|323299735|FG005|Overall Study|Withdrawal by Subject|2|||
94413522|NCT03686150|323299730|FG000|Overall Study|Physician Decision|1|||
94413523|NCT03686150|323299731|FG001|Overall Study|Physician Decision|0|||
94413524|NCT03686150|323299732|FG002|Overall Study|Physician Decision|0|||
94413525|NCT03686150|323299733|FG003|Overall Study|Physician Decision|0|||
94413526|NCT03686150|323299734|FG004|Overall Study|Physician Decision|0|||
94413527|NCT03686150|323299735|FG005|Overall Study|Physician Decision|1|||
94413528|NCT03686150|323299730|FG000|Overall Study|Lost to Follow-up|0|||
94413529|NCT03686150|323299731|FG001|Overall Study|Lost to Follow-up|1|||
94413530|NCT03686150|323299732|FG002|Overall Study|Lost to Follow-up|0|||
94413531|NCT03686150|323299733|FG003|Overall Study|Lost to Follow-up|0|||
94413532|NCT03686150|323299734|FG004|Overall Study|Lost to Follow-up|0|||
94413533|NCT03686150|323299735|FG005|Overall Study|Lost to Follow-up|0|||
94413534|NCT03341000|323299748|FG000|Overall Study|Adverse Event|1|||
94413535|NCT01592721|323299749|FG000|Long-term Follow-up|Death|1|||
94413536|NCT00754013|323299751|FG000|Overall Study|Lost to Follow-up|1|||
94413537|NCT00754013|323299752|FG001|Overall Study|Lost to Follow-up|1|||
94413538|NCT00754013|323299751|FG000|Overall Study|didn't return after study termed|3|||
94413539|NCT00754013|323299752|FG001|Overall Study|didn't return after study termed|4|||
94413540|NCT02310789|323299753|FG000|Overall Study|Adverse Event|1|||
94413541|NCT01432574|323299754|FG000|Overall Study|Moved|2|||
94413542|NCT01432574|323299754|FG000|Overall Study|Not interested|1|||
94413543|NCT01345318|323299755|FG000|Overall Study|Adverse Event|16|||
94413544|NCT01345318|323299755|FG000|Overall Study|Lack of Efficacy|17|||
94413545|NCT01345318|323299755|FG000|Overall Study|Lost to Follow-up|2|||
94413546|NCT01345318|323299755|FG000|Overall Study|Protocol Violation|1|||
94413547|NCT01345318|323299755|FG000|Overall Study|Withdrawal by Subject|41|||
94413548|NCT01345318|323299755|FG000|Overall Study|Other|3|||
94413549|NCT03919448|323299756|FG000|Overall Study|Withdrawal by Subject|1|||
94413550|NCT03919448|323299757|FG001|Overall Study|Withdrawal by Subject|0|||
94413551|NCT03919448|323299758|FG002|Overall Study|Withdrawal by Subject|0|||
94413552|NCT01652729|323299763|FG000|Overall Study|Withdrawal by Subject|14|||
94413553|NCT01652729|323299764|FG001|Overall Study|Withdrawal by Subject|7|||
94413554|NCT01652729|323299765|FG002|Overall Study|Withdrawal by Subject|7|||
94413555|NCT01652729|323299763|FG000|Overall Study|Adverse Event|4|||
94413556|NCT01652729|323299764|FG001|Overall Study|Adverse Event|0|||
94413557|NCT01652729|323299765|FG002|Overall Study|Adverse Event|3|||
94413558|NCT01652729|323299763|FG000|Overall Study|Physician Decision|1|||
94413559|NCT01652729|323299764|FG001|Overall Study|Physician Decision|0|||
94413560|NCT01652729|323299765|FG002|Overall Study|Physician Decision|1|||
94413561|NCT01652729|323299763|FG000|Overall Study|Protocol Violation|1|||
94413562|NCT01652729|323299764|FG001|Overall Study|Protocol Violation|0|||
94413563|NCT01652729|323299765|FG002|Overall Study|Protocol Violation|0|||
94413564|NCT01652729|323299763|FG000|Overall Study|Lost to Follow-up|6|||
94413565|NCT01652729|323299764|FG001|Overall Study|Lost to Follow-up|6|||
94413566|NCT01652729|323299765|FG002|Overall Study|Lost to Follow-up|3|||
94413567|NCT01652729|323299763|FG000|Overall Study|Administrative|1|||
94413568|NCT01652729|323299764|FG001|Overall Study|Administrative|0|||
94413569|NCT01652729|323299765|FG002|Overall Study|Administrative|0|||
94413570|NCT01005329|323299766|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
94413571|NCT00483548|323299769|FG000|Overall Study|Randomized; not treated with study drug|1|||
94413572|NCT00483548|323299770|FG001|Overall Study|Randomized; not treated with study drug|3|||
94413573|NCT00483548|323299769|FG000|Overall Study|Adverse Event|25|||
94413574|NCT00483548|323299770|FG001|Overall Study|Adverse Event|14|||
94413575|NCT00483548|323299769|FG000|Overall Study|Laboratory abnormality|1|||
94413576|NCT00483548|323299770|FG001|Overall Study|Laboratory abnormality|2|||
94413577|NCT00483548|323299769|FG000|Overall Study|Lack of Efficacy|4|||
94413578|NCT00483548|323299770|FG001|Overall Study|Lack of Efficacy|8|||
94413579|NCT00483548|323299769|FG000|Overall Study|Protocol Violation|11|||
94413580|NCT00483548|323299770|FG001|Overall Study|Protocol Violation|7|||
94413581|NCT00483548|323299769|FG000|Overall Study|Pregnancy|1|||
94413582|NCT00483548|323299770|FG001|Overall Study|Pregnancy|0|||
94413583|NCT00483548|323299769|FG000|Overall Study|Protocol required discontinuation|6|||
94413584|NCT00483548|323299770|FG001|Overall Study|Protocol required discontinuation|6|||
94413585|NCT00483548|323299769|FG000|Overall Study|Unable to comply with protocol schedule|1|||
94413586|NCT00483548|323299770|FG001|Overall Study|Unable to comply with protocol schedule|0|||
94413587|NCT00483548|323299769|FG000|Overall Study|Non-compliance with medication|2|||
94413588|NCT00483548|323299770|FG001|Overall Study|Non-compliance with medication|0|||
94413589|NCT00483548|323299769|FG000|Overall Study|Lost to Follow-up|3|||
94413590|NCT00483548|323299770|FG001|Overall Study|Lost to Follow-up|4|||
94413591|NCT00483548|323299769|FG000|Overall Study|Withdrawal by Subject|5|||
94413592|NCT00483548|323299770|FG001|Overall Study|Withdrawal by Subject|2|||
94413593|NCT00126126|323299774|FG000|Overall Study|Lost to Follow-up|0|||
94413594|NCT00126126|323299775|FG001|Overall Study|Lost to Follow-up|2|||
94413595|NCT02694549|323299776|FG000|Overall Study|screen failures|2|||
94413596|NCT02459665|323299777|FG000|Overall Study|Withdrawal by Subject|0|||
94413597|NCT02459665|323299778|FG001|Overall Study|Withdrawal by Subject|1|||
94413598|NCT02459665|323299779|FG002|Overall Study|Withdrawal by Subject|1|||
94413599|NCT02459665|323299780|FG003|Overall Study|Withdrawal by Subject|2|||
94413600|NCT01567826|323299781|FG000|Overall Study|Lost to Follow-up|3|||
94413601|NCT01567826|323299782|FG001|Overall Study|Lost to Follow-up|2|||
94413602|NCT04364737|323299788|FG000|Overall Study|Withdrawal by Subject|4|||
94413603|NCT04364737|323299789|FG001|Overall Study|Withdrawal by Subject|9|||
94413604|NCT04364737|323299788|FG000|Overall Study|Lost to Follow-up|1|||
94413605|NCT04364737|323299789|FG001|Overall Study|Lost to Follow-up|1|||
94413606|NCT01220609|323299790|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
94413607|NCT01220609|323299790|FG000|Overall Study|Ineligible- Wrong cell type|1|||
94413608|NCT01220609|323299790|FG000|Overall Study|Ineligible-Never treated|1|||
94413609|NCT02224573|323299794|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
94413610|NCT02224573|323299795|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
94413611|NCT02224573|323299794|FG000|Treatment Phase|Started on Other IMP|1|||
94413612|NCT02224573|323299795|FG001|Treatment Phase|Started on Other IMP|0|||
94413613|NCT02224573|323299794|FG000|Treatment Phase|Participant Discontinued IMP|0|||
94413614|NCT02224573|323299795|FG001|Treatment Phase|Participant Discontinued IMP|1|||
94413615|NCT02224573|323299794|FG000|Treatment Phase|Lack of Efficacy|15|||
94413616|NCT02224573|323299795|FG001|Treatment Phase|Lack of Efficacy|8|||
94413617|NCT02224573|323299794|FG000|Treatment Phase|Began Commercial Product|1|||
94413618|NCT02224573|323299795|FG001|Treatment Phase|Began Commercial Product|0|||
94413619|NCT02224573|323299794|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
94413620|NCT02224573|323299795|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
94413621|NCT02224573|323299794|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
94413622|NCT02224573|323299795|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
94413623|NCT02224573|323299794|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
94413624|NCT02224573|323299795|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
94413625|NCT02224573|323299794|FG000|Treatment Phase|Continued Compassionate Use|1|||
94413626|NCT02224573|323299795|FG001|Treatment Phase|Continued Compassionate Use|0|||
94413627|NCT02224573|323299794|FG000|Treatment Phase|Lack of Efficiency|2|||
94413628|NCT02224573|323299795|FG001|Treatment Phase|Lack of Efficiency|1|||
94413629|NCT02224573|323299794|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
94413630|NCT02224573|323299795|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
94413631|NCT02224573|323299794|FG000|Treatment Phase|Participant Moved|2|||
94413632|NCT02224573|323299795|FG001|Treatment Phase|Participant Moved|0|||
94413633|NCT02224573|323299794|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
94413634|NCT02224573|323299795|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
94413635|NCT02224573|323299794|FG000|Treatment Phase|Refused Medication|1|||
94413636|NCT02224573|323299795|FG001|Treatment Phase|Refused Medication|1|||
94413637|NCT02224573|323299794|FG000|Treatment Phase|Adverse Event|26|||
94413638|NCT02224573|323299795|FG001|Treatment Phase|Adverse Event|38|||
94413639|NCT02224573|323299794|FG000|Treatment Phase|Placed in Group Home|0|||
94413640|NCT02224573|323299795|FG001|Treatment Phase|Placed in Group Home|1|||
94413641|NCT02224573|323299794|FG000|Treatment Phase|Pursued Other Trials|1|||
94413642|NCT02224573|323299795|FG001|Treatment Phase|Pursued Other Trials|0|||
94413643|NCT02224573|323299794|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
94413644|NCT02224573|323299795|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
94413645|NCT02224573|323299794|FG000|Treatment Phase|Lost to Follow-up|2|||
94413646|NCT02224573|323299795|FG001|Treatment Phase|Lost to Follow-up|1|||
94413647|NCT02224573|323299794|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
94413648|NCT02224573|323299795|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
94413649|NCT02224573|323299794|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
94413650|NCT02224573|323299795|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
94413651|NCT02224573|323299794|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
94413652|NCT02224573|323299795|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
94413653|NCT02224573|323299794|FG000|Taper Phase|Adverse Event|1|||
94413654|NCT02224573|323299795|FG001|Taper Phase|Adverse Event|1|||
94413655|NCT01478828|323299796|FG000|Overall Study|Adverse Event|1|||
94413656|NCT01333072|323299797|FG000|Overall Study|Lost to Follow-up|3|||
94413657|NCT01333072|323299798|FG001|Overall Study|Lost to Follow-up|0|||
94413658|NCT01333072|323299797|FG000|Overall Study|Adverse Event|2|||
94413659|NCT01333072|323299798|FG001|Overall Study|Adverse Event|4|||
94413660|NCT01333072|323299797|FG000|Overall Study|Physician Decision|1|||
94413661|NCT01333072|323299798|FG001|Overall Study|Physician Decision|0|||
94413662|NCT01231373|323299801|FG000|Overall Study|Withdrew consent prior to randomization|2|||
94413663|NCT01231373|323299802|FG001|Overall Study|Withdrew consent prior to randomization|1|||
94413664|NCT01231373|323299803|FG002|Overall Study|Withdrew consent prior to randomization|0|||
94413665|NCT01231373|323299804|FG003|Overall Study|Withdrew consent prior to randomization|0|||
94413666|NCT01231373|323299801|FG000|Overall Study|Lost to Follow-up|0|||
94413667|NCT01231373|323299802|FG001|Overall Study|Lost to Follow-up|0|||
94413668|NCT01231373|323299803|FG002|Overall Study|Lost to Follow-up|0|||
94413669|NCT01231373|323299804|FG003|Overall Study|Lost to Follow-up|1|||
94413670|NCT01231373|323299801|FG000|Overall Study|Withdrew Consent|1|||
94413671|NCT01231373|323299802|FG001|Overall Study|Withdrew Consent|0|||
94413672|NCT01231373|323299803|FG002|Overall Study|Withdrew Consent|0|||
94413673|NCT01231373|323299804|FG003|Overall Study|Withdrew Consent|0|||
94413674|NCT00194792|323299805|FG000|Overall Study|Withdrawal by Subject|1|||
94413675|NCT00949988|323299806|FG000|Overall Study|Withdrawal by Subject|3|||
94413676|NCT02408120|323299811|FG000|Overall Study|Withdrawal by Subject|0|||
94413677|NCT02408120|323299812|FG001|Overall Study|Withdrawal by Subject|1|||
94413678|NCT02408120|323299811|FG000|Overall Study|Treatment Refusal|1|||
94413679|NCT02408120|323299812|FG001|Overall Study|Treatment Refusal|0|||
94413680|NCT02408120|323299811|FG000|Overall Study|Received Steroids|1|||
94413681|NCT02408120|323299812|FG001|Overall Study|Received Steroids|1|||
94413682|NCT02408120|323299811|FG000|Overall Study|Discharged same day|1|||
94413683|NCT02408120|323299812|FG001|Overall Study|Discharged same day|1|||
94413684|NCT02408120|323299811|FG000|Overall Study|Did not receive insulin|1|||
94413685|NCT02408120|323299812|FG001|Overall Study|Did not receive insulin|2|||
94413686|NCT03877926|323299813|FG000|Overall Study|Adverse Event|1|||
94413687|NCT03877926|323299814|FG001|Overall Study|Adverse Event|0|||
94413688|NCT03877926|323299815|FG002|Overall Study|Adverse Event|0|||
94413689|NCT03877926|323299816|FG003|Overall Study|Adverse Event|0|||
94413690|NCT03877926|323299813|FG000|Overall Study|Death|2|||
94413691|NCT03877926|323299814|FG001|Overall Study|Death|2|||
94413692|NCT03877926|323299815|FG002|Overall Study|Death|2|||
94413693|NCT03877926|323299816|FG003|Overall Study|Death|0|||
94413694|NCT03877926|323299813|FG000|Overall Study|Lost to Follow-up|41|||
94413695|NCT03877926|323299814|FG001|Overall Study|Lost to Follow-up|52|||
94413696|NCT03877926|323299815|FG002|Overall Study|Lost to Follow-up|45|||
94413697|NCT03877926|323299816|FG003|Overall Study|Lost to Follow-up|17|||
94413698|NCT03877926|323299813|FG000|Overall Study|Physician Decision|2|||
94413699|NCT03877926|323299814|FG001|Overall Study|Physician Decision|0|||
94413700|NCT03877926|323299815|FG002|Overall Study|Physician Decision|2|||
94413701|NCT03877926|323299816|FG003|Overall Study|Physician Decision|0|||
94487348|NCT03327324|323577530|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
94487349|NCT03327324|323577531|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
94487350|NCT03327324|323577532|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
94487351|NCT03327324|323577527|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
94487352|NCT03327324|323577528|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
94487353|NCT03327324|323577529|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
94487354|NCT03327324|323577530|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
94487355|NCT03327324|323577531|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
94487356|NCT03327324|323577532|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
94487357|NCT03327324|323577527|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
94487358|NCT03327324|323577528|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
94487359|NCT03327324|323577529|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
94487360|NCT03327324|323577530|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
94487361|NCT03327324|323577531|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
94487362|NCT03327324|323577532|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
94487363|NCT00249834|323577533|FG000|Overall Study|Ovarian stimulation failed|1|||
94487364|NCT00249834|323577534|FG001|Overall Study|Ovarian stimulation failed|0|||
94487365|NCT00249834|323577535|FG002|Overall Study|Ovarian stimulation failed|0|||
94487366|NCT00249834|323577536|FG003|Overall Study|Ovarian stimulation failed|0|||
94487367|NCT00249834|323577537|FG004|Overall Study|Ovarian stimulation failed|0|||
94487368|NCT00249834|323577538|FG005|Overall Study|Ovarian stimulation failed|0|||
94487369|NCT00249834|323577539|FG006|Overall Study|Ovarian stimulation failed|0|||
94487370|NCT00249834|323577540|FG007|Overall Study|Ovarian stimulation failed|0|||
94487371|NCT00249834|323577533|FG000|Overall Study|Failure of down-regulation|0|||
94487372|NCT00249834|323577534|FG001|Overall Study|Failure of down-regulation|0|||
94487373|NCT00249834|323577535|FG002|Overall Study|Failure of down-regulation|0|||
94487374|NCT00249834|323577536|FG003|Overall Study|Failure of down-regulation|0|||
94487375|NCT00249834|323577537|FG004|Overall Study|Failure of down-regulation|0|||
94487376|NCT00249834|323577538|FG005|Overall Study|Failure of down-regulation|0|||
94487377|NCT00249834|323577539|FG006|Overall Study|Failure of down-regulation|1|||
94487378|NCT00249834|323577540|FG007|Overall Study|Failure of down-regulation|0|||
94487379|NCT00249834|323577533|FG000|Overall Study|Protocol Violation|0|||
94487380|NCT00249834|323577534|FG001|Overall Study|Protocol Violation|19|||
94487381|NCT00249834|323577535|FG002|Overall Study|Protocol Violation|14|||
94487382|NCT00249834|323577536|FG003|Overall Study|Protocol Violation|8|||
94487383|NCT00249834|323577537|FG004|Overall Study|Protocol Violation|5|||
94487384|NCT00249834|323577538|FG005|Overall Study|Protocol Violation|2|||
94487385|NCT00249834|323577539|FG006|Overall Study|Protocol Violation|0|||
94487386|NCT00249834|323577540|FG007|Overall Study|Protocol Violation|0|||
94487387|NCT00171249|323577542|FG000|Overall Study|Withdrawal by Subject|2|||
94487388|NCT00171249|323577543|FG001|Overall Study|Withdrawal by Subject|0|||
94487389|NCT00171249|323577544|FG002|Overall Study|Withdrawal by Subject|0|||
94487390|NCT00171249|323577545|FG003|Overall Study|Withdrawal by Subject|6|||
94487391|NCT00171249|323577546|FG004|Overall Study|Withdrawal by Subject|0|||
94487392|NCT00171249|323577547|FG005|Overall Study|Withdrawal by Subject|0|||
94487393|NCT00171249|323577548|FG006|Overall Study|Withdrawal by Subject|0|||
94487394|NCT00171249|323577542|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
94487395|NCT00171249|323577543|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
94487396|NCT00171249|323577544|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
94487397|NCT00171249|323577545|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
94487398|NCT00171249|323577546|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
94487399|NCT00171249|323577547|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
94487400|NCT00171249|323577548|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
94487401|NCT00171249|323577542|FG000|Overall Study|Death|7|||
94487402|NCT00171249|323577543|FG001|Overall Study|Death|1|||
94487403|NCT00171249|323577544|FG002|Overall Study|Death|0|||
94487404|NCT00171249|323577545|FG003|Overall Study|Death|4|||
94487405|NCT00171249|323577546|FG004|Overall Study|Death|0|||
94487406|NCT00171249|323577547|FG005|Overall Study|Death|3|||
94487407|NCT00171249|323577548|FG006|Overall Study|Death|1|||
94487408|NCT00171249|323577542|FG000|Overall Study|Other|10|||
94487409|NCT00171249|323577543|FG001|Overall Study|Other|0|||
94487410|NCT00171249|323577544|FG002|Overall Study|Other|0|||
94487411|NCT00171249|323577545|FG003|Overall Study|Other|43|||
94487412|NCT00171249|323577546|FG004|Overall Study|Other|0|||
94487413|NCT00171249|323577547|FG005|Overall Study|Other|2|||
94487414|NCT00171249|323577548|FG006|Overall Study|Other|0|||
94487415|NCT00171249|323577542|FG000|Overall Study|No Longer Requires Study Drug|4|||
94487416|NCT00171249|323577543|FG001|Overall Study|No Longer Requires Study Drug|0|||
94487417|NCT00171249|323577544|FG002|Overall Study|No Longer Requires Study Drug|0|||
94487418|NCT00171249|323577545|FG003|Overall Study|No Longer Requires Study Drug|3|||
94487419|NCT00171249|323577546|FG004|Overall Study|No Longer Requires Study Drug|0|||
94487420|NCT00171249|323577547|FG005|Overall Study|No Longer Requires Study Drug|5|||
94413702|NCT03877926|323299813|FG000|Overall Study|Withdrawal by Subject|18|||
94413703|NCT03877926|323299814|FG001|Overall Study|Withdrawal by Subject|21|||
94413704|NCT03877926|323299815|FG002|Overall Study|Withdrawal by Subject|12|||
94413705|NCT03877926|323299816|FG003|Overall Study|Withdrawal by Subject|4|||
94413706|NCT03877926|323299813|FG000|Overall Study|Other - Various|4|||
94413707|NCT03877926|323299814|FG001|Overall Study|Other - Various|1|||
94413708|NCT03877926|323299815|FG002|Overall Study|Other - Various|1|||
94413709|NCT03877926|323299816|FG003|Overall Study|Other - Various|0|||
94413710|NCT03877926|323299813|FG000|Overall Study|Not Treated|3|||
94413711|NCT03877926|323299814|FG001|Overall Study|Not Treated|1|||
94413712|NCT03877926|323299815|FG002|Overall Study|Not Treated|1|||
94413713|NCT03877926|323299816|FG003|Overall Study|Not Treated|0|||
94413714|NCT00537199|323299818|FG000|Overall Study|Study Terminated|1|||
94413715|NCT03891329|323299819|FG000|Overall Study|Death|5|||
94413716|NCT03891329|323299819|FG000|Overall Study|Lost to Follow-up|4|||
94413717|NCT03891329|323299819|FG000|Overall Study|Physician Decision|4|||
94413718|NCT03891329|323299819|FG000|Overall Study|Device explanted|3|||
94413719|NCT03891329|323299819|FG000|Overall Study|No study device implanted|3|||
94413720|NCT02039063|323299820|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
94413721|NCT02039063|323299821|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
94413722|NCT02039063|323299822|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
94413723|NCT02039063|323299823|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
94413724|NCT02039063|323299820|FG000|Treatment Phase|Progression of disease|0|||
94413725|NCT02039063|323299821|FG001|Treatment Phase|Progression of disease|0|||
94413726|NCT02039063|323299822|FG002|Treatment Phase|Progression of disease|1|||
94413727|NCT02039063|323299823|FG003|Treatment Phase|Progression of disease|1|||
94413728|NCT02039063|323299820|FG000|Extension Phase|Inadequate therapeutic effect|0|||
94413729|NCT02039063|323299821|FG001|Extension Phase|Inadequate therapeutic effect|1|||
94413730|NCT02039063|323299822|FG002|Extension Phase|Inadequate therapeutic effect|2|||
94413731|NCT02039063|323299823|FG003|Extension Phase|Inadequate therapeutic effect|0|||
94413732|NCT02039063|323299820|FG000|Extension Phase|Progression of disease|0|||
94413733|NCT02039063|323299821|FG001|Extension Phase|Progression of disease|0|||
94413734|NCT02039063|323299822|FG002|Extension Phase|Progression of disease|0|||
94413735|NCT02039063|323299823|FG003|Extension Phase|Progression of disease|1|||
94413736|NCT02039063|323299820|FG000|Extension Phase|Adverse Event|0|||
94413737|NCT02039063|323299821|FG001|Extension Phase|Adverse Event|0|||
94413738|NCT02039063|323299822|FG002|Extension Phase|Adverse Event|1|||
94413739|NCT02039063|323299823|FG003|Extension Phase|Adverse Event|0|||
94413740|NCT00467831|323299825|FG000|Overall Study|Death|2|||
94413741|NCT00467831|323299825|FG000|Overall Study|Withdrawal by Subject|1|||
94413742|NCT01010750|323299826|FG000|Second Intervention|Adverse Event|0|||
94413743|NCT01010750|323299827|FG001|Second Intervention|Adverse Event|1|||
94413744|NCT01010750|323299828|FG002|Second Intervention|Adverse Event|0|||
94413745|NCT01010750|323299829|FG003|Second Intervention|Adverse Event|0|||
94413746|NCT01010750|323299830|FG004|Second Intervention|Adverse Event|0|||
94413747|NCT01010750|323299831|FG005|Second Intervention|Adverse Event|0|||
94413748|NCT01682148|323299832|FG000|Overall Study|Withdrawal by Subject|2|||
94413749|NCT01682148|323299833|FG001|Overall Study|Withdrawal by Subject|0|||
94413750|NCT01682148|323299832|FG000|Overall Study|Lost to Follow-up|1|||
94413751|NCT01682148|323299833|FG001|Overall Study|Lost to Follow-up|2|||
94413752|NCT01682148|323299832|FG000|Overall Study|Protocol Violation|1|||
94413753|NCT01682148|323299833|FG001|Overall Study|Protocol Violation|1|||
94413754|NCT01803269|323299839|FG000|Overall Study|Withdrawal by Subject|3|||
94413755|NCT01803269|323299840|FG001|Overall Study|Withdrawal by Subject|0|||
94413756|NCT01803269|323299841|FG002|Overall Study|Withdrawal by Subject|0|||
94413757|NCT00396331|323299842|FG000|Overall Study|Failed to mobilize - no transplant|8|||
94413758|NCT00396331|323299842|FG000|Overall Study|Did not go on to transplant|5|||
94413759|NCT00396331|323299842|FG000|Overall Study|Lost to Follow-up|3|||
94413760|NCT00396331|323299842|FG000|Overall Study|Death|16|||
94413761|NCT00605917|323299843|FG000|Overall Study|Protocol Violation|79|||
94413762|NCT03903159|323299844|FG000|Overall Study|Discharged with Staff Approval|2|||
94413763|NCT03903159|323299844|FG000|Overall Study|Discharged at Staff Request|2|||
94413764|NCT03903159|323299844|FG000|Overall Study|Discharged Against Staff Advice|1|||
94413765|NCT00724373|323299847|FG000|Overall Study|Adverse Event|41|||
94413766|NCT00724373|323299847|FG000|Overall Study|Lack of Efficacy|82|||
94413767|NCT00724373|323299847|FG000|Overall Study|Lost to Follow-up|7|||
94413768|NCT00724373|323299847|FG000|Overall Study|Non-compliance|2|||
94413769|NCT00724373|323299847|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
94413770|NCT00724373|323299847|FG000|Overall Study|Participant moved away|1|||
94413771|NCT00724373|323299847|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
94413772|NCT00724373|323299847|FG000|Overall Study|Only to have 24 week regimen|1|||
94413773|NCT00724373|323299847|FG000|Overall Study|Viral Relapse|1|||
94413774|NCT00724373|323299847|FG000|Overall Study|Acute HCV infection|1|||
94413775|NCT00724373|323299847|FG000|Overall Study|Drug Relapse|1|||
94413776|NCT00724373|323299847|FG000|Overall Study|Tolerability|23|||
94413777|NCT00536484|323299848|FG000|Overall Study|Adverse Event|21|||
94413778|NCT00536484|323299849|FG001|Overall Study|Adverse Event|34|||
94413779|NCT00536484|323299848|FG000|Overall Study|Withdrawal by Subject|11|||
94487421|NCT00171249|323577548|FG006|Overall Study|No Longer Requires Study Drug|0|||
94487422|NCT00171249|323577542|FG000|Overall Study|Administrative Problems|1|||
94487423|NCT00171249|323577543|FG001|Overall Study|Administrative Problems|0|||
94487424|NCT00171249|323577544|FG002|Overall Study|Administrative Problems|0|||
94487425|NCT00171249|323577545|FG003|Overall Study|Administrative Problems|2|||
94487426|NCT00171249|323577546|FG004|Overall Study|Administrative Problems|0|||
94487427|NCT00171249|323577547|FG005|Overall Study|Administrative Problems|0|||
94487428|NCT00171249|323577548|FG006|Overall Study|Administrative Problems|0|||
94487429|NCT00171249|323577542|FG000|Overall Study|Adverse Event|3|||
94487430|NCT00171249|323577543|FG001|Overall Study|Adverse Event|1|||
94487431|NCT00171249|323577544|FG002|Overall Study|Adverse Event|0|||
94487432|NCT00171249|323577545|FG003|Overall Study|Adverse Event|15|||
94487433|NCT00171249|323577546|FG004|Overall Study|Adverse Event|0|||
94487434|NCT00171249|323577547|FG005|Overall Study|Adverse Event|2|||
94487435|NCT00171249|323577548|FG006|Overall Study|Adverse Event|0|||
94487436|NCT00171249|323577542|FG000|Overall Study|Lost to Follow-up|5|||
94487437|NCT00171249|323577543|FG001|Overall Study|Lost to Follow-up|0|||
94487438|NCT00171249|323577544|FG002|Overall Study|Lost to Follow-up|0|||
94487439|NCT00171249|323577545|FG003|Overall Study|Lost to Follow-up|9|||
94487440|NCT00171249|323577546|FG004|Overall Study|Lost to Follow-up|0|||
94487441|NCT00171249|323577547|FG005|Overall Study|Lost to Follow-up|0|||
94487442|NCT00171249|323577548|FG006|Overall Study|Lost to Follow-up|0|||
94487443|NCT00875810|323577549|FG000|Overall Study|Withdrawal by Subject|1|||
94487444|NCT00875810|323577549|FG000|Overall Study|Physician Decision|3|||
94487445|NCT00875810|323577549|FG000|Overall Study|Lost to Follow-up|39|||
94487446|NCT00875810|323577549|FG000|Overall Study|Patient enroled but not implanted|2|||
94487447|NCT00875810|323577549|FG000|Overall Study|Device explanted|1|||
94487448|NCT01973218|323577563|FG000|Overall Study|Adverse Event|1|||
94487449|NCT01973218|323577564|FG001|Overall Study|Adverse Event|0|||
94487450|NCT01973218|323577563|FG000|Overall Study|Withdrawal by Subject|1|||
94487451|NCT01973218|323577564|FG001|Overall Study|Withdrawal by Subject|0|||
94487452|NCT02577029|323577566|FG000|Overall Study|Adverse Event|1|||
94487453|NCT02577029|323577567|FG001|Overall Study|Adverse Event|0|||
94487454|NCT02577029|323577568|FG002|Overall Study|Adverse Event|2|||
94487455|NCT02577029|323577569|FG003|Overall Study|Adverse Event|0|||
94487456|NCT02577029|323577570|FG004|Overall Study|Adverse Event|1|||
94487457|NCT02577029|323577571|FG005|Overall Study|Adverse Event|0|||
94487458|NCT02577029|323577572|FG006|Overall Study|Adverse Event|0|||
94487459|NCT02577029|323577573|FG007|Overall Study|Adverse Event|0|||
94487460|NCT02577029|323577566|FG000|Overall Study|Withdrawal by Subject|0|||
94413780|NCT00536484|323299849|FG001|Overall Study|Withdrawal by Subject|11|||
94413781|NCT00536484|323299848|FG000|Overall Study|Lost to Follow-up|8|||
94413782|NCT00536484|323299849|FG001|Overall Study|Lost to Follow-up|6|||
94413783|NCT00536484|323299848|FG000|Overall Study|Lack of Efficacy|16|||
94413784|NCT00536484|323299849|FG001|Overall Study|Lack of Efficacy|5|||
94413785|NCT00536484|323299848|FG000|Overall Study|Other|4|||
94413786|NCT00536484|323299849|FG001|Overall Study|Other|0|||
94413787|NCT02939950|323299853|FG000|Overall Study|Lost to Follow-up|13|||
94413788|NCT02939950|323299854|FG001|Overall Study|Lost to Follow-up|16|||
94413789|NCT02939950|323299853|FG000|Overall Study|Positive slit lamp findings|0|||
94413790|NCT02939950|323299854|FG001|Overall Study|Positive slit lamp findings|1|||
94413791|NCT02939950|323299853|FG000|Overall Study|Chalazion upper lid|0|||
94413792|NCT02939950|323299854|FG001|Overall Study|Chalazion upper lid|1|||
94413793|NCT02939950|323299853|FG000|Overall Study|Lack of motivation|0|||
94413794|NCT02939950|323299854|FG001|Overall Study|Lack of motivation|2|||
94413795|NCT02939950|323299853|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
94413796|NCT02939950|323299854|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
94413797|NCT02939950|323299853|FG000|Overall Study|Military orders|1|||
94413798|NCT02939950|323299854|FG001|Overall Study|Military orders|0|||
94413799|NCT02939950|323299853|FG000|Overall Study|Participant Relocated|5|||
94413800|NCT02939950|323299854|FG001|Overall Study|Participant Relocated|3|||
94487461|NCT02577029|323577567|FG001|Overall Study|Withdrawal by Subject|0|||
94413801|NCT02939950|323299853|FG000|Overall Study|Study related symptoms|8|||
94413802|NCT02939950|323299854|FG001|Overall Study|Study related symptoms|8|||
94487462|NCT02577029|323577568|FG002|Overall Study|Withdrawal by Subject|0|||
94487463|NCT02577029|323577569|FG003|Overall Study|Withdrawal by Subject|0|||
94487464|NCT02577029|323577570|FG004|Overall Study|Withdrawal by Subject|0|||
94487465|NCT02577029|323577571|FG005|Overall Study|Withdrawal by Subject|1|||
94487466|NCT02577029|323577572|FG006|Overall Study|Withdrawal by Subject|0|||
94487467|NCT02577029|323577573|FG007|Overall Study|Withdrawal by Subject|0|||
94487468|NCT02577029|323577566|FG000|Overall Study|Sponsor Termination of the Study|9|||
94487469|NCT02577029|323577567|FG001|Overall Study|Sponsor Termination of the Study|2|||
94413803|NCT02939950|323299853|FG000|Overall Study|Unacceptable lens movement|2|||
94413804|NCT02939950|323299854|FG001|Overall Study|Unacceptable lens movement|0|||
94413805|NCT02939950|323299853|FG000|Overall Study|Protocol Violation|6|||
94413806|NCT02939950|323299854|FG001|Overall Study|Protocol Violation|3|||
94487470|NCT02577029|323577568|FG002|Overall Study|Sponsor Termination of the Study|5|||
94413807|NCT02939950|323299853|FG000|Overall Study|Physician Decision|2|||
94413808|NCT02939950|323299854|FG001|Overall Study|Physician Decision|0|||
94413809|NCT02939950|323299853|FG000|Overall Study|Pregnancy|6|||
94413810|NCT02939950|323299854|FG001|Overall Study|Pregnancy|7|||
94413811|NCT02939950|323299853|FG000|Overall Study|Withdrawal by Subject|12|||
94413812|NCT02939950|323299854|FG001|Overall Study|Withdrawal by Subject|28|||
94413813|NCT02939950|323299853|FG000|Overall Study|Adverse Event|7|||
94413814|NCT02939950|323299854|FG001|Overall Study|Adverse Event|3|||
94413815|NCT02939950|323299853|FG000|Overall Study|Randomized, not dispensed|1|||
94413816|NCT02939950|323299854|FG001|Overall Study|Randomized, not dispensed|0|||
94413817|NCT02939950|323299853|FG000|Overall Study|Ineligible at Baseline|2|||
94413818|NCT02939950|323299854|FG001|Overall Study|Ineligible at Baseline|8|||
94413819|NCT03166124|323299857|FG000|Treatment Period 1|Adverse Event|0|||
94413820|NCT03166124|323299858|FG001|Treatment Period 1|Adverse Event|0|||
94413821|NCT03166124|323299859|FG002|Treatment Period 1|Adverse Event|1|||
94413822|NCT03166124|323299860|FG003|Treatment Period 1|Adverse Event|0|||
94413823|NCT03166124|323299857|FG000|Wash-out Period|Withdrawal by Subject|0|||
94413824|NCT03166124|323299858|FG001|Wash-out Period|Withdrawal by Subject|1|||
94413825|NCT03166124|323299859|FG002|Wash-out Period|Withdrawal by Subject|0|||
94413826|NCT03166124|323299860|FG003|Wash-out Period|Withdrawal by Subject|1|||
94413827|NCT03166124|323299857|FG000|Wash-out Period|Adverse Event|0|||
94413828|NCT03166124|323299858|FG001|Wash-out Period|Adverse Event|1|||
94413829|NCT03166124|323299859|FG002|Wash-out Period|Adverse Event|1|||
94413830|NCT03166124|323299860|FG003|Wash-out Period|Adverse Event|0|||
94413831|NCT01280617|323301349|FG000|Overall Study|Adverse Event|0|||
94413832|NCT01280617|323301350|FG001|Overall Study|Adverse Event|1|||
94413833|NCT02225665|323301351|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
94413834|NCT02225665|323301352|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
94413835|NCT02225665|323301351|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
94413836|NCT02225665|323301352|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
94413837|NCT02418455|323301357|FG000|48-Week Treatment Period|Other- Not Specified|1|||
94413838|NCT02418455|323301357|FG000|Continuation Period|Sponsor Decision|7|||
94413839|NCT00493454|323301358|FG000|Overall Study|Withdrawal by Subject|1|||
94413840|NCT01714739|323301359|FG000|Overall Study|Disease progression|3|||
94413841|NCT01714739|323301360|FG001|Overall Study|Disease progression|5|||
94413842|NCT01714739|323301361|FG002|Overall Study|Disease progression|5|||
94413843|NCT01714739|323301362|FG003|Overall Study|Disease progression|204|||
94413844|NCT01714739|323301363|FG004|Overall Study|Disease progression|1|||
94413845|NCT01714739|323301364|FG005|Overall Study|Disease progression|3|||
94413846|NCT01714739|323301365|FG006|Overall Study|Disease progression|5|||
94413847|NCT01714739|323301359|FG000|Overall Study|Study drug toxicity|1|||
94413848|NCT01714739|323301360|FG001|Overall Study|Study drug toxicity|1|||
94413849|NCT01714739|323301361|FG002|Overall Study|Study drug toxicity|1|||
94413850|NCT01714739|323301362|FG003|Overall Study|Study drug toxicity|15|||
94413851|NCT01714739|323301363|FG004|Overall Study|Study drug toxicity|0|||
94413852|NCT01714739|323301364|FG005|Overall Study|Study drug toxicity|0|||
94413853|NCT01714739|323301365|FG006|Overall Study|Study drug toxicity|5|||
94413854|NCT01714739|323301359|FG000|Overall Study|Death|0|||
94413855|NCT01714739|323301360|FG001|Overall Study|Death|0|||
94413856|NCT01714739|323301361|FG002|Overall Study|Death|0|||
94413857|NCT01714739|323301362|FG003|Overall Study|Death|1|||
94413858|NCT01714739|323301363|FG004|Overall Study|Death|0|||
94413859|NCT01714739|323301364|FG005|Overall Study|Death|0|||
94413860|NCT01714739|323301365|FG006|Overall Study|Death|0|||
94413861|NCT01714739|323301359|FG000|Overall Study|Adverse Event unrelated to drug|0|||
94413862|NCT01714739|323301360|FG001|Overall Study|Adverse Event unrelated to drug|0|||
94413863|NCT01714739|323301361|FG002|Overall Study|Adverse Event unrelated to drug|3|||
94413864|NCT01714739|323301362|FG003|Overall Study|Adverse Event unrelated to drug|21|||
94413865|NCT01714739|323301363|FG004|Overall Study|Adverse Event unrelated to drug|0|||
94413866|NCT01714739|323301364|FG005|Overall Study|Adverse Event unrelated to drug|0|||
94413867|NCT01714739|323301365|FG006|Overall Study|Adverse Event unrelated to drug|0|||
94413868|NCT01714739|323301359|FG000|Overall Study|Participant request to stop therapy|0|||
94413869|NCT01714739|323301360|FG001|Overall Study|Participant request to stop therapy|1|||
94413870|NCT01714739|323301361|FG002|Overall Study|Participant request to stop therapy|0|||
94413871|NCT01714739|323301362|FG003|Overall Study|Participant request to stop therapy|6|||
94413872|NCT01714739|323301363|FG004|Overall Study|Participant request to stop therapy|0|||
94413873|NCT01714739|323301364|FG005|Overall Study|Participant request to stop therapy|0|||
94413874|NCT01714739|323301365|FG006|Overall Study|Participant request to stop therapy|0|||
94413875|NCT01714739|323301359|FG000|Overall Study|Participant withdrew consent|0|||
94413876|NCT01714739|323301360|FG001|Overall Study|Participant withdrew consent|1|||
94413877|NCT01714739|323301361|FG002|Overall Study|Participant withdrew consent|0|||
94413878|NCT01714739|323301362|FG003|Overall Study|Participant withdrew consent|8|||
94413879|NCT01714739|323301363|FG004|Overall Study|Participant withdrew consent|0|||
94413880|NCT01714739|323301364|FG005|Overall Study|Participant withdrew consent|0|||
94413881|NCT01714739|323301365|FG006|Overall Study|Participant withdrew consent|0|||
94413882|NCT01714739|323301359|FG000|Overall Study|Lost to Follow-up|0|||
94413883|NCT01714739|323301360|FG001|Overall Study|Lost to Follow-up|0|||
94413884|NCT01714739|323301361|FG002|Overall Study|Lost to Follow-up|0|||
94413885|NCT01714739|323301362|FG003|Overall Study|Lost to Follow-up|1|||
94413886|NCT01714739|323301363|FG004|Overall Study|Lost to Follow-up|0|||
94413887|NCT01714739|323301364|FG005|Overall Study|Lost to Follow-up|0|||
94413888|NCT01714739|323301365|FG006|Overall Study|Lost to Follow-up|0|||
94413889|NCT01714739|323301359|FG000|Overall Study|Maximum clinical benefit|0|||
94413890|NCT01714739|323301360|FG001|Overall Study|Maximum clinical benefit|1|||
94413891|NCT01714739|323301361|FG002|Overall Study|Maximum clinical benefit|1|||
94413892|NCT01714739|323301362|FG003|Overall Study|Maximum clinical benefit|3|||
94413893|NCT01714739|323301363|FG004|Overall Study|Maximum clinical benefit|0|||
94413894|NCT01714739|323301364|FG005|Overall Study|Maximum clinical benefit|0|||
94413895|NCT01714739|323301365|FG006|Overall Study|Maximum clinical benefit|0|||
94413896|NCT01714739|323301359|FG000|Overall Study|Poor/non-comliance|0|||
94413897|NCT01714739|323301360|FG001|Overall Study|Poor/non-comliance|1|||
94413898|NCT01714739|323301361|FG002|Overall Study|Poor/non-comliance|0|||
94413899|NCT01714739|323301362|FG003|Overall Study|Poor/non-comliance|1|||
94413900|NCT01714739|323301363|FG004|Overall Study|Poor/non-comliance|0|||
94413901|NCT01714739|323301364|FG005|Overall Study|Poor/non-comliance|0|||
94413902|NCT01714739|323301365|FG006|Overall Study|Poor/non-comliance|0|||
94413903|NCT01714739|323301359|FG000|Overall Study|No longer meets study criteria|0|||
94413904|NCT01714739|323301360|FG001|Overall Study|No longer meets study criteria|0|||
94413905|NCT01714739|323301361|FG002|Overall Study|No longer meets study criteria|0|||
94413906|NCT01714739|323301362|FG003|Overall Study|No longer meets study criteria|1|||
94413907|NCT01714739|323301363|FG004|Overall Study|No longer meets study criteria|0|||
94413908|NCT01714739|323301364|FG005|Overall Study|No longer meets study criteria|0|||
94413909|NCT01714739|323301365|FG006|Overall Study|No longer meets study criteria|0|||
94413910|NCT01714739|323301359|FG000|Overall Study|Other reason|0|||
94413911|NCT01714739|323301360|FG001|Overall Study|Other reason|0|||
94413912|NCT01714739|323301361|FG002|Overall Study|Other reason|0|||
94413913|NCT01714739|323301362|FG003|Overall Study|Other reason|3|||
94413914|NCT01714739|323301363|FG004|Overall Study|Other reason|1|||
94413915|NCT01714739|323301364|FG005|Overall Study|Other reason|0|||
94413916|NCT01714739|323301365|FG006|Overall Study|Other reason|0|||
94413917|NCT03585959|323301366|FG000|Overall Study|Physician Decision|1|||
94413918|NCT03585959|323301366|FG000|Overall Study|Unsuccessful Procedure|2|||
94413919|NCT05158140|323301375|FG000|Overall Study|Death|0|||
94413920|NCT05158140|323301376|FG001|Overall Study|Death|0|||
94413921|NCT05158140|323301377|FG002|Overall Study|Death|0|||
94413922|NCT05158140|323301378|FG003|Overall Study|Death|1|||
94413923|NCT05158140|323301375|FG000|Overall Study|Lost to Follow-up|3|||
94413924|NCT05158140|323301376|FG001|Overall Study|Lost to Follow-up|6|||
94413925|NCT05158140|323301377|FG002|Overall Study|Lost to Follow-up|4|||
94413926|NCT05158140|323301378|FG003|Overall Study|Lost to Follow-up|3|||
94413927|NCT05158140|323301375|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94413928|NCT05158140|323301376|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94413929|NCT05158140|323301377|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
94413930|NCT05158140|323301378|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
94413931|NCT05158140|323301375|FG000|Overall Study|Withdrawal by Subject|3|||
94413932|NCT05158140|323301376|FG001|Overall Study|Withdrawal by Subject|7|||
94413933|NCT05158140|323301377|FG002|Overall Study|Withdrawal by Subject|3|||
94413934|NCT05158140|323301378|FG003|Overall Study|Withdrawal by Subject|7|||
94413935|NCT02751827|323301379|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
94413936|NCT02751827|323301380|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
94413937|NCT02751827|323301381|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
94413938|NCT01261624|323301382|FG000|Week 0 to Week 12|Disease Progression|1|||
94413939|NCT01261624|323301383|FG001|Week 0 to Week 12|Disease Progression|1|||
94413940|NCT01261624|323301382|FG000|Week 0 to Week 12|Insufficient Response|0|||
94413941|NCT01261624|323301383|FG001|Week 0 to Week 12|Insufficient Response|2|||
94413942|NCT01261624|323301382|FG000|Week 13 to Week 24|Insufficient Response|0|||
94413943|NCT01261624|323301383|FG001|Week 13 to Week 24|Insufficient Response|1|||
94413944|NCT03847194|323301386|FG000|Overall Study|Lost to Follow-up|2|||
94413945|NCT03847194|323301387|FG001|Overall Study|Lost to Follow-up|5|||
94413946|NCT03847194|323301386|FG000|Overall Study|Withdrawal by Subject|1|||
94413947|NCT03847194|323301387|FG001|Overall Study|Withdrawal by Subject|2|||
94413948|NCT03847194|323301386|FG000|Overall Study|Death|0|||
94413949|NCT03847194|323301387|FG001|Overall Study|Death|1|||
94413950|NCT00124462|323301394|FG000|Overall Study|Lost to Follow-up|3|||
94413951|NCT00124462|323301395|FG001|Overall Study|Lost to Follow-up|3|||
94413952|NCT00124462|323301394|FG000|Overall Study|Physician Decision|3|||
94413953|NCT00124462|323301395|FG001|Overall Study|Physician Decision|4|||
94413954|NCT00124462|323301394|FG000|Overall Study|Withdrawal by Subject|4|||
94413955|NCT00124462|323301395|FG001|Overall Study|Withdrawal by Subject|5|||
94413956|NCT00124462|323301394|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
94413957|NCT00124462|323301395|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
94413958|NCT00860743|323301400|FG000|Overall Study|Withdrawal by Subject|3|||
94413959|NCT00860743|323301401|FG001|Overall Study|Withdrawal by Subject|0|||
94413960|NCT01202877|323301407|FG000|Overall Study|Disease Progression|0|||
94413961|NCT01202877|323301408|FG001|Overall Study|Disease Progression|1|||
94413962|NCT01202877|323301409|FG002|Overall Study|Disease Progression|2|||
94413963|NCT01202877|323301407|FG000|Overall Study|Adverse Event|0|||
94413964|NCT01202877|323301408|FG001|Overall Study|Adverse Event|0|||
94413965|NCT01202877|323301409|FG002|Overall Study|Adverse Event|2|||
94413966|NCT01202877|323301407|FG000|Overall Study|Withdrawal by Subject|0|||
94413967|NCT01202877|323301408|FG001|Overall Study|Withdrawal by Subject|0|||
94413968|NCT01202877|323301409|FG002|Overall Study|Withdrawal by Subject|1|||
94413969|NCT01202877|323301407|FG000|Overall Study|Death|0|||
94413970|NCT01202877|323301408|FG001|Overall Study|Death|0|||
94413971|NCT01202877|323301409|FG002|Overall Study|Death|1|||
94413972|NCT02692482|323301410|FG000|Overall Study|Death|2|||
94413973|NCT02692482|323301411|FG001|Overall Study|Death|2|||
94413974|NCT02692482|323301410|FG000|Overall Study|Withdrawal by Subject|1|||
94413975|NCT02692482|323301411|FG001|Overall Study|Withdrawal by Subject|2|||
94413976|NCT01435031|323301412|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
94413977|NCT01435031|323301412|FG000|ITT at 1 Month|Death|1|||
94413978|NCT01435031|323301412|FG000|ITT at 1 Month|Lost to Follow-up|4|||
94413979|NCT01435031|323301412|FG000|ITT at 6 Months|Death|2|||
94413980|NCT01435031|323301412|FG000|ITT at 6 Months|Lost to Follow-up|3|||
94413981|NCT01435031|323301412|FG000|ITT at 1 Year|Death|1|||
94413982|NCT01435031|323301412|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
94413983|NCT01435031|323301412|FG000|ITT at 1 Year|Lost to Follow-up|6|||
94413984|NCT01435031|323301412|FG000|ITT at 2 Years|Death|7|||
94413985|NCT01435031|323301412|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
94413986|NCT01435031|323301412|FG000|ITT at 2 Years|Lost to Follow-up|4|||
94413987|NCT01435031|323301412|FG000|ITT at 3 Years|Death|5|||
94413988|NCT01435031|323301412|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
94413989|NCT01435031|323301412|FG000|ITT at 3 Years|Lost to Follow-up|4|||
94413990|NCT01435031|323301412|FG000|ITT at 4 Years|Death|4|||
94413991|NCT01435031|323301412|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
94413992|NCT01435031|323301412|FG000|ITT at 4 Years|Lost to Follow-up|1|||
94413993|NCT02087176|323301413|FG000|Overall Study|Withdrawal by Subject|1|||
94413994|NCT02087176|323301413|FG000|Overall Study|Death|10|||
94413995|NCT02087176|323301413|FG000|Overall Study|Censored|19|||
94413996|NCT02087176|323301413|FG000|Overall Study|Study Terminated by Sponsor|2|||
94413997|NCT02927834|323301414|FG000|Overall Study|Lost to Follow-up|1|||
94413998|NCT02927834|323301415|FG001|Overall Study|Lost to Follow-up|2|||
94413999|NCT02927834|323301416|FG002|Overall Study|Lost to Follow-up|2|||
94414000|NCT03648879|323301417|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
94414001|NCT03812991|323301418|FG000|Overall Study|Lost to Follow-up|3|||
94414002|NCT03812991|323301419|FG001|Overall Study|Lost to Follow-up|1|||
94414003|NCT04740931|323301420|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
94414004|NCT04740931|323301421|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
94414005|NCT04740931|323301420|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
94414006|NCT04740931|323301421|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
94414007|NCT04740931|323301420|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
94414008|NCT04740931|323301421|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
94414009|NCT04740931|323301420|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
94414010|NCT04740931|323301421|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
94414011|NCT04740931|323301420|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
94414012|NCT04740931|323301421|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
94414013|NCT04740931|323301420|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
94414014|NCT04740931|323301421|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
94414015|NCT04740931|323301420|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
94414016|NCT04740931|323301421|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
94414017|NCT04740931|323301420|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
94487471|NCT02577029|323577569|FG003|Overall Study|Sponsor Termination of the Study|12|||
94414018|NCT04740931|323301421|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
94414019|NCT04740931|323301420|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
94414020|NCT04740931|323301421|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
94414021|NCT04740931|323301420|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
94414022|NCT04740931|323301421|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
94414023|NCT04740931|323301420|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
94414024|NCT04740931|323301421|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
94414025|NCT04740931|323301420|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
94414026|NCT04740931|323301421|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
94414027|NCT04740931|323301420|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
94414028|NCT04740931|323301421|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
94414029|NCT04740931|323301420|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
94414030|NCT04740931|323301421|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
94414031|NCT04740931|323301420|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
94414032|NCT04740931|323301421|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
94414033|NCT02953678|323301430|FG000|Overall Study|Adverse Event|20|||
94414034|NCT02953678|323301430|FG000|Overall Study|Death|7|||
94414035|NCT02953678|323301430|FG000|Overall Study|Physician Decision|23|||
94414036|NCT02953678|323301430|FG000|Overall Study|Progressive Disease of GVHD|7|||
94414037|NCT02953678|323301430|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
94414038|NCT02953678|323301430|FG000|Overall Study|Withdrawal by participant|3|||
94414039|NCT02953678|323301430|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
94414040|NCT02953678|323301430|FG000|Overall Study|Participants were transferred to commercial product.|3|||
94414041|NCT02470091|323301433|FG000|Overall Study|Withdrawal by Subject|1|||
94414042|NCT02470091|323301434|FG001|Overall Study|Withdrawal by Subject|0|||
94414043|NCT02470091|323301433|FG000|Overall Study|Ineligible|0|||
94414044|NCT02470091|323301434|FG001|Overall Study|Ineligible|2|||
94414045|NCT00690482|323301435|FG000|Overall Study|Adverse Event|2|||
94414046|NCT00690482|323301436|FG001|Overall Study|Adverse Event|1|||
94414047|NCT00690482|323301435|FG000|Overall Study|Incorrect enrolment|0|||
94414048|NCT00690482|323301436|FG001|Overall Study|Incorrect enrolment|1|||
94414049|NCT00690482|323301435|FG000|Overall Study|Study-specific discontinuation criteria|1|||
94414050|NCT00690482|323301436|FG001|Overall Study|Study-specific discontinuation criteria|0|||
94414051|NCT00690482|323301435|FG000|Overall Study|Intake of prohibited medicine|1|||
94414052|NCT00690482|323301436|FG001|Overall Study|Intake of prohibited medicine|0|||
94414053|NCT00690482|323301435|FG000|Overall Study|withdrew consent at rand.day|0|||
94414054|NCT00690482|323301436|FG001|Overall Study|withdrew consent at rand.day|1|||
94414055|NCT02549573|323301437|FG000|Overall Study|Withdrawal by Subject|0|||
94414056|NCT02549573|323301438|FG001|Overall Study|Withdrawal by Subject|2|||
94414057|NCT02549573|323301437|FG000|Overall Study|Protocol Violation|0|||
94414058|NCT02549573|323301438|FG001|Overall Study|Protocol Violation|1|||
94414059|NCT02243293|323301444|FG000|Overall Study|Adverse Event|1|||
94414060|NCT02243293|323301445|FG001|Overall Study|Adverse Event|0|||
94414061|NCT02243293|323301446|FG002|Overall Study|Adverse Event|0|||
94414062|NCT02243293|323301447|FG003|Overall Study|Adverse Event|0|||
94414063|NCT02243293|323301448|FG004|Overall Study|Adverse Event|0|||
94414064|NCT02243293|323301449|FG005|Overall Study|Adverse Event|0|||
94414065|NCT02243293|323301450|FG006|Overall Study|Adverse Event|0|||
94414066|NCT02243293|323301451|FG007|Overall Study|Adverse Event|0|||
94414067|NCT02243293|323301452|FG008|Overall Study|Adverse Event|0|||
94414068|NCT02243293|323301453|FG009|Overall Study|Adverse Event|0|||
94414069|NCT02243293|323301454|FG010|Overall Study|Adverse Event|0|||
94414070|NCT02243293|323301455|FG011|Overall Study|Adverse Event|0|||
94414071|NCT02243293|323301456|FG012|Overall Study|Adverse Event|0|||
94414072|NCT02243293|323301457|FG013|Overall Study|Adverse Event|0|||
94414073|NCT02243293|323301458|FG014|Overall Study|Adverse Event|0|||
94414074|NCT02243293|323301459|FG015|Overall Study|Adverse Event|1|||
94414075|NCT02243293|323301460|FG016|Overall Study|Adverse Event|0|||
94414076|NCT02243293|323301461|FG017|Overall Study|Adverse Event|0|||
94414077|NCT02243293|323301462|FG018|Overall Study|Adverse Event|0|||
94414078|NCT02243293|323301463|FG019|Overall Study|Adverse Event|0|||
94414079|NCT02243293|323301464|FG020|Overall Study|Adverse Event|1|||
94414080|NCT02243293|323301465|FG021|Overall Study|Adverse Event|0|||
94414081|NCT02243293|323301444|FG000|Overall Study|Withdrawal by Subject|1|||
94414082|NCT02243293|323301445|FG001|Overall Study|Withdrawal by Subject|0|||
94414083|NCT02243293|323301446|FG002|Overall Study|Withdrawal by Subject|0|||
94414084|NCT02243293|323301447|FG003|Overall Study|Withdrawal by Subject|0|||
94414085|NCT02243293|323301448|FG004|Overall Study|Withdrawal by Subject|0|||
94414086|NCT02243293|323301449|FG005|Overall Study|Withdrawal by Subject|0|||
94414087|NCT02243293|323301450|FG006|Overall Study|Withdrawal by Subject|0|||
94414088|NCT02243293|323301451|FG007|Overall Study|Withdrawal by Subject|0|||
94414089|NCT02243293|323301452|FG008|Overall Study|Withdrawal by Subject|0|||
94414090|NCT02243293|323301453|FG009|Overall Study|Withdrawal by Subject|1|||
94414091|NCT02243293|323301454|FG010|Overall Study|Withdrawal by Subject|0|||
94414092|NCT02243293|323301455|FG011|Overall Study|Withdrawal by Subject|1|||
94414093|NCT02243293|323301456|FG012|Overall Study|Withdrawal by Subject|0|||
94414094|NCT02243293|323301457|FG013|Overall Study|Withdrawal by Subject|0|||
94414095|NCT02243293|323301458|FG014|Overall Study|Withdrawal by Subject|0|||
94414096|NCT02243293|323301459|FG015|Overall Study|Withdrawal by Subject|0|||
94414097|NCT02243293|323301460|FG016|Overall Study|Withdrawal by Subject|0|||
94414098|NCT02243293|323301461|FG017|Overall Study|Withdrawal by Subject|0|||
94414099|NCT02243293|323301462|FG018|Overall Study|Withdrawal by Subject|0|||
94414100|NCT02243293|323301463|FG019|Overall Study|Withdrawal by Subject|0|||
94414101|NCT02243293|323301464|FG020|Overall Study|Withdrawal by Subject|0|||
94414102|NCT02243293|323301465|FG021|Overall Study|Withdrawal by Subject|1|||
94414103|NCT02243293|323301444|FG000|Overall Study|Lost to Follow-up|0|||
94414104|NCT02243293|323301445|FG001|Overall Study|Lost to Follow-up|1|||
94414105|NCT02243293|323301446|FG002|Overall Study|Lost to Follow-up|1|||
94414106|NCT02243293|323301447|FG003|Overall Study|Lost to Follow-up|1|||
94487472|NCT02577029|323577570|FG004|Overall Study|Sponsor Termination of the Study|10|||
94487473|NCT02577029|323577571|FG005|Overall Study|Sponsor Termination of the Study|12|||
94487474|NCT02577029|323577572|FG006|Overall Study|Sponsor Termination of the Study|12|||
94487475|NCT02577029|323577573|FG007|Overall Study|Sponsor Termination of the Study|12|||
94487476|NCT00855218|323577574|FG000|Overall Study|Adverse Event|43|||
94487477|NCT00855218|323577575|FG001|Overall Study|Adverse Event|27|||
94487478|NCT00855218|323577574|FG000|Overall Study|Withdrawal by Subject|10|||
94487479|NCT00855218|323577575|FG001|Overall Study|Withdrawal by Subject|6|||
94487480|NCT00855218|323577574|FG000|Overall Study|Physician Decision|18|||
94487481|NCT00855218|323577575|FG001|Overall Study|Physician Decision|11|||
94487482|NCT00855218|323577574|FG000|Overall Study|Lost to Follow-up|0|||
94487483|NCT00855218|323577575|FG001|Overall Study|Lost to Follow-up|1|||
94487484|NCT00855218|323577574|FG000|Overall Study|Protocol Violation|5|||
94487485|NCT00855218|323577575|FG001|Overall Study|Protocol Violation|9|||
94487486|NCT00855218|323577574|FG000|Overall Study|non-compliant with study drug|3|||
94487487|NCT00855218|323577575|FG001|Overall Study|non-compliant with study drug|1|||
94487488|NCT00855218|323577574|FG000|Overall Study|patient convenience|2|||
94487489|NCT00855218|323577575|FG001|Overall Study|patient convenience|0|||
94487490|NCT00855218|323577574|FG000|Overall Study|technical problems|2|||
94487491|NCT00855218|323577575|FG001|Overall Study|technical problems|1|||
94487492|NCT00855218|323577574|FG000|Overall Study|Still treated with study medication|0|||
94487493|NCT00855218|323577575|FG001|Overall Study|Still treated with study medication|1|||
94487494|NCT00855218|323577574|FG000|Overall Study|Untreatable disease progression|54|||
94487495|NCT00855218|323577575|FG001|Overall Study|Untreatable disease progression|67|||
94487496|NCT00855218|323577574|FG000|Overall Study|Second malignancy|0|||
94487497|NCT00855218|323577575|FG001|Overall Study|Second malignancy|1|||
94487498|NCT00855218|323577574|FG000|Overall Study|Progression measurement proven|7|||
94487499|NCT00855218|323577575|FG001|Overall Study|Progression measurement proven|15|||
94487500|NCT00855218|323577574|FG000|Overall Study|Clinical endpoint reached|10|||
94487501|NCT00855218|323577575|FG001|Overall Study|Clinical endpoint reached|13|||
94487502|NCT01441973|323577576|FG000|Overall Study|Disease progression|8|||
94487503|NCT01441973|323577577|FG001|Overall Study|Disease progression|6|||
94487504|NCT01441973|323577576|FG000|Overall Study|Adverse event unrelated to study drug|3|||
94414107|NCT02243293|323301448|FG004|Overall Study|Lost to Follow-up|0|||
94414108|NCT02243293|323301449|FG005|Overall Study|Lost to Follow-up|0|||
94414109|NCT02243293|323301450|FG006|Overall Study|Lost to Follow-up|3|||
94414110|NCT02243293|323301451|FG007|Overall Study|Lost to Follow-up|0|||
94414111|NCT02243293|323301452|FG008|Overall Study|Lost to Follow-up|0|||
94414112|NCT02243293|323301453|FG009|Overall Study|Lost to Follow-up|0|||
94414113|NCT02243293|323301454|FG010|Overall Study|Lost to Follow-up|0|||
94414114|NCT02243293|323301455|FG011|Overall Study|Lost to Follow-up|2|||
94414115|NCT02243293|323301456|FG012|Overall Study|Lost to Follow-up|0|||
94414116|NCT02243293|323301457|FG013|Overall Study|Lost to Follow-up|0|||
94414117|NCT02243293|323301458|FG014|Overall Study|Lost to Follow-up|0|||
94414118|NCT02243293|323301459|FG015|Overall Study|Lost to Follow-up|0|||
94414119|NCT02243293|323301460|FG016|Overall Study|Lost to Follow-up|3|||
94414120|NCT02243293|323301461|FG017|Overall Study|Lost to Follow-up|1|||
94414121|NCT02243293|323301462|FG018|Overall Study|Lost to Follow-up|0|||
94414122|NCT02243293|323301463|FG019|Overall Study|Lost to Follow-up|0|||
94414123|NCT02243293|323301464|FG020|Overall Study|Lost to Follow-up|1|||
94414124|NCT02243293|323301465|FG021|Overall Study|Lost to Follow-up|2|||
94414125|NCT02243293|323301444|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
94414126|NCT02243293|323301445|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
94414127|NCT02243293|323301446|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
94414128|NCT02243293|323301447|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
94414129|NCT02243293|323301448|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
94414130|NCT02243293|323301449|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
94414131|NCT02243293|323301450|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
94414132|NCT02243293|323301451|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
94414133|NCT02243293|323301452|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
94414134|NCT02243293|323301453|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
94487505|NCT01441973|323577577|FG001|Overall Study|Adverse event unrelated to study drug|2|||
94414135|NCT02243293|323301454|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
94414136|NCT02243293|323301455|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
94414137|NCT02243293|323301456|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
94487506|NCT01441973|323577576|FG000|Overall Study|Participant request to discontinue|1|||
94487507|NCT01441973|323577577|FG001|Overall Study|Participant request to discontinue|1|||
94487508|NCT01441973|323577576|FG000|Overall Study|Poor compliance/noncompliance|0|||
94414138|NCT02243293|323301457|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
94414139|NCT02243293|323301458|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
94414140|NCT02243293|323301459|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
94487509|NCT01441973|323577577|FG001|Overall Study|Poor compliance/noncompliance|1|||
94487510|NCT01441973|323577576|FG000|Overall Study|Administrative reason by sponsor|3|||
94487511|NCT01441973|323577577|FG001|Overall Study|Administrative reason by sponsor|5|||
94487512|NCT01441973|323577576|FG000|Overall Study|Participant withdrew consent|0|||
94414141|NCT02243293|323301460|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
94414142|NCT02243293|323301461|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
94414143|NCT02243293|323301462|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
94414144|NCT02243293|323301463|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
94414145|NCT02243293|323301464|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
94414146|NCT02243293|323301465|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
94414147|NCT02243293|323301444|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
94414148|NCT02243293|323301445|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
94414149|NCT02243293|323301446|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
94414150|NCT02243293|323301447|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
94414151|NCT02243293|323301448|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
94414152|NCT02243293|323301449|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
94414153|NCT02243293|323301450|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
94414154|NCT02243293|323301451|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
94414155|NCT02243293|323301452|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
94414156|NCT02243293|323301453|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
94414157|NCT02243293|323301454|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
94414158|NCT02243293|323301455|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
94414159|NCT02243293|323301456|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
94414160|NCT02243293|323301457|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
94414161|NCT02243293|323301458|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
94414162|NCT02243293|323301459|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
94414163|NCT02243293|323301460|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
94414164|NCT02243293|323301461|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
94414165|NCT02243293|323301462|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
94414166|NCT02243293|323301463|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
94414167|NCT02243293|323301464|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
94414168|NCT02243293|323301465|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
94414169|NCT01118117|323301466|FG000|Overall Study|Death|8|||
94414170|NCT01118117|323301467|FG001|Overall Study|Death|0|||
94414171|NCT01118117|323301466|FG000|Overall Study|Lost to Follow-up|6|||
94414172|NCT01118117|323301467|FG001|Overall Study|Lost to Follow-up|0|||
94414173|NCT01118117|323301466|FG000|Overall Study|Missed 12 Month Visit|7|||
94414174|NCT01118117|323301467|FG001|Overall Study|Missed 12 Month Visit|0|||
94414175|NCT01660022|323301468|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
94414176|NCT01660022|323301469|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
94414177|NCT01660022|323301470|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
94414178|NCT01660022|323301471|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
94414179|NCT01660022|323301472|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
94414180|NCT01660022|323301473|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
94414181|NCT01660022|323301468|FG000|First Sequence (7 Days)|Adverse Event|0|||
94414182|NCT01660022|323301469|FG001|First Sequence (7 Days)|Adverse Event|0|||
94414183|NCT01660022|323301470|FG002|First Sequence (7 Days)|Adverse Event|0|||
94414184|NCT01660022|323301471|FG003|First Sequence (7 Days)|Adverse Event|0|||
94414185|NCT01660022|323301472|FG004|First Sequence (7 Days)|Adverse Event|1|||
94414186|NCT01660022|323301473|FG005|First Sequence (7 Days)|Adverse Event|3|||
94414187|NCT01660022|323301468|FG000|First Sequence (7 Days)|Protocol Violation|0|||
94414188|NCT01660022|323301469|FG001|First Sequence (7 Days)|Protocol Violation|0|||
94414189|NCT01660022|323301470|FG002|First Sequence (7 Days)|Protocol Violation|0|||
94414190|NCT01660022|323301471|FG003|First Sequence (7 Days)|Protocol Violation|0|||
94414191|NCT01660022|323301472|FG004|First Sequence (7 Days)|Protocol Violation|0|||
94414192|NCT01660022|323301473|FG005|First Sequence (7 Days)|Protocol Violation|1|||
94414193|NCT02746627|323301474|FG000|Overall Study|Withdrawal by Subject|1|||
94414194|NCT02746627|323301475|FG001|Overall Study|Withdrawal by Subject|1|||
94414195|NCT02746627|323301476|FG002|Overall Study|Withdrawal by Subject|1|||
94414196|NCT03438006|323301477|FG000|Overall Study|Adverse Event|1|||
94414197|NCT03438006|323301477|FG000|Overall Study|Lost to Follow-up|67|||
94487513|NCT01441973|323577577|FG001|Overall Study|Participant withdrew consent|1|||
94414198|NCT03438006|323301477|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
94414199|NCT03438006|323301477|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
94414200|NCT03351231|323301478|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
94414201|NCT03351231|323301478|FG000|Combination Therapy Period|Disease progression|2|||
94414202|NCT03351231|323301478|FG000|Combination Therapy Period|Study drug toxicity|1|||
94414203|NCT03351231|323301478|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
94414204|NCT03351231|323301478|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
94414205|NCT03351231|323301478|FG000|Safety Follow-Up Period|Other reason|2|||
94414206|NCT02858726|323301483|FG000|Overall Study|Adverse Event|4|||
94414207|NCT02858726|323301484|FG001|Overall Study|Adverse Event|4|||
94414208|NCT02858726|323301485|FG002|Overall Study|Adverse Event|9|||
94414209|NCT02858726|323301486|FG003|Overall Study|Adverse Event|1|||
94414210|NCT02858726|323301483|FG000|Overall Study|Physician Decision|0|||
94414211|NCT02858726|323301484|FG001|Overall Study|Physician Decision|0|||
94414212|NCT02858726|323301485|FG002|Overall Study|Physician Decision|1|||
94414213|NCT02858726|323301486|FG003|Overall Study|Physician Decision|0|||
94414214|NCT02858726|323301483|FG000|Overall Study|Protocol Violation|0|||
94414215|NCT02858726|323301484|FG001|Overall Study|Protocol Violation|0|||
94414216|NCT02858726|323301485|FG002|Overall Study|Protocol Violation|0|||
94414217|NCT02858726|323301486|FG003|Overall Study|Protocol Violation|1|||
94414218|NCT02858726|323301483|FG000|Overall Study|Study Terminated by Sponsor|0|||
94414219|NCT02858726|323301484|FG001|Overall Study|Study Terminated by Sponsor|0|||
94414220|NCT02858726|323301485|FG002|Overall Study|Study Terminated by Sponsor|0|||
94414221|NCT02858726|323301486|FG003|Overall Study|Study Terminated by Sponsor|1|||
94414222|NCT02858726|323301483|FG000|Overall Study|Withdrawal by Subject|1|||
94414223|NCT02858726|323301484|FG001|Overall Study|Withdrawal by Subject|2|||
94414224|NCT02858726|323301485|FG002|Overall Study|Withdrawal by Subject|1|||
94414225|NCT02858726|323301486|FG003|Overall Study|Withdrawal by Subject|0|||
94414226|NCT02858726|323301483|FG000|Overall Study|Noncompliance|0|||
94414227|NCT02858726|323301484|FG001|Overall Study|Noncompliance|1|||
94414228|NCT02858726|323301485|FG002|Overall Study|Noncompliance|0|||
94414229|NCT02858726|323301486|FG003|Overall Study|Noncompliance|0|||
94414230|NCT02737592|323301489|FG000|Overall Study|Withdrawal by Subject|1|||
94414231|NCT00576303|323301492|FG000|Dose Titration Period|Early withdrawal|17|||
94414232|NCT00576303|323301492|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
94414233|NCT00576303|323301492|FG000|Long Term Safety Period|Early withdrawal|16|||
94414234|NCT01688726|323301493|FG000|Overall Study|Adverse Event|1|||
94414235|NCT01688726|323301494|FG001|Overall Study|Adverse Event|0|||
94414236|NCT01688726|323301493|FG000|Overall Study|Relocated abroad|0|||
94414237|NCT01688726|323301494|FG001|Overall Study|Relocated abroad|1|||
94414238|NCT00248170|323301495|FG000|Overall Study|Withdrawal by Subject|71|||
94414239|NCT00248170|323301496|FG001|Overall Study|Withdrawal by Subject|79|||
94414240|NCT00248170|323301495|FG000|Overall Study|Protocol Violation|35|||
94414241|NCT00248170|323301496|FG001|Overall Study|Protocol Violation|30|||
94414242|NCT00248170|323301495|FG000|Overall Study|Lost to Follow-up|28|||
94414243|NCT00248170|323301496|FG001|Overall Study|Lost to Follow-up|35|||
94414244|NCT00248170|323301495|FG000|Overall Study|Disease progression|196|||
94414245|NCT00248170|323301496|FG001|Overall Study|Disease progression|216|||
94414246|NCT00248170|323301495|FG000|Overall Study|Death|28|||
94414247|NCT00248170|323301496|FG001|Overall Study|Death|47|||
94414248|NCT00248170|323301495|FG000|Overall Study|Adverse Event|311|||
94414249|NCT00248170|323301496|FG001|Overall Study|Adverse Event|296|||
94414250|NCT00248170|323301495|FG000|Overall Study|Administrative problems|22|||
94414251|NCT00248170|323301496|FG001|Overall Study|Administrative problems|25|||
94414252|NCT00248170|323301495|FG000|Overall Study|Abnormal test procedure(s) result|49|||
94414253|NCT00248170|323301496|FG001|Overall Study|Abnormal test procedure(s) result|61|||
94414254|NCT00248170|323301495|FG000|Overall Study|Abnormal laboratory values|4|||
94414255|NCT00248170|323301496|FG001|Overall Study|Abnormal laboratory values|0|||
94414256|NCT00248170|323301495|FG000|Overall Study|Protocol deviation|17|||
94414257|NCT00248170|323301496|FG001|Overall Study|Protocol deviation|19|||
94414258|NCT03581188|323303190|FG000|Overall Study|Inclusion criteria not met|3|||
94414259|NCT03581188|323303191|FG001|Overall Study|Inclusion criteria not met|2|||
94414260|NCT03581188|323303190|FG000|Overall Study|Lost to Follow-up|5|||
94414261|NCT03581188|323303191|FG001|Overall Study|Lost to Follow-up|5|||
94414262|NCT03581188|323303190|FG000|Overall Study|Discontinued intervention|11|||
94414263|NCT03581188|323303191|FG001|Overall Study|Discontinued intervention|8|||
94414264|NCT01000610|323303208|FG000|Overall Study|Adverse Event|1|||
94414265|NCT01000610|323303208|FG000|Overall Study|Lost to Follow-up|4|||
94414266|NCT01000610|323303208|FG000|Overall Study|Treatment failure|1|||
94414267|NCT03064438|323303209|FG000|Overall Study|Lost to Follow-up|1|||
94414268|NCT03064438|323303210|FG001|Overall Study|Lost to Follow-up|0|||
94414269|NCT03064438|323303209|FG000|Overall Study|Withdrawal by Subject|0|||
94414270|NCT03064438|323303210|FG001|Overall Study|Withdrawal by Subject|1|||
94414271|NCT00493246|323303211|FG000|Overall Study|Withdrawal by Subject|0|||
94414272|NCT00493246|323303212|FG001|Overall Study|Withdrawal by Subject|0|||
94414273|NCT00493246|323303213|FG002|Overall Study|Withdrawal by Subject|0|||
94414274|NCT00493246|323303214|FG003|Overall Study|Withdrawal by Subject|0|||
94414275|NCT00493246|323303215|FG004|Overall Study|Withdrawal by Subject|1|||
94414276|NCT00493246|323303216|FG005|Overall Study|Withdrawal by Subject|0|||
94414277|NCT00493246|323303217|FG006|Overall Study|Withdrawal by Subject|0|||
94414278|NCT00493246|323303218|FG007|Overall Study|Withdrawal by Subject|0|||
94414279|NCT00493246|323303211|FG000|Overall Study|No access to draw blood|0|||
94414280|NCT00493246|323303212|FG001|Overall Study|No access to draw blood|0|||
94414281|NCT00493246|323303213|FG002|Overall Study|No access to draw blood|0|||
94414282|NCT00493246|323303214|FG003|Overall Study|No access to draw blood|0|||
94414283|NCT00493246|323303215|FG004|Overall Study|No access to draw blood|0|||
94414284|NCT00493246|323303216|FG005|Overall Study|No access to draw blood|1|||
94414285|NCT00493246|323303217|FG006|Overall Study|No access to draw blood|0|||
94414286|NCT00493246|323303218|FG007|Overall Study|No access to draw blood|0|||
94414287|NCT00493246|323303211|FG000|Overall Study|Lost to Follow-up|0|||
94414288|NCT00493246|323303212|FG001|Overall Study|Lost to Follow-up|0|||
94414289|NCT00493246|323303213|FG002|Overall Study|Lost to Follow-up|0|||
94414290|NCT00493246|323303214|FG003|Overall Study|Lost to Follow-up|0|||
94414291|NCT00493246|323303215|FG004|Overall Study|Lost to Follow-up|0|||
94414292|NCT00493246|323303216|FG005|Overall Study|Lost to Follow-up|0|||
94414293|NCT00493246|323303217|FG006|Overall Study|Lost to Follow-up|1|||
94414294|NCT00493246|323303218|FG007|Overall Study|Lost to Follow-up|0|||
94414295|NCT00595335|323303221|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
94414296|NCT00595335|323303222|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
94414297|NCT00595335|323303221|FG000|Baseline to Six Months|Disease Progression|1|||
94414298|NCT00595335|323303222|FG001|Baseline to Six Months|Disease Progression|1|||
94414299|NCT00595335|323303221|FG000|Baseline to Six Months|Adverse Event|1|||
94414300|NCT00595335|323303222|FG001|Baseline to Six Months|Adverse Event|0|||
94414301|NCT00595335|323303221|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
94414302|NCT00595335|323303222|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
94414303|NCT00595335|323303221|FG000|Six Months to Twelve Months|Disease Progression|1|||
94414304|NCT00595335|323303222|FG001|Six Months to Twelve Months|Disease Progression|0|||
94414305|NCT02658487|323303229|FG000|Overall Study|Death|2|||
94414306|NCT02658487|323303229|FG000|Overall Study|Disease progression|10|||
94414307|NCT02658487|323303229|FG000|Overall Study|Alternative therapy|1|||
94414308|NCT02658487|323303229|FG000|Overall Study|Adverse Event|1|||
94414309|NCT02658487|323303229|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
94414310|NCT02658487|323303229|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
94414311|NCT00784134|323303230|FG000|Overall Study|Lost to Follow-up|3|||
94414312|NCT00784134|323303231|FG001|Overall Study|Lost to Follow-up|6|||
94414313|NCT02516410|323303233|FG000|Overall Study|Adverse Event|0|||
94414314|NCT02516410|323303234|FG001|Overall Study|Adverse Event|1|||
94414315|NCT02516410|323303233|FG000|Overall Study|Withdrawal by Subject|0|||
94414316|NCT02516410|323303234|FG001|Overall Study|Withdrawal by Subject|1|||
94414317|NCT03135899|323303240|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
94414318|NCT03135899|323303241|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
94414319|NCT03135899|323303242|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
94414320|NCT03135899|323303243|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
94414321|NCT03135899|323303244|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
94414322|NCT03135899|323303245|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
94414323|NCT03135899|323303246|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
94414324|NCT03135899|323303247|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
94414325|NCT03135899|323303240|FG000|Overall Study|Withdrawal by Subject|0|||
94414326|NCT03135899|323303241|FG001|Overall Study|Withdrawal by Subject|0|||
94414327|NCT03135899|323303242|FG002|Overall Study|Withdrawal by Subject|0|||
94414328|NCT03135899|323303243|FG003|Overall Study|Withdrawal by Subject|0|||
94414329|NCT03135899|323303244|FG004|Overall Study|Withdrawal by Subject|0|||
94414330|NCT03135899|323303245|FG005|Overall Study|Withdrawal by Subject|2|||
94414331|NCT03135899|323303246|FG006|Overall Study|Withdrawal by Subject|0|||
94414332|NCT03135899|323303247|FG007|Overall Study|Withdrawal by Subject|0|||
94414333|NCT04086641|323303248|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
94414334|NCT04086641|323303249|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
94414335|NCT00794417|323303250|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
94414336|NCT00794417|323303251|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
94414337|NCT00794417|323303252|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
94414338|NCT00794417|323303253|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
94414339|NCT00794417|323303250|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
94414340|NCT00794417|323303251|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
94414341|NCT00794417|323303252|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
94487514|NCT03054428|323577580|FG000|Overall Study|Physician Decision|0|||
94487515|NCT03054428|323577581|FG001|Overall Study|Physician Decision|1|||
94487516|NCT03054428|323577582|FG002|Overall Study|Physician Decision|1|||
94487517|NCT03054428|323577580|FG000|Overall Study|Lack of Efficacy|3|||
94487518|NCT03054428|323577581|FG001|Overall Study|Lack of Efficacy|1|||
94487519|NCT03054428|323577582|FG002|Overall Study|Lack of Efficacy|0|||
94487520|NCT03054428|323577580|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
94487521|NCT03054428|323577581|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
94487522|NCT03054428|323577582|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
94487523|NCT03054428|323577580|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
94487524|NCT03054428|323577581|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
94487525|NCT03054428|323577582|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
94487526|NCT03054428|323577580|FG000|Overall Study|Transitioned to OLE study|76|||
94414342|NCT00794417|323303253|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
94414343|NCT00794417|323303250|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
94414344|NCT00794417|323303251|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
94414345|NCT00794417|323303252|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
94414346|NCT00794417|323303253|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
94487527|NCT03054428|323577581|FG001|Overall Study|Transitioned to OLE study|76|||
94487528|NCT03054428|323577582|FG002|Overall Study|Transitioned to OLE study|73|||
94414347|NCT00794417|323303250|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
94414348|NCT00794417|323303251|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
94414349|NCT00794417|323303252|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
94414350|NCT00794417|323303253|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
94414351|NCT00794417|323303250|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
94414352|NCT00794417|323303251|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
94414353|NCT00794417|323303252|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
94414354|NCT00794417|323303253|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
94414355|NCT00794417|323303250|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
94414356|NCT00794417|323303251|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
94414357|NCT00794417|323303252|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
94414358|NCT00794417|323303253|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
94414359|NCT01213836|323303254|FG000|Period 1, First Intervention|Adverse Event|2|||
94414360|NCT01213836|323303255|FG001|Period 1, First Intervention|Adverse Event|1|||
94414361|NCT01213836|323303254|FG000|Period 1, First Intervention|Protocol Violation|0|||
94414362|NCT01213836|323303255|FG001|Period 1, First Intervention|Protocol Violation|1|||
94414363|NCT01213836|323303254|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
94414364|NCT01213836|323303255|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
94414365|NCT01559935|323303256|FG000|Car Phase|Toxicity|4|||
94414366|NCT01559935|323303256|FG000|Car Phase|Death|1|||
94414367|NCT01559935|323303256|FG000|Car Phase|Lack of Efficacy|2|||
94414368|NCT01559935|323303256|FG000|Car Phase|Lost to Follow-up|1|||
94414369|NCT01559935|323303256|FG000|Car Phase|Physician Decision|1|||
94414370|NCT01559935|323303256|FG000|Car Phase|Withdrawal by Subject|2|||
94414371|NCT01559935|323303256|FG000|Car Phase|Per protocol|1|||
94414372|NCT01559935|323303256|FG000|Car Phase|Insurance|1|||
94414373|NCT01559935|323303256|FG000|Car Phase|non-compliance|1|||
94414374|NCT01559935|323303256|FG000|BiRD Phase|Toxicity|1|||
94414375|NCT01559935|323303256|FG000|BiRD Phase|Lack of Efficacy|1|||
94414376|NCT01559935|323303256|FG000|BiRD Phase|Withdrawal by Subject|2|||
94414377|NCT01559935|323303256|FG000|Maintenance Phase|Remains on study|28|||
94414378|NCT01559935|323303256|FG000|Maintenance Phase|Toxicity|1|||
94414379|NCT01559935|323303256|FG000|Maintenance Phase|Lack of Efficacy|18|||
94414380|NCT01559935|323303256|FG000|Maintenance Phase|Withdrawal by Subject|5|||
94414381|NCT01559935|323303256|FG000|Maintenance Phase|Non-compliance|2|||
94414382|NCT01685073|323303257|FG000|Overall Study|Lost to Follow-up|6|||
94414383|NCT01685073|323303258|FG001|Overall Study|Lost to Follow-up|8|||
94414384|NCT01685073|323303257|FG000|Overall Study|Withdrawal by Subject|24|||
94414385|NCT01685073|323303258|FG001|Overall Study|Withdrawal by Subject|24|||
94414386|NCT01221090|323303262|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
94414387|NCT01221090|323303263|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
94414388|NCT01221090|323303264|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
94414389|NCT01221090|323303265|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
94414390|NCT01221090|323303262|FG000|Overall Study|Withdrawal by Subject|0|||
94414391|NCT01221090|323303263|FG001|Overall Study|Withdrawal by Subject|22|||
94414392|NCT01221090|323303264|FG002|Overall Study|Withdrawal by Subject|27|||
94414393|NCT01221090|323303265|FG003|Overall Study|Withdrawal by Subject|2|||
94414394|NCT00708708|323303266|FG000|Overall Study|Another therapy instead of Enbrel|141|||
94414395|NCT00708708|323303266|FG000|Overall Study|Lost to Follow-up|52|||
94414396|NCT00708708|323303266|FG000|Overall Study|Withdrawal by Subject|51|||
94414397|NCT00708708|323303266|FG000|Overall Study|Intolerance|42|||
94414398|NCT00708708|323303266|FG000|Overall Study|Another therapy along with Enbrel|15|||
94414399|NCT00708708|323303266|FG000|Overall Study|Other unspecified|11|||
94414400|NCT00708708|323303266|FG000|Overall Study|Good effectiveness|9|||
94414401|NCT00708708|323303266|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
94414402|NCT00708708|323303266|FG000|Overall Study|Administrative reasons|7|||
94414403|NCT00708708|323303266|FG000|Overall Study|Lack of effectiveness|4|||
94414404|NCT00708708|323303266|FG000|Overall Study|Lack of compliance|3|||
94414405|NCT00708708|323303266|FG000|Overall Study|Pregnancy|3|||
94414406|NCT00708708|323303266|FG000|Overall Study|Adverse Event|3|||
94414407|NCT00708708|323303266|FG000|Overall Study|Missing values|392|||
94414408|NCT00880087|323303272|FG000|Overall Study|Lost to Follow-up|0|||
94414409|NCT00880087|323303273|FG001|Overall Study|Lost to Follow-up|2|||
94414410|NCT01286558|323303280|FG000|Overall Study|Adverse Event|1|||
94414411|NCT01286558|323303281|FG001|Overall Study|Adverse Event|1|||
94414412|NCT01286558|323303280|FG000|Overall Study|Withdrawal by Subject|0|||
94414413|NCT01286558|323303281|FG001|Overall Study|Withdrawal by Subject|1|||
94414414|NCT00865098|323303282|FG000|Overall Study|Progressive disease|1|||
94414415|NCT00868296|323303283|FG000|Overall Study|Adverse Event|0|||
94414416|NCT00868296|323303284|FG001|Overall Study|Adverse Event|2|||
94414417|NCT00868296|323303283|FG000|Overall Study|Withdrawal by Subject|0|||
94414418|NCT00868296|323303284|FG001|Overall Study|Withdrawal by Subject|1|||
94414419|NCT00685802|323303288|FG000|Washout Period of 7 Days|Protocol Violation|2|||
94414420|NCT00685802|323303289|FG001|Washout Period of 7 Days|Protocol Violation|0|||
94414421|NCT00685802|323303288|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
94414422|NCT00685802|323303289|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
94414423|NCT01048502|323303290|FG000|Overall Study|Lost to Follow-up|2|||
94414424|NCT01048502|323303291|FG001|Overall Study|Lost to Follow-up|0|||
94414425|NCT01048502|323303292|FG002|Overall Study|Lost to Follow-up|0|||
94414426|NCT01048502|323303293|FG003|Overall Study|Lost to Follow-up|0|||
94414427|NCT01048502|323303290|FG000|Overall Study|Adverse Event|1|||
94414428|NCT01048502|323303291|FG001|Overall Study|Adverse Event|0|||
94414429|NCT01048502|323303292|FG002|Overall Study|Adverse Event|0|||
94414430|NCT01048502|323303293|FG003|Overall Study|Adverse Event|0|||
94414431|NCT01048502|323303290|FG000|Overall Study|Withdrawal by Subject|1|||
94414432|NCT01048502|323303291|FG001|Overall Study|Withdrawal by Subject|4|||
94414433|NCT01048502|323303292|FG002|Overall Study|Withdrawal by Subject|5|||
94414434|NCT01048502|323303293|FG003|Overall Study|Withdrawal by Subject|3|||
94414435|NCT01048502|323303290|FG000|Overall Study|Physician Decision|0|||
94414436|NCT01048502|323303291|FG001|Overall Study|Physician Decision|3|||
94414437|NCT01048502|323303292|FG002|Overall Study|Physician Decision|0|||
94414438|NCT01048502|323303293|FG003|Overall Study|Physician Decision|1|||
94414439|NCT03451006|323303294|FG000|Overall Study|Withdrawal by Subject|2|||
94414440|NCT03451006|323303295|FG001|Overall Study|Withdrawal by Subject|2|||
94414441|NCT00103038|323303298|FG000|Overall Study|Withdrawal by Subject|8|||
94414442|NCT00103038|323303298|FG000|Overall Study|Screen failure|3|||
94414443|NCT00103038|323303298|FG000|Overall Study|Death|1|||
94414444|NCT00103038|323303298|FG000|Overall Study|Physician Decision|1|||
94414445|NCT03649412|323303303|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
94414446|NCT03649412|323303304|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
94414447|NCT03649412|323303303|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
94414448|NCT03649412|323303304|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
94414449|NCT03649412|323303303|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
94414450|NCT03649412|323303304|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
94414451|NCT03649412|323303303|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
94414452|NCT03649412|323303304|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
94414453|NCT03649412|323303303|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
94414454|NCT03649412|323303304|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
94414455|NCT03649412|323303303|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
94414456|NCT03649412|323303304|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
94414457|NCT03827018|323303307|FG000|Overall Study|Adverse Event|1|||
94414458|NCT03827018|323303308|FG001|Overall Study|Adverse Event|0|||
94414459|NCT03827018|323303307|FG000|Overall Study|Withdrawal by Subject|2|||
94414460|NCT03827018|323303308|FG001|Overall Study|Withdrawal by Subject|2|||
94414461|NCT03827018|323303307|FG000|Overall Study|Lack of Efficacy|0|||
94414462|NCT03827018|323303308|FG001|Overall Study|Lack of Efficacy|1|||
94414463|NCT00268892|323303309|FG000|Overall Study|Adverse Event|14|||
94414464|NCT00268892|323303310|FG001|Overall Study|Adverse Event|17|||
94414465|NCT00268892|323303311|FG002|Overall Study|Adverse Event|20|||
94414466|NCT00268892|323303309|FG000|Overall Study|Lack of Efficacy|1|||
94414467|NCT00268892|323303310|FG001|Overall Study|Lack of Efficacy|3|||
94414468|NCT00268892|323303311|FG002|Overall Study|Lack of Efficacy|0|||
94414469|NCT00268892|323303309|FG000|Overall Study|Withdrawal by Subject|14|||
94414470|NCT00268892|323303310|FG001|Overall Study|Withdrawal by Subject|15|||
94414471|NCT00268892|323303311|FG002|Overall Study|Withdrawal by Subject|13|||
94414472|NCT00268892|323303309|FG000|Overall Study|Physician Decision|0|||
94414473|NCT00268892|323303310|FG001|Overall Study|Physician Decision|1|||
94414474|NCT00268892|323303311|FG002|Overall Study|Physician Decision|0|||
94414475|NCT00268892|323303309|FG000|Overall Study|Lost to Follow-up|5|||
94414476|NCT00268892|323303310|FG001|Overall Study|Lost to Follow-up|2|||
94414477|NCT00268892|323303311|FG002|Overall Study|Lost to Follow-up|4|||
94414478|NCT00268892|323303309|FG000|Overall Study|Protocol Violation|0|||
94414479|NCT00268892|323303310|FG001|Overall Study|Protocol Violation|1|||
94414480|NCT00268892|323303311|FG002|Overall Study|Protocol Violation|0|||
94414481|NCT00268892|323303309|FG000|Overall Study|Disease Progression|1|||
94414482|NCT00268892|323303310|FG001|Overall Study|Disease Progression|1|||
94414483|NCT00268892|323303311|FG002|Overall Study|Disease Progression|0|||
94414484|NCT00268892|323303309|FG000|Overall Study|Trial Site Closed|4|||
94414485|NCT00268892|323303310|FG001|Overall Study|Trial Site Closed|2|||
94414486|NCT00268892|323303311|FG002|Overall Study|Trial Site Closed|2|||
94414487|NCT01351350|323303317|FG000|Overall Study|Disease Progression|5|||
94414488|NCT01351350|323303318|FG001|Overall Study|Disease Progression|13|||
94414489|NCT01351350|323303319|FG002|Overall Study|Disease Progression|6|||
94414490|NCT01351350|323303320|FG003|Overall Study|Disease Progression|8|||
94414491|NCT01351350|323303321|FG004|Overall Study|Disease Progression|5|||
94414492|NCT01351350|323303317|FG000|Overall Study|Adverse Event|1|||
94414493|NCT01351350|323303318|FG001|Overall Study|Adverse Event|10|||
94414494|NCT01351350|323303319|FG002|Overall Study|Adverse Event|1|||
94414495|NCT01351350|323303320|FG003|Overall Study|Adverse Event|2|||
94414496|NCT01351350|323303321|FG004|Overall Study|Adverse Event|0|||
94414497|NCT01351350|323303317|FG000|Overall Study|Participant Decision|2|||
94414498|NCT01351350|323303318|FG001|Overall Study|Participant Decision|6|||
94414499|NCT01351350|323303319|FG002|Overall Study|Participant Decision|3|||
94414500|NCT01351350|323303320|FG003|Overall Study|Participant Decision|3|||
94414501|NCT01351350|323303321|FG004|Overall Study|Participant Decision|2|||
94414502|NCT01351350|323303317|FG000|Overall Study|Enrolled but not Treated|0|||
94414503|NCT01351350|323303318|FG001|Overall Study|Enrolled but not Treated|0|||
94414504|NCT01351350|323303319|FG002|Overall Study|Enrolled but not Treated|1|||
94414505|NCT01351350|323303320|FG003|Overall Study|Enrolled but not Treated|0|||
94414506|NCT01351350|323303321|FG004|Overall Study|Enrolled but not Treated|0|||
94414507|NCT00873119|323303323|FG000|Overall Study|Patient request|4|||
94414508|NCT00873119|323303324|FG001|Overall Study|Patient request|2|||
94414509|NCT00873119|323303323|FG000|Overall Study|Adverse Event|8|||
94414510|NCT00873119|323303324|FG001|Overall Study|Adverse Event|0|||
94414511|NCT00873119|323303323|FG000|Overall Study|Progressive disease|26|||
94414512|NCT00873119|323303324|FG001|Overall Study|Progressive disease|18|||
94414513|NCT00873119|323303323|FG000|Overall Study|Death|2|||
94414514|NCT00873119|323303324|FG001|Overall Study|Death|1|||
94414515|NCT00873119|323303323|FG000|Overall Study|Other|2|||
94414516|NCT00873119|323303324|FG001|Overall Study|Other|5|||
94414517|NCT00873119|323303323|FG000|Overall Study|Not treated|2|||
94414518|NCT00873119|323303324|FG001|Overall Study|Not treated|0|||
94414519|NCT00350402|323303325|FG000|Overall Study|Lost to Follow-up|1|||
94414520|NCT00350402|323303326|FG001|Overall Study|Lost to Follow-up|1|||
94414521|NCT04798482|323303328|FG000|Overall Study|Physician Decision|1|||
94414522|NCT04798482|323303328|FG000|Overall Study|Lost eligibility|1|||
94414523|NCT00303667|323303329|FG000|Overall Study|Death|0|||
94414524|NCT00303667|323303330|FG001|Overall Study|Death|4|||
94414525|NCT01807117|323303332|FG000|Overall Study|Physician Decision|2|||
94414526|NCT01807117|323303332|FG000|Overall Study|Disease diagnosis not a study disease|1|||
94414527|NCT01103479|323303333|FG000|Overall Study|Up to date with CRC screening|1|||
94414528|NCT01103479|323303334|FG001|Overall Study|Up to date with CRC screening|9|||
94414529|NCT01103479|323303335|FG002|Overall Study|Up to date with CRC screening|12|||
94414530|NCT01103479|323303333|FG000|Overall Study|Family history of CRC|1|||
94414531|NCT01103479|323303334|FG001|Overall Study|Family history of CRC|0|||
94414532|NCT01103479|323303335|FG002|Overall Study|Family history of CRC|2|||
94414533|NCT01103479|323303333|FG000|Overall Study|Active cancer|1|||
94414534|NCT01103479|323303334|FG001|Overall Study|Active cancer|0|||
94414535|NCT01103479|323303335|FG002|Overall Study|Active cancer|0|||
94414536|NCT01103479|323303333|FG000|Overall Study|Saw non-study physician|2|||
94414537|NCT01103479|323303334|FG001|Overall Study|Saw non-study physician|0|||
94414538|NCT01103479|323303335|FG002|Overall Study|Saw non-study physician|0|||
94414539|NCT00834899|323303336|FG000|Overall Study|Withdrawal by Subject|1|||
94414540|NCT00834899|323303337|FG001|Overall Study|Withdrawal by Subject|1|||
94414541|NCT01610063|323303341|FG000|Overall Study|Lost to Follow-up|42|||
94414542|NCT01610063|323303342|FG001|Overall Study|Lost to Follow-up|20|||
94414543|NCT01855048|323303348|FG000|Overall Study|Withdrawal by Subject|0|||
94414544|NCT01855048|323303349|FG001|Overall Study|Withdrawal by Subject|1|||
94414545|NCT01855048|323303350|FG002|Overall Study|Withdrawal by Subject|0|||
94414546|NCT01855048|323303351|FG003|Overall Study|Withdrawal by Subject|0|||
94414547|NCT01855048|323303352|FG004|Overall Study|Withdrawal by Subject|1|||
94414548|NCT01855048|323303353|FG005|Overall Study|Withdrawal by Subject|0|||
94414549|NCT02691741|323303354|FG000|Overall Study|Adverse Event|0|||
94414550|NCT02691741|323303355|FG001|Overall Study|Adverse Event|2|||
94414551|NCT02691741|323303354|FG000|Overall Study|Lost to Follow-up|1|||
94414552|NCT02691741|323303355|FG001|Overall Study|Lost to Follow-up|0|||
94414553|NCT02691741|323303354|FG000|Overall Study|Physician Decision|0|||
94414554|NCT02691741|323303355|FG001|Overall Study|Physician Decision|1|||
94414555|NCT02691741|323303354|FG000|Overall Study|Withdrawal by Subject|0|||
94414556|NCT02691741|323303355|FG001|Overall Study|Withdrawal by Subject|4|||
94414557|NCT02181296|323303356|FG000|Overall Study|Lost to Follow-up|7|||
94414558|NCT02181296|323303357|FG001|Overall Study|Lost to Follow-up|6|||
94414559|NCT02676284|323304823|FG000|Overall Study|Withdrawal by Subject|1|||
94414560|NCT02148913|323304825|FG000|Overall Study|Death|0|||
94414561|NCT02148913|323304826|FG001|Overall Study|Death|1|||
94414562|NCT02148913|323304827|FG002|Overall Study|Death|0|||
94414563|NCT02148913|323304828|FG003|Overall Study|Death|0|||
94414564|NCT01272921|323304829|FG000|Overall Study|Protocol Violation|2|||
94414565|NCT01272921|323304830|FG001|Overall Study|Protocol Violation|1|||
94414566|NCT01132664|323304831|FG000|Phase lb|Adverse Event|0|||
94414567|NCT01132664|323304832|FG001|Phase lb|Adverse Event|1|||
94414568|NCT01132664|323304833|FG002|Phase lb|Adverse Event|0|||
94414569|NCT01132664|323304834|FG003|Phase lb|Adverse Event|0|||
94414570|NCT01132664|323304835|FG004|Phase lb|Adverse Event|0|||
94414571|NCT01132664|323304831|FG000|Phase lb|Withdrawal by Subject|1|||
94414572|NCT01132664|323304832|FG001|Phase lb|Withdrawal by Subject|2|||
94414573|NCT01132664|323304833|FG002|Phase lb|Withdrawal by Subject|0|||
94414574|NCT01132664|323304834|FG003|Phase lb|Withdrawal by Subject|0|||
94414575|NCT01132664|323304835|FG004|Phase lb|Withdrawal by Subject|0|||
94414576|NCT01132664|323304831|FG000|Phase lb|Disease Progression|4|||
94414577|NCT01132664|323304832|FG001|Phase lb|Disease Progression|9|||
94414578|NCT01132664|323304833|FG002|Phase lb|Disease Progression|0|||
94414579|NCT01132664|323304834|FG003|Phase lb|Disease Progression|0|||
94414580|NCT01132664|323304835|FG004|Phase lb|Disease Progression|0|||
94414581|NCT01132664|323304831|FG000|Phase ll|Death|0|||
94414582|NCT01132664|323304832|FG001|Phase ll|Death|0|||
94414583|NCT01132664|323304833|FG002|Phase ll|Death|2|||
94414584|NCT01132664|323304834|FG003|Phase ll|Death|0|||
94414585|NCT01132664|323304835|FG004|Phase ll|Death|0|||
94414586|NCT01132664|323304831|FG000|Phase ll|Adverse Event|0|||
94414587|NCT01132664|323304832|FG001|Phase ll|Adverse Event|0|||
94414588|NCT01132664|323304833|FG002|Phase ll|Adverse Event|10|||
94414589|NCT01132664|323304834|FG003|Phase ll|Adverse Event|0|||
94414590|NCT01132664|323304835|FG004|Phase ll|Adverse Event|0|||
94414591|NCT01132664|323304831|FG000|Phase ll|Withdrawal by Subject|0|||
94414592|NCT01132664|323304832|FG001|Phase ll|Withdrawal by Subject|0|||
94414593|NCT01132664|323304833|FG002|Phase ll|Withdrawal by Subject|3|||
94414594|NCT01132664|323304834|FG003|Phase ll|Withdrawal by Subject|0|||
94414595|NCT01132664|323304835|FG004|Phase ll|Withdrawal by Subject|0|||
94414596|NCT01132664|323304831|FG000|Phase ll|Disease progression|0|||
94414597|NCT01132664|323304832|FG001|Phase ll|Disease progression|0|||
94414598|NCT01132664|323304833|FG002|Phase ll|Disease progression|35|||
94414599|NCT01132664|323304834|FG003|Phase ll|Disease progression|0|||
94414600|NCT01132664|323304835|FG004|Phase ll|Disease progression|0|||
94414601|NCT01132664|323304831|FG000|BM Cohort|Disease progression|0|||
94414602|NCT01132664|323304832|FG001|BM Cohort|Disease progression|0|||
94414603|NCT01132664|323304833|FG002|BM Cohort|Disease progression|0|||
94414604|NCT01132664|323304834|FG003|BM Cohort|Disease progression|3|||
94414605|NCT01132664|323304835|FG004|BM Cohort|Disease progression|4|||
94414606|NCT01132664|323304831|FG000|BM Cohort|Adverse Event|0|||
94414607|NCT01132664|323304832|FG001|BM Cohort|Adverse Event|0|||
94414608|NCT01132664|323304833|FG002|BM Cohort|Adverse Event|0|||
94414609|NCT01132664|323304834|FG003|BM Cohort|Adverse Event|0|||
94414610|NCT01132664|323304835|FG004|BM Cohort|Adverse Event|1|||
94414611|NCT01132664|323304831|FG000|BM Cohort|Withdrawal by Subject|0|||
94414612|NCT01132664|323304832|FG001|BM Cohort|Withdrawal by Subject|0|||
94414613|NCT01132664|323304833|FG002|BM Cohort|Withdrawal by Subject|0|||
94414614|NCT01132664|323304834|FG003|BM Cohort|Withdrawal by Subject|0|||
94414615|NCT01132664|323304835|FG004|BM Cohort|Withdrawal by Subject|1|||
94414616|NCT01360866|323304836|FG000|Overall Study|Lost to Follow-up|11|||
94414617|NCT01360866|323304837|FG001|Overall Study|Lost to Follow-up|28|||
94414618|NCT01360866|323304838|FG002|Overall Study|Lost to Follow-up|41|||
94414619|NCT01360866|323304839|FG003|Overall Study|Lost to Follow-up|0|||
94414620|NCT01360866|323304836|FG000|Overall Study|Adverse Event|56|||
94414621|NCT01360866|323304837|FG001|Overall Study|Adverse Event|61|||
94414622|NCT01360866|323304838|FG002|Overall Study|Adverse Event|134|||
94414623|NCT01360866|323304839|FG003|Overall Study|Adverse Event|6|||
94414624|NCT01360866|323304836|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
94414625|NCT01360866|323304837|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
94414626|NCT01360866|323304838|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
94414627|NCT01360866|323304839|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
94414628|NCT01360866|323304836|FG000|Overall Study|Withdrawn by Investigator|9|||
94414629|NCT01360866|323304837|FG001|Overall Study|Withdrawn by Investigator|8|||
94414630|NCT01360866|323304838|FG002|Overall Study|Withdrawn by Investigator|31|||
94414631|NCT01360866|323304839|FG003|Overall Study|Withdrawn by Investigator|2|||
94414632|NCT01360866|323304836|FG000|Overall Study|Withdrawal by participant|79|||
94414633|NCT01360866|323304837|FG001|Overall Study|Withdrawal by participant|89|||
94414634|NCT01360866|323304838|FG002|Overall Study|Withdrawal by participant|168|||
94414635|NCT01360866|323304839|FG003|Overall Study|Withdrawal by participant|8|||
94414636|NCT01360866|323304836|FG000|Overall Study|Protocol Deviation|25|||
94414637|NCT01360866|323304837|FG001|Overall Study|Protocol Deviation|33|||
94414638|NCT01360866|323304838|FG002|Overall Study|Protocol Deviation|61|||
94414639|NCT01360866|323304839|FG003|Overall Study|Protocol Deviation|2|||
94414640|NCT01360866|323304836|FG000|Overall Study|Lack of Efficacy|30|||
94414641|NCT01360866|323304837|FG001|Overall Study|Lack of Efficacy|40|||
94414642|NCT01360866|323304838|FG002|Overall Study|Lack of Efficacy|30|||
94414643|NCT01360866|323304839|FG003|Overall Study|Lack of Efficacy|4|||
94414644|NCT00099268|323304840|FG000|Overall Study|Withdrawal by Subject|46|||
94414645|NCT00099268|323304841|FG001|Overall Study|Withdrawal by Subject|28|||
94414646|NCT00099268|323304840|FG000|Overall Study|Adverse Event|19|||
94414647|NCT00099268|323304841|FG001|Overall Study|Adverse Event|19|||
94414648|NCT00099268|323304840|FG000|Overall Study|Protocol Violation|9|||
94414649|NCT00099268|323304841|FG001|Overall Study|Protocol Violation|8|||
94414650|NCT00099268|323304840|FG000|Overall Study|Lost to Follow-up|6|||
94414651|NCT00099268|323304841|FG001|Overall Study|Lost to Follow-up|4|||
94414652|NCT00099268|323304840|FG000|Overall Study|Lack of Efficacy|5|||
94414653|NCT00099268|323304841|FG001|Overall Study|Lack of Efficacy|18|||
94414654|NCT00099268|323304840|FG000|Overall Study|Administrative problems|4|||
94414655|NCT00099268|323304841|FG001|Overall Study|Administrative problems|4|||
94414656|NCT00099268|323304840|FG000|Overall Study|Death|3|||
94414657|NCT00099268|323304841|FG001|Overall Study|Death|1|||
94414658|NCT05016622|323304842|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
94414659|NCT05016622|323304842|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
94414660|NCT03197558|323304843|FG000|Overall Study|Tubes not placed|1|||
94414661|NCT00918463|323304853|FG000|Overall Study|Death|1|||
94414662|NCT00918463|323304853|FG000|Overall Study|Lack of Efficacy|1|||
94414663|NCT02954159|323304855|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
94414664|NCT02954159|323304856|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
94414665|NCT02954159|323304855|FG000|Overall Study|Withdrawal by Subject|0|||
94414666|NCT02954159|323304856|FG001|Overall Study|Withdrawal by Subject|1|||
94414667|NCT03463993|323304860|FG000|Overall Study|Lost to Follow-up|7|||
94414668|NCT03463993|323304861|FG001|Overall Study|Lost to Follow-up|8|||
94414669|NCT03463993|323304860|FG000|Overall Study|Withdrawal by Subject|2|||
94414670|NCT03463993|323304861|FG001|Overall Study|Withdrawal by Subject|0|||
94414671|NCT03463993|323304860|FG000|Overall Study|Protocol Violation|4|||
94414672|NCT03463993|323304861|FG001|Overall Study|Protocol Violation|1|||
94414673|NCT03463993|323304860|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
94414674|NCT03463993|323304861|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
94414675|NCT03463993|323304860|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
94414676|NCT03463993|323304861|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
94414677|NCT02100319|323304862|FG000|Overall Study|Case Report Forms Uncollected|11|||
94414678|NCT02100319|323304862|FG000|Overall Study|Protocol Deviation|5|||
94414679|NCT02370914|323304863|FG000|Overall Study|Protocol Violation|2|||
94414680|NCT01557842|323304864|FG000|Overall Study|Lost to Follow-up|0|||
94414681|NCT01557842|323304865|FG001|Overall Study|Lost to Follow-up|1|||
94414682|NCT01557842|323304864|FG000|Overall Study|Death|1|||
94414683|NCT01557842|323304865|FG001|Overall Study|Death|0|||
94414684|NCT01557842|323304864|FG000|Overall Study|Lack of Efficacy|0|||
94414685|NCT01557842|323304865|FG001|Overall Study|Lack of Efficacy|1|||
94414686|NCT01557842|323304864|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
94414687|NCT01557842|323304865|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
94414688|NCT01557842|323304864|FG000|Overall Study|Study Terminated by Sponsor|3|||
94414689|NCT01557842|323304865|FG001|Overall Study|Study Terminated by Sponsor|4|||
94414690|NCT01557842|323304864|FG000|Overall Study|Not Ablated|2|||
94414691|NCT01557842|323304865|FG001|Overall Study|Not Ablated|0|||
94414692|NCT00754442|323304866|FG000|Overall Study|Withdrawal by Subject|5|||
94414693|NCT00754442|323304867|FG001|Overall Study|Withdrawal by Subject|3|||
94414694|NCT03005067|323304868|FG000|Overall Study|Withdrawal by Subject|3|||
94414695|NCT03005067|323304869|FG001|Overall Study|Withdrawal by Subject|2|||
94414696|NCT03005067|323304868|FG000|Overall Study|Adverse Event|4|||
94414697|NCT03005067|323304869|FG001|Overall Study|Adverse Event|3|||
94414698|NCT03005067|323304868|FG000|Overall Study|Other (reason not specified)|3|||
94414699|NCT03005067|323304869|FG001|Overall Study|Other (reason not specified)|1|||
94414700|NCT03005067|323304868|FG000|Overall Study|Protocol Violation|0|||
94414701|NCT03005067|323304869|FG001|Overall Study|Protocol Violation|1|||
94414702|NCT00775606|323304876|FG000|Overall Study|Study sponsor terminated funding|3|||
94414703|NCT00775606|323304877|FG001|Overall Study|Study sponsor terminated funding|0|||
94414704|NCT00484419|323304880|FG000|Overall Study|Adverse Event|3|||
94414705|NCT00484419|323304881|FG001|Overall Study|Adverse Event|0|||
94414706|NCT00484419|323304882|FG002|Overall Study|Adverse Event|0|||
94414707|NCT00484419|323304880|FG000|Overall Study|Lost to Follow-up|1|||
94414708|NCT00484419|323304881|FG001|Overall Study|Lost to Follow-up|0|||
94414709|NCT00484419|323304882|FG002|Overall Study|Lost to Follow-up|2|||
94414710|NCT00484419|323304880|FG000|Overall Study|Withdrawal by Subject|3|||
94414711|NCT00484419|323304881|FG001|Overall Study|Withdrawal by Subject|1|||
94414712|NCT00484419|323304882|FG002|Overall Study|Withdrawal by Subject|1|||
94414713|NCT00484419|323304880|FG000|Overall Study|subject met discontinuation criteria|2|||
94414714|NCT00484419|323304881|FG001|Overall Study|subject met discontinuation criteria|2|||
94414715|NCT00484419|323304882|FG002|Overall Study|subject met discontinuation criteria|4|||
94414716|NCT00484419|323304880|FG000|Overall Study|required restricted medication|1|||
94414717|NCT00484419|323304881|FG001|Overall Study|required restricted medication|0|||
94414718|NCT00484419|323304882|FG002|Overall Study|required restricted medication|1|||
94414719|NCT00484419|323304880|FG000|Overall Study|Physician Decision|1|||
94414720|NCT00484419|323304881|FG001|Overall Study|Physician Decision|1|||
94414721|NCT00484419|323304882|FG002|Overall Study|Physician Decision|1|||
94414722|NCT00484419|323304880|FG000|Overall Study|subject unable to receive medication|1|||
94414723|NCT00484419|323304881|FG001|Overall Study|subject unable to receive medication|0|||
94414724|NCT00484419|323304882|FG002|Overall Study|subject unable to receive medication|0|||
94414725|NCT00484419|323304880|FG000|Overall Study|subject relocated|0|||
94414726|NCT00484419|323304881|FG001|Overall Study|subject relocated|1|||
94414727|NCT00484419|323304882|FG002|Overall Study|subject relocated|0|||
94414728|NCT00484419|323304880|FG000|Overall Study|sponsor decision, randomized in error|0|||
94414729|NCT00484419|323304881|FG001|Overall Study|sponsor decision, randomized in error|0|||
94414730|NCT00484419|323304882|FG002|Overall Study|sponsor decision, randomized in error|2|||
94414731|NCT01553747|323304885|FG000|Overall Study|Protocol Violation|0|||
94414732|NCT01553747|323304886|FG001|Overall Study|Protocol Violation|2|||
94414733|NCT01553747|323304887|FG002|Overall Study|Protocol Violation|0|||
94414734|NCT01553747|323304885|FG000|Overall Study|Voluntarily withdrew|70|||
94414735|NCT01553747|323304886|FG001|Overall Study|Voluntarily withdrew|66|||
94414736|NCT01553747|323304887|FG002|Overall Study|Voluntarily withdrew|74|||
94414737|NCT01553747|323304885|FG000|Overall Study|Adverse event or SAE|32|||
94414738|NCT01553747|323304886|FG001|Overall Study|Adverse event or SAE|28|||
94414739|NCT01553747|323304887|FG002|Overall Study|Adverse event or SAE|19|||
94414740|NCT01553747|323304885|FG000|Overall Study|Physician decision: other|10|||
94414741|NCT01553747|323304886|FG001|Overall Study|Physician decision: other|8|||
94414742|NCT01553747|323304887|FG002|Overall Study|Physician decision: other|7|||
94414743|NCT01553747|323304885|FG000|Overall Study|Lost to Follow-up|11|||
94414744|NCT01553747|323304886|FG001|Overall Study|Lost to Follow-up|5|||
94414745|NCT01553747|323304887|FG002|Overall Study|Lost to Follow-up|6|||
94414746|NCT01553747|323304885|FG000|Overall Study|Sponsor decision, specify|7|||
94414747|NCT01553747|323304886|FG001|Overall Study|Sponsor decision, specify|5|||
94414748|NCT01553747|323304887|FG002|Overall Study|Sponsor decision, specify|0|||
94414749|NCT01553747|323304885|FG000|Overall Study|Physician decision: lack of efficacy|1|||
94414750|NCT01553747|323304886|FG001|Overall Study|Physician decision: lack of efficacy|5|||
94414751|NCT01553747|323304887|FG002|Overall Study|Physician decision: lack of efficacy|3|||
94414752|NCT00355472|323304888|FG000|Overall Study|Physician Decision|1|||
94414753|NCT00865514|323304893|FG000|Overall Study|Infusion cost exceeded funding|2|||
94414754|NCT02865395|323304894|FG000|Overall Study|Physician Decision|6|||
94414755|NCT02865395|323304895|FG001|Overall Study|Physician Decision|10|||
94414756|NCT02865395|323304896|FG002|Overall Study|Physician Decision|7|||
94414757|NCT02075606|323304897|FG000|Overall Study|Adverse Event|5|||
94414758|NCT02075606|323304897|FG000|Overall Study|Withdrawal by Subject|1|||
94414759|NCT02075606|323304897|FG000|Overall Study|Death|1|||
94414760|NCT02075606|323304897|FG000|Overall Study|Investigator's decision|1|||
94414761|NCT02075606|323304897|FG000|Overall Study|Symptom management|1|||
94414762|NCT02075606|323304897|FG000|Overall Study|Increasing Symptoms|1|||
94414763|NCT01144403|323304898|FG000|Overall Study|Lost to Follow-up|3|||
94414764|NCT01144403|323304898|FG000|Overall Study|Death|1|||
94414765|NCT01144403|323304898|FG000|Overall Study|Adverse Event|1|||
94414766|NCT03176784|323304899|FG000|Overall Study|Lost to Follow-up|77|||
94414767|NCT03176784|323304900|FG001|Overall Study|Lost to Follow-up|79|||
94414768|NCT03176784|323304901|FG002|Overall Study|Lost to Follow-up|79|||
94414769|NCT03176784|323304902|FG003|Overall Study|Lost to Follow-up|49|||
94414770|NCT03176784|323304899|FG000|Overall Study|Withdrawal by Subject|28|||
94414771|NCT03176784|323304900|FG001|Overall Study|Withdrawal by Subject|34|||
94414772|NCT03176784|323304901|FG002|Overall Study|Withdrawal by Subject|34|||
94414773|NCT03176784|323304902|FG003|Overall Study|Withdrawal by Subject|21|||
94414774|NCT02654587|323304904|FG000|Overall Study|patient alive at end of study|22|||
94414775|NCT02654587|323304905|FG001|Overall Study|patient alive at end of study|8|||
94414776|NCT02654587|323304904|FG000|Overall Study|Withdrawal by Subject|1|||
94414777|NCT02654587|323304905|FG001|Overall Study|Withdrawal by Subject|7|||
94414778|NCT00518882|323304910|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
94414779|NCT00518882|323304911|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
94414780|NCT00518882|323304910|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
94414781|NCT00518882|323304911|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
94414782|NCT00518882|323304910|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
94414783|NCT00518882|323304911|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
94414784|NCT00518882|323304910|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
94414785|NCT00518882|323304911|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
94414786|NCT00518882|323304910|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
94414787|NCT00518882|323304911|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
94414788|NCT00518882|323304910|FG000|Double-Blind, Week 0-26|Subject decision|1|||
94414789|NCT00518882|323304911|FG001|Double-Blind, Week 0-26|Subject decision|1|||
94414790|NCT00518882|323304910|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
94414791|NCT00518882|323304911|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
94414792|NCT00518882|323304910|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
94414793|NCT00518882|323304911|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
94414794|NCT00518882|323304910|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
94414795|NCT00518882|323304911|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
94414796|NCT00518882|323304910|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
94414797|NCT00518882|323304911|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
94414798|NCT00518882|323304910|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
94414799|NCT00518882|323304911|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
94414800|NCT00518882|323304910|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
94487529|NCT03054428|323577580|FG000|Overall Study|Withdrawal by Subject|3|||
94414801|NCT00518882|323304911|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
94414802|NCT00518882|323304910|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
94414803|NCT00518882|323304911|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
94414804|NCT00518882|323304910|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
94414805|NCT00518882|323304911|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
94414806|NCT00518882|323304910|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
94414807|NCT00518882|323304911|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
94414808|NCT00518882|323304910|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
94414809|NCT00518882|323304911|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
94414810|NCT00518882|323304910|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
94414811|NCT00518882|323304911|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
94414812|NCT00518882|323304910|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
94414813|NCT00518882|323304911|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
94414814|NCT00518882|323304910|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
94414815|NCT00518882|323304911|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
94414816|NCT00518882|323304910|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
94414817|NCT00518882|323304911|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
94414818|NCT00518882|323304910|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
94414819|NCT00518882|323304911|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
94414820|NCT00518882|323304910|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
94414821|NCT00518882|323304911|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
94414822|NCT00518882|323304910|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
94414823|NCT00518882|323304911|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
94414824|NCT00518882|323304910|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
94414825|NCT00518882|323304911|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
94414826|NCT04349631|323304922|FG000|Overall Study|Lost to Follow-up|3|||
94414827|NCT04349631|323304922|FG000|Overall Study|Withdrawal by Subject|7|||
94414828|NCT01258101|323304923|FG000|Overall Study|Adverse Event|5|||
94414829|NCT01258101|323304924|FG001|Overall Study|Adverse Event|6|||
94414830|NCT01258101|323304925|FG002|Overall Study|Adverse Event|0|||
94414831|NCT01258101|323304926|FG003|Overall Study|Adverse Event|0|||
94414832|NCT01258101|323304923|FG000|Overall Study|Extra exclusion criterion amended|2|||
94414833|NCT01258101|323304924|FG001|Overall Study|Extra exclusion criterion amended|1|||
94414834|NCT01258101|323304925|FG002|Overall Study|Extra exclusion criterion amended|1|||
94414835|NCT01258101|323304926|FG003|Overall Study|Extra exclusion criterion amended|1|||
94414836|NCT01258101|323304923|FG000|Overall Study|Informed consent has been withdrawn|2|||
94414837|NCT01258101|323304924|FG001|Overall Study|Informed consent has been withdrawn|2|||
94414838|NCT01258101|323304925|FG002|Overall Study|Informed consent has been withdrawn|1|||
94414839|NCT01258101|323304926|FG003|Overall Study|Informed consent has been withdrawn|1|||
94414840|NCT01258101|323304923|FG000|Overall Study|Patient is not able to attend visits|8|||
94414841|NCT01258101|323304924|FG001|Overall Study|Patient is not able to attend visits|9|||
94414842|NCT01258101|323304925|FG002|Overall Study|Patient is not able to attend visits|7|||
94414843|NCT01258101|323304926|FG003|Overall Study|Patient is not able to attend visits|6|||
94414844|NCT01258101|323304923|FG000|Overall Study|Patient´s compliance|4|||
94414845|NCT01258101|323304924|FG001|Overall Study|Patient´s compliance|3|||
94414846|NCT01258101|323304925|FG002|Overall Study|Patient´s compliance|1|||
94414847|NCT01258101|323304926|FG003|Overall Study|Patient´s compliance|2|||
94414848|NCT01258101|323304923|FG000|Overall Study|Lost to Follow-up|5|||
94414849|NCT01258101|323304924|FG001|Overall Study|Lost to Follow-up|5|||
94414850|NCT01258101|323304925|FG002|Overall Study|Lost to Follow-up|0|||
94414851|NCT01258101|323304926|FG003|Overall Study|Lost to Follow-up|6|||
94414852|NCT01258101|323304923|FG000|Overall Study|PCR positive at week 24|0|||
94414853|NCT01258101|323304924|FG001|Overall Study|PCR positive at week 24|0|||
94414854|NCT01258101|323304925|FG002|Overall Study|PCR positive at week 24|0|||
94414855|NCT01258101|323304926|FG003|Overall Study|PCR positive at week 24|1|||
94414856|NCT01258101|323304923|FG000|Overall Study|Other reason|7|||
94414857|NCT01258101|323304924|FG001|Overall Study|Other reason|8|||
94414858|NCT01258101|323304925|FG002|Overall Study|Other reason|1|||
94414859|NCT01258101|323304926|FG003|Overall Study|Other reason|8|||
94414860|NCT01534637|323304928|FG000|Overall Study|Physician Decision|3|||
94414861|NCT01534637|323304928|FG000|Overall Study|Lack of Efficacy|3|||
94414862|NCT01534637|323304928|FG000|Overall Study|Withdrawal by Subject|1|||
94414863|NCT01534637|323304928|FG000|Overall Study|Adverse Event|1|||
94414864|NCT01534637|323304928|FG000|Overall Study|Liver Mets before treatment|1|||
94414865|NCT04965389|323304929|FG000|Overall Study|Other reasons|1|||
94487530|NCT03054428|323577581|FG001|Overall Study|Withdrawal by Subject|2|||
94487531|NCT03054428|323577582|FG002|Overall Study|Withdrawal by Subject|3|||
94487532|NCT03054428|323577580|FG000|Overall Study|Lost to Follow-up|0|||
94414866|NCT04965389|323304930|FG001|Overall Study|Other reasons|0|||
94414867|NCT04965389|323304931|FG002|Overall Study|Other reasons|0|||
94414868|NCT04965389|323304932|FG003|Overall Study|Other reasons|0|||
94414869|NCT04965389|323304929|FG000|Overall Study|Participant withdrew consent|0|||
94414870|NCT04965389|323304930|FG001|Overall Study|Participant withdrew consent|1|||
94414871|NCT04965389|323304931|FG002|Overall Study|Participant withdrew consent|0|||
94414872|NCT04965389|323304932|FG003|Overall Study|Participant withdrew consent|0|||
94414873|NCT04965389|323304929|FG000|Overall Study|Poor/Non-compliance|0|||
94487533|NCT03054428|323577581|FG001|Overall Study|Lost to Follow-up|0|||
94487534|NCT03054428|323577582|FG002|Overall Study|Lost to Follow-up|1|||
94487535|NCT04356937|323577583|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
94487536|NCT04356937|323577584|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
94487537|NCT01265498|323577585|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
94487538|NCT01265498|323577586|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
94487539|NCT02097823|323577591|FG000|Overall Study|Withdrawal by Subject|1|||
94487540|NCT02097823|323577592|FG001|Overall Study|Withdrawal by Subject|1|||
94487541|NCT02074514|323577594|FG000|Overall Study|Lack of Efficacy|3|||
94487542|NCT02074514|323577595|FG001|Overall Study|Lack of Efficacy|2|||
94487543|NCT02074514|323577594|FG000|Overall Study|Lost to Follow-up|0|||
94487544|NCT02074514|323577595|FG001|Overall Study|Lost to Follow-up|1|||
94487545|NCT02074514|323577594|FG000|Overall Study|Withdrew Consent|0|||
94487546|NCT02074514|323577595|FG001|Overall Study|Withdrew Consent|1|||
94487547|NCT01093846|323577599|FG000|Overall Study|Adverse Event|0|||
94487548|NCT01093846|323577600|FG001|Overall Study|Adverse Event|0|||
94487549|NCT01093846|323577601|FG002|Overall Study|Adverse Event|1|||
94487550|NCT01093846|323577599|FG000|Overall Study|Lack of Efficacy|0|||
94487551|NCT01093846|323577600|FG001|Overall Study|Lack of Efficacy|0|||
94414874|NCT04965389|323304930|FG001|Overall Study|Poor/Non-compliance|1|||
94414875|NCT04965389|323304931|FG002|Overall Study|Poor/Non-compliance|0|||
94414876|NCT04965389|323304932|FG003|Overall Study|Poor/Non-compliance|0|||
94414877|NCT02610816|323304940|FG000|Phase 1|Withdrawal by Subject|2|||
94414878|NCT02610816|323304941|FG001|Phase 1|Withdrawal by Subject|6|||
94414879|NCT02610816|323304942|FG002|Phase 1|Withdrawal by Subject|0|||
94414880|NCT02610816|323304943|FG003|Phase 1|Withdrawal by Subject|0|||
94414881|NCT02610816|323304940|FG000|Phase 1|Lost to Follow-up|2|||
94414882|NCT02610816|323304941|FG001|Phase 1|Lost to Follow-up|1|||
94414883|NCT02610816|323304942|FG002|Phase 1|Lost to Follow-up|0|||
94414884|NCT02610816|323304943|FG003|Phase 1|Lost to Follow-up|0|||
94414885|NCT02610816|323304940|FG000|Phase 1|Physician Decision|0|||
94414886|NCT02610816|323304941|FG001|Phase 1|Physician Decision|1|||
94414887|NCT02610816|323304942|FG002|Phase 1|Physician Decision|0|||
94414888|NCT02610816|323304943|FG003|Phase 1|Physician Decision|0|||
94414889|NCT02610816|323304940|FG000|Phase 2|Withdrawal by Subject|0|||
94414890|NCT02610816|323304941|FG001|Phase 2|Withdrawal by Subject|0|||
94414891|NCT02610816|323304942|FG002|Phase 2|Withdrawal by Subject|9|||
94414892|NCT02610816|323304943|FG003|Phase 2|Withdrawal by Subject|3|||
94414893|NCT02610816|323304940|FG000|Phase 2|Lost to Follow-up|0|||
94414894|NCT02610816|323304941|FG001|Phase 2|Lost to Follow-up|0|||
94414895|NCT02610816|323304942|FG002|Phase 2|Lost to Follow-up|2|||
94414896|NCT02610816|323304943|FG003|Phase 2|Lost to Follow-up|0|||
94414897|NCT02610816|323304940|FG000|Phase 2|Physician Decision|0|||
94414898|NCT02610816|323304941|FG001|Phase 2|Physician Decision|0|||
94414899|NCT02610816|323304942|FG002|Phase 2|Physician Decision|0|||
94414900|NCT02610816|323304943|FG003|Phase 2|Physician Decision|2|||
94487552|NCT01093846|323577601|FG002|Overall Study|Lack of Efficacy|4|||
94487553|NCT01093846|323577599|FG000|Overall Study|Condition no longer required study drug|1|||
94487554|NCT01093846|323577600|FG001|Overall Study|Condition no longer required study drug|1|||
94487555|NCT01093846|323577601|FG002|Overall Study|Condition no longer required study drug|1|||
94487556|NCT01093846|323577599|FG000|Overall Study|Administrative Problems|18|||
94487557|NCT01093846|323577600|FG001|Overall Study|Administrative Problems|17|||
94487558|NCT01093846|323577601|FG002|Overall Study|Administrative Problems|15|||
94487559|NCT03082729|323577602|FG000|Overall Study|Lost to Follow-up|7|||
94487560|NCT03082729|323577602|FG000|Overall Study|Physician Decision|2|||
94487561|NCT03082729|323577602|FG000|Overall Study|Withdrawal by Subject|1|||
94487562|NCT03082729|323577602|FG000|Overall Study|Lack of Efficacy|9|||
94414901|NCT02610816|323304940|FG000|Phase 2|Pregnancy|0|||
94414902|NCT02610816|323304941|FG001|Phase 2|Pregnancy|0|||
94414903|NCT02610816|323304942|FG002|Phase 2|Pregnancy|0|||
94487563|NCT03082729|323577602|FG000|Overall Study|Adverse Event|4|||
94487564|NCT03082729|323577602|FG000|Overall Study|Protocol Violation|6|||
94487565|NCT03082729|323577602|FG000|Overall Study|Fear of study procedure|1|||
94487566|NCT03082729|323577602|FG000|Overall Study|Scheduling conflict|1|||
94487567|NCT02481050|323579330|FG000|Overall Study|Adverse Event|1|||
94414904|NCT02610816|323304943|FG003|Phase 2|Pregnancy|1|||
94487568|NCT02481050|323579330|FG000|Overall Study|Disease Progression|47|||
94487569|NCT02481050|323579330|FG000|Overall Study|Withdrawal by Subject|7|||
94487570|NCT02481050|323579330|FG000|Overall Study|Other|3|||
94487571|NCT02357459|323579331|FG000|Overall Study|Adverse Event|0|||
94487572|NCT02357459|323579332|FG001|Overall Study|Adverse Event|1|||
94487573|NCT02357459|323579333|FG002|Overall Study|Adverse Event|1|||
94414905|NCT03407118|323304944|FG000|Period 2|Withdrawal by Subject|1|||
94414906|NCT03407118|323304945|FG001|Period 2|Withdrawal by Subject|0|||
94414907|NCT02697773|323304948|FG000|Overall Study|Adverse Event|2|||
94414908|NCT02697773|323304949|FG001|Overall Study|Adverse Event|1|||
94414909|NCT02697773|323304950|FG002|Overall Study|Adverse Event|2|||
94414910|NCT02697773|323304948|FG000|Overall Study|Death|0|||
94414911|NCT02697773|323304949|FG001|Overall Study|Death|0|||
94414912|NCT02697773|323304950|FG002|Overall Study|Death|2|||
94414913|NCT02697773|323304948|FG000|Overall Study|Lack of Efficacy|4|||
94414914|NCT02697773|323304949|FG001|Overall Study|Lack of Efficacy|6|||
94414915|NCT02697773|323304950|FG002|Overall Study|Lack of Efficacy|6|||
94414916|NCT02697773|323304948|FG000|Overall Study|Lost to Follow-up|5|||
94414917|NCT02697773|323304949|FG001|Overall Study|Lost to Follow-up|5|||
94414918|NCT02697773|323304950|FG002|Overall Study|Lost to Follow-up|7|||
94414919|NCT02697773|323304948|FG000|Overall Study|Other|15|||
94414920|NCT02697773|323304949|FG001|Overall Study|Other|11|||
94414921|NCT02697773|323304950|FG002|Overall Study|Other|10|||
94414922|NCT02697773|323304948|FG000|Overall Study|Protocol Violation|1|||
94414923|NCT02697773|323304949|FG001|Overall Study|Protocol Violation|1|||
94414924|NCT02697773|323304950|FG002|Overall Study|Protocol Violation|0|||
94414925|NCT02697773|323304948|FG000|Overall Study|Withdrawal by Subject|10|||
94414926|NCT02697773|323304949|FG001|Overall Study|Withdrawal by Subject|13|||
94414927|NCT02697773|323304950|FG002|Overall Study|Withdrawal by Subject|13|||
94414928|NCT02697773|323304948|FG000|Overall Study|Randomized but not treated|1|||
94414929|NCT02697773|323304949|FG001|Overall Study|Randomized but not treated|1|||
94414930|NCT02697773|323304950|FG002|Overall Study|Randomized but not treated|0|||
94414931|NCT00613834|323304951|FG000|Overall Study|Withdrawal by Subject|0|||
94414932|NCT00613834|323304952|FG001|Overall Study|Withdrawal by Subject|3|||
94414933|NCT00418522|323306875|FG000|Overall Study|Adverse Event|7|||
94414934|NCT00418522|323306876|FG001|Overall Study|Adverse Event|1|||
94414935|NCT00418522|323306875|FG000|Overall Study|Lack of Efficacy|1|||
94414936|NCT00418522|323306876|FG001|Overall Study|Lack of Efficacy|3|||
94414937|NCT00418522|323306875|FG000|Overall Study|Lost to Follow-up|10|||
94414938|NCT00418522|323306876|FG001|Overall Study|Lost to Follow-up|4|||
94414939|NCT00418522|323306875|FG000|Overall Study|Withdrawal by Subject|31|||
94414940|NCT00418522|323306876|FG001|Overall Study|Withdrawal by Subject|7|||
94414941|NCT00418522|323306875|FG000|Overall Study|Other|27|||
94414942|NCT00418522|323306876|FG001|Overall Study|Other|23|||
94414943|NCT00418522|323306875|FG000|Overall Study|Randomized but did not receive treatment|7|||
94414944|NCT00418522|323306876|FG001|Overall Study|Randomized but did not receive treatment|4|||
94414945|NCT00655850|323306879|FG000|Overall Study|Death|2|||
94414946|NCT00655850|323306879|FG000|Overall Study|Withdrawal by Subject|1|||
94414947|NCT03702049|323306886|FG000|Overall Study|Lost to Follow-up|4|||
94414948|NCT03702049|323306886|FG000|Overall Study|Physician Decision|1|||
94414949|NCT00573170|323306889|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
94414950|NCT00573170|323306890|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
94414951|NCT00573170|323306891|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
94414952|NCT00573170|323306892|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
94414953|NCT00573170|323306893|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
94414954|NCT00573170|323306894|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
94414955|NCT00573170|323306889|FG000|First Washout Period|Adverse Event|1|||
94414956|NCT00573170|323306890|FG001|First Washout Period|Adverse Event|1|||
94414957|NCT00573170|323306891|FG002|First Washout Period|Adverse Event|0|||
94414958|NCT00573170|323306892|FG003|First Washout Period|Adverse Event|0|||
94414959|NCT00573170|323306893|FG004|First Washout Period|Adverse Event|0|||
94414960|NCT00573170|323306894|FG005|First Washout Period|Adverse Event|1|||
94414961|NCT00573170|323306889|FG000|First Washout Period|Lack of Efficacy|0|||
94414962|NCT00573170|323306890|FG001|First Washout Period|Lack of Efficacy|0|||
94414963|NCT00573170|323306891|FG002|First Washout Period|Lack of Efficacy|0|||
94414964|NCT00573170|323306892|FG003|First Washout Period|Lack of Efficacy|0|||
94487574|NCT02357459|323579331|FG000|Overall Study|Withdrawal by Subject|5|||
94487575|NCT02357459|323579332|FG001|Overall Study|Withdrawal by Subject|3|||
94487576|NCT02357459|323579333|FG002|Overall Study|Withdrawal by Subject|3|||
94414965|NCT00573170|323306893|FG004|First Washout Period|Lack of Efficacy|0|||
94414966|NCT00573170|323306894|FG005|First Washout Period|Lack of Efficacy|1|||
94414967|NCT00573170|323306889|FG000|First Washout Period|Lost to Follow-up|1|||
94414968|NCT00573170|323306890|FG001|First Washout Period|Lost to Follow-up|1|||
94414969|NCT00573170|323306891|FG002|First Washout Period|Lost to Follow-up|0|||
94487577|NCT02357459|323579331|FG000|Overall Study|Physician Decision|0|||
94414970|NCT00573170|323306892|FG003|First Washout Period|Lost to Follow-up|2|||
94414971|NCT00573170|323306893|FG004|First Washout Period|Lost to Follow-up|0|||
94414972|NCT00573170|323306894|FG005|First Washout Period|Lost to Follow-up|2|||
94414973|NCT00573170|323306889|FG000|First Washout Period|Withdrawal by Subject|2|||
94414974|NCT00573170|323306890|FG001|First Washout Period|Withdrawal by Subject|0|||
94414975|NCT00573170|323306891|FG002|First Washout Period|Withdrawal by Subject|0|||
94487578|NCT02357459|323579332|FG001|Overall Study|Physician Decision|2|||
94414976|NCT00573170|323306892|FG003|First Washout Period|Withdrawal by Subject|2|||
94414977|NCT00573170|323306893|FG004|First Washout Period|Withdrawal by Subject|3|||
94487579|NCT02357459|323579333|FG002|Overall Study|Physician Decision|0|||
94487580|NCT02357459|323579331|FG000|Overall Study|Protocol Violation|1|||
94414978|NCT00573170|323306894|FG005|First Washout Period|Withdrawal by Subject|3|||
94414979|NCT00573170|323306889|FG000|First Washout Period|Other|4|||
94414980|NCT00573170|323306890|FG001|First Washout Period|Other|0|||
94414981|NCT00573170|323306891|FG002|First Washout Period|Other|1|||
94487581|NCT02357459|323579332|FG001|Overall Study|Protocol Violation|1|||
94487582|NCT02357459|323579333|FG002|Overall Study|Protocol Violation|0|||
94487583|NCT02357459|323579331|FG000|Overall Study|Lost to Follow-up|1|||
94487584|NCT02357459|323579332|FG001|Overall Study|Lost to Follow-up|3|||
94487585|NCT02357459|323579333|FG002|Overall Study|Lost to Follow-up|0|||
94487586|NCT02357459|323579331|FG000|Overall Study|Lack of Efficacy|7|||
94487587|NCT02357459|323579332|FG001|Overall Study|Lack of Efficacy|4|||
94487588|NCT02357459|323579333|FG002|Overall Study|Lack of Efficacy|4|||
94487589|NCT02357459|323579331|FG000|Overall Study|Patient Relocated|2|||
94487590|NCT02357459|323579332|FG001|Overall Study|Patient Relocated|0|||
94487591|NCT02357459|323579333|FG002|Overall Study|Patient Relocated|0|||
94487592|NCT02357459|323579331|FG000|Overall Study|Instruction from PCP|1|||
94487593|NCT02357459|323579332|FG001|Overall Study|Instruction from PCP|0|||
94487594|NCT02357459|323579333|FG002|Overall Study|Instruction from PCP|0|||
94487595|NCT02357459|323579331|FG000|Overall Study|Incarceration|0|||
94487596|NCT02357459|323579332|FG001|Overall Study|Incarceration|0|||
94487597|NCT02357459|323579333|FG002|Overall Study|Incarceration|1|||
94487598|NCT02357459|323579331|FG000|Overall Study|Pre-planned Knee surgery|0|||
94487599|NCT02357459|323579332|FG001|Overall Study|Pre-planned Knee surgery|0|||
94487600|NCT02357459|323579333|FG002|Overall Study|Pre-planned Knee surgery|2|||
94487601|NCT02357459|323579331|FG000|Overall Study|Job Commitments|0|||
94487602|NCT02357459|323579332|FG001|Overall Study|Job Commitments|0|||
94487603|NCT02357459|323579333|FG002|Overall Study|Job Commitments|1|||
94487604|NCT02188160|323579334|FG000|Overall Study|Adverse Event|1|||
94487605|NCT02188160|323579335|FG001|Overall Study|Adverse Event|0|||
94487606|NCT02188160|323579334|FG000|Overall Study|Use of an excluded medication|0|||
94487607|NCT02188160|323579335|FG001|Overall Study|Use of an excluded medication|1|||
94487608|NCT00916578|323579336|FG000|Overall Study|Physician Decision|2|||
94487609|NCT00916578|323579336|FG000|Overall Study|Withdrawal by Subject|3|||
94487610|NCT00916578|323579336|FG000|Overall Study|Insurance Denial|2|||
94487611|NCT00352118|323579341|FG000|Overall Study|Physician Decision|4|||
94487612|NCT00903201|323579345|FG000|Overall Study|Adverse Event|1|||
94487613|NCT00903201|323579346|FG001|Overall Study|Adverse Event|4|||
94487614|NCT00903201|323579347|FG002|Overall Study|Adverse Event|0|||
94487615|NCT00903201|323579345|FG000|Overall Study|Protocol Violation|2|||
94487616|NCT00903201|323579346|FG001|Overall Study|Protocol Violation|1|||
94487617|NCT00903201|323579347|FG002|Overall Study|Protocol Violation|0|||
94487618|NCT00903201|323579345|FG000|Overall Study|Lost to Follow-up|0|||
94487619|NCT00903201|323579346|FG001|Overall Study|Lost to Follow-up|1|||
94487620|NCT00903201|323579347|FG002|Overall Study|Lost to Follow-up|0|||
94487621|NCT00903201|323579345|FG000|Overall Study|Physician Decision|1|||
94487622|NCT00903201|323579346|FG001|Overall Study|Physician Decision|0|||
94487623|NCT00903201|323579347|FG002|Overall Study|Physician Decision|1|||
94487624|NCT00903201|323579345|FG000|Overall Study|Withdrawal by Subject|1|||
94487625|NCT00903201|323579346|FG001|Overall Study|Withdrawal by Subject|0|||
94487626|NCT00903201|323579347|FG002|Overall Study|Withdrawal by Subject|1|||
94487627|NCT00593814|323579348|FG000|Overall Study|Death|7|||
94487628|NCT00593814|323579349|FG001|Overall Study|Death|0|||
94487629|NCT00593814|323579348|FG000|Overall Study|Withdrawal by Subject|7|||
94487630|NCT00593814|323579349|FG001|Overall Study|Withdrawal by Subject|0|||
94487631|NCT00593814|323579348|FG000|Overall Study|Lost to Follow-up|7|||
94487632|NCT00593814|323579349|FG001|Overall Study|Lost to Follow-up|0|||
94487633|NCT00593814|323579348|FG000|Overall Study|Physician Decision|3|||
94414982|NCT00573170|323306892|FG003|First Washout Period|Other|1|||
94414983|NCT00573170|323306893|FG004|First Washout Period|Other|0|||
94414984|NCT00573170|323306894|FG005|First Washout Period|Other|0|||
94414985|NCT00573170|323306889|FG000|Second Washout Period|Adverse Event|1|||
94414986|NCT00573170|323306890|FG001|Second Washout Period|Adverse Event|0|||
94414987|NCT00573170|323306891|FG002|Second Washout Period|Adverse Event|0|||
94414988|NCT00573170|323306892|FG003|Second Washout Period|Adverse Event|0|||
94414989|NCT00573170|323306893|FG004|Second Washout Period|Adverse Event|1|||
94414990|NCT00573170|323306894|FG005|Second Washout Period|Adverse Event|0|||
94414991|NCT00573170|323306889|FG000|Second Washout Period|Protocol Violation|2|||
94487634|NCT00593814|323579349|FG001|Overall Study|Physician Decision|0|||
94487635|NCT01198002|323579350|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
94487636|NCT01198002|323579351|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
94487637|NCT01198002|323579352|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
94487638|NCT01198002|323579350|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
94487639|NCT01198002|323579351|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
94487640|NCT01198002|323579352|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
94487641|NCT01198002|323579350|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
94487642|NCT01198002|323579351|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
94487643|NCT01198002|323579352|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
94487644|NCT01198002|323579350|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
94487645|NCT01198002|323579351|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
94487646|NCT01198002|323579352|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
94414992|NCT00573170|323306890|FG001|Second Washout Period|Protocol Violation|1|||
94487647|NCT01198002|323579350|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
94487648|NCT01198002|323579351|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
94487649|NCT01198002|323579352|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
94487650|NCT01198002|323579350|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
94487651|NCT01198002|323579351|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
94487652|NCT01198002|323579352|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
94487653|NCT01198002|323579350|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
94487654|NCT01198002|323579351|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
94487655|NCT01198002|323579352|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
94487656|NCT01198002|323579350|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
94487657|NCT01198002|323579351|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
94487658|NCT01198002|323579352|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
94487659|NCT01198002|323579350|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
94487660|NCT01198002|323579351|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
94487661|NCT01198002|323579352|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
94487662|NCT01198002|323579350|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
94487663|NCT01198002|323579351|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
94487664|NCT01198002|323579352|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
94487665|NCT01198002|323579350|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
94487666|NCT01198002|323579351|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
94487667|NCT01198002|323579352|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
94487668|NCT01198002|323579350|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
94487669|NCT01198002|323579351|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
94487670|NCT01198002|323579352|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
94487671|NCT01198002|323579350|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
94487672|NCT01198002|323579351|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
94487673|NCT01198002|323579352|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
94487674|NCT01198002|323579350|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
94487675|NCT01198002|323579351|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
94487676|NCT01198002|323579352|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
94487677|NCT01198002|323579350|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
94487678|NCT01198002|323579351|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
94487679|NCT01198002|323579352|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
94487680|NCT01433159|323579353|FG000|Overall Study|Adverse Event|1|||
94487681|NCT01433159|323579354|FG001|Overall Study|Adverse Event|0|||
94487682|NCT01433159|323579353|FG000|Overall Study|Physician Decision|1|||
94487683|NCT01433159|323579354|FG001|Overall Study|Physician Decision|0|||
94487684|NCT01433159|323579353|FG000|Overall Study|Protocol Violation|0|||
94487685|NCT01433159|323579354|FG001|Overall Study|Protocol Violation|1|||
94487686|NCT03630393|323579355|FG000|Overall Study|Death|1|||
94487687|NCT03630393|323579356|FG001|Overall Study|Death|0|||
94487688|NCT01586195|323579357|FG000|Overall Study|Death|11|||
94487689|NCT01586195|323579357|FG000|Overall Study|Withdrawal of Consent|5|||
94487690|NCT01586195|323579357|FG000|Overall Study|Started new anti-melanoma therapy|1|||
94487691|NCT01586195|323579357|FG000|Overall Study|Reason not specified|9|||
94487692|NCT01855958|323579360|FG000|Overall Study|Withdrawal by Subject|1|||
94487693|NCT01855958|323579361|FG001|Overall Study|Withdrawal by Subject|0|||
94487694|NCT00266708|323579363|FG000|Overall Study|No renal function|1|||
94487695|NCT00266708|323579364|FG001|Overall Study|No renal function|1|||
94487696|NCT00266708|323579363|FG000|Overall Study|Refused biopsy|3|||
94487697|NCT00266708|323579364|FG001|Overall Study|Refused biopsy|6|||
94487698|NCT00266708|323579363|FG000|Overall Study|Asthma|0|||
94487699|NCT00266708|323579364|FG001|Overall Study|Asthma|2|||
94487700|NCT01721798|323579365|FG000|Overall Study|Death|0|||
94487701|NCT01721798|323579366|FG001|Overall Study|Death|0|||
94487702|NCT01721798|323579367|FG002|Overall Study|Death|1|||
94487703|NCT01721798|323579368|FG003|Overall Study|Death|1|||
94487704|NCT01721798|323579365|FG000|Overall Study|Lost to Follow-up|2|||
94487705|NCT01721798|323579366|FG001|Overall Study|Lost to Follow-up|2|||
94487706|NCT01721798|323579367|FG002|Overall Study|Lost to Follow-up|9|||
94487707|NCT01721798|323579368|FG003|Overall Study|Lost to Follow-up|9|||
94487708|NCT01721798|323579365|FG000|Overall Study|Pregnancy|0|||
94487709|NCT01721798|323579366|FG001|Overall Study|Pregnancy|0|||
94487710|NCT01721798|323579367|FG002|Overall Study|Pregnancy|1|||
94487711|NCT01721798|323579368|FG003|Overall Study|Pregnancy|1|||
94487712|NCT01721798|323579365|FG000|Overall Study|Withdrawal by Subject|1|||
94487713|NCT01721798|323579366|FG001|Overall Study|Withdrawal by Subject|0|||
94487714|NCT01721798|323579367|FG002|Overall Study|Withdrawal by Subject|2|||
94487715|NCT01721798|323579368|FG003|Overall Study|Withdrawal by Subject|1|||
94487716|NCT01721798|323579365|FG000|Overall Study|Not eligible for 24 month visit|1|||
94487717|NCT01721798|323579366|FG001|Overall Study|Not eligible for 24 month visit|0|||
94487718|NCT01721798|323579367|FG002|Overall Study|Not eligible for 24 month visit|8|||
94487719|NCT01721798|323579368|FG003|Overall Study|Not eligible for 24 month visit|7|||
94487720|NCT02791269|323579369|FG000|Overall Study|Lost to Follow-up|0|||
94487721|NCT02791269|323579370|FG001|Overall Study|Lost to Follow-up|1|||
94487722|NCT00427934|323579371|FG000|Overall Study|Adverse Event|1|||
94487723|NCT00427934|323579372|FG001|Overall Study|Adverse Event|0|||
94487724|NCT00427934|323579373|FG002|Overall Study|Adverse Event|5|||
94487725|NCT00427934|323579374|FG003|Overall Study|Adverse Event|4|||
94487726|NCT00427934|323579371|FG000|Overall Study|Lack of Efficacy|0|||
94487727|NCT00427934|323579372|FG001|Overall Study|Lack of Efficacy|0|||
94487728|NCT00427934|323579373|FG002|Overall Study|Lack of Efficacy|5|||
94487729|NCT00427934|323579374|FG003|Overall Study|Lack of Efficacy|2|||
94487730|NCT00427934|323579371|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
94487731|NCT00427934|323579372|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
94487732|NCT00427934|323579373|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
94487733|NCT00427934|323579374|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
94487734|NCT00427934|323579371|FG000|Overall Study|Other|0|||
94487735|NCT00427934|323579372|FG001|Overall Study|Other|0|||
94487736|NCT00427934|323579373|FG002|Overall Study|Other|11|||
94487737|NCT00427934|323579374|FG003|Overall Study|Other|5|||
94487738|NCT00427934|323579371|FG000|Overall Study|Withdrawal by Subject|0|||
94487739|NCT00427934|323579372|FG001|Overall Study|Withdrawal by Subject|0|||
94487740|NCT00427934|323579373|FG002|Overall Study|Withdrawal by Subject|1|||
94487741|NCT00427934|323579374|FG003|Overall Study|Withdrawal by Subject|3|||
94487742|NCT02119299|323579377|FG000|Overall Study|Withdrawal by Subject|7|||
94487743|NCT02119299|323579377|FG000|Overall Study|Lack of Efficacy|1|||
94487744|NCT02119299|323579377|FG000|Overall Study|Pregnancy|1|||
94487745|NCT00499122|323579378|FG000|Overall Study|Withdrawal by Subject|2|||
94487746|NCT04539275|323579379|FG000|Overall Study|Death|2|||
94487747|NCT04539275|323579380|FG001|Overall Study|Death|4|||
94487748|NCT04539275|323579379|FG000|Overall Study|Lost to Follow-up|1|||
94487749|NCT04539275|323579380|FG001|Overall Study|Lost to Follow-up|1|||
94487750|NCT04539275|323579379|FG000|Overall Study|Withdrawal by Subject|3|||
94487751|NCT04539275|323579380|FG001|Overall Study|Withdrawal by Subject|0|||
94487752|NCT02669849|323579381|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
94487753|NCT02669849|323579382|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
94487754|NCT02669849|323579383|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
94487755|NCT02669849|323579381|FG000|Overall Study|Lost to Follow-up|1|||
94487756|NCT02669849|323579382|FG001|Overall Study|Lost to Follow-up|0|||
94487757|NCT02669849|323579383|FG002|Overall Study|Lost to Follow-up|3|||
94487758|NCT02669849|323579381|FG000|Overall Study|Death|1|||
94487759|NCT02669849|323579382|FG001|Overall Study|Death|1|||
94487760|NCT02669849|323579383|FG002|Overall Study|Death|2|||
94487761|NCT02669849|323579381|FG000|Overall Study|Study terminated by sponsor|16|||
94487762|NCT02669849|323579382|FG001|Overall Study|Study terminated by sponsor|1|||
94487763|NCT02669849|323579383|FG002|Overall Study|Study terminated by sponsor|14|||
94487764|NCT02669849|323579381|FG000|Overall Study|Other|0|||
94487765|NCT02669849|323579382|FG001|Overall Study|Other|0|||
94487766|NCT02669849|323579383|FG002|Overall Study|Other|2|||
94487767|NCT00606008|323579384|FG000|Overall Study|Adverse Event|1|||
94487768|NCT00606008|323579384|FG000|Overall Study|Withdrawal by Subject|4|||
94487769|NCT01516216|323579387|FG000|Overall Study|Adverse Event|2|||
94487770|NCT01516216|323579388|FG001|Overall Study|Adverse Event|4|||
94487771|NCT01516216|323579387|FG000|Overall Study|Disease Progression|38|||
94487772|NCT01516216|323579388|FG001|Overall Study|Disease Progression|34|||
94487773|NCT01516216|323579387|FG000|Overall Study|Withdrawal by Subject|9|||
94487774|NCT01516216|323579388|FG001|Overall Study|Withdrawal by Subject|11|||
94487775|NCT01516216|323579387|FG000|Overall Study|Potentially Curative Resection|6|||
94487776|NCT01516216|323579388|FG001|Overall Study|Potentially Curative Resection|12|||
94487777|NCT01516216|323579387|FG000|Overall Study|Nonadherence|2|||
94487778|NCT01516216|323579388|FG001|Overall Study|Nonadherence|3|||
94487779|NCT01516216|323579387|FG000|Overall Study|Physician Decision|6|||
94487780|NCT01516216|323579388|FG001|Overall Study|Physician Decision|3|||
94487781|NCT01516216|323579387|FG000|Overall Study|Prolonged Treatment Delay|5|||
94487782|NCT01516216|323579388|FG001|Overall Study|Prolonged Treatment Delay|1|||
94487783|NCT01516216|323579387|FG000|Overall Study|Intercurrent Illness|1|||
94487784|NCT01516216|323579388|FG001|Overall Study|Intercurrent Illness|0|||
94487785|NCT01516216|323579387|FG000|Overall Study|Death|1|||
94487786|NCT01516216|323579388|FG001|Overall Study|Death|1|||
94487787|NCT02419807|323579389|FG000|Overall Study|Withdrawal by Subject|4|||
94487788|NCT02419807|323579389|FG000|Overall Study|Physician Decision|1|||
94487789|NCT02419807|323579389|FG000|Overall Study|Protocol Violation|5|||
94487790|NCT01239797|323579396|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
94487791|NCT01239797|323579397|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
94487792|NCT01239797|323579396|FG000|Randomized Participants|Participant withdrew consent|1|||
94487793|NCT01239797|323579397|FG001|Randomized Participants|Participant withdrew consent|7|||
94487794|NCT01239797|323579396|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
94487795|NCT01239797|323579397|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
94487796|NCT01239797|323579396|FG000|Treated Participants|Disease progression|185|||
94487797|NCT01239797|323579397|FG001|Treated Participants|Disease progression|185|||
94487798|NCT01239797|323579396|FG000|Treated Participants|Study drug toxicity|39|||
94487799|NCT01239797|323579397|FG001|Treated Participants|Study drug toxicity|45|||
94487800|NCT01239797|323579396|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
94487801|NCT01239797|323579397|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
94487802|NCT01239797|323579396|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
94487803|NCT01239797|323579397|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
94487804|NCT01239797|323579396|FG000|Treated Participants|Administrative reason by sponsor|13|||
94487805|NCT01239797|323579397|FG001|Treated Participants|Administrative reason by sponsor|4|||
94487806|NCT01239797|323579396|FG000|Treated Participants|Other reasons|14|||
94487807|NCT01239797|323579397|FG001|Treated Participants|Other reasons|14|||
94487808|NCT01239797|323579396|FG000|Treated Participants|Participant withdrew consent|6|||
94487809|NCT01239797|323579397|FG001|Treated Participants|Participant withdrew consent|11|||
94487810|NCT01239797|323579396|FG000|Treated Participants|Death|1|||
94487811|NCT01239797|323579397|FG001|Treated Participants|Death|1|||
94487812|NCT01239797|323579396|FG000|Treated Participants|Participant no longer meets study criteria|1|||
94487813|NCT01239797|323579397|FG001|Treated Participants|Participant no longer meets study criteria|1|||
94487814|NCT01239797|323579396|FG000|Treated Participants|Poor/non-compliance|0|||
94487815|NCT01239797|323579397|FG001|Treated Participants|Poor/non-compliance|1|||
94487816|NCT02051296|323579401|FG000|Overall Study|Lost to Follow-up|1|||
94487817|NCT02051296|323579402|FG001|Overall Study|Lost to Follow-up|2|||
94487818|NCT02051296|323579401|FG000|Overall Study|withdraw prior to treatment|7|||
94487819|NCT02051296|323579402|FG001|Overall Study|withdraw prior to treatment|7|||
94487820|NCT03722576|323579405|FG000|Overall Study|Withdrawal by Subject|3|||
94487821|NCT03722576|323579405|FG000|Overall Study|Adverse Event|2|||
94487822|NCT03722576|323579405|FG000|Overall Study|Physician Decision|1|||
94487823|NCT03722576|323579405|FG000|Overall Study|Lost to Follow-up|1|||
94487824|NCT02133508|323579406|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
94487825|NCT02133508|323579406|FG000|Overall Study|Death|12|||
94487826|NCT02133508|323579406|FG000|Overall Study|Lost to Follow-up|2|||
94487827|NCT02834975|323579411|FG000|Overall Study|Physician Decision|2|||
94487828|NCT02834975|323579411|FG000|Overall Study|Adverse Event|1|||
94487829|NCT02834975|323579411|FG000|Overall Study|Withdrawal by Subject|1|||
94487830|NCT02834975|323579411|FG000|Overall Study|Lack of Efficacy|1|||
94487831|NCT02446691|323579412|FG000|Overall Study|Withdrawal by Subject|2|||
94487832|NCT02446691|323579412|FG000|Overall Study|Lost to Follow-up|8|||
94487833|NCT02446691|323579412|FG000|Overall Study|Protocol Violation|1|||
94487834|NCT02497469|323579413|FG000|Overall Study|Randomized but not Treated|0|||
94487835|NCT02497469|323579414|FG001|Overall Study|Randomized but not Treated|2|||
94487836|NCT02497469|323579413|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
94487837|NCT02497469|323579414|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
94487838|NCT02497469|323579413|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
94487839|NCT02497469|323579414|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
94487840|NCT02497469|323579413|FG000|Overall Study|Significant Protocol Deviation|4|||
94487841|NCT02497469|323579414|FG001|Overall Study|Significant Protocol Deviation|5|||
94487842|NCT02497469|323579413|FG000|Overall Study|Lost to Follow-up|14|||
94487843|NCT02497469|323579414|FG001|Overall Study|Lost to Follow-up|4|||
94487844|NCT02497469|323579413|FG000|Overall Study|Voluntary Withdrawal|39|||
94487845|NCT02497469|323579414|FG001|Overall Study|Voluntary Withdrawal|41|||
94487846|NCT02497469|323579413|FG000|Overall Study|Pregnancy|1|||
94487847|NCT02497469|323579414|FG001|Overall Study|Pregnancy|1|||
94487848|NCT02497469|323579413|FG000|Overall Study|Lack of Efficacy|86|||
94487849|NCT02497469|323579414|FG001|Overall Study|Lack of Efficacy|40|||
94414993|NCT00573170|323306891|FG002|Second Washout Period|Protocol Violation|1|||
94414994|NCT00573170|323306892|FG003|Second Washout Period|Protocol Violation|0|||
94414995|NCT00573170|323306893|FG004|Second Washout Period|Protocol Violation|0|||
94414996|NCT00573170|323306894|FG005|Second Washout Period|Protocol Violation|0|||
94414997|NCT00573170|323306889|FG000|Second Washout Period|Withdrawal by Subject|1|||
94414998|NCT00573170|323306890|FG001|Second Washout Period|Withdrawal by Subject|1|||
94414999|NCT00573170|323306891|FG002|Second Washout Period|Withdrawal by Subject|2|||
94415000|NCT00573170|323306892|FG003|Second Washout Period|Withdrawal by Subject|0|||
94415001|NCT00573170|323306893|FG004|Second Washout Period|Withdrawal by Subject|1|||
94415002|NCT00573170|323306894|FG005|Second Washout Period|Withdrawal by Subject|0|||
94415003|NCT00573170|323306889|FG000|Second Washout Period|Lost to Follow-up|0|||
94415004|NCT00573170|323306890|FG001|Second Washout Period|Lost to Follow-up|0|||
94415005|NCT00573170|323306891|FG002|Second Washout Period|Lost to Follow-up|0|||
94415006|NCT00573170|323306892|FG003|Second Washout Period|Lost to Follow-up|1|||
94415007|NCT00573170|323306893|FG004|Second Washout Period|Lost to Follow-up|0|||
94487850|NCT02497469|323579413|FG000|Overall Study|Reason not Specified|6|||
94487851|NCT02497469|323579414|FG001|Overall Study|Reason not Specified|6|||
94487852|NCT00472420|323579415|FG000|Induction Treatment Period|Physician Decision|9|||
94487853|NCT00472420|323579415|FG000|Induction Treatment Period|Adverse Event|3|||
94487854|NCT00472420|323579415|FG000|Induction Treatment Period|Non-compliance|1|||
94487855|NCT00472420|323579415|FG000|Induction Treatment Period|Death|3|||
94487856|NCT00472420|323579415|FG000|Follow-up Period|Death|5|||
94487857|NCT00472420|323579415|FG000|Follow-up Period|Physician Decision|9|||
94415008|NCT00573170|323306894|FG005|Second Washout Period|Lost to Follow-up|0|||
94415009|NCT00573170|323306889|FG000|Second Washout Period|Other|1|||
94415010|NCT00573170|323306890|FG001|Second Washout Period|Other|2|||
94415011|NCT00573170|323306891|FG002|Second Washout Period|Other|1|||
94415012|NCT00573170|323306892|FG003|Second Washout Period|Other|4|||
94415013|NCT00573170|323306893|FG004|Second Washout Period|Other|6|||
94415014|NCT00573170|323306894|FG005|Second Washout Period|Other|2|||
94415015|NCT00573170|323306889|FG000|Third Treatment Period|Withdrawal by Subject|1|||
94415016|NCT00573170|323306890|FG001|Third Treatment Period|Withdrawal by Subject|0|||
94415017|NCT00573170|323306891|FG002|Third Treatment Period|Withdrawal by Subject|0|||
94415018|NCT00573170|323306892|FG003|Third Treatment Period|Withdrawal by Subject|0|||
94415019|NCT00573170|323306893|FG004|Third Treatment Period|Withdrawal by Subject|0|||
94415020|NCT00573170|323306894|FG005|Third Treatment Period|Withdrawal by Subject|0|||
94415021|NCT00573170|323306889|FG000|Third Treatment Period|Lost to Follow-up|0|||
94415022|NCT00573170|323306890|FG001|Third Treatment Period|Lost to Follow-up|0|||
94415023|NCT00573170|323306891|FG002|Third Treatment Period|Lost to Follow-up|0|||
94415024|NCT00573170|323306892|FG003|Third Treatment Period|Lost to Follow-up|0|||
94415025|NCT00573170|323306893|FG004|Third Treatment Period|Lost to Follow-up|0|||
94415026|NCT00573170|323306894|FG005|Third Treatment Period|Lost to Follow-up|2|||
94415027|NCT01304693|323306895|FG000|Overall Study|Adverse Event|0|||
94487858|NCT00472420|323579415|FG000|Follow-up Period|Lost to Follow-up|2|||
94487859|NCT00472420|323579415|FG000|Follow-up Period|Protocol Violation|1|||
94487860|NCT00087178|323579416|FG000|Overall Study|No follow up data|5|||
94487861|NCT00087178|323579417|FG001|Overall Study|No follow up data|15|||
94487862|NCT00087178|323579416|FG000|Overall Study|No clinical assessment|1|||
94487863|NCT00087178|323579417|FG001|Overall Study|No clinical assessment|2|||
94487864|NCT00087178|323579416|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
94487865|NCT00087178|323579417|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
94487866|NCT02378662|323579420|FG000|Overall Study|Early Discontinuation|2|||
94487867|NCT02378662|323579421|FG001|Overall Study|Early Discontinuation|0|||
94487868|NCT01774591|323579424|FG000|Overall Study|Physician Decision|1|||
94487869|NCT01774591|323579425|FG001|Overall Study|Physician Decision|1|||
94487870|NCT01774591|323579424|FG000|Overall Study|Withdrawal by Subject|0|||
94487871|NCT01774591|323579425|FG001|Overall Study|Withdrawal by Subject|1|||
94487872|NCT01774591|323579424|FG000|Overall Study|Adverse Event|0|||
94487873|NCT01774591|323579425|FG001|Overall Study|Adverse Event|2|||
94487874|NCT01787552|323579431|FG000|Overall Study|Withdrawal by Subject|2|||
94487875|NCT01787552|323579432|FG001|Overall Study|Withdrawal by Subject|0|||
94487876|NCT01787552|323579433|FG002|Overall Study|Withdrawal by Subject|0|||
94487877|NCT01787552|323579434|FG003|Overall Study|Withdrawal by Subject|4|||
94487878|NCT01787552|323579431|FG000|Overall Study|Physician Decision|2|||
94487879|NCT01787552|323579432|FG001|Overall Study|Physician Decision|2|||
94487880|NCT01787552|323579433|FG002|Overall Study|Physician Decision|1|||
94487881|NCT01787552|323579434|FG003|Overall Study|Physician Decision|2|||
94487882|NCT01787552|323579431|FG000|Overall Study|Death|0|||
94487883|NCT01787552|323579432|FG001|Overall Study|Death|0|||
94487884|NCT01787552|323579433|FG002|Overall Study|Death|0|||
94487885|NCT01787552|323579434|FG003|Overall Study|Death|1|||
94487886|NCT01787552|323579431|FG000|Overall Study|Adverse Event|2|||
94487887|NCT01787552|323579432|FG001|Overall Study|Adverse Event|5|||
94487888|NCT01787552|323579433|FG002|Overall Study|Adverse Event|2|||
94487889|NCT01787552|323579434|FG003|Overall Study|Adverse Event|16|||
94487890|NCT01787552|323579431|FG000|Overall Study|Study terminated by Sponsor|0|||
94487891|NCT01787552|323579432|FG001|Overall Study|Study terminated by Sponsor|0|||
94487892|NCT01787552|323579433|FG002|Overall Study|Study terminated by Sponsor|1|||
94487893|NCT01787552|323579434|FG003|Overall Study|Study terminated by Sponsor|3|||
94487894|NCT01787552|323579431|FG000|Overall Study|Progressive Disease|2|||
94487895|NCT01787552|323579432|FG001|Overall Study|Progressive Disease|2|||
94487896|NCT01787552|323579433|FG002|Overall Study|Progressive Disease|1|||
94487897|NCT01787552|323579434|FG003|Overall Study|Progressive Disease|1|||
94487898|NCT03504917|323579435|FG000|Blinded Treatment Period|Protocol Violation|1|||
94487899|NCT03504917|323579436|FG001|Blinded Treatment Period|Protocol Violation|0|||
94487900|NCT03504917|323579435|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
94487901|NCT03504917|323579436|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
94487902|NCT03504917|323579435|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
94487903|NCT03504917|323579436|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
94487904|NCT03504917|323579435|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
94487905|NCT03504917|323579436|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
94487906|NCT03504917|323579435|FG000|Blinded Treatment Period|Adverse Event|4|||
94415028|NCT01304693|323306896|FG001|Overall Study|Adverse Event|0|||
94415029|NCT01304693|323306897|FG002|Overall Study|Adverse Event|0|||
94487907|NCT03504917|323579436|FG001|Blinded Treatment Period|Adverse Event|4|||
94487908|NCT03504917|323579435|FG000|Blinded Treatment Period|Physician Decision|1|||
94487909|NCT03504917|323579436|FG001|Blinded Treatment Period|Physician Decision|0|||
94487910|NCT03504917|323579435|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
94512834|NCT00725985|323676420|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
94415030|NCT01304693|323306898|FG003|Overall Study|Adverse Event|0|||
94415031|NCT01304693|323306899|FG004|Overall Study|Adverse Event|1|||
94415032|NCT01304693|323306895|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
94415033|NCT01304693|323306896|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
94415034|NCT01304693|323306897|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
94415035|NCT01304693|323306898|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
94415036|NCT01304693|323306899|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
94415037|NCT02129647|323306900|FG000|Overall Study|Adverse Event|2|||
94415038|NCT02129647|323306900|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
94415039|NCT01014624|323306905|FG000|Overall Study|Adverse Event|0|||
94415040|NCT01014624|323306906|FG001|Overall Study|Adverse Event|1|||
94415041|NCT01014624|323306905|FG000|Overall Study|Protocol Violation|1|||
94415042|NCT01014624|323306906|FG001|Overall Study|Protocol Violation|0|||
94415043|NCT01014624|323306905|FG000|Overall Study|Withdrawal by Subject|1|||
94415044|NCT01014624|323306906|FG001|Overall Study|Withdrawal by Subject|0|||
94415045|NCT01715896|323306909|FG000|Overall Study|Lost to Follow-up|0|||
94415046|NCT01715896|323306910|FG001|Overall Study|Lost to Follow-up|2|||
94415047|NCT01715896|323306909|FG000|Overall Study|Withdrawal by Subject|1|||
94415048|NCT01715896|323306910|FG001|Overall Study|Withdrawal by Subject|4|||
94415049|NCT01715896|323306909|FG000|Overall Study|Other|2|||
94415050|NCT01715896|323306910|FG001|Overall Study|Other|5|||
94415051|NCT00986570|323306911|FG000|Overall Study|Lost to Follow-up|6|||
94415052|NCT00986570|323306911|FG000|Overall Study|Potential bias for objective assessment|1|||
94415053|NCT01117337|323306920|FG000|Overall Study|Lost to Follow-up|4|||
94415054|NCT01117337|323306921|FG001|Overall Study|Lost to Follow-up|0|||
94415055|NCT01045993|323306922|FG000|Overall Study|Treated-later found eligibility not met|0|||
94415056|NCT01045993|323306923|FG001|Overall Study|Treated-later found eligibility not met|1|||
94415057|NCT01045993|323306924|FG002|Overall Study|Treated-later found eligibility not met|0|||
94415058|NCT01045993|323306925|FG003|Overall Study|Treated-later found eligibility not met|0|||
94415059|NCT03604341|323306927|FG000|Overall Study|Withdrawal by Subject|1|||
94415060|NCT03604341|323306928|FG001|Overall Study|Withdrawal by Subject|1|||
94415061|NCT03604341|323306927|FG000|Overall Study|Adverse Event|1|||
94415062|NCT03604341|323306928|FG001|Overall Study|Adverse Event|0|||
94415063|NCT03604341|323306927|FG000|Overall Study|Protocol Violation|0|||
94415064|NCT03604341|323306928|FG001|Overall Study|Protocol Violation|1|||
94415065|NCT05212883|323306929|FG000|Overall Study|Invalid test result|125|||
94415066|NCT02502734|323306930|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
94415067|NCT02502734|323306931|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
94415068|NCT02502734|323306930|FG000|Washout Period|Adverse Event|1|||
94415069|NCT02502734|323306931|FG001|Washout Period|Adverse Event|0|||
94415070|NCT00614822|323306932|FG000|Overall Study|Adverse Event|3|||
94415071|NCT00102687|323306935|FG000|Initial Period|Withdrawal by Subject|6|||
94415072|NCT00102687|323306936|FG001|Initial Period|Withdrawal by Subject|3|||
94415073|NCT00102687|323306937|FG002|Initial Period|Withdrawal by Subject|5|||
94415074|NCT00102687|323306938|FG003|Initial Period|Withdrawal by Subject|0|||
94415075|NCT00102687|323306939|FG004|Initial Period|Withdrawal by Subject|0|||
94415076|NCT00102687|323306935|FG000|Initial Period|Adverse Event|4|||
94415077|NCT00102687|323306936|FG001|Initial Period|Adverse Event|7|||
94415078|NCT00102687|323306937|FG002|Initial Period|Adverse Event|9|||
94415079|NCT00102687|323306938|FG003|Initial Period|Adverse Event|0|||
94415080|NCT00102687|323306939|FG004|Initial Period|Adverse Event|0|||
94415081|NCT00102687|323306935|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
94415082|NCT00102687|323306936|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
94415083|NCT00102687|323306937|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
94415084|NCT00102687|323306938|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
94415085|NCT00102687|323306939|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
94415086|NCT00102687|323306935|FG000|Initial Period|Protocol Violation|0|||
94415087|NCT00102687|323306936|FG001|Initial Period|Protocol Violation|0|||
94415088|NCT00102687|323306937|FG002|Initial Period|Protocol Violation|2|||
94415089|NCT00102687|323306938|FG003|Initial Period|Protocol Violation|0|||
94415090|NCT00102687|323306939|FG004|Initial Period|Protocol Violation|0|||
94415091|NCT00102687|323306935|FG000|Initial Period|Physician Decision|2|||
94415092|NCT00102687|323306936|FG001|Initial Period|Physician Decision|9|||
94415093|NCT00102687|323306937|FG002|Initial Period|Physician Decision|6|||
94415094|NCT00102687|323306938|FG003|Initial Period|Physician Decision|0|||
94415095|NCT00102687|323306939|FG004|Initial Period|Physician Decision|0|||
94415096|NCT00102687|323306935|FG000|Initial Period|Sponsor's decision|0|||
94415097|NCT00102687|323306936|FG001|Initial Period|Sponsor's decision|1|||
94415098|NCT00102687|323306937|FG002|Initial Period|Sponsor's decision|1|||
94415099|NCT00102687|323306938|FG003|Initial Period|Sponsor's decision|0|||
94512835|NCT00725985|323676421|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
94415100|NCT00102687|323306939|FG004|Initial Period|Sponsor's decision|0|||
94415101|NCT00102687|323306935|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
94415102|NCT00102687|323306936|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
94415103|NCT00102687|323306937|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
94415104|NCT00102687|323306938|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
94415105|NCT00102687|323306939|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
94415106|NCT00102687|323306935|FG000|Initial Period|Death|1|||
94415107|NCT00102687|323306936|FG001|Initial Period|Death|1|||
94415108|NCT00102687|323306937|FG002|Initial Period|Death|1|||
94415109|NCT00102687|323306938|FG003|Initial Period|Death|0|||
94415110|NCT00102687|323306939|FG004|Initial Period|Death|0|||
94415111|NCT00102687|323306935|FG000|Maintenance Period|Withdrawal by Subject|4|||
94415112|NCT00102687|323306936|FG001|Maintenance Period|Withdrawal by Subject|0|||
94415113|NCT00102687|323306937|FG002|Maintenance Period|Withdrawal by Subject|2|||
94415114|NCT00102687|323306938|FG003|Maintenance Period|Withdrawal by Subject|3|||
94415115|NCT00102687|323306939|FG004|Maintenance Period|Withdrawal by Subject|1|||
94415116|NCT00102687|323306935|FG000|Maintenance Period|Adverse Event|1|||
94415117|NCT00102687|323306936|FG001|Maintenance Period|Adverse Event|0|||
94487911|NCT03504917|323579436|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
94487912|NCT03504917|323579435|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
94487913|NCT03504917|323579436|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
94487914|NCT03504917|323579435|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
94487915|NCT03504917|323579436|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
94487916|NCT03504917|323579435|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
94487917|NCT03504917|323579436|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
94487918|NCT03504917|323579435|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
94487919|NCT03504917|323579436|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
94487920|NCT03504917|323579435|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
94487921|NCT03504917|323579436|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
94487922|NCT03504917|323579435|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
94487923|NCT03504917|323579436|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
94487924|NCT03504917|323579435|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
94487925|NCT03504917|323579436|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
94487926|NCT03504917|323579435|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
94487927|NCT03504917|323579436|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
94487928|NCT03504917|323579435|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
94487929|NCT03504917|323579436|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
94487930|NCT04219189|323579437|FG000|Overall Study|Withdrawal by Subject|1|||
94487931|NCT04219189|323579438|FG001|Overall Study|Withdrawal by Subject|2|||
94487932|NCT04219189|323579437|FG000|Overall Study|Protocol Violation|0|||
94487933|NCT04219189|323579438|FG001|Overall Study|Protocol Violation|1|||
94487934|NCT04219189|323579437|FG000|Overall Study|Lost to Follow-up|0|||
94487935|NCT04219189|323579438|FG001|Overall Study|Lost to Follow-up|1|||
94487936|NCT04219189|323579437|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
94487937|NCT04219189|323579438|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
94487938|NCT00572832|323579439|FG000|Overall Study|Lost to Follow-up|0|||
94487939|NCT00572832|323579440|FG001|Overall Study|Lost to Follow-up|11|||
94487940|NCT00572832|323579439|FG000|Overall Study|Pregnancy|0|||
94487941|NCT00572832|323579440|FG001|Overall Study|Pregnancy|1|||
94487942|NCT04079790|323579441|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
94487943|NCT04079790|323579442|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
94487944|NCT04079790|323579443|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
94487945|NCT04079790|323579444|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
94487946|NCT04079790|323579441|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
94487947|NCT04079790|323579442|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
94487948|NCT04079790|323579443|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
94487949|NCT04079790|323579444|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
94487950|NCT04079790|323579441|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
94487951|NCT04079790|323579442|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
94487952|NCT04079790|323579443|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
94487953|NCT04079790|323579444|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
94487954|NCT01253161|323579445|FG000|Overall Study|Adverse Event|1|||
94487955|NCT03101020|323579446|FG000|Overall Study|Lack of time to participate|1|||
94487956|NCT03101020|323579447|FG001|Overall Study|Lack of time to participate|0|||
94487957|NCT03101020|323579446|FG000|Overall Study|Ran over by a car|0|||
94487958|NCT03101020|323579447|FG001|Overall Study|Ran over by a car|1|||
94487959|NCT03101020|323579446|FG000|Overall Study|Withdrawal by Subject|0|||
94487960|NCT03101020|323579447|FG001|Overall Study|Withdrawal by Subject|2|||
94487961|NCT01924533|323579448|FG000|Overall Study|Death|181|||
94415118|NCT00102687|323306937|FG002|Maintenance Period|Adverse Event|0|||
94415119|NCT00102687|323306938|FG003|Maintenance Period|Adverse Event|1|||
94415120|NCT00102687|323306939|FG004|Maintenance Period|Adverse Event|3|||
94415121|NCT00102687|323306935|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
94415122|NCT00102687|323306936|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
94487962|NCT01924533|323579449|FG001|Overall Study|Death|200|||
94487963|NCT01924533|323579448|FG000|Overall Study|Lost to Follow-up|0|||
94487964|NCT01924533|323579449|FG001|Overall Study|Lost to Follow-up|1|||
94487965|NCT01924533|323579448|FG000|Overall Study|Withdrawal by Subject|7|||
94487966|NCT01924533|323579449|FG001|Overall Study|Withdrawal by Subject|3|||
94487967|NCT01924533|323579448|FG000|Overall Study|Other Eligibility criteria|1|||
94487968|NCT01924533|323579449|FG001|Overall Study|Other Eligibility criteria|1|||
94487969|NCT05412134|323579452|FG000|Overall Study|Lost to Follow-up|2|||
94487970|NCT05412134|323579453|FG001|Overall Study|Lost to Follow-up|0|||
94487971|NCT00323063|323579455|FG000|Overall Study|Adverse Event|1|||
94487972|NCT00323063|323579456|FG001|Overall Study|Adverse Event|0|||
94487973|NCT00323063|323579455|FG000|Overall Study|brain mets discovered prior to treatment|1|||
94487974|NCT00323063|323579456|FG001|Overall Study|brain mets discovered prior to treatment|0|||
94487975|NCT03307174|323579457|FG000|Overall Study|Unplanned ICU Administrion|5|||
94487976|NCT03307174|323579458|FG001|Overall Study|Unplanned ICU Administrion|3|||
94487977|NCT03307174|323579457|FG000|Overall Study|Aborted Surgery|1|||
94487978|NCT03307174|323579458|FG001|Overall Study|Aborted Surgery|2|||
94487979|NCT03307174|323579457|FG000|Overall Study|Hypotension|6|||
94487980|NCT03307174|323579458|FG001|Overall Study|Hypotension|0|||
94487981|NCT03307174|323579457|FG000|Overall Study|Nonfunctional epidural|1|||
94487982|NCT03307174|323579458|FG001|Overall Study|Nonfunctional epidural|1|||
94487983|NCT03307174|323579457|FG000|Overall Study|Planned epidural removal|1|||
94487984|NCT03307174|323579458|FG001|Overall Study|Planned epidural removal|0|||
94487985|NCT03307174|323579457|FG000|Overall Study|Intrathecal catheter placement|0|||
94487986|NCT03307174|323579458|FG001|Overall Study|Intrathecal catheter placement|1|||
94487987|NCT04275336|323579459|FG000|Overall Study|First venipuncture failed|4|||
94487988|NCT04275336|323579460|FG001|Overall Study|First venipuncture failed|6|||
94487989|NCT04275336|323579461|FG002|Overall Study|First venipuncture failed|5|||
94487990|NCT04275336|323579459|FG000|Overall Study|Unscheduled venipuncture|9|||
94415123|NCT00102687|323306937|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
94415124|NCT00102687|323306938|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
94415125|NCT00102687|323306939|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
94415126|NCT00102687|323306935|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
94415127|NCT00102687|323306936|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
94415128|NCT00102687|323306937|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
94415129|NCT00102687|323306938|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
94415130|NCT00102687|323306939|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
94415131|NCT00102687|323306935|FG000|Maintenance Period|Death|0|||
94415132|NCT00102687|323306936|FG001|Maintenance Period|Death|0|||
94415133|NCT00102687|323306937|FG002|Maintenance Period|Death|0|||
94415134|NCT00102687|323306938|FG003|Maintenance Period|Death|1|||
94415135|NCT00102687|323306939|FG004|Maintenance Period|Death|1|||
94415136|NCT00102687|323306935|FG000|Maintenance Period|Physician Decision|1|||
94415137|NCT00102687|323306936|FG001|Maintenance Period|Physician Decision|2|||
94415138|NCT00102687|323306937|FG002|Maintenance Period|Physician Decision|3|||
94415139|NCT00102687|323306938|FG003|Maintenance Period|Physician Decision|0|||
94415140|NCT00102687|323306939|FG004|Maintenance Period|Physician Decision|4|||
94415141|NCT02010255|323306941|FG000|Overall Study|Death|0|||
94415142|NCT02010255|323306942|FG001|Overall Study|Death|1|||
94415143|NCT02010255|323306943|FG002|Overall Study|Death|4|||
94415144|NCT02010255|323306944|FG003|Overall Study|Death|4|||
94415145|NCT02010255|323306945|FG004|Overall Study|Death|2|||
94415146|NCT02010255|323306946|FG005|Overall Study|Death|0|||
94415147|NCT02010255|323306947|FG006|Overall Study|Death|1|||
94415148|NCT02010255|323306948|FG007|Overall Study|Death|1|||
94415149|NCT02010255|323306949|FG008|Overall Study|Death|1|||
94415150|NCT02010255|323306950|FG009|Overall Study|Death|0|||
94415151|NCT02010255|323306951|FG010|Overall Study|Death|1|||
94415152|NCT02010255|323306952|FG011|Overall Study|Death|1|||
94415153|NCT02010255|323306953|FG012|Overall Study|Death|0|||
94415154|NCT02010255|323306954|FG013|Overall Study|Death|0|||
94415155|NCT02010255|323306941|FG000|Overall Study|Lack of Efficacy|4|||
94415156|NCT02010255|323306942|FG001|Overall Study|Lack of Efficacy|1|||
94415157|NCT02010255|323306943|FG002|Overall Study|Lack of Efficacy|2|||
94415158|NCT02010255|323306944|FG003|Overall Study|Lack of Efficacy|1|||
94415159|NCT02010255|323306945|FG004|Overall Study|Lack of Efficacy|1|||
94415160|NCT02010255|323306946|FG005|Overall Study|Lack of Efficacy|0|||
94415161|NCT02010255|323306947|FG006|Overall Study|Lack of Efficacy|0|||
94415162|NCT02010255|323306948|FG007|Overall Study|Lack of Efficacy|0|||
94415163|NCT02010255|323306949|FG008|Overall Study|Lack of Efficacy|0|||
94415164|NCT02010255|323306950|FG009|Overall Study|Lack of Efficacy|0|||
94415165|NCT02010255|323306951|FG010|Overall Study|Lack of Efficacy|1|||
94415166|NCT02010255|323306952|FG011|Overall Study|Lack of Efficacy|0|||
94487991|NCT04275336|323579460|FG001|Overall Study|Unscheduled venipuncture|13|||
94487992|NCT04275336|323579461|FG002|Overall Study|Unscheduled venipuncture|7|||
94487993|NCT04275336|323579459|FG000|Overall Study|Failed specimen of saliva|4|||
94487994|NCT04275336|323579460|FG001|Overall Study|Failed specimen of saliva|3|||
94487995|NCT04275336|323579461|FG002|Overall Study|Failed specimen of saliva|4|||
94415167|NCT02010255|323306953|FG012|Overall Study|Lack of Efficacy|0|||
94415168|NCT02010255|323306954|FG013|Overall Study|Lack of Efficacy|0|||
94415169|NCT02010255|323306941|FG000|Overall Study|Withdrew Consent|1|||
94415170|NCT02010255|323306942|FG001|Overall Study|Withdrew Consent|0|||
94415171|NCT02010255|323306943|FG002|Overall Study|Withdrew Consent|0|||
94415172|NCT02010255|323306944|FG003|Overall Study|Withdrew Consent|1|||
94415173|NCT02010255|323306945|FG004|Overall Study|Withdrew Consent|0|||
94415174|NCT02010255|323306946|FG005|Overall Study|Withdrew Consent|0|||
94415175|NCT02010255|323306947|FG006|Overall Study|Withdrew Consent|0|||
94415176|NCT02010255|323306948|FG007|Overall Study|Withdrew Consent|0|||
94415177|NCT02010255|323306949|FG008|Overall Study|Withdrew Consent|0|||
94415178|NCT02010255|323306950|FG009|Overall Study|Withdrew Consent|0|||
94415179|NCT02010255|323306951|FG010|Overall Study|Withdrew Consent|0|||
94415180|NCT02010255|323306952|FG011|Overall Study|Withdrew Consent|0|||
94415181|NCT02010255|323306953|FG012|Overall Study|Withdrew Consent|0|||
94415182|NCT02010255|323306954|FG013|Overall Study|Withdrew Consent|0|||
94415183|NCT02010255|323306941|FG000|Overall Study|Adverse Event|1|||
94415184|NCT02010255|323306942|FG001|Overall Study|Adverse Event|0|||
94415185|NCT02010255|323306943|FG002|Overall Study|Adverse Event|0|||
94415186|NCT02010255|323306944|FG003|Overall Study|Adverse Event|0|||
94415187|NCT02010255|323306945|FG004|Overall Study|Adverse Event|0|||
94415188|NCT02010255|323306946|FG005|Overall Study|Adverse Event|0|||
94415189|NCT02010255|323306947|FG006|Overall Study|Adverse Event|0|||
94415190|NCT02010255|323306948|FG007|Overall Study|Adverse Event|0|||
94415191|NCT02010255|323306949|FG008|Overall Study|Adverse Event|0|||
94415192|NCT02010255|323306950|FG009|Overall Study|Adverse Event|0|||
94415193|NCT02010255|323306951|FG010|Overall Study|Adverse Event|0|||
94415194|NCT02010255|323306952|FG011|Overall Study|Adverse Event|0|||
94415195|NCT02010255|323306953|FG012|Overall Study|Adverse Event|0|||
94415196|NCT02010255|323306954|FG013|Overall Study|Adverse Event|0|||
94415197|NCT02010255|323306941|FG000|Overall Study|Lost to Follow-up|0|||
94415198|NCT02010255|323306942|FG001|Overall Study|Lost to Follow-up|0|||
94415199|NCT02010255|323306943|FG002|Overall Study|Lost to Follow-up|1|||
94415200|NCT02010255|323306944|FG003|Overall Study|Lost to Follow-up|0|||
94415201|NCT02010255|323306945|FG004|Overall Study|Lost to Follow-up|1|||
94415202|NCT02010255|323306946|FG005|Overall Study|Lost to Follow-up|0|||
94415203|NCT02010255|323306947|FG006|Overall Study|Lost to Follow-up|0|||
94415204|NCT02010255|323306948|FG007|Overall Study|Lost to Follow-up|0|||
94415205|NCT02010255|323306949|FG008|Overall Study|Lost to Follow-up|0|||
94415206|NCT02010255|323306950|FG009|Overall Study|Lost to Follow-up|0|||
94415207|NCT02010255|323306951|FG010|Overall Study|Lost to Follow-up|0|||
94415208|NCT02010255|323306952|FG011|Overall Study|Lost to Follow-up|0|||
94415209|NCT02010255|323306953|FG012|Overall Study|Lost to Follow-up|0|||
94415210|NCT02010255|323306954|FG013|Overall Study|Lost to Follow-up|0|||
94415211|NCT02010255|323306941|FG000|Overall Study|Randomized but Not Treated|0|||
94415212|NCT02010255|323306942|FG001|Overall Study|Randomized but Not Treated|0|||
94415213|NCT02010255|323306943|FG002|Overall Study|Randomized but Not Treated|0|||
94415214|NCT02010255|323306944|FG003|Overall Study|Randomized but Not Treated|0|||
94415215|NCT02010255|323306945|FG004|Overall Study|Randomized but Not Treated|0|||
94415216|NCT02010255|323306946|FG005|Overall Study|Randomized but Not Treated|0|||
94415217|NCT02010255|323306947|FG006|Overall Study|Randomized but Not Treated|0|||
94415218|NCT02010255|323306948|FG007|Overall Study|Randomized but Not Treated|0|||
94415219|NCT02010255|323306949|FG008|Overall Study|Randomized but Not Treated|0|||
94415220|NCT02010255|323306950|FG009|Overall Study|Randomized but Not Treated|0|||
94415221|NCT02010255|323306951|FG010|Overall Study|Randomized but Not Treated|0|||
94415222|NCT02010255|323306952|FG011|Overall Study|Randomized but Not Treated|0|||
94415223|NCT02010255|323306953|FG012|Overall Study|Randomized but Not Treated|0|||
94415224|NCT02010255|323306954|FG013|Overall Study|Randomized but Not Treated|1|||
94415225|NCT02990806|323306957|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
94415226|NCT02990806|323306958|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
94415227|NCT02990806|323306959|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
94415228|NCT02990806|323306960|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
94415229|NCT02990806|323306957|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
94415230|NCT02990806|323306958|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
94415231|NCT02990806|323306959|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
94415232|NCT02990806|323306960|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
94415233|NCT02990806|323306957|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
94415234|NCT02990806|323306958|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
94415235|NCT02990806|323306959|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
94415236|NCT02990806|323306960|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
94415237|NCT02990806|323306957|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
94415238|NCT02990806|323306958|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
94415239|NCT02990806|323306959|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
94415240|NCT02990806|323306960|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
94415241|NCT02990806|323306957|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
94415242|NCT02990806|323306958|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
94415243|NCT02990806|323306959|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
94415244|NCT02990806|323306960|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
94415245|NCT02990806|323306957|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
94415246|NCT02990806|323306958|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
94415247|NCT02990806|323306959|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
94415248|NCT02990806|323306960|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
94415249|NCT02990806|323306957|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
94415250|NCT02990806|323306958|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
94415251|NCT02990806|323306959|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
94415252|NCT02990806|323306960|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
94415253|NCT02990806|323306957|FG000|Stage 1 (22 Weeks)|Death|0|||
94415254|NCT02990806|323306958|FG001|Stage 1 (22 Weeks)|Death|1|||
94415255|NCT02990806|323306959|FG002|Stage 1 (22 Weeks)|Death|0|||
94415256|NCT02990806|323306960|FG003|Stage 1 (22 Weeks)|Death|0|||
94415257|NCT02990806|323306957|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
94415258|NCT02990806|323306958|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
94415259|NCT02990806|323306959|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
94415260|NCT02990806|323306960|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
94415261|NCT02990806|323306957|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
94415262|NCT02990806|323306958|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
94415263|NCT02990806|323306959|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
94415264|NCT02990806|323306960|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
94415265|NCT02990806|323306957|FG000|Stage 1 (22 Weeks)|Other|1|||
94415266|NCT02990806|323306958|FG001|Stage 1 (22 Weeks)|Other|3|||
94415267|NCT02990806|323306959|FG002|Stage 1 (22 Weeks)|Other|0|||
94415268|NCT02990806|323306960|FG003|Stage 1 (22 Weeks)|Other|0|||
94415269|NCT02990806|323306957|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
94415270|NCT02990806|323306958|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
94415271|NCT02990806|323306959|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
94415272|NCT02990806|323306960|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
94415273|NCT02990806|323306957|FG000|Stage 2 (32 Weeks)|Death|1|||
94415274|NCT02990806|323306958|FG001|Stage 2 (32 Weeks)|Death|0|||
94415275|NCT02990806|323306959|FG002|Stage 2 (32 Weeks)|Death|0|||
94415276|NCT02990806|323306960|FG003|Stage 2 (32 Weeks)|Death|0|||
94415277|NCT02990806|323306957|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
94415278|NCT02990806|323306958|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
94415279|NCT02990806|323306959|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
94415280|NCT02990806|323306960|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
94415281|NCT02990806|323306957|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
94415282|NCT02990806|323306958|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
94415283|NCT02990806|323306959|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
94415284|NCT02990806|323306960|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
94415285|NCT02990806|323306957|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
94415286|NCT02990806|323306958|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
94415287|NCT02990806|323306959|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
94415288|NCT02990806|323306960|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
94415289|NCT02990806|323306957|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
94415290|NCT02990806|323306958|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
94415291|NCT02990806|323306959|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
94415292|NCT02990806|323306960|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
94415293|NCT02990806|323306957|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
94415294|NCT02990806|323306958|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
94415295|NCT02990806|323306959|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
94415296|NCT02990806|323306960|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
94415297|NCT02990806|323306957|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
94415298|NCT02990806|323306958|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
94415299|NCT02990806|323306959|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
94415300|NCT02990806|323306960|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
94415301|NCT02990806|323306957|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
94415302|NCT02990806|323306958|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
94415303|NCT02990806|323306959|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
94415304|NCT02990806|323306960|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
94415305|NCT02990806|323306957|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
94415306|NCT02990806|323306958|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
94415307|NCT02990806|323306959|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
94415308|NCT02990806|323306960|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
94415309|NCT02990806|323306957|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
94415310|NCT02990806|323306958|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
94487996|NCT03055936|323579462|FG000|Overall Study|Adverse Event|0|||
94415311|NCT02990806|323306959|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
94415312|NCT02990806|323306960|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
94415313|NCT02990806|323306957|FG000|Stage 2 (32 Weeks)|Other|3|||
94415314|NCT02990806|323306958|FG001|Stage 2 (32 Weeks)|Other|0|||
94415315|NCT02990806|323306959|FG002|Stage 2 (32 Weeks)|Other|4|||
94415316|NCT02990806|323306960|FG003|Stage 2 (32 Weeks)|Other|1|||
94415317|NCT02990806|323306957|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
94415318|NCT02990806|323306958|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
94415319|NCT02990806|323306959|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
94415320|NCT02990806|323306960|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
94415321|NCT02990806|323306957|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
94415322|NCT02990806|323306958|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
94415323|NCT02990806|323306959|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
94415324|NCT02990806|323306960|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
94415325|NCT02990806|323306957|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
94415326|NCT02990806|323306958|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
94415327|NCT02990806|323306959|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
94415328|NCT02990806|323306960|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
94415329|NCT02990806|323306957|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
94415330|NCT02990806|323306958|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
94415331|NCT02990806|323306959|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
94415332|NCT02990806|323306960|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
94415333|NCT02990806|323306957|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
94415334|NCT02990806|323306958|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
94415335|NCT02990806|323306959|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
94415336|NCT02990806|323306960|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
94415337|NCT02990806|323306957|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
94415338|NCT02990806|323306958|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
94415339|NCT02990806|323306959|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
94415340|NCT02990806|323306960|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
94415341|NCT02990806|323306957|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
94415342|NCT02990806|323306958|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
94415343|NCT02990806|323306959|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
94415344|NCT02990806|323306960|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
94415345|NCT02990806|323306957|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
94415346|NCT02990806|323306958|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
94415347|NCT02990806|323306959|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
94415348|NCT02990806|323306960|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
94415349|NCT02990806|323306957|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
94415350|NCT02990806|323306958|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
94415351|NCT02990806|323306959|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
94415352|NCT02990806|323306960|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
94415353|NCT03739138|323306963|FG000|Overall Study|Death|0|||
94415354|NCT03739138|323306964|FG001|Overall Study|Death|7|||
94415355|NCT03739138|323306965|FG002|Overall Study|Death|4|||
94415356|NCT03739138|323306966|FG003|Overall Study|Death|13|||
94415357|NCT03739138|323306967|FG004|Overall Study|Death|0|||
94415358|NCT03739138|323306963|FG000|Overall Study|Lost to Follow-up|0|||
94415359|NCT03739138|323306964|FG001|Overall Study|Lost to Follow-up|0|||
94415360|NCT03739138|323306965|FG002|Overall Study|Lost to Follow-up|1|||
94415361|NCT03739138|323306966|FG003|Overall Study|Lost to Follow-up|0|||
94415362|NCT03739138|323306967|FG004|Overall Study|Lost to Follow-up|0|||
94415363|NCT03739138|323306963|FG000|Overall Study|Study Terminated By Sponsor|0|||
94415364|NCT03739138|323306964|FG001|Overall Study|Study Terminated By Sponsor|0|||
94415365|NCT03739138|323306965|FG002|Overall Study|Study Terminated By Sponsor|0|||
94415366|NCT03739138|323306966|FG003|Overall Study|Study Terminated By Sponsor|4|||
94415367|NCT03739138|323306967|FG004|Overall Study|Study Terminated By Sponsor|0|||
94487997|NCT03055936|323579463|FG001|Overall Study|Adverse Event|1|||
94487998|NCT03055936|323579464|FG002|Overall Study|Adverse Event|1|||
94487999|NCT03055936|323579465|FG003|Overall Study|Adverse Event|1|||
94488000|NCT03055936|323579462|FG000|Overall Study|Personal reason|2|||
94488001|NCT03055936|323579463|FG001|Overall Study|Personal reason|0|||
94488002|NCT03055936|323579464|FG002|Overall Study|Personal reason|1|||
94488003|NCT03055936|323579465|FG003|Overall Study|Personal reason|0|||
94488004|NCT03087058|323579472|FG000|Overall Study|Withdrawal by Subject|2|||
94488005|NCT03087058|323579473|FG001|Overall Study|Withdrawal by Subject|0|||
94488006|NCT03087058|323579474|FG002|Overall Study|Withdrawal by Subject|0|||
94488007|NCT02078817|323579475|FG000|Overall Study|Withdrawal by Subject|1|||
94415368|NCT03739138|323306963|FG000|Overall Study|Withdrawal by Subject|0|||
94415369|NCT03739138|323306964|FG001|Overall Study|Withdrawal by Subject|0|||
94415370|NCT03739138|323306965|FG002|Overall Study|Withdrawal by Subject|0|||
94415371|NCT03739138|323306966|FG003|Overall Study|Withdrawal by Subject|1|||
94415372|NCT03739138|323306967|FG004|Overall Study|Withdrawal by Subject|0|||
94488008|NCT00721799|323579476|FG000|Overall Study|Withdrawal by Subject|7|||
94488009|NCT00721799|323579476|FG000|Overall Study|withdraw by subject after scan 1|1|||
94488010|NCT01149655|323579481|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
94415373|NCT03395639|323306968|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
94415374|NCT03395639|323306969|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
94415375|NCT03395639|323306970|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
94415376|NCT03395639|323306968|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
94415377|NCT03395639|323306969|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
94415378|NCT03395639|323306970|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
94415379|NCT03395639|323306968|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
94415380|NCT03395639|323306969|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
94415381|NCT03395639|323306970|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
94415382|NCT03395639|323306968|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
94415383|NCT03395639|323306969|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
94415384|NCT03395639|323306970|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
94415385|NCT03395639|323306968|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
94415386|NCT03395639|323306969|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
94415387|NCT03395639|323306970|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
94415388|NCT00680186|323306971|FG000|Overall Study|Adverse Event|47|||
94415389|NCT00680186|323306972|FG001|Overall Study|Adverse Event|44|||
94415390|NCT00680186|323306971|FG000|Overall Study|Protocol Violation|31|||
94415391|NCT00680186|323306972|FG001|Overall Study|Protocol Violation|26|||
94415392|NCT00680186|323306971|FG000|Overall Study|Lost to Follow-up|11|||
94415393|NCT00680186|323306972|FG001|Overall Study|Lost to Follow-up|6|||
94415394|NCT00680186|323306971|FG000|Overall Study|Withdrawal by Subject|32|||
94415395|NCT00680186|323306972|FG001|Overall Study|Withdrawal by Subject|39|||
94415396|NCT00680186|323306971|FG000|Overall Study|Other|4|||
94415397|NCT00680186|323306972|FG001|Overall Study|Other|1|||
94415398|NCT02903238|323306973|FG000|Overall Study|Lost to Follow-up|4|||
94415399|NCT02924376|323306979|FG000|Overall Study|Progressive Disease|4|||
94415400|NCT02924376|323306980|FG001|Overall Study|Progressive Disease|0|||
94415401|NCT02924376|323306981|FG002|Overall Study|Progressive Disease|1|||
94415402|NCT02924376|323306982|FG003|Overall Study|Progressive Disease|0|||
94415403|NCT02924376|323306979|FG000|Overall Study|Death|73|||
94415404|NCT02924376|323306980|FG001|Overall Study|Death|18|||
94415405|NCT02924376|323306981|FG002|Overall Study|Death|15|||
94415406|NCT02924376|323306982|FG003|Overall Study|Death|2|||
94415407|NCT02924376|323306979|FG000|Overall Study|Lost to Follow-up|3|||
94415408|NCT02924376|323306980|FG001|Overall Study|Lost to Follow-up|0|||
94415409|NCT02924376|323306981|FG002|Overall Study|Lost to Follow-up|0|||
94415410|NCT02924376|323306982|FG003|Overall Study|Lost to Follow-up|0|||
94415411|NCT02924376|323306979|FG000|Overall Study|Study Terminated by Sponsor|19|||
94415412|NCT02924376|323306980|FG001|Overall Study|Study Terminated by Sponsor|0|||
94415413|NCT02924376|323306981|FG002|Overall Study|Study Terminated by Sponsor|0|||
94415414|NCT02924376|323306982|FG003|Overall Study|Study Terminated by Sponsor|0|||
94415415|NCT02924376|323306979|FG000|Overall Study|Physician Decision|1|||
94415416|NCT02924376|323306980|FG001|Overall Study|Physician Decision|0|||
94415417|NCT02924376|323306981|FG002|Overall Study|Physician Decision|0|||
94415418|NCT02924376|323306982|FG003|Overall Study|Physician Decision|0|||
94415419|NCT02924376|323306979|FG000|Overall Study|Withdrawal by Subject|7|||
94415420|NCT02924376|323306980|FG001|Overall Study|Withdrawal by Subject|2|||
94415421|NCT02924376|323306981|FG002|Overall Study|Withdrawal by Subject|1|||
94415422|NCT02924376|323306982|FG003|Overall Study|Withdrawal by Subject|0|||
94415423|NCT02924376|323306979|FG000|Overall Study|Rolled Over to Another Study|1|||
94415424|NCT02924376|323306980|FG001|Overall Study|Rolled Over to Another Study|0|||
94415425|NCT02924376|323306981|FG002|Overall Study|Rolled Over to Another Study|0|||
94488011|NCT01149655|323579482|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
94488012|NCT01149655|323579483|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
94415426|NCT02924376|323306982|FG003|Overall Study|Rolled Over to Another Study|0|||
94415427|NCT00958126|323306983|FG000|Overall Study|Serious Adverse Event|0|||
94415428|NCT00958126|323306984|FG001|Overall Study|Serious Adverse Event|2|||
94415429|NCT00958126|323306985|FG002|Overall Study|Serious Adverse Event|0|||
94415430|NCT00958126|323306986|FG003|Overall Study|Serious Adverse Event|0|||
94488013|NCT01149655|323579484|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
94488014|NCT01149655|323579481|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
94488015|NCT01149655|323579482|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
94415431|NCT00958126|323306987|FG004|Overall Study|Serious Adverse Event|0|||
94415432|NCT00958126|323306988|FG005|Overall Study|Serious Adverse Event|0|||
94415433|NCT00958126|323306989|FG006|Overall Study|Serious Adverse Event|1|||
94415434|NCT00958126|323306990|FG007|Overall Study|Serious Adverse Event|0|||
94415435|NCT00958126|323306983|FG000|Overall Study|Withdrawal by Subject|0|||
94415436|NCT00958126|323306984|FG001|Overall Study|Withdrawal by Subject|2|||
94415437|NCT00958126|323306985|FG002|Overall Study|Withdrawal by Subject|0|||
94415438|NCT00958126|323306986|FG003|Overall Study|Withdrawal by Subject|0|||
94415439|NCT00958126|323306987|FG004|Overall Study|Withdrawal by Subject|0|||
94415440|NCT00958126|323306988|FG005|Overall Study|Withdrawal by Subject|0|||
94415441|NCT00958126|323306989|FG006|Overall Study|Withdrawal by Subject|0|||
94415442|NCT00958126|323306990|FG007|Overall Study|Withdrawal by Subject|0|||
94415443|NCT00958126|323306983|FG000|Overall Study|Moved away from study area|0|||
94415444|NCT00958126|323306984|FG001|Overall Study|Moved away from study area|0|||
94415445|NCT00958126|323306985|FG002|Overall Study|Moved away from study area|1|||
94415446|NCT00958126|323306986|FG003|Overall Study|Moved away from study area|1|||
94415447|NCT00958126|323306987|FG004|Overall Study|Moved away from study area|0|||
94415448|NCT00958126|323306988|FG005|Overall Study|Moved away from study area|0|||
94415449|NCT00958126|323306989|FG006|Overall Study|Moved away from study area|0|||
94415450|NCT00958126|323306990|FG007|Overall Study|Moved away from study area|0|||
94415451|NCT00958126|323306983|FG000|Overall Study|Lost to Follow-up|1|||
94415452|NCT00958126|323306984|FG001|Overall Study|Lost to Follow-up|5|||
94415453|NCT00958126|323306985|FG002|Overall Study|Lost to Follow-up|9|||
94415454|NCT00958126|323306986|FG003|Overall Study|Lost to Follow-up|8|||
94415455|NCT00958126|323306987|FG004|Overall Study|Lost to Follow-up|0|||
94415456|NCT00958126|323306988|FG005|Overall Study|Lost to Follow-up|0|||
94415457|NCT00958126|323306989|FG006|Overall Study|Lost to Follow-up|0|||
94415458|NCT00958126|323306990|FG007|Overall Study|Lost to Follow-up|0|||
94415459|NCT00958126|323306983|FG000|Overall Study|Sponsor/Investigator decision|0|||
94415460|NCT00958126|323306984|FG001|Overall Study|Sponsor/Investigator decision|0|||
94415461|NCT00958126|323306985|FG002|Overall Study|Sponsor/Investigator decision|0|||
94415462|NCT00958126|323306986|FG003|Overall Study|Sponsor/Investigator decision|1|||
94415463|NCT00958126|323306987|FG004|Overall Study|Sponsor/Investigator decision|0|||
94415464|NCT00958126|323306988|FG005|Overall Study|Sponsor/Investigator decision|0|||
94415465|NCT00958126|323306989|FG006|Overall Study|Sponsor/Investigator decision|0|||
94415466|NCT00958126|323306990|FG007|Overall Study|Sponsor/Investigator decision|0|||
94415467|NCT00958126|323306983|FG000|Overall Study|Other Reason|0|||
94415468|NCT00958126|323306984|FG001|Overall Study|Other Reason|0|||
94415469|NCT00958126|323306985|FG002|Overall Study|Other Reason|0|||
94415470|NCT00958126|323306986|FG003|Overall Study|Other Reason|1|||
94415471|NCT00958126|323306987|FG004|Overall Study|Other Reason|0|||
94415472|NCT00958126|323306988|FG005|Overall Study|Other Reason|1|||
94415473|NCT00958126|323306989|FG006|Overall Study|Other Reason|0|||
94415474|NCT00958126|323306990|FG007|Overall Study|Other Reason|0|||
94415475|NCT00720226|323306991|FG000|Overall Study|Withdrawal by Subject|7|||
94415476|NCT00720226|323306992|FG001|Overall Study|Withdrawal by Subject|4|||
94415477|NCT00733369|323306993|FG000|Overall Study|Lost to Follow-up|2|||
94415478|NCT00733369|323306994|FG001|Overall Study|Lost to Follow-up|1|||
94415479|NCT00733369|323306993|FG000|Overall Study|Adverse Event|4|||
94415480|NCT00733369|323306994|FG001|Overall Study|Adverse Event|4|||
94415481|NCT00733369|323306993|FG000|Overall Study|Protocol Violation|4|||
94415482|NCT00733369|323306994|FG001|Overall Study|Protocol Violation|4|||
94415483|NCT01506908|323307000|FG000|Overall Study|Adverse Event|1|||
94415484|NCT01506908|323307001|FG001|Overall Study|Adverse Event|0|||
94415485|NCT02510014|323307008|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
94415486|NCT02510014|323307009|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
94415487|NCT02510014|323307008|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
94415488|NCT02510014|323307009|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
94415489|NCT02510014|323307008|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
94415490|NCT02510014|323307009|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
94415491|NCT02510014|323307008|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
94415492|NCT02510014|323307009|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
94415493|NCT02510014|323307008|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
94415494|NCT02510014|323307009|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
94415495|NCT02510014|323307008|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
94415496|NCT02510014|323307009|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
94415497|NCT02510014|323307008|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
94415498|NCT02510014|323307009|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
94415499|NCT02510014|323307008|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
94415500|NCT02510014|323307009|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
94415501|NCT02510014|323307008|FG000|Treatment Period|Adverse Event|11|||
94415502|NCT02510014|323307009|FG001|Treatment Period|Adverse Event|4|||
94415503|NCT02510014|323307008|FG000|Treatment Period|Withdrawal symptoms|3|||
94415504|NCT02510014|323307009|FG001|Treatment Period|Withdrawal symptoms|0|||
94415505|NCT02510014|323307008|FG000|Treatment Period|Lost to Follow-up|80|||
94415506|NCT02510014|323307009|FG001|Treatment Period|Lost to Follow-up|19|||
94415507|NCT02510014|323307008|FG000|Treatment Period|Physician Decision|5|||
94415508|NCT02510014|323307009|FG001|Treatment Period|Physician Decision|0|||
94415509|NCT02510014|323307008|FG000|Treatment Period|Withdrawal by Subject|67|||
94415510|NCT02510014|323307009|FG001|Treatment Period|Withdrawal by Subject|24|||
94415511|NCT02510014|323307008|FG000|Treatment Period|Withdrawn by the investigator|7|||
94415512|NCT02510014|323307009|FG001|Treatment Period|Withdrawn by the investigator|1|||
94415513|NCT02510014|323307008|FG000|Treatment Period|Protocol Violation|4|||
94415514|NCT02510014|323307009|FG001|Treatment Period|Protocol Violation|4|||
94415515|NCT02510014|323307008|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
94415516|NCT02510014|323307009|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
94415517|NCT01020799|323307012|FG000|Overall Study|Adverse Event|4|||
94415518|NCT01020799|323307013|FG001|Overall Study|Adverse Event|3|||
94415519|NCT01020799|323307014|FG002|Overall Study|Adverse Event|2|||
94415520|NCT01020799|323307012|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
94415521|NCT01020799|323307013|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
94415522|NCT01020799|323307014|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
94415523|NCT01020799|323307012|FG000|Overall Study|Protocol Violation|3|||
94415524|NCT01020799|323307013|FG001|Overall Study|Protocol Violation|2|||
94415525|NCT01020799|323307014|FG002|Overall Study|Protocol Violation|0|||
94415526|NCT01020799|323307012|FG000|Overall Study|Withdrawal by Subject|2|||
94415527|NCT01020799|323307013|FG001|Overall Study|Withdrawal by Subject|2|||
94415528|NCT01020799|323307014|FG002|Overall Study|Withdrawal by Subject|3|||
94415529|NCT01020799|323307012|FG000|Overall Study|Lost to Follow-up|6|||
94415530|NCT01020799|323307013|FG001|Overall Study|Lost to Follow-up|4|||
94415531|NCT01020799|323307014|FG002|Overall Study|Lost to Follow-up|2|||
94415532|NCT03856593|323307015|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
94415533|NCT03856593|323307016|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
94415534|NCT01875471|323307017|FG000|Overall Study|Adverse Event|0|||
94415535|NCT01875471|323307018|FG001|Overall Study|Adverse Event|1|||
94415536|NCT01875471|323307017|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
94415537|NCT01875471|323307018|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
94415538|NCT01949116|323307020|FG000|Overall Study|Death|2|||
94415539|NCT01949116|323307021|FG001|Overall Study|Death|0|||
94415540|NCT01949116|323307020|FG000|Overall Study|Lost to Follow-up|1|||
94415541|NCT01949116|323307021|FG001|Overall Study|Lost to Follow-up|3|||
94415542|NCT01949116|323307020|FG000|Overall Study|Withdrawal by Subject|5|||
94415543|NCT01949116|323307021|FG001|Overall Study|Withdrawal by Subject|3|||
94415544|NCT00925301|323307022|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
94415545|NCT00925301|323307023|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
94415546|NCT00925301|323307024|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
94415547|NCT00925301|323307025|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
94415548|NCT00925301|323307022|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
94415549|NCT00925301|323307023|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
94415550|NCT00925301|323307024|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
94415551|NCT00925301|323307025|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
94415552|NCT00925301|323307022|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
94415553|NCT00925301|323307023|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
94415554|NCT00925301|323307024|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
94415555|NCT00925301|323307025|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
94415556|NCT00925301|323307022|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
94415557|NCT00925301|323307023|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
94415558|NCT00925301|323307024|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
94415559|NCT00925301|323307025|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
94415560|NCT00925301|323307022|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
94415561|NCT00925301|323307023|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
94415562|NCT00925301|323307024|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
94415563|NCT00925301|323307025|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
94415564|NCT00925301|323307022|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
94415565|NCT00925301|323307023|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
94415566|NCT00925301|323307024|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
94415567|NCT00925301|323307025|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
94415568|NCT00925301|323307022|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
94415569|NCT00925301|323307023|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
94415570|NCT00925301|323307024|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
94415571|NCT00925301|323307025|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
94415572|NCT00854373|323307026|FG000|Overall Study|Withdrawal by Subject|1|||
94415573|NCT00854373|323307027|FG001|Overall Study|Withdrawal by Subject|3|||
94415574|NCT00854373|323307026|FG000|Overall Study|Forgot to take study drug|1|||
94415575|NCT00854373|323307027|FG001|Overall Study|Forgot to take study drug|1|||
94415576|NCT00842530|323307028|FG000|Overall Study|Serious adverse event|0|||
94415577|NCT00842530|323307029|FG001|Overall Study|Serious adverse event|6|||
94415578|NCT00842530|323307028|FG000|Overall Study|Other adverse event|6|||
94415579|NCT00842530|323307029|FG001|Overall Study|Other adverse event|1|||
94415580|NCT00842530|323307028|FG000|Overall Study|Protocol Violation|32|||
94415581|NCT00842530|323307029|FG001|Overall Study|Protocol Violation|14|||
94415582|NCT00842530|323307028|FG000|Overall Study|Lost to Follow-up|6|||
94415583|NCT00842530|323307029|FG001|Overall Study|Lost to Follow-up|8|||
94415584|NCT00842530|323307028|FG000|Overall Study|Withdrawal by Subject|73|||
94415585|NCT00842530|323307029|FG001|Overall Study|Withdrawal by Subject|28|||
94415586|NCT02442271|323307032|FG000|Overall Study|Adverse Event|1|||
94415587|NCT02442271|323307032|FG000|Overall Study|Withdrew Consent|1|||
94415588|NCT02442271|323307032|FG000|Overall Study|Lost to Follow-up|1|||
94415589|NCT02442271|323307032|FG000|Overall Study|Other|1|||
94415590|NCT01382251|323307035|FG000|Overall Study|Surgeries cancelled or delayed|16|||
94415591|NCT01382251|323307036|FG001|Overall Study|Surgeries cancelled or delayed|16|||
94415592|NCT01382251|323307035|FG000|Overall Study|Lost to Follow-up|4|||
94415593|NCT01382251|323307036|FG001|Overall Study|Lost to Follow-up|4|||
94415594|NCT01382251|323307035|FG000|Overall Study|Contacted after study closed|1|||
94415595|NCT01382251|323307036|FG001|Overall Study|Contacted after study closed|1|||
94415596|NCT03629028|323307037|FG000|Overall Study|Lost to Follow-up|26|||
94415597|NCT03629028|323307038|FG001|Overall Study|Lost to Follow-up|23|||
94415598|NCT03629028|323307037|FG000|Overall Study|Pregnancy|4|||
94415599|NCT03629028|323307038|FG001|Overall Study|Pregnancy|2|||
94415600|NCT03629028|323307037|FG000|Overall Study|intolerance to examination|2|||
94415601|NCT03629028|323307038|FG001|Overall Study|intolerance to examination|0|||
94415602|NCT02427984|323307039|FG000|Overall Study|Lost to Follow-up|13|||
94415603|NCT02427984|323307040|FG001|Overall Study|Lost to Follow-up|5|||
94415604|NCT02427984|323307041|FG002|Overall Study|Lost to Follow-up|18|||
94415605|NCT03097588|323307047|FG000|Overall Study|Adverse Event|1|||
94415606|NCT02631876|323308574|FG000|Overall Study|Death|96|||
94415607|NCT02631876|323308575|FG001|Overall Study|Death|50|||
94415608|NCT02631876|323308574|FG000|Overall Study|Investigator's discretion|1|||
94415609|NCT02631876|323308575|FG001|Overall Study|Investigator's discretion|0|||
94415610|NCT02631876|323308574|FG000|Overall Study|Lost to Follow-up|2|||
94415611|NCT02631876|323308575|FG001|Overall Study|Lost to Follow-up|0|||
94415612|NCT02631876|323308574|FG000|Overall Study|Withdrawal by Subject|16|||
94415613|NCT02631876|323308575|FG001|Overall Study|Withdrawal by Subject|9|||
94415614|NCT02631876|323308574|FG000|Overall Study|Other than specified|4|||
94415615|NCT02631876|323308575|FG001|Overall Study|Other than specified|4|||
94415616|NCT03346070|323308579|FG000|Overall Study|Death|0|||
94415617|NCT03346070|323308580|FG001|Overall Study|Death|0|||
94415618|NCT03346070|323308581|FG002|Overall Study|Death|0|||
94415619|NCT03346070|323308582|FG003|Overall Study|Death|0|||
94415620|NCT03346070|323308583|FG004|Overall Study|Death|1|||
94415621|NCT03346070|323308579|FG000|Overall Study|Lost to Follow-up|0|||
94415622|NCT03346070|323308580|FG001|Overall Study|Lost to Follow-up|1|||
94415623|NCT03346070|323308581|FG002|Overall Study|Lost to Follow-up|2|||
94415624|NCT03346070|323308582|FG003|Overall Study|Lost to Follow-up|0|||
94415625|NCT03346070|323308583|FG004|Overall Study|Lost to Follow-up|0|||
94415626|NCT03346070|323308579|FG000|Overall Study|Physician Decision|0|||
94415627|NCT03346070|323308580|FG001|Overall Study|Physician Decision|0|||
94415628|NCT03346070|323308581|FG002|Overall Study|Physician Decision|0|||
94415629|NCT03346070|323308582|FG003|Overall Study|Physician Decision|1|||
94415630|NCT03346070|323308583|FG004|Overall Study|Physician Decision|1|||
94415631|NCT03346070|323308579|FG000|Overall Study|Withdrawal by Subject|1|||
94415632|NCT03346070|323308580|FG001|Overall Study|Withdrawal by Subject|0|||
94415633|NCT03346070|323308581|FG002|Overall Study|Withdrawal by Subject|0|||
94415634|NCT03346070|323308582|FG003|Overall Study|Withdrawal by Subject|1|||
94415635|NCT03346070|323308583|FG004|Overall Study|Withdrawal by Subject|0|||
94415636|NCT03346070|323308579|FG000|Overall Study|Study medication not received as planned|2|||
94415637|NCT03346070|323308580|FG001|Overall Study|Study medication not received as planned|3|||
94415638|NCT03346070|323308581|FG002|Overall Study|Study medication not received as planned|2|||
94415639|NCT03346070|323308582|FG003|Overall Study|Study medication not received as planned|3|||
94415640|NCT03346070|323308583|FG004|Overall Study|Study medication not received as planned|2|||
94415641|NCT03346070|323308579|FG000|Overall Study|Screen Failure|0|||
94415642|NCT03346070|323308580|FG001|Overall Study|Screen Failure|0|||
94415643|NCT03346070|323308581|FG002|Overall Study|Screen Failure|0|||
94415644|NCT03346070|323308582|FG003|Overall Study|Screen Failure|1|||
94415645|NCT03346070|323308583|FG004|Overall Study|Screen Failure|1|||
94415646|NCT02813421|323308584|FG000|Overall Study|Withdrawal by Subject|1|||
94415647|NCT02813421|323308585|FG001|Overall Study|Withdrawal by Subject|2|||
94415648|NCT02813421|323308584|FG000|Overall Study|Lost to Follow-up|1|||
94415649|NCT02813421|323308585|FG001|Overall Study|Lost to Follow-up|1|||
94415650|NCT00856973|323308594|FG000|Overall Study|Adverse Event|5|||
94415651|NCT00856973|323308595|FG001|Overall Study|Adverse Event|5|||
94415652|NCT00856973|323308596|FG002|Overall Study|Adverse Event|3|||
94415653|NCT00856973|323308594|FG000|Overall Study|Lost to Follow-up|6|||
94415654|NCT00856973|323308595|FG001|Overall Study|Lost to Follow-up|3|||
94415655|NCT00856973|323308596|FG002|Overall Study|Lost to Follow-up|5|||
94415656|NCT00856973|323308594|FG000|Overall Study|Physician Decision|0|||
94415657|NCT00856973|323308595|FG001|Overall Study|Physician Decision|3|||
94415658|NCT00856973|323308596|FG002|Overall Study|Physician Decision|1|||
94415659|NCT00856973|323308594|FG000|Overall Study|Protocol Violation|1|||
94415660|NCT00856973|323308595|FG001|Overall Study|Protocol Violation|2|||
94415661|NCT00856973|323308596|FG002|Overall Study|Protocol Violation|1|||
94415662|NCT00856973|323308594|FG000|Overall Study|Withdrawal by Subject|13|||
94415663|NCT00856973|323308595|FG001|Overall Study|Withdrawal by Subject|16|||
94415664|NCT00856973|323308596|FG002|Overall Study|Withdrawal by Subject|15|||
94415665|NCT00856973|323308594|FG000|Overall Study|Other|11|||
94415666|NCT00856973|323308595|FG001|Overall Study|Other|12|||
94415667|NCT00856973|323308596|FG002|Overall Study|Other|13|||
94415668|NCT02695719|323308605|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
94415669|NCT02695719|323308606|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
94415670|NCT02695719|323308605|FG000|Overall Study|Significant Protocol Deviation|0|||
94415671|NCT02695719|323308606|FG001|Overall Study|Significant Protocol Deviation|1|||
94415672|NCT02695719|323308605|FG000|Overall Study|Voluntary Withdrawal|1|||
94415673|NCT02695719|323308606|FG001|Overall Study|Voluntary Withdrawal|0|||
94415674|NCT04109313|323308608|FG000|Overall Study|Pregnancy|1|||
94415675|NCT04109313|323308608|FG000|Overall Study|Adverse Event|11|||
94415676|NCT04109313|323308608|FG000|Overall Study|Lack of Efficacy|11|||
94415677|NCT04109313|323308608|FG000|Overall Study|Lost to Follow-up|1|||
94415678|NCT04109313|323308608|FG000|Overall Study|Physician Decision|2|||
94415679|NCT04109313|323308608|FG000|Overall Study|Subject Decision|13|||
94415680|NCT04109313|323308608|FG000|Overall Study|Covid-19 situation|2|||
94415681|NCT03575871|323308611|FG000|Overall Study|Adverse Event|5|||
94415682|NCT03575871|323308612|FG001|Overall Study|Adverse Event|5|||
94415683|NCT03575871|323308613|FG002|Overall Study|Adverse Event|8|||
94415684|NCT03575871|323308611|FG000|Overall Study|Death|1|||
94415685|NCT03575871|323308612|FG001|Overall Study|Death|0|||
94415686|NCT03575871|323308613|FG002|Overall Study|Death|0|||
94415687|NCT03575871|323308611|FG000|Overall Study|Lack of Efficacy|5|||
94415688|NCT03575871|323308612|FG001|Overall Study|Lack of Efficacy|4|||
94415689|NCT03575871|323308613|FG002|Overall Study|Lack of Efficacy|7|||
94415690|NCT03575871|323308611|FG000|Overall Study|Lost to Follow-up|1|||
94415691|NCT03575871|323308612|FG001|Overall Study|Lost to Follow-up|1|||
94415692|NCT03575871|323308613|FG002|Overall Study|Lost to Follow-up|1|||
94415693|NCT03575871|323308611|FG000|Overall Study|Protocol Deviation|1|||
94415694|NCT03575871|323308612|FG001|Overall Study|Protocol Deviation|1|||
94415695|NCT03575871|323308613|FG002|Overall Study|Protocol Deviation|1|||
94415696|NCT03575871|323308611|FG000|Overall Study|Withdrawal by Subject|6|||
94415697|NCT03575871|323308612|FG001|Overall Study|Withdrawal by Subject|1|||
94415698|NCT03575871|323308613|FG002|Overall Study|Withdrawal by Subject|9|||
94415699|NCT03575871|323308611|FG000|Overall Study|Other than specified|2|||
94415700|NCT03575871|323308612|FG001|Overall Study|Other than specified|2|||
94415701|NCT03575871|323308613|FG002|Overall Study|Other than specified|0|||
94415702|NCT02006628|323308616|FG000|Overall Study|Adverse Event|1|||
94415703|NCT02006628|323308617|FG001|Overall Study|Adverse Event|1|||
94415704|NCT02006628|323308616|FG000|Overall Study|Withdrawal by Subject|2|||
94415705|NCT02006628|323308617|FG001|Overall Study|Withdrawal by Subject|1|||
94415706|NCT01833533|323308620|FG000|Overall Study|Adverse Event|0|||
94415707|NCT01833533|323308621|FG001|Overall Study|Adverse Event|1|||
94415708|NCT01833533|323308620|FG000|Overall Study|Lost to Follow-up|4|||
94415709|NCT01833533|323308621|FG001|Overall Study|Lost to Follow-up|9|||
94415710|NCT01833533|323308620|FG000|Overall Study|To Enter an Extension Study|0|||
94415711|NCT01833533|323308621|FG001|Overall Study|To Enter an Extension Study|4|||
94415712|NCT01833533|323308620|FG000|Overall Study|Other|2|||
94415713|NCT01833533|323308621|FG001|Overall Study|Other|7|||
94415714|NCT02493777|323308622|FG000|Overall Study|Lost to Follow-up|0|||
94415715|NCT02493777|323308623|FG001|Overall Study|Lost to Follow-up|1|||
94415716|NCT00572039|323308624|FG000|Overall Study|Withdrawal by Subject|9|||
94415717|NCT00572039|323308625|FG001|Overall Study|Withdrawal by Subject|6|||
94415718|NCT00572039|323308624|FG000|Overall Study|Death|2|||
94415719|NCT00572039|323308625|FG001|Overall Study|Death|3|||
94415720|NCT00572039|323308624|FG000|Overall Study|Ill|5|||
94415721|NCT00572039|323308625|FG001|Overall Study|Ill|1|||
94415722|NCT03336242|323308630|FG000|Overall Study|Adverse Event|0|||
94415723|NCT03336242|323308631|FG001|Overall Study|Adverse Event|1|||
94415724|NCT00252174|323308634|FG000|Overall Study|Withdrawal by Subject|0|||
94415725|NCT00252174|323308635|FG001|Overall Study|Withdrawal by Subject|1|||
94415726|NCT00252174|323308636|FG002|Overall Study|Withdrawal by Subject|0|||
94415727|NCT01138826|323308637|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
94415728|NCT01138826|323308638|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
94415729|NCT01138826|323308639|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
94415730|NCT01138826|323308640|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
94415731|NCT01138826|323308641|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
94415732|NCT01138826|323308642|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
94415733|NCT05206448|323308643|FG000|Overall Study|Lost to Follow-up|2|||
94415734|NCT05206448|323308644|FG001|Overall Study|Lost to Follow-up|2|||
94415735|NCT05206448|323308643|FG000|Overall Study|Withdrawal by Subject|2|||
94415736|NCT05206448|323308644|FG001|Overall Study|Withdrawal by Subject|0|||
94415737|NCT05206448|323308643|FG000|Overall Study|found ineligible after randomization|1|||
94415738|NCT05206448|323308644|FG001|Overall Study|found ineligible after randomization|1|||
94415739|NCT05206448|323308643|FG000|Overall Study|unable to complete study due to personal constraints|1|||
94415740|NCT05206448|323308644|FG001|Overall Study|unable to complete study due to personal constraints|0|||
94415741|NCT05206448|323308643|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
94415742|NCT05206448|323308644|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
94415743|NCT02025010|323308651|FG000|Overall Study|Symptomatic or radiographic progression|36|||
94415744|NCT02025010|323308651|FG000|Overall Study|Adverse Event|6|||
94415745|NCT02025010|323308651|FG000|Overall Study|Physician Decision|7|||
94415746|NCT02025010|323308651|FG000|Overall Study|Withdrawal by Subject|3|||
94415747|NCT02025010|323308651|FG000|Overall Study|Intercurrent illness|3|||
94415748|NCT02025010|323308651|FG000|Overall Study|Patients still on treatment|3|||
94415749|NCT02025010|323308651|FG000|Overall Study|Never initiate the treatment|2|||
94415750|NCT00296491|323308652|FG000|Overall Study|Low Pollen Counts|18|||
94415751|NCT00296491|323308653|FG001|Overall Study|Low Pollen Counts|26|||
94415752|NCT00296491|323308654|FG002|Overall Study|Low Pollen Counts|25|||
94415753|NCT00296491|323308655|FG003|Overall Study|Low Pollen Counts|16|||
94415754|NCT00296491|323308652|FG000|Overall Study|Protocol Violation|4|||
94415755|NCT00296491|323308653|FG001|Overall Study|Protocol Violation|6|||
94415756|NCT00296491|323308654|FG002|Overall Study|Protocol Violation|2|||
94415757|NCT00296491|323308655|FG003|Overall Study|Protocol Violation|3|||
94415758|NCT00296491|323308652|FG000|Overall Study|Adverse Event|1|||
94415759|NCT00296491|323308653|FG001|Overall Study|Adverse Event|3|||
94415760|NCT00296491|323308654|FG002|Overall Study|Adverse Event|1|||
94415761|NCT00296491|323308655|FG003|Overall Study|Adverse Event|4|||
94415762|NCT00296491|323308652|FG000|Overall Study|Withdrawn due to Asthma|0|||
94488016|NCT01149655|323579483|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
94488017|NCT01149655|323579484|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
94488018|NCT01149655|323579481|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
94488019|NCT01149655|323579482|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
94488020|NCT01149655|323579483|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
94488021|NCT01149655|323579484|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
94488022|NCT01149655|323579481|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
94488023|NCT01149655|323579482|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
94488024|NCT01149655|323579483|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
94488025|NCT01149655|323579484|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
94488026|NCT01149655|323579481|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
94488027|NCT01149655|323579482|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
94488028|NCT01149655|323579483|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
94488029|NCT01149655|323579484|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
94488030|NCT01149655|323579481|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
94488031|NCT01149655|323579482|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
94488032|NCT01149655|323579483|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
94488033|NCT01149655|323579484|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
94488034|NCT01149655|323579481|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
94488035|NCT01149655|323579482|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
94488036|NCT01149655|323579483|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
94488037|NCT01149655|323579484|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
94488038|NCT01149655|323579481|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
94488039|NCT01149655|323579482|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
94488040|NCT01149655|323579483|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
94488041|NCT01149655|323579484|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
94488042|NCT01149655|323579481|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
94488043|NCT01149655|323579482|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
94488044|NCT01149655|323579483|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
94488045|NCT01149655|323579484|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
94488046|NCT01149655|323579481|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
94488047|NCT01149655|323579482|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
94488048|NCT01149655|323579483|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
94488049|NCT01149655|323579484|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
94488050|NCT01149655|323579481|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
94488051|NCT01149655|323579482|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
94488052|NCT01149655|323579483|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
94488053|NCT01149655|323579484|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
94415763|NCT00296491|323308653|FG001|Overall Study|Withdrawn due to Asthma|0|||
94415764|NCT00296491|323308654|FG002|Overall Study|Withdrawn due to Asthma|0|||
94415765|NCT00296491|323308655|FG003|Overall Study|Withdrawn due to Asthma|4|||
94415766|NCT00296491|323308652|FG000|Overall Study|Withdrawal by Subject|7|||
94415767|NCT00296491|323308653|FG001|Overall Study|Withdrawal by Subject|3|||
94415768|NCT00296491|323308654|FG002|Overall Study|Withdrawal by Subject|3|||
94415769|NCT00296491|323308655|FG003|Overall Study|Withdrawal by Subject|2|||
94415770|NCT00296491|323308652|FG000|Overall Study|Non-Compliance|12|||
94415771|NCT00296491|323308653|FG001|Overall Study|Non-Compliance|13|||
94488054|NCT01149655|323579481|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
94488055|NCT01149655|323579482|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
94488056|NCT01149655|323579483|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
94488057|NCT01149655|323579484|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
94488058|NCT01149655|323579481|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
94488059|NCT01149655|323579482|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
94488060|NCT01149655|323579483|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
94488061|NCT01149655|323579484|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
94488062|NCT01149655|323579481|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
94488063|NCT01149655|323579482|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
94488064|NCT01149655|323579483|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
94488065|NCT01149655|323579484|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
94488066|NCT01149655|323579481|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
94488067|NCT01149655|323579482|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
94488068|NCT01149655|323579483|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
94488069|NCT01149655|323579484|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
94488070|NCT01149655|323579481|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
94488071|NCT01149655|323579482|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
94488072|NCT01149655|323579483|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
94488073|NCT01149655|323579484|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
94488074|NCT03092752|323579486|FG000|Overall Study|Aged <40 years|14209|||
94488075|NCT03092752|323579486|FG000|Overall Study|At least one claim with T2DM|61299|||
94488076|NCT03092752|323579486|FG000|Overall Study|Having no claim of study drugs|29282|||
94488077|NCT03092752|323579486|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
94488078|NCT03092752|323579486|FG000|Overall Study|<6 month history|245900|||
94488079|NCT01652690|323579487|FG000|Overall Study|Withdrawal by Subject|16|||
94415772|NCT00296491|323308654|FG002|Overall Study|Non-Compliance|10|||
94415773|NCT00296491|323308655|FG003|Overall Study|Non-Compliance|14|||
94415774|NCT00296491|323308652|FG000|Overall Study|Lost to Follow-up|0|||
94415775|NCT00296491|323308653|FG001|Overall Study|Lost to Follow-up|2|||
94415776|NCT00296491|323308654|FG002|Overall Study|Lost to Follow-up|2|||
94415777|NCT00296491|323308655|FG003|Overall Study|Lost to Follow-up|0|||
94415778|NCT01300052|323308656|FG000|Overall Study|Adverse Event|3|||
94415779|NCT01300052|323308657|FG001|Overall Study|Adverse Event|0|||
94415780|NCT01300052|323308656|FG000|Overall Study|Withdrawal by Subject|2|||
94415781|NCT01300052|323308657|FG001|Overall Study|Withdrawal by Subject|2|||
94415782|NCT01300052|323308656|FG000|Overall Study|Protocol Violation|1|||
94415783|NCT01300052|323308657|FG001|Overall Study|Protocol Violation|1|||
94415784|NCT02278718|323308660|FG000|Overall Study|Adverse Event|1|||
94415785|NCT02278718|323308661|FG001|Overall Study|Adverse Event|0|||
94415786|NCT02278718|323308660|FG000|Overall Study|Lost to Follow-up|2|||
94415787|NCT02278718|323308661|FG001|Overall Study|Lost to Follow-up|4|||
94415788|NCT02278718|323308660|FG000|Overall Study|Withdrawal by Subject|1|||
94415789|NCT02278718|323308661|FG001|Overall Study|Withdrawal by Subject|4|||
94415790|NCT02278718|323308660|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
94415791|NCT02278718|323308661|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
94415792|NCT02278718|323308660|FG000|Overall Study|Missing|0|||
94415793|NCT02278718|323308661|FG001|Overall Study|Missing|1|||
94415794|NCT01615263|323308662|FG000|Overall Study|Post-randomization exclusion|0|||
94415795|NCT01615263|323308663|FG001|Overall Study|Post-randomization exclusion|2|||
94415796|NCT04440449|323308664|FG000|Overall Study|Lost to Follow-up|2|||
94415797|NCT04440449|323308665|FG001|Overall Study|Lost to Follow-up|0|||
94415798|NCT00857259|323308666|FG000|Overall Study|Protocol Violation|1|||
94415799|NCT00857259|323308667|FG001|Overall Study|Protocol Violation|0|||
94415800|NCT00857259|323308668|FG002|Overall Study|Protocol Violation|1|||
94415801|NCT00977431|323308671|FG000|Overall Study|Other than listed|1|||
94415802|NCT00977431|323308672|FG001|Overall Study|Other than listed|0|||
94415803|NCT00977431|323308673|FG002|Overall Study|Other than listed|0|||
94415804|NCT00977431|323308674|FG003|Overall Study|Other than listed|0|||
94415805|NCT00977431|323308675|FG004|Overall Study|Other than listed|2|||
94415806|NCT00977431|323308671|FG000|Overall Study|Protocol Violation|0|||
94415807|NCT00977431|323308672|FG001|Overall Study|Protocol Violation|0|||
94415808|NCT00977431|323308673|FG002|Overall Study|Protocol Violation|1|||
94415809|NCT00977431|323308674|FG003|Overall Study|Protocol Violation|0|||
94415810|NCT00977431|323308675|FG004|Overall Study|Protocol Violation|0|||
94415811|NCT00977431|323308671|FG000|Overall Study|Adverse Event|3|||
94415812|NCT00977431|323308672|FG001|Overall Study|Adverse Event|0|||
94415813|NCT00977431|323308673|FG002|Overall Study|Adverse Event|4|||
94415814|NCT00977431|323308674|FG003|Overall Study|Adverse Event|0|||
94415815|NCT00977431|323308675|FG004|Overall Study|Adverse Event|6|||
94415816|NCT00977431|323308671|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
94415817|NCT00977431|323308672|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
94415818|NCT00977431|323308673|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
94415819|NCT00977431|323308674|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
94415820|NCT00977431|323308675|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
94415821|NCT00977431|323308671|FG000|Overall Study|Progressive disease|2|||
94415822|NCT00977431|323308672|FG001|Overall Study|Progressive disease|6|||
94415823|NCT00977431|323308673|FG002|Overall Study|Progressive disease|1|||
94415824|NCT00977431|323308674|FG003|Overall Study|Progressive disease|3|||
94415825|NCT00977431|323308675|FG004|Overall Study|Progressive disease|5|||
94415826|NCT00942331|323308679|FG000|Overall Study|Did not start treatment|15|||
94415827|NCT00942331|323308680|FG001|Overall Study|Did not start treatment|22|||
94415828|NCT00567476|323308684|FG000|Overall Study|Adverse Event|2|||
94415829|NCT00567476|323308685|FG001|Overall Study|Adverse Event|0|||
94415830|NCT00567476|323308684|FG000|Overall Study|Pregnancy|1|||
94415831|NCT00567476|323308685|FG001|Overall Study|Pregnancy|0|||
94415832|NCT00567476|323308684|FG000|Overall Study|Protocol Violation|4|||
94415833|NCT00567476|323308685|FG001|Overall Study|Protocol Violation|1|||
94415834|NCT00567476|323308684|FG000|Overall Study|Lost to Follow-up|0|||
94415835|NCT00567476|323308685|FG001|Overall Study|Lost to Follow-up|1|||
94415836|NCT00567476|323308684|FG000|Overall Study|Administrative issues|1|||
94415837|NCT00567476|323308685|FG001|Overall Study|Administrative issues|0|||
94415838|NCT00567476|323308684|FG000|Overall Study|Medical Decision|0|||
94415839|NCT00567476|323308685|FG001|Overall Study|Medical Decision|1|||
94415840|NCT00567476|323308684|FG000|Overall Study|Non-adherence to protocol|0|||
94415841|NCT00567476|323308685|FG001|Overall Study|Non-adherence to protocol|1|||
94415842|NCT04403763|323308686|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
94415843|NCT04403763|323308687|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
94415844|NCT04403763|323308688|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
94415845|NCT04403763|323308689|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
94415846|NCT04403763|323308690|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
94415847|NCT04403763|323308691|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
94415848|NCT04403763|323308692|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
94415849|NCT04403763|323308686|FG000|Stage 1|Early termination due to PK tube failure|0|||
94415850|NCT04403763|323308687|FG001|Stage 1|Early termination due to PK tube failure|0|||
94415851|NCT04403763|323308688|FG002|Stage 1|Early termination due to PK tube failure|1|||
94415852|NCT04403763|323308689|FG003|Stage 1|Early termination due to PK tube failure|0|||
94415853|NCT04403763|323308690|FG004|Stage 1|Early termination due to PK tube failure|0|||
94415854|NCT04403763|323308691|FG005|Stage 1|Early termination due to PK tube failure|0|||
94415855|NCT04403763|323308692|FG006|Stage 1|Early termination due to PK tube failure|0|||
94415856|NCT04403763|323308686|FG000|Stage 2A|Adverse Event|0|||
94415857|NCT04403763|323308687|FG001|Stage 2A|Adverse Event|0|||
94415858|NCT04403763|323308688|FG002|Stage 2A|Adverse Event|0|||
94415859|NCT04403763|323308689|FG003|Stage 2A|Adverse Event|0|||
94415860|NCT04403763|323308690|FG004|Stage 2A|Adverse Event|0|||
94415861|NCT04403763|323308691|FG005|Stage 2A|Adverse Event|0|||
94415862|NCT04403763|323308692|FG006|Stage 2A|Adverse Event|1|||
94415863|NCT00606502|323308693|FG000|Randomization|Randomized but not treated|3|||
94415864|NCT00606502|323308694|FG001|Randomization|Randomized but not treated|0|||
94415865|NCT00606502|323308693|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
94415866|NCT00606502|323308694|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
94415867|NCT03401073|323308695|FG000|Overall Study|Lost to Follow-up|1|||
94415868|NCT03401073|323308696|FG001|Overall Study|Lost to Follow-up|2|||
94415869|NCT00706355|323308697|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
94415870|NCT00706355|323308698|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
94415871|NCT00706355|323308699|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
94415872|NCT00706355|323308700|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
94415873|NCT00706355|323308697|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
94415874|NCT00706355|323308698|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
94415875|NCT00706355|323308699|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
94415876|NCT00706355|323308700|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
94415877|NCT00706355|323308697|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
94415878|NCT00706355|323308698|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
94415879|NCT00706355|323308699|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
94415880|NCT00706355|323308700|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
94415881|NCT00706355|323308697|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
94488080|NCT01652690|323579488|FG001|Overall Study|Withdrawal by Subject|4|||
94488081|NCT01652690|323579487|FG000|Overall Study|Other|8|||
94488082|NCT01652690|323579488|FG001|Overall Study|Other|9|||
94415882|NCT00706355|323308698|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
94415883|NCT00706355|323308699|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
94488083|NCT01652690|323579487|FG000|Overall Study|Lost to Follow-up|6|||
94488084|NCT01652690|323579488|FG001|Overall Study|Lost to Follow-up|6|||
94415884|NCT00706355|323308700|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
94415885|NCT00706355|323308697|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
94488085|NCT01652690|323579487|FG000|Overall Study|Death|5|||
94415886|NCT00706355|323308698|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
94415887|NCT00706355|323308699|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
94415888|NCT00706355|323308700|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
94415889|NCT00706355|323308697|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
94415890|NCT00706355|323308698|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
94415891|NCT00706355|323308699|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
94415892|NCT00706355|323308700|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
94415893|NCT00706355|323308697|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
94415894|NCT00706355|323308698|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
94415895|NCT00706355|323308699|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
94415896|NCT00706355|323308700|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
94415897|NCT00706355|323308697|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
94415898|NCT00706355|323308698|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
94415899|NCT00706355|323308699|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
94415900|NCT00706355|323308700|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
94415901|NCT00706355|323308697|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
94415902|NCT00706355|323308698|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
94415903|NCT00706355|323308699|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
94415904|NCT00706355|323308700|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
94415905|NCT02083926|323308703|FG000|Overall Study|Withdrawal by Subject|1|||
94415906|NCT02083926|323308704|FG001|Overall Study|Withdrawal by Subject|0|||
94415907|NCT01564459|323308712|FG000|Run-In|Adverse Event|7|||
94415908|NCT01564459|323308713|FG001|Run-In|Adverse Event|0|||
94415909|NCT01564459|323308714|FG002|Run-In|Adverse Event|0|||
94415910|NCT01564459|323308712|FG000|Run-In|Lost to Follow-up|1|||
94415911|NCT01564459|323308713|FG001|Run-In|Lost to Follow-up|0|||
94415912|NCT01564459|323308714|FG002|Run-In|Lost to Follow-up|0|||
94415913|NCT01564459|323308712|FG000|Run-In|Non-compliance with study drug|2|||
94415914|NCT01564459|323308713|FG001|Run-In|Non-compliance with study drug|0|||
94415915|NCT01564459|323308714|FG002|Run-In|Non-compliance with study drug|0|||
94415916|NCT01564459|323308712|FG000|Run-In|Protocol Violation|1|||
94415917|NCT01564459|323308713|FG001|Run-In|Protocol Violation|0|||
94415918|NCT01564459|323308714|FG002|Run-In|Protocol Violation|0|||
94415919|NCT01564459|323308712|FG000|Run-In|Withdrawal by Subject|1|||
94415920|NCT01564459|323308713|FG001|Run-In|Withdrawal by Subject|0|||
94415921|NCT01564459|323308714|FG002|Run-In|Withdrawal by Subject|0|||
94415922|NCT01564459|323308712|FG000|Double-blind Treatment|Adverse Event|0|||
94415923|NCT01564459|323308713|FG001|Double-blind Treatment|Adverse Event|0|||
94415924|NCT01564459|323308714|FG002|Double-blind Treatment|Adverse Event|1|||
94415925|NCT00706992|323308715|FG000|Overall Study|Study termination|5|||
94415926|NCT00706992|323308716|FG001|Overall Study|Study termination|5|||
94415927|NCT00706992|323308717|FG002|Overall Study|Study termination|6|||
94415928|NCT00706992|323308718|FG003|Overall Study|Study termination|2|||
94415929|NCT00706992|323308719|FG004|Overall Study|Study termination|3|||
94415930|NCT00706992|323308720|FG005|Overall Study|Study termination|2|||
94415931|NCT00706992|323308721|FG006|Overall Study|Study termination|3|||
94415932|NCT00706992|323308715|FG000|Overall Study|Disease progression before treatment|0|||
94415933|NCT00706992|323308716|FG001|Overall Study|Disease progression before treatment|0|||
94415934|NCT00706992|323308717|FG002|Overall Study|Disease progression before treatment|0|||
94415935|NCT00706992|323308718|FG003|Overall Study|Disease progression before treatment|0|||
94415936|NCT00706992|323308719|FG004|Overall Study|Disease progression before treatment|1|||
94415937|NCT00706992|323308720|FG005|Overall Study|Disease progression before treatment|0|||
94415938|NCT00706992|323308721|FG006|Overall Study|Disease progression before treatment|0|||
94415939|NCT00532935|323308722|FG000|Overall Study|Adverse Event|11|||
94415940|NCT00532935|323308723|FG001|Overall Study|Adverse Event|12|||
94415941|NCT00532935|323308722|FG000|Overall Study|Lack of Efficacy|0|||
94415942|NCT00532935|323308723|FG001|Overall Study|Lack of Efficacy|3|||
94415943|NCT00532935|323308722|FG000|Overall Study|Lost to Follow-up|10|||
94415944|NCT00532935|323308723|FG001|Overall Study|Lost to Follow-up|6|||
94415945|NCT00532935|323308722|FG000|Overall Study|Physician Decision|4|||
94415946|NCT00532935|323308723|FG001|Overall Study|Physician Decision|5|||
94415947|NCT00532935|323308722|FG000|Overall Study|Pregnancy|1|||
94415948|NCT00532935|323308723|FG001|Overall Study|Pregnancy|0|||
94415949|NCT00532935|323308722|FG000|Overall Study|Protocol Violation|4|||
94415950|NCT00532935|323308723|FG001|Overall Study|Protocol Violation|2|||
94415951|NCT00532935|323308722|FG000|Overall Study|Withdrawal by Subject|10|||
94415952|NCT00532935|323308723|FG001|Overall Study|Withdrawal by Subject|9|||
94415953|NCT00532935|323308722|FG000|Overall Study|Protocol Specific Criteria|11|||
94415954|NCT00532935|323308723|FG001|Overall Study|Protocol Specific Criteria|15|||
94415955|NCT02192164|323308727|FG000|Overall Study|Other|8|||
94415956|NCT02192164|323308727|FG000|Overall Study|Withdrawal by Subject|1|||
94415957|NCT02192164|323308727|FG000|Overall Study|Physician Decision|4|||
94415958|NCT02192164|323308727|FG000|Overall Study|Did not meet the exclusion criteria|1|||
94415959|NCT01392326|323308730|FG000|Overall Study|Death|2|||
94415960|NCT01392326|323308731|FG001|Overall Study|Death|0|||
94415961|NCT01392326|323308732|FG002|Overall Study|Death|0|||
94415962|NCT01392326|323308730|FG000|Overall Study|Withdrawal by Subject|12|||
94415963|NCT01392326|323308731|FG001|Overall Study|Withdrawal by Subject|11|||
94415964|NCT01392326|323308732|FG002|Overall Study|Withdrawal by Subject|15|||
94415965|NCT01392326|323308730|FG000|Overall Study|Protocol Violation|2|||
94415966|NCT01392326|323308731|FG001|Overall Study|Protocol Violation|0|||
94415967|NCT01392326|323308732|FG002|Overall Study|Protocol Violation|0|||
94415968|NCT01392326|323308730|FG000|Overall Study|Pregnancy|0|||
94415969|NCT01392326|323308731|FG001|Overall Study|Pregnancy|0|||
94415970|NCT01392326|323308732|FG002|Overall Study|Pregnancy|1|||
94415971|NCT01392326|323308730|FG000|Overall Study|Physician Decision|7|||
94415972|NCT01392326|323308731|FG001|Overall Study|Physician Decision|5|||
94415973|NCT01392326|323308732|FG002|Overall Study|Physician Decision|2|||
94415974|NCT01392326|323308730|FG000|Overall Study|Lost to Follow-up|1|||
94415975|NCT01392326|323308731|FG001|Overall Study|Lost to Follow-up|3|||
94415976|NCT01392326|323308732|FG002|Overall Study|Lost to Follow-up|4|||
94415977|NCT01392326|323308730|FG000|Overall Study|Lack of Efficacy|14|||
94415978|NCT01392326|323308731|FG001|Overall Study|Lack of Efficacy|10|||
94415979|NCT01392326|323308732|FG002|Overall Study|Lack of Efficacy|15|||
94415980|NCT01392326|323308730|FG000|Overall Study|Adverse Event|9|||
94415981|NCT01392326|323308731|FG001|Overall Study|Adverse Event|6|||
94415982|NCT01392326|323308732|FG002|Overall Study|Adverse Event|11|||
94415983|NCT00518622|323308733|FG000|Overall Study|Lost to Follow-up|0|||
94415984|NCT00518622|323308734|FG001|Overall Study|Lost to Follow-up|0|||
94415985|NCT00518622|323308735|FG002|Overall Study|Lost to Follow-up|1|||
94415986|NCT00518622|323308736|FG003|Overall Study|Lost to Follow-up|0|||
94415987|NCT00518622|323308737|FG004|Overall Study|Lost to Follow-up|0|||
94415988|NCT00518622|323308738|FG005|Overall Study|Lost to Follow-up|0|||
94415989|NCT00518622|323308739|FG006|Overall Study|Lost to Follow-up|0|||
94415990|NCT00518622|323308740|FG007|Overall Study|Lost to Follow-up|0|||
94415991|NCT00518622|323308733|FG000|Overall Study|Study medication taken incorrectly|0|||
94415992|NCT00518622|323308734|FG001|Overall Study|Study medication taken incorrectly|1|||
94415993|NCT00518622|323308735|FG002|Overall Study|Study medication taken incorrectly|0|||
94415994|NCT00518622|323308736|FG003|Overall Study|Study medication taken incorrectly|0|||
94415995|NCT00518622|323308737|FG004|Overall Study|Study medication taken incorrectly|0|||
94415996|NCT00518622|323308738|FG005|Overall Study|Study medication taken incorrectly|0|||
94415997|NCT00518622|323308739|FG006|Overall Study|Study medication taken incorrectly|0|||
94415998|NCT00518622|323308740|FG007|Overall Study|Study medication taken incorrectly|0|||
94415999|NCT03499119|323308741|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
94416000|NCT03499119|323308742|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
94416001|NCT03499119|323308743|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
94416002|NCT03499119|323308744|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
94416003|NCT03499119|323308741|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
94416004|NCT03499119|323308742|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
94416005|NCT03499119|323308743|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
94416006|NCT03499119|323308744|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
94416007|NCT03499119|323308741|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
94416008|NCT03499119|323308742|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
94416009|NCT03499119|323308743|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
94416010|NCT03499119|323308744|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
94416011|NCT03499119|323308741|FG000|Optional Extension Phase|Lost to Follow-up|0|||
94416012|NCT03499119|323308742|FG001|Optional Extension Phase|Lost to Follow-up|0|||
94416013|NCT03499119|323308743|FG002|Optional Extension Phase|Lost to Follow-up|0|||
94416014|NCT03499119|323308744|FG003|Optional Extension Phase|Lost to Follow-up|1|||
94416015|NCT03499119|323308741|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
94416016|NCT03499119|323308742|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
94416017|NCT03499119|323308743|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
94416018|NCT03499119|323308744|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
94416019|NCT03499119|323308741|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
94416020|NCT03499119|323308742|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
94416021|NCT03499119|323308743|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
94416022|NCT03499119|323308744|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
94416023|NCT00710749|323308747|FG000|First Intervention|Withdrawal by Subject|1|||
94416024|NCT00710749|323308748|FG001|First Intervention|Withdrawal by Subject|0|||
94416025|NCT04678817|323310675|FG000|Overall Study|Lost to Follow-up|28|||
94416026|NCT04678817|323310676|FG001|Overall Study|Lost to Follow-up|0|||
94416027|NCT04678817|323310677|FG002|Overall Study|Lost to Follow-up|0|||
94416028|NCT05626803|323310680|FG000|Overall Study|Lost to Follow-up|0|||
94416029|NCT05626803|323310681|FG001|Overall Study|Lost to Follow-up|1|||
94416030|NCT05626803|323310682|FG002|Overall Study|Lost to Follow-up|0|||
94416031|NCT05626803|323310683|FG003|Overall Study|Lost to Follow-up|0|||
94416032|NCT01408563|323310687|FG000|Overall Study|Ineligible after consent/ registration|2|||
94416033|NCT03250299|323310688|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
94488086|NCT01652690|323579488|FG001|Overall Study|Death|2|||
94416034|NCT03250299|323310689|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
94416035|NCT03250299|323310690|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
94488087|NCT00329108|323581169|FG000|Overall Study|Adverse Event|2|||
94488088|NCT00329108|323581170|FG001|Overall Study|Adverse Event|2|||
94488089|NCT00329108|323581169|FG000|Overall Study|Lack of Efficacy|3|||
94488090|NCT00329108|323581170|FG001|Overall Study|Lack of Efficacy|3|||
94488091|NCT00329108|323581169|FG000|Overall Study|Withdrawal by Subject|0|||
94488092|NCT00329108|323581170|FG001|Overall Study|Withdrawal by Subject|2|||
94488093|NCT00329108|323581169|FG000|Overall Study|symptomatic deterioration|1|||
94488094|NCT00329108|323581170|FG001|Overall Study|symptomatic deterioration|1|||
94488095|NCT00329108|323581169|FG000|Overall Study|Subject no longer willing to participate|2|||
94488096|NCT00329108|323581170|FG001|Overall Study|Subject no longer willing to participate|2|||
94488097|NCT00329108|323581169|FG000|Overall Study|study terminated by sponsor|1|||
94488098|NCT00329108|323581170|FG001|Overall Study|study terminated by sponsor|0|||
94488099|NCT00329108|323581169|FG000|Overall Study|withdrew patient after SAE resolved|1|||
94488100|NCT00329108|323581170|FG001|Overall Study|withdrew patient after SAE resolved|0|||
94488101|NCT00329108|323581169|FG000|Overall Study|Protocol Violation|0|||
94488102|NCT00329108|323581170|FG001|Overall Study|Protocol Violation|2|||
94488103|NCT02870868|323581173|FG000|Overall Study|Withdrawal by Subject|2|||
94488104|NCT02870868|323581174|FG001|Overall Study|Withdrawal by Subject|1|||
94488105|NCT01316614|323581175|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
94488106|NCT01316614|323581175|FG000|Overall Study|Cytology slides not available for review|4|||
94488107|NCT01316614|323581175|FG000|Overall Study|Cystic lesion|5|||
94488108|NCT01316614|323581175|FG000|Overall Study|Inadequate number of passes|2|||
94488109|NCT01316614|323581175|FG000|Overall Study|Medically unstable|1|||
94488110|NCT00183430|323581176|FG000|Overall Study|Adverse Event|1|||
94488111|NCT00183430|323581177|FG001|Overall Study|Adverse Event|0|||
94488112|NCT00183430|323581176|FG000|Overall Study|Lost to Follow-up|3|||
94488113|NCT00183430|323581177|FG001|Overall Study|Lost to Follow-up|0|||
94488114|NCT00183430|323581176|FG000|Overall Study|did not meet inclusion criteria|1|||
94488115|NCT00183430|323581177|FG001|Overall Study|did not meet inclusion criteria|0|||
94488116|NCT00183430|323581176|FG000|Overall Study|Withdrawal by Subject|1|||
94488117|NCT00183430|323581177|FG001|Overall Study|Withdrawal by Subject|0|||
94488118|NCT03427411|323581178|FG000|Overall Study|Screen failure - platelets too low|0|||
94488119|NCT03427411|323581179|FG001|Overall Study|Screen failure - platelets too low|1|||
94488120|NCT00076570|323581180|FG000|Overall Study|Drug intolerance|8|||
94488121|NCT00076570|323581181|FG001|Overall Study|Drug intolerance|8|||
94488122|NCT02466399|323581185|FG000|Overall Study|Adverse Event|1|||
94488123|NCT02466399|323581186|FG001|Overall Study|Adverse Event|0|||
94488124|NCT02466399|323581185|FG000|Overall Study|Early exit due to family emergency|1|||
94488125|NCT02466399|323581186|FG001|Overall Study|Early exit due to family emergency|0|||
94488126|NCT01799941|323581189|FG000|Overall Study|Adverse Event|34|||
94488127|NCT01799941|323581189|FG000|Overall Study|Withdrawal by Subject|21|||
94488128|NCT01799941|323581189|FG000|Overall Study|Death|2|||
94488129|NCT01799941|323581189|FG000|Overall Study|Investigator Decision|4|||
94488130|NCT01799941|323581189|FG000|Overall Study|Lack of Efficacy|3|||
94488131|NCT01799941|323581189|FG000|Overall Study|Lost to Follow-up|17|||
94488132|NCT01799941|323581189|FG000|Overall Study|Other|15|||
94488133|NCT01935089|323581199|FG000|Overall Study|Adverse Event|2|||
94416036|NCT03250299|323310691|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
94416037|NCT03250299|323310692|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
94416038|NCT03250299|323310688|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
94416039|NCT03250299|323310689|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
94416040|NCT03250299|323310690|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
94416041|NCT03250299|323310691|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
94416042|NCT03250299|323310692|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
94416043|NCT03250299|323310688|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
94416044|NCT03250299|323310689|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
94416045|NCT03250299|323310690|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
94416046|NCT03250299|323310691|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
94416047|NCT03250299|323310692|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
94416048|NCT03250299|323310688|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
94488134|NCT01935089|323581199|FG000|Overall Study|Withdrawal by Subject|1|||
94488135|NCT00723229|323581205|FG000|First Intervention|Lost to Follow-up|7|||
94488136|NCT00723229|323581206|FG001|First Intervention|Lost to Follow-up|3|||
94488137|NCT02337491|323581207|FG000|Overall Study|Death|1|||
94488138|NCT02337491|323581208|FG001|Overall Study|Death|1|||
94488139|NCT02337491|323581207|FG000|Overall Study|Adverse Event|0|||
94488140|NCT02337491|323581208|FG001|Overall Study|Adverse Event|1|||
94488141|NCT02337491|323581207|FG000|Overall Study|Withdrawal by Subject|3|||
94488142|NCT02337491|323581208|FG001|Overall Study|Withdrawal by Subject|0|||
94488143|NCT02337491|323581207|FG000|Overall Study|Progressive Disease|44|||
94488144|NCT02337491|323581208|FG001|Overall Study|Progressive Disease|28|||
94488145|NCT02337491|323581207|FG000|Overall Study|On Treatment|2|||
94488146|NCT02337491|323581208|FG001|Overall Study|On Treatment|0|||
94416049|NCT03250299|323310689|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
94416050|NCT03250299|323310690|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
94488147|NCT02709746|323581209|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
94416051|NCT03250299|323310691|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
94416052|NCT03250299|323310692|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
94416053|NCT02522403|323310697|FG000|Overall Study|Lost to Follow-up|2|||
94416054|NCT02522403|323310698|FG001|Overall Study|Lost to Follow-up|2|||
94416055|NCT02522403|323310697|FG000|Overall Study|Withdrawal by Subject|2|||
94416056|NCT02522403|323310698|FG001|Overall Study|Withdrawal by Subject|4|||
94416057|NCT01475253|323310699|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
94416058|NCT01475253|323310700|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
94416059|NCT01475253|323310701|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
94416060|NCT01475253|323310702|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
94416061|NCT01475253|323310699|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
94416062|NCT01475253|323310700|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
94416063|NCT01475253|323310701|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
94416064|NCT01475253|323310702|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
94416065|NCT05142566|323310703|FG000|Overall Study|Protocol Violation|1|||
94416066|NCT04146363|323310704|FG000|Induction Period|Adverse Event|1|||
94416067|NCT04146363|323310705|FG001|Induction Period|Adverse Event|2|||
94416068|NCT04146363|323310706|FG002|Induction Period|Adverse Event|0|||
94416069|NCT04146363|323310707|FG003|Induction Period|Adverse Event|0|||
94416070|NCT04146363|323310708|FG004|Induction Period|Adverse Event|0|||
94416071|NCT04146363|323310709|FG005|Induction Period|Adverse Event|0|||
94416072|NCT04146363|323310710|FG006|Induction Period|Adverse Event|0|||
94416073|NCT04146363|323310711|FG007|Induction Period|Adverse Event|0|||
94416074|NCT04146363|323310712|FG008|Induction Period|Adverse Event|0|||
94416075|NCT04146363|323310713|FG009|Induction Period|Adverse Event|0|||
94416076|NCT04146363|323310714|FG010|Induction Period|Adverse Event|0|||
94416077|NCT04146363|323310704|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
94416078|NCT04146363|323310705|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
94416079|NCT04146363|323310706|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
94416080|NCT04146363|323310707|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
94416081|NCT04146363|323310708|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
94416082|NCT04146363|323310709|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
94416083|NCT04146363|323310710|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
94416084|NCT04146363|323310711|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
94416085|NCT04146363|323310712|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
94416086|NCT04146363|323310713|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
94416087|NCT04146363|323310714|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
94416088|NCT04146363|323310704|FG000|Induction Period|Lack of Efficacy|7|||
94416089|NCT04146363|323310705|FG001|Induction Period|Lack of Efficacy|2|||
94416090|NCT04146363|323310706|FG002|Induction Period|Lack of Efficacy|0|||
94416091|NCT04146363|323310707|FG003|Induction Period|Lack of Efficacy|0|||
94416092|NCT04146363|323310708|FG004|Induction Period|Lack of Efficacy|0|||
94416093|NCT04146363|323310709|FG005|Induction Period|Lack of Efficacy|0|||
94416094|NCT04146363|323310710|FG006|Induction Period|Lack of Efficacy|0|||
94416095|NCT04146363|323310711|FG007|Induction Period|Lack of Efficacy|0|||
94416096|NCT04146363|323310712|FG008|Induction Period|Lack of Efficacy|0|||
94416097|NCT04146363|323310713|FG009|Induction Period|Lack of Efficacy|0|||
94416098|NCT04146363|323310714|FG010|Induction Period|Lack of Efficacy|0|||
94416099|NCT04146363|323310704|FG000|Induction Period|Lost to Follow-up|1|||
94416100|NCT04146363|323310705|FG001|Induction Period|Lost to Follow-up|4|||
94416101|NCT04146363|323310706|FG002|Induction Period|Lost to Follow-up|0|||
94416102|NCT04146363|323310707|FG003|Induction Period|Lost to Follow-up|0|||
94416103|NCT04146363|323310708|FG004|Induction Period|Lost to Follow-up|0|||
94416104|NCT04146363|323310709|FG005|Induction Period|Lost to Follow-up|0|||
94416105|NCT04146363|323310710|FG006|Induction Period|Lost to Follow-up|0|||
94416106|NCT04146363|323310711|FG007|Induction Period|Lost to Follow-up|0|||
94416107|NCT04146363|323310712|FG008|Induction Period|Lost to Follow-up|0|||
94416108|NCT04146363|323310713|FG009|Induction Period|Lost to Follow-up|0|||
94416109|NCT04146363|323310714|FG010|Induction Period|Lost to Follow-up|0|||
94416110|NCT04146363|323310704|FG000|Induction Period|Positive quantiferon test|0|||
94416111|NCT04146363|323310705|FG001|Induction Period|Positive quantiferon test|1|||
94416112|NCT04146363|323310706|FG002|Induction Period|Positive quantiferon test|0|||
94416113|NCT04146363|323310707|FG003|Induction Period|Positive quantiferon test|0|||
94416114|NCT04146363|323310708|FG004|Induction Period|Positive quantiferon test|0|||
94416115|NCT04146363|323310709|FG005|Induction Period|Positive quantiferon test|0|||
94416116|NCT04146363|323310710|FG006|Induction Period|Positive quantiferon test|0|||
94416117|NCT04146363|323310711|FG007|Induction Period|Positive quantiferon test|0|||
94416118|NCT04146363|323310712|FG008|Induction Period|Positive quantiferon test|0|||
94416119|NCT04146363|323310713|FG009|Induction Period|Positive quantiferon test|0|||
94416120|NCT04146363|323310714|FG010|Induction Period|Positive quantiferon test|0|||
94416121|NCT04146363|323310704|FG000|Induction Period|Protocol Deviation|5|||
94416122|NCT04146363|323310705|FG001|Induction Period|Protocol Deviation|6|||
94416123|NCT04146363|323310706|FG002|Induction Period|Protocol Deviation|0|||
94416124|NCT04146363|323310707|FG003|Induction Period|Protocol Deviation|0|||
94416125|NCT04146363|323310708|FG004|Induction Period|Protocol Deviation|0|||
94416126|NCT04146363|323310709|FG005|Induction Period|Protocol Deviation|0|||
94416127|NCT04146363|323310710|FG006|Induction Period|Protocol Deviation|0|||
94416128|NCT04146363|323310711|FG007|Induction Period|Protocol Deviation|0|||
94416129|NCT04146363|323310712|FG008|Induction Period|Protocol Deviation|0|||
94416130|NCT04146363|323310713|FG009|Induction Period|Protocol Deviation|0|||
94416131|NCT04146363|323310714|FG010|Induction Period|Protocol Deviation|0|||
94416132|NCT04146363|323310704|FG000|Induction Period|Withdrawal by Subject|6|||
94416133|NCT04146363|323310705|FG001|Induction Period|Withdrawal by Subject|3|||
94416134|NCT04146363|323310706|FG002|Induction Period|Withdrawal by Subject|0|||
94416135|NCT04146363|323310707|FG003|Induction Period|Withdrawal by Subject|0|||
94416136|NCT04146363|323310708|FG004|Induction Period|Withdrawal by Subject|0|||
94416137|NCT04146363|323310709|FG005|Induction Period|Withdrawal by Subject|0|||
94416138|NCT04146363|323310710|FG006|Induction Period|Withdrawal by Subject|0|||
94416139|NCT04146363|323310711|FG007|Induction Period|Withdrawal by Subject|0|||
94416140|NCT04146363|323310712|FG008|Induction Period|Withdrawal by Subject|0|||
94416141|NCT04146363|323310713|FG009|Induction Period|Withdrawal by Subject|0|||
94416142|NCT04146363|323310714|FG010|Induction Period|Withdrawal by Subject|0|||
94416143|NCT04146363|323310704|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
94416144|NCT04146363|323310705|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
94416145|NCT04146363|323310706|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
94416146|NCT04146363|323310707|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
94416147|NCT04146363|323310708|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
94416148|NCT04146363|323310709|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
94416149|NCT04146363|323310710|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
94416150|NCT04146363|323310711|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
94416151|NCT04146363|323310712|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
94416152|NCT04146363|323310713|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
94416153|NCT04146363|323310714|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
94416154|NCT04146363|323310704|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94416155|NCT04146363|323310705|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94416156|NCT04146363|323310706|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94416157|NCT04146363|323310707|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94416158|NCT04146363|323310708|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94416159|NCT04146363|323310709|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94416160|NCT04146363|323310710|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94416161|NCT04146363|323310711|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
94416162|NCT04146363|323310712|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94416163|NCT04146363|323310713|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94416164|NCT04146363|323310714|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
94416165|NCT04146363|323310704|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94416166|NCT04146363|323310705|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94416167|NCT04146363|323310706|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94416168|NCT04146363|323310707|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94416169|NCT04146363|323310708|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94416170|NCT04146363|323310709|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94416171|NCT04146363|323310710|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
94416172|NCT04146363|323310711|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
94416173|NCT04146363|323310712|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94416174|NCT04146363|323310713|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94416175|NCT04146363|323310714|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
94416176|NCT04146363|323310704|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
94416177|NCT04146363|323310705|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
94416178|NCT04146363|323310706|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
94416179|NCT04146363|323310707|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
94416180|NCT04146363|323310708|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
94416181|NCT04146363|323310709|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
94416182|NCT04146363|323310710|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
94416183|NCT04146363|323310711|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
94416184|NCT04146363|323310712|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
94416185|NCT04146363|323310713|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
94416186|NCT04146363|323310714|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
94416187|NCT04146363|323310704|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
94416188|NCT04146363|323310705|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
94416189|NCT04146363|323310706|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
94416190|NCT04146363|323310707|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
94416191|NCT04146363|323310708|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
94488148|NCT02709746|323581210|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
94488149|NCT02709746|323581211|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
94488150|NCT02709746|323581212|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
94488151|NCT02709746|323581213|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
94488152|NCT02709746|323581209|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
94488153|NCT02709746|323581210|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
94488154|NCT02709746|323581211|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
94488155|NCT02709746|323581212|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
94488156|NCT02709746|323581213|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
94488157|NCT02709746|323581209|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
94488158|NCT02709746|323581210|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
94488159|NCT02709746|323581211|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
94488160|NCT02709746|323581212|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
94488161|NCT02709746|323581213|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
94488162|NCT02709746|323581209|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
94488163|NCT02709746|323581210|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
94488164|NCT02709746|323581211|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
94488165|NCT02709746|323581212|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
94488166|NCT02709746|323581213|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
94488167|NCT02709746|323581209|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
94488168|NCT02709746|323581210|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
94488169|NCT02709746|323581211|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
94488170|NCT02709746|323581212|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
94488171|NCT02709746|323581213|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
94488172|NCT02709746|323581209|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
94488173|NCT02709746|323581210|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
94488174|NCT02709746|323581211|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
94488175|NCT02709746|323581212|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
94488176|NCT02709746|323581213|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
94488177|NCT02709746|323581209|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
94488178|NCT02709746|323581210|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
94488179|NCT02709746|323581211|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
94488180|NCT02709746|323581212|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
94488181|NCT02709746|323581213|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
94488182|NCT02709746|323581209|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
94488183|NCT02709746|323581210|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
94488184|NCT02709746|323581211|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
94488185|NCT02709746|323581212|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
94488186|NCT02709746|323581213|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
94488187|NCT02709746|323581209|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
94488188|NCT02709746|323581210|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
94488189|NCT02709746|323581211|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
94488190|NCT02709746|323581212|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
94488191|NCT02709746|323581213|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
94488192|NCT02709746|323581209|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
94488193|NCT02709746|323581210|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
94488194|NCT02709746|323581211|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
94488195|NCT02709746|323581212|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
94488196|NCT02709746|323581213|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
94488197|NCT02709746|323581209|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
94488198|NCT02709746|323581210|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
94488199|NCT02709746|323581211|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
94488200|NCT02709746|323581212|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
94488201|NCT02709746|323581213|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
94488202|NCT02709746|323581209|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
94488203|NCT02709746|323581210|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
94488204|NCT02709746|323581211|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
94488205|NCT02709746|323581212|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
94488206|NCT02709746|323581213|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
94488207|NCT02709746|323581209|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
94488208|NCT02709746|323581210|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
94488209|NCT02709746|323581211|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
94488210|NCT02709746|323581212|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
94488211|NCT02709746|323581213|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
94416192|NCT04146363|323310709|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
94416193|NCT04146363|323310710|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
94416194|NCT04146363|323310711|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
94416195|NCT04146363|323310712|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
94416196|NCT04146363|323310713|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
94416197|NCT04146363|323310714|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
94416198|NCT04146363|323310704|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
94416199|NCT04146363|323310705|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
94416200|NCT04146363|323310706|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
94416201|NCT04146363|323310707|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
94416202|NCT04146363|323310708|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
94416203|NCT04146363|323310709|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
94416204|NCT04146363|323310710|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
94416205|NCT04146363|323310711|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
94416206|NCT04146363|323310712|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
94416207|NCT04146363|323310713|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
94416208|NCT04146363|323310714|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
94416209|NCT04146363|323310704|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
94416210|NCT04146363|323310705|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
94416211|NCT04146363|323310706|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
94416212|NCT04146363|323310707|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
94416213|NCT04146363|323310708|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
94416214|NCT04146363|323310709|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
94416215|NCT04146363|323310710|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
94416216|NCT04146363|323310711|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
94416217|NCT04146363|323310712|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
94416218|NCT04146363|323310713|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
94416219|NCT04146363|323310714|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
94416220|NCT04146363|323310704|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94416221|NCT04146363|323310705|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94416222|NCT04146363|323310706|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94416223|NCT04146363|323310707|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94416224|NCT04146363|323310708|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94416225|NCT04146363|323310709|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94416226|NCT04146363|323310710|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94416227|NCT04146363|323310711|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
94416228|NCT04146363|323310712|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
94416229|NCT04146363|323310713|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
94416230|NCT04146363|323310714|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
94416231|NCT04146363|323310704|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94416232|NCT04146363|323310705|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94416233|NCT04146363|323310706|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94416234|NCT04146363|323310707|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94416235|NCT04146363|323310708|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94416236|NCT04146363|323310709|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94416237|NCT04146363|323310710|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94416238|NCT04146363|323310711|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94416239|NCT04146363|323310712|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
94416240|NCT04146363|323310713|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
94416241|NCT04146363|323310714|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
94416242|NCT04146363|323310704|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
94416243|NCT04146363|323310705|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
94416244|NCT04146363|323310706|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
94416245|NCT04146363|323310707|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
94416246|NCT04146363|323310708|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
94416247|NCT04146363|323310709|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
94416248|NCT04146363|323310710|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
94416249|NCT04146363|323310711|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
94416250|NCT04146363|323310712|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
94416251|NCT04146363|323310713|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
94416252|NCT04146363|323310714|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
94488212|NCT02709746|323581209|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
94488213|NCT02709746|323581210|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
94416253|NCT04146363|323310704|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94416254|NCT04146363|323310705|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94416255|NCT04146363|323310706|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94488214|NCT02709746|323581211|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
94488215|NCT02709746|323581212|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
94488216|NCT02709746|323581213|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
94488217|NCT02709746|323581209|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
94488218|NCT02709746|323581210|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
94488219|NCT02709746|323581211|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
94488220|NCT02709746|323581212|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
94488221|NCT02709746|323581213|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
94488222|NCT02709746|323581209|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
94488223|NCT02709746|323581210|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
94488224|NCT02709746|323581211|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
94488225|NCT02709746|323581212|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
94488226|NCT02709746|323581213|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
94488227|NCT02709746|323581209|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
94488228|NCT02709746|323581210|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
94488229|NCT02709746|323581211|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
94488230|NCT02709746|323581212|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
94488231|NCT02709746|323581213|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
94488232|NCT02089347|323581216|FG000|Overall Study|Protocol Violation|1|||
94488233|NCT02089347|323581217|FG001|Overall Study|Protocol Violation|0|||
94488234|NCT02530385|323581218|FG000|Overall Study|Withdrawal by Subject|0|||
94488235|NCT02530385|323581219|FG001|Overall Study|Withdrawal by Subject|1|||
94488236|NCT00644059|323581221|FG000|Overall Study|Lost to Follow-up|37|||
94488237|NCT00644059|323581222|FG001|Overall Study|Lost to Follow-up|34|||
94488238|NCT00644059|323581223|FG002|Overall Study|Lost to Follow-up|16|||
94488239|NCT00644059|323581221|FG000|Overall Study|Withdrawal by Subject|52|||
94488240|NCT00644059|323581222|FG001|Overall Study|Withdrawal by Subject|60|||
94488241|NCT00644059|323581223|FG002|Overall Study|Withdrawal by Subject|30|||
94488242|NCT00644059|323581221|FG000|Overall Study|Adverse Event|8|||
94488243|NCT00644059|323581222|FG001|Overall Study|Adverse Event|5|||
94488244|NCT00644059|323581223|FG002|Overall Study|Adverse Event|1|||
94488245|NCT00644059|323581221|FG000|Overall Study|Inappropriate Enrollment|1|||
94488246|NCT00644059|323581222|FG001|Overall Study|Inappropriate Enrollment|3|||
94488247|NCT00644059|323581223|FG002|Overall Study|Inappropriate Enrollment|0|||
94488248|NCT00644059|323581221|FG000|Overall Study|Protocol Deviation/violation|20|||
94488249|NCT00644059|323581222|FG001|Overall Study|Protocol Deviation/violation|19|||
94488250|NCT00644059|323581223|FG002|Overall Study|Protocol Deviation/violation|15|||
94488251|NCT00644059|323581221|FG000|Overall Study|Unable to classify|6|||
94488252|NCT00644059|323581222|FG001|Overall Study|Unable to classify|2|||
94488253|NCT00644059|323581223|FG002|Overall Study|Unable to classify|3|||
94488254|NCT02065557|323581230|FG000|Induction Period|Withdrawal by Subject|2|||
94488255|NCT02065557|323581231|FG001|Induction Period|Withdrawal by Subject|1|||
94488256|NCT02065557|323581232|FG002|Induction Period|Withdrawal by Subject|0|||
94488257|NCT02065557|323581233|FG003|Induction Period|Withdrawal by Subject|0|||
94488258|NCT02065557|323581234|FG004|Induction Period|Withdrawal by Subject|0|||
94488259|NCT02065557|323581235|FG005|Induction Period|Withdrawal by Subject|0|||
94488260|NCT02065557|323581230|FG000|Induction Period|Lack of Efficacy|2|||
94488261|NCT02065557|323581231|FG001|Induction Period|Lack of Efficacy|1|||
94488262|NCT02065557|323581232|FG002|Induction Period|Lack of Efficacy|1|||
94488263|NCT02065557|323581233|FG003|Induction Period|Lack of Efficacy|0|||
94488264|NCT02065557|323581234|FG004|Induction Period|Lack of Efficacy|0|||
94488265|NCT02065557|323581235|FG005|Induction Period|Lack of Efficacy|0|||
94488266|NCT02065557|323581230|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
94488267|NCT02065557|323581231|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
94488268|NCT02065557|323581232|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
94488269|NCT02065557|323581233|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
94488270|NCT02065557|323581234|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
94488271|NCT02065557|323581235|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
94488272|NCT02065557|323581230|FG000|Induction Period|Non-Responder at Week 8|4|||
94488273|NCT02065557|323581231|FG001|Induction Period|Non-Responder at Week 8|4|||
94488274|NCT02065557|323581232|FG002|Induction Period|Non-Responder at Week 8|0|||
94488275|NCT02065557|323581233|FG003|Induction Period|Non-Responder at Week 8|0|||
94488276|NCT02065557|323581234|FG004|Induction Period|Non-Responder at Week 8|0|||
94488277|NCT02065557|323581235|FG005|Induction Period|Non-Responder at Week 8|0|||
94488278|NCT02065557|323581230|FG000|Induction Period|Adverse Event|1|||
94488279|NCT02065557|323581231|FG001|Induction Period|Adverse Event|1|||
94488280|NCT02065557|323581232|FG002|Induction Period|Adverse Event|0|||
94488281|NCT02065557|323581233|FG003|Induction Period|Adverse Event|0|||
94488282|NCT02065557|323581234|FG004|Induction Period|Adverse Event|0|||
94488283|NCT02065557|323581235|FG005|Induction Period|Adverse Event|0|||
94488284|NCT02065557|323581230|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
94488285|NCT02065557|323581231|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
94416256|NCT04146363|323310707|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94416257|NCT04146363|323310708|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94416258|NCT04146363|323310709|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94416259|NCT04146363|323310710|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94416260|NCT04146363|323310711|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
94416261|NCT04146363|323310712|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
94416262|NCT04146363|323310713|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
94416263|NCT04146363|323310714|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
94416264|NCT04146363|323310704|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
94416265|NCT04146363|323310705|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
94416266|NCT04146363|323310706|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
94416267|NCT04146363|323310707|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
94416268|NCT04146363|323310708|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
94416269|NCT04146363|323310709|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
94416270|NCT04146363|323310710|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
94416271|NCT04146363|323310711|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
94416272|NCT04146363|323310712|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
94416273|NCT04146363|323310713|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
94416274|NCT04146363|323310714|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
94416275|NCT04146363|323310704|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
94416276|NCT04146363|323310705|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
94416277|NCT04146363|323310706|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
94416278|NCT04146363|323310707|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
94416279|NCT04146363|323310708|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
94416280|NCT04146363|323310709|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
94416281|NCT04146363|323310710|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
94416282|NCT04146363|323310711|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
94416283|NCT04146363|323310712|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
94416284|NCT04146363|323310713|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
94416285|NCT04146363|323310714|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
94416286|NCT02914236|323310721|FG000|Overall Study|Lost to Follow-up|1|||
94416287|NCT04718194|323310722|FG000|Overall Study|Withdrawal by Subject|3|||
94416288|NCT04718194|323310723|FG001|Overall Study|Withdrawal by Subject|0|||
94416289|NCT04718194|323310722|FG000|Overall Study|Lost to Follow-up|3|||
94416290|NCT04718194|323310723|FG001|Overall Study|Lost to Follow-up|0|||
94416291|NCT02698865|323310725|FG000|Overall Study|Other|11|||
94416292|NCT02698865|323310726|FG001|Overall Study|Other|11|||
94416293|NCT02698865|323310725|FG000|Overall Study|Withdrawal by Subject|20|||
94416294|NCT02698865|323310726|FG001|Overall Study|Withdrawal by Subject|16|||
94416295|NCT02698865|323310725|FG000|Overall Study|Physician Decision|0|||
94416296|NCT02698865|323310726|FG001|Overall Study|Physician Decision|4|||
94416297|NCT02698865|323310725|FG000|Overall Study|Lost to Follow-up|4|||
94416298|NCT02698865|323310726|FG001|Overall Study|Lost to Follow-up|2|||
94416299|NCT00440466|323310727|FG000|Overall Study|Death|3|||
94416300|NCT00440466|323310728|FG001|Overall Study|Death|2|||
94416301|NCT00440466|323310729|FG002|Overall Study|Death|9|||
94416302|NCT00440466|323310727|FG000|Overall Study|Adverse Event|3|||
94416303|NCT00440466|323310728|FG001|Overall Study|Adverse Event|4|||
94416304|NCT00440466|323310729|FG002|Overall Study|Adverse Event|11|||
94416305|NCT00440466|323310727|FG000|Overall Study|Lost to Follow-up|1|||
94416306|NCT00440466|323310728|FG001|Overall Study|Lost to Follow-up|0|||
94416307|NCT00440466|323310729|FG002|Overall Study|Lost to Follow-up|2|||
94416308|NCT00440466|323310727|FG000|Overall Study|Physician Decision|2|||
94416309|NCT00440466|323310728|FG001|Overall Study|Physician Decision|0|||
94416310|NCT00440466|323310729|FG002|Overall Study|Physician Decision|1|||
94416311|NCT00440466|323310727|FG000|Overall Study|Protocol Violation|2|||
94416312|NCT00440466|323310728|FG001|Overall Study|Protocol Violation|0|||
94416313|NCT00440466|323310729|FG002|Overall Study|Protocol Violation|4|||
94416314|NCT00440466|323310727|FG000|Overall Study|Withdrawal by Subject|2|||
94416315|NCT00440466|323310728|FG001|Overall Study|Withdrawal by Subject|5|||
94416316|NCT00440466|323310729|FG002|Overall Study|Withdrawal by Subject|9|||
94416317|NCT00440466|323310727|FG000|Overall Study|Began Dialysis|0|||
94416318|NCT00440466|323310728|FG001|Overall Study|Began Dialysis|0|||
94416319|NCT00440466|323310729|FG002|Overall Study|Began Dialysis|1|||
94416320|NCT00440466|323310727|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
94416321|NCT00440466|323310728|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
94416322|NCT00440466|323310729|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
94416323|NCT00743509|323310732|FG000|Overall Study|Withdrawal by Subject|2|||
94416324|NCT00094458|323310733|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
94416325|NCT00094458|323310734|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
94416326|NCT00094458|323310735|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
94416327|NCT00094458|323310736|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
94416328|NCT00094458|323310737|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
94416329|NCT00094458|323310738|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
94416330|NCT00094458|323310733|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
94416331|NCT00094458|323310734|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
94416332|NCT00094458|323310735|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
94416333|NCT00094458|323310736|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
94416334|NCT00094458|323310737|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
94416335|NCT00094458|323310738|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
94416336|NCT00094458|323310733|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
94416337|NCT00094458|323310734|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
94416338|NCT00094458|323310735|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
94416339|NCT00094458|323310736|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
94416340|NCT00094458|323310737|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
94416341|NCT00094458|323310738|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
94416342|NCT00094458|323310733|FG000|Main Study: Through Week 30|Adverse Event|38|||
94416343|NCT00094458|323310734|FG001|Main Study: Through Week 30|Adverse Event|20|||
94416344|NCT00094458|323310735|FG002|Main Study: Through Week 30|Adverse Event|28|||
94416345|NCT00094458|323310736|FG003|Main Study: Through Week 30|Adverse Event|0|||
94416346|NCT00094458|323310737|FG004|Main Study: Through Week 30|Adverse Event|0|||
94416347|NCT00094458|323310738|FG005|Main Study: Through Week 30|Adverse Event|0|||
94416348|NCT00094458|323310733|FG000|Main Study: Through Week 30|Death|1|||
94416349|NCT00094458|323310734|FG001|Main Study: Through Week 30|Death|0|||
94416350|NCT00094458|323310735|FG002|Main Study: Through Week 30|Death|0|||
94416351|NCT00094458|323310736|FG003|Main Study: Through Week 30|Death|0|||
94416352|NCT00094458|323310737|FG004|Main Study: Through Week 30|Death|0|||
94416353|NCT00094458|323310738|FG005|Main Study: Through Week 30|Death|0|||
94416354|NCT00094458|323310733|FG000|Main Study: Through Week 30|Other|19|||
94416355|NCT00094458|323310734|FG001|Main Study: Through Week 30|Other|16|||
94416356|NCT00094458|323310735|FG002|Main Study: Through Week 30|Other|9|||
94416357|NCT00094458|323310736|FG003|Main Study: Through Week 30|Other|0|||
94416358|NCT00094458|323310737|FG004|Main Study: Through Week 30|Other|0|||
94416359|NCT00094458|323310738|FG005|Main Study: Through Week 30|Other|0|||
94416360|NCT00094458|323310733|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
94416361|NCT00094458|323310734|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
94416362|NCT00094458|323310735|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
94416363|NCT00094458|323310736|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
94416364|NCT00094458|323310737|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
94416365|NCT00094458|323310738|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
94416366|NCT00094458|323310733|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
94488286|NCT02065557|323581232|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
94488287|NCT02065557|323581233|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
94488288|NCT02065557|323581234|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
94488289|NCT02065557|323581235|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
94488290|NCT02065557|323581230|FG000|Maintenance Period|Withdrawal by Subject|0|||
94488291|NCT02065557|323581231|FG001|Maintenance Period|Withdrawal by Subject|0|||
94488292|NCT02065557|323581232|FG002|Maintenance Period|Withdrawal by Subject|0|||
94488293|NCT02065557|323581233|FG003|Maintenance Period|Withdrawal by Subject|0|||
94488294|NCT02065557|323581234|FG004|Maintenance Period|Withdrawal by Subject|2|||
94488295|NCT02065557|323581235|FG005|Maintenance Period|Withdrawal by Subject|1|||
94488296|NCT02065557|323581230|FG000|Maintenance Period|Lack of Efficacy|0|||
94488297|NCT02065557|323581231|FG001|Maintenance Period|Lack of Efficacy|0|||
94488298|NCT02065557|323581232|FG002|Maintenance Period|Lack of Efficacy|0|||
94488299|NCT02065557|323581233|FG003|Maintenance Period|Lack of Efficacy|0|||
94488300|NCT02065557|323581234|FG004|Maintenance Period|Lack of Efficacy|5|||
94488301|NCT02065557|323581235|FG005|Maintenance Period|Lack of Efficacy|2|||
94488302|NCT02065557|323581230|FG000|Maintenance Period|Subject Non-Compliance|0|||
94488303|NCT02065557|323581231|FG001|Maintenance Period|Subject Non-Compliance|0|||
94488304|NCT02065557|323581232|FG002|Maintenance Period|Subject Non-Compliance|0|||
94488305|NCT02065557|323581233|FG003|Maintenance Period|Subject Non-Compliance|0|||
94488306|NCT02065557|323581234|FG004|Maintenance Period|Subject Non-Compliance|0|||
94488307|NCT02065557|323581235|FG005|Maintenance Period|Subject Non-Compliance|1|||
94488308|NCT02674516|323581238|FG000|Overall Study|Lost to Follow-up|3|||
94488309|NCT02674516|323581239|FG001|Overall Study|Lost to Follow-up|0|||
94488310|NCT02674516|323581238|FG000|Overall Study|Protocol Violation|0|||
94488311|NCT02674516|323581239|FG001|Overall Study|Protocol Violation|4|||
94488312|NCT02674516|323581238|FG000|Overall Study|Knowledge of study hypothesis|1|||
94488313|NCT02674516|323581239|FG001|Overall Study|Knowledge of study hypothesis|0|||
94416367|NCT00094458|323310734|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
94416368|NCT00094458|323310735|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
94416369|NCT00094458|323310736|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
94416370|NCT00094458|323310737|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
94416371|NCT00094458|323310738|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
94488314|NCT02662569|323581243|FG000|Overall Study|Withdrawal by Subject|6|||
94488315|NCT02662569|323581244|FG001|Overall Study|Withdrawal by Subject|1|||
94488316|NCT02662569|323581245|FG002|Overall Study|Withdrawal by Subject|6|||
94488317|NCT02662569|323581246|FG003|Overall Study|Withdrawal by Subject|4|||
94488318|NCT02662569|323581243|FG000|Overall Study|Lost to Follow-up|1|||
94488319|NCT02662569|323581244|FG001|Overall Study|Lost to Follow-up|0|||
94488320|NCT02662569|323581245|FG002|Overall Study|Lost to Follow-up|0|||
94488321|NCT02662569|323581246|FG003|Overall Study|Lost to Follow-up|0|||
94488322|NCT04076917|323581247|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
94488323|NCT04076917|323581247|FG000|Overall Study|Study closure|13|||
94488324|NCT04076917|323581247|FG000|Overall Study|Physician Decision|3|||
94488325|NCT04076917|323581247|FG000|Overall Study|Death|1|||
94488326|NCT04076917|323581247|FG000|Overall Study|Lost to Follow-up|1|||
94488327|NCT04076917|323581247|FG000|Overall Study|Withdrawal by Subject|1|||
94488328|NCT04076917|323581247|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
94488329|NCT04494646|323581248|FG000|Overall Study|Adverse Event|0|||
94488330|NCT04494646|323581249|FG001|Overall Study|Adverse Event|1|||
94488331|NCT04494646|323581248|FG000|Overall Study|Withdrawal by Subject|0|||
94488332|NCT04494646|323581249|FG001|Overall Study|Withdrawal by Subject|1|||
94488333|NCT02785939|323581252|FG000|Overall Study|Progression|25|||
94488334|NCT02785939|323581253|FG001|Overall Study|Progression|8|||
94488335|NCT02785939|323581252|FG000|Overall Study|Adverse Event|3|||
94488336|NCT02785939|323581253|FG001|Overall Study|Adverse Event|1|||
94488337|NCT02785939|323581252|FG000|Overall Study|Death|1|||
94488338|NCT02785939|323581253|FG001|Overall Study|Death|0|||
94488339|NCT02785939|323581252|FG000|Overall Study|Refusal|1|||
94488340|NCT02785939|323581253|FG001|Overall Study|Refusal|0|||
94488341|NCT02785939|323581252|FG000|Overall Study|Deteriorating health|1|||
94488342|NCT02785939|323581253|FG001|Overall Study|Deteriorating health|0|||
94488343|NCT02785939|323581252|FG000|Overall Study|Not protocol specified|0|||
94488344|NCT02785939|323581253|FG001|Overall Study|Not protocol specified|1|||
94488345|NCT01474486|323581259|FG000|Overall Study|Death|2|||
94488346|NCT01474486|323581259|FG000|Overall Study|Withdrawal by Subject|4|||
94488347|NCT01474486|323581259|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
94488348|NCT03444584|323581262|FG000|Overall Study|Withdrawal by Subject|0|||
94488349|NCT03444584|323581263|FG001|Overall Study|Withdrawal by Subject|1|||
94488350|NCT03444584|323581262|FG000|Overall Study|Other|0|||
94488351|NCT03444584|323581263|FG001|Overall Study|Other|1|||
94488352|NCT00863707|323581264|FG000|Overall Study|Randomized, but drug not received|4|||
94488353|NCT00863707|323581265|FG001|Overall Study|Randomized, but drug not received|3|||
94488354|NCT03040726|323581266|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
94488355|NCT03040726|323581267|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
94488356|NCT03040726|323581266|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
94416372|NCT00094458|323310733|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
94416373|NCT00094458|323310734|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
94416374|NCT00094458|323310735|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
94416375|NCT00094458|323310736|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
94416376|NCT00094458|323310737|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
94416377|NCT00094458|323310738|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
94416378|NCT00094458|323310733|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
94416379|NCT00094458|323310734|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
94416380|NCT00094458|323310735|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
94416381|NCT00094458|323310736|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
94416382|NCT00094458|323310737|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
94416383|NCT00094458|323310738|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
94416384|NCT00094458|323310733|FG000|OLE: Open-Label Extension|Adverse Event|0|||
94416385|NCT00094458|323310734|FG001|OLE: Open-Label Extension|Adverse Event|0|||
94416386|NCT00094458|323310735|FG002|OLE: Open-Label Extension|Adverse Event|0|||
94416387|NCT00094458|323310736|FG003|OLE: Open-Label Extension|Adverse Event|0|||
94416388|NCT00094458|323310737|FG004|OLE: Open-Label Extension|Adverse Event|3|||
94416389|NCT00094458|323310738|FG005|OLE: Open-Label Extension|Adverse Event|4|||
94416390|NCT00094458|323310733|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
94488357|NCT03040726|323581267|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
94488358|NCT03040726|323581266|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
94488359|NCT03040726|323581267|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
94488360|NCT03040726|323581266|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
94488361|NCT03040726|323581267|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
94488362|NCT03040726|323581266|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
94488363|NCT03040726|323581267|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
94416391|NCT00094458|323310734|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
94416392|NCT00094458|323310735|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
94416393|NCT00094458|323310736|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
94416394|NCT00094458|323310737|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
94416395|NCT00094458|323310738|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
94416396|NCT00094458|323310733|FG000|OLE: Open-Label Extension|Patient decision|0|||
94416397|NCT00094458|323310734|FG001|OLE: Open-Label Extension|Patient decision|0|||
94416398|NCT00094458|323310735|FG002|OLE: Open-Label Extension|Patient decision|0|||
94416399|NCT00094458|323310736|FG003|OLE: Open-Label Extension|Patient decision|0|||
94416400|NCT00094458|323310737|FG004|OLE: Open-Label Extension|Patient decision|1|||
94416401|NCT00094458|323310738|FG005|OLE: Open-Label Extension|Patient decision|0|||
94416402|NCT01787279|323310739|FG000|Overall Study|Lost to Follow-up|2|||
94416403|NCT01787279|323310739|FG000|Overall Study|Lack of Efficacy|1|||
94416404|NCT00140413|323310744|FG000|Overall Study|Lost to Follow-up|1|||
94416405|NCT00140413|323310745|FG001|Overall Study|Lost to Follow-up|0|||
94416406|NCT00140413|323310744|FG000|Overall Study|Withdrawal by Subject|2|||
94416407|NCT00140413|323310745|FG001|Overall Study|Withdrawal by Subject|0|||
94416408|NCT05506358|323310746|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
94416409|NCT05506358|323310747|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
94416410|NCT05506358|323310748|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
94416411|NCT05506358|323310749|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
94416412|NCT05506358|323310750|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
94416413|NCT05506358|323310746|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
94416414|NCT05506358|323310747|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
94416415|NCT05506358|323310748|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
94416416|NCT05506358|323310749|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
94416417|NCT05506358|323310750|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
94416418|NCT05506358|323310746|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
94416419|NCT05506358|323310747|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
94416420|NCT05506358|323310748|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
94416421|NCT05506358|323310749|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
94416422|NCT05506358|323310750|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
94416423|NCT05506358|323310746|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
94416424|NCT05506358|323310747|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
94416425|NCT05506358|323310748|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
94416426|NCT05506358|323310749|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
94416427|NCT05506358|323310750|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
94416428|NCT05506358|323310746|FG000|Overall Study|HbE trait|0|||
94416429|NCT05506358|323310747|FG001|Overall Study|HbE trait|0|||
94416430|NCT05506358|323310748|FG002|Overall Study|HbE trait|0|||
94416431|NCT05506358|323310749|FG003|Overall Study|HbE trait|1|||
94416432|NCT05506358|323310750|FG004|Overall Study|HbE trait|0|||
94416433|NCT00804141|323310751|FG000|Overall Study|Adverse Event|157|||
94416434|NCT00804141|323310751|FG000|Overall Study|Death|4|||
94416435|NCT00804141|323310751|FG000|Overall Study|Failed to return|96|||
94416436|NCT00804141|323310751|FG000|Overall Study|Investigator request|8|||
94416437|NCT00804141|323310751|FG000|Overall Study|Protocol Violation|85|||
94416438|NCT00804141|323310751|FG000|Overall Study|Withdrawal by Subject|131|||
94416439|NCT00804141|323310751|FG000|Overall Study|Lack of Efficacy|46|||
94416440|NCT00804141|323310751|FG000|Overall Study|Other than specified|30|||
94416441|NCT00804141|323310751|FG000|Overall Study|Enrolled but not treated|6|||
94416442|NCT00171301|323310754|FG000|Overall Study|Death|1|||
94416443|NCT00171301|323310755|FG001|Overall Study|Death|2|||
94416444|NCT00171301|323310754|FG000|Overall Study|Adverse Event|1|||
94416445|NCT00171301|323310755|FG001|Overall Study|Adverse Event|2|||
94416446|NCT00171301|323310754|FG000|Overall Study|Lost to Follow-up|6|||
94416447|NCT00171301|323310755|FG001|Overall Study|Lost to Follow-up|2|||
94416448|NCT00171301|323310754|FG000|Overall Study|Protocol Violation|0|||
94416449|NCT00171301|323310755|FG001|Overall Study|Protocol Violation|2|||
94416450|NCT00171301|323310754|FG000|Overall Study|Withdrawal by Subject|0|||
94416451|NCT00171301|323310755|FG001|Overall Study|Withdrawal by Subject|1|||
94416452|NCT02546362|323310757|FG000|4-week Treatment Period|Lost to Follow-up|1|||
94416453|NCT02546362|323310757|FG000|4-week Treatment Period|Change in medication|2|||
94416454|NCT02546362|323310757|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
94416455|NCT02546362|323310757|FG000|12-week Treatment Period|Lost to Follow-up|2|||
94416456|NCT02546362|323310757|FG000|12-week Treatment Period|Change in medication|1|||
94416457|NCT02093221|323310764|FG000|Overall Study|Adverse Event|1|||
94416458|NCT02093221|323310765|FG001|Overall Study|Adverse Event|0|||
94416459|NCT02093221|323310766|FG002|Overall Study|Adverse Event|0|||
94416460|NCT02093221|323310767|FG003|Overall Study|Adverse Event|0|||
94416461|NCT02093221|323310768|FG004|Overall Study|Adverse Event|0|||
94416462|NCT02093221|323310764|FG000|Overall Study|Withdrawal by Subject|1|||
94416463|NCT02093221|323310765|FG001|Overall Study|Withdrawal by Subject|1|||
94416464|NCT02093221|323310766|FG002|Overall Study|Withdrawal by Subject|4|||
94416465|NCT02093221|323310767|FG003|Overall Study|Withdrawal by Subject|1|||
94416466|NCT02093221|323310768|FG004|Overall Study|Withdrawal by Subject|1|||
94416467|NCT02093221|323310764|FG000|Overall Study|Lost to Follow-up|2|||
94416468|NCT02093221|323310765|FG001|Overall Study|Lost to Follow-up|0|||
94416469|NCT02093221|323310766|FG002|Overall Study|Lost to Follow-up|1|||
94416470|NCT02093221|323310767|FG003|Overall Study|Lost to Follow-up|1|||
94416471|NCT02093221|323310768|FG004|Overall Study|Lost to Follow-up|0|||
94416472|NCT02093221|323310764|FG000|Overall Study|Death|0|||
94416473|NCT02093221|323310765|FG001|Overall Study|Death|1|||
94416474|NCT02093221|323310766|FG002|Overall Study|Death|0|||
94416475|NCT02093221|323310767|FG003|Overall Study|Death|0|||
94416476|NCT02093221|323310768|FG004|Overall Study|Death|0|||
94416477|NCT02093221|323310764|FG000|Overall Study|Protocol Violation|0|||
94416478|NCT02093221|323310765|FG001|Overall Study|Protocol Violation|1|||
94416479|NCT02093221|323310766|FG002|Overall Study|Protocol Violation|0|||
94416480|NCT02093221|323310767|FG003|Overall Study|Protocol Violation|0|||
94416481|NCT02093221|323310768|FG004|Overall Study|Protocol Violation|0|||
94416482|NCT02093221|323310764|FG000|Overall Study|Study termination|6|||
94416483|NCT02093221|323310765|FG001|Overall Study|Study termination|5|||
94416484|NCT02093221|323310766|FG002|Overall Study|Study termination|4|||
94416485|NCT02093221|323310767|FG003|Overall Study|Study termination|6|||
94416486|NCT02093221|323310768|FG004|Overall Study|Study termination|7|||
94416487|NCT03465436|323310769|FG000|Period 1|Protocol Violation|0|||
94416488|NCT03465436|323310770|FG001|Period 1|Protocol Violation|0|||
94416489|NCT03465436|323310771|FG002|Period 1|Protocol Violation|1|||
94416490|NCT03465436|323310772|FG003|Period 1|Protocol Violation|0|||
94416491|NCT03465436|323310769|FG000|Period 2|Protocol Violation|0|||
94416492|NCT03465436|323310770|FG001|Period 2|Protocol Violation|1|||
94416493|NCT03465436|323310771|FG002|Period 2|Protocol Violation|0|||
94416494|NCT03465436|323310772|FG003|Period 2|Protocol Violation|0|||
94416495|NCT03465436|323310769|FG000|Period 3|Protocol Violation|1|||
94416496|NCT03465436|323310770|FG001|Period 3|Protocol Violation|1|||
94416497|NCT03465436|323310771|FG002|Period 3|Protocol Violation|0|||
94416498|NCT03465436|323310772|FG003|Period 3|Protocol Violation|0|||
94416499|NCT03465436|323310769|FG000|Period 4|Protocol Violation|0|||
94416500|NCT03465436|323310770|FG001|Period 4|Protocol Violation|0|||
94416501|NCT03465436|323310771|FG002|Period 4|Protocol Violation|1|||
94416502|NCT03465436|323310772|FG003|Period 4|Protocol Violation|0|||
94416503|NCT00049842|323310775|FG000|Treatment Phase|Adverse Event|47|||
94416504|NCT00049842|323310776|FG001|Treatment Phase|Adverse Event|12|||
94416505|NCT00049842|323310775|FG000|Treatment Phase|Withdrawal by Subject|35|||
94416506|NCT00049842|323310776|FG001|Treatment Phase|Withdrawal by Subject|46|||
94416507|NCT00049842|323310775|FG000|Treatment Phase|Non-compliance with protocol|7|||
94416508|NCT00049842|323310776|FG001|Treatment Phase|Non-compliance with protocol|8|||
94416509|NCT00049842|323310775|FG000|Treatment Phase|Lost to Follow-up|4|||
94416510|NCT00049842|323310776|FG001|Treatment Phase|Lost to Follow-up|8|||
94416511|NCT00049842|323310775|FG000|Treatment Phase|Administrative|0|||
94416512|NCT00049842|323310776|FG001|Treatment Phase|Administrative|3|||
94416513|NCT00049842|323310775|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
94416514|NCT00049842|323310776|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
94416515|NCT00049842|323310775|FG000|Follow-up Phase|Adverse Event|6|||
94416516|NCT00049842|323310776|FG001|Follow-up Phase|Adverse Event|1|||
94416517|NCT00049842|323310775|FG000|Follow-up Phase|Other|1|||
94416518|NCT00049842|323310776|FG001|Follow-up Phase|Other|4|||
94416519|NCT01813071|323310777|FG000|Overall Study|Protocol Violation|0|||
94416520|NCT01813071|323310778|FG001|Overall Study|Protocol Violation|0|||
94416521|NCT01813071|323310779|FG002|Overall Study|Protocol Violation|0|||
94416522|NCT01813071|323310780|FG003|Overall Study|Protocol Violation|0|||
94416523|NCT01813071|323310781|FG004|Overall Study|Protocol Violation|1|||
94416524|NCT01813071|323310782|FG005|Overall Study|Protocol Violation|4|||
94416525|NCT01813071|323310783|FG006|Overall Study|Protocol Violation|2|||
94416526|NCT01813071|323310784|FG007|Overall Study|Protocol Violation|4|||
94416527|NCT01813071|323310785|FG008|Overall Study|Protocol Violation|2|||
94416528|NCT01813071|323310777|FG000|Overall Study|Withdrawal by Subject|0|||
94416529|NCT01813071|323310778|FG001|Overall Study|Withdrawal by Subject|0|||
94416530|NCT01813071|323310779|FG002|Overall Study|Withdrawal by Subject|0|||
94416531|NCT01813071|323310780|FG003|Overall Study|Withdrawal by Subject|0|||
94416532|NCT01813071|323310781|FG004|Overall Study|Withdrawal by Subject|0|||
94416533|NCT01813071|323310782|FG005|Overall Study|Withdrawal by Subject|1|||
94416534|NCT01813071|323310783|FG006|Overall Study|Withdrawal by Subject|0|||
94416535|NCT01813071|323310784|FG007|Overall Study|Withdrawal by Subject|0|||
94416536|NCT01813071|323310785|FG008|Overall Study|Withdrawal by Subject|0|||
94416537|NCT01813071|323310777|FG000|Overall Study|Adverse Event|0|||
94416538|NCT01813071|323310778|FG001|Overall Study|Adverse Event|0|||
94416539|NCT01813071|323310779|FG002|Overall Study|Adverse Event|0|||
94416540|NCT01813071|323310780|FG003|Overall Study|Adverse Event|0|||
94416541|NCT01813071|323310781|FG004|Overall Study|Adverse Event|0|||
94416542|NCT01813071|323310782|FG005|Overall Study|Adverse Event|1|||
94416543|NCT01813071|323310783|FG006|Overall Study|Adverse Event|0|||
94416544|NCT01813071|323310784|FG007|Overall Study|Adverse Event|0|||
94416545|NCT01813071|323310785|FG008|Overall Study|Adverse Event|0|||
94416546|NCT01813071|323310777|FG000|Overall Study|Physician Decision|0|||
94416547|NCT01813071|323310778|FG001|Overall Study|Physician Decision|0|||
94416548|NCT01813071|323310779|FG002|Overall Study|Physician Decision|0|||
94416549|NCT01813071|323310780|FG003|Overall Study|Physician Decision|0|||
94416550|NCT01813071|323310781|FG004|Overall Study|Physician Decision|0|||
94416551|NCT01813071|323310782|FG005|Overall Study|Physician Decision|0|||
94416552|NCT01813071|323310783|FG006|Overall Study|Physician Decision|1|||
94416553|NCT01813071|323310784|FG007|Overall Study|Physician Decision|0|||
94416554|NCT01813071|323310785|FG008|Overall Study|Physician Decision|0|||
94416555|NCT01813071|323310777|FG000|Overall Study|Met inc/exc criteria|0|||
94416556|NCT01813071|323310778|FG001|Overall Study|Met inc/exc criteria|0|||
94416557|NCT01813071|323310779|FG002|Overall Study|Met inc/exc criteria|0|||
94416558|NCT01813071|323310780|FG003|Overall Study|Met inc/exc criteria|0|||
94416559|NCT01813071|323310781|FG004|Overall Study|Met inc/exc criteria|0|||
94416560|NCT01813071|323310782|FG005|Overall Study|Met inc/exc criteria|1|||
94416561|NCT01813071|323310783|FG006|Overall Study|Met inc/exc criteria|0|||
94416562|NCT01813071|323310784|FG007|Overall Study|Met inc/exc criteria|1|||
94416563|NCT01813071|323310785|FG008|Overall Study|Met inc/exc criteria|1|||
94416564|NCT00831623|323310786|FG000|Overall Study|Withdrawal by Subject|9|||
94416565|NCT00831623|323310786|FG000|Overall Study|Lost to Follow-up|1|||
94416566|NCT00831623|323310786|FG000|Overall Study|Not 2 years post-treatment|12|||
94416567|NCT01902628|323310787|FG000|Overall Study|Withdrawal of participant's consent|7|||
94416568|NCT01902628|323310787|FG000|Overall Study|Adverse Event|41|||
94416569|NCT01902628|323310787|FG000|Overall Study|Lost to Follow-up|35|||
94416570|NCT01491035|323310794|FG000|Overall Study|Lost to Follow-up|0|||
94416571|NCT01491035|323310795|FG001|Overall Study|Lost to Follow-up|0|||
94416572|NCT01491035|323310796|FG002|Overall Study|Lost to Follow-up|0|||
94416573|NCT01491035|323310797|FG003|Overall Study|Lost to Follow-up|0|||
94416574|NCT01491035|323310798|FG004|Overall Study|Lost to Follow-up|1|||
94416575|NCT01491035|323310799|FG005|Overall Study|Lost to Follow-up|0|||
94416576|NCT01491035|323310800|FG006|Overall Study|Lost to Follow-up|0|||
94416577|NCT01491035|323310801|FG007|Overall Study|Lost to Follow-up|0|||
94416578|NCT02025751|323310803|FG000|Overall Study|Lost to Follow-up|1|||
94416579|NCT02025751|323310804|FG001|Overall Study|Lost to Follow-up|0|||
94416580|NCT02025751|323310803|FG000|Overall Study|Adverse Event|0|||
94416581|NCT02025751|323310804|FG001|Overall Study|Adverse Event|1|||
94416582|NCT02025751|323310803|FG000|Overall Study|Physician Decision|0|||
94416583|NCT02025751|323310804|FG001|Overall Study|Physician Decision|1|||
94416584|NCT02025751|323310803|FG000|Overall Study|Withdrawal by Subject|0|||
94416585|NCT02025751|323310804|FG001|Overall Study|Withdrawal by Subject|1|||
94416586|NCT02939014|323310807|FG000|Overall Study|Lost to Follow-up|1|||
94416587|NCT02939014|323310808|FG001|Overall Study|Lost to Follow-up|0|||
94416588|NCT02939014|323310807|FG000|Overall Study|Death|4|||
94416589|NCT02939014|323310808|FG001|Overall Study|Death|3|||
94416590|NCT02149121|323310809|FG000|Main Study Period|Lack of Efficacy|2|||
94416591|NCT02149121|323310810|FG001|Main Study Period|Lack of Efficacy|2|||
94416592|NCT02149121|323310811|FG002|Main Study Period|Lack of Efficacy|1|||
94416593|NCT02149121|323310812|FG003|Main Study Period|Lack of Efficacy|0|||
94416594|NCT02149121|323310813|FG004|Main Study Period|Lack of Efficacy|0|||
94416595|NCT02149121|323310814|FG005|Main Study Period|Lack of Efficacy|0|||
94416596|NCT02149121|323310815|FG006|Main Study Period|Lack of Efficacy|0|||
94416597|NCT02149121|323310809|FG000|Main Study Period|Withdrawal by Subject|9|||
94416598|NCT02149121|323310810|FG001|Main Study Period|Withdrawal by Subject|5|||
94416599|NCT02149121|323310811|FG002|Main Study Period|Withdrawal by Subject|1|||
94416600|NCT02149121|323310812|FG003|Main Study Period|Withdrawal by Subject|0|||
94416601|NCT02149121|323310813|FG004|Main Study Period|Withdrawal by Subject|0|||
94416602|NCT02149121|323310814|FG005|Main Study Period|Withdrawal by Subject|0|||
94416603|NCT02149121|323310815|FG006|Main Study Period|Withdrawal by Subject|0|||
94488364|NCT04682301|323581272|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
94488365|NCT04682301|323581272|FG000|Overall Study|Death|2|||
94488366|NCT01776554|323581273|FG000|Overall Study|Adverse Event|1|||
94416604|NCT02149121|323310809|FG000|Main Study Period|Adverse Event|2|||
94416605|NCT02149121|323310810|FG001|Main Study Period|Adverse Event|5|||
94416606|NCT02149121|323310811|FG002|Main Study Period|Adverse Event|1|||
94416607|NCT02149121|323310812|FG003|Main Study Period|Adverse Event|0|||
94416608|NCT02149121|323310813|FG004|Main Study Period|Adverse Event|0|||
94416609|NCT02149121|323310814|FG005|Main Study Period|Adverse Event|0|||
94416610|NCT02149121|323310815|FG006|Main Study Period|Adverse Event|0|||
94416611|NCT02149121|323310809|FG000|Main Study Period|Protocol Violation|2|||
94416612|NCT02149121|323310810|FG001|Main Study Period|Protocol Violation|0|||
94416613|NCT02149121|323310811|FG002|Main Study Period|Protocol Violation|0|||
94416614|NCT02149121|323310812|FG003|Main Study Period|Protocol Violation|0|||
94416615|NCT02149121|323310813|FG004|Main Study Period|Protocol Violation|0|||
94416616|NCT02149121|323310814|FG005|Main Study Period|Protocol Violation|0|||
94416617|NCT02149121|323310815|FG006|Main Study Period|Protocol Violation|0|||
94416618|NCT02149121|323310809|FG000|Main Study Period|Lost to Follow-up|2|||
94416619|NCT02149121|323310810|FG001|Main Study Period|Lost to Follow-up|1|||
94416620|NCT02149121|323310811|FG002|Main Study Period|Lost to Follow-up|0|||
94416621|NCT02149121|323310812|FG003|Main Study Period|Lost to Follow-up|0|||
94416622|NCT02149121|323310813|FG004|Main Study Period|Lost to Follow-up|0|||
94416623|NCT02149121|323310814|FG005|Main Study Period|Lost to Follow-up|0|||
94416624|NCT02149121|323310815|FG006|Main Study Period|Lost to Follow-up|0|||
94416625|NCT02149121|323310809|FG000|Main Study Period|Death|1|||
94416626|NCT02149121|323310810|FG001|Main Study Period|Death|0|||
94416627|NCT02149121|323310811|FG002|Main Study Period|Death|0|||
94416628|NCT02149121|323310812|FG003|Main Study Period|Death|0|||
94416629|NCT02149121|323310813|FG004|Main Study Period|Death|0|||
94416630|NCT02149121|323310814|FG005|Main Study Period|Death|0|||
94416631|NCT02149121|323310815|FG006|Main Study Period|Death|0|||
94416632|NCT02149121|323310809|FG000|Main Study Period|Physician Decision|1|||
94416633|NCT02149121|323310810|FG001|Main Study Period|Physician Decision|0|||
94416634|NCT02149121|323310811|FG002|Main Study Period|Physician Decision|0|||
94416635|NCT02149121|323310812|FG003|Main Study Period|Physician Decision|0|||
94416636|NCT02149121|323310813|FG004|Main Study Period|Physician Decision|0|||
94416637|NCT02149121|323310814|FG005|Main Study Period|Physician Decision|0|||
94416638|NCT02149121|323310815|FG006|Main Study Period|Physician Decision|0|||
94416639|NCT02149121|323310809|FG000|Main Study Period|Developed any malignancy|0|||
94416640|NCT02149121|323310810|FG001|Main Study Period|Developed any malignancy|1|||
94416641|NCT02149121|323310811|FG002|Main Study Period|Developed any malignancy|1|||
94416642|NCT02149121|323310812|FG003|Main Study Period|Developed any malignancy|0|||
94416643|NCT02149121|323310813|FG004|Main Study Period|Developed any malignancy|0|||
94416644|NCT02149121|323310814|FG005|Main Study Period|Developed any malignancy|0|||
94416645|NCT02149121|323310815|FG006|Main Study Period|Developed any malignancy|0|||
94416646|NCT02149121|323310809|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
94416647|NCT02149121|323310810|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
94416648|NCT02149121|323310811|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
94416649|NCT02149121|323310812|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
94416650|NCT02149121|323310813|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
94416651|NCT02149121|323310814|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
94416652|NCT02149121|323310815|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
94416653|NCT02149121|323310809|FG000|Main Study Period|Disease progression|0|||
94416654|NCT02149121|323310810|FG001|Main Study Period|Disease progression|1|||
94416655|NCT02149121|323310811|FG002|Main Study Period|Disease progression|0|||
94416656|NCT02149121|323310812|FG003|Main Study Period|Disease progression|0|||
94416657|NCT02149121|323310813|FG004|Main Study Period|Disease progression|0|||
94416658|NCT02149121|323310814|FG005|Main Study Period|Disease progression|0|||
94416659|NCT02149121|323310815|FG006|Main Study Period|Disease progression|0|||
94416660|NCT02149121|323310809|FG000|Extension Study Period|Withdrawal by Subject|0|||
94416661|NCT02149121|323310810|FG001|Extension Study Period|Withdrawal by Subject|0|||
94416662|NCT02149121|323310811|FG002|Extension Study Period|Withdrawal by Subject|0|||
94416663|NCT02149121|323310812|FG003|Extension Study Period|Withdrawal by Subject|1|||
94416664|NCT02149121|323310813|FG004|Extension Study Period|Withdrawal by Subject|0|||
94416665|NCT02149121|323310814|FG005|Extension Study Period|Withdrawal by Subject|2|||
94416666|NCT02149121|323310815|FG006|Extension Study Period|Withdrawal by Subject|0|||
94416667|NCT00766831|323310824|FG000|Overall Study|Withdrawal by Subject|4|||
94416668|NCT00766831|323310824|FG000|Overall Study|Lost to Follow-up|3|||
94416669|NCT00766831|323310824|FG000|Overall Study|Adverse Event|20|||
94416670|NCT00766831|323310824|FG000|Overall Study|Protocol Violation|15|||
94416671|NCT00766831|323310824|FG000|Overall Study|Physician Decision|5|||
94416672|NCT00766831|323310824|FG000|Overall Study|Withdrawal of consent|26|||
94416673|NCT00766831|323310824|FG000|Overall Study|Non cooperation by participants|14|||
94416674|NCT00766831|323310824|FG000|Overall Study|Other|28|||
94416675|NCT02220725|323310825|FG000|Overall Study|Lost to Follow-up|0|||
94416676|NCT02220725|323310826|FG001|Overall Study|Lost to Follow-up|0|||
94416677|NCT02220725|323310827|FG002|Overall Study|Lost to Follow-up|0|||
94416678|NCT02220725|323310828|FG003|Overall Study|Lost to Follow-up|1|||
94416679|NCT02220725|323310825|FG000|Overall Study|Withdrawal by Subject|0|||
94416680|NCT02220725|323310826|FG001|Overall Study|Withdrawal by Subject|0|||
94416681|NCT02220725|323310827|FG002|Overall Study|Withdrawal by Subject|0|||
94416682|NCT02220725|323310828|FG003|Overall Study|Withdrawal by Subject|1|||
94416683|NCT05816200|323310831|FG000|Overall Study|Lost to Follow-up|2|||
94488367|NCT01776554|323581274|FG001|Overall Study|Adverse Event|0|||
94416684|NCT05816200|323310832|FG001|Overall Study|Lost to Follow-up|1|||
94416685|NCT00103402|323310833|FG000|Overall Study|Adverse Event|3|||
94416686|NCT00103402|323310834|FG001|Overall Study|Adverse Event|4|||
94488368|NCT01776554|323581273|FG000|Overall Study|Withdrawal by Subject|3|||
94416687|NCT00103402|323310833|FG000|Overall Study|Lost to Follow-up|8|||
94416688|NCT00103402|323310834|FG001|Overall Study|Lost to Follow-up|7|||
94416689|NCT00103402|323310833|FG000|Overall Study|Dissatisfied/No longer interested|6|||
94416690|NCT00103402|323310834|FG001|Overall Study|Dissatisfied/No longer interested|6|||
94416691|NCT00103402|323310833|FG000|Overall Study|Personal constraints/Other|5|||
94416692|NCT00103402|323310834|FG001|Overall Study|Personal constraints/Other|0|||
94416693|NCT01297322|323310835|FG000|Overall Study|Lost to Follow-up|1|||
94416694|NCT01297322|323310836|FG001|Overall Study|Lost to Follow-up|0|||
94416695|NCT01297322|323310835|FG000|Overall Study|Withdrawal by Subject|0|||
94416696|NCT01297322|323310836|FG001|Overall Study|Withdrawal by Subject|1|||
94416697|NCT01297322|323310835|FG000|Overall Study|Protocol Violation|0|||
94416698|NCT01297322|323310836|FG001|Overall Study|Protocol Violation|3|||
94416699|NCT01583218|323310837|FG000|Overall Study|Withdrawal by Subject|43|||
94416700|NCT01583218|323310838|FG001|Overall Study|Withdrawal by Subject|29|||
94416701|NCT01583218|323310837|FG000|Overall Study|Death|206|||
94416702|NCT01583218|323310838|FG001|Overall Study|Death|211|||
94416703|NCT01583218|323310837|FG000|Overall Study|Lost to Follow-up|11|||
94416704|NCT01583218|323310838|FG001|Overall Study|Lost to Follow-up|17|||
94416705|NCT01583218|323310837|FG000|Overall Study|Adverse event or serious adverse event|3|||
94416706|NCT01583218|323310838|FG001|Overall Study|Adverse event or serious adverse event|3|||
94416707|NCT01583218|323310837|FG000|Overall Study|Patient /Family decision|3|||
94416708|NCT01583218|323310838|FG001|Overall Study|Patient /Family decision|0|||
94416709|NCT01583218|323310837|FG000|Overall Study|Cannot contact patient directly|1|||
94416710|NCT01583218|323310838|FG001|Overall Study|Cannot contact patient directly|2|||
94416711|NCT01583218|323310837|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
94416712|NCT01583218|323310838|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
94416713|NCT01583218|323310837|FG000|Overall Study|Patient did not wish to attend visits|0|||
94416714|NCT01583218|323310838|FG001|Overall Study|Patient did not wish to attend visits|1|||
94416715|NCT01583218|323310837|FG000|Overall Study|Patient randomized but not dosed|17|||
94416716|NCT01583218|323310838|FG001|Overall Study|Patient randomized but not dosed|16|||
94416717|NCT01583218|323310837|FG000|Overall Study|Patient was assessed via phone in person|1|||
94416718|NCT01583218|323310838|FG001|Overall Study|Patient was assessed via phone in person|0|||
94416719|NCT01583218|323310837|FG000|Overall Study|Patient deemed ineligible after random|2|||
94416720|NCT01583218|323310838|FG001|Overall Study|Patient deemed ineligible after random|0|||
94416721|NCT01583218|323310837|FG000|Overall Study|Patient was early terminated from study|0|||
94416722|NCT01583218|323310838|FG001|Overall Study|Patient was early terminated from study|1|||
94416723|NCT01583218|323310837|FG000|Overall Study|Patient was randomized due to mistake|1|||
94416724|NCT01583218|323310838|FG001|Overall Study|Patient was randomized due to mistake|0|||
94416725|NCT01583218|323310837|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
94416726|NCT01583218|323310838|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
94416727|NCT01583218|323310837|FG000|Overall Study|Withdraw of consent on day of random|1|||
94416728|NCT01583218|323310838|FG001|Overall Study|Withdraw of consent on day of random|0|||
94416729|NCT01334710|323310839|FG000|Overall Study|Trial was terminated|3|||
94416730|NCT01663727|323310841|FG000|Overall Study|Death|161|||
94416731|NCT01663727|323310842|FG001|Overall Study|Death|155|||
94416732|NCT01663727|323310841|FG000|Overall Study|Lost to Follow-up|10|||
94416733|NCT01663727|323310842|FG001|Overall Study|Lost to Follow-up|8|||
94416734|NCT01663727|323310841|FG000|Overall Study|Withdrawal by Subject|18|||
94416735|NCT01663727|323310842|FG001|Overall Study|Withdrawal by Subject|25|||
94416736|NCT01663727|323310841|FG000|Overall Study|Study Terminated|51|||
94416737|NCT01663727|323310842|FG001|Overall Study|Study Terminated|50|||
94416738|NCT01663727|323310841|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
94416739|NCT01663727|323310842|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
94416740|NCT01663727|323310841|FG000|Overall Study|Withdrawal prior to dosing.|1|||
94416741|NCT01663727|323310842|FG001|Overall Study|Withdrawal prior to dosing.|0|||
94416742|NCT01079832|323310843|FG000|Overall Study|Withdrawal by Subject|1|||
94416743|NCT04223778|323310846|FG000|Overall Study|Ongoing|322|||
94416744|NCT04223778|323310847|FG001|Overall Study|Ongoing|326|||
94416745|NCT04223778|323310846|FG000|Overall Study|Death|0|||
94416746|NCT04223778|323310847|FG001|Overall Study|Death|1|||
94416747|NCT04223778|323310846|FG000|Overall Study|Lost to Follow-up|1|||
94416748|NCT04223778|323310847|FG001|Overall Study|Lost to Follow-up|5|||
94416749|NCT04223778|323310846|FG000|Overall Study|Physician Decision|3|||
94416750|NCT04223778|323310847|FG001|Overall Study|Physician Decision|1|||
94416751|NCT04223778|323310846|FG000|Overall Study|Withdrawal by Subject|10|||
94416752|NCT04223778|323310847|FG001|Overall Study|Withdrawal by Subject|1|||
94416753|NCT04223778|323310846|FG000|Overall Study|Lack of Efficacy|0|||
94416754|NCT04223778|323310847|FG001|Overall Study|Lack of Efficacy|2|||
94416755|NCT00380692|323312040|FG000|Study Period II - Double Blind|Adverse Event|1|||
94416756|NCT00380692|323312041|FG001|Study Period II - Double Blind|Adverse Event|0|||
94416757|NCT00380692|323312040|FG000|Study Period II - Double Blind|Protocol Violation|2|||
94416758|NCT00380692|323312041|FG001|Study Period II - Double Blind|Protocol Violation|2|||
94416759|NCT00380692|323312040|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
94416760|NCT00380692|323312041|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
94416761|NCT00380692|323312040|FG000|Study Period II - Double Blind|Physician Decision|0|||
94416762|NCT00380692|323312041|FG001|Study Period II - Double Blind|Physician Decision|1|||
94416763|NCT00380692|323312040|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
94416764|NCT00380692|323312041|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
94416765|NCT00380692|323312040|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
94416766|NCT00380692|323312041|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
94416767|NCT00380692|323312040|FG000|Study Period III - Open Label|Adverse Event|5|||
94416768|NCT00380692|323312041|FG001|Study Period III - Open Label|Adverse Event|3|||
94416769|NCT00380692|323312040|FG000|Study Period III - Open Label|Protocol Violation|0|||
94416770|NCT00380692|323312041|FG001|Study Period III - Open Label|Protocol Violation|0|||
94416771|NCT00380692|323312040|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
94416772|NCT00380692|323312041|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
94416773|NCT00380692|323312040|FG000|Study Period III - Open Label|Physician Decision|0|||
94416774|NCT00380692|323312041|FG001|Study Period III - Open Label|Physician Decision|3|||
94416775|NCT00380692|323312040|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
94416776|NCT00380692|323312041|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
94416777|NCT00380692|323312040|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
94416778|NCT00380692|323312041|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
94416779|NCT00608517|323312044|FG000|Overall Study|Death|1|||
94416780|NCT00608517|323312045|FG001|Overall Study|Death|0|||
94416781|NCT00608517|323312046|FG002|Overall Study|Death|0|||
94416782|NCT02791893|323312047|FG000|Blinded Phase|Lost to Follow-up|2|||
94416783|NCT02791893|323312048|FG001|Blinded Phase|Lost to Follow-up|2|||
94416784|NCT02791893|323312047|FG000|Blinded Phase|Withdrawal by Subject|1|||
94416785|NCT02791893|323312048|FG001|Blinded Phase|Withdrawal by Subject|2|||
94416786|NCT02791893|323312047|FG000|Open Label Phase|Lost to Follow-up|3|||
94416787|NCT02791893|323312048|FG001|Open Label Phase|Lost to Follow-up|0|||
94416788|NCT02791893|323312047|FG000|Open Label Phase|Withdrawal by Subject|0|||
94416789|NCT02791893|323312048|FG001|Open Label Phase|Withdrawal by Subject|2|||
94416790|NCT02621034|323312049|FG000|Overall Study|Lost to Follow-up|3|||
94416791|NCT02621034|323312050|FG001|Overall Study|Lost to Follow-up|2|||
94416792|NCT02621034|323312051|FG002|Overall Study|Lost to Follow-up|5|||
94416793|NCT03028740|323312058|FG000|Overall Study|Did not Receive Study Drug|4|||
94416794|NCT03028740|323312059|FG001|Overall Study|Did not Receive Study Drug|5|||
94416795|NCT03028740|323312058|FG000|Overall Study|Adverse Event|8|||
94416796|NCT03028740|323312059|FG001|Overall Study|Adverse Event|26|||
94416797|NCT03028740|323312058|FG000|Overall Study|Lack of Efficacy|0|||
94416798|NCT03028740|323312059|FG001|Overall Study|Lack of Efficacy|1|||
94416799|NCT03028740|323312058|FG000|Overall Study|Withdrawal by Subject|48|||
94416800|NCT03028740|323312059|FG001|Overall Study|Withdrawal by Subject|101|||
94416801|NCT03028740|323312058|FG000|Overall Study|Lost to Follow-up|30|||
94416802|NCT03028740|323312059|FG001|Overall Study|Lost to Follow-up|54|||
94416803|NCT03028740|323312058|FG000|Overall Study|Physician Decision|4|||
94416804|NCT03028740|323312059|FG001|Overall Study|Physician Decision|11|||
94416805|NCT03028740|323312058|FG000|Overall Study|Protocol Violation|4|||
94416806|NCT03028740|323312059|FG001|Overall Study|Protocol Violation|8|||
94416807|NCT03028740|323312058|FG000|Overall Study|Non-compliance with Study Drug|0|||
94416808|NCT03028740|323312059|FG001|Overall Study|Non-compliance with Study Drug|2|||
94416809|NCT03028740|323312058|FG000|Overall Study|Study Terminated by Sponsor|467|||
94416810|NCT03028740|323312059|FG001|Overall Study|Study Terminated by Sponsor|917|||
94416811|NCT03028740|323312058|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
94416812|NCT03028740|323312059|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
94416813|NCT03028740|323312058|FG000|Overall Study|Reason not Specified|1|||
94416814|NCT03028740|323312059|FG001|Overall Study|Reason not Specified|5|||
94416815|NCT00136318|323312061|FG000|Overall Study|Adverse Event|5|||
94416816|NCT00136318|323312062|FG001|Overall Study|Adverse Event|5|||
94416817|NCT00136318|323312061|FG000|Overall Study|Withdrawal by Subject|2|||
94416818|NCT00136318|323312062|FG001|Overall Study|Withdrawal by Subject|2|||
94416819|NCT00619359|323312063|FG000|Overall Study|Adverse Event|32|||
94416820|NCT00619359|323312064|FG001|Overall Study|Adverse Event|36|||
94416821|NCT00619359|323312063|FG000|Overall Study|Lost to Follow-up|12|||
94416822|NCT00619359|323312064|FG001|Overall Study|Lost to Follow-up|16|||
94416823|NCT00619359|323312063|FG000|Overall Study|Physician Decision|0|||
94416824|NCT00619359|323312064|FG001|Overall Study|Physician Decision|7|||
94416825|NCT00619359|323312063|FG000|Overall Study|Protocol Violation|1|||
94416826|NCT00619359|323312064|FG001|Overall Study|Protocol Violation|1|||
94416827|NCT00619359|323312063|FG000|Overall Study|Withdrawal by Subject|19|||
94416828|NCT00619359|323312064|FG001|Overall Study|Withdrawal by Subject|20|||
94416829|NCT00619359|323312063|FG000|Overall Study|Progressive Disease|3|||
94416830|NCT00619359|323312064|FG001|Overall Study|Progressive Disease|1|||
94416831|NCT01661881|323312068|FG000|Overall Study|Disease Progression|1|||
94416832|NCT01546649|323312069|FG000|Overall Study|Adverse Event|4|||
94416833|NCT01546649|323312070|FG001|Overall Study|Adverse Event|5|||
94416834|NCT01546649|323312069|FG000|Overall Study|Protocol Violation|1|||
94416835|NCT01546649|323312070|FG001|Overall Study|Protocol Violation|0|||
94416836|NCT01546649|323312069|FG000|Overall Study|Lack of Efficacy|1|||
94416837|NCT01546649|323312070|FG001|Overall Study|Lack of Efficacy|0|||
94416838|NCT01546649|323312069|FG000|Overall Study|Recurrence|1|||
94416839|NCT01546649|323312070|FG001|Overall Study|Recurrence|1|||
94416840|NCT01546649|323312069|FG000|Overall Study|Discovery of secondary cancer|0|||
94416841|NCT01546649|323312070|FG001|Overall Study|Discovery of secondary cancer|1|||
94416842|NCT01546649|323312069|FG000|Overall Study|Withdrawal by Subject|1|||
94416843|NCT01546649|323312070|FG001|Overall Study|Withdrawal by Subject|2|||
94416844|NCT01929395|323312071|FG000|Overall Study|Did not complete - non-related toxicity|1|||
94416845|NCT01929395|323312072|FG001|Overall Study|Did not complete - non-related toxicity|0|||
94416846|NCT01929395|323312073|FG002|Overall Study|Did not complete - non-related toxicity|0|||
94416847|NCT01929395|323312071|FG000|Overall Study|Withdrawal by Subject|0|||
94416848|NCT01929395|323312072|FG001|Overall Study|Withdrawal by Subject|1|||
94416849|NCT01929395|323312073|FG002|Overall Study|Withdrawal by Subject|0|||
94416850|NCT01929395|323312071|FG000|Overall Study|Screen Fail|0|||
94416851|NCT01929395|323312072|FG001|Overall Study|Screen Fail|0|||
94416852|NCT01929395|323312073|FG002|Overall Study|Screen Fail|1|||
94416853|NCT02547766|323312075|FG000|Overall Study|Withdrawal by Subject|1|||
94416854|NCT03212794|323312076|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
94416855|NCT03212794|323312077|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
94416856|NCT03212794|323312076|FG000|Overall Study|Lost to Follow-up|5|||
94416857|NCT03212794|323312077|FG001|Overall Study|Lost to Follow-up|6|||
94416858|NCT03212794|323312076|FG000|Overall Study|Incarcerated; unable to participate|2|||
94416859|NCT03212794|323312077|FG001|Overall Study|Incarcerated; unable to participate|0|||
94416860|NCT03212794|323312076|FG000|Overall Study|Withdrawal by Subject|1|||
94488369|NCT01776554|323581274|FG001|Overall Study|Withdrawal by Subject|8|||
94488370|NCT01776554|323581273|FG000|Overall Study|Lost to Follow-up|6|||
94488371|NCT01776554|323581274|FG001|Overall Study|Lost to Follow-up|9|||
94488372|NCT01776554|323581273|FG000|Overall Study|Administrative Reason|2|||
94488373|NCT01776554|323581274|FG001|Overall Study|Administrative Reason|5|||
94488374|NCT01776554|323581273|FG000|Overall Study|Protocol Violation|1|||
94488375|NCT01776554|323581274|FG001|Overall Study|Protocol Violation|0|||
94488376|NCT01776554|323581273|FG000|Overall Study|Unclassified|4|||
94488377|NCT01776554|323581274|FG001|Overall Study|Unclassified|1|||
94488378|NCT01114724|323581282|FG000|Overall Study|Death|8|||
94488379|NCT01114724|323581282|FG000|Overall Study|Lost to Follow-up|1|||
94488380|NCT01114724|323581282|FG000|Overall Study|Withdrawal by Subject|1|||
94488381|NCT00843492|323581284|FG000|Overall Study|Adverse Event|0|||
94488382|NCT00843492|323581285|FG001|Overall Study|Adverse Event|3|||
94488383|NCT00843492|323581284|FG000|Overall Study|Lost to Follow-up|4|||
94488384|NCT00843492|323581285|FG001|Overall Study|Lost to Follow-up|4|||
94488385|NCT00843492|323581284|FG000|Overall Study|Withdrawal by Subject|0|||
94488386|NCT00843492|323581285|FG001|Overall Study|Withdrawal by Subject|4|||
94488387|NCT00843492|323581284|FG000|Overall Study|Immobilization Stopped|1|||
94488388|NCT00843492|323581285|FG001|Overall Study|Immobilization Stopped|0|||
94488389|NCT00843492|323581284|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
94488390|NCT00843492|323581285|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
94488391|NCT00843492|323581284|FG000|Overall Study|Orthopedic Surgery|0|||
94488392|NCT00843492|323581285|FG001|Overall Study|Orthopedic Surgery|2|||
94488393|NCT00843492|323581284|FG000|Overall Study|Visit Not Performed|1|||
94488394|NCT00843492|323581285|FG001|Overall Study|Visit Not Performed|0|||
94488395|NCT00843492|323581284|FG000|Overall Study|Deep-vein Thrombosis|1|||
94488396|NCT00843492|323581285|FG001|Overall Study|Deep-vein Thrombosis|0|||
94488397|NCT00720499|323581286|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
94488398|NCT00720499|323581287|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
94488399|NCT00720499|323581286|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
94488400|NCT00720499|323581287|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
94488401|NCT00720499|323581286|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
94488402|NCT00720499|323581287|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
94488403|NCT00251758|323581290|FG000|Overall Study|Adverse Event|7|||
94488404|NCT00251758|323581291|FG001|Overall Study|Adverse Event|9|||
94488405|NCT00251758|323581292|FG002|Overall Study|Adverse Event|11|||
94488406|NCT00251758|323581290|FG000|Overall Study|Lost to Follow-up|4|||
94488407|NCT00251758|323581291|FG001|Overall Study|Lost to Follow-up|2|||
94488408|NCT00251758|323581292|FG002|Overall Study|Lost to Follow-up|5|||
94488409|NCT00251758|323581290|FG000|Overall Study|Withdrawal by Subject|13|||
94488410|NCT00251758|323581291|FG001|Overall Study|Withdrawal by Subject|7|||
94488411|NCT00251758|323581292|FG002|Overall Study|Withdrawal by Subject|3|||
94488412|NCT00251758|323581290|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
94416861|NCT03212794|323312077|FG001|Overall Study|Withdrawal by Subject|0|||
94416862|NCT03212794|323312076|FG000|Overall Study|Death|0|||
94416863|NCT03212794|323312077|FG001|Overall Study|Death|1|||
94416864|NCT03212794|323312076|FG000|Overall Study|Found to be ineligible after allocation|0|||
94488413|NCT00251758|323581291|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
94488414|NCT00251758|323581292|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
94488415|NCT00251758|323581290|FG000|Overall Study|Lack of Efficacy|3|||
94488416|NCT00251758|323581291|FG001|Overall Study|Lack of Efficacy|0|||
94488417|NCT00251758|323581292|FG002|Overall Study|Lack of Efficacy|0|||
94488418|NCT00251758|323581290|FG000|Overall Study|Noncompliant|0|||
94416865|NCT03212794|323312077|FG001|Overall Study|Found to be ineligible after allocation|1|||
94416866|NCT03212794|323312076|FG000|Overall Study|Relocated out of area|2|||
94416867|NCT03212794|323312077|FG001|Overall Study|Relocated out of area|0|||
94416868|NCT00897949|323312083|FG000|Overall Study|Adverse Event|1|||
94416869|NCT00897949|323312084|FG001|Overall Study|Adverse Event|1|||
94416870|NCT00897949|323312085|FG002|Overall Study|Adverse Event|0|||
94416871|NCT00897949|323312083|FG000|Overall Study|Lost to Follow-up|0|||
94416872|NCT00897949|323312084|FG001|Overall Study|Lost to Follow-up|2|||
94416873|NCT00897949|323312085|FG002|Overall Study|Lost to Follow-up|1|||
94416874|NCT00897949|323312083|FG000|Overall Study|Protocol Violation|6|||
94416875|NCT00897949|323312084|FG001|Overall Study|Protocol Violation|3|||
94416876|NCT00897949|323312085|FG002|Overall Study|Protocol Violation|1|||
94416877|NCT00897949|323312083|FG000|Overall Study|Withdrawal by Subject|1|||
94416878|NCT00897949|323312084|FG001|Overall Study|Withdrawal by Subject|2|||
94416879|NCT00897949|323312085|FG002|Overall Study|Withdrawal by Subject|0|||
94416880|NCT00897949|323312083|FG000|Overall Study|Patient Uncoorperative|0|||
94416881|NCT00897949|323312084|FG001|Overall Study|Patient Uncoorperative|2|||
94416882|NCT00897949|323312085|FG002|Overall Study|Patient Uncoorperative|1|||
94416883|NCT00897949|323312083|FG000|Overall Study|Lost to Follow-up|30|||
94416884|NCT00897949|323312084|FG001|Overall Study|Lost to Follow-up|23|||
94416885|NCT00897949|323312085|FG002|Overall Study|Lost to Follow-up|17|||
94416886|NCT00897949|323312083|FG000|Overall Study|Withdrawal by Subject|24|||
94416887|NCT00897949|323312084|FG001|Overall Study|Withdrawal by Subject|31|||
94416888|NCT00897949|323312085|FG002|Overall Study|Withdrawal by Subject|17|||
94416889|NCT00897949|323312083|FG000|Overall Study|Abnormal Prestudy Labs|2|||
94416890|NCT00897949|323312084|FG001|Overall Study|Abnormal Prestudy Labs|3|||
94416891|NCT00897949|323312085|FG002|Overall Study|Abnormal Prestudy Labs|4|||
94416892|NCT00897949|323312083|FG000|Overall Study|Abnormal Baseline ECG|2|||
94416893|NCT00897949|323312084|FG001|Overall Study|Abnormal Baseline ECG|2|||
94416894|NCT00897949|323312085|FG002|Overall Study|Abnormal Baseline ECG|4|||
94416895|NCT00897949|323312083|FG000|Overall Study|Need for Concom. Med.|0|||
94416896|NCT00897949|323312084|FG001|Overall Study|Need for Concom. Med.|1|||
94416897|NCT00897949|323312085|FG002|Overall Study|Need for Concom. Med.|1|||
94416898|NCT00897949|323312083|FG000|Overall Study|Lack of Migraine Attack|29|||
94416899|NCT00897949|323312084|FG001|Overall Study|Lack of Migraine Attack|30|||
94416900|NCT00897949|323312085|FG002|Overall Study|Lack of Migraine Attack|19|||
94416901|NCT00897949|323312083|FG000|Overall Study|Did not take study drug|9|||
94416902|NCT00897949|323312084|FG001|Overall Study|Did not take study drug|3|||
94416903|NCT00897949|323312085|FG002|Overall Study|Did not take study drug|4|||
94416904|NCT01763918|323312086|FG000|Overall Study|Withdrawal by Subject|2|||
94416905|NCT01763918|323312087|FG001|Overall Study|Withdrawal by Subject|1|||
94416906|NCT01763918|323312088|FG002|Overall Study|Withdrawal by Subject|1|||
94416907|NCT01763918|323312089|FG003|Overall Study|Withdrawal by Subject|2|||
94416908|NCT01763918|323312086|FG000|Overall Study|Sponsor Decision|4|||
94416909|NCT01763918|323312087|FG001|Overall Study|Sponsor Decision|0|||
94416910|NCT01763918|323312088|FG002|Overall Study|Sponsor Decision|9|||
94416911|NCT01763918|323312089|FG003|Overall Study|Sponsor Decision|0|||
94416912|NCT03095118|323312091|FG000|Overall Study|Adverse Event|1|||
94416913|NCT03095118|323312091|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
94416914|NCT00285584|323312093|FG000|Month 3|Lost to Follow-up|3|||
94416915|NCT00285584|323312094|FG001|Month 3|Lost to Follow-up|3|||
94416916|NCT00285584|323312093|FG000|Month 3|Withdrawal by Subject|1|||
94416917|NCT00285584|323312094|FG001|Month 3|Withdrawal by Subject|0|||
94416918|NCT00285584|323312093|FG000|Month 6|Lost to Follow-up|0|||
94416919|NCT00285584|323312094|FG001|Month 6|Lost to Follow-up|1|||
94416920|NCT02696031|323312095|FG000|Up to Week 24|Adverse Event|2|||
94416921|NCT02696031|323312096|FG001|Up to Week 24|Adverse Event|4|||
94416922|NCT02696031|323312097|FG002|Up to Week 24|Adverse Event|2|||
94416923|NCT02696031|323312098|FG003|Up to Week 24|Adverse Event|0|||
94416924|NCT02696031|323312099|FG004|Up to Week 24|Adverse Event|0|||
94416925|NCT02696031|323312100|FG005|Up to Week 24|Adverse Event|0|||
94416926|NCT02696031|323312095|FG000|Up to Week 24|Lack of Efficacy|2|||
94416927|NCT02696031|323312096|FG001|Up to Week 24|Lack of Efficacy|1|||
94416928|NCT02696031|323312097|FG002|Up to Week 24|Lack of Efficacy|2|||
94416929|NCT02696031|323312098|FG003|Up to Week 24|Lack of Efficacy|0|||
94416930|NCT02696031|323312099|FG004|Up to Week 24|Lack of Efficacy|0|||
94416931|NCT02696031|323312100|FG005|Up to Week 24|Lack of Efficacy|0|||
94416932|NCT02696031|323312095|FG000|Up to Week 24|Lost to Follow-up|0|||
94416933|NCT02696031|323312096|FG001|Up to Week 24|Lost to Follow-up|1|||
94416934|NCT02696031|323312097|FG002|Up to Week 24|Lost to Follow-up|1|||
94416935|NCT02696031|323312098|FG003|Up to Week 24|Lost to Follow-up|0|||
94416936|NCT02696031|323312099|FG004|Up to Week 24|Lost to Follow-up|0|||
94416937|NCT02696031|323312100|FG005|Up to Week 24|Lost to Follow-up|0|||
94416938|NCT02696031|323312095|FG000|Up to Week 24|Physician Decision|1|||
94416939|NCT02696031|323312096|FG001|Up to Week 24|Physician Decision|0|||
94416940|NCT02696031|323312097|FG002|Up to Week 24|Physician Decision|1|||
94416941|NCT02696031|323312098|FG003|Up to Week 24|Physician Decision|0|||
94416942|NCT02696031|323312099|FG004|Up to Week 24|Physician Decision|0|||
94416943|NCT02696031|323312100|FG005|Up to Week 24|Physician Decision|0|||
94488419|NCT00251758|323581291|FG001|Overall Study|Noncompliant|2|||
94488420|NCT00251758|323581292|FG002|Overall Study|Noncompliant|2|||
94488421|NCT00251758|323581290|FG000|Overall Study|Pregnancy|0|||
94488422|NCT00251758|323581291|FG001|Overall Study|Pregnancy|1|||
94488423|NCT00251758|323581292|FG002|Overall Study|Pregnancy|0|||
94488424|NCT00251758|323581290|FG000|Overall Study|Per Subject Request|0|||
94488425|NCT00251758|323581291|FG001|Overall Study|Per Subject Request|0|||
94488426|NCT00251758|323581292|FG002|Overall Study|Per Subject Request|1|||
94488427|NCT00251758|323581290|FG000|Overall Study|Per Investigator Request|1|||
94488428|NCT00251758|323581291|FG001|Overall Study|Per Investigator Request|0|||
94488429|NCT00251758|323581292|FG002|Overall Study|Per Investigator Request|0|||
94416944|NCT02696031|323312095|FG000|Up to Week 24|Protocol Violation|1|||
94416945|NCT02696031|323312096|FG001|Up to Week 24|Protocol Violation|0|||
94416946|NCT02696031|323312097|FG002|Up to Week 24|Protocol Violation|0|||
94416947|NCT02696031|323312098|FG003|Up to Week 24|Protocol Violation|0|||
94416948|NCT02696031|323312099|FG004|Up to Week 24|Protocol Violation|0|||
94416949|NCT02696031|323312100|FG005|Up to Week 24|Protocol Violation|0|||
94416950|NCT02696031|323312095|FG000|Up to Week 24|Withdrawal by Subject|4|||
94416951|NCT02696031|323312096|FG001|Up to Week 24|Withdrawal by Subject|1|||
94416952|NCT02696031|323312097|FG002|Up to Week 24|Withdrawal by Subject|5|||
94416953|NCT02696031|323312098|FG003|Up to Week 24|Withdrawal by Subject|0|||
94416954|NCT02696031|323312099|FG004|Up to Week 24|Withdrawal by Subject|0|||
94416955|NCT02696031|323312100|FG005|Up to Week 24|Withdrawal by Subject|0|||
94416956|NCT02696031|323312095|FG000|Up to Week 52|Adverse Event|4|||
94416957|NCT02696031|323312096|FG001|Up to Week 52|Adverse Event|5|||
94416958|NCT02696031|323312097|FG002|Up to Week 52|Adverse Event|3|||
94416959|NCT02696031|323312098|FG003|Up to Week 52|Adverse Event|0|||
94416960|NCT02696031|323312099|FG004|Up to Week 52|Adverse Event|0|||
94416961|NCT02696031|323312100|FG005|Up to Week 52|Adverse Event|0|||
94488430|NCT01200329|323581300|FG000|Overall Study|Lack of financial coverage|2|||
94488431|NCT01200329|323581300|FG000|Overall Study|Progressive disease|1|||
94488432|NCT03225287|323581306|FG000|Overall Study|Adverse Event|0|||
94488433|NCT03225287|323581307|FG001|Overall Study|Adverse Event|0|||
94488434|NCT03225287|323581308|FG002|Overall Study|Adverse Event|1|||
94488435|NCT03225287|323581306|FG000|Overall Study|Protocol non-compliance|0|||
94488436|NCT03225287|323581307|FG001|Overall Study|Protocol non-compliance|0|||
94488437|NCT03225287|323581308|FG002|Overall Study|Protocol non-compliance|1|||
94488438|NCT03225287|323581306|FG000|Overall Study|Subject withdraws consent|3|||
94488439|NCT03225287|323581307|FG001|Overall Study|Subject withdraws consent|0|||
94488440|NCT03225287|323581308|FG002|Overall Study|Subject withdraws consent|0|||
94488441|NCT03225287|323581306|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
94488442|NCT03225287|323581307|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
94488443|NCT03225287|323581308|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
94488444|NCT03225287|323581306|FG000|Overall Study|Trial drug not effective|0|||
94488445|NCT03225287|323581307|FG001|Overall Study|Trial drug not effective|1|||
94488446|NCT03225287|323581308|FG002|Overall Study|Trial drug not effective|0|||
94488447|NCT03225287|323581306|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
94488448|NCT03225287|323581307|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
94488449|NCT03225287|323581308|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
94488450|NCT03225287|323581306|FG000|Overall Study|Stem cell transplantation|0|||
94488451|NCT03225287|323581307|FG001|Overall Study|Stem cell transplantation|1|||
94488452|NCT03225287|323581308|FG002|Overall Study|Stem cell transplantation|0|||
94488453|NCT03415178|323581309|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
94488454|NCT03415178|323581310|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
94488455|NCT03415178|323581309|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
94488456|NCT03415178|323581310|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
94488457|NCT03074500|323581314|FG000|Overall Study|Lost to Follow-up|1|||
94488458|NCT03074500|323581315|FG001|Overall Study|Lost to Follow-up|0|||
94488459|NCT03074500|323581316|FG002|Overall Study|Lost to Follow-up|0|||
94488460|NCT03074500|323581314|FG000|Overall Study|Lack of Efficacy|0|||
94488461|NCT03074500|323581315|FG001|Overall Study|Lack of Efficacy|1|||
94488462|NCT03074500|323581316|FG002|Overall Study|Lack of Efficacy|0|||
94488463|NCT03074500|323581314|FG000|Overall Study|Adverse Event|0|||
94488464|NCT03074500|323581315|FG001|Overall Study|Adverse Event|0|||
94488465|NCT03074500|323581316|FG002|Overall Study|Adverse Event|1|||
94488466|NCT04239924|323581319|FG000|Overall Study|Lost to Follow-up|2|||
94488467|NCT01655901|323583398|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
94488468|NCT01655901|323583399|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
94488469|NCT01655901|323583400|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
94416962|NCT02696031|323312095|FG000|Up to Week 52|Lack of Efficacy|10|||
94416963|NCT02696031|323312096|FG001|Up to Week 52|Lack of Efficacy|7|||
94416964|NCT02696031|323312097|FG002|Up to Week 52|Lack of Efficacy|11|||
94488470|NCT01655901|323583401|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
94488471|NCT01655901|323583402|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
94416965|NCT02696031|323312098|FG003|Up to Week 52|Lack of Efficacy|0|||
94488472|NCT01655901|323583403|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
94488473|NCT03256578|323583406|FG000|Overall Study|Excluded Post Randomization|66|||
94488474|NCT03256578|323583407|FG001|Overall Study|Excluded Post Randomization|56|||
94488475|NCT02371616|323583408|FG000|Overall Study|Protocol Violation|2|||
94488476|NCT02371616|323583409|FG001|Overall Study|Protocol Violation|1|||
94488477|NCT02371616|323583408|FG000|Overall Study|Adverse Event|0|||
94488478|NCT02371616|323583409|FG001|Overall Study|Adverse Event|1|||
94488479|NCT02371616|323583408|FG000|Overall Study|Withdrawal of Consent|1|||
94488480|NCT02371616|323583409|FG001|Overall Study|Withdrawal of Consent|0|||
94488481|NCT02371616|323583408|FG000|Overall Study|Other (Not specified)|1|||
94488482|NCT02371616|323583409|FG001|Overall Study|Other (Not specified)|5|||
94488483|NCT00754741|323583412|FG000|Overall Study|Died or disenrolled|57|||
94488484|NCT00754741|323583413|FG001|Overall Study|Died or disenrolled|69|||
94488485|NCT00754741|323583414|FG002|Overall Study|Died or disenrolled|54|||
94488486|NCT01863771|323583429|FG000|Induction Phase|Adverse Event|9|||
94488487|NCT01863771|323583430|FG001|Induction Phase|Adverse Event|0|||
94488488|NCT01863771|323583431|FG002|Induction Phase|Adverse Event|0|||
94488489|NCT01863771|323583432|FG003|Induction Phase|Adverse Event|0|||
94488490|NCT01863771|323583429|FG000|Induction Phase|Lack of Efficacy|10|||
94488491|NCT01863771|323583430|FG001|Induction Phase|Lack of Efficacy|0|||
94488492|NCT01863771|323583431|FG002|Induction Phase|Lack of Efficacy|0|||
94488493|NCT01863771|323583432|FG003|Induction Phase|Lack of Efficacy|0|||
94488494|NCT01863771|323583429|FG000|Induction Phase|Withdrawal by Subject|2|||
94488495|NCT01863771|323583430|FG001|Induction Phase|Withdrawal by Subject|0|||
94488496|NCT01863771|323583431|FG002|Induction Phase|Withdrawal by Subject|0|||
94488497|NCT01863771|323583432|FG003|Induction Phase|Withdrawal by Subject|0|||
94488498|NCT01863771|323583429|FG000|Maintenance Phase|Adverse Event|0|||
94488499|NCT01863771|323583430|FG001|Maintenance Phase|Adverse Event|0|||
94488500|NCT01863771|323583431|FG002|Maintenance Phase|Adverse Event|1|||
94488501|NCT01863771|323583432|FG003|Maintenance Phase|Adverse Event|1|||
94488502|NCT01863771|323583429|FG000|Maintenance Phase|Lack of Efficacy|0|||
94488503|NCT01863771|323583430|FG001|Maintenance Phase|Lack of Efficacy|3|||
94488504|NCT01863771|323583431|FG002|Maintenance Phase|Lack of Efficacy|7|||
94488505|NCT01863771|323583432|FG003|Maintenance Phase|Lack of Efficacy|38|||
94488506|NCT01863771|323583429|FG000|Maintenance Phase|Physician Decision|0|||
94488507|NCT01863771|323583430|FG001|Maintenance Phase|Physician Decision|0|||
94488508|NCT01863771|323583431|FG002|Maintenance Phase|Physician Decision|2|||
94488509|NCT01863771|323583432|FG003|Maintenance Phase|Physician Decision|1|||
94488510|NCT01863771|323583429|FG000|Maintenance Phase|Pregnancy|0|||
94488511|NCT01863771|323583430|FG001|Maintenance Phase|Pregnancy|1|||
94488512|NCT01863771|323583431|FG002|Maintenance Phase|Pregnancy|0|||
94488513|NCT01863771|323583432|FG003|Maintenance Phase|Pregnancy|0|||
94488514|NCT01863771|323583429|FG000|Maintenance Phase|Withdrawal by Subject|0|||
94488515|NCT01863771|323583430|FG001|Maintenance Phase|Withdrawal by Subject|1|||
94488516|NCT01863771|323583431|FG002|Maintenance Phase|Withdrawal by Subject|2|||
94488517|NCT01863771|323583432|FG003|Maintenance Phase|Withdrawal by Subject|3|||
94488518|NCT04400318|323583433|FG000|Overall Study|Adverse Event|1|||
94488519|NCT04400318|323583434|FG001|Overall Study|Adverse Event|0|||
94488520|NCT04400318|323583433|FG000|Overall Study|Withdrawal by Subject|1|||
94488521|NCT04400318|323583434|FG001|Overall Study|Withdrawal by Subject|1|||
94488522|NCT04400318|323583433|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
94488523|NCT04400318|323583434|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
94488524|NCT04040439|323583435|FG000|Overall Study|Invalid registration|11|||
94488525|NCT04040439|323583435|FG000|Overall Study|No IC* on publication of study results|2|||
94488526|NCT01715831|323583436|FG000|Overall Study|Adverse Event|1|||
94488527|NCT03098979|323583439|FG000|Overall Study|Adverse Event|1|||
94488528|NCT03098979|323583440|FG001|Overall Study|Adverse Event|0|||
94488529|NCT03098979|323583441|FG002|Overall Study|Adverse Event|1|||
94488530|NCT03098979|323583442|FG003|Overall Study|Adverse Event|4|||
94488531|NCT03098979|323583443|FG004|Overall Study|Adverse Event|6|||
94488532|NCT03098979|323583444|FG005|Overall Study|Adverse Event|1|||
94488533|NCT03098979|323583439|FG000|Overall Study|Withdrawal by Subject|2|||
94488534|NCT03098979|323583440|FG001|Overall Study|Withdrawal by Subject|1|||
94488535|NCT03098979|323583441|FG002|Overall Study|Withdrawal by Subject|1|||
94488536|NCT03098979|323583442|FG003|Overall Study|Withdrawal by Subject|1|||
94488537|NCT03098979|323583443|FG004|Overall Study|Withdrawal by Subject|2|||
94488538|NCT03098979|323583444|FG005|Overall Study|Withdrawal by Subject|1|||
94488539|NCT03098979|323583439|FG000|Overall Study|Death|1|||
94488540|NCT03098979|323583440|FG001|Overall Study|Death|0|||
94488541|NCT03098979|323583441|FG002|Overall Study|Death|2|||
94488542|NCT03098979|323583442|FG003|Overall Study|Death|0|||
94488543|NCT03098979|323583443|FG004|Overall Study|Death|1|||
94488544|NCT03098979|323583444|FG005|Overall Study|Death|0|||
94488545|NCT03098979|323583439|FG000|Overall Study|Physician Decision|2|||
94488546|NCT03098979|323583440|FG001|Overall Study|Physician Decision|1|||
94488547|NCT03098979|323583441|FG002|Overall Study|Physician Decision|0|||
94488548|NCT03098979|323583442|FG003|Overall Study|Physician Decision|0|||
94488549|NCT03098979|323583443|FG004|Overall Study|Physician Decision|0|||
94488550|NCT03098979|323583444|FG005|Overall Study|Physician Decision|0|||
94416966|NCT02696031|323312099|FG004|Up to Week 52|Lack of Efficacy|0|||
94416967|NCT02696031|323312100|FG005|Up to Week 52|Lack of Efficacy|0|||
94416968|NCT02696031|323312095|FG000|Up to Week 52|Lost to Follow-up|1|||
94416969|NCT02696031|323312096|FG001|Up to Week 52|Lost to Follow-up|1|||
94416970|NCT02696031|323312097|FG002|Up to Week 52|Lost to Follow-up|1|||
94416971|NCT02696031|323312098|FG003|Up to Week 52|Lost to Follow-up|0|||
94416972|NCT02696031|323312099|FG004|Up to Week 52|Lost to Follow-up|0|||
94416973|NCT02696031|323312100|FG005|Up to Week 52|Lost to Follow-up|0|||
94416974|NCT02696031|323312095|FG000|Up to Week 52|Physician Decision|1|||
94416975|NCT02696031|323312096|FG001|Up to Week 52|Physician Decision|1|||
94416976|NCT02696031|323312097|FG002|Up to Week 52|Physician Decision|2|||
94416977|NCT02696031|323312098|FG003|Up to Week 52|Physician Decision|0|||
94416978|NCT02696031|323312099|FG004|Up to Week 52|Physician Decision|0|||
94416979|NCT02696031|323312100|FG005|Up to Week 52|Physician Decision|0|||
94416980|NCT02696031|323312095|FG000|Up to Week 52|Pregnancy|0|||
94416981|NCT02696031|323312096|FG001|Up to Week 52|Pregnancy|2|||
94416982|NCT02696031|323312097|FG002|Up to Week 52|Pregnancy|0|||
94416983|NCT02696031|323312098|FG003|Up to Week 52|Pregnancy|0|||
94416984|NCT02696031|323312099|FG004|Up to Week 52|Pregnancy|0|||
94416985|NCT02696031|323312100|FG005|Up to Week 52|Pregnancy|0|||
94416986|NCT02696031|323312095|FG000|Up to Week 52|Protocol Violation|1|||
94416987|NCT02696031|323312096|FG001|Up to Week 52|Protocol Violation|0|||
94416988|NCT02696031|323312097|FG002|Up to Week 52|Protocol Violation|0|||
94416989|NCT02696031|323312098|FG003|Up to Week 52|Protocol Violation|0|||
94416990|NCT02696031|323312099|FG004|Up to Week 52|Protocol Violation|0|||
94416991|NCT02696031|323312100|FG005|Up to Week 52|Protocol Violation|0|||
94416992|NCT02696031|323312095|FG000|Up to Week 52|Withdrawal by Subject|12|||
94416993|NCT02696031|323312096|FG001|Up to Week 52|Withdrawal by Subject|3|||
94416994|NCT02696031|323312097|FG002|Up to Week 52|Withdrawal by Subject|9|||
94416995|NCT02696031|323312098|FG003|Up to Week 52|Withdrawal by Subject|0|||
94416996|NCT02696031|323312099|FG004|Up to Week 52|Withdrawal by Subject|0|||
94416997|NCT02696031|323312100|FG005|Up to Week 52|Withdrawal by Subject|0|||
94416998|NCT02696031|323312095|FG000|Up to Week 104|Pregnancy|0|||
94416999|NCT02696031|323312096|FG001|Up to Week 104|Pregnancy|2|||
94417000|NCT02696031|323312097|FG002|Up to Week 104|Pregnancy|1|||
94417001|NCT02696031|323312098|FG003|Up to Week 104|Pregnancy|0|||
94417002|NCT02696031|323312099|FG004|Up to Week 104|Pregnancy|0|||
94417003|NCT02696031|323312100|FG005|Up to Week 104|Pregnancy|0|||
94417004|NCT02696031|323312095|FG000|Up to Week 104|Withdrawal by Subject|15|||
94417005|NCT02696031|323312096|FG001|Up to Week 104|Withdrawal by Subject|10|||
94417006|NCT02696031|323312097|FG002|Up to Week 104|Withdrawal by Subject|16|||
94417007|NCT02696031|323312098|FG003|Up to Week 104|Withdrawal by Subject|0|||
94417008|NCT02696031|323312099|FG004|Up to Week 104|Withdrawal by Subject|0|||
94417009|NCT02696031|323312100|FG005|Up to Week 104|Withdrawal by Subject|0|||
94417010|NCT02696031|323312095|FG000|Up to Week 104|Protocol Violation|1|||
94417011|NCT02696031|323312096|FG001|Up to Week 104|Protocol Violation|0|||
94417012|NCT02696031|323312097|FG002|Up to Week 104|Protocol Violation|0|||
94417013|NCT02696031|323312098|FG003|Up to Week 104|Protocol Violation|0|||
94417014|NCT02696031|323312099|FG004|Up to Week 104|Protocol Violation|0|||
94417015|NCT02696031|323312100|FG005|Up to Week 104|Protocol Violation|0|||
94417016|NCT02696031|323312095|FG000|Up to Week 104|Physician Decision|1|||
94417017|NCT02696031|323312096|FG001|Up to Week 104|Physician Decision|2|||
94417018|NCT02696031|323312097|FG002|Up to Week 104|Physician Decision|3|||
94417019|NCT02696031|323312098|FG003|Up to Week 104|Physician Decision|0|||
94417020|NCT02696031|323312099|FG004|Up to Week 104|Physician Decision|0|||
94417021|NCT02696031|323312100|FG005|Up to Week 104|Physician Decision|0|||
94417022|NCT02696031|323312095|FG000|Up to Week 104|Lost to Follow-up|2|||
94417023|NCT02696031|323312096|FG001|Up to Week 104|Lost to Follow-up|3|||
94417024|NCT02696031|323312097|FG002|Up to Week 104|Lost to Follow-up|1|||
94417025|NCT02696031|323312098|FG003|Up to Week 104|Lost to Follow-up|0|||
94417026|NCT02696031|323312099|FG004|Up to Week 104|Lost to Follow-up|0|||
94417027|NCT02696031|323312100|FG005|Up to Week 104|Lost to Follow-up|0|||
94417028|NCT02696031|323312095|FG000|Up to Week 104|Lack of Efficacy|13|||
94417029|NCT02696031|323312096|FG001|Up to Week 104|Lack of Efficacy|12|||
94417030|NCT02696031|323312097|FG002|Up to Week 104|Lack of Efficacy|11|||
94417031|NCT02696031|323312098|FG003|Up to Week 104|Lack of Efficacy|0|||
94417032|NCT02696031|323312099|FG004|Up to Week 104|Lack of Efficacy|0|||
94417033|NCT02696031|323312100|FG005|Up to Week 104|Lack of Efficacy|0|||
94417034|NCT02696031|323312095|FG000|Up to Week 104|Adverse Event|7|||
94417035|NCT02696031|323312096|FG001|Up to Week 104|Adverse Event|11|||
94417036|NCT02696031|323312097|FG002|Up to Week 104|Adverse Event|5|||
94417037|NCT02696031|323312098|FG003|Up to Week 104|Adverse Event|0|||
94417038|NCT02696031|323312099|FG004|Up to Week 104|Adverse Event|0|||
94417039|NCT02696031|323312100|FG005|Up to Week 104|Adverse Event|0|||
94417040|NCT02696031|323312095|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
94417041|NCT02696031|323312096|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
94417042|NCT02696031|323312097|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
94417043|NCT02696031|323312098|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
94417044|NCT02696031|323312099|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
94488551|NCT03098979|323583439|FG000|Overall Study|Non-compliance|0|||
94488552|NCT03098979|323583440|FG001|Overall Study|Non-compliance|0|||
94488553|NCT03098979|323583441|FG002|Overall Study|Non-compliance|0|||
94488554|NCT03098979|323583442|FG003|Overall Study|Non-compliance|0|||
94488555|NCT03098979|323583443|FG004|Overall Study|Non-compliance|0|||
94488556|NCT03098979|323583444|FG005|Overall Study|Non-compliance|1|||
94488557|NCT03098979|323583439|FG000|Overall Study|Protocol Violation|0|||
94488558|NCT03098979|323583440|FG001|Overall Study|Protocol Violation|0|||
94488559|NCT03098979|323583441|FG002|Overall Study|Protocol Violation|0|||
94488560|NCT03098979|323583442|FG003|Overall Study|Protocol Violation|0|||
94488561|NCT03098979|323583443|FG004|Overall Study|Protocol Violation|0|||
94488562|NCT03098979|323583444|FG005|Overall Study|Protocol Violation|1|||
94488563|NCT02369653|323583445|FG000|Overall Study|Lost to Follow-up|0|||
94488564|NCT02369653|323583446|FG001|Overall Study|Lost to Follow-up|1|||
94488565|NCT02369653|323583445|FG000|Overall Study|Administrative reason by sponsor|0|||
94488566|NCT02369653|323583446|FG001|Overall Study|Administrative reason by sponsor|1|||
94488567|NCT02369653|323583445|FG000|Overall Study|Death|1|||
94488568|NCT02369653|323583446|FG001|Overall Study|Death|2|||
94488569|NCT02369653|323583445|FG000|Overall Study|Participant withdrew consent|13|||
94488570|NCT02369653|323583446|FG001|Overall Study|Participant withdrew consent|3|||
94488571|NCT01603602|323583447|FG000|Overall Study|Adverse Event|1|||
94488572|NCT01603602|323583448|FG001|Overall Study|Adverse Event|0|||
94488573|NCT01603602|323583449|FG002|Overall Study|Adverse Event|0|||
94488574|NCT01603602|323583447|FG000|Overall Study|Personal Reasons|1|||
94488575|NCT01603602|323583448|FG001|Overall Study|Personal Reasons|0|||
94488576|NCT01603602|323583449|FG002|Overall Study|Personal Reasons|1|||
94488577|NCT01117870|323583450|FG000|Overall Study|Inability to place needle|1|||
94488578|NCT01117870|323583451|FG001|Overall Study|Inability to place needle|0|||
94488579|NCT04748718|323583454|FG000|Overall Study|Lost to Follow-up|50|||
94488580|NCT01065818|323583455|FG000|Overall Study|Withdrawal by Subject|1|||
94488581|NCT01065818|323583455|FG000|Overall Study|Not a candidate for surgery|1|||
94488582|NCT01674725|323583459|FG000|Overall Study|Adverse Event|1|||
94488583|NCT01674725|323583460|FG001|Overall Study|Adverse Event|0|||
94488584|NCT01674725|323583459|FG000|Overall Study|Did not receive study drug|1|||
94488585|NCT01674725|323583460|FG001|Overall Study|Did not receive study drug|0|||
94488586|NCT01674725|323583459|FG000|Overall Study|Withdrawal by Subject|1|||
94488587|NCT01674725|323583460|FG001|Overall Study|Withdrawal by Subject|0|||
94488588|NCT01674725|323583459|FG000|Overall Study|Lost to Follow-up|0|||
94488589|NCT01674725|323583460|FG001|Overall Study|Lost to Follow-up|1|||
94488590|NCT03074695|323583461|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
94488591|NCT03074695|323583462|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
94488592|NCT03074695|323583461|FG000|Overall Study|Research staff not available|1|||
94488593|NCT03074695|323583462|FG001|Overall Study|Research staff not available|2|||
94417045|NCT02696031|323312100|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
94417046|NCT02696031|323312095|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
94417047|NCT02696031|323312096|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
94417048|NCT02696031|323312097|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
94417049|NCT02696031|323312098|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
94417050|NCT02696031|323312099|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
94417051|NCT02696031|323312100|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
94417052|NCT02696031|323312095|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
94417053|NCT02696031|323312096|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
94417054|NCT02696031|323312097|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
94417055|NCT02696031|323312098|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
94417056|NCT02696031|323312099|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
94417057|NCT02696031|323312100|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
94417058|NCT02696031|323312095|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
94417059|NCT02696031|323312096|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
94417060|NCT02696031|323312097|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
94417061|NCT02696031|323312098|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
94417062|NCT02696031|323312099|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
94488594|NCT03074695|323583461|FG000|Overall Study|Did not receive neuraxial block|2|||
94488595|NCT03074695|323583462|FG001|Overall Study|Did not receive neuraxial block|2|||
94488596|NCT03191799|323583463|FG000|Overall Study|Withdrawal by Subject|4|||
94488597|NCT03191799|323583463|FG000|Overall Study|Physician Decision|2|||
94488598|NCT03191799|323583463|FG000|Overall Study|Lost to Follow-up|1|||
94488599|NCT03191799|323583463|FG000|Overall Study|Death|2|||
94488600|NCT03248037|323583464|FG000|Overall Study|Withdrawal by Subject|6|||
94488601|NCT03248037|323583465|FG001|Overall Study|Withdrawal by Subject|9|||
94488602|NCT03248037|323583464|FG000|Overall Study|Adverse Event|15|||
94488603|NCT03248037|323583465|FG001|Overall Study|Adverse Event|0|||
94488604|NCT00095979|323583466|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
94417063|NCT02696031|323312100|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
94417064|NCT02696031|323312095|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
94417065|NCT02696031|323312096|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
94417066|NCT02696031|323312097|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
94417067|NCT02696031|323312098|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
94417068|NCT02696031|323312099|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
94417069|NCT02696031|323312100|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
94417070|NCT02696031|323312095|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
94417071|NCT02696031|323312096|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
94417072|NCT02696031|323312097|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
94417073|NCT02696031|323312098|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
94417074|NCT02696031|323312099|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
94417075|NCT02696031|323312100|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
94417076|NCT02696031|323312095|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
94417077|NCT02696031|323312096|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
94417078|NCT02696031|323312097|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
94417079|NCT02696031|323312098|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
94417080|NCT02696031|323312099|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
94417081|NCT02696031|323312100|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
94417082|NCT01376310|323312101|FG000|Overall Study|Study closed/terminated|1|||
94417083|NCT01376310|323312102|FG001|Overall Study|Study closed/terminated|2|||
94417084|NCT01376310|323312101|FG000|Overall Study|Withdrawal by Subject|8|||
94417085|NCT01376310|323312102|FG001|Overall Study|Withdrawal by Subject|2|||
94417086|NCT01376310|323312101|FG000|Overall Study|Physician Decision|26|||
94417087|NCT01376310|323312102|FG001|Overall Study|Physician Decision|7|||
94417088|NCT01376310|323312101|FG000|Overall Study|Lost to Follow-up|1|||
94417089|NCT01376310|323312102|FG001|Overall Study|Lost to Follow-up|0|||
94417090|NCT02777918|323312105|FG000|Overall Study|Medical reasons|1|||
94417091|NCT02777918|323312106|FG001|Overall Study|Medical reasons|2|||
94417092|NCT02777918|323312105|FG000|Overall Study|Too busy / stressed|1|||
94417093|NCT02777918|323312106|FG001|Overall Study|Too busy / stressed|1|||
94417094|NCT02777918|323312105|FG000|Overall Study|Withdrawal by Subject|1|||
94417095|NCT02777918|323312106|FG001|Overall Study|Withdrawal by Subject|1|||
94417096|NCT00058214|323312109|FG000|Overall Study|Adverse Event|1|||
94417097|NCT02556307|323312116|FG000|Overall Study|Premature treatment interruption|11|||
94417098|NCT02556307|323312116|FG000|Overall Study|Lost to Follow-up|36|||
94417099|NCT02556307|323312116|FG000|Overall Study|Change to triple therapy|4|||
94417100|NCT02556307|323312116|FG000|Overall Study|Enrolled but not treated|2|||
94417101|NCT01843348|323312117|FG000|Overall Study|Withdrawal by Subject|4|||
94417102|NCT01843348|323312118|FG001|Overall Study|Withdrawal by Subject|16|||
94417103|NCT01843348|323312119|FG002|Overall Study|Withdrawal by Subject|18|||
94417104|NCT01843348|323312117|FG000|Overall Study|Lost to Follow-up|5|||
94417105|NCT01843348|323312118|FG001|Overall Study|Lost to Follow-up|4|||
94417106|NCT01843348|323312119|FG002|Overall Study|Lost to Follow-up|2|||
94417107|NCT01843348|323312117|FG000|Overall Study|Death|5|||
94417108|NCT01843348|323312118|FG001|Overall Study|Death|3|||
94417109|NCT01843348|323312119|FG002|Overall Study|Death|4|||
94417110|NCT01843348|323312117|FG000|Overall Study|Graft loss/retransplantation|5|||
94417111|NCT01843348|323312118|FG001|Overall Study|Graft loss/retransplantation|8|||
94417112|NCT01843348|323312119|FG002|Overall Study|Graft loss/retransplantation|11|||
94417113|NCT01843348|323312117|FG000|Overall Study|Various reasons|4|||
94417114|NCT01843348|323312118|FG001|Overall Study|Various reasons|9|||
94417115|NCT01843348|323312119|FG002|Overall Study|Various reasons|6|||
94417116|NCT00257920|323312121|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
94417117|NCT00257920|323312122|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
94417118|NCT00257920|323312121|FG000|Period: Second Intervention|Other|2|||
94417119|NCT00257920|323312122|FG001|Period: Second Intervention|Other|1|||
94417120|NCT03977701|323312123|FG000|Overall Study|COVID-19 pandemic|0|||
94417121|NCT03977701|323312124|FG001|Overall Study|COVID-19 pandemic|0|||
94417122|NCT03977701|323312125|FG002|Overall Study|COVID-19 pandemic|0|||
94417123|NCT03977701|323312126|FG003|Overall Study|COVID-19 pandemic|0|||
94417124|NCT03977701|323312127|FG004|Overall Study|COVID-19 pandemic|0|||
94417125|NCT03977701|323312128|FG005|Overall Study|COVID-19 pandemic|1|||
94417126|NCT03977701|323312129|FG006|Overall Study|COVID-19 pandemic|0|||
94417127|NCT03977701|323312130|FG007|Overall Study|COVID-19 pandemic|1|||
94488605|NCT00975416|323583471|FG000|Overall Study|early discharge from tx|3|||
94488606|NCT00975416|323583472|FG001|Overall Study|early discharge from tx|5|||
94417128|NCT03977701|323312131|FG008|Overall Study|COVID-19 pandemic|0|||
94417129|NCT03977701|323312132|FG009|Overall Study|COVID-19 pandemic|0|||
94417130|NCT00770692|323312133|FG000|Overall Study|Withdrawal by Subject|7|||
94417131|NCT00770692|323312134|FG001|Overall Study|Withdrawal by Subject|9|||
94417132|NCT00770692|323312135|FG002|Overall Study|Withdrawal by Subject|9|||
94417133|NCT00770692|323312136|FG003|Overall Study|Withdrawal by Subject|6|||
94417134|NCT00770692|323312133|FG000|Overall Study|Adverse Event|3|||
94417135|NCT00770692|323312134|FG001|Overall Study|Adverse Event|0|||
94417136|NCT00770692|323312135|FG002|Overall Study|Adverse Event|4|||
94417137|NCT00770692|323312136|FG003|Overall Study|Adverse Event|4|||
94417138|NCT00770692|323312133|FG000|Overall Study|Investigator judgment|2|||
94417139|NCT00770692|323312134|FG001|Overall Study|Investigator judgment|0|||
94417140|NCT00770692|323312135|FG002|Overall Study|Investigator judgment|1|||
94417141|NCT00770692|323312136|FG003|Overall Study|Investigator judgment|1|||
94417142|NCT00293202|323312138|FG000|Overall Study|Withdrawal by Subject|1|||
94417143|NCT00293202|323312139|FG001|Overall Study|Withdrawal by Subject|2|||
94417144|NCT00293202|323312138|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
94417145|NCT00293202|323312139|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
94417146|NCT00293202|323312138|FG000|Overall Study|on-hold due to fistula maturation time|1|||
94417147|NCT00293202|323312139|FG001|Overall Study|on-hold due to fistula maturation time|0|||
94417148|NCT01230892|323312140|FG000|Overall Study|Withdrawal by Subject|1|||
94417149|NCT01230892|323312141|FG001|Overall Study|Withdrawal by Subject|1|||
94417150|NCT01230892|323312140|FG000|Overall Study|Lost to Follow-up|2|||
94417151|NCT01230892|323312141|FG001|Overall Study|Lost to Follow-up|0|||
94417152|NCT01300923|323312144|FG000|Overall Study|Physician Decision|0|||
94417153|NCT01300923|323312145|FG001|Overall Study|Physician Decision|2|||
94417154|NCT00673933|323312146|FG000|Overall Study|Withdrawal by Subject|2|||
94417155|NCT00673933|323312146|FG000|Overall Study|Lost to Follow-up|1|||
94417156|NCT04932941|323312149|FG000|Overall Study|Lost to Follow-up|3|||
94417157|NCT04932941|323312150|FG001|Overall Study|Lost to Follow-up|1|||
94417158|NCT04932941|323312149|FG000|Overall Study|Withdrawal by Subject|7|||
94417159|NCT04932941|323312150|FG001|Overall Study|Withdrawal by Subject|4|||
94417160|NCT04932941|323312149|FG000|Overall Study|Other|4|||
94417161|NCT04932941|323312150|FG001|Overall Study|Other|2|||
94417162|NCT00515034|323312151|FG000|Overall Study|Adverse Event|2|||
94417163|NCT00515034|323312152|FG001|Overall Study|Adverse Event|0|||
94417164|NCT00515034|323312153|FG002|Overall Study|Adverse Event|1|||
94417165|NCT00515034|323312154|FG003|Overall Study|Adverse Event|0|||
94417166|NCT00515034|323312151|FG000|Overall Study|Death|4|||
94417167|NCT00515034|323312152|FG001|Overall Study|Death|2|||
94417168|NCT00515034|323312153|FG002|Overall Study|Death|1|||
94417169|NCT00515034|323312154|FG003|Overall Study|Death|3|||
94417170|NCT00515034|323312151|FG000|Overall Study|Withdrawal by Subject|1|||
94417171|NCT00515034|323312152|FG001|Overall Study|Withdrawal by Subject|0|||
94417172|NCT00515034|323312153|FG002|Overall Study|Withdrawal by Subject|3|||
94417173|NCT00515034|323312154|FG003|Overall Study|Withdrawal by Subject|0|||
94417174|NCT00515034|323312151|FG000|Overall Study|Physician Decision|0|||
94417175|NCT00515034|323312152|FG001|Overall Study|Physician Decision|0|||
94417176|NCT00515034|323312153|FG002|Overall Study|Physician Decision|1|||
94417177|NCT00515034|323312154|FG003|Overall Study|Physician Decision|1|||
94417178|NCT00515034|323312151|FG000|Overall Study|Other|1|||
94417179|NCT00515034|323312152|FG001|Overall Study|Other|0|||
94417180|NCT00515034|323312153|FG002|Overall Study|Other|2|||
94417181|NCT00515034|323312154|FG003|Overall Study|Other|1|||
94417182|NCT01393730|323312155|FG000|Overall Study|Withdrawal by Subject|3|||
94417183|NCT01393730|323312155|FG000|Overall Study|Other|2|||
94417184|NCT01393730|323312155|FG000|Overall Study|Adverse Event|1|||
94417185|NCT04553913|323312156|FG000|Overall Study|patient's block resolved prior to PACU|1|||
94417186|NCT04553913|323312156|FG000|Overall Study|did not use the device properly|5|||
94417187|NCT01232491|323312160|FG000|Overall Study|Adverse Event|13|||
94417188|NCT01232491|323312161|FG001|Overall Study|Adverse Event|8|||
94417189|NCT01232491|323312160|FG000|Overall Study|Lack of Efficacy|1|||
94417190|NCT01232491|323312161|FG001|Overall Study|Lack of Efficacy|5|||
94417191|NCT01232491|323312160|FG000|Overall Study|Protocol Violation|13|||
94417192|NCT01232491|323312161|FG001|Overall Study|Protocol Violation|11|||
94417193|NCT01232491|323312160|FG000|Overall Study|Withdrawal Criteria|12|||
94417194|NCT01232491|323312161|FG001|Overall Study|Withdrawal Criteria|21|||
94417195|NCT01232491|323312160|FG000|Overall Study|Other|21|||
94417196|NCT01232491|323312161|FG001|Overall Study|Other|18|||
94417197|NCT02932228|323312162|FG000|Overall Study|Death|8|||
94417198|NCT02932228|323312163|FG001|Overall Study|Death|23|||
94417199|NCT02932228|323312162|FG000|Overall Study|not eligible upon chart review|2|||
94417200|NCT02932228|323312163|FG001|Overall Study|not eligible upon chart review|5|||
94417201|NCT01659736|323313976|FG000|Treatment Period|Adverse Event|1|||
94417202|NCT01659736|323313977|FG001|Treatment Period|Adverse Event|1|||
94417203|NCT01659736|323313976|FG000|Treatment Period|Protocol Violation|3|||
94417204|NCT01659736|323313977|FG001|Treatment Period|Protocol Violation|1|||
94417205|NCT01659736|323313976|FG000|Treatment Period|Withdrawal by Subject|1|||
94417206|NCT01659736|323313977|FG001|Treatment Period|Withdrawal by Subject|0|||
94417207|NCT01659736|323313976|FG000|3-month Follow-up|Lost to Follow-up|0|||
94417208|NCT01659736|323313977|FG001|3-month Follow-up|Lost to Follow-up|1|||
94417209|NCT01206816|323313983|FG000|Overall Study|Protocol Violation|0|||
94417210|NCT01206816|323313984|FG001|Overall Study|Protocol Violation|0|||
94417211|NCT01206816|323313985|FG002|Overall Study|Protocol Violation|1|||
94417212|NCT01206816|323313986|FG003|Overall Study|Protocol Violation|0|||
94417213|NCT01206816|323313987|FG004|Overall Study|Protocol Violation|0|||
94417214|NCT01206816|323313988|FG005|Overall Study|Protocol Violation|0|||
94417215|NCT01206816|323313989|FG006|Overall Study|Protocol Violation|0|||
94417216|NCT01206816|323313983|FG000|Overall Study|Withdrawal by Subject|0|||
94417217|NCT01206816|323313984|FG001|Overall Study|Withdrawal by Subject|0|||
94417218|NCT01206816|323313985|FG002|Overall Study|Withdrawal by Subject|1|||
94417219|NCT01206816|323313986|FG003|Overall Study|Withdrawal by Subject|0|||
94417220|NCT01206816|323313987|FG004|Overall Study|Withdrawal by Subject|0|||
94417221|NCT01206816|323313988|FG005|Overall Study|Withdrawal by Subject|0|||
94417222|NCT01206816|323313989|FG006|Overall Study|Withdrawal by Subject|0|||
94417223|NCT01206816|323313983|FG000|Overall Study|Progressive disease|3|||
94417224|NCT01206816|323313984|FG001|Overall Study|Progressive disease|3|||
94417225|NCT01206816|323313985|FG002|Overall Study|Progressive disease|13|||
94417226|NCT01206816|323313986|FG003|Overall Study|Progressive disease|3|||
94417227|NCT01206816|323313987|FG004|Overall Study|Progressive disease|3|||
94417228|NCT01206816|323313988|FG005|Overall Study|Progressive disease|16|||
94417229|NCT01206816|323313989|FG006|Overall Study|Progressive disease|3|||
94417230|NCT01206816|323313983|FG000|Overall Study|Other AE|0|||
94417231|NCT01206816|323313984|FG001|Overall Study|Other AE|0|||
94417232|NCT01206816|323313985|FG002|Overall Study|Other AE|4|||
94417233|NCT01206816|323313986|FG003|Overall Study|Other AE|0|||
94417234|NCT01206816|323313987|FG004|Overall Study|Other AE|0|||
94417235|NCT01206816|323313988|FG005|Overall Study|Other AE|3|||
94417236|NCT01206816|323313989|FG006|Overall Study|Other AE|2|||
94417237|NCT01206816|323313983|FG000|Overall Study|other than stated above|0|||
94417238|NCT01206816|323313984|FG001|Overall Study|other than stated above|0|||
94417239|NCT01206816|323313985|FG002|Overall Study|other than stated above|1|||
94417240|NCT01206816|323313986|FG003|Overall Study|other than stated above|0|||
94417241|NCT01206816|323313987|FG004|Overall Study|other than stated above|0|||
94417242|NCT01206816|323313988|FG005|Overall Study|other than stated above|0|||
94417243|NCT01206816|323313989|FG006|Overall Study|other than stated above|1|||
94417244|NCT04492020|323313990|FG000|Overall Study|Adverse Event|1|||
94417245|NCT04492020|323313991|FG001|Overall Study|Adverse Event|3|||
94417246|NCT04492020|323313990|FG000|Overall Study|Withdrawal by Subject|4|||
94417247|NCT04492020|323313991|FG001|Overall Study|Withdrawal by Subject|3|||
94417248|NCT04492020|323313990|FG000|Overall Study|Lost to Follow-up|4|||
94417249|NCT04492020|323313991|FG001|Overall Study|Lost to Follow-up|3|||
94417250|NCT04492020|323313990|FG000|Overall Study|Protocol Violation|5|||
94417251|NCT04492020|323313991|FG001|Overall Study|Protocol Violation|2|||
94417252|NCT04492020|323313990|FG000|Overall Study|Lack of Qualifying Event|25|||
94417253|NCT04492020|323313991|FG001|Overall Study|Lack of Qualifying Event|27|||
94417254|NCT04492020|323313990|FG000|Overall Study|Non-compliance with Study Drug|2|||
94417255|NCT04492020|323313991|FG001|Overall Study|Non-compliance with Study Drug|1|||
94417256|NCT01829113|323313992|FG000|Overall Study|Disease Progression|37|||
94417257|NCT01829113|323313993|FG001|Overall Study|Disease Progression|48|||
94417258|NCT01829113|323313992|FG000|Overall Study|Adverse Event|14|||
94417259|NCT01829113|323313993|FG001|Overall Study|Adverse Event|10|||
94417260|NCT01829113|323313992|FG000|Overall Study|Withdrawal by Subject|17|||
94417261|NCT01829113|323313993|FG001|Overall Study|Withdrawal by Subject|10|||
94417262|NCT01829113|323313992|FG000|Overall Study|Death|4|||
94417263|NCT01829113|323313993|FG001|Overall Study|Death|6|||
94417264|NCT01829113|323313992|FG000|Overall Study|Sponsor Decision|1|||
94417265|NCT01829113|323313993|FG001|Overall Study|Sponsor Decision|1|||
94417266|NCT01829113|323313992|FG000|Overall Study|No Study Treatment Received|3|||
94417267|NCT01829113|323313993|FG001|Overall Study|No Study Treatment Received|2|||
94417268|NCT01829113|323313992|FG000|Overall Study|Physician Decision|1|||
94417269|NCT01829113|323313993|FG001|Overall Study|Physician Decision|1|||
94417270|NCT00466726|323313996|FG000|Overall Study|Not evaluable for response|14|||
94417271|NCT00597116|323313998|FG000|Overall Study|Adverse Event|2|||
94417272|NCT00597116|323313999|FG001|Overall Study|Adverse Event|1|||
94417273|NCT00597116|323313998|FG000|Overall Study|Withdrawal by Subject|0|||
94417274|NCT00597116|323313999|FG001|Overall Study|Withdrawal by Subject|2|||
94417275|NCT00597116|323313998|FG000|Overall Study|Physician Decision|0|||
94417276|NCT00597116|323313999|FG001|Overall Study|Physician Decision|1|||
94488607|NCT05379920|323583473|FG000|Overall Study|Lost to Follow-up|0|||
94488608|NCT05379920|323583474|FG001|Overall Study|Lost to Follow-up|5|||
94417277|NCT00597116|323313998|FG000|Overall Study|Death|0|||
94488609|NCT05379920|323583475|FG002|Overall Study|Lost to Follow-up|0|||
94417278|NCT00597116|323313999|FG001|Overall Study|Death|1|||
94417279|NCT00597116|323313998|FG000|Overall Study|Lost to Follow-up|1|||
94417280|NCT00597116|323313999|FG001|Overall Study|Lost to Follow-up|0|||
94417281|NCT00597116|323313998|FG000|Overall Study|Progressive disease|11|||
94417282|NCT00597116|323313999|FG001|Overall Study|Progressive disease|6|||
94488610|NCT05379920|323583476|FG003|Overall Study|Lost to Follow-up|0|||
94488611|NCT02251275|323583479|FG000|Overall Study|Adverse Event|23|||
94417283|NCT01298778|323314000|FG000|Overall Study|Lost to Follow-up|2|||
94417284|NCT01298778|323314001|FG001|Overall Study|Lost to Follow-up|3|||
94417285|NCT01298778|323314000|FG000|Overall Study|Incorrect use of VAS|1|||
94417286|NCT01298778|323314001|FG001|Overall Study|Incorrect use of VAS|0|||
94488612|NCT02251275|323583480|FG001|Overall Study|Adverse Event|60|||
94488613|NCT02251275|323583481|FG002|Overall Study|Adverse Event|28|||
94417287|NCT01298778|323314000|FG000|Overall Study|Withdrawal by Subject|0|||
94417288|NCT01298778|323314001|FG001|Overall Study|Withdrawal by Subject|1|||
94417289|NCT01298778|323314000|FG000|Overall Study|Protocol Violation|0|||
94417290|NCT01298778|323314001|FG001|Overall Study|Protocol Violation|1|||
94417291|NCT01298778|323314000|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
94417292|NCT01298778|323314001|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
94417293|NCT00700817|323314002|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
94417294|NCT00700817|323314003|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
94417295|NCT00700817|323314004|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
94417296|NCT00700817|323314005|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
94417297|NCT00700817|323314006|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
94417298|NCT00700817|323314002|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
94417299|NCT00700817|323314003|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
94417300|NCT00700817|323314004|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
94417301|NCT00700817|323314005|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
94417302|NCT00700817|323314006|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
94417303|NCT00700817|323314002|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
94417304|NCT00700817|323314003|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
94417305|NCT00700817|323314004|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
94417306|NCT00700817|323314005|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
94417307|NCT00700817|323314006|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
94417308|NCT00700817|323314002|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
94417309|NCT00700817|323314003|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
94417310|NCT00700817|323314004|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
94417311|NCT00700817|323314005|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
94417312|NCT00700817|323314006|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
94417313|NCT00700817|323314002|FG000|Week 0-26 (Main Period)|Unclassified|14|||
94417314|NCT00700817|323314003|FG001|Week 0-26 (Main Period)|Unclassified|4|||
94417315|NCT00700817|323314004|FG002|Week 0-26 (Main Period)|Unclassified|8|||
94488614|NCT02251275|323583482|FG003|Overall Study|Adverse Event|0|||
94488615|NCT02251275|323583483|FG004|Overall Study|Adverse Event|0|||
94488616|NCT02251275|323583479|FG000|Overall Study|Lost to Follow-up|5|||
94488617|NCT02251275|323583480|FG001|Overall Study|Lost to Follow-up|6|||
94488618|NCT02251275|323583481|FG002|Overall Study|Lost to Follow-up|4|||
94488619|NCT02251275|323583482|FG003|Overall Study|Lost to Follow-up|0|||
94488620|NCT02251275|323583483|FG004|Overall Study|Lost to Follow-up|0|||
94488621|NCT02251275|323583479|FG000|Overall Study|Physician Decision|19|||
94488622|NCT02251275|323583480|FG001|Overall Study|Physician Decision|30|||
94488623|NCT02251275|323583481|FG002|Overall Study|Physician Decision|26|||
94488624|NCT02251275|323583482|FG003|Overall Study|Physician Decision|0|||
94488625|NCT02251275|323583483|FG004|Overall Study|Physician Decision|1|||
94488626|NCT02251275|323583479|FG000|Overall Study|Protocol Deviation|0|||
94488627|NCT02251275|323583480|FG001|Overall Study|Protocol Deviation|0|||
94488628|NCT02251275|323583481|FG002|Overall Study|Protocol Deviation|1|||
94488629|NCT02251275|323583482|FG003|Overall Study|Protocol Deviation|0|||
94488630|NCT02251275|323583483|FG004|Overall Study|Protocol Deviation|0|||
94488631|NCT02251275|323583479|FG000|Overall Study|Withdrawal by Subject|25|||
94488632|NCT02251275|323583480|FG001|Overall Study|Withdrawal by Subject|51|||
94488633|NCT02251275|323583481|FG002|Overall Study|Withdrawal by Subject|35|||
94488634|NCT02251275|323583482|FG003|Overall Study|Withdrawal by Subject|1|||
94488635|NCT02251275|323583483|FG004|Overall Study|Withdrawal by Subject|0|||
94488636|NCT00891813|323583486|FG000|Overall Study|Adverse Event|3|||
94488637|NCT00891813|323583486|FG000|Overall Study|Withdrawal by Subject|1|||
94488638|NCT00891813|323583486|FG000|Overall Study|Patient Noncompliance|6|||
94488639|NCT00891813|323583486|FG000|Overall Study|Protocol Violation|2|||
94488640|NCT01712178|323583489|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
94488641|NCT01712178|323583490|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
94488642|NCT01712178|323583489|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
94488643|NCT01712178|323583490|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
94488644|NCT01712178|323583489|FG000|Overall Study|Lost to Follow-up|0|||
94488645|NCT01712178|323583490|FG001|Overall Study|Lost to Follow-up|1|||
94488646|NCT01122173|323583491|FG000|Overall Study|Lost to Follow-up|3|||
94488647|NCT01122173|323583491|FG000|Overall Study|Withdrawal by Subject|3|||
94488648|NCT01122173|323583491|FG000|Overall Study|Left study for other reasons|3|||
94488649|NCT02265510|323583492|FG000|Overall Study|Withdrawal by Subject|1|||
94417316|NCT00700817|323314005|FG003|Week 0-26 (Main Period)|Unclassified|0|||
94417317|NCT00700817|323314006|FG004|Week 0-26 (Main Period)|Unclassified|0|||
94417318|NCT00700817|323314002|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
94417319|NCT00700817|323314003|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
94417320|NCT00700817|323314004|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
94488650|NCT02265510|323583493|FG001|Overall Study|Withdrawal by Subject|1|||
94488651|NCT02265510|323583494|FG002|Overall Study|Withdrawal by Subject|2|||
94488652|NCT02265510|323583495|FG003|Overall Study|Withdrawal by Subject|1|||
94488653|NCT02265510|323583496|FG004|Overall Study|Withdrawal by Subject|0|||
94488654|NCT02265510|323583497|FG005|Overall Study|Withdrawal by Subject|2|||
94417321|NCT00700817|323314005|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
94417322|NCT00700817|323314006|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
94417323|NCT00700817|323314002|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
94417324|NCT00700817|323314003|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
94417325|NCT00700817|323314004|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
94417326|NCT00700817|323314005|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
94417327|NCT00700817|323314006|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
94417328|NCT00700817|323314002|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
94417329|NCT00700817|323314003|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
94417330|NCT00700817|323314004|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
94417331|NCT00700817|323314005|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
94417332|NCT00700817|323314006|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
94417333|NCT00700817|323314002|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
94417334|NCT00700817|323314003|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
94417335|NCT00700817|323314004|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
94417336|NCT00700817|323314005|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
94417337|NCT00700817|323314006|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
94417338|NCT00700817|323314002|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
94417339|NCT00700817|323314003|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
94417340|NCT00700817|323314004|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
94417341|NCT00700817|323314005|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
94417342|NCT00700817|323314006|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
94417343|NCT00700817|323314002|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
94417344|NCT00700817|323314003|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
94417345|NCT00700817|323314004|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
94417346|NCT00700817|323314005|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
94417347|NCT00700817|323314006|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
94417348|NCT00700817|323314002|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
94417349|NCT00700817|323314003|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
94417350|NCT00700817|323314004|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
94417351|NCT00700817|323314005|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
94417352|NCT00700817|323314006|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
94417353|NCT00700817|323314002|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
94417354|NCT00700817|323314003|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
94417355|NCT00700817|323314004|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
94417356|NCT00700817|323314005|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
94417357|NCT00700817|323314006|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
94417358|NCT00700817|323314002|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
94417359|NCT00700817|323314003|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
94417360|NCT00700817|323314004|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
94417361|NCT00700817|323314005|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
94417362|NCT00700817|323314006|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
94417363|NCT00700817|323314002|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
94417364|NCT00700817|323314003|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
94417365|NCT00700817|323314004|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
94417366|NCT00700817|323314005|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
94417367|NCT00700817|323314006|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
94417368|NCT01470612|323314009|FG000|Overall Study|Adverse Event|20|||
94417369|NCT01470612|323314010|FG001|Overall Study|Adverse Event|80|||
94417370|NCT01470612|323314009|FG000|Overall Study|Death|0|||
94417371|NCT01470612|323314010|FG001|Overall Study|Death|1|||
94417372|NCT01470612|323314009|FG000|Overall Study|Lack of Efficacy|20|||
94417373|NCT01470612|323314010|FG001|Overall Study|Lack of Efficacy|326|||
94417374|NCT01470612|323314009|FG000|Overall Study|Lost to Follow-up|2|||
94417375|NCT01470612|323314010|FG001|Overall Study|Lost to Follow-up|5|||
94417376|NCT01470612|323314009|FG000|Overall Study|Did not meet entrance criteria|0|||
94417377|NCT01470612|323314010|FG001|Overall Study|Did not meet entrance criteria|1|||
94417378|NCT01470612|323314009|FG000|Overall Study|Pregnancy|2|||
94417379|NCT01470612|323314010|FG001|Overall Study|Pregnancy|10|||
94417380|NCT01470612|323314009|FG000|Overall Study|Protocol Violation|2|||
94417381|NCT01470612|323314010|FG001|Overall Study|Protocol Violation|7|||
94417382|NCT01470612|323314009|FG000|Overall Study|Withdrawal by Subject|24|||
94417383|NCT01470612|323314010|FG001|Overall Study|Withdrawal by Subject|79|||
94417384|NCT01470612|323314009|FG000|Overall Study|Other|14|||
94417385|NCT01470612|323314010|FG001|Overall Study|Other|156|||
94417386|NCT04179019|323314013|FG000|Overall Study|Lost to Follow-up|2|||
94417387|NCT04179019|323314013|FG000|Overall Study|Physician Decision|2|||
94417388|NCT04179019|323314013|FG000|Overall Study|Withdrawal by Subject|5|||
94417389|NCT04179019|323314013|FG000|Overall Study|Adverse Event|4|||
94417390|NCT01901874|323314014|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
94417391|NCT01901874|323314014|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
94417392|NCT01901874|323314014|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
94417393|NCT01901874|323314014|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
94417394|NCT01901874|323314014|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
94417395|NCT01901874|323314014|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
94417396|NCT03978091|323314015|FG000|Overall Study|Lost to Follow-up|0|||
94417397|NCT03978091|323314016|FG001|Overall Study|Lost to Follow-up|0|||
94417398|NCT03978091|323314017|FG002|Overall Study|Lost to Follow-up|1|||
94417399|NCT03978091|323314018|FG003|Overall Study|Lost to Follow-up|0|||
94417400|NCT03978091|323314019|FG004|Overall Study|Lost to Follow-up|0|||
94417401|NCT03978091|323314020|FG005|Overall Study|Lost to Follow-up|0|||
94417402|NCT03978091|323314015|FG000|Overall Study|Withdrawal by Subject|0|||
94417403|NCT03978091|323314016|FG001|Overall Study|Withdrawal by Subject|0|||
94417404|NCT03978091|323314017|FG002|Overall Study|Withdrawal by Subject|0|||
94417405|NCT03978091|323314018|FG003|Overall Study|Withdrawal by Subject|1|||
94417406|NCT03978091|323314019|FG004|Overall Study|Withdrawal by Subject|1|||
94417407|NCT03978091|323314020|FG005|Overall Study|Withdrawal by Subject|0|||
94417408|NCT02595008|323314023|FG000|Overall Study|Enrolled In Error|1|||
94417409|NCT02595008|323314024|FG001|Overall Study|Enrolled In Error|0|||
94417410|NCT03438227|323314030|FG000|Overall Study|Withdrawal by Subject|10|||
94417411|NCT03438227|323314031|FG001|Overall Study|Withdrawal by Subject|5|||
94417412|NCT00384176|323314032|FG000|Overall Study|Death|239|||
94417413|NCT00384176|323314033|FG001|Overall Study|Death|247|||
94417414|NCT00384176|323314034|FG002|Overall Study|Death|105|||
94417415|NCT00384176|323314032|FG000|Overall Study|Withdrawal by Subject|52|||
94417416|NCT00384176|323314033|FG001|Overall Study|Withdrawal by Subject|48|||
94417417|NCT00384176|323314034|FG002|Overall Study|Withdrawal by Subject|22|||
94417418|NCT00384176|323314032|FG000|Overall Study|Lost to Follow-up|16|||
94417419|NCT00384176|323314033|FG001|Overall Study|Lost to Follow-up|18|||
94417420|NCT00384176|323314034|FG002|Overall Study|Lost to Follow-up|4|||
94417421|NCT00384176|323314032|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
94417422|NCT00384176|323314033|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
94417423|NCT00384176|323314034|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
94417424|NCT00384176|323314032|FG000|Overall Study|Longer QTC as Visit 1|1|||
94417425|NCT00384176|323314033|FG001|Overall Study|Longer QTC as Visit 1|0|||
94417426|NCT00384176|323314034|FG002|Overall Study|Longer QTC as Visit 1|0|||
94417427|NCT00384176|323314032|FG000|Overall Study|Toxicity of treatment|1|||
94417428|NCT00384176|323314033|FG001|Overall Study|Toxicity of treatment|0|||
94417429|NCT00384176|323314034|FG002|Overall Study|Toxicity of treatment|0|||
94417430|NCT00384176|323314032|FG000|Overall Study|Did not receive study treatment|0|||
94417431|NCT00384176|323314033|FG001|Overall Study|Did not receive study treatment|1|||
94417432|NCT00384176|323314034|FG002|Overall Study|Did not receive study treatment|1|||
94417433|NCT00384176|323314032|FG000|Overall Study|Physician Decision|0|||
94417434|NCT00384176|323314033|FG001|Overall Study|Physician Decision|2|||
94417435|NCT00384176|323314034|FG002|Overall Study|Physician Decision|0|||
94417436|NCT00384176|323314032|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
94417437|NCT00384176|323314033|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
94417438|NCT00384176|323314034|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
94417439|NCT03078582|323314035|FG000|Overall Study|Adverse Event|0|||
94417440|NCT03078582|323314036|FG001|Overall Study|Adverse Event|8|||
94417441|NCT02458092|323314037|FG000|Overall Study|Withdrawal by Subject|1|||
94417442|NCT02458092|323314038|FG001|Overall Study|Withdrawal by Subject|0|||
94417443|NCT02139124|323314041|FG000|Overall Study|Adverse Event|2|||
94417444|NCT02139124|323314042|FG001|Overall Study|Adverse Event|0|||
94417445|NCT02139124|323314043|FG002|Overall Study|Adverse Event|1|||
94417446|NCT02139124|323314044|FG003|Overall Study|Adverse Event|2|||
94417447|NCT02139124|323314045|FG004|Overall Study|Adverse Event|5|||
94417448|NCT02139124|323314041|FG000|Overall Study|Withdrawal by Subject|2|||
94417449|NCT02139124|323314042|FG001|Overall Study|Withdrawal by Subject|2|||
94417450|NCT02139124|323314043|FG002|Overall Study|Withdrawal by Subject|2|||
94417451|NCT02139124|323314044|FG003|Overall Study|Withdrawal by Subject|2|||
94417452|NCT02139124|323314045|FG004|Overall Study|Withdrawal by Subject|3|||
94417453|NCT02139124|323314041|FG000|Overall Study|Protocol Violation|0|||
94417454|NCT02139124|323314042|FG001|Overall Study|Protocol Violation|0|||
94417455|NCT02139124|323314043|FG002|Overall Study|Protocol Violation|0|||
94417456|NCT02139124|323314044|FG003|Overall Study|Protocol Violation|1|||
94417457|NCT02139124|323314045|FG004|Overall Study|Protocol Violation|1|||
94417458|NCT02139124|323314041|FG000|Overall Study|non-compliant|1|||
94417459|NCT02139124|323314042|FG001|Overall Study|non-compliant|0|||
94417460|NCT02139124|323314043|FG002|Overall Study|non-compliant|0|||
94417461|NCT02139124|323314044|FG003|Overall Study|non-compliant|2|||
94417462|NCT02139124|323314045|FG004|Overall Study|non-compliant|0|||
94417463|NCT02139124|323314041|FG000|Overall Study|incarceration|0|||
94417464|NCT02139124|323314042|FG001|Overall Study|incarceration|0|||
94417465|NCT02139124|323314043|FG002|Overall Study|incarceration|1|||
94417466|NCT02139124|323314044|FG003|Overall Study|incarceration|0|||
94417467|NCT02139124|323314045|FG004|Overall Study|incarceration|0|||
94417468|NCT02139124|323314041|FG000|Overall Study|subject moved|1|||
94417469|NCT02139124|323314042|FG001|Overall Study|subject moved|0|||
94417470|NCT02139124|323314043|FG002|Overall Study|subject moved|0|||
94417471|NCT02139124|323314044|FG003|Overall Study|subject moved|0|||
94417472|NCT02139124|323314045|FG004|Overall Study|subject moved|0|||
94417473|NCT02139124|323314041|FG000|Overall Study|Lost to Follow-up|3|||
94417474|NCT02139124|323314042|FG001|Overall Study|Lost to Follow-up|2|||
94417475|NCT02139124|323314043|FG002|Overall Study|Lost to Follow-up|0|||
94417476|NCT02139124|323314044|FG003|Overall Study|Lost to Follow-up|5|||
94417477|NCT02139124|323314045|FG004|Overall Study|Lost to Follow-up|4|||
94417478|NCT02972502|323314050|FG000|Overall Study|Lost to Follow-up|3|||
94417479|NCT02972502|323314051|FG001|Overall Study|Lost to Follow-up|1|||
94417480|NCT02972502|323314050|FG000|Overall Study|Withdrawal by Subject|1|||
94417481|NCT02972502|323314051|FG001|Overall Study|Withdrawal by Subject|1|||
94417482|NCT03832738|323314052|FG000|Overall Study|Withdrawal by Subject|6|||
94417483|NCT03832738|323314053|FG001|Overall Study|Withdrawal by Subject|7|||
94417484|NCT03832738|323314054|FG002|Overall Study|Withdrawal by Subject|16|||
94417485|NCT03832738|323314052|FG000|Overall Study|Physician Decision|0|||
94417486|NCT03832738|323314053|FG001|Overall Study|Physician Decision|1|||
94417487|NCT03832738|323314054|FG002|Overall Study|Physician Decision|2|||
94417488|NCT03832738|323314052|FG000|Overall Study|Adverse Event|2|||
94417489|NCT03832738|323314053|FG001|Overall Study|Adverse Event|3|||
94417490|NCT03832738|323314054|FG002|Overall Study|Adverse Event|1|||
94417491|NCT03832738|323314052|FG000|Overall Study|Pregnancy|0|||
94417492|NCT03832738|323314053|FG001|Overall Study|Pregnancy|1|||
94417493|NCT03832738|323314054|FG002|Overall Study|Pregnancy|0|||
94417494|NCT03852459|323314055|FG000|Overall Study|Adverse Event|2|||
94417495|NCT03852459|323314056|FG001|Overall Study|Adverse Event|2|||
94417496|NCT03852459|323314055|FG000|Overall Study|Withdrawal by Subject|1|||
94417497|NCT03852459|323314056|FG001|Overall Study|Withdrawal by Subject|1|||
94417498|NCT00307931|323314059|FG000|Overall Study|Adverse Event|1|||
94417499|NCT02429934|323314062|FG000|Overall Study|Withdrawal by Subject|0|||
94417500|NCT02429934|323314063|FG001|Overall Study|Withdrawal by Subject|2|||
94417501|NCT02429934|323314062|FG000|Overall Study|Adverse Event|2|||
94417502|NCT02429934|323314063|FG001|Overall Study|Adverse Event|0|||
94417503|NCT02429934|323314062|FG000|Overall Study|Lost to Follow-up|1|||
94417504|NCT02429934|323314063|FG001|Overall Study|Lost to Follow-up|1|||
94417505|NCT02429934|323314062|FG000|Overall Study|Physician Decision|1|||
94417506|NCT02429934|323314063|FG001|Overall Study|Physician Decision|0|||
94417507|NCT00869024|323314064|FG000|Overall Study|Death|2|||
94417508|NCT00869024|323314065|FG001|Overall Study|Death|3|||
94417509|NCT00869024|323314064|FG000|Overall Study|Lost to Follow-up|0|||
94417510|NCT00869024|323314065|FG001|Overall Study|Lost to Follow-up|1|||
94417511|NCT00869024|323314064|FG000|Overall Study|Protocol Violation|0|||
94417512|NCT00869024|323314065|FG001|Overall Study|Protocol Violation|1|||
94417513|NCT02377063|323314071|FG000|Overall Study|Non-compliance|5|||
94417514|NCT01277718|323314072|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
94417515|NCT01277718|323314073|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
94417516|NCT01277718|323314072|FG000|Period 2 - Second Intervention|Physician Decision|0|||
94417517|NCT01277718|323314073|FG001|Period 2 - Second Intervention|Physician Decision|2|||
94417518|NCT00321737|323314076|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
94417519|NCT00321737|323314077|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
94417520|NCT00321737|323314078|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
94417521|NCT00321737|323314076|FG000|Overall Study|Adverse Event|11|||
94417522|NCT00321737|323314077|FG001|Overall Study|Adverse Event|3|||
94417523|NCT00321737|323314078|FG002|Overall Study|Adverse Event|6|||
94417524|NCT00321737|323314076|FG000|Overall Study|Lost to Follow-up|5|||
94417525|NCT00321737|323314077|FG001|Overall Study|Lost to Follow-up|5|||
94417526|NCT00321737|323314078|FG002|Overall Study|Lost to Follow-up|6|||
94417527|NCT00321737|323314076|FG000|Overall Study|Withdrawal by Subject|19|||
94417528|NCT00321737|323314077|FG001|Overall Study|Withdrawal by Subject|12|||
94417529|NCT00321737|323314078|FG002|Overall Study|Withdrawal by Subject|17|||
94417530|NCT00321737|323314076|FG000|Overall Study|Protocol Violation|0|||
94417531|NCT00321737|323314077|FG001|Overall Study|Protocol Violation|0|||
94417532|NCT00321737|323314078|FG002|Overall Study|Protocol Violation|1|||
94417533|NCT00321737|323314076|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
94417534|NCT00321737|323314077|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
94417535|NCT00321737|323314078|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
94417536|NCT00321737|323314076|FG000|Overall Study|Possible Barrett's Esophagus|2|||
94417537|NCT00321737|323314077|FG001|Overall Study|Possible Barrett's Esophagus|1|||
94417538|NCT00321737|323314078|FG002|Overall Study|Possible Barrett's Esophagus|1|||
94417539|NCT00321737|323314076|FG000|Overall Study|Therapeutic Failure|6|||
94417540|NCT00321737|323314077|FG001|Overall Study|Therapeutic Failure|0|||
94417541|NCT00321737|323314078|FG002|Overall Study|Therapeutic Failure|2|||
94417542|NCT00321737|323314076|FG000|Overall Study|Pregnancy|0|||
94417543|NCT00321737|323314077|FG001|Overall Study|Pregnancy|2|||
94417544|NCT00321737|323314078|FG002|Overall Study|Pregnancy|0|||
94417545|NCT00321737|323314076|FG000|Overall Study|Noncompliance|2|||
94417546|NCT00321737|323314077|FG001|Overall Study|Noncompliance|0|||
94417547|NCT00321737|323314078|FG002|Overall Study|Noncompliance|0|||
94488655|NCT02265510|323583498|FG006|Overall Study|Withdrawal by Subject|0|||
94488656|NCT02265510|323583499|FG007|Overall Study|Withdrawal by Subject|2|||
94488657|NCT02265510|323583500|FG008|Overall Study|Withdrawal by Subject|0|||
94488658|NCT02265510|323583501|FG009|Overall Study|Withdrawal by Subject|0|||
94488659|NCT02265510|323583502|FG010|Overall Study|Withdrawal by Subject|0|||
94488660|NCT02265510|323583503|FG011|Overall Study|Withdrawal by Subject|0|||
94488661|NCT02265510|323583504|FG012|Overall Study|Withdrawal by Subject|1|||
94488662|NCT02265510|323583505|FG013|Overall Study|Withdrawal by Subject|0|||
94488663|NCT02265510|323583492|FG000|Overall Study|Disease Progression|0|||
94488664|NCT02265510|323583493|FG001|Overall Study|Disease Progression|1|||
94488665|NCT02265510|323583494|FG002|Overall Study|Disease Progression|2|||
94488666|NCT02265510|323583495|FG003|Overall Study|Disease Progression|1|||
94488667|NCT02265510|323583496|FG004|Overall Study|Disease Progression|1|||
94488668|NCT02265510|323583497|FG005|Overall Study|Disease Progression|0|||
94488669|NCT02265510|323583498|FG006|Overall Study|Disease Progression|0|||
94488670|NCT02265510|323583499|FG007|Overall Study|Disease Progression|0|||
94488671|NCT02265510|323583500|FG008|Overall Study|Disease Progression|0|||
94488672|NCT02265510|323583501|FG009|Overall Study|Disease Progression|0|||
94488673|NCT02265510|323583502|FG010|Overall Study|Disease Progression|0|||
94488674|NCT02265510|323583503|FG011|Overall Study|Disease Progression|0|||
94488675|NCT02265510|323583504|FG012|Overall Study|Disease Progression|0|||
94488676|NCT02265510|323583505|FG013|Overall Study|Disease Progression|0|||
94488677|NCT02265510|323583492|FG000|Overall Study|Death|2|||
94488678|NCT02265510|323583493|FG001|Overall Study|Death|0|||
94488679|NCT02265510|323583494|FG002|Overall Study|Death|2|||
94488680|NCT02265510|323583495|FG003|Overall Study|Death|2|||
94488681|NCT02265510|323583496|FG004|Overall Study|Death|1|||
94488682|NCT02265510|323583497|FG005|Overall Study|Death|3|||
94488683|NCT02265510|323583498|FG006|Overall Study|Death|2|||
94488684|NCT02265510|323583499|FG007|Overall Study|Death|1|||
94488685|NCT02265510|323583500|FG008|Overall Study|Death|3|||
94488686|NCT02265510|323583501|FG009|Overall Study|Death|3|||
94417548|NCT00321737|323314076|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
94417549|NCT00321737|323314077|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
94417550|NCT00321737|323314078|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
94417551|NCT00741936|323314079|FG000|Overall Study|Lost to Follow-up|1|||
94417552|NCT00741936|323314080|FG001|Overall Study|Lost to Follow-up|1|||
94417553|NCT00741936|323314079|FG000|Overall Study|Adverse Event|3|||
94417554|NCT00741936|323314080|FG001|Overall Study|Adverse Event|4|||
94417555|NCT00741936|323314079|FG000|Overall Study|Pregnancy|0|||
94417556|NCT00741936|323314080|FG001|Overall Study|Pregnancy|1|||
94417557|NCT00741936|323314079|FG000|Overall Study|Protocol Violation|2|||
94417558|NCT00741936|323314080|FG001|Overall Study|Protocol Violation|0|||
94417559|NCT00741936|323314079|FG000|Overall Study|Lack of Efficacy|0|||
94417560|NCT00741936|323314080|FG001|Overall Study|Lack of Efficacy|2|||
94417561|NCT00741936|323314079|FG000|Overall Study|Low compliance|3|||
94417562|NCT00741936|323314080|FG001|Overall Study|Low compliance|0|||
94417563|NCT02989168|323314083|FG000|Overall Study|Withdrawal by Subject|2|||
94417564|NCT02989168|323314084|FG001|Overall Study|Withdrawal by Subject|0|||
94417565|NCT02989168|323314083|FG000|Overall Study|Physician Decision|0|||
94417566|NCT02989168|323314084|FG001|Overall Study|Physician Decision|1|||
94417567|NCT02989168|323314083|FG000|Overall Study|Adverse Event|1|||
94417568|NCT02989168|323314084|FG001|Overall Study|Adverse Event|2|||
94417569|NCT02989168|323314083|FG000|Overall Study|Sponsor stopped study.|1|||
94417570|NCT02989168|323314084|FG001|Overall Study|Sponsor stopped study.|0|||
94417571|NCT00653991|323314085|FG000|3 Month Follow-up|Participant would not respond|150|||
94417572|NCT00653991|323314086|FG001|3 Month Follow-up|Participant would not respond|157|||
94417573|NCT00653991|323314085|FG000|6 Month Follow-up|Participant would not respond|133|||
94417574|NCT00653991|323314086|FG001|6 Month Follow-up|Participant would not respond|141|||
94417575|NCT00456495|323314089|FG000|Overall Study|Physician Decision|2|||
94488687|NCT02265510|323583502|FG010|Overall Study|Death|4|||
94417576|NCT01568866|323314090|FG000|Overall Study|Disease Progression|208|||
94417577|NCT01568866|323314091|FG001|Overall Study|Disease Progression|183|||
94417578|NCT01568866|323314090|FG000|Overall Study|Adverse Event|94|||
94417579|NCT01568866|323314091|FG001|Overall Study|Adverse Event|96|||
94417580|NCT01568866|323314090|FG000|Overall Study|Patient Request|55|||
94417581|NCT01568866|323314091|FG001|Overall Study|Patient Request|71|||
94417582|NCT01568866|323314090|FG000|Overall Study|Physician Decision|40|||
94488688|NCT02265510|323583503|FG011|Overall Study|Death|12|||
94488689|NCT02265510|323583504|FG012|Overall Study|Death|7|||
94488690|NCT02265510|323583505|FG013|Overall Study|Death|6|||
94488691|NCT02265510|323583492|FG000|Overall Study|Lost to Follow-up|0|||
94488692|NCT02265510|323583493|FG001|Overall Study|Lost to Follow-up|0|||
94488693|NCT02265510|323583494|FG002|Overall Study|Lost to Follow-up|0|||
94417583|NCT01568866|323314091|FG001|Overall Study|Physician Decision|32|||
94488694|NCT02265510|323583495|FG003|Overall Study|Lost to Follow-up|0|||
94417584|NCT01568866|323314090|FG000|Overall Study|Withdrawal by Subject|19|||
94417585|NCT01568866|323314091|FG001|Overall Study|Withdrawal by Subject|11|||
94488695|NCT02265510|323583496|FG004|Overall Study|Lost to Follow-up|1|||
94488696|NCT02265510|323583497|FG005|Overall Study|Lost to Follow-up|0|||
94488697|NCT02265510|323583498|FG006|Overall Study|Lost to Follow-up|0|||
94488698|NCT02265510|323583499|FG007|Overall Study|Lost to Follow-up|0|||
94488699|NCT02265510|323583500|FG008|Overall Study|Lost to Follow-up|0|||
94488700|NCT02265510|323583501|FG009|Overall Study|Lost to Follow-up|2|||
94488701|NCT02265510|323583502|FG010|Overall Study|Lost to Follow-up|0|||
94488702|NCT02265510|323583503|FG011|Overall Study|Lost to Follow-up|0|||
94488703|NCT02265510|323583504|FG012|Overall Study|Lost to Follow-up|0|||
94488704|NCT02265510|323583505|FG013|Overall Study|Lost to Follow-up|2|||
94488705|NCT02265510|323583492|FG000|Overall Study|Other|0|||
94488706|NCT02265510|323583493|FG001|Overall Study|Other|1|||
94488707|NCT02265510|323583494|FG002|Overall Study|Other|0|||
94488708|NCT02265510|323583495|FG003|Overall Study|Other|0|||
94488709|NCT02265510|323583496|FG004|Overall Study|Other|0|||
94488710|NCT02265510|323583497|FG005|Overall Study|Other|0|||
94488711|NCT02265510|323583498|FG006|Overall Study|Other|0|||
94488712|NCT02265510|323583499|FG007|Overall Study|Other|0|||
94488713|NCT02265510|323583500|FG008|Overall Study|Other|0|||
94488714|NCT02265510|323583501|FG009|Overall Study|Other|0|||
94488715|NCT02265510|323583502|FG010|Overall Study|Other|0|||
94488716|NCT02265510|323583503|FG011|Overall Study|Other|0|||
94488717|NCT02265510|323583504|FG012|Overall Study|Other|0|||
94488718|NCT02265510|323583505|FG013|Overall Study|Other|0|||
94488719|NCT02265510|323583492|FG000|Overall Study|Study Terminated by Sponsor|0|||
94488720|NCT02265510|323583493|FG001|Overall Study|Study Terminated by Sponsor|0|||
94488721|NCT02265510|323583494|FG002|Overall Study|Study Terminated by Sponsor|0|||
94488722|NCT02265510|323583495|FG003|Overall Study|Study Terminated by Sponsor|0|||
94488723|NCT02265510|323583496|FG004|Overall Study|Study Terminated by Sponsor|0|||
94488724|NCT02265510|323583497|FG005|Overall Study|Study Terminated by Sponsor|1|||
94488725|NCT02265510|323583498|FG006|Overall Study|Study Terminated by Sponsor|1|||
94488726|NCT02265510|323583499|FG007|Overall Study|Study Terminated by Sponsor|1|||
94488727|NCT02265510|323583500|FG008|Overall Study|Study Terminated by Sponsor|1|||
94488728|NCT02265510|323583501|FG009|Overall Study|Study Terminated by Sponsor|2|||
94488729|NCT02265510|323583502|FG010|Overall Study|Study Terminated by Sponsor|1|||
94488730|NCT02265510|323583503|FG011|Overall Study|Study Terminated by Sponsor|4|||
94488731|NCT02265510|323583504|FG012|Overall Study|Study Terminated by Sponsor|1|||
94488732|NCT02265510|323583505|FG013|Overall Study|Study Terminated by Sponsor|2|||
94488733|NCT02858401|323583506|FG000|Overall Study|Withdrew Consent|0|||
94488734|NCT02858401|323583507|FG001|Overall Study|Withdrew Consent|0|||
94488735|NCT02858401|323583508|FG002|Overall Study|Withdrew Consent|0|||
94488736|NCT02858401|323583509|FG003|Overall Study|Withdrew Consent|0|||
94488737|NCT02858401|323583510|FG004|Overall Study|Withdrew Consent|0|||
94488738|NCT02858401|323583511|FG005|Overall Study|Withdrew Consent|1|||
94488739|NCT02858401|323583512|FG006|Overall Study|Withdrew Consent|0|||
94488740|NCT02858401|323583506|FG000|Overall Study|Lost to Follow-up|0|||
94488741|NCT02858401|323583507|FG001|Overall Study|Lost to Follow-up|1|||
94417586|NCT01568866|323314090|FG000|Overall Study|Death|10|||
94417587|NCT01568866|323314091|FG001|Overall Study|Death|18|||
94417588|NCT01568866|323314090|FG000|Overall Study|Protocol Non-compliance|2|||
94417589|NCT01568866|323314091|FG001|Overall Study|Protocol Non-compliance|4|||
94417590|NCT01568866|323314090|FG000|Overall Study|Lost to Follow-up|1|||
94417591|NCT01568866|323314091|FG001|Overall Study|Lost to Follow-up|0|||
94417592|NCT01568866|323314090|FG000|Overall Study|Randomized but Not Dosed|9|||
94417593|NCT01568866|323314091|FG001|Overall Study|Randomized but Not Dosed|1|||
94417594|NCT03864042|323314092|FG000|DDI Phase|Adverse Event|2|||
94417595|NCT03864042|323314093|FG001|DDI Phase|Adverse Event|0|||
94417596|NCT03864042|323314094|FG002|DDI Phase|Adverse Event|0|||
94417597|NCT03864042|323314092|FG000|DDI Phase|Physician Decision|1|||
94417598|NCT03864042|323314093|FG001|DDI Phase|Physician Decision|0|||
94417599|NCT03864042|323314094|FG002|DDI Phase|Physician Decision|0|||
94417600|NCT03864042|323314092|FG000|DDI Phase|Progressive Disease|1|||
94417601|NCT03864042|323314093|FG001|DDI Phase|Progressive Disease|0|||
94417602|NCT03864042|323314094|FG002|DDI Phase|Progressive Disease|0|||
94417603|NCT03864042|323314092|FG000|Post-DDI Phase|Adverse Event|5|||
94417604|NCT03864042|323314093|FG001|Post-DDI Phase|Adverse Event|3|||
94417605|NCT03864042|323314094|FG002|Post-DDI Phase|Adverse Event|2|||
94417606|NCT03864042|323314092|FG000|Post-DDI Phase|Progressive Disease|11|||
94417607|NCT03864042|323314093|FG001|Post-DDI Phase|Progressive Disease|6|||
94488742|NCT02858401|323583508|FG002|Overall Study|Lost to Follow-up|0|||
94417608|NCT03864042|323314094|FG002|Post-DDI Phase|Progressive Disease|13|||
94417609|NCT03864042|323314092|FG000|Post-DDI Phase|Discretion of investigator|1|||
94488743|NCT02858401|323583509|FG003|Overall Study|Lost to Follow-up|0|||
94488744|NCT02858401|323583510|FG004|Overall Study|Lost to Follow-up|0|||
94488745|NCT02858401|323583511|FG005|Overall Study|Lost to Follow-up|0|||
94417610|NCT03864042|323314093|FG001|Post-DDI Phase|Discretion of investigator|1|||
94488746|NCT02858401|323583512|FG006|Overall Study|Lost to Follow-up|0|||
94488747|NCT01004614|323583513|FG000|Washout|Withdrawal by Subject|0|||
94488748|NCT01004614|323583514|FG001|Washout|Withdrawal by Subject|1|||
94488749|NCT01004614|323583515|FG002|Washout|Withdrawal by Subject|0|||
94488750|NCT01004614|323583516|FG003|Washout|Withdrawal by Subject|0|||
94488751|NCT02915835|323583517|FG000|Overall Study|Physician Decision|1|||
94488752|NCT02915835|323583518|FG001|Overall Study|Physician Decision|0|||
94417611|NCT03864042|323314094|FG002|Post-DDI Phase|Discretion of investigator|0|||
94417612|NCT03864042|323314092|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
94417613|NCT03864042|323314093|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
94417614|NCT03864042|323314094|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
94417615|NCT03864042|323314092|FG000|Post-DDI Phase|Withdrawal of consent|1|||
94417616|NCT03864042|323314093|FG001|Post-DDI Phase|Withdrawal of consent|2|||
94417617|NCT03864042|323314094|FG002|Post-DDI Phase|Withdrawal of consent|0|||
94417618|NCT00788593|323314095|FG000|Placebo Run-in Phase|Adverse Event|2|||
94417619|NCT00788593|323314096|FG001|Placebo Run-in Phase|Adverse Event|0|||
94417620|NCT00788593|323314097|FG002|Placebo Run-in Phase|Adverse Event|0|||
94417621|NCT00788593|323314095|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
94417622|NCT00788593|323314096|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
94417623|NCT00788593|323314097|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
94417624|NCT00788593|323314095|FG000|Placebo Run-in Phase|Protocol Violation|2|||
94417625|NCT00788593|323314096|FG001|Placebo Run-in Phase|Protocol Violation|0|||
94417626|NCT00788593|323314097|FG002|Placebo Run-in Phase|Protocol Violation|0|||
94417627|NCT00788593|323314095|FG000|First Intervention Period|Adverse Event|0|||
94417628|NCT00788593|323314096|FG001|First Intervention Period|Adverse Event|1|||
94417629|NCT00788593|323314097|FG002|First Intervention Period|Adverse Event|0|||
94417630|NCT00788593|323314095|FG000|Second Intervention Period|Lost to Follow-up|0|||
94417631|NCT00788593|323314096|FG001|Second Intervention Period|Lost to Follow-up|1|||
94417632|NCT00788593|323314097|FG002|Second Intervention Period|Lost to Follow-up|0|||
94417633|NCT00788593|323314095|FG000|Second Intervention Period|Other|0|||
94417634|NCT00788593|323314096|FG001|Second Intervention Period|Other|0|||
94417635|NCT00788593|323314097|FG002|Second Intervention Period|Other|1|||
94417636|NCT02450526|323314102|FG000|DB Period (Cycle 1)|Adverse Event|0|||
94417637|NCT02450526|323314103|FG001|DB Period (Cycle 1)|Adverse Event|0|||
94417638|NCT02450526|323314104|FG002|DB Period (Cycle 1)|Adverse Event|2|||
94417639|NCT02450526|323314105|FG003|DB Period (Cycle 1)|Adverse Event|0|||
94417640|NCT02450526|323314106|FG004|DB Period (Cycle 1)|Adverse Event|0|||
94417641|NCT02450526|323314102|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
94417642|NCT02450526|323314103|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
94417643|NCT02450526|323314104|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
94417644|NCT02450526|323314105|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
94417645|NCT02450526|323314106|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
94417646|NCT02450526|323314102|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
94417647|NCT02450526|323314103|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
94417648|NCT02450526|323314104|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
94417649|NCT02450526|323314105|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
94417650|NCT02450526|323314106|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
94417651|NCT02450526|323314102|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
94417652|NCT02450526|323314103|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
94417653|NCT02450526|323314104|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
94417654|NCT02450526|323314105|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
94417655|NCT02450526|323314106|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
94417656|NCT02450526|323314102|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
94417657|NCT02450526|323314103|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
94417658|NCT02450526|323314104|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
94417659|NCT02450526|323314105|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
94417660|NCT02450526|323314106|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
94417661|NCT02450526|323314102|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
94417662|NCT02450526|323314103|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
94417663|NCT02450526|323314104|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
94417664|NCT02450526|323314105|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
94417665|NCT02450526|323314106|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
94417666|NCT02450526|323314102|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
94417667|NCT02450526|323314103|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
94417668|NCT02450526|323314104|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
94417669|NCT02450526|323314105|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
94417670|NCT02450526|323314106|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
94417671|NCT02450526|323314102|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
94417672|NCT02450526|323314103|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
94417673|NCT02450526|323314104|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
94417674|NCT02450526|323314105|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
94417675|NCT02450526|323314106|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
94417676|NCT02340221|323314107|FG000|Overall Study|Death|100|||
94417677|NCT02340221|323314108|FG001|Overall Study|Death|197|||
94417678|NCT02340221|323314107|FG000|Overall Study|Withdrawal by Participant|24|||
94417679|NCT02340221|323314108|FG001|Overall Study|Withdrawal by Participant|37|||
94417680|NCT02340221|323314107|FG000|Overall Study|Lost to Follow-up|4|||
94417681|NCT02340221|323314108|FG001|Overall Study|Lost to Follow-up|15|||
94417682|NCT02340221|323314107|FG000|Overall Study|Reason Not Specified|85|||
94417683|NCT02340221|323314108|FG001|Overall Study|Reason Not Specified|165|||
94417684|NCT02340221|323314107|FG000|Overall Study|Study Terminated by Sponsor|1|||
94417685|NCT02340221|323314108|FG001|Overall Study|Study Terminated by Sponsor|3|||
94417686|NCT00588640|323314114|FG000|Overall Study|Physician Decision|1|||
94417687|NCT00588640|323314114|FG000|Overall Study|Ineligible Patient|1|||
94417688|NCT02333487|323314115|FG000|Overall Study|Adverse Event|0|||
94417689|NCT02333487|323314116|FG001|Overall Study|Adverse Event|2|||
94417690|NCT02333487|323314117|FG002|Overall Study|Adverse Event|0|||
94417691|NCT01111019|323314118|FG000|Overall Study|Withdrew Prematurely|2|||
94417692|NCT01111019|323314118|FG000|Overall Study|Other|1|||
94417693|NCT01558297|323314124|FG000|Overall Study|Withdrawal by Subject|2|||
94417694|NCT01558297|323314125|FG001|Overall Study|Withdrawal by Subject|2|||
94417695|NCT01558297|323314126|FG002|Overall Study|Withdrawal by Subject|1|||
94417696|NCT00094094|323314127|FG000|Overall Study|Death|2|||
94417697|NCT00094094|323314127|FG000|Overall Study|Lack of Efficacy|23|||
94417698|NCT00094094|323314127|FG000|Overall Study|Adverse Event|7|||
94417699|NCT00375492|323314128|FG000|Overall Study|Adverse Event|4|||
94417700|NCT00375492|323314129|FG001|Overall Study|Adverse Event|5|||
94417701|NCT00375492|323314128|FG000|Overall Study|Entry Criteria Not Met|0|||
94417702|NCT00375492|323314129|FG001|Overall Study|Entry Criteria Not Met|1|||
94417703|NCT00375492|323314128|FG000|Overall Study|Loss of Glucose Control|0|||
94417704|NCT00375492|323314129|FG001|Overall Study|Loss of Glucose Control|1|||
94417705|NCT00375492|323314128|FG000|Overall Study|Lost to Follow-up|10|||
94417706|NCT00375492|323314129|FG001|Overall Study|Lost to Follow-up|5|||
94417707|NCT00375492|323314128|FG000|Overall Study|Physician Decision|0|||
94417708|NCT00375492|323314129|FG001|Overall Study|Physician Decision|4|||
94417709|NCT00375492|323314128|FG000|Overall Study|Protocol Violation|6|||
94417710|NCT00375492|323314129|FG001|Overall Study|Protocol Violation|3|||
94417711|NCT00375492|323314128|FG000|Overall Study|Sponsor Decision|0|||
94417712|NCT00375492|323314129|FG001|Overall Study|Sponsor Decision|1|||
94417713|NCT00375492|323314128|FG000|Overall Study|Withdrawal by Subject|6|||
94417714|NCT00375492|323314129|FG001|Overall Study|Withdrawal by Subject|6|||
94417715|NCT04495283|323315632|FG000|Overall Study|Physician Decision|0|||
94417716|NCT04495283|323315633|FG001|Overall Study|Physician Decision|0|||
94417717|NCT04495283|323315634|FG002|Overall Study|Physician Decision|1|||
94417718|NCT04495283|323315632|FG000|Overall Study|Withdrawal by Subject|0|||
94417719|NCT04495283|323315633|FG001|Overall Study|Withdrawal by Subject|1|||
94417720|NCT04495283|323315634|FG002|Overall Study|Withdrawal by Subject|1|||
94417721|NCT04495283|323315632|FG000|Overall Study|Other|1|||
94417722|NCT04495283|323315633|FG001|Overall Study|Other|0|||
94417723|NCT04495283|323315634|FG002|Overall Study|Other|1|||
94417724|NCT02221037|323315635|FG000|Overall Study|Physician Decision|0|||
94417725|NCT02221037|323315636|FG001|Overall Study|Physician Decision|0|||
94417726|NCT02221037|323315637|FG002|Overall Study|Physician Decision|1|||
94417727|NCT02221037|323315638|FG003|Overall Study|Physician Decision|0|||
94417728|NCT02246439|323315639|FG000|Overall Study|Adverse Event|3|||
94417729|NCT02246439|323315640|FG001|Overall Study|Adverse Event|0|||
94417730|NCT02246439|323315639|FG000|Overall Study|Lost to Follow-up|7|||
94417731|NCT02246439|323315640|FG001|Overall Study|Lost to Follow-up|5|||
94417732|NCT02246439|323315639|FG000|Overall Study|Protocol Violation|0|||
94417733|NCT02246439|323315640|FG001|Overall Study|Protocol Violation|2|||
94417734|NCT02246439|323315639|FG000|Overall Study|Physician Decision|0|||
94417735|NCT02246439|323315640|FG001|Overall Study|Physician Decision|1|||
94417736|NCT02246439|323315639|FG000|Overall Study|Unkonwn|1|||
94417737|NCT02246439|323315640|FG001|Overall Study|Unkonwn|3|||
94417738|NCT02246439|323315639|FG000|Overall Study|Withdrawal by Subject|1|||
94417739|NCT02246439|323315640|FG001|Overall Study|Withdrawal by Subject|0|||
94417740|NCT00706095|323315641|FG000|Overall Study|Progressive Disease|4|||
94417741|NCT00706095|323315642|FG001|Overall Study|Progressive Disease|5|||
94417742|NCT00706095|323315643|FG002|Overall Study|Progressive Disease|3|||
94417743|NCT00706095|323315641|FG000|Overall Study|Clinical Progression|1|||
94417744|NCT00706095|323315642|FG001|Overall Study|Clinical Progression|2|||
94417745|NCT00706095|323315643|FG002|Overall Study|Clinical Progression|2|||
94417746|NCT00706095|323315641|FG000|Overall Study|Withdrawal by Subject|1|||
94417747|NCT00706095|323315642|FG001|Overall Study|Withdrawal by Subject|0|||
94417748|NCT00706095|323315643|FG002|Overall Study|Withdrawal by Subject|0|||
94417749|NCT00856830|323315651|FG000|Irinotecan & Bendamustine|Death|0|||
94417750|NCT00856830|323315652|FG001|Irinotecan & Bendamustine|Death|0|||
94417751|NCT00856830|323315653|FG002|Irinotecan & Bendamustine|Death|0|||
94417752|NCT00856830|323315654|FG003|Irinotecan & Bendamustine|Death|2|||
94417753|NCT00856830|323315651|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
94417754|NCT00856830|323315652|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
94417755|NCT00856830|323315653|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
94417756|NCT00856830|323315654|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
94417757|NCT00793780|323315657|FG000|Overall Study|Withdrawal by Subject|2|||
94417758|NCT00793780|323315658|FG001|Overall Study|Withdrawal by Subject|1|||
94417759|NCT03768726|323315659|FG000|Treatment Phase|Adverse Event|2|||
94417760|NCT03768726|323315660|FG001|Treatment Phase|Adverse Event|2|||
94417761|NCT03768726|323315659|FG000|Treatment Phase|Lost to Follow-up|1|||
94417762|NCT03768726|323315660|FG001|Treatment Phase|Lost to Follow-up|0|||
94417763|NCT03768726|323315659|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
94417764|NCT03768726|323315660|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
94417765|NCT03768726|323315659|FG000|Treatment Phase|Withdrawal by Subject|3|||
94417766|NCT03768726|323315660|FG001|Treatment Phase|Withdrawal by Subject|1|||
94417767|NCT03768726|323315659|FG000|Follow-Up|Adverse Event|2|||
94417768|NCT03768726|323315660|FG001|Follow-Up|Adverse Event|2|||
94417769|NCT03768726|323315659|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
94417770|NCT03768726|323315660|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
94417771|NCT03768726|323315659|FG000|Follow-Up|Withdrawal by Subject|2|||
94417772|NCT03768726|323315660|FG001|Follow-Up|Withdrawal by Subject|0|||
94417773|NCT03768726|323315659|FG000|Follow-Up|Other|1|||
94417774|NCT03768726|323315660|FG001|Follow-Up|Other|0|||
94417775|NCT01386684|323315661|FG000|Overall Study|Lost to Follow-up|51|||
94417776|NCT01386684|323315661|FG000|Overall Study|Other|51|||
94417777|NCT01386684|323315661|FG000|Overall Study|Death|47|||
94417778|NCT01386684|323315661|FG000|Overall Study|Withdrawal of Consent|44|||
94417779|NCT01386684|323315661|FG000|Overall Study|Alternative Therapy Required|37|||
94417780|NCT01386684|323315661|FG000|Overall Study|Disease Progression|28|||
94417781|NCT01386684|323315661|FG000|Overall Study|Adverse Event|20|||
94417782|NCT01386684|323315661|FG000|Overall Study|Noncompliance|8|||
94417783|NCT01386684|323315661|FG000|Overall Study|Protocol Violation|4|||
94417784|NCT01386684|323315661|FG000|Overall Study|Missing|3|||
94417785|NCT01220297|323315664|FG000|Overall Study|Death|2|||
94417786|NCT01220297|323315664|FG000|Overall Study|Lost to Follow-up|1|||
94417787|NCT02119286|323315665|FG000|Overall Study|Adverse Event|9|||
94417788|NCT02119286|323315666|FG001|Overall Study|Adverse Event|7|||
94417789|NCT02119286|323315667|FG002|Overall Study|Adverse Event|2|||
94417790|NCT02119286|323315665|FG000|Overall Study|Lack of Efficacy|11|||
94417791|NCT02119286|323315666|FG001|Overall Study|Lack of Efficacy|3|||
94417792|NCT02119286|323315667|FG002|Overall Study|Lack of Efficacy|4|||
94417793|NCT02119286|323315665|FG000|Overall Study|Lost to Follow-up|2|||
94417794|NCT02119286|323315666|FG001|Overall Study|Lost to Follow-up|0|||
94417795|NCT02119286|323315667|FG002|Overall Study|Lost to Follow-up|1|||
94417796|NCT02119286|323315665|FG000|Overall Study|Withdrawal by Subject|4|||
94417797|NCT02119286|323315666|FG001|Overall Study|Withdrawal by Subject|1|||
94417798|NCT02119286|323315667|FG002|Overall Study|Withdrawal by Subject|0|||
94417799|NCT05855616|323315668|FG000|Overall Study|Lost to Follow-up|1|||
94417800|NCT05855616|323315669|FG001|Overall Study|Lost to Follow-up|2|||
94417801|NCT00652028|323315672|FG000|Overall Study|Adverse Event|1|||
94417802|NCT00652028|323315673|FG001|Overall Study|Adverse Event|0|||
94417803|NCT00652028|323315674|FG002|Overall Study|Adverse Event|0|||
94417804|NCT00652028|323315675|FG003|Overall Study|Adverse Event|0|||
94417805|NCT00652028|323315672|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
94417806|NCT00652028|323315673|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
94417807|NCT00652028|323315674|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
94417808|NCT00652028|323315675|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
94417809|NCT00652028|323315672|FG000|Overall Study|Physician Decision|0|||
94417810|NCT00652028|323315673|FG001|Overall Study|Physician Decision|0|||
94417811|NCT00652028|323315674|FG002|Overall Study|Physician Decision|1|||
94417812|NCT00652028|323315675|FG003|Overall Study|Physician Decision|0|||
94417813|NCT02581163|323315676|FG000|Overall Study|Failure to return|15|||
94417814|NCT02581163|323315676|FG000|Overall Study|Insufficient virological response|3|||
94417815|NCT02581163|323315676|FG000|Overall Study|Withdrew consent|1|||
94417816|NCT02581163|323315676|FG000|Overall Study|Death|1|||
94417817|NCT02581163|323315676|FG000|Overall Study|Other, not specified|9|||
94417818|NCT03438396|323315677|FG000|Overall Study|Reason Not Specified|9|||
94417819|NCT03438396|323315677|FG000|Overall Study|Withdrawal by Subject|5|||
94417820|NCT03438396|323315677|FG000|Overall Study|Lost to Follow-up|2|||
94417821|NCT03438396|323315677|FG000|Overall Study|Death|85|||
94417822|NCT03438396|323315677|FG000|Overall Study|Not treated|1|||
94417823|NCT01744093|323315681|FG000|Overall Study|Withdrawal by Subject|6|||
94417824|NCT01744093|323315682|FG001|Overall Study|Withdrawal by Subject|1|||
94417825|NCT00158756|323315683|FG000|Overall Study|Withdrawal by Subject|5|||
94417826|NCT00158756|323315684|FG001|Overall Study|Withdrawal by Subject|0|||
94417827|NCT00158756|323315685|FG002|Overall Study|Withdrawal by Subject|6|||
94417828|NCT00158756|323315686|FG003|Overall Study|Withdrawal by Subject|1|||
94417829|NCT00158756|323315687|FG004|Overall Study|Withdrawal by Subject|3|||
94417830|NCT00158756|323315683|FG000|Overall Study|Adverse Event|0|||
94417831|NCT00158756|323315684|FG001|Overall Study|Adverse Event|0|||
94417832|NCT00158756|323315685|FG002|Overall Study|Adverse Event|1|||
94417833|NCT00158756|323315686|FG003|Overall Study|Adverse Event|0|||
94417834|NCT00158756|323315687|FG004|Overall Study|Adverse Event|0|||
94417835|NCT00158756|323315683|FG000|Overall Study|Serious adverse event|0|||
94417836|NCT00158756|323315684|FG001|Overall Study|Serious adverse event|0|||
94417837|NCT00158756|323315685|FG002|Overall Study|Serious adverse event|1|||
94417838|NCT00158756|323315686|FG003|Overall Study|Serious adverse event|0|||
94417839|NCT00158756|323315687|FG004|Overall Study|Serious adverse event|0|||
94417840|NCT02400671|323315688|FG000|Overall Study|Death|5|||
94417841|NCT02400671|323315689|FG001|Overall Study|Death|3|||
94417842|NCT02400671|323315690|FG002|Overall Study|Death|4|||
94417843|NCT02400671|323315688|FG000|Overall Study|Lost to Follow-up|20|||
94417844|NCT02400671|323315689|FG001|Overall Study|Lost to Follow-up|27|||
94417845|NCT02400671|323315690|FG002|Overall Study|Lost to Follow-up|24|||
94417846|NCT02400671|323315688|FG000|Overall Study|Withdrawal by Subject|2|||
94417847|NCT02400671|323315689|FG001|Overall Study|Withdrawal by Subject|2|||
94417848|NCT02400671|323315690|FG002|Overall Study|Withdrawal by Subject|0|||
94417849|NCT00262041|323315691|FG000|Overall Study|Withdrawal by Subject|0|||
94417850|NCT00262041|323315692|FG001|Overall Study|Withdrawal by Subject|3|||
94417851|NCT00262041|323315693|FG002|Overall Study|Withdrawal by Subject|1|||
94417852|NCT00262041|323315691|FG000|Overall Study|Lost to Follow-up|1|||
94417853|NCT00262041|323315692|FG001|Overall Study|Lost to Follow-up|1|||
94417854|NCT00262041|323315693|FG002|Overall Study|Lost to Follow-up|5|||
94417855|NCT00262041|323315691|FG000|Overall Study|Unable to classify|1|||
94417856|NCT00262041|323315692|FG001|Overall Study|Unable to classify|0|||
94417857|NCT00262041|323315693|FG002|Overall Study|Unable to classify|0|||
94417858|NCT01173471|323315694|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
94417859|NCT01173471|323315695|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
94417860|NCT01173471|323315696|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
94417861|NCT01173471|323315697|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
94417862|NCT01173471|323315694|FG000|Overall Study|Condition under investigation worsened|2|||
94417863|NCT01173471|323315695|FG001|Overall Study|Condition under investigation worsened|0|||
94417864|NCT01173471|323315696|FG002|Overall Study|Condition under investigation worsened|0|||
94417865|NCT01173471|323315697|FG003|Overall Study|Condition under investigation worsened|0|||
94417866|NCT01173471|323315694|FG000|Overall Study|Lost to Follow-up|0|||
94417867|NCT01173471|323315695|FG001|Overall Study|Lost to Follow-up|0|||
94417868|NCT01173471|323315696|FG002|Overall Study|Lost to Follow-up|1|||
94417869|NCT01173471|323315697|FG003|Overall Study|Lost to Follow-up|0|||
94417870|NCT01173471|323315694|FG000|Overall Study|Reason given as Other|0|||
94417871|NCT01173471|323315695|FG001|Overall Study|Reason given as Other|0|||
94417872|NCT01173471|323315696|FG002|Overall Study|Reason given as Other|1|||
94417873|NCT01173471|323315697|FG003|Overall Study|Reason given as Other|0|||
94417874|NCT01429051|323315698|FG000|Titration Phase|Death|1|||
94417875|NCT01429051|323315698|FG000|Titration Phase|Withdrawal by Subject|7|||
94417876|NCT01429051|323315698|FG000|Titration Phase|Physician Decision|1|||
94417877|NCT01429051|323315698|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
94417878|NCT01429051|323315698|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
94417879|NCT01429051|323315698|FG000|Efficacy Phase|Adverse Event|1|||
94417880|NCT01429051|323315698|FG000|Efficacy Phase|Death|1|||
94417881|NCT01429051|323315698|FG000|Tolerability Phase|Death|5|||
94417882|NCT01429051|323315698|FG000|Tolerability Phase|Adverse Event|2|||
94417883|NCT01429051|323315698|FG000|Tolerability Phase|Withdrawal by Subject|5|||
94417884|NCT01429051|323315698|FG000|Tolerability Phase|Physician Decision|1|||
94417885|NCT01429051|323315698|FG000|Tolerability Phase|Other|2|||
94417886|NCT00186888|323315699|FG000|Overall Study|Toxicity|0|||
94417887|NCT00186888|323315700|FG001|Overall Study|Toxicity|1|||
94417888|NCT00186888|323315701|FG002|Overall Study|Toxicity|0|||
94417889|NCT00186888|323315699|FG000|Overall Study|Relapse or progression of disease|4|||
94417890|NCT00186888|323315700|FG001|Overall Study|Relapse or progression of disease|2|||
94417891|NCT00186888|323315701|FG002|Overall Study|Relapse or progression of disease|0|||
94417892|NCT01370213|323315702|FG000|Overall Study|Early Death|1|||
94417893|NCT01370213|323315703|FG001|Overall Study|Early Death|0|||
94417894|NCT01370213|323315704|FG002|Overall Study|Early Death|0|||
94417895|NCT01370213|323315702|FG000|Overall Study|Not evaluable|0|||
94417896|NCT01370213|323315703|FG001|Overall Study|Not evaluable|2|||
94417897|NCT01370213|323315704|FG002|Overall Study|Not evaluable|0|||
94417898|NCT01355159|323315709|FG000|Overall Study|Withdrew consent|39|||
94417899|NCT01355159|323315710|FG001|Overall Study|Withdrew consent|47|||
94417900|NCT01355159|323315709|FG000|Overall Study|No primary outcome data|17|||
94417901|NCT01355159|323315710|FG001|Overall Study|No primary outcome data|11|||
94417902|NCT01355159|323315709|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
94417903|NCT01355159|323315710|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
94417904|NCT01355159|323315709|FG000|Overall Study|Early intrauterine fetal death|6|||
94417905|NCT01355159|323315710|FG001|Overall Study|Early intrauterine fetal death|6|||
94417906|NCT01338987|323315712|FG000|Overall Study|enrolled on new protocol|0|||
94417907|NCT01338987|323315713|FG001|Overall Study|enrolled on new protocol|0|||
94417908|NCT01338987|323315714|FG002|Overall Study|enrolled on new protocol|1|||
94417909|NCT01338987|323315715|FG003|Overall Study|enrolled on new protocol|0|||
94417910|NCT01338987|323315716|FG004|Overall Study|enrolled on new protocol|0|||
94417911|NCT01338987|323315712|FG000|Overall Study|Disease progression on study|2|||
94417912|NCT01338987|323315713|FG001|Overall Study|Disease progression on study|1|||
94417913|NCT01338987|323315714|FG002|Overall Study|Disease progression on study|1|||
94417914|NCT01338987|323315715|FG003|Overall Study|Disease progression on study|0|||
94417915|NCT01338987|323315716|FG004|Overall Study|Disease progression on study|0|||
94417916|NCT01640873|323315718|FG000|Overall Study|Protocol Violation|2|||
94417917|NCT01640873|323315719|FG001|Overall Study|Protocol Violation|1|||
94417918|NCT02357342|323315724|FG000|First 6 Months|Death|2|||
94417919|NCT02357342|323315725|FG001|First 6 Months|Death|0|||
94417920|NCT01189500|323315726|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
94417921|NCT01189500|323315726|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
94417922|NCT01560507|323315727|FG000|Overall Study|Lost to Follow-up|3|||
94417923|NCT01560507|323315728|FG001|Overall Study|Lost to Follow-up|1|||
94417924|NCT01560507|323315729|FG002|Overall Study|Lost to Follow-up|2|||
94417925|NCT01560507|323315727|FG000|Overall Study|Withdrawal by Subject|1|||
94417926|NCT01560507|323315728|FG001|Overall Study|Withdrawal by Subject|1|||
94417927|NCT01560507|323315729|FG002|Overall Study|Withdrawal by Subject|0|||
94417928|NCT00560937|323315730|FG000|Overall Study|Withdrawal by Subject|0|||
94417929|NCT00560937|323315731|FG001|Overall Study|Withdrawal by Subject|1|||
94417930|NCT00560937|323315730|FG000|Overall Study|Physician Decision|1|||
94417931|NCT00560937|323315731|FG001|Overall Study|Physician Decision|1|||
94417932|NCT01138111|323315732|FG000|Overall Study|Withdrawal by Subject|5|||
94417933|NCT01138111|323315732|FG000|Overall Study|Adverse Event|1|||
94417934|NCT01138111|323315732|FG000|Overall Study|Death|1|||
94417935|NCT01138111|323315732|FG000|Overall Study|Lost to Follow-up|2|||
94417936|NCT01000493|323315733|FG000|Overall Study|Adverse Event|3|||
94417937|NCT01000493|323315734|FG001|Overall Study|Adverse Event|6|||
94417938|NCT01000493|323315733|FG000|Overall Study|Lack of Efficacy|1|||
94417939|NCT01000493|323315734|FG001|Overall Study|Lack of Efficacy|1|||
94417940|NCT01000493|323315733|FG000|Overall Study|Protocol Violation|1|||
94417941|NCT01000493|323315734|FG001|Overall Study|Protocol Violation|8|||
94417942|NCT01000493|323315733|FG000|Overall Study|Study closed/terminated|25|||
94417943|NCT01000493|323315734|FG001|Overall Study|Study closed/terminated|23|||
94417944|NCT01000493|323315733|FG000|Overall Study|Lost to Follow-up|5|||
94417945|NCT01000493|323315734|FG001|Overall Study|Lost to Follow-up|9|||
94417946|NCT01000493|323315733|FG000|Overall Study|Physician Decision|1|||
94417947|NCT01000493|323315734|FG001|Overall Study|Physician Decision|1|||
94417948|NCT01000493|323315733|FG000|Overall Study|Withdrawal by Subject|3|||
94417949|NCT01000493|323315734|FG001|Overall Study|Withdrawal by Subject|7|||
94417950|NCT03545191|323315737|FG000|Overall Study|Death|1|||
94417951|NCT03545191|323315738|FG001|Overall Study|Death|0|||
94417952|NCT03545191|323315739|FG002|Overall Study|Death|0|||
94417953|NCT03545191|323315737|FG000|Overall Study|Adverse Event|4|||
94417954|NCT03545191|323315738|FG001|Overall Study|Adverse Event|2|||
94417955|NCT03545191|323315739|FG002|Overall Study|Adverse Event|7|||
94417956|NCT03545191|323315737|FG000|Overall Study|Other reasons|3|||
94417957|NCT03545191|323315738|FG001|Overall Study|Other reasons|11|||
94417958|NCT03545191|323315739|FG002|Overall Study|Other reasons|8|||
94417959|NCT03545191|323315737|FG000|Overall Study|Withdrawal by Subject|13|||
94417960|NCT03545191|323315738|FG001|Overall Study|Withdrawal by Subject|10|||
94417961|NCT03545191|323315739|FG002|Overall Study|Withdrawal by Subject|12|||
94417962|NCT03545191|323315737|FG000|Overall Study|Lost to Follow-up|1|||
94417963|NCT03545191|323315738|FG001|Overall Study|Lost to Follow-up|2|||
94417964|NCT03545191|323315739|FG002|Overall Study|Lost to Follow-up|3|||
94417965|NCT00702208|323315749|FG000|Overall Study|Lost to Follow-up|28|||
94417966|NCT00702208|323315749|FG000|Overall Study|Did not self-lavage|1|||
94417967|NCT00702208|323315749|FG000|Overall Study|Unsatisfactory colposcopy|2|||
94417968|NCT02687360|323315750|FG000|Overall Study|Withdrawal by Subject|3|||
94417969|NCT02687360|323315751|FG001|Overall Study|Withdrawal by Subject|0|||
94417970|NCT03456960|323315752|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
94417971|NCT03456960|323315753|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
94417972|NCT03456960|323315754|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
94417973|NCT03456960|323315755|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
94417974|NCT03456960|323315756|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
94417975|NCT03456960|323315757|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
94417976|NCT03456960|323315752|FG000|Period 2 (1 Day)|Adverse Event|1|||
94417977|NCT03456960|323315753|FG001|Period 2 (1 Day)|Adverse Event|0|||
94417978|NCT03456960|323315754|FG002|Period 2 (1 Day)|Adverse Event|0|||
94417979|NCT03456960|323315755|FG003|Period 2 (1 Day)|Adverse Event|1|||
94417980|NCT03456960|323315756|FG004|Period 2 (1 Day)|Adverse Event|0|||
94417981|NCT03456960|323315757|FG005|Period 2 (1 Day)|Adverse Event|0|||
94417982|NCT03828448|323315758|FG000|Overall Study|Sponsor's Discretion|34|||
94417983|NCT02037165|323315759|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
94417984|NCT02037165|323315760|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
94417985|NCT02037165|323315761|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
94417986|NCT02037165|323315762|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
94417987|NCT02037165|323315763|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
94417988|NCT04969861|323315764|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
94417989|NCT04969861|323315765|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
94417990|NCT01045421|323317155|FG000|Phase 1|Progressive Disease|0|||
94417991|NCT01045421|323317156|FG001|Phase 1|Progressive Disease|0|||
94417992|NCT01045421|323317157|FG002|Phase 1|Progressive Disease|0|||
94417993|NCT01045421|323317158|FG003|Phase 1|Progressive Disease|0|||
94417994|NCT01045421|323317159|FG004|Phase 1|Progressive Disease|1|||
94417995|NCT01045421|323317160|FG005|Phase 1|Progressive Disease|0|||
94417996|NCT01045421|323317161|FG006|Phase 1|Progressive Disease|0|||
94417997|NCT01045421|323317162|FG007|Phase 1|Progressive Disease|0|||
94417998|NCT01045421|323317163|FG008|Phase 1|Progressive Disease|0|||
94417999|NCT01045421|323317164|FG009|Phase 1|Progressive Disease|0|||
94418000|NCT01045421|323317165|FG010|Phase 1|Progressive Disease|0|||
94418001|NCT01045421|323317155|FG000|Phase 1|Withdrawal by Subject|0|||
94418002|NCT01045421|323317156|FG001|Phase 1|Withdrawal by Subject|0|||
94418003|NCT01045421|323317157|FG002|Phase 1|Withdrawal by Subject|0|||
94418004|NCT01045421|323317158|FG003|Phase 1|Withdrawal by Subject|1|||
94418005|NCT01045421|323317159|FG004|Phase 1|Withdrawal by Subject|0|||
94418006|NCT01045421|323317160|FG005|Phase 1|Withdrawal by Subject|0|||
94418007|NCT01045421|323317161|FG006|Phase 1|Withdrawal by Subject|0|||
94418008|NCT01045421|323317162|FG007|Phase 1|Withdrawal by Subject|0|||
94418009|NCT01045421|323317163|FG008|Phase 1|Withdrawal by Subject|0|||
94418010|NCT01045421|323317164|FG009|Phase 1|Withdrawal by Subject|0|||
94418011|NCT01045421|323317165|FG010|Phase 1|Withdrawal by Subject|0|||
94418012|NCT01045421|323317155|FG000|Phase 2|Progressive Disease|0|||
94418013|NCT01045421|323317156|FG001|Phase 2|Progressive Disease|0|||
94418014|NCT01045421|323317157|FG002|Phase 2|Progressive Disease|0|||
94418015|NCT01045421|323317158|FG003|Phase 2|Progressive Disease|0|||
94418016|NCT01045421|323317159|FG004|Phase 2|Progressive Disease|0|||
94418017|NCT01045421|323317160|FG005|Phase 2|Progressive Disease|0|||
94418018|NCT01045421|323317161|FG006|Phase 2|Progressive Disease|0|||
94418019|NCT01045421|323317162|FG007|Phase 2|Progressive Disease|1|||
94418020|NCT01045421|323317163|FG008|Phase 2|Progressive Disease|1|||
94418021|NCT01045421|323317164|FG009|Phase 2|Progressive Disease|1|||
94418022|NCT01045421|323317165|FG010|Phase 2|Progressive Disease|1|||
94418023|NCT01045421|323317155|FG000|Phase 2|Death|0|||
94418024|NCT01045421|323317156|FG001|Phase 2|Death|0|||
94418025|NCT01045421|323317157|FG002|Phase 2|Death|0|||
94418026|NCT01045421|323317158|FG003|Phase 2|Death|0|||
94418027|NCT01045421|323317159|FG004|Phase 2|Death|0|||
94418028|NCT01045421|323317160|FG005|Phase 2|Death|0|||
94418029|NCT01045421|323317161|FG006|Phase 2|Death|0|||
94418030|NCT01045421|323317162|FG007|Phase 2|Death|1|||
94418031|NCT01045421|323317163|FG008|Phase 2|Death|1|||
94418032|NCT01045421|323317164|FG009|Phase 2|Death|2|||
94418033|NCT01045421|323317165|FG010|Phase 2|Death|0|||
94418034|NCT01045421|323317155|FG000|Phase 2|Other|0|||
94418035|NCT01045421|323317156|FG001|Phase 2|Other|0|||
94418036|NCT01045421|323317157|FG002|Phase 2|Other|0|||
94418037|NCT01045421|323317158|FG003|Phase 2|Other|0|||
94418038|NCT01045421|323317159|FG004|Phase 2|Other|0|||
94418039|NCT01045421|323317160|FG005|Phase 2|Other|0|||
94418040|NCT01045421|323317161|FG006|Phase 2|Other|0|||
94418041|NCT01045421|323317162|FG007|Phase 2|Other|3|||
94418042|NCT01045421|323317163|FG008|Phase 2|Other|0|||
94418043|NCT01045421|323317164|FG009|Phase 2|Other|0|||
94418044|NCT01045421|323317165|FG010|Phase 2|Other|1|||
94418045|NCT03340064|323317166|FG000|First Period|Adverse Event, non-fatal|2|||
94418046|NCT03340064|323317167|FG001|First Period|Adverse Event, non-fatal|0|||
94418047|NCT03340064|323317166|FG000|First Period|Lack of Efficacy|3|||
94418048|NCT03340064|323317167|FG001|First Period|Lack of Efficacy|0|||
94418049|NCT03340064|323317166|FG000|Second Period|Adverse Event, non-fatal|1|||
94418050|NCT03340064|323317167|FG001|Second Period|Adverse Event, non-fatal|1|||
94418051|NCT03340064|323317166|FG000|Second Period|Lack of Efficacy|11|||
94418052|NCT03340064|323317167|FG001|Second Period|Lack of Efficacy|0|||
94418053|NCT03340064|323317166|FG000|Second Period|Physician Decision|3|||
94418054|NCT03340064|323317167|FG001|Second Period|Physician Decision|0|||
94418055|NCT03340064|323317166|FG000|Second Period|Withdrawal by Subject|2|||
94418056|NCT03340064|323317167|FG001|Second Period|Withdrawal by Subject|1|||
94418057|NCT03340064|323317166|FG000|Second Period|Approved Drug Available For Indication|1|||
94418058|NCT03340064|323317167|FG001|Second Period|Approved Drug Available For Indication|0|||
94488753|NCT02915835|323583517|FG000|Overall Study|Withdrawal by Subject|0|||
94488754|NCT02915835|323583518|FG001|Overall Study|Withdrawal by Subject|1|||
94488755|NCT01184872|323583519|FG000|Overall Study|Adverse Event|3|||
94418059|NCT03340064|323317166|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
94418060|NCT03340064|323317167|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
94418061|NCT02177136|323317181|FG000|DB Phase|Withdrawal by Subject|2|||
94418062|NCT02177136|323317182|FG001|DB Phase|Withdrawal by Subject|0|||
94418063|NCT02177136|323317183|FG002|DB Phase|Withdrawal by Subject|0|||
94418064|NCT02177136|323317184|FG003|DB Phase|Withdrawal by Subject|0|||
94488756|NCT01184872|323583520|FG001|Overall Study|Adverse Event|4|||
94418065|NCT02177136|323317181|FG000|DB Phase|Discontinued Due to Pruritus|1|||
94418066|NCT02177136|323317182|FG001|DB Phase|Discontinued Due to Pruritus|3|||
94418067|NCT02177136|323317183|FG002|DB Phase|Discontinued Due to Pruritus|0|||
94418068|NCT02177136|323317184|FG003|DB Phase|Discontinued Due to Pruritus|0|||
94418069|NCT02177136|323317181|FG000|DB Phase|Adverse Event|3|||
94418070|NCT02177136|323317182|FG001|DB Phase|Adverse Event|2|||
94418071|NCT02177136|323317183|FG002|DB Phase|Adverse Event|3|||
94418072|NCT02177136|323317184|FG003|DB Phase|Adverse Event|0|||
94418073|NCT02177136|323317181|FG000|DB Phase|Protocol Violation|0|||
94418074|NCT02177136|323317182|FG001|DB Phase|Protocol Violation|0|||
94488757|NCT01184872|323583519|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
94418075|NCT02177136|323317183|FG002|DB Phase|Protocol Violation|1|||
94418076|NCT02177136|323317184|FG003|DB Phase|Protocol Violation|0|||
94418077|NCT02177136|323317181|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
94418078|NCT02177136|323317182|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
94418079|NCT02177136|323317183|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
94418080|NCT02177136|323317184|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
94418081|NCT02177136|323317181|FG000|LTSE Phase|Withdrawal by Subject|0|||
94418082|NCT02177136|323317182|FG001|LTSE Phase|Withdrawal by Subject|0|||
94418083|NCT02177136|323317183|FG002|LTSE Phase|Withdrawal by Subject|0|||
94418084|NCT02177136|323317184|FG003|LTSE Phase|Withdrawal by Subject|6|||
94418085|NCT02177136|323317181|FG000|LTSE Phase|Adverse Event|0|||
94418086|NCT02177136|323317182|FG001|LTSE Phase|Adverse Event|0|||
94418087|NCT02177136|323317183|FG002|LTSE Phase|Adverse Event|0|||
94418088|NCT02177136|323317184|FG003|LTSE Phase|Adverse Event|10|||
94418089|NCT02177136|323317181|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
94418090|NCT02177136|323317182|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
94418091|NCT02177136|323317183|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
94418092|NCT02177136|323317184|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
94418093|NCT02177136|323317181|FG000|LTSE Phase|Physician Decision|0|||
94418094|NCT02177136|323317182|FG001|LTSE Phase|Physician Decision|0|||
94418095|NCT02177136|323317183|FG002|LTSE Phase|Physician Decision|0|||
94418096|NCT02177136|323317184|FG003|LTSE Phase|Physician Decision|2|||
94418097|NCT02177136|323317181|FG000|LTSE Phase|Lost to Follow-up|0|||
94418098|NCT02177136|323317182|FG001|LTSE Phase|Lost to Follow-up|0|||
94418099|NCT02177136|323317183|FG002|LTSE Phase|Lost to Follow-up|0|||
94418100|NCT02177136|323317184|FG003|LTSE Phase|Lost to Follow-up|1|||
94418101|NCT02177136|323317181|FG000|LTSE Phase|Participant Moved|0|||
94418102|NCT02177136|323317182|FG001|LTSE Phase|Participant Moved|0|||
94418103|NCT02177136|323317183|FG002|LTSE Phase|Participant Moved|0|||
94418104|NCT02177136|323317184|FG003|LTSE Phase|Participant Moved|1|||
94418105|NCT02054130|323317185|FG000|Overall Study|Withdrawal by Subject|4|||
94418106|NCT02054130|323317186|FG001|Overall Study|Withdrawal by Subject|4|||
94418107|NCT02054130|323317187|FG002|Overall Study|Withdrawal by Subject|7|||
94418108|NCT02054130|323317188|FG003|Overall Study|Withdrawal by Subject|10|||
94418109|NCT02054130|323317185|FG000|Overall Study|Death|0|||
94418110|NCT02054130|323317186|FG001|Overall Study|Death|1|||
94418111|NCT02054130|323317187|FG002|Overall Study|Death|0|||
94418112|NCT02054130|323317188|FG003|Overall Study|Death|0|||
94418113|NCT02054130|323317185|FG000|Overall Study|Lost to Follow-up|0|||
94418114|NCT02054130|323317186|FG001|Overall Study|Lost to Follow-up|0|||
94418115|NCT02054130|323317187|FG002|Overall Study|Lost to Follow-up|1|||
94418116|NCT02054130|323317188|FG003|Overall Study|Lost to Follow-up|2|||
94418117|NCT02054130|323317185|FG000|Overall Study|Missed dose|4|||
94418118|NCT02054130|323317186|FG001|Overall Study|Missed dose|6|||
94418119|NCT02054130|323317187|FG002|Overall Study|Missed dose|7|||
94418120|NCT02054130|323317188|FG003|Overall Study|Missed dose|10|||
94418121|NCT00619112|323317189|FG000|Overall Study|Adverse Event|1|||
94418122|NCT00619112|323317190|FG001|Overall Study|Adverse Event|2|||
94418123|NCT01570283|323317195|FG000|Cohort 1: Dose Level 1|Death|0|||
94418124|NCT01570283|323317196|FG001|Cohort 1: Dose Level 1|Death|1|||
94418125|NCT01570283|323317197|FG002|Cohort 1: Dose Level 1|Death|0|||
94418126|NCT01570283|323317198|FG003|Cohort 1: Dose Level 1|Death|0|||
94418127|NCT01570283|323317199|FG004|Cohort 1: Dose Level 1|Death|0|||
94418128|NCT01570283|323317200|FG005|Cohort 1: Dose Level 1|Death|0|||
94418129|NCT01570283|323317195|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
94418130|NCT01570283|323317196|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
94418131|NCT01570283|323317197|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
94418132|NCT01570283|323317198|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
94418133|NCT01570283|323317199|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
94418134|NCT01570283|323317200|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
94418135|NCT01570283|323317195|FG000|Cohort 2: Dose Level 2|Death|0|||
94418136|NCT01570283|323317196|FG001|Cohort 2: Dose Level 2|Death|0|||
94418137|NCT01570283|323317197|FG002|Cohort 2: Dose Level 2|Death|1|||
94418138|NCT01570283|323317198|FG003|Cohort 2: Dose Level 2|Death|0|||
94418139|NCT01570283|323317199|FG004|Cohort 2: Dose Level 2|Death|0|||
94418140|NCT01570283|323317200|FG005|Cohort 2: Dose Level 2|Death|0|||
94418141|NCT01570283|323317195|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
94418142|NCT01570283|323317196|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
94418143|NCT01570283|323317197|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
94418144|NCT01570283|323317198|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
94418145|NCT01570283|323317199|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
94418146|NCT01570283|323317200|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
94488758|NCT01184872|323583520|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
94418147|NCT01570283|323317195|FG000|Cohort 3: Dose Level 3|Death|0|||
94418148|NCT01570283|323317196|FG001|Cohort 3: Dose Level 3|Death|0|||
94418149|NCT01570283|323317197|FG002|Cohort 3: Dose Level 3|Death|0|||
94418150|NCT01570283|323317198|FG003|Cohort 3: Dose Level 3|Death|0|||
94418151|NCT01570283|323317199|FG004|Cohort 3: Dose Level 3|Death|0|||
94418152|NCT01570283|323317200|FG005|Cohort 3: Dose Level 3|Death|1|||
94418153|NCT01570283|323317195|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
94418154|NCT01570283|323317196|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
94418155|NCT01570283|323317197|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
94418156|NCT01570283|323317198|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
94418157|NCT01570283|323317199|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
94418158|NCT01570283|323317200|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
94418159|NCT00841906|323317201|FG000|Overall Study|Withdrawal by Subject|2|||
94418160|NCT00841906|323317202|FG001|Overall Study|Withdrawal by Subject|0|||
94418161|NCT02072148|323317203|FG000|Overall Study|withdrew prior to surgery|23|||
94418162|NCT02072148|323317204|FG001|Overall Study|withdrew prior to surgery|0|||
94418163|NCT02072148|323317205|FG002|Overall Study|withdrew prior to surgery|0|||
94418164|NCT02072148|323317203|FG000|Overall Study|Death|0|||
94418165|NCT02072148|323317204|FG001|Overall Study|Death|0|||
94418166|NCT02072148|323317205|FG002|Overall Study|Death|1|||
94418167|NCT02072148|323317203|FG000|Overall Study|Withdrawal by Subject|0|||
94418168|NCT02072148|323317204|FG001|Overall Study|Withdrawal by Subject|13|||
94418169|NCT02072148|323317205|FG002|Overall Study|Withdrawal by Subject|12|||
94418170|NCT00430495|323317207|FG000|Overall Study|Adverse Event|2|||
94418171|NCT00430495|323317208|FG001|Overall Study|Adverse Event|3|||
94418172|NCT00430495|323317209|FG002|Overall Study|Adverse Event|2|||
94418173|NCT00430495|323317210|FG003|Overall Study|Adverse Event|0|||
94418174|NCT00430495|323317207|FG000|Overall Study|Death|0|||
94418175|NCT00430495|323317208|FG001|Overall Study|Death|0|||
94418176|NCT00430495|323317209|FG002|Overall Study|Death|1|||
94418177|NCT00430495|323317210|FG003|Overall Study|Death|0|||
94418178|NCT00430495|323317207|FG000|Overall Study|Lost to Follow-up|0|||
94418179|NCT00430495|323317208|FG001|Overall Study|Lost to Follow-up|1|||
94418180|NCT00430495|323317209|FG002|Overall Study|Lost to Follow-up|4|||
94418181|NCT00430495|323317210|FG003|Overall Study|Lost to Follow-up|0|||
94418182|NCT00430495|323317207|FG000|Overall Study|Protocol Violation|1|||
94418183|NCT00430495|323317208|FG001|Overall Study|Protocol Violation|0|||
94488759|NCT01184872|323583519|FG000|Overall Study|Withdrawal by Subject|2|||
94488760|NCT01184872|323583520|FG001|Overall Study|Withdrawal by Subject|0|||
94488761|NCT01184872|323583519|FG000|Overall Study|Lost to Follow-up|0|||
94488762|NCT01184872|323583520|FG001|Overall Study|Lost to Follow-up|1|||
94488763|NCT01184872|323583519|FG000|Overall Study|Administrative problems|1|||
94488764|NCT01184872|323583520|FG001|Overall Study|Administrative problems|1|||
94488765|NCT01184872|323583519|FG000|Overall Study|Protocol deviation|1|||
94488766|NCT01184872|323583520|FG001|Overall Study|Protocol deviation|0|||
94488767|NCT02111083|323583521|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
94488768|NCT02111083|323583522|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
94488769|NCT00116142|323583523|FG000|Overall Study|Adverse Event|8|||
94488770|NCT00116142|323583524|FG001|Overall Study|Adverse Event|7|||
94488771|NCT00116142|323583523|FG000|Overall Study|Protocol Violation|2|||
94488772|NCT00116142|323583524|FG001|Overall Study|Protocol Violation|1|||
94418184|NCT00430495|323317209|FG002|Overall Study|Protocol Violation|1|||
94418185|NCT00430495|323317210|FG003|Overall Study|Protocol Violation|0|||
94418186|NCT00430495|323317207|FG000|Overall Study|Disease Progression|1|||
94418187|NCT00430495|323317208|FG001|Overall Study|Disease Progression|1|||
94418188|NCT00430495|323317209|FG002|Overall Study|Disease Progression|0|||
94418189|NCT00430495|323317210|FG003|Overall Study|Disease Progression|0|||
94418190|NCT00430495|323317207|FG000|Overall Study|Other|8|||
94418191|NCT00430495|323317208|FG001|Overall Study|Other|2|||
94488773|NCT00116142|323583523|FG000|Overall Study|Withdrawal by Subject|5|||
94488774|NCT00116142|323583524|FG001|Overall Study|Withdrawal by Subject|5|||
94418192|NCT00430495|323317209|FG002|Overall Study|Other|5|||
94418193|NCT00430495|323317210|FG003|Overall Study|Other|4|||
94418194|NCT00430495|323317207|FG000|Overall Study|Randomized but not Treated|2|||
94418195|NCT00430495|323317208|FG001|Overall Study|Randomized but not Treated|0|||
94488775|NCT00116142|323583523|FG000|Overall Study|Physician Decision|3|||
94488776|NCT00116142|323583524|FG001|Overall Study|Physician Decision|1|||
94418196|NCT00430495|323317209|FG002|Overall Study|Randomized but not Treated|0|||
94418197|NCT00430495|323317210|FG003|Overall Study|Randomized but not Treated|0|||
94418198|NCT02751359|323317215|FG000|Overall Study|Lost to Follow-up|1|||
94418199|NCT01421342|323317218|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
94488777|NCT00116142|323583523|FG000|Overall Study|Delayed Radiation Therapy|1|||
94488778|NCT00116142|323583524|FG001|Overall Study|Delayed Radiation Therapy|0|||
94418200|NCT01421342|323317219|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
94418201|NCT01421342|323317220|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
94418202|NCT01421342|323317218|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
94488779|NCT00116142|323583523|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
94418203|NCT01421342|323317219|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
94418204|NCT01421342|323317220|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
94418205|NCT01421342|323317218|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
94418206|NCT01421342|323317219|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
94488780|NCT00116142|323583524|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
94418207|NCT01421342|323317220|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
94418208|NCT01421342|323317218|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
94418209|NCT01421342|323317219|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
94418210|NCT01421342|323317220|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
94418211|NCT01421342|323317218|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
94418212|NCT01421342|323317219|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
94418213|NCT01421342|323317220|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
94418214|NCT01421342|323317218|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
94418215|NCT01421342|323317219|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
94418216|NCT01421342|323317220|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
94418217|NCT01421342|323317218|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
94418218|NCT01421342|323317219|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
94418219|NCT01421342|323317220|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
94418220|NCT01421342|323317218|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
94418221|NCT01421342|323317219|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
94418222|NCT01421342|323317220|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
94418223|NCT01421342|323317218|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
94418224|NCT01421342|323317219|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
94418225|NCT01421342|323317220|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
94418226|NCT01421342|323317218|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
94418227|NCT01421342|323317219|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
94418228|NCT01421342|323317220|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
94418229|NCT01421342|323317218|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
94418230|NCT01421342|323317219|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
94418231|NCT01421342|323317220|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
94418232|NCT01421342|323317218|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
94418233|NCT01421342|323317219|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
94418234|NCT01421342|323317220|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
94418235|NCT01421342|323317218|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
94418236|NCT01421342|323317219|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
94418237|NCT01421342|323317220|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
94418238|NCT01421342|323317218|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
94418239|NCT01421342|323317219|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
94418240|NCT01421342|323317220|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
94418241|NCT01421342|323317218|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
94418242|NCT01421342|323317219|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
94418243|NCT01421342|323317220|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
94418244|NCT01421342|323317218|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
94418245|NCT01421342|323317219|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
94418246|NCT01421342|323317220|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
94418247|NCT01421342|323317218|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
94418248|NCT01421342|323317219|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
94418249|NCT01421342|323317220|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
94418250|NCT01421342|323317218|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
94418251|NCT01421342|323317219|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
94418252|NCT01421342|323317220|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
94418253|NCT01421342|323317218|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
94418254|NCT01421342|323317219|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
94418255|NCT01421342|323317220|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
94418256|NCT01421342|323317218|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
94418257|NCT01421342|323317219|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
94418258|NCT01421342|323317220|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
94418259|NCT01421342|323317218|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
94418260|NCT01421342|323317219|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
94418261|NCT01421342|323317220|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
94418262|NCT01421342|323317218|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
94418263|NCT01421342|323317219|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
94418264|NCT01421342|323317220|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
94418265|NCT01421342|323317218|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
94418266|NCT01421342|323317219|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
94418267|NCT01421342|323317220|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
94418268|NCT01421342|323317218|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
94418269|NCT01421342|323317219|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
94418270|NCT01421342|323317220|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
94418271|NCT01421342|323317218|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
94418272|NCT01421342|323317219|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
94418273|NCT01421342|323317220|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
94418274|NCT01421342|323317218|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
94418275|NCT01421342|323317219|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
94418276|NCT01421342|323317220|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
94418277|NCT01421342|323317218|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
94418278|NCT01421342|323317219|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
94418279|NCT01421342|323317220|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
94418280|NCT01421342|323317218|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
94418281|NCT01421342|323317219|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
94418282|NCT01421342|323317220|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
94418283|NCT03578237|323317223|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
94418284|NCT03578237|323317224|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
94418285|NCT03921151|323317225|FG000|Overall Study|Withdrawal by Subject|11|||
94418286|NCT03921151|323317226|FG001|Overall Study|Withdrawal by Subject|16|||
94418287|NCT02017860|323317230|FG000|Overall Study|Adverse Event|1|||
94418288|NCT02017860|323317230|FG000|Overall Study|Withdrawal by Subject|1|||
94418289|NCT02488330|323317231|FG000|Overall Study|Adverse Event|1|||
94418290|NCT02488330|323317231|FG000|Overall Study|Physician Decision|2|||
94418291|NCT02488330|323317231|FG000|Overall Study|Death|2|||
94418292|NCT02488330|323317231|FG000|Overall Study|Disease Progression|3|||
94418293|NCT02488330|323317231|FG000|Overall Study|Study Termination by Sponsor|4|||
94418294|NCT03052322|323317233|FG000|Overall Study|Other un-specified|1|||
94418295|NCT03052322|323317234|FG001|Overall Study|Other un-specified|2|||
94418296|NCT03052322|323317233|FG000|Overall Study|Withdrawal by Subject|10|||
94418297|NCT03052322|323317234|FG001|Overall Study|Withdrawal by Subject|9|||
94418298|NCT03052322|323317233|FG000|Overall Study|Death|0|||
94418299|NCT03052322|323317234|FG001|Overall Study|Death|2|||
94418300|NCT03052322|323317233|FG000|Overall Study|Lack of Efficacy|1|||
94418301|NCT03052322|323317234|FG001|Overall Study|Lack of Efficacy|2|||
94418302|NCT03052322|323317233|FG000|Overall Study|Protocol Violation|1|||
94418303|NCT03052322|323317234|FG001|Overall Study|Protocol Violation|0|||
94418304|NCT03052322|323317233|FG000|Overall Study|Lost to Follow-up|2|||
94418305|NCT03052322|323317234|FG001|Overall Study|Lost to Follow-up|4|||
94418306|NCT03052322|323317233|FG000|Overall Study|Adverse Event|6|||
94418307|NCT03052322|323317234|FG001|Overall Study|Adverse Event|13|||
94418308|NCT00289874|323317238|FG000|Overall Study|Adverse Event|1|||
94418309|NCT00289874|323317239|FG001|Overall Study|Adverse Event|5|||
94418310|NCT00289874|323317238|FG000|Overall Study|Lost to Follow-up|1|||
94418311|NCT00289874|323317239|FG001|Overall Study|Lost to Follow-up|1|||
94418312|NCT00289874|323317238|FG000|Overall Study|Protocol Violation|3|||
94418313|NCT00289874|323317239|FG001|Overall Study|Protocol Violation|2|||
94418314|NCT00289874|323317238|FG000|Overall Study|Did not meet eligibility|1|||
94418315|NCT00289874|323317239|FG001|Overall Study|Did not meet eligibility|0|||
94418316|NCT03835325|323317240|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
94418317|NCT03835325|323317240|FG000|Overall Study|Selection failure|1|||
94418318|NCT02138136|323317241|FG000|Overall Study|Protocol Violation|4|||
94418319|NCT02138136|323317241|FG000|Overall Study|Physician Decision|7|||
94418320|NCT02138136|323317241|FG000|Overall Study|Lack of Efficacy|35|||
94418321|NCT02138136|323317241|FG000|Overall Study|Pregnancy|2|||
94418322|NCT02138136|323317241|FG000|Overall Study|Adverse Event|18|||
94418323|NCT02138136|323317241|FG000|Overall Study|Withdrawal by Subject|36|||
94418324|NCT02138136|323317241|FG000|Overall Study|Lost to Follow-up|32|||
94418325|NCT02138136|323317241|FG000|Overall Study|Withdrawn by Sponsor|5|||
94418326|NCT01621191|323317242|FG000|Overall Study|Adverse Event|9|||
94418327|NCT01621191|323317242|FG000|Overall Study|Withdrawal by Subject|8|||
94418328|NCT01621191|323317242|FG000|Overall Study|Lack of Efficacy|6|||
94418329|NCT01621191|323317242|FG000|Overall Study|Lost to Follow-up|1|||
94418330|NCT01621191|323317242|FG000|Overall Study|Site Removed From Study|1|||
94418331|NCT05304611|323317245|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
94418332|NCT05304611|323317246|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
94418333|NCT05304611|323317247|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
94418334|NCT05304611|323317248|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
94488781|NCT00116142|323583523|FG000|Overall Study|Patient stopped due to depression|0|||
94418335|NCT05304611|323317249|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
94418336|NCT05304611|323317250|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
94418337|NCT05304611|323317251|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
94418338|NCT05304611|323317252|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
94418339|NCT05304611|323317253|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
94418340|NCT05304611|323317245|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
94418341|NCT05304611|323317246|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
94418342|NCT05304611|323317247|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
94418343|NCT05304611|323317248|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
94418344|NCT05304611|323317249|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
94418345|NCT05304611|323317250|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
94418346|NCT05304611|323317251|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
94418347|NCT05304611|323317252|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
94418348|NCT05304611|323317253|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
94418349|NCT00706381|323317254|FG000|Overall Study|Lost to Follow-up|0|||
94418350|NCT00706381|323317255|FG001|Overall Study|Lost to Follow-up|1|||
94418351|NCT00706381|323317256|FG002|Overall Study|Lost to Follow-up|1|||
94418352|NCT00706381|323317257|FG003|Overall Study|Lost to Follow-up|0|||
94418353|NCT00038649|323317260|FG000|Overall Study|Adverse Event|9|||
94418354|NCT00430950|323317269|FG000|Overall Study|Adverse Event|7|||
94418355|NCT00430950|323317270|FG001|Overall Study|Adverse Event|6|||
94418356|NCT00430950|323317269|FG000|Overall Study|Withdrawal by Subject|1|||
94418357|NCT00430950|323317270|FG001|Overall Study|Withdrawal by Subject|0|||
94418358|NCT00430950|323317269|FG000|Overall Study|concomitant medication,etc.|5|||
94418359|NCT00430950|323317270|FG001|Overall Study|concomitant medication,etc.|7|||
94418360|NCT02080832|323317272|FG000|Overall Study|Excluded from analysis by MRI|9|||
94418361|NCT02080832|323317273|FG001|Overall Study|Excluded from analysis by MRI|10|||
94418362|NCT02080832|323317274|FG002|Overall Study|Excluded from analysis by MRI|14|||
94418363|NCT02080832|323317272|FG000|Overall Study|Lost to Follow-up|0|||
94418364|NCT02080832|323317273|FG001|Overall Study|Lost to Follow-up|2|||
94418365|NCT02080832|323317274|FG002|Overall Study|Lost to Follow-up|2|||
94418366|NCT01524913|323317277|FG000|Overall Study|Lost to Follow-up|4|||
94418367|NCT01524913|323317278|FG001|Overall Study|Lost to Follow-up|0|||
94418368|NCT01524913|323317279|FG002|Overall Study|Lost to Follow-up|0|||
94418369|NCT01846273|323317280|FG000|Overall Study|Adverse Event|9|||
94418370|NCT01846273|323317281|FG001|Overall Study|Adverse Event|7|||
94418371|NCT01846273|323317282|FG002|Overall Study|Adverse Event|0|||
94418372|NCT01846273|323317280|FG000|Overall Study|Subject withdrew consent|5|||
94418373|NCT01846273|323317281|FG001|Overall Study|Subject withdrew consent|8|||
94418374|NCT01846273|323317282|FG002|Overall Study|Subject withdrew consent|0|||
94418375|NCT01846273|323317280|FG000|Overall Study|Lost to Follow-up|2|||
94418376|NCT01846273|323317281|FG001|Overall Study|Lost to Follow-up|1|||
94418377|NCT01846273|323317282|FG002|Overall Study|Lost to Follow-up|0|||
94418378|NCT01846273|323317280|FG000|Overall Study|Administrative problems|1|||
94418379|NCT01846273|323317281|FG001|Overall Study|Administrative problems|0|||
94418380|NCT01846273|323317282|FG002|Overall Study|Administrative problems|0|||
94418381|NCT01846273|323317280|FG000|Overall Study|Death|2|||
94418382|NCT01846273|323317281|FG001|Overall Study|Death|1|||
94418383|NCT01846273|323317282|FG002|Overall Study|Death|0|||
94418384|NCT01846273|323317280|FG000|Overall Study|Disease Progression|0|||
94418385|NCT01846273|323317281|FG001|Overall Study|Disease Progression|4|||
94418386|NCT01846273|323317282|FG002|Overall Study|Disease Progression|0|||
94418387|NCT01846273|323317280|FG000|Overall Study|Protocol Deviation|2|||
94418388|NCT01846273|323317281|FG001|Overall Study|Protocol Deviation|3|||
94418389|NCT01846273|323317282|FG002|Overall Study|Protocol Deviation|0|||
94418390|NCT01846273|323317280|FG000|Overall Study|Physician Decision|1|||
94418391|NCT01846273|323317281|FG001|Overall Study|Physician Decision|2|||
94418392|NCT01846273|323317282|FG002|Overall Study|Physician Decision|0|||
94418393|NCT00891839|323317283|FG000|Overall Study|Adverse Event|2|||
94418394|NCT00891839|323317283|FG000|Overall Study|Withdrawal by Subject|2|||
94418395|NCT00891839|323317283|FG000|Overall Study|Disease progression|3|||
94418396|NCT00750308|323317284|FG000|First Treatment|Adverse Event|0|||
94418397|NCT00750308|323317285|FG001|First Treatment|Adverse Event|1|||
94418398|NCT00750308|323317286|FG002|First Treatment|Adverse Event|0|||
94418399|NCT00750308|323317287|FG003|First Treatment|Adverse Event|0|||
94418400|NCT00750308|323317288|FG004|First Treatment|Adverse Event|0|||
94418401|NCT00750308|323317289|FG005|First Treatment|Adverse Event|0|||
94418402|NCT00750308|323317290|FG006|First Treatment|Adverse Event|0|||
94418403|NCT00750308|323317291|FG007|First Treatment|Adverse Event|0|||
94418404|NCT00750308|323317292|FG008|First Treatment|Adverse Event|0|||
94418405|NCT00750308|323317293|FG009|First Treatment|Adverse Event|0|||
94418406|NCT00750308|323317294|FG010|First Treatment|Adverse Event|1|||
94418407|NCT00750308|323317295|FG011|First Treatment|Adverse Event|1|||
94418408|NCT00750308|323317284|FG000|First Treatment|Withdrawal by Subject|0|||
94418409|NCT00750308|323317285|FG001|First Treatment|Withdrawal by Subject|0|||
94418410|NCT00750308|323317286|FG002|First Treatment|Withdrawal by Subject|0|||
94418411|NCT00750308|323317287|FG003|First Treatment|Withdrawal by Subject|1|||
94418412|NCT00750308|323317288|FG004|First Treatment|Withdrawal by Subject|0|||
94418413|NCT00750308|323317289|FG005|First Treatment|Withdrawal by Subject|0|||
94418414|NCT00750308|323317290|FG006|First Treatment|Withdrawal by Subject|0|||
94418415|NCT00750308|323317291|FG007|First Treatment|Withdrawal by Subject|1|||
94418416|NCT00750308|323317292|FG008|First Treatment|Withdrawal by Subject|0|||
94418417|NCT00750308|323317293|FG009|First Treatment|Withdrawal by Subject|0|||
94418418|NCT00750308|323317294|FG010|First Treatment|Withdrawal by Subject|0|||
94418419|NCT00750308|323317295|FG011|First Treatment|Withdrawal by Subject|0|||
94418420|NCT00750308|323317284|FG000|Second Treatment|Adverse Event|0|||
94418421|NCT00750308|323317285|FG001|Second Treatment|Adverse Event|0|||
94418422|NCT00750308|323317286|FG002|Second Treatment|Adverse Event|0|||
94418423|NCT00750308|323317287|FG003|Second Treatment|Adverse Event|0|||
94418424|NCT00750308|323317288|FG004|Second Treatment|Adverse Event|0|||
94418425|NCT00750308|323317289|FG005|Second Treatment|Adverse Event|1|||
94418426|NCT00750308|323317290|FG006|Second Treatment|Adverse Event|0|||
94418427|NCT00750308|323317291|FG007|Second Treatment|Adverse Event|0|||
94418428|NCT00750308|323317292|FG008|Second Treatment|Adverse Event|1|||
94418429|NCT00750308|323317293|FG009|Second Treatment|Adverse Event|0|||
94418430|NCT00750308|323317294|FG010|Second Treatment|Adverse Event|0|||
94418431|NCT00750308|323317295|FG011|Second Treatment|Adverse Event|0|||
94418432|NCT00750308|323317284|FG000|Second Treatment|Withdrawal by Subject|0|||
94418433|NCT00750308|323317285|FG001|Second Treatment|Withdrawal by Subject|0|||
94418434|NCT00750308|323317286|FG002|Second Treatment|Withdrawal by Subject|0|||
94418435|NCT00750308|323317287|FG003|Second Treatment|Withdrawal by Subject|0|||
94418436|NCT00750308|323317288|FG004|Second Treatment|Withdrawal by Subject|1|||
94418437|NCT00750308|323317289|FG005|Second Treatment|Withdrawal by Subject|0|||
94418438|NCT00750308|323317290|FG006|Second Treatment|Withdrawal by Subject|0|||
94418439|NCT00750308|323317291|FG007|Second Treatment|Withdrawal by Subject|0|||
94418440|NCT00750308|323317292|FG008|Second Treatment|Withdrawal by Subject|0|||
94418441|NCT00750308|323317293|FG009|Second Treatment|Withdrawal by Subject|0|||
94418442|NCT00750308|323317294|FG010|Second Treatment|Withdrawal by Subject|0|||
94418443|NCT00750308|323317295|FG011|Second Treatment|Withdrawal by Subject|0|||
94418444|NCT00750308|323317284|FG000|Third Treatment|Withdrawal by Subject|0|||
94418445|NCT00750308|323317285|FG001|Third Treatment|Withdrawal by Subject|1|||
94418446|NCT00750308|323317286|FG002|Third Treatment|Withdrawal by Subject|0|||
94418447|NCT00750308|323317287|FG003|Third Treatment|Withdrawal by Subject|0|||
94418448|NCT00750308|323317288|FG004|Third Treatment|Withdrawal by Subject|0|||
94418449|NCT00750308|323317289|FG005|Third Treatment|Withdrawal by Subject|0|||
94418450|NCT00750308|323317290|FG006|Third Treatment|Withdrawal by Subject|0|||
94418451|NCT00750308|323317291|FG007|Third Treatment|Withdrawal by Subject|0|||
94418452|NCT00750308|323317292|FG008|Third Treatment|Withdrawal by Subject|0|||
94418453|NCT00750308|323317293|FG009|Third Treatment|Withdrawal by Subject|0|||
94418454|NCT00750308|323317294|FG010|Third Treatment|Withdrawal by Subject|0|||
94418455|NCT00750308|323317295|FG011|Third Treatment|Withdrawal by Subject|0|||
94418456|NCT01698775|323317298|FG000|Phase A|Adverse Event|2|||
94418457|NCT01698775|323317299|FG001|Phase A|Adverse Event|1|||
94418458|NCT01698775|323317298|FG000|Phase A|Death|1|||
94418459|NCT01698775|323317299|FG001|Phase A|Death|1|||
94418460|NCT01698775|323317298|FG000|Phase A|Lack of Efficacy|1|||
94418461|NCT01698775|323317299|FG001|Phase A|Lack of Efficacy|0|||
94418462|NCT01698775|323317298|FG000|Phase A|Lost to Follow-up|1|||
94418463|NCT01698775|323317299|FG001|Phase A|Lost to Follow-up|2|||
94418464|NCT01698775|323317298|FG000|Phase A|Protocol Violation|1|||
94418465|NCT01698775|323317299|FG001|Phase A|Protocol Violation|0|||
94418466|NCT01698775|323317298|FG000|Phase A|Withdrawal by Subject|3|||
94418467|NCT01698775|323317299|FG001|Phase A|Withdrawal by Subject|4|||
94418468|NCT01698775|323317298|FG000|Phase A|Kidney [transplant]|0|||
94418469|NCT01698775|323317299|FG001|Phase A|Kidney [transplant]|1|||
94418470|NCT01698775|323317298|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
94418471|NCT01698775|323317299|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
94418472|NCT01698775|323317298|FG000|Phase B|Adverse Event|6|||
94418473|NCT01698775|323317299|FG001|Phase B|Adverse Event|3|||
94418474|NCT01698775|323317298|FG000|Phase B|Death|0|||
94418475|NCT01698775|323317299|FG001|Phase B|Death|1|||
94418476|NCT01698775|323317298|FG000|Phase B|Lack of Efficacy|0|||
94418477|NCT01698775|323317299|FG001|Phase B|Lack of Efficacy|1|||
94418478|NCT01698775|323317298|FG000|Phase B|Lost to Follow-up|0|||
94418479|NCT01698775|323317299|FG001|Phase B|Lost to Follow-up|1|||
94418480|NCT01698775|323317298|FG000|Phase B|Physician Decision|1|||
94418481|NCT01698775|323317299|FG001|Phase B|Physician Decision|1|||
94418482|NCT01698775|323317298|FG000|Phase B|Protocol Violation|1|||
94418483|NCT01698775|323317299|FG001|Phase B|Protocol Violation|1|||
94418484|NCT01698775|323317298|FG000|Phase B|Withdrawal by Subject|6|||
94418485|NCT01698775|323317299|FG001|Phase B|Withdrawal by Subject|2|||
94418486|NCT02707861|323317302|FG000|Overall Study|Went onto commercial drug|30|||
94418487|NCT02707861|323317303|FG001|Overall Study|Went onto commercial drug|23|||
94418488|NCT02707861|323317302|FG000|Overall Study|Adverse Event|2|||
94418489|NCT02707861|323317303|FG001|Overall Study|Adverse Event|3|||
94418490|NCT02707861|323317302|FG000|Overall Study|Death|5|||
94418491|NCT02707861|323317303|FG001|Overall Study|Death|2|||
94418492|NCT02707861|323317302|FG000|Overall Study|Lack of Efficacy|0|||
94418493|NCT02707861|323317303|FG001|Overall Study|Lack of Efficacy|2|||
94418494|NCT02707861|323317302|FG000|Overall Study|Physician Decision|1|||
94418495|NCT02707861|323317303|FG001|Overall Study|Physician Decision|4|||
94418496|NCT02707861|323317302|FG000|Overall Study|Withdrawal by Subject|2|||
94418497|NCT02707861|323317303|FG001|Overall Study|Withdrawal by Subject|1|||
94418498|NCT02707861|323317302|FG000|Overall Study|Lost to Follow-up|1|||
94418499|NCT02707861|323317303|FG001|Overall Study|Lost to Follow-up|3|||
94418500|NCT05069155|323317304|FG000|Overall Study|Withdrawal by Subject|1|||
94418501|NCT05069155|323317305|FG001|Overall Study|Withdrawal by Subject|3|||
94418502|NCT01366443|323317306|FG000|Overall Study|Lost to Follow-up|2|||
94418503|NCT01366443|323317306|FG000|Overall Study|Under 18 yo|1|||
94418504|NCT00502801|323317307|FG000|Treatment Period|Withdrawal by Subject|3|||
94418505|NCT00502801|323317307|FG000|Treatment Period|Adverse Event|7|||
94418506|NCT00502801|323317307|FG000|Treatment Period|Death|14|||
94418507|NCT00502801|323317307|FG000|Treatment Period|OTHER|30|||
94418508|NCT00502801|323317307|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
94418509|NCT00502801|323317307|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
94418510|NCT00502801|323317307|FG000|End of Therapy to Test of Cure|Death|3|||
94418511|NCT00502801|323317307|FG000|End of Therapy to Test of Cure|OTHER|2|||
94418512|NCT00731549|323317310|FG000|Overall Study|Lost to Follow-up|19|||
94418513|NCT00731549|323317310|FG000|Overall Study|Met withdrawal criteria|24|||
94418514|NCT00731549|323317310|FG000|Overall Study|Physician Decision|16|||
94418515|NCT00731549|323317310|FG000|Overall Study|Withdrawal by Subject|89|||
94418516|NCT00731549|323317310|FG000|Overall Study|Protocol deviation|1|||
94418517|NCT00731549|323317310|FG000|Overall Study|Adverse Event|31|||
94418518|NCT00731549|323317310|FG000|Overall Study|Lack of efficacy with AE|37|||
94418519|NCT00731549|323317310|FG000|Overall Study|Lack of efficacy without AE|6|||
94418520|NCT01673698|323317311|FG000|Overall Study|Lost to Follow-up|51|||
94418521|NCT01673698|323317312|FG001|Overall Study|Lost to Follow-up|13|||
94418522|NCT03212521|323317313|FG000|Overall Study|Adverse Event|1|||
94418523|NCT03212521|323317313|FG000|Overall Study|Lost to Follow-up|4|||
94418524|NCT03212521|323317313|FG000|Overall Study|Withdrawal by Subject|1|||
94418525|NCT03212521|323317313|FG000|Overall Study|Other|1|||
94418526|NCT01121666|323317315|FG000|Overall Study|Protocol Violation|29|||
94418527|NCT01121666|323317316|FG001|Overall Study|Protocol Violation|10|||
94418528|NCT03907462|323317317|FG000|Overall Study|Physician Decision|1|||
94418529|NCT03907462|323317318|FG001|Overall Study|Physician Decision|3|||
94418530|NCT03907462|323317319|FG002|Overall Study|Physician Decision|1|||
94418531|NCT03907462|323317317|FG000|Overall Study|Withdrawal by Subject|6|||
94418532|NCT03907462|323317318|FG001|Overall Study|Withdrawal by Subject|3|||
94418533|NCT03907462|323317319|FG002|Overall Study|Withdrawal by Subject|3|||
94418534|NCT03907462|323317317|FG000|Overall Study|Pregnancy|4|||
94418535|NCT03907462|323317318|FG001|Overall Study|Pregnancy|2|||
94418536|NCT03907462|323317319|FG002|Overall Study|Pregnancy|6|||
94418537|NCT03907462|323317317|FG000|Overall Study|Lost to Follow-up|16|||
94418538|NCT03907462|323317318|FG001|Overall Study|Lost to Follow-up|18|||
94418539|NCT03907462|323317319|FG002|Overall Study|Lost to Follow-up|22|||
94418540|NCT04905290|323319457|FG000|Overall Study|Adverse Event|4|||
94418541|NCT04905290|323319457|FG000|Overall Study|Death|2|||
94418542|NCT04905290|323319457|FG000|Overall Study|Withdrawal by Subject|4|||
94418543|NCT04905290|323319457|FG000|Overall Study|Physician Decision|2|||
94418544|NCT04905290|323319457|FG000|Overall Study|Lost to Follow-up|2|||
94418545|NCT04905290|323319457|FG000|Overall Study|Screen Failure|2|||
94418546|NCT04905290|323319457|FG000|Overall Study|Unsuccessful Procedure|2|||
94418547|NCT00773734|323319462|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
94418548|NCT00773734|323319463|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
94418549|NCT00773734|323319464|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
94418550|NCT00773734|323319465|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
94418551|NCT00773734|323319466|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
94418552|NCT00773734|323319467|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
94418553|NCT00773734|323319462|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
94418554|NCT00773734|323319463|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
94418555|NCT00773734|323319464|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
94418556|NCT00773734|323319465|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
94418557|NCT00773734|323319466|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
94418558|NCT00773734|323319467|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
94418559|NCT00773734|323319462|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
94418560|NCT00773734|323319463|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
94418561|NCT00773734|323319464|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
94418562|NCT00773734|323319465|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
94418563|NCT00773734|323319466|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
94418564|NCT00773734|323319467|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
94418565|NCT00773734|323319462|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
94418566|NCT00773734|323319463|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
94418567|NCT00773734|323319464|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
94418568|NCT00773734|323319465|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
94418569|NCT00773734|323319466|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
94418570|NCT00773734|323319467|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
94418571|NCT00773734|323319462|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
94418572|NCT00773734|323319463|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
94488782|NCT00116142|323583524|FG001|Overall Study|Patient stopped due to depression|1|||
94418573|NCT00773734|323319464|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
94418574|NCT00773734|323319465|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
94418575|NCT00773734|323319466|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
94418576|NCT00773734|323319467|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
94418577|NCT00773734|323319462|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
94418578|NCT00773734|323319463|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
94418579|NCT00773734|323319464|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
94418580|NCT00773734|323319465|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
94418581|NCT00773734|323319466|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
94418582|NCT00773734|323319467|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
94418583|NCT00773734|323319462|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
94418584|NCT00773734|323319463|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
94418585|NCT00773734|323319464|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
94418586|NCT00773734|323319465|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
94418587|NCT00773734|323319466|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
94418588|NCT00773734|323319467|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
94418589|NCT00773734|323319462|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
94418590|NCT00773734|323319463|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
94418591|NCT00773734|323319464|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
94418592|NCT00773734|323319465|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
94418593|NCT00773734|323319466|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
94418594|NCT00773734|323319467|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
94418595|NCT00773734|323319462|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
94418596|NCT00773734|323319463|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
94418597|NCT00773734|323319464|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
94418598|NCT00773734|323319465|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
94418599|NCT00773734|323319466|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
94418600|NCT00773734|323319467|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
94418601|NCT00773734|323319462|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
94418602|NCT00773734|323319463|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
94418603|NCT00773734|323319464|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
94418604|NCT00773734|323319465|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
94418605|NCT00773734|323319466|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
94418606|NCT00773734|323319467|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
94418607|NCT00773734|323319462|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
94418608|NCT00773734|323319463|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
94418609|NCT00773734|323319464|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
94418610|NCT00773734|323319465|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
94418611|NCT00773734|323319466|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
94418612|NCT00773734|323319467|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
94418613|NCT00773734|323319462|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
94418614|NCT00773734|323319463|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
94418615|NCT00773734|323319464|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
94418616|NCT00773734|323319465|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
94418617|NCT00773734|323319466|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
94418618|NCT00773734|323319467|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
94418619|NCT00773734|323319462|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
94418620|NCT00773734|323319463|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
94418621|NCT00773734|323319464|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
94418622|NCT00773734|323319465|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
94418623|NCT00773734|323319466|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
94418624|NCT00773734|323319467|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
94418625|NCT00773734|323319462|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
94418626|NCT00773734|323319463|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
94418627|NCT00773734|323319464|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
94418628|NCT00773734|323319465|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
94418629|NCT00773734|323319466|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
94418630|NCT00773734|323319467|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
94418631|NCT00773734|323319462|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
94418632|NCT00773734|323319463|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
94418633|NCT00773734|323319464|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
94418634|NCT00773734|323319465|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
94418635|NCT00773734|323319466|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
94418636|NCT00773734|323319467|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
94418637|NCT00773734|323319462|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
94418638|NCT00773734|323319463|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
94418639|NCT00773734|323319464|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
94418640|NCT00773734|323319465|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
94418641|NCT00773734|323319466|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
94418642|NCT00773734|323319467|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
94418643|NCT00773734|323319462|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
94418644|NCT00773734|323319463|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
94418645|NCT00773734|323319464|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
94418646|NCT00773734|323319465|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
94418647|NCT00773734|323319466|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
94418648|NCT00773734|323319467|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
94418649|NCT00773734|323319462|FG000|Extension: Active Treatment Week 24-52|Other|0|||
94418650|NCT00773734|323319463|FG001|Extension: Active Treatment Week 24-52|Other|0|||
94418651|NCT00773734|323319464|FG002|Extension: Active Treatment Week 24-52|Other|1|||
94418652|NCT00773734|323319465|FG003|Extension: Active Treatment Week 24-52|Other|2|||
94418653|NCT00773734|323319466|FG004|Extension: Active Treatment Week 24-52|Other|0|||
94418654|NCT00773734|323319467|FG005|Extension: Active Treatment Week 24-52|Other|1|||
94418655|NCT00773734|323319462|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
94418656|NCT00773734|323319463|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
94418657|NCT00773734|323319464|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
94418658|NCT00773734|323319465|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
94418659|NCT00773734|323319466|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
94418660|NCT00773734|323319467|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
94418661|NCT00773734|323319462|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
94418662|NCT00773734|323319463|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
94418663|NCT00773734|323319464|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
94418664|NCT00773734|323319465|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
94418665|NCT00773734|323319466|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
94418666|NCT00773734|323319467|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
94418667|NCT00773734|323319462|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
94418668|NCT00773734|323319463|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
94418669|NCT00773734|323319464|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
94418670|NCT00773734|323319465|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
94418671|NCT00773734|323319466|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
94418672|NCT00773734|323319467|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
94418673|NCT00773734|323319462|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
94418674|NCT00773734|323319463|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
94418675|NCT00773734|323319464|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
94418676|NCT00773734|323319465|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
94418677|NCT00773734|323319466|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
94418678|NCT00773734|323319467|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
94418679|NCT02072824|323319470|FG000|Overall Study|Insufficient clinical response|1|||
94418680|NCT02072824|323319471|FG001|Overall Study|Insufficient clinical response|0|||
94418681|NCT02072824|323319472|FG002|Overall Study|Insufficient clinical response|1|||
94418682|NCT02072824|323319470|FG000|Overall Study|No longer willing to participate|1|||
94418683|NCT02072824|323319471|FG001|Overall Study|No longer willing to participate|0|||
94418684|NCT02072824|323319472|FG002|Overall Study|No longer willing to participate|1|||
94418685|NCT02072824|323319470|FG000|Overall Study|Medication error|0|||
94418686|NCT02072824|323319471|FG001|Overall Study|Medication error|1|||
94418687|NCT02072824|323319472|FG002|Overall Study|Medication error|0|||
94418688|NCT02072824|323319470|FG000|Overall Study|Adverse Event|0|||
94418689|NCT02072824|323319471|FG001|Overall Study|Adverse Event|0|||
94418690|NCT02072824|323319472|FG002|Overall Study|Adverse Event|1|||
94418691|NCT00931268|323319475|FG000|Overall Study|Lost to Follow-up|6|||
94418692|NCT01388166|323319476|FG000|Overall Study|Adverse Event|16|||
94418693|NCT01388166|323319476|FG000|Overall Study|Lost to Follow-up|30|||
94418694|NCT01388166|323319476|FG000|Overall Study|Others than specified above|13|||
94418695|NCT02667288|323319481|FG000|Overall Study|Protocol Violation|5|||
94418696|NCT02667288|323319481|FG000|Overall Study|Lost to Follow-up|3|||
94418697|NCT02667288|323319481|FG000|Overall Study|Withdrawal by Subject|5|||
94418698|NCT00103311|323319482|FG000|Overall Study|Lost to Follow-up|1|||
94418699|NCT00103311|323319483|FG001|Overall Study|Lost to Follow-up|0|||
94418700|NCT00103311|323319482|FG000|Overall Study|Withdrawal by Subject|2|||
94418701|NCT00103311|323319483|FG001|Overall Study|Withdrawal by Subject|1|||
94418702|NCT00103311|323319482|FG000|Overall Study|Adverse Event|1|||
94418703|NCT00103311|323319483|FG001|Overall Study|Adverse Event|0|||
94418704|NCT00912093|323319484|FG000|The Controlled Phase|Death|0|||
94418705|NCT00912093|323319485|FG001|The Controlled Phase|Death|1|||
94418706|NCT00912093|323319486|FG002|The Controlled Phase|Death|0|||
94418707|NCT00912093|323319487|FG003|The Controlled Phase|Death|0|||
94418708|NCT00912093|323319488|FG004|The Controlled Phase|Death|0|||
94418709|NCT00912093|323319484|FG000|The Controlled Phase|Medical Condition|0|||
94418710|NCT00912093|323319485|FG001|The Controlled Phase|Medical Condition|1|||
94418711|NCT00912093|323319486|FG002|The Controlled Phase|Medical Condition|0|||
94418712|NCT00912093|323319487|FG003|The Controlled Phase|Medical Condition|0|||
94418713|NCT00912093|323319488|FG004|The Controlled Phase|Medical Condition|0|||
94418714|NCT00912093|323319484|FG000|The Controlled Phase|Lost to Follow-up|0|||
94418715|NCT00912093|323319485|FG001|The Controlled Phase|Lost to Follow-up|0|||
94418716|NCT00912093|323319486|FG002|The Controlled Phase|Lost to Follow-up|0|||
94418717|NCT00912093|323319487|FG003|The Controlled Phase|Lost to Follow-up|0|||
94418718|NCT00912093|323319488|FG004|The Controlled Phase|Lost to Follow-up|1|||
94418719|NCT01196078|323319489|FG000|Overall Study|Withdrawal by Subject|3|||
94418720|NCT01196078|323319490|FG001|Overall Study|Withdrawal by Subject|5|||
94418721|NCT01196078|323319489|FG000|Overall Study|Adverse Event|4|||
94418722|NCT01196078|323319490|FG001|Overall Study|Adverse Event|4|||
94418723|NCT01196078|323319489|FG000|Overall Study|Protocol Violation|2|||
94418724|NCT01196078|323319490|FG001|Overall Study|Protocol Violation|1|||
94418725|NCT01196078|323319489|FG000|Overall Study|Lack of Efficacy|17|||
94418726|NCT01196078|323319490|FG001|Overall Study|Lack of Efficacy|23|||
94418727|NCT01196078|323319489|FG000|Overall Study|Lost to Follow-up|1|||
94418728|NCT01196078|323319490|FG001|Overall Study|Lost to Follow-up|0|||
94418729|NCT01196078|323319489|FG000|Overall Study|Death|6|||
94418730|NCT01196078|323319490|FG001|Overall Study|Death|4|||
94418731|NCT02145026|323319491|FG000|Overall Study|Adverse Event|2|||
94418732|NCT02145026|323319491|FG000|Overall Study|Death|4|||
94418733|NCT02145026|323319491|FG000|Overall Study|Withdrawal by Subject|2|||
94418734|NCT02145026|323319491|FG000|Overall Study|Physician Decision|4|||
94418735|NCT04132336|323319493|FG000|Overall Study|Investigator Decision|0|||
94418736|NCT04132336|323319494|FG001|Overall Study|Investigator Decision|1|||
94418737|NCT04132336|323319495|FG002|Overall Study|Investigator Decision|0|||
94418738|NCT04132336|323319496|FG003|Overall Study|Investigator Decision|0|||
94418739|NCT04132336|323319497|FG004|Overall Study|Investigator Decision|0|||
94418740|NCT04132336|323319498|FG005|Overall Study|Investigator Decision|0|||
94418741|NCT04132336|323319499|FG006|Overall Study|Investigator Decision|0|||
94418742|NCT03656874|323319503|FG000|Overall Study|Lost to Follow-up|3|||
94418743|NCT03656874|323319504|FG001|Overall Study|Lost to Follow-up|17|||
94418744|NCT00584844|323319505|FG000|Overall Study|Withdrawal by Subject|59|||
94418745|NCT00584844|323319505|FG000|Overall Study|Screen Failure|20|||
94418746|NCT04920916|323319506|FG000|Phase IIa 60 Day Study|Death|2|||
94418747|NCT04920916|323319507|FG001|Phase IIa 60 Day Study|Death|5|||
94418748|NCT04920916|323319506|FG000|1 Year Follow up (Phone Call)|Death|1|||
94418749|NCT04920916|323319507|FG001|1 Year Follow up (Phone Call)|Death|3|||
94418750|NCT04920916|323319506|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
94418751|NCT04920916|323319507|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
94418752|NCT02011113|323319508|FG000|Overall Study|Adverse Event|4|||
94418753|NCT02011113|323319508|FG000|Overall Study|Disease Progression (DP)|16|||
94418754|NCT02011113|323319508|FG000|Overall Study|Death|1|||
94418755|NCT02011113|323319508|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
94418756|NCT02011113|323319508|FG000|Overall Study|Investigator's judgement- DP|3|||
94418757|NCT02011113|323319508|FG000|Overall Study|Study terminated by sponsor|11|||
94418758|NCT03251963|323319511|FG000|Overall Study|inappropriate Xa level timing|6|||
94418759|NCT03251963|323319512|FG001|Overall Study|inappropriate Xa level timing|3|||
94418760|NCT03251963|323319511|FG000|Overall Study|no peak Xa level drawn|2|||
94418761|NCT03251963|323319512|FG001|Overall Study|no peak Xa level drawn|0|||
94418762|NCT03251963|323319511|FG000|Overall Study|bled prior to Xa level|1|||
94488783|NCT00116142|323583523|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
94418763|NCT03251963|323319512|FG001|Overall Study|bled prior to Xa level|2|||
94488784|NCT00116142|323583524|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
94488785|NCT00116142|323583523|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
94488786|NCT00116142|323583524|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
94488787|NCT00116142|323583523|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
94488788|NCT00116142|323583524|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
94488789|NCT02513550|323583527|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
94418764|NCT00616941|323319513|FG000|Overall Study|Progressive Disease|1|||
94418765|NCT00616941|323319514|FG001|Overall Study|Progressive Disease|2|||
94418766|NCT00616941|323319515|FG002|Overall Study|Progressive Disease|1|||
94418767|NCT00616941|323319513|FG000|Overall Study|Adverse Event|0|||
94418768|NCT00616941|323319514|FG001|Overall Study|Adverse Event|1|||
94418769|NCT00616941|323319515|FG002|Overall Study|Adverse Event|1|||
94418770|NCT00616941|323319513|FG000|Overall Study|Subject Non-compliance|0|||
94418771|NCT00616941|323319514|FG001|Overall Study|Subject Non-compliance|0|||
94418772|NCT00616941|323319515|FG002|Overall Study|Subject Non-compliance|1|||
94418773|NCT00616941|323319513|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
94418774|NCT00616941|323319514|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
94418775|NCT00616941|323319515|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
94418776|NCT00616941|323319513|FG000|Overall Study|Vaccination Suspended|0|||
94418777|NCT00616941|323319514|FG001|Overall Study|Vaccination Suspended|0|||
94418778|NCT00616941|323319515|FG002|Overall Study|Vaccination Suspended|3|||
94418779|NCT02227147|323319516|FG000|Controlled Treatment Period|Adverse Event|4|||
94418780|NCT02227147|323319517|FG001|Controlled Treatment Period|Adverse Event|3|||
94418781|NCT02227147|323319516|FG000|Controlled Treatment Period|Other|2|||
94418782|NCT02227147|323319517|FG001|Controlled Treatment Period|Other|0|||
94418783|NCT02227147|323319516|FG000|Follow-up Period|Other|3|||
94418784|NCT02227147|323319517|FG001|Follow-up Period|Other|5|||
94418785|NCT00506129|323319518|FG000|Overall Study|Disease Progression/Relapse|15|||
94418786|NCT00506129|323319518|FG000|Overall Study|Death|7|||
94418787|NCT01732874|323319519|FG000|Overall Study|Withdrawal by Subject|5|||
94418788|NCT01732874|323319520|FG001|Overall Study|Withdrawal by Subject|1|||
94418789|NCT01732874|323319519|FG000|Overall Study|Death of Infant|3|||
94418790|NCT01732874|323319520|FG001|Overall Study|Death of Infant|2|||
94418791|NCT04319159|323319522|FG000|Overall Study|Screening failure|13|||
94418792|NCT04319159|323319522|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
94418793|NCT04319159|323319522|FG000|Overall Study|Withdrawal by Subject|1|||
94418794|NCT00629265|323319523|FG000|Overall Study|Lost to Follow-up|4|||
94418795|NCT00629265|323319524|FG001|Overall Study|Lost to Follow-up|5|||
94418796|NCT00629265|323319523|FG000|Overall Study|Withdrawal by Subject|11|||
94418797|NCT00629265|323319524|FG001|Overall Study|Withdrawal by Subject|8|||
94418798|NCT00629265|323319523|FG000|Overall Study|Death|1|||
94418799|NCT00629265|323319524|FG001|Overall Study|Death|0|||
94418800|NCT00629265|323319523|FG000|Overall Study|Adverse Event|2|||
94418801|NCT00629265|323319524|FG001|Overall Study|Adverse Event|0|||
94418802|NCT00629265|323319523|FG000|Overall Study|HNC Recurrence|4|||
94418803|NCT00629265|323319524|FG001|Overall Study|HNC Recurrence|0|||
94418804|NCT00629265|323319523|FG000|Overall Study|Other CA Requiring Treatment|1|||
94418805|NCT00629265|323319524|FG001|Overall Study|Other CA Requiring Treatment|3|||
94418806|NCT00629265|323319523|FG000|Overall Study|Needed Esophageal Dilation|4|||
94418807|NCT00629265|323319524|FG001|Overall Study|Needed Esophageal Dilation|1|||
94418808|NCT00629265|323319523|FG000|Overall Study|Unrelated Medical Complications|3|||
94418809|NCT00629265|323319524|FG001|Overall Study|Unrelated Medical Complications|1|||
94418810|NCT00629265|323319523|FG000|Overall Study|Unknown Reason|2|||
94418811|NCT00629265|323319524|FG001|Overall Study|Unknown Reason|2|||
94418812|NCT02566993|323319525|FG000|Overall Study|Randomized but not treated|5|||
94418813|NCT02566993|323319526|FG001|Overall Study|Randomized but not treated|16|||
94418814|NCT02566993|323319525|FG000|Overall Study|Progressive disease|213|||
94418815|NCT02566993|323319526|FG001|Overall Study|Progressive disease|152|||
94418816|NCT02566993|323319525|FG000|Overall Study|Withdrawal by Subject|12|||
94418817|NCT02566993|323319526|FG001|Overall Study|Withdrawal by Subject|28|||
94418818|NCT02566993|323319525|FG000|Overall Study|Death|17|||
94418819|NCT02566993|323319526|FG001|Overall Study|Death|23|||
94418820|NCT02566993|323319525|FG000|Overall Study|Physician Decision|10|||
94418821|NCT02566993|323319526|FG001|Overall Study|Physician Decision|17|||
94418822|NCT02566993|323319525|FG000|Overall Study|Study drug-related adverse event|20|||
94418823|NCT02566993|323319526|FG001|Overall Study|Study drug-related adverse event|41|||
94418824|NCT02566993|323319525|FG000|Overall Study|Non study drug-related adverse event|9|||
94418825|NCT02566993|323319526|FG001|Overall Study|Non study drug-related adverse event|9|||
94418826|NCT02566993|323319525|FG000|Overall Study|Symptomatic deterioration|9|||
94418827|NCT02566993|323319526|FG001|Overall Study|Symptomatic deterioration|16|||
94418828|NCT02566993|323319525|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
94418829|NCT02566993|323319526|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
94418830|NCT02566993|323319525|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
94418831|NCT02566993|323319526|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
94418832|NCT02566993|323319525|FG000|Overall Study|Screening failure|2|||
94418833|NCT02566993|323319526|FG001|Overall Study|Screening failure|0|||
94418834|NCT02566993|323319525|FG000|Overall Study|Lost to Follow-up|0|||
94418835|NCT02566993|323319526|FG001|Overall Study|Lost to Follow-up|1|||
94418836|NCT02566993|323319525|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
94418837|NCT02566993|323319526|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
94418838|NCT02701413|323319527|FG000|Overall Study|Withdrawal by Subject|7|||
94488790|NCT02513550|323583528|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
94488791|NCT02513550|323583529|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
94488792|NCT02513550|323583530|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
94418839|NCT02701413|323319528|FG001|Overall Study|Withdrawal by Subject|11|||
94418840|NCT01616953|323319532|FG000|Overall Study|Lost to Follow-up|1|||
94418841|NCT01616953|323319533|FG001|Overall Study|Lost to Follow-up|0|||
94418842|NCT01616953|323319532|FG000|Overall Study|lack of bone and soft tissue|1|||
94418843|NCT01616953|323319533|FG001|Overall Study|lack of bone and soft tissue|0|||
94418844|NCT01550744|323319534|FG000|Open-Label|Lost to Follow-up|7|||
94488793|NCT02513550|323583531|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
94488794|NCT02513550|323583532|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
94488795|NCT02513550|323583527|FG000|Double Blind Treatment Period|Adverse Event|5|||
94418845|NCT01550744|323319535|FG001|Open-Label|Lost to Follow-up|0|||
94418846|NCT01550744|323319536|FG002|Open-Label|Lost to Follow-up|0|||
94418847|NCT01550744|323319534|FG000|Open-Label|Withdrawal by Subject|13|||
94418848|NCT01550744|323319535|FG001|Open-Label|Withdrawal by Subject|0|||
94418849|NCT01550744|323319536|FG002|Open-Label|Withdrawal by Subject|0|||
94418850|NCT01550744|323319534|FG000|Open-Label|Adverse Event|11|||
94418851|NCT01550744|323319535|FG001|Open-Label|Adverse Event|0|||
94418852|NCT01550744|323319536|FG002|Open-Label|Adverse Event|0|||
94418853|NCT01550744|323319534|FG000|Open-Label|Lack of Efficacy|4|||
94418854|NCT01550744|323319535|FG001|Open-Label|Lack of Efficacy|0|||
94418855|NCT01550744|323319536|FG002|Open-Label|Lack of Efficacy|0|||
94418856|NCT01550744|323319534|FG000|Open-Label|Protocol Violation|4|||
94418857|NCT01550744|323319535|FG001|Open-Label|Protocol Violation|0|||
94418858|NCT01550744|323319536|FG002|Open-Label|Protocol Violation|0|||
94418859|NCT01550744|323319534|FG000|Open-Label|Not all 3 study drug injections received|2|||
94418860|NCT01550744|323319535|FG001|Open-Label|Not all 3 study drug injections received|0|||
94418861|NCT01550744|323319536|FG002|Open-Label|Not all 3 study drug injections received|0|||
94418862|NCT01550744|323319534|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
94418863|NCT01550744|323319535|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
94418864|NCT01550744|323319536|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
94418865|NCT01550744|323319534|FG000|Open-Label|Other|1|||
94418866|NCT01550744|323319535|FG001|Open-Label|Other|0|||
94418867|NCT01550744|323319536|FG002|Open-Label|Other|0|||
94418868|NCT01550744|323319534|FG000|Double-Blind|Lost to Follow-up|0|||
94418869|NCT01550744|323319535|FG001|Double-Blind|Lost to Follow-up|6|||
94418870|NCT01550744|323319536|FG002|Double-Blind|Lost to Follow-up|12|||
94418871|NCT01550744|323319534|FG000|Double-Blind|Withdrawal by Subject|0|||
94418872|NCT01550744|323319535|FG001|Double-Blind|Withdrawal by Subject|2|||
94418873|NCT01550744|323319536|FG002|Double-Blind|Withdrawal by Subject|15|||
94418874|NCT01550744|323319534|FG000|Double-Blind|Adverse Event|0|||
94418875|NCT01550744|323319535|FG001|Double-Blind|Adverse Event|4|||
94418876|NCT01550744|323319536|FG002|Double-Blind|Adverse Event|15|||
94418877|NCT01550744|323319534|FG000|Double-Blind|Death|0|||
94418878|NCT01550744|323319535|FG001|Double-Blind|Death|1|||
94418879|NCT01550744|323319536|FG002|Double-Blind|Death|0|||
94418880|NCT01550744|323319534|FG000|Double-Blind|Lack of Efficacy|0|||
94418881|NCT01550744|323319535|FG001|Double-Blind|Lack of Efficacy|2|||
94418882|NCT01550744|323319536|FG002|Double-Blind|Lack of Efficacy|8|||
94418883|NCT01550744|323319534|FG000|Double-Blind|Protocol Violation|0|||
94418884|NCT01550744|323319535|FG001|Double-Blind|Protocol Violation|0|||
94418885|NCT01550744|323319536|FG002|Double-Blind|Protocol Violation|4|||
94418886|NCT01550744|323319534|FG000|Double-Blind|Pregnancy|0|||
94418887|NCT01550744|323319535|FG001|Double-Blind|Pregnancy|0|||
94418888|NCT01550744|323319536|FG002|Double-Blind|Pregnancy|3|||
94418889|NCT01550744|323319534|FG000|Double-Blind|Other|0|||
94418890|NCT01550744|323319535|FG001|Double-Blind|Other|2|||
94418891|NCT01550744|323319536|FG002|Double-Blind|Other|10|||
94418892|NCT01523587|323319537|FG000|Overall Study|Other than listed|5|||
94418893|NCT01523587|323319538|FG001|Overall Study|Other than listed|5|||
94418894|NCT01523587|323319537|FG000|Overall Study|Worsening of underlying cancer disease|19|||
94418895|NCT01523587|323319538|FG001|Overall Study|Worsening of underlying cancer disease|34|||
94418896|NCT01523587|323319537|FG000|Overall Study|Adverse Event|68|||
94418897|NCT01523587|323319538|FG001|Overall Study|Adverse Event|52|||
94418898|NCT01523587|323319537|FG000|Overall Study|Protocol Violation|5|||
94418899|NCT01523587|323319538|FG001|Overall Study|Protocol Violation|3|||
94418900|NCT01523587|323319537|FG000|Overall Study|Lost to Follow-up|2|||
94418901|NCT01523587|323319538|FG001|Overall Study|Lost to Follow-up|2|||
94418902|NCT01523587|323319537|FG000|Overall Study|Withdrawal by Subject|28|||
94418903|NCT01523587|323319538|FG001|Overall Study|Withdrawal by Subject|20|||
94418904|NCT01523587|323319537|FG000|Overall Study|Withdrew due to Progressive disease|265|||
94418905|NCT01523587|323319538|FG001|Overall Study|Withdrew due to Progressive disease|279|||
94418906|NCT01523587|323319537|FG000|Overall Study|Randomised but bot treated|6|||
94418907|NCT01523587|323319538|FG001|Overall Study|Randomised but bot treated|2|||
94418908|NCT01347866|323319541|FG000|Overall Study|Death|0|||
94418909|NCT01347866|323319542|FG001|Overall Study|Death|0|||
94418910|NCT01347866|323319543|FG002|Overall Study|Death|0|||
94418911|NCT01347866|323319544|FG003|Overall Study|Death|1|||
94418912|NCT01347866|323319545|FG004|Overall Study|Death|2|||
94418913|NCT01347866|323319546|FG005|Overall Study|Death|2|||
94418914|NCT01347866|323319547|FG006|Overall Study|Death|1|||
94418915|NCT01347866|323319548|FG007|Overall Study|Death|0|||
94418916|NCT01347866|323319549|FG008|Overall Study|Death|4|||
94418917|NCT01347866|323319550|FG009|Overall Study|Death|1|||
94418918|NCT01347866|323319551|FG010|Overall Study|Death|3|||
94418919|NCT01347866|323319552|FG011|Overall Study|Death|1|||
94418920|NCT01347866|323319553|FG012|Overall Study|Death|2|||
94418921|NCT01347866|323319554|FG013|Overall Study|Death|0|||
94418922|NCT01347866|323319555|FG014|Overall Study|Death|0|||
94418923|NCT01347866|323319556|FG015|Overall Study|Death|1|||
94418924|NCT01347866|323319557|FG016|Overall Study|Death|0|||
94418925|NCT01347866|323319541|FG000|Overall Study|Lost to Follow-up|0|||
94418926|NCT01347866|323319542|FG001|Overall Study|Lost to Follow-up|0|||
94418927|NCT01347866|323319543|FG002|Overall Study|Lost to Follow-up|0|||
94418928|NCT01347866|323319544|FG003|Overall Study|Lost to Follow-up|0|||
94418929|NCT01347866|323319545|FG004|Overall Study|Lost to Follow-up|0|||
94418930|NCT01347866|323319546|FG005|Overall Study|Lost to Follow-up|0|||
94418931|NCT01347866|323319547|FG006|Overall Study|Lost to Follow-up|0|||
94418932|NCT01347866|323319548|FG007|Overall Study|Lost to Follow-up|1|||
94418933|NCT01347866|323319549|FG008|Overall Study|Lost to Follow-up|1|||
94418934|NCT01347866|323319550|FG009|Overall Study|Lost to Follow-up|0|||
94418935|NCT01347866|323319551|FG010|Overall Study|Lost to Follow-up|0|||
94418936|NCT01347866|323319552|FG011|Overall Study|Lost to Follow-up|0|||
94418937|NCT01347866|323319553|FG012|Overall Study|Lost to Follow-up|0|||
94418938|NCT01347866|323319554|FG013|Overall Study|Lost to Follow-up|0|||
94418939|NCT01347866|323319555|FG014|Overall Study|Lost to Follow-up|0|||
94418940|NCT01347866|323319556|FG015|Overall Study|Lost to Follow-up|0|||
94418941|NCT01347866|323319557|FG016|Overall Study|Lost to Follow-up|0|||
94418942|NCT01347866|323319541|FG000|Overall Study|Other|3|||
94418943|NCT01347866|323319542|FG001|Overall Study|Other|1|||
94418944|NCT01347866|323319543|FG002|Overall Study|Other|1|||
94418945|NCT01347866|323319544|FG003|Overall Study|Other|4|||
94418946|NCT01347866|323319545|FG004|Overall Study|Other|5|||
94418947|NCT01347866|323319546|FG005|Overall Study|Other|0|||
94418948|NCT01347866|323319547|FG006|Overall Study|Other|5|||
94418949|NCT01347866|323319548|FG007|Overall Study|Other|3|||
94418950|NCT01347866|323319549|FG008|Overall Study|Other|22|||
94418951|NCT01347866|323319550|FG009|Overall Study|Other|5|||
94418952|NCT01347866|323319551|FG010|Overall Study|Other|0|||
94418953|NCT01347866|323319552|FG011|Overall Study|Other|3|||
94418954|NCT01347866|323319553|FG012|Overall Study|Other|4|||
94418955|NCT01347866|323319554|FG013|Overall Study|Other|4|||
94418956|NCT01347866|323319555|FG014|Overall Study|Other|2|||
94418957|NCT01347866|323319556|FG015|Overall Study|Other|3|||
94418958|NCT01347866|323319557|FG016|Overall Study|Other|0|||
94418959|NCT01347866|323319541|FG000|Overall Study|Subject refused further follow-up|2|||
94418960|NCT01347866|323319542|FG001|Overall Study|Subject refused further follow-up|0|||
94418961|NCT01347866|323319543|FG002|Overall Study|Subject refused further follow-up|0|||
94418962|NCT01347866|323319544|FG003|Overall Study|Subject refused further follow-up|2|||
94418963|NCT01347866|323319545|FG004|Overall Study|Subject refused further follow-up|0|||
94418964|NCT01347866|323319546|FG005|Overall Study|Subject refused further follow-up|1|||
94418965|NCT01347866|323319547|FG006|Overall Study|Subject refused further follow-up|0|||
94418966|NCT01347866|323319548|FG007|Overall Study|Subject refused further follow-up|0|||
94418967|NCT01347866|323319549|FG008|Overall Study|Subject refused further follow-up|4|||
94418968|NCT01347866|323319550|FG009|Overall Study|Subject refused further follow-up|1|||
94418969|NCT01347866|323319551|FG010|Overall Study|Subject refused further follow-up|0|||
94418970|NCT01347866|323319552|FG011|Overall Study|Subject refused further follow-up|0|||
94418971|NCT01347866|323319553|FG012|Overall Study|Subject refused further follow-up|1|||
94418972|NCT01347866|323319554|FG013|Overall Study|Subject refused further follow-up|3|||
94418973|NCT01347866|323319555|FG014|Overall Study|Subject refused further follow-up|1|||
94418974|NCT01347866|323319556|FG015|Overall Study|Subject refused further follow-up|0|||
94418975|NCT01347866|323319557|FG016|Overall Study|Subject refused further follow-up|2|||
94418976|NCT02562482|323319561|FG000|Overall Study|Enrolled, but did not receive product|4|||
94418977|NCT02562482|323319562|FG001|Overall Study|Enrolled, but did not receive product|0|||
94418978|NCT02562482|323319561|FG000|Overall Study|Lost to Follow-up|9|||
94418979|NCT02562482|323319562|FG001|Overall Study|Lost to Follow-up|6|||
94418980|NCT02562482|323319561|FG000|Overall Study|Moved from area|2|||
94418981|NCT02562482|323319562|FG001|Overall Study|Moved from area|3|||
94418982|NCT02562482|323319561|FG000|Overall Study|Withdrawal by Subject|5|||
94418983|NCT02562482|323319562|FG001|Overall Study|Withdrawal by Subject|3|||
94418984|NCT02562482|323319561|FG000|Overall Study|Physician Decision|1|||
94418985|NCT02562482|323319562|FG001|Overall Study|Physician Decision|3|||
94418986|NCT02562482|323319561|FG000|Overall Study|Illness/Injury unrelated to product|0|||
94418987|NCT02562482|323319562|FG001|Overall Study|Illness/Injury unrelated to product|1|||
94418988|NCT01408628|323319566|FG000|Consented|Withdrawal by Subject|12|||
94418989|NCT01408628|323319566|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
94418990|NCT01408628|323319566|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
94418991|NCT01408628|323319566|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
94418992|NCT00359788|323319567|FG000|Overall Study|Adverse Event|11|||
94418993|NCT00359788|323319568|FG001|Overall Study|Adverse Event|10|||
94418994|NCT00359788|323319567|FG000|Overall Study|Lack of Efficacy|1|||
94418995|NCT00359788|323319568|FG001|Overall Study|Lack of Efficacy|2|||
94418996|NCT00359788|323319567|FG000|Overall Study|Lost to Follow-up|3|||
94418997|NCT00359788|323319568|FG001|Overall Study|Lost to Follow-up|2|||
94418998|NCT00359788|323319567|FG000|Overall Study|Withdrawal by Subject|4|||
94418999|NCT00359788|323319568|FG001|Overall Study|Withdrawal by Subject|1|||
94419000|NCT00359788|323319567|FG000|Overall Study|Protocol Violation|4|||
94419001|NCT00359788|323319568|FG001|Overall Study|Protocol Violation|2|||
94419002|NCT01244061|323319569|FG000|Overall Study|Death|1|||
94419003|NCT01244061|323319570|FG001|Overall Study|Death|0|||
94419004|NCT01244061|323319569|FG000|Overall Study|Did not meet entrance criteria|1|||
94419005|NCT01244061|323319570|FG001|Overall Study|Did not meet entrance criteria|0|||
94419006|NCT01244061|323319569|FG000|Overall Study|Lack of Efficacy|1|||
94419007|NCT01244061|323319570|FG001|Overall Study|Lack of Efficacy|3|||
94419008|NCT01244061|323319569|FG000|Overall Study|Lost to Follow-up|34|||
94419009|NCT01244061|323319570|FG001|Overall Study|Lost to Follow-up|30|||
94419010|NCT01244061|323319569|FG000|Overall Study|Withdrawal by Subject|29|||
94419011|NCT01244061|323319570|FG001|Overall Study|Withdrawal by Subject|46|||
94419012|NCT01244061|323319569|FG000|Overall Study|Other|8|||
94419013|NCT01244061|323319570|FG001|Overall Study|Other|19|||
94419014|NCT01244061|323319569|FG000|Overall Study|Protocol Violation|1|||
94419015|NCT01244061|323319570|FG001|Overall Study|Protocol Violation|1|||
94419016|NCT01244061|323319569|FG000|Overall Study|Adverse Event|5|||
94419017|NCT01244061|323319570|FG001|Overall Study|Adverse Event|2|||
94419018|NCT01244061|323319569|FG000|Overall Study|Randomized but not treated|2|||
94419019|NCT01244061|323319570|FG001|Overall Study|Randomized but not treated|2|||
94419020|NCT00712985|323319573|FG000|Overall Study|1 withdrew prior to start of drug|1|||
94419021|NCT00712985|323319573|FG000|Overall Study|1 patient moved out of state|1|||
94419022|NCT00712985|323319573|FG000|Overall Study|Lack of Efficacy|3|||
94419023|NCT01481324|323319576|FG000|Overall Study|Missing Data|0|||
94419024|NCT01481324|323319577|FG001|Overall Study|Missing Data|2|||
94419025|NCT01481324|323319578|FG002|Overall Study|Missing Data|2|||
94419026|NCT03334721|323319579|FG000|Overall Study|Withdrawal by Subject|1|||
94419027|NCT03334721|323319580|FG001|Overall Study|Withdrawal by Subject|0|||
94419028|NCT03334721|323319579|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
94419029|NCT03334721|323319580|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
94419030|NCT03510182|323319581|FG000|Overall Study|Withdrawal by Subject|2|||
94419031|NCT00290251|323319591|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
94419032|NCT00290251|323319592|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
94419033|NCT00290251|323319593|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
94419034|NCT00290251|323319594|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
94419035|NCT00290251|323319595|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
94419036|NCT00290251|323319596|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
94419037|NCT00290251|323319591|FG000|Treatment 1 (Months 2-4)|headache|0|||
94419038|NCT00290251|323319592|FG001|Treatment 1 (Months 2-4)|headache|0|||
94419039|NCT00290251|323319593|FG002|Treatment 1 (Months 2-4)|headache|0|||
94419040|NCT00290251|323319594|FG003|Treatment 1 (Months 2-4)|headache|0|||
94419041|NCT00290251|323319595|FG004|Treatment 1 (Months 2-4)|headache|1|||
94419042|NCT00290251|323319596|FG005|Treatment 1 (Months 2-4)|headache|0|||
94419043|NCT00290251|323319591|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
94419044|NCT00290251|323319592|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
94419045|NCT00290251|323319593|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
94419046|NCT00290251|323319594|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
94419047|NCT00290251|323319595|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
94419048|NCT00290251|323319596|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
94419049|NCT04319718|323321461|FG000|Overall Study|Adverse Event|0|||
94419050|NCT04319718|323321462|FG001|Overall Study|Adverse Event|2|||
94419051|NCT04319718|323321461|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
94419052|NCT04319718|323321462|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
94419053|NCT00003138|323321463|FG000|Step 1|Reasons off treatment not documented|60|||
94419054|NCT00003138|323321464|FG001|Step 1|Reasons off treatment not documented|57|||
94419055|NCT00003138|323321463|FG000|Step 1|Never started treatment|1|||
94419056|NCT00003138|323321464|FG001|Step 1|Never started treatment|0|||
94419057|NCT00003138|323321463|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
94419058|NCT00003138|323321464|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
94419059|NCT00003138|323321463|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
94419060|NCT00003138|323321464|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
94419061|NCT00003138|323321463|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
94419062|NCT00003138|323321464|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
94419063|NCT00003138|323321463|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
94419064|NCT00003138|323321464|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
94419065|NCT02091141|323321465|FG000|Overall Study|Death|280|||
94419066|NCT02091141|323321466|FG001|Overall Study|Death|118|||
94419067|NCT02091141|323321467|FG002|Overall Study|Death|46|||
94419068|NCT02091141|323321468|FG003|Overall Study|Death|13|||
94419069|NCT02091141|323321469|FG004|Overall Study|Death|31|||
94419070|NCT02091141|323321470|FG005|Overall Study|Death|16|||
94419071|NCT02091141|323321471|FG006|Overall Study|Death|12|||
94419072|NCT02091141|323321465|FG000|Overall Study|Withdrawal by Subject|21|||
94419073|NCT02091141|323321466|FG001|Overall Study|Withdrawal by Subject|13|||
94419074|NCT02091141|323321467|FG002|Overall Study|Withdrawal by Subject|3|||
94419075|NCT02091141|323321468|FG003|Overall Study|Withdrawal by Subject|2|||
94419076|NCT02091141|323321469|FG004|Overall Study|Withdrawal by Subject|2|||
94419077|NCT02091141|323321470|FG005|Overall Study|Withdrawal by Subject|3|||
94419078|NCT02091141|323321471|FG006|Overall Study|Withdrawal by Subject|0|||
94419079|NCT02091141|323321465|FG000|Overall Study|Lost to Follow-up|21|||
94419080|NCT02091141|323321466|FG001|Overall Study|Lost to Follow-up|5|||
94419081|NCT02091141|323321467|FG002|Overall Study|Lost to Follow-up|1|||
94419082|NCT02091141|323321468|FG003|Overall Study|Lost to Follow-up|0|||
94419083|NCT02091141|323321469|FG004|Overall Study|Lost to Follow-up|1|||
94419084|NCT02091141|323321470|FG005|Overall Study|Lost to Follow-up|2|||
94419085|NCT02091141|323321471|FG006|Overall Study|Lost to Follow-up|0|||
94419086|NCT02091141|323321465|FG000|Overall Study|Reason Not Specified|6|||
94419087|NCT02091141|323321466|FG001|Overall Study|Reason Not Specified|5|||
94419088|NCT02091141|323321467|FG002|Overall Study|Reason Not Specified|2|||
94419089|NCT02091141|323321468|FG003|Overall Study|Reason Not Specified|0|||
94419090|NCT02091141|323321469|FG004|Overall Study|Reason Not Specified|0|||
94419091|NCT02091141|323321470|FG005|Overall Study|Reason Not Specified|0|||
94419092|NCT02091141|323321471|FG006|Overall Study|Reason Not Specified|1|||
94419093|NCT02091141|323321465|FG000|Overall Study|Study Ended by Sponsor|1|||
94419094|NCT02091141|323321466|FG001|Overall Study|Study Ended by Sponsor|9|||
94419095|NCT02091141|323321467|FG002|Overall Study|Study Ended by Sponsor|0|||
94419096|NCT02091141|323321468|FG003|Overall Study|Study Ended by Sponsor|0|||
94419097|NCT02091141|323321469|FG004|Overall Study|Study Ended by Sponsor|0|||
94419098|NCT02091141|323321470|FG005|Overall Study|Study Ended by Sponsor|0|||
94419099|NCT02091141|323321471|FG006|Overall Study|Study Ended by Sponsor|0|||
94419100|NCT02091141|323321465|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
94419101|NCT02091141|323321466|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
94419102|NCT02091141|323321467|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
94419103|NCT02091141|323321468|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
94419104|NCT02091141|323321469|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
94419105|NCT02091141|323321470|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
94419106|NCT02091141|323321471|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
94419107|NCT03439852|323321472|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
94419108|NCT03439852|323321473|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
94419109|NCT03439852|323321472|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
94419110|NCT03439852|323321473|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
94419111|NCT03439852|323321472|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
94419112|NCT03439852|323321473|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
94419113|NCT01215513|323321474|FG000|Overall Study|Not completed CS42|9|||
94419114|NCT01215513|323321474|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
94419115|NCT01215513|323321474|FG000|Overall Study|Adverse event (CS42A)|2|||
94419116|NCT01215513|323321474|FG000|Overall Study|Physician decision (CS42A)|6|||
94419117|NCT01215513|323321474|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
94419118|NCT01215513|323321474|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
94419119|NCT01553279|323321475|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
94419120|NCT01553279|323321476|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
94419121|NCT01553279|323321475|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
94419122|NCT01553279|323321476|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
94419123|NCT01553279|323321475|FG000|Interim Period|Withdrawal by Subject|2|||
94419124|NCT01553279|323321476|FG001|Interim Period|Withdrawal by Subject|2|||
94419125|NCT01553279|323321475|FG000|Interim Period|Lost to Follow-up|1|||
94419126|NCT01553279|323321476|FG001|Interim Period|Lost to Follow-up|0|||
94419127|NCT01553279|323321475|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
94419128|NCT01553279|323321476|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
94419129|NCT01553279|323321475|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
94419130|NCT01553279|323321476|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
94419131|NCT00605865|323321477|FG000|Overall Study|Protocol Violation|115|||
94419132|NCT03955471|323321478|FG000|Overall Study|Death|22|||
94419133|NCT03955471|323321478|FG000|Overall Study|Lost to Follow-up|1|||
94419134|NCT03955471|323321478|FG000|Overall Study|Withdrawal by Subject|6|||
94419135|NCT03955471|323321478|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
94419136|NCT01030341|323321479|FG000|Overall Study|Withdrawal by Subject|1|||
94419137|NCT01030341|323321479|FG000|Overall Study|Lost to Follow-up|2|||
94419138|NCT00821873|323321480|FG000|Overall Study|Lost to Follow-up|4|||
94419139|NCT04032158|323321490|FG000|Overall Study|Study Termination|2|||
94419140|NCT04032158|323321491|FG001|Overall Study|Study Termination|1|||
94419141|NCT00059787|323321492|FG000|Overall Study|Adverse Event|13|||
94419142|NCT00059787|323321492|FG000|Overall Study|disease progression|2|||
94419143|NCT00059787|323321492|FG000|Overall Study|ineligible|1|||
94419144|NCT00059787|323321492|FG000|Overall Study|Other|4|||
94419145|NCT00292188|323321493|FG000|Single-Blind|Adverse Event|14|||
94419146|NCT00292188|323321494|FG001|Single-Blind|Adverse Event|0|||
94419147|NCT00292188|323321495|FG002|Single-Blind|Adverse Event|0|||
94419148|NCT00292188|323321493|FG000|Single-Blind|Lack of Efficacy|2|||
94419149|NCT00292188|323321494|FG001|Single-Blind|Lack of Efficacy|0|||
94419150|NCT00292188|323321495|FG002|Single-Blind|Lack of Efficacy|0|||
94419151|NCT00292188|323321493|FG000|Single-Blind|Laboratory Abnormality|5|||
94419152|NCT00292188|323321494|FG001|Single-Blind|Laboratory Abnormality|0|||
94419153|NCT00292188|323321495|FG002|Single-Blind|Laboratory Abnormality|0|||
94419154|NCT00292188|323321493|FG000|Single-Blind|Lost to Follow-up|3|||
94419155|NCT00292188|323321494|FG001|Single-Blind|Lost to Follow-up|0|||
94419156|NCT00292188|323321495|FG002|Single-Blind|Lost to Follow-up|0|||
94419157|NCT00292188|323321493|FG000|Single-Blind|Other|77|||
94419158|NCT00292188|323321494|FG001|Single-Blind|Other|0|||
94419159|NCT00292188|323321495|FG002|Single-Blind|Other|0|||
94419160|NCT00292188|323321493|FG000|Single-Blind|Withdrawal by Subject|12|||
94419161|NCT00292188|323321494|FG001|Single-Blind|Withdrawal by Subject|0|||
94419162|NCT00292188|323321495|FG002|Single-Blind|Withdrawal by Subject|0|||
94419163|NCT00292188|323321493|FG000|Single-Blind|Did not receive treatment|1|||
94419164|NCT00292188|323321494|FG001|Single-Blind|Did not receive treatment|0|||
94419165|NCT00292188|323321495|FG002|Single-Blind|Did not receive treatment|0|||
94419166|NCT00292188|323321493|FG000|Double-Blind|Adverse Event|0|||
94419167|NCT00292188|323321494|FG001|Double-Blind|Adverse Event|25|||
94419168|NCT00292188|323321495|FG002|Double-Blind|Adverse Event|9|||
94419169|NCT00292188|323321493|FG000|Double-Blind|Lack of Efficacy|0|||
94419170|NCT00292188|323321494|FG001|Double-Blind|Lack of Efficacy|2|||
94419171|NCT00292188|323321495|FG002|Double-Blind|Lack of Efficacy|12|||
94419172|NCT00292188|323321493|FG000|Double-Blind|Lost to Follow-up|0|||
94419173|NCT00292188|323321494|FG001|Double-Blind|Lost to Follow-up|1|||
94419174|NCT00292188|323321495|FG002|Double-Blind|Lost to Follow-up|0|||
94419175|NCT00292188|323321493|FG000|Double-Blind|Other|0|||
94419176|NCT00292188|323321494|FG001|Double-Blind|Other|3|||
94419177|NCT00292188|323321495|FG002|Double-Blind|Other|4|||
94419178|NCT00292188|323321493|FG000|Double-Blind|Withdrawal by Subject|0|||
94419179|NCT00292188|323321494|FG001|Double-Blind|Withdrawal by Subject|0|||
94419180|NCT00292188|323321495|FG002|Double-Blind|Withdrawal by Subject|3|||
94419181|NCT00292188|323321493|FG000|Double-Blind|Laboratory Abnormality|0|||
94419182|NCT00292188|323321494|FG001|Double-Blind|Laboratory Abnormality|0|||
94419183|NCT00292188|323321495|FG002|Double-Blind|Laboratory Abnormality|1|||
94419184|NCT00857792|323321496|FG000|Overall Study|inadequate image quality for analysis|12|||
94419185|NCT01797835|323321503|FG000|Overall Study|Lost to Follow-up|31|||
94419186|NCT01797835|323321504|FG001|Overall Study|Lost to Follow-up|27|||
94419187|NCT02528123|323321508|FG000|Overall Study|Lost to Follow-up|1|||
94419188|NCT03733210|323321509|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
94419189|NCT03733210|323321510|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
94419190|NCT03760250|323321511|FG000|Overall Study|Withdrawal by Subject|1|||
94419191|NCT03760250|323321511|FG000|Overall Study|Physician Decision|1|||
94419192|NCT01939496|323321519|FG000|Overall Study|Adverse Event|2|||
94419193|NCT01939496|323321520|FG001|Overall Study|Adverse Event|0|||
94419194|NCT01939496|323321521|FG002|Overall Study|Adverse Event|0|||
94419195|NCT01939496|323321519|FG000|Overall Study|Lost to Follow-up|1|||
94419196|NCT01939496|323321520|FG001|Overall Study|Lost to Follow-up|1|||
94419197|NCT01939496|323321521|FG002|Overall Study|Lost to Follow-up|0|||
94419198|NCT01939496|323321519|FG000|Overall Study|Physician Decision|1|||
94419199|NCT01939496|323321520|FG001|Overall Study|Physician Decision|0|||
94419200|NCT01939496|323321521|FG002|Overall Study|Physician Decision|0|||
94419201|NCT01939496|323321519|FG000|Overall Study|Protocol Violation|3|||
94419202|NCT01939496|323321520|FG001|Overall Study|Protocol Violation|0|||
94419203|NCT01939496|323321521|FG002|Overall Study|Protocol Violation|0|||
94419204|NCT01939496|323321519|FG000|Overall Study|Withdrawal by Subject|0|||
94419205|NCT01939496|323321520|FG001|Overall Study|Withdrawal by Subject|1|||
94419206|NCT01939496|323321521|FG002|Overall Study|Withdrawal by Subject|1|||
94419207|NCT01939496|323321519|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
94419208|NCT01939496|323321520|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
94419209|NCT01939496|323321521|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
94419210|NCT01939496|323321519|FG000|Overall Study|Other|2|||
94419211|NCT01939496|323321520|FG001|Overall Study|Other|0|||
94419212|NCT01939496|323321521|FG002|Overall Study|Other|1|||
94419213|NCT04421586|323321527|FG000|Overall Study|Death|0|||
94419214|NCT04421586|323321528|FG001|Overall Study|Death|1|||
94419215|NCT04421586|323321527|FG000|Overall Study|Lost to Follow-up|2|||
94419216|NCT04421586|323321528|FG001|Overall Study|Lost to Follow-up|2|||
94419217|NCT04421586|323321527|FG000|Overall Study|Withdrawn by PI|1|||
94419218|NCT04421586|323321528|FG001|Overall Study|Withdrawn by PI|0|||
94419219|NCT04421586|323321527|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
94419220|NCT04421586|323321528|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
94419221|NCT02963441|323321529|FG000|Overall Study|Protocol violation or withdrawn|8|||
94419222|NCT02963441|323321529|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
94419223|NCT02963441|323321529|FG000|Overall Study|IDx-DR insufficient quality|33|||
94419224|NCT02384941|323321530|FG000|Overall Study|Adverse Event|11|||
94419225|NCT02384941|323321531|FG001|Overall Study|Adverse Event|13|||
94419226|NCT02384941|323321532|FG002|Overall Study|Adverse Event|17|||
94419227|NCT02384941|323321530|FG000|Overall Study|Lost to Follow-up|3|||
94419228|NCT02384941|323321531|FG001|Overall Study|Lost to Follow-up|2|||
94419229|NCT02384941|323321532|FG002|Overall Study|Lost to Follow-up|1|||
94419230|NCT02384941|323321530|FG000|Overall Study|Non-Compliance With Study Drug|2|||
94419231|NCT02384941|323321531|FG001|Overall Study|Non-Compliance With Study Drug|0|||
94419232|NCT02384941|323321532|FG002|Overall Study|Non-Compliance With Study Drug|1|||
94419233|NCT02384941|323321530|FG000|Overall Study|Physician Decision|1|||
94419234|NCT02384941|323321531|FG001|Overall Study|Physician Decision|1|||
94419235|NCT02384941|323321532|FG002|Overall Study|Physician Decision|0|||
94419236|NCT02384941|323321530|FG000|Overall Study|Protocol Violation|3|||
94419237|NCT02384941|323321531|FG001|Overall Study|Protocol Violation|0|||
94419238|NCT02384941|323321532|FG002|Overall Study|Protocol Violation|0|||
94419239|NCT02384941|323321530|FG000|Overall Study|Withdrawal by Subject|26|||
94419240|NCT02384941|323321531|FG001|Overall Study|Withdrawal by Subject|19|||
94419241|NCT02384941|323321532|FG002|Overall Study|Withdrawal by Subject|20|||
94419242|NCT02384941|323321530|FG000|Overall Study|Pregnancy|0|||
94419243|NCT02384941|323321531|FG001|Overall Study|Pregnancy|0|||
94419244|NCT02384941|323321532|FG002|Overall Study|Pregnancy|1|||
94419245|NCT02384941|323321530|FG000|Overall Study|Other than specified above|4|||
94419246|NCT02384941|323321531|FG001|Overall Study|Other than specified above|0|||
94419247|NCT02384941|323321532|FG002|Overall Study|Other than specified above|1|||
94419248|NCT04688931|323321533|FG000|Overall Study|Adverse Event|4|||
94419249|NCT04688931|323321534|FG001|Overall Study|Adverse Event|1|||
94419250|NCT04688931|323321533|FG000|Overall Study|Withdrawal by Subject|5|||
94419251|NCT04688931|323321534|FG001|Overall Study|Withdrawal by Subject|16|||
94419252|NCT04688931|323321533|FG000|Overall Study|Physician Decision|3|||
94419253|NCT04688931|323321534|FG001|Overall Study|Physician Decision|5|||
94419254|NCT04688931|323321533|FG000|Overall Study|Noncompliance|0|||
94419255|NCT04688931|323321534|FG001|Overall Study|Noncompliance|1|||
94419256|NCT04688931|323321533|FG000|Overall Study|Lost to Follow-up|1|||
94419257|NCT04688931|323321534|FG001|Overall Study|Lost to Follow-up|3|||
94419258|NCT04688931|323321533|FG000|Overall Study|Randomization Error|3|||
94419259|NCT04688931|323321534|FG001|Overall Study|Randomization Error|0|||
94419260|NCT04688931|323321533|FG000|Overall Study|Not Eligible|1|||
94419261|NCT04688931|323321534|FG001|Overall Study|Not Eligible|3|||
94419262|NCT04688931|323321533|FG000|Overall Study|Disease Progression|0|||
94419263|NCT04688931|323321534|FG001|Overall Study|Disease Progression|2|||
94419264|NCT04688931|323321533|FG000|Overall Study|Sponsor Requirement|1|||
94419265|NCT04688931|323321534|FG001|Overall Study|Sponsor Requirement|1|||
94419266|NCT04688931|323321533|FG000|Overall Study|Other Reason|1|||
94419267|NCT04688931|323321534|FG001|Overall Study|Other Reason|2|||
94419268|NCT02372071|323321546|FG000|Overall Study|Protocol Violation|18|||
94419269|NCT04505293|323321547|FG000|Overall Study|Lost to Follow-up|2|||
94419270|NCT04505293|323321547|FG000|Overall Study|Withdrawal by Subject|6|||
94419271|NCT04505293|323321547|FG000|Overall Study|CT scan unreadable|277|||
94419272|NCT00354341|323321550|FG000|Overall Study|Adverse Event|1|||
94419273|NCT00354341|323321551|FG001|Overall Study|Adverse Event|0|||
94419274|NCT00354341|323321550|FG000|Overall Study|Death|0|||
94419275|NCT00354341|323321551|FG001|Overall Study|Death|2|||
94419276|NCT00354341|323321550|FG000|Overall Study|Refused treatment|1|||
94419277|NCT00354341|323321551|FG001|Overall Study|Refused treatment|2|||
94419278|NCT00354341|323321550|FG000|Overall Study|Failure to return|0|||
94419279|NCT00354341|323321551|FG001|Overall Study|Failure to return|1|||
94419280|NCT00354341|323321550|FG000|Overall Study|Other|1|||
94419281|NCT00354341|323321551|FG001|Overall Study|Other|2|||
94419282|NCT02836496|323321552|FG000|Overall Study|Adverse Event|2|||
94419283|NCT02836496|323321553|FG001|Overall Study|Adverse Event|1|||
94419284|NCT02836496|323321552|FG000|Overall Study|Withdrawal by Subject|0|||
94419285|NCT02836496|323321553|FG001|Overall Study|Withdrawal by Subject|1|||
94419286|NCT01642914|323321554|FG000|Overall Study|Adverse Event|11|||
94419287|NCT01642914|323321555|FG001|Overall Study|Adverse Event|7|||
94419288|NCT01642914|323321556|FG002|Overall Study|Adverse Event|15|||
94419289|NCT01642914|323321554|FG000|Overall Study|Lack of Efficacy|9|||
94419290|NCT01642914|323321555|FG001|Overall Study|Lack of Efficacy|4|||
94419291|NCT01642914|323321556|FG002|Overall Study|Lack of Efficacy|2|||
94419292|NCT01642914|323321554|FG000|Overall Study|Protocol Violation|15|||
94419293|NCT01642914|323321555|FG001|Overall Study|Protocol Violation|13|||
94419294|NCT01642914|323321556|FG002|Overall Study|Protocol Violation|6|||
94419295|NCT01642914|323321554|FG000|Overall Study|Withdrawal by Subject|5|||
94419296|NCT01642914|323321555|FG001|Overall Study|Withdrawal by Subject|5|||
94419297|NCT01642914|323321556|FG002|Overall Study|Withdrawal by Subject|10|||
94419298|NCT01642914|323321554|FG000|Overall Study|Lost to Follow-up|5|||
94419299|NCT01642914|323321555|FG001|Overall Study|Lost to Follow-up|3|||
94419300|NCT01642914|323321556|FG002|Overall Study|Lost to Follow-up|7|||
94419301|NCT01642914|323321554|FG000|Overall Study|Other Reason|1|||
94419302|NCT01642914|323321555|FG001|Overall Study|Other Reason|0|||
94419303|NCT01642914|323321556|FG002|Overall Study|Other Reason|0|||
94419304|NCT01400919|323321557|FG000|Overall Study|Withdrawal by Subject|4|||
94419305|NCT01400919|323321557|FG000|Overall Study|Lost to Follow-up|2|||
94419306|NCT01400919|323321557|FG000|Overall Study|Missed visit|2|||
94419307|NCT04594707|323321564|FG000|Overall Study|Adverse Event|0|||
94488796|NCT02513550|323583528|FG001|Double Blind Treatment Period|Adverse Event|13|||
94488797|NCT02513550|323583529|FG002|Double Blind Treatment Period|Adverse Event|17|||
94488798|NCT02513550|323583530|FG003|Double Blind Treatment Period|Adverse Event|0|||
94488799|NCT02513550|323583531|FG004|Double Blind Treatment Period|Adverse Event|1|||
94488800|NCT02513550|323583532|FG005|Double Blind Treatment Period|Adverse Event|0|||
94488801|NCT02513550|323583527|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
94488802|NCT02513550|323583528|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
94488803|NCT02513550|323583529|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
94488804|NCT02513550|323583530|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
94488805|NCT02513550|323583531|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
94488806|NCT02513550|323583532|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
94488807|NCT02513550|323583527|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
94488808|NCT02513550|323583528|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
94488809|NCT02513550|323583529|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
94488810|NCT02513550|323583530|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
94488811|NCT02513550|323583531|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
94488812|NCT02513550|323583532|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
94488813|NCT02513550|323583527|FG000|Double Blind Treatment Period|Protocol Violation|1|||
94488814|NCT02513550|323583528|FG001|Double Blind Treatment Period|Protocol Violation|1|||
94488815|NCT02513550|323583529|FG002|Double Blind Treatment Period|Protocol Violation|4|||
94488816|NCT02513550|323583530|FG003|Double Blind Treatment Period|Protocol Violation|0|||
94488817|NCT02513550|323583531|FG004|Double Blind Treatment Period|Protocol Violation|0|||
94488818|NCT02513550|323583532|FG005|Double Blind Treatment Period|Protocol Violation|0|||
94488819|NCT02513550|323583527|FG000|Double Blind Treatment Period|Physician Decision|2|||
94488820|NCT02513550|323583528|FG001|Double Blind Treatment Period|Physician Decision|0|||
94488821|NCT02513550|323583529|FG002|Double Blind Treatment Period|Physician Decision|4|||
94488822|NCT02513550|323583530|FG003|Double Blind Treatment Period|Physician Decision|0|||
94488823|NCT02513550|323583531|FG004|Double Blind Treatment Period|Physician Decision|0|||
94488824|NCT02513550|323583532|FG005|Double Blind Treatment Period|Physician Decision|0|||
94488825|NCT02513550|323583527|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
94488826|NCT02513550|323583528|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
94488827|NCT02513550|323583529|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
94488828|NCT02513550|323583530|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
94488829|NCT02513550|323583531|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
94488830|NCT02513550|323583532|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
94488831|NCT02513550|323583527|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
94488832|NCT02513550|323583528|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
94488833|NCT02513550|323583529|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
94488834|NCT02513550|323583530|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
94488835|NCT02513550|323583531|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
94488836|NCT02513550|323583532|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
94488837|NCT02513550|323583527|FG000|Double Blind Treatment Period|Due to personal business|2|||
94488838|NCT02513550|323583528|FG001|Double Blind Treatment Period|Due to personal business|0|||
94488839|NCT02513550|323583529|FG002|Double Blind Treatment Period|Due to personal business|1|||
94488840|NCT02513550|323583530|FG003|Double Blind Treatment Period|Due to personal business|0|||
94488841|NCT02513550|323583531|FG004|Double Blind Treatment Period|Due to personal business|0|||
94488842|NCT02513550|323583532|FG005|Double Blind Treatment Period|Due to personal business|0|||
94488843|NCT02513550|323583527|FG000|Double Blind Treatment Period|Death|1|||
94488844|NCT02513550|323583528|FG001|Double Blind Treatment Period|Death|0|||
94488845|NCT02513550|323583529|FG002|Double Blind Treatment Period|Death|2|||
94488846|NCT02513550|323583530|FG003|Double Blind Treatment Period|Death|0|||
94488847|NCT02513550|323583531|FG004|Double Blind Treatment Period|Death|0|||
94488848|NCT02513550|323583532|FG005|Double Blind Treatment Period|Death|0|||
94488849|NCT02513550|323583527|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
94488850|NCT02513550|323583528|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
94488851|NCT02513550|323583529|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
94488852|NCT02513550|323583530|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
94488853|NCT02513550|323583531|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
94488854|NCT02513550|323583532|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
94488855|NCT02513550|323583527|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
94488856|NCT02513550|323583528|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
94488857|NCT02513550|323583529|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
94488858|NCT02513550|323583530|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
94488859|NCT02513550|323583531|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
94488860|NCT02513550|323583532|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
94488861|NCT02513550|323583527|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
94488862|NCT02513550|323583528|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
94488863|NCT02513550|323583529|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
94488864|NCT02513550|323583530|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
94488865|NCT02513550|323583531|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
94488866|NCT02513550|323583532|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
94488867|NCT02513550|323583527|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
94488868|NCT02513550|323583528|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
94488869|NCT02513550|323583529|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
94488870|NCT02513550|323583530|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
94488871|NCT02513550|323583531|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
94488872|NCT02513550|323583532|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
94488873|NCT02513550|323583527|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
94488874|NCT02513550|323583528|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
94488875|NCT02513550|323583529|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
94488876|NCT02513550|323583530|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
94488877|NCT02513550|323583531|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
94488878|NCT02513550|323583532|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
94488879|NCT02513550|323583527|FG000|Post-Treatment Follow-up Period|Death|0|||
94488880|NCT02513550|323583528|FG001|Post-Treatment Follow-up Period|Death|0|||
94488881|NCT02513550|323583529|FG002|Post-Treatment Follow-up Period|Death|1|||
94488882|NCT02513550|323583530|FG003|Post-Treatment Follow-up Period|Death|0|||
94488883|NCT02513550|323583531|FG004|Post-Treatment Follow-up Period|Death|0|||
94488884|NCT02513550|323583532|FG005|Post-Treatment Follow-up Period|Death|0|||
94488885|NCT02513550|323583527|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
94488886|NCT02513550|323583528|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
94488887|NCT02513550|323583529|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
94488888|NCT02513550|323583530|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
94488889|NCT02513550|323583531|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
94488890|NCT02513550|323583532|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
94488891|NCT02513550|323583527|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
94488892|NCT02513550|323583528|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
94488893|NCT02513550|323583529|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
94488894|NCT02513550|323583530|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
94488895|NCT02513550|323583531|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
94488896|NCT02513550|323583532|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
94488897|NCT02513550|323583527|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
94488898|NCT02513550|323583528|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
94488899|NCT02513550|323583529|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
94488900|NCT02513550|323583530|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
94488901|NCT02513550|323583531|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
94488902|NCT02513550|323583532|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
94488903|NCT01401322|323583533|FG000|Overall Study|Withdrawal by Subject|1|||
94488904|NCT01401322|323583533|FG000|Overall Study|Physician Decision|1|||
94488905|NCT01670292|323583534|FG000|Overall Study|Lost to Follow-up|14|||
94488906|NCT00630916|323583549|FG000|Overall Study|Death|110|||
94488907|NCT00630916|323583549|FG000|Overall Study|Explant|8|||
94488908|NCT00630916|323583549|FG000|Overall Study|Lost to Follow-up|5|||
94488909|NCT00630916|323583549|FG000|Overall Study|Withdrawal by Subject|30|||
94488910|NCT00630916|323583549|FG000|Overall Study|Protocol Violation|7|||
94488911|NCT00630916|323583549|FG000|Overall Study|Physician Decision|47|||
94488912|NCT00630916|323583549|FG000|Overall Study|Lack of Efficacy|3|||
94488913|NCT01033136|323583550|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
94488914|NCT01033136|323583551|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
94488915|NCT02295644|323583560|FG000|Overall Study|Did not meet inclusion criterion|0|||
94488916|NCT02295644|323583561|FG001|Overall Study|Did not meet inclusion criterion|0|||
94488917|NCT02295644|323583562|FG002|Overall Study|Did not meet inclusion criterion|1|||
94488918|NCT02295644|323583563|FG003|Overall Study|Did not meet inclusion criterion|2|||
94488919|NCT01692119|323583564|FG000|Overall Study|Protocol Violation|3|||
94488920|NCT01692119|323583565|FG001|Overall Study|Protocol Violation|1|||
94488921|NCT01692119|323583564|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
94488922|NCT01692119|323583565|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
94488923|NCT03451045|323583581|FG000|Overall Study|Lack of Efficacy|3|||
94488924|NCT03451045|323583582|FG001|Overall Study|Lack of Efficacy|2|||
94488925|NCT03451045|323583583|FG002|Overall Study|Lack of Efficacy|2|||
94488926|NCT03451045|323583581|FG000|Overall Study|Physician Decision|1|||
94488927|NCT03451045|323583582|FG001|Overall Study|Physician Decision|1|||
94488928|NCT03451045|323583583|FG002|Overall Study|Physician Decision|1|||
94488929|NCT03451045|323583581|FG000|Overall Study|Withdrawal by Subject|4|||
94488930|NCT03451045|323583582|FG001|Overall Study|Withdrawal by Subject|0|||
94488931|NCT03451045|323583583|FG002|Overall Study|Withdrawal by Subject|5|||
94488932|NCT03451045|323583581|FG000|Overall Study|Pregnancy|0|||
94488933|NCT03451045|323583582|FG001|Overall Study|Pregnancy|0|||
94488934|NCT03451045|323583583|FG002|Overall Study|Pregnancy|2|||
94488935|NCT03451045|323583581|FG000|Overall Study|Adverse Event|7|||
94488936|NCT03451045|323583582|FG001|Overall Study|Adverse Event|1|||
94488937|NCT03451045|323583583|FG002|Overall Study|Adverse Event|3|||
94488938|NCT03451045|323583581|FG000|Overall Study|Non-compliance with study|2|||
94488939|NCT03451045|323583582|FG001|Overall Study|Non-compliance with study|0|||
94488940|NCT03451045|323583583|FG002|Overall Study|Non-compliance with study|1|||
94488941|NCT03451045|323583581|FG000|Overall Study|any other reason|10|||
94488942|NCT03451045|323583582|FG001|Overall Study|any other reason|2|||
94488943|NCT03451045|323583583|FG002|Overall Study|any other reason|13|||
94488944|NCT02722967|323583584|FG000|Overall Study|Adverse Event|1|||
94488945|NCT02722967|323583585|FG001|Overall Study|Adverse Event|0|||
94488946|NCT02722967|323583586|FG002|Overall Study|Adverse Event|0|||
94488947|NCT02722967|323583584|FG000|Overall Study|Lost to Follow-up|0|||
94488948|NCT02722967|323583585|FG001|Overall Study|Lost to Follow-up|1|||
94488949|NCT02722967|323583586|FG002|Overall Study|Lost to Follow-up|0|||
94488950|NCT02722967|323583584|FG000|Overall Study|Non-compliance with patch wearing|2|||
94488951|NCT02722967|323583585|FG001|Overall Study|Non-compliance with patch wearing|1|||
94488952|NCT02722967|323583586|FG002|Overall Study|Non-compliance with patch wearing|1|||
94488953|NCT02722967|323583584|FG000|Overall Study|Withdrawal by Subject|1|||
94488954|NCT02722967|323583585|FG001|Overall Study|Withdrawal by Subject|0|||
94488955|NCT02722967|323583586|FG002|Overall Study|Withdrawal by Subject|1|||
94488956|NCT02722967|323583584|FG000|Overall Study|Physician Decision|1|||
94488957|NCT02722967|323583585|FG001|Overall Study|Physician Decision|0|||
94488958|NCT02722967|323583586|FG002|Overall Study|Physician Decision|0|||
94488959|NCT02722967|323583584|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
94488960|NCT02722967|323583585|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
94488961|NCT02722967|323583586|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
94488962|NCT02391337|323583587|FG000|6 Months Follow-up|Death|5|||
94488963|NCT02391337|323583588|FG001|6 Months Follow-up|Death|4|||
94488964|NCT02391337|323583587|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
94488965|NCT02391337|323583588|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
94488966|NCT02391337|323583587|FG000|12 Months Follow-up|Death|2|||
94488967|NCT02391337|323583588|FG001|12 Months Follow-up|Death|0|||
94488968|NCT02391337|323583587|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
94488969|NCT02391337|323583588|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
94488970|NCT02391337|323583587|FG000|12 Months Follow-up|Lost to Follow-up|0|||
94488971|NCT02391337|323583588|FG001|12 Months Follow-up|Lost to Follow-up|2|||
94488972|NCT00465517|323583589|FG000|Overall Study|Adverse Event|7|||
94488973|NCT00465517|323583590|FG001|Overall Study|Adverse Event|3|||
94488974|NCT00465517|323583589|FG000|Overall Study|Lost to Follow-up|1|||
94488975|NCT00465517|323583590|FG001|Overall Study|Lost to Follow-up|0|||
94488976|NCT00465517|323583589|FG000|Overall Study|Withdrawal by Subject|4|||
94488977|NCT00465517|323583590|FG001|Overall Study|Withdrawal by Subject|1|||
94488978|NCT01286129|323583591|FG000|Overall Study|Withdrawal by Subject|4|||
94488979|NCT01286129|323583592|FG001|Overall Study|Withdrawal by Subject|1|||
94419308|NCT04594707|323321565|FG001|Overall Study|Adverse Event|0|||
94419309|NCT04594707|323321566|FG002|Overall Study|Adverse Event|1|||
94419310|NCT04594707|323321564|FG000|Overall Study|Death|0|||
94419311|NCT04594707|323321565|FG001|Overall Study|Death|2|||
94419312|NCT04594707|323321566|FG002|Overall Study|Death|2|||
94419313|NCT04594707|323321564|FG000|Overall Study|Lung Transplant|0|||
94419314|NCT04594707|323321565|FG001|Overall Study|Lung Transplant|0|||
94419315|NCT04594707|323321566|FG002|Overall Study|Lung Transplant|1|||
94419316|NCT04594707|323321564|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
94419317|NCT04594707|323321565|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
94419318|NCT04594707|323321566|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
94419319|NCT04594707|323321564|FG000|Overall Study|Study Terminated By Sponsor|19|||
94419320|NCT04594707|323321565|FG001|Overall Study|Study Terminated By Sponsor|47|||
94419321|NCT04594707|323321566|FG002|Overall Study|Study Terminated By Sponsor|41|||
94419322|NCT04594707|323321564|FG000|Overall Study|Withdrawal by Subject|1|||
94419323|NCT04594707|323321565|FG001|Overall Study|Withdrawal by Subject|0|||
94419324|NCT04594707|323321566|FG002|Overall Study|Withdrawal by Subject|2|||
94419325|NCT02575911|323321567|FG000|Overall Study|Lost to Follow-up|1|||
94419326|NCT02408068|323321568|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
94488980|NCT01286129|323583591|FG000|Overall Study|Could not comply with study requirements|4|||
94488981|NCT01286129|323583592|FG001|Overall Study|Could not comply with study requirements|4|||
94488982|NCT00830128|323583593|FG000|Overall Study|Adverse Event|5|||
94488983|NCT00830128|323583593|FG000|Overall Study|Lack of Efficacy|7|||
94488984|NCT00830128|323583593|FG000|Overall Study|Protocol Violation|1|||
94419327|NCT02408068|323321569|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
94488985|NCT00830128|323583593|FG000|Overall Study|Withdrawal by Subject|2|||
94488986|NCT00830128|323583593|FG000|Overall Study|Family obligation|1|||
94488987|NCT00830128|323583593|FG000|Overall Study|Relocation|1|||
94488988|NCT00830128|323583593|FG000|Overall Study|Work obligation|1|||
94419328|NCT02408068|323321570|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
94419329|NCT02408068|323321571|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
94419330|NCT02408068|323321572|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
94419331|NCT02408068|323321573|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
94419332|NCT01782482|323321585|FG000|Overall Study|Adverse Event|2|||
94419333|NCT01782482|323321586|FG001|Overall Study|Adverse Event|1|||
94419334|NCT01782482|323321585|FG000|Overall Study|Lost to Follow-up|2|||
94419335|NCT01782482|323321586|FG001|Overall Study|Lost to Follow-up|3|||
94419336|NCT01782482|323321585|FG000|Overall Study|Physician Decision|1|||
94419337|NCT01782482|323321586|FG001|Overall Study|Physician Decision|0|||
94419338|NCT01782482|323321585|FG000|Overall Study|Protocol Violation|1|||
94419339|NCT01782482|323321586|FG001|Overall Study|Protocol Violation|0|||
94419340|NCT01782482|323321585|FG000|Overall Study|Withdrawal by Subject|2|||
94419341|NCT01782482|323321586|FG001|Overall Study|Withdrawal by Subject|3|||
94419342|NCT01782482|323321585|FG000|Overall Study|Randomized in Error|2|||
94419343|NCT01782482|323321586|FG001|Overall Study|Randomized in Error|2|||
94419344|NCT01782482|323321585|FG000|Overall Study|Habitually wearing toric lens OS|0|||
94419345|NCT01782482|323321586|FG001|Overall Study|Habitually wearing toric lens OS|1|||
94419346|NCT00995085|323321590|FG000|Overall Study|Withdrawal by Subject|5|||
94419347|NCT03096847|323321591|FG000|Overall Study|Other|2|||
94419348|NCT03096847|323321592|FG001|Overall Study|Other|1|||
94419349|NCT03096847|323321593|FG002|Overall Study|Other|2|||
94419350|NCT03096847|323321591|FG000|Overall Study|Lost to Follow-up|1|||
94419351|NCT03096847|323321592|FG001|Overall Study|Lost to Follow-up|0|||
94419352|NCT03096847|323321593|FG002|Overall Study|Lost to Follow-up|1|||
94419353|NCT03096847|323321591|FG000|Overall Study|Death|6|||
94419354|NCT03096847|323321592|FG001|Overall Study|Death|0|||
94419355|NCT03096847|323321593|FG002|Overall Study|Death|2|||
94419356|NCT03096847|323321591|FG000|Overall Study|Protocol Violation|3|||
94419357|NCT03096847|323321592|FG001|Overall Study|Protocol Violation|0|||
94419358|NCT03096847|323321593|FG002|Overall Study|Protocol Violation|6|||
94419359|NCT03096847|323321591|FG000|Overall Study|Physician Decision|12|||
94419360|NCT03096847|323321592|FG001|Overall Study|Physician Decision|2|||
94419361|NCT03096847|323321593|FG002|Overall Study|Physician Decision|8|||
94419362|NCT03096847|323321591|FG000|Overall Study|Withdrawal by Subject|24|||
94419363|NCT03096847|323321592|FG001|Overall Study|Withdrawal by Subject|1|||
94419364|NCT03096847|323321593|FG002|Overall Study|Withdrawal by Subject|12|||
94419365|NCT03096847|323321591|FG000|Overall Study|Adverse Event|72|||
94419366|NCT03096847|323321592|FG001|Overall Study|Adverse Event|6|||
94419367|NCT03096847|323321593|FG002|Overall Study|Adverse Event|28|||
94419368|NCT03096847|323321591|FG000|Overall Study|Progressive disease|97|||
94419369|NCT03096847|323321592|FG001|Overall Study|Progressive disease|10|||
94419370|NCT03096847|323321593|FG002|Overall Study|Progressive disease|78|||
94419371|NCT03096847|323321591|FG000|Overall Study|Non-compliance with study medication|1|||
94419372|NCT03096847|323321592|FG001|Overall Study|Non-compliance with study medication|0|||
94419373|NCT03096847|323321593|FG002|Overall Study|Non-compliance with study medication|0|||
94419374|NCT03096847|323321591|FG000|Overall Study|New therapy for study indication|1|||
94419375|NCT03096847|323321592|FG001|Overall Study|New therapy for study indication|0|||
94419376|NCT03096847|323321593|FG002|Overall Study|New therapy for study indication|1|||
94419377|NCT00359632|323321596|FG000|Overall Study|Death|2|||
94419378|NCT00359632|323321597|FG001|Overall Study|Death|0|||
94419379|NCT00359632|323321596|FG000|Overall Study|Adverse Event|1|||
94419380|NCT00359632|323321597|FG001|Overall Study|Adverse Event|0|||
94419381|NCT00359632|323321596|FG000|Overall Study|Non-compliance with visit schedule|1|||
94419382|NCT00359632|323321597|FG001|Overall Study|Non-compliance with visit schedule|0|||
94419383|NCT00251641|323321598|FG000|Overall Study|Adverse Event|80|||
94419384|NCT00251641|323321599|FG001|Overall Study|Adverse Event|8|||
94419385|NCT00251641|323321598|FG000|Overall Study|Lack of Efficacy|2|||
94419386|NCT00251641|323321599|FG001|Overall Study|Lack of Efficacy|1|||
94419387|NCT00251641|323321598|FG000|Overall Study|Progression of Disease|0|||
94419388|NCT00251641|323321599|FG001|Overall Study|Progression of Disease|2|||
94419389|NCT00251641|323321598|FG000|Overall Study|Lost to Follow-up|3|||
94419390|NCT00251641|323321599|FG001|Overall Study|Lost to Follow-up|3|||
94419391|NCT00251641|323321598|FG000|Overall Study|Withdrawal by Subject|6|||
94488989|NCT00830128|323583593|FG000|Overall Study|Operating a vehicle|1|||
94419392|NCT00251641|323321599|FG001|Overall Study|Withdrawal by Subject|8|||
94419393|NCT00251641|323321598|FG000|Overall Study|Protocol Violation|10|||
94419394|NCT00251641|323321599|FG001|Overall Study|Protocol Violation|2|||
94419395|NCT00251641|323321598|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
94419396|NCT00251641|323321599|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
94419397|NCT00251641|323321598|FG000|Overall Study|Switched Treatment|9|||
94419398|NCT00251641|323321599|FG001|Overall Study|Switched Treatment|63|||
94419399|NCT02039414|323321602|FG000|Overall Study|Delivered|1|||
94419400|NCT02039414|323321603|FG001|Overall Study|Delivered|1|||
94419401|NCT02039414|323321602|FG000|Overall Study|Lost to Follow-up|2|||
94419402|NCT02039414|323321603|FG001|Overall Study|Lost to Follow-up|0|||
94419403|NCT02039414|323321602|FG000|Overall Study|Protocol Violation|3|||
94419404|NCT02039414|323321603|FG001|Overall Study|Protocol Violation|1|||
94419405|NCT00679913|323321606|FG000|Overall Study|Protocol Violation|18|||
94488990|NCT00314145|323583596|FG000|Overall Study|Withdrawal by Subject|8|||
94419406|NCT00679913|323321607|FG001|Overall Study|Protocol Violation|13|||
94488991|NCT00314145|323583597|FG001|Overall Study|Withdrawal by Subject|10|||
94488992|NCT00314145|323583596|FG000|Overall Study|Lost to Follow-up|5|||
94488993|NCT00314145|323583597|FG001|Overall Study|Lost to Follow-up|12|||
94488994|NCT00314145|323583596|FG000|Overall Study|Physician Decision|3|||
94488995|NCT00314145|323583597|FG001|Overall Study|Physician Decision|4|||
94488996|NCT00314145|323583596|FG000|Overall Study|Adverse Event|0|||
94488997|NCT00314145|323583597|FG001|Overall Study|Adverse Event|3|||
94488998|NCT00314145|323583596|FG000|Overall Study|Protocol Violation|3|||
94488999|NCT00314145|323583597|FG001|Overall Study|Protocol Violation|0|||
94489000|NCT00314145|323583596|FG000|Overall Study|Sponsor Decision|2|||
94489001|NCT00314145|323583597|FG001|Overall Study|Sponsor Decision|0|||
94489002|NCT01416571|323583598|FG000|Overall Study|Lost to Follow-up|2|||
94489003|NCT00959751|323585969|FG000|Overall Study|Lost to Follow-up|2|||
94489004|NCT00959751|323585970|FG001|Overall Study|Lost to Follow-up|3|||
94489005|NCT00959751|323585969|FG000|Overall Study|Consent Withdrawn|0|||
94489006|NCT00959751|323585970|FG001|Overall Study|Consent Withdrawn|1|||
94489007|NCT00959751|323585969|FG000|Overall Study|Non-compliance to Study Procedures|0|||
94489008|NCT00959751|323585970|FG001|Overall Study|Non-compliance to Study Procedures|1|||
94489009|NCT00959751|323585969|FG000|Overall Study|No migraine headache without aura|7|||
94489010|NCT00959751|323585970|FG001|Overall Study|No migraine headache without aura|7|||
94489011|NCT02807259|323585973|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
94489012|NCT02807259|323585974|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
94489013|NCT02807259|323585973|FG000|Midline (3 Months)|migration, refusal, not available|30|||
94489014|NCT02807259|323585974|FG001|Midline (3 Months)|migration, refusal, not available|34|||
94489015|NCT02807259|323585973|FG000|Endline (3 Months)|migration, refusal, not available|35|||
94489016|NCT02807259|323585974|FG001|Endline (3 Months)|migration, refusal, not available|87|||
94489017|NCT01673386|323585975|FG000|Overall Study|Study terminated by sponsor|16|||
94489018|NCT01673386|323585976|FG001|Overall Study|Study terminated by sponsor|22|||
94489019|NCT01673386|323585975|FG000|Overall Study|Adverse Event|5|||
94489020|NCT01673386|323585976|FG001|Overall Study|Adverse Event|2|||
94489021|NCT01673386|323585975|FG000|Overall Study|Progressive disease|4|||
94489022|NCT01673386|323585976|FG001|Overall Study|Progressive disease|1|||
94489023|NCT01673386|323585975|FG000|Overall Study|Withdrawal by Subject|0|||
94489024|NCT01673386|323585976|FG001|Overall Study|Withdrawal by Subject|2|||
94489025|NCT01799889|323585977|FG000|Overall Study|Adverse Event|4|||
94489026|NCT01799889|323585978|FG001|Overall Study|Adverse Event|4|||
94489027|NCT01799889|323585979|FG002|Overall Study|Adverse Event|5|||
94489028|NCT01799889|323585980|FG003|Overall Study|Adverse Event|1|||
94489029|NCT01799889|323585981|FG004|Overall Study|Adverse Event|11|||
94489030|NCT01799889|323585982|FG005|Overall Study|Adverse Event|1|||
94489031|NCT01799889|323585983|FG006|Overall Study|Adverse Event|5|||
94489032|NCT01799889|323585984|FG007|Overall Study|Adverse Event|2|||
94489033|NCT01799889|323585985|FG008|Overall Study|Adverse Event|3|||
94489034|NCT01799889|323585986|FG009|Overall Study|Adverse Event|1|||
94489035|NCT01799889|323585987|FG010|Overall Study|Adverse Event|1|||
94489036|NCT01799889|323585988|FG011|Overall Study|Adverse Event|0|||
94489037|NCT01799889|323585977|FG000|Overall Study|Death|1|||
94489038|NCT01799889|323585978|FG001|Overall Study|Death|0|||
94489039|NCT01799889|323585979|FG002|Overall Study|Death|5|||
94489040|NCT01799889|323585980|FG003|Overall Study|Death|3|||
94489041|NCT01799889|323585981|FG004|Overall Study|Death|1|||
94489042|NCT01799889|323585982|FG005|Overall Study|Death|0|||
94489043|NCT01799889|323585983|FG006|Overall Study|Death|0|||
94489044|NCT01799889|323585984|FG007|Overall Study|Death|0|||
94489045|NCT01799889|323585985|FG008|Overall Study|Death|1|||
94489046|NCT01799889|323585986|FG009|Overall Study|Death|0|||
94489047|NCT01799889|323585987|FG010|Overall Study|Death|1|||
94489048|NCT01799889|323585988|FG011|Overall Study|Death|0|||
94489049|NCT01799889|323585977|FG000|Overall Study|Lack of Efficacy|1|||
94489050|NCT01799889|323585978|FG001|Overall Study|Lack of Efficacy|1|||
94489051|NCT01799889|323585979|FG002|Overall Study|Lack of Efficacy|0|||
94489052|NCT01799889|323585980|FG003|Overall Study|Lack of Efficacy|1|||
94489053|NCT01799889|323585981|FG004|Overall Study|Lack of Efficacy|2|||
94489054|NCT01799889|323585982|FG005|Overall Study|Lack of Efficacy|2|||
94489055|NCT01799889|323585983|FG006|Overall Study|Lack of Efficacy|0|||
94489056|NCT01799889|323585984|FG007|Overall Study|Lack of Efficacy|0|||
94489057|NCT01799889|323585985|FG008|Overall Study|Lack of Efficacy|2|||
94489058|NCT01799889|323585986|FG009|Overall Study|Lack of Efficacy|0|||
94489059|NCT01799889|323585987|FG010|Overall Study|Lack of Efficacy|1|||
94489060|NCT01799889|323585988|FG011|Overall Study|Lack of Efficacy|0|||
94489061|NCT01799889|323585977|FG000|Overall Study|Lost to Follow-up|0|||
94489062|NCT01799889|323585978|FG001|Overall Study|Lost to Follow-up|1|||
94489063|NCT01799889|323585979|FG002|Overall Study|Lost to Follow-up|0|||
94489064|NCT01799889|323585980|FG003|Overall Study|Lost to Follow-up|0|||
94489065|NCT01799889|323585981|FG004|Overall Study|Lost to Follow-up|0|||
94489066|NCT01799889|323585982|FG005|Overall Study|Lost to Follow-up|0|||
94489067|NCT01799889|323585983|FG006|Overall Study|Lost to Follow-up|0|||
94489068|NCT01799889|323585984|FG007|Overall Study|Lost to Follow-up|0|||
94489069|NCT01799889|323585985|FG008|Overall Study|Lost to Follow-up|0|||
94489070|NCT01799889|323585986|FG009|Overall Study|Lost to Follow-up|0|||
94419407|NCT00725621|323321610|FG000|Overall Study|Adverse Event|25|||
94419408|NCT00725621|323321610|FG000|Overall Study|Lack of Efficacy|46|||
94419409|NCT00725621|323321610|FG000|Overall Study|Withdrawal by Subject|57|||
94419410|NCT00725621|323321610|FG000|Overall Study|Physician Decision|19|||
94419411|NCT00725621|323321610|FG000|Overall Study|Lost to Follow-up|52|||
94419412|NCT00725621|323321610|FG000|Overall Study|Non-compliance|8|||
94419413|NCT00725621|323321610|FG000|Overall Study|Continued treatment by other physician|6|||
94419414|NCT00725621|323321610|FG000|Overall Study|Switched to other study|1|||
94419415|NCT00725621|323321610|FG000|Overall Study|Switched to other drug|1|||
94419416|NCT00725621|323321610|FG000|Overall Study|Prepared for elective surgery|1|||
94419417|NCT00725621|323321610|FG000|Overall Study|Reason not specified|55|||
94419418|NCT00975286|323321611|FG000|Overall Study|Adverse Event|9|||
94419419|NCT00975286|323321612|FG001|Overall Study|Adverse Event|19|||
94419420|NCT00975286|323321611|FG000|Overall Study|Protocol Violation|1|||
94419421|NCT00975286|323321612|FG001|Overall Study|Protocol Violation|2|||
94419422|NCT00975286|323321611|FG000|Overall Study|Withdrawal by Subject|0|||
94419423|NCT00975286|323321612|FG001|Overall Study|Withdrawal by Subject|2|||
94419424|NCT00975286|323321611|FG000|Overall Study|Familial and Personal Reasons|2|||
94419425|NCT00975286|323321612|FG001|Overall Study|Familial and Personal Reasons|2|||
94419426|NCT00975286|323321611|FG000|Overall Study|Poor Compliance to Protocol|0|||
94419427|NCT00975286|323321612|FG001|Overall Study|Poor Compliance to Protocol|2|||
94419428|NCT00975286|323321611|FG000|Overall Study|Sponsor Decision|0|||
94419429|NCT00975286|323321612|FG001|Overall Study|Sponsor Decision|2|||
94419430|NCT00062751|323321613|FG000|Overall Study|Disease progression|24|||
94419431|NCT00062751|323321614|FG001|Overall Study|Disease progression|17|||
94419432|NCT00062751|323321615|FG002|Overall Study|Disease progression|24|||
94419433|NCT00062751|323321616|FG003|Overall Study|Disease progression|2|||
94419434|NCT00062751|323321617|FG004|Overall Study|Disease progression|2|||
94419435|NCT00062751|323321613|FG000|Overall Study|Adverse Event|4|||
94419436|NCT00062751|323321614|FG001|Overall Study|Adverse Event|7|||
94419437|NCT00062751|323321615|FG002|Overall Study|Adverse Event|2|||
94419438|NCT00062751|323321616|FG003|Overall Study|Adverse Event|2|||
94419439|NCT00062751|323321617|FG004|Overall Study|Adverse Event|2|||
94419440|NCT00062751|323321613|FG000|Overall Study|Other|2|||
94419441|NCT00062751|323321614|FG001|Overall Study|Other|3|||
94419442|NCT00062751|323321615|FG002|Overall Study|Other|1|||
94419443|NCT00062751|323321616|FG003|Overall Study|Other|0|||
94419444|NCT00062751|323321617|FG004|Overall Study|Other|1|||
94419445|NCT00062751|323321613|FG000|Overall Study|Withdrawal by Subject|1|||
94419446|NCT00062751|323321614|FG001|Overall Study|Withdrawal by Subject|2|||
94419447|NCT00062751|323321615|FG002|Overall Study|Withdrawal by Subject|2|||
94419448|NCT00062751|323321616|FG003|Overall Study|Withdrawal by Subject|1|||
94419449|NCT00062751|323321617|FG004|Overall Study|Withdrawal by Subject|0|||
94419450|NCT00062751|323321613|FG000|Overall Study|Symptomatic deterioration|1|||
94419451|NCT00062751|323321614|FG001|Overall Study|Symptomatic deterioration|1|||
94419452|NCT00062751|323321615|FG002|Overall Study|Symptomatic deterioration|0|||
94419453|NCT00062751|323321616|FG003|Overall Study|Symptomatic deterioration|0|||
94419454|NCT00062751|323321617|FG004|Overall Study|Symptomatic deterioration|1|||
94419455|NCT00062751|323321613|FG000|Overall Study|Death|1|||
94419456|NCT00062751|323321614|FG001|Overall Study|Death|0|||
94419457|NCT00062751|323321615|FG002|Overall Study|Death|1|||
94419458|NCT00062751|323321616|FG003|Overall Study|Death|0|||
94419459|NCT00062751|323321617|FG004|Overall Study|Death|0|||
94419460|NCT01674647|323321618|FG000|Treatment Period|Death|4|||
94419461|NCT01674647|323321619|FG001|Treatment Period|Death|1|||
94419462|NCT01674647|323321618|FG000|Treatment Period|Efficacy outcome reached|0|||
94419463|NCT01674647|323321619|FG001|Treatment Period|Efficacy outcome reached|1|||
94419464|NCT01674647|323321618|FG000|Treatment Period|Physician Decision|3|||
94419465|NCT01674647|323321619|FG001|Treatment Period|Physician Decision|1|||
94419466|NCT01674647|323321618|FG000|Treatment Period|Adverse Event|60|||
94419467|NCT01674647|323321619|FG001|Treatment Period|Adverse Event|22|||
94419468|NCT01674647|323321618|FG000|Treatment Period|Non-compliance with study drug|3|||
94419469|NCT01674647|323321619|FG001|Treatment Period|Non-compliance with study drug|0|||
94419470|NCT01674647|323321618|FG000|Treatment Period|Lost to Follow-up|1|||
94419471|NCT01674647|323321619|FG001|Treatment Period|Lost to Follow-up|1|||
94419472|NCT01674647|323321618|FG000|Treatment Period|Withdrawal by Subject|19|||
94419473|NCT01674647|323321619|FG001|Treatment Period|Withdrawal by Subject|16|||
94419474|NCT01674647|323321618|FG000|Treatment Period|Switching to other therapy|5|||
94419475|NCT01674647|323321619|FG001|Treatment Period|Switching to other therapy|2|||
94419476|NCT01674647|323321618|FG000|Treatment Period|Logistical difficulties|5|||
94419477|NCT01674647|323321619|FG001|Treatment Period|Logistical difficulties|8|||
94419478|NCT01674647|323321618|FG000|Treatment Period|Treatment failure|0|||
94419479|NCT01674647|323321619|FG001|Treatment Period|Treatment failure|14|||
94419480|NCT01674647|323321618|FG000|Treatment Period|Protocol Violation|56|||
94419481|NCT01674647|323321619|FG001|Treatment Period|Protocol Violation|36|||
94419482|NCT01674647|323321618|FG000|30-day Safety Follow-up Period|Death|3|||
94419483|NCT01674647|323321619|FG001|30-day Safety Follow-up Period|Death|2|||
94419484|NCT01674647|323321618|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
94489071|NCT01799889|323585987|FG010|Overall Study|Lost to Follow-up|0|||
94489072|NCT01799889|323585988|FG011|Overall Study|Lost to Follow-up|0|||
94489073|NCT01799889|323585977|FG000|Overall Study|Physician Decision|3|||
94489074|NCT01799889|323585978|FG001|Overall Study|Physician Decision|2|||
94489075|NCT01799889|323585979|FG002|Overall Study|Physician Decision|4|||
94489076|NCT01799889|323585980|FG003|Overall Study|Physician Decision|4|||
94489077|NCT01799889|323585981|FG004|Overall Study|Physician Decision|5|||
94489078|NCT01799889|323585982|FG005|Overall Study|Physician Decision|5|||
94489079|NCT01799889|323585983|FG006|Overall Study|Physician Decision|5|||
94489080|NCT01799889|323585984|FG007|Overall Study|Physician Decision|2|||
94489081|NCT01799889|323585985|FG008|Overall Study|Physician Decision|6|||
94489082|NCT01799889|323585986|FG009|Overall Study|Physician Decision|0|||
94489083|NCT01799889|323585987|FG010|Overall Study|Physician Decision|0|||
94489084|NCT01799889|323585988|FG011|Overall Study|Physician Decision|1|||
94489085|NCT01799889|323585977|FG000|Overall Study|Progressive Disease|30|||
94489086|NCT01799889|323585978|FG001|Overall Study|Progressive Disease|26|||
94489087|NCT01799889|323585979|FG002|Overall Study|Progressive Disease|25|||
94489088|NCT01799889|323585980|FG003|Overall Study|Progressive Disease|30|||
94489089|NCT01799889|323585981|FG004|Overall Study|Progressive Disease|23|||
94489090|NCT01799889|323585982|FG005|Overall Study|Progressive Disease|9|||
94489091|NCT01799889|323585983|FG006|Overall Study|Progressive Disease|8|||
94489092|NCT01799889|323585984|FG007|Overall Study|Progressive Disease|13|||
94489093|NCT01799889|323585985|FG008|Overall Study|Progressive Disease|18|||
94489094|NCT01799889|323585986|FG009|Overall Study|Progressive Disease|5|||
94489095|NCT01799889|323585987|FG010|Overall Study|Progressive Disease|3|||
94489096|NCT01799889|323585988|FG011|Overall Study|Progressive Disease|1|||
94489097|NCT01799889|323585977|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
94489098|NCT01799889|323585978|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
94489099|NCT01799889|323585979|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
94489100|NCT01799889|323585980|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
94489101|NCT01799889|323585981|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
94489102|NCT01799889|323585982|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
94489103|NCT01799889|323585983|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
94489104|NCT01799889|323585984|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
94489105|NCT01799889|323585985|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
94489106|NCT01799889|323585986|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
94489107|NCT01799889|323585987|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
94489108|NCT01799889|323585988|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
94489109|NCT01799889|323585977|FG000|Overall Study|Study Terminated By Sponsor|1|||
94489110|NCT01799889|323585978|FG001|Overall Study|Study Terminated By Sponsor|0|||
94489111|NCT01799889|323585979|FG002|Overall Study|Study Terminated By Sponsor|0|||
94489112|NCT01799889|323585980|FG003|Overall Study|Study Terminated By Sponsor|0|||
94489113|NCT01799889|323585981|FG004|Overall Study|Study Terminated By Sponsor|2|||
94489114|NCT01799889|323585982|FG005|Overall Study|Study Terminated By Sponsor|1|||
94489115|NCT01799889|323585983|FG006|Overall Study|Study Terminated By Sponsor|0|||
94489116|NCT01799889|323585984|FG007|Overall Study|Study Terminated By Sponsor|2|||
94489117|NCT01799889|323585985|FG008|Overall Study|Study Terminated By Sponsor|1|||
94489118|NCT01799889|323585986|FG009|Overall Study|Study Terminated By Sponsor|1|||
94489119|NCT01799889|323585987|FG010|Overall Study|Study Terminated By Sponsor|0|||
94489120|NCT01799889|323585988|FG011|Overall Study|Study Terminated By Sponsor|0|||
94489121|NCT01799889|323585977|FG000|Overall Study|Withdrawal by Subject|1|||
94489122|NCT01799889|323585978|FG001|Overall Study|Withdrawal by Subject|6|||
94489123|NCT01799889|323585979|FG002|Overall Study|Withdrawal by Subject|4|||
94489124|NCT01799889|323585980|FG003|Overall Study|Withdrawal by Subject|0|||
94489125|NCT01799889|323585981|FG004|Overall Study|Withdrawal by Subject|5|||
94489126|NCT01799889|323585982|FG005|Overall Study|Withdrawal by Subject|1|||
94489127|NCT01799889|323585983|FG006|Overall Study|Withdrawal by Subject|3|||
94489128|NCT01799889|323585984|FG007|Overall Study|Withdrawal by Subject|1|||
94489129|NCT01799889|323585985|FG008|Overall Study|Withdrawal by Subject|2|||
94489130|NCT01799889|323585986|FG009|Overall Study|Withdrawal by Subject|1|||
94489131|NCT01799889|323585987|FG010|Overall Study|Withdrawal by Subject|1|||
94489132|NCT01799889|323585988|FG011|Overall Study|Withdrawal by Subject|1|||
94489133|NCT01799889|323585977|FG000|Overall Study|Non-Compliance With Study Drug|0|||
94489134|NCT01799889|323585978|FG001|Overall Study|Non-Compliance With Study Drug|0|||
94489135|NCT01799889|323585979|FG002|Overall Study|Non-Compliance With Study Drug|0|||
94489136|NCT01799889|323585980|FG003|Overall Study|Non-Compliance With Study Drug|0|||
94489137|NCT01799889|323585981|FG004|Overall Study|Non-Compliance With Study Drug|0|||
94489138|NCT01799889|323585982|FG005|Overall Study|Non-Compliance With Study Drug|1|||
94489139|NCT01799889|323585983|FG006|Overall Study|Non-Compliance With Study Drug|0|||
94489140|NCT01799889|323585984|FG007|Overall Study|Non-Compliance With Study Drug|0|||
94489141|NCT01799889|323585985|FG008|Overall Study|Non-Compliance With Study Drug|0|||
94489142|NCT01799889|323585986|FG009|Overall Study|Non-Compliance With Study Drug|0|||
94489143|NCT01799889|323585987|FG010|Overall Study|Non-Compliance With Study Drug|0|||
94489144|NCT01799889|323585988|FG011|Overall Study|Non-Compliance With Study Drug|0|||
94489145|NCT00750269|323585989|FG000|Overall Study|Protocol Violation|0|||
94489146|NCT00750269|323585990|FG001|Overall Study|Protocol Violation|1|||
94489147|NCT00750269|323585991|FG002|Overall Study|Protocol Violation|1|||
94489148|NCT00750269|323585992|FG003|Overall Study|Protocol Violation|2|||
94489149|NCT00750269|323585993|FG004|Overall Study|Protocol Violation|4|||
94489150|NCT00750269|323585989|FG000|Overall Study|Withdrawal by Subject|0|||
94489151|NCT00750269|323585990|FG001|Overall Study|Withdrawal by Subject|0|||
94489152|NCT00750269|323585991|FG002|Overall Study|Withdrawal by Subject|2|||
94489153|NCT00750269|323585992|FG003|Overall Study|Withdrawal by Subject|2|||
94489154|NCT00750269|323585993|FG004|Overall Study|Withdrawal by Subject|2|||
94489155|NCT00750269|323585989|FG000|Overall Study|Physician Decision|0|||
94489156|NCT00750269|323585990|FG001|Overall Study|Physician Decision|0|||
94489157|NCT00750269|323585991|FG002|Overall Study|Physician Decision|0|||
94489158|NCT00750269|323585992|FG003|Overall Study|Physician Decision|0|||
94489159|NCT00750269|323585993|FG004|Overall Study|Physician Decision|2|||
94489160|NCT00750269|323585989|FG000|Overall Study|Patient too large for positioning|0|||
94489161|NCT00750269|323585990|FG001|Overall Study|Patient too large for positioning|0|||
94489162|NCT00750269|323585991|FG002|Overall Study|Patient too large for positioning|1|||
94489163|NCT00750269|323585992|FG003|Overall Study|Patient too large for positioning|0|||
94489164|NCT00750269|323585993|FG004|Overall Study|Patient too large for positioning|0|||
94489165|NCT00750269|323585989|FG000|Overall Study|Site error|0|||
94489166|NCT00750269|323585990|FG001|Overall Study|Site error|0|||
94489167|NCT00750269|323585991|FG002|Overall Study|Site error|0|||
94489168|NCT00750269|323585992|FG003|Overall Study|Site error|1|||
94489169|NCT00750269|323585993|FG004|Overall Study|Site error|0|||
94489170|NCT00750269|323585989|FG000|Overall Study|SBRT plan could not be drawn|0|||
94489171|NCT00750269|323585990|FG001|Overall Study|SBRT plan could not be drawn|0|||
94489172|NCT00750269|323585991|FG002|Overall Study|SBRT plan could not be drawn|0|||
94489173|NCT00750269|323585992|FG003|Overall Study|SBRT plan could not be drawn|0|||
94489174|NCT00750269|323585993|FG004|Overall Study|SBRT plan could not be drawn|1|||
94489175|NCT00750269|323585989|FG000|Overall Study|Fiducials could not be placed|0|||
94489176|NCT00750269|323585990|FG001|Overall Study|Fiducials could not be placed|0|||
94489177|NCT00750269|323585991|FG002|Overall Study|Fiducials could not be placed|0|||
94489178|NCT00750269|323585992|FG003|Overall Study|Fiducials could not be placed|0|||
94489179|NCT00750269|323585993|FG004|Overall Study|Fiducials could not be placed|1|||
94489180|NCT02934178|323585994|FG000|Received Vaccination 2|Death|0|||
94489181|NCT02934178|323585995|FG001|Received Vaccination 2|Death|1|||
94489182|NCT02934178|323585994|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
94489183|NCT02934178|323585995|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
94489184|NCT00870727|323585996|FG000|Overall Study|Lost to Follow-up|0|||
94489185|NCT00870727|323585997|FG001|Overall Study|Lost to Follow-up|1|||
94489186|NCT00870727|323585996|FG000|Overall Study|Lack of Efficacy|1|||
94489187|NCT00870727|323585997|FG001|Overall Study|Lack of Efficacy|3|||
94489188|NCT00870727|323585996|FG000|Overall Study|Adverse Event|0|||
94489189|NCT00870727|323585997|FG001|Overall Study|Adverse Event|1|||
94489190|NCT00720278|323585998|FG000|Overall Study|Adverse Event|5|||
94489191|NCT00720278|323585999|FG001|Overall Study|Adverse Event|3|||
94489192|NCT00720278|323586000|FG002|Overall Study|Adverse Event|4|||
94489193|NCT00720278|323585998|FG000|Overall Study|Withdrawal by Subject|0|||
94489194|NCT00720278|323585999|FG001|Overall Study|Withdrawal by Subject|1|||
94489195|NCT00720278|323586000|FG002|Overall Study|Withdrawal by Subject|0|||
94489196|NCT00720278|323585998|FG000|Overall Study|Lost to Follow-up|0|||
94489197|NCT00720278|323585999|FG001|Overall Study|Lost to Follow-up|0|||
94489198|NCT00720278|323586000|FG002|Overall Study|Lost to Follow-up|1|||
94489199|NCT00720278|323585998|FG000|Overall Study|Non-compliance|1|||
94489200|NCT00720278|323585999|FG001|Overall Study|Non-compliance|0|||
94489201|NCT00720278|323586000|FG002|Overall Study|Non-compliance|0|||
94489202|NCT00720278|323585998|FG000|Overall Study|eligibility criteria violation|1|||
94489203|NCT00720278|323585999|FG001|Overall Study|eligibility criteria violation|0|||
94489204|NCT00720278|323586000|FG002|Overall Study|eligibility criteria violation|1|||
94489205|NCT01712516|323586001|FG000|Overall Study|Technical problems|0|||
94489206|NCT01712516|323586002|FG001|Overall Study|Technical problems|0|||
94489207|NCT01712516|323586003|FG002|Overall Study|Technical problems|0|||
94489208|NCT01712516|323586004|FG003|Overall Study|Technical problems|2|||
94489209|NCT01712516|323586001|FG000|Overall Study|Lost to Follow-up|0|||
94489210|NCT01712516|323586002|FG001|Overall Study|Lost to Follow-up|0|||
94489211|NCT01712516|323586003|FG002|Overall Study|Lost to Follow-up|2|||
94489212|NCT01712516|323586004|FG003|Overall Study|Lost to Follow-up|1|||
94489213|NCT01712516|323586001|FG000|Overall Study|Death|0|||
94489214|NCT01712516|323586002|FG001|Overall Study|Death|1|||
94489215|NCT01712516|323586003|FG002|Overall Study|Death|0|||
94489216|NCT01712516|323586004|FG003|Overall Study|Death|0|||
94489217|NCT01712516|323586001|FG000|Overall Study|Protocol deviation|1|||
94489218|NCT01712516|323586002|FG001|Overall Study|Protocol deviation|0|||
94489219|NCT01712516|323586003|FG002|Overall Study|Protocol deviation|1|||
94489220|NCT01712516|323586004|FG003|Overall Study|Protocol deviation|0|||
94489221|NCT01712516|323586001|FG000|Overall Study|Physician Decision|2|||
94489222|NCT01712516|323586002|FG001|Overall Study|Physician Decision|0|||
94489223|NCT01712516|323586003|FG002|Overall Study|Physician Decision|0|||
94419485|NCT01674647|323321619|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
94419486|NCT01674647|323321618|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
94419487|NCT01674647|323321619|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
94419488|NCT01674647|323321618|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
94419489|NCT01674647|323321619|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
94419490|NCT01674647|323321618|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
94419491|NCT01674647|323321619|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
94419492|NCT01674647|323321618|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
94419493|NCT01674647|323321619|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
94419494|NCT01490866|323321620|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
94419495|NCT01490866|323321620|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
94419496|NCT01490866|323321620|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
94419497|NCT01490866|323321620|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
94419498|NCT01490866|323321620|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
94419499|NCT01490866|323321620|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
94419500|NCT01490866|323321620|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
94419501|NCT01490866|323321620|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
94419502|NCT01490866|323321620|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
94419503|NCT01490866|323321620|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
94419504|NCT01490866|323321620|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
94419505|NCT01769339|323321621|FG000|Overall Study|Lost to Follow-up|42|||
94419506|NCT01769339|323321621|FG000|Overall Study|Adverse Event|1|||
94419507|NCT01195272|323321622|FG000|Overall Study|Adverse Event|1|||
94419508|NCT01195272|323321622|FG000|Overall Study|Lack of Efficacy|3|||
94419509|NCT01884311|323323399|FG000|Overall Study|Withdrawal by Subject|3|||
94419510|NCT01884311|323323399|FG000|Overall Study|withdrew consent due to AEs|1|||
94419511|NCT01884311|323323399|FG000|Overall Study|Precautionary measure|1|||
94419512|NCT03861481|323323401|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
94419513|NCT03861481|323323402|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
94419514|NCT03861481|323323401|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
94419515|NCT03861481|323323402|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
94419516|NCT03861481|323323401|FG000|Overall Study|Relapse|1|||
94419517|NCT03861481|323323402|FG001|Overall Study|Relapse|0|||
94419518|NCT03861481|323323401|FG000|Overall Study|Withdrawal by Subject|0|||
94419519|NCT03861481|323323402|FG001|Overall Study|Withdrawal by Subject|1|||
94419520|NCT03861481|323323401|FG000|Overall Study|Lack of Efficacy|4|||
94419521|NCT03861481|323323402|FG001|Overall Study|Lack of Efficacy|5|||
94419522|NCT02858492|323323403|FG000|Overall Study|Withdrawal by Subject|0|||
94419523|NCT02858492|323323404|FG001|Overall Study|Withdrawal by Subject|1|||
94419524|NCT02858492|323323405|FG002|Overall Study|Withdrawal by Subject|0|||
94419525|NCT02858492|323323406|FG003|Overall Study|Withdrawal by Subject|1|||
94419526|NCT02858492|323323403|FG000|Overall Study|Adverse Event|0|||
94419527|NCT02858492|323323404|FG001|Overall Study|Adverse Event|0|||
94419528|NCT02858492|323323405|FG002|Overall Study|Adverse Event|0|||
94419529|NCT02858492|323323406|FG003|Overall Study|Adverse Event|3|||
94419530|NCT02858492|323323403|FG000|Overall Study|Lack of Efficacy|0|||
94419531|NCT02858492|323323404|FG001|Overall Study|Lack of Efficacy|0|||
94419532|NCT02858492|323323405|FG002|Overall Study|Lack of Efficacy|0|||
94419533|NCT02858492|323323406|FG003|Overall Study|Lack of Efficacy|1|||
94419534|NCT02858492|323323403|FG000|Overall Study|Protocol defined stopping criteria|0|||
94419535|NCT02858492|323323404|FG001|Overall Study|Protocol defined stopping criteria|0|||
94419536|NCT02858492|323323405|FG002|Overall Study|Protocol defined stopping criteria|0|||
94419537|NCT02858492|323323406|FG003|Overall Study|Protocol defined stopping criteria|1|||
94419538|NCT01032018|323323407|FG000|Overall Study|Lost to Follow-up|6|||
94419539|NCT01032018|323323408|FG001|Overall Study|Lost to Follow-up|5|||
94419540|NCT01032018|323323407|FG000|Overall Study|Death|0|||
94419541|NCT01032018|323323408|FG001|Overall Study|Death|1|||
94419542|NCT01287039|323323413|FG000|Overall Study|Noncompliance with study procedures|0|||
94419543|NCT01287039|323323414|FG001|Overall Study|Noncompliance with study procedures|1|||
94419544|NCT01287039|323323413|FG000|Overall Study|Change of location/residence|0|||
94419545|NCT01287039|323323414|FG001|Overall Study|Change of location/residence|3|||
94419546|NCT01287039|323323413|FG000|Overall Study|Elective surgery|0|||
94419547|NCT01287039|323323414|FG001|Overall Study|Elective surgery|1|||
94419548|NCT01287039|323323413|FG000|Overall Study|Protocol Violation|2|||
94419549|NCT01287039|323323414|FG001|Overall Study|Protocol Violation|3|||
94419550|NCT01287039|323323413|FG000|Overall Study|Excluded medication taken|1|||
94419551|NCT01287039|323323414|FG001|Overall Study|Excluded medication taken|0|||
94419552|NCT01287039|323323413|FG000|Overall Study|Noncompliance with study medication|0|||
94419553|NCT01287039|323323414|FG001|Overall Study|Noncompliance with study medication|1|||
94419554|NCT01287039|323323413|FG000|Overall Study|Problem with travel|0|||
94419555|NCT01287039|323323414|FG001|Overall Study|Problem with travel|1|||
94419556|NCT01287039|323323413|FG000|Overall Study|Death|1|||
94419557|NCT01287039|323323414|FG001|Overall Study|Death|0|||
94419558|NCT01287039|323323413|FG000|Overall Study|Change of residence|1|||
94419559|NCT01287039|323323414|FG001|Overall Study|Change of residence|0|||
94419560|NCT01287039|323323413|FG000|Overall Study|Adverse Event|7|||
94419561|NCT01287039|323323414|FG001|Overall Study|Adverse Event|4|||
94419562|NCT01287039|323323413|FG000|Overall Study|Withdrawal by Subject|14|||
94419563|NCT01287039|323323414|FG001|Overall Study|Withdrawal by Subject|11|||
94419564|NCT01287039|323323413|FG000|Overall Study|Lost to Follow-up|3|||
94419565|NCT01287039|323323414|FG001|Overall Study|Lost to Follow-up|2|||
94419566|NCT03853148|323323415|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
94419567|NCT03853148|323323416|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
94419568|NCT03853148|323323417|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
94419569|NCT03853148|323323418|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
94419570|NCT00852969|323323419|FG000|Overall Study|Adverse Event|0|||
94419571|NCT00852969|323323420|FG001|Overall Study|Adverse Event|1|||
94419572|NCT00852969|323323419|FG000|Overall Study|Lost to Follow-up|0|||
94419573|NCT00852969|323323420|FG001|Overall Study|Lost to Follow-up|1|||
94419574|NCT03247517|323323421|FG000|Overall Study|Adverse Event|0|||
94419575|NCT03247517|323323422|FG001|Overall Study|Adverse Event|4|||
94419576|NCT03247517|323323423|FG002|Overall Study|Adverse Event|2|||
94419577|NCT03247517|323323421|FG000|Overall Study|Lost to Follow-up|2|||
94419578|NCT03247517|323323422|FG001|Overall Study|Lost to Follow-up|6|||
94419579|NCT03247517|323323423|FG002|Overall Study|Lost to Follow-up|4|||
94419580|NCT03247517|323323421|FG000|Overall Study|Consent withdrawn by caregiver|1|||
94419581|NCT03247517|323323422|FG001|Overall Study|Consent withdrawn by caregiver|4|||
94419582|NCT03247517|323323423|FG002|Overall Study|Consent withdrawn by caregiver|7|||
94419583|NCT03247517|323323421|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
94419584|NCT03247517|323323422|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
94419585|NCT03247517|323323423|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
94419586|NCT03247517|323323421|FG000|Overall Study|Protocol Violation|0|||
94419587|NCT03247517|323323422|FG001|Overall Study|Protocol Violation|2|||
94419588|NCT03247517|323323423|FG002|Overall Study|Protocol Violation|0|||
94419589|NCT03247517|323323421|FG000|Overall Study|Multiple reasons|3|||
94419590|NCT03247517|323323422|FG001|Overall Study|Multiple reasons|1|||
94419591|NCT03247517|323323423|FG002|Overall Study|Multiple reasons|0|||
94419592|NCT00678041|323323424|FG000|Overall Study|Physician Decision|5|||
94419593|NCT00678041|323323425|FG001|Overall Study|Physician Decision|5|||
94419594|NCT03188718|323323426|FG000|Overall Study|Participant noncompliance|4|||
94419595|NCT03188718|323323426|FG000|Overall Study|Withdrawal by Subject|1|||
94419596|NCT03188718|323323426|FG000|Overall Study|Device failure|3|||
94419597|NCT01195103|323323433|FG000|Overall Study|Withdrawal by Subject|1|||
94419598|NCT01195103|323323434|FG001|Overall Study|Withdrawal by Subject|0|||
94419599|NCT01195103|323323435|FG002|Overall Study|Withdrawal by Subject|0|||
94419600|NCT00973765|323323438|FG000|Overall Study|Lost to Follow-up|8|||
94419601|NCT00973765|323323439|FG001|Overall Study|Lost to Follow-up|14|||
94419602|NCT02669940|323323442|FG000|Overall Study|Failure to return|0|||
94419603|NCT02669940|323323443|FG001|Overall Study|Failure to return|3|||
94419604|NCT02669940|323323442|FG000|Overall Study|Insufficient follow-up data|1|||
94419605|NCT02669940|323323443|FG001|Overall Study|Insufficient follow-up data|0|||
94419606|NCT01959035|323323444|FG000|Overall Study|Adverse Event|5|||
94419607|NCT01959035|323323444|FG000|Overall Study|Withdrawal by Subject|4|||
94419608|NCT01959035|323323444|FG000|Overall Study|Lost to Follow-up|1|||
94419609|NCT01959035|323323444|FG000|Overall Study|Other (no primary reason given)|1|||
94419610|NCT05065983|323323445|FG000|Overall Study|Lost to Follow-up|2|||
94419611|NCT01705236|323323453|FG000|Overall Study|Lost to Follow-up|1|||
94419612|NCT01705236|323323453|FG000|Overall Study|Administrative problems|2|||
94419613|NCT01705236|323323453|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
94419614|NCT01705236|323323453|FG000|Overall Study|Protocol Violation|3|||
94419615|NCT01705236|323323453|FG000|Overall Study|Abnormal test procedure result(s)|4|||
94419616|NCT01705236|323323453|FG000|Overall Study|Abnormal laboratory value(s)|4|||
94419617|NCT01705236|323323453|FG000|Overall Study|Withdrawal by Subject|5|||
94419618|NCT01705236|323323453|FG000|Overall Study|Adverse Event|5|||
94419619|NCT02923674|323323454|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
94419620|NCT02923674|323323455|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
94419621|NCT02923674|323323456|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
94419622|NCT02923674|323323454|FG000|Overall Study|Lost to Follow-up|7|||
94419623|NCT02923674|323323455|FG001|Overall Study|Lost to Follow-up|12|||
94419624|NCT02923674|323323456|FG002|Overall Study|Lost to Follow-up|7|||
94419625|NCT02923674|323323454|FG000|Overall Study|Problem with intervention|2|||
94419626|NCT02923674|323323455|FG001|Overall Study|Problem with intervention|2|||
94419627|NCT02923674|323323456|FG002|Overall Study|Problem with intervention|1|||
94419628|NCT02923674|323323454|FG000|Overall Study|Adverse Event|3|||
94419629|NCT02923674|323323455|FG001|Overall Study|Adverse Event|1|||
94419630|NCT02923674|323323456|FG002|Overall Study|Adverse Event|1|||
94419631|NCT02923674|323323454|FG000|Overall Study|Withdrawal by Subject|2|||
94419632|NCT02923674|323323455|FG001|Overall Study|Withdrawal by Subject|2|||
94419633|NCT02923674|323323456|FG002|Overall Study|Withdrawal by Subject|2|||
94489224|NCT01712516|323586004|FG003|Overall Study|Physician Decision|1|||
94489225|NCT01712516|323586001|FG000|Overall Study|Withdrawal by Subject|3|||
94489226|NCT01712516|323586002|FG001|Overall Study|Withdrawal by Subject|9|||
94489227|NCT01712516|323586003|FG002|Overall Study|Withdrawal by Subject|3|||
94489228|NCT01712516|323586004|FG003|Overall Study|Withdrawal by Subject|9|||
94489229|NCT01181167|323586011|FG000|Overall Study|Adverse Event|11|||
94489230|NCT01181167|323586012|FG001|Overall Study|Adverse Event|21|||
94489231|NCT01181167|323586011|FG000|Overall Study|Lost to Follow-up|1|||
94489232|NCT01181167|323586012|FG001|Overall Study|Lost to Follow-up|0|||
94489233|NCT01181167|323586011|FG000|Overall Study|Physician Decision|2|||
94489234|NCT01181167|323586012|FG001|Overall Study|Physician Decision|3|||
94489235|NCT01181167|323586011|FG000|Overall Study|Protocol Violation|3|||
94489236|NCT01181167|323586012|FG001|Overall Study|Protocol Violation|0|||
94489237|NCT01181167|323586011|FG000|Overall Study|Withdrawal by Subject|6|||
94489238|NCT01181167|323586012|FG001|Overall Study|Withdrawal by Subject|8|||
94489239|NCT03103503|323586013|FG000|Overall Study|Death|64|||
94489240|NCT03103503|323586013|FG000|Overall Study|Physician Decision|57|||
94489241|NCT03103503|323586013|FG000|Overall Study|Withdrawal by Subject|10|||
94419634|NCT03709823|323323457|FG000|Overall Study|Adverse Event|0|||
94419635|NCT03709823|323323458|FG001|Overall Study|Adverse Event|0|||
94489242|NCT03103503|323586013|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
94489243|NCT03103503|323586013|FG000|Overall Study|Lost to Follow-up|3|||
94489244|NCT03103503|323586013|FG000|Overall Study|Study Closure|757|||
94489245|NCT01649765|323586017|FG000|Overall Study|Adverse Event|5|||
94489246|NCT01649765|323586018|FG001|Overall Study|Adverse Event|3|||
94489247|NCT01649765|323586017|FG000|Overall Study|Lack of Efficacy|1|||
94489248|NCT01649765|323586018|FG001|Overall Study|Lack of Efficacy|1|||
94489249|NCT01649765|323586017|FG000|Overall Study|Physician Decision|0|||
94489250|NCT01649765|323586018|FG001|Overall Study|Physician Decision|3|||
94489251|NCT01649765|323586017|FG000|Overall Study|Protocol Violation|1|||
94489252|NCT01649765|323586018|FG001|Overall Study|Protocol Violation|0|||
94489253|NCT01649765|323586017|FG000|Overall Study|Withdrawal by Subject|2|||
94489254|NCT01649765|323586018|FG001|Overall Study|Withdrawal by Subject|1|||
94489255|NCT00903968|323586019|FG000|Overall Study|Adverse Event|0|||
94489256|NCT00903968|323586020|FG001|Overall Study|Adverse Event|0|||
94489257|NCT00903968|323586021|FG002|Overall Study|Adverse Event|0|||
94489258|NCT00903968|323586022|FG003|Overall Study|Adverse Event|0|||
94489259|NCT00903968|323586023|FG004|Overall Study|Adverse Event|0|||
94489260|NCT00903968|323586024|FG005|Overall Study|Adverse Event|0|||
94419636|NCT03709823|323323459|FG002|Overall Study|Adverse Event|1|||
94419637|NCT03709823|323323460|FG003|Overall Study|Adverse Event|0|||
94419638|NCT03709823|323323461|FG004|Overall Study|Adverse Event|0|||
94419639|NCT03709823|323323462|FG005|Overall Study|Adverse Event|0|||
94419640|NCT03709823|323323457|FG000|Overall Study|Lost to Follow-up|2|||
94419641|NCT03709823|323323458|FG001|Overall Study|Lost to Follow-up|2|||
94419642|NCT03709823|323323459|FG002|Overall Study|Lost to Follow-up|2|||
94419643|NCT03709823|323323460|FG003|Overall Study|Lost to Follow-up|1|||
94419644|NCT03709823|323323461|FG004|Overall Study|Lost to Follow-up|1|||
94419645|NCT03709823|323323462|FG005|Overall Study|Lost to Follow-up|0|||
94419646|NCT03709823|323323457|FG000|Overall Study|Withdrawal by Subject|1|||
94419647|NCT03709823|323323458|FG001|Overall Study|Withdrawal by Subject|3|||
94419648|NCT03709823|323323459|FG002|Overall Study|Withdrawal by Subject|0|||
94419649|NCT03709823|323323460|FG003|Overall Study|Withdrawal by Subject|0|||
94419650|NCT03709823|323323461|FG004|Overall Study|Withdrawal by Subject|0|||
94419651|NCT03709823|323323462|FG005|Overall Study|Withdrawal by Subject|0|||
94419652|NCT03709823|323323457|FG000|Overall Study|Other, Not Specified|0|||
94419653|NCT03709823|323323458|FG001|Overall Study|Other, Not Specified|0|||
94419654|NCT03709823|323323459|FG002|Overall Study|Other, Not Specified|0|||
94419655|NCT03709823|323323460|FG003|Overall Study|Other, Not Specified|1|||
94419656|NCT03709823|323323461|FG004|Overall Study|Other, Not Specified|0|||
94419657|NCT03709823|323323462|FG005|Overall Study|Other, Not Specified|0|||
94419658|NCT00557076|323323463|FG000|Overall Study|Unblinding|0|||
94419659|NCT00557076|323323464|FG001|Overall Study|Unblinding|1|||
94419660|NCT01249365|323323472|FG000|Overall Study|Lost to Follow-up|1|||
94419661|NCT03484117|323323473|FG000|Overall Study|Lost to Follow-up|1|||
94419662|NCT03484117|323323474|FG001|Overall Study|Lost to Follow-up|3|||
94489261|NCT00903968|323586025|FG006|Overall Study|Adverse Event|1|||
94489262|NCT00903968|323586026|FG007|Overall Study|Adverse Event|8|||
94489263|NCT00903968|323586019|FG000|Overall Study|DLT|0|||
94489264|NCT00903968|323586020|FG001|Overall Study|DLT|0|||
94419663|NCT03484117|323323473|FG000|Overall Study|Declined participation in exit assess|1|||
94419664|NCT03484117|323323474|FG001|Overall Study|Declined participation in exit assess|1|||
94419665|NCT04465630|323323478|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
94419666|NCT04465630|323323478|FG000|Overall Study|Screen failure|8|||
94489265|NCT00903968|323586021|FG002|Overall Study|DLT|0|||
94489266|NCT00903968|323586022|FG003|Overall Study|DLT|0|||
94489267|NCT00903968|323586023|FG004|Overall Study|DLT|0|||
94489268|NCT00903968|323586024|FG005|Overall Study|DLT|0|||
94489269|NCT00903968|323586025|FG006|Overall Study|DLT|2|||
94489270|NCT00903968|323586026|FG007|Overall Study|DLT|0|||
94419667|NCT04465630|323323478|FG000|Overall Study|Baseline failure|16|||
94419668|NCT01156142|323323479|FG000|Overall Study|Withdrawal by Subject|8|||
94419669|NCT01156142|323323480|FG001|Overall Study|Withdrawal by Subject|6|||
94419670|NCT01156142|323323479|FG000|Overall Study|Ineligible|0|||
94419671|NCT01156142|323323480|FG001|Overall Study|Ineligible|1|||
94419672|NCT01394952|323323481|FG000|Overall Study|Lost to Follow-up|0|||
94419673|NCT01394952|323323482|FG001|Overall Study|Lost to Follow-up|5|||
94419674|NCT01394952|323323481|FG000|Overall Study|Withdrawal by Subject|10|||
94419675|NCT01394952|323323482|FG001|Overall Study|Withdrawal by Subject|5|||
94419676|NCT01394952|323323481|FG000|Overall Study|Physician Decision|2|||
94419677|NCT01394952|323323482|FG001|Overall Study|Physician Decision|0|||
94419678|NCT01394952|323323481|FG000|Overall Study|Sponsor Decision|5|||
94419679|NCT01394952|323323482|FG001|Overall Study|Sponsor Decision|7|||
94419680|NCT03979820|323323483|FG000|Overall Study|Protocol Violation|1|||
94419681|NCT03979820|323323484|FG001|Overall Study|Protocol Violation|0|||
94419682|NCT03979820|323323485|FG002|Overall Study|Protocol Violation|0|||
94419683|NCT03979820|323323486|FG003|Overall Study|Protocol Violation|0|||
94419684|NCT03979820|323323483|FG000|Overall Study|Withdrawal by Subject|0|||
94419685|NCT03979820|323323484|FG001|Overall Study|Withdrawal by Subject|0|||
94419686|NCT03979820|323323485|FG002|Overall Study|Withdrawal by Subject|1|||
94419687|NCT03979820|323323486|FG003|Overall Study|Withdrawal by Subject|0|||
94419688|NCT03979820|323323483|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
94419689|NCT03979820|323323484|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
94419690|NCT03979820|323323485|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
94419691|NCT03979820|323323486|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
94419692|NCT00160641|323323492|FG000|Overall Study|Adverse Event|102|||
94419693|NCT00160641|323323492|FG000|Overall Study|Withdrawal by Subject|87|||
94419694|NCT00160641|323323492|FG000|Overall Study|Lost to Follow-up|8|||
94419695|NCT00160641|323323492|FG000|Overall Study|Lack of Efficacy|12|||
94419696|NCT00160641|323323492|FG000|Overall Study|Protocol Violation|3|||
94419697|NCT00160641|323323492|FG000|Overall Study|Other|9|||
94419698|NCT00669071|323323495|FG000|Overall Study|Lost to Follow-up|3|||
94419699|NCT00669071|323323495|FG000|Overall Study|Final visit 40 days out of window|1|||
94419700|NCT00985712|323323496|FG000|Overall Study|Adverse Event|0|||
94419701|NCT00985712|323323497|FG001|Overall Study|Adverse Event|1|||
94419702|NCT00985712|323323496|FG000|Overall Study|Lost to Follow-up|2|||
94419703|NCT00985712|323323497|FG001|Overall Study|Lost to Follow-up|2|||
94419704|NCT00985712|323323496|FG000|Overall Study|Protocol Violation|0|||
94419705|NCT00985712|323323497|FG001|Overall Study|Protocol Violation|1|||
94419706|NCT00985712|323323496|FG000|Overall Study|Withdrawal by Subject|4|||
94419707|NCT00985712|323323497|FG001|Overall Study|Withdrawal by Subject|1|||
94419708|NCT00985712|323323496|FG000|Overall Study|Sponsor decision|0|||
94419709|NCT00985712|323323497|FG001|Overall Study|Sponsor decision|2|||
94419710|NCT01194973|323323498|FG000|Screening Period|Screen Failure|3|||
94419711|NCT01194973|323323498|FG000|26 Week Treatment Period|Adverse Event|1|||
94419712|NCT01194973|323323498|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
94419713|NCT01194973|323323498|FG000|26 Week Treatment Period|Pregnancy|1|||
94419714|NCT01157897|323323499|FG000|Overall Study|Lost to Follow-up|2|||
94419715|NCT01157897|323323500|FG001|Overall Study|Lost to Follow-up|0|||
94419716|NCT01157897|323323501|FG002|Overall Study|Lost to Follow-up|0|||
94419717|NCT01157897|323323502|FG003|Overall Study|Lost to Follow-up|1|||
94419718|NCT01157897|323323499|FG000|Overall Study|Relocated|0|||
94419719|NCT01157897|323323500|FG001|Overall Study|Relocated|2|||
94419720|NCT01157897|323323501|FG002|Overall Study|Relocated|0|||
94419721|NCT01157897|323323502|FG003|Overall Study|Relocated|0|||
94419722|NCT00757848|323323503|FG000|Overall Study|Voluntary discontinuation|1|||
94419723|NCT00757848|323323504|FG001|Overall Study|Voluntary discontinuation|0|||
94419724|NCT00757848|323323503|FG000|Overall Study|Adverse Event|1|||
94419725|NCT00757848|323323504|FG001|Overall Study|Adverse Event|2|||
94419726|NCT00757848|323323503|FG000|Overall Study|Incorrect enrolment|1|||
94419727|NCT00757848|323323504|FG001|Overall Study|Incorrect enrolment|0|||
94419728|NCT01321008|323323507|FG000|Overall Study|Early Study Termination|1|||
94419729|NCT04700280|323323511|FG000|Overall Study|Adverse Event|4|||
94419730|NCT04700280|323323512|FG001|Overall Study|Adverse Event|0|||
94419731|NCT04700280|323323511|FG000|Overall Study|Lack of Efficacy|1|||
94419732|NCT04700280|323323512|FG001|Overall Study|Lack of Efficacy|0|||
94419733|NCT04700280|323323511|FG000|Overall Study|Study terminated by sponsor|5|||
94419734|NCT04700280|323323512|FG001|Overall Study|Study terminated by sponsor|3|||
94419735|NCT04700280|323323511|FG000|Overall Study|Other than specified|1|||
94419736|NCT04700280|323323512|FG001|Overall Study|Other than specified|0|||
94419737|NCT02749292|323323513|FG000|Overall Study|Physician Decision|1|||
94419738|NCT02749292|323323514|FG001|Overall Study|Physician Decision|0|||
94419739|NCT02749292|323323513|FG000|Overall Study|Withdrawal by Subject|5|||
94419740|NCT02749292|323323514|FG001|Overall Study|Withdrawal by Subject|7|||
94419741|NCT02749292|323323513|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
94419742|NCT02749292|323323514|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
94419743|NCT02749292|323323513|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
94419744|NCT02749292|323323514|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
94419745|NCT02749292|323323513|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
94419746|NCT02749292|323323514|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
94419747|NCT02749292|323323513|FG000|Overall Study|Adverse Event|4|||
94419748|NCT02749292|323323514|FG001|Overall Study|Adverse Event|1|||
94419749|NCT02749292|323323513|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
94419750|NCT02749292|323323514|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
94419751|NCT02749292|323323513|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
94419752|NCT02749292|323323514|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
94419753|NCT02749292|323323513|FG000|Overall Study|Requiring glucocorticoids|0|||
94419754|NCT02749292|323323514|FG001|Overall Study|Requiring glucocorticoids|3|||
94419755|NCT02749292|323323513|FG000|Overall Study|Cancer|1|||
94419756|NCT02749292|323323514|FG001|Overall Study|Cancer|0|||
94419757|NCT00876018|323323515|FG000|Overall Study|Lost to Follow-up|0|||
94419758|NCT00876018|323323516|FG001|Overall Study|Lost to Follow-up|1|||
94419759|NCT00876018|323323517|FG002|Overall Study|Lost to Follow-up|1|||
94419760|NCT00876018|323323515|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
94419761|NCT00876018|323323516|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
94419762|NCT00876018|323323517|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
94419763|NCT03923530|323323518|FG000|Overall Study|Withdrawal by Subject|1|||
94419764|NCT03923530|323323518|FG000|Overall Study|screen failure|3|||
94419765|NCT00407758|323323525|FG000|Overall Study|ineligible -improper prior treatment|1|||
94419766|NCT01181271|323323533|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
94419767|NCT01181271|323323533|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
94419768|NCT01181271|323323533|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
94419769|NCT01181271|323323533|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
94419770|NCT01941940|323323536|FG000|Overall Study|Adverse Event|11|||
94419771|NCT01941940|323323536|FG000|Overall Study|Lost to Follow-up|2|||
94419772|NCT01941940|323323536|FG000|Overall Study|Physician Decision|2|||
94419773|NCT01941940|323323536|FG000|Overall Study|Withdrawal by Subject|15|||
94419774|NCT01941940|323323536|FG000|Overall Study|Death|1|||
94419775|NCT01941940|323323536|FG000|Overall Study|Other|1|||
94419776|NCT01941940|323323536|FG000|Overall Study|Other|1|||
94419777|NCT01301508|323323537|FG000|Overall Study|Withdrawal by Subject|1|||
94419778|NCT01301508|323323538|FG001|Overall Study|Withdrawal by Subject|2|||
94419779|NCT01301508|323323537|FG000|Overall Study|Lost to Follow-up|0|||
94419780|NCT01301508|323323538|FG001|Overall Study|Lost to Follow-up|1|||
94419781|NCT02143583|323323541|FG000|Overall Study|Withdrawal by Subject|1|||
94419782|NCT02143583|323323542|FG001|Overall Study|Withdrawal by Subject|0|||
94419783|NCT02143583|323323543|FG002|Overall Study|Withdrawal by Subject|1|||
94419784|NCT02143583|323323541|FG000|Overall Study|husband illness|0|||
94419785|NCT02143583|323323542|FG001|Overall Study|husband illness|0|||
94419786|NCT02143583|323323543|FG002|Overall Study|husband illness|1|||
94419787|NCT04156620|323323544|FG000|Overall Study|Adverse event - TP 1|5|||
94419788|NCT04156620|323323545|FG001|Overall Study|Adverse event - TP 1|2|||
94419789|NCT04156620|323323544|FG000|Overall Study|Lost to follow-up TP 1|1|||
94419790|NCT04156620|323323545|FG001|Overall Study|Lost to follow-up TP 1|1|||
94419791|NCT04156620|323323544|FG000|Overall Study|Progressive disease - TP 1|0|||
94419792|NCT04156620|323323545|FG001|Overall Study|Progressive disease - TP 1|1|||
94419793|NCT04156620|323323544|FG000|Overall Study|Subject decision - TP 1|3|||
94419794|NCT04156620|323323545|FG001|Overall Study|Subject decision - TP 1|5|||
94419795|NCT04156620|323323544|FG000|Overall Study|Adverse event - TP 2|5|||
94419796|NCT04156620|323323545|FG001|Overall Study|Adverse event - TP 2|6|||
94419797|NCT04156620|323323544|FG000|Overall Study|Death - TP 2|1|||
94419798|NCT04156620|323323545|FG001|Overall Study|Death - TP 2|0|||
94419799|NCT04156620|323323544|FG000|Overall Study|Lost to follow-up - TP 2|5|||
94419800|NCT04156620|323323545|FG001|Overall Study|Lost to follow-up - TP 2|2|||
94419801|NCT04156620|323323544|FG000|Overall Study|Physician decision - TP 2|4|||
94419802|NCT04156620|323323545|FG001|Overall Study|Physician decision - TP 2|2|||
94419803|NCT04156620|323323544|FG000|Overall Study|Pregnancy - TP 2|1|||
94419804|NCT04156620|323323545|FG001|Overall Study|Pregnancy - TP 2|1|||
94419805|NCT04156620|323323544|FG000|Overall Study|Subject decision - TP 2|11|||
94419806|NCT04156620|323323545|FG001|Overall Study|Subject decision - TP 2|9|||
94419807|NCT04156620|323323544|FG000|Overall Study|New therapy for study indication - TP 2|1|||
94419808|NCT04156620|323323545|FG001|Overall Study|New therapy for study indication - TP 2|0|||
94419809|NCT02435836|323323550|FG000|Overall Study|Lost to Follow-up|21|||
94419810|NCT02435836|323323550|FG000|Overall Study|Lack of Efficacy|1|||
94419811|NCT02435836|323323550|FG000|Overall Study|Withdrawal by Subject|236|||
94419812|NCT02435836|323323550|FG000|Overall Study|Insufficient Clinical Response|26|||
94419813|NCT02435836|323323550|FG000|Overall Study|Adverse Event|44|||
94419814|NCT02435836|323323550|FG000|Overall Study|Sponsor discontinued trial|167|||
94419815|NCT02435836|323323550|FG000|Overall Study|Noncompliance|27|||
94419816|NCT02435836|323323550|FG000|Overall Study|Protocol Violation|6|||
94419817|NCT02435836|323323550|FG000|Overall Study|Met Withdrawal Criteria|7|||
94419818|NCT02435836|323323550|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
94419819|NCT03407430|323323553|FG000|Washout|Protocol Violation|1|||
94419820|NCT03407430|323323554|FG001|Washout|Protocol Violation|0|||
94419821|NCT01172821|323323555|FG000|Overall Study|Adverse Event|5|||
94419822|NCT01172821|323323556|FG001|Overall Study|Adverse Event|2|||
94419823|NCT01172821|323323557|FG002|Overall Study|Adverse Event|2|||
94419824|NCT01172821|323323558|FG003|Overall Study|Adverse Event|7|||
94419825|NCT01172821|323323555|FG000|Overall Study|Protocol Violation|0|||
94419826|NCT01172821|323323556|FG001|Overall Study|Protocol Violation|2|||
94419827|NCT01172821|323323557|FG002|Overall Study|Protocol Violation|1|||
94419828|NCT01172821|323323558|FG003|Overall Study|Protocol Violation|2|||
94419829|NCT01172821|323323555|FG000|Overall Study|Lost to Follow-up|4|||
94419830|NCT01172821|323323556|FG001|Overall Study|Lost to Follow-up|1|||
94419831|NCT01172821|323323557|FG002|Overall Study|Lost to Follow-up|2|||
94419832|NCT01172821|323323558|FG003|Overall Study|Lost to Follow-up|2|||
94419833|NCT01172821|323323555|FG000|Overall Study|Withdrawal by Subject|2|||
94419834|NCT01172821|323323556|FG001|Overall Study|Withdrawal by Subject|3|||
94419835|NCT01172821|323323557|FG002|Overall Study|Withdrawal by Subject|3|||
94419836|NCT01172821|323323558|FG003|Overall Study|Withdrawal by Subject|3|||
94419837|NCT01172821|323323555|FG000|Overall Study|Other|3|||
94419838|NCT01172821|323323556|FG001|Overall Study|Other|4|||
94419839|NCT01172821|323323557|FG002|Overall Study|Other|5|||
94419840|NCT01172821|323323558|FG003|Overall Study|Other|3|||
94419841|NCT00123955|323323559|FG000|Overall Study|Adverse Event|1|||
94419842|NCT00123955|323323560|FG001|Overall Study|Adverse Event|0|||
94419843|NCT00123955|323323559|FG000|Overall Study|Withdrawal by Subject|4|||
94419844|NCT00123955|323323560|FG001|Overall Study|Withdrawal by Subject|3|||
94419845|NCT00123955|323323559|FG000|Overall Study|Death|0|||
94419846|NCT00123955|323323560|FG001|Overall Study|Death|1|||
94419847|NCT00477295|323323561|FG000|Overall Study|Adverse Event|31|||
94419848|NCT00477295|323323562|FG001|Overall Study|Adverse Event|35|||
94419849|NCT00477295|323323561|FG000|Overall Study|Withdrawal by Subject|35|||
94419850|NCT00477295|323323562|FG001|Overall Study|Withdrawal by Subject|24|||
94419851|NCT00477295|323323561|FG000|Overall Study|Lack of Efficacy|23|||
94419852|NCT00477295|323323562|FG001|Overall Study|Lack of Efficacy|23|||
94419853|NCT00477295|323323561|FG000|Overall Study|Protocol Violation|3|||
94419854|NCT00477295|323323562|FG001|Overall Study|Protocol Violation|8|||
94419855|NCT00477295|323323561|FG000|Overall Study|Physician Decision|4|||
94419856|NCT00477295|323323562|FG001|Overall Study|Physician Decision|5|||
94419857|NCT00477295|323323561|FG000|Overall Study|Lost to Follow-up|21|||
94419858|NCT00477295|323323562|FG001|Overall Study|Lost to Follow-up|11|||
94419859|NCT00477295|323323561|FG000|Overall Study|Other|4|||
94419860|NCT00477295|323323562|FG001|Overall Study|Other|3|||
94419861|NCT03870477|323323563|FG000|Overall Study|Early Study Termination|1|||
94419862|NCT00594646|323323564|FG000|Overall Study|Withdrawal by Subject|1|||
94419863|NCT00594646|323323564|FG000|Overall Study|Lost to Follow-up|15|||
94419864|NCT04556552|323325706|FG000|Overall Study|Lost to Follow-up|1|||
94419865|NCT04556552|323325707|FG001|Overall Study|Lost to Follow-up|0|||
94419866|NCT04556552|323325706|FG000|Overall Study|Claustrophobia|0|||
94419867|NCT04556552|323325707|FG001|Overall Study|Claustrophobia|1|||
94419868|NCT04556552|323325706|FG000|Overall Study|Inability to continue|0|||
94419869|NCT04556552|323325707|FG001|Overall Study|Inability to continue|1|||
94419870|NCT04551911|323325708|FG000|Overall Study|Lost to Follow-up|2|||
94419871|NCT04551911|323325709|FG001|Overall Study|Lost to Follow-up|1|||
94419872|NCT04551911|323325708|FG000|Overall Study|Withdrawal by Subject|10|||
94419873|NCT04551911|323325709|FG001|Overall Study|Withdrawal by Subject|10|||
94419874|NCT04551911|323325708|FG000|Overall Study|Did not receive the study drug|3|||
94419875|NCT04551911|323325709|FG001|Overall Study|Did not receive the study drug|4|||
94419876|NCT00759902|323325710|FG000|Overall Study|Adverse Event|0|||
94419877|NCT00759902|323325711|FG001|Overall Study|Adverse Event|1|||
94419878|NCT00127036|323325723|FG000|Overall Study|Insufficient Data for Analysis|6|||
94419879|NCT00127036|323325724|FG001|Overall Study|Insufficient Data for Analysis|11|||
94419880|NCT00127036|323325723|FG000|Overall Study|Screen Failure|2|||
94419881|NCT00127036|323325724|FG001|Overall Study|Screen Failure|0|||
94419882|NCT01462318|323325725|FG000|Main Study / TP-DI Study|Other|2|||
94419883|NCT01462318|323325726|FG001|Main Study / TP-DI Study|Other|0|||
94419884|NCT01462318|323325727|FG002|Main Study / TP-DI Study|Other|0|||
94419885|NCT01462318|323325725|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
94419886|NCT01462318|323325726|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
94419887|NCT01462318|323325727|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
94419888|NCT01462318|323325725|FG000|Main Study / TP-DI Study|Adverse Event|4|||
94419889|NCT01462318|323325726|FG001|Main Study / TP-DI Study|Adverse Event|0|||
94419890|NCT01462318|323325727|FG002|Main Study / TP-DI Study|Adverse Event|0|||
94419891|NCT01462318|323325725|FG000|Extension Phase|Lost to Follow-up|0|||
94419892|NCT01462318|323325726|FG001|Extension Phase|Lost to Follow-up|0|||
94419893|NCT01462318|323325727|FG002|Extension Phase|Lost to Follow-up|1|||
94419894|NCT01462318|323325725|FG000|Extension Phase|Other|0|||
94419895|NCT01462318|323325726|FG001|Extension Phase|Other|0|||
94419896|NCT01462318|323325727|FG002|Extension Phase|Other|1|||
94419897|NCT01462318|323325725|FG000|Extension Phase|Disease Progression|0|||
94419898|NCT01462318|323325726|FG001|Extension Phase|Disease Progression|0|||
94419899|NCT01462318|323325727|FG002|Extension Phase|Disease Progression|1|||
94419900|NCT01462318|323325725|FG000|Extension Phase|Withdrawal by Subject|0|||
94419901|NCT01462318|323325726|FG001|Extension Phase|Withdrawal by Subject|0|||
94419902|NCT01462318|323325727|FG002|Extension Phase|Withdrawal by Subject|15|||
94419903|NCT01462318|323325725|FG000|Extension Phase|Investigator Decision|0|||
94419904|NCT01462318|323325726|FG001|Extension Phase|Investigator Decision|0|||
94419905|NCT01462318|323325727|FG002|Extension Phase|Investigator Decision|5|||
94419906|NCT01462318|323325725|FG000|Extension Phase|Adverse Event|0|||
94419907|NCT01462318|323325726|FG001|Extension Phase|Adverse Event|0|||
94419908|NCT01462318|323325727|FG002|Extension Phase|Adverse Event|22|||
94419909|NCT00270257|323325734|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
94419910|NCT00270257|323325735|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
94419911|NCT03001219|323325738|FG000|Proof of Concept|Study Termination by Sponsor|0|||
94419912|NCT03001219|323325739|FG001|Proof of Concept|Study Termination by Sponsor|1|||
94419913|NCT03001219|323325738|FG000|Proof of Concept|Withdrawal by Subject|0|||
94419914|NCT03001219|323325739|FG001|Proof of Concept|Withdrawal by Subject|4|||
94419915|NCT03001219|323325738|FG000|Proof of Concept|Protocol Deviation|0|||
94419916|NCT03001219|323325739|FG001|Proof of Concept|Protocol Deviation|1|||
94419917|NCT03001219|323325738|FG000|Proof of Concept|Adverse Event|1|||
94419918|NCT03001219|323325739|FG001|Proof of Concept|Adverse Event|1|||
94419919|NCT03001219|323325738|FG000|Proof of Concept|Physician Decision|1|||
94419920|NCT03001219|323325739|FG001|Proof of Concept|Physician Decision|0|||
94419921|NCT03001219|323325738|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
94419922|NCT03001219|323325739|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
94419923|NCT03001219|323325738|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
94419924|NCT03001219|323325739|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
94419925|NCT03001219|323325738|FG000|Extension Period Analysis|Physician Decision|0|||
94419926|NCT03001219|323325739|FG001|Extension Period Analysis|Physician Decision|1|||
94419927|NCT03001219|323325738|FG000|Extension Period Analysis|Adverse Event|1|||
94419928|NCT03001219|323325739|FG001|Extension Period Analysis|Adverse Event|1|||
94419929|NCT03001219|323325738|FG000|Extension Period Analysis|Protocol Deviation|0|||
94419930|NCT03001219|323325739|FG001|Extension Period Analysis|Protocol Deviation|1|||
94419931|NCT03001219|323325738|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
94419932|NCT03001219|323325739|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
94419933|NCT02622113|323325740|FG000|Overall Study|Adverse Event|4|||
94419934|NCT02622113|323325741|FG001|Overall Study|Adverse Event|4|||
94419935|NCT02622113|323325740|FG000|Overall Study|Physician Decision|0|||
94419936|NCT02622113|323325741|FG001|Overall Study|Physician Decision|1|||
94419937|NCT02622113|323325740|FG000|Overall Study|Withdrawal by Subject|0|||
94419938|NCT02622113|323325741|FG001|Overall Study|Withdrawal by Subject|2|||
94419939|NCT02622113|323325740|FG000|Overall Study|Stopping Criteria|1|||
94419940|NCT02622113|323325741|FG001|Overall Study|Stopping Criteria|3|||
94419941|NCT00307034|323325742|FG000|Overall Study|Adverse Event|1|||
94419942|NCT00307034|323325743|FG001|Overall Study|Adverse Event|2|||
94419943|NCT00307034|323325742|FG000|Overall Study|Withdrawal by Subject|1|||
94419944|NCT00307034|323325743|FG001|Overall Study|Withdrawal by Subject|2|||
94419945|NCT00307034|323325742|FG000|Overall Study|Lost to Follow-up|0|||
94419946|NCT00307034|323325743|FG001|Overall Study|Lost to Follow-up|3|||
94419947|NCT01892657|323325752|FG000|Overall Study|Withdrawal by Subject|6|||
94419948|NCT01892657|323325752|FG000|Overall Study|Protocol Violation|12|||
94419949|NCT00667810|323325755|FG000|Overall Study|Adverse Event|13|||
94419950|NCT00667810|323325756|FG001|Overall Study|Adverse Event|14|||
94419951|NCT00667810|323325757|FG002|Overall Study|Adverse Event|19|||
94419952|NCT00667810|323325758|FG003|Overall Study|Adverse Event|1|||
94419953|NCT00667810|323325755|FG000|Overall Study|Death|1|||
94419954|NCT00667810|323325756|FG001|Overall Study|Death|1|||
94419955|NCT00667810|323325757|FG002|Overall Study|Death|3|||
94419956|NCT00667810|323325758|FG003|Overall Study|Death|0|||
94419957|NCT00667810|323325755|FG000|Overall Study|Lack of Efficacy|1|||
94419958|NCT00667810|323325756|FG001|Overall Study|Lack of Efficacy|0|||
94419959|NCT00667810|323325757|FG002|Overall Study|Lack of Efficacy|2|||
94419960|NCT00667810|323325758|FG003|Overall Study|Lack of Efficacy|0|||
94419961|NCT00667810|323325755|FG000|Overall Study|Lost to Follow-up|1|||
94419962|NCT00667810|323325756|FG001|Overall Study|Lost to Follow-up|4|||
94419963|NCT00667810|323325757|FG002|Overall Study|Lost to Follow-up|2|||
94419964|NCT00667810|323325758|FG003|Overall Study|Lost to Follow-up|0|||
94419965|NCT00667810|323325755|FG000|Overall Study|Physician Decision|1|||
94419966|NCT00667810|323325756|FG001|Overall Study|Physician Decision|1|||
94419967|NCT00667810|323325757|FG002|Overall Study|Physician Decision|2|||
94419968|NCT00667810|323325758|FG003|Overall Study|Physician Decision|0|||
94419969|NCT00667810|323325755|FG000|Overall Study|Protocol Violation|0|||
94419970|NCT00667810|323325756|FG001|Overall Study|Protocol Violation|2|||
94419971|NCT00667810|323325757|FG002|Overall Study|Protocol Violation|0|||
94419972|NCT00667810|323325758|FG003|Overall Study|Protocol Violation|0|||
94419973|NCT00667810|323325755|FG000|Overall Study|Withdrawal by Subject|14|||
94419974|NCT00667810|323325756|FG001|Overall Study|Withdrawal by Subject|20|||
94419975|NCT00667810|323325757|FG002|Overall Study|Withdrawal by Subject|29|||
94419976|NCT00667810|323325758|FG003|Overall Study|Withdrawal by Subject|1|||
94419977|NCT00667810|323325755|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
94419978|NCT00667810|323325756|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
94419979|NCT00667810|323325757|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
94419980|NCT00667810|323325758|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
94419981|NCT00667810|323325755|FG000|Overall Study|Failed to Return|0|||
94419982|NCT00667810|323325756|FG001|Overall Study|Failed to Return|0|||
94419983|NCT00667810|323325757|FG002|Overall Study|Failed to Return|2|||
94419984|NCT00667810|323325758|FG003|Overall Study|Failed to Return|0|||
94419985|NCT00667810|323325755|FG000|Overall Study|Loss of Caregiver|0|||
94419986|NCT00667810|323325756|FG001|Overall Study|Loss of Caregiver|1|||
94419987|NCT00667810|323325757|FG002|Overall Study|Loss of Caregiver|3|||
94419988|NCT00667810|323325758|FG003|Overall Study|Loss of Caregiver|0|||
94419989|NCT00667810|323325755|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
94419990|NCT00667810|323325756|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
94419991|NCT00667810|323325757|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
94419992|NCT00667810|323325758|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
94419993|NCT00667810|323325755|FG000|Overall Study|Other|6|||
94419994|NCT00667810|323325756|FG001|Overall Study|Other|6|||
94419995|NCT00667810|323325757|FG002|Overall Study|Other|5|||
94419996|NCT00667810|323325758|FG003|Overall Study|Other|0|||
94419997|NCT02034058|323325759|FG000|Overall Study|Death|3|||
94419998|NCT03254602|323325760|FG000|Overall Study|Lost to Follow-up|4|||
94419999|NCT02963311|323325763|FG000|Overall Study|Withdrawal by Subject|1|||
94420000|NCT02963311|323325763|FG000|Overall Study|Screen Failure|4|||
94420001|NCT00468728|323325764|FG000|Treatment|criteria for mITT population|4|||
94420002|NCT00468728|323325765|FG001|Treatment|criteria for mITT population|11|||
94420003|NCT00468728|323325764|FG000|Follow-up|mITT failure|34|||
94420004|NCT00468728|323325765|FG001|Follow-up|mITT failure|31|||
94420005|NCT01691820|323325766|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
94420006|NCT01691820|323325767|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
94420007|NCT01691820|323325766|FG000|Overall Study|Migrated/moved from study area|7|||
94420008|NCT01691820|323325767|FG001|Overall Study|Migrated/moved from study area|4|||
94420009|NCT01691820|323325766|FG000|Overall Study|Lost to Follow-up|6|||
94420010|NCT01691820|323325767|FG001|Overall Study|Lost to Follow-up|17|||
94420011|NCT01691820|323325766|FG000|Overall Study|Other (unspecified)|4|||
94420012|NCT01691820|323325767|FG001|Overall Study|Other (unspecified)|1|||
94420013|NCT00076804|323325768|FG000|Overall Study|Death|9|||
94420014|NCT00076804|323325769|FG001|Overall Study|Death|20|||
94420015|NCT00076804|323325768|FG000|Overall Study|Lost to Follow-up|9|||
94420016|NCT00076804|323325769|FG001|Overall Study|Lost to Follow-up|9|||
94420017|NCT00076804|323325768|FG000|Overall Study|Withdrawal by Subject|10|||
94420018|NCT00076804|323325769|FG001|Overall Study|Withdrawal by Subject|8|||
94420019|NCT00076804|323325768|FG000|Overall Study|Early study Closure|32|||
94420020|NCT00076804|323325769|FG001|Overall Study|Early study Closure|32|||
94420021|NCT01055132|323325770|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
94420022|NCT01055132|323325771|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
94420023|NCT01055132|323325770|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
94420024|NCT01055132|323325771|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
94420025|NCT02712333|323325772|FG000|First Period|Withdrawal by Subject|3|||
94420026|NCT02712333|323325773|FG001|First Period|Withdrawal by Subject|2|||
94420027|NCT00302081|323325777|FG000|Overall Study|Adverse Event|6|||
94420028|NCT00302081|323325778|FG001|Overall Study|Adverse Event|5|||
94420029|NCT00302081|323325779|FG002|Overall Study|Adverse Event|4|||
94420030|NCT00302081|323325777|FG000|Overall Study|Lost to Follow-up|21|||
94420031|NCT00302081|323325778|FG001|Overall Study|Lost to Follow-up|18|||
94420032|NCT00302081|323325779|FG002|Overall Study|Lost to Follow-up|28|||
94420033|NCT00302081|323325777|FG000|Overall Study|Withdrawal by Subject|8|||
94420034|NCT00302081|323325778|FG001|Overall Study|Withdrawal by Subject|12|||
94420035|NCT00302081|323325779|FG002|Overall Study|Withdrawal by Subject|8|||
94420036|NCT00302081|323325777|FG000|Overall Study|Protocol Violation|5|||
94420037|NCT00302081|323325778|FG001|Overall Study|Protocol Violation|1|||
94420038|NCT00302081|323325779|FG002|Overall Study|Protocol Violation|2|||
94420039|NCT00302081|323325777|FG000|Overall Study|Lack of Efficacy|1|||
94420040|NCT00302081|323325778|FG001|Overall Study|Lack of Efficacy|0|||
94420041|NCT00302081|323325779|FG002|Overall Study|Lack of Efficacy|5|||
94420042|NCT00302081|323325777|FG000|Overall Study|Death|2|||
94420043|NCT00302081|323325778|FG001|Overall Study|Death|1|||
94420044|NCT00302081|323325779|FG002|Overall Study|Death|0|||
94420045|NCT00302081|323325777|FG000|Overall Study|Other|13|||
94420046|NCT00302081|323325778|FG001|Overall Study|Other|6|||
94420047|NCT00302081|323325779|FG002|Overall Study|Other|5|||
94420048|NCT02005887|323325780|FG000|Overall Study|Protocol Violation|0|||
94420049|NCT02005887|323325781|FG001|Overall Study|Protocol Violation|2|||
94420050|NCT01568320|323325788|FG000|Overall Study|Death|20|||
94420051|NCT01568320|323325788|FG000|Overall Study|Lost to Follow-up|9|||
94420052|NCT01568320|323325788|FG000|Overall Study|Withdrawal by Subject|10|||
94420053|NCT01568320|323325788|FG000|Overall Study|Conversion to open repair|1|||
94420054|NCT01568320|323325788|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
94420055|NCT01359644|323325791|FG000|Treatment Period|Lack of Efficacy|0|||
94420056|NCT01359644|323325792|FG001|Treatment Period|Lack of Efficacy|1|||
94420057|NCT01359644|323325793|FG002|Treatment Period|Lack of Efficacy|0|||
94420058|NCT01359644|323325794|FG003|Treatment Period|Lack of Efficacy|0|||
94420059|NCT01359644|323325795|FG004|Treatment Period|Lack of Efficacy|0|||
94420060|NCT01359644|323325796|FG005|Treatment Period|Lack of Efficacy|0|||
94420061|NCT01359644|323325797|FG006|Treatment Period|Lack of Efficacy|0|||
94420062|NCT01359644|323325798|FG007|Treatment Period|Lack of Efficacy|0|||
94420063|NCT01359644|323325799|FG008|Treatment Period|Lack of Efficacy|0|||
94420064|NCT01359644|323325800|FG009|Treatment Period|Lack of Efficacy|0|||
94420065|NCT01359644|323325791|FG000|Treatment Period|Adverse Event|0|||
94420066|NCT01359644|323325792|FG001|Treatment Period|Adverse Event|0|||
94420067|NCT01359644|323325793|FG002|Treatment Period|Adverse Event|1|||
94420068|NCT01359644|323325794|FG003|Treatment Period|Adverse Event|0|||
94420069|NCT01359644|323325795|FG004|Treatment Period|Adverse Event|0|||
94420070|NCT01359644|323325796|FG005|Treatment Period|Adverse Event|1|||
94420071|NCT01359644|323325797|FG006|Treatment Period|Adverse Event|0|||
94420072|NCT01359644|323325798|FG007|Treatment Period|Adverse Event|0|||
94420073|NCT01359644|323325799|FG008|Treatment Period|Adverse Event|0|||
94420074|NCT01359644|323325800|FG009|Treatment Period|Adverse Event|0|||
94420075|NCT01359644|323325791|FG000|Treatment Period|Lost to Follow-up|0|||
94420076|NCT01359644|323325792|FG001|Treatment Period|Lost to Follow-up|0|||
94420077|NCT01359644|323325793|FG002|Treatment Period|Lost to Follow-up|0|||
94420078|NCT01359644|323325794|FG003|Treatment Period|Lost to Follow-up|0|||
94420079|NCT01359644|323325795|FG004|Treatment Period|Lost to Follow-up|0|||
94420080|NCT01359644|323325796|FG005|Treatment Period|Lost to Follow-up|1|||
94420081|NCT01359644|323325797|FG006|Treatment Period|Lost to Follow-up|0|||
94420082|NCT01359644|323325798|FG007|Treatment Period|Lost to Follow-up|0|||
94420083|NCT01359644|323325799|FG008|Treatment Period|Lost to Follow-up|0|||
94420084|NCT01359644|323325800|FG009|Treatment Period|Lost to Follow-up|0|||
94420085|NCT01359644|323325791|FG000|Follow-up Period|Withdrawal by Subject|0|||
94420086|NCT01359644|323325792|FG001|Follow-up Period|Withdrawal by Subject|0|||
94420087|NCT01359644|323325793|FG002|Follow-up Period|Withdrawal by Subject|0|||
94420088|NCT01359644|323325794|FG003|Follow-up Period|Withdrawal by Subject|0|||
94420089|NCT01359644|323325795|FG004|Follow-up Period|Withdrawal by Subject|0|||
94420090|NCT01359644|323325796|FG005|Follow-up Period|Withdrawal by Subject|1|||
94420091|NCT01359644|323325797|FG006|Follow-up Period|Withdrawal by Subject|0|||
94420092|NCT01359644|323325798|FG007|Follow-up Period|Withdrawal by Subject|0|||
94420093|NCT01359644|323325799|FG008|Follow-up Period|Withdrawal by Subject|0|||
94420094|NCT01359644|323325800|FG009|Follow-up Period|Withdrawal by Subject|0|||
94420095|NCT01359644|323325791|FG000|Follow-up Period|Lost to Follow-up|0|||
94420096|NCT01359644|323325792|FG001|Follow-up Period|Lost to Follow-up|0|||
94420097|NCT01359644|323325793|FG002|Follow-up Period|Lost to Follow-up|0|||
94420098|NCT01359644|323325794|FG003|Follow-up Period|Lost to Follow-up|0|||
94420099|NCT01359644|323325795|FG004|Follow-up Period|Lost to Follow-up|0|||
94420100|NCT01359644|323325796|FG005|Follow-up Period|Lost to Follow-up|0|||
94420101|NCT01359644|323325797|FG006|Follow-up Period|Lost to Follow-up|1|||
94420102|NCT01359644|323325798|FG007|Follow-up Period|Lost to Follow-up|2|||
94420103|NCT01359644|323325799|FG008|Follow-up Period|Lost to Follow-up|0|||
94420104|NCT01359644|323325800|FG009|Follow-up Period|Lost to Follow-up|0|||
94420105|NCT01229735|323325801|FG000|Overall Study|Lack of Efficacy|8|||
94420106|NCT01229735|323325802|FG001|Overall Study|Lack of Efficacy|8|||
94420107|NCT01229735|323325801|FG000|Overall Study|Protocol Violation|13|||
94420108|NCT01229735|323325802|FG001|Overall Study|Protocol Violation|8|||
94420109|NCT01229735|323325801|FG000|Overall Study|Lost to Follow-up|0|||
94420110|NCT01229735|323325802|FG001|Overall Study|Lost to Follow-up|2|||
94420111|NCT01229735|323325801|FG000|Overall Study|Withdrawal by Subject|18|||
94420112|NCT01229735|323325802|FG001|Overall Study|Withdrawal by Subject|17|||
94489271|NCT00903968|323586019|FG000|Overall Study|Withdrawal by Subject|1|||
94420113|NCT01229735|323325801|FG000|Overall Study|Other Reason|13|||
94420114|NCT01229735|323325802|FG001|Overall Study|Other Reason|10|||
94420115|NCT01229735|323325801|FG000|Overall Study|SAE, non-fatal|0|||
94420116|NCT01229735|323325802|FG001|Overall Study|SAE, non-fatal|4|||
94489272|NCT00903968|323586020|FG001|Overall Study|Withdrawal by Subject|0|||
94420117|NCT01229735|323325801|FG000|Overall Study|AE, non-serious non-fatal|13|||
94420118|NCT01229735|323325802|FG001|Overall Study|AE, non-serious non-fatal|17|||
94420119|NCT01229735|323325801|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
94420120|NCT01229735|323325802|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
94420121|NCT01144364|323325814|FG000|Induction Phase|Disease progression|14|||
94420122|NCT01144364|323325815|FG001|Induction Phase|Disease progression|0|||
94420123|NCT01144364|323325816|FG002|Induction Phase|Disease progression|0|||
94420124|NCT01144364|323325814|FG000|Induction Phase|Adverse Event|9|||
94420125|NCT01144364|323325815|FG001|Induction Phase|Adverse Event|0|||
94420126|NCT01144364|323325816|FG002|Induction Phase|Adverse Event|0|||
94420127|NCT01144364|323325814|FG000|Induction Phase|Death|1|||
94420128|NCT01144364|323325815|FG001|Induction Phase|Death|0|||
94420129|NCT01144364|323325816|FG002|Induction Phase|Death|0|||
94420130|NCT01144364|323325814|FG000|Induction Phase|Withdrawal by Subject|1|||
94420131|NCT01144364|323325815|FG001|Induction Phase|Withdrawal by Subject|0|||
94420132|NCT01144364|323325816|FG002|Induction Phase|Withdrawal by Subject|0|||
94420133|NCT01144364|323325814|FG000|Induction Phase|Lost to Follow-up|2|||
94420134|NCT01144364|323325815|FG001|Induction Phase|Lost to Follow-up|0|||
94420135|NCT01144364|323325816|FG002|Induction Phase|Lost to Follow-up|0|||
94420136|NCT01144364|323325814|FG000|Induction Phase|Physician Decision|1|||
94420137|NCT01144364|323325815|FG001|Induction Phase|Physician Decision|0|||
94420138|NCT01144364|323325816|FG002|Induction Phase|Physician Decision|0|||
94420139|NCT01144364|323325814|FG000|Induction Phase|Stable disease|2|||
94420140|NCT01144364|323325815|FG001|Induction Phase|Stable disease|0|||
94420141|NCT01144364|323325816|FG002|Induction Phase|Stable disease|0|||
94420142|NCT01144364|323325814|FG000|Induction Phase|Secondary neoplasia|1|||
94420143|NCT01144364|323325815|FG001|Induction Phase|Secondary neoplasia|0|||
94420144|NCT01144364|323325816|FG002|Induction Phase|Secondary neoplasia|0|||
94420145|NCT01144364|323325814|FG000|Induction Phase|Protocol Violation|1|||
94420146|NCT01144364|323325815|FG001|Induction Phase|Protocol Violation|0|||
94420147|NCT01144364|323325816|FG002|Induction Phase|Protocol Violation|0|||
94420148|NCT01144364|323325814|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
94420149|NCT01144364|323325815|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
94420150|NCT01144364|323325816|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
94420151|NCT01144364|323325814|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
94420152|NCT01144364|323325815|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
94420153|NCT01144364|323325816|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
94420154|NCT01144364|323325814|FG000|Follow-Up/Maintenance Phase|Death|0|||
94420155|NCT01144364|323325815|FG001|Follow-Up/Maintenance Phase|Death|2|||
94420156|NCT01144364|323325816|FG002|Follow-Up/Maintenance Phase|Death|0|||
94420157|NCT01144364|323325814|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
94420158|NCT01144364|323325815|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
94420159|NCT01144364|323325816|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
94420160|NCT01144364|323325814|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
94420161|NCT01144364|323325815|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
94420162|NCT01144364|323325816|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
94420163|NCT01144364|323325814|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
94420164|NCT01144364|323325815|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
94420165|NCT01144364|323325816|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
94420166|NCT01144364|323325814|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
94420167|NCT01144364|323325815|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
94420168|NCT01144364|323325816|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
94420169|NCT00851643|323325817|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
94420170|NCT00851643|323325818|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
94420171|NCT00851643|323325819|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
94420172|NCT00851643|323325820|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
94420173|NCT00851643|323325821|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
94420174|NCT00851643|323325822|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
94420175|NCT00851643|323325817|FG000|Base Study (Up to 12 Months)|Other|0|||
94420176|NCT00851643|323325818|FG001|Base Study (Up to 12 Months)|Other|0|||
94420177|NCT00851643|323325819|FG002|Base Study (Up to 12 Months)|Other|0|||
94420178|NCT00851643|323325820|FG003|Base Study (Up to 12 Months)|Other|0|||
94420179|NCT00851643|323325821|FG004|Base Study (Up to 12 Months)|Other|0|||
94420180|NCT00851643|323325822|FG005|Base Study (Up to 12 Months)|Other|1|||
94420181|NCT00851643|323325817|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
94420182|NCT00851643|323325818|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
94420183|NCT00851643|323325819|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
94420184|NCT00851643|323325820|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
94420185|NCT00851643|323325821|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
94420186|NCT00851643|323325822|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
94420187|NCT00851643|323325817|FG000|Extension Study (Up to 36 Months)|Moved|0|||
94420188|NCT00851643|323325818|FG001|Extension Study (Up to 36 Months)|Moved|2|||
94420189|NCT00851643|323325819|FG002|Extension Study (Up to 36 Months)|Moved|1|||
94420190|NCT00851643|323325820|FG003|Extension Study (Up to 36 Months)|Moved|1|||
94420191|NCT00851643|323325821|FG004|Extension Study (Up to 36 Months)|Moved|0|||
94420192|NCT00851643|323325822|FG005|Extension Study (Up to 36 Months)|Moved|1|||
94420193|NCT01940497|323325823|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
94420194|NCT01940497|323325824|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
94420195|NCT01940497|323325823|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
94420196|NCT01940497|323325824|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
94420197|NCT01940497|323325823|FG000|Overall Study|Violation of Entry Criteria|1|||
94420198|NCT01940497|323325824|FG001|Overall Study|Violation of Entry Criteria|1|||
94420199|NCT01940497|323325823|FG000|Overall Study|Refused Treatment|1|||
94420200|NCT01940497|323325824|FG001|Overall Study|Refused Treatment|3|||
94420201|NCT01940497|323325823|FG000|Overall Study|Withdrew Consent|6|||
94420202|NCT01940497|323325824|FG001|Overall Study|Withdrew Consent|2|||
94420203|NCT01940497|323325823|FG000|Overall Study|Administrative/Other|1|||
94420204|NCT01940497|323325824|FG001|Overall Study|Administrative/Other|1|||
94420205|NCT01641133|323325825|FG000|Overall Study|Protocol Violation|0|||
94420206|NCT01641133|323325826|FG001|Overall Study|Protocol Violation|1|||
94420207|NCT01641133|323325827|FG002|Overall Study|Protocol Violation|1|||
94420208|NCT01641133|323325825|FG000|Overall Study|Migrated/moved from study area|5|||
94420209|NCT01641133|323325826|FG001|Overall Study|Migrated/moved from study area|3|||
94420210|NCT01641133|323325827|FG002|Overall Study|Migrated/moved from study area|1|||
94420211|NCT01641133|323325825|FG000|Overall Study|Adverse Event|0|||
94420212|NCT01641133|323325826|FG001|Overall Study|Adverse Event|0|||
94420213|NCT01641133|323325827|FG002|Overall Study|Adverse Event|1|||
94420214|NCT01641133|323325825|FG000|Overall Study|Withdrawal by Subject|5|||
94420215|NCT01641133|323325826|FG001|Overall Study|Withdrawal by Subject|3|||
94420216|NCT01641133|323325827|FG002|Overall Study|Withdrawal by Subject|3|||
94420217|NCT01641133|323325825|FG000|Overall Study|Lost to Follow-up|0|||
94420218|NCT01641133|323325826|FG001|Overall Study|Lost to Follow-up|2|||
94420219|NCT01641133|323325827|FG002|Overall Study|Lost to Follow-up|2|||
94420220|NCT03123861|323325828|FG000|Overall Study|Protocol Violation|1|||
94420221|NCT03123861|323325829|FG001|Overall Study|Protocol Violation|1|||
94420222|NCT03123861|323325828|FG000|Overall Study|Withdrawal by Subject|2|||
94420223|NCT03123861|323325829|FG001|Overall Study|Withdrawal by Subject|2|||
94420224|NCT01346774|323325830|FG000|Overall Study|Did not take a single dose|6|||
94420225|NCT01346774|323325831|FG001|Overall Study|Did not take a single dose|4|||
94420226|NCT01346774|323325830|FG000|Overall Study|Lost to Follow-up|3|||
94420227|NCT01346774|323325831|FG001|Overall Study|Lost to Follow-up|4|||
94420228|NCT01346774|323325830|FG000|Overall Study|Withdrawal by Subject|1|||
94420229|NCT01346774|323325831|FG001|Overall Study|Withdrawal by Subject|4|||
94420230|NCT01346774|323325830|FG000|Overall Study|Protocol Violation|2|||
94420231|NCT01346774|323325831|FG001|Overall Study|Protocol Violation|3|||
94420232|NCT01346774|323325830|FG000|Overall Study|Adverse Event|1|||
94420233|NCT01346774|323325831|FG001|Overall Study|Adverse Event|2|||
94420234|NCT00389831|323325832|FG000|Overall Study|Lack of Efficacy|0|||
94420235|NCT00389831|323325833|FG001|Overall Study|Lack of Efficacy|2|||
94420236|NCT00389831|323325832|FG000|Overall Study|Did not receive treatment.|0|||
94420237|NCT00389831|323325833|FG001|Overall Study|Did not receive treatment.|2|||
94420238|NCT00389831|323325832|FG000|Overall Study|Other reasons|0|||
94420239|NCT00389831|323325833|FG001|Overall Study|Other reasons|2|||
94420240|NCT00389831|323325832|FG000|Overall Study|Lost to Follow-up|0|||
94420241|NCT00389831|323325833|FG001|Overall Study|Lost to Follow-up|1|||
94420242|NCT02394730|323325834|FG000|Overall Study|Lost to Follow-up|1|||
94420243|NCT02394730|323325835|FG001|Overall Study|Lost to Follow-up|0|||
94420244|NCT02394730|323325834|FG000|Overall Study|Withdrawal by Subject|0|||
94420245|NCT02394730|323325835|FG001|Overall Study|Withdrawal by Subject|1|||
94420246|NCT00369382|323325836|FG000|Overall Study|Death|0|||
94420247|NCT00369382|323325837|FG001|Overall Study|Death|2|||
94420248|NCT00369382|323325836|FG000|Overall Study|Physician Decision|2|||
94420249|NCT00369382|323325837|FG001|Overall Study|Physician Decision|1|||
94420250|NCT00369382|323325836|FG000|Overall Study|Withdrawal by Subject|5|||
94420251|NCT00369382|323325837|FG001|Overall Study|Withdrawal by Subject|0|||
94420252|NCT00369382|323325836|FG000|Overall Study|Randomized, not treated|2|||
94420253|NCT00369382|323325837|FG001|Overall Study|Randomized, not treated|0|||
94420254|NCT00369382|323325836|FG000|Overall Study|Other|1|||
94420255|NCT00369382|323325837|FG001|Overall Study|Other|0|||
94420256|NCT00507546|323325838|FG000|Overall Study|Withdrawal by Subject|1|||
94420257|NCT00507546|323325839|FG001|Overall Study|Withdrawal by Subject|0|||
94420258|NCT00507546|323325838|FG000|Overall Study|Protocol Violation|1|||
94420259|NCT00507546|323325839|FG001|Overall Study|Protocol Violation|0|||
94420260|NCT00507546|323325838|FG000|Overall Study|Physician Decision|0|||
94420261|NCT00507546|323325839|FG001|Overall Study|Physician Decision|1|||
94420262|NCT02384850|323325840|FG000|Overall Study|Withdrawal by Subject|2|||
94420263|NCT02384850|323325841|FG001|Overall Study|Withdrawal by Subject|2|||
94420264|NCT00911807|323325843|FG000|Overall Study|Adverse Event|2|||
94420265|NCT00911807|323325844|FG001|Overall Study|Adverse Event|1|||
94420266|NCT00911807|323325845|FG002|Overall Study|Adverse Event|5|||
94420267|NCT00911807|323325843|FG000|Overall Study|Death|0|||
94420268|NCT00911807|323325844|FG001|Overall Study|Death|0|||
94420269|NCT00911807|323325845|FG002|Overall Study|Death|1|||
94420270|NCT00911807|323325843|FG000|Overall Study|Protocol Violation|6|||
94420271|NCT00911807|323325844|FG001|Overall Study|Protocol Violation|4|||
94420272|NCT00911807|323325845|FG002|Overall Study|Protocol Violation|9|||
94420273|NCT00911807|323325843|FG000|Overall Study|Withdrawal by Subject|8|||
94420274|NCT00911807|323325844|FG001|Overall Study|Withdrawal by Subject|10|||
94420275|NCT00911807|323325845|FG002|Overall Study|Withdrawal by Subject|7|||
94420276|NCT00911807|323325843|FG000|Overall Study|Organizational reasons|1|||
94420277|NCT00911807|323325844|FG001|Overall Study|Organizational reasons|3|||
94420278|NCT00911807|323325845|FG002|Overall Study|Organizational reasons|1|||
94420279|NCT00448136|323325846|FG000|Overall Study|Death|3|||
94420280|NCT00448136|323325847|FG001|Overall Study|Death|8|||
94420281|NCT00448136|323325846|FG000|Overall Study|Investigator's decision (progression)|1|||
94420282|NCT00448136|323325847|FG001|Overall Study|Investigator's decision (progression)|0|||
94420283|NCT00609466|323325848|FG000|Overall Study|Withdrawal by Subject|0|||
94420284|NCT00609466|323325849|FG001|Overall Study|Withdrawal by Subject|1|||
94420285|NCT00609466|323325850|FG002|Overall Study|Withdrawal by Subject|1|||
94420286|NCT00609466|323325848|FG000|Overall Study|Adverse Event|2|||
94420287|NCT00609466|323325849|FG001|Overall Study|Adverse Event|3|||
94420288|NCT00609466|323325850|FG002|Overall Study|Adverse Event|1|||
94420289|NCT00609466|323325848|FG000|Overall Study|Lack of Efficacy|0|||
94420290|NCT00609466|323325849|FG001|Overall Study|Lack of Efficacy|2|||
94420291|NCT00609466|323325850|FG002|Overall Study|Lack of Efficacy|2|||
94420292|NCT03176459|323325853|FG000|Overall Study|Lost to Follow-up|5|||
94420293|NCT03176459|323325854|FG001|Overall Study|Lost to Follow-up|7|||
94420294|NCT02013375|323325855|FG000|Overall Study|Did not engraft|1|||
94420295|NCT02013375|323325855|FG000|Overall Study|Did not engraft|1|||
94420296|NCT03512262|323325859|FG000|Overall Study|Adverse Event|8|||
94420297|NCT03512262|323325860|FG001|Overall Study|Adverse Event|3|||
94420298|NCT03512262|323325859|FG000|Overall Study|Death (non-treatment emergent)|1|||
94420299|NCT03512262|323325860|FG001|Overall Study|Death (non-treatment emergent)|0|||
94420300|NCT03512262|323325859|FG000|Overall Study|Withdrawal by Subject|17|||
94420301|NCT03512262|323325860|FG001|Overall Study|Withdrawal by Subject|9|||
94420302|NCT03512262|323325859|FG000|Overall Study|Lost to Follow-up|7|||
94420303|NCT03512262|323325860|FG001|Overall Study|Lost to Follow-up|1|||
94420304|NCT03512262|323325859|FG000|Overall Study|Other than Specified|2|||
94420305|NCT03512262|323325860|FG001|Overall Study|Other than Specified|2|||
94420306|NCT02674061|323325862|FG000|Overall Study|Death|229|||
94420307|NCT02674061|323325863|FG001|Overall Study|Death|77|||
94420308|NCT02674061|323325862|FG000|Overall Study|Lost to Follow-up|3|||
94420309|NCT02674061|323325863|FG001|Overall Study|Lost to Follow-up|3|||
94420310|NCT02674061|323325862|FG000|Overall Study|Withdrawal by Subject|9|||
94420311|NCT02674061|323325863|FG001|Overall Study|Withdrawal by Subject|1|||
94420312|NCT02674061|323325862|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
94420313|NCT02674061|323325863|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
94420314|NCT01299805|323325868|FG000|Overall Study|Adverse Event|2|||
94420315|NCT01299805|323325869|FG001|Overall Study|Adverse Event|0|||
94420316|NCT01970865|323325870|FG000|Overall Study|Death|3|||
94420317|NCT01970865|323325871|FG001|Overall Study|Death|2|||
94420318|NCT01970865|323325872|FG002|Overall Study|Death|3|||
94420319|NCT01970865|323325873|FG003|Overall Study|Death|6|||
94420320|NCT01970865|323325874|FG004|Overall Study|Death|9|||
94420321|NCT01970865|323325875|FG005|Overall Study|Death|3|||
94420322|NCT01970865|323325876|FG006|Overall Study|Death|2|||
94420323|NCT01970865|323325877|FG007|Overall Study|Death|3|||
94420324|NCT01970865|323325878|FG008|Overall Study|Death|2|||
94420325|NCT01970865|323325879|FG009|Overall Study|Death|2|||
94420326|NCT01970865|323325880|FG010|Overall Study|Death|8|||
94420327|NCT01970865|323325881|FG011|Overall Study|Death|13|||
94420328|NCT01970865|323325882|FG012|Overall Study|Death|25|||
94420329|NCT01970865|323325883|FG013|Overall Study|Death|46|||
94420330|NCT01970865|323325884|FG014|Overall Study|Death|37|||
94420331|NCT01970865|323325885|FG015|Overall Study|Death|22|||
94420332|NCT01970865|323325886|FG016|Overall Study|Death|1|||
94420333|NCT01970865|323325887|FG017|Overall Study|Death|17|||
94420334|NCT01970865|323325870|FG000|Overall Study|Lost to Follow-up|0|||
94420335|NCT01970865|323325871|FG001|Overall Study|Lost to Follow-up|0|||
94420336|NCT01970865|323325872|FG002|Overall Study|Lost to Follow-up|0|||
94420337|NCT01970865|323325873|FG003|Overall Study|Lost to Follow-up|1|||
94420338|NCT01970865|323325874|FG004|Overall Study|Lost to Follow-up|1|||
94420339|NCT01970865|323325875|FG005|Overall Study|Lost to Follow-up|0|||
94420340|NCT01970865|323325876|FG006|Overall Study|Lost to Follow-up|0|||
94420341|NCT01970865|323325877|FG007|Overall Study|Lost to Follow-up|0|||
94489273|NCT00903968|323586021|FG002|Overall Study|Withdrawal by Subject|1|||
94420342|NCT01970865|323325878|FG008|Overall Study|Lost to Follow-up|0|||
94420343|NCT01970865|323325879|FG009|Overall Study|Lost to Follow-up|0|||
94420344|NCT01970865|323325880|FG010|Overall Study|Lost to Follow-up|1|||
94420345|NCT01970865|323325881|FG011|Overall Study|Lost to Follow-up|0|||
94420346|NCT01970865|323325882|FG012|Overall Study|Lost to Follow-up|2|||
94420347|NCT01970865|323325883|FG013|Overall Study|Lost to Follow-up|0|||
94420348|NCT01970865|323325884|FG014|Overall Study|Lost to Follow-up|1|||
94420349|NCT01970865|323325885|FG015|Overall Study|Lost to Follow-up|4|||
94420350|NCT01970865|323325886|FG016|Overall Study|Lost to Follow-up|0|||
94420351|NCT01970865|323325887|FG017|Overall Study|Lost to Follow-up|1|||
94420352|NCT01970865|323325870|FG000|Overall Study|Other|0|||
94420353|NCT01970865|323325871|FG001|Overall Study|Other|1|||
94420354|NCT01970865|323325872|FG002|Overall Study|Other|0|||
94420355|NCT01970865|323325873|FG003|Overall Study|Other|1|||
94420356|NCT01970865|323325874|FG004|Overall Study|Other|1|||
94420357|NCT01970865|323325875|FG005|Overall Study|Other|0|||
94420358|NCT01970865|323325876|FG006|Overall Study|Other|1|||
94420359|NCT01970865|323325877|FG007|Overall Study|Other|0|||
94420360|NCT01970865|323325878|FG008|Overall Study|Other|0|||
94420361|NCT01970865|323325879|FG009|Overall Study|Other|0|||
94420362|NCT01970865|323325880|FG010|Overall Study|Other|2|||
94420363|NCT01970865|323325881|FG011|Overall Study|Other|3|||
94420364|NCT01970865|323325882|FG012|Overall Study|Other|8|||
94420365|NCT01970865|323325883|FG013|Overall Study|Other|3|||
94420366|NCT01970865|323325884|FG014|Overall Study|Other|2|||
94420367|NCT01970865|323325885|FG015|Overall Study|Other|3|||
94420368|NCT01970865|323325886|FG016|Overall Study|Other|0|||
94420369|NCT01970865|323325887|FG017|Overall Study|Other|2|||
94420370|NCT01970865|323325870|FG000|Overall Study|Participant refused further follow-up|0|||
94420371|NCT01970865|323325871|FG001|Overall Study|Participant refused further follow-up|0|||
94420372|NCT01970865|323325872|FG002|Overall Study|Participant refused further follow-up|0|||
94420373|NCT01970865|323325873|FG003|Overall Study|Participant refused further follow-up|2|||
94420374|NCT01970865|323325874|FG004|Overall Study|Participant refused further follow-up|3|||
94420375|NCT01970865|323325875|FG005|Overall Study|Participant refused further follow-up|0|||
94420376|NCT01970865|323325876|FG006|Overall Study|Participant refused further follow-up|0|||
94420377|NCT01970865|323325877|FG007|Overall Study|Participant refused further follow-up|0|||
94420378|NCT01970865|323325878|FG008|Overall Study|Participant refused further follow-up|0|||
94420379|NCT01970865|323325879|FG009|Overall Study|Participant refused further follow-up|0|||
94420380|NCT01970865|323325880|FG010|Overall Study|Participant refused further follow-up|1|||
94420381|NCT01970865|323325881|FG011|Overall Study|Participant refused further follow-up|4|||
94420382|NCT01970865|323325882|FG012|Overall Study|Participant refused further follow-up|7|||
94420383|NCT01970865|323325883|FG013|Overall Study|Participant refused further follow-up|8|||
94420384|NCT01970865|323325884|FG014|Overall Study|Participant refused further follow-up|3|||
94420385|NCT01970865|323325885|FG015|Overall Study|Participant refused further follow-up|11|||
94420386|NCT01970865|323325886|FG016|Overall Study|Participant refused further follow-up|0|||
94420387|NCT01970865|323325887|FG017|Overall Study|Participant refused further follow-up|6|||
94420388|NCT01602965|323325888|FG000|Overall Study|Lost to Follow-up|4|||
94420389|NCT01602965|323325889|FG001|Overall Study|Lost to Follow-up|2|||
94420390|NCT01288053|323327657|FG000|Overall Study|Death|1|||
94420391|NCT03188666|323327658|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
94420392|NCT03188666|323327659|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
94420393|NCT03188666|323327660|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
94420394|NCT03188666|323327661|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
94420395|NCT03188666|323327658|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
94420396|NCT03188666|323327659|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
94420397|NCT03188666|323327660|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
94420398|NCT03188666|323327661|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
94420399|NCT03188666|323327658|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
94420400|NCT03188666|323327659|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
94420401|NCT03188666|323327660|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
94420402|NCT03188666|323327661|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
94420403|NCT03188666|323327658|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
94420404|NCT03188666|323327659|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
94420405|NCT03188666|323327660|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
94420406|NCT03188666|323327661|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
94420407|NCT00541970|323327663|FG000|Month 7|Protocol Violation|9|||
94420408|NCT00541970|323327664|FG001|Month 7|Protocol Violation|13|||
94420409|NCT00541970|323327665|FG002|Month 7|Protocol Violation|11|||
94420410|NCT00541970|323327666|FG003|Month 7|Protocol Violation|5|||
94420411|NCT00541970|323327663|FG000|Month 12|Adverse Event|0|||
94420412|NCT00541970|323327664|FG001|Month 12|Adverse Event|1|||
94420413|NCT00541970|323327665|FG002|Month 12|Adverse Event|1|||
94420414|NCT00541970|323327666|FG003|Month 12|Adverse Event|1|||
94420415|NCT00541970|323327663|FG000|Month 12|Protocol Violation|12|||
94420416|NCT00541970|323327664|FG001|Month 12|Protocol Violation|21|||
94420417|NCT00541970|323327665|FG002|Month 12|Protocol Violation|20|||
94420418|NCT00541970|323327666|FG003|Month 12|Protocol Violation|15|||
94420419|NCT00541970|323327663|FG000|Month 18|Adverse Event|0|||
94420420|NCT00541970|323327664|FG001|Month 18|Adverse Event|1|||
94420421|NCT00541970|323327665|FG002|Month 18|Adverse Event|1|||
94420422|NCT00541970|323327666|FG003|Month 18|Adverse Event|1|||
94420423|NCT00541970|323327663|FG000|Month 18|Protocol Violation|14|||
94420424|NCT00541970|323327664|FG001|Month 18|Protocol Violation|23|||
94420425|NCT00541970|323327665|FG002|Month 18|Protocol Violation|24|||
94420426|NCT00541970|323327666|FG003|Month 18|Protocol Violation|16|||
94420427|NCT00541970|323327663|FG000|Month 24|Adverse Event|0|||
94420428|NCT00541970|323327664|FG001|Month 24|Adverse Event|1|||
94420429|NCT00541970|323327665|FG002|Month 24|Adverse Event|1|||
94420430|NCT00541970|323327666|FG003|Month 24|Adverse Event|1|||
94420431|NCT00541970|323327663|FG000|Month 24|Protocol Violation|29|||
94420432|NCT00541970|323327664|FG001|Month 24|Protocol Violation|31|||
94420433|NCT00541970|323327665|FG002|Month 24|Protocol Violation|31|||
94420434|NCT00541970|323327666|FG003|Month 24|Protocol Violation|21|||
94420435|NCT00541970|323327663|FG000|Month 36|Protocol Violation|61|||
94420436|NCT00541970|323327664|FG001|Month 36|Protocol Violation|66|||
94420437|NCT00541970|323327665|FG002|Month 36|Protocol Violation|66|||
94420438|NCT00541970|323327666|FG003|Month 36|Protocol Violation|60|||
94420439|NCT00541970|323327663|FG000|Month 48|Withdrawal by Subject|2|||
94420440|NCT00541970|323327664|FG001|Month 48|Withdrawal by Subject|4|||
94420441|NCT00541970|323327665|FG002|Month 48|Withdrawal by Subject|4|||
94420442|NCT00541970|323327666|FG003|Month 48|Withdrawal by Subject|2|||
94420443|NCT00541970|323327663|FG000|Month 48|Other|3|||
94420444|NCT00541970|323327664|FG001|Month 48|Other|1|||
94420445|NCT00541970|323327665|FG002|Month 48|Other|1|||
94420446|NCT00541970|323327666|FG003|Month 48|Other|0|||
94420447|NCT00541970|323327663|FG000|Month 48|Lost to Follow-up|66|||
94420448|NCT00541970|323327664|FG001|Month 48|Lost to Follow-up|68|||
94420449|NCT00541970|323327665|FG002|Month 48|Lost to Follow-up|68|||
94420450|NCT00541970|323327666|FG003|Month 48|Lost to Follow-up|73|||
94420451|NCT00541970|323327663|FG000|Month 60|Protocol Violation|78|||
94420452|NCT00541970|323327664|FG001|Month 60|Protocol Violation|77|||
94420453|NCT00541970|323327665|FG002|Month 60|Protocol Violation|82|||
94420454|NCT00541970|323327666|FG003|Month 60|Protocol Violation|72|||
94420455|NCT02307266|323327667|FG000|Overall Study|Adverse Event|3|||
94420456|NCT02307266|323327668|FG001|Overall Study|Adverse Event|1|||
94420457|NCT02307266|323327669|FG002|Overall Study|Adverse Event|5|||
94420458|NCT02307266|323327667|FG000|Overall Study|Withdrawal by Subject|2|||
94420459|NCT02307266|323327668|FG001|Overall Study|Withdrawal by Subject|0|||
94420460|NCT02307266|323327669|FG002|Overall Study|Withdrawal by Subject|1|||
94420461|NCT02307266|323327667|FG000|Overall Study|Lost to Follow-up|3|||
94420462|NCT02307266|323327668|FG001|Overall Study|Lost to Follow-up|0|||
94420463|NCT02307266|323327669|FG002|Overall Study|Lost to Follow-up|0|||
94420464|NCT00062010|323327670|FG000|Overall Study|Ineligible|3|||
94420465|NCT01183221|323327673|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
94420466|NCT01183221|323327674|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
94420467|NCT00858143|323327677|FG000|Overall Study|Adverse Event|16|||
94420468|NCT00858143|323327677|FG000|Overall Study|Lack of Efficacy|4|||
94420469|NCT00858143|323327677|FG000|Overall Study|Death|7|||
94420470|NCT00858143|323327677|FG000|Overall Study|Other|23|||
94420471|NCT01995266|323327682|FG000|Overall Study|Death|1|||
94420472|NCT01995266|323327682|FG000|Overall Study|Lack of Efficacy|6|||
94420473|NCT01995266|323327682|FG000|Overall Study|Adverse Event|2|||
94420474|NCT00658658|323327683|FG000|Overall Study|Withdrawal by Subject|0|||
94420475|NCT00658658|323327684|FG001|Overall Study|Withdrawal by Subject|1|||
94420476|NCT00658658|323327685|FG002|Overall Study|Withdrawal by Subject|0|||
94420477|NCT00658658|323327686|FG003|Overall Study|Withdrawal by Subject|0|||
94420478|NCT00658658|323327687|FG004|Overall Study|Withdrawal by Subject|0|||
94420479|NCT00658658|323327683|FG000|Overall Study|Death|4|||
94420480|NCT00658658|323327684|FG001|Overall Study|Death|0|||
94420481|NCT00658658|323327685|FG002|Overall Study|Death|0|||
94420482|NCT00658658|323327686|FG003|Overall Study|Death|1|||
94420483|NCT00658658|323327687|FG004|Overall Study|Death|1|||
94420484|NCT00658658|323327683|FG000|Overall Study|Disease Progression|0|||
94420485|NCT00658658|323327684|FG001|Overall Study|Disease Progression|1|||
94420486|NCT00658658|323327685|FG002|Overall Study|Disease Progression|0|||
94420487|NCT00658658|323327686|FG003|Overall Study|Disease Progression|1|||
94420488|NCT00658658|323327687|FG004|Overall Study|Disease Progression|3|||
94420489|NCT00658658|323327683|FG000|Overall Study|Protocol-specified Criteria|1|||
94420490|NCT00658658|323327684|FG001|Overall Study|Protocol-specified Criteria|0|||
94420491|NCT00658658|323327685|FG002|Overall Study|Protocol-specified Criteria|0|||
94420492|NCT00658658|323327686|FG003|Overall Study|Protocol-specified Criteria|0|||
94420493|NCT00658658|323327687|FG004|Overall Study|Protocol-specified Criteria|0|||
94420494|NCT00658658|323327683|FG000|Overall Study|Other|0|||
94420495|NCT00658658|323327684|FG001|Overall Study|Other|0|||
94420496|NCT00658658|323327685|FG002|Overall Study|Other|0|||
94420497|NCT00658658|323327686|FG003|Overall Study|Other|0|||
94420498|NCT00658658|323327687|FG004|Overall Study|Other|1|||
94420499|NCT03623386|323327691|FG000|Overall Study|Protocol Violation|3|||
94420500|NCT03623386|323327692|FG001|Overall Study|Protocol Violation|2|||
94420501|NCT03623386|323327693|FG002|Overall Study|Protocol Violation|0|||
94420502|NCT03623386|323327691|FG000|Overall Study|Physician Decision|1|||
94420503|NCT03623386|323327692|FG001|Overall Study|Physician Decision|1|||
94420504|NCT03623386|323327693|FG002|Overall Study|Physician Decision|0|||
94420505|NCT03623386|323327691|FG000|Overall Study|Lost to Follow-up|0|||
94420506|NCT03623386|323327692|FG001|Overall Study|Lost to Follow-up|2|||
94420507|NCT03623386|323327693|FG002|Overall Study|Lost to Follow-up|0|||
94420508|NCT03623386|323327691|FG000|Overall Study|COVID-19|0|||
94420509|NCT03623386|323327692|FG001|Overall Study|COVID-19|1|||
94420510|NCT03623386|323327693|FG002|Overall Study|COVID-19|0|||
94420511|NCT00210249|323327695|FG000|Overall Study|Lost to Follow-up|5|||
94420512|NCT00210249|323327695|FG000|Overall Study|Protocol Violation|11|||
94420513|NCT00922272|323327698|FG000|Open-label Phase|Adverse Event|5|||
94420514|NCT00922272|323327699|FG001|Open-label Phase|Adverse Event|0|||
94420515|NCT00922272|323327698|FG000|Open-label Phase|Protocol Violation|1|||
94420516|NCT00922272|323327699|FG001|Open-label Phase|Protocol Violation|0|||
94420517|NCT00922272|323327698|FG000|Open-label Phase|Withdrawal by Subject|11|||
94420518|NCT00922272|323327699|FG001|Open-label Phase|Withdrawal by Subject|0|||
94420519|NCT00922272|323327698|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
94420520|NCT00922272|323327699|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
94420521|NCT00922272|323327698|FG000|Open-label Phase|Withdrawal criteria met|5|||
94420522|NCT00922272|323327699|FG001|Open-label Phase|Withdrawal criteria met|0|||
94420523|NCT00922272|323327698|FG000|Double-blind Phase|Adverse Event|1|||
94420524|NCT00922272|323327699|FG001|Double-blind Phase|Adverse Event|1|||
94420525|NCT00922272|323327698|FG000|Double-blind Phase|Withdrawal by Subject|1|||
94420526|NCT00922272|323327699|FG001|Double-blind Phase|Withdrawal by Subject|1|||
94420527|NCT00922272|323327698|FG000|Double-blind Phase|Lost to Follow-up|2|||
94420528|NCT00922272|323327699|FG001|Double-blind Phase|Lost to Follow-up|1|||
94420529|NCT00922272|323327698|FG000|Double-blind Phase|Withdrawal criteria met|1|||
94420530|NCT00922272|323327699|FG001|Double-blind Phase|Withdrawal criteria met|1|||
94420531|NCT00922272|323327698|FG000|Double-blind Phase|Noncompliance|1|||
94420532|NCT00922272|323327699|FG001|Double-blind Phase|Noncompliance|1|||
94420533|NCT00922272|323327698|FG000|Double-blind Phase|Positive urine drug screen|1|||
94420534|NCT00922272|323327699|FG001|Double-blind Phase|Positive urine drug screen|1|||
94420535|NCT02588950|323327706|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
94420536|NCT02588950|323327707|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
94420537|NCT02588950|323327708|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
94420538|NCT02588950|323327709|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
94420539|NCT02588950|323327706|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
94420540|NCT02588950|323327707|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
94420541|NCT02588950|323327708|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
94420542|NCT02588950|323327709|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
94420543|NCT00866658|323327710|FG000|Overall Study|Adverse Event|5|||
94420544|NCT00866658|323327711|FG001|Overall Study|Adverse Event|14|||
94420545|NCT00866658|323327710|FG000|Overall Study|Lack of Efficacy|2|||
94420546|NCT00866658|323327711|FG001|Overall Study|Lack of Efficacy|1|||
94420547|NCT00866658|323327710|FG000|Overall Study|Withdrawal by Subject|1|||
94420548|NCT00866658|323327711|FG001|Overall Study|Withdrawal by Subject|0|||
94420549|NCT00866658|323327710|FG000|Overall Study|Protocol Violation|1|||
94420550|NCT00866658|323327711|FG001|Overall Study|Protocol Violation|1|||
94420551|NCT00866658|323327710|FG000|Overall Study|Familial and Personal Reasons|4|||
94420552|NCT00866658|323327711|FG001|Overall Study|Familial and Personal Reasons|5|||
94420553|NCT00609518|323327714|FG000|Overall Study|Death from Study Disease|32|||
94420554|NCT00609518|323327715|FG001|Overall Study|Death from Study Disease|32|||
94420555|NCT00609518|323327714|FG000|Overall Study|Withdrawal by Subject|5|||
94420556|NCT00609518|323327715|FG001|Overall Study|Withdrawal by Subject|3|||
94420557|NCT00609518|323327714|FG000|Overall Study|Lost to Follow-up|3|||
94420558|NCT00609518|323327715|FG001|Overall Study|Lost to Follow-up|0|||
94420559|NCT00609518|323327714|FG000|Overall Study|Physician Decision|1|||
94420560|NCT00609518|323327715|FG001|Overall Study|Physician Decision|3|||
94420561|NCT00609518|323327714|FG000|Overall Study|Death from Adverse Event|2|||
94420562|NCT00609518|323327715|FG001|Overall Study|Death from Adverse Event|2|||
94420563|NCT04322149|323327716|FG000|Overall Study|Adverse Event|1|||
94420564|NCT04322149|323327717|FG001|Overall Study|Adverse Event|1|||
94420565|NCT04322149|323327718|FG002|Overall Study|Adverse Event|0|||
94420566|NCT04322149|323327719|FG003|Overall Study|Adverse Event|0|||
94420567|NCT04322149|323327716|FG000|Overall Study|Withdrawal by Subject|0|||
94420568|NCT04322149|323327717|FG001|Overall Study|Withdrawal by Subject|0|||
94420569|NCT04322149|323327718|FG002|Overall Study|Withdrawal by Subject|0|||
94420570|NCT04322149|323327719|FG003|Overall Study|Withdrawal by Subject|2|||
94420571|NCT04322149|323327716|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
94420572|NCT04322149|323327717|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
94420573|NCT04322149|323327718|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
94420574|NCT04322149|323327719|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
94420575|NCT01700049|323327720|FG000|Overall Study|Withdrawal by Subject|1|||
94420576|NCT03084367|323327721|FG000|Overall Study|Lost to Follow-up|32|||
94420577|NCT03084367|323327721|FG000|Overall Study|Withdrawal by Subject|4|||
94420578|NCT03084367|323327721|FG000|Overall Study|Other|1|||
94420579|NCT03827564|323327722|FG000|Overall Study|Discontinued due to Study Termination|1|||
94420580|NCT03827564|323327723|FG001|Overall Study|Discontinued due to Study Termination|0|||
94420581|NCT04397445|323327724|FG000|Overall Study|Withdrawal by Subject|1|||
94420582|NCT04397445|323327725|FG001|Overall Study|Withdrawal by Subject|0|||
94420583|NCT04397445|323327726|FG002|Overall Study|Withdrawal by Subject|0|||
94420584|NCT04397445|323327727|FG003|Overall Study|Withdrawal by Subject|0|||
94420585|NCT02238626|323327728|FG000|Overall Study|Adverse Event|3|||
94420586|NCT02238626|323327729|FG001|Overall Study|Adverse Event|5|||
94420587|NCT02238626|323327730|FG002|Overall Study|Adverse Event|0|||
94420588|NCT02238626|323327731|FG003|Overall Study|Adverse Event|3|||
94420589|NCT02238626|323327728|FG000|Overall Study|Lost to Follow-up|2|||
94420590|NCT02238626|323327729|FG001|Overall Study|Lost to Follow-up|4|||
94420591|NCT02238626|323327730|FG002|Overall Study|Lost to Follow-up|2|||
94420592|NCT02238626|323327731|FG003|Overall Study|Lost to Follow-up|2|||
94420593|NCT02238626|323327728|FG000|Overall Study|Withdrawal by Subject|0|||
94420594|NCT02238626|323327729|FG001|Overall Study|Withdrawal by Subject|3|||
94420595|NCT02238626|323327730|FG002|Overall Study|Withdrawal by Subject|0|||
94420596|NCT02238626|323327731|FG003|Overall Study|Withdrawal by Subject|1|||
94420597|NCT02238626|323327728|FG000|Overall Study|Death|0|||
94420598|NCT02238626|323327729|FG001|Overall Study|Death|0|||
94420599|NCT02238626|323327730|FG002|Overall Study|Death|1|||
94420600|NCT02238626|323327731|FG003|Overall Study|Death|1|||
94420601|NCT02238626|323327728|FG000|Overall Study|Other|0|||
94420602|NCT02238626|323327729|FG001|Overall Study|Other|2|||
94420603|NCT02238626|323327730|FG002|Overall Study|Other|0|||
94420604|NCT02238626|323327731|FG003|Overall Study|Other|0|||
94420605|NCT01403064|323327732|FG000|Overall Study|Death|0|||
94420606|NCT01403064|323327733|FG001|Overall Study|Death|0|||
94420607|NCT01403064|323327734|FG002|Overall Study|Death|1|||
94420608|NCT01403064|323327735|FG003|Overall Study|Death|1|||
94420609|NCT01403064|323327732|FG000|Overall Study|Withdrawal by Subject|0|||
94420610|NCT01403064|323327733|FG001|Overall Study|Withdrawal by Subject|0|||
94420611|NCT01403064|323327734|FG002|Overall Study|Withdrawal by Subject|1|||
94420612|NCT01403064|323327735|FG003|Overall Study|Withdrawal by Subject|1|||
94420613|NCT01403064|323327732|FG000|Overall Study|Other|1|||
94420614|NCT01403064|323327733|FG001|Overall Study|Other|0|||
94420615|NCT01403064|323327734|FG002|Overall Study|Other|2|||
94420616|NCT01403064|323327735|FG003|Overall Study|Other|1|||
94420617|NCT00974974|323327736|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
94420618|NCT00974974|323327737|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
94420619|NCT00974974|323327736|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
94420620|NCT00974974|323327737|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
94420621|NCT00974974|323327736|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
94420622|NCT00974974|323327737|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
94420623|NCT00974974|323327736|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
94420624|NCT00974974|323327737|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
94420625|NCT00974974|323327736|FG000|IR CD-LD Dose Adjustment|Various|0|||
94420626|NCT00974974|323327737|FG001|IR CD-LD Dose Adjustment|Various|9|||
94420627|NCT00974974|323327736|FG000|IPX066 Dose Conversion|Adverse Event|23|||
94420628|NCT00974974|323327737|FG001|IPX066 Dose Conversion|Adverse Event|0|||
94420629|NCT00974974|323327736|FG000|IPX066 Dose Conversion|Death|2|||
94420630|NCT00974974|323327737|FG001|IPX066 Dose Conversion|Death|0|||
94420631|NCT00974974|323327736|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
94420632|NCT00974974|323327737|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
94420633|NCT00974974|323327736|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
94420634|NCT00974974|323327737|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
94420635|NCT00974974|323327736|FG000|IPX066 Dose Conversion|Various|3|||
94420636|NCT00974974|323327737|FG001|IPX066 Dose Conversion|Various|0|||
94420637|NCT00974974|323327736|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
94420638|NCT00974974|323327737|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
94420639|NCT00974974|323327736|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
94420640|NCT00974974|323327737|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
94420641|NCT00974974|323327736|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
94420642|NCT00974974|323327737|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
94420643|NCT00974974|323327736|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
94420644|NCT00974974|323327737|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
94420645|NCT00974974|323327736|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
94420646|NCT00974974|323327737|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
94420647|NCT00974974|323327736|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
94420648|NCT00974974|323327737|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
94420649|NCT00974974|323327736|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
94420650|NCT00974974|323327737|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
94420651|NCT00974974|323327736|FG000|Maintenance - Double Blind Treatment|Various|4|||
94420652|NCT00974974|323327737|FG001|Maintenance - Double Blind Treatment|Various|0|||
94420653|NCT00361335|323327738|FG000|IV Period: Baseline to E0|Adverse Event|9|||
94420654|NCT00361335|323327739|FG001|IV Period: Baseline to E0|Adverse Event|4|||
94420655|NCT00361335|323327740|FG002|IV Period: Baseline to E0|Adverse Event|5|||
94420656|NCT00361335|323327741|FG003|IV Period: Baseline to E0|Adverse Event|9|||
94420657|NCT00361335|323327742|FG004|IV Period: Baseline to E0|Adverse Event|8|||
94420658|NCT00361335|323327743|FG005|IV Period: Baseline to E0|Adverse Event|0|||
94420659|NCT00361335|323327744|FG006|IV Period: Baseline to E0|Adverse Event|0|||
94420660|NCT00361335|323327738|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
94420661|NCT00361335|323327739|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
94420662|NCT00361335|323327740|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
94420663|NCT00361335|323327741|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
94420664|NCT00361335|323327742|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
94420665|NCT00361335|323327743|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
94420666|NCT00361335|323327744|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
94420667|NCT00361335|323327738|FG000|IV Period: Baseline to E0|Death|1|||
94420668|NCT00361335|323327739|FG001|IV Period: Baseline to E0|Death|1|||
94420669|NCT00361335|323327740|FG002|IV Period: Baseline to E0|Death|1|||
94420670|NCT00361335|323327741|FG003|IV Period: Baseline to E0|Death|1|||
94420671|NCT00361335|323327742|FG004|IV Period: Baseline to E0|Death|0|||
94420672|NCT00361335|323327743|FG005|IV Period: Baseline to E0|Death|0|||
94420673|NCT00361335|323327744|FG006|IV Period: Baseline to E0|Death|0|||
94420674|NCT00361335|323327738|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
94420675|NCT00361335|323327739|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
94420676|NCT00361335|323327740|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
94420677|NCT00361335|323327741|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
94420678|NCT00361335|323327742|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
94420679|NCT00361335|323327743|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
94420680|NCT00361335|323327744|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
94420681|NCT00361335|323327738|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
94420682|NCT00361335|323327739|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
94420683|NCT00361335|323327740|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
94420684|NCT00361335|323327741|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
94420685|NCT00361335|323327742|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
94420686|NCT00361335|323327743|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
94420687|NCT00361335|323327744|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
94420688|NCT00361335|323327738|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
94420689|NCT00361335|323327739|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
94420690|NCT00361335|323327740|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
94420691|NCT00361335|323327741|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
94420692|NCT00361335|323327742|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
94420693|NCT00361335|323327743|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
94420694|NCT00361335|323327744|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
94420695|NCT00361335|323327738|FG000|IV Period: Baseline to E0|Other|2|||
94420696|NCT00361335|323327739|FG001|IV Period: Baseline to E0|Other|9|||
94420697|NCT00361335|323327740|FG002|IV Period: Baseline to E0|Other|9|||
94420698|NCT00361335|323327741|FG003|IV Period: Baseline to E0|Other|3|||
94420699|NCT00361335|323327742|FG004|IV Period: Baseline to E0|Other|2|||
94420700|NCT00361335|323327743|FG005|IV Period: Baseline to E0|Other|0|||
94420701|NCT00361335|323327744|FG006|IV Period: Baseline to E0|Other|0|||
94420702|NCT00361335|323327738|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
94420703|NCT00361335|323327739|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
94420704|NCT00361335|323327740|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
94420705|NCT00361335|323327741|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
94420706|NCT00361335|323327742|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
94420707|NCT00361335|323327743|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
94420708|NCT00361335|323327744|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
94420709|NCT00361335|323327738|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
94420710|NCT00361335|323327739|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
94420711|NCT00361335|323327740|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
94420712|NCT00361335|323327741|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
94420713|NCT00361335|323327742|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
94420714|NCT00361335|323327743|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
94420715|NCT00361335|323327744|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
94489274|NCT00903968|323586022|FG003|Overall Study|Withdrawal by Subject|0|||
94489275|NCT00903968|323586023|FG004|Overall Study|Withdrawal by Subject|1|||
94489276|NCT00903968|323586024|FG005|Overall Study|Withdrawal by Subject|1|||
94420716|NCT00361335|323327738|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
94420717|NCT00361335|323327739|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
94420718|NCT00361335|323327740|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
94420719|NCT00361335|323327741|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
94420720|NCT00361335|323327742|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
94420721|NCT00361335|323327743|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
94420722|NCT00361335|323327744|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
94420723|NCT00361335|323327738|FG000|SC Period: Week E0 to Week E24|Death|0|||
94420724|NCT00361335|323327739|FG001|SC Period: Week E0 to Week E24|Death|0|||
94420725|NCT00361335|323327740|FG002|SC Period: Week E0 to Week E24|Death|0|||
94420726|NCT00361335|323327741|FG003|SC Period: Week E0 to Week E24|Death|0|||
94420727|NCT00361335|323327742|FG004|SC Period: Week E0 to Week E24|Death|0|||
94420728|NCT00361335|323327743|FG005|SC Period: Week E0 to Week E24|Death|0|||
94420729|NCT00361335|323327744|FG006|SC Period: Week E0 to Week E24|Death|1|||
94420730|NCT00361335|323327738|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
94420731|NCT00361335|323327739|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
94420732|NCT00361335|323327740|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
94420733|NCT00361335|323327741|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
94420734|NCT00361335|323327742|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
94420735|NCT00361335|323327743|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
94420736|NCT00361335|323327744|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
94420737|NCT00361335|323327738|FG000|SC Period: Week E0 to Week E24|Other|1|||
94420738|NCT00361335|323327739|FG001|SC Period: Week E0 to Week E24|Other|0|||
94420739|NCT00361335|323327740|FG002|SC Period: Week E0 to Week E24|Other|0|||
94420740|NCT00361335|323327741|FG003|SC Period: Week E0 to Week E24|Other|1|||
94420741|NCT00361335|323327742|FG004|SC Period: Week E0 to Week E24|Other|0|||
94420742|NCT00361335|323327743|FG005|SC Period: Week E0 to Week E24|Other|1|||
94420743|NCT00361335|323327744|FG006|SC Period: Week E0 to Week E24|Other|2|||
94420744|NCT00361335|323327738|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
94420745|NCT00361335|323327739|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
94420746|NCT00361335|323327740|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
94420747|NCT00361335|323327741|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
94420748|NCT00361335|323327742|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
94420749|NCT00361335|323327743|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
94420750|NCT00361335|323327744|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
94420751|NCT00450619|323327745|FG000|Overall Study|refused treatment after randomization|2|||
94420752|NCT00450619|323327746|FG001|Overall Study|refused treatment after randomization|0|||
94420753|NCT00450619|323327745|FG000|Overall Study|did not progress; refused further trmt|1|||
94420754|NCT00450619|323327746|FG001|Overall Study|did not progress; refused further trmt|1|||
94420755|NCT00450619|323327745|FG000|Overall Study|Adverse Event|1|||
94420756|NCT00450619|323327746|FG001|Overall Study|Adverse Event|0|||
94420757|NCT01765582|323327747|FG000|Overall Study|Other|3|||
94420758|NCT01765582|323327748|FG001|Overall Study|Other|6|||
94420759|NCT01765582|323327749|FG002|Overall Study|Other|9|||
94420760|NCT01765582|323327747|FG000|Overall Study|Lost to Follow-up|2|||
94420761|NCT01765582|323327748|FG001|Overall Study|Lost to Follow-up|2|||
94420762|NCT01765582|323327749|FG002|Overall Study|Lost to Follow-up|1|||
94420763|NCT01765582|323327747|FG000|Overall Study|Death|31|||
94420764|NCT01765582|323327748|FG001|Overall Study|Death|36|||
94420765|NCT01765582|323327749|FG002|Overall Study|Death|33|||
94420766|NCT01765582|323327747|FG000|Overall Study|Sponsor Decision|46|||
94420767|NCT01765582|323327748|FG001|Overall Study|Sponsor Decision|42|||
94420768|NCT01765582|323327749|FG002|Overall Study|Sponsor Decision|42|||
94420769|NCT01765582|323327747|FG000|Overall Study|Withdrawal of Consent|11|||
94420770|NCT01765582|323327748|FG001|Overall Study|Withdrawal of Consent|6|||
94420771|NCT01765582|323327749|FG002|Overall Study|Withdrawal of Consent|10|||
94420772|NCT00986180|323327750|FG000|Overall Study|Adverse Event|21|||
94420773|NCT00986180|323327751|FG001|Overall Study|Adverse Event|23|||
94420774|NCT00986180|323327750|FG000|Overall Study|Lack of Efficacy|4|||
94420775|NCT00986180|323327751|FG001|Overall Study|Lack of Efficacy|3|||
94420776|NCT00986180|323327750|FG000|Overall Study|Lost to Follow-up|5|||
94420777|NCT00986180|323327751|FG001|Overall Study|Lost to Follow-up|7|||
94420778|NCT00986180|323327750|FG000|Overall Study|Physician Decision|1|||
94420779|NCT00986180|323327751|FG001|Overall Study|Physician Decision|3|||
94420780|NCT00986180|323327750|FG000|Overall Study|Protocol Violation|2|||
94420781|NCT00986180|323327751|FG001|Overall Study|Protocol Violation|0|||
94420782|NCT00986180|323327750|FG000|Overall Study|Withdrawal by Subject|1|||
94420783|NCT00986180|323327751|FG001|Overall Study|Withdrawal by Subject|9|||
94420784|NCT00986180|323327750|FG000|Overall Study|Miscellanies|10|||
94420785|NCT00986180|323327751|FG001|Overall Study|Miscellanies|11|||
94420786|NCT00714493|323327762|FG000|Overall Study|Adverse Event|11|||
94420787|NCT00714493|323327762|FG000|Overall Study|Death|3|||
94420788|NCT00714493|323327762|FG000|Overall Study|Lack of Efficacy|10|||
94420789|NCT00714493|323327762|FG000|Overall Study|Lost to Follow-up|3|||
94420790|NCT00714493|323327762|FG000|Overall Study|Protocol Violation|12|||
94420791|NCT00714493|323327762|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
94420792|NCT00714493|323327762|FG000|Overall Study|OTHER|2|||
94420793|NCT01968694|323327763|FG000|Washout (1 Month)|Lost to Follow-up|0|||
94420794|NCT01968694|323327764|FG001|Washout (1 Month)|Lost to Follow-up|1|||
94420795|NCT04295135|323327766|FG000|Overall Study|Withdrawal by Subject|2|||
94420796|NCT04295135|323327767|FG001|Overall Study|Withdrawal by Subject|1|||
94420797|NCT04295135|323327766|FG000|Overall Study|Subject left organization|8|||
94420798|NCT04295135|323327767|FG001|Overall Study|Subject left organization|4|||
94420799|NCT00251719|323327768|FG000|Overall Study|Adverse Event|14|||
94420800|NCT00251719|323327769|FG001|Overall Study|Adverse Event|8|||
94420801|NCT00251719|323327770|FG002|Overall Study|Adverse Event|7|||
94420802|NCT00251719|323327768|FG000|Overall Study|Protocol Violation|1|||
94420803|NCT00251719|323327769|FG001|Overall Study|Protocol Violation|1|||
94420804|NCT00251719|323327770|FG002|Overall Study|Protocol Violation|1|||
94420805|NCT00251719|323327768|FG000|Overall Study|Lost to Follow-up|5|||
94420806|NCT00251719|323327769|FG001|Overall Study|Lost to Follow-up|11|||
94420807|NCT00251719|323327770|FG002|Overall Study|Lost to Follow-up|8|||
94420808|NCT00251719|323327768|FG000|Overall Study|Withdrawal by Subject|14|||
94420809|NCT00251719|323327769|FG001|Overall Study|Withdrawal by Subject|12|||
94420810|NCT00251719|323327770|FG002|Overall Study|Withdrawal by Subject|11|||
94420811|NCT00251719|323327768|FG000|Overall Study|Lack of Efficacy|2|||
94420812|NCT00251719|323327769|FG001|Overall Study|Lack of Efficacy|1|||
94420813|NCT00251719|323327770|FG002|Overall Study|Lack of Efficacy|0|||
94420814|NCT00251719|323327768|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
94420815|NCT00251719|323327769|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
94420816|NCT00251719|323327770|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
94420817|NCT00251719|323327768|FG000|Overall Study|Investigator decision|1|||
94420818|NCT00251719|323327769|FG001|Overall Study|Investigator decision|1|||
94420819|NCT00251719|323327770|FG002|Overall Study|Investigator decision|0|||
94420820|NCT00251719|323327768|FG000|Overall Study|Noncompliance|2|||
94420821|NCT00251719|323327769|FG001|Overall Study|Noncompliance|3|||
94420822|NCT00251719|323327770|FG002|Overall Study|Noncompliance|1|||
94420823|NCT00251719|323327768|FG000|Overall Study|Barrett's esophagus|2|||
94420824|NCT00251719|323327769|FG001|Overall Study|Barrett's esophagus|2|||
94420825|NCT00251719|323327770|FG002|Overall Study|Barrett's esophagus|0|||
94420826|NCT03822832|323327771|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
94420827|NCT03822832|323327772|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
94420828|NCT03822832|323327771|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
94420829|NCT03822832|323327772|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
94420830|NCT03822832|323327771|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
94420831|NCT03822832|323327772|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
94420832|NCT03822832|323327771|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
94420833|NCT03822832|323327772|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
94420834|NCT03822832|323327771|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
94420835|NCT03822832|323327772|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
94420836|NCT03822832|323327771|FG000|Re-allocation|Not re-allocated to open label period|2|||
94420837|NCT03822832|323327772|FG001|Re-allocation|Not re-allocated to open label period|6|||
94420838|NCT03822832|323327771|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
94420839|NCT03822832|323327772|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
94420840|NCT03822832|323327771|FG000|Period 2 - Open Label Period|Adverse Event|0|||
94420841|NCT03822832|323327772|FG001|Period 2 - Open Label Period|Adverse Event|3|||
94420842|NCT03347422|323327774|FG000|Part A (26 Weeks)|Adverse Event|3|||
94420843|NCT03347422|323327775|FG001|Part A (26 Weeks)|Adverse Event|0|||
94420844|NCT03347422|323327774|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
94420845|NCT03347422|323327775|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
94420846|NCT03347422|323327774|FG000|Part B (149 Weeks)|Adverse Event|0|||
94420847|NCT03347422|323327775|FG001|Part B (149 Weeks)|Adverse Event|1|||
94420848|NCT03347422|323327774|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
94420849|NCT03347422|323327775|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
94420850|NCT03347422|323327774|FG000|Part B (149 Weeks)|Other|1|||
94420851|NCT03347422|323327775|FG001|Part B (149 Weeks)|Other|0|||
94420852|NCT00158600|323327778|FG000|Overall Study|unable to commit time to study|0|||
94420853|NCT00158600|323327779|FG001|Overall Study|unable to commit time to study|1|||
94420854|NCT00158600|323327778|FG000|Overall Study|Adverse Event|2|||
94420855|NCT00158600|323327779|FG001|Overall Study|Adverse Event|1|||
94420856|NCT00158600|323327778|FG000|Overall Study|Death|1|||
94420857|NCT00158600|323327779|FG001|Overall Study|Death|0|||
94420858|NCT00158600|323327778|FG000|Overall Study|Withdrawal by Subject|2|||
94420859|NCT00158600|323327779|FG001|Overall Study|Withdrawal by Subject|2|||
94420860|NCT00910091|323327782|FG000|Pre-assignment|Withdrawal by Subject|0|||
94420861|NCT00910091|323327783|FG001|Pre-assignment|Withdrawal by Subject|2|||
94420862|NCT00910091|323327782|FG000|Treatment and Survival|Withdrawal by Subject|3|||
94420863|NCT00910091|323327783|FG001|Treatment and Survival|Withdrawal by Subject|4|||
94420864|NCT00910091|323327782|FG000|Treatment and Survival|Adverse Event|1|||
94420865|NCT00910091|323327783|FG001|Treatment and Survival|Adverse Event|0|||
94420866|NCT00846521|323327784|FG000|Overall Study|Withdrawal by Subject|5|||
94420867|NCT00846521|323327784|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
94420868|NCT00846521|323327784|FG000|Overall Study|Protocol Violation|1|||
94420869|NCT01246011|323327785|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
94420870|NCT01246011|323327786|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
94420871|NCT01246011|323327787|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
94420872|NCT01246011|323327785|FG000|Overall Study|Withdrawal by Subject|0|||
94420873|NCT01246011|323327786|FG001|Overall Study|Withdrawal by Subject|0|||
94420874|NCT01246011|323327787|FG002|Overall Study|Withdrawal by Subject|1|||
94420875|NCT04392583|323327788|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
94420876|NCT03052959|323327791|FG000|Overall Study|Lost to Follow-up|4|||
94420877|NCT03052959|323327792|FG001|Overall Study|Lost to Follow-up|5|||
94420878|NCT00950963|323327793|FG000|Overall Study|Lost to Follow-up|29|||
94420879|NCT00950963|323327794|FG001|Overall Study|Lost to Follow-up|24|||
94420880|NCT02605993|323327795|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
94420881|NCT02605993|323327796|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
94420882|NCT02605993|323327797|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
94420883|NCT02605993|323327798|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
94420884|NCT01169532|323327799|FG000|Overall Study|Withdrawal by Subject|1|||
94420885|NCT02032706|323327809|FG000|Overall Study|Did not qualify|5|||
94420886|NCT02032706|323327809|FG000|Overall Study|Protocol Violation|1|||
94420887|NCT00893737|323327810|FG000|Overall Study|Adverse Event|4|||
94420888|NCT00893737|323327810|FG000|Overall Study|Withdrawal by Subject|2|||
94420889|NCT00893737|323327810|FG000|Overall Study|Lost to Follow-up|6|||
94420890|NCT01437943|323327814|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
94420891|NCT01437943|323327815|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
94420892|NCT01437943|323327814|FG000|Overall Study|Subject expressed pregnancy plans|1|||
94420893|NCT01437943|323327815|FG001|Overall Study|Subject expressed pregnancy plans|0|||
94420894|NCT01437943|323327814|FG000|Overall Study|Adverse Event|2|||
94420895|NCT01437943|323327815|FG001|Overall Study|Adverse Event|0|||
94420896|NCT03276221|323327820|FG000|Overall Study|Lost to Follow-up|6|||
94420897|NCT03276221|323327821|FG001|Overall Study|Lost to Follow-up|2|||
94420898|NCT03276221|323327822|FG002|Overall Study|Lost to Follow-up|0|||
94420899|NCT03276221|323327820|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
94420900|NCT03276221|323327821|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
94420901|NCT03276221|323327822|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
94420902|NCT01929031|323327823|FG000|Overall Study|Adverse Event|3|||
94420903|NCT01929031|323327824|FG001|Overall Study|Adverse Event|1|||
94420904|NCT01929031|323327825|FG002|Overall Study|Adverse Event|1|||
94420905|NCT01929031|323327826|FG003|Overall Study|Adverse Event|0|||
94420906|NCT01929031|323327827|FG004|Overall Study|Adverse Event|0|||
94420907|NCT01929031|323327828|FG005|Overall Study|Adverse Event|0|||
94420908|NCT01929031|323327823|FG000|Overall Study|Protocol Violation|1|||
94420909|NCT01929031|323327824|FG001|Overall Study|Protocol Violation|0|||
94420910|NCT01929031|323327825|FG002|Overall Study|Protocol Violation|0|||
94420911|NCT01929031|323327826|FG003|Overall Study|Protocol Violation|0|||
94420912|NCT01929031|323327827|FG004|Overall Study|Protocol Violation|0|||
94420913|NCT01929031|323327828|FG005|Overall Study|Protocol Violation|1|||
94420914|NCT01929031|323327823|FG000|Overall Study|Reason other than specified above|0|||
94420915|NCT01929031|323327824|FG001|Overall Study|Reason other than specified above|1|||
94420916|NCT01929031|323327825|FG002|Overall Study|Reason other than specified above|0|||
94420917|NCT01929031|323327826|FG003|Overall Study|Reason other than specified above|0|||
94420918|NCT01929031|323327827|FG004|Overall Study|Reason other than specified above|1|||
94420919|NCT01929031|323327828|FG005|Overall Study|Reason other than specified above|0|||
94420920|NCT02128217|323329617|FG000|Overall Study|Lost to Follow-up|0|||
94420921|NCT02128217|323329618|FG001|Overall Study|Lost to Follow-up|1|||
94420922|NCT00321828|323329621|FG000|Overall Study|Ineligible|3|||
94420923|NCT00321828|323329621|FG000|Overall Study|No follow up data|1|||
94420924|NCT03107026|323329624|FG000|Overall Study|Adverse Event|2|||
94420925|NCT03107026|323329625|FG001|Overall Study|Adverse Event|14|||
94420926|NCT03107026|323329626|FG002|Overall Study|Adverse Event|23|||
94420927|NCT03107026|323329624|FG000|Overall Study|Lost to Follow-up|12|||
94420928|NCT03107026|323329625|FG001|Overall Study|Lost to Follow-up|12|||
94420929|NCT03107026|323329626|FG002|Overall Study|Lost to Follow-up|13|||
94420930|NCT03107026|323329624|FG000|Overall Study|Protocol Violation|1|||
94420931|NCT03107026|323329625|FG001|Overall Study|Protocol Violation|2|||
94420932|NCT03107026|323329626|FG002|Overall Study|Protocol Violation|0|||
94420933|NCT03107026|323329624|FG000|Overall Study|Pregnancy|1|||
94420934|NCT03107026|323329625|FG001|Overall Study|Pregnancy|0|||
94420935|NCT03107026|323329626|FG002|Overall Study|Pregnancy|0|||
94420936|NCT03107026|323329624|FG000|Overall Study|Withdrawal by Subject|13|||
94420937|NCT03107026|323329625|FG001|Overall Study|Withdrawal by Subject|5|||
94420938|NCT03107026|323329626|FG002|Overall Study|Withdrawal by Subject|17|||
94420939|NCT03107026|323329624|FG000|Overall Study|non compliance with study visits|1|||
94420940|NCT03107026|323329625|FG001|Overall Study|non compliance with study visits|2|||
94420941|NCT03107026|323329626|FG002|Overall Study|non compliance with study visits|0|||
94420942|NCT03107026|323329624|FG000|Overall Study|non-compliance with study drug|2|||
94420943|NCT03107026|323329625|FG001|Overall Study|non-compliance with study drug|2|||
94420944|NCT03107026|323329626|FG002|Overall Study|non-compliance with study drug|3|||
94420945|NCT03107026|323329624|FG000|Overall Study|Physician Decision|0|||
94420946|NCT03107026|323329625|FG001|Overall Study|Physician Decision|1|||
94420947|NCT03107026|323329626|FG002|Overall Study|Physician Decision|0|||
94420948|NCT00112866|323329627|FG000|Overall Study|Protocol Violation|1|||
94420949|NCT00112866|323329628|FG001|Overall Study|Protocol Violation|0|||
94420950|NCT00112866|323329627|FG000|Overall Study|did not start treatment post-op|1|||
94420951|NCT00112866|323329628|FG001|Overall Study|did not start treatment post-op|2|||
94420952|NCT02358343|323329631|FG000|Screening Intervention|Death|0|||
94420953|NCT02358343|323329632|FG001|Screening Intervention|Death|2|||
94420954|NCT02358343|323329633|FG002|Screening Intervention|Death|0|||
94420955|NCT02358343|323329634|FG003|Screening Intervention|Death|0|||
94420956|NCT02358343|323329635|FG004|Screening Intervention|Death|0|||
94489277|NCT00903968|323586025|FG006|Overall Study|Withdrawal by Subject|0|||
94489278|NCT00903968|323586026|FG007|Overall Study|Withdrawal by Subject|4|||
94420957|NCT02358343|323329631|FG000|Screening Intervention|Withdrawal by Subject|1|||
94420958|NCT02358343|323329632|FG001|Screening Intervention|Withdrawal by Subject|0|||
94420959|NCT02358343|323329633|FG002|Screening Intervention|Withdrawal by Subject|0|||
94420960|NCT02358343|323329634|FG003|Screening Intervention|Withdrawal by Subject|0|||
94420961|NCT02358343|323329635|FG004|Screening Intervention|Withdrawal by Subject|0|||
94420962|NCT02358343|323329631|FG000|Screening Intervention|Determined Ineligible|5|||
94420963|NCT02358343|323329632|FG001|Screening Intervention|Determined Ineligible|6|||
94420964|NCT02358343|323329633|FG002|Screening Intervention|Determined Ineligible|0|||
94420965|NCT02358343|323329634|FG003|Screening Intervention|Determined Ineligible|0|||
94420966|NCT02358343|323329635|FG004|Screening Intervention|Determined Ineligible|0|||
94420967|NCT02358343|323329631|FG000|Comparative Efficacy Trial / Observation|Death|0|||
94420968|NCT02358343|323329632|FG001|Comparative Efficacy Trial / Observation|Death|0|||
94420969|NCT02358343|323329633|FG002|Comparative Efficacy Trial / Observation|Death|2|||
94420970|NCT02358343|323329634|FG003|Comparative Efficacy Trial / Observation|Death|0|||
94420971|NCT02358343|323329635|FG004|Comparative Efficacy Trial / Observation|Death|0|||
94420972|NCT02358343|323329631|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
94420973|NCT02358343|323329632|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
94420974|NCT02358343|323329633|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
94420975|NCT02358343|323329634|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
94420976|NCT02358343|323329635|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
94420977|NCT02358343|323329631|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
94420978|NCT02358343|323329632|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
94420979|NCT02358343|323329633|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
94420980|NCT02358343|323329634|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
94420981|NCT02358343|323329635|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
94420982|NCT03596151|323329638|FG000|Overall Study|Withdrawal by Subject|1|||
94420983|NCT01996332|323329641|FG000|Overall Study|Adverse Event|117|||
94420984|NCT01996332|323329641|FG000|Overall Study|Lack of Efficacy|1245|||
94420985|NCT01996332|323329641|FG000|Overall Study|Death|264|||
94420986|NCT01996332|323329641|FG000|Overall Study|Protocol Violation|9|||
94420987|NCT01996332|323329641|FG000|Overall Study|Withdrawal by Subject|71|||
94420988|NCT01996332|323329641|FG000|Overall Study|Other|20|||
94420989|NCT01996332|323329641|FG000|Overall Study|Clinical Deterioration|28|||
94420990|NCT01996332|323329641|FG000|Overall Study|Physician Decision|17|||
94420991|NCT01996332|323329641|FG000|Overall Study|Lost to Follow-up|34|||
94420992|NCT02504671|323329642|FG000|Overall Study|Withdrawal by Subject|1|||
94420993|NCT02504671|323329643|FG001|Overall Study|Withdrawal by Subject|5|||
94420994|NCT02504671|323329644|FG002|Overall Study|Withdrawal by Subject|4|||
94420995|NCT02504671|323329645|FG003|Overall Study|Withdrawal by Subject|4|||
94420996|NCT02504671|323329646|FG004|Overall Study|Withdrawal by Subject|5|||
94420997|NCT02504671|323329647|FG005|Overall Study|Withdrawal by Subject|3|||
94420998|NCT02504671|323329642|FG000|Overall Study|Lack of Efficacy|1|||
94420999|NCT02504671|323329643|FG001|Overall Study|Lack of Efficacy|3|||
94421000|NCT02504671|323329644|FG002|Overall Study|Lack of Efficacy|1|||
94421001|NCT02504671|323329645|FG003|Overall Study|Lack of Efficacy|0|||
94421002|NCT02504671|323329646|FG004|Overall Study|Lack of Efficacy|4|||
94421003|NCT02504671|323329647|FG005|Overall Study|Lack of Efficacy|4|||
94421004|NCT02504671|323329642|FG000|Overall Study|Adverse Event|1|||
94421005|NCT02504671|323329643|FG001|Overall Study|Adverse Event|1|||
94421006|NCT02504671|323329644|FG002|Overall Study|Adverse Event|0|||
94421007|NCT02504671|323329645|FG003|Overall Study|Adverse Event|1|||
94421008|NCT02504671|323329646|FG004|Overall Study|Adverse Event|0|||
94421009|NCT02504671|323329647|FG005|Overall Study|Adverse Event|2|||
94421010|NCT02504671|323329642|FG000|Overall Study|Protocol Violation|2|||
94421011|NCT02504671|323329643|FG001|Overall Study|Protocol Violation|1|||
94421012|NCT02504671|323329644|FG002|Overall Study|Protocol Violation|0|||
94421013|NCT02504671|323329645|FG003|Overall Study|Protocol Violation|0|||
94421014|NCT02504671|323329646|FG004|Overall Study|Protocol Violation|0|||
94421015|NCT02504671|323329647|FG005|Overall Study|Protocol Violation|1|||
94421016|NCT02504671|323329642|FG000|Overall Study|Lost to Follow-up|0|||
94421017|NCT02504671|323329643|FG001|Overall Study|Lost to Follow-up|0|||
94421018|NCT02504671|323329644|FG002|Overall Study|Lost to Follow-up|2|||
94421019|NCT02504671|323329645|FG003|Overall Study|Lost to Follow-up|0|||
94421020|NCT02504671|323329646|FG004|Overall Study|Lost to Follow-up|0|||
94421021|NCT02504671|323329647|FG005|Overall Study|Lost to Follow-up|1|||
94421022|NCT02504671|323329642|FG000|Overall Study|Protocol defined stopping criteria|7|||
94489279|NCT00903968|323586019|FG000|Overall Study|Non-Compliance|0|||
94489280|NCT00903968|323586020|FG001|Overall Study|Non-Compliance|0|||
94421023|NCT02504671|323329643|FG001|Overall Study|Protocol defined stopping criteria|4|||
94421024|NCT02504671|323329644|FG002|Overall Study|Protocol defined stopping criteria|3|||
94421025|NCT02504671|323329645|FG003|Overall Study|Protocol defined stopping criteria|5|||
94421026|NCT02504671|323329646|FG004|Overall Study|Protocol defined stopping criteria|3|||
94421027|NCT02504671|323329647|FG005|Overall Study|Protocol defined stopping criteria|3|||
94421028|NCT02113189|323329648|FG000|Overall Study|Lost to follow up|2|||
94421029|NCT02113189|323329649|FG001|Overall Study|Lost to follow up|1|||
94421030|NCT02113189|323329650|FG002|Overall Study|Lost to follow up|3|||
94421031|NCT04280705|323329651|FG000|Overall Study|Enrolled but not treated|4|||
94421032|NCT04280705|323329652|FG001|Overall Study|Enrolled but not treated|10|||
94421033|NCT04280705|323329651|FG000|Overall Study|Physician Decision|1|||
94421034|NCT04280705|323329652|FG001|Overall Study|Physician Decision|0|||
94421035|NCT04280705|323329651|FG000|Overall Study|Withdrawal by Subject|7|||
94421036|NCT04280705|323329652|FG001|Overall Study|Withdrawal by Subject|9|||
94421037|NCT04280705|323329651|FG000|Overall Study|Adverse Event|0|||
94421038|NCT04280705|323329652|FG001|Overall Study|Adverse Event|4|||
94421039|NCT04280705|323329651|FG000|Overall Study|Transferred to another hospital|1|||
94421040|NCT04280705|323329652|FG001|Overall Study|Transferred to another hospital|1|||
94421041|NCT03222583|323329653|FG000|Overall Study|Withdrawal by Subject|3|||
94421042|NCT03222583|323329654|FG001|Overall Study|Withdrawal by Subject|3|||
94421043|NCT03222583|323329653|FG000|Overall Study|Lost to Follow-up|1|||
94421044|NCT03222583|323329654|FG001|Overall Study|Lost to Follow-up|0|||
94421045|NCT03222583|323329653|FG000|Overall Study|Other|1|||
94421046|NCT03222583|323329654|FG001|Overall Study|Other|3|||
94421047|NCT03573505|323329657|FG000|Overall Study|Adverse Event|1|||
94421048|NCT03573505|323329658|FG001|Overall Study|Adverse Event|1|||
94421049|NCT03573505|323329657|FG000|Overall Study|Consent withdrawn|0|||
94421050|NCT03573505|323329658|FG001|Overall Study|Consent withdrawn|1|||
94421051|NCT03573505|323329657|FG000|Overall Study|Disease progression|0|||
94421052|NCT03573505|323329658|FG001|Overall Study|Disease progression|1|||
94421053|NCT03573505|323329657|FG000|Overall Study|Site Terminated by Sponsor|1|||
94421054|NCT03573505|323329658|FG001|Overall Study|Site Terminated by Sponsor|1|||
94421055|NCT03573505|323329657|FG000|Overall Study|Study terminated by sponsor|50|||
94421056|NCT03573505|323329658|FG001|Overall Study|Study terminated by sponsor|45|||
94421057|NCT03573505|323329657|FG000|Overall Study|Reason not specified|0|||
94421058|NCT03573505|323329658|FG001|Overall Study|Reason not specified|1|||
94421059|NCT03573505|323329657|FG000|Overall Study|Death|0|||
94421060|NCT03573505|323329658|FG001|Overall Study|Death|4|||
94421061|NCT00515541|323329661|FG000|Overall Study|Physician Decision|0|||
94421062|NCT00515541|323329662|FG001|Overall Study|Physician Decision|2|||
94421063|NCT00515541|323329663|FG002|Overall Study|Physician Decision|0|||
94421064|NCT00515541|323329664|FG003|Overall Study|Physician Decision|1|||
94421065|NCT00515541|323329661|FG000|Overall Study|No show for appointments|0|||
94421066|NCT00515541|323329662|FG001|Overall Study|No show for appointments|1|||
94421067|NCT00515541|323329663|FG002|Overall Study|No show for appointments|0|||
94421068|NCT00515541|323329664|FG003|Overall Study|No show for appointments|2|||
94421069|NCT00515541|323329661|FG000|Overall Study|Withdrawal by Subject|0|||
94421070|NCT00515541|323329662|FG001|Overall Study|Withdrawal by Subject|2|||
94421071|NCT00515541|323329663|FG002|Overall Study|Withdrawal by Subject|0|||
94421072|NCT00515541|323329664|FG003|Overall Study|Withdrawal by Subject|2|||
94421073|NCT04268316|323329665|FG000|Overall Study|Withdrawal by Subject|2|||
94421074|NCT04268316|323329666|FG001|Overall Study|Withdrawal by Subject|1|||
94421075|NCT04268316|323329667|FG002|Overall Study|Withdrawal by Subject|0|||
94421076|NCT00599521|323329668|FG000|Overall Study|Lack of Efficacy|4|||
94421077|NCT00599521|323329669|FG001|Overall Study|Lack of Efficacy|8|||
94421078|NCT00599521|323329668|FG000|Overall Study|Adverse Event|4|||
94421079|NCT00599521|323329669|FG001|Overall Study|Adverse Event|1|||
94421080|NCT00599521|323329668|FG000|Overall Study|Withdrawal by Subject|28|||
94421081|NCT00599521|323329669|FG001|Overall Study|Withdrawal by Subject|34|||
94421082|NCT00599521|323329668|FG000|Overall Study|Protocol Violation|1|||
94421083|NCT00599521|323329669|FG001|Overall Study|Protocol Violation|1|||
94421084|NCT00599521|323329668|FG000|Overall Study|Lost to Follow-up|23|||
94421085|NCT00599521|323329669|FG001|Overall Study|Lost to Follow-up|23|||
94421086|NCT00599521|323329668|FG000|Overall Study|Pregnancy|0|||
94421087|NCT00599521|323329669|FG001|Overall Study|Pregnancy|2|||
94421088|NCT02040779|323329670|FG000|Overall Study|Adverse Event|1|||
94421089|NCT02040779|323329671|FG001|Overall Study|Adverse Event|0|||
94421090|NCT02040779|323329672|FG002|Overall Study|Adverse Event|0|||
94421091|NCT02040779|323329670|FG000|Overall Study|Withdrawal by Subject|4|||
94489281|NCT00903968|323586021|FG002|Overall Study|Non-Compliance|0|||
94421092|NCT02040779|323329671|FG001|Overall Study|Withdrawal by Subject|1|||
94421093|NCT02040779|323329672|FG002|Overall Study|Withdrawal by Subject|3|||
94421094|NCT02040779|323329670|FG000|Overall Study|Non-compliance|0|||
94421095|NCT02040779|323329671|FG001|Overall Study|Non-compliance|1|||
94421096|NCT02040779|323329672|FG002|Overall Study|Non-compliance|0|||
94421097|NCT02040779|323329670|FG000|Overall Study|Protocol Violation|2|||
94421098|NCT02040779|323329671|FG001|Overall Study|Protocol Violation|1|||
94421099|NCT02040779|323329672|FG002|Overall Study|Protocol Violation|0|||
94421100|NCT02040779|323329670|FG000|Overall Study|Lost to Follow-up|1|||
94421101|NCT02040779|323329671|FG001|Overall Study|Lost to Follow-up|2|||
94489282|NCT00903968|323586022|FG003|Overall Study|Non-Compliance|0|||
94421102|NCT02040779|323329672|FG002|Overall Study|Lost to Follow-up|1|||
94421103|NCT02040779|323329670|FG000|Overall Study|Lack of Efficacy|4|||
94421104|NCT02040779|323329671|FG001|Overall Study|Lack of Efficacy|2|||
94421105|NCT02040779|323329672|FG002|Overall Study|Lack of Efficacy|0|||
94421106|NCT02132637|323329673|FG000|Study Period 1|Withdrawal by Subject|0|||
94421107|NCT02132637|323329674|FG001|Study Period 1|Withdrawal by Subject|4|||
94421108|NCT02132637|323329673|FG000|Study Period 1|Physician Decision|1|||
94421109|NCT02132637|323329674|FG001|Study Period 1|Physician Decision|0|||
94421110|NCT02132637|323329673|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
94421111|NCT02132637|323329674|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
94421112|NCT02132637|323329673|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
94421113|NCT02132637|323329674|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
94421114|NCT00622466|323329679|FG000|Overall Study|Death|1|||
94421115|NCT00622466|323329679|FG000|Overall Study|Adverse Event|1|||
94421116|NCT00622466|323329679|FG000|Overall Study|Withdrawal by Subject|2|||
94421117|NCT02618408|323329680|FG000|Overall Study|Withdrawal by Subject|1|||
94421118|NCT02618408|323329681|FG001|Overall Study|Withdrawal by Subject|0|||
94421119|NCT02618408|323329682|FG002|Overall Study|Withdrawal by Subject|4|||
94421120|NCT02618408|323329680|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
94421121|NCT02618408|323329681|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
94421122|NCT02618408|323329682|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
94421123|NCT02618408|323329680|FG000|Overall Study|Lost to Follow-up|4|||
94421124|NCT02618408|323329681|FG001|Overall Study|Lost to Follow-up|2|||
94421125|NCT02618408|323329682|FG002|Overall Study|Lost to Follow-up|6|||
94421126|NCT02618408|323329680|FG000|Overall Study|Adverse Event|4|||
94421127|NCT02618408|323329681|FG001|Overall Study|Adverse Event|0|||
94421128|NCT02618408|323329682|FG002|Overall Study|Adverse Event|10|||
94421129|NCT02618408|323329680|FG000|Overall Study|Physician Decision|1|||
94421130|NCT02618408|323329681|FG001|Overall Study|Physician Decision|1|||
94421131|NCT02618408|323329682|FG002|Overall Study|Physician Decision|2|||
94421132|NCT02618408|323329680|FG000|Overall Study|Protocol Violation|1|||
94421133|NCT02618408|323329681|FG001|Overall Study|Protocol Violation|1|||
94421134|NCT02618408|323329682|FG002|Overall Study|Protocol Violation|2|||
94421135|NCT02618408|323329680|FG000|Overall Study|Other, Multiple Categories|0|||
94421136|NCT02618408|323329681|FG001|Overall Study|Other, Multiple Categories|0|||
94421137|NCT02618408|323329682|FG002|Overall Study|Other, Multiple Categories|4|||
94421138|NCT03914950|323329683|FG000|Overall Study|Physician Decision|54|||
94421139|NCT01593696|323329684|FG000|Dose Escalation|Progressive Disease|2|||
94421140|NCT01593696|323329685|FG001|Dose Escalation|Progressive Disease|0|||
94421141|NCT01593696|323329686|FG002|Dose Escalation|Progressive Disease|0|||
94421142|NCT01593696|323329687|FG003|Dose Escalation|Progressive Disease|0|||
94421143|NCT01593696|323329684|FG000|Dose Expansion|Fungal infection|0|||
94421144|NCT01593696|323329685|FG001|Dose Expansion|Fungal infection|0|||
94421145|NCT01593696|323329686|FG002|Dose Expansion|Fungal infection|1|||
94421146|NCT01593696|323329687|FG003|Dose Expansion|Fungal infection|0|||
94421147|NCT01732484|323329694|FG000|Overall Study|Death|7|||
94421148|NCT01732484|323329694|FG000|Overall Study|Lost to Follow-up|14|||
94421149|NCT01732484|323329694|FG000|Overall Study|chronical illness|5|||
94421150|NCT00311311|323329697|FG000|Overall Study|Adverse Event|3|||
94421151|NCT00311311|323329698|FG001|Overall Study|Adverse Event|2|||
94489283|NCT00903968|323586023|FG004|Overall Study|Non-Compliance|0|||
94421152|NCT00311311|323329697|FG000|Overall Study|Withdrawal by Subject|1|||
94421153|NCT00311311|323329698|FG001|Overall Study|Withdrawal by Subject|1|||
94421154|NCT00311311|323329697|FG000|Overall Study|Noncompliance|0|||
94421155|NCT00311311|323329698|FG001|Overall Study|Noncompliance|1|||
94421156|NCT00311311|323329697|FG000|Overall Study|Study Termination by Sponsor|3|||
94421157|NCT00311311|323329698|FG001|Overall Study|Study Termination by Sponsor|4|||
94421158|NCT00311311|323329697|FG000|Overall Study|Death|1|||
94421159|NCT00311311|323329698|FG001|Overall Study|Death|0|||
94421160|NCT00311311|323329697|FG000|Overall Study|Lack of ancillary assistance|0|||
94421161|NCT00311311|323329698|FG001|Overall Study|Lack of ancillary assistance|1|||
94421162|NCT00988065|323329699|FG000|Overall Study|Adverse Event|4|||
94421163|NCT00988065|323329700|FG001|Overall Study|Adverse Event|10|||
94421164|NCT00988065|323329701|FG002|Overall Study|Adverse Event|2|||
94489284|NCT00903968|323586024|FG005|Overall Study|Non-Compliance|1|||
94489285|NCT00903968|323586025|FG006|Overall Study|Non-Compliance|0|||
94421165|NCT00988065|323329699|FG000|Overall Study|Lost to Follow-up|1|||
94421166|NCT00988065|323329700|FG001|Overall Study|Lost to Follow-up|2|||
94421167|NCT00988065|323329701|FG002|Overall Study|Lost to Follow-up|2|||
94421168|NCT00988065|323329699|FG000|Overall Study|Subject withdrew consent|3|||
94421169|NCT00988065|323329700|FG001|Overall Study|Subject withdrew consent|5|||
94421170|NCT00988065|323329701|FG002|Overall Study|Subject withdrew consent|2|||
94421171|NCT00988065|323329699|FG000|Overall Study|Noncompliance with protocol|5|||
94421172|NCT00988065|323329700|FG001|Overall Study|Noncompliance with protocol|6|||
94421173|NCT00988065|323329701|FG002|Overall Study|Noncompliance with protocol|9|||
94421174|NCT02685202|323329702|FG000|Overall Study|Lost to Follow-up|9|||
94421175|NCT04355663|323329703|FG000|Overall Study|Physician Decision|2|||
94421176|NCT04355663|323329704|FG001|Overall Study|Physician Decision|7|||
94421177|NCT04355663|323329705|FG002|Overall Study|Physician Decision|0|||
94421178|NCT04355663|323329703|FG000|Overall Study|Adverse Event|0|||
94421179|NCT04355663|323329704|FG001|Overall Study|Adverse Event|0|||
94421180|NCT04355663|323329705|FG002|Overall Study|Adverse Event|1|||
94421181|NCT04355663|323329703|FG000|Overall Study|Withdrawal by Subject|0|||
94421182|NCT04355663|323329704|FG001|Overall Study|Withdrawal by Subject|8|||
94421183|NCT04355663|323329705|FG002|Overall Study|Withdrawal by Subject|3|||
94421184|NCT02615171|323329706|FG000|Overall Study|Lost to Follow-up|2|||
94421185|NCT02615171|323329707|FG001|Overall Study|Lost to Follow-up|1|||
94421186|NCT02980874|323329711|FG000|Overall Study|Adverse Event|2|||
94421187|NCT02980874|323329712|FG001|Overall Study|Adverse Event|7|||
94421188|NCT02980874|323329711|FG000|Overall Study|Withdrawal by Subject|7|||
94421189|NCT02980874|323329712|FG001|Overall Study|Withdrawal by Subject|2|||
94421190|NCT02980874|323329711|FG000|Overall Study|Lost to Follow-up|5|||
94421191|NCT02980874|323329712|FG001|Overall Study|Lost to Follow-up|5|||
94421192|NCT02980874|323329711|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
94421193|NCT02980874|323329712|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
94421194|NCT02980874|323329711|FG000|Overall Study|Unknown study completion status|1|||
94421195|NCT02980874|323329712|FG001|Overall Study|Unknown study completion status|0|||
94421196|NCT00513682|323329713|FG000|Washout Phase|Adverse Event|2|||
94421197|NCT02206620|323329714|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
94421198|NCT02206620|323329715|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
94421199|NCT02206620|323329714|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
94421200|NCT02206620|323329715|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
94421201|NCT03487848|323329718|FG000|Overall Study|Lost to Follow-up|1|||
94421202|NCT00444457|323329720|FG000|Infant Series|Other|0|||
94421203|NCT00444457|323329721|FG001|Infant Series|Other|1|||
94421204|NCT00444457|323329722|FG002|Infant Series|Other|0|||
94421205|NCT00444457|323329723|FG003|Infant Series|Other|0|||
94421206|NCT00444457|323329720|FG000|Infant Series|Parent or legal guardian request|18|||
94421207|NCT00444457|323329721|FG001|Infant Series|Parent or legal guardian request|29|||
94421208|NCT00444457|323329722|FG002|Infant Series|Parent or legal guardian request|34|||
94421209|NCT00444457|323329723|FG003|Infant Series|Parent or legal guardian request|14|||
94421210|NCT00444457|323329720|FG000|Infant Series|Lost to Follow-up|10|||
94421211|NCT00444457|323329721|FG001|Infant Series|Lost to Follow-up|11|||
94421212|NCT00444457|323329722|FG002|Infant Series|Lost to Follow-up|7|||
94421213|NCT00444457|323329723|FG003|Infant Series|Lost to Follow-up|6|||
94421214|NCT00444457|323329720|FG000|Infant Series|Protocol Violation|16|||
94421215|NCT00444457|323329721|FG001|Infant Series|Protocol Violation|8|||
94421216|NCT00444457|323329722|FG002|Infant Series|Protocol Violation|6|||
94421217|NCT00444457|323329723|FG003|Infant Series|Protocol Violation|3|||
94421218|NCT00444457|323329720|FG000|Infant Series|Failed to return|5|||
94421219|NCT00444457|323329721|FG001|Infant Series|Failed to return|4|||
94421220|NCT00444457|323329722|FG002|Infant Series|Failed to return|4|||
94421221|NCT00444457|323329723|FG003|Infant Series|Failed to return|2|||
94421222|NCT00444457|323329720|FG000|Infant Series|Investigator request|4|||
94421223|NCT00444457|323329721|FG001|Infant Series|Investigator request|3|||
94421224|NCT00444457|323329722|FG002|Infant Series|Investigator request|3|||
94421225|NCT00444457|323329723|FG003|Infant Series|Investigator request|2|||
94421226|NCT00444457|323329720|FG000|Infant Series|Other|0|||
94421227|NCT00444457|323329721|FG001|Infant Series|Other|2|||
94421228|NCT00444457|323329722|FG002|Infant Series|Other|4|||
94421229|NCT00444457|323329723|FG003|Infant Series|Other|0|||
94421230|NCT00444457|323329720|FG000|Infant Series|Adverse Event|1|||
94421231|NCT00444457|323329721|FG001|Infant Series|Adverse Event|2|||
94421232|NCT00444457|323329722|FG002|Infant Series|Adverse Event|2|||
94421233|NCT00444457|323329723|FG003|Infant Series|Adverse Event|0|||
94421234|NCT00444457|323329720|FG000|Infant Series|Death|0|||
94421235|NCT00444457|323329721|FG001|Infant Series|Death|1|||
94421236|NCT00444457|323329722|FG002|Infant Series|Death|1|||
94421237|NCT00444457|323329723|FG003|Infant Series|Death|1|||
94421238|NCT00444457|323329720|FG000|After Infant Series|Other|0|||
94421239|NCT00444457|323329721|FG001|After Infant Series|Other|1|||
94421240|NCT00444457|323329722|FG002|After Infant Series|Other|1|||
94421241|NCT00444457|323329723|FG003|After Infant Series|Other|1|||
94421242|NCT00444457|323329720|FG000|After Infant Series|Parent or legal guardian request|4|||
94421243|NCT00444457|323329721|FG001|After Infant Series|Parent or legal guardian request|11|||
94421244|NCT00444457|323329722|FG002|After Infant Series|Parent or legal guardian request|6|||
94421245|NCT00444457|323329723|FG003|After Infant Series|Parent or legal guardian request|3|||
94421246|NCT00444457|323329720|FG000|After Infant Series|Failed to return|7|||
94421247|NCT00444457|323329721|FG001|After Infant Series|Failed to return|6|||
94421248|NCT00444457|323329722|FG002|After Infant Series|Failed to return|5|||
94421249|NCT00444457|323329723|FG003|After Infant Series|Failed to return|1|||
94421250|NCT00444457|323329720|FG000|After Infant Series|Lost to Follow-up|5|||
94421251|NCT00444457|323329721|FG001|After Infant Series|Lost to Follow-up|5|||
94421252|NCT00444457|323329722|FG002|After Infant Series|Lost to Follow-up|5|||
94421253|NCT00444457|323329723|FG003|After Infant Series|Lost to Follow-up|2|||
94421254|NCT00444457|323329720|FG000|After Infant Series|Protocol Violation|2|||
94421255|NCT00444457|323329721|FG001|After Infant Series|Protocol Violation|4|||
94421256|NCT00444457|323329722|FG002|After Infant Series|Protocol Violation|2|||
94421257|NCT00444457|323329723|FG003|After Infant Series|Protocol Violation|2|||
94421258|NCT00444457|323329720|FG000|After Infant Series|Adverse Event|2|||
94421259|NCT00444457|323329721|FG001|After Infant Series|Adverse Event|2|||
94421260|NCT00444457|323329722|FG002|After Infant Series|Adverse Event|0|||
94421261|NCT00444457|323329723|FG003|After Infant Series|Adverse Event|0|||
94421262|NCT00444457|323329720|FG000|After Infant Series|Investigator request|0|||
94421263|NCT00444457|323329721|FG001|After Infant Series|Investigator request|0|||
94421264|NCT00444457|323329722|FG002|After Infant Series|Investigator request|0|||
94421265|NCT00444457|323329723|FG003|After Infant Series|Investigator request|1|||
94421266|NCT00444457|323329720|FG000|After Infant Series|Other|0|||
94421267|NCT00444457|323329721|FG001|After Infant Series|Other|1|||
94421268|NCT00444457|323329722|FG002|After Infant Series|Other|0|||
94421269|NCT00444457|323329723|FG003|After Infant Series|Other|0|||
94421270|NCT00444457|323329720|FG000|Toddler Dose|Lost to Follow-up|4|||
94421271|NCT00444457|323329721|FG001|Toddler Dose|Lost to Follow-up|1|||
94421272|NCT00444457|323329722|FG002|Toddler Dose|Lost to Follow-up|1|||
94421273|NCT00444457|323329723|FG003|Toddler Dose|Lost to Follow-up|3|||
94421274|NCT00444457|323329720|FG000|Toddler Dose|Failed to return|2|||
94421275|NCT00444457|323329721|FG001|Toddler Dose|Failed to return|2|||
94421276|NCT00444457|323329722|FG002|Toddler Dose|Failed to return|1|||
94421277|NCT00444457|323329723|FG003|Toddler Dose|Failed to return|3|||
94421278|NCT00444457|323329720|FG000|Toddler Dose|Parent or legal guardian request|0|||
94421279|NCT00444457|323329721|FG001|Toddler Dose|Parent or legal guardian request|3|||
94421280|NCT00444457|323329722|FG002|Toddler Dose|Parent or legal guardian request|2|||
94421281|NCT00444457|323329723|FG003|Toddler Dose|Parent or legal guardian request|1|||
94421282|NCT00444457|323329720|FG000|Toddler Dose|Protocol Violation|1|||
94421283|NCT00444457|323329721|FG001|Toddler Dose|Protocol Violation|0|||
94421284|NCT00444457|323329722|FG002|Toddler Dose|Protocol Violation|0|||
94421285|NCT00444457|323329723|FG003|Toddler Dose|Protocol Violation|1|||
94421286|NCT01753336|323329724|FG000|Overall Study|Patient decision|12|||
94421287|NCT01753336|323329724|FG000|Overall Study|Lost to Follow-up|3|||
94421288|NCT01753336|323329724|FG000|Overall Study|Physician Decision|2|||
94421289|NCT01753336|323329724|FG000|Overall Study|Sponsor's decision|2|||
94421290|NCT01753336|323329724|FG000|Overall Study|Withdrawal by Subject|1|||
94421291|NCT00914459|323329725|FG000|Overall Study|Protocol Violation|0|||
94421292|NCT00914459|323329726|FG001|Overall Study|Protocol Violation|1|||
94421293|NCT00914459|323329725|FG000|Overall Study|Parent/Legal guardian request|1|||
94421294|NCT00914459|323329726|FG001|Overall Study|Parent/Legal guardian request|0|||
94421295|NCT00809159|323329727|FG000|Part 1|Adverse Event|1|||
94421296|NCT00809159|323329728|FG001|Part 1|Adverse Event|1|||
94421297|NCT00809159|323329729|FG002|Part 1|Adverse Event|0|||
94421298|NCT00809159|323329730|FG003|Part 1|Adverse Event|0|||
94421299|NCT00809159|323329731|FG004|Part 1|Adverse Event|0|||
94421300|NCT00809159|323329732|FG005|Part 1|Adverse Event|0|||
94421301|NCT00809159|323329727|FG000|Part 1|Lost to Follow-up|1|||
94421302|NCT00809159|323329728|FG001|Part 1|Lost to Follow-up|0|||
94421303|NCT00809159|323329729|FG002|Part 1|Lost to Follow-up|0|||
94421304|NCT00809159|323329730|FG003|Part 1|Lost to Follow-up|0|||
94421305|NCT00809159|323329731|FG004|Part 1|Lost to Follow-up|0|||
94421306|NCT00809159|323329732|FG005|Part 1|Lost to Follow-up|0|||
94421307|NCT00809159|323329727|FG000|Part 1|Withdrawal by Subject|3|||
94421308|NCT00809159|323329728|FG001|Part 1|Withdrawal by Subject|1|||
94421309|NCT00809159|323329729|FG002|Part 1|Withdrawal by Subject|0|||
94421310|NCT00809159|323329730|FG003|Part 1|Withdrawal by Subject|0|||
94421311|NCT00809159|323329731|FG004|Part 1|Withdrawal by Subject|0|||
94421312|NCT00809159|323329732|FG005|Part 1|Withdrawal by Subject|0|||
94421313|NCT00809159|323329727|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
94421314|NCT00809159|323329728|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
94421315|NCT00809159|323329729|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
94421316|NCT00809159|323329730|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
94421317|NCT00809159|323329731|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
94421318|NCT00809159|323329732|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
94421319|NCT00809159|323329727|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
94421320|NCT00809159|323329728|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
94421321|NCT00809159|323329729|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
94421322|NCT00809159|323329730|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
94421323|NCT00809159|323329731|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
94489286|NCT00903968|323586026|FG007|Overall Study|Non-Compliance|0|||
94489287|NCT00903968|323586019|FG000|Overall Study|Physician Decision|0|||
94421324|NCT00809159|323329732|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
94421325|NCT00809159|323329727|FG000|Part 1 and 2|Administrative problems|0|||
94489288|NCT00903968|323586020|FG001|Overall Study|Physician Decision|0|||
94489289|NCT00903968|323586021|FG002|Overall Study|Physician Decision|0|||
94421326|NCT00809159|323329728|FG001|Part 1 and 2|Administrative problems|0|||
94421327|NCT00809159|323329729|FG002|Part 1 and 2|Administrative problems|0|||
94421328|NCT00809159|323329730|FG003|Part 1 and 2|Administrative problems|1|||
94421329|NCT00809159|323329731|FG004|Part 1 and 2|Administrative problems|0|||
94421330|NCT00809159|323329732|FG005|Part 1 and 2|Administrative problems|0|||
94421331|NCT00809159|323329727|FG000|Part 1 and 2|Adverse Event|0|||
94421332|NCT00809159|323329728|FG001|Part 1 and 2|Adverse Event|0|||
94421333|NCT00809159|323329729|FG002|Part 1 and 2|Adverse Event|1|||
94421334|NCT00809159|323329730|FG003|Part 1 and 2|Adverse Event|0|||
94421335|NCT00809159|323329731|FG004|Part 1 and 2|Adverse Event|1|||
94421336|NCT00809159|323329732|FG005|Part 1 and 2|Adverse Event|1|||
94421337|NCT00809159|323329727|FG000|Part 1 and 2|Lost to Follow-up|0|||
94421338|NCT00809159|323329728|FG001|Part 1 and 2|Lost to Follow-up|0|||
94421339|NCT00809159|323329729|FG002|Part 1 and 2|Lost to Follow-up|1|||
94421340|NCT00809159|323329730|FG003|Part 1 and 2|Lost to Follow-up|1|||
94421341|NCT00809159|323329731|FG004|Part 1 and 2|Lost to Follow-up|0|||
94421342|NCT00809159|323329732|FG005|Part 1 and 2|Lost to Follow-up|0|||
94421343|NCT00809159|323329727|FG000|Part 1 and 2|Withdrawal by Subject|0|||
94421344|NCT00809159|323329728|FG001|Part 1 and 2|Withdrawal by Subject|0|||
94421345|NCT00809159|323329729|FG002|Part 1 and 2|Withdrawal by Subject|4|||
94421346|NCT00809159|323329730|FG003|Part 1 and 2|Withdrawal by Subject|0|||
94421347|NCT00809159|323329731|FG004|Part 1 and 2|Withdrawal by Subject|0|||
94421348|NCT00809159|323329732|FG005|Part 1 and 2|Withdrawal by Subject|1|||
94421349|NCT03201211|323329738|FG000|Overall Study|Adverse Event|1|||
94421350|NCT03201211|323329739|FG001|Overall Study|Adverse Event|0|||
94421351|NCT03201211|323329740|FG002|Overall Study|Adverse Event|0|||
94421352|NCT03201211|323329738|FG000|Overall Study|Protocol Violation|1|||
94421353|NCT03201211|323329739|FG001|Overall Study|Protocol Violation|0|||
94421354|NCT03201211|323329740|FG002|Overall Study|Protocol Violation|0|||
94421355|NCT03201211|323329738|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
94421356|NCT03201211|323329739|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
94421357|NCT03201211|323329740|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
94421358|NCT03201211|323329738|FG000|Overall Study|OTHER unknown reasons|0|||
94421359|NCT03201211|323329739|FG001|Overall Study|OTHER unknown reasons|1|||
94421360|NCT03201211|323329740|FG002|Overall Study|OTHER unknown reasons|0|||
94421361|NCT02478320|323329741|FG000|Overall Study|Adverse Event|2|||
94421362|NCT02478320|323329742|FG001|Overall Study|Adverse Event|0|||
94421363|NCT02478320|323329741|FG000|Overall Study|Death|1|||
94421364|NCT02478320|323329742|FG001|Overall Study|Death|0|||
94421365|NCT02478320|323329741|FG000|Overall Study|Lack of Efficacy|4|||
94421366|NCT02478320|323329742|FG001|Overall Study|Lack of Efficacy|0|||
94421367|NCT02478320|323329741|FG000|Overall Study|Withdrawal by Subject|2|||
94421368|NCT02478320|323329742|FG001|Overall Study|Withdrawal by Subject|0|||
94421369|NCT02478320|323329741|FG000|Overall Study|Screen Failure|3|||
94421370|NCT02478320|323329742|FG001|Overall Study|Screen Failure|0|||
94421371|NCT02041091|323329743|FG000|Treatment|Adverse Event|3|||
94421372|NCT02041091|323329744|FG001|Treatment|Adverse Event|3|||
94421373|NCT02041091|323329743|FG000|Treatment|Withdrawal by Subject|2|||
94421374|NCT02041091|323329744|FG001|Treatment|Withdrawal by Subject|4|||
94421375|NCT02041091|323329743|FG000|Treatment|Physician Decision|1|||
94421376|NCT02041091|323329744|FG001|Treatment|Physician Decision|0|||
94421377|NCT02041091|323329743|FG000|Treatment|Sponsor Decision|15|||
94421378|NCT02041091|323329744|FG001|Treatment|Sponsor Decision|16|||
94421379|NCT02041091|323329743|FG000|Treatment|Lost to Follow-up|1|||
94421380|NCT02041091|323329744|FG001|Treatment|Lost to Follow-up|0|||
94421381|NCT02041091|323329743|FG000|Optional Safety Extension Period|Adverse Event|4|||
94421382|NCT02041091|323329744|FG001|Optional Safety Extension Period|Adverse Event|2|||
94421383|NCT02041091|323329743|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
94421384|NCT02041091|323329744|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
94421385|NCT02041091|323329743|FG000|Optional Safety Extension Period|Protocol Violation|2|||
94421386|NCT02041091|323329744|FG001|Optional Safety Extension Period|Protocol Violation|0|||
94421387|NCT02041091|323329743|FG000|Optional Safety Extension Period|Physician Decision|2|||
94421388|NCT02041091|323329744|FG001|Optional Safety Extension Period|Physician Decision|1|||
94421389|NCT02041091|323329743|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
94421390|NCT02041091|323329744|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
94421391|NCT02041091|323329743|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
94421392|NCT02041091|323329744|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
94421393|NCT01855074|323329746|FG000|Overall Study|Adverse Event|1|||
94421394|NCT01855074|323329746|FG000|Overall Study|Lost to Follow-up|4|||
94421395|NCT01855074|323329746|FG000|Overall Study|Withdrawal by Subject|8|||
94421396|NCT01855074|323329746|FG000|Overall Study|Started but not treated|1|||
94421397|NCT01150890|323329747|FG000|Overall Study|Other|0|||
94421398|NCT01150890|323329748|FG001|Overall Study|Other|1|||
94421399|NCT01150890|323329749|FG002|Overall Study|Other|0|||
94421400|NCT01150890|323329750|FG003|Overall Study|Other|2|||
94421401|NCT01150890|323329747|FG000|Overall Study|Pregnancy|0|||
94421402|NCT01150890|323329748|FG001|Overall Study|Pregnancy|0|||
94421403|NCT01150890|323329749|FG002|Overall Study|Pregnancy|0|||
94421404|NCT01150890|323329750|FG003|Overall Study|Pregnancy|1|||
94421405|NCT01150890|323329747|FG000|Overall Study|Administrative Decision|4|||
94421406|NCT01150890|323329748|FG001|Overall Study|Administrative Decision|4|||
94421407|NCT01150890|323329749|FG002|Overall Study|Administrative Decision|5|||
94421408|NCT01150890|323329750|FG003|Overall Study|Administrative Decision|6|||
94421409|NCT01150890|323329747|FG000|Overall Study|Ineligibility determined|0|||
94421410|NCT01150890|323329748|FG001|Overall Study|Ineligibility determined|1|||
94421411|NCT01150890|323329749|FG002|Overall Study|Ineligibility determined|0|||
94421412|NCT01150890|323329750|FG003|Overall Study|Ineligibility determined|0|||
94421413|NCT01150890|323329747|FG000|Overall Study|Adverse Event|0|||
94421414|NCT01150890|323329748|FG001|Overall Study|Adverse Event|0|||
94421415|NCT01150890|323329749|FG002|Overall Study|Adverse Event|2|||
94421416|NCT01150890|323329750|FG003|Overall Study|Adverse Event|0|||
94421417|NCT01150890|323329747|FG000|Overall Study|Withdrawal by Subject|0|||
94421418|NCT01150890|323329748|FG001|Overall Study|Withdrawal by Subject|0|||
94421419|NCT01150890|323329749|FG002|Overall Study|Withdrawal by Subject|2|||
94421420|NCT01150890|323329750|FG003|Overall Study|Withdrawal by Subject|1|||
94421421|NCT01150890|323329747|FG000|Overall Study|Disease progression|0|||
94421422|NCT01150890|323329748|FG001|Overall Study|Disease progression|7|||
94421423|NCT01150890|323329749|FG002|Overall Study|Disease progression|3|||
94421424|NCT01150890|323329750|FG003|Overall Study|Disease progression|7|||
94421425|NCT04568031|323329755|FG000|Overall Study|Lost to Follow-up|1|||
94421426|NCT04568031|323329756|FG001|Overall Study|Lost to Follow-up|0|||
94421427|NCT04568031|323329757|FG002|Overall Study|Lost to Follow-up|0|||
94421428|NCT04568031|323329758|FG003|Overall Study|Lost to Follow-up|0|||
94421429|NCT04568031|323329755|FG000|Overall Study|Physician Decision|1|||
94421430|NCT04568031|323329756|FG001|Overall Study|Physician Decision|0|||
94421431|NCT04568031|323329757|FG002|Overall Study|Physician Decision|1|||
94421432|NCT04568031|323329758|FG003|Overall Study|Physician Decision|0|||
94421433|NCT04568031|323329755|FG000|Overall Study|Withdrawal by Subject|1|||
94421434|NCT04568031|323329756|FG001|Overall Study|Withdrawal by Subject|0|||
94421435|NCT04568031|323329757|FG002|Overall Study|Withdrawal by Subject|4|||
94421436|NCT04568031|323329758|FG003|Overall Study|Withdrawal by Subject|1|||
94421437|NCT02304458|323329759|FG000|Overall Study|Adverse Event|0|||
94421438|NCT02304458|323329760|FG001|Overall Study|Adverse Event|0|||
94421439|NCT02304458|323329761|FG002|Overall Study|Adverse Event|7|||
94421440|NCT02304458|323329762|FG003|Overall Study|Adverse Event|0|||
94421441|NCT02304458|323329763|FG004|Overall Study|Adverse Event|0|||
94421442|NCT02304458|323329764|FG005|Overall Study|Adverse Event|0|||
94421443|NCT02304458|323329765|FG006|Overall Study|Adverse Event|3|||
94421444|NCT02304458|323329766|FG007|Overall Study|Adverse Event|4|||
94421445|NCT02304458|323329759|FG000|Overall Study|Death|0|||
94421446|NCT02304458|323329760|FG001|Overall Study|Death|0|||
94421447|NCT02304458|323329761|FG002|Overall Study|Death|2|||
94421448|NCT02304458|323329762|FG003|Overall Study|Death|0|||
94421449|NCT02304458|323329763|FG004|Overall Study|Death|0|||
94421450|NCT02304458|323329764|FG005|Overall Study|Death|0|||
94421451|NCT02304458|323329765|FG006|Overall Study|Death|1|||
94421452|NCT02304458|323329766|FG007|Overall Study|Death|0|||
94421453|NCT02304458|323329759|FG000|Overall Study|Lack of Efficacy|4|||
94421454|NCT02304458|323329760|FG001|Overall Study|Lack of Efficacy|6|||
94421455|NCT02304458|323329761|FG002|Overall Study|Lack of Efficacy|38|||
94421456|NCT02304458|323329762|FG003|Overall Study|Lack of Efficacy|5|||
94421457|NCT02304458|323329763|FG004|Overall Study|Lack of Efficacy|6|||
94421458|NCT02304458|323329764|FG005|Overall Study|Lack of Efficacy|6|||
94421459|NCT02304458|323329765|FG006|Overall Study|Lack of Efficacy|21|||
94421460|NCT02304458|323329766|FG007|Overall Study|Lack of Efficacy|4|||
94421461|NCT02304458|323329759|FG000|Overall Study|Physician Decision|2|||
94421462|NCT02304458|323329760|FG001|Overall Study|Physician Decision|0|||
94421463|NCT02304458|323329761|FG002|Overall Study|Physician Decision|16|||
94421464|NCT02304458|323329762|FG003|Overall Study|Physician Decision|1|||
94421465|NCT02304458|323329763|FG004|Overall Study|Physician Decision|0|||
94421466|NCT02304458|323329764|FG005|Overall Study|Physician Decision|0|||
94421467|NCT02304458|323329765|FG006|Overall Study|Physician Decision|3|||
94421468|NCT02304458|323329766|FG007|Overall Study|Physician Decision|0|||
94421469|NCT02304458|323329759|FG000|Overall Study|Protocol Violation|0|||
94421470|NCT02304458|323329760|FG001|Overall Study|Protocol Violation|0|||
94421471|NCT02304458|323329761|FG002|Overall Study|Protocol Violation|1|||
94421472|NCT02304458|323329762|FG003|Overall Study|Protocol Violation|0|||
94421473|NCT02304458|323329763|FG004|Overall Study|Protocol Violation|0|||
94421474|NCT02304458|323329764|FG005|Overall Study|Protocol Violation|0|||
94421475|NCT02304458|323329765|FG006|Overall Study|Protocol Violation|0|||
94421476|NCT02304458|323329766|FG007|Overall Study|Protocol Violation|0|||
94421477|NCT02304458|323329759|FG000|Overall Study|Withdrawal by Subject|1|||
94421478|NCT02304458|323329760|FG001|Overall Study|Withdrawal by Subject|0|||
94421479|NCT02304458|323329761|FG002|Overall Study|Withdrawal by Subject|7|||
94421480|NCT02304458|323329762|FG003|Overall Study|Withdrawal by Subject|0|||
94421481|NCT02304458|323329763|FG004|Overall Study|Withdrawal by Subject|0|||
94421482|NCT02304458|323329764|FG005|Overall Study|Withdrawal by Subject|0|||
94421483|NCT02304458|323329765|FG006|Overall Study|Withdrawal by Subject|1|||
94421484|NCT02304458|323329766|FG007|Overall Study|Withdrawal by Subject|0|||
94421485|NCT03071094|323329767|FG000|Overall Study|Death|1|||
94421486|NCT03071094|323329768|FG001|Overall Study|Death|1|||
94421487|NCT03071094|323329767|FG000|Overall Study|Adverse Event|1|||
94421488|NCT03071094|323329768|FG001|Overall Study|Adverse Event|0|||
94421489|NCT02283294|323329775|FG000|Overall Study|Lost to Follow-up|1|||
94421490|NCT02283294|323329776|FG001|Overall Study|Lost to Follow-up|1|||
94421491|NCT02283294|323329775|FG000|Overall Study|Withdrawal by Subject|1|||
94421492|NCT02283294|323329776|FG001|Overall Study|Withdrawal by Subject|6|||
94421493|NCT02283294|323329775|FG000|Overall Study|Protocol Violation|1|||
94421494|NCT02283294|323329776|FG001|Overall Study|Protocol Violation|0|||
94421495|NCT02283294|323329775|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
94421496|NCT02283294|323329776|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
94421497|NCT03433755|323329777|FG000|Overall Study|Lost to Follow-up|1|||
94421498|NCT03433755|323329778|FG001|Overall Study|Lost to Follow-up|0|||
94421499|NCT03433755|323329779|FG002|Overall Study|Lost to Follow-up|0|||
94421500|NCT03433755|323329780|FG003|Overall Study|Lost to Follow-up|0|||
94421501|NCT03433755|323329777|FG000|Overall Study|Decision by Sponsor|1|||
94421502|NCT03433755|323329778|FG001|Overall Study|Decision by Sponsor|0|||
94421503|NCT03433755|323329779|FG002|Overall Study|Decision by Sponsor|0|||
94421504|NCT03433755|323329780|FG003|Overall Study|Decision by Sponsor|0|||
94421505|NCT01565850|323329781|FG000|Overall Study|Adverse Event|0|||
94421506|NCT01565850|323329782|FG001|Overall Study|Adverse Event|1|||
94421507|NCT01565850|323329781|FG000|Overall Study|Lost to Follow-up|12|||
94421508|NCT01565850|323329782|FG001|Overall Study|Lost to Follow-up|4|||
94421509|NCT01565850|323329781|FG000|Overall Study|Investigator's Discretion|2|||
94421510|NCT01565850|323329782|FG001|Overall Study|Investigator's Discretion|1|||
94421511|NCT01565850|323329781|FG000|Overall Study|Participant noncompliance|2|||
94421512|NCT01565850|323329782|FG001|Overall Study|Participant noncompliance|0|||
94421513|NCT01565850|323329781|FG000|Overall Study|Withdrew Consent|4|||
94421514|NCT01565850|323329782|FG001|Overall Study|Withdrew Consent|2|||
94421515|NCT00144781|323332506|FG000|Overall Study|Adverse Event|0|||
94421516|NCT00144781|323332507|FG001|Overall Study|Adverse Event|1|||
94421517|NCT00144781|323332508|FG002|Overall Study|Adverse Event|0|||
94421518|NCT00144781|323332509|FG003|Overall Study|Adverse Event|0|||
94421519|NCT00144781|323332506|FG000|Overall Study|Non-compliant|0|||
94421520|NCT00144781|323332507|FG001|Overall Study|Non-compliant|1|||
94421521|NCT00144781|323332508|FG002|Overall Study|Non-compliant|0|||
94421522|NCT00144781|323332509|FG003|Overall Study|Non-compliant|0|||
94421523|NCT00573157|323332510|FG000|Overall Study|Adverse Event|3|||
94421524|NCT00573157|323332511|FG001|Overall Study|Adverse Event|1|||
94421525|NCT00573157|323332510|FG000|Overall Study|Other|1|||
94421526|NCT00573157|323332511|FG001|Overall Study|Other|1|||
94421527|NCT02944383|323332512|FG000|Overall Study|Lost to Follow-up|0|||
94421528|NCT02944383|323332513|FG001|Overall Study|Lost to Follow-up|0|||
94421529|NCT02944383|323332514|FG002|Overall Study|Lost to Follow-up|1|||
94421530|NCT02944383|323332512|FG000|Overall Study|Withdrawal by Subject|1|||
94421531|NCT02944383|323332513|FG001|Overall Study|Withdrawal by Subject|0|||
94421532|NCT02944383|323332514|FG002|Overall Study|Withdrawal by Subject|0|||
94421533|NCT03310411|323332515|FG000|Period 1|Adverse Event|0|||
94421534|NCT03310411|323332516|FG001|Period 1|Adverse Event|0|||
94421535|NCT03310411|323332517|FG002|Period 1|Adverse Event|0|||
94421536|NCT03310411|323332518|FG003|Period 1|Adverse Event|1|||
94421537|NCT00090610|323332519|FG000|Overall Study|Withdrawal by Subject|1|||
94421538|NCT00090610|323332520|FG001|Overall Study|Withdrawal by Subject|1|||
94421539|NCT02444793|323332522|FG000|Overall Study|Lost to Follow-up|2|||
94421540|NCT02444793|323332523|FG001|Overall Study|Lost to Follow-up|2|||
94421541|NCT02444793|323332524|FG002|Overall Study|Lost to Follow-up|0|||
94421542|NCT02444793|323332525|FG003|Overall Study|Lost to Follow-up|0|||
94421543|NCT02444793|323332522|FG000|Overall Study|Death|0|||
94421544|NCT02444793|323332523|FG001|Overall Study|Death|3|||
94421545|NCT02444793|323332524|FG002|Overall Study|Death|0|||
94421546|NCT02444793|323332525|FG003|Overall Study|Death|0|||
94421547|NCT02444793|323332522|FG000|Overall Study|Other|0|||
94421548|NCT02444793|323332523|FG001|Overall Study|Other|0|||
94421549|NCT02444793|323332524|FG002|Overall Study|Other|2|||
94421550|NCT02444793|323332525|FG003|Overall Study|Other|0|||
94421551|NCT02444793|323332522|FG000|Overall Study|Objective progression or relapse|9|||
94421552|NCT02444793|323332523|FG001|Overall Study|Objective progression or relapse|1|||
94421553|NCT02444793|323332524|FG002|Overall Study|Objective progression or relapse|2|||
94421554|NCT02444793|323332525|FG003|Overall Study|Objective progression or relapse|3|||
94421555|NCT00729248|323332526|FG000|Overall Study|Physician Decision|2|||
94421556|NCT04271735|323332529|FG000|Overall Study|Physician Decision|2|||
94421557|NCT04271735|323332530|FG001|Overall Study|Physician Decision|0|||
94421558|NCT02518919|323332532|FG000|Overall Study|Protocol Violation|1|||
94421559|NCT02518919|323332533|FG001|Overall Study|Protocol Violation|1|||
94421560|NCT02518919|323332534|FG002|Overall Study|Protocol Violation|2|||
94421561|NCT04498403|323332535|FG000|Overall Study|Adverse Event|1|||
94421562|NCT04498403|323332536|FG001|Overall Study|Adverse Event|0|||
94489290|NCT00903968|323586022|FG003|Overall Study|Physician Decision|0|||
94421563|NCT04498403|323332535|FG000|Overall Study|Study Terminated By Sponsor|29|||
94421564|NCT04498403|323332536|FG001|Overall Study|Study Terminated By Sponsor|10|||
94421565|NCT02906930|323332538|FG000|Overall Study|Withdrawal by Subject|0|||
94421566|NCT02906930|323332539|FG001|Overall Study|Withdrawal by Subject|5|||
94421567|NCT02906930|323332540|FG002|Overall Study|Withdrawal by Subject|5|||
94421568|NCT02906930|323332541|FG003|Overall Study|Withdrawal by Subject|4|||
94421569|NCT02906930|323332538|FG000|Overall Study|Lost to Follow-up|5|||
94421570|NCT02906930|323332539|FG001|Overall Study|Lost to Follow-up|7|||
94421571|NCT02906930|323332540|FG002|Overall Study|Lost to Follow-up|5|||
94421572|NCT02906930|323332541|FG003|Overall Study|Lost to Follow-up|2|||
94421573|NCT02906930|323332538|FG000|Overall Study|Death|0|||
94421574|NCT02906930|323332539|FG001|Overall Study|Death|0|||
94421575|NCT02906930|323332540|FG002|Overall Study|Death|1|||
94421576|NCT02906930|323332541|FG003|Overall Study|Death|0|||
94421577|NCT02906930|323332538|FG000|Overall Study|Other|1|||
94421578|NCT02906930|323332539|FG001|Overall Study|Other|2|||
94421579|NCT02906930|323332540|FG002|Overall Study|Other|1|||
94421580|NCT02906930|323332541|FG003|Overall Study|Other|2|||
94421581|NCT02792959|323332545|FG000|Overall Study|Protocol Violation|1|||
94421582|NCT01936623|323332546|FG000|Overall Study|Lost to Follow-up|0|||
94421583|NCT01936623|323332547|FG001|Overall Study|Lost to Follow-up|5|||
94421584|NCT01175811|323332552|FG000|Overall Study|Adverse Event|1|||
94421585|NCT01175811|323332553|FG001|Overall Study|Adverse Event|1|||
94421586|NCT01175811|323332552|FG000|Overall Study|Entry criteria not met|3|||
94421587|NCT01175811|323332553|FG001|Overall Study|Entry criteria not met|1|||
94421588|NCT01175811|323332552|FG000|Overall Study|Lack of Efficacy|1|||
94421589|NCT01175811|323332553|FG001|Overall Study|Lack of Efficacy|0|||
94421590|NCT01175811|323332552|FG000|Overall Study|Lost to Follow-up|3|||
94421591|NCT01175811|323332553|FG001|Overall Study|Lost to Follow-up|2|||
94421592|NCT01175811|323332552|FG000|Overall Study|Physician Decision|1|||
94421593|NCT01175811|323332553|FG001|Overall Study|Physician Decision|1|||
94421594|NCT01175811|323332552|FG000|Overall Study|Protocol Violation|1|||
94421595|NCT01175811|323332553|FG001|Overall Study|Protocol Violation|2|||
94421596|NCT01175811|323332552|FG000|Overall Study|Withdrawal by Subject|6|||
94421597|NCT01175811|323332553|FG001|Overall Study|Withdrawal by Subject|7|||
94421598|NCT03579966|323332554|FG000|Overall Study|Adverse Event|6|||
94421599|NCT03579966|323332554|FG000|Overall Study|Lost to Follow-up|4|||
94421600|NCT03579966|323332554|FG000|Overall Study|Physician Decision|10|||
94421601|NCT03579966|323332554|FG000|Overall Study|Pregnancy|1|||
94421602|NCT03579966|323332554|FG000|Overall Study|Withdrawal by Subject|16|||
94421603|NCT03579966|323332554|FG000|Overall Study|Study terminated by Sponsor|22|||
94421604|NCT03579966|323332554|FG000|Overall Study|Protocol Violation|1|||
94421605|NCT01340768|323332555|FG000|Overall Study|Lost to Follow-up|10|||
94421606|NCT01340768|323332556|FG001|Overall Study|Lost to Follow-up|4|||
94421607|NCT01340768|323332555|FG000|Overall Study|Withdrawal by Subject|5|||
94421608|NCT01340768|323332556|FG001|Overall Study|Withdrawal by Subject|1|||
94421609|NCT01340768|323332555|FG000|Overall Study|Other|2|||
94421610|NCT01340768|323332556|FG001|Overall Study|Other|0|||
94421611|NCT01297465|323332559|FG000|Overall Study|Lack of Ovarian Response|1|||
94421612|NCT01297465|323332560|FG001|Overall Study|Lack of Ovarian Response|1|||
94421613|NCT01297465|323332559|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
94421614|NCT01297465|323332560|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
94421615|NCT01297465|323332559|FG000|Overall Study|No Oocytes Retrieved|1|||
94421616|NCT01297465|323332560|FG001|Overall Study|No Oocytes Retrieved|1|||
94421617|NCT01297465|323332559|FG000|Overall Study|Poor oocyte quality|0|||
94421618|NCT01297465|323332560|FG001|Overall Study|Poor oocyte quality|1|||
94421619|NCT01297465|323332559|FG000|Overall Study|No Fertilization|6|||
94421620|NCT01297465|323332560|FG001|Overall Study|No Fertilization|4|||
94421621|NCT01297465|323332559|FG000|Overall Study|All Embryos Discarded|0|||
94421622|NCT01297465|323332560|FG001|Overall Study|All Embryos Discarded|1|||
94421623|NCT01297465|323332559|FG000|Overall Study|Intention to Freeze all Embryos|0|||
94421624|NCT01297465|323332560|FG001|Overall Study|Intention to Freeze all Embryos|1|||
94421625|NCT00801099|323332561|FG000|Overall Study|Lost to Follow-up|101|||
94421626|NCT03127644|323332562|FG000|Overall Study|Study-specific withdrawal criteria|0|||
94421627|NCT03127644|323332563|FG001|Overall Study|Study-specific withdrawal criteria|0|||
94421628|NCT03127644|323332564|FG002|Overall Study|Study-specific withdrawal criteria|2|||
94489291|NCT00903968|323586023|FG004|Overall Study|Physician Decision|0|||
94489292|NCT00903968|323586024|FG005|Overall Study|Physician Decision|1|||
94421629|NCT00928707|323332565|FG000|Overall Study|Protocol Violation|1|||
94421630|NCT00928707|323332566|FG001|Overall Study|Protocol Violation|0|||
94421631|NCT02731326|323332574|FG000|Overall Study|Withdrawal by Subject|4|||
94421632|NCT02731326|323332575|FG001|Overall Study|Withdrawal by Subject|1|||
94421633|NCT02731326|323332574|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
94421634|NCT02731326|323332575|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
94421635|NCT02731326|323332574|FG000|Overall Study|Discharged without AliveCor|10|||
94421636|NCT02731326|323332575|FG001|Overall Study|Discharged without AliveCor|0|||
94421637|NCT02731326|323332574|FG000|Overall Study|Duplicate Participant|1|||
94421638|NCT02731326|323332575|FG001|Overall Study|Duplicate Participant|1|||
94421639|NCT02272634|323332576|FG000|Overall Study|Adverse Event|1|||
94421640|NCT02272634|323332577|FG001|Overall Study|Adverse Event|0|||
94421641|NCT02272634|323332578|FG002|Overall Study|Adverse Event|0|||
94421642|NCT02272634|323332576|FG000|Overall Study|Protocol Violation|0|||
94421643|NCT02272634|323332577|FG001|Overall Study|Protocol Violation|0|||
94421644|NCT02272634|323332578|FG002|Overall Study|Protocol Violation|1|||
94489293|NCT00903968|323586025|FG006|Overall Study|Physician Decision|0|||
94421645|NCT02272634|323332576|FG000|Overall Study|Withdrawal by Subject|0|||
94421646|NCT02272634|323332577|FG001|Overall Study|Withdrawal by Subject|1|||
94421647|NCT02272634|323332578|FG002|Overall Study|Withdrawal by Subject|0|||
94421648|NCT04620135|323332580|FG000|Study Completion|Adverse Event|2|||
94421649|NCT04620135|323332581|FG001|Study Completion|Adverse Event|3|||
94421650|NCT04620135|323332580|FG000|Study Completion|Withdrawal by Subject|2|||
94421651|NCT04620135|323332581|FG001|Study Completion|Withdrawal by Subject|0|||
94421652|NCT04771403|323332583|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
94421653|NCT04771403|323332584|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
94421654|NCT04771403|323332583|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
94421655|NCT04771403|323332584|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
94421656|NCT04771403|323332583|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
94421657|NCT04771403|323332584|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
94421658|NCT04771403|323332583|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
94421659|NCT04771403|323332584|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
94421660|NCT04771403|323332583|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
94421661|NCT04771403|323332584|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
94421662|NCT04771403|323332583|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
94421663|NCT04771403|323332584|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
94421664|NCT04771403|323332583|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
94421665|NCT04771403|323332584|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
94421666|NCT04771403|323332583|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
94421667|NCT04771403|323332584|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
94421668|NCT02387983|323332585|FG000|Overall Study|Adverse Event|4|||
94421669|NCT02387983|323332585|FG000|Overall Study|Protocol Violation|1|||
94421670|NCT02387983|323332585|FG000|Overall Study|Withdrawal by Subject|2|||
94421671|NCT01660334|323332586|FG000|Overall Study|Lost to Follow-up|1|||
94421672|NCT00816361|323332587|FG000|Overall Study|Withdrawal by Subject|0|||
94421673|NCT00816361|323332588|FG001|Overall Study|Withdrawal by Subject|0|||
94421674|NCT00816361|323332589|FG002|Overall Study|Withdrawal by Subject|0|||
94421675|NCT00816361|323332590|FG003|Overall Study|Withdrawal by Subject|0|||
94421676|NCT00816361|323332591|FG004|Overall Study|Withdrawal by Subject|1|||
94421677|NCT00816361|323332592|FG005|Overall Study|Withdrawal by Subject|2|||
94421678|NCT00816361|323332593|FG006|Overall Study|Withdrawal by Subject|0|||
94421679|NCT00816361|323332594|FG007|Overall Study|Withdrawal by Subject|2|||
94421680|NCT00816361|323332595|FG008|Overall Study|Withdrawal by Subject|1|||
94421681|NCT00816361|323332587|FG000|Overall Study|Death|4|||
94421682|NCT00816361|323332588|FG001|Overall Study|Death|3|||
94421683|NCT00816361|323332589|FG002|Overall Study|Death|3|||
94421684|NCT00816361|323332590|FG003|Overall Study|Death|3|||
94421685|NCT00816361|323332591|FG004|Overall Study|Death|1|||
94421686|NCT00816361|323332592|FG005|Overall Study|Death|1|||
94421687|NCT00816361|323332593|FG006|Overall Study|Death|3|||
94421688|NCT00816361|323332594|FG007|Overall Study|Death|7|||
94421689|NCT00816361|323332595|FG008|Overall Study|Death|8|||
94421690|NCT00816361|323332587|FG000|Overall Study|Other|0|||
94421691|NCT00816361|323332588|FG001|Overall Study|Other|0|||
94421692|NCT00816361|323332589|FG002|Overall Study|Other|0|||
94421693|NCT00816361|323332590|FG003|Overall Study|Other|0|||
94421694|NCT00816361|323332591|FG004|Overall Study|Other|0|||
94421695|NCT00816361|323332592|FG005|Overall Study|Other|0|||
94421696|NCT00816361|323332593|FG006|Overall Study|Other|0|||
94421697|NCT00816361|323332594|FG007|Overall Study|Other|0|||
94421698|NCT00816361|323332595|FG008|Overall Study|Other|1|||
94421699|NCT00546572|323332597|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
94421700|NCT00546572|323332598|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
94421701|NCT00546572|323332597|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
94421702|NCT00546572|323332598|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
94421703|NCT00546572|323332597|FG000|Vax 1 / Year 0|Protocol Violation|3|||
94421704|NCT00546572|323332598|FG001|Vax 1 / Year 0|Protocol Violation|4|||
94421705|NCT00546572|323332597|FG000|Vax 1 / Year 0|Death|2|||
94421706|NCT00546572|323332598|FG001|Vax 1 / Year 0|Death|2|||
94421707|NCT00546572|323332597|FG000|Vax 1 / Year 0|Adverse Event|0|||
94421708|NCT00546572|323332598|FG001|Vax 1 / Year 0|Adverse Event|1|||
94421709|NCT00546572|323332597|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
94421710|NCT00546572|323332598|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
94421711|NCT00546572|323332597|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
94421712|NCT00546572|323332598|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
94421713|NCT00546572|323332597|FG000|Vax 2 / Year 1|Other|1|||
94421714|NCT00546572|323332598|FG001|Vax 2 / Year 1|Other|1|||
94421715|NCT00546572|323332597|FG000|Vax 2 / Year 1|Adverse Event|1|||
94421716|NCT00546572|323332598|FG001|Vax 2 / Year 1|Adverse Event|0|||
94421717|NCT00546572|323332597|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
94421718|NCT00546572|323332598|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
94421719|NCT01986010|323332600|FG000|Overall Study|Adverse Event|0|||
94421720|NCT01986010|323332601|FG001|Overall Study|Adverse Event|1|||
94421721|NCT01986010|323332602|FG002|Overall Study|Adverse Event|0|||
94421722|NCT01986010|323332603|FG003|Overall Study|Adverse Event|0|||
94421723|NCT01986010|323332604|FG004|Overall Study|Adverse Event|0|||
94421724|NCT01986010|323332605|FG005|Overall Study|Adverse Event|0|||
94421725|NCT01986010|323332606|FG006|Overall Study|Adverse Event|0|||
94421726|NCT01986010|323332607|FG007|Overall Study|Adverse Event|0|||
94421727|NCT01986010|323332608|FG008|Overall Study|Adverse Event|0|||
94421728|NCT01986010|323332609|FG009|Overall Study|Adverse Event|0|||
94421729|NCT01986010|323332610|FG010|Overall Study|Adverse Event|0|||
94421730|NCT01986010|323332611|FG011|Overall Study|Adverse Event|0|||
94421731|NCT01986010|323332612|FG012|Overall Study|Adverse Event|0|||
94421732|NCT01986010|323332613|FG013|Overall Study|Adverse Event|0|||
94421733|NCT01986010|323332614|FG014|Overall Study|Adverse Event|0|||
94421734|NCT01986010|323332615|FG015|Overall Study|Adverse Event|1|||
94421735|NCT01986010|323332616|FG016|Overall Study|Adverse Event|0|||
94421736|NCT01986010|323332600|FG000|Overall Study|Lost to Follow-up|2|||
94421737|NCT01986010|323332601|FG001|Overall Study|Lost to Follow-up|1|||
94421738|NCT01986010|323332602|FG002|Overall Study|Lost to Follow-up|2|||
94421739|NCT01986010|323332603|FG003|Overall Study|Lost to Follow-up|2|||
94421740|NCT01986010|323332604|FG004|Overall Study|Lost to Follow-up|2|||
94421741|NCT01986010|323332605|FG005|Overall Study|Lost to Follow-up|2|||
94421742|NCT01986010|323332606|FG006|Overall Study|Lost to Follow-up|0|||
94421743|NCT01986010|323332607|FG007|Overall Study|Lost to Follow-up|0|||
94421744|NCT01986010|323332608|FG008|Overall Study|Lost to Follow-up|4|||
94421745|NCT01986010|323332609|FG009|Overall Study|Lost to Follow-up|2|||
94421746|NCT01986010|323332610|FG010|Overall Study|Lost to Follow-up|0|||
94421747|NCT01986010|323332611|FG011|Overall Study|Lost to Follow-up|1|||
94421748|NCT01986010|323332612|FG012|Overall Study|Lost to Follow-up|1|||
94421749|NCT01986010|323332613|FG013|Overall Study|Lost to Follow-up|1|||
94421750|NCT01986010|323332614|FG014|Overall Study|Lost to Follow-up|2|||
94421751|NCT01986010|323332615|FG015|Overall Study|Lost to Follow-up|0|||
94421752|NCT01986010|323332616|FG016|Overall Study|Lost to Follow-up|0|||
94421753|NCT01986010|323332600|FG000|Overall Study|Physician Decision|0|||
94421754|NCT01986010|323332601|FG001|Overall Study|Physician Decision|0|||
94421755|NCT01986010|323332602|FG002|Overall Study|Physician Decision|0|||
94421756|NCT01986010|323332603|FG003|Overall Study|Physician Decision|0|||
94421757|NCT01986010|323332604|FG004|Overall Study|Physician Decision|0|||
94421758|NCT01986010|323332605|FG005|Overall Study|Physician Decision|0|||
94421759|NCT01986010|323332606|FG006|Overall Study|Physician Decision|0|||
94421760|NCT01986010|323332607|FG007|Overall Study|Physician Decision|0|||
94421761|NCT01986010|323332608|FG008|Overall Study|Physician Decision|0|||
94421762|NCT01986010|323332609|FG009|Overall Study|Physician Decision|0|||
94421763|NCT01986010|323332610|FG010|Overall Study|Physician Decision|0|||
94421764|NCT01986010|323332611|FG011|Overall Study|Physician Decision|0|||
94421765|NCT01986010|323332612|FG012|Overall Study|Physician Decision|0|||
94421766|NCT01986010|323332613|FG013|Overall Study|Physician Decision|0|||
94421767|NCT01986010|323332614|FG014|Overall Study|Physician Decision|1|||
94421768|NCT01986010|323332615|FG015|Overall Study|Physician Decision|0|||
94421769|NCT01986010|323332616|FG016|Overall Study|Physician Decision|0|||
94421770|NCT01986010|323332600|FG000|Overall Study|Withdrawal by Subject|2|||
94421771|NCT01986010|323332601|FG001|Overall Study|Withdrawal by Subject|2|||
94421772|NCT01986010|323332602|FG002|Overall Study|Withdrawal by Subject|3|||
94421773|NCT01986010|323332603|FG003|Overall Study|Withdrawal by Subject|0|||
94421774|NCT01986010|323332604|FG004|Overall Study|Withdrawal by Subject|2|||
94421775|NCT01986010|323332605|FG005|Overall Study|Withdrawal by Subject|4|||
94421776|NCT01986010|323332606|FG006|Overall Study|Withdrawal by Subject|0|||
94421777|NCT01986010|323332607|FG007|Overall Study|Withdrawal by Subject|0|||
94421778|NCT01986010|323332608|FG008|Overall Study|Withdrawal by Subject|0|||
94421779|NCT01986010|323332609|FG009|Overall Study|Withdrawal by Subject|0|||
94421780|NCT01986010|323332610|FG010|Overall Study|Withdrawal by Subject|0|||
94421781|NCT01986010|323332611|FG011|Overall Study|Withdrawal by Subject|2|||
94421782|NCT01986010|323332612|FG012|Overall Study|Withdrawal by Subject|0|||
94421783|NCT01986010|323332613|FG013|Overall Study|Withdrawal by Subject|1|||
94421784|NCT01986010|323332614|FG014|Overall Study|Withdrawal by Subject|2|||
94421785|NCT01986010|323332615|FG015|Overall Study|Withdrawal by Subject|0|||
94421786|NCT01986010|323332616|FG016|Overall Study|Withdrawal by Subject|0|||
94421787|NCT01986010|323332600|FG000|Overall Study|Status Not Recorded|2|||
94421788|NCT01986010|323332601|FG001|Overall Study|Status Not Recorded|4|||
94421789|NCT01986010|323332602|FG002|Overall Study|Status Not Recorded|2|||
94421790|NCT01986010|323332603|FG003|Overall Study|Status Not Recorded|0|||
94421791|NCT01986010|323332604|FG004|Overall Study|Status Not Recorded|1|||
94421792|NCT01986010|323332605|FG005|Overall Study|Status Not Recorded|2|||
94421793|NCT01986010|323332606|FG006|Overall Study|Status Not Recorded|0|||
94421794|NCT01986010|323332607|FG007|Overall Study|Status Not Recorded|0|||
94421795|NCT01986010|323332608|FG008|Overall Study|Status Not Recorded|2|||
94421796|NCT01986010|323332609|FG009|Overall Study|Status Not Recorded|1|||
94421797|NCT01986010|323332610|FG010|Overall Study|Status Not Recorded|7|||
94421798|NCT01986010|323332611|FG011|Overall Study|Status Not Recorded|7|||
94421799|NCT01986010|323332612|FG012|Overall Study|Status Not Recorded|9|||
94421800|NCT01986010|323332613|FG013|Overall Study|Status Not Recorded|9|||
94421801|NCT01986010|323332614|FG014|Overall Study|Status Not Recorded|5|||
94421802|NCT01986010|323332615|FG015|Overall Study|Status Not Recorded|10|||
94421803|NCT01986010|323332616|FG016|Overall Study|Status Not Recorded|4|||
94421804|NCT01335997|323332618|FG000|Period I and II|Adverse Event|63|||
94421805|NCT01335997|323332619|FG001|Period I and II|Adverse Event|43|||
94421806|NCT01335997|323332618|FG000|Period I and II|Noncompliance with Study Drug|1|||
94421807|NCT01335997|323332619|FG001|Period I and II|Noncompliance with Study Drug|1|||
94421808|NCT01335997|323332618|FG000|Period I and II|Lost to Follow-up|3|||
94421809|NCT01335997|323332619|FG001|Period I and II|Lost to Follow-up|5|||
94421810|NCT01335997|323332618|FG000|Period I and II|Withdrawal by Subject|9|||
94421811|NCT01335997|323332619|FG001|Period I and II|Withdrawal by Subject|4|||
94421812|NCT01335997|323332618|FG000|Period I and II|Study Terminated by Sponsor|406|||
94421813|NCT01335997|323332619|FG001|Period I and II|Study Terminated by Sponsor|415|||
94421814|NCT01335997|323332618|FG000|Period I and II|Protocol Violation|9|||
94421815|NCT01335997|323332619|FG001|Period I and II|Protocol Violation|10|||
94421816|NCT01335997|323332618|FG000|Period I and II|Physician Decision|2|||
94421817|NCT01335997|323332619|FG001|Period I and II|Physician Decision|1|||
94421818|NCT01335997|323332618|FG000|Period III|Adverse Event|0|||
94421819|NCT01335997|323332619|FG001|Period III|Adverse Event|2|||
94421820|NCT01335997|323332618|FG000|Period III|Study Terminated by Sponsor|77|||
94421821|NCT01335997|323332619|FG001|Period III|Study Terminated by Sponsor|76|||
94421822|NCT01335997|323332618|FG000|Period III|Protocol Violation|0|||
94421823|NCT01335997|323332619|FG001|Period III|Protocol Violation|1|||
94421824|NCT01335997|323332618|FG000|Period III|Lost to Follow-up|1|||
94421825|NCT01335997|323332619|FG001|Period III|Lost to Follow-up|0|||
94421826|NCT02130882|323332622|FG000|Overall Study|Withdrawal by Subject|0|||
94421827|NCT02130882|323332623|FG001|Overall Study|Withdrawal by Subject|1|||
94421828|NCT04740814|323332624|FG000|Overall Study|Adverse Event|3|||
94421829|NCT04740814|323332624|FG000|Overall Study|Protocol Violation|2|||
94421830|NCT04740814|323332624|FG000|Overall Study|Lost to Follow-up|2|||
94421831|NCT04740814|323332624|FG000|Overall Study|Withdrawal by Subject|3|||
94421832|NCT02500641|323332629|FG000|Overall Study|Adverse Event|0|||
94421833|NCT02500641|323332630|FG001|Overall Study|Adverse Event|2|||
94421834|NCT02500641|323332629|FG000|Overall Study|Withdrawal by Subject|4|||
94421835|NCT02500641|323332630|FG001|Overall Study|Withdrawal by Subject|5|||
94421836|NCT02500641|323332629|FG000|Overall Study|Unable to follow study procedures|3|||
94421837|NCT02500641|323332630|FG001|Overall Study|Unable to follow study procedures|2|||
94421838|NCT02500641|323332629|FG000|Overall Study|Protocol Violation|1|||
94421839|NCT02500641|323332630|FG001|Overall Study|Protocol Violation|2|||
94421840|NCT02500641|323332629|FG000|Overall Study|Lost to Follow-up|1|||
94421841|NCT02500641|323332630|FG001|Overall Study|Lost to Follow-up|0|||
94421842|NCT02500641|323332629|FG000|Overall Study|Sponsor decision|1|||
94421843|NCT02500641|323332630|FG001|Overall Study|Sponsor decision|0|||
94421844|NCT02500641|323332629|FG000|Overall Study|Non compliance to study drug|0|||
94421845|NCT02500641|323332630|FG001|Overall Study|Non compliance to study drug|1|||
94421846|NCT02440568|323332631|FG000|Overall Study|Death|1|||
94421847|NCT02440568|323332632|FG001|Overall Study|Death|3|||
94421848|NCT02440568|323332633|FG002|Overall Study|Death|4|||
94421849|NCT02440568|323332634|FG003|Overall Study|Death|2|||
94421850|NCT02440568|323332631|FG000|Overall Study|Lack of Efficacy|2|||
94421851|NCT02440568|323332632|FG001|Overall Study|Lack of Efficacy|0|||
94421852|NCT02440568|323332633|FG002|Overall Study|Lack of Efficacy|1|||
94421853|NCT02440568|323332634|FG003|Overall Study|Lack of Efficacy|0|||
94421854|NCT02440568|323332631|FG000|Overall Study|Lost to Follow-up|1|||
94421855|NCT02440568|323332632|FG001|Overall Study|Lost to Follow-up|0|||
94421856|NCT02440568|323332633|FG002|Overall Study|Lost to Follow-up|0|||
94421857|NCT02440568|323332634|FG003|Overall Study|Lost to Follow-up|0|||
94421858|NCT00536263|323332640|FG000|Overall Study|Adverse Event|5|||
94421859|NCT00536263|323332641|FG001|Overall Study|Adverse Event|5|||
94421860|NCT00536263|323332642|FG002|Overall Study|Adverse Event|7|||
94421861|NCT00536263|323332640|FG000|Overall Study|Lost to Follow-up|3|||
94421862|NCT00536263|323332641|FG001|Overall Study|Lost to Follow-up|4|||
94421863|NCT00536263|323332642|FG002|Overall Study|Lost to Follow-up|4|||
94421864|NCT00536263|323332640|FG000|Overall Study|Subject withdrew - not treatment related|2|||
94421865|NCT00536263|323332641|FG001|Overall Study|Subject withdrew - not treatment related|0|||
94421866|NCT00536263|323332642|FG002|Overall Study|Subject withdrew - not treatment related|5|||
94421867|NCT00536263|323332640|FG000|Overall Study|Subject withdrew - treatment related|0|||
94421868|NCT00536263|323332641|FG001|Overall Study|Subject withdrew - treatment related|3|||
94421869|NCT00536263|323332642|FG002|Overall Study|Subject withdrew - treatment related|2|||
94421870|NCT00536263|323332640|FG000|Overall Study|Noncompliance with protocol|0|||
94421871|NCT00536263|323332641|FG001|Overall Study|Noncompliance with protocol|0|||
94421872|NCT00536263|323332642|FG002|Overall Study|Noncompliance with protocol|1|||
94421873|NCT00536263|323332640|FG000|Overall Study|Did not meet protocol eligibility|1|||
94421874|NCT00536263|323332641|FG001|Overall Study|Did not meet protocol eligibility|2|||
94421875|NCT00536263|323332642|FG002|Overall Study|Did not meet protocol eligibility|2|||
94421876|NCT00826449|323332645|FG000|Overall Study|Disease Progression|4|||
94421877|NCT00826449|323332645|FG000|Overall Study|Withdrawal by Subject|1|||
94421878|NCT02994940|323332648|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
94421879|NCT02994940|323332649|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
94421880|NCT02994940|323332648|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
94421881|NCT02994940|323332649|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
94421882|NCT02994940|323332648|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
94421883|NCT02994940|323332649|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
94421884|NCT03233230|323332650|FG000|Overall Study|Adverse Event|6|||
94421885|NCT03233230|323332651|FG001|Overall Study|Adverse Event|3|||
94421886|NCT03233230|323332652|FG002|Overall Study|Adverse Event|6|||
94421887|NCT03233230|323332653|FG003|Overall Study|Adverse Event|3|||
94421888|NCT03233230|323332650|FG000|Overall Study|Protocol Violation|1|||
94421889|NCT03233230|323332651|FG001|Overall Study|Protocol Violation|2|||
94421890|NCT03233230|323332652|FG002|Overall Study|Protocol Violation|1|||
94421891|NCT03233230|323332653|FG003|Overall Study|Protocol Violation|1|||
94421892|NCT03233230|323332650|FG000|Overall Study|Lack of Efficacy|1|||
94421893|NCT03233230|323332651|FG001|Overall Study|Lack of Efficacy|0|||
94421894|NCT03233230|323332652|FG002|Overall Study|Lack of Efficacy|0|||
94421895|NCT03233230|323332653|FG003|Overall Study|Lack of Efficacy|0|||
94421896|NCT03233230|323332650|FG000|Overall Study|Other|5|||
94421897|NCT03233230|323332651|FG001|Overall Study|Other|5|||
94421898|NCT03233230|323332652|FG002|Overall Study|Other|5|||
94421899|NCT03233230|323332653|FG003|Overall Study|Other|3|||
94421900|NCT03233230|323332650|FG000|Overall Study|Withdrawal by Subject|2|||
94421901|NCT03233230|323332651|FG001|Overall Study|Withdrawal by Subject|2|||
94421902|NCT03233230|323332652|FG002|Overall Study|Withdrawal by Subject|0|||
94421903|NCT03233230|323332653|FG003|Overall Study|Withdrawal by Subject|1|||
94421904|NCT03233230|323332650|FG000|Overall Study|Lost to Follow-up|0|||
94421905|NCT03233230|323332651|FG001|Overall Study|Lost to Follow-up|3|||
94421906|NCT03233230|323332652|FG002|Overall Study|Lost to Follow-up|0|||
94421907|NCT03233230|323332653|FG003|Overall Study|Lost to Follow-up|0|||
94421908|NCT02331368|323332660|FG000|Overall Study|Withdrawal by Subject|3|||
94421909|NCT00423319|323332663|FG000|Overall Study|Death|2|||
94421910|NCT00423319|323332664|FG001|Overall Study|Death|0|||
94421911|NCT00423319|323332663|FG000|Overall Study|Adverse Event|93|||
94421912|NCT00423319|323332664|FG001|Overall Study|Adverse Event|112|||
94421913|NCT00423319|323332663|FG000|Overall Study|Withdrawal by Subject|86|||
94421914|NCT00423319|323332664|FG001|Overall Study|Withdrawal by Subject|99|||
94421915|NCT00423319|323332663|FG000|Overall Study|Lost to Follow-up|4|||
94421916|NCT00423319|323332664|FG001|Overall Study|Lost to Follow-up|3|||
94421917|NCT00423319|323332663|FG000|Overall Study|Poor compliance or noncompliance|1|||
94421918|NCT00423319|323332664|FG001|Overall Study|Poor compliance or noncompliance|1|||
94421919|NCT00423319|323332663|FG000|Overall Study|No longer meets study criteria|15|||
94421920|NCT00423319|323332664|FG001|Overall Study|No longer meets study criteria|15|||
94421921|NCT00423319|323332663|FG000|Overall Study|Other|23|||
94421922|NCT00423319|323332664|FG001|Overall Study|Other|22|||
94421923|NCT01763684|323332670|FG000|Overall Study|Study terminated early due to low enrollment|126|||
94421924|NCT01763684|323332671|FG001|Overall Study|Study terminated early due to low enrollment|127|||
94421925|NCT01763684|323332670|FG000|Overall Study|Study surgery not performed|7|||
94421926|NCT01763684|323332671|FG001|Overall Study|Study surgery not performed|6|||
94421927|NCT04126213|323332674|FG000|Overall Study|Lost to Follow-up|9|||
94421928|NCT04126213|323332675|FG001|Overall Study|Lost to Follow-up|1|||
94421929|NCT04126213|323332676|FG002|Overall Study|Lost to Follow-up|5|||
94421930|NCT04126213|323332677|FG003|Overall Study|Lost to Follow-up|10|||
94421931|NCT04126213|323332678|FG004|Overall Study|Lost to Follow-up|4|||
94421932|NCT04126213|323332679|FG005|Overall Study|Lost to Follow-up|7|||
94421933|NCT04126213|323332674|FG000|Overall Study|Withdrawal by Subject|3|||
94421934|NCT04126213|323332675|FG001|Overall Study|Withdrawal by Subject|2|||
94421935|NCT04126213|323332676|FG002|Overall Study|Withdrawal by Subject|1|||
94421936|NCT04126213|323332677|FG003|Overall Study|Withdrawal by Subject|1|||
94421937|NCT04126213|323332678|FG004|Overall Study|Withdrawal by Subject|1|||
94421938|NCT04126213|323332679|FG005|Overall Study|Withdrawal by Subject|1|||
94421939|NCT04126213|323332674|FG000|Overall Study|Other|0|||
94421940|NCT04126213|323332675|FG001|Overall Study|Other|0|||
94421941|NCT04126213|323332676|FG002|Overall Study|Other|2|||
94421942|NCT04126213|323332677|FG003|Overall Study|Other|2|||
94421943|NCT04126213|323332678|FG004|Overall Study|Other|0|||
94421944|NCT04126213|323332679|FG005|Overall Study|Other|1|||
94421945|NCT04126213|323332674|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94421946|NCT04126213|323332675|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
94421947|NCT04126213|323332676|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
94421948|NCT04126213|323332677|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94421949|NCT04126213|323332678|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
94421950|NCT04126213|323332679|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
94421951|NCT02302859|323332680|FG000|Overall Study|Lost Phone|1|||
94421952|NCT02302859|323332681|FG001|Overall Study|Lost Phone|1|||
94421953|NCT02302859|323332680|FG000|Overall Study|Withdrawal by Subject|0|||
94421954|NCT02302859|323332681|FG001|Overall Study|Withdrawal by Subject|1|||
94421955|NCT02853370|323332682|FG000|Overall Study|Physician Decision|1|||
94421956|NCT02853370|323332682|FG000|Overall Study|Lack of Efficacy|2|||
94421957|NCT02853370|323332682|FG000|Overall Study|Death|1|||
94421958|NCT02853370|323332682|FG000|Overall Study|Adverse Event|4|||
94421959|NCT02853370|323332682|FG000|Overall Study|Withdrawal by Subject|3|||
94421960|NCT02196701|323332685|FG000|Overall Study|Adverse Event|1|||
94421961|NCT02196701|323332685|FG000|Overall Study|Lost to Follow-up|1|||
94421962|NCT02196701|323332685|FG000|Overall Study|Non-adherence to Protocol|1|||
94421963|NCT03734666|323332694|FG000|Overall Study|Other|7|||
94421964|NCT03734666|323332695|FG001|Overall Study|Other|4|||
94421965|NCT03734666|323332694|FG000|Overall Study|Lost to Follow-up|12|||
94421966|NCT03734666|323332695|FG001|Overall Study|Lost to Follow-up|12|||
94421967|NCT01791153|323332696|FG000|Part 1: Blinded Period|Adverse Event|7|||
94421968|NCT01791153|323332697|FG001|Part 1: Blinded Period|Adverse Event|3|||
94421969|NCT01791153|323332698|FG002|Part 1: Blinded Period|Adverse Event|2|||
94421970|NCT01791153|323332699|FG003|Part 1: Blinded Period|Adverse Event|0|||
94421971|NCT01791153|323332700|FG004|Part 1: Blinded Period|Adverse Event|0|||
94421972|NCT01791153|323332701|FG005|Part 1: Blinded Period|Adverse Event|0|||
94421973|NCT01791153|323332702|FG006|Part 1: Blinded Period|Adverse Event|0|||
94421974|NCT01791153|323332703|FG007|Part 1: Blinded Period|Adverse Event|0|||
94421975|NCT01791153|323332696|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
94421976|NCT01791153|323332697|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
94421977|NCT01791153|323332698|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
94421978|NCT01791153|323332699|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
94421979|NCT01791153|323332700|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
94421980|NCT01791153|323332701|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
94421981|NCT01791153|323332702|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
94421982|NCT01791153|323332703|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
94421983|NCT01791153|323332696|FG000|Part 1: Blinded Period|Non-Compliance|1|||
94421984|NCT01791153|323332697|FG001|Part 1: Blinded Period|Non-Compliance|0|||
94421985|NCT01791153|323332698|FG002|Part 1: Blinded Period|Non-Compliance|0|||
94421986|NCT01791153|323332699|FG003|Part 1: Blinded Period|Non-Compliance|0|||
94421987|NCT01791153|323332700|FG004|Part 1: Blinded Period|Non-Compliance|0|||
94421988|NCT01791153|323332701|FG005|Part 1: Blinded Period|Non-Compliance|0|||
94421989|NCT01791153|323332702|FG006|Part 1: Blinded Period|Non-Compliance|0|||
94421990|NCT01791153|323332703|FG007|Part 1: Blinded Period|Non-Compliance|0|||
94421991|NCT01791153|323332696|FG000|Part 1: Blinded Period|Physician Decision|0|||
94421992|NCT01791153|323332697|FG001|Part 1: Blinded Period|Physician Decision|0|||
94421993|NCT01791153|323332698|FG002|Part 1: Blinded Period|Physician Decision|0|||
94421994|NCT01791153|323332699|FG003|Part 1: Blinded Period|Physician Decision|1|||
94421995|NCT01791153|323332700|FG004|Part 1: Blinded Period|Physician Decision|0|||
94421996|NCT01791153|323332701|FG005|Part 1: Blinded Period|Physician Decision|0|||
94421997|NCT01791153|323332702|FG006|Part 1: Blinded Period|Physician Decision|0|||
94421998|NCT01791153|323332703|FG007|Part 1: Blinded Period|Physician Decision|0|||
94421999|NCT01791153|323332696|FG000|Part 1: Blinded Period|Protocol Violation|0|||
94422000|NCT01791153|323332697|FG001|Part 1: Blinded Period|Protocol Violation|0|||
94422001|NCT01791153|323332698|FG002|Part 1: Blinded Period|Protocol Violation|0|||
94422002|NCT01791153|323332699|FG003|Part 1: Blinded Period|Protocol Violation|1|||
94422003|NCT01791153|323332700|FG004|Part 1: Blinded Period|Protocol Violation|0|||
94422004|NCT01791153|323332701|FG005|Part 1: Blinded Period|Protocol Violation|0|||
94422005|NCT01791153|323332702|FG006|Part 1: Blinded Period|Protocol Violation|0|||
94422006|NCT01791153|323332703|FG007|Part 1: Blinded Period|Protocol Violation|0|||
94422007|NCT01791153|323332696|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
94422008|NCT01791153|323332697|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
94422009|NCT01791153|323332698|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
94422010|NCT01791153|323332699|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
94422011|NCT01791153|323332700|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
94422012|NCT01791153|323332701|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
94422013|NCT01791153|323332702|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
94422014|NCT01791153|323332703|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
94422015|NCT01791153|323332696|FG000|Part 2: Open-label Period|Adverse Event|0|||
94422016|NCT01791153|323332697|FG001|Part 2: Open-label Period|Adverse Event|0|||
94422017|NCT01791153|323332698|FG002|Part 2: Open-label Period|Adverse Event|0|||
94422018|NCT01791153|323332699|FG003|Part 2: Open-label Period|Adverse Event|0|||
94422019|NCT01791153|323332700|FG004|Part 2: Open-label Period|Adverse Event|0|||
94422020|NCT01791153|323332701|FG005|Part 2: Open-label Period|Adverse Event|1|||
94422021|NCT01791153|323332702|FG006|Part 2: Open-label Period|Adverse Event|1|||
94422022|NCT01791153|323332703|FG007|Part 2: Open-label Period|Adverse Event|2|||
94422023|NCT01791153|323332696|FG000|Part 2: Open-label Period|Death|0|||
94422024|NCT01791153|323332697|FG001|Part 2: Open-label Period|Death|0|||
94422025|NCT01791153|323332698|FG002|Part 2: Open-label Period|Death|0|||
94422026|NCT01791153|323332699|FG003|Part 2: Open-label Period|Death|0|||
94422027|NCT01791153|323332700|FG004|Part 2: Open-label Period|Death|0|||
94422028|NCT01791153|323332701|FG005|Part 2: Open-label Period|Death|1|||
94422029|NCT01791153|323332702|FG006|Part 2: Open-label Period|Death|1|||
94422030|NCT01791153|323332703|FG007|Part 2: Open-label Period|Death|1|||
94422031|NCT01791153|323332696|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
94422032|NCT01791153|323332697|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
94422033|NCT01791153|323332698|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
94422034|NCT01791153|323332699|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
94422035|NCT01791153|323332700|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
94422036|NCT01791153|323332701|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
94422037|NCT01791153|323332702|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
94422038|NCT01791153|323332703|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
94422039|NCT01791153|323332696|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
94422040|NCT01791153|323332697|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
94422041|NCT01791153|323332698|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
94422042|NCT01791153|323332699|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
94422043|NCT01791153|323332700|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
94422044|NCT01791153|323332701|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
94422045|NCT01791153|323332702|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
94422046|NCT01791153|323332703|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
94422047|NCT01791153|323332696|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
94422048|NCT01791153|323332697|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
94422049|NCT01791153|323332698|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
94422050|NCT01791153|323332699|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
94422051|NCT01791153|323332700|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
94422052|NCT01791153|323332701|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
94422053|NCT01791153|323332702|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
94422054|NCT01791153|323332703|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
94422055|NCT01791153|323332696|FG000|Part 2: Open-label Period|Physician Decision|0|||
94422056|NCT01791153|323332697|FG001|Part 2: Open-label Period|Physician Decision|0|||
94422057|NCT01791153|323332698|FG002|Part 2: Open-label Period|Physician Decision|0|||
94422058|NCT01791153|323332699|FG003|Part 2: Open-label Period|Physician Decision|0|||
94422059|NCT01791153|323332700|FG004|Part 2: Open-label Period|Physician Decision|1|||
94422060|NCT01791153|323332701|FG005|Part 2: Open-label Period|Physician Decision|1|||
94422061|NCT01791153|323332702|FG006|Part 2: Open-label Period|Physician Decision|0|||
94422062|NCT01791153|323332703|FG007|Part 2: Open-label Period|Physician Decision|0|||
94422063|NCT01083810|323332706|FG000|Overall Study|Lost to Follow-up|23|||
94422064|NCT01083810|323332707|FG001|Overall Study|Lost to Follow-up|11|||
94422065|NCT01083810|323332708|FG002|Overall Study|Lost to Follow-up|4|||
94422066|NCT01083810|323332706|FG000|Overall Study|Adverse Event|15|||
94422067|NCT01083810|323332707|FG001|Overall Study|Adverse Event|11|||
94422068|NCT01083810|323332708|FG002|Overall Study|Adverse Event|4|||
94422069|NCT01083810|323332706|FG000|Overall Study|Withdrawal by Subject|7|||
94422070|NCT01083810|323332707|FG001|Overall Study|Withdrawal by Subject|2|||
94422071|NCT01083810|323332708|FG002|Overall Study|Withdrawal by Subject|4|||
94422072|NCT01083810|323332706|FG000|Overall Study|Reason not reported|6|||
94422073|NCT01083810|323332707|FG001|Overall Study|Reason not reported|1|||
94422074|NCT01083810|323332708|FG002|Overall Study|Reason not reported|1|||
94422075|NCT01083810|323332706|FG000|Overall Study|Non-compliance|4|||
94422076|NCT01083810|323332707|FG001|Overall Study|Non-compliance|7|||
94422077|NCT01083810|323332708|FG002|Overall Study|Non-compliance|2|||
94422078|NCT01083810|323332706|FG000|Overall Study|Simplification|4|||
94422079|NCT01083810|323332707|FG001|Overall Study|Simplification|1|||
94489294|NCT00903968|323586026|FG007|Overall Study|Physician Decision|0|||
94422080|NCT01083810|323332708|FG002|Overall Study|Simplification|0|||
94422081|NCT01083810|323332706|FG000|Overall Study|Death|2|||
94422082|NCT01083810|323332707|FG001|Overall Study|Death|2|||
94422083|NCT01083810|323332708|FG002|Overall Study|Death|3|||
94422084|NCT01083810|323332706|FG000|Overall Study|Co-morbidities|1|||
94422085|NCT01083810|323332707|FG001|Overall Study|Co-morbidities|0|||
94422086|NCT01083810|323332708|FG002|Overall Study|Co-morbidities|0|||
94422087|NCT01083810|323332706|FG000|Overall Study|Participation in study|1|||
94422088|NCT01083810|323332707|FG001|Overall Study|Participation in study|0|||
94422089|NCT01083810|323332708|FG002|Overall Study|Participation in study|0|||
94422090|NCT01083810|323332706|FG000|Overall Study|Therapy break|1|||
94422091|NCT01083810|323332707|FG001|Overall Study|Therapy break|2|||
94422092|NCT01083810|323332708|FG002|Overall Study|Therapy break|2|||
94422093|NCT01083810|323332706|FG000|Overall Study|Virologic failure|1|||
94489295|NCT00903968|323586019|FG000|Overall Study|Progressive Disease|2|||
94422094|NCT01083810|323332707|FG001|Overall Study|Virologic failure|8|||
94422095|NCT01083810|323332708|FG002|Overall Study|Virologic failure|0|||
94422096|NCT00922987|323332709|FG000|Overall Study|Insufficient clinical response|1|||
94422097|NCT00922987|323332709|FG000|Overall Study|Protocol Violation|2|||
94422098|NCT00922987|323332709|FG000|Overall Study|Adverse Event|1|||
94422099|NCT01214915|323332710|FG000|Overall Study|Adverse Event|8|||
94422100|NCT01214915|323332710|FG000|Overall Study|Lack of Efficacy|3|||
94422101|NCT03753763|323332711|FG000|Overall Study|Adverse Event|2|||
94422102|NCT03753763|323332712|FG001|Overall Study|Adverse Event|0|||
94422103|NCT03753763|323332711|FG000|Overall Study|Withdrawal by Subject|3|||
94422104|NCT03753763|323332712|FG001|Overall Study|Withdrawal by Subject|1|||
94422105|NCT03753763|323332711|FG000|Overall Study|clinical deterioration|1|||
94422106|NCT03753763|323332712|FG001|Overall Study|clinical deterioration|0|||
94422107|NCT00871741|323332717|FG000|Overall Study|Premature study termination|9|||
94422108|NCT00871741|323332718|FG001|Overall Study|Premature study termination|7|||
94422109|NCT00704730|323332719|FG000|Overall Study|Adverse Event|35|||
94422110|NCT00704730|323332720|FG001|Overall Study|Adverse Event|9|||
94422111|NCT00704730|323332719|FG000|Overall Study|Death|11|||
94422112|NCT00704730|323332720|FG001|Overall Study|Death|5|||
94422113|NCT00704730|323332719|FG000|Overall Study|Physician Decision|2|||
94422114|NCT00704730|323332720|FG001|Overall Study|Physician Decision|0|||
94422115|NCT00704730|323332719|FG000|Overall Study|Did not receive drug|5|||
94422116|NCT00704730|323332720|FG001|Overall Study|Did not receive drug|2|||
94422117|NCT00704730|323332719|FG000|Overall Study|Disease progression per PI|58|||
94422118|NCT00704730|323332720|FG001|Overall Study|Disease progression per PI|67|||
94422119|NCT00704730|323332719|FG000|Overall Study|data unavailable|1|||
94422120|NCT00704730|323332720|FG001|Overall Study|data unavailable|0|||
94422121|NCT00704730|323332719|FG000|Overall Study|Withdrawal by Subject|9|||
94422122|NCT00704730|323332720|FG001|Overall Study|Withdrawal by Subject|13|||
94422123|NCT02551666|323332721|FG000|Overall Study|Withdrawal by Subject|1|||
94422124|NCT02551666|323332722|FG001|Overall Study|Withdrawal by Subject|3|||
94422125|NCT03295318|323335253|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
94422126|NCT03295318|323335254|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
94422127|NCT03295318|323335255|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
94422128|NCT03295318|323335253|FG000|Overall Study|Death|1|||
94422129|NCT03295318|323335254|FG001|Overall Study|Death|1|||
94422130|NCT03295318|323335255|FG002|Overall Study|Death|1|||
94422131|NCT03295318|323335253|FG000|Overall Study|Protocol Violation|4|||
94422132|NCT03295318|323335254|FG001|Overall Study|Protocol Violation|3|||
94422133|NCT03295318|323335255|FG002|Overall Study|Protocol Violation|3|||
94422134|NCT03295318|323335253|FG000|Overall Study|Withdrawal by Subject|0|||
94422135|NCT03295318|323335254|FG001|Overall Study|Withdrawal by Subject|0|||
94422136|NCT03295318|323335255|FG002|Overall Study|Withdrawal by Subject|1|||
94422137|NCT03295318|323335253|FG000|Overall Study|Subject discontinued due to travel|0|||
94422138|NCT03295318|323335254|FG001|Overall Study|Subject discontinued due to travel|1|||
94422139|NCT03295318|323335255|FG002|Overall Study|Subject discontinued due to travel|0|||
94422140|NCT02856880|323335256|FG000|Overall Study|Withdrawal of consent|1|||
94422141|NCT03265288|323335259|FG000|Overall Study|Adverse Event|0|||
94422142|NCT03265288|323335260|FG001|Overall Study|Adverse Event|1|||
94422143|NCT03265288|323335259|FG000|Overall Study|Withdrawal by Subject|13|||
94422144|NCT03265288|323335260|FG001|Overall Study|Withdrawal by Subject|5|||
94422145|NCT03265288|323335259|FG000|Overall Study|Drug Withdrawn|3|||
94422146|NCT03265288|323335260|FG001|Overall Study|Drug Withdrawn|3|||
94422147|NCT03265288|323335259|FG000|Overall Study|Any Other Reason|7|||
94422148|NCT03265288|323335260|FG001|Overall Study|Any Other Reason|3|||
94422149|NCT02031458|323335262|FG000|May 8, 2015 to January 11, 2019|Death|89|||
94422150|NCT02031458|323335263|FG001|May 8, 2015 to January 11, 2019|Death|193|||
94422151|NCT02031458|323335264|FG002|May 8, 2015 to January 11, 2019|Death|198|||
94422152|NCT02031458|323335262|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
94422153|NCT02031458|323335263|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
94422154|NCT02031458|323335264|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
94422155|NCT02031458|323335262|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
94422156|NCT02031458|323335263|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
94422157|NCT02031458|323335264|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
94422158|NCT02031458|323335262|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
94422159|NCT02031458|323335263|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
94422160|NCT02031458|323335264|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
94422161|NCT02031458|323335262|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
94422162|NCT02031458|323335263|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
94422163|NCT02031458|323335264|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
94422164|NCT02031458|323335262|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
94422165|NCT02031458|323335263|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
94422166|NCT02031458|323335264|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
94422167|NCT02031458|323335262|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
94422168|NCT02031458|323335263|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
94422169|NCT02031458|323335264|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
94422170|NCT02031458|323335262|FG000|Baseline to May 8, 2015|Death|36|||
94422171|NCT02031458|323335263|FG001|Baseline to May 8, 2015|Death|87|||
94422172|NCT02031458|323335264|FG002|Baseline to May 8, 2015|Death|100|||
94422173|NCT02031458|323335262|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
94422174|NCT02031458|323335263|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
94422175|NCT02031458|323335264|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
94422176|NCT02031458|323335262|FG000|Baseline to May 8, 2015|Physician Decision|0|||
94422177|NCT02031458|323335263|FG001|Baseline to May 8, 2015|Physician Decision|1|||
94422178|NCT02031458|323335264|FG002|Baseline to May 8, 2015|Physician Decision|0|||
94422179|NCT02031458|323335262|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
94422180|NCT02031458|323335263|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
94422181|NCT02031458|323335264|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
94422182|NCT02031458|323335262|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
94422183|NCT02031458|323335263|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
94422184|NCT02031458|323335264|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
94422185|NCT02031458|323335262|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
94422186|NCT02031458|323335263|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
94422187|NCT02031458|323335264|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
94422188|NCT02031458|323335262|FG000|Baseline to May 8, 2015|On Treatment|43|||
94422189|NCT02031458|323335263|FG001|Baseline to May 8, 2015|On Treatment|81|||
94422190|NCT02031458|323335264|FG002|Baseline to May 8, 2015|On Treatment|73|||
94422191|NCT02031458|323335262|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
94422192|NCT02031458|323335263|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
94422193|NCT02031458|323335264|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
94422194|NCT01167257|323335265|FG000|Overall Study|Lost to Follow-up|2|||
94422195|NCT01167257|323335266|FG001|Overall Study|Lost to Follow-up|2|||
94422196|NCT01167257|323335265|FG000|Overall Study|Withdrew consent|1|||
94422197|NCT01167257|323335266|FG001|Overall Study|Withdrew consent|1|||
94422198|NCT00824616|323335267|FG000|Overall Study|Adverse Event|2|||
94422199|NCT00824616|323335268|FG001|Overall Study|Adverse Event|1|||
94422200|NCT00824616|323335267|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
94422201|NCT00824616|323335268|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
94422202|NCT00824616|323335267|FG000|Overall Study|Hyperglycemia|1|||
94422203|NCT00824616|323335268|FG001|Overall Study|Hyperglycemia|1|||
94422204|NCT00824616|323335267|FG000|Overall Study|Lack of Efficacy|2|||
94422205|NCT00824616|323335268|FG001|Overall Study|Lack of Efficacy|1|||
94422206|NCT00824616|323335267|FG000|Overall Study|Lost to Follow-up|0|||
94422207|NCT00824616|323335268|FG001|Overall Study|Lost to Follow-up|1|||
94422208|NCT00824616|323335267|FG000|Overall Study|Withdrawal by Subject|1|||
94422209|NCT00824616|323335268|FG001|Overall Study|Withdrawal by Subject|1|||
94422210|NCT01206101|323335271|FG000|Overall Study|Adverse Event|1|||
94422211|NCT01206101|323335272|FG001|Overall Study|Adverse Event|0|||
94422212|NCT01206101|323335271|FG000|Overall Study|Physician Decision|0|||
94422213|NCT01206101|323335272|FG001|Overall Study|Physician Decision|1|||
94422214|NCT01206101|323335271|FG000|Overall Study|Unclassified|1|||
94422215|NCT01206101|323335272|FG001|Overall Study|Unclassified|0|||
94422216|NCT01248013|323335275|FG000|Overall Study|Withdrawal by Subject|14|||
94422217|NCT01859130|323335276|FG000|Overall Study|Death|4|||
94422218|NCT01859130|323335276|FG000|Overall Study|Lost to Follow-up|16|||
94422219|NCT01859130|323335276|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
94422220|NCT01859130|323335276|FG000|Overall Study|Physician Decision|6|||
94422221|NCT01859130|323335276|FG000|Overall Study|Withdrawal by Subject|17|||
94422222|NCT01859130|323335276|FG000|Overall Study|Adverse Event|11|||
94422223|NCT04711902|323335278|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
94422224|NCT04711902|323335279|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
94422225|NCT04711902|323335280|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
94422226|NCT04711902|323335281|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
94422227|NCT04711902|323335282|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
94422228|NCT04711902|323335283|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
94422229|NCT00891371|323335287|FG000|Pre-assignment|Inclusion/exclusion|5|||
94422230|NCT00891371|323335287|FG000|Pre-assignment|Consent withdrawal|1|||
94422231|NCT00891371|323335287|FG000|Treatment|Lack of Efficacy|5|||
94422232|NCT00891371|323335287|FG000|Treatment|Adverse Event|2|||
94422233|NCT00891371|323335287|FG000|Treatment|Death|1|||
94422234|NCT00891371|323335287|FG000|Treatment|Lost to Follow-up|1|||
94422235|NCT04442490|323335292|FG000|Overall Study|Withdrawal by Subject|18|||
94422236|NCT04442490|323335293|FG001|Overall Study|Withdrawal by Subject|10|||
94422237|NCT04442490|323335292|FG000|Overall Study|Lost to Follow-up|7|||
94422238|NCT04442490|323335293|FG001|Overall Study|Lost to Follow-up|7|||
94422239|NCT04442490|323335292|FG000|Overall Study|Adverse Event|2|||
94422240|NCT04442490|323335293|FG001|Overall Study|Adverse Event|6|||
94422241|NCT04442490|323335292|FG000|Overall Study|Noncompliance|3|||
94422242|NCT04442490|323335293|FG001|Overall Study|Noncompliance|1|||
94422243|NCT04442490|323335292|FG000|Overall Study|Physician Decision|2|||
94422244|NCT04442490|323335293|FG001|Overall Study|Physician Decision|1|||
94422245|NCT04442490|323335292|FG000|Overall Study|Reason not Specified|2|||
94422246|NCT04442490|323335293|FG001|Overall Study|Reason not Specified|1|||
94422247|NCT04442490|323335292|FG000|Overall Study|Randomized but not Treated|3|||
94422248|NCT04442490|323335293|FG001|Overall Study|Randomized but not Treated|3|||
94422249|NCT01449279|323335294|FG000|Overall Study|Lack of Efficacy|5|||
94422250|NCT01449279|323335294|FG000|Overall Study|Toxicity|2|||
94422251|NCT01345175|323335295|FG000|Overall Study|Physician Decision|0|||
94422252|NCT01345175|323335296|FG001|Overall Study|Physician Decision|1|||
94422253|NCT01345175|323335295|FG000|Overall Study|Withdrawal by Subject|1|||
94422254|NCT01345175|323335296|FG001|Overall Study|Withdrawal by Subject|1|||
94422255|NCT01345175|323335295|FG000|Overall Study|Failed to complete BFI|3|||
94422256|NCT01345175|323335296|FG001|Overall Study|Failed to complete BFI|2|||
94422257|NCT01345175|323335295|FG000|Overall Study|Stopped taking medication|2|||
94422258|NCT01345175|323335296|FG001|Overall Study|Stopped taking medication|2|||
94422259|NCT00505375|323335297|FG000|Overall Study|Death|1|||
94422260|NCT00505375|323335298|FG001|Overall Study|Death|0|||
94422261|NCT00505375|323335297|FG000|Overall Study|Withdrawal by Subject|2|||
94422262|NCT00505375|323335298|FG001|Overall Study|Withdrawal by Subject|2|||
94422263|NCT00505375|323335297|FG000|Overall Study|Lost to Follow-up|0|||
94422264|NCT00505375|323335298|FG001|Overall Study|Lost to Follow-up|2|||
94422265|NCT00505375|323335297|FG000|Overall Study|Pregnancy|1|||
94422266|NCT00505375|323335298|FG001|Overall Study|Pregnancy|0|||
94422267|NCT00505375|323335297|FG000|Overall Study|Travel issues|0|||
94422268|NCT00505375|323335298|FG001|Overall Study|Travel issues|1|||
94422269|NCT01561430|323335304|FG000|Overall Study|Adverse Event|0|||
94422270|NCT01561430|323335305|FG001|Overall Study|Adverse Event|0|||
94422271|NCT01561430|323335306|FG002|Overall Study|Adverse Event|3|||
94422272|NCT01561430|323335307|FG003|Overall Study|Adverse Event|1|||
94422273|NCT01561430|323335304|FG000|Overall Study|Withdrawal by Subject|0|||
94422274|NCT01561430|323335305|FG001|Overall Study|Withdrawal by Subject|0|||
94422275|NCT01561430|323335306|FG002|Overall Study|Withdrawal by Subject|1|||
94422276|NCT01561430|323335307|FG003|Overall Study|Withdrawal by Subject|0|||
94422277|NCT01561430|323335304|FG000|Overall Study|Physician Decision|0|||
94422278|NCT01561430|323335305|FG001|Overall Study|Physician Decision|1|||
94422279|NCT01561430|323335306|FG002|Overall Study|Physician Decision|0|||
94422280|NCT01561430|323335307|FG003|Overall Study|Physician Decision|0|||
94422281|NCT01561430|323335304|FG000|Overall Study|Sponsor Decision|1|||
94422282|NCT01561430|323335305|FG001|Overall Study|Sponsor Decision|14|||
94422283|NCT01561430|323335306|FG002|Overall Study|Sponsor Decision|13|||
94422284|NCT01561430|323335307|FG003|Overall Study|Sponsor Decision|12|||
94422285|NCT04112173|323335308|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
94422286|NCT02038907|323335309|FG000|Overall Study|Protocol Violation|0|||
94422287|NCT02038907|323335310|FG001|Overall Study|Protocol Violation|0|||
94422288|NCT02038907|323335311|FG002|Overall Study|Protocol Violation|0|||
94422289|NCT02038907|323335312|FG003|Overall Study|Protocol Violation|0|||
94422290|NCT02038907|323335313|FG004|Overall Study|Protocol Violation|0|||
94422291|NCT02038907|323335314|FG005|Overall Study|Protocol Violation|0|||
94422292|NCT02038907|323335315|FG006|Overall Study|Protocol Violation|0|||
94422293|NCT02038907|323335316|FG007|Overall Study|Protocol Violation|0|||
94422294|NCT02038907|323335317|FG008|Overall Study|Protocol Violation|0|||
94422295|NCT02038907|323335318|FG009|Overall Study|Protocol Violation|0|||
94422296|NCT02038907|323335319|FG010|Overall Study|Protocol Violation|1|||
94422297|NCT02038907|323335320|FG011|Overall Study|Protocol Violation|0|||
94422298|NCT02038907|323335321|FG012|Overall Study|Protocol Violation|0|||
94422299|NCT02038907|323335322|FG013|Overall Study|Protocol Violation|0|||
94422300|NCT02038907|323335309|FG000|Overall Study|Withdrawal by Subject|0|||
94422301|NCT02038907|323335310|FG001|Overall Study|Withdrawal by Subject|0|||
94422302|NCT02038907|323335311|FG002|Overall Study|Withdrawal by Subject|0|||
94422303|NCT02038907|323335312|FG003|Overall Study|Withdrawal by Subject|0|||
94422304|NCT02038907|323335313|FG004|Overall Study|Withdrawal by Subject|0|||
94422305|NCT02038907|323335314|FG005|Overall Study|Withdrawal by Subject|0|||
94422306|NCT02038907|323335315|FG006|Overall Study|Withdrawal by Subject|0|||
94422307|NCT02038907|323335316|FG007|Overall Study|Withdrawal by Subject|0|||
94422308|NCT02038907|323335317|FG008|Overall Study|Withdrawal by Subject|0|||
94422309|NCT02038907|323335318|FG009|Overall Study|Withdrawal by Subject|0|||
94422310|NCT02038907|323335319|FG010|Overall Study|Withdrawal by Subject|1|||
94422311|NCT02038907|323335320|FG011|Overall Study|Withdrawal by Subject|0|||
94422312|NCT02038907|323335321|FG012|Overall Study|Withdrawal by Subject|0|||
94422313|NCT02038907|323335322|FG013|Overall Study|Withdrawal by Subject|0|||
94422314|NCT00688376|323335323|FG000|Double-Blind Phase|Adverse Event|4|||
94422315|NCT00688376|323335324|FG001|Double-Blind Phase|Adverse Event|4|||
94422316|NCT00688376|323335323|FG000|Double-Blind Phase|Protocol Violation|1|||
94422317|NCT00688376|323335324|FG001|Double-Blind Phase|Protocol Violation|2|||
94422318|NCT00688376|323335323|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
94422319|NCT00688376|323335324|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
94422320|NCT00688376|323335323|FG000|Double-Blind Phase|Not treated|0|||
94422321|NCT00688376|323335324|FG001|Double-Blind Phase|Not treated|1|||
94422322|NCT00688376|323335323|FG000|Blinded Extension Phase|Adverse Event|3|||
94422323|NCT00688376|323335324|FG001|Blinded Extension Phase|Adverse Event|4|||
94422324|NCT00688376|323335323|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
94422325|NCT00688376|323335324|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
94422326|NCT00688376|323335323|FG000|Blinded Extension Phase|Physician Decision|1|||
94422327|NCT00688376|323335324|FG001|Blinded Extension Phase|Physician Decision|0|||
94422328|NCT00688376|323335323|FG000|Blinded Extension Phase|Other|1|||
94422329|NCT00688376|323335324|FG001|Blinded Extension Phase|Other|0|||
94422330|NCT01908816|323335327|FG000|Overall Study|Subject's no longer requires study drug|0|||
94422331|NCT01908816|323335328|FG001|Overall Study|Subject's no longer requires study drug|0|||
94422332|NCT01908816|323335329|FG002|Overall Study|Subject's no longer requires study drug|0|||
94422333|NCT01908816|323335330|FG003|Overall Study|Subject's no longer requires study drug|1|||
94422334|NCT01908816|323335327|FG000|Overall Study|Protocol deviation|1|||
94422335|NCT01908816|323335328|FG001|Overall Study|Protocol deviation|2|||
94422336|NCT01908816|323335329|FG002|Overall Study|Protocol deviation|1|||
94422337|NCT01908816|323335330|FG003|Overall Study|Protocol deviation|1|||
94422338|NCT01908816|323335327|FG000|Overall Study|Withdrawal by Subject|0|||
94422339|NCT01908816|323335328|FG001|Overall Study|Withdrawal by Subject|4|||
94422340|NCT01908816|323335329|FG002|Overall Study|Withdrawal by Subject|2|||
94422341|NCT01908816|323335330|FG003|Overall Study|Withdrawal by Subject|2|||
94422342|NCT01908816|323335327|FG000|Overall Study|Lost to Follow-up|3|||
94422343|NCT01908816|323335328|FG001|Overall Study|Lost to Follow-up|5|||
94422344|NCT01908816|323335329|FG002|Overall Study|Lost to Follow-up|4|||
94422345|NCT01908816|323335330|FG003|Overall Study|Lost to Follow-up|2|||
94422346|NCT01908816|323335327|FG000|Overall Study|Death|1|||
94422347|NCT01908816|323335328|FG001|Overall Study|Death|0|||
94422348|NCT01908816|323335329|FG002|Overall Study|Death|7|||
94422349|NCT01908816|323335330|FG003|Overall Study|Death|1|||
94422350|NCT01908816|323335327|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94422351|NCT01908816|323335328|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
94422352|NCT01908816|323335329|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
94422353|NCT01908816|323335330|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
94422354|NCT01908816|323335327|FG000|Overall Study|Early termination|87|||
94422355|NCT01908816|323335328|FG001|Overall Study|Early termination|60|||
94422356|NCT01908816|323335329|FG002|Overall Study|Early termination|43|||
94422357|NCT01908816|323335330|FG003|Overall Study|Early termination|28|||
94422358|NCT03201250|323335334|FG000|Overall Study|screen failures|3|||
94422359|NCT03201250|323335335|FG001|Overall Study|screen failures|0|||
94422360|NCT03201250|323335336|FG002|Overall Study|screen failures|0|||
94422361|NCT01383135|323335337|FG000|Overall Study|Not Scanned / Imaged|1|||
94422362|NCT01383135|323335338|FG001|Overall Study|Not Scanned / Imaged|0|||
94422363|NCT01383135|323335339|FG002|Overall Study|Not Scanned / Imaged|1|||
94422364|NCT01383135|323335340|FG003|Overall Study|Not Scanned / Imaged|0|||
94422365|NCT00003875|323335341|FG000|Overall Study|Screen Failed|1|||
94422366|NCT00969540|323335342|FG000|Overall Study|Lost to Follow-up|1|||
94422367|NCT00969540|323335343|FG001|Overall Study|Lost to Follow-up|1|||
94422368|NCT01646138|323335344|FG000|Overall Study|Lost to Follow-up|0|||
94422369|NCT01646138|323335345|FG001|Overall Study|Lost to Follow-up|0|||
94422370|NCT01646138|323335346|FG002|Overall Study|Lost to Follow-up|0|||
94422371|NCT01646138|323335347|FG003|Overall Study|Lost to Follow-up|0|||
94422372|NCT01646138|323335348|FG004|Overall Study|Lost to Follow-up|2|||
94422373|NCT04049617|323335349|FG000|Overall Study|Adverse Event|0|||
94422374|NCT04049617|323335350|FG001|Overall Study|Adverse Event|0|||
94422375|NCT04049617|323335351|FG002|Overall Study|Adverse Event|0|||
94422376|NCT04049617|323335352|FG003|Overall Study|Adverse Event|1|||
94422377|NCT04049617|323335353|FG004|Overall Study|Adverse Event|0|||
94422378|NCT04049617|323335354|FG005|Overall Study|Adverse Event|0|||
94422379|NCT04049617|323335349|FG000|Overall Study|Death|0|||
94422380|NCT04049617|323335350|FG001|Overall Study|Death|0|||
94422381|NCT04049617|323335351|FG002|Overall Study|Death|0|||
94422382|NCT04049617|323335352|FG003|Overall Study|Death|0|||
94422383|NCT04049617|323335353|FG004|Overall Study|Death|0|||
94422384|NCT04049617|323335354|FG005|Overall Study|Death|1|||
94422385|NCT04049617|323335349|FG000|Overall Study|Lost to Follow-up|0|||
94422386|NCT04049617|323335350|FG001|Overall Study|Lost to Follow-up|0|||
94422387|NCT04049617|323335351|FG002|Overall Study|Lost to Follow-up|0|||
94422388|NCT04049617|323335352|FG003|Overall Study|Lost to Follow-up|1|||
94422389|NCT04049617|323335353|FG004|Overall Study|Lost to Follow-up|0|||
94422390|NCT04049617|323335354|FG005|Overall Study|Lost to Follow-up|0|||
94422391|NCT04049617|323335349|FG000|Overall Study|Withdrew consent|0|||
94422392|NCT04049617|323335350|FG001|Overall Study|Withdrew consent|0|||
94422393|NCT04049617|323335351|FG002|Overall Study|Withdrew consent|1|||
94422394|NCT04049617|323335352|FG003|Overall Study|Withdrew consent|0|||
94422395|NCT04049617|323335353|FG004|Overall Study|Withdrew consent|0|||
94422396|NCT04049617|323335354|FG005|Overall Study|Withdrew consent|0|||
94422397|NCT03551496|323335355|FG000|Overall Study|Death|11|||
94422398|NCT03551496|323335356|FG001|Overall Study|Death|7|||
94422399|NCT03551496|323335355|FG000|Overall Study|Withdrawal by Subject|4|||
94422400|NCT03551496|323335356|FG001|Overall Study|Withdrawal by Subject|3|||
94422401|NCT03551496|323335355|FG000|Overall Study|Other Reasons|1|||
94422402|NCT03551496|323335356|FG001|Overall Study|Other Reasons|0|||
94422403|NCT01524679|323335357|FG000|Overall Study|Lost to Follow-up|1|||
94422404|NCT01524679|323335358|FG001|Overall Study|Lost to Follow-up|4|||
94422405|NCT01524679|323335357|FG000|Overall Study|Withdrawal by Subject|4|||
94422406|NCT01524679|323335358|FG001|Overall Study|Withdrawal by Subject|4|||
94422407|NCT01524679|323335357|FG000|Overall Study|Adverse Event|9|||
94422408|NCT01524679|323335358|FG001|Overall Study|Adverse Event|0|||
94422409|NCT01524679|323335357|FG000|Overall Study|Protocol Violation|1|||
94422410|NCT01524679|323335358|FG001|Overall Study|Protocol Violation|0|||
94422411|NCT01524679|323335357|FG000|Overall Study|Lack of Efficacy|2|||
94422412|NCT01524679|323335358|FG001|Overall Study|Lack of Efficacy|0|||
94422413|NCT01524679|323335357|FG000|Overall Study|e.g.wish for children, relocation|6|||
94422414|NCT01524679|323335358|FG001|Overall Study|e.g.wish for children, relocation|1|||
94422415|NCT01154816|323335359|FG000|Overall Study|Withdrawal by Subject|1|||
94422416|NCT01154816|323335360|FG001|Overall Study|Withdrawal by Subject|0|||
94422417|NCT01154816|323335361|FG002|Overall Study|Withdrawal by Subject|0|||
94422418|NCT01154816|323335362|FG003|Overall Study|Withdrawal by Subject|1|||
94422419|NCT01154816|323335363|FG004|Overall Study|Withdrawal by Subject|0|||
94422420|NCT01154816|323335364|FG005|Overall Study|Withdrawal by Subject|0|||
94422421|NCT01154816|323335365|FG006|Overall Study|Withdrawal by Subject|0|||
94422422|NCT01154816|323335366|FG007|Overall Study|Withdrawal by Subject|0|||
94422423|NCT01154816|323335367|FG008|Overall Study|Withdrawal by Subject|1|||
94422424|NCT01154816|323335368|FG009|Overall Study|Withdrawal by Subject|3|||
94422425|NCT01154816|323335369|FG010|Overall Study|Withdrawal by Subject|0|||
94422426|NCT01154816|323335370|FG011|Overall Study|Withdrawal by Subject|0|||
94422427|NCT01154816|323335359|FG000|Overall Study|Progressive Disease|13|||
94422428|NCT01154816|323335360|FG001|Overall Study|Progressive Disease|8|||
94422429|NCT01154816|323335361|FG002|Overall Study|Progressive Disease|9|||
94422430|NCT01154816|323335362|FG003|Overall Study|Progressive Disease|9|||
94422431|NCT01154816|323335363|FG004|Overall Study|Progressive Disease|8|||
94422432|NCT01154816|323335364|FG005|Overall Study|Progressive Disease|8|||
94422433|NCT01154816|323335365|FG006|Overall Study|Progressive Disease|5|||
94422434|NCT01154816|323335366|FG007|Overall Study|Progressive Disease|6|||
94422435|NCT01154816|323335367|FG008|Overall Study|Progressive Disease|8|||
94422436|NCT01154816|323335368|FG009|Overall Study|Progressive Disease|6|||
94422437|NCT01154816|323335369|FG010|Overall Study|Progressive Disease|10|||
94422438|NCT01154816|323335370|FG011|Overall Study|Progressive Disease|3|||
94422439|NCT01154816|323335359|FG000|Overall Study|Physician Decision|1|||
94422440|NCT01154816|323335360|FG001|Overall Study|Physician Decision|0|||
94422441|NCT01154816|323335361|FG002|Overall Study|Physician Decision|1|||
94422442|NCT01154816|323335362|FG003|Overall Study|Physician Decision|0|||
94422443|NCT01154816|323335363|FG004|Overall Study|Physician Decision|2|||
94422444|NCT01154816|323335364|FG005|Overall Study|Physician Decision|0|||
94422445|NCT01154816|323335365|FG006|Overall Study|Physician Decision|0|||
94422446|NCT01154816|323335366|FG007|Overall Study|Physician Decision|0|||
94422447|NCT01154816|323335367|FG008|Overall Study|Physician Decision|0|||
94422448|NCT01154816|323335368|FG009|Overall Study|Physician Decision|1|||
94422449|NCT01154816|323335369|FG010|Overall Study|Physician Decision|1|||
94422450|NCT01154816|323335370|FG011|Overall Study|Physician Decision|1|||
94422451|NCT01154816|323335359|FG000|Overall Study|Adverse Event|5|||
94422452|NCT01154816|323335360|FG001|Overall Study|Adverse Event|2|||
94422453|NCT01154816|323335361|FG002|Overall Study|Adverse Event|0|||
94422454|NCT01154816|323335362|FG003|Overall Study|Adverse Event|0|||
94422455|NCT01154816|323335363|FG004|Overall Study|Adverse Event|0|||
94422456|NCT01154816|323335364|FG005|Overall Study|Adverse Event|0|||
94422457|NCT01154816|323335365|FG006|Overall Study|Adverse Event|1|||
94422458|NCT01154816|323335366|FG007|Overall Study|Adverse Event|1|||
94422459|NCT01154816|323335367|FG008|Overall Study|Adverse Event|0|||
94422460|NCT01154816|323335368|FG009|Overall Study|Adverse Event|0|||
94422461|NCT01154816|323335369|FG010|Overall Study|Adverse Event|0|||
94422462|NCT01154816|323335370|FG011|Overall Study|Adverse Event|0|||
94422463|NCT01780987|323335374|FG000|Overall Study|Adverse Event|0|||
94422464|NCT01780987|323335375|FG001|Overall Study|Adverse Event|4|||
94422465|NCT01780987|323335374|FG000|Overall Study|Withdrawal by Subject|2|||
94422466|NCT01780987|323335375|FG001|Overall Study|Withdrawal by Subject|0|||
94422467|NCT01780987|323335374|FG000|Overall Study|Request of Changing Hospital|0|||
94422468|NCT01780987|323335375|FG001|Overall Study|Request of Changing Hospital|1|||
94422469|NCT01780987|323335374|FG000|Overall Study|Changing Residence|1|||
94422470|NCT01780987|323335375|FG001|Overall Study|Changing Residence|0|||
94422471|NCT01780987|323335374|FG000|Overall Study|Not Receiving any Study Medication|0|||
94422472|NCT01780987|323335375|FG001|Overall Study|Not Receiving any Study Medication|1|||
94422473|NCT04078126|323335376|FG000|Washout|Study put on hold due to COVID-19|0|||
94422474|NCT04078126|323335377|FG001|Washout|Study put on hold due to COVID-19|2|||
94422475|NCT04078126|323335376|FG000|Period 2|Study put on hold due to COVID-19|1|||
94422476|NCT04078126|323335377|FG001|Period 2|Study put on hold due to COVID-19|1|||
94422477|NCT03321630|323335378|FG000|Overall Study|Adverse Event|1|||
94422478|NCT03321630|323335378|FG000|Overall Study|Investigator Discretion|2|||
94422479|NCT03321630|323335378|FG000|Overall Study|Withdrawal by Subject|1|||
94422480|NCT02669758|323335379|FG000|Overall Study|Withdrawal by Subject|43|||
94422481|NCT02669758|323335379|FG000|Overall Study|Lost to Follow-up|19|||
94422482|NCT02669758|323335379|FG000|Overall Study|Adverse Event|16|||
94422483|NCT02669758|323335379|FG000|Overall Study|Non-Compliance with Study Drug|8|||
94422484|NCT02669758|323335379|FG000|Overall Study|Lack of Efficacy|5|||
94422485|NCT02669758|323335379|FG000|Overall Study|Pregnancy|1|||
94422486|NCT02669758|323335379|FG000|Overall Study|Study noncompliance|1|||
94422487|NCT02669758|323335379|FG000|Overall Study|Protocol Violation|1|||
94422488|NCT00806286|323335380|FG000|Overall Study|Adverse Event|5|||
94422489|NCT00806286|323335381|FG001|Overall Study|Adverse Event|2|||
94422490|NCT00806286|323335382|FG002|Overall Study|Adverse Event|0|||
94422491|NCT00806286|323335380|FG000|Overall Study|Disease progression|31|||
94422492|NCT00806286|323335381|FG001|Overall Study|Disease progression|38|||
94489296|NCT00903968|323586020|FG001|Overall Study|Progressive Disease|3|||
94489297|NCT00903968|323586021|FG002|Overall Study|Progressive Disease|2|||
94422493|NCT00806286|323335382|FG002|Overall Study|Disease progression|1|||
94422494|NCT00806286|323335380|FG000|Overall Study|Death|1|||
94422495|NCT00806286|323335381|FG001|Overall Study|Death|6|||
94422496|NCT00806286|323335382|FG002|Overall Study|Death|0|||
94422497|NCT00806286|323335380|FG000|Overall Study|Lost to Follow-up|0|||
94422498|NCT00806286|323335381|FG001|Overall Study|Lost to Follow-up|1|||
94422499|NCT00806286|323335382|FG002|Overall Study|Lost to Follow-up|0|||
94422500|NCT00806286|323335380|FG000|Overall Study|Withdrawal by Subject|8|||
94422501|NCT00806286|323335381|FG001|Overall Study|Withdrawal by Subject|3|||
94422502|NCT00806286|323335382|FG002|Overall Study|Withdrawal by Subject|1|||
94422503|NCT00806286|323335380|FG000|Overall Study|Physician Decision|2|||
94422504|NCT00806286|323335381|FG001|Overall Study|Physician Decision|2|||
94422505|NCT00806286|323335382|FG002|Overall Study|Physician Decision|0|||
94422506|NCT00806286|323335380|FG000|Overall Study|Due to a variety of reasons|7|||
94422507|NCT00806286|323335381|FG001|Overall Study|Due to a variety of reasons|2|||
94422508|NCT00806286|323335382|FG002|Overall Study|Due to a variety of reasons|1|||
94422509|NCT02303041|323335383|FG000|Overall Study|Adverse Event|1|||
94422510|NCT02303041|323335384|FG001|Overall Study|Adverse Event|2|||
94422511|NCT02455050|323335385|FG000|Treatment Period 1|Lost to Follow-up|1|||
94422512|NCT02455050|323335386|FG001|Treatment Period 1|Lost to Follow-up|1|||
94422513|NCT02455050|323335387|FG002|Treatment Period 1|Lost to Follow-up|1|||
94422514|NCT02455050|323335388|FG003|Treatment Period 1|Lost to Follow-up|2|||
94422515|NCT02455050|323335385|FG000|Treatment Period 2|Lost to Follow-up|1|||
94422516|NCT02455050|323335386|FG001|Treatment Period 2|Lost to Follow-up|0|||
94422517|NCT02455050|323335387|FG002|Treatment Period 2|Lost to Follow-up|2|||
94422518|NCT02455050|323335388|FG003|Treatment Period 2|Lost to Follow-up|1|||
94422519|NCT04168190|323335389|FG000|Overall Study|Lost to Follow-up|0|||
94422520|NCT04168190|323335390|FG001|Overall Study|Lost to Follow-up|1|||
94422521|NCT04168190|323335391|FG002|Overall Study|Lost to Follow-up|0|||
94422522|NCT04168190|323335392|FG003|Overall Study|Lost to Follow-up|7|||
94422523|NCT04168190|323335393|FG004|Overall Study|Lost to Follow-up|5|||
94422524|NCT04168190|323335389|FG000|Overall Study|Withdrawal by Subject|1|||
94422525|NCT04168190|323335390|FG001|Overall Study|Withdrawal by Subject|0|||
94422526|NCT04168190|323335391|FG002|Overall Study|Withdrawal by Subject|0|||
94422527|NCT04168190|323335392|FG003|Overall Study|Withdrawal by Subject|2|||
94422528|NCT04168190|323335393|FG004|Overall Study|Withdrawal by Subject|4|||
94422529|NCT04168190|323335389|FG000|Overall Study|Death|0|||
94422530|NCT04168190|323335390|FG001|Overall Study|Death|0|||
94422531|NCT04168190|323335391|FG002|Overall Study|Death|0|||
94422532|NCT04168190|323335392|FG003|Overall Study|Death|1|||
94422533|NCT04168190|323335393|FG004|Overall Study|Death|0|||
94422534|NCT04645966|323335395|FG000|Vaccination Phase|Adverse Event|1|||
94422535|NCT04645966|323335396|FG001|Vaccination Phase|Adverse Event|0|||
94422536|NCT04645966|323335397|FG002|Vaccination Phase|Adverse Event|0|||
94422537|NCT04645966|323335398|FG003|Vaccination Phase|Adverse Event|0|||
94422538|NCT04645966|323335399|FG004|Vaccination Phase|Adverse Event|0|||
94422539|NCT04645966|323335400|FG005|Vaccination Phase|Adverse Event|0|||
94422540|NCT04645966|323335401|FG006|Vaccination Phase|Adverse Event|1|||
94422541|NCT04645966|323335402|FG007|Vaccination Phase|Adverse Event|0|||
94422542|NCT04645966|323335403|FG008|Vaccination Phase|Adverse Event|0|||
94422543|NCT04645966|323335395|FG000|Vaccination Phase|Death|0|||
94422544|NCT04645966|323335396|FG001|Vaccination Phase|Death|0|||
94422545|NCT04645966|323335397|FG002|Vaccination Phase|Death|0|||
94422546|NCT04645966|323335398|FG003|Vaccination Phase|Death|0|||
94422547|NCT04645966|323335399|FG004|Vaccination Phase|Death|0|||
94422548|NCT04645966|323335400|FG005|Vaccination Phase|Death|1|||
94422549|NCT04645966|323335401|FG006|Vaccination Phase|Death|0|||
94422550|NCT04645966|323335402|FG007|Vaccination Phase|Death|0|||
94422551|NCT04645966|323335403|FG008|Vaccination Phase|Death|0|||
94422552|NCT04645966|323335395|FG000|Vaccination Phase|Protocol Violation|0|||
94422553|NCT04645966|323335396|FG001|Vaccination Phase|Protocol Violation|0|||
94422554|NCT04645966|323335397|FG002|Vaccination Phase|Protocol Violation|0|||
94422555|NCT04645966|323335398|FG003|Vaccination Phase|Protocol Violation|0|||
94422556|NCT04645966|323335399|FG004|Vaccination Phase|Protocol Violation|1|||
94422557|NCT04645966|323335400|FG005|Vaccination Phase|Protocol Violation|0|||
94422558|NCT04645966|323335401|FG006|Vaccination Phase|Protocol Violation|0|||
94422559|NCT04645966|323335402|FG007|Vaccination Phase|Protocol Violation|0|||
94422560|NCT04645966|323335403|FG008|Vaccination Phase|Protocol Violation|0|||
94422561|NCT04645966|323335395|FG000|Vaccination Phase|Study terminated by sponsor|0|||
94422562|NCT04645966|323335396|FG001|Vaccination Phase|Study terminated by sponsor|0|||
94422563|NCT04645966|323335397|FG002|Vaccination Phase|Study terminated by sponsor|14|||
94422564|NCT04645966|323335398|FG003|Vaccination Phase|Study terminated by sponsor|15|||
94422565|NCT04645966|323335399|FG004|Vaccination Phase|Study terminated by sponsor|47|||
94422566|NCT04645966|323335400|FG005|Vaccination Phase|Study terminated by sponsor|43|||
94422567|NCT04645966|323335401|FG006|Vaccination Phase|Study terminated by sponsor|29|||
94422568|NCT04645966|323335402|FG007|Vaccination Phase|Study terminated by sponsor|29|||
94422569|NCT04645966|323335403|FG008|Vaccination Phase|Study terminated by sponsor|12|||
94422570|NCT04645966|323335395|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
94422571|NCT04645966|323335396|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
94422572|NCT04645966|323335397|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
94422573|NCT04645966|323335398|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
94422574|NCT04645966|323335399|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
94422575|NCT04645966|323335400|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
94422576|NCT04645966|323335401|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
94422577|NCT04645966|323335402|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
94422578|NCT04645966|323335403|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
94422579|NCT04645966|323335395|FG000|Vaccination Phase|Other|0|||
94422580|NCT04645966|323335396|FG001|Vaccination Phase|Other|0|||
94422581|NCT04645966|323335397|FG002|Vaccination Phase|Other|0|||
94422582|NCT04645966|323335398|FG003|Vaccination Phase|Other|0|||
94422583|NCT04645966|323335399|FG004|Vaccination Phase|Other|0|||
94422584|NCT04645966|323335400|FG005|Vaccination Phase|Other|2|||
94422585|NCT04645966|323335401|FG006|Vaccination Phase|Other|0|||
94422586|NCT04645966|323335402|FG007|Vaccination Phase|Other|0|||
94422587|NCT04645966|323335403|FG008|Vaccination Phase|Other|0|||
94422588|NCT04645966|323335395|FG000|Vaccination Phase|Lost to Follow-up|0|||
94422589|NCT04645966|323335396|FG001|Vaccination Phase|Lost to Follow-up|0|||
94422590|NCT04645966|323335397|FG002|Vaccination Phase|Lost to Follow-up|0|||
94422591|NCT04645966|323335398|FG003|Vaccination Phase|Lost to Follow-up|0|||
94422592|NCT04645966|323335399|FG004|Vaccination Phase|Lost to Follow-up|0|||
94422593|NCT04645966|323335400|FG005|Vaccination Phase|Lost to Follow-up|0|||
94422594|NCT04645966|323335401|FG006|Vaccination Phase|Lost to Follow-up|0|||
94422595|NCT04645966|323335402|FG007|Vaccination Phase|Lost to Follow-up|1|||
94422596|NCT04645966|323335403|FG008|Vaccination Phase|Lost to Follow-up|0|||
94422597|NCT04645966|323335395|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
94422598|NCT04645966|323335396|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
94422599|NCT04645966|323335397|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
94422600|NCT04645966|323335398|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
94422601|NCT04645966|323335399|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
94422602|NCT04645966|323335400|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
94422603|NCT04645966|323335401|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
94422604|NCT04645966|323335402|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
94422605|NCT04645966|323335403|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
94422606|NCT04645966|323335395|FG000|Follow-up Phase|Lost to Follow-up|0|||
94422607|NCT04645966|323335396|FG001|Follow-up Phase|Lost to Follow-up|0|||
94422608|NCT04645966|323335397|FG002|Follow-up Phase|Lost to Follow-up|0|||
94422609|NCT04645966|323335398|FG003|Follow-up Phase|Lost to Follow-up|0|||
94422610|NCT04645966|323335399|FG004|Follow-up Phase|Lost to Follow-up|0|||
94422611|NCT04645966|323335400|FG005|Follow-up Phase|Lost to Follow-up|0|||
94422612|NCT04645966|323335401|FG006|Follow-up Phase|Lost to Follow-up|0|||
94422613|NCT04645966|323335402|FG007|Follow-up Phase|Lost to Follow-up|1|||
94422614|NCT04645966|323335403|FG008|Follow-up Phase|Lost to Follow-up|0|||
94422615|NCT01460901|323335404|FG000|Overall Study|Withdrawal by Subject|2|||
94422616|NCT00643565|323335406|FG000|Overall Study|Death|12|||
94422617|NCT00643565|323335407|FG001|Overall Study|Death|11|||
94422618|NCT00643565|323335406|FG000|Overall Study|Withdrawal by Subject|4|||
94422619|NCT00643565|323335407|FG001|Overall Study|Withdrawal by Subject|1|||
94422620|NCT00643565|323335406|FG000|Overall Study|Lost to Follow-up|0|||
94422621|NCT00643565|323335407|FG001|Overall Study|Lost to Follow-up|6|||
94422622|NCT00643565|323335406|FG000|Overall Study|Other|7|||
94422623|NCT00643565|323335407|FG001|Overall Study|Other|8|||
94422624|NCT00643565|323335406|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
94422625|NCT00643565|323335407|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
94422626|NCT00643565|323335406|FG000|Overall Study|Recurrence of Disease|2|||
94422627|NCT00643565|323335407|FG001|Overall Study|Recurrence of Disease|1|||
94422628|NCT00643565|323335406|FG000|Overall Study|Progression of Disease|18|||
94422629|NCT00643565|323335407|FG001|Overall Study|Progression of Disease|14|||
94422630|NCT00643565|323335406|FG000|Overall Study|Protocol Violation|3|||
94422631|NCT00643565|323335407|FG001|Overall Study|Protocol Violation|0|||
94422632|NCT00643565|323335406|FG000|Overall Study|Did Not Cooperate|0|||
94422633|NCT00643565|323335407|FG001|Overall Study|Did Not Cooperate|1|||
94422634|NCT00643565|323335406|FG000|Overall Study|Administrative|22|||
94422635|NCT00643565|323335407|FG001|Overall Study|Administrative|16|||
94422636|NCT00643565|323335406|FG000|Overall Study|Adverse Event|5|||
94422637|NCT00643565|323335407|FG001|Overall Study|Adverse Event|8|||
94422638|NCT00855803|323335408|FG000|Overall Study|Death|2|||
94422639|NCT00855803|323335408|FG000|Overall Study|Lost to Follow-up|2|||
94422640|NCT00855803|323335408|FG000|Overall Study|Technical inability to undergo procedure|2|||
94422641|NCT00855803|323335408|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
94422642|NCT00855803|323335408|FG000|Overall Study|Withdrawal by Subject|3|||
94422643|NCT00855803|323335408|FG000|Overall Study|Physician Decision|3|||
94422644|NCT01661179|323335409|FG000|Overall Study|Death|1|||
94422645|NCT01661179|323335409|FG000|Overall Study|Withdrawal by Subject|1|||
94422646|NCT01661179|323335409|FG000|Overall Study|Other Eligibility criteria|4|||
94422647|NCT03118570|323335410|FG000|Overall Study|Adverse Event|2|||
94422648|NCT03118570|323335411|FG001|Overall Study|Adverse Event|0|||
94422649|NCT03118570|323335412|FG002|Overall Study|Adverse Event|0|||
94422650|NCT03118570|323335413|FG003|Overall Study|Adverse Event|0|||
94422651|NCT03118570|323335414|FG004|Overall Study|Adverse Event|3|||
94422652|NCT03118570|323335410|FG000|Overall Study|Withdrawal by Subject|0|||
94422653|NCT03118570|323335411|FG001|Overall Study|Withdrawal by Subject|1|||
94422654|NCT03118570|323335412|FG002|Overall Study|Withdrawal by Subject|4|||
94422655|NCT03118570|323335413|FG003|Overall Study|Withdrawal by Subject|0|||
94422656|NCT03118570|323335414|FG004|Overall Study|Withdrawal by Subject|1|||
94422657|NCT03118570|323335410|FG000|Overall Study|Lost to Follow-up|2|||
94422658|NCT03118570|323335411|FG001|Overall Study|Lost to Follow-up|3|||
94422659|NCT03118570|323335412|FG002|Overall Study|Lost to Follow-up|1|||
94422660|NCT03118570|323335413|FG003|Overall Study|Lost to Follow-up|0|||
94422661|NCT03118570|323335414|FG004|Overall Study|Lost to Follow-up|1|||
94422662|NCT03118570|323335410|FG000|Overall Study|Other, Not Specified|1|||
94422663|NCT03118570|323335411|FG001|Overall Study|Other, Not Specified|3|||
94422664|NCT03118570|323335412|FG002|Overall Study|Other, Not Specified|0|||
94422665|NCT03118570|323335413|FG003|Overall Study|Other, Not Specified|0|||
94422666|NCT03118570|323335414|FG004|Overall Study|Other, Not Specified|0|||
94422667|NCT03970837|323335415|FG000|Overall Study|Adverse Event|23|||
94422668|NCT03970837|323335416|FG001|Overall Study|Adverse Event|20|||
94422669|NCT03970837|323335417|FG002|Overall Study|Adverse Event|16|||
94422670|NCT03970837|323335418|FG003|Overall Study|Adverse Event|6|||
94422671|NCT03970837|323335419|FG004|Overall Study|Adverse Event|4|||
94422672|NCT03970837|323335420|FG005|Overall Study|Adverse Event|5|||
94422673|NCT03970837|323335421|FG006|Overall Study|Adverse Event|1|||
94422674|NCT03970837|323335422|FG007|Overall Study|Adverse Event|5|||
94422675|NCT03970837|323335423|FG008|Overall Study|Adverse Event|0|||
94422676|NCT03970837|323335424|FG009|Overall Study|Adverse Event|0|||
94422677|NCT03970837|323335425|FG010|Overall Study|Adverse Event|1|||
94422678|NCT03970837|323335426|FG011|Overall Study|Adverse Event|1|||
94422679|NCT03970837|323335415|FG000|Overall Study|Lack of Efficacy|14|||
94422680|NCT03970837|323335416|FG001|Overall Study|Lack of Efficacy|12|||
94422681|NCT03970837|323335417|FG002|Overall Study|Lack of Efficacy|1|||
94422682|NCT03970837|323335418|FG003|Overall Study|Lack of Efficacy|2|||
94422683|NCT03970837|323335419|FG004|Overall Study|Lack of Efficacy|3|||
94422684|NCT03970837|323335420|FG005|Overall Study|Lack of Efficacy|4|||
94422685|NCT03970837|323335421|FG006|Overall Study|Lack of Efficacy|6|||
94422686|NCT03970837|323335422|FG007|Overall Study|Lack of Efficacy|1|||
94422687|NCT03970837|323335423|FG008|Overall Study|Lack of Efficacy|1|||
94422688|NCT03970837|323335424|FG009|Overall Study|Lack of Efficacy|0|||
94422689|NCT03970837|323335425|FG010|Overall Study|Lack of Efficacy|0|||
94422690|NCT03970837|323335426|FG011|Overall Study|Lack of Efficacy|0|||
94422691|NCT03970837|323335415|FG000|Overall Study|Lost to Follow-up|6|||
94422692|NCT03970837|323335416|FG001|Overall Study|Lost to Follow-up|5|||
94422693|NCT03970837|323335417|FG002|Overall Study|Lost to Follow-up|5|||
94422694|NCT03970837|323335418|FG003|Overall Study|Lost to Follow-up|1|||
94422695|NCT03970837|323335419|FG004|Overall Study|Lost to Follow-up|0|||
94422696|NCT03970837|323335420|FG005|Overall Study|Lost to Follow-up|2|||
94489298|NCT00903968|323586022|FG003|Overall Study|Progressive Disease|3|||
94489299|NCT00903968|323586023|FG004|Overall Study|Progressive Disease|3|||
94489300|NCT00903968|323586024|FG005|Overall Study|Progressive Disease|3|||
94489301|NCT00903968|323586025|FG006|Overall Study|Progressive Disease|0|||
94489302|NCT00903968|323586026|FG007|Overall Study|Progressive Disease|18|||
94422697|NCT03970837|323335421|FG006|Overall Study|Lost to Follow-up|0|||
94422698|NCT03970837|323335422|FG007|Overall Study|Lost to Follow-up|0|||
94422699|NCT03970837|323335423|FG008|Overall Study|Lost to Follow-up|0|||
94422700|NCT03970837|323335424|FG009|Overall Study|Lost to Follow-up|0|||
94422701|NCT03970837|323335425|FG010|Overall Study|Lost to Follow-up|0|||
94422702|NCT03970837|323335426|FG011|Overall Study|Lost to Follow-up|0|||
94422703|NCT03970837|323335415|FG000|Overall Study|Protocol Violation|1|||
94422704|NCT03970837|323335416|FG001|Overall Study|Protocol Violation|0|||
94422705|NCT03970837|323335417|FG002|Overall Study|Protocol Violation|0|||
94422706|NCT03970837|323335418|FG003|Overall Study|Protocol Violation|0|||
94422707|NCT03970837|323335419|FG004|Overall Study|Protocol Violation|0|||
94422708|NCT03970837|323335420|FG005|Overall Study|Protocol Violation|0|||
94422709|NCT03970837|323335421|FG006|Overall Study|Protocol Violation|0|||
94422710|NCT03970837|323335422|FG007|Overall Study|Protocol Violation|0|||
94422711|NCT03970837|323335423|FG008|Overall Study|Protocol Violation|0|||
94422712|NCT03970837|323335424|FG009|Overall Study|Protocol Violation|0|||
94422713|NCT03970837|323335425|FG010|Overall Study|Protocol Violation|0|||
94422714|NCT03970837|323335426|FG011|Overall Study|Protocol Violation|0|||
94422715|NCT03970837|323335415|FG000|Overall Study|Physician Decision|5|||
94422716|NCT03970837|323335416|FG001|Overall Study|Physician Decision|8|||
94422717|NCT03970837|323335417|FG002|Overall Study|Physician Decision|4|||
94422718|NCT03970837|323335418|FG003|Overall Study|Physician Decision|1|||
94422719|NCT03970837|323335419|FG004|Overall Study|Physician Decision|5|||
94422720|NCT03970837|323335420|FG005|Overall Study|Physician Decision|2|||
94422721|NCT03970837|323335421|FG006|Overall Study|Physician Decision|4|||
94422722|NCT03970837|323335422|FG007|Overall Study|Physician Decision|5|||
94422723|NCT03970837|323335423|FG008|Overall Study|Physician Decision|0|||
94422724|NCT03970837|323335424|FG009|Overall Study|Physician Decision|1|||
94422725|NCT03970837|323335425|FG010|Overall Study|Physician Decision|0|||
94422726|NCT03970837|323335426|FG011|Overall Study|Physician Decision|0|||
94422727|NCT03970837|323335415|FG000|Overall Study|Withdrawal by Subject|32|||
94422728|NCT03970837|323335416|FG001|Overall Study|Withdrawal by Subject|35|||
94422729|NCT03970837|323335417|FG002|Overall Study|Withdrawal by Subject|12|||
94422730|NCT03970837|323335418|FG003|Overall Study|Withdrawal by Subject|8|||
94422731|NCT03970837|323335419|FG004|Overall Study|Withdrawal by Subject|6|||
94422732|NCT03970837|323335420|FG005|Overall Study|Withdrawal by Subject|8|||
94422733|NCT03970837|323335421|FG006|Overall Study|Withdrawal by Subject|2|||
94422734|NCT03970837|323335422|FG007|Overall Study|Withdrawal by Subject|3|||
94422735|NCT03970837|323335423|FG008|Overall Study|Withdrawal by Subject|0|||
94422736|NCT03970837|323335424|FG009|Overall Study|Withdrawal by Subject|0|||
94422737|NCT03970837|323335425|FG010|Overall Study|Withdrawal by Subject|0|||
94422738|NCT03970837|323335426|FG011|Overall Study|Withdrawal by Subject|1|||
94422739|NCT03970837|323335415|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
94422740|NCT03970837|323335416|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
94422741|NCT03970837|323335417|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
94422742|NCT03970837|323335418|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
94422743|NCT03970837|323335419|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
94422744|NCT03970837|323335420|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
94422745|NCT03970837|323335421|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
94422746|NCT03970837|323335422|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
94422747|NCT03970837|323335423|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
94422748|NCT03970837|323335424|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
94422749|NCT03970837|323335425|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
94422750|NCT03970837|323335426|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
94422751|NCT03970837|323335415|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
94422752|NCT03970837|323335416|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
94422753|NCT03970837|323335417|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
94422754|NCT03970837|323335418|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
94422755|NCT03970837|323335419|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
94422756|NCT03970837|323335420|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
94422757|NCT03970837|323335421|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
94422758|NCT03970837|323335422|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
94422759|NCT03970837|323335423|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
94422760|NCT03970837|323335424|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
94422761|NCT03970837|323335425|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
94422762|NCT03970837|323335426|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
94422763|NCT03918109|323335427|FG000|Overall Study|Withdrawal by Subject|0|||
94422764|NCT03918109|323335428|FG001|Overall Study|Withdrawal by Subject|0|||
94422765|NCT03918109|323335429|FG002|Overall Study|Withdrawal by Subject|2|||
94422766|NCT03918109|323335430|FG003|Overall Study|Withdrawal by Subject|1|||
94422767|NCT03918109|323335427|FG000|Overall Study|Lost to Follow-up|0|||
94422768|NCT03918109|323335428|FG001|Overall Study|Lost to Follow-up|0|||
94422769|NCT03918109|323335429|FG002|Overall Study|Lost to Follow-up|0|||
94422770|NCT03918109|323335430|FG003|Overall Study|Lost to Follow-up|1|||
94422771|NCT00186043|323335431|FG000|Overall Study|Lack of Efficacy|1|||
94422772|NCT00186043|323335432|FG001|Overall Study|Lack of Efficacy|3|||
94422773|NCT00186043|323335431|FG000|Overall Study|Lost to Follow-up|4|||
94422774|NCT00186043|323335432|FG001|Overall Study|Lost to Follow-up|6|||
94422775|NCT00186043|323335431|FG000|Overall Study|Withdrawal by Subject|1|||
94422776|NCT00186043|323335432|FG001|Overall Study|Withdrawal by Subject|0|||
94422777|NCT00186043|323335431|FG000|Overall Study|Adverse Event|7|||
94422778|NCT00186043|323335432|FG001|Overall Study|Adverse Event|3|||
94422779|NCT00186043|323335431|FG000|Overall Study|Protocol Violation|2|||
94422780|NCT00186043|323335432|FG001|Overall Study|Protocol Violation|1|||
94422781|NCT04062448|323337559|FG000|Overall Study|Lost to Follow-up|1|||
94422782|NCT04062448|323337559|FG000|Overall Study|Withdrawal by Subject|2|||
94422783|NCT04683029|323337560|FG000|Overall Study|Withdrawal by Subject|1|||
94422784|NCT04683029|323337561|FG001|Overall Study|Withdrawal by Subject|0|||
94422785|NCT04732221|323337562|FG000|Base Period|Death|2|||
94422786|NCT04732221|323337563|FG001|Base Period|Death|0|||
94422787|NCT04732221|323337564|FG002|Base Period|Death|0|||
94422788|NCT04732221|323337565|FG003|Base Period|Death|0|||
94422789|NCT04732221|323337566|FG004|Base Period|Death|0|||
94422790|NCT04732221|323337567|FG005|Base Period|Death|0|||
94422791|NCT04732221|323337568|FG006|Base Period|Death|0|||
94422792|NCT04732221|323337562|FG000|Base Period|Withdrawal by Subject|0|||
94422793|NCT04732221|323337563|FG001|Base Period|Withdrawal by Subject|1|||
94422794|NCT04732221|323337564|FG002|Base Period|Withdrawal by Subject|1|||
94422795|NCT04732221|323337565|FG003|Base Period|Withdrawal by Subject|0|||
94422796|NCT04732221|323337566|FG004|Base Period|Withdrawal by Subject|0|||
94422797|NCT04732221|323337567|FG005|Base Period|Withdrawal by Subject|0|||
94422798|NCT04732221|323337568|FG006|Base Period|Withdrawal by Subject|0|||
94422799|NCT04732221|323337562|FG000|Extension Period|Adverse Event|0|||
94422800|NCT04732221|323337563|FG001|Extension Period|Adverse Event|0|||
94422801|NCT04732221|323337564|FG002|Extension Period|Adverse Event|0|||
94422802|NCT04732221|323337565|FG003|Extension Period|Adverse Event|0|||
94422803|NCT04732221|323337566|FG004|Extension Period|Adverse Event|0|||
94422804|NCT04732221|323337567|FG005|Extension Period|Adverse Event|1|||
94422805|NCT04732221|323337568|FG006|Extension Period|Adverse Event|0|||
94422806|NCT04732221|323337562|FG000|Extension Period|Death|0|||
94422807|NCT04732221|323337563|FG001|Extension Period|Death|0|||
94422808|NCT04732221|323337564|FG002|Extension Period|Death|0|||
94422809|NCT04732221|323337565|FG003|Extension Period|Death|0|||
94422810|NCT04732221|323337566|FG004|Extension Period|Death|1|||
94422811|NCT04732221|323337567|FG005|Extension Period|Death|0|||
94422812|NCT04732221|323337568|FG006|Extension Period|Death|2|||
94422813|NCT04732221|323337562|FG000|Extension Period|Pregnancy|0|||
94422814|NCT04732221|323337563|FG001|Extension Period|Pregnancy|0|||
94422815|NCT04732221|323337564|FG002|Extension Period|Pregnancy|0|||
94422816|NCT04732221|323337565|FG003|Extension Period|Pregnancy|0|||
94422817|NCT04732221|323337566|FG004|Extension Period|Pregnancy|1|||
94422818|NCT04732221|323337567|FG005|Extension Period|Pregnancy|0|||
94422819|NCT04732221|323337568|FG006|Extension Period|Pregnancy|0|||
94422820|NCT04732221|323337562|FG000|Extension Period|Sponsors Decision|0|||
94422821|NCT04732221|323337563|FG001|Extension Period|Sponsors Decision|0|||
94422822|NCT04732221|323337564|FG002|Extension Period|Sponsors Decision|0|||
94422823|NCT04732221|323337565|FG003|Extension Period|Sponsors Decision|0|||
94422824|NCT04732221|323337566|FG004|Extension Period|Sponsors Decision|41|||
94422825|NCT04732221|323337567|FG005|Extension Period|Sponsors Decision|40|||
94422826|NCT04732221|323337568|FG006|Extension Period|Sponsors Decision|40|||
94422827|NCT04732221|323337562|FG000|Extension Period|Withdrawal by Subject|0|||
94422828|NCT04732221|323337563|FG001|Extension Period|Withdrawal by Subject|0|||
94422829|NCT04732221|323337564|FG002|Extension Period|Withdrawal by Subject|0|||
94422830|NCT04732221|323337565|FG003|Extension Period|Withdrawal by Subject|0|||
94422831|NCT04732221|323337566|FG004|Extension Period|Withdrawal by Subject|1|||
94422832|NCT04732221|323337567|FG005|Extension Period|Withdrawal by Subject|5|||
94422833|NCT04732221|323337568|FG006|Extension Period|Withdrawal by Subject|2|||
94422834|NCT02068092|323337569|FG000|Overall Study|Physician Decision|2|||
94422835|NCT02068092|323337569|FG000|Overall Study|Adverse Event|2|||
94422836|NCT02068092|323337569|FG000|Overall Study|Lost to Follow-up|4|||
94422837|NCT02068092|323337569|FG000|Overall Study|Withdrawal by Subject|2|||
94422838|NCT00807248|323337570|FG000|Overall Study|Adverse Event|1|||
94422839|NCT00807248|323337571|FG001|Overall Study|Adverse Event|2|||
94422840|NCT00807248|323337572|FG002|Overall Study|Adverse Event|2|||
94422841|NCT00807248|323337573|FG003|Overall Study|Adverse Event|6|||
94422842|NCT00807248|323337570|FG000|Overall Study|Lack of Efficacy|14|||
94422843|NCT00807248|323337571|FG001|Overall Study|Lack of Efficacy|4|||
94422844|NCT00807248|323337572|FG002|Overall Study|Lack of Efficacy|8|||
94422845|NCT00807248|323337573|FG003|Overall Study|Lack of Efficacy|3|||
94422846|NCT00807248|323337570|FG000|Overall Study|Protocol Violation|0|||
94422847|NCT00807248|323337571|FG001|Overall Study|Protocol Violation|1|||
94422848|NCT00807248|323337572|FG002|Overall Study|Protocol Violation|1|||
94422849|NCT00807248|323337573|FG003|Overall Study|Protocol Violation|0|||
94422850|NCT00807248|323337570|FG000|Overall Study|Withdrawal of Consent|5|||
94422851|NCT00807248|323337571|FG001|Overall Study|Withdrawal of Consent|5|||
94422852|NCT00807248|323337572|FG002|Overall Study|Withdrawal of Consent|5|||
94422853|NCT00807248|323337573|FG003|Overall Study|Withdrawal of Consent|5|||
94422854|NCT00807248|323337570|FG000|Overall Study|Lost to Follow-up|1|||
94422855|NCT00807248|323337571|FG001|Overall Study|Lost to Follow-up|0|||
94422856|NCT00807248|323337572|FG002|Overall Study|Lost to Follow-up|0|||
94422857|NCT00807248|323337573|FG003|Overall Study|Lost to Follow-up|0|||
94422858|NCT00807248|323337570|FG000|Overall Study|Other Reason|0|||
94422859|NCT00807248|323337571|FG001|Overall Study|Other Reason|0|||
94422860|NCT00807248|323337572|FG002|Overall Study|Other Reason|2|||
94422861|NCT00807248|323337573|FG003|Overall Study|Other Reason|0|||
94422862|NCT01951885|323337577|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
94422863|NCT01951885|323337578|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
94422864|NCT01951885|323337577|FG000|Overall Study|Adverse Event|1|||
94422865|NCT01951885|323337578|FG001|Overall Study|Adverse Event|0|||
94422866|NCT01951885|323337577|FG000|Overall Study|Withdrawal by Subject|0|||
94422867|NCT01951885|323337578|FG001|Overall Study|Withdrawal by Subject|1|||
94422868|NCT01951885|323337577|FG000|Overall Study|ineligible due to a change in donor|0|||
94422869|NCT01951885|323337578|FG001|Overall Study|ineligible due to a change in donor|1|||
94422870|NCT01951885|323337577|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
94422871|NCT01951885|323337578|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
94422872|NCT01293539|323337579|FG000|Overall Study|Physician Decision|1|||
94422873|NCT04305587|323337580|FG000|Overall Study|Withdrawal by Subject|0|||
94422874|NCT04305587|323337581|FG001|Overall Study|Withdrawal by Subject|0|||
94422875|NCT04305587|323337582|FG002|Overall Study|Withdrawal by Subject|0|||
94422876|NCT04305587|323337583|FG003|Overall Study|Withdrawal by Subject|1|||
94422877|NCT04305587|323337584|FG004|Overall Study|Withdrawal by Subject|0|||
94422878|NCT04305587|323337585|FG005|Overall Study|Withdrawal by Subject|0|||
94422879|NCT04305587|323337586|FG006|Overall Study|Withdrawal by Subject|0|||
94422880|NCT04305587|323337587|FG007|Overall Study|Withdrawal by Subject|0|||
94422881|NCT04305587|323337588|FG008|Overall Study|Withdrawal by Subject|0|||
94422882|NCT01367665|323337589|FG000|Overall Study|Death|102|||
94422883|NCT01367665|323337590|FG001|Overall Study|Death|19|||
94422884|NCT01367665|323337589|FG000|Overall Study|Lost to Follow-up|222|||
94422885|NCT01367665|323337590|FG001|Overall Study|Lost to Follow-up|22|||
94422886|NCT01367665|323337589|FG000|Overall Study|Not Done|118|||
94422887|NCT01367665|323337590|FG001|Overall Study|Not Done|14|||
94422888|NCT02752906|323337591|FG000|Overall Study|Protocol Violation|2|||
94422889|NCT02752906|323337592|FG001|Overall Study|Protocol Violation|1|||
94422890|NCT02752906|323337591|FG000|Overall Study|Withdrawal by Subject|2|||
94422891|NCT02752906|323337592|FG001|Overall Study|Withdrawal by Subject|2|||
94422892|NCT02752906|323337591|FG000|Overall Study|Lost to Follow-up|3|||
94422893|NCT02752906|323337592|FG001|Overall Study|Lost to Follow-up|2|||
94422894|NCT01687478|323337593|FG000|Overall Study|Adverse Event|3|||
94422895|NCT01687478|323337594|FG001|Overall Study|Adverse Event|10|||
94422896|NCT01687478|323337593|FG000|Overall Study|Lost to Follow-up|1|||
94422897|NCT01687478|323337594|FG001|Overall Study|Lost to Follow-up|3|||
94422898|NCT01687478|323337593|FG000|Overall Study|Protocol Violation|0|||
94422899|NCT01687478|323337594|FG001|Overall Study|Protocol Violation|2|||
94422900|NCT01687478|323337593|FG000|Overall Study|Withdrawal by Subject|21|||
94422901|NCT01687478|323337594|FG001|Overall Study|Withdrawal by Subject|19|||
94422902|NCT01687478|323337593|FG000|Overall Study|Physician Decision|1|||
94422903|NCT01687478|323337594|FG001|Overall Study|Physician Decision|3|||
94422904|NCT01687478|323337593|FG000|Overall Study|Entry Criteria Not Met|6|||
94422905|NCT01687478|323337594|FG001|Overall Study|Entry Criteria Not Met|2|||
94422906|NCT00368979|323337595|FG000|Overall Study|Adverse Event|9|||
94422907|NCT00368979|323337596|FG001|Overall Study|Adverse Event|16|||
94422908|NCT00368979|323337595|FG000|Overall Study|Lack of Efficacy|5|||
94422909|NCT00368979|323337596|FG001|Overall Study|Lack of Efficacy|3|||
94422910|NCT00368979|323337595|FG000|Overall Study|Other|3|||
94422911|NCT00368979|323337596|FG001|Overall Study|Other|1|||
94422912|NCT00368979|323337595|FG000|Overall Study|Lost to Follow-up|1|||
94422913|NCT00368979|323337596|FG001|Overall Study|Lost to Follow-up|0|||
94422914|NCT00368979|323337595|FG000|Overall Study|Protocol Violation|2|||
94422915|NCT00368979|323337596|FG001|Overall Study|Protocol Violation|1|||
94422916|NCT00368979|323337595|FG000|Overall Study|Withdrawal by Subject|5|||
94422917|NCT00368979|323337596|FG001|Overall Study|Withdrawal by Subject|9|||
94422918|NCT02570113|323337605|FG000|Overall Study|Withdrawal by Subject|3|||
94422919|NCT02746471|323337606|FG000|Overall Study|Death|43|||
94422920|NCT02746471|323337606|FG000|Overall Study|Exited before 36 months|1119|||
94422921|NCT02564211|323337607|FG000|Overall Study|Adverse Event|4|||
94422922|NCT01007942|323337609|FG000|Overall Study|Adverse Event|29|||
94422923|NCT01007942|323337610|FG001|Overall Study|Adverse Event|14|||
94422924|NCT01007942|323337609|FG000|Overall Study|Abnormal test procedure|0|||
94422925|NCT01007942|323337610|FG001|Overall Study|Abnormal test procedure|1|||
94422926|NCT01007942|323337609|FG000|Overall Study|Disease progression|217|||
94422927|NCT01007942|323337610|FG001|Overall Study|Disease progression|242|||
94422928|NCT01007942|323337609|FG000|Overall Study|New cancer therapy|5|||
94422929|NCT01007942|323337610|FG001|Overall Study|New cancer therapy|1|||
94489303|NCT00903968|323586019|FG000|Overall Study|Lack of Efficacy|0|||
94422930|NCT01007942|323337609|FG000|Overall Study|Protocol Violation|1|||
94422931|NCT01007942|323337610|FG001|Overall Study|Protocol Violation|1|||
94422932|NCT01007942|323337609|FG000|Overall Study|Withdrawal by Subject|19|||
94422933|NCT01007942|323337610|FG001|Overall Study|Withdrawal by Subject|14|||
94422934|NCT01007942|323337609|FG000|Overall Study|Lost to Follow-up|1|||
94422935|NCT01007942|323337610|FG001|Overall Study|Lost to Follow-up|0|||
94422936|NCT01007942|323337609|FG000|Overall Study|Administrative problems|2|||
94422937|NCT01007942|323337610|FG001|Overall Study|Administrative problems|0|||
94422938|NCT01007942|323337609|FG000|Overall Study|Death|3|||
94422939|NCT01007942|323337610|FG001|Overall Study|Death|2|||
94422940|NCT01007942|323337609|FG000|Overall Study|Patients untreated|4|||
94422941|NCT01007942|323337610|FG001|Overall Study|Patients untreated|3|||
94422942|NCT03167723|323337611|FG000|Overall Study|Protocol Violation|4|||
94422943|NCT03167723|323337612|FG001|Overall Study|Protocol Violation|6|||
94422944|NCT00415194|323337614|FG000|Overall Study|Adverse Event|37|||
94422945|NCT00415194|323337615|FG001|Overall Study|Adverse Event|32|||
94422946|NCT00415194|323337614|FG000|Overall Study|Entry Criteria Not Met|4|||
94422947|NCT00415194|323337615|FG001|Overall Study|Entry Criteria Not Met|8|||
94422948|NCT00415194|323337614|FG000|Overall Study|Lost to Follow-up|1|||
94422949|NCT00415194|323337615|FG001|Overall Study|Lost to Follow-up|0|||
94422950|NCT00415194|323337614|FG000|Overall Study|Physician Decision|10|||
94422951|NCT00415194|323337615|FG001|Overall Study|Physician Decision|16|||
94422952|NCT00415194|323337614|FG000|Overall Study|Progressive Disease|180|||
94422953|NCT00415194|323337615|FG001|Overall Study|Progressive Disease|217|||
94422954|NCT00415194|323337614|FG000|Overall Study|Protocol Violation|4|||
94422955|NCT00415194|323337615|FG001|Overall Study|Protocol Violation|2|||
94422956|NCT00415194|323337614|FG000|Overall Study|Withdrawal by Subject|28|||
94422957|NCT00415194|323337615|FG001|Overall Study|Withdrawal by Subject|21|||
94422958|NCT00415194|323337614|FG000|Overall Study|Death Due to Study Disease|26|||
94422959|NCT00415194|323337615|FG001|Overall Study|Death Due to Study Disease|29|||
94422960|NCT00415194|323337614|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
94422961|NCT00415194|323337615|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
94422962|NCT00415194|323337614|FG000|Overall Study|Death Due to Procedural Related AE|0|||
94422963|NCT00415194|323337615|FG001|Overall Study|Death Due to Procedural Related AE|1|||
94422964|NCT00415194|323337614|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
94422965|NCT00415194|323337615|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
94422966|NCT00369655|323337616|FG000|Overall Study|Refusal of further treatment|2|||
94422967|NCT02325518|323337617|FG000|Overall Study|Adverse Event|4|||
94422968|NCT02325518|323337618|FG001|Overall Study|Adverse Event|1|||
94422969|NCT02325518|323337617|FG000|Overall Study|Physician Decision|0|||
94422970|NCT02325518|323337618|FG001|Overall Study|Physician Decision|1|||
94422971|NCT02325518|323337617|FG000|Overall Study|Withdrawal by Subject|0|||
94422972|NCT02325518|323337618|FG001|Overall Study|Withdrawal by Subject|1|||
94422973|NCT02740699|323337629|FG000|Overall Study|Lost to Follow-up|5|||
94422974|NCT02740699|323337629|FG000|Overall Study|Withdrawal by Subject|14|||
94422975|NCT02740699|323337629|FG000|Overall Study|Physician Decision|5|||
94422976|NCT03393806|323337631|FG000|Overall Study|Physician Decision|1|||
94422977|NCT03393806|323337632|FG001|Overall Study|Physician Decision|0|||
94422978|NCT00886288|323337633|FG000|Overall Study|no respect of the 12 weeks period|657|||
94422979|NCT00886288|323337634|FG001|Overall Study|no respect of the 12 weeks period|227|||
94422980|NCT00886288|323337633|FG000|Overall Study|Lost to Follow-up|86|||
94422981|NCT00886288|323337634|FG001|Overall Study|Lost to Follow-up|0|||
94422982|NCT01259115|323337635|FG000|Period 1|Adverse Event|1|||
94422983|NCT01259115|323337636|FG001|Period 1|Adverse Event|0|||
94422984|NCT01259115|323337635|FG000|Period 1|Protocol Violation|2|||
94422985|NCT01259115|323337636|FG001|Period 1|Protocol Violation|0|||
94422986|NCT01259115|323337635|FG000|Period 1|Lost to Follow-up|0|||
94422987|NCT01259115|323337636|FG001|Period 1|Lost to Follow-up|1|||
94422988|NCT01259115|323337635|FG000|Period 2|Adverse Event|1|||
94422989|NCT01259115|323337636|FG001|Period 2|Adverse Event|0|||
94422990|NCT03560986|323337637|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
94422991|NCT03560986|323337638|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
94422992|NCT03560986|323337637|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
94422993|NCT03560986|323337638|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
94422994|NCT03560986|323337637|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
94422995|NCT03560986|323337638|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
94422996|NCT03560986|323337637|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
94422997|NCT03560986|323337638|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
94422998|NCT03560986|323337637|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
94422999|NCT03560986|323337638|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
94423000|NCT03560986|323337637|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
94423001|NCT03560986|323337638|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
94423002|NCT03560986|323337637|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
94423003|NCT03560986|323337638|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
94423004|NCT01971970|323337639|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
94423005|NCT01971970|323337640|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
94423006|NCT01971970|323337639|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
94423007|NCT01971970|323337640|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
94423008|NCT01971970|323337639|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
94423009|NCT01971970|323337640|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
94423010|NCT01971970|323337639|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
94423011|NCT01971970|323337640|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
94423012|NCT01971970|323337639|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
94423013|NCT01971970|323337640|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
94423014|NCT01971970|323337639|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
94423015|NCT01971970|323337640|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
94423016|NCT01971970|323337639|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
94423017|NCT01971970|323337640|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
94423018|NCT04713553|323337641|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
94423019|NCT04713553|323337642|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
94423020|NCT04713553|323337643|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
94423021|NCT04713553|323337644|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
94423022|NCT04713553|323337645|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
94423023|NCT04713553|323337646|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
94423024|NCT04713553|323337647|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
94423025|NCT04713553|323337641|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
94423026|NCT04713553|323337642|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
94423027|NCT04713553|323337643|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
94423028|NCT04713553|323337644|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
94423029|NCT04713553|323337645|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
94423030|NCT04713553|323337646|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
94423031|NCT04713553|323337647|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
94423032|NCT04713553|323337641|FG000|Primary Study (2 Months)|Other|1|||
94423033|NCT04713553|323337642|FG001|Primary Study (2 Months)|Other|2|||
94423034|NCT04713553|323337643|FG002|Primary Study (2 Months)|Other|0|||
94423035|NCT04713553|323337644|FG003|Primary Study (2 Months)|Other|0|||
94423036|NCT04713553|323337645|FG004|Primary Study (2 Months)|Other|1|||
94423037|NCT04713553|323337646|FG005|Primary Study (2 Months)|Other|0|||
94423038|NCT04713553|323337647|FG006|Primary Study (2 Months)|Other|0|||
94423039|NCT04713553|323337641|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
94423040|NCT04713553|323337642|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
94423041|NCT04713553|323337643|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
94423042|NCT04713553|323337644|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
94423043|NCT04713553|323337645|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
94423044|NCT04713553|323337646|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
94423045|NCT04713553|323337647|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
94423046|NCT04713553|323337641|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
94423047|NCT04713553|323337642|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
94423048|NCT04713553|323337643|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
94423049|NCT04713553|323337644|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
94423050|NCT04713553|323337645|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
94423051|NCT04713553|323337646|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
94423052|NCT04713553|323337647|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
94423053|NCT00987389|323337659|FG000|Overall Study|Ineligible|0|||
94423054|NCT00987389|323337660|FG001|Overall Study|Ineligible|3|||
94423055|NCT00987389|323337661|FG002|Overall Study|Ineligible|0|||
94423056|NCT00987389|323337662|FG003|Overall Study|Ineligible|0|||
94423057|NCT00987389|323337659|FG000|Overall Study|Lost to Follow-up|4|||
94423058|NCT00987389|323337660|FG001|Overall Study|Lost to Follow-up|1|||
94423059|NCT00987389|323337661|FG002|Overall Study|Lost to Follow-up|3|||
94423060|NCT00987389|323337662|FG003|Overall Study|Lost to Follow-up|1|||
94423061|NCT00987389|323337659|FG000|Overall Study|Withdrawal by Subject|4|||
94423062|NCT00987389|323337660|FG001|Overall Study|Withdrawal by Subject|3|||
94423063|NCT00987389|323337661|FG002|Overall Study|Withdrawal by Subject|2|||
94423064|NCT00987389|323337662|FG003|Overall Study|Withdrawal by Subject|1|||
94423065|NCT00987389|323337659|FG000|Overall Study|Withdrawn from Treatment|0|||
94423066|NCT00987389|323337660|FG001|Overall Study|Withdrawn from Treatment|1|||
94423067|NCT00987389|323337661|FG002|Overall Study|Withdrawn from Treatment|0|||
94423068|NCT00987389|323337662|FG003|Overall Study|Withdrawn from Treatment|0|||
94423069|NCT00987389|323337659|FG000|Overall Study|Multiple different reasons|1|||
94423070|NCT00987389|323337660|FG001|Overall Study|Multiple different reasons|0|||
94423071|NCT00987389|323337661|FG002|Overall Study|Multiple different reasons|3|||
94423072|NCT00987389|323337662|FG003|Overall Study|Multiple different reasons|1|||
94423073|NCT00326963|323337663|FG000|Overall Study|Adverse Event|2|||
94423074|NCT00326963|323337663|FG000|Overall Study|Injection site reaction|1|||
94423075|NCT00326963|323337663|FG000|Overall Study|Death|1|||
94423076|NCT00326963|323337663|FG000|Overall Study|Failure to return|10|||
94423077|NCT00326963|323337663|FG000|Overall Study|Withdrawal by Subject|10|||
94423078|NCT00326963|323337663|FG000|Overall Study|Refused treatment / did not cooperate|5|||
94423079|NCT00326963|323337663|FG000|Overall Study|Violation of selection criteria at entry|2|||
94423080|NCT00326963|323337663|FG000|Overall Study|Other protocol violation|1|||
94423081|NCT00326963|323337663|FG000|Overall Study|Administrative / other|1|||
94423082|NCT00080938|323337664|FG000|Overall Study|Adverse Event|3|||
94423083|NCT00080938|323337664|FG000|Overall Study|Withdrawal by Subject|6|||
94423084|NCT00080938|323337664|FG000|Overall Study|Death|2|||
94423085|NCT00080938|323337664|FG000|Overall Study|Lack of Efficacy|7|||
94423086|NCT00080938|323337664|FG000|Overall Study|other disease|1|||
94423087|NCT00080938|323337664|FG000|Overall Study|Not started protocol therapy|1|||
94423088|NCT00080938|323337664|FG000|Overall Study|Ineligible|4|||
94423089|NCT00706511|323337665|FG000|Overall Study|Withdrawal by Subject|1|||
94423090|NCT00706511|323337666|FG001|Overall Study|Withdrawal by Subject|0|||
94423091|NCT00706511|323337667|FG002|Overall Study|Withdrawal by Subject|0|||
94423092|NCT00706511|323337668|FG003|Overall Study|Withdrawal by Subject|0|||
94423093|NCT01868893|323337670|FG000|Overall Study|Adverse Event|2|||
94423094|NCT01868893|323337670|FG000|Overall Study|Commercial availability of study drug|17|||
94423095|NCT01868893|323337670|FG000|Overall Study|Neutropenia|1|||
94423096|NCT04053465|323337679|FG000|Overall Study|Withdrawal by Subject|4|||
94423097|NCT04053465|323337680|FG001|Overall Study|Withdrawal by Subject|4|||
94423098|NCT05297578|323337683|FG000|Overall Study|Lost to Follow-up|1|||
94423099|NCT05297578|323337684|FG001|Overall Study|Lost to Follow-up|1|||
94423100|NCT05297578|323337685|FG002|Overall Study|Lost to Follow-up|2|||
94423101|NCT05297578|323337686|FG003|Overall Study|Lost to Follow-up|1|||
94423102|NCT05297578|323337683|FG000|Overall Study|Death|0|||
94423103|NCT05297578|323337684|FG001|Overall Study|Death|1|||
94423104|NCT05297578|323337685|FG002|Overall Study|Death|0|||
94423105|NCT05297578|323337686|FG003|Overall Study|Death|0|||
94423106|NCT05297578|323337683|FG000|Overall Study|Withdrawal by Subject|0|||
94423107|NCT05297578|323337684|FG001|Overall Study|Withdrawal by Subject|0|||
94423108|NCT05297578|323337685|FG002|Overall Study|Withdrawal by Subject|1|||
94423109|NCT05297578|323337686|FG003|Overall Study|Withdrawal by Subject|0|||
94423110|NCT00762437|323337687|FG000|Overall Study|Lost to Follow-up|7|||
94423111|NCT00762437|323337687|FG000|Overall Study|Missed final study visit|11|||
94423112|NCT00762437|323337687|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
94423113|NCT01103466|323337688|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
94423114|NCT01103466|323337689|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
94423115|NCT01103466|323337690|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
94423116|NCT01103466|323337688|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
94423117|NCT01103466|323337689|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
94423118|NCT01103466|323337690|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
94423119|NCT01103466|323337688|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
94423120|NCT01103466|323337689|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
94423121|NCT01103466|323337690|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
94423122|NCT01103466|323337688|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
94423123|NCT01103466|323337689|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
94423124|NCT01103466|323337690|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
94423125|NCT01103466|323337688|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
94423126|NCT01103466|323337689|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
94423127|NCT01103466|323337690|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
94423128|NCT01103466|323337688|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
94423129|NCT01103466|323337689|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
94423130|NCT01103466|323337690|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
94423131|NCT02317614|323337694|FG000|Overall Study|Lost to Follow-up|1|||
94423132|NCT02317614|323337695|FG001|Overall Study|Lost to Follow-up|1|||
94423133|NCT02317614|323337694|FG000|Overall Study|Withdrawal by Subject|1|||
94423134|NCT02317614|323337695|FG001|Overall Study|Withdrawal by Subject|0|||
94423135|NCT02317614|323337694|FG000|Overall Study|Death|1|||
94423136|NCT02317614|323337695|FG001|Overall Study|Death|1|||
94423137|NCT00311402|323337696|FG000|Overall Study|Adverse Event|118|||
94423138|NCT00311402|323337697|FG001|Overall Study|Adverse Event|105|||
94423139|NCT00311402|323337696|FG000|Overall Study|Lost to Follow-up|0|||
94423140|NCT00311402|323337697|FG001|Overall Study|Lost to Follow-up|3|||
94423141|NCT00311402|323337696|FG000|Overall Study|Withdrawal by Subject|17|||
94423142|NCT00311402|323337697|FG001|Overall Study|Withdrawal by Subject|18|||
94423143|NCT00311402|323337696|FG000|Overall Study|Lack of Efficacy|58|||
94423144|NCT00311402|323337697|FG001|Overall Study|Lack of Efficacy|42|||
94423145|NCT00311402|323337696|FG000|Overall Study|Protocol Violation|7|||
94423146|NCT00311402|323337697|FG001|Overall Study|Protocol Violation|6|||
94423147|NCT00311402|323337696|FG000|Overall Study|IRB's rejection etc.|10|||
94423148|NCT00311402|323337697|FG001|Overall Study|IRB's rejection etc.|3|||
94423149|NCT03285308|323337698|FG000|Overall Study|Adverse Event|3|||
94423150|NCT03285308|323337699|FG001|Overall Study|Adverse Event|7|||
94423151|NCT03285308|323337698|FG000|Overall Study|Withdrawal by Subject|8|||
94423152|NCT03285308|323337699|FG001|Overall Study|Withdrawal by Subject|9|||
94423153|NCT03285308|323337698|FG000|Overall Study|Lost to Follow-up|3|||
94423154|NCT03285308|323337699|FG001|Overall Study|Lost to Follow-up|1|||
94423155|NCT03285308|323337698|FG000|Overall Study|Protocol Deviation|6|||
94423156|NCT03285308|323337699|FG001|Overall Study|Protocol Deviation|5|||
94423157|NCT03285308|323337698|FG000|Overall Study|Reason not Specified|0|||
94423158|NCT03285308|323337699|FG001|Overall Study|Reason not Specified|1|||
94423159|NCT02283983|323337700|FG000|Overall Study|Inclusion criteria not met|0|||
94423160|NCT02283983|323337701|FG001|Overall Study|Inclusion criteria not met|1|||
94423161|NCT02283983|323337700|FG000|Overall Study|Withdrawal by Subject|4|||
94423162|NCT02283983|323337701|FG001|Overall Study|Withdrawal by Subject|2|||
94423163|NCT02283983|323337700|FG000|Overall Study|Protocol Violation|0|||
94423164|NCT02283983|323337701|FG001|Overall Study|Protocol Violation|4|||
94423165|NCT02283983|323337700|FG000|Overall Study|Physician Decision|2|||
94423166|NCT02283983|323337701|FG001|Overall Study|Physician Decision|4|||
94423167|NCT02283983|323337700|FG000|Overall Study|Death|1|||
94423168|NCT02283983|323337701|FG001|Overall Study|Death|0|||
94423169|NCT02283983|323337700|FG000|Overall Study|Adverse Event|1|||
94423170|NCT02283983|323337701|FG001|Overall Study|Adverse Event|0|||
94423171|NCT02283983|323337700|FG000|Overall Study|Lost to Follow-up|9|||
94423172|NCT02283983|323337701|FG001|Overall Study|Lost to Follow-up|8|||
94423173|NCT02283983|323337700|FG000|Overall Study|Relapse|1|||
94423174|NCT02283983|323337701|FG001|Overall Study|Relapse|0|||
94423175|NCT02787408|323337702|FG000|Overall Study|Death|16|||
94423176|NCT02787408|323337702|FG000|Overall Study|Withdrawal by Subject|1|||
94423177|NCT02787408|323337702|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
94423178|NCT00424775|323337707|FG000|Overall Study|Adverse Event|2|||
94423179|NCT00424775|323337708|FG001|Overall Study|Adverse Event|0|||
94423180|NCT00424775|323337707|FG000|Overall Study|Lack of Efficacy|1|||
94423181|NCT00424775|323337708|FG001|Overall Study|Lack of Efficacy|0|||
94423182|NCT00681590|323337709|FG000|Overall Study|Withdrawal by Subject|2|||
94423183|NCT00681590|323337710|FG001|Overall Study|Withdrawal by Subject|12|||
94423184|NCT01898650|323337712|FG000|Overall Study|the subject would not lie still for imaging|1|||
94423185|NCT02912650|323337713|FG000|Overall Study|Withdrawal by Subject|1|||
94423186|NCT02912650|323337714|FG001|Overall Study|Withdrawal by Subject|0|||
94423187|NCT02912650|323337715|FG002|Overall Study|Withdrawal by Subject|1|||
94423188|NCT02912650|323337716|FG003|Overall Study|Withdrawal by Subject|5|||
94423189|NCT02912650|323337713|FG000|Overall Study|Adverse Event|0|||
94423190|NCT02912650|323337714|FG001|Overall Study|Adverse Event|0|||
94423191|NCT02912650|323337715|FG002|Overall Study|Adverse Event|1|||
94423192|NCT02912650|323337716|FG003|Overall Study|Adverse Event|0|||
94423193|NCT01822275|323337717|FG000|Overall Study|Withdrawal by Subject|3|||
94423194|NCT01822275|323337717|FG000|Overall Study|Adverse Event|3|||
94423195|NCT01822275|323337717|FG000|Overall Study|Progression|14|||
94423196|NCT01822275|323337717|FG000|Overall Study|Physician Decision|2|||
94423197|NCT01946191|323337719|FG000|Allocation|Did not complete orientation|1|||
94423198|NCT01946191|323337720|FG001|Allocation|Did not complete orientation|1|||
94423199|NCT01946191|323337719|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
94423200|NCT01946191|323337720|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
94423201|NCT01946191|323337719|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
94423202|NCT01946191|323337720|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
94423203|NCT01946191|323337719|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
94423204|NCT01946191|323337720|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
94423205|NCT01629966|323337721|FG000|Overall Study|Pregnancy|0|||
94423206|NCT01629966|323337722|FG001|Overall Study|Pregnancy|1|||
94423207|NCT01629966|323337723|FG002|Overall Study|Pregnancy|0|||
94423208|NCT01629966|323337721|FG000|Overall Study|Lost to Follow-up|10|||
94423209|NCT01629966|323337722|FG001|Overall Study|Lost to Follow-up|13|||
94423210|NCT01629966|323337723|FG002|Overall Study|Lost to Follow-up|9|||
94423211|NCT01629966|323337721|FG000|Overall Study|Withdrawal by Subject|8|||
94423212|NCT01629966|323337722|FG001|Overall Study|Withdrawal by Subject|9|||
94423213|NCT01629966|323337723|FG002|Overall Study|Withdrawal by Subject|16|||
94423214|NCT01629966|323337721|FG000|Overall Study|Protocol Violation|7|||
94423215|NCT01629966|323337722|FG001|Overall Study|Protocol Violation|9|||
94423216|NCT01629966|323337723|FG002|Overall Study|Protocol Violation|7|||
94423217|NCT01629966|323337721|FG000|Overall Study|Lack of Efficacy|5|||
94423218|NCT01629966|323337722|FG001|Overall Study|Lack of Efficacy|2|||
94423219|NCT01629966|323337723|FG002|Overall Study|Lack of Efficacy|4|||
94423220|NCT01629966|323337721|FG000|Overall Study|Adverse Event|11|||
94423221|NCT01629966|323337722|FG001|Overall Study|Adverse Event|18|||
94423222|NCT01629966|323337723|FG002|Overall Study|Adverse Event|30|||
94423223|NCT03185013|323337724|FG000|Overall Study|Withdrawal by Subject|5|||
94423224|NCT03185013|323337725|FG001|Overall Study|Withdrawal by Subject|3|||
94423225|NCT03185013|323337724|FG000|Overall Study|Adverse Event|1|||
94423226|NCT03185013|323337725|FG001|Overall Study|Adverse Event|0|||
94423227|NCT03185013|323337724|FG000|Overall Study|Progressive Disease|1|||
94423228|NCT03185013|323337725|FG001|Overall Study|Progressive Disease|0|||
94423229|NCT03185013|323337724|FG000|Overall Study|Lost to Follow-up|8|||
94423230|NCT03185013|323337725|FG001|Overall Study|Lost to Follow-up|2|||
94423231|NCT03185013|323337724|FG000|Overall Study|Physician Decision|1|||
94423232|NCT03185013|323337725|FG001|Overall Study|Physician Decision|0|||
94423233|NCT03185013|323337724|FG000|Overall Study|Protocol Deviation|2|||
94423234|NCT03185013|323337725|FG001|Overall Study|Protocol Deviation|0|||
94423235|NCT03185013|323337724|FG000|Overall Study|Reason not Specified|3|||
94489304|NCT00903968|323586020|FG001|Overall Study|Lack of Efficacy|0|||
94423236|NCT03185013|323337725|FG001|Overall Study|Reason not Specified|2|||
94423237|NCT03185013|323337724|FG000|Overall Study|Death|1|||
94423238|NCT03185013|323337725|FG001|Overall Study|Death|0|||
94423239|NCT03835221|323337728|FG000|Methafilcon A|Withdrawal by Subject|1|||
94423240|NCT04874636|323337729|FG000|Overall Study|Adverse Event|17|||
94423241|NCT04874636|323337730|FG001|Overall Study|Adverse Event|7|||
94423242|NCT04874636|323337729|FG000|Overall Study|Lost to Follow-up|1|||
94423243|NCT04874636|323337730|FG001|Overall Study|Lost to Follow-up|0|||
94423244|NCT04874636|323337729|FG000|Overall Study|Non-Compliance with Study Drug|2|||
94423245|NCT04874636|323337730|FG001|Overall Study|Non-Compliance with Study Drug|0|||
94423246|NCT04874636|323337729|FG000|Overall Study|Physician Decision|1|||
94423247|NCT04874636|323337730|FG001|Overall Study|Physician Decision|0|||
94423248|NCT04874636|323337729|FG000|Overall Study|Withdrawal by Subject|6|||
94423249|NCT04874636|323337730|FG001|Overall Study|Withdrawal by Subject|5|||
94423250|NCT02352779|323337735|FG000|Overall Study|Personal Issues|1|||
94423251|NCT02352779|323337736|FG001|Overall Study|Personal Issues|1|||
94423252|NCT02352779|323337737|FG002|Overall Study|Personal Issues|0|||
94423253|NCT02352779|323337735|FG000|Overall Study|Too Many Forms|2|||
94423254|NCT02352779|323337736|FG001|Overall Study|Too Many Forms|0|||
94423255|NCT02352779|323337737|FG002|Overall Study|Too Many Forms|0|||
94423256|NCT02352779|323337735|FG000|Overall Study|Feeling Overwhelmed|1|||
94423257|NCT02352779|323337736|FG001|Overall Study|Feeling Overwhelmed|0|||
94423258|NCT02352779|323337737|FG002|Overall Study|Feeling Overwhelmed|0|||
94423259|NCT02352779|323337735|FG000|Overall Study|Disliked Intervention|1|||
94423260|NCT02352779|323337736|FG001|Overall Study|Disliked Intervention|0|||
94423261|NCT02352779|323337737|FG002|Overall Study|Disliked Intervention|0|||
94423262|NCT02352779|323337735|FG000|Overall Study|Changed Mind|1|||
94423263|NCT02352779|323337736|FG001|Overall Study|Changed Mind|0|||
94423264|NCT02352779|323337737|FG002|Overall Study|Changed Mind|0|||
94423265|NCT02352779|323337735|FG000|Overall Study|Study Related Symptoms|1|||
94423266|NCT02352779|323337736|FG001|Overall Study|Study Related Symptoms|0|||
94423267|NCT02352779|323337737|FG002|Overall Study|Study Related Symptoms|0|||
94423268|NCT02352779|323337735|FG000|Overall Study|Absence of Symptoms|1|||
94423269|NCT02352779|323337736|FG001|Overall Study|Absence of Symptoms|0|||
94423270|NCT02352779|323337737|FG002|Overall Study|Absence of Symptoms|0|||
94423271|NCT02352779|323337735|FG000|Overall Study|Other Medical Reason|0|||
94423272|NCT02352779|323337736|FG001|Overall Study|Other Medical Reason|0|||
94423273|NCT02352779|323337737|FG002|Overall Study|Other Medical Reason|1|||
94423274|NCT02352779|323337735|FG000|Overall Study|No Reason|0|||
94423275|NCT02352779|323337736|FG001|Overall Study|No Reason|0|||
94423276|NCT02352779|323337737|FG002|Overall Study|No Reason|1|||
94423277|NCT02201290|323337740|FG000|Overall Study|Withdrawal by Subject|2|||
94423278|NCT02201290|323337740|FG000|Overall Study|Lack of Efficacy|2|||
94423279|NCT02201290|323337740|FG000|Overall Study|Adverse Event|1|||
94423280|NCT03190330|323339303|FG000|Overall Study|Adverse Event|2|||
94423281|NCT03190330|323339303|FG000|Overall Study|Death|10|||
94423282|NCT03190330|323339303|FG000|Overall Study|Lost to Follow-up|1|||
94423283|NCT03190330|323339303|FG000|Overall Study|Withdrawal by Subject|6|||
94423284|NCT03190330|323339303|FG000|Overall Study|Progressive Disease|1|||
94423285|NCT05091307|323339304|FG000|Overall Study|Death|0|||
94423286|NCT05091307|323339305|FG001|Overall Study|Death|0|||
94423287|NCT05091307|323339306|FG002|Overall Study|Death|1|||
94423288|NCT05091307|323339307|FG003|Overall Study|Death|0|||
94423289|NCT05091307|323339304|FG000|Overall Study|Lost to Follow-up|33|||
94423290|NCT05091307|323339305|FG001|Overall Study|Lost to Follow-up|33|||
94423291|NCT05091307|323339306|FG002|Overall Study|Lost to Follow-up|2|||
94423292|NCT05091307|323339307|FG003|Overall Study|Lost to Follow-up|0|||
94423293|NCT05091307|323339304|FG000|Overall Study|Physician Decision|1|||
94423294|NCT05091307|323339305|FG001|Overall Study|Physician Decision|0|||
94423295|NCT05091307|323339306|FG002|Overall Study|Physician Decision|0|||
94423296|NCT05091307|323339307|FG003|Overall Study|Physician Decision|0|||
94423297|NCT05091307|323339304|FG000|Overall Study|Protocol Violation|1|||
94423298|NCT05091307|323339305|FG001|Overall Study|Protocol Violation|0|||
94423299|NCT05091307|323339306|FG002|Overall Study|Protocol Violation|0|||
94423300|NCT05091307|323339307|FG003|Overall Study|Protocol Violation|0|||
94423301|NCT05091307|323339304|FG000|Overall Study|Withdrawal by Subject|16|||
94423302|NCT05091307|323339305|FG001|Overall Study|Withdrawal by Subject|16|||
94423303|NCT05091307|323339306|FG002|Overall Study|Withdrawal by Subject|0|||
94489305|NCT00903968|323586021|FG002|Overall Study|Lack of Efficacy|0|||
94423304|NCT05091307|323339307|FG003|Overall Study|Withdrawal by Subject|1|||
94423305|NCT05091307|323339304|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
94423306|NCT05091307|323339305|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
94423307|NCT05091307|323339306|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
94423308|NCT05091307|323339307|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
94423309|NCT05091307|323339304|FG000|Overall Study|Initiated Prohibited Medication|1|||
94423310|NCT05091307|323339305|FG001|Overall Study|Initiated Prohibited Medication|0|||
94423311|NCT05091307|323339306|FG002|Overall Study|Initiated Prohibited Medication|0|||
94423312|NCT05091307|323339307|FG003|Overall Study|Initiated Prohibited Medication|0|||
94423313|NCT05091307|323339304|FG000|Overall Study|Other|4|||
94423314|NCT05091307|323339305|FG001|Overall Study|Other|4|||
94423315|NCT05091307|323339306|FG002|Overall Study|Other|0|||
94423316|NCT05091307|323339307|FG003|Overall Study|Other|0|||
94423317|NCT05091307|323339304|FG000|Overall Study|Randomized but not vaccinated|0|||
94423318|NCT05091307|323339305|FG001|Overall Study|Randomized but not vaccinated|2|||
94423319|NCT05091307|323339306|FG002|Overall Study|Randomized but not vaccinated|0|||
94423320|NCT05091307|323339307|FG003|Overall Study|Randomized but not vaccinated|0|||
94423321|NCT02788045|323339308|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
94423322|NCT02788045|323339309|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
94423323|NCT02788045|323339310|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
94423324|NCT02788045|323339308|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
94423325|NCT02788045|323339309|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
94423326|NCT02788045|323339310|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
94423327|NCT02788045|323339308|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
94423328|NCT02788045|323339309|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
94423329|NCT02788045|323339310|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
94423330|NCT02788045|323339308|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
94423331|NCT02788045|323339309|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
94423332|NCT02788045|323339310|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
94423333|NCT02788045|323339308|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
94423334|NCT02788045|323339309|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
94423335|NCT02788045|323339310|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
94423336|NCT02788045|323339308|FG000|Main Study (Up to Week 72)|Other|3|||
94423337|NCT02788045|323339309|FG001|Main Study (Up to Week 72)|Other|0|||
94423338|NCT02788045|323339310|FG002|Main Study (Up to Week 72)|Other|0|||
94423339|NCT02788045|323339308|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
94423340|NCT02788045|323339309|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
94423341|NCT02788045|323339310|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
94423342|NCT02788045|323339308|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
94423343|NCT02788045|323339309|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
94423344|NCT02788045|323339310|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
94423345|NCT02788045|323339308|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
94423346|NCT02788045|323339309|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
94423347|NCT02788045|323339310|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
94423348|NCT05104476|323339311|FG000|Overall Study|Randomized But Not Treated|1|||
94423349|NCT05104476|323339312|FG001|Overall Study|Randomized But Not Treated|2|||
94423350|NCT05104476|323339311|FG000|Overall Study|Adverse Event|2|||
94423351|NCT05104476|323339312|FG001|Overall Study|Adverse Event|2|||
94423352|NCT05104476|323339311|FG000|Overall Study|Withdrawal by Subject|3|||
94423353|NCT05104476|323339312|FG001|Overall Study|Withdrawal by Subject|3|||
94423354|NCT05104476|323339311|FG000|Overall Study|Other Than Specified|0|||
94423355|NCT05104476|323339312|FG001|Overall Study|Other Than Specified|3|||
94423356|NCT02511106|323339313|FG000|Overall Study|Lost to Follow-up|6|||
94423357|NCT02511106|323339314|FG001|Overall Study|Lost to Follow-up|4|||
94423358|NCT02511106|323339313|FG000|Overall Study|Withdrawal by Subject|24|||
94423359|NCT02511106|323339314|FG001|Overall Study|Withdrawal by Subject|21|||
94423360|NCT02511106|323339313|FG000|Overall Study|Death|42|||
94423361|NCT02511106|323339314|FG001|Overall Study|Death|82|||
94423362|NCT02511106|323339313|FG000|Overall Study|Ongoing study at data cut-off|3|||
94423363|NCT02511106|323339314|FG001|Overall Study|Ongoing study at data cut-off|2|||
94423364|NCT02511106|323339313|FG000|Overall Study|Without specified reason|3|||
94423365|NCT02511106|323339314|FG001|Overall Study|Without specified reason|0|||
94423366|NCT05071313|323339316|FG000|Overall Study|Lost to Follow-up|17|||
94423367|NCT05071313|323339317|FG001|Overall Study|Lost to Follow-up|10|||
94423368|NCT05071313|323339316|FG000|Overall Study|Physician Decision|1|||
94423369|NCT05071313|323339317|FG001|Overall Study|Physician Decision|6|||
94423370|NCT05071313|323339316|FG000|Overall Study|Death|1|||
94423371|NCT05071313|323339317|FG001|Overall Study|Death|0|||
94423372|NCT05071313|323339316|FG000|Overall Study|Withdrawal by Subject|10|||
94423373|NCT05071313|323339317|FG001|Overall Study|Withdrawal by Subject|15|||
94423374|NCT05071313|323339316|FG000|Overall Study|Other|1|||
94423375|NCT05071313|323339317|FG001|Overall Study|Other|0|||
94423376|NCT05071313|323339316|FG000|Overall Study|Randomized but not vaccinated|4|||
94423377|NCT05071313|323339317|FG001|Overall Study|Randomized but not vaccinated|2|||
94423378|NCT02049450|323339320|FG000|Overall Study|Adverse Event|2|||
94423379|NCT02049450|323339320|FG000|Overall Study|Withdrawal by Subject|1|||
94423380|NCT02049450|323339320|FG000|Overall Study|Patients/guardian decision|1|||
94423381|NCT03283319|323339321|FG000|Overall Study|Lost to Follow-up|5|||
94423382|NCT03283319|323339322|FG001|Overall Study|Lost to Follow-up|4|||
94423383|NCT03283319|323339323|FG002|Overall Study|Lost to Follow-up|5|||
94423384|NCT03283319|323339324|FG003|Overall Study|Lost to Follow-up|5|||
94423385|NCT03283319|323339325|FG004|Overall Study|Lost to Follow-up|4|||
94423386|NCT03283319|323339326|FG005|Overall Study|Lost to Follow-up|3|||
94423387|NCT03283319|323339321|FG000|Overall Study|Withdrawal by Subject|2|||
94423388|NCT03283319|323339322|FG001|Overall Study|Withdrawal by Subject|2|||
94423389|NCT03283319|323339323|FG002|Overall Study|Withdrawal by Subject|2|||
94423390|NCT03283319|323339324|FG003|Overall Study|Withdrawal by Subject|1|||
94423391|NCT03283319|323339325|FG004|Overall Study|Withdrawal by Subject|0|||
94423392|NCT03283319|323339326|FG005|Overall Study|Withdrawal by Subject|1|||
94423393|NCT03283319|323339321|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
94423394|NCT03283319|323339322|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
94423395|NCT03283319|323339323|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
94423396|NCT03283319|323339324|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
94423397|NCT03283319|323339325|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
94423398|NCT03283319|323339326|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
94423399|NCT02492880|323339327|FG000|Overall Study|Lost to Follow-up|1|||
94423400|NCT02492880|323339327|FG000|Overall Study|Protocol Violation|1|||
94423401|NCT04462471|323339328|FG000|Overall Study|Adverse Event|0|||
94423402|NCT04462471|323339329|FG001|Overall Study|Adverse Event|1|||
94423403|NCT04462471|323339330|FG002|Overall Study|Adverse Event|0|||
94423404|NCT04462471|323339331|FG003|Overall Study|Adverse Event|0|||
94423405|NCT04462471|323339328|FG000|Overall Study|Disease progression|1|||
94423406|NCT04462471|323339329|FG001|Overall Study|Disease progression|0|||
94423407|NCT04462471|323339330|FG002|Overall Study|Disease progression|0|||
94423408|NCT04462471|323339331|FG003|Overall Study|Disease progression|0|||
94423409|NCT01200992|323339332|FG000|Overall Study|Study terminated early|35|||
94423410|NCT01200992|323339333|FG001|Overall Study|Study terminated early|41|||
94423411|NCT01200992|323339332|FG000|Overall Study|Randomized but not treated|2|||
94423412|NCT01200992|323339333|FG001|Overall Study|Randomized but not treated|0|||
94423413|NCT03665441|323339334|FG000|Overall Study|survival follow up ongoing|23|||
94423414|NCT03665441|323339335|FG001|Overall Study|survival follow up ongoing|0|||
94423415|NCT03665441|323339334|FG000|Overall Study|Patients ongoing on treatment|9|||
94423416|NCT03665441|323339335|FG001|Overall Study|Patients ongoing on treatment|6|||
94423417|NCT03665441|323339334|FG000|Overall Study|Randomized but not treated|7|||
94423418|NCT03665441|323339335|FG001|Overall Study|Randomized but not treated|11|||
94423419|NCT00324649|323339337|FG000|Overall Study|Adverse Event|1|||
94423420|NCT00324649|323339338|FG001|Overall Study|Adverse Event|4|||
94423421|NCT00324649|323339337|FG000|Overall Study|Withdrawal by Subject|0|||
94423422|NCT00324649|323339338|FG001|Overall Study|Withdrawal by Subject|1|||
94423423|NCT00324649|323339337|FG000|Overall Study|Noncompliance|1|||
94423424|NCT00324649|323339338|FG001|Overall Study|Noncompliance|0|||
94423425|NCT00114166|323339339|FG000|Overall Study|Wrong primary|0|||
94423426|NCT00114166|323339340|FG001|Overall Study|Wrong primary|1|||
94423427|NCT00140426|323339341|FG000|Overall Study|Withdrawal by Subject|0|||
94423428|NCT00140426|323339342|FG001|Overall Study|Withdrawal by Subject|3|||
94423429|NCT02149108|323339343|FG000|Overall Study|Not treated|1|||
94423430|NCT02149108|323339344|FG001|Overall Study|Not treated|2|||
94423431|NCT02149108|323339343|FG000|Overall Study|Progressive Disease (PD)|324|||
94423432|NCT02149108|323339344|FG001|Overall Study|Progressive Disease (PD)|318|||
94423433|NCT02149108|323339343|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
94423434|NCT02149108|323339344|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
94423435|NCT02149108|323339343|FG000|Overall Study|Other Adverse Event (AE)|8|||
94423436|NCT02149108|323339344|FG001|Overall Study|Other Adverse Event (AE)|18|||
94423437|NCT02149108|323339343|FG000|Overall Study|Other not defined above|0|||
94423438|NCT02149108|323339344|FG001|Overall Study|Other not defined above|2|||
94423439|NCT02149108|323339343|FG000|Overall Study|Refusal to continue trial medication|15|||
94423440|NCT02149108|323339344|FG001|Overall Study|Refusal to continue trial medication|11|||
94423441|NCT02149108|323339343|FG000|Overall Study|Lost to Follow-up|1|||
94423442|NCT02149108|323339344|FG001|Overall Study|Lost to Follow-up|0|||
94423443|NCT01675661|323339347|FG000|Overall Study|Lost to Follow-up|22|||
94423444|NCT01675661|323339348|FG001|Overall Study|Lost to Follow-up|23|||
94423445|NCT01675661|323339347|FG000|Overall Study|Practical problems|9|||
94423446|NCT01675661|323339348|FG001|Overall Study|Practical problems|5|||
94423447|NCT01675661|323339347|FG000|Overall Study|Moved away|5|||
94423448|NCT01675661|323339348|FG001|Overall Study|Moved away|6|||
94423449|NCT01675661|323339347|FG000|Overall Study|Withdrawal by Subject|3|||
94423450|NCT01675661|323339348|FG001|Overall Study|Withdrawal by Subject|7|||
94423451|NCT01675661|323339347|FG000|Overall Study|Physician Decision|0|||
94423452|NCT01675661|323339348|FG001|Overall Study|Physician Decision|2|||
94423453|NCT01675661|323339347|FG000|Overall Study|Death|0|||
94423454|NCT01675661|323339348|FG001|Overall Study|Death|1|||
94423455|NCT01675661|323339347|FG000|Overall Study|Other reason|1|||
94489306|NCT00903968|323586022|FG003|Overall Study|Lack of Efficacy|0|||
94489307|NCT00903968|323586023|FG004|Overall Study|Lack of Efficacy|0|||
94489308|NCT00903968|323586024|FG005|Overall Study|Lack of Efficacy|0|||
94489309|NCT00903968|323586025|FG006|Overall Study|Lack of Efficacy|0|||
94489310|NCT00903968|323586026|FG007|Overall Study|Lack of Efficacy|3|||
94423456|NCT01675661|323339348|FG001|Overall Study|Other reason|2|||
94423457|NCT02534844|323339349|FG000|Part B|Withdrawal by Subject|0|||
94423458|NCT02534844|323339350|FG001|Part B|Withdrawal by Subject|0|||
94423459|NCT02534844|323339351|FG002|Part B|Withdrawal by Subject|0|||
94423460|NCT02534844|323339352|FG003|Part B|Withdrawal by Subject|0|||
94423461|NCT02534844|323339353|FG004|Part B|Withdrawal by Subject|2|||
94423462|NCT02534844|323339354|FG005|Part B|Withdrawal by Subject|1|||
94423463|NCT00655876|323339355|FG000|Overall Study|Protocol Violation|9|||
94423464|NCT00655876|323339356|FG001|Overall Study|Protocol Violation|7|||
94423465|NCT01359969|323339357|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
94423466|NCT01070771|323339358|FG000|Overall Study|Adverse Event|2|||
94423467|NCT01070771|323339358|FG000|Overall Study|Protocol Violation|1|||
94423468|NCT03825341|323339359|FG000|Overall Study|Withdrawal by Subject|0|||
94423469|NCT03825341|323339360|FG001|Overall Study|Withdrawal by Subject|1|||
94423470|NCT03246126|323339368|FG000|Overall Study|Withdrawal by Subject|0|||
94423471|NCT03246126|323339369|FG001|Overall Study|Withdrawal by Subject|1|||
94423472|NCT01006135|323339377|FG000|Overall Study|Adverse Event|22|||
94423473|NCT01006135|323339377|FG000|Overall Study|Protocol Violation|14|||
94423474|NCT01006135|323339377|FG000|Overall Study|Lost to Follow-up|32|||
94423475|NCT01006135|323339377|FG000|Overall Study|Other|72|||
94423476|NCT01468818|323339379|FG000|Overall Study|Death during treatment|2|||
94423477|NCT01212588|323339380|FG000|Overall Study|Physician Decision|0|||
94423478|NCT01212588|323339381|FG001|Overall Study|Physician Decision|1|||
94423479|NCT01212588|323339380|FG000|Overall Study|Protocol Violation|1|||
94423480|NCT01212588|323339381|FG001|Overall Study|Protocol Violation|1|||
94423481|NCT00132028|323339382|FG000|Overall Study|Adverse Event|7|||
94423482|NCT00132028|323339382|FG000|Overall Study|Death|2|||
94423483|NCT00132028|323339382|FG000|Overall Study|Lack of Efficacy|11|||
94423484|NCT00132028|323339382|FG000|Overall Study|Withdrawal by Subject|2|||
94423485|NCT00132028|323339382|FG000|Overall Study|not eligible|2|||
94423486|NCT00132028|323339382|FG000|Overall Study|Physician Decision|3|||
94423487|NCT02338193|323339383|FG000|Overall Study|Withdrawal by Subject|0|||
94423488|NCT02338193|323339384|FG001|Overall Study|Withdrawal by Subject|0|||
94423489|NCT02338193|323339385|FG002|Overall Study|Withdrawal by Subject|2|||
94423490|NCT02338193|323339383|FG000|Overall Study|Pregnancy|0|||
94423491|NCT02338193|323339384|FG001|Overall Study|Pregnancy|1|||
94423492|NCT02338193|323339385|FG002|Overall Study|Pregnancy|1|||
94423493|NCT02338193|323339383|FG000|Overall Study|Noncompliant with visits|2|||
94423494|NCT02338193|323339384|FG001|Overall Study|Noncompliant with visits|2|||
94423495|NCT02338193|323339385|FG002|Overall Study|Noncompliant with visits|7|||
94423496|NCT02338193|323339383|FG000|Overall Study|moved out of state|0|||
94423497|NCT02338193|323339384|FG001|Overall Study|moved out of state|1|||
94423498|NCT02338193|323339385|FG002|Overall Study|moved out of state|0|||
94423499|NCT02338193|323339383|FG000|Overall Study|intolerant of side effects|1|||
94423500|NCT02338193|323339384|FG001|Overall Study|intolerant of side effects|0|||
94423501|NCT02338193|323339385|FG002|Overall Study|intolerant of side effects|0|||
94423502|NCT02140411|323339386|FG000|Overall Study|Adverse Event|1|||
94423503|NCT01735955|323339391|FG000|Overall Study|Administrative problems|1|||
94423504|NCT01735955|323339391|FG000|Overall Study|Patient/guardian decision|1|||
94423505|NCT01735955|323339391|FG000|Overall Study|Patient withdrew consent|2|||
94423506|NCT01735955|323339391|FG000|Overall Study|Physician Decision|4|||
94423507|NCT01735955|323339391|FG000|Overall Study|Disease progression|24|||
94423508|NCT01735955|323339391|FG000|Overall Study|Adverse Event|5|||
94423509|NCT03981419|323339396|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
94423510|NCT03981419|323339397|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
94423511|NCT00895947|323339399|FG000|Overall Study|Adverse Event|3|||
94423512|NCT00895947|323339400|FG001|Overall Study|Adverse Event|4|||
94423513|NCT00895947|323339399|FG000|Overall Study|Lost to Follow-up|3|||
94423514|NCT00895947|323339400|FG001|Overall Study|Lost to Follow-up|4|||
94423515|NCT00895947|323339399|FG000|Overall Study|Protocol Violation|4|||
94423516|NCT00895947|323339400|FG001|Overall Study|Protocol Violation|2|||
94423517|NCT00895947|323339399|FG000|Overall Study|Withdrawal by Subject|2|||
94423518|NCT00895947|323339400|FG001|Overall Study|Withdrawal by Subject|0|||
94423519|NCT02266134|323339401|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
94423520|NCT02266134|323339402|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
94423521|NCT02266134|323339403|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
94423522|NCT02266134|323339404|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
94423523|NCT02266134|323339401|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
94423524|NCT02266134|323339402|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
94423525|NCT02266134|323339403|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
94423526|NCT02266134|323339404|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
94423527|NCT02266134|323339401|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
94423528|NCT02266134|323339402|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
94423529|NCT02266134|323339403|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
94423530|NCT02266134|323339404|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
94489311|NCT00420745|323586037|FG000|Overall Study|Adverse Event|2|||
94423531|NCT02266134|323339401|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
94423532|NCT02266134|323339402|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
94423533|NCT02266134|323339403|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
94423534|NCT02266134|323339404|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
94423535|NCT02266134|323339401|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
94423536|NCT02266134|323339402|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
94423537|NCT02266134|323339403|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
94423538|NCT02266134|323339404|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
94423539|NCT02266134|323339401|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
94423540|NCT02266134|323339402|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
94423541|NCT02266134|323339403|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
94423542|NCT02266134|323339404|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
94423543|NCT02348723|323339405|FG000|Overall Study|No ablation|21|||
94423544|NCT02348723|323339406|FG001|Overall Study|No ablation|20|||
94423545|NCT02348723|323339405|FG000|Overall Study|Non-compliant with Protocol|1|||
94423546|NCT02348723|323339406|FG001|Overall Study|Non-compliant with Protocol|0|||
94423547|NCT02348723|323339405|FG000|Overall Study|Lost to Follow-up|1|||
94423548|NCT02348723|323339406|FG001|Overall Study|Lost to Follow-up|1|||
94423549|NCT02348723|323339405|FG000|Overall Study|Consent withdrawn|1|||
94423550|NCT02348723|323339406|FG001|Overall Study|Consent withdrawn|3|||
94423551|NCT02348723|323339405|FG000|Overall Study|Reason other than specified|1|||
94423552|NCT02348723|323339406|FG001|Overall Study|Reason other than specified|1|||
94423553|NCT02348723|323339405|FG000|Overall Study|Adverse Event|3|||
94423554|NCT02348723|323339406|FG001|Overall Study|Adverse Event|1|||
94423555|NCT00724048|323339407|FG000|Overall Study|Adverse Event|1|||
94423556|NCT00724048|323339408|FG001|Overall Study|Adverse Event|1|||
94423557|NCT00724048|323339409|FG002|Overall Study|Adverse Event|1|||
94423558|NCT00724048|323339410|FG003|Overall Study|Adverse Event|0|||
94423559|NCT00724048|323339407|FG000|Overall Study|Lost to Follow-up|0|||
94423560|NCT00724048|323339408|FG001|Overall Study|Lost to Follow-up|1|||
94423561|NCT00724048|323339409|FG002|Overall Study|Lost to Follow-up|0|||
94423562|NCT00724048|323339410|FG003|Overall Study|Lost to Follow-up|0|||
94423563|NCT00724048|323339407|FG000|Overall Study|Withdrawal by Subject|1|||
94423564|NCT00724048|323339408|FG001|Overall Study|Withdrawal by Subject|2|||
94423565|NCT00724048|323339409|FG002|Overall Study|Withdrawal by Subject|1|||
94423566|NCT00724048|323339410|FG003|Overall Study|Withdrawal by Subject|2|||
94423567|NCT00724048|323339407|FG000|Overall Study|Investigator decision|0|||
94423568|NCT00724048|323339408|FG001|Overall Study|Investigator decision|0|||
94423569|NCT00724048|323339409|FG002|Overall Study|Investigator decision|1|||
94423570|NCT00724048|323339410|FG003|Overall Study|Investigator decision|0|||
94423571|NCT00724048|323339407|FG000|Overall Study|Did not tolerate study drug|0|||
94423572|NCT00724048|323339408|FG001|Overall Study|Did not tolerate study drug|0|||
94423573|NCT00724048|323339409|FG002|Overall Study|Did not tolerate study drug|0|||
94423574|NCT00724048|323339410|FG003|Overall Study|Did not tolerate study drug|1|||
94423575|NCT00724048|323339407|FG000|Overall Study|Other than specified|1|||
94423576|NCT00724048|323339408|FG001|Overall Study|Other than specified|1|||
94423577|NCT00724048|323339409|FG002|Overall Study|Other than specified|0|||
94423578|NCT00724048|323339410|FG003|Overall Study|Other than specified|0|||
94423579|NCT02722148|323339411|FG000|Overall Study|Lost to Follow-up|2|||
94423580|NCT02722148|323339411|FG000|Overall Study|Non compliant with treatment regimen|3|||
94423581|NCT04135196|323339412|FG000|Overall Study|Lost to Follow-up|8|||
94423582|NCT04135196|323339413|FG001|Overall Study|Lost to Follow-up|7|||
94423583|NCT04135196|323339414|FG002|Overall Study|Lost to Follow-up|8|||
94423584|NCT04135196|323339415|FG003|Overall Study|Lost to Follow-up|9|||
94423585|NCT04135196|323339416|FG004|Overall Study|Lost to Follow-up|1|||
94423586|NCT04135196|323339412|FG000|Overall Study|Pregnancy|0|||
94423587|NCT04135196|323339413|FG001|Overall Study|Pregnancy|0|||
94423588|NCT04135196|323339414|FG002|Overall Study|Pregnancy|1|||
94423589|NCT04135196|323339415|FG003|Overall Study|Pregnancy|0|||
94423590|NCT04135196|323339416|FG004|Overall Study|Pregnancy|0|||
94423591|NCT04135196|323339412|FG000|Overall Study|Withdrawal by Subject|0|||
94423592|NCT04135196|323339413|FG001|Overall Study|Withdrawal by Subject|0|||
94423593|NCT04135196|323339414|FG002|Overall Study|Withdrawal by Subject|0|||
94423594|NCT04135196|323339415|FG003|Overall Study|Withdrawal by Subject|0|||
94423595|NCT04135196|323339416|FG004|Overall Study|Withdrawal by Subject|1|||
94423596|NCT00073021|323339417|FG000|Overall Study|Protocol Violation|2|||
94423597|NCT00073021|323339418|FG001|Overall Study|Protocol Violation|1|||
94423598|NCT00073021|323339417|FG000|Overall Study|Adverse Event|4|||
94423599|NCT00073021|323339418|FG001|Overall Study|Adverse Event|4|||
94423600|NCT00073021|323339417|FG000|Overall Study|Withdrawal by Subject|6|||
94423601|NCT00073021|323339418|FG001|Overall Study|Withdrawal by Subject|5|||
94423602|NCT00073021|323339417|FG000|Overall Study|Physician Decision|3|||
94423603|NCT00073021|323339418|FG001|Overall Study|Physician Decision|1|||
94423604|NCT00073021|323339417|FG000|Overall Study|Lack of Efficacy|11|||
94423605|NCT00073021|323339418|FG001|Overall Study|Lack of Efficacy|5|||
94423606|NCT02991430|323339421|FG000|Treatment Period 1|Adverse Event|1|||
94489312|NCT00420745|323586038|FG001|Overall Study|Adverse Event|2|||
94423607|NCT02991430|323339422|FG001|Treatment Period 1|Adverse Event|0|||
94423608|NCT02991430|323339423|FG002|Treatment Period 1|Adverse Event|2|||
94423609|NCT02991430|323339421|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94423610|NCT02991430|323339422|FG001|Treatment Period 1|Withdrawal by Subject|4|||
94423611|NCT02991430|323339423|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94423612|NCT02991430|323339421|FG000|Treatment Period 2|Study Termination|6|||
94423613|NCT02991430|323339422|FG001|Treatment Period 2|Study Termination|3|||
94423614|NCT02991430|323339423|FG002|Treatment Period 2|Study Termination|3|||
94423615|NCT02991430|323339421|FG000|Treatment Period 2|Lost to Follow-up|0|||
94423616|NCT02991430|323339422|FG001|Treatment Period 2|Lost to Follow-up|0|||
94423617|NCT02991430|323339423|FG002|Treatment Period 2|Lost to Follow-up|1|||
94423618|NCT02991430|323339421|FG000|Post-treatment Observation Period|Study Termination|3|||
94423619|NCT02991430|323339422|FG001|Post-treatment Observation Period|Study Termination|6|||
94423620|NCT02991430|323339423|FG002|Post-treatment Observation Period|Study Termination|5|||
94423621|NCT01672970|323339424|FG000|Overall Study|Lack of Efficacy|12|||
94423622|NCT01672970|323339424|FG000|Overall Study|Adverse Event|18|||
94423623|NCT01672970|323339424|FG000|Overall Study|Withdrawal by Subject|2|||
94423624|NCT01672970|323339424|FG000|Overall Study|Lost to Follow-up|5|||
94423625|NCT01672970|323339424|FG000|Overall Study|Other|9|||
94423626|NCT01672970|323339424|FG000|Overall Study|Enrolled but not treated|1|||
94423627|NCT00620659|323339433|FG000|Treatment Period 1|Adverse Event|1|||
94423628|NCT00620659|323339434|FG001|Treatment Period 1|Adverse Event|0|||
94423629|NCT00620659|323339435|FG002|Treatment Period 1|Adverse Event|0|||
94423630|NCT00620659|323339436|FG003|Treatment Period 1|Adverse Event|3|||
94655532|NCT00927927|324196060|FG000|Overall Study|Withdrawal by Subject|0|||
94423631|NCT00620659|323339437|FG004|Treatment Period 1|Adverse Event|0|||
94423632|NCT00620659|323339438|FG005|Treatment Period 1|Adverse Event|0|||
94423633|NCT00620659|323339433|FG000|Treatment Period 1|Protocol Violation|1|||
94423634|NCT00620659|323339434|FG001|Treatment Period 1|Protocol Violation|0|||
94423635|NCT00620659|323339435|FG002|Treatment Period 1|Protocol Violation|0|||
94423636|NCT00620659|323339436|FG003|Treatment Period 1|Protocol Violation|0|||
94423637|NCT00620659|323339437|FG004|Treatment Period 1|Protocol Violation|0|||
94423638|NCT00620659|323339438|FG005|Treatment Period 1|Protocol Violation|0|||
94423639|NCT00620659|323339433|FG000|Treatment Period 1|Withdrawal by Subject|1|||
94423640|NCT00620659|323339434|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94423641|NCT00620659|323339435|FG002|Treatment Period 1|Withdrawal by Subject|1|||
94423642|NCT00620659|323339436|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94423643|NCT00620659|323339437|FG004|Treatment Period 1|Withdrawal by Subject|1|||
94423644|NCT00620659|323339438|FG005|Treatment Period 1|Withdrawal by Subject|0|||
94423645|NCT00620659|323339433|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
94423646|NCT00620659|323339434|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
94423647|NCT00620659|323339435|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
94423648|NCT00620659|323339436|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
94423649|NCT00620659|323339437|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
94423650|NCT00620659|323339438|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
94423651|NCT00620659|323339433|FG000|Treatment Period 2|Adverse Event|0|||
94423652|NCT00620659|323339434|FG001|Treatment Period 2|Adverse Event|3|||
94423653|NCT00620659|323339435|FG002|Treatment Period 2|Adverse Event|0|||
94423654|NCT00620659|323339436|FG003|Treatment Period 2|Adverse Event|0|||
94423655|NCT00620659|323339437|FG004|Treatment Period 2|Adverse Event|2|||
94423656|NCT00620659|323339438|FG005|Treatment Period 2|Adverse Event|0|||
94423657|NCT00620659|323339433|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94423658|NCT00620659|323339434|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94423659|NCT00620659|323339435|FG002|Treatment Period 2|Withdrawal by Subject|1|||
94423660|NCT00620659|323339436|FG003|Treatment Period 2|Withdrawal by Subject|0|||
94423661|NCT00620659|323339437|FG004|Treatment Period 2|Withdrawal by Subject|3|||
94423662|NCT00620659|323339438|FG005|Treatment Period 2|Withdrawal by Subject|0|||
94423663|NCT00620659|323339433|FG000|Placebo Washout Period 2|Adverse Event|2|||
94423664|NCT00620659|323339434|FG001|Placebo Washout Period 2|Adverse Event|0|||
94423665|NCT00620659|323339435|FG002|Placebo Washout Period 2|Adverse Event|0|||
94423666|NCT00620659|323339436|FG003|Placebo Washout Period 2|Adverse Event|0|||
94423667|NCT00620659|323339437|FG004|Placebo Washout Period 2|Adverse Event|0|||
94423668|NCT00620659|323339438|FG005|Placebo Washout Period 2|Adverse Event|0|||
94423669|NCT00620659|323339433|FG000|Treatment Period 3|Adverse Event|0|||
94423670|NCT00620659|323339434|FG001|Treatment Period 3|Adverse Event|2|||
94489313|NCT00420745|323586037|FG000|Overall Study|Lost to Follow-up|10|||
94489314|NCT00420745|323586038|FG001|Overall Study|Lost to Follow-up|2|||
94489315|NCT00420745|323586037|FG000|Overall Study|Protocol Violation|1|||
94489316|NCT00420745|323586038|FG001|Overall Study|Protocol Violation|0|||
94423671|NCT00620659|323339435|FG002|Treatment Period 3|Adverse Event|0|||
94423672|NCT00620659|323339436|FG003|Treatment Period 3|Adverse Event|0|||
94423673|NCT00620659|323339437|FG004|Treatment Period 3|Adverse Event|0|||
94423674|NCT00620659|323339438|FG005|Treatment Period 3|Adverse Event|0|||
94423675|NCT00620659|323339433|FG000|Treatment Period 3|Withdrawal by Subject|0|||
94423676|NCT00620659|323339434|FG001|Treatment Period 3|Withdrawal by Subject|0|||
94423677|NCT00620659|323339435|FG002|Treatment Period 3|Withdrawal by Subject|0|||
94423678|NCT00620659|323339436|FG003|Treatment Period 3|Withdrawal by Subject|1|||
94423679|NCT00620659|323339437|FG004|Treatment Period 3|Withdrawal by Subject|0|||
94423680|NCT00620659|323339438|FG005|Treatment Period 3|Withdrawal by Subject|0|||
94423681|NCT03365011|323339439|FG000|Overall Study|Withdrawal by Subject|1|||
94423682|NCT03365011|323339440|FG001|Overall Study|Withdrawal by Subject|2|||
94423683|NCT04853992|323339441|FG000|Treatment Period A|Adverse Event|0|||
94423684|NCT04853992|323339442|FG001|Treatment Period A|Adverse Event|1|||
94423685|NCT04853992|323339441|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
94423686|NCT04853992|323339442|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
94655533|NCT00927927|324196061|FG001|Overall Study|Withdrawal by Subject|0|||
94423687|NCT03246646|323339443|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
94423688|NCT03246646|323339444|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
94423689|NCT03246646|323339443|FG000|Overall Study|Withdrawal by Subject|3|||
94423690|NCT03246646|323339444|FG001|Overall Study|Withdrawal by Subject|0|||
94423691|NCT03246646|323339443|FG000|Overall Study|Lost to Follow-up|7|||
94423692|NCT03246646|323339444|FG001|Overall Study|Lost to Follow-up|0|||
94423693|NCT00499174|323339445|FG000|Overall Study|Physician Decision|78|||
94423694|NCT00499174|323339446|FG001|Overall Study|Physician Decision|9|||
94423695|NCT04024462|323342691|FG000|Overall Study|Withdrawal by Subject|6|||
94423696|NCT04024462|323342692|FG001|Overall Study|Withdrawal by Subject|7|||
94423697|NCT04024462|323342691|FG000|Overall Study|Progressive Disease|0|||
94423698|NCT04024462|323342692|FG001|Overall Study|Progressive Disease|1|||
94489317|NCT00420745|323586037|FG000|Overall Study|Physician Decision|1|||
94489318|NCT00420745|323586038|FG001|Overall Study|Physician Decision|1|||
94489319|NCT00420745|323586037|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
94489320|NCT00420745|323586038|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
94489321|NCT00420745|323586037|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
94489322|NCT00420745|323586038|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
94489323|NCT03408899|323586039|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
94489324|NCT03636256|323586040|FG000|Overall Study|Lost to Follow-up|3|||
94489325|NCT03636256|323586041|FG001|Overall Study|Lost to Follow-up|0|||
94489326|NCT03636256|323586042|FG002|Overall Study|Lost to Follow-up|2|||
94489327|NCT03636256|323586043|FG003|Overall Study|Lost to Follow-up|1|||
94489328|NCT03636256|323586044|FG004|Overall Study|Lost to Follow-up|0|||
94489329|NCT03636256|323586045|FG005|Overall Study|Lost to Follow-up|4|||
94489330|NCT03636256|323586046|FG006|Overall Study|Lost to Follow-up|2|||
94489331|NCT03636256|323586047|FG007|Overall Study|Lost to Follow-up|0|||
94489332|NCT03636256|323586048|FG008|Overall Study|Lost to Follow-up|4|||
94489333|NCT03636256|323586040|FG000|Overall Study|Withdrawal by Subject|0|||
94423699|NCT04024462|323342691|FG000|Overall Study|Adverse Event|0|||
94423700|NCT04024462|323342692|FG001|Overall Study|Adverse Event|1|||
94423701|NCT04024462|323342691|FG000|Overall Study|Death|0|||
94423702|NCT04024462|323342692|FG001|Overall Study|Death|1|||
94423703|NCT04024462|323342691|FG000|Overall Study|Lost to Follow-up|1|||
94423704|NCT04024462|323342692|FG001|Overall Study|Lost to Follow-up|0|||
94423705|NCT04024462|323342691|FG000|Overall Study|Ongoing in the Study|94|||
94423706|NCT04024462|323342692|FG001|Overall Study|Ongoing in the Study|89|||
94423707|NCT05101486|323342693|FG000|Overall Study|Death|1|||
94423708|NCT05101486|323342694|FG001|Overall Study|Death|0|||
94423709|NCT05101486|323342695|FG002|Overall Study|Death|1|||
94423710|NCT05101486|323342693|FG000|Overall Study|Lost to Follow-up|12|||
94423711|NCT05101486|323342694|FG001|Overall Study|Lost to Follow-up|8|||
94423712|NCT05101486|323342695|FG002|Overall Study|Lost to Follow-up|17|||
94423713|NCT05101486|323342693|FG000|Overall Study|Physician Decision|1|||
94423714|NCT05101486|323342694|FG001|Overall Study|Physician Decision|0|||
94423715|NCT05101486|323342695|FG002|Overall Study|Physician Decision|0|||
94423716|NCT05101486|323342693|FG000|Overall Study|Protocol Violation|0|||
94423717|NCT05101486|323342694|FG001|Overall Study|Protocol Violation|0|||
94423718|NCT05101486|323342695|FG002|Overall Study|Protocol Violation|1|||
94423719|NCT05101486|323342693|FG000|Overall Study|Withdrawal by Subject|5|||
94423720|NCT05101486|323342694|FG001|Overall Study|Withdrawal by Subject|2|||
94423721|NCT05101486|323342695|FG002|Overall Study|Withdrawal by Subject|4|||
94423722|NCT05101486|323342693|FG000|Overall Study|Randomized but not vaccinated|1|||
94423723|NCT05101486|323342694|FG001|Overall Study|Randomized but not vaccinated|1|||
94423724|NCT05101486|323342695|FG002|Overall Study|Randomized but not vaccinated|1|||
94423725|NCT03747601|323342696|FG000|Overall Study|COVID halt to visits|4|||
94423726|NCT03982199|323342697|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
94423727|NCT03982199|323342698|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
94423728|NCT03982199|323342699|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
94423729|NCT03982199|323342700|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
94423730|NCT03982199|323342701|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
94423731|NCT03982199|323342702|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
94423732|NCT03982199|323342703|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
94423733|NCT03982199|323342704|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
94423734|NCT03982199|323342705|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
94423735|NCT03982199|323342706|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
94423736|NCT03982199|323342707|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
94423737|NCT03982199|323342708|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
94423738|NCT03982199|323342709|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
94423739|NCT03982199|323342710|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
94489334|NCT03636256|323586041|FG001|Overall Study|Withdrawal by Subject|0|||
94423740|NCT03982199|323342697|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
94423741|NCT03982199|323342698|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
94489335|NCT03636256|323586042|FG002|Overall Study|Withdrawal by Subject|0|||
94489336|NCT03636256|323586043|FG003|Overall Study|Withdrawal by Subject|0|||
94423742|NCT03982199|323342699|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
94423743|NCT03982199|323342700|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
94423744|NCT03982199|323342701|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
94423745|NCT03982199|323342702|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
94423746|NCT03982199|323342703|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
94423747|NCT03982199|323342704|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
94423748|NCT03982199|323342705|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
94423749|NCT03982199|323342706|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
94423750|NCT03982199|323342707|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
94423751|NCT03982199|323342708|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
94423752|NCT03982199|323342709|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
94423753|NCT03982199|323342710|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
94423754|NCT03982199|323342697|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
94423755|NCT03982199|323342698|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
94423756|NCT03982199|323342699|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
94423757|NCT03982199|323342700|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
94423758|NCT03982199|323342701|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
94423759|NCT03982199|323342702|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
94423760|NCT03982199|323342703|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
94423761|NCT03982199|323342704|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
94423762|NCT03982199|323342705|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
94423763|NCT03982199|323342706|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
94423764|NCT03982199|323342707|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
94423765|NCT03982199|323342708|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
94423766|NCT03982199|323342709|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
94423767|NCT03982199|323342710|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
94423768|NCT03982199|323342697|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
94423769|NCT03982199|323342698|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
94423770|NCT03982199|323342699|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
94423771|NCT03982199|323342700|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
94423772|NCT03982199|323342701|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
94423773|NCT03982199|323342702|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
94423774|NCT03982199|323342703|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
94423775|NCT03982199|323342704|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
94423776|NCT03982199|323342705|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
94423777|NCT03982199|323342706|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
94423778|NCT03982199|323342707|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
94423779|NCT03982199|323342708|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
94423780|NCT03982199|323342709|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
94423781|NCT03982199|323342710|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
94423782|NCT03982199|323342697|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
94423783|NCT03982199|323342698|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
94423784|NCT03982199|323342699|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
94423785|NCT03982199|323342700|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
94423786|NCT03982199|323342701|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
94423787|NCT03982199|323342702|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
94423788|NCT03982199|323342703|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
94423789|NCT03982199|323342704|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
94423790|NCT03982199|323342705|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
94423791|NCT03982199|323342706|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
94423792|NCT03982199|323342707|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
94423793|NCT03982199|323342708|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
94423794|NCT03982199|323342709|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
94423795|NCT03982199|323342710|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
94423796|NCT03982199|323342697|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
94423797|NCT03982199|323342698|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
94423798|NCT03982199|323342699|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
94423799|NCT03982199|323342700|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
94423800|NCT03982199|323342701|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
94423801|NCT03982199|323342702|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
94423802|NCT03982199|323342703|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
94423803|NCT03982199|323342704|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
94423804|NCT03982199|323342705|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
94423805|NCT03982199|323342706|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
94423806|NCT03982199|323342707|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
94423807|NCT03982199|323342708|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
94423808|NCT03982199|323342709|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
94423809|NCT03982199|323342710|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
94423810|NCT03982199|323342697|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
94423811|NCT03982199|323342698|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
94423812|NCT03982199|323342699|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
94423813|NCT03982199|323342700|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
94423814|NCT03982199|323342701|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
94423815|NCT03982199|323342702|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
94423816|NCT03982199|323342703|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
94423817|NCT03982199|323342704|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
94423818|NCT03982199|323342705|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
94423819|NCT03982199|323342706|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
94423820|NCT03982199|323342707|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
94423821|NCT03982199|323342708|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
94423822|NCT03982199|323342709|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
94423823|NCT03982199|323342710|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
94423824|NCT03982199|323342697|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
94423825|NCT03982199|323342698|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
94423826|NCT03982199|323342699|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
94423827|NCT03982199|323342700|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
94423828|NCT03982199|323342701|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
94423829|NCT03982199|323342702|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
94423830|NCT03982199|323342703|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
94423831|NCT03982199|323342704|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
94423832|NCT03982199|323342705|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
94423833|NCT03982199|323342706|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
94423834|NCT03982199|323342707|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
94423835|NCT03982199|323342708|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
94423836|NCT03982199|323342709|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
94423837|NCT03982199|323342710|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
94423838|NCT03982199|323342697|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
94423839|NCT03982199|323342698|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
94423840|NCT03982199|323342699|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
94423841|NCT03982199|323342700|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
94423842|NCT03982199|323342701|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
94423843|NCT03982199|323342702|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
94423844|NCT03982199|323342703|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
94423845|NCT03982199|323342704|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
94423846|NCT03982199|323342705|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
94423847|NCT03982199|323342706|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
94423848|NCT03982199|323342707|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
94423849|NCT03982199|323342708|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
94423850|NCT03982199|323342709|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
94423851|NCT03982199|323342710|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
94423852|NCT03982199|323342697|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
94423853|NCT03982199|323342698|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
94423854|NCT03982199|323342699|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
94423855|NCT03982199|323342700|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
94423856|NCT03982199|323342701|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
94423857|NCT03982199|323342702|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
94423858|NCT03982199|323342703|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
94423859|NCT03982199|323342704|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
94423860|NCT03982199|323342705|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
94423861|NCT03982199|323342706|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
94423862|NCT03982199|323342707|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
94423863|NCT03982199|323342708|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
94423864|NCT03982199|323342709|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
94423865|NCT03982199|323342710|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
94423866|NCT03982199|323342697|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
94423867|NCT03982199|323342698|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
94423868|NCT03982199|323342699|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
94423869|NCT03982199|323342700|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
94423870|NCT03982199|323342701|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
94423871|NCT03982199|323342702|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
94423872|NCT03982199|323342703|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
94423873|NCT03982199|323342704|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
94423874|NCT03982199|323342705|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
94423875|NCT03982199|323342706|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
94423876|NCT03982199|323342707|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
94423877|NCT03982199|323342708|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
94423878|NCT03982199|323342709|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
94423879|NCT03982199|323342710|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
94423880|NCT03982199|323342697|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
94423881|NCT03982199|323342698|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
94423882|NCT03982199|323342699|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
94423883|NCT03982199|323342700|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
94423884|NCT03982199|323342701|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
94423885|NCT03982199|323342702|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
94423886|NCT03982199|323342703|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
94423887|NCT03982199|323342704|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
94423888|NCT03982199|323342705|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
94423889|NCT03982199|323342706|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
94423890|NCT03982199|323342707|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
94423891|NCT03982199|323342708|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
94423892|NCT03982199|323342709|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
94423893|NCT03982199|323342710|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
94423894|NCT03982199|323342697|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
94423895|NCT03982199|323342698|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
94423896|NCT03982199|323342699|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
94423897|NCT03982199|323342700|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
94423898|NCT03982199|323342701|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
94423899|NCT03982199|323342702|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
94423900|NCT03982199|323342703|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
94423901|NCT03982199|323342704|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
94423902|NCT03982199|323342705|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
94423903|NCT03982199|323342706|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
94423904|NCT03982199|323342707|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
94423905|NCT03982199|323342708|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
94423906|NCT03982199|323342709|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
94423907|NCT03982199|323342710|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
94423908|NCT03982199|323342697|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
94423909|NCT03982199|323342698|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
94423910|NCT03982199|323342699|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
94423911|NCT03982199|323342700|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
94423912|NCT03982199|323342701|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
94423913|NCT03982199|323342702|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
94423914|NCT03982199|323342703|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
94423915|NCT03982199|323342704|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
94423916|NCT03982199|323342705|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
94423917|NCT03982199|323342706|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
94423918|NCT03982199|323342707|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
94423919|NCT03982199|323342708|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
94423920|NCT03982199|323342709|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
94423921|NCT03982199|323342710|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
94423922|NCT03982199|323342697|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
94423923|NCT03982199|323342698|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
94423924|NCT03982199|323342699|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
94423925|NCT03982199|323342700|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
94423926|NCT03982199|323342701|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
94423927|NCT03982199|323342702|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
94423928|NCT03982199|323342703|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
94423929|NCT03982199|323342704|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
94423930|NCT03982199|323342705|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
94423931|NCT03982199|323342706|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
94423932|NCT03982199|323342707|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
94423933|NCT03982199|323342708|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
94423934|NCT03982199|323342709|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
94423935|NCT03982199|323342710|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
94423936|NCT03982199|323342697|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
94423937|NCT03982199|323342698|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
94423938|NCT03982199|323342699|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
94423939|NCT03982199|323342700|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
94423940|NCT03982199|323342701|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
94423941|NCT03982199|323342702|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
94423942|NCT03982199|323342703|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
94423943|NCT03982199|323342704|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
94423944|NCT03982199|323342705|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
94423945|NCT03982199|323342706|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
94423946|NCT03982199|323342707|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
94423947|NCT03982199|323342708|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
94423948|NCT03982199|323342709|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
94423949|NCT03982199|323342710|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
94423950|NCT03982199|323342697|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
94423951|NCT03982199|323342698|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
94423952|NCT03982199|323342699|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
94423953|NCT03982199|323342700|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
94423954|NCT03982199|323342701|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
94423955|NCT03982199|323342702|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
94423956|NCT03982199|323342703|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
94423957|NCT03982199|323342704|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
94423958|NCT03982199|323342705|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
94423959|NCT03982199|323342706|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
94423960|NCT03982199|323342707|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
94423961|NCT03982199|323342708|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
94423962|NCT03982199|323342709|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
94423963|NCT03982199|323342710|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
94423964|NCT03982199|323342697|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
94423965|NCT03982199|323342698|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
94423966|NCT03982199|323342699|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
94423967|NCT03982199|323342700|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
94423968|NCT03982199|323342701|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
94423969|NCT03982199|323342702|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
94423970|NCT03982199|323342703|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
94423971|NCT03982199|323342704|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
94423972|NCT03982199|323342705|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
94423973|NCT03982199|323342706|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
94423974|NCT03982199|323342707|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
94423975|NCT03982199|323342708|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
94423976|NCT03982199|323342709|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
94423977|NCT03982199|323342710|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
94423978|NCT03982199|323342697|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
94423979|NCT03982199|323342698|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
94423980|NCT03982199|323342699|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
94423981|NCT03982199|323342700|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
94423982|NCT03982199|323342701|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
94423983|NCT03982199|323342702|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
94423984|NCT03982199|323342703|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
94423985|NCT03982199|323342704|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
94423986|NCT03982199|323342705|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
94423987|NCT03982199|323342706|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
94423988|NCT03982199|323342707|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
94423989|NCT03982199|323342708|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
94423990|NCT03982199|323342709|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
94423991|NCT03982199|323342710|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
94423992|NCT03982199|323342697|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
94423993|NCT03982199|323342698|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
94423994|NCT03982199|323342699|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
94423995|NCT03982199|323342700|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
94423996|NCT03982199|323342701|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
94423997|NCT03982199|323342702|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
94423998|NCT03982199|323342703|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
94423999|NCT03982199|323342704|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
94424000|NCT03982199|323342705|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
94424001|NCT03982199|323342706|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
94424002|NCT03982199|323342707|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
94424003|NCT03982199|323342708|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
94424004|NCT03982199|323342709|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
94424005|NCT03982199|323342710|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
94424006|NCT03982199|323342697|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
94424007|NCT03982199|323342698|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
94424008|NCT03982199|323342699|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
94424009|NCT03982199|323342700|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
94424010|NCT03982199|323342701|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
94424011|NCT03982199|323342702|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
94424012|NCT03982199|323342703|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
94424013|NCT03982199|323342704|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
94424014|NCT03982199|323342705|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
94424015|NCT03982199|323342706|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
94424016|NCT03982199|323342707|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
94424017|NCT03982199|323342708|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
94424018|NCT03982199|323342709|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
94424019|NCT03982199|323342710|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
94424020|NCT03982199|323342697|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
94424021|NCT03982199|323342698|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
94424022|NCT03982199|323342699|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
94424023|NCT03982199|323342700|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
94424024|NCT03982199|323342701|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
94424025|NCT03982199|323342702|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
94424026|NCT03982199|323342703|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
94424027|NCT03982199|323342704|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
94424028|NCT03982199|323342705|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
94424029|NCT03982199|323342706|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
94424030|NCT03982199|323342707|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
94424031|NCT03982199|323342708|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
94424032|NCT03982199|323342709|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
94424033|NCT03982199|323342710|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
94424034|NCT03982199|323342697|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
94424035|NCT03982199|323342698|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
94424036|NCT03982199|323342699|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
94424037|NCT03982199|323342700|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
94424038|NCT03982199|323342701|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
94424039|NCT03982199|323342702|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
94424040|NCT03982199|323342703|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
94424041|NCT03982199|323342704|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
94424042|NCT03982199|323342705|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
94424043|NCT03982199|323342706|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
94424044|NCT03982199|323342707|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
94424045|NCT03982199|323342708|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
94424046|NCT03982199|323342709|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
94424047|NCT03982199|323342710|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
94424048|NCT03982199|323342697|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
94424049|NCT03982199|323342698|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
94424050|NCT03982199|323342699|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
94424051|NCT03982199|323342700|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
94424052|NCT03982199|323342701|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
94424053|NCT03982199|323342702|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
94424054|NCT03982199|323342703|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
94424055|NCT03982199|323342704|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
94424056|NCT03982199|323342705|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
94424057|NCT03982199|323342706|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
94424058|NCT03982199|323342707|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
94424059|NCT03982199|323342708|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
94424060|NCT03982199|323342709|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
94424061|NCT03982199|323342710|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
94424062|NCT03982199|323342697|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
94424063|NCT03982199|323342698|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
94424064|NCT03982199|323342699|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
94424065|NCT03982199|323342700|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
94424066|NCT03982199|323342701|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
94424067|NCT03982199|323342702|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
94424068|NCT03982199|323342703|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
94424069|NCT03982199|323342704|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
94424070|NCT03982199|323342705|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
94424071|NCT03982199|323342706|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
94424072|NCT03982199|323342707|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
94424073|NCT03982199|323342708|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
94424074|NCT03982199|323342709|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
94424075|NCT03982199|323342710|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
94424076|NCT03982199|323342697|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
94424077|NCT03982199|323342698|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
94424078|NCT03982199|323342699|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
94424079|NCT03982199|323342700|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
94424080|NCT03982199|323342701|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
94424081|NCT03982199|323342702|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
94424082|NCT03982199|323342703|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
94424083|NCT03982199|323342704|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
94424084|NCT03982199|323342705|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
94424085|NCT03982199|323342706|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
94424086|NCT03982199|323342707|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
94424087|NCT03982199|323342708|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
94424088|NCT03982199|323342709|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
94424089|NCT03982199|323342710|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
94424090|NCT03982199|323342697|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
94424091|NCT03982199|323342698|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
94424092|NCT03982199|323342699|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
94424093|NCT03982199|323342700|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
94424094|NCT03982199|323342701|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
94424095|NCT03982199|323342702|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
94424096|NCT03982199|323342703|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
94424097|NCT03982199|323342704|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
94424098|NCT03982199|323342705|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
94424099|NCT03982199|323342706|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
94424100|NCT03982199|323342707|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
94424101|NCT03982199|323342708|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
94424102|NCT03982199|323342709|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
94424103|NCT03982199|323342710|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
94424104|NCT03982199|323342697|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
94424105|NCT03982199|323342698|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
94424106|NCT03982199|323342699|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
94424107|NCT03982199|323342700|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
94424108|NCT03982199|323342701|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
94424109|NCT03982199|323342702|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
94424110|NCT03982199|323342703|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
94424111|NCT03982199|323342704|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
94424112|NCT03982199|323342705|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
94424113|NCT03982199|323342706|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
94424114|NCT03982199|323342707|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
94424115|NCT03982199|323342708|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
94424116|NCT03982199|323342709|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
94424117|NCT03982199|323342710|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
94424118|NCT03982199|323342697|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
94424119|NCT03982199|323342698|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
94424120|NCT03982199|323342699|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
94424121|NCT03982199|323342700|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
94424122|NCT03982199|323342701|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
94489337|NCT03636256|323586044|FG004|Overall Study|Withdrawal by Subject|0|||
94489338|NCT03636256|323586045|FG005|Overall Study|Withdrawal by Subject|0|||
94489339|NCT03636256|323586046|FG006|Overall Study|Withdrawal by Subject|0|||
94489340|NCT03636256|323586047|FG007|Overall Study|Withdrawal by Subject|0|||
94489341|NCT03636256|323586048|FG008|Overall Study|Withdrawal by Subject|1|||
94489342|NCT00883181|323586049|FG000|Overall Study|Hematological Adverse Event|26|||
94489343|NCT00883181|323586049|FG000|Overall Study|Non-hematological Adverse Event|55|||
94489344|NCT00883181|323586049|FG000|Overall Study|Disease Progression|94|||
94489345|NCT00883181|323586049|FG000|Overall Study|Administrative Reason|24|||
94489346|NCT00883181|323586049|FG000|Overall Study|Withdrawal by Subject|4|||
94489347|NCT00883181|323586049|FG000|Overall Study|Death|31|||
94489348|NCT00883181|323586049|FG000|Overall Study|Other|38|||
94489349|NCT00883181|323586049|FG000|Overall Study|Protocol Deviation|3|||
94489350|NCT00883181|323586049|FG000|Overall Study|Noncompliance|3|||
94489351|NCT01483118|323586050|FG000|Overall Study|Lost to Follow-up|12|||
94489352|NCT01483118|323586051|FG001|Overall Study|Lost to Follow-up|16|||
94489353|NCT01178294|323586054|FG000|Overall Study|Adverse Event|4|||
94489354|NCT01178294|323586054|FG000|Overall Study|Lost to Follow-up|2|||
94489355|NCT01178294|323586054|FG000|Overall Study|Lack of Efficacy|1|||
94489356|NCT01178294|323586054|FG000|Overall Study|Death|1|||
94489357|NCT01178294|323586054|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
94489358|NCT01178294|323586054|FG000|Overall Study|Subject status is terminal|1|||
94489359|NCT01178294|323586054|FG000|Overall Study|Completion status could not be verified|1|||
94489360|NCT03435055|323586055|FG000|Screening|Physician Decision|2|||
94489361|NCT03435055|323586055|FG000|Received Intervention|Did not complete nitrous administration|3|||
94489362|NCT02783066|323586056|FG000|Overall Study|Withdrawal by Subject|13|||
94489363|NCT04018066|323586057|FG000|Overall Study|participants started taking medications during the study period|3|||
94489364|NCT04018066|323586057|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
94489365|NCT00551369|323586059|FG000|Overall Study|Protocol Violation|5|||
94489366|NCT00551369|323586059|FG000|Overall Study|Withdrawal by Subject|1|||
94489367|NCT00551369|323586059|FG000|Overall Study|Not treated per protocol and re|1|||
94489368|NCT03817528|323586060|FG000|Overall Study|Withdrawal by Subject|1|||
94489369|NCT03817528|323586060|FG000|Overall Study|Adverse Event|2|||
94489370|NCT02914834|323586061|FG000|Overall Study|Study halted due to COVID|1|||
94489371|NCT02914834|323586062|FG001|Overall Study|Study halted due to COVID|1|||
94489372|NCT02914834|323586061|FG000|Overall Study|1 subject withdrew|0|||
94489373|NCT02914834|323586062|FG001|Overall Study|1 subject withdrew|1|||
94489374|NCT03530293|323586067|FG000|Pre-randomization|Adverse Event|12|||
94489375|NCT03530293|323586068|FG001|Pre-randomization|Adverse Event|0|||
94489376|NCT03530293|323586069|FG002|Pre-randomization|Adverse Event|0|||
94489377|NCT03530293|323586067|FG000|Pre-randomization|Protocol Violation|2|||
94489378|NCT03530293|323586068|FG001|Pre-randomization|Protocol Violation|0|||
94489379|NCT03530293|323586069|FG002|Pre-randomization|Protocol Violation|0|||
94489380|NCT03530293|323586067|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
94489381|NCT03530293|323586068|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
94489382|NCT03530293|323586069|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
94489383|NCT03530293|323586067|FG000|Pre-randomization|Withdrawal by Subject|5|||
94489384|NCT03530293|323586068|FG001|Pre-randomization|Withdrawal by Subject|0|||
94489385|NCT03530293|323586069|FG002|Pre-randomization|Withdrawal by Subject|0|||
94489386|NCT03530293|323586067|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
94489387|NCT03530293|323586068|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
94489388|NCT03530293|323586069|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
94489389|NCT03530293|323586067|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
94489390|NCT03530293|323586068|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
94489391|NCT03530293|323586069|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
94489392|NCT03530293|323586067|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
94489393|NCT03530293|323586068|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
94489394|NCT03530293|323586069|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
94489395|NCT03530293|323586067|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
94489396|NCT03530293|323586068|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
94489397|NCT03530293|323586069|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
94489398|NCT03530293|323586067|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
94489399|NCT03530293|323586068|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
94489400|NCT03530293|323586069|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
94489401|NCT00856180|323586071|FG000|Overall Study|Adverse Event|4|||
94489402|NCT00856180|323586071|FG000|Overall Study|Progressive Disease|16|||
94489403|NCT02152007|323586074|FG000|Overall Study|Withdrawal by Subject|1|||
94489404|NCT01302899|323586075|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
94489405|NCT01302899|323586076|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
94489406|NCT01302899|323586075|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
94489407|NCT01302899|323586076|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
94489408|NCT03154086|323586080|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
94424123|NCT03982199|323342702|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
94424124|NCT03982199|323342703|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
94424125|NCT03982199|323342704|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
94424126|NCT03982199|323342705|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
94424127|NCT03982199|323342706|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
94424128|NCT03982199|323342707|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
94424129|NCT03982199|323342708|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
94424130|NCT03982199|323342709|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
94424131|NCT03982199|323342710|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
94424132|NCT03982199|323342697|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
94424133|NCT03982199|323342698|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
94424134|NCT03982199|323342699|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
94424135|NCT03982199|323342700|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
94424136|NCT03982199|323342701|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
94424137|NCT03982199|323342702|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
94424138|NCT03982199|323342703|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
94424139|NCT03982199|323342704|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
94424140|NCT03982199|323342705|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
94424141|NCT03982199|323342706|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
94424142|NCT03982199|323342707|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
94424143|NCT03982199|323342708|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
94424144|NCT03982199|323342709|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
94424145|NCT03982199|323342710|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
94424146|NCT03982199|323342697|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
94424147|NCT03982199|323342698|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
94424148|NCT03982199|323342699|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
94424149|NCT03982199|323342700|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
94424150|NCT03982199|323342701|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
94424151|NCT03982199|323342702|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
94424152|NCT03982199|323342703|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
94424153|NCT03982199|323342704|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
94424154|NCT03982199|323342705|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
94424155|NCT03982199|323342706|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
94424156|NCT03982199|323342707|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
94424157|NCT03982199|323342708|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
94424158|NCT03982199|323342709|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
94424159|NCT03982199|323342710|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
94424160|NCT03982199|323342697|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
94424161|NCT03982199|323342698|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
94424162|NCT03982199|323342699|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
94424163|NCT03982199|323342700|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
94424164|NCT03982199|323342701|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
94424165|NCT03982199|323342702|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
94424166|NCT03982199|323342703|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
94424167|NCT03982199|323342704|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
94424168|NCT03982199|323342705|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
94424169|NCT03982199|323342706|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
94424170|NCT03982199|323342707|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
94424171|NCT03982199|323342708|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
94424172|NCT03982199|323342709|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
94424173|NCT03982199|323342710|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
94424174|NCT03982199|323342697|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
94424175|NCT03982199|323342698|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
94424176|NCT03982199|323342699|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
94424177|NCT03982199|323342700|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
94424178|NCT03982199|323342701|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
94424179|NCT03982199|323342702|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
94424180|NCT03982199|323342703|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
94424181|NCT03982199|323342704|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
94424182|NCT03982199|323342705|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
94424183|NCT03982199|323342706|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
94424184|NCT03982199|323342707|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
94424185|NCT03982199|323342708|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
94424186|NCT03982199|323342709|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
94424187|NCT03982199|323342710|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
94424188|NCT03696953|323342711|FG000|Overall Study|Withdrawal by Subject|6|||
94424189|NCT03696953|323342712|FG001|Overall Study|Withdrawal by Subject|1|||
94424190|NCT03696953|323342711|FG000|Overall Study|missed GBS swabs|2|||
94424191|NCT03696953|323342712|FG001|Overall Study|missed GBS swabs|2|||
94424192|NCT03696953|323342711|FG000|Overall Study|lost study bottle containing capsules|2|||
94424193|NCT03696953|323342712|FG001|Overall Study|lost study bottle containing capsules|0|||
94424194|NCT03696953|323342711|FG000|Overall Study|Premature birth|1|||
94424195|NCT03696953|323342712|FG001|Overall Study|Premature birth|4|||
94424196|NCT03696953|323342711|FG000|Overall Study|Gestational hypertension|1|||
94424197|NCT03696953|323342712|FG001|Overall Study|Gestational hypertension|1|||
94424198|NCT03696953|323342711|FG000|Overall Study|Gestational diabetes|2|||
94424199|NCT03696953|323342712|FG001|Overall Study|Gestational diabetes|1|||
94424200|NCT03696953|323342711|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
94424201|NCT03696953|323342712|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
94424202|NCT03696953|323342711|FG000|Overall Study|Changed prenatal provider|1|||
94424203|NCT03696953|323342712|FG001|Overall Study|Changed prenatal provider|1|||
94424204|NCT03502707|323342713|FG000|Overall Study|Adverse Event|0|||
94424205|NCT03502707|323342714|FG001|Overall Study|Adverse Event|0|||
94424206|NCT03502707|323342715|FG002|Overall Study|Adverse Event|0|||
94424207|NCT03502707|323342716|FG003|Overall Study|Adverse Event|0|||
94424208|NCT03502707|323342717|FG004|Overall Study|Adverse Event|0|||
94424209|NCT03502707|323342718|FG005|Overall Study|Adverse Event|0|||
94424210|NCT03502707|323342719|FG006|Overall Study|Adverse Event|0|||
94424211|NCT03502707|323342720|FG007|Overall Study|Adverse Event|0|||
94424212|NCT03502707|323342721|FG008|Overall Study|Adverse Event|0|||
94424213|NCT03502707|323342722|FG009|Overall Study|Adverse Event|0|||
94424214|NCT03502707|323342723|FG010|Overall Study|Adverse Event|0|||
94424215|NCT03502707|323342724|FG011|Overall Study|Adverse Event|0|||
94424216|NCT03502707|323342725|FG012|Overall Study|Adverse Event|0|||
94424217|NCT03502707|323342726|FG013|Overall Study|Adverse Event|0|||
94424218|NCT03502707|323342727|FG014|Overall Study|Adverse Event|0|||
94424219|NCT03502707|323342728|FG015|Overall Study|Adverse Event|1|||
94424220|NCT03502707|323342729|FG016|Overall Study|Adverse Event|5|||
94424221|NCT03502707|323342730|FG017|Overall Study|Adverse Event|0|||
94424222|NCT03502707|323342713|FG000|Overall Study|Death|0|||
94424223|NCT03502707|323342714|FG001|Overall Study|Death|0|||
94424224|NCT03502707|323342715|FG002|Overall Study|Death|0|||
94424225|NCT03502707|323342716|FG003|Overall Study|Death|1|||
94424226|NCT03502707|323342717|FG004|Overall Study|Death|0|||
94424227|NCT03502707|323342718|FG005|Overall Study|Death|0|||
94424228|NCT03502707|323342719|FG006|Overall Study|Death|0|||
94424229|NCT03502707|323342720|FG007|Overall Study|Death|0|||
94424230|NCT03502707|323342721|FG008|Overall Study|Death|1|||
94424231|NCT03502707|323342722|FG009|Overall Study|Death|1|||
94424232|NCT03502707|323342723|FG010|Overall Study|Death|0|||
94424233|NCT03502707|323342724|FG011|Overall Study|Death|0|||
94424234|NCT03502707|323342725|FG012|Overall Study|Death|1|||
94424235|NCT03502707|323342726|FG013|Overall Study|Death|0|||
94424236|NCT03502707|323342727|FG014|Overall Study|Death|0|||
94424237|NCT03502707|323342728|FG015|Overall Study|Death|1|||
94424238|NCT03502707|323342729|FG016|Overall Study|Death|0|||
94424239|NCT03502707|323342730|FG017|Overall Study|Death|0|||
94424240|NCT03502707|323342713|FG000|Overall Study|Lost to Follow-up|0|||
94424241|NCT03502707|323342714|FG001|Overall Study|Lost to Follow-up|0|||
94424242|NCT03502707|323342715|FG002|Overall Study|Lost to Follow-up|0|||
94424243|NCT03502707|323342716|FG003|Overall Study|Lost to Follow-up|0|||
94424244|NCT03502707|323342717|FG004|Overall Study|Lost to Follow-up|0|||
94424245|NCT03502707|323342718|FG005|Overall Study|Lost to Follow-up|0|||
94424246|NCT03502707|323342719|FG006|Overall Study|Lost to Follow-up|0|||
94424247|NCT03502707|323342720|FG007|Overall Study|Lost to Follow-up|5|||
94424248|NCT03502707|323342721|FG008|Overall Study|Lost to Follow-up|0|||
94424249|NCT03502707|323342722|FG009|Overall Study|Lost to Follow-up|2|||
94424250|NCT03502707|323342723|FG010|Overall Study|Lost to Follow-up|1|||
94424251|NCT03502707|323342724|FG011|Overall Study|Lost to Follow-up|2|||
94424252|NCT03502707|323342725|FG012|Overall Study|Lost to Follow-up|1|||
94424253|NCT03502707|323342726|FG013|Overall Study|Lost to Follow-up|1|||
94424254|NCT03502707|323342727|FG014|Overall Study|Lost to Follow-up|0|||
94424255|NCT03502707|323342728|FG015|Overall Study|Lost to Follow-up|4|||
94424256|NCT03502707|323342729|FG016|Overall Study|Lost to Follow-up|9|||
94655534|NCT00927927|324196062|FG002|Overall Study|Withdrawal by Subject|0|||
94424257|NCT03502707|323342730|FG017|Overall Study|Lost to Follow-up|2|||
94424258|NCT03502707|323342713|FG000|Overall Study|Physician Decision|0|||
94424259|NCT03502707|323342714|FG001|Overall Study|Physician Decision|0|||
94424260|NCT03502707|323342715|FG002|Overall Study|Physician Decision|0|||
94424261|NCT03502707|323342716|FG003|Overall Study|Physician Decision|0|||
94424262|NCT03502707|323342717|FG004|Overall Study|Physician Decision|0|||
94424263|NCT03502707|323342718|FG005|Overall Study|Physician Decision|0|||
94424264|NCT03502707|323342719|FG006|Overall Study|Physician Decision|0|||
94424265|NCT03502707|323342720|FG007|Overall Study|Physician Decision|0|||
94424266|NCT03502707|323342721|FG008|Overall Study|Physician Decision|2|||
94424267|NCT03502707|323342722|FG009|Overall Study|Physician Decision|1|||
94424268|NCT03502707|323342723|FG010|Overall Study|Physician Decision|0|||
94424269|NCT03502707|323342724|FG011|Overall Study|Physician Decision|0|||
94424270|NCT03502707|323342725|FG012|Overall Study|Physician Decision|0|||
94424271|NCT03502707|323342726|FG013|Overall Study|Physician Decision|0|||
94424272|NCT03502707|323342727|FG014|Overall Study|Physician Decision|1|||
94424273|NCT03502707|323342728|FG015|Overall Study|Physician Decision|3|||
94424274|NCT03502707|323342729|FG016|Overall Study|Physician Decision|0|||
94424275|NCT03502707|323342730|FG017|Overall Study|Physician Decision|0|||
94424276|NCT03502707|323342713|FG000|Overall Study|Protocol Violation|0|||
94424277|NCT03502707|323342714|FG001|Overall Study|Protocol Violation|0|||
94424278|NCT03502707|323342715|FG002|Overall Study|Protocol Violation|0|||
94424279|NCT03502707|323342716|FG003|Overall Study|Protocol Violation|0|||
94424280|NCT03502707|323342717|FG004|Overall Study|Protocol Violation|0|||
94424281|NCT03502707|323342718|FG005|Overall Study|Protocol Violation|0|||
94424282|NCT03502707|323342719|FG006|Overall Study|Protocol Violation|0|||
94424283|NCT03502707|323342720|FG007|Overall Study|Protocol Violation|0|||
94424284|NCT03502707|323342721|FG008|Overall Study|Protocol Violation|0|||
94424285|NCT03502707|323342722|FG009|Overall Study|Protocol Violation|0|||
94424286|NCT03502707|323342723|FG010|Overall Study|Protocol Violation|0|||
94424287|NCT03502707|323342724|FG011|Overall Study|Protocol Violation|0|||
94424288|NCT03502707|323342725|FG012|Overall Study|Protocol Violation|0|||
94424289|NCT03502707|323342726|FG013|Overall Study|Protocol Violation|0|||
94424290|NCT03502707|323342727|FG014|Overall Study|Protocol Violation|0|||
94424291|NCT03502707|323342728|FG015|Overall Study|Protocol Violation|1|||
94424292|NCT03502707|323342729|FG016|Overall Study|Protocol Violation|0|||
94424293|NCT03502707|323342730|FG017|Overall Study|Protocol Violation|0|||
94424294|NCT03502707|323342713|FG000|Overall Study|Withdrawal by Subject|1|||
94424295|NCT03502707|323342714|FG001|Overall Study|Withdrawal by Subject|1|||
94424296|NCT03502707|323342715|FG002|Overall Study|Withdrawal by Subject|0|||
94424297|NCT03502707|323342716|FG003|Overall Study|Withdrawal by Subject|0|||
94424298|NCT03502707|323342717|FG004|Overall Study|Withdrawal by Subject|0|||
94424299|NCT03502707|323342718|FG005|Overall Study|Withdrawal by Subject|2|||
94424300|NCT03502707|323342719|FG006|Overall Study|Withdrawal by Subject|0|||
94424301|NCT03502707|323342720|FG007|Overall Study|Withdrawal by Subject|3|||
94424302|NCT03502707|323342721|FG008|Overall Study|Withdrawal by Subject|1|||
94424303|NCT03502707|323342722|FG009|Overall Study|Withdrawal by Subject|2|||
94424304|NCT03502707|323342723|FG010|Overall Study|Withdrawal by Subject|12|||
94424305|NCT03502707|323342724|FG011|Overall Study|Withdrawal by Subject|23|||
94424306|NCT03502707|323342725|FG012|Overall Study|Withdrawal by Subject|5|||
94424307|NCT03502707|323342726|FG013|Overall Study|Withdrawal by Subject|3|||
94424308|NCT03502707|323342727|FG014|Overall Study|Withdrawal by Subject|3|||
94424309|NCT03502707|323342728|FG015|Overall Study|Withdrawal by Subject|43|||
94424310|NCT03502707|323342729|FG016|Overall Study|Withdrawal by Subject|44|||
94424311|NCT03502707|323342730|FG017|Overall Study|Withdrawal by Subject|18|||
94424312|NCT03502707|323342713|FG000|Overall Study|Sponsor's Decision|1|||
94424313|NCT03502707|323342714|FG001|Overall Study|Sponsor's Decision|0|||
94424314|NCT03502707|323342715|FG002|Overall Study|Sponsor's Decision|0|||
94424315|NCT03502707|323342716|FG003|Overall Study|Sponsor's Decision|0|||
94424316|NCT03502707|323342717|FG004|Overall Study|Sponsor's Decision|0|||
94424317|NCT03502707|323342718|FG005|Overall Study|Sponsor's Decision|0|||
94424318|NCT03502707|323342719|FG006|Overall Study|Sponsor's Decision|0|||
94424319|NCT03502707|323342720|FG007|Overall Study|Sponsor's Decision|0|||
94424320|NCT03502707|323342721|FG008|Overall Study|Sponsor's Decision|0|||
94424321|NCT03502707|323342722|FG009|Overall Study|Sponsor's Decision|1|||
94424322|NCT03502707|323342723|FG010|Overall Study|Sponsor's Decision|0|||
94424323|NCT03502707|323342724|FG011|Overall Study|Sponsor's Decision|0|||
94424324|NCT03502707|323342725|FG012|Overall Study|Sponsor's Decision|0|||
94424325|NCT03502707|323342726|FG013|Overall Study|Sponsor's Decision|0|||
94424326|NCT03502707|323342727|FG014|Overall Study|Sponsor's Decision|0|||
94424327|NCT03502707|323342728|FG015|Overall Study|Sponsor's Decision|2|||
94424328|NCT03502707|323342729|FG016|Overall Study|Sponsor's Decision|1|||
94424329|NCT03502707|323342730|FG017|Overall Study|Sponsor's Decision|0|||
94424330|NCT03502707|323342713|FG000|Overall Study|Initiated Prohibited Medication|0|||
94424331|NCT03502707|323342714|FG001|Overall Study|Initiated Prohibited Medication|0|||
94424332|NCT03502707|323342715|FG002|Overall Study|Initiated Prohibited Medication|0|||
94424333|NCT03502707|323342716|FG003|Overall Study|Initiated Prohibited Medication|0|||
94424334|NCT03502707|323342717|FG004|Overall Study|Initiated Prohibited Medication|0|||
94424335|NCT03502707|323342718|FG005|Overall Study|Initiated Prohibited Medication|0|||
94424336|NCT03502707|323342719|FG006|Overall Study|Initiated Prohibited Medication|0|||
94424337|NCT03502707|323342720|FG007|Overall Study|Initiated Prohibited Medication|0|||
94424338|NCT03502707|323342721|FG008|Overall Study|Initiated Prohibited Medication|0|||
94424339|NCT03502707|323342722|FG009|Overall Study|Initiated Prohibited Medication|0|||
94424340|NCT03502707|323342723|FG010|Overall Study|Initiated Prohibited Medication|0|||
94424341|NCT03502707|323342724|FG011|Overall Study|Initiated Prohibited Medication|0|||
94424342|NCT03502707|323342725|FG012|Overall Study|Initiated Prohibited Medication|0|||
94424343|NCT03502707|323342726|FG013|Overall Study|Initiated Prohibited Medication|0|||
94424344|NCT03502707|323342727|FG014|Overall Study|Initiated Prohibited Medication|0|||
94424345|NCT03502707|323342728|FG015|Overall Study|Initiated Prohibited Medication|0|||
94424346|NCT03502707|323342729|FG016|Overall Study|Initiated Prohibited Medication|1|||
94424347|NCT03502707|323342730|FG017|Overall Study|Initiated Prohibited Medication|0|||
94424348|NCT03502707|323342713|FG000|Overall Study|Other|0|||
94424349|NCT03502707|323342714|FG001|Overall Study|Other|0|||
94424350|NCT03502707|323342715|FG002|Overall Study|Other|0|||
94424351|NCT03502707|323342716|FG003|Overall Study|Other|0|||
94424352|NCT03502707|323342717|FG004|Overall Study|Other|0|||
94424353|NCT03502707|323342718|FG005|Overall Study|Other|0|||
94424354|NCT03502707|323342719|FG006|Overall Study|Other|0|||
94424355|NCT03502707|323342720|FG007|Overall Study|Other|0|||
94424356|NCT03502707|323342721|FG008|Overall Study|Other|1|||
94424357|NCT03502707|323342722|FG009|Overall Study|Other|1|||
94424358|NCT03502707|323342723|FG010|Overall Study|Other|2|||
94424359|NCT03502707|323342724|FG011|Overall Study|Other|0|||
94424360|NCT03502707|323342725|FG012|Overall Study|Other|0|||
94424361|NCT03502707|323342726|FG013|Overall Study|Other|0|||
94424362|NCT03502707|323342727|FG014|Overall Study|Other|0|||
94424363|NCT03502707|323342728|FG015|Overall Study|Other|4|||
94424364|NCT03502707|323342729|FG016|Overall Study|Other|1|||
94424365|NCT03502707|323342730|FG017|Overall Study|Other|0|||
94424366|NCT03502707|323342713|FG000|Overall Study|Randomized but not vaccinated|0|||
94424367|NCT03502707|323342714|FG001|Overall Study|Randomized but not vaccinated|0|||
94424368|NCT03502707|323342715|FG002|Overall Study|Randomized but not vaccinated|0|||
94424369|NCT03502707|323342716|FG003|Overall Study|Randomized but not vaccinated|0|||
94424370|NCT03502707|323342717|FG004|Overall Study|Randomized but not vaccinated|0|||
94424371|NCT03502707|323342718|FG005|Overall Study|Randomized but not vaccinated|0|||
94424372|NCT03502707|323342719|FG006|Overall Study|Randomized but not vaccinated|0|||
94424373|NCT03502707|323342720|FG007|Overall Study|Randomized but not vaccinated|0|||
94424374|NCT03502707|323342721|FG008|Overall Study|Randomized but not vaccinated|0|||
94424375|NCT03502707|323342722|FG009|Overall Study|Randomized but not vaccinated|0|||
94424376|NCT03502707|323342723|FG010|Overall Study|Randomized but not vaccinated|0|||
94424377|NCT03502707|323342724|FG011|Overall Study|Randomized but not vaccinated|1|||
94424378|NCT03502707|323342725|FG012|Overall Study|Randomized but not vaccinated|0|||
94424379|NCT03502707|323342726|FG013|Overall Study|Randomized but not vaccinated|0|||
94424380|NCT03502707|323342727|FG014|Overall Study|Randomized but not vaccinated|0|||
94424381|NCT03502707|323342728|FG015|Overall Study|Randomized but not vaccinated|0|||
94424382|NCT03502707|323342729|FG016|Overall Study|Randomized but not vaccinated|0|||
94424383|NCT03502707|323342730|FG017|Overall Study|Randomized but not vaccinated|1|||
94424384|NCT04908683|323342731|FG000|Overall Study|Failure to meet continuation criteria|34|||
94424385|NCT04908683|323342732|FG001|Overall Study|Failure to meet continuation criteria|22|||
94424386|NCT04908683|323342731|FG000|Overall Study|Initiated prohibited medication|3|||
94424387|NCT04908683|323342732|FG001|Overall Study|Initiated prohibited medication|0|||
94424388|NCT04908683|323342731|FG000|Overall Study|Randomized by mistake|1|||
94424389|NCT04908683|323342732|FG001|Overall Study|Randomized by mistake|0|||
94424390|NCT04908683|323342731|FG000|Overall Study|Lost to Follow-up|679|||
94424391|NCT04908683|323342732|FG001|Overall Study|Lost to Follow-up|341|||
94424392|NCT04908683|323342731|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
94424393|NCT04908683|323342732|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
94424394|NCT04908683|323342731|FG000|Overall Study|Physician Decision|44|||
94424395|NCT04908683|323342732|FG001|Overall Study|Physician Decision|35|||
94424396|NCT04908683|323342731|FG000|Overall Study|Technical problems|12|||
94424397|NCT04908683|323342732|FG001|Overall Study|Technical problems|9|||
94424398|NCT04908683|323342731|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
94424399|NCT04908683|323342732|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
94424400|NCT04908683|323342731|FG000|Overall Study|Protocol Violation|2|||
94424401|NCT04908683|323342732|FG001|Overall Study|Protocol Violation|0|||
94424402|NCT04908683|323342731|FG000|Overall Study|Withdrawal by Subject|1188|||
94424403|NCT04908683|323342732|FG001|Overall Study|Withdrawal by Subject|570|||
94424404|NCT04908683|323342731|FG000|Overall Study|Site Closure by Sponsor|6|||
94424405|NCT04908683|323342732|FG001|Overall Study|Site Closure by Sponsor|3|||
94424406|NCT04908683|323342731|FG000|Overall Study|Adverse Event|21|||
94424407|NCT04908683|323342732|FG001|Overall Study|Adverse Event|11|||
94424408|NCT04908683|323342731|FG000|Overall Study|Death|101|||
94424409|NCT04908683|323342732|FG001|Overall Study|Death|61|||
94424410|NCT04908683|323342731|FG000|Overall Study|Sponsor's decision|14398|||
94424411|NCT04908683|323342732|FG001|Overall Study|Sponsor's decision|7205|||
94424412|NCT04908683|323342731|FG000|Overall Study|Other|92|||
94424413|NCT04908683|323342732|FG001|Overall Study|Other|50|||
94424414|NCT04908683|323342731|FG000|Overall Study|Randomized not vaccinated|108|||
94424415|NCT04908683|323342732|FG001|Overall Study|Randomized not vaccinated|52|||
94424416|NCT03901963|323342733|FG000|Overall Study|Lost to Follow-up|1|||
94424417|NCT03901963|323342734|FG001|Overall Study|Lost to Follow-up|1|||
94424418|NCT03901963|323342733|FG000|Overall Study|Physician Decision|1|||
94424419|NCT03901963|323342734|FG001|Overall Study|Physician Decision|2|||
94424420|NCT03901963|323342733|FG000|Overall Study|Protocol Violation|1|||
94424421|NCT03901963|323342734|FG001|Overall Study|Protocol Violation|1|||
94424422|NCT03901963|323342733|FG000|Overall Study|Withdrawal by Subject|4|||
94424423|NCT03901963|323342734|FG001|Overall Study|Withdrawal by Subject|11|||
94424424|NCT03901963|323342733|FG000|Overall Study|Ongoing|84|||
94424425|NCT03901963|323342734|FG001|Overall Study|Ongoing|73|||
94424426|NCT03901963|323342733|FG000|Overall Study|Randomized but not treated|3|||
94424427|NCT03901963|323342734|FG001|Overall Study|Randomized but not treated|3|||
94424428|NCT05197049|323342735|FG000|Overall Study|Death|0|||
94424429|NCT05197049|323342736|FG001|Overall Study|Death|1|||
94424430|NCT05197049|323342737|FG002|Overall Study|Death|0|||
94424431|NCT05197049|323342735|FG000|Overall Study|Lost to Follow-up|3|||
94424432|NCT05197049|323342736|FG001|Overall Study|Lost to Follow-up|1|||
94424433|NCT05197049|323342737|FG002|Overall Study|Lost to Follow-up|0|||
94424434|NCT05197049|323342735|FG000|Overall Study|Withdrawal by Subject|15|||
94424435|NCT05197049|323342736|FG001|Overall Study|Withdrawal by Subject|3|||
94424436|NCT05197049|323342737|FG002|Overall Study|Withdrawal by Subject|1|||
94424437|NCT05197049|323342735|FG000|Overall Study|GCP non-compliance|1|||
94424438|NCT05197049|323342736|FG001|Overall Study|GCP non-compliance|2|||
94424439|NCT05197049|323342737|FG002|Overall Study|GCP non-compliance|0|||
94424440|NCT04994483|323342740|FG000|Overall Study|Adverse Event|26|||
94424441|NCT04994483|323342741|FG001|Overall Study|Adverse Event|17|||
94489409|NCT03154086|323586081|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
94489410|NCT03154086|323586082|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
94489411|NCT03154086|323586083|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
94489412|NCT03154086|323586084|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
94489413|NCT03154086|323586085|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
94489414|NCT03154086|323586086|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
94489415|NCT03154086|323586087|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
94489416|NCT03154086|323586088|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
94489417|NCT03154086|323586089|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
94489418|NCT03154086|323586090|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
94489419|NCT03154086|323586091|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
94489420|NCT03154086|323586092|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
94489421|NCT03154086|323586093|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
94489422|NCT03154086|323586094|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
94489423|NCT03154086|323586080|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
94489424|NCT03154086|323586081|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
94489425|NCT03154086|323586082|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
94489426|NCT03154086|323586083|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
94489427|NCT03154086|323586084|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
94489428|NCT03154086|323586085|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
94489429|NCT03154086|323586086|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
94489430|NCT03154086|323586087|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
94489431|NCT03154086|323586088|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
94489432|NCT03154086|323586089|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
94489433|NCT03154086|323586090|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
94489434|NCT03154086|323586091|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
94489435|NCT03154086|323586092|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
94489436|NCT03154086|323586093|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
94489437|NCT03154086|323586094|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
94489438|NCT03154086|323586080|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
94489439|NCT03154086|323586081|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
94489440|NCT03154086|323586082|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
94489441|NCT03154086|323586083|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
94489442|NCT03154086|323586084|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
94489443|NCT03154086|323586085|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
94489444|NCT03154086|323586086|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
94489445|NCT03154086|323586087|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
94489446|NCT03154086|323586088|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
94489447|NCT03154086|323586089|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
94489448|NCT03154086|323586090|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
94489449|NCT03154086|323586091|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
94489450|NCT03154086|323586092|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
94489451|NCT03154086|323586093|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
94489452|NCT03154086|323586094|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
94489453|NCT03154086|323586080|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
94424442|NCT04994483|323342740|FG000|Overall Study|Lost to Follow-up|6|||
94424443|NCT04994483|323342741|FG001|Overall Study|Lost to Follow-up|10|||
94424444|NCT04994483|323342740|FG000|Overall Study|Noncompliance with study drug|8|||
94424445|NCT04994483|323342741|FG001|Overall Study|Noncompliance with study drug|5|||
94424446|NCT04994483|323342740|FG000|Overall Study|Physician Decision|5|||
94424447|NCT04994483|323342741|FG001|Overall Study|Physician Decision|0|||
94424448|NCT04994483|323342740|FG000|Overall Study|Withdrawal by Subject|41|||
94424449|NCT04994483|323342741|FG001|Overall Study|Withdrawal by Subject|38|||
94424450|NCT04994483|323342740|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
94424451|NCT04994483|323342741|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
94424452|NCT04994483|323342740|FG000|Overall Study|Met stopping criteria|1|||
94424453|NCT04994483|323342741|FG001|Overall Study|Met stopping criteria|0|||
94424454|NCT04994483|323342740|FG000|Overall Study|Randomized in error, not treated|4|||
94424455|NCT04994483|323342741|FG001|Overall Study|Randomized in error, not treated|3|||
94424456|NCT04994483|323342740|FG000|Overall Study|Lack of a reliable study partner|0|||
94424457|NCT04994483|323342741|FG001|Overall Study|Lack of a reliable study partner|1|||
94424458|NCT04994483|323342740|FG000|Overall Study|Met MRI exclusion criteria|0|||
94424459|NCT04994483|323342741|FG001|Overall Study|Met MRI exclusion criteria|1|||
94424460|NCT05327816|323342742|FG000|Overall Study|Lost to Follow-up|1|||
94424461|NCT05327816|323342743|FG001|Overall Study|Lost to Follow-up|0|||
94424462|NCT05327816|323342744|FG002|Overall Study|Lost to Follow-up|0|||
94424463|NCT05327816|323342745|FG003|Overall Study|Lost to Follow-up|0|||
94424464|NCT05327816|323342746|FG004|Overall Study|Lost to Follow-up|0|||
94424465|NCT05327816|323342747|FG005|Overall Study|Lost to Follow-up|0|||
94424466|NCT05327816|323342748|FG006|Overall Study|Lost to Follow-up|0|||
94424467|NCT05327816|323342749|FG007|Overall Study|Lost to Follow-up|0|||
94424468|NCT05327816|323342750|FG008|Overall Study|Lost to Follow-up|0|||
94424469|NCT05327816|323342751|FG009|Overall Study|Lost to Follow-up|1|||
94424470|NCT05327816|323342752|FG010|Overall Study|Lost to Follow-up|0|||
94424471|NCT05327816|323342742|FG000|Overall Study|Withdrawal by Subject|0|||
94424472|NCT05327816|323342743|FG001|Overall Study|Withdrawal by Subject|0|||
94424473|NCT05327816|323342744|FG002|Overall Study|Withdrawal by Subject|0|||
94424474|NCT05327816|323342745|FG003|Overall Study|Withdrawal by Subject|0|||
94424475|NCT05327816|323342746|FG004|Overall Study|Withdrawal by Subject|1|||
94424476|NCT05327816|323342747|FG005|Overall Study|Withdrawal by Subject|1|||
94424477|NCT05327816|323342748|FG006|Overall Study|Withdrawal by Subject|0|||
94424478|NCT05327816|323342749|FG007|Overall Study|Withdrawal by Subject|0|||
94424479|NCT05327816|323342750|FG008|Overall Study|Withdrawal by Subject|0|||
94424480|NCT05327816|323342751|FG009|Overall Study|Withdrawal by Subject|0|||
94424481|NCT05327816|323342752|FG010|Overall Study|Withdrawal by Subject|0|||
94424482|NCT05327816|323342742|FG000|Overall Study|Study Terminated by Sponsor|11|||
94424483|NCT05327816|323342743|FG001|Overall Study|Study Terminated by Sponsor|12|||
94424484|NCT05327816|323342744|FG002|Overall Study|Study Terminated by Sponsor|12|||
94424485|NCT05327816|323342745|FG003|Overall Study|Study Terminated by Sponsor|12|||
94424486|NCT05327816|323342746|FG004|Overall Study|Study Terminated by Sponsor|11|||
94424487|NCT05327816|323342747|FG005|Overall Study|Study Terminated by Sponsor|11|||
94424488|NCT05327816|323342748|FG006|Overall Study|Study Terminated by Sponsor|11|||
94424489|NCT05327816|323342749|FG007|Overall Study|Study Terminated by Sponsor|11|||
94424490|NCT05327816|323342750|FG008|Overall Study|Study Terminated by Sponsor|11|||
94424491|NCT05327816|323342751|FG009|Overall Study|Study Terminated by Sponsor|11|||
94424492|NCT05327816|323342752|FG010|Overall Study|Study Terminated by Sponsor|12|||
94424493|NCT05327816|323342742|FG000|Overall Study|Randomized but not treated|0|||
94424494|NCT05327816|323342743|FG001|Overall Study|Randomized but not treated|0|||
94424495|NCT05327816|323342744|FG002|Overall Study|Randomized but not treated|0|||
94424496|NCT05327816|323342745|FG003|Overall Study|Randomized but not treated|0|||
94424497|NCT05327816|323342746|FG004|Overall Study|Randomized but not treated|0|||
94424498|NCT05327816|323342747|FG005|Overall Study|Randomized but not treated|0|||
94424499|NCT05327816|323342748|FG006|Overall Study|Randomized but not treated|1|||
94424500|NCT05327816|323342749|FG007|Overall Study|Randomized but not treated|1|||
94424501|NCT05327816|323342750|FG008|Overall Study|Randomized but not treated|1|||
94424502|NCT05327816|323342751|FG009|Overall Study|Randomized but not treated|0|||
94424503|NCT05327816|323342752|FG010|Overall Study|Randomized but not treated|0|||
94424504|NCT03748641|323342753|FG000|Overall Study|Ongoing|155|||
94424505|NCT03748641|323342754|FG001|Overall Study|Ongoing|148|||
94424506|NCT03748641|323342755|FG002|Overall Study|Ongoing|66|||
94424507|NCT03748641|323342756|FG003|Overall Study|Ongoing|79|||
94424508|NCT03748641|323342757|FG004|Overall Study|Ongoing|84|||
94424509|NCT03748641|323342753|FG000|Overall Study|Death|54|||
94424510|NCT03748641|323342754|FG001|Overall Study|Death|59|||
94424511|NCT03748641|323342755|FG002|Overall Study|Death|51|||
94424512|NCT03748641|323342756|FG003|Overall Study|Death|42|||
94424513|NCT03748641|323342757|FG004|Overall Study|Death|9|||
94424514|NCT03748641|323342753|FG000|Overall Study|Lost to Follow-up|0|||
94424515|NCT03748641|323342754|FG001|Overall Study|Lost to Follow-up|2|||
94424516|NCT03748641|323342755|FG002|Overall Study|Lost to Follow-up|1|||
94424517|NCT03748641|323342756|FG003|Overall Study|Lost to Follow-up|0|||
94424518|NCT03748641|323342757|FG004|Overall Study|Lost to Follow-up|0|||
94424519|NCT03748641|323342753|FG000|Overall Study|Withdrawal by Subject|3|||
94424520|NCT03748641|323342754|FG001|Overall Study|Withdrawal by Subject|2|||
94424521|NCT03748641|323342755|FG002|Overall Study|Withdrawal by Subject|5|||
94424522|NCT03748641|323342756|FG003|Overall Study|Withdrawal by Subject|3|||
94424523|NCT03748641|323342757|FG004|Overall Study|Withdrawal by Subject|2|||
94424524|NCT01776840|323342758|FG000|Overall Study|Lost to Follow-up|4|||
94424525|NCT01776840|323342759|FG001|Overall Study|Lost to Follow-up|4|||
94424526|NCT01776840|323342758|FG000|Overall Study|Withdrawal by Subject|42|||
94424527|NCT01776840|323342759|FG001|Overall Study|Withdrawal by Subject|22|||
94424528|NCT01776840|323342758|FG000|Overall Study|Ongoing|112|||
94424529|NCT01776840|323342759|FG001|Overall Study|Ongoing|129|||
94424530|NCT06204887|323342760|FG000|Overall Study|Lost to Follow-up|3|||
94424531|NCT06204887|323342761|FG001|Overall Study|Lost to Follow-up|4|||
94424532|NCT06204887|323342762|FG002|Overall Study|Lost to Follow-up|1|||
94424533|NCT06204887|323342763|FG003|Overall Study|Lost to Follow-up|6|||
94424534|NCT02935686|323342764|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
94424535|NCT02935686|323342765|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
94424536|NCT02935686|323342766|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
94424537|NCT02935686|323342767|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
94424538|NCT02935686|323342768|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
94424539|NCT02935686|323342764|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
94424540|NCT02935686|323342765|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
94424541|NCT02935686|323342766|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
94424542|NCT02935686|323342767|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
94424543|NCT02935686|323342768|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
94424544|NCT02935686|323342764|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
94424545|NCT02935686|323342765|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
94424546|NCT02935686|323342766|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
94424547|NCT02935686|323342767|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
94424548|NCT02935686|323342768|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
94424549|NCT02935686|323342764|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
94424550|NCT02935686|323342765|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
94424551|NCT02935686|323342766|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
94424552|NCT02935686|323342767|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
94424553|NCT02935686|323342768|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
94424554|NCT02935686|323342764|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
94424555|NCT02935686|323342765|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
94424556|NCT02935686|323342766|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
94424557|NCT02935686|323342767|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
94424558|NCT02935686|323342768|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
94424559|NCT02935686|323342764|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
94424560|NCT02935686|323342765|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
94424561|NCT02935686|323342766|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
94424562|NCT02935686|323342767|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
94424563|NCT02935686|323342768|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
94424564|NCT02935686|323342764|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
94424565|NCT02935686|323342765|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
94424566|NCT02935686|323342766|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
94424567|NCT02935686|323342767|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
94424568|NCT02935686|323342768|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
94424569|NCT02935686|323342764|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
94424570|NCT02935686|323342765|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
94424571|NCT02935686|323342766|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
94424572|NCT02935686|323342767|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
94424573|NCT02935686|323342768|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
94424574|NCT02935686|323342764|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
94424575|NCT02935686|323342765|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
94424576|NCT02935686|323342766|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
94424577|NCT02935686|323342767|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
94424578|NCT02935686|323342768|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
94424579|NCT02935686|323342764|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
94424580|NCT02935686|323342765|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
94489454|NCT03154086|323586081|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
94424581|NCT02935686|323342766|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
94424582|NCT02935686|323342767|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
94424583|NCT02935686|323342768|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
94424584|NCT02935686|323342764|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
94424585|NCT02935686|323342765|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
94424586|NCT02935686|323342766|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
94424587|NCT02935686|323342767|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
94655535|NCT00927927|324196063|FG003|Overall Study|Withdrawal by Subject|0|||
94424588|NCT02935686|323342768|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
94424589|NCT02195479|323342769|FG000|Overall Study|Lost to Follow-up|3|||
94424590|NCT02195479|323342770|FG001|Overall Study|Lost to Follow-up|0|||
94424591|NCT02195479|323342769|FG000|Overall Study|Death|48|||
94424592|NCT02195479|323342770|FG001|Overall Study|Death|45|||
94424593|NCT02195479|323342769|FG000|Overall Study|Physician Decision|1|||
94424594|NCT02195479|323342770|FG001|Overall Study|Physician Decision|0|||
94424595|NCT02195479|323342769|FG000|Overall Study|Withdrawal by Subject|11|||
94424596|NCT02195479|323342770|FG001|Overall Study|Withdrawal by Subject|6|||
94424597|NCT02195479|323342769|FG000|Overall Study|Other|2|||
94424598|NCT02195479|323342770|FG001|Overall Study|Other|2|||
94424599|NCT02195479|323342769|FG000|Overall Study|Ongoing|291|||
94424600|NCT02195479|323342770|FG001|Overall Study|Ongoing|297|||
94424601|NCT00577395|323342771|FG000|Overall Study|Study was terminated early by Sponsor|7|||
94424602|NCT00577395|323342772|FG001|Overall Study|Study was terminated early by Sponsor|6|||
94424603|NCT00325195|323342779|FG000|Randomized|Not dosed|5|||
94424604|NCT00325195|323342780|FG001|Randomized|Not dosed|5|||
94424605|NCT00325195|323342781|FG002|Randomized|Not dosed|3|||
94424606|NCT00325195|323342779|FG000|Received Intervention: ITT Population|Adverse Event|15|||
94424607|NCT00325195|323342780|FG001|Received Intervention: ITT Population|Adverse Event|17|||
94424608|NCT00325195|323342781|FG002|Received Intervention: ITT Population|Adverse Event|1|||
94424609|NCT00325195|323342779|FG000|Received Intervention: ITT Population|Death|3|||
94424610|NCT00325195|323342780|FG001|Received Intervention: ITT Population|Death|1|||
94424611|NCT00325195|323342781|FG002|Received Intervention: ITT Population|Death|0|||
94424612|NCT00325195|323342779|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
94424613|NCT00325195|323342780|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
94424614|NCT00325195|323342781|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
94424615|NCT00325195|323342779|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
94424616|NCT00325195|323342780|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
94424617|NCT00325195|323342781|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
94424618|NCT00325195|323342779|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
94424619|NCT00325195|323342780|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
94424620|NCT00325195|323342781|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
94424621|NCT05183217|323342782|FG000|Overall Study|Withdrawal by Subject|1|||
94424622|NCT05183217|323342783|FG001|Overall Study|Withdrawal by Subject|1|||
94424623|NCT01155024|323342784|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
94424624|NCT01155024|323342785|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
94424625|NCT01155024|323342784|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
94424626|NCT01155024|323342785|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
94424627|NCT01155024|323342784|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
94424628|NCT01155024|323342785|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
94424629|NCT01683838|323342786|FG000|Overall Study|Adverse Event|12|||
94424630|NCT01683838|323342787|FG001|Overall Study|Adverse Event|2|||
94424631|NCT01683838|323342786|FG000|Overall Study|Protocol Violation|3|||
94424632|NCT01683838|323342787|FG001|Overall Study|Protocol Violation|1|||
94424633|NCT01683838|323342786|FG000|Overall Study|Withdrawal by Subject|6|||
94424634|NCT01683838|323342787|FG001|Overall Study|Withdrawal by Subject|5|||
94424635|NCT01683838|323342786|FG000|Overall Study|Lost to Follow-up|1|||
94424636|NCT01683838|323342787|FG001|Overall Study|Lost to Follow-up|1|||
94424637|NCT01683838|323342786|FG000|Overall Study|Other|4|||
94424638|NCT01683838|323342787|FG001|Overall Study|Other|3|||
94424639|NCT03402750|323342794|FG000|Overall Study|Lost to Follow-up|2|||
94424640|NCT03402750|323342795|FG001|Overall Study|Lost to Follow-up|1|||
94424641|NCT03469336|323342796|FG000|Overall Study|Adverse Event|1|||
94424642|NCT02628743|323342797|FG000|Overall Study|Other|3|||
94424643|NCT02628743|323342797|FG000|Overall Study|Withdrawal by Subject|50|||
94424644|NCT02628743|323342797|FG000|Overall Study|Study Terminated by Sponsor|76|||
94424645|NCT02628743|323342797|FG000|Overall Study|Physician Decision|2|||
94424646|NCT02981303|323342798|FG000|Overall Study|Progressive Disease|17|||
94424647|NCT02981303|323342799|FG001|Overall Study|Progressive Disease|37|||
94424648|NCT02981303|323342798|FG000|Overall Study|Adverse Event|1|||
94424649|NCT02981303|323342799|FG001|Overall Study|Adverse Event|4|||
94424650|NCT02981303|323342798|FG000|Overall Study|Withdrawal by Subject|0|||
94424651|NCT02981303|323342799|FG001|Overall Study|Withdrawal by Subject|1|||
94424652|NCT04715932|323342800|FG000|Overall Study|Lost to Follow-up|1|||
94424653|NCT04715932|323342801|FG001|Overall Study|Lost to Follow-up|0|||
94424654|NCT02393248|323342802|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424655|NCT02393248|323342803|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
94489455|NCT03154086|323586082|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
94424656|NCT02393248|323342804|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424657|NCT02393248|323342805|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424658|NCT02393248|323342806|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94489456|NCT03154086|323586083|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
94424659|NCT02393248|323342807|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
94424660|NCT02393248|323342808|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
94424661|NCT02393248|323342809|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424662|NCT02393248|323342810|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424663|NCT02393248|323342811|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424664|NCT02393248|323342812|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424665|NCT02393248|323342813|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424666|NCT02393248|323342814|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424667|NCT02393248|323342815|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424668|NCT02393248|323342816|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424669|NCT02393248|323342817|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424670|NCT02393248|323342818|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424671|NCT02393248|323342819|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424672|NCT02393248|323342820|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424673|NCT02393248|323342821|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424674|NCT02393248|323342822|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424675|NCT02393248|323342823|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424676|NCT02393248|323342824|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424677|NCT02393248|323342825|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424678|NCT02393248|323342826|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
94424679|NCT02393248|323342802|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424680|NCT02393248|323342803|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
94424681|NCT02393248|323342804|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424682|NCT02393248|323342805|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424683|NCT02393248|323342806|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424684|NCT02393248|323342807|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424685|NCT02393248|323342808|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424686|NCT02393248|323342809|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424687|NCT02393248|323342810|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424688|NCT02393248|323342811|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424689|NCT02393248|323342812|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424690|NCT02393248|323342813|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424691|NCT02393248|323342814|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424692|NCT02393248|323342815|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424693|NCT02393248|323342816|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424694|NCT02393248|323342817|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424695|NCT02393248|323342818|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424696|NCT02393248|323342819|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424697|NCT02393248|323342820|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424698|NCT02393248|323342821|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424699|NCT02393248|323342822|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424700|NCT02393248|323342823|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424701|NCT02393248|323342824|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424702|NCT02393248|323342825|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424703|NCT02393248|323342826|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
94424704|NCT02393248|323342802|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
94424705|NCT02393248|323342803|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
94424706|NCT02393248|323342804|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
94424707|NCT02393248|323342805|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
94424708|NCT02393248|323342806|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
94424709|NCT02393248|323342807|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
94424710|NCT02393248|323342808|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
94424711|NCT02393248|323342809|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
94424712|NCT02393248|323342810|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
94424713|NCT02393248|323342811|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
94424714|NCT02393248|323342812|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
94424715|NCT02393248|323342813|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
94424716|NCT02393248|323342814|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
94424717|NCT02393248|323342815|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
94424718|NCT02393248|323342816|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
94424719|NCT02393248|323342817|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
94424720|NCT02393248|323342818|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
94489457|NCT03154086|323586084|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
94489458|NCT03154086|323586085|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
94489459|NCT03154086|323586086|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
94489460|NCT03154086|323586087|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
94489461|NCT03154086|323586088|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
94489462|NCT03154086|323586089|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
94424721|NCT02393248|323342819|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
94424722|NCT02393248|323342820|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
94424723|NCT02393248|323342821|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
94424724|NCT02393248|323342822|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
94424725|NCT02393248|323342823|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
94424726|NCT02393248|323342824|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
94424727|NCT02393248|323342825|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
94424728|NCT02393248|323342826|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
94424729|NCT02393248|323342802|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
94424730|NCT02393248|323342803|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424731|NCT02393248|323342804|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424732|NCT02393248|323342805|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424733|NCT02393248|323342806|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424734|NCT02393248|323342807|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424735|NCT02393248|323342808|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424736|NCT02393248|323342809|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424737|NCT02393248|323342810|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424738|NCT02393248|323342811|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424739|NCT02393248|323342812|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424740|NCT02393248|323342813|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424741|NCT02393248|323342814|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424742|NCT02393248|323342815|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424743|NCT02393248|323342816|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424744|NCT02393248|323342817|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424745|NCT02393248|323342818|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424746|NCT02393248|323342819|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424747|NCT02393248|323342820|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424748|NCT02393248|323342821|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424749|NCT02393248|323342822|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424750|NCT02393248|323342823|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424751|NCT02393248|323342824|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424752|NCT02393248|323342825|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424753|NCT02393248|323342826|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
94424754|NCT02393248|323342802|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424755|NCT02393248|323342803|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424756|NCT02393248|323342804|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424757|NCT02393248|323342805|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424758|NCT02393248|323342806|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424759|NCT02393248|323342807|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
94424760|NCT02393248|323342808|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
94424761|NCT02393248|323342809|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424762|NCT02393248|323342810|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424763|NCT02393248|323342811|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
94424764|NCT02393248|323342812|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424765|NCT02393248|323342813|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424766|NCT02393248|323342814|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424767|NCT02393248|323342815|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424768|NCT02393248|323342816|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424769|NCT02393248|323342817|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424770|NCT02393248|323342818|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424771|NCT02393248|323342819|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424772|NCT02393248|323342820|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424773|NCT02393248|323342821|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424774|NCT02393248|323342822|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424775|NCT02393248|323342823|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424776|NCT02393248|323342824|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424777|NCT02393248|323342825|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424778|NCT02393248|323342826|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
94424779|NCT02393248|323342802|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424780|NCT02393248|323342803|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424781|NCT02393248|323342804|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424782|NCT02393248|323342805|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424783|NCT02393248|323342806|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94489463|NCT03154086|323586090|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
94424784|NCT02393248|323342807|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424785|NCT02393248|323342808|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
94424786|NCT02393248|323342809|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424787|NCT02393248|323342810|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424788|NCT02393248|323342811|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424789|NCT02393248|323342812|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424790|NCT02393248|323342813|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424791|NCT02393248|323342814|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424792|NCT02393248|323342815|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424793|NCT02393248|323342816|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424794|NCT02393248|323342817|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424795|NCT02393248|323342818|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424796|NCT02393248|323342819|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424797|NCT02393248|323342820|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424798|NCT02393248|323342821|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424799|NCT02393248|323342822|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424800|NCT02393248|323342823|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424801|NCT02393248|323342824|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424802|NCT02393248|323342825|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424803|NCT02393248|323342826|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
94424804|NCT02393248|323342802|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424805|NCT02393248|323342803|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424806|NCT02393248|323342804|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424807|NCT02393248|323342805|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424808|NCT02393248|323342806|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424809|NCT02393248|323342807|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424810|NCT02393248|323342808|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424811|NCT02393248|323342809|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424812|NCT02393248|323342810|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424813|NCT02393248|323342811|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424814|NCT02393248|323342812|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424815|NCT02393248|323342813|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
94424816|NCT02393248|323342814|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
94424817|NCT02393248|323342815|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
94424818|NCT02393248|323342816|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
94424819|NCT02393248|323342817|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424820|NCT02393248|323342818|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424821|NCT02393248|323342819|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424822|NCT02393248|323342820|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424823|NCT02393248|323342821|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424824|NCT02393248|323342822|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424825|NCT02393248|323342823|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424826|NCT02393248|323342824|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424827|NCT02393248|323342825|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424828|NCT02393248|323342826|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
94424829|NCT02393248|323342802|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424830|NCT02393248|323342803|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424831|NCT02393248|323342804|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424832|NCT02393248|323342805|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424833|NCT02393248|323342806|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424834|NCT02393248|323342807|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424835|NCT02393248|323342808|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424836|NCT02393248|323342809|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424837|NCT02393248|323342810|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424838|NCT02393248|323342811|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424839|NCT02393248|323342812|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
94424840|NCT02393248|323342813|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
94424841|NCT02393248|323342814|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424842|NCT02393248|323342815|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424843|NCT02393248|323342816|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94489464|NCT03154086|323586091|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
94489465|NCT03154086|323586092|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
94489466|NCT03154086|323586093|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
94489467|NCT03154086|323586094|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
94489468|NCT03154086|323586080|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
94489469|NCT03154086|323586081|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
94489470|NCT03154086|323586082|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
94489471|NCT03154086|323586083|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
94489472|NCT03154086|323586084|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
94489473|NCT03154086|323586085|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
94489474|NCT03154086|323586086|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
94489475|NCT03154086|323586087|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
94489476|NCT03154086|323586088|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
94489477|NCT03154086|323586089|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
94489478|NCT03154086|323586090|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
94489479|NCT03154086|323586091|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
94489480|NCT03154086|323586092|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
94489481|NCT03154086|323586093|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
94489482|NCT03154086|323586094|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
94489483|NCT03154086|323586080|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
94489484|NCT03154086|323586081|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
94489485|NCT03154086|323586082|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
94489486|NCT03154086|323586083|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
94489487|NCT03154086|323586084|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
94489488|NCT03154086|323586085|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
94489489|NCT03154086|323586086|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
94489490|NCT03154086|323586087|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
94489491|NCT03154086|323586088|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
94489492|NCT03154086|323586089|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
94489493|NCT03154086|323586090|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
94489494|NCT03154086|323586091|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
94489495|NCT03154086|323586092|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
94489496|NCT03154086|323586093|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
94489497|NCT03154086|323586094|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
94489498|NCT03154086|323586080|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
94489499|NCT03154086|323586081|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
94489500|NCT03154086|323586082|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
94489501|NCT03154086|323586083|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
94489502|NCT03154086|323586084|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
94489503|NCT03154086|323586085|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
94489504|NCT03154086|323586086|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
94489505|NCT03154086|323586087|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
94489506|NCT03154086|323586088|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
94489507|NCT03154086|323586089|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
94489508|NCT03154086|323586090|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
94489509|NCT03154086|323586091|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
94489510|NCT03154086|323586092|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
94489511|NCT03154086|323586093|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
94489512|NCT03154086|323586094|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
94489513|NCT01603277|323586095|FG000|Overall Study|Adverse Event|1|||
94489514|NCT01603277|323586096|FG001|Overall Study|Adverse Event|2|||
94489515|NCT01603277|323586095|FG000|Overall Study|Physician Decision|0|||
94489516|NCT01603277|323586096|FG001|Overall Study|Physician Decision|1|||
94489517|NCT01603277|323586095|FG000|Overall Study|Protocol Violation|6|||
94489518|NCT01603277|323586096|FG001|Overall Study|Protocol Violation|10|||
94489519|NCT01603277|323586095|FG000|Overall Study|Withdrawal by Subject|5|||
94489520|NCT01603277|323586096|FG001|Overall Study|Withdrawal by Subject|4|||
94489521|NCT01603277|323586095|FG000|Overall Study|Non-Compliance|2|||
94489522|NCT01603277|323586096|FG001|Overall Study|Non-Compliance|1|||
94489523|NCT01186770|323586097|FG000|Overall Study|Ineligibility|0|||
94489524|NCT01186770|323586098|FG001|Overall Study|Ineligibility|0|||
94489525|NCT01186770|323586099|FG002|Overall Study|Ineligibility|2|||
94489526|NCT01186770|323586100|FG003|Overall Study|Ineligibility|0|||
94489527|NCT01186770|323586097|FG000|Overall Study|Protocol Violation|7|||
94489528|NCT01186770|323586098|FG001|Overall Study|Protocol Violation|9|||
94489529|NCT01186770|323586099|FG002|Overall Study|Protocol Violation|12|||
94489530|NCT01186770|323586100|FG003|Overall Study|Protocol Violation|14|||
94489531|NCT01186770|323586097|FG000|Overall Study|Adverse Event|2|||
94489532|NCT01186770|323586098|FG001|Overall Study|Adverse Event|9|||
94489533|NCT01186770|323586099|FG002|Overall Study|Adverse Event|7|||
94489534|NCT01186770|323586100|FG003|Overall Study|Adverse Event|9|||
94489535|NCT01186770|323586097|FG000|Overall Study|Withdrawal by Subject|15|||
94489536|NCT01186770|323586098|FG001|Overall Study|Withdrawal by Subject|13|||
94424844|NCT02393248|323342817|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424845|NCT02393248|323342818|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424846|NCT02393248|323342819|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424847|NCT02393248|323342820|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424848|NCT02393248|323342821|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424849|NCT02393248|323342822|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424850|NCT02393248|323342823|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424851|NCT02393248|323342824|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424852|NCT02393248|323342825|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424853|NCT02393248|323342826|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
94424854|NCT02393248|323342802|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
94424855|NCT02393248|323342803|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
94424856|NCT02393248|323342804|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
94424857|NCT02393248|323342805|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
94424858|NCT02393248|323342806|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
94424859|NCT02393248|323342807|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
94424860|NCT02393248|323342808|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
94424861|NCT02393248|323342809|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
94424862|NCT02393248|323342810|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
94424863|NCT02393248|323342811|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
94424864|NCT02393248|323342812|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
94424865|NCT02393248|323342813|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
94424866|NCT02393248|323342814|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
94424867|NCT02393248|323342815|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
94424868|NCT02393248|323342816|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
94424869|NCT02393248|323342817|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
94424870|NCT02393248|323342818|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
94424871|NCT02393248|323342819|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
94424872|NCT02393248|323342820|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
94424873|NCT02393248|323342821|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
94424874|NCT02393248|323342822|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
94424875|NCT02393248|323342823|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
94424876|NCT02393248|323342824|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
94424877|NCT02393248|323342825|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
94424878|NCT02393248|323342826|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
94424879|NCT02393248|323342802|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424880|NCT02393248|323342803|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424881|NCT02393248|323342804|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424882|NCT02393248|323342805|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424883|NCT02393248|323342806|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424884|NCT02393248|323342807|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424885|NCT02393248|323342808|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424886|NCT02393248|323342809|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424887|NCT02393248|323342810|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424888|NCT02393248|323342811|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424889|NCT02393248|323342812|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424890|NCT02393248|323342813|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
94424891|NCT02393248|323342814|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424892|NCT02393248|323342815|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
94424893|NCT02393248|323342816|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424894|NCT02393248|323342817|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424895|NCT02393248|323342818|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424896|NCT02393248|323342819|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424897|NCT02393248|323342820|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424898|NCT02393248|323342821|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424899|NCT02393248|323342822|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424900|NCT02393248|323342823|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424901|NCT02393248|323342824|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424902|NCT02393248|323342825|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424903|NCT02393248|323342826|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
94424904|NCT02393248|323342802|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424905|NCT02393248|323342803|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424906|NCT02393248|323342804|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424907|NCT02393248|323342805|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424908|NCT02393248|323342806|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424909|NCT02393248|323342807|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424910|NCT02393248|323342808|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424911|NCT02393248|323342809|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424912|NCT02393248|323342810|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424913|NCT02393248|323342811|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424914|NCT02393248|323342812|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424915|NCT02393248|323342813|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424916|NCT02393248|323342814|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424917|NCT02393248|323342815|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424918|NCT02393248|323342816|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424919|NCT02393248|323342817|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424920|NCT02393248|323342818|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424921|NCT02393248|323342819|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424922|NCT02393248|323342820|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
94424923|NCT02393248|323342821|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424924|NCT02393248|323342822|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
94424925|NCT02393248|323342823|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
94424926|NCT02393248|323342824|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424927|NCT02393248|323342825|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
94424928|NCT02393248|323342826|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
94424929|NCT02393248|323342802|FG000|Part 3: Combination Therapy|Death|0|||
94424930|NCT02393248|323342803|FG001|Part 3: Combination Therapy|Death|0|||
94424931|NCT02393248|323342804|FG002|Part 3: Combination Therapy|Death|0|||
94424932|NCT02393248|323342805|FG003|Part 3: Combination Therapy|Death|0|||
94424933|NCT02393248|323342806|FG004|Part 3: Combination Therapy|Death|0|||
94424934|NCT02393248|323342807|FG005|Part 3: Combination Therapy|Death|0|||
94424935|NCT02393248|323342808|FG006|Part 3: Combination Therapy|Death|0|||
94424936|NCT02393248|323342809|FG007|Part 3: Combination Therapy|Death|0|||
94424937|NCT02393248|323342810|FG008|Part 3: Combination Therapy|Death|0|||
94424938|NCT02393248|323342811|FG009|Part 3: Combination Therapy|Death|0|||
94424939|NCT02393248|323342812|FG010|Part 3: Combination Therapy|Death|0|||
94424940|NCT02393248|323342813|FG011|Part 3: Combination Therapy|Death|0|||
94424941|NCT02393248|323342814|FG012|Part 3: Combination Therapy|Death|0|||
94424942|NCT02393248|323342815|FG013|Part 3: Combination Therapy|Death|0|||
94424943|NCT02393248|323342816|FG014|Part 3: Combination Therapy|Death|0|||
94424944|NCT02393248|323342817|FG015|Part 3: Combination Therapy|Death|1|||
94424945|NCT02393248|323342818|FG016|Part 3: Combination Therapy|Death|7|||
94424946|NCT02393248|323342819|FG017|Part 3: Combination Therapy|Death|5|||
94424947|NCT02393248|323342820|FG018|Part 3: Combination Therapy|Death|5|||
94424948|NCT02393248|323342821|FG019|Part 3: Combination Therapy|Death|3|||
94424949|NCT02393248|323342822|FG020|Part 3: Combination Therapy|Death|7|||
94424950|NCT02393248|323342823|FG021|Part 3: Combination Therapy|Death|5|||
94424951|NCT02393248|323342824|FG022|Part 3: Combination Therapy|Death|6|||
94424952|NCT02393248|323342825|FG023|Part 3: Combination Therapy|Death|3|||
94424953|NCT02393248|323342826|FG024|Part 3: Combination Therapy|Death|0|||
94424954|NCT02393248|323342802|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
94424955|NCT02393248|323342803|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
94424956|NCT02393248|323342804|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
94424957|NCT02393248|323342805|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
94424958|NCT02393248|323342806|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
94424959|NCT02393248|323342807|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
94424960|NCT02393248|323342808|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
94424961|NCT02393248|323342809|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
94424962|NCT02393248|323342810|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
94424963|NCT02393248|323342811|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
94424964|NCT02393248|323342812|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
94424965|NCT02393248|323342813|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
94424966|NCT02393248|323342814|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
94424967|NCT02393248|323342815|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
94424968|NCT02393248|323342816|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
94424969|NCT02393248|323342817|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
94424970|NCT02393248|323342818|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
94424971|NCT02393248|323342819|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
94424972|NCT02393248|323342820|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
94424973|NCT02393248|323342821|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
94424974|NCT02393248|323342822|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
94424975|NCT02393248|323342823|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
94424976|NCT02393248|323342824|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
94424977|NCT02393248|323342825|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
94424978|NCT02393248|323342826|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
94424979|NCT02393248|323342802|FG000|Part 3: Combination Therapy|Disease Progression|0|||
94424980|NCT02393248|323342803|FG001|Part 3: Combination Therapy|Disease Progression|0|||
94424981|NCT02393248|323342804|FG002|Part 3: Combination Therapy|Disease Progression|0|||
94424982|NCT02393248|323342805|FG003|Part 3: Combination Therapy|Disease Progression|0|||
94424983|NCT02393248|323342806|FG004|Part 3: Combination Therapy|Disease Progression|0|||
94424984|NCT02393248|323342807|FG005|Part 3: Combination Therapy|Disease Progression|0|||
94424985|NCT02393248|323342808|FG006|Part 3: Combination Therapy|Disease Progression|0|||
94424986|NCT02393248|323342809|FG007|Part 3: Combination Therapy|Disease Progression|0|||
94424987|NCT02393248|323342810|FG008|Part 3: Combination Therapy|Disease Progression|0|||
94424988|NCT02393248|323342811|FG009|Part 3: Combination Therapy|Disease Progression|0|||
94424989|NCT02393248|323342812|FG010|Part 3: Combination Therapy|Disease Progression|0|||
94424990|NCT02393248|323342813|FG011|Part 3: Combination Therapy|Disease Progression|0|||
94424991|NCT02393248|323342814|FG012|Part 3: Combination Therapy|Disease Progression|0|||
94424992|NCT02393248|323342815|FG013|Part 3: Combination Therapy|Disease Progression|0|||
94424993|NCT02393248|323342816|FG014|Part 3: Combination Therapy|Disease Progression|0|||
94424994|NCT02393248|323342817|FG015|Part 3: Combination Therapy|Disease Progression|0|||
94424995|NCT02393248|323342818|FG016|Part 3: Combination Therapy|Disease Progression|0|||
94424996|NCT02393248|323342819|FG017|Part 3: Combination Therapy|Disease Progression|0|||
94424997|NCT02393248|323342820|FG018|Part 3: Combination Therapy|Disease Progression|0|||
94424998|NCT02393248|323342821|FG019|Part 3: Combination Therapy|Disease Progression|0|||
94424999|NCT02393248|323342822|FG020|Part 3: Combination Therapy|Disease Progression|2|||
94425000|NCT02393248|323342823|FG021|Part 3: Combination Therapy|Disease Progression|1|||
94425001|NCT02393248|323342824|FG022|Part 3: Combination Therapy|Disease Progression|0|||
94425002|NCT02393248|323342825|FG023|Part 3: Combination Therapy|Disease Progression|0|||
94425003|NCT02393248|323342826|FG024|Part 3: Combination Therapy|Disease Progression|0|||
94425004|NCT02393248|323342802|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425005|NCT02393248|323342803|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425006|NCT02393248|323342804|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425007|NCT02393248|323342805|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425008|NCT02393248|323342806|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425009|NCT02393248|323342807|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425010|NCT02393248|323342808|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425011|NCT02393248|323342809|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425012|NCT02393248|323342810|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425013|NCT02393248|323342811|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425014|NCT02393248|323342812|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425015|NCT02393248|323342813|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425016|NCT02393248|323342814|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425017|NCT02393248|323342815|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425018|NCT02393248|323342816|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425019|NCT02393248|323342817|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425020|NCT02393248|323342818|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425021|NCT02393248|323342819|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425022|NCT02393248|323342820|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425023|NCT02393248|323342821|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425024|NCT02393248|323342822|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
94425025|NCT02393248|323342823|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
94425026|NCT02393248|323342824|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425027|NCT02393248|323342825|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425028|NCT02393248|323342826|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
94425029|NCT02393248|323342802|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425030|NCT02393248|323342803|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425031|NCT02393248|323342804|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425032|NCT02393248|323342805|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425033|NCT02393248|323342806|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425034|NCT02393248|323342807|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425035|NCT02393248|323342808|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425036|NCT02393248|323342809|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425037|NCT02393248|323342810|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425038|NCT02393248|323342811|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425039|NCT02393248|323342812|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425040|NCT02393248|323342813|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425041|NCT02393248|323342814|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425042|NCT02393248|323342815|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425043|NCT02393248|323342816|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425044|NCT02393248|323342817|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94489537|NCT01186770|323586099|FG002|Overall Study|Withdrawal by Subject|11|||
94489538|NCT01186770|323586100|FG003|Overall Study|Withdrawal by Subject|17|||
94489539|NCT01186770|323586097|FG000|Overall Study|Lost to Follow-up|10|||
94425045|NCT02393248|323342818|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425046|NCT02393248|323342819|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425047|NCT02393248|323342820|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425048|NCT02393248|323342821|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425049|NCT02393248|323342822|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
94425050|NCT02393248|323342823|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425051|NCT02393248|323342824|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425052|NCT02393248|323342825|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425053|NCT02393248|323342826|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
94425054|NCT02393248|323342802|FG000|Part 3: Combination Therapy|Adverse Event|0|||
94425055|NCT02393248|323342803|FG001|Part 3: Combination Therapy|Adverse Event|0|||
94425056|NCT02393248|323342804|FG002|Part 3: Combination Therapy|Adverse Event|0|||
94425057|NCT02393248|323342805|FG003|Part 3: Combination Therapy|Adverse Event|0|||
94425058|NCT02393248|323342806|FG004|Part 3: Combination Therapy|Adverse Event|0|||
94425059|NCT02393248|323342807|FG005|Part 3: Combination Therapy|Adverse Event|0|||
94425060|NCT02393248|323342808|FG006|Part 3: Combination Therapy|Adverse Event|0|||
94425061|NCT02393248|323342809|FG007|Part 3: Combination Therapy|Adverse Event|0|||
94425062|NCT02393248|323342810|FG008|Part 3: Combination Therapy|Adverse Event|0|||
94425063|NCT02393248|323342811|FG009|Part 3: Combination Therapy|Adverse Event|0|||
94425064|NCT02393248|323342812|FG010|Part 3: Combination Therapy|Adverse Event|0|||
94425065|NCT02393248|323342813|FG011|Part 3: Combination Therapy|Adverse Event|0|||
94425066|NCT02393248|323342814|FG012|Part 3: Combination Therapy|Adverse Event|0|||
94425067|NCT02393248|323342815|FG013|Part 3: Combination Therapy|Adverse Event|0|||
94425068|NCT02393248|323342816|FG014|Part 3: Combination Therapy|Adverse Event|0|||
94425069|NCT02393248|323342817|FG015|Part 3: Combination Therapy|Adverse Event|0|||
94425070|NCT02393248|323342818|FG016|Part 3: Combination Therapy|Adverse Event|0|||
94425071|NCT02393248|323342819|FG017|Part 3: Combination Therapy|Adverse Event|0|||
94425072|NCT02393248|323342820|FG018|Part 3: Combination Therapy|Adverse Event|0|||
94425073|NCT02393248|323342821|FG019|Part 3: Combination Therapy|Adverse Event|0|||
94425074|NCT02393248|323342822|FG020|Part 3: Combination Therapy|Adverse Event|0|||
94425075|NCT02393248|323342823|FG021|Part 3: Combination Therapy|Adverse Event|0|||
94425076|NCT02393248|323342824|FG022|Part 3: Combination Therapy|Adverse Event|0|||
94425077|NCT02393248|323342825|FG023|Part 3: Combination Therapy|Adverse Event|1|||
94425078|NCT02393248|323342826|FG024|Part 3: Combination Therapy|Adverse Event|0|||
94425079|NCT02393248|323342802|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425080|NCT02393248|323342803|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425081|NCT02393248|323342804|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425082|NCT02393248|323342805|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425083|NCT02393248|323342806|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425084|NCT02393248|323342807|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425085|NCT02393248|323342808|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425086|NCT02393248|323342809|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425087|NCT02393248|323342810|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425088|NCT02393248|323342811|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425089|NCT02393248|323342812|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425090|NCT02393248|323342813|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425091|NCT02393248|323342814|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425092|NCT02393248|323342815|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425093|NCT02393248|323342816|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425094|NCT02393248|323342817|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425095|NCT02393248|323342818|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425096|NCT02393248|323342819|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425097|NCT02393248|323342820|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425098|NCT02393248|323342821|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425099|NCT02393248|323342822|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425100|NCT02393248|323342823|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425101|NCT02393248|323342824|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425102|NCT02393248|323342825|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
94489540|NCT01186770|323586098|FG001|Overall Study|Lost to Follow-up|6|||
94489541|NCT01186770|323586099|FG002|Overall Study|Lost to Follow-up|14|||
94425103|NCT02393248|323342826|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
94425104|NCT00848107|323342827|FG000|Overall Study|Lost to Follow-up|2|||
94489542|NCT01186770|323586100|FG003|Overall Study|Lost to Follow-up|9|||
94425105|NCT00848107|323342827|FG000|Overall Study|Withdrawal by Subject|8|||
94425106|NCT00848107|323342827|FG000|Overall Study|Adverse Event|9|||
94425107|NCT00848107|323342827|FG000|Overall Study|Death|1|||
94425108|NCT00848107|323342827|FG000|Overall Study|Pregnancy|1|||
94425109|NCT02335983|323342828|FG000|Overall Study|Sponsor Decision|0|||
94425110|NCT02335983|323342829|FG001|Overall Study|Sponsor Decision|0|||
94425111|NCT02335983|323342830|FG002|Overall Study|Sponsor Decision|1|||
94425112|NCT02335983|323342831|FG003|Overall Study|Sponsor Decision|1|||
94425113|NCT02335983|323342832|FG004|Overall Study|Sponsor Decision|0|||
94425114|NCT02335983|323342833|FG005|Overall Study|Sponsor Decision|1|||
94425115|NCT02335983|323342828|FG000|Overall Study|Withdrawal by Subject|3|||
94425116|NCT02335983|323342829|FG001|Overall Study|Withdrawal by Subject|2|||
94425117|NCT02335983|323342830|FG002|Overall Study|Withdrawal by Subject|2|||
94425118|NCT02335983|323342831|FG003|Overall Study|Withdrawal by Subject|1|||
94425119|NCT02335983|323342832|FG004|Overall Study|Withdrawal by Subject|3|||
94425120|NCT02335983|323342833|FG005|Overall Study|Withdrawal by Subject|9|||
94425121|NCT02335983|323342828|FG000|Overall Study|Death|0|||
94425122|NCT02335983|323342829|FG001|Overall Study|Death|0|||
94425123|NCT02335983|323342830|FG002|Overall Study|Death|2|||
94425124|NCT02335983|323342831|FG003|Overall Study|Death|0|||
94425125|NCT02335983|323342832|FG004|Overall Study|Death|0|||
94425126|NCT02335983|323342833|FG005|Overall Study|Death|0|||
94425127|NCT02335983|323342828|FG000|Overall Study|Lost to Follow-up|0|||
94425128|NCT02335983|323342829|FG001|Overall Study|Lost to Follow-up|0|||
94425129|NCT02335983|323342830|FG002|Overall Study|Lost to Follow-up|0|||
94425130|NCT02335983|323342831|FG003|Overall Study|Lost to Follow-up|0|||
94425131|NCT02335983|323342832|FG004|Overall Study|Lost to Follow-up|0|||
94425132|NCT02335983|323342833|FG005|Overall Study|Lost to Follow-up|1|||
94425133|NCT02335983|323342828|FG000|Overall Study|Protocol Specified Criteria|5|||
94425134|NCT02335983|323342829|FG001|Overall Study|Protocol Specified Criteria|7|||
94425135|NCT02335983|323342830|FG002|Overall Study|Protocol Specified Criteria|27|||
94425136|NCT02335983|323342831|FG003|Overall Study|Protocol Specified Criteria|7|||
94425137|NCT02335983|323342832|FG004|Overall Study|Protocol Specified Criteria|5|||
94425138|NCT02335983|323342833|FG005|Overall Study|Protocol Specified Criteria|21|||
94425139|NCT01831765|323342834|FG000|Overall Study|Lack of Efficacy|1|||
94425140|NCT01831765|323342835|FG001|Overall Study|Lack of Efficacy|0|||
94425141|NCT01831765|323342836|FG002|Overall Study|Lack of Efficacy|0|||
94425142|NCT01831765|323342834|FG000|Overall Study|Other, sponsor withdrew subject|0|||
94425143|NCT01831765|323342835|FG001|Overall Study|Other, sponsor withdrew subject|1|||
94425144|NCT01831765|323342836|FG002|Overall Study|Other, sponsor withdrew subject|0|||
94425145|NCT01831765|323342834|FG000|Overall Study|Pregnancy|1|||
94425146|NCT01831765|323342835|FG001|Overall Study|Pregnancy|1|||
94425147|NCT01831765|323342836|FG002|Overall Study|Pregnancy|2|||
94425148|NCT01831765|323342834|FG000|Overall Study|Death|0|||
94425149|NCT01831765|323342835|FG001|Overall Study|Death|1|||
94425150|NCT01831765|323342836|FG002|Overall Study|Death|1|||
94425151|NCT01831765|323342834|FG000|Overall Study|Other, site closed|1|||
94425152|NCT01831765|323342835|FG001|Overall Study|Other, site closed|1|||
94425153|NCT01831765|323342836|FG002|Overall Study|Other, site closed|0|||
94425154|NCT01831765|323342834|FG000|Overall Study|Adverse Event|5|||
94425155|NCT01831765|323342835|FG001|Overall Study|Adverse Event|3|||
94425156|NCT01831765|323342836|FG002|Overall Study|Adverse Event|3|||
94425157|NCT01831765|323342834|FG000|Overall Study|Withdrawal by Subject|22|||
94425158|NCT01831765|323342835|FG001|Overall Study|Withdrawal by Subject|7|||
94425159|NCT01831765|323342836|FG002|Overall Study|Withdrawal by Subject|17|||
94425160|NCT01831765|323342834|FG000|Overall Study|Withdrawal criteria|12|||
94425161|NCT01831765|323342835|FG001|Overall Study|Withdrawal criteria|10|||
94425162|NCT01831765|323342836|FG002|Overall Study|Withdrawal criteria|16|||
94425163|NCT01831765|323342834|FG000|Overall Study|Lost to Follow-up|2|||
94425164|NCT01831765|323342835|FG001|Overall Study|Lost to Follow-up|3|||
94425165|NCT01831765|323342836|FG002|Overall Study|Lost to Follow-up|3|||
94425166|NCT00859586|323342837|FG000|Overall Study|Donors|4|||
94425167|NCT00507130|323342838|FG000|Overall Study|Lost to Follow-up|0|||
94425168|NCT00507130|323342839|FG001|Overall Study|Lost to Follow-up|0|||
94425169|NCT00507130|323342840|FG002|Overall Study|Lost to Follow-up|1|||
94425170|NCT00507130|323342841|FG003|Overall Study|Lost to Follow-up|1|||
94425171|NCT00507130|323342838|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
94425172|NCT00507130|323342839|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
94425173|NCT00507130|323342840|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
94425174|NCT00507130|323342841|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
94425175|NCT00977379|323342848|FG000|Overall Study|Withdrawal by Subject|1|||
94425176|NCT00977379|323342849|FG001|Overall Study|Withdrawal by Subject|1|||
94425177|NCT00977379|323342848|FG000|Overall Study|Death|7|||
94425178|NCT00977379|323342849|FG001|Overall Study|Death|9|||
94425179|NCT00977379|323342848|FG000|Overall Study|Premature Study Termination|4|||
94425180|NCT00977379|323342849|FG001|Overall Study|Premature Study Termination|0|||
94425181|NCT00977379|323342848|FG000|Overall Study|Participant Moving House|0|||
94425182|NCT00977379|323342849|FG001|Overall Study|Participant Moving House|1|||
94425183|NCT00977379|323342848|FG000|Overall Study|Randomization Error|0|||
94425184|NCT00977379|323342849|FG001|Overall Study|Randomization Error|1|||
94425185|NCT02603393|323342852|FG000|Overall Study|Patient/guardian decision|32|||
94425186|NCT02603393|323342853|FG001|Overall Study|Patient/guardian decision|18|||
94425187|NCT02603393|323342852|FG000|Overall Study|Adverse Event|17|||
94425188|NCT02603393|323342853|FG001|Overall Study|Adverse Event|15|||
94425189|NCT02603393|323342852|FG000|Overall Study|Technical problems|4|||
94425190|NCT02603393|323342853|FG001|Overall Study|Technical problems|7|||
94425191|NCT02603393|323342852|FG000|Overall Study|Lack of Efficacy|7|||
94425192|NCT02603393|323342853|FG001|Overall Study|Lack of Efficacy|2|||
94425193|NCT02603393|323342852|FG000|Overall Study|Death|3|||
94425194|NCT02603393|323342853|FG001|Overall Study|Death|4|||
94425195|NCT02603393|323342852|FG000|Overall Study|Physician Decision|3|||
94425196|NCT02603393|323342853|FG001|Overall Study|Physician Decision|3|||
94425197|NCT02603393|323342852|FG000|Overall Study|Protocol deviation|2|||
94425198|NCT02603393|323342853|FG001|Overall Study|Protocol deviation|3|||
94425199|NCT02603393|323342852|FG000|Overall Study|Lost to Follow-up|1|||
94425200|NCT02603393|323342853|FG001|Overall Study|Lost to Follow-up|2|||
94425201|NCT02603393|323342852|FG000|Overall Study|Non-compliance with study treatment|1|||
94425202|NCT02603393|323342853|FG001|Overall Study|Non-compliance with study treatment|0|||
94425203|NCT02603393|323342852|FG000|Overall Study|Sponsor decision|1|||
94425204|NCT02603393|323342853|FG001|Overall Study|Sponsor decision|0|||
94425205|NCT03400943|323342855|FG000|Treatment Period 1|Adverse Event|0|||
94425206|NCT03400943|323342856|FG001|Treatment Period 1|Adverse Event|0|||
94425207|NCT03400943|323342857|FG002|Treatment Period 1|Adverse Event|0|||
94425208|NCT03400943|323342858|FG003|Treatment Period 1|Adverse Event|1|||
94425209|NCT03400943|323342855|FG000|Treatment Period 1|Lost to Follow-up|1|||
94425210|NCT03400943|323342856|FG001|Treatment Period 1|Lost to Follow-up|0|||
94425211|NCT03400943|323342857|FG002|Treatment Period 1|Lost to Follow-up|0|||
94425212|NCT03400943|323342858|FG003|Treatment Period 1|Lost to Follow-up|0|||
94425213|NCT03400943|323342855|FG000|Treatment Period 1|Protocol Violation|0|||
94425214|NCT03400943|323342856|FG001|Treatment Period 1|Protocol Violation|1|||
94425215|NCT03400943|323342857|FG002|Treatment Period 1|Protocol Violation|1|||
94425216|NCT03400943|323342858|FG003|Treatment Period 1|Protocol Violation|0|||
94425217|NCT03400943|323342855|FG000|Treatment Period 1|Study terminated by sponsor|2|||
94425218|NCT03400943|323342856|FG001|Treatment Period 1|Study terminated by sponsor|0|||
94425219|NCT03400943|323342857|FG002|Treatment Period 1|Study terminated by sponsor|0|||
94425220|NCT03400943|323342858|FG003|Treatment Period 1|Study terminated by sponsor|1|||
94425221|NCT03400943|323342855|FG000|Treatment Period 1|Withdrawal by Subject|0|||
94425222|NCT03400943|323342856|FG001|Treatment Period 1|Withdrawal by Subject|0|||
94425223|NCT03400943|323342857|FG002|Treatment Period 1|Withdrawal by Subject|3|||
94425224|NCT03400943|323342858|FG003|Treatment Period 1|Withdrawal by Subject|1|||
94425225|NCT03400943|323342855|FG000|Treatment Period 1|Other|2|||
94425226|NCT03400943|323342856|FG001|Treatment Period 1|Other|1|||
94425227|NCT03400943|323342857|FG002|Treatment Period 1|Other|2|||
94425228|NCT03400943|323342858|FG003|Treatment Period 1|Other|2|||
94425229|NCT03400943|323342855|FG000|Post-treatment Period 1|Adverse Event|2|||
94425230|NCT03400943|323342856|FG001|Post-treatment Period 1|Adverse Event|0|||
94425231|NCT03400943|323342857|FG002|Post-treatment Period 1|Adverse Event|0|||
94425232|NCT03400943|323342858|FG003|Post-treatment Period 1|Adverse Event|0|||
94425233|NCT03400943|323342855|FG000|Post-treatment Period 1|Protocol Violation|1|||
94425234|NCT03400943|323342856|FG001|Post-treatment Period 1|Protocol Violation|0|||
94425235|NCT03400943|323342857|FG002|Post-treatment Period 1|Protocol Violation|0|||
94425236|NCT03400943|323342858|FG003|Post-treatment Period 1|Protocol Violation|0|||
94425237|NCT03400943|323342855|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
94425238|NCT03400943|323342856|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
94425239|NCT03400943|323342857|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
94425240|NCT03400943|323342858|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
94425241|NCT03400943|323342855|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
94425242|NCT03400943|323342856|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
94425243|NCT03400943|323342857|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
94425244|NCT03400943|323342858|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
94425245|NCT03400943|323342855|FG000|Post-treatment Period 1|Other|2|||
94425246|NCT03400943|323342856|FG001|Post-treatment Period 1|Other|0|||
94425247|NCT03400943|323342857|FG002|Post-treatment Period 1|Other|4|||
94425248|NCT03400943|323342858|FG003|Post-treatment Period 1|Other|5|||
94425249|NCT03400943|323342855|FG000|Treatment Period 2|Study terminated by sponsor|0|||
94425250|NCT03400943|323342856|FG001|Treatment Period 2|Study terminated by sponsor|1|||
94425251|NCT03400943|323342857|FG002|Treatment Period 2|Study terminated by sponsor|0|||
94425252|NCT03400943|323342858|FG003|Treatment Period 2|Study terminated by sponsor|0|||
94425253|NCT03400943|323342855|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94425254|NCT03400943|323342856|FG001|Treatment Period 2|Withdrawal by Subject|1|||
94425255|NCT03400943|323342857|FG002|Treatment Period 2|Withdrawal by Subject|0|||
94425256|NCT03400943|323342858|FG003|Treatment Period 2|Withdrawal by Subject|0|||
94425257|NCT03400943|323342855|FG000|Treatment Period 2|Other|1|||
94425258|NCT03400943|323342856|FG001|Treatment Period 2|Other|6|||
94425259|NCT03400943|323342857|FG002|Treatment Period 2|Other|0|||
94425260|NCT03400943|323342858|FG003|Treatment Period 2|Other|0|||
94425261|NCT03400943|323342855|FG000|Follow-up Period|Withdrawal by Subject|1|||
94425262|NCT03400943|323342856|FG001|Follow-up Period|Withdrawal by Subject|0|||
94425263|NCT03400943|323342857|FG002|Follow-up Period|Withdrawal by Subject|0|||
94425264|NCT03400943|323342858|FG003|Follow-up Period|Withdrawal by Subject|0|||
94425265|NCT04729309|323342859|FG000|Period 1|Subject unable to return for Period 2|3|||
94425266|NCT04729309|323342860|FG001|Period 1|Subject unable to return for Period 2|0|||
94425267|NCT04729309|323342859|FG000|Period 1|Lost to Follow-up|1|||
94425268|NCT04729309|323342860|FG001|Period 1|Lost to Follow-up|0|||
94425269|NCT01087489|323342861|FG000|Overall Study|enrolled in another VA study|0|||
94425270|NCT01087489|323342862|FG001|Overall Study|enrolled in another VA study|1|||
94425271|NCT01087489|323342861|FG000|Overall Study|Death|0|||
94425272|NCT01087489|323342862|FG001|Overall Study|Death|1|||
94425273|NCT01087489|323342861|FG000|Overall Study|unable to survey by telephone|0|||
94425274|NCT01087489|323342862|FG001|Overall Study|unable to survey by telephone|1|||
94425275|NCT01059539|323342863|FG000|Overall Study|Adverse Event|66|||
94425276|NCT01059539|323342863|FG000|Overall Study|Insufficient Therapeutic Response|26|||
94425277|NCT01059539|323342863|FG000|Overall Study|Protocol Violation|55|||
94425278|NCT01059539|323342863|FG000|Overall Study|Withdrawal of Consent|80|||
94425279|NCT01059539|323342863|FG000|Overall Study|Lost to Follow-up|42|||
94425280|NCT01059539|323342863|FG000|Overall Study|Reason Not Specified|2|||
94425281|NCT00117325|323342864|FG000|Overall Study|Adverse Event|3|||
94425282|NCT00117325|323342865|FG001|Overall Study|Adverse Event|3|||
94425283|NCT00117325|323342864|FG000|Overall Study|Lost to Follow-up|1|||
94425284|NCT00117325|323342865|FG001|Overall Study|Lost to Follow-up|1|||
94425285|NCT00117325|323342864|FG000|Overall Study|Protocol Violation|2|||
94425286|NCT00117325|323342865|FG001|Overall Study|Protocol Violation|3|||
94425287|NCT00117325|323342864|FG000|Overall Study|Withdrawal by Subject|3|||
94425288|NCT00117325|323342865|FG001|Overall Study|Withdrawal by Subject|2|||
94425289|NCT00117325|323342864|FG000|Overall Study|Lack of Efficacy|1|||
94425290|NCT00117325|323342865|FG001|Overall Study|Lack of Efficacy|0|||
94425291|NCT00117325|323342864|FG000|Overall Study|Use of prohibited medicine|1|||
94425292|NCT00117325|323342865|FG001|Overall Study|Use of prohibited medicine|2|||
94425293|NCT00117325|323342864|FG000|Overall Study|Early termination|1|||
94425294|NCT00117325|323342865|FG001|Overall Study|Early termination|1|||
94425295|NCT00117325|323342864|FG000|Overall Study|Admisnitrative|1|||
94425296|NCT00117325|323342865|FG001|Overall Study|Admisnitrative|0|||
94425297|NCT02885181|323342871|FG000|Overall Study|Investigator's Discretion|0|||
94425298|NCT02885181|323342872|FG001|Overall Study|Investigator's Discretion|1|||
94425299|NCT02885181|323342873|FG002|Overall Study|Investigator's Discretion|0|||
94425300|NCT02885181|323342874|FG003|Overall Study|Investigator's Discretion|1|||
94425301|NCT02885181|323342871|FG000|Overall Study|Adverse Event|0|||
94425302|NCT02885181|323342872|FG001|Overall Study|Adverse Event|0|||
94425303|NCT02885181|323342873|FG002|Overall Study|Adverse Event|0|||
94425304|NCT02885181|323342874|FG003|Overall Study|Adverse Event|1|||
94425305|NCT02885181|323342871|FG000|Overall Study|Withdrawal by Subject|0|||
94425306|NCT02885181|323342872|FG001|Overall Study|Withdrawal by Subject|0|||
94425307|NCT02885181|323342873|FG002|Overall Study|Withdrawal by Subject|0|||
94425308|NCT02885181|323342874|FG003|Overall Study|Withdrawal by Subject|1|||
94425309|NCT03327792|323342875|FG000|Overall Study|Adverse Event|4|||
94425310|NCT03327792|323342876|FG001|Overall Study|Adverse Event|0|||
94425311|NCT03327792|323342875|FG000|Overall Study|Family/Personal issues|3|||
94425312|NCT03327792|323342876|FG001|Overall Study|Family/Personal issues|2|||
94425313|NCT03327792|323342875|FG000|Overall Study|Lost to Follow-up|0|||
94425314|NCT03327792|323342876|FG001|Overall Study|Lost to Follow-up|1|||
94425315|NCT00626392|323342877|FG000|Run-in Period|Adverse Event|0|||
94425316|NCT00626392|323342878|FG001|Run-in Period|Adverse Event|0|||
94425317|NCT00626392|323342879|FG002|Run-in Period|Adverse Event|1|||
94425318|NCT00626392|323342880|FG003|Run-in Period|Adverse Event|0|||
94425319|NCT00626392|323342881|FG004|Run-in Period|Adverse Event|1|||
94425320|NCT00626392|323342882|FG005|Run-in Period|Adverse Event|0|||
94425321|NCT00626392|323342877|FG000|Run-in Period|Withdrawal by Subject|0|||
94425322|NCT00626392|323342878|FG001|Run-in Period|Withdrawal by Subject|1|||
94425323|NCT00626392|323342879|FG002|Run-in Period|Withdrawal by Subject|1|||
94425324|NCT00626392|323342880|FG003|Run-in Period|Withdrawal by Subject|1|||
94425325|NCT00626392|323342881|FG004|Run-in Period|Withdrawal by Subject|3|||
94425326|NCT00626392|323342882|FG005|Run-in Period|Withdrawal by Subject|1|||
94425327|NCT00626392|323342877|FG000|Run-in Period|Noncompliance|1|||
94425328|NCT00626392|323342878|FG001|Run-in Period|Noncompliance|0|||
94425329|NCT00626392|323342879|FG002|Run-in Period|Noncompliance|1|||
94425330|NCT00626392|323342880|FG003|Run-in Period|Noncompliance|0|||
94425331|NCT00626392|323342881|FG004|Run-in Period|Noncompliance|0|||
94425332|NCT00626392|323342882|FG005|Run-in Period|Noncompliance|0|||
94425333|NCT00626392|323342877|FG000|Coadministration Period|Adverse Event|3|||
94425334|NCT00626392|323342878|FG001|Coadministration Period|Adverse Event|1|||
94425335|NCT00626392|323342879|FG002|Coadministration Period|Adverse Event|7|||
94425336|NCT00626392|323342880|FG003|Coadministration Period|Adverse Event|4|||
94425337|NCT00626392|323342881|FG004|Coadministration Period|Adverse Event|3|||
94425338|NCT00626392|323342882|FG005|Coadministration Period|Adverse Event|4|||
94425339|NCT00626392|323342877|FG000|Coadministration Period|Withdrawal by Subject|1|||
94425340|NCT00626392|323342878|FG001|Coadministration Period|Withdrawal by Subject|1|||
94425341|NCT00626392|323342879|FG002|Coadministration Period|Withdrawal by Subject|0|||
94425342|NCT00626392|323342880|FG003|Coadministration Period|Withdrawal by Subject|1|||
94425343|NCT00626392|323342881|FG004|Coadministration Period|Withdrawal by Subject|0|||
94425344|NCT00626392|323342882|FG005|Coadministration Period|Withdrawal by Subject|1|||
94425345|NCT00626392|323342877|FG000|Coadministration Period|Protocol Violation|0|||
94425346|NCT00626392|323342878|FG001|Coadministration Period|Protocol Violation|1|||
94425347|NCT00626392|323342879|FG002|Coadministration Period|Protocol Violation|0|||
94425348|NCT00626392|323342880|FG003|Coadministration Period|Protocol Violation|1|||
94425349|NCT00626392|323342881|FG004|Coadministration Period|Protocol Violation|1|||
94425350|NCT00626392|323342882|FG005|Coadministration Period|Protocol Violation|0|||
94425351|NCT00626392|323342877|FG000|Coadministration Period|Other|0|||
94425352|NCT00626392|323342878|FG001|Coadministration Period|Other|2|||
94425353|NCT00626392|323342879|FG002|Coadministration Period|Other|3|||
94425354|NCT00626392|323342880|FG003|Coadministration Period|Other|1|||
94425355|NCT00626392|323342881|FG004|Coadministration Period|Other|1|||
94425356|NCT00626392|323342882|FG005|Coadministration Period|Other|1|||
94425357|NCT00338455|323342883|FG000|Overall Study|Death|2|||
94425358|NCT00338455|323342884|FG001|Overall Study|Death|1|||
94425359|NCT00338455|323342883|FG000|Overall Study|Physician Decision|1|||
94425360|NCT00338455|323342884|FG001|Overall Study|Physician Decision|0|||
94425361|NCT04647721|323342885|FG000|Overall Study|Withdrawal by Subject|0|||
94425362|NCT04647721|323342886|FG001|Overall Study|Withdrawal by Subject|2|||
94425363|NCT04647721|323342885|FG000|Overall Study|Lost to Follow-up|2|||
94425364|NCT04647721|323342886|FG001|Overall Study|Lost to Follow-up|0|||
94425365|NCT05070546|323342887|FG000|Overall Study|Death|0|||
94425366|NCT05070546|323342888|FG001|Overall Study|Death|0|||
94425367|NCT05070546|323342889|FG002|Overall Study|Death|0|||
94425368|NCT05070546|323342890|FG003|Overall Study|Death|0|||
94425369|NCT05070546|323342891|FG004|Overall Study|Death|0|||
94425370|NCT05070546|323342892|FG005|Overall Study|Death|1|||
94425371|NCT05070546|323342887|FG000|Overall Study|Lost to Follow-up|8|||
94425372|NCT05070546|323342888|FG001|Overall Study|Lost to Follow-up|2|||
94425373|NCT05070546|323342889|FG002|Overall Study|Lost to Follow-up|7|||
94425374|NCT05070546|323342890|FG003|Overall Study|Lost to Follow-up|1|||
94425375|NCT05070546|323342891|FG004|Overall Study|Lost to Follow-up|2|||
94425376|NCT05070546|323342892|FG005|Overall Study|Lost to Follow-up|0|||
94425377|NCT05070546|323342887|FG000|Overall Study|Withdrawal by Subject|1|||
94425378|NCT05070546|323342888|FG001|Overall Study|Withdrawal by Subject|1|||
94425379|NCT05070546|323342889|FG002|Overall Study|Withdrawal by Subject|3|||
94425380|NCT05070546|323342890|FG003|Overall Study|Withdrawal by Subject|0|||
94425381|NCT05070546|323342891|FG004|Overall Study|Withdrawal by Subject|0|||
94425382|NCT05070546|323342892|FG005|Overall Study|Withdrawal by Subject|0|||
94425383|NCT05070546|323342887|FG000|Overall Study|Other|0|||
94425384|NCT05070546|323342888|FG001|Overall Study|Other|0|||
94425385|NCT05070546|323342889|FG002|Overall Study|Other|0|||
94425386|NCT05070546|323342890|FG003|Overall Study|Other|0|||
94425387|NCT05070546|323342891|FG004|Overall Study|Other|3|||
94425388|NCT05070546|323342892|FG005|Overall Study|Other|0|||
94425389|NCT05070546|323342887|FG000|Overall Study|Randomized but not vaccinated|1|||
94425390|NCT05070546|323342888|FG001|Overall Study|Randomized but not vaccinated|0|||
94425391|NCT05070546|323342889|FG002|Overall Study|Randomized but not vaccinated|1|||
94425392|NCT05070546|323342890|FG003|Overall Study|Randomized but not vaccinated|1|||
94425393|NCT05070546|323342891|FG004|Overall Study|Randomized but not vaccinated|3|||
94425394|NCT05070546|323342892|FG005|Overall Study|Randomized but not vaccinated|0|||
94425395|NCT04524364|323342895|FG000|Overall Study|Physician Decision|3|||
94425396|NCT04524364|323342896|FG001|Overall Study|Physician Decision|6|||
94425397|NCT04524364|323342895|FG000|Overall Study|Adverse Event|0|||
94425398|NCT04524364|323342896|FG001|Overall Study|Adverse Event|1|||
94425399|NCT04524364|323342895|FG000|Overall Study|Investigational device deficiency|0|||
94425400|NCT04524364|323342896|FG001|Overall Study|Investigational device deficiency|1|||
94425401|NCT04524364|323342895|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
94425402|NCT04524364|323342896|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
94425403|NCT04524364|323342895|FG000|Overall Study|Device unavailability|0|||
94425404|NCT04524364|323342896|FG001|Overall Study|Device unavailability|2|||
94425405|NCT04524364|323342895|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
94425406|NCT04524364|323342896|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
94425407|NCT04524364|323342895|FG000|Overall Study|Low International normalized ratio (INR)|1|||
94425408|NCT04524364|323342896|FG001|Overall Study|Low International normalized ratio (INR)|0|||
94425409|NCT05788289|323342897|FG000|Overall Study|Death|3|||
94425410|NCT01974440|323342898|FG000|Overall Study|Lost to Follow-up|7|||
94425411|NCT01974440|323342899|FG001|Overall Study|Lost to Follow-up|7|||
94425412|NCT01974440|323342898|FG000|Overall Study|Withdrawal by Subject|24|||
94425413|NCT01974440|323342899|FG001|Overall Study|Withdrawal by Subject|20|||
94425414|NCT01974440|323342898|FG000|Overall Study|Sponsor decision|109|||
94425415|NCT01974440|323342899|FG001|Overall Study|Sponsor decision|110|||
94425416|NCT04669691|323342907|FG000|Overall Study|Death|0|||
94425417|NCT04669691|323342908|FG001|Overall Study|Death|1|||
94425418|NCT04669691|323342909|FG002|Overall Study|Death|0|||
94425419|NCT04669691|323342910|FG003|Overall Study|Death|0|||
94425420|NCT04669691|323342911|FG004|Overall Study|Death|0|||
94425421|NCT04669691|323342912|FG005|Overall Study|Death|0|||
94425422|NCT01458106|323342914|FG000|Overall Study|Withdrawal by Subject|2|||
94425423|NCT01458106|323342915|FG001|Overall Study|Withdrawal by Subject|0|||
94425424|NCT01458106|323342914|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
94425425|NCT01458106|323342915|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
94425426|NCT01458106|323342914|FG000|Overall Study|Withdrawn Per Protocol|0|||
94425427|NCT01458106|323342915|FG001|Overall Study|Withdrawn Per Protocol|1|||
94425428|NCT02132754|323342916|FG000|Overall Study|Adverse Event|0|||
94425429|NCT02132754|323342917|FG001|Overall Study|Adverse Event|0|||
94425430|NCT02132754|323342918|FG002|Overall Study|Adverse Event|0|||
94425431|NCT02132754|323342919|FG003|Overall Study|Adverse Event|0|||
94425432|NCT02132754|323342920|FG004|Overall Study|Adverse Event|0|||
94425433|NCT02132754|323342921|FG005|Overall Study|Adverse Event|0|||
94425434|NCT02132754|323342922|FG006|Overall Study|Adverse Event|0|||
94425435|NCT02132754|323342923|FG007|Overall Study|Adverse Event|0|||
94425436|NCT02132754|323342924|FG008|Overall Study|Adverse Event|0|||
94425437|NCT02132754|323342925|FG009|Overall Study|Adverse Event|0|||
94425438|NCT02132754|323342926|FG010|Overall Study|Adverse Event|0|||
94425439|NCT02132754|323342927|FG011|Overall Study|Adverse Event|0|||
94425440|NCT02132754|323342928|FG012|Overall Study|Adverse Event|0|||
94425441|NCT02132754|323342929|FG013|Overall Study|Adverse Event|0|||
94425442|NCT02132754|323342930|FG014|Overall Study|Adverse Event|0|||
94425443|NCT02132754|323342931|FG015|Overall Study|Adverse Event|0|||
94425444|NCT02132754|323342932|FG016|Overall Study|Adverse Event|0|||
94425445|NCT02132754|323342933|FG017|Overall Study|Adverse Event|1|||
94425446|NCT02132754|323342934|FG018|Overall Study|Adverse Event|0|||
94425447|NCT02132754|323342935|FG019|Overall Study|Adverse Event|0|||
94425448|NCT02132754|323342936|FG020|Overall Study|Adverse Event|0|||
94425449|NCT02132754|323342937|FG021|Overall Study|Adverse Event|0|||
94425450|NCT02132754|323342938|FG022|Overall Study|Adverse Event|0|||
94425451|NCT02132754|323342939|FG023|Overall Study|Adverse Event|0|||
94425452|NCT02132754|323342940|FG024|Overall Study|Adverse Event|0|||
94425453|NCT02132754|323342941|FG025|Overall Study|Adverse Event|1|||
94425454|NCT02132754|323342942|FG026|Overall Study|Adverse Event|1|||
94425455|NCT02132754|323342943|FG027|Overall Study|Adverse Event|0|||
94425456|NCT02132754|323342944|FG028|Overall Study|Adverse Event|0|||
94425457|NCT02132754|323342945|FG029|Overall Study|Adverse Event|0|||
94425458|NCT02132754|323342946|FG030|Overall Study|Adverse Event|1|||
94425459|NCT02132754|323342947|FG031|Overall Study|Adverse Event|0|||
94425460|NCT02132754|323342948|FG032|Overall Study|Adverse Event|1|||
94425461|NCT02132754|323342949|FG033|Overall Study|Adverse Event|1|||
94425462|NCT02132754|323342916|FG000|Overall Study|Clinical Progression|0|||
94425463|NCT02132754|323342917|FG001|Overall Study|Clinical Progression|0|||
94425464|NCT02132754|323342918|FG002|Overall Study|Clinical Progression|0|||
94425465|NCT02132754|323342919|FG003|Overall Study|Clinical Progression|0|||
94425466|NCT02132754|323342920|FG004|Overall Study|Clinical Progression|0|||
94425467|NCT02132754|323342921|FG005|Overall Study|Clinical Progression|0|||
94425468|NCT02132754|323342922|FG006|Overall Study|Clinical Progression|0|||
94425469|NCT02132754|323342923|FG007|Overall Study|Clinical Progression|0|||
94425470|NCT02132754|323342924|FG008|Overall Study|Clinical Progression|0|||
94425471|NCT02132754|323342925|FG009|Overall Study|Clinical Progression|1|||
94425472|NCT02132754|323342926|FG010|Overall Study|Clinical Progression|0|||
94425473|NCT02132754|323342927|FG011|Overall Study|Clinical Progression|0|||
94425474|NCT02132754|323342928|FG012|Overall Study|Clinical Progression|0|||
94425475|NCT02132754|323342929|FG013|Overall Study|Clinical Progression|0|||
94425476|NCT02132754|323342930|FG014|Overall Study|Clinical Progression|0|||
94425477|NCT02132754|323342931|FG015|Overall Study|Clinical Progression|0|||
94425478|NCT02132754|323342932|FG016|Overall Study|Clinical Progression|1|||
94425479|NCT02132754|323342933|FG017|Overall Study|Clinical Progression|1|||
94425480|NCT02132754|323342934|FG018|Overall Study|Clinical Progression|0|||
94489543|NCT01186770|323586097|FG000|Overall Study|Insufficient response to treatment|7|||
94425481|NCT02132754|323342935|FG019|Overall Study|Clinical Progression|1|||
94489544|NCT01186770|323586098|FG001|Overall Study|Insufficient response to treatment|8|||
94425482|NCT02132754|323342936|FG020|Overall Study|Clinical Progression|0|||
94425483|NCT02132754|323342937|FG021|Overall Study|Clinical Progression|0|||
94425484|NCT02132754|323342938|FG022|Overall Study|Clinical Progression|1|||
94425485|NCT02132754|323342939|FG023|Overall Study|Clinical Progression|0|||
94425486|NCT02132754|323342940|FG024|Overall Study|Clinical Progression|1|||
94425487|NCT02132754|323342941|FG025|Overall Study|Clinical Progression|1|||
94425488|NCT02132754|323342942|FG026|Overall Study|Clinical Progression|0|||
94425489|NCT02132754|323342943|FG027|Overall Study|Clinical Progression|1|||
94425490|NCT02132754|323342944|FG028|Overall Study|Clinical Progression|1|||
94425491|NCT02132754|323342945|FG029|Overall Study|Clinical Progression|0|||
94425492|NCT02132754|323342946|FG030|Overall Study|Clinical Progression|1|||
94425493|NCT02132754|323342947|FG031|Overall Study|Clinical Progression|0|||
94425494|NCT02132754|323342948|FG032|Overall Study|Clinical Progression|0|||
94425495|NCT02132754|323342949|FG033|Overall Study|Clinical Progression|2|||
94425496|NCT02132754|323342916|FG000|Overall Study|Death|0|||
94425497|NCT02132754|323342917|FG001|Overall Study|Death|0|||
94425498|NCT02132754|323342918|FG002|Overall Study|Death|0|||
94425499|NCT02132754|323342919|FG003|Overall Study|Death|0|||
94425500|NCT02132754|323342920|FG004|Overall Study|Death|0|||
94425501|NCT02132754|323342921|FG005|Overall Study|Death|0|||
94425502|NCT02132754|323342922|FG006|Overall Study|Death|0|||
94425503|NCT02132754|323342923|FG007|Overall Study|Death|0|||
94425504|NCT02132754|323342924|FG008|Overall Study|Death|0|||
94425505|NCT02132754|323342925|FG009|Overall Study|Death|0|||
94425506|NCT02132754|323342926|FG010|Overall Study|Death|0|||
94425507|NCT02132754|323342927|FG011|Overall Study|Death|0|||
94425508|NCT02132754|323342928|FG012|Overall Study|Death|0|||
94425509|NCT02132754|323342929|FG013|Overall Study|Death|0|||
94425510|NCT02132754|323342930|FG014|Overall Study|Death|0|||
94425511|NCT02132754|323342931|FG015|Overall Study|Death|1|||
94425512|NCT02132754|323342932|FG016|Overall Study|Death|0|||
94425513|NCT02132754|323342933|FG017|Overall Study|Death|0|||
94425514|NCT02132754|323342934|FG018|Overall Study|Death|0|||
94425515|NCT02132754|323342935|FG019|Overall Study|Death|1|||
94425516|NCT02132754|323342936|FG020|Overall Study|Death|0|||
94425517|NCT02132754|323342937|FG021|Overall Study|Death|1|||
94425518|NCT02132754|323342938|FG022|Overall Study|Death|0|||
94425519|NCT02132754|323342939|FG023|Overall Study|Death|0|||
94425520|NCT02132754|323342940|FG024|Overall Study|Death|0|||
94425521|NCT02132754|323342941|FG025|Overall Study|Death|0|||
94425522|NCT02132754|323342942|FG026|Overall Study|Death|1|||
94425523|NCT02132754|323342943|FG027|Overall Study|Death|0|||
94425524|NCT02132754|323342944|FG028|Overall Study|Death|0|||
94425525|NCT02132754|323342945|FG029|Overall Study|Death|0|||
94425526|NCT02132754|323342946|FG030|Overall Study|Death|0|||
94425527|NCT02132754|323342947|FG031|Overall Study|Death|0|||
94425528|NCT02132754|323342948|FG032|Overall Study|Death|0|||
94425529|NCT02132754|323342949|FG033|Overall Study|Death|2|||
94425530|NCT02132754|323342916|FG000|Overall Study|Excluded Medication|0|||
94425531|NCT02132754|323342917|FG001|Overall Study|Excluded Medication|0|||
94425532|NCT02132754|323342918|FG002|Overall Study|Excluded Medication|0|||
94425533|NCT02132754|323342919|FG003|Overall Study|Excluded Medication|0|||
94425534|NCT02132754|323342920|FG004|Overall Study|Excluded Medication|0|||
94425535|NCT02132754|323342921|FG005|Overall Study|Excluded Medication|0|||
94425536|NCT02132754|323342922|FG006|Overall Study|Excluded Medication|0|||
94425537|NCT02132754|323342923|FG007|Overall Study|Excluded Medication|0|||
94425538|NCT02132754|323342924|FG008|Overall Study|Excluded Medication|0|||
94425539|NCT02132754|323342925|FG009|Overall Study|Excluded Medication|0|||
94425540|NCT02132754|323342926|FG010|Overall Study|Excluded Medication|0|||
94425541|NCT02132754|323342927|FG011|Overall Study|Excluded Medication|0|||
94425542|NCT02132754|323342928|FG012|Overall Study|Excluded Medication|0|||
94425543|NCT02132754|323342929|FG013|Overall Study|Excluded Medication|0|||
94425544|NCT02132754|323342930|FG014|Overall Study|Excluded Medication|0|||
94425545|NCT02132754|323342931|FG015|Overall Study|Excluded Medication|0|||
94425546|NCT02132754|323342932|FG016|Overall Study|Excluded Medication|0|||
94425547|NCT02132754|323342933|FG017|Overall Study|Excluded Medication|0|||
94425548|NCT02132754|323342934|FG018|Overall Study|Excluded Medication|0|||
94425549|NCT02132754|323342935|FG019|Overall Study|Excluded Medication|0|||
94425550|NCT02132754|323342936|FG020|Overall Study|Excluded Medication|1|||
94425551|NCT02132754|323342937|FG021|Overall Study|Excluded Medication|0|||
94425552|NCT02132754|323342938|FG022|Overall Study|Excluded Medication|0|||
94425553|NCT02132754|323342939|FG023|Overall Study|Excluded Medication|0|||
94425554|NCT02132754|323342940|FG024|Overall Study|Excluded Medication|0|||
94425555|NCT02132754|323342941|FG025|Overall Study|Excluded Medication|0|||
94425556|NCT02132754|323342942|FG026|Overall Study|Excluded Medication|0|||
94425557|NCT02132754|323342943|FG027|Overall Study|Excluded Medication|0|||
94425558|NCT02132754|323342944|FG028|Overall Study|Excluded Medication|0|||
94425559|NCT02132754|323342945|FG029|Overall Study|Excluded Medication|0|||
94425560|NCT02132754|323342946|FG030|Overall Study|Excluded Medication|0|||
94425561|NCT02132754|323342947|FG031|Overall Study|Excluded Medication|0|||
94425562|NCT02132754|323342948|FG032|Overall Study|Excluded Medication|0|||
94425563|NCT02132754|323342949|FG033|Overall Study|Excluded Medication|1|||
94425564|NCT02132754|323342916|FG000|Overall Study|Physician Decision|0|||
94425565|NCT02132754|323342917|FG001|Overall Study|Physician Decision|0|||
94425566|NCT02132754|323342918|FG002|Overall Study|Physician Decision|0|||
94425567|NCT02132754|323342919|FG003|Overall Study|Physician Decision|0|||
94425568|NCT02132754|323342920|FG004|Overall Study|Physician Decision|0|||
94425569|NCT02132754|323342921|FG005|Overall Study|Physician Decision|0|||
94425570|NCT02132754|323342922|FG006|Overall Study|Physician Decision|0|||
94425571|NCT02132754|323342923|FG007|Overall Study|Physician Decision|0|||
94425572|NCT02132754|323342924|FG008|Overall Study|Physician Decision|0|||
94425573|NCT02132754|323342925|FG009|Overall Study|Physician Decision|1|||
94425574|NCT02132754|323342926|FG010|Overall Study|Physician Decision|0|||
94425575|NCT02132754|323342927|FG011|Overall Study|Physician Decision|1|||
94425576|NCT02132754|323342928|FG012|Overall Study|Physician Decision|1|||
94425577|NCT02132754|323342929|FG013|Overall Study|Physician Decision|0|||
94425578|NCT02132754|323342930|FG014|Overall Study|Physician Decision|0|||
94425579|NCT02132754|323342931|FG015|Overall Study|Physician Decision|1|||
94425580|NCT02132754|323342932|FG016|Overall Study|Physician Decision|0|||
94425581|NCT02132754|323342933|FG017|Overall Study|Physician Decision|0|||
94425582|NCT02132754|323342934|FG018|Overall Study|Physician Decision|0|||
94425583|NCT02132754|323342935|FG019|Overall Study|Physician Decision|0|||
94425584|NCT02132754|323342936|FG020|Overall Study|Physician Decision|0|||
94425585|NCT02132754|323342937|FG021|Overall Study|Physician Decision|0|||
94425586|NCT02132754|323342938|FG022|Overall Study|Physician Decision|0|||
94425587|NCT02132754|323342939|FG023|Overall Study|Physician Decision|0|||
94425588|NCT02132754|323342940|FG024|Overall Study|Physician Decision|1|||
94425589|NCT02132754|323342941|FG025|Overall Study|Physician Decision|0|||
94425590|NCT02132754|323342942|FG026|Overall Study|Physician Decision|0|||
94425591|NCT02132754|323342943|FG027|Overall Study|Physician Decision|0|||
94425592|NCT02132754|323342944|FG028|Overall Study|Physician Decision|0|||
94425593|NCT02132754|323342945|FG029|Overall Study|Physician Decision|0|||
94425594|NCT02132754|323342946|FG030|Overall Study|Physician Decision|0|||
94425595|NCT02132754|323342947|FG031|Overall Study|Physician Decision|1|||
94425596|NCT02132754|323342948|FG032|Overall Study|Physician Decision|0|||
94425597|NCT02132754|323342949|FG033|Overall Study|Physician Decision|3|||
94425598|NCT02132754|323342916|FG000|Overall Study|Progressive Disease|1|||
94425599|NCT02132754|323342917|FG001|Overall Study|Progressive Disease|1|||
94425600|NCT02132754|323342918|FG002|Overall Study|Progressive Disease|1|||
94425601|NCT02132754|323342919|FG003|Overall Study|Progressive Disease|1|||
94425602|NCT02132754|323342920|FG004|Overall Study|Progressive Disease|1|||
94425603|NCT02132754|323342921|FG005|Overall Study|Progressive Disease|1|||
94425604|NCT02132754|323342922|FG006|Overall Study|Progressive Disease|1|||
94425605|NCT02132754|323342923|FG007|Overall Study|Progressive Disease|1|||
94425606|NCT02132754|323342924|FG008|Overall Study|Progressive Disease|1|||
94425607|NCT02132754|323342925|FG009|Overall Study|Progressive Disease|3|||
94425608|NCT02132754|323342926|FG010|Overall Study|Progressive Disease|3|||
94425609|NCT02132754|323342927|FG011|Overall Study|Progressive Disease|2|||
94425610|NCT02132754|323342928|FG012|Overall Study|Progressive Disease|2|||
94425611|NCT02132754|323342929|FG013|Overall Study|Progressive Disease|3|||
94425612|NCT02132754|323342930|FG014|Overall Study|Progressive Disease|2|||
94425613|NCT02132754|323342931|FG015|Overall Study|Progressive Disease|1|||
94425614|NCT02132754|323342932|FG016|Overall Study|Progressive Disease|2|||
94425615|NCT02132754|323342933|FG017|Overall Study|Progressive Disease|1|||
94425616|NCT02132754|323342934|FG018|Overall Study|Progressive Disease|3|||
94425617|NCT02132754|323342935|FG019|Overall Study|Progressive Disease|1|||
94425618|NCT02132754|323342936|FG020|Overall Study|Progressive Disease|1|||
94425619|NCT02132754|323342937|FG021|Overall Study|Progressive Disease|3|||
94425620|NCT02132754|323342938|FG022|Overall Study|Progressive Disease|2|||
94425621|NCT02132754|323342939|FG023|Overall Study|Progressive Disease|3|||
94425622|NCT02132754|323342940|FG024|Overall Study|Progressive Disease|0|||
94425623|NCT02132754|323342941|FG025|Overall Study|Progressive Disease|1|||
94425624|NCT02132754|323342942|FG026|Overall Study|Progressive Disease|2|||
94425625|NCT02132754|323342943|FG027|Overall Study|Progressive Disease|1|||
94425626|NCT02132754|323342944|FG028|Overall Study|Progressive Disease|2|||
94425627|NCT02132754|323342945|FG029|Overall Study|Progressive Disease|3|||
94425628|NCT02132754|323342946|FG030|Overall Study|Progressive Disease|1|||
94425629|NCT02132754|323342947|FG031|Overall Study|Progressive Disease|1|||
94425630|NCT02132754|323342948|FG032|Overall Study|Progressive Disease|3|||
94425631|NCT02132754|323342949|FG033|Overall Study|Progressive Disease|6|||
94425632|NCT02132754|323342916|FG000|Overall Study|Screen Failure|0|||
94425633|NCT02132754|323342917|FG001|Overall Study|Screen Failure|0|||
94425634|NCT02132754|323342918|FG002|Overall Study|Screen Failure|0|||
94425635|NCT02132754|323342919|FG003|Overall Study|Screen Failure|0|||
94425636|NCT02132754|323342920|FG004|Overall Study|Screen Failure|0|||
94425637|NCT02132754|323342921|FG005|Overall Study|Screen Failure|0|||
94425638|NCT02132754|323342922|FG006|Overall Study|Screen Failure|0|||
94425639|NCT02132754|323342923|FG007|Overall Study|Screen Failure|0|||
94425640|NCT02132754|323342924|FG008|Overall Study|Screen Failure|0|||
94425641|NCT02132754|323342925|FG009|Overall Study|Screen Failure|0|||
94425642|NCT02132754|323342926|FG010|Overall Study|Screen Failure|0|||
94425643|NCT02132754|323342927|FG011|Overall Study|Screen Failure|0|||
94425644|NCT02132754|323342928|FG012|Overall Study|Screen Failure|0|||
94425645|NCT02132754|323342929|FG013|Overall Study|Screen Failure|0|||
94425646|NCT02132754|323342930|FG014|Overall Study|Screen Failure|0|||
94425647|NCT02132754|323342931|FG015|Overall Study|Screen Failure|0|||
94425648|NCT02132754|323342932|FG016|Overall Study|Screen Failure|0|||
94425649|NCT02132754|323342933|FG017|Overall Study|Screen Failure|0|||
94425650|NCT02132754|323342934|FG018|Overall Study|Screen Failure|0|||
94425651|NCT02132754|323342935|FG019|Overall Study|Screen Failure|1|||
94425652|NCT02132754|323342936|FG020|Overall Study|Screen Failure|0|||
94425653|NCT02132754|323342937|FG021|Overall Study|Screen Failure|1|||
94425654|NCT02132754|323342938|FG022|Overall Study|Screen Failure|0|||
94425655|NCT02132754|323342939|FG023|Overall Study|Screen Failure|0|||
94425656|NCT02132754|323342940|FG024|Overall Study|Screen Failure|0|||
94425657|NCT02132754|323342941|FG025|Overall Study|Screen Failure|0|||
94425658|NCT02132754|323342942|FG026|Overall Study|Screen Failure|0|||
94425659|NCT02132754|323342943|FG027|Overall Study|Screen Failure|0|||
94425660|NCT02132754|323342944|FG028|Overall Study|Screen Failure|0|||
94425661|NCT02132754|323342945|FG029|Overall Study|Screen Failure|0|||
94425662|NCT02132754|323342946|FG030|Overall Study|Screen Failure|0|||
94425663|NCT02132754|323342947|FG031|Overall Study|Screen Failure|0|||
94425664|NCT02132754|323342948|FG032|Overall Study|Screen Failure|0|||
94425665|NCT02132754|323342949|FG033|Overall Study|Screen Failure|0|||
94425666|NCT02132754|323342916|FG000|Overall Study|Transferred to Extension Study|0|||
94489545|NCT01186770|323586099|FG002|Overall Study|Insufficient response to treatment|5|||
94489546|NCT01186770|323586100|FG003|Overall Study|Insufficient response to treatment|7|||
94489547|NCT01186770|323586097|FG000|Overall Study|Other than specified|0|||
94489548|NCT01186770|323586098|FG001|Overall Study|Other than specified|1|||
94489549|NCT01186770|323586099|FG002|Overall Study|Other than specified|1|||
94489550|NCT01186770|323586100|FG003|Overall Study|Other than specified|2|||
94489551|NCT00071981|323586104|FG000|Overall Study|Lack of Efficacy|37|||
94489552|NCT00071981|323586105|FG001|Overall Study|Lack of Efficacy|29|||
94489553|NCT00071981|323586106|FG002|Overall Study|Lack of Efficacy|30|||
94489554|NCT00071981|323586107|FG003|Overall Study|Lack of Efficacy|43|||
94489555|NCT00071981|323586104|FG000|Overall Study|Adverse Event|4|||
94425667|NCT02132754|323342917|FG001|Overall Study|Transferred to Extension Study|0|||
94425668|NCT02132754|323342918|FG002|Overall Study|Transferred to Extension Study|0|||
94425669|NCT02132754|323342919|FG003|Overall Study|Transferred to Extension Study|0|||
94425670|NCT02132754|323342920|FG004|Overall Study|Transferred to Extension Study|0|||
94425671|NCT02132754|323342921|FG005|Overall Study|Transferred to Extension Study|0|||
94425672|NCT02132754|323342922|FG006|Overall Study|Transferred to Extension Study|0|||
94425673|NCT02132754|323342923|FG007|Overall Study|Transferred to Extension Study|0|||
94425674|NCT02132754|323342924|FG008|Overall Study|Transferred to Extension Study|0|||
94425675|NCT02132754|323342925|FG009|Overall Study|Transferred to Extension Study|0|||
94425676|NCT02132754|323342926|FG010|Overall Study|Transferred to Extension Study|0|||
94425677|NCT02132754|323342927|FG011|Overall Study|Transferred to Extension Study|0|||
94425678|NCT02132754|323342928|FG012|Overall Study|Transferred to Extension Study|0|||
94425679|NCT02132754|323342929|FG013|Overall Study|Transferred to Extension Study|0|||
94425680|NCT02132754|323342930|FG014|Overall Study|Transferred to Extension Study|0|||
94425681|NCT02132754|323342931|FG015|Overall Study|Transferred to Extension Study|0|||
94425682|NCT02132754|323342932|FG016|Overall Study|Transferred to Extension Study|0|||
94425683|NCT02132754|323342933|FG017|Overall Study|Transferred to Extension Study|0|||
94425684|NCT02132754|323342934|FG018|Overall Study|Transferred to Extension Study|0|||
94425685|NCT02132754|323342935|FG019|Overall Study|Transferred to Extension Study|0|||
94425686|NCT02132754|323342936|FG020|Overall Study|Transferred to Extension Study|0|||
94425687|NCT02132754|323342937|FG021|Overall Study|Transferred to Extension Study|0|||
94425688|NCT02132754|323342938|FG022|Overall Study|Transferred to Extension Study|0|||
94425689|NCT02132754|323342939|FG023|Overall Study|Transferred to Extension Study|0|||
94425690|NCT02132754|323342940|FG024|Overall Study|Transferred to Extension Study|0|||
94425691|NCT02132754|323342941|FG025|Overall Study|Transferred to Extension Study|0|||
94425692|NCT02132754|323342942|FG026|Overall Study|Transferred to Extension Study|0|||
94425693|NCT02132754|323342943|FG027|Overall Study|Transferred to Extension Study|0|||
94425694|NCT02132754|323342944|FG028|Overall Study|Transferred to Extension Study|0|||
94425695|NCT02132754|323342945|FG029|Overall Study|Transferred to Extension Study|0|||
94425696|NCT02132754|323342946|FG030|Overall Study|Transferred to Extension Study|0|||
94425697|NCT02132754|323342947|FG031|Overall Study|Transferred to Extension Study|0|||
94425698|NCT02132754|323342948|FG032|Overall Study|Transferred to Extension Study|0|||
94425699|NCT02132754|323342949|FG033|Overall Study|Transferred to Extension Study|6|||
94425700|NCT02132754|323342916|FG000|Overall Study|Withdrawal by Subject|0|||
94425701|NCT02132754|323342917|FG001|Overall Study|Withdrawal by Subject|0|||
94425702|NCT02132754|323342918|FG002|Overall Study|Withdrawal by Subject|0|||
94425703|NCT02132754|323342919|FG003|Overall Study|Withdrawal by Subject|0|||
94489556|NCT00071981|323586105|FG001|Overall Study|Adverse Event|4|||
94489557|NCT00071981|323586106|FG002|Overall Study|Adverse Event|3|||
94489558|NCT00071981|323586107|FG003|Overall Study|Adverse Event|1|||
94425704|NCT02132754|323342920|FG004|Overall Study|Withdrawal by Subject|0|||
94425705|NCT02132754|323342921|FG005|Overall Study|Withdrawal by Subject|0|||
94425706|NCT02132754|323342922|FG006|Overall Study|Withdrawal by Subject|0|||
94425707|NCT02132754|323342923|FG007|Overall Study|Withdrawal by Subject|0|||
94425708|NCT02132754|323342924|FG008|Overall Study|Withdrawal by Subject|0|||
94425709|NCT02132754|323342925|FG009|Overall Study|Withdrawal by Subject|1|||
94489559|NCT00071981|323586104|FG000|Overall Study|Death|0|||
94489560|NCT00071981|323586105|FG001|Overall Study|Death|0|||
94489561|NCT00071981|323586106|FG002|Overall Study|Death|1|||
94489562|NCT00071981|323586107|FG003|Overall Study|Death|1|||
94489563|NCT00071981|323586104|FG000|Overall Study|Withdrawal by Subject|3|||
94425710|NCT02132754|323342926|FG010|Overall Study|Withdrawal by Subject|0|||
94425711|NCT02132754|323342927|FG011|Overall Study|Withdrawal by Subject|0|||
94425712|NCT02132754|323342928|FG012|Overall Study|Withdrawal by Subject|1|||
94425713|NCT02132754|323342929|FG013|Overall Study|Withdrawal by Subject|0|||
94425714|NCT02132754|323342930|FG014|Overall Study|Withdrawal by Subject|1|||
94425715|NCT02132754|323342931|FG015|Overall Study|Withdrawal by Subject|2|||
94425716|NCT02132754|323342932|FG016|Overall Study|Withdrawal by Subject|1|||
94425717|NCT02132754|323342933|FG017|Overall Study|Withdrawal by Subject|0|||
94425718|NCT02132754|323342934|FG018|Overall Study|Withdrawal by Subject|0|||
94425719|NCT02132754|323342935|FG019|Overall Study|Withdrawal by Subject|0|||
94425720|NCT02132754|323342936|FG020|Overall Study|Withdrawal by Subject|1|||
94425721|NCT02132754|323342937|FG021|Overall Study|Withdrawal by Subject|0|||
94425722|NCT02132754|323342938|FG022|Overall Study|Withdrawal by Subject|0|||
94425723|NCT02132754|323342939|FG023|Overall Study|Withdrawal by Subject|0|||
94425724|NCT02132754|323342940|FG024|Overall Study|Withdrawal by Subject|1|||
94425725|NCT02132754|323342941|FG025|Overall Study|Withdrawal by Subject|0|||
94425726|NCT02132754|323342942|FG026|Overall Study|Withdrawal by Subject|0|||
94425727|NCT02132754|323342943|FG027|Overall Study|Withdrawal by Subject|1|||
94425728|NCT02132754|323342944|FG028|Overall Study|Withdrawal by Subject|0|||
94425729|NCT02132754|323342945|FG029|Overall Study|Withdrawal by Subject|0|||
94425730|NCT02132754|323342946|FG030|Overall Study|Withdrawal by Subject|0|||
94425731|NCT02132754|323342947|FG031|Overall Study|Withdrawal by Subject|1|||
94425732|NCT02132754|323342948|FG032|Overall Study|Withdrawal by Subject|0|||
94425733|NCT02132754|323342949|FG033|Overall Study|Withdrawal by Subject|2|||
94425734|NCT03050060|323342950|FG000|Overall Study|Adverse Event|7|||
94425735|NCT03050060|323342950|FG000|Overall Study|Withdrawal by Subject|1|||
94425736|NCT03050060|323342950|FG000|Overall Study|Progression|7|||
94425737|NCT04430855|323342953|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
94425738|NCT04430855|323342954|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
94425739|NCT04430855|323342953|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
94425740|NCT04430855|323342954|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
94425741|NCT04430855|323342953|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
94425742|NCT04430855|323342954|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
94425743|NCT04430855|323342953|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
94425744|NCT04430855|323342954|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
94425745|NCT04430855|323342953|FG000|Period 1 (Weeks 1-12)|Other|0|||
94425746|NCT04430855|323342954|FG001|Period 1 (Weeks 1-12)|Other|1|||
94425747|NCT04430855|323342953|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
94425748|NCT04430855|323342954|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
94425749|NCT04430855|323342953|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
94425750|NCT04430855|323342954|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
94425751|NCT04430855|323342953|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
94425752|NCT04430855|323342954|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
94425753|NCT01425723|323342955|FG000|Overall Study|Lack of Efficacy|0|||
94425754|NCT01425723|323342956|FG001|Overall Study|Lack of Efficacy|1|||
94425755|NCT01425723|323342955|FG000|Overall Study|Withdrawal by Subject|1|||
94425756|NCT01425723|323342956|FG001|Overall Study|Withdrawal by Subject|4|||
94425757|NCT01425723|323342955|FG000|Overall Study|Lost to Follow-up|0|||
94425758|NCT01425723|323342956|FG001|Overall Study|Lost to Follow-up|3|||
94425759|NCT01425723|323342955|FG000|Overall Study|Physician Decision|2|||
94425760|NCT01425723|323342956|FG001|Overall Study|Physician Decision|0|||
94425761|NCT01425723|323342955|FG000|Overall Study|Other|1|||
94425762|NCT01425723|323342956|FG001|Overall Study|Other|10|||
94425763|NCT00446199|323342957|FG000|Overall Study|Adverse Event|7|||
94425764|NCT00446199|323342958|FG001|Overall Study|Adverse Event|4|||
94425765|NCT00446199|323342959|FG002|Overall Study|Adverse Event|6|||
94425766|NCT00446199|323342960|FG003|Overall Study|Adverse Event|4|||
94425767|NCT00446199|323342957|FG000|Overall Study|Lost to Follow-up|4|||
94425768|NCT00446199|323342958|FG001|Overall Study|Lost to Follow-up|5|||
94425769|NCT00446199|323342959|FG002|Overall Study|Lost to Follow-up|2|||
94425770|NCT00446199|323342960|FG003|Overall Study|Lost to Follow-up|6|||
94425771|NCT00446199|323342957|FG000|Overall Study|Protocol Violation|1|||
94425772|NCT00446199|323342958|FG001|Overall Study|Protocol Violation|2|||
94425773|NCT00446199|323342959|FG002|Overall Study|Protocol Violation|1|||
94425774|NCT00446199|323342960|FG003|Overall Study|Protocol Violation|3|||
94425775|NCT00446199|323342957|FG000|Overall Study|Withdrawal by Subject|2|||
94489564|NCT00071981|323586105|FG001|Overall Study|Withdrawal by Subject|1|||
94489565|NCT00071981|323586106|FG002|Overall Study|Withdrawal by Subject|0|||
94425776|NCT00446199|323342958|FG001|Overall Study|Withdrawal by Subject|5|||
94425777|NCT00446199|323342959|FG002|Overall Study|Withdrawal by Subject|9|||
94425778|NCT00446199|323342960|FG003|Overall Study|Withdrawal by Subject|10|||
94425779|NCT00446199|323342957|FG000|Overall Study|Site termination|2|||
94425780|NCT00446199|323342958|FG001|Overall Study|Site termination|0|||
94425781|NCT00446199|323342959|FG002|Overall Study|Site termination|0|||
94425782|NCT00446199|323342960|FG003|Overall Study|Site termination|1|||
94425783|NCT00446199|323342957|FG000|Overall Study|Randomization in Error|2|||
94425784|NCT00446199|323342958|FG001|Overall Study|Randomization in Error|0|||
94425785|NCT00446199|323342959|FG002|Overall Study|Randomization in Error|1|||
94425786|NCT00446199|323342960|FG003|Overall Study|Randomization in Error|1|||
94425787|NCT00446199|323342957|FG000|Overall Study|Lack of Efficacy|1|||
94425788|NCT00446199|323342958|FG001|Overall Study|Lack of Efficacy|0|||
94425789|NCT00446199|323342959|FG002|Overall Study|Lack of Efficacy|0|||
94425790|NCT00446199|323342960|FG003|Overall Study|Lack of Efficacy|1|||
94425791|NCT00446199|323342957|FG000|Overall Study|Non-compliant with study drug|1|||
94425792|NCT00446199|323342958|FG001|Overall Study|Non-compliant with study drug|0|||
94425793|NCT00446199|323342959|FG002|Overall Study|Non-compliant with study drug|5|||
94425794|NCT00446199|323342960|FG003|Overall Study|Non-compliant with study drug|0|||
94425795|NCT00446199|323342957|FG000|Overall Study|Non-compliant with visit schedule|1|||
94425796|NCT00446199|323342958|FG001|Overall Study|Non-compliant with visit schedule|1|||
94425797|NCT00446199|323342959|FG002|Overall Study|Non-compliant with visit schedule|1|||
94425798|NCT00446199|323342960|FG003|Overall Study|Non-compliant with visit schedule|2|||
94425799|NCT00446199|323342957|FG000|Overall Study|Hormone fear|0|||
94425800|NCT00446199|323342958|FG001|Overall Study|Hormone fear|0|||
94425801|NCT00446199|323342959|FG002|Overall Study|Hormone fear|0|||
94425802|NCT00446199|323342960|FG003|Overall Study|Hormone fear|1|||
94425803|NCT00446199|323342957|FG000|Overall Study|Lost interest in study participation|0|||
94425804|NCT00446199|323342958|FG001|Overall Study|Lost interest in study participation|1|||
94425805|NCT00446199|323342959|FG002|Overall Study|Lost interest in study participation|0|||
94425806|NCT00446199|323342960|FG003|Overall Study|Lost interest in study participation|0|||
94425807|NCT00446199|323342957|FG000|Overall Study|In-/Exclusion criterion violated|2|||
94425808|NCT00446199|323342958|FG001|Overall Study|In-/Exclusion criterion violated|1|||
94425809|NCT00446199|323342959|FG002|Overall Study|In-/Exclusion criterion violated|2|||
94425810|NCT00446199|323342960|FG003|Overall Study|In-/Exclusion criterion violated|1|||
94425811|NCT00446199|323342957|FG000|Overall Study|Move|0|||
94425812|NCT00446199|323342958|FG001|Overall Study|Move|1|||
94425813|NCT00446199|323342959|FG002|Overall Study|Move|0|||
94425814|NCT00446199|323342960|FG003|Overall Study|Move|0|||
94425815|NCT04188301|323342972|FG000|Month 3|Lost to Follow-up|0|||
94425816|NCT04188301|323342973|FG001|Month 3|Lost to Follow-up|0|||
94425817|NCT04188301|323342974|FG002|Month 3|Lost to Follow-up|1|||
94425818|NCT04188301|323342972|FG000|Month 12|Lost to Follow-up|0|||
94425819|NCT04188301|323342973|FG001|Month 12|Lost to Follow-up|0|||
94425820|NCT04188301|323342974|FG002|Month 12|Lost to Follow-up|2|||
94425821|NCT04188301|323342972|FG000|Month 12|Death|1|||
94425822|NCT04188301|323342973|FG001|Month 12|Death|1|||
94425823|NCT04188301|323342974|FG002|Month 12|Death|0|||
94425824|NCT04188301|323342972|FG000|Month 18|Lost to Follow-up|6|||
94425825|NCT04188301|323342973|FG001|Month 18|Lost to Follow-up|0|||
94425826|NCT04188301|323342974|FG002|Month 18|Lost to Follow-up|0|||
94425827|NCT02312063|323342975|FG000|Overall Study|Withdrawal by Subject|0|||
94425828|NCT02312063|323342976|FG001|Overall Study|Withdrawal by Subject|1|||
94425829|NCT04639713|323342977|FG000|Overall Study|Protocol Noncompliance|2|||
94425830|NCT04639713|323342977|FG000|Overall Study|Withdrawal by Subject|1|||
94425831|NCT00228423|323342978|FG000|Overall Study|Adverse Event|2|||
94425832|NCT00228423|323342979|FG001|Overall Study|Adverse Event|5|||
94425833|NCT00228423|323342978|FG000|Overall Study|Withdrawal by Subject|7|||
94425834|NCT00228423|323342979|FG001|Overall Study|Withdrawal by Subject|3|||
94425835|NCT00228423|323342978|FG000|Overall Study|Protocol Violation|1|||
94425836|NCT00228423|323342979|FG001|Overall Study|Protocol Violation|3|||
94425837|NCT00228423|323342978|FG000|Overall Study|Physician Decision|0|||
94425838|NCT00228423|323342979|FG001|Overall Study|Physician Decision|1|||
94425839|NCT00857584|323342982|FG000|Overall Study|Lack of Efficacy|1|||
94425840|NCT00857584|323342983|FG001|Overall Study|Lack of Efficacy|2|||
94425841|NCT00857584|323342982|FG000|Overall Study|Adverse Event|2|||
94425842|NCT00857584|323342983|FG001|Overall Study|Adverse Event|2|||
94425843|NCT00857584|323342982|FG000|Overall Study|Physician Decision|1|||
94425844|NCT00857584|323342983|FG001|Overall Study|Physician Decision|1|||
94425845|NCT03258853|323342986|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
94425846|NCT03258853|323342987|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
94425847|NCT01709838|323342988|FG000|Overall Study|Withdrawal by Subject|21|||
94425848|NCT01709838|323342988|FG000|Overall Study|Lost to Follow-up|16|||
94425849|NCT01709838|323342988|FG000|Overall Study|Pregnancy|10|||
94425850|NCT01709838|323342988|FG000|Overall Study|Subject/guardian decision|8|||
94425851|NCT01709838|323342988|FG000|Overall Study|Adverse Event|4|||
94425852|NCT01709838|323342988|FG000|Overall Study|Physician Decision|4|||
94425853|NCT01709838|323342988|FG000|Overall Study|Death|3|||
94425854|NCT01709838|323342988|FG000|Overall Study|Protocol Violation|1|||
94425855|NCT01177059|323342989|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
94425856|NCT01177059|323342989|FG000|Overall Study|Withdrew consent|2|||
94425857|NCT01177059|323342989|FG000|Overall Study|Lost to Follow-up|18|||
94425858|NCT03303625|323345179|FG000|Overall Study|Withdrawal by Subject|2|||
94425859|NCT03303625|323345180|FG001|Overall Study|Withdrawal by Subject|0|||
94425860|NCT03303625|323345181|FG002|Overall Study|Withdrawal by Subject|0|||
94425861|NCT03303625|323345182|FG003|Overall Study|Withdrawal by Subject|0|||
94425862|NCT03047473|323345183|FG000|Overall Study|Lost to Follow-up|2|||
94425863|NCT00792935|323345184|FG000|Overall Study|Adverse Event|2|||
94425864|NCT00792935|323345185|FG001|Overall Study|Adverse Event|1|||
94425865|NCT00792935|323345184|FG000|Overall Study|Lost to Follow-up|0|||
94425866|NCT00792935|323345185|FG001|Overall Study|Lost to Follow-up|1|||
94425867|NCT00792935|323345184|FG000|Overall Study|Protocol Violation|2|||
94425868|NCT00792935|323345185|FG001|Overall Study|Protocol Violation|0|||
94425869|NCT00792935|323345184|FG000|Overall Study|Withdrawal by Subject|0|||
94425870|NCT00792935|323345185|FG001|Overall Study|Withdrawal by Subject|1|||
94425871|NCT00554190|323345193|FG000|Overall Study|Termination forms not completed|10|||
94425872|NCT00191113|323345194|FG000|Core Study|Withdrawal by Subject|25|||
94425873|NCT00191113|323345195|FG001|Core Study|Withdrawal by Subject|9|||
94425874|NCT00191113|323345194|FG000|Core Study|Protocol Violation|6|||
94425875|NCT00191113|323345195|FG001|Core Study|Protocol Violation|2|||
94425876|NCT00191113|323345194|FG000|Core Study|Lost to Follow-up|3|||
94425877|NCT00191113|323345195|FG001|Core Study|Lost to Follow-up|0|||
94425878|NCT00191113|323345194|FG000|Core Study|Adverse Event|0|||
94425879|NCT00191113|323345195|FG001|Core Study|Adverse Event|2|||
94425880|NCT00191113|323345194|FG000|Core Study|Lack of Efficacy|0|||
94425881|NCT00191113|323345195|FG001|Core Study|Lack of Efficacy|2|||
94425882|NCT00191113|323345194|FG000|Core Study|Death|1|||
94425883|NCT00191113|323345195|FG001|Core Study|Death|0|||
94425884|NCT02213510|323345196|FG000|Overall Study|Death|0|||
94425885|NCT02213510|323345197|FG001|Overall Study|Death|1|||
94425886|NCT02213510|323345196|FG000|Overall Study|Lost to Follow-up|1|||
94425887|NCT02213510|323345197|FG001|Overall Study|Lost to Follow-up|0|||
94425888|NCT03954834|323345200|FG000|Overall Study|Adverse Event|1|||
94425889|NCT03954834|323345201|FG001|Overall Study|Adverse Event|3|||
94425890|NCT03954834|323345202|FG002|Overall Study|Adverse Event|1|||
94425891|NCT03954834|323345203|FG003|Overall Study|Adverse Event|1|||
94425892|NCT03954834|323345200|FG000|Overall Study|Death|0|||
94425893|NCT03954834|323345201|FG001|Overall Study|Death|0|||
94425894|NCT03954834|323345202|FG002|Overall Study|Death|0|||
94425895|NCT03954834|323345203|FG003|Overall Study|Death|1|||
94425896|NCT03954834|323345200|FG000|Overall Study|Physician Decision|0|||
94425897|NCT03954834|323345201|FG001|Overall Study|Physician Decision|1|||
94425898|NCT03954834|323345202|FG002|Overall Study|Physician Decision|0|||
94425899|NCT03954834|323345203|FG003|Overall Study|Physician Decision|2|||
94425900|NCT03954834|323345200|FG000|Overall Study|Protocol Violation|1|||
94425901|NCT03954834|323345201|FG001|Overall Study|Protocol Violation|0|||
94425902|NCT03954834|323345202|FG002|Overall Study|Protocol Violation|0|||
94425903|NCT03954834|323345203|FG003|Overall Study|Protocol Violation|1|||
94425904|NCT03954834|323345200|FG000|Overall Study|Withdrawal by Subject|2|||
94425905|NCT03954834|323345201|FG001|Overall Study|Withdrawal by Subject|3|||
94425906|NCT03954834|323345202|FG002|Overall Study|Withdrawal by Subject|13|||
94425907|NCT03954834|323345203|FG003|Overall Study|Withdrawal by Subject|6|||
94425908|NCT03954834|323345200|FG000|Overall Study|Participant left the country|0|||
94425909|NCT03954834|323345201|FG001|Overall Study|Participant left the country|0|||
94425910|NCT03954834|323345202|FG002|Overall Study|Participant left the country|1|||
94425911|NCT03954834|323345203|FG003|Overall Study|Participant left the country|0|||
94425912|NCT03954834|323345200|FG000|Overall Study|Lost to Follow-up|3|||
94425913|NCT03954834|323345201|FG001|Overall Study|Lost to Follow-up|2|||
94425914|NCT03954834|323345202|FG002|Overall Study|Lost to Follow-up|3|||
94425915|NCT03954834|323345203|FG003|Overall Study|Lost to Follow-up|5|||
94425916|NCT04709835|323345204|FG000|Overall Study|Withdrawal by Subject|0|||
94425917|NCT04709835|323345205|FG001|Overall Study|Withdrawal by Subject|1|||
94425918|NCT04709835|323345206|FG002|Overall Study|Withdrawal by Subject|0|||
94425919|NCT04241315|323345212|FG000|Overall Study|Withdrawal by Subject|0|||
94425920|NCT04241315|323345213|FG001|Overall Study|Withdrawal by Subject|1|||
94425921|NCT01398514|323345214|FG000|Overall Study|Adverse Event|1|||
94425922|NCT01398514|323345215|FG001|Overall Study|Adverse Event|0|||
94425923|NCT01398514|323345214|FG000|Overall Study|Non-compliance with study procedures|2|||
94425924|NCT01398514|323345215|FG001|Overall Study|Non-compliance with study procedures|0|||
94425925|NCT01398514|323345214|FG000|Overall Study|Physiologic non-responsiveness|1|||
94425926|NCT01398514|323345215|FG001|Overall Study|Physiologic non-responsiveness|3|||
94425927|NCT01398514|323345214|FG000|Overall Study|Failure to show a conditioned response|4|||
94425928|NCT01398514|323345215|FG001|Overall Study|Failure to show a conditioned response|3|||
94425929|NCT02771795|323345216|FG000|Overall Study|Withdrawal by Subject|47|||
94425930|NCT02771795|323345217|FG001|Overall Study|Withdrawal by Subject|37|||
94425931|NCT02771795|323345216|FG000|Overall Study|Termination by premature discontinuation of study|168|||
94425932|NCT02771795|323345217|FG001|Overall Study|Termination by premature discontinuation of study|185|||
94425933|NCT03514641|323345220|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
94425934|NCT03514641|323345221|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
94425935|NCT03514641|323345222|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
94425936|NCT03514641|323345223|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
94425937|NCT03514641|323345220|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
94425938|NCT03514641|323345221|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
94425939|NCT03514641|323345222|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
94425940|NCT03514641|323345223|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
94425941|NCT03514641|323345220|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
94425942|NCT03514641|323345221|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
94425943|NCT03514641|323345222|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
94425944|NCT03514641|323345223|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
94425945|NCT03514641|323345220|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
94425946|NCT03514641|323345221|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
94425947|NCT03514641|323345222|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
94425948|NCT03514641|323345223|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
94425949|NCT03514641|323345220|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
94425950|NCT03514641|323345221|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
94425951|NCT03514641|323345222|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
94425952|NCT03514641|323345223|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
94425953|NCT03514641|323345220|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
94425954|NCT03514641|323345221|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
94425955|NCT03514641|323345222|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
94425956|NCT03514641|323345223|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
94425957|NCT03514641|323345220|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
94425958|NCT03514641|323345221|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
94425959|NCT03514641|323345222|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
94425960|NCT03514641|323345223|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
94425961|NCT03514641|323345220|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
94425962|NCT03514641|323345221|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
94425963|NCT03514641|323345222|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
94425964|NCT03514641|323345223|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
94425965|NCT03514641|323345220|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
94425966|NCT03514641|323345221|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
94425967|NCT03514641|323345222|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
94425968|NCT03514641|323345223|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
94425969|NCT03514641|323345220|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
94425970|NCT03514641|323345221|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
94425971|NCT03514641|323345222|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
94425972|NCT03514641|323345223|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
94425973|NCT03514641|323345220|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
94425974|NCT03514641|323345221|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
94425975|NCT03514641|323345222|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
94425976|NCT03514641|323345223|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
94425977|NCT03514641|323345220|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
94425978|NCT03514641|323345221|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
94425979|NCT03514641|323345222|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
94425980|NCT03514641|323345223|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
94425981|NCT04234984|323345224|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
94425982|NCT04234984|323345224|FG000|Follow-up at the Second Time Point|Death|1|||
94425983|NCT04234984|323345224|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
94425984|NCT00540293|323345225|FG000|Overall Study|Adverse event related to study drug|10|||
94425985|NCT00540293|323345225|FG000|Overall Study|Adverse event not related to study drug|7|||
94425986|NCT00540293|323345225|FG000|Overall Study|Withdrawal by Subject|6|||
94425987|NCT00540293|323345225|FG000|Overall Study|Protocol violation, & subject schedule|12|||
94425988|NCT05083585|323345228|FG000|Overall Study|Death|1|||
94425989|NCT05083585|323345229|FG001|Overall Study|Death|1|||
94425990|NCT05083585|323345228|FG000|Overall Study|Lost to Follow-up|1|||
94425991|NCT05083585|323345229|FG001|Overall Study|Lost to Follow-up|1|||
94425992|NCT05083585|323345228|FG000|Overall Study|Withdrawal by Subject|2|||
94425993|NCT05083585|323345229|FG001|Overall Study|Withdrawal by Subject|0|||
94425994|NCT05083585|323345228|FG000|Overall Study|Randomized but not vaccinated|2|||
94425995|NCT05083585|323345229|FG001|Overall Study|Randomized but not vaccinated|0|||
94425996|NCT03929757|323345230|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
94425997|NCT03929757|323345231|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
94425998|NCT03929757|323345232|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
94425999|NCT03929757|323345230|FG000|Main Study: Up to Day 365|Other|1|||
94426000|NCT03929757|323345231|FG001|Main Study: Up to Day 365|Other|0|||
94426001|NCT03929757|323345232|FG002|Main Study: Up to Day 365|Other|0|||
94426002|NCT03929757|323345230|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
94426003|NCT03929757|323345231|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
94426004|NCT03929757|323345232|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
94426005|NCT02397408|323345234|FG000|Overall Study|Physician Decision|4|||
94426006|NCT02397408|323345234|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
94426007|NCT03397771|323345235|FG000|Overall Study|2 erroneously randomized, never treated|3|||
94426008|NCT03397771|323345236|FG001|Overall Study|2 erroneously randomized, never treated|1|||
94426009|NCT03397771|323345235|FG000|Overall Study|Withdrawal by Subject|1|||
94426010|NCT03397771|323345236|FG001|Overall Study|Withdrawal by Subject|3|||
94426011|NCT03397771|323345235|FG000|Overall Study|Protocol Violation|2|||
94426012|NCT03397771|323345236|FG001|Overall Study|Protocol Violation|2|||
94426013|NCT03397771|323345235|FG000|Overall Study|Adverse Event|2|||
94426014|NCT03397771|323345236|FG001|Overall Study|Adverse Event|1|||
94426015|NCT02524730|323345237|FG000|Overall Study|Lost to Follow-up|5|||
94426016|NCT02524730|323345237|FG000|Overall Study|Withdrawal by Subject|18|||
94426017|NCT02524730|323345237|FG000|Overall Study|Death|10|||
94426018|NCT02524730|323345237|FG000|Overall Study|Adverse Event|8|||
94426019|NCT02524730|323345237|FG000|Overall Study|Protocol Violation|1|||
94426020|NCT02524730|323345237|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
94426021|NCT03783039|323345238|FG000|Overall Study|Death|2|||
94426022|NCT03783039|323345239|FG001|Overall Study|Death|1|||
94426023|NCT00593736|323345242|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
94426024|NCT00593736|323345243|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
94426025|NCT00593736|323345244|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
94426026|NCT00593736|323345245|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
94426027|NCT00593736|323345242|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
94426028|NCT00593736|323345243|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
94426029|NCT00593736|323345244|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
94426030|NCT00593736|323345245|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
94426031|NCT00593736|323345242|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
94426032|NCT00593736|323345243|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
94426033|NCT00593736|323345244|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
94426034|NCT00593736|323345245|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
94426035|NCT00593736|323345242|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
94426036|NCT00593736|323345243|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
94426037|NCT00593736|323345244|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
94426038|NCT00593736|323345245|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
94426039|NCT00593736|323345242|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
94426040|NCT00593736|323345243|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
94426041|NCT00593736|323345244|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
94426042|NCT00593736|323345245|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
94426043|NCT00593736|323345242|FG000|Screening Period and Placebo Run-in|Various|0|||
94426044|NCT00593736|323345243|FG001|Screening Period and Placebo Run-in|Various|0|||
94426045|NCT00593736|323345244|FG002|Screening Period and Placebo Run-in|Various|0|||
94426046|NCT00593736|323345245|FG003|Screening Period and Placebo Run-in|Various|25|||
94426047|NCT00593736|323345242|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
94426048|NCT00593736|323345243|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
94426049|NCT00593736|323345244|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
94426050|NCT00593736|323345245|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
94426051|NCT00593736|323345242|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
94426052|NCT00593736|323345243|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
94426053|NCT00593736|323345244|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
94426054|NCT00593736|323345245|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
94426055|NCT00593736|323345242|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
94426056|NCT00593736|323345243|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
94426057|NCT00593736|323345244|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
94426058|NCT00593736|323345245|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
94426059|NCT00593736|323345242|FG000|Treatment Period and Placebo Run-out|Various|1|||
94426060|NCT00593736|323345243|FG001|Treatment Period and Placebo Run-out|Various|1|||
94426061|NCT00593736|323345244|FG002|Treatment Period and Placebo Run-out|Various|1|||
94426062|NCT00593736|323345245|FG003|Treatment Period and Placebo Run-out|Various|0|||
94426063|NCT01857271|323345246|FG000|Overall Study|Lost to Follow-up|1|||
94426064|NCT01783548|323345249|FG000|Overall Study|Adverse Event|8|||
94426065|NCT01783548|323345250|FG001|Overall Study|Adverse Event|4|||
94426066|NCT01783548|323345249|FG000|Overall Study|Withdrawal by Subject|11|||
94426067|NCT01783548|323345250|FG001|Overall Study|Withdrawal by Subject|8|||
94426068|NCT01783548|323345249|FG000|Overall Study|Non-compliance|4|||
94426069|NCT01783548|323345250|FG001|Overall Study|Non-compliance|0|||
94426070|NCT01783548|323345249|FG000|Overall Study|Protocol Violation|2|||
94426071|NCT01783548|323345250|FG001|Overall Study|Protocol Violation|2|||
94426072|NCT01783548|323345249|FG000|Overall Study|Lost to Follow-up|8|||
94426073|NCT01783548|323345250|FG001|Overall Study|Lost to Follow-up|3|||
94426074|NCT01783548|323345249|FG000|Overall Study|Lack of Efficacy|1|||
94426075|NCT01783548|323345250|FG001|Overall Study|Lack of Efficacy|1|||
94426076|NCT02992418|323345251|FG000|Overall Study|Withdrawal by Subject|11|||
94426077|NCT02992418|323345252|FG001|Overall Study|Withdrawal by Subject|12|||
94426078|NCT02992418|323345251|FG000|Overall Study|Non-compliance with the protocol|308|||
94426079|NCT02992418|323345252|FG001|Overall Study|Non-compliance with the protocol|308|||
94426080|NCT02992418|323345251|FG000|Overall Study|Lost to Follow-up|27|||
94426081|NCT02992418|323345252|FG001|Overall Study|Lost to Follow-up|22|||
94426082|NCT00289536|323345254|FG000|Period 3|Lost to Follow-up|0|||
94426083|NCT00289536|323345255|FG001|Period 3|Lost to Follow-up|0|||
94426084|NCT00289536|323345256|FG002|Period 3|Lost to Follow-up|1|||
94426085|NCT02116608|323345261|FG000|Overall Study|Lost to Follow-up|0|||
94426086|NCT02116608|323345262|FG001|Overall Study|Lost to Follow-up|0|||
94426087|NCT02116608|323345263|FG002|Overall Study|Lost to Follow-up|1|||
94426088|NCT02116608|323345261|FG000|Overall Study|Physician Decision|0|||
94426089|NCT02116608|323345262|FG001|Overall Study|Physician Decision|1|||
94426090|NCT02116608|323345263|FG002|Overall Study|Physician Decision|0|||
94426091|NCT02116608|323345261|FG000|Overall Study|Death|0|||
94426092|NCT02116608|323345262|FG001|Overall Study|Death|1|||
94426093|NCT02116608|323345263|FG002|Overall Study|Death|0|||
94426094|NCT04283500|323345265|FG000|Overall Study|Lost to Follow-up|8|||
94426095|NCT04283500|323345265|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
94426096|NCT00988442|323345266|FG000|Overall Study|Death|1|||
94426097|NCT00988442|323345267|FG001|Overall Study|Death|2|||
94426098|NCT00988442|323345266|FG000|Overall Study|Lost to Follow-up|0|||
94426099|NCT00988442|323345267|FG001|Overall Study|Lost to Follow-up|1|||
94426100|NCT00988442|323345266|FG000|Overall Study|Early Study Closure|29|||
94426101|NCT00988442|323345267|FG001|Overall Study|Early Study Closure|25|||
94426102|NCT02563106|323345268|FG000|Overall Study|Withdrawal by Subject|7|||
94426103|NCT02563106|323345269|FG001|Overall Study|Withdrawal by Subject|8|||
94426104|NCT02563106|323345268|FG000|Overall Study|Adverse Event|17|||
94426105|NCT02563106|323345269|FG001|Overall Study|Adverse Event|15|||
94426106|NCT02563106|323345268|FG000|Overall Study|Protocol Violation|1|||
94426107|NCT02563106|323345269|FG001|Overall Study|Protocol Violation|0|||
94426108|NCT02563106|323345268|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
94426109|NCT02563106|323345269|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
94426110|NCT02563106|323345268|FG000|Overall Study|Lost to Follow-up|3|||
94426111|NCT02563106|323345269|FG001|Overall Study|Lost to Follow-up|2|||
94426112|NCT02563106|323345268|FG000|Overall Study|Physician Decision|3|||
94426113|NCT02563106|323345269|FG001|Overall Study|Physician Decision|1|||
94426114|NCT02563106|323345268|FG000|Overall Study|Other reason - not specified|2|||
94426115|NCT02563106|323345269|FG001|Overall Study|Other reason - not specified|1|||
94426116|NCT04091659|323345270|FG000|Overall Study|Protocol Violation|3|||
94426117|NCT04091659|323345271|FG001|Overall Study|Protocol Violation|0|||
94426118|NCT04091659|323345270|FG000|Overall Study|Lost to Follow-up|0|||
94426119|NCT04091659|323345271|FG001|Overall Study|Lost to Follow-up|1|||
94426120|NCT01475097|323345273|FG000|Overall Study|Protocol Violation|1|||
94426121|NCT01475097|323345274|FG001|Overall Study|Protocol Violation|1|||
94426122|NCT00528411|323345275|FG000|Overall Study|Adverse Event|4|||
94426123|NCT00528411|323345276|FG001|Overall Study|Adverse Event|0|||
94426124|NCT00528411|323345277|FG002|Overall Study|Adverse Event|1|||
94426125|NCT00528411|323345275|FG000|Overall Study|Incorrect Enrolment|1|||
94426126|NCT00528411|323345276|FG001|Overall Study|Incorrect Enrolment|1|||
94426127|NCT00528411|323345277|FG002|Overall Study|Incorrect Enrolment|0|||
94426128|NCT00528411|323345275|FG000|Overall Study|Severe non-compliance to protocol|0|||
94426129|NCT00528411|323345276|FG001|Overall Study|Severe non-compliance to protocol|1|||
94426130|NCT00528411|323345277|FG002|Overall Study|Severe non-compliance to protocol|0|||
94426131|NCT00528411|323345275|FG000|Overall Study|Prior commitment medication|0|||
94426132|NCT00528411|323345276|FG001|Overall Study|Prior commitment medication|1|||
94426133|NCT00528411|323345277|FG002|Overall Study|Prior commitment medication|0|||
94426134|NCT03893565|323345278|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
94426135|NCT03893565|323345279|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
94426136|NCT03893565|323345280|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
94426137|NCT03893565|323345281|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
94426138|NCT03893565|323345282|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
94426139|NCT03893565|323345283|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
94426140|NCT03893565|323345284|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
94426141|NCT03893565|323345285|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
94426142|NCT03893565|323345286|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
94426143|NCT03893565|323345278|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
94426144|NCT03893565|323345279|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
94426145|NCT03893565|323345280|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
94426146|NCT03893565|323345281|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
94426147|NCT03893565|323345282|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
94426148|NCT03893565|323345283|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
94426149|NCT03893565|323345284|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
94426150|NCT03893565|323345285|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
94426151|NCT03893565|323345286|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
94426152|NCT03893565|323345278|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
94426153|NCT03893565|323345279|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
94426154|NCT03893565|323345280|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
94426155|NCT03893565|323345281|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
94426156|NCT03893565|323345282|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
94426157|NCT03893565|323345283|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
94426158|NCT03893565|323345284|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
94426159|NCT03893565|323345285|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
94426160|NCT03893565|323345286|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
94426161|NCT03893565|323345278|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
94426162|NCT03893565|323345279|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
94426163|NCT03893565|323345280|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
94426164|NCT03893565|323345281|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
94426165|NCT03893565|323345282|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
94426166|NCT03893565|323345283|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
94426167|NCT03893565|323345284|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
94426168|NCT03893565|323345285|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
94426169|NCT03893565|323345286|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
94426170|NCT03893565|323345278|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
94426171|NCT03893565|323345279|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
94426172|NCT03893565|323345280|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
94426173|NCT03893565|323345281|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
94426174|NCT03893565|323345282|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
94426175|NCT03893565|323345283|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
94426176|NCT03893565|323345284|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
94426177|NCT03893565|323345285|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
94426178|NCT03893565|323345286|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
94426179|NCT03893565|323345278|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
94426180|NCT03893565|323345279|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
94426181|NCT03893565|323345280|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
94426182|NCT03893565|323345281|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
94426183|NCT03893565|323345282|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
94426184|NCT03893565|323345283|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
94426185|NCT03893565|323345284|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
94426186|NCT03893565|323345285|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
94426187|NCT03893565|323345286|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
94426188|NCT03893565|323345278|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
94426189|NCT03893565|323345279|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
94426190|NCT03893565|323345280|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
94426191|NCT03893565|323345281|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
94426192|NCT03893565|323345282|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
94426193|NCT03893565|323345283|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
94426194|NCT03893565|323345284|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
94426195|NCT03893565|323345285|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
94426196|NCT03893565|323345286|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
94426197|NCT03893565|323345278|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
94426198|NCT03893565|323345279|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
94426199|NCT03893565|323345280|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
94426200|NCT03893565|323345281|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
94426201|NCT03893565|323345282|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
94426202|NCT03893565|323345283|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
94426203|NCT03893565|323345284|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
94426204|NCT03893565|323345285|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
94426205|NCT03893565|323345286|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
94426206|NCT03893565|323345278|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
94426207|NCT03893565|323345279|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
94426208|NCT03893565|323345280|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
94426209|NCT03893565|323345281|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
94426210|NCT03893565|323345282|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
94426211|NCT03893565|323345283|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
94426212|NCT03893565|323345284|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
94426213|NCT03893565|323345285|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
94426214|NCT03893565|323345286|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
94655536|NCT00927927|324196064|FG004|Overall Study|Withdrawal by Subject|0|||
94426215|NCT03893565|323345278|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
94426216|NCT03893565|323345279|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
94426217|NCT03893565|323345280|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
94426218|NCT03893565|323345281|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
94426219|NCT03893565|323345282|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
94426220|NCT03893565|323345283|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
94426221|NCT03893565|323345284|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
94426222|NCT03893565|323345285|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
94426223|NCT03893565|323345286|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
94426224|NCT03893565|323345278|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
94426225|NCT03893565|323345279|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
94426226|NCT03893565|323345280|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
94426227|NCT03893565|323345281|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
94426228|NCT03893565|323345282|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
94426229|NCT03893565|323345283|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
94426230|NCT03893565|323345284|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
94426231|NCT03893565|323345285|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
94426232|NCT03893565|323345286|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
94426233|NCT03893565|323345278|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
94426234|NCT03893565|323345279|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
94426235|NCT03893565|323345280|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
94426236|NCT03893565|323345281|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
94426237|NCT03893565|323345282|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
94426238|NCT03893565|323345283|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
94426239|NCT03893565|323345284|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
94426240|NCT03893565|323345285|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
94426241|NCT03893565|323345286|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
94426242|NCT03893565|323345278|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
94426243|NCT03893565|323345279|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
94426244|NCT03893565|323345280|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
94426245|NCT03893565|323345281|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
94426246|NCT03893565|323345282|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
94426247|NCT03893565|323345283|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
94426248|NCT03893565|323345284|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
94426249|NCT03893565|323345285|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
94426250|NCT03893565|323345286|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
94426251|NCT03893565|323345278|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
94426252|NCT03893565|323345279|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
94426253|NCT03893565|323345280|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
94426254|NCT03893565|323345281|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
94426255|NCT03893565|323345282|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
94426256|NCT03893565|323345283|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
94426257|NCT03893565|323345284|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
94426258|NCT03893565|323345285|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
94489566|NCT00071981|323586107|FG003|Overall Study|Withdrawal by Subject|0|||
94426259|NCT03893565|323345286|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
94426260|NCT03893565|323345278|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
94426261|NCT03893565|323345279|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
94426262|NCT03893565|323345280|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
94426263|NCT03893565|323345281|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
94426264|NCT03893565|323345282|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
94489567|NCT00071981|323586104|FG000|Overall Study|No protocol therapy|2|||
94489568|NCT00071981|323586105|FG001|Overall Study|No protocol therapy|5|||
94426265|NCT03893565|323345283|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
94426266|NCT03893565|323345284|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
94426267|NCT03893565|323345285|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
94426268|NCT03893565|323345286|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
94426269|NCT03893565|323345278|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
94426270|NCT03893565|323345279|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
94426271|NCT03893565|323345280|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
94426272|NCT03893565|323345281|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
94426273|NCT03893565|323345282|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
94426274|NCT03893565|323345283|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
94426275|NCT03893565|323345284|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
94426276|NCT03893565|323345285|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
94426277|NCT03893565|323345286|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
94426278|NCT04108208|323345287|FG000|Overall Study|Withdrawal by Subject|2|||
94426279|NCT04108208|323345288|FG001|Overall Study|Withdrawal by Subject|6|||
94426280|NCT04108208|323345287|FG000|Overall Study|other-ongoing|20|||
94426281|NCT04108208|323345288|FG001|Overall Study|other-ongoing|40|||
94426282|NCT04108208|323345287|FG000|Overall Study|Death|1|||
94426283|NCT04108208|323345288|FG001|Overall Study|Death|4|||
94426284|NCT04108208|323345287|FG000|Overall Study|Lost to Follow-up|2|||
94426285|NCT04108208|323345288|FG001|Overall Study|Lost to Follow-up|0|||
94426286|NCT04076059|323345290|FG000|Double Blind Phase|Progressive disease|22|||
94426287|NCT04076059|323345291|FG001|Double Blind Phase|Progressive disease|26|||
94426288|NCT04076059|323345292|FG002|Double Blind Phase|Progressive disease|0|||
94426289|NCT04076059|323345290|FG000|Double Blind Phase|Withdrawal by Subject|4|||
94426290|NCT04076059|323345291|FG001|Double Blind Phase|Withdrawal by Subject|11|||
94426291|NCT04076059|323345292|FG002|Double Blind Phase|Withdrawal by Subject|0|||
94426292|NCT04076059|323345290|FG000|Double Blind Phase|Death|1|||
94426293|NCT04076059|323345291|FG001|Double Blind Phase|Death|1|||
94426294|NCT04076059|323345292|FG002|Double Blind Phase|Death|0|||
94426295|NCT04076059|323345290|FG000|Double Blind Phase|Lost to Follow-up|1|||
94426296|NCT04076059|323345291|FG001|Double Blind Phase|Lost to Follow-up|0|||
94426297|NCT04076059|323345292|FG002|Double Blind Phase|Lost to Follow-up|0|||
94426298|NCT04076059|323345290|FG000|Double Blind Phase|Adverse Event|5|||
94426299|NCT04076059|323345291|FG001|Double Blind Phase|Adverse Event|1|||
94426300|NCT04076059|323345292|FG002|Double Blind Phase|Adverse Event|0|||
94426301|NCT04076059|323345290|FG000|Double Blind Phase|Ongoing Participants|82|||
94426302|NCT04076059|323345291|FG001|Double Blind Phase|Ongoing Participants|18|||
94426303|NCT04076059|323345292|FG002|Double Blind Phase|Ongoing Participants|0|||
94426304|NCT04076059|323345290|FG000|Double Blind Phase|Miscellaneous|3|||
94426305|NCT04076059|323345291|FG001|Double Blind Phase|Miscellaneous|1|||
94426306|NCT04076059|323345292|FG002|Double Blind Phase|Miscellaneous|0|||
94426307|NCT04076059|323345290|FG000|Double Blind Phase|Protocol Deviation|1|||
94426308|NCT04076059|323345291|FG001|Double Blind Phase|Protocol Deviation|1|||
94426309|NCT04076059|323345292|FG002|Double Blind Phase|Protocol Deviation|0|||
94426310|NCT04076059|323345290|FG000|Double Blind Phase|Did not take study drug|1|||
94426311|NCT04076059|323345291|FG001|Double Blind Phase|Did not take study drug|1|||
94426312|NCT04076059|323345292|FG002|Double Blind Phase|Did not take study drug|0|||
94426313|NCT04076059|323345290|FG000|Open Label Phase|Progressive disease|0|||
94426314|NCT04076059|323345291|FG001|Open Label Phase|Progressive disease|0|||
94426315|NCT04076059|323345292|FG002|Open Label Phase|Progressive disease|7|||
94426316|NCT04076059|323345290|FG000|Open Label Phase|Withdrawal by Subject|0|||
94426317|NCT04076059|323345291|FG001|Open Label Phase|Withdrawal by Subject|0|||
94426318|NCT04076059|323345292|FG002|Open Label Phase|Withdrawal by Subject|3|||
94426319|NCT04076059|323345290|FG000|Open Label Phase|Death|0|||
94426320|NCT04076059|323345291|FG001|Open Label Phase|Death|0|||
94426321|NCT04076059|323345292|FG002|Open Label Phase|Death|2|||
94426322|NCT04076059|323345290|FG000|Open Label Phase|Ongoing Participants|0|||
94426323|NCT04076059|323345291|FG001|Open Label Phase|Ongoing Participants|0|||
94426324|NCT04076059|323345292|FG002|Open Label Phase|Ongoing Participants|11|||
94426325|NCT03569228|323345293|FG000|Overall Study|Withdrawal by PI|0|||
94426326|NCT03569228|323345294|FG001|Overall Study|Withdrawal by PI|0|||
94426327|NCT03569228|323345295|FG002|Overall Study|Withdrawal by PI|2|||
94426328|NCT03569228|323345296|FG003|Overall Study|Withdrawal by PI|2|||
94426329|NCT03569228|323345297|FG004|Overall Study|Withdrawal by PI|1|||
94426330|NCT03569228|323345298|FG005|Overall Study|Withdrawal by PI|0|||
94426331|NCT03569228|323345299|FG006|Overall Study|Withdrawal by PI|0|||
94426332|NCT03569228|323345300|FG007|Overall Study|Withdrawal by PI|0|||
94426333|NCT03569228|323345301|FG008|Overall Study|Withdrawal by PI|0|||
94426334|NCT03569228|323345293|FG000|Overall Study|Lost to Follow-up|0|||
94426335|NCT03569228|323345294|FG001|Overall Study|Lost to Follow-up|0|||
94426336|NCT03569228|323345295|FG002|Overall Study|Lost to Follow-up|0|||
94426337|NCT03569228|323345296|FG003|Overall Study|Lost to Follow-up|0|||
94426338|NCT03569228|323345297|FG004|Overall Study|Lost to Follow-up|0|||
94426339|NCT03569228|323345298|FG005|Overall Study|Lost to Follow-up|0|||
94426340|NCT03569228|323345299|FG006|Overall Study|Lost to Follow-up|0|||
94426341|NCT03569228|323345300|FG007|Overall Study|Lost to Follow-up|0|||
94426342|NCT03569228|323345301|FG008|Overall Study|Lost to Follow-up|1|||
94426343|NCT03569228|323345293|FG000|Overall Study|Screen Fail|2|||
94426344|NCT03569228|323345294|FG001|Overall Study|Screen Fail|2|||
94426345|NCT03569228|323345295|FG002|Overall Study|Screen Fail|1|||
94426346|NCT03569228|323345296|FG003|Overall Study|Screen Fail|1|||
94426347|NCT03569228|323345297|FG004|Overall Study|Screen Fail|1|||
94426348|NCT03569228|323345298|FG005|Overall Study|Screen Fail|3|||
94426349|NCT03569228|323345299|FG006|Overall Study|Screen Fail|1|||
94426350|NCT03569228|323345300|FG007|Overall Study|Screen Fail|5|||
94426351|NCT03569228|323345301|FG008|Overall Study|Screen Fail|2|||
94426352|NCT03819049|323345302|FG000|Overall Study|Lost to Follow-up|1|||
94426353|NCT03819049|323345303|FG001|Overall Study|Lost to Follow-up|2|||
94426354|NCT03819049|323345304|FG002|Overall Study|Lost to Follow-up|9|||
94426355|NCT03819049|323345305|FG003|Overall Study|Lost to Follow-up|0|||
94426356|NCT03819049|323345306|FG004|Overall Study|Lost to Follow-up|3|||
94426357|NCT03819049|323345307|FG005|Overall Study|Lost to Follow-up|1|||
94426358|NCT03819049|323345308|FG006|Overall Study|Lost to Follow-up|0|||
94426359|NCT03819049|323345302|FG000|Overall Study|Withdrawal by Subject|0|||
94426360|NCT03819049|323345303|FG001|Overall Study|Withdrawal by Subject|0|||
94426361|NCT03819049|323345304|FG002|Overall Study|Withdrawal by Subject|18|||
94426362|NCT03819049|323345305|FG003|Overall Study|Withdrawal by Subject|0|||
94426363|NCT03819049|323345306|FG004|Overall Study|Withdrawal by Subject|10|||
94426364|NCT03819049|323345307|FG005|Overall Study|Withdrawal by Subject|9|||
94426365|NCT03819049|323345308|FG006|Overall Study|Withdrawal by Subject|1|||
94426366|NCT03819049|323345302|FG000|Overall Study|Ongoing|0|||
94426367|NCT03819049|323345303|FG001|Overall Study|Ongoing|0|||
94426368|NCT03819049|323345304|FG002|Overall Study|Ongoing|75|||
94426369|NCT03819049|323345305|FG003|Overall Study|Ongoing|0|||
94426370|NCT03819049|323345306|FG004|Overall Study|Ongoing|41|||
94426371|NCT03819049|323345307|FG005|Overall Study|Ongoing|0|||
94426372|NCT03819049|323345308|FG006|Overall Study|Ongoing|0|||
94426373|NCT03819049|323345302|FG000|Overall Study|Other|0|||
94426374|NCT03819049|323345303|FG001|Overall Study|Other|0|||
94426375|NCT03819049|323345304|FG002|Overall Study|Other|2|||
94426376|NCT03819049|323345305|FG003|Overall Study|Other|0|||
94426377|NCT03819049|323345306|FG004|Overall Study|Other|0|||
94426378|NCT03819049|323345307|FG005|Overall Study|Other|0|||
94426379|NCT03819049|323345308|FG006|Overall Study|Other|0|||
94426380|NCT03819049|323345302|FG000|Overall Study|Randomized but not vaccinated|0|||
94426381|NCT03819049|323345303|FG001|Overall Study|Randomized but not vaccinated|0|||
94426382|NCT03819049|323345304|FG002|Overall Study|Randomized but not vaccinated|0|||
94426383|NCT03819049|323345305|FG003|Overall Study|Randomized but not vaccinated|1|||
94426384|NCT03819049|323345306|FG004|Overall Study|Randomized but not vaccinated|0|||
94426385|NCT03819049|323345307|FG005|Overall Study|Randomized but not vaccinated|2|||
94426386|NCT03819049|323345308|FG006|Overall Study|Randomized but not vaccinated|1|||
94426387|NCT03819049|323345302|FG000|Overall Study|Physician Decision|0|||
94426388|NCT03819049|323345303|FG001|Overall Study|Physician Decision|0|||
94426389|NCT03819049|323345304|FG002|Overall Study|Physician Decision|0|||
94426390|NCT03819049|323345305|FG003|Overall Study|Physician Decision|0|||
94426391|NCT03819049|323345306|FG004|Overall Study|Physician Decision|0|||
94426392|NCT03819049|323345307|FG005|Overall Study|Physician Decision|0|||
94426393|NCT03819049|323345308|FG006|Overall Study|Physician Decision|1|||
94426394|NCT04325828|323345309|FG000|Overall Study|Ongoing|26|||
94426395|NCT00085423|323345310|FG000|Overall Study|Withdrawal by Subject|1|||
94426396|NCT00085423|323345310|FG000|Overall Study|screen failure|1|||
94426397|NCT02987959|323345311|FG000|Overall Study|Grantor stopped supply of drugs|6|||
94426398|NCT02533375|323345331|FG000|Overall Study|Lack of Efficacy|3|||
94426399|NCT02533375|323345331|FG000|Overall Study|Adverse Event|2|||
94426400|NCT02288182|323345334|FG000|Overall Study|Adverse Event|0|||
94426401|NCT02288182|323345335|FG001|Overall Study|Adverse Event|1|||
94426402|NCT02288182|323345334|FG000|Overall Study|Lost to Follow-up|0|||
94426403|NCT02288182|323345335|FG001|Overall Study|Lost to Follow-up|1|||
94426404|NCT02582866|323345340|FG000|Overall Study|Death|1|||
94426405|NCT02582866|323345340|FG000|Overall Study|Lack of Efficacy|2|||
94426406|NCT02582866|323345340|FG000|Overall Study|Lost to Follow-up|2|||
94426407|NCT02582866|323345340|FG000|Overall Study|Withdrawal by Subject|7|||
94426408|NCT02582866|323345340|FG000|Overall Study|Investigator decision|5|||
94426409|NCT02582866|323345340|FG000|Overall Study|Participant wants to get pregnant|1|||
94426410|NCT02582866|323345340|FG000|Overall Study|Pregnancy|2|||
94426411|NCT02582866|323345340|FG000|Overall Study|Sponsor decision|1|||
94426412|NCT02582866|323345340|FG000|Overall Study|Withdrawal due to personal reasons|1|||
94426413|NCT01193127|323345349|FG000|Randomized|Surgery Cancelled|0|||
94489569|NCT00071981|323586106|FG002|Overall Study|No protocol therapy|1|||
94489570|NCT00071981|323586107|FG003|Overall Study|No protocol therapy|0|||
94426414|NCT01193127|323345350|FG001|Randomized|Surgery Cancelled|0|||
94426415|NCT01193127|323345351|FG002|Randomized|Surgery Cancelled|0|||
94426416|NCT01193127|323345352|FG003|Randomized|Surgery Cancelled|1|||
94426417|NCT01193127|323345349|FG000|Treated|Withdrawal by Subject|0|||
94426418|NCT01193127|323345350|FG001|Treated|Withdrawal by Subject|0|||
94426419|NCT01193127|323345351|FG002|Treated|Withdrawal by Subject|0|||
94426420|NCT01193127|323345352|FG003|Treated|Withdrawal by Subject|1|||
94426421|NCT00721630|323346977|FG000|Overall Study|Participant found to be ineligible|1|||
94426422|NCT04765384|323346978|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
94426423|NCT04765384|323346979|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
94426424|NCT04765384|323346980|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
94426425|NCT04765384|323346981|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
94426426|NCT04765384|323346982|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
94426427|NCT04765384|323346983|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
94426428|NCT04765384|323346978|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
94426429|NCT04765384|323346979|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
94426430|NCT04765384|323346980|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
94426431|NCT04765384|323346981|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
94426432|NCT04765384|323346982|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
94426433|NCT04765384|323346983|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
94426434|NCT04765384|323346978|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
94426435|NCT04765384|323346979|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
94426436|NCT04765384|323346980|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
94426437|NCT04765384|323346981|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
94426438|NCT04765384|323346982|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
94426439|NCT04765384|323346983|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
94426440|NCT04765384|323346978|FG000|Post-natal: Neonates and Infants|Death|0|||
94426441|NCT04765384|323346979|FG001|Post-natal: Neonates and Infants|Death|0|||
94426442|NCT04765384|323346980|FG002|Post-natal: Neonates and Infants|Death|0|||
94426443|NCT04765384|323346981|FG003|Post-natal: Neonates and Infants|Death|1|||
94426444|NCT04765384|323346982|FG004|Post-natal: Neonates and Infants|Death|0|||
94426445|NCT04765384|323346983|FG005|Post-natal: Neonates and Infants|Death|0|||
94426446|NCT04765384|323346978|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
94426447|NCT04765384|323346979|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
94426448|NCT04765384|323346980|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
94426449|NCT04765384|323346981|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
94426450|NCT04765384|323346982|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
94426451|NCT04765384|323346983|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
94426452|NCT02006693|323346984|FG000|Overall Study|No Reason Specified|6|||
94426453|NCT02006693|323346985|FG001|Overall Study|No Reason Specified|8|||
94426454|NCT02006693|323346984|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
94426455|NCT02006693|323346985|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
94426456|NCT02006693|323346984|FG000|Overall Study|XEN Implant Explantation|0|||
94426457|NCT02006693|323346985|FG001|Overall Study|XEN Implant Explantation|1|||
94489571|NCT00071981|323586104|FG000|Overall Study|others (not specified in the study)|0|||
94489572|NCT00071981|323586105|FG001|Overall Study|others (not specified in the study)|2|||
94489573|NCT00071981|323586106|FG002|Overall Study|others (not specified in the study)|2|||
94489574|NCT00071981|323586107|FG003|Overall Study|others (not specified in the study)|0|||
94489575|NCT01218802|323586110|FG000|Overall Study|Lost to Follow-up|5|||
94489576|NCT01218802|323586111|FG001|Overall Study|Lost to Follow-up|6|||
94489577|NCT01218802|323586110|FG000|Overall Study|Withdrawal by Subject|3|||
94489578|NCT01218802|323586111|FG001|Overall Study|Withdrawal by Subject|10|||
94489579|NCT01218802|323586110|FG000|Overall Study|Adverse Event|0|||
94489580|NCT01218802|323586111|FG001|Overall Study|Adverse Event|2|||
94489581|NCT01218802|323586110|FG000|Overall Study|Incarcerated|2|||
94489582|NCT01218802|323586111|FG001|Overall Study|Incarcerated|0|||
94489583|NCT01123655|323586112|FG000|Overall Study|Medication for RA had to be changed|1|||
94489584|NCT01123655|323586113|FG001|Overall Study|Medication for RA had to be changed|0|||
94489585|NCT01123655|323586114|FG002|Overall Study|Medication for RA had to be changed|0|||
94489586|NCT01123655|323586112|FG000|Overall Study|new illness|0|||
94489587|NCT01123655|323586113|FG001|Overall Study|new illness|1|||
94489588|NCT01123655|323586114|FG002|Overall Study|new illness|0|||
94489589|NCT01123655|323586112|FG000|Overall Study|began prohibitive drug|0|||
94489590|NCT01123655|323586113|FG001|Overall Study|began prohibitive drug|0|||
94489591|NCT01123655|323586114|FG002|Overall Study|began prohibitive drug|1|||
94489592|NCT00262119|323586115|FG000|Overall Study|Lost to Follow-up|38|||
94489593|NCT00262119|323586116|FG001|Overall Study|Lost to Follow-up|51|||
94489594|NCT00262119|323586117|FG002|Overall Study|Lost to Follow-up|42|||
94489595|NCT00262119|323586115|FG000|Overall Study|Death|20|||
94489596|NCT00262119|323586116|FG001|Overall Study|Death|19|||
94489597|NCT00262119|323586117|FG002|Overall Study|Death|16|||
94489598|NCT03886272|323586121|FG000|Period 1|Withdrawal by Subject|0|||
94489599|NCT03886272|323586122|FG001|Period 1|Withdrawal by Subject|0|||
94489600|NCT03886272|323586123|FG002|Period 1|Withdrawal by Subject|0|||
94426458|NCT02006693|323346984|FG000|Overall Study|Death|2|||
94426459|NCT02006693|323346985|FG001|Overall Study|Death|2|||
94426460|NCT02006693|323346984|FG000|Overall Study|Lost to Follow-up|4|||
94426461|NCT02006693|323346985|FG001|Overall Study|Lost to Follow-up|1|||
94426462|NCT02006693|323346984|FG000|Overall Study|Patient Decision|4|||
94426463|NCT02006693|323346985|FG001|Overall Study|Patient Decision|0|||
94489601|NCT03886272|323586124|FG003|Period 1|Withdrawal by Subject|0|||
94489602|NCT03886272|323586125|FG004|Period 1|Withdrawal by Subject|0|||
94489603|NCT03886272|323586126|FG005|Period 1|Withdrawal by Subject|1|||
94489604|NCT03886272|323586127|FG006|Period 1|Withdrawal by Subject|0|||
94489605|NCT03608826|323586128|FG000|Overall Study|Death|3|||
94489606|NCT03608826|323586128|FG000|Overall Study|Heart Transplant|3|||
94489607|NCT03608826|323586128|FG000|Overall Study|Physician Decision|4|||
94489608|NCT04609514|323586144|FG000|Overall Study|Lost to Follow-up|5|||
94489609|NCT04609514|323586145|FG001|Overall Study|Lost to Follow-up|4|||
94426464|NCT01119508|323346986|FG000|Overall Study|Adverse Event|56|||
94426465|NCT01119508|323346986|FG000|Overall Study|Withdrawal by Subject|2|||
94426466|NCT01119508|323346986|FG000|Overall Study|Died before tumor response evaluation|1|||
94426467|NCT00265395|323346987|FG000|Overall Study|Adverse Event|3|||
94426468|NCT00265395|323346988|FG001|Overall Study|Adverse Event|6|||
94426469|NCT00265395|323346987|FG000|Overall Study|Lost to Follow-up|2|||
94426470|NCT00265395|323346988|FG001|Overall Study|Lost to Follow-up|1|||
94426471|NCT00265395|323346987|FG000|Overall Study|Withdrawal by Subject|1|||
94426472|NCT00265395|323346988|FG001|Overall Study|Withdrawal by Subject|6|||
94426473|NCT00265395|323346987|FG000|Overall Study|Protocol Violation|2|||
94426474|NCT00265395|323346988|FG001|Overall Study|Protocol Violation|2|||
94426475|NCT00265395|323346987|FG000|Overall Study|Lack of Efficacy|0|||
94426476|NCT00265395|323346988|FG001|Overall Study|Lack of Efficacy|1|||
94426477|NCT00265395|323346987|FG000|Overall Study|Administrative|0|||
94426478|NCT00265395|323346988|FG001|Overall Study|Administrative|1|||
94426479|NCT02315196|323346991|FG000|Overall Study|Withdrew consent|9|||
94426480|NCT00552578|323346994|FG000|Overall Study|Lost to Follow-up|1|||
94426481|NCT00552578|323346995|FG001|Overall Study|Lost to Follow-up|1|||
94426482|NCT00537303|323346996|FG000|Overall Study|Adverse Event|1|||
94426483|NCT00537303|323346997|FG001|Overall Study|Adverse Event|4|||
94426484|NCT00537303|323346996|FG000|Overall Study|Lack of Efficacy|6|||
94426485|NCT00537303|323346997|FG001|Overall Study|Lack of Efficacy|7|||
94426486|NCT00537303|323346996|FG000|Overall Study|Protocol Violation|8|||
94426487|NCT00537303|323346997|FG001|Overall Study|Protocol Violation|4|||
94426488|NCT00537303|323346996|FG000|Overall Study|Withdrawal criteria|3|||
94426489|NCT00537303|323346997|FG001|Overall Study|Withdrawal criteria|3|||
94426490|NCT00537303|323346996|FG000|Overall Study|Unclassified|8|||
94426491|NCT00537303|323346997|FG001|Overall Study|Unclassified|7|||
94426492|NCT02085135|323346998|FG000|Overall Study|Adverse Event|4|||
94426493|NCT02085135|323346999|FG001|Overall Study|Adverse Event|7|||
94426494|NCT02085135|323346998|FG000|Overall Study|Lost to Follow-up|2|||
94426495|NCT02085135|323346999|FG001|Overall Study|Lost to Follow-up|2|||
94426496|NCT02085135|323346998|FG000|Overall Study|Withdrawal by Subject|3|||
94426497|NCT02085135|323346999|FG001|Overall Study|Withdrawal by Subject|0|||
94426498|NCT02085135|323346998|FG000|Overall Study|Lack of Efficacy|2|||
94426499|NCT02085135|323346999|FG001|Overall Study|Lack of Efficacy|0|||
94426500|NCT03317834|323347000|FG000|Overall Study|Death|2|||
94426501|NCT03317834|323347000|FG000|Overall Study|Device Revision|5|||
94426502|NCT03317834|323347000|FG000|Overall Study|Withdrawal by Subject|13|||
94426503|NCT03317834|323347000|FG000|Overall Study|Lost to Follow-up|13|||
94426504|NCT03839823|323347004|FG000|Overall Study|Adverse Event|8|||
94426505|NCT03839823|323347005|FG001|Overall Study|Adverse Event|4|||
94426506|NCT03839823|323347004|FG000|Overall Study|Death|1|||
94426507|NCT03839823|323347005|FG001|Overall Study|Death|0|||
94426508|NCT03839823|323347004|FG000|Overall Study|Physician Decision|1|||
94426509|NCT03839823|323347005|FG001|Overall Study|Physician Decision|5|||
94426510|NCT03839823|323347004|FG000|Overall Study|Progressive Disease (PD)|65|||
94426511|NCT03839823|323347005|FG001|Overall Study|Progressive Disease (PD)|65|||
94426512|NCT03839823|323347004|FG000|Overall Study|Subject Decision|2|||
94426513|NCT03839823|323347005|FG001|Overall Study|Subject Decision|9|||
94426514|NCT03839823|323347004|FG000|Overall Study|Not Treated|0|||
94426515|NCT03839823|323347005|FG001|Overall Study|Not Treated|10|||
94426516|NCT01330459|323347006|FG000|Overall Study|Physician Decision|0|||
94426517|NCT01330459|323347007|FG001|Overall Study|Physician Decision|2|||
94426518|NCT04228783|323347008|FG000|Overall Study|Adverse Event|1|||
94426519|NCT04228783|323347009|FG001|Overall Study|Adverse Event|0|||
94426520|NCT04228783|323347010|FG002|Overall Study|Adverse Event|2|||
94426521|NCT04228783|323347011|FG003|Overall Study|Adverse Event|0|||
94426522|NCT04228783|323347012|FG004|Overall Study|Adverse Event|0|||
94426523|NCT04228783|323347013|FG005|Overall Study|Adverse Event|1|||
94426524|NCT04228783|323347008|FG000|Overall Study|Death|0|||
94426525|NCT04228783|323347009|FG001|Overall Study|Death|0|||
94426526|NCT04228783|323347010|FG002|Overall Study|Death|0|||
94426527|NCT04228783|323347011|FG003|Overall Study|Death|0|||
94426528|NCT04228783|323347012|FG004|Overall Study|Death|1|||
94426529|NCT04228783|323347013|FG005|Overall Study|Death|0|||
94426530|NCT04228783|323347008|FG000|Overall Study|Lost to Follow-up|36|||
94426531|NCT04228783|323347009|FG001|Overall Study|Lost to Follow-up|36|||
94426532|NCT04228783|323347010|FG002|Overall Study|Lost to Follow-up|28|||
94426533|NCT04228783|323347011|FG003|Overall Study|Lost to Follow-up|6|||
94426534|NCT04228783|323347012|FG004|Overall Study|Lost to Follow-up|14|||
94426535|NCT04228783|323347013|FG005|Overall Study|Lost to Follow-up|3|||
94426536|NCT04228783|323347008|FG000|Overall Study|Physician Decision|1|||
94426537|NCT04228783|323347009|FG001|Overall Study|Physician Decision|2|||
94426538|NCT04228783|323347010|FG002|Overall Study|Physician Decision|0|||
94426539|NCT04228783|323347011|FG003|Overall Study|Physician Decision|0|||
94426540|NCT04228783|323347012|FG004|Overall Study|Physician Decision|0|||
94426541|NCT04228783|323347013|FG005|Overall Study|Physician Decision|0|||
94426542|NCT04228783|323347008|FG000|Overall Study|Protocol Violation|0|||
94426543|NCT04228783|323347009|FG001|Overall Study|Protocol Violation|0|||
94426544|NCT04228783|323347010|FG002|Overall Study|Protocol Violation|0|||
94426545|NCT04228783|323347011|FG003|Overall Study|Protocol Violation|1|||
94426546|NCT04228783|323347012|FG004|Overall Study|Protocol Violation|0|||
94426547|NCT04228783|323347013|FG005|Overall Study|Protocol Violation|0|||
94426548|NCT04228783|323347008|FG000|Overall Study|Withdrawal by Subject|6|||
94426549|NCT04228783|323347009|FG001|Overall Study|Withdrawal by Subject|10|||
94426550|NCT04228783|323347010|FG002|Overall Study|Withdrawal by Subject|19|||
94426551|NCT04228783|323347011|FG003|Overall Study|Withdrawal by Subject|1|||
94426552|NCT04228783|323347012|FG004|Overall Study|Withdrawal by Subject|2|||
94426553|NCT04228783|323347013|FG005|Overall Study|Withdrawal by Subject|0|||
94426554|NCT04228783|323347008|FG000|Overall Study|Other|4|||
94426555|NCT04228783|323347009|FG001|Overall Study|Other|3|||
94426556|NCT04228783|323347010|FG002|Overall Study|Other|2|||
94426557|NCT04228783|323347011|FG003|Overall Study|Other|1|||
94426558|NCT04228783|323347012|FG004|Overall Study|Other|0|||
94426559|NCT04228783|323347013|FG005|Overall Study|Other|0|||
94426560|NCT00742924|323347016|FG000|Overall Study|Adverse Event|0|||
94426561|NCT00742924|323347017|FG001|Overall Study|Adverse Event|0|||
94426562|NCT00742924|323347018|FG002|Overall Study|Adverse Event|1|||
94426563|NCT00742924|323347019|FG003|Overall Study|Adverse Event|1|||
94426564|NCT00742924|323347016|FG000|Overall Study|Lack of Efficacy|5|||
94426565|NCT00742924|323347017|FG001|Overall Study|Lack of Efficacy|1|||
94426566|NCT00742924|323347018|FG002|Overall Study|Lack of Efficacy|2|||
94426567|NCT00742924|323347019|FG003|Overall Study|Lack of Efficacy|4|||
94426568|NCT00742924|323347016|FG000|Overall Study|Physician Decision|0|||
94426569|NCT00742924|323347017|FG001|Overall Study|Physician Decision|0|||
94426570|NCT00742924|323347018|FG002|Overall Study|Physician Decision|0|||
94426571|NCT00742924|323347019|FG003|Overall Study|Physician Decision|1|||
94426572|NCT00742924|323347016|FG000|Overall Study|Withdrawal by Subject|0|||
94426573|NCT00742924|323347017|FG001|Overall Study|Withdrawal by Subject|1|||
94426574|NCT00742924|323347018|FG002|Overall Study|Withdrawal by Subject|1|||
94426575|NCT00742924|323347019|FG003|Overall Study|Withdrawal by Subject|0|||
94426576|NCT00660400|323347022|FG000|Overall Study|Lack of insurance approval|1|||
94426577|NCT00660400|323347022|FG000|Overall Study|Suboptimal organ function|1|||
94426578|NCT00660400|323347022|FG000|Overall Study|Intracranial hemorrhage|1|||
94426579|NCT00660400|323347022|FG000|Overall Study|Withdrawal by Subject|1|||
94426580|NCT04562155|323347025|FG000|Overall Study|COVID-19 pandemic|0|||
94426581|NCT04562155|323347026|FG001|Overall Study|COVID-19 pandemic|0|||
94426582|NCT04562155|323347027|FG002|Overall Study|COVID-19 pandemic|0|||
94426583|NCT04562155|323347028|FG003|Overall Study|COVID-19 pandemic|1|||
94426584|NCT04562155|323347025|FG000|Overall Study|Adverse Event|7|||
94426585|NCT04562155|323347026|FG001|Overall Study|Adverse Event|3|||
94426586|NCT04562155|323347027|FG002|Overall Study|Adverse Event|8|||
94426587|NCT04562155|323347028|FG003|Overall Study|Adverse Event|1|||
94426588|NCT04562155|323347025|FG000|Overall Study|Withdrawal by Subject|3|||
94426589|NCT04562155|323347026|FG001|Overall Study|Withdrawal by Subject|6|||
94426590|NCT04562155|323347027|FG002|Overall Study|Withdrawal by Subject|3|||
94426591|NCT04562155|323347028|FG003|Overall Study|Withdrawal by Subject|3|||
94426592|NCT04562155|323347025|FG000|Overall Study|Participant personal reason|1|||
94426593|NCT04562155|323347026|FG001|Overall Study|Participant personal reason|0|||
94426594|NCT04562155|323347027|FG002|Overall Study|Participant personal reason|2|||
94426595|NCT04562155|323347028|FG003|Overall Study|Participant personal reason|1|||
94426596|NCT01442688|323347035|FG000|First Intervention|Withdrawal by Subject|1|||
94426597|NCT01442688|323347036|FG001|First Intervention|Withdrawal by Subject|0|||
94426598|NCT01442688|323347035|FG000|First Intervention|subject incarcerated|1|||
94426599|NCT01442688|323347036|FG001|First Intervention|subject incarcerated|0|||
94426600|NCT01442688|323347035|FG000|Second Intervention|Adverse Event|1|||
94426601|NCT01442688|323347036|FG001|Second Intervention|Adverse Event|0|||
94426602|NCT03257865|323347037|FG000|Overall Study|Adverse Event|4|||
94426603|NCT03257865|323347038|FG001|Overall Study|Adverse Event|8|||
94426604|NCT03257865|323347037|FG000|Overall Study|Lack of Efficacy|1|||
94426605|NCT03257865|323347038|FG001|Overall Study|Lack of Efficacy|2|||
94426606|NCT03257865|323347037|FG000|Overall Study|Non-compliance with Study Drug|0|||
94426607|NCT03257865|323347038|FG001|Overall Study|Non-compliance with Study Drug|2|||
94426608|NCT03257865|323347037|FG000|Overall Study|Withdrawal by Subject|23|||
94426609|NCT03257865|323347038|FG001|Overall Study|Withdrawal by Subject|17|||
94489610|NCT04609514|323586144|FG000|Overall Study|Withdrawal by PI|0|||
94489611|NCT04609514|323586145|FG001|Overall Study|Withdrawal by PI|2|||
94489612|NCT01326871|323586146|FG000|Overall Study|Major surgery|0|||
94489613|NCT01326871|323586147|FG001|Overall Study|Major surgery|1|||
94489614|NCT01326871|323586148|FG002|Overall Study|Major surgery|0|||
94426610|NCT03257865|323347037|FG000|Overall Study|Physician Decision|3|||
94426611|NCT03257865|323347038|FG001|Overall Study|Physician Decision|1|||
94426612|NCT03257865|323347037|FG000|Overall Study|Other|0|||
94426613|NCT03257865|323347038|FG001|Overall Study|Other|1|||
94489615|NCT01326871|323586146|FG000|Overall Study|SAE and death|0|||
94489616|NCT01326871|323586147|FG001|Overall Study|SAE and death|2|||
94426614|NCT03257865|323347037|FG000|Overall Study|Lost to Follow-up|4|||
94426615|NCT03257865|323347038|FG001|Overall Study|Lost to Follow-up|4|||
94426616|NCT01441947|323347039|FG000|Overall Study|Withdrawal by Subject|3|||
94426617|NCT01441947|323347040|FG001|Overall Study|Withdrawal by Subject|0|||
94426618|NCT06354998|323347041|FG000|Overall Study|Withdrawal by Subject|3|||
94426619|NCT06354998|323347042|FG001|Overall Study|Withdrawal by Subject|0|||
94426620|NCT03384654|323347043|FG000|Overall Study|Withdrawal by Subject|0|||
94426621|NCT03384654|323347044|FG001|Overall Study|Withdrawal by Subject|0|||
94426622|NCT03384654|323347045|FG002|Overall Study|Withdrawal by Subject|1|||
94426623|NCT03384654|323347046|FG003|Overall Study|Withdrawal by Subject|0|||
94426624|NCT03275064|323347047|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
94426625|NCT03275064|323347048|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
94426626|NCT03275064|323347049|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
94426627|NCT03275064|323347050|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
94426628|NCT03275064|323347051|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
94426629|NCT03275064|323347047|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
94426630|NCT03275064|323347048|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
94426631|NCT03275064|323347049|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
94426632|NCT03275064|323347050|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
94426633|NCT03275064|323347051|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
94426634|NCT03275064|323347047|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
94426635|NCT03275064|323347048|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
94426636|NCT03275064|323347049|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
94426637|NCT03275064|323347050|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
94426638|NCT03275064|323347051|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
94426639|NCT03275064|323347047|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
94426640|NCT03275064|323347048|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
94426641|NCT03275064|323347049|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
94426642|NCT03275064|323347050|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
94426643|NCT03275064|323347051|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
94426644|NCT03275064|323347047|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
94426645|NCT03275064|323347048|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
94426646|NCT03275064|323347049|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
94426647|NCT03275064|323347050|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
94426648|NCT03275064|323347051|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
94426649|NCT04159935|323347052|FG000|Overall Study|Study terminated due to COVID-19|1|||
94426650|NCT04159935|323347053|FG001|Overall Study|Study terminated due to COVID-19|3|||
94426651|NCT02036775|323347054|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
94426652|NCT02036775|323347055|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
94426653|NCT02036775|323347056|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
94426654|NCT02036775|323347057|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
94426655|NCT02036775|323347058|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
94426656|NCT02036775|323347059|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
94426657|NCT01910389|323347064|FG000|Overall Study|Withdrawal by Subject|2|||
94426658|NCT01910389|323347065|FG001|Overall Study|Withdrawal by Subject|0|||
94426659|NCT01910389|323347064|FG000|Overall Study|Study Closed|13|||
94426660|NCT01910389|323347065|FG001|Overall Study|Study Closed|8|||
94426661|NCT02365558|323347066|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
94426662|NCT02365558|323347067|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
94426663|NCT02365558|323347066|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
94426664|NCT02365558|323347067|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
94426665|NCT03276780|323347071|FG000|Overall Study|Withdrawal by Subject|5|||
94426666|NCT03276780|323347072|FG001|Overall Study|Withdrawal by Subject|3|||
94426667|NCT03276780|323347071|FG000|Overall Study|Lost to Follow-up|3|||
94426668|NCT03276780|323347072|FG001|Overall Study|Lost to Follow-up|5|||
94426669|NCT03276780|323347071|FG000|Overall Study|Moved out of state|1|||
94426670|NCT03276780|323347072|FG001|Overall Study|Moved out of state|1|||
94426671|NCT03276780|323347071|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
94426672|NCT03276780|323347072|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
94426673|NCT03276780|323347071|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
94426674|NCT03276780|323347072|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
94426675|NCT00510289|323347073|FG000|Overall Study|Withdrawal by Subject|7|||
94426676|NCT00510289|323347073|FG000|Overall Study|Refused bone marrow biopsy|2|||
94426677|NCT00510289|323347073|FG000|Overall Study|Lost to Follow-up|1|||
94426678|NCT00510289|323347073|FG000|Overall Study|Progressed prior to starting drug|2|||
94426679|NCT00197496|323347074|FG000|Baseline to Discharge|not interested|1|||
94426680|NCT00197496|323347075|FG001|Baseline to Discharge|not interested|0|||
94426681|NCT00197496|323347074|FG000|Baseline to Discharge|MRSA|1|||
94426682|NCT00197496|323347075|FG001|Baseline to Discharge|MRSA|0|||
94426683|NCT00197496|323347074|FG000|Baseline to Discharge|Physician Decision|0|||
94426684|NCT00197496|323347075|FG001|Baseline to Discharge|Physician Decision|1|||
94426685|NCT00197496|323347074|FG000|Baseline to Discharge|Protocol Violation|0|||
94426686|NCT00197496|323347075|FG001|Baseline to Discharge|Protocol Violation|1|||
94426687|NCT00197496|323347074|FG000|Follow-up|Lost to Follow-up|2|||
94426688|NCT00197496|323347075|FG001|Follow-up|Lost to Follow-up|1|||
94426689|NCT01770392|323347076|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
94426690|NCT03401450|323347080|FG000|Overall Study|Lost to Follow-up|4|||
94426691|NCT03401450|323347081|FG001|Overall Study|Lost to Follow-up|6|||
94426692|NCT03401450|323347080|FG000|Overall Study|Anesthesia plan changed|2|||
94426693|NCT03401450|323347081|FG001|Overall Study|Anesthesia plan changed|2|||
94426694|NCT03401450|323347080|FG000|Overall Study|Did not complete medication diary|4|||
94426695|NCT03401450|323347081|FG001|Overall Study|Did not complete medication diary|2|||
94426696|NCT03401450|323347080|FG000|Overall Study|post surgery medication change|2|||
94426697|NCT03401450|323347081|FG001|Overall Study|post surgery medication change|1|||
94426698|NCT03401450|323347080|FG000|Overall Study|Cancelled surgery|0|||
94426699|NCT03401450|323347081|FG001|Overall Study|Cancelled surgery|2|||
94426700|NCT00390221|323347084|FG000|Overall Study|Lost to Follow-up|0|||
94426701|NCT00390221|323347085|FG001|Overall Study|Lost to Follow-up|3|||
94426702|NCT00390221|323347086|FG002|Overall Study|Lost to Follow-up|0|||
94426703|NCT00390221|323347084|FG000|Overall Study|Adverse Event|1|||
94426704|NCT00390221|323347085|FG001|Overall Study|Adverse Event|4|||
94426705|NCT00390221|323347086|FG002|Overall Study|Adverse Event|3|||
94426706|NCT00390221|323347084|FG000|Overall Study|Investigator Decision|0|||
94426707|NCT00390221|323347085|FG001|Overall Study|Investigator Decision|0|||
94426708|NCT00390221|323347086|FG002|Overall Study|Investigator Decision|1|||
94426709|NCT00390221|323347084|FG000|Overall Study|Withdrawal by Subject|13|||
94426710|NCT00390221|323347085|FG001|Overall Study|Withdrawal by Subject|9|||
94426711|NCT00390221|323347086|FG002|Overall Study|Withdrawal by Subject|7|||
94426712|NCT00390221|323347084|FG000|Overall Study|Subject Non-compliance|1|||
94426713|NCT00390221|323347085|FG001|Overall Study|Subject Non-compliance|0|||
94426714|NCT00390221|323347086|FG002|Overall Study|Subject Non-compliance|2|||
94426715|NCT00390221|323347084|FG000|Overall Study|Other|3|||
94426716|NCT00390221|323347085|FG001|Overall Study|Other|4|||
94426717|NCT00390221|323347086|FG002|Overall Study|Other|2|||
94426718|NCT00673387|323347087|FG000|Overall Study|Withdrawal by Subject|15|||
94426719|NCT00673387|323347088|FG001|Overall Study|Withdrawal by Subject|16|||
94426720|NCT00673387|323347089|FG002|Overall Study|Withdrawal by Subject|20|||
94426721|NCT00673387|323347090|FG003|Overall Study|Withdrawal by Subject|16|||
94426722|NCT00673387|323347091|FG004|Overall Study|Withdrawal by Subject|18|||
94426723|NCT00673387|323347092|FG005|Overall Study|Withdrawal by Subject|21|||
94426724|NCT00673387|323347093|FG006|Overall Study|Withdrawal by Subject|15|||
94426725|NCT00673387|323347094|FG007|Overall Study|Withdrawal by Subject|21|||
94426726|NCT00673387|323347087|FG000|Overall Study|Adverse Event|3|||
94426727|NCT00673387|323347088|FG001|Overall Study|Adverse Event|1|||
94426728|NCT00673387|323347089|FG002|Overall Study|Adverse Event|5|||
94426729|NCT00673387|323347090|FG003|Overall Study|Adverse Event|2|||
94426730|NCT00673387|323347091|FG004|Overall Study|Adverse Event|6|||
94426731|NCT00673387|323347092|FG005|Overall Study|Adverse Event|2|||
94426732|NCT00673387|323347093|FG006|Overall Study|Adverse Event|5|||
94426733|NCT00673387|323347094|FG007|Overall Study|Adverse Event|5|||
94426734|NCT00673387|323347087|FG000|Overall Study|Physician Decision|0|||
94426735|NCT00673387|323347088|FG001|Overall Study|Physician Decision|0|||
94426736|NCT00673387|323347089|FG002|Overall Study|Physician Decision|0|||
94426737|NCT00673387|323347090|FG003|Overall Study|Physician Decision|0|||
94426738|NCT00673387|323347091|FG004|Overall Study|Physician Decision|0|||
94426739|NCT00673387|323347092|FG005|Overall Study|Physician Decision|5|||
94426740|NCT00673387|323347093|FG006|Overall Study|Physician Decision|1|||
94426741|NCT00673387|323347094|FG007|Overall Study|Physician Decision|1|||
94426742|NCT00673387|323347087|FG000|Overall Study|Protocol Violation|3|||
94426743|NCT00673387|323347088|FG001|Overall Study|Protocol Violation|0|||
94426744|NCT00673387|323347089|FG002|Overall Study|Protocol Violation|1|||
94426745|NCT00673387|323347090|FG003|Overall Study|Protocol Violation|2|||
94426746|NCT00673387|323347091|FG004|Overall Study|Protocol Violation|0|||
94426747|NCT00673387|323347092|FG005|Overall Study|Protocol Violation|1|||
94426748|NCT00673387|323347093|FG006|Overall Study|Protocol Violation|1|||
94426749|NCT00673387|323347094|FG007|Overall Study|Protocol Violation|3|||
94426750|NCT00673387|323347087|FG000|Overall Study|Lost to Follow-up|8|||
94426751|NCT00673387|323347088|FG001|Overall Study|Lost to Follow-up|6|||
94426752|NCT00673387|323347089|FG002|Overall Study|Lost to Follow-up|5|||
94426753|NCT00673387|323347090|FG003|Overall Study|Lost to Follow-up|6|||
94426754|NCT00673387|323347091|FG004|Overall Study|Lost to Follow-up|6|||
94426755|NCT00673387|323347092|FG005|Overall Study|Lost to Follow-up|5|||
94426756|NCT00673387|323347093|FG006|Overall Study|Lost to Follow-up|8|||
94426757|NCT00673387|323347094|FG007|Overall Study|Lost to Follow-up|5|||
94426758|NCT00960115|323347097|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
94426759|NCT00960115|323347098|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
94426760|NCT00861198|323347099|FG000|Overall Study|SpyGlass Failed|5|||
94426761|NCT00761865|323347103|FG000|Overall Study|Lost to Follow-up|8|||
94489617|NCT01326871|323586148|FG002|Overall Study|SAE and death|0|||
94489618|NCT01326871|323586146|FG000|Overall Study|Physician decision and decreased performance status|0|||
94489619|NCT01326871|323586147|FG001|Overall Study|Physician decision and decreased performance status|1|||
94489620|NCT01326871|323586148|FG002|Overall Study|Physician decision and decreased performance status|0|||
94489621|NCT01326871|323586146|FG000|Overall Study|Disease progression|0|||
94489622|NCT01326871|323586147|FG001|Overall Study|Disease progression|11|||
94489623|NCT01326871|323586148|FG002|Overall Study|Disease progression|5|||
94489624|NCT01326871|323586146|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
94489625|NCT01326871|323586147|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
94489626|NCT01326871|323586148|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
94489627|NCT01326871|323586146|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
94489628|NCT01326871|323586147|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
94489629|NCT01326871|323586148|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
94489630|NCT01326871|323586146|FG000|Overall Study|Withdrawal by Subject|0|||
94489631|NCT01326871|323586147|FG001|Overall Study|Withdrawal by Subject|1|||
94489632|NCT01326871|323586148|FG002|Overall Study|Withdrawal by Subject|0|||
94489633|NCT01326871|323586146|FG000|Overall Study|DLT|0|||
94489634|NCT01326871|323586147|FG001|Overall Study|DLT|2|||
94489635|NCT01326871|323586148|FG002|Overall Study|DLT|0|||
94489636|NCT01326871|323586146|FG000|Overall Study|SAE, disease progression and subject decision|0|||
94489637|NCT01326871|323586147|FG001|Overall Study|SAE, disease progression and subject decision|1|||
94489638|NCT01326871|323586148|FG002|Overall Study|SAE, disease progression and subject decision|0|||
94489639|NCT01326871|323586146|FG000|Overall Study|Death|0|||
94489640|NCT01326871|323586147|FG001|Overall Study|Death|1|||
94489641|NCT01326871|323586148|FG002|Overall Study|Death|0|||
94489642|NCT01326871|323586146|FG000|Overall Study|Other|0|||
94489643|NCT01326871|323586147|FG001|Overall Study|Other|3|||
94489644|NCT01326871|323586148|FG002|Overall Study|Other|0|||
94489645|NCT01326871|323586146|FG000|Overall Study|SAE and disease progression|0|||
94489646|NCT01326871|323586147|FG001|Overall Study|SAE and disease progression|0|||
94489647|NCT01326871|323586148|FG002|Overall Study|SAE and disease progression|1|||
94489648|NCT01326871|323586146|FG000|Overall Study|SAE and physician decision|0|||
94489649|NCT01326871|323586147|FG001|Overall Study|SAE and physician decision|0|||
94489650|NCT01326871|323586148|FG002|Overall Study|SAE and physician decision|1|||
94489651|NCT01326871|323586146|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
94489652|NCT01326871|323586147|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
94489653|NCT01326871|323586148|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
94489654|NCT01326871|323586146|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
94489655|NCT01326871|323586147|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
94489656|NCT01326871|323586148|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
94489657|NCT01326871|323586146|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
94489658|NCT01326871|323586147|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
94489659|NCT01326871|323586148|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
94489660|NCT01326871|323586146|FG000|Overall Study|Physician Decision|0|||
94489661|NCT01326871|323586147|FG001|Overall Study|Physician Decision|0|||
94489662|NCT01326871|323586148|FG002|Overall Study|Physician Decision|1|||
94489663|NCT01326871|323586146|FG000|Overall Study|SAE|0|||
94489664|NCT01326871|323586147|FG001|Overall Study|SAE|0|||
94489665|NCT01326871|323586148|FG002|Overall Study|SAE|1|||
94489666|NCT01326871|323586146|FG000|Overall Study|Disease progression and death|0|||
94489667|NCT01326871|323586147|FG001|Overall Study|Disease progression and death|0|||
94489668|NCT01326871|323586148|FG002|Overall Study|Disease progression and death|1|||
94489669|NCT01326871|323586146|FG000|Overall Study|Subject decision|0|||
94489670|NCT01326871|323586147|FG001|Overall Study|Subject decision|0|||
94489671|NCT01326871|323586148|FG002|Overall Study|Subject decision|1|||
94489672|NCT01981616|323586149|FG000|Overall Study|Adverse Event|0|||
94489673|NCT01981616|323586150|FG001|Overall Study|Adverse Event|1|||
94489674|NCT01981616|323586149|FG000|Overall Study|Protocol Violation|1|||
94489675|NCT01981616|323586150|FG001|Overall Study|Protocol Violation|0|||
94489676|NCT03642990|323586151|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
94489677|NCT03642990|323586151|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
94489678|NCT01420536|323586153|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
94489679|NCT01420536|323586154|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
94489680|NCT02781324|323586160|FG000|Overall Study|Withdrawal by Subject|1|||
94489681|NCT02781324|323586161|FG001|Overall Study|Withdrawal by Subject|0|||
94489682|NCT02781324|323586160|FG000|Overall Study|Physician Decision|1|||
94489683|NCT02781324|323586161|FG001|Overall Study|Physician Decision|2|||
94489684|NCT02160626|323586162|FG000|Overall Study|Adverse Event|1|||
94489685|NCT02160626|323586163|FG001|Overall Study|Adverse Event|0|||
94489686|NCT02160626|323586164|FG002|Overall Study|Adverse Event|0|||
94655537|NCT00927927|324196065|FG005|Overall Study|Withdrawal by Subject|0|||
94655538|NCT00927927|324196066|FG006|Overall Study|Withdrawal by Subject|0|||
94426762|NCT00761865|323347104|FG001|Overall Study|Lost to Follow-up|7|||
94426763|NCT00319982|323347105|FG000|Overall Study|Withdrawal by Subject|1|||
94426764|NCT00319982|323347106|FG001|Overall Study|Withdrawal by Subject|0|||
94426765|NCT00259272|323347109|FG000|Overall Study|Adverse Event|2|||
94426766|NCT00259272|323347110|FG001|Overall Study|Adverse Event|1|||
94426767|NCT00259272|323347111|FG002|Overall Study|Adverse Event|0|||
94426768|NCT00259272|323347112|FG003|Overall Study|Adverse Event|3|||
94426769|NCT00259272|323347109|FG000|Overall Study|Lack of Efficacy|5|||
94426770|NCT00259272|323347110|FG001|Overall Study|Lack of Efficacy|1|||
94426771|NCT00259272|323347111|FG002|Overall Study|Lack of Efficacy|2|||
94426772|NCT00259272|323347112|FG003|Overall Study|Lack of Efficacy|6|||
94426773|NCT00259272|323347109|FG000|Overall Study|Physician Decision|1|||
94426774|NCT00259272|323347110|FG001|Overall Study|Physician Decision|2|||
94426775|NCT00259272|323347111|FG002|Overall Study|Physician Decision|1|||
94426776|NCT00259272|323347112|FG003|Overall Study|Physician Decision|3|||
94426777|NCT00259272|323347109|FG000|Overall Study|Protocol Violation|2|||
94426778|NCT00259272|323347110|FG001|Overall Study|Protocol Violation|0|||
94426779|NCT00259272|323347111|FG002|Overall Study|Protocol Violation|0|||
94426780|NCT00259272|323347112|FG003|Overall Study|Protocol Violation|1|||
94426781|NCT00259272|323347109|FG000|Overall Study|Sponsor Decision|0|||
94426782|NCT00259272|323347110|FG001|Overall Study|Sponsor Decision|1|||
94426783|NCT00259272|323347111|FG002|Overall Study|Sponsor Decision|0|||
94426784|NCT00259272|323347112|FG003|Overall Study|Sponsor Decision|0|||
94426785|NCT00259272|323347109|FG000|Overall Study|Withdrawal by Subject|4|||
94426786|NCT00259272|323347110|FG001|Overall Study|Withdrawal by Subject|2|||
94426787|NCT00259272|323347111|FG002|Overall Study|Withdrawal by Subject|2|||
94426788|NCT00259272|323347112|FG003|Overall Study|Withdrawal by Subject|7|||
94426789|NCT00259272|323347109|FG000|Overall Study|Lost to Follow-up|1|||
94426790|NCT00259272|323347110|FG001|Overall Study|Lost to Follow-up|0|||
94426791|NCT00259272|323347111|FG002|Overall Study|Lost to Follow-up|0|||
94426792|NCT00259272|323347112|FG003|Overall Study|Lost to Follow-up|1|||
94426793|NCT00574912|323347113|FG000|Overall Study|Could not place IV lines.|3|||
94426794|NCT00574912|323347113|FG000|Overall Study|scheduling conflicts|3|||
94426795|NCT00574912|323347113|FG000|Overall Study|Physician Decision|2|||
94426796|NCT04555720|323347116|FG000|Overall Study|Lost to Follow-up|2|||
94426797|NCT04555720|323347117|FG001|Overall Study|Lost to Follow-up|0|||
94426798|NCT04555720|323347118|FG002|Overall Study|Lost to Follow-up|0|||
94426799|NCT04555720|323347119|FG003|Overall Study|Lost to Follow-up|0|||
94426800|NCT04555720|323347116|FG000|Overall Study|Withdrawal by Subject|4|||
94426801|NCT04555720|323347117|FG001|Overall Study|Withdrawal by Subject|6|||
94426802|NCT04555720|323347118|FG002|Overall Study|Withdrawal by Subject|0|||
94426803|NCT04555720|323347119|FG003|Overall Study|Withdrawal by Subject|0|||
94426804|NCT00968799|323347120|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
94426805|NCT01104779|323347121|FG000|Overall Study|Protocol Violation|1|||
94426806|NCT01104779|323347122|FG001|Overall Study|Protocol Violation|2|||
94426807|NCT01104779|323347123|FG002|Overall Study|Protocol Violation|2|||
94426808|NCT01104779|323347121|FG000|Overall Study|Lack of Efficacy|26|||
94426809|NCT01104779|323347122|FG001|Overall Study|Lack of Efficacy|12|||
94426810|NCT01104779|323347123|FG002|Overall Study|Lack of Efficacy|13|||
94426811|NCT01104779|323347121|FG000|Overall Study|Adverse Event|13|||
94426812|NCT01104779|323347122|FG001|Overall Study|Adverse Event|14|||
94426813|NCT01104779|323347123|FG002|Overall Study|Adverse Event|13|||
94426814|NCT01104779|323347121|FG000|Overall Study|Did not meet inc/exc criteria|1|||
94426815|NCT01104779|323347122|FG001|Overall Study|Did not meet inc/exc criteria|1|||
94426816|NCT01104779|323347123|FG002|Overall Study|Did not meet inc/exc criteria|1|||
94426817|NCT01104779|323347121|FG000|Overall Study|Other reasons|0|||
94426818|NCT01104779|323347122|FG001|Overall Study|Other reasons|1|||
94426819|NCT01104779|323347123|FG002|Overall Study|Other reasons|0|||
94426820|NCT01104779|323347121|FG000|Overall Study|Lost to Follow-up|2|||
94426821|NCT01104779|323347122|FG001|Overall Study|Lost to Follow-up|0|||
94426822|NCT01104779|323347123|FG002|Overall Study|Lost to Follow-up|1|||
94426823|NCT01104779|323347121|FG000|Overall Study|Withdrawal by Subject|16|||
94426824|NCT01104779|323347122|FG001|Overall Study|Withdrawal by Subject|25|||
94426825|NCT01104779|323347123|FG002|Overall Study|Withdrawal by Subject|32|||
94426826|NCT02968849|323347126|FG000|Overall Study|Death|8|||
94426827|NCT02968849|323347127|FG001|Overall Study|Death|10|||
94426828|NCT02968849|323347126|FG000|Overall Study|Lost to Follow-up|31|||
94426829|NCT02968849|323347127|FG001|Overall Study|Lost to Follow-up|29|||
94426830|NCT02968849|323347126|FG000|Overall Study|Withdrawal by Subject|73|||
94426831|NCT02968849|323347127|FG001|Overall Study|Withdrawal by Subject|64|||
94489687|NCT02160626|323586162|FG000|Overall Study|Schedule not conducive to study visits|0|||
94426832|NCT02968849|323347126|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
94426833|NCT02968849|323347127|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
94426834|NCT02968849|323347126|FG000|Overall Study|Physician Decision|6|||
94489688|NCT02160626|323586163|FG001|Overall Study|Schedule not conducive to study visits|0|||
94426835|NCT02968849|323347127|FG001|Overall Study|Physician Decision|9|||
94426836|NCT02968849|323347126|FG000|Overall Study|Other|16|||
94426837|NCT02968849|323347127|FG001|Overall Study|Other|10|||
94426838|NCT00416884|323347128|FG000|Overall Study|Study terminated due to low accrual|1|||
94426839|NCT01496976|323348338|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
94426840|NCT03611543|323348349|FG000|Overall Study|Withdrawal by Subject|4|||
94426841|NCT03611543|323348350|FG001|Overall Study|Withdrawal by Subject|4|||
94426842|NCT03611543|323348349|FG000|Overall Study|Physician Decision|1|||
94426843|NCT03611543|323348350|FG001|Overall Study|Physician Decision|1|||
94426844|NCT03611543|323348349|FG000|Overall Study|Protocol Violation|2|||
94426845|NCT03611543|323348350|FG001|Overall Study|Protocol Violation|2|||
94426846|NCT03611543|323348349|FG000|Overall Study|Device failure|2|||
94426847|NCT03611543|323348350|FG001|Overall Study|Device failure|2|||
94426848|NCT03611543|323348349|FG000|Overall Study|Missing information|5|||
94426849|NCT03611543|323348350|FG001|Overall Study|Missing information|5|||
94426850|NCT06077487|323348351|FG000|Overall Study|Withdrawal by Subject|0|||
94426851|NCT06077487|323348352|FG001|Overall Study|Withdrawal by Subject|1|||
94426852|NCT01682863|323348353|FG000|Overall Study|Subject/guardian decision|19|||
94426853|NCT01682863|323348354|FG001|Overall Study|Subject/guardian decision|12|||
94426854|NCT01682863|323348355|FG002|Overall Study|Subject/guardian decision|10|||
94426855|NCT01682863|323348353|FG000|Overall Study|Lost to Follow-up|5|||
94426856|NCT01682863|323348354|FG001|Overall Study|Lost to Follow-up|1|||
94426857|NCT01682863|323348355|FG002|Overall Study|Lost to Follow-up|6|||
94426858|NCT01682863|323348353|FG000|Overall Study|Death|1|||
94426859|NCT01682863|323348354|FG001|Overall Study|Death|3|||
94426860|NCT01682863|323348355|FG002|Overall Study|Death|4|||
94426861|NCT01682863|323348353|FG000|Overall Study|Protocol deviation|1|||
94426862|NCT01682863|323348354|FG001|Overall Study|Protocol deviation|0|||
94426863|NCT01682863|323348355|FG002|Overall Study|Protocol deviation|1|||
94426864|NCT01682863|323348353|FG000|Overall Study|Technical problems|1|||
94426865|NCT01682863|323348354|FG001|Overall Study|Technical problems|0|||
94426866|NCT01682863|323348355|FG002|Overall Study|Technical problems|0|||
94426867|NCT01682863|323348353|FG000|Overall Study|Adverse Event|0|||
94426868|NCT01682863|323348354|FG001|Overall Study|Adverse Event|1|||
94426869|NCT01682863|323348355|FG002|Overall Study|Adverse Event|2|||
94426870|NCT01682863|323348353|FG000|Overall Study|Physician Decision|0|||
94426871|NCT01682863|323348354|FG001|Overall Study|Physician Decision|0|||
94426872|NCT01682863|323348355|FG002|Overall Study|Physician Decision|1|||
94426873|NCT03196635|323348358|FG000|Overall Study|Withdrawal by Subject|1|||
94426874|NCT00380744|323348359|FG000|Overall Study|Death|0|||
94426875|NCT00380744|323348360|FG001|Overall Study|Death|0|||
94426876|NCT00380744|323348361|FG002|Overall Study|Death|0|||
94426877|NCT00380744|323348362|FG003|Overall Study|Death|0|||
94426878|NCT00380744|323348363|FG004|Overall Study|Death|0|||
94426879|NCT00380744|323348364|FG005|Overall Study|Death|0|||
94426880|NCT00380744|323348365|FG006|Overall Study|Death|1|||
94426881|NCT00380744|323348359|FG000|Overall Study|Withdrawal by Subject|1|||
94426882|NCT00380744|323348360|FG001|Overall Study|Withdrawal by Subject|0|||
94426883|NCT00380744|323348361|FG002|Overall Study|Withdrawal by Subject|0|||
94426884|NCT00380744|323348362|FG003|Overall Study|Withdrawal by Subject|0|||
94426885|NCT00380744|323348363|FG004|Overall Study|Withdrawal by Subject|0|||
94426886|NCT00380744|323348364|FG005|Overall Study|Withdrawal by Subject|0|||
94426887|NCT00380744|323348365|FG006|Overall Study|Withdrawal by Subject|0|||
94426888|NCT00077857|323348366|FG000|Overall Study|Adverse Event|30|||
94426889|NCT00077857|323348367|FG001|Overall Study|Adverse Event|32|||
94426890|NCT00077857|323348366|FG000|Overall Study|Death|7|||
94426891|NCT00077857|323348367|FG001|Overall Study|Death|3|||
94426892|NCT00077857|323348366|FG000|Overall Study|Insufficient therapeutic response|112|||
94426893|NCT00077857|323348367|FG001|Overall Study|Insufficient therapeutic response|128|||
94426894|NCT00077857|323348366|FG000|Overall Study|Violation of selection criteria at entry|3|||
94426895|NCT00077857|323348367|FG001|Overall Study|Violation of selection criteria at entry|1|||
94426896|NCT00077857|323348366|FG000|Overall Study|Other protocol violation|0|||
94426897|NCT00077857|323348367|FG001|Overall Study|Other protocol violation|1|||
94426898|NCT00077857|323348366|FG000|Overall Study|Refused treatment|29|||
94426899|NCT00077857|323348367|FG001|Overall Study|Refused treatment|21|||
94426900|NCT00077857|323348366|FG000|Overall Study|Failure to return|5|||
94426901|NCT00077857|323348367|FG001|Overall Study|Failure to return|5|||
94426902|NCT00077857|323348366|FG000|Overall Study|Other|15|||
94426903|NCT00077857|323348367|FG001|Overall Study|Other|13|||
94426904|NCT05084963|323348371|FG000|Overall Study|Withdrawal by Subject|0|||
94426905|NCT05084963|323348372|FG001|Overall Study|Withdrawal by Subject|0|||
94426906|NCT05084963|323348373|FG002|Overall Study|Withdrawal by Subject|1|||
94426907|NCT05442866|323348374|FG000|Overall Study|Death|1|||
94426908|NCT05442866|323348374|FG000|Overall Study|Lost to Follow-up|9|||
94426909|NCT05442866|323348374|FG000|Overall Study|Protocol Violation|1|||
94426910|NCT03283761|323348375|FG000|Study Treatment|Patient Non-Compliance|1|||
94426911|NCT03283761|323348375|FG000|Study Treatment|Alternative Cancer Therapy|7|||
94426912|NCT03283761|323348375|FG000|Study Treatment|Disease progression|21|||
94426913|NCT03283761|323348375|FG000|Study Treatment|Adverse Event|3|||
94426914|NCT03283761|323348375|FG000|Study Treatment|Withdrawal by Subject|4|||
94426915|NCT03283761|323348375|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
94426916|NCT03283761|323348375|FG000|Study Treatment|Symptomatic Deterioration|1|||
94426917|NCT03283761|323348375|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
94426918|NCT03283761|323348375|FG000|Follow up|Lost to Follow-up|1|||
94426919|NCT03283761|323348375|FG000|Follow up|Symptomatic Deterioration|1|||
94426920|NCT03283761|323348375|FG000|Follow up|Death|29|||
94426921|NCT03283761|323348375|FG000|Follow up|study terminated|4|||
94426922|NCT03283761|323348375|FG000|Follow up|Primary Investigator Withdrawal|1|||
94426923|NCT03283761|323348375|FG000|Follow up|Switched to alternative therapy|1|||
94426924|NCT03283761|323348375|FG000|Follow up|Subject is now in Hospice|1|||
94426925|NCT01341782|323348376|FG000|Overall Study|Adverse Event|1|||
94426926|NCT01341782|323348377|FG001|Overall Study|Adverse Event|1|||
94426927|NCT01341782|323348376|FG000|Overall Study|Withdrawal by Subject|6|||
94426928|NCT01341782|323348377|FG001|Overall Study|Withdrawal by Subject|5|||
94426929|NCT01341782|323348376|FG000|Overall Study|Missed 3 consecutive doses|0|||
94426930|NCT01341782|323348377|FG001|Overall Study|Missed 3 consecutive doses|4|||
94426931|NCT01341782|323348376|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
94426932|NCT01341782|323348377|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
94426933|NCT01341782|323348376|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
94426934|NCT01341782|323348377|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
94426935|NCT01341782|323348376|FG000|Overall Study|Other|5|||
94426936|NCT01341782|323348377|FG001|Overall Study|Other|0|||
94426937|NCT00620555|323348380|FG000|Overall Study|Adverse Event|4|||
94426938|NCT00620555|323348380|FG000|Overall Study|Protocol Violation|2|||
94426939|NCT00620555|323348380|FG000|Overall Study|Lack of Efficacy|12|||
94426940|NCT00620555|323348380|FG000|Overall Study|Withdrawal by Subject|1|||
94426941|NCT00620555|323348380|FG000|Overall Study|Choice of other treatment|1|||
94426942|NCT00620555|323348380|FG000|Overall Study|Visit failure against planned|1|||
94426943|NCT04453202|323348381|FG000|Overall Study|Adverse Event|0|||
94426944|NCT04453202|323348382|FG001|Overall Study|Adverse Event|0|||
94426945|NCT04453202|323348383|FG002|Overall Study|Adverse Event|0|||
94426946|NCT04453202|323348384|FG003|Overall Study|Adverse Event|0|||
94426947|NCT04453202|323348385|FG004|Overall Study|Adverse Event|0|||
94426948|NCT04453202|323348386|FG005|Overall Study|Adverse Event|0|||
94426949|NCT04453202|323348387|FG006|Overall Study|Adverse Event|1|||
94426950|NCT04453202|323348388|FG007|Overall Study|Adverse Event|0|||
94426951|NCT04453202|323348389|FG008|Overall Study|Adverse Event|0|||
94426952|NCT04453202|323348390|FG009|Overall Study|Adverse Event|0|||
94426953|NCT04453202|323348391|FG010|Overall Study|Adverse Event|0|||
94426954|NCT04453202|323348381|FG000|Overall Study|Death|0|||
94426955|NCT04453202|323348382|FG001|Overall Study|Death|0|||
94426956|NCT04453202|323348383|FG002|Overall Study|Death|0|||
94426957|NCT04453202|323348384|FG003|Overall Study|Death|0|||
94426958|NCT04453202|323348385|FG004|Overall Study|Death|0|||
94426959|NCT04453202|323348386|FG005|Overall Study|Death|0|||
94426960|NCT04453202|323348387|FG006|Overall Study|Death|0|||
94426961|NCT04453202|323348388|FG007|Overall Study|Death|0|||
94426962|NCT04453202|323348389|FG008|Overall Study|Death|0|||
94426963|NCT04453202|323348390|FG009|Overall Study|Death|1|||
94426964|NCT04453202|323348391|FG010|Overall Study|Death|0|||
94426965|NCT04453202|323348381|FG000|Overall Study|Lost to Follow-up|0|||
94426966|NCT04453202|323348382|FG001|Overall Study|Lost to Follow-up|1|||
94426967|NCT04453202|323348383|FG002|Overall Study|Lost to Follow-up|0|||
94426968|NCT04453202|323348384|FG003|Overall Study|Lost to Follow-up|1|||
94426969|NCT04453202|323348385|FG004|Overall Study|Lost to Follow-up|0|||
94426970|NCT04453202|323348386|FG005|Overall Study|Lost to Follow-up|0|||
94426971|NCT04453202|323348387|FG006|Overall Study|Lost to Follow-up|0|||
94426972|NCT04453202|323348388|FG007|Overall Study|Lost to Follow-up|0|||
94426973|NCT04453202|323348389|FG008|Overall Study|Lost to Follow-up|0|||
94426974|NCT04453202|323348390|FG009|Overall Study|Lost to Follow-up|1|||
94426975|NCT04453202|323348391|FG010|Overall Study|Lost to Follow-up|1|||
94426976|NCT04453202|323348381|FG000|Overall Study|Withdrawal by Subject|1|||
94426977|NCT04453202|323348382|FG001|Overall Study|Withdrawal by Subject|2|||
94426978|NCT04453202|323348383|FG002|Overall Study|Withdrawal by Subject|1|||
94426979|NCT04453202|323348384|FG003|Overall Study|Withdrawal by Subject|2|||
94426980|NCT04453202|323348385|FG004|Overall Study|Withdrawal by Subject|1|||
94426981|NCT04453202|323348386|FG005|Overall Study|Withdrawal by Subject|1|||
94426982|NCT04453202|323348387|FG006|Overall Study|Withdrawal by Subject|0|||
94426983|NCT04453202|323348388|FG007|Overall Study|Withdrawal by Subject|0|||
94426984|NCT04453202|323348389|FG008|Overall Study|Withdrawal by Subject|0|||
94426985|NCT04453202|323348390|FG009|Overall Study|Withdrawal by Subject|1|||
94426986|NCT04453202|323348391|FG010|Overall Study|Withdrawal by Subject|0|||
94426987|NCT04453202|323348381|FG000|Overall Study|Adverse Event|0|||
94426988|NCT04453202|323348382|FG001|Overall Study|Adverse Event|0|||
94489689|NCT02160626|323586164|FG002|Overall Study|Schedule not conducive to study visits|1|||
94489690|NCT02160626|323586162|FG000|Overall Study|Withdrawal by Subject|0|||
94426989|NCT04453202|323348383|FG002|Overall Study|Adverse Event|0|||
94426990|NCT04453202|323348384|FG003|Overall Study|Adverse Event|0|||
94426991|NCT04453202|323348385|FG004|Overall Study|Adverse Event|0|||
94426992|NCT04453202|323348386|FG005|Overall Study|Adverse Event|1|||
94426993|NCT04453202|323348387|FG006|Overall Study|Adverse Event|0|||
94426994|NCT04453202|323348388|FG007|Overall Study|Adverse Event|0|||
94426995|NCT04453202|323348389|FG008|Overall Study|Adverse Event|0|||
94426996|NCT04453202|323348390|FG009|Overall Study|Adverse Event|0|||
94426997|NCT04453202|323348391|FG010|Overall Study|Adverse Event|0|||
94426998|NCT04874155|323348392|FG000|Overall Study|Lost to Follow-up|1|||
94426999|NCT04874155|323348393|FG001|Overall Study|Lost to Follow-up|1|||
94427000|NCT04874155|323348392|FG000|Overall Study|Withdrawal by Subject|2|||
94427001|NCT04874155|323348393|FG001|Overall Study|Withdrawal by Subject|2|||
94427002|NCT02329847|323348394|FG000|Overall Study|Death|4|||
94427003|NCT02329847|323348395|FG001|Overall Study|Death|4|||
94427004|NCT02329847|323348396|FG002|Overall Study|Death|22|||
94427005|NCT02329847|323348397|FG003|Overall Study|Death|12|||
94427006|NCT02329847|323348398|FG004|Overall Study|Death|20|||
94427007|NCT02329847|323348399|FG005|Overall Study|Death|13|||
94427008|NCT02329847|323348394|FG000|Overall Study|Lost to Follow-up|0|||
94427009|NCT02329847|323348395|FG001|Overall Study|Lost to Follow-up|0|||
94427010|NCT02329847|323348396|FG002|Overall Study|Lost to Follow-up|2|||
94427011|NCT02329847|323348397|FG003|Overall Study|Lost to Follow-up|3|||
94427012|NCT02329847|323348398|FG004|Overall Study|Lost to Follow-up|0|||
94427013|NCT02329847|323348399|FG005|Overall Study|Lost to Follow-up|1|||
94427014|NCT02329847|323348394|FG000|Overall Study|Physician Decision|0|||
94427015|NCT02329847|323348395|FG001|Overall Study|Physician Decision|0|||
94427016|NCT02329847|323348396|FG002|Overall Study|Physician Decision|0|||
94427017|NCT02329847|323348397|FG003|Overall Study|Physician Decision|0|||
94427018|NCT02329847|323348398|FG004|Overall Study|Physician Decision|1|||
94427019|NCT02329847|323348399|FG005|Overall Study|Physician Decision|0|||
94427020|NCT02329847|323348394|FG000|Overall Study|Withdrawal by Subject|2|||
94427021|NCT02329847|323348395|FG001|Overall Study|Withdrawal by Subject|1|||
94427022|NCT02329847|323348396|FG002|Overall Study|Withdrawal by Subject|5|||
94427023|NCT02329847|323348397|FG003|Overall Study|Withdrawal by Subject|7|||
94427024|NCT02329847|323348398|FG004|Overall Study|Withdrawal by Subject|8|||
94427025|NCT02329847|323348399|FG005|Overall Study|Withdrawal by Subject|3|||
94427026|NCT02329847|323348394|FG000|Overall Study|Other|1|||
94427027|NCT02329847|323348395|FG001|Overall Study|Other|2|||
94427028|NCT02329847|323348396|FG002|Overall Study|Other|6|||
94427029|NCT02329847|323348397|FG003|Overall Study|Other|13|||
94427030|NCT02329847|323348398|FG004|Overall Study|Other|10|||
94427031|NCT02329847|323348399|FG005|Overall Study|Other|3|||
94427032|NCT03290079|323348400|FG000|Overall Study|Death|2|||
94427033|NCT05293639|323348401|FG000|Overall Study|Withdrawal by Subject|1|||
94427034|NCT05293639|323348402|FG001|Overall Study|Withdrawal by Subject|1|||
94427035|NCT05293639|323348403|FG002|Overall Study|Withdrawal by Subject|2|||
94427036|NCT05293639|323348401|FG000|Overall Study|Death|0|||
94427037|NCT05293639|323348402|FG001|Overall Study|Death|1|||
94427038|NCT05293639|323348403|FG002|Overall Study|Death|0|||
94427039|NCT05293639|323348401|FG000|Overall Study|Lost to Follow-up|0|||
94427040|NCT05293639|323348402|FG001|Overall Study|Lost to Follow-up|0|||
94427041|NCT05293639|323348403|FG002|Overall Study|Lost to Follow-up|5|||
94427042|NCT05293639|323348401|FG000|Overall Study|Other|0|||
94427043|NCT05293639|323348402|FG001|Overall Study|Other|0|||
94427044|NCT05293639|323348403|FG002|Overall Study|Other|1|||
94427045|NCT00827632|323348404|FG000|Overall Study|Lost to Follow-up|8|||
94427046|NCT00827632|323348405|FG001|Overall Study|Lost to Follow-up|12|||
94427047|NCT00827632|323348404|FG000|Overall Study|Early withdrawal|14|||
94427048|NCT00827632|323348405|FG001|Overall Study|Early withdrawal|11|||
94427049|NCT00418821|323348412|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
94427050|NCT02823652|323348419|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
94427051|NCT02823652|323348420|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
94489691|NCT02160626|323586163|FG001|Overall Study|Withdrawal by Subject|1|||
94489692|NCT02160626|323586164|FG002|Overall Study|Withdrawal by Subject|0|||
94489693|NCT03353220|323586167|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
94427052|NCT02823652|323348421|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
94427053|NCT02823652|323348419|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
94427054|NCT02823652|323348420|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
94427055|NCT02823652|323348421|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
94427056|NCT02823652|323348419|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
94489694|NCT03353220|323586168|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
94489695|NCT00666237|323586169|FG000|Overall Study|Death|5|||
94489696|NCT00666237|323586170|FG001|Overall Study|Death|5|||
94427057|NCT02823652|323348420|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
94427058|NCT02823652|323348421|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
94427059|NCT02823652|323348419|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
94427060|NCT02823652|323348420|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
94427061|NCT02823652|323348421|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
94427062|NCT03567382|323348424|FG000|Overall Study|Lost to Follow-up|1|||
94427063|NCT03567382|323348425|FG001|Overall Study|Lost to Follow-up|21|||
94489697|NCT00666237|323586169|FG000|Overall Study|Lost to Follow-up|29|||
94427064|NCT03567382|323348426|FG002|Overall Study|Lost to Follow-up|1|||
94427065|NCT03567382|323348427|FG003|Overall Study|Lost to Follow-up|21|||
94427066|NCT03567382|323348424|FG000|Overall Study|Withdrawal by Subject|2|||
94427067|NCT03567382|323348425|FG001|Overall Study|Withdrawal by Subject|14|||
94427068|NCT03567382|323348426|FG002|Overall Study|Withdrawal by Subject|1|||
94427069|NCT03567382|323348427|FG003|Overall Study|Withdrawal by Subject|12|||
94427070|NCT01197755|323348428|FG000|Overall Study|Adverse Event|8|||
94427071|NCT01197755|323348429|FG001|Overall Study|Adverse Event|10|||
94427072|NCT01197755|323348430|FG002|Overall Study|Adverse Event|10|||
94427073|NCT01197755|323348428|FG000|Overall Study|Study-specific discontinuation criteria|2|||
94427074|NCT01197755|323348429|FG001|Overall Study|Study-specific discontinuation criteria|1|||
94427075|NCT01197755|323348430|FG002|Overall Study|Study-specific discontinuation criteria|0|||
94427076|NCT01197755|323348428|FG000|Overall Study|Entered the long-term extension study|18|||
94427077|NCT01197755|323348429|FG001|Overall Study|Entered the long-term extension study|21|||
94427078|NCT01197755|323348430|FG002|Overall Study|Entered the long-term extension study|35|||
94427079|NCT01197755|323348428|FG000|Overall Study|Lack of therapeutic response|0|||
94427080|NCT01197755|323348429|FG001|Overall Study|Lack of therapeutic response|7|||
94427081|NCT01197755|323348430|FG002|Overall Study|Lack of therapeutic response|4|||
94427082|NCT01197755|323348428|FG000|Overall Study|Severe non-compliance to the protocol|2|||
94427083|NCT01197755|323348429|FG001|Overall Study|Severe non-compliance to the protocol|1|||
94427084|NCT01197755|323348430|FG002|Overall Study|Severe non-compliance to the protocol|2|||
94427085|NCT01197755|323348428|FG000|Overall Study|Withdrawal by Subject|1|||
94427086|NCT01197755|323348429|FG001|Overall Study|Withdrawal by Subject|0|||
94427087|NCT01197755|323348430|FG002|Overall Study|Withdrawal by Subject|0|||
94427088|NCT01197755|323348428|FG000|Overall Study|Lost to Follow-up|0|||
94427089|NCT01197755|323348429|FG001|Overall Study|Lost to Follow-up|0|||
94427090|NCT01197755|323348430|FG002|Overall Study|Lost to Follow-up|1|||
94427091|NCT01197755|323348428|FG000|Overall Study|eg, change in circumstances|7|||
94427092|NCT01197755|323348429|FG001|Overall Study|eg, change in circumstances|3|||
94427093|NCT01197755|323348430|FG002|Overall Study|eg, change in circumstances|2|||
94427094|NCT03582826|323348433|FG000|Overall Study|Lost to Follow-up|39|||
94427095|NCT03582826|323348434|FG001|Overall Study|Lost to Follow-up|0|||
94427096|NCT03582826|323348433|FG000|Overall Study|Withdrawal by Subject|2|||
94427097|NCT03582826|323348434|FG001|Overall Study|Withdrawal by Subject|0|||
94427098|NCT02269163|323348435|FG000|Overall Study|Lost to Follow-up|1|||
94427099|NCT02269163|323348436|FG001|Overall Study|Lost to Follow-up|0|||
94427100|NCT02269163|323348435|FG000|Overall Study|Major protocol violation|0|||
94427101|NCT02269163|323348436|FG001|Overall Study|Major protocol violation|1|||
94427102|NCT02269163|323348435|FG000|Overall Study|Other|2|||
94427103|NCT02269163|323348436|FG001|Overall Study|Other|2|||
94427104|NCT02269163|323348435|FG000|Overall Study|Withdrawal by Subject|0|||
94427105|NCT02269163|323348436|FG001|Overall Study|Withdrawal by Subject|3|||
94427106|NCT02269163|323348435|FG000|Overall Study|Physician Decision|0|||
94427107|NCT02269163|323348436|FG001|Overall Study|Physician Decision|1|||
94427108|NCT02056392|323348439|FG000|Overall Study|Lost to Follow-up|0|||
94427109|NCT02056392|323348440|FG001|Overall Study|Lost to Follow-up|1|||
94427110|NCT02056392|323348441|FG002|Overall Study|Lost to Follow-up|2|||
94427111|NCT02056392|323348442|FG003|Overall Study|Lost to Follow-up|0|||
94427112|NCT02056392|323348443|FG004|Overall Study|Lost to Follow-up|0|||
94427113|NCT02056392|323348444|FG005|Overall Study|Lost to Follow-up|0|||
94427114|NCT02056392|323348439|FG000|Overall Study|Protocol Violation|1|||
94427115|NCT02056392|323348440|FG001|Overall Study|Protocol Violation|0|||
94427116|NCT02056392|323348441|FG002|Overall Study|Protocol Violation|1|||
94427117|NCT02056392|323348442|FG003|Overall Study|Protocol Violation|0|||
94427118|NCT02056392|323348443|FG004|Overall Study|Protocol Violation|0|||
94427119|NCT02056392|323348444|FG005|Overall Study|Protocol Violation|0|||
94427120|NCT02056392|323348439|FG000|Overall Study|Withdrawal by Subject|1|||
94427121|NCT02056392|323348440|FG001|Overall Study|Withdrawal by Subject|0|||
94427122|NCT02056392|323348441|FG002|Overall Study|Withdrawal by Subject|0|||
94427123|NCT02056392|323348442|FG003|Overall Study|Withdrawal by Subject|0|||
94489698|NCT00666237|323586170|FG001|Overall Study|Lost to Follow-up|25|||
94427124|NCT02056392|323348443|FG004|Overall Study|Withdrawal by Subject|1|||
94427125|NCT02056392|323348444|FG005|Overall Study|Withdrawal by Subject|0|||
94427126|NCT03480386|323348445|FG000|Overall Study|Did not complete measures at 3-months|17|||
94427127|NCT03480386|323348446|FG001|Overall Study|Did not complete measures at 3-months|14|||
94427128|NCT03480386|323348445|FG000|Overall Study|No baseline measures|11|||
94427129|NCT03480386|323348446|FG001|Overall Study|No baseline measures|14|||
94427130|NCT03480386|323348445|FG000|Overall Study|Death|0|||
94427131|NCT03480386|323348446|FG001|Overall Study|Death|5|||
94427132|NCT03480386|323348445|FG000|Overall Study|Withdrawal by Subject|12|||
94427133|NCT03480386|323348446|FG001|Overall Study|Withdrawal by Subject|8|||
94427134|NCT03480386|323348445|FG000|Overall Study|Lost to Follow-up|2|||
94427135|NCT03480386|323348446|FG001|Overall Study|Lost to Follow-up|1|||
94427136|NCT03480386|323348445|FG000|Overall Study|Complicating disease|0|||
94427137|NCT03480386|323348446|FG001|Overall Study|Complicating disease|1|||
94489699|NCT03321721|323586171|FG000|Overall Study|Lost to Follow-up|4|||
94427138|NCT03480386|323348445|FG000|Overall Study|Disease progression|3|||
94427139|NCT03480386|323348446|FG001|Overall Study|Disease progression|0|||
94427140|NCT03480386|323348445|FG000|Overall Study|Became ineligible|0|||
94427141|NCT03480386|323348446|FG001|Overall Study|Became ineligible|2|||
94427142|NCT04730349|323348454|FG000|Overall Study|Participant withdrew consent|1|||
94427143|NCT04730349|323348455|FG001|Overall Study|Participant withdrew consent|0|||
94427144|NCT04730349|323348454|FG000|Overall Study|Disease progression|6|||
94427145|NCT04730349|323348455|FG001|Overall Study|Disease progression|4|||
94427146|NCT04730349|323348454|FG000|Overall Study|Study drug toxicity|0|||
94427147|NCT04730349|323348455|FG001|Overall Study|Study drug toxicity|1|||
94427148|NCT00638027|323348458|FG000|Overall Study|Adverse Event|0|||
94427149|NCT00638027|323348459|FG001|Overall Study|Adverse Event|2|||
94427150|NCT00371397|323348461|FG000|Session 1|Withdrawal by Subject|1|||
94427151|NCT00371397|323348462|FG001|Session 1|Withdrawal by Subject|0|||
94427152|NCT00371397|323348463|FG002|Session 1|Withdrawal by Subject|0|||
94427153|NCT00371397|323348464|FG003|Session 1|Withdrawal by Subject|0|||
94427154|NCT00371397|323348465|FG004|Session 1|Withdrawal by Subject|0|||
94427155|NCT00371397|323348466|FG005|Session 1|Withdrawal by Subject|0|||
94427156|NCT00371397|323348467|FG006|Session 1|Withdrawal by Subject|0|||
94427157|NCT00371397|323348468|FG007|Session 1|Withdrawal by Subject|1|||
94427158|NCT00371397|323348469|FG008|Session 1|Withdrawal by Subject|0|||
94427159|NCT00371397|323348470|FG009|Session 1|Withdrawal by Subject|0|||
94427160|NCT00371397|323348471|FG010|Session 1|Withdrawal by Subject|0|||
94427161|NCT00371397|323348472|FG011|Session 1|Withdrawal by Subject|0|||
94427162|NCT03014180|323348473|FG000|Overall Study|Protocol Violation|2|||
94427163|NCT02802631|323348474|FG000|Overall Study|Withdrawal by Subject|1|||
94427164|NCT02802631|323348475|FG001|Overall Study|Withdrawal by Subject|0|||
94427165|NCT02802631|323348476|FG002|Overall Study|Withdrawal by Subject|0|||
94427166|NCT02802631|323348477|FG003|Overall Study|Withdrawal by Subject|0|||
94427167|NCT02802631|323348478|FG004|Overall Study|Withdrawal by Subject|0|||
94427168|NCT02802631|323348479|FG005|Overall Study|Withdrawal by Subject|0|||
94427169|NCT02802631|323348480|FG006|Overall Study|Withdrawal by Subject|0|||
94427170|NCT02802631|323348481|FG007|Overall Study|Withdrawal by Subject|0|||
94427171|NCT02802631|323348474|FG000|Overall Study|Physician Decision|1|||
94427172|NCT02802631|323348475|FG001|Overall Study|Physician Decision|0|||
94427173|NCT02802631|323348476|FG002|Overall Study|Physician Decision|0|||
94427174|NCT02802631|323348477|FG003|Overall Study|Physician Decision|0|||
94427175|NCT02802631|323348478|FG004|Overall Study|Physician Decision|0|||
94427176|NCT02802631|323348479|FG005|Overall Study|Physician Decision|0|||
94427177|NCT02802631|323348480|FG006|Overall Study|Physician Decision|1|||
94427178|NCT02802631|323348481|FG007|Overall Study|Physician Decision|0|||
94427179|NCT02802631|323348474|FG000|Overall Study|Adverse Event|0|||
94427180|NCT02802631|323348475|FG001|Overall Study|Adverse Event|2|||
94427181|NCT02802631|323348476|FG002|Overall Study|Adverse Event|0|||
94427182|NCT02802631|323348477|FG003|Overall Study|Adverse Event|1|||
94427183|NCT02802631|323348478|FG004|Overall Study|Adverse Event|6|||
94427184|NCT02802631|323348479|FG005|Overall Study|Adverse Event|1|||
94427185|NCT02802631|323348480|FG006|Overall Study|Adverse Event|4|||
94427186|NCT02802631|323348481|FG007|Overall Study|Adverse Event|0|||
94427187|NCT02802631|323348474|FG000|Overall Study|Sponsor Decision|0|||
94427188|NCT02802631|323348475|FG001|Overall Study|Sponsor Decision|0|||
94427189|NCT02802631|323348476|FG002|Overall Study|Sponsor Decision|6|||
94427190|NCT02802631|323348477|FG003|Overall Study|Sponsor Decision|0|||
94427191|NCT02802631|323348478|FG004|Overall Study|Sponsor Decision|2|||
94427192|NCT02802631|323348479|FG005|Overall Study|Sponsor Decision|0|||
94427193|NCT02802631|323348480|FG006|Overall Study|Sponsor Decision|0|||
94427194|NCT02802631|323348481|FG007|Overall Study|Sponsor Decision|4|||
94427195|NCT02377427|323348482|FG000|Part A (Up to Week 20)|Physician Decision|1|||
94427196|NCT02377427|323348483|FG001|Part A (Up to Week 20)|Physician Decision|0|||
94427197|NCT02377427|323348484|FG002|Part A (Up to Week 20)|Physician Decision|0|||
94427198|NCT02377427|323348485|FG003|Part A (Up to Week 20)|Physician Decision|0|||
94489700|NCT03321721|323586172|FG001|Overall Study|Lost to Follow-up|8|||
94489701|NCT03321721|323586173|FG002|Overall Study|Lost to Follow-up|11|||
94427199|NCT02377427|323348486|FG004|Part A (Up to Week 20)|Physician Decision|0|||
94427200|NCT02377427|323348482|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
94427201|NCT02377427|323348483|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
94427202|NCT02377427|323348484|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
94427203|NCT02377427|323348485|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
94427204|NCT02377427|323348486|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
94489702|NCT03427892|323588203|FG000|Overall Study|Lost to Follow-up|2|||
94427205|NCT02377427|323348482|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
94427206|NCT02377427|323348483|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
94427207|NCT02377427|323348484|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
94427208|NCT02377427|323348485|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
94427209|NCT02377427|323348486|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
94427210|NCT02377427|323348482|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
94489703|NCT04889040|323588206|FG000|Overall Study|Withdrawal by Subject|3|||
94427211|NCT02377427|323348483|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
94427212|NCT02377427|323348484|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
94427213|NCT02377427|323348485|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
94427214|NCT02377427|323348486|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
94427215|NCT00719849|323348487|FG000|Overall Study|Death|0|||
94427216|NCT00719849|323348488|FG001|Overall Study|Death|1|||
94427217|NCT01372774|323348491|FG000|Overall Study|Withdrawal prior to treatment|4|||
94427218|NCT01372774|323348492|FG001|Overall Study|Withdrawal prior to treatment|5|||
94427219|NCT03462459|323348493|FG000|Overall Study|Death|1|||
94427220|NCT03462459|323348494|FG001|Overall Study|Death|0|||
94427221|NCT03462459|323348493|FG000|Overall Study|Lack of Efficacy|2|||
94427222|NCT03462459|323348494|FG001|Overall Study|Lack of Efficacy|4|||
94427223|NCT03462459|323348493|FG000|Overall Study|Lost to Follow-up|1|||
94427224|NCT03462459|323348494|FG001|Overall Study|Lost to Follow-up|3|||
94427225|NCT03462459|323348493|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
94427226|NCT03462459|323348494|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
94427227|NCT03462459|323348493|FG000|Overall Study|Withdrawal by Subject|3|||
94427228|NCT03462459|323348494|FG001|Overall Study|Withdrawal by Subject|2|||
94427229|NCT03462459|323348493|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
94427230|NCT03462459|323348494|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
94427231|NCT04051619|323348495|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
94427232|NCT04051619|323348496|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
94427233|NCT04051619|323348495|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
94427234|NCT04051619|323348496|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
94427235|NCT00006721|323349725|FG000|Overall Study|Adverse Event|0|||
94427236|NCT00006721|323349726|FG001|Overall Study|Adverse Event|4|||
94427237|NCT00006721|323349727|FG002|Overall Study|Adverse Event|4|||
94427238|NCT00006721|323349725|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
94427239|NCT00006721|323349726|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
94427240|NCT00006721|323349727|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
94427241|NCT00006721|323349725|FG000|Overall Study|Progression/Relapse|0|||
94427242|NCT00006721|323349726|FG001|Overall Study|Progression/Relapse|1|||
94427243|NCT00006721|323349727|FG002|Overall Study|Progression/Relapse|2|||
94427244|NCT00006721|323349725|FG000|Overall Study|Death|0|||
94427245|NCT00006721|323349726|FG001|Overall Study|Death|1|||
94427246|NCT00006721|323349727|FG002|Overall Study|Death|2|||
94427247|NCT00006721|323349725|FG000|Overall Study|Other - Not Protocol Specified|0|||
94427248|NCT00006721|323349726|FG001|Overall Study|Other - Not Protocol Specified|7|||
94427249|NCT00006721|323349727|FG002|Overall Study|Other - Not Protocol Specified|7|||
94427250|NCT00006721|323349725|FG000|Overall Study|Ineligible|2|||
94427251|NCT00006721|323349726|FG001|Overall Study|Ineligible|12|||
94427252|NCT00006721|323349727|FG002|Overall Study|Ineligible|10|||
94427253|NCT00006721|323349725|FG000|Overall Study|Eligible but no Treatment Received|1|||
94427254|NCT00006721|323349726|FG001|Overall Study|Eligible but no Treatment Received|0|||
94427255|NCT00006721|323349727|FG002|Overall Study|Eligible but no Treatment Received|0|||
94427256|NCT03845296|323349728|FG000|Overall Study|On Treatment|2|||
94427257|NCT03845296|323349729|FG001|Overall Study|On Treatment|1|||
94427258|NCT03845296|323349728|FG000|Overall Study|Adverse Event|4|||
94427259|NCT03845296|323349729|FG001|Overall Study|Adverse Event|11|||
94427260|NCT03845296|323349728|FG000|Overall Study|Refusal unrelated to adverse event|0|||
94427261|NCT03845296|323349729|FG001|Overall Study|Refusal unrelated to adverse event|1|||
94427262|NCT03845296|323349728|FG000|Overall Study|Progression/relapse|14|||
94427263|NCT03845296|323349729|FG001|Overall Study|Progression/relapse|18|||
94427264|NCT03845296|323349728|FG000|Overall Study|Death|4|||
94427265|NCT03845296|323349729|FG001|Overall Study|Death|0|||
94427266|NCT03845296|323349728|FG000|Overall Study|Other - not protocol specified|1|||
94427267|NCT03845296|323349729|FG001|Overall Study|Other - not protocol specified|3|||
94427268|NCT05061134|323349730|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
94427269|NCT05061134|323349731|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
94427270|NCT05061134|323349732|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
94427271|NCT05061134|323349730|FG000|Overall Study|Subject not treated|0|||
94427272|NCT05061134|323349731|FG001|Overall Study|Subject not treated|0|||
94427273|NCT05061134|323349732|FG002|Overall Study|Subject not treated|2|||
94427274|NCT05061134|323349730|FG000|Overall Study|Other|0|||
94427275|NCT05061134|323349731|FG001|Overall Study|Other|0|||
94427276|NCT05061134|323349732|FG002|Overall Study|Other|9|||
94427277|NCT05061134|323349730|FG000|Overall Study|Withdrawal by Subject|9|||
94427278|NCT05061134|323349731|FG001|Overall Study|Withdrawal by Subject|8|||
94427279|NCT05061134|323349732|FG002|Overall Study|Withdrawal by Subject|5|||
94427280|NCT05061134|323349730|FG000|Overall Study|Study Terminated by Sponsor|22|||
94427281|NCT05061134|323349731|FG001|Overall Study|Study Terminated by Sponsor|14|||
94427282|NCT05061134|323349732|FG002|Overall Study|Study Terminated by Sponsor|7|||
94427283|NCT05061134|323349730|FG000|Overall Study|Progressive Disease|1|||
94427284|NCT05061134|323349731|FG001|Overall Study|Progressive Disease|2|||
94427285|NCT05061134|323349732|FG002|Overall Study|Progressive Disease|0|||
94427286|NCT05061134|323349730|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
94427287|NCT05061134|323349731|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
94427288|NCT05061134|323349732|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
94427289|NCT05061134|323349730|FG000|Overall Study|Lost to Follow-up|1|||
94427290|NCT05061134|323349731|FG001|Overall Study|Lost to Follow-up|0|||
94427291|NCT05061134|323349732|FG002|Overall Study|Lost to Follow-up|0|||
94427292|NCT05061134|323349730|FG000|Overall Study|Physician Decision|1|||
94427293|NCT05061134|323349731|FG001|Overall Study|Physician Decision|1|||
94427294|NCT05061134|323349732|FG002|Overall Study|Physician Decision|0|||
94427295|NCT05061134|323349730|FG000|Overall Study|Disease progression|1|||
94427296|NCT05061134|323349731|FG001|Overall Study|Disease progression|0|||
94427297|NCT05061134|323349732|FG002|Overall Study|Disease progression|0|||
94427298|NCT05061134|323349730|FG000|Overall Study|Death|43|||
94427299|NCT05061134|323349731|FG001|Overall Study|Death|23|||
94427300|NCT05061134|323349732|FG002|Overall Study|Death|14|||
94427301|NCT05061134|323349730|FG000|Overall Study|Database lock|2|||
94427302|NCT05061134|323349731|FG001|Overall Study|Database lock|0|||
94427303|NCT05061134|323349732|FG002|Overall Study|Database lock|0|||
94427304|NCT04654468|323349733|FG000|Overall Study|Death|1|||
94427305|NCT04654468|323349733|FG000|Overall Study|Ongoing in the Study|50|||
94427306|NCT03186781|323349737|FG000|Overall Study|Lost to Follow-up|0|||
94427307|NCT03186781|323349738|FG001|Overall Study|Lost to Follow-up|0|||
94427308|NCT03186781|323349739|FG002|Overall Study|Lost to Follow-up|1|||
94427309|NCT03186781|323349740|FG003|Overall Study|Lost to Follow-up|0|||
94427310|NCT03186781|323349741|FG004|Overall Study|Lost to Follow-up|1|||
94427311|NCT03186781|323349742|FG005|Overall Study|Lost to Follow-up|0|||
94427312|NCT03186781|323349737|FG000|Overall Study|Moved from Area|0|||
94427313|NCT03186781|323349738|FG001|Overall Study|Moved from Area|0|||
94427314|NCT03186781|323349739|FG002|Overall Study|Moved from Area|0|||
94427315|NCT03186781|323349740|FG003|Overall Study|Moved from Area|0|||
94427316|NCT03186781|323349741|FG004|Overall Study|Moved from Area|1|||
94427317|NCT03186781|323349742|FG005|Overall Study|Moved from Area|0|||
94427318|NCT03186781|323349737|FG000|Overall Study|Withdrawal by Subject|0|||
94427319|NCT03186781|323349738|FG001|Overall Study|Withdrawal by Subject|0|||
94427320|NCT03186781|323349739|FG002|Overall Study|Withdrawal by Subject|0|||
94427321|NCT03186781|323349740|FG003|Overall Study|Withdrawal by Subject|0|||
94427322|NCT03186781|323349741|FG004|Overall Study|Withdrawal by Subject|1|||
94427323|NCT03186781|323349742|FG005|Overall Study|Withdrawal by Subject|0|||
94427324|NCT01502410|323349743|FG000|Overall Study|Adverse Event|1|||
94427325|NCT01502410|323349744|FG001|Overall Study|Adverse Event|2|||
94427326|NCT01502410|323349745|FG002|Overall Study|Adverse Event|0|||
94427327|NCT01502410|323349746|FG003|Overall Study|Adverse Event|0|||
94427328|NCT01502410|323349743|FG000|Overall Study|Lack of Efficacy|7|||
94427329|NCT01502410|323349744|FG001|Overall Study|Lack of Efficacy|7|||
94427330|NCT01502410|323349745|FG002|Overall Study|Lack of Efficacy|0|||
94427331|NCT01502410|323349746|FG003|Overall Study|Lack of Efficacy|0|||
94427332|NCT01502410|323349743|FG000|Overall Study|Physician Decision|0|||
94427333|NCT01502410|323349744|FG001|Overall Study|Physician Decision|1|||
94427334|NCT01502410|323349745|FG002|Overall Study|Physician Decision|0|||
94427335|NCT01502410|323349746|FG003|Overall Study|Physician Decision|0|||
94427336|NCT01502410|323349743|FG000|Overall Study|Withdrawal by Subject|2|||
94427337|NCT01502410|323349744|FG001|Overall Study|Withdrawal by Subject|0|||
94427338|NCT01502410|323349745|FG002|Overall Study|Withdrawal by Subject|0|||
94427339|NCT01502410|323349746|FG003|Overall Study|Withdrawal by Subject|0|||
94427340|NCT04325204|323349747|FG000|Overall Study|Death|0|||
94427341|NCT04325204|323349748|FG001|Overall Study|Death|1|||
94427342|NCT04325204|323349747|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
94427343|NCT04325204|323349748|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
94427344|NCT04325204|323349747|FG000|Overall Study|Lost to Follow-up|8|||
94427345|NCT04325204|323349748|FG001|Overall Study|Lost to Follow-up|8|||
94427346|NCT04325204|323349747|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
94427347|NCT04325204|323349748|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
94427348|NCT03786718|323349749|FG000|Overall Study|Lost to Follow-up|3|||
94427349|NCT03786718|323349749|FG000|Overall Study|Withdrawal by Subject|1|||
94427350|NCT03786718|323349749|FG000|Overall Study|Did not use the intervention|2|||
94427351|NCT03786718|323349749|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
94427352|NCT04710979|323349750|FG000|Overall Study|Lost to Follow-up|2|||
94427353|NCT04710979|323349751|FG001|Overall Study|Lost to Follow-up|4|||
94427354|NCT04710979|323349750|FG000|Overall Study|Withdrawal by Subject|1|||
94427355|NCT04710979|323349751|FG001|Overall Study|Withdrawal by Subject|0|||
94427356|NCT00918138|323349759|FG000|Overall Study|Subject withdrew consent|1|||
94427357|NCT00918138|323349760|FG001|Overall Study|Subject withdrew consent|1|||
94427358|NCT00918138|323349759|FG000|Overall Study|Death|1|||
94427359|NCT00918138|323349760|FG001|Overall Study|Death|0|||
94427360|NCT03262038|323349761|FG000|Overall Study|Withdrawal by Subject|0|||
94427361|NCT03262038|323349762|FG001|Overall Study|Withdrawal by Subject|1|||
94427362|NCT01716715|323349763|FG000|Overall Study|Never Treated|2|||
94427363|NCT01716715|323349764|FG001|Overall Study|Never Treated|4|||
94427364|NCT01447420|323349769|FG000|Overall Study|Adverse Event|2|||
94427365|NCT01447420|323349770|FG001|Overall Study|Adverse Event|4|||
94427366|NCT01447420|323349771|FG002|Overall Study|Adverse Event|2|||
94427367|NCT01447420|323349769|FG000|Overall Study|Protocol Violation|3|||
94427368|NCT01447420|323349770|FG001|Overall Study|Protocol Violation|3|||
94427369|NCT01447420|323349771|FG002|Overall Study|Protocol Violation|0|||
94427370|NCT01447420|323349769|FG000|Overall Study|Withdrawal by Subject|4|||
94427371|NCT01447420|323349770|FG001|Overall Study|Withdrawal by Subject|1|||
94427372|NCT01447420|323349771|FG002|Overall Study|Withdrawal by Subject|0|||
94427373|NCT01447420|323349769|FG000|Overall Study|Lack of Efficacy|1|||
94427374|NCT01447420|323349770|FG001|Overall Study|Lack of Efficacy|19|||
94427375|NCT01447420|323349771|FG002|Overall Study|Lack of Efficacy|8|||
94427376|NCT01777620|323349772|FG000|Overall Study|Subject Withdrawal|1|||
94427377|NCT01777620|323349773|FG001|Overall Study|Subject Withdrawal|0|||
94427378|NCT04516759|323349774|FG000|Overall Study|Withdrawal by Subject|1|||
94427379|NCT04516759|323349775|FG001|Overall Study|Withdrawal by Subject|1|||
94427380|NCT04516759|323349774|FG000|Overall Study|Other|0|||
94427381|NCT04516759|323349775|FG001|Overall Study|Other|1|||
94427382|NCT01283035|323349776|FG000|Overall Study|Subject later found ineligible|1|||
94427383|NCT00867503|323349777|FG000|Overall Study|Withdrawal by Subject|1|||
94427384|NCT01715571|323349781|FG000|Overall Study|Lost to Follow-up|8|||
94427385|NCT01844505|323349789|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
94427386|NCT01844505|323349790|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
94427387|NCT01844505|323349791|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
94427388|NCT01844505|323349789|FG000|Treatment Period|Other Reasons|120|||
94427389|NCT01844505|323349790|FG001|Treatment Period|Other Reasons|136|||
94427390|NCT01844505|323349791|FG002|Treatment Period|Other Reasons|58|||
94427391|NCT01844505|323349789|FG000|Treatment Period|Lost to Follow-up|9|||
94489704|NCT04889040|323588207|FG001|Overall Study|Withdrawal by Subject|3|||
94489705|NCT04889040|323588206|FG000|Overall Study|Lost to Follow-up|0|||
94489706|NCT04889040|323588207|FG001|Overall Study|Lost to Follow-up|1|||
94489707|NCT04889040|323588206|FG000|Overall Study|Adverse Event|2|||
94489708|NCT04889040|323588207|FG001|Overall Study|Adverse Event|1|||
94489709|NCT00958074|323588208|FG000|Overall Study|Withdrawal by Subject|0|||
94489710|NCT00958074|323588209|FG001|Overall Study|Withdrawal by Subject|1|||
94489711|NCT02897349|323588213|FG000|Overall Study|Lost to Follow-up|2|||
94489712|NCT02897349|323588214|FG001|Overall Study|Lost to Follow-up|2|||
94489713|NCT02897349|323588213|FG000|Overall Study|Adverse Event|3|||
94489714|NCT02897349|323588214|FG001|Overall Study|Adverse Event|3|||
94489715|NCT02897349|323588213|FG000|Overall Study|Other than listed above|0|||
94489716|NCT02897349|323588214|FG001|Overall Study|Other than listed above|1|||
94489717|NCT03176771|323588217|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
94489718|NCT03176771|323588218|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
94489719|NCT03176771|323588219|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
94489720|NCT03176771|323588220|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
94489721|NCT03176771|323588221|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
94489722|NCT03176771|323588217|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
94489723|NCT03176771|323588218|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
94489724|NCT03176771|323588219|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
94489725|NCT03176771|323588220|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
94489726|NCT03176771|323588221|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
94489727|NCT03176771|323588217|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
94489728|NCT03176771|323588218|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
94489729|NCT03176771|323588219|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
94489730|NCT03176771|323588220|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
94489731|NCT03176771|323588221|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
94489732|NCT03176771|323588217|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
94489733|NCT03176771|323588218|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
94489734|NCT03176771|323588219|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
94489735|NCT03176771|323588220|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
94489736|NCT03176771|323588221|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
94489737|NCT03176771|323588217|FG000|Double-Blind Extension Period|Adverse Event|0|||
94489738|NCT03176771|323588218|FG001|Double-Blind Extension Period|Adverse Event|0|||
94427392|NCT01844505|323349790|FG001|Treatment Period|Lost to Follow-up|11|||
94427393|NCT01844505|323349791|FG002|Treatment Period|Lost to Follow-up|6|||
94427394|NCT01844505|323349789|FG000|Treatment Period|Death|175|||
94427395|NCT01844505|323349790|FG001|Treatment Period|Death|154|||
94427396|NCT01844505|323349791|FG002|Treatment Period|Death|228|||
94427397|NCT00468650|323349792|FG000|Overall Study|Lost to Follow-up|4|||
94427398|NCT00468650|323349792|FG000|Overall Study|Withdrawal by Subject|2|||
94489739|NCT03176771|323588219|FG002|Double-Blind Extension Period|Adverse Event|0|||
94427399|NCT00468650|323349792|FG000|Overall Study|Protocol Violation|1|||
94427400|NCT01584843|323349793|FG000|First Treatment Period|Adverse Event|0|||
94427401|NCT01584843|323349794|FG001|First Treatment Period|Adverse Event|0|||
94427402|NCT01584843|323349795|FG002|First Treatment Period|Adverse Event|1|||
94427403|NCT01584843|323349796|FG003|First Treatment Period|Adverse Event|0|||
94427404|NCT01584843|323349797|FG004|First Treatment Period|Adverse Event|0|||
94427405|NCT01584843|323349798|FG005|First Treatment Period|Adverse Event|0|||
94427406|NCT01584843|323349793|FG000|First Treatment Period|Protocol Violation|0|||
94427407|NCT01584843|323349794|FG001|First Treatment Period|Protocol Violation|0|||
94427408|NCT01584843|323349795|FG002|First Treatment Period|Protocol Violation|0|||
94427409|NCT01584843|323349796|FG003|First Treatment Period|Protocol Violation|0|||
94427410|NCT01584843|323349797|FG004|First Treatment Period|Protocol Violation|0|||
94427411|NCT01584843|323349798|FG005|First Treatment Period|Protocol Violation|1|||
94427412|NCT01584843|323349793|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
94427413|NCT01584843|323349794|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
94427414|NCT01584843|323349795|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
94427415|NCT01584843|323349796|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
94427416|NCT01584843|323349797|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
94427417|NCT01584843|323349798|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
94427418|NCT01584843|323349793|FG000|Second Treatment Period|Withdrawal by Subject|0|||
94427419|NCT01584843|323349794|FG001|Second Treatment Period|Withdrawal by Subject|0|||
94427420|NCT01584843|323349795|FG002|Second Treatment Period|Withdrawal by Subject|0|||
94427421|NCT01584843|323349796|FG003|Second Treatment Period|Withdrawal by Subject|0|||
94427422|NCT01584843|323349797|FG004|Second Treatment Period|Withdrawal by Subject|0|||
94427423|NCT01584843|323349798|FG005|Second Treatment Period|Withdrawal by Subject|1|||
94427424|NCT02640053|323349800|FG000|Overall Study|Withdrawal by Subject|2|||
94427425|NCT02640053|323349801|FG001|Overall Study|Withdrawal by Subject|1|||
94427426|NCT02640053|323349800|FG000|Overall Study|Adverse Event|1|||
94427427|NCT02640053|323349801|FG001|Overall Study|Adverse Event|1|||
94427428|NCT02640053|323349800|FG000|Overall Study|Alternative Therapy|1|||
94427429|NCT02640053|323349801|FG001|Overall Study|Alternative Therapy|1|||
94427430|NCT02640053|323349800|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
94427431|NCT02640053|323349801|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
94427432|NCT01268501|323349802|FG000|Overall Study|Lost to Follow-up|1|||
94427433|NCT01268501|323349802|FG000|Overall Study|Withdrawal by Subject|3|||
94427434|NCT01268501|323349802|FG000|Overall Study|Unacceptable Subjective Vision|3|||
94427435|NCT01268501|323349802|FG000|Overall Study|Handling Difficulties|2|||
94427436|NCT01140503|323349803|FG000|Overall Study|Withdrawal by Subject|1|||
94427437|NCT03201965|323349804|FG000|Overall Study|Death|5|||
94427438|NCT03201965|323349805|FG001|Overall Study|Death|27|||
94427439|NCT03201965|323349806|FG002|Overall Study|Death|27|||
94427440|NCT03201965|323349804|FG000|Overall Study|Lost to Follow-up|0|||
94427441|NCT03201965|323349805|FG001|Overall Study|Lost to Follow-up|1|||
94427442|NCT03201965|323349806|FG002|Overall Study|Lost to Follow-up|0|||
94427443|NCT03201965|323349804|FG000|Overall Study|Withdrawal by Subject|3|||
94427444|NCT03201965|323349805|FG001|Overall Study|Withdrawal by Subject|13|||
94427445|NCT03201965|323349806|FG002|Overall Study|Withdrawal by Subject|4|||
94427446|NCT03201965|323349804|FG000|Overall Study|Ongoing|20|||
94427447|NCT03201965|323349805|FG001|Overall Study|Ongoing|152|||
94427448|NCT03201965|323349806|FG002|Overall Study|Ongoing|164|||
94427449|NCT03456453|323349807|FG000|Overall Study|Withdrawal by Subject|2|||
94427450|NCT03456453|323349808|FG001|Overall Study|Withdrawal by Subject|0|||
94427451|NCT03456453|323349807|FG000|Overall Study|Not released to community|1|||
94427452|NCT03456453|323349808|FG001|Overall Study|Not released to community|5|||
94427453|NCT03456453|323349807|FG000|Overall Study|Lost to Follow-up|0|||
94427454|NCT03456453|323349808|FG001|Overall Study|Lost to Follow-up|2|||
94427455|NCT04762277|323349809|FG000|Overall Study|Withdrawal by Subject|0|||
94427456|NCT04762277|323349810|FG001|Overall Study|Withdrawal by Subject|2|||
94427457|NCT04762277|323349809|FG000|Overall Study|Protocol Violation|0|||
94489740|NCT03176771|323588220|FG003|Double-Blind Extension Period|Adverse Event|15|||
94427458|NCT04762277|323349810|FG001|Overall Study|Protocol Violation|1|||
94427459|NCT04762277|323349809|FG000|Overall Study|Adverse Event|1|||
94427460|NCT04762277|323349810|FG001|Overall Study|Adverse Event|0|||
94427461|NCT01094886|323349813|FG000|Overall Study|Adverse Event|2|||
94427462|NCT01094886|323349813|FG000|Overall Study|Withdrawal by Subject|5|||
94427463|NCT00103610|323349814|FG000|Overall Study|Entered Rescue Procedure|10|||
94427464|NCT00103610|323349815|FG001|Overall Study|Entered Rescue Procedure|52|||
94427465|NCT00103610|323349814|FG000|Overall Study|Death|16|||
94427466|NCT00103610|323349815|FG001|Overall Study|Death|12|||
94427467|NCT00103610|323349814|FG000|Overall Study|Elective Withdrawal|4|||
94489741|NCT03176771|323588221|FG004|Double-Blind Extension Period|Adverse Event|18|||
94427468|NCT00103610|323349815|FG001|Overall Study|Elective Withdrawal|0|||
94427469|NCT00103610|323349814|FG000|Overall Study|Lost to Follow-up|3|||
94427470|NCT00103610|323349815|FG001|Overall Study|Lost to Follow-up|1|||
94427471|NCT00103610|323349814|FG000|Overall Study|Adverse Event|2|||
94427472|NCT00103610|323349815|FG001|Overall Study|Adverse Event|2|||
94427473|NCT00103610|323349814|FG000|Overall Study|Other|2|||
94427474|NCT00103610|323349815|FG001|Overall Study|Other|7|||
94427475|NCT00103610|323349814|FG000|Overall Study|Failed mobilization|1|||
94427476|NCT00103610|323349815|FG001|Overall Study|Failed mobilization|5|||
94427477|NCT00103610|323349814|FG000|Overall Study|Noncompliance|0|||
94427478|NCT00103610|323349815|FG001|Overall Study|Noncompliance|1|||
94427479|NCT03866902|323349817|FG000|Overall Study|Lost to Follow-up|98|||
94427480|NCT03866902|323349818|FG001|Overall Study|Lost to Follow-up|82|||
94427481|NCT03866902|323349817|FG000|Overall Study|Pregnancy|18|||
94427482|NCT03866902|323349818|FG001|Overall Study|Pregnancy|24|||
94427483|NCT01284621|323349821|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
94427484|NCT01284621|323349822|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
94427485|NCT01284621|323349823|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
94427486|NCT01284621|323349824|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
94427487|NCT01284621|323349825|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
94427488|NCT01284621|323349826|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
94427489|NCT02342639|323349827|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
94427490|NCT02342639|323349828|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
94427491|NCT02342639|323349827|FG000|Overall Study|Protocol Violation|0|||
94427492|NCT02342639|323349828|FG001|Overall Study|Protocol Violation|2|||
94427493|NCT02212379|323349829|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
94427494|NCT02212379|323349829|FG000|From Baseline to Week 48|Adverse Event|7|||
94427495|NCT02212379|323349829|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
94427496|NCT02212379|323349829|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
94427497|NCT02212379|323349829|FG000|From Week 48 to Week 96|Adverse Event|1|||
94427498|NCT02212379|323349829|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
94427499|NCT03155945|323349830|FG000|Overall Study|Lost to Follow-up|0|||
94427500|NCT03155945|323349831|FG001|Overall Study|Lost to Follow-up|1|||
94427501|NCT03155945|323349830|FG000|Overall Study|Withdrawal by Subject|0|||
94427502|NCT03155945|323349831|FG001|Overall Study|Withdrawal by Subject|1|||
94427503|NCT03155945|323349830|FG000|Overall Study|Other Reason|0|||
94427504|NCT03155945|323349831|FG001|Overall Study|Other Reason|1|||
94427505|NCT02013674|323349836|FG000|Overall Study|Death|0|||
94427506|NCT02013674|323349837|FG001|Overall Study|Death|1|||
94427507|NCT02013674|323349836|FG000|Overall Study|Lost to Follow-up|1|||
94427508|NCT02013674|323349837|FG001|Overall Study|Lost to Follow-up|0|||
94427509|NCT00278889|323349838|FG000|Overall Study|Withdrawal by Subject|0|||
94427510|NCT00278889|323349839|FG001|Overall Study|Withdrawal by Subject|5|||
94427511|NCT00278889|323349840|FG002|Overall Study|Withdrawal by Subject|3|||
94427512|NCT00278889|323349838|FG000|Overall Study|Lost to Follow-up|1|||
94427513|NCT00278889|323349839|FG001|Overall Study|Lost to Follow-up|1|||
94427514|NCT00278889|323349840|FG002|Overall Study|Lost to Follow-up|0|||
94427515|NCT00278889|323349838|FG000|Overall Study|Death|24|||
94427516|NCT00278889|323349839|FG001|Overall Study|Death|21|||
94427517|NCT00278889|323349840|FG002|Overall Study|Death|17|||
94427518|NCT03570892|323349841|FG000|Overall Study|Death|51|||
94427519|NCT03570892|323349842|FG001|Overall Study|Death|45|||
94427520|NCT03570892|323349841|FG000|Overall Study|Subject decision|5|||
94427521|NCT03570892|323349842|FG001|Overall Study|Subject decision|3|||
94427522|NCT03570892|323349841|FG000|Overall Study|Protocol Violation|1|||
94427523|NCT03570892|323349842|FG001|Overall Study|Protocol Violation|4|||
94427524|NCT03570892|323349841|FG000|Overall Study|Physician Decision|0|||
94427525|NCT03570892|323349842|FG001|Overall Study|Physician Decision|2|||
94427526|NCT04042376|323349843|FG000|Overall Study|Withdrawal by Subject|1|||
94427527|NCT04042376|323349843|FG000|Overall Study|Death|3|||
94427528|NCT04191096|323349844|FG000|Overall Study|Death|102|||
94427529|NCT04191096|323349845|FG001|Overall Study|Death|89|||
94427530|NCT04191096|323349844|FG000|Overall Study|Lost to Follow-up|1|||
94427531|NCT04191096|323349845|FG001|Overall Study|Lost to Follow-up|1|||
94427532|NCT04191096|323349844|FG000|Overall Study|Withdrawal by Subject|5|||
94427533|NCT04191096|323349845|FG001|Overall Study|Withdrawal by Subject|5|||
94427534|NCT04191096|323349844|FG000|Overall Study|Participants Ongoing|518|||
94427535|NCT04191096|323349845|FG001|Overall Study|Participants Ongoing|530|||
94427536|NCT03548064|323351533|FG000|Overall Study|Withdrawal by Subject|0|||
94427537|NCT03548064|323351534|FG001|Overall Study|Withdrawal by Subject|0|||
94427538|NCT03548064|323351535|FG002|Overall Study|Withdrawal by Subject|0|||
94427539|NCT03548064|323351536|FG003|Overall Study|Withdrawal by Subject|1|||
94427540|NCT03548064|323351537|FG004|Overall Study|Withdrawal by Subject|0|||
94427541|NCT03548064|323351538|FG005|Overall Study|Withdrawal by Subject|0|||
94427542|NCT03548064|323351539|FG006|Overall Study|Withdrawal by Subject|0|||
94427543|NCT03548064|323351540|FG007|Overall Study|Withdrawal by Subject|0|||
94427544|NCT03548064|323351533|FG000|Overall Study|Lost to Follow-up|0|||
94427545|NCT03548064|323351534|FG001|Overall Study|Lost to Follow-up|0|||
94427546|NCT03548064|323351535|FG002|Overall Study|Lost to Follow-up|0|||
94427547|NCT03548064|323351536|FG003|Overall Study|Lost to Follow-up|0|||
94427548|NCT03548064|323351537|FG004|Overall Study|Lost to Follow-up|2|||
94427549|NCT03548064|323351538|FG005|Overall Study|Lost to Follow-up|0|||
94427550|NCT03548064|323351539|FG006|Overall Study|Lost to Follow-up|0|||
94427551|NCT03548064|323351540|FG007|Overall Study|Lost to Follow-up|0|||
94427552|NCT03548064|323351533|FG000|Overall Study|Covid-19 Pandemic|0|||
94427553|NCT03548064|323351534|FG001|Overall Study|Covid-19 Pandemic|0|||
94427554|NCT03548064|323351535|FG002|Overall Study|Covid-19 Pandemic|0|||
94427555|NCT03548064|323351536|FG003|Overall Study|Covid-19 Pandemic|0|||
94427556|NCT03548064|323351537|FG004|Overall Study|Covid-19 Pandemic|10|||
94427557|NCT03548064|323351538|FG005|Overall Study|Covid-19 Pandemic|3|||
94427558|NCT03548064|323351539|FG006|Overall Study|Covid-19 Pandemic|0|||
94427559|NCT03548064|323351540|FG007|Overall Study|Covid-19 Pandemic|0|||
94427560|NCT05011123|323351541|FG000|Overall Study|Withdrawal by Subject|4|||
94427561|NCT05011123|323351542|FG001|Overall Study|Withdrawal by Subject|2|||
94427562|NCT05011123|323351541|FG000|Overall Study|Lost to Follow-up|7|||
94427563|NCT05011123|323351542|FG001|Overall Study|Lost to Follow-up|6|||
94427564|NCT05011123|323351541|FG000|Overall Study|Ongoing at the time of DBL date|36|||
94427565|NCT05011123|323351542|FG001|Overall Study|Ongoing at the time of DBL date|10|||
94427566|NCT05011123|323351541|FG000|Overall Study|Randomized but did not receive vaccination|1|||
94427567|NCT05011123|323351542|FG001|Overall Study|Randomized but did not receive vaccination|0|||
94427568|NCT04941729|323351543|FG000|Overall Study|Death|0|||
94427569|NCT04941729|323351544|FG001|Overall Study|Death|1|||
94427570|NCT04941729|323351543|FG000|Overall Study|Study terminated by sponsor|11|||
94427571|NCT04941729|323351544|FG001|Overall Study|Study terminated by sponsor|10|||
94427572|NCT04221789|323351546|FG000|Overall Study|deviation from protoco|22|||
94427573|NCT04221789|323351547|FG001|Overall Study|deviation from protoco|8|||
94427574|NCT03395405|323351548|FG000|Overall Study|Death|0|||
94427575|NCT03395405|323351549|FG001|Overall Study|Death|2|||
94427576|NCT03395405|323351548|FG000|Overall Study|Lost to Follow-up|0|||
94427577|NCT03395405|323351549|FG001|Overall Study|Lost to Follow-up|1|||
94427578|NCT03395405|323351548|FG000|Overall Study|Protocol Violation|0|||
94427579|NCT03395405|323351549|FG001|Overall Study|Protocol Violation|1|||
94427580|NCT03395405|323351548|FG000|Overall Study|Withdrawal by Subject|3|||
94427581|NCT03395405|323351549|FG001|Overall Study|Withdrawal by Subject|1|||
94427582|NCT03395405|323351548|FG000|Overall Study|COVID-19 Pandemic|1|||
94427583|NCT03395405|323351549|FG001|Overall Study|COVID-19 Pandemic|0|||
94427584|NCT04240392|323351559|FG000|Overall Study|Withdrawal by Subject|13|||
94427585|NCT04240392|323351560|FG001|Overall Study|Withdrawal by Subject|4|||
94427586|NCT04240392|323351559|FG000|Overall Study|Lost to Follow-up|11|||
94427587|NCT04240392|323351560|FG001|Overall Study|Lost to Follow-up|12|||
94427588|NCT03589768|323351561|FG000|Overall Study|Death|1|||
94427589|NCT03589768|323351562|FG001|Overall Study|Death|0|||
94427590|NCT03589768|323351563|FG002|Overall Study|Death|8|||
94427591|NCT03589768|323351564|FG003|Overall Study|Death|3|||
94427592|NCT03589768|323351561|FG000|Overall Study|Withdrawal by Subject|2|||
94427593|NCT03589768|323351562|FG001|Overall Study|Withdrawal by Subject|0|||
94427594|NCT03589768|323351563|FG002|Overall Study|Withdrawal by Subject|0|||
94427595|NCT03589768|323351564|FG003|Overall Study|Withdrawal by Subject|0|||
94427596|NCT03589768|323351561|FG000|Overall Study|Protocol Violation|1|||
94427597|NCT03589768|323351562|FG001|Overall Study|Protocol Violation|0|||
94427598|NCT03589768|323351563|FG002|Overall Study|Protocol Violation|0|||
94427599|NCT03589768|323351564|FG003|Overall Study|Protocol Violation|0|||
94427600|NCT04663295|323351567|FG000|Run-in Period|Withdrawal by Subject|3|||
94427601|NCT04663295|323351567|FG000|Overall Study Period|Pregnancy|1|||
94427602|NCT04663295|323351567|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
94427603|NCT02903030|323351568|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
94427604|NCT02903030|323351569|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
94427605|NCT03700385|323351580|FG000|Overall Study|Lost to Follow-up|1|||
94427606|NCT00372411|323351587|FG000|Overall Study|Withdrawal by Subject|3|||
94427607|NCT00372411|323351588|FG001|Overall Study|Withdrawal by Subject|4|||
94427608|NCT00372411|323351589|FG002|Overall Study|Withdrawal by Subject|1|||
94427609|NCT00372411|323351587|FG000|Overall Study|Death|0|||
94427610|NCT00372411|323351588|FG001|Overall Study|Death|2|||
94427611|NCT00372411|323351589|FG002|Overall Study|Death|1|||
94427612|NCT00372411|323351587|FG000|Overall Study|Lost to Follow-up|1|||
94427613|NCT00372411|323351588|FG001|Overall Study|Lost to Follow-up|1|||
94427614|NCT00372411|323351589|FG002|Overall Study|Lost to Follow-up|1|||
94427615|NCT00372411|323351587|FG000|Overall Study|Adverse Event|1|||
94427616|NCT00372411|323351588|FG001|Overall Study|Adverse Event|1|||
94427617|NCT00372411|323351589|FG002|Overall Study|Adverse Event|0|||
94427618|NCT00699283|323351590|FG000|Overall Study|Lack of Efficacy|15|||
94427619|NCT00699283|323351591|FG001|Overall Study|Lack of Efficacy|5|||
94427620|NCT00699283|323351590|FG000|Overall Study|Lost to Follow-up|2|||
94489742|NCT03176771|323588217|FG000|Double-Blind Extension Period|Death|0|||
94489743|NCT03176771|323588218|FG001|Double-Blind Extension Period|Death|0|||
94427621|NCT00699283|323351591|FG001|Overall Study|Lost to Follow-up|0|||
94427622|NCT00699283|323351590|FG000|Overall Study|Withdrawal by Subject|1|||
94427623|NCT00699283|323351591|FG001|Overall Study|Withdrawal by Subject|0|||
94427624|NCT00699283|323351590|FG000|Overall Study|Other Reason|5|||
94427625|NCT00699283|323351591|FG001|Overall Study|Other Reason|1|||
94427626|NCT00699283|323351590|FG000|Overall Study|SAE, non-fatal|1|||
94427627|NCT00699283|323351591|FG001|Overall Study|SAE, non-fatal|1|||
94427628|NCT00699283|323351590|FG000|Overall Study|AE, non-serious non-fatal|8|||
94427629|NCT00699283|323351591|FG001|Overall Study|AE, non-serious non-fatal|1|||
94427630|NCT00699283|323351590|FG000|Overall Study|AE of unknown type|1|||
94427631|NCT00699283|323351591|FG001|Overall Study|AE of unknown type|0|||
94427632|NCT00394524|323351592|FG000|Overall Study|Protocol Violation|2|||
94427633|NCT00394524|323351593|FG001|Overall Study|Protocol Violation|3|||
94427634|NCT00394524|323351592|FG000|Overall Study|Death|1|||
94427635|NCT00394524|323351593|FG001|Overall Study|Death|0|||
94427636|NCT00394524|323351592|FG000|Overall Study|Withdrawal by Subject|0|||
94427637|NCT00394524|323351593|FG001|Overall Study|Withdrawal by Subject|1|||
94427638|NCT01284361|323351607|FG000|Overall Study|Withdrawal by Subject|1|||
94427639|NCT01284361|323351607|FG000|Overall Study|Protocol Violation|5|||
94427640|NCT01284361|323351607|FG000|Overall Study|Adverse Event|1|||
94427641|NCT01284361|323351607|FG000|Overall Study|Lost to Follow-up|2|||
94427642|NCT03537599|323351608|FG000|Overall Study|Disease Progression|2|||
94427643|NCT03537599|323351609|FG001|Overall Study|Disease Progression|1|||
94427644|NCT03537599|323351608|FG000|Overall Study|Death|0|||
94427645|NCT03537599|323351609|FG001|Overall Study|Death|1|||
94427646|NCT04585789|323351610|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
94427647|NCT04585789|323351611|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
94427648|NCT04585789|323351612|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
94427649|NCT04585789|323351610|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
94427650|NCT04585789|323351611|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
94427651|NCT04585789|323351612|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
94427652|NCT00686075|323351613|FG000|Overall Study|Withdrawal by Subject|4|||
94427653|NCT00686075|323351614|FG001|Overall Study|Withdrawal by Subject|3|||
94427654|NCT00686075|323351615|FG002|Overall Study|Withdrawal by Subject|3|||
94427655|NCT00686075|323351616|FG003|Overall Study|Withdrawal by Subject|7|||
94427656|NCT00686075|323351617|FG004|Overall Study|Withdrawal by Subject|1|||
94427657|NCT00686075|323351618|FG005|Overall Study|Withdrawal by Subject|0|||
94427658|NCT00686075|323351619|FG006|Overall Study|Withdrawal by Subject|0|||
94427659|NCT00686075|323351620|FG007|Overall Study|Withdrawal by Subject|2|||
94427660|NCT00686075|323351621|FG008|Overall Study|Withdrawal by Subject|4|||
94427661|NCT00686075|323351622|FG009|Overall Study|Withdrawal by Subject|6|||
94427662|NCT00686075|323351613|FG000|Overall Study|Lost to Follow-up|3|||
94427663|NCT00686075|323351614|FG001|Overall Study|Lost to Follow-up|6|||
94427664|NCT00686075|323351615|FG002|Overall Study|Lost to Follow-up|3|||
94427665|NCT00686075|323351616|FG003|Overall Study|Lost to Follow-up|2|||
94427666|NCT00686075|323351617|FG004|Overall Study|Lost to Follow-up|3|||
94427667|NCT00686075|323351618|FG005|Overall Study|Lost to Follow-up|3|||
94427668|NCT00686075|323351619|FG006|Overall Study|Lost to Follow-up|0|||
94427669|NCT00686075|323351620|FG007|Overall Study|Lost to Follow-up|0|||
94427670|NCT00686075|323351621|FG008|Overall Study|Lost to Follow-up|2|||
94427671|NCT00686075|323351622|FG009|Overall Study|Lost to Follow-up|3|||
94427672|NCT00686075|323351613|FG000|Overall Study|Other|1|||
94427673|NCT00686075|323351614|FG001|Overall Study|Other|1|||
94427674|NCT00686075|323351615|FG002|Overall Study|Other|0|||
94427675|NCT00686075|323351616|FG003|Overall Study|Other|0|||
94427676|NCT00686075|323351617|FG004|Overall Study|Other|0|||
94427677|NCT00686075|323351618|FG005|Overall Study|Other|0|||
94427678|NCT00686075|323351619|FG006|Overall Study|Other|0|||
94427679|NCT00686075|323351620|FG007|Overall Study|Other|0|||
94427680|NCT00686075|323351621|FG008|Overall Study|Other|0|||
94427681|NCT00686075|323351622|FG009|Overall Study|Other|1|||
94427682|NCT02585934|323351623|FG000|Overall Study|Lost to Follow-up|2|||
94427683|NCT02585934|323351624|FG001|Overall Study|Lost to Follow-up|2|||
94427684|NCT02585934|323351623|FG000|Overall Study|Protocol Violation|14|||
94427685|NCT02585934|323351624|FG001|Overall Study|Protocol Violation|11|||
94427686|NCT02585934|323351623|FG000|Overall Study|Adverse Event|21|||
94427687|NCT02585934|323351624|FG001|Overall Study|Adverse Event|22|||
94427688|NCT02585934|323351623|FG000|Overall Study|Physician Decision|3|||
94427689|NCT02585934|323351624|FG001|Overall Study|Physician Decision|2|||
94427690|NCT02585934|323351623|FG000|Overall Study|Withdrawal by Subject|7|||
94427691|NCT02585934|323351624|FG001|Overall Study|Withdrawal by Subject|21|||
94427692|NCT02585934|323351623|FG000|Overall Study|Lack of Efficacy|2|||
94427693|NCT02585934|323351624|FG001|Overall Study|Lack of Efficacy|1|||
94427694|NCT02585934|323351623|FG000|Overall Study|Death|2|||
94427695|NCT02585934|323351624|FG001|Overall Study|Death|0|||
94427696|NCT02585934|323351623|FG000|Overall Study|Caregiver Withdrew Consent|7|||
94427697|NCT02585934|323351624|FG001|Overall Study|Caregiver Withdrew Consent|7|||
94427698|NCT02585934|323351623|FG000|Overall Study|Sponsor Termination|1|||
94427699|NCT02585934|323351624|FG001|Overall Study|Sponsor Termination|2|||
94427700|NCT02585934|323351623|FG000|Overall Study|Another Reason|10|||
94427701|NCT02585934|323351624|FG001|Overall Study|Another Reason|5|||
94427702|NCT05776862|323351625|FG000|Overall Study|Adverse Event|0|||
94427703|NCT05776862|323351626|FG001|Overall Study|Adverse Event|1|||
94427704|NCT05776862|323351625|FG000|Overall Study|non-compliance|1|||
94427705|NCT05776862|323351626|FG001|Overall Study|non-compliance|0|||
94427706|NCT02448706|323351627|FG000|Overall Study|Withdrawal by Subject|4|||
94427707|NCT02448706|323351628|FG001|Overall Study|Withdrawal by Subject|3|||
94489744|NCT03176771|323588219|FG002|Double-Blind Extension Period|Death|0|||
94489745|NCT03176771|323588220|FG003|Double-Blind Extension Period|Death|3|||
94489746|NCT03176771|323588221|FG004|Double-Blind Extension Period|Death|4|||
94489747|NCT03176771|323588217|FG000|Double-Blind Extension Period|Physician Decision|0|||
94489748|NCT03176771|323588218|FG001|Double-Blind Extension Period|Physician Decision|0|||
94489749|NCT03176771|323588219|FG002|Double-Blind Extension Period|Physician Decision|0|||
94489750|NCT03176771|323588220|FG003|Double-Blind Extension Period|Physician Decision|3|||
94489751|NCT03176771|323588221|FG004|Double-Blind Extension Period|Physician Decision|1|||
94489752|NCT03176771|323588217|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
94489753|NCT03176771|323588218|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
94489754|NCT03176771|323588219|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
94489755|NCT03176771|323588220|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
94489756|NCT03176771|323588221|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
94489757|NCT02349386|323588234|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
94489758|NCT02349386|323588235|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
94489759|NCT02349386|323588236|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
94489760|NCT02349386|323588237|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
94489761|NCT02349386|323588234|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
94427708|NCT02448706|323351627|FG000|Overall Study|Protocol Violation|1|||
94427709|NCT02448706|323351628|FG001|Overall Study|Protocol Violation|1|||
94427710|NCT03972163|323351637|FG000|Overall Study|Death|0|||
94427711|NCT03972163|323351638|FG001|Overall Study|Death|1|||
94427712|NCT02065700|323351640|FG000|Overall Study|Adverse Event|165|||
94427713|NCT02065700|323351641|FG001|Overall Study|Adverse Event|101|||
94427714|NCT02065700|323351640|FG000|Overall Study|Withdrawal by Subject|90|||
94427715|NCT02065700|323351641|FG001|Overall Study|Withdrawal by Subject|29|||
94427716|NCT02065700|323351640|FG000|Overall Study|Lost to Follow-up|12|||
94427717|NCT02065700|323351641|FG001|Overall Study|Lost to Follow-up|9|||
94427718|NCT02065700|323351640|FG000|Overall Study|Physician Decision|2|||
94427719|NCT02065700|323351641|FG001|Overall Study|Physician Decision|0|||
94427720|NCT02065700|323351640|FG000|Overall Study|Sponsor Request|38|||
94427721|NCT02065700|323351641|FG001|Overall Study|Sponsor Request|15|||
94427722|NCT02065700|323351640|FG000|Overall Study|Treatment Failure|3|||
94427723|NCT02065700|323351641|FG001|Overall Study|Treatment Failure|2|||
94427724|NCT02065700|323351640|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
94427725|NCT02065700|323351641|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
94427726|NCT02065700|323351640|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
94427727|NCT02065700|323351641|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
94427728|NCT02065700|323351640|FG000|Overall Study|Non-compliance with Study Procedures|2|||
94427729|NCT02065700|323351641|FG001|Overall Study|Non-compliance with Study Procedures|0|||
94427730|NCT02065700|323351640|FG000|Overall Study|Not Defined|21|||
94427731|NCT02065700|323351641|FG001|Overall Study|Not Defined|3|||
94427732|NCT01664130|323351646|FG000|Overall Study|competing secondary disease|2|||
94427733|NCT03678285|323351650|FG000|Overall Study|Adverse Event|2|||
94427734|NCT03678285|323351650|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
94427735|NCT03678285|323351650|FG000|Overall Study|Dehydrated prior to start of workout|1|||
94427736|NCT00123474|323351651|FG000|Randomized to Treatment|Randomized, never treated|1|||
94427737|NCT00123474|323351652|FG001|Randomized to Treatment|Randomized, never treated|4|||
94427738|NCT00123474|323351653|FG002|Randomized to Treatment|Randomized, never treated|2|||
94427739|NCT00123474|323351654|FG003|Randomized to Treatment|Randomized, never treated|1|||
94427740|NCT00123474|323351651|FG000|As Treated at Study Closure|not reported when site closed|1|||
94427741|NCT00123474|323351652|FG001|As Treated at Study Closure|not reported when site closed|0|||
94427742|NCT00123474|323351653|FG002|As Treated at Study Closure|not reported when site closed|1|||
94427743|NCT00123474|323351654|FG003|As Treated at Study Closure|not reported when site closed|0|||
94427744|NCT00123474|323351651|FG000|As Treated at Study Closure|Adverse Event|10|||
94427745|NCT00123474|323351652|FG001|As Treated at Study Closure|Adverse Event|4|||
94427746|NCT00123474|323351653|FG002|As Treated at Study Closure|Adverse Event|10|||
94427747|NCT00123474|323351654|FG003|As Treated at Study Closure|Adverse Event|8|||
94427748|NCT00123474|323351651|FG000|As Treated at Study Closure|Disease Progression|35|||
94427749|NCT00123474|323351652|FG001|As Treated at Study Closure|Disease Progression|42|||
94427750|NCT00123474|323351653|FG002|As Treated at Study Closure|Disease Progression|29|||
94427751|NCT00123474|323351654|FG003|As Treated at Study Closure|Disease Progression|27|||
94427752|NCT00123474|323351651|FG000|As Treated at Study Closure|Investigator Request|12|||
94427753|NCT00123474|323351652|FG001|As Treated at Study Closure|Investigator Request|6|||
94427754|NCT00123474|323351653|FG002|As Treated at Study Closure|Investigator Request|7|||
94427755|NCT00123474|323351654|FG003|As Treated at Study Closure|Investigator Request|5|||
94427756|NCT00123474|323351651|FG000|As Treated at Study Closure|non-specified|54|||
94427757|NCT00123474|323351652|FG001|As Treated at Study Closure|non-specified|47|||
94427758|NCT00123474|323351653|FG002|As Treated at Study Closure|non-specified|57|||
94427759|NCT00123474|323351654|FG003|As Treated at Study Closure|non-specified|60|||
94427760|NCT00123474|323351651|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
94427761|NCT00123474|323351652|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
94427762|NCT00123474|323351653|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
94427763|NCT00123474|323351654|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
94427764|NCT00123474|323351651|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
94427765|NCT00123474|323351652|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
94427766|NCT00123474|323351653|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
94427767|NCT00123474|323351654|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
94427768|NCT00616629|323351655|FG000|Overall Study|Protocol Violation|1|||
94427769|NCT00616629|323351656|FG001|Overall Study|Protocol Violation|2|||
94427770|NCT00616629|323351657|FG002|Overall Study|Protocol Violation|1|||
94427771|NCT00616629|323351658|FG003|Overall Study|Protocol Violation|0|||
94427772|NCT00616629|323351659|FG004|Overall Study|Protocol Violation|0|||
94427773|NCT00616629|323351655|FG000|Overall Study|AV-block|1|||
94427774|NCT00616629|323351656|FG001|Overall Study|AV-block|0|||
94427775|NCT00616629|323351657|FG002|Overall Study|AV-block|0|||
94427776|NCT00616629|323351658|FG003|Overall Study|AV-block|0|||
94427777|NCT00616629|323351659|FG004|Overall Study|AV-block|0|||
94427778|NCT01059344|323351660|FG000|Overall Study|Adverse Event|12|||
94427779|NCT01059344|323351661|FG001|Overall Study|Adverse Event|30|||
94427780|NCT01059344|323351660|FG000|Overall Study|Withdrawal by Subject|6|||
94427781|NCT01059344|323351661|FG001|Overall Study|Withdrawal by Subject|9|||
94427782|NCT01059344|323351660|FG000|Overall Study|Lost to Follow-up|1|||
94427783|NCT01059344|323351661|FG001|Overall Study|Lost to Follow-up|1|||
94427784|NCT01059344|323351660|FG000|Overall Study|Other|3|||
94427785|NCT01059344|323351661|FG001|Overall Study|Other|6|||
94427786|NCT01739348|323351662|FG000|Part I (Base Study)|Adverse Event|41|||
94427787|NCT01739348|323351663|FG001|Part I (Base Study)|Adverse Event|52|||
94427788|NCT01739348|323351664|FG002|Part I (Base Study)|Adverse Event|8|||
94427789|NCT01739348|323351665|FG003|Part I (Base Study)|Adverse Event|33|||
94427790|NCT01739348|323351662|FG000|Part I (Base Study)|Death|10|||
94427791|NCT01739348|323351663|FG001|Part I (Base Study)|Death|7|||
94427792|NCT01739348|323351664|FG002|Part I (Base Study)|Death|2|||
94427793|NCT01739348|323351665|FG003|Part I (Base Study)|Death|8|||
94427794|NCT01739348|323351662|FG000|Part I (Base Study)|Lack of Efficacy|3|||
94427795|NCT01739348|323351663|FG001|Part I (Base Study)|Lack of Efficacy|8|||
94427796|NCT01739348|323351664|FG002|Part I (Base Study)|Lack of Efficacy|0|||
94427797|NCT01739348|323351665|FG003|Part I (Base Study)|Lack of Efficacy|7|||
94427798|NCT01739348|323351662|FG000|Part I (Base Study)|Lost to Follow-up|4|||
94427799|NCT01739348|323351663|FG001|Part I (Base Study)|Lost to Follow-up|2|||
94427800|NCT01739348|323351664|FG002|Part I (Base Study)|Lost to Follow-up|4|||
94427801|NCT01739348|323351665|FG003|Part I (Base Study)|Lost to Follow-up|4|||
94427802|NCT01739348|323351662|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
94427803|NCT01739348|323351663|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
94427804|NCT01739348|323351664|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
94427805|NCT01739348|323351665|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
94427806|NCT01739348|323351662|FG000|Part I (Base Study)|Physician Decision|10|||
94427807|NCT01739348|323351663|FG001|Part I (Base Study)|Physician Decision|7|||
94427808|NCT01739348|323351664|FG002|Part I (Base Study)|Physician Decision|1|||
94427809|NCT01739348|323351665|FG003|Part I (Base Study)|Physician Decision|4|||
94427810|NCT01739348|323351662|FG000|Part I (Base Study)|Protocol Violation|2|||
94427811|NCT01739348|323351663|FG001|Part I (Base Study)|Protocol Violation|0|||
94427812|NCT01739348|323351664|FG002|Part I (Base Study)|Protocol Violation|1|||
94427813|NCT01739348|323351665|FG003|Part I (Base Study)|Protocol Violation|2|||
94427814|NCT01739348|323351662|FG000|Part I (Base Study)|Screen Failure|2|||
94427815|NCT01739348|323351663|FG001|Part I (Base Study)|Screen Failure|0|||
94427816|NCT01739348|323351664|FG002|Part I (Base Study)|Screen Failure|0|||
94427817|NCT01739348|323351665|FG003|Part I (Base Study)|Screen Failure|0|||
94427818|NCT01739348|323351662|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
94489762|NCT02349386|323588235|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
94489763|NCT02349386|323588236|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
94489764|NCT02349386|323588237|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
94489765|NCT02349386|323588234|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
94489766|NCT02349386|323588235|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
94427819|NCT01739348|323351663|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
94427820|NCT01739348|323351664|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
94427821|NCT01739348|323351665|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
94427822|NCT01739348|323351662|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
94427823|NCT01739348|323351663|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
94427824|NCT01739348|323351664|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
94489767|NCT02349386|323588236|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
94427825|NCT01739348|323351665|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
94427826|NCT01739348|323351662|FG000|Part I (Base Study)|Participant Moved|4|||
94427827|NCT01739348|323351663|FG001|Part I (Base Study)|Participant Moved|3|||
94427828|NCT01739348|323351664|FG002|Part I (Base Study)|Participant Moved|1|||
94427829|NCT01739348|323351665|FG003|Part I (Base Study)|Participant Moved|7|||
94427830|NCT01739348|323351662|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
94427831|NCT01739348|323351663|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
94427832|NCT01739348|323351664|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
94427833|NCT01739348|323351665|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
94427834|NCT01739348|323351662|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
94427835|NCT01739348|323351663|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
94427836|NCT01739348|323351664|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
94427837|NCT01739348|323351665|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
94427838|NCT01739348|323351662|FG000|Part II (Extension Study)|Adverse Event|10|||
94427839|NCT01739348|323351663|FG001|Part II (Extension Study)|Adverse Event|11|||
94427840|NCT01739348|323351664|FG002|Part II (Extension Study)|Adverse Event|7|||
94427841|NCT01739348|323351665|FG003|Part II (Extension Study)|Adverse Event|26|||
94427842|NCT01739348|323351662|FG000|Part II (Extension Study)|Death|3|||
94427843|NCT01739348|323351663|FG001|Part II (Extension Study)|Death|3|||
94427844|NCT01739348|323351664|FG002|Part II (Extension Study)|Death|2|||
94427845|NCT01739348|323351665|FG003|Part II (Extension Study)|Death|6|||
94427846|NCT01739348|323351662|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
94427847|NCT01739348|323351663|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
94427848|NCT01739348|323351664|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
94427849|NCT01739348|323351665|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
94427850|NCT01739348|323351662|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
94427851|NCT01739348|323351663|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
94427852|NCT01739348|323351664|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
94427853|NCT01739348|323351665|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
94427854|NCT01739348|323351662|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
94427855|NCT01739348|323351663|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
94427856|NCT01739348|323351664|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
94427857|NCT01739348|323351665|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
94427858|NCT01739348|323351662|FG000|Part II (Extension Study)|Physician Decision|7|||
94427859|NCT01739348|323351663|FG001|Part II (Extension Study)|Physician Decision|11|||
94427860|NCT01739348|323351664|FG002|Part II (Extension Study)|Physician Decision|6|||
94427861|NCT01739348|323351665|FG003|Part II (Extension Study)|Physician Decision|12|||
94427862|NCT01739348|323351662|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
94427863|NCT01739348|323351663|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
94427864|NCT01739348|323351664|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
94427865|NCT01739348|323351665|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
94427866|NCT01739348|323351662|FG000|Part II (Extension Study)|Participant Moved|3|||
94427867|NCT01739348|323351663|FG001|Part II (Extension Study)|Participant Moved|3|||
94427868|NCT01739348|323351664|FG002|Part II (Extension Study)|Participant Moved|0|||
94427869|NCT01739348|323351665|FG003|Part II (Extension Study)|Participant Moved|3|||
94427870|NCT01739348|323351662|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
94427871|NCT01739348|323351663|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
94427872|NCT01739348|323351664|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
94427873|NCT01739348|323351665|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
94427874|NCT01739348|323351662|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
94427875|NCT01739348|323351663|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
94427876|NCT01739348|323351664|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
94427877|NCT01739348|323351665|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
94427878|NCT01377987|323351670|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
94427879|NCT01377987|323351671|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
94427880|NCT01755767|323351674|FG000|Overall Study|Progressive Disease|8|||
94427881|NCT01755767|323351675|FG001|Overall Study|Progressive Disease|7|||
94427882|NCT01755767|323351676|FG002|Overall Study|Progressive Disease|91|||
94427883|NCT01755767|323351677|FG003|Overall Study|Progressive Disease|43|||
94427884|NCT01755767|323351674|FG000|Overall Study|Clinical Disease Progression|4|||
94427885|NCT01755767|323351675|FG001|Overall Study|Clinical Disease Progression|2|||
94427886|NCT01755767|323351676|FG002|Overall Study|Clinical Disease Progression|29|||
94427887|NCT01755767|323351677|FG003|Overall Study|Clinical Disease Progression|20|||
94427888|NCT01755767|323351674|FG000|Overall Study|Radiographic Disease Progression|9|||
94427889|NCT01755767|323351675|FG001|Overall Study|Radiographic Disease Progression|4|||
94427890|NCT01755767|323351676|FG002|Overall Study|Radiographic Disease Progression|44|||
94427891|NCT01755767|323351677|FG003|Overall Study|Radiographic Disease Progression|27|||
94427892|NCT01755767|323351674|FG000|Overall Study|Adverse Event|6|||
94427893|NCT01755767|323351675|FG001|Overall Study|Adverse Event|0|||
94427894|NCT01755767|323351676|FG002|Overall Study|Adverse Event|28|||
94427895|NCT01755767|323351677|FG003|Overall Study|Adverse Event|11|||
94427896|NCT01755767|323351674|FG000|Overall Study|Death|1|||
94427897|NCT01755767|323351675|FG001|Overall Study|Death|2|||
94427898|NCT01755767|323351676|FG002|Overall Study|Death|15|||
94427899|NCT01755767|323351677|FG003|Overall Study|Death|4|||
94427900|NCT01755767|323351674|FG000|Overall Study|Subject Decision|0|||
94427901|NCT01755767|323351675|FG001|Overall Study|Subject Decision|0|||
94427902|NCT01755767|323351676|FG002|Overall Study|Subject Decision|10|||
94427903|NCT01755767|323351677|FG003|Overall Study|Subject Decision|3|||
94427904|NCT01755767|323351674|FG000|Overall Study|Withdrawal by Subject|0|||
94427905|NCT01755767|323351675|FG001|Overall Study|Withdrawal by Subject|0|||
94427906|NCT01755767|323351676|FG002|Overall Study|Withdrawal by Subject|2|||
94427907|NCT01755767|323351677|FG003|Overall Study|Withdrawal by Subject|1|||
94427908|NCT01755767|323351674|FG000|Overall Study|Other|0|||
94427909|NCT01755767|323351675|FG001|Overall Study|Other|0|||
94427910|NCT01755767|323351676|FG002|Overall Study|Other|2|||
94427911|NCT01755767|323351677|FG003|Overall Study|Other|3|||
94427912|NCT01755767|323351674|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
94427913|NCT01755767|323351675|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
94427914|NCT01755767|323351676|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
94427915|NCT01755767|323351677|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
94427916|NCT03464630|323351678|FG000|Overall Study|Lost to Follow-up|62|||
94427917|NCT03464630|323351679|FG001|Overall Study|Lost to Follow-up|52|||
94427918|NCT03464630|323351678|FG000|Overall Study|Withdrawal by Subject|16|||
94427919|NCT03464630|323351679|FG001|Overall Study|Withdrawal by Subject|10|||
94427920|NCT03464630|323351678|FG000|Overall Study|Passive Disengagement|8|||
94427921|NCT03464630|323351679|FG001|Overall Study|Passive Disengagement|4|||
94427922|NCT04480021|323351686|FG000|Overall Study|Lost to Follow-up|3|||
94427923|NCT04480021|323351687|FG001|Overall Study|Lost to Follow-up|4|||
94427924|NCT02081209|323353369|FG000|Overall Study|Withdrawal by Subject|1|||
94427925|NCT04395001|323353370|FG000|Overall Study|Lost to Follow-up|8|||
94427926|NCT04395001|323353371|FG001|Overall Study|Lost to Follow-up|9|||
94427927|NCT04395001|323353372|FG002|Overall Study|Lost to Follow-up|5|||
94427928|NCT04395001|323353370|FG000|Overall Study|Withdrawal by Subject|3|||
94427929|NCT04395001|323353371|FG001|Overall Study|Withdrawal by Subject|1|||
94427930|NCT04395001|323353372|FG002|Overall Study|Withdrawal by Subject|3|||
94427931|NCT04395001|323353370|FG000|Overall Study|missed appointment|7|||
94427932|NCT04395001|323353371|FG001|Overall Study|missed appointment|4|||
94427933|NCT04395001|323353372|FG002|Overall Study|missed appointment|1|||
94427934|NCT02022748|323353373|FG000|Overall Study|Adverse Event|1|||
94427935|NCT02022748|323353374|FG001|Overall Study|Adverse Event|1|||
94427936|NCT02022748|323353375|FG002|Overall Study|Adverse Event|0|||
94427937|NCT02022748|323353373|FG000|Overall Study|Withdrawal by Subject|0|||
94427938|NCT02022748|323353374|FG001|Overall Study|Withdrawal by Subject|1|||
94427939|NCT02022748|323353375|FG002|Overall Study|Withdrawal by Subject|0|||
94427940|NCT02799095|323353377|FG000|Part A|Adverse Event|1|||
94427941|NCT02799095|323353378|FG001|Part A|Adverse Event|0|||
94489768|NCT02349386|323588237|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
94489769|NCT02349386|323588234|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
94489770|NCT02349386|323588235|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
94489771|NCT02349386|323588236|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
94489772|NCT02349386|323588237|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
94489773|NCT02349386|323588234|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
94489774|NCT02349386|323588235|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
94489775|NCT02349386|323588236|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
94489776|NCT02349386|323588237|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
94489777|NCT02349386|323588234|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
94489778|NCT02349386|323588235|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
94489779|NCT02349386|323588236|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
94489780|NCT02349386|323588237|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
94489781|NCT01668797|323588240|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
94489782|NCT01668797|323588241|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
94489783|NCT01668797|323588242|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
94489784|NCT01668797|323588243|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
94489785|NCT01668797|323588240|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
94489786|NCT01668797|323588241|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
94489787|NCT01668797|323588242|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
94489788|NCT01668797|323588243|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
94655539|NCT00927927|324196067|FG007|Overall Study|Withdrawal by Subject|2|||
94427942|NCT02799095|323353379|FG002|Part A|Adverse Event|1|||
94427943|NCT02799095|323353380|FG003|Part A|Adverse Event|4|||
94427944|NCT02799095|323353381|FG004|Part A|Adverse Event|1|||
94427945|NCT02799095|323353382|FG005|Part A|Adverse Event|0|||
94427946|NCT02799095|323353383|FG006|Part A|Adverse Event|0|||
94427947|NCT02799095|323353384|FG007|Part A|Adverse Event|0|||
94427948|NCT02799095|323353385|FG008|Part A|Adverse Event|0|||
94427949|NCT02799095|323353386|FG009|Part A|Adverse Event|0|||
94427950|NCT02799095|323353387|FG010|Part A|Adverse Event|0|||
94427951|NCT02799095|323353388|FG011|Part A|Adverse Event|0|||
94427952|NCT02799095|323353389|FG012|Part A|Adverse Event|0|||
94427953|NCT02799095|323353390|FG013|Part A|Adverse Event|0|||
94427954|NCT02799095|323353391|FG014|Part A|Adverse Event|0|||
94427955|NCT02799095|323353392|FG015|Part A|Adverse Event|0|||
94427956|NCT02799095|323353393|FG016|Part A|Adverse Event|0|||
94427957|NCT02799095|323353377|FG000|Part A|Death|0|||
94427958|NCT02799095|323353378|FG001|Part A|Death|0|||
94427959|NCT02799095|323353379|FG002|Part A|Death|0|||
94427960|NCT02799095|323353380|FG003|Part A|Death|0|||
94427961|NCT02799095|323353381|FG004|Part A|Death|0|||
94427962|NCT02799095|323353382|FG005|Part A|Death|0|||
94427963|NCT02799095|323353383|FG006|Part A|Death|3|||
94427964|NCT02799095|323353384|FG007|Part A|Death|0|||
94427965|NCT02799095|323353385|FG008|Part A|Death|0|||
94427966|NCT02799095|323353386|FG009|Part A|Death|0|||
94427967|NCT02799095|323353387|FG010|Part A|Death|0|||
94427968|NCT02799095|323353388|FG011|Part A|Death|0|||
94427969|NCT02799095|323353389|FG012|Part A|Death|0|||
94427970|NCT02799095|323353390|FG013|Part A|Death|0|||
94427971|NCT02799095|323353391|FG014|Part A|Death|0|||
94427972|NCT02799095|323353392|FG015|Part A|Death|0|||
94427973|NCT02799095|323353393|FG016|Part A|Death|0|||
94427974|NCT02799095|323353377|FG000|Part A|Lost to Follow-up|0|||
94427975|NCT02799095|323353378|FG001|Part A|Lost to Follow-up|1|||
94427976|NCT02799095|323353379|FG002|Part A|Lost to Follow-up|0|||
94427977|NCT02799095|323353380|FG003|Part A|Lost to Follow-up|0|||
94427978|NCT02799095|323353381|FG004|Part A|Lost to Follow-up|0|||
94427979|NCT02799095|323353382|FG005|Part A|Lost to Follow-up|0|||
94427980|NCT02799095|323353383|FG006|Part A|Lost to Follow-up|1|||
94427981|NCT02799095|323353384|FG007|Part A|Lost to Follow-up|0|||
94427982|NCT02799095|323353385|FG008|Part A|Lost to Follow-up|0|||
94427983|NCT02799095|323353386|FG009|Part A|Lost to Follow-up|0|||
94427984|NCT02799095|323353387|FG010|Part A|Lost to Follow-up|0|||
94427985|NCT02799095|323353388|FG011|Part A|Lost to Follow-up|0|||
94427986|NCT02799095|323353389|FG012|Part A|Lost to Follow-up|0|||
94427987|NCT02799095|323353390|FG013|Part A|Lost to Follow-up|0|||
94427988|NCT02799095|323353391|FG014|Part A|Lost to Follow-up|0|||
94427989|NCT02799095|323353392|FG015|Part A|Lost to Follow-up|0|||
94427990|NCT02799095|323353393|FG016|Part A|Lost to Follow-up|0|||
94427991|NCT02799095|323353377|FG000|Part A|Progressive Disease|3|||
94427992|NCT02799095|323353378|FG001|Part A|Progressive Disease|3|||
94427993|NCT02799095|323353379|FG002|Part A|Progressive Disease|3|||
94427994|NCT02799095|323353380|FG003|Part A|Progressive Disease|2|||
94427995|NCT02799095|323353381|FG004|Part A|Progressive Disease|2|||
94427996|NCT02799095|323353382|FG005|Part A|Progressive Disease|0|||
94427997|NCT02799095|323353383|FG006|Part A|Progressive Disease|0|||
94427998|NCT02799095|323353384|FG007|Part A|Progressive Disease|0|||
94427999|NCT02799095|323353385|FG008|Part A|Progressive Disease|0|||
94428000|NCT02799095|323353386|FG009|Part A|Progressive Disease|0|||
94428001|NCT02799095|323353387|FG010|Part A|Progressive Disease|0|||
94428002|NCT02799095|323353388|FG011|Part A|Progressive Disease|0|||
94428003|NCT02799095|323353389|FG012|Part A|Progressive Disease|0|||
94428004|NCT02799095|323353390|FG013|Part A|Progressive Disease|0|||
94428005|NCT02799095|323353391|FG014|Part A|Progressive Disease|0|||
94428006|NCT02799095|323353392|FG015|Part A|Progressive Disease|0|||
94428007|NCT02799095|323353393|FG016|Part A|Progressive Disease|0|||
94428008|NCT02799095|323353377|FG000|Part A|Clinical Progression|1|||
94428009|NCT02799095|323353378|FG001|Part A|Clinical Progression|0|||
94428010|NCT02799095|323353379|FG002|Part A|Clinical Progression|2|||
94428011|NCT02799095|323353380|FG003|Part A|Clinical Progression|1|||
94428012|NCT02799095|323353381|FG004|Part A|Clinical Progression|5|||
94428013|NCT02799095|323353382|FG005|Part A|Clinical Progression|0|||
94428014|NCT02799095|323353383|FG006|Part A|Clinical Progression|0|||
94428015|NCT02799095|323353384|FG007|Part A|Clinical Progression|0|||
94428016|NCT02799095|323353385|FG008|Part A|Clinical Progression|0|||
94428017|NCT02799095|323353386|FG009|Part A|Clinical Progression|0|||
94428018|NCT02799095|323353387|FG010|Part A|Clinical Progression|0|||
94428019|NCT02799095|323353388|FG011|Part A|Clinical Progression|0|||
94428020|NCT02799095|323353389|FG012|Part A|Clinical Progression|0|||
94428021|NCT02799095|323353390|FG013|Part A|Clinical Progression|0|||
94428022|NCT02799095|323353391|FG014|Part A|Clinical Progression|0|||
94428023|NCT02799095|323353392|FG015|Part A|Clinical Progression|0|||
94428024|NCT02799095|323353393|FG016|Part A|Clinical Progression|0|||
94428025|NCT02799095|323353377|FG000|Part A|Protocol Deviation|0|||
94428026|NCT02799095|323353378|FG001|Part A|Protocol Deviation|0|||
94428027|NCT02799095|323353379|FG002|Part A|Protocol Deviation|1|||
94428028|NCT02799095|323353380|FG003|Part A|Protocol Deviation|0|||
94428029|NCT02799095|323353381|FG004|Part A|Protocol Deviation|0|||
94428030|NCT02799095|323353382|FG005|Part A|Protocol Deviation|0|||
94428031|NCT02799095|323353383|FG006|Part A|Protocol Deviation|0|||
94428032|NCT02799095|323353384|FG007|Part A|Protocol Deviation|0|||
94428033|NCT02799095|323353385|FG008|Part A|Protocol Deviation|0|||
94428034|NCT02799095|323353386|FG009|Part A|Protocol Deviation|0|||
94428035|NCT02799095|323353387|FG010|Part A|Protocol Deviation|0|||
94428036|NCT02799095|323353388|FG011|Part A|Protocol Deviation|0|||
94428037|NCT02799095|323353389|FG012|Part A|Protocol Deviation|0|||
94428038|NCT02799095|323353390|FG013|Part A|Protocol Deviation|0|||
94428039|NCT02799095|323353391|FG014|Part A|Protocol Deviation|0|||
94428040|NCT02799095|323353392|FG015|Part A|Protocol Deviation|0|||
94428041|NCT02799095|323353393|FG016|Part A|Protocol Deviation|0|||
94428042|NCT02799095|323353377|FG000|Part A|Withdrawal by Subject|0|||
94428043|NCT02799095|323353378|FG001|Part A|Withdrawal by Subject|0|||
94428044|NCT02799095|323353379|FG002|Part A|Withdrawal by Subject|0|||
94428045|NCT02799095|323353380|FG003|Part A|Withdrawal by Subject|1|||
94428046|NCT02799095|323353381|FG004|Part A|Withdrawal by Subject|3|||
94428047|NCT02799095|323353382|FG005|Part A|Withdrawal by Subject|1|||
94428048|NCT02799095|323353383|FG006|Part A|Withdrawal by Subject|1|||
94428049|NCT02799095|323353384|FG007|Part A|Withdrawal by Subject|0|||
94428050|NCT02799095|323353385|FG008|Part A|Withdrawal by Subject|0|||
94428051|NCT02799095|323353386|FG009|Part A|Withdrawal by Subject|0|||
94428052|NCT02799095|323353387|FG010|Part A|Withdrawal by Subject|0|||
94428053|NCT02799095|323353388|FG011|Part A|Withdrawal by Subject|0|||
94428054|NCT02799095|323353389|FG012|Part A|Withdrawal by Subject|0|||
94428055|NCT02799095|323353390|FG013|Part A|Withdrawal by Subject|0|||
94428056|NCT02799095|323353391|FG014|Part A|Withdrawal by Subject|0|||
94428057|NCT02799095|323353392|FG015|Part A|Withdrawal by Subject|0|||
94428058|NCT02799095|323353393|FG016|Part A|Withdrawal by Subject|0|||
94428059|NCT02799095|323353377|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
94428060|NCT02799095|323353378|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
94428061|NCT02799095|323353379|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
94428062|NCT02799095|323353380|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
94428063|NCT02799095|323353381|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
94428064|NCT02799095|323353382|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
94428065|NCT02799095|323353383|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
94428066|NCT02799095|323353384|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
94428067|NCT02799095|323353385|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
94428068|NCT02799095|323353386|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
94428069|NCT02799095|323353387|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
94428070|NCT02799095|323353388|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
94428071|NCT02799095|323353389|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
94428072|NCT02799095|323353390|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
94428073|NCT02799095|323353391|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
94428074|NCT02799095|323353392|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
94428075|NCT02799095|323353393|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
94428076|NCT02799095|323353377|FG000|Part B|Death|0|||
94428077|NCT02799095|323353378|FG001|Part B|Death|0|||
94428078|NCT02799095|323353379|FG002|Part B|Death|0|||
94428079|NCT02799095|323353380|FG003|Part B|Death|0|||
94428080|NCT02799095|323353381|FG004|Part B|Death|0|||
94428081|NCT02799095|323353382|FG005|Part B|Death|0|||
94428082|NCT02799095|323353383|FG006|Part B|Death|0|||
94428083|NCT02799095|323353384|FG007|Part B|Death|7|||
94428084|NCT02799095|323353385|FG008|Part B|Death|7|||
94428085|NCT02799095|323353386|FG009|Part B|Death|0|||
94428086|NCT02799095|323353387|FG010|Part B|Death|0|||
94428087|NCT02799095|323353388|FG011|Part B|Death|0|||
94428088|NCT02799095|323353389|FG012|Part B|Death|0|||
94428089|NCT02799095|323353390|FG013|Part B|Death|0|||
94428090|NCT02799095|323353391|FG014|Part B|Death|0|||
94428091|NCT02799095|323353392|FG015|Part B|Death|0|||
94428092|NCT02799095|323353393|FG016|Part B|Death|0|||
94428093|NCT02799095|323353377|FG000|Part B|Progressive Disease|0|||
94428094|NCT02799095|323353378|FG001|Part B|Progressive Disease|0|||
94428095|NCT02799095|323353379|FG002|Part B|Progressive Disease|0|||
94428096|NCT02799095|323353380|FG003|Part B|Progressive Disease|0|||
94428097|NCT02799095|323353381|FG004|Part B|Progressive Disease|0|||
94428098|NCT02799095|323353382|FG005|Part B|Progressive Disease|0|||
94428099|NCT02799095|323353383|FG006|Part B|Progressive Disease|0|||
94428100|NCT02799095|323353384|FG007|Part B|Progressive Disease|1|||
94428101|NCT02799095|323353385|FG008|Part B|Progressive Disease|0|||
94428102|NCT02799095|323353386|FG009|Part B|Progressive Disease|0|||
94428103|NCT02799095|323353387|FG010|Part B|Progressive Disease|0|||
94428104|NCT02799095|323353388|FG011|Part B|Progressive Disease|0|||
94428105|NCT02799095|323353389|FG012|Part B|Progressive Disease|0|||
94428106|NCT02799095|323353390|FG013|Part B|Progressive Disease|0|||
94428107|NCT02799095|323353391|FG014|Part B|Progressive Disease|0|||
94428108|NCT02799095|323353392|FG015|Part B|Progressive Disease|0|||
94428109|NCT02799095|323353393|FG016|Part B|Progressive Disease|0|||
94428110|NCT02799095|323353377|FG000|Part B|Withdrawal by Subject|0|||
94428111|NCT02799095|323353378|FG001|Part B|Withdrawal by Subject|0|||
94428112|NCT02799095|323353379|FG002|Part B|Withdrawal by Subject|0|||
94428113|NCT02799095|323353380|FG003|Part B|Withdrawal by Subject|0|||
94428114|NCT02799095|323353381|FG004|Part B|Withdrawal by Subject|0|||
94428115|NCT02799095|323353382|FG005|Part B|Withdrawal by Subject|0|||
94428116|NCT02799095|323353383|FG006|Part B|Withdrawal by Subject|0|||
94428117|NCT02799095|323353384|FG007|Part B|Withdrawal by Subject|10|||
94428118|NCT02799095|323353385|FG008|Part B|Withdrawal by Subject|7|||
94428119|NCT02799095|323353386|FG009|Part B|Withdrawal by Subject|0|||
94428120|NCT02799095|323353387|FG010|Part B|Withdrawal by Subject|0|||
94428121|NCT02799095|323353388|FG011|Part B|Withdrawal by Subject|0|||
94428122|NCT02799095|323353389|FG012|Part B|Withdrawal by Subject|0|||
94428123|NCT02799095|323353390|FG013|Part B|Withdrawal by Subject|0|||
94428124|NCT02799095|323353391|FG014|Part B|Withdrawal by Subject|0|||
94428125|NCT02799095|323353392|FG015|Part B|Withdrawal by Subject|0|||
94428126|NCT02799095|323353393|FG016|Part B|Withdrawal by Subject|0|||
94428127|NCT02799095|323353377|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
94428128|NCT02799095|323353378|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
94428129|NCT02799095|323353379|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
94428130|NCT02799095|323353380|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
94428131|NCT02799095|323353381|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
94428132|NCT02799095|323353382|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
94428133|NCT02799095|323353383|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
94428134|NCT02799095|323353384|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
94428135|NCT02799095|323353385|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
94428136|NCT02799095|323353386|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
94428137|NCT02799095|323353387|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
94428138|NCT02799095|323353388|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
94428139|NCT02799095|323353389|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
94428140|NCT02799095|323353390|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
94428141|NCT02799095|323353391|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
94428142|NCT02799095|323353392|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
94428143|NCT02799095|323353393|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
94428144|NCT02799095|323353377|FG000|Part C|Adverse Event|0|||
94428145|NCT02799095|323353378|FG001|Part C|Adverse Event|0|||
94428146|NCT02799095|323353379|FG002|Part C|Adverse Event|0|||
94428147|NCT02799095|323353380|FG003|Part C|Adverse Event|0|||
94428148|NCT02799095|323353381|FG004|Part C|Adverse Event|0|||
94428149|NCT02799095|323353382|FG005|Part C|Adverse Event|0|||
94428150|NCT02799095|323353383|FG006|Part C|Adverse Event|0|||
94428151|NCT02799095|323353384|FG007|Part C|Adverse Event|0|||
94428152|NCT02799095|323353385|FG008|Part C|Adverse Event|0|||
94428153|NCT02799095|323353386|FG009|Part C|Adverse Event|0|||
94428154|NCT02799095|323353387|FG010|Part C|Adverse Event|3|||
94428155|NCT02799095|323353388|FG011|Part C|Adverse Event|1|||
94428156|NCT02799095|323353389|FG012|Part C|Adverse Event|0|||
94428157|NCT02799095|323353390|FG013|Part C|Adverse Event|1|||
94428158|NCT02799095|323353391|FG014|Part C|Adverse Event|0|||
94428159|NCT02799095|323353392|FG015|Part C|Adverse Event|0|||
94428160|NCT02799095|323353393|FG016|Part C|Adverse Event|0|||
94428161|NCT02799095|323353377|FG000|Part C|Death|0|||
94428162|NCT02799095|323353378|FG001|Part C|Death|0|||
94428163|NCT02799095|323353379|FG002|Part C|Death|0|||
94428164|NCT02799095|323353380|FG003|Part C|Death|0|||
94428165|NCT02799095|323353381|FG004|Part C|Death|0|||
94428166|NCT02799095|323353382|FG005|Part C|Death|0|||
94428167|NCT02799095|323353383|FG006|Part C|Death|0|||
94428168|NCT02799095|323353384|FG007|Part C|Death|0|||
94428169|NCT02799095|323353385|FG008|Part C|Death|0|||
94428170|NCT02799095|323353386|FG009|Part C|Death|0|||
94428171|NCT02799095|323353387|FG010|Part C|Death|7|||
94428172|NCT02799095|323353388|FG011|Part C|Death|5|||
94428173|NCT02799095|323353389|FG012|Part C|Death|6|||
94428174|NCT02799095|323353390|FG013|Part C|Death|8|||
94428175|NCT02799095|323353391|FG014|Part C|Death|1|||
94428176|NCT02799095|323353392|FG015|Part C|Death|8|||
94428177|NCT02799095|323353393|FG016|Part C|Death|1|||
94428178|NCT02799095|323353377|FG000|Part C|Lost to Follow-up|0|||
94428179|NCT02799095|323353378|FG001|Part C|Lost to Follow-up|0|||
94428180|NCT02799095|323353379|FG002|Part C|Lost to Follow-up|0|||
94428181|NCT02799095|323353380|FG003|Part C|Lost to Follow-up|0|||
94428182|NCT02799095|323353381|FG004|Part C|Lost to Follow-up|0|||
94428183|NCT02799095|323353382|FG005|Part C|Lost to Follow-up|0|||
94428184|NCT02799095|323353383|FG006|Part C|Lost to Follow-up|0|||
94428185|NCT02799095|323353384|FG007|Part C|Lost to Follow-up|0|||
94489789|NCT01668797|323588240|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
94489790|NCT01668797|323588241|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
94489791|NCT01668797|323588242|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
94489792|NCT01668797|323588243|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
94489793|NCT01668797|323588240|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
94428186|NCT02799095|323353385|FG008|Part C|Lost to Follow-up|0|||
94428187|NCT02799095|323353386|FG009|Part C|Lost to Follow-up|0|||
94655540|NCT00927927|324196068|FG008|Overall Study|Withdrawal by Subject|0|||
94428188|NCT02799095|323353387|FG010|Part C|Lost to Follow-up|1|||
94428189|NCT02799095|323353388|FG011|Part C|Lost to Follow-up|1|||
94428190|NCT02799095|323353389|FG012|Part C|Lost to Follow-up|1|||
94428191|NCT02799095|323353390|FG013|Part C|Lost to Follow-up|3|||
94428192|NCT02799095|323353391|FG014|Part C|Lost to Follow-up|0|||
94428193|NCT02799095|323353392|FG015|Part C|Lost to Follow-up|0|||
94428194|NCT02799095|323353393|FG016|Part C|Lost to Follow-up|0|||
94428195|NCT02799095|323353377|FG000|Part C|Progressive Disease|0|||
94428196|NCT02799095|323353378|FG001|Part C|Progressive Disease|0|||
94428197|NCT02799095|323353379|FG002|Part C|Progressive Disease|0|||
94428198|NCT02799095|323353380|FG003|Part C|Progressive Disease|0|||
94428199|NCT02799095|323353381|FG004|Part C|Progressive Disease|0|||
94428200|NCT02799095|323353382|FG005|Part C|Progressive Disease|0|||
94428201|NCT02799095|323353383|FG006|Part C|Progressive Disease|0|||
94428202|NCT02799095|323353384|FG007|Part C|Progressive Disease|0|||
94428203|NCT02799095|323353385|FG008|Part C|Progressive Disease|0|||
94428204|NCT02799095|323353386|FG009|Part C|Progressive Disease|2|||
94428205|NCT02799095|323353387|FG010|Part C|Progressive Disease|13|||
94428206|NCT02799095|323353388|FG011|Part C|Progressive Disease|2|||
94428207|NCT02799095|323353389|FG012|Part C|Progressive Disease|0|||
94428208|NCT02799095|323353390|FG013|Part C|Progressive Disease|1|||
94428209|NCT02799095|323353391|FG014|Part C|Progressive Disease|0|||
94428210|NCT02799095|323353392|FG015|Part C|Progressive Disease|0|||
94428211|NCT02799095|323353393|FG016|Part C|Progressive Disease|0|||
94428212|NCT02799095|323353377|FG000|Part C|Clinical Progression|0|||
94428213|NCT02799095|323353378|FG001|Part C|Clinical Progression|0|||
94428214|NCT02799095|323353379|FG002|Part C|Clinical Progression|0|||
94428215|NCT02799095|323353380|FG003|Part C|Clinical Progression|0|||
94428216|NCT02799095|323353381|FG004|Part C|Clinical Progression|0|||
94428217|NCT02799095|323353382|FG005|Part C|Clinical Progression|0|||
94428218|NCT02799095|323353383|FG006|Part C|Clinical Progression|0|||
94428219|NCT02799095|323353384|FG007|Part C|Clinical Progression|0|||
94428220|NCT02799095|323353385|FG008|Part C|Clinical Progression|0|||
94428221|NCT02799095|323353386|FG009|Part C|Clinical Progression|1|||
94428222|NCT02799095|323353387|FG010|Part C|Clinical Progression|3|||
94428223|NCT02799095|323353388|FG011|Part C|Clinical Progression|0|||
94428224|NCT02799095|323353389|FG012|Part C|Clinical Progression|0|||
94428225|NCT02799095|323353390|FG013|Part C|Clinical Progression|1|||
94428226|NCT02799095|323353391|FG014|Part C|Clinical Progression|0|||
94428227|NCT02799095|323353392|FG015|Part C|Clinical Progression|0|||
94428228|NCT02799095|323353393|FG016|Part C|Clinical Progression|0|||
94428229|NCT02799095|323353377|FG000|Part C|Withdrawal by Subject|0|||
94428230|NCT02799095|323353378|FG001|Part C|Withdrawal by Subject|0|||
94428231|NCT02799095|323353379|FG002|Part C|Withdrawal by Subject|0|||
94428232|NCT02799095|323353380|FG003|Part C|Withdrawal by Subject|0|||
94428233|NCT02799095|323353381|FG004|Part C|Withdrawal by Subject|0|||
94428234|NCT02799095|323353382|FG005|Part C|Withdrawal by Subject|0|||
94428235|NCT02799095|323353383|FG006|Part C|Withdrawal by Subject|0|||
94428236|NCT02799095|323353384|FG007|Part C|Withdrawal by Subject|0|||
94428237|NCT02799095|323353385|FG008|Part C|Withdrawal by Subject|0|||
94428238|NCT02799095|323353386|FG009|Part C|Withdrawal by Subject|0|||
94428239|NCT02799095|323353387|FG010|Part C|Withdrawal by Subject|13|||
94428240|NCT02799095|323353388|FG011|Part C|Withdrawal by Subject|15|||
94428241|NCT02799095|323353389|FG012|Part C|Withdrawal by Subject|13|||
94428242|NCT02799095|323353390|FG013|Part C|Withdrawal by Subject|21|||
94428243|NCT02799095|323353391|FG014|Part C|Withdrawal by Subject|0|||
94428244|NCT02799095|323353392|FG015|Part C|Withdrawal by Subject|12|||
94428245|NCT02799095|323353393|FG016|Part C|Withdrawal by Subject|1|||
94428246|NCT02799095|323353377|FG000|Part C|Physician Decision|0|||
94428247|NCT02799095|323353378|FG001|Part C|Physician Decision|0|||
94428248|NCT02799095|323353379|FG002|Part C|Physician Decision|0|||
94428249|NCT02799095|323353380|FG003|Part C|Physician Decision|0|||
94428250|NCT02799095|323353381|FG004|Part C|Physician Decision|0|||
94428251|NCT02799095|323353382|FG005|Part C|Physician Decision|0|||
94428252|NCT02799095|323353383|FG006|Part C|Physician Decision|0|||
94428253|NCT02799095|323353384|FG007|Part C|Physician Decision|0|||
94428254|NCT02799095|323353385|FG008|Part C|Physician Decision|0|||
94428255|NCT02799095|323353386|FG009|Part C|Physician Decision|0|||
94428256|NCT02799095|323353387|FG010|Part C|Physician Decision|1|||
94428257|NCT02799095|323353388|FG011|Part C|Physician Decision|0|||
94428258|NCT02799095|323353389|FG012|Part C|Physician Decision|0|||
94428259|NCT02799095|323353390|FG013|Part C|Physician Decision|0|||
94428260|NCT02799095|323353391|FG014|Part C|Physician Decision|0|||
94428261|NCT02799095|323353392|FG015|Part C|Physician Decision|0|||
94428262|NCT02799095|323353393|FG016|Part C|Physician Decision|0|||
94428263|NCT02799095|323353377|FG000|Part C|Other|0|||
94428264|NCT02799095|323353378|FG001|Part C|Other|0|||
94428265|NCT02799095|323353379|FG002|Part C|Other|0|||
94428266|NCT02799095|323353380|FG003|Part C|Other|0|||
94428267|NCT02799095|323353381|FG004|Part C|Other|0|||
94428268|NCT02799095|323353382|FG005|Part C|Other|0|||
94428269|NCT02799095|323353383|FG006|Part C|Other|0|||
94428270|NCT02799095|323353384|FG007|Part C|Other|0|||
94428271|NCT02799095|323353385|FG008|Part C|Other|0|||
94428272|NCT02799095|323353386|FG009|Part C|Other|0|||
94428273|NCT02799095|323353387|FG010|Part C|Other|0|||
94428274|NCT02799095|323353388|FG011|Part C|Other|2|||
94428275|NCT02799095|323353389|FG012|Part C|Other|2|||
94428276|NCT02799095|323353390|FG013|Part C|Other|0|||
94428277|NCT02799095|323353391|FG014|Part C|Other|0|||
94428278|NCT02799095|323353392|FG015|Part C|Other|0|||
94428279|NCT02799095|323353393|FG016|Part C|Other|0|||
94428280|NCT04347122|323353394|FG000|Overall Study|Physician Decision|0|||
94428281|NCT04347122|323353395|FG001|Overall Study|Physician Decision|3|||
94428282|NCT04347122|323353396|FG002|Overall Study|Physician Decision|3|||
94428283|NCT04347122|323353397|FG003|Overall Study|Physician Decision|6|||
94428284|NCT03047330|323353409|FG000|Sleep Block 1|Withdrawal by Subject|3|||
94428285|NCT04590040|323353412|FG000|Treatment Period|Lost to Follow-up|2|||
94428286|NCT04590040|323353413|FG001|Treatment Period|Lost to Follow-up|5|||
94428287|NCT04590040|323353414|FG002|Treatment Period|Lost to Follow-up|0|||
94428288|NCT04590040|323353412|FG000|Treatment Period|Physician Decision|0|||
94428289|NCT04590040|323353413|FG001|Treatment Period|Physician Decision|0|||
94428290|NCT04590040|323353414|FG002|Treatment Period|Physician Decision|2|||
94428291|NCT00663026|323353421|FG000|Overall Study|Lost to Follow-up|1|||
94428292|NCT00663026|323353422|FG001|Overall Study|Lost to Follow-up|0|||
94428293|NCT00663026|323353423|FG002|Overall Study|Lost to Follow-up|0|||
94428294|NCT00663026|323353421|FG000|Overall Study|Other|1|||
94428295|NCT00663026|323353422|FG001|Overall Study|Other|2|||
94428296|NCT00663026|323353423|FG002|Overall Study|Other|0|||
94428297|NCT00663026|323353421|FG000|Overall Study|Adverse Event|0|||
94428298|NCT00663026|323353422|FG001|Overall Study|Adverse Event|2|||
94428299|NCT00663026|323353423|FG002|Overall Study|Adverse Event|3|||
94428300|NCT00663026|323353421|FG000|Overall Study|Caregiver Request|0|||
94428301|NCT00663026|323353422|FG001|Overall Study|Caregiver Request|2|||
94428302|NCT00663026|323353423|FG002|Overall Study|Caregiver Request|0|||
94428303|NCT00663026|323353421|FG000|Overall Study|Withdrawal by Subject|0|||
94428304|NCT00663026|323353422|FG001|Overall Study|Withdrawal by Subject|0|||
94428305|NCT00663026|323353423|FG002|Overall Study|Withdrawal by Subject|1|||
94428306|NCT02932306|323353425|FG000|Overall Study|Withdrawal by Subject|16|||
94428307|NCT02932306|323353426|FG001|Overall Study|Withdrawal by Subject|25|||
94428308|NCT02932306|323353425|FG000|Overall Study|Adverse Event|3|||
94428309|NCT02932306|323353426|FG001|Overall Study|Adverse Event|0|||
94428310|NCT02932306|323353425|FG000|Overall Study|Pregnancy|2|||
94428311|NCT02932306|323353426|FG001|Overall Study|Pregnancy|0|||
94428312|NCT02932306|323353425|FG000|Overall Study|Protocol Violation|1|||
94428313|NCT02932306|323353426|FG001|Overall Study|Protocol Violation|1|||
94428314|NCT02932306|323353425|FG000|Overall Study|Noncompliance with Study Drug|1|||
94428315|NCT02932306|323353426|FG001|Overall Study|Noncompliance with Study Drug|1|||
94428316|NCT02932306|323353425|FG000|Overall Study|Lost to Follow-up|36|||
94428317|NCT02932306|323353426|FG001|Overall Study|Lost to Follow-up|40|||
94428318|NCT02932306|323353425|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
94428319|NCT02932306|323353426|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
94428320|NCT02932306|323353425|FG000|Overall Study|Lack of Efficacy|0|||
94428321|NCT02932306|323353426|FG001|Overall Study|Lack of Efficacy|2|||
94428322|NCT02932306|323353425|FG000|Overall Study|Worsening condition|2|||
94428323|NCT02932306|323353426|FG001|Overall Study|Worsening condition|0|||
94428324|NCT02932306|323353425|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
94428325|NCT02932306|323353426|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
94428326|NCT03493386|323353430|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
94428327|NCT03493386|323353431|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
94428328|NCT03493386|323353432|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
94428329|NCT03493386|323353433|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
94428330|NCT03151408|323353434|FG000|Overall Study|Adverse Event|24|||
94428331|NCT03151408|323353435|FG001|Overall Study|Adverse Event|23|||
94428332|NCT03151408|323353434|FG000|Overall Study|Death|46|||
94428333|NCT03151408|323353435|FG001|Overall Study|Death|26|||
94428334|NCT03151408|323353434|FG000|Overall Study|Physician Decision|13|||
94428335|NCT03151408|323353435|FG001|Overall Study|Physician Decision|19|||
94428336|NCT03151408|323353434|FG000|Overall Study|Withdrawal by Subject|16|||
94428337|NCT03151408|323353435|FG001|Overall Study|Withdrawal by Subject|20|||
94428338|NCT03151408|323353434|FG000|Overall Study|Progressive disease|45|||
94428339|NCT03151408|323353435|FG001|Overall Study|Progressive disease|61|||
94428340|NCT03151408|323353434|FG000|Overall Study|non-compliance by patient|1|||
94428341|NCT03151408|323353435|FG001|Overall Study|non-compliance by patient|0|||
94428342|NCT03151408|323353434|FG000|Overall Study|other reasons|56|||
94428343|NCT03151408|323353435|FG001|Overall Study|other reasons|52|||
94428344|NCT03151408|323353434|FG000|Overall Study|randomized and not treated|2|||
94428345|NCT03151408|323353435|FG001|Overall Study|randomized and not treated|2|||
94428346|NCT00837473|323353443|FG000|Overall Study|Lost to Follow-up|1|||
94428347|NCT00837473|323353443|FG000|Overall Study|Withdrawal by Subject|2|||
94428348|NCT01635218|323353444|FG000|Overall Study|Lost to Follow-up|3|||
94428349|NCT01635218|323353445|FG001|Overall Study|Lost to Follow-up|7|||
94428350|NCT01635218|323353446|FG002|Overall Study|Lost to Follow-up|6|||
94428351|NCT04576923|323353452|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
94428352|NCT01081834|323353461|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
94428353|NCT01081834|323353462|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
94428354|NCT01081834|323353463|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
94428355|NCT01081834|323353464|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
94428356|NCT01081834|323353465|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
94428357|NCT01081834|323353461|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
94428358|NCT01081834|323353462|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
94428359|NCT01081834|323353463|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
94428360|NCT01081834|323353464|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
94428361|NCT01081834|323353465|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
94428362|NCT01081834|323353461|FG000|Core Period: Baseline to Week 26|Death|1|||
94428363|NCT01081834|323353462|FG001|Core Period: Baseline to Week 26|Death|0|||
94428364|NCT01081834|323353463|FG002|Core Period: Baseline to Week 26|Death|0|||
94428365|NCT01081834|323353464|FG003|Core Period: Baseline to Week 26|Death|0|||
94428366|NCT01081834|323353465|FG004|Core Period: Baseline to Week 26|Death|0|||
94428367|NCT01081834|323353461|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
94428368|NCT01081834|323353462|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
94428369|NCT01081834|323353463|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
94428370|NCT01081834|323353464|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
94428371|NCT01081834|323353465|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
94428372|NCT01081834|323353461|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
94428373|NCT01081834|323353462|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
94489794|NCT01668797|323588241|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
94489795|NCT01668797|323588242|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
94489796|NCT01668797|323588243|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
94489797|NCT01668797|323588240|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
94489798|NCT01668797|323588241|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
94489799|NCT01668797|323588242|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
94489800|NCT01668797|323588243|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
94489801|NCT01668797|323588240|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
94489802|NCT01668797|323588241|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
94489803|NCT01668797|323588242|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
94489804|NCT01668797|323588243|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
94489805|NCT01668797|323588240|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
94489806|NCT01668797|323588241|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
94489807|NCT01668797|323588242|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
94489808|NCT01668797|323588243|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
94489809|NCT01668797|323588240|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
94489810|NCT01668797|323588241|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
94489811|NCT01668797|323588242|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
94489812|NCT01668797|323588243|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
94489813|NCT01668797|323588240|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
94489814|NCT01668797|323588241|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
94489815|NCT01668797|323588242|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
94489816|NCT01668797|323588243|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
94489817|NCT01668797|323588240|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
94489818|NCT01668797|323588241|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
94489819|NCT01668797|323588242|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
94489820|NCT01668797|323588243|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
94489821|NCT01668797|323588240|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
94489822|NCT01668797|323588241|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
94489823|NCT01668797|323588242|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
94489824|NCT01668797|323588243|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
94489825|NCT01668797|323588240|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
94489826|NCT01668797|323588241|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
94489827|NCT01668797|323588242|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
94489828|NCT01668797|323588243|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
94489829|NCT01668797|323588240|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
94489830|NCT01668797|323588241|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
94489831|NCT01668797|323588242|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
94489832|NCT01668797|323588243|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
94489833|NCT01668797|323588240|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
94489834|NCT01668797|323588241|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
94489835|NCT01668797|323588242|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
94489836|NCT01668797|323588243|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
94428374|NCT01081834|323353463|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
94428375|NCT01081834|323353464|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
94428376|NCT01081834|323353465|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
94489837|NCT01668797|323588240|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
94489838|NCT01668797|323588241|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
94489839|NCT01668797|323588242|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
94428377|NCT01081834|323353461|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
94428378|NCT01081834|323353462|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
94428379|NCT01081834|323353463|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
94489840|NCT01668797|323588243|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
94428380|NCT01081834|323353464|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
94428381|NCT01081834|323353465|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
94428382|NCT01081834|323353461|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
94428383|NCT01081834|323353462|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
94428384|NCT01081834|323353463|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
94428385|NCT01081834|323353464|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
94428386|NCT01081834|323353465|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
94428387|NCT01081834|323353461|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
94428388|NCT01081834|323353462|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
94428389|NCT01081834|323353463|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
94428390|NCT01081834|323353464|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
94428391|NCT01081834|323353465|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
94428392|NCT01081834|323353461|FG000|Core Period: Baseline to Week 26|Other|4|||
94428393|NCT01081834|323353462|FG001|Core Period: Baseline to Week 26|Other|4|||
94428394|NCT01081834|323353463|FG002|Core Period: Baseline to Week 26|Other|3|||
94428395|NCT01081834|323353464|FG003|Core Period: Baseline to Week 26|Other|1|||
94428396|NCT01081834|323353465|FG004|Core Period: Baseline to Week 26|Other|0|||
94428397|NCT01081834|323353461|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
94428398|NCT01081834|323353462|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
94428399|NCT01081834|323353463|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
94428400|NCT01081834|323353464|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
94428401|NCT01081834|323353465|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
94428402|NCT01081834|323353461|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
94428403|NCT01081834|323353462|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
94428404|NCT01081834|323353463|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
94428405|NCT01081834|323353464|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
94428406|NCT01081834|323353465|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
94428407|NCT01081834|323353461|FG000|Extension Period: Week 26 to Week 52|Death|1|||
94428408|NCT01081834|323353462|FG001|Extension Period: Week 26 to Week 52|Death|0|||
94428409|NCT01081834|323353463|FG002|Extension Period: Week 26 to Week 52|Death|0|||
94428410|NCT01081834|323353464|FG003|Extension Period: Week 26 to Week 52|Death|0|||
94428411|NCT01081834|323353465|FG004|Extension Period: Week 26 to Week 52|Death|0|||
94428412|NCT01081834|323353461|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
94428413|NCT01081834|323353462|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
94428414|NCT01081834|323353463|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
94428415|NCT01081834|323353464|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
94428416|NCT01081834|323353465|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
94428417|NCT01081834|323353461|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
94428418|NCT01081834|323353462|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
94428419|NCT01081834|323353463|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
94428420|NCT01081834|323353464|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
94428421|NCT01081834|323353465|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
94428422|NCT01081834|323353461|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
94428423|NCT01081834|323353462|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
94428424|NCT01081834|323353463|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
94428425|NCT01081834|323353464|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
94428426|NCT01081834|323353465|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
94428427|NCT01081834|323353461|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
94428428|NCT01081834|323353462|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
94428429|NCT01081834|323353463|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
94428430|NCT01081834|323353464|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
94428431|NCT01081834|323353465|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
94428432|NCT01081834|323353461|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
94428433|NCT01081834|323353462|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
94428434|NCT01081834|323353463|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
94428435|NCT01081834|323353464|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
94428436|NCT01081834|323353465|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
94428437|NCT01081834|323353461|FG000|Extension Period: Week 26 to Week 52|Other|4|||
94428438|NCT01081834|323353462|FG001|Extension Period: Week 26 to Week 52|Other|5|||
94428439|NCT01081834|323353463|FG002|Extension Period: Week 26 to Week 52|Other|4|||
94428440|NCT01081834|323353464|FG003|Extension Period: Week 26 to Week 52|Other|0|||
94428441|NCT01081834|323353465|FG004|Extension Period: Week 26 to Week 52|Other|0|||
94489841|NCT01668797|323588240|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
94428442|NCT01081834|323353461|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
94428443|NCT01081834|323353462|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
94428444|NCT01081834|323353463|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
94428445|NCT01081834|323353464|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
94428446|NCT01081834|323353465|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
94428447|NCT01081834|323353461|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
94428448|NCT01081834|323353462|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
94428449|NCT01081834|323353463|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
94428450|NCT01081834|323353464|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
94428451|NCT01081834|323353465|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
94428452|NCT01085734|323353466|FG000|Overall Study|Adverse Event|0|||
94428453|NCT01085734|323353467|FG001|Overall Study|Adverse Event|2|||
94428454|NCT01085734|323353466|FG000|Overall Study|Death|1|||
94428455|NCT01085734|323353467|FG001|Overall Study|Death|0|||
94428456|NCT01085734|323353466|FG000|Overall Study|Lost to Follow-up|0|||
94428457|NCT01085734|323353467|FG001|Overall Study|Lost to Follow-up|1|||
94428458|NCT01085734|323353466|FG000|Overall Study|Withdrawal by Subject|0|||
94428459|NCT01085734|323353467|FG001|Overall Study|Withdrawal by Subject|1|||
94428460|NCT00554606|323353468|FG000|Overall Study|Adverse Event|3|||
94428461|NCT00554606|323353468|FG000|Overall Study|Abnormal laboratory values|1|||
94428462|NCT00554606|323353468|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
94428463|NCT00554606|323353468|FG000|Overall Study|Subject withdrew consent|2|||
94428464|NCT00554606|323353468|FG000|Overall Study|Lost to Follow-up|2|||
94428465|NCT00554606|323353468|FG000|Overall Study|Administrative problems|60|||
94428466|NCT00554606|323353468|FG000|Overall Study|Death|1|||
94428467|NCT00554606|323353468|FG000|Overall Study|Protocol deviation|2|||
94428468|NCT00049530|323353475|FG000|Overall Study|Lack of Efficacy|25|||
94428469|NCT00049530|323353475|FG000|Overall Study|Adverse Event|2|||
94428470|NCT00049530|323353475|FG000|Overall Study|Death|1|||
94428471|NCT00049530|323353475|FG000|Overall Study|symptomatic deterioration|1|||
94428472|NCT00049530|323353475|FG000|Overall Study|ineligible|3|||
94428473|NCT02383810|323353476|FG000|Overall Study|Physician Decision|1|||
94428474|NCT02383810|323353477|FG001|Overall Study|Physician Decision|1|||
94428475|NCT02383810|323353478|FG002|Overall Study|Physician Decision|0|||
94428476|NCT02383810|323353479|FG003|Overall Study|Physician Decision|0|||
94428477|NCT02383810|323353480|FG004|Overall Study|Physician Decision|0|||
94428478|NCT02383810|323353481|FG005|Overall Study|Physician Decision|0|||
94428479|NCT02383810|323353482|FG006|Overall Study|Physician Decision|0|||
94428480|NCT02383810|323353483|FG007|Overall Study|Physician Decision|0|||
94428481|NCT02383810|323353476|FG000|Overall Study|Withdrawal by Subject|2|||
94428482|NCT02383810|323353477|FG001|Overall Study|Withdrawal by Subject|3|||
94428483|NCT02383810|323353478|FG002|Overall Study|Withdrawal by Subject|3|||
94428484|NCT02383810|323353479|FG003|Overall Study|Withdrawal by Subject|3|||
94428485|NCT02383810|323353480|FG004|Overall Study|Withdrawal by Subject|0|||
94428486|NCT02383810|323353481|FG005|Overall Study|Withdrawal by Subject|0|||
94428487|NCT02383810|323353482|FG006|Overall Study|Withdrawal by Subject|0|||
94428488|NCT02383810|323353483|FG007|Overall Study|Withdrawal by Subject|0|||
94428489|NCT02383810|323353476|FG000|Overall Study|Adverse Event|0|||
94428490|NCT02383810|323353477|FG001|Overall Study|Adverse Event|2|||
94428491|NCT02383810|323353478|FG002|Overall Study|Adverse Event|4|||
94428492|NCT02383810|323353479|FG003|Overall Study|Adverse Event|5|||
94428493|NCT02383810|323353480|FG004|Overall Study|Adverse Event|0|||
94428494|NCT02383810|323353481|FG005|Overall Study|Adverse Event|1|||
94428495|NCT02383810|323353482|FG006|Overall Study|Adverse Event|1|||
94428496|NCT02383810|323353483|FG007|Overall Study|Adverse Event|0|||
94428497|NCT02383810|323353476|FG000|Overall Study|Lost to Follow-up|0|||
94489842|NCT01668797|323588241|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
94428498|NCT02383810|323353477|FG001|Overall Study|Lost to Follow-up|1|||
94428499|NCT02383810|323353478|FG002|Overall Study|Lost to Follow-up|0|||
94428500|NCT02383810|323353479|FG003|Overall Study|Lost to Follow-up|1|||
94428501|NCT02383810|323353480|FG004|Overall Study|Lost to Follow-up|0|||
94428502|NCT02383810|323353481|FG005|Overall Study|Lost to Follow-up|0|||
94428503|NCT02383810|323353482|FG006|Overall Study|Lost to Follow-up|0|||
94428504|NCT02383810|323353483|FG007|Overall Study|Lost to Follow-up|0|||
94428505|NCT02383810|323353476|FG000|Overall Study|other|0|||
94428506|NCT02383810|323353477|FG001|Overall Study|other|0|||
94428507|NCT02383810|323353478|FG002|Overall Study|other|0|||
94428508|NCT02383810|323353479|FG003|Overall Study|other|2|||
94428509|NCT02383810|323353480|FG004|Overall Study|other|0|||
94428510|NCT02383810|323353481|FG005|Overall Study|other|0|||
94428511|NCT02383810|323353482|FG006|Overall Study|other|0|||
94428512|NCT02383810|323353483|FG007|Overall Study|other|0|||
94428513|NCT02383810|323353476|FG000|Overall Study|subject did not receive study treatment|0|||
94428514|NCT02383810|323353477|FG001|Overall Study|subject did not receive study treatment|1|||
94428515|NCT02383810|323353478|FG002|Overall Study|subject did not receive study treatment|0|||
94428516|NCT02383810|323353479|FG003|Overall Study|subject did not receive study treatment|0|||
94428517|NCT02383810|323353480|FG004|Overall Study|subject did not receive study treatment|0|||
94428518|NCT02383810|323353481|FG005|Overall Study|subject did not receive study treatment|0|||
94428519|NCT02383810|323353482|FG006|Overall Study|subject did not receive study treatment|0|||
94428520|NCT02383810|323353483|FG007|Overall Study|subject did not receive study treatment|0|||
94428521|NCT00492024|323353487|FG000|Treatment|Adverse Event|3|||
94428522|NCT00492024|323353488|FG001|Treatment|Adverse Event|1|||
94428523|NCT00492024|323353487|FG000|Treatment|Lack of Efficacy|21|||
94428524|NCT00492024|323353488|FG001|Treatment|Lack of Efficacy|20|||
94428525|NCT00492024|323353487|FG000|Treatment|Lost to Follow-up|3|||
94428526|NCT00492024|323353488|FG001|Treatment|Lost to Follow-up|1|||
94428527|NCT00492024|323353487|FG000|Treatment|Withdrawal by Subject|2|||
94428528|NCT00492024|323353488|FG001|Treatment|Withdrawal by Subject|0|||
94428529|NCT00492024|323353487|FG000|Follow up|Lack of Efficacy|0|||
94428530|NCT00492024|323353488|FG001|Follow up|Lack of Efficacy|1|||
94428531|NCT00492024|323353487|FG000|Follow up|Lost to Follow-up|1|||
94428532|NCT00492024|323353488|FG001|Follow up|Lost to Follow-up|1|||
94428533|NCT01221363|323353491|FG000|Overall Study|Pregnancy|1|||
94428534|NCT01221363|323353492|FG001|Overall Study|Pregnancy|0|||
94428535|NCT01221363|323353491|FG000|Overall Study|Withdrawal by Subject|11|||
94428536|NCT01221363|323353492|FG001|Overall Study|Withdrawal by Subject|5|||
94428537|NCT04040192|323353493|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
94428538|NCT04040192|323353494|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
94428539|NCT04040192|323353495|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
94428540|NCT04040192|323353493|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
94428541|NCT04040192|323353494|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
94428542|NCT04040192|323353495|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
94428543|NCT04040192|323353493|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
94428544|NCT04040192|323353494|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
94428545|NCT04040192|323353495|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
94428546|NCT04040192|323353493|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
94428547|NCT04040192|323353494|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
94428548|NCT04040192|323353495|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
94428549|NCT04040192|323353493|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
94428550|NCT04040192|323353494|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
94428551|NCT04040192|323353495|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
94489843|NCT01668797|323588242|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
94489844|NCT01668797|323588243|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
94489845|NCT01668797|323588240|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
94489846|NCT01668797|323588241|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
94489847|NCT01668797|323588242|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
94489848|NCT01668797|323588243|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
94489849|NCT01668797|323588240|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
94489850|NCT01668797|323588241|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
94489851|NCT01668797|323588242|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
94489852|NCT01668797|323588243|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
94489853|NCT01668797|323588240|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
94489854|NCT01668797|323588241|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
94489855|NCT01668797|323588242|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
94489856|NCT01668797|323588243|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
94489857|NCT01668797|323588240|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
94489858|NCT01668797|323588241|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
94489859|NCT01668797|323588242|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
94489860|NCT01668797|323588243|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
94489861|NCT01668797|323588240|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
94489862|NCT01668797|323588241|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
94489863|NCT01668797|323588242|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
94489864|NCT01668797|323588243|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
94489865|NCT01668797|323588240|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
94428552|NCT04040192|323353493|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
94428553|NCT04040192|323353494|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
94428554|NCT04040192|323353495|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
94428555|NCT04040192|323353493|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
94428556|NCT04040192|323353494|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
94428557|NCT04040192|323353495|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
94428558|NCT04040192|323353493|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
94428559|NCT04040192|323353494|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
94428560|NCT04040192|323353495|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
94428561|NCT04040192|323353493|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
94428562|NCT04040192|323353494|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
94428563|NCT04040192|323353495|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
94428564|NCT04040192|323353493|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
94428565|NCT04040192|323353494|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
94428566|NCT04040192|323353495|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
94428567|NCT04040192|323353493|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
94428568|NCT04040192|323353494|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
94428569|NCT04040192|323353495|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
94428570|NCT04040192|323353493|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
94428571|NCT04040192|323353494|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
94428572|NCT04040192|323353495|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
94428573|NCT04040192|323353493|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
94428574|NCT04040192|323353494|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
94428575|NCT04040192|323353495|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
94428576|NCT04040192|323353493|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
94428577|NCT04040192|323353494|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
94428578|NCT04040192|323353495|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
94428579|NCT04040192|323353493|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
94428580|NCT04040192|323353494|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
94428581|NCT04040192|323353495|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
94428582|NCT04040192|323353493|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
94428583|NCT04040192|323353494|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
94428584|NCT04040192|323353495|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
94428585|NCT04040192|323353493|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
94428586|NCT04040192|323353494|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
94428587|NCT04040192|323353495|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
94428588|NCT03597529|323353496|FG000|Overall Study|Lost to Follow-up|10|||
94428589|NCT03597529|323353497|FG001|Overall Study|Lost to Follow-up|12|||
94428590|NCT03597529|323353496|FG000|Overall Study|Physician Decision|3|||
94428591|NCT03597529|323353497|FG001|Overall Study|Physician Decision|1|||
94428592|NCT03597529|323353496|FG000|Overall Study|Withdrawal by Subject|6|||
94428593|NCT03597529|323353497|FG001|Overall Study|Withdrawal by Subject|3|||
94428594|NCT03597529|323353496|FG000|Overall Study|Non-compliant with study activities|1|||
94428595|NCT03597529|323353497|FG001|Overall Study|Non-compliant with study activities|2|||
94428596|NCT02792699|323353498|FG000|Overall Study|Adverse Event|1|||
94428597|NCT02792699|323353499|FG001|Overall Study|Adverse Event|2|||
94428598|NCT02792699|323353500|FG002|Overall Study|Adverse Event|4|||
94428599|NCT02792699|323353498|FG000|Overall Study|Withdrawal by Subject|4|||
94428600|NCT02792699|323353499|FG001|Overall Study|Withdrawal by Subject|4|||
94428601|NCT02792699|323353500|FG002|Overall Study|Withdrawal by Subject|3|||
94428602|NCT02792699|323353498|FG000|Overall Study|Lost to Follow-up|0|||
94428603|NCT02792699|323353499|FG001|Overall Study|Lost to Follow-up|1|||
94428604|NCT02792699|323353500|FG002|Overall Study|Lost to Follow-up|2|||
94428605|NCT02792699|323353498|FG000|Overall Study|Physician Decision|2|||
94428606|NCT02792699|323353499|FG001|Overall Study|Physician Decision|0|||
94428607|NCT02792699|323353500|FG002|Overall Study|Physician Decision|0|||
94428608|NCT02792699|323353498|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
94428609|NCT02792699|323353499|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
94428610|NCT02792699|323353500|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
94428611|NCT02792699|323353498|FG000|Overall Study|Other|1|||
94428612|NCT02792699|323353499|FG001|Overall Study|Other|0|||
94428613|NCT02792699|323353500|FG002|Overall Study|Other|0|||
94428614|NCT00191165|323353505|FG000|Overall Study|Adverse Event|2|||
94428615|NCT00191165|323353506|FG001|Overall Study|Adverse Event|0|||
94428616|NCT00191165|323353505|FG000|Overall Study|Protocol Violation|0|||
94428617|NCT00191165|323353506|FG001|Overall Study|Protocol Violation|1|||
94428618|NCT00191165|323353505|FG000|Overall Study|Participant Moved Away|0|||
94428619|NCT00191165|323353506|FG001|Overall Study|Participant Moved Away|1|||
94428620|NCT02238795|323353512|FG000|Overall Study|Patient without purpura fulminans|1|||
94428621|NCT04480710|323353513|FG000|Overall Study|Adverse Event|0|||
94428622|NCT04480710|323353514|FG001|Overall Study|Adverse Event|2|||
94428623|NCT04480710|323353515|FG002|Overall Study|Adverse Event|0|||
94428624|NCT04480710|323353516|FG003|Overall Study|Adverse Event|0|||
94489866|NCT01668797|323588241|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
94489867|NCT01668797|323588242|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
94489868|NCT01668797|323588243|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
94428625|NCT04480710|323353513|FG000|Overall Study|Withdrawal by Subject|0|||
94428626|NCT04480710|323353514|FG001|Overall Study|Withdrawal by Subject|1|||
94428627|NCT04480710|323353515|FG002|Overall Study|Withdrawal by Subject|0|||
94428628|NCT04480710|323353516|FG003|Overall Study|Withdrawal by Subject|0|||
94428629|NCT04480710|323353513|FG000|Overall Study|Physician Decision|0|||
94428630|NCT04480710|323353514|FG001|Overall Study|Physician Decision|0|||
94428631|NCT04480710|323353515|FG002|Overall Study|Physician Decision|1|||
94428632|NCT04480710|323353516|FG003|Overall Study|Physician Decision|0|||
94428633|NCT04083781|323353517|FG000|Main Part|Physician Decision|0|||
94428634|NCT04083781|323353518|FG001|Main Part|Physician Decision|1|||
94428635|NCT04083781|323353519|FG002|Main Part|Physician Decision|2|||
94428636|NCT04083781|323353520|FG003|Main Part|Physician Decision|0|||
94428637|NCT04083781|323353517|FG000|Main Part|Death|1|||
94428638|NCT04083781|323353518|FG001|Main Part|Death|3|||
94428639|NCT04083781|323353519|FG002|Main Part|Death|1|||
94428640|NCT04083781|323353520|FG003|Main Part|Death|0|||
94428641|NCT04083781|323353517|FG000|Main Part|Withdrawal by Subject|5|||
94428642|NCT04083781|323353518|FG001|Main Part|Withdrawal by Subject|2|||
94428643|NCT04083781|323353519|FG002|Main Part|Withdrawal by Subject|3|||
94428644|NCT04083781|323353520|FG003|Main Part|Withdrawal by Subject|7|||
94428645|NCT04083781|323353517|FG000|Extension Part|Physician Decision|0|||
94428646|NCT04083781|323353518|FG001|Extension Part|Physician Decision|0|||
94428647|NCT04083781|323353519|FG002|Extension Part|Physician Decision|0|||
94428648|NCT04083781|323353520|FG003|Extension Part|Physician Decision|1|||
94428649|NCT04083781|323353517|FG000|Extension Part|Death|0|||
94428650|NCT04083781|323353518|FG001|Extension Part|Death|1|||
94428651|NCT04083781|323353519|FG002|Extension Part|Death|0|||
94428652|NCT04083781|323353520|FG003|Extension Part|Death|1|||
94428653|NCT04083781|323353517|FG000|Extension Part|Withdrawal by Subject|0|||
94428654|NCT04083781|323353518|FG001|Extension Part|Withdrawal by Subject|1|||
94428655|NCT04083781|323353519|FG002|Extension Part|Withdrawal by Subject|0|||
94428656|NCT04083781|323353520|FG003|Extension Part|Withdrawal by Subject|0|||
94428657|NCT04083781|323353517|FG000|Extension Part|Ongoing|13|||
94428658|NCT04083781|323353518|FG001|Extension Part|Ongoing|25|||
94428659|NCT04083781|323353519|FG002|Extension Part|Ongoing|15|||
94428660|NCT04083781|323353520|FG003|Extension Part|Ongoing|51|||
94428661|NCT02639052|323353521|FG000|Overall Study|Lost to Follow-up|1|||
94428662|NCT00426361|323353523|FG000|Overall Study|Lost to Follow-up|3|||
94428663|NCT00426361|323353524|FG001|Overall Study|Lost to Follow-up|2|||
94428664|NCT00426361|323353525|FG002|Overall Study|Lost to Follow-up|5|||
94428665|NCT00426361|323353523|FG000|Overall Study|Withdrawal by Subject|1|||
94428666|NCT00426361|323353524|FG001|Overall Study|Withdrawal by Subject|3|||
94428667|NCT00426361|323353525|FG002|Overall Study|Withdrawal by Subject|0|||
94428668|NCT00633243|323354863|FG000|Overall Study|Withdrawal by Subject|0|||
94428669|NCT00633243|323354864|FG001|Overall Study|Withdrawal by Subject|1|||
94428670|NCT00633243|323354863|FG000|Overall Study|incarceration|0|||
94428671|NCT00633243|323354864|FG001|Overall Study|incarceration|2|||
94428672|NCT00633243|323354863|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
94428673|NCT00633243|323354864|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
94428674|NCT00633243|323354863|FG000|Overall Study|Not comfortable with self-injecting|0|||
94428675|NCT00633243|323354864|FG001|Overall Study|Not comfortable with self-injecting|1|||
94428676|NCT00633243|323354863|FG000|Overall Study|Mental Health--Depression|0|||
94428677|NCT00633243|323354864|FG001|Overall Study|Mental Health--Depression|1|||
94428678|NCT00633243|323354863|FG000|Overall Study|Couldn't tolerate side-effects|1|||
94428679|NCT00633243|323354864|FG001|Overall Study|Couldn't tolerate side-effects|1|||
94428680|NCT01570686|323354865|FG000|Overall Study|Abnormal test procedure result(s)|1|||
94428681|NCT01570686|323354866|FG001|Overall Study|Abnormal test procedure result(s)|1|||
94428682|NCT01570686|323354865|FG000|Overall Study|Administrative problems|0|||
94428683|NCT01570686|323354866|FG001|Overall Study|Administrative problems|1|||
94428684|NCT01570686|323354865|FG000|Overall Study|Adverse Event|8|||
94428685|NCT01570686|323354866|FG001|Overall Study|Adverse Event|6|||
94489869|NCT01668797|323588240|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
94428686|NCT01570686|323354865|FG000|Overall Study|Lost to Follow-up|4|||
94428687|NCT01570686|323354866|FG001|Overall Study|Lost to Follow-up|3|||
94428688|NCT01570686|323354865|FG000|Overall Study|Protocol Deviation|3|||
94428689|NCT01570686|323354866|FG001|Overall Study|Protocol Deviation|0|||
94428690|NCT01570686|323354865|FG000|Overall Study|Withdrawal by Subject|4|||
94428691|NCT01570686|323354866|FG001|Overall Study|Withdrawal by Subject|4|||
94428692|NCT01570686|323354865|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
94428693|NCT01570686|323354866|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
94428694|NCT00805675|323354869|FG000|Overall Study|Adverse Event|0|||
94428695|NCT00805675|323354870|FG001|Overall Study|Adverse Event|0|||
94428696|NCT00805675|323354871|FG002|Overall Study|Adverse Event|1|||
94428697|NCT00699374|323354877|FG000|Overall Study|Death|93|||
94428698|NCT00699374|323354878|FG001|Overall Study|Death|83|||
94428699|NCT00699374|323354877|FG000|Overall Study|Adverse Event|70|||
94428700|NCT00699374|323354878|FG001|Overall Study|Adverse Event|67|||
94428701|NCT00699374|323354877|FG000|Overall Study|Global deterioration of health status|7|||
94428702|NCT00699374|323354878|FG001|Overall Study|Global deterioration of health status|8|||
94428703|NCT00699374|323354877|FG000|Overall Study|Lost to Follow-up|3|||
94428704|NCT00699374|323354878|FG001|Overall Study|Lost to Follow-up|5|||
94428705|NCT00699374|323354877|FG000|Overall Study|Withdrawal by Subject|34|||
94428706|NCT00699374|323354878|FG001|Overall Study|Withdrawal by Subject|44|||
94428707|NCT00699374|323354877|FG000|Overall Study|Objective progression or relapse|281|||
94428708|NCT00699374|323354878|FG001|Overall Study|Objective progression or relapse|277|||
94428709|NCT00699374|323354877|FG000|Overall Study|Other|18|||
94428710|NCT00699374|323354878|FG001|Overall Study|Other|15|||
94428711|NCT00699374|323354877|FG000|Overall Study|Protocol Violation|2|||
94428712|NCT00699374|323354878|FG001|Overall Study|Protocol Violation|6|||
94428713|NCT00699374|323354877|FG000|Overall Study|Study terminated by sponsor|13|||
94428714|NCT00699374|323354878|FG001|Overall Study|Study terminated by sponsor|28|||
94428715|NCT00699374|323354877|FG000|Overall Study|Randomized but not treated|4|||
94428716|NCT00699374|323354878|FG001|Overall Study|Randomized but not treated|2|||
94428717|NCT00699374|323354877|FG000|Overall Study|Died 28 days after last dose|5|||
94428718|NCT00699374|323354878|FG001|Overall Study|Died 28 days after last dose|9|||
94428719|NCT01199471|323354879|FG000|Overall Study|Protocol Violation|4|||
94428720|NCT01199471|323354879|FG000|Overall Study|Withdrawal by Subject|1|||
94428721|NCT01199471|323354879|FG000|Overall Study|Physician Decision|1|||
94428722|NCT00470067|323354880|FG000|Overall Study|Death|1|||
94428723|NCT00470067|323354880|FG000|Overall Study|Disease Progression|6|||
94428724|NCT03559400|323354881|FG000|Overall Study|Lost to Follow-up|9|||
94428725|NCT03559400|323354882|FG001|Overall Study|Lost to Follow-up|7|||
94428726|NCT03559400|323354881|FG000|Overall Study|Death|0|||
94428727|NCT03559400|323354882|FG001|Overall Study|Death|2|||
94428728|NCT01544179|323354883|FG000|Overall Study|Death|50|||
94428729|NCT01544179|323354884|FG001|Overall Study|Death|37|||
94428730|NCT01544179|323354883|FG000|Overall Study|Lost to Follow-up|0|||
94428731|NCT01544179|323354884|FG001|Overall Study|Lost to Follow-up|1|||
94428732|NCT01544179|323354883|FG000|Overall Study|Adverse Event|0|||
94428733|NCT01544179|323354884|FG001|Overall Study|Adverse Event|1|||
94428734|NCT01544179|323354883|FG000|Overall Study|Withdrawal by Subject|12|||
94428735|NCT01544179|323354884|FG001|Overall Study|Withdrawal by Subject|7|||
94428736|NCT01544179|323354883|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
94428737|NCT01544179|323354884|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
94428738|NCT01085201|323354885|FG000|Overall Study|Scheduling conflict|1|||
94428739|NCT01085201|323354886|FG001|Overall Study|Scheduling conflict|0|||
94428740|NCT01085201|323354887|FG002|Overall Study|Scheduling conflict|1|||
94428741|NCT01085201|323354888|FG003|Overall Study|Scheduling conflict|0|||
94428742|NCT01085201|323354889|FG004|Overall Study|Scheduling conflict|0|||
94428743|NCT01085201|323354885|FG000|Overall Study|Unknown- no study drug|2|||
94428744|NCT01085201|323354886|FG001|Overall Study|Unknown- no study drug|0|||
94428745|NCT01085201|323354887|FG002|Overall Study|Unknown- no study drug|0|||
94428746|NCT01085201|323354888|FG003|Overall Study|Unknown- no study drug|0|||
94428747|NCT01085201|323354889|FG004|Overall Study|Unknown- no study drug|0|||
94428748|NCT01085201|323354885|FG000|Overall Study|Fond ineligible after consent|0|||
94428749|NCT01085201|323354886|FG001|Overall Study|Fond ineligible after consent|1|||
94428750|NCT01085201|323354887|FG002|Overall Study|Fond ineligible after consent|1|||
94428751|NCT01085201|323354888|FG003|Overall Study|Fond ineligible after consent|0|||
94428752|NCT01085201|323354889|FG004|Overall Study|Fond ineligible after consent|0|||
94428753|NCT04497948|323354891|FG000|Overall Study|Death|2|||
94428754|NCT00849186|323354894|FG000|Overall Study|Adverse Event|2|||
94428755|NCT00849186|323354894|FG000|Overall Study|Withdrawal by Subject|1|||
94428756|NCT00849186|323354894|FG000|Overall Study|not treated|6|||
94428757|NCT00849186|323354894|FG000|Overall Study|Other|1|||
94428758|NCT03247816|323354897|FG000|Overall Study|Adverse Event|12|||
94428759|NCT03247816|323354897|FG000|Overall Study|Physician Decision|3|||
94428760|NCT03247816|323354897|FG000|Overall Study|Lack of Efficacy|1|||
94428761|NCT03247816|323354897|FG000|Overall Study|Lost to Follow-up|10|||
94428762|NCT03247816|323354897|FG000|Overall Study|Missing Feraccru stop date|3|||
94428763|NCT00936897|323354900|FG000|Overall Study|Withdrawal by Subject|9|||
94428764|NCT00936897|323354901|FG001|Overall Study|Withdrawal by Subject|19|||
94428765|NCT00936897|323354900|FG000|Overall Study|Adverse Event|4|||
94428766|NCT00936897|323354901|FG001|Overall Study|Adverse Event|13|||
94428767|NCT00936897|323354900|FG000|Overall Study|Other|3|||
94428768|NCT00936897|323354901|FG001|Overall Study|Other|9|||
94428769|NCT00936897|323354900|FG000|Overall Study|Lost to Follow-up|1|||
94428770|NCT00936897|323354901|FG001|Overall Study|Lost to Follow-up|10|||
94428771|NCT00936897|323354900|FG000|Overall Study|Administrative Decision|1|||
94428772|NCT00936897|323354901|FG001|Overall Study|Administrative Decision|2|||
94428773|NCT00936897|323354900|FG000|Overall Study|Protocol Violation|1|||
94428774|NCT00936897|323354901|FG001|Overall Study|Protocol Violation|1|||
94428775|NCT00936897|323354900|FG000|Overall Study|Ineligibility Determined|0|||
94428776|NCT00936897|323354901|FG001|Overall Study|Ineligibility Determined|3|||
94428777|NCT00936897|323354900|FG000|Overall Study|Noncompliance|0|||
94428778|NCT00936897|323354901|FG001|Overall Study|Noncompliance|2|||
94428779|NCT00936897|323354900|FG000|Overall Study|Death|0|||
94428780|NCT00936897|323354901|FG001|Overall Study|Death|1|||
94428781|NCT02704403|323354904|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
94428782|NCT02704403|323354905|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
94428783|NCT02704403|323354904|FG000|Overall Study|Administrative reasons by sponsor|1251|||
94428784|NCT02704403|323354905|FG001|Overall Study|Administrative reasons by sponsor|616|||
94428785|NCT02704403|323354904|FG000|Overall Study|Death|4|||
94428786|NCT02704403|323354905|FG001|Overall Study|Death|3|||
94428787|NCT02704403|323354904|FG000|Overall Study|Endpoint event|52|||
94428788|NCT02704403|323354905|FG001|Overall Study|Endpoint event|24|||
94428789|NCT02704403|323354904|FG000|Overall Study|Lost to Follow-up|22|||
94428790|NCT02704403|323354905|FG001|Overall Study|Lost to Follow-up|11|||
94428791|NCT02704403|323354904|FG000|Overall Study|Protocol Violation|15|||
94428792|NCT02704403|323354905|FG001|Overall Study|Protocol Violation|15|||
94428793|NCT02704403|323354904|FG000|Overall Study|Adverse Event|2|||
94428794|NCT02704403|323354905|FG001|Overall Study|Adverse Event|0|||
94428795|NCT02704403|323354904|FG000|Overall Study|Withdrawal by Subject|85|||
94428796|NCT02704403|323354905|FG001|Overall Study|Withdrawal by Subject|45|||
94428797|NCT02704403|323354904|FG000|Overall Study|Investigator decision|1|||
94428798|NCT02704403|323354905|FG001|Overall Study|Investigator decision|1|||
94428799|NCT02704403|323354904|FG000|Overall Study|Follow-up not possible|1|||
94428800|NCT02704403|323354905|FG001|Overall Study|Follow-up not possible|2|||
94428801|NCT01844856|323354906|FG000|Overall Study|Lost to Follow-up|15|||
94428802|NCT01844856|323354907|FG001|Overall Study|Lost to Follow-up|3|||
94428803|NCT01844856|323354906|FG000|Overall Study|Adverse Event|3|||
94428804|NCT01844856|323354907|FG001|Overall Study|Adverse Event|6|||
94428805|NCT01844856|323354906|FG000|Overall Study|Withdrawal by Subject|3|||
94428806|NCT01844856|323354907|FG001|Overall Study|Withdrawal by Subject|2|||
94428807|NCT01844856|323354906|FG000|Overall Study|Noncompliance|2|||
94428808|NCT01844856|323354907|FG001|Overall Study|Noncompliance|3|||
94428809|NCT01844856|323354906|FG000|Overall Study|Enterococcus Resistant|0|||
94428810|NCT01844856|323354907|FG001|Overall Study|Enterococcus Resistant|1|||
94428811|NCT01844856|323354906|FG000|Overall Study|Inadvertently Not Scheduled|1|||
94428812|NCT01844856|323354907|FG001|Overall Study|Inadvertently Not Scheduled|0|||
94428813|NCT01844856|323354906|FG000|Overall Study|Randomized but was a Screen Failure|0|||
94428814|NCT01844856|323354907|FG001|Overall Study|Randomized but was a Screen Failure|1|||
94428815|NCT02677714|323354908|FG000|Overall Study|Withdrawal by Subject|2|||
94428816|NCT02677714|323354909|FG001|Overall Study|Withdrawal by Subject|0|||
94428817|NCT04628793|323354910|FG000|Overall Study|Study terminated by sponsor|0|||
94428818|NCT04628793|323354911|FG001|Overall Study|Study terminated by sponsor|0|||
94428819|NCT04628793|323354912|FG002|Overall Study|Study terminated by sponsor|8|||
94428820|NCT04628793|323354910|FG000|Overall Study|Withdrawal by Subject|2|||
94428821|NCT04628793|323354911|FG001|Overall Study|Withdrawal by Subject|3|||
94428822|NCT04628793|323354912|FG002|Overall Study|Withdrawal by Subject|0|||
94428823|NCT04628793|323354910|FG000|Overall Study|Lost to Follow-up|0|||
94428824|NCT04628793|323354911|FG001|Overall Study|Lost to Follow-up|1|||
94428825|NCT04628793|323354912|FG002|Overall Study|Lost to Follow-up|0|||
94428826|NCT02549027|323354915|FG000|Washout After Period 4|Withdrawal by Subject|0|||
94428827|NCT02549027|323354916|FG001|Washout After Period 4|Withdrawal by Subject|1|||
94428828|NCT02549027|323354917|FG002|Washout After Period 4|Withdrawal by Subject|1|||
94428829|NCT02549027|323354918|FG003|Washout After Period 4|Withdrawal by Subject|1|||
94428830|NCT02549027|323354919|FG004|Washout After Period 4|Withdrawal by Subject|0|||
94428831|NCT02549027|323354920|FG005|Washout After Period 4|Withdrawal by Subject|0|||
94428832|NCT02549027|323354915|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
94428833|NCT02549027|323354916|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
94428834|NCT02549027|323354917|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
94428835|NCT02549027|323354918|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
94428836|NCT02549027|323354919|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
94428837|NCT02549027|323354920|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
94428838|NCT01934335|323354921|FG000|Overall Study|Withdrawal by Subject|1|||
94428839|NCT01934335|323354922|FG001|Overall Study|Withdrawal by Subject|1|||
94428840|NCT05384171|323354923|FG000|Overall Study|Lost to Follow-up|9|||
94428841|NCT05384171|323354924|FG001|Overall Study|Lost to Follow-up|9|||
94428842|NCT05384171|323354923|FG000|Overall Study|Withdrawal by Subject|3|||
94428843|NCT05384171|323354924|FG001|Overall Study|Withdrawal by Subject|0|||
94428844|NCT00780910|323354925|FG000|Overall Study|Adverse Event|2|||
94428845|NCT01422187|323354928|FG000|Overall Study|Personal reason|1|||
94428846|NCT01422187|323354929|FG001|Overall Study|Personal reason|0|||
94428847|NCT01422187|323354930|FG002|Overall Study|Personal reason|0|||
94428848|NCT01422187|323354928|FG000|Overall Study|Lost to Follow-up|0|||
94428849|NCT01422187|323354929|FG001|Overall Study|Lost to Follow-up|1|||
94428850|NCT01422187|323354930|FG002|Overall Study|Lost to Follow-up|0|||
94428851|NCT00168818|323354931|FG000|Overall Study|Adverse Event|23|||
94428852|NCT00168818|323354932|FG001|Overall Study|Adverse Event|29|||
94489870|NCT01668797|323588241|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
94489871|NCT01668797|323588242|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
94489872|NCT01668797|323588243|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
94489873|NCT01668797|323588240|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
94428853|NCT00168818|323354933|FG002|Overall Study|Adverse Event|31|||
94428854|NCT00168818|323354931|FG000|Overall Study|Protocol Violation|16|||
94428855|NCT00168818|323354932|FG001|Overall Study|Protocol Violation|11|||
94428856|NCT00168818|323354933|FG002|Overall Study|Protocol Violation|11|||
94428857|NCT00168818|323354931|FG000|Overall Study|Lost to Follow-up|13|||
94428858|NCT00168818|323354932|FG001|Overall Study|Lost to Follow-up|4|||
94428859|NCT00168818|323354933|FG002|Overall Study|Lost to Follow-up|15|||
94428860|NCT00168818|323354931|FG000|Overall Study|Withdrawal by Subject|43|||
94428861|NCT00168818|323354932|FG001|Overall Study|Withdrawal by Subject|41|||
94428862|NCT00168818|323354933|FG002|Overall Study|Withdrawal by Subject|37|||
94428863|NCT00168818|323354931|FG000|Overall Study|Other|22|||
94428864|NCT00168818|323354932|FG001|Overall Study|Other|24|||
94428865|NCT00168818|323354933|FG002|Overall Study|Other|30|||
94428866|NCT00168818|323354931|FG000|Treatment|Adverse Event|77|||
94428867|NCT00168818|323354932|FG001|Treatment|Adverse Event|89|||
94428868|NCT00168818|323354933|FG002|Treatment|Adverse Event|68|||
94428869|NCT00168818|323354931|FG000|Treatment|Protocol Violation|8|||
94428870|NCT00168818|323354932|FG001|Treatment|Protocol Violation|11|||
94428871|NCT00168818|323354933|FG002|Treatment|Protocol Violation|11|||
94428872|NCT00168818|323354931|FG000|Treatment|Lost to Follow-up|0|||
94428873|NCT00168818|323354932|FG001|Treatment|Lost to Follow-up|2|||
94428874|NCT00168818|323354933|FG002|Treatment|Lost to Follow-up|1|||
94428875|NCT00168818|323354931|FG000|Treatment|Withdrawal by Subject|25|||
94428876|NCT00168818|323354932|FG001|Treatment|Withdrawal by Subject|20|||
94428877|NCT00168818|323354933|FG002|Treatment|Withdrawal by Subject|22|||
94428878|NCT00168818|323354931|FG000|Treatment|Other|23|||
94428879|NCT00168818|323354932|FG001|Treatment|Other|29|||
94428880|NCT00168818|323354933|FG002|Treatment|Other|31|||
94428881|NCT02695537|323354934|FG000|Overall Study|Adverse Event|3|||
94428882|NCT02695537|323354934|FG000|Overall Study|Lack of Efficacy|28|||
94428883|NCT02695537|323354934|FG000|Overall Study|Withdrawal by Subject|4|||
94428884|NCT02695537|323354934|FG000|Overall Study|Protocol Violation|3|||
94428885|NCT03200912|323354935|FG000|Overall Study|Adverse Event|3|||
94428886|NCT03200912|323354936|FG001|Overall Study|Adverse Event|0|||
94428887|NCT03200912|323354937|FG002|Overall Study|Adverse Event|0|||
94428888|NCT03200912|323354935|FG000|Overall Study|Withdrawal by Subject|1|||
94428889|NCT03200912|323354936|FG001|Overall Study|Withdrawal by Subject|2|||
94428890|NCT03200912|323354937|FG002|Overall Study|Withdrawal by Subject|4|||
94428891|NCT03200912|323354935|FG000|Overall Study|Non-compliance with study drug|0|||
94428892|NCT03200912|323354936|FG001|Overall Study|Non-compliance with study drug|1|||
94428893|NCT03200912|323354937|FG002|Overall Study|Non-compliance with study drug|0|||
94428894|NCT02865460|323354938|FG000|Overall Study|Adverse Event|1|||
94428895|NCT02865460|323354939|FG001|Overall Study|Adverse Event|0|||
94428896|NCT02865460|323354938|FG000|Overall Study|Withdrawal by Subject|1|||
94428897|NCT02865460|323354939|FG001|Overall Study|Withdrawal by Subject|1|||
94428898|NCT02865460|323354938|FG000|Overall Study|Lost to Follow-up|7|||
94428899|NCT02865460|323354939|FG001|Overall Study|Lost to Follow-up|4|||
94428900|NCT02865460|323354938|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
94428901|NCT02865460|323354939|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
94428902|NCT00128830|323354942|FG000|Overall Study|Adverse Event|10|||
94428903|NCT00128830|323354942|FG000|Overall Study|Withdrawal by Subject|14|||
94428904|NCT00128830|323354942|FG000|Overall Study|Lost to Follow-up|4|||
94428905|NCT00128830|323354942|FG000|Overall Study|Reached a virologic endpoint|29|||
94428906|NCT00128830|323354942|FG000|Overall Study|Non-compliant|4|||
94428907|NCT00128830|323354942|FG000|Overall Study|Discontinued or ineligible for study|2|||
94428908|NCT00128830|323354942|FG000|Overall Study|Other|9|||
94428909|NCT02927366|323354943|FG000|Overall Study|Adverse Event|1|||
94428910|NCT02927366|323354944|FG001|Overall Study|Adverse Event|0|||
94428911|NCT02927366|323354943|FG000|Overall Study|Patient schedule|1|||
94428912|NCT02927366|323354944|FG001|Overall Study|Patient schedule|0|||
94428913|NCT00478426|323354945|FG000|Overall Study|Withdrawal by Subject|1|||
94428914|NCT05119569|323354946|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
94428915|NCT05119569|323354947|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
94428916|NCT05119569|323354948|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
94428917|NCT05119569|323354949|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
94428918|NCT05119569|323354946|FG000|Double Blind Treatment Phase|Adverse Event|6|||
94428919|NCT05119569|323354947|FG001|Double Blind Treatment Phase|Adverse Event|0|||
94428920|NCT05119569|323354948|FG002|Double Blind Treatment Phase|Adverse Event|0|||
94428921|NCT05119569|323354949|FG003|Double Blind Treatment Phase|Adverse Event|0|||
94428922|NCT05119569|323354946|FG000|Open Label Extension Phase|Ongoing in the study|0|||
94428923|NCT05119569|323354947|FG001|Open Label Extension Phase|Ongoing in the study|0|||
94428924|NCT05119569|323354948|FG002|Open Label Extension Phase|Ongoing in the study|65|||
94428925|NCT05119569|323354949|FG003|Open Label Extension Phase|Ongoing in the study|34|||
94428926|NCT00530218|323354950|FG000|Overall Study|CMV Not Detected|13|||
94428927|NCT00530218|323354950|FG000|Overall Study|Death|12|||
94428928|NCT03489109|323354951|FG000|Overall Study|Lost to Follow-up|1|||
94428929|NCT03489109|323354952|FG001|Overall Study|Lost to Follow-up|2|||
94428930|NCT03477903|323354953|FG000|Overall Study|Study Terminated by Sponsor|1|||
94428931|NCT01860677|323354954|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
94428932|NCT01860677|323354955|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
94428933|NCT02828241|323354956|FG000|Overall Study|Adverse Event|7|||
94428934|NCT02828241|323354957|FG001|Overall Study|Adverse Event|2|||
94428935|NCT02828241|323354956|FG000|Overall Study|Protocol Violation|1|||
94428936|NCT02828241|323354957|FG001|Overall Study|Protocol Violation|0|||
94428937|NCT00642278|323354958|FG000|Overall Study|Adverse Event|2|||
94428938|NCT00642278|323354959|FG001|Overall Study|Adverse Event|1|||
94428939|NCT00642278|323354960|FG002|Overall Study|Adverse Event|3|||
94428940|NCT00642278|323354961|FG003|Overall Study|Adverse Event|1|||
94428941|NCT00642278|323354962|FG004|Overall Study|Adverse Event|2|||
94428942|NCT00642278|323354963|FG005|Overall Study|Adverse Event|2|||
94428943|NCT00642278|323354964|FG006|Overall Study|Adverse Event|0|||
94428944|NCT00642278|323354958|FG000|Overall Study|Lack of Efficacy|0|||
94428945|NCT00642278|323354959|FG001|Overall Study|Lack of Efficacy|1|||
94428946|NCT00642278|323354960|FG002|Overall Study|Lack of Efficacy|0|||
94428947|NCT00642278|323354961|FG003|Overall Study|Lack of Efficacy|0|||
94428948|NCT00642278|323354962|FG004|Overall Study|Lack of Efficacy|0|||
94428949|NCT00642278|323354963|FG005|Overall Study|Lack of Efficacy|0|||
94428950|NCT00642278|323354964|FG006|Overall Study|Lack of Efficacy|0|||
94428951|NCT00642278|323354958|FG000|Overall Study|Lost to Follow-up|5|||
94428952|NCT00642278|323354959|FG001|Overall Study|Lost to Follow-up|1|||
94428953|NCT00642278|323354960|FG002|Overall Study|Lost to Follow-up|0|||
94428954|NCT00642278|323354961|FG003|Overall Study|Lost to Follow-up|1|||
94428955|NCT00642278|323354962|FG004|Overall Study|Lost to Follow-up|0|||
94428956|NCT00642278|323354963|FG005|Overall Study|Lost to Follow-up|1|||
94428957|NCT00642278|323354964|FG006|Overall Study|Lost to Follow-up|1|||
94428958|NCT00642278|323354958|FG000|Overall Study|Physician Decision|0|||
94428959|NCT00642278|323354959|FG001|Overall Study|Physician Decision|0|||
94428960|NCT00642278|323354960|FG002|Overall Study|Physician Decision|0|||
94428961|NCT00642278|323354961|FG003|Overall Study|Physician Decision|1|||
94428962|NCT00642278|323354962|FG004|Overall Study|Physician Decision|0|||
94428963|NCT00642278|323354963|FG005|Overall Study|Physician Decision|0|||
94428964|NCT00642278|323354964|FG006|Overall Study|Physician Decision|0|||
94428965|NCT00642278|323354958|FG000|Overall Study|Protocol Violation|0|||
94428966|NCT00642278|323354959|FG001|Overall Study|Protocol Violation|0|||
94428967|NCT00642278|323354960|FG002|Overall Study|Protocol Violation|1|||
94428968|NCT00642278|323354961|FG003|Overall Study|Protocol Violation|1|||
94428969|NCT00642278|323354962|FG004|Overall Study|Protocol Violation|0|||
94428970|NCT00642278|323354963|FG005|Overall Study|Protocol Violation|1|||
94428971|NCT00642278|323354964|FG006|Overall Study|Protocol Violation|2|||
94428972|NCT00642278|323354958|FG000|Overall Study|Withdrawal by Subject|1|||
94428973|NCT00642278|323354959|FG001|Overall Study|Withdrawal by Subject|1|||
94428974|NCT00642278|323354960|FG002|Overall Study|Withdrawal by Subject|1|||
94428975|NCT00642278|323354961|FG003|Overall Study|Withdrawal by Subject|3|||
94428976|NCT00642278|323354962|FG004|Overall Study|Withdrawal by Subject|6|||
94428977|NCT00642278|323354963|FG005|Overall Study|Withdrawal by Subject|2|||
94428978|NCT00642278|323354964|FG006|Overall Study|Withdrawal by Subject|2|||
94428979|NCT00642278|323354958|FG000|Overall Study|Noncompliance with study drug regimen|0|||
94428980|NCT00642278|323354959|FG001|Overall Study|Noncompliance with study drug regimen|0|||
94428981|NCT00642278|323354960|FG002|Overall Study|Noncompliance with study drug regimen|0|||
94428982|NCT00642278|323354961|FG003|Overall Study|Noncompliance with study drug regimen|1|||
94428983|NCT00642278|323354962|FG004|Overall Study|Noncompliance with study drug regimen|0|||
94428984|NCT00642278|323354963|FG005|Overall Study|Noncompliance with study drug regimen|0|||
94428985|NCT00642278|323354964|FG006|Overall Study|Noncompliance with study drug regimen|0|||
94428986|NCT00642278|323354958|FG000|Overall Study|Other|2|||
94428987|NCT00642278|323354959|FG001|Overall Study|Other|1|||
94428988|NCT00642278|323354960|FG002|Overall Study|Other|0|||
94428989|NCT00642278|323354961|FG003|Overall Study|Other|1|||
94428990|NCT00642278|323354962|FG004|Overall Study|Other|0|||
94428991|NCT00642278|323354963|FG005|Overall Study|Other|1|||
94428992|NCT00642278|323354964|FG006|Overall Study|Other|0|||
94428993|NCT04642365|323354967|FG000|Overall Study|Death|3|||
94428994|NCT04642365|323354968|FG001|Overall Study|Death|2|||
94428995|NCT04642365|323354969|FG002|Overall Study|Death|4|||
94428996|NCT04642365|323354970|FG003|Overall Study|Death|5|||
94428997|NCT04642365|323354971|FG004|Overall Study|Death|5|||
94428998|NCT04642365|323354972|FG005|Overall Study|Death|3|||
94428999|NCT04642365|323354973|FG006|Overall Study|Death|2|||
94429000|NCT04642365|323354974|FG007|Overall Study|Death|1|||
94429001|NCT04642365|323354967|FG000|Overall Study|Physician Decision|1|||
94429002|NCT04642365|323354968|FG001|Overall Study|Physician Decision|0|||
94429003|NCT04642365|323354969|FG002|Overall Study|Physician Decision|0|||
94429004|NCT04642365|323354970|FG003|Overall Study|Physician Decision|0|||
94429005|NCT04642365|323354971|FG004|Overall Study|Physician Decision|0|||
94429006|NCT04642365|323354972|FG005|Overall Study|Physician Decision|0|||
94429007|NCT04642365|323354973|FG006|Overall Study|Physician Decision|0|||
94429008|NCT04642365|323354974|FG007|Overall Study|Physician Decision|0|||
94429009|NCT04642365|323354967|FG000|Overall Study|Progressive Disease|1|||
94429010|NCT04642365|323354968|FG001|Overall Study|Progressive Disease|1|||
94429011|NCT04642365|323354969|FG002|Overall Study|Progressive Disease|1|||
94429012|NCT04642365|323354970|FG003|Overall Study|Progressive Disease|0|||
94429013|NCT04642365|323354971|FG004|Overall Study|Progressive Disease|0|||
94429014|NCT04642365|323354972|FG005|Overall Study|Progressive Disease|0|||
94429015|NCT04642365|323354973|FG006|Overall Study|Progressive Disease|1|||
94429016|NCT04642365|323354974|FG007|Overall Study|Progressive Disease|0|||
94429017|NCT04642365|323354967|FG000|Overall Study|Study Terminated By Sponsor|0|||
94429018|NCT04642365|323354968|FG001|Overall Study|Study Terminated By Sponsor|2|||
94429019|NCT04642365|323354969|FG002|Overall Study|Study Terminated By Sponsor|1|||
94429020|NCT04642365|323354970|FG003|Overall Study|Study Terminated By Sponsor|1|||
94429021|NCT04642365|323354971|FG004|Overall Study|Study Terminated By Sponsor|1|||
94429022|NCT04642365|323354972|FG005|Overall Study|Study Terminated By Sponsor|2|||
94429023|NCT04642365|323354973|FG006|Overall Study|Study Terminated By Sponsor|2|||
94429024|NCT04642365|323354974|FG007|Overall Study|Study Terminated By Sponsor|1|||
94429025|NCT04642365|323354967|FG000|Overall Study|Symptomatic Deterioration|1|||
94429026|NCT04642365|323354968|FG001|Overall Study|Symptomatic Deterioration|1|||
94429027|NCT04642365|323354969|FG002|Overall Study|Symptomatic Deterioration|0|||
94429028|NCT04642365|323354970|FG003|Overall Study|Symptomatic Deterioration|0|||
94429029|NCT04642365|323354971|FG004|Overall Study|Symptomatic Deterioration|0|||
94429030|NCT04642365|323354972|FG005|Overall Study|Symptomatic Deterioration|1|||
94429031|NCT04642365|323354973|FG006|Overall Study|Symptomatic Deterioration|0|||
94429032|NCT04642365|323354974|FG007|Overall Study|Symptomatic Deterioration|0|||
94429033|NCT04642365|323354967|FG000|Overall Study|Withdrawal by Subject|0|||
94429034|NCT04642365|323354968|FG001|Overall Study|Withdrawal by Subject|0|||
94429035|NCT04642365|323354969|FG002|Overall Study|Withdrawal by Subject|1|||
94429036|NCT04642365|323354970|FG003|Overall Study|Withdrawal by Subject|1|||
94429037|NCT04642365|323354971|FG004|Overall Study|Withdrawal by Subject|0|||
94429038|NCT04642365|323354972|FG005|Overall Study|Withdrawal by Subject|0|||
94429039|NCT04642365|323354973|FG006|Overall Study|Withdrawal by Subject|2|||
94429040|NCT04642365|323354974|FG007|Overall Study|Withdrawal by Subject|0|||
94429041|NCT04642365|323354967|FG000|Overall Study|Adverse Event|0|||
94429042|NCT04642365|323354968|FG001|Overall Study|Adverse Event|0|||
94429043|NCT04642365|323354969|FG002|Overall Study|Adverse Event|0|||
94429044|NCT04642365|323354970|FG003|Overall Study|Adverse Event|0|||
94429045|NCT04642365|323354971|FG004|Overall Study|Adverse Event|0|||
94429046|NCT04642365|323354972|FG005|Overall Study|Adverse Event|0|||
94429047|NCT04642365|323354973|FG006|Overall Study|Adverse Event|0|||
94429048|NCT04642365|323354974|FG007|Overall Study|Adverse Event|1|||
94429049|NCT02369458|323354975|FG000|Overall Study|Determined to be not eligible|1|||
94429050|NCT02369458|323354976|FG001|Overall Study|Determined to be not eligible|0|||
94429051|NCT05038800|323354977|FG000|Overall Study|Death|1|||
94429052|NCT05038800|323354978|FG001|Overall Study|Death|1|||
94429053|NCT05038800|323354979|FG002|Overall Study|Death|5|||
94429054|NCT05038800|323354980|FG003|Overall Study|Death|3|||
94429055|NCT05038800|323354981|FG004|Overall Study|Death|1|||
94429056|NCT05038800|323354977|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94429057|NCT05038800|323354978|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94429058|NCT05038800|323354979|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94429059|NCT05038800|323354980|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94429060|NCT05038800|323354981|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
94429061|NCT05038800|323354977|FG000|Overall Study|Lack of Efficacy|0|||
94429062|NCT05038800|323354978|FG001|Overall Study|Lack of Efficacy|0|||
94429063|NCT05038800|323354979|FG002|Overall Study|Lack of Efficacy|0|||
94429064|NCT05038800|323354980|FG003|Overall Study|Lack of Efficacy|0|||
94429065|NCT05038800|323354981|FG004|Overall Study|Lack of Efficacy|1|||
94429066|NCT02071849|323354985|FG000|6-month Primary Endpoint|Did not receive device|4|||
94429067|NCT02071849|323354985|FG000|6-month Primary Endpoint|Adverse Event|1|||
94429068|NCT02071849|323354985|FG000|2-year Extended Follow-up|Adverse Event|1|||
94429069|NCT02011386|323354986|FG000|Overall Study|Non-compliance|2|||
94429070|NCT02011386|323354986|FG000|Overall Study|Lack of Efficacy|3|||
94429071|NCT00658021|323354987|FG000|28-Week Treatment Period|Adverse Event|3|||
94429072|NCT00658021|323354988|FG001|28-Week Treatment Period|Adverse Event|1|||
94429073|NCT00658021|323354989|FG002|28-Week Treatment Period|Adverse Event|0|||
94429074|NCT00658021|323354987|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
94429075|NCT00658021|323354988|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
94429076|NCT00658021|323354989|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
94429077|NCT00658021|323354987|FG000|28-Week Treatment Period|Protocol Violation|0|||
94429078|NCT00658021|323354988|FG001|28-Week Treatment Period|Protocol Violation|2|||
94429079|NCT00658021|323354989|FG002|28-Week Treatment Period|Protocol Violation|1|||
94429080|NCT00658021|323354987|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
94655541|NCT00927927|324196069|FG009|Overall Study|Withdrawal by Subject|0|||
94429081|NCT00658021|323354988|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
94429082|NCT00658021|323354989|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
94429083|NCT00658021|323354987|FG000|28-Week Treatment Period|Physician Decision|1|||
94429084|NCT00658021|323354988|FG001|28-Week Treatment Period|Physician Decision|2|||
94655542|NCT00927927|324196070|FG010|Overall Study|Withdrawal by Subject|0|||
94429085|NCT00658021|323354989|FG002|28-Week Treatment Period|Physician Decision|1|||
94429086|NCT00658021|323354987|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
94429087|NCT00658021|323354988|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
94429088|NCT00658021|323354989|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
94429089|NCT00658021|323354987|FG000|28-Week Treatment Period|Loss of glucose control|1|||
94429090|NCT00658021|323354988|FG001|28-Week Treatment Period|Loss of glucose control|1|||
94429091|NCT00658021|323354989|FG002|28-Week Treatment Period|Loss of glucose control|10|||
94429092|NCT00658021|323354987|FG000|28-Week Treatment Period|Other|2|||
94429093|NCT00658021|323354988|FG001|28-Week Treatment Period|Other|3|||
94429094|NCT00658021|323354989|FG002|28-Week Treatment Period|Other|1|||
94429095|NCT00658021|323354987|FG000|28-Week Treatment Period|Did not receive treatment|2|||
94429096|NCT00658021|323354988|FG001|28-Week Treatment Period|Did not receive treatment|0|||
94429097|NCT00658021|323354989|FG002|28-Week Treatment Period|Did not receive treatment|0|||
94429098|NCT00658021|323354987|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
94429099|NCT00658021|323354988|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
94429100|NCT00658021|323354989|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
94429101|NCT00658021|323354987|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
94429102|NCT00658021|323354988|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
94429103|NCT00658021|323354989|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
94429104|NCT00725205|323354992|FG000|Overall Study|Adverse Event|22|||
94429105|NCT00725205|323354992|FG000|Overall Study|Investigator Discontinued|1|||
94429106|NCT00725205|323354992|FG000|Overall Study|Non-compliance With Protocol|14|||
94429107|NCT00725205|323354992|FG000|Overall Study|Other|8|||
94429108|NCT00725205|323354992|FG000|Overall Study|Protocol Defined Clinical Event|1|||
94429109|NCT00725205|323354992|FG000|Overall Study|Treatment Failure|41|||
94429110|NCT05065567|323354993|FG000|Overall Study|Lost to Follow-up|10|||
94429111|NCT05065567|323354994|FG001|Overall Study|Lost to Follow-up|9|||
94429112|NCT05065567|323354995|FG002|Overall Study|Lost to Follow-up|6|||
94429113|NCT01136967|323356162|FG000|Overall Study|Adverse Event|9|||
94429114|NCT01136967|323356163|FG001|Overall Study|Adverse Event|12|||
94429115|NCT01136967|323356162|FG000|Overall Study|Participant Choice|8|||
94429116|NCT01136967|323356163|FG001|Overall Study|Participant Choice|3|||
94429117|NCT01136967|323356162|FG000|Overall Study|Lost to Follow-up|0|||
94429118|NCT01136967|323356163|FG001|Overall Study|Lost to Follow-up|1|||
94429119|NCT01136967|323356162|FG000|Overall Study|Withdrawal by Subject|1|||
94429120|NCT01136967|323356163|FG001|Overall Study|Withdrawal by Subject|2|||
94429121|NCT01136967|323356162|FG000|Overall Study|Clinical Progression|3|||
94429122|NCT01136967|323356163|FG001|Overall Study|Clinical Progression|5|||
94429123|NCT01136967|323356162|FG000|Overall Study|Radiation|1|||
94429124|NCT01136967|323356163|FG001|Overall Study|Radiation|0|||
94429125|NCT01136967|323356162|FG000|Overall Study|Non-compliance|1|||
94429126|NCT01136967|323356163|FG001|Overall Study|Non-compliance|0|||
94429127|NCT01136967|323356162|FG000|Overall Study|Investigator's Choice|1|||
94429128|NCT01136967|323356163|FG001|Overall Study|Investigator's Choice|1|||
94429129|NCT01136967|323356162|FG000|Overall Study|Increase in Lesion Size|0|||
94429130|NCT01136967|323356163|FG001|Overall Study|Increase in Lesion Size|2|||
94429131|NCT01136967|323356162|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
94429132|NCT01136967|323356163|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
94429133|NCT01724489|323356164|FG000|Overall Study|Adverse Event|8|||
94429134|NCT01724489|323356165|FG001|Overall Study|Adverse Event|3|||
94429135|NCT01724489|323356164|FG000|Overall Study|Surgery, medication|1|||
94429136|NCT01724489|323356165|FG001|Overall Study|Surgery, medication|1|||
94429137|NCT01724489|323356164|FG000|Overall Study|Lost to Follow-up|1|||
94429138|NCT01724489|323356165|FG001|Overall Study|Lost to Follow-up|2|||
94429139|NCT01724489|323356164|FG000|Overall Study|Withdrawal by Subject|6|||
94429140|NCT01724489|323356165|FG001|Overall Study|Withdrawal by Subject|6|||
94429141|NCT03151811|323356166|FG000|Overall Study|Randomized But Not Treated|18|||
94429142|NCT03151811|323356167|FG001|Overall Study|Randomized But Not Treated|3|||
94429143|NCT03151811|323356166|FG000|Overall Study|Progressive Disease|130|||
94429144|NCT03151811|323356167|FG001|Overall Study|Progressive Disease|170|||
94429145|NCT03151811|323356166|FG000|Overall Study|Adverse Event|49|||
94429146|NCT03151811|323356167|FG001|Overall Study|Adverse Event|40|||
94429147|NCT03151811|323356166|FG000|Overall Study|Lack of Efficacy|6|||
94429148|NCT03151811|323356167|FG001|Overall Study|Lack of Efficacy|8|||
94429149|NCT03151811|323356166|FG000|Overall Study|Physician Decision|21|||
94429150|NCT03151811|323356167|FG001|Overall Study|Physician Decision|9|||
94429151|NCT03151811|323356166|FG000|Overall Study|Withdrawal by Subject|17|||
94429152|NCT03151811|323356167|FG001|Overall Study|Withdrawal by Subject|7|||
94429153|NCT03151811|323356166|FG000|Overall Study|Lost to Follow-up|0|||
94429154|NCT03151811|323356167|FG001|Overall Study|Lost to Follow-up|1|||
94429155|NCT03151811|323356166|FG000|Overall Study|Study Terminated by Sponsor|5|||
94429156|NCT03151811|323356167|FG001|Overall Study|Study Terminated by Sponsor|11|||
94429157|NCT00094861|323356171|FG000|Overall Study|Adverse Event|5|||
94429158|NCT00094861|323356172|FG001|Overall Study|Adverse Event|2|||
94429159|NCT00094861|323356171|FG000|Overall Study|Withdrawal by Subject|5|||
94429160|NCT00094861|323356172|FG001|Overall Study|Withdrawal by Subject|3|||
94429161|NCT00094861|323356171|FG000|Overall Study|Physician Decision|1|||
94429162|NCT00094861|323356172|FG001|Overall Study|Physician Decision|1|||
94429163|NCT00094861|323356171|FG000|Overall Study|Lost to Follow-up|0|||
94429164|NCT00094861|323356172|FG001|Overall Study|Lost to Follow-up|1|||
94429165|NCT00094861|323356171|FG000|Overall Study|Death|4|||
94429166|NCT00094861|323356172|FG001|Overall Study|Death|2|||
94429167|NCT00094861|323356171|FG000|Overall Study|Other|3|||
94429168|NCT00094861|323356172|FG001|Overall Study|Other|0|||
94429169|NCT00282919|323356173|FG000|Overall Study|Lack of Efficacy|4|||
94429170|NCT00282919|323356173|FG000|Overall Study|Withdrawal by Subject|1|||
94429171|NCT00282919|323356173|FG000|Overall Study|Asymptomatic Parasitemia|2|||
94429172|NCT01635283|323356175|FG000|Overall Study|Tumor Progression|3|||
94429173|NCT01635283|323356175|FG000|Overall Study|Lost to Follow-up|1|||
94429174|NCT01438996|323356176|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
94429175|NCT01438996|323356177|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
94429176|NCT01438996|323356178|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
94429177|NCT01433549|323356179|FG000|Phase 2: Second Study Product|Adverse Event|0|||
94429178|NCT01433549|323356180|FG001|Phase 2: Second Study Product|Adverse Event|1|||
94429179|NCT02540850|323356183|FG000|Overall Study|Lost to Follow-up|69|||
94429180|NCT02540850|323356184|FG001|Overall Study|Lost to Follow-up|66|||
94429181|NCT02540850|323356185|FG002|Overall Study|Lost to Follow-up|34|||
94429182|NCT03511326|323356186|FG000|Overall Study|Withdrawal by Subject|1|||
94429183|NCT02643355|323356191|FG000|Overall Study|Withdrawal by Subject|1|||
94429184|NCT02643355|323356192|FG001|Overall Study|Withdrawal by Subject|3|||
94429185|NCT02643355|323356191|FG000|Overall Study|Protocol Violation|0|||
94429186|NCT02643355|323356192|FG001|Overall Study|Protocol Violation|2|||
94429187|NCT02278055|323356199|FG000|Overall Study|Adverse Event|1|||
94429188|NCT02278055|323356199|FG000|Overall Study|Lost to Follow-up|1|||
94429189|NCT02278055|323356199|FG000|Overall Study|Withdrawal by Subject|2|||
94429190|NCT02278055|323356199|FG000|Overall Study|Progressive Disease|4|||
94429191|NCT02186834|323356200|FG000|Dose Escalation|Death|0|||
94429192|NCT02186834|323356201|FG001|Dose Escalation|Death|0|||
94429193|NCT02186834|323356202|FG002|Dose Escalation|Death|0|||
94429194|NCT02186834|323356203|FG003|Dose Escalation|Death|1|||
94429195|NCT02186834|323356204|FG004|Dose Escalation|Death|0|||
94429196|NCT02186834|323356205|FG005|Dose Escalation|Death|0|||
94429197|NCT02186834|323356200|FG000|Treatment at RP2D|Died prior to treatment|0|||
94429198|NCT02186834|323356201|FG001|Treatment at RP2D|Died prior to treatment|0|||
94429199|NCT02186834|323356202|FG002|Treatment at RP2D|Died prior to treatment|0|||
94429200|NCT02186834|323356203|FG003|Treatment at RP2D|Died prior to treatment|0|||
94429201|NCT02186834|323356204|FG004|Treatment at RP2D|Died prior to treatment|0|||
94429202|NCT02186834|323356205|FG005|Treatment at RP2D|Died prior to treatment|1|||
94429203|NCT01329549|323356207|FG000|Overall Study|Withdrawal by Subject|1|||
94429204|NCT01329549|323356207|FG000|Overall Study|Adverse Event|1|||
94429205|NCT04546724|323356212|FG000|Overall Study|Withdrawal by Subject|145|||
94429206|NCT04546724|323356213|FG001|Overall Study|Withdrawal by Subject|41|||
94429207|NCT04546724|323356212|FG000|Overall Study|Adverse Event|1|||
94429208|NCT04546724|323356213|FG001|Overall Study|Adverse Event|1|||
94429209|NCT04546724|323356212|FG000|Overall Study|Lost to Follow-up|186|||
94429210|NCT04546724|323356213|FG001|Overall Study|Lost to Follow-up|63|||
94429211|NCT04546724|323356212|FG000|Overall Study|Physician Decision|8|||
94429212|NCT04546724|323356213|FG001|Overall Study|Physician Decision|2|||
94429213|NCT04546724|323356212|FG000|Overall Study|Death|2|||
94429214|NCT04546724|323356213|FG001|Overall Study|Death|1|||
94489874|NCT01668797|323588241|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
94489875|NCT01668797|323588242|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
94489876|NCT01668797|323588243|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
94489877|NCT01668797|323588240|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
94489878|NCT01668797|323588241|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
94512836|NCT00725985|323676422|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
94429215|NCT04546724|323356212|FG000|Overall Study|subject has been out of town|1|||
94429216|NCT04546724|323356213|FG001|Overall Study|subject has been out of town|0|||
94429217|NCT04546724|323356212|FG000|Overall Study|subject is incarcerated|2|||
94429218|NCT04546724|323356213|FG001|Overall Study|subject is incarcerated|0|||
94429219|NCT04546724|323356212|FG000|Overall Study|subject is relocating|12|||
94429220|NCT04546724|323356213|FG001|Overall Study|subject is relocating|4|||
94429221|NCT04546724|323356212|FG000|Overall Study|Subject in another study|1|||
94429222|NCT04546724|323356213|FG001|Overall Study|Subject in another study|1|||
94429223|NCT01292226|323356214|FG000|Overall Study|Adverse Event|5|||
94429224|NCT01292226|323356214|FG000|Overall Study|Death|1|||
94429225|NCT01292226|323356214|FG000|Overall Study|Graft loss|1|||
94429226|NCT01292226|323356214|FG000|Overall Study|Protocol Violation|3|||
94429227|NCT01292226|323356214|FG000|Overall Study|Withdrawal by Subject|1|||
94429228|NCT01292226|323356214|FG000|Overall Study|Other|2|||
94429229|NCT03503864|323356215|FG000|Overall Study|Protocol Violation|6|||
94429230|NCT03503864|323356215|FG000|Overall Study|Withdrawal by Subject|7|||
94429231|NCT00206323|323356220|FG000|Overall Study|Lack of Efficacy|4|||
94429232|NCT00206323|323356221|FG001|Overall Study|Lack of Efficacy|1|||
94429233|NCT00206323|323356220|FG000|Overall Study|Adverse Event|1|||
94429234|NCT00206323|323356221|FG001|Overall Study|Adverse Event|1|||
94429235|NCT00206323|323356220|FG000|Overall Study|Lost to Follow-up|1|||
94429236|NCT00206323|323356221|FG001|Overall Study|Lost to Follow-up|1|||
94429237|NCT00369317|323356225|FG000|Overall Study|Adverse Event|3|||
94429238|NCT00369317|323356225|FG000|Overall Study|Death|1|||
94429239|NCT00369317|323356225|FG000|Overall Study|Lack of Efficacy|5|||
94429240|NCT00369317|323356225|FG000|Overall Study|Physician Decision|2|||
94429241|NCT00369317|323356225|FG000|Overall Study|Withdrawal by Subject|8|||
94429242|NCT00369317|323356225|FG000|Overall Study|Ineligible|1|||
94429243|NCT03713619|323356228|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
94429244|NCT03713619|323356229|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
94429245|NCT03713619|323356230|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
94429246|NCT03713619|323356231|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
94429247|NCT03713619|323356232|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
94429248|NCT03713619|323356228|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
94429249|NCT03713619|323356229|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
94429250|NCT03713619|323356230|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
94429251|NCT03713619|323356231|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
94429252|NCT03713619|323356232|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
94429253|NCT03713619|323356228|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
94429254|NCT03713619|323356229|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
94429255|NCT03713619|323356230|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
94429256|NCT03713619|323356231|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
94429257|NCT03713619|323356232|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
94429258|NCT03713619|323356228|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
94429259|NCT03713619|323356229|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
94429260|NCT03713619|323356230|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
94429261|NCT03713619|323356231|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
94429262|NCT03713619|323356232|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
94429263|NCT03713619|323356228|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
94429264|NCT03713619|323356229|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
94429265|NCT03713619|323356230|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
94429266|NCT03713619|323356231|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
94429267|NCT03713619|323356232|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
94429268|NCT03713619|323356228|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
94429269|NCT03713619|323356229|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
94429270|NCT03713619|323356230|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
94429271|NCT03713619|323356231|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
94429272|NCT03713619|323356232|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
94429273|NCT03713619|323356228|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
94429274|NCT03713619|323356229|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
94429275|NCT03713619|323356230|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
94429276|NCT03713619|323356231|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
94429277|NCT03713619|323356232|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
94429278|NCT03713619|323356228|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
94429279|NCT03713619|323356229|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
94429280|NCT03713619|323356230|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
94429281|NCT03713619|323356231|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
94429282|NCT03713619|323356232|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
94429283|NCT03713619|323356228|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
94429284|NCT03713619|323356229|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
94429285|NCT03713619|323356230|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
94429286|NCT03713619|323356231|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
94429287|NCT03713619|323356232|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
94429288|NCT03713619|323356228|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
94429289|NCT03713619|323356229|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
94429290|NCT03713619|323356230|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
94429291|NCT03713619|323356231|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
94429292|NCT03713619|323356232|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
94429293|NCT03713619|323356228|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
94429294|NCT03713619|323356229|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
94429295|NCT03713619|323356230|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
94429296|NCT03713619|323356231|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
94429297|NCT03713619|323356232|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
94429298|NCT03713619|323356228|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
94429299|NCT03713619|323356229|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
94655543|NCT00927927|324196071|FG011|Overall Study|Withdrawal by Subject|2|||
94429300|NCT03713619|323356230|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
94429301|NCT03713619|323356231|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
94429302|NCT03713619|323356232|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
94429303|NCT03713619|323356228|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
94429304|NCT03713619|323356229|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
94429305|NCT03713619|323356230|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
94429306|NCT03713619|323356231|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
94429307|NCT03713619|323356232|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
94429308|NCT06281171|323356234|FG000|Timepoint 2|Lost to Follow-up|6|||
94429309|NCT06281171|323356235|FG001|Timepoint 2|Lost to Follow-up|4|||
94429310|NCT06281171|323356234|FG000|Timepoint 3|Lost to Follow-up|0|||
94429311|NCT06281171|323356235|FG001|Timepoint 3|Lost to Follow-up|5|||
94429312|NCT03553576|323356236|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
94429313|NCT03553576|323356237|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
94429314|NCT03553576|323356236|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
94429315|NCT03553576|323356237|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
94429316|NCT03553576|323356236|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
94429317|NCT03553576|323356237|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
94429318|NCT03553576|323356236|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
94429319|NCT03553576|323356237|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
94429320|NCT03553576|323356236|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
94429321|NCT03553576|323356237|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
94429322|NCT03553576|323356236|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
94429323|NCT03553576|323356237|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
94429324|NCT03553576|323356236|FG000|Overall Study|Physician Decision|2|||
94429325|NCT03553576|323356237|FG001|Overall Study|Physician Decision|5|||
94429326|NCT01102374|323356243|FG000|Overall Study|Death|9|||
94429327|NCT01102374|323356244|FG001|Overall Study|Death|13|||
94429328|NCT01102374|323356243|FG000|Overall Study|Lost to Follow-up|7|||
94429329|NCT01102374|323356244|FG001|Overall Study|Lost to Follow-up|6|||
94429330|NCT01104792|323356245|FG000|Overall Study|Adverse Event|77|||
94429331|NCT01104792|323356245|FG000|Overall Study|Insufficient Therapeutic Response|22|||
94429332|NCT01104792|323356245|FG000|Overall Study|Protocol Violation|45|||
94429333|NCT01104792|323356245|FG000|Overall Study|Withdrawal of Consent|179|||
94429334|NCT01104792|323356245|FG000|Overall Study|Lost to Follow-up|43|||
94429335|NCT01104792|323356245|FG000|Overall Study|Reasons Not Specified|27|||
94429336|NCT01104792|323356245|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
94429337|NCT03255655|323356247|FG000|Overall Study|Lost to Follow-up|7|||
94429338|NCT03255655|323356248|FG001|Overall Study|Lost to Follow-up|4|||
94429339|NCT04428333|323356249|FG000|Overall Study|Physician Decision|5|||
94429340|NCT04428333|323356250|FG001|Overall Study|Physician Decision|6|||
94429341|NCT04428333|323356249|FG000|Overall Study|Withdrawal by Subject|1|||
94429342|NCT04428333|323356250|FG001|Overall Study|Withdrawal by Subject|3|||
94429343|NCT04428333|323356249|FG000|Overall Study|Study Terminated By Sponsor|14|||
94429344|NCT04428333|323356250|FG001|Overall Study|Study Terminated By Sponsor|16|||
94429345|NCT00758680|323356252|FG000|Overall Study|Adverse Event|0|||
94429346|NCT00758680|323356253|FG001|Overall Study|Adverse Event|0|||
94429347|NCT00758680|323356254|FG002|Overall Study|Adverse Event|0|||
94429348|NCT00758680|323356255|FG003|Overall Study|Adverse Event|0|||
94429349|NCT00758680|323356256|FG004|Overall Study|Adverse Event|0|||
94429350|NCT00758680|323356257|FG005|Overall Study|Adverse Event|0|||
94429351|NCT00758680|323356258|FG006|Overall Study|Adverse Event|0|||
94429352|NCT00758680|323356259|FG007|Overall Study|Adverse Event|1|||
94429353|NCT00758680|323356260|FG008|Overall Study|Adverse Event|0|||
94429354|NCT00758680|323356261|FG009|Overall Study|Adverse Event|1|||
94429355|NCT00758680|323356252|FG000|Overall Study|Laboratory Adverse Event|0|||
94429356|NCT00758680|323356253|FG001|Overall Study|Laboratory Adverse Event|0|||
94429357|NCT00758680|323356254|FG002|Overall Study|Laboratory Adverse Event|0|||
94429358|NCT00758680|323356255|FG003|Overall Study|Laboratory Adverse Event|0|||
94429359|NCT00758680|323356256|FG004|Overall Study|Laboratory Adverse Event|0|||
94429360|NCT00758680|323356257|FG005|Overall Study|Laboratory Adverse Event|0|||
94429361|NCT00758680|323356258|FG006|Overall Study|Laboratory Adverse Event|0|||
94429362|NCT00758680|323356259|FG007|Overall Study|Laboratory Adverse Event|0|||
94429363|NCT00758680|323356260|FG008|Overall Study|Laboratory Adverse Event|1|||
94429364|NCT00758680|323356261|FG009|Overall Study|Laboratory Adverse Event|0|||
94429365|NCT00758680|323356252|FG000|Overall Study|Withdrawal by Subject|0|||
94429366|NCT00758680|323356253|FG001|Overall Study|Withdrawal by Subject|0|||
94429367|NCT00758680|323356254|FG002|Overall Study|Withdrawal by Subject|0|||
94429368|NCT00758680|323356255|FG003|Overall Study|Withdrawal by Subject|0|||
94429369|NCT00758680|323356256|FG004|Overall Study|Withdrawal by Subject|0|||
94429370|NCT00758680|323356257|FG005|Overall Study|Withdrawal by Subject|0|||
94429371|NCT00758680|323356258|FG006|Overall Study|Withdrawal by Subject|1|||
94429372|NCT00758680|323356259|FG007|Overall Study|Withdrawal by Subject|0|||
94429373|NCT00758680|323356260|FG008|Overall Study|Withdrawal by Subject|1|||
94429374|NCT00758680|323356261|FG009|Overall Study|Withdrawal by Subject|0|||
94429375|NCT01806506|323356262|FG000|Overall Study|Lost to Follow-up|2|||
94429376|NCT01806506|323356263|FG001|Overall Study|Lost to Follow-up|1|||
94429377|NCT00315731|323356264|FG000|Overall Study|Lost to Follow-up|1|||
94429378|NCT00315731|323356264|FG000|Overall Study|Death|5|||
94429379|NCT04614246|323356265|FG000|Overall Study|Adverse Event|0|||
94429380|NCT04614246|323356266|FG001|Overall Study|Adverse Event|1|||
94429381|NCT04614246|323356267|FG002|Overall Study|Adverse Event|1|||
94429382|NCT04614246|323356268|FG003|Overall Study|Adverse Event|2|||
94429383|NCT04614246|323356269|FG004|Overall Study|Adverse Event|1|||
94429384|NCT04614246|323356265|FG000|Overall Study|Lost to Follow-up|0|||
94429385|NCT04614246|323356266|FG001|Overall Study|Lost to Follow-up|1|||
94429386|NCT04614246|323356267|FG002|Overall Study|Lost to Follow-up|0|||
94429387|NCT04614246|323356268|FG003|Overall Study|Lost to Follow-up|1|||
94429388|NCT04614246|323356269|FG004|Overall Study|Lost to Follow-up|3|||
94429389|NCT04614246|323356265|FG000|Overall Study|Other reason|0|||
94429390|NCT04614246|323356266|FG001|Overall Study|Other reason|1|||
94429391|NCT04614246|323356267|FG002|Overall Study|Other reason|2|||
94429392|NCT04614246|323356268|FG003|Overall Study|Other reason|0|||
94429393|NCT04614246|323356269|FG004|Overall Study|Other reason|0|||
94429394|NCT04614246|323356265|FG000|Overall Study|Withdrawal by Subject|4|||
94429395|NCT04614246|323356266|FG001|Overall Study|Withdrawal by Subject|2|||
94429396|NCT04614246|323356267|FG002|Overall Study|Withdrawal by Subject|4|||
94429397|NCT04614246|323356268|FG003|Overall Study|Withdrawal by Subject|3|||
94429398|NCT04614246|323356269|FG004|Overall Study|Withdrawal by Subject|4|||
94429399|NCT04614246|323356265|FG000|Overall Study|Physician Decision|0|||
94429400|NCT04614246|323356266|FG001|Overall Study|Physician Decision|2|||
94429401|NCT04614246|323356267|FG002|Overall Study|Physician Decision|1|||
94429402|NCT04614246|323356268|FG003|Overall Study|Physician Decision|0|||
94429403|NCT04614246|323356269|FG004|Overall Study|Physician Decision|0|||
94429404|NCT04614246|323356265|FG000|Overall Study|Study terminated by sponsor|10|||
94429405|NCT04614246|323356266|FG001|Overall Study|Study terminated by sponsor|15|||
94429406|NCT04614246|323356267|FG002|Overall Study|Study terminated by sponsor|12|||
94429407|NCT04614246|323356268|FG003|Overall Study|Study terminated by sponsor|13|||
94429408|NCT04614246|323356269|FG004|Overall Study|Study terminated by sponsor|9|||
94429409|NCT04614246|323356265|FG000|Overall Study|Pregnancy|2|||
94429410|NCT04614246|323356266|FG001|Overall Study|Pregnancy|0|||
94429411|NCT04614246|323356267|FG002|Overall Study|Pregnancy|1|||
94429412|NCT04614246|323356268|FG003|Overall Study|Pregnancy|0|||
94429413|NCT04614246|323356269|FG004|Overall Study|Pregnancy|0|||
94429414|NCT02952898|323356270|FG000|Overall Study|Withdrawal by Subject|10|||
94429415|NCT02952898|323356271|FG001|Overall Study|Withdrawal by Subject|8|||
94429416|NCT02952898|323356272|FG002|Overall Study|Withdrawal by Subject|8|||
94429417|NCT02952898|323356270|FG000|Overall Study|Adverse Event|8|||
94429418|NCT02952898|323356271|FG001|Overall Study|Adverse Event|8|||
94429419|NCT02952898|323356272|FG002|Overall Study|Adverse Event|3|||
94429420|NCT02952898|323356270|FG000|Overall Study|Lost to Follow-up|3|||
94429421|NCT02952898|323356271|FG001|Overall Study|Lost to Follow-up|2|||
94429422|NCT02952898|323356272|FG002|Overall Study|Lost to Follow-up|2|||
94429423|NCT02952898|323356270|FG000|Overall Study|Non-compliance with study drug|1|||
94429424|NCT02952898|323356271|FG001|Overall Study|Non-compliance with study drug|1|||
94429425|NCT02952898|323356272|FG002|Overall Study|Non-compliance with study drug|2|||
94429426|NCT02099682|323356273|FG000|Overall Study|Data Not Available|51|||
94429427|NCT02099682|323356273|FG000|Overall Study|Lost to Follow-up|31|||
94429428|NCT02099682|323356273|FG000|Overall Study|Other|29|||
94429429|NCT02105974|323356274|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
94429430|NCT02105974|323356275|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
94429431|NCT02105974|323356276|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
94429432|NCT02105974|323356274|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
94429433|NCT02105974|323356275|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
94429434|NCT02105974|323356276|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
94429435|NCT02105974|323356274|FG000|2 Week Run-in Period|Adverse Event|6|||
94429436|NCT02105974|323356275|FG001|2 Week Run-in Period|Adverse Event|0|||
94429437|NCT02105974|323356276|FG002|2 Week Run-in Period|Adverse Event|0|||
94429438|NCT02105974|323356274|FG000|2 Week Run-in Period|Study closed/terminated|1|||
94429439|NCT02105974|323356275|FG001|2 Week Run-in Period|Study closed/terminated|0|||
94429440|NCT02105974|323356276|FG002|2 Week Run-in Period|Study closed/terminated|0|||
94429441|NCT02105974|323356274|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
94429442|NCT02105974|323356275|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
94429443|NCT02105974|323356276|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
94429444|NCT02105974|323356274|FG000|2 Week Run-in Period|Withdrew consent|23|||
94429445|NCT02105974|323356275|FG001|2 Week Run-in Period|Withdrew consent|0|||
94429446|NCT02105974|323356276|FG002|2 Week Run-in Period|Withdrew consent|0|||
94429447|NCT02105974|323356274|FG000|2 Week Run-in Period|Investigator discretion|8|||
94429448|NCT02105974|323356275|FG001|2 Week Run-in Period|Investigator discretion|0|||
94429449|NCT02105974|323356276|FG002|2 Week Run-in Period|Investigator discretion|0|||
94429450|NCT02105974|323356274|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
94429451|NCT02105974|323356275|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
94429452|NCT02105974|323356276|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
94429453|NCT02105974|323356274|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
94429454|NCT02105974|323356275|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
94429455|NCT02105974|323356276|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
94429456|NCT02105974|323356274|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
94429457|NCT02105974|323356275|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
94429458|NCT02105974|323356276|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
94429459|NCT02105974|323356274|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
94429460|NCT02105974|323356275|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
94429461|NCT02105974|323356276|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
94429462|NCT02105974|323356274|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
94429463|NCT02105974|323356275|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
94429464|NCT02105974|323356276|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
94429465|NCT02105974|323356274|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
94429466|NCT02105974|323356275|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
94429467|NCT02105974|323356276|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
94429468|NCT02105974|323356274|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
94429469|NCT02105974|323356275|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
94429470|NCT02105974|323356276|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
94429471|NCT04345601|323358062|FG000|Overall Study|Death|0|||
94429472|NCT04345601|323358063|FG001|Overall Study|Death|3|||
94429473|NCT04345601|323358064|FG002|Overall Study|Death|2|||
94429474|NCT04345601|323358062|FG000|Overall Study|Lost to Follow-up|0|||
94429475|NCT04345601|323358063|FG001|Overall Study|Lost to Follow-up|0|||
94429476|NCT04345601|323358064|FG002|Overall Study|Lost to Follow-up|2|||
94429477|NCT03610516|323358065|FG000|Treatment Epoch|Adverse Event|3|||
94429478|NCT03610516|323358066|FG001|Treatment Epoch|Adverse Event|1|||
94429479|NCT03610516|323358065|FG000|Treatment Epoch|Death|1|||
94429480|NCT03610516|323358066|FG001|Treatment Epoch|Death|0|||
94429481|NCT03610516|323358065|FG000|Treatment Epoch|Lack of Efficacy|0|||
94429482|NCT03610516|323358066|FG001|Treatment Epoch|Lack of Efficacy|1|||
94429483|NCT03610516|323358065|FG000|Treatment Epoch|No longer requires treatment|1|||
94429484|NCT03610516|323358066|FG001|Treatment Epoch|No longer requires treatment|0|||
94429485|NCT03610516|323358065|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
94429486|NCT03610516|323358066|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
94429487|NCT03610516|323358065|FG000|Treatment Epoch|Physician Decision|8|||
94429488|NCT03610516|323358066|FG001|Treatment Epoch|Physician Decision|5|||
94429489|NCT03610516|323358065|FG000|Treatment Epoch|Protocol Deviation|1|||
94429490|NCT03610516|323358066|FG001|Treatment Epoch|Protocol Deviation|0|||
94429491|NCT03610516|323358065|FG000|Treatment Epoch|Withdrawal by Subject|3|||
94429492|NCT03610516|323358066|FG001|Treatment Epoch|Withdrawal by Subject|1|||
94429493|NCT03610516|323358065|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
94429494|NCT03610516|323358066|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
94429495|NCT03610516|323358065|FG000|Post-Treatment Follow-up|Death|1|||
94429496|NCT03610516|323358066|FG001|Post-Treatment Follow-up|Death|0|||
94429497|NCT00213135|323358067|FG000|Overall Study|Adverse Event|9|||
94429498|NCT00213135|323358068|FG001|Overall Study|Adverse Event|5|||
94429499|NCT00213135|323358069|FG002|Overall Study|Adverse Event|5|||
94429500|NCT00213135|323358067|FG000|Overall Study|Lost to Follow-up|11|||
94429501|NCT00213135|323358068|FG001|Overall Study|Lost to Follow-up|8|||
94429502|NCT00213135|323358069|FG002|Overall Study|Lost to Follow-up|4|||
94429503|NCT00213135|323358067|FG000|Overall Study|Protocol Violation|4|||
94429504|NCT00213135|323358068|FG001|Overall Study|Protocol Violation|4|||
94429505|NCT00213135|323358069|FG002|Overall Study|Protocol Violation|10|||
94429506|NCT00213135|323358067|FG000|Overall Study|Death|1|||
94429507|NCT00213135|323358068|FG001|Overall Study|Death|1|||
94429508|NCT00213135|323358069|FG002|Overall Study|Death|2|||
94429509|NCT00213135|323358067|FG000|Overall Study|Disease progression|4|||
94489879|NCT01668797|323588242|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
94489880|NCT01668797|323588243|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
94429510|NCT00213135|323358068|FG001|Overall Study|Disease progression|5|||
94429511|NCT00213135|323358069|FG002|Overall Study|Disease progression|21|||
94429512|NCT00213135|323358067|FG000|Overall Study|Other|21|||
94429513|NCT00213135|323358068|FG001|Overall Study|Other|12|||
94429514|NCT00213135|323358069|FG002|Overall Study|Other|15|||
94429515|NCT01555671|323358070|FG000|Overall Study|Physician Decision|20|||
94429516|NCT01555671|323358071|FG001|Overall Study|Physician Decision|25|||
94429517|NCT00000378|323358072|FG000|Overall Study|Lack of Efficacy|16|||
94429518|NCT00000378|323358073|FG001|Overall Study|Lack of Efficacy|14|||
94489881|NCT00433836|323588244|FG000|Overall Study|Adverse Event|7|||
94489882|NCT00433836|323588245|FG001|Overall Study|Adverse Event|0|||
94489883|NCT00433836|323588244|FG000|Overall Study|Lost to Follow-up|3|||
94489884|NCT00433836|323588245|FG001|Overall Study|Lost to Follow-up|0|||
94489885|NCT00433836|323588244|FG000|Overall Study|Withdrawal by Subject|2|||
94489886|NCT00433836|323588245|FG001|Overall Study|Withdrawal by Subject|1|||
94489887|NCT00433836|323588244|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94489888|NCT00433836|323588245|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
94489889|NCT00433836|323588244|FG000|Overall Study|Protocol Violation|0|||
94489890|NCT00433836|323588245|FG001|Overall Study|Protocol Violation|2|||
94489891|NCT00433836|323588244|FG000|Overall Study|Condition no longer requires study drug|0|||
94489892|NCT00433836|323588245|FG001|Overall Study|Condition no longer requires study drug|1|||
94489893|NCT00433836|323588244|FG000|Overall Study|Abnormal laboratory values|0|||
94489894|NCT00433836|323588245|FG001|Overall Study|Abnormal laboratory values|1|||
94429519|NCT00660907|323358074|FG000|Overall Study|Incorrect Enrollment|1|||
94429520|NCT00660907|323358075|FG001|Overall Study|Incorrect Enrollment|1|||
94429521|NCT00660907|323358074|FG000|Overall Study|Adverse Event|33|||
94429522|NCT00660907|323358075|FG001|Overall Study|Adverse Event|19|||
94429523|NCT00660907|323358074|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
94429524|NCT00660907|323358075|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
94429525|NCT00660907|323358074|FG000|Overall Study|Withdrawal by Subject|23|||
94429526|NCT00660907|323358075|FG001|Overall Study|Withdrawal by Subject|32|||
94429527|NCT00660907|323358074|FG000|Overall Study|Lost to Follow-up|3|||
94429528|NCT00660907|323358075|FG001|Overall Study|Lost to Follow-up|3|||
94429529|NCT00660907|323358074|FG000|Overall Study|Poor/Non-Compliance|5|||
94429530|NCT00660907|323358075|FG001|Overall Study|Poor/Non-Compliance|1|||
94429531|NCT00660907|323358074|FG000|Overall Study|Safety|1|||
94429532|NCT00660907|323358075|FG001|Overall Study|Safety|0|||
94429533|NCT00660907|323358074|FG000|Overall Study|Death|1|||
94429534|NCT00660907|323358075|FG001|Overall Study|Death|3|||
94429535|NCT00660907|323358074|FG000|Overall Study|Various|11|||
94429536|NCT00660907|323358075|FG001|Overall Study|Various|8|||
94429537|NCT04933968|323358084|FG000|Overall Study|Adverse Event|0|||
94429538|NCT04933968|323358085|FG001|Overall Study|Adverse Event|0|||
94429539|NCT04933968|323358086|FG002|Overall Study|Adverse Event|1|||
94429540|NCT04933968|323358087|FG003|Overall Study|Adverse Event|1|||
94429541|NCT04933968|323358088|FG004|Overall Study|Adverse Event|0|||
94429542|NCT04933968|323358089|FG005|Overall Study|Adverse Event|0|||
94429543|NCT04933968|323358084|FG000|Overall Study|Lost to Follow-up|1|||
94429544|NCT04933968|323358085|FG001|Overall Study|Lost to Follow-up|0|||
94429545|NCT04933968|323358086|FG002|Overall Study|Lost to Follow-up|1|||
94429546|NCT04933968|323358087|FG003|Overall Study|Lost to Follow-up|0|||
94429547|NCT04933968|323358088|FG004|Overall Study|Lost to Follow-up|0|||
94429548|NCT04933968|323358089|FG005|Overall Study|Lost to Follow-up|0|||
94429549|NCT04933968|323358084|FG000|Overall Study|Randomized not treated|1|||
94429550|NCT04933968|323358085|FG001|Overall Study|Randomized not treated|0|||
94429551|NCT04933968|323358086|FG002|Overall Study|Randomized not treated|0|||
94429552|NCT04933968|323358087|FG003|Overall Study|Randomized not treated|0|||
94429553|NCT04933968|323358088|FG004|Overall Study|Randomized not treated|0|||
94429554|NCT04933968|323358089|FG005|Overall Study|Randomized not treated|0|||
94429555|NCT04933968|323358084|FG000|Overall Study|Sponsor terminated study|0|||
94429556|NCT04933968|323358085|FG001|Overall Study|Sponsor terminated study|0|||
94429557|NCT04933968|323358086|FG002|Overall Study|Sponsor terminated study|0|||
94429558|NCT04933968|323358087|FG003|Overall Study|Sponsor terminated study|1|||
94429559|NCT04933968|323358088|FG004|Overall Study|Sponsor terminated study|2|||
94429560|NCT04933968|323358089|FG005|Overall Study|Sponsor terminated study|0|||
94429561|NCT04933968|323358084|FG000|Overall Study|Other|0|||
94429562|NCT04933968|323358085|FG001|Overall Study|Other|0|||
94429563|NCT04933968|323358086|FG002|Overall Study|Other|0|||
94429564|NCT04933968|323358087|FG003|Overall Study|Other|1|||
94429565|NCT04933968|323358088|FG004|Overall Study|Other|0|||
94429566|NCT04933968|323358089|FG005|Overall Study|Other|0|||
94489895|NCT03451071|323588246|FG000|First Vaccine|Withdrawal by Subject|1|||
94489896|NCT03451071|323588246|FG000|Second Vaccine|Lost to Follow-up|19|||
94429567|NCT04933968|323358084|FG000|Overall Study|Missing|1|||
94429568|NCT04933968|323358085|FG001|Overall Study|Missing|3|||
94429569|NCT04933968|323358086|FG002|Overall Study|Missing|2|||
94429570|NCT04933968|323358087|FG003|Overall Study|Missing|1|||
94429571|NCT04933968|323358088|FG004|Overall Study|Missing|1|||
94489897|NCT03451071|323588246|FG000|Third Vaccine|Lost to Follow-up|22|||
94489898|NCT03451071|323588246|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
94489899|NCT03558516|323588251|FG000|Overall Study|Protocol Violation|2|||
94429572|NCT04933968|323358089|FG005|Overall Study|Missing|0|||
94429573|NCT02679235|323358092|FG000|Overall Study|Withdrawal by Subject|3|||
94429574|NCT02679235|323358092|FG000|Overall Study|Adverse Event|1|||
94429575|NCT00923273|323358093|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
94429576|NCT00923273|323358094|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
94429577|NCT00923273|323358095|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
94429578|NCT00923273|323358096|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
94429579|NCT00923273|323358097|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
94429580|NCT00923273|323358093|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
94429581|NCT00923273|323358094|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
94429582|NCT00923273|323358095|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
94429583|NCT00923273|323358096|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
94429584|NCT00923273|323358097|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
94429585|NCT00605540|323358098|FG000|Overall Study|Death|15|||
94429586|NCT00605540|323358098|FG000|Overall Study|Lost to Follow-up|23|||
94429587|NCT01161407|323358099|FG000|Overall Study|Protocol Violation|3|||
94429588|NCT01161407|323358100|FG001|Overall Study|Protocol Violation|1|||
94429589|NCT02045147|323358102|FG000|Overall Study|Withdrawal by Subject|2|||
94429590|NCT02045147|323358103|FG001|Overall Study|Withdrawal by Subject|0|||
94429591|NCT02045147|323358104|FG002|Overall Study|Withdrawal by Subject|0|||
94429592|NCT02045147|323358105|FG003|Overall Study|Withdrawal by Subject|0|||
94429593|NCT02045147|323358106|FG004|Overall Study|Withdrawal by Subject|0|||
94429594|NCT02045147|323358107|FG005|Overall Study|Withdrawal by Subject|0|||
94429595|NCT02045147|323358108|FG006|Overall Study|Withdrawal by Subject|0|||
94429596|NCT02045147|323358109|FG007|Overall Study|Withdrawal by Subject|1|||
94429597|NCT02045147|323358102|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
94429598|NCT02045147|323358103|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
94429599|NCT02045147|323358104|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
94429600|NCT02045147|323358105|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
94429601|NCT02045147|323358106|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
94429602|NCT02045147|323358107|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
94429603|NCT02045147|323358108|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
94429604|NCT02045147|323358109|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
94429605|NCT04839692|323358118|FG000|Overall Study|Withdrawal by Subject|0|||
94429606|NCT04839692|323358119|FG001|Overall Study|Withdrawal by Subject|3|||
94429607|NCT04839692|323358118|FG000|Overall Study|Physician Decision|1|||
94429608|NCT04839692|323358119|FG001|Overall Study|Physician Decision|0|||
94429609|NCT03146962|323358122|FG000|Overall Study|Lost to Follow-up|1|||
94429610|NCT03146962|323358123|FG001|Overall Study|Lost to Follow-up|1|||
94429611|NCT03146962|323358124|FG002|Overall Study|Lost to Follow-up|0|||
94429612|NCT03146962|323358125|FG003|Overall Study|Lost to Follow-up|0|||
94429613|NCT03146962|323358126|FG004|Overall Study|Lost to Follow-up|0|||
94429614|NCT03146962|323358127|FG005|Overall Study|Lost to Follow-up|0|||
94429615|NCT03146962|323358128|FG006|Overall Study|Lost to Follow-up|0|||
94429616|NCT03146962|323358129|FG007|Overall Study|Lost to Follow-up|0|||
94429617|NCT03146962|323358130|FG008|Overall Study|Lost to Follow-up|0|||
94429618|NCT03146962|323358131|FG009|Overall Study|Lost to Follow-up|0|||
94429619|NCT03146962|323358122|FG000|Overall Study|Adverse Event|0|||
94429620|NCT03146962|323358123|FG001|Overall Study|Adverse Event|3|||
94429621|NCT03146962|323358124|FG002|Overall Study|Adverse Event|0|||
94429622|NCT03146962|323358125|FG003|Overall Study|Adverse Event|0|||
94429623|NCT03146962|323358126|FG004|Overall Study|Adverse Event|0|||
94429624|NCT03146962|323358127|FG005|Overall Study|Adverse Event|0|||
94429625|NCT03146962|323358128|FG006|Overall Study|Adverse Event|0|||
94429626|NCT03146962|323358129|FG007|Overall Study|Adverse Event|1|||
94429627|NCT03146962|323358130|FG008|Overall Study|Adverse Event|0|||
94429628|NCT03146962|323358131|FG009|Overall Study|Adverse Event|0|||
94429629|NCT03146962|323358122|FG000|Overall Study|Withdrawal by Subject|0|||
94429630|NCT03146962|323358123|FG001|Overall Study|Withdrawal by Subject|0|||
94429631|NCT03146962|323358124|FG002|Overall Study|Withdrawal by Subject|0|||
94429632|NCT03146962|323358125|FG003|Overall Study|Withdrawal by Subject|0|||
94429633|NCT03146962|323358126|FG004|Overall Study|Withdrawal by Subject|1|||
94429634|NCT03146962|323358127|FG005|Overall Study|Withdrawal by Subject|0|||
94429635|NCT03146962|323358128|FG006|Overall Study|Withdrawal by Subject|0|||
94429636|NCT03146962|323358129|FG007|Overall Study|Withdrawal by Subject|0|||
94429637|NCT03146962|323358130|FG008|Overall Study|Withdrawal by Subject|0|||
94429638|NCT03146962|323358131|FG009|Overall Study|Withdrawal by Subject|0|||
94429639|NCT03146962|323358122|FG000|Overall Study|Death|0|||
94429640|NCT03146962|323358123|FG001|Overall Study|Death|1|||
94429641|NCT03146962|323358124|FG002|Overall Study|Death|0|||
94429642|NCT03146962|323358125|FG003|Overall Study|Death|0|||
94429643|NCT03146962|323358126|FG004|Overall Study|Death|0|||
94429644|NCT03146962|323358127|FG005|Overall Study|Death|0|||
94429645|NCT03146962|323358128|FG006|Overall Study|Death|0|||
94429646|NCT03146962|323358129|FG007|Overall Study|Death|0|||
94429647|NCT03146962|323358130|FG008|Overall Study|Death|0|||
94489900|NCT03558516|323588252|FG001|Overall Study|Protocol Violation|2|||
94429648|NCT03146962|323358131|FG009|Overall Study|Death|0|||
94429649|NCT03146962|323358122|FG000|Overall Study|COVID Precautions|1|||
94429650|NCT03146962|323358123|FG001|Overall Study|COVID Precautions|0|||
94429651|NCT03146962|323358124|FG002|Overall Study|COVID Precautions|0|||
94429652|NCT03146962|323358125|FG003|Overall Study|COVID Precautions|0|||
94429653|NCT03146962|323358126|FG004|Overall Study|COVID Precautions|0|||
94429654|NCT03146962|323358127|FG005|Overall Study|COVID Precautions|0|||
94429655|NCT03146962|323358128|FG006|Overall Study|COVID Precautions|0|||
94429656|NCT03146962|323358129|FG007|Overall Study|COVID Precautions|0|||
94429657|NCT03146962|323358130|FG008|Overall Study|COVID Precautions|0|||
94429658|NCT03146962|323358131|FG009|Overall Study|COVID Precautions|0|||
94429659|NCT03146962|323358122|FG000|Overall Study|Physician Decision|0|||
94429660|NCT03146962|323358123|FG001|Overall Study|Physician Decision|0|||
94429661|NCT03146962|323358124|FG002|Overall Study|Physician Decision|0|||
94429662|NCT03146962|323358125|FG003|Overall Study|Physician Decision|0|||
94429663|NCT03146962|323358126|FG004|Overall Study|Physician Decision|0|||
94429664|NCT03146962|323358127|FG005|Overall Study|Physician Decision|0|||
94429665|NCT03146962|323358128|FG006|Overall Study|Physician Decision|0|||
94429666|NCT03146962|323358129|FG007|Overall Study|Physician Decision|0|||
94429667|NCT03146962|323358130|FG008|Overall Study|Physician Decision|0|||
94429668|NCT03146962|323358131|FG009|Overall Study|Physician Decision|1|||
94429669|NCT03146962|323358122|FG000|Overall Study|Started New Treatment|0|||
94429670|NCT03146962|323358123|FG001|Overall Study|Started New Treatment|1|||
94429671|NCT03146962|323358124|FG002|Overall Study|Started New Treatment|0|||
94429672|NCT03146962|323358125|FG003|Overall Study|Started New Treatment|0|||
94429673|NCT03146962|323358126|FG004|Overall Study|Started New Treatment|0|||
94429674|NCT03146962|323358127|FG005|Overall Study|Started New Treatment|0|||
94429675|NCT03146962|323358128|FG006|Overall Study|Started New Treatment|0|||
94429676|NCT03146962|323358129|FG007|Overall Study|Started New Treatment|0|||
94429677|NCT03146962|323358130|FG008|Overall Study|Started New Treatment|0|||
94429678|NCT03146962|323358131|FG009|Overall Study|Started New Treatment|0|||
94429679|NCT03249792|323358132|FG000|Arms 1, 2, and 4|Death|1|||
94429680|NCT03249792|323358133|FG001|Arms 1, 2, and 4|Death|1|||
94429681|NCT03249792|323358134|FG002|Arms 1, 2, and 4|Death|0|||
94429682|NCT03249792|323358135|FG003|Arms 1, 2, and 4|Death|2|||
94429683|NCT03249792|323358136|FG004|Arms 1, 2, and 4|Death|3|||
94429684|NCT03249792|323358137|FG005|Arms 1, 2, and 4|Death|2|||
94429685|NCT03249792|323358138|FG006|Arms 1, 2, and 4|Death|2|||
94429686|NCT03249792|323358139|FG007|Arms 1, 2, and 4|Death|4|||
94429687|NCT03249792|323358140|FG008|Arms 1, 2, and 4|Death|2|||
94429688|NCT03249792|323358141|FG009|Arms 1, 2, and 4|Death|1|||
94429689|NCT03249792|323358142|FG010|Arms 1, 2, and 4|Death|7|||
94429690|NCT03249792|323358143|FG011|Arms 1, 2, and 4|Death|7|||
94429691|NCT03249792|323358144|FG012|Arms 1, 2, and 4|Death|12|||
94429692|NCT03249792|323358145|FG013|Arms 1, 2, and 4|Death|7|||
94429693|NCT03249792|323358146|FG014|Arms 1, 2, and 4|Death|0|||
94429694|NCT03249792|323358147|FG015|Arms 1, 2, and 4|Death|4|||
94429695|NCT03249792|323358148|FG016|Arms 1, 2, and 4|Death|4|||
94429696|NCT03249792|323358149|FG017|Arms 1, 2, and 4|Death|12|||
94429697|NCT03249792|323358150|FG018|Arms 1, 2, and 4|Death|6|||
94429698|NCT03249792|323358151|FG019|Arms 1, 2, and 4|Death|4|||
94429699|NCT03249792|323358152|FG020|Arms 1, 2, and 4|Death|2|||
94429700|NCT03249792|323358153|FG021|Arms 1, 2, and 4|Death|3|||
94429701|NCT03249792|323358154|FG022|Arms 1, 2, and 4|Death|1|||
94429702|NCT03249792|323358155|FG023|Arms 1, 2, and 4|Death|1|||
94429703|NCT03249792|323358156|FG024|Arms 1, 2, and 4|Death|4|||
94429704|NCT03249792|323358157|FG025|Arms 1, 2, and 4|Death|0|||
94429705|NCT03249792|323358158|FG026|Arms 1, 2, and 4|Death|0|||
94429706|NCT03249792|323358159|FG027|Arms 1, 2, and 4|Death|0|||
94489901|NCT03363906|323588253|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
94489902|NCT03363906|323588254|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
94489903|NCT03363906|323588253|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
94489904|NCT03363906|323588254|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
94489905|NCT03363906|323588253|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
94489906|NCT03363906|323588254|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
94429707|NCT03249792|323358160|FG028|Arms 1, 2, and 4|Death|0|||
94429708|NCT03249792|323358161|FG029|Arms 1, 2, and 4|Death|0|||
94489907|NCT03363906|323588253|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
94489908|NCT03363906|323588254|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
94489909|NCT00686972|323588257|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
94429709|NCT03249792|323358162|FG030|Arms 1, 2, and 4|Death|0|||
94429710|NCT03249792|323358163|FG031|Arms 1, 2, and 4|Death|0|||
94429711|NCT03249792|323358164|FG032|Arms 1, 2, and 4|Death|0|||
94429712|NCT03249792|323358132|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94429713|NCT03249792|323358133|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94429714|NCT03249792|323358134|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
94429715|NCT03249792|323358135|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94429716|NCT03249792|323358136|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94429717|NCT03249792|323358137|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
94429718|NCT03249792|323358138|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
94429719|NCT03249792|323358139|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94429720|NCT03249792|323358140|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
94429721|NCT03249792|323358141|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
94429722|NCT03249792|323358142|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
94429723|NCT03249792|323358143|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
94429724|NCT03249792|323358144|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
94429725|NCT03249792|323358145|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
94429726|NCT03249792|323358146|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94429727|NCT03249792|323358147|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94429728|NCT03249792|323358148|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
94429729|NCT03249792|323358149|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94429730|NCT03249792|323358150|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
94429731|NCT03249792|323358151|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94429732|NCT03249792|323358152|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94429733|NCT03249792|323358153|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94429734|NCT03249792|323358154|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
94429735|NCT03249792|323358155|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
94429736|NCT03249792|323358156|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94429737|NCT03249792|323358157|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94429738|NCT03249792|323358158|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94429739|NCT03249792|323358159|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94429740|NCT03249792|323358160|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94429741|NCT03249792|323358161|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94489910|NCT00250588|323588259|FG000|Overall Study|Withdrawal by Subject|3|||
94489911|NCT00250588|323588260|FG001|Overall Study|Withdrawal by Subject|6|||
94489912|NCT00250588|323588261|FG002|Overall Study|Withdrawal by Subject|0|||
94489913|NCT00250588|323588259|FG000|Overall Study|Lost to Follow-up|6|||
94489914|NCT00250588|323588260|FG001|Overall Study|Lost to Follow-up|13|||
94489915|NCT00250588|323588261|FG002|Overall Study|Lost to Follow-up|13|||
94489916|NCT01026493|323588267|FG000|Overall Study|Protocol Violation|0|||
94489917|NCT01026493|323588268|FG001|Overall Study|Protocol Violation|1|||
94489918|NCT01026493|323588269|FG002|Overall Study|Protocol Violation|0|||
94489919|NCT01026493|323588270|FG003|Overall Study|Protocol Violation|0|||
94489920|NCT01026493|323588271|FG004|Overall Study|Protocol Violation|2|||
94489921|NCT01026493|323588272|FG005|Overall Study|Protocol Violation|3|||
94489922|NCT01026493|323588273|FG006|Overall Study|Protocol Violation|4|||
94489923|NCT01026493|323588274|FG007|Overall Study|Protocol Violation|1|||
94489924|NCT02410629|323588275|FG000|Overall Study|Family cannot commit to the study|2|||
94489925|NCT02410629|323588276|FG001|Overall Study|Family cannot commit to the study|1|||
94489926|NCT02410629|323588275|FG000|Overall Study|Subject returned to work|1|||
94489927|NCT02410629|323588276|FG001|Overall Study|Subject returned to work|0|||
94489928|NCT02410629|323588275|FG000|Overall Study|Subject moved back to home country|0|||
94489929|NCT02410629|323588276|FG001|Overall Study|Subject moved back to home country|1|||
94489930|NCT02410629|323588275|FG000|Overall Study|Subject underwent heart surgery|0|||
94489931|NCT02410629|323588276|FG001|Overall Study|Subject underwent heart surgery|1|||
94489932|NCT01206764|323588278|FG000|Overall Study|Adverse Event|20|||
94489933|NCT01206764|323588278|FG000|Overall Study|Abnormal laboratory value|2|||
94489934|NCT01206764|323588278|FG000|Overall Study|Abnormal test procedure result|1|||
94489935|NCT01206764|323588278|FG000|Overall Study|Patient withdrew consent|5|||
94489936|NCT01206764|323588278|FG000|Overall Study|Lost to Follow-up|6|||
94489937|NCT01206764|323588278|FG000|Overall Study|Death|11|||
94489938|NCT01206764|323588278|FG000|Overall Study|New cancer therapy|2|||
94489939|NCT01206764|323588278|FG000|Overall Study|Disease progression|88|||
94489940|NCT01206764|323588278|FG000|Overall Study|Protocol deviation|3|||
94489941|NCT00142415|323588281|FG000|Overall Study|Physician Decision|0|||
94489942|NCT00142415|323588282|FG001|Overall Study|Physician Decision|0|||
94489943|NCT00142415|323588283|FG002|Overall Study|Physician Decision|0|||
94489944|NCT00142415|323588284|FG003|Overall Study|Physician Decision|0|||
94489945|NCT00142415|323588285|FG004|Overall Study|Physician Decision|1|||
94489946|NCT00142415|323588286|FG005|Overall Study|Physician Decision|2|||
94489947|NCT01299584|323588287|FG000|Overall Study|Protocol Violation|9|||
94489948|NCT01704261|323588288|FG000|Overall Study|Withdrawal by Subject|12|||
94489949|NCT01704261|323588289|FG001|Overall Study|Withdrawal by Subject|15|||
94489950|NCT01704261|323588288|FG000|Overall Study|Lost to Follow-up|1|||
94489951|NCT01704261|323588289|FG001|Overall Study|Lost to Follow-up|0|||
94489952|NCT00924898|323588291|FG000|Overall Study|Withdrawal by Subject|2|||
94489953|NCT03704064|323588292|FG000|Overall Study|Lost to Follow-up|8|||
94429742|NCT03249792|323358162|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94489954|NCT03704064|323588293|FG001|Overall Study|Lost to Follow-up|4|||
94429743|NCT03249792|323358163|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94489955|NCT03704064|323588292|FG000|Overall Study|Withdrawal by Subject|1|||
94489956|NCT03704064|323588293|FG001|Overall Study|Withdrawal by Subject|1|||
94489957|NCT03704064|323588292|FG000|Overall Study|No longer available for study visits|0|||
94489958|NCT03704064|323588293|FG001|Overall Study|No longer available for study visits|1|||
94489959|NCT03704064|323588292|FG000|Overall Study|Censoring event|1|||
94489960|NCT03704064|323588293|FG001|Overall Study|Censoring event|0|||
94489961|NCT00289276|323588298|FG000|Second Part of FAST Study (Expansion)|Death|0|||
94489962|NCT00289276|323588299|FG001|Second Part of FAST Study (Expansion)|Death|2|||
94489963|NCT00289276|323588298|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
94429744|NCT03249792|323358164|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
94429745|NCT03249792|323358132|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
94429746|NCT03249792|323358133|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
94429747|NCT03249792|323358134|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
94429748|NCT03249792|323358135|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
94429749|NCT03249792|323358136|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
94429750|NCT03249792|323358137|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
94429751|NCT03249792|323358138|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
94429752|NCT03249792|323358139|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
94429753|NCT03249792|323358140|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
94429754|NCT03249792|323358141|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
94429755|NCT03249792|323358142|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
94429756|NCT03249792|323358143|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
94429757|NCT03249792|323358144|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
94429758|NCT03249792|323358145|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
94429759|NCT03249792|323358146|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
94429760|NCT03249792|323358147|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
94429761|NCT03249792|323358148|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
94429762|NCT03249792|323358149|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
94429763|NCT03249792|323358150|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
94429764|NCT03249792|323358151|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
94429765|NCT03249792|323358152|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
94429766|NCT03249792|323358153|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
94429767|NCT03249792|323358154|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
94429768|NCT03249792|323358155|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
94429769|NCT03249792|323358156|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
94429770|NCT03249792|323358157|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
94429771|NCT03249792|323358158|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
94429772|NCT03249792|323358159|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
94429773|NCT03249792|323358160|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
94429774|NCT03249792|323358161|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
94429775|NCT03249792|323358162|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
94429776|NCT03249792|323358163|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
94429777|NCT03249792|323358164|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
94429778|NCT03249792|323358132|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429779|NCT03249792|323358133|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429780|NCT03249792|323358134|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429781|NCT03249792|323358135|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429782|NCT03249792|323358136|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429783|NCT03249792|323358137|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429784|NCT03249792|323358138|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429785|NCT03249792|323358139|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429786|NCT03249792|323358140|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
94429787|NCT03249792|323358141|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429788|NCT03249792|323358142|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429789|NCT03249792|323358143|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429790|NCT03249792|323358144|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429791|NCT03249792|323358145|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429792|NCT03249792|323358146|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429793|NCT03249792|323358147|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429794|NCT03249792|323358148|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
94429795|NCT03249792|323358149|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
94429796|NCT03249792|323358150|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429797|NCT03249792|323358151|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
94429798|NCT03249792|323358152|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429799|NCT03249792|323358153|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429800|NCT03249792|323358154|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429801|NCT03249792|323358155|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429802|NCT03249792|323358156|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429803|NCT03249792|323358157|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429804|NCT03249792|323358158|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429805|NCT03249792|323358159|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429806|NCT03249792|323358160|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
94489964|NCT00289276|323588299|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
94489965|NCT00111761|323588300|FG000|Part 1|Physician Decision|0|||
94489966|NCT00111761|323588301|FG001|Part 1|Physician Decision|1|||
94489967|NCT00111761|323588300|FG000|Part 1|Death|0|||
94429807|NCT03249792|323358161|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429808|NCT03249792|323358162|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429809|NCT03249792|323358163|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429810|NCT03249792|323358164|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
94429811|NCT03249792|323358132|FG000|Switch Over Period|Withdrawal by Subject|0|||
94429812|NCT03249792|323358133|FG001|Switch Over Period|Withdrawal by Subject|0|||
94429813|NCT03249792|323358134|FG002|Switch Over Period|Withdrawal by Subject|0|||
94429814|NCT03249792|323358135|FG003|Switch Over Period|Withdrawal by Subject|0|||
94489968|NCT00111761|323588301|FG001|Part 1|Death|2|||
94429815|NCT03249792|323358136|FG004|Switch Over Period|Withdrawal by Subject|0|||
94429816|NCT03249792|323358137|FG005|Switch Over Period|Withdrawal by Subject|0|||
94429817|NCT03249792|323358138|FG006|Switch Over Period|Withdrawal by Subject|0|||
94429818|NCT03249792|323358139|FG007|Switch Over Period|Withdrawal by Subject|0|||
94429819|NCT03249792|323358140|FG008|Switch Over Period|Withdrawal by Subject|0|||
94429820|NCT03249792|323358141|FG009|Switch Over Period|Withdrawal by Subject|0|||
94429821|NCT03249792|323358142|FG010|Switch Over Period|Withdrawal by Subject|0|||
94429822|NCT03249792|323358143|FG011|Switch Over Period|Withdrawal by Subject|0|||
94429823|NCT03249792|323358144|FG012|Switch Over Period|Withdrawal by Subject|0|||
94429824|NCT03249792|323358145|FG013|Switch Over Period|Withdrawal by Subject|0|||
94429825|NCT03249792|323358146|FG014|Switch Over Period|Withdrawal by Subject|0|||
94429826|NCT03249792|323358147|FG015|Switch Over Period|Withdrawal by Subject|0|||
94429827|NCT03249792|323358148|FG016|Switch Over Period|Withdrawal by Subject|0|||
94429828|NCT03249792|323358149|FG017|Switch Over Period|Withdrawal by Subject|0|||
94429829|NCT03249792|323358150|FG018|Switch Over Period|Withdrawal by Subject|0|||
94429830|NCT03249792|323358151|FG019|Switch Over Period|Withdrawal by Subject|0|||
94429831|NCT03249792|323358152|FG020|Switch Over Period|Withdrawal by Subject|0|||
94429832|NCT03249792|323358153|FG021|Switch Over Period|Withdrawal by Subject|0|||
94429833|NCT03249792|323358154|FG022|Switch Over Period|Withdrawal by Subject|0|||
94429834|NCT03249792|323358155|FG023|Switch Over Period|Withdrawal by Subject|0|||
94429835|NCT03249792|323358156|FG024|Switch Over Period|Withdrawal by Subject|0|||
94429836|NCT03249792|323358157|FG025|Switch Over Period|Withdrawal by Subject|0|||
94429837|NCT03249792|323358158|FG026|Switch Over Period|Withdrawal by Subject|0|||
94429838|NCT03249792|323358159|FG027|Switch Over Period|Withdrawal by Subject|0|||
94429839|NCT03249792|323358160|FG028|Switch Over Period|Withdrawal by Subject|0|||
94429840|NCT03249792|323358161|FG029|Switch Over Period|Withdrawal by Subject|0|||
94429841|NCT03249792|323358162|FG030|Switch Over Period|Withdrawal by Subject|0|||
94429842|NCT03249792|323358163|FG031|Switch Over Period|Withdrawal by Subject|1|||
94429843|NCT03249792|323358164|FG032|Switch Over Period|Withdrawal by Subject|0|||
94429844|NCT03249792|323358132|FG000|Switch Over Period|Progressive Disease|0|||
94429845|NCT03249792|323358133|FG001|Switch Over Period|Progressive Disease|0|||
94429846|NCT03249792|323358134|FG002|Switch Over Period|Progressive Disease|0|||
94429847|NCT03249792|323358135|FG003|Switch Over Period|Progressive Disease|0|||
94429848|NCT03249792|323358136|FG004|Switch Over Period|Progressive Disease|0|||
94429849|NCT03249792|323358137|FG005|Switch Over Period|Progressive Disease|0|||
94429850|NCT03249792|323358138|FG006|Switch Over Period|Progressive Disease|0|||
94429851|NCT03249792|323358139|FG007|Switch Over Period|Progressive Disease|0|||
94429852|NCT03249792|323358140|FG008|Switch Over Period|Progressive Disease|0|||
94429853|NCT03249792|323358141|FG009|Switch Over Period|Progressive Disease|0|||
94429854|NCT03249792|323358142|FG010|Switch Over Period|Progressive Disease|0|||
94429855|NCT03249792|323358143|FG011|Switch Over Period|Progressive Disease|0|||
94429856|NCT03249792|323358144|FG012|Switch Over Period|Progressive Disease|0|||
94429857|NCT03249792|323358145|FG013|Switch Over Period|Progressive Disease|0|||
94429858|NCT03249792|323358146|FG014|Switch Over Period|Progressive Disease|0|||
94429859|NCT03249792|323358147|FG015|Switch Over Period|Progressive Disease|0|||
94429860|NCT03249792|323358148|FG016|Switch Over Period|Progressive Disease|0|||
94429861|NCT03249792|323358149|FG017|Switch Over Period|Progressive Disease|0|||
94429862|NCT03249792|323358150|FG018|Switch Over Period|Progressive Disease|0|||
94429863|NCT03249792|323358151|FG019|Switch Over Period|Progressive Disease|0|||
94429864|NCT03249792|323358152|FG020|Switch Over Period|Progressive Disease|0|||
94429865|NCT03249792|323358153|FG021|Switch Over Period|Progressive Disease|0|||
94429866|NCT03249792|323358154|FG022|Switch Over Period|Progressive Disease|0|||
94429867|NCT03249792|323358155|FG023|Switch Over Period|Progressive Disease|0|||
94429868|NCT03249792|323358156|FG024|Switch Over Period|Progressive Disease|0|||
94429869|NCT03249792|323358157|FG025|Switch Over Period|Progressive Disease|0|||
94429870|NCT03249792|323358158|FG026|Switch Over Period|Progressive Disease|1|||
94429871|NCT03249792|323358159|FG027|Switch Over Period|Progressive Disease|0|||
94429872|NCT03249792|323358160|FG028|Switch Over Period|Progressive Disease|1|||
94429873|NCT03249792|323358161|FG029|Switch Over Period|Progressive Disease|2|||
94429874|NCT03249792|323358162|FG030|Switch Over Period|Progressive Disease|1|||
94429875|NCT03249792|323358163|FG031|Switch Over Period|Progressive Disease|0|||
94429876|NCT03249792|323358164|FG032|Switch Over Period|Progressive Disease|1|||
94429877|NCT03249792|323358132|FG000|Switch Over Period|Adverse Event|0|||
94429878|NCT03249792|323358133|FG001|Switch Over Period|Adverse Event|0|||
94429879|NCT03249792|323358134|FG002|Switch Over Period|Adverse Event|0|||
94429880|NCT03249792|323358135|FG003|Switch Over Period|Adverse Event|0|||
94429881|NCT03249792|323358136|FG004|Switch Over Period|Adverse Event|0|||
94429882|NCT03249792|323358137|FG005|Switch Over Period|Adverse Event|0|||
94429883|NCT03249792|323358138|FG006|Switch Over Period|Adverse Event|0|||
94429884|NCT03249792|323358139|FG007|Switch Over Period|Adverse Event|0|||
94429885|NCT03249792|323358140|FG008|Switch Over Period|Adverse Event|0|||
94429886|NCT03249792|323358141|FG009|Switch Over Period|Adverse Event|0|||
94429887|NCT03249792|323358142|FG010|Switch Over Period|Adverse Event|0|||
94429888|NCT03249792|323358143|FG011|Switch Over Period|Adverse Event|0|||
94429889|NCT03249792|323358144|FG012|Switch Over Period|Adverse Event|0|||
94429890|NCT03249792|323358145|FG013|Switch Over Period|Adverse Event|0|||
94429891|NCT03249792|323358146|FG014|Switch Over Period|Adverse Event|0|||
94429892|NCT03249792|323358147|FG015|Switch Over Period|Adverse Event|0|||
94429893|NCT03249792|323358148|FG016|Switch Over Period|Adverse Event|0|||
94429894|NCT03249792|323358149|FG017|Switch Over Period|Adverse Event|0|||
94429895|NCT03249792|323358150|FG018|Switch Over Period|Adverse Event|0|||
94429896|NCT03249792|323358151|FG019|Switch Over Period|Adverse Event|0|||
94429897|NCT03249792|323358152|FG020|Switch Over Period|Adverse Event|0|||
94429898|NCT03249792|323358153|FG021|Switch Over Period|Adverse Event|0|||
94429899|NCT03249792|323358154|FG022|Switch Over Period|Adverse Event|0|||
94429900|NCT03249792|323358155|FG023|Switch Over Period|Adverse Event|0|||
94429901|NCT03249792|323358156|FG024|Switch Over Period|Adverse Event|0|||
94429902|NCT03249792|323358157|FG025|Switch Over Period|Adverse Event|1|||
94429903|NCT03249792|323358158|FG026|Switch Over Period|Adverse Event|0|||
94429904|NCT03249792|323358159|FG027|Switch Over Period|Adverse Event|1|||
94429905|NCT03249792|323358160|FG028|Switch Over Period|Adverse Event|0|||
94429906|NCT03249792|323358161|FG029|Switch Over Period|Adverse Event|0|||
94429907|NCT03249792|323358162|FG030|Switch Over Period|Adverse Event|0|||
94429908|NCT03249792|323358163|FG031|Switch Over Period|Adverse Event|0|||
94429909|NCT03249792|323358164|FG032|Switch Over Period|Adverse Event|0|||
94429910|NCT00927394|323358167|FG000|Overall Study|Adverse Event|14|||
94429911|NCT00927394|323358168|FG001|Overall Study|Adverse Event|9|||
94429912|NCT00927394|323358167|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
94429913|NCT00927394|323358168|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
94429914|NCT00927394|323358167|FG000|Overall Study|Withdrawal by Subject|20|||
94429915|NCT00927394|323358168|FG001|Overall Study|Withdrawal by Subject|24|||
94429916|NCT00927394|323358167|FG000|Overall Study|Lost to Follow-up|8|||
94429917|NCT00927394|323358168|FG001|Overall Study|Lost to Follow-up|14|||
94429918|NCT00927394|323358167|FG000|Overall Study|Administrative Problem|1|||
94429919|NCT00927394|323358168|FG001|Overall Study|Administrative Problem|0|||
94429920|NCT00927394|323358167|FG000|Overall Study|Death|1|||
94429921|NCT00927394|323358168|FG001|Overall Study|Death|1|||
94429922|NCT00927394|323358167|FG000|Overall Study|Protocol deviation|16|||
94429923|NCT00927394|323358168|FG001|Overall Study|Protocol deviation|13|||
94429924|NCT00927394|323358167|FG000|Overall Study|Randomized in error|0|||
94429925|NCT00927394|323358168|FG001|Overall Study|Randomized in error|1|||
94429926|NCT00106964|323358169|FG000|Overall Study|Lost to Follow-up|8|||
94429927|NCT00106964|323358170|FG001|Overall Study|Lost to Follow-up|6|||
94429928|NCT00106964|323358171|FG002|Overall Study|Lost to Follow-up|2|||
94429929|NCT00106964|323358169|FG000|Overall Study|Pregnancy|2|||
94429930|NCT00106964|323358170|FG001|Overall Study|Pregnancy|3|||
94429931|NCT00106964|323358171|FG002|Overall Study|Pregnancy|2|||
94429932|NCT00106964|323358169|FG000|Overall Study|Death|1|||
94429933|NCT00106964|323358170|FG001|Overall Study|Death|1|||
94429934|NCT00106964|323358171|FG002|Overall Study|Death|0|||
94429935|NCT00106964|323358169|FG000|Overall Study|Incarceration|0|||
94429936|NCT00106964|323358170|FG001|Overall Study|Incarceration|1|||
94429937|NCT00106964|323358171|FG002|Overall Study|Incarceration|0|||
94429938|NCT00106964|323358169|FG000|Overall Study|Site Funding Terminated|0|||
94429939|NCT00106964|323358170|FG001|Overall Study|Site Funding Terminated|1|||
94429940|NCT00106964|323358171|FG002|Overall Study|Site Funding Terminated|1|||
94429941|NCT00106964|323358169|FG000|Overall Study|Failure to adhere|2|||
94429942|NCT00106964|323358170|FG001|Overall Study|Failure to adhere|0|||
94429943|NCT00106964|323358171|FG002|Overall Study|Failure to adhere|0|||
94429944|NCT00106964|323358169|FG000|Overall Study|Did not meet eligibility criteria|0|||
94429945|NCT00106964|323358170|FG001|Overall Study|Did not meet eligibility criteria|2|||
94429946|NCT00106964|323358171|FG002|Overall Study|Did not meet eligibility criteria|2|||
94429947|NCT00106964|323358169|FG000|Overall Study|Required disallowed medication|0|||
94429948|NCT00106964|323358170|FG001|Overall Study|Required disallowed medication|1|||
94429949|NCT00106964|323358171|FG002|Overall Study|Required disallowed medication|0|||
94429950|NCT00856375|323358183|FG000|Overall Study|Other|0|||
94429951|NCT00856375|323358184|FG001|Overall Study|Other|1|||
94429952|NCT00856375|323358183|FG000|Overall Study|Death|32|||
94429953|NCT00856375|323358184|FG001|Overall Study|Death|30|||
94429954|NCT00856375|323358183|FG000|Overall Study|Sponsor Terminated Study|7|||
94429955|NCT00856375|323358184|FG001|Overall Study|Sponsor Terminated Study|7|||
94429956|NCT00856375|323358183|FG000|Overall Study|Withdrawal by Subject|2|||
94429957|NCT00856375|323358184|FG001|Overall Study|Withdrawal by Subject|1|||
94429958|NCT00856375|323358183|FG000|Overall Study|Lost to Follow-up|1|||
94429959|NCT00856375|323358184|FG001|Overall Study|Lost to Follow-up|2|||
94429960|NCT02121392|323358185|FG000|Prior to Intervention|Protocol Violation|40|||
94429961|NCT02121392|323358186|FG001|Prior to Intervention|Protocol Violation|35|||
94429962|NCT02121392|323358185|FG000|Prior to Intervention|Withdrawal by Subject|8|||
94429963|NCT02121392|323358186|FG001|Prior to Intervention|Withdrawal by Subject|6|||
94429964|NCT02121392|323358185|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
94429965|NCT02121392|323358186|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
94429966|NCT02121392|323358185|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
94429967|NCT02121392|323358186|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
94489969|NCT00111761|323588300|FG000|Part 1|Other|0|||
94429968|NCT01352416|323358187|FG000|Overall Study|Physician Decision|1|||
94429969|NCT01352416|323358188|FG001|Overall Study|Physician Decision|2|||
94429970|NCT01352416|323358189|FG002|Overall Study|Physician Decision|2|||
94429971|NCT01352416|323358190|FG003|Overall Study|Physician Decision|1|||
94429972|NCT03016975|323358191|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
94429973|NCT03016975|323358192|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
94429974|NCT03016975|323358193|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
94429975|NCT03016975|323358191|FG000|At 6 Months Follow-up|Death|2|||
94429976|NCT03016975|323358192|FG001|At 6 Months Follow-up|Death|0|||
94429977|NCT03016975|323358193|FG002|At 6 Months Follow-up|Death|0|||
94429978|NCT03016975|323358191|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
94429979|NCT03016975|323358192|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
94429980|NCT03016975|323358193|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
94429981|NCT03016975|323358191|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
94429982|NCT03016975|323358192|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
94429983|NCT03016975|323358193|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
94429984|NCT03016975|323358191|FG000|At 6 Months Follow-up|Aborted implant|1|||
94429985|NCT03016975|323358192|FG001|At 6 Months Follow-up|Aborted implant|0|||
94429986|NCT03016975|323358193|FG002|At 6 Months Follow-up|Aborted implant|0|||
94429987|NCT03016975|323358191|FG000|At 2 Year Follow-up|Death|1|||
94429988|NCT03016975|323358192|FG001|At 2 Year Follow-up|Death|0|||
94429989|NCT03016975|323358193|FG002|At 2 Year Follow-up|Death|0|||
94429990|NCT03016975|323358191|FG000|At 3 Year Follow-up|Death|1|||
94429991|NCT03016975|323358192|FG001|At 3 Year Follow-up|Death|0|||
94429992|NCT03016975|323358193|FG002|At 3 Year Follow-up|Death|0|||
94429993|NCT03016975|323358191|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
94429994|NCT03016975|323358192|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
94429995|NCT03016975|323358193|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
94429996|NCT03016975|323358191|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
94429997|NCT03016975|323358192|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
94429998|NCT03016975|323358193|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
94429999|NCT00901576|323358199|FG000|Second Intervention|Withdrawal by Subject|0|||
94430000|NCT00901576|323358200|FG001|Second Intervention|Withdrawal by Subject|0|||
94430001|NCT00901576|323358201|FG002|Second Intervention|Withdrawal by Subject|0|||
94430002|NCT00901576|323358202|FG003|Second Intervention|Withdrawal by Subject|1|||
94430003|NCT00901576|323358203|FG004|Second Intervention|Withdrawal by Subject|0|||
94430004|NCT00901576|323358204|FG005|Second Intervention|Withdrawal by Subject|1|||
94430005|NCT00901576|323358199|FG000|Second Intervention|Physician Decision|1|||
94430006|NCT00901576|323358200|FG001|Second Intervention|Physician Decision|0|||
94430007|NCT00901576|323358201|FG002|Second Intervention|Physician Decision|0|||
94430008|NCT00901576|323358202|FG003|Second Intervention|Physician Decision|0|||
94430009|NCT00901576|323358203|FG004|Second Intervention|Physician Decision|0|||
94430010|NCT00901576|323358204|FG005|Second Intervention|Physician Decision|0|||
94430011|NCT02730351|323358207|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
94430012|NCT02730351|323358208|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
94430013|NCT02730351|323358207|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
94430014|NCT02730351|323358208|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
94430015|NCT02730351|323358207|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
94430016|NCT02730351|323358208|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
94430017|NCT02730351|323358207|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
94430018|NCT02730351|323358208|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
94430019|NCT02730351|323358207|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
94430020|NCT02730351|323358208|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
94430021|NCT03796039|323358209|FG000|Overall Study|Death|2|||
94430022|NCT03796039|323358210|FG001|Overall Study|Death|1|||
94430023|NCT03796039|323358209|FG000|Overall Study|Withdrawal by Subject|7|||
94430024|NCT03796039|323358210|FG001|Overall Study|Withdrawal by Subject|4|||
94430025|NCT00252239|323358211|FG000|Overall Study|Withdrawal by Subject|1|||
94430026|NCT00252239|323358212|FG001|Overall Study|Withdrawal by Subject|0|||
94430027|NCT00252239|323358213|FG002|Overall Study|Withdrawal by Subject|0|||
94430028|NCT00252239|323358214|FG003|Overall Study|Withdrawal by Subject|1|||
94430029|NCT00252239|323358211|FG000|Overall Study|Lost to Follow-up|0|||
94430030|NCT00252239|323358212|FG001|Overall Study|Lost to Follow-up|0|||
94430031|NCT00252239|323358213|FG002|Overall Study|Lost to Follow-up|2|||
94430032|NCT00252239|323358214|FG003|Overall Study|Lost to Follow-up|0|||
94430033|NCT03485365|323358219|FG000|Overall Study|Protocol Violation|0|||
94430034|NCT03485365|323358220|FG001|Overall Study|Protocol Violation|0|||
94430035|NCT03485365|323358221|FG002|Overall Study|Protocol Violation|0|||
94430036|NCT03485365|323358222|FG003|Overall Study|Protocol Violation|1|||
94489970|NCT00111761|323588301|FG001|Part 1|Other|1|||
94430037|NCT03485365|323358223|FG004|Overall Study|Protocol Violation|0|||
94430038|NCT03485365|323358224|FG005|Overall Study|Protocol Violation|0|||
94430039|NCT03485365|323358225|FG006|Overall Study|Protocol Violation|1|||
94430040|NCT03485365|323358226|FG007|Overall Study|Protocol Violation|0|||
94430041|NCT03485365|323358227|FG008|Overall Study|Protocol Violation|0|||
94430042|NCT04868968|323358228|FG000|Overall Study|Lost to Follow-up|1|||
94489971|NCT00111761|323588300|FG000|Part 1|Withdrawal by Subject|0|||
94430043|NCT00678886|323358231|FG000|Overall Study|Withdrawal by Subject|0|||
94430044|NCT00678886|323358232|FG001|Overall Study|Withdrawal by Subject|0|||
94430045|NCT00678886|323358233|FG002|Overall Study|Withdrawal by Subject|4|||
94430046|NCT00678886|323358234|FG003|Overall Study|Withdrawal by Subject|6|||
94430047|NCT00678886|323358231|FG000|Overall Study|Physician Decision|0|||
94430048|NCT00678886|323358232|FG001|Overall Study|Physician Decision|0|||
94430049|NCT00678886|323358233|FG002|Overall Study|Physician Decision|1|||
94430050|NCT00678886|323358234|FG003|Overall Study|Physician Decision|1|||
94430051|NCT00678886|323358231|FG000|Overall Study|Lost to Follow-up|0|||
94430052|NCT00678886|323358232|FG001|Overall Study|Lost to Follow-up|0|||
94430053|NCT00678886|323358233|FG002|Overall Study|Lost to Follow-up|3|||
94430054|NCT00678886|323358234|FG003|Overall Study|Lost to Follow-up|2|||
94430055|NCT00678886|323358231|FG000|Overall Study|Other|0|||
94430056|NCT00678886|323358232|FG001|Overall Study|Other|0|||
94430057|NCT00678886|323358233|FG002|Overall Study|Other|1|||
94430058|NCT00678886|323358234|FG003|Overall Study|Other|0|||
94430059|NCT02181790|323358235|FG000|Overall Study|study terminated|2|||
94430060|NCT02181790|323358236|FG001|Overall Study|study terminated|0|||
94430061|NCT00843635|323358241|FG000|Overall Study|Adverse Event|2|||
94430062|NCT00843635|323358242|FG001|Overall Study|Adverse Event|2|||
94430063|NCT00843635|323358243|FG002|Overall Study|Adverse Event|0|||
94430064|NCT02714426|323358244|FG000|Overall Study|Withdrawal by Subject|2|||
94430065|NCT02714426|323358245|FG001|Overall Study|Withdrawal by Subject|2|||
94430066|NCT04693416|323358247|FG000|Overall Study|Lost to Follow-up|13|||
94430067|NCT04693416|323358248|FG001|Overall Study|Lost to Follow-up|0|||
94430068|NCT00813800|323358252|FG000|Overall Study|Screen Failure after Consent|2|||
94430069|NCT00813800|323358252|FG000|Overall Study|Adverse Event|1|||
94430070|NCT00813800|323358252|FG000|Overall Study|Worsening of depression|2|||
94430071|NCT00813800|323358252|FG000|Overall Study|Physician Decision|1|||
94430072|NCT00090363|323358253|FG000|Overall Study|Lost to Follow-up|1|||
94430073|NCT00090363|323358254|FG001|Overall Study|Lost to Follow-up|2|||
94430074|NCT00090363|323358255|FG002|Overall Study|Lost to Follow-up|1|||
94430075|NCT00090363|323358253|FG000|Overall Study|Withdrawal by Subject|7|||
94430076|NCT00090363|323358254|FG001|Overall Study|Withdrawal by Subject|7|||
94430077|NCT00090363|323358255|FG002|Overall Study|Withdrawal by Subject|6|||
94430078|NCT00090363|323358253|FG000|Overall Study|Study-specific discontinuation criteria|75|||
94430079|NCT00090363|323358254|FG001|Overall Study|Study-specific discontinuation criteria|74|||
94430080|NCT00090363|323358255|FG002|Overall Study|Study-specific discontinuation criteria|62|||
94430081|NCT00090363|323358253|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
94430082|NCT00090363|323358254|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
94430083|NCT00090363|323358255|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
94430084|NCT00090363|323358253|FG000|Overall Study|Consent expired|7|||
94430085|NCT00090363|323358254|FG001|Overall Study|Consent expired|10|||
94430086|NCT00090363|323358255|FG002|Overall Study|Consent expired|9|||
94430087|NCT00090363|323358253|FG000|Overall Study|Reasons not specified|2|||
94430088|NCT00090363|323358254|FG001|Overall Study|Reasons not specified|1|||
94430089|NCT00090363|323358255|FG002|Overall Study|Reasons not specified|1|||
94430090|NCT00090363|323358253|FG000|Overall Study|Continuing on study off treatment|14|||
94430091|NCT00090363|323358254|FG001|Overall Study|Continuing on study off treatment|13|||
94430092|NCT00090363|323358255|FG002|Overall Study|Continuing on study off treatment|16|||
94430093|NCT02552212|323358258|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
94430094|NCT02552212|323358259|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
94430095|NCT02552212|323358260|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
94430096|NCT02552212|323358258|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
94430097|NCT02552212|323358259|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
94430098|NCT02552212|323358260|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
94430099|NCT02552212|323358258|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
94430100|NCT02552212|323358259|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
94430101|NCT02552212|323358260|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
94430102|NCT02552212|323358258|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
94430103|NCT02552212|323358259|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
94430104|NCT02552212|323358260|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
94430105|NCT02552212|323358258|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
94430106|NCT02552212|323358259|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
94430107|NCT02552212|323358260|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
94430108|NCT02552212|323358258|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
94430109|NCT02552212|323358259|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
94430110|NCT02552212|323358260|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
94489972|NCT00111761|323588301|FG001|Part 1|Withdrawal by Subject|1|||
94430111|NCT02552212|323358258|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
94430112|NCT02552212|323358259|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
94430113|NCT02552212|323358260|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
94430114|NCT02552212|323358258|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
94430115|NCT02552212|323358259|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
94430116|NCT02552212|323358260|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
94430117|NCT02552212|323358258|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
94430118|NCT02552212|323358259|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
94430119|NCT02552212|323358260|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
94430120|NCT02552212|323358258|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
94430121|NCT02552212|323358259|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
94430122|NCT02552212|323358260|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
94430123|NCT02552212|323358258|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
94430124|NCT02552212|323358259|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
94430125|NCT02552212|323358260|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
94430126|NCT02552212|323358258|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
94430127|NCT02552212|323358259|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
94430128|NCT02552212|323358260|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
94430129|NCT02552212|323358258|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
94430130|NCT02552212|323358259|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
94430131|NCT02552212|323358260|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
94430132|NCT02552212|323358258|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
94430133|NCT02552212|323358259|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
94430134|NCT02552212|323358260|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
94430135|NCT02552212|323358258|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
94430136|NCT02552212|323358259|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
94430137|NCT02552212|323358260|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
94430138|NCT02552212|323358258|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
94430139|NCT02552212|323358259|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
94430140|NCT02552212|323358260|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
94430141|NCT02552212|323358258|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
94430142|NCT02552212|323358259|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
94430143|NCT02552212|323358260|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
94430144|NCT02552212|323358258|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
94430145|NCT02552212|323358259|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
94430146|NCT02552212|323358260|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
94430147|NCT02552212|323358258|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
94430148|NCT02552212|323358259|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
94430149|NCT02552212|323358260|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
94430150|NCT02552212|323358258|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
94430151|NCT02552212|323358259|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
94430152|NCT02552212|323358260|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
94430153|NCT02552212|323358258|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
94430154|NCT02552212|323358259|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
94430155|NCT02552212|323358260|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
94430156|NCT04572893|323358262|FG000|Part A|Adverse Event|1|||
94430157|NCT04572893|323358263|FG001|Part A|Adverse Event|0|||
94430158|NCT04572893|323358264|FG002|Part A|Adverse Event|0|||
94430159|NCT04572893|323358265|FG003|Part A|Adverse Event|0|||
94430160|NCT04572893|323358266|FG004|Part A|Adverse Event|0|||
94430161|NCT04572893|323358267|FG005|Part A|Adverse Event|0|||
94430162|NCT04572893|323358268|FG006|Part A|Adverse Event|0|||
94430163|NCT04572893|323358262|FG000|Part B|Withdrawal by Subject|0|||
94430164|NCT04572893|323358263|FG001|Part B|Withdrawal by Subject|0|||
94430165|NCT04572893|323358264|FG002|Part B|Withdrawal by Subject|0|||
94430166|NCT04572893|323358265|FG003|Part B|Withdrawal by Subject|0|||
94430167|NCT04572893|323358266|FG004|Part B|Withdrawal by Subject|0|||
94430168|NCT04572893|323358267|FG005|Part B|Withdrawal by Subject|1|||
94430169|NCT04572893|323358268|FG006|Part B|Withdrawal by Subject|0|||
94430170|NCT04572893|323358262|FG000|Part B|Study terminated by sponsor|0|||
94430171|NCT04572893|323358263|FG001|Part B|Study terminated by sponsor|0|||
94430172|NCT04572893|323358264|FG002|Part B|Study terminated by sponsor|0|||
94430173|NCT04572893|323358265|FG003|Part B|Study terminated by sponsor|0|||
94430174|NCT04572893|323358266|FG004|Part B|Study terminated by sponsor|7|||
94430175|NCT04572893|323358267|FG005|Part B|Study terminated by sponsor|5|||
94430176|NCT04572893|323358268|FG006|Part B|Study terminated by sponsor|3|||
94430177|NCT04572893|323358262|FG000|Part B|Lost to Follow-up|0|||
94430178|NCT04572893|323358263|FG001|Part B|Lost to Follow-up|0|||
94489973|NCT00111761|323588300|FG000|Part 2|Adverse Event|1|||
94430179|NCT04572893|323358264|FG002|Part B|Lost to Follow-up|0|||
94430180|NCT04572893|323358265|FG003|Part B|Lost to Follow-up|0|||
94430181|NCT04572893|323358266|FG004|Part B|Lost to Follow-up|0|||
94430182|NCT04572893|323358267|FG005|Part B|Lost to Follow-up|0|||
94430183|NCT04572893|323358268|FG006|Part B|Lost to Follow-up|1|||
94430184|NCT04572893|323358262|FG000|Part B|Adverse Event|0|||
94430185|NCT04572893|323358263|FG001|Part B|Adverse Event|0|||
94430186|NCT04572893|323358264|FG002|Part B|Adverse Event|0|||
94430187|NCT04572893|323358265|FG003|Part B|Adverse Event|0|||
94430188|NCT04572893|323358266|FG004|Part B|Adverse Event|1|||
94430189|NCT04572893|323358267|FG005|Part B|Adverse Event|1|||
94430190|NCT04572893|323358268|FG006|Part B|Adverse Event|0|||
94430191|NCT04619992|323358271|FG000|Overall Study|Withdrawal by Subject|1|||
94430192|NCT04619992|323358272|FG001|Overall Study|Withdrawal by Subject|0|||
94430193|NCT02351960|323358273|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
94430194|NCT02351960|323358274|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
94430195|NCT02351960|323358273|FG000|Overall Study|Voluntary Withdrawal|5|||
94430196|NCT02351960|323358274|FG001|Overall Study|Voluntary Withdrawal|4|||
94430197|NCT02351960|323358273|FG000|Overall Study|Significant Protocol Deviation|0|||
94430198|NCT02351960|323358274|FG001|Overall Study|Significant Protocol Deviation|5|||
94430199|NCT01987479|323358281|FG000|Overall Study|Protocol Violation|1|||
94430200|NCT01987479|323358281|FG000|Overall Study|Physician Decision|2|||
94430201|NCT01987479|323358281|FG000|Overall Study|Participant/legal guardian decision|1|||
94430202|NCT01987479|323358281|FG000|Overall Study|Other|5|||
94430203|NCT01987479|323358281|FG000|Overall Study|Lost to Follow-up|1|||
94430204|NCT01987479|323358281|FG000|Overall Study|Adverse Event|7|||
94430205|NCT00461253|323360310|FG000|Overall Study|Death|985|||
94430206|NCT00461253|323360311|FG001|Overall Study|Death|0|||
94430207|NCT00461253|323360310|FG000|Overall Study|Protocol Violation|613|||
94430208|NCT00461253|323360311|FG001|Overall Study|Protocol Violation|236|||
94430209|NCT00461253|323360310|FG000|Overall Study|no response|2609|||
94430210|NCT00461253|323360311|FG001|Overall Study|no response|11789|||
94430211|NCT00461253|323360310|FG000|Overall Study|administrative|773|||
94430212|NCT00461253|323360311|FG001|Overall Study|administrative|7773|||
94430213|NCT03510598|323360312|FG000|Overall Study|Withdrawal by Subject|1|||
94430214|NCT01523457|323360315|FG000|Overall Study|Withdrawal by Subject|7|||
94430215|NCT01523457|323360316|FG001|Overall Study|Withdrawal by Subject|2|||
94430216|NCT05307510|323360317|FG000|Overall Study|Lost to Follow-up|3|||
94430217|NCT05307510|323360318|FG001|Overall Study|Lost to Follow-up|6|||
94430218|NCT05307510|323360317|FG000|Overall Study|Withdrawal by Subject|0|||
94430219|NCT05307510|323360318|FG001|Overall Study|Withdrawal by Subject|1|||
94430220|NCT00631657|323360325|FG000|6-Month Treatment Period|Adverse Event|47|||
94430221|NCT00631657|323360326|FG001|6-Month Treatment Period|Adverse Event|0|||
94430222|NCT00631657|323360327|FG002|6-Month Treatment Period|Adverse Event|7|||
94430223|NCT00631657|323360325|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
94430224|NCT00631657|323360326|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
94430225|NCT00631657|323360327|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
94430226|NCT00631657|323360325|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
94430227|NCT00631657|323360326|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
94430228|NCT00631657|323360327|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
94430229|NCT00631657|323360325|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
94430230|NCT00631657|323360326|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
94430231|NCT00631657|323360327|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
94430232|NCT00631657|323360325|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
94430233|NCT00631657|323360326|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
94430234|NCT00631657|323360327|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
94430235|NCT00631657|323360325|FG000|6-Month Treatment Period|Other|16|||
94430236|NCT00631657|323360326|FG001|6-Month Treatment Period|Other|0|||
94430237|NCT00631657|323360327|FG002|6-Month Treatment Period|Other|4|||
94430238|NCT00631657|323360325|FG000|6-Month Treatment Period|Not Treated|2|||
94430239|NCT00631657|323360326|FG001|6-Month Treatment Period|Not Treated|0|||
94430240|NCT00631657|323360327|FG002|6-Month Treatment Period|Not Treated|1|||
94430241|NCT00631657|323360325|FG000|7-Day Discontinuation Period|Not Treated|1|||
94430242|NCT00631657|323360326|FG001|7-Day Discontinuation Period|Not Treated|1|||
94430243|NCT00631657|323360327|FG002|7-Day Discontinuation Period|Not Treated|1|||
94430244|NCT00631657|323360325|FG000|7-Day Discontinuation Period|Other|1|||
94430245|NCT00631657|323360326|FG001|7-Day Discontinuation Period|Other|0|||
94430246|NCT00631657|323360327|FG002|7-Day Discontinuation Period|Other|0|||
94430247|NCT02886624|323360332|FG000|12-week Post Treatment Follow-up|Death|1|||
94430248|NCT02886624|323360332|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
94430249|NCT00402116|323360333|FG000|Overall Study|Jaw infection after surgery-other|1|||
94430250|NCT00402116|323360334|FG001|Overall Study|Jaw infection after surgery-other|0|||
94430251|NCT00402116|323360335|FG002|Overall Study|Jaw infection after surgery-other|0|||
94430252|NCT00402116|323360333|FG000|Overall Study|Withdrawal by Subject|1|||
94430253|NCT00402116|323360334|FG001|Overall Study|Withdrawal by Subject|0|||
94430254|NCT00402116|323360335|FG002|Overall Study|Withdrawal by Subject|5|||
94430255|NCT00402116|323360333|FG000|Overall Study|Treatment completed per protocol|1|||
94430256|NCT00402116|323360334|FG001|Overall Study|Treatment completed per protocol|1|||
94430257|NCT00402116|323360335|FG002|Overall Study|Treatment completed per protocol|2|||
94430258|NCT00402116|323360333|FG000|Overall Study|other complicating disease|0|||
94430259|NCT00402116|323360334|FG001|Overall Study|other complicating disease|0|||
94430260|NCT00402116|323360335|FG002|Overall Study|other complicating disease|2|||
94430261|NCT00402116|323360333|FG000|Overall Study|Disease Progression|0|||
94430262|NCT00402116|323360334|FG001|Overall Study|Disease Progression|4|||
94430263|NCT00402116|323360335|FG002|Overall Study|Disease Progression|38|||
94430264|NCT00402116|323360333|FG000|Overall Study|mistaken thrombocytopenia|0|||
94430265|NCT00402116|323360334|FG001|Overall Study|mistaken thrombocytopenia|0|||
94430266|NCT00402116|323360335|FG002|Overall Study|mistaken thrombocytopenia|1|||
94430267|NCT00402116|323360333|FG000|Overall Study|decline related hyponatremia/tumor|0|||
94430268|NCT00402116|323360334|FG001|Overall Study|decline related hyponatremia/tumor|0|||
94430269|NCT00402116|323360335|FG002|Overall Study|decline related hyponatremia/tumor|1|||
94430270|NCT00402116|323360333|FG000|Overall Study|Adverse Event|0|||
94430271|NCT00402116|323360334|FG001|Overall Study|Adverse Event|1|||
94430272|NCT00402116|323360335|FG002|Overall Study|Adverse Event|6|||
94430273|NCT04003896|323360336|FG000|Overall Study|Withdrawal by Subject|3|||
94430274|NCT04003896|323360336|FG000|Overall Study|Physician Decision|1|||
94430275|NCT03323437|323360341|FG000|Overall Study|Withdrawal by Subject|0|||
94430276|NCT03323437|323360342|FG001|Overall Study|Withdrawal by Subject|4|||
94430277|NCT01473524|323360345|FG000|DB Phase|Adverse Event|4|||
94430278|NCT01473524|323360346|FG001|DB Phase|Adverse Event|8|||
94430279|NCT01473524|323360347|FG002|DB Phase|Adverse Event|2|||
94430280|NCT01473524|323360348|FG003|DB Phase|Adverse Event|0|||
94430281|NCT01473524|323360349|FG004|DB Phase|Adverse Event|0|||
94430282|NCT01473524|323360350|FG005|DB Phase|Adverse Event|0|||
94430283|NCT01473524|323360345|FG000|DB Phase|Death|1|||
94430284|NCT01473524|323360346|FG001|DB Phase|Death|0|||
94430285|NCT01473524|323360347|FG002|DB Phase|Death|0|||
94430286|NCT01473524|323360348|FG003|DB Phase|Death|0|||
94430287|NCT01473524|323360349|FG004|DB Phase|Death|0|||
94430288|NCT01473524|323360350|FG005|DB Phase|Death|0|||
94430289|NCT01473524|323360345|FG000|DB Phase|Withdrawal by Subject|2|||
94430290|NCT01473524|323360346|FG001|DB Phase|Withdrawal by Subject|1|||
94430291|NCT01473524|323360347|FG002|DB Phase|Withdrawal by Subject|1|||
94430292|NCT01473524|323360348|FG003|DB Phase|Withdrawal by Subject|0|||
94430293|NCT01473524|323360349|FG004|DB Phase|Withdrawal by Subject|0|||
94430294|NCT01473524|323360350|FG005|DB Phase|Withdrawal by Subject|0|||
94430295|NCT01473524|323360345|FG000|LTSE Phase|Withdrawal by Subject|0|||
94430296|NCT01473524|323360346|FG001|LTSE Phase|Withdrawal by Subject|0|||
94430297|NCT01473524|323360347|FG002|LTSE Phase|Withdrawal by Subject|0|||
94430298|NCT01473524|323360348|FG003|LTSE Phase|Withdrawal by Subject|3|||
94430299|NCT01473524|323360349|FG004|LTSE Phase|Withdrawal by Subject|3|||
94430300|NCT01473524|323360350|FG005|LTSE Phase|Withdrawal by Subject|6|||
94430301|NCT01473524|323360345|FG000|LTSE Phase|Death|0|||
94430302|NCT01473524|323360346|FG001|LTSE Phase|Death|0|||
94430303|NCT01473524|323360347|FG002|LTSE Phase|Death|0|||
94430304|NCT01473524|323360348|FG003|LTSE Phase|Death|0|||
94430305|NCT01473524|323360349|FG004|LTSE Phase|Death|1|||
94430306|NCT01473524|323360350|FG005|LTSE Phase|Death|0|||
94430307|NCT01473524|323360345|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
94430308|NCT01473524|323360346|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
94430309|NCT01473524|323360347|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
94430310|NCT01473524|323360348|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
94430311|NCT01473524|323360349|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
94430312|NCT01473524|323360350|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
94430313|NCT01473524|323360345|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
94430314|NCT01473524|323360346|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
94430315|NCT01473524|323360347|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
94430316|NCT01473524|323360348|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
94430317|NCT01473524|323360349|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
94430318|NCT01473524|323360350|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
94430319|NCT01473524|323360345|FG000|LTSE Phase|Lost to Follow-up|0|||
94430320|NCT01473524|323360346|FG001|LTSE Phase|Lost to Follow-up|0|||
94430321|NCT01473524|323360347|FG002|LTSE Phase|Lost to Follow-up|0|||
94430322|NCT01473524|323360348|FG003|LTSE Phase|Lost to Follow-up|1|||
94430323|NCT01473524|323360349|FG004|LTSE Phase|Lost to Follow-up|3|||
94430324|NCT01473524|323360350|FG005|LTSE Phase|Lost to Follow-up|2|||
94430325|NCT01473524|323360345|FG000|LTSE Phase|Principal Investigator Decision|0|||
94430326|NCT01473524|323360346|FG001|LTSE Phase|Principal Investigator Decision|0|||
94430327|NCT01473524|323360347|FG002|LTSE Phase|Principal Investigator Decision|0|||
94430328|NCT01473524|323360348|FG003|LTSE Phase|Principal Investigator Decision|1|||
94430329|NCT01473524|323360349|FG004|LTSE Phase|Principal Investigator Decision|1|||
94430330|NCT01473524|323360350|FG005|LTSE Phase|Principal Investigator Decision|3|||
94430331|NCT01473524|323360345|FG000|LTSE Phase|Liver Transplantation|0|||
94430332|NCT01473524|323360346|FG001|LTSE Phase|Liver Transplantation|0|||
94430333|NCT01473524|323360347|FG002|LTSE Phase|Liver Transplantation|0|||
94489974|NCT00111761|323588301|FG001|Part 2|Adverse Event|0|||
94430334|NCT01473524|323360348|FG003|LTSE Phase|Liver Transplantation|0|||
94430335|NCT01473524|323360349|FG004|LTSE Phase|Liver Transplantation|0|||
94430336|NCT01473524|323360350|FG005|LTSE Phase|Liver Transplantation|1|||
94430337|NCT01473524|323360345|FG000|LTSE Phase|Pregnancy|0|||
94430338|NCT01473524|323360346|FG001|LTSE Phase|Pregnancy|0|||
94430339|NCT01473524|323360347|FG002|LTSE Phase|Pregnancy|0|||
94430340|NCT01473524|323360348|FG003|LTSE Phase|Pregnancy|1|||
94430341|NCT01473524|323360349|FG004|LTSE Phase|Pregnancy|0|||
94430342|NCT01473524|323360350|FG005|LTSE Phase|Pregnancy|0|||
94430343|NCT01473524|323360345|FG000|LTSE Phase|Protocol Violation|0|||
94430344|NCT01473524|323360346|FG001|LTSE Phase|Protocol Violation|0|||
94430345|NCT01473524|323360347|FG002|LTSE Phase|Protocol Violation|0|||
94430346|NCT01473524|323360348|FG003|LTSE Phase|Protocol Violation|0|||
94430347|NCT01473524|323360349|FG004|LTSE Phase|Protocol Violation|0|||
94430348|NCT01473524|323360350|FG005|LTSE Phase|Protocol Violation|1|||
94430349|NCT02119819|323360351|FG000|Overall Study|Adverse Event|3|||
94430350|NCT02119819|323360352|FG001|Overall Study|Adverse Event|1|||
94430351|NCT02119819|323360353|FG002|Overall Study|Adverse Event|2|||
94430352|NCT02119819|323360354|FG003|Overall Study|Adverse Event|3|||
94430353|NCT02119819|323360355|FG004|Overall Study|Adverse Event|0|||
94430354|NCT02119819|323360356|FG005|Overall Study|Adverse Event|1|||
94430355|NCT02119819|323360351|FG000|Overall Study|Lack of Efficacy|0|||
94430356|NCT02119819|323360352|FG001|Overall Study|Lack of Efficacy|0|||
94430357|NCT02119819|323360353|FG002|Overall Study|Lack of Efficacy|0|||
94430358|NCT02119819|323360354|FG003|Overall Study|Lack of Efficacy|0|||
94430359|NCT02119819|323360355|FG004|Overall Study|Lack of Efficacy|0|||
94430360|NCT02119819|323360356|FG005|Overall Study|Lack of Efficacy|1|||
94430361|NCT02119819|323360351|FG000|Overall Study|Lost to Follow-up|0|||
94430362|NCT02119819|323360352|FG001|Overall Study|Lost to Follow-up|0|||
94430363|NCT02119819|323360353|FG002|Overall Study|Lost to Follow-up|1|||
94430364|NCT02119819|323360354|FG003|Overall Study|Lost to Follow-up|2|||
94430365|NCT02119819|323360355|FG004|Overall Study|Lost to Follow-up|1|||
94430366|NCT02119819|323360356|FG005|Overall Study|Lost to Follow-up|2|||
94430367|NCT02119819|323360351|FG000|Overall Study|Physician Decision|1|||
94430368|NCT02119819|323360352|FG001|Overall Study|Physician Decision|1|||
94430369|NCT02119819|323360353|FG002|Overall Study|Physician Decision|0|||
94430370|NCT02119819|323360354|FG003|Overall Study|Physician Decision|0|||
94430371|NCT02119819|323360355|FG004|Overall Study|Physician Decision|0|||
94430372|NCT02119819|323360356|FG005|Overall Study|Physician Decision|1|||
94430373|NCT02119819|323360351|FG000|Overall Study|Withdrawal by Subject|5|||
94430374|NCT02119819|323360352|FG001|Overall Study|Withdrawal by Subject|3|||
94430375|NCT02119819|323360353|FG002|Overall Study|Withdrawal by Subject|0|||
94430376|NCT02119819|323360354|FG003|Overall Study|Withdrawal by Subject|0|||
94430377|NCT02119819|323360355|FG004|Overall Study|Withdrawal by Subject|6|||
94430378|NCT02119819|323360356|FG005|Overall Study|Withdrawal by Subject|10|||
94430379|NCT02119819|323360351|FG000|Overall Study|Jury Duty|0|||
94430380|NCT02119819|323360352|FG001|Overall Study|Jury Duty|0|||
94430381|NCT02119819|323360353|FG002|Overall Study|Jury Duty|1|||
94430382|NCT02119819|323360354|FG003|Overall Study|Jury Duty|0|||
94430383|NCT02119819|323360355|FG004|Overall Study|Jury Duty|0|||
94430384|NCT02119819|323360356|FG005|Overall Study|Jury Duty|0|||
94430385|NCT02119819|323360351|FG000|Overall Study|Protocol Violation|0|||
94430386|NCT02119819|323360352|FG001|Overall Study|Protocol Violation|0|||
94430387|NCT02119819|323360353|FG002|Overall Study|Protocol Violation|0|||
94430388|NCT02119819|323360354|FG003|Overall Study|Protocol Violation|1|||
94430389|NCT02119819|323360355|FG004|Overall Study|Protocol Violation|0|||
94430390|NCT02119819|323360356|FG005|Overall Study|Protocol Violation|0|||
94430391|NCT02119819|323360351|FG000|Overall Study|Left the city to get a job|0|||
94430392|NCT02119819|323360352|FG001|Overall Study|Left the city to get a job|0|||
94430393|NCT02119819|323360353|FG002|Overall Study|Left the city to get a job|0|||
94430394|NCT02119819|323360354|FG003|Overall Study|Left the city to get a job|1|||
94430395|NCT02119819|323360355|FG004|Overall Study|Left the city to get a job|0|||
94655544|NCT00927927|324196072|FG012|Overall Study|Withdrawal by Subject|0|||
94655545|NCT00927927|324196073|FG013|Overall Study|Withdrawal by Subject|0|||
94655546|NCT00927927|324196074|FG014|Overall Study|Withdrawal by Subject|0|||
94655547|NCT01208233|324196079|FG000|Overall Study|Adverse Event|0|||
94655548|NCT01208233|324196080|FG001|Overall Study|Adverse Event|1|||
94655549|NCT01208233|324196081|FG002|Overall Study|Adverse Event|2|||
94655550|NCT01208233|324196082|FG003|Overall Study|Adverse Event|0|||
94655551|NCT01208233|324196083|FG004|Overall Study|Adverse Event|3|||
94655552|NCT01208233|324196084|FG005|Overall Study|Adverse Event|5|||
94655553|NCT01208233|324196079|FG000|Overall Study|Death|0|||
94655554|NCT01208233|324196080|FG001|Overall Study|Death|0|||
94655555|NCT01208233|324196081|FG002|Overall Study|Death|0|||
94655556|NCT01208233|324196082|FG003|Overall Study|Death|0|||
94655557|NCT01208233|324196083|FG004|Overall Study|Death|3|||
94655558|NCT01208233|324196084|FG005|Overall Study|Death|5|||
94655559|NCT01208233|324196079|FG000|Overall Study|Did not meet entrance criteria|2|||
94430396|NCT02119819|323360356|FG005|Overall Study|Left the city to get a job|0|||
94430397|NCT01305044|323360361|FG000|Overall Study|Withdrawal by Subject|3|||
94430398|NCT01305044|323360362|FG001|Overall Study|Withdrawal by Subject|6|||
94430399|NCT04005352|323360363|FG000|Overall Study|Adverse Event|4|||
94430400|NCT04005352|323360364|FG001|Overall Study|Adverse Event|5|||
94430401|NCT04005352|323360363|FG000|Overall Study|Death|4|||
94430402|NCT04005352|323360364|FG001|Overall Study|Death|2|||
94430403|NCT04005352|323360363|FG000|Overall Study|Lost to Follow-up|6|||
94655560|NCT01208233|324196080|FG001|Overall Study|Did not meet entrance criteria|1|||
94655561|NCT01208233|324196081|FG002|Overall Study|Did not meet entrance criteria|1|||
94655562|NCT01208233|324196082|FG003|Overall Study|Did not meet entrance criteria|0|||
94655563|NCT01208233|324196083|FG004|Overall Study|Did not meet entrance criteria|1|||
94655564|NCT01208233|324196084|FG005|Overall Study|Did not meet entrance criteria|0|||
94655565|NCT01208233|324196079|FG000|Overall Study|Medication error without adverse event|0|||
94655566|NCT01208233|324196080|FG001|Overall Study|Medication error without adverse event|0|||
94655567|NCT01208233|324196081|FG002|Overall Study|Medication error without adverse event|0|||
94655568|NCT01208233|324196082|FG003|Overall Study|Medication error without adverse event|0|||
94655569|NCT01208233|324196083|FG004|Overall Study|Medication error without adverse event|0|||
94655570|NCT01208233|324196084|FG005|Overall Study|Medication error without adverse event|1|||
94655571|NCT01208233|324196079|FG000|Overall Study|Study terminated by sponsor|0|||
94655572|NCT01208233|324196080|FG001|Overall Study|Study terminated by sponsor|0|||
94655573|NCT01208233|324196081|FG002|Overall Study|Study terminated by sponsor|0|||
94655574|NCT01208233|324196082|FG003|Overall Study|Study terminated by sponsor|0|||
94655575|NCT01208233|324196083|FG004|Overall Study|Study terminated by sponsor|10|||
94430404|NCT04005352|323360364|FG001|Overall Study|Lost to Follow-up|2|||
94430405|NCT04005352|323360363|FG000|Overall Study|Physician Decision|7|||
94430406|NCT04005352|323360364|FG001|Overall Study|Physician Decision|13|||
94430407|NCT04005352|323360363|FG000|Overall Study|Protocol Violation|0|||
94430408|NCT04005352|323360364|FG001|Overall Study|Protocol Violation|1|||
94430409|NCT04005352|323360363|FG000|Overall Study|Withdrawal by Subject|28|||
94430410|NCT04005352|323360364|FG001|Overall Study|Withdrawal by Subject|38|||
94430411|NCT02861014|323360365|FG000|Primary Analysis|Adverse Event|7|||
94430412|NCT02861014|323360365|FG000|Primary Analysis|Death|1|||
94430413|NCT02861014|323360365|FG000|Primary Analysis|Lack of Efficacy|3|||
94430414|NCT02861014|323360365|FG000|Primary Analysis|Physician Decision|2|||
94430415|NCT02861014|323360365|FG000|Primary Analysis|Pregnancy|4|||
94430416|NCT02861014|323360365|FG000|Primary Analysis|Protocol Violation|2|||
94430417|NCT02861014|323360365|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
94430418|NCT02861014|323360365|FG000|Primary Analysis|Withdrawal by Subject|14|||
94430419|NCT02861014|323360365|FG000|Primary Analysis|Commercial ocrelizumab|3|||
94430420|NCT02861014|323360365|FG000|Safety Follow-up|Adverse Event|1|||
94430421|NCT02861014|323360365|FG000|Safety Follow-up|Pregnancy|1|||
94430422|NCT02861014|323360365|FG000|Safety Follow-up|Withdrawal by Subject|9|||
94430423|NCT02861014|323360365|FG000|Safety Follow-up|Study terminated by sponsor|1|||
94430424|NCT02861014|323360365|FG000|Safety Follow-up|Physician Decision|1|||
94430425|NCT02861014|323360365|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
94430426|NCT02861014|323360365|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
94430427|NCT01001988|323360372|FG000|Overall Study|Protocol Violation|84|||
94430428|NCT01001988|323360372|FG000|Overall Study|Withdrawal by Subject|18|||
94430429|NCT01001988|323360372|FG000|Overall Study|Lost to Follow-up|15|||
94430430|NCT00749892|323360373|FG000|Overall Study|Withdrawal by Subject|3|||
94430431|NCT04746794|323360374|FG000|Overall Study|Did not complete any study assessment|50303|||
94430432|NCT04746794|323360375|FG001|Overall Study|Did not complete any study assessment|44997|||
94430433|NCT03207243|323360376|FG000|Overall Study|Adverse Event|2|||
94430434|NCT03207243|323360377|FG001|Overall Study|Adverse Event|2|||
94430435|NCT03207243|323360376|FG000|Overall Study|Loss of Asthma Control|47|||
94430436|NCT03207243|323360377|FG001|Overall Study|Loss of Asthma Control|31|||
94430437|NCT03207243|323360376|FG000|Overall Study|Withdrawal by Subject|2|||
94430438|NCT03207243|323360377|FG001|Overall Study|Withdrawal by Subject|4|||
94430439|NCT03207243|323360376|FG000|Overall Study|Physician Decision|1|||
94430440|NCT03207243|323360377|FG001|Overall Study|Physician Decision|1|||
94430441|NCT03207243|323360376|FG000|Overall Study|Lost to Follow-up|0|||
94430442|NCT03207243|323360377|FG001|Overall Study|Lost to Follow-up|1|||
94430443|NCT03207243|323360376|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
94430444|NCT03207243|323360377|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
94430445|NCT03207243|323360376|FG000|Overall Study|Protocol Violation|0|||
94430446|NCT03207243|323360377|FG001|Overall Study|Protocol Violation|3|||
94430447|NCT02552303|323360378|FG000|Allocation|Withdrawal by Subject|2|||
94430448|NCT02552303|323360379|FG001|Allocation|Withdrawal by Subject|1|||
94430449|NCT02552303|323360380|FG002|Allocation|Withdrawal by Subject|1|||
94430450|NCT02552303|323360381|FG003|Allocation|Withdrawal by Subject|1|||
94430451|NCT02552303|323360378|FG000|Allocation|ineligible|1|||
94430452|NCT02552303|323360379|FG001|Allocation|ineligible|1|||
94430453|NCT02552303|323360380|FG002|Allocation|ineligible|0|||
94430454|NCT02552303|323360381|FG003|Allocation|ineligible|0|||
94430455|NCT02552303|323360378|FG000|Follow-Up|Lost to Follow-up|0|||
94430456|NCT02552303|323360379|FG001|Follow-Up|Lost to Follow-up|0|||
94430457|NCT02552303|323360380|FG002|Follow-Up|Lost to Follow-up|1|||
94430458|NCT02552303|323360381|FG003|Follow-Up|Lost to Follow-up|0|||
94430459|NCT02552303|323360378|FG000|Follow-Up|ineligible|0|||
94430460|NCT02552303|323360379|FG001|Follow-Up|ineligible|2|||
94430461|NCT02552303|323360380|FG002|Follow-Up|ineligible|0|||
94430462|NCT02552303|323360381|FG003|Follow-Up|ineligible|0|||
94430463|NCT02227446|323360382|FG000|Overall Study|not eligible post randomization|18|||
94430464|NCT02227446|323360383|FG001|Overall Study|not eligible post randomization|29|||
94430465|NCT02227446|323360382|FG000|Overall Study|Withdrawal by Subject|4|||
94430466|NCT02227446|323360383|FG001|Overall Study|Withdrawal by Subject|5|||
94430467|NCT00875797|323360384|FG000|Overall Study|Protocol Violation|6|||
94430468|NCT00875797|323360385|FG001|Overall Study|Protocol Violation|3|||
94430469|NCT00715624|323360386|FG000|Overall Study|Adverse Event|12|||
94430470|NCT00715624|323360387|FG001|Overall Study|Adverse Event|37|||
94430471|NCT00715624|323360386|FG000|Overall Study|Lack of Efficacy|11|||
94430472|NCT00715624|323360387|FG001|Overall Study|Lack of Efficacy|11|||
94430473|NCT00715624|323360386|FG000|Overall Study|Lost to Follow-up|1|||
94430474|NCT00715624|323360387|FG001|Overall Study|Lost to Follow-up|2|||
94430475|NCT00715624|323360386|FG000|Overall Study|Protocol Violation|1|||
94430476|NCT00715624|323360387|FG001|Overall Study|Protocol Violation|0|||
94430477|NCT00715624|323360386|FG000|Overall Study|Withdrawal by Subject|11|||
94430478|NCT00715624|323360387|FG001|Overall Study|Withdrawal by Subject|25|||
94430479|NCT00715624|323360386|FG000|Overall Study|Familial and personal reasons|10|||
94430480|NCT00715624|323360387|FG001|Overall Study|Familial and personal reasons|22|||
94430481|NCT00715624|323360386|FG000|Overall Study|Poor compliance|6|||
94430482|NCT00715624|323360387|FG001|Overall Study|Poor compliance|13|||
94430483|NCT00715624|323360386|FG000|Overall Study|Sponsor decision|0|||
94430484|NCT00715624|323360387|FG001|Overall Study|Sponsor decision|4|||
94430485|NCT00715624|323360386|FG000|Overall Study|Incorrect randomization (not treated)|0|||
94430486|NCT00715624|323360387|FG001|Overall Study|Incorrect randomization (not treated)|1|||
94430487|NCT00715624|323360386|FG000|Overall Study|Other|0|||
94430488|NCT00715624|323360387|FG001|Overall Study|Other|1|||
94430489|NCT01955083|323360395|FG000|Overall Study|Lost to Follow-up|1|||
94430490|NCT01955083|323360396|FG001|Overall Study|Lost to Follow-up|1|||
94430491|NCT02871492|323360397|FG000|Overall Study|Lost to Follow-up|6|||
94430492|NCT02871492|323360398|FG001|Overall Study|Lost to Follow-up|3|||
94430493|NCT02871492|323360399|FG002|Overall Study|Lost to Follow-up|5|||
94430494|NCT02871492|323360397|FG000|Overall Study|Withdrawal by Subject|0|||
94430495|NCT02871492|323360398|FG001|Overall Study|Withdrawal by Subject|0|||
94430496|NCT02871492|323360399|FG002|Overall Study|Withdrawal by Subject|1|||
94430497|NCT03136965|323360402|FG000|Overall Study|Lost to Follow-up|0|||
94430498|NCT03136965|323360403|FG001|Overall Study|Lost to Follow-up|1|||
94430499|NCT03136965|323360404|FG002|Overall Study|Lost to Follow-up|0|||
94430500|NCT01147107|323360405|FG000|Overall Study|Lack of Efficacy|5|||
94430501|NCT01147107|323360406|FG001|Overall Study|Lack of Efficacy|0|||
94430502|NCT01147107|323360405|FG000|Overall Study|Withdrawal by Subject|1|||
94430503|NCT01147107|323360406|FG001|Overall Study|Withdrawal by Subject|1|||
94430504|NCT01275430|323360410|FG000|Overall Study|Adverse Event|1|||
94430505|NCT01275430|323360410|FG000|Overall Study|No Contrast Injection|6|||
94430506|NCT01275430|323360410|FG000|Overall Study|Device Malfunction|1|||
94430507|NCT01275430|323360410|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
94430508|NCT02910063|323360411|FG000|Phase 2|Withdrawal by Subject|3|||
94430509|NCT02910063|323360412|FG001|Phase 2|Withdrawal by Subject|0|||
94430510|NCT02910063|323360413|FG002|Phase 2|Withdrawal by Subject|0|||
94430511|NCT02910063|323360411|FG000|Phase 2|Lost to Follow-up|1|||
94430512|NCT02910063|323360412|FG001|Phase 2|Lost to Follow-up|0|||
94430513|NCT02910063|323360413|FG002|Phase 2|Lost to Follow-up|0|||
94430514|NCT02910063|323360411|FG000|Phase 2|Death|24|||
94430515|NCT02910063|323360412|FG001|Phase 2|Death|0|||
94430516|NCT02910063|323360413|FG002|Phase 2|Death|0|||
94430517|NCT02785952|323360414|FG000|Overall Study|Adverse Event|31|||
94430518|NCT02785952|323360415|FG001|Overall Study|Adverse Event|19|||
94430519|NCT02785952|323360414|FG000|Overall Study|Refusal unrelated to adverse events|10|||
94430520|NCT02785952|323360415|FG001|Overall Study|Refusal unrelated to adverse events|5|||
94430521|NCT02785952|323360414|FG000|Overall Study|Disease progression/relapse|61|||
94430522|NCT02785952|323360415|FG001|Overall Study|Disease progression/relapse|89|||
94430523|NCT02785952|323360414|FG000|Overall Study|Death|11|||
94430524|NCT02785952|323360415|FG001|Overall Study|Death|7|||
94430525|NCT02785952|323360414|FG000|Overall Study|Other- not protocol specified|6|||
94430526|NCT02785952|323360415|FG001|Overall Study|Other- not protocol specified|4|||
94430527|NCT02785952|323360414|FG000|Overall Study|On protocol treatment|6|||
94430528|NCT02785952|323360415|FG001|Overall Study|On protocol treatment|3|||
94430529|NCT00896480|323360416|FG000|Overall Study|Disease progression/recurrence|21|||
94430530|NCT03371459|323360425|FG000|Washout|Lost to Follow-up|0|||
94430531|NCT03371459|323360426|FG001|Washout|Lost to Follow-up|1|||
94430532|NCT00205803|323360428|FG000|Infant Series|Lost to Follow-up|10|||
94430533|NCT00205803|323360429|FG001|Infant Series|Lost to Follow-up|4|||
94430534|NCT00205803|323360428|FG000|Infant Series|Withdrawal by Subject|2|||
94430535|NCT00205803|323360429|FG001|Infant Series|Withdrawal by Subject|5|||
94430536|NCT00205803|323360428|FG000|Infant Series|Physician Decision|3|||
94430537|NCT00205803|323360429|FG001|Infant Series|Physician Decision|1|||
94430538|NCT00205803|323360428|FG000|Infant Series|Protocol Violation|1|||
94430539|NCT00205803|323360429|FG001|Infant Series|Protocol Violation|0|||
94430540|NCT00205803|323360428|FG000|Infant Series|Lost Kaiser coverage|0|||
94430541|NCT00205803|323360429|FG001|Infant Series|Lost Kaiser coverage|1|||
94430542|NCT00205803|323360428|FG000|Infant Series|Non-compliant|1|||
94430543|NCT00205803|323360429|FG001|Infant Series|Non-compliant|0|||
94430544|NCT00205803|323360428|FG000|Infant Series|Sponsor request|1|||
94430545|NCT00205803|323360429|FG001|Infant Series|Sponsor request|0|||
94489975|NCT00111761|323588300|FG000|Part 2|Physician Decision|1|||
94489976|NCT00111761|323588301|FG001|Part 2|Physician Decision|0|||
94489977|NCT00111761|323588300|FG000|Part 2|Death|1|||
94489978|NCT00111761|323588301|FG001|Part 2|Death|0|||
94489979|NCT00111761|323588300|FG000|Part 2|Disease progression|3|||
94489980|NCT00111761|323588301|FG001|Part 2|Disease progression|0|||
94489981|NCT00111761|323588300|FG000|Part 2|Protocol-specified criteria|1|||
94489982|NCT00111761|323588301|FG001|Part 2|Protocol-specified criteria|0|||
94489983|NCT00111761|323588300|FG000|Part 2|Other|1|||
94489984|NCT00111761|323588301|FG001|Part 2|Other|0|||
94489985|NCT01604785|323588302|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
94489986|NCT01604785|323588303|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
94489987|NCT00869960|323588304|FG000|Overall Study|Lost to Follow-up|2|||
94489988|NCT01285518|323588305|FG000|Overall Study|Lost to Follow-up|0|||
94489989|NCT01285518|323588306|FG001|Overall Study|Lost to Follow-up|0|||
94489990|NCT01285518|323588307|FG002|Overall Study|Lost to Follow-up|0|||
94489991|NCT01285518|323588308|FG003|Overall Study|Lost to Follow-up|0|||
94489992|NCT01285518|323588309|FG004|Overall Study|Lost to Follow-up|0|||
94489993|NCT01285518|323588310|FG005|Overall Study|Lost to Follow-up|1|||
94489994|NCT01285518|323588311|FG006|Overall Study|Lost to Follow-up|0|||
94489995|NCT01285518|323588312|FG007|Overall Study|Lost to Follow-up|0|||
94489996|NCT00062166|323588323|FG000|Overall Study|Withdrawal by Subject|6|||
94489997|NCT00465179|323588324|FG000|Overall Study|Adverse Event|4|||
94489998|NCT00465179|323588324|FG000|Overall Study|Withdrawal by Subject|2|||
94489999|NCT00465179|323588324|FG000|Overall Study|Progression of Disease|47|||
94490000|NCT01933594|323588325|FG000|Overall Study|Lost to Follow-up|1|||
94490001|NCT01933594|323588326|FG001|Overall Study|Lost to Follow-up|0|||
94490002|NCT01933594|323588327|FG002|Overall Study|Lost to Follow-up|0|||
94490003|NCT01933594|323588328|FG003|Overall Study|Lost to Follow-up|0|||
94490004|NCT01933594|323588329|FG004|Overall Study|Lost to Follow-up|1|||
94490005|NCT01933594|323588330|FG005|Overall Study|Lost to Follow-up|0|||
94490006|NCT01933594|323588325|FG000|Overall Study|Ineligible for subsequent study step|0|||
94490007|NCT01933594|323588326|FG001|Overall Study|Ineligible for subsequent study step|0|||
94490008|NCT01933594|323588327|FG002|Overall Study|Ineligible for subsequent study step|0|||
94490009|NCT01933594|323588328|FG003|Overall Study|Ineligible for subsequent study step|0|||
94490010|NCT01933594|323588329|FG004|Overall Study|Ineligible for subsequent study step|1|||
94490011|NCT01933594|323588330|FG005|Overall Study|Ineligible for subsequent study step|0|||
94490012|NCT00909870|323588333|FG000|Overall Study|Adverse Event|13|||
94490013|NCT00909870|323588334|FG001|Overall Study|Adverse Event|7|||
94490014|NCT00909870|323588333|FG000|Overall Study|Protocol Violation|1|||
94490015|NCT00909870|323588334|FG001|Overall Study|Protocol Violation|2|||
94490016|NCT00909870|323588333|FG000|Overall Study|Withdrawal by Subject|5|||
94490017|NCT00909870|323588334|FG001|Overall Study|Withdrawal by Subject|8|||
94490018|NCT00909870|323588333|FG000|Overall Study|Lost to Follow-up|3|||
94490019|NCT00909870|323588334|FG001|Overall Study|Lost to Follow-up|3|||
94490020|NCT00909870|323588333|FG000|Overall Study|Physician Decision|0|||
94490021|NCT00909870|323588334|FG001|Overall Study|Physician Decision|2|||
94490022|NCT00909870|323588333|FG000|Overall Study|Other|1|||
94490023|NCT00909870|323588334|FG001|Overall Study|Other|5|||
94490024|NCT00830765|323588335|FG000|Overall Study|Protocol Violation|3|||
94490025|NCT00830765|323588336|FG001|Overall Study|Protocol Violation|2|||
94490026|NCT00885118|323588339|FG000|Overall Study|Adverse Event|1|||
94490027|NCT00885118|323588340|FG001|Overall Study|Adverse Event|0|||
94490028|NCT00885118|323588341|FG002|Overall Study|Adverse Event|0|||
94490029|NCT00885118|323588342|FG003|Overall Study|Adverse Event|0|||
94490030|NCT00885118|323588343|FG004|Overall Study|Adverse Event|0|||
94490031|NCT00885118|323588339|FG000|Overall Study|Withdrawal by Subject|0|||
94490032|NCT00885118|323588340|FG001|Overall Study|Withdrawal by Subject|0|||
94490033|NCT00885118|323588341|FG002|Overall Study|Withdrawal by Subject|0|||
94490034|NCT00885118|323588342|FG003|Overall Study|Withdrawal by Subject|0|||
94490035|NCT00885118|323588343|FG004|Overall Study|Withdrawal by Subject|1|||
94490036|NCT00885118|323588339|FG000|Overall Study|Other reason not defined above|0|||
94490037|NCT00885118|323588340|FG001|Overall Study|Other reason not defined above|0|||
94490038|NCT00885118|323588341|FG002|Overall Study|Other reason not defined above|1|||
94490039|NCT00885118|323588342|FG003|Overall Study|Other reason not defined above|0|||
94490040|NCT00885118|323588343|FG004|Overall Study|Other reason not defined above|0|||
94490041|NCT00848497|323588344|FG000|Overall Study|Screen failure|2|||
94490042|NCT00848497|323588345|FG001|Overall Study|Screen failure|0|||
94490043|NCT00848497|323588344|FG000|Overall Study|Withdrawal by Subject|0|||
94490044|NCT00848497|323588345|FG001|Overall Study|Withdrawal by Subject|1|||
94490045|NCT00296517|323588348|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
94490046|NCT00296517|323588349|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
94490047|NCT00296517|323588348|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
94490048|NCT00296517|323588349|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
94490049|NCT00296517|323588348|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
94490050|NCT00296517|323588349|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
94490051|NCT00296517|323588348|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
94430546|NCT00205803|323360428|FG000|After Infant Series|Adverse Event|1|||
94430547|NCT00205803|323360429|FG001|After Infant Series|Adverse Event|1|||
94430548|NCT00205803|323360428|FG000|After Infant Series|Protocol Violation|1|||
94430549|NCT00205803|323360429|FG001|After Infant Series|Protocol Violation|1|||
94430550|NCT00205803|323360428|FG000|After Infant Series|Lost to Follow-up|2|||
94430551|NCT00205803|323360429|FG001|After Infant Series|Lost to Follow-up|1|||
94430552|NCT00205803|323360428|FG000|After Infant Series|Physician Decision|3|||
94430553|NCT00205803|323360429|FG001|After Infant Series|Physician Decision|2|||
94430554|NCT00205803|323360428|FG000|After Infant Series|Withdrawal by Subject|1|||
94430555|NCT00205803|323360429|FG001|After Infant Series|Withdrawal by Subject|4|||
94430556|NCT00205803|323360428|FG000|After Infant Series|Other|10|||
94430557|NCT00205803|323360429|FG001|After Infant Series|Other|4|||
94430558|NCT00205803|323360428|FG000|Toddler Dose|Lost to Follow-up|2|||
94430559|NCT00205803|323360429|FG001|Toddler Dose|Lost to Follow-up|3|||
94430560|NCT00121134|323360430|FG000|Overall Study|Progression of Disease|5|||
94430561|NCT00121134|323360431|FG001|Overall Study|Progression of Disease|3|||
94430562|NCT00121134|323360432|FG002|Overall Study|Progression of Disease|4|||
94430563|NCT00121134|323360433|FG003|Overall Study|Progression of Disease|2|||
94430564|NCT00121134|323360430|FG000|Overall Study|Toxicity|4|||
94430565|NCT00121134|323360431|FG001|Overall Study|Toxicity|7|||
94430566|NCT00121134|323360432|FG002|Overall Study|Toxicity|13|||
94430567|NCT00121134|323360433|FG003|Overall Study|Toxicity|5|||
94430568|NCT00121134|323360430|FG000|Overall Study|Physician Decision|6|||
94430569|NCT00121134|323360431|FG001|Overall Study|Physician Decision|4|||
94430570|NCT00121134|323360432|FG002|Overall Study|Physician Decision|4|||
94430571|NCT00121134|323360433|FG003|Overall Study|Physician Decision|1|||
94430572|NCT00121134|323360430|FG000|Overall Study|Treatment Delay|1|||
94430573|NCT00121134|323360431|FG001|Overall Study|Treatment Delay|0|||
94430574|NCT00121134|323360432|FG002|Overall Study|Treatment Delay|0|||
94430575|NCT00121134|323360433|FG003|Overall Study|Treatment Delay|0|||
94430576|NCT00121134|323360430|FG000|Overall Study|Intercurrent Illness|0|||
94430577|NCT00121134|323360431|FG001|Overall Study|Intercurrent Illness|0|||
94430578|NCT00121134|323360432|FG002|Overall Study|Intercurrent Illness|0|||
94430579|NCT00121134|323360433|FG003|Overall Study|Intercurrent Illness|1|||
94430580|NCT00121134|323360430|FG000|Overall Study|Patient Personal Reasons|0|||
94430581|NCT00121134|323360431|FG001|Overall Study|Patient Personal Reasons|1|||
94430582|NCT00121134|323360432|FG002|Overall Study|Patient Personal Reasons|0|||
94430583|NCT00121134|323360433|FG003|Overall Study|Patient Personal Reasons|0|||
94430584|NCT05819203|323360435|FG000|Overall Study|Protocol Violation|1|||
94430585|NCT05819203|323360436|FG001|Overall Study|Protocol Violation|2|||
94430586|NCT05819203|323360435|FG000|Overall Study|Withdrawal by Subject|1|||
94430587|NCT05819203|323360436|FG001|Overall Study|Withdrawal by Subject|0|||
94430588|NCT04400682|323360438|FG000|Period 1|Withdrawal by Subject|1|||
94430589|NCT04400682|323360439|FG001|Period 1|Withdrawal by Subject|4|||
94430590|NCT02293863|323360446|FG000|Overall Study|Death|4|||
94430591|NCT02293863|323360447|FG001|Overall Study|Death|6|||
94430592|NCT02293863|323360448|FG002|Overall Study|Death|4|||
94430593|NCT02293863|323360446|FG000|Overall Study|Lost to Follow-up|2|||
94430594|NCT02293863|323360447|FG001|Overall Study|Lost to Follow-up|2|||
94430595|NCT02293863|323360448|FG002|Overall Study|Lost to Follow-up|2|||
94430596|NCT02293863|323360446|FG000|Overall Study|Withdrawal by Subject|3|||
94430597|NCT02293863|323360447|FG001|Overall Study|Withdrawal by Subject|3|||
94430598|NCT02293863|323360448|FG002|Overall Study|Withdrawal by Subject|1|||
94430599|NCT02293863|323360446|FG000|Overall Study|Reason Not Specified|0|||
94430600|NCT02293863|323360447|FG001|Overall Study|Reason Not Specified|2|||
94430601|NCT02293863|323360448|FG002|Overall Study|Reason Not Specified|2|||
94430602|NCT04784533|323360449|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
94430603|NCT04784533|323360450|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
94430604|NCT04784533|323360451|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
94430605|NCT04784533|323360452|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
94430606|NCT04784533|323360453|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
94430607|NCT04784533|323360454|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
94430608|NCT04784533|323360455|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
94430609|NCT04784533|323360456|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
94430610|NCT04784533|323360457|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
94430611|NCT04784533|323360458|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
94430612|NCT04784533|323360449|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
94430613|NCT04784533|323360450|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
94430614|NCT04784533|323360451|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
94430615|NCT04784533|323360452|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
94430616|NCT04784533|323360453|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
94430617|NCT04784533|323360454|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
94430618|NCT04784533|323360455|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
94430619|NCT04784533|323360456|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
94430620|NCT04784533|323360457|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
94430621|NCT04784533|323360458|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
94430622|NCT04784533|323360449|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
94430623|NCT04784533|323360450|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
94430624|NCT04784533|323360451|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
94430625|NCT04784533|323360452|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
94430626|NCT04784533|323360453|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
94430627|NCT04784533|323360454|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
94430628|NCT04784533|323360455|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
94430629|NCT04784533|323360456|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
94430630|NCT04784533|323360457|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
94430631|NCT04784533|323360458|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
94430632|NCT04784533|323360449|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
94430633|NCT04784533|323360450|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
94430634|NCT04784533|323360451|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
94430635|NCT04784533|323360452|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
94430636|NCT04784533|323360453|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
94430637|NCT04784533|323360454|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
94430638|NCT04784533|323360455|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
94430639|NCT04784533|323360456|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
94430640|NCT04784533|323360457|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
94430641|NCT04784533|323360458|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
94430642|NCT04784533|323360449|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
94430643|NCT04784533|323360450|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
94430644|NCT04784533|323360451|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
94430645|NCT04784533|323360452|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
94430646|NCT04784533|323360453|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
94430647|NCT04784533|323360454|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
94430648|NCT04784533|323360455|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
94430649|NCT04784533|323360456|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
94430650|NCT04784533|323360457|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
94430651|NCT04784533|323360458|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
94430652|NCT04784533|323360449|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
94430653|NCT04784533|323360450|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
94430654|NCT04784533|323360451|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
94430655|NCT04784533|323360452|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
94430656|NCT04784533|323360453|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
94430657|NCT04784533|323360454|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
94430658|NCT04784533|323360455|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
94430659|NCT04784533|323360456|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
94430660|NCT04784533|323360457|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
94430661|NCT04784533|323360458|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
94430662|NCT04784533|323360449|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
94430663|NCT04784533|323360450|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
94430664|NCT04784533|323360451|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
94430665|NCT04784533|323360452|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
94430666|NCT04784533|323360453|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
94430667|NCT04784533|323360454|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
94430668|NCT04784533|323360455|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
94430669|NCT04784533|323360456|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
94430670|NCT04784533|323360457|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
94430671|NCT04784533|323360458|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
94430672|NCT04784533|323360449|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
94430673|NCT04784533|323360450|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
94430674|NCT04784533|323360451|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
94430675|NCT04784533|323360452|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
94430676|NCT04784533|323360453|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
94430677|NCT04784533|323360454|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
94430678|NCT04784533|323360455|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
94430679|NCT04784533|323360456|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
94430680|NCT04784533|323360457|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
94430681|NCT04784533|323360458|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
94430682|NCT04784533|323360449|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
94430683|NCT04784533|323360450|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
94430684|NCT04784533|323360451|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
94430685|NCT04784533|323360452|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
94430686|NCT04784533|323360453|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
94430687|NCT04784533|323360454|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
94430688|NCT04784533|323360455|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
94430689|NCT04784533|323360456|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
94430690|NCT04784533|323360457|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
94430691|NCT04784533|323360458|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
94430692|NCT00174954|323360459|FG000|Overall Study|Adverse Event|2|||
94430693|NCT00174954|323360459|FG000|Overall Study|No tophi found in MRI|1|||
94430694|NCT00174954|323360459|FG000|Overall Study|Physician Decision|1|||
94430695|NCT00477633|323360460|FG000|Overall Study|Did not receive treatment|23|||
94430696|NCT00477633|323360460|FG000|Overall Study|Adverse Event|143|||
94430697|NCT00477633|323360460|FG000|Overall Study|Pregnancy|23|||
94430698|NCT00477633|323360460|FG000|Overall Study|Lost to Follow-up|271|||
94430699|NCT00477633|323360460|FG000|Overall Study|Withdrawal by Subject|149|||
94430700|NCT00477633|323360460|FG000|Overall Study|Protocol Violation|25|||
94430701|NCT00477633|323360460|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
94430702|NCT02185053|323360461|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
94430703|NCT02185053|323360462|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
94430704|NCT02185053|323360463|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
94430705|NCT02185053|323360461|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
94430706|NCT02185053|323360462|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
94430707|NCT02185053|323360463|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
94430708|NCT02185053|323360461|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
94430709|NCT02185053|323360462|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
94430710|NCT02185053|323360463|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
94430711|NCT02185053|323360461|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
94430712|NCT02185053|323360462|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
94430713|NCT02185053|323360463|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
94430714|NCT02185053|323360461|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
94430715|NCT02185053|323360462|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
94430716|NCT02185053|323360463|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
94430717|NCT02185053|323360461|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
94430718|NCT02185053|323360462|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
94430719|NCT02185053|323360463|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
94430720|NCT02185053|323360461|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
94430721|NCT02185053|323360462|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
94430722|NCT02185053|323360463|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
94430723|NCT02185053|323360461|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
94430724|NCT02185053|323360462|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
94430725|NCT02185053|323360463|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
94430726|NCT02203331|323360468|FG000|Overall Study|Pregnancy|1|||
94430727|NCT02203331|323360469|FG001|Overall Study|Pregnancy|0|||
94430728|NCT02203331|323360470|FG002|Overall Study|Pregnancy|0|||
94430729|NCT02203331|323360471|FG003|Overall Study|Pregnancy|0|||
94430730|NCT02203331|323360472|FG004|Overall Study|Pregnancy|2|||
94430731|NCT02203331|323360473|FG005|Overall Study|Pregnancy|0|||
94430732|NCT02203331|323360468|FG000|Overall Study|Withdrawal by Subject|1|||
94430733|NCT02203331|323360469|FG001|Overall Study|Withdrawal by Subject|0|||
94430734|NCT02203331|323360470|FG002|Overall Study|Withdrawal by Subject|1|||
94430735|NCT02203331|323360471|FG003|Overall Study|Withdrawal by Subject|0|||
94430736|NCT02203331|323360472|FG004|Overall Study|Withdrawal by Subject|0|||
94430737|NCT02203331|323360473|FG005|Overall Study|Withdrawal by Subject|3|||
94430738|NCT02203331|323360468|FG000|Overall Study|Adverse Event|4|||
94430739|NCT02203331|323360469|FG001|Overall Study|Adverse Event|8|||
94430740|NCT02203331|323360470|FG002|Overall Study|Adverse Event|3|||
94430741|NCT02203331|323360471|FG003|Overall Study|Adverse Event|4|||
94430742|NCT02203331|323360472|FG004|Overall Study|Adverse Event|3|||
94430743|NCT02203331|323360473|FG005|Overall Study|Adverse Event|3|||
94430744|NCT02203331|323360468|FG000|Overall Study|Other Reasons|1|||
94430745|NCT02203331|323360469|FG001|Overall Study|Other Reasons|2|||
94430746|NCT02203331|323360470|FG002|Overall Study|Other Reasons|0|||
94490052|NCT00296517|323588349|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
94490053|NCT00296517|323588348|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
94430747|NCT02203331|323360471|FG003|Overall Study|Other Reasons|2|||
94430748|NCT02203331|323360472|FG004|Overall Study|Other Reasons|0|||
94430749|NCT02203331|323360473|FG005|Overall Study|Other Reasons|0|||
94430750|NCT02203331|323360468|FG000|Overall Study|Lack of Efficacy|0|||
94430751|NCT02203331|323360469|FG001|Overall Study|Lack of Efficacy|2|||
94430752|NCT02203331|323360470|FG002|Overall Study|Lack of Efficacy|1|||
94430753|NCT02203331|323360471|FG003|Overall Study|Lack of Efficacy|0|||
94430754|NCT02203331|323360472|FG004|Overall Study|Lack of Efficacy|0|||
94430755|NCT02203331|323360473|FG005|Overall Study|Lack of Efficacy|1|||
94430756|NCT02203331|323360468|FG000|Overall Study|Protocol Violation|0|||
94430757|NCT02203331|323360469|FG001|Overall Study|Protocol Violation|2|||
94430758|NCT02203331|323360470|FG002|Overall Study|Protocol Violation|0|||
94430759|NCT02203331|323360471|FG003|Overall Study|Protocol Violation|1|||
94430760|NCT02203331|323360472|FG004|Overall Study|Protocol Violation|1|||
94430761|NCT02203331|323360473|FG005|Overall Study|Protocol Violation|0|||
94430762|NCT02203331|323360468|FG000|Overall Study|Lost to Follow-up|0|||
94430763|NCT02203331|323360469|FG001|Overall Study|Lost to Follow-up|0|||
94430764|NCT02203331|323360470|FG002|Overall Study|Lost to Follow-up|0|||
94430765|NCT02203331|323360471|FG003|Overall Study|Lost to Follow-up|0|||
94430766|NCT02203331|323360472|FG004|Overall Study|Lost to Follow-up|1|||
94430767|NCT02203331|323360473|FG005|Overall Study|Lost to Follow-up|0|||
94430768|NCT02542605|323360478|FG000|Part B: Challenge Phase|Sponsor decision|1|||
94430769|NCT02542605|323360479|FG001|Part B: Challenge Phase|Sponsor decision|0|||
94430770|NCT02542605|323360480|FG002|Part B: Challenge Phase|Sponsor decision|0|||
94430771|NCT02542605|323360478|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
94430772|NCT02542605|323360479|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
94430773|NCT02542605|323360480|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
94430774|NCT04102189|323360481|FG000|Overall Study|Withdrawal by Subject|1|||
94430775|NCT04102189|323360482|FG001|Overall Study|Withdrawal by Subject|2|||
94430776|NCT04102189|323360481|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94430777|NCT04102189|323360482|FG001|Overall Study|Withdrawal by parent/guardian|1|||
94430778|NCT04102189|323360481|FG000|Overall Study|Lost to Follow-up|1|||
94430779|NCT04102189|323360482|FG001|Overall Study|Lost to Follow-up|0|||
94430780|NCT01374269|323360487|FG000|Overall Study|Withdrawal by Subject|4|||
94430781|NCT01374269|323360488|FG001|Overall Study|Withdrawal by Subject|0|||
94430782|NCT01374269|323360487|FG000|Overall Study|Lost to Follow-up|1|||
94430783|NCT01374269|323360488|FG001|Overall Study|Lost to Follow-up|3|||
94430784|NCT01374269|323360487|FG000|Overall Study|closed research|1|||
94430785|NCT01374269|323360488|FG001|Overall Study|closed research|2|||
94430786|NCT00143247|323360489|FG000|Overall Study|Death|8|||
94430787|NCT00143247|323360489|FG000|Overall Study|Adverse Event|19|||
94430788|NCT00143247|323360489|FG000|Overall Study|Lack of Efficacy|3|||
94430789|NCT00143247|323360489|FG000|Overall Study|Withdrawal by Subject|55|||
94430790|NCT00143247|323360489|FG000|Overall Study|Study terminated by sponsor|31|||
94430791|NCT00143247|323360489|FG000|Overall Study|Protocol Violation|15|||
94430792|NCT00143247|323360489|FG000|Overall Study|Lost to Follow-up|12|||
94430793|NCT00143247|323360489|FG000|Overall Study|following inaccurate lab adverse event|1|||
94430794|NCT00143247|323360489|FG000|Overall Study|Other|12|||
94430795|NCT04007991|323360493|FG000|Overall Study|Withdrawal by Subject|1|||
94430796|NCT04007991|323360494|FG001|Overall Study|Withdrawal by Subject|1|||
94430797|NCT04007991|323360493|FG000|Overall Study|Physician Decision|1|||
94430798|NCT04007991|323360494|FG001|Overall Study|Physician Decision|1|||
94430799|NCT04007991|323360493|FG000|Overall Study|Non-compliance with Study Drug|0|||
94430800|NCT04007991|323360494|FG001|Overall Study|Non-compliance with Study Drug|1|||
94430801|NCT04007991|323360493|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
94430802|NCT04007991|323360494|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
94430803|NCT04007991|323360493|FG000|Overall Study|Adverse event, non-fatal|5|||
94430804|NCT04007991|323360494|FG001|Overall Study|Adverse event, non-fatal|0|||
94430805|NCT04007991|323360493|FG000|Overall Study|Lost to Follow-up|2|||
94430806|NCT04007991|323360494|FG001|Overall Study|Lost to Follow-up|1|||
94430807|NCT03654599|323360495|FG000|Overall Study|Lost to Follow-up|14|||
94430808|NCT03654599|323360496|FG001|Overall Study|Lost to Follow-up|12|||
94430809|NCT03654599|323360495|FG000|Overall Study|Death|8|||
94430810|NCT03654599|323360496|FG001|Overall Study|Death|6|||
94430811|NCT03654599|323360495|FG000|Overall Study|Withdrawal by Subject|6|||
94430812|NCT03654599|323360496|FG001|Overall Study|Withdrawal by Subject|4|||
94430813|NCT04058067|323362652|FG000|Overall Study|Adverse Event|2|||
94430814|NCT04058067|323362653|FG001|Overall Study|Adverse Event|0|||
94430815|NCT04058067|323362652|FG000|Overall Study|Death|0|||
94430816|NCT04058067|323362653|FG001|Overall Study|Death|1|||
94430817|NCT04058067|323362652|FG000|Overall Study|Physician Decision|3|||
94430818|NCT04058067|323362653|FG001|Overall Study|Physician Decision|1|||
94430819|NCT04058067|323362652|FG000|Overall Study|Protocol Violation|0|||
94430820|NCT04058067|323362653|FG001|Overall Study|Protocol Violation|1|||
94430821|NCT04058067|323362652|FG000|Overall Study|Withdrawal by Subject|7|||
94430822|NCT04058067|323362653|FG001|Overall Study|Withdrawal by Subject|8|||
94430823|NCT05005312|323362654|FG000|Overall Study|Enrolled, but not treated|0|||
94430824|NCT05005312|323362655|FG001|Overall Study|Enrolled, but not treated|1|||
94430825|NCT00851318|323362656|FG000|Overall Study|Withdrawal by Subject|7|||
94430826|NCT00851318|323362657|FG001|Overall Study|Withdrawal by Subject|1|||
94430827|NCT00851318|323362658|FG002|Overall Study|Withdrawal by Subject|5|||
94430828|NCT00851318|323362659|FG003|Overall Study|Withdrawal by Subject|3|||
94430829|NCT00851318|323362656|FG000|Overall Study|Adverse Event|13|||
94430830|NCT00851318|323362657|FG001|Overall Study|Adverse Event|2|||
94430831|NCT00851318|323362658|FG002|Overall Study|Adverse Event|9|||
94430832|NCT00851318|323362659|FG003|Overall Study|Adverse Event|12|||
94430833|NCT00851318|323362656|FG000|Overall Study|Pregnancy|0|||
94430834|NCT00851318|323362657|FG001|Overall Study|Pregnancy|0|||
94430835|NCT00851318|323362658|FG002|Overall Study|Pregnancy|1|||
94430836|NCT00851318|323362659|FG003|Overall Study|Pregnancy|1|||
94430837|NCT00851318|323362656|FG000|Overall Study|Lack of Efficacy|8|||
94430838|NCT00851318|323362657|FG001|Overall Study|Lack of Efficacy|2|||
94430839|NCT00851318|323362658|FG002|Overall Study|Lack of Efficacy|4|||
94430840|NCT00851318|323362659|FG003|Overall Study|Lack of Efficacy|2|||
94430841|NCT00851318|323362656|FG000|Overall Study|Non-compliance with Study Procedures|2|||
94430842|NCT00851318|323362657|FG001|Overall Study|Non-compliance with Study Procedures|0|||
94430843|NCT00851318|323362658|FG002|Overall Study|Non-compliance with Study Procedures|1|||
94430844|NCT00851318|323362659|FG003|Overall Study|Non-compliance with Study Procedures|0|||
94430845|NCT00851318|323362656|FG000|Overall Study|Physician Decision|0|||
94430846|NCT00851318|323362657|FG001|Overall Study|Physician Decision|0|||
94430847|NCT00851318|323362658|FG002|Overall Study|Physician Decision|1|||
94430848|NCT00851318|323362659|FG003|Overall Study|Physician Decision|1|||
94430849|NCT01696058|323362663|FG000|Overall Study|Adverse Event|21|||
94430850|NCT01696058|323362664|FG001|Overall Study|Adverse Event|11|||
94430851|NCT01696058|323362663|FG000|Overall Study|Lack of Efficacy|2|||
94430852|NCT01696058|323362664|FG001|Overall Study|Lack of Efficacy|3|||
94430853|NCT01696058|323362663|FG000|Overall Study|Protocol Violation|9|||
94430854|NCT01696058|323362664|FG001|Overall Study|Protocol Violation|3|||
94430855|NCT01696058|323362663|FG000|Overall Study|Lost to Follow-up|2|||
94430856|NCT01696058|323362664|FG001|Overall Study|Lost to Follow-up|5|||
94430857|NCT01696058|323362663|FG000|Overall Study|Withdrawal by Subject|4|||
94430858|NCT01696058|323362664|FG001|Overall Study|Withdrawal by Subject|6|||
94430859|NCT01696058|323362663|FG000|Overall Study|Other reason prematurely discontinued|5|||
94430860|NCT01696058|323362664|FG001|Overall Study|Other reason prematurely discontinued|3|||
94430861|NCT02242045|323362671|FG000|Overall Study|Investigator's Discretion|1|||
94430862|NCT02242045|323362671|FG000|Overall Study|Progressive Disease|2|||
94430863|NCT02242045|323362671|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
94430864|NCT02242045|323362671|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
94430865|NCT04581369|323362672|FG000|Overall Study|Death|7|||
94430866|NCT04581369|323362673|FG001|Overall Study|Death|6|||
94430867|NCT04581369|323362674|FG002|Overall Study|Death|0|||
94430868|NCT04581369|323362672|FG000|Overall Study|Lost to Follow-up|7|||
94430869|NCT04581369|323362673|FG001|Overall Study|Lost to Follow-up|3|||
94430870|NCT04581369|323362674|FG002|Overall Study|Lost to Follow-up|0|||
94430871|NCT04581369|323362672|FG000|Overall Study|liver transplant|2|||
94430872|NCT04581369|323362673|FG001|Overall Study|liver transplant|2|||
94430873|NCT04581369|323362674|FG002|Overall Study|liver transplant|0|||
94430874|NCT04581369|323362672|FG000|Overall Study|transitioned to hospice care|0|||
94430875|NCT04581369|323362673|FG001|Overall Study|transitioned to hospice care|5|||
94430876|NCT04581369|323362674|FG002|Overall Study|transitioned to hospice care|0|||
94430877|NCT02473523|323362675|FG000|Overall Study|Death|1|||
94430878|NCT02473523|323362675|FG000|Overall Study|Lost to Follow-up|1|||
94430879|NCT01111825|323362679|FG000|Overall Study|Withdrawal by Subject|0|||
94430880|NCT01111825|323362680|FG001|Overall Study|Withdrawal by Subject|0|||
94430881|NCT01111825|323362681|FG002|Overall Study|Withdrawal by Subject|1|||
94430882|NCT01111825|323362682|FG003|Overall Study|Withdrawal by Subject|0|||
94430883|NCT01111825|323362679|FG000|Overall Study|Lost to Follow-up|0|||
94430884|NCT01111825|323362680|FG001|Overall Study|Lost to Follow-up|0|||
94430885|NCT01111825|323362681|FG002|Overall Study|Lost to Follow-up|3|||
94430886|NCT01111825|323362682|FG003|Overall Study|Lost to Follow-up|1|||
94430887|NCT01111825|323362679|FG000|Overall Study|Adverse Event|2|||
94430888|NCT01111825|323362680|FG001|Overall Study|Adverse Event|1|||
94430889|NCT01111825|323362681|FG002|Overall Study|Adverse Event|4|||
94430890|NCT01111825|323362682|FG003|Overall Study|Adverse Event|0|||
94430891|NCT01111825|323362679|FG000|Overall Study|Disease Progression|1|||
94430892|NCT01111825|323362680|FG001|Overall Study|Disease Progression|0|||
94430893|NCT01111825|323362681|FG002|Overall Study|Disease Progression|0|||
94430894|NCT01111825|323362682|FG003|Overall Study|Disease Progression|0|||
94430895|NCT01111825|323362679|FG000|Overall Study|Discontinuation by Sponsor|0|||
94430896|NCT01111825|323362680|FG001|Overall Study|Discontinuation by Sponsor|0|||
94430897|NCT01111825|323362681|FG002|Overall Study|Discontinuation by Sponsor|0|||
94430898|NCT01111825|323362682|FG003|Overall Study|Discontinuation by Sponsor|20|||
94430899|NCT01756079|323362683|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
94430900|NCT01756079|323362683|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
94430901|NCT01756079|323362683|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
94430902|NCT01756079|323362683|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
94430903|NCT01756079|323362683|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
94430904|NCT01191944|323362684|FG000|Overall Study|Adverse Event|11|||
94430905|NCT01191944|323362685|FG001|Overall Study|Adverse Event|12|||
94430906|NCT01191944|323362684|FG000|Overall Study|Protocol Violation|1|||
94430907|NCT01191944|323362685|FG001|Overall Study|Protocol Violation|2|||
94430908|NCT01191944|323362684|FG000|Overall Study|Withdrawal by Subject|4|||
94430909|NCT01191944|323362685|FG001|Overall Study|Withdrawal by Subject|2|||
94430910|NCT01191944|323362684|FG000|Overall Study|Other|1|||
94430911|NCT01191944|323362685|FG001|Overall Study|Other|3|||
94430912|NCT00469144|323362696|FG000|Overall Study|Death|0|||
94430913|NCT00469144|323362697|FG001|Overall Study|Death|1|||
94430914|NCT00469144|323362696|FG000|Overall Study|No Response|5|||
94430915|NCT00469144|323362697|FG001|Overall Study|No Response|5|||
94430916|NCT00469144|323362696|FG000|Overall Study|Progressive Disease|1|||
94430917|NCT00469144|323362697|FG001|Overall Study|Progressive Disease|0|||
94430918|NCT02794246|323362698|FG000|Overall Study|Withdrawal by Subject|2|||
94430919|NCT02794246|323362698|FG000|Overall Study|Physician Decision|4|||
94430920|NCT04015908|323362699|FG000|Overall Study|Lost to Follow-up|0|||
94430921|NCT04015908|323362700|FG001|Overall Study|Lost to Follow-up|1|||
94430922|NCT00603837|323362701|FG000|Overall Study|Physician Decision|3|||
94430923|NCT00603837|323362702|FG001|Overall Study|Physician Decision|0|||
94430924|NCT04623086|323362706|FG000|Overall Study|Withdrawal by Subject|0|||
94430925|NCT04623086|323362707|FG001|Overall Study|Withdrawal by Subject|0|||
94430926|NCT04623086|323362708|FG002|Overall Study|Withdrawal by Subject|10|||
94430927|NCT01831258|323362709|FG000|Overall Study|Withdrawal by Subject|2|||
94430928|NCT01831258|323362710|FG001|Overall Study|Withdrawal by Subject|1|||
94430929|NCT01831258|323362709|FG000|Overall Study|Lost to Follow-up|3|||
94430930|NCT01831258|323362710|FG001|Overall Study|Lost to Follow-up|2|||
94430931|NCT00998309|323362715|FG000|Overall Study|Protocol Violation|4|||
94430932|NCT02052011|323362719|FG000|Overall Study|Lost to Follow-up|3|||
94430933|NCT02052011|323362720|FG001|Overall Study|Lost to Follow-up|0|||
94430934|NCT02052011|323362719|FG000|Overall Study|Withdrawal by Subject|1|||
94430935|NCT02052011|323362720|FG001|Overall Study|Withdrawal by Subject|2|||
94430936|NCT02648932|323362721|FG000|Overall Study|No transplant|3|||
94430937|NCT02648932|323362722|FG001|Overall Study|No transplant|1|||
94430938|NCT02960490|323362729|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
94430939|NCT02960490|323362730|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
94430940|NCT02960490|323362731|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
94430941|NCT02960490|323362732|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
94430942|NCT02960490|323362733|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
94430943|NCT02960490|323362734|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
94430944|NCT02960490|323362735|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
94430945|NCT02960490|323362736|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
94430946|NCT02960490|323362737|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
94430947|NCT02960490|323362738|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
94430948|NCT02960490|323362729|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
94430949|NCT02960490|323362730|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
94430950|NCT02960490|323362731|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
94430951|NCT02960490|323362732|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
94430952|NCT02960490|323362733|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
94430953|NCT02960490|323362734|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
94430954|NCT02960490|323362735|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
94430955|NCT02960490|323362736|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
94430956|NCT02960490|323362737|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
94430957|NCT02960490|323362738|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
94430958|NCT02960490|323362729|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
94430959|NCT02960490|323362730|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
94430960|NCT02960490|323362731|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
94430961|NCT02960490|323362732|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
94430962|NCT02960490|323362733|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
94430963|NCT02960490|323362734|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
94430964|NCT02960490|323362735|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
94430965|NCT02960490|323362736|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
94490054|NCT00296517|323588349|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
94490055|NCT00296517|323588348|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
94490056|NCT00296517|323588349|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
94490057|NCT00296517|323588348|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
94490058|NCT00296517|323588349|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
94490059|NCT00296517|323588348|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
94430966|NCT02960490|323362737|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
94430967|NCT02960490|323362738|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
94430968|NCT02960490|323362729|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
94430969|NCT02960490|323362730|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
94430970|NCT02960490|323362731|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
94430971|NCT02960490|323362732|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
94430972|NCT02960490|323362733|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
94430973|NCT02960490|323362734|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
94430974|NCT02960490|323362735|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
94430975|NCT02960490|323362736|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
94430976|NCT02960490|323362737|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
94430977|NCT02960490|323362738|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
94430978|NCT02960490|323362729|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
94430979|NCT02960490|323362730|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
94430980|NCT02960490|323362731|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
94430981|NCT02960490|323362732|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
94430982|NCT02960490|323362733|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
94430983|NCT02960490|323362734|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
94430984|NCT02960490|323362735|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
94430985|NCT02960490|323362736|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
94430986|NCT02960490|323362737|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
94430987|NCT02960490|323362738|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
94430988|NCT02960490|323362729|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
94430989|NCT02960490|323362730|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
94430990|NCT02960490|323362731|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
94430991|NCT02960490|323362732|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
94430992|NCT02960490|323362733|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
94430993|NCT02960490|323362734|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
94430994|NCT02960490|323362735|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
94430995|NCT02960490|323362736|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
94430996|NCT02960490|323362737|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
94430997|NCT02960490|323362738|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
94430998|NCT02960490|323362729|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
94430999|NCT02960490|323362730|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
94431000|NCT02960490|323362731|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
94431001|NCT02960490|323362732|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
94431002|NCT02960490|323362733|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
94431003|NCT02960490|323362734|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
94431004|NCT02960490|323362735|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
94431005|NCT02960490|323362736|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
94431006|NCT02960490|323362737|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
94431007|NCT02960490|323362738|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
94431008|NCT02960490|323362729|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
94431009|NCT02960490|323362730|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
94431010|NCT02960490|323362731|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
94431011|NCT02960490|323362732|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
94431012|NCT02960490|323362733|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
94431013|NCT02960490|323362734|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
94431014|NCT02960490|323362735|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
94431015|NCT02960490|323362736|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
94431016|NCT02960490|323362737|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
94431017|NCT02960490|323362738|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
94431018|NCT02960490|323362729|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
94431019|NCT02960490|323362730|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
94431020|NCT02960490|323362731|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
94431021|NCT02960490|323362732|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
94431022|NCT02960490|323362733|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
94431023|NCT02960490|323362734|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
94431024|NCT02960490|323362735|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
94431025|NCT02960490|323362736|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
94431026|NCT02960490|323362737|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
94431027|NCT02960490|323362738|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
94431028|NCT02960490|323362729|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
94431029|NCT02960490|323362730|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
94431030|NCT02960490|323362731|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
94431031|NCT02960490|323362732|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
94431032|NCT02960490|323362733|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
94431033|NCT02960490|323362734|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
94431034|NCT02960490|323362735|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
94431035|NCT02960490|323362736|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
94431036|NCT02960490|323362737|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
94431037|NCT02960490|323362738|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
94431038|NCT02960490|323362729|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
94431039|NCT02960490|323362730|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
94431040|NCT02960490|323362731|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
94431041|NCT02960490|323362732|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
94431042|NCT02960490|323362733|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
94431043|NCT02960490|323362734|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
94431044|NCT02960490|323362735|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
94431045|NCT02960490|323362736|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
94431046|NCT02960490|323362737|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
94431047|NCT02960490|323362738|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
94431048|NCT02960490|323362729|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
94431049|NCT02960490|323362730|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
94431050|NCT02960490|323362731|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
94431051|NCT02960490|323362732|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
94431052|NCT02960490|323362733|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
94431053|NCT02960490|323362734|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
94431054|NCT02960490|323362735|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
94431055|NCT02960490|323362736|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
94431056|NCT02960490|323362737|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
94431057|NCT02960490|323362738|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
94431058|NCT01590797|323362739|FG000|Overall Study|Adverse Event|4|||
94431059|NCT01590797|323362740|FG001|Overall Study|Adverse Event|3|||
94431060|NCT01590797|323362739|FG000|Overall Study|Lack of Efficacy|0|||
94431061|NCT01590797|323362740|FG001|Overall Study|Lack of Efficacy|2|||
94431062|NCT01590797|323362739|FG000|Overall Study|Lost to Follow-up|0|||
94431063|NCT01590797|323362740|FG001|Overall Study|Lost to Follow-up|1|||
94431064|NCT01590797|323362739|FG000|Overall Study|Protocol Violation|4|||
94431065|NCT01590797|323362740|FG001|Overall Study|Protocol Violation|1|||
94431066|NCT01590797|323362739|FG000|Overall Study|Withdrawal by Subject|7|||
94431067|NCT01590797|323362740|FG001|Overall Study|Withdrawal by Subject|5|||
94431068|NCT01590797|323362739|FG000|Overall Study|Other Protocol Specified Criteria|2|||
94431069|NCT01590797|323362740|FG001|Overall Study|Other Protocol Specified Criteria|4|||
94431070|NCT01338870|323362743|FG000|Overall Study|Lost to Follow-up|0|||
94431071|NCT01338870|323362744|FG001|Overall Study|Lost to Follow-up|0|||
94431072|NCT01338870|323362745|FG002|Overall Study|Lost to Follow-up|1|||
94431073|NCT01338870|323362746|FG003|Overall Study|Lost to Follow-up|0|||
94431074|NCT01338870|323362747|FG004|Overall Study|Lost to Follow-up|1|||
94431075|NCT01338870|323362748|FG005|Overall Study|Lost to Follow-up|0|||
94431076|NCT01338870|323362743|FG000|Overall Study|Withdrawal by Subject|2|||
94431077|NCT01338870|323362744|FG001|Overall Study|Withdrawal by Subject|3|||
94431078|NCT01338870|323362745|FG002|Overall Study|Withdrawal by Subject|4|||
94431079|NCT01338870|323362746|FG003|Overall Study|Withdrawal by Subject|0|||
94431080|NCT01338870|323362747|FG004|Overall Study|Withdrawal by Subject|0|||
94431081|NCT01338870|323362748|FG005|Overall Study|Withdrawal by Subject|2|||
94431082|NCT01338870|323362743|FG000|Overall Study|Other|3|||
94431083|NCT01338870|323362744|FG001|Overall Study|Other|3|||
94431084|NCT01338870|323362745|FG002|Overall Study|Other|3|||
94431085|NCT01338870|323362746|FG003|Overall Study|Other|2|||
94431086|NCT01338870|323362747|FG004|Overall Study|Other|0|||
94431087|NCT01338870|323362748|FG005|Overall Study|Other|2|||
94431088|NCT01338870|323362743|FG000|Overall Study|Protocol Violation|0|||
94431089|NCT01338870|323362744|FG001|Overall Study|Protocol Violation|2|||
94431090|NCT01338870|323362745|FG002|Overall Study|Protocol Violation|2|||
94431091|NCT01338870|323362746|FG003|Overall Study|Protocol Violation|2|||
94431092|NCT01338870|323362747|FG004|Overall Study|Protocol Violation|1|||
94431093|NCT01338870|323362748|FG005|Overall Study|Protocol Violation|1|||
94431094|NCT01338870|323362743|FG000|Overall Study|Adverse Event|4|||
94431095|NCT01338870|323362744|FG001|Overall Study|Adverse Event|4|||
94431096|NCT01338870|323362745|FG002|Overall Study|Adverse Event|1|||
94431097|NCT01338870|323362746|FG003|Overall Study|Adverse Event|5|||
94431098|NCT01338870|323362747|FG004|Overall Study|Adverse Event|4|||
94431099|NCT01338870|323362748|FG005|Overall Study|Adverse Event|1|||
94431100|NCT01559389|323362761|FG000|Overall Study|Withdrawal by Subject|20|||
94431101|NCT01559389|323362762|FG001|Overall Study|Withdrawal by Subject|20|||
94431102|NCT02256436|323362763|FG000|Overall Study|Adverse Event|9|||
94431103|NCT02256436|323362764|FG001|Overall Study|Adverse Event|14|||
94431104|NCT02256436|323362763|FG000|Overall Study|Death|216|||
94431105|NCT02256436|323362764|FG001|Overall Study|Death|208|||
94431106|NCT02256436|323362763|FG000|Overall Study|Lost to Follow-up|1|||
94431107|NCT02256436|323362764|FG001|Overall Study|Lost to Follow-up|2|||
94431108|NCT02256436|323362763|FG000|Overall Study|Physician Decision|1|||
94431109|NCT02256436|323362764|FG001|Overall Study|Physician Decision|0|||
94431110|NCT02256436|323362763|FG000|Overall Study|Protocol Violation|0|||
94431111|NCT02256436|323362764|FG001|Overall Study|Protocol Violation|1|||
94431112|NCT02256436|323362763|FG000|Overall Study|Withdrawal by Subject|26|||
94431113|NCT02256436|323362764|FG001|Overall Study|Withdrawal by Subject|10|||
94431114|NCT02256436|323362763|FG000|Overall Study|Transferred to Extension Study|11|||
94431115|NCT02256436|323362764|FG001|Overall Study|Transferred to Extension Study|23|||
94431116|NCT02256436|323362763|FG000|Overall Study|Did Not Continue on Extension Study|8|||
94431117|NCT02256436|323362764|FG001|Overall Study|Did Not Continue on Extension Study|12|||
94431118|NCT02252406|323362765|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
94431119|NCT02252406|323362766|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
94431120|NCT02252406|323362765|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
94431121|NCT02252406|323362766|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
94431122|NCT02252406|323362765|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
94431123|NCT02252406|323362766|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
94431124|NCT02252406|323362765|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
94431125|NCT02252406|323362766|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
94431126|NCT02252406|323362765|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
94431127|NCT02252406|323362766|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
94431128|NCT03583086|323362769|FG000|Overall Study|Death|2|||
94431129|NCT03583086|323362770|FG001|Overall Study|Death|6|||
94431130|NCT03583086|323362771|FG002|Overall Study|Death|12|||
94431131|NCT03583086|323362772|FG003|Overall Study|Death|10|||
94431132|NCT03583086|323362773|FG004|Overall Study|Death|14|||
94431133|NCT03583086|323362774|FG005|Overall Study|Death|14|||
94431134|NCT03583086|323362775|FG006|Overall Study|Death|4|||
94431135|NCT03583086|323362769|FG000|Overall Study|Withdrawal by Subject|0|||
94431136|NCT03583086|323362770|FG001|Overall Study|Withdrawal by Subject|0|||
94431137|NCT03583086|323362771|FG002|Overall Study|Withdrawal by Subject|1|||
94431138|NCT03583086|323362772|FG003|Overall Study|Withdrawal by Subject|0|||
94431139|NCT03583086|323362773|FG004|Overall Study|Withdrawal by Subject|0|||
94431140|NCT03583086|323362774|FG005|Overall Study|Withdrawal by Subject|0|||
94431141|NCT03583086|323362775|FG006|Overall Study|Withdrawal by Subject|1|||
94431142|NCT03583086|323362769|FG000|Overall Study|Refused follow-up|0|||
94431143|NCT03583086|323362770|FG001|Overall Study|Refused follow-up|0|||
94431144|NCT03583086|323362771|FG002|Overall Study|Refused follow-up|1|||
94431145|NCT03583086|323362772|FG003|Overall Study|Refused follow-up|0|||
94431146|NCT03583086|323362773|FG004|Overall Study|Refused follow-up|1|||
94431147|NCT03583086|323362774|FG005|Overall Study|Refused follow-up|0|||
94431148|NCT03583086|323362775|FG006|Overall Study|Refused follow-up|0|||
94431149|NCT03583086|323362769|FG000|Overall Study|Declining Performance Status|0|||
94431150|NCT03583086|323362770|FG001|Overall Study|Declining Performance Status|0|||
94431151|NCT03583086|323362771|FG002|Overall Study|Declining Performance Status|1|||
94431152|NCT03583086|323362772|FG003|Overall Study|Declining Performance Status|0|||
94431153|NCT03583086|323362773|FG004|Overall Study|Declining Performance Status|0|||
94431154|NCT03583086|323362774|FG005|Overall Study|Declining Performance Status|0|||
94431155|NCT03583086|323362775|FG006|Overall Study|Declining Performance Status|0|||
94431156|NCT03583086|323362769|FG000|Overall Study|Still on study|0|||
94431157|NCT03583086|323362770|FG001|Overall Study|Still on study|0|||
94431158|NCT03583086|323362771|FG002|Overall Study|Still on study|0|||
94431159|NCT03583086|323362772|FG003|Overall Study|Still on study|1|||
94431160|NCT03583086|323362773|FG004|Overall Study|Still on study|0|||
94431161|NCT03583086|323362774|FG005|Overall Study|Still on study|0|||
94431162|NCT03583086|323362775|FG006|Overall Study|Still on study|1|||
94431163|NCT03583086|323362769|FG000|Overall Study|Disease progression|0|||
94431164|NCT03583086|323362770|FG001|Overall Study|Disease progression|0|||
94431165|NCT03583086|323362771|FG002|Overall Study|Disease progression|0|||
94431166|NCT03583086|323362772|FG003|Overall Study|Disease progression|0|||
94431167|NCT03583086|323362773|FG004|Overall Study|Disease progression|0|||
94431168|NCT03583086|323362774|FG005|Overall Study|Disease progression|0|||
94431169|NCT03583086|323362775|FG006|Overall Study|Disease progression|1|||
94431170|NCT03583086|323362769|FG000|Overall Study|Undergoing radiation therapy|0|||
94431171|NCT03583086|323362770|FG001|Overall Study|Undergoing radiation therapy|0|||
94431172|NCT03583086|323362771|FG002|Overall Study|Undergoing radiation therapy|0|||
94431173|NCT03583086|323362772|FG003|Overall Study|Undergoing radiation therapy|0|||
94490060|NCT00296517|323588349|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
94490061|NCT00296517|323588348|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
94490062|NCT00296517|323588349|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
94431174|NCT03583086|323362773|FG004|Overall Study|Undergoing radiation therapy|0|||
94431175|NCT03583086|323362774|FG005|Overall Study|Undergoing radiation therapy|0|||
94431176|NCT03583086|323362775|FG006|Overall Study|Undergoing radiation therapy|1|||
94431177|NCT03583086|323362769|FG000|Overall Study|Lost to Follow-up|0|||
94431178|NCT03583086|323362770|FG001|Overall Study|Lost to Follow-up|0|||
94431179|NCT03583086|323362771|FG002|Overall Study|Lost to Follow-up|0|||
94431180|NCT03583086|323362772|FG003|Overall Study|Lost to Follow-up|0|||
94431181|NCT03583086|323362773|FG004|Overall Study|Lost to Follow-up|0|||
94431182|NCT03583086|323362774|FG005|Overall Study|Lost to Follow-up|1|||
94431183|NCT03583086|323362775|FG006|Overall Study|Lost to Follow-up|0|||
94431184|NCT03583086|323362769|FG000|Overall Study|Adverse Event|0|||
94431185|NCT03583086|323362770|FG001|Overall Study|Adverse Event|0|||
94431186|NCT03583086|323362771|FG002|Overall Study|Adverse Event|0|||
94431187|NCT03583086|323362772|FG003|Overall Study|Adverse Event|0|||
94431188|NCT03583086|323362773|FG004|Overall Study|Adverse Event|0|||
94431189|NCT03583086|323362774|FG005|Overall Study|Adverse Event|1|||
94431190|NCT03583086|323362775|FG006|Overall Study|Adverse Event|0|||
94431191|NCT01696279|323362776|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
94431192|NCT01696279|323362777|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
94431193|NCT01696279|323362778|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
94431194|NCT01696279|323362779|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
94431195|NCT01696279|323362776|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
94431196|NCT01696279|323362777|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
94431197|NCT01696279|323362778|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
94431198|NCT01696279|323362779|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
94431199|NCT01696279|323362776|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
94431200|NCT01696279|323362777|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
94431201|NCT01696279|323362778|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
94431202|NCT01696279|323362779|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
94431203|NCT01696279|323362776|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
94431204|NCT01696279|323362777|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
94431205|NCT01696279|323362778|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
94431206|NCT01696279|323362779|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
94431207|NCT01696279|323362776|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
94431208|NCT01696279|323362777|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
94431209|NCT01696279|323362778|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
94431210|NCT01696279|323362779|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
94431211|NCT01696279|323362776|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
94431212|NCT01696279|323362777|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
94431213|NCT01696279|323362778|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
94431214|NCT01696279|323362779|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
94431215|NCT01696279|323362776|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
94431216|NCT01696279|323362777|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
94431217|NCT01696279|323362778|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
94431218|NCT01696279|323362779|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
94431219|NCT01696279|323362776|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
94431220|NCT01696279|323362777|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
94431221|NCT01696279|323362778|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
94431222|NCT01696279|323362779|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
94431223|NCT01696279|323362776|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
94431224|NCT01696279|323362777|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
94431225|NCT01696279|323362778|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
94431226|NCT01696279|323362779|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
94431227|NCT01696279|323362776|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
94431228|NCT01696279|323362777|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
94431229|NCT01696279|323362778|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
94431230|NCT01696279|323362779|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
94431231|NCT01696279|323362776|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
94431232|NCT01696279|323362777|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
94431233|NCT01696279|323362778|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
94431234|NCT01696279|323362779|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
94431235|NCT00396812|323362781|FG000|Overall Study|Physician Decision|1|||
94431236|NCT00796107|323362783|FG000|Overall Study|Lack of Efficacy|1|||
94431237|NCT00796107|323362783|FG000|Overall Study|Progressive Disease|5|||
94431238|NCT01346293|323362786|FG000|Overall Study|Protocol Violation|30|||
94431239|NCT01346293|323362787|FG001|Overall Study|Protocol Violation|9|||
94431240|NCT01346293|323362786|FG000|Overall Study|Lost to Follow-up|21|||
94431241|NCT01346293|323362787|FG001|Overall Study|Lost to Follow-up|8|||
94431242|NCT01346293|323362786|FG000|Overall Study|Withdrawal by Subject|15|||
94431243|NCT01346293|323362787|FG001|Overall Study|Withdrawal by Subject|4|||
94431244|NCT01346293|323362786|FG000|Overall Study|Other|1|||
94431245|NCT01346293|323362787|FG001|Overall Study|Other|0|||
94431246|NCT00233402|323362790|FG000|Overall Study|No pathology data|12|||
94431247|NCT00233402|323362791|FG001|Overall Study|No pathology data|9|||
94431248|NCT00233402|323362790|FG000|Overall Study|No Ta/T1|89|||
94431249|NCT00233402|323362791|FG001|Overall Study|No Ta/T1|94|||
94431250|NCT00233402|323362790|FG000|Overall Study|Lost to follow up etc|3|||
94431251|NCT00233402|323362791|FG001|Overall Study|Lost to follow up etc|21|||
94431252|NCT00838435|323362794|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
94431253|NCT00838435|323362794|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
94431254|NCT00838435|323362794|FG000|Part 2 (7 Years)|Adverse Event|2|||
94431255|NCT00838435|323362794|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
94431256|NCT00838435|323362794|FG000|Part 2 (7 Years)|Physician Decision|1|||
94431257|NCT00838435|323362794|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
94431258|NCT00838435|323362794|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
94431259|NCT00895414|323362796|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
94431260|NCT00895414|323362797|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
94431261|NCT00895414|323362796|FG000|First Intervention (14 Days)|Physician Decision|0|||
94431262|NCT00895414|323362797|FG001|First Intervention (14 Days)|Physician Decision|1|||
94431263|NCT02087189|323362801|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
94431264|NCT02257385|323362802|FG000|Overall Study|Adverse Event|12|||
94431265|NCT02257385|323362803|FG001|Overall Study|Adverse Event|8|||
94431266|NCT02257385|323362802|FG000|Overall Study|Lack of Efficacy|1|||
94431267|NCT02257385|323362803|FG001|Overall Study|Lack of Efficacy|2|||
94431268|NCT02257385|323362802|FG000|Overall Study|Protocol Violation|5|||
94431269|NCT02257385|323362803|FG001|Overall Study|Protocol Violation|7|||
94431270|NCT02257385|323362802|FG000|Overall Study|Lost to Follow-up|0|||
94431271|NCT02257385|323362803|FG001|Overall Study|Lost to Follow-up|1|||
94431272|NCT02257385|323362802|FG000|Overall Study|Withdrawal by Subject|4|||
94431273|NCT02257385|323362803|FG001|Overall Study|Withdrawal by Subject|4|||
94431274|NCT00789737|323362810|FG000|Overall Study|Withdrawal by Subject|13|||
94431275|NCT00789737|323362811|FG001|Overall Study|Withdrawal by Subject|22|||
94431276|NCT00789737|323362810|FG000|Overall Study|Lost to Follow-up|10|||
94431277|NCT00789737|323362811|FG001|Overall Study|Lost to Follow-up|14|||
94431278|NCT00789737|323362810|FG000|Overall Study|Adverse Event|8|||
94431279|NCT00789737|323362811|FG001|Overall Study|Adverse Event|8|||
94431280|NCT00789737|323362810|FG000|Overall Study|Protocol Violation|3|||
94431281|NCT00789737|323362811|FG001|Overall Study|Protocol Violation|0|||
94431282|NCT00789737|323362810|FG000|Overall Study|Lack of Efficacy|3|||
94431283|NCT00789737|323362811|FG001|Overall Study|Lack of Efficacy|0|||
94431284|NCT00789737|323362810|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
94431285|NCT00789737|323362811|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
94431286|NCT00789737|323362810|FG000|Overall Study|Other|11|||
94431287|NCT00789737|323362811|FG001|Overall Study|Other|7|||
94431288|NCT01189487|323362812|FG000|Overall Study|Lack of Efficacy|2|||
94431289|NCT01189487|323362812|FG000|Overall Study|Adverse Event|1|||
94431290|NCT00587990|323362813|FG000|Overall Study|Death|0|||
94431291|NCT00587990|323362814|FG001|Overall Study|Death|0|||
94431292|NCT00587990|323362815|FG002|Overall Study|Death|1|||
94431293|NCT04630158|323362816|FG000|Overall Study|Adverse Event|1|||
94431294|NCT04630158|323362817|FG001|Overall Study|Adverse Event|1|||
94431295|NCT04630158|323362818|FG002|Overall Study|Adverse Event|1|||
94431296|NCT04630158|323362816|FG000|Overall Study|Physician Decision|0|||
94431297|NCT04630158|323362817|FG001|Overall Study|Physician Decision|2|||
94431298|NCT04630158|323362818|FG002|Overall Study|Physician Decision|0|||
94431299|NCT04630158|323362816|FG000|Overall Study|Protocol Violation|1|||
94431300|NCT04630158|323362817|FG001|Overall Study|Protocol Violation|0|||
94431301|NCT04630158|323362818|FG002|Overall Study|Protocol Violation|1|||
94431302|NCT04630158|323362816|FG000|Overall Study|Withdrawal by Subject|2|||
94431303|NCT04630158|323362817|FG001|Overall Study|Withdrawal by Subject|1|||
94431304|NCT04630158|323362818|FG002|Overall Study|Withdrawal by Subject|2|||
94431305|NCT01822366|323362819|FG000|Overall Study|Lost to Follow-up|5|||
94431306|NCT01822366|323362820|FG001|Overall Study|Lost to Follow-up|1|||
94431307|NCT01822366|323362821|FG002|Overall Study|Lost to Follow-up|5|||
94431308|NCT01822366|323362822|FG003|Overall Study|Lost to Follow-up|1|||
94431309|NCT01822366|323362819|FG000|Overall Study|Withdrawal by Subject|0|||
94431310|NCT01822366|323362820|FG001|Overall Study|Withdrawal by Subject|6|||
94431311|NCT01822366|323362821|FG002|Overall Study|Withdrawal by Subject|0|||
94431312|NCT01822366|323362822|FG003|Overall Study|Withdrawal by Subject|6|||
94431313|NCT01822366|323362819|FG000|Overall Study|Partial Intervention Completion|0|||
94431314|NCT01822366|323362820|FG001|Overall Study|Partial Intervention Completion|15|||
94431315|NCT01822366|323362821|FG002|Overall Study|Partial Intervention Completion|0|||
94431316|NCT01822366|323362822|FG003|Overall Study|Partial Intervention Completion|15|||
94431317|NCT04988087|323362823|FG000|Overall Study|Adverse Event|4|||
94431318|NCT04988087|323362824|FG001|Overall Study|Adverse Event|0|||
94431319|NCT04988087|323362825|FG002|Overall Study|Adverse Event|0|||
94431320|NCT04988087|323362826|FG003|Overall Study|Adverse Event|0|||
94431321|NCT04988087|323362823|FG000|Overall Study|Withdrawal by Subject|1|||
94431322|NCT04988087|323362824|FG001|Overall Study|Withdrawal by Subject|1|||
94431323|NCT04988087|323362825|FG002|Overall Study|Withdrawal by Subject|0|||
94431324|NCT04988087|323362826|FG003|Overall Study|Withdrawal by Subject|0|||
94431325|NCT04988087|323362823|FG000|Overall Study|Technical problems|7|||
94431326|NCT04988087|323362824|FG001|Overall Study|Technical problems|9|||
94431327|NCT04988087|323362825|FG002|Overall Study|Technical problems|1|||
94431328|NCT04988087|323362826|FG003|Overall Study|Technical problems|2|||
94431329|NCT03496610|323362827|FG000|Overall Study|Lost to Follow-up|3|||
94431330|NCT03496610|323362828|FG001|Overall Study|Lost to Follow-up|2|||
94431331|NCT03496610|323362827|FG000|Overall Study|Physician Decision|1|||
94431332|NCT03496610|323362828|FG001|Overall Study|Physician Decision|0|||
94431333|NCT03496610|323362827|FG000|Overall Study|Withdrawal by Subject|1|||
94431334|NCT03496610|323362828|FG001|Overall Study|Withdrawal by Subject|0|||
94431335|NCT04435184|323362832|FG000|Overall Study|follow-up blood draws missing|3|||
94431336|NCT04435184|323362833|FG001|Overall Study|follow-up blood draws missing|5|||
94431337|NCT00025259|323362834|FG000|Overall Study|Death|1|||
94431338|NCT00025259|323362835|FG001|Overall Study|Death|3|||
94431339|NCT00025259|323362836|FG002|Overall Study|Death|0|||
94431340|NCT00025259|323362837|FG003|Overall Study|Death|3|||
94431341|NCT00025259|323362838|FG004|Overall Study|Death|0|||
94431342|NCT00025259|323362839|FG005|Overall Study|Death|1|||
94431343|NCT00025259|323362840|FG006|Overall Study|Death|2|||
94431344|NCT00025259|323362834|FG000|Overall Study|Lack of Efficacy|2|||
94431345|NCT00025259|323362835|FG001|Overall Study|Lack of Efficacy|46|||
94431346|NCT00025259|323362836|FG002|Overall Study|Lack of Efficacy|60|||
94431347|NCT00025259|323362837|FG003|Overall Study|Lack of Efficacy|78|||
94431348|NCT00025259|323362838|FG004|Overall Study|Lack of Efficacy|11|||
94431349|NCT00025259|323362839|FG005|Overall Study|Lack of Efficacy|30|||
94431350|NCT00025259|323362840|FG006|Overall Study|Lack of Efficacy|38|||
94431351|NCT00025259|323362834|FG000|Overall Study|Lost to Follow-up|2|||
94431352|NCT00025259|323362835|FG001|Overall Study|Lost to Follow-up|9|||
94431353|NCT00025259|323362836|FG002|Overall Study|Lost to Follow-up|13|||
94431354|NCT00025259|323362837|FG003|Overall Study|Lost to Follow-up|13|||
94431355|NCT00025259|323362838|FG004|Overall Study|Lost to Follow-up|1|||
94431356|NCT00025259|323362839|FG005|Overall Study|Lost to Follow-up|3|||
94431357|NCT00025259|323362840|FG006|Overall Study|Lost to Follow-up|1|||
94431358|NCT00025259|323362834|FG000|Overall Study|Physician Decision|12|||
94431359|NCT00025259|323362835|FG001|Overall Study|Physician Decision|1|||
94431360|NCT00025259|323362836|FG002|Overall Study|Physician Decision|0|||
94431361|NCT00025259|323362837|FG003|Overall Study|Physician Decision|5|||
94431362|NCT00025259|323362838|FG004|Overall Study|Physician Decision|4|||
94431363|NCT00025259|323362839|FG005|Overall Study|Physician Decision|2|||
94431364|NCT00025259|323362840|FG006|Overall Study|Physician Decision|1|||
94431365|NCT00025259|323362834|FG000|Overall Study|Protocol Violation|3|||
94431366|NCT00025259|323362835|FG001|Overall Study|Protocol Violation|2|||
94431367|NCT00025259|323362836|FG002|Overall Study|Protocol Violation|2|||
94431368|NCT00025259|323362837|FG003|Overall Study|Protocol Violation|1|||
94431369|NCT00025259|323362838|FG004|Overall Study|Protocol Violation|2|||
94431370|NCT00025259|323362839|FG005|Overall Study|Protocol Violation|1|||
94431371|NCT00025259|323362840|FG006|Overall Study|Protocol Violation|3|||
94431372|NCT00025259|323362834|FG000|Overall Study|Withdrawal by Subject|9|||
94431373|NCT00025259|323362835|FG001|Overall Study|Withdrawal by Subject|27|||
94431374|NCT00025259|323362836|FG002|Overall Study|Withdrawal by Subject|6|||
94431375|NCT00025259|323362837|FG003|Overall Study|Withdrawal by Subject|14|||
94431376|NCT00025259|323362838|FG004|Overall Study|Withdrawal by Subject|11|||
94431377|NCT00025259|323362839|FG005|Overall Study|Withdrawal by Subject|8|||
94431378|NCT00025259|323362840|FG006|Overall Study|Withdrawal by Subject|3|||
94431379|NCT00025259|323362834|FG000|Overall Study|Ineligible|14|||
94431380|NCT00025259|323362835|FG001|Overall Study|Ineligible|1|||
94431381|NCT00025259|323362836|FG002|Overall Study|Ineligible|0|||
94431382|NCT00025259|323362837|FG003|Overall Study|Ineligible|0|||
94431383|NCT00025259|323362838|FG004|Overall Study|Ineligible|6|||
94431384|NCT00025259|323362839|FG005|Overall Study|Ineligible|0|||
94431385|NCT00025259|323362840|FG006|Overall Study|Ineligible|1|||
94431386|NCT00025259|323362834|FG000|Overall Study|Randomization error|1|||
94431387|NCT00025259|323362835|FG001|Overall Study|Randomization error|0|||
94431388|NCT00025259|323362836|FG002|Overall Study|Randomization error|0|||
94431389|NCT00025259|323362837|FG003|Overall Study|Randomization error|0|||
94431390|NCT00025259|323362838|FG004|Overall Study|Randomization error|1|||
94431391|NCT00025259|323362839|FG005|Overall Study|Randomization error|7|||
94431392|NCT00025259|323362840|FG006|Overall Study|Randomization error|2|||
94431393|NCT00025259|323362834|FG000|Overall Study|Adverse Event|1|||
94431394|NCT00025259|323362835|FG001|Overall Study|Adverse Event|0|||
94431395|NCT00025259|323362836|FG002|Overall Study|Adverse Event|0|||
94490063|NCT03883386|323588353|FG000|First Assignment|Lost to Follow-up|1|||
94431396|NCT00025259|323362837|FG003|Overall Study|Adverse Event|0|||
94431397|NCT00025259|323362838|FG004|Overall Study|Adverse Event|0|||
94431398|NCT00025259|323362839|FG005|Overall Study|Adverse Event|0|||
94431399|NCT00025259|323362840|FG006|Overall Study|Adverse Event|0|||
94431400|NCT00863772|323362841|FG000|Overall Study|Adverse Event|1|||
94431401|NCT00863772|323362842|FG001|Overall Study|Adverse Event|4|||
94431402|NCT00863772|323362843|FG002|Overall Study|Adverse Event|0|||
94431403|NCT00863772|323362841|FG000|Overall Study|Lack of Efficacy|4|||
94431404|NCT00863772|323362842|FG001|Overall Study|Lack of Efficacy|2|||
94431405|NCT00863772|323362843|FG002|Overall Study|Lack of Efficacy|4|||
94431406|NCT00863772|323362841|FG000|Overall Study|Lost to Follow-up|5|||
94431407|NCT00863772|323362842|FG001|Overall Study|Lost to Follow-up|1|||
94431408|NCT00863772|323362843|FG002|Overall Study|Lost to Follow-up|1|||
94431409|NCT00863772|323362841|FG000|Overall Study|Protocol Violation|2|||
94431410|NCT00863772|323362842|FG001|Overall Study|Protocol Violation|0|||
94431411|NCT00863772|323362843|FG002|Overall Study|Protocol Violation|2|||
94431412|NCT00863772|323362841|FG000|Overall Study|Withdrawal by Subject|4|||
94431413|NCT00863772|323362842|FG001|Overall Study|Withdrawal by Subject|7|||
94431414|NCT00863772|323362843|FG002|Overall Study|Withdrawal by Subject|5|||
94431415|NCT00863772|323362841|FG000|Overall Study|Study terminated by sponsor|44|||
94431416|NCT00863772|323362842|FG001|Overall Study|Study terminated by sponsor|45|||
94431417|NCT00863772|323362843|FG002|Overall Study|Study terminated by sponsor|36|||
94431418|NCT00863772|323362841|FG000|Overall Study|Entered extension study|6|||
94431419|NCT00863772|323362842|FG001|Overall Study|Entered extension study|4|||
94431420|NCT00863772|323362843|FG002|Overall Study|Entered extension study|9|||
94431421|NCT00863772|323362841|FG000|Overall Study|Other|1|||
94431422|NCT00863772|323362842|FG001|Overall Study|Other|2|||
94431423|NCT00863772|323362843|FG002|Overall Study|Other|4|||
94431424|NCT00863772|323362841|FG000|Overall Study|Randomized but not Treated|1|||
94431425|NCT00863772|323362842|FG001|Overall Study|Randomized but not Treated|0|||
94431426|NCT00863772|323362843|FG002|Overall Study|Randomized but not Treated|0|||
94431427|NCT01144715|323362851|FG000|Overall Study|Lost to Follow-up|2|||
94431428|NCT01144715|323362852|FG001|Overall Study|Lost to Follow-up|1|||
94431429|NCT01144715|323362851|FG000|Overall Study|Withdrawal by Subject|2|||
94431430|NCT01144715|323362852|FG001|Overall Study|Withdrawal by Subject|1|||
94431431|NCT01144715|323362851|FG000|Overall Study|Adverse Event|0|||
94431432|NCT01144715|323362852|FG001|Overall Study|Adverse Event|1|||
94431433|NCT01671332|323362854|FG000|Overall Study|Withdrawal by Subject|1|||
94431434|NCT01671332|323362855|FG001|Overall Study|Withdrawal by Subject|1|||
94431435|NCT00761657|323364541|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
94431436|NCT00761657|323364542|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
94431437|NCT00761657|323364543|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
94431438|NCT00761657|323364544|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
94431439|NCT00761657|323364545|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
94431440|NCT00761657|323364546|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
94431441|NCT00761657|323364547|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
94431442|NCT00761657|323364548|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
94431443|NCT00761657|323364549|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
94431444|NCT00761657|323364541|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
94431445|NCT00761657|323364542|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
94431446|NCT00761657|323364543|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
94431447|NCT00761657|323364544|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
94431448|NCT00761657|323364545|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
94431449|NCT00761657|323364546|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
94431450|NCT00761657|323364547|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
94431451|NCT00761657|323364548|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
94431452|NCT00761657|323364549|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
94431453|NCT00761657|323364541|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
94431454|NCT00761657|323364542|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
94431455|NCT00761657|323364543|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
94431456|NCT00761657|323364544|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
94431457|NCT00761657|323364545|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
94431458|NCT00761657|323364546|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
94431459|NCT00761657|323364547|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
94431460|NCT00761657|323364548|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
94431461|NCT00761657|323364549|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
94431462|NCT00761657|323364541|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
94431463|NCT00761657|323364542|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
94431464|NCT00761657|323364543|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
94431465|NCT00761657|323364544|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
94431466|NCT00761657|323364545|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
94431467|NCT00761657|323364546|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
94431468|NCT00761657|323364547|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
94431469|NCT00761657|323364548|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
94431470|NCT00761657|323364549|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
94431471|NCT00478244|323364550|FG000|Overall Study|Did not receive transplant|1|||
94431472|NCT01443728|323364564|FG000|Overall Study|Lost to Follow-up|2|||
94431473|NCT01443728|323364565|FG001|Overall Study|Lost to Follow-up|0|||
94431474|NCT01443728|323364564|FG000|Overall Study|Withdrawal by Subject|1|||
94431475|NCT01443728|323364565|FG001|Overall Study|Withdrawal by Subject|1|||
94431476|NCT01443728|323364564|FG000|Overall Study|Adverse Event|0|||
94431477|NCT01443728|323364565|FG001|Overall Study|Adverse Event|2|||
94431478|NCT01517373|323364566|FG000|Run-in Period|Death|1|||
94431479|NCT01517373|323364567|FG001|Run-in Period|Death|0|||
94431480|NCT01517373|323364568|FG002|Run-in Period|Death|0|||
94431481|NCT01517373|323364569|FG003|Run-in Period|Death|0|||
94431482|NCT01517373|323364570|FG004|Run-in Period|Death|0|||
94431483|NCT01517373|323364571|FG005|Run-in Period|Death|0|||
94431484|NCT01517373|323364566|FG000|Run-in Period|Adverse Event|5|||
94431485|NCT01517373|323364567|FG001|Run-in Period|Adverse Event|0|||
94431486|NCT01517373|323364568|FG002|Run-in Period|Adverse Event|0|||
94431487|NCT01517373|323364569|FG003|Run-in Period|Adverse Event|0|||
94431488|NCT01517373|323364570|FG004|Run-in Period|Adverse Event|0|||
94431489|NCT01517373|323364571|FG005|Run-in Period|Adverse Event|0|||
94431490|NCT01517373|323364566|FG000|Run-in Period|Did not meet eligibility criteria|34|||
94431491|NCT01517373|323364567|FG001|Run-in Period|Did not meet eligibility criteria|0|||
94431492|NCT01517373|323364568|FG002|Run-in Period|Did not meet eligibility criteria|0|||
94431493|NCT01517373|323364569|FG003|Run-in Period|Did not meet eligibility criteria|0|||
94431494|NCT01517373|323364570|FG004|Run-in Period|Did not meet eligibility criteria|0|||
94431495|NCT01517373|323364571|FG005|Run-in Period|Did not meet eligibility criteria|0|||
94431496|NCT01517373|323364566|FG000|Run-in Period|Lost to Follow-up|1|||
94431497|NCT01517373|323364567|FG001|Run-in Period|Lost to Follow-up|0|||
94431498|NCT01517373|323364568|FG002|Run-in Period|Lost to Follow-up|0|||
94431499|NCT01517373|323364569|FG003|Run-in Period|Lost to Follow-up|0|||
94431500|NCT01517373|323364570|FG004|Run-in Period|Lost to Follow-up|0|||
94431501|NCT01517373|323364571|FG005|Run-in Period|Lost to Follow-up|0|||
94431502|NCT01517373|323364566|FG000|Run-in Period|Withdrawal by Subject|12|||
94431503|NCT01517373|323364567|FG001|Run-in Period|Withdrawal by Subject|0|||
94431504|NCT01517373|323364568|FG002|Run-in Period|Withdrawal by Subject|0|||
94431505|NCT01517373|323364569|FG003|Run-in Period|Withdrawal by Subject|0|||
94431506|NCT01517373|323364570|FG004|Run-in Period|Withdrawal by Subject|0|||
94431507|NCT01517373|323364571|FG005|Run-in Period|Withdrawal by Subject|0|||
94431508|NCT01517373|323364566|FG000|Run-in Period|Sponsor Decision|3|||
94431509|NCT01517373|323364567|FG001|Run-in Period|Sponsor Decision|0|||
94431510|NCT01517373|323364568|FG002|Run-in Period|Sponsor Decision|0|||
94431511|NCT01517373|323364569|FG003|Run-in Period|Sponsor Decision|0|||
94431512|NCT01517373|323364570|FG004|Run-in Period|Sponsor Decision|0|||
94431513|NCT01517373|323364571|FG005|Run-in Period|Sponsor Decision|0|||
94431514|NCT01517373|323364566|FG000|Run-in Period|Other|1|||
94431515|NCT01517373|323364567|FG001|Run-in Period|Other|0|||
94431516|NCT01517373|323364568|FG002|Run-in Period|Other|0|||
94431517|NCT01517373|323364569|FG003|Run-in Period|Other|0|||
94431518|NCT01517373|323364570|FG004|Run-in Period|Other|0|||
94431519|NCT01517373|323364571|FG005|Run-in Period|Other|0|||
94431520|NCT01517373|323364566|FG000|Treatment Period|Adverse Event|0|||
94431521|NCT01517373|323364567|FG001|Treatment Period|Adverse Event|0|||
94431522|NCT01517373|323364568|FG002|Treatment Period|Adverse Event|0|||
94431523|NCT01517373|323364569|FG003|Treatment Period|Adverse Event|0|||
94431524|NCT01517373|323364570|FG004|Treatment Period|Adverse Event|0|||
94431525|NCT01517373|323364571|FG005|Treatment Period|Adverse Event|2|||
94431526|NCT01517373|323364566|FG000|Treatment Period|Lost to Follow-up|0|||
94431527|NCT01517373|323364567|FG001|Treatment Period|Lost to Follow-up|0|||
94431528|NCT01517373|323364568|FG002|Treatment Period|Lost to Follow-up|1|||
94431529|NCT01517373|323364569|FG003|Treatment Period|Lost to Follow-up|1|||
94431530|NCT01517373|323364570|FG004|Treatment Period|Lost to Follow-up|0|||
94431531|NCT01517373|323364571|FG005|Treatment Period|Lost to Follow-up|0|||
94431532|NCT01517373|323364566|FG000|Treatment Period|Withdrawal by Subject|0|||
94431533|NCT01517373|323364567|FG001|Treatment Period|Withdrawal by Subject|3|||
94431534|NCT01517373|323364568|FG002|Treatment Period|Withdrawal by Subject|2|||
94431535|NCT01517373|323364569|FG003|Treatment Period|Withdrawal by Subject|2|||
94431536|NCT01517373|323364570|FG004|Treatment Period|Withdrawal by Subject|2|||
94431537|NCT01517373|323364571|FG005|Treatment Period|Withdrawal by Subject|3|||
94431538|NCT01517373|323364566|FG000|Treatment Period|Other|0|||
94431539|NCT01517373|323364567|FG001|Treatment Period|Other|0|||
94431540|NCT01517373|323364568|FG002|Treatment Period|Other|0|||
94431541|NCT01517373|323364569|FG003|Treatment Period|Other|0|||
94431542|NCT01517373|323364570|FG004|Treatment Period|Other|1|||
94431543|NCT01517373|323364571|FG005|Treatment Period|Other|0|||
94431544|NCT01517373|323364566|FG000|Treatment Period|Protocol Violation|0|||
94431545|NCT01517373|323364567|FG001|Treatment Period|Protocol Violation|0|||
94431546|NCT01517373|323364568|FG002|Treatment Period|Protocol Violation|0|||
94431547|NCT01517373|323364569|FG003|Treatment Period|Protocol Violation|0|||
94431548|NCT01517373|323364570|FG004|Treatment Period|Protocol Violation|1|||
94431549|NCT01517373|323364571|FG005|Treatment Period|Protocol Violation|0|||
94431550|NCT01517373|323364566|FG000|Treatment Period|Lack of Efficacy|0|||
94431551|NCT01517373|323364567|FG001|Treatment Period|Lack of Efficacy|1|||
94431552|NCT01517373|323364568|FG002|Treatment Period|Lack of Efficacy|1|||
94431553|NCT01517373|323364569|FG003|Treatment Period|Lack of Efficacy|3|||
94431554|NCT01517373|323364570|FG004|Treatment Period|Lack of Efficacy|2|||
94431555|NCT01517373|323364571|FG005|Treatment Period|Lack of Efficacy|0|||
94431556|NCT01517373|323364566|FG000|Treatment Period|Medication error without AEs|0|||
94431557|NCT01517373|323364567|FG001|Treatment Period|Medication error without AEs|0|||
94431558|NCT01517373|323364568|FG002|Treatment Period|Medication error without AEs|2|||
94431559|NCT01517373|323364569|FG003|Treatment Period|Medication error without AEs|1|||
94431560|NCT01517373|323364570|FG004|Treatment Period|Medication error without AEs|0|||
94431561|NCT01517373|323364571|FG005|Treatment Period|Medication error without AEs|2|||
94431562|NCT00509366|323364572|FG000|Overall Study|Not Treated (Screen Failure)|1|||
94431563|NCT00509366|323364573|FG001|Overall Study|Not Treated (Screen Failure)|1|||
94431564|NCT00509366|323364574|FG002|Overall Study|Not Treated (Screen Failure)|1|||
94431565|NCT00509366|323364575|FG003|Overall Study|Not Treated (Screen Failure)|0|||
94431566|NCT00509366|323364576|FG004|Overall Study|Not Treated (Screen Failure)|0|||
94431567|NCT02906358|323364577|FG000|Overall Study|Withdrawal by Subject|10|||
94431568|NCT02906358|323364578|FG001|Overall Study|Withdrawal by Subject|7|||
94431569|NCT02906358|323364577|FG000|Overall Study|Lost to Follow-up|12|||
94431570|NCT02906358|323364578|FG001|Overall Study|Lost to Follow-up|15|||
94431571|NCT00417170|323364580|FG000|Overall Study|Adverse Event|1|||
94431572|NCT00417170|323364581|FG001|Overall Study|Adverse Event|1|||
94431573|NCT00417170|323364580|FG000|Overall Study|Withdrawal by Subject|1|||
94431574|NCT00417170|323364581|FG001|Overall Study|Withdrawal by Subject|1|||
94431575|NCT00417170|323364580|FG000|Overall Study|Lost to Follow-up|0|||
94431576|NCT00417170|323364581|FG001|Overall Study|Lost to Follow-up|1|||
94431577|NCT02538965|323364586|FG000|Treatment Period|Other = Death due to disease progression|1|||
94431578|NCT02538965|323364586|FG000|Treatment Period|Adverse Event|2|||
94431579|NCT02538965|323364586|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
94431580|NCT02538965|323364586|FG000|Treatment Period|Treatment Failure|9|||
94431581|NCT02538965|323364586|FG000|Treatment Period|Disease Progression|1|||
94431582|NCT02538965|323364586|FG000|Treatment Period|Physician Decision|2|||
94431583|NCT02538965|323364586|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
94431584|NCT02538965|323364586|FG000|Follow-Up Period|Withdrawal by Parent|4|||
94431585|NCT00741286|323364588|FG000|Overall Study|Lost to Follow-up|15|||
94431586|NCT00741286|323364589|FG001|Overall Study|Lost to Follow-up|10|||
94431587|NCT00741286|323364588|FG000|Overall Study|Adverse Event|1|||
94431588|NCT00741286|323364589|FG001|Overall Study|Adverse Event|6|||
94431589|NCT00741286|323364588|FG000|Overall Study|Protocol Violation|3|||
94431590|NCT00741286|323364589|FG001|Overall Study|Protocol Violation|2|||
94431591|NCT00741286|323364588|FG000|Overall Study|Primary Outcome|1|||
94431592|NCT00741286|323364589|FG001|Overall Study|Primary Outcome|1|||
94431593|NCT00253448|323364591|FG000|Overall Study|Withdrawal by Subject|1|||
94431594|NCT02309138|323364592|FG000|Overall Study|Withdrawal by Subject|44|||
94431595|NCT02309138|323364593|FG001|Overall Study|Withdrawal by Subject|15|||
94431596|NCT02309138|323364592|FG000|Overall Study|Protocol Violation|4|||
94431597|NCT02309138|323364593|FG001|Overall Study|Protocol Violation|2|||
94431598|NCT02309138|323364592|FG000|Overall Study|delivered before visit 2|0|||
94431599|NCT02309138|323364593|FG001|Overall Study|delivered before visit 2|1|||
94431600|NCT01228019|323364600|FG000|Overall Study|Dose Violation|70|||
94431601|NCT01228019|323364600|FG000|Overall Study|Duplicate enrollment|1|||
94431602|NCT01228019|323364600|FG000|Overall Study|Missing pre-treatment data|72|||
94431603|NCT01228019|323364600|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
94431604|NCT01228019|323364600|FG000|Overall Study|Violation of Entry Criterion|9|||
94431605|NCT00492778|323364601|FG000|Overall Study|Ineligible by Pathology Review|8|||
94431606|NCT00492778|323364602|FG001|Overall Study|Ineligible by Pathology Review|1|||
94431607|NCT03717012|323364603|FG000|Overall Study|Due to trial termination|1|||
94431608|NCT03717012|323364604|FG001|Overall Study|Due to trial termination|2|||
94431609|NCT03717012|323364603|FG000|Overall Study|Protocol Violation|0|||
94431610|NCT03717012|323364604|FG001|Overall Study|Protocol Violation|2|||
94431611|NCT03717012|323364603|FG000|Overall Study|Adverse Event|0|||
94431612|NCT03717012|323364604|FG001|Overall Study|Adverse Event|1|||
94431613|NCT03717012|323364603|FG000|Overall Study|Lung transplant|0|||
94431614|NCT03717012|323364604|FG001|Overall Study|Lung transplant|1|||
94431615|NCT05320887|323364607|FG000|Overall Study|Lost to Follow-up|0|||
94431616|NCT05320887|323364608|FG001|Overall Study|Lost to Follow-up|3|||
94431617|NCT05320887|323364609|FG002|Overall Study|Lost to Follow-up|0|||
94431618|NCT05320887|323364610|FG003|Overall Study|Lost to Follow-up|0|||
94431619|NCT02015065|323364616|FG000|Overall Study|Death on study|1|||
94431620|NCT02015065|323364617|FG001|Overall Study|Death on study|2|||
94431621|NCT02015065|323364618|FG002|Overall Study|Death on study|1|||
94431622|NCT01884337|323364619|FG000|Treatment|Adverse Event|2|||
94431623|NCT01884337|323364620|FG001|Treatment|Adverse Event|2|||
94431624|NCT01884337|323364619|FG000|Treatment|Subj. request to discont. treatment|2|||
94431625|NCT01884337|323364620|FG001|Treatment|Subj. request to discont. treatment|0|||
94431626|NCT01884337|323364619|FG000|Follow-up Period|Lost to Follow-up|1|||
94431627|NCT01884337|323364620|FG001|Follow-up Period|Lost to Follow-up|1|||
94431628|NCT04106661|323364621|FG000|Overall Study|Protocol Violation|3|||
94431629|NCT04106661|323364622|FG001|Overall Study|Protocol Violation|0|||
94431630|NCT04106661|323364621|FG000|Overall Study|Scheduling difficulties|1|||
94431631|NCT04106661|323364622|FG001|Overall Study|Scheduling difficulties|1|||
94431632|NCT02655666|323364623|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
94431633|NCT01267994|323364624|FG000|Overall Study|Adverse Event|2|||
94431634|NCT03837743|323364625|FG000|Overall Study|Adverse Event|1|||
94431635|NCT03837743|323364625|FG000|Overall Study|Withdrawal by Subject|2|||
94431636|NCT02754856|323364634|FG000|Overall Study|Withdrawal by Subject|1|||
94431637|NCT05199090|323364637|FG000|Overall Study|Adverse Event|1|||
94431638|NCT05199090|323364638|FG001|Overall Study|Adverse Event|4|||
94431639|NCT05199090|323364639|FG002|Overall Study|Adverse Event|0|||
94431640|NCT05199090|323364640|FG003|Overall Study|Adverse Event|0|||
94431641|NCT05199090|323364641|FG004|Overall Study|Adverse Event|0|||
94431642|NCT05199090|323364642|FG005|Overall Study|Adverse Event|0|||
94431643|NCT05199090|323364637|FG000|Overall Study|Lost to Follow-up|1|||
94431644|NCT05199090|323364638|FG001|Overall Study|Lost to Follow-up|0|||
94431645|NCT05199090|323364639|FG002|Overall Study|Lost to Follow-up|1|||
94431646|NCT05199090|323364640|FG003|Overall Study|Lost to Follow-up|4|||
94431647|NCT05199090|323364641|FG004|Overall Study|Lost to Follow-up|0|||
94431648|NCT05199090|323364642|FG005|Overall Study|Lost to Follow-up|5|||
94431649|NCT05199090|323364637|FG000|Overall Study|Physician Decision|0|||
94431650|NCT05199090|323364638|FG001|Overall Study|Physician Decision|0|||
94431651|NCT05199090|323364639|FG002|Overall Study|Physician Decision|0|||
94431652|NCT05199090|323364640|FG003|Overall Study|Physician Decision|0|||
94431653|NCT05199090|323364641|FG004|Overall Study|Physician Decision|0|||
94431654|NCT05199090|323364642|FG005|Overall Study|Physician Decision|1|||
94431655|NCT05199090|323364637|FG000|Overall Study|Study terminated by sponsor|0|||
94431656|NCT05199090|323364638|FG001|Overall Study|Study terminated by sponsor|6|||
94431657|NCT05199090|323364639|FG002|Overall Study|Study terminated by sponsor|0|||
94431658|NCT05199090|323364640|FG003|Overall Study|Study terminated by sponsor|0|||
94431659|NCT05199090|323364641|FG004|Overall Study|Study terminated by sponsor|0|||
94431660|NCT05199090|323364642|FG005|Overall Study|Study terminated by sponsor|5|||
94431661|NCT05199090|323364637|FG000|Overall Study|Subject decision|0|||
94431662|NCT05199090|323364638|FG001|Overall Study|Subject decision|4|||
94431663|NCT05199090|323364639|FG002|Overall Study|Subject decision|0|||
94431664|NCT05199090|323364640|FG003|Overall Study|Subject decision|2|||
94431665|NCT05199090|323364641|FG004|Overall Study|Subject decision|5|||
94431666|NCT05199090|323364642|FG005|Overall Study|Subject decision|2|||
94431667|NCT00384930|323364643|FG000|Overall Study|Adverse Event|5|||
94431668|NCT00384930|323364644|FG001|Overall Study|Adverse Event|4|||
94431669|NCT00384930|323364645|FG002|Overall Study|Adverse Event|12|||
94431670|NCT00384930|323364646|FG003|Overall Study|Adverse Event|11|||
94431671|NCT00384930|323364647|FG004|Overall Study|Adverse Event|14|||
94431672|NCT00384930|323364643|FG000|Overall Study|Entry Criteria Not Met|2|||
94431673|NCT00384930|323364644|FG001|Overall Study|Entry Criteria Not Met|6|||
94431674|NCT00384930|323364645|FG002|Overall Study|Entry Criteria Not Met|7|||
94431675|NCT00384930|323364646|FG003|Overall Study|Entry Criteria Not Met|8|||
94431676|NCT00384930|323364647|FG004|Overall Study|Entry Criteria Not Met|4|||
94431677|NCT00384930|323364643|FG000|Overall Study|Lack of Efficacy|1|||
94431678|NCT00384930|323364644|FG001|Overall Study|Lack of Efficacy|1|||
94431679|NCT00384930|323364645|FG002|Overall Study|Lack of Efficacy|2|||
94431680|NCT00384930|323364646|FG003|Overall Study|Lack of Efficacy|1|||
94431681|NCT00384930|323364647|FG004|Overall Study|Lack of Efficacy|2|||
94431682|NCT00384930|323364643|FG000|Overall Study|Lost to Follow-up|5|||
94431683|NCT00384930|323364644|FG001|Overall Study|Lost to Follow-up|3|||
94431684|NCT00384930|323364645|FG002|Overall Study|Lost to Follow-up|0|||
94431685|NCT00384930|323364646|FG003|Overall Study|Lost to Follow-up|4|||
94431686|NCT00384930|323364647|FG004|Overall Study|Lost to Follow-up|6|||
94431687|NCT00384930|323364643|FG000|Overall Study|Physician Decision|0|||
94431688|NCT00384930|323364644|FG001|Overall Study|Physician Decision|1|||
94431689|NCT00384930|323364645|FG002|Overall Study|Physician Decision|1|||
94431690|NCT00384930|323364646|FG003|Overall Study|Physician Decision|0|||
94431691|NCT00384930|323364647|FG004|Overall Study|Physician Decision|1|||
94431692|NCT00384930|323364643|FG000|Overall Study|Protocol Violation|1|||
94431693|NCT00384930|323364644|FG001|Overall Study|Protocol Violation|0|||
94431694|NCT00384930|323364645|FG002|Overall Study|Protocol Violation|1|||
94431695|NCT00384930|323364646|FG003|Overall Study|Protocol Violation|6|||
94431696|NCT00384930|323364647|FG004|Overall Study|Protocol Violation|4|||
94431697|NCT00384930|323364643|FG000|Overall Study|Sponsor Decision|3|||
94431698|NCT00384930|323364644|FG001|Overall Study|Sponsor Decision|4|||
94431699|NCT00384930|323364645|FG002|Overall Study|Sponsor Decision|0|||
94431700|NCT00384930|323364646|FG003|Overall Study|Sponsor Decision|5|||
94431701|NCT00384930|323364647|FG004|Overall Study|Sponsor Decision|0|||
94431702|NCT00384930|323364643|FG000|Overall Study|Withdrawal by Subject|9|||
94431703|NCT00384930|323364644|FG001|Overall Study|Withdrawal by Subject|7|||
94431704|NCT00384930|323364645|FG002|Overall Study|Withdrawal by Subject|7|||
94431705|NCT00384930|323364646|FG003|Overall Study|Withdrawal by Subject|6|||
94431706|NCT00384930|323364647|FG004|Overall Study|Withdrawal by Subject|16|||
94431707|NCT00384930|323364643|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
94431708|NCT00384930|323364644|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
94431709|NCT00384930|323364645|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
94431710|NCT00384930|323364646|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
94431711|NCT00384930|323364647|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
94431712|NCT02752087|323364648|FG000|Washout|Physician Decision|1|||
94431713|NCT02752087|323364649|FG001|Washout|Physician Decision|0|||
94431714|NCT02458287|323364650|FG000|Overall Study|Adverse Event|0|||
94431715|NCT02458287|323364651|FG001|Overall Study|Adverse Event|0|||
94431716|NCT02458287|323364652|FG002|Overall Study|Adverse Event|0|||
94431717|NCT02458287|323364653|FG003|Overall Study|Adverse Event|1|||
94431718|NCT02458287|323364650|FG000|Overall Study|Lost to Follow-up|0|||
94431719|NCT02458287|323364651|FG001|Overall Study|Lost to Follow-up|1|||
94431720|NCT02458287|323364652|FG002|Overall Study|Lost to Follow-up|1|||
94431721|NCT02458287|323364653|FG003|Overall Study|Lost to Follow-up|0|||
94431722|NCT02458287|323364650|FG000|Overall Study|Protocol Violation|0|||
94431723|NCT02458287|323364651|FG001|Overall Study|Protocol Violation|1|||
94431724|NCT02458287|323364652|FG002|Overall Study|Protocol Violation|0|||
94431725|NCT02458287|323364653|FG003|Overall Study|Protocol Violation|0|||
94431726|NCT02458287|323364650|FG000|Overall Study|Withdrawal by Subject|0|||
94490064|NCT03883386|323588354|FG001|First Assignment|Lost to Follow-up|0|||
94490065|NCT03883386|323588353|FG000|First Assignment|Withdrawal by Subject|1|||
94431727|NCT02458287|323364651|FG001|Overall Study|Withdrawal by Subject|2|||
94431728|NCT02458287|323364652|FG002|Overall Study|Withdrawal by Subject|2|||
94431729|NCT02458287|323364653|FG003|Overall Study|Withdrawal by Subject|1|||
94431730|NCT02458287|323364650|FG000|Overall Study|Relocated Out of State|0|||
94431731|NCT02458287|323364651|FG001|Overall Study|Relocated Out of State|0|||
94431732|NCT02458287|323364652|FG002|Overall Study|Relocated Out of State|0|||
94431733|NCT02458287|323364653|FG003|Overall Study|Relocated Out of State|1|||
94431734|NCT02613182|323364654|FG000|Overall Study|Death|6|||
94431735|NCT02613182|323364654|FG000|Overall Study|Physician Decision|1|||
94431736|NCT02613182|323364654|FG000|Overall Study|Study Terminated by Sponsor|21|||
94431737|NCT02613182|323364654|FG000|Overall Study|Withdrawal by Subject|6|||
94431738|NCT03968978|323364655|FG000|Overall Study|Adverse Event|1|||
94431739|NCT03968978|323364656|FG001|Overall Study|Adverse Event|0|||
94431740|NCT00474266|323364657|FG000|Overall Study|Withdrawal by Subject|7|||
94431741|NCT00474266|323364658|FG001|Overall Study|Withdrawal by Subject|20|||
94431742|NCT00474266|323364659|FG002|Overall Study|Withdrawal by Subject|4|||
94431743|NCT00474266|323364660|FG003|Overall Study|Withdrawal by Subject|7|||
94431744|NCT00534404|323364661|FG000|Overall Study|Death|0|||
94431745|NCT00534404|323364662|FG001|Overall Study|Death|0|||
94431746|NCT00534404|323364663|FG002|Overall Study|Death|2|||
94431747|NCT00534404|323364661|FG000|Overall Study|Withdrawal by Subject|8|||
94431748|NCT00534404|323364662|FG001|Overall Study|Withdrawal by Subject|2|||
94431749|NCT00534404|323364663|FG002|Overall Study|Withdrawal by Subject|38|||
94431750|NCT00534404|323364661|FG000|Overall Study|Removed by study staff|2|||
94431751|NCT00534404|323364662|FG001|Overall Study|Removed by study staff|3|||
94431752|NCT00534404|323364663|FG002|Overall Study|Removed by study staff|1|||
94431753|NCT00534404|323364661|FG000|Overall Study|Lost to Follow-up|170|||
94431754|NCT00534404|323364662|FG001|Overall Study|Lost to Follow-up|138|||
94431755|NCT00534404|323364663|FG002|Overall Study|Lost to Follow-up|201|||
94431756|NCT04759768|323364664|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
94431757|NCT04759768|323364665|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
94431758|NCT04759768|323364664|FG000|Washout (7 Days)|Physician Decision|0|||
94431759|NCT04759768|323364665|FG001|Washout (7 Days)|Physician Decision|1|||
94431760|NCT02996487|323364666|FG000|Overall Study|Lost to Follow-up|1|||
94431761|NCT02996487|323364667|FG001|Overall Study|Lost to Follow-up|1|||
94431762|NCT02996487|323364668|FG002|Overall Study|Lost to Follow-up|0|||
94431763|NCT02996487|323364666|FG000|Overall Study|Death|0|||
94431764|NCT02996487|323364667|FG001|Overall Study|Death|1|||
94431765|NCT02996487|323364668|FG002|Overall Study|Death|0|||
94431766|NCT02996487|323364666|FG000|Overall Study|Withdrawal by Subject|2|||
94431767|NCT02996487|323364667|FG001|Overall Study|Withdrawal by Subject|3|||
94431768|NCT02996487|323364668|FG002|Overall Study|Withdrawal by Subject|0|||
94431769|NCT03390426|323364669|FG000|Overall Study|Protocol Violation|0|||
94431770|NCT03390426|323364670|FG001|Overall Study|Protocol Violation|1|||
94431771|NCT01680497|323364675|FG000|Overall Study|Lost to Follow-up|2|||
94431772|NCT00307437|323364676|FG000|Controlled Period|Adverse Event|7|||
94431773|NCT00307437|323364677|FG001|Controlled Period|Adverse Event|2|||
94431774|NCT00307437|323364678|FG002|Controlled Period|Adverse Event|5|||
94431775|NCT00307437|323364679|FG003|Controlled Period|Adverse Event|0|||
94431776|NCT00307437|323364680|FG004|Controlled Period|Adverse Event|0|||
94431777|NCT00307437|323364681|FG005|Controlled Period|Adverse Event|0|||
94431778|NCT00307437|323364682|FG006|Controlled Period|Adverse Event|0|||
94431779|NCT00307437|323364676|FG000|Controlled Period|Death|0|||
94431780|NCT00307437|323364677|FG001|Controlled Period|Death|0|||
94431781|NCT00307437|323364678|FG002|Controlled Period|Death|1|||
94431782|NCT00307437|323364679|FG003|Controlled Period|Death|0|||
94431783|NCT00307437|323364680|FG004|Controlled Period|Death|0|||
94431784|NCT00307437|323364681|FG005|Controlled Period|Death|0|||
94431785|NCT00307437|323364682|FG006|Controlled Period|Death|0|||
94431786|NCT00307437|323364676|FG000|Controlled Period|Lack of Efficacy|2|||
94490066|NCT03883386|323588354|FG001|First Assignment|Withdrawal by Subject|1|||
94490067|NCT01922934|323588355|FG000|Eligible Patients|Death|0|||
94490068|NCT01922934|323588356|FG001|Eligible Patients|Death|7|||
94490069|NCT01922934|323588355|FG000|Eligible Patients|Physician Decision|17|||
94431787|NCT00307437|323364677|FG001|Controlled Period|Lack of Efficacy|0|||
94431788|NCT00307437|323364678|FG002|Controlled Period|Lack of Efficacy|0|||
94431789|NCT00307437|323364679|FG003|Controlled Period|Lack of Efficacy|0|||
94431790|NCT00307437|323364680|FG004|Controlled Period|Lack of Efficacy|0|||
94490070|NCT01922934|323588356|FG001|Eligible Patients|Physician Decision|0|||
94490071|NCT01922934|323588355|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
94431791|NCT00307437|323364681|FG005|Controlled Period|Lack of Efficacy|0|||
94431792|NCT00307437|323364682|FG006|Controlled Period|Lack of Efficacy|0|||
94431793|NCT00307437|323364676|FG000|Controlled Period|Lost to Follow-up|2|||
94431794|NCT00307437|323364677|FG001|Controlled Period|Lost to Follow-up|3|||
94431795|NCT00307437|323364678|FG002|Controlled Period|Lost to Follow-up|0|||
94431796|NCT00307437|323364679|FG003|Controlled Period|Lost to Follow-up|0|||
94431797|NCT00307437|323364680|FG004|Controlled Period|Lost to Follow-up|0|||
94431798|NCT00307437|323364681|FG005|Controlled Period|Lost to Follow-up|0|||
94431799|NCT00307437|323364682|FG006|Controlled Period|Lost to Follow-up|0|||
94431800|NCT00307437|323364676|FG000|Controlled Period|Other|5|||
94431801|NCT00307437|323364677|FG001|Controlled Period|Other|1|||
94431802|NCT00307437|323364678|FG002|Controlled Period|Other|3|||
94431803|NCT00307437|323364679|FG003|Controlled Period|Other|0|||
94431804|NCT00307437|323364680|FG004|Controlled Period|Other|0|||
94431805|NCT00307437|323364681|FG005|Controlled Period|Other|0|||
94431806|NCT00307437|323364682|FG006|Controlled Period|Other|0|||
94431807|NCT00307437|323364676|FG000|After Controlled Period|Adverse Event|0|||
94431808|NCT00307437|323364677|FG001|After Controlled Period|Adverse Event|0|||
94431809|NCT00307437|323364678|FG002|After Controlled Period|Adverse Event|0|||
94431810|NCT00307437|323364679|FG003|After Controlled Period|Adverse Event|18|||
94431811|NCT00307437|323364680|FG004|After Controlled Period|Adverse Event|16|||
94431812|NCT00307437|323364681|FG005|After Controlled Period|Adverse Event|31|||
94431813|NCT00307437|323364682|FG006|After Controlled Period|Adverse Event|40|||
94431814|NCT00307437|323364676|FG000|After Controlled Period|Death|0|||
94431815|NCT00307437|323364677|FG001|After Controlled Period|Death|0|||
94431816|NCT00307437|323364678|FG002|After Controlled Period|Death|0|||
94431817|NCT00307437|323364679|FG003|After Controlled Period|Death|3|||
94431818|NCT00307437|323364680|FG004|After Controlled Period|Death|1|||
94431819|NCT00307437|323364681|FG005|After Controlled Period|Death|1|||
94431820|NCT00307437|323364682|FG006|After Controlled Period|Death|3|||
94431821|NCT00307437|323364676|FG000|After Controlled Period|Lack of Efficacy|0|||
94431822|NCT00307437|323364677|FG001|After Controlled Period|Lack of Efficacy|0|||
94431823|NCT00307437|323364678|FG002|After Controlled Period|Lack of Efficacy|0|||
94431824|NCT00307437|323364679|FG003|After Controlled Period|Lack of Efficacy|15|||
94431825|NCT00307437|323364680|FG004|After Controlled Period|Lack of Efficacy|17|||
94431826|NCT00307437|323364681|FG005|After Controlled Period|Lack of Efficacy|37|||
94431827|NCT00307437|323364682|FG006|After Controlled Period|Lack of Efficacy|24|||
94431828|NCT00307437|323364676|FG000|After Controlled Period|Lost to Follow-up|0|||
94431829|NCT00307437|323364677|FG001|After Controlled Period|Lost to Follow-up|0|||
94431830|NCT00307437|323364678|FG002|After Controlled Period|Lost to Follow-up|0|||
94431831|NCT00307437|323364679|FG003|After Controlled Period|Lost to Follow-up|7|||
94431832|NCT00307437|323364680|FG004|After Controlled Period|Lost to Follow-up|12|||
94431833|NCT00307437|323364681|FG005|After Controlled Period|Lost to Follow-up|13|||
94431834|NCT00307437|323364682|FG006|After Controlled Period|Lost to Follow-up|18|||
94431835|NCT00307437|323364676|FG000|After Controlled Period|Other|0|||
94431836|NCT00307437|323364677|FG001|After Controlled Period|Other|0|||
94431837|NCT00307437|323364678|FG002|After Controlled Period|Other|0|||
94431838|NCT00307437|323364679|FG003|After Controlled Period|Other|15|||
94431839|NCT00307437|323364680|FG004|After Controlled Period|Other|9|||
94431840|NCT00307437|323364681|FG005|After Controlled Period|Other|40|||
94431841|NCT00307437|323364682|FG006|After Controlled Period|Other|28|||
94431842|NCT04597632|323364683|FG000|Overall Study|Withdrawal by Subject|10|||
94431843|NCT04597632|323364683|FG000|Overall Study|Lost to Follow-up|1|||
94431844|NCT04597632|323364683|FG000|Overall Study|Death|1|||
94431845|NCT04597632|323364683|FG000|Overall Study|Adverse Event|5|||
94431846|NCT04844762|323364688|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
94431847|NCT04844762|323364689|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
94431848|NCT04844762|323364690|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
94431849|NCT04844762|323364691|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
94431850|NCT04844762|323364692|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
94431851|NCT04844762|323364693|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
94431852|NCT04844762|323364688|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
94431853|NCT04844762|323364689|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
94431854|NCT04844762|323364690|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
94431855|NCT04844762|323364691|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
94431856|NCT04844762|323364692|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
94431857|NCT04844762|323364693|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
94431858|NCT04844762|323364688|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
94431859|NCT04844762|323364689|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
94431860|NCT04844762|323364690|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
94431861|NCT04844762|323364691|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
94431862|NCT04844762|323364692|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
94431863|NCT04844762|323364693|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
94431864|NCT04844762|323364688|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
94431865|NCT04844762|323364689|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
94431866|NCT04844762|323364690|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
94431867|NCT04844762|323364691|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
94431868|NCT04844762|323364692|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
94431869|NCT04844762|323364693|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
94431870|NCT04844762|323364688|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
94431871|NCT04844762|323364689|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
94431872|NCT04844762|323364690|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
94431873|NCT04844762|323364691|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
94431874|NCT04844762|323364692|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
94431875|NCT04844762|323364693|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
94431876|NCT04844762|323364688|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
94431877|NCT04844762|323364689|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
94431878|NCT04844762|323364690|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
94431879|NCT04844762|323364691|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
94431880|NCT04844762|323364692|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
94431881|NCT04844762|323364693|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
94431882|NCT04844762|323364688|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
94431883|NCT04844762|323364689|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
94431884|NCT04844762|323364690|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
94431885|NCT04844762|323364691|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
94431886|NCT04844762|323364692|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
94431887|NCT04844762|323364693|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
94431888|NCT04844762|323364688|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
94431889|NCT04844762|323364689|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
94431890|NCT04844762|323364690|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
94431891|NCT04844762|323364691|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
94431892|NCT04844762|323364692|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
94431893|NCT04844762|323364693|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
94431894|NCT04844762|323364688|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
94431895|NCT04844762|323364689|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
94431896|NCT04844762|323364690|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
94431897|NCT04844762|323364691|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
94431898|NCT04844762|323364692|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
94431899|NCT04844762|323364693|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
94431900|NCT04844762|323364688|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
94431901|NCT04844762|323364689|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
94431902|NCT04844762|323364690|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
94431903|NCT04844762|323364691|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
94431904|NCT04844762|323364692|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
94431905|NCT04844762|323364693|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
94431906|NCT04844762|323364688|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
94431907|NCT04844762|323364689|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
94431908|NCT04844762|323364690|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
94431909|NCT04844762|323364691|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
94431910|NCT04844762|323364692|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
94431911|NCT04844762|323364693|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
94431912|NCT01464931|323364694|FG000|Overall Study|Withdrawal by Subject|1|||
94431913|NCT01464931|323364695|FG001|Overall Study|Withdrawal by Subject|0|||
94431914|NCT00839254|323364698|FG000|Overall Study|Protocol Violation|0|||
94431915|NCT00839254|323364699|FG001|Overall Study|Protocol Violation|1|||
94431916|NCT00839254|323364700|FG002|Overall Study|Protocol Violation|1|||
94431917|NCT00839254|323364701|FG003|Overall Study|Protocol Violation|1|||
94431918|NCT00839254|323364702|FG004|Overall Study|Protocol Violation|0|||
94431919|NCT00839254|323364703|FG005|Overall Study|Protocol Violation|0|||
94431920|NCT00839254|323364704|FG006|Overall Study|Protocol Violation|1|||
94431921|NCT00839254|323364705|FG007|Overall Study|Protocol Violation|2|||
94431922|NCT00839254|323364698|FG000|Overall Study|Physician Decision|0|||
94431923|NCT00839254|323364699|FG001|Overall Study|Physician Decision|1|||
94431924|NCT00839254|323364700|FG002|Overall Study|Physician Decision|0|||
94431925|NCT00839254|323364701|FG003|Overall Study|Physician Decision|0|||
94431926|NCT00839254|323364702|FG004|Overall Study|Physician Decision|0|||
94431927|NCT00839254|323364703|FG005|Overall Study|Physician Decision|0|||
94431928|NCT00839254|323364704|FG006|Overall Study|Physician Decision|0|||
94431929|NCT00839254|323364705|FG007|Overall Study|Physician Decision|1|||
94431930|NCT00839254|323364698|FG000|Overall Study|Wrong treatment number allocation|0|||
94431931|NCT00839254|323364699|FG001|Overall Study|Wrong treatment number allocation|1|||
94431932|NCT00839254|323364700|FG002|Overall Study|Wrong treatment number allocation|0|||
94431933|NCT00839254|323364701|FG003|Overall Study|Wrong treatment number allocation|0|||
94431934|NCT00839254|323364702|FG004|Overall Study|Wrong treatment number allocation|0|||
94431935|NCT00839254|323364703|FG005|Overall Study|Wrong treatment number allocation|1|||
94431936|NCT00839254|323364704|FG006|Overall Study|Wrong treatment number allocation|0|||
94431937|NCT00839254|323364705|FG007|Overall Study|Wrong treatment number allocation|0|||
94431938|NCT00839254|323364698|FG000|Overall Study|Adverse Event|12|||
94431939|NCT00839254|323364699|FG001|Overall Study|Adverse Event|6|||
94431940|NCT00839254|323364700|FG002|Overall Study|Adverse Event|3|||
94431941|NCT00839254|323364701|FG003|Overall Study|Adverse Event|5|||
94431942|NCT00839254|323364702|FG004|Overall Study|Adverse Event|2|||
94431943|NCT00839254|323364703|FG005|Overall Study|Adverse Event|1|||
94431944|NCT00839254|323364704|FG006|Overall Study|Adverse Event|0|||
94431945|NCT00839254|323364705|FG007|Overall Study|Adverse Event|1|||
94431946|NCT00839254|323364698|FG000|Overall Study|Withdrawal by Subject|87|||
94431947|NCT00839254|323364699|FG001|Overall Study|Withdrawal by Subject|53|||
94431948|NCT00839254|323364700|FG002|Overall Study|Withdrawal by Subject|54|||
94431949|NCT00839254|323364701|FG003|Overall Study|Withdrawal by Subject|32|||
94431950|NCT00839254|323364702|FG004|Overall Study|Withdrawal by Subject|27|||
94431951|NCT00839254|323364703|FG005|Overall Study|Withdrawal by Subject|15|||
94431952|NCT00839254|323364704|FG006|Overall Study|Withdrawal by Subject|22|||
94431953|NCT00839254|323364705|FG007|Overall Study|Withdrawal by Subject|9|||
94431954|NCT00839254|323364698|FG000|Overall Study|Wrong group allocation|0|||
94431955|NCT00839254|323364699|FG001|Overall Study|Wrong group allocation|0|||
94431956|NCT00839254|323364700|FG002|Overall Study|Wrong group allocation|0|||
94431957|NCT00839254|323364701|FG003|Overall Study|Wrong group allocation|0|||
94431958|NCT00839254|323364702|FG004|Overall Study|Wrong group allocation|0|||
94431959|NCT00839254|323364703|FG005|Overall Study|Wrong group allocation|0|||
94431960|NCT00839254|323364704|FG006|Overall Study|Wrong group allocation|1|||
94431961|NCT00839254|323364705|FG007|Overall Study|Wrong group allocation|0|||
94431962|NCT00839254|323364698|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
94431963|NCT00839254|323364699|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
94431964|NCT00839254|323364700|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
94431965|NCT00839254|323364701|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
94431966|NCT00839254|323364702|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
94431967|NCT00839254|323364703|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
94431968|NCT00839254|323364704|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
94431969|NCT00839254|323364705|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
94431970|NCT00839254|323364698|FG000|Overall Study|Withdrawn due to non-compliance|2|||
94431971|NCT00839254|323364699|FG001|Overall Study|Withdrawn due to non-compliance|0|||
94431972|NCT00839254|323364700|FG002|Overall Study|Withdrawn due to non-compliance|0|||
94431973|NCT00839254|323364701|FG003|Overall Study|Withdrawn due to non-compliance|0|||
94431974|NCT00839254|323364702|FG004|Overall Study|Withdrawn due to non-compliance|0|||
94431975|NCT00839254|323364703|FG005|Overall Study|Withdrawn due to non-compliance|0|||
94431976|NCT00839254|323364704|FG006|Overall Study|Withdrawn due to non-compliance|0|||
94431977|NCT00839254|323364705|FG007|Overall Study|Withdrawn due to non-compliance|0|||
94431978|NCT00839254|323364698|FG000|Overall Study|Lost to Follow-up|51|||
94431979|NCT00839254|323364699|FG001|Overall Study|Lost to Follow-up|30|||
94431980|NCT00839254|323364700|FG002|Overall Study|Lost to Follow-up|32|||
94431981|NCT00839254|323364701|FG003|Overall Study|Lost to Follow-up|24|||
94431982|NCT00839254|323364702|FG004|Overall Study|Lost to Follow-up|8|||
94431983|NCT00839254|323364703|FG005|Overall Study|Lost to Follow-up|8|||
94431984|NCT00839254|323364704|FG006|Overall Study|Lost to Follow-up|4|||
94431985|NCT00839254|323364705|FG007|Overall Study|Lost to Follow-up|2|||
94431986|NCT04123561|323364706|FG000|Overall Study|Lost to Follow-up|20|||
94431987|NCT04123561|323364707|FG001|Overall Study|Lost to Follow-up|12|||
94431988|NCT04123561|323364708|FG002|Overall Study|Lost to Follow-up|5|||
94431989|NCT04123561|323364706|FG000|Overall Study|Withdrawal by Subject|9|||
94431990|NCT04123561|323364707|FG001|Overall Study|Withdrawal by Subject|7|||
94431991|NCT04123561|323364708|FG002|Overall Study|Withdrawal by Subject|9|||
94431992|NCT04123561|323364706|FG000|Overall Study|Lack of Efficacy|7|||
94431993|NCT04123561|323364707|FG001|Overall Study|Lack of Efficacy|8|||
94431994|NCT04123561|323364708|FG002|Overall Study|Lack of Efficacy|6|||
94431995|NCT04123561|323364706|FG000|Overall Study|Adverse Event|5|||
94431996|NCT04123561|323364707|FG001|Overall Study|Adverse Event|2|||
94431997|NCT04123561|323364708|FG002|Overall Study|Adverse Event|3|||
94431998|NCT04123561|323364706|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
94431999|NCT04123561|323364707|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
94490072|NCT01922934|323588356|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
94490073|NCT01922934|323588355|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
94490074|NCT01922934|323588356|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
94432000|NCT04123561|323364708|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
94432001|NCT04123561|323364706|FG000|Overall Study|Death|0|||
94432002|NCT04123561|323364707|FG001|Overall Study|Death|0|||
94432003|NCT04123561|323364708|FG002|Overall Study|Death|1|||
94432004|NCT04123561|323364706|FG000|Overall Study|Protocol Violation|0|||
94432005|NCT04123561|323364707|FG001|Overall Study|Protocol Violation|1|||
94432006|NCT04123561|323364708|FG002|Overall Study|Protocol Violation|0|||
94432007|NCT01320150|323364709|FG000|Overall Study|Protocol Violation|15|||
94432008|NCT01320150|323364709|FG000|Overall Study|Withdrawal by Subject|5|||
94432009|NCT01320150|323364709|FG000|Overall Study|Death|2|||
94432010|NCT01320150|323364709|FG000|Overall Study|Lost to Follow-up|44|||
94432011|NCT02766283|323364710|FG000|Overall Study|Lost to Follow-up|27|||
94432012|NCT00721227|323364711|FG000|Overall Study|Lost to Follow-up|3|||
94432013|NCT00721227|323364712|FG001|Overall Study|Lost to Follow-up|0|||
94432014|NCT00721227|323364711|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
94432015|NCT00721227|323364712|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
94432016|NCT01653912|323364713|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
94432017|NCT01653912|323364714|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
94432018|NCT01653912|323364715|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
94432019|NCT01653912|323364716|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
94432020|NCT01653912|323364717|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
94432021|NCT01653912|323364718|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
94432022|NCT01653912|323364713|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
94432023|NCT01653912|323364714|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
94432024|NCT01653912|323364715|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
94432025|NCT01653912|323364716|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
94432026|NCT01653912|323364717|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
94432027|NCT01653912|323364718|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
94432028|NCT01653912|323364713|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
94432029|NCT01653912|323364714|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
94432030|NCT01653912|323364715|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
94432031|NCT01653912|323364716|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
94432032|NCT01653912|323364717|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
94432033|NCT01653912|323364718|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
94432034|NCT01653912|323364713|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
94432035|NCT01653912|323364714|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
94432036|NCT01653912|323364715|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
94432037|NCT01653912|323364716|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
94432038|NCT01653912|323364717|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
94432039|NCT01653912|323364718|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
94432040|NCT01653912|323364713|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
94432041|NCT01653912|323364714|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
94432042|NCT01653912|323364715|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
94432043|NCT01653912|323364716|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
94432044|NCT01653912|323364717|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
94432045|NCT01653912|323364718|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
94432046|NCT01653912|323364713|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
94432047|NCT01653912|323364714|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
94432048|NCT01653912|323364715|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
94432049|NCT01653912|323364716|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
94432050|NCT01653912|323364717|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
94432051|NCT01653912|323364718|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
94432052|NCT01653912|323364713|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
94432053|NCT01653912|323364714|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
94432054|NCT01653912|323364715|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
94432055|NCT01653912|323364716|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
94432056|NCT01653912|323364717|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
94432057|NCT01653912|323364718|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
94432058|NCT02447744|323364719|FG000|Overall Study|Withdrawal by Subject|3|||
94432059|NCT02447744|323364720|FG001|Overall Study|Withdrawal by Subject|1|||
94432060|NCT02447744|323364719|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
94432061|NCT02447744|323364720|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
94432062|NCT00912912|323364721|FG000|Overall Study|Withdrawal by Subject|1|||
94432063|NCT00912912|323364721|FG000|Overall Study|Disease Progression|3|||
94432064|NCT00805467|323367538|FG000|Overall Study|Lack of Efficacy|0|||
94432065|NCT00805467|323367539|FG001|Overall Study|Lack of Efficacy|8|||
94432066|NCT00805467|323367540|FG002|Overall Study|Lack of Efficacy|13|||
94432067|NCT00805467|323367541|FG003|Overall Study|Lack of Efficacy|86|||
94432068|NCT00805467|323367538|FG000|Overall Study|Lost to Follow-up|0|||
94432069|NCT00805467|323367539|FG001|Overall Study|Lost to Follow-up|1|||
94432070|NCT00805467|323367540|FG002|Overall Study|Lost to Follow-up|7|||
94432071|NCT00805467|323367541|FG003|Overall Study|Lost to Follow-up|21|||
94432072|NCT00805467|323367538|FG000|Overall Study|Withdrawal by Subject|0|||
94432073|NCT00805467|323367539|FG001|Overall Study|Withdrawal by Subject|6|||
94432074|NCT00805467|323367540|FG002|Overall Study|Withdrawal by Subject|45|||
94432075|NCT00805467|323367541|FG003|Overall Study|Withdrawal by Subject|50|||
94432076|NCT00805467|323367538|FG000|Overall Study|Protocol Violation|0|||
94432077|NCT00805467|323367539|FG001|Overall Study|Protocol Violation|3|||
94432078|NCT00805467|323367540|FG002|Overall Study|Protocol Violation|0|||
94432079|NCT00805467|323367541|FG003|Overall Study|Protocol Violation|5|||
94432080|NCT00805467|323367538|FG000|Overall Study|Adverse Event|0|||
94432081|NCT00805467|323367539|FG001|Overall Study|Adverse Event|13|||
94432082|NCT00805467|323367540|FG002|Overall Study|Adverse Event|26|||
94432083|NCT00805467|323367541|FG003|Overall Study|Adverse Event|57|||
94432084|NCT00805467|323367538|FG000|Overall Study|Death|0|||
94432085|NCT00805467|323367539|FG001|Overall Study|Death|2|||
94432086|NCT00805467|323367540|FG002|Overall Study|Death|7|||
94432087|NCT00805467|323367541|FG003|Overall Study|Death|5|||
94432088|NCT00805467|323367538|FG000|Overall Study|Physician Decision|0|||
94432089|NCT00805467|323367539|FG001|Overall Study|Physician Decision|1|||
94432090|NCT00805467|323367540|FG002|Overall Study|Physician Decision|2|||
94432091|NCT00805467|323367541|FG003|Overall Study|Physician Decision|6|||
94432092|NCT00805467|323367538|FG000|Overall Study|Not reported|0|||
94432093|NCT00805467|323367539|FG001|Overall Study|Not reported|0|||
94432094|NCT00805467|323367540|FG002|Overall Study|Not reported|3|||
94432095|NCT00805467|323367541|FG003|Overall Study|Not reported|7|||
94432096|NCT01908907|323367542|FG000|Overall Study|Physician Decision|1|||
94432097|NCT01908907|323367543|FG001|Overall Study|Physician Decision|0|||
94432098|NCT01908907|323367542|FG000|Overall Study|Protocol Violation|1|||
94432099|NCT01908907|323367543|FG001|Overall Study|Protocol Violation|0|||
94432100|NCT04975191|323367544|FG000|Overall Study|Protocol Violation|1|||
94432101|NCT04975191|323367545|FG001|Overall Study|Protocol Violation|2|||
94432102|NCT04975191|323367546|FG002|Overall Study|Protocol Violation|2|||
94432103|NCT04975191|323367547|FG003|Overall Study|Protocol Violation|2|||
94432104|NCT04975191|323367544|FG000|Overall Study|Lost to Follow-up|13|||
94432105|NCT04975191|323367545|FG001|Overall Study|Lost to Follow-up|3|||
94432106|NCT04975191|323367546|FG002|Overall Study|Lost to Follow-up|8|||
94432107|NCT04975191|323367547|FG003|Overall Study|Lost to Follow-up|8|||
94432108|NCT02929056|323367553|FG000|Overall Study|Lost to Follow-up|0|||
94432109|NCT02929056|323367554|FG001|Overall Study|Lost to Follow-up|1|||
94432110|NCT02245412|323367555|FG000|Treatment Period|Death|1|||
94432111|NCT02245412|323367556|FG001|Treatment Period|Death|1|||
94432112|NCT02245412|323367557|FG002|Treatment Period|Death|0|||
94432113|NCT02245412|323367555|FG000|Treatment Period|Physician Decision|1|||
94432114|NCT02245412|323367556|FG001|Treatment Period|Physician Decision|1|||
94432115|NCT02245412|323367557|FG002|Treatment Period|Physician Decision|0|||
94432116|NCT02245412|323367555|FG000|Treatment Period|Withdrawal by Subject|2|||
94432117|NCT02245412|323367556|FG001|Treatment Period|Withdrawal by Subject|1|||
94432118|NCT02245412|323367557|FG002|Treatment Period|Withdrawal by Subject|0|||
94432119|NCT02245412|323367555|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
94432120|NCT02245412|323367556|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
94432121|NCT02245412|323367557|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
94432122|NCT02245412|323367555|FG000|Follow-Up Period|Death|4|||
94432123|NCT02245412|323367556|FG001|Follow-Up Period|Death|2|||
94432124|NCT02245412|323367557|FG002|Follow-Up Period|Death|1|||
94432125|NCT02245412|323367555|FG000|Follow-Up Period|Physician Decision|1|||
94432126|NCT02245412|323367556|FG001|Follow-Up Period|Physician Decision|0|||
94432127|NCT02245412|323367557|FG002|Follow-Up Period|Physician Decision|0|||
94432128|NCT02245412|323367555|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
94432129|NCT02245412|323367556|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
94432130|NCT02245412|323367557|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
94432131|NCT01056289|323367558|FG000|Open-label Phase|Adverse Event|29|||
94432132|NCT01056289|323367559|FG001|Open-label Phase|Adverse Event|0|||
94432133|NCT01056289|323367560|FG002|Open-label Phase|Adverse Event|0|||
94432134|NCT01056289|323367561|FG003|Open-label Phase|Adverse Event|0|||
94432135|NCT01056289|323367558|FG000|Open-label Phase|Lost to Follow-up|30|||
94432136|NCT01056289|323367559|FG001|Open-label Phase|Lost to Follow-up|0|||
94432137|NCT01056289|323367560|FG002|Open-label Phase|Lost to Follow-up|0|||
94432138|NCT01056289|323367561|FG003|Open-label Phase|Lost to Follow-up|0|||
94432139|NCT01056289|323367558|FG000|Open-label Phase|Other|9|||
94432140|NCT01056289|323367559|FG001|Open-label Phase|Other|0|||
94432141|NCT01056289|323367560|FG002|Open-label Phase|Other|0|||
94432142|NCT01056289|323367561|FG003|Open-label Phase|Other|0|||
94432143|NCT01056289|323367558|FG000|Open-label Phase|Protocol Violation|6|||
94432144|NCT01056289|323367559|FG001|Open-label Phase|Protocol Violation|0|||
94432145|NCT01056289|323367560|FG002|Open-label Phase|Protocol Violation|0|||
94432146|NCT01056289|323367561|FG003|Open-label Phase|Protocol Violation|0|||
94432147|NCT01056289|323367558|FG000|Open-label Phase|Withdrawal by Subject|26|||
94432148|NCT01056289|323367559|FG001|Open-label Phase|Withdrawal by Subject|0|||
94432149|NCT01056289|323367560|FG002|Open-label Phase|Withdrawal by Subject|0|||
94432150|NCT01056289|323367561|FG003|Open-label Phase|Withdrawal by Subject|0|||
94432151|NCT01056289|323367558|FG000|Open-label Phase|Lack of Efficacy|18|||
94432152|NCT01056289|323367559|FG001|Open-label Phase|Lack of Efficacy|0|||
94432153|NCT01056289|323367560|FG002|Open-label Phase|Lack of Efficacy|0|||
94432154|NCT01056289|323367561|FG003|Open-label Phase|Lack of Efficacy|0|||
94432155|NCT01056289|323367558|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
94432156|NCT01056289|323367559|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
94432157|NCT01056289|323367560|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
94432158|NCT01056289|323367561|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
94432159|NCT01056289|323367558|FG000|Double-blind Phase|Adverse Event|0|||
94432160|NCT01056289|323367559|FG001|Double-blind Phase|Adverse Event|1|||
94432161|NCT01056289|323367560|FG002|Double-blind Phase|Adverse Event|2|||
94432162|NCT01056289|323367561|FG003|Double-blind Phase|Adverse Event|1|||
94432163|NCT01056289|323367558|FG000|Double-blind Phase|Lost to Follow-up|0|||
94432164|NCT01056289|323367559|FG001|Double-blind Phase|Lost to Follow-up|2|||
94432165|NCT01056289|323367560|FG002|Double-blind Phase|Lost to Follow-up|2|||
94432166|NCT01056289|323367561|FG003|Double-blind Phase|Lost to Follow-up|2|||
94432167|NCT01056289|323367558|FG000|Double-blind Phase|Other|0|||
94432168|NCT01056289|323367559|FG001|Double-blind Phase|Other|0|||
94432169|NCT01056289|323367560|FG002|Double-blind Phase|Other|1|||
94432170|NCT01056289|323367561|FG003|Double-blind Phase|Other|2|||
94432171|NCT01056289|323367558|FG000|Double-blind Phase|Protocol Violation|0|||
94432172|NCT01056289|323367559|FG001|Double-blind Phase|Protocol Violation|0|||
94432173|NCT01056289|323367560|FG002|Double-blind Phase|Protocol Violation|1|||
94432174|NCT01056289|323367561|FG003|Double-blind Phase|Protocol Violation|1|||
94432175|NCT01056289|323367558|FG000|Double-blind Phase|Withdrawal by Subject|0|||
94432176|NCT01056289|323367559|FG001|Double-blind Phase|Withdrawal by Subject|0|||
94432177|NCT01056289|323367560|FG002|Double-blind Phase|Withdrawal by Subject|4|||
94432178|NCT01056289|323367561|FG003|Double-blind Phase|Withdrawal by Subject|2|||
94432179|NCT01056289|323367558|FG000|Double-blind Phase|Discontinuation symptom|0|||
94432180|NCT01056289|323367559|FG001|Double-blind Phase|Discontinuation symptom|1|||
94432181|NCT01056289|323367560|FG002|Double-blind Phase|Discontinuation symptom|2|||
94432182|NCT01056289|323367561|FG003|Double-blind Phase|Discontinuation symptom|2|||
94432183|NCT01056289|323367558|FG000|Double-blind Phase|Physician Decision|0|||
94432184|NCT01056289|323367559|FG001|Double-blind Phase|Physician Decision|0|||
94432185|NCT01056289|323367560|FG002|Double-blind Phase|Physician Decision|1|||
94432186|NCT01056289|323367561|FG003|Double-blind Phase|Physician Decision|0|||
94432187|NCT02925403|323367567|FG000|Overall Study|Lost to Follow-up|0|||
94432188|NCT02925403|323367568|FG001|Overall Study|Lost to Follow-up|1|||
94432189|NCT00369486|323367569|FG000|4-Week Visit|Missed visit|2|||
94432190|NCT00369486|323367570|FG001|4-Week Visit|Missed visit|2|||
94432191|NCT00369486|323367571|FG002|4-Week Visit|Missed visit|0|||
94432192|NCT00369486|323367572|FG003|4-Week Visit|Missed visit|2|||
94432193|NCT00369486|323367573|FG004|4-Week Visit|Missed visit|1|||
94432194|NCT00369486|323367569|FG000|4-Week Visit|Dropped|0|||
94432195|NCT00369486|323367570|FG001|4-Week Visit|Dropped|0|||
94432196|NCT00369486|323367571|FG002|4-Week Visit|Dropped|1|||
94432197|NCT00369486|323367572|FG003|4-Week Visit|Dropped|0|||
94432198|NCT00369486|323367573|FG004|4-Week Visit|Dropped|0|||
94432199|NCT00369486|323367569|FG000|8-Week Visit|Missed visit|0|||
94432200|NCT00369486|323367570|FG001|8-Week Visit|Missed visit|1|||
94432201|NCT00369486|323367571|FG002|8-Week Visit|Missed visit|0|||
94432202|NCT00369486|323367572|FG003|8-Week Visit|Missed visit|0|||
94432203|NCT00369486|323367573|FG004|8-Week Visit|Missed visit|1|||
94432204|NCT00369486|323367569|FG000|8-Week Visit|Dropped|0|||
94432205|NCT00369486|323367570|FG001|8-Week Visit|Dropped|0|||
94432206|NCT00369486|323367571|FG002|8-Week Visit|Dropped|0|||
94432207|NCT00369486|323367572|FG003|8-Week Visit|Dropped|1|||
94432208|NCT00369486|323367573|FG004|8-Week Visit|Dropped|0|||
94432209|NCT00369486|323367569|FG000|17-Week Visit|Missed visit|0|||
94432210|NCT00369486|323367570|FG001|17-Week Visit|Missed visit|0|||
94432211|NCT00369486|323367571|FG002|17-Week Visit|Missed visit|1|||
94432212|NCT00369486|323367572|FG003|17-Week Visit|Missed visit|1|||
94432213|NCT00369486|323367573|FG004|17-Week Visit|Missed visit|1|||
94432214|NCT00369486|323367569|FG000|34-Week Visit|Dropped|0|||
94432215|NCT00369486|323367570|FG001|34-Week Visit|Dropped|1|||
94432216|NCT00369486|323367571|FG002|34-Week Visit|Dropped|1|||
94432217|NCT00369486|323367572|FG003|34-Week Visit|Dropped|3|||
94432218|NCT00369486|323367573|FG004|34-Week Visit|Dropped|3|||
94432219|NCT01957397|323367578|FG000|Test Period 1|sudden leakage/small bag|1|||
94432220|NCT01957397|323367579|FG001|Test Period 1|sudden leakage/small bag|1|||
94432221|NCT01957397|323367578|FG000|Test Period 1|Withdrawal by Subject|1|||
94432222|NCT01957397|323367579|FG001|Test Period 1|Withdrawal by Subject|0|||
94432223|NCT01957397|323367578|FG000|Test Period 2|Adverse Event|0|||
94432224|NCT01957397|323367579|FG001|Test Period 2|Adverse Event|1|||
94432225|NCT01957397|323367578|FG000|Test Period 3|Adverse Event|1|||
94432226|NCT01957397|323367579|FG001|Test Period 3|Adverse Event|2|||
94432227|NCT01957397|323367578|FG000|Test Period 3|the adhesive did not work|1|||
94432228|NCT01957397|323367579|FG001|Test Period 3|the adhesive did not work|0|||
94432229|NCT00450801|323367581|FG000|Overall Study|Death|1|||
94432230|NCT03452137|323367582|FG000|Overall Study|Death|67|||
94432231|NCT03452137|323367583|FG001|Overall Study|Death|70|||
94432232|NCT03452137|323367582|FG000|Overall Study|Lost to Follow-up|4|||
94432233|NCT03452137|323367583|FG001|Overall Study|Lost to Follow-up|2|||
94432234|NCT03452137|323367582|FG000|Overall Study|Physician Decision|0|||
94432235|NCT03452137|323367583|FG001|Overall Study|Physician Decision|1|||
94432236|NCT03452137|323367582|FG000|Overall Study|Study Terminated by Sponsor|120|||
94432237|NCT03452137|323367583|FG001|Overall Study|Study Terminated by Sponsor|121|||
94432238|NCT03452137|323367582|FG000|Overall Study|Withdrawal by Subject|12|||
94432239|NCT03452137|323367583|FG001|Overall Study|Withdrawal by Subject|9|||
94432240|NCT02864992|323367584|FG000|Overall Study|still on treatment|15|||
94432241|NCT02864992|323367585|FG001|Overall Study|still on treatment|1|||
94432242|NCT02864992|323367586|FG002|Overall Study|still on treatment|33|||
94432243|NCT01810302|323367587|FG000|Overall Study|Death|1|||
94432244|NCT01810302|323367588|FG001|Overall Study|Death|0|||
94432245|NCT01810302|323367587|FG000|Overall Study|Physician Decision|0|||
94432246|NCT01810302|323367588|FG001|Overall Study|Physician Decision|1|||
94432247|NCT02856802|323367589|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
94432248|NCT02856802|323367590|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
94432249|NCT02856802|323367589|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
94432250|NCT02856802|323367590|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
94432251|NCT02856802|323367589|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
94432252|NCT02856802|323367590|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
94432253|NCT02856802|323367589|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
94432254|NCT02856802|323367590|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
94432255|NCT02856802|323367589|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
94432256|NCT02856802|323367590|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
94432257|NCT02856802|323367589|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
94432258|NCT02856802|323367590|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
94432259|NCT04138043|323367591|FG000|Overall Study|Withdrawal by Subject|0|||
94432260|NCT04138043|323367592|FG001|Overall Study|Withdrawal by Subject|1|||
94432261|NCT03772717|323367593|FG000|Overall Study|Withdrawal by Subject|2|||
94432262|NCT00587860|323367594|FG000|Overall Study|Lost to Follow-up|2|||
94432263|NCT00587860|323367595|FG001|Overall Study|Lost to Follow-up|2|||
94432264|NCT00587860|323367594|FG000|Overall Study|Withdrawal by Subject|3|||
94432265|NCT00587860|323367595|FG001|Overall Study|Withdrawal by Subject|3|||
94432266|NCT01396512|323367599|FG000|Overall Study|Withdrawal by Subject|0|||
94432267|NCT01396512|323367600|FG001|Overall Study|Withdrawal by Subject|1|||
94432268|NCT02618759|323367601|FG000|Overall Study|Lost to Follow-up|0|||
94432269|NCT02618759|323367602|FG001|Overall Study|Lost to Follow-up|1|||
94432270|NCT02618759|323367601|FG000|Overall Study|Withdrawal by Subject|1|||
94432271|NCT02618759|323367602|FG001|Overall Study|Withdrawal by Subject|0|||
94432272|NCT02618759|323367601|FG000|Overall Study|Other Reasons|1|||
94432273|NCT02618759|323367602|FG001|Overall Study|Other Reasons|4|||
94432274|NCT02152605|323367603|FG000|Overall Study|Adverse Event|6|||
94432275|NCT02152605|323367604|FG001|Overall Study|Adverse Event|8|||
94432276|NCT02152605|323367603|FG000|Overall Study|Lack of Efficacy|7|||
94432277|NCT02152605|323367604|FG001|Overall Study|Lack of Efficacy|4|||
94432278|NCT02152605|323367603|FG000|Overall Study|Protocol deviation|1|||
94432279|NCT02152605|323367604|FG001|Overall Study|Protocol deviation|4|||
94432280|NCT02152605|323367603|FG000|Overall Study|Lost to Follow-up|1|||
94432281|NCT02152605|323367604|FG001|Overall Study|Lost to Follow-up|0|||
94432282|NCT02152605|323367603|FG000|Overall Study|Withdrew consent|4|||
94432283|NCT02152605|323367604|FG001|Overall Study|Withdrew consent|2|||
94432284|NCT02699684|323367605|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
94432285|NCT02699684|323367606|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
94432286|NCT01145508|323367607|FG000|Overall Study|Adverse Event|1|||
94432287|NCT01145508|323367608|FG001|Overall Study|Adverse Event|0|||
94432288|NCT01145508|323367607|FG000|Overall Study|Death|1|||
94432289|NCT01145508|323367608|FG001|Overall Study|Death|0|||
94432290|NCT01145508|323367607|FG000|Overall Study|Physician Decision|2|||
94432291|NCT01145508|323367608|FG001|Overall Study|Physician Decision|1|||
94432292|NCT01145508|323367607|FG000|Overall Study|Never started treatment|1|||
94432293|NCT01145508|323367608|FG001|Overall Study|Never started treatment|1|||
94432294|NCT01421511|323367615|FG000|Overall Study|Lost to Follow-up|11|||
94432295|NCT01421511|323367616|FG001|Overall Study|Lost to Follow-up|14|||
94432296|NCT01421511|323367615|FG000|Overall Study|Randomized but didn't receive study drug|1|||
94432297|NCT01421511|323367616|FG001|Overall Study|Randomized but didn't receive study drug|7|||
94432298|NCT01421511|323367615|FG000|Overall Study|Physician Decision|0|||
94432299|NCT01421511|323367616|FG001|Overall Study|Physician Decision|1|||
94432300|NCT01421511|323367615|FG000|Overall Study|Withdrawal by Subject|6|||
94432301|NCT01421511|323367616|FG001|Overall Study|Withdrawal by Subject|5|||
94432302|NCT01421511|323367615|FG000|Overall Study|Death|1|||
94432303|NCT01421511|323367616|FG001|Overall Study|Death|1|||
94432304|NCT02954991|323367619|FG000|Overall Study|Death|92|||
94432305|NCT02954991|323367620|FG001|Overall Study|Death|11|||
94432306|NCT02954991|323367621|FG002|Overall Study|Death|2|||
94432307|NCT02954991|323367619|FG000|Overall Study|Lost to Follow-up|3|||
94432308|NCT02954991|323367620|FG001|Overall Study|Lost to Follow-up|2|||
94432309|NCT02954991|323367621|FG002|Overall Study|Lost to Follow-up|0|||
94432310|NCT02954991|323367619|FG000|Overall Study|Withdrawal by Subject|9|||
94432311|NCT02954991|323367620|FG001|Overall Study|Withdrawal by Subject|8|||
94432312|NCT02954991|323367621|FG002|Overall Study|Withdrawal by Subject|1|||
94432313|NCT02954991|323367619|FG000|Overall Study|Study Terminated by Sponsor|18|||
94432314|NCT02954991|323367620|FG001|Overall Study|Study Terminated by Sponsor|10|||
94432315|NCT02954991|323367621|FG002|Overall Study|Study Terminated by Sponsor|1|||
94432316|NCT02954991|323367619|FG000|Overall Study|Miscellaneous|2|||
94432317|NCT02954991|323367620|FG001|Overall Study|Miscellaneous|1|||
94432318|NCT02954991|323367621|FG002|Overall Study|Miscellaneous|1|||
94432319|NCT00576316|323367622|FG000|Overall Study|Adverse Event|9|||
94432320|NCT00576316|323367622|FG000|Overall Study|Withdrawal by Subject|2|||
94432321|NCT00576316|323367622|FG000|Overall Study|Protocol Violation|9|||
94432322|NCT01994291|323367623|FG000|Overall Study|Adverse Event|4|||
94432323|NCT01994291|323367624|FG001|Overall Study|Adverse Event|1|||
94432324|NCT01994291|323367625|FG002|Overall Study|Adverse Event|3|||
94432325|NCT01994291|323367623|FG000|Overall Study|Lost to Follow-up|1|||
94432326|NCT01994291|323367624|FG001|Overall Study|Lost to Follow-up|1|||
94432327|NCT01994291|323367625|FG002|Overall Study|Lost to Follow-up|0|||
94432328|NCT01994291|323367623|FG000|Overall Study|Does not meet entrance criteria|1|||
94432329|NCT01994291|323367624|FG001|Overall Study|Does not meet entrance criteria|0|||
94432330|NCT01994291|323367625|FG002|Overall Study|Does not meet entrance criteria|0|||
94432331|NCT01994291|323367623|FG000|Overall Study|Medication error without associated AE|1|||
94432332|NCT01994291|323367624|FG001|Overall Study|Medication error without associated AE|0|||
94432333|NCT01994291|323367625|FG002|Overall Study|Medication error without associated AE|1|||
94432334|NCT01994291|323367623|FG000|Overall Study|Protocol Violation|1|||
94432335|NCT01994291|323367624|FG001|Overall Study|Protocol Violation|0|||
94432336|NCT01994291|323367625|FG002|Overall Study|Protocol Violation|0|||
94432337|NCT01994291|323367623|FG000|Overall Study|Withdrawal by Subject|6|||
94432338|NCT01994291|323367624|FG001|Overall Study|Withdrawal by Subject|3|||
94432339|NCT01994291|323367625|FG002|Overall Study|Withdrawal by Subject|5|||
94432340|NCT01994291|323367623|FG000|Overall Study|Other|1|||
94432341|NCT01994291|323367624|FG001|Overall Study|Other|2|||
94432342|NCT01994291|323367625|FG002|Overall Study|Other|0|||
94432343|NCT00229723|323367634|FG000|Concomitant Phase|Adverse Event|4|||
94432344|NCT00229723|323367635|FG001|Concomitant Phase|Adverse Event|2|||
94432345|NCT00229723|323367636|FG002|Concomitant Phase|Adverse Event|5|||
94432346|NCT00229723|323367637|FG003|Concomitant Phase|Adverse Event|2|||
94432347|NCT00229723|323367638|FG004|Concomitant Phase|Adverse Event|0|||
94432348|NCT00229723|323367639|FG005|Concomitant Phase|Adverse Event|1|||
94432349|NCT00229723|323367640|FG006|Concomitant Phase|Adverse Event|2|||
94432350|NCT00229723|323367634|FG000|Concomitant Phase|Objective disease progression|0|||
94432351|NCT00229723|323367635|FG001|Concomitant Phase|Objective disease progression|0|||
94432352|NCT00229723|323367636|FG002|Concomitant Phase|Objective disease progression|0|||
94432353|NCT00229723|323367637|FG003|Concomitant Phase|Objective disease progression|0|||
94432354|NCT00229723|323367638|FG004|Concomitant Phase|Objective disease progression|0|||
94432355|NCT00229723|323367639|FG005|Concomitant Phase|Objective disease progression|0|||
94432356|NCT00229723|323367640|FG006|Concomitant Phase|Objective disease progression|0|||
94432357|NCT00229723|323367634|FG000|Concomitant Phase|Clinical progression|0|||
94432358|NCT00229723|323367635|FG001|Concomitant Phase|Clinical progression|0|||
94432359|NCT00229723|323367636|FG002|Concomitant Phase|Clinical progression|0|||
94432360|NCT00229723|323367637|FG003|Concomitant Phase|Clinical progression|0|||
94432361|NCT00229723|323367638|FG004|Concomitant Phase|Clinical progression|0|||
94432362|NCT00229723|323367639|FG005|Concomitant Phase|Clinical progression|0|||
94432363|NCT00229723|323367640|FG006|Concomitant Phase|Clinical progression|1|||
94432364|NCT00229723|323367634|FG000|Concomitant Phase|Lost to Follow-up|0|||
94432365|NCT00229723|323367635|FG001|Concomitant Phase|Lost to Follow-up|0|||
94432366|NCT00229723|323367636|FG002|Concomitant Phase|Lost to Follow-up|0|||
94432367|NCT00229723|323367637|FG003|Concomitant Phase|Lost to Follow-up|0|||
94432368|NCT00229723|323367638|FG004|Concomitant Phase|Lost to Follow-up|1|||
94432369|NCT00229723|323367639|FG005|Concomitant Phase|Lost to Follow-up|0|||
94432370|NCT00229723|323367640|FG006|Concomitant Phase|Lost to Follow-up|0|||
94432371|NCT00229723|323367634|FG000|Concomitant Phase|Informed consent withdrawn|3|||
94432372|NCT00229723|323367635|FG001|Concomitant Phase|Informed consent withdrawn|2|||
94432373|NCT00229723|323367636|FG002|Concomitant Phase|Informed consent withdrawn|0|||
94432374|NCT00229723|323367637|FG003|Concomitant Phase|Informed consent withdrawn|2|||
94432375|NCT00229723|323367638|FG004|Concomitant Phase|Informed consent withdrawn|0|||
94432376|NCT00229723|323367639|FG005|Concomitant Phase|Informed consent withdrawn|0|||
94432377|NCT00229723|323367640|FG006|Concomitant Phase|Informed consent withdrawn|0|||
94432378|NCT00229723|323367634|FG000|Concomitant Phase|Severe non-compliance|0|||
94432379|NCT00229723|323367635|FG001|Concomitant Phase|Severe non-compliance|1|||
94432380|NCT00229723|323367636|FG002|Concomitant Phase|Severe non-compliance|0|||
94432381|NCT00229723|323367637|FG003|Concomitant Phase|Severe non-compliance|0|||
94432382|NCT00229723|323367638|FG004|Concomitant Phase|Severe non-compliance|1|||
94432383|NCT00229723|323367639|FG005|Concomitant Phase|Severe non-compliance|0|||
94432384|NCT00229723|323367640|FG006|Concomitant Phase|Severe non-compliance|0|||
94432385|NCT00229723|323367634|FG000|Concomitant Phase|Other|3|||
94432386|NCT00229723|323367635|FG001|Concomitant Phase|Other|0|||
94432387|NCT00229723|323367636|FG002|Concomitant Phase|Other|1|||
94432388|NCT00229723|323367637|FG003|Concomitant Phase|Other|1|||
94432389|NCT00229723|323367638|FG004|Concomitant Phase|Other|0|||
94432390|NCT00229723|323367639|FG005|Concomitant Phase|Other|2|||
94432391|NCT00229723|323367640|FG006|Concomitant Phase|Other|0|||
94432392|NCT00229723|323367634|FG000|Maintenance Phase|Adverse Event|7|||
94432393|NCT00229723|323367635|FG001|Maintenance Phase|Adverse Event|2|||
94432394|NCT00229723|323367636|FG002|Maintenance Phase|Adverse Event|1|||
94432395|NCT00229723|323367637|FG003|Maintenance Phase|Adverse Event|4|||
94432396|NCT00229723|323367638|FG004|Maintenance Phase|Adverse Event|7|||
94432397|NCT00229723|323367639|FG005|Maintenance Phase|Adverse Event|5|||
94432398|NCT00229723|323367640|FG006|Maintenance Phase|Adverse Event|2|||
94432399|NCT00229723|323367634|FG000|Maintenance Phase|Objective disease progression|5|||
94432400|NCT00229723|323367635|FG001|Maintenance Phase|Objective disease progression|5|||
94432401|NCT00229723|323367636|FG002|Maintenance Phase|Objective disease progression|3|||
94432402|NCT00229723|323367637|FG003|Maintenance Phase|Objective disease progression|6|||
94432403|NCT00229723|323367638|FG004|Maintenance Phase|Objective disease progression|2|||
94432404|NCT00229723|323367639|FG005|Maintenance Phase|Objective disease progression|9|||
94432405|NCT00229723|323367640|FG006|Maintenance Phase|Objective disease progression|5|||
94432406|NCT00229723|323367634|FG000|Maintenance Phase|Clinical progression|4|||
94432407|NCT00229723|323367635|FG001|Maintenance Phase|Clinical progression|1|||
94432408|NCT00229723|323367636|FG002|Maintenance Phase|Clinical progression|2|||
94432409|NCT00229723|323367637|FG003|Maintenance Phase|Clinical progression|2|||
94432410|NCT00229723|323367638|FG004|Maintenance Phase|Clinical progression|1|||
94432411|NCT00229723|323367639|FG005|Maintenance Phase|Clinical progression|1|||
94432412|NCT00229723|323367640|FG006|Maintenance Phase|Clinical progression|1|||
94432413|NCT00229723|323367634|FG000|Maintenance Phase|Lost to Follow-up|0|||
94432414|NCT00229723|323367635|FG001|Maintenance Phase|Lost to Follow-up|1|||
94432415|NCT00229723|323367636|FG002|Maintenance Phase|Lost to Follow-up|2|||
94432416|NCT00229723|323367637|FG003|Maintenance Phase|Lost to Follow-up|2|||
94432417|NCT00229723|323367638|FG004|Maintenance Phase|Lost to Follow-up|0|||
94432418|NCT00229723|323367639|FG005|Maintenance Phase|Lost to Follow-up|0|||
94432419|NCT00229723|323367640|FG006|Maintenance Phase|Lost to Follow-up|1|||
94432420|NCT00229723|323367634|FG000|Maintenance Phase|Informed consent withdrawn|1|||
94432421|NCT00229723|323367635|FG001|Maintenance Phase|Informed consent withdrawn|0|||
94432422|NCT00229723|323367636|FG002|Maintenance Phase|Informed consent withdrawn|0|||
94432423|NCT00229723|323367637|FG003|Maintenance Phase|Informed consent withdrawn|1|||
94432424|NCT00229723|323367638|FG004|Maintenance Phase|Informed consent withdrawn|1|||
94432425|NCT00229723|323367639|FG005|Maintenance Phase|Informed consent withdrawn|1|||
94432426|NCT00229723|323367640|FG006|Maintenance Phase|Informed consent withdrawn|0|||
94432427|NCT00229723|323367634|FG000|Maintenance Phase|Severe non-compliance|3|||
94432428|NCT00229723|323367635|FG001|Maintenance Phase|Severe non-compliance|1|||
94432429|NCT00229723|323367636|FG002|Maintenance Phase|Severe non-compliance|0|||
94432430|NCT00229723|323367637|FG003|Maintenance Phase|Severe non-compliance|0|||
94432431|NCT00229723|323367638|FG004|Maintenance Phase|Severe non-compliance|1|||
94432432|NCT00229723|323367639|FG005|Maintenance Phase|Severe non-compliance|0|||
94432433|NCT00229723|323367640|FG006|Maintenance Phase|Severe non-compliance|0|||
94432434|NCT00229723|323367634|FG000|Maintenance Phase|Other|5|||
94432435|NCT00229723|323367635|FG001|Maintenance Phase|Other|4|||
94432436|NCT00229723|323367636|FG002|Maintenance Phase|Other|1|||
94432437|NCT00229723|323367637|FG003|Maintenance Phase|Other|2|||
94432438|NCT00229723|323367638|FG004|Maintenance Phase|Other|3|||
94432439|NCT00229723|323367639|FG005|Maintenance Phase|Other|3|||
94432440|NCT00229723|323367640|FG006|Maintenance Phase|Other|1|||
94432441|NCT00000620|323367641|FG000|Overall Study|Death|86|||
94432442|NCT00000620|323367642|FG001|Overall Study|Death|67|||
94432443|NCT00000620|323367643|FG002|Overall Study|Death|112|||
94432444|NCT00000620|323367644|FG003|Overall Study|Death|126|||
94432445|NCT00000620|323367645|FG004|Overall Study|Death|64|||
94432446|NCT00000620|323367646|FG005|Overall Study|Death|77|||
94432447|NCT00000620|323367647|FG006|Overall Study|Death|91|||
94432448|NCT00000620|323367648|FG007|Overall Study|Death|95|||
94432449|NCT00000620|323367641|FG000|Overall Study|Lost to Follow-up|14|||
94432450|NCT00000620|323367642|FG001|Overall Study|Lost to Follow-up|14|||
94432451|NCT00000620|323367643|FG002|Overall Study|Lost to Follow-up|14|||
94432452|NCT00000620|323367644|FG003|Overall Study|Lost to Follow-up|14|||
94432453|NCT00000620|323367645|FG004|Overall Study|Lost to Follow-up|15|||
94432454|NCT00000620|323367646|FG005|Overall Study|Lost to Follow-up|15|||
94432455|NCT00000620|323367647|FG006|Overall Study|Lost to Follow-up|13|||
94432456|NCT00000620|323367648|FG007|Overall Study|Lost to Follow-up|14|||
94432457|NCT00000620|323367641|FG000|Overall Study|Withdrawal by Subject|40|||
94432458|NCT00000620|323367642|FG001|Overall Study|Withdrawal by Subject|27|||
94432459|NCT00000620|323367643|FG002|Overall Study|Withdrawal by Subject|28|||
94432460|NCT00000620|323367644|FG003|Overall Study|Withdrawal by Subject|27|||
94432461|NCT00000620|323367645|FG004|Overall Study|Withdrawal by Subject|30|||
94432462|NCT00000620|323367646|FG005|Overall Study|Withdrawal by Subject|32|||
94432463|NCT00000620|323367647|FG006|Overall Study|Withdrawal by Subject|32|||
94432464|NCT00000620|323367648|FG007|Overall Study|Withdrawal by Subject|21|||
94432465|NCT00000620|323367641|FG000|Overall Study|missed closeout visit|22|||
94432466|NCT00000620|323367642|FG001|Overall Study|missed closeout visit|28|||
94432467|NCT00000620|323367643|FG002|Overall Study|missed closeout visit|16|||
94432468|NCT00000620|323367644|FG003|Overall Study|missed closeout visit|11|||
94432469|NCT00000620|323367645|FG004|Overall Study|missed closeout visit|26|||
94432470|NCT00000620|323367646|FG005|Overall Study|missed closeout visit|28|||
94432471|NCT00000620|323367647|FG006|Overall Study|missed closeout visit|13|||
94432472|NCT00000620|323367648|FG007|Overall Study|missed closeout visit|16|||
94432473|NCT01307111|323367652|FG000|IUD Insertion|Lost to Follow-up|2|||
94432474|NCT01307111|323367653|FG001|IUD Insertion|Lost to Follow-up|0|||
94432475|NCT01307111|323367652|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
94432476|NCT01307111|323367653|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
94432477|NCT02114385|323367656|FG000|Overall Study|Withdrawal by Subject|3|||
94432478|NCT02114385|323367657|FG001|Overall Study|Withdrawal by Subject|2|||
94432479|NCT02114385|323367656|FG000|Overall Study|Lost to Follow-up|0|||
94432480|NCT02114385|323367657|FG001|Overall Study|Lost to Follow-up|6|||
94432481|NCT00789035|323367660|FG000|Overall Study|Adverse Event|0|||
94432482|NCT00789035|323367661|FG001|Overall Study|Adverse Event|2|||
94432483|NCT00789035|323367662|FG002|Overall Study|Adverse Event|0|||
94432484|NCT00789035|323367663|FG003|Overall Study|Adverse Event|1|||
94432485|NCT00789035|323367664|FG004|Overall Study|Adverse Event|3|||
94432486|NCT00789035|323367660|FG000|Overall Study|Lack of Efficacy|3|||
94432487|NCT00789035|323367661|FG001|Overall Study|Lack of Efficacy|0|||
94432488|NCT00789035|323367662|FG002|Overall Study|Lack of Efficacy|0|||
94432489|NCT00789035|323367663|FG003|Overall Study|Lack of Efficacy|0|||
94432490|NCT00789035|323367664|FG004|Overall Study|Lack of Efficacy|2|||
94432491|NCT00789035|323367660|FG000|Overall Study|Protocol Violation|1|||
94432492|NCT00789035|323367661|FG001|Overall Study|Protocol Violation|0|||
94432493|NCT00789035|323367662|FG002|Overall Study|Protocol Violation|0|||
94432494|NCT00789035|323367663|FG003|Overall Study|Protocol Violation|0|||
94432495|NCT00789035|323367664|FG004|Overall Study|Protocol Violation|0|||
94432496|NCT00789035|323367660|FG000|Overall Study|Withdrawal by Subject|0|||
94432497|NCT00789035|323367661|FG001|Overall Study|Withdrawal by Subject|2|||
94432498|NCT00789035|323367662|FG002|Overall Study|Withdrawal by Subject|0|||
94432499|NCT00789035|323367663|FG003|Overall Study|Withdrawal by Subject|0|||
94432500|NCT00789035|323367664|FG004|Overall Study|Withdrawal by Subject|0|||
94432501|NCT00789035|323367660|FG000|Overall Study|Other reason not defined above|2|||
94432502|NCT00789035|323367661|FG001|Overall Study|Other reason not defined above|3|||
94432503|NCT00789035|323367662|FG002|Overall Study|Other reason not defined above|1|||
94432504|NCT00789035|323367663|FG003|Overall Study|Other reason not defined above|0|||
94432505|NCT00789035|323367664|FG004|Overall Study|Other reason not defined above|1|||
94432506|NCT01420965|323367667|FG000|Overall Study|Withdrawal by Subject|1|||
94432507|NCT01420965|323367668|FG001|Overall Study|Withdrawal by Subject|0|||
94432508|NCT01420965|323367669|FG002|Overall Study|Withdrawal by Subject|0|||
94432509|NCT01420965|323367667|FG000|Overall Study|Adverse Event|0|||
94432510|NCT01420965|323367668|FG001|Overall Study|Adverse Event|1|||
94432511|NCT01420965|323367669|FG002|Overall Study|Adverse Event|0|||
94432512|NCT00339144|323367702|FG000|Overall Study|Disease progression|5|||
94432513|NCT00339144|323367703|FG001|Overall Study|Disease progression|2|||
94432514|NCT00339144|323367704|FG002|Overall Study|Disease progression|2|||
94432515|NCT00339144|323367702|FG000|Overall Study|Study drug toxicity|3|||
94432516|NCT00339144|323367703|FG001|Overall Study|Study drug toxicity|1|||
94432517|NCT00339144|323367704|FG002|Overall Study|Study drug toxicity|1|||
94432518|NCT00339144|323367702|FG000|Overall Study|Participant's request to discontinuation|1|||
94432519|NCT00339144|323367703|FG001|Overall Study|Participant's request to discontinuation|0|||
94432520|NCT00339144|323367704|FG002|Overall Study|Participant's request to discontinuation|1|||
94432521|NCT01890434|323367705|FG000|Overall Study|Adverse Event|8|||
94432522|NCT01890434|323367705|FG000|Overall Study|PCI at external hospital|1|||
94432523|NCT01890434|323367705|FG000|Overall Study|Assessment discrepancy|1|||
94432524|NCT01890434|323367705|FG000|Overall Study|CRC didn't contact participant for FU|1|||
94432525|NCT01890434|323367705|FG000|Overall Study|Could not get whole set of images|1|||
94432526|NCT01890434|323367705|FG000|Overall Study|Decline to return for GSPECT|1|||
94432527|NCT01890434|323367705|FG000|Overall Study|GSPECT at rest was not done|1|||
94432528|NCT01890434|323367705|FG000|Overall Study|Participant didn't complete MRI|1|||
94432529|NCT01890434|323367705|FG000|Overall Study|Uncontactable by phone|1|||
94432530|NCT01890434|323367705|FG000|Overall Study|Moved out of position|1|||
94432531|NCT01890434|323367705|FG000|Overall Study|Unable to contact|1|||
94432532|NCT01890434|323367705|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
94432533|NCT00428116|323367706|FG000|Overall Study|Death|1|||
94432534|NCT00428116|323367707|FG001|Overall Study|Death|0|||
94432535|NCT00428116|323367706|FG000|Overall Study|Withdrawal by Subject|1|||
94432536|NCT00428116|323367707|FG001|Overall Study|Withdrawal by Subject|0|||
94432537|NCT00428116|323367706|FG000|Overall Study|Lost to Follow-up|1|||
94432538|NCT00428116|323367707|FG001|Overall Study|Lost to Follow-up|0|||
94432539|NCT02455518|323367708|FG000|Overall Study|Protocol Violation|0|||
94432540|NCT02455518|323367709|FG001|Overall Study|Protocol Violation|1|||
94432541|NCT02455518|323367710|FG002|Overall Study|Protocol Violation|1|||
94432542|NCT02455518|323367711|FG003|Overall Study|Protocol Violation|3|||
94432543|NCT02552732|323367715|FG000|Overall Study|Lost to Follow-up|2|||
94432544|NCT02552732|323367715|FG000|Overall Study|Physician Decision|1|||
94432545|NCT02552732|323367715|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
94432546|NCT02552732|323367715|FG000|Overall Study|Withdrawal by Subject|6|||
94432547|NCT02774642|323367716|FG000|Overall Study|Lost to Follow-up|9|||
94432548|NCT02774642|323367717|FG001|Overall Study|Lost to Follow-up|7|||
94432549|NCT02924727|323367727|FG000|Overall Study|Withdrawal by Subject|2|||
94432550|NCT02924727|323367728|FG001|Overall Study|Withdrawal by Subject|4|||
94432551|NCT02924727|323367727|FG000|Overall Study|Lost to Follow-up|2|||
94432552|NCT02924727|323367728|FG001|Overall Study|Lost to Follow-up|5|||
94432553|NCT02924727|323367727|FG000|Overall Study|Death|221|||
94432554|NCT02924727|323367728|FG001|Overall Study|Death|247|||
94432555|NCT02924727|323367727|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
94432556|NCT02924727|323367728|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
94432557|NCT02092467|323367729|FG000|Overall Study|Death|49|||
94432558|NCT02092467|323367730|FG001|Overall Study|Death|66|||
94432559|NCT02092467|323367731|FG002|Overall Study|Death|38|||
94432560|NCT02092467|323367729|FG000|Overall Study|Lost to Follow-up|38|||
94432561|NCT02092467|323367730|FG001|Overall Study|Lost to Follow-up|35|||
94432562|NCT02092467|323367731|FG002|Overall Study|Lost to Follow-up|40|||
94432563|NCT02092467|323367729|FG000|Overall Study|Global Deterioration of Health Status|1|||
94432564|NCT02092467|323367730|FG001|Overall Study|Global Deterioration of Health Status|0|||
94432565|NCT02092467|323367731|FG002|Overall Study|Global Deterioration of Health Status|0|||
94432566|NCT02092467|323367729|FG000|Overall Study|Other|32|||
94432567|NCT02092467|323367730|FG001|Overall Study|Other|30|||
94432568|NCT02092467|323367731|FG002|Overall Study|Other|24|||
94432569|NCT02092467|323367729|FG000|Overall Study|Withdrawal by Subject|282|||
94432570|NCT02092467|323367730|FG001|Overall Study|Withdrawal by Subject|327|||
94432571|NCT02092467|323367731|FG002|Overall Study|Withdrawal by Subject|289|||
94432572|NCT02092467|323367729|FG000|Overall Study|Randomized but not treated|2|||
94432573|NCT02092467|323367730|FG001|Overall Study|Randomized but not treated|1|||
94432574|NCT02092467|323367731|FG002|Overall Study|Randomized but not treated|7|||
94432575|NCT01982812|323367732|FG000|Overall Study|Death|1|||
94432576|NCT01982812|323367733|FG001|Overall Study|Death|5|||
94432577|NCT01982812|323367732|FG000|Overall Study|Adverse Event|0|||
94432578|NCT01982812|323367733|FG001|Overall Study|Adverse Event|5|||
94432579|NCT01823835|323367739|FG000|Overall Study|Adverse Event|0|||
94432580|NCT01823835|323367740|FG001|Overall Study|Adverse Event|0|||
94432581|NCT01823835|323367741|FG002|Overall Study|Adverse Event|0|||
94432582|NCT01823835|323367742|FG003|Overall Study|Adverse Event|0|||
94432583|NCT01823835|323367743|FG004|Overall Study|Adverse Event|1|||
94432584|NCT01823835|323367744|FG005|Overall Study|Adverse Event|0|||
94432585|NCT01823835|323367745|FG006|Overall Study|Adverse Event|1|||
94432586|NCT01823835|323367746|FG007|Overall Study|Adverse Event|0|||
94432587|NCT01823835|323367747|FG008|Overall Study|Adverse Event|0|||
94432588|NCT01823835|323367748|FG009|Overall Study|Adverse Event|0|||
94432589|NCT01823835|323367749|FG010|Overall Study|Adverse Event|1|||
94432590|NCT01823835|323367750|FG011|Overall Study|Adverse Event|2|||
94432591|NCT01823835|323367751|FG012|Overall Study|Adverse Event|0|||
94432592|NCT01823835|323367752|FG013|Overall Study|Adverse Event|0|||
94432593|NCT01823835|323367753|FG014|Overall Study|Adverse Event|0|||
94432594|NCT01823835|323367739|FG000|Overall Study|Physician Decision|0|||
94432595|NCT01823835|323367740|FG001|Overall Study|Physician Decision|0|||
94432596|NCT01823835|323367741|FG002|Overall Study|Physician Decision|0|||
94432597|NCT01823835|323367742|FG003|Overall Study|Physician Decision|0|||
94432598|NCT01823835|323367743|FG004|Overall Study|Physician Decision|0|||
94432599|NCT01823835|323367744|FG005|Overall Study|Physician Decision|0|||
94432600|NCT01823835|323367745|FG006|Overall Study|Physician Decision|0|||
94432601|NCT01823835|323367746|FG007|Overall Study|Physician Decision|0|||
94432602|NCT01823835|323367747|FG008|Overall Study|Physician Decision|0|||
94432603|NCT01823835|323367748|FG009|Overall Study|Physician Decision|0|||
94432604|NCT01823835|323367749|FG010|Overall Study|Physician Decision|0|||
94432605|NCT01823835|323367750|FG011|Overall Study|Physician Decision|2|||
94432606|NCT01823835|323367751|FG012|Overall Study|Physician Decision|0|||
94432607|NCT01823835|323367752|FG013|Overall Study|Physician Decision|0|||
94432608|NCT01823835|323367753|FG014|Overall Study|Physician Decision|0|||
94432609|NCT01823835|323367739|FG000|Overall Study|Progressive Disease|3|||
94432610|NCT01823835|323367740|FG001|Overall Study|Progressive Disease|4|||
94432611|NCT01823835|323367741|FG002|Overall Study|Progressive Disease|3|||
94432612|NCT01823835|323367742|FG003|Overall Study|Progressive Disease|6|||
94432613|NCT01823835|323367743|FG004|Overall Study|Progressive Disease|4|||
94490075|NCT01922934|323588355|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
94490076|NCT01922934|323588356|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
94490077|NCT01922934|323588355|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
94432614|NCT01823835|323367744|FG005|Overall Study|Progressive Disease|6|||
94432615|NCT01823835|323367745|FG006|Overall Study|Progressive Disease|5|||
94432616|NCT01823835|323367746|FG007|Overall Study|Progressive Disease|3|||
94432617|NCT01823835|323367747|FG008|Overall Study|Progressive Disease|3|||
94432618|NCT01823835|323367748|FG009|Overall Study|Progressive Disease|18|||
94432619|NCT01823835|323367749|FG010|Overall Study|Progressive Disease|8|||
94432620|NCT01823835|323367750|FG011|Overall Study|Progressive Disease|46|||
94432621|NCT01823835|323367751|FG012|Overall Study|Progressive Disease|18|||
94432622|NCT01823835|323367752|FG013|Overall Study|Progressive Disease|4|||
94432623|NCT01823835|323367753|FG014|Overall Study|Progressive Disease|6|||
94432624|NCT01823835|323367739|FG000|Overall Study|Study Termination|0|||
94432625|NCT01823835|323367740|FG001|Overall Study|Study Termination|0|||
94432626|NCT01823835|323367741|FG002|Overall Study|Study Termination|0|||
94432627|NCT01823835|323367742|FG003|Overall Study|Study Termination|0|||
94432628|NCT01823835|323367743|FG004|Overall Study|Study Termination|1|||
94432629|NCT01823835|323367744|FG005|Overall Study|Study Termination|0|||
94432630|NCT01823835|323367745|FG006|Overall Study|Study Termination|0|||
94432631|NCT01823835|323367746|FG007|Overall Study|Study Termination|0|||
94432632|NCT01823835|323367747|FG008|Overall Study|Study Termination|0|||
94432633|NCT01823835|323367748|FG009|Overall Study|Study Termination|0|||
94432634|NCT01823835|323367749|FG010|Overall Study|Study Termination|0|||
94432635|NCT01823835|323367750|FG011|Overall Study|Study Termination|1|||
94432636|NCT01823835|323367751|FG012|Overall Study|Study Termination|0|||
94432637|NCT01823835|323367752|FG013|Overall Study|Study Termination|0|||
94432638|NCT01823835|323367753|FG014|Overall Study|Study Termination|0|||
94432639|NCT01823835|323367739|FG000|Overall Study|Withdrawal by Subject|0|||
94432640|NCT01823835|323367740|FG001|Overall Study|Withdrawal by Subject|0|||
94432641|NCT01823835|323367741|FG002|Overall Study|Withdrawal by Subject|1|||
94432642|NCT01823835|323367742|FG003|Overall Study|Withdrawal by Subject|0|||
94432643|NCT01823835|323367743|FG004|Overall Study|Withdrawal by Subject|0|||
94432644|NCT01823835|323367744|FG005|Overall Study|Withdrawal by Subject|0|||
94432645|NCT01823835|323367745|FG006|Overall Study|Withdrawal by Subject|0|||
94432646|NCT01823835|323367746|FG007|Overall Study|Withdrawal by Subject|0|||
94432647|NCT01823835|323367747|FG008|Overall Study|Withdrawal by Subject|0|||
94432648|NCT01823835|323367748|FG009|Overall Study|Withdrawal by Subject|1|||
94432649|NCT01823835|323367749|FG010|Overall Study|Withdrawal by Subject|1|||
94432650|NCT01823835|323367750|FG011|Overall Study|Withdrawal by Subject|2|||
94432651|NCT01823835|323367751|FG012|Overall Study|Withdrawal by Subject|1|||
94432652|NCT01823835|323367752|FG013|Overall Study|Withdrawal by Subject|0|||
94432653|NCT01823835|323367753|FG014|Overall Study|Withdrawal by Subject|0|||
94432654|NCT03597464|323367758|FG000|Overall Study|Withdrawal by Subject|4|||
94432655|NCT03597464|323367759|FG001|Overall Study|Withdrawal by Subject|5|||
94432656|NCT03597464|323367758|FG000|Overall Study|Lost to Follow-up|3|||
94432657|NCT03597464|323367759|FG001|Overall Study|Lost to Follow-up|1|||
94432658|NCT03597464|323367758|FG000|Overall Study|Pregnancy|3|||
94432659|NCT03597464|323367759|FG001|Overall Study|Pregnancy|1|||
94432660|NCT03597464|323367758|FG000|Overall Study|Lack of Efficacy|2|||
94432661|NCT03597464|323367759|FG001|Overall Study|Lack of Efficacy|0|||
94432662|NCT03597464|323367758|FG000|Overall Study|Physician Decision|2|||
94432663|NCT03597464|323367759|FG001|Overall Study|Physician Decision|2|||
94432664|NCT03597464|323367758|FG000|Overall Study|Protocol Violation|1|||
94432665|NCT03597464|323367759|FG001|Overall Study|Protocol Violation|1|||
94432666|NCT03597464|323367758|FG000|Overall Study|Adverse Event|0|||
94432667|NCT03597464|323367759|FG001|Overall Study|Adverse Event|2|||
94432668|NCT03597464|323367758|FG000|Overall Study|Death|0|||
94432669|NCT03597464|323367759|FG001|Overall Study|Death|3|||
94432670|NCT02933255|323367762|FG000|Overall Study|Discontinued due to study closure.|1|||
94432671|NCT02933255|323367763|FG001|Overall Study|Discontinued due to study closure.|0|||
94432672|NCT00340678|323367769|FG000|Overall Study|Lost to Follow-up|1|||
94432673|NCT00340678|323367770|FG001|Overall Study|Lost to Follow-up|0|||
94432674|NCT00340678|323367771|FG002|Overall Study|Lost to Follow-up|0|||
94432675|NCT00340678|323367772|FG003|Overall Study|Lost to Follow-up|0|||
94432676|NCT00996892|323367773|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
94432677|NCT00996892|323367774|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
94432678|NCT00996892|323367775|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
94432679|NCT00996892|323367776|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
94432680|NCT00996892|323367777|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
94432681|NCT00996892|323367778|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
94432682|NCT00996892|323367779|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
94432683|NCT00996892|323367780|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
94432684|NCT00996892|323367781|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
94432685|NCT00996892|323367782|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
94432686|NCT00996892|323367783|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
94432687|NCT00996892|323367784|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
94432688|NCT00996892|323367785|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
94432689|NCT00996892|323367786|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
94432690|NCT00996892|323367787|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
94432691|NCT00996892|323367788|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
94432692|NCT00996892|323367789|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
94432693|NCT00996892|323367790|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
94432694|NCT00996892|323367791|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
94432695|NCT00996892|323367792|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
94432696|NCT00996892|323367773|FG000|Dose-Escalation Stage 1|Death|1|||
94432697|NCT00996892|323367774|FG001|Dose-Escalation Stage 1|Death|0|||
94432698|NCT00996892|323367775|FG002|Dose-Escalation Stage 1|Death|0|||
94432699|NCT00996892|323367776|FG003|Dose-Escalation Stage 1|Death|0|||
94432700|NCT00996892|323367777|FG004|Dose-Escalation Stage 1|Death|0|||
94432701|NCT00996892|323367778|FG005|Dose-Escalation Stage 1|Death|1|||
94432702|NCT00996892|323367779|FG006|Dose-Escalation Stage 1|Death|0|||
94432703|NCT00996892|323367780|FG007|Dose-Escalation Stage 1|Death|0|||
94432704|NCT00996892|323367781|FG008|Dose-Escalation Stage 1|Death|0|||
94432705|NCT00996892|323367782|FG009|Dose-Escalation Stage 1|Death|0|||
94432706|NCT00996892|323367783|FG010|Dose-Escalation Stage 1|Death|0|||
94432707|NCT00996892|323367784|FG011|Dose-Escalation Stage 1|Death|0|||
94432708|NCT00996892|323367785|FG012|Dose-Escalation Stage 1|Death|0|||
94432709|NCT00996892|323367786|FG013|Dose-Escalation Stage 1|Death|0|||
94432710|NCT00996892|323367787|FG014|Dose-Escalation Stage 1|Death|0|||
94432711|NCT00996892|323367788|FG015|Dose-Escalation Stage 1|Death|0|||
94432712|NCT00996892|323367789|FG016|Dose-Escalation Stage 1|Death|0|||
94432713|NCT00996892|323367790|FG017|Dose-Escalation Stage 1|Death|0|||
94432714|NCT00996892|323367791|FG018|Dose-Escalation Stage 1|Death|0|||
94432715|NCT00996892|323367792|FG019|Dose-Escalation Stage 1|Death|0|||
94432716|NCT00996892|323367773|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
94432717|NCT00996892|323367774|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
94432718|NCT00996892|323367775|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
94432719|NCT00996892|323367776|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
94432720|NCT00996892|323367777|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
94432721|NCT00996892|323367778|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
94432722|NCT00996892|323367779|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
94432723|NCT00996892|323367780|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
94432724|NCT00996892|323367781|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
94432725|NCT00996892|323367782|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
94432726|NCT00996892|323367783|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
94432727|NCT00996892|323367784|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
94432728|NCT00996892|323367785|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
94432729|NCT00996892|323367786|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
94432730|NCT00996892|323367787|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
94432731|NCT00996892|323367788|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
94432732|NCT00996892|323367789|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
94432733|NCT00996892|323367790|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
94432734|NCT00996892|323367791|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
94432735|NCT00996892|323367792|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
94432736|NCT00996892|323367773|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
94432737|NCT00996892|323367774|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
94432738|NCT00996892|323367775|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
94432739|NCT00996892|323367776|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
94432740|NCT00996892|323367777|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
94432741|NCT00996892|323367778|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
94432742|NCT00996892|323367779|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
94432743|NCT00996892|323367780|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
94432744|NCT00996892|323367781|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
94432745|NCT00996892|323367782|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
94432746|NCT00996892|323367783|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
94432747|NCT00996892|323367784|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
94432748|NCT00996892|323367785|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
94432749|NCT00996892|323367786|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
94432750|NCT00996892|323367787|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
94432751|NCT00996892|323367788|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
94432752|NCT00996892|323367789|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
94432753|NCT00996892|323367790|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
94432754|NCT00996892|323367791|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
94432755|NCT00996892|323367792|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
94432756|NCT00996892|323367773|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
94432757|NCT00996892|323367774|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
94432758|NCT00996892|323367775|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
94432759|NCT00996892|323367776|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
94432760|NCT00996892|323367777|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
94432761|NCT00996892|323367778|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
94432762|NCT00996892|323367779|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
94432763|NCT00996892|323367780|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
94432764|NCT00996892|323367781|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
94432765|NCT00996892|323367782|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
94432766|NCT00996892|323367783|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
94432767|NCT00996892|323367784|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
94432768|NCT00996892|323367785|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
94432769|NCT00996892|323367786|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
94432770|NCT00996892|323367787|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
94432771|NCT00996892|323367788|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
94432772|NCT00996892|323367789|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
94432773|NCT00996892|323367790|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
94432774|NCT00996892|323367791|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
94432775|NCT00996892|323367792|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
94432776|NCT00996892|323367773|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
94432777|NCT00996892|323367774|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
94432778|NCT00996892|323367775|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
94432779|NCT00996892|323367776|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
94432780|NCT00996892|323367777|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
94432781|NCT00996892|323367778|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
94432782|NCT00996892|323367779|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
94432783|NCT00996892|323367780|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
94432784|NCT00996892|323367781|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
94432785|NCT00996892|323367782|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
94432786|NCT00996892|323367783|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
94432787|NCT00996892|323367784|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
94432788|NCT00996892|323367785|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
94432789|NCT00996892|323367786|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
94432790|NCT00996892|323367787|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
94432791|NCT00996892|323367788|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
94432792|NCT00996892|323367789|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
94432793|NCT00996892|323367790|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
94432794|NCT00996892|323367791|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
94432795|NCT00996892|323367792|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
94432796|NCT00996892|323367773|FG000|Dose-Escalation Stage 1A|Death|0|||
94432797|NCT00996892|323367774|FG001|Dose-Escalation Stage 1A|Death|0|||
94432798|NCT00996892|323367775|FG002|Dose-Escalation Stage 1A|Death|0|||
94432799|NCT00996892|323367776|FG003|Dose-Escalation Stage 1A|Death|0|||
94432800|NCT00996892|323367777|FG004|Dose-Escalation Stage 1A|Death|0|||
94432801|NCT00996892|323367778|FG005|Dose-Escalation Stage 1A|Death|0|||
94432802|NCT00996892|323367779|FG006|Dose-Escalation Stage 1A|Death|0|||
94432803|NCT00996892|323367780|FG007|Dose-Escalation Stage 1A|Death|0|||
94432804|NCT00996892|323367781|FG008|Dose-Escalation Stage 1A|Death|0|||
94432805|NCT00996892|323367782|FG009|Dose-Escalation Stage 1A|Death|2|||
94432806|NCT00996892|323367783|FG010|Dose-Escalation Stage 1A|Death|0|||
94432807|NCT00996892|323367784|FG011|Dose-Escalation Stage 1A|Death|1|||
94432808|NCT00996892|323367785|FG012|Dose-Escalation Stage 1A|Death|1|||
94432809|NCT00996892|323367786|FG013|Dose-Escalation Stage 1A|Death|0|||
94432810|NCT00996892|323367787|FG014|Dose-Escalation Stage 1A|Death|0|||
94432811|NCT00996892|323367788|FG015|Dose-Escalation Stage 1A|Death|0|||
94432812|NCT00996892|323367789|FG016|Dose-Escalation Stage 1A|Death|0|||
94432813|NCT00996892|323367790|FG017|Dose-Escalation Stage 1A|Death|0|||
94432814|NCT00996892|323367791|FG018|Dose-Escalation Stage 1A|Death|0|||
94432815|NCT00996892|323367792|FG019|Dose-Escalation Stage 1A|Death|0|||
94432816|NCT00996892|323367773|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
94432817|NCT00996892|323367774|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
94432818|NCT00996892|323367775|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
94432819|NCT00996892|323367776|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
94432820|NCT00996892|323367777|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
94432821|NCT00996892|323367778|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
94432822|NCT00996892|323367779|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
94432823|NCT00996892|323367780|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
94432824|NCT00996892|323367781|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
94432825|NCT00996892|323367782|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
94432826|NCT00996892|323367783|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
94432827|NCT00996892|323367784|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
94432828|NCT00996892|323367785|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
94432829|NCT00996892|323367786|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
94432830|NCT00996892|323367787|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
94432831|NCT00996892|323367788|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
94432832|NCT00996892|323367789|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
94432833|NCT00996892|323367790|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
94432834|NCT00996892|323367791|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
94432835|NCT00996892|323367792|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
94432836|NCT00996892|323367773|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
94432837|NCT00996892|323367774|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
94432838|NCT00996892|323367775|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
94432839|NCT00996892|323367776|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
94432840|NCT00996892|323367777|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
94432841|NCT00996892|323367778|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
94432842|NCT00996892|323367779|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
94432843|NCT00996892|323367780|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
94432844|NCT00996892|323367781|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
94432845|NCT00996892|323367782|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
94432846|NCT00996892|323367783|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
94432847|NCT00996892|323367784|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
94432848|NCT00996892|323367785|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
94432849|NCT00996892|323367786|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
94432850|NCT00996892|323367787|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
94432851|NCT00996892|323367788|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
94432852|NCT00996892|323367789|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
94432853|NCT00996892|323367790|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
94432854|NCT00996892|323367791|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
94432855|NCT00996892|323367792|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
94432856|NCT00996892|323367773|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
94432857|NCT00996892|323367774|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
94432858|NCT00996892|323367775|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
94432859|NCT00996892|323367776|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
94432860|NCT00996892|323367777|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
94432861|NCT00996892|323367778|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
94432862|NCT00996892|323367779|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
94432863|NCT00996892|323367780|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
94432864|NCT00996892|323367781|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
94432865|NCT00996892|323367782|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
94432866|NCT00996892|323367783|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
94432867|NCT00996892|323367784|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
94432868|NCT00996892|323367785|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
94432869|NCT00996892|323367786|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
94432870|NCT00996892|323367787|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
94432871|NCT00996892|323367788|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
94432872|NCT00996892|323367789|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
94432873|NCT00996892|323367790|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
94432874|NCT00996892|323367791|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
94432875|NCT00996892|323367792|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
94432876|NCT00996892|323367773|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
94432877|NCT00996892|323367774|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
94432878|NCT00996892|323367775|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
94432879|NCT00996892|323367776|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
94432880|NCT00996892|323367777|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
94432881|NCT00996892|323367778|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
94432882|NCT00996892|323367779|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
94432883|NCT00996892|323367780|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
94432884|NCT00996892|323367781|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
94432885|NCT00996892|323367782|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
94432886|NCT00996892|323367783|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
94432887|NCT00996892|323367784|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
94432888|NCT00996892|323367785|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
94432889|NCT00996892|323367786|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
94432890|NCT00996892|323367787|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
94432891|NCT00996892|323367788|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
94432892|NCT00996892|323367789|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
94432893|NCT00996892|323367790|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
94432894|NCT00996892|323367791|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
94432895|NCT00996892|323367792|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
94432896|NCT00996892|323367773|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
94432897|NCT00996892|323367774|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
94432898|NCT00996892|323367775|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
94432899|NCT00996892|323367776|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
94432900|NCT00996892|323367777|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
94432901|NCT00996892|323367778|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
94432902|NCT00996892|323367779|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
94432903|NCT00996892|323367780|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
94432904|NCT00996892|323367781|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
94432905|NCT00996892|323367782|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
94432906|NCT00996892|323367783|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
94432907|NCT00996892|323367784|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
94432908|NCT00996892|323367785|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
94432909|NCT00996892|323367786|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
94432910|NCT00996892|323367787|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
94432911|NCT00996892|323367788|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
94432912|NCT00996892|323367789|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
94432913|NCT00996892|323367790|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
94432914|NCT00996892|323367791|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
94432915|NCT00996892|323367792|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
94432916|NCT00996892|323367773|FG000|Expansion Stage 2|Adverse Event|0|||
94432917|NCT00996892|323367774|FG001|Expansion Stage 2|Adverse Event|0|||
94432918|NCT00996892|323367775|FG002|Expansion Stage 2|Adverse Event|0|||
94432919|NCT00996892|323367776|FG003|Expansion Stage 2|Adverse Event|0|||
94432920|NCT00996892|323367777|FG004|Expansion Stage 2|Adverse Event|0|||
94490078|NCT01922934|323588356|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
94432921|NCT00996892|323367778|FG005|Expansion Stage 2|Adverse Event|0|||
94432922|NCT00996892|323367779|FG006|Expansion Stage 2|Adverse Event|0|||
94432923|NCT00996892|323367780|FG007|Expansion Stage 2|Adverse Event|0|||
94432924|NCT00996892|323367781|FG008|Expansion Stage 2|Adverse Event|0|||
94432925|NCT00996892|323367782|FG009|Expansion Stage 2|Adverse Event|0|||
94432926|NCT00996892|323367783|FG010|Expansion Stage 2|Adverse Event|0|||
94432927|NCT00996892|323367784|FG011|Expansion Stage 2|Adverse Event|0|||
94432928|NCT00996892|323367785|FG012|Expansion Stage 2|Adverse Event|0|||
94432929|NCT00996892|323367786|FG013|Expansion Stage 2|Adverse Event|0|||
94432930|NCT00996892|323367787|FG014|Expansion Stage 2|Adverse Event|0|||
94432931|NCT00996892|323367788|FG015|Expansion Stage 2|Adverse Event|0|||
94432932|NCT00996892|323367789|FG016|Expansion Stage 2|Adverse Event|0|||
94432933|NCT00996892|323367790|FG017|Expansion Stage 2|Adverse Event|0|||
94432934|NCT00996892|323367791|FG018|Expansion Stage 2|Adverse Event|3|||
94432935|NCT00996892|323367792|FG019|Expansion Stage 2|Adverse Event|0|||
94432936|NCT00996892|323367773|FG000|Expansion Stage 2|Death|0|||
94432937|NCT00996892|323367774|FG001|Expansion Stage 2|Death|0|||
94432938|NCT00996892|323367775|FG002|Expansion Stage 2|Death|0|||
94432939|NCT00996892|323367776|FG003|Expansion Stage 2|Death|0|||
94432940|NCT00996892|323367777|FG004|Expansion Stage 2|Death|0|||
94432941|NCT00996892|323367778|FG005|Expansion Stage 2|Death|0|||
94432942|NCT00996892|323367779|FG006|Expansion Stage 2|Death|0|||
94432943|NCT00996892|323367780|FG007|Expansion Stage 2|Death|0|||
94432944|NCT00996892|323367781|FG008|Expansion Stage 2|Death|0|||
94432945|NCT00996892|323367782|FG009|Expansion Stage 2|Death|0|||
94432946|NCT00996892|323367783|FG010|Expansion Stage 2|Death|0|||
94432947|NCT00996892|323367784|FG011|Expansion Stage 2|Death|0|||
94432948|NCT00996892|323367785|FG012|Expansion Stage 2|Death|0|||
94432949|NCT00996892|323367786|FG013|Expansion Stage 2|Death|0|||
94432950|NCT00996892|323367787|FG014|Expansion Stage 2|Death|0|||
94432951|NCT00996892|323367788|FG015|Expansion Stage 2|Death|0|||
94432952|NCT00996892|323367789|FG016|Expansion Stage 2|Death|0|||
94432953|NCT00996892|323367790|FG017|Expansion Stage 2|Death|0|||
94432954|NCT00996892|323367791|FG018|Expansion Stage 2|Death|2|||
94432955|NCT00996892|323367792|FG019|Expansion Stage 2|Death|0|||
94432956|NCT00996892|323367773|FG000|Expansion Stage 2|Physician Decision|0|||
94432957|NCT00996892|323367774|FG001|Expansion Stage 2|Physician Decision|0|||
94432958|NCT00996892|323367775|FG002|Expansion Stage 2|Physician Decision|0|||
94432959|NCT00996892|323367776|FG003|Expansion Stage 2|Physician Decision|0|||
94432960|NCT00996892|323367777|FG004|Expansion Stage 2|Physician Decision|0|||
94432961|NCT00996892|323367778|FG005|Expansion Stage 2|Physician Decision|0|||
94432962|NCT00996892|323367779|FG006|Expansion Stage 2|Physician Decision|0|||
94432963|NCT00996892|323367780|FG007|Expansion Stage 2|Physician Decision|0|||
94432964|NCT00996892|323367781|FG008|Expansion Stage 2|Physician Decision|0|||
94432965|NCT00996892|323367782|FG009|Expansion Stage 2|Physician Decision|0|||
94432966|NCT00996892|323367783|FG010|Expansion Stage 2|Physician Decision|0|||
94432967|NCT00996892|323367784|FG011|Expansion Stage 2|Physician Decision|0|||
94432968|NCT00996892|323367785|FG012|Expansion Stage 2|Physician Decision|0|||
94432969|NCT00996892|323367786|FG013|Expansion Stage 2|Physician Decision|0|||
94432970|NCT00996892|323367787|FG014|Expansion Stage 2|Physician Decision|0|||
94432971|NCT00996892|323367788|FG015|Expansion Stage 2|Physician Decision|0|||
94432972|NCT00996892|323367789|FG016|Expansion Stage 2|Physician Decision|0|||
94432973|NCT00996892|323367790|FG017|Expansion Stage 2|Physician Decision|0|||
94432974|NCT00996892|323367791|FG018|Expansion Stage 2|Physician Decision|1|||
94432975|NCT00996892|323367792|FG019|Expansion Stage 2|Physician Decision|0|||
94432976|NCT00996892|323367773|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
94432977|NCT00996892|323367774|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
94432978|NCT00996892|323367775|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
94432979|NCT00996892|323367776|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
94432980|NCT00996892|323367777|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
94432981|NCT00996892|323367778|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
94432982|NCT00996892|323367779|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
94432983|NCT00996892|323367780|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
94432984|NCT00996892|323367781|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
94432985|NCT00996892|323367782|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
94432986|NCT00996892|323367783|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
94432987|NCT00996892|323367784|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
94432988|NCT00996892|323367785|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
94432989|NCT00996892|323367786|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
94432990|NCT00996892|323367787|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
94432991|NCT00996892|323367788|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
94490079|NCT01294046|323590217|FG000|Overall Study|Infection and surgical explant|1|||
94432992|NCT00996892|323367789|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
94432993|NCT00996892|323367790|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
94432994|NCT00996892|323367791|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
94432995|NCT00996892|323367792|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
94432996|NCT00996892|323367773|FG000|Expansion Stage 2|Disease Progression|0|||
94432997|NCT00996892|323367774|FG001|Expansion Stage 2|Disease Progression|0|||
94432998|NCT00996892|323367775|FG002|Expansion Stage 2|Disease Progression|0|||
94432999|NCT00996892|323367776|FG003|Expansion Stage 2|Disease Progression|0|||
94433000|NCT00996892|323367777|FG004|Expansion Stage 2|Disease Progression|0|||
94433001|NCT00996892|323367778|FG005|Expansion Stage 2|Disease Progression|0|||
94433002|NCT00996892|323367779|FG006|Expansion Stage 2|Disease Progression|0|||
94433003|NCT00996892|323367780|FG007|Expansion Stage 2|Disease Progression|0|||
94433004|NCT00996892|323367781|FG008|Expansion Stage 2|Disease Progression|0|||
94433005|NCT00996892|323367782|FG009|Expansion Stage 2|Disease Progression|0|||
94433006|NCT00996892|323367783|FG010|Expansion Stage 2|Disease Progression|0|||
94433007|NCT00996892|323367784|FG011|Expansion Stage 2|Disease Progression|0|||
94433008|NCT00996892|323367785|FG012|Expansion Stage 2|Disease Progression|0|||
94433009|NCT00996892|323367786|FG013|Expansion Stage 2|Disease Progression|0|||
94433010|NCT00996892|323367787|FG014|Expansion Stage 2|Disease Progression|0|||
94433011|NCT00996892|323367788|FG015|Expansion Stage 2|Disease Progression|0|||
94433012|NCT00996892|323367789|FG016|Expansion Stage 2|Disease Progression|0|||
94433013|NCT00996892|323367790|FG017|Expansion Stage 2|Disease Progression|0|||
94433014|NCT00996892|323367791|FG018|Expansion Stage 2|Disease Progression|28|||
94433015|NCT00996892|323367792|FG019|Expansion Stage 2|Disease Progression|0|||
94433016|NCT00996892|323367773|FG000|Expansion Stage 2A|Adverse Event|0|||
94433017|NCT00996892|323367774|FG001|Expansion Stage 2A|Adverse Event|0|||
94433018|NCT00996892|323367775|FG002|Expansion Stage 2A|Adverse Event|0|||
94433019|NCT00996892|323367776|FG003|Expansion Stage 2A|Adverse Event|0|||
94433020|NCT00996892|323367777|FG004|Expansion Stage 2A|Adverse Event|0|||
94433021|NCT00996892|323367778|FG005|Expansion Stage 2A|Adverse Event|0|||
94433022|NCT00996892|323367779|FG006|Expansion Stage 2A|Adverse Event|0|||
94433023|NCT00996892|323367780|FG007|Expansion Stage 2A|Adverse Event|0|||
94433024|NCT00996892|323367781|FG008|Expansion Stage 2A|Adverse Event|0|||
94433025|NCT00996892|323367782|FG009|Expansion Stage 2A|Adverse Event|0|||
94433026|NCT00996892|323367783|FG010|Expansion Stage 2A|Adverse Event|0|||
94433027|NCT00996892|323367784|FG011|Expansion Stage 2A|Adverse Event|0|||
94433028|NCT00996892|323367785|FG012|Expansion Stage 2A|Adverse Event|0|||
94433029|NCT00996892|323367786|FG013|Expansion Stage 2A|Adverse Event|0|||
94433030|NCT00996892|323367787|FG014|Expansion Stage 2A|Adverse Event|0|||
94433031|NCT00996892|323367788|FG015|Expansion Stage 2A|Adverse Event|0|||
94433032|NCT00996892|323367789|FG016|Expansion Stage 2A|Adverse Event|0|||
94433033|NCT00996892|323367790|FG017|Expansion Stage 2A|Adverse Event|0|||
94433034|NCT00996892|323367791|FG018|Expansion Stage 2A|Adverse Event|0|||
94433035|NCT00996892|323367792|FG019|Expansion Stage 2A|Adverse Event|8|||
94433036|NCT00996892|323367773|FG000|Expansion Stage 2A|Physician Decision|0|||
94433037|NCT00996892|323367774|FG001|Expansion Stage 2A|Physician Decision|0|||
94433038|NCT00996892|323367775|FG002|Expansion Stage 2A|Physician Decision|0|||
94433039|NCT00996892|323367776|FG003|Expansion Stage 2A|Physician Decision|0|||
94433040|NCT00996892|323367777|FG004|Expansion Stage 2A|Physician Decision|0|||
94433041|NCT00996892|323367778|FG005|Expansion Stage 2A|Physician Decision|0|||
94433042|NCT00996892|323367779|FG006|Expansion Stage 2A|Physician Decision|0|||
94433043|NCT00996892|323367780|FG007|Expansion Stage 2A|Physician Decision|0|||
94433044|NCT00996892|323367781|FG008|Expansion Stage 2A|Physician Decision|0|||
94433045|NCT00996892|323367782|FG009|Expansion Stage 2A|Physician Decision|0|||
94433046|NCT00996892|323367783|FG010|Expansion Stage 2A|Physician Decision|0|||
94433047|NCT00996892|323367784|FG011|Expansion Stage 2A|Physician Decision|0|||
94433048|NCT00996892|323367785|FG012|Expansion Stage 2A|Physician Decision|0|||
94433049|NCT00996892|323367786|FG013|Expansion Stage 2A|Physician Decision|0|||
94433050|NCT00996892|323367787|FG014|Expansion Stage 2A|Physician Decision|0|||
94433051|NCT00996892|323367788|FG015|Expansion Stage 2A|Physician Decision|0|||
94433052|NCT00996892|323367789|FG016|Expansion Stage 2A|Physician Decision|0|||
94433053|NCT00996892|323367790|FG017|Expansion Stage 2A|Physician Decision|0|||
94433054|NCT00996892|323367791|FG018|Expansion Stage 2A|Physician Decision|0|||
94433055|NCT00996892|323367792|FG019|Expansion Stage 2A|Physician Decision|2|||
94433056|NCT00996892|323367773|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
94433057|NCT00996892|323367774|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
94433058|NCT00996892|323367775|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
94433059|NCT00996892|323367776|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
94433060|NCT00996892|323367777|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
94433061|NCT00996892|323367778|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
94433062|NCT00996892|323367779|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
94433063|NCT00996892|323367780|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
94433064|NCT00996892|323367781|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
94433065|NCT00996892|323367782|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
94433066|NCT00996892|323367783|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
94433067|NCT00996892|323367784|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
94433068|NCT00996892|323367785|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
94433069|NCT00996892|323367786|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
94433070|NCT00996892|323367787|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
94433071|NCT00996892|323367788|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
94433072|NCT00996892|323367789|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
94433073|NCT00996892|323367790|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
94433074|NCT00996892|323367791|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
94433075|NCT00996892|323367792|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
94433076|NCT00996892|323367773|FG000|Expansion Stage 2A|Disease Progression|0|||
94433077|NCT00996892|323367774|FG001|Expansion Stage 2A|Disease Progression|0|||
94433078|NCT00996892|323367775|FG002|Expansion Stage 2A|Disease Progression|0|||
94433079|NCT00996892|323367776|FG003|Expansion Stage 2A|Disease Progression|0|||
94433080|NCT00996892|323367777|FG004|Expansion Stage 2A|Disease Progression|0|||
94433081|NCT00996892|323367778|FG005|Expansion Stage 2A|Disease Progression|0|||
94433082|NCT00996892|323367779|FG006|Expansion Stage 2A|Disease Progression|0|||
94433083|NCT00996892|323367780|FG007|Expansion Stage 2A|Disease Progression|0|||
94433084|NCT00996892|323367781|FG008|Expansion Stage 2A|Disease Progression|0|||
94433085|NCT00996892|323367782|FG009|Expansion Stage 2A|Disease Progression|0|||
94433086|NCT00996892|323367783|FG010|Expansion Stage 2A|Disease Progression|0|||
94433087|NCT00996892|323367784|FG011|Expansion Stage 2A|Disease Progression|0|||
94433088|NCT00996892|323367785|FG012|Expansion Stage 2A|Disease Progression|0|||
94433089|NCT00996892|323367786|FG013|Expansion Stage 2A|Disease Progression|0|||
94433090|NCT00996892|323367787|FG014|Expansion Stage 2A|Disease Progression|0|||
94433091|NCT00996892|323367788|FG015|Expansion Stage 2A|Disease Progression|0|||
94433092|NCT00996892|323367789|FG016|Expansion Stage 2A|Disease Progression|0|||
94433093|NCT00996892|323367790|FG017|Expansion Stage 2A|Disease Progression|0|||
94433094|NCT00996892|323367791|FG018|Expansion Stage 2A|Disease Progression|0|||
94433095|NCT00996892|323367792|FG019|Expansion Stage 2A|Disease Progression|31|||
94433096|NCT05314816|323367793|FG000|Overall Study|Lost to Follow-up|5|||
94433097|NCT05314816|323367794|FG001|Overall Study|Lost to Follow-up|0|||
94433098|NCT05314816|323367795|FG002|Overall Study|Lost to Follow-up|1|||
94433099|NCT05314816|323367793|FG000|Overall Study|Protocol Violation|13|||
94433100|NCT05314816|323367794|FG001|Overall Study|Protocol Violation|8|||
94433101|NCT05314816|323367795|FG002|Overall Study|Protocol Violation|0|||
94433102|NCT03207867|323367796|FG000|Overall Study|Adverse Event|1|||
94433103|NCT03207867|323367797|FG001|Overall Study|Adverse Event|0|||
94433104|NCT03207867|323367798|FG002|Overall Study|Adverse Event|1|||
94433105|NCT03207867|323367799|FG003|Overall Study|Adverse Event|0|||
94433106|NCT03207867|323367800|FG004|Overall Study|Adverse Event|0|||
94433107|NCT03207867|323367801|FG005|Overall Study|Adverse Event|2|||
94433108|NCT03207867|323367802|FG006|Overall Study|Adverse Event|1|||
94433109|NCT03207867|323367803|FG007|Overall Study|Adverse Event|1|||
94433110|NCT03207867|323367804|FG008|Overall Study|Adverse Event|2|||
94433111|NCT03207867|323367805|FG009|Overall Study|Adverse Event|2|||
94433112|NCT03207867|323367806|FG010|Overall Study|Adverse Event|0|||
94433113|NCT03207867|323367807|FG011|Overall Study|Adverse Event|0|||
94433114|NCT03207867|323367808|FG012|Overall Study|Adverse Event|0|||
94433115|NCT03207867|323367809|FG013|Overall Study|Adverse Event|0|||
94433116|NCT03207867|323367810|FG014|Overall Study|Adverse Event|0|||
94433117|NCT03207867|323367811|FG015|Overall Study|Adverse Event|0|||
94433118|NCT03207867|323367812|FG016|Overall Study|Adverse Event|3|||
94433119|NCT03207867|323367813|FG017|Overall Study|Adverse Event|1|||
94433120|NCT03207867|323367814|FG018|Overall Study|Adverse Event|2|||
94433121|NCT03207867|323367815|FG019|Overall Study|Adverse Event|1|||
94433122|NCT03207867|323367816|FG020|Overall Study|Adverse Event|0|||
94433123|NCT03207867|323367817|FG021|Overall Study|Adverse Event|0|||
94433124|NCT03207867|323367818|FG022|Overall Study|Adverse Event|0|||
94433125|NCT03207867|323367819|FG023|Overall Study|Adverse Event|0|||
94433126|NCT03207867|323367796|FG000|Overall Study|Death|0|||
94433127|NCT03207867|323367797|FG001|Overall Study|Death|0|||
94433128|NCT03207867|323367798|FG002|Overall Study|Death|0|||
94433129|NCT03207867|323367799|FG003|Overall Study|Death|0|||
94433130|NCT03207867|323367800|FG004|Overall Study|Death|0|||
94433131|NCT03207867|323367801|FG005|Overall Study|Death|1|||
94433132|NCT03207867|323367802|FG006|Overall Study|Death|0|||
94433133|NCT03207867|323367803|FG007|Overall Study|Death|3|||
94433134|NCT03207867|323367804|FG008|Overall Study|Death|1|||
94433135|NCT03207867|323367805|FG009|Overall Study|Death|2|||
94433136|NCT03207867|323367806|FG010|Overall Study|Death|0|||
94433137|NCT03207867|323367807|FG011|Overall Study|Death|1|||
94433138|NCT03207867|323367808|FG012|Overall Study|Death|0|||
94433139|NCT03207867|323367809|FG013|Overall Study|Death|1|||
94433140|NCT03207867|323367810|FG014|Overall Study|Death|0|||
94433141|NCT03207867|323367811|FG015|Overall Study|Death|0|||
94433142|NCT03207867|323367812|FG016|Overall Study|Death|0|||
94433143|NCT03207867|323367813|FG017|Overall Study|Death|2|||
94433144|NCT03207867|323367814|FG018|Overall Study|Death|0|||
94433145|NCT03207867|323367815|FG019|Overall Study|Death|1|||
94433146|NCT03207867|323367816|FG020|Overall Study|Death|0|||
94433147|NCT03207867|323367817|FG021|Overall Study|Death|0|||
94433148|NCT03207867|323367818|FG022|Overall Study|Death|0|||
94433149|NCT03207867|323367819|FG023|Overall Study|Death|0|||
94433150|NCT03207867|323367796|FG000|Overall Study|Physician Decision|3|||
94433151|NCT03207867|323367797|FG001|Overall Study|Physician Decision|5|||
94433152|NCT03207867|323367798|FG002|Overall Study|Physician Decision|0|||
94433153|NCT03207867|323367799|FG003|Overall Study|Physician Decision|3|||
94433154|NCT03207867|323367800|FG004|Overall Study|Physician Decision|2|||
94433155|NCT03207867|323367801|FG005|Overall Study|Physician Decision|0|||
94433156|NCT03207867|323367802|FG006|Overall Study|Physician Decision|0|||
94433157|NCT03207867|323367803|FG007|Overall Study|Physician Decision|0|||
94433158|NCT03207867|323367804|FG008|Overall Study|Physician Decision|4|||
94433159|NCT03207867|323367805|FG009|Overall Study|Physician Decision|2|||
94433160|NCT03207867|323367806|FG010|Overall Study|Physician Decision|0|||
94433161|NCT03207867|323367807|FG011|Overall Study|Physician Decision|4|||
94433162|NCT03207867|323367808|FG012|Overall Study|Physician Decision|0|||
94433163|NCT03207867|323367809|FG013|Overall Study|Physician Decision|0|||
94433164|NCT03207867|323367810|FG014|Overall Study|Physician Decision|2|||
94433165|NCT03207867|323367811|FG015|Overall Study|Physician Decision|1|||
94433166|NCT03207867|323367812|FG016|Overall Study|Physician Decision|1|||
94433167|NCT03207867|323367813|FG017|Overall Study|Physician Decision|2|||
94433168|NCT03207867|323367814|FG018|Overall Study|Physician Decision|1|||
94433169|NCT03207867|323367815|FG019|Overall Study|Physician Decision|3|||
94433170|NCT03207867|323367816|FG020|Overall Study|Physician Decision|0|||
94433171|NCT03207867|323367817|FG021|Overall Study|Physician Decision|0|||
94433172|NCT03207867|323367818|FG022|Overall Study|Physician Decision|0|||
94433173|NCT03207867|323367819|FG023|Overall Study|Physician Decision|0|||
94433174|NCT03207867|323367796|FG000|Overall Study|Progressive Disease|7|||
94433175|NCT03207867|323367797|FG001|Overall Study|Progressive Disease|7|||
94433176|NCT03207867|323367798|FG002|Overall Study|Progressive Disease|9|||
94433177|NCT03207867|323367799|FG003|Overall Study|Progressive Disease|10|||
94433178|NCT03207867|323367800|FG004|Overall Study|Progressive Disease|11|||
94433179|NCT03207867|323367801|FG005|Overall Study|Progressive Disease|10|||
94433180|NCT03207867|323367802|FG006|Overall Study|Progressive Disease|9|||
94433181|NCT03207867|323367803|FG007|Overall Study|Progressive Disease|8|||
94433182|NCT03207867|323367804|FG008|Overall Study|Progressive Disease|19|||
94433183|NCT03207867|323367805|FG009|Overall Study|Progressive Disease|23|||
94433184|NCT03207867|323367806|FG010|Overall Study|Progressive Disease|2|||
94433185|NCT03207867|323367807|FG011|Overall Study|Progressive Disease|24|||
94433186|NCT03207867|323367808|FG012|Overall Study|Progressive Disease|3|||
94433187|NCT03207867|323367809|FG013|Overall Study|Progressive Disease|11|||
94433188|NCT03207867|323367810|FG014|Overall Study|Progressive Disease|9|||
94433189|NCT03207867|323367811|FG015|Overall Study|Progressive Disease|5|||
94433190|NCT03207867|323367812|FG016|Overall Study|Progressive Disease|10|||
94433191|NCT03207867|323367813|FG017|Overall Study|Progressive Disease|14|||
94433192|NCT03207867|323367814|FG018|Overall Study|Progressive Disease|13|||
94433193|NCT03207867|323367815|FG019|Overall Study|Progressive Disease|14|||
94433194|NCT03207867|323367816|FG020|Overall Study|Progressive Disease|6|||
94433195|NCT03207867|323367817|FG021|Overall Study|Progressive Disease|3|||
94433196|NCT03207867|323367818|FG022|Overall Study|Progressive Disease|3|||
94433197|NCT03207867|323367819|FG023|Overall Study|Progressive Disease|3|||
94433198|NCT03207867|323367796|FG000|Overall Study|Patient/guardian Decision|0|||
94433199|NCT03207867|323367797|FG001|Overall Study|Patient/guardian Decision|0|||
94433200|NCT03207867|323367798|FG002|Overall Study|Patient/guardian Decision|1|||
94433201|NCT03207867|323367799|FG003|Overall Study|Patient/guardian Decision|1|||
94433202|NCT03207867|323367800|FG004|Overall Study|Patient/guardian Decision|1|||
94433203|NCT03207867|323367801|FG005|Overall Study|Patient/guardian Decision|2|||
94433204|NCT03207867|323367802|FG006|Overall Study|Patient/guardian Decision|1|||
94433205|NCT03207867|323367803|FG007|Overall Study|Patient/guardian Decision|0|||
94433206|NCT03207867|323367804|FG008|Overall Study|Patient/guardian Decision|1|||
94433207|NCT03207867|323367805|FG009|Overall Study|Patient/guardian Decision|0|||
94433208|NCT03207867|323367806|FG010|Overall Study|Patient/guardian Decision|0|||
94433209|NCT03207867|323367807|FG011|Overall Study|Patient/guardian Decision|1|||
94433210|NCT03207867|323367808|FG012|Overall Study|Patient/guardian Decision|0|||
94433211|NCT03207867|323367809|FG013|Overall Study|Patient/guardian Decision|1|||
94433212|NCT03207867|323367810|FG014|Overall Study|Patient/guardian Decision|2|||
94433213|NCT03207867|323367811|FG015|Overall Study|Patient/guardian Decision|0|||
94433214|NCT03207867|323367812|FG016|Overall Study|Patient/guardian Decision|1|||
94433215|NCT03207867|323367813|FG017|Overall Study|Patient/guardian Decision|3|||
94433216|NCT03207867|323367814|FG018|Overall Study|Patient/guardian Decision|4|||
94433217|NCT03207867|323367815|FG019|Overall Study|Patient/guardian Decision|1|||
94433218|NCT03207867|323367816|FG020|Overall Study|Patient/guardian Decision|0|||
94433219|NCT03207867|323367817|FG021|Overall Study|Patient/guardian Decision|0|||
94433220|NCT03207867|323367818|FG022|Overall Study|Patient/guardian Decision|0|||
94433221|NCT03207867|323367819|FG023|Overall Study|Patient/guardian Decision|0|||
94433222|NCT00459043|323370090|FG000|Overall Study|Withdrawal by Subject|1|||
94433223|NCT00459043|323370091|FG001|Overall Study|Withdrawal by Subject|0|||
94490080|NCT01294046|323590217|FG000|Overall Study|Eligibility criteria expanded|1|||
94490081|NCT01294046|323590217|FG000|Overall Study|Stimulation response inadqequate|1|||
94433224|NCT01392963|323370092|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
94433225|NCT01392963|323370093|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
94433226|NCT01392963|323370092|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
94433227|NCT01392963|323370093|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
94433228|NCT01392963|323370092|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
94433229|NCT01392963|323370093|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
94433230|NCT00270855|323370094|FG000|Overall Study|Withdrawal by Subject|8|||
94433231|NCT00270855|323370095|FG001|Overall Study|Withdrawal by Subject|8|||
94433232|NCT00754650|323370096|FG000|Overall Study|Disease Progression|2|||
94433233|NCT02899195|323370097|FG000|Concurrent Durvalumab|Adverse Event|4|||
94433234|NCT02899195|323370097|FG000|Concurrent Durvalumab|Physician Decision|1|||
94433235|NCT02899195|323370097|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
94433236|NCT02899195|323370097|FG000|Concurrent Durvalumab|Progressive Disease|5|||
94433237|NCT02899195|323370097|FG000|Maintenance Durvalumab|Adverse Event|1|||
94433238|NCT02899195|323370097|FG000|Maintenance Durvalumab|Physician Decision|1|||
94433239|NCT02899195|323370097|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
94433240|NCT02899195|323370097|FG000|Maintenance Durvalumab|Progressive Disease|31|||
94433241|NCT00261443|323370100|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
94433242|NCT00261443|323370101|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
94433243|NCT00261443|323370102|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
94433244|NCT00261443|323370100|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
94433245|NCT00261443|323370101|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
94433246|NCT00261443|323370102|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
94433247|NCT00261443|323370100|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
94433248|NCT00261443|323370101|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
94433249|NCT00261443|323370102|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
94433250|NCT00261443|323370100|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
94433251|NCT00261443|323370101|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
94433252|NCT00261443|323370102|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
94433253|NCT00261443|323370100|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
94433254|NCT00261443|323370101|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
94433255|NCT00261443|323370102|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
94433256|NCT00261443|323370100|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
94433257|NCT00261443|323370101|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
94433258|NCT00261443|323370102|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
94433259|NCT00261443|323370100|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
94433260|NCT00261443|323370101|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
94433261|NCT00261443|323370102|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
94433262|NCT00261443|323370100|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
94433263|NCT00261443|323370101|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
94433264|NCT00261443|323370102|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
94433265|NCT00261443|323370100|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
94433266|NCT00261443|323370101|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
94433267|NCT00261443|323370102|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
94433268|NCT00261443|323370100|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
94433269|NCT00261443|323370101|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
94433270|NCT00261443|323370102|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
94433271|NCT00261443|323370100|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
94433272|NCT00261443|323370101|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
94433273|NCT00261443|323370102|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
94433274|NCT00261443|323370100|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
94433275|NCT00261443|323370101|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
94433276|NCT00261443|323370102|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
94433277|NCT00261443|323370100|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
94433278|NCT00261443|323370101|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
94433279|NCT00261443|323370102|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
94433280|NCT00261443|323370100|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
94433281|NCT00261443|323370101|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
94433282|NCT00261443|323370102|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
94433283|NCT00261443|323370100|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
94433284|NCT00261443|323370101|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
94433285|NCT00261443|323370102|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
94433286|NCT00261443|323370100|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
94433287|NCT00261443|323370101|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
94433288|NCT00261443|323370102|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
94433289|NCT00261443|323370100|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
94433290|NCT00261443|323370101|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
94433291|NCT00261443|323370102|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
94433292|NCT00261443|323370100|FG000|3: Assessment of Relapse|Adverse Event|0|||
94433293|NCT00261443|323370101|FG001|3: Assessment of Relapse|Adverse Event|15|||
94433294|NCT00261443|323370102|FG002|3: Assessment of Relapse|Adverse Event|19|||
94433295|NCT00261443|323370100|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
94433296|NCT00261443|323370101|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
94433297|NCT00261443|323370102|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
94433298|NCT00261443|323370100|FG000|3: Assessment of Relapse|Death|0|||
94433299|NCT00261443|323370101|FG001|3: Assessment of Relapse|Death|0|||
94433300|NCT00261443|323370102|FG002|3: Assessment of Relapse|Death|1|||
94433301|NCT00261443|323370100|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
94433302|NCT00261443|323370101|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
94433303|NCT00261443|323370102|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
94433304|NCT00261443|323370100|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
94433305|NCT00261443|323370101|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
94433306|NCT00261443|323370102|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
94433307|NCT00261443|323370100|FG000|3: Assessment of Relapse|Pregnancy|0|||
94433308|NCT00261443|323370101|FG001|3: Assessment of Relapse|Pregnancy|2|||
94433309|NCT00261443|323370102|FG002|3: Assessment of Relapse|Pregnancy|1|||
94433310|NCT00261443|323370100|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
94433311|NCT00261443|323370101|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
94433312|NCT00261443|323370102|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
94433313|NCT00261443|323370100|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
94433314|NCT00261443|323370101|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
94433315|NCT00261443|323370102|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
94433316|NCT00261443|323370100|FG000|3: Assessment of Relapse|Other Reasons|0|||
94433317|NCT00261443|323370101|FG001|3: Assessment of Relapse|Other Reasons|4|||
94433318|NCT00261443|323370102|FG002|3: Assessment of Relapse|Other Reasons|3|||
94433319|NCT00261443|323370100|FG000|4: Extension Phase|Adverse Event|0|||
94433320|NCT00261443|323370101|FG001|4: Extension Phase|Adverse Event|1|||
94433321|NCT00261443|323370102|FG002|4: Extension Phase|Adverse Event|0|||
94433322|NCT00261443|323370100|FG000|4: Extension Phase|Withdrawal by Subject|0|||
94433323|NCT00261443|323370101|FG001|4: Extension Phase|Withdrawal by Subject|1|||
94433324|NCT00261443|323370102|FG002|4: Extension Phase|Withdrawal by Subject|2|||
94433325|NCT00261443|323370100|FG000|4: Extension Phase|Lost to Follow-up|0|||
94433326|NCT00261443|323370101|FG001|4: Extension Phase|Lost to Follow-up|1|||
94433327|NCT00261443|323370102|FG002|4: Extension Phase|Lost to Follow-up|0|||
94433328|NCT02755649|323370103|FG000|Overall Study|Transitioned into OLE study|99|||
94433329|NCT02755649|323370104|FG001|Overall Study|Transitioned into OLE study|98|||
94433330|NCT02755649|323370105|FG002|Overall Study|Transitioned into OLE study|100|||
94433331|NCT02755649|323370103|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
94433332|NCT02755649|323370104|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
94433333|NCT02755649|323370105|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
94433334|NCT02755649|323370103|FG000|Overall Study|Physician Decision|0|||
94433335|NCT02755649|323370104|FG001|Overall Study|Physician Decision|0|||
94433336|NCT02755649|323370105|FG002|Overall Study|Physician Decision|2|||
94433337|NCT02755649|323370103|FG000|Overall Study|Withdrawal by Subject|0|||
94433338|NCT02755649|323370104|FG001|Overall Study|Withdrawal by Subject|1|||
94433339|NCT02755649|323370105|FG002|Overall Study|Withdrawal by Subject|0|||
94433340|NCT02755649|323370103|FG000|Overall Study|Undecided|1|||
94433341|NCT02755649|323370104|FG001|Overall Study|Undecided|0|||
94433342|NCT02755649|323370105|FG002|Overall Study|Undecided|0|||
94433343|NCT01286753|323370108|FG000|Overall Study|Adverse Event|7|||
94433344|NCT01286753|323370109|FG001|Overall Study|Adverse Event|6|||
94433345|NCT01286753|323370108|FG000|Overall Study|Progression|11|||
94433346|NCT01286753|323370109|FG001|Overall Study|Progression|13|||
94433347|NCT01286753|323370108|FG000|Overall Study|Refused Treatment|1|||
94433348|NCT01286753|323370109|FG001|Overall Study|Refused Treatment|0|||
94433349|NCT01286753|323370108|FG000|Overall Study|Withdrawal of Consent|0|||
94433350|NCT01286753|323370109|FG001|Overall Study|Withdrawal of Consent|2|||
94433351|NCT01286753|323370108|FG000|Overall Study|Discontinued to Join Extension Study|6|||
94433352|NCT01286753|323370109|FG001|Overall Study|Discontinued to Join Extension Study|4|||
94433353|NCT01286753|323370108|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
94433354|NCT01286753|323370109|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
94433355|NCT01371747|323370112|FG000|Overall Study|Adverse Event|4|||
94433356|NCT01371747|323370113|FG001|Overall Study|Adverse Event|2|||
94433357|NCT01371747|323370114|FG002|Overall Study|Adverse Event|7|||
94433358|NCT01371747|323370115|FG003|Overall Study|Adverse Event|2|||
94433359|NCT01371747|323370116|FG004|Overall Study|Adverse Event|2|||
94433360|NCT01371747|323370117|FG005|Overall Study|Adverse Event|2|||
94433361|NCT01371747|323370112|FG000|Overall Study|Death|1|||
94433362|NCT01371747|323370113|FG001|Overall Study|Death|0|||
94433363|NCT01371747|323370114|FG002|Overall Study|Death|4|||
94433364|NCT01371747|323370115|FG003|Overall Study|Death|1|||
94433365|NCT01371747|323370116|FG004|Overall Study|Death|2|||
94433366|NCT01371747|323370117|FG005|Overall Study|Death|0|||
94433367|NCT01371747|323370112|FG000|Overall Study|Abnormal Renal Function|0|||
94433368|NCT01371747|323370113|FG001|Overall Study|Abnormal Renal Function|2|||
94433369|NCT01371747|323370114|FG002|Overall Study|Abnormal Renal Function|0|||
94433370|NCT01371747|323370115|FG003|Overall Study|Abnormal Renal Function|1|||
94433371|NCT01371747|323370116|FG004|Overall Study|Abnormal Renal Function|0|||
94433372|NCT01371747|323370117|FG005|Overall Study|Abnormal Renal Function|1|||
94433373|NCT01371747|323370112|FG000|Overall Study|High Serum Potassium Results|1|||
94433374|NCT01371747|323370113|FG001|Overall Study|High Serum Potassium Results|1|||
94433375|NCT01371747|323370114|FG002|Overall Study|High Serum Potassium Results|1|||
94433376|NCT01371747|323370115|FG003|Overall Study|High Serum Potassium Results|2|||
94433377|NCT01371747|323370116|FG004|Overall Study|High Serum Potassium Results|0|||
94433378|NCT01371747|323370117|FG005|Overall Study|High Serum Potassium Results|2|||
94433379|NCT01371747|323370112|FG000|Overall Study|Low Serum Potassium Results|1|||
94433380|NCT01371747|323370113|FG001|Overall Study|Low Serum Potassium Results|1|||
94433381|NCT01371747|323370114|FG002|Overall Study|Low Serum Potassium Results|1|||
94433382|NCT01371747|323370115|FG003|Overall Study|Low Serum Potassium Results|1|||
94433383|NCT01371747|323370116|FG004|Overall Study|Low Serum Potassium Results|0|||
94433384|NCT01371747|323370117|FG005|Overall Study|Low Serum Potassium Results|3|||
94433385|NCT01371747|323370112|FG000|Overall Study|Protocol Violation|0|||
94433386|NCT01371747|323370113|FG001|Overall Study|Protocol Violation|0|||
94433387|NCT01371747|323370114|FG002|Overall Study|Protocol Violation|1|||
94433388|NCT01371747|323370115|FG003|Overall Study|Protocol Violation|0|||
94433389|NCT01371747|323370116|FG004|Overall Study|Protocol Violation|0|||
94433390|NCT01371747|323370117|FG005|Overall Study|Protocol Violation|0|||
94433391|NCT01371747|323370112|FG000|Overall Study|Non-Compliance|3|||
94433392|NCT01371747|323370113|FG001|Overall Study|Non-Compliance|4|||
94433393|NCT01371747|323370114|FG002|Overall Study|Non-Compliance|3|||
94433394|NCT01371747|323370115|FG003|Overall Study|Non-Compliance|0|||
94433395|NCT01371747|323370116|FG004|Overall Study|Non-Compliance|0|||
94433396|NCT01371747|323370117|FG005|Overall Study|Non-Compliance|1|||
94433397|NCT01371747|323370112|FG000|Overall Study|Physician Decision|0|||
94433398|NCT01371747|323370113|FG001|Overall Study|Physician Decision|0|||
94433399|NCT01371747|323370114|FG002|Overall Study|Physician Decision|0|||
94433400|NCT01371747|323370115|FG003|Overall Study|Physician Decision|0|||
94433401|NCT01371747|323370116|FG004|Overall Study|Physician Decision|1|||
94433402|NCT01371747|323370117|FG005|Overall Study|Physician Decision|0|||
94433403|NCT01371747|323370112|FG000|Overall Study|Withdrawal by Subject|6|||
94433404|NCT01371747|323370113|FG001|Overall Study|Withdrawal by Subject|12|||
94433405|NCT01371747|323370114|FG002|Overall Study|Withdrawal by Subject|5|||
94433406|NCT01371747|323370115|FG003|Overall Study|Withdrawal by Subject|2|||
94433407|NCT01371747|323370116|FG004|Overall Study|Withdrawal by Subject|2|||
94433408|NCT01371747|323370117|FG005|Overall Study|Withdrawal by Subject|4|||
94433409|NCT01371747|323370112|FG000|Overall Study|Other Reasons|2|||
94433410|NCT01371747|323370113|FG001|Overall Study|Other Reasons|1|||
94433411|NCT01371747|323370114|FG002|Overall Study|Other Reasons|2|||
94433412|NCT01371747|323370115|FG003|Overall Study|Other Reasons|0|||
94433413|NCT01371747|323370116|FG004|Overall Study|Other Reasons|0|||
94433414|NCT01371747|323370117|FG005|Overall Study|Other Reasons|1|||
94433415|NCT04971187|323370120|FG000|Overall Study|Screen failures|2|||
94433416|NCT01851330|323370126|FG000|Overall Study|Lack of Efficacy|10|||
94433417|NCT01851330|323370127|FG001|Overall Study|Lack of Efficacy|9|||
94433418|NCT01851330|323370128|FG002|Overall Study|Lack of Efficacy|2|||
94433419|NCT01851330|323370126|FG000|Overall Study|Lost to Follow-up|1|||
94433420|NCT01851330|323370127|FG001|Overall Study|Lost to Follow-up|6|||
94433421|NCT01851330|323370128|FG002|Overall Study|Lost to Follow-up|9|||
94433422|NCT01851330|323370126|FG000|Overall Study|Withdrew Consent|2|||
94433423|NCT01851330|323370127|FG001|Overall Study|Withdrew Consent|1|||
94433424|NCT01851330|323370128|FG002|Overall Study|Withdrew Consent|0|||
94433425|NCT01851330|323370126|FG000|Overall Study|Investigator's Discretion|0|||
94433426|NCT01851330|323370127|FG001|Overall Study|Investigator's Discretion|0|||
94433427|NCT01851330|323370128|FG002|Overall Study|Investigator's Discretion|1|||
94433428|NCT02901548|323370136|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
94433429|NCT04893018|323370140|FG000|Overall Study|Lost to Follow-up|1|||
94433430|NCT04893018|323370141|FG001|Overall Study|Lost to Follow-up|0|||
94433431|NCT04893018|323370140|FG000|Overall Study|Withdrawal by Subject|2|||
94433432|NCT04893018|323370141|FG001|Overall Study|Withdrawal by Subject|0|||
94433433|NCT04893018|323370140|FG000|Overall Study|Study Terminated|1|||
94433434|NCT04893018|323370141|FG001|Overall Study|Study Terminated|2|||
94433435|NCT00171951|323370147|FG000|Overall Study|Adverse Event|1|||
94433436|NCT00171951|323370147|FG000|Overall Study|Abnormal Laboratory Values|2|||
94433437|NCT00171951|323370147|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
94433438|NCT00171951|323370147|FG000|Overall Study|Participants Withdrew Consent|3|||
94433439|NCT00171951|323370147|FG000|Overall Study|New Cancer Therapy|5|||
94433440|NCT00171951|323370147|FG000|Overall Study|Reason not Specified|2|||
94433441|NCT03279692|323370152|FG000|Overall Study|Withdrawal by Subject|1|||
94433442|NCT03276078|323370153|FG000|Overall Study|Adverse Event|1|||
94433443|NCT01210612|323370155|FG000|Overall Study|Withdrawal by Subject|0|||
94433444|NCT01210612|323370156|FG001|Overall Study|Withdrawal by Subject|2|||
94433445|NCT01547130|323370160|FG000|Overall Study|Lost to Follow-up|9|||
94433446|NCT01547130|323370161|FG001|Overall Study|Lost to Follow-up|5|||
94433447|NCT01449370|323370162|FG000|Overall Study|Disease Progression|5|||
94433448|NCT01449370|323370163|FG001|Overall Study|Disease Progression|4|||
94433449|NCT01449370|323370164|FG002|Overall Study|Disease Progression|8|||
94433450|NCT01449370|323370165|FG003|Overall Study|Disease Progression|3|||
94433451|NCT01449370|323370166|FG004|Overall Study|Disease Progression|3|||
94433452|NCT01449370|323370167|FG005|Overall Study|Disease Progression|3|||
94433453|NCT01449370|323370168|FG006|Overall Study|Disease Progression|3|||
94433454|NCT01449370|323370169|FG007|Overall Study|Disease Progression|2|||
94433455|NCT01449370|323370170|FG008|Overall Study|Disease Progression|9|||
94433456|NCT01449370|323370171|FG009|Overall Study|Disease Progression|1|||
94433457|NCT01449370|323370172|FG010|Overall Study|Disease Progression|3|||
94433458|NCT01449370|323370173|FG011|Overall Study|Disease Progression|3|||
94433459|NCT01449370|323370174|FG012|Overall Study|Disease Progression|2|||
94433460|NCT01449370|323370175|FG013|Overall Study|Disease Progression|8|||
94433461|NCT01449370|323370176|FG014|Overall Study|Disease Progression|3|||
94433462|NCT01449370|323370177|FG015|Overall Study|Disease Progression|1|||
94433463|NCT01449370|323370178|FG016|Overall Study|Disease Progression|4|||
94433464|NCT01449370|323370179|FG017|Overall Study|Disease Progression|3|||
94433465|NCT01449370|323370180|FG018|Overall Study|Disease Progression|1|||
94433466|NCT01449370|323370181|FG019|Overall Study|Disease Progression|2|||
94433467|NCT01449370|323370182|FG020|Overall Study|Disease Progression|5|||
94433468|NCT01449370|323370183|FG021|Overall Study|Disease Progression|2|||
94433469|NCT01449370|323370184|FG022|Overall Study|Disease Progression|3|||
94433470|NCT01449370|323370185|FG023|Overall Study|Disease Progression|7|||
94433471|NCT01449370|323370186|FG024|Overall Study|Disease Progression|3|||
94433472|NCT01449370|323370162|FG000|Overall Study|Adverse Event|1|||
94433473|NCT01449370|323370163|FG001|Overall Study|Adverse Event|2|||
94433474|NCT01449370|323370164|FG002|Overall Study|Adverse Event|0|||
94433475|NCT01449370|323370165|FG003|Overall Study|Adverse Event|1|||
94433476|NCT01449370|323370166|FG004|Overall Study|Adverse Event|0|||
94433477|NCT01449370|323370167|FG005|Overall Study|Adverse Event|0|||
94433478|NCT01449370|323370168|FG006|Overall Study|Adverse Event|0|||
94433479|NCT01449370|323370169|FG007|Overall Study|Adverse Event|0|||
94433480|NCT01449370|323370170|FG008|Overall Study|Adverse Event|1|||
94433481|NCT01449370|323370171|FG009|Overall Study|Adverse Event|1|||
94433482|NCT01449370|323370172|FG010|Overall Study|Adverse Event|0|||
94433483|NCT01449370|323370173|FG011|Overall Study|Adverse Event|0|||
94433484|NCT01449370|323370174|FG012|Overall Study|Adverse Event|0|||
94433485|NCT01449370|323370175|FG013|Overall Study|Adverse Event|2|||
94433486|NCT01449370|323370176|FG014|Overall Study|Adverse Event|0|||
94433487|NCT01449370|323370177|FG015|Overall Study|Adverse Event|1|||
94433488|NCT01449370|323370178|FG016|Overall Study|Adverse Event|0|||
94433489|NCT01449370|323370179|FG017|Overall Study|Adverse Event|0|||
94433490|NCT01449370|323370180|FG018|Overall Study|Adverse Event|1|||
94433491|NCT01449370|323370181|FG019|Overall Study|Adverse Event|1|||
94433492|NCT01449370|323370182|FG020|Overall Study|Adverse Event|0|||
94433493|NCT01449370|323370183|FG021|Overall Study|Adverse Event|1|||
94433494|NCT01449370|323370184|FG022|Overall Study|Adverse Event|0|||
94433495|NCT01449370|323370185|FG023|Overall Study|Adverse Event|1|||
94433496|NCT01449370|323370186|FG024|Overall Study|Adverse Event|3|||
94433497|NCT01449370|323370162|FG000|Overall Study|Participant Decision|0|||
94433498|NCT01449370|323370163|FG001|Overall Study|Participant Decision|0|||
94433499|NCT01449370|323370164|FG002|Overall Study|Participant Decision|0|||
94433500|NCT01449370|323370165|FG003|Overall Study|Participant Decision|0|||
94433501|NCT01449370|323370166|FG004|Overall Study|Participant Decision|0|||
94433502|NCT01449370|323370167|FG005|Overall Study|Participant Decision|0|||
94433503|NCT01449370|323370168|FG006|Overall Study|Participant Decision|0|||
94433504|NCT01449370|323370169|FG007|Overall Study|Participant Decision|1|||
94433505|NCT01449370|323370170|FG008|Overall Study|Participant Decision|1|||
94433506|NCT01449370|323370171|FG009|Overall Study|Participant Decision|0|||
94433507|NCT01449370|323370172|FG010|Overall Study|Participant Decision|0|||
94433508|NCT01449370|323370173|FG011|Overall Study|Participant Decision|0|||
94433509|NCT01449370|323370174|FG012|Overall Study|Participant Decision|1|||
94433510|NCT01449370|323370175|FG013|Overall Study|Participant Decision|1|||
94433511|NCT01449370|323370176|FG014|Overall Study|Participant Decision|0|||
94433512|NCT01449370|323370177|FG015|Overall Study|Participant Decision|1|||
94433513|NCT01449370|323370178|FG016|Overall Study|Participant Decision|3|||
94433514|NCT01449370|323370179|FG017|Overall Study|Participant Decision|0|||
94433515|NCT01449370|323370180|FG018|Overall Study|Participant Decision|1|||
94433516|NCT01449370|323370181|FG019|Overall Study|Participant Decision|0|||
94433517|NCT01449370|323370182|FG020|Overall Study|Participant Decision|0|||
94433518|NCT01449370|323370183|FG021|Overall Study|Participant Decision|1|||
94433519|NCT01449370|323370184|FG022|Overall Study|Participant Decision|0|||
94433520|NCT01449370|323370185|FG023|Overall Study|Participant Decision|0|||
94433521|NCT01449370|323370186|FG024|Overall Study|Participant Decision|1|||
94433522|NCT01449370|323370162|FG000|Overall Study|Lost to Follow-up|0|||
94433523|NCT01449370|323370163|FG001|Overall Study|Lost to Follow-up|0|||
94433524|NCT01449370|323370164|FG002|Overall Study|Lost to Follow-up|0|||
94433525|NCT01449370|323370165|FG003|Overall Study|Lost to Follow-up|0|||
94433526|NCT01449370|323370166|FG004|Overall Study|Lost to Follow-up|0|||
94433527|NCT01449370|323370167|FG005|Overall Study|Lost to Follow-up|0|||
94433528|NCT01449370|323370168|FG006|Overall Study|Lost to Follow-up|0|||
94433529|NCT01449370|323370169|FG007|Overall Study|Lost to Follow-up|0|||
94433530|NCT01449370|323370170|FG008|Overall Study|Lost to Follow-up|0|||
94433531|NCT01449370|323370171|FG009|Overall Study|Lost to Follow-up|0|||
94433532|NCT01449370|323370172|FG010|Overall Study|Lost to Follow-up|0|||
94433533|NCT01449370|323370173|FG011|Overall Study|Lost to Follow-up|0|||
94433534|NCT01449370|323370174|FG012|Overall Study|Lost to Follow-up|0|||
94433535|NCT01449370|323370175|FG013|Overall Study|Lost to Follow-up|0|||
94433536|NCT01449370|323370176|FG014|Overall Study|Lost to Follow-up|0|||
94433537|NCT01449370|323370177|FG015|Overall Study|Lost to Follow-up|0|||
94433538|NCT01449370|323370178|FG016|Overall Study|Lost to Follow-up|0|||
94433539|NCT01449370|323370179|FG017|Overall Study|Lost to Follow-up|0|||
94433540|NCT01449370|323370180|FG018|Overall Study|Lost to Follow-up|0|||
94433541|NCT01449370|323370181|FG019|Overall Study|Lost to Follow-up|0|||
94433542|NCT01449370|323370182|FG020|Overall Study|Lost to Follow-up|1|||
94433543|NCT01449370|323370183|FG021|Overall Study|Lost to Follow-up|0|||
94433544|NCT01449370|323370184|FG022|Overall Study|Lost to Follow-up|0|||
94433545|NCT01449370|323370185|FG023|Overall Study|Lost to Follow-up|0|||
94433546|NCT01449370|323370186|FG024|Overall Study|Lost to Follow-up|0|||
94433547|NCT01449370|323370162|FG000|Overall Study|Other|0|||
94433548|NCT01449370|323370163|FG001|Overall Study|Other|0|||
94433549|NCT01449370|323370164|FG002|Overall Study|Other|0|||
94433550|NCT01449370|323370165|FG003|Overall Study|Other|0|||
94433551|NCT01449370|323370166|FG004|Overall Study|Other|0|||
94433552|NCT01449370|323370167|FG005|Overall Study|Other|0|||
94433553|NCT01449370|323370168|FG006|Overall Study|Other|0|||
94433554|NCT01449370|323370169|FG007|Overall Study|Other|0|||
94433555|NCT01449370|323370170|FG008|Overall Study|Other|1|||
94433556|NCT01449370|323370171|FG009|Overall Study|Other|1|||
94433557|NCT01449370|323370172|FG010|Overall Study|Other|0|||
94433558|NCT01449370|323370173|FG011|Overall Study|Other|0|||
94433559|NCT01449370|323370174|FG012|Overall Study|Other|0|||
94433560|NCT01449370|323370175|FG013|Overall Study|Other|0|||
94433561|NCT01449370|323370176|FG014|Overall Study|Other|0|||
94433562|NCT01449370|323370177|FG015|Overall Study|Other|0|||
94433563|NCT01449370|323370178|FG016|Overall Study|Other|0|||
94433564|NCT01449370|323370179|FG017|Overall Study|Other|0|||
94433565|NCT01449370|323370180|FG018|Overall Study|Other|0|||
94433566|NCT01449370|323370181|FG019|Overall Study|Other|0|||
94433567|NCT01449370|323370182|FG020|Overall Study|Other|0|||
94433568|NCT01449370|323370183|FG021|Overall Study|Other|0|||
94433569|NCT01449370|323370184|FG022|Overall Study|Other|1|||
94433570|NCT01449370|323370185|FG023|Overall Study|Other|1|||
94433571|NCT01449370|323370186|FG024|Overall Study|Other|0|||
94433572|NCT01449370|323370162|FG000|Overall Study|Medication Prohibited by Protocol|0|||
94433573|NCT01449370|323370163|FG001|Overall Study|Medication Prohibited by Protocol|0|||
94433574|NCT01449370|323370164|FG002|Overall Study|Medication Prohibited by Protocol|0|||
94433575|NCT01449370|323370165|FG003|Overall Study|Medication Prohibited by Protocol|0|||
94433576|NCT01449370|323370166|FG004|Overall Study|Medication Prohibited by Protocol|0|||
94433577|NCT01449370|323370167|FG005|Overall Study|Medication Prohibited by Protocol|0|||
94433578|NCT01449370|323370168|FG006|Overall Study|Medication Prohibited by Protocol|0|||
94433579|NCT01449370|323370169|FG007|Overall Study|Medication Prohibited by Protocol|0|||
94433580|NCT01449370|323370170|FG008|Overall Study|Medication Prohibited by Protocol|0|||
94433581|NCT01449370|323370171|FG009|Overall Study|Medication Prohibited by Protocol|0|||
94433582|NCT01449370|323370172|FG010|Overall Study|Medication Prohibited by Protocol|0|||
94433583|NCT01449370|323370173|FG011|Overall Study|Medication Prohibited by Protocol|0|||
94433584|NCT01449370|323370174|FG012|Overall Study|Medication Prohibited by Protocol|0|||
94433585|NCT01449370|323370175|FG013|Overall Study|Medication Prohibited by Protocol|0|||
94433586|NCT01449370|323370176|FG014|Overall Study|Medication Prohibited by Protocol|0|||
94433587|NCT01449370|323370177|FG015|Overall Study|Medication Prohibited by Protocol|0|||
94433588|NCT01449370|323370178|FG016|Overall Study|Medication Prohibited by Protocol|0|||
94490082|NCT02014272|323590218|FG000|Intervention Period 1|Withdrawal by Subject|1|||
94490083|NCT02014272|323590219|FG001|Intervention Period 1|Withdrawal by Subject|0|||
94490084|NCT02014272|323590218|FG000|Intervention Period 1|Adverse Event|0|||
94490085|NCT02014272|323590219|FG001|Intervention Period 1|Adverse Event|1|||
94490086|NCT01240746|323590220|FG000|Overall Study|Adverse Event|2|||
94433589|NCT01449370|323370179|FG017|Overall Study|Medication Prohibited by Protocol|0|||
94433590|NCT01449370|323370180|FG018|Overall Study|Medication Prohibited by Protocol|0|||
94433591|NCT01449370|323370181|FG019|Overall Study|Medication Prohibited by Protocol|0|||
94433592|NCT01449370|323370182|FG020|Overall Study|Medication Prohibited by Protocol|0|||
94433593|NCT01449370|323370183|FG021|Overall Study|Medication Prohibited by Protocol|0|||
94433594|NCT01449370|323370184|FG022|Overall Study|Medication Prohibited by Protocol|0|||
94433595|NCT01449370|323370185|FG023|Overall Study|Medication Prohibited by Protocol|1|||
94433596|NCT01449370|323370186|FG024|Overall Study|Medication Prohibited by Protocol|0|||
94433597|NCT01449370|323370162|FG000|Overall Study|Death|0|||
94433598|NCT01449370|323370163|FG001|Overall Study|Death|0|||
94433599|NCT01449370|323370164|FG002|Overall Study|Death|0|||
94490087|NCT01240746|323590221|FG001|Overall Study|Adverse Event|0|||
94433600|NCT01449370|323370165|FG003|Overall Study|Death|0|||
94433601|NCT01449370|323370166|FG004|Overall Study|Death|0|||
94433602|NCT01449370|323370167|FG005|Overall Study|Death|0|||
94433603|NCT01449370|323370168|FG006|Overall Study|Death|0|||
94490088|NCT01240746|323590222|FG002|Overall Study|Adverse Event|10|||
94433604|NCT01449370|323370169|FG007|Overall Study|Death|0|||
94433605|NCT01449370|323370170|FG008|Overall Study|Death|0|||
94433606|NCT01449370|323370171|FG009|Overall Study|Death|0|||
94433607|NCT01449370|323370172|FG010|Overall Study|Death|0|||
94433608|NCT01449370|323370173|FG011|Overall Study|Death|0|||
94433609|NCT01449370|323370174|FG012|Overall Study|Death|0|||
94433610|NCT01449370|323370175|FG013|Overall Study|Death|0|||
94433611|NCT01449370|323370176|FG014|Overall Study|Death|0|||
94433612|NCT01449370|323370177|FG015|Overall Study|Death|0|||
94433613|NCT01449370|323370178|FG016|Overall Study|Death|0|||
94433614|NCT01449370|323370179|FG017|Overall Study|Death|0|||
94433615|NCT01449370|323370180|FG018|Overall Study|Death|0|||
94433616|NCT01449370|323370181|FG019|Overall Study|Death|0|||
94433617|NCT01449370|323370182|FG020|Overall Study|Death|0|||
94433618|NCT01449370|323370183|FG021|Overall Study|Death|0|||
94433619|NCT01449370|323370184|FG022|Overall Study|Death|0|||
94433620|NCT01449370|323370185|FG023|Overall Study|Death|0|||
94433621|NCT01449370|323370186|FG024|Overall Study|Death|1|||
94433622|NCT02027428|323370187|FG000|Induction|Never treated|7|||
94433623|NCT02027428|323370188|FG001|Induction|Never treated|0|||
94433624|NCT02027428|323370189|FG002|Induction|Never treated|0|||
94433625|NCT02027428|323370187|FG000|Induction|Progressive disease|77|||
94433626|NCT02027428|323370188|FG001|Induction|Progressive disease|0|||
94433627|NCT02027428|323370189|FG002|Induction|Progressive disease|0|||
94433628|NCT02027428|323370187|FG000|Induction|Adverse Event|51|||
94433629|NCT02027428|323370188|FG001|Induction|Adverse Event|0|||
94433630|NCT02027428|323370189|FG002|Induction|Adverse Event|0|||
94433631|NCT02027428|323370187|FG000|Induction|Withdrawal by Subject|22|||
94433632|NCT02027428|323370188|FG001|Induction|Withdrawal by Subject|0|||
94433633|NCT02027428|323370189|FG002|Induction|Withdrawal by Subject|0|||
94433634|NCT02027428|323370187|FG000|Induction|Death|21|||
94433635|NCT02027428|323370188|FG001|Induction|Death|0|||
94433636|NCT02027428|323370189|FG002|Induction|Death|0|||
94433637|NCT02027428|323370187|FG000|Induction|Symptomatic deterioration|16|||
94433638|NCT02027428|323370188|FG001|Induction|Symptomatic deterioration|0|||
94433639|NCT02027428|323370189|FG002|Induction|Symptomatic deterioration|0|||
94433640|NCT02027428|323370187|FG000|Induction|Study terminated by sponsor|12|||
94433641|NCT02027428|323370188|FG001|Induction|Study terminated by sponsor|0|||
94433642|NCT02027428|323370189|FG002|Induction|Study terminated by sponsor|0|||
94433643|NCT02027428|323370187|FG000|Induction|Protocol Violation|1|||
94433644|NCT02027428|323370188|FG001|Induction|Protocol Violation|0|||
94433645|NCT02027428|323370189|FG002|Induction|Protocol Violation|0|||
94433646|NCT02027428|323370187|FG000|Induction|Miscellaneous|14|||
94433647|NCT02027428|323370188|FG001|Induction|Miscellaneous|0|||
94433648|NCT02027428|323370189|FG002|Induction|Miscellaneous|0|||
94433649|NCT02027428|323370187|FG000|Induction|Induction Treatment Ongoing|4|||
94433650|NCT02027428|323370188|FG001|Induction|Induction Treatment Ongoing|0|||
94433651|NCT02027428|323370189|FG002|Induction|Induction Treatment Ongoing|0|||
94433652|NCT02027428|323370187|FG000|Maintenance|Death|0|||
94433653|NCT02027428|323370188|FG001|Maintenance|Death|3|||
94433654|NCT02027428|323370189|FG002|Maintenance|Death|2|||
94433655|NCT02027428|323370187|FG000|Maintenance|Adverse Event|0|||
94433656|NCT02027428|323370188|FG001|Maintenance|Adverse Event|21|||
94433657|NCT02027428|323370189|FG002|Maintenance|Adverse Event|1|||
94433658|NCT02027428|323370187|FG000|Maintenance|Progressive disease|0|||
94433659|NCT02027428|323370188|FG001|Maintenance|Progressive disease|84|||
94433660|NCT02027428|323370189|FG002|Maintenance|Progressive disease|47|||
94433661|NCT02027428|323370187|FG000|Maintenance|Symptomatic deterioration|0|||
94433662|NCT02027428|323370188|FG001|Maintenance|Symptomatic deterioration|4|||
94433663|NCT02027428|323370189|FG002|Maintenance|Symptomatic deterioration|1|||
94433664|NCT02027428|323370187|FG000|Maintenance|Withdrawal by Subject|0|||
94433665|NCT02027428|323370188|FG001|Maintenance|Withdrawal by Subject|6|||
94433666|NCT02027428|323370189|FG002|Maintenance|Withdrawal by Subject|5|||
94433667|NCT02027428|323370187|FG000|Maintenance|Protocol Violation|0|||
94433668|NCT02027428|323370188|FG001|Maintenance|Protocol Violation|0|||
94433669|NCT02027428|323370189|FG002|Maintenance|Protocol Violation|1|||
94433670|NCT02027428|323370187|FG000|Maintenance|Other|0|||
94433671|NCT02027428|323370188|FG001|Maintenance|Other|6|||
94433672|NCT02027428|323370189|FG002|Maintenance|Other|3|||
94433673|NCT02027428|323370187|FG000|Survival Follow-up|Death|0|||
94433674|NCT02027428|323370188|FG001|Survival Follow-up|Death|78|||
94433675|NCT02027428|323370189|FG002|Survival Follow-up|Death|45|||
94433676|NCT02027428|323370187|FG000|Survival Follow-up|Lost to Follow-up|0|||
94433677|NCT02027428|323370188|FG001|Survival Follow-up|Lost to Follow-up|1|||
94433678|NCT02027428|323370189|FG002|Survival Follow-up|Lost to Follow-up|1|||
94433679|NCT01941498|323370190|FG000|Overall Study|Relocated out of state|1|||
94433680|NCT01004003|323370191|FG000|Overall Study|Progressive disease|2|||
94433681|NCT01004003|323370192|FG001|Overall Study|Progressive disease|1|||
94433682|NCT01004003|323370193|FG002|Overall Study|Progressive disease|1|||
94433683|NCT01004003|323370194|FG003|Overall Study|Progressive disease|0|||
94433684|NCT01004003|323370195|FG004|Overall Study|Progressive disease|2|||
94433685|NCT01004003|323370196|FG005|Overall Study|Progressive disease|1|||
94433686|NCT01004003|323370197|FG006|Overall Study|Progressive disease|1|||
94433687|NCT01004003|323370198|FG007|Overall Study|Progressive disease|39|||
94433688|NCT01004003|323370199|FG008|Overall Study|Progressive disease|22|||
94433689|NCT01004003|323370191|FG000|Overall Study|Adverse Event|4|||
94433690|NCT01004003|323370192|FG001|Overall Study|Adverse Event|2|||
94433691|NCT01004003|323370193|FG002|Overall Study|Adverse Event|3|||
94433692|NCT01004003|323370194|FG003|Overall Study|Adverse Event|3|||
94433693|NCT01004003|323370195|FG004|Overall Study|Adverse Event|2|||
94433694|NCT01004003|323370196|FG005|Overall Study|Adverse Event|2|||
94433695|NCT01004003|323370197|FG006|Overall Study|Adverse Event|7|||
94433696|NCT01004003|323370198|FG007|Overall Study|Adverse Event|21|||
94433697|NCT01004003|323370199|FG008|Overall Study|Adverse Event|6|||
94433698|NCT01004003|323370191|FG000|Overall Study|Refused to continue taking trial med.|0|||
94433699|NCT01004003|323370192|FG001|Overall Study|Refused to continue taking trial med.|0|||
94433700|NCT01004003|323370193|FG002|Overall Study|Refused to continue taking trial med.|0|||
94433701|NCT01004003|323370194|FG003|Overall Study|Refused to continue taking trial med.|0|||
94433702|NCT01004003|323370195|FG004|Overall Study|Refused to continue taking trial med.|0|||
94433703|NCT01004003|323370196|FG005|Overall Study|Refused to continue taking trial med.|0|||
94433704|NCT01004003|323370197|FG006|Overall Study|Refused to continue taking trial med.|0|||
94433705|NCT01004003|323370198|FG007|Overall Study|Refused to continue taking trial med.|0|||
94433706|NCT01004003|323370199|FG008|Overall Study|Refused to continue taking trial med.|2|||
94433707|NCT01004003|323370191|FG000|Overall Study|Other|0|||
94433708|NCT01004003|323370192|FG001|Overall Study|Other|0|||
94433709|NCT01004003|323370193|FG002|Overall Study|Other|0|||
94433710|NCT01004003|323370194|FG003|Overall Study|Other|0|||
94433711|NCT01004003|323370195|FG004|Overall Study|Other|0|||
94433712|NCT01004003|323370196|FG005|Overall Study|Other|1|||
94433713|NCT01004003|323370197|FG006|Overall Study|Other|0|||
94433714|NCT01004003|323370198|FG007|Overall Study|Other|0|||
94433715|NCT01004003|323370199|FG008|Overall Study|Other|0|||
94433716|NCT02728843|323370200|FG000|Overall Study|Adverse Event|0|||
94433717|NCT02728843|323370201|FG001|Overall Study|Adverse Event|2|||
94433718|NCT02728843|323370202|FG002|Overall Study|Adverse Event|3|||
94433719|NCT02728843|323370203|FG003|Overall Study|Adverse Event|1|||
94433720|NCT02728843|323370204|FG004|Overall Study|Adverse Event|2|||
94433721|NCT02728843|323370200|FG000|Overall Study|Lack of Efficacy|0|||
94433722|NCT02728843|323370201|FG001|Overall Study|Lack of Efficacy|1|||
94433723|NCT02728843|323370202|FG002|Overall Study|Lack of Efficacy|1|||
94433724|NCT02728843|323370203|FG003|Overall Study|Lack of Efficacy|0|||
94433725|NCT02728843|323370204|FG004|Overall Study|Lack of Efficacy|0|||
94433726|NCT02728843|323370200|FG000|Overall Study|Protocol Violation|2|||
94433727|NCT02728843|323370201|FG001|Overall Study|Protocol Violation|0|||
94433728|NCT02728843|323370202|FG002|Overall Study|Protocol Violation|4|||
94433729|NCT02728843|323370203|FG003|Overall Study|Protocol Violation|2|||
94433730|NCT02728843|323370204|FG004|Overall Study|Protocol Violation|2|||
94433731|NCT02728843|323370200|FG000|Overall Study|Withdrawal by Subject|1|||
94433732|NCT02728843|323370201|FG001|Overall Study|Withdrawal by Subject|0|||
94433733|NCT02728843|323370202|FG002|Overall Study|Withdrawal by Subject|0|||
94433734|NCT02728843|323370203|FG003|Overall Study|Withdrawal by Subject|1|||
94433735|NCT02728843|323370204|FG004|Overall Study|Withdrawal by Subject|0|||
94433736|NCT02728843|323370200|FG000|Overall Study|Use of rescue medication|0|||
94433737|NCT02728843|323370201|FG001|Overall Study|Use of rescue medication|2|||
94433738|NCT02728843|323370202|FG002|Overall Study|Use of rescue medication|0|||
94433739|NCT02728843|323370203|FG003|Overall Study|Use of rescue medication|2|||
94433740|NCT02728843|323370204|FG004|Overall Study|Use of rescue medication|1|||
94433741|NCT00351533|323370205|FG000|Overall Study|Extubated before first BAL|1|||
94433742|NCT00351533|323370206|FG001|Overall Study|Extubated before first BAL|0|||
94433743|NCT00351533|323370205|FG000|Overall Study|Lost to Follow-up|1|||
94433744|NCT00351533|323370206|FG001|Overall Study|Lost to Follow-up|3|||
94433745|NCT00351533|323370205|FG000|Overall Study|Physician Decision|0|||
94433746|NCT00351533|323370206|FG001|Overall Study|Physician Decision|1|||
94433747|NCT00351533|323370205|FG000|Overall Study|Withdrawal by Subject|0|||
94433748|NCT00351533|323370206|FG001|Overall Study|Withdrawal by Subject|1|||
94433749|NCT02516553|323370207|FG000|Overall Study|Progressive disease|2|||
94433750|NCT02516553|323370208|FG001|Overall Study|Progressive disease|2|||
94433751|NCT02516553|323370209|FG002|Overall Study|Progressive disease|3|||
94433752|NCT02516553|323370210|FG003|Overall Study|Progressive disease|5|||
94490089|NCT01240746|323590220|FG000|Overall Study|Lost to Follow-up|23|||
94433753|NCT02516553|323370211|FG004|Overall Study|Progressive disease|3|||
94433754|NCT02516553|323370212|FG005|Overall Study|Progressive disease|0|||
94433755|NCT02516553|323370213|FG006|Overall Study|Progressive disease|5|||
94433756|NCT02516553|323370214|FG007|Overall Study|Progressive disease|5|||
94490090|NCT01240746|323590221|FG001|Overall Study|Lost to Follow-up|20|||
94433757|NCT02516553|323370215|FG008|Overall Study|Progressive disease|11|||
94433758|NCT02516553|323370216|FG009|Overall Study|Progressive disease|3|||
94433759|NCT02516553|323370217|FG010|Overall Study|Progressive disease|10|||
94433760|NCT02516553|323370218|FG011|Overall Study|Progressive disease|8|||
94433761|NCT02516553|323370219|FG012|Overall Study|Progressive disease|8|||
94433762|NCT02516553|323370220|FG013|Overall Study|Progressive disease|2|||
94433763|NCT02516553|323370221|FG014|Overall Study|Progressive disease|2|||
94433764|NCT02516553|323370222|FG015|Overall Study|Progressive disease|2|||
94433765|NCT02516553|323370223|FG016|Overall Study|Progressive disease|1|||
94433766|NCT02516553|323370224|FG017|Overall Study|Progressive disease|9|||
94433767|NCT02516553|323370225|FG018|Overall Study|Progressive disease|12|||
94433768|NCT02516553|323370226|FG019|Overall Study|Progressive disease|7|||
94433769|NCT02516553|323370227|FG020|Overall Study|Progressive disease|16|||
94433770|NCT02516553|323370228|FG021|Overall Study|Progressive disease|18|||
94433771|NCT02516553|323370207|FG000|Overall Study|Dose limiting toxicity|0|||
94433772|NCT02516553|323370208|FG001|Overall Study|Dose limiting toxicity|0|||
94433773|NCT02516553|323370209|FG002|Overall Study|Dose limiting toxicity|0|||
94433774|NCT02516553|323370210|FG003|Overall Study|Dose limiting toxicity|0|||
94433775|NCT02516553|323370211|FG004|Overall Study|Dose limiting toxicity|3|||
94433776|NCT02516553|323370212|FG005|Overall Study|Dose limiting toxicity|1|||
94433777|NCT02516553|323370213|FG006|Overall Study|Dose limiting toxicity|1|||
94433778|NCT02516553|323370214|FG007|Overall Study|Dose limiting toxicity|0|||
94433779|NCT02516553|323370215|FG008|Overall Study|Dose limiting toxicity|1|||
94433780|NCT02516553|323370216|FG009|Overall Study|Dose limiting toxicity|0|||
94433781|NCT02516553|323370217|FG010|Overall Study|Dose limiting toxicity|0|||
94433782|NCT02516553|323370218|FG011|Overall Study|Dose limiting toxicity|1|||
94433783|NCT02516553|323370219|FG012|Overall Study|Dose limiting toxicity|0|||
94433784|NCT02516553|323370220|FG013|Overall Study|Dose limiting toxicity|1|||
94433785|NCT02516553|323370221|FG014|Overall Study|Dose limiting toxicity|0|||
94433786|NCT02516553|323370222|FG015|Overall Study|Dose limiting toxicity|0|||
94433787|NCT02516553|323370223|FG016|Overall Study|Dose limiting toxicity|1|||
94433788|NCT02516553|323370224|FG017|Overall Study|Dose limiting toxicity|1|||
94433789|NCT02516553|323370225|FG018|Overall Study|Dose limiting toxicity|0|||
94433790|NCT02516553|323370226|FG019|Overall Study|Dose limiting toxicity|2|||
94433791|NCT02516553|323370227|FG020|Overall Study|Dose limiting toxicity|0|||
94433792|NCT02516553|323370228|FG021|Overall Study|Dose limiting toxicity|0|||
94433793|NCT02516553|323370207|FG000|Overall Study|Other Adverse Events|0|||
94433794|NCT02516553|323370208|FG001|Overall Study|Other Adverse Events|0|||
94433795|NCT02516553|323370209|FG002|Overall Study|Other Adverse Events|0|||
94433796|NCT02516553|323370210|FG003|Overall Study|Other Adverse Events|1|||
94433797|NCT02516553|323370211|FG004|Overall Study|Other Adverse Events|0|||
94433798|NCT02516553|323370212|FG005|Overall Study|Other Adverse Events|1|||
94433799|NCT02516553|323370213|FG006|Overall Study|Other Adverse Events|0|||
94433800|NCT02516553|323370214|FG007|Overall Study|Other Adverse Events|0|||
94433801|NCT02516553|323370215|FG008|Overall Study|Other Adverse Events|0|||
94433802|NCT02516553|323370216|FG009|Overall Study|Other Adverse Events|1|||
94433803|NCT02516553|323370217|FG010|Overall Study|Other Adverse Events|3|||
94433804|NCT02516553|323370218|FG011|Overall Study|Other Adverse Events|2|||
94433805|NCT02516553|323370219|FG012|Overall Study|Other Adverse Events|0|||
94433806|NCT02516553|323370220|FG013|Overall Study|Other Adverse Events|1|||
94433807|NCT02516553|323370221|FG014|Overall Study|Other Adverse Events|0|||
94433808|NCT02516553|323370222|FG015|Overall Study|Other Adverse Events|0|||
94433809|NCT02516553|323370223|FG016|Overall Study|Other Adverse Events|0|||
94433810|NCT02516553|323370224|FG017|Overall Study|Other Adverse Events|2|||
94433811|NCT02516553|323370225|FG018|Overall Study|Other Adverse Events|1|||
94433812|NCT02516553|323370226|FG019|Overall Study|Other Adverse Events|2|||
94433813|NCT02516553|323370227|FG020|Overall Study|Other Adverse Events|2|||
94433814|NCT02516553|323370228|FG021|Overall Study|Other Adverse Events|1|||
94433815|NCT02516553|323370207|FG000|Overall Study|Refused to continue trial medication|0|||
94433816|NCT02516553|323370208|FG001|Overall Study|Refused to continue trial medication|0|||
94433817|NCT02516553|323370209|FG002|Overall Study|Refused to continue trial medication|0|||
94433818|NCT02516553|323370210|FG003|Overall Study|Refused to continue trial medication|0|||
94433819|NCT02516553|323370211|FG004|Overall Study|Refused to continue trial medication|0|||
94433820|NCT02516553|323370212|FG005|Overall Study|Refused to continue trial medication|0|||
94433821|NCT02516553|323370213|FG006|Overall Study|Refused to continue trial medication|0|||
94433822|NCT02516553|323370214|FG007|Overall Study|Refused to continue trial medication|0|||
94433823|NCT02516553|323370215|FG008|Overall Study|Refused to continue trial medication|0|||
94433824|NCT02516553|323370216|FG009|Overall Study|Refused to continue trial medication|0|||
94433825|NCT02516553|323370217|FG010|Overall Study|Refused to continue trial medication|1|||
94433826|NCT02516553|323370218|FG011|Overall Study|Refused to continue trial medication|0|||
94490091|NCT01240746|323590222|FG002|Overall Study|Lost to Follow-up|102|||
94433827|NCT02516553|323370219|FG012|Overall Study|Refused to continue trial medication|0|||
94433828|NCT02516553|323370220|FG013|Overall Study|Refused to continue trial medication|0|||
94433829|NCT02516553|323370221|FG014|Overall Study|Refused to continue trial medication|0|||
94433830|NCT02516553|323370222|FG015|Overall Study|Refused to continue trial medication|0|||
94490092|NCT01240746|323590220|FG000|Overall Study|Protocol Violation|24|||
94490093|NCT01240746|323590221|FG001|Overall Study|Protocol Violation|15|||
94490094|NCT01240746|323590222|FG002|Overall Study|Protocol Violation|72|||
94433831|NCT02516553|323370223|FG016|Overall Study|Refused to continue trial medication|0|||
94433832|NCT02516553|323370224|FG017|Overall Study|Refused to continue trial medication|0|||
94433833|NCT02516553|323370225|FG018|Overall Study|Refused to continue trial medication|1|||
94433834|NCT02516553|323370226|FG019|Overall Study|Refused to continue trial medication|0|||
94433835|NCT02516553|323370227|FG020|Overall Study|Refused to continue trial medication|0|||
94433836|NCT02516553|323370228|FG021|Overall Study|Refused to continue trial medication|1|||
94433837|NCT02516553|323370207|FG000|Overall Study|other reasons than listed|0|||
94433838|NCT02516553|323370208|FG001|Overall Study|other reasons than listed|0|||
94433839|NCT02516553|323370209|FG002|Overall Study|other reasons than listed|0|||
94433840|NCT02516553|323370210|FG003|Overall Study|other reasons than listed|0|||
94655576|NCT01208233|324196084|FG005|Overall Study|Study terminated by sponsor|7|||
94655577|NCT01208233|324196079|FG000|Overall Study|Protocol Violation|0|||
94655578|NCT01208233|324196080|FG001|Overall Study|Protocol Violation|0|||
94655579|NCT01208233|324196081|FG002|Overall Study|Protocol Violation|0|||
94655580|NCT01208233|324196082|FG003|Overall Study|Protocol Violation|0|||
94655581|NCT01208233|324196083|FG004|Overall Study|Protocol Violation|3|||
94655582|NCT01208233|324196084|FG005|Overall Study|Protocol Violation|0|||
94655583|NCT01208233|324196079|FG000|Overall Study|Other|2|||
94655584|NCT01208233|324196080|FG001|Overall Study|Other|1|||
94655585|NCT01208233|324196081|FG002|Overall Study|Other|0|||
94655586|NCT01208233|324196082|FG003|Overall Study|Other|0|||
94655587|NCT01208233|324196083|FG004|Overall Study|Other|0|||
94655588|NCT01208233|324196084|FG005|Overall Study|Other|1|||
94655589|NCT01208233|324196079|FG000|Overall Study|Withdrawal by Subject|1|||
94655590|NCT01208233|324196080|FG001|Overall Study|Withdrawal by Subject|0|||
94655591|NCT01208233|324196081|FG002|Overall Study|Withdrawal by Subject|1|||
94433841|NCT02516553|323370211|FG004|Overall Study|other reasons than listed|0|||
94433842|NCT02516553|323370212|FG005|Overall Study|other reasons than listed|0|||
94433843|NCT02516553|323370213|FG006|Overall Study|other reasons than listed|0|||
94433844|NCT02516553|323370214|FG007|Overall Study|other reasons than listed|1|||
94433845|NCT02516553|323370215|FG008|Overall Study|other reasons than listed|1|||
94433846|NCT02516553|323370216|FG009|Overall Study|other reasons than listed|0|||
94433847|NCT02516553|323370217|FG010|Overall Study|other reasons than listed|1|||
94433848|NCT02516553|323370218|FG011|Overall Study|other reasons than listed|1|||
94433849|NCT02516553|323370219|FG012|Overall Study|other reasons than listed|0|||
94433850|NCT02516553|323370220|FG013|Overall Study|other reasons than listed|0|||
94433851|NCT02516553|323370221|FG014|Overall Study|other reasons than listed|0|||
94433852|NCT02516553|323370222|FG015|Overall Study|other reasons than listed|0|||
94433853|NCT02516553|323370223|FG016|Overall Study|other reasons than listed|0|||
94433854|NCT02516553|323370224|FG017|Overall Study|other reasons than listed|0|||
94433855|NCT02516553|323370225|FG018|Overall Study|other reasons than listed|0|||
94433856|NCT02516553|323370226|FG019|Overall Study|other reasons than listed|0|||
94433857|NCT02516553|323370227|FG020|Overall Study|other reasons than listed|2|||
94433858|NCT02516553|323370228|FG021|Overall Study|other reasons than listed|2|||
94433859|NCT03694327|323370237|FG000|Overall Study|Lost to Follow-up|13|||
94433860|NCT03694327|323370238|FG001|Overall Study|Lost to Follow-up|23|||
94433861|NCT01957176|323370241|FG000|Overall Study|Adverse Event|2|||
94433862|NCT01957176|323370242|FG001|Overall Study|Adverse Event|0|||
94433863|NCT01957176|323370241|FG000|Overall Study|Physician Decision|2|||
94433864|NCT01957176|323370242|FG001|Overall Study|Physician Decision|1|||
94433865|NCT01957176|323370241|FG000|Overall Study|Withdrawal by Subject|1|||
94433866|NCT01957176|323370242|FG001|Overall Study|Withdrawal by Subject|0|||
94433867|NCT01590277|323370256|FG000|Overall Study|Withdrawal by Subject|3|||
94433868|NCT01590277|323370256|FG000|Overall Study|Withdrawal by Subject|2|||
94433869|NCT01590277|323370256|FG000|Overall Study|Withdrawal by Subject|1|||
94433870|NCT01590277|323370256|FG000|Overall Study|Withdrawal by Subject|1|||
94433871|NCT04386616|323370259|FG000|Overall Study|Death|22|||
94433872|NCT04386616|323370260|FG001|Overall Study|Death|22|||
94433873|NCT04386616|323370261|FG002|Overall Study|Death|21|||
94433874|NCT04386616|323370259|FG000|Overall Study|Lost to Follow-up|5|||
94433875|NCT04386616|323370260|FG001|Overall Study|Lost to Follow-up|8|||
94433876|NCT04386616|323370261|FG002|Overall Study|Lost to Follow-up|6|||
94433877|NCT04386616|323370259|FG000|Overall Study|Withdrawal by Subject|2|||
94433878|NCT04386616|323370260|FG001|Overall Study|Withdrawal by Subject|4|||
94433879|NCT04386616|323370261|FG002|Overall Study|Withdrawal by Subject|1|||
94433880|NCT04386616|323370259|FG000|Overall Study|Adverse Event|1|||
94433881|NCT04386616|323370260|FG001|Overall Study|Adverse Event|1|||
94433882|NCT04386616|323370261|FG002|Overall Study|Adverse Event|0|||
94433883|NCT03449446|323370262|FG000|Overall Study|Randomized but Never Treated|0|||
94433884|NCT03449446|323370263|FG001|Overall Study|Randomized but Never Treated|0|||
94433885|NCT03449446|323370264|FG002|Overall Study|Randomized but Never Treated|1|||
94433886|NCT03449446|323370265|FG003|Overall Study|Randomized but Never Treated|1|||
94433887|NCT03449446|323370266|FG004|Overall Study|Randomized but Never Treated|1|||
94433888|NCT03449446|323370267|FG005|Overall Study|Randomized but Never Treated|0|||
94433889|NCT03449446|323370268|FG006|Overall Study|Randomized but Never Treated|0|||
94490095|NCT01240746|323590220|FG000|Overall Study|Withdrawal by Subject|10|||
94655592|NCT01208233|324196082|FG003|Overall Study|Withdrawal by Subject|1|||
94433890|NCT03449446|323370262|FG000|Overall Study|Unknown Reason|33|||
94433891|NCT03449446|323370263|FG001|Overall Study|Unknown Reason|1|||
94655593|NCT01208233|324196083|FG004|Overall Study|Withdrawal by Subject|4|||
94433892|NCT03449446|323370264|FG002|Overall Study|Unknown Reason|1|||
94433893|NCT03449446|323370265|FG003|Overall Study|Unknown Reason|1|||
94433894|NCT03449446|323370266|FG004|Overall Study|Unknown Reason|2|||
94433895|NCT03449446|323370267|FG005|Overall Study|Unknown Reason|2|||
94433896|NCT03449446|323370268|FG006|Overall Study|Unknown Reason|0|||
94433897|NCT03449446|323370262|FG000|Overall Study|Withdrew Consent|1|||
94433898|NCT03449446|323370263|FG001|Overall Study|Withdrew Consent|3|||
94433899|NCT03449446|323370264|FG002|Overall Study|Withdrew Consent|1|||
94433900|NCT03449446|323370265|FG003|Overall Study|Withdrew Consent|4|||
94433901|NCT03449446|323370266|FG004|Overall Study|Withdrew Consent|4|||
94433902|NCT03449446|323370267|FG005|Overall Study|Withdrew Consent|4|||
94433903|NCT03449446|323370268|FG006|Overall Study|Withdrew Consent|1|||
94433904|NCT03449446|323370262|FG000|Overall Study|Adverse Event|1|||
94433905|NCT03449446|323370263|FG001|Overall Study|Adverse Event|2|||
94433906|NCT03449446|323370264|FG002|Overall Study|Adverse Event|1|||
94433907|NCT03449446|323370265|FG003|Overall Study|Adverse Event|0|||
94433908|NCT03449446|323370266|FG004|Overall Study|Adverse Event|0|||
94433909|NCT03449446|323370267|FG005|Overall Study|Adverse Event|2|||
94433910|NCT03449446|323370268|FG006|Overall Study|Adverse Event|0|||
94433911|NCT03449446|323370262|FG000|Overall Study|Lost to Follow-up|0|||
94433912|NCT03449446|323370263|FG001|Overall Study|Lost to Follow-up|0|||
94433913|NCT03449446|323370264|FG002|Overall Study|Lost to Follow-up|2|||
94433914|NCT03449446|323370265|FG003|Overall Study|Lost to Follow-up|1|||
94433915|NCT03449446|323370266|FG004|Overall Study|Lost to Follow-up|3|||
94433916|NCT03449446|323370267|FG005|Overall Study|Lost to Follow-up|0|||
94433917|NCT03449446|323370268|FG006|Overall Study|Lost to Follow-up|0|||
94433918|NCT03449446|323370262|FG000|Overall Study|Investigator's Discretion|0|||
94433919|NCT03449446|323370263|FG001|Overall Study|Investigator's Discretion|1|||
94433920|NCT03449446|323370264|FG002|Overall Study|Investigator's Discretion|1|||
94433921|NCT03449446|323370265|FG003|Overall Study|Investigator's Discretion|2|||
94433922|NCT03449446|323370266|FG004|Overall Study|Investigator's Discretion|0|||
94433923|NCT03449446|323370267|FG005|Overall Study|Investigator's Discretion|0|||
94433924|NCT03449446|323370268|FG006|Overall Study|Investigator's Discretion|0|||
94433925|NCT03449446|323370262|FG000|Overall Study|Non Compliance with Study Drug|1|||
94433926|NCT03449446|323370263|FG001|Overall Study|Non Compliance with Study Drug|0|||
94433927|NCT03449446|323370264|FG002|Overall Study|Non Compliance with Study Drug|0|||
94433928|NCT03449446|323370265|FG003|Overall Study|Non Compliance with Study Drug|0|||
94433929|NCT03449446|323370266|FG004|Overall Study|Non Compliance with Study Drug|0|||
94433930|NCT03449446|323370267|FG005|Overall Study|Non Compliance with Study Drug|0|||
94433931|NCT03449446|323370268|FG006|Overall Study|Non Compliance with Study Drug|0|||
94433932|NCT03449446|323370262|FG000|Overall Study|Protocol Violation|0|||
94433933|NCT03449446|323370263|FG001|Overall Study|Protocol Violation|0|||
94433934|NCT03449446|323370264|FG002|Overall Study|Protocol Violation|0|||
94433935|NCT03449446|323370265|FG003|Overall Study|Protocol Violation|0|||
94433936|NCT03449446|323370266|FG004|Overall Study|Protocol Violation|1|||
94433937|NCT03449446|323370267|FG005|Overall Study|Protocol Violation|1|||
94433938|NCT03449446|323370268|FG006|Overall Study|Protocol Violation|0|||
94433939|NCT03449446|323370262|FG000|Overall Study|Death|0|||
94433940|NCT03449446|323370263|FG001|Overall Study|Death|0|||
94433941|NCT03449446|323370264|FG002|Overall Study|Death|0|||
94433942|NCT03449446|323370265|FG003|Overall Study|Death|0|||
94433943|NCT03449446|323370266|FG004|Overall Study|Death|1|||
94433944|NCT03449446|323370267|FG005|Overall Study|Death|0|||
94433945|NCT03449446|323370268|FG006|Overall Study|Death|0|||
94433946|NCT02759692|323370269|FG000|Period 1|Test article no longer available|1|||
94433947|NCT02759692|323370270|FG001|Period 1|Test article no longer available|1|||
94433948|NCT02759692|323370269|FG000|Period 1|No longer meets eligibility criteria.|1|||
94433949|NCT02759692|323370270|FG001|Period 1|No longer meets eligibility criteria.|0|||
94433950|NCT02759692|323370269|FG000|Period 1|Miss-Randomized|1|||
94433951|NCT02759692|323370270|FG001|Period 1|Miss-Randomized|1|||
94433952|NCT02759692|323370269|FG000|Period 2|Lost to Follow-up|1|||
94433953|NCT02759692|323370270|FG001|Period 2|Lost to Follow-up|0|||
94433954|NCT02759692|323370269|FG000|Period 2|Test article no longer available|0|||
94433955|NCT02759692|323370270|FG001|Period 2|Test article no longer available|1|||
94433956|NCT01450683|323370273|FG000|Overall Study|Adverse Event|2|||
94433957|NCT01243775|323370274|FG000|Overall Study|Withdrawal by Subject|2|||
94433958|NCT00359801|323371990|FG000|Overall Study|Lost to Follow-up|72|||
94433959|NCT00359801|323371991|FG001|Overall Study|Lost to Follow-up|58|||
94433960|NCT00359801|323371990|FG000|Overall Study|Withdrawal by Subject|143|||
94433961|NCT00359801|323371991|FG001|Overall Study|Withdrawal by Subject|96|||
94433962|NCT00359801|323371990|FG000|Overall Study|Other|66|||
94433963|NCT00359801|323371991|FG001|Overall Study|Other|46|||
94433964|NCT00359801|323371990|FG000|Overall Study|Final Status Unknown: missing data|7|||
94433965|NCT00359801|323371991|FG001|Overall Study|Final Status Unknown: missing data|4|||
94433966|NCT00359801|323371990|FG000|Overall Study|Sponsor Decision|17|||
94433967|NCT00359801|323371991|FG001|Overall Study|Sponsor Decision|16|||
94433968|NCT02500043|323371996|FG000|Overall Study|Randomized, but not Treated|2|||
94433969|NCT02500043|323371997|FG001|Overall Study|Randomized, but not Treated|2|||
94433970|NCT02500043|323371996|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
94433971|NCT02500043|323371997|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
94433972|NCT02500043|323371996|FG000|Overall Study|Adverse Event|33|||
94433973|NCT02500043|323371997|FG001|Overall Study|Adverse Event|11|||
94433974|NCT02500043|323371996|FG000|Overall Study|Clinical Progression|54|||
94433975|NCT02500043|323371997|FG001|Overall Study|Clinical Progression|35|||
94433976|NCT02500043|323371996|FG000|Overall Study|Radiological Progression|192|||
94433977|NCT02500043|323371997|FG001|Overall Study|Radiological Progression|110|||
94433978|NCT02500043|323371996|FG000|Overall Study|Physician's Decision|11|||
94433979|NCT02500043|323371997|FG001|Overall Study|Physician's Decision|3|||
94433980|NCT02500043|323371996|FG000|Overall Study|Withdrawal by Subject|14|||
94433981|NCT02500043|323371997|FG001|Overall Study|Withdrawal by Subject|4|||
94433982|NCT02500043|323371996|FG000|Overall Study|Death|11|||
94433983|NCT02500043|323371997|FG001|Overall Study|Death|2|||
94433984|NCT02500043|323371996|FG000|Overall Study|Protocol Deviation|1|||
94433985|NCT02500043|323371997|FG001|Overall Study|Protocol Deviation|0|||
94433986|NCT03092219|323371998|FG000|Overall Study|Protocol Violation|7|||
94433987|NCT03092219|323371999|FG001|Overall Study|Protocol Violation|4|||
94433988|NCT00264550|323372004|FG000|Overall Study|Death|0|||
94433989|NCT00264550|323372005|FG001|Overall Study|Death|3|||
94433990|NCT00264550|323372006|FG002|Overall Study|Death|0|||
94433991|NCT00264550|323372007|FG003|Overall Study|Death|0|||
94433992|NCT00264550|323372004|FG000|Overall Study|Lost to Follow-up|3|||
94433993|NCT00264550|323372005|FG001|Overall Study|Lost to Follow-up|1|||
94433994|NCT00264550|323372006|FG002|Overall Study|Lost to Follow-up|1|||
94433995|NCT00264550|323372007|FG003|Overall Study|Lost to Follow-up|1|||
94433996|NCT00264550|323372004|FG000|Overall Study|Adverse Event|23|||
94433997|NCT00264550|323372005|FG001|Overall Study|Adverse Event|18|||
94433998|NCT00264550|323372006|FG002|Overall Study|Adverse Event|9|||
94433999|NCT00264550|323372007|FG003|Overall Study|Adverse Event|14|||
94434000|NCT00264550|323372004|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
94434001|NCT00264550|323372005|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
94434002|NCT00264550|323372006|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
94434003|NCT00264550|323372007|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
94434004|NCT00264550|323372004|FG000|Overall Study|Discontinued oral study agent|0|||
94434005|NCT00264550|323372005|FG001|Overall Study|Discontinued oral study agent|1|||
94434006|NCT00264550|323372006|FG002|Overall Study|Discontinued oral study agent|0|||
94434007|NCT00264550|323372007|FG003|Overall Study|Discontinued oral study agent|0|||
94434008|NCT00264550|323372004|FG000|Overall Study|Other|13|||
94434009|NCT00264550|323372005|FG001|Overall Study|Other|7|||
94434010|NCT00264550|323372006|FG002|Overall Study|Other|3|||
94434011|NCT00264550|323372007|FG003|Overall Study|Other|9|||
94434012|NCT03421730|323372009|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
94434013|NCT03421730|323372010|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
94434014|NCT03421730|323372011|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
94434015|NCT03421730|323372012|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
94434016|NCT03421730|323372013|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
94434017|NCT03421730|323372014|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
94434018|NCT03421730|323372015|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
94434019|NCT03421730|323372016|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
94434020|NCT03421730|323372017|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
94434021|NCT03421730|323372018|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
94434022|NCT03421730|323372019|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
94434023|NCT03421730|323372020|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
94434024|NCT03421730|323372009|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
94434025|NCT03421730|323372010|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
94434026|NCT03421730|323372011|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
94434027|NCT03421730|323372012|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
94434028|NCT03421730|323372013|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
94434029|NCT03421730|323372014|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
94434030|NCT03421730|323372015|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
94434031|NCT03421730|323372016|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
94434032|NCT03421730|323372017|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
94434033|NCT03421730|323372018|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
94434034|NCT03421730|323372019|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
94434035|NCT03421730|323372020|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
94434036|NCT01199016|323372021|FG000|Overall Study|No longer meets eligibility criteria|4|||
94434037|NCT01199016|323372021|FG000|Overall Study|Entrance criteria|5|||
94434038|NCT01199016|323372021|FG000|Overall Study|Protocol Violation|9|||
94434039|NCT01199016|323372021|FG000|Overall Study|Other|13|||
94490096|NCT01240746|323590221|FG001|Overall Study|Withdrawal by Subject|13|||
94434040|NCT01199016|323372021|FG000|Overall Study|Withdrawal by Subject|21|||
94434041|NCT01199016|323372021|FG000|Overall Study|Lost to Follow-up|25|||
94434042|NCT00811928|323372026|FG000|Overall Study|AEs and SAEs Including Death|7|||
94434043|NCT00811928|323372027|FG001|Overall Study|AEs and SAEs Including Death|11|||
94434044|NCT00811928|323372026|FG000|Overall Study|Withdrawal by Subject|18|||
94434045|NCT00811928|323372027|FG001|Overall Study|Withdrawal by Subject|12|||
94434046|NCT00811928|323372026|FG000|Overall Study|Did Not Take Study Drug|3|||
94434047|NCT00811928|323372027|FG001|Overall Study|Did Not Take Study Drug|0|||
94434048|NCT00811928|323372026|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
94434049|NCT00811928|323372027|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
94434050|NCT00811928|323372026|FG000|Overall Study|Investigator Decision|2|||
94434051|NCT00811928|323372027|FG001|Overall Study|Investigator Decision|1|||
94434052|NCT00811928|323372026|FG000|Overall Study|Poor Compliance|2|||
94434053|NCT00811928|323372027|FG001|Overall Study|Poor Compliance|5|||
94434054|NCT00447876|323372030|FG000|Overall Study|Withdrawal by Subject|1|||
94434055|NCT00447876|323372031|FG001|Overall Study|Withdrawal by Subject|4|||
94434056|NCT00447876|323372030|FG000|Overall Study|Lost to Follow-up|1|||
94434057|NCT00447876|323372031|FG001|Overall Study|Lost to Follow-up|0|||
94434058|NCT00447876|323372030|FG000|Overall Study|Deterioration of symptomology|1|||
94434059|NCT00447876|323372031|FG001|Overall Study|Deterioration of symptomology|0|||
94434060|NCT02533180|323372032|FG000|Overall Study|Death|0|||
94434061|NCT02533180|323372033|FG001|Overall Study|Death|2|||
94434062|NCT02533180|323372032|FG000|Overall Study|Lost to Follow-up|0|||
94434063|NCT02533180|323372033|FG001|Overall Study|Lost to Follow-up|1|||
94434064|NCT02533180|323372032|FG000|Overall Study|Physician Decision|0|||
94434065|NCT02533180|323372033|FG001|Overall Study|Physician Decision|1|||
94434066|NCT02533180|323372032|FG000|Overall Study|Withdrawal by Subject|2|||
94434067|NCT02533180|323372033|FG001|Overall Study|Withdrawal by Subject|5|||
94434068|NCT02533180|323372032|FG000|Overall Study|Screen Failure|37|||
94434069|NCT02533180|323372033|FG001|Overall Study|Screen Failure|0|||
94434070|NCT02533180|323372032|FG000|Overall Study|Protocol Deviation|0|||
94434071|NCT02533180|323372033|FG001|Overall Study|Protocol Deviation|1|||
94434072|NCT02533180|323372032|FG000|Overall Study|Non-compliance|0|||
94434073|NCT02533180|323372033|FG001|Overall Study|Non-compliance|1|||
94434074|NCT01609023|323372034|FG000|Overall Study|Lack of Efficacy|3|||
94434075|NCT01609023|323372034|FG000|Overall Study|Withdrawal by Subject|4|||
94434076|NCT01609023|323372034|FG000|Overall Study|Lost to Follow-up|8|||
94434077|NCT01609023|323372034|FG000|Overall Study|Toxicity|3|||
94434078|NCT01609023|323372034|FG000|Overall Study|Disease progression|10|||
94434079|NCT01609023|323372034|FG000|Overall Study|Physician Decision|2|||
94434080|NCT01609023|323372034|FG000|Overall Study|Death|2|||
94434081|NCT01609023|323372034|FG000|Overall Study|Personal reasons|1|||
94434082|NCT02047734|323372035|FG000|Overall Study|Adverse Event|18|||
94434083|NCT02047734|323372036|FG001|Overall Study|Adverse Event|13|||
94434084|NCT02047734|323372037|FG002|Overall Study|Adverse Event|13|||
94434085|NCT02047734|323372035|FG000|Overall Study|Lack of Efficacy|4|||
94434086|NCT02047734|323372036|FG001|Overall Study|Lack of Efficacy|5|||
94434087|NCT02047734|323372037|FG002|Overall Study|Lack of Efficacy|1|||
94434088|NCT02047734|323372035|FG000|Overall Study|Protocol Violation|3|||
94434089|NCT02047734|323372036|FG001|Overall Study|Protocol Violation|1|||
94434090|NCT02047734|323372037|FG002|Overall Study|Protocol Violation|1|||
94434091|NCT02047734|323372035|FG000|Overall Study|Lost to Follow-up|1|||
94434092|NCT02047734|323372036|FG001|Overall Study|Lost to Follow-up|4|||
94434093|NCT02047734|323372037|FG002|Overall Study|Lost to Follow-up|0|||
94434094|NCT02047734|323372035|FG000|Overall Study|Death|0|||
94434095|NCT02047734|323372036|FG001|Overall Study|Death|1|||
94434096|NCT02047734|323372037|FG002|Overall Study|Death|0|||
94434097|NCT02047734|323372035|FG000|Overall Study|Withdrawal by Subject|30|||
94434098|NCT02047734|323372036|FG001|Overall Study|Withdrawal by Subject|31|||
94434099|NCT02047734|323372037|FG002|Overall Study|Withdrawal by Subject|19|||
94434100|NCT02047734|323372035|FG000|Overall Study|Physician Decision|7|||
94434101|NCT02047734|323372036|FG001|Overall Study|Physician Decision|6|||
94434102|NCT02047734|323372037|FG002|Overall Study|Physician Decision|5|||
94434103|NCT02047734|323372035|FG000|Overall Study|Miscellaneous|2|||
94434104|NCT02047734|323372036|FG001|Overall Study|Miscellaneous|4|||
94434105|NCT02047734|323372037|FG002|Overall Study|Miscellaneous|6|||
94434106|NCT02047734|323372035|FG000|Overall Study|Did Not Receive Study Drug|2|||
94434107|NCT02047734|323372036|FG001|Overall Study|Did Not Receive Study Drug|4|||
94434108|NCT02047734|323372037|FG002|Overall Study|Did Not Receive Study Drug|1|||
94434109|NCT04172597|323372040|FG000|Overall Study|Disease Progression|0|||
94434110|NCT04172597|323372041|FG001|Overall Study|Disease Progression|0|||
94434111|NCT04172597|323372042|FG002|Overall Study|Disease Progression|0|||
94434112|NCT04172597|323372043|FG003|Overall Study|Disease Progression|0|||
94434113|NCT04172597|323372044|FG004|Overall Study|Disease Progression|1|||
94434114|NCT01333397|323372047|FG000|Overall Study|Lost to Follow-up|1|||
94434115|NCT01333397|323372048|FG001|Overall Study|Lost to Follow-up|0|||
94434116|NCT01333397|323372049|FG002|Overall Study|Lost to Follow-up|0|||
94434117|NCT01333397|323372050|FG003|Overall Study|Lost to Follow-up|1|||
94434118|NCT01333397|323372051|FG004|Overall Study|Lost to Follow-up|0|||
94434119|NCT02439970|323372056|FG000|Overall Study|Study Terminated|2|||
94434120|NCT02439970|323372057|FG001|Overall Study|Study Terminated|3|||
94434121|NCT00658879|323372058|FG000|Overall Study|Protocol Violation|1|||
94434122|NCT01520870|323372059|FG000|Overall Study|Withdrawal by Subject|2|||
94434123|NCT01371539|323372064|FG000|Period One: One Week|Lost to Follow-up|0|||
94434124|NCT01371539|323372065|FG001|Period One: One Week|Lost to Follow-up|1|||
94434125|NCT01371539|323372064|FG000|Period Two: One Week|Lost to Follow-up|0|||
94434126|NCT01371539|323372065|FG001|Period Two: One Week|Lost to Follow-up|1|||
94434127|NCT01371539|323372064|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
94490097|NCT01240746|323590222|FG002|Overall Study|Withdrawal by Subject|59|||
94490098|NCT02472405|323590223|FG000|Overall Study|Lost to Follow-up|9|||
94490099|NCT02472405|323590223|FG000|Overall Study|Adverse Event|1|||
94490100|NCT02426684|323590224|FG000|Overall Study|Physician Decision|1|||
94490101|NCT00426270|323590227|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
94490102|NCT00426270|323590227|FG000|Overall Study|Adverse Event|5|||
94490103|NCT03157089|323590228|FG000|Overall Study|Treated only with pembrolizumab|1|||
94490104|NCT03157089|323590229|FG001|Overall Study|Treated only with pembrolizumab|0|||
94490105|NCT03157089|323590228|FG000|Overall Study|Adverse Event|5|||
94490106|NCT03157089|323590229|FG001|Overall Study|Adverse Event|4|||
94490107|NCT03157089|323590228|FG000|Overall Study|Progressive disease|6|||
94490108|NCT03157089|323590229|FG001|Overall Study|Progressive disease|8|||
94490109|NCT00819039|323590232|FG000|Overall Study|Physician Decision|1|||
94490110|NCT00819039|323590233|FG001|Overall Study|Physician Decision|0|||
94490111|NCT00819039|323590234|FG002|Overall Study|Physician Decision|1|||
94490112|NCT00819039|323590232|FG000|Overall Study|Protocol Violation|1|||
94490113|NCT00819039|323590233|FG001|Overall Study|Protocol Violation|0|||
94490114|NCT00819039|323590234|FG002|Overall Study|Protocol Violation|0|||
94490115|NCT00929669|323590235|FG000|Overall Study|elevated glucose levels|1|||
94490116|NCT02469857|323590236|FG000|Overall Study|Death|24|||
94490117|NCT02469857|323590237|FG001|Overall Study|Death|29|||
94490118|NCT02469857|323590236|FG000|Overall Study|Discontinuation|1|||
94490119|NCT02469857|323590237|FG001|Overall Study|Discontinuation|3|||
94490120|NCT01240694|323590238|FG000|Overall Study|Adverse Event|9|||
94490121|NCT01240694|323590238|FG000|Overall Study|Lack of Efficacy|6|||
94490122|NCT01240694|323590238|FG000|Overall Study|Withdrawal by Subject|6|||
94490123|NCT01240694|323590238|FG000|Overall Study|Protocol Violation|2|||
94490124|NCT01240694|323590238|FG000|Overall Study|Lost to Follow-up|2|||
94490125|NCT01240694|323590238|FG000|Overall Study|Other than specified|3|||
94490126|NCT01240694|323590238|FG000|Overall Study|Withdrawn due to early study termination|107|||
94490127|NCT03502798|323590240|FG000|Overall Study|equipment failure|0|||
94490128|NCT03502798|323590241|FG001|Overall Study|equipment failure|7|||
94434128|NCT01371539|323372065|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
94434129|NCT01371539|323372064|FG000|Period Two: One Week|Time/job conflict|0|||
94434130|NCT01371539|323372065|FG001|Period Two: One Week|Time/job conflict|1|||
94434131|NCT03280381|323372070|FG000|Overall Study|Physician Decision|0|||
94434132|NCT03280381|323372071|FG001|Overall Study|Physician Decision|2|||
94434133|NCT01685840|323372075|FG000|Overall Study|Death|77|||
94434134|NCT01685840|323372076|FG001|Overall Study|Death|66|||
94434135|NCT01685840|323372075|FG000|Overall Study|Lost to Follow-up|27|||
94434136|NCT01685840|323372076|FG001|Overall Study|Lost to Follow-up|25|||
94434137|NCT01685840|323372075|FG000|Overall Study|Physician Decision|3|||
94434138|NCT01685840|323372076|FG001|Overall Study|Physician Decision|7|||
94434139|NCT01685840|323372075|FG000|Overall Study|Withdrawal by Subject|14|||
94434140|NCT01685840|323372076|FG001|Overall Study|Withdrawal by Subject|17|||
94434141|NCT01685840|323372075|FG000|Overall Study|Futility|197|||
94434142|NCT01685840|323372076|FG001|Overall Study|Futility|200|||
94434143|NCT01685840|323372075|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
94434144|NCT01685840|323372076|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
94434145|NCT01814553|323372077|FG000|Overall Study|PD per clinical progression|6|||
94490129|NCT00485303|323590242|FG000|Overall Study|Adverse Event|5|||
94490130|NCT00485303|323590242|FG000|Overall Study|Progressive Disease|44|||
94490131|NCT00485303|323590242|FG000|Overall Study|Other|3|||
94490132|NCT00485303|323590242|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
94490133|NCT00485303|323590242|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
94490134|NCT02737722|323590244|FG000|Overall Study|Physician Decision|0|||
94490135|NCT02737722|323590245|FG001|Overall Study|Physician Decision|0|||
94490136|NCT02737722|323590246|FG002|Overall Study|Physician Decision|1|||
94490137|NCT02737722|323590247|FG003|Overall Study|Physician Decision|0|||
94490138|NCT00390689|323590251|FG000|Overall Study|Adverse Event|2|||
94490139|NCT00390689|323590252|FG001|Overall Study|Adverse Event|5|||
94490140|NCT00390689|323590253|FG002|Overall Study|Adverse Event|2|||
94434146|NCT01814553|323372078|FG001|Overall Study|PD per clinical progression|8|||
94434147|NCT01814553|323372077|FG000|Overall Study|Other Adverse Event|4|||
94434148|NCT01814553|323372078|FG001|Overall Study|Other Adverse Event|5|||
94434149|NCT01814553|323372077|FG000|Overall Study|Withdrawal by Subject|1|||
94490141|NCT00390689|323590251|FG000|Overall Study|Lack of Efficacy|0|||
94490142|NCT00390689|323590252|FG001|Overall Study|Lack of Efficacy|0|||
94490143|NCT00390689|323590253|FG002|Overall Study|Lack of Efficacy|1|||
94434150|NCT01814553|323372078|FG001|Overall Study|Withdrawal by Subject|1|||
94434151|NCT01814553|323372077|FG000|Overall Study|Other than stated|7|||
94434152|NCT01814553|323372078|FG001|Overall Study|Other than stated|8|||
94434153|NCT00908310|323372079|FG000|Overall Study|Death|37|||
94434154|NCT00908310|323372079|FG000|Overall Study|Withdrawal by Subject|7|||
94434155|NCT00908310|323372079|FG000|Overall Study|Lost to Follow-up|7|||
94434156|NCT00908310|323372079|FG000|Overall Study|Screening failure|5|||
94434157|NCT00908310|323372079|FG000|Overall Study|Other reasons|4|||
94434158|NCT02800642|323372080|FG000|Overall Study|Death|3|||
94434159|NCT02800642|323372080|FG000|Overall Study|Other|10|||
94434160|NCT02800642|323372080|FG000|Overall Study|Physician Decision|2|||
94434161|NCT02800642|323372080|FG000|Overall Study|Adverse Event|6|||
94434162|NCT02800642|323372080|FG000|Overall Study|Withdrawal by Subject|3|||
94434163|NCT02800642|323372080|FG000|Overall Study|Lost to Follow-up|1|||
94434164|NCT03516513|323372083|FG000|Overall Study|Withdrawal by Subject|2|||
94434165|NCT03516513|323372084|FG001|Overall Study|Withdrawal by Subject|2|||
94434166|NCT03516513|323372085|FG002|Overall Study|Withdrawal by Subject|0|||
94434167|NCT03516513|323372086|FG003|Overall Study|Withdrawal by Subject|0|||
94434168|NCT00951496|323372087|FG000|Overall Study|Did not initiate study treatment|10|||
94434169|NCT00951496|323372088|FG001|Overall Study|Did not initiate study treatment|8|||
94434170|NCT00951496|323372089|FG002|Overall Study|Did not initiate study treatment|13|||
94434171|NCT00447993|323372092|FG000|Overall Study|Lost to Follow-up|0|||
94434172|NCT00447993|323372093|FG001|Overall Study|Lost to Follow-up|0|||
94434173|NCT00447993|323372094|FG002|Overall Study|Lost to Follow-up|2|||
94434174|NCT00447993|323372095|FG003|Overall Study|Lost to Follow-up|2|||
94434175|NCT00447993|323372092|FG000|Overall Study|Withdrawal by Subject|0|||
94434176|NCT00447993|323372093|FG001|Overall Study|Withdrawal by Subject|0|||
94434177|NCT00447993|323372094|FG002|Overall Study|Withdrawal by Subject|2|||
94434178|NCT00447993|323372095|FG003|Overall Study|Withdrawal by Subject|2|||
94434179|NCT01589497|323372097|FG000|Overall Study|Withdrawal by Subject|0|||
94434180|NCT01589497|323372098|FG001|Overall Study|Withdrawal by Subject|1|||
94434181|NCT01589497|323372099|FG002|Overall Study|Withdrawal by Subject|0|||
94434182|NCT01589497|323372100|FG003|Overall Study|Withdrawal by Subject|1|||
94434183|NCT01589497|323372097|FG000|Overall Study|Death|1|||
94434184|NCT01589497|323372098|FG001|Overall Study|Death|0|||
94434185|NCT01589497|323372099|FG002|Overall Study|Death|0|||
94434186|NCT01589497|323372100|FG003|Overall Study|Death|0|||
94434187|NCT01589497|323372097|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
94434188|NCT01589497|323372098|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
94434189|NCT01589497|323372099|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
94434190|NCT01589497|323372100|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
94434191|NCT03301623|323372107|FG000|Overall Study|Death|3|||
94434192|NCT03301623|323372108|FG001|Overall Study|Death|1|||
94434193|NCT03301623|323372107|FG000|Overall Study|Withdrawal by Subject|11|||
94434194|NCT03301623|323372108|FG001|Overall Study|Withdrawal by Subject|13|||
94434195|NCT03301623|323372107|FG000|Overall Study|Lost to Follow-up|3|||
94434196|NCT03301623|323372108|FG001|Overall Study|Lost to Follow-up|1|||
94434197|NCT00548093|323372109|FG000|Overall Study|Death|33|||
94434198|NCT00548093|323372110|FG001|Overall Study|Death|13|||
94434199|NCT00548093|323372109|FG000|Overall Study|Lost to Follow-up|3|||
94434200|NCT00548093|323372110|FG001|Overall Study|Lost to Follow-up|1|||
94434201|NCT00548093|323372109|FG000|Overall Study|Objective progression or relapse|1|||
94434202|NCT00548093|323372110|FG001|Overall Study|Objective progression or relapse|1|||
94434203|NCT00548093|323372109|FG000|Overall Study|Other|11|||
94434204|NCT00548093|323372110|FG001|Overall Study|Other|1|||
94434205|NCT00548093|323372109|FG000|Overall Study|Withdrawal by Subject|1|||
94434206|NCT00548093|323372110|FG001|Overall Study|Withdrawal by Subject|0|||
94434207|NCT00548093|323372109|FG000|Overall Study|Completed post-treatment follow-up|1|||
94434208|NCT00548093|323372110|FG001|Overall Study|Completed post-treatment follow-up|0|||
94434209|NCT03052127|323372111|FG000|Overall Study|Withdrawal by Subject|0|||
94434210|NCT03052127|323372112|FG001|Overall Study|Withdrawal by Subject|0|||
94434211|NCT03052127|323372113|FG002|Overall Study|Withdrawal by Subject|0|||
94434212|NCT03052127|323372114|FG003|Overall Study|Withdrawal by Subject|0|||
94434213|NCT03052127|323372115|FG004|Overall Study|Withdrawal by Subject|0|||
94434214|NCT03052127|323372116|FG005|Overall Study|Withdrawal by Subject|0|||
94434215|NCT03052127|323372117|FG006|Overall Study|Withdrawal by Subject|0|||
94434216|NCT03052127|323372118|FG007|Overall Study|Withdrawal by Subject|1|||
94434217|NCT03052127|323372119|FG008|Overall Study|Withdrawal by Subject|1|||
94490144|NCT00390689|323590251|FG000|Overall Study|Protocol Violation|1|||
94490145|NCT00390689|323590252|FG001|Overall Study|Protocol Violation|0|||
94490146|NCT00390689|323590253|FG002|Overall Study|Protocol Violation|0|||
94490147|NCT00390689|323590251|FG000|Overall Study|Investigator's judgement|2|||
94490148|NCT00390689|323590252|FG001|Overall Study|Investigator's judgement|0|||
94434218|NCT03052127|323372120|FG009|Overall Study|Withdrawal by Subject|1|||
94434219|NCT03052127|323372121|FG010|Overall Study|Withdrawal by Subject|0|||
94434220|NCT03052127|323372122|FG011|Overall Study|Withdrawal by Subject|0|||
94434221|NCT03052127|323372111|FG000|Overall Study|Discontinuation by Sponsor|0|||
94490149|NCT00390689|323590253|FG002|Overall Study|Investigator's judgement|0|||
94434222|NCT03052127|323372112|FG001|Overall Study|Discontinuation by Sponsor|0|||
94434223|NCT03052127|323372113|FG002|Overall Study|Discontinuation by Sponsor|0|||
94434224|NCT03052127|323372114|FG003|Overall Study|Discontinuation by Sponsor|0|||
94434225|NCT03052127|323372115|FG004|Overall Study|Discontinuation by Sponsor|0|||
94434226|NCT03052127|323372116|FG005|Overall Study|Discontinuation by Sponsor|0|||
94434227|NCT03052127|323372117|FG006|Overall Study|Discontinuation by Sponsor|0|||
94434228|NCT03052127|323372118|FG007|Overall Study|Discontinuation by Sponsor|0|||
94434229|NCT03052127|323372119|FG008|Overall Study|Discontinuation by Sponsor|4|||
94434230|NCT03052127|323372120|FG009|Overall Study|Discontinuation by Sponsor|2|||
94434231|NCT03052127|323372121|FG010|Overall Study|Discontinuation by Sponsor|5|||
94434232|NCT03052127|323372122|FG011|Overall Study|Discontinuation by Sponsor|13|||
94434233|NCT03052127|323372111|FG000|Overall Study|Inability to comply with trial requirements|0|||
94434234|NCT03052127|323372112|FG001|Overall Study|Inability to comply with trial requirements|0|||
94434235|NCT03052127|323372113|FG002|Overall Study|Inability to comply with trial requirements|1|||
94434236|NCT03052127|323372114|FG003|Overall Study|Inability to comply with trial requirements|0|||
94434237|NCT03052127|323372115|FG004|Overall Study|Inability to comply with trial requirements|0|||
94434238|NCT03052127|323372116|FG005|Overall Study|Inability to comply with trial requirements|0|||
94434239|NCT03052127|323372117|FG006|Overall Study|Inability to comply with trial requirements|0|||
94434240|NCT03052127|323372118|FG007|Overall Study|Inability to comply with trial requirements|0|||
94434241|NCT03052127|323372119|FG008|Overall Study|Inability to comply with trial requirements|0|||
94434242|NCT03052127|323372120|FG009|Overall Study|Inability to comply with trial requirements|0|||
94434243|NCT03052127|323372121|FG010|Overall Study|Inability to comply with trial requirements|0|||
94490150|NCT00701363|323590260|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
94434244|NCT03052127|323372122|FG011|Overall Study|Inability to comply with trial requirements|0|||
94434245|NCT03052127|323372111|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
94434246|NCT03052127|323372112|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
94434247|NCT03052127|323372113|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
94434248|NCT03052127|323372114|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
94434249|NCT03052127|323372115|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
94434250|NCT03052127|323372116|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
94434251|NCT03052127|323372117|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
94434252|NCT03052127|323372118|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
94434253|NCT03052127|323372119|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
94434254|NCT03052127|323372120|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
94434255|NCT03052127|323372121|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
94434256|NCT03052127|323372122|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
94434257|NCT02359994|323372123|FG000|Overall Population Study|Adverse Event|1|||
94434258|NCT02359994|323372124|FG001|Overall Population Study|Adverse Event|1|||
94434259|NCT02359994|323372123|FG000|Overall Population Study|Death|1|||
94434260|NCT02359994|323372124|FG001|Overall Population Study|Death|5|||
94434261|NCT02359994|323372123|FG000|Overall Population Study|Lost to Follow-up|1|||
94434262|NCT02359994|323372124|FG001|Overall Population Study|Lost to Follow-up|1|||
94434263|NCT02359994|323372123|FG000|Overall Population Study|Withdrawal by Subject|1|||
94434264|NCT02359994|323372124|FG001|Overall Population Study|Withdrawal by Subject|0|||
94434265|NCT02359994|323372123|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
94434266|NCT02359994|323372124|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
94434267|NCT02359994|323372123|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
94434268|NCT02359994|323372124|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
94434269|NCT02359994|323372123|FG000|Extended Oncology 24-Month Survival|Death|19|||
94434270|NCT02359994|323372124|FG001|Extended Oncology 24-Month Survival|Death|21|||
94434271|NCT02359994|323372123|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
94434272|NCT02359994|323372124|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
94434273|NCT02521376|323372129|FG000|Overall Study|Enrolled, But Not Treated|1|||
94434274|NCT02521376|323372130|FG001|Overall Study|Enrolled, But Not Treated|0|||
94434275|NCT02521376|323372131|FG002|Overall Study|Enrolled, But Not Treated|0|||
94434276|NCT02521376|323372132|FG003|Overall Study|Enrolled, But Not Treated|0|||
94434277|NCT00509795|323372133|FG000|Overall Study|Adverse Event|4|||
94434278|NCT00509795|323372134|FG001|Overall Study|Adverse Event|3|||
94434279|NCT00509795|323372135|FG002|Overall Study|Adverse Event|5|||
94434280|NCT00509795|323372136|FG003|Overall Study|Adverse Event|4|||
94434281|NCT00509795|323372133|FG000|Overall Study|Death|3|||
94434282|NCT00509795|323372134|FG001|Overall Study|Death|1|||
94490151|NCT00701363|323590261|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
94434283|NCT00509795|323372135|FG002|Overall Study|Death|2|||
94434284|NCT00509795|323372136|FG003|Overall Study|Death|7|||
94434285|NCT00509795|323372133|FG000|Overall Study|Lack of Efficacy|0|||
94434286|NCT00509795|323372134|FG001|Overall Study|Lack of Efficacy|0|||
94434287|NCT00509795|323372135|FG002|Overall Study|Lack of Efficacy|2|||
94434288|NCT00509795|323372136|FG003|Overall Study|Lack of Efficacy|2|||
94434289|NCT00509795|323372133|FG000|Overall Study|Lost to Follow-up|1|||
94434290|NCT00509795|323372134|FG001|Overall Study|Lost to Follow-up|2|||
94434291|NCT00509795|323372135|FG002|Overall Study|Lost to Follow-up|4|||
94434292|NCT00509795|323372136|FG003|Overall Study|Lost to Follow-up|4|||
94434293|NCT00509795|323372133|FG000|Overall Study|OTHER|1|||
94434294|NCT00509795|323372134|FG001|Overall Study|OTHER|0|||
94434295|NCT00509795|323372135|FG002|Overall Study|OTHER|4|||
94434296|NCT00509795|323372136|FG003|Overall Study|OTHER|1|||
94434297|NCT00509795|323372133|FG000|Overall Study|Protocol Violation|3|||
94434298|NCT00509795|323372134|FG001|Overall Study|Protocol Violation|0|||
94434299|NCT00509795|323372135|FG002|Overall Study|Protocol Violation|3|||
94434300|NCT00509795|323372136|FG003|Overall Study|Protocol Violation|1|||
94434301|NCT00509795|323372133|FG000|Overall Study|Withdrawal by Subject|10|||
94434302|NCT00509795|323372134|FG001|Overall Study|Withdrawal by Subject|5|||
94434303|NCT00509795|323372135|FG002|Overall Study|Withdrawal by Subject|7|||
94434304|NCT00509795|323372136|FG003|Overall Study|Withdrawal by Subject|8|||
94434305|NCT03017612|323372137|FG000|Overall Study|Adverse Event|2|||
94434306|NCT00338728|323372142|FG000|Overall Study|Screen Failure|14|||
94434307|NCT04895982|323372143|FG000|Overall Study|Withdrawal by Subject|0|||
94434308|NCT04895982|323372144|FG001|Overall Study|Withdrawal by Subject|0|||
94434309|NCT04895982|323372145|FG002|Overall Study|Withdrawal by Subject|0|||
94434310|NCT04895982|323372146|FG003|Overall Study|Withdrawal by Subject|0|||
94434311|NCT04895982|323372147|FG004|Overall Study|Withdrawal by Subject|0|||
94434312|NCT04895982|323372148|FG005|Overall Study|Withdrawal by Subject|1|||
94434313|NCT04895982|323372149|FG006|Overall Study|Withdrawal by Subject|1|||
94434314|NCT04895982|323372150|FG007|Overall Study|Withdrawal by Subject|0|||
94434315|NCT04895982|323372151|FG008|Overall Study|Withdrawal by Subject|0|||
94434316|NCT04895982|323372152|FG009|Overall Study|Withdrawal by Subject|1|||
94434317|NCT04895982|323372153|FG010|Overall Study|Withdrawal by Subject|0|||
94434318|NCT04895982|323372154|FG011|Overall Study|Withdrawal by Subject|1|||
94434319|NCT04895982|323372143|FG000|Overall Study|Withdrawal by parent/guardian|2|||
94434320|NCT04895982|323372144|FG001|Overall Study|Withdrawal by parent/guardian|3|||
94434321|NCT04895982|323372145|FG002|Overall Study|Withdrawal by parent/guardian|3|||
94434322|NCT04895982|323372146|FG003|Overall Study|Withdrawal by parent/guardian|1|||
94434323|NCT04895982|323372147|FG004|Overall Study|Withdrawal by parent/guardian|3|||
94434324|NCT04895982|323372148|FG005|Overall Study|Withdrawal by parent/guardian|2|||
94434325|NCT04895982|323372149|FG006|Overall Study|Withdrawal by parent/guardian|1|||
94434326|NCT04895982|323372150|FG007|Overall Study|Withdrawal by parent/guardian|0|||
94434327|NCT04895982|323372151|FG008|Overall Study|Withdrawal by parent/guardian|3|||
94434328|NCT04895982|323372152|FG009|Overall Study|Withdrawal by parent/guardian|0|||
94434329|NCT04895982|323372153|FG010|Overall Study|Withdrawal by parent/guardian|0|||
94434330|NCT04895982|323372154|FG011|Overall Study|Withdrawal by parent/guardian|0|||
94434331|NCT04895982|323372143|FG000|Overall Study|Other|0|||
94434332|NCT04895982|323372144|FG001|Overall Study|Other|0|||
94434333|NCT04895982|323372145|FG002|Overall Study|Other|1|||
94434334|NCT04895982|323372146|FG003|Overall Study|Other|1|||
94434335|NCT04895982|323372147|FG004|Overall Study|Other|0|||
94434336|NCT04895982|323372148|FG005|Overall Study|Other|0|||
94434337|NCT04895982|323372149|FG006|Overall Study|Other|0|||
94434338|NCT04895982|323372150|FG007|Overall Study|Other|0|||
94434339|NCT04895982|323372151|FG008|Overall Study|Other|0|||
94434340|NCT04895982|323372152|FG009|Overall Study|Other|1|||
94434341|NCT04895982|323372153|FG010|Overall Study|Other|0|||
94434342|NCT04895982|323372154|FG011|Overall Study|Other|0|||
94434343|NCT04895982|323372143|FG000|Overall Study|Protocol Violation|0|||
94434344|NCT04895982|323372144|FG001|Overall Study|Protocol Violation|0|||
94434345|NCT04895982|323372145|FG002|Overall Study|Protocol Violation|1|||
94434346|NCT04895982|323372146|FG003|Overall Study|Protocol Violation|1|||
94434347|NCT04895982|323372147|FG004|Overall Study|Protocol Violation|1|||
94434348|NCT04895982|323372148|FG005|Overall Study|Protocol Violation|0|||
94434349|NCT04895982|323372149|FG006|Overall Study|Protocol Violation|0|||
94434350|NCT04895982|323372150|FG007|Overall Study|Protocol Violation|1|||
94434351|NCT04895982|323372151|FG008|Overall Study|Protocol Violation|0|||
94434352|NCT04895982|323372152|FG009|Overall Study|Protocol Violation|0|||
94434353|NCT04895982|323372153|FG010|Overall Study|Protocol Violation|0|||
94434354|NCT04895982|323372154|FG011|Overall Study|Protocol Violation|0|||
94434355|NCT04895982|323372143|FG000|Overall Study|Lost to Follow-up|0|||
94434356|NCT04895982|323372144|FG001|Overall Study|Lost to Follow-up|0|||
94490152|NCT00701363|323590262|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
94490153|NCT00701363|323590263|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
94434357|NCT04895982|323372145|FG002|Overall Study|Lost to Follow-up|1|||
94434358|NCT04895982|323372146|FG003|Overall Study|Lost to Follow-up|0|||
94434359|NCT04895982|323372147|FG004|Overall Study|Lost to Follow-up|0|||
94434360|NCT04895982|323372148|FG005|Overall Study|Lost to Follow-up|1|||
94434361|NCT04895982|323372149|FG006|Overall Study|Lost to Follow-up|0|||
94434362|NCT04895982|323372150|FG007|Overall Study|Lost to Follow-up|0|||
94434363|NCT04895982|323372151|FG008|Overall Study|Lost to Follow-up|1|||
94434364|NCT04895982|323372152|FG009|Overall Study|Lost to Follow-up|0|||
94434365|NCT04895982|323372153|FG010|Overall Study|Lost to Follow-up|0|||
94434366|NCT04895982|323372154|FG011|Overall Study|Lost to Follow-up|0|||
94434367|NCT04895982|323372143|FG000|Overall Study|Refused further study procedures|0|||
94434368|NCT04895982|323372144|FG001|Overall Study|Refused further study procedures|0|||
94434369|NCT04895982|323372145|FG002|Overall Study|Refused further study procedures|1|||
94434370|NCT04895982|323372146|FG003|Overall Study|Refused further study procedures|0|||
94434371|NCT04895982|323372147|FG004|Overall Study|Refused further study procedures|0|||
94434372|NCT04895982|323372148|FG005|Overall Study|Refused further study procedures|0|||
94434373|NCT04895982|323372149|FG006|Overall Study|Refused further study procedures|0|||
94434374|NCT04895982|323372150|FG007|Overall Study|Refused further study procedures|0|||
94434375|NCT04895982|323372151|FG008|Overall Study|Refused further study procedures|0|||
94434376|NCT04895982|323372152|FG009|Overall Study|Refused further study procedures|0|||
94434377|NCT04895982|323372153|FG010|Overall Study|Refused further study procedures|0|||
94434378|NCT04895982|323372154|FG011|Overall Study|Refused further study procedures|0|||
94434379|NCT00985491|323372159|FG000|Overall Study|Adverse Event|8|||
94434380|NCT00985491|323372159|FG000|Overall Study|device migration|7|||
94434381|NCT00985491|323372159|FG000|Overall Study|Withdrawal by Subject|1|||
94434382|NCT00985491|323372159|FG000|Overall Study|implant failure|3|||
94434383|NCT01449812|323372160|FG000|Overall Study|Migrated/moved from study area|1|||
94434384|NCT01449812|323372161|FG001|Overall Study|Migrated/moved from study area|0|||
94434385|NCT01449812|323372162|FG002|Overall Study|Migrated/moved from study area|0|||
94434386|NCT01449812|323372160|FG000|Overall Study|Withdrawal by Subject|0|||
94434387|NCT01449812|323372161|FG001|Overall Study|Withdrawal by Subject|0|||
94434388|NCT01449812|323372162|FG002|Overall Study|Withdrawal by Subject|1|||
94434389|NCT01449812|323372160|FG000|Overall Study|Lost to Follow-up|1|||
94434390|NCT01449812|323372161|FG001|Overall Study|Lost to Follow-up|0|||
94434391|NCT01449812|323372162|FG002|Overall Study|Lost to Follow-up|0|||
94434392|NCT01866098|323372165|FG000|Overall Study|Lost to Follow-up|11|||
94434393|NCT01866098|323372166|FG001|Overall Study|Lost to Follow-up|18|||
94434394|NCT01866098|323372167|FG002|Overall Study|Lost to Follow-up|13|||
94434395|NCT01866098|323372165|FG000|Overall Study|Physician Decision|0|||
94434396|NCT01866098|323372166|FG001|Overall Study|Physician Decision|1|||
94434397|NCT01866098|323372167|FG002|Overall Study|Physician Decision|2|||
94434398|NCT01866098|323372165|FG000|Overall Study|Adverse Event|1|||
94434399|NCT01866098|323372166|FG001|Overall Study|Adverse Event|5|||
94434400|NCT01866098|323372167|FG002|Overall Study|Adverse Event|4|||
94434401|NCT01866098|323372165|FG000|Overall Study|Protocol Violation|1|||
94434402|NCT01866098|323372166|FG001|Overall Study|Protocol Violation|0|||
94434403|NCT01866098|323372167|FG002|Overall Study|Protocol Violation|0|||
94434404|NCT01866098|323372165|FG000|Overall Study|Withdrawal by Subject|1|||
94434405|NCT01866098|323372166|FG001|Overall Study|Withdrawal by Subject|2|||
94434406|NCT01866098|323372167|FG002|Overall Study|Withdrawal by Subject|0|||
94434407|NCT01866098|323372165|FG000|Overall Study|Unrelated Hospitalization|2|||
94434408|NCT01866098|323372166|FG001|Overall Study|Unrelated Hospitalization|0|||
94434409|NCT01866098|323372167|FG002|Overall Study|Unrelated Hospitalization|1|||
94434410|NCT01866098|323372165|FG000|Overall Study|Non-compliance|1|||
94434411|NCT01866098|323372166|FG001|Overall Study|Non-compliance|0|||
94434412|NCT01866098|323372167|FG002|Overall Study|Non-compliance|1|||
94434413|NCT01866098|323372165|FG000|Overall Study|Pregnancy|2|||
94434414|NCT01866098|323372166|FG001|Overall Study|Pregnancy|0|||
94434415|NCT01866098|323372167|FG002|Overall Study|Pregnancy|0|||
94434416|NCT01866098|323372165|FG000|Overall Study|Death|0|||
94434417|NCT01866098|323372166|FG001|Overall Study|Death|1|||
94434418|NCT01866098|323372167|FG002|Overall Study|Death|0|||
94434419|NCT01377012|323372170|FG000|Core Study|Study terminated by Sponsor|47|||
94434420|NCT01377012|323372171|FG001|Core Study|Study terminated by Sponsor|54|||
94434421|NCT01377012|323372172|FG002|Core Study|Study terminated by Sponsor|46|||
94434422|NCT01377012|323372170|FG000|Core Study|Technical problems|1|||
94434423|NCT01377012|323372171|FG001|Core Study|Technical problems|0|||
94434424|NCT01377012|323372172|FG002|Core Study|Technical problems|0|||
94434425|NCT01377012|323372170|FG000|Core Study|Withdrawal by Subject|15|||
94434426|NCT01377012|323372171|FG001|Core Study|Withdrawal by Subject|23|||
94434427|NCT01377012|323372172|FG002|Core Study|Withdrawal by Subject|18|||
94434428|NCT01377012|323372170|FG000|Core Study|Protocol Violation|7|||
94434429|NCT01377012|323372171|FG001|Core Study|Protocol Violation|3|||
94434430|NCT01377012|323372172|FG002|Core Study|Protocol Violation|2|||
94434431|NCT01377012|323372170|FG000|Core Study|Pregnancy|0|||
94434432|NCT01377012|323372171|FG001|Core Study|Pregnancy|0|||
94434433|NCT01377012|323372172|FG002|Core Study|Pregnancy|1|||
94434434|NCT01377012|323372170|FG000|Core Study|Physician Decision|5|||
94434435|NCT01377012|323372171|FG001|Core Study|Physician Decision|4|||
94434436|NCT01377012|323372172|FG002|Core Study|Physician Decision|10|||
94434437|NCT01377012|323372170|FG000|Core Study|Non-Compliant with study treatment|0|||
94434438|NCT01377012|323372171|FG001|Core Study|Non-Compliant with study treatment|0|||
94434439|NCT01377012|323372172|FG002|Core Study|Non-Compliant with study treatment|1|||
94434440|NCT01377012|323372170|FG000|Core Study|No Longer require treatment|0|||
94434441|NCT01377012|323372171|FG001|Core Study|No Longer require treatment|0|||
94434442|NCT01377012|323372172|FG002|Core Study|No Longer require treatment|1|||
94434443|NCT01377012|323372170|FG000|Core Study|Lost to Follow-up|7|||
94434444|NCT01377012|323372171|FG001|Core Study|Lost to Follow-up|5|||
94434445|NCT01377012|323372172|FG002|Core Study|Lost to Follow-up|4|||
94434446|NCT01377012|323372170|FG000|Core Study|Lack of Efficacy|41|||
94434447|NCT01377012|323372171|FG001|Core Study|Lack of Efficacy|28|||
94434448|NCT01377012|323372172|FG002|Core Study|Lack of Efficacy|37|||
94434449|NCT01377012|323372170|FG000|Core Study|Death|1|||
94434450|NCT01377012|323372171|FG001|Core Study|Death|1|||
94434451|NCT01377012|323372172|FG002|Core Study|Death|1|||
94434452|NCT01377012|323372170|FG000|Core Study|Adverse Event|10|||
94434453|NCT01377012|323372171|FG001|Core Study|Adverse Event|14|||
94434454|NCT01377012|323372172|FG002|Core Study|Adverse Event|13|||
94434455|NCT01377012|323372170|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
94434456|NCT01377012|323372171|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
94434457|NCT01377012|323372172|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
94434458|NCT01377012|323372170|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
94434459|NCT01377012|323372171|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
94434460|NCT01377012|323372172|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
94434461|NCT01377012|323372170|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
94434462|NCT01377012|323372171|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
94434463|NCT01377012|323372172|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
94434464|NCT01377012|323372170|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
94434465|NCT01377012|323372171|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
94434466|NCT01377012|323372172|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
94434467|NCT01377012|323372170|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
94434468|NCT01377012|323372171|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
94434469|NCT01377012|323372172|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
94434470|NCT01377012|323372170|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
94434471|NCT01377012|323372171|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
94434472|NCT01377012|323372172|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
94434473|NCT00805961|323372175|FG000|Modality Therapy|Withdrawal by Subject|1|||
94434474|NCT00805961|323372175|FG000|Modality Therapy|Adverse Event|1|||
94434475|NCT00805961|323372175|FG000|Modality Therapy|Disease Progression|2|||
94434476|NCT00805961|323372175|FG000|Treatment-Free Interval|Adverse Event|3|||
94434477|NCT00805961|323372175|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
94434478|NCT00805961|323372175|FG000|Treatment-Free Interval|Physician Decision|1|||
94434479|NCT00805961|323372175|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
94434480|NCT00805961|323372175|FG000|Maintenance Treatment|Lack of Efficacy|13|||
94434481|NCT00805961|323372175|FG000|Maintenance Treatment|Intercurrent Illness|7|||
94434482|NCT00805961|323372175|FG000|Maintenance Treatment|Adverse Event|6|||
94434483|NCT00805961|323372175|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
94434484|NCT00805961|323372175|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
94434485|NCT00805961|323372175|FG000|Maintenance Treatment|Withdrawn Consent|1|||
94434486|NCT05422625|323372177|FG000|Overall Study|Withdrawal by Subject|1|||
94434487|NCT05422625|323372178|FG001|Overall Study|Withdrawal by Subject|0|||
94434488|NCT03132155|323373929|FG000|Overall Study|Lack of Efficacy|6|||
94434489|NCT03132155|323373929|FG000|Overall Study|Lost to Follow-up|1|||
94434490|NCT03132155|323373929|FG000|Overall Study|Withdrawal by Subject|1|||
94434491|NCT02094417|323373932|FG000|Overall Study|Adverse Event|0|||
94434492|NCT02094417|323373933|FG001|Overall Study|Adverse Event|0|||
94434493|NCT02094417|323373934|FG002|Overall Study|Adverse Event|0|||
94434494|NCT02094417|323373935|FG003|Overall Study|Adverse Event|1|||
94434495|NCT02094417|323373932|FG000|Overall Study|Eligibility criteria|0|||
94434496|NCT02094417|323373933|FG001|Overall Study|Eligibility criteria|1|||
94434497|NCT02094417|323373934|FG002|Overall Study|Eligibility criteria|0|||
94434498|NCT02094417|323373935|FG003|Overall Study|Eligibility criteria|0|||
94434499|NCT02094417|323373932|FG000|Overall Study|No responder|4|||
94434500|NCT02094417|323373933|FG001|Overall Study|No responder|4|||
94434501|NCT02094417|323373934|FG002|Overall Study|No responder|4|||
94434502|NCT02094417|323373935|FG003|Overall Study|No responder|3|||
94434503|NCT02094417|323373932|FG000|Overall Study|Unable to conduct observations or assess|0|||
94434504|NCT02094417|323373933|FG001|Overall Study|Unable to conduct observations or assess|1|||
94434505|NCT02094417|323373934|FG002|Overall Study|Unable to conduct observations or assess|0|||
94434506|NCT02094417|323373935|FG003|Overall Study|Unable to conduct observations or assess|0|||
94434507|NCT02094417|323373932|FG000|Overall Study|Withdrawal by Subject|1|||
94434508|NCT02094417|323373933|FG001|Overall Study|Withdrawal by Subject|2|||
94434509|NCT02094417|323373934|FG002|Overall Study|Withdrawal by Subject|1|||
94490154|NCT00701363|323590260|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
94434510|NCT02094417|323373935|FG003|Overall Study|Withdrawal by Subject|3|||
94490155|NCT00701363|323590261|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
94434511|NCT03333941|323373936|FG000|Overall Study|Lost to Follow-up|10|||
94434512|NCT03333941|323373936|FG000|Overall Study|Death|2|||
94434513|NCT03333941|323373936|FG000|Overall Study|Adverse Event|1|||
94434514|NCT00580788|323373937|FG000|Overall Study|Adverse Event|0|||
94434515|NCT00580788|323373938|FG001|Overall Study|Adverse Event|0|||
94434516|NCT00580788|323373939|FG002|Overall Study|Adverse Event|0|||
94434517|NCT00580788|323373940|FG003|Overall Study|Adverse Event|1|||
94434518|NCT00459355|323373942|FG000|Overall Study|Subject no longer met inc criteria|20|||
94434519|NCT00459355|323373943|FG001|Overall Study|Subject no longer met inc criteria|18|||
94434520|NCT02246114|323373947|FG000|Overall Study|miscarriage|1|||
94434521|NCT02246114|323373948|FG001|Overall Study|miscarriage|0|||
94434522|NCT01439009|323373950|FG000|Overall Study|Physician Decision|5|||
94434523|NCT01439009|323373951|FG001|Overall Study|Physician Decision|3|||
94434524|NCT01439009|323373950|FG000|Overall Study|Protocol Violation|2|||
94434525|NCT01439009|323373951|FG001|Overall Study|Protocol Violation|0|||
94434526|NCT01439009|323373950|FG000|Overall Study|Deviation of exclusion criteria|1|||
94434527|NCT01439009|323373951|FG001|Overall Study|Deviation of exclusion criteria|0|||
94434528|NCT00926783|323373952|FG000|Overall Study|Incomplete CFAE Procedures|3|||
94434529|NCT00926783|323373953|FG001|Overall Study|Incomplete CFAE Procedures|3|||
94434530|NCT00696787|323373956|FG000|Overall Study|Adverse Event|1|||
94434531|NCT00696787|323373957|FG001|Overall Study|Adverse Event|0|||
94434532|NCT00696787|323373958|FG002|Overall Study|Adverse Event|6|||
94434533|NCT00696787|323373956|FG000|Overall Study|Discontinuation by Sponsor|9|||
94434534|NCT00696787|323373957|FG001|Overall Study|Discontinuation by Sponsor|13|||
94434535|NCT00696787|323373958|FG002|Overall Study|Discontinuation by Sponsor|14|||
94434536|NCT00696787|323373956|FG000|Overall Study|Lack of Efficacy|0|||
94434537|NCT00696787|323373957|FG001|Overall Study|Lack of Efficacy|1|||
94434538|NCT00696787|323373958|FG002|Overall Study|Lack of Efficacy|0|||
94434539|NCT00696787|323373956|FG000|Overall Study|Lost to Follow-up|4|||
94434540|NCT00696787|323373957|FG001|Overall Study|Lost to Follow-up|0|||
94434541|NCT00696787|323373958|FG002|Overall Study|Lost to Follow-up|3|||
94434542|NCT00696787|323373956|FG000|Overall Study|Withdrawal by Subject|0|||
94434543|NCT00696787|323373957|FG001|Overall Study|Withdrawal by Subject|3|||
94434544|NCT00696787|323373958|FG002|Overall Study|Withdrawal by Subject|2|||
94434545|NCT00696787|323373956|FG000|Overall Study|Failed to return|1|||
94434546|NCT00696787|323373957|FG001|Overall Study|Failed to return|3|||
94434547|NCT00696787|323373958|FG002|Overall Study|Failed to return|1|||
94434548|NCT00129389|323373959|FG000|Overall Study|Adverse Event|19|||
94434549|NCT00129389|323373960|FG001|Overall Study|Adverse Event|87|||
94434550|NCT00129389|323373959|FG000|Overall Study|Death|0|||
94434551|NCT00129389|323373960|FG001|Overall Study|Death|1|||
94434552|NCT00129389|323373959|FG000|Overall Study|Lost to Follow-up|2|||
94434553|NCT00129389|323373960|FG001|Overall Study|Lost to Follow-up|1|||
94434554|NCT00129389|323373959|FG000|Overall Study|Physician Decision|0|||
94434555|NCT00129389|323373960|FG001|Overall Study|Physician Decision|4|||
94434556|NCT00129389|323373959|FG000|Overall Study|Protocol Violation|0|||
94434557|NCT00129389|323373960|FG001|Overall Study|Protocol Violation|6|||
94434558|NCT00129389|323373959|FG000|Overall Study|Withdrawal by Subject|9|||
94434559|NCT00129389|323373960|FG001|Overall Study|Withdrawal by Subject|23|||
94434560|NCT00129389|323373959|FG000|Overall Study|Relapse|1|||
94434561|NCT00129389|323373960|FG001|Overall Study|Relapse|0|||
94434562|NCT00129389|323373959|FG000|Overall Study|Not eligible|1|||
94434563|NCT00129389|323373960|FG001|Overall Study|Not eligible|2|||
94434564|NCT00129389|323373959|FG000|Overall Study|Crossed to the other arm|1|||
94434565|NCT00129389|323373960|FG001|Overall Study|Crossed to the other arm|16|||
94434566|NCT03760185|323373965|FG000|Overall Study|Lost to Follow-up|1|||
94434567|NCT03760185|323373966|FG001|Overall Study|Lost to Follow-up|1|||
94434568|NCT02111603|323373972|FG000|Overall Study|Withdrawal by Subject|1|||
94434569|NCT00976911|323373973|FG000|Overall Study|Withdrawal by Subject|4|||
94434570|NCT00976911|323373974|FG001|Overall Study|Withdrawal by Subject|6|||
94434571|NCT00976911|323373973|FG000|Overall Study|Death|138|||
94434572|NCT00976911|323373974|FG001|Overall Study|Death|126|||
94434573|NCT00976911|323373973|FG000|Overall Study|Adverse Event|0|||
94434574|NCT00976911|323373974|FG001|Overall Study|Adverse Event|1|||
94434575|NCT00976911|323373973|FG000|Overall Study|Protocol Violation|2|||
94434576|NCT00976911|323373974|FG001|Overall Study|Protocol Violation|0|||
94434577|NCT00976911|323373973|FG000|Overall Study|Other|8|||
94434578|NCT00976911|323373974|FG001|Overall Study|Other|9|||
94434579|NCT00976911|323373973|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
94434580|NCT00976911|323373974|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
94434581|NCT04602546|323373977|FG000|Overall Study|Training|2|||
94434582|NCT04602546|323373978|FG001|Overall Study|Training|2|||
94434583|NCT04602546|323373979|FG002|Overall Study|Training|1|||
94434584|NCT04602546|323373980|FG003|Overall Study|Training|2|||
94434585|NCT04602546|323373981|FG004|Overall Study|Training|0|||
94434586|NCT04602546|323373977|FG000|Overall Study|Randomized with disqualified data|2|||
94434587|NCT04602546|323373978|FG001|Overall Study|Randomized with disqualified data|0|||
94434588|NCT04602546|323373979|FG002|Overall Study|Randomized with disqualified data|2|||
94434589|NCT04602546|323373980|FG003|Overall Study|Randomized with disqualified data|5|||
94434590|NCT04602546|323373981|FG004|Overall Study|Randomized with disqualified data|3|||
94434591|NCT01582152|323373982|FG000|Overall Study|Disease Progression|4|||
94434592|NCT01582152|323373983|FG001|Overall Study|Disease Progression|5|||
94434593|NCT01582152|323373982|FG000|Overall Study|Adverse Event|2|||
94434594|NCT01582152|323373983|FG001|Overall Study|Adverse Event|1|||
94434595|NCT04611529|323373985|FG000|2-day Follow up|Lost to Follow-up|5|||
94434596|NCT04611529|323373986|FG001|2-day Follow up|Lost to Follow-up|6|||
94434597|NCT04611529|323373987|FG002|2-day Follow up|Lost to Follow-up|3|||
94434598|NCT01775189|323373988|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
94434599|NCT01775189|323373989|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
94434600|NCT01775189|323373990|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
94434601|NCT01775189|323373991|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
94434602|NCT01775189|323373992|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
94434603|NCT01775189|323373993|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
94434604|NCT01775189|323373994|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
94434605|NCT01775189|323373988|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
94434606|NCT01775189|323373989|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
94434607|NCT01775189|323373990|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
94434608|NCT01775189|323373991|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
94434609|NCT01775189|323373992|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
94434610|NCT01775189|323373993|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
94434611|NCT01775189|323373994|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
94434612|NCT01775189|323373988|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
94434613|NCT01775189|323373989|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
94434614|NCT01775189|323373990|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
94434615|NCT01775189|323373991|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
94434616|NCT01775189|323373992|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
94434617|NCT01775189|323373993|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
94434618|NCT01775189|323373994|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
94434619|NCT01775189|323373988|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
94434620|NCT01775189|323373989|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
94434621|NCT01775189|323373990|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
94434622|NCT01775189|323373991|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
94434623|NCT01775189|323373992|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
94434624|NCT01775189|323373993|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
94434625|NCT01775189|323373994|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
94434626|NCT01775189|323373988|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
94434627|NCT01775189|323373989|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
94434628|NCT01775189|323373990|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
94434629|NCT01775189|323373991|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
94434630|NCT01775189|323373992|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
94434631|NCT01775189|323373993|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
94434632|NCT01775189|323373994|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
94434633|NCT01775189|323373988|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
94434634|NCT01775189|323373989|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
94434635|NCT01775189|323373990|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
94434636|NCT01775189|323373991|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
94434637|NCT01775189|323373992|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
94434638|NCT01775189|323373993|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
94434639|NCT01775189|323373994|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
94434640|NCT00425373|323374057|FG000|Overall Study|Adverse Event|2|||
94434641|NCT00425373|323374058|FG001|Overall Study|Adverse Event|2|||
94434642|NCT00425373|323374059|FG002|Overall Study|Adverse Event|0|||
94434643|NCT00425373|323374060|FG003|Overall Study|Adverse Event|1|||
94434644|NCT00425373|323374061|FG004|Overall Study|Adverse Event|4|||
94434645|NCT00425373|323374062|FG005|Overall Study|Adverse Event|6|||
94434646|NCT00425373|323374063|FG006|Overall Study|Adverse Event|2|||
94434647|NCT00425373|323374064|FG007|Overall Study|Adverse Event|3|||
94434648|NCT00425373|323374065|FG008|Overall Study|Adverse Event|8|||
94434649|NCT00425373|323374057|FG000|Overall Study|Lost to Follow-up|0|||
94434650|NCT00425373|323374058|FG001|Overall Study|Lost to Follow-up|1|||
94434651|NCT00425373|323374059|FG002|Overall Study|Lost to Follow-up|0|||
94434652|NCT00425373|323374060|FG003|Overall Study|Lost to Follow-up|0|||
94434653|NCT00425373|323374061|FG004|Overall Study|Lost to Follow-up|1|||
94434654|NCT00425373|323374062|FG005|Overall Study|Lost to Follow-up|0|||
94434655|NCT00425373|323374063|FG006|Overall Study|Lost to Follow-up|0|||
94434656|NCT00425373|323374064|FG007|Overall Study|Lost to Follow-up|0|||
94434657|NCT00425373|323374065|FG008|Overall Study|Lost to Follow-up|0|||
94434658|NCT00425373|323374057|FG000|Overall Study|Protocol Violation|1|||
94434659|NCT00425373|323374058|FG001|Overall Study|Protocol Violation|0|||
94434660|NCT00425373|323374059|FG002|Overall Study|Protocol Violation|1|||
94434661|NCT00425373|323374060|FG003|Overall Study|Protocol Violation|0|||
94434662|NCT00425373|323374061|FG004|Overall Study|Protocol Violation|0|||
94434663|NCT00425373|323374062|FG005|Overall Study|Protocol Violation|0|||
94434664|NCT00425373|323374063|FG006|Overall Study|Protocol Violation|0|||
94434665|NCT00425373|323374064|FG007|Overall Study|Protocol Violation|5|||
94434666|NCT00425373|323374065|FG008|Overall Study|Protocol Violation|3|||
94434667|NCT00425373|323374057|FG000|Overall Study|Withdrawal by Subject|2|||
94434668|NCT00425373|323374058|FG001|Overall Study|Withdrawal by Subject|0|||
94434669|NCT00425373|323374059|FG002|Overall Study|Withdrawal by Subject|2|||
94434670|NCT00425373|323374060|FG003|Overall Study|Withdrawal by Subject|1|||
94434671|NCT00425373|323374061|FG004|Overall Study|Withdrawal by Subject|4|||
94434672|NCT00425373|323374062|FG005|Overall Study|Withdrawal by Subject|0|||
94434673|NCT00425373|323374063|FG006|Overall Study|Withdrawal by Subject|2|||
94434674|NCT00425373|323374064|FG007|Overall Study|Withdrawal by Subject|2|||
94434675|NCT00425373|323374065|FG008|Overall Study|Withdrawal by Subject|2|||
94434676|NCT00425373|323374057|FG000|Overall Study|Lack of Efficacy|0|||
94434677|NCT00425373|323374058|FG001|Overall Study|Lack of Efficacy|0|||
94434678|NCT00425373|323374059|FG002|Overall Study|Lack of Efficacy|0|||
94434679|NCT00425373|323374060|FG003|Overall Study|Lack of Efficacy|0|||
94434680|NCT00425373|323374061|FG004|Overall Study|Lack of Efficacy|1|||
94434681|NCT00425373|323374062|FG005|Overall Study|Lack of Efficacy|3|||
94434682|NCT00425373|323374063|FG006|Overall Study|Lack of Efficacy|3|||
94434683|NCT00425373|323374064|FG007|Overall Study|Lack of Efficacy|0|||
94434684|NCT00425373|323374065|FG008|Overall Study|Lack of Efficacy|5|||
94434685|NCT02564887|323374067|FG000|Overall Study|Lost to Follow-up|6|||
94434686|NCT02564887|323374068|FG001|Overall Study|Lost to Follow-up|0|||
94434687|NCT00735397|323374069|FG000|Overall Study|Adverse Event|194|||
94434688|NCT00735397|323374069|FG000|Overall Study|Lost to Follow-up|33|||
94434689|NCT00735397|323374069|FG000|Overall Study|Participant choice|252|||
94434690|NCT00735397|323374069|FG000|Overall Study|Inadequate therapeutic effect|202|||
94434691|NCT00735397|323374069|FG000|Overall Study|Administrative/Other|502|||
94434692|NCT02368314|323374072|FG000|Overall Study|Withdrawal by Subject|2|||
94434693|NCT02368314|323374073|FG001|Overall Study|Withdrawal by Subject|1|||
94434694|NCT02368314|323374072|FG000|Overall Study|Adverse Event|1|||
94434695|NCT02368314|323374073|FG001|Overall Study|Adverse Event|2|||
94434696|NCT01266031|323374074|FG000|Overall Study|Not treated|0|||
94434697|NCT01266031|323374075|FG001|Overall Study|Not treated|3|||
94434698|NCT01266031|323374076|FG002|Overall Study|Not treated|2|||
94434699|NCT01434810|323374081|FG000|Overall Study|Did not receive treatment|11|||
94434700|NCT01434810|323374082|FG001|Overall Study|Did not receive treatment|3|||
94434701|NCT01434810|323374081|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
94434702|NCT01434810|323374082|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
94434703|NCT02794870|323374085|FG000|Overall Study|Withdrawal by Subject|2|||
94434704|NCT02794870|323374086|FG001|Overall Study|Withdrawal by Subject|0|||
94434705|NCT03336528|323374087|FG000|Overall Study|Protocol Violation|1|||
94434706|NCT03336528|323374088|FG001|Overall Study|Protocol Violation|1|||
94434707|NCT03336528|323374087|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
94434708|NCT03336528|323374088|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
94434709|NCT03336528|323374087|FG000|Overall Study|Did not receive study medication|1|||
94434710|NCT03336528|323374088|FG001|Overall Study|Did not receive study medication|2|||
94434711|NCT02437903|323374096|FG000|Overall Study|Adverse Event|1|||
94434712|NCT02437903|323374096|FG000|Overall Study|Withdrawal by Subject|1|||
94434713|NCT02437903|323374096|FG000|Overall Study|Lost to Follow-up|3|||
94434714|NCT00230178|323374097|FG000|Overall Study|Adverse Event|1|||
94434715|NCT00230178|323374098|FG001|Overall Study|Adverse Event|5|||
94434716|NCT00230178|323374099|FG002|Overall Study|Adverse Event|2|||
94434717|NCT00230178|323374097|FG000|Overall Study|Withdrawal by Subject|0|||
94434718|NCT00230178|323374098|FG001|Overall Study|Withdrawal by Subject|0|||
94434719|NCT00230178|323374099|FG002|Overall Study|Withdrawal by Subject|1|||
94434720|NCT00230178|323374097|FG000|Overall Study|Various other reasons|3|||
94434721|NCT00230178|323374098|FG001|Overall Study|Various other reasons|2|||
94434722|NCT00230178|323374099|FG002|Overall Study|Various other reasons|4|||
94434723|NCT01753297|323374100|FG000|Overall Study|Lost to Follow-up|7|||
94434724|NCT01753297|323374101|FG001|Overall Study|Lost to Follow-up|2|||
94434725|NCT01753297|323374100|FG000|Overall Study|Withdrawal by Subject|26|||
94434726|NCT01753297|323374101|FG001|Overall Study|Withdrawal by Subject|23|||
94434727|NCT01753297|323374100|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
94434728|NCT01753297|323374101|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
94434729|NCT01753297|323374100|FG000|Overall Study|Death|0|||
94434730|NCT01753297|323374101|FG001|Overall Study|Death|2|||
94434731|NCT01753297|323374100|FG000|Overall Study|Did not attend end of study visit|7|||
94434732|NCT01753297|323374101|FG001|Overall Study|Did not attend end of study visit|8|||
94434733|NCT01068262|323374104|FG000|Overall Study|Adverse Event|2|||
94434734|NCT01068262|323374105|FG001|Overall Study|Adverse Event|0|||
94434735|NCT01068262|323374106|FG002|Overall Study|Adverse Event|1|||
94490156|NCT00701363|323590262|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
94434736|NCT01068262|323374107|FG003|Overall Study|Adverse Event|0|||
94434737|NCT01068262|323374104|FG000|Overall Study|Protocol Violation|1|||
94434738|NCT01068262|323374105|FG001|Overall Study|Protocol Violation|0|||
94434739|NCT01068262|323374106|FG002|Overall Study|Protocol Violation|0|||
94434740|NCT01068262|323374107|FG003|Overall Study|Protocol Violation|0|||
94434741|NCT01068262|323374104|FG000|Overall Study|Withdrawal by Subject|0|||
94434742|NCT01068262|323374105|FG001|Overall Study|Withdrawal by Subject|1|||
94434743|NCT01068262|323374106|FG002|Overall Study|Withdrawal by Subject|0|||
94434744|NCT01068262|323374107|FG003|Overall Study|Withdrawal by Subject|0|||
94434745|NCT01275729|323374108|FG000|Overall Study|Death|3|||
94434746|NCT01275729|323374108|FG000|Overall Study|Withdrawal by Subject|1|||
94434747|NCT02842073|323374109|FG000|Overall Study|Withdrawal by Subject|1|||
94434748|NCT00195338|323374110|FG000|Overall Study|Lost to Follow-up|2|||
94434749|NCT00195338|323374110|FG000|Overall Study|Adverse Event|5|||
94434750|NCT00195338|323374110|FG000|Overall Study|Lack of Efficacy|1|||
94434751|NCT00195338|323374110|FG000|Overall Study|Early closure of the site|4|||
94434752|NCT00005957|323374113|FG000|Overall Study|No treated|3|||
94434753|NCT00005957|323374114|FG001|Overall Study|No treated|9|||
94434754|NCT00005957|323374113|FG000|Overall Study|Crossover to the other arm|5|||
94434755|NCT00005957|323374114|FG001|Overall Study|Crossover to the other arm|19|||
94434756|NCT01174043|323374115|FG000|Overall Study|Disease progression|5|||
94434757|NCT01174043|323374115|FG000|Overall Study|Adverse Event|3|||
94434758|NCT01174043|323374115|FG000|Overall Study|Death|1|||
94434759|NCT01174043|323374115|FG000|Overall Study|Withdrawal by Subject|2|||
94434760|NCT03201445|323374124|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
94434761|NCT03201445|323374125|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
94434762|NCT03201445|323374124|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
94434763|NCT03201445|323374125|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
94434764|NCT03201445|323374124|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
94434765|NCT03201445|323374125|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
94434766|NCT03201445|323374124|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
94434767|NCT03201445|323374125|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
94434768|NCT03201445|323374124|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
94434769|NCT03201445|323374125|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
94434770|NCT03201445|323374124|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
94434771|NCT03201445|323374125|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
94434772|NCT03201445|323374124|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
94434773|NCT03201445|323374125|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
94434774|NCT03201445|323374124|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
94434775|NCT03201445|323374125|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
94434776|NCT03201445|323374124|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
94434777|NCT03201445|323374125|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
94434778|NCT03201445|323374124|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
94434779|NCT03201445|323374125|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
94434780|NCT03201445|323374124|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
94434781|NCT03201445|323374125|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
94434782|NCT03201445|323374124|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
94434783|NCT03201445|323374125|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
94434784|NCT03201445|323374124|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
94434785|NCT03201445|323374125|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
94434786|NCT03201445|323374124|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
94434787|NCT03201445|323374125|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
94434788|NCT03201445|323374124|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
94434789|NCT03201445|323374125|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
94434790|NCT03201445|323374124|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
94434791|NCT03201445|323374125|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
94434792|NCT03201445|323374124|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
94434793|NCT03201445|323374125|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
94434794|NCT03201445|323374124|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
94434795|NCT03201445|323374125|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
94434796|NCT03201445|323374124|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
94434797|NCT03201445|323374125|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
94434798|NCT03201445|323374124|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
94434799|NCT03201445|323374125|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
94434800|NCT03201445|323374124|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
94434801|NCT03201445|323374125|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
94490157|NCT00701363|323590263|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
94490158|NCT00701363|323590260|FG000|Treatment Phase 1|Adverse Event|7|||
94434802|NCT04974749|323374129|FG000|Overall Study|Withdrawal by Subject|2|||
94434803|NCT04974749|323374129|FG000|Overall Study|Gestation|1|||
94434804|NCT02640690|323374130|FG000|Overall Study|Lost to Follow-up|7|||
94434805|NCT02640690|323374131|FG001|Overall Study|Lost to Follow-up|7|||
94434806|NCT02640690|323374130|FG000|Overall Study|Withdrawal by Subject|16|||
94434807|NCT02640690|323374131|FG001|Overall Study|Withdrawal by Subject|20|||
94490159|NCT00701363|323590261|FG001|Treatment Phase 1|Adverse Event|0|||
94490160|NCT00701363|323590262|FG002|Treatment Phase 1|Adverse Event|0|||
94434808|NCT02640690|323374130|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
94434809|NCT02640690|323374131|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
94434810|NCT02289456|323374132|FG000|Induction Period|Death|2|||
94434811|NCT02289456|323374132|FG000|Induction Period|Adverse Event|11|||
94434812|NCT02289456|323374132|FG000|Induction Period|Progressive Disease (PD)|4|||
94434813|NCT02289456|323374132|FG000|Induction Period|Symptomatic Deterioration|4|||
94434814|NCT02289456|323374132|FG000|Induction Period|Withdrawal by Subject|2|||
94434815|NCT02289456|323374132|FG000|Induction Period|Miscellaneous|1|||
94434816|NCT02289456|323374132|FG000|Monotherapy Period|Death|1|||
94434817|NCT02289456|323374132|FG000|Monotherapy Period|Adverse Event|1|||
94434818|NCT02289456|323374132|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
94434819|NCT02289456|323374132|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
94434820|NCT02289456|323374132|FG000|Monotherapy Period|Withdrawal by Subject|2|||
94434821|NCT02289456|323374132|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
94434822|NCT02289456|323374132|FG000|Monotherapy Period|Miscellaneous|1|||
94434823|NCT02910011|323374133|FG000|Overall Study|Physician Decision|2|||
94434824|NCT01399658|323374134|FG000|Overall Study|Ineligible|1|||
94434825|NCT01399658|323374134|FG000|Overall Study|Machine Technical Issue|3|||
94434826|NCT01399658|323374134|FG000|Overall Study|Alternative therapy|1|||
94434827|NCT01399658|323374134|FG000|Overall Study|No reason given|1|||
94434828|NCT00920790|323374135|FG000|Overall Study|aggravation of general condition|14|||
94434829|NCT02460679|323374138|FG000|Overall Study|Investigator Decision|1|||
94434830|NCT02460679|323374138|FG000|Overall Study|Withdrawal by Subject|4|||
94434831|NCT01661062|323374139|FG000|Overall Study|Completed Treatment Off Study|3|||
94434832|NCT01661062|323374139|FG000|Overall Study|Withdrawal by Subject|2|||
94434833|NCT04315506|323374143|FG000|Overall Study|Lost to Follow-up|74|||
94434834|NCT04315506|323374144|FG001|Overall Study|Lost to Follow-up|82|||
94434835|NCT04315506|323374143|FG000|Overall Study|Withdrawal by Subject|8|||
94434836|NCT04315506|323374144|FG001|Overall Study|Withdrawal by Subject|8|||
94434837|NCT04315506|323374143|FG000|Overall Study|Physician Decision|0|||
94434838|NCT04315506|323374144|FG001|Overall Study|Physician Decision|1|||
94434839|NCT02585778|323374145|FG000|Overall Study|Adverse Event|17|||
94434840|NCT02585778|323374146|FG001|Overall Study|Adverse Event|4|||
94434841|NCT02585778|323374145|FG000|Overall Study|Participant did not wish to continue|9|||
94434842|NCT02585778|323374146|FG001|Overall Study|Participant did not wish to continue|4|||
94434843|NCT02585778|323374145|FG000|Overall Study|Poor compliance to study protocol|0|||
94434844|NCT02585778|323374146|FG001|Overall Study|Poor compliance to study protocol|2|||
94434845|NCT02585778|323374145|FG000|Overall Study|Death|0|||
94434846|NCT02585778|323374146|FG001|Overall Study|Death|1|||
94434847|NCT02585778|323374145|FG000|Overall Study|Randomized but not treated|1|||
94434848|NCT02585778|323374146|FG001|Overall Study|Randomized but not treated|2|||
94434849|NCT02585778|323374145|FG000|Overall Study|Other than specified above|6|||
94434850|NCT02585778|323374146|FG001|Overall Study|Other than specified above|2|||
94434851|NCT00879411|323374147|FG000|Overall Study|lost to follow-up (non-AE)|162|||
94434852|NCT01141205|323374148|FG000|Overall Study|Physician Decision|1|||
94434853|NCT01141205|323374149|FG001|Overall Study|Physician Decision|1|||
94434854|NCT01141205|323374148|FG000|Overall Study|Lost to Follow-up|1|||
94434855|NCT01141205|323374149|FG001|Overall Study|Lost to Follow-up|0|||
94434856|NCT01141205|323374148|FG000|Overall Study|Withdrawal by Subject|1|||
94434857|NCT01141205|323374149|FG001|Overall Study|Withdrawal by Subject|1|||
94434858|NCT04778904|323375890|FG000|Overall Study|Protocol Violation|1|||
94434859|NCT04778904|323375891|FG001|Overall Study|Protocol Violation|0|||
94434860|NCT04778904|323375892|FG002|Overall Study|Protocol Violation|0|||
94434861|NCT04778904|323375893|FG003|Overall Study|Protocol Violation|0|||
94434862|NCT04778904|323375890|FG000|Overall Study|Withdrawal by Subject|0|||
94434863|NCT04778904|323375891|FG001|Overall Study|Withdrawal by Subject|0|||
94434864|NCT04778904|323375892|FG002|Overall Study|Withdrawal by Subject|1|||
94434865|NCT04778904|323375893|FG003|Overall Study|Withdrawal by Subject|0|||
94434866|NCT03156504|323375894|FG000|Overall Study|Withdrawal by Subject|1|||
94434867|NCT03301649|323375895|FG000|Overall Study|Need alternate therapy due to live lice|17|||
94434868|NCT03301649|323375896|FG001|Overall Study|Need alternate therapy due to live lice|25|||
94434869|NCT03301649|323375897|FG002|Overall Study|Need alternate therapy due to live lice|81|||
94434870|NCT03301649|323375895|FG000|Overall Study|Lost to Follow-up|11|||
94490161|NCT00701363|323590263|FG003|Treatment Phase 1|Adverse Event|0|||
94490162|NCT00701363|323590260|FG000|Treatment Phase 1|Protocol Violation|1|||
94434871|NCT03301649|323375896|FG001|Overall Study|Lost to Follow-up|11|||
94434872|NCT03301649|323375897|FG002|Overall Study|Lost to Follow-up|3|||
94434873|NCT03301649|323375895|FG000|Overall Study|Protocol Violation|0|||
94434874|NCT03301649|323375896|FG001|Overall Study|Protocol Violation|1|||
94434875|NCT03301649|323375897|FG002|Overall Study|Protocol Violation|1|||
94434876|NCT03301649|323375895|FG000|Overall Study|Withdrawal by Subject|10|||
94434877|NCT03301649|323375896|FG001|Overall Study|Withdrawal by Subject|4|||
94434878|NCT03301649|323375897|FG002|Overall Study|Withdrawal by Subject|0|||
94434879|NCT03301649|323375895|FG000|Overall Study|Other than specified|5|||
94434880|NCT03301649|323375896|FG001|Overall Study|Other than specified|3|||
94434881|NCT03301649|323375897|FG002|Overall Study|Other than specified|0|||
94434882|NCT01564537|323375898|FG000|Overall Study|Site Terminated by Sponsor|1|||
94434883|NCT01564537|323375899|FG001|Overall Study|Site Terminated by Sponsor|0|||
94434884|NCT01564537|323375898|FG000|Overall Study|Withdrawal by Subject|12|||
94434885|NCT01564537|323375899|FG001|Overall Study|Withdrawal by Subject|14|||
94434886|NCT01564537|323375898|FG000|Overall Study|Lost to Follow-up|7|||
94434887|NCT01564537|323375899|FG001|Overall Study|Lost to Follow-up|3|||
94434888|NCT01564537|323375898|FG000|Overall Study|Reason not specified|81|||
94434889|NCT01564537|323375899|FG001|Overall Study|Reason not specified|82|||
94434890|NCT00287586|323375900|FG000|Overall Study|Withdrew Consent|19|||
94434891|NCT00287586|323375901|FG001|Overall Study|Withdrew Consent|30|||
94434892|NCT00287586|323375900|FG000|Overall Study|Lost to Follow-up|5|||
94434893|NCT00287586|323375901|FG001|Overall Study|Lost to Follow-up|4|||
94434894|NCT00287586|323375900|FG000|Overall Study|Death|2|||
94434895|NCT00287586|323375901|FG001|Overall Study|Death|3|||
94434896|NCT00287586|323375900|FG000|Overall Study|Elevated Hematocrit|3|||
94434897|NCT00287586|323375901|FG001|Overall Study|Elevated Hematocrit|0|||
94434898|NCT00287586|323375900|FG000|Overall Study|Rash|3|||
94434899|NCT00287586|323375901|FG001|Overall Study|Rash|0|||
94434900|NCT00287586|323375900|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
94434901|NCT00287586|323375901|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
94434902|NCT00287586|323375900|FG000|Overall Study|Stroke|2|||
94434903|NCT00287586|323375901|FG001|Overall Study|Stroke|0|||
94434904|NCT00287586|323375900|FG000|Overall Study|Myocardial Infarction|1|||
94434905|NCT00287586|323375901|FG001|Overall Study|Myocardial Infarction|0|||
94434906|NCT00287586|323375900|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
94434907|NCT00287586|323375901|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
94434908|NCT00287586|323375900|FG000|Overall Study|Cognitive Impairment|1|||
94434909|NCT00287586|323375901|FG001|Overall Study|Cognitive Impairment|0|||
94434910|NCT00287586|323375900|FG000|Overall Study|Pancreatic Cancer|1|||
94434911|NCT00287586|323375901|FG001|Overall Study|Pancreatic Cancer|3|||
94434912|NCT00287586|323375900|FG000|Overall Study|Sleep Apnea|1|||
94434913|NCT00287586|323375901|FG001|Overall Study|Sleep Apnea|0|||
94434914|NCT00287586|323375900|FG000|Overall Study|Shoulder Pain|1|||
94434915|NCT00287586|323375901|FG001|Overall Study|Shoulder Pain|0|||
94434916|NCT00287586|323375900|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
94434917|NCT00287586|323375901|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
94434918|NCT00287586|323375900|FG000|Overall Study|Nonadherence|1|||
94434919|NCT00287586|323375901|FG001|Overall Study|Nonadherence|1|||
94434920|NCT00287586|323375900|FG000|Overall Study|Enrolled in Another Study|1|||
94434921|NCT00287586|323375901|FG001|Overall Study|Enrolled in Another Study|0|||
94434922|NCT00287586|323375900|FG000|Overall Study|Major Depression|0|||
94434923|NCT00287586|323375901|FG001|Overall Study|Major Depression|2|||
94434924|NCT00287586|323375900|FG000|Overall Study|Lung Cancer|0|||
94434925|NCT00287586|323375901|FG001|Overall Study|Lung Cancer|2|||
94434926|NCT00287586|323375900|FG000|Overall Study|Elevated IPSS Score|0|||
94434927|NCT00287586|323375901|FG001|Overall Study|Elevated IPSS Score|1|||
94434928|NCT00287586|323375900|FG000|Overall Study|Retroperitoneal Cancer|0|||
94434929|NCT00287586|323375901|FG001|Overall Study|Retroperitoneal Cancer|1|||
94434930|NCT00287586|323375900|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
94434931|NCT00287586|323375901|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
94434932|NCT00287586|323375900|FG000|Overall Study|Mood Swings and Irritability|0|||
94434933|NCT00287586|323375901|FG001|Overall Study|Mood Swings and Irritability|1|||
94434934|NCT00287586|323375900|FG000|Overall Study|Bradycardia|0|||
94434935|NCT00287586|323375901|FG001|Overall Study|Bradycardia|1|||
94434936|NCT00287586|323375900|FG000|Overall Study|Itchy Swollen Eyes|0|||
94434937|NCT00287586|323375901|FG001|Overall Study|Itchy Swollen Eyes|1|||
94434938|NCT00287586|323375900|FG000|Overall Study|Recurrent Melanoma|0|||
94434939|NCT00287586|323375901|FG001|Overall Study|Recurrent Melanoma|1|||
94434940|NCT03106987|323375902|FG000|Overall Study|Death|37|||
94434941|NCT03106987|323375903|FG001|Overall Study|Death|22|||
94434942|NCT03106987|323375904|FG002|Overall Study|Death|12|||
94434943|NCT03106987|323375905|FG003|Overall Study|Death|8|||
94434944|NCT03106987|323375902|FG000|Overall Study|Lost to Follow-up|2|||
94434945|NCT03106987|323375903|FG001|Overall Study|Lost to Follow-up|0|||
94490163|NCT00701363|323590261|FG001|Treatment Phase 1|Protocol Violation|0|||
94490164|NCT00701363|323590262|FG002|Treatment Phase 1|Protocol Violation|0|||
94490165|NCT00701363|323590263|FG003|Treatment Phase 1|Protocol Violation|0|||
94434946|NCT03106987|323375904|FG002|Overall Study|Lost to Follow-up|2|||
94434947|NCT03106987|323375905|FG003|Overall Study|Lost to Follow-up|2|||
94434948|NCT03106987|323375902|FG000|Overall Study|Withdrawal by Subject|5|||
94434949|NCT03106987|323375903|FG001|Overall Study|Withdrawal by Subject|1|||
94434950|NCT03106987|323375904|FG002|Overall Study|Withdrawal by Subject|4|||
94434951|NCT03106987|323375905|FG003|Overall Study|Withdrawal by Subject|1|||
94434952|NCT00799825|323375906|FG000|Overall Study|Adverse Event|1|||
94434953|NCT00799825|323375906|FG000|Overall Study|Withdrawal by Subject|6|||
94434954|NCT00799825|323375906|FG000|Overall Study|Lost to Follow-up|38|||
94434955|NCT00799825|323375906|FG000|Overall Study|Pregnancy|3|||
94434956|NCT00794339|323375907|FG000|Overall Study|Withdrawal by Subject|3|||
94434957|NCT00794339|323375907|FG000|Overall Study|Ineligible|4|||
94434958|NCT00794339|323375907|FG000|Overall Study|Tx prior to ATSM|3|||
94434959|NCT00794339|323375907|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
94434960|NCT00794339|323375907|FG000|Overall Study|Tx not per protocol|1|||
94434961|NCT01085357|323375908|FG000|Overall Study|Adverse Event|1|||
94434962|NCT01085357|323375909|FG001|Overall Study|Adverse Event|1|||
94434963|NCT01085357|323375908|FG000|Overall Study|Subject Decision|4|||
94434964|NCT01085357|323375909|FG001|Overall Study|Subject Decision|3|||
94434965|NCT01085357|323375908|FG000|Overall Study|Investigator Decision|1|||
94434966|NCT01085357|323375909|FG001|Overall Study|Investigator Decision|1|||
94434967|NCT01085357|323375908|FG000|Overall Study|Death|11|||
94434968|NCT01085357|323375909|FG001|Overall Study|Death|1|||
94434969|NCT01085357|323375908|FG000|Overall Study|Lost to Follow-up|2|||
94434970|NCT01085357|323375909|FG001|Overall Study|Lost to Follow-up|0|||
94434971|NCT01611857|323375910|FG000|Overall Study|Withdrawal by Subject|0|||
94434972|NCT01611857|323375911|FG001|Overall Study|Withdrawal by Subject|2|||
94434973|NCT00314951|323375912|FG000|Treatment|Didn't meet criteria for mITT population|16|||
94434974|NCT00314951|323375913|FG001|Treatment|Didn't meet criteria for mITT population|11|||
94434975|NCT00314951|323375912|FG000|Follow-up|mITT failure|44|||
94434976|NCT00314951|323375913|FG001|Follow-up|mITT failure|34|||
94434977|NCT02952586|323375917|FG000|Lead-In Phase (7 Days)|Death|0|||
94434978|NCT02952586|323375918|FG001|Lead-In Phase (7 Days)|Death|1|||
94434979|NCT02952586|323375917|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
94434980|NCT02952586|323375918|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
94434981|NCT02952586|323375917|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
94434982|NCT02952586|323375918|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
94434983|NCT02952586|323375917|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
94434984|NCT02952586|323375918|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
94434985|NCT02952586|323375917|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
94434986|NCT02952586|323375918|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
94434987|NCT02952586|323375917|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
94434988|NCT02952586|323375918|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
94434989|NCT02952586|323375917|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
94434990|NCT02952586|323375918|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
94434991|NCT02952586|323375917|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
94434992|NCT02952586|323375918|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
94434993|NCT02952586|323375917|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
94434994|NCT02952586|323375918|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
94434995|NCT02952586|323375917|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
94434996|NCT02952586|323375918|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
94434997|NCT02952586|323375917|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
94434998|NCT02952586|323375918|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
94434999|NCT02952586|323375917|FG000|CRT for Cisplatin (63 Days)|Death|3|||
94435000|NCT02952586|323375918|FG001|CRT for Cisplatin (63 Days)|Death|8|||
94435001|NCT02952586|323375917|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
94435002|NCT02952586|323375918|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
94435003|NCT02952586|323375917|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
94435004|NCT02952586|323375918|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
94435005|NCT02952586|323375917|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
94435006|NCT02952586|323375918|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
94435007|NCT02952586|323375917|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
94435008|NCT02952586|323375918|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
94435009|NCT02952586|323375917|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
94435010|NCT02952586|323375918|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
94435011|NCT02952586|323375917|FG000|CRT for Cisplatin (63 Days)|Other|1|||
94435012|NCT02952586|323375918|FG001|CRT for Cisplatin (63 Days)|Other|1|||
94435013|NCT02952586|323375917|FG000|CRT for IMRT (63 Days)|Death|5|||
94435014|NCT02952586|323375918|FG001|CRT for IMRT (63 Days)|Death|8|||
94435015|NCT02952586|323375917|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
94435016|NCT02952586|323375918|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
94435017|NCT02952586|323375917|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
94435018|NCT02952586|323375918|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
94435019|NCT02952586|323375917|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
94435020|NCT02952586|323375918|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
94435021|NCT02952586|323375917|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
94435022|NCT02952586|323375918|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
94435023|NCT02952586|323375917|FG000|CRT for IMRT (63 Days)|Other|1|||
94435024|NCT02952586|323375918|FG001|CRT for IMRT (63 Days)|Other|0|||
94435025|NCT02952586|323375917|FG000|Maintenance Phase (12 Months)|Death|17|||
94435026|NCT02952586|323375918|FG001|Maintenance Phase (12 Months)|Death|11|||
94435027|NCT02952586|323375917|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
94435028|NCT02952586|323375918|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
94435029|NCT02952586|323375917|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
94435030|NCT02952586|323375918|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
94435031|NCT02952586|323375917|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
94435032|NCT02952586|323375918|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
94435033|NCT02952586|323375917|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
94435034|NCT02952586|323375918|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
94435035|NCT02952586|323375917|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
94435036|NCT02952586|323375918|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
94435037|NCT02952586|323375917|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
94435038|NCT02952586|323375918|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
94435039|NCT02952586|323375917|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
94435040|NCT02952586|323375918|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
94435041|NCT02952586|323375917|FG000|Maintenance Phase (12 Months)|Other|2|||
94435042|NCT02952586|323375918|FG001|Maintenance Phase (12 Months)|Other|1|||
94435043|NCT02952586|323375917|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
94435044|NCT02952586|323375918|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
94435045|NCT02952586|323375917|FG000|Follow-Up Phase (90 Days)|Death|12|||
94435046|NCT02952586|323375918|FG001|Follow-Up Phase (90 Days)|Death|10|||
94435047|NCT02952586|323375917|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
94435048|NCT02952586|323375918|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
94435049|NCT02952586|323375917|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
94435050|NCT02952586|323375918|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
94435051|NCT02952586|323375917|FG000|Follow-Up Phase (90 Days)|Other|7|||
94435052|NCT02952586|323375918|FG001|Follow-Up Phase (90 Days)|Other|5|||
94435053|NCT02952586|323375917|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
94435054|NCT02952586|323375918|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
94435055|NCT02952586|323375917|FG000|LT Follow-up (up to 45 Months)|Death|51|||
94435056|NCT02952586|323375918|FG001|LT Follow-up (up to 45 Months)|Death|31|||
94435057|NCT02952586|323375917|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
94435058|NCT02952586|323375918|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
94435059|NCT02952586|323375917|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
94435060|NCT02952586|323375918|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
94435061|NCT02952586|323375917|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
94435062|NCT02952586|323375918|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
94435063|NCT04414618|323375935|FG000|Overall Study|Death|3|||
94435064|NCT04414618|323375936|FG001|Overall Study|Death|3|||
94435065|NCT04414618|323375935|FG000|Overall Study|Withdrawal by Subject|2|||
94435066|NCT04414618|323375936|FG001|Overall Study|Withdrawal by Subject|1|||
94435067|NCT04414618|323375935|FG000|Overall Study|Lost to Follow-up|2|||
94435068|NCT04414618|323375936|FG001|Overall Study|Lost to Follow-up|3|||
94435069|NCT04414618|323375935|FG000|Overall Study|Physician Decision|1|||
94435070|NCT04414618|323375936|FG001|Overall Study|Physician Decision|0|||
94435071|NCT01118975|323375937|FG000|Overall Study|Adverse Event|0|||
94435072|NCT01118975|323375938|FG001|Overall Study|Adverse Event|1|||
94435073|NCT04411914|323375939|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
94435074|NCT04411914|323375940|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
94435075|NCT04152863|323375942|FG000|Overall Study|Death|13|||
94435076|NCT04152863|323375943|FG001|Overall Study|Death|12|||
94435077|NCT04152863|323375944|FG002|Overall Study|Death|7|||
94435078|NCT04152863|323375942|FG000|Overall Study|Physician Decision|1|||
94435079|NCT04152863|323375943|FG001|Overall Study|Physician Decision|1|||
94435080|NCT04152863|323375944|FG002|Overall Study|Physician Decision|1|||
94435081|NCT04152863|323375942|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
94435082|NCT04152863|323375943|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
94435083|NCT04152863|323375944|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
94435084|NCT04152863|323375942|FG000|Overall Study|Withdrawal by Subject|2|||
94435085|NCT04152863|323375943|FG001|Overall Study|Withdrawal by Subject|1|||
94435086|NCT04152863|323375944|FG002|Overall Study|Withdrawal by Subject|3|||
94435087|NCT01644617|323375950|FG000|Overall Study|Withdrawal by Subject|3|||
94435088|NCT01644617|323375951|FG001|Overall Study|Withdrawal by Subject|4|||
94435089|NCT01644617|323375952|FG002|Overall Study|Withdrawal by Subject|1|||
94435090|NCT01644617|323375950|FG000|Overall Study|Lost to Follow-up|0|||
94435091|NCT01644617|323375951|FG001|Overall Study|Lost to Follow-up|1|||
94435092|NCT01644617|323375952|FG002|Overall Study|Lost to Follow-up|0|||
94435093|NCT01644617|323375950|FG000|Overall Study|Adverse Event|3|||
94435094|NCT01644617|323375951|FG001|Overall Study|Adverse Event|0|||
94435095|NCT01644617|323375952|FG002|Overall Study|Adverse Event|6|||
94435096|NCT02661217|323375953|FG000|Overall Study|Physician Decision|12|||
94435097|NCT02661217|323375954|FG001|Overall Study|Physician Decision|15|||
94435098|NCT02661217|323375953|FG000|Overall Study|Lost to Follow-up|1|||
94435099|NCT02661217|323375954|FG001|Overall Study|Lost to Follow-up|4|||
94435100|NCT02661217|323375953|FG000|Overall Study|Protocol Deviation|0|||
94435101|NCT02661217|323375954|FG001|Overall Study|Protocol Deviation|4|||
94435102|NCT02661217|323375953|FG000|Overall Study|Non-compliance with study treatment|5|||
94435103|NCT02661217|323375954|FG001|Overall Study|Non-compliance with study treatment|5|||
94435104|NCT02661217|323375953|FG000|Overall Study|Death|21|||
94435105|NCT02661217|323375954|FG001|Overall Study|Death|15|||
94435106|NCT02661217|323375953|FG000|Overall Study|Adverse Event|10|||
94435107|NCT02661217|323375954|FG001|Overall Study|Adverse Event|8|||
94435108|NCT02661217|323375953|FG000|Overall Study|Withdrawal by Subject|15|||
94435109|NCT02661217|323375954|FG001|Overall Study|Withdrawal by Subject|19|||
94435110|NCT02661217|323375953|FG000|Overall Study|Did not enter follow-up epoch|7|||
94435111|NCT02661217|323375954|FG001|Overall Study|Did not enter follow-up epoch|10|||
94435112|NCT02661217|323375953|FG000|Overall Study|Death - no study drug received|1|||
94435113|NCT02661217|323375954|FG001|Overall Study|Death - no study drug received|2|||
94435114|NCT02661217|323375953|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
94435115|NCT02661217|323375954|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
94435116|NCT02075515|323375955|FG000|Overall Study|Serious Adverse Event|1|||
94435117|NCT02075515|323375956|FG001|Overall Study|Serious Adverse Event|1|||
94435118|NCT02075515|323375957|FG002|Overall Study|Serious Adverse Event|1|||
94435119|NCT02075515|323375955|FG000|Overall Study|Non-Serious Adverse Event|0|||
94435120|NCT02075515|323375956|FG001|Overall Study|Non-Serious Adverse Event|1|||
94435121|NCT02075515|323375957|FG002|Overall Study|Non-Serious Adverse Event|0|||
94435122|NCT02075515|323375955|FG000|Overall Study|Withdrawal by Subject|2|||
94435123|NCT02075515|323375956|FG001|Overall Study|Withdrawal by Subject|0|||
94435124|NCT02075515|323375957|FG002|Overall Study|Withdrawal by Subject|1|||
94435125|NCT02075515|323375955|FG000|Overall Study|Lost to Follow-up|1|||
94435126|NCT02075515|323375956|FG001|Overall Study|Lost to Follow-up|3|||
94435127|NCT02075515|323375957|FG002|Overall Study|Lost to Follow-up|6|||
94435128|NCT00958893|323375958|FG000|Overall Study|Study prematurely terminated|4|||
94435129|NCT00378573|323375964|FG000|Treatment Period|Adverse Event|9|||
94435130|NCT00378573|323375964|FG000|Treatment Period|Physician Decision|1|||
94435131|NCT00378573|323375964|FG000|Treatment Period|Withdrawal by Subject|2|||
94435132|NCT00378573|323375964|FG000|Treatment Period|Disease Progression|4|||
94435133|NCT00378573|323375964|FG000|Treatment Period|Sponsor decision to close study|1|||
94435134|NCT00378573|323375964|FG000|Follow-up|Death|12|||
94435135|NCT00378573|323375964|FG000|Follow-up|Lost to Follow-up|1|||
94490166|NCT00701363|323590260|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
94490167|NCT00701363|323590261|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
94490168|NCT00701363|323590262|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
94490169|NCT00701363|323590263|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
94490170|NCT00701363|323590260|FG000|Treatment Phase 1|Lack of Efficacy|1|||
94490171|NCT00701363|323590261|FG001|Treatment Phase 1|Lack of Efficacy|0|||
94490172|NCT00701363|323590262|FG002|Treatment Phase 1|Lack of Efficacy|0|||
94490173|NCT00701363|323590263|FG003|Treatment Phase 1|Lack of Efficacy|0|||
94490174|NCT00701363|323590260|FG000|Treatment Phase 2|Adverse Event|0|||
94490175|NCT00701363|323590261|FG001|Treatment Phase 2|Adverse Event|0|||
94490176|NCT00701363|323590262|FG002|Treatment Phase 2|Adverse Event|1|||
94490177|NCT00701363|323590263|FG003|Treatment Phase 2|Adverse Event|0|||
94490178|NCT00701363|323590260|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
94490179|NCT00701363|323590261|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
94490180|NCT00701363|323590262|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
94490181|NCT00701363|323590263|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
94490182|NCT02747927|323590264|FG000|Overall Study|Adverse Event|5|||
94490183|NCT02747927|323590265|FG001|Overall Study|Adverse Event|14|||
94490184|NCT02747927|323590264|FG000|Overall Study|Lost to Follow-up|22|||
94490185|NCT02747927|323590265|FG001|Overall Study|Lost to Follow-up|43|||
94490186|NCT02747927|323590264|FG000|Overall Study|Pregnancy|34|||
94435136|NCT00378573|323375964|FG000|Follow-up|Withdrawal by Subject|1|||
94435137|NCT00196326|323375965|FG000|Overall Study|Did not meet protocol requirements|64|||
94435138|NCT00196326|323375965|FG000|Overall Study|Non-compliance with the protocol|81|||
94435139|NCT00196326|323375965|FG000|Overall Study|Physician Decision|3|||
94435140|NCT00196326|323375965|FG000|Overall Study|Withdrawal by Subject|225|||
94435141|NCT00196326|323375965|FG000|Overall Study|Adverse Event|253|||
94435142|NCT00196326|323375965|FG000|Overall Study|Pregnancy|34|||
94435143|NCT00196326|323375965|FG000|Overall Study|Lost to Follow-up|304|||
94435144|NCT00196326|323375965|FG000|Overall Study|Other|22|||
94435145|NCT03593395|323375970|FG000|Overall Study|Lost to Follow-up|48|||
94435146|NCT03593395|323375971|FG001|Overall Study|Lost to Follow-up|3|||
94435147|NCT03593395|323375970|FG000|Overall Study|Withdrawal by Subject|5|||
94435148|NCT03593395|323375971|FG001|Overall Study|Withdrawal by Subject|24|||
94435149|NCT03593395|323375970|FG000|Overall Study|Death|2|||
94435150|NCT03593395|323375971|FG001|Overall Study|Death|3|||
94435151|NCT03593395|323375970|FG000|Overall Study|Physician Decision|0|||
94435152|NCT03593395|323375971|FG001|Overall Study|Physician Decision|6|||
94435153|NCT03593395|323375970|FG000|Overall Study|Participant Relocated|19|||
94435154|NCT03593395|323375971|FG001|Overall Study|Participant Relocated|3|||
94435155|NCT03593395|323375970|FG000|Overall Study|No Information|1|||
94490187|NCT02747927|323590265|FG001|Overall Study|Pregnancy|66|||
94490188|NCT02747927|323590264|FG000|Overall Study|Protocol Violation|2|||
94490189|NCT02747927|323590265|FG001|Overall Study|Protocol Violation|4|||
94435156|NCT03593395|323375971|FG001|Overall Study|No Information|7|||
94435157|NCT00741338|323375972|FG000|Overall Study|Adverse Event|0|||
94435158|NCT00741338|323375973|FG001|Overall Study|Adverse Event|1|||
94435159|NCT03713632|323375974|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
94435160|NCT03713632|323375975|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
94435161|NCT03713632|323375976|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
94435162|NCT03713632|323375977|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
94435163|NCT03713632|323375978|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
94435164|NCT03713632|323375974|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
94435165|NCT03713632|323375975|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
94435166|NCT03713632|323375976|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
94435167|NCT03713632|323375977|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
94435168|NCT03713632|323375978|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
94435169|NCT03713632|323375974|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
94435170|NCT03713632|323375975|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
94435171|NCT03713632|323375976|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
94435172|NCT03713632|323375977|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
94435173|NCT03713632|323375978|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
94435174|NCT03713632|323375974|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
94435175|NCT03713632|323375975|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
94435176|NCT03713632|323375976|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
94435177|NCT03713632|323375977|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
94435178|NCT03713632|323375978|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
94435179|NCT03713632|323375974|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
94435180|NCT03713632|323375975|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
94435181|NCT03713632|323375976|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
94435182|NCT03713632|323375977|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
94435183|NCT03713632|323375978|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
94435184|NCT03713632|323375974|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
94435185|NCT03713632|323375975|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
94435186|NCT03713632|323375976|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
94435187|NCT03713632|323375977|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
94435188|NCT03713632|323375978|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
94435189|NCT03713632|323375974|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
94435190|NCT03713632|323375975|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
94435191|NCT03713632|323375976|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
94435192|NCT03713632|323375977|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
94435193|NCT03713632|323375978|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
94435194|NCT03713632|323375974|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
94435195|NCT03713632|323375975|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
94435196|NCT03713632|323375976|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
94435197|NCT03713632|323375977|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
94435198|NCT03713632|323375978|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
94435199|NCT03713632|323375974|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
94435200|NCT03713632|323375975|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
94435201|NCT03713632|323375976|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
94435202|NCT03713632|323375977|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
94435203|NCT03713632|323375978|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
94435204|NCT03713632|323375974|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
94435205|NCT03713632|323375975|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
94435206|NCT03713632|323375976|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
94435207|NCT03713632|323375977|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
94435208|NCT03713632|323375978|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
94490190|NCT02747927|323590264|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
94435209|NCT03713632|323375974|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
94435210|NCT03713632|323375975|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
94435211|NCT03713632|323375976|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
94435212|NCT03713632|323375977|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
94435213|NCT03713632|323375978|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
94435214|NCT03713632|323375974|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
94435215|NCT03713632|323375975|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
94435216|NCT03713632|323375976|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
94435217|NCT03713632|323375977|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
94435218|NCT03713632|323375978|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
94435219|NCT03713632|323375974|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
94435220|NCT03713632|323375975|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
94435221|NCT03713632|323375976|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
94435222|NCT03713632|323375977|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
94435223|NCT03713632|323375978|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
94435224|NCT03713632|323375974|FG000|Treatment Period 2 (After Week 16)|Death|0|||
94435225|NCT03713632|323375975|FG001|Treatment Period 2 (After Week 16)|Death|1|||
94435226|NCT03713632|323375976|FG002|Treatment Period 2 (After Week 16)|Death|0|||
94435227|NCT03713632|323375977|FG003|Treatment Period 2 (After Week 16)|Death|0|||
94435228|NCT03713632|323375978|FG004|Treatment Period 2 (After Week 16)|Death|0|||
94435229|NCT03713632|323375974|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
94435230|NCT03713632|323375975|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
94435231|NCT03713632|323375976|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
94435232|NCT03713632|323375977|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
94435233|NCT03713632|323375978|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
94435234|NCT01524978|323375982|FG000|Overall Study|Other|16|||
94435235|NCT01524978|323375983|FG001|Overall Study|Other|2|||
94435236|NCT01524978|323375984|FG002|Overall Study|Other|1|||
94435237|NCT01524978|323375985|FG003|Overall Study|Other|2|||
94435238|NCT01524978|323375986|FG004|Overall Study|Other|1|||
94435239|NCT01524978|323375987|FG005|Overall Study|Other|3|||
94435240|NCT01524978|323375988|FG006|Overall Study|Other|17|||
94435241|NCT01524978|323375989|FG007|Overall Study|Other|1|||
94435242|NCT01524978|323375990|FG008|Overall Study|Other|2|||
94435243|NCT01524978|323375991|FG009|Overall Study|Other|2|||
94435244|NCT01524978|323375992|FG010|Overall Study|Other|5|||
94435245|NCT01524978|323375982|FG000|Overall Study|Withdrawal by Subject|12|||
94435246|NCT01524978|323375983|FG001|Overall Study|Withdrawal by Subject|0|||
94435247|NCT01524978|323375984|FG002|Overall Study|Withdrawal by Subject|1|||
94435248|NCT01524978|323375985|FG003|Overall Study|Withdrawal by Subject|1|||
94435249|NCT01524978|323375986|FG004|Overall Study|Withdrawal by Subject|3|||
94435250|NCT01524978|323375987|FG005|Overall Study|Withdrawal by Subject|1|||
94435251|NCT01524978|323375988|FG006|Overall Study|Withdrawal by Subject|6|||
94435252|NCT01524978|323375989|FG007|Overall Study|Withdrawal by Subject|2|||
94435253|NCT01524978|323375990|FG008|Overall Study|Withdrawal by Subject|4|||
94435254|NCT01524978|323375991|FG009|Overall Study|Withdrawal by Subject|0|||
94435255|NCT01524978|323375992|FG010|Overall Study|Withdrawal by Subject|5|||
94435256|NCT01524978|323375982|FG000|Overall Study|Lost to Follow-up|0|||
94435257|NCT01524978|323375983|FG001|Overall Study|Lost to Follow-up|0|||
94435258|NCT01524978|323375984|FG002|Overall Study|Lost to Follow-up|3|||
94435259|NCT01524978|323375985|FG003|Overall Study|Lost to Follow-up|0|||
94435260|NCT01524978|323375986|FG004|Overall Study|Lost to Follow-up|1|||
94435261|NCT01524978|323375987|FG005|Overall Study|Lost to Follow-up|1|||
94435262|NCT01524978|323375988|FG006|Overall Study|Lost to Follow-up|2|||
94435263|NCT01524978|323375989|FG007|Overall Study|Lost to Follow-up|0|||
94435264|NCT01524978|323375990|FG008|Overall Study|Lost to Follow-up|1|||
94435265|NCT01524978|323375991|FG009|Overall Study|Lost to Follow-up|1|||
94435266|NCT01524978|323375992|FG010|Overall Study|Lost to Follow-up|1|||
94435267|NCT01524978|323375982|FG000|Overall Study|Death|34|||
94435268|NCT01524978|323375983|FG001|Overall Study|Death|2|||
94435269|NCT01524978|323375984|FG002|Overall Study|Death|5|||
94435270|NCT01524978|323375985|FG003|Overall Study|Death|24|||
94435271|NCT01524978|323375986|FG004|Overall Study|Death|4|||
94435272|NCT01524978|323375987|FG005|Overall Study|Death|4|||
94435273|NCT01524978|323375988|FG006|Overall Study|Death|1|||
94435274|NCT01524978|323375989|FG007|Overall Study|Death|9|||
94435275|NCT01524978|323375990|FG008|Overall Study|Death|5|||
94435276|NCT01524978|323375991|FG009|Overall Study|Death|6|||
94435277|NCT01524978|323375992|FG010|Overall Study|Death|17|||
94435278|NCT02892149|323375995|FG000|Overall Study|Death|262|||
94435279|NCT02892149|323375996|FG001|Overall Study|Death|278|||
94435280|NCT02892149|323375995|FG000|Overall Study|Withdrawal by Subject|53|||
94435281|NCT02892149|323375996|FG001|Overall Study|Withdrawal by Subject|47|||
94435282|NCT02892149|323375995|FG000|Overall Study|Lost to Follow-up|37|||
94435283|NCT02892149|323375996|FG001|Overall Study|Lost to Follow-up|31|||
94435284|NCT01098474|323376001|FG000|Active Phase|Other|0|||
94435285|NCT01098474|323376002|FG001|Active Phase|Other|0|||
94435286|NCT01098474|323376003|FG002|Active Phase|Other|3|||
94435287|NCT01098474|323376004|FG003|Active Phase|Other|0|||
94435288|NCT01098474|323376005|FG004|Active Phase|Other|0|||
94435289|NCT01098474|323376006|FG005|Active Phase|Other|0|||
94435290|NCT01098474|323376001|FG000|Active Phase|Withdrawal by Subject|1|||
94435291|NCT01098474|323376002|FG001|Active Phase|Withdrawal by Subject|1|||
94435292|NCT01098474|323376003|FG002|Active Phase|Withdrawal by Subject|2|||
94435293|NCT01098474|323376004|FG003|Active Phase|Withdrawal by Subject|0|||
94435294|NCT01098474|323376005|FG004|Active Phase|Withdrawal by Subject|0|||
94435295|NCT01098474|323376006|FG005|Active Phase|Withdrawal by Subject|0|||
94435296|NCT01098474|323376001|FG000|Active Phase|Lost to Follow-up|1|||
94435297|NCT01098474|323376002|FG001|Active Phase|Lost to Follow-up|0|||
94435298|NCT01098474|323376003|FG002|Active Phase|Lost to Follow-up|0|||
94435299|NCT01098474|323376004|FG003|Active Phase|Lost to Follow-up|0|||
94435300|NCT01098474|323376005|FG004|Active Phase|Lost to Follow-up|0|||
94435301|NCT01098474|323376006|FG005|Active Phase|Lost to Follow-up|0|||
94435302|NCT01098474|323376001|FG000|Follow Up Phase|Travelled out of study area|0|||
94435303|NCT01098474|323376002|FG001|Follow Up Phase|Travelled out of study area|0|||
94435304|NCT01098474|323376003|FG002|Follow Up Phase|Travelled out of study area|0|||
94435305|NCT01098474|323376004|FG003|Follow Up Phase|Travelled out of study area|0|||
94435306|NCT01098474|323376005|FG004|Follow Up Phase|Travelled out of study area|1|||
94435307|NCT01098474|323376006|FG005|Follow Up Phase|Travelled out of study area|0|||
94435308|NCT01098474|323376001|FG000|Follow Up Phase|Other|0|||
94435309|NCT01098474|323376002|FG001|Follow Up Phase|Other|0|||
94435310|NCT01098474|323376003|FG002|Follow Up Phase|Other|0|||
94435311|NCT01098474|323376004|FG003|Follow Up Phase|Other|0|||
94435312|NCT01098474|323376005|FG004|Follow Up Phase|Other|0|||
94435313|NCT01098474|323376006|FG005|Follow Up Phase|Other|4|||
94435314|NCT01098474|323376001|FG000|Follow Up Phase|Withdrawal by Subject|0|||
94435315|NCT01098474|323376002|FG001|Follow Up Phase|Withdrawal by Subject|0|||
94435316|NCT01098474|323376003|FG002|Follow Up Phase|Withdrawal by Subject|0|||
94435317|NCT01098474|323376004|FG003|Follow Up Phase|Withdrawal by Subject|2|||
94435318|NCT01098474|323376005|FG004|Follow Up Phase|Withdrawal by Subject|0|||
94435319|NCT01098474|323376006|FG005|Follow Up Phase|Withdrawal by Subject|1|||
94435320|NCT01098474|323376001|FG000|Follow Up Phase|Lost to Follow-up|0|||
94435321|NCT01098474|323376002|FG001|Follow Up Phase|Lost to Follow-up|0|||
94435322|NCT01098474|323376003|FG002|Follow Up Phase|Lost to Follow-up|0|||
94435323|NCT01098474|323376004|FG003|Follow Up Phase|Lost to Follow-up|0|||
94435324|NCT01098474|323376005|FG004|Follow Up Phase|Lost to Follow-up|1|||
94435325|NCT01098474|323376006|FG005|Follow Up Phase|Lost to Follow-up|0|||
94435326|NCT02685735|323376010|FG000|Overall Study|Missing construct or pain data|23|||
94435327|NCT02685735|323376011|FG001|Overall Study|Missing construct or pain data|22|||
94435328|NCT01372748|323376012|FG000|Overall Study|Lost to Follow-up|16|||
94435329|NCT01372748|323376013|FG001|Overall Study|Lost to Follow-up|34|||
94435330|NCT01372748|323376012|FG000|Overall Study|Withdrawal by Subject|7|||
94435331|NCT01372748|323376013|FG001|Overall Study|Withdrawal by Subject|5|||
94435332|NCT01473407|323376014|FG000|Overall Study|Physician Decision|1|||
94435333|NCT01473407|323376015|FG001|Overall Study|Physician Decision|4|||
94435334|NCT01473407|323376014|FG000|Overall Study|Lost to Follow-up|10|||
94435335|NCT01473407|323376015|FG001|Overall Study|Lost to Follow-up|4|||
94435336|NCT01473407|323376014|FG000|Overall Study|Adverse Event|8|||
94435337|NCT01473407|323376015|FG001|Overall Study|Adverse Event|8|||
94435338|NCT01473407|323376014|FG000|Overall Study|Randomization Error|3|||
94435339|NCT01473407|323376015|FG001|Overall Study|Randomization Error|1|||
94435340|NCT01473407|323376014|FG000|Overall Study|Withdrawal by Subject|4|||
94435341|NCT01473407|323376015|FG001|Overall Study|Withdrawal by Subject|7|||
94435342|NCT01473407|323376014|FG000|Overall Study|Kidney Transplant|7|||
94435343|NCT01473407|323376015|FG001|Overall Study|Kidney Transplant|6|||
94435344|NCT01473407|323376014|FG000|Overall Study|Vacation/Travel|1|||
94435345|NCT01473407|323376015|FG001|Overall Study|Vacation/Travel|1|||
94435346|NCT01473407|323376014|FG000|Overall Study|Elevated Hemoglobin|1|||
94435347|NCT01473407|323376015|FG001|Overall Study|Elevated Hemoglobin|0|||
94435348|NCT01473407|323376014|FG000|Overall Study|Patient Received Aranesp|1|||
94435349|NCT01473407|323376015|FG001|Overall Study|Patient Received Aranesp|0|||
94435350|NCT01473407|323376014|FG000|Overall Study|Patient Lost Green Card Status|1|||
94435351|NCT01473407|323376015|FG001|Overall Study|Patient Lost Green Card Status|0|||
94435352|NCT01473407|323376014|FG000|Overall Study|Temperature Excursion|2|||
94435353|NCT01473407|323376015|FG001|Overall Study|Temperature Excursion|3|||
94435354|NCT01473407|323376014|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
94435355|NCT01473407|323376015|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
94435356|NCT01473407|323376014|FG000|Overall Study|Sponsor's Decision|10|||
94655594|NCT01208233|324196084|FG005|Overall Study|Withdrawal by Subject|2|||
94435357|NCT01473407|323376015|FG001|Overall Study|Sponsor's Decision|10|||
94435358|NCT01473407|323376014|FG000|Overall Study|Site Closure|1|||
94435359|NCT01473407|323376015|FG001|Overall Study|Site Closure|0|||
94435360|NCT01994850|323376016|FG000|Overall Study|Physician Decision|1|||
94435361|NCT01994850|323376016|FG000|Overall Study|Withdrawal by Subject|1|||
94435362|NCT05445492|323376017|FG000|Overall Study|Physician Decision|1|||
94435363|NCT04841577|323376021|FG000|Overall Study|Adverse Event|5|||
94435364|NCT04841577|323376022|FG001|Overall Study|Adverse Event|10|||
94435365|NCT04841577|323376021|FG000|Overall Study|Lost to Follow-up|8|||
94435366|NCT04841577|323376022|FG001|Overall Study|Lost to Follow-up|7|||
94435367|NCT04841577|323376021|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
94435368|NCT04841577|323376022|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
94435369|NCT04841577|323376021|FG000|Overall Study|Other|0|||
94435370|NCT04841577|323376022|FG001|Overall Study|Other|1|||
94435371|NCT02125877|323376023|FG000|Overall Study|Physician Decision|1|||
94435372|NCT02125877|323376024|FG001|Overall Study|Physician Decision|0|||
94435373|NCT02125877|323376023|FG000|Overall Study|Death|0|||
94435374|NCT02125877|323376024|FG001|Overall Study|Death|1|||
94435375|NCT02125877|323376023|FG000|Overall Study|Administrative problems|0|||
94435376|NCT02125877|323376024|FG001|Overall Study|Administrative problems|1|||
94435377|NCT02125877|323376023|FG000|Overall Study|Participant/guardian decision|0|||
94435378|NCT02125877|323376024|FG001|Overall Study|Participant/guardian decision|2|||
94435379|NCT02125877|323376023|FG000|Overall Study|Withdrawal by Subject|2|||
94435380|NCT02125877|323376024|FG001|Overall Study|Withdrawal by Subject|1|||
94435381|NCT02125877|323376023|FG000|Overall Study|Protocol deviation|4|||
94435382|NCT02125877|323376024|FG001|Overall Study|Protocol deviation|1|||
94435383|NCT02125877|323376023|FG000|Overall Study|Adverse Event|6|||
94435384|NCT02125877|323376024|FG001|Overall Study|Adverse Event|4|||
94435385|NCT03340974|323376027|FG000|Completion of Study -Long Term Follow up|Death|8|||
94435386|NCT03340974|323376028|FG001|Completion of Study -Long Term Follow up|Death|5|||
94435387|NCT03340974|323376029|FG002|Completion of Study -Long Term Follow up|Death|5|||
94435388|NCT03340974|323376030|FG003|Completion of Study -Long Term Follow up|Death|7|||
94435389|NCT03340974|323376027|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
94435390|NCT03340974|323376028|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
94435391|NCT03340974|323376029|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
94435392|NCT03340974|323376030|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
94435393|NCT03340974|323376027|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
94435394|NCT03340974|323376028|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
94435395|NCT03340974|323376029|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
94435396|NCT03340974|323376030|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
94435397|NCT03340974|323376027|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
94435398|NCT03340974|323376028|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
94435399|NCT03340974|323376029|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
94435400|NCT03340974|323376030|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
94435401|NCT02676765|323376031|FG000|Overall Study|Lost to Follow-up|0|||
94435402|NCT02676765|323376032|FG001|Overall Study|Lost to Follow-up|1|||
94435403|NCT01128543|323376033|FG000|Overall Study|Withdrawal by Subject|3|||
94435404|NCT01128543|323376033|FG000|Overall Study|Protocol Violation|1|||
94435405|NCT05794503|323376036|FG000|Overall Study|Operation Cancelled|2|||
94435406|NCT05794503|323376037|FG001|Overall Study|Operation Cancelled|0|||
94435407|NCT05794503|323376036|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
94435408|NCT05794503|323376037|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
94435409|NCT05794503|323376036|FG000|Overall Study|Protocol Violation|1|||
94435410|NCT05794503|323376037|FG001|Overall Study|Protocol Violation|0|||
94435411|NCT01885195|323376040|FG000|Overall Study|Adverse Event|29|||
94435412|NCT01885195|323376040|FG000|Overall Study|Death|1|||
94435413|NCT01885195|323376040|FG000|Overall Study|Disease Progression|67|||
94435414|NCT01885195|323376040|FG000|Overall Study|Protocol Deviation|2|||
94435415|NCT01885195|323376040|FG000|Overall Study|Physician Decision|3|||
94435416|NCT01885195|323376040|FG000|Overall Study|Patient/guardian decision|8|||
94435417|NCT00952731|323376041|FG000|Overall Study|Drug supply expired|1|||
94435418|NCT00952731|323376042|FG001|Overall Study|Drug supply expired|0|||
94435419|NCT00919854|323376043|FG000|Overall Study|Adverse Event|1|||
94435420|NCT03316547|323376048|FG000|Overall Study|Death|3|||
94435421|NCT03316547|323376049|FG001|Overall Study|Death|1|||
94435422|NCT03316547|323376048|FG000|Overall Study|Lost to Follow-up|6|||
94435423|NCT03316547|323376049|FG001|Overall Study|Lost to Follow-up|6|||
94435424|NCT03316547|323376048|FG000|Overall Study|Withdrawal by Subject|3|||
94435425|NCT03316547|323376049|FG001|Overall Study|Withdrawal by Subject|2|||
94435426|NCT03316547|323376048|FG000|Overall Study|Transfer to another hospital|6|||
94435427|NCT03316547|323376049|FG001|Overall Study|Transfer to another hospital|4|||
94435428|NCT00582010|323378296|FG000|Overall Study|Death|0|||
94435429|NCT00582010|323378297|FG001|Overall Study|Death|1|||
94435430|NCT00362336|323378298|FG000|Overall Study|Serious Adverse Event|1|||
94435431|NCT00362336|323378299|FG001|Overall Study|Serious Adverse Event|0|||
94435432|NCT00362336|323378300|FG002|Overall Study|Serious Adverse Event|1|||
94435433|NCT00362336|323378298|FG000|Overall Study|Protocol Violation|0|||
94435434|NCT00362336|323378299|FG001|Overall Study|Protocol Violation|0|||
94435435|NCT00362336|323378300|FG002|Overall Study|Protocol Violation|1|||
94435436|NCT00362336|323378298|FG000|Overall Study|Lost to Follow-up|6|||
94512837|NCT00725985|323676423|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
94435437|NCT00362336|323378299|FG001|Overall Study|Lost to Follow-up|4|||
94435438|NCT00362336|323378300|FG002|Overall Study|Lost to Follow-up|0|||
94435439|NCT00362336|323378298|FG000|Overall Study|Withdrawal by Subject|3|||
94435440|NCT00362336|323378299|FG001|Overall Study|Withdrawal by Subject|3|||
94435441|NCT00362336|323378300|FG002|Overall Study|Withdrawal by Subject|1|||
94435442|NCT02463357|323378301|FG000|Overall Study|Withdrawal by Subject|1|||
94435443|NCT02463357|323378302|FG001|Overall Study|Withdrawal by Subject|0|||
94435444|NCT02463357|323378303|FG002|Overall Study|Withdrawal by Subject|0|||
94435445|NCT02463357|323378304|FG003|Overall Study|Withdrawal by Subject|0|||
94435446|NCT02463357|323378305|FG004|Overall Study|Withdrawal by Subject|0|||
94435447|NCT02463357|323378301|FG000|Overall Study|Withdrawal by Subject|0|||
94435448|NCT02463357|323378302|FG001|Overall Study|Withdrawal by Subject|0|||
94435449|NCT02463357|323378303|FG002|Overall Study|Withdrawal by Subject|0|||
94435450|NCT02463357|323378304|FG003|Overall Study|Withdrawal by Subject|0|||
94435451|NCT02463357|323378305|FG004|Overall Study|Withdrawal by Subject|1|||
94435452|NCT02620579|323378306|FG000|Overall Study|Physician Decision|0|||
94435453|NCT02620579|323378307|FG001|Overall Study|Physician Decision|0|||
94435454|NCT02620579|323378308|FG002|Overall Study|Physician Decision|0|||
94435455|NCT02620579|323378309|FG003|Overall Study|Physician Decision|1|||
94435456|NCT02620579|323378306|FG000|Overall Study|Withdrawal by Subject|0|||
94435457|NCT02620579|323378307|FG001|Overall Study|Withdrawal by Subject|1|||
94435458|NCT02620579|323378308|FG002|Overall Study|Withdrawal by Subject|1|||
94435459|NCT02620579|323378309|FG003|Overall Study|Withdrawal by Subject|0|||
94435460|NCT01121562|323378310|FG000|Overall Study|Objective progression or relapse|8|||
94435461|NCT01121562|323378310|FG000|Overall Study|Withdrawal by Subject|1|||
94435462|NCT01121562|323378310|FG000|Overall Study|Adverse Event|1|||
94435463|NCT01121562|323378310|FG000|Overall Study|Sponsor Decision|1|||
94435464|NCT01121562|323378310|FG000|Overall Study|Met study discontinuation criteria|1|||
94435465|NCT02681510|323378311|FG000|Overall Study|Withdrawal by Subject|1|||
94435466|NCT02681510|323378311|FG000|Overall Study|Lost to Follow-up|9|||
94435467|NCT00444587|323378318|FG000|Overall Study|Death|2|||
94435468|NCT00444587|323378319|FG001|Overall Study|Death|1|||
94435469|NCT00444587|323378318|FG000|Overall Study|Progression of the disease|73|||
94435470|NCT00444587|323378319|FG001|Overall Study|Progression of the disease|8|||
94435471|NCT00444587|323378318|FG000|Overall Study|Refused treatment/did not cooperate|4|||
94435472|NCT00444587|323378319|FG001|Overall Study|Refused treatment/did not cooperate|1|||
94435473|NCT00444587|323378318|FG000|Overall Study|Investigator decision|3|||
94435474|NCT00444587|323378319|FG001|Overall Study|Investigator decision|0|||
94435475|NCT00444587|323378318|FG000|Overall Study|Protocol Violation|1|||
94435476|NCT00444587|323378319|FG001|Overall Study|Protocol Violation|0|||
94435477|NCT00444587|323378318|FG000|Overall Study|Missing|0|||
94435478|NCT00444587|323378319|FG001|Overall Study|Missing|5|||
94435479|NCT02481869|323378329|FG000|Overall Study|Lost to Follow-up|3|||
94435480|NCT02481869|323378330|FG001|Overall Study|Lost to Follow-up|4|||
94435481|NCT02481869|323378329|FG000|Overall Study|Withdrawal by Subject|2|||
94435482|NCT02481869|323378330|FG001|Overall Study|Withdrawal by Subject|0|||
94435483|NCT00261950|323378335|FG000|Overall Study|Lost to Follow-up|2|||
94435484|NCT00261950|323378335|FG000|Overall Study|Death|6|||
94435485|NCT00261950|323378335|FG000|Overall Study|Withdrawal by Subject|5|||
94435486|NCT00261950|323378335|FG000|Overall Study|Other|1|||
94435487|NCT00261950|323378335|FG000|Overall Study|Physician Decision|1|||
94435488|NCT00261950|323378335|FG000|Overall Study|Protocol specified Criteria|11|||
94435489|NCT00182325|323378336|FG000|Overall Study|Lost to Follow-up|7|||
94435490|NCT00182325|323378337|FG001|Overall Study|Lost to Follow-up|7|||
94435491|NCT00182325|323378336|FG000|Overall Study|Miscarriage|5|||
94435492|NCT00182325|323378337|FG001|Overall Study|Miscarriage|3|||
94435493|NCT00182325|323378336|FG000|Overall Study|Did not complete survey|22|||
94435494|NCT00182325|323378337|FG001|Overall Study|Did not complete survey|43|||
94435495|NCT01937871|323378338|FG000|Overall Study|Adverse Event|6|||
94435496|NCT01937871|323378339|FG001|Overall Study|Adverse Event|6|||
94435497|NCT01937871|323378340|FG002|Overall Study|Adverse Event|2|||
94435498|NCT01937871|323378338|FG000|Overall Study|Lost to Follow-up|8|||
94435499|NCT01937871|323378339|FG001|Overall Study|Lost to Follow-up|2|||
94435500|NCT01937871|323378340|FG002|Overall Study|Lost to Follow-up|4|||
94435501|NCT01937871|323378338|FG000|Overall Study|Withdrawal by Subject|9|||
94435502|NCT01937871|323378339|FG001|Overall Study|Withdrawal by Subject|6|||
94435503|NCT01937871|323378340|FG002|Overall Study|Withdrawal by Subject|4|||
94435504|NCT01937871|323378338|FG000|Overall Study|Physician Decision|0|||
94435505|NCT01937871|323378339|FG001|Overall Study|Physician Decision|1|||
94435506|NCT01937871|323378340|FG002|Overall Study|Physician Decision|0|||
94435507|NCT01937871|323378338|FG000|Overall Study|Entry Criteria Not Met|1|||
94435508|NCT01937871|323378339|FG001|Overall Study|Entry Criteria Not Met|2|||
94435509|NCT01937871|323378340|FG002|Overall Study|Entry Criteria Not Met|1|||
94435510|NCT01569295|323378345|FG000|Overall Study|Progressive Disease|75|||
94435511|NCT01569295|323378346|FG001|Overall Study|Progressive Disease|139|||
94435512|NCT01569295|323378345|FG000|Overall Study|Adverse Event|39|||
94435513|NCT01569295|323378346|FG001|Overall Study|Adverse Event|14|||
94435514|NCT01569295|323378345|FG000|Overall Study|Withdrawal by Subject|25|||
94435515|NCT01569295|323378346|FG001|Overall Study|Withdrawal by Subject|12|||
94435516|NCT01569295|323378345|FG000|Overall Study|Death|19|||
94435517|NCT01569295|323378346|FG001|Overall Study|Death|15|||
94490191|NCT02747927|323590265|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
94490192|NCT02747927|323590264|FG000|Overall Study|Reason not Specified|11|||
94435518|NCT01569295|323378345|FG000|Overall Study|Physician Decision|13|||
94435519|NCT01569295|323378346|FG001|Overall Study|Physician Decision|18|||
94435520|NCT01569295|323378345|FG000|Overall Study|Study Terminated by Sponsor|24|||
94435521|NCT01569295|323378346|FG001|Overall Study|Study Terminated by Sponsor|2|||
94435522|NCT01569295|323378345|FG000|Overall Study|Other Reason not Specified|3|||
94435523|NCT01569295|323378346|FG001|Overall Study|Other Reason not Specified|5|||
94435524|NCT01569295|323378345|FG000|Overall Study|Non-Compliance with Study Drug|6|||
94435525|NCT01569295|323378346|FG001|Overall Study|Non-Compliance with Study Drug|1|||
94435526|NCT01569295|323378345|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
94435527|NCT01569295|323378346|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
94435528|NCT01569295|323378345|FG000|Overall Study|Lost to Follow-up|1|||
94435529|NCT01569295|323378346|FG001|Overall Study|Lost to Follow-up|1|||
94435530|NCT01038297|323378347|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
94435531|NCT01038297|323378348|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
94435532|NCT01038297|323378349|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
94435533|NCT01973595|323378350|FG000|Washout|Withdrawal by Subject|1|||
94435534|NCT01973595|323378351|FG001|Washout|Withdrawal by Subject|0|||
94435535|NCT01973595|323378352|FG002|Washout|Withdrawal by Subject|1|||
94435536|NCT01973595|323378353|FG003|Washout|Withdrawal by Subject|0|||
94435537|NCT02508935|323378357|FG000|Overall Study|Withdrawal by Subject|1|||
94435538|NCT02508935|323378357|FG000|Overall Study|Withdrawal by Caregiver|8|||
94435539|NCT02508935|323378357|FG000|Overall Study|Pain Score <4|1|||
94435540|NCT02508935|323378357|FG000|Overall Study|Emesis|3|||
94435541|NCT02508935|323378357|FG000|Overall Study|Adverse Event|3|||
94435542|NCT02508935|323378357|FG000|Overall Study|Protocol Violation|1|||
94435543|NCT02508935|323378357|FG000|Overall Study|Physician Decision|1|||
94435544|NCT02508935|323378357|FG000|Overall Study|Trial terminated by sponsor|5|||
94435545|NCT00710866|323378360|FG000|Overall Study|Protocol Violation|5|||
94435546|NCT00710866|323378361|FG001|Overall Study|Protocol Violation|4|||
94435547|NCT00710866|323378360|FG000|Overall Study|Withdrawal by Subject|2|||
94435548|NCT00710866|323378361|FG001|Overall Study|Withdrawal by Subject|1|||
94435549|NCT00710866|323378360|FG000|Overall Study|Lost to Follow-up|1|||
94435550|NCT00710866|323378361|FG001|Overall Study|Lost to Follow-up|0|||
94435551|NCT00710866|323378360|FG000|Overall Study|Failed to meet eligibility|1|||
94435552|NCT00710866|323378361|FG001|Overall Study|Failed to meet eligibility|1|||
94435553|NCT00086281|323378362|FG000|Phase 1|Adverse Event|0|||
94435554|NCT00086281|323378363|FG001|Phase 1|Adverse Event|0|||
94435555|NCT00086281|323378364|FG002|Phase 1|Adverse Event|0|||
94435556|NCT00086281|323378365|FG003|Phase 1|Adverse Event|0|||
94435557|NCT00086281|323378366|FG004|Phase 1|Adverse Event|0|||
94435558|NCT00086281|323378367|FG005|Phase 1|Adverse Event|0|||
94435559|NCT00086281|323378368|FG006|Phase 1|Adverse Event|0|||
94435560|NCT00086281|323378369|FG007|Phase 1|Adverse Event|0|||
94435561|NCT00086281|323378370|FG008|Phase 1|Adverse Event|0|||
94435562|NCT00086281|323378371|FG009|Phase 1|Adverse Event|1|||
94435563|NCT00086281|323378372|FG010|Phase 1|Adverse Event|2|||
94435564|NCT00086281|323378373|FG011|Phase 1|Adverse Event|1|||
94435565|NCT00086281|323378374|FG012|Phase 1|Adverse Event|1|||
94435566|NCT00086281|323378375|FG013|Phase 1|Adverse Event|1|||
94435567|NCT00086281|323378376|FG014|Phase 1|Adverse Event|2|||
94435568|NCT00086281|323378362|FG000|Phase 1|Protocol Violation|0|||
94435569|NCT00086281|323378363|FG001|Phase 1|Protocol Violation|0|||
94435570|NCT00086281|323378364|FG002|Phase 1|Protocol Violation|0|||
94435571|NCT00086281|323378365|FG003|Phase 1|Protocol Violation|0|||
94435572|NCT00086281|323378366|FG004|Phase 1|Protocol Violation|0|||
94435573|NCT00086281|323378367|FG005|Phase 1|Protocol Violation|0|||
94435574|NCT00086281|323378368|FG006|Phase 1|Protocol Violation|0|||
94435575|NCT00086281|323378369|FG007|Phase 1|Protocol Violation|0|||
94435576|NCT00086281|323378370|FG008|Phase 1|Protocol Violation|0|||
94435577|NCT00086281|323378371|FG009|Phase 1|Protocol Violation|0|||
94435578|NCT00086281|323378372|FG010|Phase 1|Protocol Violation|1|||
94435579|NCT00086281|323378373|FG011|Phase 1|Protocol Violation|0|||
94435580|NCT00086281|323378374|FG012|Phase 1|Protocol Violation|0|||
94435581|NCT00086281|323378375|FG013|Phase 1|Protocol Violation|0|||
94435582|NCT00086281|323378376|FG014|Phase 1|Protocol Violation|0|||
94435583|NCT00086281|323378362|FG000|Phase 1|Serious Adverse Event|0|||
94435584|NCT00086281|323378363|FG001|Phase 1|Serious Adverse Event|0|||
94435585|NCT00086281|323378364|FG002|Phase 1|Serious Adverse Event|0|||
94435586|NCT00086281|323378365|FG003|Phase 1|Serious Adverse Event|0|||
94435587|NCT00086281|323378366|FG004|Phase 1|Serious Adverse Event|0|||
94435588|NCT00086281|323378367|FG005|Phase 1|Serious Adverse Event|0|||
94435589|NCT00086281|323378368|FG006|Phase 1|Serious Adverse Event|0|||
94435590|NCT00086281|323378369|FG007|Phase 1|Serious Adverse Event|0|||
94435591|NCT00086281|323378370|FG008|Phase 1|Serious Adverse Event|0|||
94435592|NCT00086281|323378371|FG009|Phase 1|Serious Adverse Event|0|||
94435593|NCT00086281|323378372|FG010|Phase 1|Serious Adverse Event|0|||
94435594|NCT00086281|323378373|FG011|Phase 1|Serious Adverse Event|0|||
94435595|NCT00086281|323378374|FG012|Phase 1|Serious Adverse Event|0|||
94435596|NCT00086281|323378375|FG013|Phase 1|Serious Adverse Event|0|||
94435597|NCT00086281|323378376|FG014|Phase 1|Serious Adverse Event|1|||
94435598|NCT00086281|323378362|FG000|Phase 2|Adverse Event|0|||
94435599|NCT00086281|323378363|FG001|Phase 2|Adverse Event|0|||
94435600|NCT00086281|323378364|FG002|Phase 2|Adverse Event|0|||
94435601|NCT00086281|323378365|FG003|Phase 2|Adverse Event|0|||
94435602|NCT00086281|323378366|FG004|Phase 2|Adverse Event|0|||
94435603|NCT00086281|323378367|FG005|Phase 2|Adverse Event|0|||
94435604|NCT00086281|323378368|FG006|Phase 2|Adverse Event|0|||
94435605|NCT00086281|323378369|FG007|Phase 2|Adverse Event|0|||
94435606|NCT00086281|323378370|FG008|Phase 2|Adverse Event|0|||
94435607|NCT00086281|323378371|FG009|Phase 2|Adverse Event|0|||
94435608|NCT00086281|323378372|FG010|Phase 2|Adverse Event|0|||
94435609|NCT00086281|323378373|FG011|Phase 2|Adverse Event|0|||
94435610|NCT00086281|323378374|FG012|Phase 2|Adverse Event|1|||
94435611|NCT00086281|323378375|FG013|Phase 2|Adverse Event|1|||
94435612|NCT00086281|323378376|FG014|Phase 2|Adverse Event|0|||
94435613|NCT04138823|323378377|FG000|Overall Study|Clinical disease progression|0|||
94435614|NCT04138823|323378378|FG001|Overall Study|Clinical disease progression|0|||
94435615|NCT04138823|323378379|FG002|Overall Study|Clinical disease progression|1|||
94435616|NCT04138823|323378377|FG000|Overall Study|Objective disease progression|3|||
94435617|NCT04138823|323378378|FG001|Overall Study|Objective disease progression|2|||
94435618|NCT04138823|323378379|FG002|Overall Study|Objective disease progression|5|||
94435619|NCT04036110|323378389|FG000|Overall Study|Lost to Follow-up|3|||
94435620|NCT04036110|323378390|FG001|Overall Study|Lost to Follow-up|2|||
94435621|NCT04036110|323378391|FG002|Overall Study|Lost to Follow-up|1|||
94435622|NCT04036110|323378389|FG000|Overall Study|Study Suspended|4|||
94435623|NCT04036110|323378390|FG001|Overall Study|Study Suspended|5|||
94435624|NCT04036110|323378391|FG002|Overall Study|Study Suspended|1|||
94435625|NCT04868500|323378392|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
94435626|NCT04868500|323378393|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
94435627|NCT04868500|323378392|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
94435628|NCT04868500|323378393|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
94435629|NCT03519087|323378394|FG000|Clinic Evaluation|Physician Decision|15|||
94435630|NCT03519087|323378395|FG001|Clinic Evaluation|Physician Decision|18|||
94435631|NCT03519087|323378396|FG002|Clinic Evaluation|Physician Decision|0|||
94435632|NCT03519087|323378397|FG003|Clinic Evaluation|Physician Decision|0|||
94435633|NCT03519087|323378398|FG004|Clinic Evaluation|Physician Decision|0|||
94435634|NCT03519087|323378394|FG000|Clinic Evaluation|Protocol Violation|1|||
94435635|NCT03519087|323378395|FG001|Clinic Evaluation|Protocol Violation|0|||
94435636|NCT03519087|323378396|FG002|Clinic Evaluation|Protocol Violation|0|||
94435637|NCT03519087|323378397|FG003|Clinic Evaluation|Protocol Violation|0|||
94435638|NCT03519087|323378398|FG004|Clinic Evaluation|Protocol Violation|0|||
94435639|NCT03519087|323378394|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
94435640|NCT03519087|323378395|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
94435641|NCT03519087|323378396|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
94435642|NCT03519087|323378397|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
94435643|NCT03519087|323378398|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
94435644|NCT03519087|323378394|FG000|Re-randomization for Treatment|Not appropriate|2|||
94435645|NCT03519087|323378395|FG001|Re-randomization for Treatment|Not appropriate|3|||
94435646|NCT03519087|323378396|FG002|Re-randomization for Treatment|Not appropriate|0|||
94435647|NCT03519087|323378397|FG003|Re-randomization for Treatment|Not appropriate|0|||
94435648|NCT03519087|323378398|FG004|Re-randomization for Treatment|Not appropriate|0|||
94435649|NCT03519087|323378394|FG000|Laboratory Testing|Lost to Follow-up|0|||
94435650|NCT03519087|323378395|FG001|Laboratory Testing|Lost to Follow-up|0|||
94435651|NCT03519087|323378396|FG002|Laboratory Testing|Lost to Follow-up|2|||
94435652|NCT03519087|323378397|FG003|Laboratory Testing|Lost to Follow-up|3|||
94435653|NCT03519087|323378398|FG004|Laboratory Testing|Lost to Follow-up|6|||
94435654|NCT03519087|323378394|FG000|Laboratory Testing|Protocol Violation|0|||
94435655|NCT03519087|323378395|FG001|Laboratory Testing|Protocol Violation|0|||
94435656|NCT03519087|323378396|FG002|Laboratory Testing|Protocol Violation|0|||
94435657|NCT03519087|323378397|FG003|Laboratory Testing|Protocol Violation|1|||
94435658|NCT03519087|323378398|FG004|Laboratory Testing|Protocol Violation|0|||
94435659|NCT02565511|323378399|FG000|Overall Study|Study terminated by Sponsor|35|||
94435660|NCT02565511|323378400|FG001|Overall Study|Study terminated by Sponsor|22|||
94435661|NCT02565511|323378401|FG002|Overall Study|Study terminated by Sponsor|235|||
94435662|NCT02565511|323378402|FG003|Overall Study|Study terminated by Sponsor|156|||
94435663|NCT02565511|323378399|FG000|Overall Study|Withdrawal by Subject|3|||
94435664|NCT02565511|323378400|FG001|Overall Study|Withdrawal by Subject|0|||
94435665|NCT02565511|323378401|FG002|Overall Study|Withdrawal by Subject|12|||
94435666|NCT02565511|323378402|FG003|Overall Study|Withdrawal by Subject|5|||
94435667|NCT02565511|323378399|FG000|Overall Study|Adverse Event|0|||
94435668|NCT02565511|323378400|FG001|Overall Study|Adverse Event|0|||
94435669|NCT02565511|323378401|FG002|Overall Study|Adverse Event|1|||
94435670|NCT02565511|323378402|FG003|Overall Study|Adverse Event|1|||
94435671|NCT02565511|323378399|FG000|Overall Study|Lost to Follow-up|4|||
94435672|NCT02565511|323378400|FG001|Overall Study|Lost to Follow-up|1|||
94435673|NCT02565511|323378401|FG002|Overall Study|Lost to Follow-up|0|||
94435674|NCT02565511|323378402|FG003|Overall Study|Lost to Follow-up|1|||
94435675|NCT02565511|323378399|FG000|Overall Study|Physician Decision|0|||
94435676|NCT02565511|323378400|FG001|Overall Study|Physician Decision|0|||
94435677|NCT02565511|323378401|FG002|Overall Study|Physician Decision|0|||
94435678|NCT02565511|323378402|FG003|Overall Study|Physician Decision|1|||
94435679|NCT02565511|323378399|FG000|Overall Study|Protocol deviation|0|||
94435680|NCT02565511|323378400|FG001|Overall Study|Protocol deviation|0|||
94435681|NCT02565511|323378401|FG002|Overall Study|Protocol deviation|3|||
94435682|NCT02565511|323378402|FG003|Overall Study|Protocol deviation|0|||
94435683|NCT04324021|323378405|FG000|Overall Study|Adverse Event|1|||
94435684|NCT04324021|323378406|FG001|Overall Study|Adverse Event|0|||
94435685|NCT04324021|323378407|FG002|Overall Study|Adverse Event|0|||
94435686|NCT04324021|323378405|FG000|Overall Study|Lack of Efficacy|0|||
94435687|NCT04324021|323378406|FG001|Overall Study|Lack of Efficacy|0|||
94435688|NCT04324021|323378407|FG002|Overall Study|Lack of Efficacy|1|||
94435689|NCT04324021|323378405|FG000|Overall Study|Death|1|||
94435690|NCT04324021|323378406|FG001|Overall Study|Death|1|||
94435691|NCT04324021|323378407|FG002|Overall Study|Death|0|||
94435692|NCT01107197|323378410|FG000|Overall Study|Death|12|||
94435693|NCT01107197|323378411|FG001|Overall Study|Death|10|||
94435694|NCT01107197|323378410|FG000|Overall Study|Lost to Follow-up|5|||
94435695|NCT01107197|323378411|FG001|Overall Study|Lost to Follow-up|8|||
94435696|NCT01107197|323378410|FG000|Overall Study|Withdrawal by Subject|3|||
94435697|NCT01107197|323378411|FG001|Overall Study|Withdrawal by Subject|5|||
94435698|NCT02536846|323378412|FG000|Overall Study|Withdrawal by Subject|1|||
94435699|NCT01098487|323378413|FG000|Overall Study|Adverse Event|22|||
94435700|NCT01098487|323378413|FG000|Overall Study|Lack of Efficacy|11|||
94435701|NCT01098487|323378413|FG000|Overall Study|Withdrawal by Subject|7|||
94435702|NCT01098487|323378413|FG000|Overall Study|Lost to Follow-up|3|||
94435703|NCT01098487|323378413|FG000|Overall Study|Physician Decision|1|||
94435704|NCT00345631|323378414|FG000|Overall Study|Withdrawal by Subject|1|||
94435705|NCT00345631|323378415|FG001|Overall Study|Withdrawal by Subject|0|||
94435706|NCT00345631|323378416|FG002|Overall Study|Withdrawal by Subject|1|||
94435707|NCT00345631|323378414|FG000|Overall Study|Adverse Event|0|||
94435708|NCT00345631|323378415|FG001|Overall Study|Adverse Event|1|||
94435709|NCT00345631|323378416|FG002|Overall Study|Adverse Event|0|||
94435710|NCT00345631|323378414|FG000|Overall Study|Lost to Follow-up|3|||
94435711|NCT00345631|323378415|FG001|Overall Study|Lost to Follow-up|7|||
94435712|NCT00345631|323378416|FG002|Overall Study|Lost to Follow-up|4|||
94435713|NCT00345631|323378414|FG000|Overall Study|Other reasons|0|||
94435714|NCT00345631|323378415|FG001|Overall Study|Other reasons|0|||
94435715|NCT00345631|323378416|FG002|Overall Study|Other reasons|1|||
94435716|NCT03548337|323378417|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
94435717|NCT03548337|323378418|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
94435718|NCT03548337|323378417|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
94435719|NCT03548337|323378418|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
94435720|NCT03548337|323378417|FG000|Infant Series|Lost to Follow-up|2|||
94435721|NCT03548337|323378418|FG001|Infant Series|Lost to Follow-up|1|||
94435722|NCT03548337|323378417|FG000|Infant Series|Adverse Event|0|||
94435723|NCT03548337|323378418|FG001|Infant Series|Adverse Event|2|||
94435724|NCT03548337|323378417|FG000|Infant Series|Randomized but Not Vaccinated|1|||
94435725|NCT03548337|323378418|FG001|Infant Series|Randomized but Not Vaccinated|0|||
94435726|NCT03548337|323378417|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
94435727|NCT03548337|323378418|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
94435728|NCT01130597|323378419|FG000|Overall Study|Protocol-specified (High K+)|1|||
94435729|NCT01130597|323378419|FG000|Overall Study|Adverse Event|4|||
94435730|NCT01130597|323378419|FG000|Overall Study|Death|1|||
94435731|NCT01130597|323378419|FG000|Overall Study|Protocol Violation|1|||
94435732|NCT01301729|323378421|FG000|Overall Study|Withdrawal by Subject|2|||
94435733|NCT01301729|323378421|FG000|Overall Study|Participant did not Return for Treatment|1|||
94435734|NCT01301729|323378421|FG000|Overall Study|Violated Selection Criteria|1|||
94435735|NCT03071276|323378422|FG000|Overall Study|Adverse Event|1|||
94435736|NCT03071276|323378422|FG000|Overall Study|Lack of Efficacy|14|||
94435737|NCT04700137|323378428|FG000|Overall Study|Lost to Follow-up|1|||
94435738|NCT04700137|323378429|FG001|Overall Study|Lost to Follow-up|6|||
94435739|NCT04700137|323378430|FG002|Overall Study|Lost to Follow-up|1|||
94435740|NCT04700137|323378431|FG003|Overall Study|Lost to Follow-up|1|||
94435741|NCT04700137|323378428|FG000|Overall Study|Withdrawal by Subject|0|||
94435742|NCT04700137|323378429|FG001|Overall Study|Withdrawal by Subject|0|||
94435743|NCT04700137|323378430|FG002|Overall Study|Withdrawal by Subject|1|||
94435744|NCT04700137|323378431|FG003|Overall Study|Withdrawal by Subject|0|||
94435745|NCT04700137|323378428|FG000|Overall Study|Death|0|||
94435746|NCT04700137|323378429|FG001|Overall Study|Death|0|||
94435747|NCT04700137|323378430|FG002|Overall Study|Death|1|||
94435748|NCT04700137|323378431|FG003|Overall Study|Death|0|||
94435749|NCT02682927|323378435|FG000|Overall Study|Adverse Event|0|||
94490193|NCT02747927|323590265|FG001|Overall Study|Reason not Specified|27|||
94435750|NCT02682927|323378436|FG001|Overall Study|Adverse Event|0|||
94435751|NCT02682927|323378437|FG002|Overall Study|Adverse Event|5|||
94435752|NCT02682927|323378438|FG003|Overall Study|Adverse Event|1|||
94435753|NCT02682927|323378439|FG004|Overall Study|Adverse Event|0|||
94435754|NCT02682927|323378440|FG005|Overall Study|Adverse Event|2|||
94435755|NCT02682927|323378435|FG000|Overall Study|Death|0|||
94435756|NCT02682927|323378436|FG001|Overall Study|Death|0|||
94435757|NCT02682927|323378437|FG002|Overall Study|Death|0|||
94435758|NCT02682927|323378438|FG003|Overall Study|Death|1|||
94435759|NCT02682927|323378439|FG004|Overall Study|Death|0|||
94435760|NCT02682927|323378440|FG005|Overall Study|Death|0|||
94435761|NCT02682927|323378435|FG000|Overall Study|Lack of Efficacy|1|||
94435762|NCT02682927|323378436|FG001|Overall Study|Lack of Efficacy|0|||
94435763|NCT02682927|323378437|FG002|Overall Study|Lack of Efficacy|0|||
94490194|NCT00207740|323590266|FG000|Overall Study|Adverse Event|4|||
94435764|NCT02682927|323378438|FG003|Overall Study|Lack of Efficacy|1|||
94435765|NCT02682927|323378439|FG004|Overall Study|Lack of Efficacy|0|||
94435766|NCT02682927|323378440|FG005|Overall Study|Lack of Efficacy|0|||
94435767|NCT02682927|323378435|FG000|Overall Study|Other|0|||
94435768|NCT02682927|323378436|FG001|Overall Study|Other|0|||
94435769|NCT02682927|323378437|FG002|Overall Study|Other|0|||
94435770|NCT02682927|323378438|FG003|Overall Study|Other|2|||
94435771|NCT02682927|323378439|FG004|Overall Study|Other|0|||
94435772|NCT02682927|323378440|FG005|Overall Study|Other|0|||
94435773|NCT02682927|323378435|FG000|Overall Study|Withdrawal by Subject|2|||
94435774|NCT02682927|323378436|FG001|Overall Study|Withdrawal by Subject|0|||
94435775|NCT02682927|323378437|FG002|Overall Study|Withdrawal by Subject|1|||
94435776|NCT02682927|323378438|FG003|Overall Study|Withdrawal by Subject|0|||
94435777|NCT02682927|323378439|FG004|Overall Study|Withdrawal by Subject|1|||
94435778|NCT02682927|323378440|FG005|Overall Study|Withdrawal by Subject|1|||
94435779|NCT04380961|323378442|FG000|Overall Study|Lost to Follow-up|17|||
94435780|NCT04380961|323378443|FG001|Overall Study|Lost to Follow-up|11|||
94435781|NCT04380961|323378442|FG000|Overall Study|Withdrawal by Subject|3|||
94435782|NCT04380961|323378443|FG001|Overall Study|Withdrawal by Subject|0|||
94435783|NCT04380961|323378442|FG000|Overall Study|Death|22|||
94435784|NCT04380961|323378443|FG001|Overall Study|Death|16|||
94435785|NCT04380961|323378442|FG000|Overall Study|Other|1|||
94435786|NCT04380961|323378443|FG001|Overall Study|Other|0|||
94435787|NCT04380961|323378442|FG000|Overall Study|Randomized but Not Treated|1|||
94435788|NCT04380961|323378443|FG001|Overall Study|Randomized but Not Treated|2|||
94435789|NCT04803305|323378444|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
94435790|NCT04803305|323378445|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
94435791|NCT04803305|323378444|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
94435792|NCT04803305|323378445|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
94435793|NCT04803305|323378444|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
94435794|NCT04803305|323378445|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
94435795|NCT04803305|323378444|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
94435796|NCT04803305|323378445|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
94435797|NCT04803305|323378444|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
94435798|NCT04803305|323378445|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
94435799|NCT04803305|323378444|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
94435800|NCT04803305|323378445|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
94435801|NCT04803305|323378444|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
94435802|NCT04803305|323378445|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
94435803|NCT04803305|323378444|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
94435804|NCT04803305|323378445|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
94435805|NCT05513391|323378446|FG000|Overall Study|Adverse Event|1|||
94435806|NCT05513391|323378447|FG001|Overall Study|Adverse Event|0|||
94435807|NCT05513391|323378446|FG000|Overall Study|Protocol Deviation|0|||
94435808|NCT05513391|323378447|FG001|Overall Study|Protocol Deviation|1|||
94435809|NCT05513391|323378446|FG000|Overall Study|Withdrawal by Subject|3|||
94435810|NCT05513391|323378447|FG001|Overall Study|Withdrawal by Subject|1|||
94435811|NCT05513391|323378446|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
94435812|NCT05513391|323378447|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
94435813|NCT05513391|323378446|FG000|Overall Study|Lost to Follow-up|0|||
94435814|NCT05513391|323378447|FG001|Overall Study|Lost to Follow-up|2|||
94435815|NCT01632280|323378448|FG000|Overall Study|Withdrawal by Subject|1|||
94435816|NCT01632280|323378449|FG001|Overall Study|Withdrawal by Subject|0|||
94435817|NCT00993421|323378450|FG000|Overall Study|Adverse Event|2|||
94435818|NCT00993421|323378451|FG001|Overall Study|Adverse Event|7|||
94435819|NCT00993421|323378452|FG002|Overall Study|Adverse Event|6|||
94435820|NCT00993421|323378453|FG003|Overall Study|Adverse Event|9|||
94435821|NCT00993421|323378454|FG004|Overall Study|Adverse Event|5|||
94435822|NCT00993421|323378455|FG005|Overall Study|Adverse Event|7|||
94435823|NCT00993421|323378456|FG006|Overall Study|Adverse Event|1|||
94435824|NCT00993421|323378450|FG000|Overall Study|Sponsor Decision|36|||
94435825|NCT00993421|323378451|FG001|Overall Study|Sponsor Decision|31|||
94435826|NCT00993421|323378452|FG002|Overall Study|Sponsor Decision|28|||
94435827|NCT00993421|323378453|FG003|Overall Study|Sponsor Decision|30|||
94435828|NCT00993421|323378454|FG004|Overall Study|Sponsor Decision|38|||
94435829|NCT00993421|323378455|FG005|Overall Study|Sponsor Decision|30|||
94435830|NCT00993421|323378456|FG006|Overall Study|Sponsor Decision|29|||
94435831|NCT00993421|323378450|FG000|Overall Study|Lost to Follow-up|3|||
94435832|NCT00993421|323378451|FG001|Overall Study|Lost to Follow-up|5|||
94435833|NCT00993421|323378452|FG002|Overall Study|Lost to Follow-up|5|||
94435834|NCT00993421|323378453|FG003|Overall Study|Lost to Follow-up|0|||
94435835|NCT00993421|323378454|FG004|Overall Study|Lost to Follow-up|0|||
94435836|NCT00993421|323378455|FG005|Overall Study|Lost to Follow-up|0|||
94435837|NCT00993421|323378456|FG006|Overall Study|Lost to Follow-up|6|||
94435838|NCT00993421|323378450|FG000|Overall Study|Withdrawal by Subject|3|||
94435839|NCT00993421|323378451|FG001|Overall Study|Withdrawal by Subject|2|||
94435840|NCT00993421|323378452|FG002|Overall Study|Withdrawal by Subject|3|||
94435841|NCT00993421|323378453|FG003|Overall Study|Withdrawal by Subject|3|||
94435842|NCT00993421|323378454|FG004|Overall Study|Withdrawal by Subject|3|||
94435843|NCT00993421|323378455|FG005|Overall Study|Withdrawal by Subject|5|||
94435844|NCT00993421|323378456|FG006|Overall Study|Withdrawal by Subject|3|||
94435845|NCT00993421|323378450|FG000|Overall Study|Death|0|||
94435846|NCT00993421|323378451|FG001|Overall Study|Death|0|||
94435847|NCT00993421|323378452|FG002|Overall Study|Death|0|||
94435848|NCT00993421|323378453|FG003|Overall Study|Death|0|||
94435849|NCT00993421|323378454|FG004|Overall Study|Death|0|||
94435850|NCT00993421|323378455|FG005|Overall Study|Death|0|||
94435851|NCT00993421|323378456|FG006|Overall Study|Death|1|||
94435852|NCT00993421|323378450|FG000|Overall Study|Entry Criteria Exclusion|0|||
94435853|NCT00993421|323378451|FG001|Overall Study|Entry Criteria Exclusion|0|||
94435854|NCT00993421|323378452|FG002|Overall Study|Entry Criteria Exclusion|1|||
94435855|NCT00993421|323378453|FG003|Overall Study|Entry Criteria Exclusion|3|||
94435856|NCT00993421|323378454|FG004|Overall Study|Entry Criteria Exclusion|0|||
94435857|NCT00993421|323378455|FG005|Overall Study|Entry Criteria Exclusion|1|||
94435858|NCT00993421|323378456|FG006|Overall Study|Entry Criteria Exclusion|0|||
94435859|NCT00993421|323378450|FG000|Overall Study|Physician Decision|0|||
94435860|NCT00993421|323378451|FG001|Overall Study|Physician Decision|0|||
94435861|NCT00993421|323378452|FG002|Overall Study|Physician Decision|0|||
94435862|NCT00993421|323378453|FG003|Overall Study|Physician Decision|0|||
94435863|NCT00993421|323378454|FG004|Overall Study|Physician Decision|0|||
94435864|NCT00993421|323378455|FG005|Overall Study|Physician Decision|1|||
94435865|NCT00993421|323378456|FG006|Overall Study|Physician Decision|1|||
94435866|NCT00993421|323378450|FG000|Overall Study|Protocol Violation|0|||
94435867|NCT00993421|323378451|FG001|Overall Study|Protocol Violation|0|||
94435868|NCT00993421|323378452|FG002|Overall Study|Protocol Violation|0|||
94435869|NCT00993421|323378453|FG003|Overall Study|Protocol Violation|0|||
94435870|NCT00993421|323378454|FG004|Overall Study|Protocol Violation|0|||
94435871|NCT00993421|323378455|FG005|Overall Study|Protocol Violation|2|||
94435872|NCT00993421|323378456|FG006|Overall Study|Protocol Violation|1|||
94435873|NCT00708227|323378457|FG000|Overall Study|Physician Decision|0|||
94435874|NCT00708227|323378458|FG001|Overall Study|Physician Decision|3|||
94435875|NCT00708227|323378459|FG002|Overall Study|Physician Decision|1|||
94435876|NCT00708227|323378460|FG003|Overall Study|Physician Decision|2|||
94435877|NCT00708227|323378457|FG000|Overall Study|Withdrawal by Subject|1|||
94435878|NCT00708227|323378458|FG001|Overall Study|Withdrawal by Subject|2|||
94435879|NCT00708227|323378459|FG002|Overall Study|Withdrawal by Subject|0|||
94435880|NCT00708227|323378460|FG003|Overall Study|Withdrawal by Subject|1|||
94435881|NCT02108912|323378466|FG000|Overall Study|Lost to Follow-up|1|||
94435882|NCT02108912|323378467|FG001|Overall Study|Lost to Follow-up|1|||
94435883|NCT02108912|323378466|FG000|Overall Study|lack of transportation|1|||
94435884|NCT02108912|323378467|FG001|Overall Study|lack of transportation|0|||
94435885|NCT02108912|323378466|FG000|Overall Study|high blood pressure|1|||
94435886|NCT02108912|323378467|FG001|Overall Study|high blood pressure|0|||
94435887|NCT00451178|323378470|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
94435888|NCT00451178|323378471|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
94435889|NCT00451178|323378470|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
94435890|NCT00451178|323378471|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
94435891|NCT00451178|323378470|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
94435892|NCT00451178|323378471|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
94435893|NCT00451178|323378470|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
94435894|NCT00451178|323378471|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
94435895|NCT00451178|323378470|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
94435896|NCT00451178|323378471|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
94435897|NCT00451178|323378470|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
94435898|NCT00451178|323378471|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
94435899|NCT00451178|323378470|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
94435900|NCT00451178|323378471|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
94435901|NCT00451178|323378470|FG000|Prior to Maintenance Therapy|PD|2|||
94435902|NCT00451178|323378471|FG001|Prior to Maintenance Therapy|PD|0|||
94435903|NCT00451178|323378470|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
94435904|NCT00451178|323378471|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
94435905|NCT00451178|323378470|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
94435906|NCT00451178|323378471|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
94435907|NCT00451178|323378470|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
94435908|NCT00451178|323378471|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
94435909|NCT00451178|323378470|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
94435910|NCT00451178|323378471|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
94435911|NCT00451178|323378470|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
94435912|NCT00451178|323378471|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
94435913|NCT00451178|323378470|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
94435914|NCT00451178|323378471|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
94435915|NCT00451178|323378470|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
94435916|NCT00451178|323378471|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
94435917|NCT01260701|323378472|FG000|Overall Study|Adverse Event|9|||
94435918|NCT01260701|323378472|FG000|Overall Study|Withdrawal by Subject|2|||
94435919|NCT01260701|323378472|FG000|Overall Study|Progression|53|||
94435920|NCT01260701|323378472|FG000|Overall Study|Death|2|||
94435921|NCT01260701|323378472|FG000|Overall Study|Not protocol specified|3|||
94435922|NCT01260701|323378472|FG000|Overall Study|Under review|1|||
94435923|NCT01260701|323378472|FG000|Overall Study|Ineligible|4|||
94435924|NCT01260701|323378472|FG000|Overall Study|Did not begin protocol therapy|1|||
94435925|NCT00306995|323378474|FG000|Study Part I|Withdrawal by Subject|0|||
94435926|NCT00306995|323378475|FG001|Study Part I|Withdrawal by Subject|0|||
94435927|NCT00306995|323378476|FG002|Study Part I|Withdrawal by Subject|0|||
94435928|NCT00306995|323378477|FG003|Study Part I|Withdrawal by Subject|0|||
94435929|NCT00306995|323378478|FG004|Study Part I|Withdrawal by Subject|0|||
94435930|NCT00306995|323378479|FG005|Study Part I|Withdrawal by Subject|0|||
94435931|NCT00306995|323378480|FG006|Study Part I|Withdrawal by Subject|1|||
94435932|NCT00306995|323378474|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
94435933|NCT00306995|323378475|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
94435934|NCT00306995|323378476|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
94435935|NCT00306995|323378477|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
94435936|NCT00306995|323378478|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
94435937|NCT00306995|323378479|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
94435938|NCT00306995|323378480|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
94435939|NCT02017015|323379946|FG000|Overall Study|Adverse Event|9|||
94435940|NCT02017015|323379946|FG000|Overall Study|Withdrawal by Subject|21|||
94435941|NCT02017015|323379946|FG000|Overall Study|Death|4|||
94435942|NCT02017015|323379946|FG000|Overall Study|Progressive Disease|31|||
94435943|NCT02017015|323379946|FG000|Overall Study|Non-compliance with study drug|2|||
94435944|NCT02017015|323379946|FG000|Overall Study|Physician Decision|2|||
94435945|NCT01200069|323379947|FG000|Overall Study|Withdrawal by Subject|0|||
94435946|NCT01200069|323379948|FG001|Overall Study|Withdrawal by Subject|1|||
94435947|NCT00233948|323379955|FG000|Overall Study|Adverse Event|1|||
94435948|NCT00233948|323379956|FG001|Overall Study|Adverse Event|0|||
94435949|NCT00233948|323379957|FG002|Overall Study|Adverse Event|0|||
94435950|NCT00233948|323379958|FG003|Overall Study|Adverse Event|0|||
94435951|NCT00233948|323379959|FG004|Overall Study|Adverse Event|0|||
94435952|NCT00233948|323379960|FG005|Overall Study|Adverse Event|0|||
94435953|NCT01403051|323379961|FG000|Overall Study|Protocol Violation|2|||
94435954|NCT01403051|323379962|FG001|Overall Study|Protocol Violation|0|||
94435955|NCT01403051|323379961|FG000|Overall Study|Death|1|||
94435956|NCT01403051|323379962|FG001|Overall Study|Death|0|||
94435957|NCT01403051|323379961|FG000|Overall Study|Withdrawal by Subject|2|||
94435958|NCT01403051|323379962|FG001|Overall Study|Withdrawal by Subject|1|||
94435959|NCT01403051|323379961|FG000|Overall Study|Lost to Follow-up|5|||
94435960|NCT01403051|323379962|FG001|Overall Study|Lost to Follow-up|5|||
94435961|NCT00887289|323379963|FG000|Overall Study|Lack of Efficacy|14|||
94435962|NCT00887289|323379963|FG000|Overall Study|Adverse Event|27|||
94435963|NCT00887289|323379963|FG000|Overall Study|Withdrawal by Subject|26|||
94435964|NCT00887289|323379963|FG000|Overall Study|Lost to Follow-up|8|||
94435965|NCT00887289|323379963|FG000|Overall Study|Other|20|||
94435966|NCT01645787|323379972|FG000|Washout (2 Weeks)|Adverse Event|1|||
94435967|NCT01645787|323379973|FG001|Washout (2 Weeks)|Adverse Event|0|||
94435968|NCT00616421|323379974|FG000|Overall Study|Withdrawal by Subject|9|||
94435969|NCT00616421|323379975|FG001|Overall Study|Withdrawal by Subject|11|||
94435970|NCT00616421|323379976|FG002|Overall Study|Withdrawal by Subject|8|||
94435971|NCT00616421|323379974|FG000|Overall Study|Lost to Follow-up|12|||
94435972|NCT00616421|323379975|FG001|Overall Study|Lost to Follow-up|26|||
94435973|NCT00616421|323379976|FG002|Overall Study|Lost to Follow-up|30|||
94435974|NCT00616421|323379974|FG000|Overall Study|Inappropriate enrollment|3|||
94435975|NCT00616421|323379975|FG001|Overall Study|Inappropriate enrollment|0|||
94435976|NCT00616421|323379976|FG002|Overall Study|Inappropriate enrollment|1|||
94435977|NCT00616421|323379974|FG000|Overall Study|Administrative reason|1|||
94435978|NCT00616421|323379975|FG001|Overall Study|Administrative reason|0|||
94435979|NCT00616421|323379976|FG002|Overall Study|Administrative reason|0|||
94435980|NCT00616421|323379974|FG000|Overall Study|Protocol Violation|0|||
94435981|NCT00616421|323379975|FG001|Overall Study|Protocol Violation|1|||
94435982|NCT00616421|323379976|FG002|Overall Study|Protocol Violation|2|||
94435983|NCT00616421|323379974|FG000|Overall Study|Unable to classify|1|||
94435984|NCT00616421|323379975|FG001|Overall Study|Unable to classify|0|||
94435985|NCT00616421|323379976|FG002|Overall Study|Unable to classify|0|||
94435986|NCT01495702|323379977|FG000|Randomized Phase|Randomized But Not Treated|1|||
94435987|NCT01495702|323379978|FG001|Randomized Phase|Randomized But Not Treated|4|||
94435988|NCT01495702|323379977|FG000|Randomized Phase|Adverse Event|2|||
94435989|NCT01495702|323379978|FG001|Randomized Phase|Adverse Event|2|||
94435990|NCT01495702|323379977|FG000|Randomized Phase|Death|1|||
94435991|NCT01495702|323379978|FG001|Randomized Phase|Death|0|||
94435992|NCT01495702|323379977|FG000|Randomized Phase|Lack of Efficacy|2|||
94435993|NCT01495702|323379978|FG001|Randomized Phase|Lack of Efficacy|0|||
94435994|NCT01495702|323379977|FG000|Randomized Phase|Investigators Discretion|2|||
94435995|NCT01495702|323379978|FG001|Randomized Phase|Investigators Discretion|0|||
94435996|NCT01495702|323379977|FG000|Randomized Phase|Withdrew Consent|10|||
94435997|NCT01495702|323379978|FG001|Randomized Phase|Withdrew Consent|18|||
94435998|NCT01495702|323379977|FG000|Randomized Phase|Lost to Follow-up|4|||
94435999|NCT01495702|323379978|FG001|Randomized Phase|Lost to Follow-up|3|||
94436000|NCT01495702|323379977|FG000|Randomized Phase|Participant Noncompliance|1|||
94436001|NCT01495702|323379978|FG001|Randomized Phase|Participant Noncompliance|0|||
94436002|NCT01495702|323379977|FG000|Randomized Phase|Protocol Violation|3|||
94436003|NCT01495702|323379978|FG001|Randomized Phase|Protocol Violation|1|||
94436004|NCT01721317|323379980|FG000|Overall Study|Study Closed / Terminated|2|||
94436005|NCT01721317|323379981|FG001|Overall Study|Study Closed / Terminated|2|||
94436006|NCT01721317|323379980|FG000|Overall Study|Physician Decision|0|||
94436007|NCT01721317|323379981|FG001|Overall Study|Physician Decision|1|||
94436008|NCT01721317|323379980|FG000|Overall Study|Withdrawal by Subject|0|||
94436009|NCT01721317|323379981|FG001|Overall Study|Withdrawal by Subject|1|||
94436010|NCT02806024|323379984|FG000|Overall Study|Night Delivery|1|||
94436011|NCT02806024|323379985|FG001|Overall Study|Night Delivery|1|||
94436012|NCT02806024|323379984|FG000|Overall Study|DVT during antepartum admission|0|||
94436013|NCT02806024|323379985|FG001|Overall Study|DVT during antepartum admission|1|||
94436014|NCT01720225|323379988|FG000|Overall Study|Withdrawal by Subject|0|||
94436015|NCT01720225|323379989|FG001|Overall Study|Withdrawal by Subject|1|||
94436016|NCT01720225|323379988|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
94436017|NCT01720225|323379989|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
94436018|NCT02964312|323379994|FG000|Overall Study|Lost to Follow-up|28|||
94436019|NCT02964312|323379994|FG000|Overall Study|Withdrawal by Subject|11|||
94436020|NCT02964312|323379994|FG000|Overall Study|Lack of Efficacy|10|||
94436021|NCT02964312|323379994|FG000|Overall Study|Did not consent to long-term FU|14|||
94436022|NCT02964312|323379994|FG000|Overall Study|Death|1|||
94436023|NCT00606632|323379995|FG000|Overall Study|Withdrawal by Subject|13|||
94436024|NCT00606632|323379995|FG000|Overall Study|Miscellaneous reasons|9|||
94436025|NCT03685344|323379998|FG000|Overall Study|Withdrawal by Subject|1|||
94436026|NCT03685344|323379999|FG001|Overall Study|Withdrawal by Subject|1|||
94436027|NCT03685344|323380000|FG002|Overall Study|Withdrawal by Subject|2|||
94436028|NCT03685344|323380001|FG003|Overall Study|Withdrawal by Subject|0|||
94436029|NCT03685344|323379998|FG000|Overall Study|Physician Decision|1|||
94436030|NCT03685344|323379999|FG001|Overall Study|Physician Decision|1|||
94436031|NCT03685344|323380000|FG002|Overall Study|Physician Decision|5|||
94436032|NCT03685344|323380001|FG003|Overall Study|Physician Decision|0|||
94436033|NCT03685344|323379998|FG000|Overall Study|Death|1|||
94436034|NCT03685344|323379999|FG001|Overall Study|Death|1|||
94436035|NCT03685344|323380000|FG002|Overall Study|Death|0|||
94436036|NCT03685344|323380001|FG003|Overall Study|Death|0|||
94436037|NCT00191191|323380002|FG000|Overall Study|Entry Criteria Exclusion|2|||
94436038|NCT00191191|323380003|FG001|Overall Study|Entry Criteria Exclusion|0|||
94436039|NCT00191191|323380002|FG000|Overall Study|Treated with Another Systemic Agent|1|||
94436040|NCT00191191|323380003|FG001|Overall Study|Treated with Another Systemic Agent|1|||
94436041|NCT00191191|323380002|FG000|Overall Study|Adverse Event|11|||
94436042|NCT00191191|323380003|FG001|Overall Study|Adverse Event|21|||
94436043|NCT00191191|323380002|FG000|Overall Study|Progressive Disease|84|||
94436044|NCT00191191|323380003|FG001|Overall Study|Progressive Disease|72|||
94436045|NCT00191191|323380002|FG000|Overall Study|Toxicity After Dose Reduction|7|||
94436046|NCT00191191|323380003|FG001|Overall Study|Toxicity After Dose Reduction|8|||
94436047|NCT00191191|323380002|FG000|Overall Study|Family/Caregiver Decision|5|||
94436048|NCT00191191|323380003|FG001|Overall Study|Family/Caregiver Decision|7|||
94436049|NCT00191191|323380002|FG000|Overall Study|Lost to Follow-up|1|||
94436050|NCT00191191|323380003|FG001|Overall Study|Lost to Follow-up|0|||
94436051|NCT00191191|323380002|FG000|Overall Study|Physician Decision|3|||
94436052|NCT00191191|323380003|FG001|Overall Study|Physician Decision|2|||
94436053|NCT00191191|323380002|FG000|Overall Study|Good Clinical Practice Violation|0|||
94436054|NCT00191191|323380003|FG001|Overall Study|Good Clinical Practice Violation|1|||
94436055|NCT04238650|323380007|FG000|Overall Study|Withdrawal by Subject|0|||
94436056|NCT04238650|323380008|FG001|Overall Study|Withdrawal by Subject|1|||
94436057|NCT03633825|323380009|FG000|Enrollment|Did not post on network|5066|||
94436058|NCT03633825|323380010|FG001|Enrollment|Did not post on network|5080|||
94436059|NCT03633825|323380009|FG000|Enrollment|Post not classified as crisis|13967|||
94436060|NCT03633825|323380010|FG001|Enrollment|Post not classified as crisis|13757|||
94436061|NCT03633825|323380009|FG000|Follow up|Lost to Follow-up|478|||
94436062|NCT03633825|323380010|FG001|Follow up|Lost to Follow-up|450|||
94436063|NCT04289363|323380011|FG000|Overall Study|Lost to Follow-up|14|||
94436064|NCT04289363|323380012|FG001|Overall Study|Lost to Follow-up|0|||
94436065|NCT03348163|323380013|FG000|Overall Study|Withdrawal by Subject|2|||
94436066|NCT03348163|323380014|FG001|Overall Study|Withdrawal by Subject|0|||
94436067|NCT02756208|323380015|FG000|Overall Study|Withdrawal by Subject|1|||
94436068|NCT02756208|323380016|FG001|Overall Study|Withdrawal by Subject|0|||
94436069|NCT02756208|323380017|FG002|Overall Study|Withdrawal by Subject|1|||
94436070|NCT02756208|323380018|FG003|Overall Study|Withdrawal by Subject|3|||
94436071|NCT02756208|323380015|FG000|Overall Study|Lost to Follow-up|3|||
94436072|NCT02756208|323380016|FG001|Overall Study|Lost to Follow-up|1|||
94436073|NCT02756208|323380017|FG002|Overall Study|Lost to Follow-up|1|||
94436074|NCT02756208|323380018|FG003|Overall Study|Lost to Follow-up|1|||
94436075|NCT02756208|323380015|FG000|Overall Study|Physician Decision|1|||
94436076|NCT02756208|323380016|FG001|Overall Study|Physician Decision|0|||
94436077|NCT02756208|323380017|FG002|Overall Study|Physician Decision|0|||
94436078|NCT02756208|323380018|FG003|Overall Study|Physician Decision|0|||
94436079|NCT02756208|323380015|FG000|Overall Study|Protocol Violation|0|||
94436080|NCT02756208|323380016|FG001|Overall Study|Protocol Violation|1|||
94436081|NCT02756208|323380017|FG002|Overall Study|Protocol Violation|0|||
94436082|NCT02756208|323380018|FG003|Overall Study|Protocol Violation|0|||
94436083|NCT01699815|323380020|FG000|Overall Study|Protocol Violation|4|||
94436084|NCT01699815|323380021|FG001|Overall Study|Protocol Violation|7|||
94436085|NCT01699815|323380020|FG000|Overall Study|record could not be located|1|||
94436086|NCT01699815|323380021|FG001|Overall Study|record could not be located|0|||
94436087|NCT01699815|323380020|FG000|Overall Study|Adverse Event|0|||
94436088|NCT01699815|323380021|FG001|Overall Study|Adverse Event|1|||
94436089|NCT00652340|323380022|FG000|Overall Study|Had not progressed.|4|||
94436090|NCT00652340|323380023|FG001|Overall Study|Had not progressed.|3|||
94436091|NCT04123405|323380024|FG000|Overall Study|Adverse Event|1|||
94436092|NCT04123405|323380025|FG001|Overall Study|Adverse Event|2|||
94436093|NCT04123405|323380026|FG002|Overall Study|Adverse Event|3|||
94436094|NCT04123405|323380027|FG003|Overall Study|Adverse Event|3|||
94436095|NCT04123405|323380024|FG000|Overall Study|Exclusion criteria met|1|||
94436096|NCT04123405|323380025|FG001|Overall Study|Exclusion criteria met|2|||
94436097|NCT04123405|323380026|FG002|Overall Study|Exclusion criteria met|0|||
94436098|NCT04123405|323380027|FG003|Overall Study|Exclusion criteria met|2|||
94436099|NCT04123405|323380024|FG000|Overall Study|Withdrawal by Subject|1|||
94436100|NCT04123405|323380025|FG001|Overall Study|Withdrawal by Subject|3|||
94436101|NCT04123405|323380026|FG002|Overall Study|Withdrawal by Subject|0|||
94436102|NCT04123405|323380027|FG003|Overall Study|Withdrawal by Subject|2|||
94436103|NCT04123405|323380024|FG000|Overall Study|Contact to subject lost|0|||
94436104|NCT04123405|323380025|FG001|Overall Study|Contact to subject lost|0|||
94436105|NCT04123405|323380026|FG002|Overall Study|Contact to subject lost|0|||
94436106|NCT04123405|323380027|FG003|Overall Study|Contact to subject lost|1|||
94436107|NCT04123405|323380024|FG000|Overall Study|screening failure|1|||
94436108|NCT04123405|323380025|FG001|Overall Study|screening failure|0|||
94436109|NCT04123405|323380026|FG002|Overall Study|screening failure|0|||
94436110|NCT04123405|323380027|FG003|Overall Study|screening failure|0|||
94436111|NCT01750190|323380029|FG000|Overall Study|Adverse Event|47|||
94436112|NCT01750190|323380030|FG001|Overall Study|Adverse Event|19|||
94436113|NCT01750190|323380029|FG000|Overall Study|Death|38|||
94436114|NCT01750190|323380030|FG001|Overall Study|Death|11|||
94436115|NCT01750190|323380029|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
94436116|NCT01750190|323380030|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
94436117|NCT01750190|323380029|FG000|Overall Study|Lost to Follow-up|28|||
94436118|NCT01750190|323380030|FG001|Overall Study|Lost to Follow-up|7|||
94436119|NCT01750190|323380029|FG000|Overall Study|Physician Decision|16|||
94436120|NCT01750190|323380030|FG001|Overall Study|Physician Decision|17|||
94436121|NCT01750190|323380029|FG000|Overall Study|Protocol Violation|6|||
94436122|NCT01750190|323380030|FG001|Overall Study|Protocol Violation|5|||
94436123|NCT01750190|323380029|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
94436124|NCT01750190|323380030|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
94436125|NCT01750190|323380029|FG000|Overall Study|Withdrawal by Subject|83|||
94436126|NCT01750190|323380030|FG001|Overall Study|Withdrawal by Subject|89|||
94436127|NCT01750190|323380029|FG000|Overall Study|Kidney Transplant|8|||
94436128|NCT01750190|323380030|FG001|Overall Study|Kidney Transplant|4|||
94490195|NCT00207740|323590267|FG001|Overall Study|Adverse Event|14|||
94490196|NCT00207740|323590268|FG002|Overall Study|Adverse Event|14|||
94436129|NCT01750190|323380029|FG000|Overall Study|Dialysis|22|||
94436130|NCT01750190|323380030|FG001|Overall Study|Dialysis|8|||
94436131|NCT01750190|323380029|FG000|Overall Study|Other than Specified|13|||
94436132|NCT01750190|323380030|FG001|Overall Study|Other than Specified|4|||
94436133|NCT02955212|323380031|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
94436134|NCT02955212|323380032|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
94436135|NCT02955212|323380031|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
94436136|NCT02955212|323380032|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
94436137|NCT02955212|323380031|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
94436138|NCT02955212|323380032|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
94436139|NCT02955212|323380031|FG000|Period 1: Double-blind Treatment Period|Other|3|||
94436140|NCT02955212|323380032|FG001|Period 1: Double-blind Treatment Period|Other|2|||
94436141|NCT02955212|323380031|FG000|Period 2: Open-label Extension|Adverse Event|11|||
94436142|NCT02955212|323380032|FG001|Period 2: Open-label Extension|Adverse Event|7|||
94436143|NCT02955212|323380031|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
94490197|NCT00207740|323590269|FG003|Overall Study|Adverse Event|11|||
94436144|NCT02955212|323380032|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
94436145|NCT02955212|323380031|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
94436146|NCT02955212|323380032|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
94436147|NCT02955212|323380031|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
94436148|NCT02955212|323380032|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
94436149|NCT02955212|323380031|FG000|Period 2: Open-label Extension|Other|2|||
94436150|NCT02955212|323380032|FG001|Period 2: Open-label Extension|Other|4|||
94436151|NCT02290223|323380036|FG000|6 Months|Lost to Follow-up|9|||
94436152|NCT02290223|323380037|FG001|6 Months|Lost to Follow-up|6|||
94436153|NCT02290223|323380036|FG000|6 Months|Withdrawal by Subject|5|||
94436154|NCT02290223|323380037|FG001|6 Months|Withdrawal by Subject|0|||
94436155|NCT02290223|323380036|FG000|6 Months|deceased (not related to study)|2|||
94436156|NCT02290223|323380037|FG001|6 Months|deceased (not related to study)|0|||
94436157|NCT02290223|323380036|FG000|12 Months|Lost to Follow-up|16|||
94436158|NCT02290223|323380037|FG001|12 Months|Lost to Follow-up|10|||
94436159|NCT02290223|323380036|FG000|12 Months|Refusal|0|||
94436160|NCT02290223|323380037|FG001|12 Months|Refusal|1|||
94436161|NCT02859142|323380038|FG000|Overall Study|Adverse Event|1|||
94436162|NCT02859142|323380039|FG001|Overall Study|Adverse Event|2|||
94436163|NCT02859142|323380038|FG000|Overall Study|Lost to Follow-up|1|||
94436164|NCT02859142|323380039|FG001|Overall Study|Lost to Follow-up|4|||
94436165|NCT02859142|323380038|FG000|Overall Study|Withdrawal by Subject|2|||
94436166|NCT02859142|323380039|FG001|Overall Study|Withdrawal by Subject|0|||
94436167|NCT02859142|323380038|FG000|Overall Study|Scheduling difficulties|0|||
94436168|NCT02859142|323380039|FG001|Overall Study|Scheduling difficulties|3|||
94436169|NCT03076775|323380047|FG000|Overall Study|Lost to Follow-up|1|||
94436170|NCT03076775|323380048|FG001|Overall Study|Lost to Follow-up|0|||
94436171|NCT00940316|323380050|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
94436172|NCT00940316|323380051|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
94436173|NCT00940316|323380052|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
94436174|NCT00940316|323380050|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
94436175|NCT00940316|323380051|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
94436176|NCT00940316|323380052|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
94436177|NCT00940316|323380050|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
94436178|NCT00940316|323380051|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
94436179|NCT00940316|323380052|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
94436180|NCT00940316|323380050|FG000|Treated After Cycle 5|Adverse Event|0|||
94436181|NCT00940316|323380051|FG001|Treated After Cycle 5|Adverse Event|0|||
94436182|NCT00940316|323380052|FG002|Treated After Cycle 5|Adverse Event|1|||
94436183|NCT00940316|323380050|FG000|Treated After Cycle 5|Progressive disease|0|||
94436184|NCT00940316|323380051|FG001|Treated After Cycle 5|Progressive disease|1|||
94436185|NCT00940316|323380052|FG002|Treated After Cycle 5|Progressive disease|0|||
94436186|NCT03910673|323380053|FG000|Overall Study|Adverse Event|0|||
94436187|NCT03910673|323380054|FG001|Overall Study|Adverse Event|0|||
94436188|NCT03910673|323380055|FG002|Overall Study|Adverse Event|0|||
94436189|NCT03910673|323380056|FG003|Overall Study|Adverse Event|2|||
94436190|NCT03910673|323380057|FG004|Overall Study|Adverse Event|0|||
94436191|NCT00098774|323380058|FG000|Overall Study|Adverse Event|2|||
94436192|NCT00098774|323380058|FG000|Overall Study|Disease Progression|9|||
94436193|NCT00098774|323380058|FG000|Overall Study|Withdrawal by Subject|1|||
94436194|NCT00098774|323380058|FG000|Overall Study|Failed (to respond) during induction|4|||
94436195|NCT00098774|323380058|FG000|Overall Study|Physician Decision|2|||
94436196|NCT03097991|323380059|FG000|Overall Study|Didn't meet study criteria|8|||
94436197|NCT03097991|323380060|FG001|Overall Study|Didn't meet study criteria|0|||
94436198|NCT03097991|323380059|FG000|Overall Study|Withdrawal by Subject|12|||
94436199|NCT03097991|323380060|FG001|Overall Study|Withdrawal by Subject|6|||
94436200|NCT03097991|323380059|FG000|Overall Study|Death of Baby|3|||
94436201|NCT03097991|323380060|FG001|Overall Study|Death of Baby|1|||
94436202|NCT03097991|323380059|FG000|Overall Study|Lost to Follow-up|24|||
94436203|NCT03097991|323380060|FG001|Overall Study|Lost to Follow-up|38|||
94436204|NCT03097991|323380059|FG000|Overall Study|Adverse Event|3|||
94436205|NCT03097991|323380060|FG001|Overall Study|Adverse Event|5|||
94436206|NCT03404674|323380061|FG000|Overall Study|Inability to Attend Future Visits|0|||
94436207|NCT03404674|323380062|FG001|Overall Study|Inability to Attend Future Visits|1|||
94436208|NCT03404674|323380063|FG002|Overall Study|Inability to Attend Future Visits|1|||
94436209|NCT03404674|323380064|FG003|Overall Study|Inability to Attend Future Visits|0|||
94436210|NCT03404674|323380065|FG004|Overall Study|Inability to Attend Future Visits|0|||
94436211|NCT03404674|323380066|FG005|Overall Study|Inability to Attend Future Visits|0|||
94436212|NCT03404674|323380061|FG000|Overall Study|Behavioral Problems|0|||
94436213|NCT03404674|323380062|FG001|Overall Study|Behavioral Problems|0|||
94436214|NCT03404674|323380063|FG002|Overall Study|Behavioral Problems|1|||
94436215|NCT03404674|323380064|FG003|Overall Study|Behavioral Problems|0|||
94436216|NCT03404674|323380065|FG004|Overall Study|Behavioral Problems|0|||
94436217|NCT03404674|323380066|FG005|Overall Study|Behavioral Problems|0|||
94436218|NCT03404674|323380061|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
94655595|NCT01578551|324196087|FG000|Overall Study|Adverse Event|1|||
94436219|NCT03404674|323380062|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
94436220|NCT03404674|323380063|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
94436221|NCT03404674|323380064|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
94436222|NCT03404674|323380065|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
94436223|NCT03404674|323380066|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
94436224|NCT01487525|323380067|FG000|Overall Study|Withdrawal by Subject|0|||
94436225|NCT01487525|323380068|FG001|Overall Study|Withdrawal by Subject|1|||
94436226|NCT02593110|323380070|FG000|Overall Study|Withdrawal by Subject|0|||
94436227|NCT02593110|323380071|FG001|Overall Study|Withdrawal by Subject|3|||
94436228|NCT02593110|323380072|FG002|Overall Study|Withdrawal by Subject|3|||
94436229|NCT02593110|323380073|FG003|Overall Study|Withdrawal by Subject|2|||
94436230|NCT02593110|323380070|FG000|Overall Study|Death|0|||
94436231|NCT02593110|323380071|FG001|Overall Study|Death|0|||
94436232|NCT02593110|323380072|FG002|Overall Study|Death|1|||
94436233|NCT02593110|323380073|FG003|Overall Study|Death|0|||
94436234|NCT05022212|323380077|FG000|Overall Study|Lost to Follow-up|0|||
94436235|NCT05022212|323380078|FG001|Overall Study|Lost to Follow-up|2|||
94436236|NCT03765788|323382209|FG000|Overall Study|Subject decision|2|||
94436237|NCT03765788|323382210|FG001|Overall Study|Subject decision|3|||
94436238|NCT03765788|323382209|FG000|Overall Study|Physician Decision|2|||
94436239|NCT03765788|323382210|FG001|Overall Study|Physician Decision|4|||
94436240|NCT03765788|323382209|FG000|Overall Study|Death|0|||
94436241|NCT03765788|323382210|FG001|Overall Study|Death|1|||
94436242|NCT03765788|323382209|FG000|Overall Study|Lost to Follow-up|1|||
94436243|NCT03765788|323382210|FG001|Overall Study|Lost to Follow-up|0|||
94436244|NCT01924754|323382211|FG000|Overall Study|Lost to Follow-up|1|||
94436245|NCT01924754|323382212|FG001|Overall Study|Lost to Follow-up|2|||
94436246|NCT01924754|323382213|FG002|Overall Study|Lost to Follow-up|1|||
94436247|NCT01924754|323382211|FG000|Overall Study|Pregnancy|0|||
94436248|NCT01924754|323382212|FG001|Overall Study|Pregnancy|1|||
94436249|NCT01924754|323382213|FG002|Overall Study|Pregnancy|2|||
94436250|NCT03203850|323382214|FG000|Overall Study|Subject/guardian decision|4|||
94436251|NCT03203850|323382215|FG001|Overall Study|Subject/guardian decision|3|||
94436252|NCT03203850|323382214|FG000|Overall Study|Adverse Event|3|||
94436253|NCT03203850|323382215|FG001|Overall Study|Adverse Event|0|||
94436254|NCT03203850|323382214|FG000|Overall Study|Death|1|||
94436255|NCT03203850|323382215|FG001|Overall Study|Death|0|||
94436256|NCT05048329|323382216|FG000|Overall Study|Withdrawal by Subject|1|||
94436257|NCT05048329|323382216|FG000|Overall Study|Screenfail|1|||
94436258|NCT00974922|323382220|FG000|Overall Study|study terminated|24|||
94436259|NCT02013817|323382226|FG000|Overall Study|Adverse Event|12|||
94436260|NCT02013817|323382226|FG000|Overall Study|Withdrawal by Subject|4|||
94436261|NCT02013817|323382226|FG000|Overall Study|Death|2|||
94436262|NCT02013817|323382226|FG000|Overall Study|Other|9|||
94436263|NCT00451204|323382227|FG000|Overall Study|Adverse Event|4|||
94436264|NCT00451204|323382228|FG001|Overall Study|Adverse Event|6|||
94436265|NCT00451204|323382227|FG000|Overall Study|Lack of Efficacy|4|||
94436266|NCT00451204|323382228|FG001|Overall Study|Lack of Efficacy|4|||
94436267|NCT00451204|323382227|FG000|Overall Study|Lost to Follow-up|4|||
94436268|NCT00451204|323382228|FG001|Overall Study|Lost to Follow-up|4|||
94436269|NCT00451204|323382227|FG000|Overall Study|Protocol Violation|1|||
94436270|NCT00451204|323382228|FG001|Overall Study|Protocol Violation|0|||
94436271|NCT00451204|323382227|FG000|Overall Study|Patient refusal|8|||
94436272|NCT00451204|323382228|FG001|Overall Study|Patient refusal|4|||
94436273|NCT00451204|323382227|FG000|Overall Study|Other|1|||
94436274|NCT00451204|323382228|FG001|Overall Study|Other|2|||
94436275|NCT03055624|323382229|FG000|Overall Study|Study closed|9|||
94436276|NCT01625988|323382232|FG000|Overall Study|Lost to Follow-up|5|||
94436277|NCT01625988|323382233|FG001|Overall Study|Lost to Follow-up|6|||
94436278|NCT01625988|323382232|FG000|Overall Study|Withdrawal by Subject|8|||
94436279|NCT01625988|323382233|FG001|Overall Study|Withdrawal by Subject|3|||
94436280|NCT01625988|323382232|FG000|Overall Study|Adverse Event|0|||
94436281|NCT01625988|323382233|FG001|Overall Study|Adverse Event|1|||
94436282|NCT01625988|323382232|FG000|Overall Study|Lack of Efficacy|0|||
94436283|NCT01625988|323382233|FG001|Overall Study|Lack of Efficacy|1|||
94436284|NCT01625988|323382232|FG000|Overall Study|Randomized Inappropriately|1|||
94436285|NCT01625988|323382233|FG001|Overall Study|Randomized Inappropriately|0|||
94436286|NCT01625988|323382232|FG000|Overall Study|Protocol Violation|0|||
94436287|NCT01625988|323382233|FG001|Overall Study|Protocol Violation|2|||
94436288|NCT02165735|323382246|FG000|Overall Study|Lost to Follow-up|12|||
94436289|NCT02165735|323382247|FG001|Overall Study|Lost to Follow-up|10|||
94436290|NCT02165735|323382246|FG000|Overall Study|Withdrawal by Subject|3|||
94436291|NCT02165735|323382247|FG001|Overall Study|Withdrawal by Subject|0|||
94436292|NCT02165735|323382246|FG000|Overall Study|Participant indicated lack of time|1|||
94436293|NCT02165735|323382247|FG001|Overall Study|Participant indicated lack of time|3|||
94436294|NCT02165735|323382246|FG000|Overall Study|Protocol Violation|0|||
94436295|NCT02165735|323382247|FG001|Overall Study|Protocol Violation|1|||
94436296|NCT00595309|323382248|FG000|Overall Study|Lost to Follow-up|1|||
94436297|NCT00595309|323382248|FG000|Overall Study|planned vaccination against yellow fever|1|||
94436298|NCT00595309|323382248|FG000|Overall Study|acute infection after V0|1|||
94436299|NCT00595309|323382248|FG000|Overall Study|personal reason|1|||
94436300|NCT02797171|323382251|FG000|Overall Study|Lost to Follow-up|2|||
94436301|NCT02797171|323382252|FG001|Overall Study|Lost to Follow-up|0|||
94436302|NCT02797171|323382253|FG002|Overall Study|Lost to Follow-up|2|||
94436303|NCT02797171|323382254|FG003|Overall Study|Lost to Follow-up|1|||
94436304|NCT02797171|323382255|FG004|Overall Study|Lost to Follow-up|2|||
94436305|NCT02797171|323382256|FG005|Overall Study|Lost to Follow-up|0|||
94436306|NCT02797171|323382251|FG000|Overall Study|Withdrawal by Subject|1|||
94436307|NCT02797171|323382252|FG001|Overall Study|Withdrawal by Subject|1|||
94436308|NCT02797171|323382253|FG002|Overall Study|Withdrawal by Subject|0|||
94436309|NCT02797171|323382254|FG003|Overall Study|Withdrawal by Subject|0|||
94436310|NCT02797171|323382255|FG004|Overall Study|Withdrawal by Subject|0|||
94436311|NCT02797171|323382256|FG005|Overall Study|Withdrawal by Subject|0|||
94436312|NCT02797171|323382251|FG000|Overall Study|Protocol Violation|1|||
94436313|NCT02797171|323382252|FG001|Overall Study|Protocol Violation|0|||
94436314|NCT02797171|323382253|FG002|Overall Study|Protocol Violation|0|||
94436315|NCT02797171|323382254|FG003|Overall Study|Protocol Violation|0|||
94436316|NCT02797171|323382255|FG004|Overall Study|Protocol Violation|0|||
94436317|NCT02797171|323382256|FG005|Overall Study|Protocol Violation|0|||
94436318|NCT02797171|323382251|FG000|Overall Study|Participant unable to adhere|0|||
94436319|NCT02797171|323382252|FG001|Overall Study|Participant unable to adhere|1|||
94436320|NCT02797171|323382253|FG002|Overall Study|Participant unable to adhere|0|||
94436321|NCT02797171|323382254|FG003|Overall Study|Participant unable to adhere|0|||
94436322|NCT02797171|323382255|FG004|Overall Study|Participant unable to adhere|0|||
94436323|NCT02797171|323382256|FG005|Overall Study|Participant unable to adhere|0|||
94436324|NCT02797171|323382251|FG000|Overall Study|Not Randomized|0|||
94436325|NCT02797171|323382252|FG001|Overall Study|Not Randomized|0|||
94436326|NCT02797171|323382253|FG002|Overall Study|Not Randomized|0|||
94436327|NCT02797171|323382254|FG003|Overall Study|Not Randomized|0|||
94436328|NCT02797171|323382255|FG004|Overall Study|Not Randomized|0|||
94436329|NCT02797171|323382256|FG005|Overall Study|Not Randomized|1|||
94436330|NCT02540083|323382257|FG000|Overall Study|Withdrawal by Subject|16|||
94436331|NCT00101283|323382258|FG000|Overall Study|Withdrawal by Subject|0|||
94436332|NCT00101283|323382259|FG001|Overall Study|Withdrawal by Subject|1|||
94436333|NCT00101283|323382258|FG000|Overall Study|Insurance Refusal|0|||
94436334|NCT00101283|323382259|FG001|Overall Study|Insurance Refusal|1|||
94436335|NCT00101283|323382258|FG000|Overall Study|Prostate Cancer Recurrence|0|||
94436336|NCT00101283|323382259|FG001|Overall Study|Prostate Cancer Recurrence|1|||
94436337|NCT03993379|323382266|FG000|Overall Study|The study was terminated early due to business decision.|0|||
94436338|NCT03993379|323382267|FG001|Overall Study|The study was terminated early due to business decision.|2|||
94436339|NCT03993379|323382268|FG002|Overall Study|The study was terminated early due to business decision.|0|||
94436340|NCT03993379|323382269|FG003|Overall Study|The study was terminated early due to business decision.|0|||
94436341|NCT03993379|323382266|FG000|Overall Study|Withdrawal by Subject|0|||
94436342|NCT03993379|323382267|FG001|Overall Study|Withdrawal by Subject|1|||
94436343|NCT03993379|323382268|FG002|Overall Study|Withdrawal by Subject|0|||
94436344|NCT03993379|323382269|FG003|Overall Study|Withdrawal by Subject|0|||
94436345|NCT02422797|323382270|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
94436346|NCT02422797|323382271|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
94436347|NCT02422797|323382270|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
94436348|NCT02422797|323382271|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
94436349|NCT02422797|323382270|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
94436350|NCT02422797|323382271|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
94436351|NCT02422797|323382270|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
94436352|NCT02422797|323382271|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
94436353|NCT02422797|323382270|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
94436354|NCT02422797|323382271|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
94436355|NCT02422797|323382270|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
94436356|NCT02422797|323382271|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
94436357|NCT02422797|323382270|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
94436358|NCT02422797|323382271|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
94436359|NCT02422797|323382270|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
94436360|NCT02422797|323382271|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
94436361|NCT02422797|323382270|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
94436362|NCT02422797|323382271|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
94436363|NCT02422797|323382270|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
94436364|NCT02422797|323382271|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
94436365|NCT02422797|323382270|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
94436366|NCT02422797|323382271|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
94436367|NCT02422797|323382270|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
94436368|NCT02422797|323382271|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
94436369|NCT02422797|323382270|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
94436370|NCT02422797|323382271|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
94436371|NCT02422797|323382270|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
94436372|NCT02422797|323382271|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
94436373|NCT02422797|323382270|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
94436374|NCT02422797|323382271|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
94436375|NCT02422797|323382270|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
94436376|NCT02422797|323382271|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
94436377|NCT02422797|323382270|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
94436378|NCT02422797|323382271|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
94436379|NCT02422797|323382270|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
94436380|NCT02422797|323382271|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
94436381|NCT02422797|323382270|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
94436382|NCT02422797|323382271|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
94436383|NCT02422797|323382270|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
94436384|NCT02422797|323382271|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
94436385|NCT02422797|323382270|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
94436386|NCT02422797|323382271|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
94436387|NCT04071405|323382272|FG000|Overall Study|Protocol Violation|3|||
94436388|NCT00134901|323382273|FG000|Overall Study|Lost to Follow-up|5|||
94436389|NCT00134901|323382274|FG001|Overall Study|Lost to Follow-up|5|||
94436390|NCT00134901|323382273|FG000|Overall Study|discontinued intervention|12|||
94436391|NCT00134901|323382274|FG001|Overall Study|discontinued intervention|10|||
94436392|NCT00369941|323382277|FG000|Overall Study|Never Treated|1|||
94436393|NCT00369941|323382278|FG001|Overall Study|Never Treated|2|||
94436394|NCT00369941|323382277|FG000|Overall Study|Adverse Event|14|||
94436395|NCT00369941|323382278|FG001|Overall Study|Adverse Event|28|||
94436396|NCT00369941|323382277|FG000|Overall Study|Lack of Efficacy|6|||
94436397|NCT00369941|323382278|FG001|Overall Study|Lack of Efficacy|10|||
94436398|NCT00369941|323382277|FG000|Overall Study|Lost to Follow-up|12|||
94436399|NCT00369941|323382278|FG001|Overall Study|Lost to Follow-up|22|||
94436400|NCT00369941|323382277|FG000|Overall Study|Protocol Violation|5|||
94436401|NCT00369941|323382278|FG001|Overall Study|Protocol Violation|3|||
94436402|NCT00369941|323382277|FG000|Overall Study|Withdrawal by Subject|5|||
94436403|NCT00369941|323382278|FG001|Overall Study|Withdrawal by Subject|18|||
94436404|NCT00369941|323382277|FG000|Overall Study|Pregnancy|4|||
94436405|NCT00369941|323382278|FG001|Overall Study|Pregnancy|2|||
94436406|NCT00369941|323382277|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
94436407|NCT00369941|323382278|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
94436408|NCT00369941|323382277|FG000|Overall Study|Moved|11|||
94436409|NCT00369941|323382278|FG001|Overall Study|Moved|5|||
94436410|NCT00369941|323382277|FG000|Overall Study|Treatment with Prohibited Medication|3|||
94436411|NCT00369941|323382278|FG001|Overall Study|Treatment with Prohibited Medication|1|||
94436412|NCT00369941|323382277|FG000|Overall Study|Employment Interfered with Study Visits|1|||
94436413|NCT00369941|323382278|FG001|Overall Study|Employment Interfered with Study Visits|0|||
94436414|NCT00369941|323382277|FG000|Overall Study|Study Site Terminated|2|||
94436415|NCT00369941|323382278|FG001|Overall Study|Study Site Terminated|0|||
94436416|NCT00369941|323382277|FG000|Overall Study|Miscellaneous|3|||
94436417|NCT00369941|323382278|FG001|Overall Study|Miscellaneous|3|||
94436418|NCT01027702|323382279|FG000|Overall Study|Received subsequent therapy|1|||
94436419|NCT01027702|323382280|FG001|Overall Study|Received subsequent therapy|2|||
94436420|NCT01027702|323382281|FG002|Overall Study|Received subsequent therapy|0|||
94436421|NCT01027702|323382282|FG003|Overall Study|Received subsequent therapy|4|||
94436422|NCT01027702|323382283|FG004|Overall Study|Received subsequent therapy|1|||
94436423|NCT01027702|323382284|FG005|Overall Study|Received subsequent therapy|0|||
94436424|NCT01027702|323382285|FG006|Overall Study|Received subsequent therapy|1|||
94436425|NCT01027702|323382279|FG000|Overall Study|Death|0|||
94436426|NCT01027702|323382280|FG001|Overall Study|Death|0|||
94436427|NCT01027702|323382281|FG002|Overall Study|Death|1|||
94436428|NCT01027702|323382282|FG003|Overall Study|Death|0|||
94436429|NCT01027702|323382283|FG004|Overall Study|Death|0|||
94436430|NCT01027702|323382284|FG005|Overall Study|Death|0|||
94436431|NCT01027702|323382285|FG006|Overall Study|Death|0|||
94436432|NCT02604407|323382286|FG000|Overall Study|Adverse Event|0|||
94436433|NCT02604407|323382287|FG001|Overall Study|Adverse Event|7|||
94436434|NCT02604407|323382288|FG002|Overall Study|Adverse Event|5|||
94436435|NCT02604407|323382286|FG000|Overall Study|Protocol Violation|2|||
94436436|NCT02604407|323382287|FG001|Overall Study|Protocol Violation|0|||
94436437|NCT02604407|323382288|FG002|Overall Study|Protocol Violation|0|||
94436438|NCT02604407|323382286|FG000|Overall Study|Withdrawal by Subject|3|||
94436439|NCT02604407|323382287|FG001|Overall Study|Withdrawal by Subject|3|||
94436440|NCT02604407|323382288|FG002|Overall Study|Withdrawal by Subject|5|||
94436441|NCT02604407|323382286|FG000|Overall Study|Lost to Follow-up|2|||
94436442|NCT02604407|323382287|FG001|Overall Study|Lost to Follow-up|1|||
94436443|NCT02604407|323382288|FG002|Overall Study|Lost to Follow-up|2|||
94436444|NCT02604407|323382286|FG000|Overall Study|Lack of Efficacy|1|||
94436445|NCT02604407|323382287|FG001|Overall Study|Lack of Efficacy|0|||
94436446|NCT02604407|323382288|FG002|Overall Study|Lack of Efficacy|0|||
94436447|NCT02604407|323382286|FG000|Overall Study|Other|3|||
94436448|NCT02604407|323382287|FG001|Overall Study|Other|1|||
94436449|NCT02604407|323382288|FG002|Overall Study|Other|4|||
94436450|NCT00185588|323382289|FG000|Overall Study|Adverse Event|3|||
94436451|NCT00185588|323382290|FG001|Overall Study|Adverse Event|1|||
94436452|NCT00185588|323382291|FG002|Overall Study|Adverse Event|4|||
94436453|NCT00185588|323382292|FG003|Overall Study|Adverse Event|2|||
94436454|NCT00185588|323382289|FG000|Overall Study|Lost to Follow-up|0|||
94436455|NCT00185588|323382290|FG001|Overall Study|Lost to Follow-up|0|||
94436456|NCT00185588|323382291|FG002|Overall Study|Lost to Follow-up|1|||
94436457|NCT00185588|323382292|FG003|Overall Study|Lost to Follow-up|2|||
94436458|NCT00185588|323382289|FG000|Overall Study|Withdrawal by Subject|0|||
94436459|NCT00185588|323382290|FG001|Overall Study|Withdrawal by Subject|1|||
94436460|NCT00185588|323382291|FG002|Overall Study|Withdrawal by Subject|0|||
94436461|NCT00185588|323382292|FG003|Overall Study|Withdrawal by Subject|0|||
94436462|NCT00185588|323382289|FG000|Overall Study|Physician Decision|0|||
94436463|NCT00185588|323382290|FG001|Overall Study|Physician Decision|0|||
94436464|NCT00185588|323382291|FG002|Overall Study|Physician Decision|1|||
94436465|NCT00185588|323382292|FG003|Overall Study|Physician Decision|0|||
94436466|NCT00403585|323382293|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
94436467|NCT00403585|323382293|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
94436468|NCT00403585|323382293|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
94436469|NCT00661193|323382294|FG000|Overall Study|Adverse Event|2|||
94436470|NCT00661193|323382295|FG001|Overall Study|Adverse Event|1|||
94436471|NCT00661193|323382294|FG000|Overall Study|Withdrawal by Subject|3|||
94436472|NCT00661193|323382295|FG001|Overall Study|Withdrawal by Subject|1|||
94436473|NCT00661193|323382294|FG000|Overall Study|Progression|27|||
94436474|NCT00661193|323382295|FG001|Overall Study|Progression|24|||
94436475|NCT00661193|323382294|FG000|Overall Study|Not protocol specified|1|||
94436476|NCT00661193|323382295|FG001|Overall Study|Not protocol specified|0|||
94436477|NCT02862730|323382302|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
94436478|NCT02862730|323382303|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
94436479|NCT02862730|323382304|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
94436480|NCT02862730|323382305|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
94436481|NCT02862730|323382306|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
94436482|NCT02862730|323382307|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
94436483|NCT02862730|323382308|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
94436484|NCT02862730|323382302|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
94436485|NCT02862730|323382303|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
94436486|NCT02862730|323382304|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
94436487|NCT02862730|323382305|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
94436488|NCT02862730|323382306|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
94436489|NCT02862730|323382307|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
94436490|NCT02862730|323382308|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
94436491|NCT02862730|323382302|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
94436492|NCT02862730|323382303|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
94436493|NCT02862730|323382304|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
94436494|NCT02862730|323382305|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
94436495|NCT02862730|323382306|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
94436496|NCT02862730|323382307|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
94436497|NCT02862730|323382308|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
94436498|NCT02862730|323382302|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
94436499|NCT02862730|323382303|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
94436500|NCT02862730|323382304|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
94436501|NCT02862730|323382305|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
94436502|NCT02862730|323382306|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
94436503|NCT02862730|323382307|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
94436504|NCT02862730|323382308|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
94436505|NCT00704132|323382309|FG000|Overall Study|Clinical Adverse Experience|1|||
94436506|NCT00704132|323382310|FG001|Overall Study|Clinical Adverse Experience|0|||
94436507|NCT00704132|323382309|FG000|Overall Study|Lack of Efficacy|0|||
94436508|NCT00704132|323382310|FG001|Overall Study|Lack of Efficacy|1|||
94436509|NCT00704132|323382309|FG000|Overall Study|Withdrawal by Subject|0|||
94436510|NCT00704132|323382310|FG001|Overall Study|Withdrawal by Subject|1|||
94436511|NCT03908437|323382311|FG000|Overall Study|Death|0|||
94436512|NCT03908437|323382312|FG001|Overall Study|Death|1|||
94436513|NCT03908437|323382311|FG000|Overall Study|Lost to Follow-up|31|||
94436514|NCT03908437|323382312|FG001|Overall Study|Lost to Follow-up|24|||
94436515|NCT01807065|323382313|FG000|Overall Study|Receive no sip-T due to IV access|1|||
94436516|NCT01807065|323382314|FG001|Overall Study|Receive no sip-T due to IV access|1|||
94436517|NCT00445432|323382315|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
94436518|NCT00445432|323382316|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
94436519|NCT00445432|323382317|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
94436520|NCT00445432|323382318|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
94436521|NCT00445432|323382315|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
94436522|NCT00445432|323382316|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
94436523|NCT00445432|323382317|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
94436524|NCT00445432|323382318|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
94436525|NCT00445432|323382315|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
94436526|NCT00445432|323382316|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
94436527|NCT00445432|323382317|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
94436528|NCT00445432|323382318|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
94436529|NCT00445432|323382315|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
94436530|NCT00445432|323382316|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
94436531|NCT00445432|323382317|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
94436532|NCT00445432|323382318|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
94436533|NCT00445432|323382315|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
94436534|NCT00445432|323382316|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
94436535|NCT00445432|323382317|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
94436536|NCT00445432|323382318|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
94436537|NCT00445432|323382315|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
94436538|NCT00445432|323382316|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
94436539|NCT00445432|323382317|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
94436540|NCT00445432|323382318|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
94436541|NCT00445432|323382315|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
94436542|NCT00445432|323382316|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
94436543|NCT00445432|323382317|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
94436544|NCT00445432|323382318|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
94436545|NCT00356525|323382323|FG000|Overall Study|Progressive Disease|8|||
94436546|NCT00356525|323382324|FG001|Overall Study|Progressive Disease|5|||
94436547|NCT00356525|323382325|FG002|Overall Study|Progressive Disease|4|||
94436548|NCT00356525|323382326|FG003|Overall Study|Progressive Disease|2|||
94436549|NCT00356525|323382323|FG000|Overall Study|Adverse Event|1|||
94436550|NCT00356525|323382324|FG001|Overall Study|Adverse Event|3|||
94436551|NCT00356525|323382325|FG002|Overall Study|Adverse Event|1|||
94436552|NCT00356525|323382326|FG003|Overall Study|Adverse Event|1|||
94436553|NCT00356525|323382323|FG000|Overall Study|Lost to Follow-up|1|||
94436554|NCT00356525|323382324|FG001|Overall Study|Lost to Follow-up|0|||
94436555|NCT00356525|323382325|FG002|Overall Study|Lost to Follow-up|0|||
94436556|NCT00356525|323382326|FG003|Overall Study|Lost to Follow-up|0|||
94436557|NCT00356525|323382323|FG000|Overall Study|Physician Decision|2|||
94436558|NCT00356525|323382324|FG001|Overall Study|Physician Decision|2|||
94436559|NCT00356525|323382325|FG002|Overall Study|Physician Decision|2|||
94436560|NCT00356525|323382326|FG003|Overall Study|Physician Decision|1|||
94436561|NCT00356525|323382323|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
94436562|NCT00356525|323382324|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
94436563|NCT00356525|323382325|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
94436564|NCT00356525|323382326|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
94436565|NCT00356525|323382323|FG000|Overall Study|Withdrawal by Subject|1|||
94436566|NCT00356525|323382324|FG001|Overall Study|Withdrawal by Subject|1|||
94436567|NCT00356525|323382325|FG002|Overall Study|Withdrawal by Subject|0|||
94436568|NCT00356525|323382326|FG003|Overall Study|Withdrawal by Subject|3|||
94436569|NCT00356525|323382323|FG000|Overall Study|Death|0|||
94436570|NCT00356525|323382324|FG001|Overall Study|Death|0|||
94436571|NCT00356525|323382325|FG002|Overall Study|Death|0|||
94436572|NCT00356525|323382326|FG003|Overall Study|Death|1|||
94436573|NCT00356525|323382323|FG000|Overall Study|Sponsor Decision|0|||
94490198|NCT00207740|323590266|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94490199|NCT00207740|323590267|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94436574|NCT00356525|323382324|FG001|Overall Study|Sponsor Decision|0|||
94436575|NCT00356525|323382325|FG002|Overall Study|Sponsor Decision|0|||
94436576|NCT00356525|323382326|FG003|Overall Study|Sponsor Decision|1|||
94436577|NCT00799058|323382328|FG000|Overall Study|Withdrawal by Subject|2|||
94490200|NCT00207740|323590268|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
94436578|NCT00799058|323382329|FG001|Overall Study|Withdrawal by Subject|2|||
94436579|NCT00799058|323382330|FG002|Overall Study|Withdrawal by Subject|2|||
94436580|NCT00799058|323382328|FG000|Overall Study|Lost to Follow-up|1|||
94436581|NCT00799058|323382329|FG001|Overall Study|Lost to Follow-up|2|||
94436582|NCT00799058|323382330|FG002|Overall Study|Lost to Follow-up|1|||
94436583|NCT00799058|323382328|FG000|Overall Study|Adverse Event|0|||
94436584|NCT00799058|323382329|FG001|Overall Study|Adverse Event|2|||
94436585|NCT00799058|323382330|FG002|Overall Study|Adverse Event|0|||
94436586|NCT00799058|323382328|FG000|Overall Study|Pregnancy|1|||
94436587|NCT00799058|323382329|FG001|Overall Study|Pregnancy|0|||
94436588|NCT00799058|323382330|FG002|Overall Study|Pregnancy|0|||
94436589|NCT00799058|323382328|FG000|Overall Study|Not adherent|3|||
94436590|NCT00799058|323382329|FG001|Overall Study|Not adherent|2|||
94436591|NCT00799058|323382330|FG002|Overall Study|Not adherent|1|||
94436592|NCT00799058|323382328|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
94436593|NCT00799058|323382329|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
94436594|NCT00799058|323382330|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
94436595|NCT00799058|323382328|FG000|Overall Study|IP dispensing error|1|||
94436596|NCT00799058|323382329|FG001|Overall Study|IP dispensing error|0|||
94436597|NCT00799058|323382330|FG002|Overall Study|IP dispensing error|0|||
94436598|NCT00799058|323382328|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
94436599|NCT00799058|323382329|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
94436600|NCT00799058|323382330|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
94436601|NCT00799058|323382328|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
94436602|NCT00799058|323382329|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
94436603|NCT00799058|323382330|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
94436604|NCT00799058|323382328|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
94436605|NCT00799058|323382329|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
94436606|NCT00799058|323382330|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
94436607|NCT00799058|323382328|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
94436608|NCT00799058|323382329|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
94436609|NCT00799058|323382330|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
94436610|NCT00810511|323382335|FG000|Overall Study|Protocol Violation|0|||
94436611|NCT00810511|323382336|FG001|Overall Study|Protocol Violation|1|||
94436612|NCT00810511|323382335|FG000|Overall Study|Lack of Efficacy|9|||
94436613|NCT00810511|323382336|FG001|Overall Study|Lack of Efficacy|1|||
94436614|NCT00810511|323382335|FG000|Overall Study|death in the family|0|||
94436615|NCT00810511|323382336|FG001|Overall Study|death in the family|1|||
94436616|NCT00810511|323382335|FG000|Overall Study|Lost to Follow-up|1|||
94436617|NCT00810511|323382336|FG001|Overall Study|Lost to Follow-up|0|||
94436618|NCT00810511|323382335|FG000|Overall Study|deposits on contact lens|0|||
94436619|NCT00810511|323382336|FG001|Overall Study|deposits on contact lens|1|||
94436620|NCT00699816|323382343|FG000|Overall Study|Protocol Violation|1|||
94436621|NCT00699816|323382344|FG001|Overall Study|Protocol Violation|3|||
94436622|NCT02454933|323382347|FG000|Overall Study|Progressive disease|10|||
94436623|NCT02454933|323382348|FG001|Overall Study|Progressive disease|7|||
94436624|NCT02454933|323382347|FG000|Overall Study|Adverse Event|1|||
94436625|NCT02454933|323382348|FG001|Overall Study|Adverse Event|1|||
94436626|NCT02454933|323382347|FG000|Overall Study|Withdrawal by Subject|0|||
94436627|NCT02454933|323382348|FG001|Overall Study|Withdrawal by Subject|3|||
94436628|NCT02454933|323382347|FG000|Overall Study|Lost to Follow-up|1|||
94436629|NCT02454933|323382348|FG001|Overall Study|Lost to Follow-up|0|||
94436630|NCT00560391|323382349|FG000|Overall Study|Still on treatment|0|||
94436631|NCT00560391|323382350|FG001|Overall Study|Still on treatment|0|||
94436632|NCT00560391|323382351|FG002|Overall Study|Still on treatment|0|||
94436633|NCT00560391|323382352|FG003|Overall Study|Still on treatment|1|||
94436634|NCT00560391|323382353|FG004|Overall Study|Still on treatment|2|||
94436635|NCT00214383|323382354|FG000|Overall Study|Lost to Follow-up|16|||
94436636|NCT00214383|323382355|FG001|Overall Study|Lost to Follow-up|26|||
94436637|NCT02466685|323382358|FG000|Overall Study|Adverse Event|5|||
94436638|NCT02466685|323382359|FG001|Overall Study|Adverse Event|2|||
94436639|NCT02466685|323382358|FG000|Overall Study|Lost to Follow-up|1|||
94436640|NCT02466685|323382359|FG001|Overall Study|Lost to Follow-up|1|||
94436641|NCT02466685|323382358|FG000|Overall Study|Withdrawal by Subject|1|||
94436642|NCT02466685|323382359|FG001|Overall Study|Withdrawal by Subject|0|||
94436643|NCT02466685|323382358|FG000|Overall Study|Physician Decision|1|||
94436644|NCT02466685|323382359|FG001|Overall Study|Physician Decision|1|||
94436645|NCT02374346|323382360|FG000|Overall Study|operated or discharged during weekend|48|||
94436646|NCT04807400|323382361|FG000|Overall Study|Adverse Event|2|||
94436647|NCT04807400|323382362|FG001|Overall Study|Adverse Event|3|||
94436648|NCT04807400|323382363|FG002|Overall Study|Adverse Event|3|||
94436649|NCT04807400|323382361|FG000|Overall Study|Death|2|||
94436650|NCT04807400|323382362|FG001|Overall Study|Death|0|||
94436651|NCT04807400|323382363|FG002|Overall Study|Death|0|||
94436652|NCT04807400|323382361|FG000|Overall Study|Lost to Follow-up|8|||
94436653|NCT04807400|323382362|FG001|Overall Study|Lost to Follow-up|6|||
94436654|NCT04807400|323382363|FG002|Overall Study|Lost to Follow-up|6|||
94436655|NCT04807400|323382361|FG000|Overall Study|Non-Compliance With Study Drug|0|||
94436656|NCT04807400|323382362|FG001|Overall Study|Non-Compliance With Study Drug|4|||
94436657|NCT04807400|323382363|FG002|Overall Study|Non-Compliance With Study Drug|1|||
94436658|NCT04807400|323382361|FG000|Overall Study|Participant Decision|20|||
94436659|NCT04807400|323382362|FG001|Overall Study|Participant Decision|19|||
94436660|NCT04807400|323382363|FG002|Overall Study|Participant Decision|26|||
94436661|NCT04807400|323382361|FG000|Overall Study|Physician Decision|0|||
94436662|NCT04807400|323382362|FG001|Overall Study|Physician Decision|1|||
94436663|NCT04807400|323382363|FG002|Overall Study|Physician Decision|0|||
94436664|NCT04807400|323382361|FG000|Overall Study|Protocol Violation|4|||
94436665|NCT04807400|323382362|FG001|Overall Study|Protocol Violation|3|||
94436666|NCT04807400|323382363|FG002|Overall Study|Protocol Violation|7|||
94436667|NCT04807400|323382361|FG000|Overall Study|Withdrawal by Subject|13|||
94436668|NCT04807400|323382362|FG001|Overall Study|Withdrawal by Subject|9|||
94436669|NCT04807400|323382363|FG002|Overall Study|Withdrawal by Subject|20|||
94436670|NCT04807400|323382361|FG000|Overall Study|Mis-randomized|1|||
94436671|NCT04807400|323382362|FG001|Overall Study|Mis-randomized|0|||
94436672|NCT04807400|323382363|FG002|Overall Study|Mis-randomized|0|||
94436673|NCT04194645|323382364|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
94436674|NCT04194645|323382365|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
94436675|NCT04194645|323382366|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
94436676|NCT04194645|323382367|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
94436677|NCT04194645|323382368|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
94436678|NCT04194645|323382369|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
94436679|NCT04194645|323382370|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
94436680|NCT04194645|323382371|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
94436681|NCT04194645|323382372|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
94436682|NCT04194645|323382373|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
94436683|NCT04194645|323382374|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
94436684|NCT04194645|323382375|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
94436685|NCT04194645|323382376|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
94436686|NCT04194645|323382377|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
94436687|NCT04194645|323382378|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
94436688|NCT03656744|323382379|FG000|Overall Study|Adverse Event|1|||
94436689|NCT03656744|323382380|FG001|Overall Study|Adverse Event|4|||
94436690|NCT03656744|323382381|FG002|Overall Study|Adverse Event|1|||
94436691|NCT03656744|323382379|FG000|Overall Study|Protocol Violation|1|||
94436692|NCT03656744|323382380|FG001|Overall Study|Protocol Violation|0|||
94436693|NCT03656744|323382381|FG002|Overall Study|Protocol Violation|0|||
94436694|NCT03656744|323382379|FG000|Overall Study|Lost to Follow-up|2|||
94436695|NCT03656744|323382380|FG001|Overall Study|Lost to Follow-up|2|||
94436696|NCT03656744|323382381|FG002|Overall Study|Lost to Follow-up|0|||
94436697|NCT03656744|323382379|FG000|Overall Study|Withdrawal by Subject|0|||
94436698|NCT03656744|323382380|FG001|Overall Study|Withdrawal by Subject|1|||
94436699|NCT03656744|323382381|FG002|Overall Study|Withdrawal by Subject|0|||
94436700|NCT03656744|323382379|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
94436701|NCT03656744|323382380|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
94436702|NCT03656744|323382381|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
94436703|NCT01332292|323382389|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
94436704|NCT01332292|323382390|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
94436705|NCT01332292|323382389|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
94436706|NCT01332292|323382390|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
94436707|NCT01332292|323382389|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
94436708|NCT01332292|323382390|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
94436709|NCT00104572|323382391|FG000|Overall Study|Withdrawal by Subject|3|||
94436710|NCT00104572|323382392|FG001|Overall Study|Withdrawal by Subject|3|||
94436711|NCT00104572|323382393|FG002|Overall Study|Withdrawal by Subject|0|||
94436712|NCT00396565|323382394|FG000|Overall Study|Physician Decision|3|||
94436713|NCT00396565|323382395|FG001|Overall Study|Physician Decision|1|||
94436714|NCT00396565|323382396|FG002|Overall Study|Physician Decision|2|||
94436715|NCT00396565|323382394|FG000|Overall Study|Adverse Event|5|||
94436716|NCT00396565|323382395|FG001|Overall Study|Adverse Event|13|||
94436717|NCT00396565|323382396|FG002|Overall Study|Adverse Event|3|||
94436718|NCT00396565|323382394|FG000|Overall Study|Withdrawal by Subject|8|||
94436719|NCT00396565|323382395|FG001|Overall Study|Withdrawal by Subject|13|||
94436720|NCT00396565|323382396|FG002|Overall Study|Withdrawal by Subject|1|||
94436721|NCT00396565|323382394|FG000|Overall Study|Lack of Efficacy|32|||
94436722|NCT00396565|323382395|FG001|Overall Study|Lack of Efficacy|64|||
94436723|NCT00396565|323382396|FG002|Overall Study|Lack of Efficacy|11|||
94436724|NCT02006732|323382400|FG000|Overall Study|Adverse Event|10|||
94436725|NCT02006732|323382401|FG001|Overall Study|Adverse Event|7|||
94436726|NCT02006732|323382402|FG002|Overall Study|Adverse Event|4|||
94436727|NCT02006732|323382403|FG003|Overall Study|Adverse Event|2|||
94436728|NCT02006732|323382400|FG000|Overall Study|Lack of Efficacy|6|||
94436729|NCT02006732|323382401|FG001|Overall Study|Lack of Efficacy|3|||
94436730|NCT02006732|323382402|FG002|Overall Study|Lack of Efficacy|1|||
94436731|NCT02006732|323382403|FG003|Overall Study|Lack of Efficacy|1|||
94436732|NCT02006732|323382400|FG000|Overall Study|Protocol Violation|1|||
94436733|NCT02006732|323382401|FG001|Overall Study|Protocol Violation|1|||
94436734|NCT02006732|323382402|FG002|Overall Study|Protocol Violation|0|||
94436735|NCT02006732|323382403|FG003|Overall Study|Protocol Violation|0|||
94436736|NCT02006732|323382400|FG000|Overall Study|Lost to Follow-up|0|||
94436737|NCT02006732|323382401|FG001|Overall Study|Lost to Follow-up|1|||
94436738|NCT02006732|323382402|FG002|Overall Study|Lost to Follow-up|0|||
94436739|NCT02006732|323382403|FG003|Overall Study|Lost to Follow-up|0|||
94436740|NCT02006732|323382400|FG000|Overall Study|Withdrawal by Subject|3|||
94436741|NCT02006732|323382401|FG001|Overall Study|Withdrawal by Subject|0|||
94436742|NCT02006732|323382402|FG002|Overall Study|Withdrawal by Subject|4|||
94436743|NCT02006732|323382403|FG003|Overall Study|Withdrawal by Subject|1|||
94436744|NCT04650204|323382404|FG000|Overall Study|Study was Terminated|2|||
94436745|NCT04650204|323382405|FG001|Overall Study|Study was Terminated|1|||
94436746|NCT01893346|323382406|FG000|Overall Study|Lost to Follow-up|0|||
94436747|NCT01893346|323382407|FG001|Overall Study|Lost to Follow-up|1|||
94436748|NCT01893346|323382408|FG002|Overall Study|Lost to Follow-up|0|||
94436749|NCT01893346|323382409|FG003|Overall Study|Lost to Follow-up|0|||
94436750|NCT01893346|323382406|FG000|Overall Study|Protocol Violation|1|||
94436751|NCT01893346|323382407|FG001|Overall Study|Protocol Violation|0|||
94436752|NCT01893346|323382408|FG002|Overall Study|Protocol Violation|0|||
94436753|NCT01893346|323382409|FG003|Overall Study|Protocol Violation|0|||
94436754|NCT01893346|323382406|FG000|Overall Study|Withdrawal by Subject|2|||
94436755|NCT01893346|323382407|FG001|Overall Study|Withdrawal by Subject|0|||
94436756|NCT01893346|323382408|FG002|Overall Study|Withdrawal by Subject|0|||
94436757|NCT01893346|323382409|FG003|Overall Study|Withdrawal by Subject|0|||
94436758|NCT01855828|323382410|FG000|Overall Study|Adverse Event|1|||
94436759|NCT01855828|323382410|FG000|Overall Study|Withdrawal by Subject|1|||
94436760|NCT04239027|323382415|FG000|Overall Study|Adverse Event|4|||
94436761|NCT04239027|323382415|FG000|Overall Study|Withdrawal by Subject|9|||
94436762|NCT04239027|323382415|FG000|Overall Study|Death|1|||
94436763|NCT04239027|323382415|FG000|Overall Study|Physician Decision|9|||
94436764|NCT04239027|323382415|FG000|Overall Study|Lost to Follow-up|2|||
94436765|NCT04239027|323382415|FG000|Overall Study|Lack of Efficacy|1|||
94436766|NCT02296931|323382425|FG000|Overall Study|Protocol Violation|0|||
94436767|NCT02296931|323382426|FG001|Overall Study|Protocol Violation|2|||
94436768|NCT03086551|323382440|FG000|First Intervention|Failure to meet inclusion criterion|1|||
94436769|NCT03086551|323382441|FG001|First Intervention|Failure to meet inclusion criterion|0|||
94436770|NCT03086551|323382440|FG000|First Intervention|Lost to Follow-up|0|||
94436771|NCT03086551|323382441|FG001|First Intervention|Lost to Follow-up|1|||
94436772|NCT03086551|323382440|FG000|Washout|Lost to Follow-up|1|||
94436773|NCT03086551|323382441|FG001|Washout|Lost to Follow-up|2|||
94436774|NCT03086551|323382440|FG000|Washout|Withdrawal by Subject|2|||
94436775|NCT03086551|323382441|FG001|Washout|Withdrawal by Subject|1|||
94436776|NCT03408639|323384575|FG000|Overall Study|Death|5|||
94436777|NCT03408639|323384576|FG001|Overall Study|Death|5|||
94436778|NCT03408639|323384575|FG000|Overall Study|Lost to Follow-up|1|||
94436779|NCT03408639|323384576|FG001|Overall Study|Lost to Follow-up|4|||
94436780|NCT03408639|323384575|FG000|Overall Study|Withdrawal by Subject|2|||
94436781|NCT03408639|323384576|FG001|Overall Study|Withdrawal by Subject|7|||
94436782|NCT03408639|323384575|FG000|Overall Study|Physician Decision|3|||
94436783|NCT03408639|323384576|FG001|Overall Study|Physician Decision|6|||
94436784|NCT02126826|323384584|FG000|Overall Study|Withdrawal by Subject|0|||
94436785|NCT02126826|323384585|FG001|Overall Study|Withdrawal by Subject|0|||
94436786|NCT02126826|323384586|FG002|Overall Study|Withdrawal by Subject|0|||
94436787|NCT02126826|323384587|FG003|Overall Study|Withdrawal by Subject|1|||
94490201|NCT00207740|323590269|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
94490202|NCT00207740|323590266|FG000|Overall Study|Lost to Follow-up|0|||
94490203|NCT00207740|323590267|FG001|Overall Study|Lost to Follow-up|2|||
94490204|NCT00207740|323590268|FG002|Overall Study|Lost to Follow-up|1|||
94490205|NCT00207740|323590269|FG003|Overall Study|Lost to Follow-up|1|||
94490206|NCT00207740|323590266|FG000|Overall Study|Death|0|||
94490207|NCT00207740|323590267|FG001|Overall Study|Death|0|||
94490208|NCT00207740|323590268|FG002|Overall Study|Death|0|||
94436788|NCT02126826|323384588|FG004|Overall Study|Withdrawal by Subject|0|||
94436789|NCT02126826|323384589|FG005|Overall Study|Withdrawal by Subject|0|||
94436790|NCT02126826|323384590|FG006|Overall Study|Withdrawal by Subject|0|||
94436791|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criterion #1|24|||
94436792|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criterion #1|0|||
94436793|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
94436794|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
94436795|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
94490209|NCT00207740|323590269|FG003|Overall Study|Death|1|||
94436796|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
94490210|NCT00207740|323590266|FG000|Overall Study|Sponsor Directive|22|||
94436797|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
94436798|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
94490211|NCT00207740|323590267|FG001|Overall Study|Sponsor Directive|15|||
94490212|NCT00207740|323590268|FG002|Overall Study|Sponsor Directive|16|||
94436799|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
94436800|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
94436801|NCT03888066|323384592|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
94436802|NCT03888066|323384593|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
94436803|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
94436804|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
94436805|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
94436806|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
94436807|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
94436808|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
94436809|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
94436810|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
94436811|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criterion #2|5|||
94436812|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criterion #2|0|||
94436813|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
94436814|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
94436815|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
94436816|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
94436817|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
94436818|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
94436819|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criterion #3|11|||
94436820|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criterion #3|0|||
94436821|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
94436822|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
94436823|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
94436824|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
94436825|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
94436826|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
94436827|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criterion #4|3|||
94436828|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criterion #4|0|||
94436829|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
94436830|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
94436831|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
94436832|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
94436833|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
94436834|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
94436835|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
94436836|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
94436837|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
94436838|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
94436839|NCT03888066|323384592|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
94436840|NCT03888066|323384593|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
94436841|NCT03888066|323384592|FG000|Run-in Phase|AE (Adverse Event)|17|||
94436842|NCT03888066|323384593|FG001|Run-in Phase|AE (Adverse Event)|0|||
94436843|NCT03888066|323384592|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
94436844|NCT03888066|323384593|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
94436845|NCT03888066|323384592|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
94436846|NCT03888066|323384593|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
94436847|NCT03888066|323384592|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
94436848|NCT03888066|323384593|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
94436849|NCT03888066|323384592|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
94436850|NCT03888066|323384593|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
94436851|NCT03888066|323384592|FG000|Run-in Phase|Withdrawal by Subject|43|||
94436852|NCT03888066|323384593|FG001|Run-in Phase|Withdrawal by Subject|0|||
94436853|NCT03888066|323384592|FG000|Run-in Phase|AE; Physician Decision|1|||
94436854|NCT03888066|323384593|FG001|Run-in Phase|AE; Physician Decision|0|||
94490213|NCT00207740|323590269|FG003|Overall Study|Sponsor Directive|21|||
94490214|NCT00207740|323590266|FG000|Overall Study|Other|2|||
94490215|NCT00207740|323590267|FG001|Overall Study|Other|10|||
94490216|NCT00207740|323590268|FG002|Overall Study|Other|7|||
94655596|NCT01578551|324196088|FG001|Overall Study|Adverse Event|0|||
94655597|NCT01110239|324196089|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
94436855|NCT03888066|323384592|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
94436856|NCT03888066|323384593|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
94436857|NCT03888066|323384592|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
94436858|NCT03888066|323384593|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
94436859|NCT03888066|323384592|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
94436860|NCT03888066|323384593|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
94436861|NCT03888066|323384592|FG000|Run-in Phase|Death|1|||
94436862|NCT03888066|323384593|FG001|Run-in Phase|Death|0|||
94436863|NCT03888066|323384592|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
94436864|NCT03888066|323384593|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
94436865|NCT03888066|323384592|FG000|Run-in Phase|Physician Decision|1|||
94436866|NCT03888066|323384593|FG001|Run-in Phase|Physician Decision|0|||
94436867|NCT03888066|323384592|FG000|Run-in Phase|Protocol Violation|13|||
94436868|NCT03888066|323384593|FG001|Run-in Phase|Protocol Violation|0|||
94436869|NCT03888066|323384592|FG000|Run-in Phase|Sponsor Request|34|||
94436870|NCT03888066|323384593|FG001|Run-in Phase|Sponsor Request|0|||
94436871|NCT03888066|323384592|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
94436872|NCT03888066|323384593|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
94436873|NCT03888066|323384592|FG000|Run-in Phase|Withdrawal Of Consent|1|||
94436874|NCT03888066|323384593|FG001|Run-in Phase|Withdrawal Of Consent|0|||
94436875|NCT03888066|323384592|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
94436876|NCT03888066|323384593|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
94436877|NCT03888066|323384592|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
94436878|NCT03888066|323384593|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
94436879|NCT03888066|323384592|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
94436880|NCT03888066|323384593|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
94436881|NCT03888066|323384592|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
94436882|NCT03888066|323384593|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
94436883|NCT03888066|323384592|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
94436884|NCT03888066|323384593|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
94436885|NCT03888066|323384592|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
94436886|NCT03888066|323384593|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
94436887|NCT03888066|323384592|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
94436888|NCT03888066|323384593|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
94436889|NCT03888066|323384592|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
94436890|NCT03888066|323384593|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
94436891|NCT03888066|323384592|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
94436892|NCT03888066|323384593|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
94436893|NCT03888066|323384592|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
94436894|NCT03888066|323384593|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
94436895|NCT03888066|323384592|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
94436896|NCT03888066|323384593|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
94436897|NCT03888066|323384592|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
94436898|NCT03888066|323384593|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
94436899|NCT03278626|323384594|FG000|Overall Study|Death|2|||
94436900|NCT03278626|323384594|FG000|Overall Study|Toxicity|1|||
94436901|NCT03278626|323384594|FG000|Overall Study|Disease Progression|2|||
94436902|NCT02856555|323384595|FG000|Overall Study|Adverse Event|1|||
94436903|NCT02856555|323384596|FG001|Overall Study|Adverse Event|0|||
94436904|NCT02856555|323384597|FG002|Overall Study|Adverse Event|0|||
94436905|NCT02856555|323384595|FG000|Overall Study|Lost to Follow-up|1|||
94436906|NCT02856555|323384596|FG001|Overall Study|Lost to Follow-up|3|||
94436907|NCT02856555|323384597|FG002|Overall Study|Lost to Follow-up|0|||
94436908|NCT02856555|323384595|FG000|Overall Study|Withdrawal by Subject|3|||
94436909|NCT02856555|323384596|FG001|Overall Study|Withdrawal by Subject|0|||
94436910|NCT02856555|323384597|FG002|Overall Study|Withdrawal by Subject|0|||
94436911|NCT02856555|323384595|FG000|Overall Study|Randomized but Never Treated|0|||
94436912|NCT02856555|323384596|FG001|Overall Study|Randomized but Never Treated|1|||
94436913|NCT02856555|323384597|FG002|Overall Study|Randomized but Never Treated|0|||
94436914|NCT01433055|323384598|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
94436915|NCT01433055|323384599|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
94436916|NCT01433055|323384598|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
94436917|NCT01433055|323384599|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
94436918|NCT02717455|323384600|FG000|Overall Study|Adverse Event|1|||
94436919|NCT02717455|323384601|FG001|Overall Study|Adverse Event|0|||
94436920|NCT02717455|323384602|FG002|Overall Study|Adverse Event|0|||
94436921|NCT02717455|323384603|FG003|Overall Study|Adverse Event|2|||
94436922|NCT02717455|323384604|FG004|Overall Study|Adverse Event|2|||
94436923|NCT02717455|323384605|FG005|Overall Study|Adverse Event|2|||
94436924|NCT02717455|323384600|FG000|Overall Study|Withdrawal by Subject|1|||
94436925|NCT02717455|323384601|FG001|Overall Study|Withdrawal by Subject|1|||
94436926|NCT02717455|323384602|FG002|Overall Study|Withdrawal by Subject|0|||
94436927|NCT02717455|323384603|FG003|Overall Study|Withdrawal by Subject|2|||
94436928|NCT02717455|323384604|FG004|Overall Study|Withdrawal by Subject|2|||
94436929|NCT02717455|323384605|FG005|Overall Study|Withdrawal by Subject|1|||
94436930|NCT02717455|323384600|FG000|Overall Study|Death|1|||
94436931|NCT02717455|323384601|FG001|Overall Study|Death|0|||
94436932|NCT02717455|323384602|FG002|Overall Study|Death|0|||
94436933|NCT02717455|323384603|FG003|Overall Study|Death|0|||
94436934|NCT02717455|323384604|FG004|Overall Study|Death|1|||
94436935|NCT02717455|323384605|FG005|Overall Study|Death|0|||
94436936|NCT02717455|323384600|FG000|Overall Study|Did not receive study drug|0|||
94436937|NCT02717455|323384601|FG001|Overall Study|Did not receive study drug|0|||
94436938|NCT02717455|323384602|FG002|Overall Study|Did not receive study drug|0|||
94436939|NCT02717455|323384603|FG003|Overall Study|Did not receive study drug|1|||
94436940|NCT02717455|323384604|FG004|Overall Study|Did not receive study drug|0|||
94436941|NCT02717455|323384605|FG005|Overall Study|Did not receive study drug|1|||
94436942|NCT02717455|323384600|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
94436943|NCT02717455|323384601|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
94436944|NCT02717455|323384602|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
94436945|NCT02717455|323384603|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
94436946|NCT02717455|323384604|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
94436947|NCT02717455|323384605|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
94436948|NCT02717455|323384600|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
94436949|NCT02717455|323384601|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
94436950|NCT02717455|323384602|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
94436951|NCT02717455|323384603|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
94436952|NCT02717455|323384604|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
94436953|NCT02717455|323384605|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
94436954|NCT05013008|323384606|FG000|Overall Study|Exclusion from mBFAS|5|||
94436955|NCT05013008|323384607|FG001|Overall Study|Exclusion from mBFAS|25|||
94436956|NCT04981717|323384608|FG000|Overall Study|Protocol Violation|0|||
94436957|NCT04981717|323384609|FG001|Overall Study|Protocol Violation|3|||
94436958|NCT04981717|323384608|FG000|Overall Study|Adverse Event|1|||
94436959|NCT04981717|323384609|FG001|Overall Study|Adverse Event|3|||
94436960|NCT04981717|323384608|FG000|Overall Study|Pregnancy|1|||
94436961|NCT04981717|323384609|FG001|Overall Study|Pregnancy|0|||
94436962|NCT04981717|323384608|FG000|Overall Study|Physician Decision|1|||
94436963|NCT04981717|323384609|FG001|Overall Study|Physician Decision|0|||
94436964|NCT04981717|323384608|FG000|Overall Study|Sponsor Request|157|||
94436965|NCT04981717|323384609|FG001|Overall Study|Sponsor Request|172|||
94436966|NCT04981717|323384608|FG000|Overall Study|Lost to Follow-up|4|||
94436967|NCT04981717|323384609|FG001|Overall Study|Lost to Follow-up|5|||
94436968|NCT04981717|323384608|FG000|Overall Study|Withdrawal by Subject|50|||
94436969|NCT04981717|323384609|FG001|Overall Study|Withdrawal by Subject|37|||
94436970|NCT02207634|323384614|FG000|Overall Study|Withdrawal by Subject|21|||
94436971|NCT02207634|323384615|FG001|Overall Study|Withdrawal by Subject|31|||
94436972|NCT02207634|323384614|FG000|Overall Study|Lost to Follow-up|1|||
94436973|NCT02207634|323384615|FG001|Overall Study|Lost to Follow-up|0|||
94436974|NCT04825912|323384616|FG000|Overall Study|Death|3|||
94436975|NCT04825912|323384616|FG000|Overall Study|Withdrawal by Subject|1|||
94436976|NCT00591773|323384617|FG000|Overall Study|Adverse Event|9|||
94436977|NCT00591773|323384618|FG001|Overall Study|Adverse Event|9|||
94436978|NCT00591773|323384619|FG002|Overall Study|Adverse Event|6|||
94436979|NCT00591773|323384617|FG000|Overall Study|Protocol Violation|2|||
94436980|NCT00591773|323384618|FG001|Overall Study|Protocol Violation|3|||
94436981|NCT00591773|323384619|FG002|Overall Study|Protocol Violation|0|||
94436982|NCT00591773|323384617|FG000|Overall Study|Lost to Follow-up|1|||
94436983|NCT00591773|323384618|FG001|Overall Study|Lost to Follow-up|4|||
94436984|NCT00591773|323384619|FG002|Overall Study|Lost to Follow-up|1|||
94436985|NCT00591773|323384617|FG000|Overall Study|Withdrawal by Subject|2|||
94436986|NCT00591773|323384618|FG001|Overall Study|Withdrawal by Subject|5|||
94436987|NCT00591773|323384619|FG002|Overall Study|Withdrawal by Subject|3|||
94436988|NCT00591773|323384617|FG000|Overall Study|Lack of Efficacy|1|||
94436989|NCT00591773|323384618|FG001|Overall Study|Lack of Efficacy|2|||
94436990|NCT00591773|323384619|FG002|Overall Study|Lack of Efficacy|2|||
94436991|NCT00591773|323384617|FG000|Overall Study|Other|1|||
94436992|NCT00591773|323384618|FG001|Overall Study|Other|1|||
94436993|NCT00591773|323384619|FG002|Overall Study|Other|4|||
94436994|NCT01207583|323384628|FG000|Overall Study|Withdrawal by Subject|0|||
94436995|NCT01207583|323384629|FG001|Overall Study|Withdrawal by Subject|3|||
94436996|NCT01207583|323384630|FG002|Overall Study|Withdrawal by Subject|1|||
94436997|NCT01207583|323384628|FG000|Overall Study|Participant failed to return|1|||
94436998|NCT01207583|323384629|FG001|Overall Study|Participant failed to return|0|||
94436999|NCT01207583|323384630|FG002|Overall Study|Participant failed to return|0|||
94437000|NCT01207583|323384628|FG000|Overall Study|Lost to Follow-up|0|||
94437001|NCT01207583|323384629|FG001|Overall Study|Lost to Follow-up|2|||
94437002|NCT01207583|323384630|FG002|Overall Study|Lost to Follow-up|0|||
94437003|NCT03743415|323384631|FG000|Overall Study|Death|5|||
94437004|NCT03743415|323384632|FG001|Overall Study|Death|3|||
94437005|NCT03743415|323384633|FG002|Overall Study|Death|1|||
94437006|NCT03743415|323384634|FG003|Overall Study|Death|4|||
94437007|NCT03743415|323384635|FG004|Overall Study|Death|0|||
94437008|NCT03743415|323384636|FG005|Overall Study|Death|0|||
94437009|NCT03743415|323384637|FG006|Overall Study|Death|0|||
94437010|NCT03743415|323384638|FG007|Overall Study|Death|0|||
94437011|NCT03743415|323384639|FG008|Overall Study|Death|1|||
94437012|NCT03743415|323384640|FG009|Overall Study|Death|0|||
94437013|NCT03743415|323384631|FG000|Overall Study|Withdrawal by Subject|1|||
94437014|NCT03743415|323384632|FG001|Overall Study|Withdrawal by Subject|0|||
94437015|NCT03743415|323384633|FG002|Overall Study|Withdrawal by Subject|4|||
94437016|NCT03743415|323384634|FG003|Overall Study|Withdrawal by Subject|5|||
94437017|NCT03743415|323384635|FG004|Overall Study|Withdrawal by Subject|5|||
94437018|NCT03743415|323384636|FG005|Overall Study|Withdrawal by Subject|2|||
94437019|NCT03743415|323384637|FG006|Overall Study|Withdrawal by Subject|2|||
94437020|NCT03743415|323384638|FG007|Overall Study|Withdrawal by Subject|5|||
94437021|NCT03743415|323384639|FG008|Overall Study|Withdrawal by Subject|9|||
94437022|NCT03743415|323384640|FG009|Overall Study|Withdrawal by Subject|10|||
94437023|NCT03743415|323384631|FG000|Overall Study|Lost to Follow-up|2|||
94437024|NCT03743415|323384632|FG001|Overall Study|Lost to Follow-up|0|||
94437025|NCT03743415|323384633|FG002|Overall Study|Lost to Follow-up|2|||
94437026|NCT03743415|323384634|FG003|Overall Study|Lost to Follow-up|1|||
94437027|NCT03743415|323384635|FG004|Overall Study|Lost to Follow-up|1|||
94437028|NCT03743415|323384636|FG005|Overall Study|Lost to Follow-up|0|||
94437029|NCT03743415|323384637|FG006|Overall Study|Lost to Follow-up|1|||
94437030|NCT03743415|323384638|FG007|Overall Study|Lost to Follow-up|4|||
94437031|NCT03743415|323384639|FG008|Overall Study|Lost to Follow-up|13|||
94437032|NCT03743415|323384640|FG009|Overall Study|Lost to Follow-up|13|||
94437033|NCT02301390|323384644|FG000|Overall Study|Withdrawal by Subject|3|||
94437034|NCT02301390|323384645|FG001|Overall Study|Withdrawal by Subject|5|||
94437035|NCT02301390|323384644|FG000|Overall Study|Protocol Violation|1|||
94437036|NCT02301390|323384645|FG001|Overall Study|Protocol Violation|0|||
94437037|NCT02301390|323384644|FG000|Overall Study|Physician Decision|1|||
94437038|NCT02301390|323384645|FG001|Overall Study|Physician Decision|0|||
94437039|NCT02301390|323384644|FG000|Overall Study|Lost to Follow-up|0|||
94437040|NCT02301390|323384645|FG001|Overall Study|Lost to Follow-up|1|||
94437041|NCT02301390|323384644|FG000|Overall Study|Death|2|||
94437042|NCT02301390|323384645|FG001|Overall Study|Death|2|||
94437043|NCT02301390|323384644|FG000|Overall Study|Procedure not completed|0|||
94437044|NCT02301390|323384645|FG001|Overall Study|Procedure not completed|4|||
94437045|NCT02301390|323384644|FG000|Overall Study|Missed multiple visits|1|||
94437046|NCT02301390|323384645|FG001|Overall Study|Missed multiple visits|1|||
94437047|NCT02301390|323384644|FG000|Overall Study|study terminated|2|||
94437048|NCT02301390|323384645|FG001|Overall Study|study terminated|0|||
94437049|NCT00711880|323384646|FG000|Overall Study|Adverse Event|11|||
94437050|NCT00711880|323384647|FG001|Overall Study|Adverse Event|2|||
94437051|NCT00711880|323384646|FG000|Overall Study|Patient non-compliance|1|||
94437052|NCT00711880|323384647|FG001|Overall Study|Patient non-compliance|0|||
94437053|NCT00711880|323384646|FG000|Overall Study|Lack of Efficacy|1|||
94437054|NCT00711880|323384647|FG001|Overall Study|Lack of Efficacy|5|||
94437055|NCT02276807|323384650|FG000|Overall Study|Withdrawal by Subject|8|||
94437056|NCT02276807|323384651|FG001|Overall Study|Withdrawal by Subject|7|||
94437057|NCT02276807|323384650|FG000|Overall Study|Lost to Follow-up|10|||
94437058|NCT02276807|323384651|FG001|Overall Study|Lost to Follow-up|10|||
94437059|NCT03288714|323384653|FG000|Overall Study|Lost to Follow-up|2|||
94437060|NCT03288714|323384654|FG001|Overall Study|Lost to Follow-up|1|||
94437061|NCT03288714|323384653|FG000|Overall Study|Non-compliance with study schedule|2|||
94437062|NCT03288714|323384654|FG001|Overall Study|Non-compliance with study schedule|0|||
94437063|NCT03288714|323384653|FG000|Overall Study|Withdrawal by Subject|3|||
94437064|NCT03288714|323384654|FG001|Overall Study|Withdrawal by Subject|1|||
94437065|NCT03288714|323384653|FG000|Overall Study|Clinical Worsening|2|||
94437066|NCT03288714|323384654|FG001|Overall Study|Clinical Worsening|1|||
94437067|NCT03288714|323384653|FG000|Overall Study|Adverse Event|1|||
94437068|NCT03288714|323384654|FG001|Overall Study|Adverse Event|0|||
94437069|NCT01090414|323384663|FG000|Study 101-99|Progressive Disease|28|||
94437070|NCT01090414|323384664|FG001|Study 101-99|Progressive Disease|48|||
94437071|NCT01090414|323384665|FG002|Study 101-99|Progressive Disease|10|||
94437072|NCT01090414|323384666|FG003|Study 101-99|Progressive Disease|4|||
94437073|NCT01090414|323384663|FG000|Study 101-99|Adverse Event|10|||
94437074|NCT01090414|323384664|FG001|Study 101-99|Adverse Event|28|||
94437075|NCT01090414|323384665|FG002|Study 101-99|Adverse Event|18|||
94437076|NCT01090414|323384666|FG003|Study 101-99|Adverse Event|0|||
94437077|NCT01090414|323384663|FG000|Study 101-99|Investigator Request|1|||
94437078|NCT01090414|323384664|FG001|Study 101-99|Investigator Request|11|||
94437079|NCT01090414|323384665|FG002|Study 101-99|Investigator Request|4|||
94437080|NCT01090414|323384666|FG003|Study 101-99|Investigator Request|0|||
94437081|NCT01090414|323384663|FG000|Study 101-99|Death|3|||
94437082|NCT01090414|323384664|FG001|Study 101-99|Death|8|||
94437083|NCT01090414|323384665|FG002|Study 101-99|Death|1|||
94437084|NCT01090414|323384666|FG003|Study 101-99|Death|0|||
94437085|NCT01090414|323384663|FG000|Study 101-99|Sponsor Discontinued Study|0|||
94437086|NCT01090414|323384664|FG001|Study 101-99|Sponsor Discontinued Study|7|||
94437087|NCT01090414|323384665|FG002|Study 101-99|Sponsor Discontinued Study|5|||
94437088|NCT01090414|323384666|FG003|Study 101-99|Sponsor Discontinued Study|0|||
94437089|NCT01090414|323384663|FG000|Study 101-99|Other (Unknown Reasons)|3|||
94437090|NCT01090414|323384664|FG001|Study 101-99|Other (Unknown Reasons)|3|||
94437091|NCT01090414|323384665|FG002|Study 101-99|Other (Unknown Reasons)|0|||
94437092|NCT01090414|323384666|FG003|Study 101-99|Other (Unknown Reasons)|0|||
94437093|NCT01090414|323384663|FG000|Study 101-99|Withdrew Consent|0|||
94437094|NCT01090414|323384664|FG001|Study 101-99|Withdrew Consent|2|||
94437095|NCT01090414|323384665|FG002|Study 101-99|Withdrew Consent|3|||
94437096|NCT01090414|323384666|FG003|Study 101-99|Withdrew Consent|1|||
94437097|NCT01090414|323384663|FG000|Study 101-99|Participant Request|3|||
94437098|NCT01090414|323384664|FG001|Study 101-99|Participant Request|1|||
94437099|NCT01090414|323384665|FG002|Study 101-99|Participant Request|0|||
94437100|NCT01090414|323384666|FG003|Study 101-99|Participant Request|0|||
94437101|NCT02203357|323384667|FG000|Overall Study|Lost to Follow-up|58|||
94437102|NCT02203357|323384668|FG001|Overall Study|Lost to Follow-up|66|||
94437103|NCT02203357|323384669|FG002|Overall Study|Lost to Follow-up|70|||
94437104|NCT03154125|323384676|FG000|Overall Study|Lost to Follow-up|11|||
94437105|NCT03154125|323384677|FG001|Overall Study|Lost to Follow-up|11|||
94437106|NCT03154125|323384678|FG002|Overall Study|Lost to Follow-up|0|||
94437107|NCT03154125|323384676|FG000|Overall Study|Withdrawal by Subject|49|||
94437108|NCT03154125|323384677|FG001|Overall Study|Withdrawal by Subject|55|||
94437109|NCT03154125|323384678|FG002|Overall Study|Withdrawal by Subject|8|||
94437110|NCT03154125|323384676|FG000|Overall Study|Physician Decision|13|||
94437111|NCT03154125|323384677|FG001|Overall Study|Physician Decision|6|||
94437112|NCT03154125|323384678|FG002|Overall Study|Physician Decision|0|||
94437113|NCT03154125|323384676|FG000|Overall Study|Protocol Violation|3|||
94437114|NCT03154125|323384677|FG001|Overall Study|Protocol Violation|5|||
94437115|NCT03154125|323384678|FG002|Overall Study|Protocol Violation|0|||
94437116|NCT02932462|323384685|FG000|Overall Study|Adverse Event|1|||
94437117|NCT02932462|323384686|FG001|Overall Study|Adverse Event|2|||
94437118|NCT02932462|323384685|FG000|Overall Study|Lost to Follow-up|4|||
94437119|NCT02932462|323384686|FG001|Overall Study|Lost to Follow-up|1|||
94437120|NCT02932462|323384685|FG000|Overall Study|Protocol Violation|0|||
94437121|NCT02932462|323384686|FG001|Overall Study|Protocol Violation|5|||
94437122|NCT02932462|323384685|FG000|Overall Study|Withdrawal by Subject|1|||
94437123|NCT02932462|323384686|FG001|Overall Study|Withdrawal by Subject|4|||
94437124|NCT02932462|323384685|FG000|Overall Study|Non-Compliance With Study Drug|0|||
94437125|NCT02932462|323384686|FG001|Overall Study|Non-Compliance With Study Drug|1|||
94437126|NCT02932462|323384685|FG000|Overall Study|Progressive Disease|1|||
94437127|NCT02932462|323384686|FG001|Overall Study|Progressive Disease|0|||
94437128|NCT00462904|323384687|FG000|Overall Study|Lost to Follow-up|1|||
94437129|NCT05219448|323384688|FG000|Overall Study|Lost to Follow-up|9|||
94437130|NCT05219448|323384689|FG001|Overall Study|Lost to Follow-up|0|||
94437131|NCT04176250|323384690|FG000|Overall Study|Adverse Event|0|||
94437132|NCT04176250|323384691|FG001|Overall Study|Adverse Event|1|||
94437133|NCT04176250|323384692|FG002|Overall Study|Adverse Event|0|||
94437134|NCT04176250|323384693|FG003|Overall Study|Adverse Event|1|||
94437135|NCT04176250|323384694|FG004|Overall Study|Adverse Event|0|||
94437136|NCT04176250|323384695|FG005|Overall Study|Adverse Event|1|||
94437137|NCT04176250|323384690|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
94437138|NCT04176250|323384691|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
94437139|NCT04176250|323384692|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
94437140|NCT04176250|323384693|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
94437141|NCT04176250|323384694|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
94437142|NCT04176250|323384695|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
94437143|NCT04176250|323384690|FG000|Overall Study|Withdrawal by Subject|0|||
94437144|NCT04176250|323384691|FG001|Overall Study|Withdrawal by Subject|0|||
94437145|NCT04176250|323384692|FG002|Overall Study|Withdrawal by Subject|0|||
94437146|NCT04176250|323384693|FG003|Overall Study|Withdrawal by Subject|0|||
94437147|NCT04176250|323384694|FG004|Overall Study|Withdrawal by Subject|0|||
94437148|NCT04176250|323384695|FG005|Overall Study|Withdrawal by Subject|1|||
94437149|NCT04176250|323384690|FG000|Overall Study|Randomized in error|0|||
94437150|NCT04176250|323384691|FG001|Overall Study|Randomized in error|0|||
94437151|NCT04176250|323384692|FG002|Overall Study|Randomized in error|0|||
94437152|NCT04176250|323384693|FG003|Overall Study|Randomized in error|0|||
94437153|NCT04176250|323384694|FG004|Overall Study|Randomized in error|1|||
94437154|NCT04176250|323384695|FG005|Overall Study|Randomized in error|0|||
94437155|NCT01308424|323384711|FG000|Baseline Eligibility|Screen Failures|71|||
94437156|NCT01308424|323384712|FG001|Baseline Eligibility|Screen Failures|0|||
94437157|NCT01308424|323384713|FG002|Baseline Eligibility|Screen Failures|0|||
94437158|NCT01308424|323384711|FG000|Randomization|Adverse Event|0|||
94437159|NCT01308424|323384712|FG001|Randomization|Adverse Event|1|||
94437160|NCT01308424|323384713|FG002|Randomization|Adverse Event|1|||
94437161|NCT01308424|323384711|FG000|Randomization|Lost to Follow-up|0|||
94437162|NCT01308424|323384712|FG001|Randomization|Lost to Follow-up|1|||
94437163|NCT01308424|323384713|FG002|Randomization|Lost to Follow-up|0|||
94437164|NCT01308424|323384711|FG000|Randomization|Physician Decision|0|||
94437165|NCT01308424|323384712|FG001|Randomization|Physician Decision|1|||
94437166|NCT01308424|323384713|FG002|Randomization|Physician Decision|1|||
94437167|NCT03138655|323384716|FG000|Overall Study|Adverse Event|2|||
94437168|NCT03138655|323384717|FG001|Overall Study|Adverse Event|1|||
94437169|NCT03138655|323384718|FG002|Overall Study|Adverse Event|2|||
94437170|NCT03138655|323384719|FG003|Overall Study|Adverse Event|1|||
94437171|NCT03138655|323384720|FG004|Overall Study|Adverse Event|1|||
94437172|NCT03138655|323384721|FG005|Overall Study|Adverse Event|4|||
94437173|NCT03138655|323384722|FG006|Overall Study|Adverse Event|2|||
94437174|NCT03138655|323384723|FG007|Overall Study|Adverse Event|2|||
94437175|NCT03138655|323384716|FG000|Overall Study|Withdrawal by Subject|0|||
94437176|NCT03138655|323384717|FG001|Overall Study|Withdrawal by Subject|1|||
94437177|NCT03138655|323384718|FG002|Overall Study|Withdrawal by Subject|0|||
94437178|NCT03138655|323384719|FG003|Overall Study|Withdrawal by Subject|0|||
94437179|NCT03138655|323384720|FG004|Overall Study|Withdrawal by Subject|0|||
94437180|NCT03138655|323384721|FG005|Overall Study|Withdrawal by Subject|0|||
94437181|NCT03138655|323384722|FG006|Overall Study|Withdrawal by Subject|1|||
94437182|NCT03138655|323384723|FG007|Overall Study|Withdrawal by Subject|0|||
94437183|NCT03138655|323384716|FG000|Overall Study|Reason not Specified|1|||
94437184|NCT03138655|323384717|FG001|Overall Study|Reason not Specified|0|||
94437185|NCT03138655|323384718|FG002|Overall Study|Reason not Specified|0|||
94437186|NCT03138655|323384719|FG003|Overall Study|Reason not Specified|2|||
94437187|NCT03138655|323384720|FG004|Overall Study|Reason not Specified|1|||
94437188|NCT03138655|323384721|FG005|Overall Study|Reason not Specified|1|||
94437189|NCT03138655|323384722|FG006|Overall Study|Reason not Specified|0|||
94437190|NCT03138655|323384723|FG007|Overall Study|Reason not Specified|0|||
94437191|NCT00535405|323384724|FG000|Overall Study|Adverse Event|6|||
94437192|NCT00535405|323384725|FG001|Overall Study|Adverse Event|8|||
94437193|NCT00535405|323384726|FG002|Overall Study|Adverse Event|3|||
94437194|NCT00535405|323384727|FG003|Overall Study|Adverse Event|8|||
94437195|NCT00535405|323384728|FG004|Overall Study|Adverse Event|6|||
94437196|NCT00535405|323384724|FG000|Overall Study|Lost to Follow-up|1|||
94437197|NCT00535405|323384725|FG001|Overall Study|Lost to Follow-up|3|||
94437198|NCT00535405|323384726|FG002|Overall Study|Lost to Follow-up|3|||
94437199|NCT00535405|323384727|FG003|Overall Study|Lost to Follow-up|2|||
94437200|NCT00535405|323384728|FG004|Overall Study|Lost to Follow-up|1|||
94437201|NCT00535405|323384724|FG000|Overall Study|Physician Decision|3|||
94437202|NCT00535405|323384725|FG001|Overall Study|Physician Decision|2|||
94437203|NCT00535405|323384726|FG002|Overall Study|Physician Decision|0|||
94437204|NCT00535405|323384727|FG003|Overall Study|Physician Decision|1|||
94437205|NCT00535405|323384728|FG004|Overall Study|Physician Decision|1|||
94437206|NCT00535405|323384724|FG000|Overall Study|Protocol Violation|2|||
94437207|NCT00535405|323384725|FG001|Overall Study|Protocol Violation|2|||
94437208|NCT00535405|323384726|FG002|Overall Study|Protocol Violation|2|||
94437209|NCT00535405|323384727|FG003|Overall Study|Protocol Violation|1|||
94437210|NCT00535405|323384728|FG004|Overall Study|Protocol Violation|0|||
94437211|NCT00535405|323384724|FG000|Overall Study|Withdrawal by Subject|5|||
94437212|NCT00535405|323384725|FG001|Overall Study|Withdrawal by Subject|11|||
94437213|NCT00535405|323384726|FG002|Overall Study|Withdrawal by Subject|10|||
94437214|NCT00535405|323384727|FG003|Overall Study|Withdrawal by Subject|10|||
94437215|NCT00535405|323384728|FG004|Overall Study|Withdrawal by Subject|8|||
94437216|NCT00796757|323384731|FG000|Overall Study|Withdrawal by Subject|14|||
94437217|NCT00796757|323384731|FG000|Overall Study|Death|61|||
94437218|NCT00796757|323384731|FG000|Overall Study|Protocol Violation|1|||
94437219|NCT00796757|323384731|FG000|Overall Study|Participant noncompliance|1|||
94437220|NCT00796757|323384731|FG000|Overall Study|Investigator's decision|2|||
94437221|NCT00796757|323384731|FG000|Overall Study|Other|7|||
94437222|NCT04877457|323384732|FG000|Overall Study|Early termination of study due to low enrollment|2|||
94437223|NCT04877457|323384733|FG001|Overall Study|Early termination of study due to low enrollment|1|||
94437224|NCT02211417|323384734|FG000|Overall Study|Withdrawal by Subject|11|||
94437225|NCT02211417|323384735|FG001|Overall Study|Withdrawal by Subject|8|||
94437226|NCT02211417|323384734|FG000|Overall Study|Protocol Violation|1|||
94437227|NCT02211417|323384735|FG001|Overall Study|Protocol Violation|0|||
94437228|NCT02211417|323384734|FG000|Overall Study|Pregnancy|0|||
94437229|NCT02211417|323384735|FG001|Overall Study|Pregnancy|1|||
94437230|NCT02211417|323384734|FG000|Overall Study|Lost to Follow-up|2|||
94437231|NCT02211417|323384735|FG001|Overall Study|Lost to Follow-up|3|||
94437232|NCT02211417|323384734|FG000|Overall Study|Adverse Event|1|||
94437233|NCT02211417|323384735|FG001|Overall Study|Adverse Event|4|||
94437234|NCT01198132|323384737|FG000|Overall Study|Withdrawal by Subject|4|||
94437235|NCT01198132|323384738|FG001|Overall Study|Withdrawal by Subject|5|||
94437236|NCT01198132|323384737|FG000|Overall Study|Physician Decision|5|||
94437237|NCT01198132|323384738|FG001|Overall Study|Physician Decision|4|||
94437238|NCT01198132|323384737|FG000|Overall Study|Other Unspecified|3|||
94437239|NCT01198132|323384738|FG001|Overall Study|Other Unspecified|6|||
94437240|NCT01198132|323384737|FG000|Overall Study|Lack of Efficacy|2|||
94437241|NCT01198132|323384738|FG001|Overall Study|Lack of Efficacy|3|||
94437242|NCT01198132|323384737|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
94437243|NCT01198132|323384738|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
94437244|NCT01198132|323384737|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
94437245|NCT01198132|323384738|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
94437246|NCT01198132|323384737|FG000|Overall Study|Adverse Event|0|||
94437247|NCT01198132|323384738|FG001|Overall Study|Adverse Event|1|||
94437248|NCT01198132|323384737|FG000|Overall Study|Protocol Violation|1|||
94437249|NCT01198132|323384738|FG001|Overall Study|Protocol Violation|0|||
94437250|NCT01755091|323384739|FG000|Overall Study|Withdrawal by Subject|6|||
94437251|NCT01755091|323384740|FG001|Overall Study|Withdrawal by Subject|1|||
94437252|NCT01755091|323384741|FG002|Overall Study|Withdrawal by Subject|3|||
94437253|NCT01755091|323384739|FG000|Overall Study|Adverse Event|1|||
94437254|NCT01755091|323384740|FG001|Overall Study|Adverse Event|1|||
94437255|NCT01755091|323384741|FG002|Overall Study|Adverse Event|1|||
94437256|NCT01755091|323384739|FG000|Overall Study|Lost to Follow-up|1|||
94437257|NCT01755091|323384740|FG001|Overall Study|Lost to Follow-up|0|||
94437258|NCT01755091|323384741|FG002|Overall Study|Lost to Follow-up|1|||
94437259|NCT01755091|323384739|FG000|Overall Study|Physician Decision|1|||
94437260|NCT01755091|323384740|FG001|Overall Study|Physician Decision|1|||
94437261|NCT01755091|323384741|FG002|Overall Study|Physician Decision|2|||
94437262|NCT00490841|323384742|FG000|Overall Study|Death|5|||
94437263|NCT00490841|323384742|FG000|Overall Study|Withdrawal by Subject|4|||
94437264|NCT00490841|323384742|FG000|Overall Study|Lost to Follow-up|1|||
94437265|NCT00490841|323384742|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
94437266|NCT01277211|323384743|FG000|Overall Study|Adverse Event|60|||
94437267|NCT01277211|323384744|FG001|Overall Study|Adverse Event|22|||
94437268|NCT01277211|323384743|FG000|Overall Study|Pregnancy|9|||
94437269|NCT01277211|323384744|FG001|Overall Study|Pregnancy|4|||
94437270|NCT01277211|323384743|FG000|Overall Study|Lost to Follow-up|14|||
94437271|NCT01277211|323384744|FG001|Overall Study|Lost to Follow-up|9|||
94437272|NCT01277211|323384743|FG000|Overall Study|Did not wish to continue|17|||
94437273|NCT01277211|323384744|FG001|Overall Study|Did not wish to continue|0|||
94437274|NCT01277211|323384743|FG000|Overall Study|Withdrew Consent|9|||
94437275|NCT01277211|323384744|FG001|Overall Study|Withdrew Consent|9|||
94437276|NCT01277211|323384743|FG000|Overall Study|Non-compliance with protocol|13|||
94437277|NCT01277211|323384744|FG001|Overall Study|Non-compliance with protocol|4|||
94437278|NCT01277211|323384743|FG000|Overall Study|Did not meet protocol eligibility|1|||
94437279|NCT01277211|323384744|FG001|Overall Study|Did not meet protocol eligibility|0|||
94437280|NCT01277211|323384743|FG000|Overall Study|Administrative|3|||
94437281|NCT01277211|323384744|FG001|Overall Study|Administrative|0|||
94437282|NCT01277211|323384743|FG000|Overall Study|Pregnancy wish|0|||
94437283|NCT01277211|323384744|FG001|Overall Study|Pregnancy wish|2|||
94437284|NCT01277211|323384743|FG000|Overall Study|Discontinued prior to treatment|24|||
94437285|NCT01277211|323384744|FG001|Overall Study|Discontinued prior to treatment|13|||
94437286|NCT01130493|323384745|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
94437287|NCT01130493|323384746|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
94437288|NCT01130493|323384747|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
94437289|NCT01130493|323384745|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
94437290|NCT01130493|323384746|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
94437291|NCT01130493|323384747|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
94437292|NCT01130493|323384745|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
94437293|NCT01130493|323384746|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
94437294|NCT01130493|323384747|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
94437295|NCT01130493|323384745|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
94437296|NCT01130493|323384746|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
94437297|NCT01130493|323384747|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
94437298|NCT01130493|323384745|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
94437299|NCT01130493|323384746|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
94437300|NCT01130493|323384747|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
94437301|NCT01130493|323384745|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
94437302|NCT01130493|323384746|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
94437303|NCT01130493|323384747|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
94437304|NCT01130493|323384745|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
94655598|NCT01110239|324196090|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
94437305|NCT01130493|323384746|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
94437306|NCT01130493|323384747|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
94437307|NCT01130493|323384745|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
94437308|NCT01130493|323384746|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
94437309|NCT01130493|323384747|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
94437310|NCT01130493|323384745|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
94437311|NCT01130493|323384746|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
94437312|NCT01130493|323384747|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
94437313|NCT01130493|323384745|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
94437314|NCT01130493|323384746|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
94437315|NCT01130493|323384747|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
94437316|NCT01130493|323384745|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
94437317|NCT01130493|323384746|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
94437318|NCT01130493|323384747|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
94437319|NCT01130493|323384745|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
94437320|NCT01130493|323384746|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
94437321|NCT01130493|323384747|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
94437322|NCT01130493|323384745|FG000|Part 2: OLE|Adverse Event|0|||
94437323|NCT01130493|323384746|FG001|Part 2: OLE|Adverse Event|2|||
94437324|NCT01130493|323384747|FG002|Part 2: OLE|Adverse Event|1|||
94437325|NCT01130493|323384745|FG000|Part 2: OLE|Withdrawal by Subject|0|||
94437326|NCT01130493|323384746|FG001|Part 2: OLE|Withdrawal by Subject|1|||
94437327|NCT01130493|323384747|FG002|Part 2: OLE|Withdrawal by Subject|4|||
94437328|NCT00879086|323384751|FG000|Overall Study|Adverse Event|3|||
94437329|NCT00879086|323384752|FG001|Overall Study|Adverse Event|15|||
94437330|NCT00879086|323384751|FG000|Overall Study|Participant choice|2|||
94437331|NCT00879086|323384752|FG001|Overall Study|Participant choice|2|||
94437332|NCT00879086|323384751|FG000|Overall Study|Progression of disease|40|||
94437333|NCT00879086|323384752|FG001|Overall Study|Progression of disease|26|||
94437334|NCT00879086|323384751|FG000|Overall Study|Withdrawal of consent|2|||
94437335|NCT00879086|323384752|FG001|Overall Study|Withdrawal of consent|1|||
94437336|NCT00879086|323384751|FG000|Overall Study|Other|4|||
94437337|NCT00879086|323384752|FG001|Overall Study|Other|6|||
94437338|NCT00879086|323384751|FG000|Overall Study|Death|1|||
94437339|NCT00879086|323384752|FG001|Overall Study|Death|2|||
94437340|NCT04604795|323384753|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
94437341|NCT04604795|323384754|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
94437342|NCT04604795|323384755|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
94437343|NCT04604795|323384756|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
94437344|NCT04604795|323384757|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
94437345|NCT04604795|323384758|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
94437346|NCT04604795|323384759|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
94437347|NCT04604795|323384760|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
94437348|NCT04604795|323384761|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
94437349|NCT04604795|323384762|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
94437350|NCT04604795|323384753|FG000|Part B: Up to Day 14|Adverse Event|0|||
94437351|NCT04604795|323384754|FG001|Part B: Up to Day 14|Adverse Event|0|||
94437352|NCT04604795|323384755|FG002|Part B: Up to Day 14|Adverse Event|0|||
94437353|NCT04604795|323384756|FG003|Part B: Up to Day 14|Adverse Event|0|||
94437354|NCT04604795|323384757|FG004|Part B: Up to Day 14|Adverse Event|2|||
94437355|NCT04604795|323384758|FG005|Part B: Up to Day 14|Adverse Event|1|||
94437356|NCT04604795|323384759|FG006|Part B: Up to Day 14|Adverse Event|0|||
94437357|NCT04604795|323384760|FG007|Part B: Up to Day 14|Adverse Event|0|||
94437358|NCT04604795|323384761|FG008|Part B: Up to Day 14|Adverse Event|0|||
94437359|NCT04604795|323384762|FG009|Part B: Up to Day 14|Adverse Event|0|||
94437360|NCT04604795|323384753|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
94437361|NCT04604795|323384754|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
94437362|NCT04604795|323384755|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
94437363|NCT04604795|323384756|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
94437364|NCT04604795|323384757|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
94437365|NCT04604795|323384758|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
94437366|NCT04604795|323384759|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
94437367|NCT04604795|323384760|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
94437368|NCT04604795|323384761|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
94437369|NCT04604795|323384762|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
94437370|NCT04604795|323384753|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
94437371|NCT04604795|323384754|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
94437372|NCT04604795|323384755|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
94437373|NCT04604795|323384756|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
94437374|NCT04604795|323384757|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
94437375|NCT04604795|323384758|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
94437376|NCT04604795|323384759|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
94437377|NCT04604795|323384760|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
94437378|NCT04604795|323384761|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
94437379|NCT04604795|323384762|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
94437380|NCT04604795|323384753|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
94437381|NCT04604795|323384754|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
94437382|NCT04604795|323384755|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
94437383|NCT04604795|323384756|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
94437384|NCT04604795|323384757|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
94437385|NCT04604795|323384758|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
94437386|NCT04604795|323384759|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
94437387|NCT04604795|323384760|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
94437388|NCT04604795|323384761|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
94437389|NCT04604795|323384762|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
94437390|NCT04604795|323384753|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
94437391|NCT04604795|323384754|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
94437392|NCT04604795|323384755|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
94437393|NCT04604795|323384756|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
94437394|NCT04604795|323384757|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
94437395|NCT04604795|323384758|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
94437396|NCT04604795|323384759|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
94437397|NCT04604795|323384760|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
94437398|NCT04604795|323384761|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
94437399|NCT04604795|323384762|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
94437400|NCT04502212|323384763|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
94437401|NCT04502212|323384763|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
94437402|NCT00786409|323384768|FG000|Overall Study|Withdrawal by Subject|2|||
94437403|NCT00786409|323384768|FG000|Overall Study|Adverse Event|2|||
94437404|NCT00786409|323384768|FG000|Overall Study|Pregnancy|2|||
94437405|NCT00786409|323384768|FG000|Overall Study|Lost to Follow-up|1|||
94437406|NCT01911273|323384769|FG000|Overall Study|Progression of Disease|1|||
94437407|NCT01911273|323384770|FG001|Overall Study|Progression of Disease|0|||
94437408|NCT01911273|323384769|FG000|Overall Study|Withdrawal by Subject|0|||
94437409|NCT01911273|323384770|FG001|Overall Study|Withdrawal by Subject|2|||
94437410|NCT02503787|323384773|FG000|Enrollment|Withdrawal by Subject|6|||
94437411|NCT02503787|323384773|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
94437412|NCT02503787|323384773|FG000|Enrollment|Physician Decision|2|||
94437413|NCT02503787|323384773|FG000|Enrollment|Insurance issue|2|||
94437414|NCT02503787|323384773|FG000|Enrollment|Lost to Follow-up|1|||
94437415|NCT02503787|323384773|FG000|Enrollment|Study closure|1|||
94437416|NCT02503787|323384773|FG000|Enrollment|Adverse Event|1|||
94437417|NCT02503787|323384773|FG000|Enrollment|Protocol Violation|1|||
94437418|NCT02503787|323384773|FG000|Enrollment|Inability to implant system|1|||
94437419|NCT02503787|323384773|FG000|Enrollment|Unable to be programmed|1|||
94437420|NCT02503787|323384773|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
94437421|NCT02503787|323384773|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
94437422|NCT02503787|323384773|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
94437423|NCT02503787|323384773|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
94437424|NCT02503787|323384773|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
94437425|NCT02503787|323384773|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
94437426|NCT02517463|323384774|FG000|Overall Study|Lost to Follow-up|5|||
94437427|NCT02517463|323384775|FG001|Overall Study|Lost to Follow-up|2|||
94437428|NCT00143390|323384776|FG000|Overall Study|Death|2|||
94437429|NCT00143390|323384777|FG001|Overall Study|Death|0|||
94437430|NCT00143390|323384776|FG000|Overall Study|Not meeting entry criteria|2|||
94437431|NCT00143390|323384777|FG001|Overall Study|Not meeting entry criteria|5|||
94437432|NCT00143390|323384776|FG000|Overall Study|Withdrawal by Subject|4|||
94437433|NCT00143390|323384777|FG001|Overall Study|Withdrawal by Subject|4|||
94437434|NCT00143390|323384776|FG000|Overall Study|Progressive disease|119|||
94437435|NCT00143390|323384777|FG001|Overall Study|Progressive disease|115|||
94437436|NCT00143390|323384776|FG000|Overall Study|Protocol Violation|2|||
94437437|NCT00143390|323384777|FG001|Overall Study|Protocol Violation|0|||
94437438|NCT00143390|323384776|FG000|Overall Study|Study termination|10|||
94437439|NCT00143390|323384777|FG001|Overall Study|Study termination|15|||
94437440|NCT00143390|323384776|FG000|Overall Study|Adverse Event|9|||
94437441|NCT00143390|323384777|FG001|Overall Study|Adverse Event|8|||
94437442|NCT00143390|323384776|FG000|Overall Study|Other|1|||
94437443|NCT00143390|323384777|FG001|Overall Study|Other|2|||
94437444|NCT01659125|323386664|FG000|Overall Study|Withdrawal by Subject|2|||
94437445|NCT01659125|323386664|FG000|Overall Study|Lost to Follow-up|7|||
94437446|NCT01659125|323386664|FG000|Overall Study|Technical Problem|1|||
94437447|NCT01659125|323386664|FG000|Overall Study|Time Constraints|2|||
94437448|NCT01659125|323386664|FG000|Overall Study|Failed to Start Treatment|2|||
94437449|NCT00733005|323386677|FG000|Overall Study|Adverse Event|0|||
94437450|NCT00733005|323386678|FG001|Overall Study|Adverse Event|1|||
94437451|NCT00733005|323386677|FG000|Overall Study|Treatment Failure|0|||
94437452|NCT00733005|323386678|FG001|Overall Study|Treatment Failure|1|||
94437453|NCT00733005|323386677|FG000|Overall Study|Withdrawal by Subject|0|||
94437454|NCT00733005|323386678|FG001|Overall Study|Withdrawal by Subject|1|||
94437455|NCT00733005|323386677|FG000|Overall Study|Protocol Violation|2|||
94437456|NCT00733005|323386678|FG001|Overall Study|Protocol Violation|0|||
94437457|NCT01769456|323386679|FG000|Overall Study|Lost to Follow-up|19|||
94437458|NCT01769456|323386679|FG000|Overall Study|Withdrawal by Subject|3|||
94437459|NCT01769456|323386679|FG000|Overall Study|Did not receive PCC intervention|6|||
94437460|NCT01769456|323386679|FG000|Overall Study|Moved out of the area|3|||
94437461|NCT01769456|323386679|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
94437462|NCT01769456|323386679|FG000|Overall Study|Parental request to youth to withdraw|1|||
94437463|NCT05244122|323386684|FG000|Overall Study|Withdrawal by Subject|318|||
94437464|NCT03410056|323386685|FG000|Overall Study|Decision by Sponsor|0|||
94437465|NCT03410056|323386686|FG001|Overall Study|Decision by Sponsor|0|||
94437466|NCT03410056|323386687|FG002|Overall Study|Decision by Sponsor|3|||
94437467|NCT03410056|323386688|FG003|Overall Study|Decision by Sponsor|0|||
94437468|NCT03410056|323386689|FG004|Overall Study|Decision by Sponsor|0|||
94437469|NCT03410056|323386690|FG005|Overall Study|Decision by Sponsor|0|||
94437470|NCT03410056|323386691|FG006|Overall Study|Decision by Sponsor|0|||
94437471|NCT03410056|323386685|FG000|Overall Study|Withdrawal by Subject|0|||
94437472|NCT03410056|323386686|FG001|Overall Study|Withdrawal by Subject|2|||
94437473|NCT03410056|323386687|FG002|Overall Study|Withdrawal by Subject|5|||
94437474|NCT03410056|323386688|FG003|Overall Study|Withdrawal by Subject|5|||
94437475|NCT03410056|323386689|FG004|Overall Study|Withdrawal by Subject|0|||
94437476|NCT03410056|323386690|FG005|Overall Study|Withdrawal by Subject|0|||
94437477|NCT03410056|323386691|FG006|Overall Study|Withdrawal by Subject|0|||
94437478|NCT00266630|323386692|FG000|Overall Study|Adverse Event|8|||
94437479|NCT00266630|323386693|FG001|Overall Study|Adverse Event|6|||
94437480|NCT00266630|323386692|FG000|Overall Study|Lack of Efficacy|1|||
94437481|NCT00266630|323386693|FG001|Overall Study|Lack of Efficacy|4|||
94437482|NCT00266630|323386692|FG000|Overall Study|Entry Criteria not met|1|||
94437483|NCT00266630|323386693|FG001|Overall Study|Entry Criteria not met|0|||
94437484|NCT00266630|323386692|FG000|Overall Study|Protocol Violation|1|||
94437485|NCT00266630|323386693|FG001|Overall Study|Protocol Violation|3|||
94437486|NCT00266630|323386692|FG000|Overall Study|Physician Decision|1|||
94437487|NCT00266630|323386693|FG001|Overall Study|Physician Decision|2|||
94437488|NCT00266630|323386692|FG000|Overall Study|Withdrawal by Subject|10|||
94437489|NCT00266630|323386693|FG001|Overall Study|Withdrawal by Subject|2|||
94437490|NCT00266630|323386692|FG000|Overall Study|Lost to Follow-up|1|||
94437491|NCT00266630|323386693|FG001|Overall Study|Lost to Follow-up|0|||
94437492|NCT00266630|323386692|FG000|Overall Study|Other|19|||
94437493|NCT00266630|323386693|FG001|Overall Study|Other|11|||
94437494|NCT00615199|323386697|FG000|Overall Study|Adverse Event|3|||
94437495|NCT00615199|323386698|FG001|Overall Study|Adverse Event|1|||
94437496|NCT00615199|323386699|FG002|Overall Study|Adverse Event|1|||
94437497|NCT00615199|323386700|FG003|Overall Study|Adverse Event|0|||
94437498|NCT00615199|323386697|FG000|Overall Study|Lack of Efficacy|2|||
94437499|NCT00615199|323386698|FG001|Overall Study|Lack of Efficacy|0|||
94437500|NCT00615199|323386699|FG002|Overall Study|Lack of Efficacy|0|||
94437501|NCT00615199|323386700|FG003|Overall Study|Lack of Efficacy|1|||
94437502|NCT00615199|323386697|FG000|Overall Study|Lost to Follow-up|1|||
94437503|NCT00615199|323386698|FG001|Overall Study|Lost to Follow-up|0|||
94437504|NCT00615199|323386699|FG002|Overall Study|Lost to Follow-up|0|||
94437505|NCT00615199|323386700|FG003|Overall Study|Lost to Follow-up|0|||
94437506|NCT00615199|323386697|FG000|Overall Study|Other|0|||
94437507|NCT00615199|323386698|FG001|Overall Study|Other|0|||
94437508|NCT00615199|323386699|FG002|Overall Study|Other|0|||
94437509|NCT00615199|323386700|FG003|Overall Study|Other|1|||
94437510|NCT00615199|323386697|FG000|Overall Study|Withdrawal by Subject|2|||
94437511|NCT00615199|323386698|FG001|Overall Study|Withdrawal by Subject|1|||
94437512|NCT00615199|323386699|FG002|Overall Study|Withdrawal by Subject|0|||
94437513|NCT00615199|323386700|FG003|Overall Study|Withdrawal by Subject|0|||
94437514|NCT02077140|323386703|FG000|Overall Study|Lost to Follow-up|4|||
94437515|NCT02077140|323386704|FG001|Overall Study|Lost to Follow-up|1|||
94437516|NCT02077140|323386705|FG002|Overall Study|Lost to Follow-up|2|||
94437517|NCT02077140|323386706|FG003|Overall Study|Lost to Follow-up|2|||
94437518|NCT02077140|323386707|FG004|Overall Study|Lost to Follow-up|3|||
94437519|NCT02077140|323386703|FG000|Overall Study|Withdrawal by Subject|0|||
94437520|NCT02077140|323386704|FG001|Overall Study|Withdrawal by Subject|1|||
94437521|NCT02077140|323386705|FG002|Overall Study|Withdrawal by Subject|0|||
94437522|NCT02077140|323386706|FG003|Overall Study|Withdrawal by Subject|2|||
94437523|NCT02077140|323386707|FG004|Overall Study|Withdrawal by Subject|2|||
94437524|NCT02135614|323386710|FG000|Overall Study|Randomized but Not Treated|2|||
94437525|NCT02135614|323386711|FG001|Overall Study|Randomized but Not Treated|1|||
94437526|NCT02135614|323386710|FG000|Overall Study|Adverse Event|0|||
94437527|NCT02135614|323386711|FG001|Overall Study|Adverse Event|1|||
94437528|NCT02135614|323386710|FG000|Overall Study|Death|1|||
94437529|NCT02135614|323386711|FG001|Overall Study|Death|0|||
94437530|NCT02135614|323386710|FG000|Overall Study|Investigator's Discretion|0|||
94437531|NCT02135614|323386711|FG001|Overall Study|Investigator's Discretion|1|||
94437532|NCT02135614|323386710|FG000|Overall Study|Withdrew Consent|2|||
94437533|NCT02135614|323386711|FG001|Overall Study|Withdrew Consent|2|||
94437534|NCT02135614|323386710|FG000|Overall Study|Lost to Follow-up|3|||
94437535|NCT02135614|323386711|FG001|Overall Study|Lost to Follow-up|0|||
94437536|NCT01009814|323386712|FG000|Overall Study|No longer met study criteria|1|||
94437537|NCT01009814|323386713|FG001|Overall Study|No longer met study criteria|1|||
94437538|NCT01009814|323386714|FG002|Overall Study|No longer met study criteria|0|||
94437539|NCT01009814|323386715|FG003|Overall Study|No longer met study criteria|0|||
94437540|NCT01009814|323386716|FG004|Overall Study|No longer met study criteria|0|||
94437541|NCT00618371|323386717|FG000|Overall Study|Withdrawal by Subject|2|||
94437542|NCT03022084|323386718|FG000|Overall Study|Lost to Follow-up|2|||
94437543|NCT03022084|323386719|FG001|Overall Study|Lost to Follow-up|3|||
94437544|NCT05377749|323386720|FG000|3 Weeks|Lost to Follow-up|2|||
94437545|NCT05377749|323386721|FG001|3 Weeks|Lost to Follow-up|4|||
94437546|NCT05377749|323386720|FG000|3 Weeks|Withdrawal by Subject|1|||
94437547|NCT05377749|323386721|FG001|3 Weeks|Withdrawal by Subject|1|||
94437548|NCT02640482|323386723|FG000|Overall Study|Lost to Follow-up|3|||
94437549|NCT02640482|323386724|FG001|Overall Study|Lost to Follow-up|0|||
94437550|NCT01173120|323386725|FG000|Overall Study|Lack of Efficacy|2|||
94437551|NCT01173120|323386725|FG000|Overall Study|Lost to Follow-up|1|||
94437552|NCT01173120|323386725|FG000|Overall Study|Participant Decision|2|||
94437553|NCT01173120|323386725|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
94437554|NCT01173120|323386725|FG000|Overall Study|Switch-Participant Decision|12|||
94437555|NCT01173120|323386725|FG000|Overall Study|Switch-Difficulty With Device|12|||
94437556|NCT01383707|323386726|FG000|Overall Study|Consent withdrawal|6|||
94437557|NCT01383707|323386726|FG000|Overall Study|Death|19|||
94437558|NCT01383707|323386726|FG000|Overall Study|Other|8|||
94437559|NCT01383707|323386726|FG000|Overall Study|Sponsor's decision|2|||
94437560|NCT01383707|323386726|FG000|Overall Study|Adverse Event|14|||
94437561|NCT01383707|323386726|FG000|Overall Study|Progressive disease|23|||
94437562|NCT02129608|323386727|FG000|Overall Study|Lost to Follow-up|0|||
94437563|NCT02129608|323386728|FG001|Overall Study|Lost to Follow-up|1|||
94437564|NCT02129608|323386729|FG002|Overall Study|Lost to Follow-up|1|||
94437565|NCT02129608|323386727|FG000|Overall Study|Withdrawal by Subject|0|||
94437566|NCT02129608|323386728|FG001|Overall Study|Withdrawal by Subject|0|||
94437567|NCT02129608|323386729|FG002|Overall Study|Withdrawal by Subject|2|||
94437568|NCT03066258|323386735|FG000|Overall Study|Death|1|||
94437569|NCT03066258|323386736|FG001|Overall Study|Death|0|||
94437570|NCT03066258|323386737|FG002|Overall Study|Death|0|||
94437571|NCT03066258|323386738|FG003|Overall Study|Death|0|||
94437572|NCT03066258|323386739|FG004|Overall Study|Death|1|||
94437573|NCT00626561|323386740|FG000|Overall Study|Withdrawal by Subject|2|||
94437574|NCT00626561|323386740|FG000|Overall Study|Disease Progression|2|||
94437575|NCT01427608|323386741|FG000|Overall Study|Death|1|||
94437576|NCT01427608|323386742|FG001|Overall Study|Death|0|||
94437577|NCT01427608|323386741|FG000|Overall Study|Withdrawal by Subject|7|||
94437578|NCT01427608|323386742|FG001|Overall Study|Withdrawal by Subject|3|||
94437579|NCT01427608|323386741|FG000|Overall Study|Relapsed-all cause|13|||
94437580|NCT01427608|323386742|FG001|Overall Study|Relapsed-all cause|34|||
94437581|NCT01427608|323386741|FG000|Overall Study|Events not attributed to study meds|0|||
94437582|NCT01427608|323386742|FG001|Overall Study|Events not attributed to study meds|1|||
94437583|NCT00853099|323386743|FG000|Double-blind Period|Adverse Event|7|||
94437584|NCT00853099|323386744|FG001|Double-blind Period|Adverse Event|9|||
94437585|NCT00853099|323386745|FG002|Double-blind Period|Adverse Event|13|||
94437586|NCT00853099|323386746|FG003|Double-blind Period|Adverse Event|0|||
94437587|NCT00853099|323386743|FG000|Double-blind Period|Withdrawal by Subject|2|||
94437588|NCT00853099|323386744|FG001|Double-blind Period|Withdrawal by Subject|3|||
94437589|NCT00853099|323386745|FG002|Double-blind Period|Withdrawal by Subject|0|||
94437590|NCT00853099|323386746|FG003|Double-blind Period|Withdrawal by Subject|0|||
94437591|NCT00853099|323386743|FG000|Double-blind Period|Lack of Efficacy|14|||
94437592|NCT00853099|323386744|FG001|Double-blind Period|Lack of Efficacy|17|||
94437593|NCT00853099|323386745|FG002|Double-blind Period|Lack of Efficacy|16|||
94437594|NCT00853099|323386746|FG003|Double-blind Period|Lack of Efficacy|0|||
94437595|NCT00853099|323386743|FG000|Double-blind Period|Other|0|||
94437596|NCT00853099|323386744|FG001|Double-blind Period|Other|0|||
94437597|NCT00853099|323386745|FG002|Double-blind Period|Other|1|||
94437598|NCT00853099|323386746|FG003|Double-blind Period|Other|0|||
94437599|NCT00853099|323386743|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
94437600|NCT00853099|323386744|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
94437601|NCT00853099|323386745|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
94437602|NCT00853099|323386746|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
94437603|NCT00853099|323386743|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
94437604|NCT00853099|323386744|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
94437605|NCT00853099|323386745|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
94437606|NCT00853099|323386746|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
94437607|NCT00853099|323386743|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
94437608|NCT00853099|323386744|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
94437609|NCT00853099|323386745|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
94437610|NCT00853099|323386746|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
94437611|NCT00853099|323386743|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
94437612|NCT00853099|323386744|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
94437613|NCT00853099|323386745|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
94437614|NCT00853099|323386746|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
94437615|NCT00853099|323386743|FG000|Double-blind + Open-label Periods|Other|0|||
94437616|NCT00853099|323386744|FG001|Double-blind + Open-label Periods|Other|0|||
94437617|NCT00853099|323386745|FG002|Double-blind + Open-label Periods|Other|0|||
94437618|NCT00853099|323386746|FG003|Double-blind + Open-label Periods|Other|6|||
94437619|NCT00398866|323386750|FG000|Overall Study|Adverse Event|1|||
94437620|NCT00398866|323386751|FG001|Overall Study|Adverse Event|0|||
94437621|NCT00398866|323386752|FG002|Overall Study|Adverse Event|0|||
94437622|NCT00398866|323386750|FG000|Overall Study|Lack of Efficacy|0|||
94437623|NCT00398866|323386751|FG001|Overall Study|Lack of Efficacy|0|||
94437624|NCT00398866|323386752|FG002|Overall Study|Lack of Efficacy|1|||
94437625|NCT00398866|323386750|FG000|Overall Study|Lost to Follow-up|7|||
94437626|NCT00398866|323386751|FG001|Overall Study|Lost to Follow-up|6|||
94437627|NCT00398866|323386752|FG002|Overall Study|Lost to Follow-up|4|||
94437628|NCT00398866|323386750|FG000|Overall Study|Withdrawal by Subject|5|||
94437629|NCT00398866|323386751|FG001|Overall Study|Withdrawal by Subject|1|||
94437630|NCT00398866|323386752|FG002|Overall Study|Withdrawal by Subject|2|||
94437631|NCT00398866|323386750|FG000|Overall Study|Unable to complete requirements of study|1|||
94437632|NCT00398866|323386751|FG001|Overall Study|Unable to complete requirements of study|1|||
94437633|NCT00398866|323386752|FG002|Overall Study|Unable to complete requirements of study|1|||
94437634|NCT00442962|323386755|FG000|Overall Study|Pregnancy|1|||
94437635|NCT00442962|323386755|FG000|Overall Study|Lost to Follow-up|7|||
94437636|NCT03126435|323386756|FG000|Overall Study|Death|90|||
94437637|NCT03126435|323386757|FG001|Overall Study|Death|84|||
94437638|NCT03126435|323386756|FG000|Overall Study|Lost to Follow-up|4|||
94437639|NCT03126435|323386757|FG001|Overall Study|Lost to Follow-up|3|||
94437640|NCT03126435|323386756|FG000|Overall Study|Physician Decision|0|||
94437641|NCT03126435|323386757|FG001|Overall Study|Physician Decision|1|||
94437642|NCT03126435|323386756|FG000|Overall Study|Withdrawal by Subject|6|||
94437643|NCT03126435|323386757|FG001|Overall Study|Withdrawal by Subject|12|||
94437644|NCT03126435|323386756|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
94437645|NCT03126435|323386757|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
94437646|NCT03971474|323386758|FG000|Overall Study|Adverse Event|11|||
94437647|NCT03971474|323386759|FG001|Overall Study|Adverse Event|7|||
94437648|NCT03971474|323386758|FG000|Overall Study|Refusal unrelated to adverse event|5|||
94437649|NCT03971474|323386759|FG001|Overall Study|Refusal unrelated to adverse event|1|||
94437650|NCT03971474|323386758|FG000|Overall Study|Progression/relapse|40|||
94437651|NCT03971474|323386759|FG001|Overall Study|Progression/relapse|47|||
94437652|NCT03971474|323386758|FG000|Overall Study|Death|6|||
94437653|NCT03971474|323386759|FG001|Overall Study|Death|3|||
94437654|NCT03971474|323386758|FG000|Overall Study|Other - not protocol specified|5|||
94437655|NCT03971474|323386759|FG001|Overall Study|Other - not protocol specified|4|||
94437656|NCT03971474|323386758|FG000|Overall Study|On treatment|0|||
94437657|NCT03971474|323386759|FG001|Overall Study|On treatment|7|||
94437658|NCT01811472|323386761|FG000|Overall Study|Adverse Event|1|||
94437659|NCT01811472|323386762|FG001|Overall Study|Adverse Event|0|||
94437660|NCT01811472|323386763|FG002|Overall Study|Adverse Event|4|||
94437661|NCT01811472|323386761|FG000|Overall Study|Lost to Follow-up|0|||
94437662|NCT01811472|323386762|FG001|Overall Study|Lost to Follow-up|0|||
94437663|NCT01811472|323386763|FG002|Overall Study|Lost to Follow-up|1|||
94437664|NCT01811472|323386761|FG000|Overall Study|Subject/guardian decision|1|||
94437665|NCT01811472|323386762|FG001|Overall Study|Subject/guardian decision|0|||
94437666|NCT01811472|323386763|FG002|Overall Study|Subject/guardian decision|0|||
94437667|NCT01482312|323386768|FG000|Period 1, 90 Minutes of Wear|Other|1|||
94437668|NCT01482312|323386769|FG001|Period 1, 90 Minutes of Wear|Other|0|||
94437669|NCT01482312|323386770|FG002|Period 1, 90 Minutes of Wear|Other|0|||
94437670|NCT01482312|323386768|FG000|Period 2, 90 Minutes of Wear|Other|1|||
94437671|NCT01482312|323386769|FG001|Period 2, 90 Minutes of Wear|Other|0|||
94437672|NCT01482312|323386770|FG002|Period 2, 90 Minutes of Wear|Other|0|||
94437673|NCT02088697|323386773|FG000|Period I|Physician Decision|1|||
94437674|NCT02088697|323386774|FG001|Period I|Physician Decision|4|||
94437675|NCT02088697|323386773|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
94437676|NCT02088697|323386774|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
94437677|NCT01295320|323386775|FG000|Overall Study|Adverse Event|2|||
94437678|NCT01295320|323386775|FG000|Overall Study|Lost to Follow-up|4|||
94490217|NCT00207740|323590269|FG003|Overall Study|Other|5|||
94437679|NCT01295320|323386775|FG000|Overall Study|Withdrawal by Subject|2|||
94437680|NCT01295320|323386775|FG000|Overall Study|Subject was bedridden|1|||
94437681|NCT01295320|323386775|FG000|Overall Study|Unable to travel|1|||
94437682|NCT02413229|323386776|FG000|Overall Study|Adverse Event|0|||
94437683|NCT02413229|323386777|FG001|Overall Study|Adverse Event|0|||
94437684|NCT02413229|323386778|FG002|Overall Study|Adverse Event|0|||
94437685|NCT02413229|323386779|FG003|Overall Study|Adverse Event|1|||
94437686|NCT02413229|323386780|FG004|Overall Study|Adverse Event|0|||
94437687|NCT02413229|323386781|FG005|Overall Study|Adverse Event|0|||
94437688|NCT02413229|323386782|FG006|Overall Study|Adverse Event|0|||
94437689|NCT02413229|323386783|FG007|Overall Study|Adverse Event|1|||
94437690|NCT02413229|323386776|FG000|Overall Study|Lost to Follow-up|0|||
94437691|NCT02413229|323386777|FG001|Overall Study|Lost to Follow-up|0|||
94437692|NCT02413229|323386778|FG002|Overall Study|Lost to Follow-up|1|||
94437693|NCT02413229|323386779|FG003|Overall Study|Lost to Follow-up|0|||
94437694|NCT02413229|323386780|FG004|Overall Study|Lost to Follow-up|2|||
94437695|NCT02413229|323386781|FG005|Overall Study|Lost to Follow-up|0|||
94437696|NCT02413229|323386782|FG006|Overall Study|Lost to Follow-up|0|||
94437697|NCT02413229|323386783|FG007|Overall Study|Lost to Follow-up|0|||
94437698|NCT02413229|323386776|FG000|Overall Study|Withdrawal by Subject|1|||
94437699|NCT02413229|323386777|FG001|Overall Study|Withdrawal by Subject|1|||
94437700|NCT02413229|323386778|FG002|Overall Study|Withdrawal by Subject|0|||
94437701|NCT02413229|323386779|FG003|Overall Study|Withdrawal by Subject|0|||
94437702|NCT02413229|323386780|FG004|Overall Study|Withdrawal by Subject|1|||
94437703|NCT02413229|323386781|FG005|Overall Study|Withdrawal by Subject|0|||
94437704|NCT02413229|323386782|FG006|Overall Study|Withdrawal by Subject|0|||
94437705|NCT02413229|323386783|FG007|Overall Study|Withdrawal by Subject|2|||
94437706|NCT02413229|323386776|FG000|Overall Study|Progressive Disease|0|||
94437707|NCT02413229|323386777|FG001|Overall Study|Progressive Disease|0|||
94437708|NCT02413229|323386778|FG002|Overall Study|Progressive Disease|0|||
94437709|NCT02413229|323386779|FG003|Overall Study|Progressive Disease|0|||
94437710|NCT02413229|323386780|FG004|Overall Study|Progressive Disease|0|||
94437711|NCT02413229|323386781|FG005|Overall Study|Progressive Disease|0|||
94437712|NCT02413229|323386782|FG006|Overall Study|Progressive Disease|0|||
94437713|NCT02413229|323386783|FG007|Overall Study|Progressive Disease|1|||
94437714|NCT01995513|323386784|FG000|Period 1: First Open Label Treatment|Other|34|||
94437715|NCT01995513|323386785|FG001|Period 1: First Open Label Treatment|Other|0|||
94437716|NCT01995513|323386786|FG002|Period 1: First Open Label Treatment|Other|0|||
94437717|NCT01995513|323386787|FG003|Period 1: First Open Label Treatment|Other|0|||
94437718|NCT01995513|323386784|FG000|Period 1: First Open Label Treatment|Death|14|||
94437719|NCT01995513|323386785|FG001|Period 1: First Open Label Treatment|Death|0|||
94437720|NCT01995513|323386786|FG002|Period 1: First Open Label Treatment|Death|0|||
94437721|NCT01995513|323386787|FG003|Period 1: First Open Label Treatment|Death|0|||
94437722|NCT01995513|323386784|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
94437723|NCT01995513|323386785|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
94437724|NCT01995513|323386786|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
94437725|NCT01995513|323386787|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
94437726|NCT01995513|323386784|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
94437727|NCT01995513|323386785|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
94437728|NCT01995513|323386786|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
94437729|NCT01995513|323386787|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
94437730|NCT01995513|323386784|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
94437731|NCT01995513|323386785|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
94437732|NCT01995513|323386786|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
94437733|NCT01995513|323386787|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
94437734|NCT01995513|323386784|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
94437735|NCT01995513|323386785|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
94437736|NCT01995513|323386786|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
94437737|NCT01995513|323386787|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
94437738|NCT01995513|323386784|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
94437739|NCT01995513|323386785|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
94437740|NCT01995513|323386786|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
94437741|NCT01995513|323386787|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
94437742|NCT01995513|323386784|FG000|Period 1: Second Open Label Treatment|Other|0|||
94437743|NCT01995513|323386785|FG001|Period 1: Second Open Label Treatment|Other|2|||
94437744|NCT01995513|323386786|FG002|Period 1: Second Open Label Treatment|Other|0|||
94437745|NCT01995513|323386787|FG003|Period 1: Second Open Label Treatment|Other|0|||
94437746|NCT01995513|323386784|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
94437747|NCT01995513|323386785|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
94437748|NCT01995513|323386786|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
94437749|NCT01995513|323386787|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
94437750|NCT01995513|323386784|FG000|Period 2: Double Blind Treatment|Death|0|||
94437751|NCT01995513|323386785|FG001|Period 2: Double Blind Treatment|Death|0|||
94437752|NCT01995513|323386786|FG002|Period 2: Double Blind Treatment|Death|0|||
94437753|NCT01995513|323386787|FG003|Period 2: Double Blind Treatment|Death|1|||
94437754|NCT01995513|323386784|FG000|Period 2: Double Blind Treatment|Other|0|||
94437755|NCT01995513|323386785|FG001|Period 2: Double Blind Treatment|Other|0|||
94437756|NCT01995513|323386786|FG002|Period 2: Double Blind Treatment|Other|3|||
94437757|NCT01995513|323386787|FG003|Period 2: Double Blind Treatment|Other|3|||
94437758|NCT01995513|323386784|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
94437759|NCT01995513|323386785|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
94437760|NCT01995513|323386786|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
94437761|NCT01995513|323386787|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
94437762|NCT01995513|323386784|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
94437763|NCT01995513|323386785|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
94437764|NCT01995513|323386786|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
94437765|NCT01995513|323386787|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
94437766|NCT01995513|323386784|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
94437767|NCT01995513|323386785|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
94437768|NCT01995513|323386786|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
94437769|NCT01995513|323386787|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
94437770|NCT01995513|323386784|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
94437771|NCT01995513|323386785|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
94437772|NCT01995513|323386786|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
94437773|NCT01995513|323386787|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
94437774|NCT02652949|323386788|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
94437775|NCT02652949|323386788|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
94437776|NCT02652949|323386788|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
94437777|NCT02652949|323386788|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
94437778|NCT02652949|323386788|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
94437779|NCT02652949|323386788|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
94437780|NCT02652949|323386788|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
94437781|NCT02652949|323386788|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
94437782|NCT02652949|323386788|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
94437783|NCT02652949|323386788|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
94437784|NCT02652949|323386788|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
94437785|NCT02652949|323386788|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
94437786|NCT02652949|323386788|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
94437787|NCT02652949|323386788|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
94437788|NCT02652949|323386788|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
94437789|NCT02652949|323386788|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
94437790|NCT02652949|323386788|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
94437791|NCT01232452|323386792|FG000|Overall Study|Adverse Event|17|||
94437792|NCT01232452|323386793|FG001|Overall Study|Adverse Event|15|||
94437793|NCT01232452|323386792|FG000|Overall Study|Withdrawal by Subject|11|||
94437794|NCT01232452|323386793|FG001|Overall Study|Withdrawal by Subject|8|||
94437795|NCT01232452|323386792|FG000|Overall Study|Physician Decision|8|||
94437796|NCT01232452|323386793|FG001|Overall Study|Physician Decision|12|||
94437797|NCT01232452|323386792|FG000|Overall Study|Protocol entry criterion not met|0|||
94437798|NCT01232452|323386793|FG001|Overall Study|Protocol entry criterion not met|2|||
94437799|NCT01232452|323386792|FG000|Overall Study|Sponsor Decision|3|||
94437800|NCT01232452|323386793|FG001|Overall Study|Sponsor Decision|1|||
94437801|NCT01232452|323386792|FG000|Overall Study|Protocol Violation|0|||
94437802|NCT01232452|323386793|FG001|Overall Study|Protocol Violation|1|||
94437803|NCT00470535|323386795|FG000|Overall Study|Disease Progression|13|||
94437804|NCT00470535|323386795|FG000|Overall Study|Withdrawal by Subject|1|||
94437805|NCT00470535|323386795|FG000|Overall Study|Adverse Event|1|||
94437806|NCT00470535|323386795|FG000|Overall Study|Death|1|||
94437807|NCT00470535|323386795|FG000|Overall Study|Other|2|||
94437808|NCT03682107|323386800|FG000|Overall Study|Withdrawal by Subject|0|||
94437809|NCT03682107|323386801|FG001|Overall Study|Withdrawal by Subject|1|||
94437810|NCT03682107|323386802|FG002|Overall Study|Withdrawal by Subject|0|||
94437811|NCT03682107|323386803|FG003|Overall Study|Withdrawal by Subject|0|||
94437812|NCT03682107|323386804|FG004|Overall Study|Withdrawal by Subject|0|||
94437813|NCT05024747|323386805|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
94437814|NCT05024747|323386806|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
94437815|NCT05024747|323386805|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
94437816|NCT05024747|323386806|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
94437817|NCT05024747|323386805|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
94437818|NCT05024747|323386806|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
94437819|NCT01026194|323386807|FG000|Period 1：Double Blind Period|Adverse Event|2|||
94437820|NCT01026194|323386808|FG001|Period 1：Double Blind Period|Adverse Event|1|||
94437821|NCT01026194|323386807|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
94437822|NCT01026194|323386808|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
94437823|NCT01026194|323386807|FG000|Period 1：Double Blind Period|Physician Decision|0|||
94437824|NCT01026194|323386808|FG001|Period 1：Double Blind Period|Physician Decision|4|||
94437825|NCT01026194|323386807|FG000|Period 2：Open-label Period|Adverse Event|4|||
94437826|NCT01026194|323386808|FG001|Period 2：Open-label Period|Adverse Event|5|||
94437827|NCT01026194|323386807|FG000|Period 2：Open-label Period|Physician Decision|3|||
94437828|NCT01026194|323386808|FG001|Period 2：Open-label Period|Physician Decision|1|||
94437829|NCT01026194|323386807|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
94437830|NCT01026194|323386808|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
94437831|NCT04342819|323386811|FG000|Overall Study|Declined|4|||
94437832|NCT04342819|323386811|FG000|Overall Study|Not meeeting selection criteria|1|||
94437833|NCT00911300|323386812|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
94437834|NCT00911300|323386813|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
94437835|NCT00911300|323386812|FG000|Overall Study|Death|1|||
94437836|NCT00911300|323386813|FG001|Overall Study|Death|0|||
94437837|NCT00911300|323386812|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
94437838|NCT00911300|323386813|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
94437839|NCT00911300|323386812|FG000|Overall Study|Adverse Event|14|||
94437840|NCT00911300|323386813|FG001|Overall Study|Adverse Event|6|||
94437841|NCT00911300|323386812|FG000|Overall Study|Protocol Violation|3|||
94437842|NCT00911300|323386813|FG001|Overall Study|Protocol Violation|2|||
94437843|NCT00911300|323386812|FG000|Overall Study|Consent Withdrawn|4|||
94437844|NCT00911300|323386813|FG001|Overall Study|Consent Withdrawn|12|||
94437845|NCT00911300|323386812|FG000|Overall Study|Coronary Angiography Performed|1|||
94437846|NCT00911300|323386813|FG001|Overall Study|Coronary Angiography Performed|0|||
94437847|NCT00911300|323386812|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
94437848|NCT00911300|323386813|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
94437849|NCT00911300|323386812|FG000|Overall Study|Received Commercial Treatment|1|||
94437850|NCT00911300|323386813|FG001|Overall Study|Received Commercial Treatment|0|||
94437851|NCT00911300|323386812|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
94437852|NCT00911300|323386813|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
94437853|NCT00911300|323386812|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
94437854|NCT00911300|323386813|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
94437855|NCT00911300|323386812|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
94437856|NCT00911300|323386813|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
94437857|NCT00911300|323386812|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
94437858|NCT00911300|323386813|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
94437859|NCT00911300|323386812|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
94437860|NCT00911300|323386813|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
94437861|NCT00911300|323386812|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
94437862|NCT00911300|323386813|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
94437863|NCT00911300|323386812|FG000|Overall Study|International Normalized Ratio Too High|0|||
94437864|NCT00911300|323386813|FG001|Overall Study|International Normalized Ratio Too High|1|||
94437865|NCT00911300|323386812|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
94437866|NCT00911300|323386813|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
94437867|NCT00911300|323386812|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
94437868|NCT00911300|323386813|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
94437869|NCT00911300|323386812|FG000|Overall Study|Physician Decision|0|||
94437870|NCT00911300|323386813|FG001|Overall Study|Physician Decision|1|||
94437871|NCT00911300|323386812|FG000|Overall Study|Treatment Stopped by Mistake|0|||
94437872|NCT00911300|323386813|FG001|Overall Study|Treatment Stopped by Mistake|1|||
94437873|NCT00911300|323386812|FG000|Overall Study|Randomized; No Study Medication Received|0|||
94437874|NCT00911300|323386813|FG001|Overall Study|Randomized; No Study Medication Received|2|||
94437875|NCT02009722|323386814|FG000|Overall Study|Protocol Violation|1|||
94437876|NCT02009722|323386815|FG001|Overall Study|Protocol Violation|2|||
94437877|NCT02009722|323386814|FG000|Overall Study|Did not receive intervention|0|||
94437878|NCT02009722|323386815|FG001|Overall Study|Did not receive intervention|1|||
94437879|NCT00299130|323386819|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
94437880|NCT00299130|323386820|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
94437881|NCT00299130|323386821|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
94437882|NCT00299130|323386819|FG000|Treatment Period (up to 5 Years)|Death|1|||
94437883|NCT00299130|323386820|FG001|Treatment Period (up to 5 Years)|Death|3|||
94437884|NCT00299130|323386821|FG002|Treatment Period (up to 5 Years)|Death|1|||
94437885|NCT00299130|323386819|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
94437886|NCT00299130|323386820|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
94437887|NCT00299130|323386821|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
94437888|NCT00299130|323386819|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
94437889|NCT00299130|323386820|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
94490218|NCT00284856|323590270|FG000|Overall Study|Adverse Event|3|||
94437890|NCT00299130|323386821|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
94437891|NCT00299130|323386819|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
94437892|NCT00299130|323386820|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
94437893|NCT00299130|323386821|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
94437894|NCT00299130|323386819|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
94437895|NCT00299130|323386820|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
94437896|NCT00299130|323386821|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
94437897|NCT00299130|323386819|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
94437898|NCT00299130|323386820|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
94437899|NCT00299130|323386821|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
94437900|NCT00299130|323386819|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
94437901|NCT00299130|323386820|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
94437902|NCT00299130|323386821|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
94437903|NCT00299130|323386819|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
94437904|NCT00299130|323386820|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
94437905|NCT00299130|323386821|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
94437906|NCT00299130|323386819|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
94437907|NCT00299130|323386820|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
94437908|NCT00299130|323386821|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
94437909|NCT00299130|323386819|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
94437910|NCT00299130|323386820|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
94437911|NCT00299130|323386821|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
94437912|NCT00299130|323386819|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
94437913|NCT00299130|323386820|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
94437914|NCT00299130|323386821|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
94437915|NCT00299130|323386819|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
94437916|NCT00299130|323386820|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
94437917|NCT00299130|323386821|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
94437918|NCT00299130|323386819|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
94437919|NCT00299130|323386820|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
94437920|NCT00299130|323386821|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
94437921|NCT00299130|323386819|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
94437922|NCT00299130|323386820|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
94437923|NCT00299130|323386821|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
94437924|NCT00299130|323386819|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
94437925|NCT00299130|323386820|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
94437926|NCT00299130|323386821|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
94437927|NCT00299130|323386819|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
94437928|NCT00299130|323386820|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
94437929|NCT00299130|323386821|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
94437930|NCT00996489|323386822|FG000|Overall Study|Device failure|45|||
94437931|NCT00996489|323386822|FG000|Overall Study|Discontinued|116|||
94437932|NCT01862484|323386827|FG000|Overall Study|Lack of Efficacy|1|||
94437933|NCT01862484|323386828|FG001|Overall Study|Lack of Efficacy|1|||
94437934|NCT01862484|323386827|FG000|Overall Study|Lost to Follow-up|1|||
94437935|NCT01862484|323386828|FG001|Overall Study|Lost to Follow-up|2|||
94437936|NCT01862484|323386827|FG000|Overall Study|Protocol Violation|0|||
94437937|NCT01862484|323386828|FG001|Overall Study|Protocol Violation|2|||
94437938|NCT01862484|323386827|FG000|Overall Study|Withdrawal by Subject|0|||
94437939|NCT01862484|323386828|FG001|Overall Study|Withdrawal by Subject|3|||
94437940|NCT01876446|323386835|FG000|Overall Study|Death|0|||
94437941|NCT01876446|323386836|FG001|Overall Study|Death|1|||
94437942|NCT01876446|323386835|FG000|Overall Study|Withdrawal by Subject|1|||
94437943|NCT01876446|323386836|FG001|Overall Study|Withdrawal by Subject|2|||
94437944|NCT01876446|323386835|FG000|Overall Study|Physician Decision|1|||
94437945|NCT01876446|323386836|FG001|Overall Study|Physician Decision|3|||
94437946|NCT03180645|323386839|FG000|Overall Study|Adverse Event|0|||
94437947|NCT03180645|323386840|FG001|Overall Study|Adverse Event|1|||
94437948|NCT03180645|323386841|FG002|Overall Study|Adverse Event|2|||
94437949|NCT00995774|323386844|FG000|Training Period 2|Withdrawal by Subject|2|||
94437950|NCT00995774|323386845|FG001|Training Period 2|Withdrawal by Subject|0|||
94437951|NCT01808573|323386846|FG000|Overall Study|Death|212|||
94437952|NCT01808573|323386847|FG001|Overall Study|Death|240|||
94437953|NCT01808573|323386846|FG000|Overall Study|Withdrawal by Subject|12|||
94437954|NCT01808573|323386847|FG001|Overall Study|Withdrawal by Subject|10|||
94437955|NCT01808573|323386846|FG000|Overall Study|Lost to Follow-up|3|||
94437956|NCT01808573|323386847|FG001|Overall Study|Lost to Follow-up|0|||
94437957|NCT01808573|323386846|FG000|Overall Study|Discontinuation of study by sponsor|79|||
94437958|NCT01808573|323386847|FG001|Overall Study|Discontinuation of study by sponsor|64|||
94437959|NCT01808573|323386846|FG000|Overall Study|Randomized in Error|1|||
94437960|NCT01808573|323386847|FG001|Overall Study|Randomized in Error|0|||
94437961|NCT04208750|323386850|FG000|Overall Study|Lost to Follow-up|16|||
94437962|NCT04208750|323386851|FG001|Overall Study|Lost to Follow-up|15|||
94437963|NCT03573830|323389334|FG000|Overall Study|Dropped without completing treatment|0|||
94437964|NCT03573830|323389335|FG001|Overall Study|Dropped without completing treatment|7|||
94437965|NCT03573830|323389334|FG000|Overall Study|Lost to Follow-up|4|||
94437966|NCT03573830|323389335|FG001|Overall Study|Lost to Follow-up|0|||
94437967|NCT02370238|323389342|FG000|Overall Study|Death|42|||
94437968|NCT02370238|323389343|FG001|Overall Study|Death|35|||
94437969|NCT02370238|323389342|FG000|Overall Study|Lost to Follow-up|1|||
94437970|NCT02370238|323389343|FG001|Overall Study|Lost to Follow-up|3|||
94437971|NCT02370238|323389342|FG000|Overall Study|Withdrawal by Subject|2|||
94437972|NCT02370238|323389343|FG001|Overall Study|Withdrawal by Subject|6|||
94437973|NCT02370238|323389342|FG000|Overall Study|Other|2|||
94437974|NCT02370238|323389343|FG001|Overall Study|Other|1|||
94437975|NCT02789137|323389345|FG000|Overall Study|Dropped out/Died|58|||
94437976|NCT00577863|323389346|FG000|Overall Study|Adverse Event|4|||
94437977|NCT00577863|323389347|FG001|Overall Study|Adverse Event|2|||
94437978|NCT00577863|323389346|FG000|Overall Study|Death|1|||
94437979|NCT00577863|323389347|FG001|Overall Study|Death|0|||
94437980|NCT00577863|323389346|FG000|Overall Study|Lost to Follow-up|2|||
94437981|NCT00577863|323389347|FG001|Overall Study|Lost to Follow-up|2|||
94437982|NCT00577863|323389346|FG000|Overall Study|Entry Criteria Exclusion|1|||
94437983|NCT00577863|323389347|FG001|Overall Study|Entry Criteria Exclusion|0|||
94437984|NCT00577863|323389346|FG000|Overall Study|Withdrawal by Subject|0|||
94437985|NCT00577863|323389347|FG001|Overall Study|Withdrawal by Subject|2|||
94437986|NCT00577863|323389346|FG000|Overall Study|Sponsor Decision|2|||
94437987|NCT00577863|323389347|FG001|Overall Study|Sponsor Decision|7|||
94437988|NCT00577863|323389346|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
94437989|NCT00577863|323389347|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
94437990|NCT02738138|323389354|FG000|Overall Study|Adverse Event|0|||
94437991|NCT02738138|323389355|FG001|Overall Study|Adverse Event|1|||
94437992|NCT02738138|323389354|FG000|Overall Study|Lost to Follow-up|2|||
94437993|NCT02738138|323389355|FG001|Overall Study|Lost to Follow-up|0|||
94437994|NCT02738138|323389354|FG000|Overall Study|Other - not further specified|1|||
94437995|NCT02738138|323389355|FG001|Overall Study|Other - not further specified|0|||
94437996|NCT03639779|323389356|FG000|Overall Study|Lost to Follow-up|1|||
94437997|NCT04108299|323389357|FG000|Overall Study|Not interested in participating|2|||
94437998|NCT04108299|323389358|FG001|Overall Study|Not interested in participating|1|||
94437999|NCT04108299|323389359|FG002|Overall Study|Not interested in participating|2|||
94438000|NCT04108299|323389360|FG003|Overall Study|Not interested in participating|1|||
94438001|NCT02287922|323389361|FG000|Overall Study|Adverse Event|1|||
94438002|NCT02287922|323389362|FG001|Overall Study|Adverse Event|1|||
94438003|NCT02287922|323389363|FG002|Overall Study|Adverse Event|3|||
94438004|NCT02287922|323389364|FG003|Overall Study|Adverse Event|4|||
94438005|NCT02287922|323389361|FG000|Overall Study|Withdrawal by Subject|1|||
94438006|NCT02287922|323389362|FG001|Overall Study|Withdrawal by Subject|1|||
94438007|NCT02287922|323389363|FG002|Overall Study|Withdrawal by Subject|1|||
94438008|NCT02287922|323389364|FG003|Overall Study|Withdrawal by Subject|2|||
94438009|NCT02287922|323389361|FG000|Overall Study|Lost to Follow-up|0|||
94438010|NCT02287922|323389362|FG001|Overall Study|Lost to Follow-up|0|||
94438011|NCT02287922|323389363|FG002|Overall Study|Lost to Follow-up|1|||
94438012|NCT02287922|323389364|FG003|Overall Study|Lost to Follow-up|0|||
94438013|NCT02287922|323389361|FG000|Overall Study|Sponsor's decision|0|||
94438014|NCT02287922|323389362|FG001|Overall Study|Sponsor's decision|0|||
94438015|NCT02287922|323389363|FG002|Overall Study|Sponsor's decision|0|||
94438016|NCT02287922|323389364|FG003|Overall Study|Sponsor's decision|1|||
94438017|NCT02287922|323389361|FG000|Overall Study|Other|1|||
94438018|NCT02287922|323389362|FG001|Overall Study|Other|0|||
94438019|NCT02287922|323389363|FG002|Overall Study|Other|2|||
94438020|NCT02287922|323389364|FG003|Overall Study|Other|0|||
94438021|NCT00545714|323389365|FG000|Induction Phase (6 Months)|Physician Decision|3|||
94438022|NCT00545714|323389365|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
94438023|NCT00545714|323389365|FG000|Induction Phase (6 Months)|Disease Progression|1|||
94438024|NCT00545714|323389365|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
94438025|NCT00545714|323389365|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
94438026|NCT00545714|323389365|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
94438027|NCT00545714|323389365|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
94438028|NCT00545714|323389365|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
94438029|NCT00545714|323389365|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
94438030|NCT00545714|323389365|FG000|Maintenance Phase (36 Months)|Death|2|||
94438031|NCT02790437|323389368|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
94438032|NCT02790437|323389369|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
94438033|NCT02790437|323389368|FG000|Overall Study|Adverse Event|1|||
94438034|NCT02790437|323389369|FG001|Overall Study|Adverse Event|0|||
94438035|NCT02790437|323389368|FG000|Overall Study|Withdrawal by Subject|1|||
94438036|NCT02790437|323389369|FG001|Overall Study|Withdrawal by Subject|0|||
94438037|NCT03151304|323389381|FG000|Overall Study|Termination of study by Sponsor|23|||
94438038|NCT03151304|323389381|FG000|Overall Study|missing|3|||
94438039|NCT03151304|323389381|FG000|Overall Study|Withdrawal by Subject|8|||
94438040|NCT03151304|323389381|FG000|Overall Study|multiple reasons|30|||
94438041|NCT01137071|323389382|FG000|Overall Study|Disease Progression|11|||
94438042|NCT01137071|323389382|FG000|Overall Study|Withdrawal by Subject|2|||
94438043|NCT01137071|323389382|FG000|Overall Study|Wrongly Included|1|||
94438044|NCT01783886|323389383|FG000|Overall Study|Lost to Follow-up|0|||
94438045|NCT01783886|323389384|FG001|Overall Study|Lost to Follow-up|3|||
94438046|NCT01783886|323389385|FG002|Overall Study|Lost to Follow-up|0|||
94438047|NCT01783886|323389383|FG000|Overall Study|Protocol deviation|0|||
94438048|NCT01783886|323389384|FG001|Overall Study|Protocol deviation|0|||
94438049|NCT01783886|323389385|FG002|Overall Study|Protocol deviation|2|||
94438050|NCT01783886|323389383|FG000|Overall Study|Withdrawal of consent by participant|1|||
94438051|NCT01783886|323389384|FG001|Overall Study|Withdrawal of consent by participant|3|||
94438052|NCT01783886|323389385|FG002|Overall Study|Withdrawal of consent by participant|4|||
94438053|NCT01783886|323389383|FG000|Overall Study|Adverse Event|4|||
94438054|NCT01783886|323389384|FG001|Overall Study|Adverse Event|5|||
94438055|NCT01783886|323389385|FG002|Overall Study|Adverse Event|4|||
94438056|NCT04542057|323389386|FG000|Overall Study|Death|3|||
94438057|NCT04542057|323389387|FG001|Overall Study|Death|1|||
94438058|NCT04542057|323389386|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
94438059|NCT04542057|323389387|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
94438060|NCT04542057|323389386|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
94438061|NCT04542057|323389387|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
94438062|NCT04542057|323389386|FG000|Overall Study|Adverse Event|15|||
94438063|NCT04542057|323389387|FG001|Overall Study|Adverse Event|6|||
94438064|NCT04542057|323389386|FG000|Overall Study|COVID-19 adverse event|6|||
94438065|NCT04542057|323389387|FG001|Overall Study|COVID-19 adverse event|4|||
94438066|NCT04542057|323389386|FG000|Overall Study|Lack of Efficacy|2|||
94438067|NCT04542057|323389387|FG001|Overall Study|Lack of Efficacy|5|||
94438068|NCT04542057|323389386|FG000|Overall Study|Study terminated by sponsor|1|||
94438069|NCT04542057|323389387|FG001|Overall Study|Study terminated by sponsor|0|||
94438070|NCT04542057|323389386|FG000|Overall Study|Investigator discretion|2|||
94438071|NCT04542057|323389387|FG001|Overall Study|Investigator discretion|1|||
94438072|NCT04542057|323389386|FG000|Overall Study|Withdrawal by Subject|52|||
94438073|NCT04542057|323389387|FG001|Overall Study|Withdrawal by Subject|30|||
94438074|NCT04542057|323389386|FG000|Overall Study|Lost to Follow-up|8|||
94438075|NCT04542057|323389387|FG001|Overall Study|Lost to Follow-up|11|||
94438076|NCT04542057|323389386|FG000|Overall Study|Other|2|||
94438077|NCT04542057|323389387|FG001|Overall Study|Other|2|||
94438078|NCT05299528|323389390|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
94438079|NCT05299528|323389391|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
94438080|NCT05299528|323389392|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
94438081|NCT05299528|323389393|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
94438082|NCT05299528|323389394|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
94438083|NCT05299528|323389395|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
94438084|NCT05299528|323389396|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
94438085|NCT05299528|323389390|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
94438086|NCT05299528|323389391|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
94438087|NCT05299528|323389392|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
94438088|NCT05299528|323389393|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
94438089|NCT05299528|323389394|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
94438090|NCT05299528|323389395|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
94438091|NCT05299528|323389396|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
94438092|NCT05299528|323389390|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
94438093|NCT05299528|323389391|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
94438094|NCT05299528|323389392|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
94438095|NCT05299528|323389393|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
94438096|NCT05299528|323389394|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
94438097|NCT05299528|323389395|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
94438098|NCT05299528|323389396|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
94438099|NCT02324582|323389397|FG000|Overall Study|Screen Failures|0|||
94438100|NCT02324582|323389398|FG001|Overall Study|Screen Failures|5|||
94438101|NCT00246324|323389399|FG000|Overall Study|Withdrawal by Subject|1|||
94438102|NCT02290405|323389401|FG000|Overall Study|Withdrawal by Subject|1|||
94438103|NCT02290405|323389402|FG001|Overall Study|Withdrawal by Subject|0|||
94438104|NCT03645863|323389403|FG000|Overall Study|Withdrawal by Subject|1|||
94438105|NCT03645863|323389404|FG001|Overall Study|Withdrawal by Subject|0|||
94438106|NCT03645863|323389405|FG002|Overall Study|Withdrawal by Subject|0|||
94438107|NCT00770328|323389417|FG000|Overall Study|Adverse Event|11|||
94438108|NCT00770328|323389418|FG001|Overall Study|Adverse Event|2|||
94438109|NCT00770328|323389417|FG000|Overall Study|Lost to Follow-up|2|||
94438110|NCT00770328|323389418|FG001|Overall Study|Lost to Follow-up|2|||
94438111|NCT00307086|323389419|FG000|Overall Study|ineligible|5|||
94438112|NCT03541317|323389420|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
94438113|NCT03541317|323389421|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
94438114|NCT03541317|323389422|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
94438115|NCT03541317|323389423|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
94438116|NCT03541317|323389424|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
94438117|NCT03541317|323389425|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
94438118|NCT02969044|323389430|FG000|Overall Study|Withdrawal by Subject|2|||
94438119|NCT02969044|323389431|FG001|Overall Study|Withdrawal by Subject|6|||
94438120|NCT02969044|323389430|FG000|Overall Study|Adverse Event|3|||
94438121|NCT02969044|323389431|FG001|Overall Study|Adverse Event|0|||
94438122|NCT01330303|323389432|FG000|Period 1|Adverse Event|1|||
94438123|NCT01330303|323389433|FG001|Period 1|Adverse Event|0|||
94438124|NCT01330303|323389432|FG000|Period 1|Protocol Violation|0|||
94438125|NCT01330303|323389433|FG001|Period 1|Protocol Violation|1|||
94438126|NCT01330303|323389432|FG000|Period 1|Withdrawal by Subject|0|||
94438127|NCT01330303|323389433|FG001|Period 1|Withdrawal by Subject|1|||
94438128|NCT02308124|323389435|FG000|Overall Study|Lost to Follow-up|6|||
94438129|NCT02308124|323389436|FG001|Overall Study|Lost to Follow-up|6|||
94438130|NCT02308124|323389437|FG002|Overall Study|Lost to Follow-up|6|||
94438131|NCT02308124|323389435|FG000|Overall Study|Adverse Event|0|||
94438132|NCT02308124|323389436|FG001|Overall Study|Adverse Event|2|||
94438133|NCT02308124|323389437|FG002|Overall Study|Adverse Event|2|||
94438134|NCT02123446|323389438|FG000|Washout Period (1 Day)|Physician Decision|1|||
94438135|NCT02123446|323389439|FG001|Washout Period (1 Day)|Physician Decision|0|||
94438136|NCT04388553|323389440|FG000|Overall Study|Protocol Violation|1|||
94438137|NCT04388553|323389441|FG001|Overall Study|Protocol Violation|0|||
94438138|NCT02289729|323389442|FG000|Overall Study|Lack of Efficacy|3|||
94438139|NCT02289729|323389442|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
94438140|NCT02289729|323389442|FG000|Overall Study|Withdrawal by Subject|1|||
94438141|NCT02289729|323389442|FG000|Overall Study|Death|1|||
94438142|NCT02096744|323389443|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
94438143|NCT02096744|323389444|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
94438144|NCT02096744|323389443|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
94438145|NCT02096744|323389444|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
94438146|NCT02096744|323389443|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
94438147|NCT02096744|323389444|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
94438148|NCT02553772|323389453|FG000|Overall Study|Adverse Event|2|||
94438149|NCT02553772|323389454|FG001|Overall Study|Adverse Event|3|||
94438150|NCT02553772|323389453|FG000|Overall Study|Lost to Follow-up|2|||
94438151|NCT02553772|323389454|FG001|Overall Study|Lost to Follow-up|1|||
94438152|NCT02553772|323389453|FG000|Overall Study|Withdrawal of Consent|1|||
94438153|NCT02553772|323389454|FG001|Overall Study|Withdrawal of Consent|1|||
94438154|NCT02553772|323389453|FG000|Overall Study|Lack of Efficacy|1|||
94438155|NCT02553772|323389454|FG001|Overall Study|Lack of Efficacy|0|||
94438156|NCT02553772|323389453|FG000|Overall Study|Other Miscellaneous Reasons|0|||
94438157|NCT02553772|323389454|FG001|Overall Study|Other Miscellaneous Reasons|1|||
94438158|NCT01329900|323389457|FG000|Overall Study|Elevated creatinine/renal function|1|||
94438159|NCT00489827|323389458|FG000|Overall Study|Intraoperative exclusion criteria|1|||
94438160|NCT00489827|323389459|FG001|Overall Study|Intraoperative exclusion criteria|1|||
94438161|NCT00489827|323389458|FG000|Overall Study|Intraoperative exclusion criteria|1|||
94438162|NCT00489827|323389459|FG001|Overall Study|Intraoperative exclusion criteria|1|||
94438163|NCT01184079|323389462|FG000|Overall Study|Lost to Follow-up|14|||
94438164|NCT01184079|323389463|FG001|Overall Study|Lost to Follow-up|2|||
94438165|NCT03172494|323389468|FG000|Overall Study|Adverse Event|5|||
94438166|NCT03172494|323389469|FG001|Overall Study|Adverse Event|1|||
94438167|NCT03172494|323389470|FG002|Overall Study|Adverse Event|15|||
94490219|NCT00284856|323590271|FG001|Overall Study|Adverse Event|3|||
94490220|NCT00284856|323590272|FG002|Overall Study|Adverse Event|3|||
94438168|NCT03172494|323389468|FG000|Overall Study|Protocol Violation|3|||
94438169|NCT03172494|323389469|FG001|Overall Study|Protocol Violation|2|||
94438170|NCT03172494|323389470|FG002|Overall Study|Protocol Violation|1|||
94438171|NCT03172494|323389468|FG000|Overall Study|Lack of Efficacy|0|||
94490221|NCT00284856|323590270|FG000|Overall Study|Lack of Efficacy|2|||
94438172|NCT03172494|323389469|FG001|Overall Study|Lack of Efficacy|0|||
94438173|NCT03172494|323389470|FG002|Overall Study|Lack of Efficacy|4|||
94438174|NCT03172494|323389468|FG000|Overall Study|Pregnancy|0|||
94438175|NCT03172494|323389469|FG001|Overall Study|Pregnancy|1|||
94490222|NCT00284856|323590271|FG001|Overall Study|Lack of Efficacy|1|||
94438176|NCT03172494|323389470|FG002|Overall Study|Pregnancy|0|||
94438177|NCT03172494|323389468|FG000|Overall Study|Withdrawal by Subject|10|||
94438178|NCT03172494|323389469|FG001|Overall Study|Withdrawal by Subject|8|||
94438179|NCT03172494|323389470|FG002|Overall Study|Withdrawal by Subject|8|||
94490223|NCT00284856|323590272|FG002|Overall Study|Lack of Efficacy|8|||
94438180|NCT03172494|323389468|FG000|Overall Study|Severe hypoglycaemic episode|0|||
94438181|NCT03172494|323389469|FG001|Overall Study|Severe hypoglycaemic episode|0|||
94438182|NCT03172494|323389470|FG002|Overall Study|Severe hypoglycaemic episode|1|||
94438183|NCT03172494|323389468|FG000|Overall Study|Non-compliance towards treatment|2|||
94438184|NCT03172494|323389469|FG001|Overall Study|Non-compliance towards treatment|0|||
94438185|NCT03172494|323389470|FG002|Overall Study|Non-compliance towards treatment|0|||
94438186|NCT03736031|323389480|FG000|Overall Study|Death|2|||
94438187|NCT03736031|323389481|FG001|Overall Study|Death|4|||
94438188|NCT03736031|323389480|FG000|Overall Study|Lost to Follow-up|21|||
94438189|NCT03736031|323389481|FG001|Overall Study|Lost to Follow-up|2|||
94438190|NCT03736031|323389480|FG000|Overall Study|Withdrawal by Subject|9|||
94438191|NCT03736031|323389481|FG001|Overall Study|Withdrawal by Subject|0|||
94438192|NCT00625872|323389482|FG000|Overall Study|Withdrawal by Subject|1|||
94438193|NCT00625872|323389483|FG001|Overall Study|Withdrawal by Subject|0|||
94438194|NCT00625872|323389482|FG000|Overall Study|Does not meet inclusion criteria|1|||
94438195|NCT00625872|323389483|FG001|Overall Study|Does not meet inclusion criteria|0|||
94438196|NCT00625872|323389482|FG000|Overall Study|Terminated by sponsor|2|||
94438197|NCT00625872|323389483|FG001|Overall Study|Terminated by sponsor|5|||
94438198|NCT00625872|323389482|FG000|Overall Study|Randomized but not treated|0|||
94438199|NCT00625872|323389483|FG001|Overall Study|Randomized but not treated|1|||
94438200|NCT02201277|323389487|FG000|Overall Study|Death|3|||
94438201|NCT02201277|323389488|FG001|Overall Study|Death|4|||
94438202|NCT02201277|323389487|FG000|Overall Study|Lost to Follow-up|2|||
94438203|NCT02201277|323389488|FG001|Overall Study|Lost to Follow-up|1|||
94438204|NCT02201277|323389487|FG000|Overall Study|Failed retrieval|1|||
94438205|NCT02201277|323389488|FG001|Overall Study|Failed retrieval|0|||
94438206|NCT02201277|323389487|FG000|Overall Study|Physician Decision|1|||
94438207|NCT02201277|323389488|FG001|Overall Study|Physician Decision|0|||
94438208|NCT03281876|323389489|FG000|Overall Study|Adverse Event|4|||
94438209|NCT03281876|323389490|FG001|Overall Study|Adverse Event|15|||
94438210|NCT03281876|323389489|FG000|Overall Study|Lost to Follow-up|1|||
94438211|NCT03281876|323389490|FG001|Overall Study|Lost to Follow-up|4|||
94438212|NCT03281876|323389489|FG000|Overall Study|Withdrawal by Subject|11|||
94438213|NCT03281876|323389490|FG001|Overall Study|Withdrawal by Subject|15|||
94438214|NCT03281876|323389489|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
94438215|NCT03281876|323389490|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
94438216|NCT03281876|323389489|FG000|Overall Study|OTHER|5|||
94438217|NCT03281876|323389490|FG001|Overall Study|OTHER|5|||
94438218|NCT00489255|323389491|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
94438219|NCT00489255|323389492|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
94438220|NCT00489255|323389491|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
94438221|NCT00489255|323389492|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
94438222|NCT00489255|323389491|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
94438223|NCT00489255|323389492|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
94438224|NCT00489255|323389491|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
94438225|NCT00489255|323389492|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
94438226|NCT00489255|323389491|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
94438227|NCT00489255|323389492|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
94438228|NCT00489255|323389491|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
94438229|NCT00489255|323389492|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
94438230|NCT00489255|323389491|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
94438231|NCT00489255|323389492|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
94438232|NCT00489255|323389491|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
94438233|NCT00489255|323389492|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
94438234|NCT00489255|323389491|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
94438235|NCT00489255|323389492|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
94438236|NCT00489255|323389491|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
94438237|NCT00489255|323389492|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
94438238|NCT03953612|323389493|FG000|Overall Study|Randomized but did not start|1|||
94438239|NCT03953612|323389494|FG001|Overall Study|Randomized but did not start|1|||
94438240|NCT03953612|323389495|FG002|Overall Study|Randomized but did not start|1|||
94438241|NCT03953612|323389493|FG000|Overall Study|Withdrawal by Subject|2|||
94438242|NCT03953612|323389494|FG001|Overall Study|Withdrawal by Subject|1|||
94438243|NCT03953612|323389495|FG002|Overall Study|Withdrawal by Subject|0|||
94438244|NCT03485352|323389496|FG000|Overall Study|Lost to Follow-up|9|||
94438245|NCT00456300|323389497|FG000|Overall Study|Adverse Event|1|||
94438246|NCT00456300|323389498|FG001|Overall Study|Adverse Event|0|||
94438247|NCT02452476|323389499|FG000|Overall Study|Death|4|||
94438248|NCT02452476|323389500|FG001|Overall Study|Death|7|||
94438249|NCT02452476|323389499|FG000|Overall Study|Lost to Follow-up|1|||
94438250|NCT02452476|323389500|FG001|Overall Study|Lost to Follow-up|1|||
94438251|NCT02452476|323389499|FG000|Overall Study|Physician Decision|1|||
94438252|NCT02452476|323389500|FG001|Overall Study|Physician Decision|1|||
94438253|NCT02452476|323389499|FG000|Overall Study|Not treated|5|||
94438254|NCT02452476|323389500|FG001|Overall Study|Not treated|1|||
94438255|NCT01478373|323389502|FG000|Treatment Phase|Protocol Violation|1|||
94438256|NCT01478373|323389502|FG000|Survival Phase|Adverse Event|8|||
94438257|NCT01478373|323389502|FG000|Survival Phase|Protocol Violation|1|||
94438258|NCT01478373|323389502|FG000|Survival Phase|crossover to another study|2|||
94438259|NCT01478373|323389502|FG000|Survival Phase|Progressive Disease|27|||
94438260|NCT01512160|323389503|FG000|Overall Study|Lost to Follow-up|1|||
94438261|NCT01512160|323389504|FG001|Overall Study|Lost to Follow-up|0|||
94438262|NCT01512160|323389505|FG002|Overall Study|Lost to Follow-up|0|||
94438263|NCT01512160|323389506|FG003|Overall Study|Lost to Follow-up|0|||
94438264|NCT01512160|323389503|FG000|Overall Study|Withdrawal by Subject|1|||
94438265|NCT01512160|323389504|FG001|Overall Study|Withdrawal by Subject|0|||
94438266|NCT01512160|323389505|FG002|Overall Study|Withdrawal by Subject|0|||
94438267|NCT01512160|323389506|FG003|Overall Study|Withdrawal by Subject|1|||
94438268|NCT01074944|323389508|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
94438269|NCT01074944|323389509|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
94438270|NCT01074944|323389510|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
94438271|NCT01074944|323389511|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
94438272|NCT01074944|323389512|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
94438273|NCT01074944|323389508|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
94438274|NCT01074944|323389509|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
94438275|NCT01074944|323389510|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
94438276|NCT01074944|323389511|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
94438277|NCT01074944|323389512|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
94438278|NCT01074944|323389508|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
94438279|NCT01074944|323389509|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
94438280|NCT01074944|323389510|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
94438281|NCT01074944|323389511|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
94438282|NCT01074944|323389512|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
94438283|NCT01074944|323389508|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
94438284|NCT01074944|323389509|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
94438285|NCT01074944|323389510|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
94438286|NCT01074944|323389511|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
94438287|NCT01074944|323389512|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
94438288|NCT01074944|323389508|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
94438289|NCT01074944|323389509|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
94438290|NCT01074944|323389510|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
94438291|NCT01074944|323389511|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
94438292|NCT01074944|323389512|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
94438293|NCT01074944|323389508|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
94438294|NCT01074944|323389509|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
94438295|NCT01074944|323389510|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
94438296|NCT01074944|323389511|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
94438297|NCT01074944|323389512|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
94438298|NCT01074944|323389508|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
94438299|NCT01074944|323389509|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
94438300|NCT01074944|323389510|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
94438301|NCT01074944|323389511|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
94438302|NCT01074944|323389512|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
94438303|NCT01074944|323389508|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
94438304|NCT01074944|323389509|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
94438305|NCT01074944|323389510|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
94438306|NCT01074944|323389511|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
94438307|NCT01074944|323389512|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
94438308|NCT01074944|323389508|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
94438309|NCT01074944|323389509|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
94438310|NCT01074944|323389510|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
94438311|NCT01074944|323389511|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
94438312|NCT01074944|323389512|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
94438313|NCT01074944|323389508|FG000|Long Term Treatment|Adverse Event|0|||
94438314|NCT01074944|323389509|FG001|Long Term Treatment|Adverse Event|0|||
94438315|NCT01074944|323389510|FG002|Long Term Treatment|Adverse Event|0|||
94438316|NCT01074944|323389511|FG003|Long Term Treatment|Adverse Event|3|||
94438317|NCT01074944|323389512|FG004|Long Term Treatment|Adverse Event|0|||
94438318|NCT01074944|323389508|FG000|Long Term Treatment|Lost to Follow-up|0|||
94438319|NCT01074944|323389509|FG001|Long Term Treatment|Lost to Follow-up|0|||
94438320|NCT01074944|323389510|FG002|Long Term Treatment|Lost to Follow-up|0|||
94438321|NCT01074944|323389511|FG003|Long Term Treatment|Lost to Follow-up|2|||
94438322|NCT01074944|323389512|FG004|Long Term Treatment|Lost to Follow-up|0|||
94490224|NCT00284856|323590270|FG000|Overall Study|Lost to Follow-up|25|||
94438323|NCT01074944|323389508|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
94438324|NCT01074944|323389509|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
94438325|NCT01074944|323389510|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
94438326|NCT01074944|323389511|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
94438327|NCT01074944|323389512|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
94438328|NCT01074944|323389508|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
94438329|NCT01074944|323389509|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
94438330|NCT01074944|323389510|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
94438331|NCT01074944|323389511|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
94438332|NCT01074944|323389512|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
94438333|NCT01074944|323389508|FG000|Long Term Treatment|Withdrawal by Subject|0|||
94438334|NCT01074944|323389509|FG001|Long Term Treatment|Withdrawal by Subject|0|||
94438335|NCT01074944|323389510|FG002|Long Term Treatment|Withdrawal by Subject|0|||
94438336|NCT01074944|323389511|FG003|Long Term Treatment|Withdrawal by Subject|2|||
94438337|NCT01074944|323389512|FG004|Long Term Treatment|Withdrawal by Subject|0|||
94438338|NCT01074944|323389508|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
94438339|NCT01074944|323389509|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
94438340|NCT01074944|323389510|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
94438341|NCT01074944|323389511|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
94438342|NCT01074944|323389512|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
94438343|NCT01074944|323389508|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
94438344|NCT01074944|323389509|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
94438345|NCT01074944|323389510|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
94438346|NCT01074944|323389511|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
94438347|NCT01074944|323389512|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
94438348|NCT02552121|323389517|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
94438349|NCT02552121|323389518|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
94438350|NCT02552121|323389519|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
94438351|NCT02552121|323389520|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
94438352|NCT02552121|323389521|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
94438353|NCT02552121|323389522|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
94438354|NCT02552121|323389523|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
94438355|NCT02552121|323389524|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
94438356|NCT02552121|323389517|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
94438357|NCT02552121|323389518|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
94438358|NCT02552121|323389519|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
94438359|NCT02552121|323389520|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
94438360|NCT02552121|323389521|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
94438361|NCT02552121|323389522|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
94438362|NCT02552121|323389523|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
94438363|NCT02552121|323389524|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
94438364|NCT02552121|323389517|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
94438365|NCT02552121|323389518|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
94438366|NCT02552121|323389519|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
94438367|NCT02552121|323389520|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
94438368|NCT02552121|323389521|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
94438369|NCT02552121|323389522|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
94438370|NCT02552121|323389523|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
94438371|NCT02552121|323389524|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
94438372|NCT02552121|323389517|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
94438373|NCT02552121|323389518|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
94438374|NCT02552121|323389519|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
94438375|NCT02552121|323389520|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
94438376|NCT02552121|323389521|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
94438377|NCT02552121|323389522|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
94438378|NCT02552121|323389523|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
94438379|NCT02552121|323389524|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
94438380|NCT02552121|323389517|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
94438381|NCT02552121|323389518|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
94438382|NCT02552121|323389519|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
94438383|NCT02552121|323389520|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
94438384|NCT02552121|323389521|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
94490225|NCT00284856|323590271|FG001|Overall Study|Lost to Follow-up|21|||
94490226|NCT00284856|323590272|FG002|Overall Study|Lost to Follow-up|22|||
94490227|NCT00284856|323590270|FG000|Overall Study|Protocol Violation|5|||
94490228|NCT00284856|323590271|FG001|Overall Study|Protocol Violation|4|||
94490229|NCT00284856|323590272|FG002|Overall Study|Protocol Violation|5|||
94490230|NCT00284856|323590270|FG000|Overall Study|Withdrawal by Subject|12|||
94438385|NCT02552121|323389522|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
94438386|NCT02552121|323389523|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
94438387|NCT02552121|323389524|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
94438388|NCT02552121|323389517|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
94438389|NCT02552121|323389518|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
94438390|NCT02552121|323389519|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
94438391|NCT02552121|323389520|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
94438392|NCT02552121|323389521|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
94438393|NCT02552121|323389522|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
94438394|NCT02552121|323389523|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
94438395|NCT02552121|323389524|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
94438396|NCT02552121|323389517|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
94438397|NCT02552121|323389518|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
94438398|NCT02552121|323389519|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
94438399|NCT02552121|323389520|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
94438400|NCT02552121|323389521|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
94438401|NCT02552121|323389522|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
94438402|NCT02552121|323389523|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
94438403|NCT02552121|323389524|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
94438404|NCT02552121|323389517|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
94438405|NCT02552121|323389518|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
94438406|NCT02552121|323389519|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
94438407|NCT02552121|323389520|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
94438408|NCT02552121|323389521|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
94438409|NCT02552121|323389522|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
94438410|NCT02552121|323389523|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
94438411|NCT02552121|323389524|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
94438412|NCT02552121|323389517|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
94438413|NCT02552121|323389518|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
94438414|NCT02552121|323389519|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
94438415|NCT02552121|323389520|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
94438416|NCT02552121|323389521|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
94438417|NCT02552121|323389522|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
94438418|NCT02552121|323389523|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
94438419|NCT02552121|323389524|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
94438420|NCT02552121|323389517|FG000|Part 2: Cohort Expansion|Death|0|||
94438421|NCT02552121|323389518|FG001|Part 2: Cohort Expansion|Death|0|||
94438422|NCT02552121|323389519|FG002|Part 2: Cohort Expansion|Death|1|||
94438423|NCT02552121|323389520|FG003|Part 2: Cohort Expansion|Death|0|||
94438424|NCT02552121|323389521|FG004|Part 2: Cohort Expansion|Death|0|||
94438425|NCT02552121|323389522|FG005|Part 2: Cohort Expansion|Death|0|||
94438426|NCT02552121|323389523|FG006|Part 2: Cohort Expansion|Death|0|||
94438427|NCT02552121|323389524|FG007|Part 2: Cohort Expansion|Death|0|||
94438428|NCT03629184|323389525|FG000|Overall Study|Withdrawal by Subject|2|||
94438429|NCT03629184|323389526|FG001|Overall Study|Withdrawal by Subject|1|||
94438430|NCT03629184|323389525|FG000|Overall Study|Physician Decision|1|||
94438431|NCT03629184|323389526|FG001|Overall Study|Physician Decision|0|||
94438432|NCT02215967|323389527|FG000|Overall Study|Patient became ineligible for treatment|0|||
94438433|NCT02215967|323389528|FG001|Overall Study|Patient became ineligible for treatment|0|||
94438434|NCT02215967|323389529|FG002|Overall Study|Patient became ineligible for treatment|0|||
94438435|NCT02215967|323389530|FG003|Overall Study|Patient became ineligible for treatment|3|||
94438436|NCT02215967|323389527|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
94438437|NCT02215967|323389528|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
94438438|NCT02215967|323389529|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
94438439|NCT02215967|323389530|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
94438440|NCT00247676|323391791|FG000|Overall Study|Death|5|||
94438441|NCT00247676|323391791|FG000|Overall Study|Adverse Event|11|||
94438442|NCT00247676|323391791|FG000|Overall Study|Lack of Efficacy|15|||
94438443|NCT00247676|323391791|FG000|Overall Study|Other|3|||
94438444|NCT00247676|323391791|FG000|Overall Study|Withdrawal by Subject|2|||
94438445|NCT00662649|323391792|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
94438446|NCT00662649|323391793|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
94438447|NCT00662649|323391794|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
94438448|NCT00662649|323391795|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
94438449|NCT00662649|323391796|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
94438450|NCT00662649|323391792|FG000|Core Study (24 Months)|Adverse Event|22|||
94438451|NCT00662649|323391793|FG001|Core Study (24 Months)|Adverse Event|13|||
94438452|NCT00662649|323391794|FG002|Core Study (24 Months)|Adverse Event|18|||
94438453|NCT00662649|323391795|FG003|Core Study (24 Months)|Adverse Event|0|||
94438454|NCT00662649|323391796|FG004|Core Study (24 Months)|Adverse Event|0|||
94438455|NCT00662649|323391792|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
94438456|NCT00662649|323391793|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
94438457|NCT00662649|323391794|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
94438458|NCT00662649|323391795|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
94438459|NCT00662649|323391796|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
94438460|NCT00662649|323391792|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
94438461|NCT00662649|323391793|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
94438462|NCT00662649|323391794|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
94438463|NCT00662649|323391795|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
94438464|NCT00662649|323391796|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
94438465|NCT00662649|323391792|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
94438466|NCT00662649|323391793|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
94438467|NCT00662649|323391794|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
94438468|NCT00662649|323391795|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
94438469|NCT00662649|323391796|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
94438470|NCT00662649|323391792|FG000|Core Study (24 Months)|Protocol Violation|5|||
94438471|NCT00662649|323391793|FG001|Core Study (24 Months)|Protocol Violation|5|||
94438472|NCT00662649|323391794|FG002|Core Study (24 Months)|Protocol Violation|4|||
94438473|NCT00662649|323391795|FG003|Core Study (24 Months)|Protocol Violation|0|||
94438474|NCT00662649|323391796|FG004|Core Study (24 Months)|Protocol Violation|0|||
94438475|NCT00662649|323391792|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
94438476|NCT00662649|323391793|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
94438477|NCT00662649|323391794|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
94438478|NCT00662649|323391795|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
94438479|NCT00662649|323391796|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
94438480|NCT00662649|323391792|FG000|Core Study (24 Months)|Death|1|||
94438481|NCT00662649|323391793|FG001|Core Study (24 Months)|Death|0|||
94438482|NCT00662649|323391794|FG002|Core Study (24 Months)|Death|2|||
94438483|NCT00662649|323391795|FG003|Core Study (24 Months)|Death|0|||
94438484|NCT00662649|323391796|FG004|Core Study (24 Months)|Death|0|||
94438485|NCT00662649|323391792|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
94438486|NCT00662649|323391793|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
94438487|NCT00662649|323391794|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
94438488|NCT00662649|323391795|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
94438489|NCT00662649|323391796|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
94438490|NCT00662649|323391792|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
94438491|NCT00662649|323391793|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
94438492|NCT00662649|323391794|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
94438493|NCT00662649|323391795|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
94438494|NCT00662649|323391796|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
94438495|NCT00662649|323391792|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
94438496|NCT00662649|323391793|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
94438497|NCT00662649|323391794|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
94438498|NCT00662649|323391795|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
94438499|NCT00662649|323391796|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
94438500|NCT00662649|323391792|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
94438501|NCT00662649|323391793|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
94438502|NCT00662649|323391794|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
94438503|NCT00662649|323391795|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
94438504|NCT00662649|323391796|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
94438505|NCT00662649|323391792|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
94438506|NCT00662649|323391793|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
94438507|NCT00662649|323391794|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
94438508|NCT00662649|323391795|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
94438509|NCT00662649|323391796|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
94438510|NCT00662649|323391792|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
94438511|NCT00662649|323391793|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
94438512|NCT00662649|323391794|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
94438513|NCT00662649|323391795|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
94438514|NCT00662649|323391796|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
94438515|NCT00662649|323391792|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
94438516|NCT00662649|323391793|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
94438517|NCT00662649|323391794|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
94438518|NCT00662649|323391795|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
94438519|NCT00662649|323391796|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
94438520|NCT00662649|323391792|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
94438521|NCT00662649|323391793|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
94438522|NCT00662649|323391794|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
94438523|NCT00662649|323391795|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
94438524|NCT00662649|323391796|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
94438525|NCT00662649|323391792|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
94438526|NCT00662649|323391793|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
94438527|NCT00662649|323391794|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
94438528|NCT00662649|323391795|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
94438529|NCT00662649|323391796|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
94438530|NCT03594071|323391797|FG000|Overall Study|Re-operation|3|||
94438531|NCT03594071|323391797|FG000|Overall Study|Missed visit|2|||
94438532|NCT04428034|323391804|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
94438533|NCT01895777|323391809|FG000|Overall Study|Adverse Event|1|||
94438534|NCT01895777|323391810|FG001|Overall Study|Adverse Event|2|||
94438535|NCT01895777|323391809|FG000|Overall Study|Lost to Follow-up|2|||
94438536|NCT01895777|323391810|FG001|Overall Study|Lost to Follow-up|0|||
94438537|NCT01895777|323391809|FG000|Overall Study|Not treated|1|||
94438538|NCT01895777|323391810|FG001|Overall Study|Not treated|0|||
94438539|NCT01895777|323391809|FG000|Overall Study|Other reasons|3|||
94438540|NCT01895777|323391810|FG001|Overall Study|Other reasons|2|||
94438541|NCT01895777|323391809|FG000|Overall Study|Non-compliance with the CTP|2|||
94438542|NCT01895777|323391810|FG001|Overall Study|Non-compliance with the CTP|1|||
94438543|NCT00262028|323391817|FG000|Overall Study|Withdrawal by Subject|6|||
94438544|NCT00262028|323391818|FG001|Overall Study|Withdrawal by Subject|3|||
94438545|NCT00262028|323391819|FG002|Overall Study|Withdrawal by Subject|6|||
94438546|NCT00262028|323391820|FG003|Overall Study|Withdrawal by Subject|5|||
94438547|NCT00262028|323391821|FG004|Overall Study|Withdrawal by Subject|2|||
94438548|NCT00262028|323391822|FG005|Overall Study|Withdrawal by Subject|3|||
94438549|NCT00262028|323391823|FG006|Overall Study|Withdrawal by Subject|5|||
94438550|NCT00262028|323391824|FG007|Overall Study|Withdrawal by Subject|7|||
94438551|NCT00262028|323391825|FG008|Overall Study|Withdrawal by Subject|2|||
94438552|NCT00262028|323391817|FG000|Overall Study|Lost to Follow-up|7|||
94438553|NCT00262028|323391818|FG001|Overall Study|Lost to Follow-up|7|||
94438554|NCT00262028|323391819|FG002|Overall Study|Lost to Follow-up|5|||
94438555|NCT00262028|323391820|FG003|Overall Study|Lost to Follow-up|5|||
94438556|NCT00262028|323391821|FG004|Overall Study|Lost to Follow-up|4|||
94438557|NCT00262028|323391822|FG005|Overall Study|Lost to Follow-up|3|||
94438558|NCT00262028|323391823|FG006|Overall Study|Lost to Follow-up|3|||
94438559|NCT00262028|323391824|FG007|Overall Study|Lost to Follow-up|5|||
94438560|NCT00262028|323391825|FG008|Overall Study|Lost to Follow-up|6|||
94438561|NCT00262028|323391817|FG000|Overall Study|Administrative Reason|11|||
94438562|NCT00262028|323391818|FG001|Overall Study|Administrative Reason|14|||
94438563|NCT00262028|323391819|FG002|Overall Study|Administrative Reason|9|||
94438564|NCT00262028|323391820|FG003|Overall Study|Administrative Reason|12|||
94438565|NCT00262028|323391821|FG004|Overall Study|Administrative Reason|6|||
94438566|NCT00262028|323391822|FG005|Overall Study|Administrative Reason|7|||
94438567|NCT00262028|323391823|FG006|Overall Study|Administrative Reason|4|||
94438568|NCT00262028|323391824|FG007|Overall Study|Administrative Reason|6|||
94438569|NCT00262028|323391825|FG008|Overall Study|Administrative Reason|10|||
94438570|NCT00262028|323391817|FG000|Overall Study|Protocol Violation|0|||
94438571|NCT00262028|323391818|FG001|Overall Study|Protocol Violation|0|||
94438572|NCT00262028|323391819|FG002|Overall Study|Protocol Violation|0|||
94438573|NCT00262028|323391820|FG003|Overall Study|Protocol Violation|1|||
94438574|NCT00262028|323391821|FG004|Overall Study|Protocol Violation|0|||
94438575|NCT00262028|323391822|FG005|Overall Study|Protocol Violation|0|||
94438576|NCT00262028|323391823|FG006|Overall Study|Protocol Violation|0|||
94438577|NCT00262028|323391824|FG007|Overall Study|Protocol Violation|0|||
94438578|NCT00262028|323391825|FG008|Overall Study|Protocol Violation|0|||
94438579|NCT00262028|323391817|FG000|Overall Study|Unable to classify|0|||
94438580|NCT00262028|323391818|FG001|Overall Study|Unable to classify|3|||
94438581|NCT00262028|323391819|FG002|Overall Study|Unable to classify|0|||
94438582|NCT00262028|323391820|FG003|Overall Study|Unable to classify|0|||
94438583|NCT00262028|323391821|FG004|Overall Study|Unable to classify|0|||
94438584|NCT00262028|323391822|FG005|Overall Study|Unable to classify|0|||
94438585|NCT00262028|323391823|FG006|Overall Study|Unable to classify|0|||
94438586|NCT00262028|323391824|FG007|Overall Study|Unable to classify|0|||
94438587|NCT00262028|323391825|FG008|Overall Study|Unable to classify|1|||
94438588|NCT00111241|323391832|FG000|Overall Study|Lost to Follow-up|1|||
94438589|NCT00111241|323391833|FG001|Overall Study|Lost to Follow-up|0|||
94438590|NCT00111241|323391832|FG000|Overall Study|Withdrawal by Subject|4|||
94438591|NCT00111241|323391833|FG001|Overall Study|Withdrawal by Subject|0|||
94438592|NCT00111241|323391832|FG000|Overall Study|Protocol Violation|9|||
94438593|NCT00111241|323391833|FG001|Overall Study|Protocol Violation|8|||
94438594|NCT00111241|323391832|FG000|Overall Study|Adverse Event|1|||
94438595|NCT00111241|323391833|FG001|Overall Study|Adverse Event|0|||
94438596|NCT00610129|323391835|FG000|Overall Study|Not treated since patients ineligible|3|||
94438597|NCT02273388|323391836|FG000|Overall Study|Adverse Event|0|||
94438598|NCT02273388|323391837|FG001|Overall Study|Adverse Event|0|||
94438599|NCT02273388|323391838|FG002|Overall Study|Adverse Event|0|||
94438600|NCT02273388|323391839|FG003|Overall Study|Adverse Event|0|||
94438601|NCT02273388|323391840|FG004|Overall Study|Adverse Event|0|||
94438602|NCT02273388|323391841|FG005|Overall Study|Adverse Event|0|||
94438603|NCT02273388|323391842|FG006|Overall Study|Adverse Event|1|||
94438604|NCT02273388|323391843|FG007|Overall Study|Adverse Event|2|||
94438605|NCT02273388|323391844|FG008|Overall Study|Adverse Event|0|||
94438606|NCT02273388|323391845|FG009|Overall Study|Adverse Event|0|||
94438607|NCT02273388|323391846|FG010|Overall Study|Adverse Event|0|||
94438608|NCT02273388|323391847|FG011|Overall Study|Adverse Event|0|||
94438609|NCT02273388|323391836|FG000|Overall Study|Adverse Event study disease worse|4|||
94438610|NCT02273388|323391837|FG001|Overall Study|Adverse Event study disease worse|3|||
94438611|NCT02273388|323391838|FG002|Overall Study|Adverse Event study disease worse|3|||
94438612|NCT02273388|323391839|FG003|Overall Study|Adverse Event study disease worse|2|||
94438613|NCT02273388|323391840|FG004|Overall Study|Adverse Event study disease worse|4|||
94438614|NCT02273388|323391841|FG005|Overall Study|Adverse Event study disease worse|3|||
94438615|NCT02273388|323391842|FG006|Overall Study|Adverse Event study disease worse|14|||
94438616|NCT02273388|323391843|FG007|Overall Study|Adverse Event study disease worse|6|||
94438617|NCT02273388|323391844|FG008|Overall Study|Adverse Event study disease worse|6|||
94438618|NCT02273388|323391845|FG009|Overall Study|Adverse Event study disease worse|5|||
94438619|NCT02273388|323391846|FG010|Overall Study|Adverse Event study disease worse|10|||
94438620|NCT02273388|323391847|FG011|Overall Study|Adverse Event study disease worse|1|||
94438621|NCT02273388|323391836|FG000|Overall Study|Sponsor decision|0|||
94438622|NCT02273388|323391837|FG001|Overall Study|Sponsor decision|0|||
94438623|NCT02273388|323391838|FG002|Overall Study|Sponsor decision|0|||
94438624|NCT02273388|323391839|FG003|Overall Study|Sponsor decision|0|||
94438625|NCT02273388|323391840|FG004|Overall Study|Sponsor decision|0|||
94438626|NCT02273388|323391841|FG005|Overall Study|Sponsor decision|0|||
94438627|NCT02273388|323391842|FG006|Overall Study|Sponsor decision|0|||
94438628|NCT02273388|323391843|FG007|Overall Study|Sponsor decision|0|||
94438629|NCT02273388|323391844|FG008|Overall Study|Sponsor decision|0|||
94438630|NCT02273388|323391845|FG009|Overall Study|Sponsor decision|0|||
94438631|NCT02273388|323391846|FG010|Overall Study|Sponsor decision|0|||
94438632|NCT02273388|323391847|FG011|Overall Study|Sponsor decision|1|||
94438633|NCT01070953|323391848|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
94438634|NCT01070953|323391848|FG000|Participants for Safety Evaluation|Off-label use|283|||
94438635|NCT01070953|323391848|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
94438636|NCT01070953|323391848|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
94438637|NCT01070953|323391848|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
94438638|NCT01070953|323391848|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
94438639|NCT01070953|323391848|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
94438640|NCT01070953|323391848|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
94438641|NCT01070953|323391848|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
94438642|NCT01070953|323391848|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
94438643|NCT02445963|323391849|FG000|Overall Study|Lost to Follow-up|1|||
94438644|NCT02445963|323391850|FG001|Overall Study|Lost to Follow-up|0|||
94438645|NCT02445963|323391851|FG002|Overall Study|Lost to Follow-up|0|||
94438646|NCT02445963|323391852|FG003|Overall Study|Lost to Follow-up|0|||
94438647|NCT02445963|323391849|FG000|Overall Study|Change in employment|1|||
94438648|NCT02445963|323391850|FG001|Overall Study|Change in employment|0|||
94438649|NCT02445963|323391851|FG002|Overall Study|Change in employment|0|||
94438650|NCT02445963|323391852|FG003|Overall Study|Change in employment|0|||
94438651|NCT02445963|323391849|FG000|Overall Study|Symptoms post-vaccination|0|||
94438652|NCT02445963|323391850|FG001|Overall Study|Symptoms post-vaccination|0|||
94438653|NCT02445963|323391851|FG002|Overall Study|Symptoms post-vaccination|1|||
94438654|NCT02445963|323391852|FG003|Overall Study|Symptoms post-vaccination|0|||
94438655|NCT02764151|323391863|FG000|Overall Study|Subject refused further follow-up|0|||
94438656|NCT02764151|323391864|FG001|Overall Study|Subject refused further follow-up|0|||
94438657|NCT02764151|323391865|FG002|Overall Study|Subject refused further follow-up|0|||
94438658|NCT02764151|323391866|FG003|Overall Study|Subject refused further follow-up|1|||
94438659|NCT02764151|323391863|FG000|Overall Study|Other|0|||
94438660|NCT02764151|323391864|FG001|Overall Study|Other|0|||
94438661|NCT02764151|323391865|FG002|Overall Study|Other|0|||
94438662|NCT02764151|323391866|FG003|Overall Study|Other|2|||
94438663|NCT00822692|323391869|FG000|Overall Study|Lost to Follow-up|17|||
94438664|NCT00822692|323391870|FG001|Overall Study|Lost to Follow-up|25|||
94438665|NCT00852202|323391873|FG000|Overall Study|Adverse Event|2|||
94438666|NCT00852202|323391874|FG001|Overall Study|Adverse Event|3|||
94438667|NCT00852202|323391875|FG002|Overall Study|Adverse Event|7|||
94438668|NCT00852202|323391873|FG000|Overall Study|Lack of Efficacy|4|||
94438669|NCT00852202|323391874|FG001|Overall Study|Lack of Efficacy|1|||
94438670|NCT00852202|323391875|FG002|Overall Study|Lack of Efficacy|2|||
94438671|NCT00852202|323391873|FG000|Overall Study|Protocol Violation|2|||
94438672|NCT00852202|323391874|FG001|Overall Study|Protocol Violation|2|||
94438673|NCT00852202|323391875|FG002|Overall Study|Protocol Violation|7|||
94438674|NCT00852202|323391873|FG000|Overall Study|Withdrawal by Subject|3|||
94438675|NCT00852202|323391874|FG001|Overall Study|Withdrawal by Subject|1|||
94438676|NCT00852202|323391875|FG002|Overall Study|Withdrawal by Subject|2|||
94438677|NCT00852202|323391873|FG000|Overall Study|Lost to Follow-up|5|||
94438678|NCT00852202|323391874|FG001|Overall Study|Lost to Follow-up|5|||
94438679|NCT00852202|323391875|FG002|Overall Study|Lost to Follow-up|6|||
94438680|NCT00852202|323391873|FG000|Overall Study|pregnancy,moving away and surgery|1|||
94438681|NCT00852202|323391874|FG001|Overall Study|pregnancy,moving away and surgery|0|||
94438682|NCT00852202|323391875|FG002|Overall Study|pregnancy,moving away and surgery|2|||
94438683|NCT01998841|323391879|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
94438684|NCT01998841|323391880|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
94438685|NCT01998841|323391881|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
94438686|NCT01998841|323391882|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
94438687|NCT01998841|323391883|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
94438688|NCT01998841|323391879|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
94438689|NCT01998841|323391880|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
94438690|NCT01998841|323391881|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
94438691|NCT01998841|323391882|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
94438692|NCT01998841|323391883|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
94438693|NCT03200717|323391884|FG000|Overall Study|Progressive disease|24|||
94438694|NCT03200717|323391885|FG001|Overall Study|Progressive disease|5|||
94438695|NCT03200717|323391884|FG000|Overall Study|Adverse Event|11|||
94438696|NCT03200717|323391885|FG001|Overall Study|Adverse Event|8|||
94438697|NCT03200717|323391884|FG000|Overall Study|Physician Decision|3|||
94438698|NCT03200717|323391885|FG001|Overall Study|Physician Decision|2|||
94438699|NCT03200717|323391884|FG000|Overall Study|Death|2|||
94438700|NCT03200717|323391885|FG001|Overall Study|Death|0|||
94438701|NCT03200717|323391884|FG000|Overall Study|Subject/Guardian Decision|1|||
94438702|NCT03200717|323391885|FG001|Overall Study|Subject/Guardian Decision|0|||
94438703|NCT00141778|323391886|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
94438704|NCT00141778|323391887|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
94438705|NCT00141778|323391888|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
94438706|NCT00141778|323391886|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
94438707|NCT00141778|323391887|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
94438708|NCT00141778|323391888|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
94438709|NCT00141778|323391886|FG000|Started Study Medication|Withdrawal by Subject|0|||
94438710|NCT00141778|323391887|FG001|Started Study Medication|Withdrawal by Subject|2|||
94438711|NCT00141778|323391888|FG002|Started Study Medication|Withdrawal by Subject|0|||
94438712|NCT00141778|323391886|FG000|Started Study Medication|Difficulty Swallowing|0|||
94438713|NCT00141778|323391887|FG001|Started Study Medication|Difficulty Swallowing|1|||
94438714|NCT00141778|323391888|FG002|Started Study Medication|Difficulty Swallowing|0|||
94438715|NCT00141778|323391886|FG000|Started Study Medication|Chest Discomfort|0|||
94438716|NCT00141778|323391887|FG001|Started Study Medication|Chest Discomfort|0|||
94438717|NCT00141778|323391888|FG002|Started Study Medication|Chest Discomfort|1|||
94438718|NCT02046603|323391891|FG000|Overall Study|Other|11|||
94438719|NCT02046603|323391892|FG001|Overall Study|Other|66|||
94438720|NCT02046603|323391891|FG000|Overall Study|Protocol Violation|0|||
94438721|NCT02046603|323391892|FG001|Overall Study|Protocol Violation|1|||
94438722|NCT02046603|323391891|FG000|Overall Study|Participant/legal guardian decision|1|||
94438723|NCT02046603|323391892|FG001|Overall Study|Participant/legal guardian decision|3|||
94438724|NCT02046603|323391891|FG000|Overall Study|Physician Decision|2|||
94438725|NCT02046603|323391892|FG001|Overall Study|Physician Decision|1|||
94438726|NCT02046603|323391891|FG000|Overall Study|Lost to Follow-up|1|||
94438727|NCT02046603|323391892|FG001|Overall Study|Lost to Follow-up|2|||
94438728|NCT02046603|323391891|FG000|Overall Study|Death|0|||
94438729|NCT02046603|323391892|FG001|Overall Study|Death|1|||
94438730|NCT02046603|323391891|FG000|Overall Study|Adverse Event|0|||
94438731|NCT02046603|323391892|FG001|Overall Study|Adverse Event|1|||
94438732|NCT05478252|323391893|FG000|Overall Study|Withdrawal by Subject|2|||
94438733|NCT05478252|323391894|FG001|Overall Study|Withdrawal by Subject|3|||
94438734|NCT05478252|323391893|FG000|Overall Study|Lost to Follow-up|4|||
94438735|NCT05478252|323391894|FG001|Overall Study|Lost to Follow-up|2|||
94438736|NCT05478252|323391893|FG000|Overall Study|Physician Decision|1|||
94438737|NCT05478252|323391894|FG001|Overall Study|Physician Decision|1|||
94438738|NCT05478252|323391893|FG000|Overall Study|Death|1|||
94438739|NCT05478252|323391894|FG001|Overall Study|Death|0|||
94438740|NCT02854527|323391895|FG000|Overall Study|Adverse Event|0|||
94438741|NCT02854527|323391896|FG001|Overall Study|Adverse Event|0|||
94438742|NCT02854527|323391897|FG002|Overall Study|Adverse Event|0|||
94438743|NCT02854527|323391898|FG003|Overall Study|Adverse Event|0|||
94438744|NCT02854527|323391899|FG004|Overall Study|Adverse Event|1|||
94438745|NCT02854527|323391900|FG005|Overall Study|Adverse Event|0|||
94438746|NCT02854527|323391901|FG006|Overall Study|Adverse Event|0|||
94438747|NCT02854527|323391902|FG007|Overall Study|Adverse Event|0|||
94438748|NCT02854527|323391903|FG008|Overall Study|Adverse Event|0|||
94438749|NCT02854527|323391904|FG009|Overall Study|Adverse Event|0|||
94438750|NCT02854527|323391895|FG000|Overall Study|Lost to Follow-up|0|||
94438751|NCT02854527|323391896|FG001|Overall Study|Lost to Follow-up|0|||
94438752|NCT02854527|323391897|FG002|Overall Study|Lost to Follow-up|0|||
94438753|NCT02854527|323391898|FG003|Overall Study|Lost to Follow-up|1|||
94438754|NCT02854527|323391899|FG004|Overall Study|Lost to Follow-up|0|||
94438755|NCT02854527|323391900|FG005|Overall Study|Lost to Follow-up|0|||
94438756|NCT02854527|323391901|FG006|Overall Study|Lost to Follow-up|0|||
94438757|NCT02854527|323391902|FG007|Overall Study|Lost to Follow-up|0|||
94438758|NCT02854527|323391903|FG008|Overall Study|Lost to Follow-up|0|||
94438759|NCT02854527|323391904|FG009|Overall Study|Lost to Follow-up|0|||
94438760|NCT02461160|323391905|FG000|Overall Study|Lost to Follow-up|0|||
94438761|NCT02461160|323391906|FG001|Overall Study|Lost to Follow-up|0|||
94438762|NCT02461160|323391907|FG002|Overall Study|Lost to Follow-up|0|||
94438763|NCT02461160|323391908|FG003|Overall Study|Lost to Follow-up|0|||
94438764|NCT02461160|323391909|FG004|Overall Study|Lost to Follow-up|0|||
94438765|NCT02461160|323391910|FG005|Overall Study|Lost to Follow-up|0|||
94438766|NCT02461160|323391911|FG006|Overall Study|Lost to Follow-up|0|||
94438767|NCT02461160|323391912|FG007|Overall Study|Lost to Follow-up|1|||
94438768|NCT02461160|323391913|FG008|Overall Study|Lost to Follow-up|0|||
94438769|NCT02461160|323391914|FG009|Overall Study|Lost to Follow-up|0|||
94438770|NCT02461160|323391915|FG010|Overall Study|Lost to Follow-up|0|||
94438771|NCT02461160|323391916|FG011|Overall Study|Lost to Follow-up|0|||
94438772|NCT02461160|323391917|FG012|Overall Study|Lost to Follow-up|0|||
94438773|NCT00193050|323391918|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
94438774|NCT00193050|323391918|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
94438775|NCT00193050|323391918|FG000|Neoadjuvant Treatment|Physician Decision|2|||
94438776|NCT00193050|323391918|FG000|Neoadjuvant Treatment|Adverse Event|2|||
94490231|NCT00284856|323590271|FG001|Overall Study|Withdrawal by Subject|16|||
94490232|NCT00284856|323590272|FG002|Overall Study|Withdrawal by Subject|18|||
94490233|NCT00284856|323590270|FG000|Overall Study|Other|4|||
94490234|NCT00284856|323590271|FG001|Overall Study|Other|5|||
94490235|NCT00284856|323590272|FG002|Overall Study|Other|4|||
94490236|NCT01192815|323590275|FG000|Overall Study|Withdrawal by Subject|1|||
94490237|NCT01192815|323590275|FG000|Overall Study|Lack of Efficacy|1|||
94438777|NCT00193050|323391918|FG000|Adjuvant|Physician Decision|5|||
94438778|NCT00193050|323391918|FG000|Adjuvant|Intercurrent Hospitalization|3|||
94438779|NCT00193050|323391918|FG000|Adjuvant|Lack of Efficacy|2|||
94438780|NCT00061932|323391919|FG000|Overall Study|Withdrawal by Subject|13|||
94438781|NCT00061932|323391920|FG001|Overall Study|Withdrawal by Subject|4|||
94438782|NCT02899962|323391921|FG000|Open-label Phase|Adverse Event|2|||
94438783|NCT02899962|323391922|FG001|Open-label Phase|Adverse Event|0|||
94438784|NCT02899962|323391923|FG002|Open-label Phase|Adverse Event|0|||
94438785|NCT02899962|323391921|FG000|Open-label Phase|Lost to Follow-up|9|||
94438786|NCT02899962|323391922|FG001|Open-label Phase|Lost to Follow-up|0|||
94438787|NCT02899962|323391923|FG002|Open-label Phase|Lost to Follow-up|0|||
94438788|NCT02899962|323391921|FG000|Open-label Phase|Other reasons|9|||
94438789|NCT02899962|323391922|FG001|Open-label Phase|Other reasons|0|||
94438790|NCT02899962|323391923|FG002|Open-label Phase|Other reasons|0|||
94438791|NCT02899962|323391921|FG000|Open-label Phase|Withdrawal by Subject|7|||
94438792|NCT02899962|323391922|FG001|Open-label Phase|Withdrawal by Subject|0|||
94438793|NCT02899962|323391923|FG002|Open-label Phase|Withdrawal by Subject|0|||
94438794|NCT02899962|323391921|FG000|Maintenance Phase|Adverse Event|0|||
94438795|NCT02899962|323391922|FG001|Maintenance Phase|Adverse Event|2|||
94490238|NCT02592824|323590283|FG000|Overall Study|Protocol Violation|5|||
94490239|NCT02592824|323590284|FG001|Overall Study|Protocol Violation|3|||
94490240|NCT02592824|323590283|FG000|Overall Study|Lost to Follow-up|2|||
94490241|NCT02592824|323590284|FG001|Overall Study|Lost to Follow-up|1|||
94490242|NCT01142336|323590285|FG000|Overall Study|Adverse Event|1|||
94490243|NCT01142336|323590286|FG001|Overall Study|Adverse Event|1|||
94490244|NCT01142336|323590285|FG000|Overall Study|Lost to Follow-up|0|||
94438796|NCT02899962|323391923|FG002|Maintenance Phase|Adverse Event|1|||
94438797|NCT02899962|323391921|FG000|Maintenance Phase|Death|0|||
94438798|NCT02899962|323391922|FG001|Maintenance Phase|Death|0|||
94490245|NCT01142336|323590286|FG001|Overall Study|Lost to Follow-up|1|||
94438799|NCT02899962|323391923|FG002|Maintenance Phase|Death|1|||
94438800|NCT02899962|323391921|FG000|Maintenance Phase|Lack of Efficacy|0|||
94438801|NCT02899962|323391922|FG001|Maintenance Phase|Lack of Efficacy|20|||
94438802|NCT02899962|323391923|FG002|Maintenance Phase|Lack of Efficacy|16|||
94438803|NCT02899962|323391921|FG000|Maintenance Phase|Lost to Follow-up|0|||
94438804|NCT02899962|323391922|FG001|Maintenance Phase|Lost to Follow-up|12|||
94438805|NCT02899962|323391923|FG002|Maintenance Phase|Lost to Follow-up|14|||
94438806|NCT02899962|323391921|FG000|Maintenance Phase|Other reasons|0|||
94438807|NCT02899962|323391922|FG001|Maintenance Phase|Other reasons|9|||
94438808|NCT02899962|323391923|FG002|Maintenance Phase|Other reasons|13|||
94490246|NCT03805841|323590289|FG000|Overall Study|Clinical Progression|2|||
94490247|NCT03805841|323590290|FG001|Overall Study|Clinical Progression|0|||
94490248|NCT03805841|323590291|FG002|Overall Study|Clinical Progression|0|||
94490249|NCT03805841|323590289|FG000|Overall Study|Death|0|||
94490250|NCT03805841|323590290|FG001|Overall Study|Death|3|||
94438809|NCT02899962|323391921|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
94438810|NCT02899962|323391922|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
94438811|NCT02899962|323391923|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
94438812|NCT02899962|323391921|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
94438813|NCT02899962|323391922|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
94438814|NCT02899962|323391923|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
94438815|NCT02899962|323391921|FG000|Maintenance Phase|Withdrawal by Subject|0|||
94438816|NCT02899962|323391922|FG001|Maintenance Phase|Withdrawal by Subject|30|||
94438817|NCT02899962|323391923|FG002|Maintenance Phase|Withdrawal by Subject|36|||
94438818|NCT01245283|323391924|FG000|Overall Study|Lost to Follow-up|14|||
94438819|NCT01245283|323391925|FG001|Overall Study|Lost to Follow-up|11|||
94438820|NCT01245283|323391926|FG002|Overall Study|Lost to Follow-up|11|||
94438821|NCT03567980|323391935|FG000|Overall Study|Adverse Event|1|||
94438822|NCT01982955|323391936|FG000|Overall Study|Randomized but not treated|0|||
94438823|NCT01982955|323391937|FG001|Overall Study|Randomized but not treated|0|||
94438824|NCT01982955|323391938|FG002|Overall Study|Randomized but not treated|0|||
94438825|NCT01982955|323391939|FG003|Overall Study|Randomized but not treated|1|||
94438826|NCT01982955|323391940|FG004|Overall Study|Randomized but not treated|0|||
94438827|NCT03093259|323391942|FG000|Overall Study|Adverse Event|1|||
94438828|NCT03093259|323391943|FG001|Overall Study|Adverse Event|0|||
94438829|NCT03093259|323391942|FG000|Overall Study|Withdrawal by Subject|1|||
94438830|NCT03093259|323391943|FG001|Overall Study|Withdrawal by Subject|0|||
94438831|NCT02575833|323391944|FG000|Overall Study|Withdrawal by Subject|0|||
94438832|NCT02575833|323391945|FG001|Overall Study|Withdrawal by Subject|1|||
94438833|NCT02575833|323391944|FG000|Overall Study|Lost to Follow-up|1|||
94438834|NCT02575833|323391945|FG001|Overall Study|Lost to Follow-up|0|||
94438835|NCT02404805|323391948|FG000|Overall Study|Withdrawal by Subject|1|||
94438836|NCT02404805|323391949|FG001|Overall Study|Withdrawal by Subject|0|||
94438837|NCT02404805|323391950|FG002|Overall Study|Withdrawal by Subject|0|||
94438838|NCT02404805|323391951|FG003|Overall Study|Withdrawal by Subject|0|||
94438839|NCT02404805|323391952|FG004|Overall Study|Withdrawal by Subject|0|||
94438840|NCT02404805|323391953|FG005|Overall Study|Withdrawal by Subject|0|||
94438841|NCT01547390|323391958|FG000|Overall Study|Withdrawal by Subject|10|||
94438842|NCT01547390|323391959|FG001|Overall Study|Withdrawal by Subject|7|||
94438843|NCT01547390|323391958|FG000|Overall Study|termination of pregnancy|0|||
94438844|NCT01547390|323391959|FG001|Overall Study|termination of pregnancy|1|||
94438845|NCT01547390|323391958|FG000|Overall Study|Lost to Follow-up|0|||
94438846|NCT01547390|323391959|FG001|Overall Study|Lost to Follow-up|2|||
94438847|NCT01547390|323391958|FG000|Overall Study|Adverse Event|3|||
94490251|NCT03805841|323590291|FG002|Overall Study|Death|1|||
94490252|NCT03805841|323590289|FG000|Overall Study|Lost to Follow-up|0|||
94490253|NCT03805841|323590290|FG001|Overall Study|Lost to Follow-up|0|||
94490254|NCT03805841|323590291|FG002|Overall Study|Lost to Follow-up|1|||
94490255|NCT03805841|323590289|FG000|Overall Study|Withdrawal by Subject|2|||
94490256|NCT03805841|323590290|FG001|Overall Study|Withdrawal by Subject|3|||
94490257|NCT03805841|323590291|FG002|Overall Study|Withdrawal by Subject|0|||
94490258|NCT03805841|323590289|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
94490259|NCT03805841|323590290|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
94490260|NCT03805841|323590291|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
94490261|NCT00833755|323590297|FG000|Overall Study|Physician Decision|4|||
94490262|NCT00833755|323590298|FG001|Overall Study|Physician Decision|4|||
94490263|NCT00833755|323590299|FG002|Overall Study|Physician Decision|2|||
94490264|NCT00833755|323590300|FG003|Overall Study|Physician Decision|6|||
94490265|NCT00833755|323590297|FG000|Overall Study|Subject had scheduling issues|0|||
94490266|NCT00833755|323590298|FG001|Overall Study|Subject had scheduling issues|1|||
94490267|NCT00833755|323590299|FG002|Overall Study|Subject had scheduling issues|0|||
94490268|NCT00833755|323590300|FG003|Overall Study|Subject had scheduling issues|0|||
94490269|NCT02187783|323590303|FG000|Overall Study|Adverse Event|8|||
94490270|NCT02187783|323590303|FG000|Overall Study|Death|3|||
94490271|NCT02187783|323590303|FG000|Overall Study|Progressive disease|80|||
94490272|NCT02187783|323590303|FG000|Overall Study|Protocol Violation|3|||
94490273|NCT02187783|323590303|FG000|Overall Study|Physician Decision|2|||
94490274|NCT02187783|323590303|FG000|Overall Study|Withdrawal by Subject|9|||
94490275|NCT02187783|323590303|FG000|Overall Study|Study terminated by sponsor|1|||
94490276|NCT00471497|323590304|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
94490277|NCT00471497|323590305|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
94438848|NCT01547390|323391959|FG001|Overall Study|Adverse Event|0|||
94438849|NCT04211831|323391960|FG000|Overall Study|Withdrawal by Subject|4|||
94438850|NCT04211831|323391961|FG001|Overall Study|Withdrawal by Subject|1|||
94490278|NCT00471497|323590306|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
94490279|NCT00471497|323590304|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
94490280|NCT00471497|323590305|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
94438851|NCT04211831|323391962|FG002|Overall Study|Withdrawal by Subject|1|||
94438852|NCT04211831|323391960|FG000|Overall Study|Protocol Violation|0|||
94490281|NCT00471497|323590306|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
94490282|NCT00471497|323590304|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
94490283|NCT00471497|323590305|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
94490284|NCT00471497|323590306|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
94490285|NCT00471497|323590304|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
94490286|NCT00471497|323590305|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
94490287|NCT00471497|323590306|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
94490288|NCT00471497|323590304|FG000|Core Treatment Phase|Lost to Follow-up|6|||
94490289|NCT00471497|323590305|FG001|Core Treatment Phase|Lost to Follow-up|6|||
94490290|NCT00471497|323590306|FG002|Core Treatment Phase|Lost to Follow-up|3|||
94490291|NCT00471497|323590304|FG000|Core Treatment Phase|Death|3|||
94490292|NCT00471497|323590305|FG001|Core Treatment Phase|Death|9|||
94490293|NCT00471497|323590306|FG002|Core Treatment Phase|Death|3|||
94490294|NCT00471497|323590304|FG000|Core Treatment Phase|Disease Progression|10|||
94490295|NCT00471497|323590305|FG001|Core Treatment Phase|Disease Progression|2|||
94490296|NCT00471497|323590306|FG002|Core Treatment Phase|Disease Progression|4|||
94490297|NCT00471497|323590304|FG000|Core Treatment Phase|Protocol Violation|6|||
94490298|NCT00471497|323590305|FG001|Core Treatment Phase|Protocol Violation|15|||
94490299|NCT00471497|323590306|FG002|Core Treatment Phase|Protocol Violation|11|||
94490300|NCT00471497|323590304|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
94490301|NCT00471497|323590305|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
94490302|NCT00471497|323590306|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
94490303|NCT00471497|323590304|FG000|Core Treatment Phase|Administrative problems|14|||
94490304|NCT00471497|323590305|FG001|Core Treatment Phase|Administrative problems|14|||
94490305|NCT00471497|323590306|FG002|Core Treatment Phase|Administrative problems|12|||
94490306|NCT00471497|323590304|FG000|Core Treatment Phase|Adverse Event|43|||
94490307|NCT00471497|323590305|FG001|Core Treatment Phase|Adverse Event|53|||
94490308|NCT00471497|323590306|FG002|Core Treatment Phase|Adverse Event|89|||
94490309|NCT00471497|323590304|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
94490310|NCT00471497|323590305|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
94490311|NCT00471497|323590306|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
94490312|NCT00471497|323590304|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
94490313|NCT00471497|323590305|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
94490314|NCT00471497|323590306|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
94490315|NCT00471497|323590304|FG000|Extension Phase|Adverse Event|9|||
94490316|NCT00471497|323590305|FG001|Extension Phase|Adverse Event|5|||
94490317|NCT00471497|323590306|FG002|Extension Phase|Adverse Event|1|||
94490318|NCT00471497|323590304|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
94490319|NCT00471497|323590305|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
94490320|NCT00471497|323590306|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
94490321|NCT00471497|323590304|FG000|Extension Phase|Withdrawal by Subject|3|||
94490322|NCT00471497|323590305|FG001|Extension Phase|Withdrawal by Subject|1|||
94490323|NCT00471497|323590306|FG002|Extension Phase|Withdrawal by Subject|0|||
94490324|NCT00471497|323590304|FG000|Extension Phase|Lost to Follow-up|2|||
94490325|NCT00471497|323590305|FG001|Extension Phase|Lost to Follow-up|0|||
94490326|NCT00471497|323590306|FG002|Extension Phase|Lost to Follow-up|0|||
94490327|NCT00471497|323590304|FG000|Extension Phase|Death|1|||
94490328|NCT00471497|323590305|FG001|Extension Phase|Death|0|||
94490329|NCT00471497|323590306|FG002|Extension Phase|Death|0|||
94490330|NCT00471497|323590304|FG000|Extension Phase|Disease progression|2|||
94490331|NCT00471497|323590305|FG001|Extension Phase|Disease progression|0|||
94490332|NCT00471497|323590306|FG002|Extension Phase|Disease progression|0|||
94490333|NCT00471497|323590304|FG000|Extension Phase|Protocol Violation|2|||
94490334|NCT00471497|323590305|FG001|Extension Phase|Protocol Violation|2|||
94490335|NCT00471497|323590306|FG002|Extension Phase|Protocol Violation|0|||
94490336|NCT01654276|323590307|FG000|Overall Study|Lack of Efficacy|1|||
94490337|NCT01654276|323590307|FG000|Overall Study|Lost to Follow-up|4|||
94490338|NCT01654276|323590307|FG000|Overall Study|Withdrawal by Subject|1|||
94490339|NCT03462680|323590310|FG000|Overall Study|Withdrawal by Subject|3|||
94490340|NCT03462680|323590311|FG001|Overall Study|Withdrawal by Subject|5|||
94490341|NCT02908347|323590314|FG000|Overall Study|Adverse Event|0|||
94490342|NCT02908347|323590315|FG001|Overall Study|Adverse Event|1|||
94490343|NCT02908347|323590314|FG000|Overall Study|Lost to Follow-up|1|||
94490344|NCT02908347|323590315|FG001|Overall Study|Lost to Follow-up|0|||
94490345|NCT03329885|323590316|FG000|Overall Study|Sponsor discontinued the study early|0|||
94490346|NCT03329885|323590317|FG001|Overall Study|Sponsor discontinued the study early|0|||
94490347|NCT03329885|323590318|FG002|Overall Study|Sponsor discontinued the study early|0|||
94490348|NCT03329885|323590319|FG003|Overall Study|Sponsor discontinued the study early|0|||
94490349|NCT03329885|323590320|FG004|Overall Study|Sponsor discontinued the study early|0|||
94490350|NCT03329885|323590321|FG005|Overall Study|Sponsor discontinued the study early|0|||
94490351|NCT03329885|323590322|FG006|Overall Study|Sponsor discontinued the study early|1|||
94490352|NCT03329885|323590323|FG007|Overall Study|Sponsor discontinued the study early|1|||
94490353|NCT03329885|323590324|FG008|Overall Study|Sponsor discontinued the study early|0|||
94490354|NCT02121210|323590325|FG000|Overall Study|Adverse Event|5|||
94490355|NCT02121210|323590326|FG001|Overall Study|Adverse Event|7|||
94490356|NCT02121210|323590325|FG000|Overall Study|Lack of Efficacy|2|||
94490357|NCT02121210|323590326|FG001|Overall Study|Lack of Efficacy|0|||
94490358|NCT02121210|323590325|FG000|Overall Study|Other than specified above|0|||
94490359|NCT02121210|323590326|FG001|Overall Study|Other than specified above|2|||
94490360|NCT03122171|323590327|FG000|Overall Study|Withdrawal by Subject|1|||
94490361|NCT01232283|323590328|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
94490362|NCT01232283|323590329|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
94490363|NCT01232283|323590330|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
94490364|NCT01232283|323590331|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
94490365|NCT01232283|323590332|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
94490366|NCT01232283|323590333|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
94490367|NCT01232283|323590334|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
94490368|NCT01232283|323590335|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
94490369|NCT01232283|323590336|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
94490370|NCT01232283|323590337|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
94490371|NCT01232283|323590328|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
94490372|NCT01232283|323590329|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
94490373|NCT01232283|323590330|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
94490374|NCT01232283|323590331|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
94490375|NCT01232283|323590332|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
94490376|NCT01232283|323590333|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
94490377|NCT01232283|323590334|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
94490378|NCT01232283|323590335|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
94490379|NCT01232283|323590336|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
94490380|NCT01232283|323590337|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
94490381|NCT01232283|323590328|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
94490382|NCT01232283|323590329|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
94490383|NCT01232283|323590330|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
94490384|NCT01232283|323590331|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
94490385|NCT01232283|323590332|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
94490386|NCT01232283|323590333|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
94490387|NCT01232283|323590334|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
94490388|NCT01232283|323590335|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
94490389|NCT01232283|323590336|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
94490390|NCT01232283|323590337|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
94490391|NCT01232283|323590328|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
94490392|NCT01232283|323590329|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
94490393|NCT01232283|323590330|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
94490394|NCT01232283|323590331|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
94490395|NCT01232283|323590332|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
94490396|NCT01232283|323590333|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
94490397|NCT01232283|323590334|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
94490398|NCT01232283|323590335|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
94490399|NCT01232283|323590336|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
94490400|NCT01232283|323590337|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
94490401|NCT01232283|323590328|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
94490402|NCT01232283|323590329|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
94490403|NCT01232283|323590330|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
94490404|NCT01232283|323590331|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
94490405|NCT01232283|323590332|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
94490406|NCT01232283|323590333|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
94490407|NCT01232283|323590334|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
94490408|NCT01232283|323590335|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
94490409|NCT01232283|323590336|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
94490410|NCT01232283|323590337|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
94490411|NCT01232283|323590328|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
94490412|NCT01232283|323590329|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
94490413|NCT01232283|323590330|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
94490414|NCT01232283|323590331|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
94490415|NCT01232283|323590332|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
94655599|NCT01110239|324196091|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
94490416|NCT01232283|323590333|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
94490417|NCT01232283|323590334|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
94490418|NCT01232283|323590335|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
94490419|NCT01232283|323590336|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
94490420|NCT01232283|323590337|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
94490421|NCT01232283|323590328|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
94490422|NCT01232283|323590329|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
94490423|NCT01232283|323590330|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
94490424|NCT01232283|323590331|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
94490425|NCT01232283|323590332|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
94490426|NCT01232283|323590333|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
94490427|NCT01232283|323590334|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
94490428|NCT01232283|323590335|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
94490429|NCT01232283|323590336|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
94490430|NCT01232283|323590337|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
94490431|NCT01232283|323590328|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
94490432|NCT01232283|323590329|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
94490433|NCT01232283|323590330|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
94490434|NCT01232283|323590331|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
94490435|NCT01232283|323590332|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
94490436|NCT01232283|323590333|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
94490437|NCT01232283|323590334|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
94490438|NCT01232283|323590335|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
94490439|NCT01232283|323590336|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
94490440|NCT01232283|323590337|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
94490441|NCT01232283|323590328|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
94490442|NCT01232283|323590329|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
94490443|NCT01232283|323590330|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
94490444|NCT01232283|323590331|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
94490445|NCT01232283|323590332|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
94490446|NCT01232283|323590333|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
94490447|NCT01232283|323590334|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
94490448|NCT01232283|323590335|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
94490449|NCT01232283|323590336|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
94490450|NCT01232283|323590337|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
94490451|NCT01232283|323590328|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
94490452|NCT01232283|323590329|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
94490453|NCT01232283|323590330|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
94490454|NCT01232283|323590331|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
94490455|NCT01232283|323590332|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
94490456|NCT01232283|323590333|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
94490457|NCT01232283|323590334|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
94490458|NCT01232283|323590335|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
94490459|NCT01232283|323590336|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
94490460|NCT01232283|323590337|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
94490461|NCT01232283|323590328|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
94490462|NCT01232283|323590329|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
94490463|NCT01232283|323590330|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
94490464|NCT01232283|323590331|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
94490465|NCT01232283|323590332|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
94490466|NCT01232283|323590333|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
94490467|NCT01232283|323590334|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
94490468|NCT01232283|323590335|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
94490469|NCT01232283|323590336|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
94490470|NCT01232283|323590337|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
94490471|NCT01232283|323590328|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
94490472|NCT01232283|323590329|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
94490473|NCT01232283|323590330|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
94490474|NCT01232283|323590331|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
94490475|NCT01232283|323590332|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
94490476|NCT01232283|323590333|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
94490477|NCT01232283|323590334|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
94490478|NCT01232283|323590335|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
94490479|NCT01232283|323590336|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
94490480|NCT01232283|323590337|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
94490481|NCT01232283|323590328|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
94490482|NCT01232283|323590329|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
94490483|NCT01232283|323590330|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
94490484|NCT01232283|323590331|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
94490485|NCT01232283|323590332|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
94490486|NCT01232283|323590333|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
94490487|NCT01232283|323590334|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
94490488|NCT01232283|323590335|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
94490489|NCT01232283|323590336|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
94490490|NCT01232283|323590337|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
94490491|NCT01232283|323590328|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
94490492|NCT01232283|323590329|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
94490493|NCT01232283|323590330|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
94490494|NCT01232283|323590331|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
94490495|NCT01232283|323590332|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
94490496|NCT01232283|323590333|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
94490497|NCT01232283|323590334|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
94490498|NCT01232283|323590335|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
94490499|NCT01232283|323590336|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
94490500|NCT01232283|323590337|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
94490501|NCT01232283|323590328|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
94490502|NCT01232283|323590329|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
94490503|NCT01232283|323590330|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
94490504|NCT01232283|323590331|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
94490505|NCT01232283|323590332|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
94490506|NCT01232283|323590333|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
94490507|NCT01232283|323590334|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
94490508|NCT01232283|323590335|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
94490509|NCT01232283|323590336|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
94490510|NCT01232283|323590337|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
94490511|NCT01232283|323590328|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
94490512|NCT01232283|323590329|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
94490513|NCT01232283|323590330|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
94490514|NCT01232283|323590331|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
94490515|NCT01232283|323590332|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
94490516|NCT01232283|323590333|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
94490517|NCT01232283|323590334|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
94490518|NCT01232283|323590335|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
94490519|NCT01232283|323590336|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
94490520|NCT01232283|323590337|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
94490521|NCT01232283|323590328|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
94490522|NCT01232283|323590329|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
94490523|NCT01232283|323590330|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
94490524|NCT01232283|323590331|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
94490525|NCT01232283|323590332|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
94490526|NCT01232283|323590333|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
94490527|NCT01232283|323590334|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
94490528|NCT01232283|323590335|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
94490529|NCT01232283|323590336|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
94490530|NCT01232283|323590337|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
94490531|NCT01232283|323590328|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
94490532|NCT01232283|323590329|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
94490533|NCT01232283|323590330|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
94490534|NCT01232283|323590331|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
94490535|NCT01232283|323590332|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
94490536|NCT01232283|323590333|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
94490537|NCT01232283|323590334|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
94490538|NCT01232283|323590335|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
94490539|NCT01232283|323590336|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
94490540|NCT01232283|323590337|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
94490541|NCT01232283|323590328|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
94490542|NCT01232283|323590329|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
94490543|NCT01232283|323590330|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
94490544|NCT01232283|323590331|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
94490545|NCT01232283|323590332|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
94490546|NCT01232283|323590333|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
94490547|NCT01232283|323590334|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
94490548|NCT01232283|323590335|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
94490549|NCT01232283|323590336|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
94438853|NCT04211831|323391961|FG001|Overall Study|Protocol Violation|0|||
94438854|NCT04211831|323391962|FG002|Overall Study|Protocol Violation|1|||
94438855|NCT04211831|323391960|FG000|Overall Study|Adverse Event|0|||
94438856|NCT04211831|323391961|FG001|Overall Study|Adverse Event|1|||
94438857|NCT04211831|323391962|FG002|Overall Study|Adverse Event|0|||
94438858|NCT04211831|323391960|FG000|Overall Study|Lack of Efficacy|0|||
94438859|NCT04211831|323391961|FG001|Overall Study|Lack of Efficacy|0|||
94438860|NCT04211831|323391962|FG002|Overall Study|Lack of Efficacy|1|||
94438861|NCT04211831|323391960|FG000|Overall Study|Lost to Follow-up|0|||
94438862|NCT04211831|323391961|FG001|Overall Study|Lost to Follow-up|0|||
94438863|NCT04211831|323391962|FG002|Overall Study|Lost to Follow-up|2|||
94438864|NCT04211831|323391960|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
94438865|NCT04211831|323391961|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
94438866|NCT04211831|323391962|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
94438867|NCT04211831|323391960|FG000|Overall Study|Other|0|||
94438868|NCT04211831|323391961|FG001|Overall Study|Other|1|||
94438869|NCT04211831|323391962|FG002|Overall Study|Other|0|||
94438870|NCT00397514|323391965|FG000|Overall Study|Withdrawal by Subject|1|||
94438871|NCT00397514|323391965|FG000|Overall Study|Pacing wire malfunction|1|||
94438872|NCT00397514|323391965|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
94438873|NCT00397514|323391965|FG000|Overall Study|early extubation|2|||
94438874|NCT00397514|323391965|FG000|Overall Study|poor echocardiographic windows|1|||
94438875|NCT00445146|323391966|FG000|Overall Study|Withdrew Consent|29|||
94438876|NCT00445146|323391966|FG000|Overall Study|Lack of Efficacy|28|||
94438877|NCT00445146|323391966|FG000|Overall Study|Investigator's Discretion|22|||
94438878|NCT00445146|323391966|FG000|Overall Study|Adverse Event|13|||
94438879|NCT00445146|323391966|FG000|Overall Study|Lost to Follow-up|13|||
94438880|NCT00445146|323391966|FG000|Overall Study|Death|9|||
94438881|NCT00445146|323391966|FG000|Overall Study|Protocol Violation|4|||
94438882|NCT00445146|323391966|FG000|Overall Study|Pregnancy|1|||
94438883|NCT00640315|323391968|FG000|Overall Study|Withdrawal by Subject|0|||
94438884|NCT00640315|323391969|FG001|Overall Study|Withdrawal by Subject|1|||
94438885|NCT01256879|323391970|FG000|Overall Study|Withdrawal by Subject|1|||
94438886|NCT01959295|323391978|FG000|Overall Study|Adverse Event|2|||
94438887|NCT01959295|323391979|FG001|Overall Study|Adverse Event|0|||
94438888|NCT01959295|323391978|FG000|Overall Study|Lost to Follow-up|0|||
94438889|NCT01959295|323391979|FG001|Overall Study|Lost to Follow-up|2|||
94438890|NCT01959295|323391978|FG000|Overall Study|Physician Decision|2|||
94438891|NCT01959295|323391979|FG001|Overall Study|Physician Decision|3|||
94438892|NCT01959295|323391978|FG000|Overall Study|Protocol Violation|16|||
94438893|NCT01959295|323391979|FG001|Overall Study|Protocol Violation|5|||
94438894|NCT01959295|323391978|FG000|Overall Study|Withdrawal by Subject|3|||
94438895|NCT01959295|323391979|FG001|Overall Study|Withdrawal by Subject|1|||
94438896|NCT01959295|323391978|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
94438897|NCT01959295|323391979|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
94438898|NCT01128179|323391981|FG000|Overall Study|Death|1|||
94438899|NCT01128179|323391982|FG001|Overall Study|Death|0|||
94438900|NCT01128179|323391981|FG000|Overall Study|Protocol Violation|1|||
94438901|NCT01128179|323391982|FG001|Overall Study|Protocol Violation|0|||
94438902|NCT01682811|323391984|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
94438903|NCT01682811|323391985|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
94438904|NCT01682811|323391986|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
94438905|NCT01682811|323391987|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
94438906|NCT01682811|323391988|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
94438907|NCT01682811|323391989|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
94438908|NCT01682811|323391990|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
94438909|NCT01682811|323391984|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
94438910|NCT01682811|323391985|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
94438911|NCT01682811|323391986|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
94438912|NCT01682811|323391987|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
94438913|NCT01682811|323391988|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
94438914|NCT01682811|323391989|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
94438915|NCT01682811|323391990|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
94438916|NCT01682811|323391984|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
94438917|NCT01682811|323391985|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
94438918|NCT01682811|323391986|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
94438919|NCT01682811|323391987|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
94438920|NCT01682811|323391988|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
94438921|NCT01682811|323391989|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
94438922|NCT01682811|323391990|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
94438923|NCT01682811|323391984|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
94438924|NCT01682811|323391985|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
94438925|NCT01682811|323391986|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
94438926|NCT01682811|323391987|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
94438927|NCT01682811|323391988|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
94438928|NCT01682811|323391989|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
94438929|NCT01682811|323391990|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
94438930|NCT02694328|323391994|FG000|Overall Study|Adverse Event|27|||
94438931|NCT02694328|323391995|FG001|Overall Study|Adverse Event|33|||
94438932|NCT02694328|323391994|FG000|Overall Study|Withdrawal by Subject|27|||
94438933|NCT02694328|323391995|FG001|Overall Study|Withdrawal by Subject|23|||
94438934|NCT02694328|323391994|FG000|Overall Study|Lost to Follow-up|26|||
94438935|NCT02694328|323391995|FG001|Overall Study|Lost to Follow-up|22|||
94438936|NCT02694328|323391994|FG000|Overall Study|Noncompliant with study drug|11|||
94438937|NCT02694328|323391995|FG001|Overall Study|Noncompliant with study drug|8|||
94438938|NCT02694328|323391994|FG000|Overall Study|Incarceration|1|||
94438939|NCT02694328|323391995|FG001|Overall Study|Incarceration|1|||
94438940|NCT02694328|323391994|FG000|Overall Study|Lack of Efficacy|1|||
94438941|NCT02694328|323391995|FG001|Overall Study|Lack of Efficacy|2|||
94438942|NCT02694328|323391994|FG000|Overall Study|Pregnancy|1|||
94438943|NCT02694328|323391995|FG001|Overall Study|Pregnancy|1|||
94438944|NCT02694328|323391994|FG000|Overall Study|Protocol Violation|6|||
94438945|NCT02694328|323391995|FG001|Overall Study|Protocol Violation|5|||
94438946|NCT02694328|323391994|FG000|Overall Study|Abnormal Laboratory Value|0|||
94438947|NCT02694328|323391995|FG001|Overall Study|Abnormal Laboratory Value|3|||
94438948|NCT00352417|323391996|FG000|Overall Study|Adverse Event|1|||
94438949|NCT00352417|323391997|FG001|Overall Study|Adverse Event|0|||
94438950|NCT00352417|323391996|FG000|Overall Study|Protocol Violation|0|||
94438951|NCT00352417|323391997|FG001|Overall Study|Protocol Violation|2|||
94438952|NCT00352417|323391996|FG000|Overall Study|Withdrawal by Subject|1|||
94438953|NCT00352417|323391997|FG001|Overall Study|Withdrawal by Subject|2|||
94438954|NCT00352417|323391996|FG000|Overall Study|Lost to Follow-up|1|||
94438955|NCT00352417|323391997|FG001|Overall Study|Lost to Follow-up|0|||
94438956|NCT00352417|323391996|FG000|Overall Study|Schedule Change|2|||
94438957|NCT00352417|323391997|FG001|Overall Study|Schedule Change|1|||
94438958|NCT00720382|323391998|FG000|Overall Study|Adverse Event|54|||
94438959|NCT00720382|323391999|FG001|Overall Study|Adverse Event|17|||
94438960|NCT00720382|323391998|FG000|Overall Study|Lack of Efficacy|18|||
94438961|NCT00720382|323391999|FG001|Overall Study|Lack of Efficacy|7|||
94438962|NCT00720382|323391998|FG000|Overall Study|Non-Compliance|15|||
94438963|NCT00720382|323391999|FG001|Overall Study|Non-Compliance|5|||
94438964|NCT00720382|323391998|FG000|Overall Study|Withdrawal by Subject|47|||
94438965|NCT00720382|323391999|FG001|Overall Study|Withdrawal by Subject|11|||
94438966|NCT00720382|323391998|FG000|Overall Study|Lost to Follow-up|28|||
94438967|NCT00720382|323391999|FG001|Overall Study|Lost to Follow-up|14|||
94438968|NCT00720382|323391998|FG000|Overall Study|administrative|14|||
94438969|NCT00720382|323391999|FG001|Overall Study|administrative|5|||
94438970|NCT01277601|323394094|FG000|Overall Study|Adverse Event|5|||
94438971|NCT01277601|323394095|FG001|Overall Study|Adverse Event|3|||
94438972|NCT01277601|323394096|FG002|Overall Study|Adverse Event|0|||
94438973|NCT01277601|323394097|FG003|Overall Study|Adverse Event|7|||
94438974|NCT01277601|323394094|FG000|Overall Study|Withdrawal by Subject|18|||
94438975|NCT01277601|323394095|FG001|Overall Study|Withdrawal by Subject|21|||
94438976|NCT01277601|323394096|FG002|Overall Study|Withdrawal by Subject|8|||
94438977|NCT01277601|323394097|FG003|Overall Study|Withdrawal by Subject|17|||
94438978|NCT01277601|323394094|FG000|Overall Study|Lost to Follow-up|7|||
94438979|NCT01277601|323394095|FG001|Overall Study|Lost to Follow-up|9|||
94438980|NCT01277601|323394096|FG002|Overall Study|Lost to Follow-up|4|||
94438981|NCT01277601|323394097|FG003|Overall Study|Lost to Follow-up|2|||
94438982|NCT01277601|323394094|FG000|Overall Study|Physician Decision|3|||
94438983|NCT01277601|323394095|FG001|Overall Study|Physician Decision|5|||
94438984|NCT01277601|323394096|FG002|Overall Study|Physician Decision|1|||
94438985|NCT01277601|323394097|FG003|Overall Study|Physician Decision|6|||
94438986|NCT01277601|323394094|FG000|Overall Study|Pregnancy|2|||
94438987|NCT01277601|323394095|FG001|Overall Study|Pregnancy|2|||
94438988|NCT01277601|323394096|FG002|Overall Study|Pregnancy|4|||
94438989|NCT01277601|323394097|FG003|Overall Study|Pregnancy|1|||
94438990|NCT01277601|323394094|FG000|Overall Study|Noncompliance with Study Drug|1|||
94438991|NCT01277601|323394095|FG001|Overall Study|Noncompliance with Study Drug|3|||
94438992|NCT01277601|323394096|FG002|Overall Study|Noncompliance with Study Drug|2|||
94438993|NCT01277601|323394097|FG003|Overall Study|Noncompliance with Study Drug|0|||
94438994|NCT01277601|323394094|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
94438995|NCT01277601|323394095|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
94438996|NCT01277601|323394096|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
94438997|NCT01277601|323394097|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
94438998|NCT01277601|323394094|FG000|Overall Study|Protocol Violation|0|||
94438999|NCT01277601|323394095|FG001|Overall Study|Protocol Violation|2|||
94439000|NCT01277601|323394096|FG002|Overall Study|Protocol Violation|5|||
94439001|NCT01277601|323394097|FG003|Overall Study|Protocol Violation|0|||
94439002|NCT01277601|323394094|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
94439003|NCT01277601|323394095|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
94439004|NCT01277601|323394096|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
94439005|NCT01277601|323394097|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
94439006|NCT02291510|323394099|FG000|Overall Study|Adverse Event|0|||
94439007|NCT02291510|323394100|FG001|Overall Study|Adverse Event|0|||
94439008|NCT02291510|323394101|FG002|Overall Study|Adverse Event|0|||
94439009|NCT02291510|323394102|FG003|Overall Study|Adverse Event|1|||
94439010|NCT02454608|323394103|FG000|Double-Blind Period|Lack of Efficacy|0|||
94439011|NCT02454608|323394104|FG001|Double-Blind Period|Lack of Efficacy|2|||
94439012|NCT02454608|323394105|FG002|Double-Blind Period|Lack of Efficacy|0|||
94439013|NCT02454608|323394103|FG000|Open Label Period|Lost to Follow-up|0|||
94439014|NCT02454608|323394104|FG001|Open Label Period|Lost to Follow-up|0|||
94439015|NCT02454608|323394105|FG002|Open Label Period|Lost to Follow-up|11|||
94439016|NCT02454608|323394103|FG000|Open Label Period|Withdrawal by Subject|0|||
94439017|NCT02454608|323394104|FG001|Open Label Period|Withdrawal by Subject|0|||
94439018|NCT02454608|323394105|FG002|Open Label Period|Withdrawal by Subject|8|||
94439019|NCT03284723|323394106|FG000|Overall Study|Death|0|||
94439020|NCT03284723|323394107|FG001|Overall Study|Death|0|||
94439021|NCT03284723|323394108|FG002|Overall Study|Death|0|||
94439022|NCT03284723|323394109|FG003|Overall Study|Death|1|||
94439023|NCT03284723|323394110|FG004|Overall Study|Death|0|||
94439024|NCT03284723|323394111|FG005|Overall Study|Death|0|||
94439025|NCT03284723|323394112|FG006|Overall Study|Death|1|||
94439026|NCT03284723|323394113|FG007|Overall Study|Death|0|||
94439027|NCT03284723|323394114|FG008|Overall Study|Death|0|||
94439028|NCT03284723|323394115|FG009|Overall Study|Death|2|||
94439029|NCT03284723|323394116|FG010|Overall Study|Death|1|||
94439030|NCT03284723|323394117|FG011|Overall Study|Death|0|||
94439031|NCT03284723|323394106|FG000|Overall Study|Lost to Follow-up|0|||
94439032|NCT03284723|323394107|FG001|Overall Study|Lost to Follow-up|0|||
94439033|NCT03284723|323394108|FG002|Overall Study|Lost to Follow-up|0|||
94439034|NCT03284723|323394109|FG003|Overall Study|Lost to Follow-up|0|||
94439035|NCT03284723|323394110|FG004|Overall Study|Lost to Follow-up|0|||
94439036|NCT03284723|323394111|FG005|Overall Study|Lost to Follow-up|2|||
94439037|NCT03284723|323394112|FG006|Overall Study|Lost to Follow-up|1|||
94439038|NCT03284723|323394113|FG007|Overall Study|Lost to Follow-up|0|||
94439039|NCT03284723|323394114|FG008|Overall Study|Lost to Follow-up|0|||
94439040|NCT03284723|323394115|FG009|Overall Study|Lost to Follow-up|2|||
94439041|NCT03284723|323394116|FG010|Overall Study|Lost to Follow-up|0|||
94439042|NCT03284723|323394117|FG011|Overall Study|Lost to Follow-up|0|||
94439043|NCT03284723|323394106|FG000|Overall Study|Study Terminated By Sponsor|0|||
94439044|NCT03284723|323394107|FG001|Overall Study|Study Terminated By Sponsor|0|||
94439045|NCT03284723|323394108|FG002|Overall Study|Study Terminated By Sponsor|0|||
94439046|NCT03284723|323394109|FG003|Overall Study|Study Terminated By Sponsor|0|||
94439047|NCT03284723|323394110|FG004|Overall Study|Study Terminated By Sponsor|1|||
94439048|NCT03284723|323394111|FG005|Overall Study|Study Terminated By Sponsor|0|||
94439049|NCT03284723|323394112|FG006|Overall Study|Study Terminated By Sponsor|0|||
94439050|NCT03284723|323394113|FG007|Overall Study|Study Terminated By Sponsor|0|||
94439051|NCT03284723|323394114|FG008|Overall Study|Study Terminated By Sponsor|1|||
94439052|NCT03284723|323394115|FG009|Overall Study|Study Terminated By Sponsor|1|||
94439053|NCT03284723|323394116|FG010|Overall Study|Study Terminated By Sponsor|1|||
94439054|NCT03284723|323394117|FG011|Overall Study|Study Terminated By Sponsor|1|||
94439055|NCT03284723|323394106|FG000|Overall Study|Withdrawal by Subject|0|||
94439056|NCT03284723|323394107|FG001|Overall Study|Withdrawal by Subject|0|||
94439057|NCT03284723|323394108|FG002|Overall Study|Withdrawal by Subject|0|||
94439058|NCT03284723|323394109|FG003|Overall Study|Withdrawal by Subject|0|||
94439059|NCT03284723|323394110|FG004|Overall Study|Withdrawal by Subject|5|||
94439060|NCT03284723|323394111|FG005|Overall Study|Withdrawal by Subject|3|||
94439061|NCT03284723|323394112|FG006|Overall Study|Withdrawal by Subject|1|||
94439062|NCT03284723|323394113|FG007|Overall Study|Withdrawal by Subject|0|||
94439063|NCT03284723|323394114|FG008|Overall Study|Withdrawal by Subject|6|||
94439064|NCT03284723|323394115|FG009|Overall Study|Withdrawal by Subject|0|||
94439065|NCT03284723|323394116|FG010|Overall Study|Withdrawal by Subject|3|||
94439066|NCT03284723|323394117|FG011|Overall Study|Withdrawal by Subject|1|||
94439067|NCT03284723|323394106|FG000|Overall Study|Other|1|||
94439068|NCT03284723|323394107|FG001|Overall Study|Other|0|||
94439069|NCT03284723|323394108|FG002|Overall Study|Other|1|||
94439070|NCT03284723|323394109|FG003|Overall Study|Other|0|||
94439071|NCT03284723|323394110|FG004|Overall Study|Other|1|||
94439072|NCT03284723|323394111|FG005|Overall Study|Other|0|||
94439073|NCT03284723|323394112|FG006|Overall Study|Other|0|||
94439074|NCT03284723|323394113|FG007|Overall Study|Other|0|||
94439075|NCT03284723|323394114|FG008|Overall Study|Other|0|||
94439076|NCT03284723|323394115|FG009|Overall Study|Other|0|||
94439077|NCT03284723|323394116|FG010|Overall Study|Other|1|||
94439078|NCT03284723|323394117|FG011|Overall Study|Other|0|||
94439079|NCT03284723|323394106|FG000|Overall Study|Adverse Event|0|||
94439080|NCT03284723|323394107|FG001|Overall Study|Adverse Event|0|||
94439081|NCT03284723|323394108|FG002|Overall Study|Adverse Event|0|||
94439082|NCT03284723|323394109|FG003|Overall Study|Adverse Event|0|||
94439083|NCT03284723|323394110|FG004|Overall Study|Adverse Event|0|||
94439084|NCT03284723|323394111|FG005|Overall Study|Adverse Event|0|||
94439085|NCT03284723|323394112|FG006|Overall Study|Adverse Event|0|||
94439086|NCT03284723|323394113|FG007|Overall Study|Adverse Event|0|||
94439087|NCT03284723|323394114|FG008|Overall Study|Adverse Event|1|||
94439088|NCT03284723|323394115|FG009|Overall Study|Adverse Event|0|||
94439089|NCT03284723|323394116|FG010|Overall Study|Adverse Event|0|||
94439090|NCT03284723|323394117|FG011|Overall Study|Adverse Event|0|||
94439091|NCT00517881|323394118|FG000|Overall Study|Protocol Violation|2|||
94439092|NCT00517881|323394118|FG000|Overall Study|Adverse Event|1|||
94439093|NCT00517881|323394118|FG000|Overall Study|Renal transplantation|2|||
94439094|NCT04054765|323394123|FG000|Baseline|Withdrawal by Subject|5|||
94439095|NCT04054765|323394124|FG001|Baseline|Withdrawal by Subject|3|||
94439096|NCT04054765|323394123|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
94439097|NCT04054765|323394124|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
94439098|NCT04054765|323394123|FG000|3-month Follow up|Withdrawal by Subject|0|||
94439099|NCT04054765|323394124|FG001|3-month Follow up|Withdrawal by Subject|3|||
94439100|NCT04054765|323394123|FG000|6-month Follow up|Lost to Follow-up|32|||
94439101|NCT04054765|323394124|FG001|6-month Follow up|Lost to Follow-up|32|||
94439102|NCT02548156|323394127|FG000|Washout Period 1|Lost to Follow-up|0|||
94439103|NCT02548156|323394128|FG001|Washout Period 1|Lost to Follow-up|0|||
94439104|NCT02548156|323394129|FG002|Washout Period 1|Lost to Follow-up|0|||
94439105|NCT02548156|323394130|FG003|Washout Period 1|Lost to Follow-up|0|||
94439106|NCT02548156|323394131|FG004|Washout Period 1|Lost to Follow-up|1|||
94439107|NCT02548156|323394132|FG005|Washout Period 1|Lost to Follow-up|0|||
94439108|NCT02121652|323394137|FG000|Overall Study|Lost to Follow-up|2|||
94439109|NCT02121652|323394138|FG001|Overall Study|Lost to Follow-up|1|||
94439110|NCT02121652|323394137|FG000|Overall Study|Death|1|||
94439111|NCT02121652|323394138|FG001|Overall Study|Death|0|||
94439112|NCT02121652|323394137|FG000|Overall Study|Withdrawal by Subject|3|||
94439113|NCT02121652|323394138|FG001|Overall Study|Withdrawal by Subject|3|||
94439114|NCT01023035|323394143|FG000|Treatment Period|Adverse Event|27|||
94439115|NCT01023035|323394144|FG001|Treatment Period|Adverse Event|32|||
94439116|NCT01023035|323394145|FG002|Treatment Period|Adverse Event|50|||
94439117|NCT01023035|323394143|FG000|Treatment Period|Non-Medical Reasons|19|||
94439118|NCT01023035|323394144|FG001|Treatment Period|Non-Medical Reasons|22|||
94439119|NCT01023035|323394145|FG002|Treatment Period|Non-Medical Reasons|44|||
94439120|NCT01023035|323394143|FG000|Treatment Period|Treatment Failure|26|||
94439121|NCT01023035|323394144|FG001|Treatment Period|Treatment Failure|31|||
94439122|NCT01023035|323394145|FG002|Treatment Period|Treatment Failure|24|||
94439123|NCT01023035|323394143|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
94439124|NCT01023035|323394144|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
94439125|NCT01023035|323394145|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
94439126|NCT01023035|323394143|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
94439127|NCT01023035|323394144|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
94439128|NCT01023035|323394145|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
94439129|NCT03280264|323394146|FG000|Overall Study|Adverse Event|1|||
94439130|NCT03280264|323394146|FG000|Overall Study|Physician Decision|1|||
94439131|NCT03280264|323394146|FG000|Overall Study|Withdrawal by Subject|1|||
94439132|NCT01153425|323394149|FG000|Overall Study|Withdrawal by Subject|3|||
94439133|NCT01153425|323394150|FG001|Overall Study|Withdrawal by Subject|3|||
94439134|NCT00524420|323394153|FG000|Overall Study|Lack of Efficacy|1|||
94439135|NCT00524420|323394154|FG001|Overall Study|Lack of Efficacy|0|||
94439136|NCT03022370|323394155|FG000|Overall Study|Death|6|||
94439137|NCT03022370|323394156|FG001|Overall Study|Death|12|||
94439138|NCT03022370|323394155|FG000|Overall Study|Lost to Follow-up|174|||
94439139|NCT03022370|323394156|FG001|Overall Study|Lost to Follow-up|109|||
94439140|NCT00668317|323394157|FG000|Overall Study|Adverse Event|2|||
94439141|NCT02556801|323394160|FG000|Overall Study|Lost to Follow-up|1|||
94439142|NCT02556801|323394161|FG001|Overall Study|Lost to Follow-up|0|||
94439143|NCT02556801|323394162|FG002|Overall Study|Lost to Follow-up|2|||
94439144|NCT02556801|323394163|FG003|Overall Study|Lost to Follow-up|0|||
94439145|NCT02556801|323394160|FG000|Overall Study|Withdrawal by Subject|1|||
94439146|NCT02556801|323394161|FG001|Overall Study|Withdrawal by Subject|1|||
94439147|NCT02556801|323394162|FG002|Overall Study|Withdrawal by Subject|1|||
94439148|NCT02556801|323394163|FG003|Overall Study|Withdrawal by Subject|0|||
94439149|NCT02556801|323394160|FG000|Overall Study|Protocol Violation|0|||
94439150|NCT02556801|323394161|FG001|Overall Study|Protocol Violation|3|||
94439151|NCT02556801|323394162|FG002|Overall Study|Protocol Violation|1|||
94439152|NCT02556801|323394163|FG003|Overall Study|Protocol Violation|1|||
94439153|NCT02556801|323394160|FG000|Overall Study|Adverse Event|0|||
94439154|NCT02556801|323394161|FG001|Overall Study|Adverse Event|2|||
94439155|NCT02556801|323394162|FG002|Overall Study|Adverse Event|0|||
94439156|NCT02556801|323394163|FG003|Overall Study|Adverse Event|3|||
94439157|NCT02556801|323394160|FG000|Overall Study|Pregnancy|0|||
94439158|NCT02556801|323394161|FG001|Overall Study|Pregnancy|1|||
94439159|NCT02556801|323394162|FG002|Overall Study|Pregnancy|0|||
94439160|NCT02556801|323394163|FG003|Overall Study|Pregnancy|0|||
94490550|NCT01232283|323590337|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
94490551|NCT01232283|323590328|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
94490552|NCT01232283|323590329|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
94490553|NCT01232283|323590330|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
94490554|NCT01232283|323590331|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
94490555|NCT01232283|323590332|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
94490556|NCT01232283|323590333|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
94490557|NCT01232283|323590334|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
94490558|NCT01232283|323590335|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
94490559|NCT01232283|323590336|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
94490560|NCT01232283|323590337|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
94490561|NCT01232283|323590328|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
94490562|NCT01232283|323590329|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
94490563|NCT01232283|323590330|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
94490564|NCT01232283|323590331|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
94490565|NCT01232283|323590332|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
94490566|NCT01232283|323590333|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
94490567|NCT01232283|323590334|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
94490568|NCT01232283|323590335|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
94490569|NCT01232283|323590336|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
94490570|NCT01232283|323590337|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
94490571|NCT01232283|323590328|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
94490572|NCT01232283|323590329|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
94490573|NCT01232283|323590330|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
94490574|NCT01232283|323590331|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
94490575|NCT01232283|323590332|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
94490576|NCT01232283|323590333|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
94490577|NCT01232283|323590334|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
94490578|NCT01232283|323590335|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
94490579|NCT01232283|323590336|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
94490580|NCT01232283|323590337|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
94490581|NCT01232283|323590328|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
94490582|NCT01232283|323590329|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
94490583|NCT01232283|323590330|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
94490584|NCT01232283|323590331|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
94490585|NCT01232283|323590332|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
94490586|NCT01232283|323590333|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
94490587|NCT01232283|323590334|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
94490588|NCT01232283|323590335|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
94490589|NCT01232283|323590336|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
94490590|NCT01232283|323590337|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
94490591|NCT01232283|323590328|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
94490592|NCT01232283|323590329|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
94490593|NCT01232283|323590330|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
94490594|NCT01232283|323590331|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
94490595|NCT01232283|323590332|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
94490596|NCT01232283|323590333|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
94490597|NCT01232283|323590334|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
94490598|NCT01232283|323590335|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
94490599|NCT01232283|323590336|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
94490600|NCT01232283|323590337|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
94490601|NCT01232283|323590328|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
94490602|NCT01232283|323590329|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
94490603|NCT01232283|323590330|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
94490604|NCT01232283|323590331|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
94490605|NCT01232283|323590332|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
94490606|NCT01232283|323590333|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
94490607|NCT01232283|323590334|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
94490608|NCT01232283|323590335|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
94490609|NCT01232283|323590336|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
94490610|NCT01232283|323590337|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
94490611|NCT01232283|323590328|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
94490612|NCT01232283|323590329|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
94490613|NCT01232283|323590330|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
94490614|NCT01232283|323590331|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
94490615|NCT01232283|323590332|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
94490616|NCT01232283|323590333|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
94490617|NCT01232283|323590334|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
94490618|NCT01232283|323590335|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
94490619|NCT01232283|323590336|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
94490620|NCT01232283|323590337|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
94490621|NCT01232283|323590328|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
94490622|NCT01232283|323590329|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
94490623|NCT01232283|323590330|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
94490624|NCT01232283|323590331|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
94490625|NCT01232283|323590332|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
94490626|NCT01232283|323590333|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
94490627|NCT01232283|323590334|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
94490628|NCT01232283|323590335|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
94490629|NCT01232283|323590336|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
94490630|NCT01232283|323590337|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
94490631|NCT01232283|323590328|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
94490632|NCT01232283|323590329|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
94490633|NCT01232283|323590330|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
94490634|NCT01232283|323590331|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
94490635|NCT01232283|323590332|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
94490636|NCT01232283|323590333|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
94490637|NCT01232283|323590334|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
94490638|NCT01232283|323590335|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
94490639|NCT01232283|323590336|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
94490640|NCT01232283|323590337|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
94490641|NCT00315445|323590338|FG000|Overall Study|Adverse Event|7|||
94490642|NCT00315445|323590339|FG001|Overall Study|Adverse Event|12|||
94490643|NCT00315445|323590340|FG002|Overall Study|Adverse Event|15|||
94490644|NCT00315445|323590338|FG000|Overall Study|Lack of Efficacy|16|||
94490645|NCT00315445|323590339|FG001|Overall Study|Lack of Efficacy|1|||
94490646|NCT00315445|323590340|FG002|Overall Study|Lack of Efficacy|7|||
94490647|NCT00315445|323590338|FG000|Overall Study|Lost to Follow-up|1|||
94490648|NCT00315445|323590339|FG001|Overall Study|Lost to Follow-up|0|||
94490649|NCT00315445|323590340|FG002|Overall Study|Lost to Follow-up|1|||
94490650|NCT00315445|323590338|FG000|Overall Study|Protocol Violation|2|||
94490651|NCT00315445|323590339|FG001|Overall Study|Protocol Violation|0|||
94490652|NCT00315445|323590340|FG002|Overall Study|Protocol Violation|1|||
94490653|NCT00315445|323590338|FG000|Overall Study|Other|1|||
94490654|NCT00315445|323590339|FG001|Overall Study|Other|3|||
94490655|NCT00315445|323590340|FG002|Overall Study|Other|0|||
94490656|NCT00671788|323590343|FG000|Overall Study|Adverse Event|8|||
94490657|NCT00671788|323590343|FG000|Overall Study|Refused further treatment|3|||
94490658|NCT00671788|323590343|FG000|Overall Study|Ineligible|1|||
94490659|NCT00671788|323590343|FG000|Overall Study|MD Decision|1|||
94490660|NCT00671788|323590343|FG000|Overall Study|Other|1|||
94490661|NCT01035138|323590344|FG000|Overall Study|Adverse Event|4|||
94490662|NCT01035138|323590345|FG001|Overall Study|Adverse Event|0|||
94490663|NCT01035138|323590346|FG002|Overall Study|Adverse Event|2|||
94490664|NCT01035138|323590344|FG000|Overall Study|Caregiver Decision|2|||
94490665|NCT01035138|323590345|FG001|Overall Study|Caregiver Decision|0|||
94490666|NCT01035138|323590346|FG002|Overall Study|Caregiver Decision|1|||
94490667|NCT01035138|323590344|FG000|Overall Study|Withdrawal by Subject|1|||
94490668|NCT01035138|323590345|FG001|Overall Study|Withdrawal by Subject|0|||
94490669|NCT01035138|323590346|FG002|Overall Study|Withdrawal by Subject|0|||
94490670|NCT01035138|323590344|FG000|Overall Study|Physician Decision|0|||
94490671|NCT01035138|323590345|FG001|Overall Study|Physician Decision|0|||
94490672|NCT01035138|323590346|FG002|Overall Study|Physician Decision|1|||
94490673|NCT01035138|323590344|FG000|Overall Study|Sponsor Decision|66|||
94490674|NCT01035138|323590345|FG001|Overall Study|Sponsor Decision|60|||
94490675|NCT01035138|323590346|FG002|Overall Study|Sponsor Decision|42|||
94490676|NCT01035138|323590344|FG000|Overall Study|Lost to Follow-up|0|||
94490677|NCT01035138|323590345|FG001|Overall Study|Lost to Follow-up|0|||
94490678|NCT01035138|323590346|FG002|Overall Study|Lost to Follow-up|1|||
94490679|NCT01811238|323590347|FG000|Overall Study|Withdrawal by Subject|42|||
94490680|NCT01811238|323590347|FG000|Overall Study|Adverse Event|25|||
94490681|NCT01811238|323590347|FG000|Overall Study|Protocol Violation|4|||
94490682|NCT01811238|323590347|FG000|Overall Study|Lack of Efficacy|4|||
94490683|NCT01811238|323590347|FG000|Overall Study|subject refused study medication|6|||
94490684|NCT02966834|323590354|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
94490685|NCT02966834|323590355|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
94490686|NCT02966834|323590356|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
94490687|NCT02966834|323590357|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
94490688|NCT02966834|323590358|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
94490689|NCT02966834|323590359|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
94490690|NCT02966834|323590354|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
94490691|NCT02966834|323590355|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
94490692|NCT02966834|323590356|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
94490693|NCT02966834|323590357|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
94490694|NCT02966834|323590358|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
94490695|NCT02966834|323590359|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
94490696|NCT02966834|323590354|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
94490697|NCT02966834|323590355|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
94490698|NCT02966834|323590356|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
94490699|NCT02966834|323590357|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
94490700|NCT02966834|323590358|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
94490701|NCT02966834|323590359|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
94490702|NCT02966834|323590354|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
94490703|NCT02966834|323590355|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
94490704|NCT02966834|323590356|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
94490705|NCT02966834|323590357|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
94490706|NCT02966834|323590358|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
94490707|NCT02966834|323590359|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
94490708|NCT02966834|323590354|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
94490709|NCT02966834|323590355|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
94490710|NCT02966834|323590356|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
94490711|NCT02966834|323590357|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
94490712|NCT02966834|323590358|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
94490713|NCT02966834|323590359|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
94490714|NCT02966834|323590354|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
94490715|NCT02966834|323590355|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
94490716|NCT02966834|323590356|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
94490717|NCT02966834|323590357|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
94490718|NCT02966834|323590358|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
94490719|NCT02966834|323590359|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
94490720|NCT00964782|323590362|FG000|Overall Study|Lost to Follow-up|1|||
94490721|NCT00964782|323590363|FG001|Overall Study|Lost to Follow-up|0|||
94490722|NCT01384877|323592029|FG000|Treatment 2|Lost to Follow-up|2|||
94490723|NCT01384877|323592030|FG001|Treatment 2|Lost to Follow-up|2|||
94490724|NCT00408499|323592032|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
94490725|NCT00408499|323592033|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
94490726|NCT00408499|323592034|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
94490727|NCT00408499|323592035|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
94490728|NCT00408499|323592036|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
94490729|NCT00408499|323592032|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
94490730|NCT00408499|323592033|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
94490731|NCT00408499|323592034|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
94490732|NCT00408499|323592035|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
94490733|NCT00408499|323592036|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
94490734|NCT00408499|323592032|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
94490735|NCT00408499|323592033|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
94490736|NCT00408499|323592034|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
94490737|NCT00408499|323592035|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
94490738|NCT00408499|323592036|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
94490739|NCT00408499|323592032|FG000|Phase II- MTD Expansion|Adverse Event|0|||
94490740|NCT00408499|323592033|FG001|Phase II- MTD Expansion|Adverse Event|0|||
94490741|NCT00408499|323592034|FG002|Phase II- MTD Expansion|Adverse Event|0|||
94490742|NCT00408499|323592035|FG003|Phase II- MTD Expansion|Adverse Event|0|||
94490743|NCT00408499|323592036|FG004|Phase II- MTD Expansion|Adverse Event|9|||
94490744|NCT00408499|323592032|FG000|Phase II- MTD Expansion|Death|0|||
94490745|NCT00408499|323592033|FG001|Phase II- MTD Expansion|Death|0|||
94490746|NCT00408499|323592034|FG002|Phase II- MTD Expansion|Death|0|||
94490747|NCT00408499|323592035|FG003|Phase II- MTD Expansion|Death|0|||
94490748|NCT00408499|323592036|FG004|Phase II- MTD Expansion|Death|2|||
94490749|NCT00408499|323592032|FG000|Phase II- MTD Expansion|Physician Decision|0|||
94490750|NCT00408499|323592033|FG001|Phase II- MTD Expansion|Physician Decision|0|||
94490751|NCT00408499|323592034|FG002|Phase II- MTD Expansion|Physician Decision|0|||
94490752|NCT00408499|323592035|FG003|Phase II- MTD Expansion|Physician Decision|0|||
94490753|NCT00408499|323592036|FG004|Phase II- MTD Expansion|Physician Decision|1|||
94490754|NCT00408499|323592032|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
94490755|NCT00408499|323592033|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
94490756|NCT00408499|323592034|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
94490757|NCT00408499|323592035|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
94490758|NCT00408499|323592036|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
94490759|NCT00408499|323592032|FG000|Phase II- MTD Expansion|treatment delay|0|||
94490760|NCT00408499|323592033|FG001|Phase II- MTD Expansion|treatment delay|0|||
94490761|NCT00408499|323592034|FG002|Phase II- MTD Expansion|treatment delay|0|||
94490762|NCT00408499|323592035|FG003|Phase II- MTD Expansion|treatment delay|0|||
94490763|NCT00408499|323592036|FG004|Phase II- MTD Expansion|treatment delay|3|||
94490764|NCT01287936|323592037|FG000|Overall Study|Lost to Follow-up|0|||
94490765|NCT01287936|323592038|FG001|Overall Study|Lost to Follow-up|1|||
94490766|NCT01287936|323592039|FG002|Overall Study|Lost to Follow-up|1|||
94490767|NCT00296244|323592040|FG000|Overall Study|Underwent retransplant|0|||
94490768|NCT00296244|323592041|FG001|Overall Study|Underwent retransplant|1|||
94490769|NCT01373164|323592042|FG000|Overall Study|Lost to Follow-up|0|||
94490770|NCT01373164|323592043|FG001|Overall Study|Lost to Follow-up|0|||
94490771|NCT01373164|323592044|FG002|Overall Study|Lost to Follow-up|1|||
94490772|NCT01373164|323592045|FG003|Overall Study|Lost to Follow-up|2|||
94490773|NCT01373164|323592046|FG004|Overall Study|Lost to Follow-up|0|||
94490774|NCT01373164|323592042|FG000|Overall Study|Withdrawal by Subject|0|||
94490775|NCT01373164|323592043|FG001|Overall Study|Withdrawal by Subject|1|||
94490776|NCT01373164|323592044|FG002|Overall Study|Withdrawal by Subject|0|||
94490777|NCT01373164|323592045|FG003|Overall Study|Withdrawal by Subject|10|||
94490778|NCT01373164|323592046|FG004|Overall Study|Withdrawal by Subject|2|||
94490779|NCT04745351|323592047|FG000|Overall Study|Death|51|||
94490780|NCT04745351|323592048|FG001|Overall Study|Death|25|||
94490781|NCT04745351|323592047|FG000|Overall Study|Lost to Follow-up|9|||
94490782|NCT04745351|323592048|FG001|Overall Study|Lost to Follow-up|3|||
94490783|NCT04745351|323592047|FG000|Overall Study|Randomized but Never Treated|3|||
94490784|NCT04745351|323592048|FG001|Overall Study|Randomized but Never Treated|3|||
94490785|NCT04745351|323592047|FG000|Overall Study|Adverse Event|4|||
94490786|NCT04745351|323592048|FG001|Overall Study|Adverse Event|0|||
94490787|NCT04745351|323592047|FG000|Overall Study|Withdrew Consent|1|||
94490788|NCT04745351|323592048|FG001|Overall Study|Withdrew Consent|2|||
94490789|NCT04745351|323592047|FG000|Overall Study|Investigator's Discretion|2|||
94490790|NCT04745351|323592048|FG001|Overall Study|Investigator's Discretion|0|||
94490791|NCT04745351|323592047|FG000|Overall Study|Protocol Violation|1|||
94490792|NCT04745351|323592048|FG001|Overall Study|Protocol Violation|0|||
94490793|NCT03587636|323592049|FG000|Overall Study|Lost to Follow-up|2|||
94490794|NCT03587636|323592050|FG001|Overall Study|Lost to Follow-up|5|||
94490795|NCT02058095|323592051|FG000|Overall Study|Adverse Event|1|||
94490796|NCT02058095|323592052|FG001|Overall Study|Adverse Event|0|||
94490797|NCT01458587|323592053|FG000|Overall Study|Withdrawal by Subject|1|||
94490798|NCT01458587|323592054|FG001|Overall Study|Withdrawal by Subject|0|||
94490799|NCT00726453|323592056|FG000|Primary Enrollment Group|Death|18|||
94490800|NCT00726453|323592057|FG001|Primary Enrollment Group|Death|0|||
94490801|NCT00726453|323592056|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
94490802|NCT00726453|323592057|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
94490803|NCT00726453|323592056|FG000|38 mm Length Group|Death|0|||
94490804|NCT00726453|323592057|FG001|38 mm Length Group|Death|3|||
94490805|NCT00977197|323592061|FG000|Overall Study|Withdrawal by Subject|3|||
94490806|NCT00977197|323592062|FG001|Overall Study|Withdrawal by Subject|4|||
94490807|NCT00977197|323592061|FG000|Overall Study|Adverse Event|3|||
94490808|NCT00977197|323592062|FG001|Overall Study|Adverse Event|1|||
94490809|NCT00977197|323592061|FG000|Overall Study|Lack of Efficacy|1|||
94490810|NCT00977197|323592062|FG001|Overall Study|Lack of Efficacy|0|||
94490811|NCT00977197|323592061|FG000|Overall Study|Lost to Follow-up|1|||
94490812|NCT00977197|323592062|FG001|Overall Study|Lost to Follow-up|3|||
94490813|NCT00977197|323592061|FG000|Overall Study|Nonadherence|1|||
94490814|NCT00977197|323592062|FG001|Overall Study|Nonadherence|1|||
94490815|NCT02736617|323592064|FG000|Treatment|Adverse Event|1|||
94490816|NCT02736617|323592064|FG000|Treatment|Lack of Efficacy|1|||
94490817|NCT02736617|323592064|FG000|Treatment|Withdrawal by Subject|1|||
94490818|NCT02736617|323592064|FG000|Maintenance|Lack of Efficacy|4|||
94490819|NCT02736617|323592064|FG000|Maintenance|Physician Decision|1|||
94490820|NCT00676143|323592065|FG000|Overall Study|Adverse Event|34|||
94490821|NCT00676143|323592066|FG001|Overall Study|Adverse Event|60|||
94490822|NCT00676143|323592065|FG000|Overall Study|Death|4|||
94490823|NCT00676143|323592066|FG001|Overall Study|Death|4|||
94490824|NCT00676143|323592065|FG000|Overall Study|Lack of Efficacy|0|||
94490825|NCT00676143|323592066|FG001|Overall Study|Lack of Efficacy|6|||
94490826|NCT00676143|323592065|FG000|Overall Study|Lost to Follow-up|0|||
94490827|NCT00676143|323592066|FG001|Overall Study|Lost to Follow-up|13|||
94490828|NCT00676143|323592065|FG000|Overall Study|Physician Decision|5|||
94490829|NCT00676143|323592066|FG001|Overall Study|Physician Decision|8|||
94490830|NCT00676143|323592065|FG000|Overall Study|Protocol Violation|4|||
94490831|NCT00676143|323592066|FG001|Overall Study|Protocol Violation|8|||
94490832|NCT00676143|323592065|FG000|Overall Study|Withdrawal by Subject|24|||
94490833|NCT00676143|323592066|FG001|Overall Study|Withdrawal by Subject|42|||
94490834|NCT00676143|323592065|FG000|Overall Study|Discontinuation of study by sponsor|65|||
94490835|NCT00676143|323592066|FG001|Overall Study|Discontinuation of study by sponsor|88|||
94490836|NCT00676143|323592065|FG000|Overall Study|Failed to return|2|||
94490837|NCT00676143|323592066|FG001|Overall Study|Failed to return|1|||
94490838|NCT00676143|323592065|FG000|Overall Study|Loss of caregiver|5|||
94490839|NCT00676143|323592066|FG001|Overall Study|Loss of caregiver|3|||
94490840|NCT00676143|323592065|FG000|Overall Study|Other|11|||
94490841|NCT00676143|323592066|FG001|Overall Study|Other|20|||
94490842|NCT00676143|323592065|FG000|Overall Study|Participant participation unknown|1|||
94490843|NCT00676143|323592066|FG001|Overall Study|Participant participation unknown|4|||
94490844|NCT00676143|323592065|FG000|Overall Study|Vasogenic edema recurrence|1|||
94490845|NCT00676143|323592066|FG001|Overall Study|Vasogenic edema recurrence|3|||
94490846|NCT02110693|323592067|FG000|Overall Study|Withdrawal by Subject|6|||
94490847|NCT02110693|323592068|FG001|Overall Study|Withdrawal by Subject|7|||
94490848|NCT02110693|323592067|FG000|Overall Study|skipped assessment|15|||
94490849|NCT02110693|323592068|FG001|Overall Study|skipped assessment|18|||
94490850|NCT02110693|323592067|FG000|Overall Study|technical difficulties|6|||
94490851|NCT02110693|323592068|FG001|Overall Study|technical difficulties|4|||
94490852|NCT02110693|323592067|FG000|Overall Study|Other|1|||
94490853|NCT02110693|323592068|FG001|Overall Study|Other|0|||
94490854|NCT02714153|323592069|FG000|Overall Study|Death|1|||
94490855|NCT01881425|323592070|FG000|Overall Study|Death|5|||
94490856|NCT01881425|323592071|FG001|Overall Study|Death|1|||
94490857|NCT01881425|323592070|FG000|Overall Study|Withdrawal by Subject|8|||
94490858|NCT01881425|323592071|FG001|Overall Study|Withdrawal by Subject|3|||
94490859|NCT01881425|323592070|FG000|Overall Study|Physician Decision|2|||
94490860|NCT01881425|323592071|FG001|Overall Study|Physician Decision|1|||
94490861|NCT01881425|323592070|FG000|Overall Study|Adverse Event|3|||
94490862|NCT01881425|323592071|FG001|Overall Study|Adverse Event|0|||
94490863|NCT01881425|323592070|FG000|Overall Study|General Anesthesia panic attack|0|||
94490864|NCT01881425|323592071|FG001|Overall Study|General Anesthesia panic attack|1|||
94490865|NCT01881425|323592070|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
94490866|NCT01881425|323592071|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
94490867|NCT01881425|323592070|FG000|Overall Study|Lost to Follow-up|7|||
94490868|NCT01881425|323592071|FG001|Overall Study|Lost to Follow-up|2|||
94490869|NCT01901185|323592072|FG000|Overall Study|Withdrawal by Subject|2|||
94490870|NCT00706797|323592077|FG000|Overall Study|Lack of Efficacy|3|||
94490871|NCT00706797|323592078|FG001|Overall Study|Lack of Efficacy|0|||
94490872|NCT00706797|323592077|FG000|Overall Study|Adverse Event|0|||
94490873|NCT00706797|323592078|FG001|Overall Study|Adverse Event|3|||
94490874|NCT00706797|323592077|FG000|Overall Study|Withdrawal by Subject|8|||
94490875|NCT00706797|323592078|FG001|Overall Study|Withdrawal by Subject|1|||
94490876|NCT00706797|323592077|FG000|Overall Study|Death|1|||
94490877|NCT00706797|323592078|FG001|Overall Study|Death|0|||
94490878|NCT00706797|323592077|FG000|Overall Study|Discontinuation of study by sponsor|52|||
94490879|NCT00706797|323592078|FG001|Overall Study|Discontinuation of study by sponsor|63|||
94490880|NCT00706797|323592077|FG000|Overall Study|Protocol Violation|3|||
94490881|NCT00706797|323592078|FG001|Overall Study|Protocol Violation|2|||
94490882|NCT00706797|323592077|FG000|Overall Study|Lost to Follow-up|1|||
94490883|NCT00706797|323592078|FG001|Overall Study|Lost to Follow-up|2|||
94490884|NCT00706797|323592077|FG000|Overall Study|Other|1|||
94490885|NCT00706797|323592078|FG001|Overall Study|Other|0|||
94490886|NCT01462942|323592081|FG000|Overall Study|Adverse Event|7|||
94490887|NCT01462942|323592082|FG001|Overall Study|Adverse Event|12|||
94490888|NCT01462942|323592083|FG002|Overall Study|Adverse Event|10|||
94490889|NCT01462942|323592084|FG003|Overall Study|Adverse Event|11|||
94490890|NCT01462942|323592085|FG004|Overall Study|Adverse Event|11|||
94490891|NCT01462942|323592081|FG000|Overall Study|Other, including COPD exacerbation|3|||
94490892|NCT01462942|323592082|FG001|Overall Study|Other, including COPD exacerbation|5|||
94490893|NCT01462942|323592083|FG002|Overall Study|Other, including COPD exacerbation|2|||
94490894|NCT01462942|323592084|FG003|Overall Study|Other, including COPD exacerbation|8|||
94490895|NCT01462942|323592085|FG004|Overall Study|Other, including COPD exacerbation|5|||
94490896|NCT01462942|323592081|FG000|Overall Study|Withdrawal by Subject|14|||
94490897|NCT01462942|323592082|FG001|Overall Study|Withdrawal by Subject|10|||
94490898|NCT01462942|323592083|FG002|Overall Study|Withdrawal by Subject|14|||
94490899|NCT01462942|323592084|FG003|Overall Study|Withdrawal by Subject|16|||
94490900|NCT01462942|323592085|FG004|Overall Study|Withdrawal by Subject|19|||
94490901|NCT01462942|323592081|FG000|Overall Study|Lack of Efficacy|6|||
94490902|NCT01462942|323592082|FG001|Overall Study|Lack of Efficacy|0|||
94490903|NCT01462942|323592083|FG002|Overall Study|Lack of Efficacy|4|||
94490904|NCT01462942|323592084|FG003|Overall Study|Lack of Efficacy|5|||
94490905|NCT01462942|323592085|FG004|Overall Study|Lack of Efficacy|3|||
94490906|NCT01462942|323592081|FG000|Overall Study|Lost to Follow-up|0|||
94490907|NCT01462942|323592082|FG001|Overall Study|Lost to Follow-up|1|||
94490908|NCT01462942|323592083|FG002|Overall Study|Lost to Follow-up|1|||
94490909|NCT01462942|323592084|FG003|Overall Study|Lost to Follow-up|1|||
94490910|NCT01462942|323592085|FG004|Overall Study|Lost to Follow-up|1|||
94490911|NCT01462942|323592081|FG000|Overall Study|Protocol Violation|4|||
94490912|NCT01462942|323592082|FG001|Overall Study|Protocol Violation|6|||
94490913|NCT01462942|323592083|FG002|Overall Study|Protocol Violation|9|||
94490914|NCT01462942|323592084|FG003|Overall Study|Protocol Violation|9|||
94490915|NCT01462942|323592085|FG004|Overall Study|Protocol Violation|6|||
94490916|NCT00297167|323592086|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
94490917|NCT00297167|323592087|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
94490918|NCT00297167|323592088|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
94490919|NCT00297167|323592086|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
94490920|NCT00297167|323592087|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
94490921|NCT00297167|323592088|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
94490922|NCT00296335|323592089|FG000|Overall Study|Recurrence|3|||
94490923|NCT00296335|323592090|FG001|Overall Study|Recurrence|51|||
94490924|NCT00296335|323592089|FG000|Overall Study|Adverse Event|17|||
94490925|NCT00296335|323592090|FG001|Overall Study|Adverse Event|27|||
94490926|NCT00296335|323592089|FG000|Overall Study|Lost to Follow-up|7|||
94490927|NCT00296335|323592090|FG001|Overall Study|Lost to Follow-up|33|||
94490928|NCT00296335|323592089|FG000|Overall Study|Physician Decision|3|||
94490929|NCT00296335|323592090|FG001|Overall Study|Physician Decision|11|||
94490930|NCT01027845|323592092|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
94490931|NCT01027845|323592093|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
94490932|NCT01027845|323592094|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
94490933|NCT01027845|323592095|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
94490934|NCT01027845|323592092|FG000|Primary Vaccination Phase|Adverse Event|1|||
94490935|NCT01027845|323592093|FG001|Primary Vaccination Phase|Adverse Event|0|||
94490936|NCT01027845|323592094|FG002|Primary Vaccination Phase|Adverse Event|0|||
94490937|NCT01027845|323592095|FG003|Primary Vaccination Phase|Adverse Event|0|||
94490938|NCT01027845|323592092|FG000|Primary Vaccination Phase|Protocol Violation|1|||
94490939|NCT01027845|323592093|FG001|Primary Vaccination Phase|Protocol Violation|0|||
94490940|NCT01027845|323592094|FG002|Primary Vaccination Phase|Protocol Violation|0|||
94490941|NCT01027845|323592095|FG003|Primary Vaccination Phase|Protocol Violation|0|||
94490942|NCT01027845|323592092|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
94490943|NCT01027845|323592093|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
94490944|NCT01027845|323592094|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
94490945|NCT01027845|323592095|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
94490946|NCT01027845|323592092|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
94490947|NCT01027845|323592093|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
94490948|NCT01027845|323592094|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
94490949|NCT01027845|323592095|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
94490950|NCT01027845|323592092|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
94490951|NCT01027845|323592093|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
94490952|NCT01027845|323592094|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
94490953|NCT01027845|323592095|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
94490954|NCT00368550|323592096|FG000|Overall Study|Adverse Event|7|||
94490955|NCT00368550|323592097|FG001|Overall Study|Adverse Event|4|||
94490956|NCT00368550|323592096|FG000|Overall Study|Lack of Efficacy|4|||
94490957|NCT00368550|323592097|FG001|Overall Study|Lack of Efficacy|9|||
94490958|NCT00368550|323592096|FG000|Overall Study|Withdrawal by Subject|17|||
94490959|NCT00368550|323592097|FG001|Overall Study|Withdrawal by Subject|10|||
94490960|NCT00486044|323592098|FG000|Overall Study|Withdrawal by Subject|2|||
94490961|NCT00486044|323592099|FG001|Overall Study|Withdrawal by Subject|1|||
94490962|NCT00486044|323592098|FG000|Overall Study|Adverse Event|0|||
94490963|NCT00486044|323592099|FG001|Overall Study|Adverse Event|1|||
94490964|NCT00486044|323592098|FG000|Overall Study|Lost to Follow-up|0|||
94490965|NCT00486044|323592099|FG001|Overall Study|Lost to Follow-up|1|||
94490966|NCT00321763|323592102|FG000|Overall Study|Adverse Event|1|||
94490967|NCT00321763|323592103|FG001|Overall Study|Adverse Event|1|||
94490968|NCT00321763|323592104|FG002|Overall Study|Adverse Event|0|||
94490969|NCT00321763|323592105|FG003|Overall Study|Adverse Event|1|||
94490970|NCT00321763|323592102|FG000|Overall Study|Withdrawal by Subject|2|||
94490971|NCT00321763|323592103|FG001|Overall Study|Withdrawal by Subject|0|||
94490972|NCT00321763|323592104|FG002|Overall Study|Withdrawal by Subject|1|||
94490973|NCT00321763|323592105|FG003|Overall Study|Withdrawal by Subject|0|||
94490974|NCT00321763|323592102|FG000|Overall Study|Lost to Follow-up|3|||
94490975|NCT00321763|323592103|FG001|Overall Study|Lost to Follow-up|1|||
94490976|NCT00321763|323592104|FG002|Overall Study|Lost to Follow-up|5|||
94490977|NCT00321763|323592105|FG003|Overall Study|Lost to Follow-up|4|||
94490978|NCT00324155|323592108|FG000|Enrolled and Randomized|No longer met study criteria|3|||
94490979|NCT00324155|323592109|FG001|Enrolled and Randomized|No longer met study criteria|0|||
94490980|NCT00324155|323592108|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
94490981|NCT00324155|323592109|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
94490982|NCT00324155|323592108|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
94490983|NCT00324155|323592109|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
94490984|NCT00324155|323592108|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
94490985|NCT00324155|323592109|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
94490986|NCT00324155|323592108|FG000|Received Treatment in Induction Phase|Death|8|||
94490987|NCT00324155|323592109|FG001|Received Treatment in Induction Phase|Death|15|||
94490988|NCT00324155|323592108|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
94490989|NCT00324155|323592109|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
94490990|NCT00324155|323592108|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
94490991|NCT00324155|323592109|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
94490992|NCT00324155|323592108|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
94490993|NCT00324155|323592109|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
94490994|NCT00324155|323592108|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
94490995|NCT00324155|323592109|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
94490996|NCT00324155|323592108|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
94490997|NCT00324155|323592109|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
94490998|NCT00324155|323592108|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
94490999|NCT00324155|323592109|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
94491000|NCT00324155|323592108|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
94491001|NCT00324155|323592109|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
94491002|NCT00324155|323592108|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
94491003|NCT00324155|323592109|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
94491004|NCT00324155|323592108|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
94491005|NCT00324155|323592109|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
94491006|NCT00324155|323592108|FG000|Follow-up Phase|On-going participants still on drug|11|||
94491007|NCT00324155|323592109|FG001|Follow-up Phase|On-going participants still on drug|6|||
94491008|NCT01299909|323592110|FG000|Overall Study|Lost to Follow-up|22|||
94491009|NCT01299909|323592111|FG001|Overall Study|Lost to Follow-up|18|||
94491010|NCT01299909|323592112|FG002|Overall Study|Lost to Follow-up|17|||
94491011|NCT02792504|323592115|FG000|Overall Study|Lost to Follow-up|24|||
94491012|NCT02792504|323592115|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
94491013|NCT01832766|323592116|FG000|Washout|Lost to Follow-up|0|||
94491014|NCT01832766|323592117|FG001|Washout|Lost to Follow-up|1|||
94491015|NCT02916927|323592123|FG000|Overall Study|Discharged prior to study drug receipt|0|||
94491016|NCT02916927|323592124|FG001|Overall Study|Discharged prior to study drug receipt|2|||
94491017|NCT02916927|323592123|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
94491018|NCT02916927|323592124|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
94491019|NCT02916927|323592123|FG000|Overall Study|Withdrawal before first time point|1|||
94491020|NCT02916927|323592124|FG001|Overall Study|Withdrawal before first time point|0|||
94491021|NCT01387269|323592125|FG000|Overall Study|Death|38|||
94491022|NCT01387269|323592126|FG001|Overall Study|Death|20|||
94491023|NCT01387269|323592125|FG000|Overall Study|Other|8|||
94491024|NCT01387269|323592126|FG001|Overall Study|Other|7|||
94491025|NCT01387269|323592125|FG000|Overall Study|Unrelated AE|12|||
94491026|NCT01387269|323592126|FG001|Overall Study|Unrelated AE|3|||
94491027|NCT01387269|323592125|FG000|Overall Study|Withdrawal by patient|32|||
94491028|NCT01387269|323592126|FG001|Overall Study|Withdrawal by patient|10|||
94491029|NCT01387269|323592125|FG000|Overall Study|Study drug-related AE|1|||
94491030|NCT01387269|323592126|FG001|Overall Study|Study drug-related AE|0|||
94491031|NCT01387269|323592125|FG000|Overall Study|Lost to Follow-up|1|||
94491032|NCT01387269|323592126|FG001|Overall Study|Lost to Follow-up|0|||
94491033|NCT01850641|323592127|FG000|Overall Study|Physician Decision|1|||
94491034|NCT01850641|323592127|FG000|Overall Study|Decrease in serum phosphorus|1|||
94491035|NCT01850641|323592127|FG000|Overall Study|Decrease in serum calcium|2|||
94491036|NCT01850641|323592127|FG000|Overall Study|Increase in serum ferritin|1|||
94491037|NCT00141817|323592132|FG000|Overall Study|Protocol Violation|0|||
94491038|NCT00141817|323592133|FG001|Overall Study|Protocol Violation|0|||
94491039|NCT00141817|323592134|FG002|Overall Study|Protocol Violation|1|||
94491040|NCT00141817|323592135|FG003|Overall Study|Protocol Violation|0|||
94491041|NCT00141817|323592132|FG000|Overall Study|Parent request|1|||
94491042|NCT00141817|323592133|FG001|Overall Study|Parent request|0|||
94491043|NCT00141817|323592134|FG002|Overall Study|Parent request|0|||
94491044|NCT00141817|323592135|FG003|Overall Study|Parent request|0|||
94491045|NCT00127803|323592136|FG000|Overall Study|Adverse Event|2|||
94491046|NCT00127803|323592137|FG001|Overall Study|Adverse Event|0|||
94491047|NCT00127803|323592138|FG002|Overall Study|Adverse Event|0|||
94491048|NCT00127803|323592139|FG003|Overall Study|Adverse Event|0|||
94491049|NCT00127803|323592136|FG000|Overall Study|Withdrawal by Subject|1|||
94491050|NCT00127803|323592137|FG001|Overall Study|Withdrawal by Subject|0|||
94491051|NCT00127803|323592138|FG002|Overall Study|Withdrawal by Subject|0|||
94491052|NCT00127803|323592139|FG003|Overall Study|Withdrawal by Subject|0|||
94491053|NCT00127803|323592136|FG000|Overall Study|Lost to Follow-up|0|||
94491054|NCT00127803|323592137|FG001|Overall Study|Lost to Follow-up|0|||
94491055|NCT00127803|323592138|FG002|Overall Study|Lost to Follow-up|0|||
94491056|NCT00127803|323592139|FG003|Overall Study|Lost to Follow-up|1|||
94491057|NCT02774889|323592151|FG000|Overall Study|Lost to Follow-up|2|||
94491058|NCT02774889|323592152|FG001|Overall Study|Lost to Follow-up|1|||
94491059|NCT01020123|323592154|FG000|Main Period|Withdrawal by Subject|6|||
94491060|NCT01020123|323592155|FG001|Main Period|Withdrawal by Subject|5|||
94439161|NCT02556801|323394160|FG000|Overall Study|Personal reasons patient|0|||
94439162|NCT02556801|323394161|FG001|Overall Study|Personal reasons patient|0|||
94439163|NCT02556801|323394162|FG002|Overall Study|Personal reasons patient|0|||
94439164|NCT02556801|323394163|FG003|Overall Study|Personal reasons patient|1|||
94439165|NCT03668808|323394164|FG000|First Intervention|Withdrawal by Subject|2|||
94439166|NCT03668808|323394165|FG001|First Intervention|Withdrawal by Subject|2|||
94439167|NCT01526655|323394171|FG000|Overall Study|Withdrawal by Subject|0|||
94439168|NCT01526655|323394172|FG001|Overall Study|Withdrawal by Subject|1|||
94439169|NCT03889886|323394173|FG000|Overall Study|Other|0|||
94439170|NCT03889886|323394174|FG001|Overall Study|Other|1|||
94439171|NCT03889886|323394175|FG002|Overall Study|Other|0|||
94439172|NCT03889886|323394176|FG003|Overall Study|Other|1|||
94439173|NCT03889886|323394173|FG000|Overall Study|Withdrawal by Subject|0|||
94439174|NCT03889886|323394174|FG001|Overall Study|Withdrawal by Subject|0|||
94439175|NCT03889886|323394175|FG002|Overall Study|Withdrawal by Subject|1|||
94439176|NCT03889886|323394176|FG003|Overall Study|Withdrawal by Subject|0|||
94439177|NCT03889886|323394173|FG000|Overall Study|Adverse Event|0|||
94439178|NCT03889886|323394174|FG001|Overall Study|Adverse Event|0|||
94439179|NCT03889886|323394175|FG002|Overall Study|Adverse Event|0|||
94439180|NCT03889886|323394176|FG003|Overall Study|Adverse Event|6|||
94439181|NCT04753216|323394177|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
94439182|NCT04753216|323394177|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
94439183|NCT04753216|323394177|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
94439184|NCT02001987|323394179|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
94439185|NCT02001987|323394179|FG000|Core Study Period (24 Weeks)|Death|1|||
94439186|NCT02001987|323394179|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
94439187|NCT02001987|323394179|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
94439188|NCT02001987|323394179|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
94439189|NCT02001987|323394179|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
94439190|NCT02001987|323394179|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
94439191|NCT02001987|323394179|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
94439192|NCT02001987|323394179|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
94439193|NCT02001987|323394179|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
94439194|NCT02001987|323394179|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
94439195|NCT02001987|323394179|FG000|LTE Period (52 Weeks)|Other|3|||
94439196|NCT01965860|323394180|FG000|Overall Study|Pregnancy|1|||
94439197|NCT01965860|323394181|FG001|Overall Study|Pregnancy|0|||
94439198|NCT01965860|323394182|FG002|Overall Study|Pregnancy|1|||
94439199|NCT01965860|323394180|FG000|Overall Study|Logistics|1|||
94439200|NCT01965860|323394181|FG001|Overall Study|Logistics|0|||
94439201|NCT01965860|323394182|FG002|Overall Study|Logistics|0|||
94439202|NCT02064296|323394186|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
94439203|NCT02064296|323394187|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
94439204|NCT02064296|323394188|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
94439205|NCT02064296|323394186|FG000|Intervention|Withdrawal by Subject|0|||
94439206|NCT02064296|323394187|FG001|Intervention|Withdrawal by Subject|1|||
94439207|NCT02064296|323394188|FG002|Intervention|Withdrawal by Subject|2|||
94439208|NCT01202175|323394189|FG000|Overall Study|Lost to Follow-up|2|||
94439209|NCT01202175|323394189|FG000|Overall Study|Withdrawal by Subject|1|||
94439210|NCT01202175|323394189|FG000|Overall Study|Adverse Event|2|||
94439211|NCT01626690|323394193|FG000|Overall Study|Protocol Violation|1|||
94439212|NCT01626690|323394194|FG001|Overall Study|Protocol Violation|0|||
94439213|NCT01626690|323394193|FG000|Overall Study|Adverse Event|1|||
94439214|NCT01626690|323394194|FG001|Overall Study|Adverse Event|0|||
94439215|NCT01960257|323394195|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
94439216|NCT01960257|323394196|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
94439217|NCT01960257|323394197|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
94439218|NCT01960257|323394195|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
94439219|NCT01960257|323394196|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
94439220|NCT01960257|323394197|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
94439221|NCT01960257|323394195|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
94439222|NCT01960257|323394196|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
94439223|NCT01960257|323394197|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
94439224|NCT00344448|323394201|FG000|Screening|Withdrawal by Subject|0|||
94439225|NCT00344448|323394202|FG001|Screening|Withdrawal by Subject|1|||
94439226|NCT00344448|323394201|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
94439227|NCT00344448|323394202|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
94439228|NCT00344448|323394201|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
94439229|NCT00344448|323394202|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
94439230|NCT00344448|323394201|FG000|Open Label|Withdrawal by Subject|1|||
94439231|NCT00344448|323394202|FG001|Open Label|Withdrawal by Subject|1|||
94439232|NCT00344448|323394201|FG000|Open Label|Study terminated|1|||
94439233|NCT00344448|323394202|FG001|Open Label|Study terminated|0|||
94439234|NCT02016183|323394203|FG000|Overall Study|Case Report Forms Uncollected|13|||
94439235|NCT02016183|323394203|FG000|Overall Study|Protocol Violation|52|||
94439236|NCT03142191|323394204|FG000|Placebo Controlled Period|Death|0|||
94439237|NCT03142191|323394205|FG001|Placebo Controlled Period|Death|1|||
94439238|NCT03142191|323394206|FG002|Placebo Controlled Period|Death|1|||
94439239|NCT03142191|323394207|FG003|Placebo Controlled Period|Death|0|||
94439240|NCT03142191|323394208|FG004|Placebo Controlled Period|Death|0|||
94439241|NCT03142191|323394204|FG000|Placebo Controlled Period|Adverse Event|4|||
94439242|NCT03142191|323394205|FG001|Placebo Controlled Period|Adverse Event|5|||
94439243|NCT03142191|323394206|FG002|Placebo Controlled Period|Adverse Event|1|||
94439244|NCT03142191|323394207|FG003|Placebo Controlled Period|Adverse Event|0|||
94439245|NCT03142191|323394208|FG004|Placebo Controlled Period|Adverse Event|0|||
94439246|NCT03142191|323394204|FG000|Placebo Controlled Period|Progressive Disease|1|||
94439247|NCT03142191|323394205|FG001|Placebo Controlled Period|Progressive Disease|0|||
94439248|NCT03142191|323394206|FG002|Placebo Controlled Period|Progressive Disease|1|||
94439249|NCT03142191|323394207|FG003|Placebo Controlled Period|Progressive Disease|0|||
94439250|NCT03142191|323394208|FG004|Placebo Controlled Period|Progressive Disease|0|||
94439251|NCT03142191|323394204|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
94439252|NCT03142191|323394205|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
94439253|NCT03142191|323394206|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
94439254|NCT03142191|323394207|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
94439255|NCT03142191|323394208|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
94439256|NCT03142191|323394204|FG000|Placebo Controlled Period|Other Reasons|1|||
94439257|NCT03142191|323394205|FG001|Placebo Controlled Period|Other Reasons|0|||
94439258|NCT03142191|323394206|FG002|Placebo Controlled Period|Other Reasons|0|||
94439259|NCT03142191|323394207|FG003|Placebo Controlled Period|Other Reasons|0|||
94439260|NCT03142191|323394208|FG004|Placebo Controlled Period|Other Reasons|0|||
94439261|NCT03142191|323394204|FG000|Active Treatment Extension Period|Death|2|||
94439262|NCT03142191|323394205|FG001|Active Treatment Extension Period|Death|1|||
94439263|NCT03142191|323394206|FG002|Active Treatment Extension Period|Death|1|||
94439264|NCT03142191|323394207|FG003|Active Treatment Extension Period|Death|1|||
94439265|NCT03142191|323394208|FG004|Active Treatment Extension Period|Death|0|||
94439266|NCT03142191|323394204|FG000|Active Treatment Extension Period|Adverse Event|6|||
94439267|NCT03142191|323394205|FG001|Active Treatment Extension Period|Adverse Event|5|||
94439268|NCT03142191|323394206|FG002|Active Treatment Extension Period|Adverse Event|4|||
94439269|NCT03142191|323394207|FG003|Active Treatment Extension Period|Adverse Event|1|||
94439270|NCT03142191|323394208|FG004|Active Treatment Extension Period|Adverse Event|0|||
94439271|NCT03142191|323394204|FG000|Active Treatment Extension Period|Progressive Disease|10|||
94439272|NCT03142191|323394205|FG001|Active Treatment Extension Period|Progressive Disease|5|||
94439273|NCT03142191|323394206|FG002|Active Treatment Extension Period|Progressive Disease|4|||
94439274|NCT03142191|323394207|FG003|Active Treatment Extension Period|Progressive Disease|1|||
94439275|NCT03142191|323394208|FG004|Active Treatment Extension Period|Progressive Disease|2|||
94439276|NCT03142191|323394204|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
94439277|NCT03142191|323394205|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
94439278|NCT03142191|323394206|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
94439279|NCT03142191|323394207|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
94439280|NCT03142191|323394208|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
94439281|NCT03142191|323394204|FG000|Active Treatment Extension Period|Physician Decision|2|||
94439282|NCT03142191|323394205|FG001|Active Treatment Extension Period|Physician Decision|0|||
94439283|NCT03142191|323394206|FG002|Active Treatment Extension Period|Physician Decision|0|||
94439284|NCT03142191|323394207|FG003|Active Treatment Extension Period|Physician Decision|0|||
94439285|NCT03142191|323394208|FG004|Active Treatment Extension Period|Physician Decision|0|||
94439286|NCT03142191|323394204|FG000|Active Treatment Extension Period|Other Reasons|3|||
94439287|NCT03142191|323394205|FG001|Active Treatment Extension Period|Other Reasons|3|||
94439288|NCT03142191|323394206|FG002|Active Treatment Extension Period|Other Reasons|3|||
94439289|NCT03142191|323394207|FG003|Active Treatment Extension Period|Other Reasons|8|||
94439290|NCT03142191|323394208|FG004|Active Treatment Extension Period|Other Reasons|3|||
94439291|NCT03142191|323394204|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
94439292|NCT03142191|323394205|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
94439293|NCT03142191|323394206|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
94439294|NCT03142191|323394207|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
94439295|NCT03142191|323394208|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
94439296|NCT00129545|323394211|FG000|Overall Study|Death|5|||
94439297|NCT00129545|323394212|FG001|Overall Study|Death|60|||
94439298|NCT00129545|323394213|FG002|Overall Study|Death|44|||
94439299|NCT00129545|323394211|FG000|Overall Study|Withdrawal by Subject|3|||
94439300|NCT00129545|323394212|FG001|Overall Study|Withdrawal by Subject|18|||
94439301|NCT00129545|323394213|FG002|Overall Study|Withdrawal by Subject|44|||
94439302|NCT00129545|323394211|FG000|Overall Study|Lost to Follow-up|2|||
94439303|NCT00129545|323394212|FG001|Overall Study|Lost to Follow-up|22|||
94439304|NCT00129545|323394213|FG002|Overall Study|Lost to Follow-up|13|||
94439305|NCT00129545|323394211|FG000|Overall Study|Physician Decision|0|||
94439306|NCT00129545|323394212|FG001|Overall Study|Physician Decision|3|||
94439307|NCT00129545|323394213|FG002|Overall Study|Physician Decision|10|||
94439308|NCT00129545|323394211|FG000|Overall Study|Device not implanted|16|||
94439309|NCT00129545|323394212|FG001|Overall Study|Device not implanted|61|||
94439310|NCT00129545|323394213|FG002|Overall Study|Device not implanted|0|||
94439311|NCT04660331|323394218|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
94439312|NCT04660331|323394219|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
94439313|NCT04660331|323394220|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
94439314|NCT04233073|323394224|FG000|Overall Study|Death|5|||
94439315|NCT00041132|323394228|FG000|Overall Study|Adverse Event|19|||
94439316|NCT00041132|323394228|FG000|Overall Study|Death|1|||
94439317|NCT00041132|323394228|FG000|Overall Study|Not Eligible|7|||
94439318|NCT00041132|323394228|FG000|Overall Study|Withdrawal by Subject|1|||
94439319|NCT00041132|323394228|FG000|Overall Study|Physician Decision|2|||
94439320|NCT01523002|323394229|FG000|Period 1|Withdrawal by Subject|1|||
94439321|NCT01523002|323394230|FG001|Period 1|Withdrawal by Subject|3|||
94439322|NCT01523002|323394229|FG000|Period 1|Lost to Follow-up|1|||
94439323|NCT01523002|323394230|FG001|Period 1|Lost to Follow-up|0|||
94439324|NCT01523002|323394229|FG000|Period 1|Adverse Event|0|||
94439325|NCT01523002|323394230|FG001|Period 1|Adverse Event|8|||
94439326|NCT01523002|323394229|FG000|Period 2|Withdrawal by Subject|4|||
94439327|NCT01523002|323394230|FG001|Period 2|Withdrawal by Subject|1|||
94439328|NCT01523002|323394229|FG000|Period 2|Adverse Event|2|||
94439329|NCT01523002|323394230|FG001|Period 2|Adverse Event|5|||
94439330|NCT01523002|323394229|FG000|Period 3|Withdrawal by Subject|1|||
94439331|NCT01523002|323394230|FG001|Period 3|Withdrawal by Subject|0|||
94439332|NCT01523002|323394229|FG000|Period 3|Adverse Event|3|||
94439333|NCT01523002|323394230|FG001|Period 3|Adverse Event|0|||
94439334|NCT01256502|323394231|FG000|Overall Study|Had scaffold removed|4|||
94439335|NCT01256502|323394231|FG000|Overall Study|Personal reasons|5|||
94439336|NCT01256502|323394231|FG000|Overall Study|Protocol deviation|1|||
94439337|NCT01408043|323394247|FG000|Overall Study|unable to collect cells|1|||
94439338|NCT02905032|323394250|FG000|Overall Study|Withdrawal by Subject|2|||
94439339|NCT02905032|323394251|FG001|Overall Study|Withdrawal by Subject|0|||
94439340|NCT02905032|323394252|FG002|Overall Study|Withdrawal by Subject|0|||
94439341|NCT02905032|323394250|FG000|Overall Study|Protocol Violation|6|||
94439342|NCT02905032|323394251|FG001|Overall Study|Protocol Violation|12|||
94439343|NCT02905032|323394252|FG002|Overall Study|Protocol Violation|0|||
94439344|NCT02729909|323394253|FG000|Overall Study|Lost to Follow-up|0|||
94439345|NCT02729909|323394254|FG001|Overall Study|Lost to Follow-up|1|||
94439346|NCT02729909|323394253|FG000|Overall Study|Lack of Efficacy|0|||
94439347|NCT02729909|323394254|FG001|Overall Study|Lack of Efficacy|2|||
94439348|NCT02729909|323394253|FG000|Overall Study|Significant Protocol Deviation|0|||
94439349|NCT02729909|323394254|FG001|Overall Study|Significant Protocol Deviation|2|||
94439350|NCT02729909|323394253|FG000|Overall Study|Voluntary Withdrawal|1|||
94439351|NCT02729909|323394254|FG001|Overall Study|Voluntary Withdrawal|0|||
94439352|NCT00550459|323394261|FG000|Overall Study|Adverse Event|0|||
94439353|NCT00550459|323394262|FG001|Overall Study|Adverse Event|2|||
94439354|NCT00550459|323394261|FG000|Overall Study|Withdrawal by Subject|1|||
94439355|NCT00550459|323394262|FG001|Overall Study|Withdrawal by Subject|1|||
94439356|NCT01742897|323394263|FG000|Overall Study|Adverse Event|3|||
94439357|NCT01742897|323394263|FG000|Overall Study|Withdrawal by Subject|1|||
94439358|NCT01742897|323394263|FG000|Overall Study|Other|1|||
94439359|NCT01168427|323394267|FG000|Overall Study|Patient exited prior to implant|1|||
94439360|NCT01954745|323394268|FG000|Overall Study|Radiological Progression|11|||
94439361|NCT01954745|323394268|FG000|Overall Study|Clinical Progression|5|||
94439362|NCT01954745|323394268|FG000|Overall Study|Adverse Event|2|||
94439363|NCT01954745|323394268|FG000|Overall Study|Death|1|||
94439364|NCT00967330|323394270|FG000|Overall Study|Protocol Violation|3|||
94439365|NCT00967330|323394271|FG001|Overall Study|Protocol Violation|4|||
94439366|NCT00967330|323394270|FG000|Overall Study|Regular|10|||
94439367|NCT00967330|323394271|FG001|Overall Study|Regular|3|||
94439368|NCT00967330|323394270|FG000|Overall Study|Withdrawal by Subject|6|||
94439369|NCT00967330|323394271|FG001|Overall Study|Withdrawal by Subject|0|||
94439370|NCT00967330|323394270|FG000|Overall Study|Lost to Follow-up|1|||
94439371|NCT00967330|323394271|FG001|Overall Study|Lost to Follow-up|1|||
94439372|NCT00967330|323394270|FG000|Overall Study|Death|102|||
94439373|NCT00967330|323394271|FG001|Overall Study|Death|51|||
94439374|NCT00967330|323394270|FG000|Overall Study|Severe protocol deviation|0|||
94439375|NCT00967330|323394271|FG001|Overall Study|Severe protocol deviation|1|||
94491061|NCT01020123|323592156|FG002|Main Period|Withdrawal by Subject|3|||
94491062|NCT01020123|323592157|FG003|Main Period|Withdrawal by Subject|1|||
94491063|NCT01020123|323592158|FG004|Main Period|Withdrawal by Subject|6|||
94491064|NCT01020123|323592159|FG005|Main Period|Withdrawal by Subject|3|||
94491065|NCT01020123|323592160|FG006|Main Period|Withdrawal by Subject|2|||
94491066|NCT01020123|323592154|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
94491067|NCT01020123|323592155|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
94491068|NCT01020123|323592156|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
94491069|NCT01020123|323592157|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
94491070|NCT01020123|323592158|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
94491071|NCT01020123|323592159|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
94491072|NCT01020123|323592160|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
94491073|NCT01020123|323592154|FG000|Main Period|Adverse Event|5|||
94491074|NCT01020123|323592155|FG001|Main Period|Adverse Event|2|||
94491075|NCT01020123|323592156|FG002|Main Period|Adverse Event|2|||
94491076|NCT01020123|323592157|FG003|Main Period|Adverse Event|1|||
94491077|NCT01020123|323592158|FG004|Main Period|Adverse Event|1|||
94491078|NCT01020123|323592159|FG005|Main Period|Adverse Event|2|||
94491079|NCT01020123|323592160|FG006|Main Period|Adverse Event|1|||
94491080|NCT01020123|323592154|FG000|Main Period|Protocol Violation|4|||
94491081|NCT01020123|323592155|FG001|Main Period|Protocol Violation|4|||
94491082|NCT01020123|323592156|FG002|Main Period|Protocol Violation|2|||
94491083|NCT01020123|323592157|FG003|Main Period|Protocol Violation|5|||
94491084|NCT01020123|323592158|FG004|Main Period|Protocol Violation|2|||
94491085|NCT01020123|323592159|FG005|Main Period|Protocol Violation|3|||
94491086|NCT01020123|323592160|FG006|Main Period|Protocol Violation|2|||
94491087|NCT01020123|323592154|FG000|Main Period|Lost to Follow-up|0|||
94491088|NCT01020123|323592155|FG001|Main Period|Lost to Follow-up|2|||
94491089|NCT01020123|323592156|FG002|Main Period|Lost to Follow-up|0|||
94491090|NCT01020123|323592157|FG003|Main Period|Lost to Follow-up|0|||
94491091|NCT01020123|323592158|FG004|Main Period|Lost to Follow-up|0|||
94491092|NCT01020123|323592159|FG005|Main Period|Lost to Follow-up|0|||
94491093|NCT01020123|323592160|FG006|Main Period|Lost to Follow-up|0|||
94491094|NCT01020123|323592154|FG000|Main Period|Unclasified|2|||
94491095|NCT01020123|323592155|FG001|Main Period|Unclasified|0|||
94491096|NCT01020123|323592156|FG002|Main Period|Unclasified|1|||
94491097|NCT01020123|323592157|FG003|Main Period|Unclasified|0|||
94491098|NCT01020123|323592158|FG004|Main Period|Unclasified|1|||
94491099|NCT01020123|323592159|FG005|Main Period|Unclasified|3|||
94491100|NCT01020123|323592160|FG006|Main Period|Unclasified|6|||
94491101|NCT01020123|323592154|FG000|Extention Period|Withdrawal by Subject|2|||
94491102|NCT01020123|323592155|FG001|Extention Period|Withdrawal by Subject|1|||
94491103|NCT01020123|323592156|FG002|Extention Period|Withdrawal by Subject|1|||
94491104|NCT01020123|323592157|FG003|Extention Period|Withdrawal by Subject|0|||
94491105|NCT01020123|323592158|FG004|Extention Period|Withdrawal by Subject|0|||
94491106|NCT01020123|323592159|FG005|Extention Period|Withdrawal by Subject|0|||
94491107|NCT01020123|323592160|FG006|Extention Period|Withdrawal by Subject|0|||
94491108|NCT01020123|323592154|FG000|Extention Period|Adverse Event|0|||
94491109|NCT01020123|323592155|FG001|Extention Period|Adverse Event|0|||
94491110|NCT01020123|323592156|FG002|Extention Period|Adverse Event|0|||
94491111|NCT01020123|323592157|FG003|Extention Period|Adverse Event|1|||
94491112|NCT01020123|323592158|FG004|Extention Period|Adverse Event|0|||
94491113|NCT01020123|323592159|FG005|Extention Period|Adverse Event|0|||
94491114|NCT01020123|323592160|FG006|Extention Period|Adverse Event|0|||
94491115|NCT01020123|323592154|FG000|Extention Period|Protocol Violation|1|||
94491116|NCT01020123|323592155|FG001|Extention Period|Protocol Violation|1|||
94491117|NCT01020123|323592156|FG002|Extention Period|Protocol Violation|1|||
94491118|NCT01020123|323592157|FG003|Extention Period|Protocol Violation|0|||
94491119|NCT01020123|323592158|FG004|Extention Period|Protocol Violation|0|||
94491120|NCT01020123|323592159|FG005|Extention Period|Protocol Violation|0|||
94491121|NCT01020123|323592160|FG006|Extention Period|Protocol Violation|1|||
94491122|NCT01020123|323592154|FG000|Extention Period|Lost to Follow-up|0|||
94491123|NCT01020123|323592155|FG001|Extention Period|Lost to Follow-up|0|||
94491124|NCT01020123|323592156|FG002|Extention Period|Lost to Follow-up|0|||
94491125|NCT01020123|323592157|FG003|Extention Period|Lost to Follow-up|0|||
94491126|NCT01020123|323592158|FG004|Extention Period|Lost to Follow-up|0|||
94491127|NCT01020123|323592159|FG005|Extention Period|Lost to Follow-up|2|||
94491128|NCT01020123|323592160|FG006|Extention Period|Lost to Follow-up|0|||
94491129|NCT00094445|323592161|FG000|Overall Study|Withdrawal by Subject|3|||
94491130|NCT00094445|323592161|FG000|Overall Study|Lost to Follow-up|1|||
94491131|NCT00094445|323592161|FG000|Overall Study|Progressive Disease|2|||
94491132|NCT00720759|323592164|FG000|Overall Study|Lost to Follow-up|0|||
94491133|NCT00720759|323592165|FG001|Overall Study|Lost to Follow-up|1|||
94491134|NCT00720759|323592166|FG002|Overall Study|Lost to Follow-up|1|||
94491135|NCT00720759|323592167|FG003|Overall Study|Lost to Follow-up|0|||
94491136|NCT00769561|323592168|FG000|Overall Study|Withdrawal by Subject|2|||
94491137|NCT00769561|323592169|FG001|Overall Study|Withdrawal by Subject|2|||
94491138|NCT00769561|323592168|FG000|Overall Study|Lost to Follow-up|1|||
94491139|NCT00769561|323592169|FG001|Overall Study|Lost to Follow-up|3|||
94491140|NCT01047319|323592170|FG000|Overall Study|Teva requested participant withdrawal|3|||
94491141|NCT01047319|323592171|FG001|Overall Study|Teva requested participant withdrawal|0|||
94491142|NCT01047319|323592172|FG002|Overall Study|Teva requested participant withdrawal|1|||
94491143|NCT01047319|323592170|FG000|Overall Study|Protocol Violation|3|||
94491144|NCT01047319|323592171|FG001|Overall Study|Protocol Violation|2|||
94491145|NCT01047319|323592172|FG002|Overall Study|Protocol Violation|4|||
94491146|NCT01047319|323592170|FG000|Overall Study|Lack of Efficacy|4|||
94491147|NCT01047319|323592171|FG001|Overall Study|Lack of Efficacy|3|||
94491148|NCT01047319|323592172|FG002|Overall Study|Lack of Efficacy|3|||
94491149|NCT01047319|323592170|FG000|Overall Study|Death|5|||
94491150|NCT01047319|323592171|FG001|Overall Study|Death|1|||
94491151|NCT01047319|323592172|FG002|Overall Study|Death|5|||
94491152|NCT01047319|323592170|FG000|Overall Study|Pregnancy|13|||
94491153|NCT01047319|323592171|FG001|Overall Study|Pregnancy|8|||
94491154|NCT01047319|323592172|FG002|Overall Study|Pregnancy|8|||
94491155|NCT01047319|323592170|FG000|Overall Study|Physician Decision|12|||
94491156|NCT01047319|323592171|FG001|Overall Study|Physician Decision|9|||
94491157|NCT01047319|323592172|FG002|Overall Study|Physician Decision|10|||
94491158|NCT01047319|323592170|FG000|Overall Study|Lost to Follow-up|14|||
94491159|NCT01047319|323592171|FG001|Overall Study|Lost to Follow-up|10|||
94491160|NCT01047319|323592172|FG002|Overall Study|Lost to Follow-up|10|||
94491161|NCT01047319|323592170|FG000|Overall Study|Adverse Event|16|||
94491162|NCT01047319|323592171|FG001|Overall Study|Adverse Event|27|||
94491163|NCT01047319|323592172|FG002|Overall Study|Adverse Event|21|||
94491164|NCT01047319|323592170|FG000|Overall Study|Withdrawal by Subject|77|||
94491165|NCT01047319|323592171|FG001|Overall Study|Withdrawal by Subject|75|||
94491166|NCT01047319|323592172|FG002|Overall Study|Withdrawal by Subject|87|||
94491167|NCT01047319|323592170|FG000|Overall Study|Study terminated by Sponsor|198|||
94491168|NCT01047319|323592171|FG001|Overall Study|Study terminated by Sponsor|215|||
94491169|NCT01047319|323592172|FG002|Overall Study|Study terminated by Sponsor|203|||
94491170|NCT00921024|323592182|FG000|Overall Study|Lost to Follow-up|2|||
94491171|NCT00921024|323592183|FG001|Overall Study|Lost to Follow-up|0|||
94491172|NCT00921024|323592182|FG000|Overall Study|Received concomittant therapy|2|||
94491173|NCT00921024|323592183|FG001|Overall Study|Received concomittant therapy|0|||
94491174|NCT00921024|323592182|FG000|Overall Study|Withdrawal by Subject|0|||
94491175|NCT00921024|323592183|FG001|Overall Study|Withdrawal by Subject|3|||
94491176|NCT03573297|323592186|FG000|Open Label Treatment Period|Adverse Event|67|||
94491177|NCT03573297|323592187|FG001|Open Label Treatment Period|Adverse Event|0|||
94491178|NCT03573297|323592188|FG002|Open Label Treatment Period|Adverse Event|0|||
94491179|NCT03573297|323592189|FG003|Open Label Treatment Period|Adverse Event|0|||
94491180|NCT03573297|323592186|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
94491181|NCT03573297|323592187|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
94491182|NCT03573297|323592188|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
94491183|NCT03573297|323592189|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
94491184|NCT03573297|323592186|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
94491185|NCT03573297|323592187|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
94491186|NCT03573297|323592188|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
94491187|NCT03573297|323592189|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
94491188|NCT03573297|323592186|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
94491189|NCT03573297|323592187|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
94491190|NCT03573297|323592188|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
94491191|NCT03573297|323592189|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
94491192|NCT03573297|323592186|FG000|Open Label Treatment Period|Pregnancy|1|||
94491193|NCT03573297|323592187|FG001|Open Label Treatment Period|Pregnancy|0|||
94491194|NCT03573297|323592188|FG002|Open Label Treatment Period|Pregnancy|0|||
94491195|NCT03573297|323592189|FG003|Open Label Treatment Period|Pregnancy|0|||
94491196|NCT03573297|323592186|FG000|Open Label Treatment Period|Protocol Violation|17|||
94491197|NCT03573297|323592187|FG001|Open Label Treatment Period|Protocol Violation|0|||
94491198|NCT03573297|323592188|FG002|Open Label Treatment Period|Protocol Violation|0|||
94491199|NCT03573297|323592189|FG003|Open Label Treatment Period|Protocol Violation|0|||
94491200|NCT03573297|323592186|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
94491201|NCT03573297|323592187|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
94491202|NCT03573297|323592188|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
94491203|NCT03573297|323592189|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
94491204|NCT03573297|323592186|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
94491205|NCT03573297|323592187|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
94491206|NCT03573297|323592188|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
94491207|NCT03573297|323592189|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
94491208|NCT03573297|323592186|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
94491209|NCT03573297|323592187|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
94491210|NCT03573297|323592188|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
94491211|NCT03573297|323592189|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
94491212|NCT03573297|323592186|FG000|Open Label Treatment Period|Other, Not Specified|7|||
94491213|NCT03573297|323592187|FG001|Open Label Treatment Period|Other, Not Specified|0|||
94491214|NCT03573297|323592188|FG002|Open Label Treatment Period|Other, Not Specified|0|||
94491215|NCT03573297|323592189|FG003|Open Label Treatment Period|Other, Not Specified|0|||
94491216|NCT03573297|323592186|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
94491217|NCT03573297|323592187|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
94491218|NCT03573297|323592188|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
94491219|NCT03573297|323592189|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
94491220|NCT03573297|323592186|FG000|Double-Blind Treatment Period|Adverse Event|0|||
94491221|NCT03573297|323592187|FG001|Double-Blind Treatment Period|Adverse Event|1|||
94491222|NCT03573297|323592188|FG002|Double-Blind Treatment Period|Adverse Event|5|||
94491223|NCT03573297|323592189|FG003|Double-Blind Treatment Period|Adverse Event|1|||
94491224|NCT03573297|323592186|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
94491225|NCT03573297|323592187|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
94491226|NCT03573297|323592188|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
94491227|NCT03573297|323592189|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
94491228|NCT03573297|323592186|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
94491229|NCT03573297|323592187|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
94491230|NCT03573297|323592188|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
94491231|NCT03573297|323592189|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
94491232|NCT03573297|323592186|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
94491233|NCT03573297|323592187|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
94491234|NCT03573297|323592188|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
94491235|NCT03573297|323592189|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
94491236|NCT03573297|323592186|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
94491237|NCT03573297|323592187|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
94491238|NCT03573297|323592188|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
94491239|NCT03573297|323592189|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
94491240|NCT03573297|323592186|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
94491241|NCT03573297|323592187|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
94491242|NCT03573297|323592188|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
94491243|NCT03573297|323592189|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
94491244|NCT03573297|323592186|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
94491245|NCT03573297|323592187|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
94491246|NCT03573297|323592188|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
94491247|NCT03573297|323592189|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
94491248|NCT03861039|323593721|FG000|Overall Study|Adverse Event|2|||
94491249|NCT03861039|323593722|FG001|Overall Study|Adverse Event|5|||
94491250|NCT03861039|323593723|FG002|Overall Study|Adverse Event|11|||
94491251|NCT03861039|323593721|FG000|Overall Study|Withdrawal by Subject|1|||
94491252|NCT03861039|323593722|FG001|Overall Study|Withdrawal by Subject|3|||
94491253|NCT03861039|323593723|FG002|Overall Study|Withdrawal by Subject|4|||
94491254|NCT00375752|323593728|FG000|Overall Study|Lack of Efficacy|4|||
94491255|NCT00375752|323593729|FG001|Overall Study|Lack of Efficacy|4|||
94491256|NCT00375752|323593728|FG000|Overall Study|Adverse Event|1|||
94491257|NCT00375752|323593729|FG001|Overall Study|Adverse Event|6|||
94491258|NCT00375752|323593728|FG000|Overall Study|Withdrawal by Subject|6|||
94491259|NCT00375752|323593729|FG001|Overall Study|Withdrawal by Subject|1|||
94491260|NCT00375752|323593728|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
94491261|NCT00375752|323593729|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
94491262|NCT00375752|323593728|FG000|Overall Study|Protocol Violation|0|||
94491263|NCT00375752|323593729|FG001|Overall Study|Protocol Violation|2|||
94491264|NCT00375752|323593728|FG000|Overall Study|Administrative Problems|0|||
94491265|NCT00375752|323593729|FG001|Overall Study|Administrative Problems|1|||
94491266|NCT02034006|323593730|FG000|Overall Study|Withdrawal by Subject|7|||
94491267|NCT02034006|323593730|FG000|Overall Study|Lost to Follow-up|5|||
94491268|NCT02034006|323593730|FG000|Overall Study|Death|1|||
94491269|NCT02034006|323593730|FG000|Overall Study|Pregnancy|1|||
94491270|NCT00997334|323593732|FG000|Overall Study|still on therapy|12|||
94491271|NCT00997334|323593732|FG000|Overall Study|Adverse Event|3|||
94491272|NCT00997334|323593732|FG000|Overall Study|Patient non-compliance|1|||
94491273|NCT00997334|323593732|FG000|Overall Study|Withdrawal by Subject|3|||
94491274|NCT00997334|323593732|FG000|Overall Study|Death|2|||
94491275|NCT00997334|323593732|FG000|Overall Study|Urgent Palliative Care|2|||
94491276|NCT00997334|323593732|FG000|Overall Study|No lesion amenable|1|||
94491277|NCT00997334|323593732|FG000|Overall Study|Ineligible|1|||
94491278|NCT00336544|323593736|FG000|Overall Study|Lack of Efficacy|8|||
94491279|NCT00336544|323593737|FG001|Overall Study|Lack of Efficacy|5|||
94491280|NCT00336544|323593736|FG000|Overall Study|Adverse Event|4|||
94491281|NCT00336544|323593737|FG001|Overall Study|Adverse Event|9|||
94491282|NCT00336544|323593736|FG000|Overall Study|Withdrawal by Subject|4|||
94491283|NCT00336544|323593737|FG001|Overall Study|Withdrawal by Subject|3|||
94491284|NCT00336544|323593736|FG000|Overall Study|Other|3|||
94491285|NCT00336544|323593737|FG001|Overall Study|Other|5|||
94491286|NCT02194465|323593740|FG000|Overall Study|Adverse Event|6|||
94491287|NCT02194465|323593741|FG001|Overall Study|Adverse Event|1|||
94491288|NCT02194465|323593742|FG002|Overall Study|Adverse Event|4|||
94491289|NCT02194465|323593743|FG003|Overall Study|Adverse Event|4|||
94491290|NCT02194465|323593744|FG004|Overall Study|Adverse Event|4|||
94491291|NCT02194465|323593745|FG005|Overall Study|Adverse Event|2|||
94491292|NCT02194465|323593746|FG006|Overall Study|Adverse Event|0|||
94491293|NCT02194465|323593740|FG000|Overall Study|Lost to Follow-up|0|||
94491294|NCT02194465|323593741|FG001|Overall Study|Lost to Follow-up|0|||
94491295|NCT02194465|323593742|FG002|Overall Study|Lost to Follow-up|0|||
94491296|NCT02194465|323593743|FG003|Overall Study|Lost to Follow-up|1|||
94491297|NCT02194465|323593744|FG004|Overall Study|Lost to Follow-up|0|||
94491298|NCT02194465|323593745|FG005|Overall Study|Lost to Follow-up|1|||
94491299|NCT02194465|323593746|FG006|Overall Study|Lost to Follow-up|0|||
94491300|NCT02194465|323593740|FG000|Overall Study|Physician Decision|1|||
94491301|NCT02194465|323593741|FG001|Overall Study|Physician Decision|0|||
94491302|NCT02194465|323593742|FG002|Overall Study|Physician Decision|0|||
94491303|NCT02194465|323593743|FG003|Overall Study|Physician Decision|0|||
94491304|NCT02194465|323593744|FG004|Overall Study|Physician Decision|0|||
94491305|NCT02194465|323593745|FG005|Overall Study|Physician Decision|0|||
94491306|NCT02194465|323593746|FG006|Overall Study|Physician Decision|0|||
94491307|NCT02194465|323593740|FG000|Overall Study|Protocol Violation|1|||
94491308|NCT02194465|323593741|FG001|Overall Study|Protocol Violation|1|||
94491309|NCT02194465|323593742|FG002|Overall Study|Protocol Violation|2|||
94491310|NCT02194465|323593743|FG003|Overall Study|Protocol Violation|1|||
94491311|NCT02194465|323593744|FG004|Overall Study|Protocol Violation|1|||
94491312|NCT02194465|323593745|FG005|Overall Study|Protocol Violation|0|||
94491313|NCT02194465|323593746|FG006|Overall Study|Protocol Violation|0|||
94491314|NCT02194465|323593740|FG000|Overall Study|Withdrawal by Subject|1|||
94491315|NCT02194465|323593741|FG001|Overall Study|Withdrawal by Subject|3|||
94491316|NCT02194465|323593742|FG002|Overall Study|Withdrawal by Subject|1|||
94491317|NCT02194465|323593743|FG003|Overall Study|Withdrawal by Subject|2|||
94491318|NCT02194465|323593744|FG004|Overall Study|Withdrawal by Subject|2|||
94491319|NCT02194465|323593745|FG005|Overall Study|Withdrawal by Subject|1|||
94491320|NCT02194465|323593746|FG006|Overall Study|Withdrawal by Subject|2|||
94491321|NCT02194465|323593740|FG000|Overall Study|Discontinued follow-up period|0|||
94491322|NCT02194465|323593741|FG001|Overall Study|Discontinued follow-up period|2|||
94491323|NCT02194465|323593742|FG002|Overall Study|Discontinued follow-up period|1|||
94491324|NCT02194465|323593743|FG003|Overall Study|Discontinued follow-up period|0|||
94491325|NCT02194465|323593744|FG004|Overall Study|Discontinued follow-up period|2|||
94491326|NCT02194465|323593745|FG005|Overall Study|Discontinued follow-up period|0|||
94491327|NCT02194465|323593746|FG006|Overall Study|Discontinued follow-up period|0|||
94491328|NCT00961064|323593747|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
94491329|NCT00961064|323593747|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
94491330|NCT00961064|323593747|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
94491331|NCT00961064|323593747|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
94491332|NCT00961064|323593747|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
94491333|NCT00961064|323593747|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
94491334|NCT00961064|323593747|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
94491335|NCT00961064|323593747|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
94491336|NCT01408641|323593748|FG000|Overall Study|Physician Decision|1|||
94491337|NCT01408641|323593749|FG001|Overall Study|Physician Decision|0|||
94491338|NCT00715208|323593750|FG000|Overall Study|Withdrawal by Subject|1|||
94491339|NCT00715208|323593751|FG001|Overall Study|Withdrawal by Subject|1|||
94491340|NCT00715208|323593750|FG000|Overall Study|Adverse Event|0|||
94491341|NCT00715208|323593751|FG001|Overall Study|Adverse Event|6|||
94491342|NCT00715208|323593750|FG000|Overall Study|Lack of Efficacy|0|||
94491343|NCT00715208|323593751|FG001|Overall Study|Lack of Efficacy|2|||
94491344|NCT00947544|323593752|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
94491345|NCT00947544|323593753|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
94491346|NCT00761319|323593756|FG000|Overall Study|Protocol Violation|21|||
94491347|NCT00761319|323593757|FG001|Overall Study|Protocol Violation|14|||
94491348|NCT00761319|323593756|FG000|Overall Study|Adverse Event|11|||
94491349|NCT00761319|323593757|FG001|Overall Study|Adverse Event|7|||
94491350|NCT00761319|323593756|FG000|Overall Study|Withdrawal by Subject|8|||
94491351|NCT00761319|323593757|FG001|Overall Study|Withdrawal by Subject|7|||
94491352|NCT00761319|323593756|FG000|Overall Study|Noncompliance|4|||
94491353|NCT00761319|323593757|FG001|Overall Study|Noncompliance|3|||
94491354|NCT00761319|323593756|FG000|Overall Study|Lost to Follow-up|1|||
94491355|NCT00761319|323593757|FG001|Overall Study|Lost to Follow-up|1|||
94491356|NCT00761319|323593756|FG000|Overall Study|Nonspecified|2|||
94491357|NCT00761319|323593757|FG001|Overall Study|Nonspecified|2|||
94491358|NCT00761319|323593756|FG000|Overall Study|Missing|1|||
94491359|NCT00761319|323593757|FG001|Overall Study|Missing|0|||
94491360|NCT00607893|323593758|FG000|Overall Study|Lost to Follow-up|4|||
94491361|NCT00607893|323593759|FG001|Overall Study|Lost to Follow-up|0|||
94491362|NCT00607893|323593758|FG000|Overall Study|withdrew due to loss of interest|0|||
94491363|NCT00607893|323593759|FG001|Overall Study|withdrew due to loss of interest|1|||
94491364|NCT00607893|323593758|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
94491365|NCT00607893|323593759|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
94491366|NCT00607893|323593758|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
94491367|NCT00607893|323593759|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
94491368|NCT00607893|323593758|FG000|Overall Study|Declined to be treated|1|||
94491369|NCT00607893|323593759|FG001|Overall Study|Declined to be treated|0|||
94491370|NCT00607893|323593758|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
94491371|NCT00607893|323593759|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
94491372|NCT00089648|323593760|FG000|Overall Study|Adverse Event|7|||
94491373|NCT00089648|323593760|FG000|Overall Study|Withdrawal by Subject|1|||
94491374|NCT00089648|323593760|FG000|Overall Study|Lack of Efficacy|33|||
94491375|NCT00300053|323593761|FG000|Overall Study|Patient/Caregiver Preference|2|||
94491376|NCT00300053|323593762|FG001|Overall Study|Patient/Caregiver Preference|2|||
94491377|NCT00300053|323593763|FG002|Overall Study|Patient/Caregiver Preference|3|||
94491378|NCT00300053|323593761|FG000|Overall Study|Death|0|||
94491379|NCT00300053|323593762|FG001|Overall Study|Death|0|||
94491380|NCT00300053|323593763|FG002|Overall Study|Death|3|||
94491381|NCT00300053|323593761|FG000|Overall Study|Lost to Follow-up|0|||
94491382|NCT00300053|323593762|FG001|Overall Study|Lost to Follow-up|1|||
94491383|NCT00300053|323593763|FG002|Overall Study|Lost to Follow-up|0|||
94491384|NCT00900562|323593764|FG000|Overall Study|Progressive disease|9|||
94491385|NCT00900562|323593765|FG001|Overall Study|Progressive disease|5|||
94491386|NCT00900562|323593764|FG000|Overall Study|Toxicity|1|||
94491387|NCT00900562|323593765|FG001|Overall Study|Toxicity|0|||
94491388|NCT00900562|323593764|FG000|Overall Study|Death|1|||
94491389|NCT00900562|323593765|FG001|Overall Study|Death|1|||
94491390|NCT00900562|323593764|FG000|Overall Study|Withdrawal by Subject|0|||
94491391|NCT00900562|323593765|FG001|Overall Study|Withdrawal by Subject|1|||
94491392|NCT00900562|323593764|FG000|Overall Study|Unrelated adverse event|1|||
94491393|NCT00900562|323593765|FG001|Overall Study|Unrelated adverse event|0|||
94491394|NCT01294514|323593766|FG000|Overall Study|Excluded due to Arrhythmia|1|||
94491395|NCT03736967|323593767|FG000|Overall Study|Withdrawal by Subject|26|||
94491396|NCT03736967|323593768|FG001|Overall Study|Withdrawal by Subject|25|||
94491397|NCT03736967|323593769|FG002|Overall Study|Withdrawal by Subject|23|||
94491398|NCT03736967|323593770|FG003|Overall Study|Withdrawal by Subject|26|||
94491399|NCT03736967|323593767|FG000|Overall Study|Lost to Follow-up|3|||
94491400|NCT03736967|323593768|FG001|Overall Study|Lost to Follow-up|2|||
94491401|NCT03736967|323593769|FG002|Overall Study|Lost to Follow-up|1|||
94491402|NCT03736967|323593770|FG003|Overall Study|Lost to Follow-up|1|||
94491403|NCT03736967|323593767|FG000|Overall Study|Physician Decision|1|||
94491404|NCT03736967|323593768|FG001|Overall Study|Physician Decision|0|||
94491405|NCT03736967|323593769|FG002|Overall Study|Physician Decision|0|||
94491406|NCT03736967|323593770|FG003|Overall Study|Physician Decision|1|||
94491407|NCT03736967|323593767|FG000|Overall Study|Adverse Event|0|||
94491408|NCT03736967|323593768|FG001|Overall Study|Adverse Event|1|||
94491409|NCT03736967|323593769|FG002|Overall Study|Adverse Event|0|||
94491410|NCT03736967|323593770|FG003|Overall Study|Adverse Event|1|||
94491411|NCT03736967|323593767|FG000|Overall Study|Death|0|||
94491412|NCT03736967|323593768|FG001|Overall Study|Death|0|||
94491413|NCT03736967|323593769|FG002|Overall Study|Death|0|||
94491414|NCT03736967|323593770|FG003|Overall Study|Death|1|||
94491415|NCT03736967|323593767|FG000|Overall Study|Randomized but never treated|1|||
94491416|NCT03736967|323593768|FG001|Overall Study|Randomized but never treated|0|||
94491417|NCT03736967|323593769|FG002|Overall Study|Randomized but never treated|0|||
94491418|NCT03736967|323593770|FG003|Overall Study|Randomized but never treated|0|||
94491419|NCT01715298|323593771|FG000|Overall Study|Lost to Follow-up|0|||
94491420|NCT01715298|323593772|FG001|Overall Study|Lost to Follow-up|2|||
94491421|NCT01715298|323593771|FG000|Overall Study|Patient/guardian decision|7|||
94491422|NCT01715298|323593772|FG001|Overall Study|Patient/guardian decision|9|||
94491423|NCT03286504|323593775|FG000|Overall Study|Lost to Follow-up|19|||
94491424|NCT03286504|323593776|FG001|Overall Study|Lost to Follow-up|16|||
94491425|NCT02842866|323593777|FG000|Overall Study|Serious Adverse Event|0|||
94491426|NCT02842866|323593778|FG001|Overall Study|Serious Adverse Event|1|||
94491427|NCT02842866|323593777|FG000|Overall Study|Protocol Violation|4|||
94491428|NCT02842866|323593778|FG001|Overall Study|Protocol Violation|2|||
94491429|NCT02842866|323593777|FG000|Overall Study|Lost to Follow-up|2|||
94491430|NCT02842866|323593778|FG001|Overall Study|Lost to Follow-up|0|||
94491431|NCT02842866|323593777|FG000|Overall Study|Withdrawal by Subject|1|||
94491432|NCT02842866|323593778|FG001|Overall Study|Withdrawal by Subject|0|||
94491433|NCT00941928|323593783|FG000|Overall Study|Withdrawal by Subject|1|||
94491434|NCT00941928|323593783|FG000|Overall Study|Disease Progression|1|||
94491435|NCT03743194|323593785|FG000|Overall Study|Protocol Violation|7|||
94491436|NCT03743194|323593786|FG001|Overall Study|Protocol Violation|7|||
94491437|NCT03743194|323593785|FG000|Overall Study|Physician Decision|0|||
94491438|NCT03743194|323593786|FG001|Overall Study|Physician Decision|2|||
94491439|NCT01829347|323593789|FG000|VTI-210|Death|5|||
94491440|NCT01829347|323593790|FG001|VTI-210|Death|3|||
94491441|NCT01829347|323593789|FG000|VTI-210|Withdrawal by Subject|1|||
94491442|NCT01829347|323593790|FG001|VTI-210|Withdrawal by Subject|0|||
94491443|NCT01829347|323593789|FG000|VTI-210E|Death|2|||
94491444|NCT01829347|323593790|FG001|VTI-210E|Death|1|||
94491445|NCT01829347|323593789|FG000|VTI-210E|Study terminated prematurely|1|||
94491446|NCT01829347|323593790|FG001|VTI-210E|Study terminated prematurely|5|||
94491447|NCT00656617|323593791|FG000|Overall Study|Adverse Event|1|||
94491448|NCT00656617|323593791|FG000|Overall Study|Death|2|||
94491449|NCT00656617|323593791|FG000|Overall Study|Insurance Issues|2|||
94491450|NCT00656617|323593791|FG000|Overall Study|Move to different clinical trial|2|||
94491451|NCT01259245|323593792|FG000|Overall Study|Withdrawal by Subject|27|||
94491452|NCT01259245|323593793|FG001|Overall Study|Withdrawal by Subject|24|||
94491453|NCT01259245|323593792|FG000|Overall Study|Death|1|||
94491454|NCT01259245|323593793|FG001|Overall Study|Death|2|||
94491455|NCT00634504|323593798|FG000|Overall Study|Protocol Violation|1|||
94491456|NCT00634504|323593799|FG001|Overall Study|Protocol Violation|0|||
94491457|NCT03482024|323593800|FG000|Overall Study|Physician Decision|1|||
94491458|NCT03482024|323593801|FG001|Overall Study|Physician Decision|0|||
94491459|NCT03482024|323593802|FG002|Overall Study|Physician Decision|0|||
94491460|NCT03482024|323593803|FG003|Overall Study|Physician Decision|0|||
94491461|NCT03482024|323593804|FG004|Overall Study|Physician Decision|0|||
94491462|NCT01513590|323593805|FG000|Overall Study|Adverse Event|2|||
94491463|NCT01513590|323593806|FG001|Overall Study|Adverse Event|3|||
94491464|NCT01513590|323593805|FG000|Overall Study|Withdrawal Criteria|3|||
94491465|NCT01513590|323593806|FG001|Overall Study|Withdrawal Criteria|0|||
94491466|NCT01513590|323593805|FG000|Overall Study|Unclassified|5|||
94491467|NCT01513590|323593806|FG001|Overall Study|Unclassified|10|||
94491468|NCT02765165|323593807|FG000|Treatment Period|Progressive disease|3|||
94491469|NCT02765165|323593808|FG001|Treatment Period|Progressive disease|2|||
94491470|NCT02765165|323593809|FG002|Treatment Period|Progressive disease|3|||
94491471|NCT02765165|323593810|FG003|Treatment Period|Progressive disease|3|||
94491472|NCT02765165|323593811|FG004|Treatment Period|Progressive disease|4|||
94491473|NCT02765165|323593812|FG005|Treatment Period|Progressive disease|2|||
94491474|NCT02765165|323593813|FG006|Treatment Period|Progressive disease|2|||
94491475|NCT02765165|323593807|FG000|Treatment Period|Physician Decision|0|||
94491476|NCT02765165|323593808|FG001|Treatment Period|Physician Decision|1|||
94491477|NCT02765165|323593809|FG002|Treatment Period|Physician Decision|0|||
94491478|NCT02765165|323593810|FG003|Treatment Period|Physician Decision|0|||
94491479|NCT02765165|323593811|FG004|Treatment Period|Physician Decision|0|||
94491480|NCT02765165|323593812|FG005|Treatment Period|Physician Decision|0|||
94491481|NCT02765165|323593813|FG006|Treatment Period|Physician Decision|0|||
94491482|NCT02765165|323593807|FG000|Treatment Period|Adverse Event|0|||
94491483|NCT02765165|323593808|FG001|Treatment Period|Adverse Event|1|||
94491484|NCT02765165|323593809|FG002|Treatment Period|Adverse Event|0|||
94491485|NCT02765165|323593810|FG003|Treatment Period|Adverse Event|0|||
94491486|NCT02765165|323593811|FG004|Treatment Period|Adverse Event|0|||
94491487|NCT02765165|323593812|FG005|Treatment Period|Adverse Event|0|||
94491488|NCT02765165|323593813|FG006|Treatment Period|Adverse Event|0|||
94491489|NCT02765165|323593807|FG000|Treatment Period|Withdrawal by Subject|0|||
94491490|NCT02765165|323593808|FG001|Treatment Period|Withdrawal by Subject|0|||
94491491|NCT02765165|323593809|FG002|Treatment Period|Withdrawal by Subject|0|||
94491492|NCT02765165|323593810|FG003|Treatment Period|Withdrawal by Subject|0|||
94491493|NCT02765165|323593811|FG004|Treatment Period|Withdrawal by Subject|2|||
94491494|NCT02765165|323593812|FG005|Treatment Period|Withdrawal by Subject|0|||
94491495|NCT02765165|323593813|FG006|Treatment Period|Withdrawal by Subject|0|||
94491496|NCT02765165|323593807|FG000|Treatment Period|Study terminated|0|||
94491497|NCT02765165|323593808|FG001|Treatment Period|Study terminated|0|||
94491498|NCT02765165|323593809|FG002|Treatment Period|Study terminated|0|||
94491499|NCT02765165|323593810|FG003|Treatment Period|Study terminated|0|||
94491500|NCT02765165|323593811|FG004|Treatment Period|Study terminated|0|||
94491501|NCT02765165|323593812|FG005|Treatment Period|Study terminated|1|||
94491502|NCT02765165|323593813|FG006|Treatment Period|Study terminated|2|||
94491503|NCT02765165|323593807|FG000|Post-treatment Follow-up|Death|1|||
94491504|NCT02765165|323593808|FG001|Post-treatment Follow-up|Death|2|||
94491505|NCT02765165|323593809|FG002|Post-treatment Follow-up|Death|1|||
94491506|NCT02765165|323593810|FG003|Post-treatment Follow-up|Death|1|||
94491507|NCT02765165|323593811|FG004|Post-treatment Follow-up|Death|1|||
94491508|NCT02765165|323593812|FG005|Post-treatment Follow-up|Death|1|||
94491509|NCT02765165|323593813|FG006|Post-treatment Follow-up|Death|0|||
94491510|NCT02765165|323593807|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
94491511|NCT02765165|323593808|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
94491512|NCT02765165|323593809|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
94491513|NCT02765165|323593810|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
94491514|NCT02765165|323593811|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
94491515|NCT02765165|323593812|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
94491516|NCT02765165|323593813|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
94491517|NCT02765165|323593807|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
94491518|NCT02765165|323593808|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
94491519|NCT02765165|323593809|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
94491520|NCT02765165|323593810|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
94491521|NCT02765165|323593811|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
94491522|NCT02765165|323593812|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
94491523|NCT02765165|323593813|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
94491524|NCT02765165|323593807|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
94491525|NCT02765165|323593808|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
94491526|NCT02765165|323593809|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
94491527|NCT02765165|323593810|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
94491528|NCT02765165|323593811|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
94491529|NCT02765165|323593812|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
94491530|NCT02765165|323593813|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
94491531|NCT02765165|323593807|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
94491532|NCT02765165|323593808|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
94491533|NCT02765165|323593809|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
94491534|NCT02765165|323593810|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
94491535|NCT02765165|323593811|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
94491536|NCT02765165|323593812|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
94491537|NCT02765165|323593813|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
94491538|NCT02765165|323593807|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
94491539|NCT02765165|323593808|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
94491540|NCT02765165|323593809|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
94491541|NCT02765165|323593810|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
94491542|NCT02765165|323593811|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
94491543|NCT02765165|323593812|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
94491544|NCT02765165|323593813|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
94491545|NCT04465422|323593814|FG000|Overall Study|Lost to Follow-up|0|||
94491546|NCT04465422|323593815|FG001|Overall Study|Lost to Follow-up|2|||
94491547|NCT00537277|323593820|FG000|Overall Study|Adverse Event|1|||
94491548|NCT00537277|323593820|FG000|Overall Study|Lack of Efficacy|2|||
94491549|NCT00537277|323593820|FG000|Overall Study|Lost to Follow-up|12|||
94491550|NCT00537277|323593820|FG000|Overall Study|Protocol Violation|11|||
94491551|NCT00537277|323593820|FG000|Overall Study|Unclassified|4|||
94491552|NCT00537277|323593820|FG000|Overall Study|Inability to tolerate trial medication|4|||
94491553|NCT00537277|323593820|FG000|Overall Study|Non-compliance with trial procedures|15|||
94491554|NCT00997893|323593821|FG000|Overall Study|Adverse Event|1|||
94491555|NCT00997893|323593822|FG001|Overall Study|Adverse Event|0|||
94491556|NCT00997893|323593823|FG002|Overall Study|Adverse Event|0|||
94491557|NCT00997893|323593821|FG000|Overall Study|Unable to meet study timelines|1|||
94491558|NCT00997893|323593822|FG001|Overall Study|Unable to meet study timelines|0|||
94491559|NCT00997893|323593823|FG002|Overall Study|Unable to meet study timelines|0|||
94491560|NCT00997893|323593821|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
94491561|NCT00997893|323593822|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
94491562|NCT00997893|323593823|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
94491563|NCT02147626|323593824|FG000|Overall Study|Lost to Follow-up|4|||
94491564|NCT02147626|323593825|FG001|Overall Study|Lost to Follow-up|4|||
94491565|NCT02147626|323593824|FG000|Overall Study|Pregnancy|1|||
94491566|NCT02147626|323593825|FG001|Overall Study|Pregnancy|2|||
94491567|NCT02147626|323593824|FG000|Overall Study|Withdrawal by Subject|0|||
94491568|NCT02147626|323593825|FG001|Overall Study|Withdrawal by Subject|1|||
94491569|NCT00410163|323593826|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
94491570|NCT00410163|323593827|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
94491571|NCT00410163|323593826|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
94491572|NCT00410163|323593827|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
94491573|NCT00410163|323593826|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
94491574|NCT00410163|323593827|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
94491575|NCT00410163|323593826|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
94491576|NCT00410163|323593827|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
94491577|NCT00410163|323593826|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
94491578|NCT00410163|323593827|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
94491579|NCT00410163|323593826|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
94491580|NCT00410163|323593827|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
94491581|NCT00410163|323593826|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
94491582|NCT00410163|323593827|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
94491583|NCT00410163|323593826|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
94491584|NCT00410163|323593827|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
94491585|NCT00410163|323593826|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
94491586|NCT00410163|323593827|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
94491587|NCT00410163|323593826|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
94491588|NCT00410163|323593827|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
94491589|NCT00410163|323593826|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
94491590|NCT00410163|323593827|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
94491591|NCT00410163|323593826|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
94491592|NCT00410163|323593827|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
94491593|NCT00410163|323593826|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
94491594|NCT00410163|323593827|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
94491595|NCT00410163|323593826|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
94491596|NCT00410163|323593827|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
94491597|NCT00797563|323593829|FG000|Overall Study|Adverse Event|1|||
94491598|NCT02309359|323593830|FG000|Overall Study|Adverse Event|4|||
94491599|NCT02309359|323593831|FG001|Overall Study|Adverse Event|5|||
94491600|NCT02309359|323593832|FG002|Overall Study|Adverse Event|5|||
94491601|NCT02309359|323593833|FG003|Overall Study|Adverse Event|4|||
94491602|NCT02309359|323593834|FG004|Overall Study|Adverse Event|4|||
94491603|NCT02309359|323593830|FG000|Overall Study|Death|1|||
94491604|NCT02309359|323593831|FG001|Overall Study|Death|0|||
94491605|NCT02309359|323593832|FG002|Overall Study|Death|0|||
94491606|NCT02309359|323593833|FG003|Overall Study|Death|0|||
94491607|NCT02309359|323593834|FG004|Overall Study|Death|0|||
94491608|NCT02309359|323593830|FG000|Overall Study|Withdrawal by Subject|2|||
94491609|NCT02309359|323593831|FG001|Overall Study|Withdrawal by Subject|2|||
94491610|NCT02309359|323593832|FG002|Overall Study|Withdrawal by Subject|4|||
94491611|NCT02309359|323593833|FG003|Overall Study|Withdrawal by Subject|4|||
94491612|NCT02309359|323593834|FG004|Overall Study|Withdrawal by Subject|0|||
94491613|NCT02309359|323593830|FG000|Overall Study|Lack of Efficacy|3|||
94491614|NCT02309359|323593831|FG001|Overall Study|Lack of Efficacy|1|||
94491615|NCT02309359|323593832|FG002|Overall Study|Lack of Efficacy|0|||
94491616|NCT02309359|323593833|FG003|Overall Study|Lack of Efficacy|0|||
94491617|NCT02309359|323593834|FG004|Overall Study|Lack of Efficacy|3|||
94491618|NCT02309359|323593830|FG000|Overall Study|Lost to Follow-up|0|||
94491619|NCT02309359|323593831|FG001|Overall Study|Lost to Follow-up|0|||
94491620|NCT02309359|323593832|FG002|Overall Study|Lost to Follow-up|0|||
94491621|NCT02309359|323593833|FG003|Overall Study|Lost to Follow-up|1|||
94491622|NCT02309359|323593834|FG004|Overall Study|Lost to Follow-up|0|||
94491623|NCT02309359|323593830|FG000|Overall Study|Other|2|||
94491624|NCT02309359|323593831|FG001|Overall Study|Other|0|||
94491625|NCT02309359|323593832|FG002|Overall Study|Other|2|||
94491626|NCT02309359|323593833|FG003|Overall Study|Other|3|||
94491627|NCT02309359|323593834|FG004|Overall Study|Other|2|||
94491628|NCT01316575|323593836|FG000|Overall Study|Withdrawal by Subject|2|||
94491629|NCT01316575|323593837|FG001|Overall Study|Withdrawal by Subject|0|||
94491630|NCT01316575|323593836|FG000|Overall Study|Required alternate treatment|0|||
94491631|NCT01316575|323593837|FG001|Overall Study|Required alternate treatment|1|||
94491632|NCT00402831|323593838|FG000|Overall Study|Lost to Follow-up|1|||
94491633|NCT00402831|323593839|FG001|Overall Study|Lost to Follow-up|2|||
94491634|NCT00402831|323593838|FG000|Overall Study|Non-compliance with protocol|0|||
94491635|NCT00402831|323593839|FG001|Overall Study|Non-compliance with protocol|1|||
94491636|NCT02340949|323593840|FG000|Overall Study|Adverse Event|4|||
94491637|NCT02340949|323593841|FG001|Overall Study|Adverse Event|2|||
94491638|NCT02340949|323593840|FG000|Overall Study|Withdrawal by Subject|2|||
94491639|NCT02340949|323593841|FG001|Overall Study|Withdrawal by Subject|0|||
94491640|NCT02340949|323593840|FG000|Overall Study|Progression disease|6|||
94491641|NCT02340949|323593841|FG001|Overall Study|Progression disease|2|||
94491642|NCT02340949|323593840|FG000|Overall Study|Death|3|||
94491643|NCT02340949|323593841|FG001|Overall Study|Death|0|||
94491644|NCT02340949|323593840|FG000|Overall Study|Physician Decision|1|||
94491645|NCT02340949|323593841|FG001|Overall Study|Physician Decision|0|||
94491646|NCT01192178|323593842|FG000|Overall Study|Withdrawal by Subject|6|||
94491647|NCT01192178|323593843|FG001|Overall Study|Withdrawal by Subject|10|||
94491648|NCT01192178|323593842|FG000|Overall Study|Protocol Violation|10|||
94491649|NCT01192178|323593843|FG001|Overall Study|Protocol Violation|3|||
94491650|NCT01192178|323593842|FG000|Overall Study|Physician Decision|2|||
94491651|NCT01192178|323593843|FG001|Overall Study|Physician Decision|4|||
94491652|NCT01192178|323593842|FG000|Overall Study|Lost to Follow-up|3|||
94491653|NCT01192178|323593843|FG001|Overall Study|Lost to Follow-up|3|||
94491654|NCT01192178|323593842|FG000|Overall Study|Adverse Event|2|||
94491655|NCT01192178|323593843|FG001|Overall Study|Adverse Event|1|||
94491656|NCT01192178|323593842|FG000|Overall Study|Lack of Efficacy|1|||
94491657|NCT01192178|323593843|FG001|Overall Study|Lack of Efficacy|2|||
94491658|NCT02460289|323593844|FG000|Overall Study|Adverse Event|1|||
94491659|NCT02460289|323593844|FG000|Overall Study|Withdrawal by Subject|8|||
94491660|NCT02460289|323593844|FG000|Overall Study|Lost to Follow-up|1|||
94491661|NCT01155570|323593845|FG000|Overall Study|Adverse Event|39|||
94491662|NCT01155570|323593845|FG000|Overall Study|Lack of Efficacy|46|||
94491663|NCT01155570|323593845|FG000|Overall Study|Participant's Economic Reasons|17|||
94491664|NCT01155570|323593845|FG000|Overall Study|No Hospital Visits|7|||
94491665|NCT01155570|323593845|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
94491666|NCT01155570|323593845|FG000|Overall Study|Adverse Event + Other Reasons|7|||
94491667|NCT01155570|323593845|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
94491668|NCT01155570|323593845|FG000|Overall Study|Other Reasons|23|||
94491669|NCT02164916|323593846|FG000|Overall Study|Adverse Event|3|||
94491670|NCT02164916|323593847|FG001|Overall Study|Adverse Event|8|||
94491671|NCT02164916|323593846|FG000|Overall Study|Death|1|||
94491672|NCT02164916|323593847|FG001|Overall Study|Death|1|||
94491673|NCT02164916|323593846|FG000|Overall Study|Refusal unrelated to adverse event|3|||
94491674|NCT02164916|323593847|FG001|Overall Study|Refusal unrelated to adverse event|7|||
94491675|NCT02164916|323593846|FG000|Overall Study|Progression|37|||
94491676|NCT02164916|323593847|FG001|Overall Study|Progression|26|||
94491677|NCT02164916|323593846|FG000|Overall Study|Not protocol specified|5|||
94491678|NCT02164916|323593847|FG001|Overall Study|Not protocol specified|1|||
94491679|NCT02164916|323593846|FG000|Overall Study|Reason under review|1|||
94491680|NCT02164916|323593847|FG001|Overall Study|Reason under review|6|||
94491681|NCT02164916|323593846|FG000|Overall Study|Not eligible|2|||
94491682|NCT02164916|323593847|FG001|Overall Study|Not eligible|5|||
94491683|NCT03122106|323593850|FG000|Overall Study|Not enough tissue|1|||
94491684|NCT03122106|323593850|FG000|Overall Study|Disease progression during screening|2|||
94491685|NCT03122106|323593850|FG000|Overall Study|Poor RNA quality for vaccine|1|||
94491686|NCT01143324|323593853|FG000|Overall Study|Lost to Follow-up|11|||
94491687|NCT01143324|323593853|FG000|Overall Study|Withdrawal by Subject|4|||
94491688|NCT01143324|323593853|FG000|Overall Study|Explant of the device|4|||
94491689|NCT00596635|323593854|FG000|Overall Study|Lost to Follow-up|0|||
94491690|NCT00596635|323593855|FG001|Overall Study|Lost to Follow-up|2|||
94491691|NCT00596635|323593856|FG002|Overall Study|Lost to Follow-up|0|||
94491692|NCT00596635|323593854|FG000|Overall Study|Treatment for symptomatic UTI|4|||
94491693|NCT00596635|323593855|FG001|Overall Study|Treatment for symptomatic UTI|6|||
94491694|NCT00596635|323593856|FG002|Overall Study|Treatment for symptomatic UTI|3|||
94491695|NCT00596635|323593854|FG000|Overall Study|Hip fracture|2|||
94491696|NCT00596635|323593855|FG001|Overall Study|Hip fracture|3|||
94491697|NCT00596635|323593856|FG002|Overall Study|Hip fracture|3|||
94491698|NCT00596635|323593854|FG000|Overall Study|Could not provide urine specimen|1|||
94491699|NCT00596635|323593855|FG001|Overall Study|Could not provide urine specimen|2|||
94491700|NCT00596635|323593856|FG002|Overall Study|Could not provide urine specimen|2|||
94491701|NCT01101178|323593858|FG000|Period 1|Withdrawal by Subject|1|||
94491702|NCT01101178|323593859|FG001|Period 1|Withdrawal by Subject|2|||
94491703|NCT01101178|323593858|FG000|Period 1|Positive drug screen|1|||
94491704|NCT01101178|323593859|FG001|Period 1|Positive drug screen|1|||
94491705|NCT01101178|323593858|FG000|Period 1|Adverse Event|2|||
94491706|NCT01101178|323593859|FG001|Period 1|Adverse Event|1|||
94491707|NCT01101178|323593858|FG000|Period 2|Withdrawal by Subject|0|||
94491708|NCT01101178|323593859|FG001|Period 2|Withdrawal by Subject|1|||
94491709|NCT00858988|323593862|FG000|Analysis|Lactulose unable to be detected in urine|2|||
94491710|NCT00858988|323593863|FG001|Analysis|Lactulose unable to be detected in urine|1|||
94491711|NCT00846365|323593868|FG000|Overall Study|Adverse Event|20|||
94491712|NCT00846365|323593869|FG001|Overall Study|Adverse Event|30|||
94491713|NCT00846365|323593870|FG002|Overall Study|Adverse Event|11|||
94491714|NCT00846365|323593868|FG000|Overall Study|Protocol Violation|5|||
94491715|NCT00846365|323593869|FG001|Overall Study|Protocol Violation|4|||
94491716|NCT00846365|323593870|FG002|Overall Study|Protocol Violation|0|||
94491717|NCT00846365|323593868|FG000|Overall Study|Lost to Follow-up|8|||
94491718|NCT00846365|323593869|FG001|Overall Study|Lost to Follow-up|2|||
94491719|NCT00846365|323593870|FG002|Overall Study|Lost to Follow-up|5|||
94491720|NCT00846365|323593868|FG000|Overall Study|Withdrawal by Subject|11|||
94491721|NCT00846365|323593869|FG001|Overall Study|Withdrawal by Subject|11|||
94491722|NCT00846365|323593870|FG002|Overall Study|Withdrawal by Subject|9|||
94491723|NCT00846365|323593868|FG000|Overall Study|Pregnancy|1|||
94491724|NCT00846365|323593869|FG001|Overall Study|Pregnancy|0|||
94491725|NCT00846365|323593870|FG002|Overall Study|Pregnancy|0|||
94491726|NCT00846365|323593868|FG000|Overall Study|Lack of Efficacy|1|||
94491727|NCT00846365|323593869|FG001|Overall Study|Lack of Efficacy|1|||
94491728|NCT00846365|323593870|FG002|Overall Study|Lack of Efficacy|2|||
94491729|NCT00846365|323593868|FG000|Overall Study|Other|9|||
94491730|NCT00846365|323593869|FG001|Overall Study|Other|1|||
94491731|NCT00846365|323593870|FG002|Overall Study|Other|6|||
94491732|NCT01349595|323593871|FG000|Overall Study|Lack of funding|2|||
94491733|NCT01349595|323593872|FG001|Overall Study|Lack of funding|2|||
94491734|NCT02318940|323593873|FG000|Overall Study|lost the record|1|||
94491735|NCT02318940|323593874|FG001|Overall Study|lost the record|0|||
94491736|NCT04711005|323593875|FG000|Overall Study|Withdrawal by Subject|0|||
94491737|NCT04711005|323593876|FG001|Overall Study|Withdrawal by Subject|0|||
94491738|NCT04711005|323593877|FG002|Overall Study|Withdrawal by Subject|0|||
94491739|NCT04711005|323593878|FG003|Overall Study|Withdrawal by Subject|0|||
94491740|NCT04711005|323593879|FG004|Overall Study|Withdrawal by Subject|0|||
94491741|NCT04711005|323593880|FG005|Overall Study|Withdrawal by Subject|0|||
94491742|NCT04711005|323593881|FG006|Overall Study|Withdrawal by Subject|0|||
94491743|NCT04711005|323593882|FG007|Overall Study|Withdrawal by Subject|1|||
94491744|NCT04711005|323593883|FG008|Overall Study|Withdrawal by Subject|0|||
94491745|NCT04711005|323593884|FG009|Overall Study|Withdrawal by Subject|0|||
94491746|NCT04711005|323593875|FG000|Overall Study|Physician Decision|0|||
94491747|NCT04711005|323593876|FG001|Overall Study|Physician Decision|0|||
94491748|NCT04711005|323593877|FG002|Overall Study|Physician Decision|0|||
94491749|NCT04711005|323593878|FG003|Overall Study|Physician Decision|0|||
94491750|NCT04711005|323593879|FG004|Overall Study|Physician Decision|0|||
94491751|NCT04711005|323593880|FG005|Overall Study|Physician Decision|0|||
94491752|NCT04711005|323593881|FG006|Overall Study|Physician Decision|0|||
94491753|NCT04711005|323593882|FG007|Overall Study|Physician Decision|2|||
94491754|NCT04711005|323593883|FG008|Overall Study|Physician Decision|1|||
94491755|NCT04711005|323593884|FG009|Overall Study|Physician Decision|0|||
94491756|NCT02273167|323593885|FG000|Overall Study|Adverse Event|1|||
94491757|NCT02273167|323593886|FG001|Overall Study|Adverse Event|0|||
94491758|NCT02273167|323593887|FG002|Overall Study|Adverse Event|0|||
94491759|NCT02273167|323593885|FG000|Overall Study|Protocol Violation|3|||
94491760|NCT02273167|323593886|FG001|Overall Study|Protocol Violation|1|||
94491761|NCT02273167|323593887|FG002|Overall Study|Protocol Violation|1|||
94491762|NCT02273167|323593885|FG000|Overall Study|Lost to Follow-up|0|||
94491763|NCT02273167|323593886|FG001|Overall Study|Lost to Follow-up|1|||
94491764|NCT02273167|323593887|FG002|Overall Study|Lost to Follow-up|1|||
94491765|NCT02273167|323593885|FG000|Overall Study|Withdrawal by Subject|10|||
94491766|NCT02273167|323593886|FG001|Overall Study|Withdrawal by Subject|12|||
94491767|NCT02273167|323593887|FG002|Overall Study|Withdrawal by Subject|11|||
94491768|NCT02273167|323593885|FG000|Overall Study|Various|10|||
94491769|NCT02273167|323593886|FG001|Overall Study|Various|9|||
94491770|NCT02273167|323593887|FG002|Overall Study|Various|8|||
94491771|NCT01157845|323593889|FG000|Overall Study|Lost to Follow-up|5|||
94491772|NCT01157845|323593889|FG000|Overall Study|Withdrawal by Subject|12|||
94491773|NCT01157845|323593889|FG000|Overall Study|Physician Decision|3|||
94491774|NCT01157845|323593889|FG000|Overall Study|Protocol Violation|13|||
94491775|NCT01157845|323593889|FG000|Overall Study|Study was ended|1|||
94491776|NCT01157845|323593889|FG000|Overall Study|Device malfunction|1|||
94491777|NCT03311555|323593891|FG000|Overall Study|Adverse Event|1|||
94491778|NCT00834041|323593893|FG000|Overall Study|Withdrawal by Subject|1|||
94491779|NCT00834041|323593894|FG001|Overall Study|Withdrawal by Subject|0|||
94491780|NCT00834041|323593893|FG000|Overall Study|Lost to Follow-up|0|||
94491781|NCT00834041|323593894|FG001|Overall Study|Lost to Follow-up|1|||
94491782|NCT00350545|323594935|FG000|Overall Study|Withdrawal by Subject|2|||
94491783|NCT00753519|323594936|FG000|Overall Study|Withdrawal by Subject|0|||
94491784|NCT00753519|323594937|FG001|Overall Study|Withdrawal by Subject|2|||
94491785|NCT00434252|323594938|FG000|Overall Study|Lack of Efficacy|50|||
94491786|NCT00434252|323594939|FG001|Overall Study|Lack of Efficacy|100|||
94491787|NCT00434252|323594938|FG000|Overall Study|Adverse Event|6|||
94491788|NCT00434252|323594939|FG001|Overall Study|Adverse Event|13|||
94491789|NCT00434252|323594938|FG000|Overall Study|Death|1|||
94491790|NCT00434252|323594939|FG001|Overall Study|Death|2|||
94491791|NCT00434252|323594938|FG000|Overall Study|Lost to Follow-up|0|||
94491792|NCT00434252|323594939|FG001|Overall Study|Lost to Follow-up|1|||
94491793|NCT00434252|323594938|FG000|Overall Study|Physician Decision|4|||
94491794|NCT00434252|323594939|FG001|Overall Study|Physician Decision|8|||
94491795|NCT00434252|323594938|FG000|Overall Study|Withdrawal by Subject|3|||
94491796|NCT00434252|323594939|FG001|Overall Study|Withdrawal by Subject|7|||
94491797|NCT01171534|323594947|FG000|Overall Study|Lost to Follow-up|0|||
94491798|NCT01171534|323594948|FG001|Overall Study|Lost to Follow-up|2|||
94491799|NCT01171534|323594947|FG000|Overall Study|screen failure|0|||
94491800|NCT01171534|323594948|FG001|Overall Study|screen failure|1|||
94491801|NCT02337764|323594949|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
94491802|NCT02337764|323594949|FG000|Overall Study|Voluntary Withdrawal|12|||
94491803|NCT02337764|323594949|FG000|Overall Study|Lack of Efficacy|2|||
94491804|NCT03255187|323594950|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
94491805|NCT03255187|323594951|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
94491806|NCT03255187|323594950|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
94491807|NCT03255187|323594951|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
94491808|NCT00109343|323594952|FG000|Overall Study|Adverse Event|1|||
94491809|NCT00109343|323594953|FG001|Overall Study|Adverse Event|0|||
94491810|NCT00109343|323594954|FG002|Overall Study|Adverse Event|2|||
94491811|NCT00109343|323594952|FG000|Overall Study|Lack of Efficacy|1|||
94491812|NCT00109343|323594953|FG001|Overall Study|Lack of Efficacy|0|||
94491813|NCT00109343|323594954|FG002|Overall Study|Lack of Efficacy|0|||
94491814|NCT00109343|323594952|FG000|Overall Study|Lost to Follow-up|35|||
94491815|NCT00109343|323594953|FG001|Overall Study|Lost to Follow-up|20|||
94491816|NCT00109343|323594954|FG002|Overall Study|Lost to Follow-up|14|||
94491817|NCT00109343|323594952|FG000|Overall Study|Protocol Violation|1|||
94491818|NCT00109343|323594953|FG001|Overall Study|Protocol Violation|2|||
94491819|NCT00109343|323594954|FG002|Overall Study|Protocol Violation|2|||
94491820|NCT00109343|323594952|FG000|Overall Study|Withdrawal by Subject|15|||
94491821|NCT00109343|323594953|FG001|Overall Study|Withdrawal by Subject|11|||
94491822|NCT00109343|323594954|FG002|Overall Study|Withdrawal by Subject|10|||
94491823|NCT00109343|323594952|FG000|Overall Study|Subject Moved|6|||
94491824|NCT00109343|323594953|FG001|Overall Study|Subject Moved|2|||
94491825|NCT00109343|323594954|FG002|Overall Study|Subject Moved|1|||
94491826|NCT00109343|323594952|FG000|Overall Study|Other|5|||
94491827|NCT00109343|323594953|FG001|Overall Study|Other|2|||
94491828|NCT00109343|323594954|FG002|Overall Study|Other|1|||
94491829|NCT01898078|323594960|FG000|Overall Study|Progressive Disease|1|||
94491830|NCT01898078|323594961|FG001|Overall Study|Progressive Disease|5|||
94491831|NCT01898078|323594960|FG000|Overall Study|Adverse Event|2|||
94491832|NCT01898078|323594961|FG001|Overall Study|Adverse Event|1|||
94491833|NCT01898078|323594960|FG000|Overall Study|Withdrawal by Subject|1|||
94491834|NCT01898078|323594961|FG001|Overall Study|Withdrawal by Subject|1|||
94491835|NCT01898078|323594960|FG000|Overall Study|Symptomatic Deterioration|2|||
94491836|NCT01898078|323594961|FG001|Overall Study|Symptomatic Deterioration|0|||
94491837|NCT01898078|323594960|FG000|Overall Study|Reason not Specified|0|||
94491838|NCT01898078|323594961|FG001|Overall Study|Reason not Specified|1|||
94491839|NCT01075048|323594962|FG000|Overall Study|Death|4|||
94491840|NCT01075048|323594963|FG001|Overall Study|Death|17|||
94491841|NCT01075048|323594964|FG002|Overall Study|Death|12|||
94491842|NCT01075048|323594962|FG000|Overall Study|Start of other or new therapy|4|||
94491843|NCT01075048|323594963|FG001|Overall Study|Start of other or new therapy|36|||
94491844|NCT01075048|323594964|FG002|Overall Study|Start of other or new therapy|46|||
94491845|NCT01075048|323594962|FG000|Overall Study|Withdrawal by Subject|1|||
94491846|NCT01075048|323594963|FG001|Overall Study|Withdrawal by Subject|6|||
94491847|NCT01075048|323594964|FG002|Overall Study|Withdrawal by Subject|3|||
94491848|NCT01075048|323594962|FG000|Overall Study|Lost to Follow-up|0|||
94491849|NCT01075048|323594963|FG001|Overall Study|Lost to Follow-up|1|||
94491850|NCT01075048|323594964|FG002|Overall Study|Lost to Follow-up|1|||
94491851|NCT01125930|323594967|FG000|Overall Study|Adverse Event|0|||
94491852|NCT01125930|323594968|FG001|Overall Study|Adverse Event|1|||
94491853|NCT01125930|323594967|FG000|Overall Study|Withdrawal by Subject|1|||
94491854|NCT01125930|323594968|FG001|Overall Study|Withdrawal by Subject|6|||
94491855|NCT01125930|323594967|FG000|Overall Study|Protocol Violation|0|||
94491856|NCT01125930|323594968|FG001|Overall Study|Protocol Violation|1|||
94491857|NCT01125930|323594967|FG000|Overall Study|Lost to Follow-up|0|||
94491858|NCT01125930|323594968|FG001|Overall Study|Lost to Follow-up|2|||
94491859|NCT02566005|323594971|FG000|Overall Study|vaginal bleeding|0|||
94491860|NCT02566005|323594972|FG001|Overall Study|vaginal bleeding|1|||
94491861|NCT02566005|323594971|FG000|Overall Study|received foley|8|||
94491862|NCT02566005|323594972|FG001|Overall Study|received foley|0|||
94491863|NCT02566005|323594971|FG000|Overall Study|did not receive foley|0|||
94491864|NCT02566005|323594972|FG001|Overall Study|did not receive foley|1|||
94491865|NCT02566005|323594971|FG000|Overall Study|labor after randomization|0|||
94491866|NCT02566005|323594972|FG001|Overall Study|labor after randomization|4|||
94491867|NCT03617588|323594973|FG000|Overall Study|Withdrawal by Subject|1|||
94491868|NCT03617588|323594974|FG001|Overall Study|Withdrawal by Subject|0|||
94491869|NCT02690727|323594978|FG000|Overall Study|Adverse Event|2|||
94491870|NCT02690727|323594979|FG001|Overall Study|Adverse Event|2|||
94491871|NCT01432951|323594980|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
94491872|NCT00141921|323594981|FG000|Overall Study|Remain on Study|28|||
94491873|NCT00141921|323594981|FG000|Overall Study|Withdrawal by Subject|42|||
94491874|NCT00141921|323594981|FG000|Overall Study|Lost to Follow-up|19|||
94491875|NCT00141921|323594981|FG000|Overall Study|Noncompliance|17|||
94491876|NCT00141921|323594981|FG000|Overall Study|Disease Progression|7|||
94491877|NCT00141921|323594981|FG000|Overall Study|Protocol Deviation|7|||
94491878|NCT00141921|323594981|FG000|Overall Study|Adverse Event|5|||
94491879|NCT00141921|323594981|FG000|Overall Study|Administrative Decision|2|||
94491880|NCT00141921|323594981|FG000|Overall Study|Pregnancy|4|||
94491881|NCT00141921|323594981|FG000|Overall Study|Ineligibility Determined|2|||
94491882|NCT00141921|323594981|FG000|Overall Study|Other|8|||
94491883|NCT02765035|323594987|FG000|First Intervention (90 Days)|Adverse Event|1|||
94491884|NCT02765035|323594988|FG001|First Intervention (90 Days)|Adverse Event|1|||
94491885|NCT02765035|323594987|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
94491886|NCT02765035|323594988|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
94491887|NCT00091819|323594989|FG000|Overall Study|Adverse Event|1|||
94491888|NCT00091819|323594990|FG001|Overall Study|Adverse Event|1|||
94491889|NCT00091819|323594989|FG000|Overall Study|Death|4|||
94491890|NCT00091819|323594990|FG001|Overall Study|Death|5|||
94491891|NCT00091819|323594989|FG000|Overall Study|Lost to Follow-up|26|||
94491892|NCT00091819|323594990|FG001|Overall Study|Lost to Follow-up|23|||
94491893|NCT00091819|323594989|FG000|Overall Study|Withdrawal by Subject|5|||
94491894|NCT00091819|323594990|FG001|Overall Study|Withdrawal by Subject|8|||
94491895|NCT00091819|323594989|FG000|Overall Study|Protocol Violation|1|||
94491896|NCT00091819|323594990|FG001|Overall Study|Protocol Violation|2|||
94491897|NCT00091819|323594989|FG000|Overall Study|Other|2|||
94491898|NCT00091819|323594990|FG001|Overall Study|Other|3|||
94491899|NCT00091819|323594989|FG000|Overall Study|Never received study treatment|3|||
94491900|NCT00091819|323594990|FG001|Overall Study|Never received study treatment|4|||
94491901|NCT02471339|323594991|FG000|Overall Study|Did not provide follow-up data|2|||
94491902|NCT02471339|323594992|FG001|Overall Study|Did not provide follow-up data|0|||
94491903|NCT00984867|323594993|FG000|Overall Study|Adverse Event|3|||
94491904|NCT00984867|323594994|FG001|Overall Study|Adverse Event|7|||
94491905|NCT00984867|323594993|FG000|Overall Study|Death|1|||
94491906|NCT00984867|323594994|FG001|Overall Study|Death|0|||
94491907|NCT00984867|323594993|FG000|Overall Study|Withdrawal by Subject|13|||
94491908|NCT00984867|323594994|FG001|Overall Study|Withdrawal by Subject|4|||
94491909|NCT00984867|323594993|FG000|Overall Study|Lost to Follow-up|3|||
94491910|NCT00984867|323594994|FG001|Overall Study|Lost to Follow-up|4|||
94491911|NCT00984867|323594993|FG000|Overall Study|Poor/non-compliance|0|||
94491912|NCT00984867|323594994|FG001|Overall Study|Poor/non-compliance|1|||
94491913|NCT00984867|323594993|FG000|Overall Study|Subject no longer meets study criteria|1|||
94491914|NCT00984867|323594994|FG001|Overall Study|Subject no longer meets study criteria|1|||
94491915|NCT00984867|323594993|FG000|Overall Study|site closing|1|||
94491916|NCT00984867|323594994|FG001|Overall Study|site closing|0|||
94491917|NCT00984867|323594993|FG000|Overall Study|lack of efficacy and subject compliance|1|||
94491918|NCT00984867|323594994|FG001|Overall Study|lack of efficacy and subject compliance|0|||
94491919|NCT03473197|323594995|FG000|Overall Study|Adverse Event|4|||
94491920|NCT03473197|323594995|FG000|Overall Study|Lost to Follow-up|1|||
94491921|NCT03473197|323594995|FG000|Overall Study|Withdrawal by Subject|5|||
94491922|NCT00785629|323594996|FG000|Overall Study|Adverse Event|2|||
94491923|NCT00785629|323594997|FG001|Overall Study|Adverse Event|1|||
94491924|NCT00785629|323594998|FG002|Overall Study|Adverse Event|1|||
94491925|NCT00785629|323594999|FG003|Overall Study|Adverse Event|5|||
94491926|NCT00785629|323594996|FG000|Overall Study|Protocol Violation|1|||
94491927|NCT00785629|323594997|FG001|Overall Study|Protocol Violation|2|||
94491928|NCT00785629|323594998|FG002|Overall Study|Protocol Violation|4|||
94491929|NCT00785629|323594999|FG003|Overall Study|Protocol Violation|5|||
94491930|NCT00785629|323594996|FG000|Overall Study|administrative decision|5|||
94491931|NCT00785629|323594997|FG001|Overall Study|administrative decision|1|||
94491932|NCT00785629|323594998|FG002|Overall Study|administrative decision|3|||
94491933|NCT00785629|323594999|FG003|Overall Study|administrative decision|4|||
94491934|NCT00785629|323594996|FG000|Overall Study|Withdrawal by Subject|0|||
94491935|NCT00785629|323594997|FG001|Overall Study|Withdrawal by Subject|1|||
94491936|NCT00785629|323594998|FG002|Overall Study|Withdrawal by Subject|2|||
94491937|NCT00785629|323594999|FG003|Overall Study|Withdrawal by Subject|2|||
94491938|NCT00851591|323595000|FG000|Overall Study|Withdrawal by Subject|2|||
94491939|NCT00851591|323595001|FG001|Overall Study|Withdrawal by Subject|0|||
94491940|NCT02326883|323595002|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
94491941|NCT02326883|323595003|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
94491942|NCT02326883|323595004|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
94491943|NCT02178956|323595007|FG000|Overall Study|Lost to Follow-up|4|||
94491944|NCT02178956|323595008|FG001|Overall Study|Lost to Follow-up|4|||
94491945|NCT02178956|323595007|FG000|Overall Study|Sponsor terminated study|49|||
94491946|NCT02178956|323595008|FG001|Overall Study|Sponsor terminated study|58|||
94491947|NCT02178956|323595007|FG000|Overall Study|Withdrawal by Subject|15|||
94491948|NCT02178956|323595008|FG001|Overall Study|Withdrawal by Subject|11|||
94491949|NCT02178956|323595007|FG000|Overall Study|Various Reasons|3|||
94491950|NCT02178956|323595008|FG001|Overall Study|Various Reasons|5|||
94491951|NCT01900314|323595010|FG000|Overall Study|Lost to Follow-up|1|||
94491952|NCT01900314|323595011|FG001|Overall Study|Lost to Follow-up|0|||
94491953|NCT01900314|323595010|FG000|Overall Study|Protocol Violation|0|||
94491954|NCT01900314|323595011|FG001|Overall Study|Protocol Violation|1|||
94491955|NCT01900314|323595010|FG000|Overall Study|Withdrawal by Subject|3|||
94491956|NCT01900314|323595011|FG001|Overall Study|Withdrawal by Subject|3|||
94491957|NCT03188822|323595016|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
94491958|NCT03188822|323595016|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
94491959|NCT00639509|323595017|FG000|Overall Study|Death|1|||
94491960|NCT02029417|323595018|FG000|Overall Study|Death|1|||
94491961|NCT02029417|323595018|FG000|Overall Study|Adverse Event|1|||
94491962|NCT02814526|323595023|FG000|Overall Study|Adverse Event|4|||
94491963|NCT02814526|323595024|FG001|Overall Study|Adverse Event|3|||
94491964|NCT02814526|323595023|FG000|Overall Study|Death|1|||
94491965|NCT02814526|323595024|FG001|Overall Study|Death|1|||
94491966|NCT02814526|323595023|FG000|Overall Study|Lost to Follow-up|3|||
94491967|NCT02814526|323595024|FG001|Overall Study|Lost to Follow-up|4|||
94491968|NCT02814526|323595023|FG000|Overall Study|non site physician decision|1|||
94491969|NCT02814526|323595024|FG001|Overall Study|non site physician decision|0|||
94491970|NCT02814526|323595023|FG000|Overall Study|participant noncompliance|1|||
94491971|NCT02814526|323595024|FG001|Overall Study|participant noncompliance|1|||
94491972|NCT02814526|323595023|FG000|Overall Study|Withdrawal by Subject|20|||
94491973|NCT02814526|323595024|FG001|Overall Study|Withdrawal by Subject|14|||
94491974|NCT02814526|323595023|FG000|Overall Study|safety risk|2|||
94491975|NCT02814526|323595024|FG001|Overall Study|safety risk|1|||
94491976|NCT02814526|323595023|FG000|Overall Study|early termination-study terminated|1|||
94491977|NCT02814526|323595024|FG001|Overall Study|early termination-study terminated|2|||
94491978|NCT02814526|323595023|FG000|Overall Study|Other|0|||
94491979|NCT02814526|323595024|FG001|Overall Study|Other|4|||
94491980|NCT00724945|323595030|FG000|Period 1|non-compliance|1|||
94491981|NCT00724945|323595031|FG001|Period 1|non-compliance|0|||
94491982|NCT00724945|323595030|FG000|Period 1|Adverse Event|1|||
94491983|NCT00724945|323595031|FG001|Period 1|Adverse Event|1|||
94491984|NCT00724945|323595030|FG000|Period 1|Lost to Follow-up|1|||
94491985|NCT00724945|323595031|FG001|Period 1|Lost to Follow-up|0|||
94491986|NCT00724945|323595030|FG000|Period 2|lens comfort issue|3|||
94491987|NCT00724945|323595031|FG001|Period 2|lens comfort issue|0|||
94491988|NCT00724945|323595030|FG000|Period 2|lens physiology issue|1|||
94491989|NCT00724945|323595031|FG001|Period 2|lens physiology issue|0|||
94491990|NCT01937299|323595033|FG000|Overall Study|Adverse Event|13|||
94491991|NCT01937299|323595034|FG001|Overall Study|Adverse Event|0|||
94491992|NCT01937299|323595033|FG000|Overall Study|Lack of Efficacy|0|||
94491993|NCT01937299|323595034|FG001|Overall Study|Lack of Efficacy|4|||
94491994|NCT01937299|323595033|FG000|Overall Study|Withdrawal by Subject|1|||
94491995|NCT01937299|323595034|FG001|Overall Study|Withdrawal by Subject|0|||
94491996|NCT00385840|323595037|FG000|Overall Study|Adverse Event|1|||
94491997|NCT00385840|323595038|FG001|Overall Study|Adverse Event|1|||
94491998|NCT00385840|323595037|FG000|Overall Study|Lost to Follow-up|3|||
94491999|NCT00385840|323595038|FG001|Overall Study|Lost to Follow-up|13|||
94492000|NCT00640289|323595040|FG000|Overall Study|Death|3|||
94492001|NCT00640289|323595040|FG000|Overall Study|Withdrawal by Subject|1|||
94492002|NCT00640289|323595040|FG000|Overall Study|Lost to Follow-up|1|||
94492003|NCT00640289|323595040|FG000|Overall Study|Data collected under different amendment|2|||
94492004|NCT00640289|323595040|FG000|Overall Study|Transferred to another center|1|||
94492005|NCT00640289|323595040|FG000|Overall Study|Missing status|5|||
94492006|NCT00849056|323596633|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
94492007|NCT00849056|323596634|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
94492008|NCT00849056|323596633|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
94492009|NCT00849056|323596634|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
94492010|NCT00849056|323596633|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
94492011|NCT00849056|323596634|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
94492012|NCT00849056|323596633|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
94492013|NCT00849056|323596634|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
94492014|NCT00849056|323596633|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
94492015|NCT00849056|323596634|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
94492016|NCT00849056|323596633|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
94492017|NCT00849056|323596634|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
94492018|NCT00849056|323596633|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
94492019|NCT00849056|323596634|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
94492020|NCT00849056|323596633|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
94492021|NCT00849056|323596634|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
94492022|NCT00849056|323596633|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
94492023|NCT00849056|323596634|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
94492024|NCT00849056|323596633|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
94492025|NCT00849056|323596634|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
94492026|NCT00849056|323596633|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
94492027|NCT00849056|323596634|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
94492028|NCT00849056|323596633|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
94492029|NCT00849056|323596634|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
94492030|NCT00849056|323596633|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
94492031|NCT00849056|323596634|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
94492032|NCT00849056|323596633|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
94492033|NCT00849056|323596634|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
94492034|NCT00849056|323596633|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
94492035|NCT00849056|323596634|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
94492036|NCT00849056|323596633|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
94492037|NCT00849056|323596634|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
94492038|NCT02711137|323596635|FG000|Overall Study|Death|1|||
94492039|NCT02711137|323596636|FG001|Overall Study|Death|4|||
94492040|NCT02711137|323596637|FG002|Overall Study|Death|5|||
94492041|NCT02711137|323596638|FG003|Overall Study|Death|5|||
94492042|NCT02711137|323596639|FG004|Overall Study|Death|3|||
94492043|NCT02711137|323596640|FG005|Overall Study|Death|1|||
94492044|NCT02711137|323596641|FG006|Overall Study|Death|61|||
94492045|NCT02711137|323596642|FG007|Overall Study|Death|3|||
94492046|NCT02711137|323596643|FG008|Overall Study|Death|0|||
94492047|NCT02711137|323596644|FG009|Overall Study|Death|1|||
94492048|NCT02711137|323596645|FG010|Overall Study|Death|1|||
94492049|NCT02711137|323596646|FG011|Overall Study|Death|1|||
94492050|NCT02711137|323596647|FG012|Overall Study|Death|0|||
94492051|NCT02711137|323596648|FG013|Overall Study|Death|0|||
94492052|NCT02711137|323596649|FG014|Overall Study|Death|0|||
94492053|NCT02711137|323596635|FG000|Overall Study|Study Terminated by Sponsor|0|||
94492054|NCT02711137|323596636|FG001|Overall Study|Study Terminated by Sponsor|0|||
94492055|NCT02711137|323596637|FG002|Overall Study|Study Terminated by Sponsor|1|||
94492056|NCT02711137|323596638|FG003|Overall Study|Study Terminated by Sponsor|0|||
94492057|NCT02711137|323596639|FG004|Overall Study|Study Terminated by Sponsor|0|||
94492058|NCT02711137|323596640|FG005|Overall Study|Study Terminated by Sponsor|0|||
94492059|NCT02711137|323596641|FG006|Overall Study|Study Terminated by Sponsor|1|||
94492060|NCT02711137|323596642|FG007|Overall Study|Study Terminated by Sponsor|0|||
94492061|NCT02711137|323596643|FG008|Overall Study|Study Terminated by Sponsor|0|||
94492062|NCT02711137|323596644|FG009|Overall Study|Study Terminated by Sponsor|0|||
94492063|NCT02711137|323596645|FG010|Overall Study|Study Terminated by Sponsor|0|||
94492064|NCT02711137|323596646|FG011|Overall Study|Study Terminated by Sponsor|0|||
94492065|NCT02711137|323596647|FG012|Overall Study|Study Terminated by Sponsor|0|||
94492066|NCT02711137|323596648|FG013|Overall Study|Study Terminated by Sponsor|0|||
94492067|NCT02711137|323596649|FG014|Overall Study|Study Terminated by Sponsor|0|||
94492068|NCT02711137|323596635|FG000|Overall Study|Physician Decision|1|||
94492069|NCT02711137|323596636|FG001|Overall Study|Physician Decision|0|||
94492070|NCT02711137|323596637|FG002|Overall Study|Physician Decision|2|||
94492071|NCT02711137|323596638|FG003|Overall Study|Physician Decision|1|||
94492072|NCT02711137|323596639|FG004|Overall Study|Physician Decision|1|||
94492073|NCT02711137|323596640|FG005|Overall Study|Physician Decision|0|||
94492074|NCT02711137|323596641|FG006|Overall Study|Physician Decision|12|||
94492075|NCT02711137|323596642|FG007|Overall Study|Physician Decision|2|||
94492076|NCT02711137|323596643|FG008|Overall Study|Physician Decision|1|||
94492077|NCT02711137|323596644|FG009|Overall Study|Physician Decision|1|||
94492078|NCT02711137|323596645|FG010|Overall Study|Physician Decision|3|||
94492079|NCT02711137|323596646|FG011|Overall Study|Physician Decision|2|||
94492080|NCT02711137|323596647|FG012|Overall Study|Physician Decision|1|||
94492081|NCT02711137|323596648|FG013|Overall Study|Physician Decision|1|||
94492082|NCT02711137|323596649|FG014|Overall Study|Physician Decision|2|||
94492083|NCT02711137|323596635|FG000|Overall Study|Other|0|||
94492084|NCT02711137|323596636|FG001|Overall Study|Other|1|||
94492085|NCT02711137|323596637|FG002|Overall Study|Other|0|||
94492086|NCT02711137|323596638|FG003|Overall Study|Other|0|||
94492087|NCT02711137|323596639|FG004|Overall Study|Other|0|||
94492088|NCT02711137|323596640|FG005|Overall Study|Other|0|||
94492089|NCT02711137|323596641|FG006|Overall Study|Other|3|||
94492090|NCT02711137|323596642|FG007|Overall Study|Other|0|||
94492091|NCT02711137|323596643|FG008|Overall Study|Other|0|||
94492092|NCT02711137|323596644|FG009|Overall Study|Other|0|||
94492093|NCT02711137|323596645|FG010|Overall Study|Other|0|||
94492094|NCT02711137|323596646|FG011|Overall Study|Other|0|||
94492095|NCT02711137|323596647|FG012|Overall Study|Other|0|||
94492096|NCT02711137|323596648|FG013|Overall Study|Other|0|||
94492097|NCT02711137|323596649|FG014|Overall Study|Other|1|||
94492098|NCT02711137|323596635|FG000|Overall Study|Withdrawal by Subject|1|||
94492099|NCT02711137|323596636|FG001|Overall Study|Withdrawal by Subject|0|||
94492100|NCT02711137|323596637|FG002|Overall Study|Withdrawal by Subject|0|||
94492101|NCT02711137|323596638|FG003|Overall Study|Withdrawal by Subject|1|||
94492102|NCT02711137|323596639|FG004|Overall Study|Withdrawal by Subject|1|||
94492103|NCT02711137|323596640|FG005|Overall Study|Withdrawal by Subject|0|||
94492104|NCT02711137|323596641|FG006|Overall Study|Withdrawal by Subject|7|||
94492105|NCT02711137|323596642|FG007|Overall Study|Withdrawal by Subject|0|||
94492106|NCT02711137|323596643|FG008|Overall Study|Withdrawal by Subject|0|||
94492107|NCT02711137|323596644|FG009|Overall Study|Withdrawal by Subject|0|||
94492108|NCT02711137|323596645|FG010|Overall Study|Withdrawal by Subject|0|||
94492109|NCT02711137|323596646|FG011|Overall Study|Withdrawal by Subject|0|||
94492110|NCT02711137|323596647|FG012|Overall Study|Withdrawal by Subject|0|||
94492111|NCT02711137|323596648|FG013|Overall Study|Withdrawal by Subject|1|||
94492112|NCT02711137|323596649|FG014|Overall Study|Withdrawal by Subject|0|||
94492113|NCT02711137|323596635|FG000|Overall Study|Lost to Follow-up|1|||
94492114|NCT02711137|323596636|FG001|Overall Study|Lost to Follow-up|0|||
94492115|NCT02711137|323596637|FG002|Overall Study|Lost to Follow-up|0|||
94492116|NCT02711137|323596638|FG003|Overall Study|Lost to Follow-up|0|||
94492117|NCT02711137|323596639|FG004|Overall Study|Lost to Follow-up|0|||
94492118|NCT02711137|323596640|FG005|Overall Study|Lost to Follow-up|0|||
94492119|NCT02711137|323596641|FG006|Overall Study|Lost to Follow-up|2|||
94492120|NCT02711137|323596642|FG007|Overall Study|Lost to Follow-up|0|||
94492121|NCT02711137|323596643|FG008|Overall Study|Lost to Follow-up|0|||
94492122|NCT02711137|323596644|FG009|Overall Study|Lost to Follow-up|0|||
94492123|NCT02711137|323596645|FG010|Overall Study|Lost to Follow-up|0|||
94492124|NCT02711137|323596646|FG011|Overall Study|Lost to Follow-up|0|||
94492125|NCT02711137|323596647|FG012|Overall Study|Lost to Follow-up|0|||
94492126|NCT02711137|323596648|FG013|Overall Study|Lost to Follow-up|0|||
94492127|NCT02711137|323596649|FG014|Overall Study|Lost to Follow-up|0|||
94492128|NCT00548327|323596650|FG000|Overall Study|Adverse Event|0|||
94492129|NCT00548327|323596651|FG001|Overall Study|Adverse Event|1|||
94492130|NCT01140906|323596654|FG000|Overall Study|Adverse Event|7|||
94492131|NCT01140906|323596655|FG001|Overall Study|Adverse Event|10|||
94492132|NCT01140906|323596656|FG002|Overall Study|Adverse Event|17|||
94492133|NCT01140906|323596657|FG003|Overall Study|Adverse Event|7|||
94492134|NCT01140906|323596654|FG000|Overall Study|Lack of Efficacy|6|||
94492135|NCT01140906|323596655|FG001|Overall Study|Lack of Efficacy|8|||
94492136|NCT01140906|323596656|FG002|Overall Study|Lack of Efficacy|2|||
94492137|NCT01140906|323596657|FG003|Overall Study|Lack of Efficacy|1|||
94492138|NCT01140906|323596654|FG000|Overall Study|Non-compliance|0|||
94492139|NCT01140906|323596655|FG001|Overall Study|Non-compliance|1|||
94492140|NCT01140906|323596656|FG002|Overall Study|Non-compliance|0|||
94492141|NCT01140906|323596657|FG003|Overall Study|Non-compliance|1|||
94492142|NCT01140906|323596654|FG000|Overall Study|Protocol Violation|5|||
94492143|NCT01140906|323596655|FG001|Overall Study|Protocol Violation|3|||
94492144|NCT01140906|323596656|FG002|Overall Study|Protocol Violation|2|||
94492145|NCT01140906|323596657|FG003|Overall Study|Protocol Violation|1|||
94492146|NCT01140906|323596654|FG000|Overall Study|Withdrawal of consent|6|||
94492147|NCT01140906|323596655|FG001|Overall Study|Withdrawal of consent|6|||
94492148|NCT01140906|323596656|FG002|Overall Study|Withdrawal of consent|2|||
94492149|NCT01140906|323596657|FG003|Overall Study|Withdrawal of consent|2|||
94492150|NCT01140906|323596654|FG000|Overall Study|Lost to Follow-up|1|||
94492151|NCT01140906|323596655|FG001|Overall Study|Lost to Follow-up|1|||
94492152|NCT01140906|323596656|FG002|Overall Study|Lost to Follow-up|0|||
94492153|NCT01140906|323596657|FG003|Overall Study|Lost to Follow-up|2|||
94492154|NCT01140906|323596654|FG000|Overall Study|Administrative or other reason|0|||
94492155|NCT01140906|323596655|FG001|Overall Study|Administrative or other reason|5|||
94492156|NCT01140906|323596656|FG002|Overall Study|Administrative or other reason|3|||
94492157|NCT01140906|323596657|FG003|Overall Study|Administrative or other reason|2|||
94492158|NCT00703534|323596658|FG000|Overall Study|Adverse Event|14|||
94492159|NCT00703534|323596659|FG001|Overall Study|Adverse Event|3|||
94492160|NCT00703534|323596658|FG000|Overall Study|Withdrawal by Subject|8|||
94492161|NCT00703534|323596659|FG001|Overall Study|Withdrawal by Subject|7|||
94492162|NCT00703534|323596658|FG000|Overall Study|Incorrect Enrollment|6|||
94492163|NCT00703534|323596659|FG001|Overall Study|Incorrect Enrollment|6|||
94492164|NCT00703534|323596658|FG000|Overall Study|Lost to Follow-up|1|||
94492165|NCT00703534|323596659|FG001|Overall Study|Lost to Follow-up|4|||
94492166|NCT00703534|323596658|FG000|Overall Study|Severe Non Compliance|1|||
94492167|NCT00703534|323596659|FG001|Overall Study|Severe Non Compliance|5|||
94492168|NCT01126424|323596662|FG000|Overall Study|Adverse Event|0|||
94492169|NCT01126424|323596663|FG001|Overall Study|Adverse Event|0|||
94492170|NCT01126424|323596664|FG002|Overall Study|Adverse Event|0|||
94492171|NCT01126424|323596665|FG003|Overall Study|Adverse Event|0|||
94492172|NCT01126424|323596666|FG004|Overall Study|Adverse Event|1|||
94492173|NCT01126424|323596667|FG005|Overall Study|Adverse Event|0|||
94492174|NCT01126424|323596662|FG000|Overall Study|Withdrawal by Subject|0|||
94492175|NCT01126424|323596663|FG001|Overall Study|Withdrawal by Subject|0|||
94492176|NCT01126424|323596664|FG002|Overall Study|Withdrawal by Subject|1|||
94492177|NCT01126424|323596665|FG003|Overall Study|Withdrawal by Subject|3|||
94492178|NCT01126424|323596666|FG004|Overall Study|Withdrawal by Subject|1|||
94492179|NCT01126424|323596667|FG005|Overall Study|Withdrawal by Subject|0|||
94492180|NCT02300610|323596672|FG000|Overall Study|Withdrawal by Subject|1|||
94492181|NCT02300610|323596673|FG001|Overall Study|Withdrawal by Subject|0|||
94492182|NCT02300610|323596674|FG002|Overall Study|Withdrawal by Subject|1|||
94492183|NCT02911116|323596683|FG000|Overall Study|Insufficient Therapeutic Response|1|||
94492184|NCT02911116|323596684|FG001|Overall Study|Insufficient Therapeutic Response|0|||
94492185|NCT02911116|323596683|FG000|Overall Study|Lost to Follow-up|0|||
94492186|NCT02911116|323596684|FG001|Overall Study|Lost to Follow-up|1|||
94492187|NCT01056276|323596685|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
94492188|NCT01056276|323596686|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
94492189|NCT01056276|323596685|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
94492190|NCT01056276|323596686|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
94492191|NCT01056276|323596685|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
94492192|NCT01056276|323596686|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
94492193|NCT01056276|323596685|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
94492194|NCT01056276|323596686|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
94492195|NCT01056276|323596685|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
94492196|NCT01056276|323596686|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
94492197|NCT01056276|323596685|FG000|Treatment Period-Cycles 1-8|Death|3|||
94492198|NCT01056276|323596686|FG001|Treatment Period-Cycles 1-8|Death|1|||
94492199|NCT01056276|323596685|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
94492200|NCT01056276|323596686|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
94492201|NCT01056276|323596685|FG000|Maintenance Therapy|Toxicity|0|||
94492202|NCT01056276|323596686|FG001|Maintenance Therapy|Toxicity|2|||
94492203|NCT01056276|323596685|FG000|Maintenance Therapy|Progressive Disease|0|||
94492204|NCT01056276|323596686|FG001|Maintenance Therapy|Progressive Disease|9|||
94492205|NCT01056276|323596685|FG000|Maintenance Therapy|Physician Decision|0|||
94492206|NCT01056276|323596686|FG001|Maintenance Therapy|Physician Decision|1|||
94492207|NCT01056276|323596685|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
94492208|NCT01056276|323596686|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
94492209|NCT01056276|323596685|FG000|Maintenance Therapy|Intercurrent Illness|0|||
94492210|NCT01056276|323596686|FG001|Maintenance Therapy|Intercurrent Illness|1|||
94492211|NCT01056276|323596685|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
94492212|NCT01056276|323596686|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
94492213|NCT04424901|323596687|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
94492214|NCT04424901|323596688|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
94492215|NCT00147238|323596689|FG000|Overall Study|Inevaluable|8|||
94492216|NCT01970371|323596690|FG000|Overall Study|Death|8|||
94492217|NCT01970371|323596691|FG001|Overall Study|Death|13|||
94492218|NCT01970371|323596692|FG002|Overall Study|Death|12|||
94492219|NCT01970371|323596690|FG000|Overall Study|Lost to Follow-up|0|||
94492220|NCT01970371|323596691|FG001|Overall Study|Lost to Follow-up|0|||
94492221|NCT01970371|323596692|FG002|Overall Study|Lost to Follow-up|1|||
94492222|NCT01348269|323596693|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
94492223|NCT01348269|323596694|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
94492224|NCT01348269|323596693|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
94492225|NCT01348269|323596694|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
94492226|NCT01348269|323596693|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
94492227|NCT01348269|323596694|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
94492228|NCT02412657|323596697|FG000|Overall Study|Lost to Follow-up|1|||
94492229|NCT02412657|323596698|FG001|Overall Study|Lost to Follow-up|0|||
94492230|NCT02412657|323596699|FG002|Overall Study|Lost to Follow-up|0|||
94492231|NCT02412657|323596697|FG000|Overall Study|Protocol Violation|0|||
94492232|NCT02412657|323596698|FG001|Overall Study|Protocol Violation|2|||
94492233|NCT02412657|323596699|FG002|Overall Study|Protocol Violation|3|||
94492234|NCT01189266|323596700|FG000|Overall Study|Adverse Event|1|||
94492235|NCT01189266|323596701|FG001|Overall Study|Adverse Event|0|||
94492236|NCT01189266|323596702|FG002|Overall Study|Adverse Event|5|||
94492237|NCT01189266|323596700|FG000|Overall Study|Death|0|||
94492238|NCT01189266|323596701|FG001|Overall Study|Death|0|||
94492239|NCT01189266|323596702|FG002|Overall Study|Death|5|||
94492240|NCT01189266|323596700|FG000|Overall Study|Lack of Efficacy|4|||
94492241|NCT01189266|323596701|FG001|Overall Study|Lack of Efficacy|5|||
94492242|NCT01189266|323596702|FG002|Overall Study|Lack of Efficacy|44|||
94492243|NCT01189266|323596700|FG000|Overall Study|Physician Decision|0|||
94492244|NCT01189266|323596701|FG001|Overall Study|Physician Decision|0|||
94492245|NCT01189266|323596702|FG002|Overall Study|Physician Decision|1|||
94492246|NCT01189266|323596700|FG000|Overall Study|Protocol Violation|0|||
94492247|NCT01189266|323596701|FG001|Overall Study|Protocol Violation|1|||
94492248|NCT01189266|323596702|FG002|Overall Study|Protocol Violation|1|||
94492249|NCT01189266|323596700|FG000|Overall Study|Withdrawal by Subject|0|||
94492250|NCT01189266|323596701|FG001|Overall Study|Withdrawal by Subject|0|||
94492251|NCT01189266|323596702|FG002|Overall Study|Withdrawal by Subject|1|||
94492252|NCT01189266|323596700|FG000|Overall Study|Patient refuses further therapy|1|||
94492253|NCT01189266|323596701|FG001|Overall Study|Patient refuses further therapy|0|||
94492254|NCT01189266|323596702|FG002|Overall Study|Patient refuses further therapy|7|||
94492255|NCT01189266|323596700|FG000|Overall Study|No treatment|0|||
94492256|NCT01189266|323596701|FG001|Overall Study|No treatment|0|||
94492257|NCT01189266|323596702|FG002|Overall Study|No treatment|1|||
94492258|NCT00112957|323596705|FG000|Overall Study|Progressive disease|18|||
94492259|NCT00112957|323596705|FG000|Overall Study|Physician Decision|1|||
94492260|NCT01572792|323596706|FG000|Lead-in Study|Lost to Follow-up|5|||
94492261|NCT01572792|323596707|FG001|Lead-in Study|Lost to Follow-up|9|||
94492262|NCT01572792|323596708|FG002|Lead-in Study|Lost to Follow-up|4|||
94492263|NCT01572792|323596709|FG003|Lead-in Study|Lost to Follow-up|2|||
94492264|NCT01572792|323596710|FG004|Lead-in Study|Lost to Follow-up|4|||
94492265|NCT01572792|323596706|FG000|Lead-in Study|Withdrawal by Subject|22|||
94492266|NCT01572792|323596707|FG001|Lead-in Study|Withdrawal by Subject|11|||
94492267|NCT01572792|323596708|FG002|Lead-in Study|Withdrawal by Subject|12|||
94492268|NCT01572792|323596709|FG003|Lead-in Study|Withdrawal by Subject|24|||
94492269|NCT01572792|323596710|FG004|Lead-in Study|Withdrawal by Subject|11|||
94492270|NCT01572792|323596706|FG000|Lead-in Study|Protocol Violation|19|||
94492271|NCT01572792|323596707|FG001|Lead-in Study|Protocol Violation|10|||
94492272|NCT01572792|323596708|FG002|Lead-in Study|Protocol Violation|12|||
94492273|NCT01572792|323596709|FG003|Lead-in Study|Protocol Violation|13|||
94492274|NCT01572792|323596710|FG004|Lead-in Study|Protocol Violation|21|||
94492275|NCT01572792|323596706|FG000|Lead-in Study|Lack of Efficacy|20|||
94492276|NCT01572792|323596707|FG001|Lead-in Study|Lack of Efficacy|5|||
94492277|NCT01572792|323596708|FG002|Lead-in Study|Lack of Efficacy|4|||
94492278|NCT01572792|323596709|FG003|Lead-in Study|Lack of Efficacy|8|||
94492279|NCT01572792|323596710|FG004|Lead-in Study|Lack of Efficacy|10|||
94492280|NCT01572792|323596706|FG000|Lead-in Study|Adverse Event|21|||
94492281|NCT01572792|323596707|FG001|Lead-in Study|Adverse Event|21|||
94492282|NCT01572792|323596708|FG002|Lead-in Study|Adverse Event|22|||
94492283|NCT01572792|323596709|FG003|Lead-in Study|Adverse Event|16|||
94492284|NCT01572792|323596710|FG004|Lead-in Study|Adverse Event|14|||
94492285|NCT01572792|323596706|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
94492286|NCT01572792|323596707|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
94492287|NCT01572792|323596708|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
94492288|NCT01572792|323596709|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
94492289|NCT01572792|323596710|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
94492290|NCT01572792|323596706|FG000|Extension Study|Lost to Follow-up|6|||
94492291|NCT01572792|323596707|FG001|Extension Study|Lost to Follow-up|2|||
94492292|NCT01572792|323596708|FG002|Extension Study|Lost to Follow-up|0|||
94492293|NCT01572792|323596709|FG003|Extension Study|Lost to Follow-up|3|||
94492294|NCT01572792|323596710|FG004|Extension Study|Lost to Follow-up|3|||
94492295|NCT01572792|323596706|FG000|Extension Study|Withdrawal by Subject|7|||
94492296|NCT01572792|323596707|FG001|Extension Study|Withdrawal by Subject|6|||
94492297|NCT01572792|323596708|FG002|Extension Study|Withdrawal by Subject|11|||
94492298|NCT01572792|323596709|FG003|Extension Study|Withdrawal by Subject|8|||
94492299|NCT01572792|323596710|FG004|Extension Study|Withdrawal by Subject|14|||
94492300|NCT01572792|323596706|FG000|Extension Study|Protocol Violation|0|||
94492301|NCT01572792|323596707|FG001|Extension Study|Protocol Violation|4|||
94492302|NCT01572792|323596708|FG002|Extension Study|Protocol Violation|3|||
94492303|NCT01572792|323596709|FG003|Extension Study|Protocol Violation|4|||
94492304|NCT01572792|323596710|FG004|Extension Study|Protocol Violation|3|||
94492305|NCT01572792|323596706|FG000|Extension Study|Lack of Efficacy|2|||
94492306|NCT01572792|323596707|FG001|Extension Study|Lack of Efficacy|3|||
94492307|NCT01572792|323596708|FG002|Extension Study|Lack of Efficacy|3|||
94492308|NCT01572792|323596709|FG003|Extension Study|Lack of Efficacy|2|||
94492309|NCT01572792|323596710|FG004|Extension Study|Lack of Efficacy|2|||
94492310|NCT01572792|323596706|FG000|Extension Study|Adverse Event|7|||
94492311|NCT01572792|323596707|FG001|Extension Study|Adverse Event|6|||
94492312|NCT01572792|323596708|FG002|Extension Study|Adverse Event|5|||
94492313|NCT01572792|323596709|FG003|Extension Study|Adverse Event|6|||
94492314|NCT01572792|323596710|FG004|Extension Study|Adverse Event|4|||
94492315|NCT01572792|323596706|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
94492316|NCT01572792|323596707|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
94492317|NCT01572792|323596708|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
94492318|NCT01572792|323596709|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
94492319|NCT01572792|323596710|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
94492320|NCT00487188|323596711|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
94492321|NCT00487188|323596712|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
94492322|NCT00487188|323596713|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
94492323|NCT00487188|323596711|FG000|Induction Phase|Adverse Event|5|||
94492324|NCT00487188|323596712|FG001|Induction Phase|Adverse Event|0|||
94492325|NCT00487188|323596713|FG002|Induction Phase|Adverse Event|0|||
94492326|NCT00487188|323596711|FG000|Induction Phase|Lack of Efficacy|0|||
94492327|NCT00487188|323596712|FG001|Induction Phase|Lack of Efficacy|1|||
94492328|NCT00487188|323596713|FG002|Induction Phase|Lack of Efficacy|0|||
94492329|NCT00487188|323596711|FG000|Induction Phase|Protocol Violation|1|||
94492330|NCT00487188|323596712|FG001|Induction Phase|Protocol Violation|0|||
94492331|NCT00487188|323596713|FG002|Induction Phase|Protocol Violation|0|||
94492332|NCT00487188|323596711|FG000|Induction Phase|Refused Treatment|1|||
94492333|NCT00487188|323596712|FG001|Induction Phase|Refused Treatment|2|||
94492334|NCT00487188|323596713|FG002|Induction Phase|Refused Treatment|0|||
94492335|NCT00487188|323596711|FG000|Induction Phase|Lost to Follow-up|2|||
94492336|NCT00487188|323596712|FG001|Induction Phase|Lost to Follow-up|2|||
94492337|NCT00487188|323596713|FG002|Induction Phase|Lost to Follow-up|0|||
94492338|NCT00487188|323596711|FG000|Induction Phase|Administrative|0|||
94492339|NCT00487188|323596712|FG001|Induction Phase|Administrative|1|||
94492340|NCT00487188|323596713|FG002|Induction Phase|Administrative|0|||
94492341|NCT00487188|323596711|FG000|Maintenance Phase|Adverse Event|1|||
94492342|NCT00487188|323596712|FG001|Maintenance Phase|Adverse Event|0|||
94492343|NCT00487188|323596713|FG002|Maintenance Phase|Adverse Event|0|||
94492344|NCT00487188|323596711|FG000|Maintenance Phase|Death|1|||
94492345|NCT00487188|323596712|FG001|Maintenance Phase|Death|0|||
94492346|NCT00487188|323596713|FG002|Maintenance Phase|Death|0|||
94492347|NCT00487188|323596711|FG000|Maintenance Phase|Lost to Follow-up|1|||
94492348|NCT00487188|323596712|FG001|Maintenance Phase|Lost to Follow-up|0|||
94492349|NCT00487188|323596713|FG002|Maintenance Phase|Lost to Follow-up|0|||
94492350|NCT00487188|323596711|FG000|Maintenance Phase|Administrative|0|||
94492351|NCT00487188|323596712|FG001|Maintenance Phase|Administrative|0|||
94492352|NCT00487188|323596713|FG002|Maintenance Phase|Administrative|1|||
94492353|NCT03530696|323596714|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
94492354|NCT03530696|323596715|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
94492355|NCT02472353|323596716|FG000|Overall Study|Lost to Follow-up|1|||
94492356|NCT02472353|323596717|FG001|Overall Study|Lost to Follow-up|1|||
94492357|NCT02472353|323596716|FG000|Overall Study|Withdrawal by Subject|2|||
94492358|NCT02472353|323596717|FG001|Overall Study|Withdrawal by Subject|1|||
94492359|NCT02472353|323596716|FG000|Overall Study|Study Termination|1|||
94492360|NCT02472353|323596717|FG001|Overall Study|Study Termination|4|||
94492361|NCT01838876|323596718|FG000|Overall Study|Adverse Event|49|||
94492362|NCT01838876|323596718|FG000|Overall Study|Insufficient Therapeutic Response|10|||
94492363|NCT01838876|323596718|FG000|Overall Study|Protocol Violation|34|||
94492364|NCT01838876|323596718|FG000|Overall Study|Withdrawal of Consent|33|||
94492365|NCT01838876|323596718|FG000|Overall Study|Lost to Follow-up|21|||
94492366|NCT01838876|323596718|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
94492367|NCT01838876|323596718|FG000|Overall Study|Reason not Specified|7|||
94492368|NCT01838876|323596718|FG000|Overall Study|Did not meet eligibility criteria|78|||
94492369|NCT02101294|323596719|FG000|Overall Study|Withdrawal by Subject|5|||
94492370|NCT02101294|323596719|FG000|Overall Study|Lost to Follow-up|6|||
94492371|NCT03416179|323596720|FG000|Overall Study|Death|90|||
94492372|NCT03416179|323596721|FG001|Overall Study|Death|87|||
94492373|NCT03416179|323596722|FG002|Overall Study|Death|117|||
94492374|NCT03416179|323596723|FG003|Overall Study|Death|113|||
94492375|NCT03416179|323596720|FG000|Overall Study|Withdrawal by Subject|15|||
94492376|NCT03416179|323596721|FG001|Overall Study|Withdrawal by Subject|20|||
94492377|NCT03416179|323596722|FG002|Overall Study|Withdrawal by Subject|6|||
94492378|NCT03416179|323596723|FG003|Overall Study|Withdrawal by Subject|9|||
94492379|NCT03416179|323596720|FG000|Overall Study|Lost to Follow-up|1|||
94492380|NCT03416179|323596721|FG001|Overall Study|Lost to Follow-up|1|||
94492381|NCT03416179|323596722|FG002|Overall Study|Lost to Follow-up|0|||
94492382|NCT03416179|323596723|FG003|Overall Study|Lost to Follow-up|3|||
94492383|NCT03416179|323596720|FG000|Overall Study|Study participation terminated by Sponsor|93|||
94492384|NCT03416179|323596721|FG001|Overall Study|Study participation terminated by Sponsor|91|||
94492385|NCT03416179|323596722|FG002|Overall Study|Study participation terminated by Sponsor|26|||
94492386|NCT03416179|323596723|FG003|Overall Study|Study participation terminated by Sponsor|31|||
94492387|NCT03416179|323596720|FG000|Overall Study|Other|2|||
94492388|NCT03416179|323596721|FG001|Overall Study|Other|3|||
94492389|NCT03416179|323596722|FG002|Overall Study|Other|1|||
94492390|NCT03416179|323596723|FG003|Overall Study|Other|0|||
94492391|NCT01682031|323596727|FG000|Overall Study|Withdrawal by Subject|0|||
94492392|NCT01682031|323596728|FG001|Overall Study|Withdrawal by Subject|1|||
94492393|NCT01682031|323596727|FG000|Overall Study|Adverse Event|0|||
94492394|NCT01682031|323596728|FG001|Overall Study|Adverse Event|2|||
94492395|NCT01682031|323596727|FG000|Overall Study|MRI results indicate increased nodul|0|||
94492396|NCT01682031|323596728|FG001|Overall Study|MRI results indicate increased nodul|1|||
94492397|NCT01682031|323596727|FG000|Overall Study|Patient could not swallow tablets|1|||
94492398|NCT01682031|323596728|FG001|Overall Study|Patient could not swallow tablets|0|||
94492399|NCT01682031|323596727|FG000|Overall Study|Patient stopped selenium on his own|0|||
94492400|NCT01682031|323596728|FG001|Overall Study|Patient stopped selenium on his own|1|||
94492401|NCT00963235|323596729|FG000|Overall Study|Withdrawal by Subject|22|||
94492402|NCT00963235|323596729|FG000|Overall Study|Lost to Follow-up|14|||
94492403|NCT00963235|323596729|FG000|Overall Study|Failed to return|9|||
94492404|NCT00963235|323596729|FG000|Overall Study|Protocol Violation|7|||
94492405|NCT00963235|323596729|FG000|Overall Study|Adverse Event|5|||
94492406|NCT00963235|323596729|FG000|Overall Study|Physician Decision|2|||
94492407|NCT00963235|323596729|FG000|Overall Study|Other|1|||
94492408|NCT01056536|323596730|FG000|Overall Study|Lost to Follow-up|202|||
94492409|NCT01056536|323596731|FG001|Overall Study|Lost to Follow-up|116|||
94492410|NCT01056536|323596732|FG002|Overall Study|Lost to Follow-up|248|||
94492411|NCT03839641|323596733|FG000|Overall Study|Withdrawal by Subject|1|||
94492412|NCT03839641|323596734|FG001|Overall Study|Withdrawal by Subject|1|||
94492413|NCT00390013|323596735|FG000|Phase 1|tired|0|||
94492414|NCT00390013|323596736|FG001|Phase 1|tired|0|||
94492415|NCT00390013|323596737|FG002|Phase 1|tired|0|||
94492416|NCT00390013|323596738|FG003|Phase 1|tired|1|||
94492417|NCT00390013|323596735|FG000|Phase 2 First Treatment|tired|1|||
94492418|NCT00390013|323596736|FG001|Phase 2 First Treatment|tired|0|||
94492419|NCT00390013|323596737|FG002|Phase 2 First Treatment|tired|0|||
94492420|NCT00390013|323596738|FG003|Phase 2 First Treatment|tired|0|||
94492421|NCT00390013|323596735|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
94492422|NCT00390013|323596736|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
94492423|NCT00390013|323596737|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
94492424|NCT00390013|323596738|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
94492425|NCT03034967|323596739|FG000|Overall Study|Withdrawal by Subject|9|||
94492426|NCT03034967|323596740|FG001|Overall Study|Withdrawal by Subject|2|||
94492427|NCT03034967|323596741|FG002|Overall Study|Withdrawal by Subject|6|||
94492428|NCT03034967|323596742|FG003|Overall Study|Withdrawal by Subject|6|||
94492429|NCT03034967|323596743|FG004|Overall Study|Withdrawal by Subject|9|||
94492430|NCT03034967|323596744|FG005|Overall Study|Withdrawal by Subject|2|||
94492431|NCT03034967|323596739|FG000|Overall Study|Physician Decision|1|||
94492432|NCT03034967|323596740|FG001|Overall Study|Physician Decision|0|||
94492433|NCT03034967|323596741|FG002|Overall Study|Physician Decision|1|||
94492434|NCT03034967|323596742|FG003|Overall Study|Physician Decision|1|||
94492435|NCT03034967|323596743|FG004|Overall Study|Physician Decision|1|||
94492436|NCT03034967|323596744|FG005|Overall Study|Physician Decision|0|||
94492437|NCT03034967|323596739|FG000|Overall Study|Lost to Follow-up|0|||
94492438|NCT03034967|323596740|FG001|Overall Study|Lost to Follow-up|0|||
94492439|NCT03034967|323596741|FG002|Overall Study|Lost to Follow-up|0|||
94492440|NCT03034967|323596742|FG003|Overall Study|Lost to Follow-up|1|||
94492441|NCT03034967|323596743|FG004|Overall Study|Lost to Follow-up|0|||
94492442|NCT03034967|323596744|FG005|Overall Study|Lost to Follow-up|2|||
94492443|NCT03034967|323596739|FG000|Overall Study|Liver function test abnormality|0|||
94492444|NCT03034967|323596740|FG001|Overall Study|Liver function test abnormality|0|||
94492445|NCT03034967|323596741|FG002|Overall Study|Liver function test abnormality|1|||
94492446|NCT03034967|323596742|FG003|Overall Study|Liver function test abnormality|0|||
94492447|NCT03034967|323596743|FG004|Overall Study|Liver function test abnormality|0|||
94492448|NCT03034967|323596744|FG005|Overall Study|Liver function test abnormality|0|||
94492449|NCT03034967|323596739|FG000|Overall Study|Protocol Violation|1|||
94492450|NCT03034967|323596740|FG001|Overall Study|Protocol Violation|0|||
94492451|NCT03034967|323596741|FG002|Overall Study|Protocol Violation|0|||
94492452|NCT03034967|323596742|FG003|Overall Study|Protocol Violation|0|||
94492453|NCT03034967|323596743|FG004|Overall Study|Protocol Violation|0|||
94492454|NCT03034967|323596744|FG005|Overall Study|Protocol Violation|2|||
94492455|NCT03034967|323596739|FG000|Overall Study|Lack of Efficacy|0|||
94492456|NCT03034967|323596740|FG001|Overall Study|Lack of Efficacy|1|||
94492457|NCT03034967|323596741|FG002|Overall Study|Lack of Efficacy|2|||
94492458|NCT03034967|323596742|FG003|Overall Study|Lack of Efficacy|1|||
94492459|NCT03034967|323596743|FG004|Overall Study|Lack of Efficacy|1|||
94492460|NCT03034967|323596744|FG005|Overall Study|Lack of Efficacy|0|||
94492461|NCT03034967|323596739|FG000|Overall Study|Adverse Event, non-fatal|3|||
94492462|NCT03034967|323596740|FG001|Overall Study|Adverse Event, non-fatal|1|||
94492463|NCT03034967|323596741|FG002|Overall Study|Adverse Event, non-fatal|2|||
94492464|NCT03034967|323596742|FG003|Overall Study|Adverse Event, non-fatal|0|||
94492465|NCT03034967|323596743|FG004|Overall Study|Adverse Event, non-fatal|2|||
94492466|NCT03034967|323596744|FG005|Overall Study|Adverse Event, non-fatal|8|||
94492467|NCT03034967|323596739|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
94492468|NCT03034967|323596740|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
94492469|NCT03034967|323596741|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
94492470|NCT03034967|323596742|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
94492471|NCT03034967|323596743|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
94492472|NCT03034967|323596744|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
94492473|NCT00695019|323596748|FG000|Overall Study|Withdrawal by Subject|8|||
94492474|NCT00695019|323596749|FG001|Overall Study|Withdrawal by Subject|6|||
94492475|NCT00695019|323596750|FG002|Overall Study|Withdrawal by Subject|4|||
94492476|NCT00695019|323596748|FG000|Overall Study|Protocol Violation|1|||
94492477|NCT00695019|323596749|FG001|Overall Study|Protocol Violation|3|||
94492478|NCT00695019|323596750|FG002|Overall Study|Protocol Violation|1|||
94492479|NCT00695019|323596748|FG000|Overall Study|Lack of Efficacy|0|||
94492480|NCT00695019|323596749|FG001|Overall Study|Lack of Efficacy|0|||
94492481|NCT00695019|323596750|FG002|Overall Study|Lack of Efficacy|1|||
94492482|NCT00695019|323596748|FG000|Overall Study|Various|4|||
94492483|NCT00695019|323596749|FG001|Overall Study|Various|5|||
94492484|NCT00695019|323596750|FG002|Overall Study|Various|4|||
94492485|NCT02225587|323596751|FG000|Overall Study|Adverse Event|5|||
94492486|NCT02225587|323596752|FG001|Overall Study|Adverse Event|5|||
94492487|NCT02225587|323596751|FG000|Overall Study|Lost to Follow-up|5|||
94492488|NCT02225587|323596752|FG001|Overall Study|Lost to Follow-up|5|||
94492489|NCT02225587|323596751|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94492490|NCT02225587|323596752|FG001|Overall Study|Non-Compliance With Study Drug|0|||
94492491|NCT02225587|323596751|FG000|Overall Study|Physician Decision|2|||
94492492|NCT02225587|323596752|FG001|Overall Study|Physician Decision|0|||
94492493|NCT02225587|323596751|FG000|Overall Study|Protocol Violation|1|||
94492494|NCT02225587|323596752|FG001|Overall Study|Protocol Violation|0|||
94492495|NCT02225587|323596751|FG000|Overall Study|Participant Moved|1|||
94492496|NCT02225587|323596752|FG001|Overall Study|Participant Moved|0|||
94492497|NCT02225587|323596751|FG000|Overall Study|Withdrawal by Subject|13|||
94492498|NCT02225587|323596752|FG001|Overall Study|Withdrawal by Subject|28|||
94492499|NCT00879658|323596753|FG000|Overall Study|Abnormal laboratory value(s)|3|||
94492500|NCT00879658|323596754|FG001|Overall Study|Abnormal laboratory value(s)|0|||
94492501|NCT00879658|323596755|FG002|Overall Study|Abnormal laboratory value(s)|0|||
94492502|NCT00879658|323596756|FG003|Overall Study|Abnormal laboratory value(s)|1|||
94492503|NCT00879658|323596757|FG004|Overall Study|Abnormal laboratory value(s)|0|||
94492504|NCT00879658|323596758|FG005|Overall Study|Abnormal laboratory value(s)|0|||
94492505|NCT00879658|323596759|FG006|Overall Study|Abnormal laboratory value(s)|0|||
94492506|NCT00879658|323596753|FG000|Overall Study|Administrative problems|2|||
94492507|NCT00879658|323596754|FG001|Overall Study|Administrative problems|1|||
94492508|NCT00879658|323596755|FG002|Overall Study|Administrative problems|0|||
94492509|NCT00879658|323596756|FG003|Overall Study|Administrative problems|1|||
94492510|NCT00879658|323596757|FG004|Overall Study|Administrative problems|0|||
94492511|NCT00879658|323596758|FG005|Overall Study|Administrative problems|0|||
94492512|NCT00879658|323596759|FG006|Overall Study|Administrative problems|0|||
94492513|NCT00879658|323596753|FG000|Overall Study|Adverse Event|6|||
94492514|NCT00879658|323596754|FG001|Overall Study|Adverse Event|4|||
94492515|NCT00879658|323596755|FG002|Overall Study|Adverse Event|3|||
94492516|NCT00879658|323596756|FG003|Overall Study|Adverse Event|1|||
94492517|NCT00879658|323596757|FG004|Overall Study|Adverse Event|2|||
94492518|NCT00879658|323596758|FG005|Overall Study|Adverse Event|0|||
94492519|NCT00879658|323596759|FG006|Overall Study|Adverse Event|0|||
94492520|NCT00879658|323596753|FG000|Overall Study|Protocol Violation|1|||
94492521|NCT00879658|323596754|FG001|Overall Study|Protocol Violation|0|||
94492522|NCT00879658|323596755|FG002|Overall Study|Protocol Violation|0|||
94492523|NCT00879658|323596756|FG003|Overall Study|Protocol Violation|0|||
94492524|NCT00879658|323596757|FG004|Overall Study|Protocol Violation|0|||
94492525|NCT00879658|323596758|FG005|Overall Study|Protocol Violation|0|||
94492526|NCT00879658|323596759|FG006|Overall Study|Protocol Violation|0|||
94492527|NCT00879658|323596753|FG000|Overall Study|Withdrawal by Subject|3|||
94492528|NCT00879658|323596754|FG001|Overall Study|Withdrawal by Subject|0|||
94492529|NCT00879658|323596755|FG002|Overall Study|Withdrawal by Subject|2|||
94492530|NCT00879658|323596756|FG003|Overall Study|Withdrawal by Subject|0|||
94492531|NCT00879658|323596757|FG004|Overall Study|Withdrawal by Subject|0|||
94492532|NCT00879658|323596758|FG005|Overall Study|Withdrawal by Subject|1|||
94492533|NCT00879658|323596759|FG006|Overall Study|Withdrawal by Subject|0|||
94492534|NCT00879658|323596753|FG000|Overall Study|Lack of Efficacy|0|||
94492535|NCT00879658|323596754|FG001|Overall Study|Lack of Efficacy|0|||
94492536|NCT00879658|323596755|FG002|Overall Study|Lack of Efficacy|2|||
94492537|NCT00879658|323596756|FG003|Overall Study|Lack of Efficacy|0|||
94492538|NCT00879658|323596757|FG004|Overall Study|Lack of Efficacy|0|||
94492539|NCT00879658|323596758|FG005|Overall Study|Lack of Efficacy|0|||
94492540|NCT00879658|323596759|FG006|Overall Study|Lack of Efficacy|0|||
94492541|NCT00879658|323596753|FG000|Overall Study|misrandomized (never received study med)|0|||
94492542|NCT00879658|323596754|FG001|Overall Study|misrandomized (never received study med)|0|||
94492543|NCT00879658|323596755|FG002|Overall Study|misrandomized (never received study med)|0|||
94492544|NCT00879658|323596756|FG003|Overall Study|misrandomized (never received study med)|1|||
94492545|NCT00879658|323596757|FG004|Overall Study|misrandomized (never received study med)|0|||
94492546|NCT00879658|323596758|FG005|Overall Study|misrandomized (never received study med)|0|||
94492547|NCT00879658|323596759|FG006|Overall Study|misrandomized (never received study med)|0|||
94492548|NCT03479905|323596762|FG000|Overall Study|Other airway method used|4|||
94492549|NCT03479905|323596763|FG001|Overall Study|Other airway method used|5|||
94492550|NCT03479905|323596764|FG002|Overall Study|Other airway method used|5|||
94492551|NCT01260948|323596765|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
94492552|NCT01260948|323596766|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
94492553|NCT01260948|323596765|FG000|Second Intervention|Emesis|0|||
94492554|NCT01260948|323596766|FG001|Second Intervention|Emesis|1|||
94492555|NCT01685437|323596767|FG000|Overall Study|Withdrawal by Subject|22|||
94492556|NCT01685437|323596767|FG000|Overall Study|Lost to Follow-up|3|||
94492557|NCT01685437|323596767|FG000|Overall Study|Adverse Event|1|||
94492558|NCT01685437|323596767|FG000|Overall Study|Protocol Violation|4|||
94492559|NCT01685437|323596767|FG000|Overall Study|Unable to make visits due to work|1|||
94492560|NCT02394756|323596768|FG000|Period 1|Lens Discomfort|0|||
94492561|NCT02394756|323596769|FG001|Period 1|Lens Discomfort|0|||
94492562|NCT02394756|323596770|FG002|Period 1|Lens Discomfort|0|||
94492563|NCT02394756|323596771|FG003|Period 1|Lens Discomfort|0|||
94492564|NCT02394756|323596772|FG004|Period 1|Lens Discomfort|0|||
94492565|NCT02394756|323596773|FG005|Period 1|Lens Discomfort|1|||
94492566|NCT02394756|323596768|FG000|Period 1|Withdrawal by Subject|0|||
94492567|NCT02394756|323596769|FG001|Period 1|Withdrawal by Subject|1|||
94492568|NCT02394756|323596770|FG002|Period 1|Withdrawal by Subject|1|||
94492569|NCT02394756|323596771|FG003|Period 1|Withdrawal by Subject|1|||
94492570|NCT02394756|323596772|FG004|Period 1|Withdrawal by Subject|0|||
94492571|NCT02394756|323596773|FG005|Period 1|Withdrawal by Subject|0|||
94492572|NCT02394756|323596768|FG000|Period 2|Unsatisfactory Visual Response|0|||
94492573|NCT02394756|323596769|FG001|Period 2|Unsatisfactory Visual Response|0|||
94492574|NCT02394756|323596770|FG002|Period 2|Unsatisfactory Visual Response|0|||
94492575|NCT02394756|323596771|FG003|Period 2|Unsatisfactory Visual Response|0|||
94492576|NCT02394756|323596772|FG004|Period 2|Unsatisfactory Visual Response|1|||
94492577|NCT02394756|323596773|FG005|Period 2|Unsatisfactory Visual Response|0|||
94492578|NCT00768053|323596774|FG000|Overall Study|Adverse Event|10|||
94492579|NCT00768053|323596774|FG000|Overall Study|Lost to Follow-up|1|||
94492580|NCT03069989|323596775|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
94492581|NCT03069989|323596776|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
94492582|NCT02145390|323596777|FG000|Overall Study|Withdrawal by Subject|1|||
94492583|NCT02100631|323598697|FG000|Overall Study|Withdrawal by Subject|1|||
94492584|NCT02100631|323598698|FG001|Overall Study|Withdrawal by Subject|0|||
94492585|NCT02100631|323598699|FG002|Overall Study|Withdrawal by Subject|0|||
94492586|NCT02100631|323598697|FG000|Overall Study|Lost to Follow-up|3|||
94492587|NCT02100631|323598698|FG001|Overall Study|Lost to Follow-up|4|||
94492588|NCT02100631|323598699|FG002|Overall Study|Lost to Follow-up|0|||
94492589|NCT02100631|323598697|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
94492590|NCT02100631|323598698|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
94492591|NCT02100631|323598699|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
94492592|NCT01648764|323598700|FG000|Overall Study|Progressive Disease|0|||
94492593|NCT01648764|323598701|FG001|Overall Study|Progressive Disease|1|||
94655600|NCT01110239|324196092|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
94492594|NCT01648764|323598702|FG002|Overall Study|Progressive Disease|0|||
94492595|NCT01648764|323598703|FG003|Overall Study|Progressive Disease|0|||
94492596|NCT01648764|323598704|FG004|Overall Study|Progressive Disease|0|||
94492597|NCT01648764|323598705|FG005|Overall Study|Progressive Disease|1|||
94492598|NCT01648764|323598706|FG006|Overall Study|Progressive Disease|1|||
94492599|NCT01648764|323598707|FG007|Overall Study|Progressive Disease|0|||
94492600|NCT01648764|323598708|FG008|Overall Study|Progressive Disease|0|||
94492601|NCT01648764|323598709|FG009|Overall Study|Progressive Disease|2|||
94492602|NCT01648764|323598710|FG010|Overall Study|Progressive Disease|0|||
94492603|NCT01648764|323598711|FG011|Overall Study|Progressive Disease|1|||
94492604|NCT01648764|323598712|FG012|Overall Study|Progressive Disease|2|||
94492605|NCT01648764|323598713|FG013|Overall Study|Progressive Disease|1|||
94492606|NCT01648764|323598700|FG000|Overall Study|Adverse Event|0|||
94492607|NCT01648764|323598701|FG001|Overall Study|Adverse Event|0|||
94492608|NCT01648764|323598702|FG002|Overall Study|Adverse Event|0|||
94492609|NCT01648764|323598703|FG003|Overall Study|Adverse Event|0|||
94492610|NCT01648764|323598704|FG004|Overall Study|Adverse Event|0|||
94492611|NCT01648764|323598705|FG005|Overall Study|Adverse Event|1|||
94492612|NCT01648764|323598706|FG006|Overall Study|Adverse Event|0|||
94492613|NCT01648764|323598707|FG007|Overall Study|Adverse Event|0|||
94492614|NCT01648764|323598708|FG008|Overall Study|Adverse Event|0|||
94492615|NCT01648764|323598709|FG009|Overall Study|Adverse Event|1|||
94492616|NCT01648764|323598710|FG010|Overall Study|Adverse Event|0|||
94492617|NCT01648764|323598711|FG011|Overall Study|Adverse Event|3|||
94492618|NCT01648764|323598712|FG012|Overall Study|Adverse Event|1|||
94492619|NCT01648764|323598713|FG013|Overall Study|Adverse Event|1|||
94492620|NCT01648764|323598700|FG000|Overall Study|Death|0|||
94492621|NCT01648764|323598701|FG001|Overall Study|Death|0|||
94492622|NCT01648764|323598702|FG002|Overall Study|Death|0|||
94492623|NCT01648764|323598703|FG003|Overall Study|Death|0|||
94492624|NCT01648764|323598704|FG004|Overall Study|Death|0|||
94492625|NCT01648764|323598705|FG005|Overall Study|Death|0|||
94492626|NCT01648764|323598706|FG006|Overall Study|Death|1|||
94492627|NCT01648764|323598707|FG007|Overall Study|Death|0|||
94492628|NCT01648764|323598708|FG008|Overall Study|Death|0|||
94492629|NCT01648764|323598709|FG009|Overall Study|Death|0|||
94492630|NCT01648764|323598710|FG010|Overall Study|Death|0|||
94492631|NCT01648764|323598711|FG011|Overall Study|Death|0|||
94492632|NCT01648764|323598712|FG012|Overall Study|Death|0|||
94492633|NCT01648764|323598713|FG013|Overall Study|Death|1|||
94492634|NCT01648764|323598700|FG000|Overall Study|Withdrawal by Subject|0|||
94492635|NCT01648764|323598701|FG001|Overall Study|Withdrawal by Subject|0|||
94492636|NCT01648764|323598702|FG002|Overall Study|Withdrawal by Subject|0|||
94492637|NCT01648764|323598703|FG003|Overall Study|Withdrawal by Subject|0|||
94492638|NCT01648764|323598704|FG004|Overall Study|Withdrawal by Subject|0|||
94492639|NCT01648764|323598705|FG005|Overall Study|Withdrawal by Subject|0|||
94492640|NCT01648764|323598706|FG006|Overall Study|Withdrawal by Subject|2|||
94492641|NCT01648764|323598707|FG007|Overall Study|Withdrawal by Subject|0|||
94492642|NCT01648764|323598708|FG008|Overall Study|Withdrawal by Subject|0|||
94492643|NCT01648764|323598709|FG009|Overall Study|Withdrawal by Subject|0|||
94492644|NCT01648764|323598710|FG010|Overall Study|Withdrawal by Subject|0|||
94492645|NCT01648764|323598711|FG011|Overall Study|Withdrawal by Subject|0|||
94492646|NCT01648764|323598712|FG012|Overall Study|Withdrawal by Subject|1|||
94492647|NCT01648764|323598713|FG013|Overall Study|Withdrawal by Subject|0|||
94492648|NCT01648764|323598700|FG000|Overall Study|Investigator Decision|0|||
94492649|NCT01648764|323598701|FG001|Overall Study|Investigator Decision|0|||
94492650|NCT01648764|323598702|FG002|Overall Study|Investigator Decision|0|||
94492651|NCT01648764|323598703|FG003|Overall Study|Investigator Decision|0|||
94492652|NCT01648764|323598704|FG004|Overall Study|Investigator Decision|0|||
94492653|NCT01648764|323598705|FG005|Overall Study|Investigator Decision|0|||
94492654|NCT01648764|323598706|FG006|Overall Study|Investigator Decision|1|||
94492655|NCT01648764|323598707|FG007|Overall Study|Investigator Decision|0|||
94492656|NCT01648764|323598708|FG008|Overall Study|Investigator Decision|0|||
94492657|NCT01648764|323598709|FG009|Overall Study|Investigator Decision|0|||
94492658|NCT01648764|323598710|FG010|Overall Study|Investigator Decision|0|||
94492659|NCT01648764|323598711|FG011|Overall Study|Investigator Decision|1|||
94492660|NCT01648764|323598712|FG012|Overall Study|Investigator Decision|0|||
94492661|NCT01648764|323598713|FG013|Overall Study|Investigator Decision|0|||
94492662|NCT00576758|323598714|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
94492663|NCT00576758|323598715|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
94492664|NCT00576758|323598714|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
94492665|NCT00576758|323598715|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
94492666|NCT00576758|323598714|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
94492667|NCT00576758|323598715|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
94492668|NCT00576758|323598714|FG000|Induction Treatment Period|Death|1|||
94492669|NCT00576758|323598715|FG001|Induction Treatment Period|Death|0|||
94492670|NCT00576758|323598714|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
94492671|NCT00576758|323598715|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
94492672|NCT00576758|323598714|FG000|Induction Treatment Period|Withdrew consent|1|||
94492673|NCT00576758|323598715|FG001|Induction Treatment Period|Withdrew consent|0|||
94492674|NCT00576758|323598714|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
94492675|NCT00576758|323598715|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
94492676|NCT00576758|323598714|FG000|Extension Treatment Period|Death|1|||
94492677|NCT00576758|323598715|FG001|Extension Treatment Period|Death|1|||
94492678|NCT00576758|323598714|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
94492679|NCT00576758|323598715|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
94492680|NCT00576758|323598714|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
94492681|NCT00576758|323598715|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
94492682|NCT00576758|323598714|FG000|Extension Treatment Period|Administrative/Other|3|||
94492683|NCT00576758|323598715|FG001|Extension Treatment Period|Administrative/Other|1|||
94492684|NCT00576758|323598714|FG000|Follow-up Period|Administrative/Other|6|||
94492685|NCT00576758|323598715|FG001|Follow-up Period|Administrative/Other|8|||
94492686|NCT00576758|323598714|FG000|Follow-up Period|Death|3|||
94492687|NCT00576758|323598715|FG001|Follow-up Period|Death|3|||
94492688|NCT00576758|323598714|FG000|Follow-up Period|Insufficient therapeutic response|16|||
94492689|NCT00576758|323598715|FG001|Follow-up Period|Insufficient therapeutic response|5|||
94492690|NCT00576758|323598714|FG000|Follow-up Period|Withdrew consent|2|||
94492691|NCT00576758|323598715|FG001|Follow-up Period|Withdrew consent|1|||
94492692|NCT03979313|323598716|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
94492693|NCT03979313|323598717|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
94492694|NCT03979313|323598716|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
94492695|NCT03979313|323598717|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
94492696|NCT03979313|323598716|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
94492697|NCT03979313|323598717|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
94492698|NCT03979313|323598716|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
94492699|NCT03979313|323598717|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
94492700|NCT03979313|323598716|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
94492701|NCT03979313|323598717|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
94492702|NCT03979313|323598716|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
94492703|NCT03979313|323598717|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
94492704|NCT03979313|323598716|FG000|All Subjects|Any Other Reason|16|||
94492705|NCT03979313|323598717|FG001|All Subjects|Any Other Reason|23|||
94492706|NCT03979313|323598716|FG000|All Subjects|Covid-19|1|||
94492707|NCT03979313|323598717|FG001|All Subjects|Covid-19|3|||
94492708|NCT03979313|323598716|FG000|All Subjects|Withdrawal by Subject|35|||
94492709|NCT03979313|323598717|FG001|All Subjects|Withdrawal by Subject|44|||
94492710|NCT03979313|323598716|FG000|All Subjects|Death|0|||
94492711|NCT03979313|323598717|FG001|All Subjects|Death|5|||
94492712|NCT03979313|323598716|FG000|All Subjects|Lost to Follow-up|28|||
94492713|NCT03979313|323598717|FG001|All Subjects|Lost to Follow-up|61|||
94492714|NCT00423605|323598722|FG000|Overall Study|Adverse Event|129|||
94492715|NCT00423605|323598722|FG000|Overall Study|Withdrawal by Subject|36|||
94492716|NCT00423605|323598722|FG000|Overall Study|Lost to Follow-up|15|||
94492717|NCT00423605|323598722|FG000|Overall Study|Lack of Efficacy|38|||
94492718|NCT00423605|323598722|FG000|Overall Study|Sponsor Decision|3|||
94492719|NCT00423605|323598722|FG000|Overall Study|Physician Decision|8|||
94492720|NCT00423605|323598722|FG000|Overall Study|Protocol Violation|7|||
94492721|NCT00423605|323598722|FG000|Overall Study|Not one of the pre-specified options|5|||
94492722|NCT03183908|323598723|FG000|Overall Study|Missing Symptom Diary Data|0|||
94492723|NCT03183908|323598724|FG001|Overall Study|Missing Symptom Diary Data|2|||
94492724|NCT03738696|323598728|FG000|Overall Study|Withdrawal by Subject|0|||
94492725|NCT03738696|323598729|FG001|Overall Study|Withdrawal by Subject|1|||
94492726|NCT03738696|323598728|FG000|Overall Study|Lost to Follow-up|8|||
94492727|NCT03738696|323598729|FG001|Overall Study|Lost to Follow-up|14|||
94492728|NCT01134042|323598732|FG000|Overall Study|Adverse Event|3|||
94492729|NCT01134042|323598733|FG001|Overall Study|Adverse Event|7|||
94492730|NCT01134042|323598734|FG002|Overall Study|Adverse Event|2|||
94492731|NCT01134042|323598732|FG000|Overall Study|Lack of Efficacy|21|||
94492732|NCT01134042|323598733|FG001|Overall Study|Lack of Efficacy|6|||
94492733|NCT01134042|323598734|FG002|Overall Study|Lack of Efficacy|18|||
94492734|NCT01134042|323598732|FG000|Overall Study|Protocol Violation|5|||
94492735|NCT01134042|323598733|FG001|Overall Study|Protocol Violation|3|||
94492736|NCT01134042|323598734|FG002|Overall Study|Protocol Violation|5|||
94492737|NCT01134042|323598732|FG000|Overall Study|Lost to Follow-up|2|||
94492738|NCT01134042|323598733|FG001|Overall Study|Lost to Follow-up|0|||
94492739|NCT01134042|323598734|FG002|Overall Study|Lost to Follow-up|1|||
94492740|NCT01134042|323598732|FG000|Overall Study|Physician Decision|4|||
94492741|NCT01134042|323598733|FG001|Overall Study|Physician Decision|8|||
94492742|NCT01134042|323598734|FG002|Overall Study|Physician Decision|1|||
94492743|NCT01134042|323598732|FG000|Overall Study|Withdrawal by Subject|13|||
94492744|NCT01134042|323598733|FG001|Overall Study|Withdrawal by Subject|4|||
94492745|NCT01134042|323598734|FG002|Overall Study|Withdrawal by Subject|7|||
94492746|NCT01118299|323598735|FG000|Overall Study|Death|7|||
94492747|NCT01118299|323598736|FG001|Overall Study|Death|5|||
94492748|NCT01118299|323598735|FG000|Overall Study|Withdrawal by Subject|8|||
94492749|NCT01118299|323598736|FG001|Overall Study|Withdrawal by Subject|8|||
94492750|NCT01118299|323598735|FG000|Overall Study|Lost to Follow-up|2|||
94492751|NCT01118299|323598736|FG001|Overall Study|Lost to Follow-up|1|||
94492752|NCT01118299|323598735|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
94492753|NCT01118299|323598736|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
94492754|NCT02932943|323598739|FG000|Overall Study|Lost to Follow-up|0|||
94492755|NCT02932943|323598740|FG001|Overall Study|Lost to Follow-up|2|||
94492756|NCT02932943|323598739|FG000|Overall Study|Adverse Event|2|||
94492757|NCT02932943|323598740|FG001|Overall Study|Adverse Event|2|||
94492758|NCT02932943|323598739|FG000|Overall Study|Withdrawal by Subject|3|||
94492759|NCT02932943|323598740|FG001|Overall Study|Withdrawal by Subject|3|||
94492760|NCT01983930|323598741|FG000|Overall Study|Withdrawal by Subject|9|||
94492761|NCT01983930|323598742|FG001|Overall Study|Withdrawal by Subject|8|||
94492762|NCT01983930|323598741|FG000|Overall Study|Adverse Event|0|||
94492763|NCT01983930|323598742|FG001|Overall Study|Adverse Event|1|||
94492764|NCT01454284|323598747|FG000|Overall Study|Adverse Event|20|||
94492765|NCT01454284|323598748|FG001|Overall Study|Adverse Event|7|||
94492766|NCT01454284|323598747|FG000|Overall Study|Death|0|||
94492767|NCT01454284|323598748|FG001|Overall Study|Death|3|||
94492768|NCT01454284|323598747|FG000|Overall Study|Lost to Follow-up|13|||
94492769|NCT01454284|323598748|FG001|Overall Study|Lost to Follow-up|8|||
94492770|NCT01454284|323598747|FG000|Overall Study|Protocol Violation|9|||
94492771|NCT01454284|323598748|FG001|Overall Study|Protocol Violation|6|||
94492772|NCT01454284|323598747|FG000|Overall Study|Withdrawal by Subject|58|||
94492773|NCT01454284|323598748|FG001|Overall Study|Withdrawal by Subject|36|||
94492774|NCT01454284|323598747|FG000|Overall Study|Physician Decision|16|||
94492775|NCT01454284|323598748|FG001|Overall Study|Physician Decision|11|||
94492776|NCT01454284|323598747|FG000|Overall Study|Sponsor Decision|0|||
94492777|NCT01454284|323598748|FG001|Overall Study|Sponsor Decision|2|||
94492778|NCT02665117|323598749|FG000|Overall Study|Physician Decision|1|||
94492779|NCT02665117|323598750|FG001|Overall Study|Physician Decision|0|||
94492780|NCT00784875|323598753|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
94492781|NCT00784875|323598754|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
94492782|NCT00784875|323598755|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
94492783|NCT00784875|323598756|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
94492784|NCT00784875|323598753|FG000|Period A - Baseline|Adverse Event|0|||
94492785|NCT00784875|323598754|FG001|Period A - Baseline|Adverse Event|0|||
94492786|NCT00784875|323598755|FG002|Period A - Baseline|Adverse Event|0|||
94492787|NCT00784875|323598756|FG003|Period A - Baseline|Adverse Event|8|||
94492788|NCT00784875|323598753|FG000|Period A - Baseline|Protocol Violation|0|||
94492789|NCT00784875|323598754|FG001|Period A - Baseline|Protocol Violation|0|||
94492790|NCT00784875|323598755|FG002|Period A - Baseline|Protocol Violation|0|||
94492791|NCT00784875|323598756|FG003|Period A - Baseline|Protocol Violation|25|||
94492792|NCT00784875|323598753|FG000|Period A - Baseline|Withdrawal by Subject|0|||
94492793|NCT00784875|323598754|FG001|Period A - Baseline|Withdrawal by Subject|0|||
94492794|NCT00784875|323598755|FG002|Period A - Baseline|Withdrawal by Subject|0|||
94492795|NCT00784875|323598756|FG003|Period A - Baseline|Withdrawal by Subject|27|||
94492796|NCT00784875|323598753|FG000|Period A - Baseline|Physician Decision|0|||
94492797|NCT00784875|323598754|FG001|Period A - Baseline|Physician Decision|0|||
94492798|NCT00784875|323598755|FG002|Period A - Baseline|Physician Decision|0|||
94492799|NCT00784875|323598756|FG003|Period A - Baseline|Physician Decision|2|||
94492800|NCT00784875|323598753|FG000|Period A - Baseline|Sponsor Decision|0|||
94492801|NCT00784875|323598754|FG001|Period A - Baseline|Sponsor Decision|0|||
94492802|NCT00784875|323598755|FG002|Period A - Baseline|Sponsor Decision|0|||
94492803|NCT00784875|323598756|FG003|Period A - Baseline|Sponsor Decision|113|||
94492804|NCT00784875|323598753|FG000|Period A - Baseline|Lost to Follow-up|0|||
94492805|NCT00784875|323598754|FG001|Period A - Baseline|Lost to Follow-up|0|||
94492806|NCT00784875|323598755|FG002|Period A - Baseline|Lost to Follow-up|0|||
94492807|NCT00784875|323598756|FG003|Period A - Baseline|Lost to Follow-up|2|||
94492808|NCT00784875|323598753|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
94492809|NCT00784875|323598754|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
94492810|NCT00784875|323598755|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
94492811|NCT00784875|323598756|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
94492812|NCT00784875|323598753|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
94492813|NCT00784875|323598754|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
94492814|NCT00784875|323598755|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
94492815|NCT00784875|323598756|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
94492816|NCT00784875|323598753|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
94492817|NCT00784875|323598754|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
94492818|NCT00784875|323598755|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
94492819|NCT00784875|323598756|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
94492820|NCT00784875|323598753|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
94492821|NCT00784875|323598754|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
94492822|NCT00784875|323598755|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
94492823|NCT00784875|323598756|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
94492824|NCT00784875|323598753|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
94492825|NCT00784875|323598754|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
94492826|NCT00784875|323598755|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
94492827|NCT00784875|323598756|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
94492828|NCT00784875|323598753|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
94492829|NCT00784875|323598754|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
94492830|NCT00784875|323598755|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
94492831|NCT00784875|323598756|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
94492832|NCT00784875|323598753|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
94492833|NCT00784875|323598754|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
94492834|NCT00784875|323598755|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
94492835|NCT00784875|323598756|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
94492836|NCT00784875|323598753|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
94492837|NCT00784875|323598754|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
94492838|NCT00784875|323598755|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
94492839|NCT00784875|323598756|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
94492840|NCT00784875|323598753|FG000|Period C|Adverse Event|1|||
94492841|NCT00784875|323598754|FG001|Period C|Adverse Event|0|||
94492842|NCT00784875|323598755|FG002|Period C|Adverse Event|4|||
94492843|NCT00784875|323598756|FG003|Period C|Adverse Event|2|||
94492844|NCT00784875|323598753|FG000|Period C|Protocol Violation|0|||
94492845|NCT00784875|323598754|FG001|Period C|Protocol Violation|0|||
94492846|NCT00784875|323598755|FG002|Period C|Protocol Violation|1|||
94492847|NCT00784875|323598756|FG003|Period C|Protocol Violation|2|||
94492848|NCT00784875|323598753|FG000|Period C|Lack of Efficacy|0|||
94492849|NCT00784875|323598754|FG001|Period C|Lack of Efficacy|0|||
94492850|NCT00784875|323598755|FG002|Period C|Lack of Efficacy|1|||
94492851|NCT00784875|323598756|FG003|Period C|Lack of Efficacy|0|||
94492852|NCT00784875|323598753|FG000|Period C|Withdrawal by Subject|1|||
94492853|NCT00784875|323598754|FG001|Period C|Withdrawal by Subject|1|||
94492854|NCT00784875|323598755|FG002|Period C|Withdrawal by Subject|2|||
94492855|NCT00784875|323598756|FG003|Period C|Withdrawal by Subject|0|||
94492856|NCT00784875|323598753|FG000|Period C|Physician Decision|0|||
94492857|NCT00784875|323598754|FG001|Period C|Physician Decision|0|||
94492858|NCT00784875|323598755|FG002|Period C|Physician Decision|1|||
94492859|NCT00784875|323598756|FG003|Period C|Physician Decision|1|||
94492860|NCT00784875|323598753|FG000|Period C|Sponsor Decision|5|||
94492861|NCT00784875|323598754|FG001|Period C|Sponsor Decision|5|||
94492862|NCT00784875|323598755|FG002|Period C|Sponsor Decision|4|||
94492863|NCT00784875|323598756|FG003|Period C|Sponsor Decision|2|||
94492864|NCT00784875|323598753|FG000|Period D|Adverse Event|0|||
94492865|NCT00784875|323598754|FG001|Period D|Adverse Event|2|||
94492866|NCT00784875|323598755|FG002|Period D|Adverse Event|2|||
94492867|NCT00784875|323598756|FG003|Period D|Adverse Event|0|||
94492868|NCT00784875|323598753|FG000|Period D|Protocol Violation|1|||
94492869|NCT00784875|323598754|FG001|Period D|Protocol Violation|0|||
94492870|NCT00784875|323598755|FG002|Period D|Protocol Violation|0|||
94492871|NCT00784875|323598756|FG003|Period D|Protocol Violation|0|||
94492872|NCT00784875|323598753|FG000|Period D|Withdrawal by Subject|2|||
94492873|NCT00784875|323598754|FG001|Period D|Withdrawal by Subject|0|||
94492874|NCT00784875|323598755|FG002|Period D|Withdrawal by Subject|2|||
94492875|NCT00784875|323598756|FG003|Period D|Withdrawal by Subject|0|||
94492876|NCT00784875|323598753|FG000|Period D|Physician Decision|0|||
94492877|NCT00784875|323598754|FG001|Period D|Physician Decision|1|||
94492878|NCT00784875|323598755|FG002|Period D|Physician Decision|0|||
94492879|NCT00784875|323598756|FG003|Period D|Physician Decision|0|||
94492880|NCT00784875|323598753|FG000|Period D|Sponsor Decision|1|||
94492881|NCT00784875|323598754|FG001|Period D|Sponsor Decision|1|||
94492882|NCT00784875|323598755|FG002|Period D|Sponsor Decision|1|||
94492883|NCT00784875|323598756|FG003|Period D|Sponsor Decision|0|||
94492884|NCT00784875|323598753|FG000|Period D|Lost to Follow-up|1|||
94492885|NCT00784875|323598754|FG001|Period D|Lost to Follow-up|0|||
94492886|NCT00784875|323598755|FG002|Period D|Lost to Follow-up|1|||
94492887|NCT00784875|323598756|FG003|Period D|Lost to Follow-up|1|||
94492888|NCT00853385|323598759|FG000|Overall Study|Death|0|||
94492889|NCT00853385|323598760|FG001|Overall Study|Death|0|||
94492890|NCT00853385|323598761|FG002|Overall Study|Death|0|||
94492891|NCT00853385|323598762|FG003|Overall Study|Death|0|||
94492892|NCT00853385|323598763|FG004|Overall Study|Death|1|||
94492893|NCT00853385|323598759|FG000|Overall Study|Adverse Event|24|||
94492894|NCT00853385|323598760|FG001|Overall Study|Adverse Event|24|||
94492895|NCT00853385|323598761|FG002|Overall Study|Adverse Event|2|||
94492896|NCT00853385|323598762|FG003|Overall Study|Adverse Event|5|||
94492897|NCT00853385|323598763|FG004|Overall Study|Adverse Event|22|||
94492898|NCT00853385|323598759|FG000|Overall Study|Lack of Efficacy|6|||
94492899|NCT00853385|323598760|FG001|Overall Study|Lack of Efficacy|7|||
94492900|NCT00853385|323598761|FG002|Overall Study|Lack of Efficacy|3|||
94492901|NCT00853385|323598762|FG003|Overall Study|Lack of Efficacy|3|||
94492902|NCT00853385|323598763|FG004|Overall Study|Lack of Efficacy|6|||
94492903|NCT00853385|323598759|FG000|Overall Study|Lost to Follow-up|2|||
94492904|NCT00853385|323598760|FG001|Overall Study|Lost to Follow-up|1|||
94492905|NCT00853385|323598761|FG002|Overall Study|Lost to Follow-up|0|||
94492906|NCT00853385|323598762|FG003|Overall Study|Lost to Follow-up|0|||
94492907|NCT00853385|323598763|FG004|Overall Study|Lost to Follow-up|0|||
94492908|NCT00853385|323598759|FG000|Overall Study|Withdrawal by Subject|4|||
94492909|NCT00853385|323598760|FG001|Overall Study|Withdrawal by Subject|2|||
94492910|NCT00853385|323598761|FG002|Overall Study|Withdrawal by Subject|0|||
94492911|NCT00853385|323598762|FG003|Overall Study|Withdrawal by Subject|1|||
94492912|NCT00853385|323598763|FG004|Overall Study|Withdrawal by Subject|1|||
94492913|NCT00853385|323598759|FG000|Overall Study|Other|18|||
94492914|NCT00853385|323598760|FG001|Overall Study|Other|9|||
94492915|NCT00853385|323598761|FG002|Overall Study|Other|4|||
94492916|NCT00853385|323598762|FG003|Overall Study|Other|4|||
94492917|NCT00853385|323598763|FG004|Overall Study|Other|12|||
94492918|NCT00764517|323598765|FG000|Overall Study|Adverse Event|9|||
94492919|NCT00764517|323598766|FG001|Overall Study|Adverse Event|3|||
94492920|NCT00764517|323598765|FG000|Overall Study|Death|3|||
94492921|NCT00764517|323598766|FG001|Overall Study|Death|11|||
94492922|NCT00764517|323598765|FG000|Overall Study|Physician Decision|3|||
94492923|NCT00764517|323598766|FG001|Overall Study|Physician Decision|0|||
94492924|NCT00577408|323598773|FG000|Overall Study|Stopped attending study visits|9|||
94492925|NCT00577408|323598774|FG001|Overall Study|Stopped attending study visits|11|||
94492926|NCT00577408|323598773|FG000|Overall Study|Continued opioid use|3|||
94492927|NCT00577408|323598774|FG001|Overall Study|Continued opioid use|2|||
94492928|NCT00577408|323598773|FG000|Overall Study|Non-compliance with study meds|0|||
94492929|NCT00577408|323598774|FG001|Overall Study|Non-compliance with study meds|3|||
94492930|NCT00577408|323598773|FG000|Overall Study|Refused Oral Naltrexone|0|||
94492931|NCT00577408|323598774|FG001|Overall Study|Refused Oral Naltrexone|1|||
94492932|NCT00577408|323598773|FG000|Overall Study|Moved out of state|0|||
94492933|NCT00577408|323598774|FG001|Overall Study|Moved out of state|1|||
94492934|NCT00577408|323598773|FG000|Overall Study|Scheduling Issues|0|||
94492935|NCT00577408|323598774|FG001|Overall Study|Scheduling Issues|3|||
94492936|NCT00577408|323598773|FG000|Overall Study|Death|0|||
94492937|NCT00577408|323598774|FG001|Overall Study|Death|1|||
94492938|NCT00577408|323598773|FG000|Overall Study|Psychiatric hospitalization|0|||
94492939|NCT00577408|323598774|FG001|Overall Study|Psychiatric hospitalization|1|||
94492940|NCT01027949|323598776|FG000|Overall Study|Death|174|||
94492941|NCT01027949|323598776|FG000|Overall Study|Progressive Disease|163|||
94492942|NCT01027949|323598776|FG000|Overall Study|Adverse Event|172|||
94492943|NCT01027949|323598776|FG000|Overall Study|Withdrawal by Subject|113|||
94492944|NCT01027949|323598776|FG000|Overall Study|Lost to Follow-up|17|||
94492945|NCT01027949|323598776|FG000|Overall Study|Protocol Violation|13|||
94492946|NCT01027949|323598776|FG000|Overall Study|PI Decision|8|||
94492947|NCT01027949|323598776|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
94492948|NCT01027949|323598776|FG000|Overall Study|Non-compliance with Study Procedures|7|||
94492949|NCT01027949|323598776|FG000|Overall Study|Lung Transplant|5|||
94492950|NCT01027949|323598776|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
94492951|NCT01027949|323598776|FG000|Overall Study|Use of Excluded Medication|2|||
94492952|NCT01027949|323598776|FG000|Overall Study|Patient Self-discontinuation|1|||
94492953|NCT01027949|323598776|FG000|Overall Study|Pregnancy|1|||
94492954|NCT01027949|323598776|FG000|Overall Study|Surgery|1|||
94492955|NCT00303186|323598778|FG000|Overall Study|Other|52|||
94492956|NCT02020941|323598779|FG000|Overall Study|Adverse Event|1|||
94492957|NCT02020941|323598779|FG000|Overall Study|Physician Decision|2|||
94492958|NCT02020941|323598779|FG000|Overall Study|Withdrawal by Subject|1|||
94492959|NCT02020941|323598779|FG000|Overall Study|Disease Progression|4|||
94492960|NCT03329989|323598781|FG000|Overall Study|Withdrawal by Subject|9|||
94492961|NCT03329989|323598781|FG000|Overall Study|Lost to Follow-up|8|||
94492962|NCT03329989|323598781|FG000|Overall Study|Adverse Event|5|||
94492963|NCT03329989|323598781|FG000|Overall Study|Protocol Violation|1|||
94492964|NCT03937778|323598782|FG000|Overall Study|Withdrawal by Subject|1|||
94492965|NCT03937778|323598782|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
94492966|NCT00937950|323598783|FG000|Overall Study|Withdrawal by Subject|23|||
94492967|NCT00937950|323598783|FG000|Overall Study|Migrated/moved from study area|27|||
94492968|NCT00937950|323598783|FG000|Overall Study|Lost to Follow-up|144|||
94492969|NCT00937950|323598783|FG000|Overall Study|Missing confirmed|4|||
94492970|NCT00937950|323598783|FG000|Overall Study|Other|18|||
94492971|NCT01137786|323598785|FG000|Overall Study|Lost to Follow-up|0|||
94492972|NCT01137786|323598786|FG001|Overall Study|Lost to Follow-up|2|||
94492973|NCT01137786|323598785|FG000|Overall Study|Withdrawal by Subject|1|||
94492974|NCT01137786|323598786|FG001|Overall Study|Withdrawal by Subject|1|||
94492975|NCT01200355|323598789|FG000|Overall Study|Death|7|||
94492976|NCT01200355|323598790|FG001|Overall Study|Death|2|||
94492977|NCT02701634|323598791|FG000|Overall Study|Adverse Event|2|||
94492978|NCT02701634|323598792|FG001|Overall Study|Adverse Event|3|||
94492979|NCT02701634|323598791|FG000|Overall Study|Death|1|||
94492980|NCT02701634|323598792|FG001|Overall Study|Death|0|||
94492981|NCT02701634|323598791|FG000|Overall Study|Investigator's Discretion|7|||
94492982|NCT02701634|323598792|FG001|Overall Study|Investigator's Discretion|4|||
94492983|NCT02701634|323598791|FG000|Overall Study|Study terminated by Sponsor|15|||
94492984|NCT02701634|323598792|FG001|Overall Study|Study terminated by Sponsor|17|||
94492985|NCT02701634|323598791|FG000|Overall Study|Withdrew Consent|6|||
94492986|NCT02701634|323598792|FG001|Overall Study|Withdrew Consent|7|||
94492987|NCT02701634|323598791|FG000|Overall Study|Randomized but not treated|1|||
94492988|NCT02701634|323598792|FG001|Overall Study|Randomized but not treated|0|||
94492989|NCT00630292|323598793|FG000|Overall Study|Withdrawal by Subject|1|||
94492990|NCT03620162|323598794|FG000|Overall Study|Physician Decision|4|||
94492991|NCT03620162|323598795|FG001|Overall Study|Physician Decision|0|||
94492992|NCT03620162|323598796|FG002|Overall Study|Physician Decision|1|||
94492993|NCT03620162|323598797|FG003|Overall Study|Physician Decision|0|||
94492994|NCT03620162|323598798|FG004|Overall Study|Physician Decision|2|||
94492995|NCT03620162|323598794|FG000|Overall Study|Lost to Follow-up|2|||
94492996|NCT03620162|323598795|FG001|Overall Study|Lost to Follow-up|6|||
94492997|NCT03620162|323598796|FG002|Overall Study|Lost to Follow-up|7|||
94492998|NCT03620162|323598797|FG003|Overall Study|Lost to Follow-up|3|||
94492999|NCT03620162|323598798|FG004|Overall Study|Lost to Follow-up|2|||
94493000|NCT03620162|323598794|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
94493001|NCT03620162|323598795|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
94493002|NCT03620162|323598796|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
94493003|NCT03620162|323598797|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
94493004|NCT03620162|323598798|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
94493005|NCT04009837|323598803|FG000|Overall Study|Withdrawal by Subject|5|||
94493006|NCT04009837|323598804|FG001|Overall Study|Withdrawal by Subject|4|||
94493007|NCT04009837|323598803|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
94493008|NCT04009837|323598804|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
94493009|NCT00717886|323598805|FG000|Overall Study|Withdrawal by Subject|3|||
94493010|NCT00717886|323598805|FG000|Overall Study|Treatment Failure|1|||
94493011|NCT01369433|323598806|FG000|Overall Study|Adverse Event|31|||
94493012|NCT01369433|323598807|FG001|Overall Study|Adverse Event|1|||
94493013|NCT01369433|323598806|FG000|Overall Study|Required significant surgical procedure|1|||
94493014|NCT01369433|323598807|FG001|Overall Study|Required significant surgical procedure|0|||
94493015|NCT01369433|323598806|FG000|Overall Study|Non-compliance|1|||
94493016|NCT01369433|323598807|FG001|Overall Study|Non-compliance|0|||
94493017|NCT01369433|323598806|FG000|Overall Study|Withdrawal by Subject|5|||
94493018|NCT01369433|323598807|FG001|Overall Study|Withdrawal by Subject|2|||
94493019|NCT01369433|323598806|FG000|Overall Study|Study terminated by Sponsor|67|||
94493020|NCT01369433|323598807|FG001|Overall Study|Study terminated by Sponsor|0|||
94493021|NCT01369433|323598806|FG000|Overall Study|Lost to Follow-up|1|||
94493022|NCT01369433|323598807|FG001|Overall Study|Lost to Follow-up|0|||
94493023|NCT01369433|323598806|FG000|Overall Study|Death|5|||
94493024|NCT01369433|323598807|FG001|Overall Study|Death|0|||
94493025|NCT01369433|323598806|FG000|Overall Study|Investigator discretion|6|||
94493026|NCT01369433|323598807|FG001|Overall Study|Investigator discretion|1|||
94493027|NCT01369433|323598806|FG000|Overall Study|Progressive Disease|92|||
94493028|NCT01369433|323598807|FG001|Overall Study|Progressive Disease|12|||
94493029|NCT01553851|323598808|FG000|Overall Study|Adverse Event|2|||
94493030|NCT01553851|323598808|FG000|Overall Study|constipation|1|||
94493031|NCT00961415|323598813|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
94493032|NCT00961415|323598814|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
94493033|NCT00961415|323598815|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
94493034|NCT00961415|323598813|FG000|Induction Treatment Phase|Death|77|||
94493035|NCT00961415|323598814|FG001|Induction Treatment Phase|Death|0|||
94493036|NCT00961415|323598815|FG002|Induction Treatment Phase|Death|0|||
94493037|NCT00961415|323598813|FG000|Induction Treatment Phase|Protocol Violation|1|||
94493038|NCT00961415|323598814|FG001|Induction Treatment Phase|Protocol Violation|0|||
94493039|NCT00961415|323598815|FG002|Induction Treatment Phase|Protocol Violation|0|||
94493040|NCT00961415|323598813|FG000|Induction Treatment Phase|Physician Decision|2|||
94493041|NCT00961415|323598814|FG001|Induction Treatment Phase|Physician Decision|0|||
94493042|NCT00961415|323598815|FG002|Induction Treatment Phase|Physician Decision|0|||
94493043|NCT00961415|323598813|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
94493044|NCT00961415|323598814|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
94493045|NCT00961415|323598815|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
94493046|NCT00961415|323598813|FG000|Induction Treatment Phase|Other Reason|5|||
94493047|NCT00961415|323598814|FG001|Induction Treatment Phase|Other Reason|0|||
94493048|NCT00961415|323598815|FG002|Induction Treatment Phase|Other Reason|0|||
94493049|NCT00961415|323598813|FG000|Maintenance Treatment Phase|Death|0|||
94493050|NCT00961415|323598814|FG001|Maintenance Treatment Phase|Death|42|||
94493051|NCT00961415|323598815|FG002|Maintenance Treatment Phase|Death|34|||
94493052|NCT00961415|323598813|FG000|Maintenance Treatment Phase|Investigators decision|0|||
94493053|NCT00961415|323598814|FG001|Maintenance Treatment Phase|Investigators decision|2|||
94493054|NCT00961415|323598815|FG002|Maintenance Treatment Phase|Investigators decision|0|||
94493055|NCT00961415|323598813|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
94493056|NCT00961415|323598814|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
94493057|NCT00961415|323598815|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
94493058|NCT00961415|323598813|FG000|Maintenance Treatment Phase|Other reason|0|||
94493059|NCT00961415|323598814|FG001|Maintenance Treatment Phase|Other reason|1|||
94493060|NCT00961415|323598815|FG002|Maintenance Treatment Phase|Other reason|3|||
94493061|NCT00226655|323598816|FG000|Overall Study|Death|13|||
94493062|NCT00226655|323598816|FG000|Overall Study|Withdrawal by Subject|15|||
94493063|NCT00226655|323598816|FG000|Overall Study|Adverse Event|35|||
94493064|NCT00226655|323598816|FG000|Overall Study|Physician Decision|6|||
94493065|NCT00226655|323598816|FG000|Overall Study|Clinical deterioration|10|||
94493066|NCT01104766|323598817|FG000|Overall Study|Did not meet inc/exc criteria|1|||
94493067|NCT01104766|323598818|FG001|Overall Study|Did not meet inc/exc criteria|0|||
94493068|NCT01104766|323598819|FG002|Overall Study|Did not meet inc/exc criteria|0|||
94493069|NCT01104766|323598820|FG003|Overall Study|Did not meet inc/exc criteria|0|||
94493070|NCT01104766|323598817|FG000|Overall Study|Adverse Event|17|||
94493071|NCT01104766|323598818|FG001|Overall Study|Adverse Event|15|||
94493072|NCT01104766|323598819|FG002|Overall Study|Adverse Event|20|||
94493073|NCT01104766|323598820|FG003|Overall Study|Adverse Event|14|||
94493074|NCT01104766|323598817|FG000|Overall Study|Lack of Efficacy|20|||
94493075|NCT01104766|323598818|FG001|Overall Study|Lack of Efficacy|15|||
94493076|NCT01104766|323598819|FG002|Overall Study|Lack of Efficacy|14|||
94493077|NCT01104766|323598820|FG003|Overall Study|Lack of Efficacy|8|||
94493078|NCT01104766|323598817|FG000|Overall Study|Protocol Violation|2|||
94493079|NCT01104766|323598818|FG001|Overall Study|Protocol Violation|0|||
94493080|NCT01104766|323598819|FG002|Overall Study|Protocol Violation|0|||
94493081|NCT01104766|323598820|FG003|Overall Study|Protocol Violation|0|||
94493082|NCT01104766|323598817|FG000|Overall Study|Withdrawal by Subject|17|||
94493083|NCT01104766|323598818|FG001|Overall Study|Withdrawal by Subject|19|||
94493084|NCT01104766|323598819|FG002|Overall Study|Withdrawal by Subject|25|||
94493085|NCT01104766|323598820|FG003|Overall Study|Withdrawal by Subject|15|||
94493086|NCT01104766|323598817|FG000|Overall Study|Lost to Follow-up|1|||
94493087|NCT01104766|323598818|FG001|Overall Study|Lost to Follow-up|2|||
94493088|NCT01104766|323598819|FG002|Overall Study|Lost to Follow-up|1|||
94493089|NCT01104766|323598820|FG003|Overall Study|Lost to Follow-up|1|||
94493090|NCT01136915|323598821|FG000|Overall Study|Lost to Follow-up|2|||
94493091|NCT01136915|323598822|FG001|Overall Study|Lost to Follow-up|0|||
94493092|NCT01136915|323598821|FG000|Overall Study|Exclusion criterion met|0|||
94493093|NCT01136915|323598822|FG001|Overall Study|Exclusion criterion met|1|||
94493094|NCT02550795|323598827|FG000|Overall Study|Physician Decision|0|||
94493095|NCT02550795|323598828|FG001|Overall Study|Physician Decision|1|||
94493096|NCT02550795|323598829|FG002|Overall Study|Physician Decision|0|||
94493097|NCT02278354|323598833|FG000|Overall Study|Lost to Follow-up|2|||
94493098|NCT02278354|323598834|FG001|Overall Study|Lost to Follow-up|2|||
94493099|NCT02278354|323598833|FG000|Overall Study|Withdrawal by Subject|0|||
94493100|NCT02278354|323598834|FG001|Overall Study|Withdrawal by Subject|1|||
94493101|NCT02278354|323598833|FG000|Overall Study|<10 professional fights|2|||
94493102|NCT02278354|323598834|FG001|Overall Study|<10 professional fights|0|||
94493103|NCT01564407|323598839|FG000|Overall Study|Lost to Follow-up|0|||
94493104|NCT01564407|323598840|FG001|Overall Study|Lost to Follow-up|1|||
94493105|NCT01564407|323598841|FG002|Overall Study|Lost to Follow-up|0|||
94493106|NCT01564407|323598842|FG003|Overall Study|Lost to Follow-up|0|||
94493107|NCT01564407|323598843|FG004|Overall Study|Lost to Follow-up|0|||
94493108|NCT01564407|323598839|FG000|Overall Study|Withdrawal by Subject|0|||
94493109|NCT01564407|323598840|FG001|Overall Study|Withdrawal by Subject|1|||
94493110|NCT01564407|323598841|FG002|Overall Study|Withdrawal by Subject|0|||
94493111|NCT01564407|323598842|FG003|Overall Study|Withdrawal by Subject|0|||
94493112|NCT01564407|323598843|FG004|Overall Study|Withdrawal by Subject|0|||
94493113|NCT01564407|323598839|FG000|Overall Study|funding lost, study ended|0|||
94493114|NCT01564407|323598840|FG001|Overall Study|funding lost, study ended|0|||
94493115|NCT01564407|323598841|FG002|Overall Study|funding lost, study ended|0|||
94493116|NCT01564407|323598842|FG003|Overall Study|funding lost, study ended|1|||
94493117|NCT01564407|323598843|FG004|Overall Study|funding lost, study ended|0|||
94493118|NCT01551173|323598844|FG000|Overall Study|Withdrawal by Subject|11|||
94493119|NCT01551173|323598845|FG001|Overall Study|Withdrawal by Subject|16|||
94493120|NCT01551173|323598844|FG000|Overall Study|Adverse Event|7|||
94493121|NCT01551173|323598845|FG001|Overall Study|Adverse Event|6|||
94493122|NCT01551173|323598844|FG000|Overall Study|Lost to Follow-up|5|||
94493123|NCT01551173|323598845|FG001|Overall Study|Lost to Follow-up|7|||
94493124|NCT01551173|323598844|FG000|Overall Study|Other|5|||
94493125|NCT01551173|323598845|FG001|Overall Study|Other|3|||
94493126|NCT01910441|323598846|FG000|Overall Study|Sponsor decision|0|||
94493127|NCT01910441|323598847|FG001|Overall Study|Sponsor decision|2|||
94493128|NCT01910441|323598846|FG000|Overall Study|Lost to Follow-up|6|||
94493129|NCT01910441|323598847|FG001|Overall Study|Lost to Follow-up|5|||
94493130|NCT01910441|323598846|FG000|Overall Study|Withdrawal by Subject|0|||
94493131|NCT01910441|323598847|FG001|Overall Study|Withdrawal by Subject|1|||
94493132|NCT01910441|323598846|FG000|Overall Study|Non-compliance|0|||
94493133|NCT01910441|323598847|FG001|Overall Study|Non-compliance|1|||
94493134|NCT01910441|323598846|FG000|Overall Study|Adverse Event|1|||
94493135|NCT01910441|323598847|FG001|Overall Study|Adverse Event|0|||
94493136|NCT01910441|323598846|FG000|Overall Study|Physician Decision|0|||
94493137|NCT01910441|323598847|FG001|Overall Study|Physician Decision|1|||
94493138|NCT00262925|323598848|FG000|Overall Study|Lack of Efficacy|3|||
94493139|NCT00262925|323598848|FG000|Overall Study|Adverse Event|4|||
94493140|NCT00262925|323598848|FG000|Overall Study|Death|2|||
94493141|NCT00262925|323598848|FG000|Overall Study|alternative therapy|1|||
94493142|NCT00262925|323598848|FG000|Overall Study|Other|1|||
94493143|NCT00927472|323598853|FG000|Overall Study|Withdrawal by Subject|10|||
94493144|NCT00927472|323598854|FG001|Overall Study|Withdrawal by Subject|11|||
94493145|NCT00927472|323598853|FG000|Overall Study|Lost to Follow-up|1|||
94493146|NCT00927472|323598854|FG001|Overall Study|Lost to Follow-up|6|||
94493147|NCT00927472|323598853|FG000|Overall Study|Protocol Violation|0|||
94493148|NCT00927472|323598854|FG001|Overall Study|Protocol Violation|1|||
94493149|NCT00927472|323598853|FG000|Overall Study|Post treatment Assessment out of window|0|||
94493150|NCT00927472|323598854|FG001|Overall Study|Post treatment Assessment out of window|4|||
94493151|NCT01977846|323598857|FG000|Total Study - Prospective|Death|0|||
94493152|NCT01977846|323598858|FG001|Total Study - Prospective|Death|1|||
94493153|NCT01977846|323598857|FG000|Total Study - Prospective|Lost to Follow-up|0|||
94493154|NCT01977846|323598858|FG001|Total Study - Prospective|Lost to Follow-up|8|||
94493155|NCT01977846|323598857|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
94493156|NCT01977846|323598858|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
94493157|NCT01977846|323598857|FG000|Total Study - Prospective|Not available at time of visit|0|||
94493158|NCT01977846|323598858|FG001|Total Study - Prospective|Not available at time of visit|5|||
94493159|NCT01977846|323598857|FG000|Total Study - Prospective|No show|0|||
94493160|NCT01977846|323598858|FG001|Total Study - Prospective|No show|1|||
94493161|NCT01977846|323598857|FG000|Total Study - Prospective|Protocol Violation|0|||
94493162|NCT01977846|323598858|FG001|Total Study - Prospective|Protocol Violation|1|||
94493163|NCT00655889|323598859|FG000|Overall Study|Inadequate cell growth|1|||
94493164|NCT00655889|323598859|FG000|Overall Study|Protocol Violation|1|||
94493165|NCT00765076|323598869|FG000|Overall Study|Adverse Event|1|||
94493166|NCT00765076|323598870|FG001|Overall Study|Adverse Event|0|||
94493167|NCT00765076|323598871|FG002|Overall Study|Adverse Event|0|||
94493168|NCT00765076|323598869|FG000|Overall Study|Withdrawal by Subject|0|||
94493169|NCT00765076|323598870|FG001|Overall Study|Withdrawal by Subject|0|||
94493170|NCT00765076|323598871|FG002|Overall Study|Withdrawal by Subject|1|||
94493171|NCT01163617|323598872|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
94493172|NCT01163617|323598873|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
94493173|NCT01163617|323598874|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
94493174|NCT01163617|323598875|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
94493175|NCT01163617|323598876|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
94493176|NCT01163617|323598877|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
94493177|NCT01163617|323598878|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
94493178|NCT01163617|323598879|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
94493179|NCT01163617|323598872|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
94493180|NCT01163617|323598873|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
94493181|NCT01163617|323598874|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
94493182|NCT01163617|323598875|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
94493183|NCT01163617|323598876|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
94493184|NCT01163617|323598877|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
94493185|NCT01163617|323598878|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
94493186|NCT01163617|323598879|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
94493187|NCT01163617|323598872|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
94493188|NCT01163617|323598873|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
94493189|NCT01163617|323598874|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
94493190|NCT01163617|323598875|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
94493191|NCT01163617|323598876|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
94493192|NCT01163617|323598877|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
94493193|NCT01163617|323598878|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
94493194|NCT01163617|323598879|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
94493195|NCT01164475|323598880|FG000|Overall Study|Lack of Efficacy|1|||
94493196|NCT01164475|323598881|FG001|Overall Study|Lack of Efficacy|0|||
94493197|NCT01164475|323598880|FG000|Overall Study|Other|0|||
94493198|NCT01164475|323598881|FG001|Overall Study|Other|1|||
94493199|NCT01164475|323598880|FG000|Overall Study|Progressive disease|0|||
94493200|NCT01164475|323598881|FG001|Overall Study|Progressive disease|1|||
94493201|NCT01164475|323598880|FG000|Overall Study|Protocol Violation|1|||
94493202|NCT01164475|323598881|FG001|Overall Study|Protocol Violation|0|||
94493203|NCT02335944|323598882|FG000|Treatment Phase|Progressive Disease|2|||
94493204|NCT02335944|323598883|FG001|Treatment Phase|Progressive Disease|5|||
94493205|NCT02335944|323598884|FG002|Treatment Phase|Progressive Disease|2|||
94493206|NCT02335944|323598885|FG003|Treatment Phase|Progressive Disease|11|||
94493207|NCT02335944|323598886|FG004|Treatment Phase|Progressive Disease|4|||
94493208|NCT02335944|323598887|FG005|Treatment Phase|Progressive Disease|25|||
94493209|NCT02335944|323598888|FG006|Treatment Phase|Progressive Disease|2|||
94493210|NCT02335944|323598889|FG007|Treatment Phase|Progressive Disease|30|||
94493211|NCT02335944|323598890|FG008|Treatment Phase|Progressive Disease|27|||
94493212|NCT02335944|323598891|FG009|Treatment Phase|Progressive Disease|0|||
94493213|NCT02335944|323598882|FG000|Treatment Phase|Adverse Event|2|||
94493214|NCT02335944|323598883|FG001|Treatment Phase|Adverse Event|0|||
94493215|NCT02335944|323598884|FG002|Treatment Phase|Adverse Event|0|||
94493216|NCT02335944|323598885|FG003|Treatment Phase|Adverse Event|2|||
94493217|NCT02335944|323598886|FG004|Treatment Phase|Adverse Event|1|||
94493218|NCT02335944|323598887|FG005|Treatment Phase|Adverse Event|15|||
94493219|NCT02335944|323598888|FG006|Treatment Phase|Adverse Event|0|||
94493220|NCT02335944|323598889|FG007|Treatment Phase|Adverse Event|5|||
94493221|NCT02335944|323598890|FG008|Treatment Phase|Adverse Event|7|||
94493222|NCT02335944|323598891|FG009|Treatment Phase|Adverse Event|0|||
94493223|NCT02335944|323598882|FG000|Treatment Phase|Physician Decision|0|||
94493224|NCT02335944|323598883|FG001|Treatment Phase|Physician Decision|0|||
94493225|NCT02335944|323598884|FG002|Treatment Phase|Physician Decision|0|||
94493226|NCT02335944|323598885|FG003|Treatment Phase|Physician Decision|1|||
94493227|NCT02335944|323598886|FG004|Treatment Phase|Physician Decision|0|||
94493228|NCT02335944|323598887|FG005|Treatment Phase|Physician Decision|6|||
94493229|NCT02335944|323598888|FG006|Treatment Phase|Physician Decision|1|||
94493230|NCT02335944|323598889|FG007|Treatment Phase|Physician Decision|2|||
94493231|NCT02335944|323598890|FG008|Treatment Phase|Physician Decision|1|||
94493232|NCT02335944|323598891|FG009|Treatment Phase|Physician Decision|0|||
94493233|NCT02335944|323598882|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
94493234|NCT02335944|323598883|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
94493235|NCT02335944|323598884|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
94493236|NCT02335944|323598885|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
94493237|NCT02335944|323598886|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
94493238|NCT02335944|323598887|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
94493239|NCT02335944|323598888|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
94493240|NCT02335944|323598889|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
94493241|NCT02335944|323598890|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
94493242|NCT02335944|323598891|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
94493243|NCT02335944|323598882|FG000|Treatment Phase|Subject/Guardian Decision|0|||
94493244|NCT02335944|323598883|FG001|Treatment Phase|Subject/Guardian Decision|0|||
94493245|NCT02335944|323598884|FG002|Treatment Phase|Subject/Guardian Decision|1|||
94493246|NCT02335944|323598885|FG003|Treatment Phase|Subject/Guardian Decision|0|||
94493247|NCT02335944|323598886|FG004|Treatment Phase|Subject/Guardian Decision|0|||
94493248|NCT02335944|323598887|FG005|Treatment Phase|Subject/Guardian Decision|1|||
94493249|NCT02335944|323598888|FG006|Treatment Phase|Subject/Guardian Decision|0|||
94493250|NCT02335944|323598889|FG007|Treatment Phase|Subject/Guardian Decision|4|||
94493251|NCT02335944|323598890|FG008|Treatment Phase|Subject/Guardian Decision|0|||
94493252|NCT02335944|323598891|FG009|Treatment Phase|Subject/Guardian Decision|0|||
94493253|NCT02335944|323598882|FG000|Post-treatment Follow-up|Progressive Disease|0|||
94493254|NCT02335944|323598883|FG001|Post-treatment Follow-up|Progressive Disease|0|||
94493255|NCT02335944|323598884|FG002|Post-treatment Follow-up|Progressive Disease|0|||
94493256|NCT02335944|323598885|FG003|Post-treatment Follow-up|Progressive Disease|1|||
94493257|NCT02335944|323598886|FG004|Post-treatment Follow-up|Progressive Disease|0|||
94493258|NCT02335944|323598887|FG005|Post-treatment Follow-up|Progressive Disease|9|||
94493259|NCT02335944|323598888|FG006|Post-treatment Follow-up|Progressive Disease|0|||
94493260|NCT02335944|323598889|FG007|Post-treatment Follow-up|Progressive Disease|2|||
94493261|NCT02335944|323598890|FG008|Post-treatment Follow-up|Progressive Disease|3|||
94493262|NCT02335944|323598891|FG009|Post-treatment Follow-up|Progressive Disease|0|||
94493263|NCT02335944|323598882|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
94493264|NCT02335944|323598883|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
94493265|NCT02335944|323598884|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
94493266|NCT02335944|323598885|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
94493267|NCT02335944|323598886|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
94493268|NCT02335944|323598887|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
94493269|NCT02335944|323598888|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
94493270|NCT02335944|323598889|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
94493271|NCT02335944|323598890|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
94493272|NCT02335944|323598891|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
94493273|NCT02335944|323598882|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
94493274|NCT02335944|323598883|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
94493275|NCT02335944|323598884|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
94493276|NCT02335944|323598885|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
94493277|NCT02335944|323598886|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
94493278|NCT02335944|323598887|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
94493279|NCT02335944|323598888|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
94493280|NCT02335944|323598889|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
94493281|NCT02335944|323598890|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
94493282|NCT02335944|323598891|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
94493283|NCT02335944|323598882|FG000|Post-treatment Follow-up|Adverse Event|0|||
94493284|NCT02335944|323598883|FG001|Post-treatment Follow-up|Adverse Event|0|||
94493285|NCT02335944|323598884|FG002|Post-treatment Follow-up|Adverse Event|0|||
94493286|NCT02335944|323598885|FG003|Post-treatment Follow-up|Adverse Event|0|||
94493287|NCT02335944|323598886|FG004|Post-treatment Follow-up|Adverse Event|0|||
94493288|NCT02335944|323598887|FG005|Post-treatment Follow-up|Adverse Event|1|||
94493289|NCT02335944|323598888|FG006|Post-treatment Follow-up|Adverse Event|0|||
94493290|NCT02335944|323598889|FG007|Post-treatment Follow-up|Adverse Event|0|||
94493291|NCT02335944|323598890|FG008|Post-treatment Follow-up|Adverse Event|0|||
94493292|NCT02335944|323598891|FG009|Post-treatment Follow-up|Adverse Event|0|||
94493293|NCT02335944|323598882|FG000|Post-treatment Follow-up|Death|0|||
94493294|NCT02335944|323598883|FG001|Post-treatment Follow-up|Death|0|||
94493295|NCT02335944|323598884|FG002|Post-treatment Follow-up|Death|0|||
94493296|NCT02335944|323598885|FG003|Post-treatment Follow-up|Death|1|||
94493297|NCT02335944|323598886|FG004|Post-treatment Follow-up|Death|0|||
94493298|NCT02335944|323598887|FG005|Post-treatment Follow-up|Death|1|||
94493299|NCT02335944|323598888|FG006|Post-treatment Follow-up|Death|0|||
94493300|NCT02335944|323598889|FG007|Post-treatment Follow-up|Death|0|||
94493301|NCT02335944|323598890|FG008|Post-treatment Follow-up|Death|0|||
94493302|NCT02335944|323598891|FG009|Post-treatment Follow-up|Death|0|||
94493303|NCT02335944|323598882|FG000|Post-treatment Follow-up|Physician Decision|1|||
94493304|NCT02335944|323598883|FG001|Post-treatment Follow-up|Physician Decision|0|||
94493305|NCT02335944|323598884|FG002|Post-treatment Follow-up|Physician Decision|0|||
94493306|NCT02335944|323598885|FG003|Post-treatment Follow-up|Physician Decision|0|||
94493307|NCT02335944|323598886|FG004|Post-treatment Follow-up|Physician Decision|0|||
94493308|NCT02335944|323598887|FG005|Post-treatment Follow-up|Physician Decision|0|||
94493309|NCT02335944|323598888|FG006|Post-treatment Follow-up|Physician Decision|0|||
94493310|NCT02335944|323598889|FG007|Post-treatment Follow-up|Physician Decision|1|||
94493311|NCT02335944|323598890|FG008|Post-treatment Follow-up|Physician Decision|0|||
94493312|NCT02335944|323598891|FG009|Post-treatment Follow-up|Physician Decision|0|||
94493313|NCT01706328|323598892|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
94493314|NCT01706328|323598893|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
94493315|NCT01706328|323598894|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
94493316|NCT01706328|323598892|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
94493317|NCT01706328|323598893|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
94493318|NCT01706328|323598894|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
94493319|NCT01706328|323598892|FG000|2-week Run-in Period|Physician Decision|4|||
94493320|NCT01706328|323598893|FG001|2-week Run-in Period|Physician Decision|0|||
94493321|NCT01706328|323598894|FG002|2-week Run-in Period|Physician Decision|0|||
94493322|NCT01706328|323598892|FG000|2-week Run-in Period|Adverse Event|4|||
94493323|NCT01706328|323598893|FG001|2-week Run-in Period|Adverse Event|0|||
94493324|NCT01706328|323598894|FG002|2-week Run-in Period|Adverse Event|0|||
94493325|NCT01706328|323598892|FG000|2-week Run-in Period|Lost to Follow-up|2|||
94493326|NCT01706328|323598893|FG001|2-week Run-in Period|Lost to Follow-up|0|||
94493327|NCT01706328|323598894|FG002|2-week Run-in Period|Lost to Follow-up|0|||
94493328|NCT01706328|323598892|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
94493329|NCT01706328|323598893|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
94493330|NCT01706328|323598894|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
94493331|NCT01706328|323598892|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
94493332|NCT01706328|323598893|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
94493333|NCT01706328|323598894|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
94493334|NCT01706328|323598892|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
94493335|NCT01706328|323598893|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
94493336|NCT01706328|323598894|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
94493337|NCT01706328|323598892|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
94493338|NCT01706328|323598893|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
94493339|NCT01706328|323598894|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
94493340|NCT01706328|323598892|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
94493341|NCT01706328|323598893|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
94493342|NCT01706328|323598894|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
94493343|NCT01706328|323598892|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
94493344|NCT01706328|323598893|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
94493345|NCT01706328|323598894|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
94493346|NCT01706328|323598892|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
94493347|NCT01706328|323598893|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
94493348|NCT01706328|323598894|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
94493349|NCT03018938|323598897|FG000|Overall Study|Death|0|||
94493350|NCT03018938|323598898|FG001|Overall Study|Death|1|||
94493351|NCT03018938|323598897|FG000|Overall Study|Lost to Follow-up|21|||
94493352|NCT03018938|323598898|FG001|Overall Study|Lost to Follow-up|32|||
94493353|NCT03018938|323598897|FG000|Overall Study|Withdrawal by Subject|38|||
94493354|NCT03018938|323598898|FG001|Overall Study|Withdrawal by Subject|45|||
94493355|NCT03018938|323598897|FG000|Overall Study|Physician Decision|3|||
94493356|NCT03018938|323598898|FG001|Overall Study|Physician Decision|2|||
94493357|NCT03018938|323598897|FG000|Overall Study|Sponsor Decision|0|||
94493358|NCT03018938|323598898|FG001|Overall Study|Sponsor Decision|1|||
94493359|NCT03018938|323598897|FG000|Overall Study|Screen failure-After randomization|4|||
94493360|NCT03018938|323598898|FG001|Overall Study|Screen failure-After randomization|2|||
94493361|NCT03018938|323598897|FG000|Overall Study|Not recorded|0|||
94493362|NCT03018938|323598898|FG001|Overall Study|Not recorded|2|||
94493363|NCT03261401|323600592|FG000|Overall Study|Withdrawal by Subject|0|||
94493364|NCT03261401|323600593|FG001|Overall Study|Withdrawal by Subject|0|||
94493365|NCT03261401|323600594|FG002|Overall Study|Withdrawal by Subject|0|||
94493366|NCT03261401|323600595|FG003|Overall Study|Withdrawal by Subject|0|||
94493367|NCT03261401|323600596|FG004|Overall Study|Withdrawal by Subject|0|||
94493368|NCT03261401|323600597|FG005|Overall Study|Withdrawal by Subject|1|||
94493369|NCT03261401|323600598|FG006|Overall Study|Withdrawal by Subject|0|||
94493370|NCT03261401|323600599|FG007|Overall Study|Withdrawal by Subject|0|||
94493371|NCT03261401|323600600|FG008|Overall Study|Withdrawal by Subject|0|||
94493372|NCT03261401|323600601|FG009|Overall Study|Withdrawal by Subject|0|||
94493373|NCT03261401|323600602|FG010|Overall Study|Withdrawal by Subject|0|||
94493374|NCT03261401|323600603|FG011|Overall Study|Withdrawal by Subject|0|||
94493375|NCT03261401|323600604|FG012|Overall Study|Withdrawal by Subject|0|||
94493376|NCT03261401|323600592|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
94493377|NCT03261401|323600593|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
94493378|NCT03261401|323600594|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
94493379|NCT03261401|323600595|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
94493380|NCT03261401|323600596|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
94493381|NCT03261401|323600597|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
94493382|NCT03261401|323600598|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
94493383|NCT03261401|323600599|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
94493384|NCT03261401|323600600|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
94493385|NCT03261401|323600601|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
94493386|NCT03261401|323600602|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
94493387|NCT03261401|323600603|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
94493388|NCT03261401|323600604|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
94493389|NCT03095287|323600605|FG000|Overall Study|Treatment Failure|1|||
94493390|NCT03095287|323600605|FG000|Overall Study|Adverse Event|1|||
94493391|NCT00970944|323600606|FG000|Overall Study|Death|1|||
94493392|NCT00970944|323600607|FG001|Overall Study|Death|0|||
94493393|NCT00970944|323600606|FG000|Overall Study|Physician Decision|0|||
94493394|NCT00970944|323600607|FG001|Overall Study|Physician Decision|2|||
94493395|NCT01136954|323600608|FG000|Overall Study|Adverse Event|3|||
94493396|NCT01136954|323600609|FG001|Overall Study|Adverse Event|2|||
94493397|NCT01136954|323600608|FG000|Overall Study|Withdrawal by Subject|6|||
94493398|NCT01136954|323600609|FG001|Overall Study|Withdrawal by Subject|2|||
94493399|NCT01136954|323600608|FG000|Overall Study|Lack of Efficacy|14|||
94493400|NCT01136954|323600609|FG001|Overall Study|Lack of Efficacy|13|||
94493401|NCT01136954|323600608|FG000|Overall Study|Physician Decision|0|||
94493402|NCT01136954|323600609|FG001|Overall Study|Physician Decision|1|||
94493403|NCT01136954|323600608|FG000|Overall Study|Other|1|||
94493404|NCT01136954|323600609|FG001|Overall Study|Other|3|||
94493405|NCT01006629|323600612|FG000|Overall Study|Adverse Event|1|||
94493406|NCT01006629|323600612|FG000|Overall Study|Parent refused to continue participation|1|||
94493407|NCT01006629|323600612|FG000|Overall Study|Parent unable to perform site visit|4|||
94493408|NCT01499511|323600613|FG000|Overall Study|Death|1|||
94493409|NCT01499511|323600614|FG001|Overall Study|Death|0|||
94493410|NCT04459338|323600615|FG000|Overall Study|Loss of IV during study|1|||
94493411|NCT04459338|323600616|FG001|Overall Study|Loss of IV during study|0|||
94493412|NCT01732692|323600618|FG000|Overall Study|Adverse Event|0|||
94493413|NCT01732692|323600619|FG001|Overall Study|Adverse Event|1|||
94493414|NCT02030600|323600620|FG000|Treatment Period 1|Adverse Event|5|||
94493415|NCT02030600|323600621|FG001|Treatment Period 1|Adverse Event|7|||
94493416|NCT02030600|323600620|FG000|Treatment Period 1|Lack of Efficacy|0|||
94493417|NCT02030600|323600621|FG001|Treatment Period 1|Lack of Efficacy|1|||
94493418|NCT02030600|323600620|FG000|Treatment Period 1|Lost to Follow-up|11|||
94493419|NCT02030600|323600621|FG001|Treatment Period 1|Lost to Follow-up|3|||
94493420|NCT02030600|323600620|FG000|Treatment Period 1|Protocol Violation|22|||
94493421|NCT02030600|323600621|FG001|Treatment Period 1|Protocol Violation|17|||
94493422|NCT02030600|323600620|FG000|Treatment Period 1|Withdrawal by Subject|13|||
94493423|NCT02030600|323600621|FG001|Treatment Period 1|Withdrawal by Subject|17|||
94493424|NCT02030600|323600620|FG000|Treatment Period 1|Casebook Unsigned|1|||
94493425|NCT02030600|323600621|FG001|Treatment Period 1|Casebook Unsigned|0|||
94493426|NCT02030600|323600620|FG000|Treatment Period 1|Unclassified|1|||
94493427|NCT02030600|323600621|FG001|Treatment Period 1|Unclassified|0|||
94493428|NCT02030600|323600620|FG000|Treatment Period 2|Adverse Event|4|||
94493429|NCT02030600|323600621|FG001|Treatment Period 2|Adverse Event|4|||
94493430|NCT02030600|323600620|FG000|Treatment Period 2|Lack of Efficacy|2|||
94493431|NCT02030600|323600621|FG001|Treatment Period 2|Lack of Efficacy|1|||
94493432|NCT02030600|323600620|FG000|Treatment Period 2|Lost to Follow-up|4|||
94493433|NCT02030600|323600621|FG001|Treatment Period 2|Lost to Follow-up|2|||
94493434|NCT02030600|323600620|FG000|Treatment Period 2|Protocol Violation|1|||
94493435|NCT02030600|323600621|FG001|Treatment Period 2|Protocol Violation|2|||
94493436|NCT02030600|323600620|FG000|Treatment Period 2|Withdrawal by Subject|13|||
94493437|NCT02030600|323600621|FG001|Treatment Period 2|Withdrawal by Subject|9|||
94493438|NCT02030600|323600620|FG000|Treatment Period 2|Unclassified|1|||
94493439|NCT02030600|323600621|FG001|Treatment Period 2|Unclassified|0|||
94493440|NCT00973973|323600640|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
94493441|NCT00973973|323600641|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
94493442|NCT00973973|323600640|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
94493443|NCT00973973|323600641|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
94493444|NCT00973973|323600640|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
94493445|NCT00973973|323600641|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
94493446|NCT00973973|323600640|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
94493447|NCT00973973|323600641|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
94493448|NCT00973973|323600640|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
94493449|NCT00973973|323600641|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
94493450|NCT00973973|323600640|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
94493451|NCT00973973|323600641|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
94493452|NCT00973973|323600640|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
94493453|NCT00973973|323600641|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
94493454|NCT00973973|323600640|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
94493455|NCT00973973|323600641|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
94493456|NCT00973973|323600640|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
94493457|NCT00973973|323600641|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
94493458|NCT00973973|323600640|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
94493459|NCT00973973|323600641|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
94493460|NCT00973973|323600640|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
94493461|NCT00973973|323600641|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
94493462|NCT00973973|323600640|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
94493463|NCT00973973|323600641|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
94493464|NCT00671060|323600642|FG000|Overall Study|Protocol Violation|1|||
94493465|NCT00671060|323600643|FG001|Overall Study|Protocol Violation|0|||
94493466|NCT00671060|323600642|FG000|Overall Study|Physician Decision|0|||
94493467|NCT00671060|323600643|FG001|Overall Study|Physician Decision|1|||
94493468|NCT02515227|323600650|FG000|Overall Study|Adverse Event|0|||
94493469|NCT02515227|323600651|FG001|Overall Study|Adverse Event|2|||
94493470|NCT02515227|323600650|FG000|Overall Study|Progressive disease|2|||
94493471|NCT02515227|323600651|FG001|Overall Study|Progressive disease|9|||
94493472|NCT00626639|323600653|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
94493473|NCT00626639|323600654|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
94493474|NCT00827567|323600655|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
94493475|NCT01461551|323600656|FG000|Overall Study|Physician Decision|2|||
94493476|NCT01461551|323600657|FG001|Overall Study|Physician Decision|1|||
94493477|NCT01461551|323600658|FG002|Overall Study|Physician Decision|2|||
94493478|NCT02832037|323600659|FG000|Overall Study|Administrative reasons|0|||
94493479|NCT02832037|323600660|FG001|Overall Study|Administrative reasons|0|||
94493480|NCT02832037|323600661|FG002|Overall Study|Administrative reasons|1|||
94493481|NCT02832037|323600662|FG003|Overall Study|Administrative reasons|0|||
94493482|NCT02832037|323600663|FG004|Overall Study|Administrative reasons|0|||
94493483|NCT02832037|323600659|FG000|Overall Study|Protocol Violation|3|||
94493484|NCT02832037|323600660|FG001|Overall Study|Protocol Violation|0|||
94493485|NCT02832037|323600661|FG002|Overall Study|Protocol Violation|4|||
94493486|NCT02832037|323600662|FG003|Overall Study|Protocol Violation|1|||
94493487|NCT02832037|323600663|FG004|Overall Study|Protocol Violation|2|||
94493488|NCT02832037|323600659|FG000|Overall Study|Lost to Follow-up|2|||
94493489|NCT02832037|323600660|FG001|Overall Study|Lost to Follow-up|0|||
94493490|NCT02832037|323600661|FG002|Overall Study|Lost to Follow-up|3|||
94493491|NCT02832037|323600662|FG003|Overall Study|Lost to Follow-up|0|||
94493492|NCT02832037|323600663|FG004|Overall Study|Lost to Follow-up|5|||
94493493|NCT02832037|323600659|FG000|Overall Study|Withdrawal by Subject|9|||
94493494|NCT02832037|323600660|FG001|Overall Study|Withdrawal by Subject|8|||
94493495|NCT02832037|323600661|FG002|Overall Study|Withdrawal by Subject|0|||
94493496|NCT02832037|323600662|FG003|Overall Study|Withdrawal by Subject|4|||
94493497|NCT02832037|323600663|FG004|Overall Study|Withdrawal by Subject|8|||
94493498|NCT02832037|323600659|FG000|Overall Study|Adverse Event|5|||
94493499|NCT02832037|323600660|FG001|Overall Study|Adverse Event|4|||
94493500|NCT02832037|323600661|FG002|Overall Study|Adverse Event|0|||
94493501|NCT02832037|323600662|FG003|Overall Study|Adverse Event|2|||
94493502|NCT02832037|323600663|FG004|Overall Study|Adverse Event|4|||
94493503|NCT00712920|323600664|FG000|Overall Study|Adverse Event|3|||
94493504|NCT00712920|323600665|FG001|Overall Study|Adverse Event|4|||
94493505|NCT00712920|323600666|FG002|Overall Study|Adverse Event|7|||
94493506|NCT00712920|323600664|FG000|Overall Study|Withdrawal by Subject|4|||
94493507|NCT00712920|323600665|FG001|Overall Study|Withdrawal by Subject|2|||
94493508|NCT00712920|323600666|FG002|Overall Study|Withdrawal by Subject|1|||
94493509|NCT00712920|323600664|FG000|Overall Study|Lost to Follow-up|1|||
94493510|NCT00712920|323600665|FG001|Overall Study|Lost to Follow-up|4|||
94493511|NCT00712920|323600666|FG002|Overall Study|Lost to Follow-up|0|||
94493512|NCT00712920|323600664|FG000|Overall Study|Lack of Efficacy|1|||
94493513|NCT00712920|323600665|FG001|Overall Study|Lack of Efficacy|0|||
94493514|NCT00712920|323600666|FG002|Overall Study|Lack of Efficacy|1|||
94493515|NCT00712920|323600664|FG000|Overall Study|Other|5|||
94493516|NCT00712920|323600665|FG001|Overall Study|Other|7|||
94493517|NCT00712920|323600666|FG002|Overall Study|Other|3|||
94493518|NCT00712920|323600664|FG000|Overall Study|Non-compliance|3|||
94493519|NCT00712920|323600665|FG001|Overall Study|Non-compliance|0|||
94493520|NCT00712920|323600666|FG002|Overall Study|Non-compliance|0|||
94493521|NCT00481676|323600667|FG000|Overall Study|Adverse Event|0|||
94493522|NCT00481676|323600668|FG001|Overall Study|Adverse Event|1|||
94493523|NCT00481676|323600667|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94493524|NCT00481676|323600668|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
94493525|NCT00481676|323600667|FG000|Overall Study|Administrative problem|1|||
94493526|NCT00481676|323600668|FG001|Overall Study|Administrative problem|0|||
94493527|NCT02239328|323600670|FG000|Overall Study|Benign disease noted at time of surgery|6|||
94493528|NCT02239328|323600670|FG000|Overall Study|Equipment or website malfunction|2|||
94493529|NCT00920816|323600674|FG000|Overall Study|Death|116|||
94493530|NCT00920816|323600675|FG001|Overall Study|Death|63|||
94493531|NCT00920816|323600676|FG002|Overall Study|Death|8|||
94493532|NCT00920816|323600677|FG003|Overall Study|Death|3|||
94493533|NCT00920816|323600674|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
94493534|NCT00920816|323600675|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
94493535|NCT00920816|323600676|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
94493536|NCT00920816|323600677|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
94493537|NCT00920816|323600674|FG000|Overall Study|Global deterioration of health status|2|||
94493538|NCT00920816|323600675|FG001|Overall Study|Global deterioration of health status|0|||
94493539|NCT00920816|323600676|FG002|Overall Study|Global deterioration of health status|0|||
94493540|NCT00920816|323600677|FG003|Overall Study|Global deterioration of health status|0|||
94493541|NCT00920816|323600674|FG000|Overall Study|Objective progression or relapse|6|||
94493542|NCT00920816|323600675|FG001|Overall Study|Objective progression or relapse|2|||
94493543|NCT00920816|323600676|FG002|Overall Study|Objective progression or relapse|0|||
94493544|NCT00920816|323600677|FG003|Overall Study|Objective progression or relapse|0|||
94493545|NCT00920816|323600674|FG000|Overall Study|Other|26|||
94493546|NCT00920816|323600675|FG001|Overall Study|Other|15|||
94493547|NCT00920816|323600676|FG002|Overall Study|Other|1|||
94493548|NCT00920816|323600677|FG003|Overall Study|Other|2|||
94493549|NCT00920816|323600674|FG000|Overall Study|Lost to Follow-up|11|||
94493550|NCT00920816|323600675|FG001|Overall Study|Lost to Follow-up|2|||
94493551|NCT00920816|323600676|FG002|Overall Study|Lost to Follow-up|0|||
94493552|NCT00920816|323600677|FG003|Overall Study|Lost to Follow-up|0|||
94493553|NCT00920816|323600674|FG000|Overall Study|Adverse Event|1|||
94493554|NCT00920816|323600675|FG001|Overall Study|Adverse Event|1|||
94493555|NCT00920816|323600676|FG002|Overall Study|Adverse Event|1|||
94493556|NCT00920816|323600677|FG003|Overall Study|Adverse Event|0|||
94493557|NCT00920816|323600674|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
94493558|NCT00920816|323600675|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
94493559|NCT00920816|323600676|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
94493560|NCT00920816|323600677|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
94493561|NCT00920816|323600674|FG000|Overall Study|Randomized but not treated|3|||
94493562|NCT00920816|323600675|FG001|Overall Study|Randomized but not treated|0|||
94493563|NCT00920816|323600676|FG002|Overall Study|Randomized but not treated|0|||
94493564|NCT00920816|323600677|FG003|Overall Study|Randomized but not treated|0|||
94493565|NCT00505921|323600678|FG000|Overall Study|Ineligible|1|||
94493566|NCT00505921|323600678|FG000|Overall Study|Failed to Mobilize|8|||
94493567|NCT01044498|323600681|FG000|Overall Study|Withdrew consent|1|||
94493568|NCT01044498|323600682|FG001|Overall Study|Withdrew consent|1|||
94493569|NCT01044498|323600681|FG000|Overall Study|Adverse Event|1|||
94493570|NCT01044498|323600682|FG001|Overall Study|Adverse Event|1|||
94493571|NCT01044498|323600681|FG000|Overall Study|Other|1|||
94493572|NCT01044498|323600682|FG001|Overall Study|Other|0|||
94493573|NCT03197129|323600692|FG000|Overall Study|did not answer the VPT: shyness|4|||
94493574|NCT03197129|323600693|FG001|Overall Study|did not answer the VPT: shyness|5|||
94493575|NCT00294658|323600694|FG000|Overall Study|Death|0|||
94493576|NCT00294658|323600695|FG001|Overall Study|Death|1|||
94493577|NCT00294658|323600694|FG000|Overall Study|Lost to Follow-up|4|||
94493578|NCT00294658|323600695|FG001|Overall Study|Lost to Follow-up|0|||
94493579|NCT00294658|323600694|FG000|Overall Study|Physician Decision|1|||
94493580|NCT00294658|323600695|FG001|Overall Study|Physician Decision|2|||
94493581|NCT00294658|323600694|FG000|Overall Study|Pregnancy|0|||
94493582|NCT00294658|323600695|FG001|Overall Study|Pregnancy|1|||
94493583|NCT00294658|323600694|FG000|Overall Study|Withdrawal by Subject|0|||
94493584|NCT00294658|323600695|FG001|Overall Study|Withdrawal by Subject|4|||
94493585|NCT00294658|323600694|FG000|Overall Study|Found to have invasive thymoma|1|||
94493586|NCT00294658|323600695|FG001|Overall Study|Found to have invasive thymoma|0|||
94493587|NCT00294658|323600694|FG000|Overall Study|Patient and family were not satisfied|0|||
94493588|NCT00294658|323600695|FG001|Overall Study|Patient and family were not satisfied|1|||
94493589|NCT03506477|323600699|FG000|Overall Study|Withdrawal by Subject|1|||
94493590|NCT03506477|323600700|FG001|Overall Study|Withdrawal by Subject|0|||
94493591|NCT00392223|323600701|FG000|Overall Study|Adverse Event|5|||
94493592|NCT00392223|323600702|FG001|Overall Study|Adverse Event|4|||
94493593|NCT00392223|323600701|FG000|Overall Study|Lost to Follow-up|1|||
94493594|NCT00392223|323600702|FG001|Overall Study|Lost to Follow-up|4|||
94493595|NCT00392223|323600701|FG000|Overall Study|Protocol Violation|0|||
94493596|NCT00392223|323600702|FG001|Overall Study|Protocol Violation|3|||
94493597|NCT00392223|323600701|FG000|Overall Study|Withdrawal by Subject|3|||
94493598|NCT00392223|323600702|FG001|Overall Study|Withdrawal by Subject|2|||
94493599|NCT02246777|323600703|FG000|Overall Study|Adverse Event|2|||
94493600|NCT02246777|323600703|FG000|Overall Study|Change of residence|1|||
94493601|NCT02401230|323600709|FG000|Overall Study|Adverse Event|3|||
94493602|NCT02401230|323600710|FG001|Overall Study|Adverse Event|2|||
94493603|NCT02401230|323600711|FG002|Overall Study|Adverse Event|0|||
94493604|NCT02401230|323600709|FG000|Overall Study|Withdrawal by Subject|2|||
94493605|NCT02401230|323600710|FG001|Overall Study|Withdrawal by Subject|1|||
94493606|NCT02401230|323600711|FG002|Overall Study|Withdrawal by Subject|1|||
94493607|NCT02401230|323600709|FG000|Overall Study|Lost to Follow-up|1|||
94493608|NCT02401230|323600710|FG001|Overall Study|Lost to Follow-up|3|||
94493609|NCT02401230|323600711|FG002|Overall Study|Lost to Follow-up|3|||
94493610|NCT01757847|323600712|FG000|Overall Study|Withdrawal by Subject|3|||
94493611|NCT01757847|323600713|FG001|Overall Study|Withdrawal by Subject|4|||
94493612|NCT01925417|323600714|FG000|Overall Study|Withdrawal by Subject|2|||
94493613|NCT01925417|323600714|FG000|Overall Study|Death|1|||
94493614|NCT00862992|323600719|FG000|Overall Study|Adverse Event|2|||
94493615|NCT00862992|323600720|FG001|Overall Study|Adverse Event|1|||
94493616|NCT00862992|323600721|FG002|Overall Study|Adverse Event|1|||
94493617|NCT00862992|323600719|FG000|Overall Study|Physician Decision|1|||
94493618|NCT00862992|323600720|FG001|Overall Study|Physician Decision|0|||
94493619|NCT00862992|323600721|FG002|Overall Study|Physician Decision|0|||
94493620|NCT00862992|323600719|FG000|Overall Study|Withdrawal by Subject|0|||
94493621|NCT00862992|323600720|FG001|Overall Study|Withdrawal by Subject|0|||
94493622|NCT00862992|323600721|FG002|Overall Study|Withdrawal by Subject|2|||
94493623|NCT05172570|323600722|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
94493624|NCT05172570|323600723|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
94493625|NCT05172570|323600724|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
94493626|NCT05172570|323600722|FG000|Overall Study|PI Decision due to equipment shortages|0|||
94493627|NCT05172570|323600723|FG001|Overall Study|PI Decision due to equipment shortages|0|||
94493628|NCT05172570|323600724|FG002|Overall Study|PI Decision due to equipment shortages|1|||
94493629|NCT00462462|323600726|FG000|Overall Study|Physician Decision|0|||
94493630|NCT00462462|323600727|FG001|Overall Study|Physician Decision|1|||
94493631|NCT02811159|323600729|FG000|Treatment Course 1|Lost to Follow-up|1|||
94493632|NCT01277861|323600735|FG000|Overall Study|Physician Decision|2|||
94493633|NCT01277861|323600736|FG001|Overall Study|Physician Decision|2|||
94493634|NCT02696798|323600737|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
94493635|NCT02696798|323600738|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
94493636|NCT02696798|323600739|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
94493637|NCT02696798|323600737|FG000|Blinded Treatment Dosing Period|Death|0|||
94493638|NCT02696798|323600738|FG001|Blinded Treatment Dosing Period|Death|0|||
94493639|NCT02696798|323600739|FG002|Blinded Treatment Dosing Period|Death|1|||
94493640|NCT02696798|323600737|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
94493641|NCT02696798|323600738|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
94493642|NCT02696798|323600739|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
94493643|NCT02696798|323600737|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
94493644|NCT02696798|323600738|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
94493645|NCT02696798|323600739|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
94493646|NCT02696798|323600737|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
94493647|NCT02696798|323600738|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
94493648|NCT02696798|323600739|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
94493649|NCT02696798|323600737|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
94493650|NCT02696798|323600738|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
94493651|NCT02696798|323600739|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
94493652|NCT02696798|323600737|FG000|Extended Treatment Period|Adverse Event|1|||
94493653|NCT02696798|323600738|FG001|Extended Treatment Period|Adverse Event|4|||
94493654|NCT02696798|323600739|FG002|Extended Treatment Period|Adverse Event|5|||
94493655|NCT02696798|323600737|FG000|Extended Treatment Period|Lack of Efficacy|7|||
94493656|NCT02696798|323600738|FG001|Extended Treatment Period|Lack of Efficacy|2|||
94493657|NCT02696798|323600739|FG002|Extended Treatment Period|Lack of Efficacy|2|||
94493658|NCT02696798|323600737|FG000|Extended Treatment Period|Lost to Follow-up|1|||
94493659|NCT02696798|323600738|FG001|Extended Treatment Period|Lost to Follow-up|0|||
94493660|NCT02696798|323600739|FG002|Extended Treatment Period|Lost to Follow-up|0|||
94493661|NCT02696798|323600737|FG000|Extended Treatment Period|Physician Decision|0|||
94493662|NCT02696798|323600738|FG001|Extended Treatment Period|Physician Decision|1|||
94493663|NCT02696798|323600739|FG002|Extended Treatment Period|Physician Decision|0|||
94493664|NCT02696798|323600737|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
94493665|NCT02696798|323600738|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
94493666|NCT02696798|323600739|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
94493667|NCT02696798|323600737|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
94493668|NCT02696798|323600738|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
94493669|NCT02696798|323600739|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
94493670|NCT02696798|323600737|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
94493671|NCT02696798|323600738|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
94493672|NCT02696798|323600739|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
94493673|NCT02696798|323600737|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
94493674|NCT02696798|323600738|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
94493675|NCT02696798|323600739|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
94493676|NCT02696798|323600737|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
94493677|NCT02696798|323600738|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
94493678|NCT02696798|323600739|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
94493679|NCT02696798|323600737|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
94493680|NCT02696798|323600738|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
94493681|NCT02696798|323600739|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
94493682|NCT02696798|323600737|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
94493683|NCT02696798|323600738|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
94493684|NCT02696798|323600739|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
94493685|NCT00857389|323600740|FG000|Overall Study|Did not proceed to transplant|2|||
94493686|NCT04584788|323600741|FG000|Overall Study|Physician Decision|8|||
94493687|NCT04584788|323600741|FG000|Overall Study|Withdrawal by Subject|1|||
94493688|NCT04584788|323600741|FG000|Overall Study|Adverse Event|3|||
94493689|NCT02207608|323600742|FG000|Overall Study|Adverse Event|1|||
94493690|NCT02207608|323600743|FG001|Overall Study|Adverse Event|0|||
94493691|NCT00632359|323600746|FG000|Overall Study|Withdrawal by Subject|2|||
94493692|NCT04167670|323602104|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
94493693|NCT04167670|323602105|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
94493694|NCT04167670|323602106|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
94493695|NCT04167670|323602104|FG000|Overall Study|Significant protocol deviation|3|||
94493696|NCT04167670|323602105|FG001|Overall Study|Significant protocol deviation|1|||
94493697|NCT04167670|323602106|FG002|Overall Study|Significant protocol deviation|0|||
94493698|NCT04167670|323602104|FG000|Overall Study|Lost to Follow-up|0|||
94493699|NCT04167670|323602105|FG001|Overall Study|Lost to Follow-up|3|||
94493700|NCT04167670|323602106|FG002|Overall Study|Lost to Follow-up|3|||
94493701|NCT04167670|323602104|FG000|Overall Study|Voluntary Withdrawal|0|||
94493702|NCT04167670|323602105|FG001|Overall Study|Voluntary Withdrawal|1|||
94493703|NCT04167670|323602106|FG002|Overall Study|Voluntary Withdrawal|1|||
94493704|NCT04167670|323602104|FG000|Overall Study|Withdrawal of Consent|4|||
94493705|NCT04167670|323602105|FG001|Overall Study|Withdrawal of Consent|1|||
94493706|NCT04167670|323602106|FG002|Overall Study|Withdrawal of Consent|3|||
94493707|NCT04167670|323602104|FG000|Overall Study|Miscellaneous|7|||
94493708|NCT04167670|323602105|FG001|Overall Study|Miscellaneous|5|||
94493709|NCT04167670|323602106|FG002|Overall Study|Miscellaneous|3|||
94493710|NCT01288430|323602109|FG000|Part 1|Progressive disease|2|||
94493711|NCT01288430|323602110|FG001|Part 1|Progressive disease|1|||
94493712|NCT01288430|323602111|FG002|Part 1|Progressive disease|1|||
94493713|NCT01288430|323602112|FG003|Part 1|Progressive disease|6|||
94493714|NCT01288430|323602113|FG004|Part 1|Progressive disease|2|||
94493715|NCT01288430|323602114|FG005|Part 1|Progressive disease|4|||
94493716|NCT01288430|323602115|FG006|Part 1|Progressive disease|2|||
94493717|NCT01288430|323602116|FG007|Part 1|Progressive disease|0|||
94493718|NCT01288430|323602117|FG008|Part 1|Progressive disease|0|||
94493719|NCT01288430|323602118|FG009|Part 1|Progressive disease|0|||
94493720|NCT01288430|323602109|FG000|Part 1|Clinical disease progression|0|||
94493721|NCT01288430|323602110|FG001|Part 1|Clinical disease progression|0|||
94493722|NCT01288430|323602111|FG002|Part 1|Clinical disease progression|1|||
94493723|NCT01288430|323602112|FG003|Part 1|Clinical disease progression|0|||
94493724|NCT01288430|323602113|FG004|Part 1|Clinical disease progression|0|||
94493725|NCT01288430|323602114|FG005|Part 1|Clinical disease progression|2|||
94493726|NCT01288430|323602115|FG006|Part 1|Clinical disease progression|2|||
94493727|NCT01288430|323602116|FG007|Part 1|Clinical disease progression|0|||
94493728|NCT01288430|323602117|FG008|Part 1|Clinical disease progression|0|||
94493729|NCT01288430|323602118|FG009|Part 1|Clinical disease progression|0|||
94493730|NCT01288430|323602109|FG000|Part 1|Death due to disease progression|0|||
94493731|NCT01288430|323602110|FG001|Part 1|Death due to disease progression|0|||
94493732|NCT01288430|323602111|FG002|Part 1|Death due to disease progression|0|||
94493733|NCT01288430|323602112|FG003|Part 1|Death due to disease progression|0|||
94493734|NCT01288430|323602113|FG004|Part 1|Death due to disease progression|1|||
94493735|NCT01288430|323602114|FG005|Part 1|Death due to disease progression|0|||
94493736|NCT01288430|323602115|FG006|Part 1|Death due to disease progression|0|||
94493737|NCT01288430|323602116|FG007|Part 1|Death due to disease progression|0|||
94493738|NCT01288430|323602117|FG008|Part 1|Death due to disease progression|0|||
94493739|NCT01288430|323602118|FG009|Part 1|Death due to disease progression|0|||
94493740|NCT01288430|323602109|FG000|Part 1|Adverse Event|0|||
94493741|NCT01288430|323602110|FG001|Part 1|Adverse Event|0|||
94493742|NCT01288430|323602111|FG002|Part 1|Adverse Event|3|||
94493743|NCT01288430|323602112|FG003|Part 1|Adverse Event|1|||
94493744|NCT01288430|323602113|FG004|Part 1|Adverse Event|0|||
94493745|NCT01288430|323602114|FG005|Part 1|Adverse Event|0|||
94493746|NCT01288430|323602115|FG006|Part 1|Adverse Event|2|||
94493747|NCT01288430|323602116|FG007|Part 1|Adverse Event|0|||
94493748|NCT01288430|323602117|FG008|Part 1|Adverse Event|0|||
94493749|NCT01288430|323602118|FG009|Part 1|Adverse Event|0|||
94493750|NCT01288430|323602109|FG000|Part 1|Other|0|||
94493751|NCT01288430|323602110|FG001|Part 1|Other|2|||
94493752|NCT01288430|323602111|FG002|Part 1|Other|0|||
94493753|NCT01288430|323602112|FG003|Part 1|Other|0|||
94493754|NCT01288430|323602113|FG004|Part 1|Other|0|||
94493755|NCT01288430|323602114|FG005|Part 1|Other|0|||
94493756|NCT01288430|323602115|FG006|Part 1|Other|1|||
94493757|NCT01288430|323602116|FG007|Part 1|Other|0|||
94493758|NCT01288430|323602117|FG008|Part 1|Other|0|||
94493759|NCT01288430|323602118|FG009|Part 1|Other|0|||
94493760|NCT01288430|323602109|FG000|Part 2|Progressive disease|0|||
94493761|NCT01288430|323602110|FG001|Part 2|Progressive disease|0|||
94493762|NCT01288430|323602111|FG002|Part 2|Progressive disease|0|||
94493763|NCT01288430|323602112|FG003|Part 2|Progressive disease|0|||
94493764|NCT01288430|323602113|FG004|Part 2|Progressive disease|0|||
94493765|NCT01288430|323602114|FG005|Part 2|Progressive disease|0|||
94493766|NCT01288430|323602115|FG006|Part 2|Progressive disease|0|||
94493767|NCT01288430|323602116|FG007|Part 2|Progressive disease|8|||
94493768|NCT01288430|323602117|FG008|Part 2|Progressive disease|7|||
94493769|NCT01288430|323602118|FG009|Part 2|Progressive disease|2|||
94493770|NCT01288430|323602109|FG000|Part 2|Clinical disease progression|0|||
94493771|NCT01288430|323602110|FG001|Part 2|Clinical disease progression|0|||
94493772|NCT01288430|323602111|FG002|Part 2|Clinical disease progression|0|||
94493773|NCT01288430|323602112|FG003|Part 2|Clinical disease progression|0|||
94493774|NCT01288430|323602113|FG004|Part 2|Clinical disease progression|0|||
94493775|NCT01288430|323602114|FG005|Part 2|Clinical disease progression|0|||
94493776|NCT01288430|323602115|FG006|Part 2|Clinical disease progression|0|||
94493777|NCT01288430|323602116|FG007|Part 2|Clinical disease progression|2|||
94493778|NCT01288430|323602117|FG008|Part 2|Clinical disease progression|0|||
94493779|NCT01288430|323602118|FG009|Part 2|Clinical disease progression|0|||
94493780|NCT01288430|323602109|FG000|Part 2|Withdrawal by Subject|0|||
94493781|NCT01288430|323602110|FG001|Part 2|Withdrawal by Subject|0|||
94493782|NCT01288430|323602111|FG002|Part 2|Withdrawal by Subject|0|||
94493783|NCT01288430|323602112|FG003|Part 2|Withdrawal by Subject|0|||
94493784|NCT01288430|323602113|FG004|Part 2|Withdrawal by Subject|0|||
94493785|NCT01288430|323602114|FG005|Part 2|Withdrawal by Subject|0|||
94493786|NCT01288430|323602115|FG006|Part 2|Withdrawal by Subject|0|||
94493787|NCT01288430|323602116|FG007|Part 2|Withdrawal by Subject|1|||
94493788|NCT01288430|323602117|FG008|Part 2|Withdrawal by Subject|4|||
94493789|NCT01288430|323602118|FG009|Part 2|Withdrawal by Subject|0|||
94493790|NCT01288430|323602109|FG000|Part 2|Adverse Event|0|||
94493791|NCT01288430|323602110|FG001|Part 2|Adverse Event|0|||
94493792|NCT01288430|323602111|FG002|Part 2|Adverse Event|0|||
94493793|NCT01288430|323602112|FG003|Part 2|Adverse Event|0|||
94493794|NCT01288430|323602113|FG004|Part 2|Adverse Event|0|||
94493795|NCT01288430|323602114|FG005|Part 2|Adverse Event|0|||
94493796|NCT01288430|323602115|FG006|Part 2|Adverse Event|0|||
94493797|NCT01288430|323602116|FG007|Part 2|Adverse Event|1|||
94493798|NCT01288430|323602117|FG008|Part 2|Adverse Event|1|||
94493799|NCT01288430|323602118|FG009|Part 2|Adverse Event|0|||
94493800|NCT01288430|323602109|FG000|Part 2|Other|0|||
94493801|NCT01288430|323602110|FG001|Part 2|Other|0|||
94493802|NCT01288430|323602111|FG002|Part 2|Other|0|||
94493803|NCT01288430|323602112|FG003|Part 2|Other|0|||
94493804|NCT01288430|323602113|FG004|Part 2|Other|0|||
94493805|NCT01288430|323602114|FG005|Part 2|Other|0|||
94493806|NCT01288430|323602115|FG006|Part 2|Other|0|||
94493807|NCT01288430|323602116|FG007|Part 2|Other|0|||
94493808|NCT01288430|323602117|FG008|Part 2|Other|0|||
94493809|NCT01288430|323602118|FG009|Part 2|Other|1|||
94493810|NCT00549055|323602119|FG000|Overall Study|Adverse Event|4|||
94493811|NCT00549055|323602119|FG000|Overall Study|Lack of Efficacy|18|||
94493812|NCT00549055|323602119|FG000|Overall Study|Stabilization|5|||
94493813|NCT00549055|323602119|FG000|Overall Study|Progression to fibrosis|2|||
94493814|NCT00549055|323602119|FG000|Overall Study|Decrease of size|1|||
94493815|NCT00549055|323602119|FG000|Overall Study|Active choroidal neovascula increased|1|||
94493816|NCT00549055|323602119|FG000|Overall Study|Vitreous hemorrhage|1|||
94493817|NCT00549055|323602119|FG000|Overall Study|Growth choroidal neovascularisation|1|||
94493818|NCT00549055|323602119|FG000|Overall Study|Choroidal neovascularization|1|||
94493819|NCT00549055|323602119|FG000|Overall Study|Very low visual acuity (VA)|1|||
94493820|NCT00316004|323602123|FG000|Overall Study|Subject was not given study fluid.|14|||
94493821|NCT00316004|323602124|FG001|Overall Study|Subject was not given study fluid.|14|||
94493822|NCT00316004|323602125|FG002|Overall Study|Subject was not given study fluid.|21|||
94493823|NCT00782067|323602128|FG000|Overall Study|Adverse Event|35|||
94493824|NCT00782067|323602128|FG000|Overall Study|Subject withdrew consent|11|||
94493825|NCT00782067|323602128|FG000|Overall Study|Lost to Follow-up|2|||
94493826|NCT00782067|323602128|FG000|Overall Study|Administrative problems|14|||
94493827|NCT00782067|323602128|FG000|Overall Study|Death|9|||
94493828|NCT00782067|323602128|FG000|Overall Study|Disease progression|43|||
94493829|NCT00782067|323602128|FG000|Overall Study|Protocol deviation|2|||
94493830|NCT03801252|323602129|FG000|Overall Study|Protocol Violation|1|||
94493831|NCT03801252|323602130|FG001|Overall Study|Protocol Violation|2|||
94493832|NCT02471183|323602133|FG000|Main Treatment Period|Adverse Event|1|||
94493833|NCT02471183|323602133|FG000|Main Treatment Period|Withdrawal by Subject|1|||
94493834|NCT02471183|323602133|FG000|Extended Treatment Period|Lack of Efficacy|1|||
94493835|NCT01496456|323602135|FG000|Overall Study|Protocol Violation|1|||
94493836|NCT01496456|323602135|FG000|Overall Study|Lost to Follow-up|7|||
94493837|NCT00671749|323602136|FG000|Overall Study|Adverse Event|2|||
94493838|NCT00671749|323602136|FG000|Overall Study|Withdrawal by Subject|4|||
94493839|NCT00671749|323602136|FG000|Overall Study|Protocol Violation|1|||
94493840|NCT00671749|323602136|FG000|Overall Study|Lost to Follow-up|1|||
94493841|NCT00529035|323602137|FG000|Overall Study|Withdrawal by Subject|1|||
94493842|NCT01541748|323602138|FG000|Overall Study|Lost to Follow-up|17|||
94493843|NCT01541748|323602138|FG000|Overall Study|Moved out of state|1|||
94493844|NCT01541748|323602138|FG000|Overall Study|Withdrawal by Subject|7|||
94493845|NCT01541748|323602138|FG000|Overall Study|Screen failure|5|||
94493846|NCT01541748|323602138|FG000|Overall Study|Did not receive study device|1|||
94493847|NCT01155141|323602139|FG000|Overall Study|Withdrawal by Subject|1|||
94493848|NCT01155141|323602139|FG000|Overall Study|Screen Failure|1|||
94493849|NCT05001620|323602146|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
94493850|NCT05001620|323602147|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
94493851|NCT00620542|323602148|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
94493852|NCT00620542|323602149|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
94493853|NCT00620542|323602150|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
94493854|NCT00620542|323602151|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
94493855|NCT00620542|323602148|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
94493856|NCT00620542|323602149|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
94493857|NCT00620542|323602150|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
94493858|NCT00620542|323602151|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
94493859|NCT00620542|323602148|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
94493860|NCT00620542|323602149|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
94493861|NCT00620542|323602150|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
94493862|NCT00620542|323602151|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
94493863|NCT00620542|323602148|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
94493864|NCT00620542|323602149|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
94493865|NCT00620542|323602150|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
94493866|NCT00620542|323602151|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
94493867|NCT00620542|323602148|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
94493868|NCT00620542|323602149|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
94493869|NCT00620542|323602150|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
94493870|NCT00620542|323602151|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
94493871|NCT00620542|323602148|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
94493872|NCT00620542|323602149|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
94493873|NCT00620542|323602150|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
94493874|NCT00620542|323602151|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
94493875|NCT00620542|323602148|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
94493876|NCT00620542|323602149|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
94493877|NCT00620542|323602150|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
94493878|NCT00620542|323602151|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
94493879|NCT00620542|323602148|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
94493880|NCT00620542|323602149|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
94493881|NCT00620542|323602150|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
94493882|NCT00620542|323602151|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
94493883|NCT00620542|323602148|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
94493884|NCT00620542|323602149|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
94493885|NCT00620542|323602150|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
94493886|NCT00620542|323602151|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
94493887|NCT00620542|323602148|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
94493888|NCT00620542|323602149|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
94493889|NCT00620542|323602150|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
94493890|NCT00620542|323602151|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
94493891|NCT00620542|323602148|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
94493892|NCT00620542|323602149|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
94493893|NCT00620542|323602150|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
94493894|NCT00620542|323602151|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
94493895|NCT00620542|323602148|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
94493896|NCT00620542|323602149|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
94493897|NCT00620542|323602150|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
94493898|NCT00620542|323602151|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
94493899|NCT00620542|323602148|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
94493900|NCT00620542|323602149|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
94493901|NCT00620542|323602150|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
94493902|NCT00620542|323602151|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
94493903|NCT00620542|323602148|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
94493904|NCT00620542|323602149|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
94493905|NCT00620542|323602150|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
94493906|NCT00620542|323602151|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
94493907|NCT00620542|323602148|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
94493908|NCT00620542|323602149|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
94493909|NCT00620542|323602150|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
94493910|NCT00620542|323602151|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
94493911|NCT02453048|323602156|FG000|Overall Study|Only part of initial 6 mo. study|0|||
94493912|NCT02453048|323602157|FG001|Overall Study|Only part of initial 6 mo. study|0|||
94493913|NCT02453048|323602158|FG002|Overall Study|Only part of initial 6 mo. study|0|||
94493914|NCT02453048|323602159|FG003|Overall Study|Only part of initial 6 mo. study|0|||
94493915|NCT02453048|323602160|FG004|Overall Study|Only part of initial 6 mo. study|6|||
94493916|NCT02453048|323602156|FG000|Overall Study|Lost to Follow-up|0|||
94493917|NCT02453048|323602157|FG001|Overall Study|Lost to Follow-up|1|||
94493918|NCT02453048|323602158|FG002|Overall Study|Lost to Follow-up|2|||
94493919|NCT02453048|323602159|FG003|Overall Study|Lost to Follow-up|0|||
94493920|NCT02453048|323602160|FG004|Overall Study|Lost to Follow-up|0|||
94493921|NCT02696616|323602163|FG000|Overall Study|Adverse Event|0|||
94493922|NCT02696616|323602164|FG001|Overall Study|Adverse Event|1|||
94493923|NCT02696616|323602165|FG002|Overall Study|Adverse Event|0|||
94493924|NCT02696616|323602166|FG003|Overall Study|Adverse Event|0|||
94493925|NCT02696616|323602167|FG004|Overall Study|Adverse Event|0|||
94493926|NCT02696616|323602168|FG005|Overall Study|Adverse Event|0|||
94493927|NCT02696616|323602169|FG006|Overall Study|Adverse Event|0|||
94493928|NCT00770367|323602170|FG000|First Intervention|Withdrawal by Subject|0|||
94493929|NCT00770367|323602171|FG001|First Intervention|Withdrawal by Subject|2|||
94493930|NCT00770367|323602170|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
94493931|NCT00770367|323602171|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
94493932|NCT00770367|323602170|FG000|Second Intervention|Lost to Follow-up|2|||
94493933|NCT00770367|323602171|FG001|Second Intervention|Lost to Follow-up|0|||
94493934|NCT01481779|323602172|FG000|Overall Study|Adverse Event|23|||
94493935|NCT01481779|323602173|FG001|Overall Study|Adverse Event|5|||
94493936|NCT01481779|323602172|FG000|Overall Study|Lost to Follow-up|3|||
94493937|NCT01481779|323602173|FG001|Overall Study|Lost to Follow-up|2|||
94493938|NCT01481779|323602172|FG000|Overall Study|Protocol Violation|2|||
94493939|NCT01481779|323602173|FG001|Overall Study|Protocol Violation|3|||
94493940|NCT01481779|323602172|FG000|Overall Study|Withdrawal by Subject|26|||
94493941|NCT01481779|323602173|FG001|Overall Study|Withdrawal by Subject|13|||
94493942|NCT01481779|323602172|FG000|Overall Study|Physician Decision|13|||
94493943|NCT01481779|323602173|FG001|Overall Study|Physician Decision|4|||
94493944|NCT01481779|323602172|FG000|Overall Study|Sponsor Decision|3|||
94493945|NCT01481779|323602173|FG001|Overall Study|Sponsor Decision|1|||
94493946|NCT00460798|323602174|FG000|Overall Study|Death|59|||
94493947|NCT00460798|323602174|FG000|Overall Study|Adverse Event|27|||
94493948|NCT00460798|323602174|FG000|Overall Study|Lost to Follow-up|19|||
94493949|NCT00460798|323602174|FG000|Overall Study|Progressive Disease|99|||
94493950|NCT00460798|323602174|FG000|Overall Study|Other|27|||
94493951|NCT00460798|323602174|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
94493952|NCT00460798|323602174|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
94493953|NCT01180777|323602176|FG000|Overall Study|Protocol Violation|6|||
94493954|NCT01180777|323602176|FG000|Overall Study|Poor lens fit|4|||
94493955|NCT01180777|323602176|FG000|Overall Study|Lost to Follow-up|1|||
94493956|NCT01180777|323602176|FG000|Overall Study|Adverse Event|1|||
94493957|NCT03834350|323602177|FG000|Overall Study|Withdrawal by Subject|1|||
94493958|NCT02441283|323602178|FG000|Overall Study|Withdrew consent|15|||
94493959|NCT02441283|323602178|FG000|Overall Study|Lost to Follow-up|42|||
94493960|NCT02441283|323602178|FG000|Overall Study|Death|1|||
94493961|NCT02441283|323602178|FG000|Overall Study|Other, not specified|32|||
94493962|NCT01129128|323602181|FG000|Overall Study|Lost to Follow-up|2|||
94493963|NCT01129128|323602182|FG001|Overall Study|Lost to Follow-up|2|||
94493964|NCT01129128|323602183|FG002|Overall Study|Lost to Follow-up|1|||
94493965|NCT01129128|323602181|FG000|Overall Study|Protocol Violation|0|||
94493966|NCT01129128|323602182|FG001|Overall Study|Protocol Violation|1|||
94493967|NCT01129128|323602183|FG002|Overall Study|Protocol Violation|0|||
94493968|NCT01129128|323602181|FG000|Overall Study|Withdrawal by Subject|0|||
94493969|NCT01129128|323602182|FG001|Overall Study|Withdrawal by Subject|1|||
94493970|NCT01129128|323602183|FG002|Overall Study|Withdrawal by Subject|3|||
94493971|NCT01129128|323602181|FG000|Overall Study|Physician Decision|1|||
94493972|NCT01129128|323602182|FG001|Overall Study|Physician Decision|0|||
94493973|NCT01129128|323602183|FG002|Overall Study|Physician Decision|0|||
94493974|NCT00933933|323602188|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
94493975|NCT00933933|323602189|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
94493976|NCT00933933|323602190|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
94493977|NCT00933933|323602188|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
94493978|NCT00933933|323602189|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
94493979|NCT00933933|323602190|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
94493980|NCT03822416|323602191|FG000|Overall Study|Lost to Follow-up|1|||
94493981|NCT03822416|323602192|FG001|Overall Study|Lost to Follow-up|0|||
94493982|NCT03822416|323602191|FG000|Overall Study|Withdrawal by Subject|0|||
94493983|NCT03822416|323602192|FG001|Overall Study|Withdrawal by Subject|1|||
94493984|NCT04666298|323602193|FG000|Overall Study|Subject decision|1|||
94493985|NCT04666298|323602194|FG001|Overall Study|Subject decision|0|||
94493986|NCT04666298|323602195|FG002|Overall Study|Subject decision|0|||
94493987|NCT04666298|323602196|FG003|Overall Study|Subject decision|2|||
94493988|NCT04666298|323602193|FG000|Overall Study|Death|1|||
94493989|NCT04666298|323602194|FG001|Overall Study|Death|0|||
94493990|NCT04666298|323602195|FG002|Overall Study|Death|0|||
94493991|NCT04666298|323602196|FG003|Overall Study|Death|0|||
94493992|NCT04666298|323602193|FG000|Overall Study|Lost to Follow-up|0|||
94493993|NCT04666298|323602194|FG001|Overall Study|Lost to Follow-up|0|||
94493994|NCT04666298|323602195|FG002|Overall Study|Lost to Follow-up|0|||
94493995|NCT04666298|323602196|FG003|Overall Study|Lost to Follow-up|1|||
94493996|NCT04666298|323602193|FG000|Overall Study|Physician Decision|0|||
94493997|NCT04666298|323602194|FG001|Overall Study|Physician Decision|0|||
94493998|NCT04666298|323602195|FG002|Overall Study|Physician Decision|0|||
94493999|NCT04666298|323602196|FG003|Overall Study|Physician Decision|1|||
94494000|NCT04666298|323602193|FG000|Overall Study|Protocol deviation|0|||
94494001|NCT04666298|323602194|FG001|Overall Study|Protocol deviation|0|||
94494002|NCT04666298|323602195|FG002|Overall Study|Protocol deviation|1|||
94494003|NCT04666298|323602196|FG003|Overall Study|Protocol deviation|0|||
94494004|NCT00844519|323602197|FG000|Overall Study|Withdrawal by Subject|1|||
94494005|NCT00844519|323602198|FG001|Overall Study|Withdrawal by Subject|1|||
94494006|NCT00844519|323602197|FG000|Overall Study|Adverse Event|1|||
94494007|NCT00844519|323602198|FG001|Overall Study|Adverse Event|0|||
94494008|NCT01303419|323602199|FG000|Overall Study|Discontinuation of study|60|||
94494009|NCT01303419|323602199|FG000|Overall Study|Did not complete both imaging methods|5|||
94494010|NCT01303419|323602199|FG000|Overall Study|Did not meet all I/E after screening|31|||
94494011|NCT01995201|323602200|FG000|From Baseline Until Week 24|Adverse Event|4|||
94494012|NCT01995201|323602201|FG001|From Baseline Until Week 24|Adverse Event|15|||
94494013|NCT01995201|323602202|FG002|From Baseline Until Week 24|Adverse Event|0|||
94494014|NCT01995201|323602203|FG003|From Baseline Until Week 24|Adverse Event|0|||
94494015|NCT01995201|323602204|FG004|From Baseline Until Week 24|Adverse Event|0|||
94494016|NCT01995201|323602205|FG005|From Baseline Until Week 24|Adverse Event|0|||
94494017|NCT01995201|323602206|FG006|From Baseline Until Week 24|Adverse Event|0|||
94494018|NCT01995201|323602200|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
94494019|NCT01995201|323602201|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
94494020|NCT01995201|323602202|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
94494021|NCT01995201|323602203|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
94494022|NCT01995201|323602204|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
94494023|NCT01995201|323602205|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
94494024|NCT01995201|323602206|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
94494025|NCT01995201|323602200|FG000|From Baseline Until Week 24|Death|0|||
94494026|NCT01995201|323602201|FG001|From Baseline Until Week 24|Death|1|||
94494027|NCT01995201|323602202|FG002|From Baseline Until Week 24|Death|0|||
94494028|NCT01995201|323602203|FG003|From Baseline Until Week 24|Death|0|||
94494029|NCT01995201|323602204|FG004|From Baseline Until Week 24|Death|0|||
94494030|NCT01995201|323602205|FG005|From Baseline Until Week 24|Death|0|||
94494031|NCT01995201|323602206|FG006|From Baseline Until Week 24|Death|0|||
94494032|NCT01995201|323602200|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
94494033|NCT01995201|323602201|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
94494034|NCT01995201|323602202|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
94494035|NCT01995201|323602203|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
94494036|NCT01995201|323602204|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
94494037|NCT01995201|323602205|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
94494038|NCT01995201|323602206|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
94494039|NCT01995201|323602200|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
94494040|NCT01995201|323602201|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
94494041|NCT01995201|323602202|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
94494042|NCT01995201|323602203|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
94494043|NCT01995201|323602204|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
94494044|NCT01995201|323602205|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
94494045|NCT01995201|323602206|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
94494046|NCT01995201|323602200|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
94494047|NCT01995201|323602201|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
94494048|NCT01995201|323602202|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
94494049|NCT01995201|323602203|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
94494050|NCT01995201|323602204|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
94494051|NCT01995201|323602205|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
94494052|NCT01995201|323602206|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
94494053|NCT01995201|323602200|FG000|From Baseline Until Week 24|Physician Decision|0|||
94494054|NCT01995201|323602201|FG001|From Baseline Until Week 24|Physician Decision|2|||
94494055|NCT01995201|323602202|FG002|From Baseline Until Week 24|Physician Decision|0|||
94494056|NCT01995201|323602203|FG003|From Baseline Until Week 24|Physician Decision|0|||
94494057|NCT01995201|323602204|FG004|From Baseline Until Week 24|Physician Decision|0|||
94494058|NCT01995201|323602205|FG005|From Baseline Until Week 24|Physician Decision|0|||
94494059|NCT01995201|323602206|FG006|From Baseline Until Week 24|Physician Decision|0|||
94494060|NCT01995201|323602200|FG000|From Baseline Until Week 24|Protocol Violation|0|||
94494061|NCT01995201|323602201|FG001|From Baseline Until Week 24|Protocol Violation|9|||
94494062|NCT01995201|323602202|FG002|From Baseline Until Week 24|Protocol Violation|0|||
94494063|NCT01995201|323602203|FG003|From Baseline Until Week 24|Protocol Violation|0|||
94494064|NCT01995201|323602204|FG004|From Baseline Until Week 24|Protocol Violation|0|||
94494065|NCT01995201|323602205|FG005|From Baseline Until Week 24|Protocol Violation|0|||
94494066|NCT01995201|323602206|FG006|From Baseline Until Week 24|Protocol Violation|0|||
94494067|NCT01995201|323602200|FG000|From Week 24 Until Week 48|Adverse Event|0|||
94494068|NCT01995201|323602201|FG001|From Week 24 Until Week 48|Adverse Event|0|||
94494069|NCT01995201|323602202|FG002|From Week 24 Until Week 48|Adverse Event|2|||
94494070|NCT01995201|323602203|FG003|From Week 24 Until Week 48|Adverse Event|1|||
94494071|NCT01995201|323602204|FG004|From Week 24 Until Week 48|Adverse Event|1|||
94494072|NCT01995201|323602205|FG005|From Week 24 Until Week 48|Adverse Event|3|||
94494073|NCT01995201|323602206|FG006|From Week 24 Until Week 48|Adverse Event|1|||
94494074|NCT01995201|323602200|FG000|From Week 24 Until Week 48|Death|0|||
94494075|NCT01995201|323602201|FG001|From Week 24 Until Week 48|Death|0|||
94494076|NCT01995201|323602202|FG002|From Week 24 Until Week 48|Death|0|||
94494077|NCT01995201|323602203|FG003|From Week 24 Until Week 48|Death|0|||
94494078|NCT01995201|323602204|FG004|From Week 24 Until Week 48|Death|0|||
94494079|NCT01995201|323602205|FG005|From Week 24 Until Week 48|Death|2|||
94494080|NCT01995201|323602206|FG006|From Week 24 Until Week 48|Death|0|||
94494081|NCT01995201|323602200|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
94494082|NCT01995201|323602201|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
94494083|NCT01995201|323602202|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
94494084|NCT01995201|323602203|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
94494085|NCT01995201|323602204|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
94494086|NCT01995201|323602205|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
94494087|NCT01995201|323602206|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
94494088|NCT01995201|323602200|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
94494089|NCT01995201|323602201|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
94494090|NCT01995201|323602202|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
94494091|NCT01995201|323602203|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
94494092|NCT01995201|323602204|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
94494093|NCT01995201|323602205|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
94494094|NCT01995201|323602206|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
94494095|NCT01995201|323602200|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
94494096|NCT01995201|323602201|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
94494097|NCT01995201|323602202|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
94494098|NCT01995201|323602203|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
94494099|NCT01995201|323602204|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
94494100|NCT01995201|323602205|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
94494101|NCT01995201|323602206|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
94494102|NCT01995201|323602200|FG000|From Week 24 Until Week 48|Physician Decision|0|||
94494103|NCT01995201|323602201|FG001|From Week 24 Until Week 48|Physician Decision|0|||
94494104|NCT01995201|323602202|FG002|From Week 24 Until Week 48|Physician Decision|0|||
94494105|NCT01995201|323602203|FG003|From Week 24 Until Week 48|Physician Decision|0|||
94494106|NCT01995201|323602204|FG004|From Week 24 Until Week 48|Physician Decision|1|||
94494107|NCT01995201|323602205|FG005|From Week 24 Until Week 48|Physician Decision|0|||
94494108|NCT01995201|323602206|FG006|From Week 24 Until Week 48|Physician Decision|0|||
94494109|NCT01995201|323602200|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
94494110|NCT01995201|323602201|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
94494111|NCT01995201|323602202|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
94494112|NCT01995201|323602203|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
94494113|NCT01995201|323602204|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
94494114|NCT01995201|323602205|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
94494115|NCT01995201|323602206|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
94494116|NCT03329001|323602207|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
94494117|NCT03329001|323602208|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
94494118|NCT03329001|323602209|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
94494119|NCT03329001|323602210|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
94494120|NCT03329001|323602211|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
94494121|NCT03329001|323602212|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
94494122|NCT03329001|323602213|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
94494123|NCT03329001|323602214|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
94494124|NCT03329001|323602207|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
94494125|NCT03329001|323602208|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
94494126|NCT03329001|323602209|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
94494127|NCT03329001|323602210|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
94494128|NCT03329001|323602211|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
94494129|NCT03329001|323602212|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
94494130|NCT03329001|323602213|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
94494131|NCT03329001|323602214|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
94494132|NCT03329001|323602207|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
94494133|NCT03329001|323602208|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
94494134|NCT03329001|323602209|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
94494135|NCT03329001|323602210|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
94494136|NCT03329001|323602211|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
94494137|NCT03329001|323602212|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
94494138|NCT03329001|323602213|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
94494139|NCT03329001|323602214|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
94494140|NCT03329001|323602207|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
94494141|NCT03329001|323602208|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
94494142|NCT03329001|323602209|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
94494143|NCT03329001|323602210|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
94494144|NCT03329001|323602211|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
94494145|NCT03329001|323602212|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
94494146|NCT03329001|323602213|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
94494147|NCT03329001|323602214|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
94494148|NCT03329001|323602207|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
94494149|NCT03329001|323602208|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
94494150|NCT03329001|323602209|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
94494151|NCT03329001|323602210|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
94494152|NCT03329001|323602211|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
94494153|NCT03329001|323602212|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
94494154|NCT03329001|323602213|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
94494155|NCT03329001|323602214|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
94494156|NCT03329001|323602207|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
94494157|NCT03329001|323602208|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
94494158|NCT03329001|323602209|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
94494159|NCT03329001|323602210|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
94494160|NCT03329001|323602211|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
94494161|NCT03329001|323602212|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
94494162|NCT03329001|323602213|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
94494163|NCT03329001|323602214|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
94494164|NCT03329001|323602207|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
94494165|NCT03329001|323602208|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
94494166|NCT03329001|323602209|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
94494167|NCT03329001|323602210|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
94494168|NCT03329001|323602211|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
94494169|NCT03329001|323602212|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
94494170|NCT03329001|323602213|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
94494171|NCT03329001|323602214|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
94494172|NCT03329001|323602207|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
94494173|NCT03329001|323602208|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
94494174|NCT03329001|323602209|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
94494175|NCT03329001|323602210|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
94494176|NCT03329001|323602211|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
94494177|NCT03329001|323602212|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
94494178|NCT03329001|323602213|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
94494179|NCT03329001|323602214|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
94494180|NCT03329001|323602207|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
94494181|NCT03329001|323602208|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
94494182|NCT03329001|323602209|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
94494183|NCT03329001|323602210|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
94494184|NCT03329001|323602211|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
94494185|NCT03329001|323602212|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
94494186|NCT03329001|323602213|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
94494187|NCT03329001|323602214|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
94494188|NCT03329001|323602207|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
94494189|NCT03329001|323602208|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
94494190|NCT03329001|323602209|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
94494191|NCT03329001|323602210|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
94494192|NCT03329001|323602211|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
94494193|NCT03329001|323602212|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
94494194|NCT03329001|323602213|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
94494195|NCT03329001|323602214|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
94494196|NCT03329001|323602207|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
94494197|NCT03329001|323602208|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
94494198|NCT03329001|323602209|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
94494199|NCT03329001|323602210|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
94494200|NCT03329001|323602211|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
94494201|NCT03329001|323602212|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
94494202|NCT03329001|323602213|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
94494203|NCT03329001|323602214|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
94494204|NCT03329001|323602207|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
94494205|NCT03329001|323602208|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
94494206|NCT03329001|323602209|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
94494207|NCT03329001|323602210|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
94494208|NCT03329001|323602211|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
94494209|NCT03329001|323602212|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
94494210|NCT03329001|323602213|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
94494211|NCT03329001|323602214|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
94494212|NCT03329001|323602207|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
94494213|NCT03329001|323602208|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
94494214|NCT03329001|323602209|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
94494215|NCT03329001|323602210|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
94494216|NCT03329001|323602211|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
94494217|NCT03329001|323602212|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
94494218|NCT03329001|323602213|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
94494219|NCT03329001|323602214|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
94494220|NCT03329001|323602207|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
94494221|NCT03329001|323602208|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
94494222|NCT03329001|323602209|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
94494223|NCT03329001|323602210|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
94494224|NCT03329001|323602211|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
94494225|NCT03329001|323602212|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
94494226|NCT03329001|323602213|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
94494227|NCT03329001|323602214|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
94494228|NCT03329001|323602207|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
94494229|NCT03329001|323602208|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
94494230|NCT03329001|323602209|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
94494231|NCT03329001|323602210|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
94494232|NCT03329001|323602211|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
94494233|NCT03329001|323602212|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
94494234|NCT03329001|323602213|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
94494235|NCT03329001|323602214|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
94494236|NCT03329001|323602207|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
94494237|NCT03329001|323602208|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
94494238|NCT03329001|323602209|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
94494239|NCT03329001|323602210|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
94494240|NCT03329001|323602211|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
94494241|NCT03329001|323602212|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
94494242|NCT03329001|323602213|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
94494243|NCT03329001|323602214|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
94494244|NCT03329001|323602207|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
94494245|NCT03329001|323602208|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
94494246|NCT03329001|323602209|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
94494247|NCT03329001|323602210|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
94494248|NCT03329001|323602211|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
94494249|NCT03329001|323602212|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
94494250|NCT03329001|323602213|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
94494251|NCT03329001|323602214|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
94494252|NCT03329001|323602207|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
94494253|NCT03329001|323602208|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
94494254|NCT03329001|323602209|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
94494255|NCT03329001|323602210|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
94494256|NCT03329001|323602211|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
94494257|NCT03329001|323602212|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
94494258|NCT03329001|323602213|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
94494259|NCT03329001|323602214|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
94494260|NCT03329001|323602207|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
94494261|NCT03329001|323602208|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
94494262|NCT03329001|323602209|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
94494263|NCT03329001|323602210|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
94494264|NCT03329001|323602211|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
94494265|NCT03329001|323602212|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
94494266|NCT03329001|323602213|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
94655601|NCT01110239|324196089|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
94655602|NCT01110239|324196090|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
94494267|NCT03329001|323602214|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
94494268|NCT03329001|323602207|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
94494269|NCT03329001|323602208|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
94494270|NCT03329001|323602209|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
94494271|NCT03329001|323602210|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
94494272|NCT03329001|323602211|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
94494273|NCT03329001|323602212|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
94494274|NCT03329001|323602213|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
94494275|NCT03329001|323602214|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
94494276|NCT03329001|323602207|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
94494277|NCT03329001|323602208|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
94494278|NCT03329001|323602209|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
94494279|NCT03329001|323602210|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
94494280|NCT03329001|323602211|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
94494281|NCT03329001|323602212|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
94494282|NCT03329001|323602213|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
94494283|NCT03329001|323602214|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
94494284|NCT03329001|323602207|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
94494285|NCT03329001|323602208|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
94494286|NCT03329001|323602209|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
94494287|NCT03329001|323602210|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
94494288|NCT03329001|323602211|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
94494289|NCT03329001|323602212|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
94494290|NCT03329001|323602213|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
94494291|NCT03329001|323602214|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
94494292|NCT03329001|323602207|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
94494293|NCT03329001|323602208|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
94494294|NCT03329001|323602209|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
94494295|NCT03329001|323602210|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
94494296|NCT03329001|323602211|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
94494297|NCT03329001|323602212|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
94494298|NCT03329001|323602213|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
94494299|NCT03329001|323602214|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
94494300|NCT03329001|323602207|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
94494301|NCT03329001|323602208|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
94494302|NCT03329001|323602209|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
94494303|NCT03329001|323602210|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
94494304|NCT03329001|323602211|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
94494305|NCT03329001|323602212|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
94494306|NCT03329001|323602213|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
94494307|NCT03329001|323602214|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
94494308|NCT03329001|323602207|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
94494309|NCT03329001|323602208|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
94494310|NCT03329001|323602209|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
94494311|NCT03329001|323602210|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
94494312|NCT03329001|323602211|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
94494313|NCT03329001|323602212|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
94494314|NCT03329001|323602213|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
94494315|NCT03329001|323602214|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
94494316|NCT03329001|323602207|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
94494317|NCT03329001|323602208|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
94494318|NCT03329001|323602209|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
94494319|NCT03329001|323602210|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
94494320|NCT03329001|323602211|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
94494321|NCT03329001|323602212|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
94494322|NCT03329001|323602213|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
94494323|NCT03329001|323602214|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
94494324|NCT03329001|323602207|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
94494325|NCT03329001|323602208|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
94494326|NCT03329001|323602209|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
94494327|NCT03329001|323602210|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
94655603|NCT01110239|324196091|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
94655604|NCT01110239|324196092|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
94494328|NCT03329001|323602211|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
94494329|NCT03329001|323602212|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
94494330|NCT03329001|323602213|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
94494331|NCT03329001|323602214|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
94494332|NCT03329001|323602207|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
94494333|NCT03329001|323602208|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
94494334|NCT03329001|323602209|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
94494335|NCT03329001|323602210|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
94494336|NCT03329001|323602211|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
94494337|NCT03329001|323602212|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
94494338|NCT03329001|323602213|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
94494339|NCT03329001|323602214|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
94494340|NCT03329001|323602207|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
94494341|NCT03329001|323602208|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
94494342|NCT03329001|323602209|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
94494343|NCT03329001|323602210|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
94494344|NCT03329001|323602211|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
94494345|NCT03329001|323602212|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
94494346|NCT03329001|323602213|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
94494347|NCT03329001|323602214|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
94494348|NCT02948400|323602216|FG000|Overall Study|Withdrawal by Subject|17|||
94494349|NCT02948400|323602217|FG001|Overall Study|Withdrawal by Subject|10|||
94494350|NCT02948400|323602216|FG000|Overall Study|failed to attend appointments|47|||
94494351|NCT02948400|323602217|FG001|Overall Study|failed to attend appointments|34|||
94494352|NCT02948400|323602216|FG000|Overall Study|COVID-related closure|6|||
94494353|NCT02948400|323602217|FG001|Overall Study|COVID-related closure|2|||
94494354|NCT02948400|323602216|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
94494355|NCT02948400|323602217|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
94494356|NCT02948400|323602216|FG000|Overall Study|motion sickness in virtual reality|2|||
94494357|NCT02948400|323602217|FG001|Overall Study|motion sickness in virtual reality|0|||
94494358|NCT02403271|323602218|FG000|Period 1|Other varied reasons|1|||
94494359|NCT02403271|323602219|FG001|Period 1|Other varied reasons|0|||
94494360|NCT02403271|323602218|FG000|Period 2|Withdrawal by Subject|0|||
94494361|NCT02403271|323602219|FG001|Period 2|Withdrawal by Subject|14|||
94494362|NCT02403271|323602218|FG000|Period 2|Death|0|||
94494363|NCT02403271|323602219|FG001|Period 2|Death|84|||
94494364|NCT02403271|323602218|FG000|Period 2|Lost to Follow-up|0|||
94494365|NCT02403271|323602219|FG001|Period 2|Lost to Follow-up|2|||
94494366|NCT02403271|323602218|FG000|Period 2|Study Terminated by Sponsor|0|||
94494367|NCT02403271|323602219|FG001|Period 2|Study Terminated by Sponsor|14|||
94494368|NCT02403271|323602218|FG000|Period 2|Other varied reasons|0|||
94494369|NCT02403271|323602219|FG001|Period 2|Other varied reasons|10|||
94494370|NCT00975923|323602223|FG000|Overall Study|Withdrawal by Subject|0|||
94494371|NCT00975923|323602224|FG001|Overall Study|Withdrawal by Subject|1|||
94494372|NCT04470427|323602226|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
94494373|NCT04470427|323602227|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
94494374|NCT04470427|323602228|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
94494375|NCT04470427|323602229|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
94494376|NCT04470427|323602230|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
94494377|NCT04470427|323602231|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
94494378|NCT04470427|323602226|FG000|Part B :Open-label|Other than specified|0|||
94494379|NCT04470427|323602227|FG001|Part B :Open-label|Other than specified|0|||
94494380|NCT04470427|323602228|FG002|Part B :Open-label|Other than specified|788|||
94494381|NCT04470427|323602229|FG003|Part B :Open-label|Other than specified|0|||
94494382|NCT04470427|323602230|FG004|Part B :Open-label|Other than specified|523|||
94494383|NCT04470427|323602231|FG005|Part B :Open-label|Other than specified|0|||
94494384|NCT04470427|323602226|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
94494385|NCT04470427|323602227|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
94494386|NCT04470427|323602228|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
94494387|NCT04470427|323602229|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
94494388|NCT04470427|323602230|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
94494389|NCT04470427|323602231|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
94494390|NCT04470427|323602226|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
94494391|NCT04470427|323602227|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
94494392|NCT04470427|323602228|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
94494393|NCT04470427|323602229|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
94494394|NCT04470427|323602230|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
94494395|NCT04470427|323602231|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
94494396|NCT00157755|323602234|FG000|Overall Study|Death|2|||
94494397|NCT00157755|323602235|FG001|Overall Study|Death|3|||
94494398|NCT00157755|323602236|FG002|Overall Study|Death|3|||
94494399|NCT00157755|323602237|FG003|Overall Study|Death|2|||
94494400|NCT00157755|323602238|FG004|Overall Study|Death|0|||
94494401|NCT00157755|323602239|FG005|Overall Study|Death|0|||
94494402|NCT00157755|323602234|FG000|Overall Study|Lost to Follow-up|0|||
94494403|NCT00157755|323602235|FG001|Overall Study|Lost to Follow-up|0|||
94494404|NCT00157755|323602236|FG002|Overall Study|Lost to Follow-up|1|||
94494405|NCT00157755|323602237|FG003|Overall Study|Lost to Follow-up|0|||
94494406|NCT00157755|323602238|FG004|Overall Study|Lost to Follow-up|0|||
94494407|NCT00157755|323602239|FG005|Overall Study|Lost to Follow-up|0|||
94494408|NCT00157755|323602234|FG000|Overall Study|Withdrawal by Subject|0|||
94494409|NCT00157755|323602235|FG001|Overall Study|Withdrawal by Subject|0|||
94494410|NCT00157755|323602236|FG002|Overall Study|Withdrawal by Subject|1|||
94494411|NCT00157755|323602237|FG003|Overall Study|Withdrawal by Subject|1|||
94494412|NCT00157755|323602238|FG004|Overall Study|Withdrawal by Subject|1|||
94494413|NCT00157755|323602239|FG005|Overall Study|Withdrawal by Subject|2|||
94494414|NCT00157755|323602234|FG000|Overall Study|Explant due to infection|0|||
94494415|NCT00157755|323602235|FG001|Overall Study|Explant due to infection|0|||
94494416|NCT00157755|323602236|FG002|Overall Study|Explant due to infection|1|||
94494417|NCT00157755|323602237|FG003|Overall Study|Explant due to infection|0|||
94494418|NCT00157755|323602238|FG004|Overall Study|Explant due to infection|0|||
94494419|NCT00157755|323602239|FG005|Overall Study|Explant due to infection|0|||
94494420|NCT00157755|323602234|FG000|Overall Study|Medical reason|0|||
94494421|NCT00157755|323602235|FG001|Overall Study|Medical reason|0|||
94494422|NCT00157755|323602236|FG002|Overall Study|Medical reason|1|||
94494423|NCT00157755|323602237|FG003|Overall Study|Medical reason|1|||
94494424|NCT00157755|323602238|FG004|Overall Study|Medical reason|0|||
94494425|NCT00157755|323602239|FG005|Overall Study|Medical reason|0|||
94494426|NCT00157755|323602234|FG000|Overall Study|Study site closure|0|||
94494427|NCT00157755|323602235|FG001|Overall Study|Study site closure|1|||
94494428|NCT00157755|323602236|FG002|Overall Study|Study site closure|0|||
94494429|NCT00157755|323602237|FG003|Overall Study|Study site closure|0|||
94494430|NCT00157755|323602238|FG004|Overall Study|Study site closure|0|||
94494431|NCT00157755|323602239|FG005|Overall Study|Study site closure|0|||
94494432|NCT00157755|323602234|FG000|Overall Study|Subject non-compliance|0|||
94494433|NCT00157755|323602235|FG001|Overall Study|Subject non-compliance|0|||
94494434|NCT00157755|323602236|FG002|Overall Study|Subject non-compliance|0|||
94494435|NCT00157755|323602237|FG003|Overall Study|Subject non-compliance|0|||
94494436|NCT00157755|323602238|FG004|Overall Study|Subject non-compliance|0|||
94494437|NCT00157755|323602239|FG005|Overall Study|Subject non-compliance|1|||
94494438|NCT00157755|323602234|FG000|Overall Study|Study completion|0|||
94494439|NCT00157755|323602235|FG001|Overall Study|Study completion|0|||
94494440|NCT00157755|323602236|FG002|Overall Study|Study completion|0|||
94494441|NCT00157755|323602237|FG003|Overall Study|Study completion|0|||
94494442|NCT00157755|323602238|FG004|Overall Study|Study completion|1|||
94494443|NCT00157755|323602239|FG005|Overall Study|Study completion|2|||
94494444|NCT01991795|323602240|FG000|Overall Study|Lost to Follow-up|6|||
94494445|NCT01991795|323602241|FG001|Overall Study|Lost to Follow-up|4|||
94494446|NCT01991795|323602240|FG000|Overall Study|Withdrawal by Subject|117|||
94494447|NCT01991795|323602241|FG001|Overall Study|Withdrawal by Subject|94|||
94494448|NCT01991795|323602240|FG000|Overall Study|Site prematurely closed by sponsor|26|||
94494449|NCT01991795|323602241|FG001|Overall Study|Site prematurely closed by sponsor|25|||
94494450|NCT00433537|323602242|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
94494451|NCT00433537|323602243|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
94494452|NCT00433537|323602244|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
94494453|NCT00433537|323602242|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
94494454|NCT00433537|323602243|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
94494455|NCT00433537|323602244|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
94494456|NCT00433537|323602242|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
94494457|NCT00433537|323602243|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
94494458|NCT00433537|323602244|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
94494459|NCT00433537|323602242|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
94494460|NCT00433537|323602243|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
94494461|NCT00433537|323602244|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
94494462|NCT00433537|323602242|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
94494463|NCT00433537|323602243|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
94494464|NCT00433537|323602244|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
94494465|NCT00433537|323602242|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
94494466|NCT00433537|323602243|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
94494467|NCT00433537|323602244|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
94494468|NCT00433537|323602242|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
94494469|NCT00433537|323602243|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
94494470|NCT00433537|323602244|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
94494471|NCT00433537|323602242|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
94494472|NCT00433537|323602243|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
94494473|NCT00433537|323602244|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
94494474|NCT00433537|323602242|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
94494475|NCT00433537|323602243|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
94494476|NCT00433537|323602244|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
94494477|NCT00831844|323602245|FG000|Overall Study|Adverse Event|2|||
94494478|NCT00831844|323602246|FG001|Overall Study|Adverse Event|0|||
94494479|NCT00831844|323602247|FG002|Overall Study|Adverse Event|0|||
94494480|NCT00831844|323602248|FG003|Overall Study|Adverse Event|0|||
94494481|NCT00831844|323602249|FG004|Overall Study|Adverse Event|1|||
94494482|NCT00831844|323602250|FG005|Overall Study|Adverse Event|1|||
94494483|NCT00831844|323602251|FG006|Overall Study|Adverse Event|2|||
94494484|NCT00831844|323602252|FG007|Overall Study|Adverse Event|0|||
94494485|NCT00831844|323602253|FG008|Overall Study|Adverse Event|0|||
94494486|NCT00831844|323602254|FG009|Overall Study|Adverse Event|0|||
94494487|NCT00831844|323602245|FG000|Overall Study|Death|0|||
94494488|NCT00831844|323602246|FG001|Overall Study|Death|0|||
94494489|NCT00831844|323602247|FG002|Overall Study|Death|0|||
94494490|NCT00831844|323602248|FG003|Overall Study|Death|1|||
94494491|NCT00831844|323602249|FG004|Overall Study|Death|0|||
94494492|NCT00831844|323602250|FG005|Overall Study|Death|0|||
94494493|NCT00831844|323602251|FG006|Overall Study|Death|0|||
94494494|NCT00831844|323602252|FG007|Overall Study|Death|0|||
94494495|NCT00831844|323602253|FG008|Overall Study|Death|0|||
94494496|NCT00831844|323602254|FG009|Overall Study|Death|0|||
94494497|NCT00831844|323602245|FG000|Overall Study|Lack of Efficacy|8|||
94494498|NCT00831844|323602246|FG001|Overall Study|Lack of Efficacy|10|||
94494499|NCT00831844|323602247|FG002|Overall Study|Lack of Efficacy|15|||
94494500|NCT00831844|323602248|FG003|Overall Study|Lack of Efficacy|8|||
94494501|NCT00831844|323602249|FG004|Overall Study|Lack of Efficacy|11|||
94494502|NCT00831844|323602250|FG005|Overall Study|Lack of Efficacy|17|||
94494503|NCT00831844|323602251|FG006|Overall Study|Lack of Efficacy|8|||
94494504|NCT00831844|323602252|FG007|Overall Study|Lack of Efficacy|9|||
94494505|NCT00831844|323602253|FG008|Overall Study|Lack of Efficacy|7|||
94494506|NCT00831844|323602254|FG009|Overall Study|Lack of Efficacy|0|||
94494507|NCT00831844|323602245|FG000|Overall Study|Physician Decision|0|||
94494508|NCT00831844|323602246|FG001|Overall Study|Physician Decision|1|||
94494509|NCT00831844|323602247|FG002|Overall Study|Physician Decision|3|||
94494510|NCT00831844|323602248|FG003|Overall Study|Physician Decision|1|||
94494511|NCT00831844|323602249|FG004|Overall Study|Physician Decision|1|||
94494512|NCT00831844|323602250|FG005|Overall Study|Physician Decision|1|||
94494513|NCT00831844|323602251|FG006|Overall Study|Physician Decision|0|||
94494514|NCT00831844|323602252|FG007|Overall Study|Physician Decision|0|||
94494515|NCT00831844|323602253|FG008|Overall Study|Physician Decision|1|||
94494516|NCT00831844|323602254|FG009|Overall Study|Physician Decision|0|||
94494517|NCT00831844|323602245|FG000|Overall Study|Withdrawal by Subject|0|||
94494518|NCT00831844|323602246|FG001|Overall Study|Withdrawal by Subject|0|||
94494519|NCT00831844|323602247|FG002|Overall Study|Withdrawal by Subject|1|||
94494520|NCT00831844|323602248|FG003|Overall Study|Withdrawal by Subject|0|||
94494521|NCT00831844|323602249|FG004|Overall Study|Withdrawal by Subject|0|||
94494522|NCT00831844|323602250|FG005|Overall Study|Withdrawal by Subject|0|||
94494523|NCT00831844|323602251|FG006|Overall Study|Withdrawal by Subject|0|||
94494524|NCT00831844|323602252|FG007|Overall Study|Withdrawal by Subject|1|||
94494525|NCT00831844|323602253|FG008|Overall Study|Withdrawal by Subject|1|||
94494526|NCT00831844|323602254|FG009|Overall Study|Withdrawal by Subject|0|||
94494527|NCT00831844|323602245|FG000|Overall Study|Ineligible|0|||
94494528|NCT00831844|323602246|FG001|Overall Study|Ineligible|1|||
94494529|NCT00831844|323602247|FG002|Overall Study|Ineligible|1|||
94494530|NCT00831844|323602248|FG003|Overall Study|Ineligible|0|||
94494531|NCT00831844|323602249|FG004|Overall Study|Ineligible|1|||
94494532|NCT00831844|323602250|FG005|Overall Study|Ineligible|0|||
94494533|NCT00831844|323602251|FG006|Overall Study|Ineligible|0|||
94494534|NCT00831844|323602252|FG007|Overall Study|Ineligible|0|||
94494535|NCT00831844|323602253|FG008|Overall Study|Ineligible|0|||
94494536|NCT00831844|323602254|FG009|Overall Study|Ineligible|0|||
94494537|NCT01127061|323603903|FG000|Overall Study|Lost to Follow-up|7|||
94494538|NCT01127061|323603904|FG001|Overall Study|Lost to Follow-up|10|||
94494539|NCT01127061|323603903|FG000|Overall Study|Physician Decision|3|||
94494540|NCT01127061|323603904|FG001|Overall Study|Physician Decision|3|||
94494541|NCT03595748|323603905|FG000|Overall Study|Death|11|||
94494542|NCT03595748|323603906|FG001|Overall Study|Death|12|||
94494543|NCT03595748|323603905|FG000|Overall Study|Withdrawal by Subject|28|||
94494544|NCT03595748|323603906|FG001|Overall Study|Withdrawal by Subject|29|||
94494545|NCT03595748|323603905|FG000|Overall Study|Protocol Violation|0|||
94494546|NCT03595748|323603906|FG001|Overall Study|Protocol Violation|1|||
94494547|NCT03846479|323603909|FG000|Overall Study|Death|8|||
94494548|NCT03846479|323603909|FG000|Overall Study|Lost to Follow-up|1|||
94494549|NCT01113749|323603910|FG000|Overall Study|Lost to Follow-up|1|||
94494550|NCT01113749|323603911|FG001|Overall Study|Lost to Follow-up|2|||
94494551|NCT00362232|323603912|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
94494552|NCT00362232|323603913|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
94494553|NCT00362232|323603912|FG000|Treatment (12 +/- 2 Days)|Death|1|||
94494554|NCT00362232|323603913|FG001|Treatment (12 +/- 2 Days)|Death|3|||
94494555|NCT00362232|323603912|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
94494556|NCT00362232|323603913|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
94494557|NCT00362232|323603912|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
94494558|NCT00362232|323603913|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
94494559|NCT00362232|323603912|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
94494560|NCT00362232|323603913|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
94494561|NCT00362232|323603912|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
94494562|NCT00362232|323603913|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
94494563|NCT00362232|323603912|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
94494564|NCT00362232|323603913|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
94494565|NCT00362232|323603912|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
94494566|NCT00362232|323603913|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
94494567|NCT00362232|323603912|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
94494568|NCT00362232|323603913|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
94494569|NCT00362232|323603912|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
94494570|NCT00362232|323603913|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
94494571|NCT00362232|323603912|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
94494572|NCT00362232|323603913|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
94494573|NCT00362232|323603912|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
94494574|NCT00362232|323603913|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
94494575|NCT00362232|323603912|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
94494576|NCT00362232|323603913|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
94494577|NCT00274456|323603914|FG000|Overall Study|Still on treatment|2|||
94494578|NCT00274456|323603915|FG001|Overall Study|Still on treatment|3|||
94494579|NCT00274456|323603916|FG002|Overall Study|Still on treatment|5|||
94494580|NCT00274456|323603917|FG003|Overall Study|Still on treatment|1|||
94494581|NCT00274456|323603914|FG000|Overall Study|Unacceptable toxicity|10|||
94494582|NCT00274456|323603915|FG001|Overall Study|Unacceptable toxicity|5|||
94494583|NCT00274456|323603916|FG002|Overall Study|Unacceptable toxicity|12|||
94494584|NCT00274456|323603917|FG003|Overall Study|Unacceptable toxicity|16|||
94494585|NCT00274456|323603914|FG000|Overall Study|Adverse Event|0|||
94494586|NCT00274456|323603915|FG001|Overall Study|Adverse Event|1|||
94494587|NCT00274456|323603916|FG002|Overall Study|Adverse Event|2|||
94494588|NCT00274456|323603917|FG003|Overall Study|Adverse Event|2|||
94494589|NCT00274456|323603914|FG000|Overall Study|Physician Decision|7|||
94494590|NCT00274456|323603915|FG001|Overall Study|Physician Decision|5|||
94494591|NCT00274456|323603916|FG002|Overall Study|Physician Decision|6|||
94494592|NCT00274456|323603917|FG003|Overall Study|Physician Decision|13|||
94494593|NCT00274456|323603914|FG000|Overall Study|Lost to Follow-up|0|||
94494594|NCT00274456|323603915|FG001|Overall Study|Lost to Follow-up|0|||
94494595|NCT00274456|323603916|FG002|Overall Study|Lost to Follow-up|1|||
94494596|NCT00274456|323603917|FG003|Overall Study|Lost to Follow-up|0|||
94494597|NCT00274456|323603914|FG000|Overall Study|Withdrawal by Subject|18|||
94494598|NCT00274456|323603915|FG001|Overall Study|Withdrawal by Subject|13|||
94494599|NCT00274456|323603916|FG002|Overall Study|Withdrawal by Subject|9|||
94494600|NCT00274456|323603917|FG003|Overall Study|Withdrawal by Subject|13|||
94494601|NCT02233413|323603918|FG000|Overall Study|Lost to Follow-up|7|||
94494602|NCT02233413|323603919|FG001|Overall Study|Lost to Follow-up|9|||
94494603|NCT02233413|323603918|FG000|Overall Study|Withdrawal by Subject|4|||
94494604|NCT02233413|323603919|FG001|Overall Study|Withdrawal by Subject|5|||
94494605|NCT02394275|323603922|FG000|Overall Study|Adverse Event|22|||
94494606|NCT02394275|323603922|FG000|Overall Study|Lost to Follow-up|7|||
94494607|NCT01588509|323603930|FG000|Overall Study|Lost to Follow-up|1|||
94494608|NCT01588509|323603931|FG001|Overall Study|Lost to Follow-up|0|||
94494609|NCT03345004|323603932|FG000|Overall Study|Physician Decision|1|||
94494610|NCT03345004|323603933|FG001|Overall Study|Physician Decision|0|||
94494611|NCT03345004|323603932|FG000|Overall Study|Withdrawal by Subject|0|||
94494612|NCT03345004|323603933|FG001|Overall Study|Withdrawal by Subject|1|||
94494613|NCT04167462|323603937|FG000|Overall Study|Other reasons|3|||
94494614|NCT04167462|323603938|FG001|Overall Study|Other reasons|2|||
94494615|NCT04167462|323603937|FG000|Overall Study|Withdrawal by Subject|6|||
94494616|NCT04167462|323603938|FG001|Overall Study|Withdrawal by Subject|7|||
94494617|NCT04167462|323603937|FG000|Overall Study|Adverse Event|4|||
94494618|NCT04167462|323603938|FG001|Overall Study|Adverse Event|0|||
94494619|NCT04167462|323603937|FG000|Overall Study|Pregnancy|1|||
94494620|NCT04167462|323603938|FG001|Overall Study|Pregnancy|0|||
94494621|NCT04167462|323603937|FG000|Overall Study|Lack of Efficacy|0|||
94494622|NCT04167462|323603938|FG001|Overall Study|Lack of Efficacy|1|||
94494623|NCT03331562|323603939|FG000|Overall Study|Adverse Event|2|||
94494624|NCT03331562|323603940|FG001|Overall Study|Adverse Event|0|||
94494625|NCT03331562|323603939|FG000|Overall Study|Death|1|||
94494626|NCT03331562|323603940|FG001|Overall Study|Death|0|||
94494627|NCT03718000|323603941|FG000|Overall Study|Relocation|2|||
94494628|NCT03718000|323603942|FG001|Overall Study|Relocation|4|||
94494629|NCT03718000|323603941|FG000|Overall Study|Pregnancy|0|||
94494630|NCT03718000|323603942|FG001|Overall Study|Pregnancy|1|||
94494631|NCT02382939|323603948|FG000|Overall Study|Adverse Event|1|||
94494632|NCT02382939|323603949|FG001|Overall Study|Adverse Event|1|||
94494633|NCT02382939|323603948|FG000|Overall Study|Withdrawal by Subject|2|||
94494634|NCT02382939|323603949|FG001|Overall Study|Withdrawal by Subject|2|||
94494635|NCT01582451|323603950|FG000|Overall Study|Adverse Event|1|||
94494636|NCT01582451|323603951|FG001|Overall Study|Adverse Event|3|||
94494637|NCT01582451|323603950|FG000|Overall Study|Death|3|||
94494638|NCT01582451|323603951|FG001|Overall Study|Death|3|||
94494639|NCT01582451|323603950|FG000|Overall Study|Lost to Follow-up|0|||
94494640|NCT01582451|323603951|FG001|Overall Study|Lost to Follow-up|2|||
94494641|NCT01582451|323603950|FG000|Overall Study|Protocol Violation|11|||
94494642|NCT01582451|323603951|FG001|Overall Study|Protocol Violation|3|||
94494643|NCT01582451|323603950|FG000|Overall Study|Withdrawal by Subject|13|||
94494644|NCT01582451|323603951|FG001|Overall Study|Withdrawal by Subject|9|||
94494645|NCT01582451|323603950|FG000|Overall Study|Physician Decision|3|||
94494646|NCT01582451|323603951|FG001|Overall Study|Physician Decision|0|||
94494647|NCT01582451|323603950|FG000|Overall Study|Sponsor Decision|1|||
94494648|NCT01582451|323603951|FG001|Overall Study|Sponsor Decision|0|||
94494649|NCT03881371|323603953|FG000|Overall Study|Adverse Event|8|||
94494650|NCT03881371|323603954|FG001|Overall Study|Adverse Event|9|||
94494651|NCT03881371|323603953|FG000|Overall Study|Death|1|||
94494652|NCT03881371|323603954|FG001|Overall Study|Death|0|||
94494653|NCT03881371|323603953|FG000|Overall Study|Lost to Follow-up|1|||
94494654|NCT03881371|323603954|FG001|Overall Study|Lost to Follow-up|0|||
94494655|NCT03881371|323603953|FG000|Overall Study|Non-Compliance with Study Drug|0|||
94494656|NCT03881371|323603954|FG001|Overall Study|Non-Compliance with Study Drug|2|||
94494657|NCT03881371|323603953|FG000|Overall Study|Physician Decision|3|||
94494658|NCT03881371|323603954|FG001|Overall Study|Physician Decision|3|||
94494659|NCT03881371|323603953|FG000|Overall Study|Withdrawal by Subject|2|||
94494660|NCT03881371|323603954|FG001|Overall Study|Withdrawal by Subject|10|||
94494661|NCT03881371|323603953|FG000|Overall Study|Discontinuation from Study|1|||
94494662|NCT03881371|323603954|FG001|Overall Study|Discontinuation from Study|0|||
94494663|NCT01341470|323603959|FG000|Overall Study|Sponsor decision|0|||
94494664|NCT01341470|323603960|FG001|Overall Study|Sponsor decision|0|||
94494665|NCT01341470|323603961|FG002|Overall Study|Sponsor decision|1|||
94494666|NCT01341470|323603962|FG003|Overall Study|Sponsor decision|1|||
94494667|NCT01341470|323603963|FG004|Overall Study|Sponsor decision|0|||
94494668|NCT01341470|323603964|FG005|Overall Study|Sponsor decision|1|||
94494669|NCT01756235|323603965|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
94494670|NCT00303628|323603966|FG000|Overall Study|Disease progression|0|||
94494671|NCT00303628|323603967|FG001|Overall Study|Disease progression|1|||
94494672|NCT00303628|323603966|FG000|Overall Study|Adverse Event|26|||
94494673|NCT00303628|323603967|FG001|Overall Study|Adverse Event|36|||
94494674|NCT00303628|323603966|FG000|Overall Study|Death|0|||
94494675|NCT00303628|323603967|FG001|Overall Study|Death|1|||
94494676|NCT00303628|323603966|FG000|Overall Study|Withdrawal by Subject|11|||
94494677|NCT00303628|323603967|FG001|Overall Study|Withdrawal by Subject|20|||
94494678|NCT00303628|323603966|FG000|Overall Study|Alternative therapy|2|||
94494679|NCT00303628|323603967|FG001|Overall Study|Alternative therapy|0|||
94494680|NCT00303628|323603966|FG000|Overall Study|Other complicating disease|0|||
94494681|NCT00303628|323603967|FG001|Overall Study|Other complicating disease|1|||
94494682|NCT00303628|323603966|FG000|Overall Study|Not start protocol therapy|3|||
94494683|NCT00303628|323603967|FG001|Overall Study|Not start protocol therapy|5|||
94494684|NCT00303628|323603966|FG000|Overall Study|Other|8|||
94494685|NCT00303628|323603967|FG001|Overall Study|Other|9|||
94494686|NCT00376506|323603968|FG000|Overall Study|Death|0|||
94494687|NCT00376506|323603969|FG001|Overall Study|Death|2|||
94494688|NCT02452190|323603973|FG000|Overall Study|Withdrawal by Sponsor|1|||
94494689|NCT02452190|323603974|FG001|Overall Study|Withdrawal by Sponsor|3|||
94494690|NCT02452190|323603973|FG000|Overall Study|Pregnancy|1|||
94494691|NCT02452190|323603974|FG001|Overall Study|Pregnancy|0|||
94494692|NCT02452190|323603973|FG000|Overall Study|Investigator's Decision|2|||
94494693|NCT02452190|323603974|FG001|Overall Study|Investigator's Decision|0|||
94494694|NCT02452190|323603973|FG000|Overall Study|Lack of Efficacy|3|||
94494695|NCT02452190|323603974|FG001|Overall Study|Lack of Efficacy|1|||
94494696|NCT02452190|323603973|FG000|Overall Study|Lost to Follow-up|4|||
94494697|NCT02452190|323603974|FG001|Overall Study|Lost to Follow-up|3|||
94494698|NCT02452190|323603973|FG000|Overall Study|Adverse Event|2|||
94494699|NCT02452190|323603974|FG001|Overall Study|Adverse Event|5|||
94494700|NCT02452190|323603973|FG000|Overall Study|Withdrawal by Subject|20|||
94494701|NCT02452190|323603974|FG001|Overall Study|Withdrawal by Subject|11|||
94494702|NCT02452190|323603973|FG000|Overall Study|Noncompliance with study drug|1|||
94494703|NCT02452190|323603974|FG001|Overall Study|Noncompliance with study drug|0|||
94494704|NCT02452190|323603973|FG000|Overall Study|Participant traveled abroad|1|||
94494705|NCT02452190|323603974|FG001|Overall Study|Participant traveled abroad|0|||
94494706|NCT02452190|323603973|FG000|Overall Study|Death|0|||
94494707|NCT02452190|323603974|FG001|Overall Study|Death|1|||
94494708|NCT02691572|323603989|FG000|Overall Study|Withdrawal by Subject|1|||
94494709|NCT02691572|323603990|FG001|Overall Study|Withdrawal by Subject|0|||
94494710|NCT02691572|323603989|FG000|Overall Study|Protocol Violation|0|||
94494711|NCT02691572|323603990|FG001|Overall Study|Protocol Violation|1|||
94494712|NCT00699751|323603991|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
94494713|NCT00699751|323603992|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
94494714|NCT00699751|323603991|FG000|Period 1: Without/Before Drug Switch|Death|28|||
94494715|NCT00699751|323603992|FG001|Period 1: Without/Before Drug Switch|Death|29|||
94494716|NCT00699751|323603991|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
94494717|NCT00699751|323603992|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
94494718|NCT00699751|323603991|FG000|Period 1: Without/Before Drug Switch|Other|30|||
94494719|NCT00699751|323603992|FG001|Period 1: Without/Before Drug Switch|Other|20|||
94494720|NCT00699751|323603991|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
94494721|NCT00699751|323603992|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
94494722|NCT00699751|323603991|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
94494723|NCT00699751|323603992|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
94494724|NCT00699751|323603991|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
94494725|NCT00699751|323603992|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
94494726|NCT00699751|323603991|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
94494727|NCT00699751|323603992|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
94494728|NCT00325416|323603995|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
94494729|NCT00325416|323603996|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
94494730|NCT00325416|323603995|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
94494731|NCT00325416|323603996|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
94494732|NCT00325416|323603995|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
94494733|NCT00325416|323603996|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
94494734|NCT00325416|323603995|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
94494735|NCT00325416|323603996|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
94494736|NCT00325416|323603995|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
94494737|NCT00325416|323603996|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
94494738|NCT00325416|323603995|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
94494739|NCT00325416|323603996|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
94494740|NCT03980223|323603997|FG000|Overall Study|Lost to Follow-up|3|||
94494741|NCT03980223|323603998|FG001|Overall Study|Lost to Follow-up|7|||
94494742|NCT03980223|323603999|FG002|Overall Study|Lost to Follow-up|10|||
94494743|NCT03980223|323604000|FG003|Overall Study|Lost to Follow-up|8|||
94494744|NCT03980223|323603997|FG000|Overall Study|Withdrawal by Subject|0|||
94494745|NCT03980223|323603998|FG001|Overall Study|Withdrawal by Subject|0|||
94494746|NCT03980223|323603999|FG002|Overall Study|Withdrawal by Subject|1|||
94494747|NCT03980223|323604000|FG003|Overall Study|Withdrawal by Subject|2|||
94494748|NCT03980223|323603997|FG000|Overall Study|Physician Decision|0|||
94494749|NCT03980223|323603998|FG001|Overall Study|Physician Decision|0|||
94494750|NCT03980223|323603999|FG002|Overall Study|Physician Decision|1|||
94494751|NCT03980223|323604000|FG003|Overall Study|Physician Decision|0|||
94494752|NCT03980223|323603997|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
94494753|NCT03980223|323603998|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
94494754|NCT03980223|323603999|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
94494755|NCT03980223|323604000|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
94494756|NCT02324153|323604006|FG000|Overall Study|Withdrawal by Subject|4|||
94494757|NCT02324153|323604007|FG001|Overall Study|Withdrawal by Subject|1|||
94494758|NCT02324153|323604006|FG000|Overall Study|Surgery postponed after randomization|3|||
94494759|NCT02324153|323604007|FG001|Overall Study|Surgery postponed after randomization|0|||
94494760|NCT02324153|323604006|FG000|Overall Study|Developed delirium preoperatively|1|||
94494761|NCT02324153|323604007|FG001|Overall Study|Developed delirium preoperatively|0|||
94494762|NCT01860989|323604010|FG000|Overall Study|Unsatisfactory therapeutic|5|||
94494763|NCT01069939|323604016|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
94494764|NCT01069939|323604017|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
94494765|NCT01069939|323604016|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
94494766|NCT01069939|323604017|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
94494767|NCT01069939|323604016|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
94494768|NCT01069939|323604017|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
94494769|NCT01069939|323604016|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
94494770|NCT01069939|323604017|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
94494771|NCT01069939|323604016|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
94494772|NCT01069939|323604017|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
94494773|NCT01069939|323604016|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
94494774|NCT01069939|323604017|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
94494775|NCT01069939|323604016|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
94494776|NCT01069939|323604017|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
94494777|NCT01069939|323604016|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
94494778|NCT01069939|323604017|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
94494779|NCT01069939|323604016|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
94494780|NCT01069939|323604017|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
94494781|NCT01069939|323604016|FG000|Randomised and Included in the Analyses|Removal|1|||
94494782|NCT01069939|323604017|FG001|Randomised and Included in the Analyses|Removal|0|||
94494783|NCT05166876|323604018|FG000|Overall Study|Withdrawal by Subject|1|||
94494784|NCT05166876|323604019|FG001|Overall Study|Withdrawal by Subject|0|||
94494785|NCT05166876|323604020|FG002|Overall Study|Withdrawal by Subject|0|||
94494786|NCT00658528|323604021|FG000|Overall Study|Adverse Event|5|||
94494787|NCT00658528|323604022|FG001|Overall Study|Adverse Event|7|||
94494788|NCT00658528|323604021|FG000|Overall Study|Lost to Follow-up|14|||
94494789|NCT00658528|323604022|FG001|Overall Study|Lost to Follow-up|22|||
94494790|NCT00658528|323604021|FG000|Overall Study|Withdrawal by Subject|8|||
94494791|NCT00658528|323604022|FG001|Overall Study|Withdrawal by Subject|6|||
94494792|NCT00658528|323604021|FG000|Overall Study|Withdrawal of consent|5|||
94494793|NCT00658528|323604022|FG001|Overall Study|Withdrawal of consent|6|||
94494794|NCT00658528|323604021|FG000|Overall Study|Other|8|||
94494795|NCT00658528|323604022|FG001|Overall Study|Other|4|||
94494796|NCT01913353|323604023|FG000|Overall Study|Adverse Event|2|||
94494797|NCT01913353|323604024|FG001|Overall Study|Adverse Event|0|||
94494798|NCT01913353|323604023|FG000|Overall Study|Physician Decision|0|||
94494799|NCT01913353|323604024|FG001|Overall Study|Physician Decision|2|||
94494800|NCT01913353|323604023|FG000|Overall Study|Withdrawal by Subject|20|||
94494801|NCT01913353|323604024|FG001|Overall Study|Withdrawal by Subject|6|||
94494802|NCT01913353|323604023|FG000|Overall Study|multiple reasons|10|||
94494803|NCT01913353|323604024|FG001|Overall Study|multiple reasons|7|||
94494804|NCT00700635|323604027|FG000|Overall Study|Adverse Event|1|||
94494805|NCT00700635|323604028|FG001|Overall Study|Adverse Event|0|||
94494806|NCT00700635|323604029|FG002|Overall Study|Adverse Event|0|||
94494807|NCT00700635|323604027|FG000|Overall Study|Lost to Follow-up|1|||
94494808|NCT00700635|323604028|FG001|Overall Study|Lost to Follow-up|3|||
94494809|NCT00700635|323604029|FG002|Overall Study|Lost to Follow-up|0|||
94494810|NCT00700635|323604027|FG000|Overall Study|Protocol Violation|2|||
94494811|NCT00700635|323604028|FG001|Overall Study|Protocol Violation|2|||
94494812|NCT00700635|323604029|FG002|Overall Study|Protocol Violation|0|||
94494813|NCT00700635|323604027|FG000|Overall Study|Withdrawal by Subject|7|||
94494814|NCT00700635|323604028|FG001|Overall Study|Withdrawal by Subject|3|||
94494815|NCT00700635|323604029|FG002|Overall Study|Withdrawal by Subject|1|||
94494816|NCT03010501|323604030|FG000|Study Week 1|Withdrawal by Subject|2|||
94494817|NCT03010501|323604031|FG001|Study Week 1|Withdrawal by Subject|1|||
94494818|NCT03010501|323604032|FG002|Study Week 1|Withdrawal by Subject|0|||
94494819|NCT03010501|323604033|FG003|Study Week 1|Withdrawal by Subject|2|||
94494820|NCT03010501|323604034|FG004|Study Week 1|Withdrawal by Subject|0|||
94494821|NCT03010501|323604035|FG005|Study Week 1|Withdrawal by Subject|0|||
94494822|NCT03010501|323604030|FG000|Study Week 3|Withdrawal by Subject|0|||
94494823|NCT03010501|323604031|FG001|Study Week 3|Withdrawal by Subject|0|||
94494824|NCT03010501|323604032|FG002|Study Week 3|Withdrawal by Subject|0|||
94494825|NCT03010501|323604033|FG003|Study Week 3|Withdrawal by Subject|1|||
94494826|NCT03010501|323604034|FG004|Study Week 3|Withdrawal by Subject|0|||
94494827|NCT03010501|323604035|FG005|Study Week 3|Withdrawal by Subject|0|||
94494828|NCT01147458|323604036|FG000|First Intervention|Study terminated by sponsor|8|||
94494829|NCT01147458|323604037|FG001|First Intervention|Study terminated by sponsor|8|||
94494830|NCT01147458|323604038|FG002|First Intervention|Study terminated by sponsor|7|||
94494831|NCT01147458|323604039|FG003|First Intervention|Study terminated by sponsor|8|||
94494832|NCT01147458|323604036|FG000|First Intervention|Protocol Violation|2|||
94494833|NCT01147458|323604037|FG001|First Intervention|Protocol Violation|3|||
94494834|NCT01147458|323604038|FG002|First Intervention|Protocol Violation|2|||
94494835|NCT01147458|323604039|FG003|First Intervention|Protocol Violation|3|||
94494836|NCT01147458|323604036|FG000|First Intervention|Withdrawal by Subject|3|||
94494837|NCT01147458|323604037|FG001|First Intervention|Withdrawal by Subject|0|||
94494838|NCT01147458|323604038|FG002|First Intervention|Withdrawal by Subject|1|||
94494839|NCT01147458|323604039|FG003|First Intervention|Withdrawal by Subject|0|||
94494840|NCT01147458|323604036|FG000|First Intervention|Adverse Event|0|||
94494841|NCT01147458|323604037|FG001|First Intervention|Adverse Event|3|||
94494842|NCT01147458|323604038|FG002|First Intervention|Adverse Event|2|||
94494843|NCT01147458|323604039|FG003|First Intervention|Adverse Event|3|||
94494844|NCT01147458|323604036|FG000|First Intervention|Other|1|||
94494845|NCT01147458|323604037|FG001|First Intervention|Other|2|||
94494846|NCT01147458|323604038|FG002|First Intervention|Other|0|||
94494847|NCT01147458|323604039|FG003|First Intervention|Other|0|||
94494848|NCT01147458|323604036|FG000|Second Intervention|Study terminated by sponsor|7|||
94494849|NCT01147458|323604037|FG001|Second Intervention|Study terminated by sponsor|5|||
94494850|NCT01147458|323604038|FG002|Second Intervention|Study terminated by sponsor|5|||
94494851|NCT01147458|323604039|FG003|Second Intervention|Study terminated by sponsor|3|||
94494852|NCT01147458|323604036|FG000|Second Intervention|Protocol Violation|0|||
94494853|NCT01147458|323604037|FG001|Second Intervention|Protocol Violation|1|||
94494854|NCT01147458|323604038|FG002|Second Intervention|Protocol Violation|1|||
94494855|NCT01147458|323604039|FG003|Second Intervention|Protocol Violation|0|||
94494856|NCT01147458|323604036|FG000|Second Intervention|Withdrawal by Subject|0|||
94494857|NCT01147458|323604037|FG001|Second Intervention|Withdrawal by Subject|1|||
94494858|NCT01147458|323604038|FG002|Second Intervention|Withdrawal by Subject|0|||
94494859|NCT01147458|323604039|FG003|Second Intervention|Withdrawal by Subject|0|||
94494860|NCT01147458|323604036|FG000|Second Intervention|Adverse Event|2|||
94494861|NCT01147458|323604037|FG001|Second Intervention|Adverse Event|0|||
94494862|NCT01147458|323604038|FG002|Second Intervention|Adverse Event|1|||
94494863|NCT01147458|323604039|FG003|Second Intervention|Adverse Event|1|||
94494864|NCT01147458|323604036|FG000|Second Intervention|Other|0|||
94494865|NCT01147458|323604037|FG001|Second Intervention|Other|0|||
94494866|NCT01147458|323604038|FG002|Second Intervention|Other|1|||
94494867|NCT01147458|323604039|FG003|Second Intervention|Other|0|||
94494868|NCT03550209|323604040|FG000|Overall Study|Lost to Follow-up|1|||
94494869|NCT03550209|323604041|FG001|Overall Study|Lost to Follow-up|0|||
94494870|NCT03550209|323604042|FG002|Overall Study|Lost to Follow-up|1|||
94494871|NCT03550209|323604043|FG003|Overall Study|Lost to Follow-up|0|||
94494872|NCT03550209|323604040|FG000|Overall Study|Withdrawal by Subject|0|||
94494873|NCT03550209|323604041|FG001|Overall Study|Withdrawal by Subject|3|||
94494874|NCT03550209|323604042|FG002|Overall Study|Withdrawal by Subject|1|||
94494875|NCT03550209|323604043|FG003|Overall Study|Withdrawal by Subject|2|||
94494876|NCT03550209|323604040|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
94494877|NCT03550209|323604041|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
94494878|NCT03550209|323604042|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
94494879|NCT03550209|323604043|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
94494880|NCT02555878|323604044|FG000|Overall Study|Lost to Follow-up|2|||
94494881|NCT02555878|323604045|FG001|Overall Study|Lost to Follow-up|3|||
94494882|NCT02555878|323604044|FG000|Overall Study|Withdrawal by Subject|48|||
94494883|NCT02555878|323604045|FG001|Overall Study|Withdrawal by Subject|48|||
94494884|NCT02555878|323604044|FG000|Overall Study|Adverse Event|12|||
94494885|NCT02555878|323604045|FG001|Overall Study|Adverse Event|8|||
94494886|NCT02555878|323604044|FG000|Overall Study|Death|74|||
94494887|NCT02555878|323604045|FG001|Overall Study|Death|59|||
94494888|NCT02555878|323604044|FG000|Overall Study|Protocol Violation|1|||
94494889|NCT02555878|323604045|FG001|Overall Study|Protocol Violation|2|||
94494890|NCT02555878|323604044|FG000|Overall Study|Physician Decision|12|||
94494891|NCT02555878|323604045|FG001|Overall Study|Physician Decision|13|||
94494892|NCT02555878|323604044|FG000|Overall Study|Other|17|||
94494893|NCT02555878|323604045|FG001|Overall Study|Other|17|||
94494894|NCT00832975|323604046|FG000|Overall Study|Lost to Follow-up|7|||
94494895|NCT00832975|323604046|FG000|Overall Study|Protocol Violation|6|||
94494896|NCT00832975|323604046|FG000|Overall Study|Death|5|||
94494897|NCT00832975|323604046|FG000|Overall Study|Physician Decision|4|||
94494898|NCT00832975|323604046|FG000|Overall Study|Withdrawal by Subject|3|||
94494899|NCT00832975|323604046|FG000|Overall Study|Other reasons|14|||
94494900|NCT02347787|323604051|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
94494901|NCT02347787|323604052|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
94494902|NCT02347787|323604051|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
94494903|NCT02347787|323604052|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
94494904|NCT02347787|323604051|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
94494905|NCT02347787|323604052|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
94494906|NCT02347787|323604051|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
94494907|NCT02347787|323604052|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
94494908|NCT01202591|323604053|FG000|Overall Study|Adverse Event|2|||
94494909|NCT01202591|323604054|FG001|Overall Study|Adverse Event|1|||
94494910|NCT01202591|323604055|FG002|Overall Study|Adverse Event|4|||
94494911|NCT01202591|323604056|FG003|Overall Study|Adverse Event|4|||
94494912|NCT01202591|323604057|FG004|Overall Study|Adverse Event|0|||
94494913|NCT01202591|323604058|FG005|Overall Study|Adverse Event|0|||
94494914|NCT01202591|323604053|FG000|Overall Study|Other reason as per investigator|3|||
94494915|NCT01202591|323604054|FG001|Overall Study|Other reason as per investigator|4|||
94494916|NCT01202591|323604055|FG002|Overall Study|Other reason as per investigator|7|||
94494917|NCT01202591|323604056|FG003|Overall Study|Other reason as per investigator|3|||
94494918|NCT01202591|323604057|FG004|Overall Study|Other reason as per investigator|1|||
94494919|NCT01202591|323604058|FG005|Overall Study|Other reason as per investigator|3|||
94494920|NCT01202591|323604053|FG000|Overall Study|Withdrawal by Subject|0|||
94494921|NCT01202591|323604054|FG001|Overall Study|Withdrawal by Subject|0|||
94494922|NCT01202591|323604055|FG002|Overall Study|Withdrawal by Subject|0|||
94494923|NCT01202591|323604056|FG003|Overall Study|Withdrawal by Subject|0|||
94494924|NCT01202591|323604057|FG004|Overall Study|Withdrawal by Subject|2|||
94494925|NCT01202591|323604058|FG005|Overall Study|Withdrawal by Subject|1|||
94494926|NCT01202591|323604053|FG000|Overall Study|Objective Disease Progression|0|||
94494927|NCT01202591|323604054|FG001|Overall Study|Objective Disease Progression|0|||
94494928|NCT01202591|323604055|FG002|Overall Study|Objective Disease Progression|0|||
94494929|NCT01202591|323604056|FG003|Overall Study|Objective Disease Progression|0|||
94494930|NCT01202591|323604057|FG004|Overall Study|Objective Disease Progression|2|||
94494931|NCT01202591|323604058|FG005|Overall Study|Objective Disease Progression|0|||
94494932|NCT00191100|323604061|FG000|Overall Study|Adverse Event|18|||
94494933|NCT00191100|323604062|FG001|Overall Study|Adverse Event|1|||
94494934|NCT00191100|323604061|FG000|Overall Study|Lost to Follow-up|2|||
94494935|NCT00191100|323604062|FG001|Overall Study|Lost to Follow-up|0|||
94494936|NCT00191100|323604061|FG000|Overall Study|Patient Moved|0|||
94494937|NCT00191100|323604062|FG001|Overall Study|Patient Moved|1|||
94494938|NCT00191100|323604061|FG000|Overall Study|Withdrawal by Subject|9|||
94494939|NCT00191100|323604062|FG001|Overall Study|Withdrawal by Subject|3|||
94494940|NCT00191100|323604061|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
94494941|NCT00191100|323604062|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
94494942|NCT00191100|323604061|FG000|Overall Study|Clinical Relapse|2|||
94494943|NCT00191100|323604062|FG001|Overall Study|Clinical Relapse|1|||
94494944|NCT00191100|323604061|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
94494945|NCT00191100|323604062|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
94494946|NCT00191100|323604061|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
94494947|NCT00191100|323604062|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
94494948|NCT00191100|323604061|FG000|Overall Study|Physician Decision|3|||
94494949|NCT00191100|323604062|FG001|Overall Study|Physician Decision|1|||
94494950|NCT00191100|323604061|FG000|Overall Study|Death from Study Drug Toxicity|2|||
94494951|NCT00191100|323604062|FG001|Overall Study|Death from Study Drug Toxicity|0|||
94494952|NCT00191100|323604061|FG000|Overall Study|Protocol Violation|1|||
94494953|NCT00191100|323604062|FG001|Overall Study|Protocol Violation|1|||
94494954|NCT00191100|323604061|FG000|Overall Study|Death from Other Cause|1|||
94494955|NCT00191100|323604062|FG001|Overall Study|Death from Other Cause|0|||
94494956|NCT00191100|323604061|FG000|Overall Study|Reason Not Specified|0|||
94494957|NCT00191100|323604062|FG001|Overall Study|Reason Not Specified|1|||
94494958|NCT00433290|323604064|FG000|Overall Study|Adverse Event|24|||
94494959|NCT00433290|323604065|FG001|Overall Study|Adverse Event|7|||
94494960|NCT00433290|323604064|FG000|Overall Study|Lack of Efficacy|1|||
94494961|NCT00433290|323604065|FG001|Overall Study|Lack of Efficacy|5|||
94494962|NCT00433290|323604064|FG000|Overall Study|Withdrawal by Subject|4|||
94494963|NCT00433290|323604065|FG001|Overall Study|Withdrawal by Subject|2|||
94494964|NCT00433290|323604064|FG000|Overall Study|Protocol Violation|3|||
94494965|NCT00433290|323604065|FG001|Overall Study|Protocol Violation|2|||
94494966|NCT00433290|323604064|FG000|Overall Study|Physician Decision|2|||
94494967|NCT00433290|323604065|FG001|Overall Study|Physician Decision|0|||
94494968|NCT00433290|323604064|FG000|Overall Study|Entry Criteria Not Met|0|||
94494969|NCT00433290|323604065|FG001|Overall Study|Entry Criteria Not Met|1|||
94494970|NCT00433290|323604064|FG000|Overall Study|Lost to Follow-up|1|||
94494971|NCT00433290|323604065|FG001|Overall Study|Lost to Follow-up|0|||
94494972|NCT01525589|323604070|FG000|Overall Study|Non-treatment-related AE|1|||
94494973|NCT01525589|323604071|FG001|Overall Study|Non-treatment-related AE|0|||
94494974|NCT01525589|323604072|FG002|Overall Study|Non-treatment-related AE|0|||
94494975|NCT01525589|323604070|FG000|Overall Study|Progressive disease|48|||
94494976|NCT01525589|323604071|FG001|Overall Study|Progressive disease|15|||
94494977|NCT01525589|323604072|FG002|Overall Study|Progressive disease|29|||
94494978|NCT01525589|323604070|FG000|Overall Study|Never treated|2|||
94494979|NCT01525589|323604071|FG001|Overall Study|Never treated|0|||
94494980|NCT01525589|323604072|FG002|Overall Study|Never treated|0|||
94494981|NCT01525589|323604070|FG000|Overall Study|Physician Decision|4|||
94494982|NCT01525589|323604071|FG001|Overall Study|Physician Decision|2|||
94494983|NCT01525589|323604072|FG002|Overall Study|Physician Decision|2|||
94494984|NCT01525589|323604070|FG000|Overall Study|Death|0|||
94494985|NCT01525589|323604071|FG001|Overall Study|Death|0|||
94494986|NCT01525589|323604072|FG002|Overall Study|Death|2|||
94494987|NCT01525589|323604070|FG000|Overall Study|Treatment-related AE|1|||
94494988|NCT01525589|323604071|FG001|Overall Study|Treatment-related AE|1|||
94494989|NCT01525589|323604072|FG002|Overall Study|Treatment-related AE|2|||
94494990|NCT01525589|323604070|FG000|Overall Study|Other reasons|0|||
94494991|NCT01525589|323604071|FG001|Overall Study|Other reasons|1|||
94494992|NCT01525589|323604072|FG002|Overall Study|Other reasons|0|||
94494993|NCT01525589|323604070|FG000|Overall Study|Withdrawal by Subject|0|||
94494994|NCT01525589|323604071|FG001|Overall Study|Withdrawal by Subject|1|||
94494995|NCT01525589|323604072|FG002|Overall Study|Withdrawal by Subject|0|||
94494996|NCT02583269|323604073|FG000|Overall Study|Patient hospitalized prior to start|1|||
94494997|NCT02583269|323604074|FG001|Overall Study|Patient hospitalized prior to start|0|||
94494998|NCT02583269|323604075|FG002|Overall Study|Patient hospitalized prior to start|0|||
94494999|NCT02583269|323604076|FG003|Overall Study|Patient hospitalized prior to start|0|||
94495000|NCT02583269|323604077|FG004|Overall Study|Patient hospitalized prior to start|0|||
94495001|NCT01179399|323604078|FG000|Overall Study|Adverse Event|1|||
94495002|NCT01179399|323604078|FG000|Overall Study|Lack of Efficacy|30|||
94495003|NCT01179399|323604078|FG000|Overall Study|Withdrawal by Subject|1|||
94512838|NCT00725985|323676424|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
94512839|NCT00725985|323676425|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
94512840|NCT00725985|323676426|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
94495004|NCT01373229|323606290|FG000|Overall Study|Death|3|||
94495005|NCT01373229|323606290|FG000|Overall Study|Physician Decision|3|||
94495006|NCT00587457|323606293|FG000|Overall Study|Adverse Event|1|||
94495007|NCT00587457|323606294|FG001|Overall Study|Adverse Event|2|||
94495008|NCT00587457|323606295|FG002|Overall Study|Adverse Event|1|||
94495009|NCT00587457|323606293|FG000|Overall Study|Disease progression|2|||
94495010|NCT00587457|323606294|FG001|Overall Study|Disease progression|0|||
94495011|NCT00587457|323606295|FG002|Overall Study|Disease progression|2|||
94495012|NCT00587457|323606293|FG000|Overall Study|Initiation of alternative therapy|0|||
94495013|NCT00587457|323606294|FG001|Overall Study|Initiation of alternative therapy|1|||
94495014|NCT00587457|323606295|FG002|Overall Study|Initiation of alternative therapy|0|||
94495015|NCT00587457|323606293|FG000|Overall Study|Undefined|0|||
94495016|NCT00587457|323606294|FG001|Overall Study|Undefined|0|||
94495017|NCT00587457|323606295|FG002|Overall Study|Undefined|1|||
94495018|NCT00587457|323606293|FG000|Overall Study|Development of neutralizing Abs|0|||
94495019|NCT00587457|323606294|FG001|Overall Study|Development of neutralizing Abs|0|||
94495020|NCT00587457|323606295|FG002|Overall Study|Development of neutralizing Abs|1|||
94495021|NCT01847209|323606298|FG000|Overall Study|Withdrawal by Subject|1|||
94495022|NCT01847209|323606298|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
94495023|NCT01787838|323606299|FG000|Overall Study|refused|1413|||
94495024|NCT01963611|323606319|FG000|Overall Study|Adverse Event|1|||
94495025|NCT01963611|323606320|FG001|Overall Study|Adverse Event|1|||
94495026|NCT01963611|323606321|FG002|Overall Study|Adverse Event|3|||
94495027|NCT01963611|323606322|FG003|Overall Study|Adverse Event|4|||
94495028|NCT01963611|323606323|FG004|Overall Study|Adverse Event|3|||
94495029|NCT01963611|323606319|FG000|Overall Study|Protocol Violation|0|||
94495030|NCT01963611|323606320|FG001|Overall Study|Protocol Violation|0|||
94495031|NCT01963611|323606321|FG002|Overall Study|Protocol Violation|0|||
94495032|NCT01963611|323606322|FG003|Overall Study|Protocol Violation|1|||
94495033|NCT01963611|323606323|FG004|Overall Study|Protocol Violation|0|||
94495034|NCT01963611|323606319|FG000|Overall Study|Lack of Efficacy|0|||
94495035|NCT01963611|323606320|FG001|Overall Study|Lack of Efficacy|0|||
94495036|NCT01963611|323606321|FG002|Overall Study|Lack of Efficacy|0|||
94495037|NCT01963611|323606322|FG003|Overall Study|Lack of Efficacy|1|||
94495038|NCT01963611|323606323|FG004|Overall Study|Lack of Efficacy|0|||
94495039|NCT01963611|323606319|FG000|Overall Study|Withdrawal by Subject|3|||
94495040|NCT01963611|323606320|FG001|Overall Study|Withdrawal by Subject|2|||
94495041|NCT01963611|323606321|FG002|Overall Study|Withdrawal by Subject|1|||
94495042|NCT01963611|323606322|FG003|Overall Study|Withdrawal by Subject|1|||
94495043|NCT01963611|323606323|FG004|Overall Study|Withdrawal by Subject|3|||
94495044|NCT01963611|323606319|FG000|Overall Study|Other|47|||
94495045|NCT01963611|323606320|FG001|Overall Study|Other|46|||
94495046|NCT01963611|323606321|FG002|Overall Study|Other|48|||
94495047|NCT01963611|323606322|FG003|Overall Study|Other|45|||
94495048|NCT01963611|323606323|FG004|Overall Study|Other|45|||
94495049|NCT05177094|323606325|FG000|Overall Study|Adverse Event|5|||
94495050|NCT05177094|323606326|FG001|Overall Study|Adverse Event|5|||
94495051|NCT05177094|323606325|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
94495052|NCT05177094|323606326|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
94495053|NCT05177094|323606325|FG000|Overall Study|Protocol Deviation|3|||
94495054|NCT05177094|323606326|FG001|Overall Study|Protocol Deviation|0|||
94495055|NCT05177094|323606325|FG000|Overall Study|Withdrawal by Subject|6|||
94495056|NCT05177094|323606326|FG001|Overall Study|Withdrawal by Subject|3|||
94495057|NCT05177094|323606325|FG000|Overall Study|Participant could not tolerate long study visits|1|||
94495058|NCT05177094|323606326|FG001|Overall Study|Participant could not tolerate long study visits|0|||
94495059|NCT00998946|323606327|FG000|Overall Study|Lost to Follow-up|1|||
94495060|NCT00998946|323606327|FG000|Overall Study|Withdrawal by Subject|1|||
94495061|NCT00998946|323606327|FG000|Overall Study|Death|2|||
94495062|NCT00998946|323606327|FG000|Overall Study|Reason Unspecified|3|||
94495063|NCT00998946|323606327|FG000|Overall Study|Enrolled but not Dosed|2|||
94495064|NCT00855582|323606328|FG000|Overall Study|Adverse Event|2|||
94495065|NCT00855582|323606329|FG001|Overall Study|Adverse Event|6|||
94495066|NCT00855582|323606330|FG002|Overall Study|Adverse Event|3|||
94495067|NCT00855582|323606328|FG000|Overall Study|Death|1|||
94495068|NCT00855582|323606329|FG001|Overall Study|Death|0|||
94495069|NCT00855582|323606330|FG002|Overall Study|Death|0|||
94495070|NCT00855582|323606328|FG000|Overall Study|Lack of Efficacy|1|||
94495071|NCT00855582|323606329|FG001|Overall Study|Lack of Efficacy|3|||
94495072|NCT00855582|323606330|FG002|Overall Study|Lack of Efficacy|8|||
94495073|NCT00855582|323606328|FG000|Overall Study|Lost to Follow-up|1|||
94495074|NCT00855582|323606329|FG001|Overall Study|Lost to Follow-up|3|||
94495075|NCT00855582|323606330|FG002|Overall Study|Lost to Follow-up|1|||
94495076|NCT00855582|323606328|FG000|Overall Study|Physician Decision|0|||
94495077|NCT00855582|323606329|FG001|Overall Study|Physician Decision|0|||
94495078|NCT00855582|323606330|FG002|Overall Study|Physician Decision|1|||
94495079|NCT00855582|323606328|FG000|Overall Study|Protocol Violation|6|||
94495080|NCT00855582|323606329|FG001|Overall Study|Protocol Violation|2|||
94495081|NCT00855582|323606330|FG002|Overall Study|Protocol Violation|6|||
94495082|NCT00855582|323606328|FG000|Overall Study|Entry Criteria Not Met|8|||
94495083|NCT00855582|323606329|FG001|Overall Study|Entry Criteria Not Met|6|||
94495084|NCT00855582|323606330|FG002|Overall Study|Entry Criteria Not Met|3|||
94495085|NCT00855582|323606328|FG000|Overall Study|Withdrawal by Subject|7|||
94495086|NCT00855582|323606329|FG001|Overall Study|Withdrawal by Subject|4|||
94495087|NCT00855582|323606330|FG002|Overall Study|Withdrawal by Subject|8|||
94495088|NCT00393367|323606333|FG000|Overall Study|Protocol Violation|2|||
94495089|NCT00393367|323606334|FG001|Overall Study|Protocol Violation|5|||
94495090|NCT00393367|323606333|FG000|Overall Study|Withdrawal by Subject|0|||
94495091|NCT00393367|323606334|FG001|Overall Study|Withdrawal by Subject|2|||
94495092|NCT00915525|323606335|FG000|Overall Study|Protocol Violation|9|||
94495093|NCT00915525|323606336|FG001|Overall Study|Protocol Violation|4|||
94495094|NCT00915525|323606335|FG000|Overall Study|Withdrawal by Subject|59|||
94495095|NCT00915525|323606336|FG001|Overall Study|Withdrawal by Subject|21|||
94495096|NCT00915525|323606335|FG000|Overall Study|Lost to Follow-up|27|||
94495097|NCT00915525|323606336|FG001|Overall Study|Lost to Follow-up|16|||
94495098|NCT00915525|323606335|FG000|Overall Study|Pregnancy|2|||
94495099|NCT00915525|323606336|FG001|Overall Study|Pregnancy|0|||
94495100|NCT00915525|323606335|FG000|Overall Study|Lack of Efficacy|15|||
94495101|NCT00915525|323606336|FG001|Overall Study|Lack of Efficacy|32|||
94495102|NCT00915525|323606335|FG000|Overall Study|Adverse Event|29|||
94495103|NCT00915525|323606336|FG001|Overall Study|Adverse Event|13|||
94495104|NCT00915525|323606335|FG000|Overall Study|Missing|12|||
94495105|NCT00915525|323606336|FG001|Overall Study|Missing|1|||
94495106|NCT00915525|323606335|FG000|Overall Study|Other Reason|35|||
94495107|NCT00915525|323606336|FG001|Overall Study|Other Reason|12|||
94495108|NCT00915525|323606335|FG000|Overall Study|Site Closed|27|||
94495109|NCT00915525|323606336|FG001|Overall Study|Site Closed|9|||
94495110|NCT00915525|323606335|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
94495111|NCT00915525|323606336|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
94495112|NCT00915525|323606335|FG000|Overall Study|Study Burden|28|||
94495113|NCT00915525|323606336|FG001|Overall Study|Study Burden|12|||
94495114|NCT00915525|323606335|FG000|Overall Study|Non-Compliance|3|||
94495115|NCT00915525|323606336|FG001|Overall Study|Non-Compliance|1|||
94495116|NCT00915525|323606335|FG000|Overall Study|Patient Moved|15|||
94495117|NCT00915525|323606336|FG001|Overall Study|Patient Moved|9|||
94495118|NCT02097277|323606337|FG000|Overall Study|Subject no longer meets study criteria|0|||
94495119|NCT02097277|323606338|FG001|Overall Study|Subject no longer meets study criteria|1|||
94495120|NCT02097277|323606339|FG002|Overall Study|Subject no longer meets study criteria|0|||
94495121|NCT02097277|323606340|FG003|Overall Study|Subject no longer meets study criteria|1|||
94495122|NCT02097277|323606341|FG004|Overall Study|Subject no longer meets study criteria|0|||
94495123|NCT02097277|323606337|FG000|Overall Study|Subject request to discontinue treatment|0|||
94495124|NCT02097277|323606338|FG001|Overall Study|Subject request to discontinue treatment|0|||
94495125|NCT02097277|323606339|FG002|Overall Study|Subject request to discontinue treatment|0|||
94495126|NCT02097277|323606340|FG003|Overall Study|Subject request to discontinue treatment|0|||
94495127|NCT02097277|323606341|FG004|Overall Study|Subject request to discontinue treatment|1|||
94495128|NCT02097277|323606337|FG000|Overall Study|Lost to Follow-up|0|||
94495129|NCT02097277|323606338|FG001|Overall Study|Lost to Follow-up|1|||
94495130|NCT02097277|323606339|FG002|Overall Study|Lost to Follow-up|1|||
94495131|NCT02097277|323606340|FG003|Overall Study|Lost to Follow-up|0|||
94495132|NCT02097277|323606341|FG004|Overall Study|Lost to Follow-up|0|||
94495133|NCT02097277|323606337|FG000|Overall Study|Withdrawal by Subject|2|||
94495134|NCT02097277|323606338|FG001|Overall Study|Withdrawal by Subject|1|||
94495135|NCT02097277|323606339|FG002|Overall Study|Withdrawal by Subject|0|||
94495136|NCT02097277|323606340|FG003|Overall Study|Withdrawal by Subject|1|||
94495137|NCT02097277|323606341|FG004|Overall Study|Withdrawal by Subject|0|||
94495138|NCT02097277|323606337|FG000|Overall Study|Adverse Event|0|||
94495139|NCT02097277|323606338|FG001|Overall Study|Adverse Event|0|||
94495140|NCT02097277|323606339|FG002|Overall Study|Adverse Event|1|||
94495141|NCT02097277|323606340|FG003|Overall Study|Adverse Event|2|||
94495142|NCT02097277|323606341|FG004|Overall Study|Adverse Event|0|||
94495143|NCT01091259|323606346|FG000|Overall Study|Adverse Event|3|||
94495144|NCT01091259|323606346|FG000|Overall Study|Lack of Efficacy|2|||
94495145|NCT02378181|323606351|FG000|Overall Study|Lost to Follow-up|2|||
94495146|NCT02378181|323606352|FG001|Overall Study|Lost to Follow-up|5|||
94495147|NCT02378181|323606351|FG000|Overall Study|Withdrawal by Subject|1|||
94495148|NCT02378181|323606352|FG001|Overall Study|Withdrawal by Subject|1|||
94495149|NCT02378181|323606351|FG000|Overall Study|Incarcerated|0|||
94495150|NCT02378181|323606352|FG001|Overall Study|Incarcerated|1|||
94495151|NCT00805532|323606356|FG000|Overall Study|invalid data|0|||
94495152|NCT00805532|323606357|FG001|Overall Study|invalid data|1|||
94495153|NCT04871113|323606358|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
94495154|NCT04871113|323606359|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
94495155|NCT04871113|323606360|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
94495156|NCT04871113|323606361|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
94495157|NCT04871113|323606362|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
94495158|NCT04871113|323606363|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
94495159|NCT04871113|323606364|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
94495160|NCT04871113|323606365|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
94495161|NCT04871113|323606366|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
94495162|NCT04871113|323606367|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
94495163|NCT04871113|323606358|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
94495164|NCT04871113|323606359|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
94495165|NCT04871113|323606360|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
94495166|NCT04871113|323606361|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
94495167|NCT04871113|323606362|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
94495168|NCT04871113|323606363|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
94495169|NCT04871113|323606364|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
94495170|NCT04871113|323606365|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
94495171|NCT04871113|323606366|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
94495172|NCT04871113|323606367|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
94495173|NCT02299167|323606369|FG000|Overall Study|patients were excluded from the study|11|||
94495174|NCT01281306|323606378|FG000|Overall Study|Lack of Efficacy|0|||
94495175|NCT01281306|323606379|FG001|Overall Study|Lack of Efficacy|1|||
94495176|NCT01281306|323606380|FG002|Overall Study|Lack of Efficacy|3|||
94495177|NCT01281306|323606381|FG003|Overall Study|Lack of Efficacy|0|||
94495178|NCT01281306|323606382|FG004|Overall Study|Lack of Efficacy|2|||
94495179|NCT01281306|323606383|FG005|Overall Study|Lack of Efficacy|0|||
94495180|NCT01281306|323606384|FG006|Overall Study|Lack of Efficacy|1|||
94495181|NCT01281306|323606378|FG000|Overall Study|Withdrawal by Subject|1|||
94495182|NCT01281306|323606379|FG001|Overall Study|Withdrawal by Subject|0|||
94495183|NCT01281306|323606380|FG002|Overall Study|Withdrawal by Subject|2|||
94495184|NCT01281306|323606381|FG003|Overall Study|Withdrawal by Subject|4|||
94495185|NCT01281306|323606382|FG004|Overall Study|Withdrawal by Subject|1|||
94495186|NCT01281306|323606383|FG005|Overall Study|Withdrawal by Subject|3|||
94495187|NCT01281306|323606384|FG006|Overall Study|Withdrawal by Subject|1|||
94495188|NCT01281306|323606378|FG000|Overall Study|Protocol deviation|0|||
94495189|NCT01281306|323606379|FG001|Overall Study|Protocol deviation|1|||
94495190|NCT01281306|323606380|FG002|Overall Study|Protocol deviation|1|||
94495191|NCT01281306|323606381|FG003|Overall Study|Protocol deviation|1|||
94495192|NCT01281306|323606382|FG004|Overall Study|Protocol deviation|1|||
94495193|NCT01281306|323606383|FG005|Overall Study|Protocol deviation|0|||
94495194|NCT01281306|323606384|FG006|Overall Study|Protocol deviation|0|||
94495195|NCT01281306|323606378|FG000|Overall Study|Condition no longer requires study drug|1|||
94495196|NCT01281306|323606379|FG001|Overall Study|Condition no longer requires study drug|0|||
94495197|NCT01281306|323606380|FG002|Overall Study|Condition no longer requires study drug|0|||
94495198|NCT01281306|323606381|FG003|Overall Study|Condition no longer requires study drug|0|||
94495199|NCT01281306|323606382|FG004|Overall Study|Condition no longer requires study drug|0|||
94495200|NCT01281306|323606383|FG005|Overall Study|Condition no longer requires study drug|1|||
94495201|NCT01281306|323606384|FG006|Overall Study|Condition no longer requires study drug|1|||
94495202|NCT01281306|323606378|FG000|Overall Study|Lost to Follow-up|1|||
94495203|NCT01281306|323606379|FG001|Overall Study|Lost to Follow-up|0|||
94495204|NCT01281306|323606380|FG002|Overall Study|Lost to Follow-up|0|||
94495205|NCT01281306|323606381|FG003|Overall Study|Lost to Follow-up|2|||
94495206|NCT01281306|323606382|FG004|Overall Study|Lost to Follow-up|0|||
94495207|NCT01281306|323606383|FG005|Overall Study|Lost to Follow-up|0|||
94495208|NCT01281306|323606384|FG006|Overall Study|Lost to Follow-up|1|||
94495209|NCT01281306|323606378|FG000|Overall Study|Death|1|||
94495210|NCT01281306|323606379|FG001|Overall Study|Death|0|||
94495211|NCT01281306|323606380|FG002|Overall Study|Death|0|||
94495212|NCT01281306|323606381|FG003|Overall Study|Death|0|||
94495213|NCT01281306|323606382|FG004|Overall Study|Death|0|||
94495214|NCT01281306|323606383|FG005|Overall Study|Death|0|||
94495215|NCT01281306|323606384|FG006|Overall Study|Death|0|||
94495216|NCT01281306|323606378|FG000|Overall Study|Adverse Event|3|||
94495217|NCT01281306|323606379|FG001|Overall Study|Adverse Event|2|||
94495218|NCT01281306|323606380|FG002|Overall Study|Adverse Event|2|||
94495219|NCT01281306|323606381|FG003|Overall Study|Adverse Event|3|||
94495220|NCT01281306|323606382|FG004|Overall Study|Adverse Event|5|||
94495221|NCT01281306|323606383|FG005|Overall Study|Adverse Event|3|||
94495222|NCT01281306|323606384|FG006|Overall Study|Adverse Event|3|||
94495223|NCT01281306|323606378|FG000|Overall Study|Randomized in error|1|||
94495224|NCT01281306|323606379|FG001|Overall Study|Randomized in error|0|||
94495225|NCT01281306|323606380|FG002|Overall Study|Randomized in error|0|||
94495226|NCT01281306|323606381|FG003|Overall Study|Randomized in error|1|||
94495227|NCT01281306|323606382|FG004|Overall Study|Randomized in error|0|||
94495228|NCT01281306|323606383|FG005|Overall Study|Randomized in error|0|||
94495229|NCT01281306|323606384|FG006|Overall Study|Randomized in error|0|||
94495230|NCT04115059|323606385|FG000|Overall Study|Withdrawal by Subject|1|||
94495231|NCT04115059|323606385|FG000|Overall Study|Lack of Efficacy|2|||
94495232|NCT02320396|323606389|FG000|Overall Study|Adverse Event|2|||
94495233|NCT02320396|323606390|FG001|Overall Study|Adverse Event|2|||
94495234|NCT02320396|323606389|FG000|Overall Study|Pregnancy|0|||
94495235|NCT02320396|323606390|FG001|Overall Study|Pregnancy|1|||
94495236|NCT02320396|323606389|FG000|Overall Study|Protocol Violation|0|||
94495237|NCT02320396|323606390|FG001|Overall Study|Protocol Violation|1|||
94495238|NCT02320396|323606389|FG000|Overall Study|Withdrawal by Subject|2|||
94495239|NCT02320396|323606390|FG001|Overall Study|Withdrawal by Subject|0|||
94495240|NCT00689936|323606395|FG000|Active Treatment Phase|Adverse Event|68|||
94495241|NCT00689936|323606396|FG001|Active Treatment Phase|Adverse Event|71|||
94495242|NCT00689936|323606397|FG002|Active Treatment Phase|Adverse Event|76|||
94495243|NCT00689936|323606395|FG000|Active Treatment Phase|Disease Progression|273|||
94495244|NCT00689936|323606396|FG001|Active Treatment Phase|Disease Progression|362|||
94495245|NCT00689936|323606397|FG002|Active Treatment Phase|Disease Progression|339|||
94495246|NCT00689936|323606395|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
94495247|NCT00689936|323606396|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
94495248|NCT00689936|323606397|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
94495249|NCT00689936|323606395|FG000|Active Treatment Phase|Death|60|||
94495250|NCT00689936|323606396|FG001|Active Treatment Phase|Death|28|||
94495251|NCT00689936|323606397|FG002|Active Treatment Phase|Death|37|||
94495252|NCT00689936|323606395|FG000|Active Treatment Phase|Lost to Follow-up|0|||
94495253|NCT00689936|323606396|FG001|Active Treatment Phase|Lost to Follow-up|2|||
94495254|NCT00689936|323606397|FG002|Active Treatment Phase|Lost to Follow-up|2|||
94495255|NCT00689936|323606395|FG000|Active Treatment Phase|Protocol Violation|2|||
94495256|NCT00689936|323606396|FG001|Active Treatment Phase|Protocol Violation|2|||
94495257|NCT00689936|323606397|FG002|Active Treatment Phase|Protocol Violation|4|||
94495258|NCT00689936|323606395|FG000|Active Treatment Phase|Study Close Out|64|||
94495259|NCT00689936|323606396|FG001|Active Treatment Phase|Study Close Out|26|||
94495260|NCT00689936|323606397|FG002|Active Treatment Phase|Study Close Out|21|||
94495261|NCT00689936|323606395|FG000|Active Treatment Phase|Miscellaneous|52|||
94495262|NCT00689936|323606396|FG001|Active Treatment Phase|Miscellaneous|34|||
94495263|NCT00689936|323606397|FG002|Active Treatment Phase|Miscellaneous|47|||
94495264|NCT00689936|323606395|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
94495265|NCT00689936|323606396|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
94495266|NCT00689936|323606397|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
94495267|NCT02709369|323606398|FG000|Overall Study|Lost to Follow-up|15|||
94495268|NCT02709369|323606398|FG000|Overall Study|Withdrawal by Subject|10|||
94495269|NCT02709369|323606398|FG000|Overall Study|Did not received intervention|2|||
94495270|NCT01311661|323606399|FG000|Overall Study|Adverse Event|2|||
94495271|NCT01311661|323606399|FG000|Overall Study|Protocol Violation|3|||
94495272|NCT01311661|323606399|FG000|Overall Study|Withdrawal by Subject|2|||
94495273|NCT04327271|323606400|FG000|Overall Study|Death|1|||
94495274|NCT04327271|323606401|FG001|Overall Study|Death|0|||
94495275|NCT04327271|323606400|FG000|Overall Study|Withdrawal by Subject|1|||
94495276|NCT04327271|323606401|FG001|Overall Study|Withdrawal by Subject|0|||
94495277|NCT04327271|323606400|FG000|Overall Study|randomization error (data capture)|4|||
94495278|NCT04327271|323606401|FG001|Overall Study|randomization error (data capture)|3|||
94495279|NCT03637374|323606402|FG000|Overall Study|Death|2|||
94495280|NCT03637374|323606403|FG001|Overall Study|Death|0|||
94495281|NCT01697579|323606406|FG000|Base Study-Cycle 1|Adverse Event|1|||
94495282|NCT01697579|323606407|FG001|Base Study-Cycle 1|Adverse Event|0|||
94495283|NCT01697579|323606408|FG002|Base Study-Cycle 1|Adverse Event|0|||
94495284|NCT01697579|323606409|FG003|Base Study-Cycle 1|Adverse Event|0|||
94495285|NCT01697579|323606410|FG004|Base Study-Cycle 1|Adverse Event|0|||
94495286|NCT01697579|323606411|FG005|Base Study-Cycle 1|Adverse Event|0|||
94495287|NCT01697579|323606412|FG006|Base Study-Cycle 1|Adverse Event|0|||
94495288|NCT01697579|323606406|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
94495289|NCT01697579|323606407|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
94495290|NCT01697579|323606408|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
94495291|NCT01697579|323606409|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
94495292|NCT01697579|323606410|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
94495293|NCT01697579|323606411|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
94495294|NCT01697579|323606412|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
94495295|NCT01697579|323606406|FG000|Base Study-Cycle 1|Protocol Violation|0|||
94495296|NCT01697579|323606407|FG001|Base Study-Cycle 1|Protocol Violation|0|||
94495297|NCT01697579|323606408|FG002|Base Study-Cycle 1|Protocol Violation|0|||
94495298|NCT01697579|323606409|FG003|Base Study-Cycle 1|Protocol Violation|0|||
94495299|NCT01697579|323606410|FG004|Base Study-Cycle 1|Protocol Violation|3|||
94495300|NCT01697579|323606411|FG005|Base Study-Cycle 1|Protocol Violation|0|||
94495301|NCT01697579|323606412|FG006|Base Study-Cycle 1|Protocol Violation|0|||
94495302|NCT01697579|323606406|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
94495303|NCT01697579|323606407|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
94495304|NCT01697579|323606408|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
94495305|NCT01697579|323606409|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
94495306|NCT01697579|323606410|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
94495307|NCT01697579|323606411|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
94655605|NCT00080223|324196093|FG000|Overall Study|Adverse Event|23|||
94495308|NCT01697579|323606412|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
94495309|NCT01697579|323606406|FG000|Base Study-Cycle 1|Technical Problems|0|||
94495310|NCT01697579|323606407|FG001|Base Study-Cycle 1|Technical Problems|0|||
94495311|NCT01697579|323606408|FG002|Base Study-Cycle 1|Technical Problems|1|||
94495312|NCT01697579|323606409|FG003|Base Study-Cycle 1|Technical Problems|1|||
94495313|NCT01697579|323606410|FG004|Base Study-Cycle 1|Technical Problems|0|||
94495314|NCT01697579|323606411|FG005|Base Study-Cycle 1|Technical Problems|0|||
94495315|NCT01697579|323606412|FG006|Base Study-Cycle 1|Technical Problems|0|||
94495316|NCT01697579|323606406|FG000|Optional Extension-Cycles 2-6|Death|0|||
94495317|NCT01697579|323606407|FG001|Optional Extension-Cycles 2-6|Death|0|||
94495318|NCT01697579|323606408|FG002|Optional Extension-Cycles 2-6|Death|0|||
94495319|NCT01697579|323606409|FG003|Optional Extension-Cycles 2-6|Death|0|||
94495320|NCT01697579|323606410|FG004|Optional Extension-Cycles 2-6|Death|0|||
94495321|NCT01697579|323606411|FG005|Optional Extension-Cycles 2-6|Death|0|||
94495322|NCT01697579|323606412|FG006|Optional Extension-Cycles 2-6|Death|2|||
94495323|NCT01697579|323606406|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
94495324|NCT01697579|323606407|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
94495325|NCT01697579|323606408|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
94495326|NCT01697579|323606409|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
94495327|NCT01697579|323606410|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
94495328|NCT01697579|323606411|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
94495329|NCT01697579|323606412|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
94495330|NCT01697579|323606406|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
94495331|NCT01697579|323606407|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
94495332|NCT01697579|323606408|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
94495333|NCT01697579|323606409|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
94495334|NCT01697579|323606410|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
94495335|NCT01697579|323606411|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
94495336|NCT01697579|323606412|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
94495337|NCT01697579|323606406|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
94495338|NCT01697579|323606407|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
94495339|NCT01697579|323606408|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
94495340|NCT01697579|323606409|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
94495341|NCT01697579|323606410|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
94495342|NCT01697579|323606411|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
94495343|NCT01697579|323606412|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
94495344|NCT01697579|323606406|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
94495345|NCT01697579|323606407|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
94495346|NCT01697579|323606408|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
94495347|NCT01697579|323606409|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
94495348|NCT01697579|323606410|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
94495349|NCT01697579|323606411|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
94495350|NCT01697579|323606412|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
94495351|NCT01697579|323606406|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
94495352|NCT01697579|323606407|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
94495353|NCT01697579|323606408|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
94495354|NCT01697579|323606409|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
94495355|NCT01697579|323606410|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
94495356|NCT01697579|323606411|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
94495357|NCT01697579|323606412|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
94495358|NCT01697579|323606406|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
94495359|NCT01697579|323606407|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
94495360|NCT01697579|323606408|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
94495361|NCT01697579|323606409|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
94495362|NCT01697579|323606410|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
94495363|NCT01697579|323606411|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
94495364|NCT01697579|323606412|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
94495365|NCT01697579|323606406|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
94495366|NCT01697579|323606407|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
94495367|NCT01697579|323606408|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
94495368|NCT01697579|323606409|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
94495369|NCT01697579|323606410|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
94495370|NCT01697579|323606411|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
94495371|NCT01697579|323606412|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
94495372|NCT01697579|323606406|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
94495373|NCT01697579|323606407|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
94495374|NCT01697579|323606408|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
94495375|NCT01697579|323606409|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
94495376|NCT01697579|323606410|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
94495377|NCT01697579|323606411|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
94495378|NCT01697579|323606412|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
94495379|NCT01697579|323606406|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
94495380|NCT01697579|323606407|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
94495381|NCT01697579|323606408|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
94495382|NCT01697579|323606409|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
94495383|NCT01697579|323606410|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
94495384|NCT01697579|323606411|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
94495385|NCT01697579|323606412|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
94495386|NCT01697579|323606406|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
94495387|NCT01697579|323606407|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
94495388|NCT01697579|323606408|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
94495389|NCT01697579|323606409|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
94495390|NCT01697579|323606410|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
94495391|NCT01697579|323606411|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
94495392|NCT01697579|323606412|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
94495393|NCT01697579|323606406|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
94495394|NCT01697579|323606407|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
94495395|NCT01697579|323606408|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
94495396|NCT01697579|323606409|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
94495397|NCT01697579|323606410|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
94495398|NCT01697579|323606411|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
94495399|NCT01697579|323606412|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
94495400|NCT01697579|323606406|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
94495401|NCT01697579|323606407|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
94495402|NCT01697579|323606408|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
94495403|NCT01697579|323606409|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
94495404|NCT01697579|323606410|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
94495405|NCT01697579|323606411|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
94495406|NCT01697579|323606412|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
94495407|NCT02989389|323606413|FG000|Period 1|Lost to Follow-up|0|||
94495408|NCT02989389|323606414|FG001|Period 1|Lost to Follow-up|1|||
94495409|NCT02989389|323606415|FG002|Period 1|Lost to Follow-up|0|||
94495410|NCT02989389|323606416|FG003|Period 1|Lost to Follow-up|0|||
94495411|NCT02989389|323606417|FG004|Period 1|Lost to Follow-up|0|||
94495412|NCT02989389|323606418|FG005|Period 1|Lost to Follow-up|0|||
94495413|NCT02989389|323606419|FG006|Period 1|Lost to Follow-up|0|||
94495414|NCT02989389|323606420|FG007|Period 1|Lost to Follow-up|0|||
94495415|NCT02989389|323606421|FG008|Period 1|Lost to Follow-up|0|||
94495416|NCT02989389|323606422|FG009|Period 1|Lost to Follow-up|0|||
94495417|NCT02989389|323606413|FG000|Period 1|Physician Decision|0|||
94495418|NCT02989389|323606414|FG001|Period 1|Physician Decision|0|||
94495419|NCT02989389|323606415|FG002|Period 1|Physician Decision|0|||
94495420|NCT02989389|323606416|FG003|Period 1|Physician Decision|0|||
94495421|NCT02989389|323606417|FG004|Period 1|Physician Decision|0|||
94495422|NCT02989389|323606418|FG005|Period 1|Physician Decision|0|||
94495423|NCT02989389|323606419|FG006|Period 1|Physician Decision|0|||
94495424|NCT02989389|323606420|FG007|Period 1|Physician Decision|0|||
94495425|NCT02989389|323606421|FG008|Period 1|Physician Decision|1|||
94495426|NCT02989389|323606422|FG009|Period 1|Physician Decision|0|||
94495427|NCT00374868|323606423|FG000|Overall Study|Adverse Event|12|||
94495428|NCT00374868|323606423|FG000|Overall Study|Progressive Disease|7|||
94495429|NCT00374868|323606423|FG000|Overall Study|Physician Decision|13|||
94495430|NCT00374868|323606423|FG000|Overall Study|Lost to Follow-up|1|||
94495431|NCT00374868|323606423|FG000|Overall Study|Death|2|||
94495432|NCT00374868|323606423|FG000|Overall Study|Other - Not Specified|1|||
94495433|NCT02802228|323606425|FG000|Overall Study|Withdrawal by Subject|2|||
94495434|NCT02802228|323606426|FG001|Overall Study|Withdrawal by Subject|0|||
94495435|NCT02802228|323606425|FG000|Overall Study|Lost to Follow-up|1|||
94495436|NCT02802228|323606426|FG001|Overall Study|Lost to Follow-up|0|||
94495437|NCT02802228|323606425|FG000|Overall Study|Adverse Event|1|||
94495438|NCT02802228|323606426|FG001|Overall Study|Adverse Event|0|||
94495439|NCT02802228|323606425|FG000|Overall Study|Physician Decision|1|||
94495440|NCT02802228|323606426|FG001|Overall Study|Physician Decision|0|||
94495441|NCT01018979|323606427|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
94495442|NCT01018979|323606428|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
94495443|NCT01018979|323606427|FG000|Overall Study|Not received at least one dose|0|||
94495444|NCT01018979|323606428|FG001|Overall Study|Not received at least one dose|1|||
94495445|NCT03301714|323606429|FG000|Overall Study|Lost to Follow-up|10|||
94495446|NCT03301714|323606430|FG001|Overall Study|Lost to Follow-up|4|||
94495447|NCT03301714|323606431|FG002|Overall Study|Lost to Follow-up|4|||
94495448|NCT03301714|323606429|FG000|Overall Study|Did not receive allocated intervention|0|||
94495449|NCT03301714|323606430|FG001|Overall Study|Did not receive allocated intervention|2|||
94495450|NCT03301714|323606431|FG002|Overall Study|Did not receive allocated intervention|3|||
94495451|NCT01901562|323606432|FG000|Overall Study|Protocol Violation|5|||
94495452|NCT01901562|323606432|FG000|Overall Study|Excluded intraoperatively|4|||
94495453|NCT03188185|323606433|FG000|Stage 1|Adverse Event|4|||
94495454|NCT03188185|323606434|FG001|Stage 1|Adverse Event|12|||
94495455|NCT03188185|323606435|FG002|Stage 1|Adverse Event|0|||
94495456|NCT03188185|323606436|FG003|Stage 1|Adverse Event|0|||
94495457|NCT03188185|323606433|FG000|Stage 1|Lack of Efficacy|0|||
94495458|NCT03188185|323606434|FG001|Stage 1|Lack of Efficacy|2|||
94495459|NCT03188185|323606435|FG002|Stage 1|Lack of Efficacy|0|||
94495460|NCT03188185|323606436|FG003|Stage 1|Lack of Efficacy|0|||
94495461|NCT03188185|323606433|FG000|Stage 1|Lost to Follow-up|6|||
94495462|NCT03188185|323606434|FG001|Stage 1|Lost to Follow-up|1|||
94495463|NCT03188185|323606435|FG002|Stage 1|Lost to Follow-up|0|||
94495464|NCT03188185|323606436|FG003|Stage 1|Lost to Follow-up|0|||
94495465|NCT03188185|323606433|FG000|Stage 1|Withdrawal by Subject|9|||
94495466|NCT03188185|323606434|FG001|Stage 1|Withdrawal by Subject|0|||
94495467|NCT03188185|323606435|FG002|Stage 1|Withdrawal by Subject|0|||
94495468|NCT03188185|323606436|FG003|Stage 1|Withdrawal by Subject|0|||
94495469|NCT03188185|323606433|FG000|Stage 1|Identified as a professional patient|0|||
94495470|NCT03188185|323606434|FG001|Stage 1|Identified as a professional patient|1|||
94495471|NCT03188185|323606435|FG002|Stage 1|Identified as a professional patient|0|||
94495472|NCT03188185|323606436|FG003|Stage 1|Identified as a professional patient|0|||
94495473|NCT03188185|323606433|FG000|Stage 2|Adverse Event|0|||
94495474|NCT03188185|323606434|FG001|Stage 2|Adverse Event|0|||
94495475|NCT03188185|323606435|FG002|Stage 2|Adverse Event|2|||
94495476|NCT03188185|323606436|FG003|Stage 2|Adverse Event|4|||
94495477|NCT03188185|323606433|FG000|Stage 2|Lack of Efficacy|0|||
94495478|NCT03188185|323606434|FG001|Stage 2|Lack of Efficacy|0|||
94495479|NCT03188185|323606435|FG002|Stage 2|Lack of Efficacy|3|||
94495480|NCT03188185|323606436|FG003|Stage 2|Lack of Efficacy|0|||
94495481|NCT03188185|323606433|FG000|Stage 2|Lost to Follow-up|0|||
94495482|NCT03188185|323606434|FG001|Stage 2|Lost to Follow-up|0|||
94495483|NCT03188185|323606435|FG002|Stage 2|Lost to Follow-up|1|||
94495484|NCT03188185|323606436|FG003|Stage 2|Lost to Follow-up|0|||
94495485|NCT03188185|323606433|FG000|Stage 2|Physician Decision|0|||
94495486|NCT03188185|323606434|FG001|Stage 2|Physician Decision|0|||
94495487|NCT03188185|323606435|FG002|Stage 2|Physician Decision|0|||
94495488|NCT03188185|323606436|FG003|Stage 2|Physician Decision|1|||
94495489|NCT03188185|323606433|FG000|Stage 2|Withdrawal by Subject|0|||
94495490|NCT03188185|323606434|FG001|Stage 2|Withdrawal by Subject|0|||
94495491|NCT03188185|323606435|FG002|Stage 2|Withdrawal by Subject|3|||
94495492|NCT03188185|323606436|FG003|Stage 2|Withdrawal by Subject|1|||
94495493|NCT00790036|323606437|FG000|Overall Study|Abnormal lab values|3|||
94495494|NCT00790036|323606438|FG001|Overall Study|Abnormal lab values|2|||
94495495|NCT00790036|323606437|FG000|Overall Study|Administrative problems|5|||
94495496|NCT00790036|323606438|FG001|Overall Study|Administrative problems|9|||
94495497|NCT00790036|323606437|FG000|Overall Study|Adverse Event|113|||
94495498|NCT00790036|323606438|FG001|Overall Study|Adverse Event|44|||
94495499|NCT00790036|323606437|FG000|Overall Study|Death|1|||
94495500|NCT00790036|323606438|FG001|Overall Study|Death|0|||
94495501|NCT00790036|323606437|FG000|Overall Study|Disease progression|24|||
94495502|NCT00790036|323606438|FG001|Overall Study|Disease progression|48|||
94495503|NCT00790036|323606437|FG000|Overall Study|Lost to Follow-up|1|||
94495504|NCT00790036|323606438|FG001|Overall Study|Lost to Follow-up|2|||
94495505|NCT00790036|323606437|FG000|Overall Study|Protocol Violation|10|||
94495506|NCT00790036|323606438|FG001|Overall Study|Protocol Violation|2|||
94495507|NCT00790036|323606437|FG000|Overall Study|Withdrawal by Subject|18|||
94495508|NCT00790036|323606438|FG001|Overall Study|Withdrawal by Subject|7|||
94495509|NCT00790036|323606437|FG000|Overall Study|Subject/guardian decision|20|||
94495510|NCT00790036|323606438|FG001|Overall Study|Subject/guardian decision|7|||
94495511|NCT02612155|323606439|FG000|Overall Study|Death|1|||
94495512|NCT02612155|323606440|FG001|Overall Study|Death|1|||
94495513|NCT02612155|323606439|FG000|Overall Study|Lost to Follow-up|2|||
94495514|NCT02612155|323606440|FG001|Overall Study|Lost to Follow-up|2|||
94495515|NCT01179516|323606441|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
94495516|NCT01179516|323606442|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
94495517|NCT01179516|323606443|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
94495518|NCT01179516|323606441|FG000|Overall Study|Lack of Efficacy|4|||
94495519|NCT01179516|323606442|FG001|Overall Study|Lack of Efficacy|2|||
94495520|NCT01179516|323606443|FG002|Overall Study|Lack of Efficacy|0|||
94495521|NCT01179516|323606441|FG000|Overall Study|Noncompliance with Study Drug|2|||
94495522|NCT01179516|323606442|FG001|Overall Study|Noncompliance with Study Drug|0|||
94495523|NCT01179516|323606443|FG002|Overall Study|Noncompliance with Study Drug|1|||
94495524|NCT01179516|323606441|FG000|Overall Study|Protocol Deviations|4|||
94495525|NCT01179516|323606442|FG001|Overall Study|Protocol Deviations|3|||
94495526|NCT01179516|323606443|FG002|Overall Study|Protocol Deviations|3|||
94655606|NCT00080223|324196093|FG000|Overall Study|Death|21|||
94495527|NCT01179516|323606441|FG000|Overall Study|Withdrawal of Consent|2|||
94495528|NCT01179516|323606442|FG001|Overall Study|Withdrawal of Consent|6|||
94495529|NCT01179516|323606443|FG002|Overall Study|Withdrawal of Consent|10|||
94495530|NCT01179516|323606441|FG000|Overall Study|Lost to Follow-up|7|||
94495531|NCT01179516|323606442|FG001|Overall Study|Lost to Follow-up|7|||
94495532|NCT01179516|323606443|FG002|Overall Study|Lost to Follow-up|3|||
94495533|NCT01179516|323606441|FG000|Overall Study|Other|2|||
94495534|NCT01179516|323606442|FG001|Overall Study|Other|0|||
94495535|NCT01179516|323606443|FG002|Overall Study|Other|2|||
94495536|NCT02875080|323606449|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
94495537|NCT02875080|323606450|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
94495538|NCT02875080|323606451|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
94495539|NCT02406612|323606453|FG000|Overall Study|Screening Failure|3|||
94495540|NCT02406612|323606454|FG001|Overall Study|Screening Failure|0|||
94495541|NCT02406612|323606453|FG000|Overall Study|Intra-procedural Exclusion|1|||
94495542|NCT02406612|323606454|FG001|Overall Study|Intra-procedural Exclusion|3|||
94495543|NCT02406612|323606453|FG000|Overall Study|Guidewire Failure|0|||
94495544|NCT02406612|323606454|FG001|Overall Study|Guidewire Failure|1|||
94495545|NCT00003456|323607864|FG000|Overall Study|Not evaluable|8|||
94495546|NCT00479232|323607865|FG000|Overall Study|Adverse Event|0|||
94495547|NCT00479232|323607866|FG001|Overall Study|Adverse Event|0|||
94495548|NCT00479232|323607867|FG002|Overall Study|Adverse Event|5|||
94495549|NCT00479232|323607868|FG003|Overall Study|Adverse Event|0|||
94495550|NCT00479232|323607869|FG004|Overall Study|Adverse Event|0|||
94495551|NCT00479232|323607870|FG005|Overall Study|Adverse Event|10|||
94495552|NCT00479232|323607865|FG000|Overall Study|Deviation from Protocol|0|||
94495553|NCT00479232|323607866|FG001|Overall Study|Deviation from Protocol|0|||
94495554|NCT00479232|323607867|FG002|Overall Study|Deviation from Protocol|1|||
94495555|NCT00479232|323607868|FG003|Overall Study|Deviation from Protocol|0|||
94495556|NCT00479232|323607869|FG004|Overall Study|Deviation from Protocol|0|||
94495557|NCT00479232|323607870|FG005|Overall Study|Deviation from Protocol|0|||
94495558|NCT00479232|323607865|FG000|Overall Study|Lack of Efficacy|0|||
94495559|NCT00479232|323607866|FG001|Overall Study|Lack of Efficacy|0|||
94495560|NCT00479232|323607867|FG002|Overall Study|Lack of Efficacy|2|||
94495561|NCT00479232|323607868|FG003|Overall Study|Lack of Efficacy|0|||
94495562|NCT00479232|323607869|FG004|Overall Study|Lack of Efficacy|0|||
94495563|NCT00479232|323607870|FG005|Overall Study|Lack of Efficacy|4|||
94495564|NCT00479232|323607865|FG000|Overall Study|Physician Decision|0|||
94495565|NCT00479232|323607866|FG001|Overall Study|Physician Decision|0|||
94495566|NCT00479232|323607867|FG002|Overall Study|Physician Decision|2|||
94495567|NCT00479232|323607868|FG003|Overall Study|Physician Decision|0|||
94495568|NCT00479232|323607869|FG004|Overall Study|Physician Decision|0|||
94495569|NCT00479232|323607870|FG005|Overall Study|Physician Decision|1|||
94495570|NCT00479232|323607865|FG000|Overall Study|Progressive Disease|3|||
94495571|NCT00479232|323607866|FG001|Overall Study|Progressive Disease|1|||
94495572|NCT00479232|323607867|FG002|Overall Study|Progressive Disease|12|||
94495573|NCT00479232|323607868|FG003|Overall Study|Progressive Disease|3|||
94495574|NCT00479232|323607869|FG004|Overall Study|Progressive Disease|3|||
94495575|NCT00479232|323607870|FG005|Overall Study|Progressive Disease|12|||
94495576|NCT00479232|323607865|FG000|Overall Study|Withdrew Consent|0|||
94495577|NCT00479232|323607866|FG001|Overall Study|Withdrew Consent|2|||
94495578|NCT00479232|323607867|FG002|Overall Study|Withdrew Consent|6|||
94495579|NCT00479232|323607868|FG003|Overall Study|Withdrew Consent|0|||
94495580|NCT00479232|323607869|FG004|Overall Study|Withdrew Consent|1|||
94495581|NCT00479232|323607870|FG005|Overall Study|Withdrew Consent|3|||
94495582|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
94495583|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
94495584|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
94495585|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
94495586|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
94495587|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
94495588|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
94495589|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
94495590|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
94495591|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
94495592|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
94495593|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
94495594|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
94495595|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
94495596|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
94495597|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
94495598|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
94495599|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
94495600|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
94495601|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
94495602|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
94495603|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
94495604|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
94495605|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
94495606|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
94495607|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
94495608|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
94495609|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
94495610|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
94495611|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
94495612|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
94495613|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
94495614|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
94495615|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
94495616|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
94495617|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
94495618|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
94495619|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
94495620|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
94495621|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
94495622|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
94495623|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
94495624|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
94495625|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
94495626|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
94495627|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
94495628|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
94495629|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
94495630|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
94495631|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
94495632|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
94495633|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
94495634|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
94495635|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
94495636|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
94495637|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
94495638|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
94495639|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
94495640|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
94495641|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
94495642|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
94495643|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
94495644|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
94495645|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
94495646|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
94495647|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
94495648|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
94495649|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
94495650|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
94495651|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
94495652|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
94495653|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
94495654|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
94495655|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
94495656|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
94495657|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
94495658|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
94495659|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
94495660|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
94495661|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
94495662|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
94495663|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
94495664|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
94495665|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
94495666|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
94495667|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
94495668|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
94495669|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
94495670|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
94495671|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
94495672|NCT00090103|323607871|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
94495673|NCT00090103|323607872|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
94495674|NCT00090103|323607873|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
94495675|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
94495676|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
94495677|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
94495678|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
94495679|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
94495680|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
94495681|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
94495682|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
94495683|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
94495684|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
94495685|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
94495686|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
94495687|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
94495688|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
94495689|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
94495690|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
94495691|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
94495692|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
94495693|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
94495694|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
94495695|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
94495696|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
94495697|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
94495698|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
94495699|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
94495700|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
94495701|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
94495702|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
94495703|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
94495704|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
94495705|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
94495706|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
94495707|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
94495708|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
94495709|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
94495710|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
94495711|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
94495712|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
94495713|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
94495714|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
94495715|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
94495716|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
94495717|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
94495718|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
94495719|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
94495720|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
94495721|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
94495722|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
94495723|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Death|1|||
94495724|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Death|0|||
94495725|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Death|1|||
94495726|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
94495727|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
94495728|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
94495729|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
94495730|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
94495731|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
94495732|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
94495733|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
94495734|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
94495735|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
94495736|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
94495737|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
94495738|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
94495739|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
94495740|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
94495741|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
94495742|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
94495743|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
94495744|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
94495745|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
94495746|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
94495747|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Depression|0|||
94495748|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Depression|1|||
94495749|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Depression|0|||
94495750|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
94495751|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
94495752|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
94495753|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Jailed|0|||
94495754|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Jailed|1|||
94495755|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Jailed|0|||
94495756|NCT00090103|323607871|FG000|16-Week Safety Follow-up Period|Other|0|||
94495757|NCT00090103|323607872|FG001|16-Week Safety Follow-up Period|Other|1|||
94495758|NCT00090103|323607873|FG002|16-Week Safety Follow-up Period|Other|0|||
94495759|NCT01991314|323607876|FG000|Overall Study|Adverse Event|5|||
94495760|NCT01991314|323607877|FG001|Overall Study|Adverse Event|1|||
94495761|NCT01991314|323607876|FG000|Overall Study|Lost to Follow-up|6|||
94495762|NCT01991314|323607877|FG001|Overall Study|Lost to Follow-up|10|||
94495763|NCT01431976|323607878|FG000|Overall Study|Adverse Event|6|||
94495764|NCT01431976|323607878|FG000|Overall Study|Lack of Efficacy|2|||
94495765|NCT01431976|323607878|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
94495766|NCT01431976|323607878|FG000|Overall Study|Physician Decision|1|||
94495767|NCT01431976|323607878|FG000|Overall Study|Withdrawal by Subject|1|||
94495768|NCT00614393|323607879|FG000|Overall Study|Adverse Event|20|||
94495769|NCT00614393|323607880|FG001|Overall Study|Adverse Event|2|||
94495770|NCT00614393|323607881|FG002|Overall Study|Adverse Event|3|||
94495771|NCT00614393|323607882|FG003|Overall Study|Adverse Event|13|||
94495772|NCT00614393|323607883|FG004|Overall Study|Adverse Event|21|||
94495773|NCT00614393|323607879|FG000|Overall Study|Lost to Follow-up|0|||
94495774|NCT00614393|323607880|FG001|Overall Study|Lost to Follow-up|0|||
94495775|NCT00614393|323607881|FG002|Overall Study|Lost to Follow-up|0|||
94495776|NCT00614393|323607882|FG003|Overall Study|Lost to Follow-up|1|||
94495777|NCT00614393|323607883|FG004|Overall Study|Lost to Follow-up|2|||
94495778|NCT00614393|323607879|FG000|Overall Study|Physician Decision|17|||
94495779|NCT00614393|323607880|FG001|Overall Study|Physician Decision|0|||
94495780|NCT00614393|323607881|FG002|Overall Study|Physician Decision|1|||
94495781|NCT00614393|323607882|FG003|Overall Study|Physician Decision|8|||
94495782|NCT00614393|323607883|FG004|Overall Study|Physician Decision|9|||
94495783|NCT00614393|323607879|FG000|Overall Study|Progressive Disease|118|||
94495784|NCT00614393|323607880|FG001|Overall Study|Progressive Disease|5|||
94495785|NCT00614393|323607881|FG002|Overall Study|Progressive Disease|5|||
94495786|NCT00614393|323607882|FG003|Overall Study|Progressive Disease|138|||
94495787|NCT00614393|323607883|FG004|Overall Study|Progressive Disease|130|||
94495788|NCT00614393|323607879|FG000|Overall Study|Protocol Violation|1|||
94495789|NCT00614393|323607880|FG001|Overall Study|Protocol Violation|0|||
94495790|NCT00614393|323607881|FG002|Overall Study|Protocol Violation|0|||
94495791|NCT00614393|323607882|FG003|Overall Study|Protocol Violation|0|||
94495792|NCT00614393|323607883|FG004|Overall Study|Protocol Violation|0|||
94495793|NCT00614393|323607879|FG000|Overall Study|Terminated by Sponsor|0|||
94495794|NCT00614393|323607880|FG001|Overall Study|Terminated by Sponsor|0|||
94495795|NCT00614393|323607881|FG002|Overall Study|Terminated by Sponsor|0|||
94495796|NCT00614393|323607882|FG003|Overall Study|Terminated by Sponsor|0|||
94495797|NCT00614393|323607883|FG004|Overall Study|Terminated by Sponsor|1|||
94495798|NCT00614393|323607879|FG000|Overall Study|Withdrawal by Subject|20|||
94495799|NCT00614393|323607880|FG001|Overall Study|Withdrawal by Subject|1|||
94495800|NCT00614393|323607881|FG002|Overall Study|Withdrawal by Subject|1|||
94495801|NCT00614393|323607882|FG003|Overall Study|Withdrawal by Subject|16|||
94495802|NCT00614393|323607883|FG004|Overall Study|Withdrawal by Subject|13|||
94495803|NCT00614393|323607879|FG000|Overall Study|Other|4|||
94495804|NCT00614393|323607880|FG001|Overall Study|Other|0|||
94495805|NCT00614393|323607881|FG002|Overall Study|Other|0|||
94495806|NCT00614393|323607882|FG003|Overall Study|Other|4|||
94495807|NCT00614393|323607883|FG004|Overall Study|Other|2|||
94495808|NCT00614393|323607879|FG000|Overall Study|Not Treated|0|||
94495809|NCT00614393|323607880|FG001|Overall Study|Not Treated|0|||
94495810|NCT00614393|323607881|FG002|Overall Study|Not Treated|0|||
94495811|NCT00614393|323607882|FG003|Overall Study|Not Treated|0|||
94495812|NCT00614393|323607883|FG004|Overall Study|Not Treated|2|||
94495813|NCT02328105|323607884|FG000|Overall Study|Death|6|||
94495814|NCT02328105|323607884|FG000|Overall Study|Withdrawal by Subject|1|||
94495815|NCT02328105|323607884|FG000|Overall Study|Still On Study in Follow-Up|4|||
94495816|NCT05350423|323607887|FG000|Overall Study|Lost to Follow-up|3|||
94495817|NCT05350423|323607888|FG001|Overall Study|Lost to Follow-up|3|||
94495818|NCT05350423|323607887|FG000|Overall Study|screen failure|5|||
94495819|NCT05350423|323607888|FG001|Overall Study|screen failure|6|||
94495820|NCT01432327|323607889|FG000|Posttest 3 Months|depression|3|||
94495821|NCT01432327|323607890|FG001|Posttest 3 Months|depression|0|||
94495822|NCT01432327|323607891|FG002|Posttest 3 Months|depression|0|||
94495823|NCT01432327|323607892|FG003|Posttest 3 Months|depression|0|||
94495824|NCT01432327|323607889|FG000|Posttest 3 Months|Lost to Follow-up|1|||
94495825|NCT01432327|323607890|FG001|Posttest 3 Months|Lost to Follow-up|0|||
94495826|NCT01432327|323607891|FG002|Posttest 3 Months|Lost to Follow-up|2|||
94495827|NCT01432327|323607892|FG003|Posttest 3 Months|Lost to Follow-up|1|||
94495828|NCT01432327|323607889|FG000|Posttest 3 Months|Allergic reaction|0|||
94495829|NCT01432327|323607890|FG001|Posttest 3 Months|Allergic reaction|2|||
94495830|NCT01432327|323607891|FG002|Posttest 3 Months|Allergic reaction|0|||
94495831|NCT01432327|323607892|FG003|Posttest 3 Months|Allergic reaction|0|||
94495832|NCT01432327|323607889|FG000|Posttest 6 Months|Lost to Follow-up|0|||
94495833|NCT01432327|323607890|FG001|Posttest 6 Months|Lost to Follow-up|0|||
94495834|NCT01432327|323607891|FG002|Posttest 6 Months|Lost to Follow-up|3|||
94495835|NCT01432327|323607892|FG003|Posttest 6 Months|Lost to Follow-up|2|||
94495836|NCT01432327|323607889|FG000|Posttest 6 Months|Allergic reaction|0|||
94495837|NCT01432327|323607890|FG001|Posttest 6 Months|Allergic reaction|0|||
94495838|NCT01432327|323607891|FG002|Posttest 6 Months|Allergic reaction|1|||
94495839|NCT01432327|323607892|FG003|Posttest 6 Months|Allergic reaction|0|||
94495840|NCT01432327|323607889|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
94495841|NCT01432327|323607890|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
94495842|NCT01432327|323607891|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
94495843|NCT01432327|323607892|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
94495844|NCT01432327|323607889|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
94495845|NCT01432327|323607890|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
94495846|NCT01432327|323607891|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
94495847|NCT01432327|323607892|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
94495848|NCT01432327|323607889|FG000|Posttest 1 Year|Lost to Follow-up|0|||
94495849|NCT01432327|323607890|FG001|Posttest 1 Year|Lost to Follow-up|0|||
94495850|NCT01432327|323607891|FG002|Posttest 1 Year|Lost to Follow-up|4|||
94495851|NCT01432327|323607892|FG003|Posttest 1 Year|Lost to Follow-up|2|||
94495852|NCT01432327|323607889|FG000|Posttest 1 Year|Allergic reaction|0|||
94495853|NCT01432327|323607890|FG001|Posttest 1 Year|Allergic reaction|0|||
94495854|NCT01432327|323607891|FG002|Posttest 1 Year|Allergic reaction|1|||
94495855|NCT01432327|323607892|FG003|Posttest 1 Year|Allergic reaction|1|||
94495856|NCT02536794|323607893|FG000|Reached 1st Response Assessment|Adverse Event|2|||
94495857|NCT02536794|323607893|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
94495858|NCT02536794|323607893|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
94495859|NCT02536794|323607893|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
94495860|NCT02536794|323607893|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
94495861|NCT02536794|323607893|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
94495862|NCT04919161|323607894|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
94495863|NCT04919161|323607895|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
94495864|NCT04919161|323607894|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
94495865|NCT04919161|323607895|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
94495866|NCT04919161|323607894|FG000|Overall Study|Acute ankle sprain after session 1|0|||
94495867|NCT04919161|323607895|FG001|Overall Study|Acute ankle sprain after session 1|1|||
94495868|NCT02115386|323607898|FG000|Overall Study|Protocol Violation|1|||
94495869|NCT02115386|323607898|FG000|Overall Study|Administrative - trial was terminated|6|||
94495870|NCT03483103|323607899|FG000|Pre-Treatment Phase|Other reasons|1|||
94495871|NCT03483103|323607899|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
94495872|NCT03483103|323607899|FG000|Pre-Treatment Phase|Disease-related complications|1|||
94495873|NCT03483103|323607899|FG000|Pre-Treatment Phase|Death|5|||
94495874|NCT03483103|323607899|FG000|Treatment Phase|Withdrawal by Subject|7|||
94495875|NCT03483103|323607899|FG000|Treatment Phase|Other reasons|1|||
94495876|NCT03483103|323607899|FG000|Treatment Phase|Death|23|||
94495877|NCT03483103|323607899|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
94495878|NCT03483103|323607899|FG000|Treatment Phase|Received nonconforming product|1|||
94495879|NCT04810962|323607900|FG000|Overall Study|Adverse Event|0|||
94495880|NCT04810962|323607901|FG001|Overall Study|Adverse Event|1|||
94495881|NCT04810962|323607900|FG000|Overall Study|Lost to Follow-up|2|||
94495882|NCT04810962|323607901|FG001|Overall Study|Lost to Follow-up|1|||
94495883|NCT04810962|323607900|FG000|Overall Study|Physician Decision|1|||
94495884|NCT04810962|323607901|FG001|Overall Study|Physician Decision|0|||
94495885|NCT04810962|323607900|FG000|Overall Study|Withdrawal by Subject|1|||
94495886|NCT04810962|323607901|FG001|Overall Study|Withdrawal by Subject|3|||
94495887|NCT04810962|323607900|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
94495888|NCT04810962|323607901|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
94495889|NCT00435942|323607902|FG000|Overall Study|Death|17|||
94495890|NCT00435942|323607903|FG001|Overall Study|Death|10|||
94495891|NCT00435942|323607902|FG000|Overall Study|Withdrawal by Subject|2|||
94495892|NCT00435942|323607903|FG001|Overall Study|Withdrawal by Subject|0|||
94495893|NCT00435942|323607902|FG000|Overall Study|Lost to Follow-up|0|||
94495894|NCT00435942|323607903|FG001|Overall Study|Lost to Follow-up|16|||
94495895|NCT00435942|323607902|FG000|Overall Study|Conversion to Open Repair|1|||
94495896|NCT00435942|323607903|FG001|Overall Study|Conversion to Open Repair|0|||
94495897|NCT00435942|323607902|FG000|Overall Study|Technical Failure|3|||
94495898|NCT00435942|323607903|FG001|Overall Study|Technical Failure|0|||
94495899|NCT00435942|323607902|FG000|Overall Study|Other|0|||
94495900|NCT00435942|323607903|FG001|Overall Study|Other|1|||
94495901|NCT04727749|323607904|FG000|Overall Study|Lost to Follow-up|10|||
94495902|NCT04727749|323607905|FG001|Overall Study|Lost to Follow-up|3|||
94495903|NCT01555931|323607909|FG000|Overall Study|Lost to Follow-up|2|||
94495904|NCT01555931|323607910|FG001|Overall Study|Lost to Follow-up|5|||
94495905|NCT01859741|323607913|FG000|Overall Study|Death|3|||
94495906|NCT01859741|323607914|FG001|Overall Study|Death|2|||
94495907|NCT01859741|323607915|FG002|Overall Study|Death|4|||
94495908|NCT01859741|323607916|FG003|Overall Study|Death|3|||
94495909|NCT01859741|323607917|FG004|Overall Study|Death|5|||
94495910|NCT01859741|323607918|FG005|Overall Study|Death|4|||
94495911|NCT01859741|323607919|FG006|Overall Study|Death|51|||
94495912|NCT01859741|323607920|FG007|Overall Study|Death|51|||
94495913|NCT01859741|323607913|FG000|Overall Study|Lost to Follow-up|0|||
94495914|NCT01859741|323607914|FG001|Overall Study|Lost to Follow-up|0|||
94495915|NCT01859741|323607915|FG002|Overall Study|Lost to Follow-up|0|||
94495916|NCT01859741|323607916|FG003|Overall Study|Lost to Follow-up|0|||
94495917|NCT01859741|323607917|FG004|Overall Study|Lost to Follow-up|0|||
94495918|NCT01859741|323607918|FG005|Overall Study|Lost to Follow-up|1|||
94655607|NCT00080223|324196093|FG000|Overall Study|Withdrawal by Subject|13|||
94655608|NCT00080223|324196093|FG000|Overall Study|Lung Transplantation|9|||
94655609|NCT00080223|324196093|FG000|Overall Study|Non-compliance With Study Treatment|7|||
94655610|NCT00080223|324196093|FG000|Overall Study|Participant unwilling to continue|2|||
94655611|NCT00080223|324196093|FG000|Overall Study|Physician Decision|1|||
94655612|NCT04369469|324196100|FG000|Overall Study|Lost to Follow-up|2|||
94655613|NCT04369469|324196101|FG001|Overall Study|Lost to Follow-up|4|||
94655614|NCT04369469|324196100|FG000|Overall Study|Physician Decision|2|||
94655615|NCT04369469|324196101|FG001|Overall Study|Physician Decision|1|||
94655616|NCT04369469|324196100|FG000|Overall Study|Withdrawal by Subject|2|||
94655617|NCT04369469|324196101|FG001|Overall Study|Withdrawal by Subject|3|||
94655618|NCT04369469|324196100|FG000|Overall Study|Adverse Event|1|||
94495919|NCT01859741|323607919|FG006|Overall Study|Lost to Follow-up|0|||
94495920|NCT01859741|323607920|FG007|Overall Study|Lost to Follow-up|4|||
94495921|NCT01859741|323607913|FG000|Overall Study|Withdrawal by Subject|0|||
94495922|NCT01859741|323607914|FG001|Overall Study|Withdrawal by Subject|1|||
94495923|NCT01859741|323607915|FG002|Overall Study|Withdrawal by Subject|2|||
94495924|NCT01859741|323607916|FG003|Overall Study|Withdrawal by Subject|0|||
94495925|NCT01859741|323607917|FG004|Overall Study|Withdrawal by Subject|0|||
94495926|NCT01859741|323607918|FG005|Overall Study|Withdrawal by Subject|1|||
94495927|NCT01859741|323607919|FG006|Overall Study|Withdrawal by Subject|1|||
94495928|NCT01859741|323607920|FG007|Overall Study|Withdrawal by Subject|1|||
94495929|NCT01859741|323607913|FG000|Overall Study|Study Terminated by Sponsor|0|||
94495930|NCT01859741|323607914|FG001|Overall Study|Study Terminated by Sponsor|0|||
94495931|NCT01859741|323607915|FG002|Overall Study|Study Terminated by Sponsor|0|||
94495932|NCT01859741|323607916|FG003|Overall Study|Study Terminated by Sponsor|0|||
94495933|NCT01859741|323607917|FG004|Overall Study|Study Terminated by Sponsor|1|||
94655619|NCT04369469|324196101|FG001|Overall Study|Adverse Event|0|||
94495934|NCT01859741|323607918|FG005|Overall Study|Study Terminated by Sponsor|0|||
94495935|NCT01859741|323607919|FG006|Overall Study|Study Terminated by Sponsor|16|||
94495936|NCT01859741|323607920|FG007|Overall Study|Study Terminated by Sponsor|14|||
94495937|NCT01859741|323607913|FG000|Overall Study|Other|0|||
94495938|NCT01859741|323607914|FG001|Overall Study|Other|0|||
94655620|NCT04369469|324196100|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
94495939|NCT01859741|323607915|FG002|Overall Study|Other|0|||
94495940|NCT01859741|323607916|FG003|Overall Study|Other|0|||
94495941|NCT01859741|323607917|FG004|Overall Study|Other|0|||
94495942|NCT01859741|323607918|FG005|Overall Study|Other|0|||
94495943|NCT01859741|323607919|FG006|Overall Study|Other|2|||
94495944|NCT01859741|323607920|FG007|Overall Study|Other|0|||
94495945|NCT02313155|323607923|FG000|Overall Study|Lost to Follow-up|0|||
94495946|NCT02313155|323607924|FG001|Overall Study|Lost to Follow-up|1|||
94495947|NCT00876343|323607926|FG000|Overall Study|Adverse Event|7|||
94495948|NCT00876343|323607927|FG001|Overall Study|Adverse Event|8|||
94495949|NCT00876343|323607928|FG002|Overall Study|Adverse Event|2|||
94495950|NCT00876343|323607926|FG000|Overall Study|Withdrawal by Subject|4|||
94495951|NCT00876343|323607927|FG001|Overall Study|Withdrawal by Subject|4|||
94495952|NCT00876343|323607928|FG002|Overall Study|Withdrawal by Subject|3|||
94495953|NCT00876343|323607926|FG000|Overall Study|Lack of Efficacy|0|||
94495954|NCT00876343|323607927|FG001|Overall Study|Lack of Efficacy|0|||
94495955|NCT00876343|323607928|FG002|Overall Study|Lack of Efficacy|1|||
94495956|NCT00876343|323607926|FG000|Overall Study|Protocol Violation|4|||
94495957|NCT00876343|323607927|FG001|Overall Study|Protocol Violation|1|||
94495958|NCT00876343|323607928|FG002|Overall Study|Protocol Violation|1|||
94495959|NCT00876343|323607926|FG000|Overall Study|Physician Decision|0|||
94495960|NCT00876343|323607927|FG001|Overall Study|Physician Decision|1|||
94495961|NCT00876343|323607928|FG002|Overall Study|Physician Decision|1|||
94495962|NCT00876343|323607926|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
94495963|NCT00876343|323607927|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
94495964|NCT00876343|323607928|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
94495965|NCT00876343|323607926|FG000|Overall Study|Change of residence or other commitments|2|||
94495966|NCT00876343|323607927|FG001|Overall Study|Change of residence or other commitments|2|||
94495967|NCT00876343|323607928|FG002|Overall Study|Change of residence or other commitments|3|||
94495968|NCT01925794|323607929|FG000|180 Days|Death|2|||
94495969|NCT01925794|323607929|FG000|180 Days|Withdrawal by Subject|2|||
94495970|NCT01925794|323607929|FG000|270 Days|Death|2|||
94495971|NCT01925794|323607929|FG000|270 Days|Protocol Violation|3|||
94495972|NCT03325439|323607930|FG000|Overall Study|Ineligibility|3|||
94495973|NCT02572167|323607943|FG000|Overall Study|Withdrawal by Subject|0|||
94495974|NCT02572167|323607944|FG001|Overall Study|Withdrawal by Subject|3|||
94495975|NCT02572167|323607945|FG002|Overall Study|Withdrawal by Subject|0|||
94495976|NCT02572167|323607943|FG000|Overall Study|Lost to Follow-up|2|||
94495977|NCT02572167|323607944|FG001|Overall Study|Lost to Follow-up|5|||
94495978|NCT02572167|323607945|FG002|Overall Study|Lost to Follow-up|3|||
94495979|NCT02572167|323607943|FG000|Overall Study|Death|0|||
94495980|NCT02572167|323607944|FG001|Overall Study|Death|8|||
94495981|NCT02572167|323607945|FG002|Overall Study|Death|3|||
94495982|NCT02572167|323607943|FG000|Overall Study|Did not meet inclusion criteria|0|||
94495983|NCT02572167|323607944|FG001|Overall Study|Did not meet inclusion criteria|0|||
94495984|NCT02572167|323607945|FG002|Overall Study|Did not meet inclusion criteria|1|||
94495985|NCT02572167|323607943|FG000|Overall Study|Study closure by Sponsor|4|||
94495986|NCT02572167|323607944|FG001|Overall Study|Study closure by Sponsor|40|||
94495987|NCT02572167|323607945|FG002|Overall Study|Study closure by Sponsor|24|||
94495988|NCT00303953|323607946|FG000|Overall Study|Ineligible|1|||
94495989|NCT00303953|323607946|FG000|Overall Study|Death|1|||
94495990|NCT00303953|323607946|FG000|Overall Study|Adverse Event|4|||
94495991|NCT00303953|323607946|FG000|Overall Study|Lack of Efficacy|12|||
94495992|NCT00303953|323607946|FG000|Overall Study|Physician Decision|1|||
94495993|NCT00580840|323607947|FG000|Run-in|Adverse Event|17|||
94495994|NCT00580840|323607948|FG001|Run-in|Adverse Event|0|||
94495995|NCT00580840|323607949|FG002|Run-in|Adverse Event|0|||
94495996|NCT00580840|323607950|FG003|Run-in|Adverse Event|0|||
94495997|NCT00580840|323607947|FG000|Run-in|Lack of Efficacy|93|||
94495998|NCT00580840|323607948|FG001|Run-in|Lack of Efficacy|0|||
94495999|NCT00580840|323607949|FG002|Run-in|Lack of Efficacy|0|||
94496000|NCT00580840|323607950|FG003|Run-in|Lack of Efficacy|0|||
94496001|NCT00580840|323607947|FG000|Run-in|Loss of Efficacy|1|||
94496002|NCT00580840|323607948|FG001|Run-in|Loss of Efficacy|0|||
94496003|NCT00580840|323607949|FG002|Run-in|Loss of Efficacy|0|||
94496004|NCT00580840|323607950|FG003|Run-in|Loss of Efficacy|0|||
94496005|NCT00580840|323607947|FG000|Run-in|Lost to Follow-up|4|||
94496006|NCT00580840|323607948|FG001|Run-in|Lost to Follow-up|0|||
94496007|NCT00580840|323607949|FG002|Run-in|Lost to Follow-up|0|||
94496008|NCT00580840|323607950|FG003|Run-in|Lost to Follow-up|0|||
94496009|NCT00580840|323607947|FG000|Run-in|Withdrawal by Subject|5|||
94496010|NCT00580840|323607948|FG001|Run-in|Withdrawal by Subject|0|||
94496011|NCT00580840|323607949|FG002|Run-in|Withdrawal by Subject|0|||
94496012|NCT00580840|323607950|FG003|Run-in|Withdrawal by Subject|0|||
94496013|NCT00580840|323607947|FG000|Run-in|Other: Per Sponsor Request|2|||
94496014|NCT00580840|323607948|FG001|Run-in|Other: Per Sponsor Request|0|||
94496015|NCT00580840|323607949|FG002|Run-in|Other: Per Sponsor Request|0|||
94496016|NCT00580840|323607950|FG003|Run-in|Other: Per Sponsor Request|0|||
94496017|NCT00580840|323607947|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
94496018|NCT00580840|323607948|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
94496019|NCT00580840|323607949|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
94496020|NCT00580840|323607950|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
94496021|NCT00580840|323607947|FG000|Run-in|Other: Exclusionary Lab Value|1|||
94496022|NCT00580840|323607948|FG001|Run-in|Other: Exclusionary Lab Value|0|||
94496023|NCT00580840|323607949|FG002|Run-in|Other: Exclusionary Lab Value|0|||
94496024|NCT00580840|323607950|FG003|Run-in|Other: Exclusionary Lab Value|0|||
94496025|NCT00580840|323607947|FG000|Double-Blind|Adverse Event|0|||
94496026|NCT00580840|323607948|FG001|Double-Blind|Adverse Event|3|||
94496027|NCT00580840|323607949|FG002|Double-Blind|Adverse Event|4|||
94496028|NCT00580840|323607950|FG003|Double-Blind|Adverse Event|1|||
94496029|NCT00580840|323607947|FG000|Double-Blind|Loss of Efficacy|0|||
94496030|NCT00580840|323607948|FG001|Double-Blind|Loss of Efficacy|1|||
94496031|NCT00580840|323607949|FG002|Double-Blind|Loss of Efficacy|2|||
94496032|NCT00580840|323607950|FG003|Double-Blind|Loss of Efficacy|10|||
94496033|NCT00580840|323607947|FG000|Double-Blind|Lost to Follow-up|0|||
94496034|NCT00580840|323607948|FG001|Double-Blind|Lost to Follow-up|1|||
94496035|NCT00580840|323607949|FG002|Double-Blind|Lost to Follow-up|0|||
94496036|NCT00580840|323607950|FG003|Double-Blind|Lost to Follow-up|2|||
94496037|NCT00580840|323607947|FG000|Double-Blind|Withdrawal by Subject|0|||
94496038|NCT00580840|323607948|FG001|Double-Blind|Withdrawal by Subject|1|||
94496039|NCT00580840|323607949|FG002|Double-Blind|Withdrawal by Subject|2|||
94496040|NCT00580840|323607950|FG003|Double-Blind|Withdrawal by Subject|2|||
94496041|NCT00580840|323607947|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
94496042|NCT00580840|323607948|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
94496043|NCT00580840|323607949|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
94496044|NCT00580840|323607950|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
94496045|NCT00580840|323607947|FG000|Double-Blind|Other: Forbidden Medication|0|||
94496046|NCT00580840|323607948|FG001|Double-Blind|Other: Forbidden Medication|0|||
94496047|NCT00580840|323607949|FG002|Double-Blind|Other: Forbidden Medication|1|||
94496048|NCT00580840|323607950|FG003|Double-Blind|Other: Forbidden Medication|0|||
94496049|NCT00088153|323607951|FG000|Overall Study|Physician Decision|3|||
94496050|NCT00088153|323607952|FG001|Overall Study|Physician Decision|3|||
94496051|NCT00088153|323607951|FG000|Overall Study|Withdrawal by Subject|10|||
94496052|NCT00088153|323607952|FG001|Overall Study|Withdrawal by Subject|10|||
94496053|NCT00088153|323607951|FG000|Overall Study|Lost to Follow-up|11|||
94496054|NCT00088153|323607952|FG001|Overall Study|Lost to Follow-up|12|||
94496055|NCT00976027|323607954|FG000|Overall Study|Serious Adverse Event|36|||
94496056|NCT00976027|323607955|FG001|Overall Study|Serious Adverse Event|17|||
94496057|NCT00976027|323607954|FG000|Overall Study|Adverse Event|0|||
94496058|NCT00976027|323607955|FG001|Overall Study|Adverse Event|2|||
94496059|NCT00976027|323607954|FG000|Overall Study|Protocol Violation|60|||
94496060|NCT00976027|323607955|FG001|Overall Study|Protocol Violation|27|||
94496061|NCT00976027|323607954|FG000|Overall Study|Lost to Follow-up|208|||
94496062|NCT00976027|323607955|FG001|Overall Study|Lost to Follow-up|103|||
94496063|NCT00976027|323607954|FG000|Overall Study|Withdrawal by Subject|107|||
94496064|NCT00976027|323607955|FG001|Overall Study|Withdrawal by Subject|66|||
94496065|NCT01695746|323607958|FG000|Overall Study|Adverse Event|1|||
94496066|NCT01695746|323607958|FG000|Overall Study|Non-compliance by the participant|3|||
94496067|NCT01695746|323607958|FG000|Overall Study|Protocol Violation|5|||
94496068|NCT01695746|323607958|FG000|Overall Study|Participant not willing to participate|3|||
94496069|NCT02315625|323607959|FG000|First Intervention|Disease Progression|1|||
94496070|NCT02315625|323607960|FG001|First Intervention|Disease Progression|0|||
94496071|NCT02315625|323607959|FG000|Second Intervention|Physician Decision|2|||
94496072|NCT02315625|323607960|FG001|Second Intervention|Physician Decision|1|||
94496073|NCT02315625|323607959|FG000|Second Intervention|Study closure|1|||
94496074|NCT02315625|323607960|FG001|Second Intervention|Study closure|0|||
94496075|NCT02315625|323607959|FG000|Second Intervention|Disease Progression|1|||
94496076|NCT02315625|323607960|FG001|Second Intervention|Disease Progression|0|||
94496077|NCT00021255|323607963|FG000|Overall Study|Death|1|||
94496078|NCT00021255|323607964|FG001|Overall Study|Death|0|||
94496079|NCT00021255|323607965|FG002|Overall Study|Death|2|||
94496080|NCT00021255|323607963|FG000|Overall Study|Breast cancer relapse|5|||
94496081|NCT00021255|323607964|FG001|Overall Study|Breast cancer relapse|18|||
94496082|NCT00021255|323607965|FG002|Overall Study|Breast cancer relapse|11|||
94496083|NCT00021255|323607963|FG000|Overall Study|Second primary malignancy|0|||
94496084|NCT00021255|323607964|FG001|Overall Study|Second primary malignancy|4|||
94496085|NCT00021255|323607965|FG002|Overall Study|Second primary malignancy|1|||
94496086|NCT00021255|323607963|FG000|Overall Study|Withdrawal by Subject|41|||
94496087|NCT00021255|323607964|FG001|Overall Study|Withdrawal by Subject|64|||
94496088|NCT00021255|323607965|FG002|Overall Study|Withdrawal by Subject|26|||
94496089|NCT00021255|323607963|FG000|Overall Study|Lost to Follow-up|0|||
94496090|NCT00021255|323607964|FG001|Overall Study|Lost to Follow-up|2|||
94496091|NCT00021255|323607965|FG002|Overall Study|Lost to Follow-up|3|||
94496092|NCT00021255|323607963|FG000|Overall Study|Cardiac toxicity|0|||
94496093|NCT00021255|323607964|FG001|Overall Study|Cardiac toxicity|61|||
94496094|NCT00021255|323607965|FG002|Overall Study|Cardiac toxicity|32|||
94496095|NCT00021255|323607963|FG000|Overall Study|Herceptin toxicity|0|||
94496096|NCT00021255|323607964|FG001|Overall Study|Herceptin toxicity|22|||
94496097|NCT00021255|323607965|FG002|Overall Study|Herceptin toxicity|6|||
94496098|NCT00021255|323607963|FG000|Overall Study|Adverse Event|46|||
94496099|NCT00021255|323607964|FG001|Overall Study|Adverse Event|30|||
94496100|NCT00021255|323607965|FG002|Overall Study|Adverse Event|18|||
94496101|NCT00021255|323607963|FG000|Overall Study|Protocol Violation|0|||
94496102|NCT00021255|323607964|FG001|Overall Study|Protocol Violation|2|||
94496103|NCT00021255|323607965|FG002|Overall Study|Protocol Violation|0|||
94496104|NCT00021255|323607963|FG000|Overall Study|Other than specified above|0|||
94496105|NCT00021255|323607964|FG001|Overall Study|Other than specified above|38|||
94496106|NCT00021255|323607965|FG002|Overall Study|Other than specified above|19|||
94496107|NCT00021255|323607963|FG000|Overall Study|Missing|0|||
94496108|NCT00021255|323607964|FG001|Overall Study|Missing|27|||
94496109|NCT00021255|323607965|FG002|Overall Study|Missing|13|||
94496110|NCT00021255|323607963|FG000|Overall Study|Randomized but not treated|28|||
94496111|NCT00021255|323607964|FG001|Overall Study|Randomized but not treated|2|||
94496112|NCT00021255|323607965|FG002|Overall Study|Randomized but not treated|18|||
94496113|NCT02232698|323607970|FG000|Overall Study|Pregnancy|1|||
94496114|NCT02232698|323607971|FG001|Overall Study|Pregnancy|1|||
94496115|NCT02232698|323607970|FG000|Overall Study|Met exclusion criteria|1|||
94496116|NCT02232698|323607971|FG001|Overall Study|Met exclusion criteria|1|||
94496117|NCT02232698|323607970|FG000|Overall Study|Had device-associated symptoms|7|||
94496118|NCT02232698|323607971|FG001|Overall Study|Had device-associated symptoms|0|||
94496119|NCT02232698|323607970|FG000|Overall Study|Non-compliance with study device|1|||
94496120|NCT02232698|323607971|FG001|Overall Study|Non-compliance with study device|4|||
94496121|NCT02232698|323607970|FG000|Overall Study|Allocated to control group|0|||
94496122|NCT02232698|323607971|FG001|Overall Study|Allocated to control group|3|||
94496123|NCT02232698|323607970|FG000|Overall Study|Withdrawal by Subject|0|||
94496124|NCT02232698|323607971|FG001|Overall Study|Withdrawal by Subject|11|||
94496125|NCT01160614|323607972|FG000|Overall Study|Withdrawal by Subject|0|||
94496126|NCT01160614|323607973|FG001|Overall Study|Withdrawal by Subject|2|||
94496127|NCT01860404|323607974|FG000|Overall Study|Lost to Follow-up|3|||
94496128|NCT01860404|323607975|FG001|Overall Study|Lost to Follow-up|4|||
94496129|NCT01860404|323607976|FG002|Overall Study|Lost to Follow-up|1|||
94496130|NCT01860404|323607977|FG003|Overall Study|Lost to Follow-up|6|||
94496131|NCT01860404|323607978|FG004|Overall Study|Lost to Follow-up|4|||
94496132|NCT01860404|323607974|FG000|Overall Study|Withdrawal by Subject|0|||
94496133|NCT01860404|323607975|FG001|Overall Study|Withdrawal by Subject|0|||
94496134|NCT01860404|323607976|FG002|Overall Study|Withdrawal by Subject|4|||
94496135|NCT01860404|323607977|FG003|Overall Study|Withdrawal by Subject|0|||
94496136|NCT01860404|323607978|FG004|Overall Study|Withdrawal by Subject|0|||
94496137|NCT02965833|323607980|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
94496138|NCT02965833|323607981|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
94496139|NCT02965833|323607980|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
94496140|NCT02965833|323607981|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
94496141|NCT02965833|323607980|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
94496142|NCT02965833|323607981|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
94496143|NCT02965833|323607980|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
94496144|NCT02965833|323607981|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
94496145|NCT02965833|323607980|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
94496146|NCT02965833|323607981|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
94496147|NCT03091439|323607985|FG000|Overall Study|Study Terminated by the Sponsor|1|||
94496148|NCT03091439|323607986|FG001|Overall Study|Study Terminated by the Sponsor|0|||
94496149|NCT01214720|323607987|FG000|Overall Study|Alive and still on treatment|34|||
94496150|NCT01214720|323607988|FG001|Overall Study|Alive and still on treatment|18|||
94496151|NCT01214720|323607987|FG000|Overall Study|Alive and in follow-up|45|||
94496152|NCT01214720|323607988|FG001|Overall Study|Alive and in follow-up|48|||
94496153|NCT01214720|323607987|FG000|Overall Study|Lost to Follow-up|6|||
94496154|NCT01214720|323607988|FG001|Overall Study|Lost to Follow-up|2|||
94496155|NCT05399771|323609616|FG000|Overall Study|Physician Decision|3|||
94496156|NCT05399771|323609616|FG000|Overall Study|Adverse Event|1|||
94496157|NCT00177671|323609617|FG000|Overall Study|Withdrawal by Subject|5|||
94496158|NCT00177671|323609618|FG001|Overall Study|Withdrawal by Subject|6|||
94496159|NCT00177671|323609617|FG000|Overall Study|medical complications|2|||
94496160|NCT00177671|323609618|FG001|Overall Study|medical complications|0|||
94496161|NCT00177671|323609617|FG000|Overall Study|Adverse Event|6|||
94496162|NCT00177671|323609618|FG001|Overall Study|Adverse Event|0|||
94496163|NCT00177671|323609617|FG000|Overall Study|Physician Decision|12|||
94496164|NCT00177671|323609618|FG001|Overall Study|Physician Decision|8|||
94496165|NCT02293499|323609619|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
94496166|NCT02293499|323609620|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
94496167|NCT02293499|323609621|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
94496168|NCT02293499|323609619|FG000|Intervention - Camp|Withdrawal by Subject|3|||
94496169|NCT02293499|323609620|FG001|Intervention - Camp|Withdrawal by Subject|6|||
94496170|NCT02293499|323609621|FG002|Intervention - Camp|Withdrawal by Subject|2|||
94496171|NCT02293499|323609619|FG000|Intervention - Camp|these are those not showing up at camp|24|||
94496172|NCT02293499|323609620|FG001|Intervention - Camp|these are those not showing up at camp|28|||
94496173|NCT02293499|323609621|FG002|Intervention - Camp|these are those not showing up at camp|4|||
94496174|NCT02293499|323609619|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
94496175|NCT02293499|323609620|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
94496176|NCT02293499|323609621|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
94496177|NCT02293499|323609619|FG000|3 Month Follow Up|Lost to Follow-up|14|||
94496178|NCT02293499|323609620|FG001|3 Month Follow Up|Lost to Follow-up|15|||
94496179|NCT02293499|323609621|FG002|3 Month Follow Up|Lost to Follow-up|6|||
94496180|NCT02293499|323609619|FG000|6 Month Follow Up|Lost to Follow-up|17|||
94496181|NCT02293499|323609620|FG001|6 Month Follow Up|Lost to Follow-up|27|||
94496182|NCT02293499|323609621|FG002|6 Month Follow Up|Lost to Follow-up|6|||
94496183|NCT02293499|323609619|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
94496184|NCT02293499|323609620|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
94496185|NCT02293499|323609621|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
94496186|NCT02293499|323609619|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
94496187|NCT02293499|323609620|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
94496188|NCT02293499|323609621|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
94496189|NCT02293499|323609619|FG000|9 Month Follow Up|Lost to Follow-up|24|||
94496190|NCT02293499|323609620|FG001|9 Month Follow Up|Lost to Follow-up|28|||
94496191|NCT02293499|323609621|FG002|9 Month Follow Up|Lost to Follow-up|4|||
94496192|NCT02293499|323609619|FG000|12 Month Follow Up|Lost to Follow-up|26|||
94496193|NCT02293499|323609620|FG001|12 Month Follow Up|Lost to Follow-up|25|||
94496194|NCT02293499|323609621|FG002|12 Month Follow Up|Lost to Follow-up|6|||
94496195|NCT02293499|323609619|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
94496196|NCT02293499|323609620|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
94496197|NCT02293499|323609621|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
94496198|NCT02293499|323609619|FG000|15 Month Follow Up|Lost to Follow-up|22|||
94496199|NCT02293499|323609620|FG001|15 Month Follow Up|Lost to Follow-up|22|||
94496200|NCT02293499|323609621|FG002|15 Month Follow Up|Lost to Follow-up|7|||
94496201|NCT00541229|323609622|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
94496202|NCT00541229|323609623|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
94496203|NCT00541229|323609624|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
94496204|NCT00541229|323609625|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
94496205|NCT00541229|323609626|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
94496206|NCT00541229|323609627|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
94496207|NCT00541229|323609622|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
94496208|NCT00541229|323609623|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
94496209|NCT00541229|323609624|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
94496210|NCT00541229|323609625|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
94496211|NCT00541229|323609626|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
94496212|NCT00541229|323609627|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
94496213|NCT00541229|323609622|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
94496214|NCT00541229|323609623|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
94496215|NCT00541229|323609624|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
94496216|NCT00541229|323609625|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
94496217|NCT00541229|323609626|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
94496218|NCT00541229|323609627|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
94496219|NCT00541229|323609622|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
94496220|NCT00541229|323609623|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
94496221|NCT00541229|323609624|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
94496222|NCT00541229|323609625|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
94496223|NCT00541229|323609626|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
94496224|NCT00541229|323609627|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
94496225|NCT00541229|323609622|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
94496226|NCT00541229|323609623|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
94496227|NCT00541229|323609624|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
94496228|NCT00541229|323609625|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
94496229|NCT00541229|323609626|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
94496230|NCT00541229|323609627|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
94496231|NCT00541229|323609622|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
94496232|NCT00541229|323609623|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
94496233|NCT00541229|323609624|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
94496234|NCT00541229|323609625|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
94496235|NCT00541229|323609626|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
94496236|NCT00541229|323609627|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
94496237|NCT00541229|323609622|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
94496238|NCT00541229|323609623|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
94496239|NCT00541229|323609624|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
94496240|NCT00541229|323609625|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
94496241|NCT00541229|323609626|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
94496242|NCT00541229|323609627|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
94496243|NCT00541229|323609622|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
94496244|NCT00541229|323609623|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
94496245|NCT00541229|323609624|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
94496246|NCT00541229|323609625|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
94496247|NCT00541229|323609626|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
94496248|NCT00541229|323609627|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
94496249|NCT00541229|323609622|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
94496250|NCT00541229|323609623|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
94496251|NCT00541229|323609624|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
94496252|NCT00541229|323609625|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
94496253|NCT00541229|323609626|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
94496254|NCT00541229|323609627|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
94496255|NCT00541229|323609622|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
94496256|NCT00541229|323609623|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
94496257|NCT00541229|323609624|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
94496258|NCT00541229|323609625|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
94496259|NCT00541229|323609626|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
94496260|NCT00541229|323609627|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
94496261|NCT00541229|323609622|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
94496262|NCT00541229|323609623|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
94496263|NCT00541229|323609624|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
94496264|NCT00541229|323609625|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
94496265|NCT00541229|323609626|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
94496266|NCT00541229|323609627|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
94496267|NCT00541229|323609622|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
94496268|NCT00541229|323609623|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
94496269|NCT00541229|323609624|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
94496270|NCT00541229|323609625|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
94496271|NCT00541229|323609626|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
94496272|NCT00541229|323609627|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
94496273|NCT00541229|323609622|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
94496274|NCT00541229|323609623|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
94496275|NCT00541229|323609624|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
94496276|NCT00541229|323609625|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
94496277|NCT00541229|323609626|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
94496278|NCT00541229|323609627|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
94496279|NCT00541229|323609622|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
94496280|NCT00541229|323609623|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
94496281|NCT00541229|323609624|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
94496282|NCT00541229|323609625|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
94496283|NCT00541229|323609626|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
94496284|NCT00541229|323609627|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
94496285|NCT00541229|323609622|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
94496286|NCT00541229|323609623|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
94496287|NCT00541229|323609624|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
94496288|NCT00541229|323609625|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
94496289|NCT00541229|323609626|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
94496290|NCT00541229|323609627|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
94496291|NCT00541229|323609622|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
94496292|NCT00541229|323609623|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
94496293|NCT00541229|323609624|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
94496294|NCT00541229|323609625|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
94496295|NCT00541229|323609626|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
94496296|NCT00541229|323609627|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
94496297|NCT03439839|323609628|FG000|Overall Study|Death|3|||
94496298|NCT03439839|323609629|FG001|Overall Study|Death|0|||
94496299|NCT03807843|323609632|FG000|Overall Study|Lost to Follow-up|1|||
94496300|NCT03807843|323609633|FG001|Overall Study|Lost to Follow-up|0|||
94496301|NCT01312129|323609634|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
94496302|NCT01312129|323609635|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
94496303|NCT01239680|323609638|FG000|Overall Study|Withdrawal by Subject|2|||
94496304|NCT01239680|323609639|FG001|Overall Study|Withdrawal by Subject|0|||
94496305|NCT03033901|323609640|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
94496306|NCT03033901|323609640|FG000|Overall Study|Refused PSG|23|||
94496307|NCT03033901|323609640|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
94496308|NCT03033901|323609640|FG000|Overall Study|Missing Oximetry Data|3|||
94496309|NCT01750346|323609653|FG000|Overall Study|Adverse Event|1|||
94496310|NCT01750346|323609654|FG001|Overall Study|Adverse Event|0|||
94496311|NCT01750346|323609655|FG002|Overall Study|Adverse Event|0|||
94496312|NCT01013753|323609659|FG000|Overall Study|Adverse Event|8|||
94496313|NCT01013753|323609659|FG000|Overall Study|Protocol Violation|3|||
94496314|NCT01013753|323609659|FG000|Overall Study|Lost to Follow-up|1|||
94496315|NCT01013753|323609659|FG000|Overall Study|Withdrawal by Subject|2|||
94496316|NCT01013753|323609659|FG000|Overall Study|Other|2|||
94496317|NCT02397837|323609662|FG000|Overall Study|Withdrawal by Subject|6|||
94496318|NCT02397837|323609663|FG001|Overall Study|Withdrawal by Subject|5|||
94496319|NCT02397837|323609662|FG000|Overall Study|Physician Decision|1|||
94496320|NCT02397837|323609663|FG001|Overall Study|Physician Decision|1|||
94496321|NCT03320369|323609664|FG000|Overall Study|Adverse Event|1|||
94496322|NCT03320369|323609664|FG000|Overall Study|Withdrawal by Subject|2|||
94496323|NCT01771913|323609665|FG000|Overall Study|Withdrawal by Subject|1|||
94496324|NCT01771913|323609666|FG001|Overall Study|Withdrawal by Subject|0|||
94496325|NCT04307394|323609667|FG000|Overall Study|Lost to Follow-up|3|||
94496326|NCT04307394|323609667|FG000|Overall Study|Withdrawal by Subject|2|||
94496327|NCT01121926|323609668|FG000|First Intervention Period|Adverse Event|1|||
94496328|NCT01121926|323609669|FG001|First Intervention Period|Adverse Event|0|||
94496329|NCT01121926|323609668|FG000|Washout Period|Adverse Event|0|||
94496330|NCT01121926|323609669|FG001|Washout Period|Adverse Event|1|||
94496331|NCT01121926|323609668|FG000|Washout Period|Positive pregnancy test|0|||
94496332|NCT01121926|323609669|FG001|Washout Period|Positive pregnancy test|1|||
94496333|NCT04137887|323609670|FG000|Overall Study|Death|102|||
94496334|NCT04137887|323609671|FG001|Overall Study|Death|92|||
94496335|NCT04137887|323609670|FG000|Overall Study|Withdrawal by Subject|2|||
94496336|NCT04137887|323609671|FG001|Overall Study|Withdrawal by Subject|3|||
94496337|NCT04137887|323609670|FG000|Overall Study|Randomized but not treated|0|||
94496338|NCT04137887|323609671|FG001|Overall Study|Randomized but not treated|1|||
94496339|NCT00416949|323609674|FG000|Overall Study|Patients refused to participate|5|||
94496340|NCT02782468|323609675|FG000|Overall Study|Progressive Disease|2|||
94496341|NCT02782468|323609676|FG001|Overall Study|Progressive Disease|5|||
94496342|NCT02782468|323609677|FG002|Overall Study|Progressive Disease|0|||
94496343|NCT02782468|323609678|FG003|Overall Study|Progressive Disease|4|||
94496344|NCT02782468|323609675|FG000|Overall Study|Adverse Event|0|||
94496345|NCT02782468|323609676|FG001|Overall Study|Adverse Event|2|||
94496346|NCT02782468|323609677|FG002|Overall Study|Adverse Event|2|||
94496347|NCT02782468|323609678|FG003|Overall Study|Adverse Event|3|||
94496348|NCT02782468|323609675|FG000|Overall Study|Other|0|||
94496349|NCT02782468|323609676|FG001|Overall Study|Other|0|||
94496350|NCT02782468|323609677|FG002|Overall Study|Other|1|||
94496351|NCT02782468|323609678|FG003|Overall Study|Other|1|||
94496352|NCT02782468|323609675|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
94496353|NCT02782468|323609676|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
94496354|NCT02782468|323609677|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
94496355|NCT02782468|323609678|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
94496356|NCT02782468|323609675|FG000|Overall Study|Symptomatic Deterioration|0|||
94496357|NCT02782468|323609676|FG001|Overall Study|Symptomatic Deterioration|0|||
94496358|NCT02782468|323609677|FG002|Overall Study|Symptomatic Deterioration|0|||
94496359|NCT02782468|323609678|FG003|Overall Study|Symptomatic Deterioration|1|||
94496360|NCT02782468|323609675|FG000|Overall Study|Withdrawal by Subject|1|||
94496361|NCT02782468|323609676|FG001|Overall Study|Withdrawal by Subject|0|||
94496362|NCT02782468|323609677|FG002|Overall Study|Withdrawal by Subject|0|||
94496363|NCT02782468|323609678|FG003|Overall Study|Withdrawal by Subject|0|||
94496364|NCT00313170|323609679|FG000|Overall Study|Death|2|||
94496365|NCT00313170|323609680|FG001|Overall Study|Death|4|||
94496366|NCT00313170|323609681|FG002|Overall Study|Death|2|||
94496367|NCT00313170|323609679|FG000|Overall Study|Adverse Event|1|||
94496368|NCT00313170|323609680|FG001|Overall Study|Adverse Event|2|||
94496369|NCT00313170|323609681|FG002|Overall Study|Adverse Event|0|||
94496370|NCT00313170|323609679|FG000|Overall Study|Disease progression|31|||
94496371|NCT00313170|323609680|FG001|Overall Study|Disease progression|26|||
94496372|NCT00313170|323609681|FG002|Overall Study|Disease progression|27|||
94496373|NCT00313170|323609679|FG000|Overall Study|Withdrawal by Subject|1|||
94496374|NCT00313170|323609680|FG001|Overall Study|Withdrawal by Subject|0|||
94496375|NCT00313170|323609681|FG002|Overall Study|Withdrawal by Subject|1|||
94496376|NCT00313170|323609679|FG000|Overall Study|Incorrect enrollment|0|||
94496377|NCT00313170|323609680|FG001|Overall Study|Incorrect enrollment|2|||
94496378|NCT00313170|323609681|FG002|Overall Study|Incorrect enrollment|1|||
94496379|NCT00313170|323609679|FG000|Overall Study|Lost to Follow-up|0|||
94496380|NCT00313170|323609680|FG001|Overall Study|Lost to Follow-up|0|||
94496381|NCT00313170|323609681|FG002|Overall Study|Lost to Follow-up|1|||
94496382|NCT00313170|323609679|FG000|Overall Study|Progression (investigators opinion)|1|||
94496383|NCT00313170|323609680|FG001|Overall Study|Progression (investigators opinion)|0|||
94496384|NCT00313170|323609681|FG002|Overall Study|Progression (investigators opinion)|0|||
94496385|NCT01155323|323609682|FG000|First Intervention|exclusion criteria|1|||
94496386|NCT01155323|323609683|FG001|First Intervention|exclusion criteria|1|||
94496387|NCT01155323|323609682|FG000|Second Intervention|Lost to Follow-up|1|||
94496388|NCT01155323|323609683|FG001|Second Intervention|Lost to Follow-up|1|||
94496389|NCT01410604|323609684|FG000|Overall Study|Adverse Event|2|||
94496390|NCT01410604|323609685|FG001|Overall Study|Adverse Event|1|||
94496391|NCT01410604|323609684|FG000|Overall Study|Lost to Follow-up|1|||
94496392|NCT01410604|323609685|FG001|Overall Study|Lost to Follow-up|0|||
94496393|NCT01410604|323609684|FG000|Overall Study|Physician Decision|0|||
94496394|NCT01410604|323609685|FG001|Overall Study|Physician Decision|1|||
94496395|NCT00356590|323609692|FG000|Overall Study|Adverse Event|54|||
94496396|NCT00356590|323609692|FG000|Overall Study|Death|10|||
94496397|NCT00356590|323609692|FG000|Overall Study|Lost to Follow-up|35|||
94496398|NCT00356590|323609692|FG000|Overall Study|Physician Decision|46|||
94496399|NCT00356590|323609692|FG000|Overall Study|Withdrawal by Subject|41|||
94496400|NCT00356590|323609692|FG000|Overall Study|Completed month 12 only|2|||
94496401|NCT00356590|323609692|FG000|Overall Study|Protocol issues|6|||
94496402|NCT00356590|323609692|FG000|Overall Study|Response status|28|||
94496403|NCT00356590|323609692|FG000|Overall Study|Other|52|||
94496404|NCT01208051|323609695|FG000|Total Enrollment|Withdrawal by Subject|0|||
94496405|NCT01208051|323609696|FG001|Total Enrollment|Withdrawal by Subject|1|||
94496406|NCT01208051|323609697|FG002|Total Enrollment|Withdrawal by Subject|0|||
94496407|NCT01208051|323609698|FG003|Total Enrollment|Withdrawal by Subject|0|||
94496408|NCT01208051|323609699|FG004|Total Enrollment|Withdrawal by Subject|2|||
94496409|NCT01208051|323609695|FG000|Total Enrollment|Brain metastases|0|||
94496410|NCT01208051|323609696|FG001|Total Enrollment|Brain metastases|0|||
94496411|NCT01208051|323609697|FG002|Total Enrollment|Brain metastases|1|||
94496412|NCT01208051|323609698|FG003|Total Enrollment|Brain metastases|0|||
94496413|NCT01208051|323609699|FG004|Total Enrollment|Brain metastases|0|||
94496414|NCT00898807|323609700|FG000|Overall Study|Withdrawal by Subject|5|||
94496415|NCT00898807|323609701|FG001|Overall Study|Withdrawal by Subject|3|||
94496416|NCT00898807|323609700|FG000|Overall Study|Family pressure to discontinue|2|||
94496417|NCT00898807|323609701|FG001|Overall Study|Family pressure to discontinue|2|||
94496418|NCT00898807|323609700|FG000|Overall Study|Lost to Follow-up|1|||
94496419|NCT00898807|323609701|FG001|Overall Study|Lost to Follow-up|3|||
94496420|NCT00898807|323609700|FG000|Overall Study|Death|0|||
94496421|NCT00898807|323609701|FG001|Overall Study|Death|1|||
94496422|NCT00817063|323609704|FG000|Overall Study|Adverse Event|32|||
94496423|NCT00817063|323609705|FG001|Overall Study|Adverse Event|13|||
94496424|NCT00817063|323609704|FG000|Overall Study|Death|1|||
94496425|NCT00817063|323609705|FG001|Overall Study|Death|1|||
94496426|NCT00817063|323609704|FG000|Overall Study|Lack of Efficacy|33|||
94496427|NCT00817063|323609705|FG001|Overall Study|Lack of Efficacy|86|||
94496428|NCT00817063|323609704|FG000|Overall Study|Failure to Return|13|||
94496429|NCT00817063|323609705|FG001|Overall Study|Failure to Return|12|||
94496430|NCT00817063|323609704|FG000|Overall Study|Violation of Selection at Entry|7|||
94496431|NCT00817063|323609705|FG001|Overall Study|Violation of Selection at Entry|4|||
94496432|NCT00817063|323609704|FG000|Overall Study|Protocol Violation|3|||
94496433|NCT00817063|323609705|FG001|Overall Study|Protocol Violation|8|||
94496434|NCT00817063|323609704|FG000|Overall Study|Withdrawal by Subject|17|||
94496435|NCT00817063|323609705|FG001|Overall Study|Withdrawal by Subject|37|||
94496436|NCT00817063|323609704|FG000|Overall Study|Early Improvement|19|||
94496437|NCT00817063|323609705|FG001|Overall Study|Early Improvement|4|||
94496438|NCT00817063|323609704|FG000|Overall Study|Administrative|10|||
94496439|NCT00817063|323609705|FG001|Overall Study|Administrative|4|||
94496440|NCT00817063|323609704|FG000|Overall Study|Abnormality of Laboratory Test|2|||
94496441|NCT00817063|323609705|FG001|Overall Study|Abnormality of Laboratory Test|1|||
94496442|NCT00407511|323609706|FG000|Overall Study|Adverse Event|9|||
94496443|NCT00407511|323609706|FG000|Overall Study|Lost to Follow-up|4|||
94496444|NCT00407511|323609706|FG000|Overall Study|Other|5|||
94496445|NCT00407511|323609706|FG000|Overall Study|Withdrawal by Subject|4|||
94496446|NCT03439514|323609707|FG000|Double-Blind Treatment Period|Other|4|||
94496447|NCT03439514|323609708|FG001|Double-Blind Treatment Period|Other|1|||
94496448|NCT03439514|323609707|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
94496449|NCT03439514|323609708|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
94496450|NCT03439514|323609707|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
94496451|NCT03439514|323609708|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
94496452|NCT03439514|323609707|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
94496453|NCT03439514|323609708|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
94496454|NCT03439514|323609707|FG000|Double-Blind Treatment Period|Death|1|||
94496455|NCT03439514|323609708|FG001|Double-Blind Treatment Period|Death|2|||
94496456|NCT02107898|323609709|FG000|Overall Study|Adverse Event|4|||
94496457|NCT02107898|323609710|FG001|Overall Study|Adverse Event|7|||
94496458|NCT02107898|323609709|FG000|Overall Study|Poor compliance to protocol|0|||
94496459|NCT02107898|323609710|FG001|Overall Study|Poor compliance to protocol|1|||
94496460|NCT02107898|323609709|FG000|Overall Study|Participant moved|0|||
94496461|NCT02107898|323609710|FG001|Overall Study|Participant moved|2|||
94496462|NCT02107898|323609709|FG000|Overall Study|Consent withdrawn by participant|2|||
94496463|NCT02107898|323609710|FG001|Overall Study|Consent withdrawn by participant|1|||
94496464|NCT02107898|323609709|FG000|Overall Study|Randomized but not treated|0|||
94496465|NCT02107898|323609710|FG001|Overall Study|Randomized but not treated|1|||
94496466|NCT01283386|323609713|FG000|Overall Study|Death|2|||
94496467|NCT01283386|323609714|FG001|Overall Study|Death|0|||
94496468|NCT01283386|323609713|FG000|Overall Study|Withdrawal by Subject|2|||
94496469|NCT01283386|323609714|FG001|Overall Study|Withdrawal by Subject|1|||
94496470|NCT01283386|323609713|FG000|Overall Study|Relapse of underlying disease|1|||
94496471|NCT01283386|323609714|FG001|Overall Study|Relapse of underlying disease|3|||
94496472|NCT01283386|323609713|FG000|Overall Study|Progression of underlying disease|2|||
94496473|NCT01283386|323609714|FG001|Overall Study|Progression of underlying disease|7|||
94496474|NCT01283386|323609713|FG000|Overall Study|Reason not specified|1|||
94496475|NCT01283386|323609714|FG001|Overall Study|Reason not specified|0|||
94496476|NCT01283386|323609713|FG000|Overall Study|Protocol Violation|0|||
94496477|NCT01283386|323609714|FG001|Overall Study|Protocol Violation|1|||
94496478|NCT04796415|323609717|FG000|Overall Study|not interested|12|||
94496479|NCT04796415|323609717|FG000|Overall Study|health issue|8|||
94496480|NCT04796415|323609717|FG000|Overall Study|Other|4|||
94496481|NCT04796415|323609717|FG000|Overall Study|discharged from home health service|3|||
94496482|NCT04796415|323609717|FG000|Overall Study|re-hospitalization|2|||
94496483|NCT04796415|323609717|FG000|Overall Study|moving to nursing home|1|||
94496484|NCT04796415|323609717|FG000|Overall Study|lost contact|1|||
94496485|NCT01732783|323609718|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
94496486|NCT01732783|323609719|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
94496487|NCT01732783|323609720|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
94496488|NCT01732783|323609718|FG000|Overall Study|Death|13|||
94496489|NCT01732783|323609719|FG001|Overall Study|Death|4|||
94496490|NCT01732783|323609720|FG002|Overall Study|Death|1|||
94496491|NCT01732783|323609718|FG000|Overall Study|Lost to Follow-up|7|||
94496492|NCT01732783|323609719|FG001|Overall Study|Lost to Follow-up|1|||
94496493|NCT01732783|323609720|FG002|Overall Study|Lost to Follow-up|1|||
94496494|NCT01732783|323609718|FG000|Overall Study|Administrative Decision|8|||
94496495|NCT01732783|323609719|FG001|Overall Study|Administrative Decision|2|||
94496496|NCT01732783|323609720|FG002|Overall Study|Administrative Decision|1|||
94496497|NCT01732783|323609718|FG000|Overall Study|Withdrawal by Subject|1|||
94496498|NCT01732783|323609719|FG001|Overall Study|Withdrawal by Subject|0|||
94496499|NCT01732783|323609720|FG002|Overall Study|Withdrawal by Subject|0|||
94496500|NCT04900272|323609721|FG000|Overall Study|Lost to Follow-up|2|||
94496501|NCT04900272|323609721|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
94496502|NCT04900272|323609721|FG000|Overall Study|Withdrawal by Subject|1|||
94496503|NCT01510756|323609722|FG000|Overall Study|Death|1|||
94496504|NCT01510756|323609722|FG000|Overall Study|Lack of Efficacy|2|||
94496505|NCT01510756|323609722|FG000|Overall Study|Physician Decision|1|||
94496506|NCT00726557|323609723|FG000|Overall Study|Screening failure|4|||
94496507|NCT00726557|323609723|FG000|Overall Study|No end of treatment documentation|37|||
94496508|NCT00726557|323609723|FG000|Overall Study|No follow-up documentation available|55|||
94496509|NCT00726557|323609723|FG000|Overall Study|Treatment less than 3 months|17|||
94496510|NCT00726557|323609723|FG000|Overall Study|Inclusion criteria not met|15|||
94496511|NCT00770484|323609724|FG000|Overall Study|Withdrawal by Subject|1|||
94496512|NCT00770484|323609725|FG001|Overall Study|Withdrawal by Subject|0|||
94496513|NCT04491994|323609726|FG000|Overall Study|Withdrawal by Subject|10|||
94496514|NCT04491994|323609727|FG001|Overall Study|Withdrawal by Subject|5|||
94496515|NCT04491994|323609726|FG000|Overall Study|developed fever > 3 days|4|||
94496516|NCT04491994|323609727|FG001|Overall Study|developed fever > 3 days|1|||
94496517|NCT04491994|323609726|FG000|Overall Study|Protocol Violation|11|||
94496518|NCT04491994|323609727|FG001|Overall Study|Protocol Violation|2|||
94496519|NCT04491994|323609726|FG000|Overall Study|Lost to Follow-up|4|||
94496520|NCT04491994|323609727|FG001|Overall Study|Lost to Follow-up|3|||
94496521|NCT00311168|323609730|FG000|First Intervention|Withdrawal by Subject|2|||
94496522|NCT00311168|323609731|FG001|First Intervention|Withdrawal by Subject|2|||
94496523|NCT00311168|323609730|FG000|First Intervention|Lost to Follow-up|1|||
94496524|NCT00311168|323609731|FG001|First Intervention|Lost to Follow-up|1|||
94496525|NCT00311168|323609730|FG000|First Intervention|Protocol Violation|1|||
94496526|NCT00311168|323609731|FG001|First Intervention|Protocol Violation|1|||
94496527|NCT00311168|323609730|FG000|First Intervention|Adverse Event|1|||
94496528|NCT00311168|323609731|FG001|First Intervention|Adverse Event|0|||
94496529|NCT00311168|323609730|FG000|First Intervention|Other|2|||
94496530|NCT00311168|323609731|FG001|First Intervention|Other|2|||
94496531|NCT00311168|323609730|FG000|Second Intervention|Lost to Follow-up|9|||
94496532|NCT00311168|323609731|FG001|Second Intervention|Lost to Follow-up|2|||
94496533|NCT00311168|323609730|FG000|Second Intervention|Withdrawal by Subject|0|||
94496534|NCT00311168|323609731|FG001|Second Intervention|Withdrawal by Subject|1|||
94496535|NCT00311168|323609730|FG000|Second Intervention|Other|1|||
94496536|NCT00311168|323609731|FG001|Second Intervention|Other|1|||
94496537|NCT02755090|323609732|FG000|Overall Study|equipment malfunction|1|||
94496538|NCT02755090|323609733|FG001|Overall Study|equipment malfunction|0|||
94496539|NCT02112552|323609734|FG000|Overall Study|Withdrawal by Subject|1|||
94496540|NCT02112552|323609734|FG000|Overall Study|Adverse Event|1|||
94496541|NCT00774748|323609735|FG000|Overall Study|Lost to Follow-up|3|||
94496542|NCT00866320|323609736|FG000|Overall Study|Withdrawal by Subject|4|||
94496543|NCT00866320|323609736|FG000|Overall Study|Death|2|||
94496544|NCT03349515|323609738|FG000|Overall Study|Lack of Efficacy|2|||
94496545|NCT03349515|323609739|FG001|Overall Study|Lack of Efficacy|0|||
94496546|NCT03349515|323609738|FG000|Overall Study|Physician Decision|3|||
94496547|NCT03349515|323609739|FG001|Overall Study|Physician Decision|1|||
94496548|NCT00896233|323609741|FG000|Overall Study|Claustrophobia during MRI|1|||
94496549|NCT05073315|323609742|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
94496550|NCT05073315|323609743|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
94496551|NCT05073315|323609744|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
94496552|NCT05073315|323609742|FG000|Period 1 (Lead-in Period)|Death|1|||
94496553|NCT05073315|323609743|FG001|Period 1 (Lead-in Period)|Death|0|||
94496554|NCT05073315|323609744|FG002|Period 1 (Lead-in Period)|Death|0|||
94496555|NCT05073315|323609742|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
94496556|NCT05073315|323609743|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
94496557|NCT05073315|323609744|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
94496558|NCT05073315|323609742|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
94496559|NCT05073315|323609743|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
94496560|NCT05073315|323609744|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
94496561|NCT05073315|323609742|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
94496562|NCT05073315|323609743|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
94496563|NCT05073315|323609744|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
94496564|NCT05073315|323609742|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
94496565|NCT05073315|323609743|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
94496566|NCT05073315|323609744|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
94496567|NCT05073315|323609742|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
94496568|NCT05073315|323609743|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
94496569|NCT05073315|323609744|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
94496570|NCT05073315|323609742|FG000|Period 2|Adverse Event|0|||
94496571|NCT05073315|323609743|FG001|Period 2|Adverse Event|3|||
94496572|NCT05073315|323609744|FG002|Period 2|Adverse Event|6|||
94496573|NCT05073315|323609742|FG000|Period 2|Lost to Follow-up|0|||
94496574|NCT05073315|323609743|FG001|Period 2|Lost to Follow-up|5|||
94496575|NCT05073315|323609744|FG002|Period 2|Lost to Follow-up|5|||
94496576|NCT05073315|323609742|FG000|Period 2|Withdrawal by Subject|0|||
94496577|NCT05073315|323609743|FG001|Period 2|Withdrawal by Subject|4|||
94496578|NCT05073315|323609744|FG002|Period 2|Withdrawal by Subject|9|||
94496579|NCT05073315|323609742|FG000|Period 2|Protocol Violation|0|||
94496580|NCT05073315|323609743|FG001|Period 2|Protocol Violation|0|||
94496581|NCT05073315|323609744|FG002|Period 2|Protocol Violation|1|||
94496582|NCT01529268|323609745|FG000|Overall Study|Lost to Follow-up|9|||
94496583|NCT01529268|323609746|FG001|Overall Study|Lost to Follow-up|3|||
94496584|NCT01529268|323609745|FG000|Overall Study|Moved|3|||
94496585|NCT01529268|323609746|FG001|Overall Study|Moved|0|||
94496586|NCT00005047|323609747|FG000|Overall Study|Withdrawal by Subject|12|||
94496587|NCT00005047|323609748|FG001|Overall Study|Withdrawal by Subject|0|||
94496588|NCT00005047|323609749|FG002|Overall Study|Withdrawal by Subject|0|||
94496589|NCT00005047|323609750|FG003|Overall Study|Withdrawal by Subject|0|||
94496590|NCT00005047|323609747|FG000|Overall Study|Adverse Event|5|||
94496591|NCT00005047|323609748|FG001|Overall Study|Adverse Event|0|||
94496592|NCT00005047|323609749|FG002|Overall Study|Adverse Event|0|||
94496593|NCT00005047|323609750|FG003|Overall Study|Adverse Event|0|||
94496594|NCT00005047|323609747|FG000|Overall Study|Lost to Follow-up|1|||
94496595|NCT00005047|323609748|FG001|Overall Study|Lost to Follow-up|0|||
94496596|NCT00005047|323609749|FG002|Overall Study|Lost to Follow-up|0|||
94496597|NCT00005047|323609750|FG003|Overall Study|Lost to Follow-up|0|||
94496598|NCT00005047|323609747|FG000|Overall Study|Lack of Efficacy|1|||
94496599|NCT00005047|323609748|FG001|Overall Study|Lack of Efficacy|0|||
94496600|NCT00005047|323609749|FG002|Overall Study|Lack of Efficacy|0|||
94496601|NCT00005047|323609750|FG003|Overall Study|Lack of Efficacy|0|||
94496602|NCT01402700|323609751|FG000|Overall Study|Death|3|||
94496603|NCT01402700|323609751|FG000|Overall Study|Withdrawal by Subject|3|||
94496604|NCT01402700|323609751|FG000|Overall Study|Missed Visit|1|||
94496605|NCT02949934|323609757|FG000|Natural Drinking Period|Adverse Event|1|||
94496606|NCT02949934|323609758|FG001|Natural Drinking Period|Adverse Event|0|||
94496607|NCT02949934|323609759|FG002|Natural Drinking Period|Adverse Event|0|||
94496608|NCT02949934|323609760|FG003|Natural Drinking Period|Adverse Event|1|||
94496609|NCT02949934|323609761|FG004|Natural Drinking Period|Adverse Event|0|||
94496610|NCT02949934|323609762|FG005|Natural Drinking Period|Adverse Event|0|||
94496611|NCT02949934|323609757|FG000|Natural Drinking Period|Lost to Follow-up|0|||
94496612|NCT02949934|323609758|FG001|Natural Drinking Period|Lost to Follow-up|0|||
94496613|NCT02949934|323609759|FG002|Natural Drinking Period|Lost to Follow-up|0|||
94496614|NCT02949934|323609760|FG003|Natural Drinking Period|Lost to Follow-up|0|||
94496615|NCT02949934|323609761|FG004|Natural Drinking Period|Lost to Follow-up|1|||
94496616|NCT02949934|323609762|FG005|Natural Drinking Period|Lost to Follow-up|0|||
94496617|NCT02949934|323609757|FG000|Neuroimaging|Protocol Violation|2|||
94496618|NCT02949934|323609758|FG001|Neuroimaging|Protocol Violation|0|||
94496619|NCT02949934|323609759|FG002|Neuroimaging|Protocol Violation|0|||
94496620|NCT02949934|323609760|FG003|Neuroimaging|Protocol Violation|0|||
94496621|NCT02949934|323609761|FG004|Neuroimaging|Protocol Violation|1|||
94496622|NCT02949934|323609762|FG005|Neuroimaging|Protocol Violation|0|||
94496623|NCT02949934|323609757|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
94496624|NCT02949934|323609758|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
94496625|NCT02949934|323609759|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
94496626|NCT02949934|323609760|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
94496627|NCT02949934|323609761|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
94496628|NCT02949934|323609762|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
94496629|NCT02949934|323609757|FG000|Neuroimaging|Not scanned|0|||
94496630|NCT02949934|323609758|FG001|Neuroimaging|Not scanned|0|||
94496631|NCT02949934|323609759|FG002|Neuroimaging|Not scanned|1|||
94496632|NCT02949934|323609760|FG003|Neuroimaging|Not scanned|0|||
94496633|NCT02949934|323609761|FG004|Neuroimaging|Not scanned|0|||
94496634|NCT02949934|323609762|FG005|Neuroimaging|Not scanned|2|||
94496635|NCT02949934|323609757|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
94496636|NCT02949934|323609758|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
94496637|NCT02949934|323609759|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
94496638|NCT02949934|323609760|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
94496639|NCT02949934|323609761|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
94496640|NCT02949934|323609762|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
94496641|NCT02949934|323609757|FG000|Bar Laboratory|Adverse Event|1|||
94496642|NCT02949934|323609758|FG001|Bar Laboratory|Adverse Event|0|||
94496643|NCT02949934|323609759|FG002|Bar Laboratory|Adverse Event|2|||
94496644|NCT02949934|323609760|FG003|Bar Laboratory|Adverse Event|0|||
94496645|NCT02949934|323609761|FG004|Bar Laboratory|Adverse Event|1|||
94496646|NCT02949934|323609762|FG005|Bar Laboratory|Adverse Event|0|||
94496647|NCT02949934|323609757|FG000|Bar Laboratory|Protocol Violation|0|||
94496648|NCT02949934|323609758|FG001|Bar Laboratory|Protocol Violation|0|||
94496649|NCT02949934|323609759|FG002|Bar Laboratory|Protocol Violation|0|||
94496650|NCT02949934|323609760|FG003|Bar Laboratory|Protocol Violation|1|||
94496651|NCT02949934|323609761|FG004|Bar Laboratory|Protocol Violation|0|||
94496652|NCT02949934|323609762|FG005|Bar Laboratory|Protocol Violation|0|||
94496653|NCT01928771|323609774|FG000|Overall Study|Adverse Event|6|||
94496654|NCT01928771|323609775|FG001|Overall Study|Adverse Event|5|||
94496655|NCT01928771|323609776|FG002|Overall Study|Adverse Event|1|||
94496656|NCT01928771|323609774|FG000|Overall Study|Death|2|||
94496657|NCT01928771|323609775|FG001|Overall Study|Death|2|||
94496658|NCT01928771|323609776|FG002|Overall Study|Death|2|||
94496659|NCT01928771|323609774|FG000|Overall Study|Lost to Follow-up|5|||
94496660|NCT01928771|323609775|FG001|Overall Study|Lost to Follow-up|6|||
94496661|NCT01928771|323609776|FG002|Overall Study|Lost to Follow-up|3|||
94496662|NCT01928771|323609774|FG000|Overall Study|Withdrawal by Subject|20|||
94496663|NCT01928771|323609775|FG001|Overall Study|Withdrawal by Subject|15|||
94496664|NCT01928771|323609776|FG002|Overall Study|Withdrawal by Subject|17|||
94496665|NCT01928771|323609774|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
94496666|NCT01928771|323609775|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
94496667|NCT01928771|323609776|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
94496668|NCT01928771|323609774|FG000|Overall Study|Other Reasons|9|||
94496669|NCT01928771|323609775|FG001|Overall Study|Other Reasons|9|||
94496670|NCT01928771|323609776|FG002|Overall Study|Other Reasons|14|||
94496671|NCT01928771|323609774|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
94496672|NCT01928771|323609775|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
94496673|NCT01928771|323609776|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
94496674|NCT02332707|323611095|FG000|Overall Study|Adverse Event|0|||
94496675|NCT02332707|323611096|FG001|Overall Study|Adverse Event|0|||
94496676|NCT02332707|323611097|FG002|Overall Study|Adverse Event|0|||
94496677|NCT02332707|323611098|FG003|Overall Study|Adverse Event|0|||
94496678|NCT02332707|323611099|FG004|Overall Study|Adverse Event|0|||
94496679|NCT02332707|323611100|FG005|Overall Study|Adverse Event|0|||
94496680|NCT02332707|323611101|FG006|Overall Study|Adverse Event|0|||
94496681|NCT02332707|323611102|FG007|Overall Study|Adverse Event|0|||
94496682|NCT02332707|323611103|FG008|Overall Study|Adverse Event|0|||
94496683|NCT02332707|323611104|FG009|Overall Study|Adverse Event|0|||
94496684|NCT02332707|323611105|FG010|Overall Study|Adverse Event|0|||
94496685|NCT02332707|323611106|FG011|Overall Study|Adverse Event|0|||
94496686|NCT02332707|323611107|FG012|Overall Study|Adverse Event|1|||
94496687|NCT02332707|323611108|FG013|Overall Study|Adverse Event|0|||
94496688|NCT02332707|323611109|FG014|Overall Study|Adverse Event|0|||
94496689|NCT02332707|323611110|FG015|Overall Study|Adverse Event|0|||
94496690|NCT02332707|323611111|FG016|Overall Study|Adverse Event|0|||
94496691|NCT02332707|323611112|FG017|Overall Study|Adverse Event|0|||
94496692|NCT02332707|323611095|FG000|Overall Study|Lost to Follow-up|0|||
94496693|NCT02332707|323611096|FG001|Overall Study|Lost to Follow-up|0|||
94496694|NCT02332707|323611097|FG002|Overall Study|Lost to Follow-up|0|||
94496695|NCT02332707|323611098|FG003|Overall Study|Lost to Follow-up|0|||
94496696|NCT02332707|323611099|FG004|Overall Study|Lost to Follow-up|0|||
94496697|NCT02332707|323611100|FG005|Overall Study|Lost to Follow-up|1|||
94496698|NCT02332707|323611101|FG006|Overall Study|Lost to Follow-up|0|||
94496699|NCT02332707|323611102|FG007|Overall Study|Lost to Follow-up|0|||
94496700|NCT02332707|323611103|FG008|Overall Study|Lost to Follow-up|0|||
94496701|NCT02332707|323611104|FG009|Overall Study|Lost to Follow-up|0|||
94496702|NCT02332707|323611105|FG010|Overall Study|Lost to Follow-up|2|||
94496703|NCT02332707|323611106|FG011|Overall Study|Lost to Follow-up|0|||
94496704|NCT02332707|323611107|FG012|Overall Study|Lost to Follow-up|3|||
94496705|NCT02332707|323611108|FG013|Overall Study|Lost to Follow-up|0|||
94496706|NCT02332707|323611109|FG014|Overall Study|Lost to Follow-up|0|||
94496707|NCT02332707|323611110|FG015|Overall Study|Lost to Follow-up|0|||
94496708|NCT02332707|323611111|FG016|Overall Study|Lost to Follow-up|0|||
94496709|NCT02332707|323611112|FG017|Overall Study|Lost to Follow-up|0|||
94496710|NCT02332707|323611095|FG000|Overall Study|Physician Decision|0|||
94496711|NCT02332707|323611096|FG001|Overall Study|Physician Decision|0|||
94496712|NCT02332707|323611097|FG002|Overall Study|Physician Decision|0|||
94496713|NCT02332707|323611098|FG003|Overall Study|Physician Decision|1|||
94496714|NCT02332707|323611099|FG004|Overall Study|Physician Decision|0|||
94496715|NCT02332707|323611100|FG005|Overall Study|Physician Decision|0|||
94496716|NCT02332707|323611101|FG006|Overall Study|Physician Decision|0|||
94496717|NCT02332707|323611102|FG007|Overall Study|Physician Decision|0|||
94496718|NCT02332707|323611103|FG008|Overall Study|Physician Decision|0|||
94496719|NCT02332707|323611104|FG009|Overall Study|Physician Decision|0|||
94496720|NCT02332707|323611105|FG010|Overall Study|Physician Decision|0|||
94496721|NCT02332707|323611106|FG011|Overall Study|Physician Decision|0|||
94496722|NCT02332707|323611107|FG012|Overall Study|Physician Decision|1|||
94496723|NCT02332707|323611108|FG013|Overall Study|Physician Decision|0|||
94496724|NCT02332707|323611109|FG014|Overall Study|Physician Decision|0|||
94496725|NCT02332707|323611110|FG015|Overall Study|Physician Decision|0|||
94496726|NCT02332707|323611111|FG016|Overall Study|Physician Decision|0|||
94496727|NCT02332707|323611112|FG017|Overall Study|Physician Decision|0|||
94496728|NCT02332707|323611095|FG000|Overall Study|Withdrawal by Subject|0|||
94496729|NCT02332707|323611096|FG001|Overall Study|Withdrawal by Subject|0|||
94496730|NCT02332707|323611097|FG002|Overall Study|Withdrawal by Subject|1|||
94496731|NCT02332707|323611098|FG003|Overall Study|Withdrawal by Subject|0|||
94496732|NCT02332707|323611099|FG004|Overall Study|Withdrawal by Subject|0|||
94496733|NCT02332707|323611100|FG005|Overall Study|Withdrawal by Subject|0|||
94496734|NCT02332707|323611101|FG006|Overall Study|Withdrawal by Subject|0|||
94496735|NCT02332707|323611102|FG007|Overall Study|Withdrawal by Subject|0|||
94496736|NCT02332707|323611103|FG008|Overall Study|Withdrawal by Subject|0|||
94496737|NCT02332707|323611104|FG009|Overall Study|Withdrawal by Subject|3|||
94496738|NCT02332707|323611105|FG010|Overall Study|Withdrawal by Subject|0|||
94496739|NCT02332707|323611106|FG011|Overall Study|Withdrawal by Subject|0|||
94496740|NCT02332707|323611107|FG012|Overall Study|Withdrawal by Subject|0|||
94496741|NCT02332707|323611108|FG013|Overall Study|Withdrawal by Subject|0|||
94496742|NCT02332707|323611109|FG014|Overall Study|Withdrawal by Subject|0|||
94496743|NCT02332707|323611110|FG015|Overall Study|Withdrawal by Subject|0|||
94496744|NCT02332707|323611111|FG016|Overall Study|Withdrawal by Subject|0|||
94496745|NCT02332707|323611112|FG017|Overall Study|Withdrawal by Subject|0|||
94496746|NCT00690898|323611116|FG000|SCREENING|Screen failure|18|||
94496747|NCT00690898|323611116|FG000|TREATMENT|Adverse Event|3|||
94496748|NCT00690898|323611116|FG000|TREATMENT|Lack of Efficacy|18|||
94496749|NCT00690898|323611116|FG000|TREATMENT|Withdrawal by Subject|4|||
94496750|NCT00690898|323611116|FG000|TREATMENT|Other (not otherwise specified)|1|||
94496751|NCT02513199|323611121|FG000|Treatment|Death|1|||
94496752|NCT02513199|323611121|FG000|Treatment|Lost to Follow-up|1|||
94496753|NCT02513199|323611121|FG000|Follow-Up|Death|11|||
94496754|NCT02034591|323611122|FG000|Overall Study|Withdrawal by Subject|0|||
94496755|NCT02034591|323611123|FG001|Overall Study|Withdrawal by Subject|0|||
94496756|NCT02034591|323611124|FG002|Overall Study|Withdrawal by Subject|0|||
94496757|NCT02034591|323611125|FG003|Overall Study|Withdrawal by Subject|0|||
94496758|NCT02034591|323611126|FG004|Overall Study|Withdrawal by Subject|1|||
94496759|NCT02034591|323611127|FG005|Overall Study|Withdrawal by Subject|0|||
94496760|NCT03086343|323611128|FG000|Period 1|Adverse Event|7|||
94496761|NCT03086343|323611129|FG001|Period 1|Adverse Event|7|||
94496762|NCT03086343|323611130|FG002|Period 1|Adverse Event|0|||
94496763|NCT03086343|323611131|FG003|Period 1|Adverse Event|1|||
94496764|NCT03086343|323611128|FG000|Period 1|Withdrawal by Subject|6|||
94496765|NCT03086343|323611129|FG001|Period 1|Withdrawal by Subject|10|||
94496766|NCT03086343|323611130|FG002|Period 1|Withdrawal by Subject|0|||
94496767|NCT03086343|323611131|FG003|Period 1|Withdrawal by Subject|0|||
94496768|NCT03086343|323611128|FG000|Period 1|Lost to Follow-up|1|||
94655621|NCT04369469|324196101|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
94496769|NCT03086343|323611129|FG001|Period 1|Lost to Follow-up|3|||
94496770|NCT03086343|323611130|FG002|Period 1|Lost to Follow-up|1|||
94496771|NCT03086343|323611131|FG003|Period 1|Lost to Follow-up|0|||
94496772|NCT03086343|323611128|FG000|Period 1|Other, Not Specified|10|||
94496773|NCT03086343|323611129|FG001|Period 1|Other, Not Specified|12|||
94496774|NCT03086343|323611130|FG002|Period 1|Other, Not Specified|2|||
94496775|NCT03086343|323611131|FG003|Period 1|Other, Not Specified|1|||
94496776|NCT03086343|323611128|FG000|Period 1|Missing|1|||
94496777|NCT03086343|323611129|FG001|Period 1|Missing|0|||
94496778|NCT03086343|323611130|FG002|Period 1|Missing|0|||
94496779|NCT03086343|323611131|FG003|Period 1|Missing|0|||
94496780|NCT03086343|323611128|FG000|Period 2|Adverse Event|20|||
94496781|NCT03086343|323611129|FG001|Period 2|Adverse Event|11|||
94496782|NCT03086343|323611130|FG002|Period 2|Adverse Event|1|||
94496783|NCT03086343|323611131|FG003|Period 2|Adverse Event|2|||
94496784|NCT03086343|323611128|FG000|Period 2|Withdrawal by Subject|15|||
94496785|NCT03086343|323611129|FG001|Period 2|Withdrawal by Subject|25|||
94496786|NCT03086343|323611130|FG002|Period 2|Withdrawal by Subject|2|||
94496787|NCT03086343|323611131|FG003|Period 2|Withdrawal by Subject|2|||
94496788|NCT03086343|323611128|FG000|Period 2|Lost to Follow-up|6|||
94496789|NCT03086343|323611129|FG001|Period 2|Lost to Follow-up|11|||
94496790|NCT03086343|323611130|FG002|Period 2|Lost to Follow-up|1|||
94496791|NCT03086343|323611131|FG003|Period 2|Lost to Follow-up|0|||
94496792|NCT03086343|323611128|FG000|Period 2|COVID-19 Infection|5|||
94496793|NCT03086343|323611129|FG001|Period 2|COVID-19 Infection|0|||
94496794|NCT03086343|323611130|FG002|Period 2|COVID-19 Infection|0|||
94496795|NCT03086343|323611131|FG003|Period 2|COVID-19 Infection|0|||
94496796|NCT03086343|323611128|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
94496797|NCT03086343|323611129|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
94496798|NCT03086343|323611130|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
94496799|NCT03086343|323611131|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
94496800|NCT03086343|323611128|FG000|Period 2|Other, Not Specified|23|||
94496801|NCT03086343|323611129|FG001|Period 2|Other, Not Specified|22|||
94496802|NCT03086343|323611130|FG002|Period 2|Other, Not Specified|2|||
94496803|NCT03086343|323611131|FG003|Period 2|Other, Not Specified|4|||
94496804|NCT01500083|323611132|FG000|Overall Study|Adverse Event|4|||
94496805|NCT01500083|323611133|FG001|Overall Study|Adverse Event|17|||
94496806|NCT01500083|323611132|FG000|Overall Study|Death|0|||
94496807|NCT01500083|323611133|FG001|Overall Study|Death|2|||
94496808|NCT01500083|323611132|FG000|Overall Study|Lost to Follow-up|1|||
94496809|NCT01500083|323611133|FG001|Overall Study|Lost to Follow-up|0|||
94496810|NCT01500083|323611132|FG000|Overall Study|Withdrawal of Consent|0|||
94496811|NCT01500083|323611133|FG001|Overall Study|Withdrawal of Consent|1|||
94496812|NCT01500083|323611132|FG000|Overall Study|Disease Progression|2|||
94496813|NCT01500083|323611133|FG001|Overall Study|Disease Progression|10|||
94496814|NCT01500083|323611132|FG000|Overall Study|Investigator Discretion|3|||
94496815|NCT01500083|323611133|FG001|Overall Study|Investigator Discretion|8|||
94496816|NCT01500083|323611132|FG000|Overall Study|Other Reasons|2|||
94496817|NCT01500083|323611133|FG001|Overall Study|Other Reasons|5|||
94496818|NCT01531153|323611134|FG000|Overall Study|Withdrawal by Subject|10|||
94496819|NCT01531153|323611135|FG001|Overall Study|Withdrawal by Subject|9|||
94496820|NCT01531153|323611136|FG002|Overall Study|Withdrawal by Subject|15|||
94496821|NCT00800540|323611142|FG000|Period One: 6 Weeks|Noncompliance|1|||
94496822|NCT00800540|323611143|FG001|Period One: 6 Weeks|Noncompliance|0|||
94496823|NCT00800540|323611142|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
94496824|NCT00800540|323611143|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
94496825|NCT00800540|323611142|FG000|Period 2: 6 Weeks|Adverse Event|0|||
94496826|NCT00800540|323611143|FG001|Period 2: 6 Weeks|Adverse Event|1|||
94496827|NCT01922011|323611144|FG000|Overall Study|Protocol Violation|0|||
94496828|NCT01922011|323611145|FG001|Overall Study|Protocol Violation|1|||
94496829|NCT01922011|323611144|FG000|Overall Study|Physician Decision|0|||
94496830|NCT01922011|323611145|FG001|Overall Study|Physician Decision|1|||
94496831|NCT01922011|323611144|FG000|Overall Study|Parent/Guardian Decision|3|||
94496832|NCT01922011|323611145|FG001|Overall Study|Parent/Guardian Decision|0|||
94496833|NCT01922011|323611144|FG000|Overall Study|Lost to Follow-up|0|||
94496834|NCT01922011|323611145|FG001|Overall Study|Lost to Follow-up|1|||
94496835|NCT01922011|323611144|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
94496836|NCT01922011|323611145|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
94496837|NCT01922011|323611144|FG000|Overall Study|Not Treated|1|||
94496838|NCT01922011|323611145|FG001|Overall Study|Not Treated|0|||
94496839|NCT01922011|323611144|FG000|Overall Study|Lack of willing home health agency|1|||
94496840|NCT01922011|323611145|FG001|Overall Study|Lack of willing home health agency|0|||
94496841|NCT01922011|323611144|FG000|Overall Study|Randomized in error|1|||
94496842|NCT01922011|323611145|FG001|Overall Study|Randomized in error|0|||
94496843|NCT01239745|323611146|FG000|Overall Study|Study terminated by sponsor|45|||
94496844|NCT01239745|323611146|FG000|Overall Study|Adverse Event|1|||
94496845|NCT01898130|323611149|FG000|Treatment|Withdrawal by Subject|2|||
94496846|NCT01898130|323611149|FG000|Treatment|Progressive Disease|4|||
94496847|NCT01898130|323611149|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
94496848|NCT03600428|323611152|FG000|Overall Study|Not eligible|0|||
94496849|NCT03600428|323611153|FG001|Overall Study|Not eligible|1|||
94496850|NCT03600428|323611152|FG000|Overall Study|Lost to Follow-up|5|||
94496851|NCT03600428|323611153|FG001|Overall Study|Lost to Follow-up|4|||
94496852|NCT00549328|323611154|FG000|Overall Study|Adverse Event|2|||
94496853|NCT00549328|323611154|FG000|Overall Study|Disease Progression|10|||
94496854|NCT00549328|323611154|FG000|Overall Study|Death|1|||
94496855|NCT00549328|323611154|FG000|Overall Study|Use of Prohibited Medication|1|||
94496856|NCT03097315|323611159|FG000|Overall Study|Withdrawal by Subject|1|||
94496857|NCT01946802|323611160|FG000|Overall Study|Death|1|||
94496858|NCT01946802|323611160|FG000|Overall Study|Withdrawal by Subject|2|||
94496859|NCT01946802|323611160|FG000|Overall Study|Combined septic shock|1|||
94496860|NCT01946802|323611160|FG000|Overall Study|Protocol Violation|1|||
94496861|NCT02153827|323611161|FG000|Overall Study|Lost to Follow-up|3|||
94496862|NCT02153827|323611162|FG001|Overall Study|Lost to Follow-up|9|||
94496863|NCT02606253|323611165|FG000|Overall Study|Adverse Event|2|||
94496864|NCT02606253|323611166|FG001|Overall Study|Adverse Event|0|||
94496865|NCT02606253|323611167|FG002|Overall Study|Adverse Event|0|||
94496866|NCT02606253|323611165|FG000|Overall Study|Protocol Violation|2|||
94496867|NCT02606253|323611166|FG001|Overall Study|Protocol Violation|1|||
94496868|NCT02606253|323611167|FG002|Overall Study|Protocol Violation|0|||
94496869|NCT02606253|323611165|FG000|Overall Study|Physician Decision|1|||
94496870|NCT02606253|323611166|FG001|Overall Study|Physician Decision|1|||
94496871|NCT02606253|323611167|FG002|Overall Study|Physician Decision|0|||
94496872|NCT01158404|323611168|FG000|Overall Study|Withdrawal by Subject|0|||
94496873|NCT01158404|323611169|FG001|Overall Study|Withdrawal by Subject|1|||
94496874|NCT01158404|323611170|FG002|Overall Study|Withdrawal by Subject|0|||
94496875|NCT01158404|323611171|FG003|Overall Study|Withdrawal by Subject|0|||
94496876|NCT01158404|323611172|FG004|Overall Study|Withdrawal by Subject|3|||
94496877|NCT01158404|323611173|FG005|Overall Study|Withdrawal by Subject|1|||
94496878|NCT01158404|323611174|FG006|Overall Study|Withdrawal by Subject|0|||
94496879|NCT01158404|323611175|FG007|Overall Study|Withdrawal by Subject|1|||
94496880|NCT01158404|323611168|FG000|Overall Study|Physician Decision|0|||
94496881|NCT01158404|323611169|FG001|Overall Study|Physician Decision|0|||
94496882|NCT01158404|323611170|FG002|Overall Study|Physician Decision|0|||
94496883|NCT01158404|323611171|FG003|Overall Study|Physician Decision|0|||
94496884|NCT01158404|323611172|FG004|Overall Study|Physician Decision|0|||
94496885|NCT01158404|323611173|FG005|Overall Study|Physician Decision|0|||
94496886|NCT01158404|323611174|FG006|Overall Study|Physician Decision|0|||
94496887|NCT01158404|323611175|FG007|Overall Study|Physician Decision|1|||
94496888|NCT01158404|323611168|FG000|Overall Study|Progressive Disease|0|||
94496889|NCT01158404|323611169|FG001|Overall Study|Progressive Disease|0|||
94496890|NCT01158404|323611170|FG002|Overall Study|Progressive Disease|0|||
94496891|NCT01158404|323611171|FG003|Overall Study|Progressive Disease|0|||
94496892|NCT01158404|323611172|FG004|Overall Study|Progressive Disease|0|||
94496893|NCT01158404|323611173|FG005|Overall Study|Progressive Disease|0|||
94496894|NCT01158404|323611174|FG006|Overall Study|Progressive Disease|1|||
94496895|NCT01158404|323611175|FG007|Overall Study|Progressive Disease|0|||
94496896|NCT00997126|323611180|FG000|Overall Study|Physician Decision|7|||
94496897|NCT00997126|323611181|FG001|Overall Study|Physician Decision|11|||
94496898|NCT02691663|323611182|FG000|Overall Study|Screen failure after baseline|2|||
94496899|NCT02691663|323611183|FG001|Overall Study|Screen failure after baseline|2|||
94496900|NCT02691663|323611182|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
94496901|NCT02691663|323611183|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
94496902|NCT02691663|323611182|FG000|Overall Study|Withdrawn after Follow up 2|1|||
94496903|NCT02691663|323611183|FG001|Overall Study|Withdrawn after Follow up 2|1|||
94496904|NCT02691663|323611182|FG000|Overall Study|Lost to Follow-up|3|||
94496905|NCT02691663|323611183|FG001|Overall Study|Lost to Follow-up|2|||
94496906|NCT03142750|323611184|FG000|Overall Study|Lost to Follow-up|4|||
94496907|NCT03142750|323611185|FG001|Overall Study|Lost to Follow-up|1|||
94496908|NCT00387127|323611190|FG000|Overall Study|Lost to Follow-up|0|||
94496909|NCT00387127|323611191|FG001|Overall Study|Lost to Follow-up|4|||
94496910|NCT00387127|323611190|FG000|Overall Study|Death|16|||
94496911|NCT00387127|323611191|FG001|Overall Study|Death|16|||
94496912|NCT00387127|323611190|FG000|Overall Study|Physician Decision|0|||
94496913|NCT00387127|323611191|FG001|Overall Study|Physician Decision|1|||
94496914|NCT00387127|323611190|FG000|Overall Study|Withdrawal by Subject|3|||
94496915|NCT00387127|323611191|FG001|Overall Study|Withdrawal by Subject|2|||
94496916|NCT00387127|323611190|FG000|Overall Study|Required by Protocol Amendment #4|12|||
94496917|NCT00387127|323611191|FG001|Overall Study|Required by Protocol Amendment #4|10|||
94496918|NCT00387127|323611190|FG000|Overall Study|Serious Adverse Event|1|||
94496919|NCT00387127|323611191|FG001|Overall Study|Serious Adverse Event|1|||
94496920|NCT00387127|323611190|FG000|Overall Study|Sponsor Unblinded|1|||
94496921|NCT00387127|323611191|FG001|Overall Study|Sponsor Unblinded|0|||
94496922|NCT03983109|323611192|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
94496923|NCT03983109|323611193|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
94496924|NCT00317369|323611194|FG000|Overall Study|Adverse Event|2|||
94496925|NCT00317369|323611195|FG001|Overall Study|Adverse Event|1|||
94496926|NCT00317369|323611196|FG002|Overall Study|Adverse Event|0|||
94496927|NCT00317369|323611194|FG000|Overall Study|Lack of Efficacy|0|||
94496928|NCT00317369|323611195|FG001|Overall Study|Lack of Efficacy|1|||
94496929|NCT00317369|323611196|FG002|Overall Study|Lack of Efficacy|1|||
94496930|NCT00317369|323611194|FG000|Overall Study|Withdrawal by Subject|0|||
94496931|NCT00317369|323611195|FG001|Overall Study|Withdrawal by Subject|0|||
94496932|NCT00317369|323611196|FG002|Overall Study|Withdrawal by Subject|1|||
94496933|NCT04615507|323611198|FG000|Period 1|Covid-19 exposure|2|||
94496934|NCT04615507|323611199|FG001|Period 1|Covid-19 exposure|1|||
94496935|NCT04615507|323611198|FG000|Period 2|Covid-19 exposure|0|||
94496936|NCT04615507|323611199|FG001|Period 2|Covid-19 exposure|1|||
94496937|NCT04615507|323611198|FG000|Period 2|Protocol Violation|1|||
94496938|NCT04615507|323611199|FG001|Period 2|Protocol Violation|0|||
94496939|NCT04615507|323611198|FG000|Period 2|Withdrawal by Subject|1|||
94496940|NCT04615507|323611199|FG001|Period 2|Withdrawal by Subject|0|||
94496941|NCT04615507|323611198|FG000|Period 2|Adverse Event|0|||
94496942|NCT04615507|323611199|FG001|Period 2|Adverse Event|1|||
94496943|NCT04615507|323611198|FG000|Period 3|Covid-19 exposure|0|||
94496944|NCT04615507|323611199|FG001|Period 3|Covid-19 exposure|1|||
94496945|NCT01947933|323611200|FG000|Overall Study|Withdrawal by Subject|0|||
94496946|NCT01947933|323611201|FG001|Overall Study|Withdrawal by Subject|0|||
94496947|NCT01947933|323611202|FG002|Overall Study|Withdrawal by Subject|1|||
94496948|NCT01947933|323611203|FG003|Overall Study|Withdrawal by Subject|0|||
94496949|NCT01947933|323611204|FG004|Overall Study|Withdrawal by Subject|0|||
94496950|NCT01947933|323611205|FG005|Overall Study|Withdrawal by Subject|0|||
94496951|NCT01947933|323611206|FG006|Overall Study|Withdrawal by Subject|0|||
94496952|NCT01947933|323611207|FG007|Overall Study|Withdrawal by Subject|0|||
94496953|NCT01947933|323611208|FG008|Overall Study|Withdrawal by Subject|0|||
94496954|NCT01947933|323611200|FG000|Overall Study|Lost to Follow-up|0|||
94496955|NCT01947933|323611201|FG001|Overall Study|Lost to Follow-up|0|||
94496956|NCT01947933|323611202|FG002|Overall Study|Lost to Follow-up|0|||
94496957|NCT01947933|323611203|FG003|Overall Study|Lost to Follow-up|0|||
94496958|NCT01947933|323611204|FG004|Overall Study|Lost to Follow-up|0|||
94496959|NCT01947933|323611205|FG005|Overall Study|Lost to Follow-up|0|||
94496960|NCT01947933|323611206|FG006|Overall Study|Lost to Follow-up|0|||
94496961|NCT01947933|323611207|FG007|Overall Study|Lost to Follow-up|0|||
94496962|NCT01947933|323611208|FG008|Overall Study|Lost to Follow-up|1|||
94496963|NCT03370302|323611209|FG000|Dose Escalation Phase|Other|0|||
94496964|NCT03370302|323611210|FG001|Dose Escalation Phase|Other|1|||
94496965|NCT03370302|323611211|FG002|Dose Escalation Phase|Other|1|||
94496966|NCT03370302|323611212|FG003|Dose Escalation Phase|Other|0|||
94496967|NCT03370302|323611213|FG004|Dose Escalation Phase|Other|0|||
94496968|NCT03370302|323611214|FG005|Dose Escalation Phase|Other|0|||
94496969|NCT03370302|323611209|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
94496970|NCT03370302|323611210|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
94496971|NCT03370302|323611211|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
94496972|NCT03370302|323611212|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
94496973|NCT03370302|323611213|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
94496974|NCT03370302|323611214|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
94496975|NCT03370302|323611209|FG000|Dose Escalation Phase|Adverse Event|1|||
94496976|NCT03370302|323611210|FG001|Dose Escalation Phase|Adverse Event|0|||
94496977|NCT03370302|323611211|FG002|Dose Escalation Phase|Adverse Event|2|||
94496978|NCT03370302|323611212|FG003|Dose Escalation Phase|Adverse Event|0|||
94496979|NCT03370302|323611213|FG004|Dose Escalation Phase|Adverse Event|0|||
94496980|NCT03370302|323611214|FG005|Dose Escalation Phase|Adverse Event|0|||
94496981|NCT03370302|323611209|FG000|Dose Escalation Phase|Progressive Disease|2|||
94496982|NCT03370302|323611210|FG001|Dose Escalation Phase|Progressive Disease|4|||
94496983|NCT03370302|323611211|FG002|Dose Escalation Phase|Progressive Disease|2|||
94496984|NCT03370302|323611212|FG003|Dose Escalation Phase|Progressive Disease|0|||
94496985|NCT03370302|323611213|FG004|Dose Escalation Phase|Progressive Disease|3|||
94496986|NCT03370302|323611214|FG005|Dose Escalation Phase|Progressive Disease|1|||
94496987|NCT03370302|323611209|FG000|Dose Expansion Phase|Progressive Disease|0|||
94496988|NCT03370302|323611210|FG001|Dose Expansion Phase|Progressive Disease|0|||
94496989|NCT03370302|323611211|FG002|Dose Expansion Phase|Progressive Disease|0|||
94496990|NCT03370302|323611212|FG003|Dose Expansion Phase|Progressive Disease|6|||
94496991|NCT03370302|323611213|FG004|Dose Expansion Phase|Progressive Disease|0|||
94496992|NCT03370302|323611214|FG005|Dose Expansion Phase|Progressive Disease|0|||
94496993|NCT04124965|323611215|FG000|Overall Study|Adverse event, non-fatal|3|||
94496994|NCT04124965|323611216|FG001|Overall Study|Adverse event, non-fatal|1|||
94496995|NCT04124965|323611215|FG000|Overall Study|Withdrawal by Subject|1|||
94496996|NCT04124965|323611216|FG001|Overall Study|Withdrawal by Subject|1|||
94496997|NCT04124965|323611215|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
94496998|NCT04124965|323611216|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
94496999|NCT04124965|323611215|FG000|Overall Study|Pregnancy|1|||
94497000|NCT04124965|323611216|FG001|Overall Study|Pregnancy|0|||
94497001|NCT04124965|323611215|FG000|Overall Study|Sponsor and participant decision|0|||
94497002|NCT04124965|323611216|FG001|Overall Study|Sponsor and participant decision|1|||
94497003|NCT04124965|323611215|FG000|Overall Study|Personal surgery|0|||
94497004|NCT04124965|323611216|FG001|Overall Study|Personal surgery|1|||
94497005|NCT04124965|323611215|FG000|Overall Study|Physician Decision|0|||
94497006|NCT04124965|323611216|FG001|Overall Study|Physician Decision|1|||
94497007|NCT01397747|323611230|FG000|Overall Study|Multitarget DNA test excluded|689|||
94497008|NCT01397747|323611230|FG000|Overall Study|Colonoscopy excluded|304|||
94497009|NCT01397747|323611230|FG000|Overall Study|FIT excluded|34|||
94497010|NCT00544882|323611231|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
94497011|NCT00544882|323611232|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
94497012|NCT00544882|323611233|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
94497013|NCT00544882|323611231|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
94497014|NCT00544882|323611232|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
94497015|NCT00544882|323611233|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
94497016|NCT00544882|323611231|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
94497017|NCT00544882|323611232|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
94497018|NCT00544882|323611233|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
94497019|NCT00544882|323611231|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
94497020|NCT00544882|323611232|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
94497021|NCT00544882|323611233|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
94497022|NCT00544882|323611231|FG000|Cycle 3: Follow-up|Noncompliance|0|||
94497023|NCT00544882|323611232|FG001|Cycle 3: Follow-up|Noncompliance|1|||
94497024|NCT00544882|323611233|FG002|Cycle 3: Follow-up|Noncompliance|0|||
94497025|NCT00544882|323611231|FG000|Cycle 3: Follow-up|Pregnancy|0|||
94497026|NCT00544882|323611232|FG001|Cycle 3: Follow-up|Pregnancy|1|||
94497027|NCT00544882|323611233|FG002|Cycle 3: Follow-up|Pregnancy|0|||
94497028|NCT02830087|323611234|FG000|Overall Study|No study staff to follow-up patients|4|||
94497029|NCT02830087|323611235|FG001|Overall Study|No study staff to follow-up patients|4|||
94497030|NCT02830087|323611236|FG002|Overall Study|No study staff to follow-up patients|4|||
94497031|NCT02830087|323611237|FG003|Overall Study|No study staff to follow-up patients|3|||
94497032|NCT02830087|323611238|FG004|Overall Study|No study staff to follow-up patients|3|||
94497033|NCT02830087|323611239|FG005|Overall Study|No study staff to follow-up patients|3|||
94497034|NCT01039675|323611242|FG000|Overall Study|Adverse Event|0|||
94497035|NCT01039675|323611243|FG001|Overall Study|Adverse Event|2|||
94497036|NCT01039675|323611242|FG000|Overall Study|Lack of Efficacy|0|||
94497037|NCT01039675|323611243|FG001|Overall Study|Lack of Efficacy|2|||
94497038|NCT01039675|323611242|FG000|Overall Study|Withdrawal by Subject|0|||
94497039|NCT01039675|323611243|FG001|Overall Study|Withdrawal by Subject|1|||
94497040|NCT01039675|323611242|FG000|Overall Study|Lost to Follow-up|0|||
94497041|NCT01039675|323611243|FG001|Overall Study|Lost to Follow-up|1|||
94497042|NCT01039675|323611242|FG000|Overall Study|Physician Decision|0|||
94497043|NCT01039675|323611243|FG001|Overall Study|Physician Decision|1|||
94497044|NCT01350973|323611246|FG000|Overall Study|Adverse Event|4|||
94497045|NCT01350973|323611247|FG001|Overall Study|Adverse Event|7|||
94497046|NCT01350973|323611248|FG002|Overall Study|Adverse Event|7|||
94497047|NCT01350973|323611246|FG000|Overall Study|Voluntary Withdrawal|2|||
94497048|NCT01350973|323611247|FG001|Overall Study|Voluntary Withdrawal|1|||
94497049|NCT01350973|323611248|FG002|Overall Study|Voluntary Withdrawal|1|||
94497050|NCT01695772|323611252|FG000|Overall Study|Withdrawal by Subject|18|||
94497051|NCT01695772|323611252|FG000|Overall Study|Progressive Disease|8|||
94497052|NCT01695772|323611252|FG000|Overall Study|Investigator Decision|5|||
94497053|NCT01695772|323611252|FG000|Overall Study|Lost to Follow-up|4|||
94497054|NCT01695772|323611252|FG000|Overall Study|Protocol Violation|2|||
94497055|NCT01695772|323611252|FG000|Overall Study|Unspecified Reason|1|||
94497056|NCT04073407|323611253|FG000|Part 1|Withdrawal by Subject|1|||
94497057|NCT04073407|323611254|FG001|Part 1|Withdrawal by Subject|0|||
94497058|NCT04073407|323611253|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
94497059|NCT04073407|323611254|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
94497060|NCT04073407|323611253|FG000|Part 2|Withdrawal by Subject|0|||
94497061|NCT04073407|323611254|FG001|Part 2|Withdrawal by Subject|1|||
94497062|NCT01653262|323612764|FG000|Overall Study|Lack of Efficacy|1|||
94497063|NCT01653262|323612764|FG000|Overall Study|SAE, non-fatal|1|||
94497064|NCT01653262|323612764|FG000|Overall Study|AE, non-serious non-fatal|1|||
94497065|NCT01793935|323612771|FG000|Overall Study|Pregnancy|1|||
94497066|NCT01793935|323612772|FG001|Overall Study|Pregnancy|0|||
94497067|NCT01793935|323612771|FG000|Overall Study|Protocol Violation|2|||
94497068|NCT01793935|323612772|FG001|Overall Study|Protocol Violation|1|||
94497069|NCT01793935|323612771|FG000|Overall Study|Adverse Event|2|||
94497070|NCT01793935|323612772|FG001|Overall Study|Adverse Event|0|||
94497071|NCT01793935|323612771|FG000|Overall Study|Patient did not take study medication|1|||
94497072|NCT01793935|323612772|FG001|Overall Study|Patient did not take study medication|1|||
94497073|NCT01793935|323612771|FG000|Overall Study|Lost to Follow-up|0|||
94497074|NCT01793935|323612772|FG001|Overall Study|Lost to Follow-up|1|||
94497075|NCT00741611|323612774|FG000|Overall Study|Death|0|||
94497076|NCT00741611|323612775|FG001|Overall Study|Death|0|||
94497077|NCT00741611|323612776|FG002|Overall Study|Death|1|||
94497078|NCT00741611|323612774|FG000|Overall Study|Withdrawal by Subject|0|||
94497079|NCT00741611|323612775|FG001|Overall Study|Withdrawal by Subject|2|||
94497080|NCT00741611|323612776|FG002|Overall Study|Withdrawal by Subject|2|||
94497081|NCT00429299|323612784|FG000|Overall Study|Disease Progression|1|||
94497082|NCT00429299|323612785|FG001|Overall Study|Disease Progression|1|||
94497083|NCT00429299|323612786|FG002|Overall Study|Disease Progression|0|||
94497084|NCT00429299|323612784|FG000|Overall Study|Adverse Event|2|||
94497085|NCT00429299|323612785|FG001|Overall Study|Adverse Event|5|||
94497086|NCT00429299|323612786|FG002|Overall Study|Adverse Event|1|||
94497087|NCT00429299|323612784|FG000|Overall Study|Protocol Violation|1|||
94497088|NCT00429299|323612785|FG001|Overall Study|Protocol Violation|0|||
94497089|NCT00429299|323612786|FG002|Overall Study|Protocol Violation|0|||
94497090|NCT00429299|323612784|FG000|Overall Study|Withdrawal by Subject|0|||
94497091|NCT00429299|323612785|FG001|Overall Study|Withdrawal by Subject|1|||
94497092|NCT00429299|323612786|FG002|Overall Study|Withdrawal by Subject|3|||
94497093|NCT02447029|323612788|FG000|Overall Study|Withdrawal by Subject|3|||
94497094|NCT02447029|323612789|FG001|Overall Study|Withdrawal by Subject|2|||
94497095|NCT01257542|323612790|FG000|Overall Study|Protocol Violation|3|||
94497096|NCT01257542|323612791|FG001|Overall Study|Protocol Violation|5|||
94497097|NCT01257542|323612790|FG000|Overall Study|Withdrawal by Subject|0|||
94497098|NCT01257542|323612791|FG001|Overall Study|Withdrawal by Subject|2|||
94497099|NCT00081458|323612793|FG000|Overall Study|Adverse Event|1|||
94497100|NCT00081458|323612794|FG001|Overall Study|Adverse Event|5|||
94497101|NCT00081458|323612795|FG002|Overall Study|Adverse Event|2|||
94497102|NCT00081458|323612793|FG000|Overall Study|Withdrawal by Subject|0|||
94497103|NCT00081458|323612794|FG001|Overall Study|Withdrawal by Subject|3|||
94497104|NCT00081458|323612795|FG002|Overall Study|Withdrawal by Subject|1|||
94497105|NCT00081458|323612793|FG000|Overall Study|Randomized but not dosed|0|||
94497106|NCT00081458|323612794|FG001|Overall Study|Randomized but not dosed|0|||
94497107|NCT00081458|323612795|FG002|Overall Study|Randomized but not dosed|1|||
94497108|NCT00875667|323612798|FG000|Overall Study|Adverse Event|29|||
94497109|NCT00875667|323612799|FG001|Overall Study|Adverse Event|10|||
94497110|NCT00875667|323612798|FG000|Overall Study|Withdrawal by Subject|17|||
94497111|NCT00875667|323612799|FG001|Overall Study|Withdrawal by Subject|5|||
94497112|NCT00875667|323612798|FG000|Overall Study|Death|7|||
94497113|NCT00875667|323612799|FG001|Overall Study|Death|2|||
94497114|NCT00875667|323612798|FG000|Overall Study|Protocol Violation|2|||
94497115|NCT00875667|323612799|FG001|Overall Study|Protocol Violation|0|||
94497116|NCT00875667|323612798|FG000|Overall Study|Disease Progression|100|||
94497117|NCT00875667|323612799|FG001|Overall Study|Disease Progression|49|||
94497118|NCT00875667|323612798|FG000|Overall Study|Miscellaneous|12|||
94497119|NCT00875667|323612799|FG001|Overall Study|Miscellaneous|6|||
94497120|NCT00875667|323612798|FG000|Overall Study|Randomized but no Study Drug Given|3|||
94497121|NCT00875667|323612799|FG001|Overall Study|Randomized but no Study Drug Given|1|||
94497122|NCT04398134|323612800|FG000|Overall Study|Adverse Event|0|||
94497123|NCT04398134|323612801|FG001|Overall Study|Adverse Event|0|||
94497124|NCT04398134|323612802|FG002|Overall Study|Adverse Event|1|||
94497125|NCT04398134|323612803|FG003|Overall Study|Adverse Event|0|||
94497126|NCT04398134|323612800|FG000|Overall Study|Withdrawal by Subject|2|||
94497127|NCT04398134|323612801|FG001|Overall Study|Withdrawal by Subject|0|||
94497128|NCT04398134|323612802|FG002|Overall Study|Withdrawal by Subject|0|||
94497129|NCT04398134|323612803|FG003|Overall Study|Withdrawal by Subject|1|||
94497130|NCT04398134|323612800|FG000|Overall Study|Study Terminated by Sponsor|30|||
94497131|NCT04398134|323612801|FG001|Overall Study|Study Terminated by Sponsor|11|||
94497132|NCT04398134|323612802|FG002|Overall Study|Study Terminated by Sponsor|32|||
94497133|NCT04398134|323612803|FG003|Overall Study|Study Terminated by Sponsor|11|||
94497134|NCT05161936|323612804|FG000|Overall Study|Study terminated by Sponsor|1|||
94497135|NCT05161936|323612805|FG001|Overall Study|Study terminated by Sponsor|0|||
94497136|NCT05161936|323612806|FG002|Overall Study|Study terminated by Sponsor|0|||
94497137|NCT05161936|323612804|FG000|Overall Study|Withdrawal by Subject|0|||
94497138|NCT05161936|323612805|FG001|Overall Study|Withdrawal by Subject|0|||
94497139|NCT05161936|323612806|FG002|Overall Study|Withdrawal by Subject|1|||
94497140|NCT01334515|323612810|FG000|Overall Study|Adverse Event|1|||
94497141|NCT01334515|323612811|FG001|Overall Study|Adverse Event|6|||
94497142|NCT01334515|323612810|FG000|Overall Study|Death|1|||
94497143|NCT01334515|323612811|FG001|Overall Study|Death|0|||
94497144|NCT01334515|323612810|FG000|Overall Study|Lack of Efficacy|8|||
94497145|NCT01334515|323612811|FG001|Overall Study|Lack of Efficacy|21|||
94497146|NCT01334515|323612810|FG000|Overall Study|Physician Decision|1|||
94497147|NCT01334515|323612811|FG001|Overall Study|Physician Decision|1|||
94497148|NCT01334515|323612810|FG000|Overall Study|Withdrawal by Subject|1|||
94497149|NCT01334515|323612811|FG001|Overall Study|Withdrawal by Subject|1|||
94497150|NCT01479530|323612812|FG000|Overall Study|Adverse Event|5|||
94497151|NCT01479530|323612813|FG001|Overall Study|Adverse Event|6|||
94497152|NCT01479530|323612812|FG000|Overall Study|Lack of Efficacy|0|||
94497153|NCT01479530|323612813|FG001|Overall Study|Lack of Efficacy|1|||
94497154|NCT01479530|323612812|FG000|Overall Study|Protocol Violation|2|||
94497155|NCT01479530|323612813|FG001|Overall Study|Protocol Violation|3|||
94497156|NCT01479530|323612812|FG000|Overall Study|Withdrawal of Consent|3|||
94497157|NCT01479530|323612813|FG001|Overall Study|Withdrawal of Consent|2|||
94497158|NCT04795323|323612814|FG000|Overall Study|Did not interact with TARA|1|||
94497159|NCT04795323|323612815|FG001|Overall Study|Did not interact with TARA|0|||
94497160|NCT02836769|323612816|FG000|Overall Study|Lost to Follow-up|10|||
94497161|NCT02836769|323612816|FG000|Overall Study|Medical withdrawal|2|||
94497162|NCT02836769|323612816|FG000|Overall Study|Withdrawal by Subject|3|||
94497163|NCT00776997|323612818|FG000|Overall Study|Adverse Event|2|||
94497164|NCT01716156|323612819|FG000|Overall Study|Protocol Violation|1|||
94497165|NCT01716156|323612820|FG001|Overall Study|Protocol Violation|0|||
94497166|NCT01716156|323612821|FG002|Overall Study|Protocol Violation|0|||
94497167|NCT01716156|323612819|FG000|Overall Study|Withdrawal by Subject|0|||
94497168|NCT01716156|323612820|FG001|Overall Study|Withdrawal by Subject|1|||
94497169|NCT01716156|323612821|FG002|Overall Study|Withdrawal by Subject|2|||
94497170|NCT01716156|323612819|FG000|Overall Study|Lost to Follow-up|1|||
94497171|NCT01716156|323612820|FG001|Overall Study|Lost to Follow-up|0|||
94497172|NCT01716156|323612821|FG002|Overall Study|Lost to Follow-up|0|||
94497173|NCT00221104|323612822|FG000|Overall Study|Adverse Event|1|||
94497174|NCT00221104|323612823|FG001|Overall Study|Adverse Event|0|||
94497175|NCT00221104|323612822|FG000|Overall Study|Physician Decision|1|||
94497176|NCT00221104|323612823|FG001|Overall Study|Physician Decision|0|||
94497177|NCT00221104|323612822|FG000|Overall Study|Protocol Violation|2|||
94497178|NCT00221104|323612823|FG001|Overall Study|Protocol Violation|0|||
94497179|NCT00221104|323612822|FG000|Overall Study|Withdrawal by Subject|42|||
94497180|NCT00221104|323612823|FG001|Overall Study|Withdrawal by Subject|29|||
94497181|NCT00221104|323612822|FG000|Overall Study|Others|37|||
94497182|NCT00221104|323612823|FG001|Overall Study|Others|47|||
94497183|NCT03412890|323612826|FG000|Overall Study|Adverse Event|5|||
94497184|NCT03412890|323612827|FG001|Overall Study|Adverse Event|5|||
94497185|NCT03412890|323612828|FG002|Overall Study|Adverse Event|9|||
94497186|NCT03412890|323612826|FG000|Overall Study|Protocol deviation|2|||
94497187|NCT03412890|323612827|FG001|Overall Study|Protocol deviation|1|||
94497188|NCT03412890|323612828|FG002|Overall Study|Protocol deviation|2|||
94497189|NCT03412890|323612826|FG000|Overall Study|Lost to Follow-up|7|||
94497190|NCT03412890|323612827|FG001|Overall Study|Lost to Follow-up|10|||
94497191|NCT03412890|323612828|FG002|Overall Study|Lost to Follow-up|10|||
94497192|NCT03412890|323612826|FG000|Overall Study|Withdrawal by Subject|9|||
94497193|NCT03412890|323612827|FG001|Overall Study|Withdrawal by Subject|12|||
94497194|NCT03412890|323612828|FG002|Overall Study|Withdrawal by Subject|11|||
94497195|NCT03412890|323612826|FG000|Overall Study|Lack of Efficacy|2|||
94497196|NCT03412890|323612827|FG001|Overall Study|Lack of Efficacy|7|||
94497197|NCT03412890|323612828|FG002|Overall Study|Lack of Efficacy|5|||
94497198|NCT03412890|323612826|FG000|Overall Study|Other|5|||
94497199|NCT03412890|323612827|FG001|Overall Study|Other|6|||
94497200|NCT03412890|323612828|FG002|Overall Study|Other|5|||
94497201|NCT03412890|323612826|FG000|Overall Study|Participants who did not receive any study drug|0|||
94497202|NCT03412890|323612827|FG001|Overall Study|Participants who did not receive any study drug|1|||
94497203|NCT03412890|323612828|FG002|Overall Study|Participants who did not receive any study drug|0|||
94497204|NCT02503865|323612829|FG000|Overall Study|Moved out of area|1|||
94497205|NCT02503865|323612830|FG001|Overall Study|Moved out of area|8|||
94497206|NCT02503865|323612831|FG002|Overall Study|Moved out of area|0|||
94497207|NCT02503865|323612829|FG000|Overall Study|Refused treatment|4|||
94497208|NCT02503865|323612830|FG001|Overall Study|Refused treatment|39|||
94497209|NCT02503865|323612831|FG002|Overall Study|Refused treatment|2|||
94497210|NCT01132755|323612832|FG000|Overall Study|Procedure not done due to medical reason|23|||
94497211|NCT01132755|323612832|FG000|Overall Study|Protocol Violation|15|||
94497212|NCT01132755|323612832|FG000|Overall Study|Withdrawal by Subject|4|||
94497213|NCT02393755|323612833|FG000|Overall Study|Withdrawal by Subject|0|||
94497214|NCT02393755|323612834|FG001|Overall Study|Withdrawal by Subject|3|||
94497215|NCT02393755|323612833|FG000|Overall Study|Adverse Event|0|||
94497216|NCT02393755|323612834|FG001|Overall Study|Adverse Event|2|||
94497217|NCT02393755|323612833|FG000|Overall Study|Physician Decision|0|||
94497218|NCT02393755|323612834|FG001|Overall Study|Physician Decision|2|||
94497219|NCT02337946|323612835|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
94497220|NCT02337946|323612836|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
94497221|NCT02337946|323612837|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
94497222|NCT02337946|323612835|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
94497223|NCT02337946|323612836|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
94497224|NCT02337946|323612837|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
94497225|NCT02337946|323612835|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
94497226|NCT02337946|323612836|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
94497227|NCT02337946|323612837|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
94497228|NCT02337946|323612835|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
94497229|NCT02337946|323612836|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
94497230|NCT02337946|323612837|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
94497231|NCT02337946|323612835|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
94497232|NCT02337946|323612836|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
94497233|NCT02337946|323612837|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
94497234|NCT02337946|323612835|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
94497235|NCT02337946|323612836|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
94497236|NCT02337946|323612837|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
94497237|NCT02337946|323612835|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
94497238|NCT02337946|323612836|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
94497239|NCT02337946|323612837|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
94497240|NCT02337946|323612835|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
94497241|NCT02337946|323612836|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
94497242|NCT02337946|323612837|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
94497243|NCT02337946|323612835|FG000|In-between Period|Without Informed Consent|1|||
94497244|NCT02337946|323612836|FG001|In-between Period|Without Informed Consent|0|||
94497245|NCT02337946|323612837|FG002|In-between Period|Without Informed Consent|0|||
94497246|NCT02337946|323612835|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
94497247|NCT02337946|323612836|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
94497248|NCT02337946|323612837|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
94497249|NCT02337946|323612835|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
94497250|NCT02337946|323612836|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
94497251|NCT02337946|323612837|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
94497252|NCT02337946|323612835|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
94497253|NCT02337946|323612836|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
94497254|NCT02337946|323612837|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
94497255|NCT02337946|323612835|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
94497256|NCT02337946|323612836|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
94497257|NCT02337946|323612837|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
94497258|NCT02337946|323612835|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
94497259|NCT02337946|323612836|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
94497260|NCT02337946|323612837|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
94497261|NCT02337946|323612835|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
94497262|NCT02337946|323612836|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
94497263|NCT02337946|323612837|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
94497264|NCT01327703|323612838|FG000|Second Treatment Period|Adverse Event|1|||
94497265|NCT01327703|323612839|FG001|Second Treatment Period|Adverse Event|1|||
94497266|NCT01327703|323612838|FG000|Second Treatment Period|Protocol Violation|0|||
94497267|NCT01327703|323612839|FG001|Second Treatment Period|Protocol Violation|1|||
94497268|NCT00927082|323612841|FG000|Overall Study|Lost to Follow-up|9|||
94497269|NCT00927082|323612842|FG001|Overall Study|Lost to Follow-up|8|||
94497270|NCT00927082|323612843|FG002|Overall Study|Lost to Follow-up|12|||
94497271|NCT00927082|323612844|FG003|Overall Study|Lost to Follow-up|16|||
94497272|NCT00927082|323612841|FG000|Overall Study|Withdrawal by Subject|3|||
94497273|NCT00927082|323612842|FG001|Overall Study|Withdrawal by Subject|2|||
94497274|NCT00927082|323612843|FG002|Overall Study|Withdrawal by Subject|7|||
94497275|NCT00927082|323612844|FG003|Overall Study|Withdrawal by Subject|2|||
94497276|NCT00927082|323612841|FG000|Overall Study|Death|0|||
94497277|NCT00927082|323612842|FG001|Overall Study|Death|0|||
94497278|NCT00927082|323612843|FG002|Overall Study|Death|1|||
94497279|NCT00927082|323612844|FG003|Overall Study|Death|0|||
94497280|NCT00927082|323612841|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
94497281|NCT00927082|323612842|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
94497282|NCT00927082|323612843|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
94497283|NCT00927082|323612844|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
94497284|NCT01786109|323612846|FG000|Overall Study|fail manometry barostat tube placement|1|||
94497285|NCT01786109|323612847|FG001|Overall Study|fail manometry barostat tube placement|0|||
94497286|NCT01786109|323612848|FG002|Overall Study|fail manometry barostat tube placement|0|||
94497287|NCT01786109|323612846|FG000|Overall Study|unrelated illness|0|||
94497288|NCT01786109|323612847|FG001|Overall Study|unrelated illness|0|||
94497289|NCT01786109|323612848|FG002|Overall Study|unrelated illness|1|||
94497290|NCT01786109|323612846|FG000|Overall Study|adverse effects colon preparation|0|||
94497291|NCT01786109|323612847|FG001|Overall Study|adverse effects colon preparation|0|||
94497292|NCT01786109|323612848|FG002|Overall Study|adverse effects colon preparation|1|||
94497293|NCT04069520|323612849|FG000|Overall Study|Lost to Follow-up|0|||
94497294|NCT04069520|323612850|FG001|Overall Study|Lost to Follow-up|2|||
94497295|NCT04069520|323612849|FG000|Overall Study|Withdrawal by Subject|0|||
94497296|NCT04069520|323612850|FG001|Overall Study|Withdrawal by Subject|1|||
94497297|NCT04069520|323612849|FG000|Overall Study|Prior Injury|1|||
94497298|NCT04069520|323612850|FG001|Overall Study|Prior Injury|0|||
94497299|NCT04069520|323612849|FG000|Overall Study|Orthodontia|1|||
94497300|NCT04069520|323612850|FG001|Overall Study|Orthodontia|0|||
94497301|NCT04069520|323612849|FG000|Overall Study|Cut from team|0|||
94497302|NCT04069520|323612850|FG001|Overall Study|Cut from team|2|||
94497303|NCT00849472|323612851|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
94497304|NCT00849472|323612851|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
94497305|NCT00849472|323612851|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
94497306|NCT00849472|323612851|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
94497307|NCT00849472|323612851|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
94497308|NCT00849472|323612851|FG000|Weekly Paclitaxel|Disease Progression|1|||
94497309|NCT00849472|323612851|FG000|Weekly Paclitaxel|Adverse Event|11|||
94497310|NCT00849472|323612851|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
94497311|NCT00849472|323612851|FG000|Weekly Paclitaxel|Physician Decision|3|||
94497312|NCT00849472|323612851|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
94497313|NCT00849472|323612851|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
94497314|NCT00849472|323612851|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
94497315|NCT00849472|323612851|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
94497316|NCT00849472|323612851|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
94497317|NCT00849472|323612851|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
94497318|NCT00849472|323612851|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
94497319|NCT00849472|323612851|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
94497320|NCT01068912|323612852|FG000|Overall Study|Adverse Event|2|||
94497321|NCT01068912|323612853|FG001|Overall Study|Adverse Event|3|||
94497322|NCT01068912|323612854|FG002|Overall Study|Adverse Event|2|||
94497323|NCT01068912|323612852|FG000|Overall Study|Withdrawal by Subject|5|||
94497324|NCT01068912|323612853|FG001|Overall Study|Withdrawal by Subject|6|||
94497325|NCT01068912|323612854|FG002|Overall Study|Withdrawal by Subject|6|||
94497326|NCT01068912|323612852|FG000|Overall Study|Lost to Follow-up|3|||
94497327|NCT01068912|323612853|FG001|Overall Study|Lost to Follow-up|7|||
94497328|NCT01068912|323612854|FG002|Overall Study|Lost to Follow-up|3|||
94497329|NCT01068912|323612852|FG000|Overall Study|Protocol Violation|0|||
94497330|NCT01068912|323612853|FG001|Overall Study|Protocol Violation|2|||
94497331|NCT01068912|323612854|FG002|Overall Study|Protocol Violation|0|||
94497332|NCT01068912|323612852|FG000|Overall Study|aggravation influenza|1|||
94497333|NCT01068912|323612853|FG001|Overall Study|aggravation influenza|1|||
94497334|NCT01068912|323612854|FG002|Overall Study|aggravation influenza|1|||
94497335|NCT01068912|323612852|FG000|Overall Study|other underlying illness|0|||
94497336|NCT01068912|323612853|FG001|Overall Study|other underlying illness|3|||
94497337|NCT01068912|323612854|FG002|Overall Study|other underlying illness|3|||
94497338|NCT00294398|323612855|FG000|Overall Study|Lost to Follow-up|21|||
94497339|NCT00294398|323612856|FG001|Overall Study|Lost to Follow-up|26|||
94497340|NCT04739709|323612863|FG000|Overall Study|Physician Decision|1|||
94497341|NCT04739709|323612864|FG001|Overall Study|Physician Decision|0|||
94497342|NCT02184156|323612868|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
94497343|NCT02184156|323612869|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
94497344|NCT02184156|323612868|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
94497345|NCT02184156|323612869|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
94497346|NCT03770455|323612875|FG000|Overall Study|Screen failures|3|||
94497347|NCT01121575|323612876|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
94497348|NCT01121575|323612877|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
94497349|NCT01121575|323612878|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
94497350|NCT01121575|323612879|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
94497351|NCT01121575|323612880|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
94497352|NCT01121575|323612881|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
94497353|NCT01121575|323612876|FG000|Overall Study|Unspecified Reasons|8|||
94497354|NCT01121575|323612877|FG001|Overall Study|Unspecified Reasons|6|||
94497355|NCT01121575|323612878|FG002|Overall Study|Unspecified Reasons|7|||
94497356|NCT01121575|323612879|FG003|Overall Study|Unspecified Reasons|5|||
94497357|NCT01121575|323612880|FG004|Overall Study|Unspecified Reasons|13|||
94497358|NCT01121575|323612881|FG005|Overall Study|Unspecified Reasons|10|||
94497359|NCT01121575|323612876|FG000|Overall Study|Death|6|||
94497360|NCT01121575|323612877|FG001|Overall Study|Death|0|||
94497361|NCT01121575|323612878|FG002|Overall Study|Death|0|||
94497362|NCT01121575|323612879|FG003|Overall Study|Death|1|||
94497363|NCT01121575|323612880|FG004|Overall Study|Death|7|||
94497364|NCT01121575|323612881|FG005|Overall Study|Death|1|||
94497365|NCT03158311|323612884|FG000|Overall Study|Subject/Guardian Decision|10|||
94497366|NCT03158311|323612885|FG001|Overall Study|Subject/Guardian Decision|6|||
94497367|NCT03158311|323612886|FG002|Overall Study|Subject/Guardian Decision|11|||
94497368|NCT03158311|323612884|FG000|Overall Study|Adverse Event|5|||
94497369|NCT03158311|323612885|FG001|Overall Study|Adverse Event|3|||
94497370|NCT03158311|323612886|FG002|Overall Study|Adverse Event|3|||
94497371|NCT03158311|323612884|FG000|Overall Study|Techinical Problems|3|||
94497372|NCT03158311|323612885|FG001|Overall Study|Techinical Problems|1|||
94497373|NCT03158311|323612886|FG002|Overall Study|Techinical Problems|5|||
94497374|NCT03158311|323612884|FG000|Overall Study|Physician Decision|2|||
94497375|NCT03158311|323612885|FG001|Overall Study|Physician Decision|3|||
94497376|NCT03158311|323612886|FG002|Overall Study|Physician Decision|7|||
94497377|NCT03158311|323612884|FG000|Overall Study|Lost to Follow-up|1|||
94497378|NCT03158311|323612885|FG001|Overall Study|Lost to Follow-up|1|||
94497379|NCT03158311|323612886|FG002|Overall Study|Lost to Follow-up|1|||
94497380|NCT03158311|323612884|FG000|Overall Study|Sponsor decision|1|||
94497381|NCT03158311|323612885|FG001|Overall Study|Sponsor decision|0|||
94497382|NCT03158311|323612886|FG002|Overall Study|Sponsor decision|0|||
94497383|NCT03158311|323612884|FG000|Overall Study|Pregnancy|0|||
94497384|NCT03158311|323612885|FG001|Overall Study|Pregnancy|2|||
94497385|NCT03158311|323612886|FG002|Overall Study|Pregnancy|0|||
94497386|NCT03158311|323612884|FG000|Overall Study|Randomized in error|0|||
94497387|NCT03158311|323612885|FG001|Overall Study|Randomized in error|0|||
94497388|NCT03158311|323612886|FG002|Overall Study|Randomized in error|1|||
94497389|NCT01018953|323612887|FG000|Overall Study|Adverse Event|2|||
94497390|NCT01018953|323612887|FG000|Overall Study|Withdrawal by Subject|1|||
94497391|NCT01018953|323612887|FG000|Overall Study|Study termination by sponsor|5|||
94497392|NCT00724503|323612888|FG000|Overall Study|Lost to Follow-up|4|||
94497393|NCT00724503|323612889|FG001|Overall Study|Lost to Follow-up|8|||
94497394|NCT00724503|323612888|FG000|Overall Study|Withdrawal by Subject|11|||
94497395|NCT00724503|323612889|FG001|Overall Study|Withdrawal by Subject|23|||
94497396|NCT00724503|323612888|FG000|Overall Study|Death|190|||
94497397|NCT00724503|323612889|FG001|Overall Study|Death|182|||
94497398|NCT00724503|323612888|FG000|Overall Study|Adverse Event|1|||
94497399|NCT00724503|323612889|FG001|Overall Study|Adverse Event|0|||
94497400|NCT00724503|323612888|FG000|Overall Study|Not otherwise specified|4|||
94497401|NCT00724503|323612889|FG001|Overall Study|Not otherwise specified|7|||
94497402|NCT01452347|323612892|FG000|Overall Study|Adverse Event|2|||
94497403|NCT01452347|323612893|FG001|Overall Study|Adverse Event|1|||
94497404|NCT01452347|323612892|FG000|Overall Study|Non compliance protocol|2|||
94497405|NCT01452347|323612893|FG001|Overall Study|Non compliance protocol|0|||
94497406|NCT01452347|323612892|FG000|Overall Study|Lost to Follow-up|2|||
94497407|NCT01452347|323612893|FG001|Overall Study|Lost to Follow-up|0|||
94497408|NCT01452347|323612892|FG000|Overall Study|Withdrawal by Subject|3|||
94497409|NCT01452347|323612893|FG001|Overall Study|Withdrawal by Subject|3|||
94497410|NCT01452347|323612892|FG000|Overall Study|Not treated|6|||
94497411|NCT01452347|323612893|FG001|Overall Study|Not treated|3|||
94497412|NCT01452347|323612892|FG000|Overall Study|Other reason not defined above|2|||
94497413|NCT01452347|323612893|FG001|Overall Study|Other reason not defined above|0|||
94497414|NCT01671059|323612894|FG000|Overall Study|Adverse Event|4|||
94497415|NCT01671059|323612894|FG000|Overall Study|Lack of Efficacy|1|||
94497416|NCT01030900|323612898|FG000|Overall Study|Not treated due to congestive heart failure|1|||
94497417|NCT01030900|323612898|FG000|Overall Study|Not treated due to rapid disease|1|||
94497418|NCT00441896|323612901|FG000|Overall Study|Withdrawal by Subject|0|||
94497419|NCT00441896|323612902|FG001|Overall Study|Withdrawal by Subject|0|||
94497420|NCT00441896|323612903|FG002|Overall Study|Withdrawal by Subject|0|||
94497421|NCT00441896|323612904|FG003|Overall Study|Withdrawal by Subject|1|||
94497422|NCT00441896|323612905|FG004|Overall Study|Withdrawal by Subject|0|||
94497423|NCT00441896|323612906|FG005|Overall Study|Withdrawal by Subject|0|||
94497424|NCT00441896|323612907|FG006|Overall Study|Withdrawal by Subject|0|||
94497425|NCT00441896|323612908|FG007|Overall Study|Withdrawal by Subject|0|||
94497426|NCT00441896|323612909|FG008|Overall Study|Withdrawal by Subject|0|||
94497427|NCT00441896|323612910|FG009|Overall Study|Withdrawal by Subject|0|||
94497428|NCT00441896|323612901|FG000|Overall Study|Other|0|||
94497429|NCT00441896|323612902|FG001|Overall Study|Other|0|||
94497430|NCT00441896|323612903|FG002|Overall Study|Other|0|||
94497431|NCT00441896|323612904|FG003|Overall Study|Other|0|||
94497432|NCT00441896|323612905|FG004|Overall Study|Other|1|||
94497433|NCT00441896|323612906|FG005|Overall Study|Other|0|||
94497434|NCT00441896|323612907|FG006|Overall Study|Other|0|||
94497435|NCT00441896|323612908|FG007|Overall Study|Other|0|||
94497436|NCT00441896|323612909|FG008|Overall Study|Other|0|||
94497437|NCT00441896|323612910|FG009|Overall Study|Other|0|||
94497438|NCT01301092|323612911|FG000|Overall Study|Lost to Follow-up|0|||
94497439|NCT01301092|323612912|FG001|Overall Study|Lost to Follow-up|0|||
94497440|NCT01301092|323612913|FG002|Overall Study|Lost to Follow-up|1|||
94497441|NCT03334175|323612914|FG000|Overall Study|Lost to Follow-up|0|||
94497442|NCT03334175|323612915|FG001|Overall Study|Lost to Follow-up|1|||
94497443|NCT01363076|323614790|FG000|Overall Study|Withdrawal by Subject|0|||
94497444|NCT01363076|323614791|FG001|Overall Study|Withdrawal by Subject|1|||
94497445|NCT04333498|323614792|FG000|Overall Study|Lost to Follow-up|1|||
94497446|NCT04333498|323614793|FG001|Overall Study|Lost to Follow-up|0|||
94497447|NCT04333498|323614792|FG000|Overall Study|Lost to Follow-up|0|||
94497448|NCT04333498|323614793|FG001|Overall Study|Lost to Follow-up|1|||
94497449|NCT00143507|323614799|FG000|Overall Study|Death|572|||
94497450|NCT00143507|323614800|FG001|Overall Study|Death|547|||
94497451|NCT00143507|323614799|FG000|Overall Study|Withdrawal by Subject|114|||
94497452|NCT00143507|323614800|FG001|Overall Study|Withdrawal by Subject|102|||
94497453|NCT00143507|323614799|FG000|Overall Study|Lost to Follow-up|1|||
94497454|NCT00143507|323614800|FG001|Overall Study|Lost to Follow-up|0|||
94497455|NCT00143507|323614799|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
94497456|NCT00143507|323614800|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
94497457|NCT00484159|323614801|FG000|Overall Study|Lost to Follow-up|1|||
94497458|NCT00484159|323614802|FG001|Overall Study|Lost to Follow-up|1|||
94497459|NCT00484159|323614803|FG002|Overall Study|Lost to Follow-up|0|||
94497460|NCT04766333|323614804|FG000|Overall Study|Lost to Follow-up|40|||
94497461|NCT04766333|323614805|FG001|Overall Study|Lost to Follow-up|826|||
94497462|NCT05417113|323614806|FG000|Overall Study|Lost to Follow-up|2|||
94497463|NCT05417113|323614807|FG001|Overall Study|Lost to Follow-up|2|||
94497464|NCT01022580|323614808|FG000|Overall Study|Death|18|||
94497465|NCT01022580|323614809|FG001|Overall Study|Death|22|||
94497466|NCT00134719|323614810|FG000|Primary Vaccination Phase|Adverse Event|4|||
94497467|NCT00134719|323614811|FG001|Primary Vaccination Phase|Adverse Event|0|||
94497468|NCT00134719|323614812|FG002|Primary Vaccination Phase|Adverse Event|0|||
94497469|NCT00134719|323614810|FG000|Primary Vaccination Phase|Protocol Violation|1|||
94497470|NCT00134719|323614811|FG001|Primary Vaccination Phase|Protocol Violation|0|||
94497471|NCT00134719|323614812|FG002|Primary Vaccination Phase|Protocol Violation|0|||
94497472|NCT00134719|323614810|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
94497473|NCT00134719|323614811|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
94497474|NCT00134719|323614812|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
94497475|NCT00134719|323614810|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
94497476|NCT00134719|323614811|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
94497477|NCT00134719|323614812|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
94497478|NCT00134719|323614810|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
94497479|NCT00134719|323614811|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
94497480|NCT00134719|323614812|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
94497481|NCT00134719|323614810|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
94497482|NCT00134719|323614811|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
94497483|NCT00134719|323614812|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
94497484|NCT00876395|323614813|FG000|Overall Study|Untreated|8|||
94497485|NCT00876395|323614814|FG001|Overall Study|Untreated|1|||
94497486|NCT00876395|323614813|FG000|Overall Study|Adverse Event|63|||
94497487|NCT00876395|323614814|FG001|Overall Study|Adverse Event|11|||
94497488|NCT00876395|323614813|FG000|Overall Study|Abnormal test procedure result(s)|1|||
94497489|NCT00876395|323614814|FG001|Overall Study|Abnormal test procedure result(s)|0|||
94497490|NCT00876395|323614813|FG000|Overall Study|Disease progression|259|||
94497491|NCT00876395|323614814|FG001|Overall Study|Disease progression|162|||
94497492|NCT00876395|323614813|FG000|Overall Study|New cancer therapy|25|||
94497493|NCT00876395|323614814|FG001|Overall Study|New cancer therapy|7|||
94497494|NCT00876395|323614813|FG000|Overall Study|Protocol Violation|5|||
94497495|NCT00876395|323614814|FG001|Overall Study|Protocol Violation|2|||
94497496|NCT00876395|323614813|FG000|Overall Study|Withdrawal by Subject|66|||
94497497|NCT00876395|323614814|FG001|Overall Study|Withdrawal by Subject|33|||
94497498|NCT00876395|323614813|FG000|Overall Study|Lost to Follow-up|2|||
94497499|NCT00876395|323614814|FG001|Overall Study|Lost to Follow-up|0|||
94497500|NCT00876395|323614813|FG000|Overall Study|Administrative problems|39|||
94497501|NCT00876395|323614814|FG001|Overall Study|Administrative problems|23|||
94497502|NCT00876395|323614813|FG000|Overall Study|Death|12|||
94497503|NCT00876395|323614814|FG001|Overall Study|Death|0|||
94497504|NCT03720847|323614815|FG000|Washout|Physician Decision|1|||
94497505|NCT03720847|323614816|FG001|Washout|Physician Decision|2|||
94497506|NCT03022630|323614817|FG000|Overall Study|Death|9|||
94497507|NCT03022630|323614818|FG001|Overall Study|Death|7|||
94497508|NCT03022630|323614817|FG000|Overall Study|Withdrawal by Subject|0|||
94497509|NCT03022630|323614818|FG001|Overall Study|Withdrawal by Subject|5|||
94497510|NCT00884949|323614819|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
94497511|NCT00884949|323614819|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
94497512|NCT01807520|323614822|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
94497513|NCT01807520|323614823|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
94497514|NCT01807520|323614824|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
94497515|NCT01807520|323614825|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
94497516|NCT01807520|323614826|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
94497517|NCT01807520|323614827|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
94497518|NCT01807520|323614828|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
94497519|NCT01807520|323614822|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
94497520|NCT01807520|323614823|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
94497521|NCT01807520|323614824|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
94497522|NCT01807520|323614825|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
94497523|NCT01807520|323614826|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
94497524|NCT01807520|323614827|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
94497525|NCT01807520|323614828|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
94497526|NCT01807520|323614822|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
94497527|NCT01807520|323614823|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
94497528|NCT01807520|323614824|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
94497529|NCT01807520|323614825|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
94497530|NCT01807520|323614826|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
94497531|NCT01807520|323614827|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
94497532|NCT01807520|323614828|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
94497533|NCT01807520|323614822|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
94497534|NCT01807520|323614823|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
94497535|NCT01807520|323614824|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
94497536|NCT01807520|323614825|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
94497537|NCT01807520|323614826|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
94497538|NCT01807520|323614827|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
94497539|NCT01807520|323614828|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
94497540|NCT01807520|323614822|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
94497541|NCT01807520|323614823|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
94497542|NCT01807520|323614824|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
94497543|NCT01807520|323614825|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
94497544|NCT01807520|323614826|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
94497545|NCT01807520|323614827|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
94497546|NCT01807520|323614828|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
94497547|NCT01807520|323614822|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
94497548|NCT01807520|323614823|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
94497549|NCT01807520|323614824|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
94497550|NCT01807520|323614825|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
94497551|NCT01807520|323614826|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
94497552|NCT01807520|323614827|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
94497553|NCT01807520|323614828|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
94497554|NCT01807520|323614822|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
94497555|NCT01807520|323614823|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
94497556|NCT01807520|323614824|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
94497557|NCT01807520|323614825|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
94497558|NCT01807520|323614826|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
94497559|NCT01807520|323614827|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
94497560|NCT01807520|323614828|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
94497561|NCT01807520|323614822|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
94497562|NCT01807520|323614823|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
94497563|NCT01807520|323614824|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
94497564|NCT01807520|323614825|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
94497565|NCT01807520|323614826|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
94497566|NCT01807520|323614827|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
94497567|NCT01807520|323614828|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
94497568|NCT01807520|323614822|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
94497569|NCT01807520|323614823|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
94497570|NCT01807520|323614824|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
94497571|NCT01807520|323614825|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
94497572|NCT01807520|323614826|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
94497573|NCT01807520|323614827|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
94497574|NCT01807520|323614828|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
94497575|NCT01807520|323614822|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
94497576|NCT01807520|323614823|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
94497577|NCT01807520|323614824|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
94497578|NCT01807520|323614825|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
94497579|NCT01807520|323614826|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
94497580|NCT01807520|323614827|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
94497581|NCT01807520|323614828|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
94497582|NCT01807520|323614822|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
94497583|NCT01807520|323614823|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
94497584|NCT01807520|323614824|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
94497585|NCT01807520|323614825|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
94497586|NCT01807520|323614826|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
94497587|NCT01807520|323614827|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
94497588|NCT01807520|323614828|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
94497589|NCT01807520|323614822|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
94497590|NCT01807520|323614823|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
94497591|NCT01807520|323614824|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
94497592|NCT01807520|323614825|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
94497593|NCT01807520|323614826|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
94497594|NCT01807520|323614827|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
94497595|NCT01807520|323614828|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
94497596|NCT01807520|323614822|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
94497597|NCT01807520|323614823|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
94497598|NCT01807520|323614824|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
94497599|NCT01807520|323614825|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
94497600|NCT01807520|323614826|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
94497601|NCT01807520|323614827|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
94497602|NCT01807520|323614828|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
94497603|NCT01807520|323614822|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
94497604|NCT01807520|323614823|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
94497605|NCT01807520|323614824|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
94497606|NCT01807520|323614825|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
94497607|NCT01807520|323614826|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
94497608|NCT01807520|323614827|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
94497609|NCT01807520|323614828|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
94497610|NCT01807520|323614822|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
94497611|NCT01807520|323614823|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
94497612|NCT01807520|323614824|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
94497613|NCT01807520|323614825|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
94497614|NCT01807520|323614826|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
94497615|NCT01807520|323614827|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
94497616|NCT01807520|323614828|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
94497617|NCT01807520|323614822|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
94497618|NCT01807520|323614823|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
94497619|NCT01807520|323614824|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
94497620|NCT01807520|323614825|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
94497621|NCT01807520|323614826|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
94497622|NCT01807520|323614827|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
94497623|NCT01807520|323614828|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
94497624|NCT01807520|323614822|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
94497625|NCT01807520|323614823|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
94497626|NCT01807520|323614824|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
94497627|NCT01807520|323614825|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
94497628|NCT01807520|323614826|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
94497629|NCT01807520|323614827|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
94497630|NCT01807520|323614828|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
94497631|NCT00639379|323614829|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
94497632|NCT00639379|323614830|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
94497633|NCT00639379|323614829|FG000|Period 1 - 2 Weeks|lens issue|3|||
94497634|NCT00639379|323614830|FG001|Period 1 - 2 Weeks|lens issue|0|||
94497635|NCT00924651|323614833|FG000|Overall Study|Chemo started too soon|2|||
94497636|NCT00924651|323614834|FG001|Overall Study|Chemo started too soon|3|||
94497637|NCT00924651|323614833|FG000|Overall Study|No Reason|3|||
94497638|NCT00924651|323614834|FG001|Overall Study|No Reason|7|||
94497639|NCT00924651|323614833|FG000|Overall Study|Overwhelmed|6|||
94497640|NCT00924651|323614834|FG001|Overall Study|Overwhelmed|6|||
94497641|NCT00924651|323614833|FG000|Overall Study|Noncompliant|1|||
94497642|NCT00924651|323614834|FG001|Overall Study|Noncompliant|4|||
94497643|NCT00924651|323614833|FG000|Overall Study|Medical|1|||
94497644|NCT00924651|323614834|FG001|Overall Study|Medical|3|||
94497645|NCT00924651|323614833|FG000|Overall Study|Changed Mind|10|||
94497646|NCT00924651|323614834|FG001|Overall Study|Changed Mind|1|||
94497647|NCT00924651|323614833|FG000|Overall Study|Incomplete Form|2|||
94497648|NCT00924651|323614834|FG001|Overall Study|Incomplete Form|1|||
94497649|NCT00729586|323614835|FG000|Overall Study|Ineligible|0|||
94497650|NCT00729586|323614836|FG001|Overall Study|Ineligible|1|||
94497651|NCT00729586|323614835|FG000|Overall Study|never treated|1|||
94497652|NCT00729586|323614836|FG001|Overall Study|never treated|0|||
94497653|NCT02008370|323614839|FG000|Overall Study|Lost to Follow-up|7|||
94497654|NCT00662259|323614840|FG000|Overall Study|Adverse Event|2|||
94497655|NCT00662259|323614841|FG001|Overall Study|Adverse Event|0|||
94497656|NCT02260986|323614844|FG000|Overall Study|Adverse Event|24|||
94497657|NCT02260986|323614845|FG001|Overall Study|Adverse Event|0|||
94497658|NCT02260986|323614846|FG002|Overall Study|Adverse Event|11|||
94497659|NCT02260986|323614844|FG000|Overall Study|Lack of Efficacy|27|||
94497660|NCT02260986|323614845|FG001|Overall Study|Lack of Efficacy|3|||
94497661|NCT02260986|323614846|FG002|Overall Study|Lack of Efficacy|0|||
94497662|NCT02260986|323614844|FG000|Overall Study|Protocol Violation|14|||
94497663|NCT02260986|323614845|FG001|Overall Study|Protocol Violation|5|||
94497664|NCT02260986|323614846|FG002|Overall Study|Protocol Violation|16|||
94497665|NCT02260986|323614844|FG000|Overall Study|Car accident|0|||
94497666|NCT02260986|323614845|FG001|Overall Study|Car accident|0|||
94497667|NCT02260986|323614846|FG002|Overall Study|Car accident|1|||
94497668|NCT02260986|323614844|FG000|Overall Study|Withdrawal by Subject|17|||
94497669|NCT02260986|323614845|FG001|Overall Study|Withdrawal by Subject|4|||
94497670|NCT02260986|323614846|FG002|Overall Study|Withdrawal by Subject|9|||
94497671|NCT02260986|323614844|FG000|Overall Study|Incorrect randomization|0|||
94497672|NCT02260986|323614845|FG001|Overall Study|Incorrect randomization|1|||
94497673|NCT02260986|323614846|FG002|Overall Study|Incorrect randomization|0|||
94497674|NCT02260986|323614844|FG000|Overall Study|Lack of investigation product supply|2|||
94497675|NCT02260986|323614845|FG001|Overall Study|Lack of investigation product supply|0|||
94497676|NCT02260986|323614846|FG002|Overall Study|Lack of investigation product supply|1|||
94497677|NCT02260986|323614844|FG000|Overall Study|Lost to Follow-up|4|||
94497678|NCT02260986|323614845|FG001|Overall Study|Lost to Follow-up|0|||
94497679|NCT02260986|323614846|FG002|Overall Study|Lost to Follow-up|3|||
94497680|NCT02260986|323614844|FG000|Overall Study|Pregnancy|2|||
94497681|NCT02260986|323614845|FG001|Overall Study|Pregnancy|0|||
94497682|NCT02260986|323614846|FG002|Overall Study|Pregnancy|0|||
94497683|NCT01001104|323614847|FG000|Overall Study|Adverse Event|2|||
94497684|NCT01001104|323614848|FG001|Overall Study|Adverse Event|1|||
94497685|NCT01001104|323614849|FG002|Overall Study|Adverse Event|0|||
94497686|NCT01001104|323614850|FG003|Overall Study|Adverse Event|0|||
94497687|NCT01001104|323614847|FG000|Overall Study|Lost to Follow-up|0|||
94497688|NCT01001104|323614848|FG001|Overall Study|Lost to Follow-up|0|||
94497689|NCT01001104|323614849|FG002|Overall Study|Lost to Follow-up|1|||
94497690|NCT01001104|323614850|FG003|Overall Study|Lost to Follow-up|0|||
94497691|NCT01001104|323614847|FG000|Overall Study|Entry Criteria Not Met|0|||
94497692|NCT01001104|323614848|FG001|Overall Study|Entry Criteria Not Met|0|||
94497693|NCT01001104|323614849|FG002|Overall Study|Entry Criteria Not Met|0|||
94497694|NCT01001104|323614850|FG003|Overall Study|Entry Criteria Not Met|1|||
94497695|NCT01001104|323614847|FG000|Overall Study|Withdrawal by Subject|0|||
94497696|NCT01001104|323614848|FG001|Overall Study|Withdrawal by Subject|0|||
94497697|NCT01001104|323614849|FG002|Overall Study|Withdrawal by Subject|0|||
94497698|NCT01001104|323614850|FG003|Overall Study|Withdrawal by Subject|2|||
94497699|NCT00599313|323614854|FG000|Overall Study|Adverse Event|19|||
94497700|NCT00599313|323614854|FG000|Overall Study|Disease Progression|12|||
94497701|NCT00599313|323614854|FG000|Overall Study|Patient Request|4|||
94497702|NCT00599313|323614854|FG000|Overall Study|Ineligible|1|||
94497703|NCT02175758|323614858|FG000|Treatment Phase|Lost to Follow-up|0|||
94497704|NCT02175758|323614859|FG001|Treatment Phase|Lost to Follow-up|1|||
94497705|NCT02175758|323614860|FG002|Treatment Phase|Lost to Follow-up|0|||
94497706|NCT02175758|323614861|FG003|Treatment Phase|Lost to Follow-up|0|||
94497707|NCT02175758|323614862|FG004|Treatment Phase|Lost to Follow-up|0|||
94497708|NCT02175758|323614863|FG005|Treatment Phase|Lost to Follow-up|0|||
94497709|NCT02175758|323614858|FG000|Treatment Phase|Adverse Event|0|||
94497710|NCT02175758|323614859|FG001|Treatment Phase|Adverse Event|0|||
94497711|NCT02175758|323614860|FG002|Treatment Phase|Adverse Event|0|||
94497712|NCT02175758|323614861|FG003|Treatment Phase|Adverse Event|0|||
94497713|NCT02175758|323614862|FG004|Treatment Phase|Adverse Event|1|||
94497714|NCT02175758|323614863|FG005|Treatment Phase|Adverse Event|0|||
94497715|NCT02362451|323614865|FG000|Overall Study|Withdrawal by Subject|0|||
94497716|NCT02362451|323614866|FG001|Overall Study|Withdrawal by Subject|1|||
94497717|NCT02362451|323614865|FG000|Overall Study|Lack of Efficacy|2|||
94497718|NCT02362451|323614866|FG001|Overall Study|Lack of Efficacy|0|||
94497719|NCT02362451|323614865|FG000|Overall Study|Progression|1|||
94497720|NCT02362451|323614866|FG001|Overall Study|Progression|0|||
94497721|NCT02362451|323614865|FG000|Overall Study|Participant chose other therapy.|1|||
94497722|NCT02362451|323614866|FG001|Overall Study|Participant chose other therapy.|0|||
94497723|NCT01879852|323614869|FG000|Overall Study|Withdrawal by Subject|2|||
94497724|NCT01879852|323614870|FG001|Overall Study|Withdrawal by Subject|0|||
94497725|NCT00263562|323614871|FG000|Overall Study|Protocol Violation|3|||
94497726|NCT00263562|323614872|FG001|Overall Study|Protocol Violation|0|||
94497727|NCT05059080|323614873|FG000|Overall Study|Withdrawal by Subject|3|||
94497728|NCT05059080|323614873|FG000|Overall Study|Study Terminated by Sponsor|64|||
94497729|NCT05607043|323614876|FG000|Overall Study|Lost to Follow-up|2|||
94497730|NCT00923702|323614881|FG000|Overall Study|Ongoing enrollment|0|||
94497731|NCT00923702|323614882|FG001|Overall Study|Ongoing enrollment|0|||
94497732|NCT00923702|323614883|FG002|Overall Study|Ongoing enrollment|0|||
94497733|NCT00923702|323614884|FG003|Overall Study|Ongoing enrollment|0|||
94497734|NCT00923702|323614885|FG004|Overall Study|Ongoing enrollment|354|||
94497735|NCT00625378|323614889|FG000|Overall Study|Adverse Event|22|||
94497736|NCT00625378|323614890|FG001|Overall Study|Adverse Event|0|||
94497737|NCT00625378|323614889|FG000|Overall Study|Withdrawal by Subject|16|||
94497738|NCT00625378|323614890|FG001|Overall Study|Withdrawal by Subject|0|||
94497739|NCT00625378|323614889|FG000|Overall Study|Death|38|||
94497740|NCT00625378|323614890|FG001|Overall Study|Death|0|||
94497741|NCT00625378|323614889|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
94497742|NCT00625378|323614890|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
94497743|NCT00625378|323614889|FG000|Overall Study|Lost to Follow-up|17|||
94497744|NCT00625378|323614890|FG001|Overall Study|Lost to Follow-up|0|||
94497745|NCT00625378|323614889|FG000|Overall Study|Non-compliant with study medication|3|||
94497746|NCT00625378|323614890|FG001|Overall Study|Non-compliant with study medication|0|||
94497747|NCT00625378|323614889|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
94497748|NCT00625378|323614890|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
94497749|NCT00625378|323614889|FG000|Overall Study|Medical decision|1|||
94497750|NCT00625378|323614890|FG001|Overall Study|Medical decision|0|||
94497751|NCT00625378|323614889|FG000|Overall Study|Multiple toxicities|1|||
94497752|NCT00625378|323614890|FG001|Overall Study|Multiple toxicities|0|||
94497753|NCT00625378|323614889|FG000|Overall Study|New cancer|1|||
94497754|NCT00625378|323614890|FG001|Overall Study|New cancer|0|||
94497755|NCT00625378|323614889|FG000|Overall Study|PTA program|2|||
94497756|NCT00625378|323614890|FG001|Overall Study|PTA program|0|||
94497757|NCT00625378|323614889|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
94497758|NCT00625378|323614890|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
94497759|NCT00625378|323614889|FG000|Overall Study|Sponsor decision|1|||
94497760|NCT00625378|323614890|FG001|Overall Study|Sponsor decision|0|||
94497761|NCT00625378|323614889|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
94497762|NCT00625378|323614890|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
94497763|NCT00625378|323614889|FG000|Overall Study|Switch to commercial drug|6|||
94497764|NCT00625378|323614890|FG001|Overall Study|Switch to commercial drug|1|||
94497765|NCT00625378|323614889|FG000|Overall Study|Missing|2|||
94497766|NCT00625378|323614890|FG001|Overall Study|Missing|0|||
94497767|NCT00625378|323614889|FG000|Overall Study|End of treatment not available|2|||
94497768|NCT00625378|323614890|FG001|Overall Study|End of treatment not available|0|||
94497769|NCT00625378|323614889|FG000|Overall Study|Never treated|2|||
94497770|NCT00625378|323614890|FG001|Overall Study|Never treated|0|||
94497771|NCT02070991|323614894|FG000|Overall Study|Death|2|||
94497772|NCT02070991|323614895|FG001|Overall Study|Death|0|||
94497773|NCT02070991|323614894|FG000|Overall Study|Withdrawal by Subject|1|||
94497774|NCT02070991|323614895|FG001|Overall Study|Withdrawal by Subject|0|||
94497775|NCT03880565|323614896|FG000|Overall Study|Withdrawal by Subject|1|||
94497776|NCT03880565|323614897|FG001|Overall Study|Withdrawal by Subject|0|||
94497777|NCT02969018|323614898|FG000|Overall Study|Adverse Event|2|||
94497778|NCT02969018|323614899|FG001|Overall Study|Adverse Event|4|||
94497779|NCT02969018|323614900|FG002|Overall Study|Adverse Event|1|||
94497780|NCT02969018|323614901|FG003|Overall Study|Adverse Event|2|||
94497781|NCT02969018|323614902|FG004|Overall Study|Adverse Event|0|||
94497782|NCT02969018|323614903|FG005|Overall Study|Adverse Event|1|||
94497783|NCT02969018|323614904|FG006|Overall Study|Adverse Event|2|||
94497784|NCT02969018|323614905|FG007|Overall Study|Adverse Event|0|||
94497785|NCT02969018|323614898|FG000|Overall Study|Lack of Efficacy|0|||
94497786|NCT02969018|323614899|FG001|Overall Study|Lack of Efficacy|1|||
94497787|NCT02969018|323614900|FG002|Overall Study|Lack of Efficacy|0|||
94497788|NCT02969018|323614901|FG003|Overall Study|Lack of Efficacy|0|||
94497789|NCT02969018|323614902|FG004|Overall Study|Lack of Efficacy|1|||
94497790|NCT02969018|323614903|FG005|Overall Study|Lack of Efficacy|1|||
94497791|NCT02969018|323614904|FG006|Overall Study|Lack of Efficacy|1|||
94497792|NCT02969018|323614905|FG007|Overall Study|Lack of Efficacy|1|||
94497793|NCT02969018|323614898|FG000|Overall Study|Lost to Follow-up|1|||
94497794|NCT02969018|323614899|FG001|Overall Study|Lost to Follow-up|2|||
94497795|NCT02969018|323614900|FG002|Overall Study|Lost to Follow-up|2|||
94497796|NCT02969018|323614901|FG003|Overall Study|Lost to Follow-up|0|||
94497797|NCT02969018|323614902|FG004|Overall Study|Lost to Follow-up|1|||
94497798|NCT02969018|323614903|FG005|Overall Study|Lost to Follow-up|1|||
94497799|NCT02969018|323614904|FG006|Overall Study|Lost to Follow-up|0|||
94497800|NCT02969018|323614905|FG007|Overall Study|Lost to Follow-up|1|||
94497801|NCT02969018|323614898|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
94497802|NCT02969018|323614899|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
94497803|NCT02969018|323614900|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
94497804|NCT02969018|323614901|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
94497805|NCT02969018|323614902|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
94497806|NCT02969018|323614903|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
94497807|NCT02969018|323614904|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
94497808|NCT02969018|323614905|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
94497809|NCT02969018|323614898|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94497810|NCT02969018|323614899|FG001|Overall Study|Non-Compliance With Study Drug|0|||
94497811|NCT02969018|323614900|FG002|Overall Study|Non-Compliance With Study Drug|0|||
94497812|NCT02969018|323614901|FG003|Overall Study|Non-Compliance With Study Drug|0|||
94497813|NCT02969018|323614902|FG004|Overall Study|Non-Compliance With Study Drug|0|||
94497814|NCT02969018|323614903|FG005|Overall Study|Non-Compliance With Study Drug|0|||
94497815|NCT02969018|323614904|FG006|Overall Study|Non-Compliance With Study Drug|0|||
94497816|NCT02969018|323614905|FG007|Overall Study|Non-Compliance With Study Drug|0|||
94497817|NCT02969018|323614898|FG000|Overall Study|Other|0|||
94497818|NCT02969018|323614899|FG001|Overall Study|Other|0|||
94497819|NCT02969018|323614900|FG002|Overall Study|Other|0|||
94497820|NCT02969018|323614901|FG003|Overall Study|Other|1|||
94497821|NCT02969018|323614902|FG004|Overall Study|Other|0|||
94497822|NCT02969018|323614903|FG005|Overall Study|Other|0|||
94497823|NCT02969018|323614904|FG006|Overall Study|Other|0|||
94497824|NCT02969018|323614905|FG007|Overall Study|Other|2|||
94497825|NCT02969018|323614898|FG000|Overall Study|Pregnancy|0|||
94497826|NCT02969018|323614899|FG001|Overall Study|Pregnancy|0|||
94497827|NCT02969018|323614900|FG002|Overall Study|Pregnancy|0|||
94497828|NCT02969018|323614901|FG003|Overall Study|Pregnancy|0|||
94497829|NCT02969018|323614902|FG004|Overall Study|Pregnancy|0|||
94497830|NCT02969018|323614903|FG005|Overall Study|Pregnancy|1|||
94497831|NCT02969018|323614904|FG006|Overall Study|Pregnancy|0|||
94497832|NCT02969018|323614905|FG007|Overall Study|Pregnancy|0|||
94497833|NCT02969018|323614898|FG000|Overall Study|Protocol Violation|0|||
94497834|NCT02969018|323614899|FG001|Overall Study|Protocol Violation|0|||
94497835|NCT02969018|323614900|FG002|Overall Study|Protocol Violation|1|||
94497836|NCT02969018|323614901|FG003|Overall Study|Protocol Violation|1|||
94497837|NCT02969018|323614902|FG004|Overall Study|Protocol Violation|0|||
94497838|NCT02969018|323614903|FG005|Overall Study|Protocol Violation|0|||
94497839|NCT02969018|323614904|FG006|Overall Study|Protocol Violation|0|||
94497840|NCT02969018|323614905|FG007|Overall Study|Protocol Violation|0|||
94497841|NCT02969018|323614898|FG000|Overall Study|Withdrawal by Subject|0|||
94497842|NCT02969018|323614899|FG001|Overall Study|Withdrawal by Subject|1|||
94497843|NCT02969018|323614900|FG002|Overall Study|Withdrawal by Subject|2|||
94497844|NCT02969018|323614901|FG003|Overall Study|Withdrawal by Subject|1|||
94497845|NCT02969018|323614902|FG004|Overall Study|Withdrawal by Subject|0|||
94497846|NCT02969018|323614903|FG005|Overall Study|Withdrawal by Subject|4|||
94497847|NCT02969018|323614904|FG006|Overall Study|Withdrawal by Subject|4|||
94497848|NCT02969018|323614905|FG007|Overall Study|Withdrawal by Subject|3|||
94497849|NCT00367458|323614906|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
94497850|NCT00367458|323614907|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
94497851|NCT02448043|323614912|FG000|Overall Study|Withdrawal by Subject|2|||
94497852|NCT02448043|323614913|FG001|Overall Study|Withdrawal by Subject|2|||
94497853|NCT02448043|323614912|FG000|Overall Study|Protocol Violation|1|||
94497854|NCT02448043|323614913|FG001|Overall Study|Protocol Violation|2|||
94497855|NCT01428128|323614922|FG000|Overall Study|Withdrawal by Subject|4|||
94497856|NCT01428128|323614922|FG000|Overall Study|Screen failure by p53|10|||
94497857|NCT01428128|323614922|FG000|Overall Study|Received Neulasta in one cycle|2|||
94497858|NCT01428128|323614922|FG000|Overall Study|Adverse Event|1|||
94497859|NCT00118287|323614923|FG000|Overall Study|Intracranial haemorrhage|1|||
94497860|NCT00118287|323614923|FG000|Overall Study|Muscle pain|1|||
94497861|NCT03407482|323614924|FG000|Overall Study|Adverse Event|12|||
94497862|NCT03407482|323614924|FG000|Overall Study|Disease Relapse|1|||
94497863|NCT03407482|323614924|FG000|Overall Study|Lost to Follow-up|1|||
94497864|NCT03407482|323614924|FG000|Overall Study|Non-Compliance With Study Drug|1|||
94497865|NCT03407482|323614924|FG000|Overall Study|Pregnancy|2|||
94497866|NCT03407482|323614924|FG000|Overall Study|Protocol Violation|1|||
94497867|NCT03407482|323614924|FG000|Overall Study|Study Terminated By Sponsor|106|||
94497868|NCT03407482|323614924|FG000|Overall Study|Withdrawal by Subject|6|||
94497869|NCT03407482|323614924|FG000|Overall Study|Data Entry Error|1|||
94497870|NCT00424008|323614925|FG000|Overall Study|Adverse Event|8|||
94497871|NCT00424008|323614926|FG001|Overall Study|Adverse Event|6|||
94497872|NCT00424008|323614925|FG000|Overall Study|Lack of Efficacy|40|||
94497873|NCT00424008|323614926|FG001|Overall Study|Lack of Efficacy|34|||
94497874|NCT00424008|323614925|FG000|Overall Study|Lost to Follow-up|1|||
94497875|NCT00424008|323614926|FG001|Overall Study|Lost to Follow-up|2|||
94497876|NCT00424008|323614925|FG000|Overall Study|Withdrawal by Subject|5|||
94497877|NCT00424008|323614926|FG001|Overall Study|Withdrawal by Subject|8|||
94497878|NCT00424008|323614925|FG000|Overall Study|Noncompliance with protocol|13|||
94497879|NCT00424008|323614926|FG001|Overall Study|Noncompliance with protocol|7|||
94497880|NCT00424008|323614925|FG000|Overall Study|Did not meet protocol eligibility|16|||
94497881|NCT00424008|323614926|FG001|Overall Study|Did not meet protocol eligibility|21|||
94497882|NCT00424008|323614925|FG000|Overall Study|Administrative|266|||
94497883|NCT00424008|323614926|FG001|Overall Study|Administrative|257|||
94497884|NCT02593864|323614927|FG000|Overall Study|Withdrawal by Subject|3|||
94497885|NCT02593864|323614927|FG000|Overall Study|Lost to Follow-up|3|||
94497886|NCT01405911|323614928|FG000|Overall Study|Pre-treatment lab AE|0|||
94497887|NCT01405911|323614929|FG001|Overall Study|Pre-treatment lab AE|1|||
94497888|NCT01405911|323614930|FG002|Overall Study|Pre-treatment lab AE|0|||
94497889|NCT01405911|323614928|FG000|Overall Study|Lost to Follow-up|0|||
94497890|NCT01405911|323614929|FG001|Overall Study|Lost to Follow-up|1|||
94497891|NCT01405911|323614930|FG002|Overall Study|Lost to Follow-up|0|||
94497892|NCT01405911|323614928|FG000|Overall Study|Protocol Violation|1|||
94497893|NCT01405911|323614929|FG001|Overall Study|Protocol Violation|0|||
94497894|NCT01405911|323614930|FG002|Overall Study|Protocol Violation|0|||
94497895|NCT01405911|323614928|FG000|Overall Study|Withdrawal by Subject|3|||
94497896|NCT01405911|323614929|FG001|Overall Study|Withdrawal by Subject|1|||
94497897|NCT01405911|323614930|FG002|Overall Study|Withdrawal by Subject|1|||
94497898|NCT00421993|323614933|FG000|Overall Study|Withdrawal by Subject|22|||
94497899|NCT00421993|323614934|FG001|Overall Study|Withdrawal by Subject|23|||
94497900|NCT00421993|323614935|FG002|Overall Study|Withdrawal by Subject|23|||
94497901|NCT00421993|323614936|FG003|Overall Study|Withdrawal by Subject|24|||
94497902|NCT00421993|323614933|FG000|Overall Study|Lost to Follow-up|18|||
94497903|NCT00421993|323614934|FG001|Overall Study|Lost to Follow-up|19|||
94497904|NCT00421993|323614935|FG002|Overall Study|Lost to Follow-up|22|||
94497905|NCT00421993|323614936|FG003|Overall Study|Lost to Follow-up|20|||
94497906|NCT00421993|323614933|FG000|Overall Study|Adverse Event|11|||
94497907|NCT00421993|323614934|FG001|Overall Study|Adverse Event|1|||
94497908|NCT00421993|323614935|FG002|Overall Study|Adverse Event|6|||
94497909|NCT00421993|323614936|FG003|Overall Study|Adverse Event|4|||
94497910|NCT00421993|323614933|FG000|Overall Study|Protocol Violation|2|||
94497911|NCT00421993|323614934|FG001|Overall Study|Protocol Violation|2|||
94497912|NCT00421993|323614935|FG002|Overall Study|Protocol Violation|0|||
94497913|NCT00421993|323614936|FG003|Overall Study|Protocol Violation|1|||
94497914|NCT00421993|323614933|FG000|Overall Study|Lack of Efficacy|0|||
94497915|NCT00421993|323614934|FG001|Overall Study|Lack of Efficacy|3|||
94497916|NCT00421993|323614935|FG002|Overall Study|Lack of Efficacy|0|||
94497917|NCT00421993|323614936|FG003|Overall Study|Lack of Efficacy|5|||
94497918|NCT00421993|323614933|FG000|Overall Study|Pregnancy|0|||
94497919|NCT00421993|323614934|FG001|Overall Study|Pregnancy|1|||
94497920|NCT00421993|323614935|FG002|Overall Study|Pregnancy|1|||
94497921|NCT00421993|323614936|FG003|Overall Study|Pregnancy|2|||
94497922|NCT00421993|323614933|FG000|Overall Study|Subject transportation issues|0|||
94497923|NCT00421993|323614934|FG001|Overall Study|Subject transportation issues|0|||
94497924|NCT00421993|323614935|FG002|Overall Study|Subject transportation issues|0|||
94497925|NCT00421993|323614936|FG003|Overall Study|Subject transportation issues|1|||
94497926|NCT02114684|323614937|FG000|Overall Study|Death|6|||
94497927|NCT02114684|323614938|FG001|Overall Study|Death|4|||
94497928|NCT02114684|323614937|FG000|Overall Study|Lost to Follow-up|1|||
94497929|NCT02114684|323614938|FG001|Overall Study|Lost to Follow-up|2|||
94497930|NCT02114684|323614937|FG000|Overall Study|Withdrawal by Subject|1|||
94497931|NCT02114684|323614938|FG001|Overall Study|Withdrawal by Subject|2|||
94497932|NCT02114684|323614937|FG000|Overall Study|Relocation|3|||
94497933|NCT02114684|323614938|FG001|Overall Study|Relocation|1|||
94497934|NCT02114684|323614937|FG000|Overall Study|Rifampicin resistant on culture|0|||
94497935|NCT02114684|323614938|FG001|Overall Study|Rifampicin resistant on culture|1|||
94497936|NCT02114684|323614937|FG000|Overall Study|Patient Incarcerated|1|||
94497937|NCT02114684|323614938|FG001|Overall Study|Patient Incarcerated|0|||
94497938|NCT03828383|323614947|FG000|Overall Study|Lost to Follow-up|3|||
94497939|NCT03828383|323614948|FG001|Overall Study|Lost to Follow-up|2|||
94497940|NCT03828383|323614947|FG000|Overall Study|Withdrawal by Subject|4|||
94497941|NCT03828383|323614948|FG001|Overall Study|Withdrawal by Subject|5|||
94497942|NCT02665455|323614950|FG000|Overall Study|Withdrawal by Subject|6|||
94497943|NCT02665455|323614950|FG000|Overall Study|Lost to Follow-up|1|||
94497944|NCT02665455|323614950|FG000|Overall Study|Adverse Event|1|||
94497945|NCT02665455|323614950|FG000|Overall Study|Protocol Violation|1|||
94497946|NCT01186419|323614959|FG000|Overall Study|Withdrawal by Subject|5|||
94497947|NCT01186419|323614960|FG001|Overall Study|Withdrawal by Subject|3|||
94497948|NCT01186419|323614959|FG000|Overall Study|Adverse Event|1|||
94497949|NCT01186419|323614960|FG001|Overall Study|Adverse Event|2|||
94497950|NCT01186419|323614959|FG000|Overall Study|Physician Decision|0|||
94497951|NCT01186419|323614960|FG001|Overall Study|Physician Decision|3|||
94497952|NCT01186419|323614959|FG000|Overall Study|Other|1|||
94497953|NCT01186419|323614960|FG001|Overall Study|Other|1|||
94497954|NCT01407367|323614965|FG000|Overall Study|Death|24|||
94497955|NCT01407367|323614966|FG001|Overall Study|Death|32|||
94497956|NCT01407367|323614965|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
94497957|NCT01407367|323614966|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
94497958|NCT01407367|323614965|FG000|Overall Study|Withdrawal by Subject|4|||
94497959|NCT01407367|323614966|FG001|Overall Study|Withdrawal by Subject|15|||
94497960|NCT01407367|323614965|FG000|Overall Study|Lost to Follow-up|0|||
94497961|NCT01407367|323614966|FG001|Overall Study|Lost to Follow-up|2|||
94497962|NCT02487199|323614967|FG000|Overall Study|Withdrew Consent|0|||
94497963|NCT02487199|323614968|FG001|Overall Study|Withdrew Consent|1|||
94497964|NCT01033071|323614969|FG000|Overall Study|Adverse Event|28|||
94497965|NCT01033071|323614970|FG001|Overall Study|Adverse Event|51|||
94497966|NCT01033071|323614971|FG002|Overall Study|Adverse Event|26|||
94497967|NCT01033071|323614969|FG000|Overall Study|Protocol Violation|0|||
94497968|NCT01033071|323614970|FG001|Overall Study|Protocol Violation|2|||
94497969|NCT01033071|323614971|FG002|Overall Study|Protocol Violation|1|||
94497970|NCT01033071|323614969|FG000|Overall Study|Lost to Follow-up|4|||
94497971|NCT01033071|323614970|FG001|Overall Study|Lost to Follow-up|5|||
94497972|NCT01033071|323614971|FG002|Overall Study|Lost to Follow-up|5|||
94497973|NCT01033071|323614969|FG000|Overall Study|Withdrawal by Subject|17|||
94497974|NCT01033071|323614970|FG001|Overall Study|Withdrawal by Subject|14|||
94497975|NCT01033071|323614971|FG002|Overall Study|Withdrawal by Subject|11|||
94497976|NCT01033071|323614969|FG000|Overall Study|Lack of Efficacy|0|||
94497977|NCT01033071|323614970|FG001|Overall Study|Lack of Efficacy|1|||
94497978|NCT01033071|323614971|FG002|Overall Study|Lack of Efficacy|1|||
94497979|NCT01033071|323614969|FG000|Overall Study|Other|6|||
94497980|NCT01033071|323614970|FG001|Overall Study|Other|4|||
94497981|NCT01033071|323614971|FG002|Overall Study|Other|3|||
94497982|NCT04706403|323617227|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
94497983|NCT04706403|323617228|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
94497984|NCT04706403|323617229|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
94497985|NCT04706403|323617230|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
94497986|NCT04706403|323617231|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
94497987|NCT01631188|323617233|FG000|Overall Study|Physician Decision|75|||
94497988|NCT00972738|323617234|FG000|Overall Study|Adverse Event|7|||
94497989|NCT00972738|323617235|FG001|Overall Study|Adverse Event|1|||
94497990|NCT00972738|323617236|FG002|Overall Study|Adverse Event|8|||
94497991|NCT00972738|323617234|FG000|Overall Study|Protocol Violation|2|||
94497992|NCT00972738|323617235|FG001|Overall Study|Protocol Violation|1|||
94497993|NCT00972738|323617236|FG002|Overall Study|Protocol Violation|3|||
94497994|NCT00972738|323617234|FG000|Overall Study|Lost to Follow-up|1|||
94497995|NCT00972738|323617235|FG001|Overall Study|Lost to Follow-up|0|||
94497996|NCT00972738|323617236|FG002|Overall Study|Lost to Follow-up|1|||
94497997|NCT00972738|323617234|FG000|Overall Study|Lack of Efficacy|5|||
94497998|NCT00972738|323617235|FG001|Overall Study|Lack of Efficacy|1|||
94497999|NCT00972738|323617236|FG002|Overall Study|Lack of Efficacy|11|||
94498000|NCT00972738|323617234|FG000|Overall Study|Withdrawal by Subject|5|||
94498001|NCT00972738|323617235|FG001|Overall Study|Withdrawal by Subject|1|||
94498002|NCT00972738|323617236|FG002|Overall Study|Withdrawal by Subject|4|||
94498003|NCT00972738|323617234|FG000|Overall Study|Moved|0|||
94498004|NCT00972738|323617235|FG001|Overall Study|Moved|0|||
94498005|NCT00972738|323617236|FG002|Overall Study|Moved|1|||
94498006|NCT00972738|323617234|FG000|Overall Study|Other|1|||
94498007|NCT00972738|323617235|FG001|Overall Study|Other|2|||
94498008|NCT00972738|323617236|FG002|Overall Study|Other|1|||
94498009|NCT01033942|323617239|FG000|Overall Study|Withdrawal by Subject|1|||
94498010|NCT01033942|323617240|FG001|Overall Study|Withdrawal by Subject|1|||
94498011|NCT01033942|323617241|FG002|Overall Study|Withdrawal by Subject|1|||
94498012|NCT01033942|323617239|FG000|Overall Study|Lost to Follow-up|1|||
94498013|NCT01033942|323617240|FG001|Overall Study|Lost to Follow-up|0|||
94498014|NCT01033942|323617241|FG002|Overall Study|Lost to Follow-up|0|||
94498015|NCT01033942|323617239|FG000|Overall Study|Enrolled in Extension Study|0|||
94498016|NCT01033942|323617240|FG001|Overall Study|Enrolled in Extension Study|3|||
94498017|NCT01033942|323617241|FG002|Overall Study|Enrolled in Extension Study|0|||
94498018|NCT03915067|323617242|FG000|Overall Study|Adverse Event|0|||
94498019|NCT03915067|323617243|FG001|Overall Study|Adverse Event|0|||
94498020|NCT03915067|323617244|FG002|Overall Study|Adverse Event|1|||
94498021|NCT03915067|323617242|FG000|Overall Study|Withdrawal by Subject|4|||
94498022|NCT03915067|323617243|FG001|Overall Study|Withdrawal by Subject|3|||
94498023|NCT03915067|323617244|FG002|Overall Study|Withdrawal by Subject|0|||
94498024|NCT03915067|323617242|FG000|Overall Study|Lost to Follow-up|3|||
94498025|NCT03915067|323617243|FG001|Overall Study|Lost to Follow-up|2|||
94498026|NCT03915067|323617244|FG002|Overall Study|Lost to Follow-up|0|||
94498027|NCT03915067|323617242|FG000|Overall Study|Protocol Deviation|0|||
94498028|NCT03915067|323617243|FG001|Overall Study|Protocol Deviation|0|||
94498029|NCT03915067|323617244|FG002|Overall Study|Protocol Deviation|1|||
94498030|NCT03915067|323617242|FG000|Overall Study|Covid-19 Related Issues|2|||
94498031|NCT03915067|323617243|FG001|Overall Study|Covid-19 Related Issues|4|||
94498032|NCT03915067|323617244|FG002|Overall Study|Covid-19 Related Issues|4|||
94498033|NCT03915067|323617242|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
94498034|NCT03915067|323617243|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
94498035|NCT03915067|323617244|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
94498036|NCT03317496|323617245|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
94498037|NCT03317496|323617246|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
94498038|NCT03317496|323617247|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
94498039|NCT03317496|323617248|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
94498040|NCT03317496|323617249|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
94498041|NCT03317496|323617245|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
94498042|NCT03317496|323617246|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
94498043|NCT03317496|323617247|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
94498044|NCT03317496|323617248|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
94498045|NCT03317496|323617249|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
94498046|NCT03317496|323617245|FG000|Phase 1b Lead-in: Treatment|Death|0|||
94498047|NCT03317496|323617246|FG001|Phase 1b Lead-in: Treatment|Death|0|||
94498048|NCT03317496|323617247|FG002|Phase 1b Lead-in: Treatment|Death|1|||
94498049|NCT03317496|323617248|FG003|Phase 1b Lead-in: Treatment|Death|0|||
94498050|NCT03317496|323617249|FG004|Phase 1b Lead-in: Treatment|Death|0|||
94498051|NCT03317496|323617245|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
94498052|NCT03317496|323617246|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
94498053|NCT03317496|323617247|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
94498054|NCT03317496|323617248|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
94498055|NCT03317496|323617249|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
94498056|NCT03317496|323617245|FG000|Phase 1b Lead-in: Treatment|Other|2|||
94498057|NCT03317496|323617246|FG001|Phase 1b Lead-in: Treatment|Other|1|||
94498058|NCT03317496|323617247|FG002|Phase 1b Lead-in: Treatment|Other|0|||
94498059|NCT03317496|323617248|FG003|Phase 1b Lead-in: Treatment|Other|0|||
94498060|NCT03317496|323617249|FG004|Phase 1b Lead-in: Treatment|Other|0|||
94498061|NCT03317496|323617245|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
94498062|NCT03317496|323617246|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
94498063|NCT03317496|323617247|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
94498064|NCT03317496|323617248|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
94498065|NCT03317496|323617249|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
94498066|NCT03317496|323617245|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
94498067|NCT03317496|323617246|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
94498068|NCT03317496|323617247|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
94498069|NCT03317496|323617248|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
94498070|NCT03317496|323617249|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
94498071|NCT03317496|323617245|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
94498072|NCT03317496|323617246|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
94498073|NCT03317496|323617247|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
94498074|NCT03317496|323617248|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
94498075|NCT03317496|323617249|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
94498076|NCT03317496|323617245|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
94498077|NCT03317496|323617246|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
94498078|NCT03317496|323617247|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
94498079|NCT03317496|323617248|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
94498080|NCT03317496|323617249|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
94498081|NCT03317496|323617245|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
94498082|NCT03317496|323617246|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
94498083|NCT03317496|323617247|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
94498084|NCT03317496|323617248|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
94498085|NCT03317496|323617249|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
94498086|NCT03317496|323617245|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
94498087|NCT03317496|323617246|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
94498088|NCT03317496|323617247|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
94498089|NCT03317496|323617248|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
94498090|NCT03317496|323617249|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
94498091|NCT03317496|323617245|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
94498092|NCT03317496|323617246|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
94498093|NCT03317496|323617247|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
94498094|NCT03317496|323617248|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
94498095|NCT03317496|323617249|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
94498096|NCT03317496|323617245|FG000|Phase 2: Treatment|Adverse Event|0|||
94498097|NCT03317496|323617246|FG001|Phase 2: Treatment|Adverse Event|0|||
94498098|NCT03317496|323617247|FG002|Phase 2: Treatment|Adverse Event|0|||
94498099|NCT03317496|323617248|FG003|Phase 2: Treatment|Adverse Event|0|||
94498100|NCT03317496|323617249|FG004|Phase 2: Treatment|Adverse Event|6|||
94498101|NCT03317496|323617245|FG000|Phase 2: Treatment|Progressive disease|0|||
94498102|NCT03317496|323617246|FG001|Phase 2: Treatment|Progressive disease|0|||
94498103|NCT03317496|323617247|FG002|Phase 2: Treatment|Progressive disease|0|||
94498104|NCT03317496|323617248|FG003|Phase 2: Treatment|Progressive disease|0|||
94498105|NCT03317496|323617249|FG004|Phase 2: Treatment|Progressive disease|22|||
94498106|NCT03317496|323617245|FG000|Phase 2: Treatment|Other|0|||
94498107|NCT03317496|323617246|FG001|Phase 2: Treatment|Other|0|||
94498108|NCT03317496|323617247|FG002|Phase 2: Treatment|Other|0|||
94498109|NCT03317496|323617248|FG003|Phase 2: Treatment|Other|0|||
94498110|NCT03317496|323617249|FG004|Phase 2: Treatment|Other|4|||
94498111|NCT03317496|323617245|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
94498112|NCT03317496|323617246|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
94498113|NCT03317496|323617247|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
94498114|NCT03317496|323617248|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
94498115|NCT03317496|323617249|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
94498116|NCT03317496|323617245|FG000|Phase 2: Treatment|Physician Decision|0|||
94498117|NCT03317496|323617246|FG001|Phase 2: Treatment|Physician Decision|0|||
94498118|NCT03317496|323617247|FG002|Phase 2: Treatment|Physician Decision|0|||
94498119|NCT03317496|323617248|FG003|Phase 2: Treatment|Physician Decision|0|||
94498120|NCT03317496|323617249|FG004|Phase 2: Treatment|Physician Decision|1|||
94498121|NCT03317496|323617245|FG000|Phase 2: Treatment|Death|0|||
94498122|NCT03317496|323617246|FG001|Phase 2: Treatment|Death|0|||
94498123|NCT03317496|323617247|FG002|Phase 2: Treatment|Death|0|||
94498124|NCT03317496|323617248|FG003|Phase 2: Treatment|Death|0|||
94498125|NCT03317496|323617249|FG004|Phase 2: Treatment|Death|1|||
94498126|NCT03317496|323617245|FG000|Phase 2: Follow-up|Death|0|||
94498127|NCT03317496|323617246|FG001|Phase 2: Follow-up|Death|0|||
94498128|NCT03317496|323617247|FG002|Phase 2: Follow-up|Death|0|||
94498129|NCT03317496|323617248|FG003|Phase 2: Follow-up|Death|0|||
94498130|NCT03317496|323617249|FG004|Phase 2: Follow-up|Death|24|||
94498131|NCT03317496|323617245|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
94498132|NCT03317496|323617246|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
94498133|NCT03317496|323617247|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
94498134|NCT03317496|323617248|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
94498135|NCT03317496|323617249|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
94498136|NCT03317496|323617245|FG000|Phase 2: Follow-up|Other|0|||
94498137|NCT03317496|323617246|FG001|Phase 2: Follow-up|Other|0|||
94498138|NCT03317496|323617247|FG002|Phase 2: Follow-up|Other|0|||
94498139|NCT03317496|323617248|FG003|Phase 2: Follow-up|Other|0|||
94498140|NCT03317496|323617249|FG004|Phase 2: Follow-up|Other|1|||
94498141|NCT03317496|323617245|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
94498142|NCT03317496|323617246|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
94498143|NCT03317496|323617247|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
94498144|NCT03317496|323617248|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
94498145|NCT03317496|323617249|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
94498146|NCT02693418|323617250|FG000|Overall Study|Lost to Follow-up|1|||
94498147|NCT02693418|323617251|FG001|Overall Study|Lost to Follow-up|2|||
94498148|NCT02693418|323617252|FG002|Overall Study|Lost to Follow-up|0|||
94498149|NCT02693418|323617253|FG003|Overall Study|Lost to Follow-up|0|||
94498150|NCT02693418|323617254|FG004|Overall Study|Lost to Follow-up|0|||
94498151|NCT02693418|323617250|FG000|Overall Study|Menses during study period|0|||
94498152|NCT02693418|323617251|FG001|Overall Study|Menses during study period|0|||
94498153|NCT02693418|323617252|FG002|Overall Study|Menses during study period|2|||
94498154|NCT02693418|323617253|FG003|Overall Study|Menses during study period|0|||
94498155|NCT02693418|323617254|FG004|Overall Study|Menses during study period|0|||
94498156|NCT02737618|323617255|FG000|Overall Study|Withdrawal by Subject|9|||
94498157|NCT01521364|323617260|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
94498158|NCT01521364|323617260|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
94498159|NCT02493855|323617263|FG000|Overall Study|Non-compliance|1|||
94498160|NCT02493855|323617264|FG001|Overall Study|Non-compliance|0|||
94498161|NCT02493855|323617265|FG002|Overall Study|Non-compliance|0|||
94498162|NCT02493855|323617263|FG000|Overall Study|Adverse Event|0|||
94498163|NCT02493855|323617264|FG001|Overall Study|Adverse Event|1|||
94498164|NCT02493855|323617265|FG002|Overall Study|Adverse Event|0|||
94498165|NCT02493855|323617263|FG000|Overall Study|Withdrawal by Subject|1|||
94498166|NCT02493855|323617264|FG001|Overall Study|Withdrawal by Subject|0|||
94498167|NCT02493855|323617265|FG002|Overall Study|Withdrawal by Subject|0|||
94498168|NCT01137812|323617267|FG000|Overall Study|Adverse Event|21|||
94498169|NCT01137812|323617268|FG001|Overall Study|Adverse Event|14|||
94498170|NCT01137812|323617267|FG000|Overall Study|Lost to Follow-up|6|||
94498171|NCT01137812|323617268|FG001|Overall Study|Lost to Follow-up|8|||
94498172|NCT01137812|323617267|FG000|Overall Study|Physician Decision|25|||
94498173|NCT01137812|323617268|FG001|Overall Study|Physician Decision|17|||
94498174|NCT01137812|323617267|FG000|Overall Study|Protocol Violation|5|||
94498175|NCT01137812|323617268|FG001|Overall Study|Protocol Violation|4|||
94498176|NCT01137812|323617267|FG000|Overall Study|Withdrawal by Subject|5|||
94498177|NCT01137812|323617268|FG001|Overall Study|Withdrawal by Subject|13|||
94498178|NCT01137812|323617267|FG000|Overall Study|Death|2|||
94498179|NCT01137812|323617268|FG001|Overall Study|Death|0|||
94498180|NCT01137812|323617267|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
94498181|NCT01137812|323617268|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
94498182|NCT01137812|323617267|FG000|Overall Study|Other|19|||
94498183|NCT01137812|323617268|FG001|Overall Study|Other|27|||
94498184|NCT01482221|323617276|FG000|Overall Study|Lack of Efficacy|1|||
94498185|NCT01482221|323617277|FG001|Overall Study|Lack of Efficacy|0|||
94498186|NCT01482221|323617278|FG002|Overall Study|Lack of Efficacy|1|||
94498187|NCT01482221|323617276|FG000|Overall Study|Lost to Follow-up|3|||
94498188|NCT01482221|323617277|FG001|Overall Study|Lost to Follow-up|2|||
94498189|NCT01482221|323617278|FG002|Overall Study|Lost to Follow-up|1|||
94498190|NCT01482221|323617276|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
94498191|NCT01482221|323617277|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
94498192|NCT01482221|323617278|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
94498193|NCT01482221|323617276|FG000|Overall Study|Condition under Investigation Worsened|3|||
94498194|NCT01482221|323617277|FG001|Overall Study|Condition under Investigation Worsened|2|||
94498195|NCT01482221|323617278|FG002|Overall Study|Condition under Investigation Worsened|4|||
94498196|NCT01482221|323617276|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
94498197|NCT01482221|323617277|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
94498198|NCT01482221|323617278|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
94498199|NCT01482221|323617276|FG000|Overall Study|Adverse Event|1|||
94498200|NCT01482221|323617277|FG001|Overall Study|Adverse Event|7|||
94498201|NCT01482221|323617278|FG002|Overall Study|Adverse Event|3|||
94498202|NCT01482221|323617276|FG000|Overall Study|Withdrawal by Subject|10|||
94498203|NCT01482221|323617277|FG001|Overall Study|Withdrawal by Subject|7|||
94498204|NCT01482221|323617278|FG002|Overall Study|Withdrawal by Subject|12|||
94498205|NCT01482221|323617276|FG000|Overall Study|Incorrect randomization|0|||
94498206|NCT01482221|323617277|FG001|Overall Study|Incorrect randomization|1|||
94498207|NCT01482221|323617278|FG002|Overall Study|Incorrect randomization|0|||
94498208|NCT01482221|323617276|FG000|Overall Study|Physician Decision|0|||
94498209|NCT01482221|323617277|FG001|Overall Study|Physician Decision|1|||
94498210|NCT01482221|323617278|FG002|Overall Study|Physician Decision|0|||
94498211|NCT00845182|323617279|FG000|Overall Study|Lost to Follow-up|3|||
94498212|NCT00845182|323617280|FG001|Overall Study|Lost to Follow-up|3|||
94498213|NCT00845182|323617281|FG002|Overall Study|Lost to Follow-up|4|||
94498214|NCT00845182|323617279|FG000|Overall Study|Adverse Event|0|||
94498215|NCT00845182|323617280|FG001|Overall Study|Adverse Event|1|||
94498216|NCT00845182|323617281|FG002|Overall Study|Adverse Event|1|||
94498217|NCT00845182|323617279|FG000|Overall Study|Physician Decision|0|||
94498218|NCT00845182|323617280|FG001|Overall Study|Physician Decision|0|||
94498219|NCT00845182|323617281|FG002|Overall Study|Physician Decision|1|||
94498220|NCT00762788|323617282|FG000|Overall Study|Lost to Follow-up|26|||
94498221|NCT00762788|323617283|FG001|Overall Study|Lost to Follow-up|37|||
94498222|NCT00762788|323617284|FG002|Overall Study|Lost to Follow-up|21|||
94498223|NCT00762788|323617285|FG003|Overall Study|Lost to Follow-up|26|||
94498224|NCT00762788|323617286|FG004|Overall Study|Lost to Follow-up|13|||
94498225|NCT00762788|323617287|FG005|Overall Study|Lost to Follow-up|21|||
94498226|NCT04621760|323617288|FG000|Overall Study|Lost to Follow-up|2|||
94498227|NCT04621760|323617289|FG001|Overall Study|Lost to Follow-up|4|||
94498228|NCT04621760|323617288|FG000|Overall Study|Withdrawal by Subject|1|||
94498229|NCT04621760|323617289|FG001|Overall Study|Withdrawal by Subject|0|||
94498230|NCT01297244|323617292|FG000|Overall Study|Progressive disease|22|||
94498231|NCT01297244|323617293|FG001|Overall Study|Progressive disease|3|||
94498232|NCT01297244|323617292|FG000|Overall Study|Adverse Event|9|||
94498233|NCT01297244|323617293|FG001|Overall Study|Adverse Event|1|||
94498234|NCT01297244|323617292|FG000|Overall Study|Death|1|||
94498235|NCT01297244|323617293|FG001|Overall Study|Death|1|||
94498236|NCT01297244|323617292|FG000|Overall Study|Clinical progression|1|||
94498237|NCT01297244|323617293|FG001|Overall Study|Clinical progression|1|||
94498238|NCT01297244|323617292|FG000|Overall Study|Withdrawal by Subject|2|||
94498239|NCT01297244|323617293|FG001|Overall Study|Withdrawal by Subject|0|||
94498240|NCT03677401|323617294|FG000|Overall Study|Adverse Event|4|||
94498241|NCT03677401|323617295|FG001|Overall Study|Adverse Event|14|||
94498242|NCT03677401|323617294|FG000|Overall Study|Lack of Efficacy|3|||
94498243|NCT03677401|323617295|FG001|Overall Study|Lack of Efficacy|1|||
94498244|NCT03677401|323617294|FG000|Overall Study|Withdrawal by Subject|2|||
94498245|NCT03677401|323617295|FG001|Overall Study|Withdrawal by Subject|2|||
94498246|NCT03677401|323617294|FG000|Overall Study|Sponsor decision|0|||
94498247|NCT03677401|323617295|FG001|Overall Study|Sponsor decision|1|||
94498248|NCT03677401|323617294|FG000|Overall Study|Reason Unspecified|1|||
94498249|NCT03677401|323617295|FG001|Overall Study|Reason Unspecified|0|||
94498250|NCT02595749|323617296|FG000|Overall Study|Withdrawal by Subject|12|||
94498251|NCT02595749|323617297|FG001|Overall Study|Withdrawal by Subject|7|||
94498252|NCT01047501|323617300|FG000|Overall Study|Adverse Event|7|||
94498253|NCT01047501|323617301|FG001|Overall Study|Adverse Event|8|||
94498254|NCT01047501|323617302|FG002|Overall Study|Adverse Event|5|||
94498255|NCT01047501|323617300|FG000|Overall Study|Withdrew Consent|6|||
94498256|NCT01047501|323617301|FG001|Overall Study|Withdrew Consent|2|||
94498257|NCT01047501|323617302|FG002|Overall Study|Withdrew Consent|4|||
94498258|NCT01047501|323617300|FG000|Overall Study|Lost to Follow-up|0|||
94498259|NCT01047501|323617301|FG001|Overall Study|Lost to Follow-up|1|||
94498260|NCT01047501|323617302|FG002|Overall Study|Lost to Follow-up|1|||
94498261|NCT01047501|323617300|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
94498262|NCT01047501|323617301|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
94498263|NCT01047501|323617302|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
94498264|NCT01047501|323617300|FG000|Overall Study|Death|1|||
94498265|NCT01047501|323617301|FG001|Overall Study|Death|0|||
94498266|NCT01047501|323617302|FG002|Overall Study|Death|0|||
94498267|NCT01047501|323617300|FG000|Overall Study|Other discontinuation|1|||
94498268|NCT01047501|323617301|FG001|Overall Study|Other discontinuation|0|||
94498269|NCT01047501|323617302|FG002|Overall Study|Other discontinuation|1|||
94498270|NCT01047501|323617300|FG000|Overall Study|Investigator judgement|0|||
94498271|NCT01047501|323617301|FG001|Overall Study|Investigator judgement|0|||
94498272|NCT01047501|323617302|FG002|Overall Study|Investigator judgement|1|||
94498273|NCT01562444|323617303|FG000|Overall Study|Did not meet entry criteria|2|||
94498274|NCT01562444|323617304|FG001|Overall Study|Did not meet entry criteria|0|||
94498275|NCT01562444|323617305|FG002|Overall Study|Did not meet entry criteria|3|||
94498276|NCT01562444|323617303|FG000|Overall Study|Did not comply with blood draw schedule|1|||
94498277|NCT01562444|323617304|FG001|Overall Study|Did not comply with blood draw schedule|0|||
94498278|NCT01562444|323617305|FG002|Overall Study|Did not comply with blood draw schedule|1|||
94498279|NCT01562444|323617303|FG000|Overall Study|Unavailable serological results|0|||
94498280|NCT01562444|323617304|FG001|Overall Study|Unavailable serological results|2|||
94498281|NCT01562444|323617305|FG002|Overall Study|Unavailable serological results|2|||
94498282|NCT01562444|323617303|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
94498283|NCT01562444|323617304|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
94498284|NCT01562444|323617305|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
94498285|NCT01562444|323617303|FG000|Overall Study|Protocol forbidden medication|1|||
94498286|NCT01562444|323617304|FG001|Overall Study|Protocol forbidden medication|0|||
94498287|NCT01562444|323617305|FG002|Overall Study|Protocol forbidden medication|0|||
94498288|NCT01177410|323617307|FG000|Overall Study|Adverse Event|0|||
94498289|NCT01177410|323617308|FG001|Overall Study|Adverse Event|2|||
94498290|NCT01177410|323617309|FG002|Overall Study|Adverse Event|2|||
94498291|NCT01177410|323617307|FG000|Overall Study|Withdrawal by Subject|1|||
94498292|NCT01177410|323617308|FG001|Overall Study|Withdrawal by Subject|4|||
94655622|NCT04369469|324196100|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
94498293|NCT01177410|323617309|FG002|Overall Study|Withdrawal by Subject|3|||
94498294|NCT01177410|323617307|FG000|Overall Study|Lost to Follow-up|0|||
94498295|NCT01177410|323617308|FG001|Overall Study|Lost to Follow-up|1|||
94498296|NCT01177410|323617309|FG002|Overall Study|Lost to Follow-up|0|||
94498297|NCT00986232|323617311|FG000|Overall Study|Adverse Event|1|||
94498298|NCT00986232|323617312|FG001|Overall Study|Adverse Event|2|||
94498299|NCT00986232|323617313|FG002|Overall Study|Adverse Event|3|||
94498300|NCT00986232|323617314|FG003|Overall Study|Adverse Event|0|||
94498301|NCT00986232|323617311|FG000|Overall Study|Lost to Follow-up|19|||
94498302|NCT00986232|323617312|FG001|Overall Study|Lost to Follow-up|12|||
94498303|NCT00986232|323617313|FG002|Overall Study|Lost to Follow-up|12|||
94498304|NCT00986232|323617314|FG003|Overall Study|Lost to Follow-up|7|||
94498305|NCT00986232|323617311|FG000|Overall Study|Protocol Violation|2|||
94498306|NCT00986232|323617312|FG001|Overall Study|Protocol Violation|3|||
94498307|NCT00986232|323617313|FG002|Overall Study|Protocol Violation|0|||
94498308|NCT00986232|323617314|FG003|Overall Study|Protocol Violation|1|||
94498309|NCT00986232|323617311|FG000|Overall Study|Withdrawal by Subject|13|||
94498310|NCT00986232|323617312|FG001|Overall Study|Withdrawal by Subject|16|||
94498311|NCT00986232|323617313|FG002|Overall Study|Withdrawal by Subject|12|||
94498312|NCT00986232|323617314|FG003|Overall Study|Withdrawal by Subject|3|||
94498313|NCT00986232|323617311|FG000|Overall Study|Missed one or more bleeds|13|||
94498314|NCT00986232|323617312|FG001|Overall Study|Missed one or more bleeds|10|||
94498315|NCT00986232|323617313|FG002|Overall Study|Missed one or more bleeds|6|||
94498316|NCT00986232|323617314|FG003|Overall Study|Missed one or more bleeds|7|||
94498317|NCT00986232|323617311|FG000|Overall Study|Incomplete safety follow-up|3|||
94498318|NCT00986232|323617312|FG001|Overall Study|Incomplete safety follow-up|7|||
94498319|NCT00986232|323617313|FG002|Overall Study|Incomplete safety follow-up|2|||
94498320|NCT00986232|323617314|FG003|Overall Study|Incomplete safety follow-up|2|||
94498321|NCT01027416|323617318|FG000|Overall Study|Withdrawal by Subject|0|||
94498322|NCT01027416|323617319|FG001|Overall Study|Withdrawal by Subject|1|||
94498323|NCT01027416|323617318|FG000|Overall Study|Physician Decision|1|||
94498324|NCT01027416|323617319|FG001|Overall Study|Physician Decision|4|||
94498325|NCT02930941|323617322|FG000|Overall Study|Lost to Follow-up|1|||
94498326|NCT02930941|323617323|FG001|Overall Study|Lost to Follow-up|2|||
94498327|NCT00894647|323617329|FG000|Overall Study|Adverse Event|5|||
94498328|NCT00894647|323617330|FG001|Overall Study|Adverse Event|4|||
94498329|NCT00894647|323617329|FG000|Overall Study|Withdrawal by Subject|4|||
94498330|NCT00894647|323617330|FG001|Overall Study|Withdrawal by Subject|4|||
94498331|NCT00894647|323617329|FG000|Overall Study|Lost to Follow-up|0|||
94498332|NCT00894647|323617330|FG001|Overall Study|Lost to Follow-up|2|||
94498333|NCT00894647|323617329|FG000|Overall Study|Non-compliance with study procedures|0|||
94498334|NCT00894647|323617330|FG001|Overall Study|Non-compliance with study procedures|2|||
94498335|NCT00894647|323617329|FG000|Overall Study|Other, not due to AE|1|||
94498336|NCT00894647|323617330|FG001|Overall Study|Other, not due to AE|2|||
94498337|NCT00585585|323617331|FG000|Overall Study|Adverse Event|1|||
94498338|NCT01243424|323617332|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
94498339|NCT01243424|323617333|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
94498340|NCT01243424|323617332|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
94498341|NCT01243424|323617333|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
94498342|NCT01243424|323617332|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
94498343|NCT01243424|323617333|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
94498344|NCT01243424|323617332|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
94498345|NCT01243424|323617333|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
94498346|NCT01243424|323617332|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
94498347|NCT01243424|323617333|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
94498348|NCT01243424|323617332|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
94498349|NCT01243424|323617333|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
94498350|NCT01243424|323617332|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
94498351|NCT01243424|323617333|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
94498352|NCT01243424|323617332|FG000|Discontinuation From Treatment|Not treated|5|||
94498353|NCT01243424|323617333|FG001|Discontinuation From Treatment|Not treated|4|||
94498354|NCT01243424|323617332|FG000|Discontinuation From Treatment|Adverse Event|457|||
94498355|NCT01243424|323617333|FG001|Discontinuation From Treatment|Adverse Event|523|||
94498356|NCT01243424|323617332|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
94498357|NCT01243424|323617333|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
94498358|NCT01243424|323617332|FG000|Discontinuation From Treatment|Protocol Violation|46|||
94498359|NCT01243424|323617333|FG001|Discontinuation From Treatment|Protocol Violation|47|||
94498360|NCT01243424|323617332|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
94498361|NCT01243424|323617333|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
94498362|NCT01243424|323617332|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
94498363|NCT01243424|323617333|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
94498364|NCT01243424|323617332|FG000|Discontinuation From Treatment|Other than listed above|230|||
94498365|NCT01243424|323617333|FG001|Discontinuation From Treatment|Other than listed above|211|||
94498366|NCT00153920|323617334|FG000|Overall Study|Adverse Event|9|||
94498367|NCT00153920|323617334|FG000|Overall Study|Progressive Disease|9|||
94498368|NCT00153920|323617334|FG000|Overall Study|Physician Decision|3|||
94498369|NCT00153920|323617334|FG000|Overall Study|Lack of Response|3|||
94498370|NCT00153920|323617334|FG000|Overall Study|Death|2|||
94498371|NCT00153920|323617334|FG000|Overall Study|Withdrawal by Subject|1|||
94498372|NCT00153920|323617334|FG000|Overall Study|Non-Protocol Therapy|1|||
94498373|NCT00153920|323617334|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
94498374|NCT00153920|323617334|FG000|Overall Study|Progressive Disease before Trt|1|||
94498375|NCT03954938|323617338|FG000|Overall Study|Withdrawal by Subject|2|||
94498376|NCT03954938|323617338|FG000|Overall Study|Adverse Event|1|||
94498377|NCT02421510|323617341|FG000|Overall Study|Other|4|||
94498378|NCT02421510|323617342|FG001|Overall Study|Other|2|||
94498379|NCT02421510|323617343|FG002|Overall Study|Other|3|||
94498380|NCT02421510|323617341|FG000|Overall Study|Protocol Violation|1|||
94498381|NCT02421510|323617342|FG001|Overall Study|Protocol Violation|2|||
94498382|NCT02421510|323617343|FG002|Overall Study|Protocol Violation|0|||
94498383|NCT02421510|323617341|FG000|Overall Study|Death|1|||
94498384|NCT02421510|323617342|FG001|Overall Study|Death|0|||
94498385|NCT02421510|323617343|FG002|Overall Study|Death|0|||
94498386|NCT02421510|323617341|FG000|Overall Study|Noncompliance with study drug|1|||
94498387|NCT02421510|323617342|FG001|Overall Study|Noncompliance with study drug|0|||
94498388|NCT02421510|323617343|FG002|Overall Study|Noncompliance with study drug|0|||
94498389|NCT02421510|323617341|FG000|Overall Study|Physician Decision|1|||
94498390|NCT02421510|323617342|FG001|Overall Study|Physician Decision|1|||
94498391|NCT02421510|323617343|FG002|Overall Study|Physician Decision|3|||
94498392|NCT02421510|323617341|FG000|Overall Study|Adverse Event|9|||
94498393|NCT02421510|323617342|FG001|Overall Study|Adverse Event|10|||
94498394|NCT02421510|323617343|FG002|Overall Study|Adverse Event|18|||
94498395|NCT02421510|323617341|FG000|Overall Study|Pregnancy|1|||
94498396|NCT02421510|323617342|FG001|Overall Study|Pregnancy|1|||
94498397|NCT02421510|323617343|FG002|Overall Study|Pregnancy|0|||
94498398|NCT02421510|323617341|FG000|Overall Study|Withdrawal by Subject|14|||
94498399|NCT02421510|323617342|FG001|Overall Study|Withdrawal by Subject|18|||
94498400|NCT02421510|323617343|FG002|Overall Study|Withdrawal by Subject|12|||
94498401|NCT02421510|323617341|FG000|Overall Study|Lost to Follow-up|1|||
94498402|NCT02421510|323617342|FG001|Overall Study|Lost to Follow-up|1|||
94498403|NCT02421510|323617343|FG002|Overall Study|Lost to Follow-up|0|||
94498404|NCT00471107|323617350|FG000|Overall Study|Technical problems/data loss|3|||
94498405|NCT00471107|323617351|FG001|Overall Study|Technical problems/data loss|1|||
94498406|NCT00471107|323617352|FG002|Overall Study|Technical problems/data loss|3|||
94498407|NCT01769443|323617354|FG000|Overall Study|Study closure|1|||
94498408|NCT01769443|323617355|FG001|Overall Study|Study closure|0|||
94498409|NCT00933166|323617356|FG000|Overall Study|Lost to Follow-up|4|||
94498410|NCT00933166|323617356|FG000|Overall Study|Lack of Efficacy|9|||
94498411|NCT00933166|323617356|FG000|Overall Study|Unavailable|4|||
94498412|NCT00933166|323617356|FG000|Overall Study|Withdrawal by Subject|1|||
94498413|NCT02346370|323617357|FG000|Overall Study|Not treated|1|||
94498414|NCT02346370|323617358|FG001|Overall Study|Not treated|0|||
94498415|NCT02346370|323617359|FG002|Overall Study|Not treated|0|||
94498416|NCT02346370|323617357|FG000|Overall Study|Withdrawal of consent|1|||
94498417|NCT02346370|323617358|FG001|Overall Study|Withdrawal of consent|0|||
94498418|NCT02346370|323617359|FG002|Overall Study|Withdrawal of consent|0|||
94498419|NCT02346370|323617357|FG000|Overall Study|Death|1|||
94498420|NCT02346370|323617358|FG001|Overall Study|Death|3|||
94498421|NCT02346370|323617359|FG002|Overall Study|Death|1|||
94498422|NCT02346370|323617357|FG000|Overall Study|Sponsor discontinued study|5|||
94498423|NCT02346370|323617358|FG001|Overall Study|Sponsor discontinued study|0|||
94498424|NCT02346370|323617359|FG002|Overall Study|Sponsor discontinued study|2|||
94498425|NCT02346370|323617357|FG000|Overall Study|Radiologic progression|0|||
94498426|NCT02346370|323617358|FG001|Overall Study|Radiologic progression|0|||
94498427|NCT02346370|323617359|FG002|Overall Study|Radiologic progression|1|||
94498428|NCT02346370|323617357|FG000|Overall Study|Physician Decision|0|||
94498429|NCT02346370|323617358|FG001|Overall Study|Physician Decision|1|||
94498430|NCT02346370|323617359|FG002|Overall Study|Physician Decision|0|||
94498431|NCT00724893|323617362|FG000|Overall Study|Adverse Event|76|||
94498432|NCT00724893|323617363|FG001|Overall Study|Adverse Event|142|||
94498433|NCT00724893|323617362|FG000|Overall Study|Withdrawal by Subject|0|||
94498434|NCT00724893|323617363|FG001|Overall Study|Withdrawal by Subject|1|||
94498435|NCT00724893|323617362|FG000|Overall Study|Lack of virologic response|94|||
94498436|NCT00724893|323617363|FG001|Overall Study|Lack of virologic response|202|||
94498437|NCT00724893|323617362|FG000|Overall Study|Reason not specified|193|||
94498438|NCT00724893|323617363|FG001|Overall Study|Reason not specified|7|||
94498439|NCT00724893|323617362|FG000|Overall Study|Patient choice|0|||
94498440|NCT00724893|323617363|FG001|Overall Study|Patient choice|26|||
94498441|NCT00724893|323617362|FG000|Overall Study|Geographic reasons|0|||
94498442|NCT00724893|323617363|FG001|Overall Study|Geographic reasons|11|||
94498443|NCT00724893|323617362|FG000|Overall Study|Incarceration|0|||
94498444|NCT00724893|323617363|FG001|Overall Study|Incarceration|9|||
94498445|NCT00724893|323617362|FG000|Overall Study|Substance abuse|0|||
94498446|NCT00724893|323617363|FG001|Overall Study|Substance abuse|3|||
94498447|NCT00724893|323617362|FG000|Overall Study|Financial reasons|0|||
94498448|NCT00724893|323617363|FG001|Overall Study|Financial reasons|2|||
94498449|NCT00724893|323617362|FG000|Overall Study|Assigned shorter treatment|0|||
94498450|NCT00724893|323617363|FG001|Overall Study|Assigned shorter treatment|2|||
94498451|NCT00724893|323617362|FG000|Overall Study|Lost to Follow-up|0|||
94498452|NCT00724893|323617363|FG001|Overall Study|Lost to Follow-up|52|||
94498453|NCT00724893|323617362|FG000|Overall Study|Unknown, missing data|1|||
94498454|NCT00724893|323617363|FG001|Overall Study|Unknown, missing data|1|||
94498455|NCT01666652|323617366|FG000|Overall Study|Serious Adverse Event|0|||
94498456|NCT01666652|323617367|FG001|Overall Study|Serious Adverse Event|0|||
94498457|NCT01666652|323617368|FG002|Overall Study|Serious Adverse Event|0|||
94498458|NCT01666652|323617369|FG003|Overall Study|Serious Adverse Event|1|||
94498459|NCT01666652|323617370|FG004|Overall Study|Serious Adverse Event|0|||
94498460|NCT01666652|323617366|FG000|Overall Study|Withdrawal by Subject|0|||
94498461|NCT01666652|323617367|FG001|Overall Study|Withdrawal by Subject|0|||
94498462|NCT01666652|323617368|FG002|Overall Study|Withdrawal by Subject|0|||
94498463|NCT01666652|323617369|FG003|Overall Study|Withdrawal by Subject|0|||
94498464|NCT01666652|323617370|FG004|Overall Study|Withdrawal by Subject|1|||
94498465|NCT01666652|323617366|FG000|Overall Study|Moved from study area|1|||
94498466|NCT01666652|323617367|FG001|Overall Study|Moved from study area|0|||
94498467|NCT01666652|323617368|FG002|Overall Study|Moved from study area|0|||
94498468|NCT01666652|323617369|FG003|Overall Study|Moved from study area|2|||
94498469|NCT01666652|323617370|FG004|Overall Study|Moved from study area|0|||
94498470|NCT01666652|323617366|FG000|Overall Study|Lost to Follow-up|1|||
94498471|NCT01666652|323617367|FG001|Overall Study|Lost to Follow-up|1|||
94498472|NCT01666652|323617368|FG002|Overall Study|Lost to Follow-up|1|||
94498473|NCT01666652|323617369|FG003|Overall Study|Lost to Follow-up|1|||
94498474|NCT01666652|323617370|FG004|Overall Study|Lost to Follow-up|0|||
94498475|NCT00985790|323617372|FG000|Overall Study|Withdrawal by Subject|1|||
94498476|NCT00985790|323617373|FG001|Overall Study|Withdrawal by Subject|1|||
94498477|NCT00985790|323617372|FG000|Overall Study|Lost to Follow-up|6|||
94498478|NCT00985790|323617373|FG001|Overall Study|Lost to Follow-up|7|||
94498479|NCT03753542|323617374|FG000|Overall Study|Lost to Follow-up|9|||
94498480|NCT03753542|323617375|FG001|Overall Study|Lost to Follow-up|14|||
94498481|NCT03003468|323617376|FG000|Overall Study|Withdrawal by Subject|0|||
94498482|NCT03003468|323617377|FG001|Overall Study|Withdrawal by Subject|0|||
94498483|NCT03003468|323617378|FG002|Overall Study|Withdrawal by Subject|1|||
94498484|NCT03003468|323617376|FG000|Overall Study|No measurable lesions|0|||
94498485|NCT03003468|323617377|FG001|Overall Study|No measurable lesions|0|||
94498486|NCT03003468|323617378|FG002|Overall Study|No measurable lesions|1|||
94498487|NCT00002874|323617379|FG000|Overall Study|Withdrawal by Subject|1|||
94498488|NCT00002874|323617380|FG001|Overall Study|Withdrawal by Subject|1|||
94498489|NCT00002874|323617379|FG000|Overall Study|Protocol Violation|44|||
94498490|NCT00002874|323617380|FG001|Overall Study|Protocol Violation|34|||
94498491|NCT02530242|323617381|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
94498492|NCT02530242|323617382|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
94498493|NCT00283959|323617383|FG000|Extension Period|Low Compliance|1|||
94498494|NCT01980888|323617384|FG000|Overall Study|Study Terminated by Sponsor|116|||
94498495|NCT01980888|323617385|FG001|Overall Study|Study Terminated by Sponsor|122|||
94498496|NCT01980888|323617384|FG000|Overall Study|Withdrew Consent|17|||
94498497|NCT01980888|323617385|FG001|Overall Study|Withdrew Consent|6|||
94498498|NCT01980888|323617384|FG000|Overall Study|Investigator's Discretion|8|||
94498499|NCT01980888|323617385|FG001|Overall Study|Investigator's Discretion|3|||
94498500|NCT01980888|323617384|FG000|Overall Study|Non-Compliance with Study Drug|3|||
94498501|NCT01980888|323617385|FG001|Overall Study|Non-Compliance with Study Drug|2|||
94498502|NCT01483651|323617387|FG000|Overall Study|Withdrawal by Subject|0|||
94498503|NCT01483651|323617388|FG001|Overall Study|Withdrawal by Subject|1|||
94498504|NCT01483651|323617389|FG002|Overall Study|Withdrawal by Subject|1|||
94498505|NCT01483651|323617390|FG003|Overall Study|Withdrawal by Subject|0|||
94498506|NCT01483651|323617391|FG004|Overall Study|Withdrawal by Subject|0|||
94498507|NCT01483651|323617392|FG005|Overall Study|Withdrawal by Subject|1|||
94498508|NCT00504309|323617399|FG000|Overall Study|Death|0|||
94498509|NCT00504309|323617400|FG001|Overall Study|Death|0|||
94498510|NCT00504309|323617401|FG002|Overall Study|Death|0|||
94498511|NCT00504309|323617402|FG003|Overall Study|Death|0|||
94498512|NCT00504309|323617403|FG004|Overall Study|Death|1|||
94498513|NCT00504309|323617404|FG005|Overall Study|Death|0|||
94498514|NCT00504309|323617399|FG000|Overall Study|Withdrawal by Subject|0|||
94498515|NCT00504309|323617400|FG001|Overall Study|Withdrawal by Subject|0|||
94498516|NCT00504309|323617401|FG002|Overall Study|Withdrawal by Subject|1|||
94498517|NCT00504309|323617402|FG003|Overall Study|Withdrawal by Subject|0|||
94498518|NCT00504309|323617403|FG004|Overall Study|Withdrawal by Subject|0|||
94498519|NCT00504309|323617404|FG005|Overall Study|Withdrawal by Subject|0|||
94498520|NCT00308685|323617406|FG000|Overall Study|Lost to Follow-up|1|||
94498521|NCT00308685|323617407|FG001|Overall Study|Lost to Follow-up|0|||
94498522|NCT00308685|323617406|FG000|Overall Study|Need to administer prohibited medication|1|||
94498523|NCT00308685|323617407|FG001|Overall Study|Need to administer prohibited medication|2|||
94498524|NCT00308685|323617406|FG000|Overall Study|Other than specified|1|||
94498525|NCT00308685|323617407|FG001|Overall Study|Other than specified|3|||
94498526|NCT00683384|323617408|FG000|Overall Study|Death|1|||
94498527|NCT00683384|323617408|FG000|Overall Study|Adverse Event|1|||
94498528|NCT00120874|323617410|FG000|Overall Study|Death|0|||
94498529|NCT00120874|323617411|FG001|Overall Study|Death|1|||
94498530|NCT01727154|323617412|FG000|Overall Study|Death|17|||
94498531|NCT01727154|323617412|FG000|Overall Study|Withdrawal by Subject|14|||
94498532|NCT01727154|323617412|FG000|Overall Study|Subject Withdrew Consent|18|||
94498533|NCT01727154|323617412|FG000|Overall Study|Study Terminated|6|||
94498534|NCT01727154|323617412|FG000|Overall Study|No Discontinuation Documentation|4|||
94498535|NCT01198548|323617419|FG000|Overall Study|Disease Progression|9|||
94498536|NCT01198548|323617419|FG000|Overall Study|Administrative Decision|1|||
94498537|NCT02638493|323617421|FG000|Overall Study|Inability to provide semen samples|2|||
94498538|NCT02638493|323617422|FG001|Overall Study|Inability to provide semen samples|0|||
94498539|NCT02638493|323617423|FG002|Overall Study|Inability to provide semen samples|0|||
94498540|NCT00004859|323617428|FG000|Overall Study|Lack of Efficacy|43|||
94498541|NCT00004859|323617429|FG001|Overall Study|Lack of Efficacy|113|||
94498542|NCT00004859|323617428|FG000|Overall Study|Adverse Event|31|||
94498543|NCT00004859|323617429|FG001|Overall Study|Adverse Event|93|||
94498544|NCT00004859|323617428|FG000|Overall Study|Death|5|||
94498545|NCT00004859|323617429|FG001|Overall Study|Death|5|||
94498546|NCT00004859|323617428|FG000|Overall Study|Withdrawal by Subject|7|||
94498547|NCT00004859|323617429|FG001|Overall Study|Withdrawal by Subject|33|||
94498548|NCT00004859|323617428|FG000|Overall Study|Protocol Violation|2|||
94498549|NCT00004859|323617429|FG001|Overall Study|Protocol Violation|2|||
94498550|NCT00004859|323617428|FG000|Overall Study|other disease|0|||
94498551|NCT00004859|323617429|FG001|Overall Study|other disease|3|||
94498552|NCT00004859|323617428|FG000|Overall Study|error|3|||
94498553|NCT00004859|323617429|FG001|Overall Study|error|1|||
94498554|NCT00004859|323617428|FG000|Overall Study|missing data|14|||
94498555|NCT00004859|323617429|FG001|Overall Study|missing data|11|||
94498556|NCT00004859|323617428|FG000|Overall Study|Other|13|||
94498557|NCT00004859|323617429|FG001|Overall Study|Other|21|||
94498558|NCT03684057|323619285|FG000|Overall Study|Withdrawal by Subject|4|||
94498559|NCT03684057|323619286|FG001|Overall Study|Withdrawal by Subject|5|||
94498560|NCT01105130|323619287|FG000|Overall Study|Withdrawal by Subject|4|||
94498561|NCT01105130|323619288|FG001|Overall Study|Withdrawal by Subject|6|||
94498562|NCT01105130|323619289|FG002|Overall Study|Withdrawal by Subject|2|||
94498563|NCT01105130|323619287|FG000|Overall Study|Never Started|2|||
94498564|NCT01105130|323619288|FG001|Overall Study|Never Started|2|||
94498565|NCT01105130|323619289|FG002|Overall Study|Never Started|4|||
94498566|NCT01105130|323619287|FG000|Overall Study|Toxicity|1|||
94498567|NCT01105130|323619288|FG001|Overall Study|Toxicity|3|||
94498568|NCT01105130|323619289|FG002|Overall Study|Toxicity|2|||
94498569|NCT01105130|323619287|FG000|Overall Study|Multiple Reasons|3|||
94498570|NCT01105130|323619288|FG001|Overall Study|Multiple Reasons|0|||
94498571|NCT01105130|323619289|FG002|Overall Study|Multiple Reasons|2|||
94498572|NCT03298061|323619294|FG000|Overall Study|Adverse Event|3|||
94498573|NCT03298061|323619294|FG000|Overall Study|Lack of Efficacy|6|||
94498574|NCT03298061|323619294|FG000|Overall Study|Protocol Violation|1|||
94498575|NCT03298061|323619294|FG000|Overall Study|Physician Decision|7|||
94498576|NCT03298061|323619294|FG000|Overall Study|Withdrawal by Subject|10|||
94498577|NCT00327171|323619296|FG000|Overall Study|Did not receive study medication|3|||
94498578|NCT00327171|323619297|FG001|Overall Study|Did not receive study medication|0|||
94498579|NCT00327171|323619296|FG000|Overall Study|Adverse Event|23|||
94498580|NCT00327171|323619297|FG001|Overall Study|Adverse Event|23|||
94498581|NCT00327171|323619296|FG000|Overall Study|Disease progression/lack of efficacy|68|||
94498582|NCT00327171|323619297|FG001|Overall Study|Disease progression/lack of efficacy|69|||
94498583|NCT00327171|323619296|FG000|Overall Study|Investigator/participant request|1|||
94498584|NCT00327171|323619297|FG001|Overall Study|Investigator/participant request|8|||
94498585|NCT00327171|323619296|FG000|Overall Study|Clinical progression|12|||
94498586|NCT00327171|323619297|FG001|Overall Study|Clinical progression|8|||
94498587|NCT00327171|323619296|FG000|Overall Study|Undisclosed history of ischemia|0|||
94498588|NCT00327171|323619297|FG001|Overall Study|Undisclosed history of ischemia|1|||
94498589|NCT00327171|323619296|FG000|Overall Study|Other|1|||
94498590|NCT00327171|323619297|FG001|Overall Study|Other|0|||
94498591|NCT01363440|323619300|FG000|Overall Study|Adverse Event|5|||
94498592|NCT01363440|323619301|FG001|Overall Study|Adverse Event|4|||
94498593|NCT01363440|323619302|FG002|Overall Study|Adverse Event|4|||
94498594|NCT01363440|323619300|FG000|Overall Study|Death|3|||
94498595|NCT01363440|323619301|FG001|Overall Study|Death|7|||
94498596|NCT01363440|323619302|FG002|Overall Study|Death|5|||
94498597|NCT01363440|323619300|FG000|Overall Study|Withdrawal by Subject|9|||
94498598|NCT01363440|323619301|FG001|Overall Study|Withdrawal by Subject|11|||
94498599|NCT01363440|323619302|FG002|Overall Study|Withdrawal by Subject|11|||
94498600|NCT01363440|323619300|FG000|Overall Study|Lost to Follow-up|2|||
94498601|NCT01363440|323619301|FG001|Overall Study|Lost to Follow-up|4|||
94498602|NCT01363440|323619302|FG002|Overall Study|Lost to Follow-up|5|||
94498603|NCT01363440|323619300|FG000|Overall Study|Other|4|||
94498604|NCT01363440|323619301|FG001|Overall Study|Other|5|||
94498605|NCT01363440|323619302|FG002|Overall Study|Other|2|||
94498606|NCT00992836|323619305|FG000|Overall Study|Lost to Follow-up|1|||
94498607|NCT00992836|323619305|FG000|Overall Study|Withdrawal by Subject|2|||
94498608|NCT00992836|323619305|FG000|Overall Study|Protocol Violation|2|||
94498609|NCT02323334|323619308|FG000|Period 3|Lost to Follow-up|0|||
94498610|NCT02323334|323619309|FG001|Period 3|Lost to Follow-up|0|||
94498611|NCT02323334|323619310|FG002|Period 3|Lost to Follow-up|1|||
94498612|NCT02323334|323619311|FG003|Period 3|Lost to Follow-up|0|||
94498613|NCT02323334|323619312|FG004|Period 3|Lost to Follow-up|0|||
94498614|NCT02323334|323619313|FG005|Period 3|Lost to Follow-up|0|||
94498615|NCT02323334|323619314|FG006|Period 3|Lost to Follow-up|0|||
94498616|NCT02323334|323619315|FG007|Period 3|Lost to Follow-up|0|||
94498617|NCT02323334|323619316|FG008|Period 3|Lost to Follow-up|0|||
94498618|NCT02323334|323619317|FG009|Period 3|Lost to Follow-up|0|||
94498619|NCT02323334|323619318|FG010|Period 3|Lost to Follow-up|0|||
94498620|NCT02323334|323619319|FG011|Period 3|Lost to Follow-up|0|||
94498621|NCT02323334|323619320|FG012|Period 3|Lost to Follow-up|0|||
94498622|NCT02323334|323619321|FG013|Period 3|Lost to Follow-up|0|||
94498623|NCT02323334|323619322|FG014|Period 3|Lost to Follow-up|0|||
94498624|NCT02323334|323619323|FG015|Period 3|Lost to Follow-up|0|||
94498625|NCT02323334|323619324|FG016|Period 3|Lost to Follow-up|0|||
94498626|NCT02323334|323619308|FG000|Period 3|Withdrawal by Subject|1|||
94498627|NCT02323334|323619309|FG001|Period 3|Withdrawal by Subject|0|||
94498628|NCT02323334|323619310|FG002|Period 3|Withdrawal by Subject|0|||
94498629|NCT02323334|323619311|FG003|Period 3|Withdrawal by Subject|0|||
94498630|NCT02323334|323619312|FG004|Period 3|Withdrawal by Subject|0|||
94498631|NCT02323334|323619313|FG005|Period 3|Withdrawal by Subject|0|||
94498632|NCT02323334|323619314|FG006|Period 3|Withdrawal by Subject|0|||
94498633|NCT02323334|323619315|FG007|Period 3|Withdrawal by Subject|0|||
94498634|NCT02323334|323619316|FG008|Period 3|Withdrawal by Subject|0|||
94498635|NCT02323334|323619317|FG009|Period 3|Withdrawal by Subject|0|||
94498636|NCT02323334|323619318|FG010|Period 3|Withdrawal by Subject|0|||
94498637|NCT02323334|323619319|FG011|Period 3|Withdrawal by Subject|0|||
94498638|NCT02323334|323619320|FG012|Period 3|Withdrawal by Subject|0|||
94498639|NCT02323334|323619321|FG013|Period 3|Withdrawal by Subject|0|||
94498640|NCT02323334|323619322|FG014|Period 3|Withdrawal by Subject|0|||
94498641|NCT02323334|323619323|FG015|Period 3|Withdrawal by Subject|0|||
94498642|NCT02323334|323619324|FG016|Period 3|Withdrawal by Subject|0|||
94498643|NCT01617967|323619325|FG000|Overall Study|Protocol Violation|0|||
94498644|NCT01617967|323619326|FG001|Overall Study|Protocol Violation|0|||
94498645|NCT01617967|323619327|FG002|Overall Study|Protocol Violation|0|||
94498646|NCT01617967|323619328|FG003|Overall Study|Protocol Violation|1|||
94498647|NCT01617967|323619329|FG004|Overall Study|Protocol Violation|0|||
94498648|NCT01617967|323619330|FG005|Overall Study|Protocol Violation|0|||
94498649|NCT01617967|323619325|FG000|Overall Study|Withdrawal by Subject|0|||
94498650|NCT01617967|323619326|FG001|Overall Study|Withdrawal by Subject|0|||
94498651|NCT01617967|323619327|FG002|Overall Study|Withdrawal by Subject|0|||
94498652|NCT01617967|323619328|FG003|Overall Study|Withdrawal by Subject|0|||
94498653|NCT01617967|323619329|FG004|Overall Study|Withdrawal by Subject|0|||
94498654|NCT01617967|323619330|FG005|Overall Study|Withdrawal by Subject|1|||
94498655|NCT01617967|323619325|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
94498656|NCT01617967|323619326|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
94498657|NCT01617967|323619327|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
94498658|NCT01617967|323619328|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
94498659|NCT01617967|323619329|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
94498660|NCT01617967|323619330|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
94498661|NCT02506036|323619332|FG000|First Intervention (4-6 Weeks)|Death|1|||
94498662|NCT02506036|323619333|FG001|First Intervention (4-6 Weeks)|Death|0|||
94498663|NCT02506036|323619332|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
94498664|NCT02506036|323619333|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
94498665|NCT02506036|323619332|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
94498666|NCT02506036|323619333|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
94498667|NCT02316613|323619336|FG000|Overall Study|Death|63|||
94498668|NCT02316613|323619336|FG000|Overall Study|Lost to Follow-up|9|||
94498669|NCT02316613|323619336|FG000|Overall Study|Lymphoma transformation|2|||
94498670|NCT02316613|323619336|FG000|Overall Study|Participant moved/changed medical team|11|||
94498671|NCT02316613|323619336|FG000|Overall Study|No data and duplicate cases|5|||
94498672|NCT02316613|323619336|FG000|Overall Study|Did not met selection criteria|14|||
94498673|NCT02827708|323619343|FG000|Overall Study|Lost to Follow-up|3|||
94498674|NCT02827708|323619344|FG001|Overall Study|Lost to Follow-up|1|||
94498675|NCT02827708|323619343|FG000|Overall Study|Withdrawal by Subject|1|||
94498676|NCT02827708|323619344|FG001|Overall Study|Withdrawal by Subject|2|||
94498677|NCT02827708|323619343|FG000|Overall Study|Death|1|||
94498678|NCT02827708|323619344|FG001|Overall Study|Death|2|||
94498679|NCT02489773|323619345|FG000|Overall Study|Lost to Follow-up|4|||
94498680|NCT02489773|323619346|FG001|Overall Study|Lost to Follow-up|1|||
94498681|NCT02489773|323619345|FG000|Overall Study|Physician Decision|1|||
94498682|NCT02489773|323619346|FG001|Overall Study|Physician Decision|0|||
94498683|NCT02489773|323619345|FG000|Overall Study|Withdrawal by Subject|1|||
94498684|NCT02489773|323619346|FG001|Overall Study|Withdrawal by Subject|0|||
94498685|NCT02489773|323619345|FG000|Overall Study|Leave the country or the state|1|||
94498686|NCT02489773|323619346|FG001|Overall Study|Leave the country or the state|1|||
94498687|NCT01625182|323619351|FG000|Overall Study|Administrative problems|1|||
94498688|NCT01625182|323619352|FG001|Overall Study|Administrative problems|0|||
94498689|NCT01625182|323619351|FG000|Overall Study|Protocol deviation|0|||
94498690|NCT01625182|323619352|FG001|Overall Study|Protocol deviation|2|||
94498691|NCT01625182|323619351|FG000|Overall Study|Adverse Event|2|||
94498692|NCT01625182|323619352|FG001|Overall Study|Adverse Event|0|||
94498693|NCT01625182|323619351|FG000|Overall Study|Withdrawal by Subject|5|||
94498694|NCT01625182|323619352|FG001|Overall Study|Withdrawal by Subject|1|||
94498695|NCT01625182|323619351|FG000|Overall Study|Lack of Efficacy|12|||
94498696|NCT01625182|323619352|FG001|Overall Study|Lack of Efficacy|8|||
94498697|NCT01348698|323619353|FG000|Overall Study|Does not meet lesion size criteria|1|||
94498698|NCT01348698|323619353|FG000|Overall Study|Death|3|||
94498699|NCT01348698|323619353|FG000|Overall Study|PI decision to close study|68|||
94498700|NCT02541903|323619361|FG000|Overall Study|Death|1|||
94498701|NCT02639559|323619362|FG000|Overall Study|Mobilization failure|0|||
94498702|NCT02639559|323619363|FG001|Overall Study|Mobilization failure|3|||
94498703|NCT02639559|323619362|FG000|Overall Study|Issues with vascular acess|1|||
94498704|NCT02639559|323619363|FG001|Overall Study|Issues with vascular acess|0|||
94498705|NCT02202616|323619364|FG000|Overall Study|Screen failed|24|||
94498706|NCT02202616|323619364|FG000|Overall Study|Adverse Event|32|||
94498707|NCT02202616|323619364|FG000|Overall Study|Protocol deviation|18|||
94498708|NCT02202616|323619364|FG000|Overall Study|Patient withdrew consent|12|||
94498709|NCT02202616|323619364|FG000|Overall Study|Lost to Follow-up|6|||
94498710|NCT02202616|323619364|FG000|Overall Study|Administrative problems|6|||
94498711|NCT02202616|323619364|FG000|Overall Study|Abnormal test procedure result|1|||
94498712|NCT02202616|323619364|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94498713|NCT01138046|323619365|FG000|Overall Study|Withdrawal due to death|6|||
94498714|NCT00827242|323619366|FG000|Overall Study|Withdrawal by Subject|2|||
94498715|NCT00827242|323619367|FG001|Overall Study|Withdrawal by Subject|4|||
94498716|NCT00827242|323619366|FG000|Overall Study|Protocol Violation|1|||
94498717|NCT00827242|323619367|FG001|Overall Study|Protocol Violation|3|||
94498718|NCT00827242|323619366|FG000|Overall Study|Lost to Follow-up|0|||
94498719|NCT00827242|323619367|FG001|Overall Study|Lost to Follow-up|3|||
94498720|NCT00827242|323619366|FG000|Overall Study|Adverse Event Excluding Death|2|||
94498721|NCT00827242|323619367|FG001|Overall Study|Adverse Event Excluding Death|1|||
94498722|NCT00827242|323619366|FG000|Overall Study|Entry Criteria Not Met|4|||
94498723|NCT00827242|323619367|FG001|Overall Study|Entry Criteria Not Met|1|||
94498724|NCT00827242|323619366|FG000|Overall Study|Physician Decision|2|||
94498725|NCT00827242|323619367|FG001|Overall Study|Physician Decision|0|||
94498726|NCT00827242|323619366|FG000|Overall Study|Death|1|||
94498727|NCT00827242|323619367|FG001|Overall Study|Death|0|||
94498728|NCT00827242|323619366|FG000|Overall Study|Lack of Efficacy|1|||
94498729|NCT00827242|323619367|FG001|Overall Study|Lack of Efficacy|0|||
94498730|NCT04790201|323619372|FG000|Overall Study|Lost to Follow-up|0|||
94498731|NCT04790201|323619373|FG001|Overall Study|Lost to Follow-up|0|||
94498732|NCT04790201|323619374|FG002|Overall Study|Lost to Follow-up|2|||
94498733|NCT04790201|323619372|FG000|Overall Study|Death|0|||
94498734|NCT04790201|323619373|FG001|Overall Study|Death|1|||
94498735|NCT04790201|323619374|FG002|Overall Study|Death|0|||
94498736|NCT04790201|323619372|FG000|Overall Study|Protocol Violation|1|||
94498737|NCT04790201|323619373|FG001|Overall Study|Protocol Violation|0|||
94498738|NCT04790201|323619374|FG002|Overall Study|Protocol Violation|1|||
94498739|NCT03670628|323619375|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
94498740|NCT03670628|323619376|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
94498741|NCT03670628|323619375|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
94498742|NCT03670628|323619376|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
94498743|NCT04925934|323619379|FG000|Overall Study|Adverse Event|1|||
94498744|NCT04925934|323619380|FG001|Overall Study|Adverse Event|0|||
94498745|NCT04925934|323619381|FG002|Overall Study|Adverse Event|0|||
94498746|NCT04925934|323619379|FG000|Overall Study|Lost to Follow-up|2|||
94498747|NCT04925934|323619380|FG001|Overall Study|Lost to Follow-up|0|||
94498748|NCT04925934|323619381|FG002|Overall Study|Lost to Follow-up|1|||
94498749|NCT04925934|323619379|FG000|Overall Study|Death|0|||
94498750|NCT04925934|323619380|FG001|Overall Study|Death|1|||
94498751|NCT04925934|323619381|FG002|Overall Study|Death|0|||
94498752|NCT04925934|323619379|FG000|Overall Study|Withdrawal by Subject|8|||
94498753|NCT04925934|323619380|FG001|Overall Study|Withdrawal by Subject|5|||
94498754|NCT04925934|323619381|FG002|Overall Study|Withdrawal by Subject|9|||
94498755|NCT04925934|323619379|FG000|Overall Study|Other|2|||
94498756|NCT04925934|323619380|FG001|Overall Study|Other|2|||
94498757|NCT04925934|323619381|FG002|Overall Study|Other|2|||
94498758|NCT04925934|323619379|FG000|Overall Study|Eastern European Conflict|7|||
94498759|NCT04925934|323619380|FG001|Overall Study|Eastern European Conflict|3|||
94498760|NCT04925934|323619381|FG002|Overall Study|Eastern European Conflict|2|||
94498761|NCT02942407|323619382|FG000|Overall Study|Lost to Follow-up|3|||
94498762|NCT02942407|323619383|FG001|Overall Study|Lost to Follow-up|2|||
94498763|NCT02942407|323619382|FG000|Overall Study|Withdrawal by Subject|7|||
94498764|NCT02942407|323619383|FG001|Overall Study|Withdrawal by Subject|9|||
94498765|NCT02942407|323619382|FG000|Overall Study|Death|16|||
94498766|NCT02942407|323619383|FG001|Overall Study|Death|13|||
94498767|NCT03528577|323619384|FG000|Sequence 1|Failed Spirometry|1|||
94498768|NCT03528577|323619384|FG000|Sequence 1|Restricted medication|1|||
94498769|NCT03528577|323619384|FG000|Sequence 2|Adverse Event|1|||
94498770|NCT03528577|323619384|FG000|Sequence 2|Withdrawal by Subject|1|||
94498771|NCT03528577|323619384|FG000|Sequence 2|Failed Spirometry|1|||
94498772|NCT03528577|323619384|FG000|Sequence 3|Failed Spirometry|1|||
94498773|NCT03528577|323619384|FG000|Sequence 4|Failed Spirometry|2|||
94498774|NCT03528577|323619384|FG000|Sequence 4|Adverse Event|1|||
94498775|NCT01279200|323619388|FG000|Overall Study|Withdrawal by Subject|1|||
94498776|NCT01279200|323619389|FG001|Overall Study|Withdrawal by Subject|3|||
94498777|NCT01279200|323619388|FG000|Overall Study|Patient withdrawal due to high cost|0|||
94498778|NCT01279200|323619389|FG001|Overall Study|Patient withdrawal due to high cost|1|||
94498779|NCT01279200|323619388|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
94498780|NCT01279200|323619389|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
94498781|NCT01279200|323619388|FG000|Overall Study|ultrasound screening failure|0|||
94498782|NCT01279200|323619389|FG001|Overall Study|ultrasound screening failure|1|||
94498783|NCT01279200|323619388|FG000|Overall Study|Lost to Follow-up|0|||
94498784|NCT01279200|323619389|FG001|Overall Study|Lost to Follow-up|1|||
94498785|NCT01279200|323619388|FG000|Overall Study|Adverse Event|1|||
94498786|NCT01279200|323619389|FG001|Overall Study|Adverse Event|0|||
94498787|NCT01668537|323619390|FG000|Overall Study|Request to Discontinue Prematurely|1|||
94498788|NCT01668537|323619391|FG001|Overall Study|Request to Discontinue Prematurely|1|||
94498789|NCT01668537|323619390|FG000|Overall Study|Subject unwilling/unable to comply|5|||
94498790|NCT01668537|323619391|FG001|Overall Study|Subject unwilling/unable to comply|0|||
94498791|NCT01668537|323619390|FG000|Overall Study|Reason Precludes Participation|1|||
94498792|NCT01668537|323619391|FG001|Overall Study|Reason Precludes Participation|0|||
94498793|NCT01668537|323619390|FG000|Overall Study|Lost to Follow-up|13|||
94498794|NCT01668537|323619391|FG001|Overall Study|Lost to Follow-up|6|||
94498795|NCT01668537|323619390|FG000|Overall Study|Other|2|||
94498796|NCT01668537|323619391|FG001|Overall Study|Other|3|||
94498797|NCT01149538|323619392|FG000|Overall Study|Lost to Follow-up|0|||
94498798|NCT01149538|323619393|FG001|Overall Study|Lost to Follow-up|1|||
94498799|NCT01149538|323619392|FG000|Overall Study|Withdrawal by Subject|5|||
94498800|NCT01149538|323619393|FG001|Overall Study|Withdrawal by Subject|3|||
94498801|NCT00629239|323619398|FG000|Overall Study|Adverse Event|7|||
94498802|NCT00629239|323619399|FG001|Overall Study|Adverse Event|4|||
94498803|NCT00629239|323619398|FG000|Overall Study|Physician Decision|1|||
94498804|NCT00629239|323619399|FG001|Overall Study|Physician Decision|0|||
94498805|NCT02583477|323619406|FG000|Overall Study|Adverse Event|0|||
94498806|NCT02583477|323619407|FG001|Overall Study|Adverse Event|2|||
94498807|NCT02583477|323619406|FG000|Overall Study|Death|1|||
94498808|NCT02583477|323619407|FG001|Overall Study|Death|16|||
94498809|NCT02583477|323619406|FG000|Overall Study|Study terminated|2|||
94498810|NCT02583477|323619407|FG001|Overall Study|Study terminated|2|||
94498811|NCT01078545|323619408|FG000|Overall Study|Lost to Follow-up|13|||
94498812|NCT01078545|323619408|FG000|Overall Study|Physician Decision|6|||
94498813|NCT01078545|323619408|FG000|Overall Study|Withdrawal by Subject|3|||
94498814|NCT01078545|323619408|FG000|Overall Study|Death|3|||
94498815|NCT01078545|323619408|FG000|Overall Study|Participant moved to another physician|1|||
94498816|NCT02497755|323619409|FG000|Overall Study|Protocol Violation|1|||
94498817|NCT02497755|323619410|FG001|Overall Study|Protocol Violation|0|||
94498818|NCT01774370|323619413|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
94498819|NCT01774370|323619413|FG000|Overall Study|Administered prior to the contract date|4|||
94498820|NCT01774370|323619413|FG000|Overall Study|Subjects of contraindications|34|||
94498821|NCT01774370|323619413|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
94498822|NCT01774370|323619413|FG000|Overall Study|Follow-up failure|34|||
94498823|NCT05436288|323619414|FG000|Overall Study|Lost to Follow-up|1|||
94498824|NCT05436288|323619414|FG000|Overall Study|Adverse Event|1|||
94498825|NCT00514917|323619420|FG000|Overall Study|Death|4|||
94498826|NCT00514917|323619421|FG001|Overall Study|Death|10|||
94498827|NCT00514917|323619420|FG000|Overall Study|Protocol Violation|1|||
94498828|NCT00514917|323619421|FG001|Overall Study|Protocol Violation|0|||
94498829|NCT00514917|323619420|FG000|Overall Study|Lost to Follow-up|4|||
94498830|NCT00514917|323619421|FG001|Overall Study|Lost to Follow-up|3|||
94498831|NCT00514917|323619420|FG000|Overall Study|Withdrawal by Subject|18|||
94498832|NCT00514917|323619421|FG001|Overall Study|Withdrawal by Subject|16|||
94498833|NCT00514917|323619420|FG000|Overall Study|Discontinued due to study closure|88|||
94498834|NCT00514917|323619421|FG001|Overall Study|Discontinued due to study closure|81|||
94498835|NCT00514917|323619420|FG000|Overall Study|Undefined|11|||
94498836|NCT00514917|323619421|FG001|Overall Study|Undefined|5|||
94498837|NCT02697422|323619425|FG000|Overall Study|Declined exit survey|9|||
94498838|NCT02697422|323619426|FG001|Overall Study|Declined exit survey|2|||
94498839|NCT02697422|323619425|FG000|Overall Study|Lost to Follow-up|13|||
94498840|NCT02697422|323619426|FG001|Overall Study|Lost to Follow-up|8|||
94498841|NCT02697422|323619425|FG000|Overall Study|Death|2|||
94498842|NCT02697422|323619426|FG001|Overall Study|Death|1|||
94498843|NCT02697422|323619425|FG000|Overall Study|Withdrawal by Subject|0|||
94498844|NCT02697422|323619426|FG001|Overall Study|Withdrawal by Subject|1|||
94498845|NCT02697422|323619425|FG000|Overall Study|Physician Decision|1|||
94498846|NCT02697422|323619426|FG001|Overall Study|Physician Decision|1|||
94498847|NCT02697422|323619425|FG000|Overall Study|Exit survey data lost|1|||
94498848|NCT02697422|323619426|FG001|Overall Study|Exit survey data lost|0|||
94498849|NCT03501277|323619428|FG000|Intervention Period 1 (4 Days)|Other|0|||
94498850|NCT03501277|323619429|FG001|Intervention Period 1 (4 Days)|Other|0|||
94498851|NCT03501277|323619430|FG002|Intervention Period 1 (4 Days)|Other|1|||
94498852|NCT03501277|323619431|FG003|Intervention Period 1 (4 Days)|Other|0|||
94498853|NCT03501277|323619428|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
94498854|NCT03501277|323619429|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
94498855|NCT03501277|323619430|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
94498856|NCT03501277|323619431|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
94498857|NCT03501277|323619428|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
94498858|NCT03501277|323619429|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
94498859|NCT03501277|323619430|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
94498860|NCT03501277|323619431|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
94498861|NCT03501277|323619428|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
94498862|NCT03501277|323619429|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
94498863|NCT03501277|323619430|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
94498864|NCT03501277|323619431|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
94498865|NCT01436500|323619434|FG000|Overall Study|Death|1|||
94498866|NCT01436500|323619435|FG001|Overall Study|Death|0|||
94498867|NCT01436500|323619436|FG002|Overall Study|Death|0|||
94498868|NCT01436500|323619437|FG003|Overall Study|Death|0|||
94498869|NCT01436500|323619438|FG004|Overall Study|Death|0|||
94498870|NCT01436500|323619434|FG000|Overall Study|Adverse Event|0|||
94498871|NCT01436500|323619435|FG001|Overall Study|Adverse Event|2|||
94498872|NCT01436500|323619436|FG002|Overall Study|Adverse Event|2|||
94498873|NCT01436500|323619437|FG003|Overall Study|Adverse Event|0|||
94498874|NCT01436500|323619438|FG004|Overall Study|Adverse Event|1|||
94498875|NCT01436500|323619434|FG000|Overall Study|Withdrawal by Subject|0|||
94498876|NCT01436500|323619435|FG001|Overall Study|Withdrawal by Subject|0|||
94498877|NCT01436500|323619436|FG002|Overall Study|Withdrawal by Subject|2|||
94498878|NCT01436500|323619437|FG003|Overall Study|Withdrawal by Subject|0|||
94498879|NCT01436500|323619438|FG004|Overall Study|Withdrawal by Subject|2|||
94498880|NCT01436500|323619434|FG000|Overall Study|Physician Decision|0|||
94498881|NCT01436500|323619435|FG001|Overall Study|Physician Decision|0|||
94498882|NCT01436500|323619436|FG002|Overall Study|Physician Decision|1|||
94498883|NCT01436500|323619437|FG003|Overall Study|Physician Decision|0|||
94498884|NCT01436500|323619438|FG004|Overall Study|Physician Decision|0|||
94498885|NCT01436500|323619434|FG000|Overall Study|liver transplant|1|||
94498886|NCT01436500|323619435|FG001|Overall Study|liver transplant|0|||
94498887|NCT01436500|323619436|FG002|Overall Study|liver transplant|0|||
94498888|NCT01436500|323619437|FG003|Overall Study|liver transplant|0|||
94498889|NCT01436500|323619438|FG004|Overall Study|liver transplant|0|||
94498890|NCT01436500|323619434|FG000|Overall Study|initiation of dialysis|0|||
94498891|NCT01436500|323619435|FG001|Overall Study|initiation of dialysis|0|||
94498892|NCT01436500|323619436|FG002|Overall Study|initiation of dialysis|0|||
94498893|NCT01436500|323619437|FG003|Overall Study|initiation of dialysis|0|||
94498894|NCT01436500|323619438|FG004|Overall Study|initiation of dialysis|1|||
94498895|NCT01436500|323619434|FG000|Overall Study|discontinued study drug|1|||
94498896|NCT01436500|323619435|FG001|Overall Study|discontinued study drug|0|||
94498897|NCT01436500|323619436|FG002|Overall Study|discontinued study drug|0|||
94498898|NCT01436500|323619437|FG003|Overall Study|discontinued study drug|0|||
94498899|NCT01436500|323619438|FG004|Overall Study|discontinued study drug|0|||
94498900|NCT01436500|323619434|FG000|Overall Study|Other|0|||
94498901|NCT01436500|323619435|FG001|Overall Study|Other|1|||
94498902|NCT01436500|323619436|FG002|Overall Study|Other|0|||
94498903|NCT01436500|323619437|FG003|Overall Study|Other|1|||
94498904|NCT01436500|323619438|FG004|Overall Study|Other|0|||
94498905|NCT00977561|323619439|FG000|Overall Study|Death|3|||
94498906|NCT00977561|323619440|FG001|Overall Study|Death|2|||
94498907|NCT00977561|323619439|FG000|Overall Study|Study terminated|0|||
94498908|NCT00977561|323619440|FG001|Overall Study|Study terminated|2|||
94498909|NCT00977561|323619439|FG000|Overall Study|Other|2|||
94498910|NCT00977561|323619440|FG001|Overall Study|Other|0|||
94498911|NCT01131585|323619443|FG000|Overall Study|Adverse Event|0|||
94498912|NCT01131585|323619444|FG001|Overall Study|Adverse Event|2|||
94498913|NCT01131585|323619443|FG000|Overall Study|Abnormal laboratory value|1|||
94498914|NCT01131585|323619444|FG001|Overall Study|Abnormal laboratory value|0|||
94498915|NCT01131585|323619443|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94498916|NCT01131585|323619444|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
94498917|NCT01131585|323619443|FG000|Overall Study|Protocol Violation|2|||
94498918|NCT01131585|323619444|FG001|Overall Study|Protocol Violation|1|||
94498919|NCT01131585|323619443|FG000|Overall Study|Withdrawal by Subject|3|||
94498920|NCT01131585|323619444|FG001|Overall Study|Withdrawal by Subject|3|||
94498921|NCT01131585|323619443|FG000|Overall Study|Lost to Follow-up|0|||
94498922|NCT01131585|323619444|FG001|Overall Study|Lost to Follow-up|1|||
94498923|NCT01131585|323619443|FG000|Overall Study|Administrative problems|1|||
94498924|NCT01131585|323619444|FG001|Overall Study|Administrative problems|1|||
94498925|NCT01131585|323619443|FG000|Overall Study|Study termination|78|||
94498926|NCT01131585|323619444|FG001|Overall Study|Study termination|32|||
94498927|NCT01968785|323619445|FG000|Overall Study|Withdrawal by Subject|1|||
94498928|NCT01968785|323619446|FG001|Overall Study|Withdrawal by Subject|0|||
94498929|NCT00812097|323619447|FG000|Overall Study|Death|3|||
94498930|NCT00812097|323619448|FG001|Overall Study|Death|10|||
94498931|NCT00812097|323619449|FG002|Overall Study|Death|3|||
94498932|NCT00812097|323619450|FG003|Overall Study|Death|3|||
94498933|NCT00812097|323619447|FG000|Overall Study|Withdrawal by Subject|14|||
94498934|NCT00812097|323619448|FG001|Overall Study|Withdrawal by Subject|12|||
94498935|NCT00812097|323619449|FG002|Overall Study|Withdrawal by Subject|8|||
94498936|NCT00812097|323619450|FG003|Overall Study|Withdrawal by Subject|2|||
94498937|NCT00812097|323619447|FG000|Overall Study|Lost to Follow-up|90|||
94498938|NCT00812097|323619448|FG001|Overall Study|Lost to Follow-up|14|||
94498939|NCT00812097|323619449|FG002|Overall Study|Lost to Follow-up|17|||
94498940|NCT00812097|323619450|FG003|Overall Study|Lost to Follow-up|5|||
94498941|NCT00812097|323619447|FG000|Overall Study|Explantation of study device(s)|27|||
94498942|NCT00812097|323619448|FG001|Overall Study|Explantation of study device(s)|29|||
94498943|NCT00812097|323619449|FG002|Overall Study|Explantation of study device(s)|14|||
94498944|NCT00812097|323619450|FG003|Overall Study|Explantation of study device(s)|20|||
94498945|NCT00812097|323619447|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
94498946|NCT00812097|323619448|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
94498947|NCT00812097|323619449|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
94498948|NCT00812097|323619450|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
94498949|NCT02068599|323619451|FG000|Overall Study|Adverse Event|4|||
94498950|NCT02068599|323619452|FG001|Overall Study|Adverse Event|1|||
94498951|NCT02068599|323619453|FG002|Overall Study|Adverse Event|1|||
94498952|NCT02068599|323619451|FG000|Overall Study|Withdrawal by Subject|2|||
94498953|NCT02068599|323619452|FG001|Overall Study|Withdrawal by Subject|7|||
94498954|NCT02068599|323619453|FG002|Overall Study|Withdrawal by Subject|5|||
94498955|NCT02068599|323619451|FG000|Overall Study|Protocol Violation|4|||
94498956|NCT02068599|323619452|FG001|Overall Study|Protocol Violation|2|||
94498957|NCT02068599|323619453|FG002|Overall Study|Protocol Violation|3|||
94498958|NCT02068599|323619451|FG000|Overall Study|Lost to Follow-up|1|||
94498959|NCT02068599|323619452|FG001|Overall Study|Lost to Follow-up|0|||
94498960|NCT02068599|323619453|FG002|Overall Study|Lost to Follow-up|0|||
94498961|NCT02068599|323619451|FG000|Overall Study|Lack of Efficacy|0|||
94498962|NCT02068599|323619452|FG001|Overall Study|Lack of Efficacy|0|||
94498963|NCT02068599|323619453|FG002|Overall Study|Lack of Efficacy|3|||
94498964|NCT02068599|323619451|FG000|Overall Study|Noncompliance|0|||
94498965|NCT02068599|323619452|FG001|Overall Study|Noncompliance|0|||
94498966|NCT02068599|323619453|FG002|Overall Study|Noncompliance|1|||
94498967|NCT02939781|323619456|FG000|Overall Study|Protocol Violation|8|||
94498968|NCT02939781|323619456|FG000|Overall Study|Withdrawal by Subject|1|||
94498969|NCT04625972|323619458|FG000|Overall Study|Death|3|||
94498970|NCT04625972|323619459|FG001|Overall Study|Death|2|||
94498971|NCT04625972|323619458|FG000|Overall Study|Lost to Follow-up|82|||
94498972|NCT04625972|323619459|FG001|Overall Study|Lost to Follow-up|38|||
94498973|NCT04625972|323619458|FG000|Overall Study|Physician Decision|2|||
94498974|NCT04625972|323619459|FG001|Overall Study|Physician Decision|0|||
94498975|NCT04625972|323619458|FG000|Overall Study|Protocol Violation|0|||
94498976|NCT04625972|323619459|FG001|Overall Study|Protocol Violation|1|||
94498977|NCT04625972|323619458|FG000|Overall Study|Withdrawal by Subject|37|||
94498978|NCT04625972|323619459|FG001|Overall Study|Withdrawal by Subject|24|||
94498979|NCT04625972|323619458|FG000|Overall Study|Not specified elsewhere|8|||
94498980|NCT04625972|323619459|FG001|Overall Study|Not specified elsewhere|6|||
94498981|NCT00165698|323619460|FG000|Overall Study|Adverse Event|2|||
94498982|NCT00165698|323619461|FG001|Overall Study|Adverse Event|10|||
94498983|NCT00165698|323619460|FG000|Overall Study|Lost to Follow-up|2|||
94498984|NCT00165698|323619461|FG001|Overall Study|Lost to Follow-up|2|||
94498985|NCT00165698|323619460|FG000|Overall Study|Withdrawal by Subject|2|||
94498986|NCT00165698|323619461|FG001|Overall Study|Withdrawal by Subject|1|||
94498987|NCT00165698|323619460|FG000|Overall Study|Protocol Violation|1|||
94498988|NCT00165698|323619461|FG001|Overall Study|Protocol Violation|0|||
94498989|NCT00165698|323619460|FG000|Overall Study|Not Taken/Lost the medicine|1|||
94498990|NCT00165698|323619461|FG001|Overall Study|Not Taken/Lost the medicine|2|||
94498991|NCT01107457|323619462|FG000|Part A|Adverse Event|1|||
94498992|NCT01107457|323619463|FG001|Part A|Adverse Event|2|||
94498993|NCT01107457|323619464|FG002|Part A|Adverse Event|1|||
94498994|NCT01107457|323619465|FG003|Part A|Adverse Event|0|||
94498995|NCT01107457|323619466|FG004|Part A|Adverse Event|0|||
94498996|NCT01107457|323619467|FG005|Part A|Adverse Event|0|||
94498997|NCT01107457|323619462|FG000|Part A|Withdrawal by Subject|3|||
94498998|NCT01107457|323619463|FG001|Part A|Withdrawal by Subject|3|||
94498999|NCT01107457|323619464|FG002|Part A|Withdrawal by Subject|0|||
94499000|NCT01107457|323619465|FG003|Part A|Withdrawal by Subject|3|||
94499001|NCT01107457|323619466|FG004|Part A|Withdrawal by Subject|1|||
94499002|NCT01107457|323619467|FG005|Part A|Withdrawal by Subject|0|||
94499003|NCT01107457|323619462|FG000|Part A|Lost to Follow-up|0|||
94499004|NCT01107457|323619463|FG001|Part A|Lost to Follow-up|1|||
94499005|NCT01107457|323619464|FG002|Part A|Lost to Follow-up|0|||
94499006|NCT01107457|323619465|FG003|Part A|Lost to Follow-up|0|||
94499007|NCT01107457|323619466|FG004|Part A|Lost to Follow-up|0|||
94499008|NCT01107457|323619467|FG005|Part A|Lost to Follow-up|0|||
94499009|NCT01107457|323619462|FG000|Part A|Lack of Efficacy|1|||
94499010|NCT01107457|323619463|FG001|Part A|Lack of Efficacy|0|||
94499011|NCT01107457|323619464|FG002|Part A|Lack of Efficacy|0|||
94499012|NCT01107457|323619465|FG003|Part A|Lack of Efficacy|0|||
94499013|NCT01107457|323619466|FG004|Part A|Lack of Efficacy|0|||
94499014|NCT01107457|323619467|FG005|Part A|Lack of Efficacy|0|||
94499015|NCT01107457|323619462|FG000|Part A|Protocol Violation|0|||
94499016|NCT01107457|323619463|FG001|Part A|Protocol Violation|1|||
94499017|NCT01107457|323619464|FG002|Part A|Protocol Violation|0|||
94499018|NCT01107457|323619465|FG003|Part A|Protocol Violation|0|||
94499019|NCT01107457|323619466|FG004|Part A|Protocol Violation|0|||
94499020|NCT01107457|323619467|FG005|Part A|Protocol Violation|0|||
94499021|NCT01107457|323619462|FG000|Part B and C|Adverse Event|0|||
94499022|NCT01107457|323619463|FG001|Part B and C|Adverse Event|0|||
94499023|NCT01107457|323619464|FG002|Part B and C|Adverse Event|0|||
94499024|NCT01107457|323619465|FG003|Part B and C|Adverse Event|0|||
94499025|NCT01107457|323619466|FG004|Part B and C|Adverse Event|0|||
94499026|NCT01107457|323619467|FG005|Part B and C|Adverse Event|12|||
94499027|NCT01107457|323619462|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
94499028|NCT01107457|323619463|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
94499029|NCT01107457|323619464|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
94499030|NCT01107457|323619465|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
94499031|NCT01107457|323619466|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
94499032|NCT01107457|323619467|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
94499033|NCT01107457|323619462|FG000|Part B and C|Physician Decision|0|||
94499034|NCT01107457|323619463|FG001|Part B and C|Physician Decision|0|||
94499035|NCT01107457|323619464|FG002|Part B and C|Physician Decision|0|||
94499036|NCT01107457|323619465|FG003|Part B and C|Physician Decision|0|||
94499037|NCT01107457|323619466|FG004|Part B and C|Physician Decision|0|||
94499038|NCT01107457|323619467|FG005|Part B and C|Physician Decision|3|||
94499039|NCT01107457|323619462|FG000|Part B and C|Lack of Efficacy|0|||
94499040|NCT01107457|323619463|FG001|Part B and C|Lack of Efficacy|0|||
94499041|NCT01107457|323619464|FG002|Part B and C|Lack of Efficacy|0|||
94499042|NCT01107457|323619465|FG003|Part B and C|Lack of Efficacy|0|||
94499043|NCT01107457|323619466|FG004|Part B and C|Lack of Efficacy|0|||
94499044|NCT01107457|323619467|FG005|Part B and C|Lack of Efficacy|7|||
94499045|NCT01107457|323619462|FG000|Part B and C|Lost to Follow-up|0|||
94499046|NCT01107457|323619463|FG001|Part B and C|Lost to Follow-up|0|||
94499047|NCT01107457|323619464|FG002|Part B and C|Lost to Follow-up|0|||
94499048|NCT01107457|323619465|FG003|Part B and C|Lost to Follow-up|0|||
94499049|NCT01107457|323619466|FG004|Part B and C|Lost to Follow-up|0|||
94499050|NCT01107457|323619467|FG005|Part B and C|Lost to Follow-up|10|||
94499051|NCT01107457|323619462|FG000|Part B and C|Protocol Violation|0|||
94499052|NCT01107457|323619463|FG001|Part B and C|Protocol Violation|0|||
94499053|NCT01107457|323619464|FG002|Part B and C|Protocol Violation|0|||
94499054|NCT01107457|323619465|FG003|Part B and C|Protocol Violation|0|||
94499055|NCT01107457|323619466|FG004|Part B and C|Protocol Violation|0|||
94499056|NCT01107457|323619467|FG005|Part B and C|Protocol Violation|1|||
94499057|NCT01107457|323619462|FG000|Part B and C|Sponsor Decision|0|||
94499058|NCT01107457|323619463|FG001|Part B and C|Sponsor Decision|0|||
94499059|NCT01107457|323619464|FG002|Part B and C|Sponsor Decision|0|||
94499060|NCT01107457|323619465|FG003|Part B and C|Sponsor Decision|0|||
94499061|NCT01107457|323619466|FG004|Part B and C|Sponsor Decision|0|||
94499062|NCT01107457|323619467|FG005|Part B and C|Sponsor Decision|66|||
94499063|NCT01107457|323619462|FG000|Part B and C|Withdrawal by Subject|0|||
94499064|NCT01107457|323619463|FG001|Part B and C|Withdrawal by Subject|0|||
94499065|NCT01107457|323619464|FG002|Part B and C|Withdrawal by Subject|0|||
94499066|NCT01107457|323619465|FG003|Part B and C|Withdrawal by Subject|0|||
94499067|NCT01107457|323619466|FG004|Part B and C|Withdrawal by Subject|0|||
94499068|NCT01107457|323619467|FG005|Part B and C|Withdrawal by Subject|16|||
94499069|NCT01107457|323619462|FG000|Part B and C|Clinical Relapse|0|||
94499070|NCT01107457|323619463|FG001|Part B and C|Clinical Relapse|0|||
94499071|NCT01107457|323619464|FG002|Part B and C|Clinical Relapse|0|||
94499072|NCT01107457|323619465|FG003|Part B and C|Clinical Relapse|0|||
94499073|NCT01107457|323619466|FG004|Part B and C|Clinical Relapse|0|||
94499074|NCT01107457|323619467|FG005|Part B and C|Clinical Relapse|4|||
94499075|NCT02547935|323619468|FG000|Overall Study|Other|0|||
94499076|NCT02547935|323619469|FG001|Overall Study|Other|1|||
94499077|NCT02547935|323619470|FG002|Overall Study|Other|0|||
94499078|NCT02547935|323619468|FG000|Overall Study|Withdrawal by Subject|2|||
94499079|NCT02547935|323619469|FG001|Overall Study|Withdrawal by Subject|3|||
94499080|NCT02547935|323619470|FG002|Overall Study|Withdrawal by Subject|4|||
94499081|NCT02547935|323619468|FG000|Overall Study|Screen Failure|2|||
94499082|NCT02547935|323619469|FG001|Overall Study|Screen Failure|0|||
94499083|NCT02547935|323619470|FG002|Overall Study|Screen Failure|0|||
94499084|NCT02547935|323619468|FG000|Overall Study|Physician Decision|0|||
94499085|NCT02547935|323619469|FG001|Overall Study|Physician Decision|1|||
94499086|NCT02547935|323619470|FG002|Overall Study|Physician Decision|0|||
94499087|NCT02547935|323619468|FG000|Overall Study|Lost to Follow-up|0|||
94499088|NCT02547935|323619469|FG001|Overall Study|Lost to Follow-up|2|||
94499089|NCT02547935|323619470|FG002|Overall Study|Lost to Follow-up|1|||
94499090|NCT02547935|323619468|FG000|Overall Study|Death|1|||
94499091|NCT02547935|323619469|FG001|Overall Study|Death|1|||
94499092|NCT02547935|323619470|FG002|Overall Study|Death|0|||
94499093|NCT00086307|323619471|FG000|Overall Study|Lack of Efficacy|1|||
94499094|NCT00086307|323619472|FG001|Overall Study|Lack of Efficacy|1|||
94499095|NCT00086307|323619473|FG002|Overall Study|Lack of Efficacy|2|||
94499096|NCT00086307|323619471|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
94499097|NCT00086307|323619472|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
94499098|NCT00086307|323619473|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
94499099|NCT00086307|323619471|FG000|Overall Study|Nausea and headaches|0|||
94499100|NCT00086307|323619472|FG001|Overall Study|Nausea and headaches|0|||
94499101|NCT00086307|323619473|FG002|Overall Study|Nausea and headaches|1|||
94499102|NCT00086307|323619471|FG000|Overall Study|Constipation and sleepiness|0|||
94499103|NCT00086307|323619472|FG001|Overall Study|Constipation and sleepiness|0|||
94499104|NCT00086307|323619473|FG002|Overall Study|Constipation and sleepiness|1|||
94499105|NCT00086307|323619471|FG000|Overall Study|Suicidal ideation|0|||
94499106|NCT00086307|323619472|FG001|Overall Study|Suicidal ideation|0|||
94499107|NCT00086307|323619473|FG002|Overall Study|Suicidal ideation|1|||
94499108|NCT00086307|323619471|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
94499109|NCT00086307|323619472|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
94499110|NCT00086307|323619473|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
94499111|NCT00086307|323619471|FG000|Overall Study|Withdrawal by Subject|0|||
94499112|NCT00086307|323619472|FG001|Overall Study|Withdrawal by Subject|0|||
94499113|NCT00086307|323619473|FG002|Overall Study|Withdrawal by Subject|2|||
94499114|NCT03382561|323622127|FG000|Overall Study|Disease progression|47|||
94499115|NCT03382561|323622128|FG001|Overall Study|Disease progression|6|||
94499116|NCT03382561|323622127|FG000|Overall Study|Adverse Event|10|||
94499117|NCT03382561|323622128|FG001|Overall Study|Adverse Event|2|||
94499118|NCT03382561|323622127|FG000|Overall Study|Death|8|||
94499119|NCT03382561|323622128|FG001|Overall Study|Death|3|||
94499120|NCT03382561|323622127|FG000|Overall Study|Withdrawal by Subject|6|||
94499121|NCT03382561|323622128|FG001|Overall Study|Withdrawal by Subject|5|||
94499122|NCT03382561|323622127|FG000|Overall Study|Alternative therapy|2|||
94499123|NCT03382561|323622128|FG001|Overall Study|Alternative therapy|8|||
94499124|NCT03382561|323622127|FG000|Overall Study|Never started treatment|3|||
94499125|NCT03382561|323622128|FG001|Overall Study|Never started treatment|6|||
94499126|NCT03382561|323622127|FG000|Overall Study|Lack of Efficacy|0|||
94499127|NCT03382561|323622128|FG001|Overall Study|Lack of Efficacy|1|||
94499128|NCT03382561|323622127|FG000|Overall Study|Physician Decision|0|||
94499129|NCT03382561|323622128|FG001|Overall Study|Physician Decision|1|||
94499130|NCT03382561|323622127|FG000|Overall Study|Other complicating disease|0|||
94499131|NCT03382561|323622128|FG001|Overall Study|Other complicating disease|1|||
94499132|NCT02724644|323622129|FG000|Overall Study|Adverse Event|7|||
94499133|NCT02724644|323622130|FG001|Overall Study|Adverse Event|1|||
94499134|NCT02724644|323622129|FG000|Overall Study|Lost to Follow-up|6|||
94499135|NCT02724644|323622130|FG001|Overall Study|Lost to Follow-up|2|||
94499136|NCT02724644|323622129|FG000|Overall Study|Withdrawal by Subject|7|||
94499137|NCT02724644|323622130|FG001|Overall Study|Withdrawal by Subject|1|||
94499138|NCT02724644|323622129|FG000|Overall Study|Administrative|1|||
94499139|NCT02724644|323622130|FG001|Overall Study|Administrative|0|||
94499140|NCT00835978|323622138|FG000|Overall Study|Death|33|||
94499141|NCT00835978|323622139|FG001|Overall Study|Death|40|||
94499142|NCT00835978|323622140|FG002|Overall Study|Death|49|||
94499143|NCT00835978|323622141|FG003|Overall Study|Death|4|||
94499144|NCT00835978|323622138|FG000|Overall Study|Lost to Follow-up|3|||
94499145|NCT00835978|323622139|FG001|Overall Study|Lost to Follow-up|4|||
94499146|NCT00835978|323622140|FG002|Overall Study|Lost to Follow-up|2|||
94499147|NCT00835978|323622141|FG003|Overall Study|Lost to Follow-up|1|||
94499148|NCT00835978|323622138|FG000|Overall Study|Other|5|||
94499149|NCT00835978|323622139|FG001|Overall Study|Other|1|||
94499150|NCT00835978|323622140|FG002|Overall Study|Other|8|||
94499151|NCT00835978|323622141|FG003|Overall Study|Other|0|||
94499152|NCT00835978|323622138|FG000|Overall Study|Objective progression or relapse|2|||
94499153|NCT00835978|323622139|FG001|Overall Study|Objective progression or relapse|0|||
94499154|NCT00835978|323622140|FG002|Overall Study|Objective progression or relapse|1|||
94499155|NCT00835978|323622141|FG003|Overall Study|Objective progression or relapse|0|||
94499156|NCT00835978|323622138|FG000|Overall Study|Adverse Event|1|||
94499157|NCT00835978|323622139|FG001|Overall Study|Adverse Event|0|||
94499158|NCT00835978|323622140|FG002|Overall Study|Adverse Event|1|||
94499159|NCT00835978|323622141|FG003|Overall Study|Adverse Event|0|||
94499160|NCT00835978|323622138|FG000|Overall Study|Withdrawal by Subject|0|||
94499161|NCT00835978|323622139|FG001|Overall Study|Withdrawal by Subject|3|||
94499162|NCT00835978|323622140|FG002|Overall Study|Withdrawal by Subject|0|||
94499163|NCT00835978|323622141|FG003|Overall Study|Withdrawal by Subject|5|||
94499164|NCT00835978|323622138|FG000|Overall Study|Study terminated by sponsor|12|||
94499165|NCT00835978|323622139|FG001|Overall Study|Study terminated by sponsor|8|||
94499166|NCT00835978|323622140|FG002|Overall Study|Study terminated by sponsor|30|||
94499167|NCT00835978|323622141|FG003|Overall Study|Study terminated by sponsor|0|||
94499168|NCT04575324|323622142|FG000|Overall Study|Lost to Follow-up|29|||
94499169|NCT04575324|323622143|FG001|Overall Study|Lost to Follow-up|25|||
94499170|NCT04575324|323622142|FG000|Overall Study|Death|1|||
94499171|NCT04575324|323622143|FG001|Overall Study|Death|2|||
94499172|NCT04575324|323622142|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
94499173|NCT04575324|323622143|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
94499174|NCT02400736|323622144|FG000|Overall Study|Lost to Follow-up|6|||
94499175|NCT02400736|323622145|FG001|Overall Study|Lost to Follow-up|6|||
94499176|NCT02400736|323622144|FG000|Overall Study|Withdrawal by Subject|2|||
94499177|NCT02400736|323622145|FG001|Overall Study|Withdrawal by Subject|1|||
94499178|NCT02400736|323622144|FG000|Overall Study|Moved from the area|3|||
94499179|NCT02400736|323622145|FG001|Overall Study|Moved from the area|1|||
94499180|NCT02582632|323622146|FG000|Overall Study|Other|1|||
94499181|NCT01002105|323622147|FG000|Overall Study|Lost to Follow-up|10|||
94499182|NCT01002105|323622148|FG001|Overall Study|Lost to Follow-up|16|||
94499183|NCT01002105|323622147|FG000|Overall Study|non compliance|5|||
94499184|NCT01002105|323622148|FG001|Overall Study|non compliance|3|||
94499185|NCT01002105|323622147|FG000|Overall Study|condition worsened|4|||
94499186|NCT01002105|323622148|FG001|Overall Study|condition worsened|2|||
94499187|NCT02636283|323622151|FG000|Overall Study|Adverse Event|2|||
94499188|NCT02636283|323622152|FG001|Overall Study|Adverse Event|0|||
94499189|NCT02636283|323622151|FG000|Overall Study|Trial Terminated Prematurely|0|||
94499190|NCT02636283|323622152|FG001|Overall Study|Trial Terminated Prematurely|3|||
94499191|NCT03418675|323622153|FG000|Overall Study|Lost to Follow-up|13|||
94499192|NCT03418675|323622154|FG001|Overall Study|Lost to Follow-up|10|||
94499193|NCT03418675|323622153|FG000|Overall Study|Adverse Event|2|||
94499194|NCT03418675|323622154|FG001|Overall Study|Adverse Event|0|||
94499195|NCT03422718|323622155|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
94499196|NCT03422718|323622156|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
94499197|NCT03422718|323622157|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
94499198|NCT03422718|323622158|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
94499199|NCT03422718|323622159|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
94499200|NCT03422718|323622160|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
94499201|NCT03422718|323622161|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
94499202|NCT03422718|323622162|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
94499203|NCT03422718|323622155|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
94499204|NCT03422718|323622156|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
94499205|NCT03422718|323622157|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
94499206|NCT03422718|323622158|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
94499207|NCT03422718|323622159|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
94499208|NCT03422718|323622160|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
94499209|NCT03422718|323622161|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
94499210|NCT03422718|323622162|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
94499211|NCT03422718|323622155|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
94499212|NCT03422718|323622156|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
94499213|NCT03422718|323622157|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
94499214|NCT03422718|323622158|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
94499215|NCT03422718|323622159|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
94499216|NCT03422718|323622160|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
94499217|NCT03422718|323622161|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
94499218|NCT03422718|323622162|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
94499219|NCT03422718|323622155|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
94499220|NCT03422718|323622156|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
94499221|NCT03422718|323622157|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
94499222|NCT03422718|323622158|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
94499223|NCT03422718|323622159|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
94499224|NCT03422718|323622160|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
94499225|NCT03422718|323622161|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
94499226|NCT03422718|323622162|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
94499227|NCT03422718|323622155|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
94499228|NCT03422718|323622156|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
94499229|NCT03422718|323622157|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
94499230|NCT03422718|323622158|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
94499231|NCT03422718|323622159|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
94499232|NCT03422718|323622160|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
94499233|NCT03422718|323622161|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
94499234|NCT03422718|323622162|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
94499235|NCT03422718|323622155|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
94499236|NCT03422718|323622156|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
94499237|NCT03422718|323622157|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
94499238|NCT03422718|323622158|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
94499239|NCT03422718|323622159|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
94499240|NCT03422718|323622160|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
94499241|NCT03422718|323622161|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
94499242|NCT03422718|323622162|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
94499243|NCT03309605|323622163|FG000|Overall Study|Adverse Event|0|||
94499244|NCT03309605|323622164|FG001|Overall Study|Adverse Event|0|||
94499245|NCT03309605|323622165|FG002|Overall Study|Adverse Event|0|||
94499246|NCT03309605|323622166|FG003|Overall Study|Adverse Event|1|||
94499247|NCT03309605|323622167|FG004|Overall Study|Adverse Event|0|||
94499248|NCT03309605|323622168|FG005|Overall Study|Adverse Event|0|||
94499249|NCT03309605|323622169|FG006|Overall Study|Adverse Event|2|||
94499250|NCT03309605|323622170|FG007|Overall Study|Adverse Event|1|||
94499251|NCT03309605|323622163|FG000|Overall Study|Withdrawal by Subject|0|||
94499252|NCT03309605|323622164|FG001|Overall Study|Withdrawal by Subject|0|||
94499253|NCT03309605|323622165|FG002|Overall Study|Withdrawal by Subject|0|||
94499254|NCT03309605|323622166|FG003|Overall Study|Withdrawal by Subject|0|||
94499255|NCT03309605|323622167|FG004|Overall Study|Withdrawal by Subject|1|||
94499256|NCT03309605|323622168|FG005|Overall Study|Withdrawal by Subject|0|||
94499257|NCT03309605|323622169|FG006|Overall Study|Withdrawal by Subject|1|||
94499258|NCT03309605|323622170|FG007|Overall Study|Withdrawal by Subject|1|||
94499259|NCT02265744|323622173|FG000|Overall Study|Poor/Non-compliance|1|||
94499260|NCT02265744|323622174|FG001|Overall Study|Poor/Non-compliance|1|||
94499261|NCT02265744|323622175|FG002|Overall Study|Poor/Non-compliance|0|||
94499262|NCT02265744|323622176|FG003|Overall Study|Poor/Non-compliance|0|||
94499263|NCT02265744|323622177|FG004|Overall Study|Poor/Non-compliance|2|||
94499264|NCT02265744|323622173|FG000|Overall Study|Lost to Follow-up|0|||
94499265|NCT02265744|323622174|FG001|Overall Study|Lost to Follow-up|0|||
94499266|NCT02265744|323622175|FG002|Overall Study|Lost to Follow-up|0|||
94499267|NCT02265744|323622176|FG003|Overall Study|Lost to Follow-up|1|||
94499268|NCT02265744|323622177|FG004|Overall Study|Lost to Follow-up|0|||
94499269|NCT02265744|323622173|FG000|Overall Study|Death|0|||
94499270|NCT02265744|323622174|FG001|Overall Study|Death|0|||
94499271|NCT02265744|323622175|FG002|Overall Study|Death|0|||
94499272|NCT02265744|323622176|FG003|Overall Study|Death|2|||
94499273|NCT02265744|323622177|FG004|Overall Study|Death|0|||
94499274|NCT02265744|323622173|FG000|Overall Study|Withdrawal by Subject|2|||
94499275|NCT02265744|323622174|FG001|Overall Study|Withdrawal by Subject|0|||
94499276|NCT02265744|323622175|FG002|Overall Study|Withdrawal by Subject|0|||
94499277|NCT02265744|323622176|FG003|Overall Study|Withdrawal by Subject|2|||
94499278|NCT02265744|323622177|FG004|Overall Study|Withdrawal by Subject|0|||
94499279|NCT02265744|323622173|FG000|Overall Study|Participant request to discontinue|2|||
94499280|NCT02265744|323622174|FG001|Overall Study|Participant request to discontinue|2|||
94499281|NCT02265744|323622175|FG002|Overall Study|Participant request to discontinue|2|||
94499282|NCT02265744|323622176|FG003|Overall Study|Participant request to discontinue|0|||
94499283|NCT02265744|323622177|FG004|Overall Study|Participant request to discontinue|0|||
94499284|NCT02265744|323622173|FG000|Overall Study|Adverse Event|8|||
94499285|NCT02265744|323622174|FG001|Overall Study|Adverse Event|4|||
94499286|NCT02265744|323622175|FG002|Overall Study|Adverse Event|9|||
94499287|NCT02265744|323622176|FG003|Overall Study|Adverse Event|8|||
94499288|NCT02265744|323622177|FG004|Overall Study|Adverse Event|2|||
94499289|NCT02265744|323622173|FG000|Overall Study|Lack of Efficacy|2|||
94499290|NCT02265744|323622174|FG001|Overall Study|Lack of Efficacy|4|||
94499291|NCT02265744|323622175|FG002|Overall Study|Lack of Efficacy|3|||
94499292|NCT02265744|323622176|FG003|Overall Study|Lack of Efficacy|4|||
94499293|NCT02265744|323622177|FG004|Overall Study|Lack of Efficacy|5|||
94499294|NCT02265744|323622173|FG000|Overall Study|Reason not provided by Investigator|1|||
94499295|NCT02265744|323622174|FG001|Overall Study|Reason not provided by Investigator|0|||
94499296|NCT02265744|323622175|FG002|Overall Study|Reason not provided by Investigator|0|||
94499297|NCT02265744|323622176|FG003|Overall Study|Reason not provided by Investigator|2|||
94499298|NCT02265744|323622177|FG004|Overall Study|Reason not provided by Investigator|0|||
94499299|NCT02265744|323622173|FG000|Overall Study|Administrative reason by sponsor|3|||
94499300|NCT02265744|323622174|FG001|Overall Study|Administrative reason by sponsor|2|||
94499301|NCT02265744|323622175|FG002|Overall Study|Administrative reason by sponsor|2|||
94499302|NCT02265744|323622176|FG003|Overall Study|Administrative reason by sponsor|3|||
94499303|NCT02265744|323622177|FG004|Overall Study|Administrative reason by sponsor|3|||
94499304|NCT02265744|323622173|FG000|Overall Study|Subject no longer meets study criteria|0|||
94499305|NCT02265744|323622174|FG001|Overall Study|Subject no longer meets study criteria|0|||
94499306|NCT02265744|323622175|FG002|Overall Study|Subject no longer meets study criteria|0|||
94499307|NCT02265744|323622176|FG003|Overall Study|Subject no longer meets study criteria|0|||
94499308|NCT02265744|323622177|FG004|Overall Study|Subject no longer meets study criteria|1|||
94499309|NCT02265744|323622173|FG000|Overall Study|Pregnancy|1|||
94499310|NCT02265744|323622174|FG001|Overall Study|Pregnancy|2|||
94499311|NCT02265744|323622175|FG002|Overall Study|Pregnancy|1|||
94499312|NCT02265744|323622176|FG003|Overall Study|Pregnancy|1|||
94499313|NCT02265744|323622177|FG004|Overall Study|Pregnancy|0|||
94499314|NCT02573467|323622185|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
94499315|NCT02573467|323622186|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
94499316|NCT02573467|323622187|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
94499317|NCT02573467|323622188|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
94499318|NCT02573467|323622185|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
94499319|NCT02573467|323622186|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
94499320|NCT02573467|323622187|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
94499321|NCT02573467|323622188|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
94499322|NCT02573467|323622185|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
94499323|NCT02573467|323622186|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
94499324|NCT02573467|323622187|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
94499325|NCT02573467|323622188|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
94499326|NCT02573467|323622185|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
94499327|NCT02573467|323622186|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
94499328|NCT02573467|323622187|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
94499329|NCT02573467|323622188|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
94499330|NCT02573467|323622185|FG000|Post-treatment Follow up Epoch|Death|1|||
94499331|NCT02573467|323622186|FG001|Post-treatment Follow up Epoch|Death|1|||
94499332|NCT02573467|323622187|FG002|Post-treatment Follow up Epoch|Death|0|||
94499333|NCT02573467|323622188|FG003|Post-treatment Follow up Epoch|Death|1|||
94499334|NCT02573467|323622185|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
94499335|NCT02573467|323622186|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
94499336|NCT02573467|323622187|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
94499337|NCT02573467|323622188|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
94499338|NCT02573467|323622185|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
94499339|NCT02573467|323622186|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
94499340|NCT02573467|323622187|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
94499341|NCT02573467|323622188|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
94499342|NCT04339972|323622201|FG000|Overall Study|Scheduling Issues|3|||
94499343|NCT04339972|323622202|FG001|Overall Study|Scheduling Issues|3|||
94499344|NCT04339972|323622201|FG000|Overall Study|dropout|1|||
94499345|NCT04339972|323622202|FG001|Overall Study|dropout|1|||
94499346|NCT04339972|323622201|FG000|Overall Study|Technical issues|1|||
94499347|NCT04339972|323622202|FG001|Overall Study|Technical issues|0|||
94499348|NCT04339972|323622201|FG000|Overall Study|Claustraphobia|0|||
94499349|NCT04339972|323622202|FG001|Overall Study|Claustraphobia|1|||
94499350|NCT05064800|323622204|FG000|Period 3|Withdrawal by Subject|0|||
94499351|NCT05064800|323622205|FG001|Period 3|Withdrawal by Subject|0|||
94499352|NCT05064800|323622206|FG002|Period 3|Withdrawal by Subject|0|||
94499353|NCT05064800|323622207|FG003|Period 3|Withdrawal by Subject|0|||
94499354|NCT05064800|323622208|FG004|Period 3|Withdrawal by Subject|1|||
94499355|NCT05064800|323622209|FG005|Period 3|Withdrawal by Subject|0|||
94499356|NCT01851369|323622210|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
94499357|NCT01851369|323622211|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
94499358|NCT01851369|323622212|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
94499359|NCT01851369|323622213|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
94499360|NCT01851369|323622214|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
94499361|NCT01851369|323622215|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
94499362|NCT01851369|323622216|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
94499363|NCT01851369|323622217|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
94499364|NCT01851369|323622218|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
94499365|NCT01851369|323622219|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
94499366|NCT01851369|323622220|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
94499367|NCT01851369|323622221|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
94499368|NCT01851369|323622222|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
94499369|NCT04595370|323622228|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
94499370|NCT04595370|323622229|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
94499371|NCT04595370|323622230|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
94499372|NCT04595370|323622231|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
94499373|NCT04595370|323622232|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
94499374|NCT04595370|323622233|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
94499375|NCT04595370|323622228|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
94499376|NCT04595370|323622229|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
94499377|NCT04595370|323622230|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
94499378|NCT04595370|323622231|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
94499379|NCT04595370|323622232|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
94499380|NCT04595370|323622233|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
94499381|NCT04595370|323622228|FG000|Overall Study|Adverse Event|0|||
94499382|NCT04595370|323622229|FG001|Overall Study|Adverse Event|4|||
94499383|NCT04595370|323622230|FG002|Overall Study|Adverse Event|3|||
94499384|NCT04595370|323622231|FG003|Overall Study|Adverse Event|1|||
94499385|NCT04595370|323622232|FG004|Overall Study|Adverse Event|1|||
94499386|NCT04595370|323622233|FG005|Overall Study|Adverse Event|1|||
94499387|NCT04595370|323622228|FG000|Overall Study|Withdrawal of Consent|1|||
94499388|NCT04595370|323622229|FG001|Overall Study|Withdrawal of Consent|1|||
94499389|NCT04595370|323622230|FG002|Overall Study|Withdrawal of Consent|1|||
94499390|NCT04595370|323622231|FG003|Overall Study|Withdrawal of Consent|0|||
94499391|NCT04595370|323622232|FG004|Overall Study|Withdrawal of Consent|0|||
94499392|NCT04595370|323622233|FG005|Overall Study|Withdrawal of Consent|0|||
94499393|NCT04595370|323622228|FG000|Overall Study|Death|0|||
94499394|NCT04595370|323622229|FG001|Overall Study|Death|1|||
94499395|NCT04595370|323622230|FG002|Overall Study|Death|0|||
94499396|NCT04595370|323622231|FG003|Overall Study|Death|0|||
94499397|NCT04595370|323622232|FG004|Overall Study|Death|1|||
94499398|NCT04595370|323622233|FG005|Overall Study|Death|0|||
94499399|NCT04595370|323622228|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
94499400|NCT04595370|323622229|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
94499401|NCT04595370|323622230|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
94499402|NCT04595370|323622231|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
94499403|NCT04595370|323622232|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
94499404|NCT04595370|323622233|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
94499405|NCT04595370|323622228|FG000|Overall Study|Withdrawal by Subject|0|||
94499406|NCT04595370|323622229|FG001|Overall Study|Withdrawal by Subject|0|||
94499407|NCT04595370|323622230|FG002|Overall Study|Withdrawal by Subject|1|||
94499408|NCT04595370|323622231|FG003|Overall Study|Withdrawal by Subject|0|||
94499409|NCT04595370|323622232|FG004|Overall Study|Withdrawal by Subject|2|||
94499410|NCT04595370|323622233|FG005|Overall Study|Withdrawal by Subject|0|||
94499411|NCT04595370|323622228|FG000|Overall Study|Lost to Follow-up|0|||
94499412|NCT04595370|323622229|FG001|Overall Study|Lost to Follow-up|0|||
94499413|NCT04595370|323622230|FG002|Overall Study|Lost to Follow-up|0|||
94499414|NCT04595370|323622231|FG003|Overall Study|Lost to Follow-up|0|||
94499415|NCT04595370|323622232|FG004|Overall Study|Lost to Follow-up|1|||
94499416|NCT04595370|323622233|FG005|Overall Study|Lost to Follow-up|0|||
94499417|NCT04595370|323622228|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
94499418|NCT04595370|323622229|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
94499419|NCT04595370|323622230|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
94499420|NCT04595370|323622231|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
94499421|NCT04595370|323622232|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
94499422|NCT04595370|323622233|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
94499423|NCT02187055|323622234|FG000|Overall Study|Lack of Efficacy|10|||
94499424|NCT02187055|323622235|FG001|Overall Study|Lack of Efficacy|3|||
94499425|NCT02187055|323622236|FG002|Overall Study|Lack of Efficacy|7|||
94499426|NCT02187055|323622234|FG000|Overall Study|Lost to Follow-up|2|||
94499427|NCT02187055|323622235|FG001|Overall Study|Lost to Follow-up|7|||
94499428|NCT02187055|323622236|FG002|Overall Study|Lost to Follow-up|3|||
94499429|NCT02187055|323622234|FG000|Overall Study|No longer meets eligibility criteria|0|||
94499430|NCT02187055|323622235|FG001|Overall Study|No longer meets eligibility criteria|2|||
94499431|NCT02187055|323622236|FG002|Overall Study|No longer meets eligibility criteria|0|||
94499432|NCT02187055|323622234|FG000|Overall Study|No longer willing to participate|6|||
94499433|NCT02187055|323622235|FG001|Overall Study|No longer willing to participate|8|||
94499434|NCT02187055|323622236|FG002|Overall Study|No longer willing to participate|10|||
94499435|NCT02187055|323622234|FG000|Overall Study|Other|5|||
94499436|NCT02187055|323622235|FG001|Overall Study|Other|6|||
94499437|NCT02187055|323622236|FG002|Overall Study|Other|3|||
94499438|NCT02187055|323622234|FG000|Overall Study|Protocol Violation|9|||
94499439|NCT02187055|323622235|FG001|Overall Study|Protocol Violation|9|||
94499440|NCT02187055|323622236|FG002|Overall Study|Protocol Violation|4|||
94499441|NCT02187055|323622234|FG000|Overall Study|Pregnancy|3|||
94499442|NCT02187055|323622235|FG001|Overall Study|Pregnancy|1|||
94499443|NCT02187055|323622236|FG002|Overall Study|Pregnancy|0|||
94499444|NCT02187055|323622234|FG000|Overall Study|Withdrawal by Subject|11|||
94499445|NCT02187055|323622235|FG001|Overall Study|Withdrawal by Subject|11|||
94499446|NCT02187055|323622236|FG002|Overall Study|Withdrawal by Subject|11|||
94499447|NCT02187055|323622234|FG000|Overall Study|Adverse Event|21|||
94499448|NCT02187055|323622235|FG001|Overall Study|Adverse Event|26|||
94499449|NCT02187055|323622236|FG002|Overall Study|Adverse Event|36|||
94499450|NCT02187055|323622234|FG000|Overall Study|Death|2|||
94499451|NCT02187055|323622235|FG001|Overall Study|Death|0|||
94499452|NCT02187055|323622236|FG002|Overall Study|Death|0|||
94499453|NCT03520387|323622237|FG000|Pre-Randomization|Withdrawal by Subject|1|||
94499454|NCT03520387|323622238|FG001|Pre-Randomization|Withdrawal by Subject|0|||
94499455|NCT03520387|323622239|FG002|Pre-Randomization|Withdrawal by Subject|0|||
94499456|NCT03520387|323622240|FG003|Pre-Randomization|Withdrawal by Subject|0|||
94499457|NCT03520387|323622241|FG004|Pre-Randomization|Withdrawal by Subject|0|||
94499458|NCT03520387|323622237|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
94499459|NCT03520387|323622238|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
94499460|NCT03520387|323622239|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
94499461|NCT03520387|323622240|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
94499462|NCT03520387|323622241|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
94499463|NCT00250718|323622243|FG000|Overall Study|Death|1|||
94499464|NCT00250718|323622243|FG000|Overall Study|Adverse Event|1|||
94499465|NCT00250718|323622243|FG000|Overall Study|Withdrawal by Subject|1|||
94499466|NCT00541775|323622247|FG000|Overall Study|Adverse Event|3|||
94499467|NCT00541775|323622248|FG001|Overall Study|Adverse Event|2|||
94499468|NCT00541775|323622249|FG002|Overall Study|Adverse Event|1|||
94499469|NCT00541775|323622247|FG000|Overall Study|Lack of Efficacy|0|||
94499470|NCT00541775|323622248|FG001|Overall Study|Lack of Efficacy|0|||
94499471|NCT00541775|323622249|FG002|Overall Study|Lack of Efficacy|3|||
94499472|NCT00541775|323622247|FG000|Overall Study|Lost to Follow-up|0|||
94499473|NCT00541775|323622248|FG001|Overall Study|Lost to Follow-up|0|||
94499474|NCT00541775|323622249|FG002|Overall Study|Lost to Follow-up|2|||
94499475|NCT00541775|323622247|FG000|Overall Study|Protocol Violation|1|||
94499476|NCT00541775|323622248|FG001|Overall Study|Protocol Violation|0|||
94499477|NCT00541775|323622249|FG002|Overall Study|Protocol Violation|0|||
94499478|NCT00541775|323622247|FG000|Overall Study|Withdrawal by Subject and Other|5|||
94499479|NCT00541775|323622248|FG001|Overall Study|Withdrawal by Subject and Other|0|||
94499480|NCT00541775|323622249|FG002|Overall Study|Withdrawal by Subject and Other|2|||
94499481|NCT00032487|323622250|FG000|Overall Study|Withdrawal by Subject|67|||
94499482|NCT00032487|323622251|FG001|Overall Study|Withdrawal by Subject|43|||
94499483|NCT00032487|323622250|FG000|Overall Study|Adverse Event|3|||
94499484|NCT00032487|323622251|FG001|Overall Study|Adverse Event|7|||
94499485|NCT00032487|323622250|FG000|Overall Study|Lost to Follow-up|57|||
94499486|NCT00032487|323622251|FG001|Overall Study|Lost to Follow-up|58|||
94499487|NCT00032487|323622250|FG000|Overall Study|Had other reason|12|||
94499488|NCT00032487|323622251|FG001|Overall Study|Had other reason|12|||
94499489|NCT04518410|323622253|FG000|Overall Study|Lost to Follow-up|1|||
94499490|NCT04518410|323622254|FG001|Overall Study|Lost to Follow-up|1|||
94499491|NCT04518410|323622255|FG002|Overall Study|Lost to Follow-up|8|||
94499492|NCT04518410|323622256|FG003|Overall Study|Lost to Follow-up|5|||
94499493|NCT04518410|323622257|FG004|Overall Study|Lost to Follow-up|92|||
94499494|NCT04518410|323622258|FG005|Overall Study|Lost to Follow-up|25|||
94499495|NCT04518410|323622259|FG006|Overall Study|Lost to Follow-up|25|||
94499496|NCT04518410|323622260|FG007|Overall Study|Lost to Follow-up|3|||
94499497|NCT04518410|323622261|FG008|Overall Study|Lost to Follow-up|2|||
94499498|NCT04518410|323622262|FG009|Overall Study|Lost to Follow-up|13|||
94499499|NCT04518410|323622263|FG010|Overall Study|Lost to Follow-up|9|||
94499500|NCT04518410|323622264|FG011|Overall Study|Lost to Follow-up|13|||
94499501|NCT04518410|323622265|FG012|Overall Study|Lost to Follow-up|9|||
94499502|NCT04518410|323622266|FG013|Overall Study|Lost to Follow-up|13|||
94499503|NCT04518410|323622267|FG014|Overall Study|Lost to Follow-up|8|||
94499504|NCT04518410|323622268|FG015|Overall Study|Lost to Follow-up|10|||
94499505|NCT04518410|323622269|FG016|Overall Study|Lost to Follow-up|6|||
94499506|NCT04518410|323622270|FG017|Overall Study|Lost to Follow-up|13|||
94499507|NCT04518410|323622271|FG018|Overall Study|Lost to Follow-up|21|||
94499508|NCT04518410|323622272|FG019|Overall Study|Lost to Follow-up|6|||
94499509|NCT04518410|323622273|FG020|Overall Study|Lost to Follow-up|7|||
94499510|NCT04518410|323622274|FG021|Overall Study|Lost to Follow-up|21|||
94499511|NCT04518410|323622275|FG022|Overall Study|Lost to Follow-up|1|||
94499512|NCT04518410|323622276|FG023|Overall Study|Lost to Follow-up|7|||
94499513|NCT04518410|323622277|FG024|Overall Study|Lost to Follow-up|6|||
94499514|NCT04518410|323622253|FG000|Overall Study|Withdrawal by Subject|1|||
94499515|NCT04518410|323622254|FG001|Overall Study|Withdrawal by Subject|2|||
94499516|NCT04518410|323622255|FG002|Overall Study|Withdrawal by Subject|2|||
94499517|NCT04518410|323622256|FG003|Overall Study|Withdrawal by Subject|3|||
94499518|NCT04518410|323622257|FG004|Overall Study|Withdrawal by Subject|20|||
94499519|NCT04518410|323622258|FG005|Overall Study|Withdrawal by Subject|20|||
94499520|NCT04518410|323622259|FG006|Overall Study|Withdrawal by Subject|25|||
94499521|NCT04518410|323622260|FG007|Overall Study|Withdrawal by Subject|6|||
94499522|NCT04518410|323622261|FG008|Overall Study|Withdrawal by Subject|1|||
94499523|NCT04518410|323622262|FG009|Overall Study|Withdrawal by Subject|12|||
94499524|NCT04518410|323622263|FG010|Overall Study|Withdrawal by Subject|5|||
94499525|NCT04518410|323622264|FG011|Overall Study|Withdrawal by Subject|7|||
94499526|NCT04518410|323622265|FG012|Overall Study|Withdrawal by Subject|2|||
94499527|NCT04518410|323622266|FG013|Overall Study|Withdrawal by Subject|13|||
94499528|NCT04518410|323622267|FG014|Overall Study|Withdrawal by Subject|4|||
94499529|NCT04518410|323622268|FG015|Overall Study|Withdrawal by Subject|9|||
94499530|NCT04518410|323622269|FG016|Overall Study|Withdrawal by Subject|0|||
94499531|NCT04518410|323622270|FG017|Overall Study|Withdrawal by Subject|15|||
94499532|NCT04518410|323622271|FG018|Overall Study|Withdrawal by Subject|12|||
94499533|NCT04518410|323622272|FG019|Overall Study|Withdrawal by Subject|9|||
94499534|NCT04518410|323622273|FG020|Overall Study|Withdrawal by Subject|14|||
94499535|NCT04518410|323622274|FG021|Overall Study|Withdrawal by Subject|3|||
94499536|NCT04518410|323622275|FG022|Overall Study|Withdrawal by Subject|2|||
94499537|NCT04518410|323622276|FG023|Overall Study|Withdrawal by Subject|9|||
94499538|NCT04518410|323622277|FG024|Overall Study|Withdrawal by Subject|8|||
94499539|NCT04518410|323622253|FG000|Overall Study|Other|1|||
94499540|NCT04518410|323622254|FG001|Overall Study|Other|0|||
94499541|NCT04518410|323622255|FG002|Overall Study|Other|0|||
94499542|NCT04518410|323622256|FG003|Overall Study|Other|1|||
94499543|NCT04518410|323622257|FG004|Overall Study|Other|6|||
94499544|NCT04518410|323622258|FG005|Overall Study|Other|6|||
94499545|NCT04518410|323622259|FG006|Overall Study|Other|5|||
94499546|NCT04518410|323622260|FG007|Overall Study|Other|2|||
94499547|NCT04518410|323622261|FG008|Overall Study|Other|0|||
94499548|NCT04518410|323622262|FG009|Overall Study|Other|1|||
94499549|NCT04518410|323622263|FG010|Overall Study|Other|0|||
94499550|NCT04518410|323622264|FG011|Overall Study|Other|2|||
94499551|NCT04518410|323622265|FG012|Overall Study|Other|0|||
94499552|NCT04518410|323622266|FG013|Overall Study|Other|0|||
94499553|NCT04518410|323622267|FG014|Overall Study|Other|0|||
94499554|NCT04518410|323622268|FG015|Overall Study|Other|3|||
94499555|NCT04518410|323622269|FG016|Overall Study|Other|1|||
94499556|NCT04518410|323622270|FG017|Overall Study|Other|1|||
94499557|NCT04518410|323622271|FG018|Overall Study|Other|1|||
94499558|NCT04518410|323622272|FG019|Overall Study|Other|0|||
94499559|NCT04518410|323622273|FG020|Overall Study|Other|1|||
94499560|NCT04518410|323622274|FG021|Overall Study|Other|0|||
94499561|NCT04518410|323622275|FG022|Overall Study|Other|1|||
94499562|NCT04518410|323622276|FG023|Overall Study|Other|2|||
94499563|NCT04518410|323622277|FG024|Overall Study|Other|2|||
94499564|NCT04518410|323622253|FG000|Overall Study|Protocol Violation|0|||
94499565|NCT04518410|323622254|FG001|Overall Study|Protocol Violation|0|||
94499566|NCT04518410|323622255|FG002|Overall Study|Protocol Violation|0|||
94499567|NCT04518410|323622256|FG003|Overall Study|Protocol Violation|2|||
94499568|NCT04518410|323622257|FG004|Overall Study|Protocol Violation|17|||
94499569|NCT04518410|323622258|FG005|Overall Study|Protocol Violation|1|||
94499570|NCT04518410|323622259|FG006|Overall Study|Protocol Violation|2|||
94499571|NCT04518410|323622260|FG007|Overall Study|Protocol Violation|1|||
94499572|NCT04518410|323622261|FG008|Overall Study|Protocol Violation|0|||
94499573|NCT04518410|323622262|FG009|Overall Study|Protocol Violation|0|||
94499574|NCT04518410|323622263|FG010|Overall Study|Protocol Violation|0|||
94499575|NCT04518410|323622264|FG011|Overall Study|Protocol Violation|0|||
94499576|NCT04518410|323622265|FG012|Overall Study|Protocol Violation|0|||
94499577|NCT04518410|323622266|FG013|Overall Study|Protocol Violation|0|||
94499578|NCT04518410|323622267|FG014|Overall Study|Protocol Violation|0|||
94499579|NCT04518410|323622268|FG015|Overall Study|Protocol Violation|0|||
94499580|NCT04518410|323622269|FG016|Overall Study|Protocol Violation|1|||
94499581|NCT04518410|323622270|FG017|Overall Study|Protocol Violation|1|||
94499582|NCT04518410|323622271|FG018|Overall Study|Protocol Violation|0|||
94499583|NCT04518410|323622272|FG019|Overall Study|Protocol Violation|0|||
94499584|NCT04518410|323622273|FG020|Overall Study|Protocol Violation|1|||
94499585|NCT04518410|323622274|FG021|Overall Study|Protocol Violation|2|||
94499586|NCT04518410|323622275|FG022|Overall Study|Protocol Violation|0|||
94499587|NCT04518410|323622276|FG023|Overall Study|Protocol Violation|3|||
94499588|NCT04518410|323622277|FG024|Overall Study|Protocol Violation|0|||
94499589|NCT04518410|323622253|FG000|Overall Study|Death|0|||
94499590|NCT04518410|323622254|FG001|Overall Study|Death|0|||
94499591|NCT04518410|323622255|FG002|Overall Study|Death|0|||
94499592|NCT04518410|323622256|FG003|Overall Study|Death|0|||
94499593|NCT04518410|323622257|FG004|Overall Study|Death|12|||
94499594|NCT04518410|323622258|FG005|Overall Study|Death|2|||
94499595|NCT04518410|323622259|FG006|Overall Study|Death|11|||
94499596|NCT04518410|323622260|FG007|Overall Study|Death|0|||
94499597|NCT04518410|323622261|FG008|Overall Study|Death|1|||
94499598|NCT04518410|323622262|FG009|Overall Study|Death|0|||
94499599|NCT04518410|323622263|FG010|Overall Study|Death|0|||
94499600|NCT04518410|323622264|FG011|Overall Study|Death|0|||
94499601|NCT04518410|323622265|FG012|Overall Study|Death|0|||
94499602|NCT04518410|323622266|FG013|Overall Study|Death|1|||
94499603|NCT04518410|323622267|FG014|Overall Study|Death|1|||
94499604|NCT04518410|323622268|FG015|Overall Study|Death|0|||
94499605|NCT04518410|323622269|FG016|Overall Study|Death|0|||
94499606|NCT04518410|323622270|FG017|Overall Study|Death|1|||
94499607|NCT04518410|323622271|FG018|Overall Study|Death|4|||
94499608|NCT04518410|323622272|FG019|Overall Study|Death|4|||
94499609|NCT04518410|323622273|FG020|Overall Study|Death|1|||
94499610|NCT04518410|323622274|FG021|Overall Study|Death|0|||
94499611|NCT04518410|323622275|FG022|Overall Study|Death|0|||
94499612|NCT04518410|323622276|FG023|Overall Study|Death|0|||
94499613|NCT04518410|323622277|FG024|Overall Study|Death|0|||
94499614|NCT04518410|323622253|FG000|Overall Study|Requirement to start alternative therapy|0|||
94499615|NCT04518410|323622254|FG001|Overall Study|Requirement to start alternative therapy|0|||
94499616|NCT04518410|323622255|FG002|Overall Study|Requirement to start alternative therapy|1|||
94499617|NCT04518410|323622256|FG003|Overall Study|Requirement to start alternative therapy|0|||
94499618|NCT04518410|323622257|FG004|Overall Study|Requirement to start alternative therapy|0|||
94499619|NCT04518410|323622258|FG005|Overall Study|Requirement to start alternative therapy|0|||
94499620|NCT04518410|323622259|FG006|Overall Study|Requirement to start alternative therapy|0|||
94499621|NCT04518410|323622260|FG007|Overall Study|Requirement to start alternative therapy|0|||
94499622|NCT04518410|323622261|FG008|Overall Study|Requirement to start alternative therapy|0|||
94499623|NCT04518410|323622262|FG009|Overall Study|Requirement to start alternative therapy|0|||
94499624|NCT04518410|323622263|FG010|Overall Study|Requirement to start alternative therapy|0|||
94499625|NCT04518410|323622264|FG011|Overall Study|Requirement to start alternative therapy|0|||
94499626|NCT04518410|323622265|FG012|Overall Study|Requirement to start alternative therapy|0|||
94499627|NCT04518410|323622266|FG013|Overall Study|Requirement to start alternative therapy|0|||
94499628|NCT04518410|323622267|FG014|Overall Study|Requirement to start alternative therapy|0|||
94499629|NCT04518410|323622268|FG015|Overall Study|Requirement to start alternative therapy|0|||
94499630|NCT04518410|323622269|FG016|Overall Study|Requirement to start alternative therapy|0|||
94499631|NCT04518410|323622270|FG017|Overall Study|Requirement to start alternative therapy|0|||
94499632|NCT04518410|323622271|FG018|Overall Study|Requirement to start alternative therapy|0|||
94499633|NCT04518410|323622272|FG019|Overall Study|Requirement to start alternative therapy|0|||
94499634|NCT04518410|323622273|FG020|Overall Study|Requirement to start alternative therapy|0|||
94499635|NCT04518410|323622274|FG021|Overall Study|Requirement to start alternative therapy|0|||
94499636|NCT04518410|323622275|FG022|Overall Study|Requirement to start alternative therapy|0|||
94499637|NCT04518410|323622276|FG023|Overall Study|Requirement to start alternative therapy|0|||
94499638|NCT04518410|323622277|FG024|Overall Study|Requirement to start alternative therapy|0|||
94499639|NCT04518410|323622253|FG000|Overall Study|Randomized but not treated|0|||
94499640|NCT04518410|323622254|FG001|Overall Study|Randomized but not treated|0|||
94499641|NCT04518410|323622255|FG002|Overall Study|Randomized but not treated|0|||
94499642|NCT04518410|323622256|FG003|Overall Study|Randomized but not treated|2|||
94499643|NCT04518410|323622257|FG004|Overall Study|Randomized but not treated|6|||
94499644|NCT04518410|323622258|FG005|Overall Study|Randomized but not treated|4|||
94499645|NCT04518410|323622259|FG006|Overall Study|Randomized but not treated|3|||
94499646|NCT04518410|323622260|FG007|Overall Study|Randomized but not treated|3|||
94499647|NCT04518410|323622261|FG008|Overall Study|Randomized but not treated|0|||
94499648|NCT04518410|323622262|FG009|Overall Study|Randomized but not treated|4|||
94499649|NCT04518410|323622263|FG010|Overall Study|Randomized but not treated|0|||
94499650|NCT04518410|323622264|FG011|Overall Study|Randomized but not treated|0|||
94499651|NCT04518410|323622265|FG012|Overall Study|Randomized but not treated|1|||
94499652|NCT04518410|323622266|FG013|Overall Study|Randomized but not treated|3|||
94499653|NCT04518410|323622267|FG014|Overall Study|Randomized but not treated|3|||
94499654|NCT04518410|323622268|FG015|Overall Study|Randomized but not treated|3|||
94499655|NCT04518410|323622269|FG016|Overall Study|Randomized but not treated|4|||
94499656|NCT04518410|323622270|FG017|Overall Study|Randomized but not treated|5|||
94499657|NCT04518410|323622271|FG018|Overall Study|Randomized but not treated|4|||
94499658|NCT04518410|323622272|FG019|Overall Study|Randomized but not treated|0|||
94499659|NCT04518410|323622273|FG020|Overall Study|Randomized but not treated|0|||
94499660|NCT04518410|323622274|FG021|Overall Study|Randomized but not treated|5|||
94499661|NCT04518410|323622275|FG022|Overall Study|Randomized but not treated|0|||
94499662|NCT04518410|323622276|FG023|Overall Study|Randomized but not treated|3|||
94499663|NCT04518410|323622277|FG024|Overall Study|Randomized but not treated|1|||
94499664|NCT04518410|323622253|FG000|Overall Study|Screen Fail but Randomized|0|||
94499665|NCT04518410|323622254|FG001|Overall Study|Screen Fail but Randomized|0|||
94499666|NCT04518410|323622255|FG002|Overall Study|Screen Fail but Randomized|0|||
94499667|NCT04518410|323622256|FG003|Overall Study|Screen Fail but Randomized|0|||
94499668|NCT04518410|323622257|FG004|Overall Study|Screen Fail but Randomized|2|||
94499669|NCT04518410|323622258|FG005|Overall Study|Screen Fail but Randomized|0|||
94499670|NCT04518410|323622259|FG006|Overall Study|Screen Fail but Randomized|0|||
94499671|NCT04518410|323622260|FG007|Overall Study|Screen Fail but Randomized|0|||
94655623|NCT04369469|324196101|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
94499672|NCT04518410|323622261|FG008|Overall Study|Screen Fail but Randomized|0|||
94499673|NCT04518410|323622262|FG009|Overall Study|Screen Fail but Randomized|0|||
94499674|NCT04518410|323622263|FG010|Overall Study|Screen Fail but Randomized|0|||
94499675|NCT04518410|323622264|FG011|Overall Study|Screen Fail but Randomized|0|||
94499676|NCT04518410|323622265|FG012|Overall Study|Screen Fail but Randomized|0|||
94499677|NCT04518410|323622266|FG013|Overall Study|Screen Fail but Randomized|0|||
94499678|NCT04518410|323622267|FG014|Overall Study|Screen Fail but Randomized|0|||
94499679|NCT04518410|323622268|FG015|Overall Study|Screen Fail but Randomized|0|||
94499680|NCT04518410|323622269|FG016|Overall Study|Screen Fail but Randomized|0|||
94499681|NCT04518410|323622270|FG017|Overall Study|Screen Fail but Randomized|0|||
94499682|NCT04518410|323622271|FG018|Overall Study|Screen Fail but Randomized|0|||
94499683|NCT04518410|323622272|FG019|Overall Study|Screen Fail but Randomized|0|||
94499684|NCT04518410|323622273|FG020|Overall Study|Screen Fail but Randomized|0|||
94499685|NCT04518410|323622274|FG021|Overall Study|Screen Fail but Randomized|0|||
94499686|NCT04518410|323622275|FG022|Overall Study|Screen Fail but Randomized|0|||
94499687|NCT04518410|323622276|FG023|Overall Study|Screen Fail but Randomized|0|||
94499688|NCT04518410|323622277|FG024|Overall Study|Screen Fail but Randomized|0|||
94499689|NCT04518410|323622253|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
94499690|NCT04518410|323622254|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
94499691|NCT04518410|323622255|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
94499692|NCT04518410|323622256|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
94499693|NCT04518410|323622257|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
94499694|NCT04518410|323622258|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
94499695|NCT04518410|323622259|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
94499696|NCT04518410|323622260|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
94499697|NCT04518410|323622261|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
94499698|NCT04518410|323622262|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
94499699|NCT04518410|323622263|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
94499700|NCT04518410|323622264|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
94499701|NCT04518410|323622265|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
94499702|NCT04518410|323622266|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
94499703|NCT04518410|323622267|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
94499704|NCT04518410|323622268|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
94499705|NCT04518410|323622269|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
94499706|NCT04518410|323622270|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
94499707|NCT04518410|323622271|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
94499708|NCT04518410|323622272|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
94499709|NCT04518410|323622273|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
94499710|NCT04518410|323622274|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
94499711|NCT04518410|323622275|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
94499712|NCT04518410|323622276|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
94499713|NCT04518410|323622277|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
94499714|NCT04518410|323622253|FG000|Overall Study|Dual Enrolled Subject|0|||
94499715|NCT04518410|323622254|FG001|Overall Study|Dual Enrolled Subject|0|||
94499716|NCT04518410|323622255|FG002|Overall Study|Dual Enrolled Subject|0|||
94499717|NCT04518410|323622256|FG003|Overall Study|Dual Enrolled Subject|0|||
94499718|NCT04518410|323622257|FG004|Overall Study|Dual Enrolled Subject|0|||
94499719|NCT04518410|323622258|FG005|Overall Study|Dual Enrolled Subject|0|||
94499720|NCT04518410|323622259|FG006|Overall Study|Dual Enrolled Subject|0|||
94499721|NCT04518410|323622260|FG007|Overall Study|Dual Enrolled Subject|0|||
94499722|NCT04518410|323622261|FG008|Overall Study|Dual Enrolled Subject|0|||
94499723|NCT04518410|323622262|FG009|Overall Study|Dual Enrolled Subject|0|||
94499724|NCT04518410|323622263|FG010|Overall Study|Dual Enrolled Subject|0|||
94499725|NCT04518410|323622264|FG011|Overall Study|Dual Enrolled Subject|0|||
94499726|NCT04518410|323622265|FG012|Overall Study|Dual Enrolled Subject|0|||
94499727|NCT04518410|323622266|FG013|Overall Study|Dual Enrolled Subject|0|||
94499728|NCT04518410|323622267|FG014|Overall Study|Dual Enrolled Subject|0|||
94499729|NCT04518410|323622268|FG015|Overall Study|Dual Enrolled Subject|0|||
94499730|NCT04518410|323622269|FG016|Overall Study|Dual Enrolled Subject|0|||
94499731|NCT04518410|323622270|FG017|Overall Study|Dual Enrolled Subject|1|||
94499732|NCT04518410|323622271|FG018|Overall Study|Dual Enrolled Subject|0|||
94499733|NCT04518410|323622272|FG019|Overall Study|Dual Enrolled Subject|0|||
94499734|NCT04518410|323622273|FG020|Overall Study|Dual Enrolled Subject|0|||
94499735|NCT04518410|323622274|FG021|Overall Study|Dual Enrolled Subject|0|||
94499736|NCT04518410|323622275|FG022|Overall Study|Dual Enrolled Subject|0|||
94499737|NCT04518410|323622276|FG023|Overall Study|Dual Enrolled Subject|0|||
94499738|NCT04518410|323622277|FG024|Overall Study|Dual Enrolled Subject|0|||
94499739|NCT01125748|323622278|FG000|Overall Study|Adverse Event|0|||
94499740|NCT01125748|323622279|FG001|Overall Study|Adverse Event|2|||
94499741|NCT01125748|323622278|FG000|Overall Study|Lost to Follow-up|0|||
94499742|NCT01125748|323622279|FG001|Overall Study|Lost to Follow-up|1|||
94499743|NCT01125748|323622278|FG000|Overall Study|Physician Decision|8|||
94499744|NCT01125748|323622279|FG001|Overall Study|Physician Decision|7|||
94499745|NCT01125748|323622278|FG000|Overall Study|Patient Decision to Withdraw|2|||
94499746|NCT01125748|323622279|FG001|Overall Study|Patient Decision to Withdraw|4|||
94499747|NCT01049828|323622288|FG000|Overall Study|Claustrophibia and Frustration|2|||
94499748|NCT01800058|323622289|FG000|Overall Study|Lost to Follow-up|1|||
94499749|NCT01245062|323622290|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
94499750|NCT01245062|323622291|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
94499751|NCT01245062|323622292|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
94499752|NCT01245062|323622290|FG000|Randomization and Crossover Phase|Physician Decision|2|||
94499753|NCT01245062|323622291|FG001|Randomization and Crossover Phase|Physician Decision|4|||
94499754|NCT01245062|323622292|FG002|Randomization and Crossover Phase|Physician Decision|0|||
94499755|NCT01245062|323622290|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
94499756|NCT01245062|323622291|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
94499757|NCT01245062|323622292|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
94499758|NCT01245062|323622290|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
94499759|NCT01245062|323622291|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
94499760|NCT01245062|323622292|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
94499761|NCT01245062|323622290|FG000|Cross-over Phase|Lost to Follow-up|0|||
94499762|NCT01245062|323622291|FG001|Cross-over Phase|Lost to Follow-up|0|||
94499763|NCT01245062|323622292|FG002|Cross-over Phase|Lost to Follow-up|1|||
94499764|NCT01245062|323622290|FG000|Cross-over Phase|Physician Decision|0|||
94499765|NCT01245062|323622291|FG001|Cross-over Phase|Physician Decision|0|||
94499766|NCT01245062|323622292|FG002|Cross-over Phase|Physician Decision|1|||
94499767|NCT01245062|323622290|FG000|Cross-over Phase|Withdrew Consent|0|||
94499768|NCT01245062|323622291|FG001|Cross-over Phase|Withdrew Consent|0|||
94499769|NCT01245062|323622292|FG002|Cross-over Phase|Withdrew Consent|4|||
94499770|NCT01245062|323622290|FG000|Cross-over Phase|Study closed/ terminated|0|||
94499771|NCT01245062|323622291|FG001|Cross-over Phase|Study closed/ terminated|0|||
94499772|NCT01245062|323622292|FG002|Cross-over Phase|Study closed/ terminated|11|||
94499773|NCT06025695|323622294|FG000|Overall Study|Adverse Event|5|||
94499774|NCT06025695|323622295|FG001|Overall Study|Adverse Event|6|||
94499775|NCT06025695|323622294|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
94499776|NCT06025695|323622295|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
94499777|NCT06025695|323622294|FG000|Overall Study|Other|23|||
94499778|NCT06025695|323622295|FG001|Overall Study|Other|19|||
94499779|NCT06025695|323622294|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
94499780|NCT06025695|323622295|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
94499781|NCT06868667|323622296|FG000|Overall Study|Death|0|||
94499782|NCT06868667|323622297|FG001|Overall Study|Death|4|||
94499783|NCT06868667|323622296|FG000|Overall Study|Lost to Follow-up|0|||
94499784|NCT06868667|323622297|FG001|Overall Study|Lost to Follow-up|1|||
94499785|NCT06868667|323622296|FG000|Overall Study|Withdrawal by Subject|1|||
94499786|NCT06868667|323622297|FG001|Overall Study|Withdrawal by Subject|0|||
94499787|NCT06868667|323622296|FG000|Overall Study|Ongoing|9|||
94499788|NCT06868667|323622297|FG001|Overall Study|Ongoing|9|||
94499789|NCT03572218|323622299|FG000|Overall Study|Lost to Follow-up|3|||
94499790|NCT03572218|323622300|FG001|Overall Study|Lost to Follow-up|2|||
94499791|NCT03572218|323622299|FG000|Overall Study|No longer available for study visits|2|||
94499792|NCT03572218|323622300|FG001|Overall Study|No longer available for study visits|1|||
94499793|NCT03572218|323622299|FG000|Overall Study|No longer interested|1|||
94499794|NCT03572218|323622300|FG001|Overall Study|No longer interested|2|||
94499795|NCT00286455|323622301|FG000|Overall Study|Hyperglycemia rescue|19|||
94499796|NCT00286455|323622302|FG001|Overall Study|Hyperglycemia rescue|13|||
94499797|NCT00286455|323622303|FG002|Overall Study|Hyperglycemia rescue|10|||
94499798|NCT00286455|323622301|FG000|Overall Study|Adverse Event|1|||
94499799|NCT00286455|323622302|FG001|Overall Study|Adverse Event|3|||
94499800|NCT00286455|323622303|FG002|Overall Study|Adverse Event|2|||
94499801|NCT00286455|323622301|FG000|Overall Study|Lost to Follow-up|0|||
94499802|NCT00286455|323622302|FG001|Overall Study|Lost to Follow-up|3|||
94499803|NCT00286455|323622303|FG002|Overall Study|Lost to Follow-up|3|||
94499804|NCT00286455|323622301|FG000|Overall Study|Physician Decision|3|||
94499805|NCT00286455|323622302|FG001|Overall Study|Physician Decision|0|||
94499806|NCT00286455|323622303|FG002|Overall Study|Physician Decision|2|||
94499807|NCT00286455|323622301|FG000|Overall Study|Protocol Violation|1|||
94499808|NCT00286455|323622302|FG001|Overall Study|Protocol Violation|1|||
94499809|NCT00286455|323622303|FG002|Overall Study|Protocol Violation|0|||
94499810|NCT00286455|323622301|FG000|Overall Study|Participant Non-compliance|1|||
94499811|NCT00286455|323622302|FG001|Overall Study|Participant Non-compliance|0|||
94499812|NCT00286455|323622303|FG002|Overall Study|Participant Non-compliance|0|||
94499813|NCT00286455|323622301|FG000|Overall Study|Withdrawal by Subject|0|||
94499814|NCT00286455|323622302|FG001|Overall Study|Withdrawal by Subject|8|||
94499815|NCT00286455|323622303|FG002|Overall Study|Withdrawal by Subject|7|||
94499816|NCT03738215|323622304|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
94499817|NCT03738215|323622305|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
94499818|NCT03738215|323622306|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
94499819|NCT03738215|323622304|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
94499820|NCT03738215|323622305|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
94499821|NCT03738215|323622306|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
94499822|NCT03738215|323622304|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
94499823|NCT03738215|323622305|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
94499824|NCT03738215|323622306|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
94499825|NCT03738215|323622304|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
94499826|NCT03738215|323622305|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
94499827|NCT03738215|323622306|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
94499828|NCT03738215|323622304|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
94499829|NCT03738215|323622305|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
94499830|NCT03738215|323622306|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
94499831|NCT03738215|323622304|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
94499832|NCT03738215|323622305|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
94499833|NCT03738215|323622306|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
94499834|NCT03738215|323622304|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
94499835|NCT03738215|323622305|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
94499836|NCT03738215|323622306|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
94499837|NCT03738215|323622304|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
94499838|NCT03738215|323622305|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
94499839|NCT03738215|323622306|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
94499840|NCT03738215|323622304|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
94499841|NCT03738215|323622305|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
94499842|NCT03738215|323622306|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
94499843|NCT03738215|323622304|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
94499844|NCT03738215|323622305|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
94499845|NCT03738215|323622306|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
94499846|NCT00853047|323622307|FG000|Core Phase|Participant Request|0|||
94499847|NCT00853047|323622308|FG001|Core Phase|Participant Request|0|||
94499848|NCT00853047|323622309|FG002|Core Phase|Participant Request|0|||
94499849|NCT00853047|323622310|FG003|Core Phase|Participant Request|1|||
94499850|NCT00853047|323622311|FG004|Core Phase|Participant Request|0|||
94499851|NCT00853047|323622312|FG005|Core Phase|Participant Request|0|||
94499852|NCT00853047|323622307|FG000|Open-Label Extension Phase|Participant Request|0|||
94499853|NCT00853047|323622308|FG001|Open-Label Extension Phase|Participant Request|0|||
94499854|NCT00853047|323622309|FG002|Open-Label Extension Phase|Participant Request|0|||
94499855|NCT00853047|323622310|FG003|Open-Label Extension Phase|Participant Request|0|||
94499856|NCT00853047|323622311|FG004|Open-Label Extension Phase|Participant Request|0|||
94499857|NCT00853047|323622312|FG005|Open-Label Extension Phase|Participant Request|7|||
94499858|NCT00853047|323622307|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
94499859|NCT00853047|323622308|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
94499860|NCT00853047|323622309|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
94499861|NCT00853047|323622310|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
94499862|NCT00853047|323622311|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
94499863|NCT00853047|323622312|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
94499864|NCT00853047|323622307|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
94499865|NCT00853047|323622308|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
94499866|NCT00853047|323622309|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
94499867|NCT00853047|323622310|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
94499868|NCT00853047|323622311|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
94499869|NCT00853047|323622312|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
94499870|NCT00853047|323622307|FG000|Open-Label Extension Phase|Investigator Decision|0|||
94499871|NCT00853047|323622308|FG001|Open-Label Extension Phase|Investigator Decision|0|||
94499872|NCT00853047|323622309|FG002|Open-Label Extension Phase|Investigator Decision|0|||
94499873|NCT00853047|323622310|FG003|Open-Label Extension Phase|Investigator Decision|0|||
94499874|NCT00853047|323622311|FG004|Open-Label Extension Phase|Investigator Decision|0|||
94499875|NCT00853047|323622312|FG005|Open-Label Extension Phase|Investigator Decision|1|||
94499876|NCT00853047|323622307|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
94499877|NCT00853047|323622308|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
94499878|NCT00853047|323622309|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
94499879|NCT00853047|323622310|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
94499880|NCT00853047|323622311|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
94499881|NCT00853047|323622312|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
94499882|NCT00182637|323624526|FG000|Overall Study|Adverse Event|2|||
94499883|NCT00182637|323624526|FG000|Overall Study|Disease Progression|1|||
94499884|NCT02927145|323624527|FG000|Initial Recruitment|Withdrawal by Subject|0|||
94499885|NCT02927145|323624528|FG001|Initial Recruitment|Withdrawal by Subject|1|||
94499886|NCT02927145|323624529|FG002|Initial Recruitment|Withdrawal by Subject|1|||
94499887|NCT02927145|323624530|FG003|Initial Recruitment|Withdrawal by Subject|4|||
94499888|NCT02927145|323624531|FG004|Initial Recruitment|Withdrawal by Subject|1|||
94499889|NCT02927145|323624532|FG005|Initial Recruitment|Withdrawal by Subject|1|||
94499890|NCT02927145|323624533|FG006|Initial Recruitment|Withdrawal by Subject|0|||
94499891|NCT02927145|323624534|FG007|Initial Recruitment|Withdrawal by Subject|0|||
94499892|NCT02927145|323624535|FG008|Initial Recruitment|Withdrawal by Subject|2|||
94499893|NCT02927145|323624527|FG000|Initial Recruitment|Adverse Event|0|||
94499894|NCT02927145|323624528|FG001|Initial Recruitment|Adverse Event|0|||
94499895|NCT02927145|323624529|FG002|Initial Recruitment|Adverse Event|0|||
94499896|NCT02927145|323624530|FG003|Initial Recruitment|Adverse Event|0|||
94499897|NCT02927145|323624531|FG004|Initial Recruitment|Adverse Event|2|||
94499898|NCT02927145|323624532|FG005|Initial Recruitment|Adverse Event|0|||
94499899|NCT02927145|323624533|FG006|Initial Recruitment|Adverse Event|0|||
94499900|NCT02927145|323624534|FG007|Initial Recruitment|Adverse Event|0|||
94499901|NCT02927145|323624535|FG008|Initial Recruitment|Adverse Event|0|||
94499902|NCT02927145|323624527|FG000|Invitation for Additional Challenge|Pregnancy|0|||
94499903|NCT02927145|323624528|FG001|Invitation for Additional Challenge|Pregnancy|0|||
94499904|NCT02927145|323624529|FG002|Invitation for Additional Challenge|Pregnancy|0|||
94499905|NCT02927145|323624530|FG003|Invitation for Additional Challenge|Pregnancy|0|||
94499906|NCT02927145|323624531|FG004|Invitation for Additional Challenge|Pregnancy|0|||
94499907|NCT02927145|323624532|FG005|Invitation for Additional Challenge|Pregnancy|0|||
94499908|NCT02927145|323624533|FG006|Invitation for Additional Challenge|Pregnancy|1|||
94499909|NCT02927145|323624534|FG007|Invitation for Additional Challenge|Pregnancy|0|||
94499910|NCT02927145|323624535|FG008|Invitation for Additional Challenge|Pregnancy|0|||
94499911|NCT00530075|323624536|FG000|Overall Study|Adverse Event|1|||
94499912|NCT00530075|323624536|FG000|Overall Study|Death|1|||
94499913|NCT00530075|323624536|FG000|Overall Study|Lack of Efficacy|3|||
94499914|NCT00530075|323624536|FG000|Overall Study|Protocol Violation|1|||
94499915|NCT00530075|323624536|FG000|Overall Study|Withdrawal by Subject|1|||
94499916|NCT00552058|323624537|FG000|Overall Study|Adverse Event|8|||
94499917|NCT00552058|323624538|FG001|Overall Study|Adverse Event|7|||
94499918|NCT00552058|323624537|FG000|Overall Study|Lack of Efficacy|1|||
94499919|NCT00552058|323624538|FG001|Overall Study|Lack of Efficacy|5|||
94499920|NCT00552058|323624537|FG000|Overall Study|Lost to Follow-up|1|||
94499921|NCT00552058|323624538|FG001|Overall Study|Lost to Follow-up|0|||
94499922|NCT00552058|323624537|FG000|Overall Study|Withdrawal by Subject|4|||
94499923|NCT00552058|323624538|FG001|Overall Study|Withdrawal by Subject|4|||
94499924|NCT00552058|323624537|FG000|Overall Study|Other: Protocol Violation|0|||
94499925|NCT00552058|323624538|FG001|Overall Study|Other: Protocol Violation|1|||
94499926|NCT00552058|323624537|FG000|Overall Study|Other: Non Compliance|1|||
94499927|NCT00552058|323624538|FG001|Overall Study|Other: Non Compliance|2|||
94499928|NCT00552058|323624537|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
94499929|NCT00552058|323624538|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
94499930|NCT00552058|323624537|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
94499931|NCT00552058|323624538|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
94499932|NCT00552058|323624537|FG000|Overall Study|Other: Positive Stool Result|0|||
94499933|NCT00552058|323624538|FG001|Overall Study|Other: Positive Stool Result|1|||
94499934|NCT00552058|323624537|FG000|Overall Study|Other: Randomized in error|0|||
94499935|NCT00552058|323624538|FG001|Overall Study|Other: Randomized in error|1|||
94499936|NCT00552058|323624537|FG000|Overall Study|Other: Sponsors Decision|0|||
94499937|NCT00552058|323624538|FG001|Overall Study|Other: Sponsors Decision|1|||
94499938|NCT00552058|323624537|FG000|Overall Study|Other: Early Roll Over|1|||
94499939|NCT00552058|323624538|FG001|Overall Study|Other: Early Roll Over|0|||
94499940|NCT03520569|323624539|FG000|Overall Study|Withdrawal by Subject|1|||
94499941|NCT01178411|323624542|FG000|Overall Study|Adverse Event|5|||
94499942|NCT01178411|323624542|FG000|Overall Study|Withdrawal by Subject|4|||
94499943|NCT01178411|323624542|FG000|Overall Study|Protocol Violation|1|||
94499944|NCT01178411|323624542|FG000|Overall Study|Progressive disease per RECIST|32|||
94499945|NCT01178411|323624542|FG000|Overall Study|Progressive disease per clinician|9|||
94499946|NCT01178411|323624542|FG000|Overall Study|Physician Decision|6|||
94499947|NCT01178411|323624542|FG000|Overall Study|Death|1|||
94499948|NCT01178411|323624542|FG000|Overall Study|No reason provided|1|||
94499949|NCT01178411|323624542|FG000|Overall Study|Drug manufacturing ended|1|||
94499950|NCT01245751|323624543|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
94499951|NCT01245751|323624544|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
94499952|NCT01245751|323624545|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
94499953|NCT01245751|323624546|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
94499954|NCT01245751|323624543|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
94499955|NCT01245751|323624544|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
94499956|NCT01245751|323624545|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
94499957|NCT01245751|323624546|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
94499958|NCT01245751|323624543|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
94499959|NCT01245751|323624544|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
94499960|NCT01245751|323624545|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
94499961|NCT01245751|323624546|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
94499962|NCT03197935|323624549|FG000|Overall Study|Death due to any cause|26|||
94499963|NCT03197935|323624550|FG001|Overall Study|Death due to any cause|15|||
94499964|NCT03197935|323624549|FG000|Overall Study|Lost to Follow-up|3|||
94499965|NCT03197935|323624550|FG001|Overall Study|Lost to Follow-up|5|||
94499966|NCT03197935|323624549|FG000|Overall Study|Physician Decision|2|||
94499967|NCT03197935|323624550|FG001|Overall Study|Physician Decision|1|||
94499968|NCT03197935|323624549|FG000|Overall Study|Withdrawal by Subject|16|||
94499969|NCT03197935|323624550|FG001|Overall Study|Withdrawal by Subject|8|||
94499970|NCT00145327|323624551|FG000|Overall Study|Withdrawal by Subject|77|||
94499971|NCT00145327|323624552|FG001|Overall Study|Withdrawal by Subject|72|||
94499972|NCT00145327|323624553|FG002|Overall Study|Withdrawal by Subject|164|||
94499973|NCT00145327|323624551|FG000|Overall Study|Death|26|||
94499974|NCT00145327|323624552|FG001|Overall Study|Death|18|||
94499975|NCT00145327|323624553|FG002|Overall Study|Death|30|||
94499976|NCT00145327|323624551|FG000|Overall Study|Adverse Event|14|||
94499977|NCT00145327|323624552|FG001|Overall Study|Adverse Event|11|||
94499978|NCT00145327|323624553|FG002|Overall Study|Adverse Event|22|||
94499979|NCT00145327|323624551|FG000|Overall Study|Lost to Follow-up|9|||
94499980|NCT00145327|323624552|FG001|Overall Study|Lost to Follow-up|14|||
94499981|NCT00145327|323624553|FG002|Overall Study|Lost to Follow-up|14|||
94499982|NCT00145327|323624551|FG000|Overall Study|Administrative problems|12|||
94499983|NCT00145327|323624552|FG001|Overall Study|Administrative problems|9|||
94499984|NCT00145327|323624553|FG002|Overall Study|Administrative problems|13|||
94499985|NCT00145327|323624551|FG000|Overall Study|Protocol Violation|2|||
94499986|NCT00145327|323624552|FG001|Overall Study|Protocol Violation|0|||
94499987|NCT00145327|323624553|FG002|Overall Study|Protocol Violation|2|||
94499988|NCT00145327|323624551|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94499989|NCT00145327|323624552|FG001|Overall Study|Abnormal laboratory value(s)|0|||
94499990|NCT00145327|323624553|FG002|Overall Study|Abnormal laboratory value(s)|2|||
94499991|NCT00145327|323624551|FG000|Overall Study|Missing - not stated|1|||
94499992|NCT00145327|323624552|FG001|Overall Study|Missing - not stated|0|||
94499993|NCT00145327|323624553|FG002|Overall Study|Missing - not stated|1|||
94499994|NCT01795937|323624554|FG000|Overall Study|Withdrawal by Subject|1|||
94499995|NCT01795937|323624555|FG001|Overall Study|Withdrawal by Subject|0|||
94499996|NCT01795937|323624556|FG002|Overall Study|Withdrawal by Subject|0|||
94499997|NCT01795937|323624554|FG000|Overall Study|Physician Decision|0|||
94499998|NCT01795937|323624555|FG001|Overall Study|Physician Decision|1|||
94499999|NCT01795937|323624556|FG002|Overall Study|Physician Decision|0|||
94500000|NCT03073109|323624557|FG000|Overall Study|Adverse Event|0|||
94500001|NCT03073109|323624558|FG001|Overall Study|Adverse Event|1|||
94500002|NCT03073109|323624557|FG000|Overall Study|Other|2|||
94500003|NCT03073109|323624558|FG001|Overall Study|Other|0|||
94500004|NCT03073109|323624557|FG000|Overall Study|Lost to Follow-up|8|||
94500005|NCT03073109|323624558|FG001|Overall Study|Lost to Follow-up|1|||
94500006|NCT01783015|323624559|FG000|Blinded Treatment|Adverse Event|0|||
94500007|NCT01783015|323624560|FG001|Blinded Treatment|Adverse Event|1|||
94500008|NCT01783015|323624561|FG002|Blinded Treatment|Adverse Event|0|||
94500009|NCT01783015|323624559|FG000|Blinded Treatment|Protocol Violation|0|||
94500010|NCT01783015|323624560|FG001|Blinded Treatment|Protocol Violation|1|||
94500011|NCT01783015|323624561|FG002|Blinded Treatment|Protocol Violation|0|||
94500012|NCT01783015|323624559|FG000|Blinded Treatment|Withdrawal by Subject|0|||
94500013|NCT01783015|323624560|FG001|Blinded Treatment|Withdrawal by Subject|1|||
94500014|NCT01783015|323624561|FG002|Blinded Treatment|Withdrawal by Subject|0|||
94500015|NCT01783015|323624559|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
94500016|NCT01783015|323624560|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
94500017|NCT01783015|323624561|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
94500018|NCT01783015|323624559|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
94500019|NCT01783015|323624560|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
94500020|NCT01783015|323624561|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
94500021|NCT00447278|323624562|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
94500022|NCT00447278|323624563|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
94500023|NCT00447278|323624562|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
94500024|NCT00447278|323624563|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
94500025|NCT00447278|323624562|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
94500026|NCT00447278|323624563|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
94500027|NCT00447278|323624562|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
94500028|NCT00447278|323624563|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
94500029|NCT00447278|323624562|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
94500030|NCT00447278|323624563|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
94500031|NCT00447278|323624562|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
94500032|NCT00447278|323624563|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
94500033|NCT00447278|323624562|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
94500034|NCT00447278|323624563|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
94500035|NCT00447278|323624562|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
94500036|NCT00447278|323624563|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
94500037|NCT00447278|323624562|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
94500038|NCT00447278|323624563|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
94500039|NCT00447278|323624562|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
94500040|NCT00447278|323624563|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
94500041|NCT00447278|323624562|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
94500042|NCT00447278|323624563|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
94500043|NCT00447278|323624562|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
94500044|NCT00447278|323624563|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
94500045|NCT00447278|323624562|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
94500046|NCT00447278|323624563|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
94500047|NCT00447278|323624562|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
94500048|NCT00447278|323624563|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
94500049|NCT00669331|323624564|FG000|Randomisation to First Dose|Adverse Event|1|||
94500050|NCT00669331|323624565|FG001|Randomisation to First Dose|Adverse Event|0|||
94500051|NCT00669331|323624564|FG000|Randomisation to First Dose|Protocol Violation|1|||
94500052|NCT00669331|323624565|FG001|Randomisation to First Dose|Protocol Violation|0|||
94500053|NCT00669331|323624564|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
94500054|NCT00669331|323624565|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
94500055|NCT00669331|323624564|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
94500056|NCT00669331|323624565|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
94500057|NCT00669331|323624564|FG000|Randomisation to First Dose|Death|1|||
94500058|NCT00669331|323624565|FG001|Randomisation to First Dose|Death|0|||
94500059|NCT00669331|323624564|FG000|Randomisation to First Dose|Sponsor decision|0|||
94500060|NCT00669331|323624565|FG001|Randomisation to First Dose|Sponsor decision|1|||
94500061|NCT00669331|323624564|FG000|Randomisation to First Dose|Randomised in error|3|||
94500062|NCT00669331|323624565|FG001|Randomisation to First Dose|Randomised in error|10|||
94500063|NCT00669331|323624564|FG000|Blinded Treatment Period|Adverse Event|16|||
94500064|NCT00669331|323624565|FG001|Blinded Treatment Period|Adverse Event|10|||
94500065|NCT00669331|323624564|FG000|Blinded Treatment Period|Protocol Violation|1|||
94500066|NCT00669331|323624565|FG001|Blinded Treatment Period|Protocol Violation|1|||
94500067|NCT00669331|323624564|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
94500068|NCT00669331|323624565|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
94500069|NCT00669331|323624564|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
94500070|NCT00669331|323624565|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
94500071|NCT00669331|323624564|FG000|Blinded Treatment Period|Death|0|||
94500072|NCT00669331|323624565|FG001|Blinded Treatment Period|Death|2|||
94500073|NCT00669331|323624564|FG000|Blinded Treatment Period|Physician Decision|3|||
94500074|NCT00669331|323624565|FG001|Blinded Treatment Period|Physician Decision|3|||
94500075|NCT00669331|323624564|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
94500076|NCT00669331|323624565|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
94500077|NCT04602000|323624567|FG000|Overall Study|Withdrawal by Subject|3|||
94500078|NCT04602000|323624568|FG001|Overall Study|Withdrawal by Subject|6|||
94500079|NCT04602000|323624569|FG002|Overall Study|Withdrawal by Subject|3|||
94500080|NCT04602000|323624570|FG003|Overall Study|Withdrawal by Subject|27|||
94500081|NCT04602000|323624571|FG004|Overall Study|Withdrawal by Subject|39|||
94500082|NCT04602000|323624567|FG000|Overall Study|Physician Decision|1|||
94500083|NCT04602000|323624568|FG001|Overall Study|Physician Decision|0|||
94500084|NCT04602000|323624569|FG002|Overall Study|Physician Decision|0|||
94500085|NCT04602000|323624570|FG003|Overall Study|Physician Decision|2|||
94500086|NCT04602000|323624571|FG004|Overall Study|Physician Decision|2|||
94500087|NCT04602000|323624567|FG000|Overall Study|Death|0|||
94500088|NCT04602000|323624568|FG001|Overall Study|Death|1|||
94500089|NCT04602000|323624569|FG002|Overall Study|Death|0|||
94500090|NCT04602000|323624570|FG003|Overall Study|Death|1|||
94500091|NCT04602000|323624571|FG004|Overall Study|Death|2|||
94500092|NCT04602000|323624567|FG000|Overall Study|Lost to Follow-up|0|||
94500093|NCT04602000|323624568|FG001|Overall Study|Lost to Follow-up|0|||
94500094|NCT04602000|323624569|FG002|Overall Study|Lost to Follow-up|0|||
94500095|NCT04602000|323624570|FG003|Overall Study|Lost to Follow-up|3|||
94500096|NCT04602000|323624571|FG004|Overall Study|Lost to Follow-up|4|||
94500097|NCT04602000|323624567|FG000|Overall Study|Other|4|||
94500098|NCT04602000|323624568|FG001|Overall Study|Other|1|||
94500099|NCT04602000|323624569|FG002|Overall Study|Other|2|||
94500100|NCT04602000|323624570|FG003|Overall Study|Other|5|||
94500101|NCT04602000|323624571|FG004|Overall Study|Other|4|||
94500102|NCT04602000|323624567|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
94500103|NCT04602000|323624568|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
94500104|NCT04602000|323624569|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
94500105|NCT04602000|323624570|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
94500106|NCT04602000|323624571|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
94500107|NCT00471354|323624577|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
94500108|NCT00471354|323624577|FG000|Overall Study|Adverse Event|13|||
94500109|NCT00471354|323624577|FG000|Overall Study|Protocol Violation|12|||
94500110|NCT00471354|323624577|FG000|Overall Study|Withdrawal by Subject|1|||
94500111|NCT00471354|323624577|FG000|Overall Study|Physician Decision|4|||
94500112|NCT00471354|323624577|FG000|Overall Study|Sponsor Decision|1|||
94500113|NCT00471354|323624577|FG000|Overall Study|Lost to Follow-up|3|||
94500114|NCT00471354|323624577|FG000|Overall Study|Lack of Efficacy|5|||
94500115|NCT00471354|323624577|FG000|Overall Study|Patient/Caregiver Decision|12|||
94500116|NCT05427916|323624578|FG000|Overall Study|Adverse Event|3|||
94500117|NCT05427916|323624579|FG001|Overall Study|Adverse Event|0|||
94500118|NCT05427916|323624578|FG000|Overall Study|Lack of Efficacy|6|||
94500119|NCT05427916|323624579|FG001|Overall Study|Lack of Efficacy|0|||
94500120|NCT05427916|323624578|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
94500121|NCT05427916|323624579|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
94500122|NCT01875237|323624580|FG000|Overall Study|GVDH before DLI|1|||
94500123|NCT01875237|323624581|FG001|Overall Study|GVDH before DLI|0|||
94500124|NCT01875237|323624580|FG000|Overall Study|DLI cells could not be produced|1|||
94500125|NCT01875237|323624581|FG001|Overall Study|DLI cells could not be produced|0|||
94500126|NCT04076579|323624582|FG000|Overall Study|Adverse Event|2|||
94500127|NCT04076579|323624583|FG001|Overall Study|Adverse Event|0|||
94500128|NCT04076579|323624582|FG000|Overall Study|discontinued due to toxicity|1|||
94500129|NCT04076579|323624583|FG001|Overall Study|discontinued due to toxicity|0|||
94500130|NCT04076579|323624582|FG000|Overall Study|Physician Decision|1|||
94500131|NCT04076579|323624583|FG001|Overall Study|Physician Decision|0|||
94500132|NCT04076579|323624582|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
94500133|NCT04076579|323624583|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
94500134|NCT04076579|323624582|FG000|Overall Study|Noncompliance|0|||
94500135|NCT04076579|323624583|FG001|Overall Study|Noncompliance|1|||
94500136|NCT04076579|323624582|FG000|Overall Study|Withdrawal by Subject|0|||
94500137|NCT04076579|323624583|FG001|Overall Study|Withdrawal by Subject|2|||
94500138|NCT03558672|323624584|FG000|Overall Study|Study Early Termination|10|||
94500139|NCT00509600|323624586|FG000|Overall Study|Adverse Event|1|||
94500140|NCT00421733|323624589|FG000|Overall Study|Adverse Event|4|||
94500141|NCT00421733|323624590|FG001|Overall Study|Adverse Event|9|||
94500142|NCT00421733|323624591|FG002|Overall Study|Adverse Event|2|||
94500143|NCT00421733|323624589|FG000|Overall Study|Lost to Follow-up|1|||
94500144|NCT00421733|323624590|FG001|Overall Study|Lost to Follow-up|2|||
94500145|NCT00421733|323624591|FG002|Overall Study|Lost to Follow-up|4|||
94500146|NCT00421733|323624589|FG000|Overall Study|Withdrawal by Subject|1|||
94500147|NCT00421733|323624590|FG001|Overall Study|Withdrawal by Subject|2|||
94500148|NCT00421733|323624591|FG002|Overall Study|Withdrawal by Subject|7|||
94500149|NCT00421733|323624589|FG000|Overall Study|Death|0|||
94500150|NCT00421733|323624590|FG001|Overall Study|Death|3|||
94500151|NCT00421733|323624591|FG002|Overall Study|Death|0|||
94500152|NCT00421733|323624589|FG000|Overall Study|Required dialysis|1|||
94500153|NCT00421733|323624590|FG001|Overall Study|Required dialysis|0|||
94500154|NCT00421733|323624591|FG002|Overall Study|Required dialysis|0|||
94500155|NCT00421733|323624589|FG000|Overall Study|Administrative|2|||
94500156|NCT00421733|323624590|FG001|Overall Study|Administrative|0|||
94500157|NCT00421733|323624591|FG002|Overall Study|Administrative|0|||
94500158|NCT00421733|323624589|FG000|Overall Study|Did not satisfy entry criteria|1|||
94500159|NCT00421733|323624590|FG001|Overall Study|Did not satisfy entry criteria|3|||
94500160|NCT00421733|323624591|FG002|Overall Study|Did not satisfy entry criteria|2|||
94500161|NCT00421733|323624589|FG000|Overall Study|Sponsor request|1|||
94500162|NCT00421733|323624590|FG001|Overall Study|Sponsor request|0|||
94500163|NCT00421733|323624591|FG002|Overall Study|Sponsor request|3|||
94500164|NCT00421733|323624589|FG000|Overall Study|Protocol deviation|4|||
94500165|NCT00421733|323624590|FG001|Overall Study|Protocol deviation|7|||
94500166|NCT00421733|323624591|FG002|Overall Study|Protocol deviation|2|||
94500167|NCT00790933|323624592|FG000|Overall Study|Adverse Event|94|||
94500168|NCT00790933|323624593|FG001|Overall Study|Adverse Event|119|||
94500169|NCT00790933|323624594|FG002|Overall Study|Adverse Event|65|||
94500170|NCT00790933|323624595|FG003|Overall Study|Adverse Event|5|||
94500171|NCT00790933|323624596|FG004|Overall Study|Adverse Event|69|||
94500172|NCT00790933|323624592|FG000|Overall Study|Protocol Violation(s)|8|||
94500173|NCT00790933|323624593|FG001|Overall Study|Protocol Violation(s)|18|||
94500174|NCT00790933|323624594|FG002|Overall Study|Protocol Violation(s)|7|||
94500175|NCT00790933|323624595|FG003|Overall Study|Protocol Violation(s)|0|||
94500176|NCT00790933|323624596|FG004|Overall Study|Protocol Violation(s)|12|||
94500177|NCT00790933|323624592|FG000|Overall Study|Lack of Efficacy|192|||
94500178|NCT00790933|323624593|FG001|Overall Study|Lack of Efficacy|176|||
94500179|NCT00790933|323624594|FG002|Overall Study|Lack of Efficacy|130|||
94500180|NCT00790933|323624595|FG003|Overall Study|Lack of Efficacy|1|||
94500181|NCT00790933|323624596|FG004|Overall Study|Lack of Efficacy|121|||
94500182|NCT00790933|323624592|FG000|Overall Study|Study Terminated by Sponsor|0|||
94500183|NCT00790933|323624593|FG001|Overall Study|Study Terminated by Sponsor|0|||
94500184|NCT00790933|323624594|FG002|Overall Study|Study Terminated by Sponsor|1|||
94500185|NCT00790933|323624595|FG003|Overall Study|Study Terminated by Sponsor|0|||
94500186|NCT00790933|323624596|FG004|Overall Study|Study Terminated by Sponsor|0|||
94500187|NCT00790933|323624592|FG000|Overall Study|Withdrawal by Subject|123|||
94500188|NCT00790933|323624593|FG001|Overall Study|Withdrawal by Subject|120|||
94500189|NCT00790933|323624594|FG002|Overall Study|Withdrawal by Subject|52|||
94500190|NCT00790933|323624595|FG003|Overall Study|Withdrawal by Subject|6|||
94500191|NCT00790933|323624596|FG004|Overall Study|Withdrawal by Subject|50|||
94500192|NCT00790933|323624592|FG000|Overall Study|Lost to Follow-up|13|||
94500193|NCT00790933|323624593|FG001|Overall Study|Lost to Follow-up|31|||
94500194|NCT00790933|323624594|FG002|Overall Study|Lost to Follow-up|10|||
94500195|NCT00790933|323624595|FG003|Overall Study|Lost to Follow-up|1|||
94500196|NCT00790933|323624596|FG004|Overall Study|Lost to Follow-up|15|||
94500197|NCT00790933|323624592|FG000|Overall Study|Reason Not Specified|8|||
94500198|NCT00790933|323624593|FG001|Overall Study|Reason Not Specified|16|||
94500199|NCT00790933|323624594|FG002|Overall Study|Reason Not Specified|4|||
94500200|NCT00790933|323624595|FG003|Overall Study|Reason Not Specified|1|||
94500201|NCT00790933|323624596|FG004|Overall Study|Reason Not Specified|9|||
94500202|NCT00676052|323624597|FG000|Overall Study|Adverse Event|0|||
94500203|NCT00676052|323624598|FG001|Overall Study|Adverse Event|1|||
94500204|NCT00676052|323624599|FG002|Overall Study|Adverse Event|1|||
94500205|NCT00676052|323624600|FG003|Overall Study|Adverse Event|2|||
94500206|NCT00676052|323624601|FG004|Overall Study|Adverse Event|2|||
94500207|NCT00676052|323624602|FG005|Overall Study|Adverse Event|2|||
94500208|NCT00676052|323624597|FG000|Overall Study|Lack of Efficacy|2|||
94500209|NCT00676052|323624598|FG001|Overall Study|Lack of Efficacy|2|||
94500210|NCT00676052|323624599|FG002|Overall Study|Lack of Efficacy|1|||
94500211|NCT00676052|323624600|FG003|Overall Study|Lack of Efficacy|1|||
94500212|NCT00676052|323624601|FG004|Overall Study|Lack of Efficacy|2|||
94500213|NCT00676052|323624602|FG005|Overall Study|Lack of Efficacy|1|||
94500214|NCT00676052|323624597|FG000|Overall Study|Protocol Violation|5|||
94500215|NCT00676052|323624598|FG001|Overall Study|Protocol Violation|3|||
94500216|NCT00676052|323624599|FG002|Overall Study|Protocol Violation|2|||
94500217|NCT00676052|323624600|FG003|Overall Study|Protocol Violation|2|||
94500218|NCT00676052|323624601|FG004|Overall Study|Protocol Violation|1|||
94500219|NCT00676052|323624602|FG005|Overall Study|Protocol Violation|2|||
94500220|NCT00676052|323624597|FG000|Overall Study|Lost to Follow-up|0|||
94500221|NCT00676052|323624598|FG001|Overall Study|Lost to Follow-up|0|||
94500222|NCT00676052|323624599|FG002|Overall Study|Lost to Follow-up|0|||
94500223|NCT00676052|323624600|FG003|Overall Study|Lost to Follow-up|0|||
94500224|NCT00676052|323624601|FG004|Overall Study|Lost to Follow-up|1|||
94500225|NCT00676052|323624602|FG005|Overall Study|Lost to Follow-up|0|||
94500226|NCT00676052|323624597|FG000|Overall Study|Physician Decision|1|||
94500227|NCT00676052|323624598|FG001|Overall Study|Physician Decision|1|||
94500228|NCT00676052|323624599|FG002|Overall Study|Physician Decision|1|||
94500229|NCT00676052|323624600|FG003|Overall Study|Physician Decision|0|||
94500230|NCT00676052|323624601|FG004|Overall Study|Physician Decision|0|||
94500231|NCT00676052|323624602|FG005|Overall Study|Physician Decision|1|||
94500232|NCT00676052|323624597|FG000|Overall Study|Withdrawal by Subject|1|||
94500233|NCT00676052|323624598|FG001|Overall Study|Withdrawal by Subject|0|||
94500234|NCT00676052|323624599|FG002|Overall Study|Withdrawal by Subject|1|||
94500235|NCT00676052|323624600|FG003|Overall Study|Withdrawal by Subject|0|||
94500236|NCT00676052|323624601|FG004|Overall Study|Withdrawal by Subject|0|||
94500237|NCT00676052|323624602|FG005|Overall Study|Withdrawal by Subject|0|||
94500238|NCT01967277|323624603|FG000|Overall Study|Lost to Follow-up|1|||
94500239|NCT01967277|323624604|FG001|Overall Study|Lost to Follow-up|2|||
94500240|NCT01967277|323624603|FG000|Overall Study|Unrelated illness|0|||
94500241|NCT01967277|323624604|FG001|Overall Study|Unrelated illness|1|||
94500242|NCT01913470|323624605|FG000|Overall Study|Lost to Follow-up|0|||
94500243|NCT01913470|323624606|FG001|Overall Study|Lost to Follow-up|1|||
94500244|NCT01913470|323624605|FG000|Overall Study|Physician Decision|0|||
94500245|NCT01913470|323624606|FG001|Overall Study|Physician Decision|1|||
94500246|NCT01913470|323624605|FG000|Overall Study|Withdrawal by Subject|0|||
94500247|NCT01913470|323624606|FG001|Overall Study|Withdrawal by Subject|1|||
94500248|NCT00397930|323624607|FG000|Overall Study|Personal reasons|14|||
94500249|NCT00397930|323624608|FG001|Overall Study|Personal reasons|8|||
94500250|NCT00397930|323624607|FG000|Overall Study|Other medical|9|||
94500251|NCT00397930|323624608|FG001|Overall Study|Other medical|4|||
94500252|NCT00397930|323624607|FG000|Overall Study|Unknown reasons|9|||
94500253|NCT00397930|323624608|FG001|Overall Study|Unknown reasons|14|||
94500254|NCT00397930|323624607|FG000|Overall Study|Noncompliant|3|||
94500255|NCT00397930|323624608|FG001|Overall Study|Noncompliant|2|||
94500256|NCT00397930|323624607|FG000|Overall Study|Too time-consuming|2|||
94500257|NCT00397930|323624608|FG001|Overall Study|Too time-consuming|9|||
94500258|NCT00397930|323624607|FG000|Overall Study|Started own yoga program|1|||
94500259|NCT00397930|323624608|FG001|Overall Study|Started own yoga program|1|||
94500260|NCT00397930|323624607|FG000|Overall Study|Did not want to be in control group|0|||
94500261|NCT00397930|323624608|FG001|Overall Study|Did not want to be in control group|1|||
94500262|NCT00397930|323624607|FG000|Overall Study|Withdrawal by Subject|0|||
94500263|NCT00397930|323624608|FG001|Overall Study|Withdrawal by Subject|8|||
94500264|NCT00397930|323624607|FG000|Overall Study|Missing data|0|||
94500265|NCT00397930|323624608|FG001|Overall Study|Missing data|4|||
94500266|NCT01160744|323624615|FG000|Overall Study|Withdrawal by Subject|11|||
94500267|NCT01160744|323624616|FG001|Overall Study|Withdrawal by Subject|5|||
94500268|NCT01160744|323624617|FG002|Overall Study|Withdrawal by Subject|6|||
94500269|NCT01160744|323624618|FG003|Overall Study|Withdrawal by Subject|4|||
94500270|NCT01160744|323624615|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
94500271|NCT01160744|323624616|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
94500272|NCT01160744|323624617|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
94500273|NCT01160744|323624618|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
94500274|NCT02056288|323624619|FG000|In-Hospital Data|Surgery cancelled|1|||
94500275|NCT02056288|323624620|FG001|In-Hospital Data|Surgery cancelled|0|||
94500276|NCT02056288|323624619|FG000|In-Hospital Data|Protocol Violation|3|||
94500277|NCT02056288|323624620|FG001|In-Hospital Data|Protocol Violation|0|||
94500278|NCT02056288|323624619|FG000|In-Hospital Data|Physician Decision|1|||
94500279|NCT02056288|323624620|FG001|In-Hospital Data|Physician Decision|0|||
94500280|NCT02056288|323624619|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
94500281|NCT02056288|323624620|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
94500282|NCT00195429|323624622|FG000|Overall Study|Adverse Event|2|||
94500283|NCT00195429|323624623|FG001|Overall Study|Adverse Event|4|||
94500284|NCT00195429|323624622|FG000|Overall Study|Lack of Efficacy|2|||
94500285|NCT00195429|323624623|FG001|Overall Study|Lack of Efficacy|1|||
94500286|NCT00195429|323624622|FG000|Overall Study|Lost to Follow-up|1|||
94500287|NCT00195429|323624623|FG001|Overall Study|Lost to Follow-up|0|||
94500288|NCT02384460|323624624|FG000|Overall Study|Protocol Violation|0|||
94500289|NCT02384460|323624625|FG001|Overall Study|Protocol Violation|1|||
94500290|NCT02384460|323624624|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
94500291|NCT02384460|323624625|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
94500292|NCT02384460|323624624|FG000|Overall Study|Adverse Event|5|||
94500293|NCT02384460|323624625|FG001|Overall Study|Adverse Event|2|||
94500294|NCT02384460|323624624|FG000|Overall Study|Withdrawal by Subject|0|||
94500295|NCT02384460|323624625|FG001|Overall Study|Withdrawal by Subject|3|||
94500296|NCT02384460|323624624|FG000|Overall Study|Elective medical treatment|1|||
94500297|NCT02384460|323624625|FG001|Overall Study|Elective medical treatment|0|||
94500298|NCT02384460|323624624|FG000|Overall Study|Non-compliance|1|||
94500299|NCT02384460|323624625|FG001|Overall Study|Non-compliance|0|||
94500300|NCT00500110|323624626|FG000|Overall Study|Withdrawal by Subject|3|||
94500301|NCT03446573|323624627|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
94500302|NCT03446573|323624628|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
94500303|NCT03446573|323624627|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
94500304|NCT03446573|323624628|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
94500305|NCT03446573|323624627|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
94500306|NCT03446573|323624628|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
94500307|NCT03446573|323624627|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
94500308|NCT03446573|323624628|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
94500309|NCT03446573|323624627|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
94500310|NCT03446573|323624628|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
94500311|NCT03446573|323624627|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
94500312|NCT03446573|323624628|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
94500313|NCT03446573|323624627|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
94500314|NCT03446573|323624628|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
94500315|NCT03446573|323624627|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
94500316|NCT03446573|323624628|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
94500317|NCT03446573|323624627|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
94500318|NCT03446573|323624628|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
94500319|NCT03446573|323624627|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
94500320|NCT03446573|323624628|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
94500321|NCT03446573|323624627|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
94500322|NCT03446573|323624628|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
94500323|NCT03446573|323624627|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
94500324|NCT03446573|323624628|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
94500325|NCT03446573|323624627|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
94500326|NCT03446573|323624628|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
94500327|NCT03123588|323624629|FG000|Overall Study|Study Terminated by Sponsor|2|||
94500328|NCT03123588|323624630|FG001|Overall Study|Study Terminated by Sponsor|5|||
94500329|NCT03123588|323624629|FG000|Overall Study|Withdrawal by Subject|1|||
94500330|NCT03123588|323624630|FG001|Overall Study|Withdrawal by Subject|0|||
94500331|NCT03123588|323624629|FG000|Overall Study|Adverse Event|1|||
94500332|NCT03123588|323624630|FG001|Overall Study|Adverse Event|0|||
94500333|NCT03123588|323624629|FG000|Overall Study|Physician Decision|2|||
94500334|NCT03123588|323624630|FG001|Overall Study|Physician Decision|1|||
94500335|NCT01755637|323624631|FG000|Period 1|Adverse Event|0|||
94500336|NCT01755637|323624632|FG001|Period 1|Adverse Event|1|||
94500337|NCT01814332|323624634|FG000|Overall Study|Adverse Event|8|||
94500338|NCT01814332|323624635|FG001|Overall Study|Adverse Event|3|||
94500339|NCT01814332|323624634|FG000|Overall Study|Withdrawal by Subject|3|||
94500340|NCT01814332|323624635|FG001|Overall Study|Withdrawal by Subject|8|||
94500341|NCT01814332|323624634|FG000|Overall Study|Protocol Violation|0|||
94500342|NCT01814332|323624635|FG001|Overall Study|Protocol Violation|4|||
94500343|NCT01814332|323624634|FG000|Overall Study|Lost to Follow-up|5|||
94500344|NCT01814332|323624635|FG001|Overall Study|Lost to Follow-up|1|||
94500345|NCT02287025|323624636|FG000|Overall Study|Not treated|2|||
94500346|NCT02287025|323624637|FG001|Overall Study|Not treated|0|||
94500347|NCT02287025|323624636|FG000|Overall Study|Progression of disease|3|||
94500348|NCT02287025|323624637|FG001|Overall Study|Progression of disease|2|||
94500349|NCT02287025|323624636|FG000|Overall Study|Adverse Event|2|||
94500350|NCT02287025|323624637|FG001|Overall Study|Adverse Event|4|||
94500351|NCT02287025|323624636|FG000|Overall Study|Withdrawal by Subject|2|||
94500352|NCT02287025|323624637|FG001|Overall Study|Withdrawal by Subject|2|||
94500353|NCT02287025|323624636|FG000|Overall Study|Screening failed|1|||
94500354|NCT02287025|323624637|FG001|Overall Study|Screening failed|1|||
94500355|NCT00899847|323624638|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
94500356|NCT00122187|323624641|FG000|Overall Study|Withdrew because of resource limitations|2|||
94500357|NCT00122187|323624642|FG001|Overall Study|Withdrew because of resource limitations|2|||
94500358|NCT02061592|323624645|FG000|Period 1|Withdrawal by Subject|1|||
94500359|NCT02061592|323624646|FG001|Period 1|Withdrawal by Subject|0|||
94500360|NCT02061592|323624645|FG000|Period 1|Protocol Violation|1|||
94500361|NCT02061592|323624646|FG001|Period 1|Protocol Violation|0|||
94500362|NCT02061592|323624645|FG000|Period 2|Lost to Follow-up|0|||
94500363|NCT02061592|323624646|FG001|Period 2|Lost to Follow-up|1|||
94500364|NCT03338023|323624647|FG000|Overall Study|Withdrawal by Subject|3|||
94500365|NCT03338023|323624648|FG001|Overall Study|Withdrawal by Subject|4|||
94500366|NCT03338023|323624647|FG000|Overall Study|Protocol Violation|3|||
94500367|NCT03338023|323624648|FG001|Overall Study|Protocol Violation|3|||
94500368|NCT03338023|323624647|FG000|Overall Study|Lost to Follow-up|2|||
94500369|NCT03338023|323624648|FG001|Overall Study|Lost to Follow-up|1|||
94500370|NCT03338023|323624647|FG000|Overall Study|Physician Decision|1|||
94500371|NCT03338023|323624648|FG001|Overall Study|Physician Decision|2|||
94500372|NCT04034056|323624649|FG000|Overall Study|Withdrawal by Subject|2|||
94500373|NCT04034056|323624649|FG000|Overall Study|Reason Not Specified|13|||
94500374|NCT04034056|323624649|FG000|Overall Study|Adverse Event|56|||
94500375|NCT05061706|323624650|FG000|Overall Study|Adverse Event|29|||
94500376|NCT05061706|323624651|FG001|Overall Study|Adverse Event|1|||
94500377|NCT05061706|323624650|FG000|Overall Study|Lack of Efficacy|0|||
94500378|NCT05061706|323624651|FG001|Overall Study|Lack of Efficacy|1|||
94500379|NCT05061706|323624650|FG000|Overall Study|Lost to Follow-up|2|||
94500380|NCT05061706|323624651|FG001|Overall Study|Lost to Follow-up|2|||
94500381|NCT05061706|323624650|FG000|Overall Study|Protocol Violation|3|||
94500382|NCT05061706|323624651|FG001|Overall Study|Protocol Violation|1|||
94500383|NCT05061706|323624650|FG000|Overall Study|Withdrawal by Subject|3|||
94500384|NCT05061706|323624651|FG001|Overall Study|Withdrawal by Subject|9|||
94500385|NCT00888849|323624654|FG000|Overall Study|Death|4|||
94500386|NCT00888849|323624655|FG001|Overall Study|Death|7|||
94500387|NCT00888849|323624654|FG000|Overall Study|Lost to Follow-up|1|||
94500388|NCT00888849|323624655|FG001|Overall Study|Lost to Follow-up|2|||
94500389|NCT01873833|323624658|FG000|Overall Study|Withdrawal by Subject|1|||
94500390|NCT04000724|323624661|FG000|Overall Study|Withdrawal by Subject|5|||
94500391|NCT04000724|323624662|FG001|Overall Study|Withdrawal by Subject|3|||
94500392|NCT04000724|323624663|FG002|Overall Study|Withdrawal by Subject|4|||
94500393|NCT04000724|323624661|FG000|Overall Study|Lost to Follow-up|11|||
94500394|NCT04000724|323624662|FG001|Overall Study|Lost to Follow-up|7|||
94500395|NCT04000724|323624663|FG002|Overall Study|Lost to Follow-up|13|||
94500396|NCT00455455|323624664|FG000|Washout|Withdrawal by Subject|0|||
94500397|NCT00455455|323624665|FG001|Washout|Withdrawal by Subject|1|||
94500398|NCT00455455|323624664|FG000|Washout|Withdrawal by Subject|1|||
94500399|NCT00455455|323624665|FG001|Washout|Withdrawal by Subject|0|||
94500400|NCT04149353|323624668|FG000|Overall Study|Study terminated|1|||
94500401|NCT00356421|323624670|FG000|Overall Study|Lack of Efficacy|3|||
94500402|NCT00356421|323624671|FG001|Overall Study|Lack of Efficacy|0|||
94500403|NCT00356421|323624670|FG000|Overall Study|Withdrawal by Subject|9|||
94500404|NCT00356421|323624671|FG001|Overall Study|Withdrawal by Subject|2|||
94500405|NCT00356421|323624670|FG000|Overall Study|Related to study drug|15|||
94500406|NCT00356421|323624671|FG001|Overall Study|Related to study drug|12|||
94500407|NCT00356421|323624670|FG000|Overall Study|Not related to study drug|5|||
94500408|NCT00356421|323624671|FG001|Overall Study|Not related to study drug|3|||
94500409|NCT00825175|323624672|FG000|Overall Study|Withdrawal by Subject|0|||
94500410|NCT00825175|323624673|FG001|Overall Study|Withdrawal by Subject|5|||
94500411|NCT02762604|323624674|FG000|Overall Study|Lost to Follow-up|2|||
94500412|NCT02762604|323624675|FG001|Overall Study|Lost to Follow-up|7|||
94500413|NCT02762604|323624674|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
94500414|NCT02762604|323624675|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
94500415|NCT00501085|323624676|FG000|Overall Study|Lost to Follow-up|195|||
94500416|NCT00501085|323624676|FG000|Overall Study|Withdrawal by Subject|34|||
94500417|NCT00501085|323624676|FG000|Overall Study|Subject Decision|1|||
94500418|NCT00501085|323624676|FG000|Overall Study|Revision Surgery|7|||
94500419|NCT00501085|323624676|FG000|Overall Study|Explantation Surgery|26|||
94500420|NCT00501085|323624676|FG000|Overall Study|Adverse Event|4|||
94500421|NCT00501085|323624676|FG000|Overall Study|Non-Compliance|24|||
94500422|NCT00501085|323624676|FG000|Overall Study|Study closed by sponsor|109|||
94500423|NCT00501085|323624676|FG000|Overall Study|Other loss to follow-up|32|||
94500424|NCT00887588|323624677|FG000|Core Period|Death|1|||
94500425|NCT00887588|323624678|FG001|Core Period|Death|1|||
94500426|NCT00887588|323624677|FG000|Core Period|Lost to Follow-up|3|||
94500427|NCT00887588|323624678|FG001|Core Period|Lost to Follow-up|1|||
94500428|NCT00887588|323624677|FG000|Core Period|Withdrawal by Subject|6|||
94500429|NCT00887588|323624678|FG001|Core Period|Withdrawal by Subject|8|||
94500430|NCT00887588|323624677|FG000|Core Period|Adverse Event|9|||
94500431|NCT00887588|323624678|FG001|Core Period|Adverse Event|11|||
94500432|NCT00887588|323624677|FG000|Extension Period|Adverse Event|4|||
94500433|NCT00887588|323624678|FG001|Extension Period|Adverse Event|4|||
94500434|NCT00887588|323624677|FG000|Extension Period|Death|0|||
94500435|NCT00887588|323624678|FG001|Extension Period|Death|1|||
94500436|NCT00887588|323624677|FG000|Extension Period|Protocol deviation|1|||
94500437|NCT00887588|323624678|FG001|Extension Period|Protocol deviation|0|||
94500438|NCT00887588|323624677|FG000|Extension Period|Lost to Follow-up|1|||
94500439|NCT00887588|323624678|FG001|Extension Period|Lost to Follow-up|0|||
94500440|NCT00567112|323624679|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
94500441|NCT00567112|323624680|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
94500442|NCT00567112|323624681|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
94500443|NCT00567112|323624679|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
94500444|NCT00567112|323624680|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
94500445|NCT00567112|323624681|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
94500446|NCT00567112|323624679|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
94500447|NCT00567112|323624680|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
94500448|NCT00567112|323624681|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
94500449|NCT03467945|323624682|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94500450|NCT03467945|323624683|FG001|Treatment Period 2|Withdrawal by Subject|1|||
94500451|NCT03467945|323624684|FG002|Treatment Period 2|Withdrawal by Subject|0|||
94500452|NCT03467945|323624685|FG003|Treatment Period 2|Withdrawal by Subject|0|||
94500453|NCT03467945|323624682|FG000|Treatment Period 3|Withdrawal by Subject|1|||
94500454|NCT03467945|323624683|FG001|Treatment Period 3|Withdrawal by Subject|0|||
94500455|NCT03467945|323624684|FG002|Treatment Period 3|Withdrawal by Subject|2|||
94500456|NCT03467945|323624685|FG003|Treatment Period 3|Withdrawal by Subject|1|||
94500457|NCT01026038|323624686|FG000|Overall Study|Lost to Follow-up|1|||
94500458|NCT01026038|323624687|FG001|Overall Study|Lost to Follow-up|1|||
94500459|NCT01026038|323624688|FG002|Overall Study|Lost to Follow-up|0|||
94500460|NCT00290238|323624689|FG000|Overall Study|Study terminated|27|||
94500461|NCT00290238|323624690|FG001|Overall Study|Study terminated|27|||
94500462|NCT00290238|323624689|FG000|Overall Study|Lost to Follow-up|0|||
94500463|NCT00290238|323624690|FG001|Overall Study|Lost to Follow-up|1|||
94500464|NCT00290238|323624689|FG000|Overall Study|Withdrawal by Subject|15|||
94500465|NCT00290238|323624690|FG001|Overall Study|Withdrawal by Subject|13|||
94500466|NCT01112267|323626207|FG000|Overall Study|Adverse Event|24|||
94500467|NCT01112267|323626208|FG001|Overall Study|Adverse Event|6|||
94500468|NCT01112267|323626207|FG000|Overall Study|Withdrawal by Subject|3|||
94500469|NCT01112267|323626208|FG001|Overall Study|Withdrawal by Subject|5|||
94500470|NCT01112267|323626207|FG000|Overall Study|Protocol Violation|5|||
94500471|NCT01112267|323626208|FG001|Overall Study|Protocol Violation|3|||
94500472|NCT01112267|323626207|FG000|Overall Study|Participants not compliant|1|||
94500473|NCT01112267|323626208|FG001|Overall Study|Participants not compliant|2|||
94500474|NCT01112267|323626207|FG000|Overall Study|Participants not receive any study drug|1|||
94500475|NCT01112267|323626208|FG001|Overall Study|Participants not receive any study drug|2|||
94500476|NCT01565694|323626209|FG000|Dose-Titration Period|Adverse Event|4|||
94500477|NCT01565694|323626209|FG000|Dose-Titration Period|Protocol Violation|10|||
94500478|NCT01565694|323626209|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
94500479|NCT03695094|323626216|FG000|Overall Study|Adverse Event|1|||
94500480|NCT03695094|323626217|FG001|Overall Study|Adverse Event|1|||
94500481|NCT03695094|323626216|FG000|Overall Study|Withdrawal by Subject|1|||
94500482|NCT03695094|323626217|FG001|Overall Study|Withdrawal by Subject|0|||
94500483|NCT01166945|323626218|FG000|Randomized|diagnosed with Group A strep|4|||
94500484|NCT01166945|323626219|FG001|Randomized|diagnosed with Group A strep|4|||
94500485|NCT01166945|323626218|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
94500486|NCT01166945|323626219|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
94500487|NCT01166945|323626218|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
94500488|NCT01166945|323626219|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
94500489|NCT01166945|323626218|FG000|Day 30|Lost to Follow-up|4|||
94500490|NCT01166945|323626219|FG001|Day 30|Lost to Follow-up|3|||
94500491|NCT00864513|323626220|FG000|Overall Study|Withdrawal by Subject|3|||
94500492|NCT03055195|323626221|FG000|Overall Study|Lack of Efficacy|1|||
94500493|NCT03055195|323626222|FG001|Overall Study|Lack of Efficacy|0|||
94500494|NCT03055195|323626221|FG000|Overall Study|Withdrawal by Subject|6|||
94500495|NCT03055195|323626222|FG001|Overall Study|Withdrawal by Subject|7|||
94500496|NCT03055195|323626221|FG000|Overall Study|Study Terminated by Sponsor|2|||
94500497|NCT03055195|323626222|FG001|Overall Study|Study Terminated by Sponsor|6|||
94500498|NCT03055195|323626221|FG000|Overall Study|Protocol Violation|2|||
94500499|NCT03055195|323626222|FG001|Overall Study|Protocol Violation|1|||
94500500|NCT03055195|323626221|FG000|Overall Study|Physician Decision|1|||
94500501|NCT03055195|323626222|FG001|Overall Study|Physician Decision|0|||
94500502|NCT02568423|323626223|FG000|Overall Study|Lost to Follow-up|0|||
94500503|NCT02568423|323626224|FG001|Overall Study|Lost to Follow-up|2|||
94500504|NCT02568423|323626225|FG002|Overall Study|Lost to Follow-up|0|||
94500505|NCT02568423|323626226|FG003|Overall Study|Lost to Follow-up|0|||
94500506|NCT02568423|323626227|FG004|Overall Study|Lost to Follow-up|0|||
94500507|NCT02568423|323626228|FG005|Overall Study|Lost to Follow-up|0|||
94500508|NCT02568423|323626229|FG006|Overall Study|Lost to Follow-up|0|||
94500509|NCT02568423|323626230|FG007|Overall Study|Lost to Follow-up|0|||
94500510|NCT02568423|323626223|FG000|Overall Study|Physician Decision|0|||
94500511|NCT02568423|323626224|FG001|Overall Study|Physician Decision|0|||
94500512|NCT02568423|323626225|FG002|Overall Study|Physician Decision|0|||
94500513|NCT02568423|323626226|FG003|Overall Study|Physician Decision|0|||
94500514|NCT02568423|323626227|FG004|Overall Study|Physician Decision|0|||
94500515|NCT02568423|323626228|FG005|Overall Study|Physician Decision|1|||
94500516|NCT02568423|323626229|FG006|Overall Study|Physician Decision|0|||
94500517|NCT02568423|323626230|FG007|Overall Study|Physician Decision|0|||
94500518|NCT02400580|323626247|FG000|Overall Study|Withdrawal by Subject|1|||
94500519|NCT02400580|323626248|FG001|Overall Study|Withdrawal by Subject|1|||
94500520|NCT02400580|323626247|FG000|Overall Study|Adverse Event|1|||
94500521|NCT02400580|323626248|FG001|Overall Study|Adverse Event|0|||
94500522|NCT01060111|323626249|FG000|Overall Study|Adverse Event|9|||
94500523|NCT01060111|323626250|FG001|Overall Study|Adverse Event|5|||
94500524|NCT01060111|323626251|FG002|Overall Study|Adverse Event|18|||
94500525|NCT01060111|323626249|FG000|Overall Study|Lack of Efficacy|2|||
94500526|NCT01060111|323626250|FG001|Overall Study|Lack of Efficacy|1|||
94500527|NCT01060111|323626251|FG002|Overall Study|Lack of Efficacy|0|||
94500528|NCT01060111|323626249|FG000|Overall Study|Inappropriate participant|5|||
94500529|NCT01060111|323626250|FG001|Overall Study|Inappropriate participant|4|||
94500530|NCT01060111|323626251|FG002|Overall Study|Inappropriate participant|5|||
94500531|NCT01060111|323626249|FG000|Overall Study|Participants' evasion for hospital visit|0|||
94500532|NCT01060111|323626250|FG001|Overall Study|Participants' evasion for hospital visit|3|||
94500533|NCT01060111|323626251|FG002|Overall Study|Participants' evasion for hospital visit|2|||
94500534|NCT01060111|323626249|FG000|Overall Study|Participants' non-cooperation|8|||
94500535|NCT01060111|323626250|FG001|Overall Study|Participants' non-cooperation|6|||
94500536|NCT01060111|323626251|FG002|Overall Study|Participants' non-cooperation|6|||
94500537|NCT01060111|323626249|FG000|Overall Study|Adverse event and insufficient effect|0|||
94500538|NCT01060111|323626250|FG001|Overall Study|Adverse event and insufficient effect|1|||
94500539|NCT01060111|323626251|FG002|Overall Study|Adverse event and insufficient effect|0|||
94500540|NCT01060111|323626249|FG000|Overall Study|Participants' non-cooperation|1|||
94500541|NCT01060111|323626250|FG001|Overall Study|Participants' non-cooperation|0|||
94500542|NCT01060111|323626251|FG002|Overall Study|Participants' non-cooperation|0|||
94500543|NCT01060111|323626249|FG000|Overall Study|Other|2|||
94500544|NCT01060111|323626250|FG001|Overall Study|Other|3|||
94500545|NCT01060111|323626251|FG002|Overall Study|Other|4|||
94500546|NCT01441414|323626252|FG000|Overall Study|Participant died|9|||
94500547|NCT01441414|323626252|FG000|Overall Study|Other reasons|3|||
94500548|NCT01441414|323626252|FG000|Overall Study|Study terminated by sponsor|2|||
94500549|NCT01441414|323626252|FG000|Overall Study|Subject refused further follow-up|1|||
94500550|NCT01336972|323626257|FG000|Overall Study|Adverse Event|1|||
94500551|NCT01336972|323626258|FG001|Overall Study|Adverse Event|1|||
94500552|NCT01336972|323626259|FG002|Overall Study|Adverse Event|0|||
94500553|NCT04233580|323626260|FG000|Overall Study|Adverse Event|3|||
94500554|NCT04233580|323626261|FG001|Overall Study|Adverse Event|3|||
94500555|NCT04233580|323626260|FG000|Overall Study|Withdrawal by Subject|2|||
94500556|NCT04233580|323626261|FG001|Overall Study|Withdrawal by Subject|1|||
94500557|NCT02441114|323626262|FG000|Washout2|Withdrawal by Subject|4|||
94500558|NCT02143778|323626265|FG000|Overall Study|Withdrawal by Subject|2|||
94500559|NCT02143778|323626265|FG000|Overall Study|Device malfunction|1|||
94500560|NCT00378560|323626266|FG000|Overall Study|Adverse Event|1|||
94500561|NCT00378560|323626267|FG001|Overall Study|Adverse Event|0|||
94500562|NCT00378560|323626266|FG000|Overall Study|Lost to Follow-up|24|||
94500563|NCT00378560|323626267|FG001|Overall Study|Lost to Follow-up|29|||
94500564|NCT00378560|323626266|FG000|Overall Study|Protocol Violation|2|||
94500565|NCT00378560|323626267|FG001|Overall Study|Protocol Violation|0|||
94500566|NCT00378560|323626266|FG000|Overall Study|Withdrawal by Subject|17|||
94500567|NCT00378560|323626267|FG001|Overall Study|Withdrawal by Subject|21|||
94500568|NCT00378560|323626266|FG000|Overall Study|Moved|4|||
94500569|NCT00378560|323626267|FG001|Overall Study|Moved|3|||
94500570|NCT00378560|323626266|FG000|Overall Study|Pregnancy|7|||
94500571|NCT00378560|323626267|FG001|Overall Study|Pregnancy|5|||
94500572|NCT00378560|323626266|FG000|Overall Study|Laboratory test values abnormal|1|||
94500573|NCT00378560|323626267|FG001|Overall Study|Laboratory test values abnormal|0|||
94500574|NCT01371565|323626273|FG000|Overall Study|Withdrawal by Subject|1|||
94500575|NCT01371565|323626273|FG000|Overall Study|Death|1|||
94500576|NCT01371565|323626273|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
94500577|NCT00976391|323626274|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
94500578|NCT00976391|323626275|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
94500579|NCT00976391|323626274|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
94500580|NCT00976391|323626275|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
94500581|NCT00976391|323626274|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
94500582|NCT00976391|323626275|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
94500583|NCT00976391|323626274|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
94500584|NCT00976391|323626275|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
94500585|NCT00976391|323626274|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
94500586|NCT00976391|323626275|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
94500587|NCT00976391|323626274|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
94500588|NCT00976391|323626275|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
94500589|NCT00976391|323626274|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
94500590|NCT00976391|323626275|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
94500591|NCT00976391|323626274|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
94500592|NCT00976391|323626275|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
94500593|NCT00976391|323626274|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
94500594|NCT00976391|323626275|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
94500595|NCT00976391|323626274|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
94500596|NCT00976391|323626275|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
94500597|NCT00976391|323626274|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
94500598|NCT00976391|323626275|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
94500599|NCT00976391|323626274|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
94500600|NCT00976391|323626275|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
94500601|NCT00976391|323626274|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
94500602|NCT00976391|323626275|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
94500603|NCT00976391|323626274|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
94500604|NCT00976391|323626275|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
94500605|NCT00617903|323626276|FG000|Overall Study|Withdrawal by Subject|2|||
94500606|NCT00617903|323626277|FG001|Overall Study|Withdrawal by Subject|3|||
94500607|NCT00617903|323626276|FG000|Overall Study|Lost to Follow-up|1|||
94500608|NCT00617903|323626277|FG001|Overall Study|Lost to Follow-up|1|||
94500609|NCT00617903|323626276|FG000|Overall Study|Lack of Efficacy|0|||
94500610|NCT00617903|323626277|FG001|Overall Study|Lack of Efficacy|1|||
94500611|NCT00617903|323626276|FG000|Overall Study|Adverse Event|0|||
94500612|NCT00617903|323626277|FG001|Overall Study|Adverse Event|1|||
94500613|NCT00617903|323626276|FG000|Overall Study|noncompliance|0|||
94500614|NCT00617903|323626277|FG001|Overall Study|noncompliance|1|||
94500615|NCT02217982|323626278|FG000|Overall Study|Trial discontinued|1|||
94500616|NCT02217982|323626279|FG001|Overall Study|Trial discontinued|0|||
94500617|NCT02217982|323626278|FG000|Overall Study|Adverse Event|0|||
94500618|NCT02217982|323626279|FG001|Overall Study|Adverse Event|1|||
94500619|NCT04270760|323626280|FG000|Overall Study|Withdrawal by Subject|0|||
94500620|NCT04270760|323626281|FG001|Overall Study|Withdrawal by Subject|1|||
94500621|NCT04270760|323626282|FG002|Overall Study|Withdrawal by Subject|3|||
94500622|NCT04270760|323626283|FG003|Overall Study|Withdrawal by Subject|0|||
94500623|NCT04270760|323626284|FG004|Overall Study|Withdrawal by Subject|0|||
94500624|NCT04270760|323626280|FG000|Overall Study|Lost to Follow-up|1|||
94500625|NCT04270760|323626281|FG001|Overall Study|Lost to Follow-up|2|||
94500626|NCT04270760|323626282|FG002|Overall Study|Lost to Follow-up|1|||
94500627|NCT04270760|323626283|FG003|Overall Study|Lost to Follow-up|0|||
94500628|NCT04270760|323626284|FG004|Overall Study|Lost to Follow-up|0|||
94500629|NCT04270760|323626280|FG000|Overall Study|Death|0|||
94500630|NCT04270760|323626281|FG001|Overall Study|Death|0|||
94500631|NCT04270760|323626282|FG002|Overall Study|Death|0|||
94500632|NCT04270760|323626283|FG003|Overall Study|Death|0|||
94500633|NCT04270760|323626284|FG004|Overall Study|Death|1|||
94500634|NCT03188705|323626285|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
94500635|NCT03188705|323626285|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
94500636|NCT01011283|323626294|FG000|Overall Study|Adverse Event|4|||
94500637|NCT01011283|323626295|FG001|Overall Study|Adverse Event|2|||
94500638|NCT01011283|323626294|FG000|Overall Study|Progressive Disease|0|||
94500639|NCT01011283|323626295|FG001|Overall Study|Progressive Disease|2|||
94500640|NCT01011283|323626294|FG000|Overall Study|Terminated by Sponsor|5|||
94500641|NCT01011283|323626295|FG001|Overall Study|Terminated by Sponsor|5|||
94500642|NCT01011283|323626294|FG000|Overall Study|Other|2|||
94500643|NCT01011283|323626295|FG001|Overall Study|Other|2|||
94500644|NCT01717859|323626296|FG000|Overall Study|Adverse Event|5|||
94500645|NCT01717859|323626296|FG000|Overall Study|Moved out of state|1|||
94500646|NCT01717859|323626296|FG000|Overall Study|Patient concerned about mental health|1|||
94500647|NCT01717859|323626296|FG000|Overall Study|Lost to Follow-up|1|||
94500648|NCT01717859|323626296|FG000|Overall Study|Withdrawal by Subject|2|||
94500649|NCT01111292|323626298|FG000|Treatment|Physician Decision|1|||
94500650|NCT01111292|323626299|FG001|Treatment|Physician Decision|1|||
94500651|NCT05987540|323626300|FG000|Overall Study|Withdrawal by Subject|2|||
94500652|NCT05987540|323626300|FG000|Overall Study|Death|1|||
94500653|NCT05987540|323626300|FG000|Overall Study|Study Termination|1|||
94500654|NCT05987540|323626300|FG000|Overall Study|Adverse Event|2|||
94500655|NCT03158688|323626301|FG000|Overall Study|Withdrawal by Subject|14|||
94500656|NCT03158688|323626302|FG001|Overall Study|Withdrawal by Subject|28|||
94500657|NCT03158688|323626301|FG000|Overall Study|Decision by sponsor|13|||
94500658|NCT03158688|323626302|FG001|Overall Study|Decision by sponsor|37|||
94500659|NCT03158688|323626301|FG000|Overall Study|Lost to Follow-up|4|||
94500660|NCT03158688|323626302|FG001|Overall Study|Lost to Follow-up|3|||
94500661|NCT03158688|323626301|FG000|Overall Study|Death|74|||
94500662|NCT03158688|323626302|FG001|Overall Study|Death|142|||
94500663|NCT01290731|323626306|FG000|Overall Study|Withdrawal by Subject|1|||
94500664|NCT02280499|323626309|FG000|Overall Study|Death|14|||
94500665|NCT02280499|323626309|FG000|Overall Study|Lost to Follow-up|42|||
94500666|NCT02280499|323626309|FG000|Overall Study|Adverse Event|5|||
94500667|NCT00309244|323626316|FG000|Overall Study|Adverse Event|29|||
94500668|NCT00309244|323626317|FG001|Overall Study|Adverse Event|12|||
94500669|NCT00309244|323626316|FG000|Overall Study|Lost to Follow-up|6|||
94500670|NCT00309244|323626317|FG001|Overall Study|Lost to Follow-up|22|||
94500671|NCT00309244|323626316|FG000|Overall Study|Physician Decision|5|||
94500672|NCT00309244|323626317|FG001|Overall Study|Physician Decision|8|||
94500673|NCT00309244|323626316|FG000|Overall Study|Protocol Violation|6|||
94500674|NCT00309244|323626317|FG001|Overall Study|Protocol Violation|3|||
94500675|NCT00309244|323626316|FG000|Overall Study|Withdrawal by Subject|50|||
94500676|NCT00309244|323626317|FG001|Overall Study|Withdrawal by Subject|32|||
94500677|NCT00309244|323626316|FG000|Overall Study|Various|7|||
94500678|NCT00309244|323626317|FG001|Overall Study|Various|7|||
94500679|NCT00309244|323626316|FG000|Overall Study|Randomized but not dosed|11|||
94500680|NCT00309244|323626317|FG001|Overall Study|Randomized but not dosed|12|||
94500681|NCT00309244|323626316|FG000|Overall Study|Death|4|||
94500682|NCT00309244|323626317|FG001|Overall Study|Death|1|||
94500683|NCT02958527|323626318|FG000|Overall Study|Not collected CRFs|12|||
94500684|NCT02366130|323626319|FG000|Overall Study|Withdrawal by Subject|3|||
94500685|NCT02366130|323626319|FG000|Overall Study|Ineligible|6|||
94500686|NCT02945046|323626320|FG000|Overall Study|Adverse Event|1|||
94500687|NCT02945046|323626321|FG001|Overall Study|Adverse Event|0|||
94500688|NCT02945046|323626322|FG002|Overall Study|Adverse Event|2|||
94500689|NCT02945046|323626320|FG000|Overall Study|Withdrawal by Subject|3|||
94500690|NCT02945046|323626321|FG001|Overall Study|Withdrawal by Subject|3|||
94500691|NCT02945046|323626322|FG002|Overall Study|Withdrawal by Subject|3|||
94500692|NCT02945046|323626320|FG000|Overall Study|Protocol Violation|2|||
94500693|NCT02945046|323626321|FG001|Overall Study|Protocol Violation|3|||
94500694|NCT02945046|323626322|FG002|Overall Study|Protocol Violation|2|||
94500695|NCT02945046|323626320|FG000|Overall Study|Lost to Follow-up|1|||
94500696|NCT02945046|323626321|FG001|Overall Study|Lost to Follow-up|1|||
94500697|NCT02945046|323626322|FG002|Overall Study|Lost to Follow-up|0|||
94500698|NCT02945046|323626320|FG000|Overall Study|Lack of Efficacy|1|||
94500699|NCT02945046|323626321|FG001|Overall Study|Lack of Efficacy|2|||
94500700|NCT02945046|323626322|FG002|Overall Study|Lack of Efficacy|1|||
94500701|NCT02945046|323626320|FG000|Overall Study|Other than specified|5|||
94500702|NCT02945046|323626321|FG001|Overall Study|Other than specified|4|||
94500703|NCT02945046|323626322|FG002|Overall Study|Other than specified|7|||
94500704|NCT03113136|323626325|FG000|Overall Study|Lost to Follow-up|22|||
94500705|NCT03113136|323626326|FG001|Overall Study|Lost to Follow-up|47|||
94500706|NCT03113136|323626327|FG002|Overall Study|Lost to Follow-up|54|||
94500707|NCT03113136|323626325|FG000|Overall Study|Withdrawal by Subject|4|||
94500708|NCT03113136|323626326|FG001|Overall Study|Withdrawal by Subject|13|||
94500709|NCT03113136|323626327|FG002|Overall Study|Withdrawal by Subject|14|||
94500710|NCT03113136|323626325|FG000|Overall Study|Ineligible|0|||
94500711|NCT03113136|323626326|FG001|Overall Study|Ineligible|2|||
94500712|NCT03113136|323626327|FG002|Overall Study|Ineligible|1|||
94500713|NCT03113136|323626325|FG000|Overall Study|Study Team Decision|1|||
94500714|NCT03113136|323626326|FG001|Overall Study|Study Team Decision|4|||
94500715|NCT03113136|323626327|FG002|Overall Study|Study Team Decision|0|||
94500716|NCT00545948|323626329|FG000|Overall Study|Not Treated|1|||
94500717|NCT00545948|323626330|FG001|Overall Study|Not Treated|1|||
94500718|NCT00545948|323626331|FG002|Overall Study|Not Treated|7|||
94500719|NCT03336866|323626336|FG000|Overall Study|Lost to Follow-up|2|||
94500720|NCT03336866|323626337|FG001|Overall Study|Lost to Follow-up|0|||
94500721|NCT03336866|323626338|FG002|Overall Study|Lost to Follow-up|3|||
94500722|NCT03336866|323626336|FG000|Overall Study|Withdrawal by Subject|1|||
94500723|NCT03336866|323626337|FG001|Overall Study|Withdrawal by Subject|1|||
94500724|NCT03336866|323626338|FG002|Overall Study|Withdrawal by Subject|0|||
94500725|NCT03336866|323626336|FG000|Overall Study|Noncompliance with clinic house rules|0|||
94500726|NCT03336866|323626337|FG001|Overall Study|Noncompliance with clinic house rules|0|||
94500727|NCT03336866|323626338|FG002|Overall Study|Noncompliance with clinic house rules|1|||
94500728|NCT01666314|323626339|FG000|Overall Study|Adverse Event|3|||
94500729|NCT01666314|323626340|FG001|Overall Study|Adverse Event|13|||
94500730|NCT01666314|323626341|FG002|Overall Study|Adverse Event|7|||
94500731|NCT01666314|323626342|FG003|Overall Study|Adverse Event|7|||
94500732|NCT01666314|323626339|FG000|Overall Study|Progressive Disease|11|||
94500733|NCT01666314|323626340|FG001|Overall Study|Progressive Disease|9|||
94500734|NCT01666314|323626341|FG002|Overall Study|Progressive Disease|19|||
94500735|NCT01666314|323626342|FG003|Overall Study|Progressive Disease|20|||
94500736|NCT01666314|323626339|FG000|Overall Study|Symptomatic Deterioration|1|||
94500737|NCT01666314|323626340|FG001|Overall Study|Symptomatic Deterioration|0|||
94500738|NCT01666314|323626341|FG002|Overall Study|Symptomatic Deterioration|2|||
94500739|NCT01666314|323626342|FG003|Overall Study|Symptomatic Deterioration|0|||
94500740|NCT01666314|323626339|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
94500741|NCT01666314|323626340|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
94500742|NCT01666314|323626341|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
94500743|NCT01666314|323626342|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
94500744|NCT01666314|323626339|FG000|Overall Study|Withdrawal by Subject|1|||
94500745|NCT01666314|323626340|FG001|Overall Study|Withdrawal by Subject|1|||
94500746|NCT01666314|323626341|FG002|Overall Study|Withdrawal by Subject|2|||
94500747|NCT01666314|323626342|FG003|Overall Study|Withdrawal by Subject|3|||
94500748|NCT01666314|323626339|FG000|Overall Study|Reason not Specified|10|||
94500749|NCT01666314|323626340|FG001|Overall Study|Reason not Specified|7|||
94500750|NCT01666314|323626341|FG002|Overall Study|Reason not Specified|5|||
94500751|NCT01666314|323626342|FG003|Overall Study|Reason not Specified|5|||
94500752|NCT01945242|323626343|FG000|Overall Study|Physician Decision|3|||
94500753|NCT01945242|323626344|FG001|Overall Study|Physician Decision|3|||
94500754|NCT04913675|323626345|FG000|Main Study (Up to Week 36)|Death|0|||
94500755|NCT04913675|323626346|FG001|Main Study (Up to Week 36)|Death|2|||
94500756|NCT04913675|323626347|FG002|Main Study (Up to Week 36)|Death|2|||
94500757|NCT04913675|323626348|FG003|Main Study (Up to Week 36)|Death|0|||
94500758|NCT04913675|323626345|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
94500759|NCT04913675|323626346|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
94500760|NCT04913675|323626347|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
94500761|NCT04913675|323626348|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
94500762|NCT04913675|323626345|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
94500763|NCT04913675|323626346|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
94500764|NCT04913675|323626347|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
94500765|NCT04913675|323626348|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
94500766|NCT04913675|323626345|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
94500767|NCT04913675|323626346|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
94500768|NCT04913675|323626347|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
94500769|NCT04913675|323626348|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
94500770|NCT04913675|323626345|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
94500771|NCT04913675|323626346|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
94500772|NCT04913675|323626347|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
94500773|NCT04913675|323626348|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
94500774|NCT02657551|323626349|FG000|Overall Study|Adverse Event|2|||
94500775|NCT02657551|323626349|FG000|Overall Study|Withdrawal by Subject|1|||
94500776|NCT02657551|323626349|FG000|Overall Study|Non-Compliance|1|||
94500777|NCT02657551|323626349|FG000|Overall Study|Progression / Relapse|4|||
94500778|NCT02975700|323626350|FG000|Overall Study|Adverse Event|1|||
94500779|NCT02975700|323626350|FG000|Overall Study|Progressive disease|3|||
94500780|NCT02975700|323626350|FG000|Overall Study|Failed screening criteria|2|||
94500781|NCT03462563|323626352|FG000|Overall Study|Death|1|||
94500782|NCT03462563|323626353|FG001|Overall Study|Death|1|||
94500783|NCT03462563|323626352|FG000|Overall Study|Termination of study|2|||
94500784|NCT03462563|323626353|FG001|Overall Study|Termination of study|1|||
94500785|NCT03462563|323626352|FG000|Overall Study|Adverse Event|1|||
94500786|NCT03462563|323626353|FG001|Overall Study|Adverse Event|3|||
94500787|NCT03462563|323626352|FG000|Overall Study|Unspecified reason|10|||
94500788|NCT03462563|323626353|FG001|Overall Study|Unspecified reason|12|||
94500789|NCT03462563|323626352|FG000|Overall Study|Physician Decision|1|||
94500790|NCT03462563|323626353|FG001|Overall Study|Physician Decision|0|||
94500791|NCT05737745|323626354|FG000|Overall Study|Withdrawal by Subject|0|||
94500792|NCT05737745|323626355|FG001|Overall Study|Withdrawal by Subject|6|||
94500793|NCT05737745|323626356|FG002|Overall Study|Withdrawal by Subject|1|||
94500794|NCT03228537|323626357|FG000|Neoadjuvant|Adverse Event|2|||
94500795|NCT03228537|323626357|FG000|Neoadjuvant|Progression/Relapse|4|||
94500796|NCT03228537|323626357|FG000|Neoadjuvant|Death|1|||
94500797|NCT03228537|323626357|FG000|Surgery|Death|1|||
94500798|NCT03228537|323626357|FG000|Surgery|Other - Not Protocol Specified|2|||
94500799|NCT03228537|323626357|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
94500800|NCT03228537|323626357|FG000|Maintenance|Progression/Relapse|10|||
94500801|NCT02021318|323626358|FG000|Overall Study|Adverse Event|2|||
94500802|NCT02021318|323626359|FG001|Overall Study|Adverse Event|1|||
94500803|NCT02021318|323626358|FG000|Overall Study|Death|33|||
94500804|NCT02021318|323626359|FG001|Overall Study|Death|34|||
94500805|NCT02021318|323626358|FG000|Overall Study|Lost to Follow-up|3|||
94500806|NCT02021318|323626359|FG001|Overall Study|Lost to Follow-up|3|||
94500807|NCT02021318|323626358|FG000|Overall Study|Progressive Disease|0|||
94500808|NCT02021318|323626359|FG001|Overall Study|Progressive Disease|1|||
94500809|NCT02021318|323626358|FG000|Overall Study|Withdrawal by Subject|30|||
94500810|NCT02021318|323626359|FG001|Overall Study|Withdrawal by Subject|18|||
94500811|NCT02021318|323626358|FG000|Overall Study|Physician Decision|3|||
94500812|NCT02021318|323626359|FG001|Overall Study|Physician Decision|3|||
94500813|NCT02021318|323626358|FG000|Overall Study|Miscellaneous|2|||
94500814|NCT02021318|323626359|FG001|Overall Study|Miscellaneous|3|||
94500815|NCT00689052|323626360|FG000|Overall Study|Adverse Event|4|||
94500816|NCT00689052|323626361|FG001|Overall Study|Adverse Event|6|||
94500817|NCT00689052|323626360|FG000|Overall Study|Protocol Violation|1|||
94500818|NCT00689052|323626361|FG001|Overall Study|Protocol Violation|0|||
94500819|NCT00689052|323626360|FG000|Overall Study|Lost to Follow-up|2|||
94500820|NCT00689052|323626361|FG001|Overall Study|Lost to Follow-up|0|||
94500821|NCT00689052|323626360|FG000|Overall Study|Withdrawal by Subject|2|||
94500822|NCT00689052|323626361|FG001|Overall Study|Withdrawal by Subject|0|||
94500823|NCT00689052|323626360|FG000|Overall Study|Early termination of the trial|22|||
94500824|NCT00689052|323626361|FG001|Overall Study|Early termination of the trial|24|||
94500825|NCT02569242|323626362|FG000|Overall Study|Death|1|||
94500826|NCT02569242|323626363|FG001|Overall Study|Death|0|||
94500827|NCT02569242|323626362|FG000|Overall Study|Withdrawal by Subject|0|||
94500828|NCT02569242|323626363|FG001|Overall Study|Withdrawal by Subject|1|||
94500829|NCT03651336|323626364|FG000|Overall Study|Withdrawal by Subject|4|||
94500830|NCT01341990|323626365|FG000|Overall Study|Adverse Event|0|||
94500831|NCT01341990|323626366|FG001|Overall Study|Adverse Event|1|||
94500832|NCT01341990|323626365|FG000|Overall Study|Torn Study Lens|1|||
94500833|NCT01341990|323626366|FG001|Overall Study|Torn Study Lens|0|||
94500834|NCT01341990|323626365|FG000|Overall Study|Withdrawal by Subject|2|||
94500835|NCT01341990|323626366|FG001|Overall Study|Withdrawal by Subject|0|||
94500836|NCT01567085|323627757|FG000|Overall Study|Death|6|||
94500837|NCT01567085|323627757|FG000|Overall Study|Adverse Event|6|||
94500838|NCT01567085|323627757|FG000|Overall Study|Lost to Follow-up|3|||
94500839|NCT01567085|323627757|FG000|Overall Study|Graft loss|2|||
94500840|NCT01567085|323627757|FG000|Overall Study|Renal transplantectomy|1|||
94500841|NCT01567085|323627757|FG000|Overall Study|Returned to chronic dialysis|1|||
94500842|NCT01567085|323627757|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
94500843|NCT04289298|323627758|FG000|Overall Study|Lost to Follow-up|5|||
94500844|NCT04289298|323627759|FG001|Overall Study|Lost to Follow-up|0|||
94500845|NCT04289298|323627758|FG000|Overall Study|Withdrawal by Subject|2|||
94500846|NCT04289298|323627759|FG001|Overall Study|Withdrawal by Subject|0|||
94500847|NCT01797185|323627760|FG000|Overall Study|Adverse Event|5|||
94500848|NCT01797185|323627761|FG001|Overall Study|Adverse Event|15|||
94500849|NCT01797185|323627762|FG002|Overall Study|Adverse Event|6|||
94500850|NCT01797185|323627760|FG000|Overall Study|Withdrawal by Subject|6|||
94500851|NCT01797185|323627761|FG001|Overall Study|Withdrawal by Subject|9|||
94500852|NCT01797185|323627762|FG002|Overall Study|Withdrawal by Subject|5|||
94500853|NCT01797185|323627760|FG000|Overall Study|Site terminated|8|||
94500854|NCT01797185|323627761|FG001|Overall Study|Site terminated|4|||
94500855|NCT01797185|323627762|FG002|Overall Study|Site terminated|0|||
94500856|NCT01797185|323627760|FG000|Overall Study|Lost to Follow-up|2|||
94500857|NCT01797185|323627761|FG001|Overall Study|Lost to Follow-up|6|||
94500858|NCT01797185|323627762|FG002|Overall Study|Lost to Follow-up|1|||
94500859|NCT01797185|323627760|FG000|Overall Study|Withdrawn per sponsor|5|||
94500860|NCT01797185|323627761|FG001|Overall Study|Withdrawn per sponsor|0|||
94500861|NCT01797185|323627762|FG002|Overall Study|Withdrawn per sponsor|0|||
94500862|NCT01797185|323627760|FG000|Overall Study|Physician Decision|1|||
94500863|NCT01797185|323627761|FG001|Overall Study|Physician Decision|3|||
94500864|NCT01797185|323627762|FG002|Overall Study|Physician Decision|0|||
94500865|NCT01797185|323627760|FG000|Overall Study|Protocol Violation|1|||
94500866|NCT01797185|323627761|FG001|Overall Study|Protocol Violation|1|||
94500867|NCT01797185|323627762|FG002|Overall Study|Protocol Violation|0|||
94500868|NCT01778985|323627763|FG000|Overall Study|Lost to Follow-up|1|||
94500869|NCT01778985|323627764|FG001|Overall Study|Lost to Follow-up|0|||
94500870|NCT01778985|323627763|FG000|Overall Study|Physician Decision|2|||
94500871|NCT01778985|323627764|FG001|Overall Study|Physician Decision|2|||
94500872|NCT01778985|323627763|FG000|Overall Study|Protocol Violation|4|||
94500873|NCT01778985|323627764|FG001|Overall Study|Protocol Violation|1|||
94500874|NCT00723944|323627765|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
94500875|NCT00723944|323627766|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
94500876|NCT00723944|323627765|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
94500877|NCT00723944|323627766|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
94500878|NCT00723944|323627765|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
94500879|NCT00723944|323627766|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
94500880|NCT00266812|323627770|FG000|Overall Study|Disease Progression|9|||
94500881|NCT00266812|323627771|FG001|Overall Study|Disease Progression|3|||
94500882|NCT00266812|323627770|FG000|Overall Study|Death|5|||
94500883|NCT00266812|323627771|FG001|Overall Study|Death|4|||
94500884|NCT00266812|323627770|FG000|Overall Study|Adverse Event|3|||
94500885|NCT00266812|323627771|FG001|Overall Study|Adverse Event|1|||
94500886|NCT00266812|323627770|FG000|Overall Study|Protocol Violation|0|||
94500887|NCT00266812|323627771|FG001|Overall Study|Protocol Violation|1|||
94500888|NCT00266812|323627770|FG000|Overall Study|Withdrawal by Subject|0|||
94500889|NCT00266812|323627771|FG001|Overall Study|Withdrawal by Subject|2|||
94500890|NCT00266812|323627770|FG000|Overall Study|Discontinued before starting study drug|4|||
94500891|NCT00266812|323627771|FG001|Overall Study|Discontinued before starting study drug|0|||
94500892|NCT01129284|323627779|FG000|Overall Study|Adverse Event|2|||
94500893|NCT01129284|323627780|FG001|Overall Study|Adverse Event|0|||
94500894|NCT01129284|323627781|FG002|Overall Study|Adverse Event|1|||
94500895|NCT00784927|323627785|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
94500896|NCT00784927|323627785|FG000|Overall Study|Protocol Violation|1|||
94500897|NCT00784927|323627785|FG000|Overall Study|Ineligible|1|||
94500898|NCT00422461|323627789|FG000|Overall Study|Adverse Event|1|||
94500899|NCT00422461|323627790|FG001|Overall Study|Adverse Event|2|||
94500900|NCT00422461|323627791|FG002|Overall Study|Adverse Event|1|||
94500901|NCT00422461|323627792|FG003|Overall Study|Adverse Event|1|||
94500902|NCT00422461|323627789|FG000|Overall Study|Other|0|||
94500903|NCT00422461|323627790|FG001|Overall Study|Other|0|||
94500904|NCT00422461|323627791|FG002|Overall Study|Other|0|||
94500905|NCT00422461|323627792|FG003|Overall Study|Other|2|||
94500906|NCT00422461|323627789|FG000|Overall Study|Participants no longer willing to participate in study|1|||
94500907|NCT00422461|323627790|FG001|Overall Study|Participants no longer willing to participate in study|0|||
94500908|NCT00422461|323627791|FG002|Overall Study|Participants no longer willing to participate in study|0|||
94500909|NCT00422461|323627792|FG003|Overall Study|Participants no longer willing to participate in study|0|||
94500910|NCT00422461|323627789|FG000|Overall Study|Randomized but not treated|1|||
94500911|NCT00422461|323627790|FG001|Overall Study|Randomized but not treated|1|||
94500912|NCT00422461|323627791|FG002|Overall Study|Randomized but not treated|0|||
94500913|NCT00422461|323627792|FG003|Overall Study|Randomized but not treated|0|||
94500914|NCT01471574|323627795|FG000|Treatment Period|Lack of Efficacy|12|||
94500915|NCT01471574|323627796|FG001|Treatment Period|Lack of Efficacy|4|||
94500916|NCT01471574|323627797|FG002|Treatment Period|Lack of Efficacy|14|||
94500917|NCT01471574|323627798|FG003|Treatment Period|Lack of Efficacy|1|||
94500918|NCT01471574|323627795|FG000|Treatment Period|Adverse Event|7|||
94500919|NCT01471574|323627796|FG001|Treatment Period|Adverse Event|3|||
94500920|NCT01471574|323627797|FG002|Treatment Period|Adverse Event|6|||
94500921|NCT01471574|323627798|FG003|Treatment Period|Adverse Event|1|||
94500922|NCT01471574|323627795|FG000|Treatment Period|Withdrawal by Subject|5|||
94500923|NCT01471574|323627796|FG001|Treatment Period|Withdrawal by Subject|1|||
94500924|NCT01471574|323627797|FG002|Treatment Period|Withdrawal by Subject|1|||
94500925|NCT01471574|323627798|FG003|Treatment Period|Withdrawal by Subject|0|||
94500926|NCT01471574|323627795|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
94500927|NCT01471574|323627796|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
94500928|NCT01471574|323627797|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
94500929|NCT01471574|323627798|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
94500930|NCT01471574|323627795|FG000|Treatment Period|Lost to Follow-up|1|||
94500931|NCT01471574|323627796|FG001|Treatment Period|Lost to Follow-up|2|||
94500932|NCT01471574|323627797|FG002|Treatment Period|Lost to Follow-up|2|||
94500933|NCT01471574|323627798|FG003|Treatment Period|Lost to Follow-up|0|||
94500934|NCT01471574|323627795|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
94500935|NCT01471574|323627796|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
94500936|NCT01471574|323627797|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
94500937|NCT01471574|323627798|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
94500938|NCT01471574|323627795|FG000|Treatment Period|Other|1|||
94500939|NCT01471574|323627796|FG001|Treatment Period|Other|0|||
94500940|NCT01471574|323627797|FG002|Treatment Period|Other|0|||
94500941|NCT01471574|323627798|FG003|Treatment Period|Other|0|||
94500942|NCT01471574|323627795|FG000|Follow-up Period|Withdrawal by Subject|3|||
94500943|NCT01471574|323627796|FG001|Follow-up Period|Withdrawal by Subject|0|||
94500944|NCT01471574|323627797|FG002|Follow-up Period|Withdrawal by Subject|3|||
94500945|NCT01471574|323627798|FG003|Follow-up Period|Withdrawal by Subject|1|||
94500946|NCT01471574|323627795|FG000|Follow-up Period|Lost to Follow-up|4|||
94500947|NCT01471574|323627796|FG001|Follow-up Period|Lost to Follow-up|1|||
94500948|NCT01471574|323627797|FG002|Follow-up Period|Lost to Follow-up|3|||
94500949|NCT01471574|323627798|FG003|Follow-up Period|Lost to Follow-up|2|||
94500950|NCT01471574|323627795|FG000|Follow-up Period|Death|0|||
94500951|NCT01471574|323627796|FG001|Follow-up Period|Death|0|||
94500952|NCT01471574|323627797|FG002|Follow-up Period|Death|1|||
94500953|NCT01471574|323627798|FG003|Follow-up Period|Death|0|||
94500954|NCT01471574|323627795|FG000|Follow-up Period|Follow-up no longer required|0|||
94500955|NCT01471574|323627796|FG001|Follow-up Period|Follow-up no longer required|1|||
94500956|NCT01471574|323627797|FG002|Follow-up Period|Follow-up no longer required|0|||
94500957|NCT01471574|323627798|FG003|Follow-up Period|Follow-up no longer required|0|||
94500958|NCT04027946|323627799|FG000|Overall Study|Screen failures|3|||
94500959|NCT01028053|323627800|FG000|Overall Study|Screen Failure|113|||
94500960|NCT01028053|323627800|FG000|Overall Study|Patient Request|11|||
94500961|NCT01028053|323627800|FG000|Overall Study|Protocol Violation|1|||
94500962|NCT01028053|323627800|FG000|Overall Study|Physician Decision|2|||
94500963|NCT01028053|323627800|FG000|Overall Study|Technical Problem|1|||
94500964|NCT01028053|323627800|FG000|Overall Study|Terminated by Sponsor|1|||
94500965|NCT01028053|323627800|FG000|Overall Study|Various reasons|4|||
94500966|NCT03315689|323627801|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
94500967|NCT03315689|323627802|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
94500968|NCT03315689|323627801|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
94500969|NCT03315689|323627802|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
94500970|NCT03315689|323627801|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
94500971|NCT03315689|323627802|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
94500972|NCT00983957|323627805|FG000|Overall Study|Adverse Event|1|||
94500973|NCT00983957|323627805|FG000|Overall Study|Personal Reasons|1|||
94500974|NCT01829165|323627810|FG000|Overall Study|Did not complete intervention|2|||
94500975|NCT01829165|323627811|FG001|Overall Study|Did not complete intervention|0|||
94500976|NCT00574951|323627812|FG000|Overall Study|Ineligible - improper prior treatment|1|||
94500977|NCT00103506|323627813|FG000|Overall Study|Study closed by sponsor|34|||
94500978|NCT00103506|323627814|FG001|Overall Study|Study closed by sponsor|37|||
94500979|NCT00103506|323627813|FG000|Overall Study|Death|257|||
94500980|NCT00103506|323627814|FG001|Overall Study|Death|253|||
94500981|NCT00103506|323627813|FG000|Overall Study|Lost to Follow-up|13|||
94500982|NCT00103506|323627814|FG001|Overall Study|Lost to Follow-up|13|||
94500983|NCT00103506|323627813|FG000|Overall Study|Withdrawal by Subject|18|||
94500984|NCT00103506|323627814|FG001|Overall Study|Withdrawal by Subject|21|||
94500985|NCT00585169|323627815|FG000|Overall Study|Withdrawal by Subject|1|||
94500986|NCT00965094|323627833|FG000|Overall Study|Adverse Event|5|||
94500987|NCT00965094|323627834|FG001|Overall Study|Adverse Event|0|||
94500988|NCT00965094|323627833|FG000|Overall Study|Lost to Follow-up|0|||
94500989|NCT00965094|323627834|FG001|Overall Study|Lost to Follow-up|1|||
94500990|NCT02609633|323627838|FG000|Overall Study|Consent Withdrawn|0|||
94500991|NCT02609633|323627839|FG001|Overall Study|Consent Withdrawn|1|||
94500992|NCT02609633|323627838|FG000|Overall Study|Protocol Deviation|1|||
94500993|NCT02609633|323627839|FG001|Overall Study|Protocol Deviation|0|||
94500994|NCT02609633|323627838|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
94500995|NCT02609633|323627839|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
94500996|NCT02609633|323627838|FG000|Overall Study|Reason not Specified|2|||
94500997|NCT02609633|323627839|FG001|Overall Study|Reason not Specified|1|||
94500998|NCT01174459|323627847|FG000|Overall Study|case report form (CRF) not collected|5|||
94500999|NCT01058005|323627848|FG000|Overall Study|Adverse Event|0|||
94501000|NCT01058005|323627849|FG001|Overall Study|Adverse Event|2|||
94501001|NCT01058005|323627850|FG002|Overall Study|Adverse Event|1|||
94501002|NCT01058005|323627848|FG000|Overall Study|Physician Decision|2|||
94501003|NCT01058005|323627849|FG001|Overall Study|Physician Decision|2|||
94501004|NCT01058005|323627850|FG002|Overall Study|Physician Decision|0|||
94501005|NCT01058005|323627848|FG000|Overall Study|Withdrawal by Subject|4|||
94501006|NCT01058005|323627849|FG001|Overall Study|Withdrawal by Subject|5|||
94501007|NCT01058005|323627850|FG002|Overall Study|Withdrawal by Subject|11|||
94501008|NCT01058005|323627848|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
94501009|NCT01058005|323627849|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
94501010|NCT01058005|323627850|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
94501011|NCT01058005|323627848|FG000|Overall Study|Reason Missing|5|||
94501012|NCT01058005|323627849|FG001|Overall Study|Reason Missing|3|||
94501013|NCT01058005|323627850|FG002|Overall Study|Reason Missing|1|||
94501014|NCT01145222|323627851|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
94501015|NCT01145222|323627852|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
94501016|NCT01145222|323627853|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
94501017|NCT01145222|323627854|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
94501018|NCT01145222|323627851|FG000|Overall Study|Poor bowel preparation|0|||
94501019|NCT01145222|323627852|FG001|Overall Study|Poor bowel preparation|0|||
94501020|NCT01145222|323627853|FG002|Overall Study|Poor bowel preparation|0|||
94501021|NCT01145222|323627854|FG003|Overall Study|Poor bowel preparation|1|||
94501022|NCT01698008|323627855|FG000|Overall Study|Withdrawal by Subject|1|||
94501023|NCT01698008|323627856|FG001|Overall Study|Withdrawal by Subject|2|||
94501024|NCT01623752|323627858|FG000|Phase 1 (78 Weeks)|No Data|249|||
94501025|NCT01623752|323627859|FG001|Phase 1 (78 Weeks)|No Data|66|||
94501026|NCT01623752|323627860|FG002|Phase 1 (78 Weeks)|No Data|2|||
94501027|NCT01623752|323627858|FG000|Phase 1 (78 Weeks)|Other|33|||
94501028|NCT01623752|323627859|FG001|Phase 1 (78 Weeks)|Other|20|||
94501029|NCT01623752|323627860|FG002|Phase 1 (78 Weeks)|Other|0|||
94501030|NCT01623752|323627858|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
94501031|NCT01623752|323627859|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
94501032|NCT01623752|323627860|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
94501033|NCT01623752|323627858|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
94501034|NCT01623752|323627859|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
94501035|NCT01623752|323627860|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
94501036|NCT01623752|323627858|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
94501037|NCT01623752|323627859|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
94501038|NCT01623752|323627860|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
94501039|NCT01623752|323627858|FG000|Phase 2 (78 Weeks)|Other|5|||
94501040|NCT01623752|323627859|FG001|Phase 2 (78 Weeks)|Other|1|||
94501041|NCT01623752|323627860|FG002|Phase 2 (78 Weeks)|Other|0|||
94501042|NCT01623752|323627858|FG000|Phase 2 (78 Weeks)|No Data|43|||
94501043|NCT01623752|323627859|FG001|Phase 2 (78 Weeks)|No Data|11|||
94501044|NCT01623752|323627860|FG002|Phase 2 (78 Weeks)|No Data|0|||
94501045|NCT01623752|323627858|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
94501046|NCT01623752|323627859|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
94501047|NCT01623752|323627860|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
94501048|NCT04053452|323627861|FG000|Overall Study|Withdrawal by Subject|1|||
94501049|NCT04053452|323627862|FG001|Overall Study|Withdrawal by Subject|0|||
94501050|NCT04053452|323627861|FG000|Overall Study|Time restraint due to inpatient needs|1|||
94501051|NCT04053452|323627862|FG001|Overall Study|Time restraint due to inpatient needs|2|||
94501052|NCT01750281|323627863|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
94501053|NCT01750281|323627864|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
94501054|NCT01750281|323627865|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
94501055|NCT01750281|323627863|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
94501056|NCT01750281|323627864|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
94501057|NCT01750281|323627865|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
94501058|NCT01750281|323627863|FG000|Overall Study|Did not receive treatment|0|||
94501059|NCT01750281|323627864|FG001|Overall Study|Did not receive treatment|1|||
94501060|NCT01750281|323627865|FG002|Overall Study|Did not receive treatment|0|||
94501061|NCT02959892|323627866|FG000|Overall Study|PET tracer synthesis failure|1|||
94501062|NCT02959892|323627867|FG001|Overall Study|PET tracer synthesis failure|0|||
94501063|NCT02959892|323627866|FG000|Overall Study|Study termination|0|||
94501064|NCT02959892|323627867|FG001|Overall Study|Study termination|1|||
94501065|NCT05463705|323627868|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
94501066|NCT05463705|323627869|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
94501067|NCT05463705|323627870|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
94501068|NCT05463705|323627871|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
94501069|NCT05463705|323627872|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
94501070|NCT05463705|323627873|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
94501071|NCT00799864|323627874|FG000|Overall Study|Participant reached a virologic endpoint|9|||
94501072|NCT00799864|323627875|FG001|Overall Study|Participant reached a virologic endpoint|2|||
94501073|NCT00799864|323627876|FG002|Overall Study|Participant reached a virologic endpoint|2|||
94501074|NCT00799864|323627877|FG003|Overall Study|Participant reached a virologic endpoint|0|||
94501075|NCT00799864|323627878|FG004|Overall Study|Participant reached a virologic endpoint|0|||
94501076|NCT00799864|323627874|FG000|Overall Study|Other|2|||
94501077|NCT00799864|323627875|FG001|Overall Study|Other|1|||
94501078|NCT00799864|323627876|FG002|Overall Study|Other|0|||
94501079|NCT00799864|323627877|FG003|Overall Study|Other|0|||
94501080|NCT00799864|323627878|FG004|Overall Study|Other|0|||
94501081|NCT00756444|323627879|FG000|Overall Study|Adverse Event|1|||
94501082|NCT00756444|323627880|FG001|Overall Study|Adverse Event|1|||
94501083|NCT00756444|323627879|FG000|Overall Study|Withdrawal by Subject|6|||
94501084|NCT00756444|323627880|FG001|Overall Study|Withdrawal by Subject|8|||
94501085|NCT00756444|323627879|FG000|Overall Study|Lost to Follow-up|0|||
94501086|NCT00756444|323627880|FG001|Overall Study|Lost to Follow-up|1|||
94501087|NCT00756444|323627879|FG000|Overall Study|Death|5|||
94501088|NCT00756444|323627880|FG001|Overall Study|Death|4|||
94501089|NCT00756444|323627879|FG000|Overall Study|Disease Progression|2|||
94501090|NCT00756444|323627880|FG001|Overall Study|Disease Progression|7|||
94501091|NCT00756444|323627879|FG000|Overall Study|Ineligibility Determined|1|||
94501092|NCT00756444|323627880|FG001|Overall Study|Ineligibility Determined|0|||
94501093|NCT00564070|323627881|FG000|Overall Study|Lost to Follow-up|9|||
94501094|NCT00564070|323627882|FG001|Overall Study|Lost to Follow-up|7|||
94501095|NCT00564070|323627881|FG000|Overall Study|Worsening depression, referred to care|3|||
94501096|NCT00564070|323627882|FG001|Overall Study|Worsening depression, referred to care|0|||
94501097|NCT05529173|323627885|FG000|Overall Study|Physician Decision|3|||
94501098|NCT05529173|323627886|FG001|Overall Study|Physician Decision|6|||
94501099|NCT05529173|323627885|FG000|Overall Study|Sample shipment delay more than one day|4|||
94501100|NCT05529173|323627886|FG001|Overall Study|Sample shipment delay more than one day|0|||
94501101|NCT04865978|323627889|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
94501102|NCT04865978|323627890|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
94501103|NCT02306161|323627891|FG000|Overall Study|Death|1|||
94501104|NCT02306161|323627892|FG001|Overall Study|Death|3|||
94501105|NCT02306161|323627891|FG000|Overall Study|Lack of Efficacy|20|||
94501106|NCT02306161|323627892|FG001|Overall Study|Lack of Efficacy|43|||
94501107|NCT02306161|323627891|FG000|Overall Study|Physician Decision|30|||
94501108|NCT02306161|323627892|FG001|Overall Study|Physician Decision|18|||
94501109|NCT02306161|323627891|FG000|Overall Study|Withdrawal by Subject|4|||
94501110|NCT02306161|323627892|FG001|Overall Study|Withdrawal by Subject|0|||
94501111|NCT02306161|323627891|FG000|Overall Study|Ineligible|9|||
94501112|NCT02306161|323627892|FG001|Overall Study|Ineligible|5|||
94501113|NCT04098302|323627893|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
94501114|NCT04098302|323627894|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
94501115|NCT04098302|323627895|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
94501116|NCT04098302|323627896|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
94501117|NCT04098302|323627893|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
94501118|NCT04098302|323627894|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
94501119|NCT04098302|323627895|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
94501120|NCT04098302|323627896|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
94501121|NCT04098302|323627893|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
94501122|NCT04098302|323627894|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
94501123|NCT04098302|323627895|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
94501124|NCT04098302|323627896|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
94501125|NCT04098302|323627893|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
94501126|NCT04098302|323627894|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
94501127|NCT04098302|323627895|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
94501128|NCT04098302|323627896|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
94501129|NCT04098302|323627893|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
94501130|NCT04098302|323627894|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
94501131|NCT04098302|323627895|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
94501132|NCT04098302|323627896|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
94501133|NCT04098302|323627893|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
94501134|NCT04098302|323627894|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
94501135|NCT04098302|323627895|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
94501136|NCT04098302|323627896|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
94501137|NCT04098302|323627893|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
94501138|NCT04098302|323627894|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
94501139|NCT04098302|323627895|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
94501140|NCT04098302|323627896|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
94501141|NCT04098302|323627893|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
94501142|NCT04098302|323627894|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
94501143|NCT04098302|323627895|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
94501144|NCT04098302|323627896|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
94501145|NCT00609973|323627897|FG000|Overall Study|Adverse Event|2|||
94501146|NCT00609973|323627898|FG001|Overall Study|Adverse Event|1|||
94501147|NCT00609973|323627897|FG000|Overall Study|Protocol Violation|4|||
94501148|NCT00609973|323627898|FG001|Overall Study|Protocol Violation|3|||
94501149|NCT00609973|323627897|FG000|Overall Study|Lost to Follow-up|2|||
94501150|NCT00609973|323627898|FG001|Overall Study|Lost to Follow-up|1|||
94501151|NCT00609973|323627897|FG000|Overall Study|Withdrawal by Subject|0|||
94501152|NCT00609973|323627898|FG001|Overall Study|Withdrawal by Subject|1|||
94501153|NCT01309100|323627909|FG000|Overall Study|Protocol Violation|1|||
94501154|NCT01309100|323627909|FG000|Overall Study|Positive Slit lamp finding|1|||
94501155|NCT01370538|323627910|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
94501156|NCT01370538|323627911|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
94501157|NCT01370538|323627910|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
94501158|NCT01370538|323627911|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
94501159|NCT01370538|323627910|FG000|Overall Study|Adverse Event|1|||
94501160|NCT01370538|323627911|FG001|Overall Study|Adverse Event|0|||
94501161|NCT01370538|323627910|FG000|Overall Study|Protocol Violation|8|||
94501162|NCT01370538|323627911|FG001|Overall Study|Protocol Violation|5|||
94501163|NCT01370538|323627910|FG000|Overall Study|Development of study specific withdrawal|1|||
94501164|NCT01370538|323627911|FG001|Overall Study|Development of study specific withdrawal|1|||
94501165|NCT01370538|323627910|FG000|Overall Study|Lost to follow up|6|||
94501166|NCT01370538|323627911|FG001|Overall Study|Lost to follow up|10|||
94501167|NCT02003209|323627912|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
94501168|NCT02003209|323627913|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
94501169|NCT00962650|323627915|FG000|Overall Study|Transgastric DP was not completed|2|||
94501170|NCT01751685|323627917|FG000|6-mo Followup|Missed study visit|1|||
94501171|NCT01751685|323627918|FG001|6-mo Followup|Missed study visit|0|||
94501172|NCT01751685|323627917|FG000|6-mo Followup|Withdrawal by Subject|2|||
94501173|NCT01751685|323627918|FG001|6-mo Followup|Withdrawal by Subject|2|||
94501174|NCT01751685|323627917|FG000|6-mo Followup|Lost to Follow-up|0|||
94501175|NCT01751685|323627918|FG001|6-mo Followup|Lost to Follow-up|1|||
94501176|NCT01751685|323627917|FG000|12-mo Followup|Lost to Follow-up|5|||
94501177|NCT01751685|323627918|FG001|12-mo Followup|Lost to Follow-up|0|||
94501178|NCT04401293|323627919|FG000|Overall Study|Withdrawal by Subject|1|||
94501179|NCT04401293|323627920|FG001|Overall Study|Withdrawal by Subject|3|||
94501180|NCT03679884|323627921|FG000|Overall Study|Other|12|||
94501181|NCT03679884|323627922|FG001|Overall Study|Other|12|||
94501182|NCT03679884|323627923|FG002|Overall Study|Other|12|||
94501183|NCT03679884|323627924|FG003|Overall Study|Other|7|||
94501184|NCT03679884|323627925|FG004|Overall Study|Other|8|||
94501185|NCT03679884|323627921|FG000|Overall Study|Lack of Efficacy|15|||
94501186|NCT03679884|323627922|FG001|Overall Study|Lack of Efficacy|29|||
94501187|NCT03679884|323627923|FG002|Overall Study|Lack of Efficacy|13|||
94501188|NCT03679884|323627924|FG003|Overall Study|Lack of Efficacy|29|||
94501189|NCT03679884|323627925|FG004|Overall Study|Lack of Efficacy|10|||
94501190|NCT03679884|323627921|FG000|Overall Study|Death|1|||
94501191|NCT03679884|323627922|FG001|Overall Study|Death|0|||
94501192|NCT03679884|323627923|FG002|Overall Study|Death|0|||
94501193|NCT03679884|323627924|FG003|Overall Study|Death|0|||
94501194|NCT03679884|323627925|FG004|Overall Study|Death|0|||
94501195|NCT03679884|323627921|FG000|Overall Study|Adverse Event|2|||
94501196|NCT03679884|323627922|FG001|Overall Study|Adverse Event|10|||
94501197|NCT03679884|323627923|FG002|Overall Study|Adverse Event|9|||
94501198|NCT03679884|323627924|FG003|Overall Study|Adverse Event|6|||
94501199|NCT03679884|323627925|FG004|Overall Study|Adverse Event|6|||
94501200|NCT03679884|323627921|FG000|Overall Study|Withdrawal by Subject|12|||
94501201|NCT03679884|323627922|FG001|Overall Study|Withdrawal by Subject|23|||
94501202|NCT03679884|323627923|FG002|Overall Study|Withdrawal by Subject|8|||
94501203|NCT03679884|323627924|FG003|Overall Study|Withdrawal by Subject|8|||
94501204|NCT03679884|323627925|FG004|Overall Study|Withdrawal by Subject|9|||
94501205|NCT03679884|323627921|FG000|Overall Study|Lost to Follow-up|1|||
94501206|NCT03679884|323627922|FG001|Overall Study|Lost to Follow-up|4|||
94501207|NCT03679884|323627923|FG002|Overall Study|Lost to Follow-up|2|||
94501208|NCT03679884|323627924|FG003|Overall Study|Lost to Follow-up|0|||
94501209|NCT03679884|323627925|FG004|Overall Study|Lost to Follow-up|3|||
94501210|NCT03601052|323627926|FG000|Overall Study|Lost to Follow-up|2|||
94501211|NCT00837330|323627927|FG000|Overall Study|Lost to Follow-up|1|||
94501212|NCT00837330|323627928|FG001|Overall Study|Lost to Follow-up|3|||
94501213|NCT01227395|323627929|FG000|Overall Study|Protocol Violation|0|||
94501214|NCT01227395|323627930|FG001|Overall Study|Protocol Violation|1|||
94501215|NCT00694122|323627935|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
94501216|NCT00694122|323627936|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
94501217|NCT00694122|323627935|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
94501218|NCT00694122|323627936|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
94501219|NCT00694122|323627935|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
94501220|NCT00694122|323627936|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
94501221|NCT00105508|323627937|FG000|Overall Study|Prephase Dropout|1|||
94501222|NCT00105508|323627938|FG001|Overall Study|Prephase Dropout|0|||
94501223|NCT00105508|323627937|FG000|Overall Study|Adverse Event|16|||
94501224|NCT00105508|323627938|FG001|Overall Study|Adverse Event|19|||
94501225|NCT00105508|323627937|FG000|Overall Study|Insufficient Efficacy|1|||
94501226|NCT00105508|323627938|FG001|Overall Study|Insufficient Efficacy|0|||
94501227|NCT00105508|323627937|FG000|Overall Study|Withdrawal by Subject|10|||
94501228|NCT00105508|323627938|FG001|Overall Study|Withdrawal by Subject|6|||
94501229|NCT00105508|323627937|FG000|Overall Study|Lost to Follow-up|3|||
94501230|NCT00105508|323627938|FG001|Overall Study|Lost to Follow-up|0|||
94501231|NCT00105508|323627937|FG000|Overall Study|Protocol Violation|1|||
94501232|NCT00105508|323627938|FG001|Overall Study|Protocol Violation|2|||
94501233|NCT00105508|323627937|FG000|Overall Study|Other|8|||
94501234|NCT00105508|323627938|FG001|Overall Study|Other|9|||
94501235|NCT00003474|323627939|FG000|Overall Study|Not Evaluable|14|||
94501236|NCT03554473|323629346|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
94501237|NCT03554473|323629347|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
94501238|NCT03554473|323629348|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
94501239|NCT03554473|323629346|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
94501240|NCT03554473|323629347|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
94501241|NCT03554473|323629348|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
94501242|NCT03554473|323629346|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
94501243|NCT03554473|323629347|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
94501244|NCT03554473|323629348|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
94501245|NCT01500096|323629349|FG000|Overall Study|Lost to Follow-up|1|||
94501246|NCT01500096|323629350|FG001|Overall Study|Lost to Follow-up|0|||
94501247|NCT01500096|323629351|FG002|Overall Study|Lost to Follow-up|0|||
94501248|NCT01500096|323629352|FG003|Overall Study|Lost to Follow-up|2|||
94501249|NCT02370394|323629355|FG000|Overall Study|Lost to Follow-up|2|||
94501250|NCT02370394|323629356|FG001|Overall Study|Lost to Follow-up|1|||
94501251|NCT02370394|323629355|FG000|Overall Study|Withdrawal by Subject|0|||
94501252|NCT02370394|323629356|FG001|Overall Study|Withdrawal by Subject|1|||
94501253|NCT00456612|323629358|FG000|Overall Study|Withdrawal by Subject|3|||
94501254|NCT01108796|323629359|FG000|Overall Study|Adverse Event|0|||
94501255|NCT01108796|323629360|FG001|Overall Study|Adverse Event|1|||
94501256|NCT01108796|323629359|FG000|Overall Study|Lost to Follow-up|7|||
94501257|NCT01108796|323629360|FG001|Overall Study|Lost to Follow-up|6|||
94501258|NCT02082483|323629369|FG000|Overall Study|Lost to Follow-up|1|||
94501259|NCT02082483|323629370|FG001|Overall Study|Lost to Follow-up|1|||
94501260|NCT02082483|323629369|FG000|Overall Study|Withdrawal by Subject|2|||
94501261|NCT02082483|323629370|FG001|Overall Study|Withdrawal by Subject|1|||
94501262|NCT02082483|323629369|FG000|Overall Study|Physician Decision|1|||
94501263|NCT02082483|323629370|FG001|Overall Study|Physician Decision|1|||
94501264|NCT02082483|323629369|FG000|Overall Study|Death|2|||
94501265|NCT02082483|323629370|FG001|Overall Study|Death|3|||
94501266|NCT03607695|323629375|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
94501267|NCT03607695|323629375|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
94501268|NCT00245570|323629376|FG000|Washout Between Periods III and IV|Adverse Event|0|||
94501269|NCT00245570|323629377|FG001|Washout Between Periods III and IV|Adverse Event|1|||
94501270|NCT00245570|323629378|FG002|Washout Between Periods III and IV|Adverse Event|0|||
94501271|NCT00245570|323629379|FG003|Washout Between Periods III and IV|Adverse Event|0|||
94501272|NCT00245570|323629380|FG004|Washout Between Periods III and IV|Adverse Event|0|||
94501273|NCT00245570|323629381|FG005|Washout Between Periods III and IV|Adverse Event|0|||
94501274|NCT01399099|323629382|FG000|Overall Study|Lost to Follow-up|14|||
94501275|NCT01399099|323629382|FG000|Overall Study|Physician Decision|1|||
94501276|NCT01399099|323629382|FG000|Overall Study|Protocol Violation|1|||
94501277|NCT01399099|323629382|FG000|Overall Study|Skin Irritation|13|||
94501278|NCT01399099|323629382|FG000|Overall Study|Infection|1|||
94501279|NCT01399099|323629382|FG000|Overall Study|Miscellaneous|4|||
94501280|NCT02181738|323629384|FG000|Overall Study|Participant Withdrew Consent|2|||
94501281|NCT02181738|323629385|FG001|Overall Study|Participant Withdrew Consent|1|||
94501282|NCT02181738|323629386|FG002|Overall Study|Participant Withdrew Consent|1|||
94501283|NCT02181738|323629387|FG003|Overall Study|Participant Withdrew Consent|1|||
94501284|NCT02181738|323629384|FG000|Overall Study|Lost to Follow-up|1|||
94501285|NCT02181738|323629385|FG001|Overall Study|Lost to Follow-up|2|||
94501286|NCT02181738|323629386|FG002|Overall Study|Lost to Follow-up|1|||
94501287|NCT02181738|323629387|FG003|Overall Study|Lost to Follow-up|1|||
94501288|NCT02181738|323629384|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
94501289|NCT02181738|323629385|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
94501290|NCT02181738|323629386|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
94501291|NCT02181738|323629387|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
94501292|NCT02181738|323629384|FG000|Overall Study|Poor/Non-Compliance|1|||
94501293|NCT02181738|323629385|FG001|Overall Study|Poor/Non-Compliance|0|||
94501294|NCT02181738|323629386|FG002|Overall Study|Poor/Non-Compliance|2|||
94501295|NCT02181738|323629387|FG003|Overall Study|Poor/Non-Compliance|1|||
94501296|NCT02181738|323629384|FG000|Overall Study|Disease Progression|28|||
94501297|NCT02181738|323629385|FG001|Overall Study|Disease Progression|35|||
94501298|NCT02181738|323629386|FG002|Overall Study|Disease Progression|40|||
94501299|NCT02181738|323629387|FG003|Overall Study|Disease Progression|0|||
94501300|NCT02181738|323629384|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
94501301|NCT02181738|323629385|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
94501302|NCT02181738|323629386|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
94501303|NCT02181738|323629387|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
94501304|NCT02181738|323629384|FG000|Overall Study|Study Drug Toxicity|6|||
94501305|NCT02181738|323629385|FG001|Overall Study|Study Drug Toxicity|11|||
94501306|NCT02181738|323629386|FG002|Overall Study|Study Drug Toxicity|8|||
94501307|NCT02181738|323629387|FG003|Overall Study|Study Drug Toxicity|1|||
94501308|NCT02181738|323629384|FG000|Overall Study|Other Reasons|14|||
94501309|NCT02181738|323629385|FG001|Overall Study|Other Reasons|16|||
94501310|NCT02181738|323629386|FG002|Overall Study|Other Reasons|28|||
94501311|NCT02181738|323629387|FG003|Overall Study|Other Reasons|0|||
94501312|NCT02181738|323629384|FG000|Overall Study|Maximum Clinical Benefit|3|||
94501313|NCT02181738|323629385|FG001|Overall Study|Maximum Clinical Benefit|0|||
94501314|NCT02181738|323629386|FG002|Overall Study|Maximum Clinical Benefit|1|||
94501315|NCT02181738|323629387|FG003|Overall Study|Maximum Clinical Benefit|0|||
94501316|NCT02181738|323629384|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
94501317|NCT02181738|323629385|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
94501318|NCT02181738|323629386|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
94501319|NCT02181738|323629387|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
94501320|NCT00191152|323629388|FG000|Initial Treatment|Adverse Event|43|||
94501321|NCT00191152|323629389|FG001|Initial Treatment|Adverse Event|67|||
94501322|NCT00191152|323629388|FG000|Initial Treatment|Physician Decision|40|||
94501323|NCT00191152|323629389|FG001|Initial Treatment|Physician Decision|31|||
94501324|NCT00191152|323629388|FG000|Initial Treatment|Withdrawal by Subject|40|||
94501325|NCT00191152|323629389|FG001|Initial Treatment|Withdrawal by Subject|28|||
94501326|NCT00191152|323629388|FG000|Initial Treatment|Lost to Follow-up|0|||
94501327|NCT00191152|323629389|FG001|Initial Treatment|Lost to Follow-up|6|||
94501328|NCT00191152|323629388|FG000|Initial Treatment|Other|18|||
94501329|NCT00191152|323629389|FG001|Initial Treatment|Other|21|||
94501330|NCT00191152|323629388|FG000|Crossover Treatment|Adverse Event|8|||
94501331|NCT00191152|323629389|FG001|Crossover Treatment|Adverse Event|8|||
94501332|NCT00191152|323629388|FG000|Crossover Treatment|Physician Decision|7|||
94501333|NCT00191152|323629389|FG001|Crossover Treatment|Physician Decision|7|||
94501334|NCT00191152|323629388|FG000|Crossover Treatment|Withdrawal by Subject|6|||
94501335|NCT00191152|323629389|FG001|Crossover Treatment|Withdrawal by Subject|9|||
94501336|NCT00191152|323629388|FG000|Crossover Treatment|Lost to Follow-up|2|||
94501337|NCT00191152|323629389|FG001|Crossover Treatment|Lost to Follow-up|1|||
94501338|NCT00191152|323629388|FG000|Crossover Treatment|Other|4|||
94501339|NCT00191152|323629389|FG001|Crossover Treatment|Other|3|||
94501340|NCT00114777|323629390|FG000|Randomization to Month 36|Death|10|||
94501341|NCT00114777|323629391|FG001|Randomization to Month 36|Death|4|||
94501342|NCT00114777|323629392|FG002|Randomization to Month 36|Death|3|||
94501343|NCT00114777|323629390|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
94501344|NCT00114777|323629391|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
94501345|NCT00114777|323629392|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
94501346|NCT00114777|323629390|FG000|Randomization to Month 36|Lack of Efficacy|19|||
94501347|NCT00114777|323629391|FG001|Randomization to Month 36|Lack of Efficacy|15|||
94501348|NCT00114777|323629392|FG002|Randomization to Month 36|Lack of Efficacy|17|||
94501349|NCT00114777|323629390|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
94501350|NCT00114777|323629391|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
94501351|NCT00114777|323629392|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
94501352|NCT00114777|323629390|FG000|Randomization to Month 36|Adverse Event|34|||
94501353|NCT00114777|323629391|FG001|Randomization to Month 36|Adverse Event|35|||
94501354|NCT00114777|323629392|FG002|Randomization to Month 36|Adverse Event|44|||
94501355|NCT00114777|323629390|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
94501356|NCT00114777|323629391|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
94501357|NCT00114777|323629392|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
94501358|NCT00114777|323629390|FG000|Randomization to Month 36|Other|9|||
94501359|NCT00114777|323629391|FG001|Randomization to Month 36|Other|3|||
94501360|NCT00114777|323629392|FG002|Randomization to Month 36|Other|12|||
94501361|NCT00114777|323629390|FG000|Long-Term Extension to Month 84|Death|8|||
94501362|NCT00114777|323629391|FG001|Long-Term Extension to Month 84|Death|13|||
94501363|NCT00114777|323629392|FG002|Long-Term Extension to Month 84|Death|7|||
94501364|NCT00114777|323629390|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
94501365|NCT00114777|323629391|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
94501366|NCT00114777|323629392|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
94501367|NCT00114777|323629390|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
94501368|NCT00114777|323629391|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
94501369|NCT00114777|323629392|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
94501370|NCT00114777|323629390|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
94501371|NCT00114777|323629391|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
94501372|NCT00114777|323629392|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
94501373|NCT00114777|323629390|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
94501374|NCT00114777|323629391|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
94501375|NCT00114777|323629392|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
94501376|NCT00114777|323629390|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
94501377|NCT00114777|323629391|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
94501378|NCT00114777|323629392|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
94501379|NCT00114777|323629390|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
94501380|NCT00114777|323629391|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
94501381|NCT00114777|323629392|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
94501382|NCT00114777|323629390|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
94501383|NCT00114777|323629391|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
94501384|NCT00114777|323629392|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
94501385|NCT00114777|323629390|FG000|Long-Term Extension to Month 84|Other|2|||
94501386|NCT00114777|323629391|FG001|Long-Term Extension to Month 84|Other|0|||
94501387|NCT00114777|323629392|FG002|Long-Term Extension to Month 84|Other|2|||
94501388|NCT02453191|323629393|FG000|Overall Study|Withdrawal by Subject|1|||
94501389|NCT03364686|323629394|FG000|Overall Study|Physician Decision|2|||
94501390|NCT02336503|323629397|FG000|Overall Study|Lost to Follow-up|0|||
94501391|NCT02336503|323629398|FG001|Overall Study|Lost to Follow-up|3|||
94501392|NCT02336503|323629399|FG002|Overall Study|Lost to Follow-up|0|||
94501393|NCT02336503|323629400|FG003|Overall Study|Lost to Follow-up|2|||
94501394|NCT02336503|323629397|FG000|Overall Study|Withdrawal by Subject|2|||
94501395|NCT02336503|323629398|FG001|Overall Study|Withdrawal by Subject|0|||
94501396|NCT02336503|323629399|FG002|Overall Study|Withdrawal by Subject|0|||
94501397|NCT02336503|323629400|FG003|Overall Study|Withdrawal by Subject|4|||
94501398|NCT02336503|323629397|FG000|Overall Study|Adverse Event|0|||
94501399|NCT02336503|323629398|FG001|Overall Study|Adverse Event|0|||
94501400|NCT02336503|323629399|FG002|Overall Study|Adverse Event|1|||
94501401|NCT02336503|323629400|FG003|Overall Study|Adverse Event|0|||
94501402|NCT00052715|323629408|FG000|Overall Study|wrong histology|1|||
94501403|NCT01936974|323629409|FG000|Overall Study|Physician Decision|2|||
94501404|NCT01936974|323629410|FG001|Overall Study|Physician Decision|5|||
94501405|NCT04584554|323629411|FG000|Overall Study|Withdrawal by Subject|2|||
94501406|NCT04584554|323629412|FG001|Overall Study|Withdrawal by Subject|2|||
94501407|NCT02807181|323629413|FG000|Overall Study|Death|28|||
94501408|NCT02807181|323629414|FG001|Overall Study|Death|24|||
94501409|NCT02807181|323629413|FG000|Overall Study|Withdrawal by Subject|1|||
94501410|NCT02807181|323629414|FG001|Overall Study|Withdrawal by Subject|1|||
94501411|NCT02807181|323629413|FG000|Overall Study|Lost to Follow-up|0|||
94501412|NCT02807181|323629414|FG001|Overall Study|Lost to Follow-up|2|||
94501413|NCT02807181|323629413|FG000|Overall Study|Subject decision|1|||
94501414|NCT02807181|323629414|FG001|Overall Study|Subject decision|0|||
94501415|NCT02807181|323629413|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
94501416|NCT02807181|323629414|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
94501417|NCT02807181|323629413|FG000|Overall Study|In Study|3|||
94501418|NCT02807181|323629414|FG001|Overall Study|In Study|3|||
94501419|NCT02807181|323629413|FG000|Overall Study|Post Progression|3|||
94501420|NCT02807181|323629414|FG001|Overall Study|Post Progression|2|||
94501421|NCT05507450|323629419|FG000|Overall Study|Death|0|||
94501422|NCT05507450|323629420|FG001|Overall Study|Death|0|||
94501423|NCT05507450|323629421|FG002|Overall Study|Death|1|||
94501424|NCT05507450|323629422|FG003|Overall Study|Death|0|||
94501425|NCT05507450|323629419|FG000|Overall Study|Lost to Follow-up|22|||
94501426|NCT05507450|323629420|FG001|Overall Study|Lost to Follow-up|20|||
94501427|NCT05507450|323629421|FG002|Overall Study|Lost to Follow-up|20|||
94501428|NCT05507450|323629422|FG003|Overall Study|Lost to Follow-up|7|||
94501429|NCT05507450|323629419|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94501430|NCT05507450|323629420|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
94501431|NCT05507450|323629421|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
94501432|NCT05507450|323629422|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94501433|NCT05507450|323629419|FG000|Overall Study|Withdrawal by Subject|4|||
94501434|NCT05507450|323629420|FG001|Overall Study|Withdrawal by Subject|11|||
94501435|NCT05507450|323629421|FG002|Overall Study|Withdrawal by Subject|7|||
94501436|NCT05507450|323629422|FG003|Overall Study|Withdrawal by Subject|3|||
94501437|NCT05507450|323629419|FG000|Overall Study|Participant left the country|0|||
94501438|NCT05507450|323629420|FG001|Overall Study|Participant left the country|0|||
94501439|NCT05507450|323629421|FG002|Overall Study|Participant left the country|1|||
94501440|NCT05507450|323629422|FG003|Overall Study|Participant left the country|0|||
94501441|NCT03767894|323629423|FG000|Overall Study|Withdrawal by Subject|1|||
94501442|NCT00407030|323629424|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
94501443|NCT00407030|323629425|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
94501444|NCT00407030|323629426|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
94501445|NCT00407030|323629424|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
94501446|NCT00407030|323629425|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
94501447|NCT00407030|323629426|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
94501448|NCT00407030|323629424|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
94501449|NCT00407030|323629425|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
94501450|NCT00407030|323629426|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
94501451|NCT00407030|323629424|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
94501452|NCT00407030|323629425|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
94501453|NCT00407030|323629426|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
94501454|NCT00407030|323629424|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
94501455|NCT00407030|323629425|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
94501456|NCT00407030|323629426|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
94501457|NCT00407030|323629424|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
94501458|NCT00407030|323629425|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
94501459|NCT00407030|323629426|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
94501460|NCT00407030|323629424|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
94501461|NCT00407030|323629425|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
94501462|NCT00407030|323629426|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
94501463|NCT00407030|323629424|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
94501464|NCT00407030|323629425|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
94501465|NCT00407030|323629426|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
94501466|NCT00407030|323629424|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
94501467|NCT00407030|323629425|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
94501468|NCT00407030|323629426|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
94501469|NCT00407030|323629424|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
94501470|NCT00407030|323629425|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
94501471|NCT00407030|323629426|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
94501472|NCT00407030|323629424|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
94501473|NCT00407030|323629425|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
94501474|NCT00407030|323629426|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
94501475|NCT00407030|323629424|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
94501476|NCT00407030|323629425|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
94501477|NCT00407030|323629426|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
94501478|NCT00407030|323629424|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
94501479|NCT00407030|323629425|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
94501480|NCT00407030|323629426|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
94501481|NCT04243837|323629427|FG000|Overall Study|Adverse Event|2|||
94501482|NCT04243837|323629428|FG001|Overall Study|Adverse Event|1|||
94501483|NCT04243837|323629427|FG000|Overall Study|Withdrawal by Subject|4|||
94501484|NCT04243837|323629428|FG001|Overall Study|Withdrawal by Subject|2|||
94501485|NCT04243837|323629427|FG000|Overall Study|Covid-19 lock down|1|||
94501486|NCT04243837|323629428|FG001|Overall Study|Covid-19 lock down|0|||
94501487|NCT04243837|323629427|FG000|Overall Study|Study Terminated by Sponsor|11|||
94501488|NCT04243837|323629428|FG001|Overall Study|Study Terminated by Sponsor|12|||
94501489|NCT03182244|323629430|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
94501490|NCT03182244|323629431|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
94501491|NCT03182244|323629430|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
94501492|NCT03182244|323629431|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
94501493|NCT03182244|323629430|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
94501494|NCT03182244|323629431|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
94501495|NCT03182244|323629430|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
94501496|NCT03182244|323629431|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
94501497|NCT03182244|323629430|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
94501498|NCT03182244|323629431|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
94501499|NCT03182244|323629430|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
94501500|NCT03182244|323629431|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
94501501|NCT03182244|323629430|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
94501502|NCT03182244|323629431|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
94501503|NCT03182244|323629430|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
94501504|NCT03182244|323629431|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
94501505|NCT03182244|323629430|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
94501506|NCT03182244|323629431|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
94501507|NCT03182244|323629430|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
94501508|NCT03182244|323629431|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
94501509|NCT03182244|323629430|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
94501510|NCT03182244|323629431|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
94501511|NCT03182244|323629430|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
94501512|NCT03182244|323629431|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
94501513|NCT03182244|323629430|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
94501514|NCT03182244|323629431|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
94501515|NCT01663987|323629432|FG000|Overall Study|Adverse Event|7|||
94501516|NCT01663987|323629433|FG001|Overall Study|Adverse Event|2|||
94501517|NCT01663987|323629432|FG000|Overall Study|Lost to Follow-up|1|||
94501518|NCT01663987|323629433|FG001|Overall Study|Lost to Follow-up|1|||
94501519|NCT01663987|323629432|FG000|Overall Study|Withdrawal by Subject|2|||
94501520|NCT01663987|323629433|FG001|Overall Study|Withdrawal by Subject|3|||
94501521|NCT01663987|323629432|FG000|Overall Study|Other reason not defined above|3|||
94501522|NCT01663987|323629433|FG001|Overall Study|Other reason not defined above|0|||
94501523|NCT02006654|323629435|FG000|Overall Study|Withdrawal before treatment|4|||
94501524|NCT02006654|323629436|FG001|Overall Study|Withdrawal before treatment|2|||
94501525|NCT02006654|323629435|FG000|Overall Study|Adverse Event|16|||
94501526|NCT02006654|323629436|FG001|Overall Study|Adverse Event|17|||
94501527|NCT02006654|323629435|FG000|Overall Study|Death|1|||
94501528|NCT02006654|323629436|FG001|Overall Study|Death|0|||
94501529|NCT02006654|323629435|FG000|Overall Study|Withdrawal by Subject|14|||
94501530|NCT02006654|323629436|FG001|Overall Study|Withdrawal by Subject|12|||
94501531|NCT02006654|323629435|FG000|Overall Study|Protocol Violation|5|||
94501532|NCT02006654|323629436|FG001|Overall Study|Protocol Violation|8|||
94501533|NCT02006654|323629435|FG000|Overall Study|Lost to Follow-up|1|||
94501534|NCT02006654|323629436|FG001|Overall Study|Lost to Follow-up|0|||
94501535|NCT02006654|323629435|FG000|Overall Study|patient's will|2|||
94501536|NCT02006654|323629436|FG001|Overall Study|patient's will|1|||
94501537|NCT02006654|323629435|FG000|Overall Study|insufficient compliance|1|||
94501538|NCT02006654|323629436|FG001|Overall Study|insufficient compliance|0|||
94501539|NCT02006654|323629435|FG000|Overall Study|worsening cognitive condition|0|||
94501540|NCT02006654|323629436|FG001|Overall Study|worsening cognitive condition|1|||
94501541|NCT02006654|323629435|FG000|Overall Study|faecal incontinence|0|||
94501542|NCT02006654|323629436|FG001|Overall Study|faecal incontinence|1|||
94501543|NCT02006654|323629435|FG000|Overall Study|mood disorder|0|||
94501544|NCT02006654|323629436|FG001|Overall Study|mood disorder|1|||
94501545|NCT02006654|323629435|FG000|Overall Study|disallowed medication|1|||
94501546|NCT02006654|323629436|FG001|Overall Study|disallowed medication|0|||
94501547|NCT02006654|323629435|FG000|Overall Study|moving out of state|0|||
94501548|NCT02006654|323629436|FG001|Overall Study|moving out of state|1|||
94501549|NCT00478140|323629437|FG000|Overall Study|Clinical Disease Progression|1|||
94501550|NCT01827943|323629438|FG000|Overall Study|Protocol Violation|8|||
94501551|NCT01827943|323629438|FG000|Overall Study|Never treated because of an rapid progression|1|||
94501552|NCT01263028|323629439|FG000|Overall Study|Withdrawal by Subject|1|||
94501553|NCT01263028|323629439|FG000|Overall Study|Adverse Event|1|||
94501554|NCT01263028|323629439|FG000|Overall Study|Study terminated due to low enrollment.|4|||
94501555|NCT00366535|323629440|FG000|First Phase: 12 Weeks|Adverse Event|1|||
94501556|NCT00366535|323629441|FG001|First Phase: 12 Weeks|Adverse Event|3|||
94501557|NCT00366535|323629440|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
94501558|NCT00366535|323629441|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
94501559|NCT00366535|323629440|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
94501560|NCT00366535|323629441|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
94501561|NCT00366535|323629440|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
94501562|NCT00366535|323629441|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
94501563|NCT00663351|323629442|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
94501564|NCT00663351|323629443|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
94501565|NCT00663351|323629442|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
94501566|NCT00663351|323629443|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
94501567|NCT00663351|323629442|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
94501568|NCT00663351|323629443|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
94501569|NCT00663351|323629442|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
94501570|NCT00663351|323629443|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
94501571|NCT00663351|323629442|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
94501572|NCT00663351|323629443|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
94501573|NCT00663351|323629442|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
94501574|NCT00663351|323629443|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
94501575|NCT02642042|323629444|FG000|Overall Study|Adverse Event|22|||
94501576|NCT02642042|323629444|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
94501577|NCT02642042|323629444|FG000|Overall Study|Progression/Relapse|28|||
94501578|NCT02642042|323629444|FG000|Overall Study|Death|1|||
94501579|NCT02642042|323629444|FG000|Overall Study|Not Protocol Specified|2|||
94501580|NCT04689009|323629445|FG000|Overall Study|Adverse Event|1|||
94501581|NCT04689009|323629446|FG001|Overall Study|Adverse Event|0|||
94501582|NCT04689009|323629445|FG000|Overall Study|Lost to Follow-up|1|||
94501583|NCT04689009|323629446|FG001|Overall Study|Lost to Follow-up|2|||
94501584|NCT04689009|323629445|FG000|Overall Study|Withdrawal by Subject|4|||
94501585|NCT04689009|323629446|FG001|Overall Study|Withdrawal by Subject|3|||
94501586|NCT04689009|323629445|FG000|Overall Study|Protocol Violation|1|||
94501587|NCT04689009|323629446|FG001|Overall Study|Protocol Violation|0|||
94501588|NCT02218268|323629447|FG000|24 Hour Washout|Physician Decision|11|||
94501589|NCT02218268|323629448|FG001|24 Hour Washout|Physician Decision|9|||
94501590|NCT05259722|323629450|FG000|Overall Study|Adverse Event|2|||
94501591|NCT05259722|323629451|FG001|Overall Study|Adverse Event|24|||
94501592|NCT05259722|323629450|FG000|Overall Study|Lost to Follow-up|5|||
94501593|NCT05259722|323629451|FG001|Overall Study|Lost to Follow-up|1|||
94501594|NCT05259722|323629450|FG000|Overall Study|Lack of Efficacy|8|||
94501595|NCT05259722|323629451|FG001|Overall Study|Lack of Efficacy|26|||
94501596|NCT05259722|323629450|FG000|Overall Study|Withdrawal by Subject|15|||
94501597|NCT05259722|323629451|FG001|Overall Study|Withdrawal by Subject|33|||
94501598|NCT05259722|323629450|FG000|Overall Study|Various reasons|3|||
94501599|NCT05259722|323629451|FG001|Overall Study|Various reasons|9|||
94501600|NCT05259722|323629450|FG000|Overall Study|Not exposed to IMP|1|||
94501601|NCT05259722|323629451|FG001|Overall Study|Not exposed to IMP|12|||
94501602|NCT05259722|323629450|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
94501603|NCT05259722|323629451|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
94501604|NCT03069937|323629452|FG000|Overall Study|Second primary malignancy noted|1|||
94501605|NCT01028391|323629453|FG000|Overall Study|Adverse Event|4|||
94501606|NCT01028391|323629454|FG001|Overall Study|Adverse Event|0|||
94501607|NCT01028391|323629453|FG000|Overall Study|Lack of Efficacy|0|||
94501608|NCT01028391|323629454|FG001|Overall Study|Lack of Efficacy|2|||
94501609|NCT01028391|323629453|FG000|Overall Study|Lost to Follow-up|3|||
94501610|NCT01028391|323629454|FG001|Overall Study|Lost to Follow-up|4|||
94501611|NCT01028391|323629453|FG000|Overall Study|Physician Decision|0|||
94501612|NCT01028391|323629454|FG001|Overall Study|Physician Decision|1|||
94501613|NCT01028391|323629453|FG000|Overall Study|Withdrawal by Subject|6|||
94501614|NCT01028391|323629454|FG001|Overall Study|Withdrawal by Subject|3|||
94501615|NCT01028391|323629453|FG000|Overall Study|Needed excluded medication|1|||
94501616|NCT01028391|323629454|FG001|Overall Study|Needed excluded medication|1|||
94501617|NCT00694161|323629457|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
94501618|NCT00694161|323629457|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
94501619|NCT00694161|323629457|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
94501620|NCT03259308|323629464|FG000|Overall Study|Adverse Event|5|||
94501621|NCT03259308|323629465|FG001|Overall Study|Adverse Event|4|||
94501622|NCT03259308|323629466|FG002|Overall Study|Adverse Event|1|||
94501623|NCT03259308|323629464|FG000|Overall Study|Withdrawal by Subject|2|||
94501624|NCT03259308|323629465|FG001|Overall Study|Withdrawal by Subject|1|||
94501625|NCT03259308|323629466|FG002|Overall Study|Withdrawal by Subject|3|||
94501626|NCT03259308|323629464|FG000|Overall Study|Lost to Follow-up|0|||
94501627|NCT03259308|323629465|FG001|Overall Study|Lost to Follow-up|0|||
94501628|NCT03259308|323629466|FG002|Overall Study|Lost to Follow-up|1|||
94501629|NCT03259308|323629464|FG000|Overall Study|Pregnancy|0|||
94501630|NCT03259308|323629465|FG001|Overall Study|Pregnancy|0|||
94501631|NCT03259308|323629466|FG002|Overall Study|Pregnancy|1|||
94501632|NCT03259308|323629464|FG000|Overall Study|Protocol Deviation|0|||
94501633|NCT03259308|323629465|FG001|Overall Study|Protocol Deviation|3|||
94501634|NCT03259308|323629466|FG002|Overall Study|Protocol Deviation|0|||
94501635|NCT03259308|323629464|FG000|Overall Study|Lack of Efficacy|0|||
94501636|NCT03259308|323629465|FG001|Overall Study|Lack of Efficacy|0|||
94501637|NCT03259308|323629466|FG002|Overall Study|Lack of Efficacy|1|||
94501638|NCT01108055|323629471|FG000|Overall Study|Ineligible|11|||
94501639|NCT01108055|323629471|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
94501640|NCT00362609|323629472|FG000|Overall Study|Withdrawal by Subject|0|||
94501641|NCT00362609|323629473|FG001|Overall Study|Withdrawal by Subject|1|||
94501642|NCT00362609|323629472|FG000|Overall Study|Protocol Violation|0|||
94501643|NCT00362609|323629473|FG001|Overall Study|Protocol Violation|1|||
94501644|NCT00682435|323629474|FG000|Overall Study|Insufficient data|5|||
94501645|NCT00682435|323629474|FG000|Overall Study|Erroneously enrolled twice|2|||
94501646|NCT01117350|323629475|FG000|Comparative Period|Not Treated|5|||
94501647|NCT01117350|323629476|FG001|Comparative Period|Not Treated|8|||
94501648|NCT01117350|323629475|FG000|Comparative Period|Adverse Event|6|||
94501649|NCT01117350|323629476|FG001|Comparative Period|Adverse Event|33|||
94501650|NCT01117350|323629475|FG000|Comparative Period|Lost to Follow-up|11|||
94501651|NCT01117350|323629476|FG001|Comparative Period|Lost to Follow-up|7|||
94501652|NCT01117350|323629475|FG000|Comparative Period|Withdrawal by Subject|9|||
94501653|NCT01117350|323629476|FG001|Comparative Period|Withdrawal by Subject|13|||
94501654|NCT01117350|323629475|FG000|Comparative Period|Protocol Violation|8|||
94501655|NCT01117350|323629476|FG001|Comparative Period|Protocol Violation|12|||
94501656|NCT01117350|323629475|FG000|Comparative Period|Lack of Efficacy|1|||
94501657|NCT01117350|323629476|FG001|Comparative Period|Lack of Efficacy|0|||
94501658|NCT01117350|323629475|FG000|Comparative Period|Physician Decision|0|||
94501659|NCT01117350|323629476|FG001|Comparative Period|Physician Decision|1|||
94501660|NCT01117350|323629475|FG000|Comparative Period|Move to another city/country|2|||
94501661|NCT01117350|323629476|FG001|Comparative Period|Move to another city/country|1|||
94501662|NCT01117350|323629475|FG000|Extension Period|Not included in extension, not treated|0|||
94501663|NCT01117350|323629476|FG001|Extension Period|Not included in extension, not treated|50|||
94501664|NCT01117350|323629475|FG000|Extension Period|Adverse Event|0|||
94501665|NCT01117350|323629476|FG001|Extension Period|Adverse Event|2|||
94501666|NCT01117350|323629475|FG000|Extension Period|Protocol Violation|0|||
94501667|NCT01117350|323629476|FG001|Extension Period|Protocol Violation|2|||
94501668|NCT01117350|323629475|FG000|Extension Period|Lost to Follow-up|0|||
94501669|NCT01117350|323629476|FG001|Extension Period|Lost to Follow-up|2|||
94501670|NCT01117350|323629475|FG000|Extension Period|Withdrawal by Subject|0|||
94501671|NCT01117350|323629476|FG001|Extension Period|Withdrawal by Subject|3|||
94501672|NCT01117350|323629475|FG000|Extension Period|Lack of Efficacy|0|||
94501673|NCT01117350|323629476|FG001|Extension Period|Lack of Efficacy|2|||
94501674|NCT01117350|323629475|FG000|Extension Period|Inclusion criteria not respected|0|||
94501675|NCT01117350|323629476|FG001|Extension Period|Inclusion criteria not respected|1|||
94501676|NCT01117350|323629475|FG000|Extension Period|Prohibited medication|0|||
94501677|NCT01117350|323629476|FG001|Extension Period|Prohibited medication|1|||
94501678|NCT02257528|323629477|FG000|Overall Study|Never received study treatment|1|||
94501679|NCT03166631|323631204|FG000|Overall Study|Progressive disease|2|||
94501680|NCT03166631|323631205|FG001|Overall Study|Progressive disease|1|||
94501681|NCT03166631|323631206|FG002|Overall Study|Progressive disease|3|||
94501682|NCT03166631|323631207|FG003|Overall Study|Progressive disease|4|||
94501683|NCT03166631|323631208|FG004|Overall Study|Progressive disease|2|||
94501684|NCT03166631|323631209|FG005|Overall Study|Progressive disease|2|||
94501685|NCT03166631|323631210|FG006|Overall Study|Progressive disease|5|||
94501686|NCT03166631|323631211|FG007|Overall Study|Progressive disease|6|||
94501687|NCT03166631|323631212|FG008|Overall Study|Progressive disease|11|||
94501688|NCT03166631|323631213|FG009|Overall Study|Progressive disease|5|||
94501689|NCT03166631|323631214|FG010|Overall Study|Progressive disease|7|||
94501690|NCT03166631|323631204|FG000|Overall Study|Physician Decision|0|||
94501691|NCT03166631|323631205|FG001|Overall Study|Physician Decision|0|||
94501692|NCT03166631|323631206|FG002|Overall Study|Physician Decision|0|||
94501693|NCT03166631|323631207|FG003|Overall Study|Physician Decision|0|||
94501694|NCT03166631|323631208|FG004|Overall Study|Physician Decision|0|||
94501695|NCT03166631|323631209|FG005|Overall Study|Physician Decision|0|||
94501696|NCT03166631|323631210|FG006|Overall Study|Physician Decision|1|||
94501697|NCT03166631|323631211|FG007|Overall Study|Physician Decision|0|||
94501698|NCT03166631|323631212|FG008|Overall Study|Physician Decision|1|||
94501699|NCT03166631|323631213|FG009|Overall Study|Physician Decision|0|||
94501700|NCT03166631|323631214|FG010|Overall Study|Physician Decision|1|||
94501701|NCT03166631|323631204|FG000|Overall Study|Death|0|||
94501702|NCT03166631|323631205|FG001|Overall Study|Death|0|||
94501703|NCT03166631|323631206|FG002|Overall Study|Death|0|||
94501704|NCT03166631|323631207|FG003|Overall Study|Death|0|||
94501705|NCT03166631|323631208|FG004|Overall Study|Death|1|||
94501706|NCT03166631|323631209|FG005|Overall Study|Death|0|||
94501707|NCT03166631|323631210|FG006|Overall Study|Death|1|||
94501708|NCT03166631|323631211|FG007|Overall Study|Death|0|||
94501709|NCT03166631|323631212|FG008|Overall Study|Death|0|||
94501710|NCT03166631|323631213|FG009|Overall Study|Death|0|||
94501711|NCT03166631|323631214|FG010|Overall Study|Death|0|||
94501712|NCT03166631|323631204|FG000|Overall Study|Adverse Event|1|||
94501713|NCT03166631|323631205|FG001|Overall Study|Adverse Event|0|||
94501714|NCT03166631|323631206|FG002|Overall Study|Adverse Event|0|||
94501715|NCT03166631|323631207|FG003|Overall Study|Adverse Event|0|||
94501716|NCT03166631|323631208|FG004|Overall Study|Adverse Event|0|||
94501717|NCT03166631|323631209|FG005|Overall Study|Adverse Event|1|||
94501718|NCT03166631|323631210|FG006|Overall Study|Adverse Event|1|||
94501719|NCT03166631|323631211|FG007|Overall Study|Adverse Event|0|||
94501720|NCT03166631|323631212|FG008|Overall Study|Adverse Event|1|||
94501721|NCT03166631|323631213|FG009|Overall Study|Adverse Event|2|||
94501722|NCT03166631|323631214|FG010|Overall Study|Adverse Event|1|||
94501723|NCT03166631|323631204|FG000|Overall Study|Withdrawal by Subject|0|||
94501724|NCT03166631|323631205|FG001|Overall Study|Withdrawal by Subject|0|||
94501725|NCT03166631|323631206|FG002|Overall Study|Withdrawal by Subject|0|||
94501726|NCT03166631|323631207|FG003|Overall Study|Withdrawal by Subject|0|||
94501727|NCT03166631|323631208|FG004|Overall Study|Withdrawal by Subject|0|||
94501728|NCT03166631|323631209|FG005|Overall Study|Withdrawal by Subject|0|||
94501729|NCT03166631|323631210|FG006|Overall Study|Withdrawal by Subject|0|||
94501730|NCT03166631|323631211|FG007|Overall Study|Withdrawal by Subject|0|||
94501731|NCT03166631|323631212|FG008|Overall Study|Withdrawal by Subject|1|||
94501732|NCT03166631|323631213|FG009|Overall Study|Withdrawal by Subject|1|||
94501733|NCT03166631|323631214|FG010|Overall Study|Withdrawal by Subject|0|||
94501734|NCT03641924|323631217|FG000|Overall Study|Withdrawal by Subject|26|||
94501735|NCT03641924|323631217|FG000|Overall Study|Lost to Follow-up|16|||
94501736|NCT03641924|323631217|FG000|Overall Study|Protocol Violation|10|||
94501737|NCT00567580|323631218|FG000|Overall Study|Protocol Violation|28|||
94501738|NCT00567580|323631219|FG001|Overall Study|Protocol Violation|24|||
94501739|NCT00567580|323631220|FG002|Overall Study|Protocol Violation|24|||
94501740|NCT00394472|323631227|FG000|Overall Study|Protocol Violation|1|||
94501741|NCT00394472|323631228|FG001|Overall Study|Protocol Violation|3|||
94501742|NCT00394472|323631227|FG000|Overall Study|incorrect enrolment|4|||
94501743|NCT00394472|323631228|FG001|Overall Study|incorrect enrolment|2|||
94501744|NCT00394472|323631227|FG000|Overall Study|Adverse Event|4|||
94501745|NCT00394472|323631228|FG001|Overall Study|Adverse Event|2|||
94501746|NCT00394472|323631227|FG000|Overall Study|Withdrawal by Subject|0|||
94501747|NCT00394472|323631228|FG001|Overall Study|Withdrawal by Subject|2|||
94501748|NCT00394472|323631227|FG000|Overall Study|Physician Decision|0|||
94501749|NCT00394472|323631228|FG001|Overall Study|Physician Decision|1|||
94501750|NCT00394472|323631227|FG000|Overall Study|Lost to Follow-up|0|||
94501751|NCT00394472|323631228|FG001|Overall Study|Lost to Follow-up|1|||
94501752|NCT02383173|323631229|FG000|Overall Study|Palliative Care Team withdrew|0|||
94501753|NCT02383173|323631230|FG001|Overall Study|Palliative Care Team withdrew|2|||
94501754|NCT03055221|323631231|FG000|Overall Study|Adverse Event|2|||
94501755|NCT03055221|323631231|FG000|Overall Study|Withdrawal by Subject|4|||
94501756|NCT03055221|323631231|FG000|Overall Study|Death|6|||
94501757|NCT03055221|323631231|FG000|Overall Study|Physician Decision|1|||
94501758|NCT03055221|323631231|FG000|Overall Study|Study terminated by Sponsor|3|||
94501759|NCT03055221|323631231|FG000|Overall Study|Lost to Follow-up|4|||
94501760|NCT02391584|323631232|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
94501761|NCT02391584|323631233|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
94501762|NCT02391584|323631232|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
94501763|NCT02391584|323631233|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
94501764|NCT02391584|323631232|FG000|3 Month|Lost to Follow-up|1|||
94501765|NCT02391584|323631233|FG001|3 Month|Lost to Follow-up|0|||
94501766|NCT02391584|323631232|FG000|6 Month|Withdrawal by Subject|1|||
94501767|NCT02391584|323631233|FG001|6 Month|Withdrawal by Subject|0|||
94501768|NCT02391584|323631232|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
94501769|NCT02391584|323631233|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
94501770|NCT00710554|323631239|FG000|Overall Study|Adverse Event|24|||
94501771|NCT00710554|323631240|FG001|Overall Study|Adverse Event|7|||
94501772|NCT00710554|323631239|FG000|Overall Study|Withdrawal by Subject|7|||
94501773|NCT00710554|323631240|FG001|Overall Study|Withdrawal by Subject|3|||
94501774|NCT00710554|323631239|FG000|Overall Study|Lost to Follow-up|7|||
94501775|NCT00710554|323631240|FG001|Overall Study|Lost to Follow-up|1|||
94501776|NCT00710554|323631239|FG000|Overall Study|Lack of Efficacy|11|||
94501777|NCT00710554|323631240|FG001|Overall Study|Lack of Efficacy|12|||
94501778|NCT00710554|323631239|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
94501779|NCT00710554|323631240|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
94501780|NCT01560988|323631241|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
94501781|NCT01560988|323631242|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
94501782|NCT01560988|323631241|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
94501783|NCT01560988|323631242|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
94501784|NCT01560988|323631241|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
94501785|NCT01560988|323631242|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
94501786|NCT01346709|323631243|FG000|Overall Study|Protocol Violation|35|||
94501787|NCT01346709|323631243|FG000|Overall Study|Lost to Follow-up|31|||
94501788|NCT01346709|323631243|FG000|Overall Study|Missing data in candidate risk factor|285|||
94501789|NCT05156125|323631254|FG000|Overall Study|Lack of Efficacy|1|||
94501790|NCT05156125|323631255|FG001|Overall Study|Lack of Efficacy|1|||
94501791|NCT05156125|323631256|FG002|Overall Study|Lack of Efficacy|1|||
94501792|NCT05156125|323631254|FG000|Overall Study|Physician Decision|0|||
94501793|NCT05156125|323631255|FG001|Overall Study|Physician Decision|0|||
94501794|NCT05156125|323631256|FG002|Overall Study|Physician Decision|1|||
94501795|NCT05156125|323631254|FG000|Overall Study|Non-compliance|0|||
94501796|NCT05156125|323631255|FG001|Overall Study|Non-compliance|1|||
94501797|NCT05156125|323631256|FG002|Overall Study|Non-compliance|1|||
94501798|NCT05156125|323631254|FG000|Overall Study|Withdrawal by Subject|0|||
94501799|NCT05156125|323631255|FG001|Overall Study|Withdrawal by Subject|0|||
94501800|NCT05156125|323631256|FG002|Overall Study|Withdrawal by Subject|1|||
94501801|NCT05156125|323631254|FG000|Overall Study|Adverse Event|2|||
94501802|NCT05156125|323631255|FG001|Overall Study|Adverse Event|1|||
94501803|NCT05156125|323631256|FG002|Overall Study|Adverse Event|0|||
94501804|NCT02852434|323631257|FG000|Overall Study|Withdrawal by Subject|0|||
94501805|NCT02852434|323631258|FG001|Overall Study|Withdrawal by Subject|1|||
94501806|NCT02852434|323631257|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
94501807|NCT02852434|323631258|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
94501808|NCT00337194|323631259|FG000|Overall Study|Adverse Event|5|||
94501809|NCT00337194|323631260|FG001|Overall Study|Adverse Event|1|||
94501810|NCT00337194|323631259|FG000|Overall Study|Death|2|||
94501811|NCT00337194|323631260|FG001|Overall Study|Death|0|||
94501812|NCT00337194|323631259|FG000|Overall Study|Withdrawal by Subject|1|||
94501813|NCT00337194|323631260|FG001|Overall Study|Withdrawal by Subject|0|||
94501814|NCT00337194|323631259|FG000|Overall Study|Disease progression|1|||
94501815|NCT00337194|323631260|FG001|Overall Study|Disease progression|2|||
94501816|NCT00337194|323631259|FG000|Overall Study|Subsequent non-protocol therapy|3|||
94501817|NCT00337194|323631260|FG001|Overall Study|Subsequent non-protocol therapy|1|||
94501818|NCT02018887|323631261|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
94501819|NCT02018887|323631262|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
94501820|NCT02018887|323631263|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
94501821|NCT02018887|323631264|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
94501822|NCT02018887|323631265|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
94501823|NCT02018887|323631266|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
94501824|NCT02018887|323631267|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
94501825|NCT02018887|323631268|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
94501826|NCT02018887|323631269|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
94501827|NCT02018887|323631270|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
94501828|NCT02018887|323631271|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
94501829|NCT02018887|323631261|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
94501830|NCT02018887|323631262|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
94501831|NCT02018887|323631263|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
94501832|NCT02018887|323631264|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
94501833|NCT02018887|323631265|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
94501834|NCT02018887|323631266|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
94501835|NCT02018887|323631267|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
94501836|NCT02018887|323631268|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
94501837|NCT02018887|323631269|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
94501838|NCT02018887|323631270|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
94501839|NCT02018887|323631271|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
94501840|NCT02018887|323631261|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
94501841|NCT02018887|323631262|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
94501842|NCT02018887|323631263|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
94501843|NCT02018887|323631264|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
94501844|NCT02018887|323631265|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
94501845|NCT02018887|323631266|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
94501846|NCT02018887|323631267|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
94501847|NCT02018887|323631268|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
94501848|NCT02018887|323631269|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
94501849|NCT02018887|323631270|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
94501850|NCT02018887|323631271|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
94501851|NCT02018887|323631261|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
94501852|NCT02018887|323631262|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
94501853|NCT02018887|323631263|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
94501854|NCT02018887|323631264|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
94501855|NCT02018887|323631265|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
94501856|NCT02018887|323631266|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
94501857|NCT02018887|323631267|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
94501858|NCT02018887|323631268|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
94501859|NCT02018887|323631269|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
94501860|NCT02018887|323631270|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
94501861|NCT02018887|323631271|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
94501862|NCT00927186|323631276|FG000|12 Months Primary Study|Adverse Event|5|||
94501863|NCT00927186|323631277|FG001|12 Months Primary Study|Adverse Event|2|||
94501864|NCT00927186|323631276|FG000|12 Months Primary Study|Lost to Follow-up|1|||
94501865|NCT00927186|323631277|FG001|12 Months Primary Study|Lost to Follow-up|0|||
94501866|NCT00927186|323631276|FG000|12 Months Primary Study|Protocol Violation|0|||
94501867|NCT00927186|323631277|FG001|12 Months Primary Study|Protocol Violation|1|||
94501868|NCT00927186|323631276|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
94501869|NCT00927186|323631277|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
94501870|NCT00604383|323631278|FG000|Overall Study|Withdrawal by Subject|33|||
94501871|NCT00604383|323631279|FG001|Overall Study|Withdrawal by Subject|31|||
94501872|NCT00604383|323631278|FG000|Overall Study|Lost to Follow-up|24|||
94501873|NCT00604383|323631279|FG001|Overall Study|Lost to Follow-up|19|||
94501874|NCT00604383|323631278|FG000|Overall Study|Death|14|||
94501875|NCT00604383|323631279|FG001|Overall Study|Death|22|||
94501876|NCT00604383|323631278|FG000|Overall Study|Adverse Event|16|||
94501877|NCT00604383|323631279|FG001|Overall Study|Adverse Event|9|||
94501878|NCT00604383|323631278|FG000|Overall Study|Physician Decision|0|||
94501879|NCT00604383|323631279|FG001|Overall Study|Physician Decision|3|||
94501880|NCT01421134|323631284|FG000|Overall Study|Adverse Event|3|||
94501881|NCT01421134|323631285|FG001|Overall Study|Adverse Event|5|||
94501882|NCT01421134|323631284|FG000|Overall Study|Lack of Efficacy|2|||
94501883|NCT01421134|323631285|FG001|Overall Study|Lack of Efficacy|4|||
94501884|NCT01421134|323631284|FG000|Overall Study|Protocol Violation|0|||
94501885|NCT01421134|323631285|FG001|Overall Study|Protocol Violation|3|||
94501886|NCT01421134|323631284|FG000|Overall Study|Withdrawal by Subject|1|||
94501887|NCT01421134|323631285|FG001|Overall Study|Withdrawal by Subject|1|||
94501888|NCT01421134|323631284|FG000|Overall Study|Administrative|0|||
94501889|NCT01421134|323631285|FG001|Overall Study|Administrative|1|||
94501890|NCT01421134|323631284|FG000|Overall Study|Lost to Follow-up|1|||
94501891|NCT01421134|323631285|FG001|Overall Study|Lost to Follow-up|1|||
94501892|NCT03071965|323631289|FG000|Overall Study|Adverse Event|0|||
94501893|NCT03071965|323631290|FG001|Overall Study|Adverse Event|0|||
94501894|NCT03071965|323631291|FG002|Overall Study|Adverse Event|1|||
94501895|NCT03071965|323631292|FG003|Overall Study|Adverse Event|0|||
94501896|NCT03071965|323631289|FG000|Overall Study|Death|0|||
94501897|NCT03071965|323631290|FG001|Overall Study|Death|0|||
94501898|NCT03071965|323631291|FG002|Overall Study|Death|1|||
94501899|NCT03071965|323631292|FG003|Overall Study|Death|1|||
94501900|NCT03071965|323631289|FG000|Overall Study|COVID-19|0|||
94501901|NCT03071965|323631290|FG001|Overall Study|COVID-19|1|||
94501902|NCT03071965|323631291|FG002|Overall Study|COVID-19|0|||
94501903|NCT03071965|323631292|FG003|Overall Study|COVID-19|1|||
94501904|NCT03071965|323631289|FG000|Overall Study|Other Health Reason|0|||
94501905|NCT03071965|323631290|FG001|Overall Study|Other Health Reason|0|||
94501906|NCT03071965|323631291|FG002|Overall Study|Other Health Reason|0|||
94501907|NCT03071965|323631292|FG003|Overall Study|Other Health Reason|1|||
94501908|NCT01181128|323631294|FG000|Overall Study|Withdrawal by Subject|2|||
94501909|NCT01181128|323631295|FG001|Overall Study|Withdrawal by Subject|2|||
94501910|NCT01181128|323631296|FG002|Overall Study|Withdrawal by Subject|0|||
94501911|NCT01181128|323631294|FG000|Overall Study|Death|1|||
94501912|NCT01181128|323631295|FG001|Overall Study|Death|0|||
94501913|NCT01181128|323631296|FG002|Overall Study|Death|0|||
94501914|NCT01181128|323631294|FG000|Overall Study|Physician Decision|2|||
94501915|NCT01181128|323631295|FG001|Overall Study|Physician Decision|0|||
94501916|NCT01181128|323631296|FG002|Overall Study|Physician Decision|0|||
94501917|NCT01181128|323631294|FG000|Overall Study|Adverse Event|0|||
94501918|NCT01181128|323631295|FG001|Overall Study|Adverse Event|2|||
94501919|NCT01181128|323631296|FG002|Overall Study|Adverse Event|0|||
94501920|NCT01181128|323631294|FG000|Overall Study|Other|1|||
94501921|NCT01181128|323631295|FG001|Overall Study|Other|1|||
94501922|NCT01181128|323631296|FG002|Overall Study|Other|1|||
94501923|NCT04576949|323631300|FG000|Overall Study|Adverse Event|1|||
94501924|NCT04576949|323631301|FG001|Overall Study|Adverse Event|3|||
94501925|NCT04576949|323631302|FG002|Overall Study|Adverse Event|2|||
94501926|NCT04576949|323631300|FG000|Overall Study|Withdrawal by Subject|41|||
94501927|NCT04576949|323631301|FG001|Overall Study|Withdrawal by Subject|26|||
94501928|NCT04576949|323631302|FG002|Overall Study|Withdrawal by Subject|18|||
94501929|NCT04576949|323631300|FG000|Overall Study|Physician Decision|3|||
94501930|NCT04576949|323631301|FG001|Overall Study|Physician Decision|0|||
94501931|NCT04576949|323631302|FG002|Overall Study|Physician Decision|0|||
94501932|NCT04576949|323631300|FG000|Overall Study|Death|0|||
94501933|NCT04576949|323631301|FG001|Overall Study|Death|1|||
94501934|NCT04576949|323631302|FG002|Overall Study|Death|0|||
94501935|NCT04576949|323631300|FG000|Overall Study|Lost to Follow-up|29|||
94501936|NCT04576949|323631301|FG001|Overall Study|Lost to Follow-up|37|||
94501937|NCT04576949|323631302|FG002|Overall Study|Lost to Follow-up|24|||
94501938|NCT04576949|323631300|FG000|Overall Study|Other, Not Specified|2|||
94501939|NCT04576949|323631301|FG001|Overall Study|Other, Not Specified|3|||
94501940|NCT04576949|323631302|FG002|Overall Study|Other, Not Specified|1|||
94501941|NCT04576949|323631300|FG000|Overall Study|Other|1|||
94501942|NCT04576949|323631301|FG001|Overall Study|Other|0|||
94501943|NCT04576949|323631302|FG002|Overall Study|Other|0|||
94501944|NCT01210443|323631303|FG000|Overall Study|Study terminated by sponsor|2|||
94501945|NCT00472641|323631307|FG000|Overall Study|Lack of Efficacy|3|||
94501946|NCT00472641|323631307|FG000|Overall Study|Adverse Event|3|||
94501947|NCT00472641|323631307|FG000|Overall Study|Lost to Follow-up|1|||
94501948|NCT05652140|323631320|FG000|Overall Study|Lost to Follow-up|7|||
94501949|NCT05652140|323631321|FG001|Overall Study|Lost to Follow-up|16|||
94501950|NCT05652140|323631322|FG002|Overall Study|Lost to Follow-up|22|||
94501951|NCT05652140|323631323|FG003|Overall Study|Lost to Follow-up|31|||
94501952|NCT04796207|323631326|FG000|Overall Study|Lost to Follow-up|7|||
94501953|NCT04796207|323631327|FG001|Overall Study|Lost to Follow-up|2|||
94501954|NCT02205359|323631335|FG000|Overall Study|Death|293|||
94501955|NCT02205359|323631336|FG001|Overall Study|Death|327|||
94501956|NCT02205359|323631335|FG000|Overall Study|Lost to Follow-up|182|||
94501957|NCT02205359|323631336|FG001|Overall Study|Lost to Follow-up|162|||
94501958|NCT02205359|323631335|FG000|Overall Study|Physician Decision|51|||
94501959|NCT02205359|323631336|FG001|Overall Study|Physician Decision|53|||
94501960|NCT02205359|323631335|FG000|Overall Study|Withdrawal by Subject|167|||
94501961|NCT02205359|323631336|FG001|Overall Study|Withdrawal by Subject|169|||
94501962|NCT00562861|323631337|FG000|Overall Study|Adverse Event|1|||
94501963|NCT00562861|323631338|FG001|Overall Study|Adverse Event|1|||
94501964|NCT00562861|323631337|FG000|Overall Study|Lack of Efficacy|5|||
94501965|NCT00562861|323631338|FG001|Overall Study|Lack of Efficacy|5|||
94501966|NCT00562861|323631337|FG000|Overall Study|noncompliance, moved|7|||
94501967|NCT00562861|323631338|FG001|Overall Study|noncompliance, moved|2|||
94501968|NCT00562861|323631337|FG000|Overall Study|Lost to Follow-up|7|||
94501969|NCT00562861|323631338|FG001|Overall Study|Lost to Follow-up|3|||
94501970|NCT01348490|323631339|FG000|Overall Study|Death|1|||
94501971|NCT01348490|323631339|FG000|Overall Study|Adverse Event|3|||
94501972|NCT01348490|323631339|FG000|Overall Study|Consent withdrawn|7|||
94501973|NCT01348490|323631339|FG000|Overall Study|Disease progression|3|||
94501974|NCT01348490|323631339|FG000|Overall Study|Lost to Follow-up|1|||
94501975|NCT01348490|323631339|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
94501976|NCT01348490|323631339|FG000|Overall Study|Other Unspecified|8|||
94501977|NCT02792257|323631344|FG000|Overall Study|Lost to Follow-up|3|||
94501978|NCT02792257|323631345|FG001|Overall Study|Lost to Follow-up|4|||
94501979|NCT02792257|323631344|FG000|Overall Study|Allergy|0|||
94501980|NCT02792257|323631345|FG001|Overall Study|Allergy|1|||
94501981|NCT02792257|323631344|FG000|Overall Study|Protocol Violation|2|||
94501982|NCT02792257|323631345|FG001|Overall Study|Protocol Violation|0|||
94501983|NCT02792257|323631344|FG000|Overall Study|Excessive Agitation|0|||
94501984|NCT02792257|323631345|FG001|Overall Study|Excessive Agitation|1|||
94501985|NCT02792257|323631344|FG000|Overall Study|Not Feeling Well|0|||
94501986|NCT02792257|323631345|FG001|Overall Study|Not Feeling Well|1|||
94501987|NCT00507507|323631346|FG000|Treatment Period|Lost to Follow-up|0|||
94501988|NCT00507507|323631347|FG001|Treatment Period|Lost to Follow-up|2|||
94501989|NCT00507507|323631346|FG000|Treatment Period|Physician Decision|4|||
94501990|NCT00507507|323631347|FG001|Treatment Period|Physician Decision|1|||
94501991|NCT00507507|323631346|FG000|Treatment Period|Protocol Violation|1|||
94501992|NCT00507507|323631347|FG001|Treatment Period|Protocol Violation|2|||
94501993|NCT00507507|323631346|FG000|Treatment Period|Adverse Event|1|||
94501994|NCT00507507|323631347|FG001|Treatment Period|Adverse Event|1|||
94501995|NCT00507507|323631346|FG000|Treatment Period|Withdrawal by Subject|46|||
94501996|NCT00507507|323631347|FG001|Treatment Period|Withdrawal by Subject|47|||
94501997|NCT00507507|323631346|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
94501998|NCT00507507|323631347|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
94501999|NCT00507507|323631346|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
94502000|NCT00507507|323631347|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
94502001|NCT00507507|323631346|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
94502002|NCT00507507|323631347|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
94502003|NCT01694771|323631348|FG000|Overall Study|Adverse Event|18|||
94502004|NCT01694771|323631349|FG001|Overall Study|Adverse Event|16|||
94502005|NCT01694771|323631348|FG000|Overall Study|Lack of Efficacy|1|||
94502006|NCT01694771|323631349|FG001|Overall Study|Lack of Efficacy|0|||
94502007|NCT01694771|323631348|FG000|Overall Study|Non compliance protocol|7|||
94502008|NCT01694771|323631349|FG001|Overall Study|Non compliance protocol|6|||
94502009|NCT01694771|323631348|FG000|Overall Study|Lost to Follow-up|2|||
94502010|NCT01694771|323631349|FG001|Overall Study|Lost to Follow-up|3|||
94502011|NCT01694771|323631348|FG000|Overall Study|Consent withdrawn|7|||
94502012|NCT01694771|323631349|FG001|Overall Study|Consent withdrawn|9|||
94502013|NCT01694771|323631348|FG000|Overall Study|Other reasons|5|||
94502014|NCT01694771|323631349|FG001|Overall Study|Other reasons|6|||
94502015|NCT02946996|323631352|FG000|Overall Study|non-evaluable|3|||
94502016|NCT02946996|323631353|FG001|Overall Study|non-evaluable|6|||
94502017|NCT02946996|323631354|FG002|Overall Study|non-evaluable|5|||
94502018|NCT03289741|323631355|FG000|Overall Study|Adverse Event|1|||
94502019|NCT03289741|323631356|FG001|Overall Study|Adverse Event|1|||
94502020|NCT03289741|323631355|FG000|Overall Study|Physician Decision|2|||
94502021|NCT03289741|323631356|FG001|Overall Study|Physician Decision|2|||
94502022|NCT03289741|323631355|FG000|Overall Study|Withdrawal by Subject|1|||
94502023|NCT03289741|323631356|FG001|Overall Study|Withdrawal by Subject|0|||
94502024|NCT00954538|323631364|FG000|Part III|Withdrawal by Subject|0|||
94502025|NCT00954538|323631365|FG001|Part III|Withdrawal by Subject|0|||
94502026|NCT00954538|323631366|FG002|Part III|Withdrawal by Subject|0|||
94502027|NCT00954538|323631367|FG003|Part III|Withdrawal by Subject|0|||
94502028|NCT00954538|323631368|FG004|Part III|Withdrawal by Subject|1|||
94502029|NCT00954538|323631369|FG005|Part III|Withdrawal by Subject|0|||
94502030|NCT00450749|323631370|FG000|Overall Study|Withdrawal by Subject|0|||
94502031|NCT00450749|323631371|FG001|Overall Study|Withdrawal by Subject|0|||
94502032|NCT00450749|323631372|FG002|Overall Study|Withdrawal by Subject|2|||
94502033|NCT00450749|323631370|FG000|Overall Study|Noncompliant|0|||
94502034|NCT00450749|323631371|FG001|Overall Study|Noncompliant|1|||
94502035|NCT00450749|323631372|FG002|Overall Study|Noncompliant|0|||
94502036|NCT01245049|323631373|FG000|Overall Study|Migrated/moved from study area|0|||
94502037|NCT01245049|323631374|FG001|Overall Study|Migrated/moved from study area|1|||
94502038|NCT01245049|323631373|FG000|Overall Study|Withdrawal by Subject|0|||
94502039|NCT01245049|323631374|FG001|Overall Study|Withdrawal by Subject|1|||
94502040|NCT01245049|323631373|FG000|Overall Study|Lost to Follow-up|1|||
94502041|NCT01245049|323631374|FG001|Overall Study|Lost to Follow-up|2|||
94502042|NCT02568254|323631375|FG000|Period 2|Adverse Event|0|||
94502043|NCT02568254|323631376|FG001|Period 2|Adverse Event|0|||
94502044|NCT02568254|323631377|FG002|Period 2|Adverse Event|1|||
94502045|NCT02568254|323631378|FG003|Period 2|Adverse Event|0|||
94502046|NCT02568254|323631379|FG004|Period 2|Adverse Event|0|||
94502047|NCT02568254|323631380|FG005|Period 2|Adverse Event|0|||
94502048|NCT02568254|323631375|FG000|Period 3|Unstatisfactory Lens fitting|0|||
94502049|NCT02568254|323631376|FG001|Period 3|Unstatisfactory Lens fitting|0|||
94502050|NCT02568254|323631377|FG002|Period 3|Unstatisfactory Lens fitting|0|||
94502051|NCT02568254|323631378|FG003|Period 3|Unstatisfactory Lens fitting|0|||
94502052|NCT02568254|323631379|FG004|Period 3|Unstatisfactory Lens fitting|1|||
94502053|NCT02568254|323631380|FG005|Period 3|Unstatisfactory Lens fitting|0|||
94502054|NCT01734928|323633173|FG000|Randomization|Physician Decision|0|||
94502055|NCT01734928|323633174|FG001|Randomization|Physician Decision|1|||
94502056|NCT01734928|323633173|FG000|Randomization|clinical progression|0|||
94502057|NCT01734928|323633174|FG001|Randomization|clinical progression|1|||
94502058|NCT01734928|323633173|FG000|Randomization|progressive disease|0|||
94502059|NCT01734928|323633174|FG001|Randomization|progressive disease|2|||
94502060|NCT01734928|323633173|FG000|Randomization|Withdrew informed consent|0|||
94502061|NCT01734928|323633174|FG001|Randomization|Withdrew informed consent|4|||
94502062|NCT01734928|323633173|FG000|Randomization|Death|1|||
94502063|NCT01734928|323633174|FG001|Randomization|Death|0|||
94502064|NCT01734928|323633173|FG000|Randomization|Randomization error|1|||
94502065|NCT01734928|323633174|FG001|Randomization|Randomization error|0|||
94502066|NCT01734928|323633173|FG000|Randomization|Lost to Follow-up|1|||
94502067|NCT01734928|323633174|FG001|Randomization|Lost to Follow-up|0|||
94502068|NCT01734928|323633173|FG000|Treatment Period|Lost to Follow-up|0|||
94502069|NCT01734928|323633174|FG001|Treatment Period|Lost to Follow-up|2|||
94502070|NCT01734928|323633173|FG000|Treatment Period|Progressive Disease|167|||
94502071|NCT01734928|323633174|FG001|Treatment Period|Progressive Disease|165|||
94502072|NCT01734928|323633173|FG000|Treatment Period|Adverse Event|39|||
94502073|NCT01734928|323633174|FG001|Treatment Period|Adverse Event|52|||
94502074|NCT01734928|323633173|FG000|Treatment Period|Withdrawal of Consent|25|||
94502075|NCT01734928|323633174|FG001|Treatment Period|Withdrawal of Consent|22|||
94502076|NCT01734928|323633173|FG000|Treatment Period|Death|20|||
94502077|NCT01734928|323633174|FG001|Treatment Period|Death|9|||
94502078|NCT01734928|323633173|FG000|Treatment Period|Other Reasons|27|||
94502079|NCT01734928|323633174|FG001|Treatment Period|Other Reasons|19|||
94502080|NCT01734928|323633173|FG000|Treatment Period|Pregnancy|0|||
94502081|NCT01734928|323633174|FG001|Treatment Period|Pregnancy|1|||
94502082|NCT00985192|323633175|FG000|Overall Study|Withdrawal by Subject|1|||
94502083|NCT00985192|323633175|FG000|Overall Study|Disease Progression|1|||
94502084|NCT00985192|323633175|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
94502085|NCT00120250|323633181|FG000|Overall Study|Lost to Follow-up|1|||
94502086|NCT00120250|323633182|FG001|Overall Study|Lost to Follow-up|1|||
94502087|NCT00120250|323633181|FG000|Overall Study|Protocol Violation|0|||
94502088|NCT00120250|323633182|FG001|Overall Study|Protocol Violation|1|||
94502089|NCT00720083|323633183|FG000|Overall Study|Ineligible|1|||
94502090|NCT00720083|323633184|FG001|Overall Study|Ineligible|2|||
94502091|NCT03142451|323633185|FG000|Overall Study|Adverse Event|5|||
94502092|NCT03142451|323633186|FG001|Overall Study|Adverse Event|2|||
94502093|NCT03142451|323633185|FG000|Overall Study|Lost to Follow-up|25|||
94502094|NCT03142451|323633186|FG001|Overall Study|Lost to Follow-up|8|||
94502095|NCT03142451|323633185|FG000|Overall Study|Participant request|24|||
94502096|NCT03142451|323633186|FG001|Overall Study|Participant request|12|||
94502097|NCT03142451|323633185|FG000|Overall Study|Protocol Violation|3|||
94502098|NCT03142451|323633186|FG001|Overall Study|Protocol Violation|1|||
94502099|NCT03142451|323633185|FG000|Overall Study|Other|1|||
94502100|NCT03142451|323633186|FG001|Overall Study|Other|1|||
94502101|NCT00090402|323633187|FG000|Overall Study|Death|1|||
94502102|NCT00090402|323633188|FG001|Overall Study|Death|1|||
94502103|NCT00090402|323633189|FG002|Overall Study|Death|0|||
94502104|NCT00090402|323633187|FG000|Overall Study|subject moved|0|||
94502105|NCT00090402|323633188|FG001|Overall Study|subject moved|1|||
94502106|NCT00090402|323633189|FG002|Overall Study|subject moved|0|||
94502107|NCT00090402|323633187|FG000|Overall Study|stopped taking study medication|1|||
94502108|NCT00090402|323633188|FG001|Overall Study|stopped taking study medication|0|||
94502109|NCT00090402|323633189|FG002|Overall Study|stopped taking study medication|1|||
94502110|NCT00710970|323633192|FG000|Overall Study|Never took drug|3|||
94502111|NCT02004275|323633193|FG000|Phase 1|Ineligible|0|||
94502112|NCT02004275|323633194|FG001|Phase 1|Ineligible|0|||
94502113|NCT02004275|323633195|FG002|Phase 1|Ineligible|0|||
94502114|NCT02004275|323633196|FG003|Phase 1|Ineligible|1|||
94502115|NCT02004275|323633197|FG004|Phase 1|Ineligible|1|||
94502116|NCT02004275|323633198|FG005|Phase 1|Ineligible|0|||
94502117|NCT02004275|323633193|FG000|Phase 1|Protocol Violation|0|||
94502118|NCT02004275|323633194|FG001|Phase 1|Protocol Violation|0|||
94502119|NCT02004275|323633195|FG002|Phase 1|Protocol Violation|0|||
94502120|NCT02004275|323633196|FG003|Phase 1|Protocol Violation|1|||
94502121|NCT02004275|323633197|FG004|Phase 1|Protocol Violation|0|||
94502122|NCT02004275|323633198|FG005|Phase 1|Protocol Violation|5|||
94502123|NCT02004275|323633193|FG000|Phase 2 Part 1|Ineligible|6|||
94502124|NCT02004275|323633194|FG001|Phase 2 Part 1|Ineligible|9|||
94502125|NCT02004275|323633195|FG002|Phase 2 Part 1|Ineligible|0|||
94502126|NCT02004275|323633196|FG003|Phase 2 Part 1|Ineligible|0|||
94502127|NCT02004275|323633197|FG004|Phase 2 Part 1|Ineligible|0|||
94502128|NCT02004275|323633198|FG005|Phase 2 Part 1|Ineligible|0|||
94502129|NCT02004275|323633193|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
94502130|NCT02004275|323633194|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
94502131|NCT02004275|323633195|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
94502132|NCT02004275|323633196|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
94502133|NCT02004275|323633197|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
94502134|NCT02004275|323633198|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
94502135|NCT02533674|323633199|FG000|Dose Level I|Progressive disease|1|||
94502136|NCT02533674|323633200|FG001|Dose Level I|Progressive disease|0|||
94502137|NCT02533674|323633201|FG002|Dose Level I|Progressive disease|0|||
94502138|NCT02533674|323633202|FG003|Dose Level I|Progressive disease|0|||
94502139|NCT02533674|323633203|FG004|Dose Level I|Progressive disease|0|||
94502140|NCT02533674|323633204|FG005|Dose Level I|Progressive disease|0|||
94502141|NCT02533674|323633205|FG006|Dose Level I|Progressive disease|0|||
94502142|NCT02533674|323633206|FG007|Dose Level I|Progressive disease|0|||
94502143|NCT02533674|323633199|FG000|Dose Level I|Withdrawal by Subject|1|||
94502144|NCT02533674|323633200|FG001|Dose Level I|Withdrawal by Subject|0|||
94502145|NCT02533674|323633201|FG002|Dose Level I|Withdrawal by Subject|0|||
94502146|NCT02533674|323633202|FG003|Dose Level I|Withdrawal by Subject|0|||
94502147|NCT02533674|323633203|FG004|Dose Level I|Withdrawal by Subject|0|||
94502148|NCT02533674|323633204|FG005|Dose Level I|Withdrawal by Subject|0|||
94502149|NCT02533674|323633205|FG006|Dose Level I|Withdrawal by Subject|0|||
94502150|NCT02533674|323633206|FG007|Dose Level I|Withdrawal by Subject|0|||
94502151|NCT02533674|323633199|FG000|Dose Level I|Physician Decision|1|||
94502152|NCT02533674|323633200|FG001|Dose Level I|Physician Decision|0|||
94502153|NCT02533674|323633201|FG002|Dose Level I|Physician Decision|0|||
94502154|NCT02533674|323633202|FG003|Dose Level I|Physician Decision|0|||
94502155|NCT02533674|323633203|FG004|Dose Level I|Physician Decision|0|||
94502156|NCT02533674|323633204|FG005|Dose Level I|Physician Decision|0|||
94502157|NCT02533674|323633205|FG006|Dose Level I|Physician Decision|0|||
94502158|NCT02533674|323633206|FG007|Dose Level I|Physician Decision|0|||
94502159|NCT02533674|323633199|FG000|Dose Level I|Death|1|||
94502160|NCT02533674|323633200|FG001|Dose Level I|Death|0|||
94502161|NCT02533674|323633201|FG002|Dose Level I|Death|0|||
94502162|NCT02533674|323633202|FG003|Dose Level I|Death|0|||
94502163|NCT02533674|323633203|FG004|Dose Level I|Death|0|||
94502164|NCT02533674|323633204|FG005|Dose Level I|Death|0|||
94502165|NCT02533674|323633205|FG006|Dose Level I|Death|0|||
94502166|NCT02533674|323633206|FG007|Dose Level I|Death|0|||
94502167|NCT02533674|323633199|FG000|Dose Level I|Never Treated|1|||
94502168|NCT02533674|323633200|FG001|Dose Level I|Never Treated|0|||
94502169|NCT02533674|323633201|FG002|Dose Level I|Never Treated|0|||
94502170|NCT02533674|323633202|FG003|Dose Level I|Never Treated|0|||
94502171|NCT02533674|323633203|FG004|Dose Level I|Never Treated|0|||
94502172|NCT02533674|323633204|FG005|Dose Level I|Never Treated|0|||
94502173|NCT02533674|323633205|FG006|Dose Level I|Never Treated|0|||
94502174|NCT02533674|323633206|FG007|Dose Level I|Never Treated|0|||
94502175|NCT02533674|323633199|FG000|Dose Level II|Progressive disease|0|||
94502176|NCT02533674|323633200|FG001|Dose Level II|Progressive disease|3|||
94502177|NCT02533674|323633201|FG002|Dose Level II|Progressive disease|0|||
94502178|NCT02533674|323633202|FG003|Dose Level II|Progressive disease|0|||
94502179|NCT02533674|323633203|FG004|Dose Level II|Progressive disease|0|||
94502180|NCT02533674|323633204|FG005|Dose Level II|Progressive disease|0|||
94502181|NCT02533674|323633205|FG006|Dose Level II|Progressive disease|0|||
94502182|NCT02533674|323633206|FG007|Dose Level II|Progressive disease|0|||
94502183|NCT02533674|323633199|FG000|Dose Level II|Withdrawal by Subject|0|||
94502184|NCT02533674|323633200|FG001|Dose Level II|Withdrawal by Subject|1|||
94502185|NCT02533674|323633201|FG002|Dose Level II|Withdrawal by Subject|0|||
94502186|NCT02533674|323633202|FG003|Dose Level II|Withdrawal by Subject|0|||
94502187|NCT02533674|323633203|FG004|Dose Level II|Withdrawal by Subject|0|||
94502188|NCT02533674|323633204|FG005|Dose Level II|Withdrawal by Subject|0|||
94502189|NCT02533674|323633205|FG006|Dose Level II|Withdrawal by Subject|0|||
94502190|NCT02533674|323633206|FG007|Dose Level II|Withdrawal by Subject|0|||
94502191|NCT02533674|323633199|FG000|Dose Level II|Treatment-related AE|0|||
94502192|NCT02533674|323633200|FG001|Dose Level II|Treatment-related AE|1|||
94502193|NCT02533674|323633201|FG002|Dose Level II|Treatment-related AE|0|||
94502194|NCT02533674|323633202|FG003|Dose Level II|Treatment-related AE|0|||
94502195|NCT02533674|323633203|FG004|Dose Level II|Treatment-related AE|0|||
94502196|NCT02533674|323633204|FG005|Dose Level II|Treatment-related AE|0|||
94502197|NCT02533674|323633205|FG006|Dose Level II|Treatment-related AE|0|||
94502198|NCT02533674|323633206|FG007|Dose Level II|Treatment-related AE|0|||
94502199|NCT02533674|323633199|FG000|Dose Level II|Physician Decision|0|||
94502200|NCT02533674|323633200|FG001|Dose Level II|Physician Decision|1|||
94502201|NCT02533674|323633201|FG002|Dose Level II|Physician Decision|0|||
94502202|NCT02533674|323633202|FG003|Dose Level II|Physician Decision|0|||
94502203|NCT02533674|323633203|FG004|Dose Level II|Physician Decision|0|||
94502204|NCT02533674|323633204|FG005|Dose Level II|Physician Decision|0|||
94502205|NCT02533674|323633205|FG006|Dose Level II|Physician Decision|0|||
94502206|NCT02533674|323633206|FG007|Dose Level II|Physician Decision|0|||
94502207|NCT02533674|323633199|FG000|Dose Level II|Non-treatment-related AE|0|||
94502208|NCT02533674|323633200|FG001|Dose Level II|Non-treatment-related AE|1|||
94502209|NCT02533674|323633201|FG002|Dose Level II|Non-treatment-related AE|0|||
94502210|NCT02533674|323633202|FG003|Dose Level II|Non-treatment-related AE|0|||
94502211|NCT02533674|323633203|FG004|Dose Level II|Non-treatment-related AE|0|||
94502212|NCT02533674|323633204|FG005|Dose Level II|Non-treatment-related AE|0|||
94502213|NCT02533674|323633205|FG006|Dose Level II|Non-treatment-related AE|0|||
94502214|NCT02533674|323633206|FG007|Dose Level II|Non-treatment-related AE|0|||
94502215|NCT02533674|323633199|FG000|Dose Level III|Progressive disease|0|||
94502216|NCT02533674|323633200|FG001|Dose Level III|Progressive disease|0|||
94502217|NCT02533674|323633201|FG002|Dose Level III|Progressive disease|2|||
94502218|NCT02533674|323633202|FG003|Dose Level III|Progressive disease|0|||
94502219|NCT02533674|323633203|FG004|Dose Level III|Progressive disease|0|||
94502220|NCT02533674|323633204|FG005|Dose Level III|Progressive disease|0|||
94502221|NCT02533674|323633205|FG006|Dose Level III|Progressive disease|0|||
94502222|NCT02533674|323633206|FG007|Dose Level III|Progressive disease|0|||
94502223|NCT02533674|323633199|FG000|Dose Level III|Withdrawal by Subject|0|||
94502224|NCT02533674|323633200|FG001|Dose Level III|Withdrawal by Subject|0|||
94502225|NCT02533674|323633201|FG002|Dose Level III|Withdrawal by Subject|1|||
94502226|NCT02533674|323633202|FG003|Dose Level III|Withdrawal by Subject|0|||
94502227|NCT02533674|323633203|FG004|Dose Level III|Withdrawal by Subject|0|||
94502228|NCT02533674|323633204|FG005|Dose Level III|Withdrawal by Subject|0|||
94502229|NCT02533674|323633205|FG006|Dose Level III|Withdrawal by Subject|0|||
94502230|NCT02533674|323633206|FG007|Dose Level III|Withdrawal by Subject|0|||
94502231|NCT02533674|323633199|FG000|Dose Level III|Treatment-related AE|0|||
94502232|NCT02533674|323633200|FG001|Dose Level III|Treatment-related AE|0|||
94502233|NCT02533674|323633201|FG002|Dose Level III|Treatment-related AE|1|||
94502234|NCT02533674|323633202|FG003|Dose Level III|Treatment-related AE|0|||
94502235|NCT02533674|323633203|FG004|Dose Level III|Treatment-related AE|0|||
94502236|NCT02533674|323633204|FG005|Dose Level III|Treatment-related AE|0|||
94502237|NCT02533674|323633205|FG006|Dose Level III|Treatment-related AE|0|||
94502238|NCT02533674|323633206|FG007|Dose Level III|Treatment-related AE|0|||
94502239|NCT02533674|323633199|FG000|Dose Level IV|Progressive disease|0|||
94502240|NCT02533674|323633200|FG001|Dose Level IV|Progressive disease|0|||
94502241|NCT02533674|323633201|FG002|Dose Level IV|Progressive disease|0|||
94502242|NCT02533674|323633202|FG003|Dose Level IV|Progressive disease|3|||
94502243|NCT02533674|323633203|FG004|Dose Level IV|Progressive disease|0|||
94502244|NCT02533674|323633204|FG005|Dose Level IV|Progressive disease|0|||
94502245|NCT02533674|323633205|FG006|Dose Level IV|Progressive disease|0|||
94502246|NCT02533674|323633206|FG007|Dose Level IV|Progressive disease|0|||
94502247|NCT02533674|323633199|FG000|Dose Level IV|Withdrawal by Subject|0|||
94502248|NCT02533674|323633200|FG001|Dose Level IV|Withdrawal by Subject|0|||
94502249|NCT02533674|323633201|FG002|Dose Level IV|Withdrawal by Subject|0|||
94502250|NCT02533674|323633202|FG003|Dose Level IV|Withdrawal by Subject|1|||
94502251|NCT02533674|323633203|FG004|Dose Level IV|Withdrawal by Subject|0|||
94502252|NCT02533674|323633204|FG005|Dose Level IV|Withdrawal by Subject|0|||
94502253|NCT02533674|323633205|FG006|Dose Level IV|Withdrawal by Subject|0|||
94502254|NCT02533674|323633206|FG007|Dose Level IV|Withdrawal by Subject|0|||
94502255|NCT02533674|323633199|FG000|Dose Level IV|Physician Decision|0|||
94502256|NCT02533674|323633200|FG001|Dose Level IV|Physician Decision|0|||
94502257|NCT02533674|323633201|FG002|Dose Level IV|Physician Decision|0|||
94502258|NCT02533674|323633202|FG003|Dose Level IV|Physician Decision|1|||
94502259|NCT02533674|323633203|FG004|Dose Level IV|Physician Decision|0|||
94502260|NCT02533674|323633204|FG005|Dose Level IV|Physician Decision|0|||
94502261|NCT02533674|323633205|FG006|Dose Level IV|Physician Decision|0|||
94502262|NCT02533674|323633206|FG007|Dose Level IV|Physician Decision|0|||
94502263|NCT02533674|323633199|FG000|Dose Level V|Progressive disease|0|||
94502264|NCT02533674|323633200|FG001|Dose Level V|Progressive disease|0|||
94502265|NCT02533674|323633201|FG002|Dose Level V|Progressive disease|0|||
94502266|NCT02533674|323633202|FG003|Dose Level V|Progressive disease|0|||
94502267|NCT02533674|323633203|FG004|Dose Level V|Progressive disease|3|||
94502268|NCT02533674|323633204|FG005|Dose Level V|Progressive disease|0|||
94502269|NCT02533674|323633205|FG006|Dose Level V|Progressive disease|0|||
94502270|NCT02533674|323633206|FG007|Dose Level V|Progressive disease|0|||
94502271|NCT02533674|323633199|FG000|Dose Level V|Withdrawal by Subject|0|||
94502272|NCT02533674|323633200|FG001|Dose Level V|Withdrawal by Subject|0|||
94502273|NCT02533674|323633201|FG002|Dose Level V|Withdrawal by Subject|0|||
94502274|NCT02533674|323633202|FG003|Dose Level V|Withdrawal by Subject|0|||
94502275|NCT02533674|323633203|FG004|Dose Level V|Withdrawal by Subject|1|||
94502276|NCT02533674|323633204|FG005|Dose Level V|Withdrawal by Subject|0|||
94502277|NCT02533674|323633205|FG006|Dose Level V|Withdrawal by Subject|0|||
94502278|NCT02533674|323633206|FG007|Dose Level V|Withdrawal by Subject|0|||
94502279|NCT02533674|323633199|FG000|Dose Level V|Physician Decision|0|||
94502280|NCT02533674|323633200|FG001|Dose Level V|Physician Decision|0|||
94502281|NCT02533674|323633201|FG002|Dose Level V|Physician Decision|0|||
94502282|NCT02533674|323633202|FG003|Dose Level V|Physician Decision|0|||
94502283|NCT02533674|323633203|FG004|Dose Level V|Physician Decision|1|||
94502284|NCT02533674|323633204|FG005|Dose Level V|Physician Decision|0|||
94502285|NCT02533674|323633205|FG006|Dose Level V|Physician Decision|0|||
94502286|NCT02533674|323633206|FG007|Dose Level V|Physician Decision|0|||
94502287|NCT02533674|323633199|FG000|Dose Level VI|Progressive disease|0|||
94502288|NCT02533674|323633200|FG001|Dose Level VI|Progressive disease|0|||
94502289|NCT02533674|323633201|FG002|Dose Level VI|Progressive disease|0|||
94502290|NCT02533674|323633202|FG003|Dose Level VI|Progressive disease|0|||
94502291|NCT02533674|323633203|FG004|Dose Level VI|Progressive disease|0|||
94502292|NCT02533674|323633204|FG005|Dose Level VI|Progressive disease|7|||
94502293|NCT02533674|323633205|FG006|Dose Level VI|Progressive disease|0|||
94502294|NCT02533674|323633206|FG007|Dose Level VI|Progressive disease|0|||
94502295|NCT02533674|323633199|FG000|Dose Level VI|Withdrawal by Subject|0|||
94502296|NCT02533674|323633200|FG001|Dose Level VI|Withdrawal by Subject|0|||
94502297|NCT02533674|323633201|FG002|Dose Level VI|Withdrawal by Subject|0|||
94502298|NCT02533674|323633202|FG003|Dose Level VI|Withdrawal by Subject|0|||
94502299|NCT02533674|323633203|FG004|Dose Level VI|Withdrawal by Subject|0|||
94502300|NCT02533674|323633204|FG005|Dose Level VI|Withdrawal by Subject|1|||
94502301|NCT02533674|323633205|FG006|Dose Level VI|Withdrawal by Subject|0|||
94502302|NCT02533674|323633206|FG007|Dose Level VI|Withdrawal by Subject|0|||
94502303|NCT02533674|323633199|FG000|Dose Level VI|Treatment-related AE|0|||
94502304|NCT02533674|323633200|FG001|Dose Level VI|Treatment-related AE|0|||
94502305|NCT02533674|323633201|FG002|Dose Level VI|Treatment-related AE|0|||
94502306|NCT02533674|323633202|FG003|Dose Level VI|Treatment-related AE|0|||
94502307|NCT02533674|323633203|FG004|Dose Level VI|Treatment-related AE|0|||
94502308|NCT02533674|323633204|FG005|Dose Level VI|Treatment-related AE|1|||
94502309|NCT02533674|323633205|FG006|Dose Level VI|Treatment-related AE|0|||
94502310|NCT02533674|323633206|FG007|Dose Level VI|Treatment-related AE|0|||
94502311|NCT02533674|323633199|FG000|Dose Level VII|Progressive disease|0|||
94502312|NCT02533674|323633200|FG001|Dose Level VII|Progressive disease|0|||
94502313|NCT02533674|323633201|FG002|Dose Level VII|Progressive disease|0|||
94502314|NCT02533674|323633202|FG003|Dose Level VII|Progressive disease|0|||
94502315|NCT02533674|323633203|FG004|Dose Level VII|Progressive disease|0|||
94502316|NCT02533674|323633204|FG005|Dose Level VII|Progressive disease|0|||
94502317|NCT02533674|323633205|FG006|Dose Level VII|Progressive disease|10|||
94502318|NCT02533674|323633206|FG007|Dose Level VII|Progressive disease|0|||
94502319|NCT02533674|323633199|FG000|Dose Level VII|Withdrawal by Subject|0|||
94502320|NCT02533674|323633200|FG001|Dose Level VII|Withdrawal by Subject|0|||
94502321|NCT02533674|323633201|FG002|Dose Level VII|Withdrawal by Subject|0|||
94502322|NCT02533674|323633202|FG003|Dose Level VII|Withdrawal by Subject|0|||
94502323|NCT02533674|323633203|FG004|Dose Level VII|Withdrawal by Subject|0|||
94502324|NCT02533674|323633204|FG005|Dose Level VII|Withdrawal by Subject|0|||
94502325|NCT02533674|323633205|FG006|Dose Level VII|Withdrawal by Subject|3|||
94502326|NCT02533674|323633206|FG007|Dose Level VII|Withdrawal by Subject|0|||
94502327|NCT02533674|323633199|FG000|Dose Level VII|Treatment-related AE|0|||
94502328|NCT02533674|323633200|FG001|Dose Level VII|Treatment-related AE|0|||
94502329|NCT02533674|323633201|FG002|Dose Level VII|Treatment-related AE|0|||
94502330|NCT02533674|323633202|FG003|Dose Level VII|Treatment-related AE|0|||
94502331|NCT02533674|323633203|FG004|Dose Level VII|Treatment-related AE|0|||
94502332|NCT02533674|323633204|FG005|Dose Level VII|Treatment-related AE|0|||
94502333|NCT02533674|323633205|FG006|Dose Level VII|Treatment-related AE|1|||
94502334|NCT02533674|323633206|FG007|Dose Level VII|Treatment-related AE|0|||
94502335|NCT02533674|323633199|FG000|Dose Level VII|Death|0|||
94502336|NCT02533674|323633200|FG001|Dose Level VII|Death|0|||
94502337|NCT02533674|323633201|FG002|Dose Level VII|Death|0|||
94502338|NCT02533674|323633202|FG003|Dose Level VII|Death|0|||
94502339|NCT02533674|323633203|FG004|Dose Level VII|Death|0|||
94502340|NCT02533674|323633204|FG005|Dose Level VII|Death|0|||
94502341|NCT02533674|323633205|FG006|Dose Level VII|Death|2|||
94502342|NCT02533674|323633206|FG007|Dose Level VII|Death|0|||
94502343|NCT02533674|323633199|FG000|Dose Level VIII|Progressive disease|0|||
94502344|NCT02533674|323633200|FG001|Dose Level VIII|Progressive disease|0|||
94502345|NCT02533674|323633201|FG002|Dose Level VIII|Progressive disease|0|||
94502346|NCT02533674|323633202|FG003|Dose Level VIII|Progressive disease|0|||
94502347|NCT02533674|323633203|FG004|Dose Level VIII|Progressive disease|0|||
94502348|NCT02533674|323633204|FG005|Dose Level VIII|Progressive disease|0|||
94502349|NCT02533674|323633205|FG006|Dose Level VIII|Progressive disease|0|||
94502350|NCT02533674|323633206|FG007|Dose Level VIII|Progressive disease|3|||
94502351|NCT02533674|323633199|FG000|Dose Level VIII|Withdrawal by Subject|0|||
94502352|NCT02533674|323633200|FG001|Dose Level VIII|Withdrawal by Subject|0|||
94502353|NCT02533674|323633201|FG002|Dose Level VIII|Withdrawal by Subject|0|||
94502354|NCT02533674|323633202|FG003|Dose Level VIII|Withdrawal by Subject|0|||
94502355|NCT02533674|323633203|FG004|Dose Level VIII|Withdrawal by Subject|0|||
94502356|NCT02533674|323633204|FG005|Dose Level VIII|Withdrawal by Subject|0|||
94502357|NCT02533674|323633205|FG006|Dose Level VIII|Withdrawal by Subject|0|||
94502358|NCT02533674|323633206|FG007|Dose Level VIII|Withdrawal by Subject|1|||
94502359|NCT02533674|323633199|FG000|Dose Level VIII|Treatment-related AE|0|||
94502360|NCT02533674|323633200|FG001|Dose Level VIII|Treatment-related AE|0|||
94502361|NCT02533674|323633201|FG002|Dose Level VIII|Treatment-related AE|0|||
94502362|NCT02533674|323633202|FG003|Dose Level VIII|Treatment-related AE|0|||
94502363|NCT02533674|323633203|FG004|Dose Level VIII|Treatment-related AE|0|||
94502364|NCT02533674|323633204|FG005|Dose Level VIII|Treatment-related AE|0|||
94502365|NCT02533674|323633205|FG006|Dose Level VIII|Treatment-related AE|0|||
94502366|NCT02533674|323633206|FG007|Dose Level VIII|Treatment-related AE|1|||
94502367|NCT02533674|323633199|FG000|Dose Level VIII|Never treated|0|||
94502368|NCT02533674|323633200|FG001|Dose Level VIII|Never treated|0|||
94502369|NCT02533674|323633201|FG002|Dose Level VIII|Never treated|0|||
94502370|NCT02533674|323633202|FG003|Dose Level VIII|Never treated|0|||
94502371|NCT02533674|323633203|FG004|Dose Level VIII|Never treated|0|||
94502372|NCT02533674|323633204|FG005|Dose Level VIII|Never treated|0|||
94502373|NCT02533674|323633205|FG006|Dose Level VIII|Never treated|0|||
94502374|NCT02533674|323633206|FG007|Dose Level VIII|Never treated|1|||
94502375|NCT01433978|323633213|FG000|Core Study|Adverse Event, Non-Fatal|0|||
94502376|NCT01433978|323633214|FG001|Core Study|Adverse Event, Non-Fatal|1|||
94502377|NCT01433978|323633215|FG002|Core Study|Adverse Event, Non-Fatal|0|||
94502378|NCT01433978|323633213|FG000|Core Study|Lack of Efficacy|5|||
94502379|NCT01433978|323633214|FG001|Core Study|Lack of Efficacy|1|||
94502380|NCT01433978|323633215|FG002|Core Study|Lack of Efficacy|0|||
94502381|NCT01433978|323633213|FG000|Core Study|Study Terminated by Sponsor|6|||
94502382|NCT01433978|323633214|FG001|Core Study|Study Terminated by Sponsor|9|||
94502383|NCT01433978|323633215|FG002|Core Study|Study Terminated by Sponsor|0|||
94502384|NCT01433978|323633213|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
94502385|NCT01433978|323633214|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
94502386|NCT01433978|323633215|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
94502387|NCT01433978|323633213|FG000|Extension Phase|Lack of Efficacy|0|||
94502388|NCT01433978|323633214|FG001|Extension Phase|Lack of Efficacy|0|||
94502389|NCT01433978|323633215|FG002|Extension Phase|Lack of Efficacy|1|||
94502390|NCT01433978|323633213|FG000|Extension Phase|Study Terminated by Sponsor|0|||
94502391|NCT01433978|323633214|FG001|Extension Phase|Study Terminated by Sponsor|0|||
94502392|NCT01433978|323633215|FG002|Extension Phase|Study Terminated by Sponsor|4|||
94502393|NCT01773889|323633222|FG000|Overall Study|lack of funding|2|||
94502394|NCT02301429|323633223|FG000|Overall Study|not acceptable vascular anatomy|3|||
94502397|NCT01716559|323633226|FG000|Overall Study|Adverse Event|11|||
94502398|NCT01716559|323633226|FG000|Overall Study|Death|21|||
94502399|NCT01716559|323633226|FG000|Overall Study|Withdrawal by Subject|4|||
94502400|NCT01716559|323633226|FG000|Overall Study|Other withdrawal reason|75|||
94502401|NCT03636269|323633229|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
94502402|NCT03636269|323633230|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
94502403|NCT03636269|323633231|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
94502404|NCT03636269|323633229|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
94502405|NCT03636269|323633230|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
94502406|NCT03636269|323633231|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
94502407|NCT03636269|323633229|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
94502408|NCT03636269|323633230|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
94502409|NCT03636269|323633231|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
94502410|NCT03636269|323633229|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
94502411|NCT03636269|323633230|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
94502412|NCT03636269|323633231|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
94502413|NCT03636269|323633229|FG000|Period 1: Double-blind Phase|Other|6|||
94502414|NCT03636269|323633230|FG001|Period 1: Double-blind Phase|Other|3|||
94502415|NCT03636269|323633231|FG002|Period 1: Double-blind Phase|Other|0|||
94502416|NCT03636269|323633229|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
94502417|NCT03636269|323633230|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
94502418|NCT03636269|323633231|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
94502419|NCT03636269|323633229|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
94502420|NCT03636269|323633230|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
94502421|NCT03636269|323633231|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
94502422|NCT03636269|323633229|FG000|Period 2: Open-label Phase|Adverse Event|0|||
94502423|NCT03636269|323633230|FG001|Period 2: Open-label Phase|Adverse Event|0|||
94502424|NCT03636269|323633231|FG002|Period 2: Open-label Phase|Adverse Event|21|||
94502425|NCT03636269|323633229|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
94502426|NCT03636269|323633230|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
94502427|NCT03636269|323633231|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
94502428|NCT03636269|323633229|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
94502429|NCT03636269|323633230|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
94502430|NCT03636269|323633231|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
94502431|NCT03636269|323633229|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
94502432|NCT03636269|323633230|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
94502433|NCT03636269|323633231|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
94502434|NCT03636269|323633229|FG000|Period 2: Open-label Phase|Administrative|0|||
94502435|NCT03636269|323633230|FG001|Period 2: Open-label Phase|Administrative|0|||
94502436|NCT03636269|323633231|FG002|Period 2: Open-label Phase|Administrative|36|||
94502437|NCT03636269|323633229|FG000|Period 2: Open-label Phase|Other|0|||
94502438|NCT03636269|323633230|FG001|Period 2: Open-label Phase|Other|0|||
94502439|NCT03636269|323633231|FG002|Period 2: Open-label Phase|Other|9|||
94502440|NCT03636269|323633229|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
94502441|NCT03636269|323633230|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
94502442|NCT03636269|323633231|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
94502443|NCT00290758|323633236|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
94502444|NCT00290758|323633237|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
94502445|NCT00290758|323633236|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
94502446|NCT00290758|323633237|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
94502447|NCT00290758|323633236|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
94502448|NCT00290758|323633237|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
94502449|NCT00290758|323633236|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
94502450|NCT00290758|323633237|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
94502451|NCT00290758|323633236|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
94502452|NCT00290758|323633237|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
94502453|NCT00290758|323633236|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
94502454|NCT00290758|323633237|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
94502455|NCT00290758|323633236|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
94502456|NCT00290758|323633237|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
94502457|NCT00290758|323633236|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
94502458|NCT00290758|323633237|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
94502459|NCT03436420|323633239|FG000|Overall Study|Lack of Efficacy|3|||
94502460|NCT04389671|323633240|FG000|Overall Study|Death|7|||
94502461|NCT03994120|323633241|FG000|Overall Study|Lost to Follow-up|3|||
94502462|NCT03994120|323633242|FG001|Overall Study|Lost to Follow-up|1|||
94502463|NCT00474968|323633243|FG000|Overall Study|Withdrawal by Subject|8|||
94502464|NCT00474968|323633244|FG001|Overall Study|Withdrawal by Subject|7|||
94502465|NCT00474968|323633243|FG000|Overall Study|Protocol Violation|9|||
94502466|NCT00474968|323633244|FG001|Overall Study|Protocol Violation|8|||
94502467|NCT00474968|323633243|FG000|Overall Study|Sample not collected|1|||
94502468|NCT00474968|323633244|FG001|Overall Study|Sample not collected|1|||
94502469|NCT04914000|323633245|FG000|Overall Study|Lost to Follow-up|8|||
94502470|NCT04914000|323633245|FG000|Overall Study|Withdrawal by Subject|1|||
94502471|NCT03178942|323633246|FG000|Overall Study|Withdrawal by Subject|2|||
94502472|NCT03178942|323633247|FG001|Overall Study|Withdrawal by Subject|0|||
94502473|NCT03178942|323633246|FG000|Overall Study|Lost to Follow-up|1|||
94502474|NCT03178942|323633247|FG001|Overall Study|Lost to Follow-up|2|||
94502475|NCT00981175|323633248|FG000|Primary Dose Vaccination|Adverse Event|1|||
94502476|NCT00981175|323633249|FG001|Primary Dose Vaccination|Adverse Event|0|||
94502477|NCT00981175|323633248|FG000|Primary Dose Vaccination|Protocol Violation|0|||
94502478|NCT00981175|323633249|FG001|Primary Dose Vaccination|Protocol Violation|1|||
94502479|NCT00981175|323633248|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
94502480|NCT00981175|323633249|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
94502481|NCT00981175|323633248|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
94502482|NCT00981175|323633249|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
94502483|NCT02619812|323633250|FG000|Overall Study|Withdrawal by Subject|0|||
94502484|NCT02619812|323633251|FG001|Overall Study|Withdrawal by Subject|0|||
94502485|NCT02619812|323633252|FG002|Overall Study|Withdrawal by Subject|1|||
94502486|NCT02619812|323633253|FG003|Overall Study|Withdrawal by Subject|2|||
94502487|NCT01096186|323633254|FG000|Overall Study|Adverse Event|16|||
94502488|NCT01096186|323633254|FG000|Overall Study|Death|4|||
94502489|NCT01096186|323633254|FG000|Overall Study|Lack of Efficacy|4|||
94502490|NCT01096186|323633254|FG000|Overall Study|Lost to Follow-up|2|||
94502491|NCT01096186|323633254|FG000|Overall Study|Withdrawal by Subject|22|||
94502492|NCT01096186|323633254|FG000|Overall Study|Physician Decision|1|||
94502493|NCT01096186|323633254|FG000|Overall Study|Noncompliance with study drug|1|||
94502494|NCT01896986|323633255|FG000|Overall Study|samples lost|14|||
94502495|NCT01896986|323633256|FG001|Overall Study|samples lost|23|||
94502496|NCT04189588|323633257|FG000|Overall Study|Death|0|||
94502497|NCT04189588|323633258|FG001|Overall Study|Death|1|||
94502498|NCT04189588|323633257|FG000|Overall Study|Lost to Follow-up|0|||
94502499|NCT04189588|323633258|FG001|Overall Study|Lost to Follow-up|1|||
94502500|NCT00281580|323633261|FG000|Overall Study|Adverse Event|2|||
94502501|NCT00281580|323633262|FG001|Overall Study|Adverse Event|0|||
94502502|NCT00281580|323633263|FG002|Overall Study|Adverse Event|2|||
94502503|NCT00281580|323633264|FG003|Overall Study|Adverse Event|4|||
94502504|NCT00281580|323633265|FG004|Overall Study|Adverse Event|1|||
94502505|NCT00281580|323633266|FG005|Overall Study|Adverse Event|0|||
94502506|NCT00281580|323633267|FG006|Overall Study|Adverse Event|1|||
94502507|NCT00281580|323633268|FG007|Overall Study|Adverse Event|0|||
94502508|NCT00281580|323633269|FG008|Overall Study|Adverse Event|1|||
94502509|NCT00281580|323633270|FG009|Overall Study|Adverse Event|6|||
94502510|NCT00281580|323633271|FG010|Overall Study|Adverse Event|0|||
94502511|NCT00281580|323633272|FG011|Overall Study|Adverse Event|5|||
94502512|NCT00281580|323633273|FG012|Overall Study|Adverse Event|8|||
94502513|NCT00281580|323633274|FG013|Overall Study|Adverse Event|2|||
94502514|NCT00281580|323633275|FG014|Overall Study|Adverse Event|3|||
94502515|NCT00281580|323633276|FG015|Overall Study|Adverse Event|3|||
94502516|NCT00281580|323633261|FG000|Overall Study|Protocol Violation|0|||
94502517|NCT00281580|323633262|FG001|Overall Study|Protocol Violation|0|||
94502518|NCT00281580|323633263|FG002|Overall Study|Protocol Violation|1|||
94502519|NCT00281580|323633264|FG003|Overall Study|Protocol Violation|1|||
94502520|NCT00281580|323633265|FG004|Overall Study|Protocol Violation|0|||
94502521|NCT00281580|323633266|FG005|Overall Study|Protocol Violation|0|||
94502522|NCT00281580|323633267|FG006|Overall Study|Protocol Violation|1|||
94502523|NCT00281580|323633268|FG007|Overall Study|Protocol Violation|0|||
94502524|NCT00281580|323633269|FG008|Overall Study|Protocol Violation|2|||
94502525|NCT00281580|323633270|FG009|Overall Study|Protocol Violation|0|||
94502526|NCT00281580|323633271|FG010|Overall Study|Protocol Violation|1|||
94502527|NCT00281580|323633272|FG011|Overall Study|Protocol Violation|2|||
94502528|NCT00281580|323633273|FG012|Overall Study|Protocol Violation|0|||
94502529|NCT00281580|323633274|FG013|Overall Study|Protocol Violation|1|||
94502530|NCT00281580|323633275|FG014|Overall Study|Protocol Violation|1|||
94502531|NCT00281580|323633276|FG015|Overall Study|Protocol Violation|3|||
94502532|NCT00281580|323633261|FG000|Overall Study|Withdrawal by Subject|3|||
94502533|NCT00281580|323633262|FG001|Overall Study|Withdrawal by Subject|0|||
94502534|NCT00281580|323633263|FG002|Overall Study|Withdrawal by Subject|1|||
94502535|NCT00281580|323633264|FG003|Overall Study|Withdrawal by Subject|1|||
94502536|NCT00281580|323633265|FG004|Overall Study|Withdrawal by Subject|1|||
94502537|NCT00281580|323633266|FG005|Overall Study|Withdrawal by Subject|2|||
94502538|NCT00281580|323633267|FG006|Overall Study|Withdrawal by Subject|2|||
94502539|NCT00281580|323633268|FG007|Overall Study|Withdrawal by Subject|0|||
94502540|NCT00281580|323633269|FG008|Overall Study|Withdrawal by Subject|1|||
94502541|NCT00281580|323633270|FG009|Overall Study|Withdrawal by Subject|4|||
94502542|NCT00281580|323633271|FG010|Overall Study|Withdrawal by Subject|1|||
94502543|NCT00281580|323633272|FG011|Overall Study|Withdrawal by Subject|1|||
94502544|NCT00281580|323633273|FG012|Overall Study|Withdrawal by Subject|2|||
94502545|NCT00281580|323633274|FG013|Overall Study|Withdrawal by Subject|2|||
94502546|NCT00281580|323633275|FG014|Overall Study|Withdrawal by Subject|1|||
94502547|NCT00281580|323633276|FG015|Overall Study|Withdrawal by Subject|5|||
94502548|NCT00281580|323633261|FG000|Overall Study|Lack of Efficacy|2|||
94502549|NCT00281580|323633262|FG001|Overall Study|Lack of Efficacy|1|||
94502550|NCT00281580|323633263|FG002|Overall Study|Lack of Efficacy|1|||
94502551|NCT00281580|323633264|FG003|Overall Study|Lack of Efficacy|6|||
94502552|NCT00281580|323633265|FG004|Overall Study|Lack of Efficacy|2|||
94502553|NCT00281580|323633266|FG005|Overall Study|Lack of Efficacy|0|||
94502554|NCT00281580|323633267|FG006|Overall Study|Lack of Efficacy|0|||
94502555|NCT00281580|323633268|FG007|Overall Study|Lack of Efficacy|0|||
94502556|NCT00281580|323633269|FG008|Overall Study|Lack of Efficacy|0|||
94502557|NCT00281580|323633270|FG009|Overall Study|Lack of Efficacy|0|||
94502558|NCT00281580|323633271|FG010|Overall Study|Lack of Efficacy|0|||
94502559|NCT00281580|323633272|FG011|Overall Study|Lack of Efficacy|1|||
94502560|NCT00281580|323633273|FG012|Overall Study|Lack of Efficacy|0|||
94502561|NCT00281580|323633274|FG013|Overall Study|Lack of Efficacy|2|||
94502562|NCT00281580|323633275|FG014|Overall Study|Lack of Efficacy|1|||
94502563|NCT00281580|323633276|FG015|Overall Study|Lack of Efficacy|0|||
94502564|NCT00281580|323633261|FG000|Overall Study|Lost to Follow-up|0|||
94502565|NCT00281580|323633262|FG001|Overall Study|Lost to Follow-up|0|||
94502566|NCT00281580|323633263|FG002|Overall Study|Lost to Follow-up|0|||
94502567|NCT00281580|323633264|FG003|Overall Study|Lost to Follow-up|3|||
94502568|NCT00281580|323633265|FG004|Overall Study|Lost to Follow-up|0|||
94502569|NCT00281580|323633266|FG005|Overall Study|Lost to Follow-up|1|||
94502570|NCT00281580|323633267|FG006|Overall Study|Lost to Follow-up|0|||
94502571|NCT00281580|323633268|FG007|Overall Study|Lost to Follow-up|1|||
94502572|NCT00281580|323633269|FG008|Overall Study|Lost to Follow-up|2|||
94502573|NCT00281580|323633270|FG009|Overall Study|Lost to Follow-up|1|||
94502574|NCT00281580|323633271|FG010|Overall Study|Lost to Follow-up|1|||
94502575|NCT00281580|323633272|FG011|Overall Study|Lost to Follow-up|0|||
94502576|NCT00281580|323633273|FG012|Overall Study|Lost to Follow-up|1|||
94502577|NCT00281580|323633274|FG013|Overall Study|Lost to Follow-up|0|||
94502578|NCT00281580|323633275|FG014|Overall Study|Lost to Follow-up|0|||
94502579|NCT00281580|323633276|FG015|Overall Study|Lost to Follow-up|0|||
94502580|NCT00281580|323633261|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
94502581|NCT00281580|323633262|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
94502582|NCT00281580|323633263|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
94502583|NCT00281580|323633264|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
94502584|NCT00281580|323633265|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
94502585|NCT00281580|323633266|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
94502586|NCT00281580|323633267|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
94502587|NCT00281580|323633268|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
94502588|NCT00281580|323633269|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
94502589|NCT00281580|323633270|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
94502590|NCT00281580|323633271|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
94502591|NCT00281580|323633272|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
94502592|NCT00281580|323633273|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
94502593|NCT00281580|323633274|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
94502594|NCT00281580|323633275|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
94502595|NCT00281580|323633276|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
94502596|NCT00621322|323633277|FG000|Overall Study|Lost to Follow-up|0|||
94502597|NCT00621322|323633278|FG001|Overall Study|Lost to Follow-up|0|||
94502598|NCT00621322|323633279|FG002|Overall Study|Lost to Follow-up|0|||
94502599|NCT00621322|323633280|FG003|Overall Study|Lost to Follow-up|0|||
94502600|NCT00621322|323633281|FG004|Overall Study|Lost to Follow-up|1|||
94502601|NCT00621322|323633282|FG005|Overall Study|Lost to Follow-up|0|||
94502602|NCT00621322|323633277|FG000|Overall Study|Physician Decision|0|||
94502603|NCT00621322|323633278|FG001|Overall Study|Physician Decision|0|||
94502604|NCT00621322|323633279|FG002|Overall Study|Physician Decision|1|||
94502605|NCT00621322|323633280|FG003|Overall Study|Physician Decision|1|||
94502606|NCT00621322|323633281|FG004|Overall Study|Physician Decision|0|||
94502607|NCT00621322|323633282|FG005|Overall Study|Physician Decision|0|||
94502608|NCT00621322|323633277|FG000|Overall Study|Withdrawal by Subject|0|||
94502609|NCT00621322|323633278|FG001|Overall Study|Withdrawal by Subject|0|||
94502610|NCT00621322|323633279|FG002|Overall Study|Withdrawal by Subject|0|||
94502611|NCT00621322|323633280|FG003|Overall Study|Withdrawal by Subject|1|||
94502612|NCT00621322|323633281|FG004|Overall Study|Withdrawal by Subject|0|||
94502613|NCT00621322|323633282|FG005|Overall Study|Withdrawal by Subject|2|||
94502614|NCT00621322|323633277|FG000|Overall Study|Migrated/moved from study area|1|||
94502615|NCT00621322|323633278|FG001|Overall Study|Migrated/moved from study area|0|||
94502616|NCT00621322|323633279|FG002|Overall Study|Migrated/moved from study area|1|||
94502617|NCT00621322|323633280|FG003|Overall Study|Migrated/moved from study area|1|||
94502618|NCT00621322|323633281|FG004|Overall Study|Migrated/moved from study area|0|||
94502619|NCT00621322|323633282|FG005|Overall Study|Migrated/moved from study area|2|||
94502620|NCT00225758|323633283|FG000|Overall Study|Adverse Event|4|||
94502621|NCT04882215|323633284|FG000|Overall Study|Withdrawal by Subject|5|||
94502622|NCT04882215|323633285|FG001|Overall Study|Withdrawal by Subject|0|||
94502623|NCT03835117|323633286|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
94502624|NCT03835117|323633287|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
94502625|NCT04263532|323633288|FG000|Overall Study|Withdrawal by Subject|2|||
94502626|NCT04263532|323633289|FG001|Overall Study|Withdrawal by Subject|0|||
94502627|NCT03225989|323633292|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
94502628|NCT03225989|323633293|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
94502629|NCT03225989|323633294|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
94502630|NCT03225989|323633292|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
94502631|NCT03225989|323633293|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
94502632|NCT03225989|323633294|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
94502633|NCT03225989|323633292|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
94502634|NCT03225989|323633293|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
94502635|NCT03225989|323633294|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
94502636|NCT03225989|323633292|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
94502637|NCT03225989|323633293|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
94502638|NCT03225989|323633294|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
94502639|NCT03225989|323633292|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
94502640|NCT03225989|323633293|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
94502641|NCT03225989|323633294|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
94502642|NCT03225989|323633292|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
94502643|NCT03225989|323633293|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
94502644|NCT03225989|323633294|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
94502645|NCT03225989|323633292|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
94502646|NCT03225989|323633293|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
94502647|NCT03225989|323633294|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
94502648|NCT03225989|323633292|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
94502649|NCT03225989|323633293|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
94502650|NCT03225989|323633294|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
94502651|NCT03225989|323633292|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
94502652|NCT03225989|323633293|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
94502653|NCT03225989|323633294|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
94502654|NCT03225989|323633292|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
94502655|NCT03225989|323633293|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
94502656|NCT03225989|323633294|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
94502657|NCT03225989|323633292|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
94502658|NCT03225989|323633293|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
94502659|NCT03225989|323633294|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
94502660|NCT03225989|323633292|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
94502661|NCT03225989|323633293|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
94502662|NCT03225989|323633294|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
94502663|NCT00601107|323633295|FG000|Overall Study|Adverse Event|0|||
94502664|NCT00601107|323633296|FG001|Overall Study|Adverse Event|1|||
94502665|NCT00601107|323633297|FG002|Overall Study|Adverse Event|3|||
94502666|NCT00601107|323633298|FG003|Overall Study|Adverse Event|0|||
94502667|NCT00601107|323633295|FG000|Overall Study|Withdrawal by Subject|5|||
94502668|NCT00601107|323633296|FG001|Overall Study|Withdrawal by Subject|4|||
94502669|NCT00601107|323633297|FG002|Overall Study|Withdrawal by Subject|7|||
94502670|NCT00601107|323633298|FG003|Overall Study|Withdrawal by Subject|4|||
94502671|NCT00601107|323633295|FG000|Overall Study|Lost to Follow-up|3|||
94502672|NCT00601107|323633296|FG001|Overall Study|Lost to Follow-up|3|||
94502673|NCT00601107|323633297|FG002|Overall Study|Lost to Follow-up|0|||
94502674|NCT00601107|323633298|FG003|Overall Study|Lost to Follow-up|3|||
94502675|NCT00601107|323633295|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
94502676|NCT00601107|323633296|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
94502677|NCT00601107|323633297|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
94502678|NCT00601107|323633298|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
94502679|NCT00601107|323633295|FG000|Overall Study|Worsening of Psoriasis|4|||
94502680|NCT00601107|323633296|FG001|Overall Study|Worsening of Psoriasis|1|||
94502681|NCT00601107|323633297|FG002|Overall Study|Worsening of Psoriasis|1|||
94502682|NCT00601107|323633298|FG003|Overall Study|Worsening of Psoriasis|4|||
94502683|NCT00601107|323633295|FG000|Overall Study|Undefined|1|||
94502684|NCT00601107|323633296|FG001|Overall Study|Undefined|0|||
94502685|NCT00601107|323633297|FG002|Overall Study|Undefined|1|||
94502686|NCT00601107|323633298|FG003|Overall Study|Undefined|0|||
94502687|NCT03892915|323633301|FG000|Overall Study|Lost to Follow-up|6|||
94502688|NCT03892915|323633302|FG001|Overall Study|Lost to Follow-up|12|||
94502689|NCT03892915|323633301|FG000|Overall Study|Death|0|||
94502690|NCT03892915|323633302|FG001|Overall Study|Death|2|||
94502691|NCT03892915|323633301|FG000|Overall Study|Withdrawal by Subject|1|||
94502692|NCT03892915|323633302|FG001|Overall Study|Withdrawal by Subject|1|||
94502693|NCT03892915|323633301|FG000|Overall Study|unsuccessful delivery|13|||
94502694|NCT03892915|323633302|FG001|Overall Study|unsuccessful delivery|18|||
94502695|NCT01543503|323633303|FG000|Overall Study|Lost to Follow-up|32|||
94502696|NCT01543503|323633304|FG001|Overall Study|Lost to Follow-up|36|||
94502697|NCT01543503|323633303|FG000|Overall Study|Adverse Event|9|||
94502698|NCT01543503|323633304|FG001|Overall Study|Adverse Event|13|||
94502699|NCT01543503|323633303|FG000|Overall Study|Lack of Efficacy|4|||
94502700|NCT01543503|323633304|FG001|Overall Study|Lack of Efficacy|16|||
94502701|NCT01543503|323633303|FG000|Overall Study|Participant withdrew informed consent|8|||
94502702|NCT01543503|323633304|FG001|Overall Study|Participant withdrew informed consent|10|||
94502703|NCT01543503|323633303|FG000|Overall Study|Change of jobs|0|||
94502704|NCT01543503|323633304|FG001|Overall Study|Change of jobs|1|||
94502705|NCT01543503|323633303|FG000|Overall Study|Intolerance to the biologic treatment|0|||
94502706|NCT01543503|323633304|FG001|Overall Study|Intolerance to the biologic treatment|1|||
94502707|NCT01543503|323633303|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
94502708|NCT01543503|323633304|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
94502709|NCT01543503|323633303|FG000|Overall Study|Participant did not complete last visit|0|||
94502710|NCT01543503|323633304|FG001|Overall Study|Participant did not complete last visit|2|||
94502711|NCT01543503|323633303|FG000|Overall Study|Refused to continue treatment|7|||
94502712|NCT01543503|323633304|FG001|Overall Study|Refused to continue treatment|0|||
94502713|NCT01543503|323633303|FG000|Overall Study|Incorrect medication received|1|||
94502714|NCT01543503|323633304|FG001|Overall Study|Incorrect medication received|0|||
94502715|NCT01543503|323633303|FG000|Overall Study|Participant moved to another city|2|||
94502716|NCT01543503|323633304|FG001|Overall Study|Participant moved to another city|0|||
94502717|NCT01543503|323633303|FG000|Overall Study|Participant will not return for visits|0|||
94502718|NCT01543503|323633304|FG001|Overall Study|Participant will not return for visits|2|||
94502719|NCT01543503|323633303|FG000|Overall Study|Participant transferred to another city|1|||
94502720|NCT01543503|323633304|FG001|Overall Study|Participant transferred to another city|0|||
94502721|NCT01543503|323633303|FG000|Overall Study|Participant moved to Scotland|1|||
94502722|NCT01543503|323633304|FG001|Overall Study|Participant moved to Scotland|0|||
94502723|NCT01543503|323633303|FG000|Overall Study|Participant decision to stop treatment|1|||
94502724|NCT01543503|323633304|FG001|Overall Study|Participant decision to stop treatment|0|||
94502725|NCT01543503|323633303|FG000|Overall Study|Investigator did not wish to participate|1|||
94502726|NCT01543503|323633304|FG001|Overall Study|Investigator did not wish to participate|1|||
94502727|NCT01543503|323633303|FG000|Overall Study|Participant recruited after closing date|0|||
94502728|NCT01543503|323633304|FG001|Overall Study|Participant recruited after closing date|1|||
94502729|NCT01543503|323633303|FG000|Overall Study|Site stopped participation|5|||
94502730|NCT01543503|323633304|FG001|Overall Study|Site stopped participation|1|||
94502731|NCT01543503|323633303|FG000|Overall Study|Participant did not attend a visit|1|||
94502732|NCT01543503|323633304|FG001|Overall Study|Participant did not attend a visit|0|||
94502733|NCT01543503|323633303|FG000|Overall Study|Moved to other rheumatologic site|0|||
94502734|NCT01543503|323633304|FG001|Overall Study|Moved to other rheumatologic site|1|||
94502735|NCT01543503|323633303|FG000|Overall Study|Participant consented to another study|0|||
94502736|NCT01543503|323633304|FG001|Overall Study|Participant consented to another study|2|||
94502737|NCT01543503|323633303|FG000|Overall Study|Participant went to United States|1|||
94502738|NCT01543503|323633304|FG001|Overall Study|Participant went to United States|0|||
94502739|NCT01543503|323633303|FG000|Overall Study|Screen failure|1|||
94502740|NCT01543503|323633304|FG001|Overall Study|Screen failure|0|||
94502741|NCT02460380|323633305|FG000|Overall Study|Withdrawal by Subject|10|||
94502742|NCT02460380|323633306|FG001|Overall Study|Withdrawal by Subject|5|||
94502743|NCT02965456|323633307|FG000|Overall Study|Lost to Follow-up|40|||
94502744|NCT02965456|323633308|FG001|Overall Study|Lost to Follow-up|18|||
94502745|NCT02965456|323633307|FG000|Overall Study|Subject Request|22|||
94502746|NCT02965456|323633308|FG001|Overall Study|Subject Request|13|||
94502747|NCT02965456|323633307|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
94502748|NCT02965456|323633308|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
94502749|NCT02965456|323633307|FG000|Overall Study|Adverse Event|3|||
94502750|NCT02965456|323633308|FG001|Overall Study|Adverse Event|0|||
94502751|NCT02965456|323633307|FG000|Overall Study|Noncompliance with Study Drug|1|||
94502752|NCT02965456|323633308|FG001|Overall Study|Noncompliance with Study Drug|1|||
94502753|NCT02965456|323633307|FG000|Overall Study|Worsening Condition|0|||
94502754|NCT02965456|323633308|FG001|Overall Study|Worsening Condition|2|||
94502755|NCT02965456|323633307|FG000|Overall Study|Lack of Efficacy|1|||
94502756|NCT02965456|323633308|FG001|Overall Study|Lack of Efficacy|0|||
94502757|NCT02965456|323633307|FG000|Overall Study|Physician Decision|0|||
94502758|NCT02965456|323633308|FG001|Overall Study|Physician Decision|1|||
94502759|NCT02965456|323633307|FG000|Overall Study|Pregnancy|1|||
94502760|NCT02965456|323633308|FG001|Overall Study|Pregnancy|0|||
94502761|NCT02965456|323633307|FG000|Overall Study|Protocol Violation|0|||
94502762|NCT02965456|323633308|FG001|Overall Study|Protocol Violation|1|||
94502763|NCT02965456|323633307|FG000|Overall Study|Participant ran out of study drug|0|||
94502764|NCT02965456|323633308|FG001|Overall Study|Participant ran out of study drug|1|||
94502765|NCT01489358|323633309|FG000|Overall Study|Lost to Follow-up|0|||
94502766|NCT01489358|323633310|FG001|Overall Study|Lost to Follow-up|0|||
94502767|NCT01489358|323633311|FG002|Overall Study|Lost to Follow-up|2|||
94502768|NCT00736476|323633317|FG000|Overall Study|Adverse Event|1|||
94502769|NCT00736476|323633318|FG001|Overall Study|Adverse Event|0|||
94502770|NCT02839707|323633326|FG000|Phase I|Not eligible for analysis|9|||
94502771|NCT02839707|323633327|FG001|Phase I|Not eligible for analysis|0|||
94502772|NCT02839707|323633328|FG002|Phase I|Not eligible for analysis|0|||
94502773|NCT02839707|323633326|FG000|Phase II|Not treated according to protocol|4|||
94502774|NCT02839707|323633327|FG001|Phase II|Not treated according to protocol|0|||
94502775|NCT02839707|323633328|FG002|Phase II|Not treated according to protocol|2|||
94502776|NCT02839707|323633326|FG000|Phase III|Not treated according to protocol|0|||
94502777|NCT02839707|323633327|FG001|Phase III|Not treated according to protocol|0|||
94502778|NCT02839707|323633328|FG002|Phase III|Not treated according to protocol|4|||
94502779|NCT00537082|323633329|FG000|Overall Study|Adverse Event|6|||
94502780|NCT00537082|323633330|FG001|Overall Study|Adverse Event|6|||
94502781|NCT00537082|323633331|FG002|Overall Study|Adverse Event|3|||
94502782|NCT00537082|323633329|FG000|Overall Study|Protocol Violation|0|||
94502783|NCT00537082|323633330|FG001|Overall Study|Protocol Violation|2|||
94502784|NCT00537082|323633331|FG002|Overall Study|Protocol Violation|1|||
94502785|NCT00537082|323633329|FG000|Overall Study|Lack of Efficacy|0|||
94502786|NCT00537082|323633330|FG001|Overall Study|Lack of Efficacy|0|||
94502787|NCT00537082|323633331|FG002|Overall Study|Lack of Efficacy|2|||
94502788|NCT00537082|323633329|FG000|Overall Study|Withdrawal by Subject|0|||
94502789|NCT00537082|323633330|FG001|Overall Study|Withdrawal by Subject|1|||
94502790|NCT00537082|323633331|FG002|Overall Study|Withdrawal by Subject|0|||
94502791|NCT00537082|323633329|FG000|Overall Study|Discontinued before initiating treatment|3|||
94502792|NCT00537082|323633330|FG001|Overall Study|Discontinued before initiating treatment|0|||
94502793|NCT00537082|323633331|FG002|Overall Study|Discontinued before initiating treatment|0|||
94502794|NCT03921541|323634928|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
94502795|NCT03921541|323634929|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
94502796|NCT02642679|323634930|FG000|Overall Study|Withdrawal by Subject|1|||
94502797|NCT02642679|323634930|FG000|Overall Study|Physician Decision|1|||
94502798|NCT02642679|323634930|FG000|Overall Study|Physician Decision|1|||
94502799|NCT00420407|323634932|FG000|Overall Study|Lost to Follow-up|0|||
94502800|NCT00420407|323634933|FG001|Overall Study|Lost to Follow-up|3|||
94502801|NCT00420407|323634932|FG000|Overall Study|Physician Decision|2|||
94502802|NCT00420407|323634933|FG001|Overall Study|Physician Decision|1|||
94502803|NCT00420407|323634932|FG000|Overall Study|subject identified as detainee|1|||
94502804|NCT00420407|323634933|FG001|Overall Study|subject identified as detainee|0|||
94502805|NCT00420407|323634932|FG000|Overall Study|subject identified as Jehovah's witness|1|||
94502806|NCT00420407|323634933|FG001|Overall Study|subject identified as Jehovah's witness|0|||
94502807|NCT00420407|323634932|FG000|Overall Study|Withdrawal by Subject|0|||
94502808|NCT00420407|323634933|FG001|Overall Study|Withdrawal by Subject|2|||
94502809|NCT00382070|323634936|FG000|Overall Study|No follow up data mapped to Other|17|||
94502810|NCT00382070|323634937|FG001|Overall Study|No follow up data mapped to Other|19|||
94502811|NCT00382070|323634936|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
94502812|NCT00382070|323634937|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
94502813|NCT00382070|323634936|FG000|Overall Study|No clinical assessment|9|||
94502814|NCT00382070|323634937|FG001|Overall Study|No clinical assessment|11|||
94502815|NCT00504231|323634938|FG000|Overall Study|Discrepant chart documentation re route|0|||
94502816|NCT00504231|323634939|FG001|Overall Study|Discrepant chart documentation re route|0|||
94502817|NCT00504231|323634940|FG002|Overall Study|Discrepant chart documentation re route|1|||
94502818|NCT00504231|323634941|FG003|Overall Study|Discrepant chart documentation re route|0|||
94502819|NCT00088881|323634943|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
94502820|NCT00088881|323634943|FG000|Step 1 - R-CHOP|Adverse Event|1|||
94502821|NCT00088881|323634943|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
94502822|NCT00088881|323634943|FG000|Step 1 - R-CHOP|Physician Decision|1|||
94502823|NCT00088881|323634943|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
94502824|NCT00088881|323634943|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
94502825|NCT00088881|323634943|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
94502826|NCT03928704|323634952|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
94502827|NCT03928704|323634953|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
94502828|NCT03928704|323634954|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
94502829|NCT03928704|323634955|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
94502830|NCT03928704|323634956|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
94502831|NCT03928704|323634957|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
94502832|NCT03928704|323634952|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
94502833|NCT03928704|323634953|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
94502834|NCT03928704|323634954|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
94502835|NCT03928704|323634955|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
94502836|NCT03928704|323634956|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
94502837|NCT03928704|323634957|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
94502838|NCT03928704|323634952|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
94502839|NCT03928704|323634953|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
94502840|NCT03928704|323634954|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
94502841|NCT03928704|323634955|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
94502842|NCT03928704|323634956|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
94502843|NCT03928704|323634957|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
94502844|NCT03928704|323634952|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
94502845|NCT03928704|323634953|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
94502846|NCT03928704|323634954|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
94502847|NCT03928704|323634955|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
94502848|NCT03928704|323634956|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
94502849|NCT03928704|323634957|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
94502850|NCT03928704|323634952|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
94502851|NCT03928704|323634953|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
94502852|NCT03928704|323634954|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
94502853|NCT03928704|323634955|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
94502854|NCT03928704|323634956|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
94502855|NCT03928704|323634957|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
94502856|NCT03928704|323634952|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
94502857|NCT03928704|323634953|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
94502858|NCT03928704|323634954|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
94502859|NCT03928704|323634955|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
94502860|NCT03928704|323634956|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
94502861|NCT03928704|323634957|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
94502862|NCT03928704|323634952|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
94502863|NCT03928704|323634953|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
94502864|NCT03928704|323634954|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
94502865|NCT03928704|323634955|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
94502866|NCT03928704|323634956|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
94502867|NCT03928704|323634957|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
94502868|NCT03928704|323634952|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
94502869|NCT03928704|323634953|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
94502870|NCT03928704|323634954|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
94502871|NCT03928704|323634955|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
94502872|NCT03928704|323634956|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
94502873|NCT03928704|323634957|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
94502874|NCT03928704|323634952|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
94502875|NCT03928704|323634953|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
94502876|NCT03928704|323634954|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
94502877|NCT03928704|323634955|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
94502878|NCT03928704|323634956|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
94502879|NCT03928704|323634957|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
94502880|NCT03928704|323634952|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
94502881|NCT03928704|323634953|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
94502882|NCT03928704|323634954|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
94502883|NCT03928704|323634955|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
94502884|NCT03928704|323634956|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
94502885|NCT03928704|323634957|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
94502886|NCT03600350|323634958|FG000|Overall Study|Death|1|||
94502887|NCT03600350|323634958|FG000|Overall Study|On Follow Up|18|||
94502888|NCT03548415|323634962|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
94502889|NCT03548415|323634963|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
94502890|NCT03548415|323634964|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
94502891|NCT03548415|323634965|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
94502892|NCT03548415|323634966|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
94502893|NCT05938010|323634967|FG000|Overall Study|Lost to Follow-up|2|||
94502894|NCT01803737|323634968|FG000|Overall Study|Lack of Time|1|||
94502895|NCT01803737|323634969|FG001|Overall Study|Lack of Time|0|||
94502896|NCT01803737|323634968|FG000|Overall Study|Medical Reason|0|||
94502897|NCT01803737|323634969|FG001|Overall Study|Medical Reason|1|||
94502898|NCT01803737|323634968|FG000|Overall Study|Lost to Follow-up|0|||
94502899|NCT01803737|323634969|FG001|Overall Study|Lost to Follow-up|2|||
94502900|NCT01454063|323634970|FG000|Randomized|Adverse Event|1|||
94502901|NCT01454063|323634971|FG001|Randomized|Adverse Event|1|||
94502902|NCT01454063|323634970|FG000|Randomized|Protocol Violation|0|||
94502903|NCT01454063|323634971|FG001|Randomized|Protocol Violation|1|||
94502904|NCT02596893|323634972|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
94502905|NCT02596893|323634973|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
94502906|NCT02596893|323634974|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
94502907|NCT02596893|323634975|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
94502908|NCT02596893|323634972|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
94502909|NCT02596893|323634973|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
94502910|NCT02596893|323634974|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
94502911|NCT02596893|323634975|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
94502912|NCT02596893|323634972|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
94502913|NCT02596893|323634973|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
94502914|NCT02596893|323634974|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
94502915|NCT02596893|323634975|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
94502916|NCT02596893|323634972|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
94502917|NCT02596893|323634973|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
94502918|NCT02596893|323634974|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
94502919|NCT02596893|323634975|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
94502920|NCT02596893|323634972|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
94502921|NCT02596893|323634973|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
94502922|NCT02596893|323634974|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
94502923|NCT02596893|323634975|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
94502924|NCT02596893|323634972|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
94502925|NCT02596893|323634973|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
94502926|NCT02596893|323634974|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
94502927|NCT02596893|323634975|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
94502928|NCT02596893|323634972|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
94502929|NCT02596893|323634973|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
94502930|NCT02596893|323634974|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
94502931|NCT02596893|323634975|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
94502932|NCT02596893|323634972|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
94502933|NCT02596893|323634973|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
94502934|NCT02596893|323634974|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
94502935|NCT02596893|323634975|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
94502936|NCT02596893|323634972|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
94502937|NCT02596893|323634973|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
94502938|NCT02596893|323634974|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
94502939|NCT02596893|323634975|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
94502940|NCT02596893|323634972|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
94502941|NCT02596893|323634973|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
94502942|NCT02596893|323634974|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
94502943|NCT02596893|323634975|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
94502944|NCT02596893|323634972|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
94502945|NCT02596893|323634973|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
94502946|NCT02596893|323634974|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
94502947|NCT02596893|323634975|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
94502948|NCT03387046|323634976|FG000|Overall Study|Adverse Event|1|||
94502949|NCT03387046|323634977|FG001|Overall Study|Adverse Event|1|||
94502950|NCT01529112|323634978|FG000|Overall Study|Adverse Event|2|||
94502951|NCT01529112|323634979|FG001|Overall Study|Adverse Event|0|||
94502952|NCT01529112|323634978|FG000|Overall Study|Death|59|||
94502953|NCT01529112|323634979|FG001|Overall Study|Death|38|||
94502954|NCT01529112|323634978|FG000|Overall Study|Protocol Violation|1|||
94502955|NCT01529112|323634979|FG001|Overall Study|Protocol Violation|0|||
94502956|NCT01529112|323634978|FG000|Overall Study|Withdrawal by Subject|7|||
94502957|NCT01529112|323634979|FG001|Overall Study|Withdrawal by Subject|3|||
94502958|NCT02255279|323634980|FG000|Overall Study|Lost to Follow-up|2|||
94502959|NCT02255279|323634981|FG001|Overall Study|Lost to Follow-up|2|||
94502960|NCT02255279|323634980|FG000|Overall Study|Protocol Violation|0|||
94502961|NCT02255279|323634981|FG001|Overall Study|Protocol Violation|1|||
94502962|NCT02255279|323634980|FG000|Overall Study|Withdrawal by Subject|3|||
94502963|NCT02255279|323634981|FG001|Overall Study|Withdrawal by Subject|6|||
94502964|NCT03794544|323634982|FG000|Overall Study|Withdrawal by Subject|1|||
94502965|NCT03794544|323634983|FG001|Overall Study|Withdrawal by Subject|1|||
94502966|NCT03794544|323634984|FG002|Overall Study|Withdrawal by Subject|0|||
94502967|NCT03794544|323634985|FG003|Overall Study|Withdrawal by Subject|0|||
94502968|NCT03794544|323634982|FG000|Overall Study|Death|0|||
94502969|NCT03794544|323634983|FG001|Overall Study|Death|0|||
94502970|NCT03794544|323634984|FG002|Overall Study|Death|0|||
94502971|NCT03794544|323634985|FG003|Overall Study|Death|1|||
94502972|NCT03794544|323634982|FG000|Overall Study|Lost to Follow-up|0|||
94502973|NCT03794544|323634983|FG001|Overall Study|Lost to Follow-up|1|||
94502974|NCT03794544|323634984|FG002|Overall Study|Lost to Follow-up|1|||
94502975|NCT03794544|323634985|FG003|Overall Study|Lost to Follow-up|0|||
94502976|NCT03794544|323634982|FG000|Overall Study|Other|0|||
94502977|NCT03794544|323634983|FG001|Overall Study|Other|1|||
94502978|NCT03794544|323634984|FG002|Overall Study|Other|0|||
94502979|NCT03794544|323634985|FG003|Overall Study|Other|0|||
94502980|NCT02741193|323634987|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
94502981|NCT02741193|323634987|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
94502982|NCT00363467|323634990|FG000|Overall Study|Physician Decision|1|||
94502983|NCT00976898|323634991|FG000|Overall Study|Protocol Violation|1|||
94502984|NCT00976898|323634991|FG000|Overall Study|Adverse Event|1|||
94502985|NCT00976898|323634991|FG000|Overall Study|Physician Decision|1|||
94502986|NCT00976898|323634991|FG000|Overall Study|Liver Transplant|1|||
94502987|NCT00976898|323634991|FG000|Overall Study|Progressive Disease|1|||
94502988|NCT01524705|323634993|FG000|Overall Study|Adverse Event|2|||
94502989|NCT01524705|323634994|FG001|Overall Study|Adverse Event|0|||
94502990|NCT01524705|323634993|FG000|Overall Study|Death|1|||
94502991|NCT01524705|323634994|FG001|Overall Study|Death|0|||
94502992|NCT01524705|323634993|FG000|Overall Study|Lost to Follow-up|0|||
94502993|NCT01524705|323634994|FG001|Overall Study|Lost to Follow-up|1|||
94502994|NCT01524705|323634993|FG000|Overall Study|Withdrawal by Subject|0|||
94502995|NCT01524705|323634994|FG001|Overall Study|Withdrawal by Subject|1|||
94502996|NCT01524705|323634993|FG000|Overall Study|Pancreatic Cancer|0|||
94502997|NCT01524705|323634994|FG001|Overall Study|Pancreatic Cancer|1|||
94502998|NCT01755156|323635004|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
94502999|NCT01755156|323635005|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
94503000|NCT01755156|323635004|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
94503001|NCT01755156|323635005|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
94503002|NCT01755156|323635004|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
94503003|NCT01755156|323635005|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
94503004|NCT01755156|323635004|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
94503005|NCT01755156|323635005|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
94503006|NCT01755156|323635004|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
94503007|NCT01755156|323635005|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
94503008|NCT01755156|323635004|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
94503009|NCT01755156|323635005|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
94503010|NCT01755156|323635004|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
94503011|NCT01755156|323635005|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
94503012|NCT01755156|323635004|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
94503013|NCT01755156|323635005|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
94503014|NCT01755156|323635004|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
94503015|NCT01755156|323635005|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
94503016|NCT01755156|323635004|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
94503017|NCT01755156|323635005|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
94503018|NCT01755156|323635004|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
94503019|NCT01755156|323635005|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
94503020|NCT01530256|323635010|FG000|Overall Study|Death|2|||
94503021|NCT01960842|323635020|FG000|Overall Study|Adverse Event|1|||
94503022|NCT01960842|323635020|FG000|Overall Study|Withdrawal by Subject|2|||
94503023|NCT01301001|323635021|FG000|First Intervention|Lost to Follow-up|4|||
94503024|NCT01301001|323635022|FG001|First Intervention|Lost to Follow-up|4|||
94503025|NCT01301001|323635021|FG000|First Intervention|Withdrawal by Subject|1|||
94503026|NCT01301001|323635022|FG001|First Intervention|Withdrawal by Subject|4|||
94503027|NCT01301001|323635021|FG000|First Intervention|Adverse Event|5|||
94503028|NCT01301001|323635022|FG001|First Intervention|Adverse Event|0|||
94503029|NCT01301001|323635021|FG000|First Intervention|Protocol Violation|0|||
94503030|NCT01301001|323635022|FG001|First Intervention|Protocol Violation|1|||
94503031|NCT01301001|323635021|FG000|Second Intervention|Adverse Event|2|||
94503032|NCT01301001|323635022|FG001|Second Intervention|Adverse Event|0|||
94503033|NCT01301001|323635021|FG000|Second Intervention|Withdrawal by Subject|2|||
94503034|NCT01301001|323635022|FG001|Second Intervention|Withdrawal by Subject|0|||
94503035|NCT01502072|323635023|FG000|Overall Study|Withdrawal by Subject|1|||
94503036|NCT01502072|323635024|FG001|Overall Study|Withdrawal by Subject|0|||
94503037|NCT01502072|323635025|FG002|Overall Study|Withdrawal by Subject|0|||
94503038|NCT01502072|323635023|FG000|Overall Study|Death|0|||
94503039|NCT01502072|323635024|FG001|Overall Study|Death|1|||
94503040|NCT01502072|323635025|FG002|Overall Study|Death|0|||
94503041|NCT04821245|323635026|FG000|Overall Study|Withdrawal by Subject|3|||
94503042|NCT04821245|323635026|FG000|Overall Study|Physician Decision|1|||
94503043|NCT04821245|323635026|FG000|Overall Study|Protocol Violation|5|||
94503044|NCT02565186|323635027|FG000|Overall Study|Adverse Event|113|||
94503045|NCT02565186|323635028|FG001|Overall Study|Adverse Event|148|||
94503046|NCT02565186|323635027|FG000|Overall Study|Lost to Follow-up|102|||
94503047|NCT02565186|323635028|FG001|Overall Study|Lost to Follow-up|93|||
94503048|NCT02565186|323635027|FG000|Overall Study|Non-Compliance|57|||
94503049|NCT02565186|323635028|FG001|Overall Study|Non-Compliance|55|||
94503050|NCT02565186|323635027|FG000|Overall Study|Withdrawal by Subject|229|||
94503051|NCT02565186|323635028|FG001|Overall Study|Withdrawal by Subject|214|||
94503052|NCT02565186|323635027|FG000|Overall Study|Physician Decision|18|||
94503053|NCT02565186|323635028|FG001|Overall Study|Physician Decision|16|||
94503054|NCT02565186|323635027|FG000|Overall Study|Sponsor Request|5|||
94503055|NCT02565186|323635028|FG001|Overall Study|Sponsor Request|9|||
94503056|NCT02565186|323635027|FG000|Overall Study|Missing|1|||
94503057|NCT02565186|323635028|FG001|Overall Study|Missing|0|||
94503058|NCT02565186|323635027|FG000|Overall Study|Did Not Receive Study Drug|55|||
94503059|NCT02565186|323635028|FG001|Overall Study|Did Not Receive Study Drug|86|||
94503060|NCT01575548|323635036|FG000|Overall Study|Adverse Event|15|||
94503061|NCT01575548|323635037|FG001|Overall Study|Adverse Event|2|||
94503062|NCT01575548|323635036|FG000|Overall Study|Disease progression|12|||
94503063|NCT01575548|323635037|FG001|Overall Study|Disease progression|25|||
94503064|NCT01575548|323635036|FG000|Overall Study|Death|1|||
94503065|NCT01575548|323635037|FG001|Overall Study|Death|0|||
94503066|NCT01575548|323635036|FG000|Overall Study|Other complicating disease|1|||
94503067|NCT01575548|323635037|FG001|Overall Study|Other complicating disease|0|||
94503068|NCT01575548|323635036|FG000|Overall Study|Withdrawal by Subject|7|||
94503069|NCT01575548|323635037|FG001|Overall Study|Withdrawal by Subject|3|||
94503070|NCT01575548|323635036|FG000|Overall Study|Noncompliance|1|||
94503071|NCT01575548|323635037|FG001|Overall Study|Noncompliance|0|||
94503072|NCT01575548|323635036|FG000|Overall Study|Anticipated surgery|0|||
94503073|NCT01575548|323635037|FG001|Overall Study|Anticipated surgery|1|||
94503074|NCT01575548|323635036|FG000|Overall Study|Never started protocol therapy|3|||
94503075|NCT01575548|323635037|FG001|Overall Study|Never started protocol therapy|2|||
94503076|NCT01691482|323635038|FG000|Treatment Period 2|Adverse Event|0|||
94503077|NCT01691482|323635039|FG001|Treatment Period 2|Adverse Event|1|||
94503078|NCT01691482|323635038|FG000|Treatment Period 2|Protocol Violation|1|||
94503079|NCT01691482|323635039|FG001|Treatment Period 2|Protocol Violation|1|||
94503080|NCT00395512|323635040|FG000|Overall Study|Adverse Event|3|||
94503081|NCT00395512|323635041|FG001|Overall Study|Adverse Event|8|||
94503082|NCT00395512|323635042|FG002|Overall Study|Adverse Event|6|||
94503083|NCT00395512|323635043|FG003|Overall Study|Adverse Event|6|||
94503084|NCT00395512|323635040|FG000|Overall Study|Protocol Violation|2|||
94503085|NCT00395512|323635041|FG001|Overall Study|Protocol Violation|3|||
94503086|NCT00395512|323635042|FG002|Overall Study|Protocol Violation|6|||
94503087|NCT00395512|323635043|FG003|Overall Study|Protocol Violation|7|||
94503088|NCT00395512|323635040|FG000|Overall Study|Lost to Follow-up|2|||
94503089|NCT00395512|323635041|FG001|Overall Study|Lost to Follow-up|6|||
94503090|NCT00395512|323635042|FG002|Overall Study|Lost to Follow-up|5|||
94503091|NCT00395512|323635043|FG003|Overall Study|Lost to Follow-up|5|||
94503092|NCT00395512|323635040|FG000|Overall Study|Withdrawal by Subject|6|||
94503093|NCT00395512|323635041|FG001|Overall Study|Withdrawal by Subject|5|||
94503094|NCT00395512|323635042|FG002|Overall Study|Withdrawal by Subject|5|||
94503095|NCT00395512|323635043|FG003|Overall Study|Withdrawal by Subject|12|||
94503096|NCT00395512|323635040|FG000|Overall Study|Physician Decision|6|||
94503097|NCT00395512|323635041|FG001|Overall Study|Physician Decision|4|||
94503098|NCT00395512|323635042|FG002|Overall Study|Physician Decision|2|||
94503099|NCT00395512|323635043|FG003|Overall Study|Physician Decision|2|||
94503100|NCT00395512|323635040|FG000|Overall Study|Other|1|||
94503101|NCT00395512|323635041|FG001|Overall Study|Other|1|||
94503102|NCT00395512|323635042|FG002|Overall Study|Other|0|||
94503103|NCT00395512|323635043|FG003|Overall Study|Other|0|||
94503104|NCT00395512|323635040|FG000|Overall Study|Hyperglycemic Rescue|18|||
94503105|NCT00395512|323635041|FG001|Overall Study|Hyperglycemic Rescue|10|||
94503106|NCT00395512|323635042|FG002|Overall Study|Hyperglycemic Rescue|4|||
94503107|NCT00395512|323635043|FG003|Overall Study|Hyperglycemic Rescue|6|||
94503108|NCT03518203|323635044|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
94503109|NCT03518203|323635044|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
94503110|NCT02829957|323635045|FG000|Overall Study|Lost to Follow-up|2|||
94503111|NCT02829957|323635046|FG001|Overall Study|Lost to Follow-up|1|||
94503112|NCT03511066|323635047|FG000|Overall Study|Withdrawal by Subject|1|||
94503113|NCT03511066|323635048|FG001|Overall Study|Withdrawal by Subject|2|||
94503114|NCT03511066|323635049|FG002|Overall Study|Withdrawal by Subject|3|||
94503115|NCT03511066|323635047|FG000|Overall Study|Lost to Follow-up|2|||
94503116|NCT03511066|323635048|FG001|Overall Study|Lost to Follow-up|3|||
94503117|NCT03511066|323635049|FG002|Overall Study|Lost to Follow-up|0|||
94503118|NCT03163264|323635052|FG000|Overall Study|Withdrawal by Subject|13|||
94503119|NCT03163264|323635053|FG001|Overall Study|Withdrawal by Subject|3|||
94503120|NCT03163264|323635054|FG002|Overall Study|Withdrawal by Subject|4|||
94503121|NCT03163264|323635055|FG003|Overall Study|Withdrawal by Subject|2|||
94503122|NCT03163264|323635052|FG000|Overall Study|Lost to Follow-up|17|||
94503123|NCT03163264|323635053|FG001|Overall Study|Lost to Follow-up|20|||
94503124|NCT03163264|323635054|FG002|Overall Study|Lost to Follow-up|0|||
94503125|NCT03163264|323635055|FG003|Overall Study|Lost to Follow-up|0|||
94503126|NCT03163264|323635052|FG000|Overall Study|Death|0|||
94503127|NCT03163264|323635053|FG001|Overall Study|Death|2|||
94503128|NCT03163264|323635054|FG002|Overall Study|Death|0|||
94503129|NCT03163264|323635055|FG003|Overall Study|Death|0|||
94503130|NCT02405962|323635058|FG000|Overall Study|Lost to Follow-up|1|||
94503131|NCT02405962|323635059|FG001|Overall Study|Lost to Follow-up|4|||
94503132|NCT02405962|323635058|FG000|Overall Study|A participant has moved to another place|0|||
94503133|NCT02405962|323635059|FG001|Overall Study|A participant has moved to another place|1|||
94503134|NCT02774278|323635060|FG000|Overall Study|Lack of Efficacy|199|||
94503135|NCT02774278|323635060|FG000|Overall Study|Death|29|||
94503136|NCT02774278|323635060|FG000|Overall Study|Adverse event/intercurrent illness|16|||
94503137|NCT02774278|323635060|FG000|Overall Study|Refused treatment/did not cooperate|9|||
94503138|NCT02774278|323635060|FG000|Overall Study|Administrative reasons|6|||
94503139|NCT02774278|323635060|FG000|Overall Study|Withdrawal by Subject|3|||
94503140|NCT02774278|323635060|FG000|Overall Study|Protocol Violation|2|||
94503141|NCT03478787|323635061|FG000|Overall Study|Adverse Event|5|||
94503142|NCT03478787|323635062|FG001|Overall Study|Adverse Event|1|||
94503143|NCT03478787|323635061|FG000|Overall Study|Protocol Violation|3|||
94503144|NCT03478787|323635062|FG001|Overall Study|Protocol Violation|0|||
94503145|NCT03478787|323635061|FG000|Overall Study|Lack of Efficacy|7|||
94503146|NCT03478787|323635062|FG001|Overall Study|Lack of Efficacy|1|||
94503147|NCT03478787|323635061|FG000|Overall Study|Lost to Follow-up|9|||
94503148|NCT03478787|323635062|FG001|Overall Study|Lost to Follow-up|5|||
94503149|NCT03478787|323635061|FG000|Overall Study|Withdrawal by Subject|2|||
94503150|NCT03478787|323635062|FG001|Overall Study|Withdrawal by Subject|6|||
94503151|NCT03478787|323635061|FG000|Overall Study|Other, Not Specified|3|||
94503152|NCT03478787|323635062|FG001|Overall Study|Other, Not Specified|0|||
94503153|NCT02413346|323635067|FG000|Overall Study|Adverse Event|6|||
94503154|NCT02413346|323635068|FG001|Overall Study|Adverse Event|6|||
94503155|NCT02413346|323635067|FG000|Overall Study|Withdrawal by Subject|30|||
94503156|NCT02413346|323635068|FG001|Overall Study|Withdrawal by Subject|40|||
94503157|NCT02413346|323635067|FG000|Overall Study|Lost to Follow-up|17|||
94503158|NCT02413346|323635068|FG001|Overall Study|Lost to Follow-up|21|||
94503159|NCT02413346|323635067|FG000|Overall Study|Protocol Violation|2|||
94503160|NCT02413346|323635068|FG001|Overall Study|Protocol Violation|0|||
94503161|NCT02413346|323635067|FG000|Overall Study|Other Miscellaneous Reasons|4|||
94503162|NCT02413346|323635068|FG001|Overall Study|Other Miscellaneous Reasons|3|||
94503163|NCT00300495|323635069|FG000|Overall Study|Protocol Violation|4|||
94503164|NCT00300495|323635070|FG001|Overall Study|Protocol Violation|1|||
94503165|NCT03632720|323635072|FG000|Overall Study|Adverse Event|2|||
94503166|NCT03632720|323635073|FG001|Overall Study|Adverse Event|0|||
94503167|NCT03632720|323635074|FG002|Overall Study|Adverse Event|0|||
94503168|NCT03632720|323635072|FG000|Overall Study|Lost to Follow-up|0|||
94503169|NCT03632720|323635073|FG001|Overall Study|Lost to Follow-up|1|||
94503170|NCT03632720|323635074|FG002|Overall Study|Lost to Follow-up|0|||
94503171|NCT03632720|323635072|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
94503172|NCT03632720|323635073|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
94503173|NCT03632720|323635074|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
94503174|NCT03632720|323635072|FG000|Overall Study|Screen failure|0|||
94503175|NCT03632720|323635073|FG001|Overall Study|Screen failure|1|||
94503176|NCT03632720|323635074|FG002|Overall Study|Screen failure|0|||
94503177|NCT00800384|323635075|FG000|Overall Study|Withdrawal by Subject|24|||
94503178|NCT00800384|323635076|FG001|Overall Study|Withdrawal by Subject|17|||
94503179|NCT00800384|323635075|FG000|Overall Study|Lost to Follow-up|17|||
94503180|NCT00800384|323635076|FG001|Overall Study|Lost to Follow-up|26|||
94503181|NCT02186171|323635077|FG000|Overall Study|Withdrawal by Subject|1|||
94503182|NCT02186171|323635078|FG001|Overall Study|Withdrawal by Subject|9|||
94503183|NCT02186171|323635077|FG000|Overall Study|Lost to Follow-up|2|||
94503184|NCT02186171|323635078|FG001|Overall Study|Lost to Follow-up|2|||
94503185|NCT02186171|323635077|FG000|Overall Study|Death|1|||
94503186|NCT02186171|323635078|FG001|Overall Study|Death|2|||
94503187|NCT02186171|323635077|FG000|Overall Study|Protocol-specified Criteria|0|||
94503188|NCT02186171|323635078|FG001|Overall Study|Protocol-specified Criteria|2|||
94503189|NCT02890355|323635081|FG000|Overall Study|Adverse Event|5|||
94503190|NCT02890355|323635082|FG001|Overall Study|Adverse Event|5|||
94503191|NCT02890355|323635081|FG000|Overall Study|Refusal unrelated to adverse event|5|||
94503192|NCT02890355|323635082|FG001|Overall Study|Refusal unrelated to adverse event|10|||
94503193|NCT02890355|323635081|FG000|Overall Study|Progression/relapse|46|||
94503194|NCT02890355|323635082|FG001|Overall Study|Progression/relapse|39|||
94503195|NCT02890355|323635081|FG000|Overall Study|Not protocol specified|3|||
94503196|NCT02890355|323635082|FG001|Overall Study|Not protocol specified|4|||
94503197|NCT02968810|323637394|FG000|Overall Study|Lost to Follow-up|1|||
94503198|NCT02968810|323637395|FG001|Overall Study|Lost to Follow-up|0|||
94503199|NCT02968810|323637394|FG000|Overall Study|Physician Decision|1|||
94503200|NCT02968810|323637395|FG001|Overall Study|Physician Decision|0|||
94503201|NCT02968810|323637394|FG000|Overall Study|Withdrawal by Subject|1|||
94503202|NCT02968810|323637395|FG001|Overall Study|Withdrawal by Subject|3|||
94503203|NCT02968810|323637394|FG000|Overall Study|Disease Progression|0|||
94503204|NCT02968810|323637395|FG001|Overall Study|Disease Progression|1|||
94503205|NCT00284934|323637396|FG000|Overall Study|Adverse Event|1|||
94503206|NCT00284934|323637397|FG001|Overall Study|Adverse Event|2|||
94503207|NCT00284934|323637396|FG000|Overall Study|Other reasons|3|||
94503208|NCT00284934|323637397|FG001|Overall Study|Other reasons|1|||
94503209|NCT00368849|323637398|FG000|Overall Study|Withdrawal by Subject|0|||
94503210|NCT00368849|323637399|FG001|Overall Study|Withdrawal by Subject|1|||
94503211|NCT00368849|323637398|FG000|Overall Study|Physician Decision|0|||
94503212|NCT00368849|323637399|FG001|Overall Study|Physician Decision|1|||
94503213|NCT00454142|323637400|FG000|Overall Study|Withdrawal by Subject|1|||
94503214|NCT00758043|323637401|FG000|Overall Study|Adverse Event|1|||
94503215|NCT00758043|323637402|FG001|Overall Study|Adverse Event|20|||
94503216|NCT00758043|323637403|FG002|Overall Study|Adverse Event|12|||
94503217|NCT00758043|323637404|FG003|Overall Study|Adverse Event|62|||
94503218|NCT00758043|323637401|FG000|Overall Study|Lack of Efficacy|0|||
94503219|NCT00758043|323637402|FG001|Overall Study|Lack of Efficacy|6|||
94503220|NCT00758043|323637403|FG002|Overall Study|Lack of Efficacy|18|||
94503221|NCT00758043|323637404|FG003|Overall Study|Lack of Efficacy|12|||
94503222|NCT00758043|323637401|FG000|Overall Study|Refused Further Treatment|0|||
94503223|NCT00758043|323637402|FG001|Overall Study|Refused Further Treatment|11|||
94503224|NCT00758043|323637403|FG002|Overall Study|Refused Further Treatment|5|||
94503225|NCT00758043|323637404|FG003|Overall Study|Refused Further Treatment|8|||
94503226|NCT00758043|323637401|FG000|Overall Study|Lost to Follow-up|0|||
94503227|NCT00758043|323637402|FG001|Overall Study|Lost to Follow-up|2|||
94503228|NCT00758043|323637403|FG002|Overall Study|Lost to Follow-up|2|||
94503229|NCT00758043|323637404|FG003|Overall Study|Lost to Follow-up|5|||
94503230|NCT00758043|323637401|FG000|Overall Study|Withdrawal by Subject|0|||
94503231|NCT00758043|323637402|FG001|Overall Study|Withdrawal by Subject|1|||
94503232|NCT00758043|323637403|FG002|Overall Study|Withdrawal by Subject|1|||
94503233|NCT00758043|323637404|FG003|Overall Study|Withdrawal by Subject|4|||
94503234|NCT00758043|323637401|FG000|Overall Study|Required Prohibited Medication|0|||
94503235|NCT00758043|323637402|FG001|Overall Study|Required Prohibited Medication|0|||
94503236|NCT00758043|323637403|FG002|Overall Study|Required Prohibited Medication|1|||
94503237|NCT00758043|323637404|FG003|Overall Study|Required Prohibited Medication|3|||
94503238|NCT00758043|323637401|FG000|Overall Study|Non-Compliant With study Drug|0|||
94503239|NCT00758043|323637402|FG001|Overall Study|Non-Compliant With study Drug|0|||
94503240|NCT00758043|323637403|FG002|Overall Study|Non-Compliant With study Drug|0|||
94503241|NCT00758043|323637404|FG003|Overall Study|Non-Compliant With study Drug|1|||
94503242|NCT00758043|323637401|FG000|Overall Study|Other Reasons|0|||
94503243|NCT00758043|323637402|FG001|Overall Study|Other Reasons|1|||
94503244|NCT00758043|323637403|FG002|Overall Study|Other Reasons|0|||
94503245|NCT00758043|323637404|FG003|Overall Study|Other Reasons|5|||
94503246|NCT01902303|323637405|FG000|Overall Study|Adverse Event|0|||
94503247|NCT01902303|323637406|FG001|Overall Study|Adverse Event|1|||
94503248|NCT01902303|323637405|FG000|Overall Study|Lost to Follow-up|0|||
94503249|NCT01902303|323637406|FG001|Overall Study|Lost to Follow-up|1|||
94503250|NCT01902303|323637405|FG000|Overall Study|Protocol Violation|2|||
94503251|NCT01902303|323637406|FG001|Overall Study|Protocol Violation|2|||
94503252|NCT01902303|323637405|FG000|Overall Study|subject lost investigational product|0|||
94503253|NCT01902303|323637406|FG001|Overall Study|subject lost investigational product|1|||
94503254|NCT01902303|323637405|FG000|Overall Study|Did not develop a cold sore|21|||
94503255|NCT01902303|323637406|FG001|Overall Study|Did not develop a cold sore|19|||
94503256|NCT02821000|323637408|FG000|Overall Study|Death|89|||
94503257|NCT02821000|323637408|FG000|Overall Study|Sponsor Decision|12|||
94503258|NCT02821000|323637408|FG000|Overall Study|Withdrawal by Subject|2|||
94503259|NCT02545127|323637412|FG000|Overall Study|Lost to Follow-up|1|||
94503260|NCT02545127|323637413|FG001|Overall Study|Lost to Follow-up|0|||
94503261|NCT00326495|323637414|FG000|Overall Study|Switched to alternative treatment|1|||
94503262|NCT00326495|323637414|FG000|Overall Study|Disease progression before treatment|1|||
94503263|NCT00326495|323637414|FG000|Overall Study|Refused further treatment|2|||
94503264|NCT00326495|323637414|FG000|Overall Study|Subject off study before assessment|1|||
94503265|NCT05788328|323637415|FG000|Treatment Period 4 (5 Days)|Other|1|||
94503266|NCT05788328|323637415|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
94503267|NCT00520572|323637416|FG000|Overall Study|Adverse Event|9|||
94503268|NCT00520572|323637417|FG001|Overall Study|Adverse Event|3|||
94503269|NCT00520572|323637418|FG002|Overall Study|Adverse Event|6|||
94503270|NCT00520572|323637419|FG003|Overall Study|Adverse Event|9|||
94503271|NCT00520572|323637420|FG004|Overall Study|Adverse Event|7|||
94503272|NCT00520572|323637421|FG005|Overall Study|Adverse Event|2|||
94503273|NCT00520572|323637416|FG000|Overall Study|Withdrawal by Subject|0|||
94503274|NCT00520572|323637417|FG001|Overall Study|Withdrawal by Subject|9|||
94503275|NCT00520572|323637418|FG002|Overall Study|Withdrawal by Subject|5|||
94503276|NCT00520572|323637419|FG003|Overall Study|Withdrawal by Subject|2|||
94503277|NCT00520572|323637420|FG004|Overall Study|Withdrawal by Subject|2|||
94503278|NCT00520572|323637421|FG005|Overall Study|Withdrawal by Subject|0|||
94503279|NCT00520572|323637416|FG000|Overall Study|Protocol Violation|0|||
94503280|NCT00520572|323637417|FG001|Overall Study|Protocol Violation|0|||
94503281|NCT00520572|323637418|FG002|Overall Study|Protocol Violation|1|||
94503282|NCT00520572|323637419|FG003|Overall Study|Protocol Violation|0|||
94503283|NCT00520572|323637420|FG004|Overall Study|Protocol Violation|0|||
94503284|NCT00520572|323637421|FG005|Overall Study|Protocol Violation|0|||
94503285|NCT00520572|323637416|FG000|Overall Study|Lack of Efficacy|1|||
94503286|NCT00520572|323637417|FG001|Overall Study|Lack of Efficacy|1|||
94503287|NCT00520572|323637418|FG002|Overall Study|Lack of Efficacy|1|||
94503288|NCT00520572|323637419|FG003|Overall Study|Lack of Efficacy|2|||
94503289|NCT00520572|323637420|FG004|Overall Study|Lack of Efficacy|1|||
94503290|NCT00520572|323637421|FG005|Overall Study|Lack of Efficacy|0|||
94503291|NCT00520572|323637416|FG000|Overall Study|Lost to Follow-up|0|||
94503292|NCT00520572|323637417|FG001|Overall Study|Lost to Follow-up|0|||
94503293|NCT00520572|323637418|FG002|Overall Study|Lost to Follow-up|0|||
94503294|NCT00520572|323637419|FG003|Overall Study|Lost to Follow-up|0|||
94503295|NCT00520572|323637420|FG004|Overall Study|Lost to Follow-up|1|||
94503296|NCT00520572|323637421|FG005|Overall Study|Lost to Follow-up|0|||
94503297|NCT00520572|323637416|FG000|Overall Study|Incorrect enrollment|1|||
94503298|NCT00520572|323637417|FG001|Overall Study|Incorrect enrollment|0|||
94503299|NCT00520572|323637418|FG002|Overall Study|Incorrect enrollment|1|||
94503300|NCT00520572|323637419|FG003|Overall Study|Incorrect enrollment|0|||
94503301|NCT00520572|323637420|FG004|Overall Study|Incorrect enrollment|1|||
94503302|NCT00520572|323637421|FG005|Overall Study|Incorrect enrollment|0|||
94503303|NCT00520572|323637416|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
94503304|NCT00520572|323637417|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
94503305|NCT00520572|323637418|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
94503306|NCT00520572|323637419|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
94503307|NCT00520572|323637420|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
94503308|NCT00520572|323637421|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
94503309|NCT00520572|323637416|FG000|Overall Study|Long break in taking Medication|0|||
94503310|NCT00520572|323637417|FG001|Overall Study|Long break in taking Medication|0|||
94503311|NCT00520572|323637418|FG002|Overall Study|Long break in taking Medication|0|||
94503312|NCT00520572|323637419|FG003|Overall Study|Long break in taking Medication|1|||
94503313|NCT00520572|323637420|FG004|Overall Study|Long break in taking Medication|0|||
94503314|NCT00520572|323637421|FG005|Overall Study|Long break in taking Medication|0|||
94503315|NCT00520572|323637416|FG000|Overall Study|Did not receive Treatment|1|||
94503316|NCT00520572|323637417|FG001|Overall Study|Did not receive Treatment|0|||
94503317|NCT00520572|323637418|FG002|Overall Study|Did not receive Treatment|1|||
94503318|NCT00520572|323637419|FG003|Overall Study|Did not receive Treatment|0|||
94503319|NCT00520572|323637420|FG004|Overall Study|Did not receive Treatment|0|||
94503320|NCT00520572|323637421|FG005|Overall Study|Did not receive Treatment|0|||
94503321|NCT03774810|323637424|FG000|Phase 1|Lack of Efficacy|21|||
94503322|NCT03774810|323637425|FG001|Phase 1|Lack of Efficacy|0|||
94503323|NCT03774810|323637426|FG002|Phase 1|Lack of Efficacy|0|||
94503324|NCT03774810|323637427|FG003|Phase 1|Lack of Efficacy|0|||
94503325|NCT03774810|323637428|FG004|Phase 1|Lack of Efficacy|0|||
94503326|NCT03774810|323637424|FG000|Phase 1|Withdrawal by Subject|9|||
94503327|NCT03774810|323637425|FG001|Phase 1|Withdrawal by Subject|0|||
94503328|NCT03774810|323637426|FG002|Phase 1|Withdrawal by Subject|0|||
94503329|NCT03774810|323637427|FG003|Phase 1|Withdrawal by Subject|0|||
94503330|NCT03774810|323637428|FG004|Phase 1|Withdrawal by Subject|0|||
94503331|NCT03774810|323637424|FG000|Phase 1|Lost to Follow-up|2|||
94503332|NCT03774810|323637425|FG001|Phase 1|Lost to Follow-up|0|||
94503333|NCT03774810|323637426|FG002|Phase 1|Lost to Follow-up|0|||
94503334|NCT03774810|323637427|FG003|Phase 1|Lost to Follow-up|0|||
94503335|NCT03774810|323637428|FG004|Phase 1|Lost to Follow-up|0|||
94503336|NCT03774810|323637424|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
94503337|NCT03774810|323637425|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
94503338|NCT03774810|323637426|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
94503339|NCT03774810|323637427|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
94503340|NCT03774810|323637428|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
94503341|NCT03774810|323637424|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
94503342|NCT03774810|323637425|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
94503343|NCT03774810|323637426|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
94503344|NCT03774810|323637427|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
94503345|NCT03774810|323637428|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
94503346|NCT03774810|323637424|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
94503347|NCT03774810|323637425|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
94503348|NCT03774810|323637426|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
94503349|NCT03774810|323637427|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
94503350|NCT03774810|323637428|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
94503351|NCT03774810|323637424|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
94503352|NCT03774810|323637425|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
94503353|NCT03774810|323637426|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
94503354|NCT03774810|323637427|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
94503355|NCT03774810|323637428|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
94503356|NCT03774810|323637424|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
94503357|NCT03774810|323637425|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
94503358|NCT03774810|323637426|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
94503359|NCT03774810|323637427|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
94503360|NCT03774810|323637428|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
94503361|NCT03774810|323637424|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
94503362|NCT03774810|323637425|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
94503363|NCT03774810|323637426|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
94503364|NCT03774810|323637427|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
94503365|NCT03774810|323637428|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
94503366|NCT01122680|323637429|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
94503367|NCT01122680|323637430|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
94503368|NCT01122680|323637431|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
94503369|NCT01122680|323637432|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
94503370|NCT01122680|323637429|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
94503371|NCT01122680|323637430|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
94503372|NCT01122680|323637431|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
94503373|NCT01122680|323637432|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
94503374|NCT01122680|323637429|FG000|Period 1 (4 Weeks)|Other|1|||
94503375|NCT01122680|323637430|FG001|Period 1 (4 Weeks)|Other|1|||
94503376|NCT01122680|323637431|FG002|Period 1 (4 Weeks)|Other|0|||
94503377|NCT01122680|323637432|FG003|Period 1 (4 Weeks)|Other|0|||
94503378|NCT01122680|323637429|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
94503379|NCT01122680|323637430|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
94503380|NCT01122680|323637431|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
94503381|NCT01122680|323637432|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
94503382|NCT01122680|323637429|FG000|Period 2 (4 Weeks)|Other|1|||
94503383|NCT01122680|323637430|FG001|Period 2 (4 Weeks)|Other|0|||
94503384|NCT01122680|323637431|FG002|Period 2 (4 Weeks)|Other|0|||
94503385|NCT01122680|323637432|FG003|Period 2 (4 Weeks)|Other|0|||
94503386|NCT01122680|323637429|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
94503387|NCT01122680|323637430|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
94503388|NCT01122680|323637431|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
94503389|NCT01122680|323637432|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
94503390|NCT01122680|323637429|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
94503391|NCT01122680|323637430|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
94503392|NCT01122680|323637431|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
94503393|NCT01122680|323637432|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
94503394|NCT04641975|323637433|FG000|Overall Study|Protocol Violation|1|||
94503395|NCT04641975|323637434|FG001|Overall Study|Protocol Violation|2|||
94503396|NCT04641975|323637435|FG002|Overall Study|Protocol Violation|0|||
94503397|NCT04641975|323637436|FG003|Overall Study|Protocol Violation|0|||
94503398|NCT04641975|323637433|FG000|Overall Study|Adverse Event|0|||
94503399|NCT04641975|323637434|FG001|Overall Study|Adverse Event|0|||
94503400|NCT04641975|323637435|FG002|Overall Study|Adverse Event|1|||
94503401|NCT04641975|323637436|FG003|Overall Study|Adverse Event|1|||
94503402|NCT04641975|323637433|FG000|Overall Study|Withdrawal by Subject|1|||
94503403|NCT04641975|323637434|FG001|Overall Study|Withdrawal by Subject|0|||
94503404|NCT04641975|323637435|FG002|Overall Study|Withdrawal by Subject|0|||
94503405|NCT04641975|323637436|FG003|Overall Study|Withdrawal by Subject|0|||
94503406|NCT01259024|323637437|FG000|Overall Study|Physician Decision|1|||
94503407|NCT05029362|323637438|FG000|Overall Study|Lost to Follow-up|9|||
94503408|NCT01217047|323637439|FG000|Overall Study|Lost to Follow-up|0|||
94503409|NCT01217047|323637440|FG001|Overall Study|Lost to Follow-up|1|||
94503410|NCT01217047|323637441|FG002|Overall Study|Lost to Follow-up|0|||
94503411|NCT00986102|323637444|FG000|Overall Study|Lost to Follow-up|0|||
94503412|NCT00986102|323637445|FG001|Overall Study|Lost to Follow-up|1|||
94503413|NCT00986102|323637446|FG002|Overall Study|Lost to Follow-up|0|||
94503414|NCT00986102|323637447|FG003|Overall Study|Lost to Follow-up|1|||
94503415|NCT00986102|323637444|FG000|Overall Study|Withdrawal by Subject|1|||
94503416|NCT00986102|323637445|FG001|Overall Study|Withdrawal by Subject|1|||
94503417|NCT00986102|323637446|FG002|Overall Study|Withdrawal by Subject|0|||
94503418|NCT00986102|323637447|FG003|Overall Study|Withdrawal by Subject|0|||
94503419|NCT06083493|323637448|FG000|Overall Study|Technical issues with the interventional device|2|||
94503420|NCT06083493|323637449|FG001|Overall Study|Technical issues with the interventional device|2|||
94503421|NCT06083493|323637448|FG000|Overall Study|Performed incorrect visual task|1|||
94503422|NCT06083493|323637449|FG001|Overall Study|Performed incorrect visual task|0|||
94503423|NCT06083493|323637448|FG000|Overall Study|Insufficient baseline performance|0|||
94655624|NCT04369469|324196100|FG000|Overall Study|Unable to Provide Consent|0|||
94655625|NCT04369469|324196101|FG001|Overall Study|Unable to Provide Consent|1|||
94655626|NCT00555438|324196102|FG000|10 Days Post-operative|Death|4|||
94655627|NCT00555438|324196102|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
94503424|NCT06083493|323637449|FG001|Overall Study|Insufficient baseline performance|1|||
94503425|NCT03671148|323637450|FG000|Overall Study|Adverse Event|3|||
94503426|NCT03671148|323637451|FG001|Overall Study|Adverse Event|2|||
94503427|NCT03671148|323637450|FG000|Overall Study|Withdrawal by Subject|8|||
94503428|NCT03671148|323637451|FG001|Overall Study|Withdrawal by Subject|2|||
94503429|NCT03671148|323637450|FG000|Overall Study|Lost to Follow-up|1|||
94503430|NCT03671148|323637451|FG001|Overall Study|Lost to Follow-up|2|||
94503431|NCT03671148|323637450|FG000|Overall Study|Lack of Efficacy|7|||
94503432|NCT03671148|323637451|FG001|Overall Study|Lack of Efficacy|2|||
94503433|NCT03671148|323637450|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
94503434|NCT03671148|323637451|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
94503435|NCT03671148|323637450|FG000|Overall Study|Other|1|||
94503436|NCT03671148|323637451|FG001|Overall Study|Other|0|||
94503437|NCT03671148|323637450|FG000|Overall Study|Incomplete Randomization Visit|1|||
94503438|NCT03671148|323637451|FG001|Overall Study|Incomplete Randomization Visit|0|||
94503439|NCT03093870|323637455|FG000|Overall Study|Withdrawal by Subject|2|||
94503440|NCT03093870|323637456|FG001|Overall Study|Withdrawal by Subject|6|||
94503441|NCT03093870|323637457|FG002|Overall Study|Withdrawal by Subject|5|||
94503442|NCT03093870|323637455|FG000|Overall Study|Death|1|||
94503443|NCT03093870|323637456|FG001|Overall Study|Death|35|||
94503444|NCT03093870|323637457|FG002|Overall Study|Death|35|||
94503445|NCT03093870|323637455|FG000|Overall Study|Radiographic disease progression|10|||
94503446|NCT03093870|323637456|FG001|Overall Study|Radiographic disease progression|0|||
94503447|NCT03093870|323637457|FG002|Overall Study|Radiographic disease progression|0|||
94503448|NCT03093870|323637455|FG000|Overall Study|Clinical disease progression|1|||
94503449|NCT03093870|323637456|FG001|Overall Study|Clinical disease progression|0|||
94503450|NCT03093870|323637457|FG002|Overall Study|Clinical disease progression|0|||
94503451|NCT03093870|323637455|FG000|Overall Study|Physician Decision|2|||
94503452|NCT03093870|323637456|FG001|Overall Study|Physician Decision|0|||
94503453|NCT03093870|323637457|FG002|Overall Study|Physician Decision|0|||
94503454|NCT03093870|323637455|FG000|Overall Study|Adverse Event|7|||
94503455|NCT03093870|323637456|FG001|Overall Study|Adverse Event|0|||
94503456|NCT03093870|323637457|FG002|Overall Study|Adverse Event|0|||
94503457|NCT03093870|323637455|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
94503458|NCT03093870|323637456|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
94503459|NCT03093870|323637457|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
94503460|NCT03093870|323637455|FG000|Overall Study|Lost to Follow-up|0|||
94503461|NCT03093870|323637456|FG001|Overall Study|Lost to Follow-up|0|||
94503462|NCT03093870|323637457|FG002|Overall Study|Lost to Follow-up|1|||
94503463|NCT01530997|323637458|FG000|Overall Study|Physician Decision|1|||
94503464|NCT01530997|323637458|FG000|Overall Study|Withdrawal by Subject|1|||
94503465|NCT02739828|323637459|FG000|Overall Study|Adverse Event|1|||
94503466|NCT02739828|323637459|FG000|Overall Study|Lost to Follow-up|4|||
94503467|NCT02318277|323637460|FG000|Overall Study|Physician Decision|0|||
94503468|NCT02318277|323637461|FG001|Overall Study|Physician Decision|0|||
94503469|NCT02318277|323637462|FG002|Overall Study|Physician Decision|0|||
94503470|NCT02318277|323637463|FG003|Overall Study|Physician Decision|0|||
94503471|NCT02318277|323637464|FG004|Overall Study|Physician Decision|0|||
94503472|NCT02318277|323637465|FG005|Overall Study|Physician Decision|0|||
94503473|NCT02318277|323637466|FG006|Overall Study|Physician Decision|0|||
94503474|NCT02318277|323637467|FG007|Overall Study|Physician Decision|1|||
94503475|NCT02318277|323637460|FG000|Overall Study|Other|0|||
94503476|NCT02318277|323637461|FG001|Overall Study|Other|0|||
94503477|NCT02318277|323637462|FG002|Overall Study|Other|0|||
94503478|NCT02318277|323637463|FG003|Overall Study|Other|0|||
94503479|NCT02318277|323637464|FG004|Overall Study|Other|0|||
94503480|NCT02318277|323637465|FG005|Overall Study|Other|0|||
94503481|NCT02318277|323637466|FG006|Overall Study|Other|1|||
94503482|NCT02318277|323637467|FG007|Overall Study|Other|0|||
94503483|NCT02318277|323637460|FG000|Overall Study|Withdrawal by Subject|0|||
94503484|NCT02318277|323637461|FG001|Overall Study|Withdrawal by Subject|0|||
94503485|NCT02318277|323637462|FG002|Overall Study|Withdrawal by Subject|1|||
94503486|NCT02318277|323637463|FG003|Overall Study|Withdrawal by Subject|0|||
94503487|NCT02318277|323637464|FG004|Overall Study|Withdrawal by Subject|1|||
94503488|NCT02318277|323637465|FG005|Overall Study|Withdrawal by Subject|1|||
94503489|NCT02318277|323637466|FG006|Overall Study|Withdrawal by Subject|6|||
94503490|NCT02318277|323637467|FG007|Overall Study|Withdrawal by Subject|14|||
94655628|NCT03135522|324196105|FG000|Overall Study|Adverse Event|1|||
94503491|NCT02318277|323637460|FG000|Overall Study|Participant trial terminated by sponsor|0|||
94503492|NCT02318277|323637461|FG001|Overall Study|Participant trial terminated by sponsor|0|||
94503493|NCT02318277|323637462|FG002|Overall Study|Participant trial terminated by sponsor|1|||
94503494|NCT02318277|323637463|FG003|Overall Study|Participant trial terminated by sponsor|0|||
94503495|NCT02318277|323637464|FG004|Overall Study|Participant trial terminated by sponsor|1|||
94503496|NCT02318277|323637465|FG005|Overall Study|Participant trial terminated by sponsor|2|||
94503497|NCT02318277|323637466|FG006|Overall Study|Participant trial terminated by sponsor|5|||
94503498|NCT02318277|323637467|FG007|Overall Study|Participant trial terminated by sponsor|16|||
94503499|NCT02318277|323637460|FG000|Overall Study|Lost to Follow-up|1|||
94503500|NCT02318277|323637461|FG001|Overall Study|Lost to Follow-up|0|||
94503501|NCT02318277|323637462|FG002|Overall Study|Lost to Follow-up|1|||
94503502|NCT02318277|323637463|FG003|Overall Study|Lost to Follow-up|0|||
94503503|NCT02318277|323637464|FG004|Overall Study|Lost to Follow-up|0|||
94503504|NCT02318277|323637465|FG005|Overall Study|Lost to Follow-up|0|||
94503505|NCT02318277|323637466|FG006|Overall Study|Lost to Follow-up|3|||
94503506|NCT02318277|323637467|FG007|Overall Study|Lost to Follow-up|4|||
94503507|NCT02318277|323637460|FG000|Overall Study|Death|5|||
94503508|NCT02318277|323637461|FG001|Overall Study|Death|3|||
94503509|NCT02318277|323637462|FG002|Overall Study|Death|1|||
94503510|NCT02318277|323637463|FG003|Overall Study|Death|4|||
94503511|NCT02318277|323637464|FG004|Overall Study|Death|6|||
94503512|NCT02318277|323637465|FG005|Overall Study|Death|5|||
94503513|NCT02318277|323637466|FG006|Overall Study|Death|34|||
94503514|NCT02318277|323637467|FG007|Overall Study|Death|58|||
94503515|NCT02318277|323637460|FG000|Overall Study|Transitioned to Hospice|0|||
94503516|NCT02318277|323637461|FG001|Overall Study|Transitioned to Hospice|0|||
94503517|NCT02318277|323637462|FG002|Overall Study|Transitioned to Hospice|0|||
94503518|NCT02318277|323637463|FG003|Overall Study|Transitioned to Hospice|0|||
94503519|NCT02318277|323637464|FG004|Overall Study|Transitioned to Hospice|0|||
94503520|NCT02318277|323637465|FG005|Overall Study|Transitioned to Hospice|1|||
94503521|NCT02318277|323637466|FG006|Overall Study|Transitioned to Hospice|0|||
94503522|NCT02318277|323637467|FG007|Overall Study|Transitioned to Hospice|0|||
94503523|NCT02314247|323637470|FG000|Overall Study|Adverse Event|2|||
94503524|NCT02314247|323637471|FG001|Overall Study|Adverse Event|1|||
94503525|NCT02314247|323637472|FG002|Overall Study|Adverse Event|0|||
94503526|NCT02314247|323637470|FG000|Overall Study|Withdrawal by Subject|1|||
94503527|NCT02314247|323637471|FG001|Overall Study|Withdrawal by Subject|3|||
94503528|NCT02314247|323637472|FG002|Overall Study|Withdrawal by Subject|1|||
94503529|NCT02314247|323637470|FG000|Overall Study|Progression of Disease|6|||
94503530|NCT02314247|323637471|FG001|Overall Study|Progression of Disease|2|||
94503531|NCT02314247|323637472|FG002|Overall Study|Progression of Disease|0|||
94503532|NCT01986751|323637477|FG000|Overall Study|improperly consented|10|||
94503533|NCT01986751|323637478|FG001|Overall Study|improperly consented|2|||
94503534|NCT01063881|323637481|FG000|Overall Study|Adverse Event|12|||
94503535|NCT01063881|323637482|FG001|Overall Study|Adverse Event|2|||
94503536|NCT01063881|323637483|FG002|Overall Study|Adverse Event|0|||
94503537|NCT01063881|323637481|FG000|Overall Study|Lost to Follow-up|13|||
94503538|NCT01063881|323637482|FG001|Overall Study|Lost to Follow-up|7|||
94503539|NCT01063881|323637483|FG002|Overall Study|Lost to Follow-up|1|||
94503540|NCT01063881|323637481|FG000|Overall Study|Withdrawal by Subject|25|||
94503541|NCT01063881|323637482|FG001|Overall Study|Withdrawal by Subject|1|||
94503542|NCT01063881|323637483|FG002|Overall Study|Withdrawal by Subject|0|||
94503543|NCT01063881|323637481|FG000|Overall Study|Reason for not completed not specified|5|||
94503544|NCT01063881|323637482|FG001|Overall Study|Reason for not completed not specified|1|||
94503545|NCT01063881|323637483|FG002|Overall Study|Reason for not completed not specified|0|||
94503546|NCT03722030|323637484|FG000|Overall Study|Withdrawal by Subject|1|||
94503547|NCT03722030|323637485|FG001|Overall Study|Withdrawal by Subject|0|||
94503548|NCT04560309|323637489|FG000|Overall Study|Meet drop out criteria|1|||
94503549|NCT04560309|323637490|FG001|Overall Study|Meet drop out criteria|1|||
94503550|NCT05085405|323637491|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
94503551|NCT05085405|323637492|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
94503552|NCT05085405|323637493|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
94503553|NCT05085405|323637494|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
94503554|NCT05085405|323637495|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
94503555|NCT05085405|323637496|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
94503556|NCT05085405|323637491|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
94503557|NCT05085405|323637492|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
94503558|NCT05085405|323637493|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
94503559|NCT05085405|323637494|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
94503560|NCT05085405|323637495|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
94503561|NCT05085405|323637496|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
94503562|NCT04146909|323637497|FG000|Overall Study|Withdrawal by Subject|3|||
94503563|NCT04146909|323637497|FG000|Overall Study|Did not qualify after consented|1|||
94503564|NCT04193527|323637502|FG000|Overall Study|Other|1|||
94503565|NCT04193527|323637503|FG001|Overall Study|Other|1|||
94503566|NCT04193527|323637504|FG002|Overall Study|Other|0|||
94503567|NCT03808909|323637506|FG000|Overall Study|Lost to Follow-up|3|||
94503568|NCT03808909|323637507|FG001|Overall Study|Lost to Follow-up|0|||
94503569|NCT00560404|323637510|FG000|Overall Study|Adverse Event|2|||
94503570|NCT00560404|323637511|FG001|Overall Study|Adverse Event|3|||
94503571|NCT00560404|323637510|FG000|Overall Study|Death|3|||
94503572|NCT00560404|323637511|FG001|Overall Study|Death|3|||
94503573|NCT00560404|323637510|FG000|Overall Study|Protocol Violation|12|||
94503574|NCT00560404|323637511|FG001|Overall Study|Protocol Violation|7|||
94503575|NCT00560404|323637510|FG000|Overall Study|Administrative Reasons|1|||
94503576|NCT00560404|323637511|FG001|Overall Study|Administrative Reasons|1|||
94503577|NCT00560404|323637510|FG000|Overall Study|Withdrew Consent|4|||
94503578|NCT00560404|323637511|FG001|Overall Study|Withdrew Consent|0|||
94503579|NCT00560404|323637510|FG000|Overall Study|Failure to return|1|||
94503580|NCT00560404|323637511|FG001|Overall Study|Failure to return|2|||
94503581|NCT00560404|323637510|FG000|Overall Study|Other withdrawal reason|13|||
94503582|NCT00560404|323637511|FG001|Overall Study|Other withdrawal reason|5|||
94503583|NCT00676689|323637512|FG000|Overall Study|Screen Failure|2|||
94503584|NCT00676689|323637512|FG000|Overall Study|Death|2|||
94503585|NCT00676689|323637512|FG000|Overall Study|Lost to Follow-up|4|||
94503586|NCT00676689|323637512|FG000|Overall Study|Physician Decision|1|||
94503587|NCT00676689|323637512|FG000|Overall Study|Withdrawal by Subject|3|||
94503588|NCT00676689|323637512|FG000|Overall Study|Continuing FU|49|||
94503589|NCT01618708|323637513|FG000|Overall Study|Adverse Event|10|||
94503590|NCT01618708|323637514|FG001|Overall Study|Adverse Event|10|||
94503591|NCT01618708|323637513|FG000|Overall Study|Lost to Follow-up|3|||
94503592|NCT01618708|323637514|FG001|Overall Study|Lost to Follow-up|3|||
94503593|NCT01618708|323637513|FG000|Overall Study|Withdrawal by Subject|17|||
94503594|NCT01618708|323637514|FG001|Overall Study|Withdrawal by Subject|22|||
94503595|NCT01618708|323637513|FG000|Overall Study|Lack of Efficacy|8|||
94503596|NCT01618708|323637514|FG001|Overall Study|Lack of Efficacy|8|||
94503597|NCT01618708|323637513|FG000|Overall Study|Technical problems|2|||
94503598|NCT01618708|323637514|FG001|Overall Study|Technical problems|0|||
94503599|NCT01618708|323637513|FG000|Overall Study|Other than specified above|1|||
94503600|NCT01618708|323637514|FG001|Overall Study|Other than specified above|1|||
94503601|NCT01618708|323637513|FG000|Overall Study|Randomized but not treated|3|||
94503602|NCT01618708|323637514|FG001|Overall Study|Randomized but not treated|2|||
94503603|NCT03888482|323637515|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
94503604|NCT03888482|323637516|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
94503605|NCT03888482|323637515|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
94503606|NCT03888482|323637516|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
94503607|NCT03721107|323637517|FG000|Overall Study|Adverse Event|1|||
94503608|NCT03721107|323637518|FG001|Overall Study|Adverse Event|1|||
94503609|NCT03721107|323637519|FG002|Overall Study|Adverse Event|6|||
94503610|NCT03721107|323637520|FG003|Overall Study|Adverse Event|5|||
94503611|NCT03721107|323637517|FG000|Overall Study|Lost to Follow-up|2|||
94503612|NCT03721107|323637518|FG001|Overall Study|Lost to Follow-up|0|||
94503613|NCT03721107|323637519|FG002|Overall Study|Lost to Follow-up|3|||
94503614|NCT03721107|323637520|FG003|Overall Study|Lost to Follow-up|0|||
94503615|NCT03721107|323637517|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
94503616|NCT03721107|323637518|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
94503617|NCT03721107|323637519|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
94503618|NCT03721107|323637520|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
94503619|NCT03721107|323637517|FG000|Overall Study|Physician Decision|0|||
94503620|NCT03721107|323637518|FG001|Overall Study|Physician Decision|1|||
94503621|NCT03721107|323637519|FG002|Overall Study|Physician Decision|0|||
94503622|NCT03721107|323637520|FG003|Overall Study|Physician Decision|0|||
94503623|NCT03721107|323637517|FG000|Overall Study|Pregnancy|0|||
94503624|NCT03721107|323637518|FG001|Overall Study|Pregnancy|0|||
94503625|NCT03721107|323637519|FG002|Overall Study|Pregnancy|1|||
94503626|NCT03721107|323637520|FG003|Overall Study|Pregnancy|0|||
94503627|NCT03721107|323637517|FG000|Overall Study|Withdrawal by Subject|1|||
94503628|NCT03721107|323637518|FG001|Overall Study|Withdrawal by Subject|1|||
94503629|NCT03721107|323637519|FG002|Overall Study|Withdrawal by Subject|5|||
94503630|NCT03721107|323637520|FG003|Overall Study|Withdrawal by Subject|5|||
94503631|NCT03721107|323637517|FG000|Overall Study|Other|1|||
94503632|NCT03721107|323637518|FG001|Overall Study|Other|0|||
94503633|NCT03721107|323637519|FG002|Overall Study|Other|0|||
94503634|NCT03721107|323637520|FG003|Overall Study|Other|1|||
94503635|NCT02369159|323637521|FG000|Overall Study|Adverse Event|0|||
94503636|NCT02369159|323637522|FG001|Overall Study|Adverse Event|1|||
94503637|NCT02369159|323637521|FG000|Overall Study|Lost to Follow-up|1|||
94503638|NCT02369159|323637522|FG001|Overall Study|Lost to Follow-up|1|||
94655629|NCT03135522|324196106|FG001|Overall Study|Adverse Event|0|||
94503639|NCT02369159|323637521|FG000|Overall Study|Withdrawal by Subject|7|||
94503640|NCT02369159|323637522|FG001|Overall Study|Withdrawal by Subject|0|||
94503641|NCT03438656|323637523|FG000|Overall Study|Lost to Follow-up|2|||
94503642|NCT03335566|323637524|FG000|Overall Study|Adverse Event|0|||
94503643|NCT03335566|323637525|FG001|Overall Study|Adverse Event|1|||
94503644|NCT03335566|323637524|FG000|Overall Study|Lost to Follow-up|1|||
94503645|NCT03335566|323637525|FG001|Overall Study|Lost to Follow-up|0|||
94503646|NCT03335566|323637524|FG000|Overall Study|Technical Problems|1|||
94503647|NCT03335566|323637525|FG001|Overall Study|Technical Problems|0|||
94503648|NCT03335566|323637524|FG000|Overall Study|Protocol Violation|1|||
94503649|NCT03335566|323637525|FG001|Overall Study|Protocol Violation|0|||
94503650|NCT03335566|323637524|FG000|Overall Study|Other than specified above|1|||
94503651|NCT03335566|323637525|FG001|Overall Study|Other than specified above|2|||
94503652|NCT01084135|323637526|FG000|20 Week|Physician Decision|0|||
94503653|NCT01084135|323637527|FG001|20 Week|Physician Decision|1|||
94503654|NCT03211832|323637528|FG000|Overall Study|No longer with agency|32|||
94503655|NCT03211832|323637529|FG001|Overall Study|No longer with agency|49|||
94503656|NCT03211832|323637530|FG002|Overall Study|No longer with agency|30|||
94503657|NCT03211832|323637528|FG000|Overall Study|Declined survey|3|||
94503658|NCT03211832|323637529|FG001|Overall Study|Declined survey|3|||
94503659|NCT03211832|323637530|FG002|Overall Study|Declined survey|2|||
94503660|NCT03211832|323637528|FG000|Overall Study|Not available during data collection|1|||
94503661|NCT03211832|323637529|FG001|Overall Study|Not available during data collection|0|||
94503662|NCT03211832|323637530|FG002|Overall Study|Not available during data collection|2|||
94503663|NCT02991859|323637534|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
94503664|NCT02991859|323637535|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
94503665|NCT02991859|323637536|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
94503666|NCT02991859|323637537|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
94503667|NCT02991859|323637538|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
94503668|NCT02991859|323637539|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
94503669|NCT02991859|323637540|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
94503670|NCT02991859|323637541|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
94503671|NCT02991859|323637542|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
94503672|NCT02991859|323637543|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
94503673|NCT02991859|323637544|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
94503674|NCT02991859|323637545|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
94503675|NCT02991859|323637546|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
94503676|NCT02991859|323637547|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
94503677|NCT02991859|323637548|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
94503678|NCT02991859|323637549|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
94503679|NCT02991859|323637550|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
94503680|NCT02991859|323637534|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
94503681|NCT02991859|323637535|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
94503682|NCT02991859|323637536|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
94503683|NCT02991859|323637537|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
94503684|NCT02991859|323637538|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
94503685|NCT02991859|323637539|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
94503686|NCT02991859|323637540|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
94503687|NCT02991859|323637541|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
94503688|NCT02991859|323637542|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
94503689|NCT02991859|323637543|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
94503690|NCT02991859|323637544|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
94503691|NCT02991859|323637545|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
94503692|NCT02991859|323637546|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
94503693|NCT02991859|323637547|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
94503694|NCT02991859|323637548|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
94503695|NCT02991859|323637549|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
94503696|NCT02991859|323637550|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
94503697|NCT02991859|323637534|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
94503698|NCT02991859|323637535|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
94503699|NCT02991859|323637536|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
94503700|NCT02991859|323637537|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
94503701|NCT02991859|323637538|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
94503702|NCT02991859|323637539|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
94503703|NCT02991859|323637540|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
94503704|NCT02991859|323637541|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
94503705|NCT02991859|323637542|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
94503706|NCT02991859|323637543|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
94503707|NCT02991859|323637544|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
94503708|NCT02991859|323637545|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
94503709|NCT02991859|323637546|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
94503710|NCT02991859|323637547|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
94503711|NCT02991859|323637548|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
94503712|NCT02991859|323637549|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
94503713|NCT02991859|323637550|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
94503714|NCT02991859|323637534|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
94503715|NCT02991859|323637535|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
94503716|NCT02991859|323637536|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
94503717|NCT02991859|323637537|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
94503718|NCT02991859|323637538|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
94503719|NCT02991859|323637539|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
94503720|NCT02991859|323637540|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
94503721|NCT02991859|323637541|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
94503722|NCT02991859|323637542|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
94503723|NCT02991859|323637543|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
94503724|NCT02991859|323637544|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
94503725|NCT02991859|323637545|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
94503726|NCT02991859|323637546|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
94503727|NCT02991859|323637547|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
94503728|NCT02991859|323637548|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
94503729|NCT02991859|323637549|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
94503730|NCT02991859|323637550|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
94503731|NCT02991859|323637534|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
94503732|NCT02991859|323637535|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
94503733|NCT02991859|323637536|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
94503734|NCT02991859|323637537|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
94503735|NCT02991859|323637538|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
94503736|NCT02991859|323637539|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
94503737|NCT02991859|323637540|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
94503738|NCT02991859|323637541|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
94503739|NCT02991859|323637542|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
94503740|NCT02991859|323637543|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
94503741|NCT02991859|323637544|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
94503742|NCT02991859|323637545|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
94503743|NCT02991859|323637546|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
94503744|NCT02991859|323637547|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
94503745|NCT02991859|323637548|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
94503746|NCT02991859|323637549|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
94503747|NCT02991859|323637550|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
94503748|NCT04565756|323637552|FG000|Overall Study|Withdrawal by Subject|0|||
94503749|NCT04565756|323637553|FG001|Overall Study|Withdrawal by Subject|0|||
94503750|NCT04565756|323637554|FG002|Overall Study|Withdrawal by Subject|0|||
94503751|NCT04565756|323637555|FG003|Overall Study|Withdrawal by Subject|0|||
94503752|NCT04565756|323637556|FG004|Overall Study|Withdrawal by Subject|1|||
94503753|NCT04565756|323637557|FG005|Overall Study|Withdrawal by Subject|0|||
94503754|NCT04565756|323637552|FG000|Overall Study|Protocol Violation|0|||
94503755|NCT04565756|323637553|FG001|Overall Study|Protocol Violation|0|||
94503756|NCT04565756|323637554|FG002|Overall Study|Protocol Violation|0|||
94503757|NCT04565756|323637555|FG003|Overall Study|Protocol Violation|0|||
94503758|NCT04565756|323637556|FG004|Overall Study|Protocol Violation|0|||
94503759|NCT04565756|323637557|FG005|Overall Study|Protocol Violation|1|||
94503760|NCT01185366|323637560|FG000|First Line Therapy|Insurance Coverage Denied|1|||
94503761|NCT01185366|323637561|FG001|First Line Therapy|Insurance Coverage Denied|1|||
94503762|NCT01185366|323637560|FG000|First Line Therapy|Withdrawal by Subject|1|||
94503763|NCT01185366|323637561|FG001|First Line Therapy|Withdrawal by Subject|0|||
94503764|NCT01185366|323637560|FG000|First Line Therapy|Lack of Metastatic Site|1|||
94503765|NCT01185366|323637561|FG001|First Line Therapy|Lack of Metastatic Site|0|||
94503766|NCT01185366|323637560|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
94503767|NCT01185366|323637561|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
94503768|NCT01185366|323637560|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
94503769|NCT01185366|323637561|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
94503770|NCT01185366|323637560|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
94503771|NCT01185366|323637561|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
94503772|NCT01185366|323637560|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
94503773|NCT01185366|323637561|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
94503774|NCT00127933|323637562|FG000|Overall Study|Randomized but not dosed|1|||
94503775|NCT00127933|323637563|FG001|Overall Study|Randomized but not dosed|0|||
94503776|NCT01783938|323637564|FG000|Overall Study|Disease Progression|18|||
94503777|NCT01783938|323637565|FG001|Overall Study|Disease Progression|41|||
94503778|NCT01783938|323637564|FG000|Overall Study|Study Drug Toxicity|27|||
94503779|NCT01783938|323637565|FG001|Overall Study|Study Drug Toxicity|14|||
94503780|NCT01783938|323637564|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
94503781|NCT01783938|323637565|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
94503782|NCT01783938|323637564|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
94503783|NCT01783938|323637565|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
94503784|NCT01783938|323637564|FG000|Overall Study|Participant Withdrew Consent|2|||
94503785|NCT01783938|323637565|FG001|Overall Study|Participant Withdrew Consent|0|||
94503786|NCT01783938|323637564|FG000|Overall Study|Maximum Clinical Benefit|1|||
94503787|NCT01783938|323637565|FG001|Overall Study|Maximum Clinical Benefit|0|||
94503788|NCT01783938|323637564|FG000|Overall Study|Other Reasons|3|||
94503789|NCT01783938|323637565|FG001|Overall Study|Other Reasons|1|||
94503790|NCT00498485|323637566|FG000|Overall Study|Adverse Event|1|||
94503791|NCT00498485|323637567|FG001|Overall Study|Adverse Event|5|||
94503792|NCT00452400|323637569|FG000|Overall Study|Adverse Event|1|||
94503793|NCT00452400|323637570|FG001|Overall Study|Adverse Event|1|||
94503794|NCT00452400|323637571|FG002|Overall Study|Adverse Event|5|||
94503795|NCT00452400|323637572|FG003|Overall Study|Adverse Event|0|||
94503796|NCT00452400|323637573|FG004|Overall Study|Adverse Event|2|||
94503797|NCT00452400|323637569|FG000|Overall Study|Protocol Violation|0|||
94503798|NCT00452400|323637570|FG001|Overall Study|Protocol Violation|0|||
94503799|NCT00452400|323637571|FG002|Overall Study|Protocol Violation|1|||
94503800|NCT00452400|323637572|FG003|Overall Study|Protocol Violation|0|||
94503801|NCT00452400|323637573|FG004|Overall Study|Protocol Violation|0|||
94503802|NCT00452400|323637569|FG000|Overall Study|Lost to Follow-up|1|||
94503803|NCT00452400|323637570|FG001|Overall Study|Lost to Follow-up|0|||
94503804|NCT00452400|323637571|FG002|Overall Study|Lost to Follow-up|0|||
94503805|NCT00452400|323637572|FG003|Overall Study|Lost to Follow-up|0|||
94503806|NCT00452400|323637573|FG004|Overall Study|Lost to Follow-up|0|||
94503807|NCT00452400|323637569|FG000|Overall Study|Withdrawal by Subject|1|||
94503808|NCT00452400|323637570|FG001|Overall Study|Withdrawal by Subject|0|||
94503809|NCT00452400|323637571|FG002|Overall Study|Withdrawal by Subject|1|||
94503810|NCT00452400|323637572|FG003|Overall Study|Withdrawal by Subject|0|||
94503811|NCT00452400|323637573|FG004|Overall Study|Withdrawal by Subject|0|||
94503812|NCT00452400|323637569|FG000|Overall Study|Lack of Efficacy|2|||
94503813|NCT00452400|323637570|FG001|Overall Study|Lack of Efficacy|0|||
94503814|NCT00452400|323637571|FG002|Overall Study|Lack of Efficacy|0|||
94503815|NCT00452400|323637572|FG003|Overall Study|Lack of Efficacy|0|||
94503816|NCT00452400|323637573|FG004|Overall Study|Lack of Efficacy|0|||
94503817|NCT00452400|323637569|FG000|Overall Study|Other reasons not listed above|0|||
94503818|NCT00452400|323637570|FG001|Overall Study|Other reasons not listed above|0|||
94503819|NCT00452400|323637571|FG002|Overall Study|Other reasons not listed above|0|||
94503820|NCT00452400|323637572|FG003|Overall Study|Other reasons not listed above|1|||
94503821|NCT00452400|323637573|FG004|Overall Study|Other reasons not listed above|1|||
94503822|NCT03339453|323637574|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
94503823|NCT03339453|323637575|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
94503824|NCT01712074|323637576|FG000|Placebo Run-in Period|Adverse Event|2|||
94503825|NCT01712074|323637577|FG001|Placebo Run-in Period|Adverse Event|0|||
94503826|NCT01712074|323637578|FG002|Placebo Run-in Period|Adverse Event|0|||
94503827|NCT01712074|323637576|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
94503828|NCT01712074|323637577|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
94503829|NCT01712074|323637578|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
94503830|NCT01712074|323637576|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
94503831|NCT01712074|323637577|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
94503832|NCT01712074|323637578|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
94503833|NCT01712074|323637576|FG000|Placebo Run-in Period|Other|1|||
94503834|NCT01712074|323637577|FG001|Placebo Run-in Period|Other|0|||
94503835|NCT01712074|323637578|FG002|Placebo Run-in Period|Other|0|||
94503836|NCT01712074|323637576|FG000|Placebo Run-in Period|No longer willing to participate|1|||
94503837|NCT01712074|323637577|FG001|Placebo Run-in Period|No longer willing to participate|0|||
94503838|NCT01712074|323637578|FG002|Placebo Run-in Period|No longer willing to participate|0|||
94503839|NCT01712074|323637576|FG000|Double Blind Period|Adverse Event|0|||
94503840|NCT01712074|323637577|FG001|Double Blind Period|Adverse Event|2|||
94503841|NCT01712074|323637578|FG002|Double Blind Period|Adverse Event|1|||
94503842|NCT01712074|323637576|FG000|Double Blind Period|No longer willing to participate|0|||
94503843|NCT01712074|323637577|FG001|Double Blind Period|No longer willing to participate|2|||
94503844|NCT01712074|323637578|FG002|Double Blind Period|No longer willing to participate|4|||
94503845|NCT01712074|323637576|FG000|Double Blind Period|Death|0|||
94503846|NCT01712074|323637577|FG001|Double Blind Period|Death|1|||
94503847|NCT01712074|323637578|FG002|Double Blind Period|Death|0|||
94503848|NCT01712074|323637576|FG000|Double Blind Period|Lost to Follow-up|0|||
94503849|NCT01712074|323637577|FG001|Double Blind Period|Lost to Follow-up|2|||
94503850|NCT01712074|323637578|FG002|Double Blind Period|Lost to Follow-up|1|||
94503851|NCT01712074|323637576|FG000|Double Blind Period|Other|0|||
94503852|NCT01712074|323637577|FG001|Double Blind Period|Other|4|||
94503853|NCT01712074|323637578|FG002|Double Blind Period|Other|1|||
94503854|NCT01712074|323637576|FG000|Double Blind Period|Protocol Violation|0|||
94503855|NCT01712074|323637577|FG001|Double Blind Period|Protocol Violation|0|||
94503856|NCT01712074|323637578|FG002|Double Blind Period|Protocol Violation|1|||
94503857|NCT01712074|323637576|FG000|Double Blind Period|No longer met eligibility criteria|0|||
94503858|NCT01712074|323637577|FG001|Double Blind Period|No longer met eligibility criteria|3|||
94503859|NCT01712074|323637578|FG002|Double Blind Period|No longer met eligibility criteria|0|||
94503860|NCT02268851|323637579|FG000|Overall Study|Death|0|||
94503861|NCT02268851|323637580|FG001|Overall Study|Death|0|||
94503862|NCT02268851|323637581|FG002|Overall Study|Death|0|||
94503863|NCT02268851|323637582|FG003|Overall Study|Death|1|||
94503864|NCT02268851|323637583|FG004|Overall Study|Death|2|||
94503865|NCT02268851|323637584|FG005|Overall Study|Death|1|||
94503866|NCT02268851|323637579|FG000|Overall Study|Adverse Event|0|||
94503867|NCT02268851|323637580|FG001|Overall Study|Adverse Event|0|||
94503868|NCT02268851|323637581|FG002|Overall Study|Adverse Event|0|||
94503869|NCT02268851|323637582|FG003|Overall Study|Adverse Event|0|||
94503870|NCT02268851|323637583|FG004|Overall Study|Adverse Event|2|||
94503871|NCT02268851|323637584|FG005|Overall Study|Adverse Event|2|||
94503872|NCT02268851|323637579|FG000|Overall Study|Withdrawal by Subject|0|||
94503873|NCT02268851|323637580|FG001|Overall Study|Withdrawal by Subject|0|||
94503874|NCT02268851|323637581|FG002|Overall Study|Withdrawal by Subject|0|||
94503875|NCT02268851|323637582|FG003|Overall Study|Withdrawal by Subject|2|||
94503876|NCT02268851|323637583|FG004|Overall Study|Withdrawal by Subject|0|||
94503877|NCT02268851|323637584|FG005|Overall Study|Withdrawal by Subject|1|||
94503878|NCT02268851|323637579|FG000|Overall Study|Progressive Disease|1|||
94503879|NCT02268851|323637580|FG001|Overall Study|Progressive Disease|3|||
94503880|NCT02268851|323637581|FG002|Overall Study|Progressive Disease|0|||
94503881|NCT02268851|323637582|FG003|Overall Study|Progressive Disease|0|||
94503882|NCT02268851|323637583|FG004|Overall Study|Progressive Disease|1|||
94503883|NCT02268851|323637584|FG005|Overall Study|Progressive Disease|4|||
94503884|NCT02268851|323637579|FG000|Overall Study|Physician Decision|0|||
94503885|NCT02268851|323637580|FG001|Overall Study|Physician Decision|0|||
94503886|NCT02268851|323637581|FG002|Overall Study|Physician Decision|1|||
94503887|NCT02268851|323637582|FG003|Overall Study|Physician Decision|0|||
94503888|NCT02268851|323637583|FG004|Overall Study|Physician Decision|0|||
94503889|NCT02268851|323637584|FG005|Overall Study|Physician Decision|1|||
94503890|NCT02268851|323637579|FG000|Overall Study|Patient Compliance|0|||
94503891|NCT02268851|323637580|FG001|Overall Study|Patient Compliance|0|||
94503892|NCT02268851|323637581|FG002|Overall Study|Patient Compliance|0|||
94503893|NCT02268851|323637582|FG003|Overall Study|Patient Compliance|0|||
94503894|NCT02268851|323637583|FG004|Overall Study|Patient Compliance|1|||
94503895|NCT02268851|323637584|FG005|Overall Study|Patient Compliance|1|||
94503896|NCT02268851|323637579|FG000|Overall Study|Co-Morbid Condition|0|||
94503897|NCT02268851|323637580|FG001|Overall Study|Co-Morbid Condition|0|||
94503898|NCT02268851|323637581|FG002|Overall Study|Co-Morbid Condition|0|||
94503899|NCT02268851|323637582|FG003|Overall Study|Co-Morbid Condition|0|||
94503900|NCT02268851|323637583|FG004|Overall Study|Co-Morbid Condition|1|||
94503901|NCT02268851|323637584|FG005|Overall Study|Co-Morbid Condition|1|||
94503902|NCT01472835|323637585|FG000|Overall Study|Lost to Follow-up|2|||
94503903|NCT01472835|323637586|FG001|Overall Study|Lost to Follow-up|0|||
94503904|NCT03020888|323637587|FG000|Overall Study|Physician Decision|4|||
94503905|NCT03020888|323637587|FG000|Overall Study|Withdrawal by Subject|6|||
94503906|NCT03020888|323637587|FG000|Overall Study|Insurance coverage|2|||
94503907|NCT03020888|323637587|FG000|Overall Study|Lost to Follow-up|1|||
94503908|NCT01184118|323637588|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
94503909|NCT01184118|323637588|FG000|Overall Study|No physiologic confirmation of asthma|8|||
94503910|NCT01184118|323637588|FG000|Overall Study|FEV1 <60% predicted|2|||
94503911|NCT01184118|323637588|FG000|Overall Study|Exclusionary medical condition|2|||
94503912|NCT01184118|323637588|FG000|Overall Study|Withdrawal by Subject|5|||
94503913|NCT00553475|323637591|FG000|Overall Study|Adverse Event|7|||
94503914|NCT00553475|323637592|FG001|Overall Study|Adverse Event|17|||
94503915|NCT00553475|323637593|FG002|Overall Study|Adverse Event|13|||
94503916|NCT00553475|323637591|FG000|Overall Study|Lack of Efficacy|7|||
94503917|NCT00553475|323637592|FG001|Overall Study|Lack of Efficacy|1|||
94503918|NCT00553475|323637593|FG002|Overall Study|Lack of Efficacy|0|||
94503919|NCT00553475|323637591|FG000|Overall Study|Withdrawal by Subject|1|||
94503920|NCT00553475|323637592|FG001|Overall Study|Withdrawal by Subject|1|||
94503921|NCT00553475|323637593|FG002|Overall Study|Withdrawal by Subject|0|||
94503922|NCT00553475|323637591|FG000|Overall Study|Physician Decision|1|||
94503923|NCT00553475|323637592|FG001|Overall Study|Physician Decision|0|||
94503924|NCT00553475|323637593|FG002|Overall Study|Physician Decision|0|||
94503925|NCT00553475|323637591|FG000|Overall Study|Due to moving|0|||
94503926|NCT00553475|323637592|FG001|Overall Study|Due to moving|1|||
94503927|NCT00553475|323637593|FG002|Overall Study|Due to moving|0|||
94503928|NCT04971837|323638864|FG000|Overall Study|Long Term Illness|1|||
94503929|NCT04971837|323638864|FG000|Overall Study|BMI too low|9|||
94503930|NCT04971837|323638864|FG000|Overall Study|geographic location|1|||
94503931|NCT04971837|323638864|FG000|Overall Study|Discontinued scheduling conflict|1|||
94503932|NCT04941898|323638865|FG000|Overall Study|Protocol Violation|1|||
94503933|NCT03735498|323638866|FG000|Overall Study|Withdrawal by Subject|3|||
94503934|NCT03735498|323638866|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
94503935|NCT00160615|323638867|FG000|Overall Study|Adverse Event|5|||
94503936|NCT00160615|323638868|FG001|Overall Study|Adverse Event|12|||
94503937|NCT00160615|323638867|FG000|Overall Study|Withdrawal by Subject|0|||
94503938|NCT00160615|323638868|FG001|Overall Study|Withdrawal by Subject|2|||
94503939|NCT00160615|323638867|FG000|Overall Study|Lack of Efficacy|11|||
94503940|NCT00160615|323638868|FG001|Overall Study|Lack of Efficacy|23|||
94503941|NCT00160615|323638867|FG000|Overall Study|Patient decision|1|||
94503942|NCT00160615|323638868|FG001|Overall Study|Patient decision|2|||
94503943|NCT00160615|323638867|FG000|Overall Study|Investigator decision|1|||
94503944|NCT00160615|323638868|FG001|Overall Study|Investigator decision|1|||
94503945|NCT00160615|323638867|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
94503946|NCT00160615|323638868|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
94503947|NCT00160615|323638867|FG000|Overall Study|Switch to surgical treatment|0|||
94503948|NCT00160615|323638868|FG001|Overall Study|Switch to surgical treatment|2|||
94503949|NCT00160615|323638867|FG000|Overall Study|Non-compliance was suspected|0|||
94503950|NCT00160615|323638868|FG001|Overall Study|Non-compliance was suspected|1|||
94503951|NCT00160615|323638867|FG000|Overall Study|Poor compliance|0|||
94503952|NCT00160615|323638868|FG001|Overall Study|Poor compliance|1|||
94503953|NCT00620035|323638871|FG000|Overall Study|Adverse Event|106|||
94503954|NCT00620035|323638871|FG000|Overall Study|Withdrawal of Informed Consent|1|||
94503955|NCT00620035|323638871|FG000|Overall Study|Other Reason|38|||
94503956|NCT04193176|323638873|FG000|Overall Study|Withdrawal by Subject|6|||
94503957|NCT04193176|323638874|FG001|Overall Study|Withdrawal by Subject|10|||
94503958|NCT03537729|323638875|FG000|Overall Study|Death|2|||
94503959|NCT03537729|323638876|FG001|Overall Study|Death|2|||
94503960|NCT03537729|323638877|FG002|Overall Study|Death|7|||
94503961|NCT03537729|323638875|FG000|Overall Study|Withdrawal by Subject|3|||
94503962|NCT03537729|323638876|FG001|Overall Study|Withdrawal by Subject|3|||
94503963|NCT03537729|323638877|FG002|Overall Study|Withdrawal by Subject|0|||
94503964|NCT03537729|323638875|FG000|Overall Study|Subject Moved|8|||
94503965|NCT03537729|323638876|FG001|Overall Study|Subject Moved|5|||
94503966|NCT03537729|323638877|FG002|Overall Study|Subject Moved|4|||
94503967|NCT03537729|323638875|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
94503968|NCT03537729|323638876|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
94503969|NCT03537729|323638877|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
94503970|NCT03537729|323638875|FG000|Overall Study|COVID-19 Site Restrictions|11|||
94503971|NCT03537729|323638876|FG001|Overall Study|COVID-19 Site Restrictions|15|||
94503972|NCT03537729|323638877|FG002|Overall Study|COVID-19 Site Restrictions|18|||
94503973|NCT03537729|323638875|FG000|Overall Study|Decline in Health|5|||
94503974|NCT03537729|323638876|FG001|Overall Study|Decline in Health|9|||
94503975|NCT03537729|323638877|FG002|Overall Study|Decline in Health|4|||
94503976|NCT03537729|323638875|FG000|Overall Study|Determined Ineligible|0|||
94503977|NCT03537729|323638876|FG001|Overall Study|Determined Ineligible|0|||
94503978|NCT03537729|323638877|FG002|Overall Study|Determined Ineligible|1|||
94503979|NCT02562040|323638878|FG000|Overall Study|Lost to Follow-up|20|||
94503980|NCT02562040|323638879|FG001|Overall Study|Lost to Follow-up|28|||
94503981|NCT02562040|323638878|FG000|Overall Study|Withdrawal by Subject|8|||
94503982|NCT02562040|323638879|FG001|Overall Study|Withdrawal by Subject|7|||
94503983|NCT02562040|323638878|FG000|Overall Study|Adverse Event|1|||
94503984|NCT02562040|323638879|FG001|Overall Study|Adverse Event|0|||
94503985|NCT04359680|323638881|FG000|Overall Study|Withdrawal by Subject|29|||
94503986|NCT04359680|323638882|FG001|Overall Study|Withdrawal by Subject|24|||
94503987|NCT04359680|323638881|FG000|Overall Study|Adverse Event|6|||
94503988|NCT04359680|323638882|FG001|Overall Study|Adverse Event|2|||
94503989|NCT04359680|323638881|FG000|Overall Study|Lost to Follow-up|56|||
94503990|NCT04359680|323638882|FG001|Overall Study|Lost to Follow-up|59|||
94503991|NCT04359680|323638881|FG000|Overall Study|Protocol Violation|3|||
94503992|NCT04359680|323638882|FG001|Overall Study|Protocol Violation|5|||
94503993|NCT04359680|323638881|FG000|Overall Study|Physician Decision|1|||
94503994|NCT04359680|323638882|FG001|Overall Study|Physician Decision|1|||
94503995|NCT04359680|323638881|FG000|Overall Study|Sponsor Decision|0|||
94503996|NCT04359680|323638882|FG001|Overall Study|Sponsor Decision|1|||
94503997|NCT00960856|323638883|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
94503998|NCT00960856|323638884|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
94503999|NCT00960856|323638885|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
94504000|NCT00960856|323638886|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
94504001|NCT00960856|323638883|FG000|Washout Period of 7 Days|Adverse Event|0|||
94504002|NCT00960856|323638884|FG001|Washout Period of 7 Days|Adverse Event|0|||
94504003|NCT00960856|323638885|FG002|Washout Period of 7 Days|Adverse Event|1|||
94504004|NCT00960856|323638886|FG003|Washout Period of 7 Days|Adverse Event|0|||
94504005|NCT03280615|323638889|FG000|Overall Study|Lost to Follow-up|1|||
94504006|NCT03280615|323638890|FG001|Overall Study|Lost to Follow-up|2|||
94504007|NCT03280615|323638889|FG000|Overall Study|Adverse Event|1|||
94504008|NCT03280615|323638890|FG001|Overall Study|Adverse Event|1|||
94504009|NCT03280615|323638889|FG000|Overall Study|Withdrawal by Subject|2|||
94504010|NCT03280615|323638890|FG001|Overall Study|Withdrawal by Subject|2|||
94504011|NCT01013870|323638894|FG000|Overall Study|Lost to Follow-up|1|||
94504012|NCT01013870|323638895|FG001|Overall Study|Lost to Follow-up|3|||
94504013|NCT01093885|323638896|FG000|Overall Study|Adverse Event|4|||
94504014|NCT01093885|323638896|FG000|Overall Study|Lost to Follow-up|1|||
94504015|NCT04621786|323638897|FG000|Overall Study|Lost to Follow-up|9|||
94504016|NCT04621786|323638897|FG000|Overall Study|Protocol Violation|3|||
94504017|NCT01292473|323638901|FG000|Overall Study|Adverse Event|1|||
94504018|NCT01292473|323638902|FG001|Overall Study|Adverse Event|0|||
94504019|NCT01292473|323638903|FG002|Overall Study|Adverse Event|1|||
94504020|NCT01292473|323638904|FG003|Overall Study|Adverse Event|1|||
94504021|NCT01292473|323638901|FG000|Overall Study|Lost to Follow-up|1|||
94504022|NCT01292473|323638902|FG001|Overall Study|Lost to Follow-up|1|||
94504023|NCT01292473|323638903|FG002|Overall Study|Lost to Follow-up|2|||
94504024|NCT01292473|323638904|FG003|Overall Study|Lost to Follow-up|2|||
94504025|NCT01292473|323638901|FG000|Overall Study|Withdrawal by Subject|3|||
94504026|NCT01292473|323638902|FG001|Overall Study|Withdrawal by Subject|4|||
94504027|NCT01292473|323638903|FG002|Overall Study|Withdrawal by Subject|3|||
94504028|NCT01292473|323638904|FG003|Overall Study|Withdrawal by Subject|3|||
94504029|NCT01292473|323638901|FG000|Overall Study|Physician Decision|0|||
94504030|NCT01292473|323638902|FG001|Overall Study|Physician Decision|1|||
94504031|NCT01292473|323638903|FG002|Overall Study|Physician Decision|0|||
94504032|NCT01292473|323638904|FG003|Overall Study|Physician Decision|0|||
94504033|NCT01292473|323638901|FG000|Overall Study|Disease Progression|0|||
94504034|NCT01292473|323638902|FG001|Overall Study|Disease Progression|1|||
94504035|NCT01292473|323638903|FG002|Overall Study|Disease Progression|3|||
94504036|NCT01292473|323638904|FG003|Overall Study|Disease Progression|6|||
94504037|NCT02365064|323638905|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
94504038|NCT02365064|323638906|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
94504039|NCT02365064|323638905|FG000|Overall Study|Withdrawal by Subject|6|||
94504040|NCT02365064|323638906|FG001|Overall Study|Withdrawal by Subject|9|||
94504041|NCT02365064|323638905|FG000|Overall Study|Treatment intolerance|2|||
94504042|NCT02365064|323638906|FG001|Overall Study|Treatment intolerance|4|||
94504043|NCT00348374|323638907|FG000|Overall Study|Adverse Event|1|||
94504044|NCT00348374|323638908|FG001|Overall Study|Adverse Event|4|||
94504045|NCT00348374|323638907|FG000|Overall Study|Lost to Follow-up|1|||
94504046|NCT00348374|323638908|FG001|Overall Study|Lost to Follow-up|3|||
94504047|NCT00348374|323638907|FG000|Overall Study|Withdrawal by Subject|5|||
94504048|NCT00348374|323638908|FG001|Overall Study|Withdrawal by Subject|5|||
94504049|NCT00348374|323638907|FG000|Overall Study|Other|11|||
94504050|NCT00348374|323638908|FG001|Overall Study|Other|12|||
94504051|NCT00348374|323638907|FG000|Overall Study|ongoing at date of cutoff|1|||
94504052|NCT00348374|323638908|FG001|Overall Study|ongoing at date of cutoff|1|||
94504053|NCT00348374|323638907|FG000|Overall Study|randomized but did not receive treatment|0|||
94504054|NCT00348374|323638908|FG001|Overall Study|randomized but did not receive treatment|7|||
94504055|NCT06399471|323638913|FG000|Overall Study|Withdrawal by Subject|1|||
94504056|NCT05587998|323638914|FG000|Overall Study|Withdrawal by Subject|1|||
94504057|NCT05587998|323638915|FG001|Overall Study|Withdrawal by Subject|1|||
94504058|NCT05587998|323638914|FG000|Overall Study|Not treated|3|||
94504059|NCT05587998|323638915|FG001|Overall Study|Not treated|1|||
94504060|NCT05587998|323638914|FG000|Overall Study|Non-compliance with study procedures|0|||
94504061|NCT05587998|323638915|FG001|Overall Study|Non-compliance with study procedures|1|||
94504062|NCT02571244|323638916|FG000|Overall Study|Lost to Follow-up|0|||
94504063|NCT02571244|323638917|FG001|Overall Study|Lost to Follow-up|1|||
94504064|NCT02571244|323638916|FG000|Overall Study|Unable to reach out post discharge|3|||
94504065|NCT02571244|323638917|FG001|Overall Study|Unable to reach out post discharge|0|||
94504066|NCT03566550|323638922|FG000|Overall Study|Withdrawal by Subject|0|||
94504067|NCT03566550|323638923|FG001|Overall Study|Withdrawal by Subject|1|||
94504068|NCT00819832|323638924|FG000|Overall Study|Sponsor Termination of Study|3|||
94504069|NCT00819832|323638925|FG001|Overall Study|Sponsor Termination of Study|0|||
94504070|NCT00819832|323638926|FG002|Overall Study|Sponsor Termination of Study|0|||
94504071|NCT00819832|323638927|FG003|Overall Study|Sponsor Termination of Study|0|||
94504072|NCT00819832|323638928|FG004|Overall Study|Sponsor Termination of Study|0|||
94504073|NCT00819832|323638929|FG005|Overall Study|Sponsor Termination of Study|0|||
94504074|NCT00063999|323638931|FG000|Overall Study|Withdrawal by Subject|1|||
94504075|NCT00063999|323638932|FG001|Overall Study|Withdrawal by Subject|0|||
94504076|NCT00063999|323638931|FG000|Overall Study|Ineligible|44|||
94504077|NCT00063999|323638932|FG001|Overall Study|Ineligible|24|||
94504078|NCT01260311|323638933|FG000|Overall Study|Adverse Event|11|||
94504079|NCT01260311|323638933|FG000|Overall Study|Lack of Efficacy|4|||
94504080|NCT01260311|323638933|FG000|Overall Study|Lost to Follow-up|25|||
94504081|NCT01260311|323638933|FG000|Overall Study|Withdrawal by Subject|6|||
94504082|NCT01260311|323638933|FG000|Overall Study|Financial Constraints|77|||
94504083|NCT01260311|323638933|FG000|Overall Study|Gone to Province|2|||
94504084|NCT01260311|323638933|FG000|Overall Study|Medication Stopped|1|||
94504085|NCT01260311|323638933|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
94504086|NCT01452789|323638936|FG000|Overall Study|Withdrawal by Subject|3|||
94504087|NCT01452789|323638937|FG001|Overall Study|Withdrawal by Subject|2|||
94504088|NCT00066170|323638938|FG000|Overall Study|Adverse Event|2|||
94504089|NCT00066170|323638939|FG001|Overall Study|Adverse Event|4|||
94504090|NCT00066170|323638940|FG002|Overall Study|Adverse Event|1|||
94504091|NCT00066170|323638941|FG003|Overall Study|Adverse Event|7|||
94504092|NCT00066170|323638938|FG000|Overall Study|Serious Adverse Event|0|||
94504093|NCT00066170|323638939|FG001|Overall Study|Serious Adverse Event|0|||
94504094|NCT00066170|323638940|FG002|Overall Study|Serious Adverse Event|1|||
94504095|NCT00066170|323638941|FG003|Overall Study|Serious Adverse Event|1|||
94504096|NCT00066170|323638938|FG000|Overall Study|Lost to Follow-up|0|||
94504097|NCT00066170|323638939|FG001|Overall Study|Lost to Follow-up|1|||
94504098|NCT00066170|323638940|FG002|Overall Study|Lost to Follow-up|0|||
94504099|NCT00066170|323638941|FG003|Overall Study|Lost to Follow-up|0|||
94504100|NCT00066170|323638938|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
94504101|NCT00066170|323638939|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
94504102|NCT00066170|323638940|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
94504103|NCT00066170|323638941|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
94504104|NCT00066170|323638938|FG000|Overall Study|Protocol Violation|3|||
94504105|NCT00066170|323638939|FG001|Overall Study|Protocol Violation|0|||
94504106|NCT00066170|323638940|FG002|Overall Study|Protocol Violation|0|||
94504107|NCT00066170|323638941|FG003|Overall Study|Protocol Violation|0|||
94504108|NCT00066170|323638938|FG000|Overall Study|Other|1|||
94504109|NCT00066170|323638939|FG001|Overall Study|Other|5|||
94504110|NCT00066170|323638940|FG002|Overall Study|Other|2|||
94504111|NCT00066170|323638941|FG003|Overall Study|Other|0|||
94504112|NCT01871727|323638942|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
94504113|NCT01871727|323638943|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
94504114|NCT01871727|323638944|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
94504115|NCT01871727|323638945|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
94504116|NCT01871727|323638946|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
94504117|NCT01871727|323638942|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
94504118|NCT01871727|323638943|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
94504119|NCT01871727|323638944|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
94504120|NCT01871727|323638945|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
94504121|NCT01871727|323638946|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
94504122|NCT01871727|323638942|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
94504123|NCT01871727|323638943|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
94504124|NCT01871727|323638944|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
94504125|NCT01871727|323638945|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
94504126|NCT01871727|323638946|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
94504127|NCT01871727|323638942|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
94504128|NCT01871727|323638943|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
94504129|NCT01871727|323638944|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
94504130|NCT01871727|323638945|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
94504131|NCT01871727|323638946|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
94504132|NCT01871727|323638942|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
94504133|NCT01871727|323638943|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
94504134|NCT01871727|323638944|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
94504135|NCT01871727|323638945|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
94504136|NCT01871727|323638946|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
94504137|NCT01871727|323638942|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
94504138|NCT01871727|323638943|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
94504139|NCT01871727|323638944|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
94504140|NCT01871727|323638945|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
94504141|NCT01871727|323638946|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
94504142|NCT01871727|323638942|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
94504143|NCT01871727|323638943|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
94504144|NCT01871727|323638944|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
94504145|NCT01871727|323638945|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
94504146|NCT01871727|323638946|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
94504147|NCT01905267|323638947|FG000|Overall Study|Physician Decision|2|||
94504148|NCT01905267|323638948|FG001|Overall Study|Physician Decision|2|||
94504149|NCT03019588|323638949|FG000|Overall Study|Death|44|||
94504150|NCT03019588|323638950|FG001|Overall Study|Death|46|||
94504151|NCT03019588|323638949|FG000|Overall Study|Study terminated by Sponsor|3|||
94504152|NCT03019588|323638950|FG001|Overall Study|Study terminated by Sponsor|1|||
94504153|NCT01189227|323638951|FG000|Overall Study|Study terminated due to low accrual|6|||
94504154|NCT01189227|323638952|FG001|Overall Study|Study terminated due to low accrual|3|||
94504155|NCT01487161|323638953|FG000|Overall Study|Adverse Event|1|||
94504156|NCT01487161|323638954|FG001|Overall Study|Adverse Event|0|||
94504157|NCT01487161|323638955|FG002|Overall Study|Adverse Event|0|||
94504158|NCT01487161|323638956|FG003|Overall Study|Adverse Event|0|||
94504159|NCT01487161|323638953|FG000|Overall Study|Withdrawal by Subject|1|||
94504160|NCT01487161|323638954|FG001|Overall Study|Withdrawal by Subject|1|||
94504161|NCT01487161|323638955|FG002|Overall Study|Withdrawal by Subject|1|||
94504162|NCT01487161|323638956|FG003|Overall Study|Withdrawal by Subject|2|||
94504163|NCT01487161|323638953|FG000|Overall Study|missing data|0|||
94504164|NCT01487161|323638954|FG001|Overall Study|missing data|1|||
94504165|NCT01487161|323638955|FG002|Overall Study|missing data|0|||
94504166|NCT01487161|323638956|FG003|Overall Study|missing data|0|||
94504167|NCT03721965|323638957|FG000|Overall Study|Death|1|||
94504168|NCT03721965|323638957|FG000|Overall Study|Study Terminated by Sponsor|1|||
94504169|NCT00563316|323638961|FG000|Overall Study|Adverse Event|2|||
94504170|NCT00563316|323638961|FG000|Overall Study|Physician Decision|1|||
94504171|NCT00563316|323638961|FG000|Overall Study|Lost to Follow-up|2|||
94504172|NCT00563316|323638961|FG000|Overall Study|Death|1|||
94504173|NCT00563316|323638961|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
94504174|NCT00563316|323638961|FG000|Overall Study|Other|1|||
94504175|NCT01065766|323638962|FG000|Overall Study|Assessed before the contracted date|1|||
94504176|NCT01065766|323638962|FG000|Overall Study|Contraindication to administration|6|||
94504177|NCT01065766|323638962|FG000|Overall Study|Violated dosage/administration|25|||
94504178|NCT00425854|323638969|FG000|Overall Study|Progressive Disease|19|||
94504179|NCT00425854|323638970|FG001|Overall Study|Progressive Disease|12|||
94504180|NCT00425854|323638969|FG000|Overall Study|Dose reduction toxicity AE|8|||
94504181|NCT00425854|323638970|FG001|Overall Study|Dose reduction toxicity AE|7|||
94504182|NCT00425854|323638969|FG000|Overall Study|Other Adverse Event|2|||
94504183|NCT00425854|323638970|FG001|Overall Study|Other Adverse Event|2|||
94504184|NCT01016015|323638978|FG000|Overall Study|Not Treated|3|||
94504185|NCT01016015|323638978|FG000|Overall Study|Withdrawal by Subject|1|||
94504186|NCT01016015|323638978|FG000|Overall Study|Adverse Event|15|||
94504187|NCT00289978|323640839|FG000|Overall Study|Withdrawal by Subject|31|||
94504188|NCT00289978|323640840|FG001|Overall Study|Withdrawal by Subject|17|||
94504189|NCT00289978|323640841|FG002|Overall Study|Withdrawal by Subject|28|||
94504190|NCT00289978|323640839|FG000|Overall Study|Adverse Event|22|||
94504191|NCT00289978|323640840|FG001|Overall Study|Adverse Event|13|||
94504192|NCT00289978|323640841|FG002|Overall Study|Adverse Event|18|||
94504193|NCT00289978|323640839|FG000|Overall Study|Lack of Efficacy|13|||
94504194|NCT00289978|323640840|FG001|Overall Study|Lack of Efficacy|6|||
94504195|NCT00289978|323640841|FG002|Overall Study|Lack of Efficacy|25|||
94504196|NCT00289978|323640839|FG000|Overall Study|Abnormal laboratory value(s)|20|||
94504197|NCT00289978|323640840|FG001|Overall Study|Abnormal laboratory value(s)|9|||
94504198|NCT00289978|323640841|FG002|Overall Study|Abnormal laboratory value(s)|1|||
94504199|NCT00289978|323640839|FG000|Overall Study|Lost to Follow-up|3|||
94504200|NCT00289978|323640840|FG001|Overall Study|Lost to Follow-up|5|||
94504201|NCT00289978|323640841|FG002|Overall Study|Lost to Follow-up|7|||
94504202|NCT00289978|323640839|FG000|Overall Study|Protocol Violation|5|||
94504203|NCT00289978|323640840|FG001|Overall Study|Protocol Violation|5|||
94504204|NCT00289978|323640841|FG002|Overall Study|Protocol Violation|4|||
94504205|NCT00289978|323640839|FG000|Overall Study|Abnormal test procedure result(s)|2|||
94504206|NCT00289978|323640840|FG001|Overall Study|Abnormal test procedure result(s)|1|||
94504207|NCT00289978|323640841|FG002|Overall Study|Abnormal test procedure result(s)|1|||
94504208|NCT00289978|323640839|FG000|Overall Study|Death|1|||
94504209|NCT00289978|323640840|FG001|Overall Study|Death|0|||
94504210|NCT00289978|323640841|FG002|Overall Study|Death|2|||
94504211|NCT00866775|323640853|FG000|Overall Study|Adverse Event|5|||
94504212|NCT00866775|323640854|FG001|Overall Study|Adverse Event|19|||
94504213|NCT00866775|323640853|FG000|Overall Study|Death|1|||
94504214|NCT00866775|323640854|FG001|Overall Study|Death|0|||
94504215|NCT00866775|323640853|FG000|Overall Study|Lost to Follow-up|0|||
94504216|NCT00866775|323640854|FG001|Overall Study|Lost to Follow-up|4|||
94504217|NCT00866775|323640853|FG000|Overall Study|Physician Decision|0|||
94504218|NCT00866775|323640854|FG001|Overall Study|Physician Decision|3|||
94504219|NCT00866775|323640853|FG000|Overall Study|Protocol Violation|3|||
94504220|NCT00866775|323640854|FG001|Overall Study|Protocol Violation|4|||
94504221|NCT00866775|323640853|FG000|Overall Study|Withdrawal by Subject|4|||
94504222|NCT00866775|323640854|FG001|Overall Study|Withdrawal by Subject|4|||
94504223|NCT00866775|323640853|FG000|Overall Study|met exit criteria|23|||
94504224|NCT00866775|323640854|FG001|Overall Study|met exit criteria|17|||
94504225|NCT00866775|323640853|FG000|Overall Study|discontinued due to communication error|0|||
94504226|NCT00866775|323640854|FG001|Overall Study|discontinued due to communication error|1|||
94504227|NCT01034657|323640874|FG000|Core Phase|Withdrawal by Subject|1|||
94504228|NCT01034657|323640875|FG001|Core Phase|Withdrawal by Subject|0|||
94504229|NCT01034657|323640876|FG002|Core Phase|Withdrawal by Subject|0|||
94504230|NCT01034657|323640874|FG000|Core Phase|Lack of Efficacy|2|||
94504231|NCT01034657|323640875|FG001|Core Phase|Lack of Efficacy|0|||
94504232|NCT01034657|323640876|FG002|Core Phase|Lack of Efficacy|0|||
94504233|NCT01034657|323640874|FG000|Core Phase|Abnormal laboratory value|1|||
94504234|NCT01034657|323640875|FG001|Core Phase|Abnormal laboratory value|0|||
94504235|NCT01034657|323640876|FG002|Core Phase|Abnormal laboratory value|0|||
94504236|NCT01034657|323640874|FG000|Core Phase|Adverse Event|8|||
94504237|NCT01034657|323640875|FG001|Core Phase|Adverse Event|0|||
94504238|NCT01034657|323640876|FG002|Core Phase|Adverse Event|0|||
94504239|NCT01034657|323640874|FG000|Core Phase|Protocol Violation|2|||
94504240|NCT01034657|323640875|FG001|Core Phase|Protocol Violation|0|||
94504241|NCT01034657|323640876|FG002|Core Phase|Protocol Violation|0|||
94504242|NCT01034657|323640874|FG000|Randomized Phase|Withdrawal by Subject|0|||
94504243|NCT01034657|323640875|FG001|Randomized Phase|Withdrawal by Subject|2|||
94504244|NCT01034657|323640876|FG002|Randomized Phase|Withdrawal by Subject|0|||
94504245|NCT01034657|323640874|FG000|Randomized Phase|Lack of Efficacy|5|||
94504246|NCT01034657|323640875|FG001|Randomized Phase|Lack of Efficacy|1|||
94504247|NCT01034657|323640876|FG002|Randomized Phase|Lack of Efficacy|0|||
94504248|NCT01034657|323640874|FG000|Randomized Phase|Abnormal laboratory value|0|||
94504249|NCT01034657|323640875|FG001|Randomized Phase|Abnormal laboratory value|1|||
94504250|NCT01034657|323640876|FG002|Randomized Phase|Abnormal laboratory value|0|||
94504251|NCT01034657|323640874|FG000|Randomized Phase|Adverse Event|0|||
94504252|NCT01034657|323640875|FG001|Randomized Phase|Adverse Event|2|||
94504253|NCT01034657|323640876|FG002|Randomized Phase|Adverse Event|1|||
94504254|NCT01133977|323640877|FG000|Overall Study|Adverse Event|0|||
94504255|NCT01133977|323640878|FG001|Overall Study|Adverse Event|0|||
94504256|NCT01133977|323640879|FG002|Overall Study|Adverse Event|1|||
94504257|NCT01133977|323640880|FG003|Overall Study|Adverse Event|0|||
94504258|NCT01133977|323640881|FG004|Overall Study|Adverse Event|0|||
94504259|NCT01133977|323640877|FG000|Overall Study|Death|1|||
94504260|NCT01133977|323640878|FG001|Overall Study|Death|1|||
94504261|NCT01133977|323640879|FG002|Overall Study|Death|1|||
94504262|NCT01133977|323640880|FG003|Overall Study|Death|7|||
94504263|NCT01133977|323640881|FG004|Overall Study|Death|3|||
94504264|NCT01133977|323640877|FG000|Overall Study|Started a New Line of Therapy|2|||
94504265|NCT01133977|323640878|FG001|Overall Study|Started a New Line of Therapy|6|||
94504266|NCT01133977|323640879|FG002|Overall Study|Started a New Line of Therapy|4|||
94504267|NCT01133977|323640880|FG003|Overall Study|Started a New Line of Therapy|25|||
94504268|NCT01133977|323640881|FG004|Overall Study|Started a New Line of Therapy|33|||
94504269|NCT01133977|323640877|FG000|Overall Study|Lost to Follow-up|0|||
94504270|NCT01133977|323640878|FG001|Overall Study|Lost to Follow-up|0|||
94504271|NCT01133977|323640879|FG002|Overall Study|Lost to Follow-up|0|||
94504272|NCT01133977|323640880|FG003|Overall Study|Lost to Follow-up|2|||
94504273|NCT01133977|323640881|FG004|Overall Study|Lost to Follow-up|1|||
94504274|NCT01133977|323640877|FG000|Overall Study|Withdrawal by Subject|0|||
94504275|NCT01133977|323640878|FG001|Overall Study|Withdrawal by Subject|0|||
94504276|NCT01133977|323640879|FG002|Overall Study|Withdrawal by Subject|0|||
94504277|NCT01133977|323640880|FG003|Overall Study|Withdrawal by Subject|5|||
94504278|NCT01133977|323640881|FG004|Overall Study|Withdrawal by Subject|1|||
94504279|NCT02773537|323640882|FG000|Overall Study|Lost to Follow-up|0|||
94504280|NCT02773537|323640883|FG001|Overall Study|Lost to Follow-up|1|||
94504281|NCT02773537|323640884|FG002|Overall Study|Lost to Follow-up|4|||
94504282|NCT02242903|323640887|FG000|Overall Study|Withdrawal by Subject|1|||
94504283|NCT02242903|323640888|FG001|Overall Study|Withdrawal by Subject|0|||
94504284|NCT02242903|323640889|FG002|Overall Study|Withdrawal by Subject|0|||
94504285|NCT02242903|323640890|FG003|Overall Study|Withdrawal by Subject|0|||
94504286|NCT02242903|323640891|FG004|Overall Study|Withdrawal by Subject|0|||
94504287|NCT02242903|323640892|FG005|Overall Study|Withdrawal by Subject|0|||
94504288|NCT02242903|323640893|FG006|Overall Study|Withdrawal by Subject|0|||
94504289|NCT02105012|323640896|FG000|Overall Study|Withdrawal by Subject|11|||
94504290|NCT02105012|323640896|FG000|Overall Study|Protocol Specified Criteria|9|||
94504291|NCT02105012|323640896|FG000|Overall Study|Lost to Follow-up|4|||
94504292|NCT02105012|323640896|FG000|Overall Study|Protocol Violation|4|||
94504293|NCT02105012|323640896|FG000|Overall Study|Physician Decision|3|||
94504294|NCT02105012|323640896|FG000|Overall Study|Adverse Event|1|||
94504295|NCT02105012|323640896|FG000|Overall Study|Lack of Efficacy|1|||
94504296|NCT01975285|323640897|FG000|Overall Study|Failed Block and follow up|2|||
94504297|NCT01975285|323640898|FG001|Overall Study|Failed Block and follow up|2|||
94504298|NCT01061710|323640901|FG000|Overall Study|Protocol Violation|14|||
94504299|NCT05287685|323640904|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
94504300|NCT05287685|323640905|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
94504301|NCT05287685|323640904|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
94504302|NCT05287685|323640905|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
94504303|NCT01362270|323640906|FG000|Overall Study|Withdrawal by Subject|1|||
94504304|NCT01362270|323640907|FG001|Overall Study|Withdrawal by Subject|0|||
94504305|NCT01362270|323640906|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
94504306|NCT01362270|323640907|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
94504307|NCT01362270|323640906|FG000|Overall Study|Met excl. criteria before 1st session|1|||
94504308|NCT01362270|323640907|FG001|Overall Study|Met excl. criteria before 1st session|1|||
94504309|NCT01520714|323640908|FG000|Overall Study|Protocol Violation|0|||
94504310|NCT01520714|323640909|FG001|Overall Study|Protocol Violation|3|||
94504311|NCT01520714|323640908|FG000|Overall Study|Adverse Event|0|||
94504312|NCT01520714|323640909|FG001|Overall Study|Adverse Event|2|||
94655630|NCT01312467|324196107|FG000|Overall Study|Adverse Event|4|||
94504313|NCT01520714|323640908|FG000|Overall Study|Lack of Efficacy|0|||
94504314|NCT01520714|323640909|FG001|Overall Study|Lack of Efficacy|1|||
94504315|NCT00183391|323640910|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
94504316|NCT00183391|323640911|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
94504317|NCT00183391|323640910|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
94504318|NCT00183391|323640911|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
94504319|NCT01570192|323640912|FG000|Overall Study|no qualifying organism|6|||
94504320|NCT01570192|323640913|FG001|Overall Study|no qualifying organism|12|||
94504321|NCT01570192|323640912|FG000|Overall Study|changed to palliative care|1|||
94504322|NCT01570192|323640913|FG001|Overall Study|changed to palliative care|0|||
94504323|NCT01570192|323640912|FG000|Overall Study|Physician Decision|0|||
94504324|NCT01570192|323640913|FG001|Overall Study|Physician Decision|1|||
94504325|NCT01478087|323640914|FG000|Overall Study|due to sponsor closing study|1|||
94504326|NCT00098293|323640917|FG000|Double-blind (DB) Phase|Adverse Event|14|||
94504327|NCT00098293|323640918|FG001|Double-blind (DB) Phase|Adverse Event|27|||
94504328|NCT00098293|323640919|FG002|Double-blind (DB) Phase|Adverse Event|60|||
94504329|NCT00098293|323640920|FG003|Double-blind (DB) Phase|Adverse Event|0|||
94504330|NCT00098293|323640921|FG004|Double-blind (DB) Phase|Adverse Event|0|||
94504331|NCT00098293|323640917|FG000|Double-blind (DB) Phase|Pregnancy|0|||
94504332|NCT00098293|323640918|FG001|Double-blind (DB) Phase|Pregnancy|7|||
94504333|NCT00098293|323640919|FG002|Double-blind (DB) Phase|Pregnancy|9|||
94504334|NCT00098293|323640920|FG003|Double-blind (DB) Phase|Pregnancy|0|||
94504335|NCT00098293|323640921|FG004|Double-blind (DB) Phase|Pregnancy|0|||
94504336|NCT00098293|323640917|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
94504337|NCT00098293|323640918|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
94504338|NCT00098293|323640919|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
94504339|NCT00098293|323640920|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
94504340|NCT00098293|323640921|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
94504341|NCT00098293|323640917|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
94504342|NCT00098293|323640918|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
94504343|NCT00098293|323640919|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
94504344|NCT00098293|323640920|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
94504345|NCT00098293|323640921|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
94504346|NCT00098293|323640917|FG000|Double-blind (DB) Phase|Death|1|||
94504347|NCT00098293|323640918|FG001|Double-blind (DB) Phase|Death|2|||
94504348|NCT00098293|323640919|FG002|Double-blind (DB) Phase|Death|2|||
94504349|NCT00098293|323640920|FG003|Double-blind (DB) Phase|Death|0|||
94504350|NCT00098293|323640921|FG004|Double-blind (DB) Phase|Death|0|||
94504351|NCT00098293|323640917|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
94504352|NCT00098293|323640918|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
94504353|NCT00098293|323640919|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
94504354|NCT00098293|323640920|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
94504355|NCT00098293|323640921|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
94504356|NCT00098293|323640917|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
94504357|NCT00098293|323640918|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
94504358|NCT00098293|323640919|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
94504359|NCT00098293|323640920|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
94504360|NCT00098293|323640921|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
94504361|NCT00098293|323640917|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
94504362|NCT00098293|323640918|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
94504363|NCT00098293|323640919|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
94504364|NCT00098293|323640920|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
94504365|NCT00098293|323640921|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
94504366|NCT00098293|323640917|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
94504367|NCT00098293|323640918|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
94504368|NCT00098293|323640919|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
94504369|NCT00098293|323640920|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
94504370|NCT00098293|323640921|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
94504371|NCT00098293|323640917|FG000|Open-label (OL) Phase|Adverse Event|0|||
94504372|NCT00098293|323640918|FG001|Open-label (OL) Phase|Adverse Event|3|||
94504373|NCT00098293|323640919|FG002|Open-label (OL) Phase|Adverse Event|7|||
94504374|NCT00098293|323640920|FG003|Open-label (OL) Phase|Adverse Event|6|||
94504375|NCT00098293|323640921|FG004|Open-label (OL) Phase|Adverse Event|0|||
94504376|NCT00098293|323640917|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
94504377|NCT00098293|323640918|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
94504378|NCT00098293|323640919|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
94504379|NCT00098293|323640920|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
94504380|NCT00098293|323640921|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
94504381|NCT00098293|323640917|FG000|Open-label (OL) Phase|Pregnancy|0|||
94504382|NCT00098293|323640918|FG001|Open-label (OL) Phase|Pregnancy|1|||
94504383|NCT00098293|323640919|FG002|Open-label (OL) Phase|Pregnancy|0|||
94504384|NCT00098293|323640920|FG003|Open-label (OL) Phase|Pregnancy|3|||
94504385|NCT00098293|323640921|FG004|Open-label (OL) Phase|Pregnancy|0|||
94504386|NCT00098293|323640917|FG000|Open-label (OL) Phase|Protocol Violation|0|||
94504387|NCT00098293|323640918|FG001|Open-label (OL) Phase|Protocol Violation|6|||
94504388|NCT00098293|323640919|FG002|Open-label (OL) Phase|Protocol Violation|13|||
94504389|NCT00098293|323640920|FG003|Open-label (OL) Phase|Protocol Violation|16|||
94504390|NCT00098293|323640921|FG004|Open-label (OL) Phase|Protocol Violation|0|||
94504391|NCT00098293|323640917|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
94504392|NCT00098293|323640918|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
94504393|NCT00098293|323640919|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
94504394|NCT00098293|323640920|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
94504395|NCT00098293|323640921|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
94504396|NCT00098293|323640917|FG000|Open-label (OL) Phase|Death|0|||
94504397|NCT00098293|323640918|FG001|Open-label (OL) Phase|Death|2|||
94504398|NCT00098293|323640919|FG002|Open-label (OL) Phase|Death|3|||
94504399|NCT00098293|323640920|FG003|Open-label (OL) Phase|Death|0|||
94504400|NCT00098293|323640921|FG004|Open-label (OL) Phase|Death|0|||
94504401|NCT00098293|323640917|FG000|Supplemental Phase (SP)|Death|0|||
94504402|NCT00098293|323640918|FG001|Supplemental Phase (SP)|Death|0|||
94504403|NCT00098293|323640919|FG002|Supplemental Phase (SP)|Death|0|||
94504404|NCT00098293|323640920|FG003|Supplemental Phase (SP)|Death|0|||
94504405|NCT00098293|323640921|FG004|Supplemental Phase (SP)|Death|1|||
94504406|NCT00098293|323640917|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
94504407|NCT00098293|323640918|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
94504408|NCT00098293|323640919|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
94504409|NCT00098293|323640920|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
94504410|NCT00098293|323640921|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
94504411|NCT00098293|323640917|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
94504412|NCT00098293|323640918|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
94504413|NCT00098293|323640919|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
94504414|NCT00098293|323640920|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
94504415|NCT00098293|323640921|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
94504416|NCT00098293|323640917|FG000|Supplemental Phase (SP)|Other|0|||
94504417|NCT00098293|323640918|FG001|Supplemental Phase (SP)|Other|0|||
94504418|NCT00098293|323640919|FG002|Supplemental Phase (SP)|Other|0|||
94504419|NCT00098293|323640920|FG003|Supplemental Phase (SP)|Other|0|||
94504420|NCT00098293|323640921|FG004|Supplemental Phase (SP)|Other|22|||
94504421|NCT01370642|323640923|FG000|Overall Study|Adverse Event|2|||
94504422|NCT01370642|323640924|FG001|Overall Study|Adverse Event|1|||
94504423|NCT01370642|323640925|FG002|Overall Study|Adverse Event|1|||
94504424|NCT01370642|323640923|FG000|Overall Study|Detectable HCV RNA|0|||
94504425|NCT01370642|323640924|FG001|Overall Study|Detectable HCV RNA|0|||
94504426|NCT01370642|323640925|FG002|Overall Study|Detectable HCV RNA|22|||
94504427|NCT01370642|323640923|FG000|Overall Study|Lost to Follow-up|0|||
94504428|NCT01370642|323640924|FG001|Overall Study|Lost to Follow-up|0|||
94504429|NCT01370642|323640925|FG002|Overall Study|Lost to Follow-up|1|||
94504430|NCT01370642|323640923|FG000|Overall Study|Physician Decision|4|||
94504431|NCT01370642|323640924|FG001|Overall Study|Physician Decision|1|||
94504432|NCT01370642|323640925|FG002|Overall Study|Physician Decision|2|||
94504433|NCT01370642|323640923|FG000|Overall Study|Withdrawal by Subject|2|||
94504434|NCT01370642|323640924|FG001|Overall Study|Withdrawal by Subject|4|||
94504435|NCT01370642|323640925|FG002|Overall Study|Withdrawal by Subject|3|||
94504436|NCT00147537|323640930|FG000|Phase 1b|Death|0|||
94504437|NCT00147537|323640931|FG001|Phase 1b|Death|1|||
94504438|NCT00147537|323640932|FG002|Phase 1b|Death|2|||
94504439|NCT00147537|323640933|FG003|Phase 1b|Death|1|||
94504440|NCT00147537|323640934|FG004|Phase 1b|Death|2|||
94504441|NCT00147537|323640935|FG005|Phase 1b|Death|2|||
94504442|NCT00147537|323640936|FG006|Phase 1b|Death|1|||
94504443|NCT00147537|323640937|FG007|Phase 1b|Death|3|||
94504444|NCT00147537|323640938|FG008|Phase 1b|Death|9|||
94504445|NCT00147537|323640939|FG009|Phase 1b|Death|0|||
94504446|NCT00147537|323640940|FG010|Phase 1b|Death|0|||
94504447|NCT00147537|323640930|FG000|Phase 1b|Lost to Follow-up|2|||
94504448|NCT00147537|323640931|FG001|Phase 1b|Lost to Follow-up|1|||
94504449|NCT00147537|323640932|FG002|Phase 1b|Lost to Follow-up|0|||
94504450|NCT00147537|323640933|FG003|Phase 1b|Lost to Follow-up|0|||
94504451|NCT00147537|323640934|FG004|Phase 1b|Lost to Follow-up|0|||
94504452|NCT00147537|323640935|FG005|Phase 1b|Lost to Follow-up|0|||
94504453|NCT00147537|323640936|FG006|Phase 1b|Lost to Follow-up|2|||
94504454|NCT00147537|323640937|FG007|Phase 1b|Lost to Follow-up|0|||
94504455|NCT00147537|323640938|FG008|Phase 1b|Lost to Follow-up|1|||
94504456|NCT00147537|323640939|FG009|Phase 1b|Lost to Follow-up|0|||
94504457|NCT00147537|323640940|FG010|Phase 1b|Lost to Follow-up|0|||
94504458|NCT00147537|323640930|FG000|Phase 1b|Other|0|||
94504459|NCT00147537|323640931|FG001|Phase 1b|Other|0|||
94504460|NCT00147537|323640932|FG002|Phase 1b|Other|2|||
94504461|NCT00147537|323640933|FG003|Phase 1b|Other|1|||
94504462|NCT00147537|323640934|FG004|Phase 1b|Other|1|||
94504463|NCT00147537|323640935|FG005|Phase 1b|Other|1|||
94504464|NCT00147537|323640936|FG006|Phase 1b|Other|14|||
94504465|NCT00147537|323640937|FG007|Phase 1b|Other|4|||
94504466|NCT00147537|323640938|FG008|Phase 1b|Other|4|||
94504467|NCT00147537|323640939|FG009|Phase 1b|Other|0|||
94504468|NCT00147537|323640940|FG010|Phase 1b|Other|0|||
94504469|NCT00147537|323640930|FG000|Phase 1b|Withdrawal by Subject|0|||
94504470|NCT00147537|323640931|FG001|Phase 1b|Withdrawal by Subject|0|||
94504471|NCT00147537|323640932|FG002|Phase 1b|Withdrawal by Subject|0|||
94504472|NCT00147537|323640933|FG003|Phase 1b|Withdrawal by Subject|0|||
94504473|NCT00147537|323640934|FG004|Phase 1b|Withdrawal by Subject|0|||
94504474|NCT00147537|323640935|FG005|Phase 1b|Withdrawal by Subject|0|||
94504475|NCT00147537|323640936|FG006|Phase 1b|Withdrawal by Subject|0|||
94504476|NCT00147537|323640937|FG007|Phase 1b|Withdrawal by Subject|0|||
94504477|NCT00147537|323640938|FG008|Phase 1b|Withdrawal by Subject|2|||
94504478|NCT00147537|323640939|FG009|Phase 1b|Withdrawal by Subject|0|||
94504479|NCT00147537|323640940|FG010|Phase 1b|Withdrawal by Subject|0|||
94504480|NCT00147537|323640930|FG000|Phase 1b|Randomized but not treated|0|||
94504481|NCT00147537|323640931|FG001|Phase 1b|Randomized but not treated|0|||
94504482|NCT00147537|323640932|FG002|Phase 1b|Randomized but not treated|0|||
94504483|NCT00147537|323640933|FG003|Phase 1b|Randomized but not treated|0|||
94504484|NCT00147537|323640934|FG004|Phase 1b|Randomized but not treated|0|||
94504485|NCT00147537|323640935|FG005|Phase 1b|Randomized but not treated|0|||
94504486|NCT00147537|323640936|FG006|Phase 1b|Randomized but not treated|1|||
94504487|NCT00147537|323640937|FG007|Phase 1b|Randomized but not treated|0|||
94504488|NCT00147537|323640938|FG008|Phase 1b|Randomized but not treated|1|||
94504489|NCT00147537|323640939|FG009|Phase 1b|Randomized but not treated|0|||
94504490|NCT00147537|323640940|FG010|Phase 1b|Randomized but not treated|0|||
94504491|NCT00147537|323640930|FG000|Phase 2|Death|0|||
94504492|NCT00147537|323640931|FG001|Phase 2|Death|0|||
94504493|NCT00147537|323640932|FG002|Phase 2|Death|0|||
94504494|NCT00147537|323640933|FG003|Phase 2|Death|0|||
94504495|NCT00147537|323640934|FG004|Phase 2|Death|0|||
94504496|NCT00147537|323640935|FG005|Phase 2|Death|0|||
94504497|NCT00147537|323640936|FG006|Phase 2|Death|0|||
94504498|NCT00147537|323640937|FG007|Phase 2|Death|0|||
94504499|NCT00147537|323640938|FG008|Phase 2|Death|0|||
94504500|NCT00147537|323640939|FG009|Phase 2|Death|85|||
94504501|NCT00147537|323640940|FG010|Phase 2|Death|31|||
94504502|NCT00147537|323640930|FG000|Phase 2|Lost to Follow-up|0|||
94504503|NCT00147537|323640931|FG001|Phase 2|Lost to Follow-up|0|||
94504504|NCT00147537|323640932|FG002|Phase 2|Lost to Follow-up|0|||
94504505|NCT00147537|323640933|FG003|Phase 2|Lost to Follow-up|0|||
94504506|NCT00147537|323640934|FG004|Phase 2|Lost to Follow-up|0|||
94504507|NCT00147537|323640935|FG005|Phase 2|Lost to Follow-up|0|||
94504508|NCT00147537|323640936|FG006|Phase 2|Lost to Follow-up|0|||
94504509|NCT00147537|323640937|FG007|Phase 2|Lost to Follow-up|0|||
94504510|NCT00147537|323640938|FG008|Phase 2|Lost to Follow-up|0|||
94504511|NCT00147537|323640939|FG009|Phase 2|Lost to Follow-up|12|||
94504512|NCT00147537|323640940|FG010|Phase 2|Lost to Follow-up|4|||
94504513|NCT00147537|323640930|FG000|Phase 2|Other|0|||
94504514|NCT00147537|323640931|FG001|Phase 2|Other|0|||
94504515|NCT00147537|323640932|FG002|Phase 2|Other|0|||
94504516|NCT00147537|323640933|FG003|Phase 2|Other|0|||
94504517|NCT00147537|323640934|FG004|Phase 2|Other|0|||
94504518|NCT00147537|323640935|FG005|Phase 2|Other|0|||
94504519|NCT00147537|323640936|FG006|Phase 2|Other|0|||
94504520|NCT00147537|323640937|FG007|Phase 2|Other|0|||
94504521|NCT00147537|323640938|FG008|Phase 2|Other|0|||
94504522|NCT00147537|323640939|FG009|Phase 2|Other|47|||
94504523|NCT00147537|323640940|FG010|Phase 2|Other|12|||
94504524|NCT00147537|323640930|FG000|Phase 2|Withdrawal by Subject|0|||
94504525|NCT00147537|323640931|FG001|Phase 2|Withdrawal by Subject|0|||
94504526|NCT00147537|323640932|FG002|Phase 2|Withdrawal by Subject|0|||
94504527|NCT00147537|323640933|FG003|Phase 2|Withdrawal by Subject|0|||
94504528|NCT00147537|323640934|FG004|Phase 2|Withdrawal by Subject|0|||
94504529|NCT00147537|323640935|FG005|Phase 2|Withdrawal by Subject|0|||
94504530|NCT00147537|323640936|FG006|Phase 2|Withdrawal by Subject|0|||
94504531|NCT00147537|323640937|FG007|Phase 2|Withdrawal by Subject|0|||
94504532|NCT00147537|323640938|FG008|Phase 2|Withdrawal by Subject|0|||
94504533|NCT00147537|323640939|FG009|Phase 2|Withdrawal by Subject|16|||
94504534|NCT00147537|323640940|FG010|Phase 2|Withdrawal by Subject|4|||
94504535|NCT00147537|323640930|FG000|Phase 2|Randomized but not treated|0|||
94504536|NCT00147537|323640931|FG001|Phase 2|Randomized but not treated|0|||
94504537|NCT00147537|323640932|FG002|Phase 2|Randomized but not treated|0|||
94504538|NCT00147537|323640933|FG003|Phase 2|Randomized but not treated|0|||
94504539|NCT00147537|323640934|FG004|Phase 2|Randomized but not treated|0|||
94504540|NCT00147537|323640935|FG005|Phase 2|Randomized but not treated|0|||
94504541|NCT00147537|323640936|FG006|Phase 2|Randomized but not treated|0|||
94504542|NCT00147537|323640937|FG007|Phase 2|Randomized but not treated|0|||
94504543|NCT00147537|323640938|FG008|Phase 2|Randomized but not treated|0|||
94504544|NCT00147537|323640939|FG009|Phase 2|Randomized but not treated|1|||
94504545|NCT00147537|323640940|FG010|Phase 2|Randomized but not treated|1|||
94504546|NCT01089543|323640941|FG000|Overall Study|Withdrawal by Subject|2|||
94504547|NCT01089543|323640942|FG001|Overall Study|Withdrawal by Subject|3|||
94504548|NCT01089543|323640943|FG002|Overall Study|Withdrawal by Subject|3|||
94504549|NCT01089543|323640944|FG003|Overall Study|Withdrawal by Subject|1|||
94504550|NCT01089543|323640941|FG000|Overall Study|Physician Decision|1|||
94504551|NCT01089543|323640942|FG001|Overall Study|Physician Decision|0|||
94504552|NCT01089543|323640943|FG002|Overall Study|Physician Decision|0|||
94504553|NCT01089543|323640944|FG003|Overall Study|Physician Decision|1|||
94504554|NCT01089543|323640941|FG000|Overall Study|Adverse Event|0|||
94504555|NCT01089543|323640942|FG001|Overall Study|Adverse Event|1|||
94504556|NCT01089543|323640943|FG002|Overall Study|Adverse Event|0|||
94504557|NCT01089543|323640944|FG003|Overall Study|Adverse Event|0|||
94504558|NCT02176525|323640945|FG000|Overall Study|Adverse Event|0|||
94504559|NCT02176525|323640946|FG001|Overall Study|Adverse Event|0|||
94504560|NCT02176525|323640947|FG002|Overall Study|Adverse Event|0|||
94504561|NCT02176525|323640948|FG003|Overall Study|Adverse Event|1|||
94504562|NCT02176525|323640949|FG004|Overall Study|Adverse Event|1|||
94504563|NCT02176525|323640950|FG005|Overall Study|Adverse Event|0|||
94504564|NCT02176525|323640951|FG006|Overall Study|Adverse Event|1|||
94504565|NCT02176525|323640952|FG007|Overall Study|Adverse Event|0|||
94504566|NCT02176525|323640945|FG000|Overall Study|not treated|1|||
94504567|NCT02176525|323640946|FG001|Overall Study|not treated|0|||
94504568|NCT02176525|323640947|FG002|Overall Study|not treated|0|||
94504569|NCT02176525|323640948|FG003|Overall Study|not treated|0|||
94504570|NCT02176525|323640949|FG004|Overall Study|not treated|0|||
94504571|NCT02176525|323640950|FG005|Overall Study|not treated|1|||
94504572|NCT02176525|323640951|FG006|Overall Study|not treated|0|||
94504573|NCT02176525|323640952|FG007|Overall Study|not treated|0|||
94504574|NCT03760068|323640953|FG000|Overall Study|Withdrawal by Subject|7|||
94504575|NCT03760068|323640954|FG001|Overall Study|Withdrawal by Subject|8|||
94504576|NCT03760068|323640953|FG000|Overall Study|Adverse Event|1|||
94504577|NCT03760068|323640954|FG001|Overall Study|Adverse Event|2|||
94504578|NCT03760068|323640953|FG000|Overall Study|Administrative Decision by Sponsor|0|||
94504579|NCT03760068|323640954|FG001|Overall Study|Administrative Decision by Sponsor|2|||
94504580|NCT03760068|323640953|FG000|Overall Study|Physician Decision|1|||
94504581|NCT03760068|323640954|FG001|Overall Study|Physician Decision|2|||
94504582|NCT03760068|323640953|FG000|Overall Study|Lost to Follow-up|4|||
94504583|NCT03760068|323640954|FG001|Overall Study|Lost to Follow-up|9|||
94504584|NCT03760068|323640953|FG000|Overall Study|Subject Moved Out of State|1|||
94504585|NCT03760068|323640954|FG001|Overall Study|Subject Moved Out of State|0|||
94504586|NCT00728182|323640955|FG000|Overall Study|Adverse Event|1|||
94504587|NCT00728182|323640956|FG001|Overall Study|Adverse Event|0|||
94504588|NCT00728182|323640955|FG000|Overall Study|Lost to Follow-up|2|||
94504589|NCT00728182|323640956|FG001|Overall Study|Lost to Follow-up|0|||
94504590|NCT00728182|323640955|FG000|Overall Study|Death|0|||
94504591|NCT00728182|323640956|FG001|Overall Study|Death|2|||
94504592|NCT00728182|323640955|FG000|Overall Study|Protocol Noncompliance|0|||
94504593|NCT00728182|323640956|FG001|Overall Study|Protocol Noncompliance|1|||
94504594|NCT01898091|323640957|FG000|Overall Study|Lost to Follow-up|1|||
94504595|NCT01898091|323640958|FG001|Overall Study|Lost to Follow-up|1|||
94504596|NCT01898091|323640957|FG000|Overall Study|Withdrawal by Subject|1|||
94504597|NCT01898091|323640958|FG001|Overall Study|Withdrawal by Subject|5|||
94504598|NCT01608308|323640960|FG000|Overall Study|pretreatment medical and billing reasons|0|||
94504599|NCT01608308|323640961|FG001|Overall Study|pretreatment medical and billing reasons|2|||
94504600|NCT01630811|323640962|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
94504601|NCT01630811|323640963|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
94504602|NCT02362412|323640966|FG000|Treatment Period III|Lost to Follow-up|0|||
94504603|NCT02362412|323640967|FG001|Treatment Period III|Lost to Follow-up|1|||
94504604|NCT01725308|323640968|FG000|Treatment Period I|Did Not Receive Drug|1|||
94504605|NCT01725308|323640969|FG001|Treatment Period I|Did Not Receive Drug|0|||
94504606|NCT01725308|323640970|FG002|Treatment Period I|Did Not Receive Drug|0|||
94504607|NCT01725308|323640968|FG000|Treatment Period I|Adverse Event|5|||
94504608|NCT01725308|323640969|FG001|Treatment Period I|Adverse Event|4|||
94504609|NCT01725308|323640970|FG002|Treatment Period I|Adverse Event|21|||
94504610|NCT01725308|323640968|FG000|Treatment Period I|Insufficient Response|7|||
94504611|NCT01725308|323640969|FG001|Treatment Period I|Insufficient Response|0|||
94504612|NCT01725308|323640970|FG002|Treatment Period I|Insufficient Response|5|||
94504613|NCT01725308|323640968|FG000|Treatment Period I|Worsening of the Target Disease|8|||
94504614|NCT01725308|323640969|FG001|Treatment Period I|Worsening of the Target Disease|0|||
94504615|NCT01725308|323640970|FG002|Treatment Period I|Worsening of the Target Disease|2|||
94504616|NCT01725308|323640968|FG000|Treatment Period I|Changes in the Episodes|3|||
94504617|NCT01725308|323640969|FG001|Treatment Period I|Changes in the Episodes|0|||
94504618|NCT01725308|323640970|FG002|Treatment Period I|Changes in the Episodes|2|||
94504619|NCT01725308|323640968|FG000|Treatment Period I|Withdrawal of Consent|12|||
94504620|NCT01725308|323640969|FG001|Treatment Period I|Withdrawal of Consent|7|||
94504621|NCT01725308|323640970|FG002|Treatment Period I|Withdrawal of Consent|5|||
94504622|NCT01725308|323640968|FG000|Treatment Period I|Lost to Follow-up|3|||
94504623|NCT01725308|323640969|FG001|Treatment Period I|Lost to Follow-up|2|||
94504624|NCT01725308|323640970|FG002|Treatment Period I|Lost to Follow-up|2|||
94504625|NCT01725308|323640968|FG000|Treatment Period I|Protocol Deviations|3|||
94504626|NCT01725308|323640969|FG001|Treatment Period I|Protocol Deviations|1|||
94504627|NCT01725308|323640970|FG002|Treatment Period I|Protocol Deviations|1|||
94504628|NCT01725308|323640968|FG000|Treatment Period I|Miscellaneous|2|||
94504629|NCT01725308|323640969|FG001|Treatment Period I|Miscellaneous|0|||
94504630|NCT01725308|323640970|FG002|Treatment Period I|Miscellaneous|3|||
94655631|NCT01312467|324196107|FG000|Overall Study|Lost to Follow-up|1|||
94504631|NCT01725308|323640968|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
94504632|NCT01725308|323640969|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
94504633|NCT01725308|323640970|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
94504634|NCT01725308|323640968|FG000|Treatment Period II|Did Not Receive Drug|4|||
94504635|NCT01725308|323640969|FG001|Treatment Period II|Did Not Receive Drug|0|||
94504636|NCT01725308|323640970|FG002|Treatment Period II|Did Not Receive Drug|0|||
94504637|NCT01725308|323640968|FG000|Treatment Period II|Adverse Event|13|||
94504638|NCT01725308|323640969|FG001|Treatment Period II|Adverse Event|8|||
94504639|NCT01725308|323640970|FG002|Treatment Period II|Adverse Event|20|||
94504640|NCT01725308|323640968|FG000|Treatment Period II|Insufficient Response|2|||
94504641|NCT01725308|323640969|FG001|Treatment Period II|Insufficient Response|4|||
94504642|NCT01725308|323640970|FG002|Treatment Period II|Insufficient Response|6|||
94504643|NCT01725308|323640968|FG000|Treatment Period II|Worsening of the Target Disease|1|||
94504644|NCT01725308|323640969|FG001|Treatment Period II|Worsening of the Target Disease|4|||
94504645|NCT01725308|323640970|FG002|Treatment Period II|Worsening of the Target Disease|2|||
94504646|NCT01725308|323640968|FG000|Treatment Period II|Changes in the Episodes|1|||
94504647|NCT01725308|323640969|FG001|Treatment Period II|Changes in the Episodes|0|||
94504648|NCT01725308|323640970|FG002|Treatment Period II|Changes in the Episodes|5|||
94504649|NCT01725308|323640968|FG000|Treatment Period II|Withdrawal of Consent|28|||
94504650|NCT01725308|323640969|FG001|Treatment Period II|Withdrawal of Consent|2|||
94504651|NCT01725308|323640970|FG002|Treatment Period II|Withdrawal of Consent|16|||
94504652|NCT01725308|323640968|FG000|Treatment Period II|Lost to Follow-up|1|||
94504653|NCT01725308|323640969|FG001|Treatment Period II|Lost to Follow-up|5|||
94504654|NCT01725308|323640970|FG002|Treatment Period II|Lost to Follow-up|3|||
94504655|NCT01725308|323640968|FG000|Treatment Period II|Protocol Deviations|0|||
94504656|NCT01725308|323640969|FG001|Treatment Period II|Protocol Deviations|0|||
94504657|NCT01725308|323640970|FG002|Treatment Period II|Protocol Deviations|1|||
94504658|NCT01725308|323640968|FG000|Treatment Period II|Miscellaneous|5|||
94504659|NCT01725308|323640969|FG001|Treatment Period II|Miscellaneous|3|||
94504660|NCT01725308|323640970|FG002|Treatment Period II|Miscellaneous|7|||
94504661|NCT04128228|323640972|FG000|Overall Study|Withdrawal by Subject|3|||
94504662|NCT04128228|323640973|FG001|Overall Study|Withdrawal by Subject|3|||
94504663|NCT04128228|323640974|FG002|Overall Study|Withdrawal by Subject|0|||
94504664|NCT04128228|323640975|FG003|Overall Study|Withdrawal by Subject|0|||
94504665|NCT04128228|323640972|FG000|Overall Study|noncompliance|2|||
94504666|NCT04128228|323640973|FG001|Overall Study|noncompliance|2|||
94504667|NCT04128228|323640974|FG002|Overall Study|noncompliance|0|||
94504668|NCT04128228|323640975|FG003|Overall Study|noncompliance|0|||
94504669|NCT06048705|323640983|FG000|Overall Study|Physician Decision|1|||
94504670|NCT06048705|323640984|FG001|Overall Study|Physician Decision|0|||
94504671|NCT06048705|323640985|FG002|Overall Study|Physician Decision|0|||
94504672|NCT06048705|323640983|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
94504673|NCT06048705|323640984|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
94504674|NCT06048705|323640985|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
94504675|NCT06048705|323640983|FG000|Overall Study|Death prior to lymphodepletion|0|||
94504676|NCT06048705|323640984|FG001|Overall Study|Death prior to lymphodepletion|0|||
94504677|NCT06048705|323640985|FG002|Overall Study|Death prior to lymphodepletion|1|||
94504678|NCT04648241|323640986|FG000|Overall Study|Lost to Follow-up|1|||
94504679|NCT04648241|323640987|FG001|Overall Study|Lost to Follow-up|0|||
94504680|NCT02057666|323640988|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
94504681|NCT02057666|323640989|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
94504682|NCT02057666|323640988|FG000|Double Blind Treatment Period|Poor tolerability|7|||
94504683|NCT02057666|323640989|FG001|Double Blind Treatment Period|Poor tolerability|2|||
94504684|NCT02057666|323640988|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
94504685|NCT02057666|323640989|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
94504686|NCT02057666|323640988|FG000|Double Blind Treatment Period|Physician Decision|1|||
94504687|NCT02057666|323640989|FG001|Double Blind Treatment Period|Physician Decision|0|||
94504688|NCT02057666|323640988|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
94504689|NCT02057666|323640989|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
94504690|NCT02057666|323640988|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
94504691|NCT02057666|323640989|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
94504692|NCT02057666|323640988|FG000|Double Blind Treatment Period|Sponsor's request|70|||
94504693|NCT02057666|323640989|FG001|Double Blind Treatment Period|Sponsor's request|34|||
94504694|NCT02057666|323640988|FG000|Open-Label Treatment Period|Poor tolerability|0|||
94504695|NCT02057666|323640989|FG001|Open-Label Treatment Period|Poor tolerability|1|||
94504696|NCT02057666|323640988|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
94504697|NCT02057666|323640989|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
94504698|NCT02057666|323640988|FG000|Open-Label Treatment Period|Sponsor's request|0|||
94504699|NCT02057666|323640989|FG001|Open-Label Treatment Period|Sponsor's request|4|||
94504700|NCT01602666|323640990|FG000|Induction Chemotherapy|Death|2|||
94504701|NCT01602666|323640991|FG001|Induction Chemotherapy|Death|1|||
94504702|NCT01602666|323640990|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
94504703|NCT01602666|323640991|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
94504704|NCT01602666|323640990|FG000|Induction Chemotherapy|Physician Decision|12|||
94504705|NCT01602666|323640991|FG001|Induction Chemotherapy|Physician Decision|5|||
94504706|NCT01602666|323640990|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
94504707|NCT01602666|323640991|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
94504708|NCT01602666|323640990|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
94504709|NCT01602666|323640991|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
94504710|NCT01602666|323640990|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
94504711|NCT01602666|323640991|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
94504712|NCT01602666|323640990|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
94504713|NCT01602666|323640991|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
94504714|NCT01602666|323640990|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
94504715|NCT01602666|323640991|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
94504716|NCT01602666|323640990|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
94504717|NCT01602666|323640991|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
94504718|NCT01602666|323640990|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
94504719|NCT01602666|323640991|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
94504720|NCT01602666|323640990|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
94504721|NCT01602666|323640991|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
94504722|NCT01740427|323640992|FG000|Overall Study|Objective Progression or Relapse|286|||
94504723|NCT01740427|323640993|FG001|Overall Study|Objective Progression or Relapse|172|||
94504724|NCT01740427|323640992|FG000|Overall Study|Adverse Event|32|||
94504725|NCT01740427|323640993|FG001|Overall Study|Adverse Event|9|||
94504726|NCT01740427|323640992|FG000|Overall Study|Global Deterioration of Health Status|28|||
94504727|NCT01740427|323640993|FG001|Overall Study|Global Deterioration of Health Status|12|||
94504728|NCT01740427|323640992|FG000|Overall Study|Participant Refused Continued Treatment|27|||
94504729|NCT01740427|323640993|FG001|Overall Study|Participant Refused Continued Treatment|15|||
94504730|NCT01740427|323640992|FG000|Overall Study|Unspecified reasons|52|||
94504731|NCT01740427|323640993|FG001|Overall Study|Unspecified reasons|8|||
94504732|NCT01740427|323640992|FG000|Overall Study|Death|10|||
94504733|NCT01740427|323640993|FG001|Overall Study|Death|3|||
94504734|NCT01740427|323640992|FG000|Overall Study|Protocol Violation|5|||
94504735|NCT01740427|323640993|FG001|Overall Study|Protocol Violation|3|||
94504736|NCT01740427|323640992|FG000|Overall Study|Lost to Follow-up|3|||
94504737|NCT01740427|323640993|FG001|Overall Study|Lost to Follow-up|0|||
94504738|NCT01740427|323640992|FG000|Overall Study|Site Terminated by Sponsor|1|||
94504739|NCT01740427|323640993|FG001|Overall Study|Site Terminated by Sponsor|0|||
94504740|NCT04754399|323640994|FG000|Overall Study|Adverse Event|5|||
94504741|NCT04754399|323640994|FG000|Overall Study|Withdrawal by Subject|6|||
94504742|NCT02614066|323640995|FG000|Overall Study|Death|6|||
94504743|NCT02614066|323640996|FG001|Overall Study|Death|14|||
94504744|NCT02614066|323640997|FG002|Overall Study|Death|11|||
94504745|NCT02614066|323640998|FG003|Overall Study|Death|29|||
94504746|NCT02614066|323640995|FG000|Overall Study|Full consent withdrawn|0|||
94504747|NCT02614066|323640996|FG001|Overall Study|Full consent withdrawn|1|||
94504748|NCT02614066|323640997|FG002|Overall Study|Full consent withdrawn|0|||
94504749|NCT02614066|323640998|FG003|Overall Study|Full consent withdrawn|8|||
94504750|NCT02614066|323640995|FG000|Overall Study|Lost to Follow-up|0|||
94504751|NCT02614066|323640996|FG001|Overall Study|Lost to Follow-up|2|||
94504752|NCT02614066|323640997|FG002|Overall Study|Lost to Follow-up|2|||
94504753|NCT02614066|323640998|FG003|Overall Study|Lost to Follow-up|2|||
94504754|NCT02614066|323640995|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
94504755|NCT02614066|323640996|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
94504756|NCT02614066|323640997|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
94504757|NCT02614066|323640998|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
94504758|NCT02614066|323640995|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
94504759|NCT02614066|323640996|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
94504760|NCT02614066|323640997|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
94504761|NCT02614066|323640998|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
94504762|NCT02614066|323640995|FG000|Overall Study|Reason not specified|0|||
94504763|NCT02614066|323640996|FG001|Overall Study|Reason not specified|2|||
94504764|NCT02614066|323640997|FG002|Overall Study|Reason not specified|1|||
94504765|NCT02614066|323640998|FG003|Overall Study|Reason not specified|1|||
94504766|NCT03624036|323640999|FG000|Overall Study|Death|2|||
94504767|NCT03624036|323641000|FG001|Overall Study|Death|3|||
94504768|NCT03624036|323641001|FG002|Overall Study|Death|0|||
94504769|NCT03624036|323641002|FG003|Overall Study|Death|1|||
94504770|NCT03624036|323640999|FG000|Overall Study|Withdrawal by Subject|1|||
94504771|NCT03624036|323641000|FG001|Overall Study|Withdrawal by Subject|0|||
94504772|NCT03624036|323641001|FG002|Overall Study|Withdrawal by Subject|1|||
94504773|NCT03624036|323641002|FG003|Overall Study|Withdrawal by Subject|0|||
94504774|NCT03624036|323640999|FG000|Overall Study|Enrolled but Never Treated|1|||
94504775|NCT03624036|323641000|FG001|Overall Study|Enrolled but Never Treated|0|||
94504776|NCT03624036|323641001|FG002|Overall Study|Enrolled but Never Treated|0|||
94504777|NCT03624036|323641002|FG003|Overall Study|Enrolled but Never Treated|0|||
94504778|NCT03624036|323640999|FG000|Overall Study|Reason not Specified|3|||
94504779|NCT03624036|323641000|FG001|Overall Study|Reason not Specified|0|||
94504780|NCT03624036|323641001|FG002|Overall Study|Reason not Specified|2|||
94504781|NCT03624036|323641002|FG003|Overall Study|Reason not Specified|2|||
94504782|NCT03072875|323641011|FG000|Overall Study|Lost to Follow-up|1|||
94504783|NCT00289900|323641016|FG000|Overall Study|Adverse Event|28|||
94504784|NCT00289900|323641017|FG001|Overall Study|Adverse Event|40|||
94504785|NCT00289900|323641018|FG002|Overall Study|Adverse Event|13|||
94504786|NCT00289900|323641019|FG003|Overall Study|Adverse Event|19|||
94504787|NCT00289900|323641020|FG004|Overall Study|Adverse Event|20|||
94504788|NCT00289900|323641021|FG005|Overall Study|Adverse Event|33|||
94504789|NCT00289900|323641016|FG000|Overall Study|Lost to Follow-up|7|||
94504790|NCT00289900|323641017|FG001|Overall Study|Lost to Follow-up|7|||
94504791|NCT00289900|323641018|FG002|Overall Study|Lost to Follow-up|8|||
94504792|NCT00289900|323641019|FG003|Overall Study|Lost to Follow-up|8|||
94504793|NCT00289900|323641020|FG004|Overall Study|Lost to Follow-up|4|||
94504794|NCT00289900|323641021|FG005|Overall Study|Lost to Follow-up|8|||
94504795|NCT00289900|323641016|FG000|Overall Study|Participant had flushing|18|||
94504796|NCT00289900|323641017|FG001|Overall Study|Participant had flushing|42|||
94504797|NCT00289900|323641018|FG002|Overall Study|Participant had flushing|1|||
94504798|NCT00289900|323641019|FG003|Overall Study|Participant had flushing|2|||
94504799|NCT00289900|323641020|FG004|Overall Study|Participant had flushing|0|||
94504800|NCT00289900|323641021|FG005|Overall Study|Participant had flushing|4|||
94504801|NCT00289900|323641016|FG000|Overall Study|Other|0|||
94504802|NCT00289900|323641017|FG001|Overall Study|Other|0|||
94504803|NCT00289900|323641018|FG002|Overall Study|Other|0|||
94504804|NCT00289900|323641019|FG003|Overall Study|Other|5|||
94504805|NCT00289900|323641020|FG004|Overall Study|Other|1|||
94504806|NCT00289900|323641021|FG005|Overall Study|Other|0|||
94504807|NCT00289900|323641016|FG000|Overall Study|Participant moved|1|||
94504808|NCT00289900|323641017|FG001|Overall Study|Participant moved|0|||
94504809|NCT00289900|323641018|FG002|Overall Study|Participant moved|0|||
94504810|NCT00289900|323641019|FG003|Overall Study|Participant moved|1|||
94504811|NCT00289900|323641020|FG004|Overall Study|Participant moved|1|||
94504812|NCT00289900|323641021|FG005|Overall Study|Participant moved|1|||
94504813|NCT00289900|323641016|FG000|Overall Study|Withdrawal by Subject|10|||
94504814|NCT00289900|323641017|FG001|Overall Study|Withdrawal by Subject|21|||
94504815|NCT00289900|323641018|FG002|Overall Study|Withdrawal by Subject|8|||
94504816|NCT00289900|323641019|FG003|Overall Study|Withdrawal by Subject|18|||
94504817|NCT00289900|323641020|FG004|Overall Study|Withdrawal by Subject|12|||
94504818|NCT00289900|323641021|FG005|Overall Study|Withdrawal by Subject|11|||
94504819|NCT00289900|323641016|FG000|Overall Study|Protocol Violation|3|||
94504820|NCT00289900|323641017|FG001|Overall Study|Protocol Violation|9|||
94504821|NCT00289900|323641018|FG002|Overall Study|Protocol Violation|2|||
94504822|NCT00289900|323641019|FG003|Overall Study|Protocol Violation|6|||
94504823|NCT00289900|323641020|FG004|Overall Study|Protocol Violation|7|||
94504824|NCT00289900|323641021|FG005|Overall Study|Protocol Violation|4|||
94504825|NCT00289900|323641016|FG000|Overall Study|site terminated|1|||
94504826|NCT00289900|323641017|FG001|Overall Study|site terminated|0|||
94504827|NCT00289900|323641018|FG002|Overall Study|site terminated|1|||
94504828|NCT00289900|323641019|FG003|Overall Study|site terminated|0|||
94504829|NCT00289900|323641020|FG004|Overall Study|site terminated|0|||
94504830|NCT00289900|323641021|FG005|Overall Study|site terminated|0|||
94504831|NCT00289900|323641016|FG000|Overall Study|Not treated|0|||
94504832|NCT00289900|323641017|FG001|Overall Study|Not treated|1|||
94504833|NCT00289900|323641018|FG002|Overall Study|Not treated|0|||
94504834|NCT00289900|323641019|FG003|Overall Study|Not treated|0|||
94504835|NCT00289900|323641020|FG004|Overall Study|Not treated|0|||
94504836|NCT00289900|323641021|FG005|Overall Study|Not treated|0|||
94504837|NCT00992394|323641022|FG000|Overall Study|Lack of Efficacy|6|||
94504838|NCT00992394|323641023|FG001|Overall Study|Lack of Efficacy|3|||
94504839|NCT00992394|323641022|FG000|Overall Study|Adverse Event|4|||
94504840|NCT00992394|323641023|FG001|Overall Study|Adverse Event|5|||
94504841|NCT00992394|323641022|FG000|Overall Study|Withdrawal by Subject|8|||
94504842|NCT00992394|323641023|FG001|Overall Study|Withdrawal by Subject|2|||
94504843|NCT00992394|323641022|FG000|Overall Study|Physician Decision|1|||
94504844|NCT00992394|323641023|FG001|Overall Study|Physician Decision|0|||
94504845|NCT00992394|323641022|FG000|Overall Study|Protocol Violation|2|||
94504846|NCT00992394|323641023|FG001|Overall Study|Protocol Violation|4|||
94504847|NCT00992394|323641022|FG000|Overall Study|Lost to Follow-up|2|||
94504848|NCT00992394|323641023|FG001|Overall Study|Lost to Follow-up|0|||
94504849|NCT00992394|323641022|FG000|Overall Study|Other event|1|||
94504850|NCT00992394|323641023|FG001|Overall Study|Other event|0|||
94504851|NCT01905683|323641024|FG000|Overall Study|Protocol Violation|1|||
94504852|NCT01905683|323641024|FG000|Overall Study|Re-injection criteria not met; others|13|||
94504853|NCT01905683|323641024|FG000|Overall Study|Physician Decision|1|||
94504854|NCT01905683|323641024|FG000|Overall Study|Lack of Efficacy|8|||
94504855|NCT01905683|323641024|FG000|Overall Study|Withdrawal by Subject|20|||
94504856|NCT01905683|323641024|FG000|Overall Study|Adverse Event|4|||
94504857|NCT01905683|323641024|FG000|Overall Study|Lost to Follow-up|4|||
94504858|NCT02151604|323641028|FG000|Overall Study|Lost to Follow-up|3|||
94504859|NCT02151604|323641028|FG000|Overall Study|Withdrawal by Subject|2|||
94504860|NCT02151604|323641028|FG000|Overall Study|Physician Decision|3|||
94504861|NCT02151604|323641028|FG000|Overall Study|Death|1|||
94504862|NCT01691092|323641029|FG000|Overall Study|Lost to Follow-up|10|||
94504863|NCT01691092|323641029|FG000|Overall Study|Physician Decision|4|||
94504864|NCT01691092|323641029|FG000|Overall Study|Withdrawal by Subject|3|||
94504865|NCT01691092|323641029|FG000|Overall Study|non-compliance|3|||
94504866|NCT01691092|323641029|FG000|Overall Study|used for different study|2|||
94504867|NCT01691092|323641029|FG000|Overall Study|screen fail|19|||
94504868|NCT00655746|323641030|FG000|Overall Study|Withdrawal by Subject|1|||
94504869|NCT01699685|323642552|FG000|Period 1|Adverse Event|1|||
94504870|NCT01699685|323642553|FG001|Period 1|Adverse Event|1|||
94504871|NCT01699685|323642552|FG000|Period 1|Medical or ethical, noncompliance|2|||
94504872|NCT01699685|323642553|FG001|Period 1|Medical or ethical, noncompliance|0|||
94504873|NCT01699685|323642552|FG000|Period 1|Other|0|||
94504874|NCT01699685|323642553|FG001|Period 1|Other|1|||
94504875|NCT01699685|323642552|FG000|Period 1|Patient request|0|||
94504876|NCT01699685|323642553|FG001|Period 1|Patient request|1|||
94504877|NCT01699685|323642552|FG000|Period 2|Lost to Follow-up|1|||
94504878|NCT01699685|323642553|FG001|Period 2|Lost to Follow-up|0|||
94504879|NCT02181621|323642554|FG000|Overall Study|Adverse Event|1|||
94504880|NCT02181621|323642555|FG001|Overall Study|Adverse Event|0|||
94504881|NCT02181621|323642554|FG000|Overall Study|Previously Enrolled|0|||
94504882|NCT02181621|323642555|FG001|Overall Study|Previously Enrolled|1|||
94504883|NCT02181621|323642554|FG000|Overall Study|Enrollment Hold|1|||
94504884|NCT02181621|323642555|FG001|Overall Study|Enrollment Hold|1|||
94504885|NCT02802865|323642556|FG000|Overall Study|Pregnancy|1|||
94504886|NCT02802865|323642557|FG001|Overall Study|Pregnancy|1|||
94504887|NCT02802865|323642556|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
94504888|NCT02802865|323642557|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
94504889|NCT01862029|323642558|FG000|Overall Study|Physician Decision|1|||
94504890|NCT03931785|323642559|FG000|Overall Study|Lost to Follow-up|4|||
94504891|NCT03931785|323642560|FG001|Overall Study|Lost to Follow-up|1|||
94504892|NCT03931785|323642561|FG002|Overall Study|Lost to Follow-up|4|||
94504893|NCT03931785|323642562|FG003|Overall Study|Lost to Follow-up|3|||
94504894|NCT03931785|323642559|FG000|Overall Study|Adverse Event|1|||
94504895|NCT03931785|323642560|FG001|Overall Study|Adverse Event|0|||
94504896|NCT03931785|323642561|FG002|Overall Study|Adverse Event|3|||
94504897|NCT03931785|323642562|FG003|Overall Study|Adverse Event|4|||
94504898|NCT03931785|323642559|FG000|Overall Study|Protocol Violation|0|||
94504899|NCT03931785|323642560|FG001|Overall Study|Protocol Violation|1|||
94504900|NCT03931785|323642561|FG002|Overall Study|Protocol Violation|0|||
94504901|NCT03931785|323642562|FG003|Overall Study|Protocol Violation|0|||
94504902|NCT03931785|323642559|FG000|Overall Study|Noncompliance With Study drug|0|||
94504903|NCT03931785|323642560|FG001|Overall Study|Noncompliance With Study drug|1|||
94504904|NCT03931785|323642561|FG002|Overall Study|Noncompliance With Study drug|0|||
94504905|NCT03931785|323642562|FG003|Overall Study|Noncompliance With Study drug|0|||
94504906|NCT03931785|323642559|FG000|Overall Study|Other Not specified|0|||
94504907|NCT03931785|323642560|FG001|Overall Study|Other Not specified|2|||
94504908|NCT03931785|323642561|FG002|Overall Study|Other Not specified|2|||
94504909|NCT03931785|323642562|FG003|Overall Study|Other Not specified|2|||
94504910|NCT03931785|323642559|FG000|Overall Study|Withdrawal by Subject|0|||
94504911|NCT03931785|323642560|FG001|Overall Study|Withdrawal by Subject|2|||
94504912|NCT03931785|323642561|FG002|Overall Study|Withdrawal by Subject|4|||
94504913|NCT03931785|323642562|FG003|Overall Study|Withdrawal by Subject|1|||
94504914|NCT03931785|323642559|FG000|Overall Study|Pregnancy|0|||
94504915|NCT03931785|323642560|FG001|Overall Study|Pregnancy|0|||
94504916|NCT03931785|323642561|FG002|Overall Study|Pregnancy|0|||
94504917|NCT03931785|323642562|FG003|Overall Study|Pregnancy|1|||
94504918|NCT02502383|323642566|FG000|Overall Study|Lost to Follow-up|130|||
94504919|NCT02502383|323642567|FG001|Overall Study|Lost to Follow-up|131|||
94504920|NCT02502383|323642566|FG000|Overall Study|Withdrawal by Subject|31|||
94504921|NCT02502383|323642567|FG001|Overall Study|Withdrawal by Subject|24|||
94504922|NCT00432991|323642568|FG000|Overall Study|Protocol Violation|7|||
94504923|NCT00432991|323642569|FG001|Overall Study|Protocol Violation|12|||
94504924|NCT00527748|323642571|FG000|Overall Study|Other|3|||
94504925|NCT01028560|323642572|FG000|Overall Study|Lack of Efficacy|3|||
94504926|NCT01028560|323642573|FG001|Overall Study|Lack of Efficacy|6|||
94504927|NCT01028560|323642572|FG000|Overall Study|Withdrawal by Subject|7|||
94504928|NCT01028560|323642573|FG001|Overall Study|Withdrawal by Subject|12|||
94504929|NCT01964560|323642574|FG000|Overall Study|Adverse Event|23|||
94504930|NCT01964560|323642574|FG000|Overall Study|Lack of Efficacy|46|||
94504931|NCT01964560|323642574|FG000|Overall Study|Protocol deviation|2|||
94504932|NCT01964560|323642574|FG000|Overall Study|Lost to Follow-up|4|||
94504933|NCT01964560|323642574|FG000|Overall Study|Withdrawal by Subject|64|||
94504934|NCT01964560|323642574|FG000|Overall Study|Surgery-hemispherotomy|1|||
94504935|NCT01964560|323642574|FG000|Overall Study|Surgery|1|||
94504936|NCT01964560|323642574|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
94504937|NCT01964560|323642574|FG000|Overall Study|Patient and Investigator choice|1|||
94504938|NCT01964560|323642574|FG000|Overall Study|Patient was prescribed CBD|1|||
94504939|NCT01964560|323642574|FG000|Overall Study|Participant moved to another country|1|||
94504940|NCT00292370|323642575|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
94504941|NCT00292370|323642576|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
94504942|NCT00292370|323642577|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
94504943|NCT00292370|323642575|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
94504944|NCT00292370|323642576|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
94504945|NCT00292370|323642577|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
94504946|NCT00292370|323642575|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
94504947|NCT00292370|323642576|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
94504948|NCT00292370|323642577|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
94504949|NCT00292370|323642575|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
94504950|NCT00292370|323642576|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
94504951|NCT00292370|323642577|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
94504952|NCT00292370|323642575|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
94504953|NCT00292370|323642576|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
94504954|NCT00292370|323642577|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
94504955|NCT00292370|323642575|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
94504956|NCT00292370|323642576|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
94504957|NCT00292370|323642577|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
94504958|NCT00215553|323642583|FG000|Overall Study|Adverse Event|0|||
94504959|NCT00215553|323642584|FG001|Overall Study|Adverse Event|1|||
94504960|NCT00215553|323642585|FG002|Overall Study|Adverse Event|2|||
94504961|NCT00215553|323642586|FG003|Overall Study|Adverse Event|1|||
94504962|NCT00215553|323642587|FG004|Overall Study|Adverse Event|2|||
94504963|NCT00215553|323642588|FG005|Overall Study|Adverse Event|6|||
94504964|NCT00215553|323642589|FG006|Overall Study|Adverse Event|0|||
94504965|NCT01429623|323642590|FG000|Overall Study|Death|1|||
94504966|NCT01429623|323642591|FG001|Overall Study|Death|0|||
94504967|NCT01429623|323642590|FG000|Overall Study|Adverse Event|7|||
94504968|NCT01429623|323642591|FG001|Overall Study|Adverse Event|14|||
94504969|NCT01429623|323642590|FG000|Overall Study|Withdrawal by Subject|19|||
94504970|NCT01429623|323642591|FG001|Overall Study|Withdrawal by Subject|13|||
94504971|NCT01429623|323642590|FG000|Overall Study|Physician Decision|2|||
94504972|NCT01429623|323642591|FG001|Overall Study|Physician Decision|3|||
94504973|NCT01429623|323642590|FG000|Overall Study|Protocol Violation|3|||
94504974|NCT01429623|323642591|FG001|Overall Study|Protocol Violation|2|||
94504975|NCT01429623|323642590|FG000|Overall Study|Assorted|1|||
94504976|NCT01429623|323642591|FG001|Overall Study|Assorted|2|||
94504977|NCT01429623|323642590|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
94504978|NCT01429623|323642591|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
94504979|NCT01429623|323642590|FG000|Overall Study|No post baseline data|4|||
94504980|NCT01429623|323642591|FG001|Overall Study|No post baseline data|4|||
94504981|NCT03302936|323642592|FG000|Overall Study|Protocol Violation|3|||
94504982|NCT03302936|323642593|FG001|Overall Study|Protocol Violation|4|||
94504983|NCT01379937|323642594|FG000|Overall Study|Protocol Violation|0|||
94504984|NCT01379937|323642595|FG001|Overall Study|Protocol Violation|0|||
94504985|NCT01379937|323642596|FG002|Overall Study|Protocol Violation|0|||
94504986|NCT01379937|323642597|FG003|Overall Study|Protocol Violation|1|||
94504987|NCT01379937|323642594|FG000|Overall Study|Consent withdrawal|0|||
94504988|NCT01379937|323642595|FG001|Overall Study|Consent withdrawal|1|||
94504989|NCT01379937|323642596|FG002|Overall Study|Consent withdrawal|0|||
94504990|NCT01379937|323642597|FG003|Overall Study|Consent withdrawal|0|||
94504991|NCT01379937|323642594|FG000|Overall Study|Lost to Follow-up|1|||
94504992|NCT01379937|323642595|FG001|Overall Study|Lost to Follow-up|2|||
94504993|NCT01379937|323642596|FG002|Overall Study|Lost to Follow-up|2|||
94504994|NCT01379937|323642597|FG003|Overall Study|Lost to Follow-up|0|||
94504995|NCT01104870|323642598|FG000|Overall Study|Adverse Event|1|||
94504996|NCT01104870|323642599|FG001|Overall Study|Adverse Event|1|||
94504997|NCT01104870|323642600|FG002|Overall Study|Adverse Event|0|||
94504998|NCT01104870|323642598|FG000|Overall Study|Death|0|||
94504999|NCT01104870|323642599|FG001|Overall Study|Death|0|||
94505000|NCT01104870|323642600|FG002|Overall Study|Death|1|||
94505001|NCT01104870|323642598|FG000|Overall Study|Withdrawal by Subject|0|||
94505002|NCT01104870|323642599|FG001|Overall Study|Withdrawal by Subject|0|||
94505003|NCT01104870|323642600|FG002|Overall Study|Withdrawal by Subject|1|||
94505004|NCT04985682|323642601|FG000|Overall Study|Withdrawal by Subject|1|||
94505005|NCT01550965|323642602|FG000|Overall Study|Adverse Event|26|||
94505006|NCT01550965|323642602|FG000|Overall Study|Withdrawal by Subject|10|||
94505007|NCT01550965|323642602|FG000|Overall Study|Lost to Follow-up|2|||
94505008|NCT01550965|323642602|FG000|Overall Study|Lack of Efficacy|59|||
94505009|NCT01550965|323642602|FG000|Overall Study|Other|13|||
94505010|NCT01953354|323642607|FG000|Overall Study|Withdrawal by Subject|0|||
94505011|NCT01953354|323642608|FG001|Overall Study|Withdrawal by Subject|1|||
94505012|NCT01953354|323642607|FG000|Overall Study|Decision of Sponsor|0|||
94505013|NCT01953354|323642608|FG001|Overall Study|Decision of Sponsor|1|||
94505014|NCT01953354|323642607|FG000|Overall Study|Disease Exacerbation|1|||
94505015|NCT01953354|323642608|FG001|Overall Study|Disease Exacerbation|0|||
94505016|NCT01392495|323642609|FG000|Overall Study|Death|3|||
94505017|NCT01392495|323642609|FG000|Overall Study|Administrative problems|8|||
94505018|NCT01392495|323642609|FG000|Overall Study|Withdrawal by Subject|2|||
94505019|NCT01392495|323642609|FG000|Overall Study|Adverse Event|3|||
94505020|NCT01646216|323642615|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
94505021|NCT01646216|323642616|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
94505022|NCT01646216|323642615|FG000|Overall Study|Did not complete training|0|||
94505023|NCT01646216|323642616|FG001|Overall Study|Did not complete training|2|||
94505024|NCT01646216|323642615|FG000|Overall Study|Investigator decision|1|||
94505025|NCT01646216|323642616|FG001|Overall Study|Investigator decision|1|||
94505026|NCT01340170|323642617|FG000|Overall Study|Lost to Follow-up|2|||
94505027|NCT01340170|323642618|FG001|Overall Study|Lost to Follow-up|4|||
94505028|NCT01340170|323642619|FG002|Overall Study|Lost to Follow-up|0|||
94505029|NCT01340170|323642617|FG000|Overall Study|Implant failure|1|||
94505030|NCT01340170|323642618|FG001|Overall Study|Implant failure|3|||
94505031|NCT01340170|323642619|FG002|Overall Study|Implant failure|0|||
94505032|NCT02554474|323642622|FG000|Overall Study|Protocol Violation|1|||
94505033|NCT02554474|323642623|FG001|Overall Study|Protocol Violation|1|||
94505034|NCT02554474|323642622|FG000|Overall Study|Health issue not related to the study|1|||
94505035|NCT02554474|323642623|FG001|Overall Study|Health issue not related to the study|0|||
94505036|NCT02554474|323642622|FG000|Overall Study|Withdrawal by Subject|1|||
94505037|NCT02554474|323642623|FG001|Overall Study|Withdrawal by Subject|1|||
94505038|NCT03511209|323642625|FG000|Overall Study|Withdrawal by Subject|2|||
94505039|NCT03511209|323642626|FG001|Overall Study|Withdrawal by Subject|4|||
94505040|NCT03511209|323642625|FG000|Overall Study|Death|1|||
94505041|NCT03511209|323642626|FG001|Overall Study|Death|0|||
94505042|NCT03511209|323642625|FG000|Overall Study|Lost to Follow-up|0|||
94505043|NCT03511209|323642626|FG001|Overall Study|Lost to Follow-up|2|||
94505044|NCT03769116|323642629|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
94505045|NCT03769116|323642630|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
94505046|NCT03769116|323642629|FG000|Part 3 - Open Label|Physician Decision|1|||
94505047|NCT03769116|323642630|FG001|Part 3 - Open Label|Physician Decision|0|||
94505048|NCT03769116|323642629|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
94505049|NCT03769116|323642630|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
94505050|NCT04042311|323642633|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
94505051|NCT04042311|323642633|FG000|Overall Study|Unable to tolerate|4|||
94505052|NCT04042311|323642633|FG000|Overall Study|Concurrent illness|2|||
94505053|NCT04042311|323642633|FG000|Overall Study|Adverse Event|2|||
94505054|NCT04042311|323642633|FG000|Overall Study|No longer meeting inclusion criteria|2|||
94505055|NCT04042311|323642633|FG000|Overall Study|No reason given|1|||
94505056|NCT04042311|323642633|FG000|Overall Study|Withdrawal by Subject|4|||
94505057|NCT03769467|323642640|FG000|Overall Study|Adverse Event|1|||
94505058|NCT03769467|323642641|FG001|Overall Study|Adverse Event|1|||
94505059|NCT03769467|323642642|FG002|Overall Study|Adverse Event|0|||
94505060|NCT03769467|323642640|FG000|Overall Study|Death|3|||
94505061|NCT03769467|323642641|FG001|Overall Study|Death|3|||
94505062|NCT03769467|323642642|FG002|Overall Study|Death|0|||
94505063|NCT03769467|323642640|FG000|Overall Study|Study Terminated By Sponsor|2|||
94505064|NCT03769467|323642641|FG001|Overall Study|Study Terminated By Sponsor|1|||
94505065|NCT03769467|323642642|FG002|Overall Study|Study Terminated By Sponsor|0|||
94505066|NCT03769467|323642640|FG000|Overall Study|Withdrawal by Subject|0|||
94505067|NCT03769467|323642641|FG001|Overall Study|Withdrawal by Subject|1|||
94505068|NCT03769467|323642642|FG002|Overall Study|Withdrawal by Subject|0|||
94505069|NCT00968968|323642643|FG000|Overall Study|Study closed/terminated|10|||
94505070|NCT00968968|323642644|FG001|Overall Study|Study closed/terminated|10|||
94505071|NCT00968968|323642643|FG000|Overall Study|Protocol defined stopping criteria|3|||
94505072|NCT00968968|323642644|FG001|Overall Study|Protocol defined stopping criteria|1|||
94505073|NCT00968968|323642643|FG000|Overall Study|Withdrawal by Subject|2|||
94505074|NCT00968968|323642644|FG001|Overall Study|Withdrawal by Subject|0|||
94505075|NCT00968968|323642643|FG000|Overall Study|Physician Decision|1|||
94505076|NCT00968968|323642644|FG001|Overall Study|Physician Decision|2|||
94505077|NCT00968968|323642643|FG000|Overall Study|Lost to Follow-up|0|||
94505078|NCT00968968|323642644|FG001|Overall Study|Lost to Follow-up|1|||
94505079|NCT00025233|323642645|FG000|Overall Study|Ineligible: wrong cell type|1|||
94505080|NCT00025233|323642645|FG000|Overall Study|Ineligible: wrong primary|1|||
94505081|NCT00025233|323642645|FG000|Overall Study|Ineligible: improper prior treatment|1|||
94505082|NCT00025233|323642645|FG000|Overall Study|Never treated|1|||
94505083|NCT00930176|323642651|FG000|Overall Study|Death|1|||
94505084|NCT03111732|323642652|FG000|Overall Study|Enrolled in different study|1|||
94505085|NCT03111732|323642652|FG000|Overall Study|Progressive disease|3|||
94505086|NCT03111732|323642652|FG000|Overall Study|Withdrawal by Subject|1|||
94505087|NCT01943825|323642653|FG000|Overall Study|Lost to Follow-up|9|||
94505088|NCT01943825|323642654|FG001|Overall Study|Lost to Follow-up|3|||
94505089|NCT01943825|323642655|FG002|Overall Study|Lost to Follow-up|12|||
94505090|NCT01943825|323642656|FG003|Overall Study|Lost to Follow-up|8|||
94505091|NCT01943825|323642653|FG000|Overall Study|Withdrawal by Subject|1|||
94505092|NCT01943825|323642654|FG001|Overall Study|Withdrawal by Subject|0|||
94505093|NCT01943825|323642655|FG002|Overall Study|Withdrawal by Subject|3|||
94505094|NCT01943825|323642656|FG003|Overall Study|Withdrawal by Subject|2|||
94505095|NCT01943825|323642653|FG000|Overall Study|Other than specified above|0|||
94505096|NCT01943825|323642654|FG001|Overall Study|Other than specified above|1|||
94505097|NCT01943825|323642655|FG002|Overall Study|Other than specified above|0|||
94505098|NCT01943825|323642656|FG003|Overall Study|Other than specified above|1|||
94505099|NCT01539525|323642661|FG000|Overall Study|Lost to Follow-up|19|||
94505100|NCT01539525|323642662|FG001|Overall Study|Lost to Follow-up|12|||
94505101|NCT01539525|323642663|FG002|Overall Study|Lost to Follow-up|11|||
94505102|NCT01539525|323642661|FG000|Overall Study|Withdrawal by Subject|0|||
94505103|NCT01539525|323642662|FG001|Overall Study|Withdrawal by Subject|3|||
94505104|NCT01539525|323642663|FG002|Overall Study|Withdrawal by Subject|2|||
94505105|NCT01539525|323642661|FG000|Overall Study|Protocol Violation|1|||
94505106|NCT01539525|323642662|FG001|Overall Study|Protocol Violation|1|||
94505107|NCT01539525|323642663|FG002|Overall Study|Protocol Violation|4|||
94505108|NCT02539394|323642664|FG000|Overall Study|Protocol Violation|1|||
94505109|NCT02539394|323642665|FG001|Overall Study|Protocol Violation|3|||
94505110|NCT02539394|323642664|FG000|Overall Study|Lost to Follow-up|1|||
94505111|NCT02539394|323642665|FG001|Overall Study|Lost to Follow-up|2|||
94505112|NCT02539394|323642664|FG000|Overall Study|Incomplete dataset|6|||
94505113|NCT02539394|323642665|FG001|Overall Study|Incomplete dataset|6|||
94505114|NCT01835431|323642668|FG000|Overall Study|Adverse Event|1|||
94505115|NCT01835431|323642669|FG001|Overall Study|Adverse Event|0|||
94505116|NCT01835431|323642668|FG000|Overall Study|other|0|||
94505117|NCT01835431|323642669|FG001|Overall Study|other|2|||
94505118|NCT01835431|323642668|FG000|Overall Study|Withdrawal by Subject|6|||
94505119|NCT01835431|323642669|FG001|Overall Study|Withdrawal by Subject|10|||
94505120|NCT01835431|323642668|FG000|Overall Study|Protocol Violation|1|||
94505121|NCT01835431|323642669|FG001|Overall Study|Protocol Violation|0|||
94505122|NCT03061214|323642670|FG000|Overall Study|Withdrawal by Subject|21|||
94505123|NCT03061214|323642671|FG001|Overall Study|Withdrawal by Subject|26|||
94505124|NCT03061214|323642672|FG002|Overall Study|Withdrawal by Subject|9|||
94505125|NCT03061214|323642670|FG000|Overall Study|Lost to Follow-up|3|||
94505126|NCT03061214|323642671|FG001|Overall Study|Lost to Follow-up|1|||
94505127|NCT03061214|323642672|FG002|Overall Study|Lost to Follow-up|1|||
94505128|NCT03061214|323642670|FG000|Overall Study|Death|1|||
94505129|NCT03061214|323642671|FG001|Overall Study|Death|1|||
94505130|NCT03061214|323642672|FG002|Overall Study|Death|0|||
94505131|NCT00655356|323642673|FG000|Overall Study|Withdrawal by Subject|3|||
94505132|NCT00655356|323642674|FG001|Overall Study|Withdrawal by Subject|4|||
94505133|NCT00655356|323642673|FG000|Overall Study|Sponsor Request|10|||
94505134|NCT00655356|323642674|FG001|Overall Study|Sponsor Request|4|||
94505135|NCT00655356|323642673|FG000|Overall Study|Adverse Event|1|||
94505136|NCT00655356|323642674|FG001|Overall Study|Adverse Event|1|||
94505137|NCT00655356|323642673|FG000|Overall Study|Protocol Violation|2|||
94505138|NCT00655356|323642674|FG001|Overall Study|Protocol Violation|1|||
94505139|NCT00655356|323642673|FG000|Overall Study|Other Reason|1|||
94505140|NCT00655356|323642674|FG001|Overall Study|Other Reason|0|||
94505141|NCT05626686|323642676|FG000|Overall Study|Protocol Violation|3|||
94505142|NCT05626686|323642676|FG000|Overall Study|Withdrawal by Subject|3|||
94505143|NCT04349098|323642677|FG000|Overall Study|Death|16|||
94505144|NCT04349098|323642678|FG001|Overall Study|Death|8|||
94505145|NCT04349098|323642677|FG000|Overall Study|Lost to Follow-up|11|||
94505146|NCT04349098|323642678|FG001|Overall Study|Lost to Follow-up|8|||
94505147|NCT04349098|323642677|FG000|Overall Study|Withdrawal by Subject|8|||
94505148|NCT04349098|323642678|FG001|Overall Study|Withdrawal by Subject|5|||
94505149|NCT04349098|323642677|FG000|Overall Study|Other|3|||
94505150|NCT04349098|323642678|FG001|Overall Study|Other|5|||
94505151|NCT02536339|323642680|FG000|Overall Study|Death|20|||
94505152|NCT02536339|323642680|FG000|Overall Study|Withdrawal by Subject|3|||
94505153|NCT02536339|323642680|FG000|Overall Study|Lost to Follow-up|2|||
94505154|NCT02536339|323642680|FG000|Overall Study|Treatment discontinued|2|||
94505155|NCT02536339|323642680|FG000|Overall Study|Physician Decision|1|||
94505156|NCT04495478|323642683|FG000|Overall Study|Withdrawal by Subject|0|||
94505157|NCT04495478|323642684|FG001|Overall Study|Withdrawal by Subject|0|||
94505158|NCT04495478|323642685|FG002|Overall Study|Withdrawal by Subject|0|||
94505159|NCT04495478|323642686|FG003|Overall Study|Withdrawal by Subject|1|||
94505160|NCT04495478|323642687|FG004|Overall Study|Withdrawal by Subject|0|||
94505161|NCT04495478|323642688|FG005|Overall Study|Withdrawal by Subject|0|||
94505162|NCT04495478|323642689|FG006|Overall Study|Withdrawal by Subject|0|||
94505163|NCT04495478|323642683|FG000|Overall Study|Physician Decision|0|||
94505164|NCT04495478|323642684|FG001|Overall Study|Physician Decision|1|||
94505165|NCT04495478|323642685|FG002|Overall Study|Physician Decision|0|||
94505166|NCT04495478|323642686|FG003|Overall Study|Physician Decision|0|||
94505167|NCT04495478|323642687|FG004|Overall Study|Physician Decision|1|||
94505168|NCT04495478|323642688|FG005|Overall Study|Physician Decision|0|||
94505169|NCT04495478|323642689|FG006|Overall Study|Physician Decision|0|||
94505170|NCT02931539|323642692|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
94505171|NCT02931539|323642693|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
94505172|NCT02931539|323642694|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
94505173|NCT02931539|323642692|FG000|Period 1: Treatment Phase|Adverse Event|5|||
94505174|NCT02931539|323642693|FG001|Period 1: Treatment Phase|Adverse Event|1|||
94505175|NCT02931539|323642694|FG002|Period 1: Treatment Phase|Adverse Event|0|||
94505176|NCT02931539|323642692|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
94505177|NCT02931539|323642693|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
94505178|NCT02931539|323642694|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
94505179|NCT02931539|323642692|FG000|Period 1: Treatment Phase|Death|8|||
94505180|NCT02931539|323642693|FG001|Period 1: Treatment Phase|Death|24|||
94505181|NCT02931539|323642694|FG002|Period 1: Treatment Phase|Death|0|||
94505182|NCT02931539|323642692|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
94505183|NCT02931539|323642693|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
94505184|NCT02931539|323642694|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
94505185|NCT02931539|323642692|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
94505186|NCT02931539|323642693|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
94505187|NCT02931539|323642694|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
94505188|NCT02931539|323642692|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
94505189|NCT02931539|323642693|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
94505190|NCT02931539|323642694|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
94505191|NCT02931539|323642692|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
94505192|NCT02931539|323642693|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
94505193|NCT02931539|323642694|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
94505194|NCT01657942|323642695|FG000|Overall Study|Alternative Treatment|7|||
94505195|NCT01657942|323642695|FG000|Overall Study|Lost to Follow-up|1|||
94505196|NCT04605588|323644509|FG000|Overall Study|Withdrawal by Subject|1|||
94505197|NCT04605588|323644510|FG001|Overall Study|Withdrawal by Subject|0|||
94505198|NCT01230814|323644511|FG000|Overall Study|Lost to Follow-up|11|||
94505199|NCT01230814|323644512|FG001|Overall Study|Lost to Follow-up|3|||
94505200|NCT01230814|323644511|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
94505201|NCT01230814|323644512|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
94505202|NCT00004228|323644513|FG000|Overall Study|Adverse Event|0|||
94505203|NCT00004228|323644514|FG001|Overall Study|Adverse Event|1|||
94505204|NCT00004228|323644515|FG002|Overall Study|Adverse Event|0|||
94505205|NCT00004228|323644516|FG003|Overall Study|Adverse Event|0|||
94505206|NCT00004228|323644517|FG004|Overall Study|Adverse Event|1|||
94505207|NCT00004228|323644518|FG005|Overall Study|Adverse Event|0|||
94505208|NCT00004228|323644519|FG006|Overall Study|Adverse Event|0|||
94505209|NCT00004228|323644513|FG000|Overall Study|Death|0|||
94505210|NCT00004228|323644514|FG001|Overall Study|Death|1|||
94505211|NCT00004228|323644515|FG002|Overall Study|Death|2|||
94505212|NCT00004228|323644516|FG003|Overall Study|Death|0|||
94505213|NCT00004228|323644517|FG004|Overall Study|Death|1|||
94505214|NCT00004228|323644518|FG005|Overall Study|Death|0|||
94505215|NCT00004228|323644519|FG006|Overall Study|Death|0|||
94505216|NCT00004228|323644513|FG000|Overall Study|Lack of Efficacy|1|||
94505217|NCT00004228|323644514|FG001|Overall Study|Lack of Efficacy|6|||
94505218|NCT00004228|323644515|FG002|Overall Study|Lack of Efficacy|5|||
94505219|NCT00004228|323644516|FG003|Overall Study|Lack of Efficacy|3|||
94505220|NCT00004228|323644517|FG004|Overall Study|Lack of Efficacy|9|||
94505221|NCT00004228|323644518|FG005|Overall Study|Lack of Efficacy|8|||
94505222|NCT00004228|323644519|FG006|Overall Study|Lack of Efficacy|4|||
94505223|NCT00004228|323644513|FG000|Overall Study|Lost to Follow-up|0|||
94505224|NCT00004228|323644514|FG001|Overall Study|Lost to Follow-up|0|||
94505225|NCT00004228|323644515|FG002|Overall Study|Lost to Follow-up|1|||
94505226|NCT00004228|323644516|FG003|Overall Study|Lost to Follow-up|0|||
94505227|NCT00004228|323644517|FG004|Overall Study|Lost to Follow-up|0|||
94505228|NCT00004228|323644518|FG005|Overall Study|Lost to Follow-up|0|||
94505229|NCT00004228|323644519|FG006|Overall Study|Lost to Follow-up|0|||
94505230|NCT00004228|323644513|FG000|Overall Study|Physician Decision|1|||
94505231|NCT00004228|323644514|FG001|Overall Study|Physician Decision|0|||
94505232|NCT00004228|323644515|FG002|Overall Study|Physician Decision|3|||
94505233|NCT00004228|323644516|FG003|Overall Study|Physician Decision|2|||
94505234|NCT00004228|323644517|FG004|Overall Study|Physician Decision|1|||
94505235|NCT00004228|323644518|FG005|Overall Study|Physician Decision|1|||
94505236|NCT00004228|323644519|FG006|Overall Study|Physician Decision|1|||
94505237|NCT00004228|323644513|FG000|Overall Study|Protocol Violation|0|||
94505238|NCT00004228|323644514|FG001|Overall Study|Protocol Violation|5|||
94505239|NCT00004228|323644515|FG002|Overall Study|Protocol Violation|2|||
94505240|NCT00004228|323644516|FG003|Overall Study|Protocol Violation|1|||
94505241|NCT00004228|323644517|FG004|Overall Study|Protocol Violation|1|||
94505242|NCT00004228|323644518|FG005|Overall Study|Protocol Violation|2|||
94505243|NCT00004228|323644519|FG006|Overall Study|Protocol Violation|0|||
94505244|NCT00004228|323644513|FG000|Overall Study|Withdrawal by Subject|3|||
94505245|NCT00004228|323644514|FG001|Overall Study|Withdrawal by Subject|0|||
94505246|NCT00004228|323644515|FG002|Overall Study|Withdrawal by Subject|1|||
94505247|NCT00004228|323644516|FG003|Overall Study|Withdrawal by Subject|0|||
94505248|NCT00004228|323644517|FG004|Overall Study|Withdrawal by Subject|2|||
94505249|NCT00004228|323644518|FG005|Overall Study|Withdrawal by Subject|1|||
94505250|NCT00004228|323644519|FG006|Overall Study|Withdrawal by Subject|2|||
94505251|NCT00004228|323644513|FG000|Overall Study|Other|0|||
94505252|NCT00004228|323644514|FG001|Overall Study|Other|0|||
94505253|NCT00004228|323644515|FG002|Overall Study|Other|1|||
94505254|NCT00004228|323644516|FG003|Overall Study|Other|0|||
94505255|NCT00004228|323644517|FG004|Overall Study|Other|0|||
94505256|NCT00004228|323644518|FG005|Overall Study|Other|0|||
94505257|NCT00004228|323644519|FG006|Overall Study|Other|0|||
94505258|NCT00004228|323644513|FG000|Overall Study|ineligible|4|||
94505259|NCT00004228|323644514|FG001|Overall Study|ineligible|2|||
94505260|NCT00004228|323644515|FG002|Overall Study|ineligible|4|||
94505261|NCT00004228|323644516|FG003|Overall Study|ineligible|1|||
94505262|NCT00004228|323644517|FG004|Overall Study|ineligible|1|||
94505263|NCT00004228|323644518|FG005|Overall Study|ineligible|2|||
94505264|NCT00004228|323644519|FG006|Overall Study|ineligible|5|||
94505265|NCT02595437|323644520|FG000|Triferic Via IV|Withdrawal by Subject|1|||
94505266|NCT00458705|323644521|FG000|Overall Study|Adverse Event|4|||
94505267|NCT00458705|323644521|FG000|Overall Study|Not Treated|1|||
94505268|NCT03021005|323644533|FG000|Overall Study|Lost to Follow-up|39|||
94505269|NCT03021005|323644534|FG001|Overall Study|Lost to Follow-up|26|||
94505270|NCT00756314|323644535|FG000|Overall Study|Lost to Follow-up|2|||
94505271|NCT00756314|323644536|FG001|Overall Study|Lost to Follow-up|59|||
94505272|NCT02872142|323644545|FG000|Overall Study|Adverse Event|2|||
94505273|NCT02872142|323644545|FG000|Overall Study|Death|1|||
94505274|NCT02872142|323644545|FG000|Overall Study|Participant Decision|3|||
94505275|NCT05122143|323644546|FG000|Overall Study|Adverse Event|1|||
94505276|NCT05122143|323644547|FG001|Overall Study|Adverse Event|0|||
94505277|NCT05122143|323644548|FG002|Overall Study|Adverse Event|0|||
94505278|NCT05122143|323644549|FG003|Overall Study|Adverse Event|0|||
94505279|NCT05122143|323644550|FG004|Overall Study|Adverse Event|1|||
94505280|NCT05122143|323644551|FG005|Overall Study|Adverse Event|0|||
94505281|NCT05122143|323644546|FG000|Overall Study|Protocol non-compliance|0|||
94505282|NCT05122143|323644547|FG001|Overall Study|Protocol non-compliance|0|||
94505283|NCT05122143|323644548|FG002|Overall Study|Protocol non-compliance|1|||
94505284|NCT05122143|323644549|FG003|Overall Study|Protocol non-compliance|0|||
94505285|NCT05122143|323644550|FG004|Overall Study|Protocol non-compliance|0|||
94505286|NCT05122143|323644551|FG005|Overall Study|Protocol non-compliance|0|||
94505287|NCT05122143|323644546|FG000|Overall Study|Covid contact|0|||
94505288|NCT05122143|323644547|FG001|Overall Study|Covid contact|0|||
94505289|NCT05122143|323644548|FG002|Overall Study|Covid contact|0|||
94505290|NCT05122143|323644549|FG003|Overall Study|Covid contact|0|||
94505291|NCT05122143|323644550|FG004|Overall Study|Covid contact|1|||
94505292|NCT05122143|323644551|FG005|Overall Study|Covid contact|0|||
94505293|NCT03016403|323644556|FG000|Baseline|Death|5|||
94505294|NCT03016403|323644557|FG001|Baseline|Death|8|||
94505295|NCT03016403|323644558|FG002|Baseline|Death|1|||
94505296|NCT03016403|323644559|FG003|Baseline|Death|0|||
94505297|NCT03016403|323644556|FG000|Baseline|Withdrawal by Subject|2|||
94505298|NCT03016403|323644557|FG001|Baseline|Withdrawal by Subject|8|||
94505299|NCT03016403|323644558|FG002|Baseline|Withdrawal by Subject|4|||
94505300|NCT03016403|323644559|FG003|Baseline|Withdrawal by Subject|10|||
94505301|NCT03016403|323644556|FG000|Baseline|Lost to Follow-up|9|||
94505302|NCT03016403|323644557|FG001|Baseline|Lost to Follow-up|11|||
94505303|NCT03016403|323644558|FG002|Baseline|Lost to Follow-up|6|||
94505304|NCT03016403|323644559|FG003|Baseline|Lost to Follow-up|24|||
94505305|NCT03016403|323644556|FG000|6-week Follow-up|Death|1|||
94505306|NCT03016403|323644557|FG001|6-week Follow-up|Death|4|||
94505307|NCT03016403|323644558|FG002|6-week Follow-up|Death|0|||
94655632|NCT01312467|324196107|FG000|Overall Study|Withdrawal by Subject|2|||
94505308|NCT03016403|323644559|FG003|6-week Follow-up|Death|0|||
94505309|NCT03016403|323644556|FG000|6-week Follow-up|Lost to Follow-up|2|||
94505310|NCT03016403|323644557|FG001|6-week Follow-up|Lost to Follow-up|7|||
94505311|NCT03016403|323644558|FG002|6-week Follow-up|Lost to Follow-up|4|||
94505312|NCT03016403|323644559|FG003|6-week Follow-up|Lost to Follow-up|8|||
94505313|NCT03016403|323644556|FG000|6-week Follow-up|Withdrawal by Subject|0|||
94505314|NCT03016403|323644557|FG001|6-week Follow-up|Withdrawal by Subject|2|||
94505315|NCT03016403|323644558|FG002|6-week Follow-up|Withdrawal by Subject|0|||
94505316|NCT03016403|323644559|FG003|6-week Follow-up|Withdrawal by Subject|1|||
94505317|NCT03016403|323644556|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
94505318|NCT03016403|323644557|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
94505319|NCT03016403|323644558|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
94505320|NCT03016403|323644559|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
94505321|NCT03016403|323644556|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
94505322|NCT03016403|323644557|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
94505323|NCT03016403|323644558|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
94505324|NCT03016403|323644559|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
94505325|NCT03016403|323644556|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
94505326|NCT03016403|323644557|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
94505327|NCT03016403|323644558|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
94505328|NCT03016403|323644559|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
94505329|NCT00079781|323644560|FG000|Pre-implant Period|Withdrawal by Subject|2|||
94505330|NCT00079781|323644561|FG001|Pre-implant Period|Withdrawal by Subject|0|||
94505331|NCT00079781|323644562|FG002|Pre-implant Period|Withdrawal by Subject|0|||
94505332|NCT00079781|323644560|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
94505333|NCT00079781|323644561|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
94505334|NCT00079781|323644562|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
94505335|NCT00079781|323644560|FG000|Follow-up Period|Withdrawal by Subject|3|||
94505336|NCT00079781|323644561|FG001|Follow-up Period|Withdrawal by Subject|0|||
94505337|NCT00079781|323644562|FG002|Follow-up Period|Withdrawal by Subject|1|||
94505338|NCT00079781|323644560|FG000|Follow-up Period|Lost to Follow-up|1|||
94505339|NCT00079781|323644561|FG001|Follow-up Period|Lost to Follow-up|0|||
94505340|NCT00079781|323644562|FG002|Follow-up Period|Lost to Follow-up|0|||
94505341|NCT00079781|323644560|FG000|Follow-up Period|Death|0|||
94505342|NCT00079781|323644561|FG001|Follow-up Period|Death|0|||
94505343|NCT00079781|323644562|FG002|Follow-up Period|Death|1|||
94505344|NCT01657500|323644564|FG000|Overall Study|set impropperly matched|3|||
94505345|NCT01657500|323644565|FG001|Overall Study|set impropperly matched|3|||
94505346|NCT01657500|323644564|FG000|Overall Study|Lost to Follow-up|2|||
94505347|NCT01657500|323644565|FG001|Overall Study|Lost to Follow-up|2|||
94505348|NCT01347086|323644568|FG000|Overall Study|failed screening visit|0|||
94505349|NCT01347086|323644569|FG001|Overall Study|failed screening visit|0|||
94505350|NCT01347086|323644570|FG002|Overall Study|failed screening visit|1|||
94505351|NCT01347086|323644571|FG003|Overall Study|failed screening visit|0|||
94505352|NCT01347086|323644572|FG004|Overall Study|failed screening visit|0|||
94505353|NCT01347086|323644573|FG005|Overall Study|failed screening visit|0|||
94505354|NCT01347086|323644574|FG006|Overall Study|failed screening visit|1|||
94505355|NCT01347086|323644575|FG007|Overall Study|failed screening visit|1|||
94505356|NCT01347086|323644576|FG008|Overall Study|failed screening visit|0|||
94505357|NCT01347086|323644577|FG009|Overall Study|failed screening visit|1|||
94505358|NCT02134028|323644579|FG000|Overall Study|Lack of Efficacy|1|||
94505359|NCT02134028|323644580|FG001|Overall Study|Lack of Efficacy|0|||
94505360|NCT02134028|323644581|FG002|Overall Study|Lack of Efficacy|3|||
94505361|NCT02134028|323644582|FG003|Overall Study|Lack of Efficacy|2|||
94505362|NCT02134028|323644583|FG004|Overall Study|Lack of Efficacy|1|||
94505363|NCT02134028|323644584|FG005|Overall Study|Lack of Efficacy|2|||
94505364|NCT02134028|323644585|FG006|Overall Study|Lack of Efficacy|1|||
94505365|NCT02134028|323644586|FG007|Overall Study|Lack of Efficacy|0|||
94505366|NCT02134028|323644579|FG000|Overall Study|Poor compliance to protocol|1|||
94505367|NCT02134028|323644580|FG001|Overall Study|Poor compliance to protocol|1|||
94505368|NCT02134028|323644581|FG002|Overall Study|Poor compliance to protocol|3|||
94505369|NCT02134028|323644582|FG003|Overall Study|Poor compliance to protocol|7|||
94505370|NCT02134028|323644583|FG004|Overall Study|Poor compliance to protocol|1|||
94505371|NCT02134028|323644584|FG005|Overall Study|Poor compliance to protocol|1|||
94505372|NCT02134028|323644585|FG006|Overall Study|Poor compliance to protocol|0|||
94505373|NCT02134028|323644586|FG007|Overall Study|Poor compliance to protocol|0|||
94505374|NCT02134028|323644579|FG000|Overall Study|Other unspecified|4|||
94505375|NCT02134028|323644580|FG001|Overall Study|Other unspecified|22|||
94505376|NCT02134028|323644581|FG002|Overall Study|Other unspecified|33|||
94505377|NCT02134028|323644582|FG003|Overall Study|Other unspecified|64|||
94505378|NCT02134028|323644583|FG004|Overall Study|Other unspecified|8|||
94505379|NCT02134028|323644584|FG005|Overall Study|Other unspecified|6|||
94505380|NCT02134028|323644585|FG006|Overall Study|Other unspecified|2|||
94505381|NCT02134028|323644586|FG007|Overall Study|Other unspecified|1|||
94505382|NCT02134028|323644579|FG000|Overall Study|Adverse Event|3|||
94505383|NCT02134028|323644580|FG001|Overall Study|Adverse Event|19|||
94505384|NCT02134028|323644581|FG002|Overall Study|Adverse Event|13|||
94505385|NCT02134028|323644582|FG003|Overall Study|Adverse Event|32|||
94505386|NCT02134028|323644583|FG004|Overall Study|Adverse Event|4|||
94505387|NCT02134028|323644584|FG005|Overall Study|Adverse Event|5|||
94505388|NCT02134028|323644585|FG006|Overall Study|Adverse Event|1|||
94505389|NCT02134028|323644586|FG007|Overall Study|Adverse Event|2|||
94505390|NCT02965976|323644587|FG000|Overall Study|Withdrawal by Subject|2|||
94505391|NCT02965976|323644588|FG001|Overall Study|Withdrawal by Subject|0|||
94505392|NCT00806026|323644589|FG000|Overall Study|Death|0|||
94505393|NCT00806026|323644590|FG001|Overall Study|Death|0|||
94505394|NCT00806026|323644591|FG002|Overall Study|Death|0|||
94505395|NCT00806026|323644592|FG003|Overall Study|Death|1|||
94505396|NCT00806026|323644593|FG004|Overall Study|Death|0|||
94505397|NCT00806026|323644594|FG005|Overall Study|Death|0|||
94505398|NCT00806026|323644589|FG000|Overall Study|Did not meet entrance criteria|4|||
94505399|NCT00806026|323644590|FG001|Overall Study|Did not meet entrance criteria|1|||
94505400|NCT00806026|323644591|FG002|Overall Study|Did not meet entrance criteria|2|||
94505401|NCT00806026|323644592|FG003|Overall Study|Did not meet entrance criteria|1|||
94505402|NCT00806026|323644593|FG004|Overall Study|Did not meet entrance criteria|0|||
94505403|NCT00806026|323644594|FG005|Overall Study|Did not meet entrance criteria|0|||
94505404|NCT00806026|323644589|FG000|Overall Study|Lack of Efficacy|5|||
94505405|NCT00806026|323644590|FG001|Overall Study|Lack of Efficacy|18|||
94505406|NCT00806026|323644591|FG002|Overall Study|Lack of Efficacy|13|||
94505407|NCT00806026|323644592|FG003|Overall Study|Lack of Efficacy|4|||
94505408|NCT00806026|323644593|FG004|Overall Study|Lack of Efficacy|8|||
94505409|NCT00806026|323644594|FG005|Overall Study|Lack of Efficacy|7|||
94505410|NCT00806026|323644589|FG000|Overall Study|Lost to Follow-up|8|||
94505411|NCT00806026|323644590|FG001|Overall Study|Lost to Follow-up|15|||
94505412|NCT00806026|323644591|FG002|Overall Study|Lost to Follow-up|8|||
94505413|NCT00806026|323644592|FG003|Overall Study|Lost to Follow-up|2|||
94505414|NCT00806026|323644593|FG004|Overall Study|Lost to Follow-up|6|||
94505415|NCT00806026|323644594|FG005|Overall Study|Lost to Follow-up|6|||
94505416|NCT00806026|323644589|FG000|Overall Study|Withdrawal by Subject|14|||
94505417|NCT00806026|323644590|FG001|Overall Study|Withdrawal by Subject|17|||
94505418|NCT00806026|323644591|FG002|Overall Study|Withdrawal by Subject|9|||
94505419|NCT00806026|323644592|FG003|Overall Study|Withdrawal by Subject|2|||
94505420|NCT00806026|323644593|FG004|Overall Study|Withdrawal by Subject|5|||
94505421|NCT00806026|323644594|FG005|Overall Study|Withdrawal by Subject|3|||
94505422|NCT00806026|323644589|FG000|Overall Study|Other|3|||
94505423|NCT00806026|323644590|FG001|Overall Study|Other|6|||
94505424|NCT00806026|323644591|FG002|Overall Study|Other|8|||
94505425|NCT00806026|323644592|FG003|Overall Study|Other|2|||
94505426|NCT00806026|323644593|FG004|Overall Study|Other|0|||
94505427|NCT00806026|323644594|FG005|Overall Study|Other|4|||
94505428|NCT00806026|323644589|FG000|Overall Study|Protocol Violation|6|||
94505429|NCT00806026|323644590|FG001|Overall Study|Protocol Violation|9|||
94505430|NCT00806026|323644591|FG002|Overall Study|Protocol Violation|9|||
94505431|NCT00806026|323644592|FG003|Overall Study|Protocol Violation|0|||
94505432|NCT00806026|323644593|FG004|Overall Study|Protocol Violation|2|||
94505433|NCT00806026|323644594|FG005|Overall Study|Protocol Violation|3|||
94505434|NCT00806026|323644589|FG000|Overall Study|Adverse Event|52|||
94505435|NCT00806026|323644590|FG001|Overall Study|Adverse Event|35|||
94505436|NCT00806026|323644591|FG002|Overall Study|Adverse Event|44|||
94505437|NCT00806026|323644592|FG003|Overall Study|Adverse Event|17|||
94505438|NCT00806026|323644593|FG004|Overall Study|Adverse Event|9|||
94505439|NCT00806026|323644594|FG005|Overall Study|Adverse Event|9|||
94505440|NCT03878602|323644597|FG000|Overall Study|cord blood donation|7|||
94505441|NCT03878602|323644598|FG001|Overall Study|cord blood donation|1|||
94505442|NCT03878602|323644597|FG000|Overall Study|incomplete data collection|2|||
94505443|NCT03878602|323644598|FG001|Overall Study|incomplete data collection|0|||
94505444|NCT02395627|323644599|FG000|Overall Study|Withdrawal by Subject|0|||
94505445|NCT02395627|323644600|FG001|Overall Study|Withdrawal by Subject|2|||
94505446|NCT02395627|323644601|FG002|Overall Study|Withdrawal by Subject|0|||
94505447|NCT02395627|323644599|FG000|Overall Study|Did not receive pembrolizumab|3|||
94505448|NCT02395627|323644600|FG001|Overall Study|Did not receive pembrolizumab|1|||
94505449|NCT02395627|323644601|FG002|Overall Study|Did not receive pembrolizumab|0|||
94505450|NCT01796470|323644602|FG000|Overall Study|Adverse Event|4|||
94505451|NCT01796470|323644603|FG001|Overall Study|Adverse Event|2|||
94505452|NCT01796470|323644604|FG002|Overall Study|Adverse Event|2|||
94505453|NCT01796470|323644605|FG003|Overall Study|Adverse Event|1|||
94505454|NCT01796470|323644606|FG004|Overall Study|Adverse Event|3|||
94505455|NCT01796470|323644602|FG000|Overall Study|Death|2|||
94505456|NCT01796470|323644603|FG001|Overall Study|Death|0|||
94505457|NCT01796470|323644604|FG002|Overall Study|Death|0|||
94505458|NCT01796470|323644605|FG003|Overall Study|Death|0|||
94505459|NCT01796470|323644606|FG004|Overall Study|Death|1|||
94505460|NCT01796470|323644602|FG000|Overall Study|Initiated New Therapy|9|||
94505461|NCT01796470|323644603|FG001|Overall Study|Initiated New Therapy|0|||
94505462|NCT01796470|323644604|FG002|Overall Study|Initiated New Therapy|0|||
94505463|NCT01796470|323644605|FG003|Overall Study|Initiated New Therapy|0|||
94505464|NCT01796470|323644606|FG004|Overall Study|Initiated New Therapy|2|||
94505465|NCT01796470|323644602|FG000|Overall Study|Lost to Follow-up|0|||
94505466|NCT01796470|323644603|FG001|Overall Study|Lost to Follow-up|1|||
94505467|NCT01796470|323644604|FG002|Overall Study|Lost to Follow-up|0|||
94505468|NCT01796470|323644605|FG003|Overall Study|Lost to Follow-up|0|||
94505469|NCT01796470|323644606|FG004|Overall Study|Lost to Follow-up|0|||
94505470|NCT01796470|323644602|FG000|Overall Study|Physician Decision|5|||
94505471|NCT01796470|323644603|FG001|Overall Study|Physician Decision|4|||
94505472|NCT01796470|323644604|FG002|Overall Study|Physician Decision|1|||
94505473|NCT01796470|323644605|FG003|Overall Study|Physician Decision|0|||
94505474|NCT01796470|323644606|FG004|Overall Study|Physician Decision|1|||
94505475|NCT01796470|323644602|FG000|Overall Study|Progressive Disease|7|||
94505476|NCT01796470|323644603|FG001|Overall Study|Progressive Disease|7|||
94505477|NCT01796470|323644604|FG002|Overall Study|Progressive Disease|3|||
94505478|NCT01796470|323644605|FG003|Overall Study|Progressive Disease|2|||
94505479|NCT01796470|323644606|FG004|Overall Study|Progressive Disease|0|||
94505480|NCT01796470|323644602|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
94505481|NCT01796470|323644603|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
94505482|NCT01796470|323644604|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
94505483|NCT01796470|323644605|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
94505484|NCT01796470|323644606|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
94505485|NCT01796470|323644602|FG000|Overall Study|Withdrawal by Subject|7|||
94505486|NCT01796470|323644603|FG001|Overall Study|Withdrawal by Subject|0|||
94505487|NCT01796470|323644604|FG002|Overall Study|Withdrawal by Subject|0|||
94505488|NCT01796470|323644605|FG003|Overall Study|Withdrawal by Subject|0|||
94505489|NCT01796470|323644606|FG004|Overall Study|Withdrawal by Subject|1|||
94505490|NCT01927861|323644607|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
94505491|NCT01927861|323644608|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
94505492|NCT01927861|323644607|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
94505493|NCT01927861|323644608|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
94505494|NCT00987935|323644609|FG000|Overall Study|Progressive disease|3|||
94505495|NCT00987935|323644610|FG001|Overall Study|Progressive disease|2|||
94505496|NCT00987935|323644611|FG002|Overall Study|Progressive disease|3|||
94505497|NCT00987935|323644612|FG003|Overall Study|Progressive disease|2|||
94505498|NCT00987935|323644613|FG004|Overall Study|Progressive disease|5|||
94505499|NCT00987935|323644614|FG005|Overall Study|Progressive disease|3|||
94505500|NCT00987935|323644615|FG006|Overall Study|Progressive disease|9|||
94505501|NCT00987935|323644616|FG007|Overall Study|Progressive disease|48|||
94505502|NCT00987935|323644617|FG008|Overall Study|Progressive disease|23|||
94505503|NCT00987935|323644609|FG000|Overall Study|Adverse Event|0|||
94505504|NCT00987935|323644610|FG001|Overall Study|Adverse Event|1|||
94505505|NCT00987935|323644611|FG002|Overall Study|Adverse Event|0|||
94505506|NCT00987935|323644612|FG003|Overall Study|Adverse Event|1|||
94505507|NCT00987935|323644613|FG004|Overall Study|Adverse Event|1|||
94505508|NCT00987935|323644614|FG005|Overall Study|Adverse Event|0|||
94505509|NCT00987935|323644615|FG006|Overall Study|Adverse Event|2|||
94505510|NCT00987935|323644616|FG007|Overall Study|Adverse Event|10|||
94505511|NCT00987935|323644617|FG008|Overall Study|Adverse Event|6|||
94505512|NCT00987935|323644609|FG000|Overall Study|Refused to continue taking trial med.|1|||
94505513|NCT00987935|323644610|FG001|Overall Study|Refused to continue taking trial med.|0|||
94505514|NCT00987935|323644611|FG002|Overall Study|Refused to continue taking trial med.|0|||
94505515|NCT00987935|323644612|FG003|Overall Study|Refused to continue taking trial med.|0|||
94505516|NCT00987935|323644613|FG004|Overall Study|Refused to continue taking trial med.|1|||
94505517|NCT00987935|323644614|FG005|Overall Study|Refused to continue taking trial med.|0|||
94505518|NCT00987935|323644615|FG006|Overall Study|Refused to continue taking trial med.|4|||
94505519|NCT00987935|323644616|FG007|Overall Study|Refused to continue taking trial med.|4|||
94505520|NCT00987935|323644617|FG008|Overall Study|Refused to continue taking trial med.|2|||
94505521|NCT00987935|323644609|FG000|Overall Study|Reason other than those specified above|0|||
94505522|NCT00987935|323644610|FG001|Overall Study|Reason other than those specified above|0|||
94505523|NCT00987935|323644611|FG002|Overall Study|Reason other than those specified above|0|||
94505524|NCT00987935|323644612|FG003|Overall Study|Reason other than those specified above|0|||
94505525|NCT00987935|323644613|FG004|Overall Study|Reason other than those specified above|0|||
94505526|NCT00987935|323644614|FG005|Overall Study|Reason other than those specified above|0|||
94505527|NCT00987935|323644615|FG006|Overall Study|Reason other than those specified above|0|||
94505528|NCT00987935|323644616|FG007|Overall Study|Reason other than those specified above|0|||
94505529|NCT00987935|323644617|FG008|Overall Study|Reason other than those specified above|1|||
94505530|NCT00452530|323644618|FG000|Overall Study|Death|1|||
94505531|NCT00452530|323644619|FG001|Overall Study|Death|0|||
94505532|NCT00452530|323644618|FG000|Overall Study|Adverse Event|40|||
94505533|NCT00452530|323644619|FG001|Overall Study|Adverse Event|44|||
94505534|NCT00452530|323644618|FG000|Overall Study|Withdrawal by Subject|68|||
94505535|NCT00452530|323644619|FG001|Overall Study|Withdrawal by Subject|57|||
94505536|NCT00452530|323644618|FG000|Overall Study|Lost to Follow-up|1|||
94505537|NCT00452530|323644619|FG001|Overall Study|Lost to Follow-up|0|||
94505538|NCT00452530|323644618|FG000|Overall Study|Poor compliance/noncompliance|1|||
94505539|NCT00452530|323644619|FG001|Overall Study|Poor compliance/noncompliance|2|||
94505540|NCT00452530|323644618|FG000|Overall Study|No longer met study criteria|18|||
94505541|NCT00452530|323644619|FG001|Overall Study|No longer met study criteria|22|||
94505542|NCT00452530|323644618|FG000|Overall Study|Other|7|||
94505543|NCT00452530|323644619|FG001|Overall Study|Other|11|||
94505544|NCT00754559|323644621|FG000|Overall Study|Adverse Event|15|||
94505545|NCT00754559|323644621|FG000|Overall Study|Protocol Violation|11|||
94505546|NCT00754559|323644621|FG000|Overall Study|Lack of Efficacy|10|||
94505547|NCT00754559|323644621|FG000|Overall Study|Lost to Follow-up|2|||
94505548|NCT00754559|323644621|FG000|Overall Study|Administrative reason|1|||
94505549|NCT00754559|323644621|FG000|Overall Study|Other|5|||
94505550|NCT00754559|323644621|FG000|Overall Study|Withdrawal by Subject|3|||
94505551|NCT00345592|323644622|FG000|Overall Study|Death|14|||
94505552|NCT00345592|323644623|FG001|Overall Study|Death|16|||
94505553|NCT00345592|323644622|FG000|Overall Study|Withdrawal by Subject|11|||
94505554|NCT00345592|323644623|FG001|Overall Study|Withdrawal by Subject|8|||
94505555|NCT01248468|323644624|FG000|Overall Study|Administrative problem|1|||
94505556|NCT01248468|323644625|FG001|Overall Study|Administrative problem|0|||
94505557|NCT01248468|323644626|FG002|Overall Study|Administrative problem|0|||
94505558|NCT01248468|323644624|FG000|Overall Study|Lost to Follow-up|9|||
94505559|NCT01248468|323644625|FG001|Overall Study|Lost to Follow-up|12|||
94505560|NCT01248468|323644626|FG002|Overall Study|Lost to Follow-up|4|||
94505561|NCT01248468|323644624|FG000|Overall Study|Pregnancy|1|||
94505562|NCT01248468|323644625|FG001|Overall Study|Pregnancy|0|||
94505563|NCT01248468|323644626|FG002|Overall Study|Pregnancy|0|||
94505564|NCT01248468|323644624|FG000|Overall Study|Withdrawal by Subject|4|||
94505565|NCT01248468|323644625|FG001|Overall Study|Withdrawal by Subject|2|||
94505566|NCT01248468|323644626|FG002|Overall Study|Withdrawal by Subject|0|||
94505567|NCT02191397|323644627|FG000|Overall Study|Adverse Event|28|||
94505568|NCT02191397|323644628|FG001|Overall Study|Adverse Event|17|||
94505569|NCT02191397|323644627|FG000|Overall Study|Lack of Efficacy|10|||
94505570|NCT02191397|323644628|FG001|Overall Study|Lack of Efficacy|5|||
94505571|NCT02191397|323644627|FG000|Overall Study|Protocol Violation|0|||
94505572|NCT02191397|323644628|FG001|Overall Study|Protocol Violation|3|||
94505573|NCT02191397|323644627|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
94505574|NCT02191397|323644628|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
94505575|NCT02191397|323644627|FG000|Overall Study|Lost to Follow-up|10|||
94505576|NCT02191397|323644628|FG001|Overall Study|Lost to Follow-up|11|||
94505577|NCT02191397|323644627|FG000|Overall Study|Physician Decision|8|||
94505578|NCT02191397|323644628|FG001|Overall Study|Physician Decision|3|||
94505579|NCT02191397|323644627|FG000|Overall Study|Withdrawal by Subject|22|||
94505580|NCT02191397|323644628|FG001|Overall Study|Withdrawal by Subject|27|||
94505581|NCT02100644|323644629|FG000|LTG Escalation Phase|Adverse Event|9|||
94505582|NCT02100644|323644630|FG001|LTG Escalation Phase|Adverse Event|0|||
94505583|NCT02100644|323644631|FG002|LTG Escalation Phase|Adverse Event|0|||
94505584|NCT02100644|323644629|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
94505585|NCT02100644|323644630|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
94505586|NCT02100644|323644631|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
94505587|NCT02100644|323644629|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
94505588|NCT02100644|323644630|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
94505589|NCT02100644|323644631|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
94505590|NCT00468546|323644632|FG000|Week 24 Analysis|Lack of Efficacy|83|||
94505591|NCT00468546|323644633|FG001|Week 24 Analysis|Lack of Efficacy|37|||
94505592|NCT00468546|323644632|FG000|Week 24 Analysis|Refused treatment|5|||
94505593|NCT00468546|323644633|FG001|Week 24 Analysis|Refused treatment|5|||
94505594|NCT00468546|323644632|FG000|Week 24 Analysis|Adverse Event|1|||
94505595|NCT00468546|323644633|FG001|Week 24 Analysis|Adverse Event|8|||
94505596|NCT00468546|323644632|FG000|Week 24 Analysis|Failure to return|3|||
94505597|NCT00468546|323644633|FG001|Week 24 Analysis|Failure to return|4|||
94505598|NCT00468546|323644632|FG000|Week 24 Analysis|Rescue therapy|2|||
94505599|NCT00468546|323644633|FG001|Week 24 Analysis|Rescue therapy|0|||
94505600|NCT00468546|323644632|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
94505601|NCT00468546|323644633|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
94505602|NCT00468546|323644632|FG000|Week 24 Analysis|Due to clinical hold|1|||
94505603|NCT00468546|323644633|FG001|Week 24 Analysis|Due to clinical hold|0|||
94505604|NCT00468546|323644632|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
94505605|NCT00468546|323644633|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
94505606|NCT00468546|323644632|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
94505607|NCT00468546|323644633|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
94505608|NCT00468546|323644632|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
94505609|NCT00468546|323644633|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
94505610|NCT00468546|323644632|FG000|Week 24 to Week 104 Analysis|Death|1|||
94505611|NCT00468546|323644633|FG001|Week 24 to Week 104 Analysis|Death|0|||
94505612|NCT00468546|323644632|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
94505613|NCT00468546|323644633|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
94505614|NCT00468546|323644632|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
94505615|NCT00468546|323644633|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
94505616|NCT00468546|323644632|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
94505617|NCT00468546|323644633|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
94505618|NCT00468546|323644632|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
94505619|NCT00468546|323644633|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
94505620|NCT00468546|323644632|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
94505621|NCT00468546|323644633|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
94505622|NCT00468546|323644632|FG000|Week 24 to Week 104 Analysis|Other|17|||
94505623|NCT00468546|323644633|FG001|Week 24 to Week 104 Analysis|Other|14|||
94505624|NCT02852005|323644634|FG000|Overall Study|Lost to Follow-up|0|||
94505625|NCT02852005|323644635|FG001|Overall Study|Lost to Follow-up|0|||
94505626|NCT02852005|323644636|FG002|Overall Study|Lost to Follow-up|0|||
94505627|NCT02852005|323644637|FG003|Overall Study|Lost to Follow-up|0|||
94505628|NCT02852005|323644638|FG004|Overall Study|Lost to Follow-up|1|||
94505629|NCT02852005|323644634|FG000|Overall Study|Withdrawal by Subject|1|||
94505630|NCT02852005|323644635|FG001|Overall Study|Withdrawal by Subject|0|||
94505631|NCT02852005|323644636|FG002|Overall Study|Withdrawal by Subject|0|||
94505632|NCT02852005|323644637|FG003|Overall Study|Withdrawal by Subject|0|||
94505633|NCT02852005|323644638|FG004|Overall Study|Withdrawal by Subject|0|||
94505634|NCT04629521|323644639|FG000|Overall Study|Death|1|||
94505635|NCT04629521|323644639|FG000|Overall Study|Lost to Follow-up|3|||
94505636|NCT04629521|323644639|FG000|Overall Study|Subject withdrew consent|3|||
94505637|NCT04629521|323644639|FG000|Overall Study|Enrolled in error|1|||
94505638|NCT02294019|323644642|FG000|Overall Study|Adverse Event|2|||
94505639|NCT02294019|323644642|FG000|Overall Study|Protocol Violation|68|||
94505640|NCT02294019|323644642|FG000|Overall Study|Lost to Follow-up|31|||
94505641|NCT02294019|323644642|FG000|Overall Study|Other|1|||
94505642|NCT02294019|323644642|FG000|Overall Study|Withdrawal by Subject|1|||
94505643|NCT01390584|323644649|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
94505644|NCT01390584|323644650|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
94505645|NCT01390584|323644651|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
94505646|NCT00401830|323644652|FG000|Overall Study|Adverse Event|10|||
94505647|NCT00401830|323644653|FG001|Overall Study|Adverse Event|18|||
94505648|NCT00401830|323644652|FG000|Overall Study|Lack of Efficacy|11|||
94505649|NCT00401830|323644653|FG001|Overall Study|Lack of Efficacy|5|||
94505650|NCT00401830|323644652|FG000|Overall Study|Withdrawal by Subject|4|||
94505651|NCT00401830|323644653|FG001|Overall Study|Withdrawal by Subject|3|||
94505652|NCT00401830|323644652|FG000|Overall Study|Protocol Violation|3|||
94505653|NCT00401830|323644653|FG001|Overall Study|Protocol Violation|3|||
94505654|NCT00401830|323644652|FG000|Overall Study|Non-compliance with drug study|1|||
94505655|NCT00401830|323644653|FG001|Overall Study|Non-compliance with drug study|0|||
94505656|NCT00401830|323644652|FG000|Overall Study|Lost to Follow-up|1|||
94505657|NCT00401830|323644653|FG001|Overall Study|Lost to Follow-up|3|||
94505658|NCT00401830|323644652|FG000|Overall Study|Other: Personal / Family problems|1|||
94505659|NCT00401830|323644653|FG001|Overall Study|Other: Personal / Family problems|0|||
94505660|NCT01720602|323644656|FG000|Overall Study|Adverse Event|3|||
94505661|NCT01720602|323644656|FG000|Overall Study|Progressive disease on therapy|2|||
94505662|NCT03425188|323644658|FG000|Overall Study|Withdrawal by Subject|1|||
94505663|NCT01684033|323644659|FG000|Period 1, First 30 Days|Adverse Event|1|||
94505664|NCT01684033|323644660|FG001|Period 1, First 30 Days|Adverse Event|1|||
94505665|NCT01684033|323644659|FG000|Period 1, First 30 Days|Noncompliance|1|||
94505666|NCT01684033|323644660|FG001|Period 1, First 30 Days|Noncompliance|0|||
94505667|NCT01684033|323644659|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
94505668|NCT01684033|323644660|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
94505669|NCT01684033|323644659|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
94505670|NCT01684033|323644660|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
94505671|NCT01684033|323644659|FG000|Period 2, Second 30 Days|Adverse Event|1|||
94505672|NCT01684033|323644660|FG001|Period 2, Second 30 Days|Adverse Event|0|||
94505673|NCT01623154|323644662|FG000|Overall Study|Did not drink Pranactin Citric|4|||
94505674|NCT00890097|323644665|FG000|Overall Study|Adverse Event|21|||
94505675|NCT00890097|323644666|FG001|Overall Study|Adverse Event|32|||
94505676|NCT00890097|323644667|FG002|Overall Study|Adverse Event|28|||
94505677|NCT00890097|323644665|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
94505678|NCT00890097|323644666|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
94505679|NCT00890097|323644667|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
94505680|NCT00890097|323644665|FG000|Overall Study|Withdrew Consent|9|||
94505681|NCT00890097|323644666|FG001|Overall Study|Withdrew Consent|6|||
94505682|NCT00890097|323644667|FG002|Overall Study|Withdrew Consent|9|||
94505683|NCT00890097|323644665|FG000|Overall Study|Lost to Follow-up|5|||
94505684|NCT00890097|323644666|FG001|Overall Study|Lost to Follow-up|5|||
94505685|NCT00890097|323644667|FG002|Overall Study|Lost to Follow-up|5|||
94505686|NCT00890097|323644665|FG000|Overall Study|Noncompliance|0|||
94505687|NCT00890097|323644666|FG001|Overall Study|Noncompliance|4|||
94505688|NCT00890097|323644667|FG002|Overall Study|Noncompliance|4|||
94505689|NCT00890097|323644665|FG000|Overall Study|Sponsor Decision|7|||
94505690|NCT00890097|323644666|FG001|Overall Study|Sponsor Decision|11|||
94505691|NCT00890097|323644667|FG002|Overall Study|Sponsor Decision|7|||
94505692|NCT00890097|323644665|FG000|Overall Study|Did not attend final visit|2|||
94505693|NCT00890097|323644666|FG001|Overall Study|Did not attend final visit|3|||
94505694|NCT00890097|323644667|FG002|Overall Study|Did not attend final visit|0|||
94505695|NCT00890097|323644665|FG000|Overall Study|Subject Decision|3|||
94505696|NCT00890097|323644666|FG001|Overall Study|Subject Decision|2|||
94505697|NCT00890097|323644667|FG002|Overall Study|Subject Decision|6|||
94505698|NCT00890097|323644665|FG000|Overall Study|Randomization Error|2|||
94505699|NCT00890097|323644666|FG001|Overall Study|Randomization Error|0|||
94505700|NCT00890097|323644667|FG002|Overall Study|Randomization Error|0|||
94505701|NCT00890097|323644665|FG000|Overall Study|Failed inclusion criteria|3|||
94505702|NCT00890097|323644666|FG001|Overall Study|Failed inclusion criteria|4|||
94505703|NCT00890097|323644667|FG002|Overall Study|Failed inclusion criteria|0|||
94505704|NCT00890097|323644665|FG000|Overall Study|Transportation|0|||
94505705|NCT00890097|323644666|FG001|Overall Study|Transportation|2|||
94505706|NCT00890097|323644667|FG002|Overall Study|Transportation|0|||
94505707|NCT00890097|323644665|FG000|Overall Study|Subject Moved|0|||
94505708|NCT00890097|323644666|FG001|Overall Study|Subject Moved|4|||
94505709|NCT00890097|323644667|FG002|Overall Study|Subject Moved|0|||
94505710|NCT00890097|323644665|FG000|Overall Study|Protocol Deviation|1|||
94505711|NCT00890097|323644666|FG001|Overall Study|Protocol Deviation|1|||
94505712|NCT00890097|323644667|FG002|Overall Study|Protocol Deviation|1|||
94505713|NCT02037984|323644673|FG000|Overall Study|Lack of Efficacy|0|||
94505714|NCT02037984|323644674|FG001|Overall Study|Lack of Efficacy|0|||
94505715|NCT02037984|323644675|FG002|Overall Study|Lack of Efficacy|3|||
94505716|NCT02037984|323644676|FG003|Overall Study|Lack of Efficacy|10|||
94505717|NCT02037984|323644677|FG004|Overall Study|Lack of Efficacy|2|||
94505718|NCT02037984|323644678|FG005|Overall Study|Lack of Efficacy|2|||
94505719|NCT02037984|323644679|FG006|Overall Study|Lack of Efficacy|4|||
94505720|NCT02037984|323644680|FG007|Overall Study|Lack of Efficacy|3|||
94505721|NCT02037984|323644673|FG000|Overall Study|Lost to Follow-up|1|||
94505722|NCT02037984|323644674|FG001|Overall Study|Lost to Follow-up|0|||
94505723|NCT02037984|323644675|FG002|Overall Study|Lost to Follow-up|3|||
94505724|NCT02037984|323644676|FG003|Overall Study|Lost to Follow-up|5|||
94505725|NCT02037984|323644677|FG004|Overall Study|Lost to Follow-up|2|||
94505726|NCT02037984|323644678|FG005|Overall Study|Lost to Follow-up|2|||
94505727|NCT02037984|323644679|FG006|Overall Study|Lost to Follow-up|2|||
94505728|NCT02037984|323644680|FG007|Overall Study|Lost to Follow-up|4|||
94505729|NCT02037984|323644673|FG000|Overall Study|Physician Decision|0|||
94505730|NCT02037984|323644674|FG001|Overall Study|Physician Decision|0|||
94505731|NCT02037984|323644675|FG002|Overall Study|Physician Decision|0|||
94505732|NCT02037984|323644676|FG003|Overall Study|Physician Decision|0|||
94505733|NCT02037984|323644677|FG004|Overall Study|Physician Decision|0|||
94505734|NCT02037984|323644678|FG005|Overall Study|Physician Decision|0|||
94505735|NCT02037984|323644679|FG006|Overall Study|Physician Decision|1|||
94505736|NCT02037984|323644680|FG007|Overall Study|Physician Decision|0|||
94505737|NCT02037984|323644673|FG000|Overall Study|Protocol Violation|0|||
94505738|NCT02037984|323644674|FG001|Overall Study|Protocol Violation|0|||
94505739|NCT02037984|323644675|FG002|Overall Study|Protocol Violation|0|||
94505740|NCT02037984|323644676|FG003|Overall Study|Protocol Violation|0|||
94505741|NCT02037984|323644677|FG004|Overall Study|Protocol Violation|0|||
94505742|NCT02037984|323644678|FG005|Overall Study|Protocol Violation|1|||
94505743|NCT02037984|323644679|FG006|Overall Study|Protocol Violation|2|||
94505744|NCT02037984|323644680|FG007|Overall Study|Protocol Violation|0|||
94505745|NCT02037984|323644673|FG000|Overall Study|Technical Problems|0|||
94505746|NCT02037984|323644674|FG001|Overall Study|Technical Problems|0|||
94505747|NCT02037984|323644675|FG002|Overall Study|Technical Problems|3|||
94505748|NCT02037984|323644676|FG003|Overall Study|Technical Problems|3|||
94505749|NCT02037984|323644677|FG004|Overall Study|Technical Problems|2|||
94505750|NCT02037984|323644678|FG005|Overall Study|Technical Problems|3|||
94505751|NCT02037984|323644679|FG006|Overall Study|Technical Problems|4|||
94505752|NCT02037984|323644680|FG007|Overall Study|Technical Problems|2|||
94505753|NCT02037984|323644673|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
94505754|NCT02037984|323644674|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94505755|NCT02037984|323644675|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
94505756|NCT02037984|323644676|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
94505757|NCT02037984|323644677|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
94505758|NCT02037984|323644678|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
94505759|NCT02037984|323644679|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
94505760|NCT02037984|323644680|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
94505761|NCT02037984|323644673|FG000|Overall Study|Withdrawal by Subject|0|||
94505762|NCT02037984|323644674|FG001|Overall Study|Withdrawal by Subject|0|||
94505763|NCT02037984|323644675|FG002|Overall Study|Withdrawal by Subject|0|||
94505764|NCT02037984|323644676|FG003|Overall Study|Withdrawal by Subject|1|||
94505765|NCT02037984|323644677|FG004|Overall Study|Withdrawal by Subject|1|||
94505766|NCT02037984|323644678|FG005|Overall Study|Withdrawal by Subject|3|||
94505767|NCT02037984|323644679|FG006|Overall Study|Withdrawal by Subject|0|||
94505768|NCT02037984|323644680|FG007|Overall Study|Withdrawal by Subject|1|||
94505769|NCT00974233|323644681|FG000|Induction Chemoimmunotherapy|Death|2|||
94505770|NCT00974233|323644681|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
94505771|NCT00974233|323644681|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
94505772|NCT00974233|323644681|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
94505773|NCT00974233|323644681|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
94505774|NCT00974233|323644681|FG000|Maintenance Lenalidomide|Adverse Event|8|||
94505775|NCT03449147|323646368|FG000|52-week Treatment Period|Death|0|||
94505776|NCT03449147|323646369|FG001|52-week Treatment Period|Death|1|||
94505777|NCT03449147|323646370|FG002|52-week Treatment Period|Death|0|||
94505778|NCT03449147|323646368|FG000|52-week Treatment Period|Lost to Follow-up|6|||
94505779|NCT03449147|323646369|FG001|52-week Treatment Period|Lost to Follow-up|2|||
94505780|NCT03449147|323646370|FG002|52-week Treatment Period|Lost to Follow-up|5|||
94505781|NCT03449147|323646368|FG000|52-week Treatment Period|Other|0|||
94505782|NCT03449147|323646369|FG001|52-week Treatment Period|Other|1|||
94505783|NCT03449147|323646370|FG002|52-week Treatment Period|Other|2|||
94505784|NCT03449147|323646368|FG000|52-week Treatment Period|Physician Decision|1|||
94505785|NCT03449147|323646369|FG001|52-week Treatment Period|Physician Decision|0|||
94505786|NCT03449147|323646370|FG002|52-week Treatment Period|Physician Decision|3|||
94505787|NCT03449147|323646368|FG000|52-week Treatment Period|Screen Failure|1|||
94505788|NCT03449147|323646369|FG001|52-week Treatment Period|Screen Failure|2|||
94505789|NCT03449147|323646370|FG002|52-week Treatment Period|Screen Failure|0|||
94505790|NCT03449147|323646368|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
94505791|NCT03449147|323646369|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
94505792|NCT03449147|323646370|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
94505793|NCT03449147|323646368|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
94505794|NCT03449147|323646369|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
94505795|NCT03449147|323646370|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
94505796|NCT03449147|323646368|FG000|12-Week Off-Treatment Durability Period|Other|0|||
94505797|NCT03449147|323646369|FG001|12-Week Off-Treatment Durability Period|Other|1|||
94505798|NCT03449147|323646370|FG002|12-Week Off-Treatment Durability Period|Other|0|||
94505799|NCT00605657|323646373|FG000|Overall Study|Adverse Event|1|||
94505800|NCT00605657|323646373|FG000|Overall Study|Protocol Violation|1|||
94505801|NCT02123511|323646374|FG000|Overall Study|Cancelled treatment|1|||
94505802|NCT02123511|323646375|FG001|Overall Study|Cancelled treatment|0|||
94505803|NCT02123511|323646374|FG000|Overall Study|Incomplete data|1|||
94505804|NCT02123511|323646375|FG001|Overall Study|Incomplete data|3|||
94505805|NCT02123511|323646374|FG000|Overall Study|Ineligible|0|||
94505806|NCT02123511|323646375|FG001|Overall Study|Ineligible|1|||
94505807|NCT02070380|323646376|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
94505808|NCT02070380|323646377|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
94505809|NCT02070380|323646378|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
94505810|NCT02070380|323646379|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
94505811|NCT02070380|323646376|FG000|Second Injection|Image sets missing or technically inadeq|0|||
94505812|NCT02070380|323646377|FG001|Second Injection|Image sets missing or technically inadeq|1|||
94505813|NCT02070380|323646378|FG002|Second Injection|Image sets missing or technically inadeq|0|||
94505814|NCT02070380|323646379|FG003|Second Injection|Image sets missing or technically inadeq|0|||
94505815|NCT02070380|323646376|FG000|Second Injection|Protocol Violation|0|||
94505816|NCT02070380|323646377|FG001|Second Injection|Protocol Violation|1|||
94505817|NCT02070380|323646378|FG002|Second Injection|Protocol Violation|1|||
94505818|NCT02070380|323646379|FG003|Second Injection|Protocol Violation|5|||
94505819|NCT01362530|323646380|FG000|Base Study (Cycle 1)|Adverse Event|2|||
94505820|NCT01362530|323646381|FG001|Base Study (Cycle 1)|Adverse Event|0|||
94505821|NCT01362530|323646380|FG000|Base Study (Cycle 1)|Physician Decision|0|||
94505822|NCT01362530|323646381|FG001|Base Study (Cycle 1)|Physician Decision|1|||
94505823|NCT01362530|323646380|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
94505824|NCT01362530|323646381|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
94505825|NCT01362530|323646380|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
94505826|NCT01362530|323646381|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
94505827|NCT01362530|323646380|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
94505828|NCT01362530|323646381|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
94505829|NCT01362530|323646380|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
94505830|NCT01362530|323646381|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
94505831|NCT01362530|323646380|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
94505832|NCT01362530|323646381|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
94505833|NCT01362530|323646380|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
94505834|NCT01362530|323646381|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
94505835|NCT01362530|323646380|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
94505836|NCT01362530|323646381|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
94505837|NCT01362530|323646380|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
94505838|NCT01362530|323646381|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
94505839|NCT01362530|323646380|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
94505840|NCT01362530|323646381|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
94505841|NCT01362530|323646380|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
94505842|NCT01362530|323646381|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
94505843|NCT01362530|323646380|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
94505844|NCT01362530|323646381|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
94505845|NCT00662038|323646382|FG000|Overall Study|Reason not specified|3|||
94505846|NCT00662038|323646382|FG000|Overall Study|Withdrawn consent|22|||
94505847|NCT00662038|323646382|FG000|Overall Study|Withdrawal by Subject|83|||
94505848|NCT00662038|323646382|FG000|Overall Study|Sponsor decision|1|||
94505849|NCT00662038|323646382|FG000|Overall Study|Physician Decision|19|||
94505850|NCT00662038|323646382|FG000|Overall Study|Lung transplantation|44|||
94505851|NCT00662038|323646382|FG000|Overall Study|Lost to Follow-up|1|||
94505852|NCT00662038|323646382|FG000|Overall Study|Death|95|||
94505853|NCT00662038|323646382|FG000|Overall Study|Adverse Event|358|||
94505854|NCT00662038|323646382|FG000|Overall Study|Continued treatment|5|||
94505855|NCT00397046|323646383|FG000|Overall Study|Disease Progression|3|||
94505856|NCT00397046|323646384|FG001|Overall Study|Disease Progression|3|||
94505857|NCT00397046|323646385|FG002|Overall Study|Disease Progression|10|||
94505858|NCT00397046|323646386|FG003|Overall Study|Disease Progression|5|||
94505859|NCT01772693|323646387|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
94505860|NCT01772693|323646388|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
94505861|NCT01772693|323646387|FG000|Overall Study|Withdrawal by Subject|2|||
94505862|NCT01772693|323646388|FG001|Overall Study|Withdrawal by Subject|0|||
94505863|NCT01772693|323646387|FG000|Overall Study|Alternative Treatment|2|||
94505864|NCT01772693|323646388|FG001|Overall Study|Alternative Treatment|0|||
94505865|NCT01791205|323646391|FG000|Phase II|Lack of Efficacy|6|||
94505866|NCT01791205|323646392|FG001|Phase II|Lack of Efficacy|0|||
94505867|NCT01791205|323646391|FG000|Phase II|Adverse Event|2|||
94505868|NCT01791205|323646392|FG001|Phase II|Adverse Event|0|||
94505869|NCT01791205|323646391|FG000|Phase II|Safety|1|||
94505870|NCT01791205|323646392|FG001|Phase II|Safety|0|||
94505871|NCT01791205|323646391|FG000|Phase II|Lost to Follow-up|1|||
94505872|NCT01791205|323646392|FG001|Phase II|Lost to Follow-up|0|||
94505873|NCT01791205|323646391|FG000|Phase II|Remission of disease|1|||
94505874|NCT01791205|323646392|FG001|Phase II|Remission of disease|0|||
94505875|NCT01791205|323646391|FG000|Phase II|Physician's decision|1|||
94505876|NCT01791205|323646392|FG001|Phase II|Physician's decision|0|||
94505877|NCT00493285|323646393|FG000|Overall Study|Lost to Follow-up|0|||
94505878|NCT00493285|323646394|FG001|Overall Study|Lost to Follow-up|0|||
94505879|NCT00493285|323646395|FG002|Overall Study|Lost to Follow-up|0|||
94505880|NCT00493285|323646396|FG003|Overall Study|Lost to Follow-up|0|||
94505881|NCT00493285|323646397|FG004|Overall Study|Lost to Follow-up|1|||
94505882|NCT00493285|323646398|FG005|Overall Study|Lost to Follow-up|0|||
94505883|NCT01658735|323646409|FG000|Overall Study|Lack of Efficacy|1|||
94505884|NCT01658735|323646410|FG001|Overall Study|Lack of Efficacy|0|||
94505885|NCT01658735|323646411|FG002|Overall Study|Lack of Efficacy|1|||
94505886|NCT01658735|323646409|FG000|Overall Study|Lost to Follow-up|1|||
94505887|NCT01658735|323646410|FG001|Overall Study|Lost to Follow-up|1|||
94505888|NCT01658735|323646411|FG002|Overall Study|Lost to Follow-up|0|||
94505889|NCT01658735|323646409|FG000|Overall Study|Protocol Violation|0|||
94505890|NCT01658735|323646410|FG001|Overall Study|Protocol Violation|1|||
94505891|NCT01658735|323646411|FG002|Overall Study|Protocol Violation|0|||
94505892|NCT01658735|323646409|FG000|Overall Study|Withdrawal by Subject|3|||
94505893|NCT01658735|323646410|FG001|Overall Study|Withdrawal by Subject|5|||
94505894|NCT01658735|323646411|FG002|Overall Study|Withdrawal by Subject|3|||
94505895|NCT03156621|323646412|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
94505896|NCT03156621|323646413|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
94505897|NCT03156621|323646412|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
94505898|NCT03156621|323646413|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
94505899|NCT03757715|323646414|FG000|Overall Study|Lost to Follow-up|4|||
94505900|NCT03757715|323646415|FG001|Overall Study|Lost to Follow-up|9|||
94505901|NCT03757715|323646414|FG000|Overall Study|Withdrawal by Subject|1|||
94505902|NCT03757715|323646415|FG001|Overall Study|Withdrawal by Subject|1|||
94505903|NCT00692237|323646421|FG000|Overall Study|Withdrawal by Subject|1|||
94505904|NCT00692237|323646422|FG001|Overall Study|Withdrawal by Subject|3|||
94505905|NCT00692237|323646421|FG000|Overall Study|Adverse Event|0|||
94505906|NCT00692237|323646422|FG001|Overall Study|Adverse Event|1|||
94505907|NCT00576407|323646425|FG000|Overall Study|Death|7|||
94505908|NCT00576407|323646425|FG000|Overall Study|Physician Decision|1|||
94505909|NCT02067156|323646432|FG000|Overall Study|Lost to Follow-up|4|||
94505910|NCT01655069|323646433|FG000|Overall Study|Physician Decision|0|||
94505911|NCT01655069|323646434|FG001|Overall Study|Physician Decision|0|||
94505912|NCT01655069|323646435|FG002|Overall Study|Physician Decision|0|||
94505913|NCT01655069|323646436|FG003|Overall Study|Physician Decision|1|||
94505914|NCT01655069|323646433|FG000|Overall Study|Adverse Event|6|||
94505915|NCT01655069|323646434|FG001|Overall Study|Adverse Event|7|||
94505916|NCT01655069|323646435|FG002|Overall Study|Adverse Event|2|||
94505917|NCT01655069|323646436|FG003|Overall Study|Adverse Event|3|||
94505918|NCT01655069|323646433|FG000|Overall Study|Lack of Efficacy|0|||
94505919|NCT01655069|323646434|FG001|Overall Study|Lack of Efficacy|1|||
94505920|NCT01655069|323646435|FG002|Overall Study|Lack of Efficacy|0|||
94505921|NCT01655069|323646436|FG003|Overall Study|Lack of Efficacy|0|||
94505922|NCT01655069|323646433|FG000|Overall Study|No Treatment Needed|0|||
94505923|NCT01655069|323646434|FG001|Overall Study|No Treatment Needed|1|||
94505924|NCT01655069|323646435|FG002|Overall Study|No Treatment Needed|0|||
94505925|NCT01655069|323646436|FG003|Overall Study|No Treatment Needed|0|||
94505926|NCT01655069|323646433|FG000|Overall Study|Withdrawal by Subject|2|||
94505927|NCT01655069|323646434|FG001|Overall Study|Withdrawal by Subject|3|||
94505928|NCT01655069|323646435|FG002|Overall Study|Withdrawal by Subject|0|||
94505929|NCT01655069|323646436|FG003|Overall Study|Withdrawal by Subject|0|||
94505930|NCT03473301|323646438|FG000|Overall Study|Protocol Violation|4|||
94505931|NCT03473301|323646439|FG001|Overall Study|Protocol Violation|0|||
94505932|NCT03473301|323646440|FG002|Overall Study|Protocol Violation|0|||
94505933|NCT03473301|323646438|FG000|Overall Study|Withdrawal by Subject|0|||
94505934|NCT03473301|323646439|FG001|Overall Study|Withdrawal by Subject|1|||
94505935|NCT03473301|323646440|FG002|Overall Study|Withdrawal by Subject|0|||
94505936|NCT03473301|323646438|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
94505937|NCT03473301|323646439|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
94505938|NCT03473301|323646440|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
94505939|NCT02662582|323646441|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
94505940|NCT02662582|323646442|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
94505941|NCT02662582|323646441|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
94505942|NCT02662582|323646442|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
94505943|NCT02662582|323646441|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
94505944|NCT02662582|323646442|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
94505945|NCT02662582|323646441|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
94505946|NCT02662582|323646442|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
94505947|NCT04135352|323646443|FG000|Overall Study|Not treated-randomization error|0|||
94505948|NCT04135352|323646444|FG001|Overall Study|Not treated-randomization error|0|||
94505949|NCT04135352|323646445|FG002|Overall Study|Not treated-randomization error|1|||
94505950|NCT04135352|323646446|FG003|Overall Study|Not treated-randomization error|0|||
94505951|NCT04135352|323646447|FG004|Overall Study|Not treated-randomization error|0|||
94505952|NCT04135352|323646448|FG005|Overall Study|Not treated-randomization error|0|||
94505953|NCT04135352|323646449|FG006|Overall Study|Not treated-randomization error|0|||
94505954|NCT04135352|323646450|FG007|Overall Study|Not treated-randomization error|0|||
94505955|NCT04135352|323646443|FG000|Overall Study|Withdrawal by Subject|0|||
94505956|NCT04135352|323646444|FG001|Overall Study|Withdrawal by Subject|0|||
94505957|NCT04135352|323646445|FG002|Overall Study|Withdrawal by Subject|2|||
94505958|NCT04135352|323646446|FG003|Overall Study|Withdrawal by Subject|0|||
94505959|NCT04135352|323646447|FG004|Overall Study|Withdrawal by Subject|0|||
94505960|NCT04135352|323646448|FG005|Overall Study|Withdrawal by Subject|0|||
94505961|NCT04135352|323646449|FG006|Overall Study|Withdrawal by Subject|0|||
94505962|NCT04135352|323646450|FG007|Overall Study|Withdrawal by Subject|0|||
94505963|NCT04135352|323646443|FG000|Overall Study|Sponsor Decision|0|||
94505964|NCT04135352|323646444|FG001|Overall Study|Sponsor Decision|0|||
94505965|NCT04135352|323646445|FG002|Overall Study|Sponsor Decision|2|||
94505966|NCT04135352|323646446|FG003|Overall Study|Sponsor Decision|5|||
94505967|NCT04135352|323646447|FG004|Overall Study|Sponsor Decision|1|||
94505968|NCT04135352|323646448|FG005|Overall Study|Sponsor Decision|4|||
94505969|NCT04135352|323646449|FG006|Overall Study|Sponsor Decision|0|||
94505970|NCT04135352|323646450|FG007|Overall Study|Sponsor Decision|0|||
94505971|NCT04135352|323646443|FG000|Overall Study|Physician Decision|0|||
94505972|NCT04135352|323646444|FG001|Overall Study|Physician Decision|0|||
94505973|NCT04135352|323646445|FG002|Overall Study|Physician Decision|1|||
94505974|NCT04135352|323646446|FG003|Overall Study|Physician Decision|0|||
94505975|NCT04135352|323646447|FG004|Overall Study|Physician Decision|1|||
94505976|NCT04135352|323646448|FG005|Overall Study|Physician Decision|0|||
94505977|NCT04135352|323646449|FG006|Overall Study|Physician Decision|0|||
94505978|NCT04135352|323646450|FG007|Overall Study|Physician Decision|0|||
94505979|NCT04135352|323646443|FG000|Overall Study|Death|3|||
94505980|NCT04135352|323646444|FG001|Overall Study|Death|4|||
94505981|NCT04135352|323646445|FG002|Overall Study|Death|7|||
94505982|NCT04135352|323646446|FG003|Overall Study|Death|0|||
94505983|NCT04135352|323646447|FG004|Overall Study|Death|3|||
94505984|NCT04135352|323646448|FG005|Overall Study|Death|1|||
94505985|NCT04135352|323646449|FG006|Overall Study|Death|0|||
94505986|NCT04135352|323646450|FG007|Overall Study|Death|0|||
94505987|NCT04008069|323646451|FG000|Open-Label Period|Adverse Event|1|||
94505988|NCT04008069|323646452|FG001|Open-Label Period|Adverse Event|0|||
94505989|NCT04008069|323646453|FG002|Open-Label Period|Adverse Event|0|||
94505990|NCT04008069|323646451|FG000|Open-Label Period|Lack of Efficacy|4|||
94505991|NCT04008069|323646452|FG001|Open-Label Period|Lack of Efficacy|0|||
94505992|NCT04008069|323646453|FG002|Open-Label Period|Lack of Efficacy|0|||
94505993|NCT04008069|323646451|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
94505994|NCT04008069|323646452|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
94505995|NCT04008069|323646453|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
94505996|NCT04008069|323646451|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
94505997|NCT04008069|323646452|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
94505998|NCT04008069|323646453|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
94505999|NCT01696214|323646468|FG000|Overall Study|Lost to Follow-up|1|||
94506000|NCT01696214|323646469|FG001|Overall Study|Lost to Follow-up|0|||
94506001|NCT01696214|323646470|FG002|Overall Study|Lost to Follow-up|0|||
94506002|NCT01696214|323646471|FG003|Overall Study|Lost to Follow-up|0|||
94506003|NCT01682720|323646473|FG000|Overall Study|Randomized but Not Treated|0|||
94506004|NCT01682720|323646474|FG001|Overall Study|Randomized but Not Treated|1|||
94506005|NCT01682720|323646475|FG002|Overall Study|Randomized but Not Treated|1|||
94506006|NCT01682720|323646476|FG003|Overall Study|Randomized but Not Treated|0|||
94506007|NCT01682720|323646473|FG000|Overall Study|Terminated by Sponsor|83|||
94506008|NCT01682720|323646474|FG001|Overall Study|Terminated by Sponsor|0|||
94506009|NCT01682720|323646475|FG002|Overall Study|Terminated by Sponsor|0|||
94506010|NCT01682720|323646476|FG003|Overall Study|Terminated by Sponsor|0|||
94506011|NCT01682720|323646473|FG000|Overall Study|Efficacy Failure|0|||
94506012|NCT01682720|323646474|FG001|Overall Study|Efficacy Failure|3|||
94506013|NCT01682720|323646475|FG002|Overall Study|Efficacy Failure|3|||
94506014|NCT01682720|323646476|FG003|Overall Study|Efficacy Failure|30|||
94506015|NCT01682720|323646473|FG000|Overall Study|Lost to Follow-up|1|||
94506016|NCT01682720|323646474|FG001|Overall Study|Lost to Follow-up|1|||
94506017|NCT01682720|323646475|FG002|Overall Study|Lost to Follow-up|0|||
94506018|NCT01682720|323646476|FG003|Overall Study|Lost to Follow-up|6|||
94506019|NCT01682720|323646473|FG000|Overall Study|Subject Withdrew Consent|0|||
94506020|NCT01682720|323646474|FG001|Overall Study|Subject Withdrew Consent|0|||
94506021|NCT01682720|323646475|FG002|Overall Study|Subject Withdrew Consent|2|||
94506022|NCT01682720|323646476|FG003|Overall Study|Subject Withdrew Consent|2|||
94506023|NCT01682720|323646473|FG000|Overall Study|Adverse Event|1|||
94506024|NCT01682720|323646474|FG001|Overall Study|Adverse Event|0|||
94506025|NCT01682720|323646475|FG002|Overall Study|Adverse Event|1|||
94506026|NCT01682720|323646476|FG003|Overall Study|Adverse Event|1|||
94506027|NCT01687595|323646477|FG000|Overall Study|Withdrawal by Subject|8|||
94506028|NCT01687595|323646478|FG001|Overall Study|Withdrawal by Subject|0|||
94506029|NCT01687595|323646477|FG000|Overall Study|Lost to Follow-up|3|||
94506030|NCT01687595|323646478|FG001|Overall Study|Lost to Follow-up|1|||
94506031|NCT01687595|323646477|FG000|Overall Study|Investigator's decision|1|||
94506032|NCT01687595|323646478|FG001|Overall Study|Investigator's decision|0|||
94506033|NCT01687595|323646477|FG000|Overall Study|Sponsor's decision|1|||
94506034|NCT01687595|323646478|FG001|Overall Study|Sponsor's decision|0|||
94506035|NCT01687595|323646477|FG000|Overall Study|Noncompliance|1|||
94506036|NCT01687595|323646478|FG001|Overall Study|Noncompliance|2|||
94506037|NCT01687595|323646477|FG000|Overall Study|Other than specified|56|||
94506038|NCT01687595|323646478|FG001|Overall Study|Other than specified|7|||
94506039|NCT04204902|323646479|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
94506040|NCT04204902|323646480|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
94506041|NCT03180138|323646483|FG000|Overall Study|Mobile-phone could not be verified|2|||
94506042|NCT03180138|323646484|FG001|Overall Study|Mobile-phone could not be verified|13|||
94506043|NCT03180138|323646485|FG002|Overall Study|Mobile-phone could not be verified|15|||
94506044|NCT03180138|323646483|FG000|Overall Study|No prior immunization records|17|||
94506045|NCT03180138|323646484|FG001|Overall Study|No prior immunization records|0|||
94506046|NCT03180138|323646485|FG002|Overall Study|No prior immunization records|6|||
94506047|NCT03180138|323646483|FG000|Overall Study|Found to be >24 mon after randomization|3|||
94506048|NCT03180138|323646484|FG001|Overall Study|Found to be >24 mon after randomization|0|||
94506049|NCT03180138|323646485|FG002|Overall Study|Found to be >24 mon after randomization|3|||
94506050|NCT04191733|323646487|FG000|Overall Study|Withdrawn due to study closure|13|||
94506051|NCT04191733|323646488|FG001|Overall Study|Withdrawn due to study closure|14|||
94506052|NCT04191733|323646487|FG000|Overall Study|Withdrawal by Subject|2|||
94506053|NCT04191733|323646488|FG001|Overall Study|Withdrawal by Subject|4|||
94506054|NCT04191733|323646487|FG000|Overall Study|Physician Decision|1|||
94506055|NCT04191733|323646488|FG001|Overall Study|Physician Decision|1|||
94506056|NCT04191733|323646487|FG000|Overall Study|Lost to Follow-up|5|||
94506057|NCT04191733|323646488|FG001|Overall Study|Lost to Follow-up|6|||
94506058|NCT04191733|323646487|FG000|Overall Study|Death|0|||
94506059|NCT04191733|323646488|FG001|Overall Study|Death|1|||
94506060|NCT04191616|323646491|FG000|Overall Study|Death|26|||
94506061|NCT04191616|323646491|FG000|Overall Study|Withdrawal by Subject|1|||
94506062|NCT04191616|323646491|FG000|Overall Study|Sponsor decision|2|||
94506063|NCT04191616|323646491|FG000|Overall Study|Continuing study|25|||
94506064|NCT04380753|323646500|FG000|Overall Study|Participants continuing study|4|||
94506065|NCT04380753|323646500|FG000|Overall Study|Death|2|||
94506066|NCT01316900|323646517|FG000|Overall Study|Adverse Event|10|||
94506067|NCT01316900|323646518|FG001|Overall Study|Adverse Event|10|||
94506068|NCT01316900|323646519|FG002|Overall Study|Adverse Event|15|||
94506069|NCT01316900|323646520|FG003|Overall Study|Adverse Event|9|||
94506070|NCT01316900|323646517|FG000|Overall Study|Lack of Efficacy|17|||
94506071|NCT01316900|323646518|FG001|Overall Study|Lack of Efficacy|9|||
94506072|NCT01316900|323646519|FG002|Overall Study|Lack of Efficacy|5|||
94506073|NCT01316900|323646520|FG003|Overall Study|Lack of Efficacy|7|||
94506074|NCT01316900|323646517|FG000|Overall Study|Protocol Violation|7|||
94506075|NCT01316900|323646518|FG001|Overall Study|Protocol Violation|1|||
94506076|NCT01316900|323646519|FG002|Overall Study|Protocol Violation|4|||
94506077|NCT01316900|323646520|FG003|Overall Study|Protocol Violation|0|||
94506078|NCT01316900|323646517|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
94506079|NCT01316900|323646518|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
94506080|NCT01316900|323646519|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
94506081|NCT01316900|323646520|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
94506082|NCT01316900|323646517|FG000|Overall Study|Lost to Follow-up|1|||
94506083|NCT01316900|323646518|FG001|Overall Study|Lost to Follow-up|0|||
94506084|NCT01316900|323646519|FG002|Overall Study|Lost to Follow-up|1|||
94506085|NCT01316900|323646520|FG003|Overall Study|Lost to Follow-up|1|||
94506086|NCT01316900|323646517|FG000|Overall Study|Withdrawal by Subject|7|||
94506087|NCT01316900|323646518|FG001|Overall Study|Withdrawal by Subject|8|||
94506088|NCT01316900|323646519|FG002|Overall Study|Withdrawal by Subject|6|||
94506089|NCT01316900|323646520|FG003|Overall Study|Withdrawal by Subject|9|||
94506090|NCT00236197|323646521|FG000|Overall Study|Withdrawal by Subject|3|||
94506091|NCT00236197|323646522|FG001|Overall Study|Withdrawal by Subject|2|||
94506092|NCT00236197|323646521|FG000|Overall Study|Lost to Follow-up|1|||
94506093|NCT00236197|323646522|FG001|Overall Study|Lost to Follow-up|5|||
94506094|NCT00236197|323646521|FG000|Overall Study|Protocol Violation|0|||
94506095|NCT00236197|323646522|FG001|Overall Study|Protocol Violation|3|||
94506096|NCT00236197|323646521|FG000|Overall Study|Medication non-compliance|1|||
94506097|NCT00236197|323646522|FG001|Overall Study|Medication non-compliance|2|||
94506098|NCT00236197|323646521|FG000|Overall Study|Other|0|||
94506099|NCT00236197|323646522|FG001|Overall Study|Other|2|||
94506100|NCT04634331|323646523|FG000|Overall Study|Withdrawal by Subject|2|||
94506101|NCT04634331|323646524|FG001|Overall Study|Withdrawal by Subject|2|||
94506102|NCT05943990|323646526|FG000|Overall Study|Study Terminated by Sponsor|0|||
94506103|NCT05943990|323646527|FG001|Overall Study|Study Terminated by Sponsor|0|||
94506104|NCT05943990|323646528|FG002|Overall Study|Study Terminated by Sponsor|1|||
94506105|NCT05206604|323647990|FG000|Overall Study|Non-compliance with study drug|0|||
94506106|NCT05206604|323647991|FG001|Overall Study|Non-compliance with study drug|0|||
94506107|NCT05206604|323647992|FG002|Overall Study|Non-compliance with study drug|0|||
94506108|NCT05206604|323647993|FG003|Overall Study|Non-compliance with study drug|0|||
94506109|NCT05206604|323647994|FG004|Overall Study|Non-compliance with study drug|0|||
94506110|NCT05206604|323647995|FG005|Overall Study|Non-compliance with study drug|1|||
94506111|NCT05206604|323647996|FG006|Overall Study|Non-compliance with study drug|0|||
94506112|NCT05206604|323647997|FG007|Overall Study|Non-compliance with study drug|0|||
94506113|NCT01793129|323647998|FG000|Overall Study|Lost to Follow-up|3|||
94506114|NCT01793129|323647999|FG001|Overall Study|Lost to Follow-up|7|||
94506115|NCT01793129|323647998|FG000|Overall Study|Withdrawal by Subject|0|||
94506116|NCT01793129|323647999|FG001|Overall Study|Withdrawal by Subject|2|||
94506117|NCT04744831|323648002|FG000|Overall Study|Progressive Disease|31|||
94506118|NCT04744831|323648003|FG001|Overall Study|Progressive Disease|27|||
94506119|NCT04744831|323648004|FG002|Overall Study|Progressive Disease|25|||
94506120|NCT04744831|323648002|FG000|Overall Study|Adverse Event|3|||
94506121|NCT04744831|323648003|FG001|Overall Study|Adverse Event|3|||
94506122|NCT04744831|323648004|FG002|Overall Study|Adverse Event|3|||
94506123|NCT04744831|323648002|FG000|Overall Study|Clinical Progression|3|||
94506124|NCT04744831|323648003|FG001|Overall Study|Clinical Progression|2|||
94506125|NCT04744831|323648004|FG002|Overall Study|Clinical Progression|5|||
94506126|NCT04744831|323648002|FG000|Overall Study|Other|0|||
94506127|NCT04744831|323648003|FG001|Overall Study|Other|2|||
94506128|NCT04744831|323648004|FG002|Overall Study|Other|1|||
94506129|NCT04744831|323648002|FG000|Overall Study|Death|0|||
94506130|NCT04744831|323648003|FG001|Overall Study|Death|2|||
94506131|NCT04744831|323648004|FG002|Overall Study|Death|1|||
94506132|NCT03004183|323648005|FG000|Overall Study|Adverse Event|7|||
94506133|NCT03004183|323648005|FG000|Overall Study|Lost to Follow-up|1|||
94506134|NCT03004183|323648005|FG000|Overall Study|Physician Decision|40|||
94506135|NCT03004183|323648005|FG000|Overall Study|Withdrawal by Subject|1|||
94506136|NCT03004183|323648005|FG000|Overall Study|COVID-19|1|||
94506137|NCT03681093|323648008|FG000|Overall Study|Subject decision|0|||
94506138|NCT03681093|323648009|FG001|Overall Study|Subject decision|2|||
94506139|NCT03681093|323648010|FG002|Overall Study|Subject decision|1|||
94506140|NCT01027754|323648012|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
94506141|NCT01027754|323648013|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
94506142|NCT01027754|323648012|FG000|Overall Study|Withdrawal by Subject|0|||
94506143|NCT01027754|323648013|FG001|Overall Study|Withdrawal by Subject|5|||
94506144|NCT01213251|323648014|FG000|Overall Study|Death|2|||
94506145|NCT01213251|323648015|FG001|Overall Study|Death|1|||
94506146|NCT01213251|323648016|FG002|Overall Study|Death|2|||
94506147|NCT01213251|323648014|FG000|Overall Study|Exit|3|||
94506148|NCT01213251|323648015|FG001|Overall Study|Exit|2|||
94506149|NCT01213251|323648016|FG002|Overall Study|Exit|8|||
94506150|NCT01213251|323648014|FG000|Overall Study|Protocol Violation|1|||
94506151|NCT01213251|323648015|FG001|Overall Study|Protocol Violation|1|||
94506152|NCT01213251|323648016|FG002|Overall Study|Protocol Violation|0|||
94506153|NCT01213251|323648014|FG000|Overall Study|Missed 18-Month Follow-up|0|||
94506154|NCT01213251|323648015|FG001|Overall Study|Missed 18-Month Follow-up|0|||
94506155|NCT01213251|323648016|FG002|Overall Study|Missed 18-Month Follow-up|1|||
94506156|NCT01629563|323648017|FG000|Overall Study|Adverse Event|16|||
94506157|NCT01629563|323648018|FG001|Overall Study|Adverse Event|16|||
94506158|NCT01629563|323648017|FG000|Overall Study|Death|2|||
94506159|NCT01629563|323648018|FG001|Overall Study|Death|0|||
94506160|NCT01629563|323648017|FG000|Overall Study|Lack of Efficacy|2|||
94506161|NCT01629563|323648018|FG001|Overall Study|Lack of Efficacy|3|||
94506162|NCT01629563|323648017|FG000|Overall Study|Lost to Follow-up|1|||
94506163|NCT01629563|323648018|FG001|Overall Study|Lost to Follow-up|0|||
94506164|NCT01629563|323648017|FG000|Overall Study|Pregnancy|1|||
94506165|NCT01629563|323648018|FG001|Overall Study|Pregnancy|2|||
94506166|NCT01629563|323648017|FG000|Overall Study|Protocol Violation|0|||
94506167|NCT01629563|323648018|FG001|Overall Study|Protocol Violation|1|||
94506168|NCT01629563|323648017|FG000|Overall Study|Withdrawal by Subject|27|||
94506169|NCT01629563|323648018|FG001|Overall Study|Withdrawal by Subject|20|||
94506170|NCT01629563|323648017|FG000|Overall Study|surgery|0|||
94506171|NCT01629563|323648018|FG001|Overall Study|surgery|3|||
94506172|NCT01629563|323648017|FG000|Overall Study|Lack of return of menses|12|||
94506173|NCT01629563|323648018|FG001|Overall Study|Lack of return of menses|7|||
94506174|NCT01629563|323648017|FG000|Overall Study|Protocol Violation|0|||
94506175|NCT01629563|323648018|FG001|Overall Study|Protocol Violation|1|||
94506176|NCT02451007|323648021|FG000|Overall Study|Withdrawal by Subject|4|||
94506177|NCT02451007|323648021|FG000|Overall Study|Adverse Event|1|||
94506178|NCT02451007|323648021|FG000|Overall Study|Disease Progression|2|||
94506179|NCT02715856|323648022|FG000|Overall Study|Software Issues|12|||
94506180|NCT02715856|323648023|FG001|Overall Study|Software Issues|7|||
94506181|NCT02715856|323648022|FG000|Overall Study|Death|6|||
94506182|NCT02715856|323648023|FG001|Overall Study|Death|5|||
94506183|NCT02715856|323648022|FG000|Overall Study|Non- Compliant|0|||
94506184|NCT02715856|323648023|FG001|Overall Study|Non- Compliant|40|||
94506185|NCT01633112|323648026|FG000|Overall Study|Lack of Efficacy|1|||
94506186|NCT01633112|323648027|FG001|Overall Study|Lack of Efficacy|6|||
94506187|NCT01633112|323648028|FG002|Overall Study|Lack of Efficacy|13|||
94506188|NCT01633112|323648026|FG000|Overall Study|Abnormal laboratory value(s)|3|||
94506189|NCT01633112|323648027|FG001|Overall Study|Abnormal laboratory value(s)|1|||
94506190|NCT01633112|323648028|FG002|Overall Study|Abnormal laboratory value(s)|0|||
94506191|NCT01633112|323648026|FG000|Overall Study|Abnormal test procedure result(s)|0|||
94506192|NCT01633112|323648027|FG001|Overall Study|Abnormal test procedure result(s)|1|||
94506193|NCT01633112|323648028|FG002|Overall Study|Abnormal test procedure result(s)|0|||
94506194|NCT01633112|323648026|FG000|Overall Study|Administrative problems|1|||
94506195|NCT01633112|323648027|FG001|Overall Study|Administrative problems|2|||
94506196|NCT01633112|323648028|FG002|Overall Study|Administrative problems|5|||
94506197|NCT01633112|323648026|FG000|Overall Study|Adverse Event|16|||
94506198|NCT01633112|323648027|FG001|Overall Study|Adverse Event|18|||
94506199|NCT01633112|323648028|FG002|Overall Study|Adverse Event|20|||
94506200|NCT01633112|323648026|FG000|Overall Study|Lost to Follow-up|7|||
94506201|NCT01633112|323648027|FG001|Overall Study|Lost to Follow-up|19|||
94506202|NCT01633112|323648028|FG002|Overall Study|Lost to Follow-up|6|||
94506203|NCT01633112|323648026|FG000|Overall Study|Protocol Violation|4|||
94506204|NCT01633112|323648027|FG001|Overall Study|Protocol Violation|0|||
94506205|NCT01633112|323648028|FG002|Overall Study|Protocol Violation|2|||
94506206|NCT01633112|323648026|FG000|Overall Study|Subject no longer requires study drug|0|||
94506207|NCT01633112|323648027|FG001|Overall Study|Subject no longer requires study drug|0|||
94506208|NCT01633112|323648028|FG002|Overall Study|Subject no longer requires study drug|1|||
94506209|NCT01633112|323648026|FG000|Overall Study|Withdrawal by Subject|20|||
94506210|NCT01633112|323648027|FG001|Overall Study|Withdrawal by Subject|12|||
94506211|NCT01633112|323648028|FG002|Overall Study|Withdrawal by Subject|41|||
94506212|NCT01633112|323648026|FG000|Overall Study|missing Study Completion CRF|1|||
94506213|NCT01633112|323648027|FG001|Overall Study|missing Study Completion CRF|1|||
94506214|NCT01633112|323648028|FG002|Overall Study|missing Study Completion CRF|4|||
94506215|NCT01908699|323648029|FG000|Overall Study|Adverse Event|8|||
94506216|NCT01908699|323648030|FG001|Overall Study|Adverse Event|12|||
94506217|NCT01908699|323648029|FG000|Overall Study|Lack of Efficacy|2|||
94506218|NCT01908699|323648030|FG001|Overall Study|Lack of Efficacy|2|||
94506219|NCT01908699|323648029|FG000|Overall Study|Lost to Follow-up|2|||
94506220|NCT01908699|323648030|FG001|Overall Study|Lost to Follow-up|4|||
94506221|NCT01908699|323648029|FG000|Overall Study|Physician Decision|8|||
94506222|NCT01908699|323648030|FG001|Overall Study|Physician Decision|8|||
94506223|NCT01908699|323648029|FG000|Overall Study|Withdrawal by Subject|15|||
94506224|NCT01908699|323648030|FG001|Overall Study|Withdrawal by Subject|10|||
94506225|NCT01908699|323648029|FG000|Overall Study|Pregnancy|0|||
94506226|NCT01908699|323648030|FG001|Overall Study|Pregnancy|1|||
94506227|NCT01908699|323648029|FG000|Overall Study|Randomized in Error|1|||
94506228|NCT01908699|323648030|FG001|Overall Study|Randomized in Error|0|||
94506229|NCT01908699|323648029|FG000|Overall Study|Death|9|||
94506230|NCT01908699|323648030|FG001|Overall Study|Death|12|||
94506231|NCT01908699|323648029|FG000|Overall Study|Progressive Disease|30|||
94506232|NCT01908699|323648030|FG001|Overall Study|Progressive Disease|29|||
94506233|NCT02094885|323648031|FG000|Overall Study|Death|1|||
94506234|NCT02094885|323648032|FG001|Overall Study|Death|5|||
94506235|NCT02094885|323648031|FG000|Overall Study|Withdrawn due to age|1|||
94506236|NCT02094885|323648032|FG001|Overall Study|Withdrawn due to age|0|||
94506237|NCT04535362|323648035|FG000|Overall Study|Lost to Follow-up|3|||
94506238|NCT04535362|323648036|FG001|Overall Study|Lost to Follow-up|1|||
94506239|NCT00128492|323648037|FG000|Overall Study|AE unrelated to study|2|||
94506240|NCT00128492|323648038|FG001|Overall Study|AE unrelated to study|9|||
94506241|NCT00128492|323648037|FG000|Overall Study|Study drug intolerance (AE)|2|||
94506242|NCT00128492|323648038|FG001|Overall Study|Study drug intolerance (AE)|8|||
94506243|NCT00128492|323648037|FG000|Overall Study|AE related to study|1|||
94506244|NCT00128492|323648038|FG001|Overall Study|AE related to study|4|||
94506245|NCT00128492|323648037|FG000|Overall Study|Death|1|||
94506246|NCT00128492|323648038|FG001|Overall Study|Death|0|||
94506247|NCT00128492|323648037|FG000|Overall Study|Lost to Follow-up|1|||
94506248|NCT00128492|323648038|FG001|Overall Study|Lost to Follow-up|5|||
94506249|NCT00128492|323648037|FG000|Overall Study|Noncompliance|0|||
94506250|NCT00128492|323648038|FG001|Overall Study|Noncompliance|5|||
94506251|NCT00128492|323648037|FG000|Overall Study|Personal or administrative|10|||
94506252|NCT00128492|323648038|FG001|Overall Study|Personal or administrative|22|||
94506253|NCT00128492|323648037|FG000|Overall Study|Withdrawal by Subject|3|||
94506254|NCT00128492|323648038|FG001|Overall Study|Withdrawal by Subject|5|||
94506255|NCT00128492|323648037|FG000|Overall Study|Pregnancy|0|||
94506256|NCT00128492|323648038|FG001|Overall Study|Pregnancy|1|||
94506257|NCT00414609|323648039|FG000|Core Study|Adverse Event|9|||
94506258|NCT00414609|323648040|FG001|Core Study|Adverse Event|11|||
94506259|NCT00414609|323648041|FG002|Core Study|Adverse Event|0|||
94506260|NCT00414609|323648039|FG000|Core Study|Abnormal laboratory values|0|||
94506261|NCT00414609|323648040|FG001|Core Study|Abnormal laboratory values|1|||
94506262|NCT00414609|323648041|FG002|Core Study|Abnormal laboratory values|0|||
94506263|NCT00414609|323648039|FG000|Core Study|Abnormal test procedure results|1|||
94506264|NCT00414609|323648040|FG001|Core Study|Abnormal test procedure results|1|||
94506265|NCT00414609|323648041|FG002|Core Study|Abnormal test procedure results|0|||
94506266|NCT00414609|323648039|FG000|Core Study|Protocol deviation|0|||
94506267|NCT00414609|323648040|FG001|Core Study|Protocol deviation|1|||
94506268|NCT00414609|323648041|FG002|Core Study|Protocol deviation|0|||
94506269|NCT00414609|323648039|FG000|Core Study|Patient withdrew consent|10|||
94506270|NCT00414609|323648040|FG001|Core Study|Patient withdrew consent|11|||
94506271|NCT00414609|323648041|FG002|Core Study|Patient withdrew consent|0|||
94506272|NCT00414609|323648039|FG000|Core Study|Lost to Follow-up|7|||
94506273|NCT00414609|323648040|FG001|Core Study|Lost to Follow-up|4|||
94506274|NCT00414609|323648041|FG002|Core Study|Lost to Follow-up|0|||
94506275|NCT00414609|323648039|FG000|Core Study|Administrative problems|0|||
94506276|NCT00414609|323648040|FG001|Core Study|Administrative problems|2|||
94506277|NCT00414609|323648041|FG002|Core Study|Administrative problems|0|||
94506278|NCT00414609|323648039|FG000|Core Study|Death|7|||
94506279|NCT00414609|323648040|FG001|Core Study|Death|14|||
94506280|NCT00414609|323648041|FG002|Core Study|Death|0|||
94506281|NCT00414609|323648039|FG000|Extension Study|Adverse Event|0|||
94506282|NCT00414609|323648040|FG001|Extension Study|Adverse Event|0|||
94506283|NCT00414609|323648041|FG002|Extension Study|Adverse Event|14|||
94506284|NCT00414609|323648039|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
94506285|NCT00414609|323648040|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
94506286|NCT00414609|323648041|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
94506287|NCT00414609|323648039|FG000|Extension Study|Withdrawal by Subject|0|||
94506288|NCT00414609|323648040|FG001|Extension Study|Withdrawal by Subject|0|||
94506289|NCT00414609|323648041|FG002|Extension Study|Withdrawal by Subject|13|||
94506290|NCT00414609|323648039|FG000|Extension Study|Lost to Follow-up|0|||
94506291|NCT00414609|323648040|FG001|Extension Study|Lost to Follow-up|0|||
94506292|NCT00414609|323648041|FG002|Extension Study|Lost to Follow-up|10|||
94506293|NCT00414609|323648039|FG000|Extension Study|Administrative problems|0|||
94506294|NCT00414609|323648040|FG001|Extension Study|Administrative problems|0|||
94506295|NCT00414609|323648041|FG002|Extension Study|Administrative problems|1|||
94506296|NCT00414609|323648039|FG000|Extension Study|Death|0|||
94506297|NCT00414609|323648040|FG001|Extension Study|Death|0|||
94506298|NCT00414609|323648041|FG002|Extension Study|Death|17|||
94506299|NCT00159874|323648046|FG000|Overall Study|Adverse Event|2|||
94506300|NCT00159874|323648047|FG001|Overall Study|Adverse Event|2|||
94506301|NCT00159874|323648048|FG002|Overall Study|Adverse Event|5|||
94506302|NCT00159874|323648049|FG003|Overall Study|Adverse Event|1|||
94506303|NCT00159874|323648050|FG004|Overall Study|Adverse Event|1|||
94506304|NCT00159874|323648051|FG005|Overall Study|Adverse Event|2|||
94506305|NCT00159874|323648052|FG006|Overall Study|Adverse Event|0|||
94506306|NCT00159874|323648046|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
94506307|NCT00159874|323648047|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
94506308|NCT00159874|323648048|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
94506309|NCT00159874|323648049|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
94506310|NCT00159874|323648050|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
94506311|NCT00159874|323648051|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
94506312|NCT00159874|323648052|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
94506313|NCT00159874|323648046|FG000|Overall Study|Lack of Efficacy|2|||
94506314|NCT00159874|323648047|FG001|Overall Study|Lack of Efficacy|0|||
94506315|NCT00159874|323648048|FG002|Overall Study|Lack of Efficacy|1|||
94506316|NCT00159874|323648049|FG003|Overall Study|Lack of Efficacy|1|||
94506317|NCT00159874|323648050|FG004|Overall Study|Lack of Efficacy|0|||
94506318|NCT00159874|323648051|FG005|Overall Study|Lack of Efficacy|3|||
94506319|NCT00159874|323648052|FG006|Overall Study|Lack of Efficacy|0|||
94506320|NCT00159874|323648046|FG000|Overall Study|Lost to Follow-up|1|||
94506321|NCT00159874|323648047|FG001|Overall Study|Lost to Follow-up|0|||
94506322|NCT00159874|323648048|FG002|Overall Study|Lost to Follow-up|3|||
94506323|NCT00159874|323648049|FG003|Overall Study|Lost to Follow-up|0|||
94506324|NCT00159874|323648050|FG004|Overall Study|Lost to Follow-up|1|||
94506325|NCT00159874|323648051|FG005|Overall Study|Lost to Follow-up|2|||
94506326|NCT00159874|323648052|FG006|Overall Study|Lost to Follow-up|1|||
94506327|NCT00159874|323648046|FG000|Overall Study|Other|8|||
94506328|NCT00159874|323648047|FG001|Overall Study|Other|8|||
94506329|NCT00159874|323648048|FG002|Overall Study|Other|8|||
94506330|NCT00159874|323648049|FG003|Overall Study|Other|0|||
94506331|NCT00159874|323648050|FG004|Overall Study|Other|2|||
94506332|NCT00159874|323648051|FG005|Overall Study|Other|1|||
94506333|NCT00159874|323648052|FG006|Overall Study|Other|3|||
94506334|NCT00159874|323648046|FG000|Overall Study|Protocol Violation|0|||
94506335|NCT00159874|323648047|FG001|Overall Study|Protocol Violation|5|||
94506336|NCT00159874|323648048|FG002|Overall Study|Protocol Violation|2|||
94506337|NCT00159874|323648049|FG003|Overall Study|Protocol Violation|0|||
94506338|NCT00159874|323648050|FG004|Overall Study|Protocol Violation|0|||
94506339|NCT00159874|323648051|FG005|Overall Study|Protocol Violation|0|||
94506340|NCT00159874|323648052|FG006|Overall Study|Protocol Violation|0|||
94506341|NCT00159874|323648046|FG000|Overall Study|Death|3|||
94506342|NCT00159874|323648047|FG001|Overall Study|Death|8|||
94506343|NCT00159874|323648048|FG002|Overall Study|Death|15|||
94506344|NCT00159874|323648049|FG003|Overall Study|Death|0|||
94506345|NCT00159874|323648050|FG004|Overall Study|Death|1|||
94506346|NCT00159874|323648051|FG005|Overall Study|Death|2|||
94506347|NCT00159874|323648052|FG006|Overall Study|Death|0|||
94506348|NCT00159874|323648046|FG000|Overall Study|Withdrawal by Subject|2|||
94506349|NCT00159874|323648047|FG001|Overall Study|Withdrawal by Subject|6|||
94506350|NCT00159874|323648048|FG002|Overall Study|Withdrawal by Subject|8|||
94506351|NCT00159874|323648049|FG003|Overall Study|Withdrawal by Subject|4|||
94506352|NCT00159874|323648050|FG004|Overall Study|Withdrawal by Subject|3|||
94506353|NCT00159874|323648051|FG005|Overall Study|Withdrawal by Subject|2|||
94506354|NCT00159874|323648052|FG006|Overall Study|Withdrawal by Subject|1|||
94506355|NCT00159874|323648046|FG000|Overall Study|Pregnancy|1|||
94506356|NCT00159874|323648047|FG001|Overall Study|Pregnancy|1|||
94506357|NCT00159874|323648048|FG002|Overall Study|Pregnancy|0|||
94506358|NCT00159874|323648049|FG003|Overall Study|Pregnancy|0|||
94506359|NCT00159874|323648050|FG004|Overall Study|Pregnancy|0|||
94506360|NCT00159874|323648051|FG005|Overall Study|Pregnancy|0|||
94506361|NCT00159874|323648052|FG006|Overall Study|Pregnancy|0|||
94506362|NCT00395447|323648056|FG000|Overall Study|Death|37|||
94506363|NCT00395447|323648057|FG001|Overall Study|Death|32|||
94506364|NCT00395447|323648056|FG000|Overall Study|Lost to Follow-up|52|||
94506365|NCT00395447|323648057|FG001|Overall Study|Lost to Follow-up|43|||
94506366|NCT00395447|323648056|FG000|Overall Study|Withdrawal by Subject|24|||
94506367|NCT00395447|323648057|FG001|Overall Study|Withdrawal by Subject|19|||
94506368|NCT00395447|323648056|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
94506369|NCT00395447|323648057|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
94506370|NCT03766906|323648058|FG000|Overall Study|Withdrawal by Subject|6|||
94506371|NCT02624687|323648060|FG000|Overall Study|Withdrawal by Subject|1|||
94506372|NCT02624687|323648061|FG001|Overall Study|Withdrawal by Subject|1|||
94506373|NCT02624687|323648060|FG000|Overall Study|medical leave from work|0|||
94506374|NCT02624687|323648061|FG001|Overall Study|medical leave from work|1|||
94506375|NCT03142334|323648062|FG000|Overall Study|Death|18|||
94506376|NCT03142334|323648063|FG001|Overall Study|Death|33|||
94506377|NCT03142334|323648062|FG000|Overall Study|Withdrawal by Subject|15|||
94506378|NCT03142334|323648063|FG001|Overall Study|Withdrawal by Subject|11|||
94506379|NCT03142334|323648062|FG000|Overall Study|Ongoing on trial follow up|463|||
94506380|NCT03142334|323648063|FG001|Overall Study|Ongoing on trial follow up|454|||
94506381|NCT04829214|323648064|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
94506382|NCT04829214|323648065|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
94506383|NCT04829214|323648064|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
94506384|NCT04829214|323648065|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
94506385|NCT01229111|323648066|FG000|Overall Study|Death|1|||
94506386|NCT05071027|323648067|FG000|Overall Study|Lost to Follow-up|1|||
94506387|NCT05071027|323648068|FG001|Overall Study|Lost to Follow-up|4|||
94506388|NCT04576481|323648069|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
94506389|NCT04576481|323648070|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
94506390|NCT04576481|323648071|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
94506391|NCT04576481|323648072|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
94506392|NCT05463952|323648073|FG000|Treatment|Progressive disease|4|||
94506393|NCT05463952|323648073|FG000|Treatment|Ongoing|2|||
94506394|NCT00511199|323648074|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
94506395|NCT00511199|323648075|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
94506396|NCT00511199|323648074|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
94506397|NCT00511199|323648075|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
94506398|NCT00511199|323648074|FG000|Overall Study|Withdrawal of Informed Consent|19|||
94506399|NCT00511199|323648075|FG001|Overall Study|Withdrawal of Informed Consent|4|||
94506400|NCT00511199|323648074|FG000|Overall Study|Pregnancy|6|||
94506401|NCT00511199|323648075|FG001|Overall Study|Pregnancy|3|||
94506402|NCT00511199|323648074|FG000|Overall Study|Pregnancy Wish|16|||
94506403|NCT00511199|323648075|FG001|Overall Study|Pregnancy Wish|8|||
94506404|NCT00511199|323648074|FG000|Overall Study|Lost to Follow-up|40|||
94506405|NCT00511199|323648075|FG001|Overall Study|Lost to Follow-up|17|||
94506406|NCT00511199|323648074|FG000|Overall Study|Other Reason|78|||
94506407|NCT00511199|323648075|FG001|Overall Study|Other Reason|37|||
94506408|NCT05261490|323648076|FG000|Overall Study|Other|1|||
94506409|NCT05261490|323648077|FG001|Overall Study|Other|0|||
94506410|NCT05261490|323648078|FG002|Overall Study|Other|0|||
94506411|NCT05261490|323648076|FG000|Overall Study|Study Terminated by Sponsor|1|||
94506412|NCT05261490|323648077|FG001|Overall Study|Study Terminated by Sponsor|1|||
94506413|NCT05261490|323648078|FG002|Overall Study|Study Terminated by Sponsor|4|||
94506414|NCT05261490|323648076|FG000|Overall Study|Death|1|||
94506415|NCT05261490|323648077|FG001|Overall Study|Death|2|||
94506416|NCT05261490|323648078|FG002|Overall Study|Death|0|||
94506417|NCT04223687|323648084|FG000|Overall Study|Missing primary outcome|1|||
94506418|NCT04223687|323648085|FG001|Overall Study|Missing primary outcome|0|||
94506419|NCT01272219|323648086|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
94506420|NCT01272219|323648087|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
94506421|NCT01272219|323648088|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
94506422|NCT01272219|323648089|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
94506423|NCT01272219|323648090|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
94506424|NCT01272219|323648091|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
94506425|NCT01272219|323648086|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
94506426|NCT01272219|323648087|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
94506427|NCT01272219|323648088|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
94506428|NCT01272219|323648089|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
94506429|NCT01272219|323648090|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
94506430|NCT01272219|323648091|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
94506431|NCT01272219|323648086|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
94506432|NCT01272219|323648087|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
94506433|NCT01272219|323648088|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
94506434|NCT01272219|323648089|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
94506435|NCT01272219|323648090|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
94506436|NCT01272219|323648091|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
94506437|NCT01272219|323648086|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
94506438|NCT01272219|323648087|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
94506439|NCT01272219|323648088|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
94506440|NCT01272219|323648089|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
94506441|NCT01272219|323648090|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
94506442|NCT01272219|323648091|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
94506443|NCT01272219|323648086|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
94506444|NCT01272219|323648087|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
94506445|NCT01272219|323648088|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
94506446|NCT01272219|323648089|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
94506447|NCT01272219|323648090|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
94506448|NCT01272219|323648091|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
94506449|NCT01272219|323648086|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
94506450|NCT01272219|323648087|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
94506451|NCT01272219|323648088|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
94506452|NCT01272219|323648089|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
94506453|NCT01272219|323648090|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
94506454|NCT01272219|323648091|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
94506455|NCT01272219|323648086|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
94506456|NCT01272219|323648087|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
94506457|NCT01272219|323648088|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
94506458|NCT01272219|323648089|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
94506459|NCT01272219|323648090|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
94506460|NCT01272219|323648091|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
94506461|NCT01272219|323648086|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
94506462|NCT01272219|323648087|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
94506463|NCT01272219|323648088|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
94506464|NCT01272219|323648089|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
94506465|NCT01272219|323648090|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
94506466|NCT01272219|323648091|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
94506467|NCT01272219|323648086|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
94506468|NCT01272219|323648087|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
94506469|NCT01272219|323648088|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
94506470|NCT01272219|323648089|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
94506471|NCT01272219|323648090|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
94506472|NCT01272219|323648091|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
94506473|NCT01272219|323648086|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
94506474|NCT01272219|323648087|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
94506475|NCT01272219|323648088|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
94506476|NCT01272219|323648089|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
94506477|NCT01272219|323648090|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
94506478|NCT01272219|323648091|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
94506479|NCT01272219|323648086|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
94506480|NCT01272219|323648087|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
94506481|NCT01272219|323648088|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
94506482|NCT01272219|323648089|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
94506483|NCT01272219|323648090|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
94506484|NCT01272219|323648091|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
94506485|NCT01272219|323648086|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
94506486|NCT01272219|323648087|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
94506487|NCT01272219|323648088|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
94506488|NCT01272219|323648089|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
94506489|NCT01272219|323648090|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
94506490|NCT01272219|323648091|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
94506491|NCT01272219|323648086|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
94506492|NCT01272219|323648087|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
94506493|NCT01272219|323648088|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
94506494|NCT01272219|323648089|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
94506495|NCT01272219|323648090|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
94506496|NCT01272219|323648091|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
94506497|NCT01272219|323648086|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
94506498|NCT01272219|323648087|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
94506499|NCT01272219|323648088|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
94506500|NCT01272219|323648089|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
94506501|NCT01272219|323648090|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
94506502|NCT01272219|323648091|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
94506503|NCT01272219|323648086|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
94506504|NCT01272219|323648087|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
94506505|NCT01272219|323648088|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
94506506|NCT01272219|323648089|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
94506507|NCT01272219|323648090|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
94506508|NCT01272219|323648091|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
94506509|NCT01272219|323648086|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
94506510|NCT01272219|323648087|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
94506511|NCT01272219|323648088|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
94506512|NCT01272219|323648089|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
94506513|NCT01272219|323648090|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
94506514|NCT01272219|323648091|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
94506515|NCT02489045|323648094|FG000|Overall Study|unable to collect usable data|53|||
94506516|NCT02489045|323648094|FG000|Follow-up|Lost to Follow-up|10|||
94506517|NCT00215657|323648097|FG000|Overall Study|Adverse Event|5|||
94506518|NCT00215657|323648098|FG001|Overall Study|Adverse Event|1|||
94506519|NCT00215657|323648099|FG002|Overall Study|Adverse Event|3|||
94506520|NCT00215657|323648100|FG003|Overall Study|Adverse Event|0|||
94506521|NCT00215657|323648101|FG004|Overall Study|Adverse Event|3|||
94506522|NCT00215657|323648102|FG005|Overall Study|Adverse Event|1|||
94506523|NCT00215657|323648103|FG006|Overall Study|Adverse Event|0|||
94506524|NCT00215657|323648104|FG007|Overall Study|Adverse Event|3|||
94506525|NCT00215657|323648097|FG000|Overall Study|Withdrawal by Subject|6|||
94506526|NCT00215657|323648098|FG001|Overall Study|Withdrawal by Subject|3|||
94506527|NCT00215657|323648099|FG002|Overall Study|Withdrawal by Subject|3|||
94506528|NCT00215657|323648100|FG003|Overall Study|Withdrawal by Subject|1|||
94506529|NCT00215657|323648101|FG004|Overall Study|Withdrawal by Subject|6|||
94506530|NCT00215657|323648102|FG005|Overall Study|Withdrawal by Subject|1|||
94506531|NCT00215657|323648103|FG006|Overall Study|Withdrawal by Subject|10|||
94506532|NCT00215657|323648104|FG007|Overall Study|Withdrawal by Subject|3|||
94506533|NCT00215657|323648097|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
94506534|NCT00215657|323648098|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
94506535|NCT00215657|323648099|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
94506536|NCT00215657|323648100|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
94506537|NCT00215657|323648101|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
94506538|NCT00215657|323648102|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
94506539|NCT00215657|323648103|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
94506540|NCT00215657|323648104|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
94506541|NCT00215657|323648097|FG000|Overall Study|Insufficient testosterone response|5|||
94506542|NCT00215657|323648098|FG001|Overall Study|Insufficient testosterone response|4|||
94506543|NCT00215657|323648099|FG002|Overall Study|Insufficient testosterone response|1|||
94506544|NCT00215657|323648100|FG003|Overall Study|Insufficient testosterone response|12|||
94506545|NCT00215657|323648101|FG004|Overall Study|Insufficient testosterone response|8|||
94506546|NCT00215657|323648102|FG005|Overall Study|Insufficient testosterone response|12|||
94506547|NCT00215657|323648103|FG006|Overall Study|Insufficient testosterone response|4|||
94506548|NCT00215657|323648104|FG007|Overall Study|Insufficient testosterone response|7|||
94506549|NCT00215657|323648097|FG000|Overall Study|Other|3|||
94506550|NCT00215657|323648098|FG001|Overall Study|Other|1|||
94506551|NCT00215657|323648099|FG002|Overall Study|Other|2|||
94506552|NCT00215657|323648100|FG003|Overall Study|Other|3|||
94506553|NCT00215657|323648101|FG004|Overall Study|Other|5|||
94506554|NCT00215657|323648102|FG005|Overall Study|Other|4|||
94506555|NCT00215657|323648103|FG006|Overall Study|Other|6|||
94506556|NCT00215657|323648104|FG007|Overall Study|Other|1|||
94506557|NCT00231465|323648107|FG000|Overall Study|Completed only one cycle|1|||
94506558|NCT00231465|323648107|FG000|Overall Study|Did not have follow up CT scans|1|||
94506559|NCT04090749|323648108|FG000|Open Label Pilot|Lost to Follow-up|1|||
94506560|NCT04090749|323648109|FG001|Open Label Pilot|Lost to Follow-up|0|||
94506561|NCT04090749|323648110|FG002|Open Label Pilot|Lost to Follow-up|0|||
94506562|NCT04090749|323648108|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
94506563|NCT04090749|323648109|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
94506564|NCT04090749|323648110|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
94506565|NCT04090749|323648108|FG000|Pilot Trial|Lost to Follow-up|0|||
94506566|NCT04090749|323648109|FG001|Pilot Trial|Lost to Follow-up|1|||
94506567|NCT04090749|323648110|FG002|Pilot Trial|Lost to Follow-up|1|||
94506568|NCT00421408|323648111|FG000|Overall Study|Lost to Follow-up|30|||
94506569|NCT00421408|323648112|FG001|Overall Study|Lost to Follow-up|20|||
94506570|NCT00421408|323648111|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
94506571|NCT00421408|323648112|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
94506572|NCT04105725|323648113|FG000|Primary Intervention|Lost to Follow-up|0|||
94506573|NCT04105725|323648114|FG001|Primary Intervention|Lost to Follow-up|2|||
94506574|NCT04105725|323648113|FG000|Primary Intervention|Withdrawal by Subject|0|||
94506575|NCT04105725|323648114|FG001|Primary Intervention|Withdrawal by Subject|1|||
94506576|NCT02766478|323648115|FG000|Overall Study|Withdrawal by Subject|1|||
94506577|NCT02766478|323648116|FG001|Overall Study|Withdrawal by Subject|1|||
94506578|NCT01093573|323648117|FG000|Overall Study|Physician Decision|0|||
94506579|NCT01093573|323648118|FG001|Overall Study|Physician Decision|0|||
94506580|NCT01093573|323648119|FG002|Overall Study|Physician Decision|1|||
94506581|NCT01093573|323648117|FG000|Overall Study|Insurance Denied|0|||
94506582|NCT01093573|323648118|FG001|Overall Study|Insurance Denied|0|||
94506583|NCT01093573|323648119|FG002|Overall Study|Insurance Denied|1|||
94506584|NCT00089583|323648120|FG000|Overall Study|Adverse Event|0|||
94506585|NCT00089583|323648121|FG001|Overall Study|Adverse Event|3|||
94506586|NCT00089583|323648120|FG000|Overall Study|Insufficient Viral Load Response|5|||
94506587|NCT00089583|323648121|FG001|Overall Study|Insufficient Viral Load Response|5|||
94506588|NCT00089583|323648120|FG000|Overall Study|Withdrawal by Subject|0|||
94506589|NCT00089583|323648121|FG001|Overall Study|Withdrawal by Subject|4|||
94506590|NCT00089583|323648120|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
94506591|NCT00089583|323648121|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
94506592|NCT00089583|323648120|FG000|Overall Study|Participant Refused Study Medication|0|||
94506593|NCT00089583|323648121|FG001|Overall Study|Participant Refused Study Medication|2|||
94506594|NCT00089583|323648120|FG000|Overall Study|Non-Compliance|0|||
94506595|NCT00089583|323648121|FG001|Overall Study|Non-Compliance|4|||
94506596|NCT00089583|323648120|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
94506597|NCT00089583|323648121|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
94506598|NCT00089583|323648120|FG000|Overall Study|Participant Management Criteria Met|0|||
94506599|NCT00089583|323648121|FG001|Overall Study|Participant Management Criteria Met|1|||
94506600|NCT00089583|323648120|FG000|Overall Study|Reason Not Provided|0|||
94506601|NCT00089583|323648121|FG001|Overall Study|Reason Not Provided|1|||
94506602|NCT00089583|323648120|FG000|Overall Study|Protocol Violation|0|||
94506603|NCT00089583|323648121|FG001|Overall Study|Protocol Violation|3|||
94506604|NCT00089583|323648120|FG000|Overall Study|Principal Investigator Decision|0|||
94506605|NCT00089583|323648121|FG001|Overall Study|Principal Investigator Decision|10|||
94506606|NCT00089583|323648120|FG000|Overall Study|Start of Disallowed Medication|0|||
94506607|NCT00089583|323648121|FG001|Overall Study|Start of Disallowed Medication|1|||
94506608|NCT00089583|323648120|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
94506609|NCT00089583|323648121|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
94506610|NCT00089583|323648120|FG000|Overall Study|Participant Incarcerated|0|||
94506611|NCT00089583|323648121|FG001|Overall Study|Participant Incarcerated|1|||
94506612|NCT02916433|323648122|FG000|Overall Study|Withdrawal by Subject|1|||
94506613|NCT02916433|323648123|FG001|Overall Study|Withdrawal by Subject|0|||
94506614|NCT02916433|323648122|FG000|Overall Study|Physician Decision|1|||
94506615|NCT02916433|323648123|FG001|Overall Study|Physician Decision|0|||
94506616|NCT03760666|323648124|FG000|Overall Study|Adverse Event|2|||
94506617|NCT03760666|323648125|FG001|Overall Study|Adverse Event|4|||
94506618|NCT03760666|323648126|FG002|Overall Study|Adverse Event|1|||
94506619|NCT03760666|323648124|FG000|Overall Study|AML Disease Progression|3|||
94506620|NCT03760666|323648125|FG001|Overall Study|AML Disease Progression|3|||
94506621|NCT03760666|323648126|FG002|Overall Study|AML Disease Progression|0|||
94506622|NCT03760666|323648124|FG000|Overall Study|Physician Decision|0|||
94506623|NCT03760666|323648125|FG001|Overall Study|Physician Decision|3|||
94506624|NCT03760666|323648126|FG002|Overall Study|Physician Decision|0|||
94506625|NCT03760666|323648124|FG000|Overall Study|Withdrawal by Subject|0|||
94506626|NCT03760666|323648125|FG001|Overall Study|Withdrawal by Subject|1|||
94506627|NCT03760666|323648126|FG002|Overall Study|Withdrawal by Subject|0|||
94506628|NCT01412983|323648127|FG000|1st Period|Ineligible|0|||
94506629|NCT01412983|323648128|FG001|1st Period|Ineligible|1|||
94506630|NCT01412983|323648127|FG000|1st Period|Positive slit lamp finding|0|||
94506631|NCT01412983|323648128|FG001|1st Period|Positive slit lamp finding|1|||
94506632|NCT01412983|323648127|FG000|1st Period|Unacceptable lens movement|0|||
94506633|NCT01412983|323648128|FG001|1st Period|Unacceptable lens movement|1|||
94506634|NCT01412983|323648127|FG000|1st Period|Inability to maintain wear|0|||
94506635|NCT01412983|323648128|FG001|1st Period|Inability to maintain wear|1|||
94506636|NCT01703221|323648130|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
94506637|NCT01703221|323648131|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
94506638|NCT01703221|323648132|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
94506639|NCT01703221|323648130|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
94506640|NCT01703221|323648131|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
94506641|NCT01703221|323648132|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
94506642|NCT01703221|323648130|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
94506643|NCT01703221|323648131|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
94506644|NCT01703221|323648132|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
94506645|NCT01703221|323648130|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
94506646|NCT01703221|323648131|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
94506647|NCT01703221|323648132|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
94506648|NCT01703221|323648130|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
94506649|NCT01703221|323648131|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
94506650|NCT01703221|323648132|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
94506651|NCT01703221|323648130|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
94506652|NCT01703221|323648131|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
94506653|NCT01703221|323648132|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
94506654|NCT01703221|323648130|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
94506655|NCT01703221|323648131|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
94506656|NCT01703221|323648132|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
94506657|NCT01703221|323648130|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
94506658|NCT01703221|323648131|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
94506659|NCT01703221|323648132|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
94506660|NCT01152385|323648133|FG000|Overall Study|Withdrawal by Subject|3|||
94506661|NCT01152385|323648134|FG001|Overall Study|Withdrawal by Subject|1|||
94506662|NCT01152385|323648135|FG002|Overall Study|Withdrawal by Subject|1|||
94506663|NCT01152385|323648136|FG003|Overall Study|Withdrawal by Subject|1|||
94506664|NCT01152385|323648133|FG000|Overall Study|Protocol Violation|0|||
94506665|NCT01152385|323648134|FG001|Overall Study|Protocol Violation|0|||
94506666|NCT01152385|323648135|FG002|Overall Study|Protocol Violation|0|||
94506667|NCT01152385|323648136|FG003|Overall Study|Protocol Violation|1|||
94506668|NCT01152385|323648133|FG000|Overall Study|Adverse Event|1|||
94506669|NCT01152385|323648134|FG001|Overall Study|Adverse Event|1|||
94506670|NCT01152385|323648135|FG002|Overall Study|Adverse Event|0|||
94506671|NCT01152385|323648136|FG003|Overall Study|Adverse Event|0|||
94506672|NCT01152385|323648133|FG000|Overall Study|Study-specific withdrawal criteria|1|||
94506673|NCT01152385|323648134|FG001|Overall Study|Study-specific withdrawal criteria|1|||
94506674|NCT01152385|323648135|FG002|Overall Study|Study-specific withdrawal criteria|2|||
94506675|NCT01152385|323648136|FG003|Overall Study|Study-specific withdrawal criteria|0|||
94506676|NCT01152385|323648133|FG000|Overall Study|Other|4|||
94506677|NCT01152385|323648134|FG001|Overall Study|Other|3|||
94506678|NCT01152385|323648135|FG002|Overall Study|Other|2|||
94506679|NCT01152385|323648136|FG003|Overall Study|Other|3|||
94506680|NCT05486065|323648137|FG000|Overall Study|Withdrawal by Subject|1|||
94506681|NCT05486065|323648138|FG001|Overall Study|Withdrawal by Subject|5|||
94506682|NCT05486065|323648139|FG002|Overall Study|Withdrawal by Subject|4|||
94506683|NCT05486065|323648140|FG003|Overall Study|Withdrawal by Subject|3|||
94506684|NCT05486065|323648137|FG000|Overall Study|Lost to Follow-up|4|||
94506685|NCT05486065|323648138|FG001|Overall Study|Lost to Follow-up|2|||
94506686|NCT05486065|323648139|FG002|Overall Study|Lost to Follow-up|2|||
94506687|NCT05486065|323648140|FG003|Overall Study|Lost to Follow-up|2|||
94506688|NCT05486065|323648137|FG000|Overall Study|Physician Decision|0|||
94506689|NCT05486065|323648138|FG001|Overall Study|Physician Decision|1|||
94506690|NCT05486065|323648139|FG002|Overall Study|Physician Decision|1|||
94506691|NCT05486065|323648140|FG003|Overall Study|Physician Decision|0|||
94506692|NCT05486065|323648137|FG000|Overall Study|Failure to meet randomization criteria|0|||
94506693|NCT05486065|323648138|FG001|Overall Study|Failure to meet randomization criteria|0|||
94506694|NCT05486065|323648139|FG002|Overall Study|Failure to meet randomization criteria|0|||
94506695|NCT05486065|323648140|FG003|Overall Study|Failure to meet randomization criteria|1|||
94506696|NCT03927846|323648142|FG000|Overall Study|Lost to Follow-up|10|||
94506697|NCT03927846|323648143|FG001|Overall Study|Lost to Follow-up|11|||
94506698|NCT03878069|323648144|FG000|Overall Study|Death|0|||
94506699|NCT03878069|323648145|FG001|Overall Study|Death|1|||
94506700|NCT03878069|323648146|FG002|Overall Study|Death|0|||
94506701|NCT00834587|323648147|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
94506702|NCT00834587|323648148|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
94506703|NCT00176254|323648149|FG000|Overall Study|Lost to Follow-up|1|||
94506704|NCT01569763|323649825|FG000|Overall Study|Lack of Efficacy|2|||
94506705|NCT01569763|323649826|FG001|Overall Study|Lack of Efficacy|7|||
94506706|NCT01569763|323649825|FG000|Overall Study|Adverse Event|1|||
94506707|NCT01569763|323649826|FG001|Overall Study|Adverse Event|0|||
94506708|NCT03787212|323649827|FG000|Period 1|Study Termination|2|||
94506709|NCT03787212|323649828|FG001|Period 1|Study Termination|2|||
94506710|NCT01197300|323649832|FG000|Overall Study|Lost to Follow-up|0|||
94506711|NCT01197300|323649833|FG001|Overall Study|Lost to Follow-up|1|||
94506712|NCT01197300|323649832|FG000|Overall Study|Protocol Violation|0|||
94506713|NCT01197300|323649833|FG001|Overall Study|Protocol Violation|1|||
94506714|NCT02529488|323649834|FG000|Overall Study|Adverse Event|1|||
94506715|NCT02529488|323649834|FG000|Overall Study|Death|3|||
94506716|NCT02698787|323649835|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
94506717|NCT02698787|323649836|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
94506718|NCT01882829|323649845|FG000|Overall Study|Adverse Event|4|||
94506719|NCT01882829|323649845|FG000|Overall Study|Protocol Violation|1|||
94506720|NCT01882829|323649845|FG000|Overall Study|Withdrawal by Subject|1|||
94506721|NCT01557244|323649849|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
94506722|NCT01557244|323649850|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
94506723|NCT01557244|323649851|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
94506724|NCT01557244|323649852|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
94506725|NCT01557244|323649853|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
94506726|NCT01557244|323649854|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
94506727|NCT01557244|323649855|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
94506728|NCT01557244|323649849|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
94506729|NCT01557244|323649850|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
94506730|NCT01557244|323649851|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
94506731|NCT01557244|323649852|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
94506732|NCT01557244|323649853|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
94506733|NCT01557244|323649854|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
94506734|NCT01557244|323649855|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
94506735|NCT01557244|323649849|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
94506736|NCT01557244|323649850|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
94506737|NCT01557244|323649851|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
94506738|NCT01557244|323649852|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
94506739|NCT01557244|323649853|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
94506740|NCT01557244|323649854|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
94506741|NCT01557244|323649855|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
94506742|NCT01557244|323649849|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
94506743|NCT01557244|323649850|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
94506744|NCT01557244|323649851|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
94506745|NCT01557244|323649852|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
94506746|NCT01557244|323649853|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
94506747|NCT01557244|323649854|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
94506748|NCT01557244|323649855|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
94506749|NCT01557244|323649849|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
94506750|NCT01557244|323649850|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
94506751|NCT01557244|323649851|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
94506752|NCT01557244|323649852|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
94506753|NCT01557244|323649853|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
94506754|NCT01557244|323649854|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
94506755|NCT01557244|323649855|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
94506756|NCT01557244|323649849|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
94506757|NCT01557244|323649850|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
94506758|NCT01557244|323649851|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
94506759|NCT01557244|323649852|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
94506760|NCT01557244|323649853|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
94506761|NCT01557244|323649854|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
94506762|NCT01557244|323649855|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
94506763|NCT01557244|323649849|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
94506764|NCT01557244|323649850|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
94506765|NCT01557244|323649851|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
94506766|NCT01557244|323649852|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
94506767|NCT01557244|323649853|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
94506768|NCT01557244|323649854|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
94506769|NCT01557244|323649855|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
94506770|NCT01557244|323649849|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
94506771|NCT01557244|323649850|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
94506772|NCT01557244|323649851|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
94506773|NCT01557244|323649852|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
94506774|NCT01557244|323649853|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
94506775|NCT01557244|323649854|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
94506776|NCT01557244|323649855|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
94506777|NCT01557244|323649849|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
94506778|NCT01557244|323649850|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
94506779|NCT01557244|323649851|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
94506780|NCT01557244|323649852|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
94506781|NCT01557244|323649853|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
94506782|NCT01557244|323649854|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
94506783|NCT01557244|323649855|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
94506784|NCT01557244|323649849|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
94506785|NCT01557244|323649850|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
94506786|NCT01557244|323649851|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
94506787|NCT01557244|323649852|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
94506788|NCT01557244|323649853|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
94506789|NCT01557244|323649854|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
94506790|NCT01557244|323649855|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
94506791|NCT01557244|323649849|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
94506792|NCT01557244|323649850|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
94506793|NCT01557244|323649851|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
94506794|NCT01557244|323649852|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
94506795|NCT01557244|323649853|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
94506796|NCT01557244|323649854|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
94506797|NCT01557244|323649855|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
94506798|NCT01557244|323649849|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
94506799|NCT01557244|323649850|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
94506800|NCT01557244|323649851|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
94506801|NCT01557244|323649852|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
94506802|NCT01557244|323649853|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
94506803|NCT01557244|323649854|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
94506804|NCT01557244|323649855|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
94506805|NCT03312114|323649856|FG000|Overall Study|All the five enrolled dropped out of the|5|||
94506806|NCT00944645|323649857|FG000|Period 2|Adverse Event|1|||
94506807|NCT00944645|323649858|FG001|Period 2|Adverse Event|0|||
94506808|NCT00944645|323649857|FG000|Period 2|Lost to Follow-up|0|||
94506809|NCT00944645|323649858|FG001|Period 2|Lost to Follow-up|3|||
94506810|NCT00944645|323649857|FG000|Period 2|Withdrawal by Subject|7|||
94506811|NCT00944645|323649858|FG001|Period 2|Withdrawal by Subject|6|||
94506812|NCT02469961|323649859|FG000|Overall Study|Physician Decision|4|||
94506813|NCT02469961|323649860|FG001|Overall Study|Physician Decision|1|||
94506814|NCT05130281|323649861|FG000|Overall Study|Withdrawal by Subject|0|||
94506815|NCT05130281|323649862|FG001|Overall Study|Withdrawal by Subject|0|||
94506816|NCT05130281|323649863|FG002|Overall Study|Withdrawal by Subject|1|||
94506817|NCT03635996|323649869|FG000|Overall Study|Study terminated by Sponsor|94|||
94506818|NCT03635996|323649869|FG000|Overall Study|Withdrawal by Subject|20|||
94506819|NCT03635996|323649869|FG000|Overall Study|Ablation|26|||
94506820|NCT03635996|323649869|FG000|Overall Study|Adverse Event|7|||
94506821|NCT03635996|323649869|FG000|Overall Study|Physician Decision|3|||
94506822|NCT03635996|323649869|FG000|Overall Study|Prohibited medication|5|||
94506823|NCT03635996|323649869|FG000|Overall Study|Did not meet eligibility criteria|5|||
94506824|NCT03635996|323649869|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
94506825|NCT03635996|323649869|FG000|Overall Study|Protocol Violation|1|||
94506826|NCT03635996|323649869|FG000|Overall Study|Lost to Follow-up|1|||
94506827|NCT01832038|323649870|FG000|Overall Study|Death|5|||
94506828|NCT01832038|323649870|FG000|Overall Study|Adverse Event|50|||
94506829|NCT01832038|323649870|FG000|Overall Study|Lack of Efficacy|81|||
94506830|NCT01832038|323649870|FG000|Overall Study|Protocol Violation|7|||
94506831|NCT01832038|323649870|FG000|Overall Study|Lost to Follow-up|10|||
94506832|NCT01832038|323649870|FG000|Overall Study|Withdrawal by Subject|49|||
94506833|NCT01832038|323649870|FG000|Overall Study|Visit non-compliance|2|||
94506834|NCT01832038|323649870|FG000|Overall Study|Subject refused to return visit|2|||
94506835|NCT01832038|323649870|FG000|Overall Study|Not convenient to come back to site|2|||
94506836|NCT01832038|323649870|FG000|Overall Study|Participant was asked to quit|5|||
94506837|NCT01832038|323649870|FG000|Overall Study|Back home|1|||
94506838|NCT01832038|323649870|FG000|Overall Study|Pregnancy|1|||
94506839|NCT01832038|323649870|FG000|Overall Study|Low compliance|3|||
94506840|NCT01832038|323649870|FG000|Overall Study|Prohibit procedure|2|||
94506841|NCT01832038|323649870|FG000|Overall Study|Not possible to visit the hospital|1|||
94506842|NCT01832038|323649870|FG000|Overall Study|Changes of implementation system|3|||
94506843|NCT01832038|323649870|FG000|Overall Study|Plan to pregnancy|7|||
94506844|NCT01832038|323649870|FG000|Overall Study|Bad mood and has suicidal thought|1|||
94506845|NCT01832038|323649870|FG000|Overall Study|Prohibited concomitant medication|1|||
94506846|NCT01832038|323649870|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
94506847|NCT01832038|323649870|FG000|Overall Study|Subject considered the efficacy was poor|1|||
94506848|NCT00504556|323649871|FG000|Overall Study|Adverse Event|11|||
94506849|NCT00504556|323649872|FG001|Overall Study|Adverse Event|11|||
94506850|NCT00504556|323649873|FG002|Overall Study|Adverse Event|14|||
94506851|NCT00504556|323649874|FG003|Overall Study|Adverse Event|13|||
94506852|NCT00504556|323649875|FG004|Overall Study|Adverse Event|5|||
94506853|NCT00504556|323649871|FG000|Overall Study|Death|3|||
94506854|NCT00504556|323649872|FG001|Overall Study|Death|3|||
94506855|NCT00504556|323649873|FG002|Overall Study|Death|1|||
94506856|NCT00504556|323649874|FG003|Overall Study|Death|0|||
94506857|NCT00504556|323649875|FG004|Overall Study|Death|2|||
94506858|NCT00504556|323649871|FG000|Overall Study|Protocol Violation|1|||
94506859|NCT00504556|323649872|FG001|Overall Study|Protocol Violation|3|||
94506860|NCT00504556|323649873|FG002|Overall Study|Protocol Violation|2|||
94506861|NCT00504556|323649874|FG003|Overall Study|Protocol Violation|1|||
94506862|NCT00504556|323649875|FG004|Overall Study|Protocol Violation|2|||
94506863|NCT00504556|323649871|FG000|Overall Study|Lost to Follow-up|0|||
94506864|NCT00504556|323649872|FG001|Overall Study|Lost to Follow-up|0|||
94506865|NCT00504556|323649873|FG002|Overall Study|Lost to Follow-up|1|||
94506866|NCT00504556|323649874|FG003|Overall Study|Lost to Follow-up|1|||
94506867|NCT00504556|323649875|FG004|Overall Study|Lost to Follow-up|1|||
94506868|NCT00504556|323649871|FG000|Overall Study|Withdrawal by Subject|16|||
94506869|NCT00504556|323649872|FG001|Overall Study|Withdrawal by Subject|16|||
94506870|NCT00504556|323649873|FG002|Overall Study|Withdrawal by Subject|7|||
94506871|NCT00504556|323649874|FG003|Overall Study|Withdrawal by Subject|8|||
94506872|NCT00504556|323649875|FG004|Overall Study|Withdrawal by Subject|12|||
94506873|NCT00504556|323649871|FG000|Overall Study|administrative reasons|0|||
94506874|NCT00504556|323649872|FG001|Overall Study|administrative reasons|2|||
94506875|NCT00504556|323649873|FG002|Overall Study|administrative reasons|2|||
94506876|NCT00504556|323649874|FG003|Overall Study|administrative reasons|1|||
94506877|NCT00504556|323649875|FG004|Overall Study|administrative reasons|2|||
94506878|NCT00504556|323649871|FG000|Overall Study|did not meet entry criteria|2|||
94506879|NCT00504556|323649872|FG001|Overall Study|did not meet entry criteria|0|||
94506880|NCT00504556|323649873|FG002|Overall Study|did not meet entry criteria|1|||
94506881|NCT00504556|323649874|FG003|Overall Study|did not meet entry criteria|1|||
94506882|NCT00504556|323649875|FG004|Overall Study|did not meet entry criteria|0|||
94506883|NCT00504556|323649871|FG000|Overall Study|data monitor committee decision|0|||
94506884|NCT00504556|323649872|FG001|Overall Study|data monitor committee decision|0|||
94506885|NCT00504556|323649873|FG002|Overall Study|data monitor committee decision|0|||
94506886|NCT00504556|323649874|FG003|Overall Study|data monitor committee decision|100|||
94506887|NCT00504556|323649875|FG004|Overall Study|data monitor committee decision|0|||
94506888|NCT00504556|323649871|FG000|Overall Study|Other|2|||
94506889|NCT00504556|323649872|FG001|Overall Study|Other|2|||
94506890|NCT00504556|323649873|FG002|Overall Study|Other|2|||
94506891|NCT00504556|323649874|FG003|Overall Study|Other|3|||
94506892|NCT00504556|323649875|FG004|Overall Study|Other|0|||
94506893|NCT00504556|323649871|FG000|Overall Study|not in safety analysis set|0|||
94506894|NCT00504556|323649872|FG001|Overall Study|not in safety analysis set|1|||
94506895|NCT00504556|323649873|FG002|Overall Study|not in safety analysis set|1|||
94506896|NCT00504556|323649874|FG003|Overall Study|not in safety analysis set|0|||
94506897|NCT00504556|323649875|FG004|Overall Study|not in safety analysis set|1|||
94506898|NCT03048019|323649876|FG000|Overall Study|Adverse Event|1|||
94506899|NCT03048019|323649877|FG001|Overall Study|Adverse Event|0|||
94506900|NCT00862277|323649878|FG000|Overall Study|Protocol Violation|1|||
94506901|NCT00862277|323649879|FG001|Overall Study|Protocol Violation|2|||
94506902|NCT00862277|323649880|FG002|Overall Study|Protocol Violation|5|||
94506903|NCT01730729|323649881|FG000|Overall Study|Adverse Event|1|||
94506904|NCT01730729|323649881|FG000|Overall Study|Death|1|||
94506905|NCT01730729|323649881|FG000|Overall Study|Progressive Disease|12|||
94506906|NCT00871000|323649882|FG000|Overall Study|Withdrawal by Subject|1|||
94506907|NCT00871000|323649883|FG001|Overall Study|Withdrawal by Subject|0|||
94506908|NCT01052428|323649884|FG000|Overall Study|Death|1|||
94506909|NCT01052428|323649885|FG001|Overall Study|Death|0|||
94506910|NCT01052428|323649884|FG000|Overall Study|Withdrawal by Subject|0|||
94506911|NCT01052428|323649885|FG001|Overall Study|Withdrawal by Subject|1|||
94506912|NCT00382863|323649886|FG000|Overall Study|Death|9|||
94506913|NCT00382863|323649887|FG001|Overall Study|Death|9|||
94506914|NCT00382863|323649886|FG000|Overall Study|Lost to Follow-up|1|||
94506915|NCT00382863|323649887|FG001|Overall Study|Lost to Follow-up|2|||
94506916|NCT00382863|323649886|FG000|Overall Study|Withdrawal by Subject|5|||
94506917|NCT00382863|323649887|FG001|Overall Study|Withdrawal by Subject|25|||
94506918|NCT02168439|323649888|FG000|Overall Study|Protocol Violation|0|||
94506919|NCT02168439|323649889|FG001|Overall Study|Protocol Violation|2|||
94506920|NCT03400787|323649895|FG000|Overall Study|Lost to Follow-up|1|||
94506921|NCT03400787|323649896|FG001|Overall Study|Lost to Follow-up|0|||
94506922|NCT03400787|323649895|FG000|Overall Study|Death|1|||
94506923|NCT03400787|323649896|FG001|Overall Study|Death|0|||
94506924|NCT03400787|323649895|FG000|Overall Study|Protocol Violation|0|||
94506925|NCT03400787|323649896|FG001|Overall Study|Protocol Violation|2|||
94506926|NCT03400787|323649895|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
94506927|NCT03400787|323649896|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
94506928|NCT04432298|323649899|FG000|Overall Study|Other than specified|1|||
94506929|NCT04432298|323649900|FG001|Overall Study|Other than specified|0|||
94506930|NCT04432298|323649899|FG000|Overall Study|Lost to Follow-up|0|||
94506931|NCT04432298|323649900|FG001|Overall Study|Lost to Follow-up|1|||
94506932|NCT04432298|323649899|FG000|Overall Study|Death|3|||
94506933|NCT04432298|323649900|FG001|Overall Study|Death|2|||
94506934|NCT04432298|323649899|FG000|Overall Study|Withdrawal by Subject|2|||
94506935|NCT04432298|323649900|FG001|Overall Study|Withdrawal by Subject|0|||
94506936|NCT00912509|323649901|FG000|Overall Study|Lost to Follow-up|1|||
94506937|NCT00912509|323649902|FG001|Overall Study|Lost to Follow-up|0|||
94506938|NCT00912509|323649901|FG000|Overall Study|Lack of Efficacy|4|||
94506939|NCT00912509|323649902|FG001|Overall Study|Lack of Efficacy|3|||
94506940|NCT01840163|323649903|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
94506941|NCT01840163|323649904|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
94506942|NCT01840163|323649903|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
94506943|NCT01840163|323649904|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
94506944|NCT01840163|323649903|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
94506945|NCT01840163|323649904|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
94506946|NCT03596983|323649913|FG000|Overall Study|Withdrawal by Subject|3|||
94506947|NCT04818086|323649916|FG000|Overall Study|Physician Decision|1|||
94506948|NCT04818086|323649917|FG001|Overall Study|Physician Decision|0|||
94506949|NCT04818086|323649916|FG000|Overall Study|Withdrawal by Subject|0|||
94506950|NCT04818086|323649917|FG001|Overall Study|Withdrawal by Subject|1|||
94506951|NCT02181413|323649918|FG000|Overall Study|Withdrawal by Subject|45|||
94506952|NCT02181413|323649919|FG001|Overall Study|Withdrawal by Subject|61|||
94506953|NCT02181413|323649918|FG000|Overall Study|Reason Not Specified|2|||
94506954|NCT02181413|323649919|FG001|Overall Study|Reason Not Specified|5|||
94506955|NCT02181413|323649918|FG000|Overall Study|Lost to Follow-up|8|||
94506956|NCT02181413|323649919|FG001|Overall Study|Lost to Follow-up|7|||
94506957|NCT03382873|323649923|FG000|Overall Study|Lost to Follow-up|9|||
94506958|NCT03382873|323649924|FG001|Overall Study|Lost to Follow-up|10|||
94506959|NCT03382873|323649923|FG000|Overall Study|Withdrawal by Subject|6|||
94506960|NCT03382873|323649924|FG001|Overall Study|Withdrawal by Subject|11|||
94506961|NCT03382873|323649923|FG000|Overall Study|Visit not completed due to pandemic|16|||
94506962|NCT03382873|323649924|FG001|Overall Study|Visit not completed due to pandemic|41|||
94506963|NCT01887600|323649925|FG000|Overall Study|Death|39|||
94506964|NCT01887600|323649926|FG001|Overall Study|Death|16|||
94506965|NCT01887600|323649925|FG000|Overall Study|Lack of Efficacy|3|||
94506966|NCT01887600|323649926|FG001|Overall Study|Lack of Efficacy|26|||
94506967|NCT01887600|323649925|FG000|Overall Study|Lost to Follow-up|5|||
94506968|NCT01887600|323649926|FG001|Overall Study|Lost to Follow-up|1|||
94506969|NCT01887600|323649925|FG000|Overall Study|Physician Decision|7|||
94506970|NCT01887600|323649926|FG001|Overall Study|Physician Decision|8|||
94506971|NCT01887600|323649925|FG000|Overall Study|Protocol Deviation|3|||
94506972|NCT01887600|323649926|FG001|Overall Study|Protocol Deviation|0|||
94506973|NCT01887600|323649925|FG000|Overall Study|Withdrawal by Subject|58|||
94506974|NCT01887600|323649926|FG001|Overall Study|Withdrawal by Subject|52|||
94506975|NCT01887600|323649925|FG000|Overall Study|Adverse Event|21|||
94506976|NCT01887600|323649926|FG001|Overall Study|Adverse Event|9|||
94506977|NCT01887600|323649925|FG000|Overall Study|Non-compliance with study drug|3|||
94506978|NCT01887600|323649926|FG001|Overall Study|Non-compliance with study drug|0|||
94506979|NCT01887600|323649925|FG000|Overall Study|Miscellaneous|6|||
94506980|NCT01887600|323649926|FG001|Overall Study|Miscellaneous|2|||
94506981|NCT01887600|323649925|FG000|Overall Study|Progressive Disease|1|||
94506982|NCT01887600|323649926|FG001|Overall Study|Progressive Disease|0|||
94506983|NCT03688139|323649927|FG000|Overall Study|Lost to Follow-up|2|||
94506984|NCT03688139|323649928|FG001|Overall Study|Lost to Follow-up|0|||
94506985|NCT03688139|323649927|FG000|Overall Study|Physician Decision|0|||
94506986|NCT03688139|323649928|FG001|Overall Study|Physician Decision|1|||
94506987|NCT03688139|323649927|FG000|Overall Study|Withdrawal by Subject|2|||
94506988|NCT03688139|323649928|FG001|Overall Study|Withdrawal by Subject|3|||
94506989|NCT00420056|323649929|FG000|Overall Study|Objective progression or relapse|17|||
94506990|NCT03378635|323649930|FG000|Overall Study|Adverse Event|1|||
94506991|NCT03378635|323649931|FG001|Overall Study|Adverse Event|0|||
94506992|NCT03378635|323649932|FG002|Overall Study|Adverse Event|0|||
94506993|NCT03378635|323649930|FG000|Overall Study|Withdrawal by Subject|1|||
94506994|NCT03378635|323649931|FG001|Overall Study|Withdrawal by Subject|0|||
94506995|NCT03378635|323649932|FG002|Overall Study|Withdrawal by Subject|0|||
94506996|NCT02184442|323649933|FG000|Overall Study|Death|61|||
94506997|NCT02184442|323649934|FG001|Overall Study|Death|65|||
94506998|NCT02184442|323649933|FG000|Overall Study|Withdrawal by Subject|3|||
94506999|NCT02184442|323649934|FG001|Overall Study|Withdrawal by Subject|11|||
94507000|NCT01044459|323649935|FG000|Overall Study|Withdrawal by Subject|21|||
94507001|NCT01044459|323649936|FG001|Overall Study|Withdrawal by Subject|28|||
94507002|NCT01044459|323649935|FG000|Overall Study|Terminated by Sponsor|22|||
94507003|NCT01044459|323649936|FG001|Overall Study|Terminated by Sponsor|21|||
94507004|NCT01044459|323649935|FG000|Overall Study|Adverse Event|22|||
94507005|NCT01044459|323649936|FG001|Overall Study|Adverse Event|20|||
94507006|NCT01044459|323649935|FG000|Overall Study|Lack of Efficacy|23|||
94507007|NCT01044459|323649936|FG001|Overall Study|Lack of Efficacy|12|||
94507008|NCT01044459|323649935|FG000|Overall Study|Protocol Violation|11|||
94507009|NCT01044459|323649936|FG001|Overall Study|Protocol Violation|16|||
94507010|NCT01044459|323649935|FG000|Overall Study|Other Reason|7|||
94507011|NCT01044459|323649936|FG001|Overall Study|Other Reason|14|||
94507012|NCT01044459|323649935|FG000|Overall Study|COPD exacerbation|9|||
94507013|NCT01044459|323649936|FG001|Overall Study|COPD exacerbation|8|||
94507014|NCT01044459|323649935|FG000|Overall Study|Lost to Follow-up|18|||
94507015|NCT01044459|323649936|FG001|Overall Study|Lost to Follow-up|12|||
94507016|NCT02656173|323649937|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
94507017|NCT02656173|323649938|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
94507018|NCT02656173|323649937|FG000|Overall Study|Adverse Event|7|||
94507019|NCT02656173|323649938|FG001|Overall Study|Adverse Event|5|||
94507020|NCT02656173|323649937|FG000|Overall Study|Withdrawal by Subject|1|||
94507021|NCT02656173|323649938|FG001|Overall Study|Withdrawal by Subject|3|||
94507022|NCT02656173|323649937|FG000|Overall Study|Protocol Violation|0|||
94507023|NCT02656173|323649938|FG001|Overall Study|Protocol Violation|1|||
94507024|NCT02656173|323649937|FG000|Overall Study|Miscellaneous|2|||
94507025|NCT02656173|323649938|FG001|Overall Study|Miscellaneous|0|||
94507026|NCT01064622|323649939|FG000|Randomized Phase II|Withdrawal by Subject|2|||
94507027|NCT01064622|323649940|FG001|Randomized Phase II|Withdrawal by Subject|2|||
94507028|NCT01064622|323649939|FG000|Randomized Phase II|Protocol Violation|0|||
94507029|NCT01064622|323649940|FG001|Randomized Phase II|Protocol Violation|1|||
94507030|NCT04398706|323649941|FG000|Overall Study|Adverse Event|0|||
94507031|NCT04398706|323649942|FG001|Overall Study|Adverse Event|0|||
94507032|NCT04398706|323649943|FG002|Overall Study|Adverse Event|0|||
94507033|NCT04398706|323649944|FG003|Overall Study|Adverse Event|0|||
94507034|NCT04398706|323649945|FG004|Overall Study|Adverse Event|0|||
94507035|NCT04398706|323649946|FG005|Overall Study|Adverse Event|1|||
94507036|NCT04398706|323649947|FG006|Overall Study|Adverse Event|1|||
94507037|NCT04398706|323649948|FG007|Overall Study|Adverse Event|0|||
94507038|NCT04398706|323649941|FG000|Overall Study|Lost to Follow-up|0|||
94507039|NCT04398706|323649942|FG001|Overall Study|Lost to Follow-up|1|||
94507040|NCT04398706|323649943|FG002|Overall Study|Lost to Follow-up|2|||
94507041|NCT04398706|323649944|FG003|Overall Study|Lost to Follow-up|1|||
94507042|NCT04398706|323649945|FG004|Overall Study|Lost to Follow-up|6|||
94507043|NCT04398706|323649946|FG005|Overall Study|Lost to Follow-up|3|||
94507044|NCT04398706|323649947|FG006|Overall Study|Lost to Follow-up|8|||
94507045|NCT04398706|323649948|FG007|Overall Study|Lost to Follow-up|2|||
94507046|NCT04398706|323649941|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94507047|NCT04398706|323649942|FG001|Overall Study|Withdrawal by parent/guardian|2|||
94507048|NCT04398706|323649943|FG002|Overall Study|Withdrawal by parent/guardian|1|||
94507049|NCT04398706|323649944|FG003|Overall Study|Withdrawal by parent/guardian|2|||
94507050|NCT04398706|323649945|FG004|Overall Study|Withdrawal by parent/guardian|19|||
94507051|NCT04398706|323649946|FG005|Overall Study|Withdrawal by parent/guardian|23|||
94507052|NCT04398706|323649947|FG006|Overall Study|Withdrawal by parent/guardian|13|||
94507053|NCT04398706|323649948|FG007|Overall Study|Withdrawal by parent/guardian|11|||
94507054|NCT04398706|323649941|FG000|Overall Study|Protocol deviation|0|||
94507055|NCT04398706|323649942|FG001|Overall Study|Protocol deviation|1|||
94507056|NCT04398706|323649943|FG002|Overall Study|Protocol deviation|0|||
94507057|NCT04398706|323649944|FG003|Overall Study|Protocol deviation|0|||
94507058|NCT04398706|323649945|FG004|Overall Study|Protocol deviation|6|||
94507059|NCT04398706|323649946|FG005|Overall Study|Protocol deviation|4|||
94507060|NCT04398706|323649947|FG006|Overall Study|Protocol deviation|6|||
94507061|NCT04398706|323649948|FG007|Overall Study|Protocol deviation|3|||
94507062|NCT02613507|323649953|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
94507063|NCT02613507|323649954|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
94507064|NCT02613507|323649953|FG000|Pre-Treamtent|Participant withdrew consent|0|||
94507065|NCT02613507|323649954|FG001|Pre-Treamtent|Participant withdrew consent|4|||
94507066|NCT02613507|323649953|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
94507067|NCT02613507|323649954|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
94507068|NCT02613507|323649953|FG000|Treatment|Not reported|3|||
94507069|NCT02613507|323649954|FG001|Treatment|Not reported|0|||
94507070|NCT02613507|323649953|FG000|Treatment|Other reasons|8|||
94507071|NCT02613507|323649954|FG001|Treatment|Other reasons|0|||
94507072|NCT02613507|323649953|FG000|Treatment|Participant no longer meets criteria|3|||
94507073|NCT02613507|323649954|FG001|Treatment|Participant no longer meets criteria|0|||
94507074|NCT02613507|323649953|FG000|Treatment|Maximum clinical benefit|5|||
94507075|NCT02613507|323649954|FG001|Treatment|Maximum clinical benefit|10|||
94507076|NCT02613507|323649953|FG000|Treatment|Lost to Follow-up|1|||
94507077|NCT02613507|323649954|FG001|Treatment|Lost to Follow-up|0|||
94507078|NCT02613507|323649953|FG000|Treatment|Participant withdrew consent|0|||
94507079|NCT02613507|323649954|FG001|Treatment|Participant withdrew consent|2|||
94507080|NCT02613507|323649953|FG000|Treatment|Participant request to discontinue study treatment|13|||
94507081|NCT02613507|323649954|FG001|Treatment|Participant request to discontinue study treatment|17|||
94507082|NCT02613507|323649953|FG000|Treatment|Adverse event unrelated to study drug|20|||
94507083|NCT02613507|323649954|FG001|Treatment|Adverse event unrelated to study drug|3|||
94507084|NCT02613507|323649953|FG000|Treatment|Death|2|||
94507085|NCT02613507|323649954|FG001|Treatment|Death|0|||
94507086|NCT02613507|323649953|FG000|Treatment|Study drug toxicity|19|||
94507087|NCT02613507|323649954|FG001|Treatment|Study drug toxicity|14|||
94507088|NCT02613507|323649953|FG000|Treatment|Disease progression|263|||
94507089|NCT02613507|323649954|FG001|Treatment|Disease progression|110|||
94507090|NCT03359395|323649958|FG000|First Intervention A / B|Withdrawal by Subject|1|||
94507091|NCT03359395|323649959|FG001|First Intervention A / B|Withdrawal by Subject|0|||
94507092|NCT03359395|323649958|FG000|First Intervention A / B|Lost to Follow-up|2|||
94507093|NCT03359395|323649959|FG001|First Intervention A / B|Lost to Follow-up|3|||
94507094|NCT03359395|323649958|FG000|Second Intervention B/A|Exclusion criteria|0|||
94507095|NCT03359395|323649959|FG001|Second Intervention B/A|Exclusion criteria|1|||
94507096|NCT03359395|323649958|FG000|Second Intervention B/A|Lost to Follow-up|3|||
94507097|NCT03359395|323649959|FG001|Second Intervention B/A|Lost to Follow-up|2|||
94507098|NCT00908141|323649960|FG000|Overall Study|Withdrawal by Subject|0|||
94507099|NCT00908141|323649961|FG001|Overall Study|Withdrawal by Subject|1|||
94507100|NCT03882801|323651353|FG000|Period 1|Adverse Event|0|||
94507101|NCT03882801|323651354|FG001|Period 1|Adverse Event|1|||
94507102|NCT03882801|323651353|FG000|Period 1|Non-compliance with study drug|1|||
94507103|NCT03882801|323651354|FG001|Period 1|Non-compliance with study drug|1|||
94507104|NCT03882801|323651353|FG000|Period 1|Never treated with study drug|1|||
94507105|NCT03882801|323651354|FG001|Period 1|Never treated with study drug|0|||
94507106|NCT03882801|323651353|FG000|Washout Period|Physician Decision|0|||
94507107|NCT03882801|323651354|FG001|Washout Period|Physician Decision|1|||
94507108|NCT03882801|323651353|FG000|Period 2|Non-compliance with study drug|0|||
94507109|NCT03882801|323651354|FG001|Period 2|Non-compliance with study drug|1|||
94507110|NCT02014103|323651355|FG000|Overall Study|Protocol Violation|7|||
94507111|NCT02014103|323651356|FG001|Overall Study|Protocol Violation|7|||
94507112|NCT02014103|323651355|FG000|Overall Study|Adverse Event|1|||
94507113|NCT02014103|323651356|FG001|Overall Study|Adverse Event|0|||
94507114|NCT02014103|323651355|FG000|Overall Study|Lost venous access|1|||
94507115|NCT02014103|323651356|FG001|Overall Study|Lost venous access|0|||
94507116|NCT02014103|323651355|FG000|Overall Study|Withdrawal by Subject|0|||
94507117|NCT02014103|323651356|FG001|Overall Study|Withdrawal by Subject|2|||
94507118|NCT00107614|323651366|FG000|Overall Study|Physician Decision|10|||
94507119|NCT00107614|323651366|FG000|Overall Study|Death|2|||
94507120|NCT00185614|323651367|FG000|Inter-treatment Period|Physician Decision|1|||
94507121|NCT00185614|323651367|FG000|Inter-treatment Period|Relapse|2|||
94507122|NCT00185614|323651367|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
94507123|NCT01428713|323651375|FG000|Overall Study|Non-compliance|2|||
94507124|NCT01428713|323651376|FG001|Overall Study|Non-compliance|2|||
94507125|NCT01428713|323651375|FG000|Overall Study|Withdrawal by Subject|1|||
94507126|NCT01428713|323651376|FG001|Overall Study|Withdrawal by Subject|1|||
94507127|NCT01428713|323651375|FG000|Overall Study|Adverse Event|0|||
94507128|NCT01428713|323651376|FG001|Overall Study|Adverse Event|2|||
94507129|NCT03160573|323651379|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
94507130|NCT03160573|323651380|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
94507131|NCT03160573|323651381|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
94507132|NCT03160573|323651382|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
94507133|NCT00101400|323651383|FG000|Survival Follow-Up|Alive|7|||
94507134|NCT05333965|323651405|FG000|First Intervention|Adverse Event|0|||
94507135|NCT05333965|323651406|FG001|First Intervention|Adverse Event|1|||
94507136|NCT05333965|323651405|FG000|First Intervention|Withdrawal by Subject|0|||
94507137|NCT05333965|323651406|FG001|First Intervention|Withdrawal by Subject|1|||
94507138|NCT02402907|323651407|FG000|Overall Study|Delivered vaginally|9|||
94507139|NCT02402907|323651408|FG001|Overall Study|Delivered vaginally|3|||
94507140|NCT02402907|323651407|FG000|Overall Study|Delivered outside of Sinai|1|||
94507141|NCT02402907|323651408|FG001|Overall Study|Delivered outside of Sinai|1|||
94507142|NCT02402907|323651407|FG000|Overall Study|Lost to follow up after C-Section|10|||
94507143|NCT02402907|323651408|FG001|Overall Study|Lost to follow up after C-Section|23|||
94507144|NCT00203242|323651409|FG000|Overall Study|Lost to Follow-up|1|||
94507145|NCT01423084|323651412|FG000|Overall Study|Adverse Event|0|||
94507146|NCT01423084|323651413|FG001|Overall Study|Adverse Event|1|||
94507147|NCT01423084|323651412|FG000|Overall Study|Withdrawal by Subject|2|||
94507148|NCT01423084|323651413|FG001|Overall Study|Withdrawal by Subject|3|||
94507149|NCT01661595|323651414|FG000|Phase 1: Week 0-4|Adverse Event|1|||
94507150|NCT01661595|323651415|FG001|Phase 1: Week 0-4|Adverse Event|0|||
94507151|NCT01661595|323651416|FG002|Phase 1: Week 0-4|Adverse Event|0|||
94507152|NCT01661595|323651417|FG003|Phase 1: Week 0-4|Adverse Event|0|||
94507153|NCT01661595|323651414|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
94507154|NCT01661595|323651415|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
94507155|NCT01661595|323651416|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
94507156|NCT01661595|323651417|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
94507157|NCT01500135|323651418|FG000|Overall Study|Withdrawal of Consent|4|||
94507158|NCT01500135|323651419|FG001|Overall Study|Withdrawal of Consent|0|||
94507159|NCT01500135|323651418|FG000|Overall Study|Lost to Follow-up|6|||
94507160|NCT01500135|323651419|FG001|Overall Study|Lost to Follow-up|4|||
94507161|NCT01500135|323651418|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
94507162|NCT01500135|323651419|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
94507163|NCT01500135|323651418|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
94507164|NCT01500135|323651419|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
94507165|NCT01500135|323651418|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
94507166|NCT01500135|323651419|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
94507167|NCT01500135|323651418|FG000|Overall Study|Participant was a Safety Concern|1|||
94507168|NCT01500135|323651419|FG001|Overall Study|Participant was a Safety Concern|0|||
94507169|NCT01500135|323651418|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
94507170|NCT01500135|323651419|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
94507171|NCT02180672|323651420|FG000|Overall Study|Lost to Follow-up|5|||
94507172|NCT02180672|323651421|FG001|Overall Study|Lost to Follow-up|7|||
94507173|NCT03574389|323651423|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
94507174|NCT03574389|323651424|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
94507175|NCT03574389|323651425|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
94507176|NCT03574389|323651426|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
94507177|NCT03574389|323651427|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
94507178|NCT03574389|323651428|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
94507179|NCT03574389|323651429|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
94507180|NCT03574389|323651423|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
94507181|NCT03574389|323651424|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
94507182|NCT03574389|323651425|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
94507183|NCT03574389|323651426|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
94507184|NCT03574389|323651427|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
94507185|NCT03574389|323651428|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
94507186|NCT03574389|323651429|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
94507187|NCT03574389|323651423|FG000|Vaccination Period|Other|6|||
94507188|NCT03574389|323651424|FG001|Vaccination Period|Other|0|||
94507189|NCT03574389|323651425|FG002|Vaccination Period|Other|0|||
94507190|NCT03574389|323651426|FG003|Vaccination Period|Other|0|||
94507191|NCT03574389|323651427|FG004|Vaccination Period|Other|0|||
94507192|NCT03574389|323651428|FG005|Vaccination Period|Other|0|||
94507193|NCT03574389|323651429|FG006|Vaccination Period|Other|0|||
94507194|NCT03574389|323651423|FG000|Vaccination Period|Adverse Event|0|||
94507195|NCT03574389|323651424|FG001|Vaccination Period|Adverse Event|1|||
94507196|NCT03574389|323651425|FG002|Vaccination Period|Adverse Event|0|||
94507197|NCT03574389|323651426|FG003|Vaccination Period|Adverse Event|0|||
94507198|NCT03574389|323651427|FG004|Vaccination Period|Adverse Event|0|||
94507199|NCT03574389|323651428|FG005|Vaccination Period|Adverse Event|0|||
94507200|NCT03574389|323651429|FG006|Vaccination Period|Adverse Event|0|||
94507201|NCT03574389|323651423|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
94507202|NCT03574389|323651424|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
94507203|NCT03574389|323651425|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
94507204|NCT03574389|323651426|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
94507205|NCT03574389|323651427|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
94507206|NCT03574389|323651428|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
94507207|NCT03574389|323651429|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
94507208|NCT02837952|323651430|FG000|Overall Study|Adverse Event|0|||
94507209|NCT02837952|323651431|FG001|Overall Study|Adverse Event|1|||
94507210|NCT02837952|323651430|FG000|Overall Study|Withdrawal by Subject|4|||
94507211|NCT02837952|323651431|FG001|Overall Study|Withdrawal by Subject|5|||
94507212|NCT02837952|323651430|FG000|Overall Study|Medication Error|1|||
94507213|NCT02837952|323651431|FG001|Overall Study|Medication Error|0|||
94507214|NCT00836901|323651433|FG000|First Intervention|Withdrawal by Subject|1|||
94507215|NCT00836901|323651434|FG001|First Intervention|Withdrawal by Subject|0|||
94507216|NCT00595075|323651439|FG000|Overall Study|Withdrawal by Subject|1|||
94507217|NCT00595075|323651440|FG001|Overall Study|Withdrawal by Subject|0|||
94507218|NCT02633527|323651441|FG000|Overall Study|Failed to meet eligibility|0|||
94507219|NCT02633527|323651442|FG001|Overall Study|Failed to meet eligibility|1|||
94507220|NCT02633527|323651443|FG002|Overall Study|Failed to meet eligibility|1|||
94507221|NCT02633527|323651444|FG003|Overall Study|Failed to meet eligibility|0|||
94507222|NCT02633527|323651445|FG004|Overall Study|Failed to meet eligibility|1|||
94507223|NCT02633527|323651441|FG000|Overall Study|Adverse Event|0|||
94507224|NCT02633527|323651442|FG001|Overall Study|Adverse Event|4|||
94507225|NCT02633527|323651443|FG002|Overall Study|Adverse Event|3|||
94507226|NCT02633527|323651444|FG003|Overall Study|Adverse Event|1|||
94507227|NCT02633527|323651445|FG004|Overall Study|Adverse Event|5|||
94507228|NCT02633527|323651441|FG000|Overall Study|Lost to Follow-up|1|||
94507229|NCT02633527|323651442|FG001|Overall Study|Lost to Follow-up|2|||
94507230|NCT02633527|323651443|FG002|Overall Study|Lost to Follow-up|5|||
94507231|NCT02633527|323651444|FG003|Overall Study|Lost to Follow-up|5|||
94507232|NCT02633527|323651445|FG004|Overall Study|Lost to Follow-up|4|||
94507233|NCT02633527|323651441|FG000|Overall Study|Withdrawal by Subject|0|||
94507234|NCT02633527|323651442|FG001|Overall Study|Withdrawal by Subject|3|||
94507235|NCT02633527|323651443|FG002|Overall Study|Withdrawal by Subject|5|||
94507236|NCT02633527|323651444|FG003|Overall Study|Withdrawal by Subject|4|||
94507237|NCT02633527|323651445|FG004|Overall Study|Withdrawal by Subject|4|||
94507238|NCT02633527|323651441|FG000|Overall Study|Protocol Violation|0|||
94507239|NCT02633527|323651442|FG001|Overall Study|Protocol Violation|1|||
94507240|NCT02633527|323651443|FG002|Overall Study|Protocol Violation|1|||
94507241|NCT02633527|323651444|FG003|Overall Study|Protocol Violation|1|||
94507242|NCT02633527|323651445|FG004|Overall Study|Protocol Violation|1|||
94507243|NCT02633527|323651441|FG000|Overall Study|Physician Decision|0|||
94507244|NCT02633527|323651442|FG001|Overall Study|Physician Decision|0|||
94507245|NCT02633527|323651443|FG002|Overall Study|Physician Decision|0|||
94507246|NCT02633527|323651444|FG003|Overall Study|Physician Decision|0|||
94507247|NCT02633527|323651445|FG004|Overall Study|Physician Decision|1|||
94507248|NCT02633527|323651441|FG000|Overall Study|Administrative reason|1|||
94507249|NCT02633527|323651442|FG001|Overall Study|Administrative reason|0|||
94507250|NCT02633527|323651443|FG002|Overall Study|Administrative reason|0|||
94507251|NCT02633527|323651444|FG003|Overall Study|Administrative reason|1|||
94507252|NCT02633527|323651445|FG004|Overall Study|Administrative reason|0|||
94507253|NCT02633527|323651441|FG000|Overall Study|Multiple reasons|1|||
94507254|NCT02633527|323651442|FG001|Overall Study|Multiple reasons|0|||
94507255|NCT02633527|323651443|FG002|Overall Study|Multiple reasons|2|||
94507256|NCT02633527|323651444|FG003|Overall Study|Multiple reasons|2|||
94507257|NCT02633527|323651445|FG004|Overall Study|Multiple reasons|1|||
94507258|NCT04525183|323651446|FG000|Overall Study|Withdrawal by Subject|0|||
94507259|NCT04525183|323651447|FG001|Overall Study|Withdrawal by Subject|0|||
94507260|NCT04525183|323651448|FG002|Overall Study|Withdrawal by Subject|3|||
94507261|NCT04525183|323651446|FG000|Overall Study|Study non-compliance|0|||
94507262|NCT04525183|323651447|FG001|Overall Study|Study non-compliance|0|||
94507263|NCT04525183|323651448|FG002|Overall Study|Study non-compliance|1|||
94507264|NCT04525183|323651446|FG000|Overall Study|Recurrent disease before starting on study|0|||
94507265|NCT04525183|323651447|FG001|Overall Study|Recurrent disease before starting on study|0|||
94507266|NCT04525183|323651448|FG002|Overall Study|Recurrent disease before starting on study|1|||
94507267|NCT01922895|323651449|FG000|Overall Study|Death|0|||
94507268|NCT01922895|323651450|FG001|Overall Study|Death|1|||
94507269|NCT01922895|323651449|FG000|Overall Study|Withdrawal by Subject|1|||
94507270|NCT01922895|323651450|FG001|Overall Study|Withdrawal by Subject|2|||
94507271|NCT01922895|323651449|FG000|Overall Study|Lost to Follow-up|5|||
94507272|NCT01922895|323651450|FG001|Overall Study|Lost to Follow-up|11|||
94507273|NCT01335685|323651452|FG000|Overall Study|Study Terminated by Sponsor|2|||
94507274|NCT01335685|323651453|FG001|Overall Study|Study Terminated by Sponsor|1|||
94507275|NCT01335685|323651454|FG002|Overall Study|Study Terminated by Sponsor|1|||
94507276|NCT01335685|323651455|FG003|Overall Study|Study Terminated by Sponsor|10|||
94507277|NCT01335685|323651456|FG004|Overall Study|Study Terminated by Sponsor|0|||
94507278|NCT01335685|323651457|FG005|Overall Study|Study Terminated by Sponsor|4|||
94507279|NCT01335685|323651458|FG006|Overall Study|Study Terminated by Sponsor|2|||
94507280|NCT01335685|323651459|FG007|Overall Study|Study Terminated by Sponsor|3|||
94507281|NCT01335685|323651452|FG000|Overall Study|Withdrawal by Subject|1|||
94507282|NCT01335685|323651453|FG001|Overall Study|Withdrawal by Subject|0|||
94507283|NCT01335685|323651454|FG002|Overall Study|Withdrawal by Subject|0|||
94507284|NCT01335685|323651455|FG003|Overall Study|Withdrawal by Subject|1|||
94507285|NCT01335685|323651456|FG004|Overall Study|Withdrawal by Subject|0|||
94507286|NCT01335685|323651457|FG005|Overall Study|Withdrawal by Subject|0|||
94507287|NCT01335685|323651458|FG006|Overall Study|Withdrawal by Subject|0|||
94507288|NCT01335685|323651459|FG007|Overall Study|Withdrawal by Subject|0|||
94507289|NCT01335685|323651452|FG000|Overall Study|Reason not Specified|0|||
94507290|NCT01335685|323651453|FG001|Overall Study|Reason not Specified|0|||
94507291|NCT01335685|323651454|FG002|Overall Study|Reason not Specified|1|||
94507292|NCT01335685|323651455|FG003|Overall Study|Reason not Specified|0|||
94507293|NCT01335685|323651456|FG004|Overall Study|Reason not Specified|0|||
94507294|NCT01335685|323651457|FG005|Overall Study|Reason not Specified|1|||
94507295|NCT01335685|323651458|FG006|Overall Study|Reason not Specified|0|||
94507296|NCT01335685|323651459|FG007|Overall Study|Reason not Specified|0|||
94507297|NCT00489476|323651460|FG000|Overall Study|Lost to Follow-up|0|||
94507298|NCT00489476|323651461|FG001|Overall Study|Lost to Follow-up|1|||
94507299|NCT00489476|323651462|FG002|Overall Study|Lost to Follow-up|0|||
94507300|NCT00489476|323651463|FG003|Overall Study|Lost to Follow-up|0|||
94507301|NCT04003389|323651474|FG000|Overall Study|Adverse Event|27|||
94507302|NCT04003389|323651475|FG001|Overall Study|Adverse Event|34|||
94507303|NCT04003389|323651476|FG002|Overall Study|Adverse Event|28|||
94507304|NCT04003389|323651474|FG000|Overall Study|Lost to Follow-up|39|||
94507305|NCT04003389|323651475|FG001|Overall Study|Lost to Follow-up|30|||
94507306|NCT04003389|323651476|FG002|Overall Study|Lost to Follow-up|33|||
94507307|NCT04003389|323651474|FG000|Overall Study|Protocol Violation|1|||
94507308|NCT04003389|323651475|FG001|Overall Study|Protocol Violation|6|||
94507309|NCT04003389|323651476|FG002|Overall Study|Protocol Violation|5|||
94507310|NCT04003389|323651474|FG000|Overall Study|Withdrawal by Subject|119|||
94507311|NCT04003389|323651475|FG001|Overall Study|Withdrawal by Subject|79|||
94507312|NCT04003389|323651476|FG002|Overall Study|Withdrawal by Subject|85|||
94507313|NCT04003389|323651474|FG000|Overall Study|Miscellaneous|14|||
94507314|NCT04003389|323651475|FG001|Overall Study|Miscellaneous|11|||
94507315|NCT04003389|323651476|FG002|Overall Study|Miscellaneous|14|||
94507316|NCT04003389|323651474|FG000|Overall Study|Participant did not receive study drug|1|||
94507317|NCT04003389|323651475|FG001|Overall Study|Participant did not receive study drug|0|||
94507318|NCT04003389|323651476|FG002|Overall Study|Participant did not receive study drug|0|||
94507319|NCT04003142|323651480|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
94507320|NCT04003142|323651481|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
94507321|NCT04003142|323651482|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
94507322|NCT04003142|323651483|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
94507323|NCT04003142|323651484|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
94507324|NCT04003142|323651480|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
94507325|NCT04003142|323651481|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
94507326|NCT04003142|323651482|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
94507327|NCT04003142|323651483|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
94507328|NCT04003142|323651484|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
94507329|NCT04003142|323651480|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
94507330|NCT04003142|323651481|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
94507331|NCT04003142|323651482|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
94507332|NCT04003142|323651483|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
94507333|NCT04003142|323651484|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
94507334|NCT04003142|323651480|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
94507335|NCT04003142|323651481|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
94507336|NCT04003142|323651482|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
94507337|NCT04003142|323651483|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
94507338|NCT04003142|323651484|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
94507339|NCT04003142|323651480|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
94507340|NCT04003142|323651481|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
94507341|NCT04003142|323651482|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
94507342|NCT04003142|323651483|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
94507343|NCT04003142|323651484|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
94507344|NCT04003142|323651480|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
94507345|NCT04003142|323651481|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
94507346|NCT04003142|323651482|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
94507347|NCT04003142|323651483|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
94507348|NCT04003142|323651484|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
94507349|NCT04003142|323651480|FG000|Extension Period (40 Weeks)|Death|0|||
94507350|NCT04003142|323651481|FG001|Extension Period (40 Weeks)|Death|0|||
94507351|NCT04003142|323651482|FG002|Extension Period (40 Weeks)|Death|0|||
94507352|NCT04003142|323651483|FG003|Extension Period (40 Weeks)|Death|0|||
94507353|NCT04003142|323651484|FG004|Extension Period (40 Weeks)|Death|1|||
94507354|NCT04003142|323651480|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
94507355|NCT04003142|323651481|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
94507356|NCT04003142|323651482|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
94507357|NCT04003142|323651483|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
94507358|NCT04003142|323651484|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
94507359|NCT04003142|323651480|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
94507360|NCT04003142|323651481|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
94507361|NCT04003142|323651482|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
94507362|NCT04003142|323651483|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
94507363|NCT04003142|323651484|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
94507364|NCT04003142|323651480|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
94507365|NCT04003142|323651481|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
94507366|NCT04003142|323651482|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
94507367|NCT04003142|323651483|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
94507368|NCT04003142|323651484|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
94507369|NCT04003142|323651480|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
94507370|NCT04003142|323651481|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
94507371|NCT04003142|323651482|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
94507372|NCT04003142|323651483|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
94507373|NCT04003142|323651484|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
94507374|NCT01852214|323651492|FG000|Period 1|Adverse Event|1|||
94507375|NCT01852214|323651493|FG001|Period 1|Adverse Event|2|||
94507376|NCT01852214|323651492|FG000|Period 1|Withdrawal by Subject|0|||
94507377|NCT01852214|323651493|FG001|Period 1|Withdrawal by Subject|1|||
94507378|NCT01852214|323651492|FG000|Washout Period|Withdrawal by Subject|0|||
94507379|NCT01852214|323651493|FG001|Washout Period|Withdrawal by Subject|1|||
94507380|NCT04091438|323651494|FG000|Treatment Period 1 (1 Day)|Other|1|||
94507381|NCT04091438|323651495|FG001|Treatment Period 1 (1 Day)|Other|0|||
94507382|NCT04091438|323651494|FG000|Washout Period (1 Day)|Protocol deviation|0|||
94507383|NCT04091438|323651495|FG001|Washout Period (1 Day)|Protocol deviation|1|||
94507384|NCT04091438|323651494|FG000|Washout Period (1 Day)|Other|0|||
94507385|NCT04091438|323651495|FG001|Washout Period (1 Day)|Other|1|||
94507386|NCT05346640|323651496|FG000|Overall Study|Lack of Efficacy|2|||
94507387|NCT05346640|323651496|FG000|Overall Study|Lost to Follow-up|14|||
94507388|NCT05346640|323651496|FG000|Overall Study|Protocol Violation|4|||
94507389|NCT05346640|323651496|FG000|Overall Study|Withdrawal by Subject|2|||
94507390|NCT05346640|323651496|FG000|Overall Study|Physiological Complications|3|||
94507391|NCT05346640|323651496|FG000|Overall Study|Other Reason|3|||
94507392|NCT00480025|323651497|FG000|Overall Study|Protocol Violation|12|||
94507393|NCT00480025|323651498|FG001|Overall Study|Protocol Violation|7|||
94507394|NCT00480025|323651497|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
94507395|NCT00480025|323651498|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
94507396|NCT00480025|323651497|FG000|Overall Study|Disease Progression / Recurrence|449|||
94507397|NCT00480025|323651498|FG001|Overall Study|Disease Progression / Recurrence|224|||
94507398|NCT00480025|323651497|FG000|Overall Study|Adverse Event|44|||
94507399|NCT00480025|323651498|FG001|Overall Study|Adverse Event|12|||
94507400|NCT00480025|323651497|FG000|Overall Study|Other|70|||
94507401|NCT00480025|323651498|FG001|Overall Study|Other|29|||
94507402|NCT00480025|323651497|FG000|Overall Study|SAE including intercurrent illness|76|||
94507403|NCT00480025|323651498|FG001|Overall Study|SAE including intercurrent illness|42|||
94507404|NCT00787800|323651499|FG000|Overall Study|Withdrawal by Subject|3|||
94507405|NCT00787800|323651500|FG001|Overall Study|Withdrawal by Subject|5|||
94507406|NCT00787800|323651499|FG000|Overall Study|Death|0|||
94507407|NCT00787800|323651500|FG001|Overall Study|Death|2|||
94507408|NCT04309500|323651504|FG000|Overall Study|Lost to Follow-up|1|||
94507409|NCT04309500|323651505|FG001|Overall Study|Lost to Follow-up|0|||
94507410|NCT04309500|323651506|FG002|Overall Study|Lost to Follow-up|0|||
94507411|NCT04309500|323651507|FG003|Overall Study|Lost to Follow-up|0|||
94507412|NCT03164356|323651512|FG000|Overall Study|Lost to Follow-up|1|||
94507413|NCT03164356|323651513|FG001|Overall Study|Lost to Follow-up|1|||
94507414|NCT03164356|323651514|FG002|Overall Study|Lost to Follow-up|2|||
94507415|NCT03164356|323651515|FG003|Overall Study|Lost to Follow-up|1|||
94507416|NCT03164356|323651512|FG000|Overall Study|Physician Decision|0|||
94507417|NCT03164356|323651513|FG001|Overall Study|Physician Decision|0|||
94507418|NCT03164356|323651514|FG002|Overall Study|Physician Decision|3|||
94507419|NCT03164356|323651515|FG003|Overall Study|Physician Decision|0|||
94507420|NCT03164356|323651512|FG000|Overall Study|Protocol Violation|2|||
94507421|NCT03164356|323651513|FG001|Overall Study|Protocol Violation|1|||
94507422|NCT03164356|323651514|FG002|Overall Study|Protocol Violation|0|||
94507423|NCT03164356|323651515|FG003|Overall Study|Protocol Violation|0|||
94507424|NCT03164356|323651512|FG000|Overall Study|Withdrawal by Subject|1|||
94507425|NCT03164356|323651513|FG001|Overall Study|Withdrawal by Subject|0|||
94507426|NCT03164356|323651514|FG002|Overall Study|Withdrawal by Subject|0|||
94507427|NCT03164356|323651515|FG003|Overall Study|Withdrawal by Subject|0|||
94507428|NCT03164356|323651512|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
94507429|NCT03164356|323651513|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
94507430|NCT03164356|323651514|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
94507431|NCT03164356|323651515|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
94507432|NCT03164356|323651512|FG000|Overall Study|Subject Incarcerated|0|||
94507433|NCT03164356|323651513|FG001|Overall Study|Subject Incarcerated|1|||
94507434|NCT03164356|323651514|FG002|Overall Study|Subject Incarcerated|0|||
94507435|NCT03164356|323651515|FG003|Overall Study|Subject Incarcerated|0|||
94507436|NCT03164356|323651512|FG000|Overall Study|Prosthetist unable to participate|0|||
94507437|NCT03164356|323651513|FG001|Overall Study|Prosthetist unable to participate|2|||
94507438|NCT03164356|323651514|FG002|Overall Study|Prosthetist unable to participate|1|||
94507439|NCT03164356|323651515|FG003|Overall Study|Prosthetist unable to participate|0|||
94507440|NCT01654250|323652957|FG000|Overall Study|Lost to Follow-up|1|||
94507441|NCT01654250|323652958|FG001|Overall Study|Lost to Follow-up|0|||
94507442|NCT01748552|323652960|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
94507443|NCT01748552|323652961|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
94507444|NCT01748552|323652962|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
94507445|NCT01748552|323652963|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
94507446|NCT01748552|323652964|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
94507447|NCT01748552|323652965|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
94507448|NCT01748552|323652966|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
94507449|NCT01748552|323652967|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
94507450|NCT01748552|323652968|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
94507451|NCT01748552|323652969|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
94507452|NCT01748552|323652970|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
94507453|NCT01748552|323652971|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
94507454|NCT01748552|323652960|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
94507455|NCT01748552|323652961|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
94507456|NCT01748552|323652962|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
94507457|NCT01748552|323652963|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
94507458|NCT01748552|323652964|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
94507459|NCT01748552|323652965|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
94507460|NCT01748552|323652966|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
94507461|NCT01748552|323652967|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
94507462|NCT01748552|323652968|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
94507463|NCT01748552|323652969|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
94507464|NCT01748552|323652970|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
94507465|NCT01748552|323652971|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
94507466|NCT01386645|323652972|FG000|Overall Study|Physician Decision|0|||
94507467|NCT01386645|323652973|FG001|Overall Study|Physician Decision|0|||
94507468|NCT01386645|323652974|FG002|Overall Study|Physician Decision|1|||
94507469|NCT01386645|323652972|FG000|Overall Study|Withdrawal by Subject|0|||
94507470|NCT01386645|323652973|FG001|Overall Study|Withdrawal by Subject|1|||
94507471|NCT01386645|323652974|FG002|Overall Study|Withdrawal by Subject|1|||
94507472|NCT02410200|323652975|FG000|Overall Study|Adverse Event|2|||
94507473|NCT01897896|323652976|FG000|Overall Study|Death|1|||
94507474|NCT01897896|323652977|FG001|Overall Study|Death|0|||
94507475|NCT01897896|323652976|FG000|Overall Study|Adverse Event|11|||
94507476|NCT01897896|323652977|FG001|Overall Study|Adverse Event|1|||
94507477|NCT01897896|323652976|FG000|Overall Study|Lost to Follow-up|1|||
94507478|NCT01897896|323652977|FG001|Overall Study|Lost to Follow-up|0|||
94507479|NCT01897896|323652976|FG000|Overall Study|Non-compliance with study drug dosing|1|||
94507480|NCT01897896|323652977|FG001|Overall Study|Non-compliance with study drug dosing|1|||
94507481|NCT01897896|323652976|FG000|Overall Study|Withdrawal by Subject|7|||
94507482|NCT01897896|323652977|FG001|Overall Study|Withdrawal by Subject|1|||
94507483|NCT01897896|323652976|FG000|Overall Study|Require drug that interfere with study|1|||
94507484|NCT01897896|323652977|FG001|Overall Study|Require drug that interfere with study|4|||
94507485|NCT01897896|323652976|FG000|Overall Study|Protocol Violation|1|||
94507486|NCT01897896|323652977|FG001|Overall Study|Protocol Violation|1|||
94507487|NCT01897896|323652976|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
94507488|NCT01897896|323652977|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
94507489|NCT01897896|323652976|FG000|Overall Study|Caregiver can no longer participate|0|||
94507490|NCT01897896|323652977|FG001|Overall Study|Caregiver can no longer participate|2|||
94507491|NCT01897896|323652976|FG000|Overall Study|Other than specified|2|||
94507492|NCT01897896|323652977|FG001|Overall Study|Other than specified|1|||
94507493|NCT00903344|323652981|FG000|Overall Study|Pregnancy|2|||
94507494|NCT00903344|323652982|FG001|Overall Study|Pregnancy|3|||
94507495|NCT00903344|323652981|FG000|Overall Study|Lost to Follow-up|3|||
94507496|NCT00903344|323652982|FG001|Overall Study|Lost to Follow-up|0|||
94507497|NCT02144337|323652983|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
94507498|NCT02144337|323652984|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
94507499|NCT02144337|323652983|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
94507500|NCT02144337|323652984|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
94507501|NCT02144337|323652983|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
94507502|NCT02144337|323652984|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
94507503|NCT02144337|323652983|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
94507504|NCT02144337|323652984|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
94507505|NCT02144337|323652983|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
94507506|NCT02144337|323652984|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
94507507|NCT00449787|323652987|FG000|Overall Study|Lost to Follow-up|10|||
94507508|NCT00449787|323652988|FG001|Overall Study|Lost to Follow-up|8|||
94507509|NCT00449787|323652987|FG000|Overall Study|Did not require medication|95|||
94507510|NCT00449787|323652988|FG001|Overall Study|Did not require medication|92|||
94507511|NCT02336555|323652992|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
94507512|NCT02336555|323652993|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
94507513|NCT02336555|323652992|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
94507514|NCT02336555|323652993|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
94507515|NCT02336555|323652992|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
94507516|NCT02336555|323652993|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
94507517|NCT00668642|323652997|FG000|First Off-cycle|Cancer progression|1|||
94507518|NCT00668642|323652998|FG001|First Off-cycle|Cancer progression|0|||
94507519|NCT00668642|323652997|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
94507520|NCT00668642|323652998|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
94507521|NCT03412591|323652999|FG000|Overall Study|Withdrawal by Subject|1|||
94507522|NCT03412591|323653000|FG001|Overall Study|Withdrawal by Subject|8|||
94507523|NCT03412591|323652999|FG000|Overall Study|Adverse Event|0|||
94507524|NCT03412591|323653000|FG001|Overall Study|Adverse Event|1|||
94507525|NCT00889005|323653001|FG000|Overall Study|Lost to Follow-up|4|||
94507526|NCT00889005|323653002|FG001|Overall Study|Lost to Follow-up|2|||
94507527|NCT00889005|323653001|FG000|Overall Study|Withdrawal by Subject|4|||
94507528|NCT00889005|323653002|FG001|Overall Study|Withdrawal by Subject|0|||
94507529|NCT03791060|323653003|FG000|Overall Study|Withdrawal by Subject|1|||
94507530|NCT05166902|323653004|FG000|First Intervention|Lost to Follow-up|0|||
94507531|NCT05166902|323653005|FG001|First Intervention|Lost to Follow-up|1|||
94507532|NCT05345405|323653006|FG000|Overall Study|Withdrawal by Subject|2|||
94507533|NCT05345405|323653007|FG001|Overall Study|Withdrawal by Subject|0|||
94507534|NCT05345405|323653008|FG002|Overall Study|Withdrawal by Subject|0|||
94507535|NCT05345405|323653006|FG000|Overall Study|Did not meet eligibility criteria|0|||
94507536|NCT05345405|323653007|FG001|Overall Study|Did not meet eligibility criteria|2|||
94507537|NCT05345405|323653008|FG002|Overall Study|Did not meet eligibility criteria|0|||
94507538|NCT05345405|323653006|FG000|Overall Study|Lost to Follow-up|0|||
94507539|NCT05345405|323653007|FG001|Overall Study|Lost to Follow-up|0|||
94507540|NCT05345405|323653008|FG002|Overall Study|Lost to Follow-up|1|||
94507541|NCT01592747|323653009|FG000|Overall Study|Loss of Therapeutic Response|107|||
94507542|NCT01592747|323653010|FG001|Overall Study|Loss of Therapeutic Response|108|||
94507543|NCT01592747|323653011|FG002|Overall Study|Loss of Therapeutic Response|100|||
94507544|NCT01592747|323653009|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
94507545|NCT01592747|323653010|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
94507546|NCT01592747|323653011|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
94507547|NCT01592747|323653009|FG000|Overall Study|Adverse Event|1|||
94507548|NCT01592747|323653010|FG001|Overall Study|Adverse Event|0|||
94507549|NCT01592747|323653011|FG002|Overall Study|Adverse Event|0|||
94507550|NCT01592747|323653009|FG000|Overall Study|Protocol Violation|4|||
94507551|NCT01592747|323653010|FG001|Overall Study|Protocol Violation|0|||
94507552|NCT01592747|323653011|FG002|Overall Study|Protocol Violation|4|||
94507553|NCT01592747|323653009|FG000|Overall Study|Lack of Efficacy|0|||
94507554|NCT01592747|323653010|FG001|Overall Study|Lack of Efficacy|1|||
94507555|NCT01592747|323653011|FG002|Overall Study|Lack of Efficacy|0|||
94507556|NCT01592747|323653009|FG000|Overall Study|Withdrawal by Subject|2|||
94507557|NCT01592747|323653010|FG001|Overall Study|Withdrawal by Subject|0|||
94507558|NCT01592747|323653011|FG002|Overall Study|Withdrawal by Subject|2|||
94507559|NCT01592747|323653009|FG000|Overall Study|Lost to Follow-up|1|||
94507560|NCT01592747|323653010|FG001|Overall Study|Lost to Follow-up|0|||
94507561|NCT01592747|323653011|FG002|Overall Study|Lost to Follow-up|1|||
94507562|NCT01592747|323653009|FG000|Overall Study|Other Reasons|1|||
94507563|NCT01592747|323653010|FG001|Overall Study|Other Reasons|1|||
94507564|NCT01592747|323653011|FG002|Overall Study|Other Reasons|0|||
94507565|NCT02605967|323653012|FG000|Overall Study|subject / guardian decision|1|||
94507566|NCT02605967|323653013|FG001|Overall Study|subject / guardian decision|2|||
94507567|NCT02605967|323653012|FG000|Overall Study|Physician Decision|10|||
94507568|NCT02605967|323653013|FG001|Overall Study|Physician Decision|1|||
94507569|NCT02605967|323653012|FG000|Overall Study|Death|4|||
94507570|NCT02605967|323653013|FG001|Overall Study|Death|2|||
94507571|NCT02605967|323653012|FG000|Overall Study|Adverse Event|1|||
94507572|NCT02605967|323653013|FG001|Overall Study|Adverse Event|0|||
94507573|NCT02605967|323653012|FG000|Overall Study|progressive disease|66|||
94507574|NCT02605967|323653013|FG001|Overall Study|progressive disease|35|||
94507575|NCT00266032|323653014|FG000|Treatment|Adverse Event|42|||
94507576|NCT00266032|323653015|FG001|Treatment|Adverse Event|26|||
94507577|NCT00266032|323653016|FG002|Treatment|Adverse Event|10|||
94507578|NCT00266032|323653014|FG000|Treatment|Lost to Follow-up|19|||
94507579|NCT00266032|323653015|FG001|Treatment|Lost to Follow-up|4|||
94507580|NCT00266032|323653016|FG002|Treatment|Lost to Follow-up|2|||
94507581|NCT00266032|323653014|FG000|Treatment|Pregnancy|3|||
94507582|NCT00266032|323653015|FG001|Treatment|Pregnancy|2|||
94507583|NCT00266032|323653016|FG002|Treatment|Pregnancy|2|||
94507584|NCT00266032|323653014|FG000|Treatment|Protocol Violation|6|||
94507585|NCT00266032|323653015|FG001|Treatment|Protocol Violation|14|||
94507586|NCT00266032|323653016|FG002|Treatment|Protocol Violation|13|||
94507587|NCT00266032|323653014|FG000|Treatment|Withdrawal by Subject|28|||
94507588|NCT00266032|323653015|FG001|Treatment|Withdrawal by Subject|13|||
94507589|NCT00266032|323653016|FG002|Treatment|Withdrawal by Subject|12|||
94507590|NCT00266032|323653014|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
94507591|NCT00266032|323653015|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
94507592|NCT00266032|323653016|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
94507593|NCT00266032|323653014|FG000|Open-label Safety Extension|Adverse Event|5|||
94507594|NCT00266032|323653015|FG001|Open-label Safety Extension|Adverse Event|0|||
94507595|NCT00266032|323653016|FG002|Open-label Safety Extension|Adverse Event|4|||
94507596|NCT00266032|323653014|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
94507597|NCT00266032|323653015|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
94507598|NCT00266032|323653016|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
94507599|NCT00266032|323653014|FG000|Open-label Safety Extension|Pregnancy|4|||
94507600|NCT00266032|323653015|FG001|Open-label Safety Extension|Pregnancy|1|||
94507601|NCT00266032|323653016|FG002|Open-label Safety Extension|Pregnancy|2|||
94507602|NCT00266032|323653014|FG000|Open-label Safety Extension|Protocol Violation|1|||
94507603|NCT00266032|323653015|FG001|Open-label Safety Extension|Protocol Violation|3|||
94507604|NCT00266032|323653016|FG002|Open-label Safety Extension|Protocol Violation|2|||
94507605|NCT00266032|323653014|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
94507606|NCT00266032|323653015|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
94507607|NCT00266032|323653016|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
94507608|NCT00266032|323653014|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
94507609|NCT00266032|323653015|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
94507610|NCT00266032|323653016|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
94507611|NCT00814983|323653020|FG000|Overall Study|Screen failure|1|||
94507612|NCT00814983|323653021|FG001|Overall Study|Screen failure|0|||
94507613|NCT00814983|323653020|FG000|Overall Study|Withdrawal by Subject|1|||
94507614|NCT00814983|323653021|FG001|Overall Study|Withdrawal by Subject|0|||
94507615|NCT00814983|323653020|FG000|Overall Study|Graft failure|1|||
94507616|NCT00814983|323653021|FG001|Overall Study|Graft failure|0|||
94507617|NCT01475825|323653022|FG000|Overall Study|Adverse Event|41|||
94507618|NCT01475825|323653023|FG001|Overall Study|Adverse Event|15|||
94507619|NCT01475825|323653024|FG002|Overall Study|Adverse Event|27|||
94507620|NCT01475825|323653025|FG003|Overall Study|Adverse Event|11|||
94507621|NCT01475825|323653022|FG000|Overall Study|Death|1|||
94507622|NCT01475825|323653023|FG001|Overall Study|Death|0|||
94507623|NCT01475825|323653024|FG002|Overall Study|Death|1|||
94507624|NCT01475825|323653025|FG003|Overall Study|Death|0|||
94507625|NCT01475825|323653022|FG000|Overall Study|Lack of Efficacy|0|||
94507626|NCT01475825|323653023|FG001|Overall Study|Lack of Efficacy|0|||
94507627|NCT01475825|323653024|FG002|Overall Study|Lack of Efficacy|1|||
94507628|NCT01475825|323653025|FG003|Overall Study|Lack of Efficacy|0|||
94507629|NCT01475825|323653022|FG000|Overall Study|Lost to Follow-up|0|||
94507630|NCT01475825|323653023|FG001|Overall Study|Lost to Follow-up|0|||
94507631|NCT01475825|323653024|FG002|Overall Study|Lost to Follow-up|3|||
94507632|NCT01475825|323653025|FG003|Overall Study|Lost to Follow-up|1|||
94507633|NCT01475825|323653022|FG000|Overall Study|Non-compliance with Study Drug|1|||
94507634|NCT01475825|323653023|FG001|Overall Study|Non-compliance with Study Drug|2|||
94507635|NCT01475825|323653024|FG002|Overall Study|Non-compliance with Study Drug|4|||
94507636|NCT01475825|323653025|FG003|Overall Study|Non-compliance with Study Drug|0|||
94507637|NCT01475825|323653022|FG000|Overall Study|Other: Not available|0|||
94507638|NCT01475825|323653023|FG001|Overall Study|Other: Not available|0|||
94507639|NCT01475825|323653024|FG002|Overall Study|Other: Not available|2|||
94507640|NCT01475825|323653025|FG003|Overall Study|Other: Not available|0|||
94507641|NCT01475825|323653022|FG000|Overall Study|Protocol Violation|1|||
94507642|NCT01475825|323653023|FG001|Overall Study|Protocol Violation|0|||
94507643|NCT01475825|323653024|FG002|Overall Study|Protocol Violation|0|||
94507644|NCT01475825|323653025|FG003|Overall Study|Protocol Violation|0|||
94507645|NCT01475825|323653022|FG000|Overall Study|Physician Decision|0|||
94507646|NCT01475825|323653023|FG001|Overall Study|Physician Decision|1|||
94507647|NCT01475825|323653024|FG002|Overall Study|Physician Decision|0|||
94507648|NCT01475825|323653025|FG003|Overall Study|Physician Decision|0|||
94507649|NCT01475825|323653022|FG000|Overall Study|Withdrawal by Subject|8|||
94507650|NCT01475825|323653023|FG001|Overall Study|Withdrawal by Subject|3|||
94507651|NCT01475825|323653024|FG002|Overall Study|Withdrawal by Subject|11|||
94507652|NCT01475825|323653025|FG003|Overall Study|Withdrawal by Subject|7|||
94507653|NCT01475825|323653022|FG000|Overall Study|Did not enter OLC|15|||
94507654|NCT01475825|323653023|FG001|Overall Study|Did not enter OLC|11|||
94507655|NCT01475825|323653024|FG002|Overall Study|Did not enter OLC|15|||
94507656|NCT01475825|323653025|FG003|Overall Study|Did not enter OLC|11|||
94507657|NCT02244957|323653026|FG000|Overall Study|Lack of Efficacy|1|||
94507658|NCT02244957|323653027|FG001|Overall Study|Lack of Efficacy|0|||
94507659|NCT01546987|323653035|FG000|Overall Study|Protocol Violation|3|||
94507660|NCT01546987|323653036|FG001|Overall Study|Protocol Violation|4|||
94507661|NCT02771145|323653037|FG000|Overall Study|Adverse Event|3|||
94507662|NCT02771145|323653037|FG000|Overall Study|Lost to Follow-up|1|||
94507663|NCT00276380|323653038|FG000|Overall Study|Adverse Event|5|||
94507664|NCT00276380|323653039|FG001|Overall Study|Adverse Event|3|||
94507665|NCT00276380|323653038|FG000|Overall Study|Lost to Follow-up|1|||
94507666|NCT00276380|323653039|FG001|Overall Study|Lost to Follow-up|1|||
94507667|NCT00276380|323653038|FG000|Overall Study|Withdrawal by Subject|3|||
94507668|NCT00276380|323653039|FG001|Overall Study|Withdrawal by Subject|6|||
94507669|NCT00276380|323653038|FG000|Overall Study|Death|5|||
94507670|NCT00276380|323653039|FG001|Overall Study|Death|3|||
94507671|NCT00276380|323653038|FG000|Overall Study|Abnormal aPPT Levels|0|||
94507672|NCT00276380|323653039|FG001|Overall Study|Abnormal aPPT Levels|1|||
94507673|NCT02264821|323653040|FG000|Overall Study|Protocol Violation|1|||
94507674|NCT02264821|323653041|FG001|Overall Study|Protocol Violation|3|||
94507675|NCT02264821|323653042|FG002|Overall Study|Protocol Violation|6|||
94507676|NCT01689649|323653044|FG000|Overall Study|Lack of Efficacy|3|||
94507677|NCT01689649|323653044|FG000|Overall Study|Non-compliance|11|||
94507678|NCT01689649|323653044|FG000|Overall Study|Protocol Violation|3|||
94507679|NCT01689649|323653044|FG000|Overall Study|Lost to Follow-up|5|||
94507680|NCT04893811|323653045|FG000|Vaccination Phase|Death|1|||
94507681|NCT04893811|323653046|FG001|Vaccination Phase|Death|0|||
94507682|NCT04893811|323653045|FG000|Vaccination Phase|Lost to Follow-up|1|||
94507683|NCT04893811|323653046|FG001|Vaccination Phase|Lost to Follow-up|1|||
94507684|NCT04893811|323653045|FG000|Vaccination Phase|Protocol Violation|2|||
94507685|NCT04893811|323653046|FG001|Vaccination Phase|Protocol Violation|0|||
94507686|NCT04893811|323653045|FG000|Vaccination Phase|Withdrawal by Subject|2|||
94507687|NCT04893811|323653046|FG001|Vaccination Phase|Withdrawal by Subject|1|||
94507688|NCT04893811|323653045|FG000|Vaccination Phase|Other|0|||
94507689|NCT04893811|323653046|FG001|Vaccination Phase|Other|1|||
94507690|NCT04893811|323653045|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
94507691|NCT04893811|323653046|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
94507692|NCT04893811|323653045|FG000|Follow-up Phase|Lost to Follow-up|0|||
94507693|NCT04893811|323653046|FG001|Follow-up Phase|Lost to Follow-up|1|||
94507694|NCT03268499|323653047|FG000|Overall Study|Withdrawal by Subject|2|||
94507695|NCT03268499|323653048|FG001|Overall Study|Withdrawal by Subject|1|||
94507696|NCT00680914|323653054|FG000|Overall Study|Consent withdrawal|6|||
94507697|NCT00680914|323653055|FG001|Overall Study|Consent withdrawal|3|||
94507698|NCT00680914|323653054|FG000|Overall Study|Lost to Follow-up|4|||
94507699|NCT00680914|323653055|FG001|Overall Study|Lost to Follow-up|0|||
94507700|NCT00680914|323653054|FG000|Overall Study|serious adverse event (SAE)|0|||
94507701|NCT00680914|323653055|FG001|Overall Study|serious adverse event (SAE)|1|||
94507702|NCT00855166|323653056|FG000|Overall Study|Adverse Event|0|||
94507703|NCT00855166|323653057|FG001|Overall Study|Adverse Event|2|||
94507704|NCT00855166|323653056|FG000|Overall Study|Death|0|||
94507705|NCT00855166|323653057|FG001|Overall Study|Death|1|||
94507706|NCT00855166|323653056|FG000|Overall Study|Withdrawal by Subject|1|||
94507707|NCT00855166|323653057|FG001|Overall Study|Withdrawal by Subject|4|||
94507708|NCT00855166|323653056|FG000|Overall Study|Poor/non-compliance|2|||
94507709|NCT00855166|323653057|FG001|Overall Study|Poor/non-compliance|0|||
94507710|NCT00855166|323653056|FG000|Overall Study|Administrative reasons by sponsor|1|||
94507711|NCT00855166|323653057|FG001|Overall Study|Administrative reasons by sponsor|0|||
94507712|NCT00855166|323653056|FG000|Overall Study|Subject no longer meets study criteria|1|||
94507713|NCT00855166|323653057|FG001|Overall Study|Subject no longer meets study criteria|1|||
94507714|NCT03460704|323653058|FG000|Overall Study|Withdrawal by Subject|11|||
94507715|NCT03460704|323653059|FG001|Overall Study|Withdrawal by Subject|14|||
94507716|NCT03460704|323653058|FG000|Overall Study|Study terminated by the Sponsor|29|||
94507717|NCT03460704|323653059|FG001|Overall Study|Study terminated by the Sponsor|19|||
94507718|NCT03460704|323653058|FG000|Overall Study|Adverse Event|10|||
94507719|NCT03460704|323653059|FG001|Overall Study|Adverse Event|5|||
94507720|NCT03460704|323653058|FG000|Overall Study|Death|3|||
94507721|NCT03460704|323653059|FG001|Overall Study|Death|2|||
94507722|NCT03460704|323653058|FG000|Overall Study|Non-Compliance with Study Drug|3|||
94507723|NCT03460704|323653059|FG001|Overall Study|Non-Compliance with Study Drug|0|||
94507724|NCT03460704|323653058|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
94507725|NCT03460704|323653059|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
94507726|NCT03460704|323653058|FG000|Overall Study|Other|2|||
94507727|NCT03460704|323653059|FG001|Overall Study|Other|1|||
94507728|NCT01299961|323653060|FG000|Overall Study|Adverse Event|3|||
94507729|NCT01299961|323653060|FG000|Overall Study|Lack of Efficacy|2|||
94507730|NCT01299961|323653060|FG000|Overall Study|Lost to Follow-up|1|||
94507731|NCT03973489|323653066|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
94507732|NCT03973489|323653067|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
94507733|NCT03973489|323653068|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
94507734|NCT03973489|323653069|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
94507735|NCT03973489|323653070|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
94507736|NCT03973489|323653071|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
94507737|NCT03973489|323653072|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
94507738|NCT03973489|323653073|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
94507739|NCT03973489|323653066|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
94507740|NCT03973489|323653067|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
94507741|NCT03973489|323653068|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
94507742|NCT03973489|323653069|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
94507743|NCT03973489|323653070|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
94507744|NCT03973489|323653071|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
94507745|NCT03973489|323653072|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
94507746|NCT03973489|323653073|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
94507747|NCT03973489|323653066|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
94507748|NCT03973489|323653067|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
94507749|NCT03973489|323653068|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
94507750|NCT03973489|323653069|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
94507751|NCT03973489|323653070|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
94507752|NCT03973489|323653071|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
94507753|NCT03973489|323653072|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
94507754|NCT03973489|323653073|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
94507755|NCT03973489|323653066|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
94507756|NCT03973489|323653067|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
94507757|NCT03973489|323653068|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
94507758|NCT03973489|323653069|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
94507759|NCT03973489|323653070|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
94507760|NCT03973489|323653071|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
94507761|NCT03973489|323653072|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
94507762|NCT03973489|323653073|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
94507763|NCT03973489|323653066|FG000|Second Intervention (1 Day)|Adverse Event|0|||
94507764|NCT03973489|323653067|FG001|Second Intervention (1 Day)|Adverse Event|0|||
94507765|NCT03973489|323653068|FG002|Second Intervention (1 Day)|Adverse Event|0|||
94507766|NCT03973489|323653069|FG003|Second Intervention (1 Day)|Adverse Event|1|||
94507767|NCT03973489|323653070|FG004|Second Intervention (1 Day)|Adverse Event|0|||
94507768|NCT03973489|323653071|FG005|Second Intervention (1 Day)|Adverse Event|0|||
94507769|NCT03973489|323653072|FG006|Second Intervention (1 Day)|Adverse Event|0|||
94507770|NCT03973489|323653073|FG007|Second Intervention (1 Day)|Adverse Event|0|||
94507771|NCT03726879|323653078|FG000|Overall Study|Death|11|||
94507772|NCT03726879|323653079|FG001|Overall Study|Death|13|||
94507773|NCT03726879|323653078|FG000|Overall Study|Physician Decision|0|||
94507774|NCT03726879|323653079|FG001|Overall Study|Physician Decision|2|||
94507775|NCT03726879|323653078|FG000|Overall Study|Protocol Violation|0|||
94507776|NCT03726879|323653079|FG001|Overall Study|Protocol Violation|1|||
94507777|NCT03726879|323653078|FG000|Overall Study|Withdrawal by Subject|5|||
94507778|NCT03726879|323653079|FG001|Overall Study|Withdrawal by Subject|6|||
94507779|NCT03726879|323653078|FG000|Overall Study|TSH result is unstable|0|||
94507780|NCT03726879|323653079|FG001|Overall Study|TSH result is unstable|1|||
94507781|NCT03726879|323653078|FG000|Overall Study|Disease relapse|1|||
94507782|NCT03726879|323653079|FG001|Overall Study|Disease relapse|0|||
94507783|NCT03726879|323653078|FG000|Overall Study|Lost to Follow-up|3|||
94507784|NCT03726879|323653079|FG001|Overall Study|Lost to Follow-up|0|||
94507785|NCT00461812|323653081|FG000|Overall Study|study terminated|10|||
94507786|NCT02496156|323653082|FG000|Overall Study|Lost to Follow-up|5|||
94507787|NCT02496156|323653083|FG001|Overall Study|Lost to Follow-up|0|||
94507788|NCT02496156|323653082|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
94507789|NCT02496156|323653083|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
94507790|NCT03193437|323653090|FG000|Overall Study|Adverse Event|4|||
94507791|NCT03193437|323653090|FG000|Overall Study|Withdrawal by Subject|2|||
94507792|NCT03193437|323653090|FG000|Overall Study|Disease Progression|2|||
94507793|NCT03941093|323653091|FG000|Overall Study|Protocol Violation|0|||
94507794|NCT03941093|323653092|FG001|Overall Study|Protocol Violation|1|||
94507795|NCT03941093|323653091|FG000|Overall Study|Withdrawal by Subject|9|||
94507796|NCT03941093|323653092|FG001|Overall Study|Withdrawal by Subject|6|||
94507797|NCT03810495|323653093|FG000|Overall Study|Lost to Follow-up|2|||
94507798|NCT03810495|323653093|FG000|Overall Study|Withdrawal by Subject|1|||
94507799|NCT01313676|323654567|FG000|Overall Study|Adverse Event|395|||
94507800|NCT01313676|323654568|FG001|Overall Study|Adverse Event|365|||
94507801|NCT01313676|323654569|FG002|Overall Study|Adverse Event|372|||
94507802|NCT01313676|323654570|FG003|Overall Study|Adverse Event|333|||
94507803|NCT01313676|323654567|FG000|Overall Study|Lack of Efficacy|98|||
94507804|NCT01313676|323654568|FG001|Overall Study|Lack of Efficacy|90|||
94507805|NCT01313676|323654569|FG002|Overall Study|Lack of Efficacy|65|||
94507806|NCT01313676|323654570|FG003|Overall Study|Lack of Efficacy|46|||
94507807|NCT01313676|323654567|FG000|Overall Study|Protocol Violation|37|||
94507808|NCT01313676|323654568|FG001|Overall Study|Protocol Violation|44|||
94507809|NCT01313676|323654569|FG002|Overall Study|Protocol Violation|46|||
94507810|NCT01313676|323654570|FG003|Overall Study|Protocol Violation|44|||
94507811|NCT01313676|323654567|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
94507812|NCT01313676|323654568|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
94507813|NCT01313676|323654569|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
94507814|NCT01313676|323654570|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
94507815|NCT01313676|323654567|FG000|Overall Study|Study Closed/terminated|7|||
94507816|NCT01313676|323654568|FG001|Overall Study|Study Closed/terminated|6|||
94507817|NCT01313676|323654569|FG002|Overall Study|Study Closed/terminated|9|||
94507818|NCT01313676|323654570|FG003|Overall Study|Study Closed/terminated|9|||
94507819|NCT01313676|323654567|FG000|Overall Study|Lost to Follow-up|0|||
94507820|NCT01313676|323654568|FG001|Overall Study|Lost to Follow-up|0|||
94507821|NCT01313676|323654569|FG002|Overall Study|Lost to Follow-up|1|||
94507822|NCT01313676|323654570|FG003|Overall Study|Lost to Follow-up|0|||
94507823|NCT01313676|323654567|FG000|Overall Study|Physician Decision|53|||
94507824|NCT01313676|323654568|FG001|Overall Study|Physician Decision|64|||
94507825|NCT01313676|323654569|FG002|Overall Study|Physician Decision|62|||
94507826|NCT01313676|323654570|FG003|Overall Study|Physician Decision|48|||
94507827|NCT01313676|323654567|FG000|Overall Study|Decision by Participant or Proxy|643|||
94507828|NCT01313676|323654568|FG001|Overall Study|Decision by Participant or Proxy|527|||
94507829|NCT01313676|323654569|FG002|Overall Study|Decision by Participant or Proxy|515|||
94507830|NCT01313676|323654570|FG003|Overall Study|Decision by Participant or Proxy|492|||
94507831|NCT01313676|323654567|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
94507832|NCT01313676|323654568|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
94507833|NCT01313676|323654569|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
94507834|NCT01313676|323654570|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
94507835|NCT01313676|323654567|FG000|Overall Study|Investigator Site Closed|12|||
94507836|NCT01313676|323654568|FG001|Overall Study|Investigator Site Closed|11|||
94507837|NCT01313676|323654569|FG002|Overall Study|Investigator Site Closed|15|||
94507838|NCT01313676|323654570|FG003|Overall Study|Investigator Site Closed|10|||
94507839|NCT01313676|323654567|FG000|Overall Study|Missing|1|||
94507840|NCT01313676|323654568|FG001|Overall Study|Missing|1|||
94507841|NCT01313676|323654569|FG002|Overall Study|Missing|1|||
94507842|NCT01313676|323654570|FG003|Overall Study|Missing|0|||
94507843|NCT05401409|323654572|FG000|Overall Study|Lost to Follow-up|1|||
94507844|NCT05401409|323654573|FG001|Overall Study|Lost to Follow-up|0|||
94507845|NCT02933151|323654577|FG000|Overall Study|Lost to Follow-up|19|||
94507846|NCT02933151|323654578|FG001|Overall Study|Lost to Follow-up|18|||
94507847|NCT02933151|323654577|FG000|Overall Study|Death|1732|||
94507848|NCT02933151|323654578|FG001|Overall Study|Death|1827|||
94507849|NCT02933151|323654577|FG000|Overall Study|Transplant|210|||
94507850|NCT02933151|323654578|FG001|Overall Study|Transplant|278|||
94507851|NCT02933151|323654577|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
94507852|NCT02933151|323654578|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
94507853|NCT02933151|323654577|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
94507854|NCT02933151|323654578|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
94507855|NCT02933151|323654577|FG000|Overall Study|Recovered Kidney Function|47|||
94507856|NCT02933151|323654578|FG001|Overall Study|Recovered Kidney Function|29|||
94507857|NCT03211858|323654580|FG000|Overall Study|Adverse Event|8|||
94507858|NCT03211858|323654581|FG001|Overall Study|Adverse Event|6|||
94507859|NCT03211858|323654580|FG000|Overall Study|Lack of Efficacy|0|||
94507860|NCT03211858|323654581|FG001|Overall Study|Lack of Efficacy|4|||
94507861|NCT03211858|323654580|FG000|Overall Study|Poor compliance to protocol|6|||
94507862|NCT03211858|323654581|FG001|Overall Study|Poor compliance to protocol|2|||
94507863|NCT03211858|323654580|FG000|Overall Study|Non-serious Hypoglycemia|1|||
94507864|NCT03211858|323654581|FG001|Overall Study|Non-serious Hypoglycemia|0|||
94507865|NCT03211858|323654580|FG000|Overall Study|Other than specified above|22|||
94507866|NCT03211858|323654581|FG001|Overall Study|Other than specified above|21|||
94507867|NCT02462057|323654586|FG000|Overall Study|Left Vitality|32|||
94507868|NCT02462057|323654587|FG001|Overall Study|Left Vitality|27|||
94507869|NCT02462057|323654588|FG002|Overall Study|Left Vitality|23|||
94507870|NCT02462057|323654589|FG003|Overall Study|Left Vitality|35|||
94507871|NCT02462057|323654590|FG004|Overall Study|Left Vitality|33|||
94507872|NCT02462057|323654586|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
94507873|NCT02462057|323654587|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
94507874|NCT02462057|323654588|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
94507875|NCT02462057|323654589|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
94507876|NCT02462057|323654590|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
94507877|NCT00993473|323654595|FG000|Overall Study|Adverse Event|0|||
94507878|NCT00993473|323654596|FG001|Overall Study|Adverse Event|2|||
94507879|NCT00993473|323654595|FG000|Overall Study|Protocol Violation|1|||
94507880|NCT00993473|323654596|FG001|Overall Study|Protocol Violation|2|||
94507881|NCT00993473|323654595|FG000|Overall Study|Lost to Follow-up|1|||
94507882|NCT00993473|323654596|FG001|Overall Study|Lost to Follow-up|0|||
94507883|NCT00993473|323654595|FG000|Overall Study|Withdrawal by Subject|1|||
94507884|NCT00993473|323654596|FG001|Overall Study|Withdrawal by Subject|5|||
94507885|NCT00993473|323654595|FG000|Overall Study|Technical problem with CGM device|0|||
94507886|NCT00993473|323654596|FG001|Overall Study|Technical problem with CGM device|1|||
94507887|NCT00993473|323654595|FG000|Overall Study|Family event|1|||
94507888|NCT00993473|323654596|FG001|Overall Study|Family event|0|||
94507889|NCT01959919|323654597|FG000|Overall Study|Did not meet the eligibility criteria|2|||
94507890|NCT01697501|323654600|FG000|Overall Study|Protocol Violation|2|||
94507891|NCT03439072|323654606|FG000|Overall Study|Withdrawal by Subject|2|||
94507892|NCT03439072|323654607|FG001|Overall Study|Withdrawal by Subject|3|||
94507893|NCT03439072|323654606|FG000|Overall Study|Physician Decision|0|||
94507894|NCT03439072|323654607|FG001|Overall Study|Physician Decision|1|||
94507895|NCT02003898|323654608|FG000|Overall Study|Death|3|||
94507896|NCT02003898|323654608|FG000|Overall Study|Lost to Follow-up|12|||
94507897|NCT02003898|323654608|FG000|Overall Study|Withdrawal by Subject|52|||
94507898|NCT02272985|323654609|FG000|Overall Study|Withdrawal by Subject|1|||
94507899|NCT02272985|323654609|FG000|Overall Study|hip fracture|1|||
94507900|NCT02272985|323654609|FG000|Overall Study|kidney transplantation|1|||
94507901|NCT03707821|323654610|FG000|Overall Study|Protocol Violation|0|||
94507902|NCT03707821|323654611|FG001|Overall Study|Protocol Violation|1|||
94507903|NCT03707821|323654610|FG000|Overall Study|Unsatisfactory Visual Response|1|||
94507904|NCT03707821|323654611|FG001|Overall Study|Unsatisfactory Visual Response|0|||
94507905|NCT03707821|323654610|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
94507906|NCT03707821|323654611|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
94507907|NCT01437189|323654612|FG000|Overall Study|Adverse Event|3|||
94507908|NCT01437189|323654612|FG000|Overall Study|Lack of Efficacy|4|||
94507909|NCT01437189|323654612|FG000|Overall Study|Withdrawal by Subject|8|||
94507910|NCT03760081|323654613|FG000|Overall Study|Miscellaneous|0|||
94507911|NCT03760081|323654614|FG001|Overall Study|Miscellaneous|1|||
94507912|NCT03760081|323654613|FG000|Overall Study|Progressive Disease|5|||
94507913|NCT03760081|323654614|FG001|Overall Study|Progressive Disease|10|||
94507914|NCT03760081|323654613|FG000|Overall Study|Death|1|||
94507915|NCT03760081|323654614|FG001|Overall Study|Death|1|||
94507916|NCT03533491|323654615|FG000|Overall Study|Lost to Follow-up|2|||
94507917|NCT01725282|323654617|FG000|Overall Study|Adverse Event|1|||
94507918|NCT01725282|323654618|FG001|Overall Study|Adverse Event|3|||
94507919|NCT01725282|323654619|FG002|Overall Study|Adverse Event|6|||
94507920|NCT01725282|323654620|FG003|Overall Study|Adverse Event|4|||
94507921|NCT01725282|323654617|FG000|Overall Study|Exacerbation of Target Disease|1|||
94507922|NCT01725282|323654618|FG001|Overall Study|Exacerbation of Target Disease|0|||
94507923|NCT01725282|323654619|FG002|Overall Study|Exacerbation of Target Disease|0|||
94507924|NCT01725282|323654620|FG003|Overall Study|Exacerbation of Target Disease|1|||
94507925|NCT01725282|323654617|FG000|Overall Study|Met Exclusion Criteria|0|||
94507926|NCT01725282|323654618|FG001|Overall Study|Met Exclusion Criteria|0|||
94507927|NCT01725282|323654619|FG002|Overall Study|Met Exclusion Criteria|1|||
94507928|NCT01725282|323654620|FG003|Overall Study|Met Exclusion Criteria|0|||
94507929|NCT01725282|323654617|FG000|Overall Study|Study Site Withdrawal|0|||
94507930|NCT01725282|323654618|FG001|Overall Study|Study Site Withdrawal|1|||
94507931|NCT01725282|323654619|FG002|Overall Study|Study Site Withdrawal|0|||
94507932|NCT01725282|323654620|FG003|Overall Study|Study Site Withdrawal|0|||
94507933|NCT01725282|323654617|FG000|Overall Study|Withdrawal by Subject|0|||
94507934|NCT01725282|323654618|FG001|Overall Study|Withdrawal by Subject|0|||
94507935|NCT01725282|323654619|FG002|Overall Study|Withdrawal by Subject|1|||
94507936|NCT01725282|323654620|FG003|Overall Study|Withdrawal by Subject|1|||
94507937|NCT01725282|323654617|FG000|Overall Study|Lack of Efficacy|0|||
94507938|NCT01725282|323654618|FG001|Overall Study|Lack of Efficacy|1|||
94507939|NCT01725282|323654619|FG002|Overall Study|Lack of Efficacy|0|||
94507940|NCT01725282|323654620|FG003|Overall Study|Lack of Efficacy|1|||
94507941|NCT05524948|323654621|FG000|Overall Study|Withdrawal by Subject|1|||
94507942|NCT05524948|323654622|FG001|Overall Study|Withdrawal by Subject|0|||
94507943|NCT05524948|323654621|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
94507944|NCT05524948|323654622|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
94507945|NCT05418426|323654623|FG000|Overall Study|Adverse Event|0|||
94507946|NCT05418426|323654624|FG001|Overall Study|Adverse Event|1|||
94507947|NCT05418426|323654625|FG002|Overall Study|Adverse Event|0|||
94507948|NCT05418426|323654623|FG000|Overall Study|Withdrawal by Subject|0|||
94507949|NCT05418426|323654624|FG001|Overall Study|Withdrawal by Subject|1|||
94507950|NCT05418426|323654625|FG002|Overall Study|Withdrawal by Subject|0|||
94507951|NCT05418426|323654623|FG000|Overall Study|Protocol Violation|0|||
94507952|NCT05418426|323654624|FG001|Overall Study|Protocol Violation|0|||
94507953|NCT05418426|323654625|FG002|Overall Study|Protocol Violation|1|||
94507954|NCT01946880|323654626|FG000|Overall Study|Lost to Follow-up|1|||
94507955|NCT01946880|323654627|FG001|Overall Study|Lost to Follow-up|0|||
94507956|NCT01946880|323654626|FG000|Overall Study|Physician Decision|1|||
94507957|NCT01946880|323654627|FG001|Overall Study|Physician Decision|1|||
94507958|NCT01946880|323654626|FG000|Overall Study|Withdrawal by Subject|3|||
94507959|NCT01946880|323654627|FG001|Overall Study|Withdrawal by Subject|2|||
94507960|NCT01946880|323654626|FG000|Overall Study|Met Primary Endpoint|1|||
94507961|NCT01946880|323654627|FG001|Overall Study|Met Primary Endpoint|0|||
94507962|NCT01946880|323654626|FG000|Overall Study|Personal and Family Issues|1|||
94507963|NCT01946880|323654627|FG001|Overall Study|Personal and Family Issues|0|||
94507964|NCT00489359|323654629|FG000|Overall Study|Death|0|||
94507965|NCT00489359|323654630|FG001|Overall Study|Death|2|||
94507966|NCT00489359|323654629|FG000|Overall Study|Progressive Disease|5|||
94507967|NCT00489359|323654630|FG001|Overall Study|Progressive Disease|6|||
94507968|NCT00489359|323654629|FG000|Overall Study|Lost to Follow-up|1|||
94507969|NCT00489359|323654630|FG001|Overall Study|Lost to Follow-up|0|||
94507970|NCT00489359|323654629|FG000|Overall Study|Withdrawal by Subject|1|||
94507971|NCT00489359|323654630|FG001|Overall Study|Withdrawal by Subject|5|||
94507972|NCT00489359|323654629|FG000|Overall Study|Adverse Event|0|||
94507973|NCT00489359|323654630|FG001|Overall Study|Adverse Event|16|||
94507974|NCT00456365|323654633|FG000|Overall Study|Lost to Follow-up|1|||
94507975|NCT00456365|323654634|FG001|Overall Study|Lost to Follow-up|3|||
94507976|NCT00456365|323654633|FG000|Overall Study|Withdrawal by Subject|4|||
94507977|NCT00456365|323654634|FG001|Overall Study|Withdrawal by Subject|7|||
94507978|NCT00456365|323654633|FG000|Overall Study|Pregnancy|1|||
94507979|NCT00456365|323654634|FG001|Overall Study|Pregnancy|1|||
94507980|NCT00456365|323654633|FG000|Overall Study|oncologic diagnosis|1|||
94507981|NCT00456365|323654634|FG001|Overall Study|oncologic diagnosis|1|||
94507982|NCT03715829|323654635|FG000|Dose Ranging Period|Adverse Event|2|||
94507983|NCT03715829|323654636|FG001|Dose Ranging Period|Adverse Event|4|||
94507984|NCT03715829|323654637|FG002|Dose Ranging Period|Adverse Event|5|||
94507985|NCT03715829|323654638|FG003|Dose Ranging Period|Adverse Event|2|||
94507986|NCT03715829|323654639|FG004|Dose Ranging Period|Adverse Event|3|||
94507987|NCT03715829|323654640|FG005|Dose Ranging Period|Adverse Event|3|||
94507988|NCT03715829|323654641|FG006|Dose Ranging Period|Adverse Event|0|||
94507989|NCT03715829|323654642|FG007|Dose Ranging Period|Adverse Event|0|||
94507990|NCT03715829|323654643|FG008|Dose Ranging Period|Adverse Event|0|||
94507991|NCT03715829|323654644|FG009|Dose Ranging Period|Adverse Event|0|||
94507992|NCT03715829|323654645|FG010|Dose Ranging Period|Adverse Event|0|||
94507993|NCT03715829|323654635|FG000|Dose Ranging Period|Lack of Efficacy|0|||
94507994|NCT03715829|323654636|FG001|Dose Ranging Period|Lack of Efficacy|1|||
94507995|NCT03715829|323654637|FG002|Dose Ranging Period|Lack of Efficacy|0|||
94507996|NCT03715829|323654638|FG003|Dose Ranging Period|Lack of Efficacy|1|||
94507997|NCT03715829|323654639|FG004|Dose Ranging Period|Lack of Efficacy|0|||
94507998|NCT03715829|323654640|FG005|Dose Ranging Period|Lack of Efficacy|0|||
94507999|NCT03715829|323654641|FG006|Dose Ranging Period|Lack of Efficacy|0|||
94508000|NCT03715829|323654642|FG007|Dose Ranging Period|Lack of Efficacy|0|||
94508001|NCT03715829|323654643|FG008|Dose Ranging Period|Lack of Efficacy|0|||
94508002|NCT03715829|323654644|FG009|Dose Ranging Period|Lack of Efficacy|0|||
94508003|NCT03715829|323654645|FG010|Dose Ranging Period|Lack of Efficacy|0|||
94508004|NCT03715829|323654635|FG000|Dose Ranging Period|Lost to Follow-up|2|||
94508005|NCT03715829|323654636|FG001|Dose Ranging Period|Lost to Follow-up|0|||
94508006|NCT03715829|323654637|FG002|Dose Ranging Period|Lost to Follow-up|1|||
94508007|NCT03715829|323654638|FG003|Dose Ranging Period|Lost to Follow-up|1|||
94508008|NCT03715829|323654639|FG004|Dose Ranging Period|Lost to Follow-up|1|||
94508009|NCT03715829|323654640|FG005|Dose Ranging Period|Lost to Follow-up|2|||
94508010|NCT03715829|323654641|FG006|Dose Ranging Period|Lost to Follow-up|0|||
94508011|NCT03715829|323654642|FG007|Dose Ranging Period|Lost to Follow-up|0|||
94508012|NCT03715829|323654643|FG008|Dose Ranging Period|Lost to Follow-up|0|||
94508013|NCT03715829|323654644|FG009|Dose Ranging Period|Lost to Follow-up|0|||
94508014|NCT03715829|323654645|FG010|Dose Ranging Period|Lost to Follow-up|0|||
94508015|NCT03715829|323654635|FG000|Dose Ranging Period|Protocol Violation|0|||
94508016|NCT03715829|323654636|FG001|Dose Ranging Period|Protocol Violation|0|||
94508017|NCT03715829|323654637|FG002|Dose Ranging Period|Protocol Violation|0|||
94508018|NCT03715829|323654638|FG003|Dose Ranging Period|Protocol Violation|1|||
94508019|NCT03715829|323654639|FG004|Dose Ranging Period|Protocol Violation|0|||
94508020|NCT03715829|323654640|FG005|Dose Ranging Period|Protocol Violation|0|||
94508021|NCT03715829|323654641|FG006|Dose Ranging Period|Protocol Violation|0|||
94508022|NCT03715829|323654642|FG007|Dose Ranging Period|Protocol Violation|0|||
94508023|NCT03715829|323654643|FG008|Dose Ranging Period|Protocol Violation|0|||
94508024|NCT03715829|323654644|FG009|Dose Ranging Period|Protocol Violation|0|||
94508025|NCT03715829|323654645|FG010|Dose Ranging Period|Protocol Violation|0|||
94508026|NCT03715829|323654635|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
94508027|NCT03715829|323654636|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
94508028|NCT03715829|323654637|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
94508029|NCT03715829|323654638|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
94508030|NCT03715829|323654639|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
94508031|NCT03715829|323654640|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
94508032|NCT03715829|323654641|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
94508033|NCT03715829|323654642|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
94508034|NCT03715829|323654643|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
94508035|NCT03715829|323654644|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
94508036|NCT03715829|323654645|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
94508037|NCT03715829|323654635|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
94508038|NCT03715829|323654636|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
94508039|NCT03715829|323654637|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
94508040|NCT03715829|323654638|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
94508041|NCT03715829|323654639|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
94508042|NCT03715829|323654640|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
94508043|NCT03715829|323654641|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
94508044|NCT03715829|323654642|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
94508045|NCT03715829|323654643|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
94508046|NCT03715829|323654644|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
94508047|NCT03715829|323654645|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
94508048|NCT03715829|323654635|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
94508049|NCT03715829|323654636|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
94508050|NCT03715829|323654637|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
94508051|NCT03715829|323654638|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
94508052|NCT03715829|323654639|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
94508053|NCT03715829|323654640|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
94508054|NCT03715829|323654641|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
94508055|NCT03715829|323654642|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
94508056|NCT03715829|323654643|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
94508057|NCT03715829|323654644|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
94508058|NCT03715829|323654645|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
94508059|NCT03715829|323654635|FG000|Dose Ranging Period|Other|0|||
94508060|NCT03715829|323654636|FG001|Dose Ranging Period|Other|0|||
94508061|NCT03715829|323654637|FG002|Dose Ranging Period|Other|2|||
94508062|NCT03715829|323654638|FG003|Dose Ranging Period|Other|0|||
94508063|NCT03715829|323654639|FG004|Dose Ranging Period|Other|0|||
94508064|NCT03715829|323654640|FG005|Dose Ranging Period|Other|3|||
94508065|NCT03715829|323654641|FG006|Dose Ranging Period|Other|0|||
94508066|NCT03715829|323654642|FG007|Dose Ranging Period|Other|0|||
94508067|NCT03715829|323654643|FG008|Dose Ranging Period|Other|0|||
94508068|NCT03715829|323654644|FG009|Dose Ranging Period|Other|0|||
94508069|NCT03715829|323654645|FG010|Dose Ranging Period|Other|0|||
94508070|NCT03715829|323654635|FG000|Extension Period|Adverse Event|0|||
94508071|NCT03715829|323654636|FG001|Extension Period|Adverse Event|0|||
94508072|NCT03715829|323654637|FG002|Extension Period|Adverse Event|0|||
94508073|NCT03715829|323654638|FG003|Extension Period|Adverse Event|0|||
94508074|NCT03715829|323654639|FG004|Extension Period|Adverse Event|0|||
94508075|NCT03715829|323654640|FG005|Extension Period|Adverse Event|0|||
94508076|NCT03715829|323654641|FG006|Extension Period|Adverse Event|3|||
94508077|NCT03715829|323654642|FG007|Extension Period|Adverse Event|1|||
94508078|NCT03715829|323654643|FG008|Extension Period|Adverse Event|6|||
94508079|NCT03715829|323654644|FG009|Extension Period|Adverse Event|0|||
94508080|NCT03715829|323654645|FG010|Extension Period|Adverse Event|0|||
94508081|NCT03715829|323654635|FG000|Extension Period|Lack of Efficacy|0|||
94508082|NCT03715829|323654636|FG001|Extension Period|Lack of Efficacy|0|||
94508083|NCT03715829|323654637|FG002|Extension Period|Lack of Efficacy|0|||
94508084|NCT03715829|323654638|FG003|Extension Period|Lack of Efficacy|0|||
94508085|NCT03715829|323654639|FG004|Extension Period|Lack of Efficacy|0|||
94508086|NCT03715829|323654640|FG005|Extension Period|Lack of Efficacy|0|||
94508087|NCT03715829|323654641|FG006|Extension Period|Lack of Efficacy|1|||
94508088|NCT03715829|323654642|FG007|Extension Period|Lack of Efficacy|9|||
94508089|NCT03715829|323654643|FG008|Extension Period|Lack of Efficacy|2|||
94508090|NCT03715829|323654644|FG009|Extension Period|Lack of Efficacy|0|||
94508091|NCT03715829|323654645|FG010|Extension Period|Lack of Efficacy|0|||
94508092|NCT03715829|323654635|FG000|Extension Period|Lost to Follow-up|0|||
94508093|NCT03715829|323654636|FG001|Extension Period|Lost to Follow-up|0|||
94508094|NCT03715829|323654637|FG002|Extension Period|Lost to Follow-up|0|||
94508095|NCT03715829|323654638|FG003|Extension Period|Lost to Follow-up|0|||
94508096|NCT03715829|323654639|FG004|Extension Period|Lost to Follow-up|0|||
94508097|NCT03715829|323654640|FG005|Extension Period|Lost to Follow-up|0|||
94508098|NCT03715829|323654641|FG006|Extension Period|Lost to Follow-up|0|||
94508099|NCT03715829|323654642|FG007|Extension Period|Lost to Follow-up|0|||
94508100|NCT03715829|323654643|FG008|Extension Period|Lost to Follow-up|2|||
94508101|NCT03715829|323654644|FG009|Extension Period|Lost to Follow-up|0|||
94508102|NCT03715829|323654645|FG010|Extension Period|Lost to Follow-up|0|||
94508103|NCT03715829|323654635|FG000|Extension Period|Protocol Violation|0|||
94508104|NCT03715829|323654636|FG001|Extension Period|Protocol Violation|0|||
94508105|NCT03715829|323654637|FG002|Extension Period|Protocol Violation|0|||
94508106|NCT03715829|323654638|FG003|Extension Period|Protocol Violation|0|||
94508107|NCT03715829|323654639|FG004|Extension Period|Protocol Violation|0|||
94508108|NCT03715829|323654640|FG005|Extension Period|Protocol Violation|0|||
94508109|NCT03715829|323654641|FG006|Extension Period|Protocol Violation|0|||
94508110|NCT03715829|323654642|FG007|Extension Period|Protocol Violation|0|||
94508111|NCT03715829|323654643|FG008|Extension Period|Protocol Violation|1|||
94508112|NCT03715829|323654644|FG009|Extension Period|Protocol Violation|0|||
94508113|NCT03715829|323654645|FG010|Extension Period|Protocol Violation|0|||
94508114|NCT03715829|323654635|FG000|Extension Period|Withdrawal by Subject|0|||
94508115|NCT03715829|323654636|FG001|Extension Period|Withdrawal by Subject|0|||
94508116|NCT03715829|323654637|FG002|Extension Period|Withdrawal by Subject|0|||
94508117|NCT03715829|323654638|FG003|Extension Period|Withdrawal by Subject|0|||
94508118|NCT03715829|323654639|FG004|Extension Period|Withdrawal by Subject|0|||
94508119|NCT03715829|323654640|FG005|Extension Period|Withdrawal by Subject|0|||
94508120|NCT03715829|323654641|FG006|Extension Period|Withdrawal by Subject|3|||
94508121|NCT03715829|323654642|FG007|Extension Period|Withdrawal by Subject|3|||
94508122|NCT03715829|323654643|FG008|Extension Period|Withdrawal by Subject|12|||
94508123|NCT03715829|323654644|FG009|Extension Period|Withdrawal by Subject|3|||
94508124|NCT03715829|323654645|FG010|Extension Period|Withdrawal by Subject|0|||
94508125|NCT03715829|323654635|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
94508126|NCT03715829|323654636|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
94508127|NCT03715829|323654637|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
94508128|NCT03715829|323654638|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
94508129|NCT03715829|323654639|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
94508130|NCT03715829|323654640|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
94508131|NCT03715829|323654641|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
94508132|NCT03715829|323654642|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
94508133|NCT03715829|323654643|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
94508134|NCT03715829|323654644|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
94508135|NCT03715829|323654645|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
94508136|NCT03715829|323654635|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
94508137|NCT03715829|323654636|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
94508138|NCT03715829|323654637|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
94508139|NCT03715829|323654638|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
94508140|NCT03715829|323654639|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
94508141|NCT03715829|323654640|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
94508142|NCT03715829|323654641|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
94508143|NCT03715829|323654642|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
94508144|NCT03715829|323654643|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
94508145|NCT03715829|323654644|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
94508146|NCT03715829|323654645|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
94508147|NCT03715829|323654635|FG000|Extension Period|Other|0|||
94508148|NCT03715829|323654636|FG001|Extension Period|Other|0|||
94508149|NCT03715829|323654637|FG002|Extension Period|Other|0|||
94508150|NCT03715829|323654638|FG003|Extension Period|Other|0|||
94508151|NCT03715829|323654639|FG004|Extension Period|Other|0|||
94508152|NCT03715829|323654640|FG005|Extension Period|Other|0|||
94508153|NCT03715829|323654641|FG006|Extension Period|Other|1|||
94508154|NCT03715829|323654642|FG007|Extension Period|Other|2|||
94508155|NCT03715829|323654643|FG008|Extension Period|Other|4|||
94508156|NCT03715829|323654644|FG009|Extension Period|Other|0|||
94508157|NCT03715829|323654645|FG010|Extension Period|Other|0|||
94508158|NCT01903733|323654646|FG000|Overall Study|Death|23|||
94508159|NCT01903733|323654647|FG001|Overall Study|Death|54|||
94508160|NCT01903733|323654648|FG002|Overall Study|Death|30|||
94508161|NCT01903733|323654649|FG003|Overall Study|Death|98|||
94508162|NCT01903733|323654646|FG000|Overall Study|Participant refused further follow-up|35|||
94508163|NCT01903733|323654647|FG001|Overall Study|Participant refused further follow-up|38|||
94508164|NCT01903733|323654648|FG002|Overall Study|Participant refused further follow-up|13|||
94508165|NCT01903733|323654649|FG003|Overall Study|Participant refused further follow-up|9|||
94508166|NCT01903733|323654646|FG000|Overall Study|Lost to Follow-up|18|||
94508167|NCT01903733|323654647|FG001|Overall Study|Lost to Follow-up|19|||
94508168|NCT01903733|323654648|FG002|Overall Study|Lost to Follow-up|6|||
94508169|NCT01903733|323654649|FG003|Overall Study|Lost to Follow-up|9|||
94508170|NCT01903733|323654646|FG000|Overall Study|Other|10|||
94508171|NCT01903733|323654647|FG001|Overall Study|Other|15|||
94508172|NCT01903733|323654648|FG002|Overall Study|Other|12|||
94508173|NCT01903733|323654649|FG003|Overall Study|Other|3|||
94508174|NCT01903733|323654646|FG000|Overall Study|Missing|2|||
94508175|NCT01903733|323654647|FG001|Overall Study|Missing|0|||
94508176|NCT01903733|323654648|FG002|Overall Study|Missing|0|||
94508177|NCT01903733|323654649|FG003|Overall Study|Missing|0|||
94508178|NCT01903733|323654646|FG000|Overall Study|Investigator request|18|||
94508179|NCT01903733|323654647|FG001|Overall Study|Investigator request|0|||
94508180|NCT01903733|323654648|FG002|Overall Study|Investigator request|0|||
94508181|NCT01903733|323654649|FG003|Overall Study|Investigator request|0|||
94508182|NCT01714063|323654650|FG000|Overall Study|Equipment malfunction|2|||
94508183|NCT00069953|323654651|FG000|Overall Study|Protocol Violation|2|||
94508184|NCT04918771|323654660|FG000|Overall Study|Withdrawal by Subject|4|||
94508185|NCT04918771|323654661|FG001|Overall Study|Withdrawal by Subject|5|||
94508186|NCT04918771|323654660|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
94508187|NCT04918771|323654661|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
94508188|NCT02940223|323654667|FG000|Overall Study|Failed Requirement|2|||
94508189|NCT02940223|323654668|FG001|Overall Study|Failed Requirement|0|||
94508190|NCT04134936|323654671|FG000|Overall Study|Adverse Event|3|||
94508191|NCT04134936|323654672|FG001|Overall Study|Adverse Event|2|||
94508192|NCT04134936|323654671|FG000|Overall Study|Withdrawal by Subject|2|||
94508193|NCT04134936|323654672|FG001|Overall Study|Withdrawal by Subject|3|||
94508194|NCT04134936|323654671|FG000|Overall Study|Physician Decision|0|||
94508195|NCT04134936|323654672|FG001|Overall Study|Physician Decision|1|||
94508196|NCT04134936|323654671|FG000|Overall Study|Progressive disease, joined another trial|1|||
94508197|NCT04134936|323654672|FG001|Overall Study|Progressive disease, joined another trial|0|||
94508198|NCT04134936|323654671|FG000|Overall Study|Progressive disease|1|||
94508199|NCT04134936|323654672|FG001|Overall Study|Progressive disease|0|||
94508200|NCT03996395|323654674|FG000|Overall Study|Lost to Follow-up|4|||
94508201|NCT03996395|323654674|FG000|Overall Study|Withdrawal by Subject|1|||
94508202|NCT03996395|323654674|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
94508203|NCT04650893|323654675|FG000|Overall Study|Lost to Follow-up|11|||
94508204|NCT04650893|323654676|FG001|Overall Study|Lost to Follow-up|10|||
94508205|NCT04650893|323654677|FG002|Overall Study|Lost to Follow-up|11|||
94508206|NCT02691494|323654682|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
94508207|NCT02691494|323654683|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
94508208|NCT02691494|323654684|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
94508209|NCT02691494|323654682|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
94508210|NCT02691494|323654683|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
94508211|NCT02691494|323654684|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
94508212|NCT02691494|323654682|FG000|Post-Treatment Follow-Up Period|Other|2|||
94508213|NCT02691494|323654683|FG001|Post-Treatment Follow-Up Period|Other|1|||
94508214|NCT02691494|323654684|FG002|Post-Treatment Follow-Up Period|Other|1|||
94508215|NCT02691494|323654682|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
94508216|NCT02691494|323654683|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
94508217|NCT02691494|323654684|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
94508218|NCT02691494|323654682|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
94508219|NCT02691494|323654683|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
94508220|NCT02691494|323654684|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
94508221|NCT00637156|323654687|FG000|Overall Study|Withdrawal by Subject|0|||
94508222|NCT00637156|323654688|FG001|Overall Study|Withdrawal by Subject|7|||
94508223|NCT00637156|323654687|FG000|Overall Study|Death|0|||
94508224|NCT00637156|323654688|FG001|Overall Study|Death|1|||
94508225|NCT00637156|323654687|FG000|Overall Study|Lost to Follow-up|10|||
94508226|NCT00637156|323654688|FG001|Overall Study|Lost to Follow-up|16|||
94508227|NCT01308788|323654689|FG000|2-year Treatment|medication change by treating physician|4|||
94508228|NCT01308788|323654690|FG001|2-year Treatment|medication change by treating physician|11|||
94508229|NCT01385995|323654691|FG000|Period 1, 2 Months|Physician Decision|1|||
94508230|NCT01385995|323654692|FG001|Period 1, 2 Months|Physician Decision|0|||
94508231|NCT02414841|323654693|FG000|Overall Study|Withdrawal by Subject|7|||
94508232|NCT02414841|323654694|FG001|Overall Study|Withdrawal by Subject|5|||
94508233|NCT02414841|323654693|FG000|Overall Study|Lost to Follow-up|13|||
94508234|NCT02414841|323654694|FG001|Overall Study|Lost to Follow-up|6|||
94508235|NCT02414841|323654693|FG000|Overall Study|Death|17|||
94508236|NCT02414841|323654694|FG001|Overall Study|Death|14|||
94508237|NCT02414841|323654693|FG000|Overall Study|Received a Kidney Transplant|13|||
94508238|NCT02414841|323654694|FG001|Overall Study|Received a Kidney Transplant|4|||
94508239|NCT02414841|323654693|FG000|Overall Study|Randomized But Not Treated|6|||
94508240|NCT02414841|323654694|FG001|Overall Study|Randomized But Not Treated|4|||
94508241|NCT03249558|323654701|FG000|Overall Study|Lost to Follow-up|2|||
94508242|NCT03249558|323654702|FG001|Overall Study|Lost to Follow-up|1|||
94508243|NCT03249558|323654703|FG002|Overall Study|Lost to Follow-up|4|||
94508244|NCT03249558|323654701|FG000|Overall Study|Physician Decision|1|||
94508245|NCT03249558|323654702|FG001|Overall Study|Physician Decision|0|||
94508246|NCT03249558|323654703|FG002|Overall Study|Physician Decision|0|||
94508247|NCT03249558|323654701|FG000|Overall Study|Withdrawal by Subject|6|||
94508248|NCT03249558|323654702|FG001|Overall Study|Withdrawal by Subject|5|||
94508249|NCT03249558|323654703|FG002|Overall Study|Withdrawal by Subject|7|||
94508250|NCT03249558|323654701|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
94508251|NCT03249558|323654702|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
94508252|NCT03249558|323654703|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
94508253|NCT03249558|323654701|FG000|Overall Study|Protocol Violation|1|||
94508254|NCT03249558|323654702|FG001|Overall Study|Protocol Violation|1|||
94508255|NCT03249558|323654703|FG002|Overall Study|Protocol Violation|2|||
94508256|NCT03493945|323656852|FG000|Phase I Dose Escalation|Ineligible|0|||
94508257|NCT03493945|323656853|FG001|Phase I Dose Escalation|Ineligible|0|||
94508258|NCT03493945|323656854|FG002|Phase I Dose Escalation|Ineligible|1|||
94508259|NCT03493945|323656855|FG003|Phase I Dose Escalation|Ineligible|0|||
94508260|NCT03493945|323656856|FG004|Phase I Dose Escalation|Ineligible|0|||
94508261|NCT03493945|323656857|FG005|Phase I Dose Escalation|Ineligible|0|||
94508262|NCT03493945|323656858|FG006|Phase I Dose Escalation|Ineligible|0|||
94508263|NCT03493945|323656852|FG000|Phase I Dose Escalation|New therapy|0|||
94508264|NCT03493945|323656853|FG001|Phase I Dose Escalation|New therapy|1|||
94508265|NCT03493945|323656854|FG002|Phase I Dose Escalation|New therapy|0|||
94508266|NCT03493945|323656855|FG003|Phase I Dose Escalation|New therapy|0|||
94508267|NCT03493945|323656856|FG004|Phase I Dose Escalation|New therapy|0|||
94508268|NCT03493945|323656857|FG005|Phase I Dose Escalation|New therapy|0|||
94508269|NCT03493945|323656858|FG006|Phase I Dose Escalation|New therapy|0|||
94508270|NCT03493945|323656852|FG000|Phase II Dose Expansion|Refused further treatment|0|||
94508271|NCT03493945|323656853|FG001|Phase II Dose Expansion|Refused further treatment|0|||
94508272|NCT03493945|323656854|FG002|Phase II Dose Expansion|Refused further treatment|0|||
94508273|NCT03493945|323656855|FG003|Phase II Dose Expansion|Refused further treatment|0|||
94508274|NCT03493945|323656856|FG004|Phase II Dose Expansion|Refused further treatment|1|||
94508275|NCT03493945|323656857|FG005|Phase II Dose Expansion|Refused further treatment|1|||
94508276|NCT03493945|323656858|FG006|Phase II Dose Expansion|Refused further treatment|0|||
94508277|NCT03493945|323656852|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
94508278|NCT03493945|323656853|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
94508279|NCT03493945|323656854|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
94508280|NCT03493945|323656855|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
94508281|NCT03493945|323656856|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
94508282|NCT03493945|323656857|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
94508283|NCT03493945|323656858|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
94508284|NCT01926509|323656859|FG000|Overall Study|vital sign met discontinuation criteria|1|||
94508285|NCT01926509|323656860|FG001|Overall Study|vital sign met discontinuation criteria|0|||
94508286|NCT01926509|323656861|FG002|Overall Study|vital sign met discontinuation criteria|0|||
94508287|NCT01926509|323656862|FG003|Overall Study|vital sign met discontinuation criteria|0|||
94508288|NCT04115293|323656863|FG000|Overall Study|Adverse Event|0|||
94508289|NCT04115293|323656864|FG001|Overall Study|Adverse Event|2|||
94508290|NCT04115293|323656863|FG000|Overall Study|Withdrawal by Subject|2|||
94508291|NCT04115293|323656864|FG001|Overall Study|Withdrawal by Subject|1|||
94508292|NCT04115293|323656863|FG000|Overall Study|Physician Decision|1|||
94508293|NCT04115293|323656864|FG001|Overall Study|Physician Decision|0|||
94508294|NCT04115293|323656863|FG000|Overall Study|Death|1|||
94508295|NCT04115293|323656864|FG001|Overall Study|Death|1|||
94508296|NCT00661687|323656876|FG000|Overall Study|Study related symptoms and complaints|5|||
94508297|NCT00661687|323656876|FG000|Overall Study|Positive slit lamp findings|4|||
94508298|NCT00661687|323656876|FG000|Overall Study|Inability to maintain wearing schedule|3|||
94508299|NCT00661687|323656876|FG000|Overall Study|Physician Decision|1|||
94508300|NCT00661687|323656876|FG000|Overall Study|Adverse Event|2|||
94508301|NCT01682603|323656877|FG000|Overall Study|Lost to Follow-up|3|||
94508302|NCT01050218|323656878|FG000|Overall Study|Adverse Event|37|||
94508303|NCT01050218|323656878|FG000|Overall Study|Lack of Efficacy|8|||
94508304|NCT01050218|323656878|FG000|Overall Study|Protocol Violation|3|||
94508305|NCT01050218|323656878|FG000|Overall Study|Withdrawal by Subject|18|||
94508306|NCT01050218|323656878|FG000|Overall Study|Discontinued by sponsor|18|||
94508307|NCT01050218|323656878|FG000|Overall Study|Compliance|2|||
94508308|NCT01050218|323656878|FG000|Overall Study|Failed to return|7|||
94508309|NCT01050218|323656878|FG000|Overall Study|Serious Adverse Event|1|||
94508310|NCT01050218|323656878|FG000|Overall Study|Family emergency|1|||
94508311|NCT00552279|323656883|FG000|Overall Study|Adverse Event|0|||
94508312|NCT00552279|323656884|FG001|Overall Study|Adverse Event|1|||
94508313|NCT00552279|323656883|FG000|Overall Study|Withdrawal by Subject|12|||
94508314|NCT00552279|323656884|FG001|Overall Study|Withdrawal by Subject|1|||
94508315|NCT00552279|323656883|FG000|Overall Study|Lost to Follow-up|1|||
94508316|NCT00552279|323656884|FG001|Overall Study|Lost to Follow-up|0|||
94508317|NCT00552279|323656883|FG000|Overall Study|Other|1|||
94508318|NCT00552279|323656884|FG001|Overall Study|Other|1|||
94508319|NCT02150863|323656887|FG000|Overall Study|Lost to Follow-up|0|||
94508320|NCT02150863|323656888|FG001|Overall Study|Lost to Follow-up|1|||
94508321|NCT02150863|323656889|FG002|Overall Study|Lost to Follow-up|0|||
94508322|NCT01651208|323656890|FG000|Overall Study|Lost to Follow-up|14|||
94508323|NCT01651208|323656891|FG001|Overall Study|Lost to Follow-up|16|||
94508324|NCT00835549|323656900|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
94508325|NCT00835549|323656901|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
94508326|NCT03253627|323656908|FG000|Overall Study|Lost to Follow-up|1|||
94508327|NCT03253627|323656909|FG001|Overall Study|Lost to Follow-up|2|||
94508328|NCT03253627|323656908|FG000|Overall Study|Withdrawal by Subject|0|||
94508329|NCT03253627|323656909|FG001|Overall Study|Withdrawal by Subject|2|||
94508330|NCT03253627|323656908|FG000|Overall Study|Inability to complete MRI|1|||
94508331|NCT03253627|323656909|FG001|Overall Study|Inability to complete MRI|0|||
94508332|NCT00979407|323656921|FG000|Overall Study|Withdrawal by Subject|3|||
94508333|NCT00979407|323656922|FG001|Overall Study|Withdrawal by Subject|4|||
94508334|NCT00979407|323656921|FG000|Overall Study|Lost to Follow-up|3|||
94508335|NCT00979407|323656922|FG001|Overall Study|Lost to Follow-up|3|||
94508336|NCT01166646|323656923|FG000|Overall Study|Protocol Violation|0|||
94508337|NCT01166646|323656924|FG001|Overall Study|Protocol Violation|1|||
94508338|NCT01166646|323656923|FG000|Overall Study|Adverse Event|1|||
94508339|NCT01166646|323656924|FG001|Overall Study|Adverse Event|0|||
94508340|NCT02420314|323656925|FG000|Overall Study|Withdrawal by Subject|1|||
94508341|NCT02420314|323656925|FG000|Overall Study|Protocol Violation|1|||
94508342|NCT02251041|323656926|FG000|Overall Study|Did not receive intervention|15|||
94508343|NCT02251041|323656927|FG001|Overall Study|Did not receive intervention|4|||
94508344|NCT05430919|323656928|FG000|Overall Study|Protocol Violation|0|||
94508345|NCT05430919|323656929|FG001|Overall Study|Protocol Violation|0|||
94508346|NCT05430919|323656930|FG002|Overall Study|Protocol Violation|1|||
94508347|NCT05430919|323656931|FG003|Overall Study|Protocol Violation|0|||
94508348|NCT05430919|323656928|FG000|Overall Study|Lost to Follow-up|0|||
94508349|NCT05430919|323656929|FG001|Overall Study|Lost to Follow-up|1|||
94508350|NCT05430919|323656930|FG002|Overall Study|Lost to Follow-up|0|||
94508351|NCT05430919|323656931|FG003|Overall Study|Lost to Follow-up|0|||
94508352|NCT05430919|323656928|FG000|Overall Study|Withdrawal by Subject|3|||
94508353|NCT05430919|323656929|FG001|Overall Study|Withdrawal by Subject|0|||
94508354|NCT05430919|323656930|FG002|Overall Study|Withdrawal by Subject|0|||
94508355|NCT05430919|323656931|FG003|Overall Study|Withdrawal by Subject|1|||
94508356|NCT01848457|323656943|FG000|Overall Study|Death|1|||
94508357|NCT01848457|323656944|FG001|Overall Study|Death|0|||
94508358|NCT01848457|323656945|FG002|Overall Study|Death|0|||
94508359|NCT01848457|323656946|FG003|Overall Study|Death|0|||
94508360|NCT03777020|323656947|FG000|Overall Study|Withdrawal by Subject|4|||
94508361|NCT03777020|323656948|FG001|Overall Study|Withdrawal by Subject|4|||
94508362|NCT03777020|323656947|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
94508363|NCT03777020|323656948|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
94508364|NCT02904096|323656949|FG000|Overall Study|Adverse Event|1|||
94508365|NCT02904096|323656950|FG001|Overall Study|Adverse Event|0|||
94508366|NCT02904096|323656949|FG000|Overall Study|Withdrawal by Subject|4|||
94508367|NCT02904096|323656950|FG001|Overall Study|Withdrawal by Subject|3|||
94508368|NCT02904096|323656949|FG000|Overall Study|Lost to Follow-up|10|||
94508369|NCT02904096|323656950|FG001|Overall Study|Lost to Follow-up|17|||
94508370|NCT02904096|323656949|FG000|Overall Study|Non-compliant|3|||
94508371|NCT02904096|323656950|FG001|Overall Study|Non-compliant|1|||
94508372|NCT02904096|323656949|FG000|Overall Study|Sponsor instructed|1|||
94508373|NCT02904096|323656950|FG001|Overall Study|Sponsor instructed|0|||
94508374|NCT02913326|323656955|FG000|Overall Study|Reason not listed|0|||
94508375|NCT02913326|323656956|FG001|Overall Study|Reason not listed|1|||
94508376|NCT02913326|323656955|FG000|Overall Study|Lost to Follow-up|0|||
94508377|NCT02913326|323656956|FG001|Overall Study|Lost to Follow-up|1|||
94508378|NCT02913326|323656955|FG000|Overall Study|Adverse Event|1|||
94508379|NCT02913326|323656956|FG001|Overall Study|Adverse Event|0|||
94508380|NCT00803049|323656957|FG000|Overall Study|Adverse Event|21|||
94508381|NCT00803049|323656958|FG001|Overall Study|Adverse Event|33|||
94508382|NCT00803049|323656959|FG002|Overall Study|Adverse Event|13|||
94508383|NCT00803049|323656960|FG003|Overall Study|Adverse Event|27|||
94508384|NCT00803049|323656957|FG000|Overall Study|Lack of Efficacy|10|||
94508385|NCT00803049|323656958|FG001|Overall Study|Lack of Efficacy|19|||
94508386|NCT00803049|323656959|FG002|Overall Study|Lack of Efficacy|6|||
94508387|NCT00803049|323656960|FG003|Overall Study|Lack of Efficacy|13|||
94508388|NCT00803049|323656957|FG000|Overall Study|Lost to Follow-up|0|||
94508389|NCT00803049|323656958|FG001|Overall Study|Lost to Follow-up|2|||
94508390|NCT00803049|323656959|FG002|Overall Study|Lost to Follow-up|0|||
94508391|NCT00803049|323656960|FG003|Overall Study|Lost to Follow-up|3|||
94508392|NCT00803049|323656957|FG000|Overall Study|Death|2|||
94508393|NCT00803049|323656958|FG001|Overall Study|Death|1|||
94508394|NCT00803049|323656959|FG002|Overall Study|Death|0|||
94508395|NCT00803049|323656960|FG003|Overall Study|Death|2|||
94508396|NCT00803049|323656957|FG000|Overall Study|Progressive Disease|6|||
94508397|NCT00803049|323656958|FG001|Overall Study|Progressive Disease|10|||
94508398|NCT00803049|323656959|FG002|Overall Study|Progressive Disease|6|||
94508399|NCT00803049|323656960|FG003|Overall Study|Progressive Disease|6|||
94508400|NCT00803049|323656957|FG000|Overall Study|Withdrawal by Subject|19|||
94508401|NCT00803049|323656958|FG001|Overall Study|Withdrawal by Subject|43|||
94508402|NCT00803049|323656959|FG002|Overall Study|Withdrawal by Subject|16|||
94508403|NCT00803049|323656960|FG003|Overall Study|Withdrawal by Subject|44|||
94508404|NCT00803049|323656957|FG000|Overall Study|Protocol Violation|0|||
94508405|NCT00803049|323656958|FG001|Overall Study|Protocol Violation|1|||
94508406|NCT00803049|323656959|FG002|Overall Study|Protocol Violation|1|||
94508407|NCT00803049|323656960|FG003|Overall Study|Protocol Violation|0|||
94508408|NCT00803049|323656957|FG000|Overall Study|Randomized and Not Treated|0|||
94508409|NCT00803049|323656958|FG001|Overall Study|Randomized and Not Treated|0|||
94508410|NCT00803049|323656959|FG002|Overall Study|Randomized and Not Treated|0|||
94508411|NCT00803049|323656960|FG003|Overall Study|Randomized and Not Treated|2|||
94508412|NCT00803049|323656957|FG000|Overall Study|Other than Specified Above|3|||
94508413|NCT00803049|323656958|FG001|Overall Study|Other than Specified Above|9|||
94508414|NCT00803049|323656959|FG002|Overall Study|Other than Specified Above|2|||
94508415|NCT00803049|323656960|FG003|Overall Study|Other than Specified Above|5|||
94508416|NCT01421459|323656961|FG000|Overall Study|Adverse Event|6|||
94508417|NCT01421459|323656962|FG001|Overall Study|Adverse Event|10|||
94508418|NCT01421459|323656961|FG000|Overall Study|Death|1|||
94508419|NCT01421459|323656962|FG001|Overall Study|Death|1|||
94508420|NCT01421459|323656961|FG000|Overall Study|Lack of Efficacy|1|||
94508421|NCT01421459|323656962|FG001|Overall Study|Lack of Efficacy|2|||
94508422|NCT01421459|323656961|FG000|Overall Study|Lost to Follow-up|8|||
94508423|NCT01421459|323656962|FG001|Overall Study|Lost to Follow-up|9|||
94508424|NCT01421459|323656961|FG000|Overall Study|Physician Decision|9|||
94508425|NCT01421459|323656962|FG001|Overall Study|Physician Decision|9|||
94508426|NCT01421459|323656961|FG000|Overall Study|Protocol Violation|8|||
94508427|NCT01421459|323656962|FG001|Overall Study|Protocol Violation|5|||
94508428|NCT01421459|323656961|FG000|Overall Study|Withdrawal by Subject|12|||
94508429|NCT01421459|323656962|FG001|Overall Study|Withdrawal by Subject|16|||
94508430|NCT01514422|323656963|FG000|Overall Study|Lost to Follow-up|1|||
94508431|NCT01422382|323656966|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
94508432|NCT02899754|323656967|FG000|Overall Study|Lost to Follow-up|7|||
94508433|NCT02899754|323656968|FG001|Overall Study|Lost to Follow-up|9|||
94508434|NCT03186378|323656971|FG000|Overall Study|Lost to Follow-up|1|||
94508435|NCT03186378|323656972|FG001|Overall Study|Lost to Follow-up|0|||
94508436|NCT00050011|323656974|FG000|Overall Study|Adverse Event|41|||
94508437|NCT00050011|323656975|FG001|Overall Study|Adverse Event|46|||
94508438|NCT00050011|323656974|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94508439|NCT00050011|323656975|FG001|Overall Study|Abnormal laboratory value(s)|1|||
94508440|NCT00050011|323656974|FG000|Overall Study|Abnormal test procedure results|0|||
94508441|NCT00050011|323656975|FG001|Overall Study|Abnormal test procedure results|1|||
94508442|NCT00050011|323656974|FG000|Overall Study|Lack of Efficacy|16|||
94508443|NCT00050011|323656975|FG001|Overall Study|Lack of Efficacy|21|||
94508444|NCT00050011|323656974|FG000|Overall Study|Participant condition no longer required|1|||
94508445|NCT00050011|323656975|FG001|Overall Study|Participant condition no longer required|0|||
94508446|NCT00050011|323656974|FG000|Overall Study|Protocol Violation|4|||
94508447|NCT00050011|323656975|FG001|Overall Study|Protocol Violation|10|||
94508448|NCT00050011|323656974|FG000|Overall Study|Withdrawal by Subject|34|||
94508449|NCT00050011|323656975|FG001|Overall Study|Withdrawal by Subject|26|||
94508450|NCT00050011|323656974|FG000|Overall Study|Lost to Follow-up|7|||
94508451|NCT00050011|323656975|FG001|Overall Study|Lost to Follow-up|9|||
94508452|NCT00050011|323656974|FG000|Overall Study|Administrative problems|10|||
94508453|NCT00050011|323656975|FG001|Overall Study|Administrative problems|6|||
94508454|NCT00050011|323656974|FG000|Overall Study|Death|7|||
94508455|NCT00050011|323656975|FG001|Overall Study|Death|4|||
94508456|NCT00050011|323656974|FG000|Overall Study|Unknown - Reason is missing|0|||
94508457|NCT00050011|323656975|FG001|Overall Study|Unknown - Reason is missing|2|||
94508458|NCT04903093|323656980|FG000|Overall Study|Withdrawal by Subject|0|||
94508459|NCT04903093|323656981|FG001|Overall Study|Withdrawal by Subject|0|||
94508460|NCT04903093|323656982|FG002|Overall Study|Withdrawal by Subject|0|||
94508461|NCT04903093|323656983|FG003|Overall Study|Withdrawal by Subject|1|||
94508462|NCT04903093|323656984|FG004|Overall Study|Withdrawal by Subject|0|||
94508463|NCT04903093|323656985|FG005|Overall Study|Withdrawal by Subject|0|||
94508464|NCT03301415|323656986|FG000|Overall Study|Lost to Follow-up|2|||
94508465|NCT03301415|323656986|FG000|Overall Study|Unable to comply with visit schedule|2|||
94508466|NCT01346592|323656990|FG000|Overall Study|Lost to Follow-up|62|||
94508467|NCT01346592|323656991|FG001|Overall Study|Lost to Follow-up|29|||
94508468|NCT01346592|323656992|FG002|Overall Study|Lost to Follow-up|29|||
94508469|NCT01346592|323656990|FG000|Overall Study|Protocol Violation|2|||
94508470|NCT01346592|323656991|FG001|Overall Study|Protocol Violation|1|||
94508471|NCT01346592|323656992|FG002|Overall Study|Protocol Violation|0|||
94508472|NCT01346592|323656990|FG000|Overall Study|Death|1|||
94508473|NCT01346592|323656991|FG001|Overall Study|Death|3|||
94508474|NCT01346592|323656992|FG002|Overall Study|Death|4|||
94508475|NCT01346592|323656990|FG000|Overall Study|Adverse Event|0|||
94508476|NCT01346592|323656991|FG001|Overall Study|Adverse Event|1|||
94508477|NCT01346592|323656992|FG002|Overall Study|Adverse Event|0|||
94508478|NCT01346592|323656990|FG000|Overall Study|Withdrawal by Subject|77|||
94508479|NCT01346592|323656991|FG001|Overall Study|Withdrawal by Subject|51|||
94508480|NCT01346592|323656992|FG002|Overall Study|Withdrawal by Subject|38|||
94508481|NCT01346592|323656990|FG000|Overall Study|Inappropriate enrollment|3|||
94508482|NCT01346592|323656991|FG001|Overall Study|Inappropriate enrollment|1|||
94508483|NCT01346592|323656992|FG002|Overall Study|Inappropriate enrollment|1|||
94508484|NCT01346592|323656990|FG000|Overall Study|Administrative reason|1|||
94508485|NCT01346592|323656991|FG001|Overall Study|Administrative reason|0|||
94508486|NCT01346592|323656992|FG002|Overall Study|Administrative reason|0|||
94508487|NCT01346592|323656990|FG000|Overall Study|Unable to Classify|7|||
94508488|NCT01346592|323656991|FG001|Overall Study|Unable to Classify|3|||
94508489|NCT01346592|323656992|FG002|Overall Study|Unable to Classify|6|||
94508490|NCT00773461|323656993|FG000|Overall Study|Adverse Event|1|||
94508491|NCT00773461|323656994|FG001|Overall Study|Adverse Event|3|||
94508492|NCT00773461|323656993|FG000|Overall Study|Withdrawal by Subject|4|||
94508493|NCT00773461|323656994|FG001|Overall Study|Withdrawal by Subject|1|||
94508494|NCT00112385|323656996|FG000|Overall Study|Lost to Follow-up|1|||
94508495|NCT00112385|323656997|FG001|Overall Study|Lost to Follow-up|0|||
94508496|NCT00112385|323656996|FG000|Overall Study|Withdrawal by Subject|0|||
94508497|NCT00112385|323656997|FG001|Overall Study|Withdrawal by Subject|1|||
94508498|NCT00964678|323657005|FG000|Overall Study|Physician Decision|4|||
94508499|NCT00561821|323657006|FG000|Overall Study|Not treated|0|||
94508500|NCT00561821|323657007|FG001|Overall Study|Not treated|0|||
94508501|NCT00561821|323657008|FG002|Overall Study|Not treated|1|||
94508502|NCT00561821|323657009|FG003|Overall Study|Not treated|0|||
94508503|NCT00561821|323657006|FG000|Overall Study|Withdrawal by Subject|0|||
94508504|NCT00561821|323657007|FG001|Overall Study|Withdrawal by Subject|1|||
94508505|NCT00561821|323657008|FG002|Overall Study|Withdrawal by Subject|0|||
94508506|NCT00561821|323657009|FG003|Overall Study|Withdrawal by Subject|2|||
94508507|NCT00561821|323657006|FG000|Overall Study|Reasons not related to trial|2|||
94508508|NCT00561821|323657007|FG001|Overall Study|Reasons not related to trial|1|||
94508509|NCT00561821|323657008|FG002|Overall Study|Reasons not related to trial|0|||
94508510|NCT00561821|323657009|FG003|Overall Study|Reasons not related to trial|0|||
94508511|NCT00561821|323657006|FG000|Overall Study|Other (reason not specified)|1|||
94508512|NCT00561821|323657007|FG001|Overall Study|Other (reason not specified)|1|||
94508513|NCT00561821|323657008|FG002|Overall Study|Other (reason not specified)|0|||
94508514|NCT00561821|323657009|FG003|Overall Study|Other (reason not specified)|0|||
94508515|NCT00561821|323657006|FG000|Overall Study|Adverse Event|2|||
94508516|NCT00561821|323657007|FG001|Overall Study|Adverse Event|3|||
94508517|NCT00561821|323657008|FG002|Overall Study|Adverse Event|1|||
94508518|NCT00561821|323657009|FG003|Overall Study|Adverse Event|1|||
94508519|NCT03648372|323657011|FG000|Overall Study|Withdrawal by Subject|2|||
94508520|NCT03648372|323657012|FG001|Overall Study|Withdrawal by Subject|0|||
94508521|NCT03648372|323657013|FG002|Overall Study|Withdrawal by Subject|0|||
94508522|NCT03648372|323657014|FG003|Overall Study|Withdrawal by Subject|0|||
94508523|NCT03648372|323657015|FG004|Overall Study|Withdrawal by Subject|0|||
94508524|NCT03648372|323657016|FG005|Overall Study|Withdrawal by Subject|1|||
94508525|NCT03648372|323657017|FG006|Overall Study|Withdrawal by Subject|2|||
94508526|NCT03648372|323657018|FG007|Overall Study|Withdrawal by Subject|0|||
94508527|NCT03648372|323657019|FG008|Overall Study|Withdrawal by Subject|0|||
94508528|NCT03648372|323657020|FG009|Overall Study|Withdrawal by Subject|0|||
94508529|NCT03648372|323657021|FG010|Overall Study|Withdrawal by Subject|2|||
94508530|NCT03648372|323657022|FG011|Overall Study|Withdrawal by Subject|0|||
94508531|NCT03648372|323657023|FG012|Overall Study|Withdrawal by Subject|2|||
94508532|NCT03648372|323657024|FG013|Overall Study|Withdrawal by Subject|0|||
94508533|NCT03648372|323657025|FG014|Overall Study|Withdrawal by Subject|0|||
94508534|NCT03648372|323657026|FG015|Overall Study|Withdrawal by Subject|0|||
94508535|NCT03648372|323657027|FG016|Overall Study|Withdrawal by Subject|1|||
94508536|NCT03648372|323657028|FG017|Overall Study|Withdrawal by Subject|0|||
94508537|NCT03648372|323657029|FG018|Overall Study|Withdrawal by Subject|0|||
94508538|NCT03648372|323657030|FG019|Overall Study|Withdrawal by Subject|0|||
94508539|NCT03648372|323657031|FG020|Overall Study|Withdrawal by Subject|0|||
94508540|NCT03648372|323657011|FG000|Overall Study|Progressive Disease|2|||
94508541|NCT03648372|323657012|FG001|Overall Study|Progressive Disease|3|||
94508542|NCT03648372|323657013|FG002|Overall Study|Progressive Disease|4|||
94508543|NCT03648372|323657014|FG003|Overall Study|Progressive Disease|3|||
94508544|NCT03648372|323657015|FG004|Overall Study|Progressive Disease|2|||
94508545|NCT03648372|323657016|FG005|Overall Study|Progressive Disease|2|||
94508546|NCT03648372|323657017|FG006|Overall Study|Progressive Disease|3|||
94508547|NCT03648372|323657018|FG007|Overall Study|Progressive Disease|3|||
94508548|NCT03648372|323657019|FG008|Overall Study|Progressive Disease|5|||
94508549|NCT03648372|323657020|FG009|Overall Study|Progressive Disease|5|||
94508550|NCT03648372|323657021|FG010|Overall Study|Progressive Disease|2|||
94508551|NCT03648372|323657022|FG011|Overall Study|Progressive Disease|3|||
94508552|NCT03648372|323657023|FG012|Overall Study|Progressive Disease|3|||
94508553|NCT03648372|323657024|FG013|Overall Study|Progressive Disease|3|||
94508554|NCT03648372|323657025|FG014|Overall Study|Progressive Disease|6|||
94508555|NCT03648372|323657026|FG015|Overall Study|Progressive Disease|0|||
94508556|NCT03648372|323657027|FG016|Overall Study|Progressive Disease|0|||
94508557|NCT03648372|323657028|FG017|Overall Study|Progressive Disease|0|||
94508558|NCT03648372|323657029|FG018|Overall Study|Progressive Disease|0|||
94508559|NCT03648372|323657030|FG019|Overall Study|Progressive Disease|0|||
94508560|NCT03648372|323657031|FG020|Overall Study|Progressive Disease|0|||
94508561|NCT03648372|323657011|FG000|Overall Study|Other|0|||
94508562|NCT03648372|323657012|FG001|Overall Study|Other|0|||
94508563|NCT03648372|323657013|FG002|Overall Study|Other|0|||
94508564|NCT03648372|323657014|FG003|Overall Study|Other|0|||
94508565|NCT03648372|323657015|FG004|Overall Study|Other|1|||
94508566|NCT03648372|323657016|FG005|Overall Study|Other|0|||
94508567|NCT03648372|323657017|FG006|Overall Study|Other|0|||
94508568|NCT03648372|323657018|FG007|Overall Study|Other|0|||
94508569|NCT03648372|323657019|FG008|Overall Study|Other|0|||
94508570|NCT03648372|323657020|FG009|Overall Study|Other|0|||
94508571|NCT03648372|323657021|FG010|Overall Study|Other|1|||
94508572|NCT03648372|323657022|FG011|Overall Study|Other|2|||
94508573|NCT03648372|323657023|FG012|Overall Study|Other|1|||
94508574|NCT03648372|323657024|FG013|Overall Study|Other|3|||
94508575|NCT03648372|323657025|FG014|Overall Study|Other|0|||
94508576|NCT03648372|323657026|FG015|Overall Study|Other|5|||
94508577|NCT03648372|323657027|FG016|Overall Study|Other|1|||
94508578|NCT03648372|323657028|FG017|Overall Study|Other|5|||
94508579|NCT03648372|323657029|FG018|Overall Study|Other|0|||
94508580|NCT03648372|323657030|FG019|Overall Study|Other|1|||
94508581|NCT03648372|323657031|FG020|Overall Study|Other|0|||
94508582|NCT03648372|323657011|FG000|Overall Study|Lost to Follow-up|0|||
94508583|NCT03648372|323657012|FG001|Overall Study|Lost to Follow-up|0|||
94508584|NCT03648372|323657013|FG002|Overall Study|Lost to Follow-up|0|||
94508585|NCT03648372|323657014|FG003|Overall Study|Lost to Follow-up|0|||
94508586|NCT03648372|323657015|FG004|Overall Study|Lost to Follow-up|0|||
94508587|NCT03648372|323657016|FG005|Overall Study|Lost to Follow-up|0|||
94508588|NCT03648372|323657017|FG006|Overall Study|Lost to Follow-up|0|||
94508589|NCT03648372|323657018|FG007|Overall Study|Lost to Follow-up|0|||
94508590|NCT03648372|323657019|FG008|Overall Study|Lost to Follow-up|0|||
94508591|NCT03648372|323657020|FG009|Overall Study|Lost to Follow-up|0|||
94508592|NCT03648372|323657021|FG010|Overall Study|Lost to Follow-up|0|||
94508593|NCT03648372|323657022|FG011|Overall Study|Lost to Follow-up|0|||
94508594|NCT03648372|323657023|FG012|Overall Study|Lost to Follow-up|0|||
94508595|NCT03648372|323657024|FG013|Overall Study|Lost to Follow-up|1|||
94508596|NCT03648372|323657025|FG014|Overall Study|Lost to Follow-up|0|||
94508597|NCT03648372|323657026|FG015|Overall Study|Lost to Follow-up|1|||
94508598|NCT03648372|323657027|FG016|Overall Study|Lost to Follow-up|0|||
94508599|NCT03648372|323657028|FG017|Overall Study|Lost to Follow-up|1|||
94508600|NCT03648372|323657029|FG018|Overall Study|Lost to Follow-up|0|||
94508601|NCT03648372|323657030|FG019|Overall Study|Lost to Follow-up|0|||
94508602|NCT03648372|323657031|FG020|Overall Study|Lost to Follow-up|0|||
94508603|NCT03648372|323657011|FG000|Overall Study|Start of a New Systemic Treatment|0|||
94508604|NCT03648372|323657012|FG001|Overall Study|Start of a New Systemic Treatment|0|||
94508605|NCT03648372|323657013|FG002|Overall Study|Start of a New Systemic Treatment|0|||
94508606|NCT03648372|323657014|FG003|Overall Study|Start of a New Systemic Treatment|0|||
94508607|NCT03648372|323657015|FG004|Overall Study|Start of a New Systemic Treatment|0|||
94508608|NCT03648372|323657016|FG005|Overall Study|Start of a New Systemic Treatment|0|||
94508609|NCT03648372|323657017|FG006|Overall Study|Start of a New Systemic Treatment|0|||
94508610|NCT03648372|323657018|FG007|Overall Study|Start of a New Systemic Treatment|2|||
94508611|NCT03648372|323657019|FG008|Overall Study|Start of a New Systemic Treatment|0|||
94508612|NCT03648372|323657020|FG009|Overall Study|Start of a New Systemic Treatment|0|||
94508613|NCT03648372|323657021|FG010|Overall Study|Start of a New Systemic Treatment|1|||
94508614|NCT03648372|323657022|FG011|Overall Study|Start of a New Systemic Treatment|0|||
94508615|NCT03648372|323657023|FG012|Overall Study|Start of a New Systemic Treatment|0|||
94508616|NCT03648372|323657024|FG013|Overall Study|Start of a New Systemic Treatment|0|||
94508617|NCT03648372|323657025|FG014|Overall Study|Start of a New Systemic Treatment|0|||
94508618|NCT03648372|323657026|FG015|Overall Study|Start of a New Systemic Treatment|0|||
94508619|NCT03648372|323657027|FG016|Overall Study|Start of a New Systemic Treatment|0|||
94508620|NCT03648372|323657028|FG017|Overall Study|Start of a New Systemic Treatment|0|||
94508621|NCT03648372|323657029|FG018|Overall Study|Start of a New Systemic Treatment|0|||
94508622|NCT03648372|323657030|FG019|Overall Study|Start of a New Systemic Treatment|0|||
94508623|NCT03648372|323657031|FG020|Overall Study|Start of a New Systemic Treatment|0|||
94508624|NCT04191135|323657032|FG000|Induction Treatment|Not Treated|2|||
94508625|NCT04191135|323657033|FG001|Induction Treatment|Not Treated|0|||
94508626|NCT04191135|323657034|FG002|Induction Treatment|Not Treated|0|||
94508627|NCT04191135|323657032|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
94508628|NCT04191135|323657033|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
94508629|NCT04191135|323657034|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
94508630|NCT04191135|323657032|FG000|Induction Treatment|Adverse Event|25|||
94508631|NCT04191135|323657033|FG001|Induction Treatment|Adverse Event|0|||
94508632|NCT04191135|323657034|FG002|Induction Treatment|Adverse Event|0|||
94508633|NCT04191135|323657032|FG000|Induction Treatment|Clinical Progression|8|||
94508634|NCT04191135|323657033|FG001|Induction Treatment|Clinical Progression|0|||
94508635|NCT04191135|323657034|FG002|Induction Treatment|Clinical Progression|0|||
94508636|NCT04191135|323657032|FG000|Induction Treatment|Excluded Medication|1|||
94508637|NCT04191135|323657033|FG001|Induction Treatment|Excluded Medication|0|||
94508638|NCT04191135|323657034|FG002|Induction Treatment|Excluded Medication|0|||
94508639|NCT04191135|323657032|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
94508640|NCT04191135|323657033|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
94508641|NCT04191135|323657034|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
94508642|NCT04191135|323657032|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
94508643|NCT04191135|323657033|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
94508644|NCT04191135|323657034|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
94508645|NCT04191135|323657032|FG000|Induction Treatment|Physician Decision|2|||
94508646|NCT04191135|323657033|FG001|Induction Treatment|Physician Decision|0|||
94508647|NCT04191135|323657034|FG002|Induction Treatment|Physician Decision|0|||
94508648|NCT04191135|323657032|FG000|Induction Treatment|Progressive Disease|135|||
94508649|NCT04191135|323657033|FG001|Induction Treatment|Progressive Disease|0|||
94508650|NCT04191135|323657034|FG002|Induction Treatment|Progressive Disease|0|||
94508651|NCT04191135|323657032|FG000|Induction Treatment|Protocol Violation|10|||
94508652|NCT04191135|323657033|FG001|Induction Treatment|Protocol Violation|0|||
94508653|NCT04191135|323657034|FG002|Induction Treatment|Protocol Violation|0|||
94508654|NCT04191135|323657032|FG000|Induction Treatment|Withdrawal by Subject|4|||
94508655|NCT04191135|323657033|FG001|Induction Treatment|Withdrawal by Subject|0|||
94508656|NCT04191135|323657034|FG002|Induction Treatment|Withdrawal by Subject|0|||
94508657|NCT04191135|323657032|FG000|Randomized Treatment|Death|0|||
94508658|NCT04191135|323657033|FG001|Randomized Treatment|Death|50|||
94508659|NCT04191135|323657034|FG002|Randomized Treatment|Death|54|||
94508660|NCT04191135|323657032|FG000|Randomized Treatment|Lost to Follow-up|0|||
94508661|NCT04191135|323657033|FG001|Randomized Treatment|Lost to Follow-up|0|||
94508662|NCT04191135|323657034|FG002|Randomized Treatment|Lost to Follow-up|1|||
94508663|NCT04191135|323657032|FG000|Randomized Treatment|Withdrawal by Subject|0|||
94508664|NCT04191135|323657033|FG001|Randomized Treatment|Withdrawal by Subject|2|||
94508665|NCT04191135|323657034|FG002|Randomized Treatment|Withdrawal by Subject|0|||
94508666|NCT04191135|323657032|FG000|Randomized Treatment|Ongoing in Trial|0|||
94508667|NCT04191135|323657033|FG001|Randomized Treatment|Ongoing in Trial|83|||
94508668|NCT04191135|323657034|FG002|Randomized Treatment|Ongoing in Trial|81|||
94508669|NCT02363283|323658069|FG000|Overall Study|Withdrawal by Subject|1|||
94508670|NCT02363283|323658069|FG000|Overall Study|Not eligible due to transaminitis|1|||
94508671|NCT04616196|323658070|FG000|Overall Study|Progressive Disease|3|||
94508672|NCT04616196|323658071|FG001|Overall Study|Progressive Disease|0|||
94508673|NCT04616196|323658072|FG002|Overall Study|Progressive Disease|4|||
94508674|NCT04616196|323658073|FG003|Overall Study|Progressive Disease|1|||
94508675|NCT04616196|323658070|FG000|Overall Study|Death|2|||
94508676|NCT04616196|323658071|FG001|Overall Study|Death|4|||
94508677|NCT04616196|323658072|FG002|Overall Study|Death|1|||
94508678|NCT04616196|323658073|FG003|Overall Study|Death|0|||
94508679|NCT04616196|323658070|FG000|Overall Study|Withdrawal by Subject|0|||
94508680|NCT04616196|323658071|FG001|Overall Study|Withdrawal by Subject|2|||
94508681|NCT04616196|323658072|FG002|Overall Study|Withdrawal by Subject|0|||
94508682|NCT04616196|323658073|FG003|Overall Study|Withdrawal by Subject|0|||
94508683|NCT04616196|323658070|FG000|Overall Study|Lost to Follow-up|1|||
94508684|NCT04616196|323658071|FG001|Overall Study|Lost to Follow-up|0|||
94508685|NCT04616196|323658072|FG002|Overall Study|Lost to Follow-up|0|||
94508686|NCT04616196|323658073|FG003|Overall Study|Lost to Follow-up|0|||
94508687|NCT04616196|323658070|FG000|Overall Study|Sponsor request|2|||
94508688|NCT04616196|323658071|FG001|Overall Study|Sponsor request|1|||
94508689|NCT04616196|323658072|FG002|Overall Study|Sponsor request|1|||
94508690|NCT04616196|323658073|FG003|Overall Study|Sponsor request|2|||
94508691|NCT06844812|323658074|FG000|Overall Study|Lost to Follow-up|5|||
94508692|NCT06844812|323658074|FG000|Overall Study|stigmatization concerns|2|||
94508693|NCT06844812|323658074|FG000|Overall Study|medication refusal|2|||
94508694|NCT06844812|323658074|FG000|Overall Study|concerns about possible side effects|2|||
94508695|NCT06844812|323658074|FG000|Overall Study|wanting to seek another specialist opinion|2|||
94508696|NCT06844812|323658074|FG000|Overall Study|side effects (dizziness)|1|||
94508697|NCT02457546|323658075|FG000|Overall Study|Other reasons|4|||
94508698|NCT02457546|323658076|FG001|Overall Study|Other reasons|1|||
94508699|NCT02457546|323658075|FG000|Overall Study|Refused to complete study/procedures|1|||
94508700|NCT02457546|323658076|FG001|Overall Study|Refused to complete study/procedures|1|||
94508701|NCT02457546|323658075|FG000|Overall Study|Lost to Follow-up|4|||
94508702|NCT02457546|323658076|FG001|Overall Study|Lost to Follow-up|1|||
94508703|NCT02457546|323658075|FG000|Overall Study|Adverse Event|0|||
94508704|NCT02457546|323658076|FG001|Overall Study|Adverse Event|1|||
94508705|NCT05069415|323658077|FG000|Overall Study|Withdrawal by Subject|2|||
94508706|NCT05069415|323658078|FG001|Overall Study|Withdrawal by Subject|0|||
94508707|NCT05069415|323658077|FG000|Overall Study|Adverse Event|2|||
94508708|NCT05069415|323658078|FG001|Overall Study|Adverse Event|0|||
94508709|NCT00003907|323658082|FG000|Overall Study|Adverse Event|2|||
94508710|NCT00003907|323658083|FG001|Overall Study|Adverse Event|11|||
94508711|NCT00003907|323658082|FG000|Overall Study|Death|2|||
94508712|NCT00003907|323658083|FG001|Overall Study|Death|0|||
94508713|NCT00003907|323658082|FG000|Overall Study|Withdrawal by Subject|1|||
94508714|NCT00003907|323658083|FG001|Overall Study|Withdrawal by Subject|3|||
94508715|NCT00003907|323658082|FG000|Overall Study|Progressive disease|4|||
94508716|NCT00003907|323658083|FG001|Overall Study|Progressive disease|4|||
94508717|NCT00003907|323658082|FG000|Overall Study|Complicating disease|1|||
94508718|NCT00003907|323658083|FG001|Overall Study|Complicating disease|0|||
94508719|NCT00003907|323658082|FG000|Overall Study|Other|1|||
94508720|NCT00003907|323658083|FG001|Overall Study|Other|3|||
94508721|NCT00003907|323658082|FG000|Overall Study|ineligible or not treated|2|||
94508722|NCT00003907|323658083|FG001|Overall Study|ineligible or not treated|2|||
94508723|NCT01998477|323658084|FG000|Overall Study|Lost to Follow-up|4|||
94508724|NCT01998477|323658085|FG001|Overall Study|Lost to Follow-up|5|||
94508725|NCT01998477|323658084|FG000|Overall Study|Withdrawal by Subject|6|||
94508726|NCT01998477|323658085|FG001|Overall Study|Withdrawal by Subject|0|||
94508727|NCT01903720|323658086|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
94508728|NCT01903720|323658086|FG000|Overall Study|Adverse Event|1|||
94508729|NCT01903720|323658086|FG000|Overall Study|Rescinding of informed consent|2|||
94508730|NCT01903720|323658086|FG000|Overall Study|Lost to Follow-up|2|||
94508731|NCT01903720|323658086|FG000|Overall Study|Treatment with alternative drug|1|||
94508732|NCT03627468|323658087|FG000|Overall Study|Adverse Event|5|||
94508733|NCT03627468|323658088|FG001|Overall Study|Adverse Event|33|||
94508734|NCT03627468|323658087|FG000|Overall Study|Withdrawal by Subject|13|||
94508735|NCT03627468|323658088|FG001|Overall Study|Withdrawal by Subject|23|||
94508736|NCT03627468|323658087|FG000|Overall Study|Physician Decision|1|||
94508737|NCT03627468|323658088|FG001|Overall Study|Physician Decision|0|||
94508738|NCT03627468|323658087|FG000|Overall Study|Protocol Violation|0|||
94508739|NCT03627468|323658088|FG001|Overall Study|Protocol Violation|2|||
94508740|NCT03627468|323658087|FG000|Overall Study|Lost to Follow-up|10|||
94508741|NCT03627468|323658088|FG001|Overall Study|Lost to Follow-up|16|||
94508742|NCT03627468|323658087|FG000|Overall Study|Death|1|||
94508743|NCT03627468|323658088|FG001|Overall Study|Death|0|||
94508744|NCT03627468|323658087|FG000|Overall Study|Pregnancy|1|||
94508745|NCT03627468|323658088|FG001|Overall Study|Pregnancy|1|||
94508746|NCT03627468|323658087|FG000|Overall Study|Lack of Efficacy|0|||
94508747|NCT03627468|323658088|FG001|Overall Study|Lack of Efficacy|2|||
94508748|NCT03627468|323658087|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
94508749|NCT03627468|323658088|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
94508750|NCT04157738|323658089|FG000|Overall Study|Moved out of state|0|||
94508751|NCT04157738|323658090|FG001|Overall Study|Moved out of state|2|||
94508752|NCT04157738|323658089|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
94508753|NCT04157738|323658090|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
94508754|NCT00160563|323658091|FG000|Overall Study|Adverse Event|1|||
94508755|NCT00160563|323658092|FG001|Overall Study|Adverse Event|1|||
94508756|NCT00160563|323658093|FG002|Overall Study|Adverse Event|1|||
94508757|NCT00160563|323658091|FG000|Overall Study|Lost to Follow-up|1|||
94508758|NCT00160563|323658092|FG001|Overall Study|Lost to Follow-up|1|||
94508759|NCT00160563|323658093|FG002|Overall Study|Lost to Follow-up|2|||
94508760|NCT00160563|323658091|FG000|Overall Study|Protocol Violation|0|||
94508761|NCT00160563|323658092|FG001|Overall Study|Protocol Violation|0|||
94508762|NCT00160563|323658093|FG002|Overall Study|Protocol Violation|3|||
94508763|NCT00160563|323658091|FG000|Overall Study|Withdrawal by Subject|1|||
94508764|NCT00160563|323658092|FG001|Overall Study|Withdrawal by Subject|2|||
94508765|NCT00160563|323658093|FG002|Overall Study|Withdrawal by Subject|3|||
94508766|NCT00160563|323658091|FG000|Overall Study|Other (listed in the study report)|48|||
94508767|NCT00160563|323658092|FG001|Overall Study|Other (listed in the study report)|40|||
94508768|NCT00160563|323658093|FG002|Overall Study|Other (listed in the study report)|81|||
94508769|NCT00160563|323658091|FG000|Overall Study|Missing reason|0|||
94508770|NCT00160563|323658092|FG001|Overall Study|Missing reason|1|||
94508771|NCT00160563|323658093|FG002|Overall Study|Missing reason|0|||
94508772|NCT00309946|323658094|FG000|Overall Study|Withdrawal by Subject|1|||
94508773|NCT03111108|323658095|FG000|Overall Study|Death|0|||
94508774|NCT03111108|323658096|FG001|Overall Study|Death|1|||
94508775|NCT03111108|323658095|FG000|Overall Study|Withdrawal by Subject|1|||
94508776|NCT03111108|323658096|FG001|Overall Study|Withdrawal by Subject|0|||
94508777|NCT01514357|323658097|FG000|Overall Study|Screen failure|2|||
94508778|NCT01514357|323658098|FG001|Overall Study|Screen failure|0|||
94508779|NCT01514357|323658097|FG000|Overall Study|Withdrawal by Subject|2|||
94508780|NCT01514357|323658098|FG001|Overall Study|Withdrawal by Subject|0|||
94508781|NCT04691115|323658101|FG000|Overall Study|Withdrawal by Subject|0|||
94508782|NCT04691115|323658102|FG001|Overall Study|Withdrawal by Subject|0|||
94508783|NCT04691115|323658103|FG002|Overall Study|Withdrawal by Subject|0|||
94508784|NCT04691115|323658104|FG003|Overall Study|Withdrawal by Subject|0|||
94508785|NCT04691115|323658105|FG004|Overall Study|Withdrawal by Subject|0|||
94508786|NCT04691115|323658106|FG005|Overall Study|Withdrawal by Subject|1|||
94508787|NCT04691115|323658107|FG006|Overall Study|Withdrawal by Subject|0|||
94508788|NCT04691115|323658108|FG007|Overall Study|Withdrawal by Subject|0|||
94508789|NCT04691115|323658109|FG008|Overall Study|Withdrawal by Subject|0|||
94508790|NCT04691115|323658110|FG009|Overall Study|Withdrawal by Subject|0|||
94508791|NCT04691115|323658111|FG010|Overall Study|Withdrawal by Subject|0|||
94508792|NCT04691115|323658112|FG011|Overall Study|Withdrawal by Subject|0|||
94508793|NCT04691115|323658113|FG012|Overall Study|Withdrawal by Subject|0|||
94508794|NCT04691115|323658114|FG013|Overall Study|Withdrawal by Subject|0|||
94508795|NCT01853280|323658116|FG000|Overall Study|Lack of Efficacy|2|||
94508796|NCT01853280|323658117|FG001|Overall Study|Lack of Efficacy|2|||
94508797|NCT01853280|323658116|FG000|Overall Study|Lost to Follow-up|0|||
94508798|NCT01853280|323658117|FG001|Overall Study|Lost to Follow-up|1|||
94508799|NCT01853280|323658116|FG000|Overall Study|Physician Decision|0|||
94508800|NCT01853280|323658117|FG001|Overall Study|Physician Decision|1|||
94508801|NCT01853280|323658116|FG000|Overall Study|Withdrawal by Subject|0|||
94508802|NCT01853280|323658117|FG001|Overall Study|Withdrawal by Subject|1|||
94508803|NCT01853280|323658116|FG000|Overall Study|Ineligible|0|||
94508804|NCT01853280|323658117|FG001|Overall Study|Ineligible|1|||
94508805|NCT00104884|323658118|FG000|Overall Study|Disease progression|4|||
94508806|NCT03032484|323658119|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
94508807|NCT03032484|323658120|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
94508808|NCT03032484|323658119|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
94508809|NCT03032484|323658120|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
94508810|NCT01674062|323658127|FG000|Overall Study|Insufficient Therapeutic Response|56|||
94508811|NCT01674062|323658128|FG001|Overall Study|Insufficient Therapeutic Response|26|||
94508812|NCT01674062|323658127|FG000|Overall Study|Other|8|||
94508813|NCT01674062|323658128|FG001|Overall Study|Other|1|||
94508814|NCT01674062|323658127|FG000|Overall Study|Adverse Event|1|||
94508815|NCT01674062|323658128|FG001|Overall Study|Adverse Event|1|||
94508816|NCT01674062|323658127|FG000|Overall Study|Death|0|||
94508817|NCT01674062|323658128|FG001|Overall Study|Death|1|||
94508818|NCT01674062|323658127|FG000|Overall Study|Programming Error|1|||
94508819|NCT01674062|323658128|FG001|Overall Study|Programming Error|0|||
94508820|NCT04661839|323658129|FG000|Overall Study|Not Treated|0|||
94508821|NCT04661839|323658130|FG001|Overall Study|Not Treated|0|||
94508822|NCT04661839|323658131|FG002|Overall Study|Not Treated|1|||
94508823|NCT04661839|323658132|FG003|Overall Study|Not Treated|0|||
94508824|NCT04661839|323658129|FG000|Overall Study|Lost to Follow-up|1|||
94508825|NCT04661839|323658130|FG001|Overall Study|Lost to Follow-up|0|||
94508826|NCT04661839|323658131|FG002|Overall Study|Lost to Follow-up|0|||
94508827|NCT04661839|323658132|FG003|Overall Study|Lost to Follow-up|1|||
94508828|NCT01681849|323658133|FG000|Overall Study|Protocol Violation|2|||
94508829|NCT01681849|323658134|FG001|Overall Study|Protocol Violation|0|||
94508830|NCT01681849|323658135|FG002|Overall Study|Protocol Violation|0|||
94508831|NCT01681849|323658133|FG000|Overall Study|Withdrawal by Subject|3|||
94508832|NCT01681849|323658134|FG001|Overall Study|Withdrawal by Subject|5|||
94508833|NCT01681849|323658135|FG002|Overall Study|Withdrawal by Subject|33|||
94508834|NCT01681849|323658133|FG000|Overall Study|Lost to Follow-up|3|||
94508835|NCT01681849|323658134|FG001|Overall Study|Lost to Follow-up|2|||
94508836|NCT01681849|323658135|FG002|Overall Study|Lost to Follow-up|6|||
94508837|NCT04439903|323658139|FG000|Overall Study|Withdrawal by Subject|2|||
94508838|NCT04439903|323658139|FG000|Overall Study|Screen Failure|1|||
94508839|NCT04818229|323658140|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
94508840|NCT04818229|323658141|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
94508841|NCT04818229|323658142|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
94508842|NCT04818229|323658140|FG000|Overall Study|Adverse Event|3|||
94508843|NCT04818229|323658141|FG001|Overall Study|Adverse Event|1|||
94508844|NCT04818229|323658142|FG002|Overall Study|Adverse Event|1|||
94508845|NCT04818229|323658140|FG000|Overall Study|Withdrawal by Subject|0|||
94508846|NCT04818229|323658141|FG001|Overall Study|Withdrawal by Subject|0|||
94508847|NCT04818229|323658142|FG002|Overall Study|Withdrawal by Subject|2|||
94508848|NCT04818229|323658140|FG000|Overall Study|Lost to Follow-up|0|||
94508849|NCT04818229|323658141|FG001|Overall Study|Lost to Follow-up|0|||
94508850|NCT04818229|323658142|FG002|Overall Study|Lost to Follow-up|1|||
94508851|NCT02514746|323658143|FG000|Overall Study|Chronically Ill|1|||
94508852|NCT02514746|323658144|FG001|Overall Study|Chronically Ill|2|||
94508853|NCT02514746|323658143|FG000|Overall Study|Physician Decision|4|||
94508854|NCT02514746|323658144|FG001|Overall Study|Physician Decision|2|||
94508855|NCT02514746|323658143|FG000|Overall Study|Withdrawal by Subject|12|||
94508856|NCT02514746|323658144|FG001|Overall Study|Withdrawal by Subject|10|||
94508857|NCT02514746|323658143|FG000|Overall Study|Other|5|||
94508858|NCT02514746|323658144|FG001|Overall Study|Other|1|||
94508859|NCT03633058|323658145|FG000|Overall Study|Adverse Event|0|||
94508860|NCT03633058|323658146|FG001|Overall Study|Adverse Event|0|||
94508861|NCT03633058|323658147|FG002|Overall Study|Adverse Event|1|||
94508862|NCT03633058|323658148|FG003|Overall Study|Adverse Event|0|||
94508863|NCT02298946|323658149|FG000|Overall Study|Did not receive treatment|2|||
94508864|NCT02298946|323658150|FG001|Overall Study|Did not receive treatment|0|||
94508865|NCT02298946|323658149|FG000|Overall Study|Unevaluable|2|||
94508866|NCT02298946|323658150|FG001|Overall Study|Unevaluable|1|||
94508867|NCT02061085|323658155|FG000|Overall Study|Adverse Event|8|||
94508868|NCT03247673|323658156|FG000|Overall Study|Withdrawal by Subject|1|||
94508869|NCT03247673|323658157|FG001|Overall Study|Withdrawal by Subject|0|||
94508870|NCT03247673|323658158|FG002|Overall Study|Withdrawal by Subject|3|||
94508871|NCT03247673|323658156|FG000|Overall Study|Lost to Follow-up|0|||
94508872|NCT03247673|323658157|FG001|Overall Study|Lost to Follow-up|0|||
94508873|NCT03247673|323658158|FG002|Overall Study|Lost to Follow-up|1|||
94508874|NCT02971137|323658159|FG000|Overall Study|Lost to Follow-up|44|||
94508875|NCT02971137|323658160|FG001|Overall Study|Lost to Follow-up|56|||
94508876|NCT02528305|323658163|FG000|Overall Study|Withdrawal by Subject|1|||
94508877|NCT02528305|323658163|FG000|Overall Study|Adverse Event|1|||
94508878|NCT02528305|323658163|FG000|Overall Study|Physician Decision|1|||
94508879|NCT00913835|323658164|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
94508880|NCT00913835|323658165|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
94508881|NCT00913835|323658164|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
94508882|NCT00913835|323658165|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
94508883|NCT00913835|323658164|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
94508884|NCT00913835|323658165|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
94508885|NCT00913835|323658164|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
94508886|NCT00913835|323658165|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
94508887|NCT00913835|323658164|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
94508888|NCT00913835|323658165|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
94508889|NCT02520154|323658174|FG000|Overall Study|Death|1|||
94508890|NCT02520154|323658174|FG000|Overall Study|Withdrawal by Subject|2|||
94508891|NCT02520154|323658174|FG000|Overall Study|Physician Decision|2|||
94508892|NCT02730169|323659562|FG000|Overall Study|Protocol Violation|1|||
94508893|NCT02730169|323659563|FG001|Overall Study|Protocol Violation|0|||
94508894|NCT02730169|323659564|FG002|Overall Study|Protocol Violation|0|||
94508895|NCT02730169|323659565|FG003|Overall Study|Protocol Violation|1|||
94508896|NCT02730169|323659562|FG000|Overall Study|Adverse Event|2|||
94508897|NCT02730169|323659563|FG001|Overall Study|Adverse Event|3|||
94508898|NCT02730169|323659564|FG002|Overall Study|Adverse Event|3|||
94508899|NCT02730169|323659565|FG003|Overall Study|Adverse Event|0|||
94508900|NCT02730169|323659562|FG000|Overall Study|Adverse Event of Special Interest|0|||
94508901|NCT02730169|323659563|FG001|Overall Study|Adverse Event of Special Interest|1|||
94508902|NCT02730169|323659564|FG002|Overall Study|Adverse Event of Special Interest|2|||
94508903|NCT02730169|323659565|FG003|Overall Study|Adverse Event of Special Interest|0|||
94508904|NCT02730169|323659562|FG000|Overall Study|Withdrawal by Subject|6|||
94508905|NCT02730169|323659563|FG001|Overall Study|Withdrawal by Subject|11|||
94508906|NCT02730169|323659564|FG002|Overall Study|Withdrawal by Subject|6|||
94508907|NCT02730169|323659565|FG003|Overall Study|Withdrawal by Subject|8|||
94508908|NCT02730169|323659562|FG000|Overall Study|Lost to Follow-up|5|||
94508909|NCT02730169|323659563|FG001|Overall Study|Lost to Follow-up|6|||
94508910|NCT02730169|323659564|FG002|Overall Study|Lost to Follow-up|5|||
94508911|NCT02730169|323659565|FG003|Overall Study|Lost to Follow-up|6|||
94508912|NCT02730169|323659562|FG000|Overall Study|Other|0|||
94508913|NCT02730169|323659563|FG001|Overall Study|Other|0|||
94508914|NCT02730169|323659564|FG002|Overall Study|Other|1|||
94508915|NCT02730169|323659565|FG003|Overall Study|Other|1|||
94508916|NCT01251965|323659572|FG000|Overall Study|Participant/physician decision|1|||
94508917|NCT01251965|323659573|FG001|Overall Study|Participant/physician decision|2|||
94508918|NCT01251965|323659574|FG002|Overall Study|Participant/physician decision|0|||
94508919|NCT01251965|323659572|FG000|Overall Study|Death|0|||
94508920|NCT01251965|323659573|FG001|Overall Study|Death|0|||
94508921|NCT01251965|323659574|FG002|Overall Study|Death|11|||
94508922|NCT02371889|323659577|FG000|Overall Study|Adverse medication effect|11|||
94508923|NCT02371889|323659578|FG001|Overall Study|Adverse medication effect|2|||
94508924|NCT02371889|323659577|FG000|Overall Study|Lost to Follow-up|6|||
94508925|NCT02371889|323659578|FG001|Overall Study|Lost to Follow-up|5|||
94508926|NCT02371889|323659577|FG000|Overall Study|Personal time constraints|2|||
94508927|NCT02371889|323659578|FG001|Overall Study|Personal time constraints|4|||
94508928|NCT02371889|323659577|FG000|Overall Study|Lack of Efficacy|0|||
94508929|NCT02371889|323659578|FG001|Overall Study|Lack of Efficacy|2|||
94508930|NCT02371889|323659577|FG000|Overall Study|Relapse|0|||
94508931|NCT02371889|323659578|FG001|Overall Study|Relapse|1|||
94508932|NCT05520333|323659585|FG000|Overall Study|Lost to Follow-up|3|||
94508933|NCT05520333|323659586|FG001|Overall Study|Lost to Follow-up|6|||
94508934|NCT05058456|323659587|FG000|Overall Study|Death|1|||
94508935|NCT05058456|323659587|FG000|Overall Study|End of Study data not yet due for release|34|||
94508936|NCT03810365|323659588|FG000|Overall Study|Lost to Follow-up|2|||
94508937|NCT03810365|323659589|FG001|Overall Study|Lost to Follow-up|2|||
94508938|NCT03810365|323659588|FG000|Overall Study|Withdrawal by Subject|4|||
94508939|NCT03810365|323659589|FG001|Overall Study|Withdrawal by Subject|5|||
94508940|NCT03701074|323659590|FG000|Overall Study|Physician Decision|1|||
94508941|NCT03701074|323659591|FG001|Overall Study|Physician Decision|0|||
94508942|NCT01517178|323659595|FG000|Period 1|Adverse Event|1|||
94508943|NCT01517178|323659596|FG001|Period 1|Adverse Event|2|||
94508944|NCT01517178|323659595|FG000|Period 1|Lack of Efficacy|0|||
94508945|NCT01517178|323659596|FG001|Period 1|Lack of Efficacy|1|||
94508946|NCT01517178|323659595|FG000|Period 1|E.g. study termination|3|||
94508947|NCT01517178|323659596|FG001|Period 1|E.g. study termination|1|||
94508948|NCT01517178|323659595|FG000|Period 1|Withdrawal by Subject|0|||
94508949|NCT01517178|323659596|FG001|Period 1|Withdrawal by Subject|1|||
94508950|NCT01517178|323659595|FG000|Period 2|Adverse Event|1|||
94508951|NCT01517178|323659596|FG001|Period 2|Adverse Event|0|||
94508952|NCT01517178|323659595|FG000|Period 2|Withdrawal by Subject|3|||
94508953|NCT01517178|323659596|FG001|Period 2|Withdrawal by Subject|0|||
94508954|NCT01517178|323659595|FG000|Period 2|E.g. study termination|2|||
94508955|NCT01517178|323659596|FG001|Period 2|E.g. study termination|2|||
94508956|NCT03523585|323659602|FG000|Overall Study|Progressive Disease|174|||
94508957|NCT03523585|323659603|FG001|Overall Study|Progressive Disease|64|||
94508958|NCT03523585|323659604|FG002|Overall Study|Progressive Disease|77|||
94508959|NCT03523585|323659602|FG000|Overall Study|Adverse Event|74|||
94508960|NCT03523585|323659603|FG001|Overall Study|Adverse Event|5|||
94508961|NCT03523585|323659604|FG002|Overall Study|Adverse Event|9|||
94508962|NCT03523585|323659602|FG000|Overall Study|Withdrawal by Subject|30|||
94508963|NCT03523585|323659603|FG001|Overall Study|Withdrawal by Subject|11|||
94508964|NCT03523585|323659604|FG002|Overall Study|Withdrawal by Subject|6|||
94508965|NCT03523585|323659602|FG000|Overall Study|Clinical Progression|23|||
94508966|NCT03523585|323659603|FG001|Overall Study|Clinical Progression|5|||
94508967|NCT03523585|323659604|FG002|Overall Study|Clinical Progression|10|||
94508968|NCT03523585|323659602|FG000|Overall Study|Death|4|||
94508969|NCT03523585|323659603|FG001|Overall Study|Death|0|||
94508970|NCT03523585|323659604|FG002|Overall Study|Death|1|||
94508971|NCT03523585|323659602|FG000|Overall Study|Physician Decision|2|||
94508972|NCT03523585|323659603|FG001|Overall Study|Physician Decision|1|||
94508973|NCT03523585|323659604|FG002|Overall Study|Physician Decision|0|||
94508974|NCT03523585|323659602|FG000|Overall Study|Lost to Follow-up|1|||
94508975|NCT03523585|323659603|FG001|Overall Study|Lost to Follow-up|0|||
94508976|NCT03523585|323659604|FG002|Overall Study|Lost to Follow-up|0|||
94508977|NCT03523585|323659602|FG000|Overall Study|Miscellaneous|1|||
94508978|NCT03523585|323659603|FG001|Overall Study|Miscellaneous|0|||
94508979|NCT03523585|323659604|FG002|Overall Study|Miscellaneous|0|||
94508980|NCT03523585|323659602|FG000|Overall Study|Protocol Deviation|1|||
94508981|NCT03523585|323659603|FG001|Overall Study|Protocol Deviation|0|||
94508982|NCT03523585|323659604|FG002|Overall Study|Protocol Deviation|1|||
94508983|NCT03523585|323659602|FG000|Overall Study|Randomized But Not Treated|2|||
94508984|NCT03523585|323659603|FG001|Overall Study|Randomized But Not Treated|4|||
94508985|NCT03523585|323659604|FG002|Overall Study|Randomized But Not Treated|3|||
94508986|NCT03654326|323659605|FG000|Overall Study|Withdrawal by Subject|5|||
94508987|NCT03654326|323659606|FG001|Overall Study|Withdrawal by Subject|3|||
94508988|NCT03654326|323659605|FG000|Overall Study|Physician Decision|0|||
94508989|NCT03654326|323659606|FG001|Overall Study|Physician Decision|1|||
94508990|NCT03654326|323659605|FG000|Overall Study|Unable to adhere to study schedule|0|||
94508991|NCT03654326|323659606|FG001|Overall Study|Unable to adhere to study schedule|1|||
94508992|NCT03654326|323659605|FG000|Overall Study|Lost to Follow-up|1|||
94508993|NCT03654326|323659606|FG001|Overall Study|Lost to Follow-up|1|||
94508994|NCT04102514|323659607|FG000|Overall Study|Death|3|||
94508995|NCT04102514|323659608|FG001|Overall Study|Death|0|||
94508996|NCT04102514|323659609|FG002|Overall Study|Death|0|||
94508997|NCT04102514|323659610|FG003|Overall Study|Death|0|||
94508998|NCT04102514|323659607|FG000|Overall Study|Lost to Follow-up|0|||
94508999|NCT04102514|323659608|FG001|Overall Study|Lost to Follow-up|0|||
94509000|NCT04102514|323659609|FG002|Overall Study|Lost to Follow-up|3|||
94509001|NCT04102514|323659610|FG003|Overall Study|Lost to Follow-up|0|||
94509002|NCT04102514|323659607|FG000|Overall Study|Physician Decision|0|||
94509003|NCT04102514|323659608|FG001|Overall Study|Physician Decision|0|||
94509004|NCT04102514|323659609|FG002|Overall Study|Physician Decision|1|||
94509005|NCT04102514|323659610|FG003|Overall Study|Physician Decision|0|||
94509006|NCT04102514|323659607|FG000|Overall Study|Withdrawal by Subject|7|||
94509007|NCT04102514|323659608|FG001|Overall Study|Withdrawal by Subject|13|||
94509008|NCT04102514|323659609|FG002|Overall Study|Withdrawal by Subject|7|||
94509009|NCT04102514|323659610|FG003|Overall Study|Withdrawal by Subject|14|||
94509010|NCT04102514|323659607|FG000|Overall Study|Moved to longterm care facility|6|||
94509011|NCT04102514|323659608|FG001|Overall Study|Moved to longterm care facility|0|||
94509012|NCT04102514|323659609|FG002|Overall Study|Moved to longterm care facility|4|||
94509013|NCT04102514|323659610|FG003|Overall Study|Moved to longterm care facility|0|||
94509014|NCT00835042|323659611|FG000|First Intervention|Withdrawal by Subject|3|||
94509015|NCT00835042|323659612|FG001|First Intervention|Withdrawal by Subject|0|||
94509016|NCT00835042|323659611|FG000|First Intervention|Adverse Event|1|||
94509017|NCT00835042|323659612|FG001|First Intervention|Adverse Event|2|||
94509018|NCT00835042|323659611|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
94509019|NCT00835042|323659612|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
94509020|NCT00619918|323659613|FG000|Overall Study|Withdrawal by Subject|4|||
94509021|NCT00619918|323659614|FG001|Overall Study|Withdrawal by Subject|3|||
94509022|NCT00619918|323659613|FG000|Overall Study|Physician Decision|2|||
94509023|NCT00619918|323659614|FG001|Overall Study|Physician Decision|4|||
94509024|NCT00619918|323659613|FG000|Overall Study|Transfer to outside facility|3|||
94509025|NCT00619918|323659614|FG001|Overall Study|Transfer to outside facility|3|||
94509026|NCT00619918|323659613|FG000|Overall Study|Left before receiving first dose|7|||
94509027|NCT00619918|323659614|FG001|Overall Study|Left before receiving first dose|6|||
94509028|NCT00619918|323659613|FG000|Overall Study|ICU admission|4|||
94509029|NCT00619918|323659614|FG001|Overall Study|ICU admission|6|||
94509030|NCT04725188|323659628|FG000|Overall Study|Death|44|||
94509031|NCT04725188|323659629|FG001|Overall Study|Death|46|||
94509032|NCT04725188|323659630|FG002|Overall Study|Death|48|||
94509033|NCT04725188|323659628|FG000|Overall Study|Lost to Follow-up|0|||
94509034|NCT04725188|323659629|FG001|Overall Study|Lost to Follow-up|0|||
94509035|NCT04725188|323659630|FG002|Overall Study|Lost to Follow-up|1|||
94509036|NCT04725188|323659628|FG000|Overall Study|Withdrawal by Subject|2|||
94509037|NCT04725188|323659629|FG001|Overall Study|Withdrawal by Subject|2|||
94509038|NCT04725188|323659630|FG002|Overall Study|Withdrawal by Subject|1|||
94509039|NCT04725188|323659628|FG000|Overall Study|Participants ongoing in the study|41|||
94509040|NCT04725188|323659629|FG001|Overall Study|Participants ongoing in the study|35|||
94509041|NCT04725188|323659630|FG002|Overall Study|Participants ongoing in the study|35|||
94509042|NCT03411044|323659635|FG000|Overall Study|Death|30|||
94509043|NCT03411044|323659635|FG000|Overall Study|Withdrawal by Subject|48|||
94509044|NCT03411044|323659635|FG000|Overall Study|Lost to Follow-up|78|||
94509045|NCT03411044|323659635|FG000|Overall Study|Adverse Event|30|||
94509046|NCT03411044|323659635|FG000|Overall Study|Missing status|4|||
94509047|NCT05451329|323659637|FG000|Overall Study|Adverse Event|1|||
94509048|NCT05451329|323659638|FG001|Overall Study|Adverse Event|1|||
94509049|NCT05451329|323659639|FG002|Overall Study|Adverse Event|0|||
94509050|NCT05451329|323659637|FG000|Overall Study|Withdrawal by Subject|1|||
94509051|NCT05451329|323659638|FG001|Overall Study|Withdrawal by Subject|0|||
94509052|NCT05451329|323659639|FG002|Overall Study|Withdrawal by Subject|0|||
94509053|NCT05451329|323659637|FG000|Overall Study|Investigational Product Lot exchange|1|||
94509054|NCT05451329|323659638|FG001|Overall Study|Investigational Product Lot exchange|1|||
94509055|NCT05451329|323659639|FG002|Overall Study|Investigational Product Lot exchange|0|||
94509056|NCT03579719|323659643|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
94509057|NCT01443026|323659644|FG000|Overall Study|Physician Decision|1|||
94509058|NCT01443026|323659645|FG001|Overall Study|Physician Decision|0|||
94509059|NCT01443026|323659644|FG000|Overall Study|Death|0|||
94509060|NCT01443026|323659645|FG001|Overall Study|Death|1|||
94509061|NCT01443026|323659644|FG000|Overall Study|Withdrawal by Subject|0|||
94509062|NCT01443026|323659645|FG001|Overall Study|Withdrawal by Subject|3|||
94509063|NCT01443026|323659644|FG000|Overall Study|Lost to Follow-up|2|||
94509064|NCT01443026|323659645|FG001|Overall Study|Lost to Follow-up|1|||
94509065|NCT02034565|323659646|FG000|Overall Study|Adverse Event|1|||
94509066|NCT02034565|323659647|FG001|Overall Study|Adverse Event|0|||
94509067|NCT02655601|323659648|FG000|Overall Study|Adverse Event|0|||
94509068|NCT02655601|323659649|FG001|Overall Study|Adverse Event|0|||
94509069|NCT02655601|323659650|FG002|Overall Study|Adverse Event|0|||
94509070|NCT02655601|323659651|FG003|Overall Study|Adverse Event|1|||
94509071|NCT02655601|323659652|FG004|Overall Study|Adverse Event|1|||
94509072|NCT02655601|323659653|FG005|Overall Study|Adverse Event|0|||
94509073|NCT02655601|323659648|FG000|Overall Study|Physician Decision|0|||
94509074|NCT02655601|323659649|FG001|Overall Study|Physician Decision|0|||
94509075|NCT02655601|323659650|FG002|Overall Study|Physician Decision|0|||
94509076|NCT02655601|323659651|FG003|Overall Study|Physician Decision|0|||
94509077|NCT02655601|323659652|FG004|Overall Study|Physician Decision|1|||
94509078|NCT02655601|323659653|FG005|Overall Study|Physician Decision|1|||
94509079|NCT02655601|323659648|FG000|Overall Study|Withdrawal by Subject|0|||
94509080|NCT02655601|323659649|FG001|Overall Study|Withdrawal by Subject|0|||
94509081|NCT02655601|323659650|FG002|Overall Study|Withdrawal by Subject|0|||
94509082|NCT02655601|323659651|FG003|Overall Study|Withdrawal by Subject|0|||
94509083|NCT02655601|323659652|FG004|Overall Study|Withdrawal by Subject|4|||
94509084|NCT02655601|323659653|FG005|Overall Study|Withdrawal by Subject|8|||
94509085|NCT02655601|323659648|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
94509086|NCT02655601|323659649|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
94509087|NCT02655601|323659650|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
94509088|NCT02655601|323659651|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
94509089|NCT02655601|323659652|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
94509090|NCT02655601|323659653|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
94509091|NCT01969409|323659656|FG000|Overall Study|Death|2|||
94509092|NCT01969409|323659657|FG001|Overall Study|Death|2|||
94509093|NCT01969409|323659656|FG000|Overall Study|Transplant|1|||
94509094|NCT01969409|323659657|FG001|Overall Study|Transplant|1|||
94509095|NCT01969409|323659656|FG000|Overall Study|Withdrawal by Subject|0|||
94509096|NCT01969409|323659657|FG001|Overall Study|Withdrawal by Subject|1|||
94509097|NCT03975647|323659658|FG000|Overall Study|Death|71|||
94509098|NCT03975647|323659659|FG001|Overall Study|Death|63|||
94509099|NCT03975647|323659658|FG000|Overall Study|Lost to Follow-up|2|||
94509100|NCT03975647|323659659|FG001|Overall Study|Lost to Follow-up|2|||
94509101|NCT03975647|323659658|FG000|Overall Study|Subject withdrawal of consent|7|||
94509102|NCT03975647|323659659|FG001|Overall Study|Subject withdrawal of consent|11|||
94509103|NCT06091956|323659660|FG000|Overall Study|Withdrawal by Subject|1|||
94509104|NCT06091956|323659660|FG000|Overall Study|Complicating Disease|1|||
94509105|NCT00539500|323659671|FG000|Overall Study|Disease Progression|1|||
94509106|NCT00539500|323659671|FG000|Overall Study|Lost to Follow-up|2|||
94509107|NCT02231580|323659676|FG000|Overall Study|Adverse Event|5|||
94509108|NCT02231580|323659677|FG001|Overall Study|Adverse Event|0|||
94509109|NCT04221438|323659678|FG000|Overall Study|Adverse Event|1|||
94509110|NCT04221438|323659678|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
94509111|NCT03034044|323659683|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
94509112|NCT04806373|323659684|FG000|Overall Study|Withdrawal by Subject|1|||
94509113|NCT04806373|323659685|FG001|Overall Study|Withdrawal by Subject|1|||
94509114|NCT05021224|323659686|FG000|Overall Study|Did not complete all survey items|4|||
94509115|NCT05021224|323659687|FG001|Overall Study|Did not complete all survey items|1|||
94509116|NCT05021224|323659688|FG002|Overall Study|Did not complete all survey items|0|||
94509117|NCT05021224|323659689|FG003|Overall Study|Did not complete all survey items|2|||
94509118|NCT02420717|323659694|FG000|Overall Study|Did not receive all study medication|2|||
94509119|NCT02420717|323659695|FG001|Overall Study|Did not receive all study medication|0|||
94509120|NCT02420717|323659696|FG002|Overall Study|Did not receive all study medication|0|||
94509121|NCT02544763|323659697|FG000|Overall Study|Adverse Event|8|||
94509122|NCT02544763|323659698|FG001|Overall Study|Adverse Event|8|||
94509123|NCT02544763|323659699|FG002|Overall Study|Adverse Event|0|||
94509124|NCT02544763|323659697|FG000|Overall Study|Withdrawn by parent/guardian|1|||
94509125|NCT02544763|323659698|FG001|Overall Study|Withdrawn by parent/guardian|1|||
94509126|NCT02544763|323659699|FG002|Overall Study|Withdrawn by parent/guardian|1|||
94509127|NCT02544763|323659697|FG000|Overall Study|Met withdrawal criteria|0|||
94509128|NCT02544763|323659698|FG001|Overall Study|Met withdrawal criteria|2|||
94509129|NCT02544763|323659699|FG002|Overall Study|Met withdrawal criteria|0|||
94509130|NCT02544763|323659697|FG000|Overall Study|Physician Decision|0|||
94509131|NCT02544763|323659698|FG001|Overall Study|Physician Decision|1|||
94509132|NCT02544763|323659699|FG002|Overall Study|Physician Decision|0|||
94509133|NCT02544763|323659697|FG000|Overall Study|Difficulties taking IMP|1|||
94509134|NCT02544763|323659698|FG001|Overall Study|Difficulties taking IMP|0|||
94509135|NCT02544763|323659699|FG002|Overall Study|Difficulties taking IMP|0|||
94509136|NCT01027351|323659700|FG000|Overall Study|Withdrawal by Subject|1|||
94509137|NCT01027351|323659701|FG001|Overall Study|Withdrawal by Subject|0|||
94509138|NCT01027351|323659702|FG002|Overall Study|Withdrawal by Subject|1|||
94509139|NCT01027351|323659703|FG003|Overall Study|Withdrawal by Subject|0|||
94509140|NCT01027351|323659704|FG004|Overall Study|Withdrawal by Subject|3|||
94509141|NCT01027351|323659705|FG005|Overall Study|Withdrawal by Subject|5|||
94509142|NCT01027351|323659700|FG000|Overall Study|Lost to Follow-up|1|||
94509143|NCT01027351|323659701|FG001|Overall Study|Lost to Follow-up|1|||
94509144|NCT01027351|323659702|FG002|Overall Study|Lost to Follow-up|0|||
94509145|NCT01027351|323659703|FG003|Overall Study|Lost to Follow-up|1|||
94509146|NCT01027351|323659704|FG004|Overall Study|Lost to Follow-up|6|||
94509147|NCT01027351|323659705|FG005|Overall Study|Lost to Follow-up|0|||
94509148|NCT01027351|323659700|FG000|Overall Study|Inappropriate enrollment|0|||
94509149|NCT01027351|323659701|FG001|Overall Study|Inappropriate enrollment|0|||
94509150|NCT01027351|323659702|FG002|Overall Study|Inappropriate enrollment|0|||
94509151|NCT01027351|323659703|FG003|Overall Study|Inappropriate enrollment|0|||
94509152|NCT01027351|323659704|FG004|Overall Study|Inappropriate enrollment|1|||
94509153|NCT01027351|323659705|FG005|Overall Study|Inappropriate enrollment|0|||
94509154|NCT01027351|323659700|FG000|Overall Study|Protocol Violation|1|||
94509155|NCT01027351|323659701|FG001|Overall Study|Protocol Violation|0|||
94509156|NCT01027351|323659702|FG002|Overall Study|Protocol Violation|0|||
94509157|NCT01027351|323659703|FG003|Overall Study|Protocol Violation|1|||
94509158|NCT01027351|323659704|FG004|Overall Study|Protocol Violation|1|||
94509159|NCT01027351|323659705|FG005|Overall Study|Protocol Violation|0|||
94509160|NCT00911157|323659706|FG000|Overall Study|Adverse Event|4|||
94509161|NCT00911157|323659707|FG001|Overall Study|Adverse Event|1|||
94509162|NCT00911157|323659706|FG000|Overall Study|Withdrawal by Subject|1|||
94509163|NCT00911157|323659707|FG001|Overall Study|Withdrawal by Subject|1|||
94509164|NCT00911157|323659706|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
94509165|NCT00911157|323659707|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
94509166|NCT00911157|323659706|FG000|Overall Study|Need to treat for lung cancer|1|||
94509167|NCT00911157|323659707|FG001|Overall Study|Need to treat for lung cancer|0|||
94509168|NCT03379870|323661107|FG000|Overall Study|Lost to Follow-up|1|||
94509169|NCT03379870|323661108|FG001|Overall Study|Lost to Follow-up|0|||
94509170|NCT03379870|323661107|FG000|Overall Study|Protocol Violation|1|||
94509171|NCT03379870|323661108|FG001|Overall Study|Protocol Violation|1|||
94509172|NCT00530257|323661113|FG000|Overall Study|Lost to Follow-up|1|||
94509173|NCT00500331|323661116|FG000|Overall Study|Adverse Event|0|||
94509174|NCT00500331|323661117|FG001|Overall Study|Adverse Event|2|||
94509175|NCT00500331|323661118|FG002|Overall Study|Adverse Event|0|||
94509176|NCT00500331|323661119|FG003|Overall Study|Adverse Event|1|||
94509177|NCT00500331|323661120|FG004|Overall Study|Adverse Event|2|||
94509178|NCT00500331|323661121|FG005|Overall Study|Adverse Event|2|||
94509179|NCT00500331|323661122|FG006|Overall Study|Adverse Event|0|||
94509180|NCT00500331|323661116|FG000|Overall Study|Lost to Follow-up|1|||
94509181|NCT00500331|323661117|FG001|Overall Study|Lost to Follow-up|1|||
94509182|NCT00500331|323661118|FG002|Overall Study|Lost to Follow-up|1|||
94509183|NCT00500331|323661119|FG003|Overall Study|Lost to Follow-up|2|||
94509184|NCT00500331|323661120|FG004|Overall Study|Lost to Follow-up|1|||
94509185|NCT00500331|323661121|FG005|Overall Study|Lost to Follow-up|0|||
94509186|NCT00500331|323661122|FG006|Overall Study|Lost to Follow-up|0|||
94509187|NCT00500331|323661116|FG000|Overall Study|Protocol Violation|3|||
94509188|NCT00500331|323661117|FG001|Overall Study|Protocol Violation|1|||
94509189|NCT00500331|323661118|FG002|Overall Study|Protocol Violation|1|||
94509190|NCT00500331|323661119|FG003|Overall Study|Protocol Violation|0|||
94509191|NCT00500331|323661120|FG004|Overall Study|Protocol Violation|1|||
94509192|NCT00500331|323661121|FG005|Overall Study|Protocol Violation|1|||
94509193|NCT00500331|323661122|FG006|Overall Study|Protocol Violation|1|||
94509194|NCT00500331|323661116|FG000|Overall Study|Withdrawal by Subject|4|||
94509195|NCT00500331|323661117|FG001|Overall Study|Withdrawal by Subject|0|||
94509196|NCT00500331|323661118|FG002|Overall Study|Withdrawal by Subject|1|||
94509197|NCT00500331|323661119|FG003|Overall Study|Withdrawal by Subject|5|||
94509198|NCT00500331|323661120|FG004|Overall Study|Withdrawal by Subject|0|||
94509199|NCT00500331|323661121|FG005|Overall Study|Withdrawal by Subject|1|||
94509200|NCT00500331|323661122|FG006|Overall Study|Withdrawal by Subject|1|||
94509201|NCT00500331|323661116|FG000|Overall Study|Lack of Efficacy|3|||
94509202|NCT00500331|323661117|FG001|Overall Study|Lack of Efficacy|1|||
94509203|NCT00500331|323661118|FG002|Overall Study|Lack of Efficacy|0|||
94509204|NCT00500331|323661119|FG003|Overall Study|Lack of Efficacy|0|||
94509205|NCT00500331|323661120|FG004|Overall Study|Lack of Efficacy|0|||
94509206|NCT00500331|323661121|FG005|Overall Study|Lack of Efficacy|0|||
94509207|NCT00500331|323661122|FG006|Overall Study|Lack of Efficacy|0|||
94509208|NCT00500331|323661116|FG000|Overall Study|Liver function test abnormality|0|||
94509209|NCT00500331|323661117|FG001|Overall Study|Liver function test abnormality|0|||
94509210|NCT00500331|323661118|FG002|Overall Study|Liver function test abnormality|1|||
94509211|NCT00500331|323661119|FG003|Overall Study|Liver function test abnormality|0|||
94509212|NCT00500331|323661120|FG004|Overall Study|Liver function test abnormality|0|||
94509213|NCT00500331|323661121|FG005|Overall Study|Liver function test abnormality|0|||
94509214|NCT00500331|323661122|FG006|Overall Study|Liver function test abnormality|0|||
94509215|NCT00500331|323661116|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
94509216|NCT00500331|323661117|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
94509217|NCT00500331|323661118|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
94509218|NCT00500331|323661119|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
94509219|NCT00500331|323661120|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
94509220|NCT00500331|323661121|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
94509221|NCT00500331|323661122|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
94509222|NCT00500331|323661116|FG000|Overall Study|Didn't return for continuation of study|1|||
94509223|NCT00500331|323661117|FG001|Overall Study|Didn't return for continuation of study|0|||
94509224|NCT00500331|323661118|FG002|Overall Study|Didn't return for continuation of study|0|||
94509225|NCT00500331|323661119|FG003|Overall Study|Didn't return for continuation of study|0|||
94509226|NCT00500331|323661120|FG004|Overall Study|Didn't return for continuation of study|0|||
94509227|NCT00500331|323661121|FG005|Overall Study|Didn't return for continuation of study|0|||
94509228|NCT00500331|323661122|FG006|Overall Study|Didn't return for continuation of study|0|||
94509229|NCT00500331|323661116|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
94509230|NCT00500331|323661117|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
94509231|NCT00500331|323661118|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
94509232|NCT00500331|323661119|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
94509233|NCT00500331|323661120|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
94509234|NCT00500331|323661121|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
94509235|NCT00500331|323661122|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
94509236|NCT00500331|323661116|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
94509237|NCT00500331|323661117|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
94509238|NCT00500331|323661118|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
94509239|NCT00500331|323661119|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
94509240|NCT00500331|323661120|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
94509241|NCT00500331|323661121|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
94509242|NCT00500331|323661122|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
94509243|NCT00500331|323661116|FG000|Overall Study|Participant was randomized by mistake|1|||
94509244|NCT00500331|323661117|FG001|Overall Study|Participant was randomized by mistake|0|||
94509245|NCT00500331|323661118|FG002|Overall Study|Participant was randomized by mistake|0|||
94509246|NCT00500331|323661119|FG003|Overall Study|Participant was randomized by mistake|0|||
94509247|NCT00500331|323661120|FG004|Overall Study|Participant was randomized by mistake|0|||
94509248|NCT00500331|323661121|FG005|Overall Study|Participant was randomized by mistake|0|||
94509249|NCT00500331|323661122|FG006|Overall Study|Participant was randomized by mistake|0|||
94509250|NCT00500331|323661116|FG000|Overall Study|Diabetologist nurse in the study|0|||
94509251|NCT00500331|323661117|FG001|Overall Study|Diabetologist nurse in the study|0|||
94509252|NCT00500331|323661118|FG002|Overall Study|Diabetologist nurse in the study|1|||
94509253|NCT00500331|323661119|FG003|Overall Study|Diabetologist nurse in the study|0|||
94509254|NCT00500331|323661120|FG004|Overall Study|Diabetologist nurse in the study|0|||
94509255|NCT00500331|323661121|FG005|Overall Study|Diabetologist nurse in the study|0|||
94509256|NCT00500331|323661122|FG006|Overall Study|Diabetologist nurse in the study|0|||
94509257|NCT00500331|323661116|FG000|Overall Study|State ban of biological samples export|0|||
94509258|NCT00500331|323661117|FG001|Overall Study|State ban of biological samples export|0|||
94509259|NCT00500331|323661118|FG002|Overall Study|State ban of biological samples export|0|||
94509260|NCT00500331|323661119|FG003|Overall Study|State ban of biological samples export|1|||
94509261|NCT00500331|323661120|FG004|Overall Study|State ban of biological samples export|0|||
94509262|NCT00500331|323661121|FG005|Overall Study|State ban of biological samples export|0|||
94509263|NCT00500331|323661122|FG006|Overall Study|State ban of biological samples export|0|||
94509264|NCT00500331|323661116|FG000|Overall Study|Protocol violated|0|||
94509265|NCT00500331|323661117|FG001|Overall Study|Protocol violated|0|||
94509266|NCT00500331|323661118|FG002|Overall Study|Protocol violated|0|||
94509267|NCT00500331|323661119|FG003|Overall Study|Protocol violated|1|||
94509268|NCT00500331|323661120|FG004|Overall Study|Protocol violated|0|||
94509269|NCT00500331|323661121|FG005|Overall Study|Protocol violated|0|||
94509270|NCT00500331|323661122|FG006|Overall Study|Protocol violated|0|||
94509271|NCT01149460|323661124|FG000|Overall Study|Withdrawal by Subject|0|||
94509272|NCT01149460|323661125|FG001|Overall Study|Withdrawal by Subject|2|||
94509273|NCT03682367|323661126|FG000|Overall Study|Protocol Violation|2|||
94509274|NCT03682367|323661127|FG001|Overall Study|Protocol Violation|1|||
94509275|NCT03682367|323661126|FG000|Overall Study|Closed Study Early|0|||
94509276|NCT03682367|323661127|FG001|Overall Study|Closed Study Early|3|||
94509277|NCT03242434|323661128|FG000|Overall Study|Death|0|||
94509278|NCT03242434|323661129|FG001|Overall Study|Death|2|||
94509279|NCT00347269|323661130|FG000|Overall Study|Lost to Follow-up|74|||
94509280|NCT00347269|323661131|FG001|Overall Study|Lost to Follow-up|65|||
94509281|NCT00347269|323661130|FG000|Overall Study|Withdrawal by Subject|18|||
94509282|NCT00347269|323661131|FG001|Overall Study|Withdrawal by Subject|38|||
94509283|NCT00347269|323661130|FG000|Overall Study|Death|2|||
94509284|NCT00347269|323661131|FG001|Overall Study|Death|3|||
94509285|NCT03766399|323661132|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
94509286|NCT03766399|323661133|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
94509287|NCT03766399|323661134|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
94509288|NCT03766399|323661135|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
94509289|NCT03766399|323661136|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
94509290|NCT03766399|323661137|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
94509291|NCT03766399|323661138|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
94509292|NCT03766399|323661139|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
94509293|NCT03766399|323661140|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
94509294|NCT03766399|323661141|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
94509295|NCT03766399|323661142|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
94509296|NCT03766399|323661143|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
94509297|NCT03766399|323661144|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
94509298|NCT03766399|323661145|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
94509299|NCT03766399|323661146|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
94509300|NCT03766399|323661147|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
94509301|NCT03766399|323661148|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
94509302|NCT03766399|323661149|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
94509303|NCT04064567|323661150|FG000|Overall Study|Lost to Follow-up|23|||
94509304|NCT04064567|323661151|FG001|Overall Study|Lost to Follow-up|22|||
94509305|NCT04064567|323661150|FG000|Overall Study|Withdrawal by Subject|0|||
94509306|NCT04064567|323661151|FG001|Overall Study|Withdrawal by Subject|1|||
94509307|NCT04064567|323661150|FG000|Overall Study|Reincarcerated|7|||
94509308|NCT04064567|323661151|FG001|Overall Study|Reincarcerated|10|||
94509309|NCT04064567|323661150|FG000|Overall Study|Moved out of U.S.|0|||
94509310|NCT04064567|323661151|FG001|Overall Study|Moved out of U.S.|1|||
94509311|NCT03464461|323661152|FG000|Overall Study|exclusionary medication given ,|1|||
94509312|NCT03464461|323661153|FG001|Overall Study|exclusionary medication given ,|2|||
94509313|NCT03464461|323661154|FG002|Overall Study|exclusionary medication given ,|0|||
94509314|NCT03464461|323661152|FG000|Overall Study|Physician Decision|0|||
94509315|NCT03464461|323661153|FG001|Overall Study|Physician Decision|1|||
94509316|NCT03464461|323661154|FG002|Overall Study|Physician Decision|0|||
94509317|NCT04281485|323661155|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
94509318|NCT04281485|323661156|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
94509319|NCT04281485|323661155|FG000|Overall Study|Ongoing (Safety data collection)|10|||
94509320|NCT04281485|323661156|FG001|Overall Study|Ongoing (Safety data collection)|5|||
94509321|NCT02951819|323661157|FG000|Overall Study|Death|9|||
94509322|NCT02951819|323661158|FG001|Overall Study|Death|7|||
94509323|NCT02951819|323661157|FG000|Overall Study|Withdrawal by Subject|3|||
94509324|NCT02951819|323661158|FG001|Overall Study|Withdrawal by Subject|0|||
94509325|NCT02951819|323661157|FG000|Overall Study|Adverse Event|1|||
94509326|NCT02951819|323661158|FG001|Overall Study|Adverse Event|0|||
94509327|NCT02951819|323661157|FG000|Overall Study|Lack of Efficacy|4|||
94509328|NCT02951819|323661158|FG001|Overall Study|Lack of Efficacy|0|||
94509329|NCT02951819|323661157|FG000|Overall Study|Lost to Follow-up|1|||
94509330|NCT02951819|323661158|FG001|Overall Study|Lost to Follow-up|0|||
94509331|NCT02951819|323661157|FG000|Overall Study|Progressive Disease|1|||
94509332|NCT02951819|323661158|FG001|Overall Study|Progressive Disease|0|||
94509333|NCT02951819|323661157|FG000|Overall Study|Other|9|||
94509334|NCT02951819|323661158|FG001|Overall Study|Other|0|||
94509335|NCT02202577|323661160|FG000|Overall Study|Lost to Follow-up|6|||
94509336|NCT02202577|323661161|FG001|Overall Study|Lost to Follow-up|16|||
94509337|NCT02202577|323661160|FG000|Overall Study|Protocol Violation|7|||
94509338|NCT02202577|323661161|FG001|Overall Study|Protocol Violation|3|||
94509339|NCT00829868|323661162|FG000|Washout|Physician Decision|1|||
94509340|NCT00829868|323661163|FG001|Washout|Physician Decision|0|||
94509341|NCT02799043|323661164|FG000|Overall Study|Adverse Event|0|||
94509342|NCT02799043|323661165|FG001|Overall Study|Adverse Event|1|||
94509343|NCT02799043|323661164|FG000|Overall Study|Death|1|||
94509344|NCT02799043|323661165|FG001|Overall Study|Death|1|||
94509345|NCT02799043|323661164|FG000|Overall Study|Lost to Follow-up|3|||
94509346|NCT02799043|323661165|FG001|Overall Study|Lost to Follow-up|6|||
94509347|NCT02799043|323661164|FG000|Overall Study|Withdrawal by Subject|4|||
94509348|NCT02799043|323661165|FG001|Overall Study|Withdrawal by Subject|4|||
94509349|NCT02799043|323661164|FG000|Overall Study|Moved to different country|0|||
94509350|NCT02799043|323661165|FG001|Overall Study|Moved to different country|1|||
94509351|NCT02799043|323661164|FG000|Overall Study|Trial Screen Failure|1|||
94509352|NCT02799043|323661165|FG001|Overall Study|Trial Screen Failure|0|||
94509353|NCT02799043|323661164|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
94509354|NCT02799043|323661165|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
94509355|NCT03829683|323661166|FG000|Overall Study|Lost to Follow-up|1|||
94509356|NCT03829683|323661167|FG001|Overall Study|Lost to Follow-up|0|||
94509357|NCT03829683|323661166|FG000|Overall Study|Physician Decision|3|||
94509358|NCT03829683|323661167|FG001|Overall Study|Physician Decision|1|||
94509359|NCT03829683|323661166|FG000|Overall Study|Withdrawal by Subject|0|||
94509360|NCT03829683|323661167|FG001|Overall Study|Withdrawal by Subject|1|||
94509361|NCT03829683|323661166|FG000|Overall Study|Discharge from hospital|1|||
94509362|NCT03829683|323661167|FG001|Overall Study|Discharge from hospital|0|||
94509363|NCT04642079|323661171|FG000|Overall Study|Lost to Follow-up|2|||
94509364|NCT04642079|323661172|FG001|Overall Study|Lost to Follow-up|5|||
94509365|NCT04642079|323661173|FG002|Overall Study|Lost to Follow-up|2|||
94509366|NCT04642079|323661174|FG003|Overall Study|Lost to Follow-up|0|||
94509367|NCT04642079|323661171|FG000|Overall Study|Withdrawal by Subject|0|||
94509368|NCT04642079|323661172|FG001|Overall Study|Withdrawal by Subject|4|||
94509369|NCT04642079|323661173|FG002|Overall Study|Withdrawal by Subject|1|||
94509370|NCT04642079|323661174|FG003|Overall Study|Withdrawal by Subject|2|||
94509371|NCT04642079|323661171|FG000|Overall Study|Other|0|||
94509372|NCT04642079|323661172|FG001|Overall Study|Other|0|||
94509373|NCT04642079|323661173|FG002|Overall Study|Other|0|||
94509374|NCT04642079|323661174|FG003|Overall Study|Other|1|||
94509375|NCT04642079|323661171|FG000|Overall Study|No longer met eligibility criteria|1|||
94509376|NCT04642079|323661172|FG001|Overall Study|No longer met eligibility criteria|0|||
94509377|NCT04642079|323661173|FG002|Overall Study|No longer met eligibility criteria|1|||
94509378|NCT04642079|323661174|FG003|Overall Study|No longer met eligibility criteria|1|||
94509379|NCT02226653|323661175|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
94509380|NCT02226653|323661176|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
94509381|NCT02226653|323661175|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
94509382|NCT02226653|323661176|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
94509383|NCT00635050|323661177|FG000|Overall Study|Withdrawal by Subject|1|||
94509384|NCT04876391|323661178|FG000|Overall Study|Withdrawal by Subject|1|||
94509385|NCT04876391|323661179|FG001|Overall Study|Withdrawal by Subject|10|||
94509386|NCT04876391|323661178|FG000|Overall Study|Lost to Follow-up|2|||
94509387|NCT04876391|323661179|FG001|Overall Study|Lost to Follow-up|4|||
94509388|NCT04876391|323661178|FG000|Overall Study|Lack of Efficacy|0|||
94509389|NCT04876391|323661179|FG001|Overall Study|Lack of Efficacy|2|||
94509390|NCT04876391|323661178|FG000|Overall Study|Adverse Event|3|||
94509391|NCT04876391|323661179|FG001|Overall Study|Adverse Event|1|||
94509392|NCT04876391|323661178|FG000|Overall Study|Patient non-compliance|0|||
94509393|NCT04876391|323661179|FG001|Overall Study|Patient non-compliance|1|||
94509394|NCT04876391|323661178|FG000|Overall Study|Personal reasons|0|||
94509395|NCT04876391|323661179|FG001|Overall Study|Personal reasons|1|||
94509396|NCT04876391|323661178|FG000|Overall Study|Withdrawn as per protocol|2|||
94509397|NCT04876391|323661179|FG001|Overall Study|Withdrawn as per protocol|2|||
94509398|NCT01435356|323661183|FG000|Overall Study|Adverse Event|2|||
94509399|NCT01435356|323661184|FG001|Overall Study|Adverse Event|0|||
94509400|NCT01435356|323661183|FG000|Overall Study|Disease progression/recurrence|17|||
94509401|NCT01435356|323661184|FG001|Overall Study|Disease progression/recurrence|10|||
94509402|NCT01435356|323661183|FG000|Overall Study|Protocol Violation|0|||
94509403|NCT01435356|323661184|FG001|Overall Study|Protocol Violation|1|||
94509404|NCT01435356|323661183|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
94509405|NCT01435356|323661184|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
94509406|NCT01435356|323661183|FG000|Overall Study|Withdrawal by Subject|1|||
94509407|NCT01435356|323661184|FG001|Overall Study|Withdrawal by Subject|1|||
94509408|NCT01435356|323661183|FG000|Overall Study|Facial palsy|1|||
94509409|NCT01435356|323661184|FG001|Overall Study|Facial palsy|0|||
94509410|NCT01435356|323661183|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
94509411|NCT01435356|323661184|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
94509412|NCT01435356|323661183|FG000|Overall Study|Physician Decision|1|||
94509413|NCT01435356|323661184|FG001|Overall Study|Physician Decision|0|||
94509414|NCT01435356|323661183|FG000|Overall Study|Patient decision|3|||
94509415|NCT01435356|323661184|FG001|Overall Study|Patient decision|0|||
94509416|NCT01435356|323661183|FG000|Overall Study|Patient moved to another city|1|||
94509417|NCT01435356|323661184|FG001|Overall Study|Patient moved to another city|1|||
94509418|NCT00209131|323661185|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
94509419|NCT00209131|323661186|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
94509420|NCT05360784|323661187|FG000|Overall Study|Discontinued|25|||
94509421|NCT05360784|323661188|FG001|Overall Study|Discontinued|11|||
94509422|NCT02796651|323661189|FG000|Overall Study|Adverse Event|6|||
94509423|NCT02796651|323661189|FG000|Overall Study|Lost to Follow-up|1|||
94509424|NCT02796651|323661189|FG000|Overall Study|Withdrawal by Subject|4|||
94509425|NCT02796651|323661189|FG000|Overall Study|Protocol Violation|4|||
94509426|NCT02796651|323661189|FG000|Overall Study|Lack of Efficacy|1|||
94509427|NCT02796651|323661189|FG000|Overall Study|Other|10|||
94509428|NCT00265122|323661192|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
94509429|NCT00265122|323661193|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
94509430|NCT00265122|323661194|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
94509431|NCT00265122|323661195|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
94509432|NCT00265122|323661196|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
94509433|NCT00265122|323661197|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
94509434|NCT00265122|323661192|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
94509435|NCT00265122|323661193|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
94509436|NCT00265122|323661194|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
94509437|NCT00265122|323661195|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
94509438|NCT00265122|323661196|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
94509439|NCT00265122|323661197|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
94509440|NCT00265122|323661192|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
94509441|NCT00265122|323661193|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
94509442|NCT00265122|323661194|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
94509443|NCT00265122|323661195|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
94509444|NCT00265122|323661196|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
94509445|NCT00265122|323661197|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
94509446|NCT00265122|323661192|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
94509447|NCT00265122|323661193|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
94509448|NCT00265122|323661194|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
94509449|NCT00265122|323661195|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
94509450|NCT00265122|323661196|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
94509451|NCT00265122|323661197|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
94509452|NCT00265122|323661192|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
94509453|NCT00265122|323661193|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
94509454|NCT00265122|323661194|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
94509455|NCT00265122|323661195|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
94509456|NCT00265122|323661196|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
94509457|NCT00265122|323661197|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
94509458|NCT00265122|323661192|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
94509459|NCT00265122|323661193|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
94509460|NCT00265122|323661194|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
94509461|NCT00265122|323661195|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
94509462|NCT00265122|323661196|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
94509463|NCT00265122|323661197|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
94509464|NCT05142306|323661198|FG000|Overall Study|Withdrawal by Subject|0|||
94509465|NCT05142306|323661199|FG001|Overall Study|Withdrawal by Subject|0|||
94509466|NCT05142306|323661200|FG002|Overall Study|Withdrawal by Subject|1|||
94509467|NCT04079920|323661201|FG000|Overall Study|Adverse event, not related to study drug|2|||
94509468|NCT04079920|323661201|FG000|Overall Study|Adverse event related to study drug|10|||
94509469|NCT04079920|323661201|FG000|Overall Study|Death|2|||
94509470|NCT04079920|323661201|FG000|Overall Study|Lost to Follow-up|22|||
94509471|NCT04079920|323661201|FG000|Overall Study|Physician Decision|1|||
94509472|NCT04079920|323661201|FG000|Overall Study|Withdrawal by Subject|11|||
94509473|NCT02971163|323661202|FG000|Overall Study|Lost to Follow-up|4|||
94509474|NCT02971163|323661203|FG001|Overall Study|Lost to Follow-up|2|||
94509475|NCT01767857|323661206|FG000|Overall Study|Adverse Event|27|||
94509476|NCT01767857|323661207|FG001|Overall Study|Adverse Event|7|||
94509477|NCT01767857|323661206|FG000|Overall Study|Death|28|||
94509478|NCT01767857|323661207|FG001|Overall Study|Death|13|||
94509479|NCT01767857|323661206|FG000|Overall Study|Lack of Efficacy|299|||
94509480|NCT01767857|323661207|FG001|Overall Study|Lack of Efficacy|151|||
94509481|NCT01767857|323661206|FG000|Overall Study|Lost to Follow-up|1|||
94509482|NCT01767857|323661207|FG001|Overall Study|Lost to Follow-up|1|||
94509483|NCT01767857|323661206|FG000|Overall Study|Withdrawal by Subject|38|||
94509484|NCT01767857|323661207|FG001|Overall Study|Withdrawal by Subject|18|||
94509485|NCT01767857|323661206|FG000|Overall Study|Physician Decision|17|||
94509486|NCT01767857|323661207|FG001|Overall Study|Physician Decision|10|||
94509487|NCT01767857|323661206|FG000|Overall Study|Protocol Terminated|1|||
94509488|NCT01767857|323661207|FG001|Overall Study|Protocol Terminated|0|||
94509489|NCT01767857|323661206|FG000|Overall Study|Randomized But Never Treated|19|||
94509490|NCT01767857|323661207|FG001|Overall Study|Randomized But Never Treated|13|||
94509491|NCT01813357|323661210|FG000|Overall Study|Lost to Follow-up|5|||
94509492|NCT01813357|323661211|FG001|Overall Study|Lost to Follow-up|6|||
94509493|NCT03709472|323661214|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
94509494|NCT03709472|323661215|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
94509495|NCT03709472|323661214|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
94509496|NCT03709472|323661215|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
94509497|NCT02412436|323661216|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
94509498|NCT02412436|323661216|FG000|Overall Study|Lost to Follow-up|6|||
94509499|NCT02412436|323661216|FG000|Overall Study|Unable to get to clinic|3|||
94509500|NCT02412436|323661216|FG000|Overall Study|Death|1|||
94509501|NCT02412436|323661216|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
94509502|NCT02097225|323661217|FG000|Dose Level 4|Adverse Event|0|||
94509503|NCT02097225|323661218|FG001|Dose Level 4|Adverse Event|0|||
94509504|NCT02097225|323661219|FG002|Dose Level 4|Adverse Event|0|||
94509505|NCT02097225|323661220|FG003|Dose Level 4|Adverse Event|0|||
94509506|NCT02097225|323661221|FG004|Dose Level 4|Adverse Event|1|||
94509507|NCT03734536|323661222|FG000|Overall Study|Withdrew Consent|1|||
94509508|NCT03734536|323661223|FG001|Overall Study|Withdrew Consent|5|||
94509509|NCT03734536|323661222|FG000|Overall Study|Lost to Follow-up|10|||
94509510|NCT03734536|323661223|FG001|Overall Study|Lost to Follow-up|7|||
94509511|NCT02757963|323661225|FG000|Overall Study|Adverse Event|3|||
94509512|NCT02757963|323661225|FG000|Overall Study|Reached Stopping Criteria|1054|||
94509513|NCT02757963|323661225|FG000|Overall Study|Lost to Follow-up|5|||
94509514|NCT02757963|323661225|FG000|Overall Study|Physician Decision|1|||
94509515|NCT02757963|323661225|FG000|Overall Study|Withdrawal by Subject|34|||
94509516|NCT04755231|323661226|FG000|Overall Study|Lost to Follow-up|5|||
94509517|NCT04755231|323661226|FG000|Overall Study|Withdrawal by Subject|5|||
94509518|NCT02321514|323661227|FG000|Overall Study|Death|15|||
94509519|NCT02321514|323661227|FG000|Overall Study|Missed Visit|7|||
94509520|NCT02321514|323661227|FG000|Overall Study|Study Exit|3|||
94509521|NCT05487378|323661232|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
94509522|NCT05487378|323661233|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
94509523|NCT05487378|323661232|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
94509524|NCT05487378|323661233|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
94509525|NCT01557569|323662274|FG000|Overall Study|Adverse Event|2|||
94509526|NCT01557569|323662275|FG001|Overall Study|Adverse Event|0|||
94509527|NCT01557569|323662274|FG000|Overall Study|high blood pressure|0|||
94509528|NCT01557569|323662275|FG001|Overall Study|high blood pressure|1|||
94509529|NCT01557569|323662274|FG000|Overall Study|Withdrawal by Subject|3|||
94509530|NCT01557569|323662275|FG001|Overall Study|Withdrawal by Subject|5|||
94509531|NCT01557569|323662274|FG000|Overall Study|noncompliance with rules of residential|0|||
94509532|NCT01557569|323662275|FG001|Overall Study|noncompliance with rules of residential|1|||
94509533|NCT02801578|323662280|FG000|Overall Study|Adverse Event|2|||
94509534|NCT00137449|323662281|FG000|Overall Study|Disease Progression|8|||
94509535|NCT00137449|323662282|FG001|Overall Study|Disease Progression|13|||
94509536|NCT00137449|323662281|FG000|Overall Study|Death|4|||
94509537|NCT00137449|323662282|FG001|Overall Study|Death|3|||
94509538|NCT00137449|323662281|FG000|Overall Study|Adverse Event|3|||
94509539|NCT00137449|323662282|FG001|Overall Study|Adverse Event|1|||
94509540|NCT00137449|323662281|FG000|Overall Study|Withdrawal by Subject|1|||
94509541|NCT00137449|323662282|FG001|Overall Study|Withdrawal by Subject|1|||
94509542|NCT01356940|323662283|FG000|First Intervention (28 Days)|Adverse Event|1|||
94509543|NCT01356940|323662284|FG001|First Intervention (28 Days)|Adverse Event|0|||
94509544|NCT01356940|323662283|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
94509545|NCT01356940|323662284|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
94509546|NCT02263547|323662286|FG000|Overall Study|Adverse Event|1|||
94509547|NCT02263547|323662286|FG000|Overall Study|Lost to Follow-up|2|||
94509548|NCT00124657|323662289|FG000|Overall Study|Toxicity|0|||
94509549|NCT00124657|323662290|FG001|Overall Study|Toxicity|0|||
94509550|NCT00124657|323662291|FG002|Overall Study|Toxicity|1|||
94509551|NCT00124657|323662289|FG000|Overall Study|Non-compliance|1|||
94509552|NCT00124657|323662290|FG001|Overall Study|Non-compliance|0|||
94509553|NCT00124657|323662291|FG002|Overall Study|Non-compliance|4|||
94509554|NCT00124657|323662289|FG000|Overall Study|Progressive disease|14|||
94509555|NCT00124657|323662290|FG001|Overall Study|Progressive disease|5|||
94509556|NCT00124657|323662291|FG002|Overall Study|Progressive disease|27|||
94509557|NCT00124657|323662289|FG000|Overall Study|Intercurrent illness|1|||
94509558|NCT00124657|323662290|FG001|Overall Study|Intercurrent illness|0|||
94509559|NCT00124657|323662291|FG002|Overall Study|Intercurrent illness|0|||
94509560|NCT02367885|323662294|FG000|Overall Study|Lost to Follow-up|1|||
94509561|NCT02367885|323662295|FG001|Overall Study|Lost to Follow-up|0|||
94509562|NCT02367885|323662296|FG002|Overall Study|Lost to Follow-up|0|||
94509563|NCT02367885|323662294|FG000|Overall Study|Withdrawal by Subject|1|||
94509564|NCT02367885|323662295|FG001|Overall Study|Withdrawal by Subject|0|||
94509565|NCT02367885|323662296|FG002|Overall Study|Withdrawal by Subject|0|||
94509566|NCT03729609|323662297|FG000|Overall Study|Protocol Violation|1|||
94509567|NCT00830336|323662298|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
94509568|NCT00830336|323662299|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
94509569|NCT04620668|323662302|FG000|Overall Study|Withdrawal by Subject|2|||
94509570|NCT04620668|323662303|FG001|Overall Study|Withdrawal by Subject|0|||
94509571|NCT04620668|323662302|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
94509572|NCT04620668|323662303|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
94509573|NCT04620668|323662302|FG000|Overall Study|Removed before analysis: missing data|2|||
94509574|NCT04620668|323662303|FG001|Overall Study|Removed before analysis: missing data|0|||
94509575|NCT04620668|323662302|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
94509576|NCT04620668|323662303|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
94509577|NCT04620668|323662302|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
94509578|NCT04620668|323662303|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
94509579|NCT03685149|323662305|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
94509580|NCT03685149|323662306|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
94509581|NCT03685149|323662305|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
94509582|NCT03685149|323662306|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
94509583|NCT03685149|323662305|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
94509584|NCT03685149|323662306|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
94509585|NCT02096354|323662311|FG000|Overall Study|Physician Decision|4|||
94509586|NCT02096354|323662312|FG001|Overall Study|Physician Decision|5|||
94509587|NCT02096354|323662313|FG002|Overall Study|Physician Decision|0|||
94509588|NCT02096354|323662311|FG000|Overall Study|Withdrawal by Subject|3|||
94509589|NCT02096354|323662312|FG001|Overall Study|Withdrawal by Subject|1|||
94509590|NCT02096354|323662313|FG002|Overall Study|Withdrawal by Subject|0|||
94509591|NCT02096354|323662311|FG000|Overall Study|Adverse Event|7|||
94509592|NCT02096354|323662312|FG001|Overall Study|Adverse Event|4|||
94509593|NCT02096354|323662313|FG002|Overall Study|Adverse Event|0|||
94509594|NCT02096354|323662311|FG000|Overall Study|Ineligible|0|||
94509595|NCT02096354|323662312|FG001|Overall Study|Ineligible|0|||
94509596|NCT02096354|323662313|FG002|Overall Study|Ineligible|11|||
94509597|NCT03078868|323662317|FG000|Overall Study|Physician Decision|3|||
94509598|NCT01916226|323662321|FG000|Overall Study|Adverse Event|1|||
94509599|NCT01916226|323662322|FG001|Overall Study|Adverse Event|0|||
94509600|NCT01916226|323662323|FG002|Overall Study|Adverse Event|1|||
94509601|NCT01916226|323662324|FG003|Overall Study|Adverse Event|1|||
94509602|NCT01916226|323662321|FG000|Overall Study|Lack of Efficacy|0|||
94509603|NCT01916226|323662322|FG001|Overall Study|Lack of Efficacy|0|||
94509604|NCT01916226|323662323|FG002|Overall Study|Lack of Efficacy|2|||
94509605|NCT01916226|323662324|FG003|Overall Study|Lack of Efficacy|1|||
94509606|NCT01916226|323662321|FG000|Overall Study|Protocol Violation|0|||
94509607|NCT01916226|323662322|FG001|Overall Study|Protocol Violation|1|||
94509608|NCT01916226|323662323|FG002|Overall Study|Protocol Violation|0|||
94509609|NCT01916226|323662324|FG003|Overall Study|Protocol Violation|1|||
94509610|NCT01916226|323662321|FG000|Overall Study|Physician Decision|0|||
94509611|NCT01916226|323662322|FG001|Overall Study|Physician Decision|0|||
94509612|NCT01916226|323662323|FG002|Overall Study|Physician Decision|0|||
94509613|NCT01916226|323662324|FG003|Overall Study|Physician Decision|1|||
94509614|NCT03163667|323662329|FG000|Overall Study|Death|15|||
94509615|NCT03163667|323662330|FG001|Overall Study|Death|27|||
94509616|NCT03163667|323662329|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
94509617|NCT03163667|323662330|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
94509618|NCT04126174|323662331|FG000|Overall Study|Lost to Follow-up|3|||
94509619|NCT04126174|323662332|FG001|Overall Study|Lost to Follow-up|3|||
94509620|NCT03620981|323662333|FG000|Overall Study|Adverse Event|14|||
94509621|NCT03620981|323662334|FG001|Overall Study|Adverse Event|38|||
94509622|NCT03620981|323662335|FG002|Overall Study|Adverse Event|25|||
94509623|NCT03620981|323662333|FG000|Overall Study|Lack of Efficacy|2|||
94509624|NCT03620981|323662334|FG001|Overall Study|Lack of Efficacy|1|||
94509625|NCT03620981|323662335|FG002|Overall Study|Lack of Efficacy|1|||
94509626|NCT03620981|323662333|FG000|Overall Study|Physician Decision|7|||
94509627|NCT03620981|323662334|FG001|Overall Study|Physician Decision|4|||
94509628|NCT03620981|323662335|FG002|Overall Study|Physician Decision|4|||
94509629|NCT03620981|323662333|FG000|Overall Study|Protocol Violation|1|||
94509630|NCT03620981|323662334|FG001|Overall Study|Protocol Violation|2|||
94509631|NCT03620981|323662335|FG002|Overall Study|Protocol Violation|1|||
94509632|NCT03620981|323662333|FG000|Overall Study|Withdrawal by Legal Representative|2|||
94509633|NCT03620981|323662334|FG001|Overall Study|Withdrawal by Legal Representative|1|||
94509634|NCT03620981|323662335|FG002|Overall Study|Withdrawal by Legal Representative|1|||
94509635|NCT03620981|323662333|FG000|Overall Study|Withdrawal by Care Giver|2|||
94509636|NCT03620981|323662334|FG001|Overall Study|Withdrawal by Care Giver|0|||
94509637|NCT03620981|323662335|FG002|Overall Study|Withdrawal by Care Giver|1|||
94509638|NCT03620981|323662333|FG000|Overall Study|Non-compliance with Study Drug|1|||
94509639|NCT03620981|323662334|FG001|Overall Study|Non-compliance with Study Drug|1|||
94509640|NCT03620981|323662335|FG002|Overall Study|Non-compliance with Study Drug|0|||
94509641|NCT04551053|323662338|FG000|Overall Study|Death|9|||
94509642|NCT04551053|323662339|FG001|Overall Study|Death|9|||
94509643|NCT04551053|323662338|FG000|Overall Study|Lost to Follow-up|0|||
94509644|NCT04551053|323662339|FG001|Overall Study|Lost to Follow-up|2|||
94509645|NCT04551053|323662338|FG000|Overall Study|Study Terminated by Sponsor|53|||
94509646|NCT04551053|323662339|FG001|Overall Study|Study Terminated by Sponsor|63|||
94509647|NCT04551053|323662338|FG000|Overall Study|Withdrawal by Subject|12|||
94509648|NCT04551053|323662339|FG001|Overall Study|Withdrawal by Subject|5|||
94509649|NCT04551053|323662338|FG000|Overall Study|Adverse Event|1|||
94509650|NCT04551053|323662339|FG001|Overall Study|Adverse Event|0|||
94509651|NCT04551053|323662338|FG000|Overall Study|Lack of Efficacy|2|||
94509652|NCT04551053|323662339|FG001|Overall Study|Lack of Efficacy|0|||
94509653|NCT04551053|323662338|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
94509654|NCT04551053|323662339|FG001|Overall Study|Transitioned to Rollover per Protocol|3|||
94509655|NCT04551053|323662338|FG000|Overall Study|Splenapendectomi|1|||
94509656|NCT04551053|323662339|FG001|Overall Study|Splenapendectomi|0|||
94509657|NCT04551053|323662338|FG000|Overall Study|Cytomegalovirus pneumonia|1|||
94509658|NCT04551053|323662339|FG001|Overall Study|Cytomegalovirus pneumonia|0|||
94509659|NCT04551053|323662338|FG000|Overall Study|Medical Decision|0|||
94509660|NCT04551053|323662339|FG001|Overall Study|Medical Decision|1|||
94509661|NCT04551053|323662338|FG000|Overall Study|Ongoing|6|||
94509662|NCT04551053|323662339|FG001|Overall Study|Ongoing|4|||
94509663|NCT05375929|323662340|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
94509664|NCT05375929|323662341|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
94509665|NCT05375929|323662342|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
94509666|NCT05375929|323662343|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
94509667|NCT05375929|323662340|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
94509668|NCT05375929|323662341|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
94509669|NCT05375929|323662342|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
94509670|NCT05375929|323662343|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
94509671|NCT05375929|323662340|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
94509672|NCT05375929|323662341|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
94509673|NCT05375929|323662342|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
94509674|NCT05375929|323662343|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
94509675|NCT05375929|323662340|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
94509676|NCT05375929|323662341|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
94509677|NCT05375929|323662342|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
94509678|NCT05375929|323662343|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
94509679|NCT05375929|323662340|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
94509680|NCT05375929|323662341|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
94509681|NCT05375929|323662342|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
94509682|NCT05375929|323662343|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
94509683|NCT05375929|323662340|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
94509684|NCT05375929|323662341|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
94509685|NCT05375929|323662342|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
94509686|NCT05375929|323662343|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
94509687|NCT05375929|323662340|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
94509688|NCT05375929|323662341|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
94509689|NCT05375929|323662342|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
94509690|NCT05375929|323662343|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
94509691|NCT05375929|323662340|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
94509692|NCT05375929|323662341|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
94509693|NCT05375929|323662342|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
94509694|NCT05375929|323662343|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
94509695|NCT05375929|323662340|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
94509696|NCT05375929|323662341|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
94509697|NCT05375929|323662342|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
94509698|NCT05375929|323662343|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
94509699|NCT05375929|323662340|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
94509700|NCT05375929|323662341|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
94509701|NCT05375929|323662342|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
94509702|NCT05375929|323662343|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
94509703|NCT00392288|323662344|FG000|Overall Study|Adverse Event|17|||
94509704|NCT00392288|323662345|FG001|Overall Study|Adverse Event|7|||
94509705|NCT00392288|323662346|FG002|Overall Study|Adverse Event|8|||
94509706|NCT00392288|323662344|FG000|Overall Study|Lack of Efficacy|8|||
94509707|NCT00392288|323662345|FG001|Overall Study|Lack of Efficacy|5|||
94509708|NCT00392288|323662346|FG002|Overall Study|Lack of Efficacy|3|||
94509709|NCT00392288|323662344|FG000|Overall Study|Protocol Violation|1|||
94509710|NCT00392288|323662345|FG001|Overall Study|Protocol Violation|3|||
94509711|NCT00392288|323662346|FG002|Overall Study|Protocol Violation|1|||
94509712|NCT00392288|323662344|FG000|Overall Study|Lost to Follow-up|1|||
94509713|NCT00392288|323662345|FG001|Overall Study|Lost to Follow-up|1|||
94509714|NCT00392288|323662346|FG002|Overall Study|Lost to Follow-up|1|||
94509715|NCT00392288|323662344|FG000|Overall Study|Withdrawal by Subject|1|||
94509716|NCT00392288|323662345|FG001|Overall Study|Withdrawal by Subject|0|||
94509717|NCT00392288|323662346|FG002|Overall Study|Withdrawal by Subject|2|||
94509718|NCT00392288|323662344|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
94509719|NCT00392288|323662345|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
94509720|NCT00392288|323662346|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
94509721|NCT00392288|323662344|FG000|Overall Study|Other|3|||
94509722|NCT00392288|323662345|FG001|Overall Study|Other|4|||
94509723|NCT00392288|323662346|FG002|Overall Study|Other|1|||
94509724|NCT02496000|323662347|FG000|Overall Study|Withdrawal by Subject|1|||
94509725|NCT02496000|323662348|FG001|Overall Study|Withdrawal by Subject|2|||
94509726|NCT02496000|323662349|FG002|Overall Study|Withdrawal by Subject|0|||
94509727|NCT02496000|323662347|FG000|Overall Study|Lost to Follow-up|1|||
94509728|NCT02496000|323662348|FG001|Overall Study|Lost to Follow-up|0|||
94509729|NCT02496000|323662349|FG002|Overall Study|Lost to Follow-up|1|||
94509730|NCT02496000|323662347|FG000|Overall Study|Protocol Violation|0|||
94509731|NCT02496000|323662348|FG001|Overall Study|Protocol Violation|0|||
94509732|NCT02496000|323662349|FG002|Overall Study|Protocol Violation|1|||
94509733|NCT02496000|323662347|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
94509734|NCT02496000|323662348|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
94509735|NCT02496000|323662349|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
94509736|NCT02496000|323662347|FG000|Overall Study|undetermined|0|||
94509737|NCT02496000|323662348|FG001|Overall Study|undetermined|1|||
94509738|NCT02496000|323662349|FG002|Overall Study|undetermined|0|||
94509739|NCT01111552|323662350|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
94509740|NCT01111552|323662351|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
94509741|NCT01111552|323662352|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
94509742|NCT01111552|323662353|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
94509743|NCT01111552|323662354|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
94509744|NCT01111552|323662350|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
94509745|NCT01111552|323662351|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
94509746|NCT01111552|323662352|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
94509747|NCT01111552|323662353|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
94509748|NCT01111552|323662354|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
94509749|NCT01111552|323662350|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
94509750|NCT01111552|323662351|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
94509751|NCT01111552|323662352|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
94509752|NCT01111552|323662353|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
94509753|NCT01111552|323662354|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
94509754|NCT01111552|323662350|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
94509755|NCT01111552|323662351|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
94509756|NCT01111552|323662352|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
94509757|NCT01111552|323662353|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
94509758|NCT01111552|323662354|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
94509759|NCT01111552|323662350|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
94509760|NCT01111552|323662351|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
94509761|NCT01111552|323662352|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
94509762|NCT01111552|323662353|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
94509763|NCT01111552|323662354|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
94509764|NCT01111552|323662350|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
94509765|NCT01111552|323662351|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
94509766|NCT01111552|323662352|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
94509767|NCT01111552|323662353|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
94509768|NCT01111552|323662354|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
94509769|NCT01111552|323662350|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
94509770|NCT01111552|323662351|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
94509771|NCT01111552|323662352|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
94509772|NCT01111552|323662353|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
94509773|NCT01111552|323662354|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
94509774|NCT01111552|323662350|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
94509775|NCT01111552|323662351|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
94509776|NCT01111552|323662352|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
94509777|NCT01111552|323662353|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
94509778|NCT01111552|323662354|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
94509779|NCT01111552|323662350|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
94509780|NCT01111552|323662351|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
94509781|NCT01111552|323662352|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
94509782|NCT01111552|323662353|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
94509783|NCT01111552|323662354|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
94509784|NCT01111552|323662350|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
94509785|NCT01111552|323662351|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
94509786|NCT01111552|323662352|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
94509787|NCT01111552|323662353|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
94509788|NCT01111552|323662354|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
94509789|NCT01111552|323662350|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
94509790|NCT01111552|323662351|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
94509791|NCT01111552|323662352|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
94509792|NCT01111552|323662353|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
94509793|NCT01111552|323662354|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
94509794|NCT01111552|323662350|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
94509795|NCT01111552|323662351|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
94509796|NCT01111552|323662352|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
94509797|NCT01111552|323662353|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
94509798|NCT01111552|323662354|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
94509799|NCT01111552|323662350|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
94509800|NCT01111552|323662351|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
94509801|NCT01111552|323662352|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
94509802|NCT01111552|323662353|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
94509803|NCT01111552|323662354|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
94509804|NCT01111552|323662350|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
94509805|NCT01111552|323662351|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
94509806|NCT01111552|323662352|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
94509807|NCT01111552|323662353|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
94509808|NCT01111552|323662354|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
94509809|NCT02255656|323662355|FG000|Overall Study|Adverse Event|11|||
94509810|NCT02255656|323662355|FG000|Overall Study|Poor compliance to protocol|3|||
94509811|NCT02255656|323662355|FG000|Overall Study|Lost to Follow-up|30|||
94509812|NCT02255656|323662355|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
94509813|NCT02255656|323662355|FG000|Overall Study|Other|126|||
94509814|NCT01877278|323662356|FG000|Overall Study|Lost to Follow-up|3|||
94509815|NCT01877278|323662357|FG001|Overall Study|Lost to Follow-up|3|||
94509816|NCT04727151|323662358|FG000|Overall Study|Death|0|||
94509817|NCT04727151|323662359|FG001|Overall Study|Death|0|||
94509818|NCT04727151|323662360|FG002|Overall Study|Death|0|||
94509819|NCT04727151|323662361|FG003|Overall Study|Death|0|||
94509820|NCT04727151|323662362|FG004|Overall Study|Death|3|||
94509821|NCT04727151|323662358|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
94509822|NCT04727151|323662359|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
94509823|NCT04727151|323662360|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
94509824|NCT04727151|323662361|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
94509825|NCT04727151|323662362|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
94509826|NCT02679274|323662364|FG000|Overall Study|Withdrawal by Subject|1|||
94509827|NCT02679274|323662365|FG001|Overall Study|Withdrawal by Subject|0|||
94509828|NCT00322218|323662366|FG000|Overall Study|Death|3|||
94509829|NCT00322218|323662367|FG001|Overall Study|Death|6|||
94509830|NCT04144517|323662368|FG000|Overall Study|Physician Decision|0|||
94509831|NCT04144517|323662369|FG001|Overall Study|Physician Decision|1|||
94509832|NCT04144517|323662368|FG000|Overall Study|Other|2|||
94509833|NCT04144517|323662369|FG001|Overall Study|Other|2|||
94509834|NCT04144517|323662368|FG000|Overall Study|Death|6|||
94509835|NCT04144517|323662369|FG001|Overall Study|Death|3|||
94509836|NCT04801420|323662378|FG000|Overall Study|Other|1|||
94509837|NCT04801420|323662379|FG001|Overall Study|Other|2|||
94509838|NCT04801420|323662380|FG002|Overall Study|Other|1|||
94509839|NCT04801420|323662378|FG000|Overall Study|Lost to Follow-up|7|||
94509840|NCT04801420|323662379|FG001|Overall Study|Lost to Follow-up|9|||
94509841|NCT04801420|323662380|FG002|Overall Study|Lost to Follow-up|10|||
94509842|NCT04801420|323662378|FG000|Overall Study|Moved from study area|0|||
94509843|NCT04801420|323662379|FG001|Overall Study|Moved from study area|1|||
94509844|NCT04801420|323662380|FG002|Overall Study|Moved from study area|1|||
94509845|NCT04801420|323662378|FG000|Overall Study|Withdrawal by Subject|5|||
94509846|NCT04801420|323662379|FG001|Overall Study|Withdrawal by Subject|1|||
94509847|NCT04801420|323662380|FG002|Overall Study|Withdrawal by Subject|4|||
94509848|NCT04801420|323662378|FG000|Overall Study|Individual stopping criteria reached|0|||
94509849|NCT04801420|323662379|FG001|Overall Study|Individual stopping criteria reached|1|||
94509850|NCT04801420|323662380|FG002|Overall Study|Individual stopping criteria reached|0|||
94509851|NCT04801420|323662378|FG000|Overall Study|Ongoing in the study|195|||
94509852|NCT04801420|323662379|FG001|Overall Study|Ongoing in the study|195|||
94509853|NCT04801420|323662380|FG002|Overall Study|Ongoing in the study|192|||
94509854|NCT02113878|323663646|FG000|Overall Study|Adverse Event|1|||
94509855|NCT02113878|323663647|FG001|Overall Study|Adverse Event|0|||
94509856|NCT02113878|323663646|FG000|Overall Study|Withdrawal by Subject|1|||
94509857|NCT02113878|323663647|FG001|Overall Study|Withdrawal by Subject|0|||
94509858|NCT02113878|323663646|FG000|Overall Study|patient non-compliance|1|||
94509859|NCT02113878|323663647|FG001|Overall Study|patient non-compliance|0|||
94509860|NCT00581100|323663648|FG000|Overall Study|Death|1|||
94509861|NCT00581100|323663649|FG001|Overall Study|Death|0|||
94509862|NCT00581100|323663648|FG000|Overall Study|Adverse Event|2|||
94509863|NCT00581100|323663649|FG001|Overall Study|Adverse Event|1|||
94509864|NCT00581100|323663648|FG000|Overall Study|Withdrawal by Subject|1|||
94509865|NCT00581100|323663649|FG001|Overall Study|Withdrawal by Subject|4|||
94509866|NCT00581100|323663648|FG000|Overall Study|Other|3|||
94509867|NCT00581100|323663649|FG001|Overall Study|Other|0|||
94509868|NCT03058952|323663652|FG000|Overall Study|Adverse Event|1|||
94509869|NCT03058952|323663653|FG001|Overall Study|Adverse Event|0|||
94509870|NCT03058952|323663652|FG000|Overall Study|Lost to Follow-up|15|||
94509871|NCT03058952|323663653|FG001|Overall Study|Lost to Follow-up|15|||
94509872|NCT03058952|323663652|FG000|Overall Study|Withdrawal by Subject|7|||
94509873|NCT03058952|323663653|FG001|Overall Study|Withdrawal by Subject|11|||
94509874|NCT00590317|323663654|FG000|Overall Study|Lack of Efficacy|1|||
94509875|NCT00590317|323663655|FG001|Overall Study|Lack of Efficacy|5|||
94509876|NCT03977155|323663658|FG000|Overall Study|Adverse Event|3|||
94509877|NCT03977155|323663659|FG001|Overall Study|Adverse Event|0|||
94509878|NCT03977155|323663660|FG002|Overall Study|Adverse Event|0|||
94509879|NCT03977155|323663658|FG000|Overall Study|Lost to Follow-up|0|||
94509880|NCT03977155|323663659|FG001|Overall Study|Lost to Follow-up|1|||
94509881|NCT03977155|323663660|FG002|Overall Study|Lost to Follow-up|0|||
94509882|NCT03977155|323663658|FG000|Overall Study|Withdrawal by Subject|1|||
94509883|NCT03977155|323663659|FG001|Overall Study|Withdrawal by Subject|1|||
94509884|NCT03977155|323663660|FG002|Overall Study|Withdrawal by Subject|2|||
94509885|NCT03977155|323663658|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
94509886|NCT03977155|323663659|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
94509887|NCT03977155|323663660|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
94509888|NCT02904265|323663661|FG000|Overall Study|Physician Decision|1|||
94509889|NCT02904265|323663662|FG001|Overall Study|Physician Decision|2|||
94509890|NCT02579759|323663663|FG000|Overall Study|Protocol Violation|2|||
94509891|NCT02579759|323663664|FG001|Overall Study|Protocol Violation|0|||
94509892|NCT02579759|323663665|FG002|Overall Study|Protocol Violation|0|||
94509893|NCT02579759|323663663|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
94509894|NCT02579759|323663664|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
94509895|NCT02579759|323663665|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
94509896|NCT02579759|323663663|FG000|Overall Study|BfArM hold|13|||
94509897|NCT02579759|323663664|FG001|Overall Study|BfArM hold|12|||
94509898|NCT02579759|323663665|FG002|Overall Study|BfArM hold|12|||
94509899|NCT02579759|323663663|FG000|Overall Study|Sponsor stopped Dose 2|0|||
94509900|NCT02579759|323663664|FG001|Overall Study|Sponsor stopped Dose 2|41|||
94509901|NCT02579759|323663665|FG002|Overall Study|Sponsor stopped Dose 2|0|||
94509902|NCT02579759|323663663|FG000|Overall Study|Non compliance|0|||
94509903|NCT02579759|323663664|FG001|Overall Study|Non compliance|1|||
94509904|NCT02579759|323663665|FG002|Overall Study|Non compliance|0|||
94509905|NCT02579759|323663663|FG000|Overall Study|Pregnancy|0|||
94509906|NCT02579759|323663664|FG001|Overall Study|Pregnancy|1|||
94509907|NCT02579759|323663665|FG002|Overall Study|Pregnancy|0|||
94509908|NCT02579759|323663663|FG000|Overall Study|Inclusion/exclusion criteria|0|||
94509909|NCT02579759|323663664|FG001|Overall Study|Inclusion/exclusion criteria|0|||
94509910|NCT02579759|323663665|FG002|Overall Study|Inclusion/exclusion criteria|1|||
94509911|NCT02579759|323663663|FG000|Overall Study|Adverse Event|4|||
94509912|NCT02579759|323663664|FG001|Overall Study|Adverse Event|3|||
94509913|NCT02579759|323663665|FG002|Overall Study|Adverse Event|1|||
94509914|NCT02579759|323663663|FG000|Overall Study|Withdrawal by Subject|3|||
94509915|NCT02579759|323663664|FG001|Overall Study|Withdrawal by Subject|3|||
94509916|NCT02579759|323663665|FG002|Overall Study|Withdrawal by Subject|5|||
94509917|NCT02579759|323663663|FG000|Overall Study|Lost to Follow-up|2|||
94509918|NCT02579759|323663664|FG001|Overall Study|Lost to Follow-up|2|||
94509919|NCT02579759|323663665|FG002|Overall Study|Lost to Follow-up|2|||
94509920|NCT00488293|323663666|FG000|Overall Study|Lost to Follow-up|28|||
94509921|NCT00488293|323663667|FG001|Overall Study|Lost to Follow-up|25|||
94509922|NCT00488293|323663666|FG000|Overall Study|Withdrawal by Subject|5|||
94509923|NCT00488293|323663667|FG001|Overall Study|Withdrawal by Subject|3|||
94509924|NCT00488293|323663666|FG000|Overall Study|Death|2|||
94509925|NCT00488293|323663667|FG001|Overall Study|Death|1|||
94509926|NCT00488293|323663666|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
94509927|NCT00488293|323663667|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
94509928|NCT03345550|323663668|FG000|Overall Study|Withdrawal by Subject|1|||
94509929|NCT03345550|323663669|FG001|Overall Study|Withdrawal by Subject|0|||
94509930|NCT03345550|323663668|FG000|Overall Study|Lost to Follow-up|4|||
94509931|NCT03345550|323663669|FG001|Overall Study|Lost to Follow-up|5|||
94509932|NCT01892189|323663674|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
94509933|NCT01892189|323663675|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
94509934|NCT01892189|323663676|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
94509935|NCT01892189|323663677|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
94509936|NCT01892189|323663678|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
94509937|NCT01892189|323663679|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
94509938|NCT01892189|323663680|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
94509939|NCT01892189|323663681|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
94509940|NCT01892189|323663682|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
94509941|NCT01892189|323663674|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
94509942|NCT01892189|323663675|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
94509943|NCT01892189|323663676|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
94509944|NCT01892189|323663677|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
94509945|NCT01892189|323663678|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
94509946|NCT01892189|323663679|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
94509947|NCT01892189|323663680|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
94509948|NCT01892189|323663681|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
94509949|NCT01892189|323663682|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
94509950|NCT01892189|323663674|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
94509951|NCT01892189|323663675|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
94509952|NCT01892189|323663676|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
94509953|NCT01892189|323663677|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
94509954|NCT01892189|323663678|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
94509955|NCT01892189|323663679|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
94509956|NCT01892189|323663680|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
94509957|NCT01892189|323663681|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
94509958|NCT01892189|323663682|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
94509959|NCT01537432|323663683|FG000|Overall Study|Lost to Follow-up|3|||
94509960|NCT01537432|323663684|FG001|Overall Study|Lost to Follow-up|1|||
94509961|NCT01537432|323663683|FG000|Overall Study|Withdrawal by Subject|0|||
94509962|NCT01537432|323663684|FG001|Overall Study|Withdrawal by Subject|1|||
94509963|NCT01537432|323663683|FG000|Overall Study|Administrative problems|1|||
94509964|NCT01537432|323663684|FG001|Overall Study|Administrative problems|0|||
94509965|NCT01537432|323663683|FG000|Overall Study|Adverse Event|1|||
94509966|NCT01537432|323663684|FG001|Overall Study|Adverse Event|0|||
94509967|NCT01537432|323663683|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94509968|NCT01537432|323663684|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94509969|NCT04992273|323663685|FG000|Overall Study|Lost to Follow-up|0|||
94509970|NCT04992273|323663686|FG001|Overall Study|Lost to Follow-up|1|||
94509971|NCT02439957|323663687|FG000|Overall Study|Study Terminated|3|||
94509972|NCT02439957|323663688|FG001|Overall Study|Study Terminated|3|||
94509973|NCT00770679|323663689|FG000|Overall Study|Lost to Follow-up|3|||
94509974|NCT00770679|323663689|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
94509975|NCT03802916|323663690|FG000|Overall Study|Adverse Event|0|||
94509976|NCT03802916|323663691|FG001|Overall Study|Adverse Event|1|||
94509977|NCT03802916|323663690|FG000|Overall Study|Withdrawal by Subject|0|||
94509978|NCT03802916|323663691|FG001|Overall Study|Withdrawal by Subject|1|||
94509979|NCT00779909|323663692|FG000|Overall Study|Lost to Follow-up|1|||
94509980|NCT00779909|323663693|FG001|Overall Study|Lost to Follow-up|0|||
94509981|NCT00779909|323663694|FG002|Overall Study|Lost to Follow-up|0|||
94509982|NCT00779909|323663695|FG003|Overall Study|Lost to Follow-up|1|||
94509983|NCT00779909|323663692|FG000|Overall Study|Withdrawal by Subject|0|||
94509984|NCT00779909|323663693|FG001|Overall Study|Withdrawal by Subject|1|||
94509985|NCT00779909|323663694|FG002|Overall Study|Withdrawal by Subject|0|||
94509986|NCT00779909|323663695|FG003|Overall Study|Withdrawal by Subject|0|||
94509987|NCT01285102|323663696|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
94509988|NCT01817777|323663698|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
94509989|NCT01817777|323663699|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
94509990|NCT01817777|323663700|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
94509991|NCT01817777|323663698|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
94509992|NCT01817777|323663699|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
94509993|NCT01817777|323663700|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
94509994|NCT01817777|323663698|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
94509995|NCT01817777|323663699|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
94509996|NCT01817777|323663700|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
94509997|NCT01817777|323663698|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
94509998|NCT01817777|323663699|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
94509999|NCT01817777|323663700|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
94510000|NCT01817777|323663698|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
94510001|NCT01817777|323663699|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
94510002|NCT01817777|323663700|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
94510003|NCT03847519|323663703|FG000|Overall Study|Death|5|||
94510004|NCT03847519|323663704|FG001|Overall Study|Death|8|||
94510005|NCT03847519|323663705|FG002|Overall Study|Death|1|||
94510006|NCT03847519|323663703|FG000|Overall Study|Lost to Follow-up|1|||
94510007|NCT03847519|323663704|FG001|Overall Study|Lost to Follow-up|2|||
94510008|NCT03847519|323663705|FG002|Overall Study|Lost to Follow-up|0|||
94510009|NCT03847519|323663703|FG000|Overall Study|Study Terminated by Sponsor|0|||
94510010|NCT03847519|323663704|FG001|Overall Study|Study Terminated by Sponsor|3|||
94510011|NCT03847519|323663705|FG002|Overall Study|Study Terminated by Sponsor|2|||
94510012|NCT00425555|323663706|FG000|Overall Study|Withdrawal by Subject|11|||
94510013|NCT00425555|323663707|FG001|Overall Study|Withdrawal by Subject|8|||
94510014|NCT00425555|323663706|FG000|Overall Study|Lost to Follow-up|0|||
94510015|NCT00425555|323663707|FG001|Overall Study|Lost to Follow-up|1|||
94510016|NCT00425555|323663706|FG000|Overall Study|Administrative problems|3|||
94510017|NCT00425555|323663707|FG001|Overall Study|Administrative problems|0|||
94510018|NCT00425555|323663706|FG000|Overall Study|Death|1|||
94510019|NCT00425555|323663707|FG001|Overall Study|Death|2|||
94510020|NCT00425555|323663706|FG000|Overall Study|New cancer therapy|2|||
94510021|NCT00425555|323663707|FG001|Overall Study|New cancer therapy|1|||
94510022|NCT00425555|323663706|FG000|Overall Study|Disease progression|36|||
94510023|NCT00425555|323663707|FG001|Overall Study|Disease progression|33|||
94510024|NCT00425555|323663706|FG000|Overall Study|Adverse Event|25|||
94510025|NCT00425555|323663707|FG001|Overall Study|Adverse Event|15|||
94510026|NCT00425555|323663706|FG000|Overall Study|Protocol Violation|1|||
94510027|NCT00425555|323663707|FG001|Overall Study|Protocol Violation|0|||
94510028|NCT00867334|323663708|FG000|Overall Study|Withdrawal by Subject|0|||
94510029|NCT00867334|323663709|FG001|Overall Study|Withdrawal by Subject|1|||
94510030|NCT00867334|323663708|FG000|Overall Study|Withdrawal by Subject|1|||
94510031|NCT00867334|323663709|FG001|Overall Study|Withdrawal by Subject|0|||
94510032|NCT00867334|323663708|FG000|Overall Study|Withdrawal by Subject|1|||
94510033|NCT00867334|323663709|FG001|Overall Study|Withdrawal by Subject|0|||
94510034|NCT00863304|323663713|FG000|Overall Study|Adverse Event|10|||
94510035|NCT00863304|323663714|FG001|Overall Study|Adverse Event|4|||
94510036|NCT00863304|323663715|FG002|Overall Study|Adverse Event|14|||
94510037|NCT00863304|323663716|FG003|Overall Study|Adverse Event|16|||
94510038|NCT00863304|323663713|FG000|Overall Study|Lost to Follow-up|1|||
94510039|NCT00863304|323663714|FG001|Overall Study|Lost to Follow-up|5|||
94510040|NCT00863304|323663715|FG002|Overall Study|Lost to Follow-up|4|||
94510041|NCT00863304|323663716|FG003|Overall Study|Lost to Follow-up|2|||
94510042|NCT00863304|323663713|FG000|Overall Study|Lack of Efficacy|57|||
94510043|NCT00863304|323663714|FG001|Overall Study|Lack of Efficacy|26|||
94510044|NCT00863304|323663715|FG002|Overall Study|Lack of Efficacy|30|||
94510045|NCT00863304|323663716|FG003|Overall Study|Lack of Efficacy|28|||
94510046|NCT00863304|323663713|FG000|Overall Study|Withdrawal by Subject|19|||
94510047|NCT00863304|323663714|FG001|Overall Study|Withdrawal by Subject|14|||
94510048|NCT00863304|323663715|FG002|Overall Study|Withdrawal by Subject|20|||
94510049|NCT00863304|323663716|FG003|Overall Study|Withdrawal by Subject|18|||
94510050|NCT00863304|323663713|FG000|Overall Study|Other|1|||
94510051|NCT00863304|323663714|FG001|Overall Study|Other|0|||
94510052|NCT00863304|323663715|FG002|Overall Study|Other|0|||
94510053|NCT00863304|323663716|FG003|Overall Study|Other|1|||
94510054|NCT00863304|323663713|FG000|Overall Study|Protocol Violation|2|||
94510055|NCT00863304|323663714|FG001|Overall Study|Protocol Violation|6|||
94510056|NCT00863304|323663715|FG002|Overall Study|Protocol Violation|2|||
94510057|NCT00863304|323663716|FG003|Overall Study|Protocol Violation|0|||
94510058|NCT00863304|323663713|FG000|Overall Study|Randomized, but not Treated|3|||
94510059|NCT00863304|323663714|FG001|Overall Study|Randomized, but not Treated|1|||
94510060|NCT00863304|323663715|FG002|Overall Study|Randomized, but not Treated|4|||
94510061|NCT00863304|323663716|FG003|Overall Study|Randomized, but not Treated|1|||
94510062|NCT00863304|323663713|FG000|Overall Study|Entered extension study|101|||
94510063|NCT00863304|323663714|FG001|Overall Study|Entered extension study|129|||
94510064|NCT00863304|323663715|FG002|Overall Study|Entered extension study|113|||
94510065|NCT00863304|323663716|FG003|Overall Study|Entered extension study|125|||
94510066|NCT01148771|323663717|FG000|Washout Period|Withdrawal by Subject|0|||
94510067|NCT01148771|323663718|FG001|Washout Period|Withdrawal by Subject|1|||
94510068|NCT02758626|323663725|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
94510069|NCT02758626|323663726|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
94510070|NCT02758626|323663725|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
94510071|NCT02758626|323663726|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
94510072|NCT02758626|323663725|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
94510073|NCT02758626|323663726|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
94510074|NCT02758626|323663725|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
94510075|NCT02758626|323663726|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
94510076|NCT01309230|323663727|FG000|Overall Study|Withdrawal by Subject|0|||
94510077|NCT01309230|323663728|FG001|Overall Study|Withdrawal by Subject|2|||
94510078|NCT01309230|323663727|FG000|Overall Study|Observation arm closed|0|||
94510079|NCT01309230|323663728|FG001|Overall Study|Observation arm closed|2|||
94510080|NCT02661815|323663729|FG000|Overall Study|Withdrawal by Subject|1|||
94510081|NCT02661815|323663730|FG001|Overall Study|Withdrawal by Subject|0|||
94510082|NCT02661815|323663731|FG002|Overall Study|Withdrawal by Subject|0|||
94510083|NCT02661815|323663732|FG003|Overall Study|Withdrawal by Subject|0|||
94510084|NCT00581919|323663733|FG000|Overall Study|Adverse Event|8|||
94510085|NCT00581919|323663733|FG000|Overall Study|Death|1|||
94510086|NCT00581919|323663733|FG000|Overall Study|Disease Progression|10|||
94510087|NCT00581919|323663733|FG000|Overall Study|Physician Decision|1|||
94510088|NCT00581919|323663733|FG000|Overall Study|Other Complicating Disease|1|||
94510089|NCT00581919|323663733|FG000|Overall Study|Started Non-Protocol Therapy|2|||
94510090|NCT00581919|323663733|FG000|Overall Study|Withdrawal by Subject|1|||
94510091|NCT03900650|323663734|FG000|Overall Study|Withdrawal by Subject|1|||
94510092|NCT03900650|323663735|FG001|Overall Study|Withdrawal by Subject|1|||
94510093|NCT03900650|323663736|FG002|Overall Study|Withdrawal by Subject|0|||
94510094|NCT03900650|323663737|FG003|Overall Study|Withdrawal by Subject|0|||
94510095|NCT03900650|323663734|FG000|Overall Study|Withdrawn by staff|1|||
94510096|NCT03900650|323663735|FG001|Overall Study|Withdrawn by staff|0|||
94510097|NCT03900650|323663736|FG002|Overall Study|Withdrawn by staff|0|||
94510098|NCT03900650|323663737|FG003|Overall Study|Withdrawn by staff|0|||
94510099|NCT00113373|323663738|FG000|Overall Study|Ineligible: wrong primary|1|||
94510100|NCT00113373|323663738|FG000|Overall Study|Ineligible: second primary|1|||
94510101|NCT00113373|323663738|FG000|Overall Study|Never Treated|1|||
94510102|NCT04875533|323663746|FG000|Overall Study|Adverse Event|6|||
94510103|NCT04875533|323663747|FG001|Overall Study|Adverse Event|4|||
94510104|NCT04875533|323663746|FG000|Overall Study|Protocol Violation|4|||
94510105|NCT04875533|323663747|FG001|Overall Study|Protocol Violation|0|||
94510106|NCT04875533|323663746|FG000|Overall Study|Withdrawal by Subject|8|||
94510107|NCT04875533|323663747|FG001|Overall Study|Withdrawal by Subject|5|||
94510108|NCT04875533|323663746|FG000|Overall Study|No longer meets eligibility criteria|1|||
94510109|NCT04875533|323663747|FG001|Overall Study|No longer meets eligibility criteria|0|||
94510110|NCT04875533|323663746|FG000|Overall Study|Other|0|||
94510111|NCT04875533|323663747|FG001|Overall Study|Other|2|||
94510112|NCT03131479|323663753|FG000|Overall Study|Adverse Event|0|||
94510113|NCT03131479|323663754|FG001|Overall Study|Adverse Event|0|||
94510114|NCT03131479|323663755|FG002|Overall Study|Adverse Event|1|||
94510115|NCT03131479|323663756|FG003|Overall Study|Adverse Event|1|||
94510116|NCT03131479|323663757|FG004|Overall Study|Adverse Event|0|||
94510117|NCT03131479|323663753|FG000|Overall Study|Subject/Guardian Decision|0|||
94510118|NCT03131479|323663754|FG001|Overall Study|Subject/Guardian Decision|0|||
94510119|NCT03131479|323663755|FG002|Overall Study|Subject/Guardian Decision|0|||
94510120|NCT03131479|323663756|FG003|Overall Study|Subject/Guardian Decision|1|||
94510121|NCT03131479|323663757|FG004|Overall Study|Subject/Guardian Decision|0|||
94510122|NCT05305651|323663758|FG000|Overall Study|Death|1|||
94510123|NCT05305651|323663758|FG000|Overall Study|Withdrawal by Subject|4|||
94510124|NCT05305651|323663758|FG000|Overall Study|Lost to Follow-up|4|||
94510125|NCT01979185|323663759|FG000|Period 2|Other|0|||
94510126|NCT01979185|323663760|FG001|Period 2|Other|1|||
94510127|NCT02871219|323663761|FG000|Overall Study|Adverse Event|15|||
94510128|NCT02871219|323663761|FG000|Overall Study|Death|3|||
94510129|NCT02871219|323663761|FG000|Overall Study|Progression|3|||
94510130|NCT02871219|323663761|FG000|Overall Study|Infections|7|||
94510131|NCT02871219|323663761|FG000|Overall Study|Infusion Related|4|||
94510132|NCT04082364|323663762|FG000|Overall Study|Death|23|||
94510133|NCT04082364|323663763|FG001|Overall Study|Death|1|||
94510134|NCT04082364|323663764|FG002|Overall Study|Death|1|||
94510135|NCT04082364|323663765|FG003|Overall Study|Death|2|||
94510136|NCT04082364|323663766|FG004|Overall Study|Death|1|||
94510137|NCT04082364|323663762|FG000|Overall Study|Lost to Follow-up|1|||
94510138|NCT04082364|323663763|FG001|Overall Study|Lost to Follow-up|0|||
94510139|NCT04082364|323663764|FG002|Overall Study|Lost to Follow-up|0|||
94510140|NCT04082364|323663765|FG003|Overall Study|Lost to Follow-up|0|||
94510141|NCT04082364|323663766|FG004|Overall Study|Lost to Follow-up|1|||
94510142|NCT04082364|323663762|FG000|Overall Study|Physician Decision|1|||
94510143|NCT04082364|323663763|FG001|Overall Study|Physician Decision|1|||
94510144|NCT04082364|323663764|FG002|Overall Study|Physician Decision|0|||
94510145|NCT04082364|323663765|FG003|Overall Study|Physician Decision|2|||
94510146|NCT04082364|323663766|FG004|Overall Study|Physician Decision|1|||
94510147|NCT04082364|323663762|FG000|Overall Study|Withdrawal by Subject|1|||
94510148|NCT04082364|323663763|FG001|Overall Study|Withdrawal by Subject|1|||
94510149|NCT04082364|323663764|FG002|Overall Study|Withdrawal by Subject|0|||
94510150|NCT04082364|323663765|FG003|Overall Study|Withdrawal by Subject|0|||
94510151|NCT04082364|323663766|FG004|Overall Study|Withdrawal by Subject|1|||
94510152|NCT04082364|323663762|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
94510153|NCT04082364|323663763|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
94510154|NCT04082364|323663764|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
94510155|NCT04082364|323663765|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
94510156|NCT04082364|323663766|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
94510157|NCT04082364|323663762|FG000|Overall Study|Disease progression|0|||
94510158|NCT04082364|323663763|FG001|Overall Study|Disease progression|0|||
94510159|NCT04082364|323663764|FG002|Overall Study|Disease progression|0|||
94510160|NCT04082364|323663765|FG003|Overall Study|Disease progression|1|||
94510161|NCT04082364|323663766|FG004|Overall Study|Disease progression|0|||
94510162|NCT03934684|323663767|FG000|Overall Study|Participants continuing in study|11|||
94510163|NCT03934684|323663768|FG001|Overall Study|Participants continuing in study|4|||
94510164|NCT03934684|323663767|FG000|Overall Study|Discontinuation of carfilzomib|20|||
94510165|NCT03934684|323663768|FG001|Overall Study|Discontinuation of carfilzomib|30|||
94510166|NCT03934684|323663767|FG000|Overall Study|Death|2|||
94510167|NCT03934684|323663768|FG001|Overall Study|Death|2|||
94510168|NCT03934684|323663767|FG000|Overall Study|Lost to Follow-up|2|||
94510169|NCT03934684|323663768|FG001|Overall Study|Lost to Follow-up|5|||
94510170|NCT03934684|323663767|FG000|Overall Study|Withdrawal by Subject|7|||
94510171|NCT03934684|323663768|FG001|Overall Study|Withdrawal by Subject|8|||
94510172|NCT03312543|323663771|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
94510173|NCT03312543|323663772|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
94510174|NCT03312543|323663771|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
94510175|NCT03312543|323663772|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
94510176|NCT03312543|323663771|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
94510177|NCT03312543|323663772|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
94510178|NCT03312543|323663771|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
94510179|NCT03312543|323663772|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
94510180|NCT03312543|323663771|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
94510181|NCT03312543|323663772|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
94510182|NCT03312543|323663771|FG000|Regression (Week 12 to Week 24)|Death|0|||
94510183|NCT03312543|323663772|FG001|Regression (Week 12 to Week 24)|Death|1|||
94510184|NCT01450631|323663773|FG000|Overall Study|Lost to Follow-up|2|||
94510185|NCT01450631|323663774|FG001|Overall Study|Lost to Follow-up|4|||
94510186|NCT01450631|323663773|FG000|Overall Study|Withdrawal by Subject|1|||
94510187|NCT01450631|323663774|FG001|Overall Study|Withdrawal by Subject|0|||
94510188|NCT01903863|323663778|FG000|Overall Study|Physician Decision|2|||
94510189|NCT01903863|323663779|FG001|Overall Study|Physician Decision|0|||
94510190|NCT00835354|323663780|FG000|First Intervention|Adverse Event|0|||
94510191|NCT00835354|323663781|FG001|First Intervention|Adverse Event|1|||
94510192|NCT04116489|323663788|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
94510193|NCT04116489|323663788|FG000|Overall Study|Withdrawal by Subject|1|||
94510194|NCT00642759|323663790|FG000|Overall Study|Protocol Violation|1|||
94510195|NCT04129398|323664769|FG000|Overall Study|Physician Decision|2|||
94510196|NCT03436732|323664772|FG000|Overall Study|Not treated-enrolled in different study|1|||
94510197|NCT03436732|323664773|FG001|Overall Study|Not treated-enrolled in different study|0|||
94510198|NCT03436732|323664772|FG000|Overall Study|Off study after cycle 1|1|||
94510199|NCT03436732|323664773|FG001|Overall Study|Off study after cycle 1|0|||
94510200|NCT03436732|323664772|FG000|Overall Study|Adverse Event|2|||
94510201|NCT03436732|323664773|FG001|Overall Study|Adverse Event|0|||
94510202|NCT03436732|323664772|FG000|Overall Study|Death|0|||
94510203|NCT03436732|323664773|FG001|Overall Study|Death|1|||
94510204|NCT03033784|323664774|FG000|Overall Study|Anxiety related to MRI scanner|0|||
94510205|NCT03033784|323664775|FG001|Overall Study|Anxiety related to MRI scanner|1|||
94510206|NCT03033784|323664776|FG002|Overall Study|Anxiety related to MRI scanner|0|||
94510207|NCT03033784|323664777|FG003|Overall Study|Anxiety related to MRI scanner|0|||
94510208|NCT03033784|323664778|FG004|Overall Study|Anxiety related to MRI scanner|0|||
94510209|NCT03033784|323664779|FG005|Overall Study|Anxiety related to MRI scanner|0|||
94510210|NCT03033784|323664780|FG006|Overall Study|Anxiety related to MRI scanner|0|||
94510211|NCT03033784|323664781|FG007|Overall Study|Anxiety related to MRI scanner|0|||
94510212|NCT03033784|323664782|FG008|Overall Study|Anxiety related to MRI scanner|0|||
94510213|NCT03033784|323664783|FG009|Overall Study|Anxiety related to MRI scanner|0|||
94510214|NCT03033784|323664784|FG010|Overall Study|Anxiety related to MRI scanner|0|||
94510215|NCT03033784|323664785|FG011|Overall Study|Anxiety related to MRI scanner|0|||
94510216|NCT03033784|323664786|FG012|Overall Study|Anxiety related to MRI scanner|0|||
94510217|NCT03033784|323664774|FG000|Overall Study|Withdrawal by Subject|0|||
94510218|NCT03033784|323664775|FG001|Overall Study|Withdrawal by Subject|0|||
94510219|NCT03033784|323664776|FG002|Overall Study|Withdrawal by Subject|0|||
94510220|NCT03033784|323664777|FG003|Overall Study|Withdrawal by Subject|0|||
94510221|NCT03033784|323664778|FG004|Overall Study|Withdrawal by Subject|0|||
94510222|NCT03033784|323664779|FG005|Overall Study|Withdrawal by Subject|0|||
94510223|NCT03033784|323664780|FG006|Overall Study|Withdrawal by Subject|0|||
94510224|NCT03033784|323664781|FG007|Overall Study|Withdrawal by Subject|0|||
94510225|NCT03033784|323664782|FG008|Overall Study|Withdrawal by Subject|0|||
94510226|NCT03033784|323664783|FG009|Overall Study|Withdrawal by Subject|0|||
94510227|NCT03033784|323664784|FG010|Overall Study|Withdrawal by Subject|0|||
94510228|NCT03033784|323664785|FG011|Overall Study|Withdrawal by Subject|0|||
94510229|NCT03033784|323664786|FG012|Overall Study|Withdrawal by Subject|2|||
94510230|NCT00267488|323664789|FG000|Overall Study|Sponsor Terminated Study|9|||
94510231|NCT00267488|323664789|FG000|Overall Study|Protocol Violation|1|||
94510232|NCT00267488|323664789|FG000|Overall Study|Other (Disease Progression)|1|||
94510233|NCT02374255|323664790|FG000|Overall Study|Withdrawal by Subject|2|||
94510234|NCT02374255|323664791|FG001|Overall Study|Withdrawal by Subject|0|||
94510235|NCT02374255|323664792|FG002|Overall Study|Withdrawal by Subject|0|||
94510236|NCT02374255|323664793|FG003|Overall Study|Withdrawal by Subject|0|||
94510237|NCT02254460|323664794|FG000|Overall Study|Adverse Event|1|||
94510238|NCT02254460|323664795|FG001|Overall Study|Adverse Event|0|||
94510239|NCT02093520|323664796|FG000|Overall Study|Not treated|6|||
94510240|NCT02093520|323664797|FG001|Overall Study|Not treated|22|||
94510241|NCT03384966|323664808|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
94510242|NCT03384966|323664809|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
94510243|NCT03384966|323664810|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
94510244|NCT03384966|323664808|FG000|Follow-up Period|Adverse Event|1|||
94510245|NCT03384966|323664809|FG001|Follow-up Period|Adverse Event|0|||
94510246|NCT03384966|323664810|FG002|Follow-up Period|Adverse Event|0|||
94510247|NCT02489279|323664816|FG000|Overall Study|Lost to Follow-up|12|||
94510248|NCT02489279|323664817|FG001|Overall Study|Lost to Follow-up|10|||
94510249|NCT00567502|323664820|FG000|Overall Study|Lost to Follow-up|91|||
94510250|NCT00567502|323664821|FG001|Overall Study|Lost to Follow-up|14|||
94510251|NCT00567502|323664822|FG002|Overall Study|Lost to Follow-up|351|||
94510252|NCT00567502|323664823|FG003|Overall Study|Lost to Follow-up|2|||
94510253|NCT00567502|323664820|FG000|Overall Study|Death|65|||
94510254|NCT00567502|323664821|FG001|Overall Study|Death|16|||
94510255|NCT00567502|323664822|FG002|Overall Study|Death|360|||
94510256|NCT00567502|323664823|FG003|Overall Study|Death|5|||
94510257|NCT00567502|323664820|FG000|Overall Study|Other|64|||
94510258|NCT00567502|323664821|FG001|Overall Study|Other|2|||
94510259|NCT00567502|323664822|FG002|Overall Study|Other|134|||
94510260|NCT00567502|323664823|FG003|Overall Study|Other|6|||
94510261|NCT00567502|323664820|FG000|Overall Study|Participant request|12|||
94510262|NCT00567502|323664821|FG001|Overall Study|Participant request|1|||
94510263|NCT00567502|323664822|FG002|Overall Study|Participant request|33|||
94510264|NCT00567502|323664823|FG003|Overall Study|Participant request|1|||
94510265|NCT00567502|323664820|FG000|Overall Study|Sponsor request|9|||
94510266|NCT00567502|323664821|FG001|Overall Study|Sponsor request|0|||
94510267|NCT00567502|323664822|FG002|Overall Study|Sponsor request|30|||
94510268|NCT00567502|323664823|FG003|Overall Study|Sponsor request|1|||
94510269|NCT00567502|323664820|FG000|Overall Study|Never Initiated Treatment|0|||
94510270|NCT00567502|323664821|FG001|Overall Study|Never Initiated Treatment|0|||
94510271|NCT00567502|323664822|FG002|Overall Study|Never Initiated Treatment|0|||
94510272|NCT00567502|323664823|FG003|Overall Study|Never Initiated Treatment|72|||
94510273|NCT02014467|323664824|FG000|Overall Study|Adverse Event|4|||
94510274|NCT02014467|323664825|FG001|Overall Study|Adverse Event|0|||
94510275|NCT02014467|323664824|FG000|Overall Study|Protocol Violation|3|||
94510276|NCT02014467|323664825|FG001|Overall Study|Protocol Violation|0|||
94510277|NCT02014467|323664824|FG000|Overall Study|Physician Decision|2|||
94510278|NCT02014467|323664825|FG001|Overall Study|Physician Decision|3|||
94510279|NCT02014467|323664824|FG000|Overall Study|Withdrawal by Subject|16|||
94510280|NCT02014467|323664825|FG001|Overall Study|Withdrawal by Subject|4|||
94510281|NCT00480532|323664829|FG000|Overall Study|Withdrawal by Subject|2|||
94510282|NCT00480532|323664830|FG001|Overall Study|Withdrawal by Subject|4|||
94510283|NCT00480532|323664831|FG002|Overall Study|Withdrawal by Subject|3|||
94510284|NCT00480532|323664832|FG003|Overall Study|Withdrawal by Subject|1|||
94510285|NCT00480532|323664829|FG000|Overall Study|Protocol Violation|0|||
94510286|NCT00480532|323664830|FG001|Overall Study|Protocol Violation|0|||
94510287|NCT00480532|323664831|FG002|Overall Study|Protocol Violation|1|||
94510288|NCT00480532|323664832|FG003|Overall Study|Protocol Violation|0|||
94510289|NCT00129974|323664833|FG000|Overall Study|Other|1|||
94510290|NCT00557440|323664834|FG000|Treatment Period 1|Adverse Event|0|||
94510291|NCT00557440|323664835|FG001|Treatment Period 1|Adverse Event|0|||
94510292|NCT00557440|323664836|FG002|Treatment Period 1|Adverse Event|1|||
94510293|NCT03524157|323664837|FG000|Overall Study|cytology not readable|0|||
94510294|NCT03524157|323664838|FG001|Overall Study|cytology not readable|0|||
94510295|NCT03524157|323664839|FG002|Overall Study|cytology not readable|1|||
94510296|NCT02157610|323664840|FG000|Overall Study|Death|4|||
94510297|NCT02157610|323664841|FG001|Overall Study|Death|4|||
94510298|NCT01378195|323664842|FG000|Overall Study|Lost to Follow-up|29|||
94510299|NCT01378195|323664843|FG001|Overall Study|Lost to Follow-up|18|||
94510300|NCT00752219|323664844|FG000|Overall Study|Clinical failure|0|||
94510301|NCT00752219|323664845|FG001|Overall Study|Clinical failure|1|||
94510302|NCT00752219|323664844|FG000|Overall Study|Adverse Event|5|||
94510303|NCT00752219|323664845|FG001|Overall Study|Adverse Event|3|||
94510304|NCT00752219|323664844|FG000|Overall Study|Protocol deviation|1|||
94510305|NCT00752219|323664845|FG001|Overall Study|Protocol deviation|0|||
94510306|NCT00752219|323664844|FG000|Overall Study|Lost to Follow-up|1|||
94510307|NCT00752219|323664845|FG001|Overall Study|Lost to Follow-up|2|||
94510308|NCT00752219|323664844|FG000|Overall Study|Randomized but not treated|1|||
94510309|NCT00752219|323664845|FG001|Overall Study|Randomized but not treated|0|||
94510310|NCT00752219|323664844|FG000|Overall Study|Other|3|||
94510311|NCT00752219|323664845|FG001|Overall Study|Other|0|||
94510312|NCT02743962|323664848|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
94510313|NCT02743962|323664849|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
94510314|NCT01047540|323664853|FG000|Overall Study|Protocol Violation|1|||
94510315|NCT01047540|323664854|FG001|Overall Study|Protocol Violation|0|||
94510316|NCT01047540|323664855|FG002|Overall Study|Protocol Violation|0|||
94510317|NCT01047540|323664856|FG003|Overall Study|Protocol Violation|0|||
94510318|NCT01047540|323664857|FG004|Overall Study|Protocol Violation|0|||
94510319|NCT01047540|323664853|FG000|Overall Study|Lost to Follow-up|1|||
94510320|NCT01047540|323664854|FG001|Overall Study|Lost to Follow-up|0|||
94510321|NCT01047540|323664855|FG002|Overall Study|Lost to Follow-up|0|||
94510322|NCT01047540|323664856|FG003|Overall Study|Lost to Follow-up|0|||
94510323|NCT01047540|323664857|FG004|Overall Study|Lost to Follow-up|0|||
94510324|NCT01047540|323664853|FG000|Overall Study|Withdrawal by Subject|1|||
94510325|NCT01047540|323664854|FG001|Overall Study|Withdrawal by Subject|0|||
94510326|NCT01047540|323664855|FG002|Overall Study|Withdrawal by Subject|3|||
94510327|NCT01047540|323664856|FG003|Overall Study|Withdrawal by Subject|0|||
94510328|NCT01047540|323664857|FG004|Overall Study|Withdrawal by Subject|1|||
94510329|NCT01047540|323664853|FG000|Overall Study|Pregnancy|1|||
94510330|NCT01047540|323664854|FG001|Overall Study|Pregnancy|0|||
94510331|NCT01047540|323664855|FG002|Overall Study|Pregnancy|0|||
94510332|NCT01047540|323664856|FG003|Overall Study|Pregnancy|0|||
94510333|NCT01047540|323664857|FG004|Overall Study|Pregnancy|0|||
94510334|NCT01047540|323664853|FG000|Overall Study|Adverse Event|1|||
94510335|NCT01047540|323664854|FG001|Overall Study|Adverse Event|0|||
94510336|NCT01047540|323664855|FG002|Overall Study|Adverse Event|0|||
94510337|NCT01047540|323664856|FG003|Overall Study|Adverse Event|0|||
94510338|NCT01047540|323664857|FG004|Overall Study|Adverse Event|0|||
94510339|NCT03787615|323664858|FG000|Overall Study|Withdrawal by Subject|2|||
94510340|NCT03787615|323664858|FG000|Overall Study|Lost to Follow-up|2|||
94510341|NCT02592863|323664859|FG000|Overall Study|Withdrawal by Subject|2|||
94510342|NCT02592863|323664860|FG001|Overall Study|Withdrawal by Subject|2|||
94510343|NCT02592863|323664859|FG000|Overall Study|Lost to Follow-up|1|||
94510344|NCT02592863|323664860|FG001|Overall Study|Lost to Follow-up|1|||
94510345|NCT02609503|323664864|FG000|Overall Study|Adverse Event|1|||
94510346|NCT02609503|323664864|FG000|Overall Study|Death|1|||
94510347|NCT02609503|323664864|FG000|Overall Study|Withdrawal by Subject|1|||
94510348|NCT02609503|323664864|FG000|Overall Study|Disease progression|1|||
94510349|NCT01472185|323664867|FG000|Overall Study|Randomized but Not Treated|0|||
94510350|NCT01472185|323664868|FG001|Overall Study|Randomized but Not Treated|1|||
94510351|NCT01472185|323664867|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
94510352|NCT01472185|323664868|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
94510353|NCT01472185|323664867|FG000|Overall Study|Hyperglycemia|5|||
94510354|NCT01472185|323664868|FG001|Overall Study|Hyperglycemia|2|||
94510355|NCT01472185|323664867|FG000|Overall Study|Investigator's Discretion|3|||
94510356|NCT01472185|323664868|FG001|Overall Study|Investigator's Discretion|1|||
94510357|NCT01472185|323664867|FG000|Overall Study|Lost to Follow-up|4|||
94510358|NCT01472185|323664868|FG001|Overall Study|Lost to Follow-up|1|||
94510359|NCT01472185|323664867|FG000|Overall Study|Protocol Violation|5|||
94510360|NCT01472185|323664868|FG001|Overall Study|Protocol Violation|1|||
94510361|NCT01472185|323664867|FG000|Overall Study|Subject Noncompliance|8|||
94510362|NCT01472185|323664868|FG001|Overall Study|Subject Noncompliance|15|||
94510363|NCT01472185|323664867|FG000|Overall Study|Subject Withdrew Consent|6|||
94510364|NCT01472185|323664868|FG001|Overall Study|Subject Withdrew Consent|3|||
94510365|NCT03647137|323664871|FG000|Overall Study|Scan Limitation|2|||
94510366|NCT03647137|323664872|FG001|Overall Study|Scan Limitation|1|||
94510367|NCT03647137|323664873|FG002|Overall Study|Scan Limitation|1|||
94510368|NCT03647137|323664874|FG003|Overall Study|Scan Limitation|2|||
94510369|NCT02011542|323664876|FG000|Overall Study|Physician Decision|1|||
94510370|NCT03773562|323664879|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
94510371|NCT03773562|323664879|FG000|Overall Study|Lost to Follow-up|10|||
94510372|NCT03773562|323664879|FG000|Overall Study|Withdrawal by Subject|1|||
94510373|NCT05852340|323664880|FG000|Period 5|Not completing the meal|0|||
94510374|NCT05852340|323664881|FG001|Period 5|Not completing the meal|1|||
94510375|NCT05852340|323664882|FG002|Period 5|Not completing the meal|0|||
94510376|NCT05852340|323664883|FG003|Period 5|Not completing the meal|0|||
94510377|NCT05852340|323664880|FG000|Period 5|Adverse Event|0|||
94510378|NCT05852340|323664881|FG001|Period 5|Adverse Event|0|||
94510379|NCT05852340|323664882|FG002|Period 5|Adverse Event|0|||
94510380|NCT05852340|323664883|FG003|Period 5|Adverse Event|1|||
94510381|NCT05013905|323664884|FG000|Overall Study|Adverse Event|1|||
94510382|NCT05013905|323664884|FG000|Overall Study|Lack of Efficacy|1|||
94510383|NCT05852470|323664885|FG000|Overall Study|Withdrawal by Subject|0|||
94510384|NCT05852470|323664886|FG001|Overall Study|Withdrawal by Subject|1|||
94510385|NCT00323622|323664887|FG000|Overall Study|Other|30|||
94510386|NCT00323622|323664888|FG001|Overall Study|Other|91|||
94510387|NCT00323622|323664889|FG002|Overall Study|Other|4|||
94510388|NCT00323622|323664890|FG003|Overall Study|Other|12|||
94510389|NCT00323622|323664891|FG004|Overall Study|Other|32|||
94510390|NCT00323622|323664892|FG005|Overall Study|Other|74|||
94510391|NCT00323622|323664893|FG006|Overall Study|Other|5|||
94510392|NCT00323622|323664894|FG007|Overall Study|Other|13|||
94510393|NCT00323622|323664887|FG000|Overall Study|Death|1|||
94510394|NCT00323622|323664888|FG001|Overall Study|Death|1|||
94510395|NCT00323622|323664889|FG002|Overall Study|Death|0|||
94510396|NCT00323622|323664890|FG003|Overall Study|Death|0|||
94510397|NCT00323622|323664891|FG004|Overall Study|Death|7|||
94510398|NCT00323622|323664892|FG005|Overall Study|Death|0|||
94510399|NCT00323622|323664893|FG006|Overall Study|Death|0|||
94510400|NCT00323622|323664894|FG007|Overall Study|Death|2|||
94510401|NCT02302222|323664899|FG000|Overall Study|Physician Decision|0|||
94510402|NCT02302222|323664900|FG001|Overall Study|Physician Decision|4|||
94510403|NCT02302222|323664899|FG000|Overall Study|Lost to Follow-up|1|||
94510404|NCT02302222|323664900|FG001|Overall Study|Lost to Follow-up|0|||
94510405|NCT02302222|323664899|FG000|Overall Study|Treatment discontinued before day 5|0|||
94510406|NCT02302222|323664900|FG001|Overall Study|Treatment discontinued before day 5|1|||
94510407|NCT02302222|323664899|FG000|Overall Study|Withdrawn prior to any treatment|0|||
94510408|NCT02302222|323664900|FG001|Overall Study|Withdrawn prior to any treatment|1|||
94510409|NCT01972659|323664901|FG000|Overall Study|Protocol Violation|2|||
94510410|NCT01972659|323664902|FG001|Overall Study|Protocol Violation|2|||
94510411|NCT01972659|323664901|FG000|Overall Study|problems realted to acceleromyograph|2|||
94510412|NCT01972659|323664902|FG001|Overall Study|problems realted to acceleromyograph|1|||
94510413|NCT00835367|323664906|FG000|Washout|Adverse Event|2|||
94510414|NCT00835367|323664907|FG001|Washout|Adverse Event|0|||
94510415|NCT00835367|323664906|FG000|Washout|Withdrawal by Subject|1|||
94510416|NCT00835367|323664907|FG001|Washout|Withdrawal by Subject|0|||
94510417|NCT00835367|323664906|FG000|Second Intervention|Adverse Event|1|||
94510418|NCT00835367|323664907|FG001|Second Intervention|Adverse Event|1|||
94510419|NCT04280783|323666303|FG000|Overall Study|Family issues unrelated to the study.|1|||
94510420|NCT04280783|323666304|FG001|Overall Study|Family issues unrelated to the study.|0|||
94510421|NCT04280783|323666303|FG000|Overall Study|Withdrawal by Subject|0|||
94510422|NCT04280783|323666304|FG001|Overall Study|Withdrawal by Subject|1|||
94510423|NCT05654181|323666305|FG000|Overall Study|Adverse Event|1|||
94510424|NCT05654181|323666306|FG001|Overall Study|Adverse Event|0|||
94510425|NCT05654181|323666307|FG002|Overall Study|Adverse Event|0|||
94510426|NCT05654181|323666308|FG003|Overall Study|Adverse Event|0|||
94510427|NCT05654181|323666309|FG004|Overall Study|Adverse Event|0|||
94510428|NCT05654181|323666310|FG005|Overall Study|Adverse Event|0|||
94510429|NCT05654181|323666311|FG006|Overall Study|Adverse Event|0|||
94510430|NCT05654181|323666312|FG007|Overall Study|Adverse Event|1|||
94510431|NCT05654181|323666313|FG008|Overall Study|Adverse Event|0|||
94510432|NCT05654181|323666314|FG009|Overall Study|Adverse Event|0|||
94510433|NCT05654181|323666305|FG000|Overall Study|Withdrawal by Subject|0|||
94510434|NCT05654181|323666306|FG001|Overall Study|Withdrawal by Subject|0|||
94510435|NCT05654181|323666307|FG002|Overall Study|Withdrawal by Subject|0|||
94510436|NCT05654181|323666308|FG003|Overall Study|Withdrawal by Subject|0|||
94510437|NCT05654181|323666309|FG004|Overall Study|Withdrawal by Subject|0|||
94510438|NCT05654181|323666310|FG005|Overall Study|Withdrawal by Subject|0|||
94510439|NCT05654181|323666311|FG006|Overall Study|Withdrawal by Subject|0|||
94510440|NCT05654181|323666312|FG007|Overall Study|Withdrawal by Subject|1|||
94510441|NCT05654181|323666313|FG008|Overall Study|Withdrawal by Subject|0|||
94510442|NCT05654181|323666314|FG009|Overall Study|Withdrawal by Subject|0|||
94510443|NCT05654181|323666305|FG000|Overall Study|Other|0|||
94510444|NCT05654181|323666306|FG001|Overall Study|Other|0|||
94510445|NCT05654181|323666307|FG002|Overall Study|Other|0|||
94510446|NCT05654181|323666308|FG003|Overall Study|Other|0|||
94510447|NCT05654181|323666309|FG004|Overall Study|Other|1|||
94510448|NCT05654181|323666310|FG005|Overall Study|Other|1|||
94510449|NCT05654181|323666311|FG006|Overall Study|Other|0|||
94510450|NCT05654181|323666312|FG007|Overall Study|Other|0|||
94510451|NCT05654181|323666313|FG008|Overall Study|Other|0|||
94510452|NCT05654181|323666314|FG009|Overall Study|Other|0|||
94510453|NCT03443401|323666315|FG000|Overall Study|Lost to Follow-up|13|||
94510454|NCT03443401|323666315|FG000|Overall Study|Influential outlier|1|||
94510455|NCT04101331|323666316|FG000|Overall Study|Adverse Event|9|||
94510456|NCT04101331|323666316|FG000|Overall Study|Disease progression|82|||
94510457|NCT04101331|323666316|FG000|Overall Study|Withdrawal by Subject|1|||
94510458|NCT04101331|323666316|FG000|Overall Study|Investigator decision|6|||
94510459|NCT04101331|323666316|FG000|Overall Study|Death|6|||
94510460|NCT04101331|323666316|FG000|Overall Study|Allogenic transplant|1|||
94510461|NCT05543174|323666317|FG000|Overall Study|Ongoing|7|||
94510462|NCT00980044|323666318|FG000|Overall Study|Withdrawal by Subject|5|||
94510463|NCT00980044|323666319|FG001|Overall Study|Withdrawal by Subject|7|||
94510464|NCT00980044|323666320|FG002|Overall Study|Withdrawal by Subject|3|||
94510465|NCT00980044|323666318|FG000|Overall Study|Protocol Violation|0|||
94510466|NCT00980044|323666319|FG001|Overall Study|Protocol Violation|0|||
94510467|NCT00980044|323666320|FG002|Overall Study|Protocol Violation|2|||
94510468|NCT03283241|323666321|FG000|Overall Study|Adverse Event|4|||
94510469|NCT03283241|323666322|FG001|Overall Study|Adverse Event|1|||
94510470|NCT03283241|323666321|FG000|Overall Study|Withdrawal by Subject|0|||
94510471|NCT03283241|323666322|FG001|Overall Study|Withdrawal by Subject|1|||
94510472|NCT03283241|323666321|FG000|Overall Study|Subject relocated to Finland|0|||
94510473|NCT03283241|323666322|FG001|Overall Study|Subject relocated to Finland|1|||
94510474|NCT00666263|323666323|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
94510475|NCT00666263|323666324|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
94510476|NCT00666263|323666323|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
94510477|NCT00666263|323666324|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
94510478|NCT00666263|323666323|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
94510479|NCT00666263|323666324|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
94510480|NCT04484857|323666330|FG000|Overall Study|Adverse Event|2|||
94510481|NCT04484857|323666330|FG000|Overall Study|Death|10|||
94510482|NCT04484857|323666330|FG000|Overall Study|Withdrawal by Subject|3|||
94510483|NCT04484857|323666330|FG000|Overall Study|Transferred/Relocation|5|||
94510484|NCT04484857|323666330|FG000|Overall Study|Kidney Transplant|7|||
94510485|NCT04484857|323666330|FG000|Overall Study|Other than specified|4|||
94510486|NCT04484857|323666330|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
94510487|NCT01225952|323666331|FG000|Overall Study|Lost to Follow-up|1|||
94510488|NCT01225952|323666332|FG001|Overall Study|Lost to Follow-up|0|||
94510489|NCT01225952|323666333|FG002|Overall Study|Lost to Follow-up|0|||
94510490|NCT01225952|323666331|FG000|Overall Study|Study Eye Explanted|0|||
94510491|NCT01225952|323666332|FG001|Overall Study|Study Eye Explanted|0|||
94510492|NCT01225952|323666333|FG002|Overall Study|Study Eye Explanted|1|||
94510493|NCT01225952|323666331|FG000|Overall Study|Withdrawal by Subject|4|||
94510494|NCT01225952|323666332|FG001|Overall Study|Withdrawal by Subject|4|||
94510495|NCT01225952|323666333|FG002|Overall Study|Withdrawal by Subject|5|||
94510496|NCT01225952|323666331|FG000|Overall Study|Surgical complications|1|||
94510497|NCT01225952|323666332|FG001|Overall Study|Surgical complications|0|||
94510498|NCT01225952|323666333|FG002|Overall Study|Surgical complications|0|||
94510499|NCT00841815|323666345|FG000|Washout|Withdrawal by Subject|0|||
94510500|NCT00841815|323666346|FG001|Washout|Withdrawal by Subject|1|||
94510501|NCT01554904|323666351|FG000|Overall Study|Withdrawal by Subject|3|||
94510502|NCT01554904|323666351|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
94510503|NCT05805150|323666352|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
94510504|NCT05805150|323666353|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
94510505|NCT02284893|323666354|FG000|26 Week (Short Term)|Adverse Event|1|||
94510506|NCT02284893|323666355|FG001|26 Week (Short Term)|Adverse Event|9|||
94510507|NCT02284893|323666354|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
94510508|NCT02284893|323666355|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
94510509|NCT02284893|323666354|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
94510510|NCT02284893|323666355|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
94510511|NCT02284893|323666354|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
94510512|NCT02284893|323666355|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
94510513|NCT02284893|323666354|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
94510514|NCT02284893|323666355|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
94510515|NCT02284893|323666354|FG000|26 Week (Short Term)|Other|1|||
94510516|NCT02284893|323666355|FG001|26 Week (Short Term)|Other|1|||
94510517|NCT02284893|323666354|FG000|52 Week (Long Term)|Adverse Event|3|||
94510518|NCT02284893|323666355|FG001|52 Week (Long Term)|Adverse Event|1|||
94510519|NCT02284893|323666354|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
94510520|NCT02284893|323666355|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
94510521|NCT02284893|323666354|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
94510522|NCT02284893|323666355|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
94510523|NCT02284893|323666354|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
94510524|NCT02284893|323666355|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
94510525|NCT02284893|323666354|FG000|52 Week (Long Term)|Non-Compliance|2|||
94510526|NCT02284893|323666355|FG001|52 Week (Long Term)|Non-Compliance|3|||
94510527|NCT03038620|323666356|FG000|Overall Study|Lost to Follow-up|18|||
94510528|NCT03038620|323666357|FG001|Overall Study|Lost to Follow-up|23|||
94510529|NCT03038620|323666356|FG000|Overall Study|Withdrawal by Subject|0|||
94510530|NCT03038620|323666357|FG001|Overall Study|Withdrawal by Subject|15|||
94510531|NCT03038620|323666356|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
94510532|NCT03038620|323666357|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
94510533|NCT00086515|323666358|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
94510534|NCT00086515|323666359|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
94510535|NCT00086515|323666358|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
94510536|NCT00086515|323666359|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
94510537|NCT00086515|323666358|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
94510538|NCT00086515|323666359|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
94510539|NCT00086515|323666358|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
94510540|NCT00086515|323666359|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
94510541|NCT00086515|323666358|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
94510542|NCT00086515|323666359|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
94510543|NCT00086515|323666358|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
94510544|NCT00086515|323666359|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
94510545|NCT00086515|323666358|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
94510546|NCT00086515|323666359|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
94510547|NCT00086515|323666358|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
94510548|NCT00086515|323666359|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
94510549|NCT00086515|323666358|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
94510550|NCT00086515|323666359|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
94510551|NCT00086515|323666358|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
94510552|NCT00086515|323666359|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
94510553|NCT00086515|323666358|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
94510554|NCT00086515|323666359|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
94510555|NCT00086515|323666358|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
94510556|NCT00086515|323666359|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
94510557|NCT00086515|323666358|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
94510558|NCT00086515|323666359|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
94510559|NCT00086515|323666358|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
94510560|NCT00086515|323666359|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
94510561|NCT00086515|323666358|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
94510562|NCT00086515|323666359|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
94510563|NCT00086515|323666358|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
94510564|NCT00086515|323666359|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
94510565|NCT00086515|323666358|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
94510566|NCT00086515|323666359|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
94510567|NCT00086515|323666358|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
94510568|NCT00086515|323666359|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
94510569|NCT00086515|323666358|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
94510570|NCT00086515|323666359|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
94510571|NCT00086515|323666358|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
94510572|NCT00086515|323666359|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
94510573|NCT00086515|323666358|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
94510574|NCT00086515|323666359|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
94510575|NCT00086515|323666358|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
94510576|NCT00086515|323666359|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
94510577|NCT00086515|323666358|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
94510578|NCT00086515|323666359|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
94510579|NCT00086515|323666358|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
94510580|NCT00086515|323666359|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
94510581|NCT00086515|323666358|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
94510582|NCT00086515|323666359|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
94510583|NCT00086515|323666358|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
94510584|NCT00086515|323666359|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
94510585|NCT00086515|323666358|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
94510586|NCT00086515|323666359|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
94510587|NCT00086515|323666358|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
94510588|NCT00086515|323666359|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
94510589|NCT00086515|323666358|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
94510590|NCT00086515|323666359|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
94510591|NCT00086515|323666358|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
94510592|NCT00086515|323666359|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
94510593|NCT00086515|323666358|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
94510594|NCT00086515|323666359|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
94510595|NCT05014919|323666361|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
94510596|NCT05014919|323666362|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
94510597|NCT05014919|323666363|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
94510598|NCT05014919|323666361|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
94510599|NCT05014919|323666362|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
94510600|NCT05014919|323666363|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
94510601|NCT05014919|323666361|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
94510602|NCT05014919|323666362|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
94510603|NCT05014919|323666363|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
94510604|NCT05014919|323666361|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
94510605|NCT05014919|323666362|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
94510606|NCT05014919|323666363|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
94510607|NCT05014919|323666361|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
94510608|NCT05014919|323666362|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
94510609|NCT05014919|323666363|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
94510610|NCT05014919|323666361|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
94510611|NCT05014919|323666362|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
94510612|NCT05014919|323666363|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
94510613|NCT05014919|323666361|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
94510614|NCT05014919|323666362|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
94510615|NCT05014919|323666363|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
94510616|NCT05014919|323666361|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
94510617|NCT05014919|323666362|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
94510618|NCT05014919|323666363|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
94510619|NCT02657343|323666364|FG000|Overall Study|Death|0|||
94510620|NCT02657343|323666365|FG001|Overall Study|Death|2|||
94510621|NCT02657343|323666366|FG002|Overall Study|Death|0|||
94510622|NCT02657343|323666367|FG003|Overall Study|Death|0|||
94510623|NCT02657343|323666368|FG004|Overall Study|Death|0|||
94510624|NCT02657343|323666369|FG005|Overall Study|Death|0|||
94510625|NCT02657343|323666364|FG000|Overall Study|Patient went to hospice|1|||
94510626|NCT02657343|323666365|FG001|Overall Study|Patient went to hospice|0|||
94510627|NCT02657343|323666366|FG002|Overall Study|Patient went to hospice|0|||
94510628|NCT02657343|323666367|FG003|Overall Study|Patient went to hospice|0|||
94510629|NCT02657343|323666368|FG004|Overall Study|Patient went to hospice|0|||
94510630|NCT02657343|323666369|FG005|Overall Study|Patient went to hospice|0|||
94510631|NCT02657343|323666364|FG000|Overall Study|Withdrawal by Subject|0|||
94510632|NCT02657343|323666365|FG001|Overall Study|Withdrawal by Subject|0|||
94510633|NCT02657343|323666366|FG002|Overall Study|Withdrawal by Subject|0|||
94510634|NCT02657343|323666367|FG003|Overall Study|Withdrawal by Subject|0|||
94510635|NCT02657343|323666368|FG004|Overall Study|Withdrawal by Subject|1|||
94510636|NCT02657343|323666369|FG005|Overall Study|Withdrawal by Subject|0|||
94510637|NCT00663260|323666371|FG000|Overall Study|Lack of Efficacy|2|||
94510638|NCT00663260|323666372|FG001|Overall Study|Lack of Efficacy|0|||
94510639|NCT00663260|323666373|FG002|Overall Study|Lack of Efficacy|0|||
94510640|NCT00663260|323666371|FG000|Overall Study|Adverse Event|12|||
94510641|NCT00663260|323666372|FG001|Overall Study|Adverse Event|7|||
94510642|NCT00663260|323666373|FG002|Overall Study|Adverse Event|6|||
94510643|NCT00663260|323666371|FG000|Overall Study|Withdrawal by Subject|3|||
94510644|NCT00663260|323666372|FG001|Overall Study|Withdrawal by Subject|1|||
94510645|NCT00663260|323666373|FG002|Overall Study|Withdrawal by Subject|6|||
94510646|NCT00663260|323666371|FG000|Overall Study|Death|1|||
94510647|NCT00663260|323666372|FG001|Overall Study|Death|0|||
94510648|NCT00663260|323666373|FG002|Overall Study|Death|1|||
94510649|NCT00663260|323666371|FG000|Overall Study|Lost to Follow-up|0|||
94510650|NCT00663260|323666372|FG001|Overall Study|Lost to Follow-up|1|||
94510651|NCT00663260|323666373|FG002|Overall Study|Lost to Follow-up|0|||
94510652|NCT00663260|323666371|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
94510653|NCT00663260|323666372|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
94510654|NCT00663260|323666373|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
94510655|NCT01491919|323666379|FG000|Overall Study|Insufficient PK sampling|1|||
94510656|NCT01491919|323666380|FG001|Overall Study|Insufficient PK sampling|2|||
94510657|NCT01491919|323666381|FG002|Overall Study|Insufficient PK sampling|1|||
94510658|NCT04724837|323666382|FG000|Overall Study|Other|4|||
94510659|NCT04724837|323666383|FG001|Overall Study|Other|16|||
94510660|NCT04724837|323666384|FG002|Overall Study|Other|0|||
94510661|NCT04724837|323666382|FG000|Overall Study|Withdrawal by Subject|2|||
94510662|NCT04724837|323666383|FG001|Overall Study|Withdrawal by Subject|9|||
94510663|NCT04724837|323666384|FG002|Overall Study|Withdrawal by Subject|9|||
94510664|NCT04724837|323666382|FG000|Overall Study|Adverse Event|2|||
94510665|NCT04724837|323666383|FG001|Overall Study|Adverse Event|7|||
94510666|NCT04724837|323666384|FG002|Overall Study|Adverse Event|4|||
94510667|NCT04724837|323666382|FG000|Overall Study|Lost to Follow-up|0|||
94510668|NCT04724837|323666383|FG001|Overall Study|Lost to Follow-up|1|||
94510669|NCT04724837|323666384|FG002|Overall Study|Lost to Follow-up|3|||
94510670|NCT04724837|323666382|FG000|Overall Study|Physician Decision|1|||
94510671|NCT04724837|323666383|FG001|Overall Study|Physician Decision|2|||
94510672|NCT04724837|323666384|FG002|Overall Study|Physician Decision|0|||
94510673|NCT04724837|323666382|FG000|Overall Study|Death|0|||
94510674|NCT04724837|323666383|FG001|Overall Study|Death|0|||
94510675|NCT04724837|323666384|FG002|Overall Study|Death|1|||
94510676|NCT04724837|323666382|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
94510677|NCT04724837|323666383|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
94510678|NCT04724837|323666384|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
94510679|NCT04724837|323666382|FG000|Overall Study|Study Terminated by Sponsor|0|||
94510680|NCT04724837|323666383|FG001|Overall Study|Study Terminated by Sponsor|1|||
94510681|NCT04724837|323666384|FG002|Overall Study|Study Terminated by Sponsor|0|||
94510682|NCT00522379|323666385|FG000|Overall Study|Adverse Event|12|||
94510683|NCT00522379|323666386|FG001|Overall Study|Adverse Event|15|||
94510684|NCT00522379|323666387|FG002|Overall Study|Adverse Event|12|||
94510685|NCT00522379|323666388|FG003|Overall Study|Adverse Event|5|||
94510686|NCT00522379|323666389|FG004|Overall Study|Adverse Event|17|||
94510687|NCT00522379|323666385|FG000|Overall Study|Lack of Efficacy|3|||
94510688|NCT00522379|323666386|FG001|Overall Study|Lack of Efficacy|0|||
94510689|NCT00522379|323666387|FG002|Overall Study|Lack of Efficacy|2|||
94510690|NCT00522379|323666388|FG003|Overall Study|Lack of Efficacy|2|||
94510691|NCT00522379|323666389|FG004|Overall Study|Lack of Efficacy|7|||
94510692|NCT00522379|323666385|FG000|Overall Study|Withdrawal by Subject|2|||
94510693|NCT00522379|323666386|FG001|Overall Study|Withdrawal by Subject|3|||
94510694|NCT00522379|323666387|FG002|Overall Study|Withdrawal by Subject|1|||
94510695|NCT00522379|323666388|FG003|Overall Study|Withdrawal by Subject|2|||
94510696|NCT00522379|323666389|FG004|Overall Study|Withdrawal by Subject|0|||
94510697|NCT00522379|323666385|FG000|Overall Study|Protocol Violation|1|||
94510698|NCT00522379|323666386|FG001|Overall Study|Protocol Violation|1|||
94510699|NCT00522379|323666387|FG002|Overall Study|Protocol Violation|2|||
94510700|NCT00522379|323666388|FG003|Overall Study|Protocol Violation|0|||
94510701|NCT00522379|323666389|FG004|Overall Study|Protocol Violation|0|||
94510702|NCT00522379|323666385|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
94510703|NCT00522379|323666386|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
94510704|NCT00522379|323666387|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
94510705|NCT00522379|323666388|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
94510706|NCT00522379|323666389|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
94510707|NCT00522379|323666385|FG000|Overall Study|Lost to Follow-up|1|||
94510708|NCT00522379|323666386|FG001|Overall Study|Lost to Follow-up|0|||
94510709|NCT00522379|323666387|FG002|Overall Study|Lost to Follow-up|4|||
94510710|NCT00522379|323666388|FG003|Overall Study|Lost to Follow-up|2|||
94510711|NCT00522379|323666389|FG004|Overall Study|Lost to Follow-up|2|||
94510712|NCT00522379|323666385|FG000|Overall Study|Randomization error|0|||
94510713|NCT00522379|323666386|FG001|Overall Study|Randomization error|0|||
94510714|NCT00522379|323666387|FG002|Overall Study|Randomization error|0|||
94510715|NCT00522379|323666388|FG003|Overall Study|Randomization error|0|||
94510716|NCT00522379|323666389|FG004|Overall Study|Randomization error|1|||
94510717|NCT00522379|323666385|FG000|Overall Study|Dispensing error|1|||
94510718|NCT00522379|323666386|FG001|Overall Study|Dispensing error|0|||
94510719|NCT00522379|323666387|FG002|Overall Study|Dispensing error|0|||
94510720|NCT00522379|323666388|FG003|Overall Study|Dispensing error|1|||
94510721|NCT00522379|323666389|FG004|Overall Study|Dispensing error|0|||
94510722|NCT00522379|323666385|FG000|Overall Study|Subject Moved|1|||
94510723|NCT00522379|323666386|FG001|Overall Study|Subject Moved|1|||
94510724|NCT00522379|323666387|FG002|Overall Study|Subject Moved|0|||
94510725|NCT00522379|323666388|FG003|Overall Study|Subject Moved|0|||
94510726|NCT00522379|323666389|FG004|Overall Study|Subject Moved|0|||
94510727|NCT00522379|323666385|FG000|Overall Study|Sponsor Request|0|||
94510728|NCT00522379|323666386|FG001|Overall Study|Sponsor Request|1|||
94510729|NCT00522379|323666387|FG002|Overall Study|Sponsor Request|0|||
94510730|NCT00522379|323666388|FG003|Overall Study|Sponsor Request|0|||
94510731|NCT00522379|323666389|FG004|Overall Study|Sponsor Request|0|||
94510732|NCT00522379|323666385|FG000|Overall Study|Family Problem|0|||
94510733|NCT00522379|323666386|FG001|Overall Study|Family Problem|0|||
94510734|NCT00522379|323666387|FG002|Overall Study|Family Problem|1|||
94510735|NCT00522379|323666388|FG003|Overall Study|Family Problem|0|||
94510736|NCT00522379|323666389|FG004|Overall Study|Family Problem|0|||
94510737|NCT00522379|323666385|FG000|Overall Study|Site Closed|0|||
94510738|NCT00522379|323666386|FG001|Overall Study|Site Closed|0|||
94510739|NCT00522379|323666387|FG002|Overall Study|Site Closed|0|||
94510740|NCT00522379|323666388|FG003|Overall Study|Site Closed|1|||
94510741|NCT00522379|323666389|FG004|Overall Study|Site Closed|0|||
94510742|NCT00522379|323666385|FG000|Overall Study|Subject Withdrawal|0|||
94510743|NCT00522379|323666386|FG001|Overall Study|Subject Withdrawal|0|||
94510744|NCT00522379|323666387|FG002|Overall Study|Subject Withdrawal|0|||
94510745|NCT00522379|323666388|FG003|Overall Study|Subject Withdrawal|1|||
94510746|NCT00522379|323666389|FG004|Overall Study|Subject Withdrawal|0|||
94510747|NCT05252702|323666394|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
94510748|NCT05252702|323666394|FG000|Overall Study|Death|16|||
94510749|NCT05252702|323666394|FG000|Overall Study|System explant|5|||
94510750|NCT05252702|323666394|FG000|Overall Study|Lost to Follow-up|1|||
94510751|NCT05252702|323666394|FG000|Overall Study|Withdrawn by investigator|1|||
94510752|NCT05252702|323666394|FG000|Overall Study|Visit not due|306|||
94510753|NCT05252702|323666394|FG000|Overall Study|Visit within window but not completed|92|||
94510754|NCT05252702|323666394|FG000|Overall Study|Unsuccessful implant|1|||
94510755|NCT03238196|323666395|FG000|Overall Study|Adverse Event|3|||
94510756|NCT03238196|323666396|FG001|Overall Study|Adverse Event|0|||
94510757|NCT03238196|323666397|FG002|Overall Study|Adverse Event|2|||
94510758|NCT03238196|323666398|FG003|Overall Study|Adverse Event|2|||
94510759|NCT03238196|323666395|FG000|Overall Study|Withdrawal by Subject|4|||
94510760|NCT03238196|323666396|FG001|Overall Study|Withdrawal by Subject|1|||
94510761|NCT03238196|323666397|FG002|Overall Study|Withdrawal by Subject|1|||
94510762|NCT03238196|323666398|FG003|Overall Study|Withdrawal by Subject|0|||
94510763|NCT03238196|323666395|FG000|Overall Study|Disease progression|14|||
94510764|NCT03238196|323666396|FG001|Overall Study|Disease progression|2|||
94510765|NCT03238196|323666397|FG002|Overall Study|Disease progression|3|||
94510766|NCT03238196|323666398|FG003|Overall Study|Disease progression|2|||
94510767|NCT03238196|323666395|FG000|Overall Study|Still on treatment|1|||
94510768|NCT03238196|323666396|FG001|Overall Study|Still on treatment|0|||
94510769|NCT03238196|323666397|FG002|Overall Study|Still on treatment|0|||
94510770|NCT03238196|323666398|FG003|Overall Study|Still on treatment|0|||
94510771|NCT04562090|323666399|FG000|Overall Study|Withdrawal by Subject|3|||
94510772|NCT04562090|323666400|FG001|Overall Study|Withdrawal by Subject|4|||
94510773|NCT04562090|323666399|FG000|Overall Study|Protocol Violation|2|||
94510774|NCT04562090|323666400|FG001|Overall Study|Protocol Violation|0|||
94510775|NCT04562090|323666399|FG000|Overall Study|Lack of Efficacy|0|||
94510776|NCT04562090|323666400|FG001|Overall Study|Lack of Efficacy|1|||
94510777|NCT04562090|323666399|FG000|Overall Study|Adverse Event|1|||
94510778|NCT04562090|323666400|FG001|Overall Study|Adverse Event|4|||
94510779|NCT04562090|323666399|FG000|Overall Study|Miscellaneous|0|||
94510780|NCT04562090|323666400|FG001|Overall Study|Miscellaneous|3|||
94510781|NCT05535972|323666403|FG000|Overall Study|Withdrawal by Subject|31|||
94510782|NCT05535972|323666403|FG000|Overall Study|Lost to Follow-up|5|||
94510783|NCT05535972|323666403|FG000|Overall Study|Adverse Event|6|||
94510784|NCT05535972|323666403|FG000|Overall Study|Protocol Deviation|2|||
94510785|NCT04507269|323666406|FG000|Overall Study|Withdrawal by Subject|1|||
94510786|NCT04507269|323666407|FG001|Overall Study|Withdrawal by Subject|1|||
94510787|NCT04507269|323666408|FG002|Overall Study|Withdrawal by Subject|0|||
94510788|NCT04507269|323666409|FG003|Overall Study|Withdrawal by Subject|0|||
94510789|NCT04507269|323666410|FG004|Overall Study|Withdrawal by Subject|0|||
94510790|NCT04507269|323666411|FG005|Overall Study|Withdrawal by Subject|0|||
94510791|NCT04507269|323666406|FG000|Overall Study|Lost to Follow-up|0|||
94510792|NCT04507269|323666407|FG001|Overall Study|Lost to Follow-up|0|||
94510793|NCT04507269|323666408|FG002|Overall Study|Lost to Follow-up|0|||
94510794|NCT04507269|323666409|FG003|Overall Study|Lost to Follow-up|0|||
94510795|NCT04507269|323666410|FG004|Overall Study|Lost to Follow-up|1|||
94510796|NCT04507269|323666411|FG005|Overall Study|Lost to Follow-up|0|||
94510797|NCT00432965|323666412|FG000|Overall Study|Lost to Follow-up|22|||
94510798|NCT00432965|323666413|FG001|Overall Study|Lost to Follow-up|19|||
94510799|NCT00432965|323666412|FG000|Overall Study|Withdrawal by Subject|13|||
94510800|NCT00432965|323666413|FG001|Overall Study|Withdrawal by Subject|13|||
94510801|NCT00432965|323666412|FG000|Overall Study|Physician Decision|14|||
94510802|NCT00432965|323666413|FG001|Overall Study|Physician Decision|13|||
94510803|NCT00432965|323666412|FG000|Overall Study|Lack of Efficacy|8|||
94510804|NCT00432965|323666413|FG001|Overall Study|Lack of Efficacy|13|||
94510805|NCT00432965|323666412|FG000|Overall Study|Non-compliance|7|||
94510806|NCT00432965|323666413|FG001|Overall Study|Non-compliance|0|||
94510807|NCT00432965|323666412|FG000|Overall Study|Adverse Event|22|||
94510808|NCT00432965|323666413|FG001|Overall Study|Adverse Event|19|||
94510809|NCT00432965|323666412|FG000|Overall Study|Death|3|||
94510810|NCT00432965|323666413|FG001|Overall Study|Death|4|||
94510811|NCT00432965|323666412|FG000|Overall Study|Exclusionary Methods|1|||
94510812|NCT00432965|323666413|FG001|Overall Study|Exclusionary Methods|2|||
94510813|NCT00432965|323666412|FG000|Overall Study|Incomplete Data|4|||
94510814|NCT00432965|323666413|FG001|Overall Study|Incomplete Data|3|||
94510815|NCT02402647|323666414|FG000|Overall Study|Lost to Follow-up|13|||
94510816|NCT02402647|323666415|FG001|Overall Study|Lost to Follow-up|7|||
94510817|NCT02402647|323666414|FG000|Overall Study|Protocol Violation|1|||
94510818|NCT02402647|323666415|FG001|Overall Study|Protocol Violation|1|||
94510819|NCT02402647|323666414|FG000|Overall Study|scheduled and timed out|2|||
94510820|NCT02402647|323666415|FG001|Overall Study|scheduled and timed out|1|||
94510821|NCT02402647|323666414|FG000|Overall Study|medical illness|2|||
94510822|NCT02402647|323666415|FG001|Overall Study|medical illness|4|||
94510823|NCT02402647|323666414|FG000|Overall Study|Moved|2|||
94510824|NCT02402647|323666415|FG001|Overall Study|Moved|0|||
94510825|NCT02402647|323666414|FG000|Overall Study|loved one illness|1|||
94510826|NCT02402647|323666415|FG001|Overall Study|loved one illness|0|||
94510827|NCT02402647|323666414|FG000|Overall Study|deceased preexisting condition|2|||
94510828|NCT02402647|323666415|FG001|Overall Study|deceased preexisting condition|0|||
94510829|NCT02402647|323666414|FG000|Overall Study|Other|2|||
94510830|NCT02402647|323666415|FG001|Overall Study|Other|1|||
94510831|NCT04197583|323666419|FG000|Overall Study|Study Stent Replacement|34|||
94510832|NCT04197583|323666420|FG001|Overall Study|Study Stent Replacement|8|||
94510833|NCT04197583|323666419|FG000|Overall Study|Lost to Follow-up|14|||
94510834|NCT04197583|323666420|FG001|Overall Study|Lost to Follow-up|3|||
94510835|NCT04197583|323666419|FG000|Overall Study|Death|3|||
94510836|NCT04197583|323666420|FG001|Overall Study|Death|0|||
94510837|NCT04197583|323666419|FG000|Overall Study|Physician Decision|1|||
94510838|NCT04197583|323666420|FG001|Overall Study|Physician Decision|0|||
94510839|NCT04197583|323666419|FG000|Overall Study|Withdrawal by Subject|1|||
94510840|NCT04197583|323666420|FG001|Overall Study|Withdrawal by Subject|1|||
94510841|NCT04197583|323666419|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
94510842|NCT04197583|323666420|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
94510843|NCT04197583|323666419|FG000|Overall Study|Screen Failure|0|||
94510844|NCT04197583|323666420|FG001|Overall Study|Screen Failure|20|||
94510845|NCT03518060|323666421|FG000|Overall Study|Death|1|||
94510846|NCT03518060|323666421|FG000|Overall Study|Poor adherence|1|||
94510847|NCT03518060|323666421|FG000|Overall Study|Withdrawal of informed consent|2|||
94510848|NCT03518060|323666421|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
94510849|NCT03518060|323666421|FG000|Overall Study|Physician Decision|7|||
94510850|NCT03518060|323666421|FG000|Overall Study|Adverse drug reactions|23|||
94510851|NCT03518060|323666421|FG000|Overall Study|Withdrawal by Subject|25|||
94510852|NCT03518060|323666421|FG000|Overall Study|Lost to Follow-up|13|||
94510853|NCT03204812|323666422|FG000|Overall Study|Adverse Event|3|||
94510854|NCT01854775|323666423|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
94510855|NCT01854775|323666424|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
94510856|NCT01854775|323666425|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
94510857|NCT01854775|323666423|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
94510858|NCT01854775|323666424|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
94510859|NCT01854775|323666425|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
94510860|NCT01854775|323666423|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
94510861|NCT01854775|323666424|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
94510862|NCT01854775|323666425|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
94510863|NCT01854775|323666423|FG000|Extension Phase|Pregnancy|3|||
94510864|NCT01854775|323666424|FG001|Extension Phase|Pregnancy|0|||
94510865|NCT01854775|323666425|FG002|Extension Phase|Pregnancy|0|||
94510866|NCT01854775|323666423|FG000|Extension Phase|Investigator's Discretion|1|||
94510867|NCT01854775|323666424|FG001|Extension Phase|Investigator's Discretion|0|||
94510868|NCT01854775|323666425|FG002|Extension Phase|Investigator's Discretion|0|||
94510869|NCT01854775|323666423|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
94510870|NCT01854775|323666424|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
94510871|NCT01854775|323666425|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
94510872|NCT01854775|323666423|FG000|Extension Phase|Lost to Follow-up|2|||
94510873|NCT01854775|323666424|FG001|Extension Phase|Lost to Follow-up|0|||
94510874|NCT01854775|323666425|FG002|Extension Phase|Lost to Follow-up|0|||
94510875|NCT01854775|323666423|FG000|Extension Phase|Still on Study|32|||
94510876|NCT01854775|323666424|FG001|Extension Phase|Still on Study|47|||
94510877|NCT01854775|323666425|FG002|Extension Phase|Still on Study|18|||
94510878|NCT02495883|323666426|FG000|Overall Study|Excessive head motion|1|||
94510879|NCT02495883|323666427|FG001|Overall Study|Excessive head motion|0|||
94510880|NCT01107886|323666429|FG000|Overall Study|Lost to Follow-up|15|||
94510881|NCT01107886|323666430|FG001|Overall Study|Lost to Follow-up|13|||
94510882|NCT01107886|323666429|FG000|Overall Study|Withdrawal by Subject|180|||
94510883|NCT01107886|323666430|FG001|Overall Study|Withdrawal by Subject|196|||
94510884|NCT01107886|323666429|FG000|Overall Study|Administrative withdrawal of consent|7|||
94510885|NCT01107886|323666430|FG001|Overall Study|Administrative withdrawal of consent|5|||
94510886|NCT03837509|323667726|FG000|Phase 1|Death|5|||
94510887|NCT03837509|323667727|FG001|Phase 1|Death|2|||
94510888|NCT03837509|323667728|FG002|Phase 1|Death|0|||
94510889|NCT03837509|323667729|FG003|Phase 1|Death|0|||
94510890|NCT03837509|323667730|FG004|Phase 1|Death|0|||
94510891|NCT03837509|323667726|FG000|Phase 2|Death|0|||
94510892|NCT03837509|323667727|FG001|Phase 2|Death|0|||
94510893|NCT03837509|323667728|FG002|Phase 2|Death|0|||
94510894|NCT03837509|323667729|FG003|Phase 2|Death|1|||
94510895|NCT03837509|323667730|FG004|Phase 2|Death|1|||
94510896|NCT01373281|323667731|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
94510897|NCT01373281|323667732|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
94510898|NCT01373281|323667731|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
94510899|NCT01373281|323667732|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
94510900|NCT01373281|323667731|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
94510901|NCT01373281|323667732|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
94510902|NCT01373281|323667731|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
94510903|NCT01373281|323667732|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
94510904|NCT01373281|323667731|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
94510905|NCT01373281|323667732|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
94510906|NCT01373281|323667731|FG000|Surveillance Expansion Period|Protocol Violation|9|||
94510907|NCT01373281|323667732|FG001|Surveillance Expansion Period|Protocol Violation|1|||
94510908|NCT01373281|323667731|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
94510909|NCT01373281|323667732|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
94510910|NCT01373281|323667731|FG000|Surveillance Expansion Period|Serious adverse event|3|||
94510911|NCT01373281|323667732|FG001|Surveillance Expansion Period|Serious adverse event|4|||
94510912|NCT04110145|323667733|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
94510913|NCT04110145|323667734|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
94510914|NCT04110145|323667735|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
94510915|NCT04110145|323667736|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
94510916|NCT04110145|323667737|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
94510917|NCT02254291|323667738|FG000|Overall Study|Withdrawal by Subject|0|||
94510918|NCT02254291|323667739|FG001|Overall Study|Withdrawal by Subject|3|||
94510919|NCT02254291|323667740|FG002|Overall Study|Withdrawal by Subject|1|||
94510920|NCT02254291|323667738|FG000|Overall Study|Missing follow-up information|0|||
94510921|NCT02254291|323667739|FG001|Overall Study|Missing follow-up information|0|||
94510922|NCT02254291|323667740|FG002|Overall Study|Missing follow-up information|1|||
94510923|NCT00939185|323667745|FG000|Overall Study|Adverse Event|3|||
94510924|NCT00939185|323667745|FG000|Overall Study|Lack of Efficacy|1|||
94510925|NCT00939185|323667745|FG000|Overall Study|Lost to Follow-up|6|||
94510926|NCT00939185|323667745|FG000|Overall Study|Other|3|||
94510927|NCT00939185|323667745|FG000|Overall Study|Withdrawal by Subject|2|||
94510928|NCT00939185|323667745|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
94510929|NCT00836706|323667753|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
94510930|NCT00836706|323667754|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
94510931|NCT02989857|323667755|FG000|Randomization Phase|Not Treated|3|||
94510932|NCT02989857|323667756|FG001|Randomization Phase|Not Treated|2|||
94510933|NCT02989857|323667757|FG002|Randomization Phase|Not Treated|0|||
94510934|NCT03122184|323667760|FG000|Overall Study|Lost to Follow-up|4|||
94510935|NCT03122184|323667761|FG001|Overall Study|Lost to Follow-up|6|||
94510936|NCT03122184|323667760|FG000|Overall Study|Withdrawal by Subject|3|||
94510937|NCT03122184|323667761|FG001|Overall Study|Withdrawal by Subject|0|||
94510938|NCT03122184|323667760|FG000|Overall Study|Terminated due to cognitive problem|1|||
94510939|NCT03122184|323667761|FG001|Overall Study|Terminated due to cognitive problem|0|||
94510940|NCT01992757|323667762|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
94510941|NCT00688740|323667763|FG000|Overall Study|Adverse Event|45|||
94510942|NCT00688740|323667764|FG001|Overall Study|Adverse Event|8|||
94510943|NCT00688740|323667763|FG000|Overall Study|Death|2|||
94510944|NCT00688740|323667764|FG001|Overall Study|Death|2|||
94510945|NCT00688740|323667763|FG000|Overall Study|Lost to Follow-up|0|||
94510946|NCT00688740|323667764|FG001|Overall Study|Lost to Follow-up|1|||
94510947|NCT00688740|323667763|FG000|Overall Study|Consent Withdrawn|17|||
94510948|NCT00688740|323667764|FG001|Overall Study|Consent Withdrawn|17|||
94510949|NCT00688740|323667763|FG000|Overall Study|Breast Cancer Relapse|1|||
94510950|NCT00688740|323667764|FG001|Overall Study|Breast Cancer Relapse|4|||
94510951|NCT00688740|323667763|FG000|Overall Study|Violation of Inclusion Criteria|1|||
94510952|NCT00688740|323667764|FG001|Overall Study|Violation of Inclusion Criteria|3|||
94510953|NCT01344356|323667765|FG000|Overall Study|Physician Decision|0|||
94510954|NCT01344356|323667766|FG001|Overall Study|Physician Decision|3|||
94510955|NCT01344356|323667765|FG000|Overall Study|Lost to Follow-up|0|||
94510956|NCT01344356|323667766|FG001|Overall Study|Lost to Follow-up|6|||
94510957|NCT00505687|323667769|FG000|Overall Study|Important protocol violation|2|||
94510958|NCT00505687|323667769|FG000|Overall Study|Lack of Efficacy|15|||
94510959|NCT00505687|323667769|FG000|Overall Study|Adverse Event|48|||
94510960|NCT00505687|323667769|FG000|Overall Study|Subject withdrew consent|15|||
94510961|NCT00505687|323667769|FG000|Overall Study|Lost to Follow-up|1|||
94510962|NCT00505687|323667769|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
94510963|NCT00505687|323667769|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
94510964|NCT00505687|323667769|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
94510965|NCT00505687|323667769|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
94510966|NCT00505687|323667769|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
94510967|NCT00505687|323667769|FG000|Overall Study|Other: Disease Progression|1|||
94510968|NCT00505687|323667769|FG000|Overall Study|Other: As Per Sponsor|8|||
94510969|NCT00856557|323667770|FG000|Overall Study|No patients with contextual flags|12|||
94510970|NCT00856557|323667771|FG001|Overall Study|No patients with contextual flags|16|||
94510971|NCT03673176|323667772|FG000|Overall Study|Death prior to intervention|1|||
94510972|NCT03673176|323667772|FG000|Overall Study|Death following intervention|3|||
94510973|NCT03673176|323667772|FG000|Overall Study|Withdrawal by Subject|1|||
94510974|NCT00337168|323667773|FG000|Overall Study|Death|5|||
94510975|NCT00337168|323667773|FG000|Overall Study|Not protocol specified|2|||
94510976|NCT00337168|323667773|FG000|Overall Study|Did not start therapy|1|||
94510977|NCT01217892|323667774|FG000|Overall Study|Adverse Event|1|||
94510978|NCT01217892|323667775|FG001|Overall Study|Adverse Event|1|||
94510979|NCT01217892|323667776|FG002|Overall Study|Adverse Event|1|||
94510980|NCT01217892|323667777|FG003|Overall Study|Adverse Event|0|||
94510981|NCT01217892|323667774|FG000|Overall Study|Withdrawal by Subject|0|||
94510982|NCT01217892|323667775|FG001|Overall Study|Withdrawal by Subject|2|||
94510983|NCT01217892|323667776|FG002|Overall Study|Withdrawal by Subject|1|||
94510984|NCT01217892|323667777|FG003|Overall Study|Withdrawal by Subject|0|||
94510985|NCT01217892|323667774|FG000|Overall Study|Lab value|1|||
94510986|NCT01217892|323667775|FG001|Overall Study|Lab value|0|||
94510987|NCT01217892|323667776|FG002|Overall Study|Lab value|1|||
94510988|NCT01217892|323667777|FG003|Overall Study|Lab value|0|||
94510989|NCT01217892|323667774|FG000|Overall Study|Subject no longer meets study criteria|5|||
94510990|NCT01217892|323667775|FG001|Overall Study|Subject no longer meets study criteria|2|||
94510991|NCT01217892|323667776|FG002|Overall Study|Subject no longer meets study criteria|4|||
94510992|NCT01217892|323667777|FG003|Overall Study|Subject no longer meets study criteria|8|||
94510993|NCT01217892|323667774|FG000|Overall Study|Incorrect enrollment|0|||
94510994|NCT01217892|323667775|FG001|Overall Study|Incorrect enrollment|1|||
94510995|NCT01217892|323667776|FG002|Overall Study|Incorrect enrollment|1|||
94510996|NCT01217892|323667777|FG003|Overall Study|Incorrect enrollment|0|||
94510997|NCT01217892|323667774|FG000|Overall Study|Poor/Non-Compliance|0|||
94510998|NCT01217892|323667775|FG001|Overall Study|Poor/Non-Compliance|0|||
94510999|NCT01217892|323667776|FG002|Overall Study|Poor/Non-Compliance|1|||
94511000|NCT01217892|323667777|FG003|Overall Study|Poor/Non-Compliance|0|||
94511001|NCT01052779|323667778|FG000|Overall Study|Adverse Event|1|||
94511002|NCT01052779|323667779|FG001|Overall Study|Adverse Event|4|||
94511003|NCT01052779|323667778|FG000|Overall Study|Withdrawal by Subject|1|||
94511004|NCT01052779|323667779|FG001|Overall Study|Withdrawal by Subject|2|||
94511005|NCT01052779|323667778|FG000|Overall Study|Other-Protocol Violation|1|||
94511006|NCT01052779|323667779|FG001|Overall Study|Other-Protocol Violation|1|||
94511007|NCT01052779|323667778|FG000|Overall Study|Other-Surgery|0|||
94511008|NCT01052779|323667779|FG001|Overall Study|Other-Surgery|2|||
94511009|NCT01052779|323667778|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
94511010|NCT01052779|323667779|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
94511011|NCT03427619|323667780|FG000|Overall Study|Physician Decision|3|||
94511012|NCT03427619|323667780|FG000|Overall Study|Withdrawal by Subject|4|||
94511013|NCT03427619|323667780|FG000|Overall Study|Lost to Follow-up|5|||
94511014|NCT03427619|323667780|FG000|Overall Study|Administrative|4|||
94511015|NCT03427619|323667780|FG000|Overall Study|Other|2|||
94511016|NCT03427619|323667780|FG000|Overall Study|Unknown or Missing Completion Status|48|||
94511017|NCT02853136|323667781|FG000|Wash-out|Adverse Event|0|||
94511018|NCT02853136|323667782|FG001|Wash-out|Adverse Event|0|||
94511019|NCT02853136|323667783|FG002|Wash-out|Adverse Event|0|||
94511020|NCT02853136|323667784|FG003|Wash-out|Adverse Event|1|||
94511021|NCT06582732|323667788|FG000|Initial Study Period|Adverse Event|0|||
94511022|NCT06582732|323667789|FG001|Initial Study Period|Adverse Event|0|||
94511023|NCT06582732|323667790|FG002|Initial Study Period|Adverse Event|0|||
94511024|NCT06582732|323667791|FG003|Initial Study Period|Adverse Event|2|||
94511025|NCT06582732|323667792|FG004|Initial Study Period|Adverse Event|0|||
94511026|NCT06582732|323667793|FG005|Initial Study Period|Adverse Event|0|||
94511027|NCT06582732|323667794|FG006|Initial Study Period|Adverse Event|0|||
94511028|NCT06582732|323667788|FG000|Initial Study Period|Death|1|||
94511029|NCT06582732|323667789|FG001|Initial Study Period|Death|0|||
94511030|NCT06582732|323667790|FG002|Initial Study Period|Death|0|||
94511031|NCT06582732|323667791|FG003|Initial Study Period|Death|0|||
94511032|NCT06582732|323667792|FG004|Initial Study Period|Death|1|||
94511033|NCT06582732|323667793|FG005|Initial Study Period|Death|0|||
94511034|NCT06582732|323667794|FG006|Initial Study Period|Death|0|||
94511035|NCT06582732|323667788|FG000|Initial Study Period|Lost to Follow-up|0|||
94511036|NCT06582732|323667789|FG001|Initial Study Period|Lost to Follow-up|0|||
94511037|NCT06582732|323667790|FG002|Initial Study Period|Lost to Follow-up|2|||
94511038|NCT06582732|323667791|FG003|Initial Study Period|Lost to Follow-up|0|||
94511039|NCT06582732|323667792|FG004|Initial Study Period|Lost to Follow-up|0|||
94511040|NCT06582732|323667793|FG005|Initial Study Period|Lost to Follow-up|0|||
94511041|NCT06582732|323667794|FG006|Initial Study Period|Lost to Follow-up|0|||
94511042|NCT06582732|323667788|FG000|Initial Study Period|Withdrawal by Subject|0|||
94511043|NCT06582732|323667789|FG001|Initial Study Period|Withdrawal by Subject|1|||
94511044|NCT06582732|323667790|FG002|Initial Study Period|Withdrawal by Subject|0|||
94511045|NCT06582732|323667791|FG003|Initial Study Period|Withdrawal by Subject|1|||
94511046|NCT06582732|323667792|FG004|Initial Study Period|Withdrawal by Subject|3|||
94511047|NCT06582732|323667793|FG005|Initial Study Period|Withdrawal by Subject|1|||
94511048|NCT06582732|323667794|FG006|Initial Study Period|Withdrawal by Subject|2|||
94511049|NCT06582732|323667788|FG000|Initial Study Period|Moved Away|0|||
94511050|NCT06582732|323667789|FG001|Initial Study Period|Moved Away|0|||
94511051|NCT06582732|323667790|FG002|Initial Study Period|Moved Away|0|||
94511052|NCT06582732|323667791|FG003|Initial Study Period|Moved Away|0|||
94511053|NCT06582732|323667792|FG004|Initial Study Period|Moved Away|1|||
94511054|NCT06582732|323667793|FG005|Initial Study Period|Moved Away|0|||
94511055|NCT06582732|323667794|FG006|Initial Study Period|Moved Away|0|||
94511056|NCT03931330|323667795|FG000|Overall Study|Physician Decision|1|||
94511057|NCT01381679|323667796|FG000|Overall Study|Adverse Event|3|||
94511058|NCT01381679|323667796|FG000|Overall Study|Lost to Follow-up|885|||
94511059|NCT00605189|323667797|FG000|Overall Study|Adverse Event|1|||
94511060|NCT00605189|323667798|FG001|Overall Study|Adverse Event|0|||
94511061|NCT00605189|323667799|FG002|Overall Study|Adverse Event|0|||
94511062|NCT00605189|323667797|FG000|Overall Study|Other|2|||
94511063|NCT00605189|323667798|FG001|Overall Study|Other|2|||
94511064|NCT00605189|323667799|FG002|Overall Study|Other|0|||
94511065|NCT02507934|323667800|FG000|Overall Study|Lost to Follow-up|2|||
94511066|NCT02507934|323667801|FG001|Overall Study|Lost to Follow-up|0|||
94511067|NCT02507934|323667800|FG000|Overall Study|Withdrawal by Subject|2|||
94511068|NCT02507934|323667801|FG001|Overall Study|Withdrawal by Subject|0|||
94511069|NCT02919618|323667802|FG000|Overall Study|Death|1|||
94511070|NCT02743221|323667803|FG000|Overall Study|Progressive disease|29|||
94511071|NCT02743221|323667804|FG001|Overall Study|Progressive disease|38|||
94511072|NCT02743221|323667803|FG000|Overall Study|Adverse Event|17|||
94511073|NCT02743221|323667804|FG001|Overall Study|Adverse Event|14|||
94511074|NCT02743221|323667803|FG000|Overall Study|non medical reason|8|||
94511075|NCT02743221|323667804|FG001|Overall Study|non medical reason|2|||
94511076|NCT02743221|323667803|FG000|Overall Study|Physician Decision|2|||
94511077|NCT02743221|323667804|FG001|Overall Study|Physician Decision|5|||
94511078|NCT02743221|323667803|FG000|Overall Study|Patient not eligible, not treated|0|||
94511079|NCT02743221|323667804|FG001|Overall Study|Patient not eligible, not treated|1|||
94511080|NCT04770285|323667806|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
94511081|NCT04770285|323667807|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
94511082|NCT04770285|323667806|FG000|Overall Study|Lack of Efficacy|0|||
94511083|NCT04770285|323667807|FG001|Overall Study|Lack of Efficacy|1|||
94511084|NCT04770285|323667806|FG000|Overall Study|Lost to Follow-up|11|||
94511085|NCT04770285|323667807|FG001|Overall Study|Lost to Follow-up|8|||
94511086|NCT04770285|323667806|FG000|Overall Study|Protocol Deviation|6|||
94511087|NCT04770285|323667807|FG001|Overall Study|Protocol Deviation|6|||
94511088|NCT04770285|323667806|FG000|Overall Study|Technical Problem|0|||
94511089|NCT04770285|323667807|FG001|Overall Study|Technical Problem|1|||
94511090|NCT04770285|323667806|FG000|Overall Study|Withdrawal by Subject|9|||
94511091|NCT04770285|323667807|FG001|Overall Study|Withdrawal by Subject|8|||
94511092|NCT04770285|323667806|FG000|Overall Study|Reason Not Specified|0|||
94511093|NCT04770285|323667807|FG001|Overall Study|Reason Not Specified|1|||
94511094|NCT02082977|323667808|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
94511095|NCT02082977|323667809|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
94511096|NCT02082977|323667810|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
94511097|NCT02082977|323667811|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
94511098|NCT02082977|323667812|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
94511099|NCT02082977|323667813|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
94511100|NCT02082977|323667814|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
94511101|NCT02082977|323667815|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
94511102|NCT02082977|323667816|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
94511103|NCT02082977|323667817|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
94511104|NCT02082977|323667808|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
94511105|NCT02082977|323667809|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
94511106|NCT02082977|323667810|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
94511107|NCT02082977|323667811|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
94511108|NCT02082977|323667812|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
94511109|NCT02082977|323667813|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
94511110|NCT02082977|323667814|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
94511111|NCT02082977|323667815|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
94511112|NCT02082977|323667816|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
94511113|NCT02082977|323667817|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
94511114|NCT02082977|323667808|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
94511115|NCT02082977|323667809|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
94511116|NCT02082977|323667810|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
94511117|NCT02082977|323667811|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
94511118|NCT02082977|323667812|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
94511119|NCT02082977|323667813|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
94511120|NCT02082977|323667814|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
94511121|NCT02082977|323667815|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
94511122|NCT02082977|323667816|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
94511123|NCT02082977|323667817|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
94511124|NCT02082977|323667808|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
94511125|NCT02082977|323667809|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
94511126|NCT02082977|323667810|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
94511127|NCT02082977|323667811|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
94511128|NCT02082977|323667812|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
94511129|NCT02082977|323667813|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
94511130|NCT02082977|323667814|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
94511131|NCT02082977|323667815|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
94511132|NCT02082977|323667816|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
94511133|NCT02082977|323667817|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
94511134|NCT02082977|323667808|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
94511135|NCT02082977|323667809|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
94511136|NCT02082977|323667810|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
94511137|NCT02082977|323667811|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
94511138|NCT02082977|323667812|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
94511139|NCT02082977|323667813|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
94511140|NCT02082977|323667814|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
94511141|NCT02082977|323667815|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
94511142|NCT02082977|323667816|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
94511143|NCT02082977|323667817|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
94511144|NCT01344226|323667820|FG000|Overall Study|Protocol Violation|2|||
94511145|NCT01344226|323667820|FG000|Overall Study|Withdrawal by Subject|3|||
94511146|NCT01344226|323667820|FG000|Overall Study|Lack of Efficacy|3|||
94511147|NCT01107496|323667829|FG000|Overall Study|Adverse Event|1|||
94511148|NCT01107496|323667830|FG001|Overall Study|Adverse Event|0|||
94511149|NCT01107496|323667829|FG000|Overall Study|Lack of Efficacy|1|||
94511150|NCT01107496|323667830|FG001|Overall Study|Lack of Efficacy|0|||
94511151|NCT01107496|323667829|FG000|Overall Study|Protocol Violation|0|||
94511152|NCT01107496|323667830|FG001|Overall Study|Protocol Violation|1|||
94511153|NCT01107496|323667829|FG000|Overall Study|Lost to Follow-up|0|||
94511154|NCT01107496|323667830|FG001|Overall Study|Lost to Follow-up|1|||
94511155|NCT03559556|323667831|FG000|Overall Study|Withdrawal by Subject|1|||
94511156|NCT03110562|323667832|FG000|Initial Treatment Period|Disease Progression|1|||
94511157|NCT03110562|323667833|FG001|Initial Treatment Period|Disease Progression|1|||
94511158|NCT03110562|323667834|FG002|Initial Treatment Period|Disease Progression|0|||
94511159|NCT03110562|323667835|FG003|Initial Treatment Period|Disease Progression|0|||
94511160|NCT03110562|323667832|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
94511161|NCT03110562|323667833|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
94511162|NCT03110562|323667834|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
94511163|NCT03110562|323667835|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
94511164|NCT03110562|323667832|FG000|Initial Treatment Period|Adverse Event|1|||
94511165|NCT03110562|323667833|FG001|Initial Treatment Period|Adverse Event|0|||
94511166|NCT03110562|323667834|FG002|Initial Treatment Period|Adverse Event|0|||
94511167|NCT03110562|323667835|FG003|Initial Treatment Period|Adverse Event|0|||
94511168|NCT03110562|323667832|FG000|Initial Treatment Period|Death|74|||
94511169|NCT03110562|323667833|FG001|Initial Treatment Period|Death|82|||
94511170|NCT03110562|323667834|FG002|Initial Treatment Period|Death|0|||
94511171|NCT03110562|323667835|FG003|Initial Treatment Period|Death|0|||
94511172|NCT03110562|323667832|FG000|Initial Treatment Period|Lost to Follow-up|13|||
94511173|NCT03110562|323667833|FG001|Initial Treatment Period|Lost to Follow-up|8|||
94511174|NCT03110562|323667834|FG002|Initial Treatment Period|Lost to Follow-up|0|||
94511175|NCT03110562|323667835|FG003|Initial Treatment Period|Lost to Follow-up|0|||
94511176|NCT03110562|323667832|FG000|Initial Treatment Period|Protocol Deviation|1|||
94511177|NCT03110562|323667833|FG001|Initial Treatment Period|Protocol Deviation|0|||
94511178|NCT03110562|323667834|FG002|Initial Treatment Period|Protocol Deviation|0|||
94511179|NCT03110562|323667835|FG003|Initial Treatment Period|Protocol Deviation|0|||
94511180|NCT03110562|323667832|FG000|Initial Treatment Period|Physician Decision|2|||
94511181|NCT03110562|323667833|FG001|Initial Treatment Period|Physician Decision|1|||
94511182|NCT03110562|323667834|FG002|Initial Treatment Period|Physician Decision|0|||
94511183|NCT03110562|323667835|FG003|Initial Treatment Period|Physician Decision|0|||
94511184|NCT03110562|323667832|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
94511185|NCT03110562|323667833|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
94511186|NCT03110562|323667834|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
94511187|NCT03110562|323667835|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
94511188|NCT03110562|323667832|FG000|Initial Treatment Period|Other|5|||
94511189|NCT03110562|323667833|FG001|Initial Treatment Period|Other|4|||
94511190|NCT03110562|323667834|FG002|Initial Treatment Period|Other|0|||
94511191|NCT03110562|323667835|FG003|Initial Treatment Period|Other|0|||
94511192|NCT03110562|323667832|FG000|Initial Treatment Period|Randomized but never treated|0|||
94511193|NCT03110562|323667833|FG001|Initial Treatment Period|Randomized but never treated|3|||
94511194|NCT03110562|323667834|FG002|Initial Treatment Period|Randomized but never treated|0|||
94511195|NCT03110562|323667835|FG003|Initial Treatment Period|Randomized but never treated|0|||
94511196|NCT03110562|323667832|FG000|Crossover Period|Disease Progression|0|||
94511197|NCT03110562|323667833|FG001|Crossover Period|Disease Progression|0|||
94511198|NCT03110562|323667834|FG002|Crossover Period|Disease Progression|1|||
94511199|NCT03110562|323667835|FG003|Crossover Period|Disease Progression|0|||
94511200|NCT03110562|323667832|FG000|Crossover Period|Withdrawal by Subject|0|||
94511201|NCT03110562|323667833|FG001|Crossover Period|Withdrawal by Subject|0|||
94511202|NCT03110562|323667834|FG002|Crossover Period|Withdrawal by Subject|8|||
94511203|NCT03110562|323667835|FG003|Crossover Period|Withdrawal by Subject|6|||
94511204|NCT03110562|323667832|FG000|Crossover Period|Death|0|||
94511205|NCT03110562|323667833|FG001|Crossover Period|Death|0|||
94511206|NCT03110562|323667834|FG002|Crossover Period|Death|37|||
94511207|NCT03110562|323667835|FG003|Crossover Period|Death|3|||
94511208|NCT03110562|323667832|FG000|Crossover Period|Lost to Follow-up|0|||
94511209|NCT03110562|323667833|FG001|Crossover Period|Lost to Follow-up|0|||
94511210|NCT03110562|323667834|FG002|Crossover Period|Lost to Follow-up|0|||
94511211|NCT03110562|323667835|FG003|Crossover Period|Lost to Follow-up|1|||
94511212|NCT03110562|323667832|FG000|Crossover Period|Other|0|||
94511213|NCT03110562|323667833|FG001|Crossover Period|Other|0|||
94511214|NCT03110562|323667834|FG002|Crossover Period|Other|1|||
94511215|NCT03110562|323667835|FG003|Crossover Period|Other|1|||
94511216|NCT03110562|323667832|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
94511217|NCT03110562|323667833|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
94511218|NCT03110562|323667834|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
94511219|NCT03110562|323667835|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
94511220|NCT01355627|323667838|FG000|Overall Study|Request By the Patient to Discontinue|5|||
94511221|NCT01355627|323667839|FG001|Overall Study|Request By the Patient to Discontinue|7|||
94511222|NCT01355627|323667838|FG000|Overall Study|Lost to Follow-up|8|||
94511223|NCT01355627|323667839|FG001|Overall Study|Lost to Follow-up|7|||
94511224|NCT01355627|323667838|FG000|Overall Study|Fatal Adverse Event|19|||
94511225|NCT01355627|323667839|FG001|Overall Study|Fatal Adverse Event|23|||
94511226|NCT01355627|323667838|FG000|Overall Study|Other|1|||
94511227|NCT01355627|323667839|FG001|Overall Study|Other|1|||
94511228|NCT02022202|323667840|FG000|Overall Study|Withdrawal by Subject|2|||
94511229|NCT02022202|323667840|FG000|Overall Study|Disease Progression|3|||
94511230|NCT02022202|323667840|FG000|Overall Study|Desire go to immediately to surgery|3|||
94511231|NCT02769481|323667841|FG000|Overall Study|Protocol Violation|1|||
94511232|NCT02769481|323667842|FG001|Overall Study|Protocol Violation|0|||
94511233|NCT02769481|323667841|FG000|Overall Study|Adverse Event|3|||
94511234|NCT02769481|323667842|FG001|Overall Study|Adverse Event|6|||
94511235|NCT02769481|323667841|FG000|Overall Study|Entry Criteria Not Met|1|||
94511236|NCT02769481|323667842|FG001|Overall Study|Entry Criteria Not Met|2|||
94511237|NCT02769481|323667841|FG000|Overall Study|Withdrawal by Subject|14|||
94511238|NCT02769481|323667842|FG001|Overall Study|Withdrawal by Subject|16|||
94511239|NCT02769481|323667841|FG000|Overall Study|Lost to Follow-up|9|||
94511240|NCT02769481|323667842|FG001|Overall Study|Lost to Follow-up|9|||
94511241|NCT02769481|323667841|FG000|Overall Study|Physician Decision|0|||
94511242|NCT02769481|323667842|FG001|Overall Study|Physician Decision|1|||
94511243|NCT02769481|323667841|FG000|Overall Study|Terminated by Sponsor|1|||
94511244|NCT02769481|323667842|FG001|Overall Study|Terminated by Sponsor|0|||
94511245|NCT02769481|323667841|FG000|Overall Study|Death|0|||
94511246|NCT02769481|323667842|FG001|Overall Study|Death|1|||
94511247|NCT02769481|323667841|FG000|Overall Study|Undefined|4|||
94511248|NCT02769481|323667842|FG001|Overall Study|Undefined|1|||
94511249|NCT03510715|323667843|FG000|Overall Study|Adverse Event|1|||
94511250|NCT03510715|323667844|FG001|Overall Study|Adverse Event|0|||
94511251|NCT04976855|323667847|FG000|Part I|Withdrawal by Subject|0|||
94511252|NCT04976855|323667848|FG001|Part I|Withdrawal by Subject|1|||
94511253|NCT04976855|323667849|FG002|Part I|Withdrawal by Subject|0|||
94511254|NCT04976855|323667850|FG003|Part I|Withdrawal by Subject|0|||
94511255|NCT04976855|323667851|FG004|Part I|Withdrawal by Subject|0|||
94511256|NCT04976855|323667852|FG005|Part I|Withdrawal by Subject|0|||
94511257|NCT04976855|323667853|FG006|Part I|Withdrawal by Subject|0|||
94511258|NCT04976855|323667847|FG000|Part II|Adverse Event|0|||
94511259|NCT04976855|323667848|FG001|Part II|Adverse Event|0|||
94511260|NCT04976855|323667849|FG002|Part II|Adverse Event|0|||
94511261|NCT04976855|323667850|FG003|Part II|Adverse Event|1|||
94511262|NCT04976855|323667851|FG004|Part II|Adverse Event|0|||
94511263|NCT04976855|323667852|FG005|Part II|Adverse Event|0|||
94511264|NCT04976855|323667853|FG006|Part II|Adverse Event|0|||
94511265|NCT04976855|323667847|FG000|Part II|Withdrawal by Subject|0|||
94511266|NCT04976855|323667848|FG001|Part II|Withdrawal by Subject|0|||
94511267|NCT04976855|323667849|FG002|Part II|Withdrawal by Subject|0|||
94511268|NCT04976855|323667850|FG003|Part II|Withdrawal by Subject|0|||
94511269|NCT04976855|323667851|FG004|Part II|Withdrawal by Subject|1|||
94511270|NCT04976855|323667852|FG005|Part II|Withdrawal by Subject|0|||
94511271|NCT04976855|323667853|FG006|Part II|Withdrawal by Subject|0|||
94511272|NCT04976855|323667847|FG000|Part II|Lost to Follow-up|0|||
94511273|NCT04976855|323667848|FG001|Part II|Lost to Follow-up|0|||
94511274|NCT04976855|323667849|FG002|Part II|Lost to Follow-up|0|||
94511275|NCT04976855|323667850|FG003|Part II|Lost to Follow-up|0|||
94511276|NCT04976855|323667851|FG004|Part II|Lost to Follow-up|0|||
94511277|NCT04976855|323667852|FG005|Part II|Lost to Follow-up|1|||
94511278|NCT04976855|323667853|FG006|Part II|Lost to Follow-up|0|||
94511279|NCT02757768|323667854|FG000|Overall Study|Randomized Never Received Study Drug|3|||
94511280|NCT02757768|323667855|FG001|Overall Study|Randomized Never Received Study Drug|4|||
94511281|NCT02757768|323667854|FG000|Overall Study|Adverse Event|5|||
94511282|NCT02757768|323667855|FG001|Overall Study|Adverse Event|3|||
94511283|NCT02757768|323667854|FG000|Overall Study|Lack of Efficacy|2|||
94511284|NCT02757768|323667855|FG001|Overall Study|Lack of Efficacy|1|||
94511285|NCT02757768|323667854|FG000|Overall Study|Lost to Follow-up|1|||
94511286|NCT02757768|323667855|FG001|Overall Study|Lost to Follow-up|0|||
94511287|NCT02757768|323667854|FG000|Overall Study|Protocol Deviation|2|||
94511288|NCT02757768|323667855|FG001|Overall Study|Protocol Deviation|9|||
94511289|NCT02757768|323667854|FG000|Overall Study|Withdrawal by Subject|16|||
94511290|NCT02757768|323667855|FG001|Overall Study|Withdrawal by Subject|9|||
94511291|NCT02757768|323667854|FG000|Overall Study|Miscellaneous|4|||
94511292|NCT02757768|323667855|FG001|Overall Study|Miscellaneous|2|||
94511293|NCT02657356|323669316|FG000|Overall Study|Death|1|||
94511294|NCT02657356|323669317|FG001|Overall Study|Death|0|||
94511295|NCT02657356|323669316|FG000|Overall Study|Withdrawal by Subject|5|||
94511296|NCT02657356|323669317|FG001|Overall Study|Withdrawal by Subject|6|||
94511297|NCT02657356|323669316|FG000|Overall Study|Terminated by Sponsor|8|||
94511298|NCT02657356|323669317|FG001|Overall Study|Terminated by Sponsor|5|||
94511299|NCT02657356|323669316|FG000|Overall Study|Rolled over to EAP study|6|||
94511300|NCT02657356|323669317|FG001|Overall Study|Rolled over to EAP study|4|||
94511301|NCT00936936|323669318|FG000|Overall Study|Adverse Event|7|||
94511302|NCT00936936|323669319|FG001|Overall Study|Adverse Event|1|||
94511303|NCT00936936|323669318|FG000|Overall Study|Disease Progression|2|||
94511304|NCT00936936|323669319|FG001|Overall Study|Disease Progression|2|||
94511305|NCT00936936|323669318|FG000|Overall Study|Unrelated|3|||
94511306|NCT00936936|323669319|FG001|Overall Study|Unrelated|1|||
94511307|NCT01394185|323669320|FG000|Overall Study|Withdrawal by Subject|2|||
94511308|NCT01394185|323669321|FG001|Overall Study|Withdrawal by Subject|0|||
94511309|NCT01394185|323669322|FG002|Overall Study|Withdrawal by Subject|0|||
94511310|NCT01394185|323669323|FG003|Overall Study|Withdrawal by Subject|0|||
94511311|NCT01394185|323669324|FG004|Overall Study|Withdrawal by Subject|1|||
94511312|NCT01394185|323669325|FG005|Overall Study|Withdrawal by Subject|0|||
94511313|NCT01394185|323669320|FG000|Overall Study|Change in protocol|3|||
94511314|NCT01394185|323669321|FG001|Overall Study|Change in protocol|0|||
94511315|NCT01394185|323669322|FG002|Overall Study|Change in protocol|0|||
94511316|NCT01394185|323669323|FG003|Overall Study|Change in protocol|0|||
94511317|NCT01394185|323669324|FG004|Overall Study|Change in protocol|3|||
94511318|NCT01394185|323669325|FG005|Overall Study|Change in protocol|0|||
94511319|NCT01394185|323669320|FG000|Overall Study|Protocol Violation|1|||
94511320|NCT01394185|323669321|FG001|Overall Study|Protocol Violation|0|||
94511321|NCT01394185|323669322|FG002|Overall Study|Protocol Violation|0|||
94511322|NCT01394185|323669323|FG003|Overall Study|Protocol Violation|1|||
94511323|NCT01394185|323669324|FG004|Overall Study|Protocol Violation|0|||
94511324|NCT01394185|323669325|FG005|Overall Study|Protocol Violation|1|||
94511325|NCT00833703|323669326|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
94511326|NCT00833703|323669327|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
94511327|NCT03552029|323669328|FG000|Overall Study|Death|3|||
94511328|NCT03552029|323669329|FG001|Overall Study|Death|0|||
94511329|NCT03552029|323669328|FG000|Overall Study|Adverse Event|1|||
94511330|NCT03552029|323669329|FG001|Overall Study|Adverse Event|0|||
94511331|NCT03552029|323669328|FG000|Overall Study|Lack of Efficacy|0|||
94511332|NCT03552029|323669329|FG001|Overall Study|Lack of Efficacy|2|||
94511333|NCT03552029|323669328|FG000|Overall Study|Physician Decision|0|||
94511334|NCT03552029|323669329|FG001|Overall Study|Physician Decision|1|||
94511335|NCT03552029|323669328|FG000|Overall Study|Study terminated by Sponsor|0|||
94511336|NCT03552029|323669329|FG001|Overall Study|Study terminated by Sponsor|1|||
94511337|NCT03552029|323669328|FG000|Overall Study|Other|0|||
94511338|NCT03552029|323669329|FG001|Overall Study|Other|2|||
94511339|NCT03332056|323669331|FG000|Overall Study|Incomplete questionnaires|8|||
94511340|NCT03332056|323669332|FG001|Overall Study|Incomplete questionnaires|9|||
94511341|NCT03332056|323669331|FG000|Overall Study|Passed stone prior to surgery date|1|||
94511342|NCT03332056|323669332|FG001|Overall Study|Passed stone prior to surgery date|0|||
94511343|NCT03332056|323669331|FG000|Overall Study|Did not require a ureteral stent|0|||
94511344|NCT03332056|323669332|FG001|Overall Study|Did not require a ureteral stent|1|||
94511345|NCT00851084|323669333|FG000|Overall Study|Randomized but not treated|1|||
94511346|NCT00851084|323669334|FG001|Overall Study|Randomized but not treated|0|||
94511347|NCT00851084|323669333|FG000|Overall Study|Adverse Event|26|||
94511348|NCT00851084|323669334|FG001|Overall Study|Adverse Event|36|||
94511349|NCT00851084|323669333|FG000|Overall Study|Disease progression|52|||
94511350|NCT00851084|323669334|FG001|Overall Study|Disease progression|47|||
94511351|NCT00851084|323669333|FG000|Overall Study|Poor compliance to protocol|1|||
94511352|NCT00851084|323669334|FG001|Overall Study|Poor compliance to protocol|1|||
94511353|NCT00851084|323669333|FG000|Overall Study|Physician Decision|13|||
94511354|NCT00851084|323669334|FG001|Overall Study|Physician Decision|14|||
94511355|NCT00851084|323669333|FG000|Overall Study|Consent withdrawn|0|||
94511356|NCT00851084|323669334|FG001|Overall Study|Consent withdrawn|2|||
94511357|NCT00851084|323669333|FG000|Overall Study|Withdrawal by Subject|11|||
94511358|NCT00851084|323669334|FG001|Overall Study|Withdrawal by Subject|12|||
94511359|NCT00851084|323669333|FG000|Overall Study|Metastatic surgery|6|||
94511360|NCT00851084|323669334|FG001|Overall Study|Metastatic surgery|6|||
94511361|NCT00851084|323669333|FG000|Overall Study|Other|7|||
94511362|NCT00851084|323669334|FG001|Overall Study|Other|1|||
94511363|NCT00321932|323669336|FG000|Overall Study|Death|3|||
94511364|NCT00321932|323669337|FG001|Overall Study|Death|6|||
94511365|NCT00321932|323669336|FG000|Overall Study|Withdrawal by Subject|3|||
94511366|NCT00321932|323669337|FG001|Overall Study|Withdrawal by Subject|6|||
94511367|NCT00321932|323669336|FG000|Overall Study|Early relapse|2|||
94511368|NCT00321932|323669337|FG001|Overall Study|Early relapse|8|||
94511369|NCT00321932|323669336|FG000|Overall Study|Missing data|2|||
94511370|NCT00321932|323669337|FG001|Overall Study|Missing data|1|||
94511371|NCT00734032|323669338|FG000|Overall Study|Adverse Event|0|||
94511372|NCT00734032|323669339|FG001|Overall Study|Adverse Event|1|||
94511373|NCT00734032|323669340|FG002|Overall Study|Adverse Event|0|||
94511374|NCT00734032|323669341|FG003|Overall Study|Adverse Event|0|||
94511375|NCT01904279|323669342|FG000|Overall Study|Lack of Efficacy|2|||
94511376|NCT01904279|323669343|FG001|Overall Study|Lack of Efficacy|3|||
94511377|NCT01904279|323669342|FG000|Overall Study|Withdrawal by Subject|1|||
94511378|NCT01904279|323669343|FG001|Overall Study|Withdrawal by Subject|0|||
94511379|NCT03360344|323669345|FG000|Overall Study|Withdrawal by Subject|0|||
94511380|NCT03360344|323669346|FG001|Overall Study|Withdrawal by Subject|1|||
94511381|NCT03360344|323669347|FG002|Overall Study|Withdrawal by Subject|1|||
94511382|NCT00959049|323669348|FG000|Overall Study|Adverse Event|1|||
94511383|NCT00959049|323669349|FG001|Overall Study|Adverse Event|0|||
94511384|NCT00959049|323669350|FG002|Overall Study|Adverse Event|0|||
94511385|NCT00959049|323669351|FG003|Overall Study|Adverse Event|0|||
94511386|NCT00959049|323669352|FG004|Overall Study|Adverse Event|0|||
94511387|NCT00959049|323669353|FG005|Overall Study|Adverse Event|0|||
94511388|NCT00959049|323669348|FG000|Overall Study|Lost to Follow-up|17|||
94511389|NCT00959049|323669349|FG001|Overall Study|Lost to Follow-up|5|||
94511390|NCT00959049|323669350|FG002|Overall Study|Lost to Follow-up|1|||
94511391|NCT00959049|323669351|FG003|Overall Study|Lost to Follow-up|10|||
94511392|NCT00959049|323669352|FG004|Overall Study|Lost to Follow-up|9|||
94511393|NCT00959049|323669353|FG005|Overall Study|Lost to Follow-up|1|||
94511394|NCT00959049|323669348|FG000|Overall Study|Contraindicated medication|0|||
94511395|NCT00959049|323669349|FG001|Overall Study|Contraindicated medication|0|||
94511396|NCT00959049|323669350|FG002|Overall Study|Contraindicated medication|0|||
94511397|NCT00959049|323669351|FG003|Overall Study|Contraindicated medication|1|||
94511398|NCT00959049|323669352|FG004|Overall Study|Contraindicated medication|0|||
94511399|NCT00959049|323669353|FG005|Overall Study|Contraindicated medication|0|||
94511400|NCT00959049|323669348|FG000|Overall Study|Withdrawal by Subject|0|||
94511401|NCT00959049|323669349|FG001|Overall Study|Withdrawal by Subject|2|||
94511402|NCT00959049|323669350|FG002|Overall Study|Withdrawal by Subject|0|||
94511403|NCT00959049|323669351|FG003|Overall Study|Withdrawal by Subject|0|||
94511404|NCT00959049|323669352|FG004|Overall Study|Withdrawal by Subject|0|||
94511405|NCT00959049|323669353|FG005|Overall Study|Withdrawal by Subject|0|||
94511406|NCT03257657|323669356|FG000|Overall Study|Lost to Follow-up|0|||
94511407|NCT03257657|323669357|FG001|Overall Study|Lost to Follow-up|3|||
94511408|NCT03257657|323669356|FG000|Overall Study|Withdrawn|0|||
94511409|NCT03257657|323669357|FG001|Overall Study|Withdrawn|1|||
94511410|NCT03257657|323669356|FG000|Overall Study|Noted not eligible right after enrolled|0|||
94511411|NCT03257657|323669357|FG001|Overall Study|Noted not eligible right after enrolled|1|||
94511412|NCT00095576|323669364|FG000|Overall Study|Adverse Event|5|||
94511413|NCT00095576|323669365|FG001|Overall Study|Adverse Event|3|||
94511414|NCT00095576|323669364|FG000|Overall Study|Lost to Follow-up|233|||
94511415|NCT00095576|323669365|FG001|Overall Study|Lost to Follow-up|229|||
94511416|NCT00095576|323669364|FG000|Overall Study|Protocol Violation|1|||
94511417|NCT00095576|323669365|FG001|Overall Study|Protocol Violation|0|||
94511418|NCT00095576|323669364|FG000|Overall Study|Withdrawal by Subject|34|||
94511419|NCT00095576|323669365|FG001|Overall Study|Withdrawal by Subject|47|||
94511420|NCT00095576|323669364|FG000|Overall Study|Option to switch to a rollover study|1097|||
94511421|NCT00095576|323669365|FG001|Overall Study|Option to switch to a rollover study|1099|||
94511422|NCT00095576|323669364|FG000|Overall Study|Site terminated|75|||
94511423|NCT00095576|323669365|FG001|Overall Study|Site terminated|67|||
94511424|NCT00095576|323669364|FG000|Overall Study|Subject moved|30|||
94511425|NCT00095576|323669365|FG001|Overall Study|Subject moved|36|||
94511426|NCT02301897|323669366|FG000|Treatment Course 1|Non-Compliance|0|||
94511427|NCT02301897|323669367|FG001|Treatment Course 1|Non-Compliance|0|||
94511428|NCT02301897|323669368|FG002|Treatment Course 1|Non-Compliance|1|||
94511429|NCT02301897|323669366|FG000|Treatment Course 1|Adverse Event|1|||
94511430|NCT02301897|323669367|FG001|Treatment Course 1|Adverse Event|1|||
94511431|NCT02301897|323669368|FG002|Treatment Course 1|Adverse Event|0|||
94511432|NCT02301897|323669366|FG000|Treatment Course 1|Lost to Follow-up|1|||
94511433|NCT02301897|323669367|FG001|Treatment Course 1|Lost to Follow-up|2|||
94511434|NCT02301897|323669368|FG002|Treatment Course 1|Lost to Follow-up|1|||
94511435|NCT02301897|323669366|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
94511436|NCT02301897|323669367|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
94511437|NCT02301897|323669368|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
94511438|NCT02301897|323669366|FG000|Treatment Course 1|Withdrawal by Subject|0|||
94511439|NCT02301897|323669367|FG001|Treatment Course 1|Withdrawal by Subject|0|||
94511440|NCT02301897|323669368|FG002|Treatment Course 1|Withdrawal by Subject|2|||
94511441|NCT02301897|323669366|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
94511442|NCT02301897|323669367|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
94511443|NCT02301897|323669368|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
94511444|NCT02301897|323669366|FG000|Treatment Course 2|Lost to Follow-up|0|||
94511445|NCT02301897|323669367|FG001|Treatment Course 2|Lost to Follow-up|2|||
94511446|NCT02301897|323669368|FG002|Treatment Course 2|Lost to Follow-up|0|||
94511447|NCT02301897|323669366|FG000|Treatment Course 2|Pregnancy|0|||
94511448|NCT02301897|323669367|FG001|Treatment Course 2|Pregnancy|1|||
94511449|NCT02301897|323669368|FG002|Treatment Course 2|Pregnancy|1|||
94511450|NCT02301897|323669366|FG000|Treatment Course 2|Withdrawal by Subject|0|||
94511451|NCT02301897|323669367|FG001|Treatment Course 2|Withdrawal by Subject|2|||
94511452|NCT02301897|323669368|FG002|Treatment Course 2|Withdrawal by Subject|0|||
94511453|NCT02301897|323669366|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
94511454|NCT02301897|323669367|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
94511455|NCT02301897|323669368|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
94511456|NCT00586157|323669371|FG000|First Intervention|Worsening behavior|1|||
94511457|NCT00586157|323669372|FG001|First Intervention|Worsening behavior|0|||
94511458|NCT00586157|323669371|FG000|Second Intervention|Withdrawal by Subject|1|||
94511459|NCT00586157|323669372|FG001|Second Intervention|Withdrawal by Subject|0|||
94511460|NCT00586157|323669371|FG000|Second Intervention|Worsening behavior|1|||
94511461|NCT00586157|323669372|FG001|Second Intervention|Worsening behavior|0|||
94511462|NCT00586157|323669371|FG000|Second Intervention|Adverse Event|0|||
94511463|NCT00586157|323669372|FG001|Second Intervention|Adverse Event|1|||
94511464|NCT02378480|323669375|FG000|Overall Study|Physician Decision|1|||
94511465|NCT02378480|323669376|FG001|Overall Study|Physician Decision|1|||
94511466|NCT02378480|323669375|FG000|Overall Study|Death|1|||
94511467|NCT02378480|323669376|FG001|Overall Study|Death|2|||
94511468|NCT02378480|323669375|FG000|Overall Study|Randomized, but Not Treated|6|||
94511469|NCT02378480|323669376|FG001|Overall Study|Randomized, but Not Treated|4|||
94511470|NCT02378480|323669375|FG000|Overall Study|Adverse Event|0|||
94511471|NCT02378480|323669376|FG001|Overall Study|Adverse Event|1|||
94511472|NCT02378480|323669375|FG000|Overall Study|Missed EOT/PTE Visit|1|||
94511473|NCT02378480|323669376|FG001|Overall Study|Missed EOT/PTE Visit|2|||
94511474|NCT02378480|323669375|FG000|Overall Study|Withdrawal by Subject|9|||
94511475|NCT02378480|323669376|FG001|Overall Study|Withdrawal by Subject|4|||
94511476|NCT02378480|323669375|FG000|Overall Study|Lost to Follow-up|10|||
94511477|NCT02378480|323669376|FG001|Overall Study|Lost to Follow-up|18|||
94511478|NCT01230060|323669377|FG000|Overall Study|Withdrawal by Subject|1|||
94511479|NCT03331354|323669380|FG000|Overall Study|Withdrawal by Subject|1|||
94511480|NCT03331354|323669381|FG001|Overall Study|Withdrawal by Subject|3|||
94511481|NCT03331354|323669380|FG000|Overall Study|Lost to Follow-up|3|||
94511482|NCT03331354|323669381|FG001|Overall Study|Lost to Follow-up|3|||
94511483|NCT03331354|323669380|FG000|Overall Study|Found employment before initiated active intervention|0|||
94511484|NCT03331354|323669381|FG001|Overall Study|Found employment before initiated active intervention|4|||
94511485|NCT02757430|323669384|FG000|Overall Study|Physician Decision|6|||
94511486|NCT02757430|323669384|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
94511487|NCT02757430|323669384|FG000|Overall Study|No informed consent|1|||
94511488|NCT02757430|323669384|FG000|Overall Study|No procedure performed|2|||
94511489|NCT03485157|323669385|FG000|Double Blind Phase|Lost to Follow-up|4|||
94511490|NCT03485157|323669386|FG001|Double Blind Phase|Lost to Follow-up|4|||
94511491|NCT03485157|323669385|FG000|Double Blind Phase|Adverse Event|2|||
94511492|NCT03485157|323669386|FG001|Double Blind Phase|Adverse Event|1|||
94511493|NCT03485157|323669385|FG000|Double Blind Phase|Withdrawal by Subject|6|||
94511494|NCT03485157|323669386|FG001|Double Blind Phase|Withdrawal by Subject|9|||
94511495|NCT03485157|323669385|FG000|Double Blind Phase|Removal by PI|3|||
94511496|NCT03485157|323669386|FG001|Double Blind Phase|Removal by PI|7|||
94511497|NCT03485157|323669385|FG000|Open Label Phase|Lost to Follow-up|1|||
94511498|NCT03485157|323669386|FG001|Open Label Phase|Lost to Follow-up|2|||
94511499|NCT03485157|323669385|FG000|Open Label Phase|Adverse Event|0|||
94511500|NCT03485157|323669386|FG001|Open Label Phase|Adverse Event|1|||
94511501|NCT03485157|323669385|FG000|Open Label Phase|Withdrawal by Subject|1|||
94511502|NCT03485157|323669386|FG001|Open Label Phase|Withdrawal by Subject|2|||
94511503|NCT03485157|323669385|FG000|Open Label Phase|Removal by PI|2|||
94511504|NCT03485157|323669386|FG001|Open Label Phase|Removal by PI|0|||
94511505|NCT02607722|323669389|FG000|Overall Study|No data reliability|1|||
94511506|NCT02607722|323669389|FG000|Overall Study|no patient visit|18|||
94511507|NCT02607722|323669389|FG000|Overall Study|missing info in CRF|13|||
94511508|NCT02607722|323669389|FG000|Overall Study|Withdrawal by Subject|616|||
94511509|NCT02607722|323669389|FG000|Overall Study|Lost to Follow-up|312|||
94511510|NCT02607722|323669389|FG000|Overall Study|Improved|22|||
94511511|NCT02607722|323669389|FG000|Overall Study|Lack of Efficacy|316|||
94511512|NCT02607722|323669389|FG000|Overall Study|Adverse Event|2553|||
94511513|NCT02607722|323669389|FG000|Overall Study|Not treated|1|||
94511514|NCT02607722|323669389|FG000|Overall Study|No CRF collected|138|||
94511515|NCT02607722|323669389|FG000|Overall Study|without CRF|4225|||
94511516|NCT02607722|323669389|FG000|Overall Study|Physician Decision|367|||
94511517|NCT00847730|323669390|FG000|Overall Study|Multiple interruptions in therapy|8|||
94511518|NCT04938427|323669391|FG000|Overall Study|Adverse Event|5|||
94511519|NCT04938427|323669392|FG001|Overall Study|Adverse Event|19|||
94511520|NCT04938427|323669391|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
94511521|NCT04938427|323669392|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94511522|NCT04938427|323669391|FG000|Overall Study|Withdrawal by Subject|1|||
94511523|NCT04938427|323669392|FG001|Overall Study|Withdrawal by Subject|0|||
94511524|NCT04938427|323669391|FG000|Overall Study|Reason Not Specified|2|||
94511525|NCT04938427|323669392|FG001|Overall Study|Reason Not Specified|1|||
94511526|NCT00071032|323669393|FG000|Overall Study|Lost to Follow-up|1|||
94511527|NCT00071032|323669394|FG001|Overall Study|Lost to Follow-up|1|||
94511528|NCT00071032|323669393|FG000|Overall Study|Withdrawal by Subject|8|||
94511529|NCT00071032|323669394|FG001|Overall Study|Withdrawal by Subject|6|||
94511530|NCT00071032|323669393|FG000|Overall Study|Missing Primary Outcome|0|||
94511531|NCT00071032|323669394|FG001|Overall Study|Missing Primary Outcome|1|||
94511532|NCT01889251|323669395|FG000|Overall Study|Adverse Event|1|||
94511533|NCT01889251|323669396|FG001|Overall Study|Adverse Event|0|||
94511534|NCT04629196|323669398|FG000|Overall Study|Subject discontinued study drug|1|||
94511535|NCT04629196|323669399|FG001|Overall Study|Subject discontinued study drug|0|||
94511536|NCT04629196|323669398|FG000|Overall Study|Subject study drug dosing increased|1|||
94511537|NCT04629196|323669399|FG001|Overall Study|Subject study drug dosing increased|1|||
94511538|NCT04629196|323669398|FG000|Overall Study|Withdrawal by Subject|1|||
94511539|NCT04629196|323669399|FG001|Overall Study|Withdrawal by Subject|2|||
94511540|NCT03636022|323669407|FG000|Overall Study|Withdrawal by Subject|1|||
94511541|NCT03636022|323669408|FG001|Overall Study|Withdrawal by Subject|3|||
94511542|NCT01969058|323669409|FG000|Overall Study|Withdrawal by Subject|2|||
94511543|NCT01969058|323669410|FG001|Overall Study|Withdrawal by Subject|0|||
94511544|NCT01969058|323669409|FG000|Overall Study|Adverse Event|1|||
94511545|NCT01969058|323669410|FG001|Overall Study|Adverse Event|0|||
94511546|NCT03189719|323669411|FG000|Overall Study|Death|325|||
94511547|NCT03189719|323669412|FG001|Overall Study|Death|361|||
94511548|NCT03189719|323669411|FG000|Overall Study|Physician Decision|1|||
94511549|NCT03189719|323669412|FG001|Overall Study|Physician Decision|0|||
94511550|NCT03189719|323669411|FG000|Overall Study|Sponsor Decision|40|||
94511551|NCT03189719|323669412|FG001|Overall Study|Sponsor Decision|12|||
94511552|NCT03189719|323669411|FG000|Overall Study|Withdrawal by Subject|7|||
94511553|NCT03189719|323669412|FG001|Overall Study|Withdrawal by Subject|3|||
94511554|NCT01587196|323669413|FG000|Overall Study|Lost to Follow-up|50|||
94511555|NCT01587196|323669413|FG000|Overall Study|Withdrawal by Subject|4|||
94511556|NCT05185453|323669414|FG000|Overall Study|Lost to Follow-up|13|||
94511557|NCT05185453|323669415|FG001|Overall Study|Lost to Follow-up|3|||
94511558|NCT03274466|323669428|FG000|Overall Study|Withdrawal by Subject|7|||
94511559|NCT03274466|323669429|FG001|Overall Study|Withdrawal by Subject|3|||
94511560|NCT03274466|323669428|FG000|Overall Study|Protocol Specified Withdrawal|5|||
94511561|NCT03274466|323669429|FG001|Overall Study|Protocol Specified Withdrawal|11|||
94511562|NCT03274466|323669428|FG000|Overall Study|Lost to Follow-up|5|||
94511563|NCT03274466|323669429|FG001|Overall Study|Lost to Follow-up|7|||
94511564|NCT03274466|323669428|FG000|Overall Study|Subject Non-compliance|0|||
94511565|NCT03274466|323669429|FG001|Overall Study|Subject Non-compliance|1|||
94511566|NCT03274466|323669428|FG000|Overall Study|Adverse Event|3|||
94511567|NCT03274466|323669429|FG001|Overall Study|Adverse Event|3|||
94511568|NCT03274466|323669428|FG000|Overall Study|Physician Decision|0|||
94511569|NCT03274466|323669429|FG001|Overall Study|Physician Decision|1|||
94511570|NCT03274466|323669428|FG000|Overall Study|Protocol Violation|3|||
94511571|NCT03274466|323669429|FG001|Overall Study|Protocol Violation|3|||
94511572|NCT00618787|323669432|FG000|Overall Study|Adverse Event|0|||
94511573|NCT00618787|323669433|FG001|Overall Study|Adverse Event|1|||
94511574|NCT00618787|323669432|FG000|Overall Study|Withdrawal by Subject|2|||
94511575|NCT00618787|323669433|FG001|Overall Study|Withdrawal by Subject|1|||
94511576|NCT00618787|323669432|FG000|Overall Study|Lost to Follow-up|1|||
94511577|NCT00618787|323669433|FG001|Overall Study|Lost to Follow-up|0|||
94511578|NCT03599713|323669438|FG000|Overall Study|Death|26|||
94511579|NCT03599713|323669439|FG001|Overall Study|Death|3|||
94511580|NCT03599713|323669438|FG000|Overall Study|Withdrawal by Subject|6|||
94511581|NCT03599713|323669439|FG001|Overall Study|Withdrawal by Subject|0|||
94511582|NCT03599713|323669438|FG000|Overall Study|Ongoing|69|||
94511583|NCT03599713|323669439|FG001|Overall Study|Ongoing|3|||
94511584|NCT01649869|323669440|FG000|Overall Study|Family member illness|1|||
94511585|NCT01649869|323669441|FG001|Overall Study|Family member illness|0|||
94511586|NCT01649869|323669440|FG000|Overall Study|Required treatment outside protocol|1|||
94511587|NCT01649869|323669441|FG001|Overall Study|Required treatment outside protocol|0|||
94511588|NCT01649869|323669440|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
94511589|NCT01649869|323669441|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
94511590|NCT02776735|323669442|FG000|Overall Study|Adverse Event|0|||
94511591|NCT02776735|323669443|FG001|Overall Study|Adverse Event|0|||
94511592|NCT02776735|323669444|FG002|Overall Study|Adverse Event|0|||
94511593|NCT02776735|323669445|FG003|Overall Study|Adverse Event|1|||
94511594|NCT02776735|323669446|FG004|Overall Study|Adverse Event|0|||
94511595|NCT02776735|323669447|FG005|Overall Study|Adverse Event|1|||
94511596|NCT02776735|323669442|FG000|Overall Study|Lost to Follow-up|0|||
94511597|NCT02776735|323669443|FG001|Overall Study|Lost to Follow-up|0|||
94511598|NCT02776735|323669444|FG002|Overall Study|Lost to Follow-up|0|||
94511599|NCT02776735|323669445|FG003|Overall Study|Lost to Follow-up|1|||
94511600|NCT02776735|323669446|FG004|Overall Study|Lost to Follow-up|0|||
94511601|NCT02776735|323669447|FG005|Overall Study|Lost to Follow-up|0|||
94511602|NCT02776735|323669442|FG000|Overall Study|Withdrawal by parent/guardian|0|||
94511603|NCT02776735|323669443|FG001|Overall Study|Withdrawal by parent/guardian|0|||
94511604|NCT02776735|323669444|FG002|Overall Study|Withdrawal by parent/guardian|2|||
94511605|NCT02776735|323669445|FG003|Overall Study|Withdrawal by parent/guardian|2|||
94511606|NCT02776735|323669446|FG004|Overall Study|Withdrawal by parent/guardian|0|||
94511607|NCT02776735|323669447|FG005|Overall Study|Withdrawal by parent/guardian|0|||
94511608|NCT02776735|323669442|FG000|Overall Study|Withdrawal by Subject|1|||
94511609|NCT02776735|323669443|FG001|Overall Study|Withdrawal by Subject|0|||
94511610|NCT02776735|323669444|FG002|Overall Study|Withdrawal by Subject|0|||
94511611|NCT02776735|323669445|FG003|Overall Study|Withdrawal by Subject|0|||
94511612|NCT02776735|323669446|FG004|Overall Study|Withdrawal by Subject|0|||
94511613|NCT02776735|323669447|FG005|Overall Study|Withdrawal by Subject|1|||
94511614|NCT02776735|323669442|FG000|Overall Study|Other|0|||
94511615|NCT02776735|323669443|FG001|Overall Study|Other|0|||
94511616|NCT02776735|323669444|FG002|Overall Study|Other|3|||
94511617|NCT02776735|323669445|FG003|Overall Study|Other|0|||
94511618|NCT02776735|323669446|FG004|Overall Study|Other|0|||
94511619|NCT02776735|323669447|FG005|Overall Study|Other|0|||
94511620|NCT00754572|323671111|FG000|Overall Study|Adverse Event|19|||
94511621|NCT00754572|323671111|FG000|Overall Study|Other|39|||
94511622|NCT00754572|323671111|FG000|Overall Study|Protocol Violation|3|||
94511623|NCT00754572|323671111|FG000|Overall Study|Withdrawal by Subject|3|||
94511624|NCT00754572|323671111|FG000|Overall Study|Lack of Efficacy|2|||
94511625|NCT00754572|323671111|FG000|Overall Study|Death|1|||
94511626|NCT00754572|323671111|FG000|Overall Study|Administrative Reason|3|||
94511627|NCT00754572|323671111|FG000|Overall Study|Lost to Follow-up|1|||
94511628|NCT02327169|323671112|FG000|Overall Study|Progressive Disease|1|||
94511629|NCT02327169|323671113|FG001|Overall Study|Progressive Disease|3|||
94511630|NCT02327169|323671114|FG002|Overall Study|Progressive Disease|4|||
94511631|NCT02327169|323671115|FG003|Overall Study|Progressive Disease|3|||
94511632|NCT02327169|323671116|FG004|Overall Study|Progressive Disease|4|||
94511633|NCT02327169|323671117|FG005|Overall Study|Progressive Disease|3|||
94511634|NCT02327169|323671118|FG006|Overall Study|Progressive Disease|3|||
94511635|NCT02327169|323671119|FG007|Overall Study|Progressive Disease|3|||
94511636|NCT02327169|323671120|FG008|Overall Study|Progressive Disease|4|||
94511637|NCT02327169|323671121|FG009|Overall Study|Progressive Disease|4|||
94511638|NCT02327169|323671122|FG010|Overall Study|Progressive Disease|4|||
94511639|NCT02327169|323671123|FG011|Overall Study|Progressive Disease|3|||
94511640|NCT02327169|323671124|FG012|Overall Study|Progressive Disease|1|||
94511641|NCT02327169|323671125|FG013|Overall Study|Progressive Disease|3|||
94511642|NCT02327169|323671126|FG014|Overall Study|Progressive Disease|3|||
94511643|NCT02327169|323671112|FG000|Overall Study|Adverse Event|2|||
94511644|NCT02327169|323671113|FG001|Overall Study|Adverse Event|0|||
94511645|NCT02327169|323671114|FG002|Overall Study|Adverse Event|1|||
94511646|NCT02327169|323671115|FG003|Overall Study|Adverse Event|0|||
94511647|NCT02327169|323671116|FG004|Overall Study|Adverse Event|1|||
94511648|NCT02327169|323671117|FG005|Overall Study|Adverse Event|0|||
94511649|NCT02327169|323671118|FG006|Overall Study|Adverse Event|0|||
94511650|NCT02327169|323671119|FG007|Overall Study|Adverse Event|0|||
94511651|NCT02327169|323671120|FG008|Overall Study|Adverse Event|0|||
94511652|NCT02327169|323671121|FG009|Overall Study|Adverse Event|2|||
94511653|NCT02327169|323671122|FG010|Overall Study|Adverse Event|0|||
94511654|NCT02327169|323671123|FG011|Overall Study|Adverse Event|3|||
94511655|NCT02327169|323671124|FG012|Overall Study|Adverse Event|0|||
94511656|NCT02327169|323671125|FG013|Overall Study|Adverse Event|2|||
94511657|NCT02327169|323671126|FG014|Overall Study|Adverse Event|1|||
94511658|NCT02327169|323671112|FG000|Overall Study|Symptomatic Deterioration|0|||
94511659|NCT02327169|323671113|FG001|Overall Study|Symptomatic Deterioration|0|||
94511660|NCT02327169|323671114|FG002|Overall Study|Symptomatic Deterioration|1|||
94511661|NCT02327169|323671115|FG003|Overall Study|Symptomatic Deterioration|0|||
94511662|NCT02327169|323671116|FG004|Overall Study|Symptomatic Deterioration|1|||
94511663|NCT02327169|323671117|FG005|Overall Study|Symptomatic Deterioration|1|||
94511664|NCT02327169|323671118|FG006|Overall Study|Symptomatic Deterioration|0|||
94511665|NCT02327169|323671119|FG007|Overall Study|Symptomatic Deterioration|0|||
94511666|NCT02327169|323671120|FG008|Overall Study|Symptomatic Deterioration|2|||
94511667|NCT02327169|323671121|FG009|Overall Study|Symptomatic Deterioration|1|||
94511668|NCT02327169|323671122|FG010|Overall Study|Symptomatic Deterioration|0|||
94511669|NCT02327169|323671123|FG011|Overall Study|Symptomatic Deterioration|0|||
94511670|NCT02327169|323671124|FG012|Overall Study|Symptomatic Deterioration|0|||
94511671|NCT02327169|323671125|FG013|Overall Study|Symptomatic Deterioration|2|||
94511672|NCT02327169|323671126|FG014|Overall Study|Symptomatic Deterioration|1|||
94511673|NCT02327169|323671112|FG000|Overall Study|Reason Not Specified|0|||
94511674|NCT02327169|323671113|FG001|Overall Study|Reason Not Specified|0|||
94511675|NCT02327169|323671114|FG002|Overall Study|Reason Not Specified|1|||
94511676|NCT02327169|323671115|FG003|Overall Study|Reason Not Specified|0|||
94511677|NCT02327169|323671116|FG004|Overall Study|Reason Not Specified|0|||
94511678|NCT02327169|323671117|FG005|Overall Study|Reason Not Specified|0|||
94511679|NCT02327169|323671118|FG006|Overall Study|Reason Not Specified|0|||
94511680|NCT02327169|323671119|FG007|Overall Study|Reason Not Specified|0|||
94511681|NCT02327169|323671120|FG008|Overall Study|Reason Not Specified|0|||
94511682|NCT02327169|323671121|FG009|Overall Study|Reason Not Specified|1|||
94511683|NCT02327169|323671122|FG010|Overall Study|Reason Not Specified|2|||
94511684|NCT02327169|323671123|FG011|Overall Study|Reason Not Specified|1|||
94511685|NCT02327169|323671124|FG012|Overall Study|Reason Not Specified|0|||
94511686|NCT02327169|323671125|FG013|Overall Study|Reason Not Specified|0|||
94511687|NCT02327169|323671126|FG014|Overall Study|Reason Not Specified|2|||
94511688|NCT02327169|323671112|FG000|Overall Study|Withdrawal by Subject|1|||
94511689|NCT02327169|323671113|FG001|Overall Study|Withdrawal by Subject|0|||
94511690|NCT02327169|323671114|FG002|Overall Study|Withdrawal by Subject|0|||
94511691|NCT02327169|323671115|FG003|Overall Study|Withdrawal by Subject|0|||
94511692|NCT02327169|323671116|FG004|Overall Study|Withdrawal by Subject|1|||
94511693|NCT02327169|323671117|FG005|Overall Study|Withdrawal by Subject|0|||
94511694|NCT02327169|323671118|FG006|Overall Study|Withdrawal by Subject|0|||
94511695|NCT02327169|323671119|FG007|Overall Study|Withdrawal by Subject|1|||
94511696|NCT02327169|323671120|FG008|Overall Study|Withdrawal by Subject|0|||
94511697|NCT02327169|323671121|FG009|Overall Study|Withdrawal by Subject|0|||
94511698|NCT02327169|323671122|FG010|Overall Study|Withdrawal by Subject|0|||
94511699|NCT02327169|323671123|FG011|Overall Study|Withdrawal by Subject|0|||
94511700|NCT02327169|323671124|FG012|Overall Study|Withdrawal by Subject|0|||
94511701|NCT02327169|323671125|FG013|Overall Study|Withdrawal by Subject|0|||
94511702|NCT02327169|323671126|FG014|Overall Study|Withdrawal by Subject|3|||
94511703|NCT02327169|323671112|FG000|Overall Study|Lost to Follow-up|0|||
94511704|NCT02327169|323671113|FG001|Overall Study|Lost to Follow-up|0|||
94511705|NCT02327169|323671114|FG002|Overall Study|Lost to Follow-up|0|||
94511706|NCT02327169|323671115|FG003|Overall Study|Lost to Follow-up|0|||
94511707|NCT02327169|323671116|FG004|Overall Study|Lost to Follow-up|1|||
94511708|NCT02327169|323671117|FG005|Overall Study|Lost to Follow-up|0|||
94511709|NCT02327169|323671118|FG006|Overall Study|Lost to Follow-up|0|||
94511710|NCT02327169|323671119|FG007|Overall Study|Lost to Follow-up|0|||
94511711|NCT02327169|323671120|FG008|Overall Study|Lost to Follow-up|0|||
94511712|NCT02327169|323671121|FG009|Overall Study|Lost to Follow-up|0|||
94511713|NCT02327169|323671122|FG010|Overall Study|Lost to Follow-up|0|||
94511714|NCT02327169|323671123|FG011|Overall Study|Lost to Follow-up|0|||
94511715|NCT02327169|323671124|FG012|Overall Study|Lost to Follow-up|0|||
94511716|NCT02327169|323671125|FG013|Overall Study|Lost to Follow-up|0|||
94511717|NCT02327169|323671126|FG014|Overall Study|Lost to Follow-up|0|||
94511718|NCT04023487|323671129|FG000|Overall Study|Lost to Follow-up|5|||
94511719|NCT04023487|323671130|FG001|Overall Study|Lost to Follow-up|4|||
94511720|NCT04023487|323671129|FG000|Overall Study|Pregnancy|1|||
94511721|NCT04023487|323671130|FG001|Overall Study|Pregnancy|2|||
94511722|NCT04023487|323671129|FG000|Overall Study|Withdrawal by Subject|4|||
94511723|NCT04023487|323671130|FG001|Overall Study|Withdrawal by Subject|5|||
94511724|NCT04023487|323671129|FG000|Overall Study|Partially completed testing|8|||
94511725|NCT04023487|323671130|FG001|Overall Study|Partially completed testing|4|||
94511726|NCT00023595|323671135|FG000|5 Year Follow up|Lost to Follow-up|2|||
94511727|NCT00023595|323671136|FG001|5 Year Follow up|Lost to Follow-up|2|||
94511728|NCT00023595|323671137|FG002|5 Year Follow up|Lost to Follow-up|1|||
94511729|NCT00023595|323671138|FG003|5 Year Follow up|Lost to Follow-up|7|||
94511730|NCT00023595|323671139|FG004|5 Year Follow up|Lost to Follow-up|3|||
94511731|NCT00023595|323671135|FG000|10 Year Follow up|Lost to Follow-up|12|||
94511732|NCT00023595|323671136|FG001|10 Year Follow up|Lost to Follow-up|10|||
94511733|NCT00023595|323671137|FG002|10 Year Follow up|Lost to Follow-up|3|||
94511734|NCT00023595|323671138|FG003|10 Year Follow up|Lost to Follow-up|0|||
94511735|NCT00023595|323671139|FG004|10 Year Follow up|Lost to Follow-up|0|||
94511736|NCT01767987|323671143|FG000|Overall Study|Physician Decision|4|||
94511737|NCT01767987|323671144|FG001|Overall Study|Physician Decision|1|||
94511738|NCT05837481|323671145|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
94511739|NCT05837481|323671146|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
94511740|NCT00427700|323671147|FG000|Overall Study|Lost to Follow-up|2|||
94511741|NCT00427700|323671148|FG001|Overall Study|Lost to Follow-up|5|||
94511742|NCT00427700|323671147|FG000|Overall Study|no induction of menses|1|||
94511743|NCT00427700|323671148|FG001|Overall Study|no induction of menses|4|||
94511744|NCT00427700|323671147|FG000|Overall Study|Pregnancy|0|||
94511745|NCT00427700|323671148|FG001|Overall Study|Pregnancy|2|||
94511746|NCT02014376|323671149|FG000|Overall Study|Adverse Event|1|||
94511747|NCT02014376|323671150|FG001|Overall Study|Adverse Event|1|||
94511748|NCT02014376|323671151|FG002|Overall Study|Adverse Event|0|||
94511749|NCT02014376|323671149|FG000|Overall Study|Lost to Follow-up|2|||
94511750|NCT02014376|323671150|FG001|Overall Study|Lost to Follow-up|0|||
94511751|NCT02014376|323671151|FG002|Overall Study|Lost to Follow-up|0|||
94511752|NCT04581395|323671152|FG000|Overall Study|Protocol Violation|4|||
94511753|NCT04581395|323671153|FG001|Overall Study|Protocol Violation|3|||
94511754|NCT04581395|323671154|FG002|Overall Study|Protocol Violation|2|||
94511755|NCT04581395|323671152|FG000|Overall Study|Physician Decision|0|||
94511756|NCT04581395|323671153|FG001|Overall Study|Physician Decision|1|||
94511757|NCT04581395|323671154|FG002|Overall Study|Physician Decision|0|||
94511758|NCT00815633|323671159|FG000|Overall Study|study terminated|1|||
94511759|NCT00721110|323671163|FG000|Overall Study|Ultram use|1|||
94511760|NCT00721110|323671164|FG001|Overall Study|Ultram use|0|||
94511761|NCT00721110|323671165|FG002|Overall Study|Ultram use|0|||
94511762|NCT00721110|323671166|FG003|Overall Study|Ultram use|0|||
94511763|NCT00721110|323671163|FG000|Overall Study|vertical incision|0|||
94511764|NCT00721110|323671164|FG001|Overall Study|vertical incision|0|||
94511765|NCT00721110|323671165|FG002|Overall Study|vertical incision|1|||
94511766|NCT00721110|323671166|FG003|Overall Study|vertical incision|0|||
94511767|NCT02457065|323671167|FG000|Overall Study|Lost to Follow-up|9|||
94511768|NCT02457065|323671168|FG001|Overall Study|Lost to Follow-up|11|||
94511769|NCT03038087|323671169|FG000|Overall Study|lost data|1|||
94511770|NCT00654355|323671170|FG000|Overall Study|Lost to Follow-up|2|||
94511771|NCT00654355|323671171|FG001|Overall Study|Lost to Follow-up|2|||
94511772|NCT01051661|323671178|FG000|Overall Study|Adverse Event|1|||
94511773|NCT01051661|323671179|FG001|Overall Study|Adverse Event|1|||
94511774|NCT01051661|323671180|FG002|Overall Study|Adverse Event|1|||
94511775|NCT01051661|323671181|FG003|Overall Study|Adverse Event|1|||
94511776|NCT01051661|323671182|FG004|Overall Study|Adverse Event|0|||
94511777|NCT01051661|323671183|FG005|Overall Study|Adverse Event|0|||
94511778|NCT01051661|323671178|FG000|Overall Study|Lost to Follow-up|13|||
94511779|NCT01051661|323671179|FG001|Overall Study|Lost to Follow-up|22|||
94511780|NCT01051661|323671180|FG002|Overall Study|Lost to Follow-up|15|||
94511781|NCT01051661|323671181|FG003|Overall Study|Lost to Follow-up|17|||
94511782|NCT01051661|323671182|FG004|Overall Study|Lost to Follow-up|10|||
94511783|NCT01051661|323671183|FG005|Overall Study|Lost to Follow-up|24|||
94511784|NCT01051661|323671178|FG000|Overall Study|Migrated/moved from study area|1|||
94511785|NCT01051661|323671179|FG001|Overall Study|Migrated/moved from study area|6|||
94511786|NCT01051661|323671180|FG002|Overall Study|Migrated/moved from study area|6|||
94511787|NCT01051661|323671181|FG003|Overall Study|Migrated/moved from study area|8|||
94511788|NCT01051661|323671182|FG004|Overall Study|Migrated/moved from study area|7|||
94511789|NCT01051661|323671183|FG005|Overall Study|Migrated/moved from study area|3|||
94511790|NCT01051661|323671178|FG000|Overall Study|Refused blood sampling|0|||
94511791|NCT01051661|323671179|FG001|Overall Study|Refused blood sampling|0|||
94511792|NCT01051661|323671180|FG002|Overall Study|Refused blood sampling|0|||
94511793|NCT01051661|323671181|FG003|Overall Study|Refused blood sampling|0|||
94511794|NCT01051661|323671182|FG004|Overall Study|Refused blood sampling|0|||
94511795|NCT01051661|323671183|FG005|Overall Study|Refused blood sampling|1|||
94511796|NCT01051661|323671178|FG000|Overall Study|Data not reliable|1|||
94511797|NCT01051661|323671179|FG001|Overall Study|Data not reliable|0|||
94511798|NCT01051661|323671180|FG002|Overall Study|Data not reliable|0|||
94511799|NCT01051661|323671181|FG003|Overall Study|Data not reliable|0|||
94511800|NCT01051661|323671182|FG004|Overall Study|Data not reliable|0|||
94511801|NCT01051661|323671183|FG005|Overall Study|Data not reliable|1|||
94511802|NCT01051661|323671178|FG000|Overall Study|Unable to attend visit(s)|2|||
94511803|NCT01051661|323671179|FG001|Overall Study|Unable to attend visit(s)|4|||
94511804|NCT01051661|323671180|FG002|Overall Study|Unable to attend visit(s)|2|||
94511805|NCT01051661|323671181|FG003|Overall Study|Unable to attend visit(s)|1|||
94511806|NCT01051661|323671182|FG004|Overall Study|Unable to attend visit(s)|3|||
94511807|NCT01051661|323671183|FG005|Overall Study|Unable to attend visit(s)|2|||
94511808|NCT01051661|323671178|FG000|Overall Study|Consent not received from both parents|0|||
94511809|NCT01051661|323671179|FG001|Overall Study|Consent not received from both parents|0|||
94511810|NCT01051661|323671180|FG002|Overall Study|Consent not received from both parents|0|||
94511811|NCT01051661|323671181|FG003|Overall Study|Consent not received from both parents|0|||
94511812|NCT01051661|323671182|FG004|Overall Study|Consent not received from both parents|0|||
94511813|NCT01051661|323671183|FG005|Overall Study|Consent not received from both parents|1|||
94511814|NCT01051661|323671178|FG000|Overall Study|Failure to comply with protocol|0|||
94511815|NCT01051661|323671179|FG001|Overall Study|Failure to comply with protocol|0|||
94511816|NCT01051661|323671180|FG002|Overall Study|Failure to comply with protocol|2|||
94511817|NCT01051661|323671181|FG003|Overall Study|Failure to comply with protocol|0|||
94511818|NCT01051661|323671182|FG004|Overall Study|Failure to comply with protocol|0|||
94511819|NCT01051661|323671183|FG005|Overall Study|Failure to comply with protocol|0|||
94511820|NCT01051661|323671178|FG000|Overall Study|Subject lost legal representation|0|||
94511821|NCT01051661|323671179|FG001|Overall Study|Subject lost legal representation|0|||
94511822|NCT01051661|323671180|FG002|Overall Study|Subject lost legal representation|0|||
94511823|NCT01051661|323671181|FG003|Overall Study|Subject lost legal representation|0|||
94511824|NCT01051661|323671182|FG004|Overall Study|Subject lost legal representation|1|||
94511825|NCT01051661|323671183|FG005|Overall Study|Subject lost legal representation|0|||
94511826|NCT01051661|323671178|FG000|Overall Study|Protocol Violation|0|||
94511827|NCT01051661|323671179|FG001|Overall Study|Protocol Violation|0|||
94511828|NCT01051661|323671180|FG002|Overall Study|Protocol Violation|0|||
94511829|NCT01051661|323671181|FG003|Overall Study|Protocol Violation|1|||
94511830|NCT01051661|323671182|FG004|Overall Study|Protocol Violation|2|||
94511831|NCT01051661|323671183|FG005|Overall Study|Protocol Violation|1|||
94511832|NCT01051661|323671178|FG000|Overall Study|Withdrawal by Subject|16|||
94511833|NCT01051661|323671179|FG001|Overall Study|Withdrawal by Subject|30|||
94511834|NCT01051661|323671180|FG002|Overall Study|Withdrawal by Subject|13|||
94511835|NCT01051661|323671181|FG003|Overall Study|Withdrawal by Subject|28|||
94511836|NCT01051661|323671182|FG004|Overall Study|Withdrawal by Subject|12|||
94511837|NCT01051661|323671183|FG005|Overall Study|Withdrawal by Subject|34|||
94511838|NCT02038647|323671184|FG000|Overall Study|Progressive Disease|50|||
94511839|NCT02038647|323671185|FG001|Overall Study|Progressive Disease|59|||
94511840|NCT02038647|323671184|FG000|Overall Study|Adverse Event|18|||
94511841|NCT02038647|323671185|FG001|Overall Study|Adverse Event|10|||
94511842|NCT02038647|323671184|FG000|Overall Study|Symptomatic Deterioration|7|||
94511843|NCT02038647|323671185|FG001|Overall Study|Symptomatic Deterioration|7|||
94511844|NCT02038647|323671184|FG000|Overall Study|Withdrawal by Subject|5|||
94511845|NCT02038647|323671185|FG001|Overall Study|Withdrawal by Subject|2|||
94511846|NCT02038647|323671184|FG000|Overall Study|Not Reported|0|||
94511847|NCT02038647|323671185|FG001|Overall Study|Not Reported|1|||
94511848|NCT02038647|323671184|FG000|Overall Study|Ongoing at Datacut|9|||
94511849|NCT02038647|323671185|FG001|Overall Study|Ongoing at Datacut|10|||
94511850|NCT01983111|323671190|FG000|Overall Study|Withdrawal by Subject|8|||
94511851|NCT01983111|323671191|FG001|Overall Study|Withdrawal by Subject|6|||
94511852|NCT01983111|323671190|FG000|Overall Study|Adverse Event|4|||
94511853|NCT01983111|323671191|FG001|Overall Study|Adverse Event|0|||
94511854|NCT01983111|323671190|FG000|Overall Study|Protocol Violation|0|||
94511855|NCT01983111|323671191|FG001|Overall Study|Protocol Violation|1|||
94511856|NCT00855335|323671192|FG000|Overall Study|Lost to Follow-up|0|||
94511857|NCT00855335|323671193|FG001|Overall Study|Lost to Follow-up|0|||
94511858|NCT00855335|323671194|FG002|Overall Study|Lost to Follow-up|3|||
94511859|NCT00855335|323671195|FG003|Overall Study|Lost to Follow-up|1|||
94511860|NCT00855335|323671196|FG004|Overall Study|Lost to Follow-up|0|||
94511861|NCT00855335|323671192|FG000|Overall Study|Withdrawal by Subject|0|||
94511862|NCT00855335|323671193|FG001|Overall Study|Withdrawal by Subject|0|||
94511863|NCT00855335|323671194|FG002|Overall Study|Withdrawal by Subject|0|||
94511864|NCT00855335|323671195|FG003|Overall Study|Withdrawal by Subject|1|||
94511865|NCT00855335|323671196|FG004|Overall Study|Withdrawal by Subject|0|||
94511866|NCT00855335|323671192|FG000|Overall Study|Adverse Event|2|||
94511867|NCT00855335|323671193|FG001|Overall Study|Adverse Event|0|||
94511868|NCT00855335|323671194|FG002|Overall Study|Adverse Event|0|||
94511869|NCT00855335|323671195|FG003|Overall Study|Adverse Event|0|||
94511870|NCT00855335|323671196|FG004|Overall Study|Adverse Event|0|||
94511871|NCT00855335|323671192|FG000|Overall Study|Physician Decision|1|||
94511872|NCT00855335|323671193|FG001|Overall Study|Physician Decision|1|||
94511873|NCT00855335|323671194|FG002|Overall Study|Physician Decision|0|||
94511874|NCT00855335|323671195|FG003|Overall Study|Physician Decision|0|||
94511875|NCT00855335|323671196|FG004|Overall Study|Physician Decision|0|||
94511876|NCT00855335|323671192|FG000|Overall Study|Other|2|||
94511877|NCT00855335|323671193|FG001|Overall Study|Other|1|||
94511878|NCT00855335|323671194|FG002|Overall Study|Other|2|||
94511879|NCT00855335|323671195|FG003|Overall Study|Other|5|||
94511880|NCT00855335|323671196|FG004|Overall Study|Other|1|||
94511881|NCT03502200|323671197|FG000|Overall Study|Adverse Event|1|||
94511882|NCT03502200|323671198|FG001|Overall Study|Adverse Event|0|||
94511883|NCT03502200|323671197|FG000|Overall Study|Lost to Follow-up|36|||
94511884|NCT03502200|323671198|FG001|Overall Study|Lost to Follow-up|38|||
94511885|NCT03502200|323671197|FG000|Overall Study|Study Team Decision|1|||
94511886|NCT03502200|323671198|FG001|Overall Study|Study Team Decision|1|||
94511887|NCT03502200|323671197|FG000|Overall Study|Withdrawal by Subject|5|||
94511888|NCT03502200|323671198|FG001|Overall Study|Withdrawal by Subject|7|||
94511889|NCT03502200|323671197|FG000|Overall Study|Death|0|||
94511890|NCT03502200|323671198|FG001|Overall Study|Death|2|||
94511891|NCT00759395|323671201|FG000|Overall Study|Adverse Event|1|||
94511892|NCT00759395|323671202|FG001|Overall Study|Adverse Event|0|||
94511893|NCT00759395|323671201|FG000|Overall Study|Withdrawal by Subject|1|||
94511894|NCT00759395|323671202|FG001|Overall Study|Withdrawal by Subject|0|||
94511895|NCT00759395|323671201|FG000|Overall Study|Lack of Efficacy|0|||
94511896|NCT00759395|323671202|FG001|Overall Study|Lack of Efficacy|2|||
94511897|NCT02526290|323671205|FG000|Overall Study|Adverse Event|3|||
94511898|NCT02526290|323671205|FG000|Overall Study|Withdrawal by Subject|4|||
94511899|NCT02526290|323671205|FG000|Overall Study|Physician Decision|1|||
94511900|NCT00105066|323671206|FG000|Overall Study|Adverse Event|2|||
94511901|NCT00105066|323671207|FG001|Overall Study|Adverse Event|5|||
94511902|NCT02106832|323671208|FG000|Overall Study|Adverse Event|1|||
94511903|NCT02106832|323671209|FG001|Overall Study|Adverse Event|2|||
94511904|NCT02106832|323671210|FG002|Overall Study|Adverse Event|3|||
94511905|NCT02106832|323671211|FG003|Overall Study|Adverse Event|0|||
94511906|NCT02106832|323671208|FG000|Overall Study|Death|4|||
94511907|NCT02106832|323671209|FG001|Overall Study|Death|4|||
94511908|NCT02106832|323671210|FG002|Overall Study|Death|1|||
94511909|NCT02106832|323671211|FG003|Overall Study|Death|4|||
94511910|NCT02106832|323671208|FG000|Overall Study|Deterioration of general conditions|0|||
94511911|NCT02106832|323671209|FG001|Overall Study|Deterioration of general conditions|0|||
94511912|NCT02106832|323671210|FG002|Overall Study|Deterioration of general conditions|1|||
94511913|NCT02106832|323671211|FG003|Overall Study|Deterioration of general conditions|0|||
94511914|NCT02106832|323671208|FG000|Overall Study|Lost to Follow-up|0|||
94511915|NCT02106832|323671209|FG001|Overall Study|Lost to Follow-up|1|||
94511916|NCT02106832|323671210|FG002|Overall Study|Lost to Follow-up|1|||
94511917|NCT02106832|323671211|FG003|Overall Study|Lost to Follow-up|3|||
94511918|NCT02106832|323671208|FG000|Overall Study|Physician Decision|1|||
94511919|NCT02106832|323671209|FG001|Overall Study|Physician Decision|0|||
94511920|NCT02106832|323671210|FG002|Overall Study|Physician Decision|0|||
94511921|NCT02106832|323671211|FG003|Overall Study|Physician Decision|0|||
94511922|NCT02106832|323671208|FG000|Overall Study|Protocol Violation|0|||
94511923|NCT02106832|323671209|FG001|Overall Study|Protocol Violation|0|||
94511924|NCT02106832|323671210|FG002|Overall Study|Protocol Violation|0|||
94511925|NCT02106832|323671211|FG003|Overall Study|Protocol Violation|1|||
94511926|NCT02106832|323671208|FG000|Overall Study|Withdrawal by Subject|17|||
94511927|NCT02106832|323671209|FG001|Overall Study|Withdrawal by Subject|17|||
94511928|NCT02106832|323671210|FG002|Overall Study|Withdrawal by Subject|10|||
94511929|NCT02106832|323671211|FG003|Overall Study|Withdrawal by Subject|7|||
94511930|NCT02106832|323671208|FG000|Overall Study|Technical problems|0|||
94511931|NCT02106832|323671209|FG001|Overall Study|Technical problems|1|||
94511932|NCT02106832|323671210|FG002|Overall Study|Technical problems|0|||
94511933|NCT02106832|323671211|FG003|Overall Study|Technical problems|0|||
94511934|NCT00437073|323671212|FG000|Overall Study|Sponsor Terminated Study|1|||
94511935|NCT00437073|323671213|FG001|Overall Study|Sponsor Terminated Study|0|||
94511936|NCT00437073|323671212|FG000|Overall Study|Physician Decision|0|||
94511937|NCT00437073|323671213|FG001|Overall Study|Physician Decision|1|||
94511938|NCT00982280|323671215|FG000|Observation Period|Not eligible to be dosed|19|||
94511939|NCT00982280|323671215|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
94511940|NCT00982280|323671215|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
94511941|NCT00982280|323671215|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
94511942|NCT00982280|323671215|FG000|Maintenance Period|Adverse Event|1|||
94511943|NCT00980798|323671216|FG000|Overall Study|Adverse Event|7|||
94511944|NCT00980798|323671217|FG001|Overall Study|Adverse Event|36|||
94511945|NCT00980798|323671216|FG000|Overall Study|Lack of Efficacy|16|||
94511946|NCT00980798|323671217|FG001|Overall Study|Lack of Efficacy|5|||
94511947|NCT00980798|323671216|FG000|Overall Study|Lost to Follow-up|0|||
94511948|NCT00980798|323671217|FG001|Overall Study|Lost to Follow-up|1|||
94511949|NCT00980798|323671216|FG000|Overall Study|Physician Decision|2|||
94511950|NCT00980798|323671217|FG001|Overall Study|Physician Decision|1|||
94511951|NCT00980798|323671216|FG000|Overall Study|Withdrawal by Subject|8|||
94511952|NCT00980798|323671217|FG001|Overall Study|Withdrawal by Subject|11|||
94511953|NCT00980798|323671216|FG000|Overall Study|Other|0|||
94511954|NCT00980798|323671217|FG001|Overall Study|Other|1|||
94511955|NCT01506726|323671218|FG000|Overall Study|Adverse Event|1|||
94511956|NCT01506726|323671219|FG001|Overall Study|Adverse Event|2|||
94511957|NCT03773484|323671220|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
94511958|NCT00967499|323671221|FG000|Overall Study|Adverse Event|0|||
94511959|NCT00967499|323671222|FG001|Overall Study|Adverse Event|1|||
94511960|NCT00967499|323671221|FG000|Overall Study|Protocol Violation|1|||
94511961|NCT00967499|323671222|FG001|Overall Study|Protocol Violation|0|||
94511962|NCT00967499|323671221|FG000|Overall Study|Sponsor Decision|1|||
94511963|NCT00967499|323671222|FG001|Overall Study|Sponsor Decision|0|||
94511964|NCT00967499|323671221|FG000|Overall Study|Randomized but not treated|63|||
94511965|NCT00967499|323671222|FG001|Overall Study|Randomized but not treated|59|||
94511966|NCT04347538|323671223|FG000|Overall Study|Lost to Follow-up|4|||
94511967|NCT04347538|323671224|FG001|Overall Study|Lost to Follow-up|5|||
94511968|NCT04347538|323671225|FG002|Overall Study|Lost to Follow-up|7|||
94511969|NCT02185768|323671226|FG000|Overall Study|Patients were not treated|2|||
94511970|NCT05810597|323671230|FG000|Period 1|Adverse Event|2|||
94511971|NCT05810597|323671231|FG001|Period 1|Adverse Event|0|||
94511972|NCT05810597|323671230|FG000|Period 1|Physician Decision|1|||
94511973|NCT05810597|323671231|FG001|Period 1|Physician Decision|0|||
94511974|NCT03781570|323671232|FG000|Overall Study|Technical Issues (equipment failure)|31|||
94511975|NCT03781570|323671232|FG000|Overall Study|Withdrawal by Subject|7|||
94511976|NCT03781570|323671232|FG000|Overall Study|Physical Constraints|11|||
94511977|NCT03012880|323671233|FG000|Overall Study|Withdrawal by Subject|1|||
94511978|NCT03012880|323671234|FG001|Overall Study|Withdrawal by Subject|0|||
94511979|NCT03012880|323671233|FG000|Overall Study|Ineligible|1|||
94511980|NCT03012880|323671234|FG001|Overall Study|Ineligible|0|||
94511981|NCT05715827|323671250|FG000|Overall Study|Physician Decision|0|||
94511982|NCT05715827|323671251|FG001|Overall Study|Physician Decision|1|||
94511983|NCT05715827|323671250|FG000|Overall Study|console communication error|0|||
94511984|NCT05715827|323671251|FG001|Overall Study|console communication error|1|||
94511985|NCT03514134|323673563|FG000|Overall Study|Lost to Follow-up|0|||
94511986|NCT03514134|323673564|FG001|Overall Study|Lost to Follow-up|1|||
94511987|NCT03502681|323673566|FG000|Overall Study|Adverse Event|1|||
94511988|NCT03502681|323673567|FG001|Overall Study|Adverse Event|1|||
94511989|NCT03502681|323673566|FG000|Overall Study|Disease Progression|2|||
94511990|NCT03502681|323673567|FG001|Overall Study|Disease Progression|1|||
94511991|NCT01444781|323673568|FG000|Overall Study|Lost to Follow-up|0|||
94511992|NCT01444781|323673569|FG001|Overall Study|Lost to Follow-up|3|||
94511993|NCT01444781|323673570|FG002|Overall Study|Lost to Follow-up|1|||
94511994|NCT01444781|323673568|FG000|Overall Study|Withdrawal by Subject|3|||
94511995|NCT01444781|323673569|FG001|Overall Study|Withdrawal by Subject|1|||
94511996|NCT01444781|323673570|FG002|Overall Study|Withdrawal by Subject|2|||
94511997|NCT00363298|323673584|FG000|First Study Week|Lack of Efficacy|6|||
94511998|NCT00363298|323673585|FG001|First Study Week|Lack of Efficacy|5|||
94511999|NCT00363298|323673584|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
94512000|NCT00363298|323673585|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
94512001|NCT05538728|323673586|FG000|Overall Study|Withdrawal by Subject|1|||
94512002|NCT05538728|323673587|FG001|Overall Study|Withdrawal by Subject|1|||
94512003|NCT03014089|323673588|FG000|Overall Study|Withdrawal by Subject|0|||
94512004|NCT03014089|323673589|FG001|Overall Study|Withdrawal by Subject|1|||
94512005|NCT03014089|323673590|FG002|Overall Study|Withdrawal by Subject|1|||
94512006|NCT03014089|323673591|FG003|Overall Study|Withdrawal by Subject|1|||
94512007|NCT03014089|323673588|FG000|Overall Study|Lost to Follow-up|1|||
94512008|NCT03014089|323673589|FG001|Overall Study|Lost to Follow-up|0|||
94512009|NCT03014089|323673590|FG002|Overall Study|Lost to Follow-up|0|||
94512010|NCT03014089|323673591|FG003|Overall Study|Lost to Follow-up|0|||
94512011|NCT03014089|323673588|FG000|Overall Study|Adverse Event|1|||
94512012|NCT03014089|323673589|FG001|Overall Study|Adverse Event|0|||
94512013|NCT03014089|323673590|FG002|Overall Study|Adverse Event|1|||
94512014|NCT03014089|323673591|FG003|Overall Study|Adverse Event|0|||
94512015|NCT00133705|323673592|FG000|Overall Study|Withdrawal by Subject|2|||
94512016|NCT00133705|323673593|FG001|Overall Study|Withdrawal by Subject|3|||
94512017|NCT00189423|323673599|FG000|Overall Study|Death|746|||
94512018|NCT00189423|323673600|FG001|Overall Study|Death|747|||
94512019|NCT00189423|323673599|FG000|Overall Study|Withdrawal by Subject|9|||
94512020|NCT00189423|323673600|FG001|Overall Study|Withdrawal by Subject|9|||
94512021|NCT00189423|323673599|FG000|Overall Study|Lost to Follow-up|10|||
94512022|NCT00189423|323673600|FG001|Overall Study|Lost to Follow-up|10|||
94512023|NCT04622592|323673601|FG000|Overall Study|Death|0|||
94512024|NCT04622592|323673602|FG001|Overall Study|Death|0|||
94512025|NCT04622592|323673603|FG002|Overall Study|Death|1|||
94512026|NCT04622592|323673604|FG003|Overall Study|Death|0|||
94512027|NCT04622592|323673605|FG004|Overall Study|Death|0|||
94512028|NCT04622592|323673606|FG005|Overall Study|Death|0|||
94512029|NCT04622592|323673607|FG006|Overall Study|Death|0|||
94512030|NCT04622592|323673608|FG007|Overall Study|Death|1|||
94512031|NCT04622592|323673601|FG000|Overall Study|Lost to Follow-up|0|||
94512032|NCT04622592|323673602|FG001|Overall Study|Lost to Follow-up|0|||
94512033|NCT04622592|323673603|FG002|Overall Study|Lost to Follow-up|0|||
94512034|NCT04622592|323673604|FG003|Overall Study|Lost to Follow-up|3|||
94512035|NCT04622592|323673605|FG004|Overall Study|Lost to Follow-up|1|||
94512036|NCT04622592|323673606|FG005|Overall Study|Lost to Follow-up|0|||
94512037|NCT04622592|323673607|FG006|Overall Study|Lost to Follow-up|2|||
94512038|NCT04622592|323673608|FG007|Overall Study|Lost to Follow-up|2|||
94512039|NCT04622592|323673601|FG000|Overall Study|Physician Decision|0|||
94512040|NCT04622592|323673602|FG001|Overall Study|Physician Decision|0|||
94512041|NCT04622592|323673603|FG002|Overall Study|Physician Decision|0|||
94512042|NCT04622592|323673604|FG003|Overall Study|Physician Decision|0|||
94512043|NCT04622592|323673605|FG004|Overall Study|Physician Decision|1|||
94512044|NCT04622592|323673606|FG005|Overall Study|Physician Decision|0|||
94512045|NCT04622592|323673607|FG006|Overall Study|Physician Decision|0|||
94512046|NCT04622592|323673608|FG007|Overall Study|Physician Decision|0|||
94512047|NCT04622592|323673601|FG000|Overall Study|Withdrawal by Subject|1|||
94512048|NCT04622592|323673602|FG001|Overall Study|Withdrawal by Subject|0|||
94512049|NCT04622592|323673603|FG002|Overall Study|Withdrawal by Subject|2|||
94512050|NCT04622592|323673604|FG003|Overall Study|Withdrawal by Subject|0|||
94512051|NCT04622592|323673605|FG004|Overall Study|Withdrawal by Subject|0|||
94512052|NCT04622592|323673606|FG005|Overall Study|Withdrawal by Subject|0|||
94512053|NCT04622592|323673607|FG006|Overall Study|Withdrawal by Subject|1|||
94512054|NCT04622592|323673608|FG007|Overall Study|Withdrawal by Subject|4|||
94512055|NCT04622592|323673601|FG000|Overall Study|Other than specified above|0|||
94512056|NCT04622592|323673602|FG001|Overall Study|Other than specified above|0|||
94512057|NCT04622592|323673603|FG002|Overall Study|Other than specified above|1|||
94512058|NCT04622592|323673604|FG003|Overall Study|Other than specified above|0|||
94512059|NCT04622592|323673605|FG004|Overall Study|Other than specified above|0|||
94512060|NCT04622592|323673606|FG005|Overall Study|Other than specified above|0|||
94512061|NCT04622592|323673607|FG006|Overall Study|Other than specified above|0|||
94512062|NCT04622592|323673608|FG007|Overall Study|Other than specified above|0|||
94512063|NCT00183248|323673610|FG000|Overall Study|Lost to Follow-up|0|||
94512064|NCT00183248|323673611|FG001|Overall Study|Lost to Follow-up|1|||
94512065|NCT00183248|323673610|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
94512066|NCT00183248|323673611|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
94512067|NCT04734210|323673612|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
94512068|NCT04734210|323673613|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
94512069|NCT04734210|323673614|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
94512070|NCT04734210|323673612|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
94512071|NCT04734210|323673613|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
94512072|NCT04734210|323673614|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
94512073|NCT04734210|323673612|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
94512074|NCT04734210|323673613|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
94512075|NCT04734210|323673614|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
94512076|NCT04734210|323673612|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
94512077|NCT04734210|323673613|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
94512078|NCT04734210|323673614|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
94512079|NCT01209767|323673615|FG000|Overall Study|Withdrawal by Subject|1|||
94512080|NCT01209767|323673615|FG000|Overall Study|Lost to Follow-up|3|||
94512081|NCT03580044|323673616|FG000|Overall Study|Death|2|||
94512082|NCT03580044|323673617|FG001|Overall Study|Death|1|||
94512083|NCT03580044|323673616|FG000|Overall Study|Withdrawal by Subject|1|||
94512084|NCT03580044|323673617|FG001|Overall Study|Withdrawal by Subject|1|||
94512085|NCT00278161|323673618|FG000|Overall Study|Death|11|||
94512086|NCT00573768|323673635|FG000|Overall Study|Adverse Event|1|||
94512087|NCT00573768|323673636|FG001|Overall Study|Adverse Event|1|||
94512088|NCT00573768|323673637|FG002|Overall Study|Adverse Event|2|||
94512089|NCT00573768|323673635|FG000|Overall Study|Protocol Violation|1|||
94512090|NCT00573768|323673636|FG001|Overall Study|Protocol Violation|0|||
94512091|NCT00573768|323673637|FG002|Overall Study|Protocol Violation|1|||
94512092|NCT00573768|323673635|FG000|Overall Study|Withdrawal by Subject|0|||
94512093|NCT00573768|323673636|FG001|Overall Study|Withdrawal by Subject|1|||
94512094|NCT00573768|323673637|FG002|Overall Study|Withdrawal by Subject|0|||
94512095|NCT00573768|323673635|FG000|Overall Study|Lost to Follow-up|0|||
94512096|NCT00573768|323673636|FG001|Overall Study|Lost to Follow-up|0|||
94512097|NCT00573768|323673637|FG002|Overall Study|Lost to Follow-up|1|||
94512098|NCT03243084|323673638|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
94512099|NCT03243084|323673639|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
94512100|NCT02314923|323673640|FG000|Overall Study|Death|0|||
94512101|NCT02314923|323673641|FG001|Overall Study|Death|0|||
94512102|NCT02314923|323673642|FG002|Overall Study|Death|0|||
94512103|NCT02314923|323673643|FG003|Overall Study|Death|1|||
94512104|NCT02314923|323673644|FG004|Overall Study|Death|0|||
94512105|NCT02314923|323673645|FG005|Overall Study|Death|0|||
94512106|NCT02314923|323673646|FG006|Overall Study|Death|0|||
94512107|NCT02314923|323673647|FG007|Overall Study|Death|0|||
94512108|NCT02314923|323673648|FG008|Overall Study|Death|0|||
94512109|NCT02314923|323673649|FG009|Overall Study|Death|0|||
94512110|NCT02314923|323673640|FG000|Overall Study|Lost to Follow-up|2|||
94512111|NCT02314923|323673641|FG001|Overall Study|Lost to Follow-up|3|||
94512112|NCT02314923|323673642|FG002|Overall Study|Lost to Follow-up|1|||
94512113|NCT02314923|323673643|FG003|Overall Study|Lost to Follow-up|0|||
94512114|NCT02314923|323673644|FG004|Overall Study|Lost to Follow-up|0|||
94512115|NCT02314923|323673645|FG005|Overall Study|Lost to Follow-up|0|||
94512116|NCT02314923|323673646|FG006|Overall Study|Lost to Follow-up|3|||
94512117|NCT02314923|323673647|FG007|Overall Study|Lost to Follow-up|4|||
94512118|NCT02314923|323673648|FG008|Overall Study|Lost to Follow-up|2|||
94512119|NCT02314923|323673649|FG009|Overall Study|Lost to Follow-up|0|||
94512120|NCT02314923|323673640|FG000|Overall Study|Withdrawal by Subject|0|||
94512121|NCT02314923|323673641|FG001|Overall Study|Withdrawal by Subject|0|||
94512122|NCT02314923|323673642|FG002|Overall Study|Withdrawal by Subject|1|||
94512123|NCT02314923|323673643|FG003|Overall Study|Withdrawal by Subject|0|||
94512124|NCT02314923|323673644|FG004|Overall Study|Withdrawal by Subject|1|||
94512125|NCT02314923|323673645|FG005|Overall Study|Withdrawal by Subject|0|||
94512126|NCT02314923|323673646|FG006|Overall Study|Withdrawal by Subject|1|||
94512127|NCT02314923|323673647|FG007|Overall Study|Withdrawal by Subject|0|||
94512128|NCT02314923|323673648|FG008|Overall Study|Withdrawal by Subject|0|||
94512129|NCT02314923|323673649|FG009|Overall Study|Withdrawal by Subject|0|||
94512130|NCT02314923|323673640|FG000|Overall Study|Physician Decision|0|||
94512131|NCT02314923|323673641|FG001|Overall Study|Physician Decision|1|||
94512132|NCT02314923|323673642|FG002|Overall Study|Physician Decision|0|||
94512133|NCT02314923|323673643|FG003|Overall Study|Physician Decision|0|||
94512134|NCT02314923|323673644|FG004|Overall Study|Physician Decision|0|||
94512135|NCT02314923|323673645|FG005|Overall Study|Physician Decision|0|||
94512136|NCT02314923|323673646|FG006|Overall Study|Physician Decision|0|||
94512137|NCT02314923|323673647|FG007|Overall Study|Physician Decision|0|||
94512138|NCT02314923|323673648|FG008|Overall Study|Physician Decision|0|||
94512139|NCT02314923|323673649|FG009|Overall Study|Physician Decision|0|||
94512140|NCT02314923|323673640|FG000|Overall Study|Participant unavailable|0|||
94512141|NCT02314923|323673641|FG001|Overall Study|Participant unavailable|0|||
94512142|NCT02314923|323673642|FG002|Overall Study|Participant unavailable|0|||
94512143|NCT02314923|323673643|FG003|Overall Study|Participant unavailable|0|||
94512144|NCT02314923|323673644|FG004|Overall Study|Participant unavailable|0|||
94512145|NCT02314923|323673645|FG005|Overall Study|Participant unavailable|1|||
94512146|NCT02314923|323673646|FG006|Overall Study|Participant unavailable|0|||
94512147|NCT02314923|323673647|FG007|Overall Study|Participant unavailable|0|||
94512148|NCT02314923|323673648|FG008|Overall Study|Participant unavailable|0|||
94512149|NCT02314923|323673649|FG009|Overall Study|Participant unavailable|0|||
94512150|NCT02314923|323673640|FG000|Overall Study|Screen failure|0|||
94512151|NCT02314923|323673641|FG001|Overall Study|Screen failure|0|||
94512152|NCT02314923|323673642|FG002|Overall Study|Screen failure|0|||
94512153|NCT02314923|323673643|FG003|Overall Study|Screen failure|0|||
94512154|NCT02314923|323673644|FG004|Overall Study|Screen failure|0|||
94512155|NCT02314923|323673645|FG005|Overall Study|Screen failure|0|||
94512156|NCT02314923|323673646|FG006|Overall Study|Screen failure|1|||
94512157|NCT02314923|323673647|FG007|Overall Study|Screen failure|0|||
94512158|NCT02314923|323673648|FG008|Overall Study|Screen failure|0|||
94512159|NCT02314923|323673649|FG009|Overall Study|Screen failure|0|||
94512160|NCT02314923|323673640|FG000|Overall Study|Participant relocation|1|||
94512161|NCT02314923|323673641|FG001|Overall Study|Participant relocation|0|||
94512162|NCT02314923|323673642|FG002|Overall Study|Participant relocation|0|||
94512163|NCT02314923|323673643|FG003|Overall Study|Participant relocation|0|||
94512164|NCT02314923|323673644|FG004|Overall Study|Participant relocation|0|||
94512165|NCT02314923|323673645|FG005|Overall Study|Participant relocation|0|||
94512166|NCT02314923|323673646|FG006|Overall Study|Participant relocation|0|||
94512167|NCT02314923|323673647|FG007|Overall Study|Participant relocation|1|||
94512168|NCT02314923|323673648|FG008|Overall Study|Participant relocation|0|||
94512169|NCT02314923|323673649|FG009|Overall Study|Participant relocation|0|||
94512170|NCT02546323|323673650|FG000|Overall Study|Withdrawal by Subject|36|||
94512171|NCT02546323|323673651|FG001|Overall Study|Withdrawal by Subject|33|||
94512172|NCT02546323|323673650|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
94512173|NCT02546323|323673651|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
94512174|NCT02546323|323673650|FG000|Overall Study|Adverse Event|17|||
94512175|NCT02546323|323673651|FG001|Overall Study|Adverse Event|11|||
94512176|NCT02546323|323673650|FG000|Overall Study|Patient Specific Reasons|1|||
94512177|NCT02546323|323673651|FG001|Overall Study|Patient Specific Reasons|2|||
94512178|NCT02546323|323673650|FG000|Overall Study|Lost to Follow-up|2|||
94512179|NCT02546323|323673651|FG001|Overall Study|Lost to Follow-up|3|||
94512180|NCT02546323|323673650|FG000|Overall Study|Non-compliance with Study Drug|2|||
94512181|NCT02546323|323673651|FG001|Overall Study|Non-compliance with Study Drug|2|||
94512182|NCT02546323|323673650|FG000|Overall Study|Met Withdrawal Criteria|2|||
94512183|NCT02546323|323673651|FG001|Overall Study|Met Withdrawal Criteria|14|||
94512184|NCT05763381|323673652|FG000|Overall Study|Lost to Follow-up|2|||
94512185|NCT05763381|323673653|FG001|Overall Study|Lost to Follow-up|3|||
94512186|NCT05763381|323673652|FG000|Overall Study|Withdrawal by Subject|1|||
94512187|NCT05763381|323673653|FG001|Overall Study|Withdrawal by Subject|2|||
94512188|NCT04617860|323673659|FG000|Overall Study|Adverse Event|0|||
94512189|NCT04617860|323673660|FG001|Overall Study|Adverse Event|2|||
94512190|NCT04617860|323673661|FG002|Overall Study|Adverse Event|2|||
94512191|NCT04617860|323673659|FG000|Overall Study|Withdrawal by Subject|0|||
94512192|NCT04617860|323673660|FG001|Overall Study|Withdrawal by Subject|0|||
94512193|NCT04617860|323673661|FG002|Overall Study|Withdrawal by Subject|2|||
94512194|NCT04617860|323673659|FG000|Overall Study|Physician Decision|0|||
94512195|NCT04617860|323673660|FG001|Overall Study|Physician Decision|1|||
94512196|NCT04617860|323673661|FG002|Overall Study|Physician Decision|0|||
94512197|NCT04617860|323673659|FG000|Overall Study|Sponsor Decision|0|||
94512198|NCT04617860|323673660|FG001|Overall Study|Sponsor Decision|3|||
94512199|NCT04617860|323673661|FG002|Overall Study|Sponsor Decision|1|||
94512200|NCT04617860|323673659|FG000|Overall Study|Termination of Study by Sponsor|8|||
94512201|NCT04617860|323673660|FG001|Overall Study|Termination of Study by Sponsor|4|||
94512202|NCT04617860|323673661|FG002|Overall Study|Termination of Study by Sponsor|13|||
94512203|NCT00478257|323673662|FG000|Overall Study|Withdrawal by Subject|8|||
94512204|NCT00478257|323673663|FG001|Overall Study|Withdrawal by Subject|3|||
94512205|NCT01055028|323673664|FG000|Screening|Screen Failure|1|||
94512206|NCT01055028|323673665|FG001|Screening|Screen Failure|1|||
94512207|NCT01055028|323673664|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
94512208|NCT01055028|323673665|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
94512209|NCT01055028|323673664|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
94512210|NCT01055028|323673665|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
94512211|NCT01055028|323673664|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
94512212|NCT01055028|323673665|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
94512213|NCT00833690|323673666|FG000|Overall Study|Withdrawal by Subject|1|||
94512214|NCT00833690|323673667|FG001|Overall Study|Withdrawal by Subject|0|||
94512215|NCT00833690|323673668|FG002|Overall Study|Withdrawal by Subject|0|||
94512216|NCT00833690|323673666|FG000|Overall Study|Discontinued study drug|3|||
94512217|NCT00833690|323673667|FG001|Overall Study|Discontinued study drug|2|||
94512218|NCT00833690|323673668|FG002|Overall Study|Discontinued study drug|0|||
94512219|NCT03898180|323673671|FG000|Overall Study|Death|178|||
94512220|NCT03898180|323673672|FG001|Overall Study|Death|173|||
94512221|NCT03898180|323673671|FG000|Overall Study|Physician Decision|1|||
94512222|NCT03898180|323673672|FG001|Overall Study|Physician Decision|0|||
94512223|NCT03898180|323673671|FG000|Overall Study|Sponsor Decision|3|||
94512224|NCT03898180|323673672|FG001|Overall Study|Sponsor Decision|0|||
94512225|NCT03898180|323673671|FG000|Overall Study|Lost to Follow-up|1|||
94512226|NCT03898180|323673672|FG001|Overall Study|Lost to Follow-up|0|||
94512227|NCT03898180|323673671|FG000|Overall Study|Withdrawal by Subject|5|||
94512228|NCT03898180|323673672|FG001|Overall Study|Withdrawal by Subject|4|||
94512229|NCT02697448|323673673|FG000|Overall Study|Protocol Violation|2|||
94512230|NCT02697448|323673674|FG001|Overall Study|Protocol Violation|4|||
94512231|NCT02697448|323673673|FG000|Overall Study|Clinical concerns during ablation|1|||
94512232|NCT02697448|323673674|FG001|Overall Study|Clinical concerns during ablation|1|||
94512233|NCT02697448|323673673|FG000|Overall Study|No data collected|2|||
94512234|NCT02697448|323673674|FG001|Overall Study|No data collected|0|||
94512235|NCT05473715|323673675|FG000|Overall Study|Trial terminate|2|||
94512236|NCT05473715|323673676|FG001|Overall Study|Trial terminate|1|||
94512237|NCT01362790|323673687|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
94512238|NCT01362790|323673688|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
94512239|NCT01362790|323673689|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
94512240|NCT01362790|323673690|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
94512241|NCT01362790|323673691|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
94512242|NCT01362790|323673692|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
94512243|NCT01362790|323673693|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
94512244|NCT01362790|323673687|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
94512245|NCT01362790|323673688|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
94512246|NCT01362790|323673689|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
94512247|NCT01362790|323673690|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
94512248|NCT01362790|323673691|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
94512249|NCT01362790|323673692|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
94512250|NCT01362790|323673693|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
94512251|NCT01362790|323673687|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
94512252|NCT01362790|323673688|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
94512253|NCT01362790|323673689|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
94512254|NCT01362790|323673690|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
94512255|NCT01362790|323673691|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
94512256|NCT01362790|323673692|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
94512257|NCT01362790|323673693|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
94512258|NCT01362790|323673687|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
94512259|NCT01362790|323673688|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
94512260|NCT01362790|323673689|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
94512261|NCT01362790|323673690|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
94512262|NCT01362790|323673691|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
94512263|NCT01362790|323673692|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
94512264|NCT01362790|323673693|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
94512265|NCT01362790|323673687|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
94512266|NCT01362790|323673688|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
94512267|NCT01362790|323673689|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
94512268|NCT01362790|323673690|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
94512269|NCT01362790|323673691|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
94512270|NCT01362790|323673692|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
94512271|NCT01362790|323673693|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
94512272|NCT01362790|323673687|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
94512273|NCT01362790|323673688|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
94512274|NCT01362790|323673689|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
94512275|NCT01362790|323673690|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
94512276|NCT01362790|323673691|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
94512277|NCT01362790|323673692|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
94512278|NCT01362790|323673693|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
94512279|NCT01362790|323673687|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
94512280|NCT01362790|323673688|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
94512281|NCT01362790|323673689|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
94512282|NCT01362790|323673690|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
94512283|NCT01362790|323673691|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
94512284|NCT01362790|323673692|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
94512285|NCT01362790|323673693|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
94512286|NCT01362790|323673687|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
94512287|NCT01362790|323673688|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
94512288|NCT01362790|323673689|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
94512289|NCT01362790|323673690|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
94512290|NCT01362790|323673691|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
94512291|NCT01362790|323673692|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
94512292|NCT01362790|323673693|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
94512293|NCT01362790|323673687|FG000|Pilot Phase & Phase 2|Death on study|0|||
94512294|NCT01362790|323673688|FG001|Pilot Phase & Phase 2|Death on study|0|||
94512295|NCT01362790|323673689|FG002|Pilot Phase & Phase 2|Death on study|0|||
94512296|NCT01362790|323673690|FG003|Pilot Phase & Phase 2|Death on study|1|||
94512297|NCT01362790|323673691|FG004|Pilot Phase & Phase 2|Death on study|0|||
94512298|NCT01362790|323673692|FG005|Pilot Phase & Phase 2|Death on study|0|||
94512299|NCT01362790|323673693|FG006|Pilot Phase & Phase 2|Death on study|0|||
94512300|NCT01362790|323673687|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
94512301|NCT01362790|323673688|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
94512302|NCT01362790|323673689|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
94512303|NCT01362790|323673690|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
94512304|NCT01362790|323673691|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
94512305|NCT01362790|323673692|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
94512306|NCT01362790|323673693|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
94512307|NCT01362790|323673687|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
94512308|NCT01362790|323673688|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
94512309|NCT01362790|323673689|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
94512310|NCT01362790|323673690|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
94512311|NCT01362790|323673691|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
94512312|NCT01362790|323673692|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
94512313|NCT01362790|323673693|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
94512314|NCT01362790|323673687|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
94512315|NCT01362790|323673688|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
94512316|NCT01362790|323673689|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
94512317|NCT01362790|323673690|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
94512318|NCT01362790|323673691|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
94512319|NCT01362790|323673692|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
94512320|NCT01362790|323673693|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
94512321|NCT02781558|323673704|FG000|Overall Study|Lost to Follow-up|2|||
94512322|NCT02781558|323673705|FG001|Overall Study|Lost to Follow-up|2|||
94512323|NCT02781558|323673704|FG000|Overall Study|Adverse Event|1|||
94512324|NCT02781558|323673705|FG001|Overall Study|Adverse Event|0|||
94512325|NCT02457793|323673715|FG000|Overall Study|Reason not specified|0|||
94512326|NCT02457793|323673716|FG001|Overall Study|Reason not specified|0|||
94512327|NCT02457793|323673717|FG002|Overall Study|Reason not specified|0|||
94512328|NCT02457793|323673718|FG003|Overall Study|Reason not specified|1|||
94512329|NCT02457793|323673719|FG004|Overall Study|Reason not specified|1|||
94512330|NCT02457793|323673720|FG005|Overall Study|Reason not specified|1|||
94512331|NCT02457793|323673715|FG000|Overall Study|Withdrawal by Subject|0|||
94512332|NCT02457793|323673716|FG001|Overall Study|Withdrawal by Subject|4|||
94512333|NCT02457793|323673717|FG002|Overall Study|Withdrawal by Subject|2|||
94512334|NCT02457793|323673718|FG003|Overall Study|Withdrawal by Subject|2|||
94512335|NCT02457793|323673719|FG004|Overall Study|Withdrawal by Subject|2|||
94512336|NCT02457793|323673720|FG005|Overall Study|Withdrawal by Subject|2|||
94512337|NCT02457793|323673715|FG000|Overall Study|Adverse Event|0|||
94512338|NCT02457793|323673716|FG001|Overall Study|Adverse Event|0|||
94512339|NCT02457793|323673717|FG002|Overall Study|Adverse Event|0|||
94512340|NCT02457793|323673718|FG003|Overall Study|Adverse Event|1|||
94512341|NCT02457793|323673719|FG004|Overall Study|Adverse Event|0|||
94512342|NCT02457793|323673720|FG005|Overall Study|Adverse Event|0|||
94512343|NCT02457793|323673715|FG000|Overall Study|Physician Decision|1|||
94512344|NCT02457793|323673716|FG001|Overall Study|Physician Decision|0|||
94512345|NCT02457793|323673717|FG002|Overall Study|Physician Decision|1|||
94512346|NCT02457793|323673718|FG003|Overall Study|Physician Decision|1|||
94512347|NCT02457793|323673719|FG004|Overall Study|Physician Decision|1|||
94512348|NCT02457793|323673720|FG005|Overall Study|Physician Decision|3|||
94512349|NCT03984188|323673725|FG000|Overall Study|Death|2|||
94512350|NCT03984188|323673726|FG001|Overall Study|Death|4|||
94512351|NCT03984188|323673725|FG000|Overall Study|Physician Decision|0|||
94512352|NCT03984188|323673726|FG001|Overall Study|Physician Decision|2|||
94512353|NCT03984188|323673725|FG000|Overall Study|Lost to Follow-up|3|||
94512354|NCT03984188|323673726|FG001|Overall Study|Lost to Follow-up|2|||
94512355|NCT03984188|323673725|FG000|Overall Study|Withdrawal by Subject|6|||
94512356|NCT03984188|323673726|FG001|Overall Study|Withdrawal by Subject|0|||
94512357|NCT03556891|323673727|FG000|Overall Study|Adverse Event|4|||
94512358|NCT03556891|323673727|FG000|Overall Study|MRI Need|3|||
94512359|NCT03556891|323673727|FG000|Overall Study|Device Failure|1|||
94512360|NCT03556891|323673727|FG000|Overall Study|Death|1|||
94512361|NCT03556891|323673727|FG000|Overall Study|Lost to Follow-up|1|||
94512362|NCT03556891|323673727|FG000|Overall Study|Missing at random|1|||
94512363|NCT03556891|323673727|FG000|Overall Study|Missing due to COVID|1|||
94512364|NCT03556891|323673727|FG000|Overall Study|Protocol Violation|1|||
94512365|NCT03768336|323674700|FG000|Overall Study|Lost to Follow-up|3|||
94512366|NCT03768336|323674701|FG001|Overall Study|Lost to Follow-up|2|||
94512367|NCT03768336|323674700|FG000|Overall Study|Became Ineligible|2|||
94512368|NCT03768336|323674701|FG001|Overall Study|Became Ineligible|0|||
94512369|NCT03768336|323674700|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
94512370|NCT03768336|323674701|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
94512371|NCT03768336|323674700|FG000|Overall Study|Missed final survey (post-treatment|0|||
94512372|NCT03768336|323674701|FG001|Overall Study|Missed final survey (post-treatment|1|||
94512373|NCT06790303|323674704|FG000|Overall Study|Study Terminated by sponsor|4|||
94512374|NCT06790303|323674704|FG000|Overall Study|Death|4|||
94512375|NCT04123704|323674712|FG000|Overall Study|Disease progression|2|||
94512376|NCT02475681|323674713|FG000|Overall Study|Death|16|||
94512377|NCT02475681|323674714|FG001|Overall Study|Death|6|||
94512378|NCT02475681|323674715|FG002|Overall Study|Death|9|||
94512379|NCT02475681|323674713|FG000|Overall Study|Physician Decision|0|||
94512380|NCT02475681|323674714|FG001|Overall Study|Physician Decision|3|||
94512381|NCT02475681|323674715|FG002|Overall Study|Physician Decision|1|||
94512382|NCT02475681|323674713|FG000|Overall Study|Withdrawal by Subject|12|||
94512383|NCT02475681|323674714|FG001|Overall Study|Withdrawal by Subject|6|||
94512384|NCT02475681|323674715|FG002|Overall Study|Withdrawal by Subject|9|||
94512385|NCT02475681|323674713|FG000|Overall Study|Lost to Follow-up|2|||
94512386|NCT02475681|323674714|FG001|Overall Study|Lost to Follow-up|1|||
94512387|NCT02475681|323674715|FG002|Overall Study|Lost to Follow-up|3|||
94512388|NCT02475681|323674713|FG000|Overall Study|Ongoing in Study|0|||
94512389|NCT02475681|323674714|FG001|Overall Study|Ongoing in Study|163|||
94512390|NCT02475681|323674715|FG002|Overall Study|Ongoing in Study|157|||
94512391|NCT02475681|323674713|FG000|Overall Study|Reasons other than above listed|2|||
94512392|NCT02475681|323674714|FG001|Overall Study|Reasons other than above listed|0|||
94512393|NCT02475681|323674715|FG002|Overall Study|Reasons other than above listed|0|||
94512394|NCT01935947|323674720|FG000|Overall Study|Adverse Event|0|||
94512395|NCT01935947|323674721|FG001|Overall Study|Adverse Event|2|||
94512396|NCT01935947|323674722|FG002|Overall Study|Adverse Event|0|||
94512397|NCT01935947|323674720|FG000|Overall Study|Diease Progression|2|||
94512398|NCT01935947|323674721|FG001|Overall Study|Diease Progression|2|||
94512399|NCT01935947|323674722|FG002|Overall Study|Diease Progression|2|||
94512400|NCT01935947|323674720|FG000|Overall Study|Death|1|||
94512401|NCT01935947|323674721|FG001|Overall Study|Death|0|||
94512402|NCT01935947|323674722|FG002|Overall Study|Death|0|||
94512403|NCT04507763|323674723|FG000|Overall Study|Participants did not meet entrance criteria|201|||
94512404|NCT04476784|323674724|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
94512405|NCT04476784|323674725|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
94512406|NCT02090764|323674726|FG000|Overall Study|Adverse Event|1|||
94512407|NCT02090764|323674727|FG001|Overall Study|Adverse Event|3|||
94512408|NCT02090764|323674726|FG000|Overall Study|Lack of Efficacy|0|||
94512409|NCT02090764|323674727|FG001|Overall Study|Lack of Efficacy|13|||
94512410|NCT02090764|323674726|FG000|Overall Study|Withdrawal by Subject|2|||
94512411|NCT02090764|323674727|FG001|Overall Study|Withdrawal by Subject|1|||
94512412|NCT02090764|323674726|FG000|Overall Study|Intercurrent illness and other|1|||
94512413|NCT02090764|323674727|FG001|Overall Study|Intercurrent illness and other|1|||
94512414|NCT02090764|323674726|FG000|Overall Study|Lost to Follow-up|2|||
94512415|NCT02090764|323674727|FG001|Overall Study|Lost to Follow-up|2|||
94512416|NCT04924114|323674728|FG000|Overall Study|Withdrawal by Subject|0|||
94512417|NCT04924114|323674729|FG001|Overall Study|Withdrawal by Subject|2|||
94512418|NCT04924114|323674730|FG002|Overall Study|Withdrawal by Subject|2|||
94512419|NCT04924114|323674731|FG003|Overall Study|Withdrawal by Subject|0|||
94512420|NCT04924114|323674732|FG004|Overall Study|Withdrawal by Subject|1|||
94512421|NCT05030766|323674736|FG000|Phase 1 Participants|Lost to Follow-up|12|||
94512422|NCT05030766|323674737|FG001|Phase 1 Participants|Lost to Follow-up|22|||
94512423|NCT05030766|323674738|FG002|Phase 1 Participants|Lost to Follow-up|0|||
94512424|NCT05030766|323674739|FG003|Phase 1 Participants|Lost to Follow-up|0|||
94512425|NCT05030766|323674736|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
94512426|NCT05030766|323674737|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
94512427|NCT05030766|323674738|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
94512428|NCT05030766|323674739|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
94512429|NCT05030766|323674736|FG000|Phase 2 Participants|Lost to Follow-up|0|||
94512430|NCT05030766|323674737|FG001|Phase 2 Participants|Lost to Follow-up|0|||
94512431|NCT05030766|323674738|FG002|Phase 2 Participants|Lost to Follow-up|6|||
94512432|NCT05030766|323674739|FG003|Phase 2 Participants|Lost to Follow-up|2|||
94512433|NCT00928668|323674742|FG000|Overall Study|Adverse Event|1|||
94512434|NCT00928668|323674743|FG001|Overall Study|Adverse Event|0|||
94512435|NCT00928668|323674744|FG002|Overall Study|Adverse Event|0|||
94512436|NCT00928668|323674745|FG003|Overall Study|Adverse Event|0|||
94512437|NCT00928668|323674746|FG004|Overall Study|Adverse Event|0|||
94512438|NCT00928668|323674742|FG000|Overall Study|Protocol Violation|0|||
94512439|NCT00928668|323674743|FG001|Overall Study|Protocol Violation|0|||
94512440|NCT00928668|323674744|FG002|Overall Study|Protocol Violation|0|||
94512441|NCT00928668|323674745|FG003|Overall Study|Protocol Violation|0|||
94512442|NCT00928668|323674746|FG004|Overall Study|Protocol Violation|1|||
94512443|NCT00928668|323674742|FG000|Overall Study|Withdrawal by Subject|0|||
94512444|NCT00928668|323674743|FG001|Overall Study|Withdrawal by Subject|1|||
94512445|NCT00928668|323674744|FG002|Overall Study|Withdrawal by Subject|1|||
94512446|NCT00928668|323674745|FG003|Overall Study|Withdrawal by Subject|0|||
94512447|NCT00928668|323674746|FG004|Overall Study|Withdrawal by Subject|0|||
94512448|NCT00928668|323674742|FG000|Overall Study|Other reasons not listed above|0|||
94512449|NCT00928668|323674743|FG001|Overall Study|Other reasons not listed above|0|||
94512450|NCT00928668|323674744|FG002|Overall Study|Other reasons not listed above|0|||
94512451|NCT00928668|323674745|FG003|Overall Study|Other reasons not listed above|1|||
94512452|NCT00928668|323674746|FG004|Overall Study|Other reasons not listed above|0|||
94512453|NCT04569032|323674747|FG000|Overall Study|Death|10|||
94512454|NCT04569032|323674748|FG001|Overall Study|Death|13|||
94512455|NCT04569032|323674747|FG000|Overall Study|Withdrawal by Subject|2|||
94512456|NCT04569032|323674748|FG001|Overall Study|Withdrawal by Subject|0|||
94512457|NCT04569032|323674747|FG000|Overall Study|Lost to Follow-up|0|||
94512458|NCT04569032|323674748|FG001|Overall Study|Lost to Follow-up|1|||
94512459|NCT04569032|323674747|FG000|Overall Study|In long term follow up|22|||
94512460|NCT04569032|323674748|FG001|Overall Study|In long term follow up|34|||
94512461|NCT04380142|323674750|FG000|LD/CD Stabilization Period|Adverse Event|3|||
94512462|NCT04380142|323674751|FG001|LD/CD Stabilization Period|Adverse Event|0|||
94512463|NCT04380142|323674752|FG002|LD/CD Stabilization Period|Adverse Event|0|||
94512464|NCT04380142|323674750|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
94512465|NCT04380142|323674751|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
94512466|NCT04380142|323674752|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
94512467|NCT04380142|323674750|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
94512468|NCT04380142|323674751|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
94512469|NCT04380142|323674752|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
94512470|NCT04380142|323674750|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
94512471|NCT04380142|323674751|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
94512472|NCT04380142|323674752|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
94512473|NCT04380142|323674750|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
94512474|NCT04380142|323674751|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
94512475|NCT04380142|323674752|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
94512476|NCT04380142|323674750|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
94512477|NCT04380142|323674751|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
94512478|NCT04380142|323674752|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
94512479|NCT04380142|323674750|FG000|Double-Blind Treatment Period|Adverse Event|0|||
94512480|NCT04380142|323674751|FG001|Double-Blind Treatment Period|Adverse Event|1|||
94512481|NCT04380142|323674752|FG002|Double-Blind Treatment Period|Adverse Event|14|||
94512482|NCT04380142|323674750|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
94512483|NCT04380142|323674751|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
94512484|NCT04380142|323674752|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
94512485|NCT04380142|323674750|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
94512486|NCT04380142|323674751|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
94512487|NCT04380142|323674752|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
94512488|NCT04380142|323674750|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
94512489|NCT04380142|323674751|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
94512490|NCT04380142|323674752|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
94512491|NCT04380142|323674750|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
94512492|NCT04380142|323674751|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
94512493|NCT04380142|323674752|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
94512494|NCT04380142|323674750|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
94512495|NCT04380142|323674751|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
94512496|NCT04380142|323674752|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
94512497|NCT02706392|323674771|FG000|Overall Study|Death|1|||
94512498|NCT02706392|323674772|FG001|Overall Study|Death|0|||
94512499|NCT02706392|323674773|FG002|Overall Study|Death|2|||
94512500|NCT02706392|323674774|FG003|Overall Study|Death|2|||
94512501|NCT02706392|323674775|FG004|Overall Study|Death|5|||
94512502|NCT02706392|323674776|FG005|Overall Study|Death|2|||
94512503|NCT02711202|323674777|FG000|Overall Study|Adverse Event|3|||
94512504|NCT02711202|323674778|FG001|Overall Study|Adverse Event|0|||
94512505|NCT02711202|323674777|FG000|Overall Study|graft loss|1|||
94512506|NCT02711202|323674778|FG001|Overall Study|graft loss|0|||
94512507|NCT06071104|323674779|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
94512508|NCT03211416|323674780|FG000|Overall Study|Adverse Event|7|||
94512509|NCT03211416|323674780|FG000|Overall Study|Lack of Efficacy|2|||
94512510|NCT03211416|323674780|FG000|Overall Study|Physician Decision|1|||
94512511|NCT04532749|323674786|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
94512512|NCT04532749|323674787|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
94512513|NCT04532749|323674786|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
94512514|NCT04532749|323674787|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
94512515|NCT04532749|323674786|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
94512516|NCT04532749|323674787|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
94512517|NCT04532749|323674786|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
94512518|NCT04532749|323674787|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
94512519|NCT04532749|323674786|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
94512520|NCT04532749|323674787|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
94512521|NCT04532749|323674786|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
94512522|NCT04532749|323674787|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
94512523|NCT04532749|323674786|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
94512524|NCT04532749|323674787|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
94512525|NCT04532749|323674786|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
94512526|NCT04532749|323674787|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
94512527|NCT04532749|323674786|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
94512528|NCT04532749|323674787|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
94512529|NCT04532749|323674786|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
94512530|NCT04532749|323674787|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
94512531|NCT02936323|323674788|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
94512532|NCT02936323|323674789|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
94512533|NCT02936323|323674790|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
94512534|NCT02936323|323674791|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
94512535|NCT02936323|323674792|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
94512536|NCT02936323|323674793|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
94512537|NCT02936323|323674794|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
94512538|NCT02936323|323674795|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
94512539|NCT02936323|323674796|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
94512540|NCT02936323|323674797|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
94512541|NCT02936323|323674788|FG000|Phase 1 Dose Escalation|Death|2|||
94512542|NCT02936323|323674789|FG001|Phase 1 Dose Escalation|Death|1|||
94512543|NCT02936323|323674790|FG002|Phase 1 Dose Escalation|Death|3|||
94512544|NCT02936323|323674791|FG003|Phase 1 Dose Escalation|Death|1|||
94512545|NCT02936323|323674792|FG004|Phase 1 Dose Escalation|Death|2|||
94512546|NCT02936323|323674793|FG005|Phase 1 Dose Escalation|Death|3|||
94512547|NCT02936323|323674794|FG006|Phase 1 Dose Escalation|Death|3|||
94512548|NCT02936323|323674795|FG007|Phase 1 Dose Escalation|Death|0|||
94512549|NCT02936323|323674796|FG008|Phase 1 Dose Escalation|Death|0|||
94512550|NCT02936323|323674797|FG009|Phase 1 Dose Escalation|Death|0|||
94512551|NCT02936323|323674788|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
94512552|NCT02936323|323674789|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
94512553|NCT02936323|323674790|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
94512554|NCT02936323|323674791|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
94512555|NCT02936323|323674792|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
94512556|NCT02936323|323674793|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
94512557|NCT02936323|323674794|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
94512558|NCT02936323|323674795|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
94512559|NCT02936323|323674796|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
94512560|NCT02936323|323674797|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
94512561|NCT02936323|323674788|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
94512562|NCT02936323|323674789|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
94512563|NCT02936323|323674790|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
94512564|NCT02936323|323674791|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
94512565|NCT02936323|323674792|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
94512566|NCT02936323|323674793|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
94512567|NCT02936323|323674794|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
94512568|NCT02936323|323674795|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
94512569|NCT02936323|323674796|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
94512570|NCT02936323|323674797|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
94512571|NCT02936323|323674788|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
94512572|NCT02936323|323674789|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
94512573|NCT02936323|323674790|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
94512574|NCT02936323|323674791|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
94512575|NCT02936323|323674792|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
94512576|NCT02936323|323674793|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
94512577|NCT02936323|323674794|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
94512578|NCT02936323|323674795|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
94512579|NCT02936323|323674796|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
94512580|NCT02936323|323674797|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
94512581|NCT02936323|323674788|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
94512582|NCT02936323|323674789|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
94512583|NCT02936323|323674790|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
94512584|NCT02936323|323674791|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
94512585|NCT02936323|323674792|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
94512586|NCT02936323|323674793|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
94512587|NCT02936323|323674794|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
94512588|NCT02936323|323674795|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
94512589|NCT02936323|323674796|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
94512590|NCT02936323|323674797|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
94512591|NCT02936323|323674788|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
94512592|NCT02936323|323674789|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
94512593|NCT02936323|323674790|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
94512594|NCT02936323|323674791|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
94512595|NCT02936323|323674792|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
94512596|NCT02936323|323674793|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
94512597|NCT02936323|323674794|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
94512598|NCT02936323|323674795|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
94512599|NCT02936323|323674796|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
94512600|NCT02936323|323674797|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
94512601|NCT02936323|323674788|FG000|Phase 2a Dose Expansion|Death|0|||
94512602|NCT02936323|323674789|FG001|Phase 2a Dose Expansion|Death|0|||
94512603|NCT02936323|323674790|FG002|Phase 2a Dose Expansion|Death|0|||
94512604|NCT02936323|323674791|FG003|Phase 2a Dose Expansion|Death|0|||
94512605|NCT02936323|323674792|FG004|Phase 2a Dose Expansion|Death|0|||
94512606|NCT02936323|323674793|FG005|Phase 2a Dose Expansion|Death|0|||
94512607|NCT02936323|323674794|FG006|Phase 2a Dose Expansion|Death|0|||
94512608|NCT02936323|323674795|FG007|Phase 2a Dose Expansion|Death|4|||
94512609|NCT02936323|323674796|FG008|Phase 2a Dose Expansion|Death|8|||
94512610|NCT02936323|323674797|FG009|Phase 2a Dose Expansion|Death|10|||
94512611|NCT00643279|323674800|FG000|Overall Study|Death|13|||
94512612|NCT00643279|323674801|FG001|Overall Study|Death|11|||
94512613|NCT00643279|323674800|FG000|Overall Study|Withdrawal by Subject|3|||
94512614|NCT00643279|323674801|FG001|Overall Study|Withdrawal by Subject|0|||
94512615|NCT00643279|323674800|FG000|Overall Study|Lost to Follow-up|0|||
94512616|NCT00643279|323674801|FG001|Overall Study|Lost to Follow-up|1|||
94512617|NCT00643279|323674800|FG000|Overall Study|Physician Decision|0|||
94512618|NCT00643279|323674801|FG001|Overall Study|Physician Decision|1|||
94512619|NCT05318287|323674812|FG000|Overall Study|Lost to Follow-up|8|||
94512620|NCT03537508|323674813|FG000|Overall Study|Adverse Event|2|||
94512621|NCT03537508|323674814|FG001|Overall Study|Adverse Event|1|||
94512622|NCT03537508|323674813|FG000|Overall Study|Protocol Violation|65|||
94512623|NCT03537508|323674814|FG001|Overall Study|Protocol Violation|48|||
94512624|NCT03537508|323674813|FG000|Overall Study|Lost to Follow-up|86|||
94512625|NCT03537508|323674814|FG001|Overall Study|Lost to Follow-up|60|||
94512626|NCT03537508|323674813|FG000|Overall Study|Withdrawal by parent/guardian|263|||
94512627|NCT03537508|323674814|FG001|Overall Study|Withdrawal by parent/guardian|149|||
94512628|NCT04466891|323674817|FG000|Overall Study|Death|52|||
94512629|NCT04466891|323674818|FG001|Overall Study|Death|5|||
94512630|NCT04466891|323674817|FG000|Overall Study|Withdrawal by Subject|8|||
94512631|NCT04466891|323674818|FG001|Overall Study|Withdrawal by Subject|1|||
94512632|NCT00835172|323674828|FG000|Washout|Protocol Violation|0|||
94512633|NCT00835172|323674829|FG001|Washout|Protocol Violation|1|||
94512634|NCT04464473|323674830|FG000|Overall Study|New piercing could not be removed for scanning|0|||
94512635|NCT04464473|323674831|FG001|Overall Study|New piercing could not be removed for scanning|0|||
94512636|NCT04464473|323674832|FG002|Overall Study|New piercing could not be removed for scanning|0|||
94512637|NCT04464473|323674833|FG003|Overall Study|New piercing could not be removed for scanning|1|||
94512638|NCT04464473|323674834|FG004|Overall Study|New piercing could not be removed for scanning|0|||
94512639|NCT04464473|323674835|FG005|Overall Study|New piercing could not be removed for scanning|0|||
94512640|NCT04464473|323674830|FG000|Overall Study|Adverse Event|0|||
94512641|NCT04464473|323674831|FG001|Overall Study|Adverse Event|0|||
94512642|NCT04464473|323674832|FG002|Overall Study|Adverse Event|0|||
94512643|NCT04464473|323674833|FG003|Overall Study|Adverse Event|1|||
94512644|NCT04464473|323674834|FG004|Overall Study|Adverse Event|0|||
94512645|NCT04464473|323674835|FG005|Overall Study|Adverse Event|0|||
94512646|NCT04464473|323674830|FG000|Overall Study|Lost to Follow-up|0|||
94512647|NCT04464473|323674831|FG001|Overall Study|Lost to Follow-up|0|||
94512648|NCT04464473|323674832|FG002|Overall Study|Lost to Follow-up|0|||
94512649|NCT04464473|323674833|FG003|Overall Study|Lost to Follow-up|1|||
94512650|NCT04464473|323674834|FG004|Overall Study|Lost to Follow-up|0|||
94512651|NCT04464473|323674835|FG005|Overall Study|Lost to Follow-up|0|||
94512652|NCT03423979|323674839|FG000|Overall Study|Death|1|||
94512653|NCT03440411|323676394|FG000|Overall Study|Adverse Event|0|||
94512654|NCT03440411|323676395|FG001|Overall Study|Adverse Event|0|||
94512655|NCT03440411|323676396|FG002|Overall Study|Adverse Event|1|||
94512656|NCT03440411|323676397|FG003|Overall Study|Adverse Event|0|||
94512657|NCT03440411|323676394|FG000|Overall Study|PD|2|||
94512658|NCT03440411|323676395|FG001|Overall Study|PD|1|||
94512659|NCT03440411|323676396|FG002|Overall Study|PD|1|||
94512660|NCT03440411|323676397|FG003|Overall Study|PD|1|||
94512661|NCT03440411|323676394|FG000|Overall Study|Withdrawal by Subject|1|||
94512662|NCT03440411|323676395|FG001|Overall Study|Withdrawal by Subject|0|||
94512663|NCT03440411|323676396|FG002|Overall Study|Withdrawal by Subject|0|||
94512664|NCT03440411|323676397|FG003|Overall Study|Withdrawal by Subject|0|||
94512665|NCT03440411|323676394|FG000|Overall Study|Closed study by sponsor|0|||
94512666|NCT03440411|323676395|FG001|Overall Study|Closed study by sponsor|0|||
94512667|NCT03440411|323676396|FG002|Overall Study|Closed study by sponsor|0|||
94512668|NCT03440411|323676397|FG003|Overall Study|Closed study by sponsor|1|||
94512669|NCT00443456|323676402|FG000|Overall Study|Adverse Event|16|||
94512670|NCT00443456|323676402|FG000|Overall Study|Move|1|||
94512671|NCT00443456|323676402|FG000|Overall Study|Withdrawal by Subject|1|||
94512672|NCT05878067|323676404|FG000|Overall Study|Lost to Follow-up|2|||
94512673|NCT02164864|323676407|FG000|Overall Study|Trial disease worsening|7|||
94512674|NCT02164864|323676408|FG001|Overall Study|Trial disease worsening|5|||
94512675|NCT02164864|323676409|FG002|Overall Study|Trial disease worsening|1|||
94512676|NCT02164864|323676407|FG000|Overall Study|Other pre-existing disease worsening|6|||
94512677|NCT02164864|323676408|FG001|Overall Study|Other pre-existing disease worsening|4|||
94512678|NCT02164864|323676409|FG002|Overall Study|Other pre-existing disease worsening|9|||
94512679|NCT02164864|323676407|FG000|Overall Study|Other Adverse Event (AE)|52|||
94512680|NCT02164864|323676408|FG001|Overall Study|Other Adverse Event (AE)|32|||
94512681|NCT02164864|323676409|FG002|Overall Study|Other Adverse Event (AE)|49|||
94512682|NCT02164864|323676407|FG000|Overall Study|Protocol Violation|2|||
94512683|NCT02164864|323676408|FG001|Overall Study|Protocol Violation|4|||
94512684|NCT02164864|323676409|FG002|Overall Study|Protocol Violation|1|||
94512685|NCT02164864|323676407|FG000|Overall Study|Lost to Follow-up|4|||
94512686|NCT02164864|323676408|FG001|Overall Study|Lost to Follow-up|3|||
94512687|NCT02164864|323676409|FG002|Overall Study|Lost to Follow-up|2|||
94512688|NCT02164864|323676407|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
94512689|NCT02164864|323676408|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
94512690|NCT02164864|323676409|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
94512691|NCT02164864|323676407|FG000|Overall Study|Other than stated|3|||
94512692|NCT02164864|323676408|FG001|Overall Study|Other than stated|4|||
94512693|NCT02164864|323676409|FG002|Overall Study|Other than stated|14|||
94512694|NCT01905540|323676410|FG000|Period 3|Other|1|||
94512695|NCT01905540|323676411|FG001|Period 3|Other|0|||
94512696|NCT01905540|323676412|FG002|Period 3|Other|1|||
94512697|NCT01905540|323676413|FG003|Period 3|Other|1|||
94512698|NCT00652834|323676415|FG000|Overall Study|Withdrawal by Subject|3|||
94512699|NCT00652834|323676415|FG000|Overall Study|Lost to Follow-up|2|||
94512700|NCT01602484|323676416|FG000|Overall Study|Airway issues unrelated to study|0|||
94512701|NCT01602484|323676417|FG001|Overall Study|Airway issues unrelated to study|1|||
94512702|NCT00725985|323676420|FG000|ITP- Treatment Disposition|Adverse Event|20|||
94512703|NCT00725985|323676421|FG001|ITP- Treatment Disposition|Adverse Event|10|||
94512704|NCT00725985|323676422|FG002|ITP- Treatment Disposition|Adverse Event|5|||
94512705|NCT00725985|323676423|FG003|ITP- Treatment Disposition|Adverse Event|0|||
94512706|NCT00725985|323676424|FG004|ITP- Treatment Disposition|Adverse Event|0|||
94512707|NCT00725985|323676425|FG005|ITP- Treatment Disposition|Adverse Event|0|||
94512708|NCT00725985|323676426|FG006|ITP- Treatment Disposition|Adverse Event|0|||
94512709|NCT00725985|323676427|FG007|ITP- Treatment Disposition|Adverse Event|0|||
94512710|NCT00725985|323676428|FG008|ITP- Treatment Disposition|Adverse Event|0|||
94512711|NCT00725985|323676429|FG009|ITP- Treatment Disposition|Adverse Event|0|||
94512712|NCT00725985|323676430|FG010|ITP- Treatment Disposition|Adverse Event|0|||
94512713|NCT00725985|323676431|FG011|ITP- Treatment Disposition|Adverse Event|0|||
94512714|NCT00725985|323676420|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
94512715|NCT00725985|323676421|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
94512716|NCT00725985|323676422|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
94512717|NCT00725985|323676423|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
94512718|NCT00725985|323676424|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
94512719|NCT00725985|323676425|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
94512720|NCT00725985|323676426|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
94512721|NCT00725985|323676427|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
94512722|NCT00725985|323676428|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
94512723|NCT00725985|323676429|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
94512724|NCT00725985|323676430|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
94512725|NCT00725985|323676431|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
94512726|NCT00725985|323676420|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
94512727|NCT00725985|323676421|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
94512728|NCT00725985|323676422|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
94512729|NCT00725985|323676423|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
94512730|NCT00725985|323676424|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
94512731|NCT00725985|323676425|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
94512732|NCT00725985|323676426|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
94512733|NCT00725985|323676427|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
94512734|NCT00725985|323676428|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
94512735|NCT00725985|323676429|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
94512736|NCT00725985|323676430|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
94512737|NCT00725985|323676431|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
94512738|NCT00725985|323676420|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
94512739|NCT00725985|323676421|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
94512740|NCT00725985|323676422|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
94512741|NCT00725985|323676423|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
94512742|NCT00725985|323676424|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
94512743|NCT00725985|323676425|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
94512744|NCT00725985|323676426|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
94512745|NCT00725985|323676427|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
94512746|NCT00725985|323676428|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
94512747|NCT00725985|323676429|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
94512748|NCT00725985|323676430|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
94512749|NCT00725985|323676431|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
94512750|NCT00725985|323676420|FG000|ITP- Treatment Disposition|Other|50|||
94512751|NCT00725985|323676421|FG001|ITP- Treatment Disposition|Other|38|||
94512752|NCT00725985|323676422|FG002|ITP- Treatment Disposition|Other|24|||
94512753|NCT00725985|323676423|FG003|ITP- Treatment Disposition|Other|0|||
94512754|NCT00725985|323676424|FG004|ITP- Treatment Disposition|Other|0|||
94512755|NCT00725985|323676425|FG005|ITP- Treatment Disposition|Other|0|||
94512756|NCT00725985|323676426|FG006|ITP- Treatment Disposition|Other|0|||
94512757|NCT00725985|323676427|FG007|ITP- Treatment Disposition|Other|0|||
94512758|NCT00725985|323676428|FG008|ITP- Treatment Disposition|Other|0|||
94512759|NCT00725985|323676429|FG009|ITP- Treatment Disposition|Other|0|||
94512760|NCT00725985|323676430|FG010|ITP- Treatment Disposition|Other|0|||
94512761|NCT00725985|323676431|FG011|ITP- Treatment Disposition|Other|0|||
94512762|NCT00725985|323676420|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
94512763|NCT00725985|323676421|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
94512764|NCT00725985|323676422|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
94512765|NCT00725985|323676423|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
94512766|NCT00725985|323676424|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
94512767|NCT00725985|323676425|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
94512768|NCT00725985|323676426|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
94512769|NCT00725985|323676427|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
94512770|NCT00725985|323676428|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
94512771|NCT00725985|323676429|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
94512772|NCT00725985|323676430|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
94512773|NCT00725985|323676431|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
94512774|NCT00725985|323676420|FG000|OLMP (Up to 96 Weeks)|Death|0|||
94512775|NCT00725985|323676421|FG001|OLMP (Up to 96 Weeks)|Death|0|||
94512776|NCT00725985|323676422|FG002|OLMP (Up to 96 Weeks)|Death|0|||
94512777|NCT00725985|323676423|FG003|OLMP (Up to 96 Weeks)|Death|0|||
94512778|NCT00725985|323676424|FG004|OLMP (Up to 96 Weeks)|Death|1|||
94512779|NCT00725985|323676425|FG005|OLMP (Up to 96 Weeks)|Death|0|||
94512780|NCT00725985|323676426|FG006|OLMP (Up to 96 Weeks)|Death|0|||
94512781|NCT00725985|323676427|FG007|OLMP (Up to 96 Weeks)|Death|0|||
94512782|NCT00725985|323676428|FG008|OLMP (Up to 96 Weeks)|Death|0|||
94512783|NCT00725985|323676429|FG009|OLMP (Up to 96 Weeks)|Death|0|||
94512784|NCT00725985|323676430|FG010|OLMP (Up to 96 Weeks)|Death|0|||
94512785|NCT00725985|323676431|FG011|OLMP (Up to 96 Weeks)|Death|0|||
94512786|NCT00725985|323676420|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
94512787|NCT00725985|323676421|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
94512788|NCT00725985|323676422|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
94512789|NCT00725985|323676423|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
94512790|NCT00725985|323676424|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
94512791|NCT00725985|323676425|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
94512792|NCT00725985|323676426|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
94512793|NCT00725985|323676427|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
94512794|NCT00725985|323676428|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
94512795|NCT00725985|323676429|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
94512796|NCT00725985|323676430|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
94512797|NCT00725985|323676431|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
94512798|NCT00725985|323676420|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
94512799|NCT00725985|323676421|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
94512800|NCT00725985|323676422|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
94512801|NCT00725985|323676423|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
94512802|NCT00725985|323676424|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
94512803|NCT00725985|323676425|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
94512804|NCT00725985|323676426|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
94512805|NCT00725985|323676427|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
94512841|NCT00725985|323676427|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
94512842|NCT00725985|323676428|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
94512843|NCT00725985|323676429|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
94512844|NCT00725985|323676430|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
94512845|NCT00725985|323676431|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
94512846|NCT00725985|323676420|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
94512847|NCT00725985|323676421|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
94512848|NCT00725985|323676422|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
94512849|NCT00725985|323676423|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
94512850|NCT00725985|323676424|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
94512851|NCT00725985|323676425|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
94512852|NCT00725985|323676426|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
94512853|NCT00725985|323676427|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
94512854|NCT00725985|323676428|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
94512855|NCT00725985|323676429|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
94512856|NCT00725985|323676430|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
94512857|NCT00725985|323676431|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
94512858|NCT00725985|323676420|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
94512859|NCT00725985|323676421|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
94512860|NCT00725985|323676422|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
94512861|NCT00725985|323676423|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
94512862|NCT00725985|323676424|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
94512863|NCT00725985|323676425|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
94512864|NCT00725985|323676426|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
94512865|NCT00725985|323676427|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
94512866|NCT00725985|323676428|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
94512867|NCT00725985|323676429|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
94512868|NCT00725985|323676430|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
94512869|NCT00725985|323676431|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
94512870|NCT03528902|323676432|FG000|Overall Study|Adverse Event|1|||
94512871|NCT03528902|323676433|FG001|Overall Study|Adverse Event|0|||
94512872|NCT00645658|323676434|FG000|Overall Study|Withdrawal by Subject|1|||
94512873|NCT00645658|323676435|FG001|Overall Study|Withdrawal by Subject|0|||
94512874|NCT00645658|323676434|FG000|Overall Study|Did not complete all assesments|0|||
94512875|NCT00645658|323676435|FG001|Overall Study|Did not complete all assesments|2|||
94512876|NCT05889468|323676440|FG000|Overall Study|Lost to Follow-up|9|||
94512877|NCT05889468|323676441|FG001|Overall Study|Lost to Follow-up|2|||
94512878|NCT05889468|323676440|FG000|Overall Study|Withdrawal by Subject|2|||
94512879|NCT05889468|323676441|FG001|Overall Study|Withdrawal by Subject|2|||
94512880|NCT03232567|323676444|FG000|Overall Study|Withdrawal by Subject|0|||
94512881|NCT03232567|323676445|FG001|Overall Study|Withdrawal by Subject|1|||
94512882|NCT03232567|323676446|FG002|Overall Study|Withdrawal by Subject|0|||
94512883|NCT03232567|323676447|FG003|Overall Study|Withdrawal by Subject|0|||
94512884|NCT01153516|323676448|FG000|Overall Study|Both subjects refused surgery|2|||
94512885|NCT01153516|323676449|FG001|Overall Study|Both subjects refused surgery|0|||
94512886|NCT00787150|323676465|FG000|Overall Study|Adverse Event|4|||
94512887|NCT00787150|323676466|FG001|Overall Study|Adverse Event|4|||
94512888|NCT00787150|323676467|FG002|Overall Study|Adverse Event|4|||
94512889|NCT00787150|323676465|FG000|Overall Study|Physician Decision|1|||
94512890|NCT00787150|323676466|FG001|Overall Study|Physician Decision|2|||
94512891|NCT00787150|323676467|FG002|Overall Study|Physician Decision|1|||
94512892|NCT00787150|323676465|FG000|Overall Study|Withdrawal by Subject|2|||
94512893|NCT00787150|323676466|FG001|Overall Study|Withdrawal by Subject|1|||
94512894|NCT00787150|323676467|FG002|Overall Study|Withdrawal by Subject|0|||
94512895|NCT00787150|323676465|FG000|Overall Study|Dosing incorrect study durg|2|||
94512896|NCT00787150|323676466|FG001|Overall Study|Dosing incorrect study durg|0|||
94512897|NCT00787150|323676467|FG002|Overall Study|Dosing incorrect study durg|0|||
94512898|NCT00879398|323676473|FG000|Overall Study|Visit Stop|399|||
94512899|NCT00879398|323676473|FG000|Overall Study|Lack of Efficacy|64|||
94512900|NCT00879398|323676473|FG000|Overall Study|Adverse Event|41|||
94512901|NCT00879398|323676473|FG000|Overall Study|Other Reasons|171|||
94512902|NCT00526799|323676475|FG000|Overall Study|Withdrawal by Subject|1|||
94512903|NCT00526799|323676476|FG001|Overall Study|Withdrawal by Subject|0|||
94512904|NCT00526799|323676475|FG000|Overall Study|Intercurrent Complicating Disease|0|||
94512905|NCT00526799|323676476|FG001|Overall Study|Intercurrent Complicating Disease|1|||
94512906|NCT01121757|323676479|FG000|First Drug|Death|1|||
94512907|NCT01121757|323676480|FG001|First Drug|Death|0|||
94512908|NCT01121757|323676479|FG000|First Drug|Disease Progression|0|||
94512909|NCT01121757|323676480|FG001|First Drug|Disease Progression|2|||
94512910|NCT01121757|323676479|FG000|Combination|Physician Decision|0|||
94512911|NCT01121757|323676480|FG001|Combination|Physician Decision|1|||
94512912|NCT01121757|323676479|FG000|Combination|Disease Progression|2|||
94512913|NCT01121757|323676480|FG001|Combination|Disease Progression|0|||
94512914|NCT03770286|323676483|FG000|Overall Study|Lost to Follow-up|6|||
94512915|NCT03770286|323676484|FG001|Overall Study|Lost to Follow-up|4|||
94512916|NCT03770286|323676485|FG002|Overall Study|Lost to Follow-up|3|||
94512917|NCT03770286|323676483|FG000|Overall Study|Protocol Violation|1|||
94512918|NCT03770286|323676484|FG001|Overall Study|Protocol Violation|0|||
94512919|NCT03770286|323676485|FG002|Overall Study|Protocol Violation|2|||
94512920|NCT01380080|323676489|FG000|Overall Study|Death|36|||
94512921|NCT01380080|323676490|FG001|Overall Study|Death|44|||
94512922|NCT01380080|323676489|FG000|Overall Study|Site is closing|28|||
94512923|NCT01380080|323676490|FG001|Overall Study|Site is closing|31|||
94512924|NCT01380080|323676489|FG000|Overall Study|Not able to get to clinic|7|||
94512925|NCT01380080|323676490|FG001|Overall Study|Not able to get to clinic|1|||
94512926|NCT01380080|323676489|FG000|Overall Study|Not willing to adhere to requirements|6|||
94512927|NCT01380080|323676490|FG001|Overall Study|Not willing to adhere to requirements|2|||
94512928|NCT01380080|323676489|FG000|Overall Study|Withdrawal by Subject|5|||
94512929|NCT01380080|323676490|FG001|Overall Study|Withdrawal by Subject|2|||
94512930|NCT01380080|323676489|FG000|Overall Study|Lost to Follow-up|3|||
94512931|NCT01380080|323676490|FG001|Overall Study|Lost to Follow-up|3|||
94512932|NCT02135133|323676491|FG000|Overall Study|Adverse Event|10|||
94512933|NCT02135133|323676491|FG000|Overall Study|regulatory mandate|5|||
94512934|NCT05081843|323676492|FG000|Overall Study|Lost to Follow-up|135|||
94512935|NCT05081843|323676493|FG001|Overall Study|Lost to Follow-up|145|||
94512936|NCT04803214|323676494|FG000|Overall Study|Adverse Event|1|||
94512937|NCT04803214|323676495|FG001|Overall Study|Adverse Event|0|||
94512938|NCT04803214|323676494|FG000|Overall Study|Withdrawal by Subject|1|||
94512939|NCT04803214|323676495|FG001|Overall Study|Withdrawal by Subject|2|||
94512940|NCT04803214|323676494|FG000|Overall Study|Lost to Follow-up|2|||
94512941|NCT04803214|323676495|FG001|Overall Study|Lost to Follow-up|4|||
94512942|NCT04803214|323676494|FG000|Overall Study|Physician Decision|1|||
94512943|NCT04803214|323676495|FG001|Overall Study|Physician Decision|1|||
94512944|NCT04803214|323676494|FG000|Overall Study|Missed 12 month visit|0|||
94512945|NCT04803214|323676495|FG001|Overall Study|Missed 12 month visit|3|||
94512946|NCT03448393|323676500|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
94512947|NCT03448393|323676501|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
94512948|NCT03448393|323676502|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
94512949|NCT03448393|323676503|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
94512950|NCT03448393|323676504|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
94512951|NCT03448393|323676505|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
94512952|NCT03448393|323676506|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
94512953|NCT03448393|323676507|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
94512954|NCT03448393|323676508|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
94512955|NCT03448393|323676500|FG000|Dose Expansion|Not treated - screen failure|0|||
94512956|NCT03448393|323676501|FG001|Dose Expansion|Not treated - screen failure|0|||
94512957|NCT03448393|323676502|FG002|Dose Expansion|Not treated - screen failure|0|||
94512958|NCT03448393|323676503|FG003|Dose Expansion|Not treated - screen failure|0|||
94512959|NCT03448393|323676504|FG004|Dose Expansion|Not treated - screen failure|0|||
94512960|NCT03448393|323676505|FG005|Dose Expansion|Not treated - screen failure|0|||
94512961|NCT03448393|323676506|FG006|Dose Expansion|Not treated - screen failure|0|||
94512962|NCT03448393|323676507|FG007|Dose Expansion|Not treated - screen failure|0|||
94512963|NCT03448393|323676508|FG008|Dose Expansion|Not treated - screen failure|7|||
94512964|NCT04756531|323676509|FG000|Overall Study|Adverse Event|0|||
94512965|NCT04756531|323676510|FG001|Overall Study|Adverse Event|0|||
94512966|NCT04756531|323676511|FG002|Overall Study|Adverse Event|0|||
94512967|NCT04756531|323676512|FG003|Overall Study|Adverse Event|0|||
94512968|NCT04756531|323676513|FG004|Overall Study|Adverse Event|1|||
94512969|NCT04756531|323676514|FG005|Overall Study|Adverse Event|0|||
94512970|NCT04756531|323676515|FG006|Overall Study|Adverse Event|0|||
94512971|NCT04756531|323676516|FG007|Overall Study|Adverse Event|0|||
94512972|NCT04756531|323676517|FG008|Overall Study|Adverse Event|0|||
94512973|NCT04756531|323676518|FG009|Overall Study|Adverse Event|0|||
94512974|NCT04756531|323676519|FG010|Overall Study|Adverse Event|0|||
94512975|NCT04756531|323676520|FG011|Overall Study|Adverse Event|0|||
94512976|NCT04756531|323676521|FG012|Overall Study|Adverse Event|0|||
94512977|NCT04756531|323676522|FG013|Overall Study|Adverse Event|0|||
94512978|NCT04756531|323676523|FG014|Overall Study|Adverse Event|0|||
94512979|NCT04756531|323676524|FG015|Overall Study|Adverse Event|0|||
94512980|NCT04756531|323676525|FG016|Overall Study|Adverse Event|0|||
94512981|NCT04756531|323676526|FG017|Overall Study|Adverse Event|0|||
94512982|NCT04756531|323676509|FG000|Overall Study|Withdrawal by Subject|0|||
94512983|NCT04756531|323676510|FG001|Overall Study|Withdrawal by Subject|0|||
94512984|NCT04756531|323676511|FG002|Overall Study|Withdrawal by Subject|0|||
94512985|NCT04756531|323676512|FG003|Overall Study|Withdrawal by Subject|0|||
94655633|NCT01312467|324196107|FG000|Overall Study|Deported to country of origin|1|||
94512986|NCT04756531|323676513|FG004|Overall Study|Withdrawal by Subject|0|||
94512987|NCT04756531|323676514|FG005|Overall Study|Withdrawal by Subject|0|||
94512988|NCT04756531|323676515|FG006|Overall Study|Withdrawal by Subject|1|||
94512989|NCT04756531|323676516|FG007|Overall Study|Withdrawal by Subject|0|||
94512990|NCT04756531|323676517|FG008|Overall Study|Withdrawal by Subject|0|||
94512991|NCT04756531|323676518|FG009|Overall Study|Withdrawal by Subject|0|||
94512992|NCT04756531|323676519|FG010|Overall Study|Withdrawal by Subject|0|||
94512993|NCT04756531|323676520|FG011|Overall Study|Withdrawal by Subject|0|||
94512994|NCT04756531|323676521|FG012|Overall Study|Withdrawal by Subject|0|||
94512995|NCT04756531|323676522|FG013|Overall Study|Withdrawal by Subject|0|||
94512996|NCT04756531|323676523|FG014|Overall Study|Withdrawal by Subject|0|||
94512997|NCT04756531|323676524|FG015|Overall Study|Withdrawal by Subject|0|||
94512998|NCT04756531|323676525|FG016|Overall Study|Withdrawal by Subject|0|||
94512999|NCT04756531|323676526|FG017|Overall Study|Withdrawal by Subject|0|||
94513000|NCT03814044|323676527|FG000|Overall Study|Protocol deviation|1|||
94513001|NCT03557502|323676528|FG000|Protocol 2|Withdrawal by Subject|1|||
94513002|NCT03557502|323676529|FG001|Protocol 2|Withdrawal by Subject|1|||
94513003|NCT03557502|323676528|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
94513004|NCT03557502|323676529|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
94513005|NCT01400412|323676534|FG000|Overall Study|Lost to Follow-up|4|||
94513006|NCT01400412|323676535|FG001|Overall Study|Lost to Follow-up|7|||
94513007|NCT01400412|323676534|FG000|Overall Study|Withdrawal by Subject|3|||
94513008|NCT01400412|323676535|FG001|Overall Study|Withdrawal by Subject|4|||
94513009|NCT01400412|323676534|FG000|Overall Study|Unable to complete|3|||
94513010|NCT01400412|323676535|FG001|Overall Study|Unable to complete|3|||
94513011|NCT01400412|323676534|FG000|Overall Study|Never started study treatment|0|||
94513012|NCT01400412|323676535|FG001|Overall Study|Never started study treatment|3|||
94513013|NCT03440385|323677491|FG000|Overall Study|Other Reason|4|||
94513014|NCT03440385|323677492|FG001|Overall Study|Other Reason|1|||
94513015|NCT03440385|323677491|FG000|Overall Study|Site Closed|1|||
94513016|NCT03440385|323677492|FG001|Overall Study|Site Closed|0|||
94513017|NCT03440385|323677491|FG000|Overall Study|Lost to Follow-up|2|||
94513018|NCT03440385|323677492|FG001|Overall Study|Lost to Follow-up|0|||
94513019|NCT03440385|323677491|FG000|Overall Study|Withdrawal by Subject|12|||
94513020|NCT03440385|323677492|FG001|Overall Study|Withdrawal by Subject|6|||
94513021|NCT03440385|323677491|FG000|Overall Study|Lack of Efficacy|9|||
94513022|NCT03440385|323677492|FG001|Overall Study|Lack of Efficacy|2|||
94513023|NCT03440385|323677491|FG000|Overall Study|Adverse Event|15|||
94513024|NCT03440385|323677492|FG001|Overall Study|Adverse Event|11|||
94513025|NCT03663582|323677494|FG000|Overall Study|Physician Decision|1|||
94513026|NCT02390076|323677495|FG000|Overall Study|Lost to Follow-up|2|||
94513027|NCT02390076|323677496|FG001|Overall Study|Lost to Follow-up|1|||
94513028|NCT02390076|323677497|FG002|Overall Study|Lost to Follow-up|4|||
94513029|NCT03386773|323677504|FG000|Overall Study|Lost to Follow-up|24|||
94513030|NCT03386773|323677505|FG001|Overall Study|Lost to Follow-up|33|||
94513031|NCT03386773|323677504|FG000|Overall Study|Withdrawal by Subject|3|||
94513032|NCT03386773|323677505|FG001|Overall Study|Withdrawal by Subject|2|||
94513033|NCT01358734|323677506|FG000|Overall Study|Adverse Event|4|||
94513034|NCT01358734|323677507|FG001|Overall Study|Adverse Event|7|||
94513035|NCT01358734|323677508|FG002|Overall Study|Adverse Event|3|||
94513036|NCT01358734|323677506|FG000|Overall Study|Lack of Efficacy|0|||
94513037|NCT01358734|323677507|FG001|Overall Study|Lack of Efficacy|1|||
94513038|NCT01358734|323677508|FG002|Overall Study|Lack of Efficacy|3|||
94513039|NCT01358734|323677506|FG000|Overall Study|Withdrawal by Subject|1|||
94513040|NCT01358734|323677507|FG001|Overall Study|Withdrawal by Subject|6|||
94513041|NCT01358734|323677508|FG002|Overall Study|Withdrawal by Subject|3|||
94513042|NCT01358734|323677506|FG000|Overall Study|Death|3|||
94513043|NCT01358734|323677507|FG001|Overall Study|Death|7|||
94513044|NCT01358734|323677508|FG002|Overall Study|Death|2|||
94513045|NCT01358734|323677506|FG000|Overall Study|Progressive Disease|5|||
94513046|NCT01358734|323677507|FG001|Overall Study|Progressive Disease|13|||
94513047|NCT01358734|323677508|FG002|Overall Study|Progressive Disease|16|||
94513048|NCT01358734|323677506|FG000|Overall Study|Non-compliance with study drug|0|||
94513049|NCT01358734|323677507|FG001|Overall Study|Non-compliance with study drug|0|||
94513050|NCT01358734|323677508|FG002|Overall Study|Non-compliance with study drug|1|||
94513051|NCT01358734|323677506|FG000|Overall Study|Other|2|||
94513052|NCT01358734|323677507|FG001|Overall Study|Other|5|||
94513053|NCT01358734|323677508|FG002|Overall Study|Other|4|||
94513054|NCT01358734|323677506|FG000|Overall Study|Protocol Violation|0|||
94513055|NCT01358734|323677507|FG001|Overall Study|Protocol Violation|0|||
94513056|NCT01358734|323677508|FG002|Overall Study|Protocol Violation|2|||
94513057|NCT01822925|323677509|FG000|Overall Study|Adverse Event|1|||
94513058|NCT01822925|323677510|FG001|Overall Study|Adverse Event|1|||
94513059|NCT01822925|323677511|FG002|Overall Study|Adverse Event|1|||
94513060|NCT01822925|323677512|FG003|Overall Study|Adverse Event|1|||
94513061|NCT01822925|323677509|FG000|Overall Study|Lost to Follow-up|0|||
94513062|NCT01822925|323677510|FG001|Overall Study|Lost to Follow-up|1|||
94513063|NCT01822925|323677511|FG002|Overall Study|Lost to Follow-up|0|||
94513064|NCT01822925|323677512|FG003|Overall Study|Lost to Follow-up|0|||
94513065|NCT01822925|323677509|FG000|Overall Study|Protocol Violation|1|||
94513066|NCT01822925|323677510|FG001|Overall Study|Protocol Violation|0|||
94513067|NCT01822925|323677511|FG002|Overall Study|Protocol Violation|0|||
94513068|NCT01822925|323677512|FG003|Overall Study|Protocol Violation|1|||
94513069|NCT01822925|323677509|FG000|Overall Study|Withdrawal by Subject|2|||
94513070|NCT01822925|323677510|FG001|Overall Study|Withdrawal by Subject|0|||
94513071|NCT01822925|323677511|FG002|Overall Study|Withdrawal by Subject|2|||
94513072|NCT01822925|323677512|FG003|Overall Study|Withdrawal by Subject|2|||
94513073|NCT01822925|323677509|FG000|Overall Study|Taking prohibited medication|2|||
94513074|NCT01822925|323677510|FG001|Overall Study|Taking prohibited medication|0|||
94513075|NCT01822925|323677511|FG002|Overall Study|Taking prohibited medication|0|||
94513076|NCT01822925|323677512|FG003|Overall Study|Taking prohibited medication|1|||
94513077|NCT04573972|323677515|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
94513078|NCT04573972|323677516|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
94513079|NCT01517984|323677517|FG000|Overall Study|Lost to Follow-up|0|||
94513080|NCT01517984|323677518|FG001|Overall Study|Lost to Follow-up|1|||
94513081|NCT01517984|323677519|FG002|Overall Study|Lost to Follow-up|0|||
94513082|NCT01517984|323677520|FG003|Overall Study|Lost to Follow-up|0|||
94513083|NCT01517984|323677517|FG000|Overall Study|Withdrawal by Subject|1|||
94513084|NCT01517984|323677518|FG001|Overall Study|Withdrawal by Subject|8|||
94513085|NCT01517984|323677519|FG002|Overall Study|Withdrawal by Subject|4|||
94513086|NCT01517984|323677520|FG003|Overall Study|Withdrawal by Subject|1|||
94513087|NCT01517984|323677517|FG000|Overall Study|Screen Failure|4|||
94513088|NCT01517984|323677518|FG001|Overall Study|Screen Failure|0|||
94513089|NCT01517984|323677519|FG002|Overall Study|Screen Failure|0|||
94513090|NCT01517984|323677520|FG003|Overall Study|Screen Failure|0|||
94513091|NCT01517984|323677517|FG000|Overall Study|Ineligible for randomization|0|||
94513092|NCT01517984|323677518|FG001|Overall Study|Ineligible for randomization|14|||
94513093|NCT01517984|323677519|FG002|Overall Study|Ineligible for randomization|0|||
94513094|NCT01517984|323677520|FG003|Overall Study|Ineligible for randomization|0|||
94513095|NCT02724839|323677521|FG000|Overall Study|Withdrawal by Subject|1|||
94513096|NCT02724839|323677522|FG001|Overall Study|Withdrawal by Subject|1|||
94513097|NCT02724839|323677523|FG002|Overall Study|Withdrawal by Subject|0|||
94513098|NCT02724839|323677521|FG000|Overall Study|Lost to Follow-up|0|||
94513099|NCT02724839|323677522|FG001|Overall Study|Lost to Follow-up|3|||
94513100|NCT02724839|323677523|FG002|Overall Study|Lost to Follow-up|2|||
94513101|NCT02724839|323677521|FG000|Overall Study|Physician Decision|0|||
94513102|NCT02724839|323677522|FG001|Overall Study|Physician Decision|0|||
94513103|NCT02724839|323677523|FG002|Overall Study|Physician Decision|3|||
94513104|NCT03610048|323677524|FG000|Overall Study|Study terminated by sponsor|84|||
94513105|NCT03610048|323677524|FG000|Overall Study|Adverse Event|32|||
94513106|NCT03610048|323677524|FG000|Overall Study|Withdrawal by Subject|31|||
94513107|NCT03610048|323677524|FG000|Overall Study|Lost to Follow-up|8|||
94513108|NCT03610048|323677524|FG000|Overall Study|Other|4|||
94513109|NCT03610048|323677524|FG000|Overall Study|Physician Decision|1|||
94513110|NCT03610048|323677524|FG000|Overall Study|Pregnancy|1|||
94513111|NCT03322566|323677525|FG000|Overall Study|Death|34|||
94513112|NCT03322566|323677526|FG001|Overall Study|Death|35|||
94513113|NCT03322566|323677527|FG002|Overall Study|Death|23|||
94513114|NCT03322566|323677525|FG000|Overall Study|Physician Decision|6|||
94513115|NCT03322566|323677526|FG001|Overall Study|Physician Decision|7|||
94513116|NCT03322566|323677527|FG002|Overall Study|Physician Decision|2|||
94513117|NCT03322566|323677525|FG000|Overall Study|Withdrawal by Subject|4|||
94513118|NCT03322566|323677526|FG001|Overall Study|Withdrawal by Subject|3|||
94513119|NCT03322566|323677527|FG002|Overall Study|Withdrawal by Subject|6|||
94513120|NCT03322566|323677525|FG000|Overall Study|Lost to Follow-up|0|||
94513121|NCT03322566|323677526|FG001|Overall Study|Lost to Follow-up|0|||
94513122|NCT03322566|323677527|FG002|Overall Study|Lost to Follow-up|1|||
94513123|NCT03322566|323677525|FG000|Overall Study|Study terminated by sponsor|1|||
94513124|NCT03322566|323677526|FG001|Overall Study|Study terminated by sponsor|0|||
94513125|NCT03322566|323677527|FG002|Overall Study|Study terminated by sponsor|1|||
94513126|NCT00560417|323677528|FG000|Overall Study|Adverse Event|3|||
94513127|NCT00560417|323677529|FG001|Overall Study|Adverse Event|2|||
94513128|NCT00560417|323677528|FG000|Overall Study|Entry Criteria Not Met|1|||
94513129|NCT00560417|323677529|FG001|Overall Study|Entry Criteria Not Met|0|||
94513130|NCT00560417|323677528|FG000|Overall Study|Lost to Follow-up|0|||
94513131|NCT00560417|323677529|FG001|Overall Study|Lost to Follow-up|1|||
94513132|NCT00560417|323677528|FG000|Overall Study|Physician Decision|2|||
94513133|NCT00560417|323677529|FG001|Overall Study|Physician Decision|6|||
94513134|NCT00560417|323677528|FG000|Overall Study|Protocol Violation|6|||
94513135|NCT00560417|323677529|FG001|Overall Study|Protocol Violation|5|||
94513136|NCT00560417|323677528|FG000|Overall Study|Sponsor Decision|2|||
94513137|NCT00560417|323677529|FG001|Overall Study|Sponsor Decision|0|||
94513138|NCT00560417|323677528|FG000|Overall Study|Withdrawal by Subject|3|||
94513139|NCT00560417|323677529|FG001|Overall Study|Withdrawal by Subject|3|||
94513140|NCT02259231|323677539|FG000|Overall Study|Adverse Event|1|||
94513141|NCT02259231|323677540|FG001|Overall Study|Adverse Event|1|||
94513142|NCT02259231|323677541|FG002|Overall Study|Adverse Event|2|||
94513143|NCT02259231|323677542|FG003|Overall Study|Adverse Event|0|||
94513144|NCT02259231|323677543|FG004|Overall Study|Adverse Event|0|||
94513145|NCT02259231|323677544|FG005|Overall Study|Adverse Event|0|||
94513146|NCT02259231|323677545|FG006|Overall Study|Adverse Event|0|||
94513147|NCT02259231|323677539|FG000|Overall Study|Progressive Disease|4|||
94513148|NCT02259231|323677540|FG001|Overall Study|Progressive Disease|5|||
94513149|NCT02259231|323677541|FG002|Overall Study|Progressive Disease|4|||
94513150|NCT02259231|323677542|FG003|Overall Study|Progressive Disease|5|||
94513151|NCT02259231|323677543|FG004|Overall Study|Progressive Disease|4|||
94513152|NCT02259231|323677544|FG005|Overall Study|Progressive Disease|5|||
94513153|NCT02259231|323677545|FG006|Overall Study|Progressive Disease|4|||
94513154|NCT02259231|323677539|FG000|Overall Study|Sponsor termination of study|1|||
94513155|NCT02259231|323677540|FG001|Overall Study|Sponsor termination of study|0|||
94513156|NCT02259231|323677541|FG002|Overall Study|Sponsor termination of study|0|||
94513157|NCT02259231|323677542|FG003|Overall Study|Sponsor termination of study|1|||
94513158|NCT02259231|323677543|FG004|Overall Study|Sponsor termination of study|2|||
94513159|NCT02259231|323677544|FG005|Overall Study|Sponsor termination of study|1|||
94513160|NCT02259231|323677545|FG006|Overall Study|Sponsor termination of study|1|||
94513161|NCT02993263|323677550|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
94513162|NCT00404248|323677552|FG000|Overall Study|pts declining status|0|||
94513163|NCT00404248|323677553|FG001|Overall Study|pts declining status|1|||
94513164|NCT00404248|323677554|FG002|Overall Study|pts declining status|0|||
94513165|NCT00404248|323677555|FG003|Overall Study|pts declining status|0|||
94513166|NCT00404248|323677556|FG004|Overall Study|pts declining status|0|||
94513167|NCT00404248|323677557|FG005|Overall Study|pts declining status|0|||
94513168|NCT00404248|323677558|FG006|Overall Study|pts declining status|0|||
94513169|NCT00404248|323677559|FG007|Overall Study|pts declining status|0|||
94513170|NCT00404248|323677560|FG008|Overall Study|pts declining status|0|||
94513171|NCT02038036|323677561|FG000|Core Study|Adverse Event|7|||
94513172|NCT02038036|323677562|FG001|Core Study|Adverse Event|7|||
94513173|NCT02038036|323677561|FG000|Core Study|Death|1|||
94513174|NCT02038036|323677562|FG001|Core Study|Death|1|||
94513175|NCT02038036|323677561|FG000|Core Study|Disease progression|2|||
94513176|NCT02038036|323677562|FG001|Core Study|Disease progression|2|||
94513177|NCT02038036|323677561|FG000|Core Study|Lost to Follow-up|0|||
94513178|NCT02038036|323677562|FG001|Core Study|Lost to Follow-up|1|||
94513179|NCT02038036|323677561|FG000|Core Study|Physician Decision|2|||
94513180|NCT02038036|323677562|FG001|Core Study|Physician Decision|1|||
94513181|NCT02038036|323677561|FG000|Core Study|Subject/guardian decision|0|||
94513182|NCT02038036|323677562|FG001|Core Study|Subject/guardian decision|1|||
94513183|NCT02038036|323677561|FG000|Core Study|Withdrawal by Subject|3|||
94513184|NCT02038036|323677562|FG001|Core Study|Withdrawal by Subject|1|||
94513185|NCT02038036|323677561|FG000|Crossover Period|Withdrawal by Subject|0|||
94513186|NCT02038036|323677562|FG001|Crossover Period|Withdrawal by Subject|3|||
94513187|NCT02038036|323677561|FG000|Crossover Period|Adverse Event|0|||
94513188|NCT02038036|323677562|FG001|Crossover Period|Adverse Event|9|||
94513189|NCT02038036|323677561|FG000|Crossover Period|Death|0|||
94513190|NCT02038036|323677562|FG001|Crossover Period|Death|2|||
94513191|NCT02038036|323677561|FG000|Crossover Period|Disease progression|0|||
94513192|NCT02038036|323677562|FG001|Crossover Period|Disease progression|3|||
94513193|NCT02038036|323677561|FG000|Crossover Period|Lost to Follow-up|0|||
94513194|NCT02038036|323677562|FG001|Crossover Period|Lost to Follow-up|1|||
94513195|NCT02038036|323677561|FG000|Crossover Period|Physician Decision|0|||
94513196|NCT02038036|323677562|FG001|Crossover Period|Physician Decision|2|||
94513197|NCT00545779|323677563|FG000|Overall Study|Violation of selection criteria at entry|8|||
94513198|NCT00545779|323677563|FG000|Overall Study|Other protocol violation|1|||
94513199|NCT00545779|323677563|FG000|Overall Study|Did not cooperate|7|||
94513200|NCT00545779|323677563|FG000|Overall Study|Withdrawal by Subject|20|||
94513201|NCT00545779|323677563|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
94513202|NCT00545779|323677563|FG000|Overall Study|Failure to return|3|||
94513203|NCT01405196|323677564|FG000|Overall Study|Study Terminated by Sponsor|0|||
94513204|NCT01405196|323677565|FG001|Overall Study|Study Terminated by Sponsor|0|||
94513205|NCT01405196|323677566|FG002|Overall Study|Study Terminated by Sponsor|9|||
94513206|NCT01405196|323677567|FG003|Overall Study|Study Terminated by Sponsor|0|||
94513207|NCT01405196|323677564|FG000|Overall Study|Other|2|||
94513208|NCT01405196|323677565|FG001|Overall Study|Other|2|||
94513209|NCT01405196|323677566|FG002|Overall Study|Other|5|||
94513210|NCT01405196|323677567|FG003|Overall Study|Other|0|||
94513211|NCT01405196|323677564|FG000|Overall Study|Withdrawal by Subject|4|||
94513212|NCT01405196|323677565|FG001|Overall Study|Withdrawal by Subject|6|||
94513213|NCT01405196|323677566|FG002|Overall Study|Withdrawal by Subject|3|||
94513214|NCT01405196|323677567|FG003|Overall Study|Withdrawal by Subject|6|||
94513215|NCT01405196|323677564|FG000|Overall Study|Adverse Event|2|||
94513216|NCT01405196|323677565|FG001|Overall Study|Adverse Event|2|||
94513217|NCT01405196|323677566|FG002|Overall Study|Adverse Event|0|||
94513218|NCT01405196|323677567|FG003|Overall Study|Adverse Event|2|||
94513219|NCT01405196|323677564|FG000|Overall Study|Death|1|||
94513220|NCT01405196|323677565|FG001|Overall Study|Death|0|||
94513221|NCT01405196|323677566|FG002|Overall Study|Death|3|||
94513222|NCT01405196|323677567|FG003|Overall Study|Death|0|||
94513223|NCT01405196|323677564|FG000|Overall Study|Lost to Follow-up|2|||
94513224|NCT01405196|323677565|FG001|Overall Study|Lost to Follow-up|2|||
94513225|NCT01405196|323677566|FG002|Overall Study|Lost to Follow-up|3|||
94513226|NCT01405196|323677567|FG003|Overall Study|Lost to Follow-up|1|||
94513227|NCT03612570|323677568|FG000|Overall Study|Lost to Follow-up|1|||
94513228|NCT04704193|323677571|FG000|Overall Study|Withdrawal by Subject|1|||
94513229|NCT05929326|323677575|FG000|Overall Study|unqualified sample|2|||
94513230|NCT05929326|323677576|FG001|Overall Study|unqualified sample|3|||
94513231|NCT05929326|323677577|FG002|Overall Study|unqualified sample|7|||
94513232|NCT04890509|323677578|FG000|Overall Study|Death|4|||
94513233|NCT04890509|323677579|FG001|Overall Study|Death|4|||
94513234|NCT04712669|323677582|FG000|Double Blind Phase|Adverse Event|4|||
94513235|NCT04712669|323677583|FG001|Double Blind Phase|Adverse Event|4|||
94513236|NCT04712669|323677584|FG002|Double Blind Phase|Adverse Event|3|||
94513237|NCT04712669|323677585|FG003|Double Blind Phase|Adverse Event|0|||
94513238|NCT04712669|323677586|FG004|Double Blind Phase|Adverse Event|0|||
94513239|NCT04712669|323677587|FG005|Double Blind Phase|Adverse Event|0|||
94513240|NCT04712669|323677588|FG006|Double Blind Phase|Adverse Event|0|||
94513241|NCT04712669|323677589|FG007|Double Blind Phase|Adverse Event|0|||
94513242|NCT04712669|323677582|FG000|Double Blind Phase|Physician Decision|1|||
94513243|NCT04712669|323677583|FG001|Double Blind Phase|Physician Decision|0|||
94513244|NCT04712669|323677584|FG002|Double Blind Phase|Physician Decision|0|||
94513245|NCT04712669|323677585|FG003|Double Blind Phase|Physician Decision|0|||
94513246|NCT04712669|323677586|FG004|Double Blind Phase|Physician Decision|0|||
94513247|NCT04712669|323677587|FG005|Double Blind Phase|Physician Decision|0|||
94513248|NCT04712669|323677588|FG006|Double Blind Phase|Physician Decision|0|||
94513249|NCT04712669|323677589|FG007|Double Blind Phase|Physician Decision|0|||
94513250|NCT04712669|323677582|FG000|Double Blind Phase|Withdrawal by Subject|3|||
94513251|NCT04712669|323677583|FG001|Double Blind Phase|Withdrawal by Subject|6|||
94513252|NCT04712669|323677584|FG002|Double Blind Phase|Withdrawal by Subject|0|||
94513253|NCT04712669|323677585|FG003|Double Blind Phase|Withdrawal by Subject|0|||
94513254|NCT04712669|323677586|FG004|Double Blind Phase|Withdrawal by Subject|0|||
94513255|NCT04712669|323677587|FG005|Double Blind Phase|Withdrawal by Subject|0|||
94513256|NCT04712669|323677588|FG006|Double Blind Phase|Withdrawal by Subject|0|||
94513257|NCT04712669|323677589|FG007|Double Blind Phase|Withdrawal by Subject|0|||
94513258|NCT04712669|323677582|FG000|Double Blind Phase|Termination by Sponsor|0|||
94513259|NCT04712669|323677583|FG001|Double Blind Phase|Termination by Sponsor|0|||
94513260|NCT04712669|323677584|FG002|Double Blind Phase|Termination by Sponsor|1|||
94513261|NCT04712669|323677585|FG003|Double Blind Phase|Termination by Sponsor|0|||
94513262|NCT04712669|323677586|FG004|Double Blind Phase|Termination by Sponsor|0|||
94513263|NCT04712669|323677587|FG005|Double Blind Phase|Termination by Sponsor|0|||
94513264|NCT04712669|323677588|FG006|Double Blind Phase|Termination by Sponsor|0|||
94513265|NCT04712669|323677589|FG007|Double Blind Phase|Termination by Sponsor|0|||
94513266|NCT04712669|323677582|FG000|Open Label Phase|Adverse Event|0|||
94513267|NCT04712669|323677583|FG001|Open Label Phase|Adverse Event|0|||
94513268|NCT04712669|323677584|FG002|Open Label Phase|Adverse Event|0|||
94513269|NCT04712669|323677585|FG003|Open Label Phase|Adverse Event|1|||
94513270|NCT04712669|323677586|FG004|Open Label Phase|Adverse Event|1|||
94513271|NCT04712669|323677587|FG005|Open Label Phase|Adverse Event|3|||
94513272|NCT04712669|323677588|FG006|Open Label Phase|Adverse Event|1|||
94513273|NCT04712669|323677589|FG007|Open Label Phase|Adverse Event|2|||
94513274|NCT04712669|323677582|FG000|Open Label Phase|Death|0|||
94513275|NCT04712669|323677583|FG001|Open Label Phase|Death|0|||
94513276|NCT04712669|323677584|FG002|Open Label Phase|Death|0|||
94513277|NCT04712669|323677585|FG003|Open Label Phase|Death|1|||
94513278|NCT04712669|323677586|FG004|Open Label Phase|Death|0|||
94513279|NCT04712669|323677587|FG005|Open Label Phase|Death|0|||
94513280|NCT04712669|323677588|FG006|Open Label Phase|Death|0|||
94513281|NCT04712669|323677589|FG007|Open Label Phase|Death|0|||
94513282|NCT04712669|323677582|FG000|Open Label Phase|Lack of Efficacy|0|||
94513283|NCT04712669|323677583|FG001|Open Label Phase|Lack of Efficacy|0|||
94513284|NCT04712669|323677584|FG002|Open Label Phase|Lack of Efficacy|0|||
94513285|NCT04712669|323677585|FG003|Open Label Phase|Lack of Efficacy|0|||
94513286|NCT04712669|323677586|FG004|Open Label Phase|Lack of Efficacy|1|||
94513287|NCT04712669|323677587|FG005|Open Label Phase|Lack of Efficacy|0|||
94513288|NCT04712669|323677588|FG006|Open Label Phase|Lack of Efficacy|0|||
94513289|NCT04712669|323677589|FG007|Open Label Phase|Lack of Efficacy|0|||
94513290|NCT04712669|323677582|FG000|Open Label Phase|Lost to Follow-up|0|||
94513291|NCT04712669|323677583|FG001|Open Label Phase|Lost to Follow-up|0|||
94513292|NCT04712669|323677584|FG002|Open Label Phase|Lost to Follow-up|0|||
94513293|NCT04712669|323677585|FG003|Open Label Phase|Lost to Follow-up|0|||
94513294|NCT04712669|323677586|FG004|Open Label Phase|Lost to Follow-up|0|||
94513295|NCT04712669|323677587|FG005|Open Label Phase|Lost to Follow-up|0|||
94513296|NCT04712669|323677588|FG006|Open Label Phase|Lost to Follow-up|1|||
94513297|NCT04712669|323677589|FG007|Open Label Phase|Lost to Follow-up|1|||
94513298|NCT04712669|323677582|FG000|Open Label Phase|Physician Decision|0|||
94513299|NCT04712669|323677583|FG001|Open Label Phase|Physician Decision|0|||
94513300|NCT04712669|323677584|FG002|Open Label Phase|Physician Decision|0|||
94513301|NCT04712669|323677585|FG003|Open Label Phase|Physician Decision|1|||
94513302|NCT04712669|323677586|FG004|Open Label Phase|Physician Decision|0|||
94513303|NCT04712669|323677587|FG005|Open Label Phase|Physician Decision|0|||
94513304|NCT04712669|323677588|FG006|Open Label Phase|Physician Decision|0|||
94513305|NCT04712669|323677589|FG007|Open Label Phase|Physician Decision|0|||
94513306|NCT04712669|323677582|FG000|Open Label Phase|Withdrawal by Subject|0|||
94513307|NCT04712669|323677583|FG001|Open Label Phase|Withdrawal by Subject|0|||
94513308|NCT04712669|323677584|FG002|Open Label Phase|Withdrawal by Subject|0|||
94513309|NCT04712669|323677585|FG003|Open Label Phase|Withdrawal by Subject|1|||
94513310|NCT04712669|323677586|FG004|Open Label Phase|Withdrawal by Subject|5|||
94513311|NCT04712669|323677587|FG005|Open Label Phase|Withdrawal by Subject|5|||
94513312|NCT04712669|323677588|FG006|Open Label Phase|Withdrawal by Subject|0|||
94513313|NCT04712669|323677589|FG007|Open Label Phase|Withdrawal by Subject|4|||
94513314|NCT04712669|323677582|FG000|Open Label Phase|Termination by Sponsor|0|||
94513315|NCT04712669|323677583|FG001|Open Label Phase|Termination by Sponsor|0|||
94513316|NCT04712669|323677584|FG002|Open Label Phase|Termination by Sponsor|0|||
94513317|NCT04712669|323677585|FG003|Open Label Phase|Termination by Sponsor|11|||
94513318|NCT04712669|323677586|FG004|Open Label Phase|Termination by Sponsor|9|||
94513319|NCT04712669|323677587|FG005|Open Label Phase|Termination by Sponsor|14|||
94513320|NCT04712669|323677588|FG006|Open Label Phase|Termination by Sponsor|0|||
94513321|NCT04712669|323677589|FG007|Open Label Phase|Termination by Sponsor|14|||
94513322|NCT03802396|323677590|FG000|Overall Study|Withdrawal by Subject|2|||
94513323|NCT03802396|323677591|FG001|Overall Study|Withdrawal by Subject|0|||
94513324|NCT03802396|323677590|FG000|Overall Study|Surgery Cancelled|1|||
94513325|NCT03802396|323677591|FG001|Overall Study|Surgery Cancelled|0|||
94513326|NCT01346176|323677592|FG000|Recruited|Protocol Violation|1|||
94513327|NCT01346176|323677593|FG001|Recruited|Protocol Violation|0|||
94513328|NCT01346176|323677594|FG002|Recruited|Protocol Violation|0|||
94513329|NCT01346176|323677592|FG000|Completed Advance Directive|Death|3|||
94513330|NCT01346176|323677593|FG001|Completed Advance Directive|Death|2|||
94513331|NCT01346176|323677594|FG002|Completed Advance Directive|Death|2|||
94513332|NCT01346176|323677592|FG000|Completed Advance Directive|Became Ineligible|3|||
94513333|NCT01346176|323677593|FG001|Completed Advance Directive|Became Ineligible|0|||
94513334|NCT01346176|323677594|FG002|Completed Advance Directive|Became Ineligible|1|||
94513335|NCT01346176|323677592|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
94513336|NCT01346176|323677593|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
94513337|NCT01346176|323677594|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
94513338|NCT01346176|323677592|FG000|Completed Satisfaction Survey|Death|3|||
94513339|NCT01346176|323677593|FG001|Completed Satisfaction Survey|Death|0|||
94513340|NCT01346176|323677594|FG002|Completed Satisfaction Survey|Death|2|||
94513341|NCT01346176|323677592|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
94513342|NCT01346176|323677593|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
94513343|NCT01346176|323677594|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
94513344|NCT01994876|323677595|FG000|Test Period 1|Withdrawal by Subject|0|||
94513345|NCT01994876|323677596|FG001|Test Period 1|Withdrawal by Subject|1|||
94513346|NCT01994876|323677595|FG000|Test Period 1|Adverse Event|0|||
94513347|NCT01994876|323677596|FG001|Test Period 1|Adverse Event|1|||
94513348|NCT01994876|323677595|FG000|Test Period 2|Adverse Event|1|||
94513349|NCT01994876|323677596|FG001|Test Period 2|Adverse Event|0|||
94513350|NCT01994876|323677595|FG000|Test Period 2|Protocol Violation|0|||
94513351|NCT01994876|323677596|FG001|Test Period 2|Protocol Violation|1|||
94513352|NCT03468998|323679159|FG000|Overall Study|Withdrawal by Subject|1|||
94513353|NCT03468998|323679160|FG001|Overall Study|Withdrawal by Subject|1|||
94513354|NCT03468998|323679161|FG002|Overall Study|Withdrawal by Subject|0|||
94513355|NCT03468998|323679162|FG003|Overall Study|Withdrawal by Subject|4|||
94513356|NCT03468998|323679163|FG004|Overall Study|Withdrawal by Subject|1|||
94513357|NCT03468998|323679164|FG005|Overall Study|Withdrawal by Subject|0|||
94513358|NCT01432444|323679172|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
94513359|NCT01432444|323679173|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
94513360|NCT01432444|323679174|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
94513361|NCT01432444|323679172|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
94513362|NCT01432444|323679173|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
94513363|NCT01432444|323679174|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
94513364|NCT01432444|323679172|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
94513365|NCT01432444|323679173|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
94513366|NCT01432444|323679174|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
94513367|NCT01432444|323679172|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
94513368|NCT01432444|323679173|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
94513369|NCT01432444|323679174|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
94513370|NCT01432444|323679172|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
94513371|NCT01432444|323679173|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
94513372|NCT01432444|323679174|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
94513373|NCT01432444|323679172|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
94513374|NCT01432444|323679173|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
94513375|NCT01432444|323679174|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
94513376|NCT01432444|323679172|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
94513377|NCT01432444|323679173|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
94513378|NCT01432444|323679174|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
94513379|NCT01432444|323679172|FG000|Treatment Phase|Lost to Follow-up|0|||
94513380|NCT01432444|323679173|FG001|Treatment Phase|Lost to Follow-up|33|||
94513381|NCT01432444|323679174|FG002|Treatment Phase|Lost to Follow-up|0|||
94513382|NCT01432444|323679172|FG000|Treatment Phase|Adverse Event|0|||
94513383|NCT01432444|323679173|FG001|Treatment Phase|Adverse Event|37|||
94513384|NCT01432444|323679174|FG002|Treatment Phase|Adverse Event|0|||
94513385|NCT01432444|323679172|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
94513386|NCT01432444|323679173|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
94513387|NCT01432444|323679174|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
94513388|NCT01432444|323679172|FG000|Treatment Phase|Physician Decision|0|||
94513389|NCT01432444|323679173|FG001|Treatment Phase|Physician Decision|5|||
94513390|NCT01432444|323679174|FG002|Treatment Phase|Physician Decision|0|||
94513391|NCT01432444|323679172|FG000|Treatment Phase|Withdrawal by Subject|0|||
94513392|NCT01432444|323679173|FG001|Treatment Phase|Withdrawal by Subject|41|||
94513393|NCT01432444|323679174|FG002|Treatment Phase|Withdrawal by Subject|0|||
94513394|NCT01432444|323679172|FG000|Treatment Phase|Protocol Deviation|0|||
94513395|NCT01432444|323679173|FG001|Treatment Phase|Protocol Deviation|3|||
94513396|NCT01432444|323679174|FG002|Treatment Phase|Protocol Deviation|0|||
94513397|NCT01432444|323679172|FG000|Treatment Phase|Lack of Efficacy|0|||
94513398|NCT01432444|323679173|FG001|Treatment Phase|Lack of Efficacy|10|||
94513399|NCT01432444|323679174|FG002|Treatment Phase|Lack of Efficacy|0|||
94513400|NCT01432444|323679172|FG000|Extension Phase|Lost to Follow-up|0|||
94513401|NCT01432444|323679173|FG001|Extension Phase|Lost to Follow-up|0|||
94513402|NCT01432444|323679174|FG002|Extension Phase|Lost to Follow-up|17|||
94513403|NCT01432444|323679172|FG000|Extension Phase|Adverse Event|0|||
94513404|NCT01432444|323679173|FG001|Extension Phase|Adverse Event|0|||
94513405|NCT01432444|323679174|FG002|Extension Phase|Adverse Event|10|||
94513406|NCT01432444|323679172|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
94513407|NCT01432444|323679173|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
94513408|NCT01432444|323679174|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
94513409|NCT01432444|323679172|FG000|Extension Phase|Met Withdrawal Criteria|0|||
94513410|NCT01432444|323679173|FG001|Extension Phase|Met Withdrawal Criteria|0|||
94513411|NCT01432444|323679174|FG002|Extension Phase|Met Withdrawal Criteria|144|||
94513412|NCT01432444|323679172|FG000|Extension Phase|Physician Decision|0|||
94513413|NCT01432444|323679173|FG001|Extension Phase|Physician Decision|0|||
94513414|NCT01432444|323679174|FG002|Extension Phase|Physician Decision|1|||
94513415|NCT01432444|323679172|FG000|Extension Phase|Withdrawal by Subject|0|||
94513416|NCT01432444|323679173|FG001|Extension Phase|Withdrawal by Subject|0|||
94513417|NCT01432444|323679174|FG002|Extension Phase|Withdrawal by Subject|13|||
94513418|NCT02538614|323679175|FG000|Overall Study|Progressive Disease|2|||
94513419|NCT00565747|323679177|FG000|Overall Study|No embryo transfer|67|||
94513420|NCT00565747|323679178|FG001|Overall Study|No embryo transfer|73|||
94513421|NCT03309202|323679179|FG000|Overall Study|Lost to Follow-up|1|||
94513422|NCT03309202|323679180|FG001|Overall Study|Lost to Follow-up|0|||
94513423|NCT03309202|323679181|FG002|Overall Study|Lost to Follow-up|0|||
94513424|NCT03309202|323679182|FG003|Overall Study|Lost to Follow-up|0|||
94513425|NCT00415636|323679183|FG000|Overall Study|Symptomatic deterioration|1|||
94513426|NCT00415636|323679184|FG001|Overall Study|Symptomatic deterioration|0|||
94513427|NCT00415636|323679185|FG002|Overall Study|Symptomatic deterioration|1|||
94513428|NCT00415636|323679186|FG003|Overall Study|Symptomatic deterioration|2|||
94513429|NCT00415636|323679187|FG004|Overall Study|Symptomatic deterioration|0|||
94513430|NCT00415636|323679188|FG005|Overall Study|Symptomatic deterioration|1|||
94513431|NCT00415636|323679183|FG000|Overall Study|Adverse Event|0|||
94513432|NCT00415636|323679184|FG001|Overall Study|Adverse Event|0|||
94513433|NCT00415636|323679185|FG002|Overall Study|Adverse Event|0|||
94513434|NCT00415636|323679186|FG003|Overall Study|Adverse Event|1|||
94513435|NCT00415636|323679187|FG004|Overall Study|Adverse Event|1|||
94513436|NCT00415636|323679188|FG005|Overall Study|Adverse Event|0|||
94513437|NCT00415636|323679183|FG000|Overall Study|Withdrawal by Subject|0|||
94513438|NCT00415636|323679184|FG001|Overall Study|Withdrawal by Subject|0|||
94513439|NCT00415636|323679185|FG002|Overall Study|Withdrawal by Subject|0|||
94513440|NCT00415636|323679186|FG003|Overall Study|Withdrawal by Subject|0|||
94513441|NCT00415636|323679187|FG004|Overall Study|Withdrawal by Subject|1|||
94513442|NCT00415636|323679188|FG005|Overall Study|Withdrawal by Subject|0|||
94513443|NCT00415636|323679183|FG000|Overall Study|Disease progression|0|||
94513444|NCT00415636|323679184|FG001|Overall Study|Disease progression|0|||
94513445|NCT00415636|323679185|FG002|Overall Study|Disease progression|0|||
94513446|NCT00415636|323679186|FG003|Overall Study|Disease progression|3|||
94513447|NCT00415636|323679187|FG004|Overall Study|Disease progression|0|||
94513448|NCT00415636|323679188|FG005|Overall Study|Disease progression|1|||
94513449|NCT04507204|323679189|FG000|Overall Study|Adverse Event|8|||
94513450|NCT04507204|323679190|FG001|Overall Study|Adverse Event|13|||
94513451|NCT04507204|323679189|FG000|Overall Study|Death|0|||
94513452|NCT04507204|323679190|FG001|Overall Study|Death|1|||
94513453|NCT04507204|323679189|FG000|Overall Study|Lost to Follow-up|15|||
94513454|NCT04507204|323679190|FG001|Overall Study|Lost to Follow-up|14|||
94513455|NCT04507204|323679189|FG000|Overall Study|Poor Compliance with Protocol|2|||
94513456|NCT04507204|323679190|FG001|Overall Study|Poor Compliance with Protocol|4|||
94513457|NCT04507204|323679189|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
94513458|NCT04507204|323679190|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
94513459|NCT04507204|323679189|FG000|Overall Study|Withdrawal of Patient Consent|21|||
94513460|NCT04507204|323679190|FG001|Overall Study|Withdrawal of Patient Consent|13|||
94513461|NCT00831389|323679191|FG000|Overall Study|Withdrawal by Subject|0|||
94513462|NCT00831389|323679192|FG001|Overall Study|Withdrawal by Subject|1|||
94513463|NCT03983421|323679194|FG000|Overall Study|Lost to Follow-up|1|||
94513464|NCT05067335|323679197|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
94513465|NCT05067335|323679198|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
94513466|NCT05067335|323679199|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
94513467|NCT05067335|323679200|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
94513468|NCT05067335|323679197|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
94513469|NCT05067335|323679198|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
94513470|NCT05067335|323679199|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
94513471|NCT05067335|323679200|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
94513472|NCT05067335|323679197|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
94513473|NCT05067335|323679198|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
94513474|NCT05067335|323679199|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
94513475|NCT05067335|323679200|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
94513476|NCT05067335|323679197|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
94513477|NCT05067335|323679198|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
94513478|NCT05067335|323679199|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
94513479|NCT05067335|323679200|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
94513480|NCT05067335|323679197|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
94513481|NCT05067335|323679198|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
94513482|NCT05067335|323679199|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
94513483|NCT05067335|323679200|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
94513484|NCT05067335|323679197|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
94513485|NCT05067335|323679198|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
94513486|NCT05067335|323679199|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
94513487|NCT05067335|323679200|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
94513488|NCT05067335|323679197|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
94513489|NCT05067335|323679198|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
94513490|NCT05067335|323679199|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
94513491|NCT05067335|323679200|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
94513492|NCT05067335|323679197|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
94513493|NCT05067335|323679198|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
94513494|NCT05067335|323679199|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
94513495|NCT05067335|323679200|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
94513496|NCT05067335|323679197|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
94513497|NCT05067335|323679198|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
94513498|NCT05067335|323679199|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
94513499|NCT05067335|323679200|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
94513500|NCT05067335|323679197|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
94513501|NCT05067335|323679198|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
94513502|NCT05067335|323679199|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
94513503|NCT05067335|323679200|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
94513504|NCT01155050|323679201|FG000|Overall Study|Lost to Follow-up|15|||
94513505|NCT01155050|323679202|FG001|Overall Study|Lost to Follow-up|20|||
94513506|NCT01155050|323679203|FG002|Overall Study|Lost to Follow-up|19|||
94513507|NCT01155050|323679204|FG003|Overall Study|Lost to Follow-up|22|||
94513508|NCT00553254|323679205|FG000|Overall Study|Death|3|||
94513509|NCT00553254|323679206|FG001|Overall Study|Death|6|||
94513510|NCT00553254|323679207|FG002|Overall Study|Death|25|||
94513511|NCT00553254|323679205|FG000|Overall Study|Lost to Follow-up|0|||
94513512|NCT00553254|323679206|FG001|Overall Study|Lost to Follow-up|0|||
94513513|NCT00553254|323679207|FG002|Overall Study|Lost to Follow-up|2|||
94513514|NCT00553254|323679205|FG000|Overall Study|Withdrawal by Subject|2|||
94513515|NCT00553254|323679206|FG001|Overall Study|Withdrawal by Subject|0|||
94513516|NCT00553254|323679207|FG002|Overall Study|Withdrawal by Subject|2|||
94513517|NCT00553254|323679205|FG000|Overall Study|Study terminated by Sponsor|0|||
94513518|NCT00553254|323679206|FG001|Overall Study|Study terminated by Sponsor|0|||
94513519|NCT00553254|323679207|FG002|Overall Study|Study terminated by Sponsor|1|||
94513520|NCT00553254|323679205|FG000|Overall Study|Other|1|||
94513521|NCT00553254|323679206|FG001|Overall Study|Other|0|||
94513522|NCT00553254|323679207|FG002|Overall Study|Other|13|||
94513523|NCT02735200|323679210|FG000|Overall Study|Lost to Follow-up|0|||
94513524|NCT02735200|323679211|FG001|Overall Study|Lost to Follow-up|5|||
94513525|NCT02735200|323679210|FG000|Overall Study|Withdrawal by Subject|8|||
94513526|NCT02735200|323679211|FG001|Overall Study|Withdrawal by Subject|0|||
94513527|NCT04856527|323679212|FG000|Overall Study|Unable to complete experimental task|2|||
94513528|NCT04856527|323679213|FG001|Overall Study|Unable to complete experimental task|0|||
94513529|NCT01076010|323679214|FG000|Overall Study|Death|15|||
94513530|NCT01076010|323679215|FG001|Overall Study|Death|1|||
94513531|NCT01076010|323679216|FG002|Overall Study|Death|0|||
94513532|NCT01076010|323679214|FG000|Overall Study|Adverse Event|7|||
94513533|NCT01076010|323679215|FG001|Overall Study|Adverse Event|2|||
94513534|NCT01076010|323679216|FG002|Overall Study|Adverse Event|0|||
94513535|NCT01076010|323679214|FG000|Overall Study|Progressive disease|90|||
94513536|NCT01076010|323679215|FG001|Overall Study|Progressive disease|30|||
94513537|NCT01076010|323679216|FG002|Overall Study|Progressive disease|1|||
94513538|NCT01076010|323679214|FG000|Overall Study|Lack of Efficacy|4|||
94513539|NCT01076010|323679215|FG001|Overall Study|Lack of Efficacy|0|||
94513540|NCT01076010|323679216|FG002|Overall Study|Lack of Efficacy|0|||
94513541|NCT01076010|323679214|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
94513542|NCT01076010|323679215|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
94513543|NCT01076010|323679216|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
94513544|NCT01076010|323679214|FG000|Overall Study|Significant Surgical Procedure|0|||
94513545|NCT01076010|323679215|FG001|Overall Study|Significant Surgical Procedure|1|||
94513546|NCT01076010|323679216|FG002|Overall Study|Significant Surgical Procedure|0|||
94513547|NCT01076010|323679214|FG000|Overall Study|Protocol Violation|0|||
94513548|NCT01076010|323679215|FG001|Overall Study|Protocol Violation|1|||
94513549|NCT01076010|323679216|FG002|Overall Study|Protocol Violation|0|||
94513550|NCT01076010|323679214|FG000|Overall Study|Noncompliance|1|||
94513551|NCT01076010|323679215|FG001|Overall Study|Noncompliance|1|||
94513552|NCT01076010|323679216|FG002|Overall Study|Noncompliance|0|||
94513553|NCT01076010|323679214|FG000|Overall Study|Withdrawal by Subject|3|||
94513554|NCT01076010|323679215|FG001|Overall Study|Withdrawal by Subject|0|||
94513555|NCT01076010|323679216|FG002|Overall Study|Withdrawal by Subject|1|||
94513556|NCT01076010|323679214|FG000|Overall Study|Other|5|||
94513557|NCT01076010|323679215|FG001|Overall Study|Other|2|||
94513558|NCT01076010|323679216|FG002|Overall Study|Other|0|||
94513559|NCT03895372|323679218|FG000|Investigational Treatment Period|Adverse Event|1|||
94513560|NCT03895372|323679219|FG001|Investigational Treatment Period|Adverse Event|0|||
94513561|NCT03895372|323679220|FG002|Investigational Treatment Period|Adverse Event|0|||
94513562|NCT03895372|323679221|FG003|Investigational Treatment Period|Adverse Event|0|||
94513563|NCT03895372|323679222|FG004|Investigational Treatment Period|Adverse Event|0|||
94513564|NCT03895372|323679223|FG005|Investigational Treatment Period|Adverse Event|0|||
94513565|NCT03895372|323679224|FG006|Investigational Treatment Period|Adverse Event|4|||
94513566|NCT03895372|323679225|FG007|Investigational Treatment Period|Adverse Event|3|||
94513567|NCT03895372|323679218|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
94513568|NCT03895372|323679219|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
94513569|NCT03895372|323679220|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
94513570|NCT03895372|323679221|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
94513571|NCT03895372|323679222|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
94513572|NCT03895372|323679223|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
94513573|NCT03895372|323679224|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
94513574|NCT03895372|323679225|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
94513575|NCT03895372|323679218|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
94513576|NCT03895372|323679219|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
94513577|NCT03895372|323679220|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
94513578|NCT03895372|323679221|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
94513579|NCT03895372|323679222|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
94513580|NCT03895372|323679223|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
94513581|NCT03895372|323679224|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
94513582|NCT03895372|323679225|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
94513583|NCT03895372|323679218|FG000|Investigational Treatment Period|Other|0|||
94513584|NCT03895372|323679219|FG001|Investigational Treatment Period|Other|0|||
94513585|NCT03895372|323679220|FG002|Investigational Treatment Period|Other|0|||
94513586|NCT03895372|323679221|FG003|Investigational Treatment Period|Other|0|||
94513587|NCT03895372|323679222|FG004|Investigational Treatment Period|Other|0|||
94513588|NCT03895372|323679223|FG005|Investigational Treatment Period|Other|1|||
94513589|NCT03895372|323679224|FG006|Investigational Treatment Period|Other|0|||
94513590|NCT03895372|323679225|FG007|Investigational Treatment Period|Other|2|||
94513591|NCT03895372|323679218|FG000|Investigational Treatment Period|Protocol Violation|0|||
94513592|NCT03895372|323679219|FG001|Investigational Treatment Period|Protocol Violation|0|||
94513593|NCT03895372|323679220|FG002|Investigational Treatment Period|Protocol Violation|0|||
94513594|NCT03895372|323679221|FG003|Investigational Treatment Period|Protocol Violation|1|||
94513595|NCT03895372|323679222|FG004|Investigational Treatment Period|Protocol Violation|0|||
94513596|NCT03895372|323679223|FG005|Investigational Treatment Period|Protocol Violation|0|||
94513597|NCT03895372|323679224|FG006|Investigational Treatment Period|Protocol Violation|0|||
94513598|NCT03895372|323679225|FG007|Investigational Treatment Period|Protocol Violation|0|||
94513599|NCT03895372|323679218|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
94513600|NCT03895372|323679219|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
94513601|NCT03895372|323679220|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
94513602|NCT03895372|323679221|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
94513603|NCT03895372|323679222|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
94513604|NCT03895372|323679223|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
94513605|NCT03895372|323679224|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
94513606|NCT03895372|323679225|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
94513607|NCT03895372|323679218|FG000|Extension Treatment Period|Adverse Event|0|||
94513608|NCT03895372|323679219|FG001|Extension Treatment Period|Adverse Event|1|||
94513609|NCT03895372|323679220|FG002|Extension Treatment Period|Adverse Event|0|||
94513610|NCT03895372|323679221|FG003|Extension Treatment Period|Adverse Event|1|||
94513611|NCT03895372|323679222|FG004|Extension Treatment Period|Adverse Event|0|||
94513612|NCT03895372|323679223|FG005|Extension Treatment Period|Adverse Event|0|||
94513613|NCT03895372|323679224|FG006|Extension Treatment Period|Adverse Event|3|||
94513614|NCT03895372|323679225|FG007|Extension Treatment Period|Adverse Event|3|||
94513615|NCT03895372|323679218|FG000|Extension Treatment Period|Other|1|||
94513616|NCT03895372|323679219|FG001|Extension Treatment Period|Other|3|||
94513617|NCT03895372|323679220|FG002|Extension Treatment Period|Other|0|||
94513618|NCT03895372|323679221|FG003|Extension Treatment Period|Other|0|||
94513619|NCT03895372|323679222|FG004|Extension Treatment Period|Other|1|||
94513620|NCT03895372|323679223|FG005|Extension Treatment Period|Other|0|||
94513621|NCT03895372|323679224|FG006|Extension Treatment Period|Other|0|||
94513622|NCT03895372|323679225|FG007|Extension Treatment Period|Other|2|||
94513623|NCT03895372|323679218|FG000|Extension Treatment Period|Pregnancy|0|||
94513624|NCT03895372|323679219|FG001|Extension Treatment Period|Pregnancy|0|||
94513625|NCT03895372|323679220|FG002|Extension Treatment Period|Pregnancy|0|||
94513626|NCT03895372|323679221|FG003|Extension Treatment Period|Pregnancy|0|||
94513627|NCT03895372|323679222|FG004|Extension Treatment Period|Pregnancy|1|||
94513628|NCT03895372|323679223|FG005|Extension Treatment Period|Pregnancy|0|||
94513629|NCT03895372|323679224|FG006|Extension Treatment Period|Pregnancy|0|||
94513630|NCT03895372|323679225|FG007|Extension Treatment Period|Pregnancy|0|||
94513631|NCT03895372|323679218|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
94513632|NCT03895372|323679219|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
94513633|NCT03895372|323679220|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
94513634|NCT03895372|323679221|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
94513635|NCT03895372|323679222|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
94513636|NCT03895372|323679223|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
94513637|NCT03895372|323679224|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
94513638|NCT03895372|323679225|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
94513639|NCT03093415|323679226|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
94513640|NCT03093415|323679227|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
94513641|NCT03093415|323679228|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
94513642|NCT03093415|323679226|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
94513643|NCT03093415|323679227|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
94513644|NCT03093415|323679228|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
94513645|NCT03093415|323679226|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
94513646|NCT03093415|323679227|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
94513647|NCT03093415|323679228|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
94513648|NCT03093415|323679226|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
94513649|NCT03093415|323679227|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
94513650|NCT03093415|323679228|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
94513651|NCT03093415|323679226|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
94513652|NCT03093415|323679227|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
94513653|NCT03093415|323679228|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
94513654|NCT03093415|323679226|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
94513655|NCT03093415|323679227|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
94513656|NCT03093415|323679228|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
94513657|NCT03093415|323679226|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
94513658|NCT03093415|323679227|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
94513659|NCT03093415|323679228|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
94513660|NCT03093415|323679226|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
94513661|NCT03093415|323679227|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
94513662|NCT03093415|323679228|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
94513663|NCT03093415|323679226|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
94513664|NCT03093415|323679227|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
94513665|NCT03093415|323679228|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
94513666|NCT03093415|323679226|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
94513667|NCT03093415|323679227|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
94513668|NCT03093415|323679228|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
94513669|NCT03093415|323679226|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
94513670|NCT03093415|323679227|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
94513671|NCT03093415|323679228|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
94513672|NCT01646827|323679231|FG000|Overall Study|Lost to Follow-up|0|||
94513673|NCT01646827|323679232|FG001|Overall Study|Lost to Follow-up|3|||
94513674|NCT01646827|323679231|FG000|Overall Study|Physician Decision|1|||
94513675|NCT01646827|323679232|FG001|Overall Study|Physician Decision|2|||
94513676|NCT01646827|323679231|FG000|Overall Study|Withdrawal by Subject|1|||
94513677|NCT01646827|323679232|FG001|Overall Study|Withdrawal by Subject|0|||
94513678|NCT02303262|323679233|FG000|Overall Study|Withdrawal by Subject|2|||
94513679|NCT02958865|323679234|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
94513680|NCT02958865|323679235|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
94513681|NCT02958865|323679236|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
94513682|NCT02958865|323679237|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
94513683|NCT02958865|323679238|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
94513684|NCT02958865|323679239|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
94513685|NCT02958865|323679240|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
94513686|NCT02958865|323679241|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
94513687|NCT02958865|323679242|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
94513688|NCT02958865|323679243|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
94513689|NCT02958865|323679244|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
94513690|NCT02958865|323679245|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
94513691|NCT02958865|323679246|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
94513692|NCT02958865|323679247|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
94513693|NCT02958865|323679248|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
94513694|NCT02958865|323679249|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
94513695|NCT02958865|323679234|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
94513696|NCT02958865|323679235|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
94513697|NCT02958865|323679236|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
94513698|NCT02958865|323679237|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
94513699|NCT02958865|323679238|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
94513700|NCT02958865|323679239|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
94513701|NCT02958865|323679240|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
94513702|NCT02958865|323679241|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
94513703|NCT02958865|323679242|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
94513704|NCT02958865|323679243|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
94513705|NCT02958865|323679244|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
94513706|NCT02958865|323679245|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
94513707|NCT02958865|323679246|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
94513708|NCT02958865|323679247|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
94513709|NCT02958865|323679248|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
94513710|NCT02958865|323679249|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
94513711|NCT02958865|323679234|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
94513712|NCT02958865|323679235|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
94513713|NCT02958865|323679236|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
94513714|NCT02958865|323679237|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
94513715|NCT02958865|323679238|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
94513716|NCT02958865|323679239|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
94513717|NCT02958865|323679240|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
94513718|NCT02958865|323679241|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
94513719|NCT02958865|323679242|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
94513720|NCT02958865|323679243|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
94513721|NCT02958865|323679244|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
94513722|NCT02958865|323679245|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
94513723|NCT02958865|323679246|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
94513724|NCT02958865|323679247|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
94513725|NCT02958865|323679248|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
94513726|NCT02958865|323679249|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
94513727|NCT02958865|323679234|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
94655634|NCT01312467|324196107|FG000|Overall Study|Another medical condition|1|||
94655635|NCT01312467|324196107|FG000|Overall Study|Ineligible|4|||
94513728|NCT02958865|323679235|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94513729|NCT02958865|323679236|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
94513730|NCT02958865|323679237|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
94513731|NCT02958865|323679238|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
94513732|NCT02958865|323679239|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
94513733|NCT02958865|323679240|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
94513734|NCT02958865|323679241|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94513735|NCT02958865|323679242|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94513736|NCT02958865|323679243|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94513737|NCT02958865|323679244|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94513738|NCT02958865|323679245|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94513739|NCT02958865|323679246|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94513740|NCT02958865|323679247|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94513741|NCT02958865|323679248|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94513742|NCT02958865|323679249|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94513743|NCT02958865|323679234|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
94513744|NCT02958865|323679235|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
94513745|NCT02958865|323679236|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
94513746|NCT02958865|323679237|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
94513747|NCT02958865|323679238|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
94513748|NCT02958865|323679239|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
94513749|NCT02958865|323679240|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
94513750|NCT02958865|323679241|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
94513751|NCT02958865|323679242|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
94513752|NCT02958865|323679243|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
94513753|NCT02958865|323679244|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
94513754|NCT02958865|323679245|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
94513755|NCT02958865|323679246|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
94513756|NCT02958865|323679247|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
94513757|NCT02958865|323679248|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
94513758|NCT02958865|323679249|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
94513759|NCT02958865|323679234|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
94513760|NCT02958865|323679235|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
94513761|NCT02958865|323679236|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
94513762|NCT02958865|323679237|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
94513763|NCT02958865|323679238|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
94513764|NCT02958865|323679239|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
94513765|NCT02958865|323679240|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
94513766|NCT02958865|323679241|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
94513767|NCT02958865|323679242|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
94513768|NCT02958865|323679243|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
94513769|NCT02958865|323679244|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
94513770|NCT02958865|323679245|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
94513771|NCT02958865|323679246|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
94513772|NCT02958865|323679247|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
94513773|NCT02958865|323679248|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
94513774|NCT02958865|323679249|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
94513775|NCT02958865|323679234|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
94513776|NCT02958865|323679235|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
94513777|NCT02958865|323679236|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
94513778|NCT02958865|323679237|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94513779|NCT02958865|323679238|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94513780|NCT02958865|323679239|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94513781|NCT02958865|323679240|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94513782|NCT02958865|323679241|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94513783|NCT02958865|323679242|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94513784|NCT02958865|323679243|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94655636|NCT00061048|324196108|FG000|Overall Study|Adverse Event|2|||
94655637|NCT00061048|324196108|FG000|Overall Study|disease progression|20|||
94513785|NCT02958865|323679244|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94513786|NCT02958865|323679245|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94513787|NCT02958865|323679246|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94513788|NCT02958865|323679247|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94513789|NCT02958865|323679248|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94513790|NCT02958865|323679249|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94513791|NCT02958865|323679234|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
94513792|NCT02958865|323679235|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
94513793|NCT02958865|323679236|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
94513794|NCT02958865|323679237|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
94513795|NCT02958865|323679238|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
94513796|NCT02958865|323679239|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
94513797|NCT02958865|323679240|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
94513798|NCT02958865|323679241|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
94513799|NCT02958865|323679242|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
94513800|NCT02958865|323679243|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
94513801|NCT02958865|323679244|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
94513802|NCT02958865|323679245|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
94513803|NCT02958865|323679246|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
94513804|NCT02958865|323679247|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
94513805|NCT02958865|323679248|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
94513806|NCT02958865|323679249|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
94513807|NCT02958865|323679234|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94513808|NCT02958865|323679235|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94513809|NCT02958865|323679236|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94513810|NCT02958865|323679237|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94513811|NCT02958865|323679238|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
94513812|NCT02958865|323679239|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94513813|NCT02958865|323679240|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94513814|NCT02958865|323679241|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94513815|NCT02958865|323679242|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94513816|NCT02958865|323679243|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94513817|NCT02958865|323679244|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94513818|NCT02958865|323679245|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94513819|NCT02958865|323679246|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94513820|NCT02958865|323679247|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94513821|NCT02958865|323679248|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94513822|NCT02958865|323679249|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94513823|NCT02958865|323679234|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
94513824|NCT02958865|323679235|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
94513825|NCT02958865|323679236|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
94513826|NCT02958865|323679237|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
94513827|NCT02958865|323679238|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
94513828|NCT02958865|323679239|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
94513829|NCT02958865|323679240|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
94513830|NCT02958865|323679241|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
94513831|NCT02958865|323679242|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
94513832|NCT02958865|323679243|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
94513833|NCT02958865|323679244|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
94513834|NCT02958865|323679245|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
94513835|NCT02958865|323679246|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
94513836|NCT02958865|323679247|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
94513837|NCT02958865|323679248|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
94513838|NCT02958865|323679249|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
94513839|NCT02958865|323679234|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
94513840|NCT02958865|323679235|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
94513841|NCT02958865|323679236|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
94513842|NCT02958865|323679237|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
94513843|NCT02958865|323679238|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
94513844|NCT02958865|323679239|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
94513845|NCT02958865|323679240|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
94513846|NCT02958865|323679241|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
94513847|NCT02958865|323679242|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
94513848|NCT02958865|323679243|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
94513849|NCT02958865|323679244|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
94513850|NCT02958865|323679245|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
94513851|NCT02958865|323679246|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
94513852|NCT02958865|323679247|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
94655638|NCT01632579|324196110|FG000|Washout Period|Adverse Event|1|||
94513853|NCT02958865|323679248|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
94513854|NCT02958865|323679249|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
94513855|NCT02958865|323679234|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
94513856|NCT02958865|323679235|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
94513857|NCT02958865|323679236|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
94513858|NCT02958865|323679237|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
94513859|NCT02958865|323679238|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
94513860|NCT02958865|323679239|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
94513861|NCT02958865|323679240|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
94513862|NCT02958865|323679241|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
94513863|NCT02958865|323679242|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
94513864|NCT02958865|323679243|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
94513865|NCT02958865|323679244|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
94513866|NCT02958865|323679245|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
94513867|NCT02958865|323679246|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
94513868|NCT02958865|323679247|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
94513869|NCT02958865|323679248|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
94513870|NCT02958865|323679249|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
94513871|NCT02958865|323679234|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
94513872|NCT02958865|323679235|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
94513873|NCT02958865|323679236|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
94513874|NCT02958865|323679237|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
94513875|NCT02958865|323679238|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
94513876|NCT02958865|323679239|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
94513877|NCT02958865|323679240|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
94513878|NCT02958865|323679241|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
94513879|NCT02958865|323679242|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
94513880|NCT02958865|323679243|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
94513881|NCT02958865|323679244|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
94513882|NCT02958865|323679245|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
94513883|NCT02958865|323679246|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
94513884|NCT02958865|323679247|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
94513885|NCT02958865|323679248|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
94513886|NCT02958865|323679249|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
94513887|NCT02958865|323679234|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
94513888|NCT02958865|323679235|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
94513889|NCT02958865|323679236|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
94513890|NCT02958865|323679237|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
94513891|NCT02958865|323679238|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
94513892|NCT02958865|323679239|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
94513893|NCT02958865|323679240|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
94513894|NCT02958865|323679241|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
94513895|NCT02958865|323679242|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
94513896|NCT02958865|323679243|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
94513897|NCT02958865|323679244|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
94513898|NCT02958865|323679245|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
94513899|NCT02958865|323679246|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
94513900|NCT02958865|323679247|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
94513901|NCT02958865|323679248|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
94513902|NCT02958865|323679249|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
94513903|NCT02958865|323679234|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
94513904|NCT02958865|323679235|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
94513905|NCT02958865|323679236|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
94513906|NCT02958865|323679237|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
94513907|NCT02958865|323679238|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
94513908|NCT02958865|323679239|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
94513909|NCT02958865|323679240|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
94513910|NCT02958865|323679241|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
94513911|NCT02958865|323679242|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
94513912|NCT02958865|323679243|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
94513913|NCT02958865|323679244|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
94513914|NCT02958865|323679245|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
94513915|NCT02958865|323679246|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
94513916|NCT02958865|323679247|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
94513917|NCT02958865|323679248|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
94513918|NCT02958865|323679249|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
94513919|NCT02958865|323679234|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
94655639|NCT01632579|324196111|FG001|Washout Period|Adverse Event|0|||
94513920|NCT02958865|323679235|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
94513921|NCT02958865|323679236|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
94513922|NCT02958865|323679237|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
94513923|NCT02958865|323679238|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
94513924|NCT02958865|323679239|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
94513925|NCT02958865|323679240|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
94513926|NCT02958865|323679241|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
94513927|NCT02958865|323679242|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
94513928|NCT02958865|323679243|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
94513929|NCT02958865|323679244|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
94513930|NCT02958865|323679245|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
94513931|NCT02958865|323679246|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
94513932|NCT02958865|323679247|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
94513933|NCT02958865|323679248|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
94513934|NCT02958865|323679249|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
94513935|NCT02958865|323679234|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
94513936|NCT02958865|323679235|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
94513937|NCT02958865|323679236|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
94513938|NCT02958865|323679237|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
94513939|NCT02958865|323679238|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
94513940|NCT02958865|323679239|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
94513941|NCT02958865|323679240|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
94513942|NCT02958865|323679241|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
94513943|NCT02958865|323679242|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
94513944|NCT02958865|323679243|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
94513945|NCT02958865|323679244|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
94513946|NCT02958865|323679245|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
94513947|NCT02958865|323679246|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
94513948|NCT02958865|323679247|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
94513949|NCT02958865|323679248|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
94513950|NCT02958865|323679249|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
94513951|NCT01605097|323679252|FG000|Overall Study|Protocol Violation|1|||
94513952|NCT01038323|323679253|FG000|Overall Study|Withdrawal by Subject|3|||
94513953|NCT01038323|323679254|FG001|Overall Study|Withdrawal by Subject|2|||
94513954|NCT01038323|323679255|FG002|Overall Study|Withdrawal by Subject|4|||
94513955|NCT01728246|323679256|FG000|Overall Study|Participant needed rescue medication|1|||
94513956|NCT01728246|323679257|FG001|Overall Study|Participant needed rescue medication|5|||
94513957|NCT01728246|323679256|FG000|Overall Study|Protocol Violation|1|||
94513958|NCT01728246|323679257|FG001|Overall Study|Protocol Violation|0|||
94513959|NCT01728246|323679256|FG000|Overall Study|Withdrawal by Subject|2|||
94513960|NCT01728246|323679257|FG001|Overall Study|Withdrawal by Subject|3|||
94513961|NCT01728246|323679256|FG000|Overall Study|Lost to Follow-up|23|||
94513962|NCT01728246|323679257|FG001|Overall Study|Lost to Follow-up|22|||
94513963|NCT01728246|323679256|FG000|Overall Study|Lack of Efficacy|1|||
94513964|NCT01728246|323679257|FG001|Overall Study|Lack of Efficacy|1|||
94513965|NCT01728246|323679256|FG000|Overall Study|Adverse Event|8|||
94513966|NCT01728246|323679257|FG001|Overall Study|Adverse Event|5|||
94513967|NCT00431964|323679260|FG000|Overall Study|Adverse Event|1|||
94513968|NCT00431964|323679261|FG001|Overall Study|Adverse Event|0|||
94513969|NCT00431964|323679260|FG000|Overall Study|Lost to Follow-up|1|||
94513970|NCT00431964|323679261|FG001|Overall Study|Lost to Follow-up|2|||
94513971|NCT00431964|323679260|FG000|Overall Study|Physician Decision|2|||
94513972|NCT00431964|323679261|FG001|Overall Study|Physician Decision|2|||
94513973|NCT00431964|323679260|FG000|Overall Study|Withdrawal by Subject|2|||
94513974|NCT00431964|323679261|FG001|Overall Study|Withdrawal by Subject|1|||
94513975|NCT00431964|323679260|FG000|Overall Study|Parental Consent Withdrawn|0|||
94513976|NCT00431964|323679261|FG001|Overall Study|Parental Consent Withdrawn|2|||
94513977|NCT00431964|323679260|FG000|Overall Study|Due to Unstable Health|0|||
94513978|NCT00431964|323679261|FG001|Overall Study|Due to Unstable Health|1|||
94513979|NCT03434834|323679265|FG000|Overall Study|unable to swallow OCT probe|16|||
94513980|NCT01968980|323679268|FG000|Overall Study|Death|0|||
94513981|NCT01968980|323679269|FG001|Overall Study|Death|1|||
94513982|NCT01968980|323679268|FG000|Overall Study|Adverse Event|1|||
94513983|NCT01968980|323679269|FG001|Overall Study|Adverse Event|3|||
94513984|NCT01968980|323679268|FG000|Overall Study|Does not meet entry criteria|1|||
94513985|NCT01968980|323679269|FG001|Overall Study|Does not meet entry criteria|3|||
94513986|NCT01968980|323679268|FG000|Overall Study|Withdrawal by Subject|13|||
94513987|NCT01968980|323679269|FG001|Overall Study|Withdrawal by Subject|5|||
94513988|NCT01968980|323679268|FG000|Overall Study|Other unspecified|1|||
94513989|NCT01968980|323679269|FG001|Overall Study|Other unspecified|2|||
94513990|NCT00518180|323679270|FG000|Overall Study|Withdrawal by Subject|29|||
94513991|NCT00518180|323679271|FG001|Overall Study|Withdrawal by Subject|30|||
94513992|NCT00518180|323679272|FG002|Overall Study|Withdrawal by Subject|42|||
94513993|NCT00518180|323679270|FG000|Overall Study|Lost to Follow-up|30|||
94513994|NCT00518180|323679271|FG001|Overall Study|Lost to Follow-up|28|||
94513995|NCT00518180|323679272|FG002|Overall Study|Lost to Follow-up|34|||
94513996|NCT00518180|323679270|FG000|Overall Study|Administrative reason|0|||
94513997|NCT00518180|323679271|FG001|Overall Study|Administrative reason|2|||
94513998|NCT00518180|323679272|FG002|Overall Study|Administrative reason|2|||
94513999|NCT00518180|323679270|FG000|Overall Study|Protocol Violation|5|||
94514000|NCT00518180|323679271|FG001|Overall Study|Protocol Violation|7|||
94514001|NCT00518180|323679272|FG002|Overall Study|Protocol Violation|4|||
94514002|NCT00518180|323679270|FG000|Overall Study|Unable to classify|0|||
94514003|NCT00518180|323679271|FG001|Overall Study|Unable to classify|2|||
94514004|NCT00518180|323679272|FG002|Overall Study|Unable to classify|0|||
94514005|NCT00518180|323679270|FG000|Overall Study|Adverse Event|1|||
94514006|NCT00518180|323679271|FG001|Overall Study|Adverse Event|0|||
94514007|NCT00518180|323679272|FG002|Overall Study|Adverse Event|0|||
94514008|NCT01374425|323679275|FG000|Overall Study|Radiographic Disease Progression|86|||
94514009|NCT01374425|323679276|FG001|Overall Study|Radiographic Disease Progression|81|||
94514010|NCT01374425|323679275|FG000|Overall Study|Clinical Disease Progression|9|||
94514011|NCT01374425|323679276|FG001|Overall Study|Clinical Disease Progression|6|||
94514012|NCT01374425|323679275|FG000|Overall Study|Adverse Event|29|||
94514013|NCT01374425|323679276|FG001|Overall Study|Adverse Event|18|||
94514014|NCT01374425|323679275|FG000|Overall Study|Death (Progression of Disease)|1|||
94514015|NCT01374425|323679276|FG001|Overall Study|Death (Progression of Disease)|0|||
94514016|NCT01374425|323679275|FG000|Overall Study|Death (Adverse Event)|2|||
94514017|NCT01374425|323679276|FG001|Overall Study|Death (Adverse Event)|4|||
94514018|NCT01374425|323679275|FG000|Overall Study|Withdrawal by Subject|6|||
94514019|NCT01374425|323679276|FG001|Overall Study|Withdrawal by Subject|7|||
94514020|NCT01374425|323679275|FG000|Overall Study|Refused Treatment|10|||
94514021|NCT01374425|323679276|FG001|Overall Study|Refused Treatment|24|||
94514022|NCT01374425|323679275|FG000|Overall Study|Protocol Violation|2|||
94514023|NCT01374425|323679276|FG001|Overall Study|Protocol Violation|3|||
94514024|NCT01374425|323679275|FG000|Overall Study|Sponsor Decision|0|||
94514025|NCT01374425|323679276|FG001|Overall Study|Sponsor Decision|1|||
94514026|NCT01374425|323679275|FG000|Overall Study|Lost to Follow-up|2|||
94514027|NCT01374425|323679276|FG001|Overall Study|Lost to Follow-up|1|||
94514028|NCT01374425|323679275|FG000|Overall Study|Other|41|||
94514029|NCT01374425|323679276|FG001|Overall Study|Other|43|||
94514030|NCT04716894|323679283|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
94514031|NCT04716894|323679283|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
94514032|NCT00862940|323679284|FG000|Overall Study|Adverse Event|15|||
94514033|NCT00862940|323679285|FG001|Overall Study|Adverse Event|12|||
94514034|NCT00862940|323679284|FG000|Overall Study|Lack of Efficacy|1|||
94514035|NCT00862940|323679285|FG001|Overall Study|Lack of Efficacy|3|||
94514036|NCT00862940|323679284|FG000|Overall Study|Protocol Violation|2|||
94514037|NCT00862940|323679285|FG001|Overall Study|Protocol Violation|5|||
94514038|NCT00862940|323679284|FG000|Overall Study|Withdrawal by Subject|4|||
94514039|NCT00862940|323679285|FG001|Overall Study|Withdrawal by Subject|6|||
94514040|NCT00862940|323679284|FG000|Overall Study|Non-compliance|4|||
94514041|NCT00862940|323679285|FG001|Overall Study|Non-compliance|0|||
94514042|NCT00862940|323679284|FG000|Overall Study|Lost to Follow-up|0|||
94514043|NCT00862940|323679285|FG001|Overall Study|Lost to Follow-up|1|||
94514044|NCT00862940|323679284|FG000|Overall Study|Administrative or other reason(s)|4|||
94514045|NCT00862940|323679285|FG001|Overall Study|Administrative or other reason(s)|3|||
94514046|NCT05205616|323679286|FG000|Overall Study|Lost to Follow-up|4|||
94514047|NCT05205616|323679287|FG001|Overall Study|Lost to Follow-up|4|||
94514048|NCT04079738|323679288|FG000|Study Treatment|Death|1|||
94514049|NCT04079738|323679289|FG001|Study Treatment|Death|0|||
94514050|NCT04079738|323679290|FG002|Study Treatment|Death|0|||
94514051|NCT04079738|323679291|FG003|Study Treatment|Death|0|||
94514052|NCT04079738|323679288|FG000|Study Treatment|Adverse Event|2|||
94514053|NCT04079738|323679289|FG001|Study Treatment|Adverse Event|0|||
94514054|NCT04079738|323679290|FG002|Study Treatment|Adverse Event|0|||
94514055|NCT04079738|323679291|FG003|Study Treatment|Adverse Event|0|||
94514056|NCT04079738|323679288|FG000|Study Treatment|withdrawal before treatment|1|||
94514057|NCT04079738|323679289|FG001|Study Treatment|withdrawal before treatment|0|||
94514058|NCT04079738|323679290|FG002|Study Treatment|withdrawal before treatment|0|||
94514059|NCT04079738|323679291|FG003|Study Treatment|withdrawal before treatment|0|||
94514060|NCT04079738|323679288|FG000|Study Treatment|symptomatic deterioration|2|||
94514061|NCT04079738|323679289|FG001|Study Treatment|symptomatic deterioration|0|||
94514062|NCT04079738|323679290|FG002|Study Treatment|symptomatic deterioration|0|||
94514063|NCT04079738|323679291|FG003|Study Treatment|symptomatic deterioration|0|||
94514064|NCT04079738|323679288|FG000|Study Treatment|Disease Progression|1|||
94514065|NCT04079738|323679289|FG001|Study Treatment|Disease Progression|0|||
94514066|NCT04079738|323679290|FG002|Study Treatment|Disease Progression|0|||
94514067|NCT04079738|323679291|FG003|Study Treatment|Disease Progression|0|||
94514068|NCT04079738|323679288|FG000|Study Treatment|withdrawal after treatment|1|||
94514069|NCT04079738|323679289|FG001|Study Treatment|withdrawal after treatment|0|||
94514070|NCT04079738|323679290|FG002|Study Treatment|withdrawal after treatment|0|||
94514071|NCT04079738|323679291|FG003|Study Treatment|withdrawal after treatment|0|||
94514072|NCT04079738|323679288|FG000|Follow up|Withdrawal by Subject|3|||
94514073|NCT04079738|323679289|FG001|Follow up|Withdrawal by Subject|0|||
94514074|NCT04079738|323679290|FG002|Follow up|Withdrawal by Subject|0|||
94514075|NCT04079738|323679291|FG003|Follow up|Withdrawal by Subject|0|||
94514076|NCT04079738|323679288|FG000|Follow up|Death|5|||
94514077|NCT04079738|323679289|FG001|Follow up|Death|0|||
94514078|NCT04079738|323679290|FG002|Follow up|Death|0|||
94514079|NCT04079738|323679291|FG003|Follow up|Death|0|||
94514080|NCT02031302|323679292|FG000|Overall Study|Death|115|||
94514081|NCT02031302|323679293|FG001|Overall Study|Death|0|||
94514082|NCT02031302|323679292|FG000|Overall Study|Not treated with study valve system|18|||
94514083|NCT02031302|323679293|FG001|Overall Study|Not treated with study valve system|0|||
94514084|NCT02031302|323679292|FG000|Overall Study|Missed Follow Up|27|||
94514085|NCT02031302|323679293|FG001|Overall Study|Missed Follow Up|0|||
94514086|NCT02031302|323679292|FG000|Overall Study|Lost to Follow-up|4|||
94514087|NCT02031302|323679293|FG001|Overall Study|Lost to Follow-up|0|||
94514088|NCT04697628|323679294|FG000|Overall Study|Withdrawal by Subject|17|||
94514089|NCT04697628|323679295|FG001|Overall Study|Withdrawal by Subject|23|||
94514090|NCT04697628|323679294|FG000|Overall Study|Lost to Follow-up|0|||
94514091|NCT04697628|323679295|FG001|Overall Study|Lost to Follow-up|4|||
94514092|NCT04697628|323679294|FG000|Overall Study|On-going in study|122|||
94514093|NCT04697628|323679295|FG001|Overall Study|On-going in study|91|||
94514094|NCT02303821|323679296|FG000|Overall Study|Withdrawal by Subject|0|||
94514095|NCT02303821|323679297|FG001|Overall Study|Withdrawal by Subject|0|||
94514096|NCT02303821|323679298|FG002|Overall Study|Withdrawal by Subject|0|||
94514097|NCT02303821|323679299|FG003|Overall Study|Withdrawal by Subject|0|||
94514098|NCT02303821|323679300|FG004|Overall Study|Withdrawal by Subject|0|||
94514099|NCT02303821|323679301|FG005|Overall Study|Withdrawal by Subject|0|||
94514100|NCT02303821|323679302|FG006|Overall Study|Withdrawal by Subject|0|||
94514101|NCT02303821|323679303|FG007|Overall Study|Withdrawal by Subject|2|||
94514102|NCT02303821|323679296|FG000|Overall Study|Death|0|||
94514103|NCT02303821|323679297|FG001|Overall Study|Death|2|||
94514104|NCT02303821|323679298|FG002|Overall Study|Death|0|||
94514105|NCT02303821|323679299|FG003|Overall Study|Death|0|||
94514106|NCT02303821|323679300|FG004|Overall Study|Death|0|||
94514107|NCT02303821|323679301|FG005|Overall Study|Death|3|||
94514108|NCT02303821|323679302|FG006|Overall Study|Death|41|||
94514109|NCT02303821|323679303|FG007|Overall Study|Death|29|||
94514110|NCT02303821|323679296|FG000|Overall Study|Lost to Follow-up|0|||
94514111|NCT02303821|323679297|FG001|Overall Study|Lost to Follow-up|0|||
94514112|NCT02303821|323679298|FG002|Overall Study|Lost to Follow-up|0|||
94514113|NCT02303821|323679299|FG003|Overall Study|Lost to Follow-up|0|||
94514114|NCT02303821|323679300|FG004|Overall Study|Lost to Follow-up|0|||
94514115|NCT02303821|323679301|FG005|Overall Study|Lost to Follow-up|0|||
94514116|NCT02303821|323679302|FG006|Overall Study|Lost to Follow-up|1|||
94514117|NCT02303821|323679303|FG007|Overall Study|Lost to Follow-up|0|||
94514118|NCT02303821|323679296|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
94514119|NCT02303821|323679297|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
94514120|NCT02303821|323679298|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
94514121|NCT02303821|323679299|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
94514122|NCT02303821|323679300|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
94514123|NCT02303821|323679301|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
94514124|NCT02303821|323679302|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
94514125|NCT02303821|323679303|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
94514126|NCT02303821|323679296|FG000|Overall Study|Decision by sponsor|0|||
94514127|NCT02303821|323679297|FG001|Overall Study|Decision by sponsor|0|||
94514128|NCT02303821|323679298|FG002|Overall Study|Decision by sponsor|0|||
94514129|NCT02303821|323679299|FG003|Overall Study|Decision by sponsor|0|||
94514130|NCT02303821|323679300|FG004|Overall Study|Decision by sponsor|0|||
94514131|NCT02303821|323679301|FG005|Overall Study|Decision by sponsor|1|||
94514132|NCT02303821|323679302|FG006|Overall Study|Decision by sponsor|0|||
94514133|NCT02303821|323679303|FG007|Overall Study|Decision by sponsor|0|||
94514134|NCT02303821|323679296|FG000|Overall Study|Protocol-specified criteria|0|||
94514135|NCT02303821|323679297|FG001|Overall Study|Protocol-specified criteria|1|||
94514136|NCT02303821|323679298|FG002|Overall Study|Protocol-specified criteria|0|||
94514137|NCT02303821|323679299|FG003|Overall Study|Protocol-specified criteria|0|||
94514138|NCT02303821|323679300|FG004|Overall Study|Protocol-specified criteria|0|||
94514139|NCT02303821|323679301|FG005|Overall Study|Protocol-specified criteria|1|||
94514140|NCT02303821|323679302|FG006|Overall Study|Protocol-specified criteria|0|||
94514141|NCT02303821|323679303|FG007|Overall Study|Protocol-specified criteria|0|||
94514142|NCT00698841|323679305|FG000|Overall Study|Withdrawal by Subject|2|||
94514143|NCT00698841|323679305|FG000|Overall Study|Adverse Event|3|||
94514144|NCT00698841|323679305|FG000|Overall Study|Disease progression|7|||
94514145|NCT00698841|323679305|FG000|Overall Study|Failure to meet eligibility criteria|2|||
94514146|NCT00698841|323679305|FG000|Overall Study|Study drug toxicity|2|||
94514147|NCT00698841|323679305|FG000|Overall Study|Other|2|||
94514148|NCT03586973|323679306|FG000|Overall Study|Death|15|||
94514149|NCT03586973|323679307|FG001|Overall Study|Death|8|||
94514150|NCT03586973|323679306|FG000|Overall Study|Site Terminated by Sponsor|3|||
94514151|NCT03586973|323679307|FG001|Overall Study|Site Terminated by Sponsor|6|||
94514152|NCT03586973|323679306|FG000|Overall Study|Withdrawal by Subject|1|||
94514153|NCT03586973|323679307|FG001|Overall Study|Withdrawal by Subject|0|||
94514154|NCT03586973|323679306|FG000|Overall Study|Lost to Follow-up|1|||
94514155|NCT03586973|323679307|FG001|Overall Study|Lost to Follow-up|0|||
94514156|NCT02661672|323679309|FG000|Overall Study|Lost to Follow-up|1|||
94514157|NCT02661672|323679309|FG000|Overall Study|Death|4|||
94514158|NCT01397253|323680799|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
94514159|NCT01397253|323680800|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
94514160|NCT00442702|323680803|FG000|Titration Period|Adverse Event|2|||
94514161|NCT00442702|323680804|FG001|Titration Period|Adverse Event|0|||
94514162|NCT00442702|323680803|FG000|Titration Period|Death|3|||
94514163|NCT00442702|323680804|FG001|Titration Period|Death|2|||
94514164|NCT00442702|323680803|FG000|Titration Period|Insufficient Therapeutic Response|1|||
94514165|NCT00442702|323680804|FG001|Titration Period|Insufficient Therapeutic Response|0|||
94514166|NCT00442702|323680803|FG000|Titration Period|Refused Treatment|4|||
94514167|NCT00442702|323680804|FG001|Titration Period|Refused Treatment|1|||
94514168|NCT00442702|323680803|FG000|Titration Period|Failure to return|1|||
94514169|NCT00442702|323680804|FG001|Titration Period|Failure to return|0|||
94514170|NCT00442702|323680803|FG000|Titration Period|Hospitalized in another hospital|1|||
94514171|NCT00442702|323680804|FG001|Titration Period|Hospitalized in another hospital|0|||
94514172|NCT00442702|323680803|FG000|Evaluation Period|Adverse Event|1|||
94514173|NCT00442702|323680804|FG001|Evaluation Period|Adverse Event|0|||
94514174|NCT00442702|323680803|FG000|Evaluation Period|Death|1|||
94514175|NCT00442702|323680804|FG001|Evaluation Period|Death|1|||
94514176|NCT00442702|323680803|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
94514177|NCT00442702|323680804|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
94514178|NCT00442702|323680803|FG000|Evaluation Period|Refused treatment|1|||
94514179|NCT00442702|323680804|FG001|Evaluation Period|Refused treatment|1|||
94514180|NCT00442702|323680803|FG000|Evaluation Period|Renal transplant|0|||
94514181|NCT00442702|323680804|FG001|Evaluation Period|Renal transplant|1|||
94514182|NCT00442702|323680803|FG000|Evaluation Period|Failure to return|1|||
94514183|NCT00442702|323680804|FG001|Evaluation Period|Failure to return|0|||
94514184|NCT00442702|323680803|FG000|Evaluation Period|Site closure|0|||
94514185|NCT00442702|323680804|FG001|Evaluation Period|Site closure|1|||
94514186|NCT00730327|323680805|FG000|Overall Study|Lost to Follow-up|14|||
94514187|NCT00730327|323680806|FG001|Overall Study|Lost to Follow-up|16|||
94514188|NCT00730327|323680805|FG000|Overall Study|Adverse Event|8|||
94514189|NCT00730327|323680806|FG001|Overall Study|Adverse Event|1|||
94514190|NCT00730327|323680805|FG000|Overall Study|Withdrawal by Subject|3|||
94514191|NCT00730327|323680806|FG001|Overall Study|Withdrawal by Subject|13|||
94514192|NCT00730327|323680805|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
94514193|NCT00730327|323680806|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
94514194|NCT00633126|323680809|FG000|Overall Study|Did not receive full dose|1|||
94514195|NCT01168596|323680818|FG000|Overall Study|Withdrawal by Subject|3|||
94514196|NCT01168596|323680819|FG001|Overall Study|Withdrawal by Subject|1|||
94514197|NCT02297516|323680822|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
94514198|NCT02297516|323680823|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
94514199|NCT02297516|323680822|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
94514200|NCT02297516|323680823|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
94514201|NCT02297516|323680822|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
94514202|NCT02297516|323680823|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
94514203|NCT03674281|323680824|FG000|Overall Study|screen failure|2|||
94514204|NCT03674281|323680825|FG001|Overall Study|screen failure|0|||
94514205|NCT03674281|323680826|FG002|Overall Study|screen failure|0|||
94514206|NCT03674281|323680824|FG000|Overall Study|Withdrawal by Subject|1|||
94514207|NCT03674281|323680825|FG001|Overall Study|Withdrawal by Subject|3|||
94514208|NCT03674281|323680826|FG002|Overall Study|Withdrawal by Subject|3|||
94514209|NCT00366457|323680830|FG000|Overall Study|never began study therapy|2|||
94514210|NCT02138825|323680832|FG000|Main Study Treatment|Adverse Event|11|||
94514211|NCT02138825|323680833|FG001|Main Study Treatment|Adverse Event|3|||
94514212|NCT02138825|323680832|FG000|Main Study Treatment|Death|1|||
94514213|NCT02138825|323680833|FG001|Main Study Treatment|Death|2|||
94514214|NCT02138825|323680832|FG000|Main Study Treatment|Protocol Violation|2|||
94514215|NCT02138825|323680833|FG001|Main Study Treatment|Protocol Violation|2|||
94514216|NCT02138825|323680832|FG000|Main Study Treatment|Sponsor decision|12|||
94514217|NCT02138825|323680833|FG001|Main Study Treatment|Sponsor decision|18|||
94514218|NCT02138825|323680832|FG000|Main Study Treatment|Study terminated by sponsor|10|||
94514219|NCT02138825|323680833|FG001|Main Study Treatment|Study terminated by sponsor|9|||
94514220|NCT02138825|323680832|FG000|Main Study Treatment|Withdrawal by Subject|3|||
94514221|NCT02138825|323680833|FG001|Main Study Treatment|Withdrawal by Subject|1|||
94514222|NCT02138825|323680832|FG000|Main Study Treatment|Medical decision|1|||
94514223|NCT02138825|323680833|FG001|Main Study Treatment|Medical decision|0|||
94514224|NCT02138825|323680832|FG000|Long-term Extension|Study termination by sponsor|32|||
94514225|NCT02138825|323680833|FG001|Long-term Extension|Study termination by sponsor|38|||
94514226|NCT02138825|323680832|FG000|Safety Follow-up|Adverse Event|4|||
94514227|NCT02138825|323680833|FG001|Safety Follow-up|Adverse Event|3|||
94514228|NCT02138825|323680832|FG000|Safety Follow-up|Death|11|||
94514229|NCT02138825|323680833|FG001|Safety Follow-up|Death|5|||
94514230|NCT02138825|323680832|FG000|Safety Follow-up|Withdrawal by Subject|5|||
94514231|NCT02138825|323680833|FG001|Safety Follow-up|Withdrawal by Subject|3|||
94514232|NCT02138825|323680832|FG000|Safety Follow-up|clinic worsening|1|||
94514233|NCT02138825|323680833|FG001|Safety Follow-up|clinic worsening|0|||
94514234|NCT02138825|323680832|FG000|Safety Follow-up|withdrawal by PI|1|||
94514235|NCT02138825|323680833|FG001|Safety Follow-up|withdrawal by PI|0|||
94514236|NCT02138825|323680832|FG000|Safety Follow-up|logistical difficulties|0|||
94514237|NCT02138825|323680833|FG001|Safety Follow-up|logistical difficulties|1|||
94514238|NCT02138825|323680832|FG000|Safety Follow-up|progressive disease|0|||
94514239|NCT02138825|323680833|FG001|Safety Follow-up|progressive disease|2|||
94514240|NCT02138825|323680832|FG000|Safety Follow-up|too unwell to attend the visit|0|||
94514241|NCT02138825|323680833|FG001|Safety Follow-up|too unwell to attend the visit|1|||
94514242|NCT02138825|323680832|FG000|Safety Follow-up|treatment unblinded|0|||
94514243|NCT02138825|323680833|FG001|Safety Follow-up|treatment unblinded|1|||
94514244|NCT02138825|323680832|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
94514245|NCT02138825|323680833|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
94514246|NCT05201807|323680834|FG000|Overall Study|Adverse Event|1|||
94514247|NCT05201807|323680834|FG000|Overall Study|COVID-19 Related|1|||
94514248|NCT01198587|323680836|FG000|Overall Study|Lost to Follow-up|8|||
94514249|NCT01198587|323680837|FG001|Overall Study|Lost to Follow-up|0|||
94514250|NCT01198587|323680838|FG002|Overall Study|Lost to Follow-up|9|||
94514251|NCT01198587|323680839|FG003|Overall Study|Lost to Follow-up|0|||
94514252|NCT00904371|323680840|FG000|Overall Study|Adverse Event|2|||
94514253|NCT00904371|323680840|FG000|Overall Study|Lost to Follow-up|4|||
94514254|NCT00904371|323680840|FG000|Overall Study|Discontinued at target blood pressure|2|||
94514255|NCT00904371|323680840|FG000|Overall Study|Continued with Tritace|1|||
94514256|NCT00261833|323680845|FG000|Overall Study|Death|1|||
94514257|NCT00261833|323680846|FG001|Overall Study|Death|3|||
94514258|NCT00261833|323680845|FG000|Overall Study|Adverse Event|1|||
94514259|NCT00261833|323680846|FG001|Overall Study|Adverse Event|4|||
94514260|NCT00261833|323680845|FG000|Overall Study|Withdrawal by Subject|5|||
94514261|NCT00261833|323680846|FG001|Overall Study|Withdrawal by Subject|7|||
94514262|NCT00261833|323680845|FG000|Overall Study|Protocol Violation|0|||
94514263|NCT00261833|323680846|FG001|Overall Study|Protocol Violation|1|||
94514264|NCT00261833|323680845|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
94514265|NCT00261833|323680846|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
94514266|NCT00261833|323680845|FG000|Overall Study|Lung transplantation|1|||
94514267|NCT00261833|323680846|FG001|Overall Study|Lung transplantation|1|||
94514268|NCT00261833|323680845|FG000|Overall Study|Missing reason|1|||
94514269|NCT00261833|323680846|FG001|Overall Study|Missing reason|0|||
94514270|NCT00261833|323680845|FG000|Overall Study|Not interested in being participant|0|||
94514271|NCT00261833|323680846|FG001|Overall Study|Not interested in being participant|1|||
94514272|NCT00622726|323680847|FG000|March, 2008 to August, 2010|Death|5|||
94514273|NCT00622726|323680848|FG001|March, 2008 to August, 2010|Death|2|||
94514274|NCT00622726|323680847|FG000|August, 2010 to April, 2013|Death|1|||
94514275|NCT00622726|323680848|FG001|August, 2010 to April, 2013|Death|5|||
94514276|NCT02434081|323680851|FG000|Overall Study|Death (never started treatment)|2|||
94514277|NCT02434081|323680851|FG000|Overall Study|Death|2|||
94514278|NCT02434081|323680851|FG000|Overall Study|Progression|20|||
94514279|NCT02434081|323680851|FG000|Overall Study|Adverse Event|20|||
94514280|NCT02434081|323680851|FG000|Overall Study|Physician Decision|2|||
94514281|NCT02434081|323680851|FG000|Overall Study|Withdrawal by Subject|1|||
94514282|NCT02434081|323680851|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
94514283|NCT02095106|323680852|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
94514284|NCT02095106|323680853|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
94514285|NCT00419744|323680854|FG000|Overall Study|Adverse Event|39|||
94514286|NCT00419744|323680855|FG001|Overall Study|Adverse Event|40|||
94514287|NCT00419744|323680856|FG002|Overall Study|Adverse Event|50|||
94514288|NCT00419744|323680854|FG000|Overall Study|Withdrawal by Subject|45|||
94514289|NCT00419744|323680855|FG001|Overall Study|Withdrawal by Subject|49|||
94514290|NCT00419744|323680856|FG002|Overall Study|Withdrawal by Subject|52|||
94514291|NCT00419744|323680854|FG000|Overall Study|Lost to Follow-up|8|||
94514292|NCT00419744|323680855|FG001|Overall Study|Lost to Follow-up|10|||
94514293|NCT00419744|323680856|FG002|Overall Study|Lost to Follow-up|6|||
94514294|NCT00419744|323680854|FG000|Overall Study|Protocol Violation|4|||
94514295|NCT00419744|323680855|FG001|Overall Study|Protocol Violation|7|||
94514296|NCT00419744|323680856|FG002|Overall Study|Protocol Violation|8|||
94514297|NCT00419744|323680854|FG000|Overall Study|Randomized in error|9|||
94514298|NCT00419744|323680855|FG001|Overall Study|Randomized in error|6|||
94514299|NCT00419744|323680856|FG002|Overall Study|Randomized in error|7|||
94514300|NCT00419744|323680854|FG000|Overall Study|Moving out of state|2|||
94514301|NCT00419744|323680855|FG001|Overall Study|Moving out of state|0|||
94514302|NCT00419744|323680856|FG002|Overall Study|Moving out of state|1|||
94514303|NCT00419744|323680854|FG000|Overall Study|Physician Decision|10|||
94514304|NCT00419744|323680855|FG001|Overall Study|Physician Decision|5|||
94514305|NCT00419744|323680856|FG002|Overall Study|Physician Decision|6|||
94514306|NCT00419744|323680854|FG000|Overall Study|Spirometry mouthpiece issues|0|||
94514307|NCT00419744|323680855|FG001|Overall Study|Spirometry mouthpiece issues|1|||
94514308|NCT00419744|323680856|FG002|Overall Study|Spirometry mouthpiece issues|2|||
94514309|NCT00419744|323680854|FG000|Overall Study|Incorrect medication kit dispensed|0|||
94514310|NCT00419744|323680855|FG001|Overall Study|Incorrect medication kit dispensed|0|||
94514311|NCT00419744|323680856|FG002|Overall Study|Incorrect medication kit dispensed|1|||
94514312|NCT00335829|323680866|FG000|Overall Study|Withdrawal by Subject|1|||
94514313|NCT00335829|323680866|FG000|Overall Study|Lost to Follow-up|1|||
94514314|NCT00335829|323680866|FG000|Overall Study|Adverse Event|1|||
94514315|NCT00583219|323680867|FG000|Phase 2|Withdrawal by Subject|1|||
94514316|NCT00744861|323680871|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
94514317|NCT00744861|323680872|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
94514318|NCT00744861|323680873|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
94514319|NCT00744861|323680874|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
94514320|NCT00744861|323680871|FG000|Feasibility Stage 1|Pregnancy|0|||
94514321|NCT00744861|323680872|FG001|Feasibility Stage 1|Pregnancy|1|||
94514322|NCT00744861|323680873|FG002|Feasibility Stage 1|Pregnancy|0|||
94514323|NCT00744861|323680874|FG003|Feasibility Stage 1|Pregnancy|0|||
94514324|NCT00744861|323680871|FG000|Pivotal Stage 2|Adverse Event|0|||
94514325|NCT00744861|323680872|FG001|Pivotal Stage 2|Adverse Event|0|||
94514326|NCT00744861|323680873|FG002|Pivotal Stage 2|Adverse Event|6|||
94514327|NCT00744861|323680874|FG003|Pivotal Stage 2|Adverse Event|11|||
94514328|NCT00744861|323680871|FG000|Pivotal Stage 2|Death|0|||
94514329|NCT00744861|323680872|FG001|Pivotal Stage 2|Death|0|||
94514330|NCT00744861|323680873|FG002|Pivotal Stage 2|Death|0|||
94514331|NCT00744861|323680874|FG003|Pivotal Stage 2|Death|1|||
94514332|NCT00744861|323680871|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
94514333|NCT00744861|323680872|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
94514334|NCT00744861|323680873|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
94514335|NCT00744861|323680874|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
94514336|NCT00744861|323680871|FG000|Pivotal Stage 2|Physician Decision|0|||
94514337|NCT00744861|323680872|FG001|Pivotal Stage 2|Physician Decision|0|||
94514338|NCT00744861|323680873|FG002|Pivotal Stage 2|Physician Decision|3|||
94514339|NCT00744861|323680874|FG003|Pivotal Stage 2|Physician Decision|1|||
94514340|NCT00744861|323680871|FG000|Pivotal Stage 2|Protocol Violation|0|||
94514341|NCT00744861|323680872|FG001|Pivotal Stage 2|Protocol Violation|0|||
94514342|NCT00744861|323680873|FG002|Pivotal Stage 2|Protocol Violation|0|||
94514343|NCT00744861|323680874|FG003|Pivotal Stage 2|Protocol Violation|1|||
94514344|NCT00744861|323680871|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
94514345|NCT00744861|323680872|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
94514346|NCT00744861|323680873|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
94514347|NCT00744861|323680874|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
94514348|NCT00744861|323680871|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
94514349|NCT00744861|323680872|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
94514350|NCT00744861|323680873|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
94514351|NCT00744861|323680874|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
94514352|NCT01561976|323680878|FG000|Period 1|Adverse Event|0|||
94514353|NCT01561976|323680879|FG001|Period 1|Adverse Event|0|||
94514354|NCT01561976|323680880|FG002|Period 1|Adverse Event|1|||
94514355|NCT01561976|323680881|FG003|Period 1|Adverse Event|0|||
94514356|NCT01561976|323680882|FG004|Period 1|Adverse Event|0|||
94514357|NCT01561976|323680883|FG005|Period 1|Adverse Event|0|||
94514358|NCT01561976|323680878|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
94514359|NCT01561976|323680879|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
94514360|NCT01561976|323680880|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
94514361|NCT01561976|323680881|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
94514362|NCT01561976|323680882|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
94514363|NCT01561976|323680883|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
94514364|NCT01561976|323680878|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
94514365|NCT01561976|323680879|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
94514366|NCT01561976|323680880|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
94514367|NCT01561976|323680881|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
94514368|NCT01561976|323680882|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
94514369|NCT01561976|323680883|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
94514370|NCT01561976|323680878|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
94514371|NCT01561976|323680879|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
94514372|NCT01561976|323680880|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
94514373|NCT01561976|323680881|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
94514374|NCT01561976|323680882|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
94514375|NCT01561976|323680883|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
94514376|NCT03412929|323680884|FG000|Overall Study|Protocol Violation|3|||
94514377|NCT01493414|323680885|FG000|Overall Study|Adverse Event|405|||
94514378|NCT01493414|323680885|FG000|Overall Study|Disease progression|204|||
94514379|NCT01493414|323680885|FG000|Overall Study|Death|101|||
94514380|NCT01493414|323680885|FG000|Overall Study|Physician Decision|93|||
94514381|NCT01493414|323680885|FG000|Overall Study|Withdrawal by Subject|79|||
94514382|NCT01493414|323680885|FG000|Overall Study|Protocol deviation|27|||
94514383|NCT01493414|323680885|FG000|Overall Study|Administrative problems|25|||
94514384|NCT01493414|323680885|FG000|Overall Study|Lost to Follow-up|16|||
94514385|NCT01816295|323680886|FG000|Double Blind Phase|Adverse Event|11|||
94514386|NCT01816295|323680887|FG001|Double Blind Phase|Adverse Event|8|||
94514387|NCT01816295|323680886|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
94514388|NCT01816295|323680887|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
94514389|NCT01816295|323680886|FG000|Double Blind Phase|Lost to Follow-up|3|||
94514390|NCT01816295|323680887|FG001|Double Blind Phase|Lost to Follow-up|5|||
94514391|NCT01816295|323680886|FG000|Double Blind Phase|Physician Decision|2|||
94514392|NCT01816295|323680887|FG001|Double Blind Phase|Physician Decision|2|||
94514393|NCT01816295|323680886|FG000|Double Blind Phase|Protocol Violation|17|||
94514394|NCT01816295|323680887|FG001|Double Blind Phase|Protocol Violation|11|||
94514395|NCT01816295|323680886|FG000|Double Blind Phase|Sponsor Decision|8|||
94514396|NCT01816295|323680887|FG001|Double Blind Phase|Sponsor Decision|8|||
94514397|NCT01816295|323680886|FG000|Double Blind Phase|Withdrawal by Subject|22|||
94514398|NCT01816295|323680887|FG001|Double Blind Phase|Withdrawal by Subject|20|||
94514399|NCT01816295|323680886|FG000|OLE Phase|Adverse Event|17|||
94514400|NCT01816295|323680887|FG001|OLE Phase|Adverse Event|15|||
94514401|NCT01816295|323680886|FG000|OLE Phase|Death|1|||
94514402|NCT01816295|323680887|FG001|OLE Phase|Death|0|||
94514403|NCT01816295|323680886|FG000|OLE Phase|Entry Criteria Not Met|3|||
94514404|NCT01816295|323680887|FG001|OLE Phase|Entry Criteria Not Met|5|||
94514405|NCT01816295|323680886|FG000|OLE Phase|Lost to Follow-up|5|||
94514406|NCT01816295|323680887|FG001|OLE Phase|Lost to Follow-up|5|||
94514407|NCT01816295|323680886|FG000|OLE Phase|Physician Decision|3|||
94514408|NCT01816295|323680887|FG001|OLE Phase|Physician Decision|1|||
94514409|NCT01816295|323680886|FG000|OLE Phase|Protocol Violation|4|||
94514410|NCT01816295|323680887|FG001|OLE Phase|Protocol Violation|4|||
94514411|NCT01816295|323680886|FG000|OLE Phase|Sponsor Decision|7|||
94514412|NCT01816295|323680887|FG001|OLE Phase|Sponsor Decision|9|||
94514413|NCT01816295|323680886|FG000|OLE Phase|Withdrawal by Subject|10|||
94514414|NCT01816295|323680887|FG001|OLE Phase|Withdrawal by Subject|10|||
94514415|NCT01816295|323680886|FG000|OLE Phase|Lack of Efficacy|3|||
94514416|NCT01816295|323680887|FG001|OLE Phase|Lack of Efficacy|7|||
94514417|NCT01182350|323680888|FG000|Overall Study|Adverse Event|5|||
94514418|NCT01182350|323680889|FG001|Overall Study|Adverse Event|0|||
94514419|NCT01182350|323680890|FG002|Overall Study|Adverse Event|0|||
94514420|NCT01182350|323680891|FG003|Overall Study|Adverse Event|0|||
94514421|NCT01182350|323680892|FG004|Overall Study|Adverse Event|0|||
94514422|NCT01182350|323680888|FG000|Overall Study|Disease Progression|15|||
94514423|NCT01182350|323680889|FG001|Overall Study|Disease Progression|12|||
94514424|NCT01182350|323680890|FG002|Overall Study|Disease Progression|0|||
94514425|NCT01182350|323680891|FG003|Overall Study|Disease Progression|1|||
94514426|NCT01182350|323680892|FG004|Overall Study|Disease Progression|0|||
94514427|NCT01182350|323680888|FG000|Overall Study|Death|0|||
94514428|NCT01182350|323680889|FG001|Overall Study|Death|1|||
94514429|NCT01182350|323680890|FG002|Overall Study|Death|1|||
94514430|NCT01182350|323680891|FG003|Overall Study|Death|0|||
94514431|NCT01182350|323680892|FG004|Overall Study|Death|0|||
94514432|NCT01182350|323680888|FG000|Overall Study|Withdrawal by Subject|3|||
94514433|NCT01182350|323680889|FG001|Overall Study|Withdrawal by Subject|1|||
94514434|NCT01182350|323680890|FG002|Overall Study|Withdrawal by Subject|0|||
94514435|NCT01182350|323680891|FG003|Overall Study|Withdrawal by Subject|1|||
94514436|NCT01182350|323680892|FG004|Overall Study|Withdrawal by Subject|0|||
94514437|NCT01182350|323680888|FG000|Overall Study|Alternative Therapy|2|||
94514438|NCT01182350|323680889|FG001|Overall Study|Alternative Therapy|0|||
94514439|NCT01182350|323680890|FG002|Overall Study|Alternative Therapy|1|||
94514440|NCT01182350|323680891|FG003|Overall Study|Alternative Therapy|0|||
94514441|NCT01182350|323680892|FG004|Overall Study|Alternative Therapy|0|||
94514442|NCT01182350|323680888|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
94514443|NCT01182350|323680889|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
94514444|NCT01182350|323680890|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
94514445|NCT01182350|323680891|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
94514446|NCT01182350|323680892|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
94514447|NCT01182350|323680888|FG000|Overall Study|Unevaluable for Biopsy|0|||
94514448|NCT01182350|323680889|FG001|Overall Study|Unevaluable for Biopsy|0|||
94514449|NCT01182350|323680890|FG002|Overall Study|Unevaluable for Biopsy|0|||
94514450|NCT01182350|323680891|FG003|Overall Study|Unevaluable for Biopsy|0|||
94514451|NCT01182350|323680892|FG004|Overall Study|Unevaluable for Biopsy|3|||
94514452|NCT05448950|323680895|FG000|Overall Study|Death|2|||
94514453|NCT05448950|323680895|FG000|Overall Study|Withdrawal by Subject|1|||
94514454|NCT05448950|323680895|FG000|Overall Study|AVG abandoned|4|||
94514455|NCT02836249|323680896|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
94514456|NCT02836249|323680897|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
94514457|NCT02836249|323680898|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
94514458|NCT02836249|323680899|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
94514459|NCT02836249|323680896|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
94514460|NCT02836249|323680897|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
94514461|NCT02836249|323680898|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
94514462|NCT02836249|323680899|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
94514463|NCT02836249|323680896|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
94514464|NCT02836249|323680897|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
94514465|NCT02836249|323680898|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
94514466|NCT02836249|323680899|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
94514467|NCT02836249|323680896|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
94514468|NCT02836249|323680897|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
94514469|NCT02836249|323680898|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
94514470|NCT02836249|323680899|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
94514471|NCT02836249|323680896|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
94514472|NCT02836249|323680897|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
94514473|NCT02836249|323680898|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
94514474|NCT02836249|323680899|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
94514475|NCT02836249|323680896|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
94514476|NCT02836249|323680897|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
94514477|NCT02836249|323680898|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
94514478|NCT02836249|323680899|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
94514479|NCT02836249|323680896|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
94514480|NCT02836249|323680897|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
94514481|NCT02836249|323680898|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
94514482|NCT02836249|323680899|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
94514483|NCT02836249|323680896|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
94514484|NCT02836249|323680897|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
94514485|NCT02836249|323680898|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
94514486|NCT02836249|323680899|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
94514487|NCT02836249|323680896|FG000|Open-Label TAF Treatment Phase|Death|0|||
94514488|NCT02836249|323680897|FG001|Open-Label TAF Treatment Phase|Death|0|||
94514489|NCT02836249|323680898|FG002|Open-Label TAF Treatment Phase|Death|1|||
94514490|NCT02836249|323680899|FG003|Open-Label TAF Treatment Phase|Death|0|||
94514491|NCT02836249|323680896|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
94514492|NCT02836249|323680897|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
94514493|NCT02836249|323680898|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
94514494|NCT02836249|323680899|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
94514495|NCT02836249|323680896|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
94514496|NCT02836249|323680897|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
94514497|NCT02836249|323680898|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
94514498|NCT02836249|323680899|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
94514499|NCT03559530|323680900|FG000|Overall Study|non-location of medical records|44|||
94514500|NCT03559530|323680901|FG001|Overall Study|non-location of medical records|0|||
94514501|NCT03559530|323680900|FG000|Overall Study|culture results not considered for treat|29|||
94514502|NCT03559530|323680901|FG001|Overall Study|culture results not considered for treat|0|||
94514503|NCT03559530|323680900|FG000|Overall Study|duplicate cases|8|||
94514504|NCT03559530|323680901|FG001|Overall Study|duplicate cases|0|||
94514505|NCT03559530|323680900|FG000|Overall Study|other species of Acinetobacte|7|||
94514506|NCT03559530|323680901|FG001|Overall Study|other species of Acinetobacte|0|||
94514507|NCT03559530|323680900|FG000|Overall Study|contamination / colonization|3|||
94514508|NCT03559530|323680901|FG001|Overall Study|contamination / colonization|0|||
94514509|NCT04138056|323680902|FG000|Primary Study|Lost to Follow-up|3|||
94514510|NCT04138056|323680903|FG001|Primary Study|Lost to Follow-up|4|||
94514511|NCT04138056|323680904|FG002|Primary Study|Lost to Follow-up|1|||
94514512|NCT04138056|323680905|FG003|Primary Study|Lost to Follow-up|1|||
94514513|NCT04138056|323680906|FG004|Primary Study|Lost to Follow-up|4|||
94514514|NCT04138056|323680902|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
94514515|NCT04138056|323680903|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
94514516|NCT04138056|323680904|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
94514517|NCT04138056|323680905|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
94514518|NCT04138056|323680906|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
94514519|NCT04138056|323680902|FG000|Extension Study|Lost to Follow-up|1|||
94514520|NCT04138056|323680903|FG001|Extension Study|Lost to Follow-up|2|||
94514521|NCT04138056|323680904|FG002|Extension Study|Lost to Follow-up|1|||
94514522|NCT04138056|323680905|FG003|Extension Study|Lost to Follow-up|0|||
94514523|NCT04138056|323680906|FG004|Extension Study|Lost to Follow-up|1|||
94514524|NCT00654732|323680907|FG000|Overall Study|Adverse Event|4|||
94514525|NCT00654732|323680908|FG001|Overall Study|Adverse Event|6|||
94514526|NCT01734902|323680909|FG000|Overall Study|Other than listed|0|||
94514527|NCT01734902|323680910|FG001|Overall Study|Other than listed|2|||
94514528|NCT01959932|323680911|FG000|Overall Study|Withdrawal by Subject|1|||
94514529|NCT01959932|323680912|FG001|Overall Study|Withdrawal by Subject|0|||
94514530|NCT01959932|323680913|FG002|Overall Study|Withdrawal by Subject|0|||
94514531|NCT00619866|323680916|FG000|Weeks 1 - 12|Adverse Event|0|||
94514532|NCT00619866|323680917|FG001|Weeks 1 - 12|Adverse Event|1|||
94514533|NCT00619866|323680918|FG002|Weeks 1 - 12|Adverse Event|2|||
94514534|NCT00619866|323680919|FG003|Weeks 1 - 12|Adverse Event|0|||
94514535|NCT00619866|323680920|FG004|Weeks 1 - 12|Adverse Event|0|||
94514536|NCT00619866|323680916|FG000|Weeks 1 - 12|Non-compliance|0|||
94514537|NCT00619866|323680917|FG001|Weeks 1 - 12|Non-compliance|0|||
94514538|NCT00619866|323680918|FG002|Weeks 1 - 12|Non-compliance|1|||
94514539|NCT00619866|323680919|FG003|Weeks 1 - 12|Non-compliance|0|||
94514540|NCT00619866|323680920|FG004|Weeks 1 - 12|Non-compliance|0|||
94514541|NCT00619866|323680916|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
94514542|NCT00619866|323680917|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
94514543|NCT00619866|323680918|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
94514544|NCT00619866|323680919|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
94514545|NCT00619866|323680920|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
94514546|NCT00619866|323680916|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
94514547|NCT00619866|323680917|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
94514548|NCT00619866|323680918|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
94514549|NCT00619866|323680919|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
94514550|NCT00619866|323680920|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
94514551|NCT00619866|323680916|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
94514552|NCT00619866|323680917|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
94514553|NCT00619866|323680918|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
94514554|NCT00619866|323680919|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
94514555|NCT00619866|323680920|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
94514556|NCT00619866|323680916|FG000|Weeks 1 - 12|Sponsor Decision|0|||
94514557|NCT00619866|323680917|FG001|Weeks 1 - 12|Sponsor Decision|1|||
94514558|NCT00619866|323680918|FG002|Weeks 1 - 12|Sponsor Decision|0|||
94514559|NCT00619866|323680919|FG003|Weeks 1 - 12|Sponsor Decision|0|||
94514560|NCT00619866|323680920|FG004|Weeks 1 - 12|Sponsor Decision|0|||
94514561|NCT00619866|323680916|FG000|Weeks 13 - 24|Adverse Event|0|||
94514562|NCT00619866|323680917|FG001|Weeks 13 - 24|Adverse Event|0|||
94514563|NCT00619866|323680918|FG002|Weeks 13 - 24|Adverse Event|2|||
94514564|NCT00619866|323680919|FG003|Weeks 13 - 24|Adverse Event|1|||
94514565|NCT00619866|323680920|FG004|Weeks 13 - 24|Adverse Event|0|||
94514566|NCT00619866|323680916|FG000|Weeks 13 - 24|Protocol Deviation|0|||
94514567|NCT00619866|323680917|FG001|Weeks 13 - 24|Protocol Deviation|0|||
94514568|NCT00619866|323680918|FG002|Weeks 13 - 24|Protocol Deviation|0|||
94514569|NCT00619866|323680919|FG003|Weeks 13 - 24|Protocol Deviation|1|||
94514570|NCT00619866|323680920|FG004|Weeks 13 - 24|Protocol Deviation|0|||
94514571|NCT00619866|323680916|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
94514572|NCT00619866|323680917|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
94514573|NCT00619866|323680918|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
94514574|NCT00619866|323680919|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
94514575|NCT00619866|323680920|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
94514576|NCT00619866|323680916|FG000|Weeks 13 - 24|Non-compliance|0|||
94514577|NCT00619866|323680917|FG001|Weeks 13 - 24|Non-compliance|1|||
94514578|NCT00619866|323680918|FG002|Weeks 13 - 24|Non-compliance|1|||
94514579|NCT00619866|323680919|FG003|Weeks 13 - 24|Non-compliance|0|||
94514580|NCT00619866|323680920|FG004|Weeks 13 - 24|Non-compliance|0|||
94514581|NCT00619866|323680916|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
94514582|NCT00619866|323680917|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
94514583|NCT00619866|323680918|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
94514584|NCT00619866|323680919|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
94514585|NCT00619866|323680920|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
94514586|NCT01242514|323680924|FG000|Overall Study|e.g., project closure|1042|||
94514587|NCT01242514|323680925|FG001|Overall Study|e.g., project closure|305|||
94514588|NCT01242514|323680926|FG002|Overall Study|e.g., project closure|171|||
94514589|NCT01242514|323680924|FG000|Overall Study|Subject decision|33|||
94514590|NCT01242514|323680925|FG001|Overall Study|Subject decision|8|||
94514591|NCT01242514|323680926|FG002|Overall Study|Subject decision|2|||
94514592|NCT01242514|323680924|FG000|Overall Study|Severe non-compliance to protocol|5|||
94514593|NCT01242514|323680925|FG001|Overall Study|Severe non-compliance to protocol|2|||
94514594|NCT01242514|323680926|FG002|Overall Study|Severe non-compliance to protocol|1|||
94514595|NCT01242514|323680924|FG000|Overall Study|Lack of therapeutic response|99|||
94514596|NCT01242514|323680925|FG001|Overall Study|Lack of therapeutic response|16|||
94514597|NCT01242514|323680926|FG002|Overall Study|Lack of therapeutic response|10|||
94514598|NCT01242514|323680924|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
94514599|NCT01242514|323680925|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
94514600|NCT01242514|323680926|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
94514601|NCT01242514|323680924|FG000|Overall Study|Lost to Follow-up|14|||
94514602|NCT01242514|323680925|FG001|Overall Study|Lost to Follow-up|5|||
94514603|NCT01242514|323680926|FG002|Overall Study|Lost to Follow-up|4|||
94514604|NCT01242514|323680924|FG000|Overall Study|Adverse Event|129|||
94514605|NCT01242514|323680925|FG001|Overall Study|Adverse Event|18|||
94514606|NCT01242514|323680926|FG002|Overall Study|Adverse Event|19|||
94514607|NCT03950856|323680930|FG000|Overall Study|Death|1|||
94514608|NCT03950856|323680931|FG001|Overall Study|Death|2|||
94514609|NCT03950856|323680932|FG002|Overall Study|Death|0|||
94514610|NCT03950856|323680933|FG003|Overall Study|Death|0|||
94514611|NCT03950856|323680930|FG000|Overall Study|Lost to Follow-up|5|||
94514612|NCT03950856|323680931|FG001|Overall Study|Lost to Follow-up|6|||
94514613|NCT03950856|323680932|FG002|Overall Study|Lost to Follow-up|8|||
94514614|NCT03950856|323680933|FG003|Overall Study|Lost to Follow-up|2|||
94514615|NCT03950856|323680930|FG000|Overall Study|Protocol Violation|2|||
94514616|NCT03950856|323680931|FG001|Overall Study|Protocol Violation|0|||
94514617|NCT03950856|323680932|FG002|Overall Study|Protocol Violation|0|||
94514618|NCT03950856|323680933|FG003|Overall Study|Protocol Violation|1|||
94514619|NCT03950856|323680930|FG000|Overall Study|Withdrawal by Subject|4|||
94514620|NCT03950856|323680931|FG001|Overall Study|Withdrawal by Subject|1|||
94514621|NCT03950856|323680932|FG002|Overall Study|Withdrawal by Subject|3|||
94514622|NCT03950856|323680933|FG003|Overall Study|Withdrawal by Subject|1|||
94514623|NCT03950856|323680930|FG000|Overall Study|Unable to phone|7|||
94514624|NCT03950856|323680931|FG001|Overall Study|Unable to phone|6|||
94514625|NCT03950856|323680932|FG002|Overall Study|Unable to phone|7|||
94514626|NCT03950856|323680933|FG003|Overall Study|Unable to phone|2|||
94514627|NCT04549454|323680939|FG000|T1 to T2|Lost to Follow-up|22|||
94514628|NCT04549454|323680940|FG001|T1 to T2|Lost to Follow-up|26|||
94514629|NCT04549454|323680939|FG000|T1 to T3|Lost to Follow-up|31|||
94514630|NCT04549454|323680940|FG001|T1 to T3|Lost to Follow-up|36|||
94514631|NCT00867035|323680941|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
94514632|NCT00867035|323680942|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
94514633|NCT00867035|323680941|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
94514634|NCT00867035|323680942|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
94514635|NCT00016354|323680948|FG000|Overall Study|Lack of Efficacy|0|||
94514636|NCT00016354|323680949|FG001|Overall Study|Lack of Efficacy|0|||
94514637|NCT00016354|323680950|FG002|Overall Study|Lack of Efficacy|0|||
94514638|NCT00016354|323680951|FG003|Overall Study|Lack of Efficacy|0|||
94514639|NCT00016354|323680952|FG004|Overall Study|Lack of Efficacy|0|||
94514640|NCT00016354|323680953|FG005|Overall Study|Lack of Efficacy|0|||
94514641|NCT00016354|323680954|FG006|Overall Study|Lack of Efficacy|0|||
94514642|NCT00016354|323680955|FG007|Overall Study|Lack of Efficacy|1|||
94514643|NCT03913130|323680962|FG000|Overall Study|Sponsor Decision|1|||
94514644|NCT01174563|323680963|FG000|Overall Study|Progressive Disease|45|||
94514645|NCT01174563|323680963|FG000|Overall Study|Death|5|||
94514646|NCT01174563|323680963|FG000|Overall Study|Investigator's Discretion|5|||
94514647|NCT01174563|323680963|FG000|Overall Study|Participant Withdrew Consent|3|||
94514648|NCT01174563|323680963|FG000|Overall Study|Rash Adverse Event|1|||
94514649|NCT01174563|323680963|FG000|Overall Study|Sponsor's decision|1|||
94514650|NCT01664624|323682531|FG000|Overall Study|Adverse Event|0|||
94514651|NCT01664624|323682532|FG001|Overall Study|Adverse Event|1|||
94514652|NCT01664624|323682533|FG002|Overall Study|Adverse Event|0|||
94514653|NCT01664624|323682534|FG003|Overall Study|Adverse Event|0|||
94514654|NCT02367456|323682537|FG000|Overall Study|Death|8|||
94514655|NCT02367456|323682538|FG001|Overall Study|Death|24|||
94514656|NCT02367456|323682539|FG002|Overall Study|Death|17|||
94514657|NCT02367456|323682537|FG000|Overall Study|Lost to Follow-up|1|||
94514658|NCT02367456|323682538|FG001|Overall Study|Lost to Follow-up|3|||
94514659|NCT02367456|323682539|FG002|Overall Study|Lost to Follow-up|1|||
94514660|NCT02367456|323682537|FG000|Overall Study|Other reason|3|||
94514661|NCT02367456|323682538|FG001|Overall Study|Other reason|3|||
94514662|NCT02367456|323682539|FG002|Overall Study|Other reason|9|||
94514663|NCT02367456|323682537|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
94514664|NCT02367456|323682538|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
94514665|NCT02367456|323682539|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
94514666|NCT01645176|323682541|FG000|Overall Study|Lack of Efficacy|4|||
94514667|NCT01645176|323682541|FG000|Overall Study|did not complete final MRI|1|||
94514668|NCT02234362|323682542|FG000|Overall Study|Not eligible after first screening visit|17|||
94514669|NCT02234362|323682542|FG000|Overall Study|Lost to Follow-up|6|||
94514670|NCT02234362|323682542|FG000|Overall Study|Withdrawal by Subject|3|||
94514671|NCT00320606|323682545|FG000|Overall Study|Adverse Event|1|||
94514672|NCT00320606|323682545|FG000|Overall Study|Protocol Violation|1|||
94655640|NCT01632579|324196112|FG002|Washout Period|Adverse Event|0|||
94514673|NCT00320606|323682545|FG000|Overall Study|Withdrawal by Subject|1|||
94514674|NCT02569853|323682546|FG000|Overall Study|Adverse Event|2|||
94514675|NCT02569853|323682547|FG001|Overall Study|Adverse Event|0|||
94514676|NCT02569853|323682546|FG000|Overall Study|Withdrawal by Subject|3|||
94514677|NCT02569853|323682547|FG001|Overall Study|Withdrawal by Subject|2|||
94514678|NCT02569853|323682546|FG000|Overall Study|Lost to Follow-up|3|||
94514679|NCT02569853|323682547|FG001|Overall Study|Lost to Follow-up|3|||
94514680|NCT02569853|323682546|FG000|Overall Study|Protocol Violation|1|||
94514681|NCT02569853|323682547|FG001|Overall Study|Protocol Violation|1|||
94514682|NCT02569853|323682546|FG000|Overall Study|Did not experience migraine attack|10|||
94514683|NCT02569853|323682547|FG001|Overall Study|Did not experience migraine attack|7|||
94514684|NCT02569853|323682546|FG000|Overall Study|Physician Decision|1|||
94514685|NCT02569853|323682547|FG001|Overall Study|Physician Decision|1|||
94514686|NCT01668004|323682548|FG000|Overall Study|Adverse Event|7|||
94514687|NCT01668004|323682548|FG000|Overall Study|Withdrawal by Subject|2|||
94514688|NCT01668004|323682548|FG000|Overall Study|Lost to Follow-up|5|||
94514689|NCT01668004|323682548|FG000|Overall Study|Lack of Efficacy|9|||
94514690|NCT01668004|323682548|FG000|Overall Study|Non-compliance with treatment|2|||
94514691|NCT00474903|323682549|FG000|Overall Study|Protocol Violation|1|||
94514692|NCT00474903|323682550|FG001|Overall Study|Protocol Violation|5|||
94514693|NCT00474903|323682551|FG002|Overall Study|Protocol Violation|2|||
94514694|NCT02006927|323682554|FG000|Overall Study|Adverse Event|2|||
94514695|NCT02006927|323682554|FG000|Overall Study|Withdrawal by Subject|1|||
94514696|NCT00673920|323682559|FG000|Baseline up to Week 48|Withdrew consent|1|||
94514697|NCT00673920|323682560|FG001|Baseline up to Week 48|Withdrew consent|0|||
94514698|NCT00673920|323682561|FG002|Baseline up to Week 48|Withdrew consent|2|||
94514699|NCT00673920|323682562|FG003|Baseline up to Week 48|Withdrew consent|0|||
94514700|NCT00673920|323682563|FG004|Baseline up to Week 48|Withdrew consent|0|||
94514701|NCT00673920|323682564|FG005|Baseline up to Week 48|Withdrew consent|0|||
94514702|NCT00673920|323682565|FG006|Baseline up to Week 48|Withdrew consent|0|||
94514703|NCT00673920|323682566|FG007|Baseline up to Week 48|Withdrew consent|0|||
94514704|NCT00673920|323682559|FG000|Baseline up to Week 48|Refused treatment|1|||
94514705|NCT00673920|323682560|FG001|Baseline up to Week 48|Refused treatment|0|||
94514706|NCT00673920|323682561|FG002|Baseline up to Week 48|Refused treatment|0|||
94514707|NCT00673920|323682562|FG003|Baseline up to Week 48|Refused treatment|0|||
94514708|NCT00673920|323682563|FG004|Baseline up to Week 48|Refused treatment|0|||
94514709|NCT00673920|323682564|FG005|Baseline up to Week 48|Refused treatment|0|||
94514710|NCT00673920|323682565|FG006|Baseline up to Week 48|Refused treatment|0|||
94514711|NCT00673920|323682566|FG007|Baseline up to Week 48|Refused treatment|0|||
94514712|NCT00673920|323682559|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
94514713|NCT00673920|323682560|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
94514714|NCT00673920|323682561|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
94514715|NCT00673920|323682562|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
94514716|NCT00673920|323682563|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
94514717|NCT00673920|323682564|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
94514718|NCT00673920|323682565|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
94514719|NCT00673920|323682566|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
94514720|NCT00673920|323682559|FG000|Baseline up to Week 48|Protocol Violation|0|||
94514721|NCT00673920|323682560|FG001|Baseline up to Week 48|Protocol Violation|0|||
94514722|NCT00673920|323682561|FG002|Baseline up to Week 48|Protocol Violation|1|||
94514723|NCT00673920|323682562|FG003|Baseline up to Week 48|Protocol Violation|0|||
94514724|NCT00673920|323682563|FG004|Baseline up to Week 48|Protocol Violation|0|||
94514725|NCT00673920|323682564|FG005|Baseline up to Week 48|Protocol Violation|0|||
94514726|NCT00673920|323682565|FG006|Baseline up to Week 48|Protocol Violation|0|||
94514727|NCT00673920|323682566|FG007|Baseline up to Week 48|Protocol Violation|0|||
94514728|NCT00673920|323682559|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
94514729|NCT00673920|323682560|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
94514730|NCT00673920|323682561|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
94514731|NCT00673920|323682562|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
94514732|NCT00673920|323682563|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
94514733|NCT00673920|323682564|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
94514734|NCT00673920|323682565|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
94514735|NCT00673920|323682566|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
94514736|NCT00673920|323682559|FG000|Baseline up to Week 48|Administrative/Other|0|||
94514737|NCT00673920|323682560|FG001|Baseline up to Week 48|Administrative/Other|1|||
94514738|NCT00673920|323682561|FG002|Baseline up to Week 48|Administrative/Other|2|||
94514739|NCT00673920|323682562|FG003|Baseline up to Week 48|Administrative/Other|0|||
94514740|NCT00673920|323682563|FG004|Baseline up to Week 48|Administrative/Other|0|||
94514741|NCT00673920|323682564|FG005|Baseline up to Week 48|Administrative/Other|0|||
94514742|NCT00673920|323682565|FG006|Baseline up to Week 48|Administrative/Other|0|||
94514743|NCT00673920|323682566|FG007|Baseline up to Week 48|Administrative/Other|0|||
94514744|NCT00673920|323682559|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
94514745|NCT00673920|323682560|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
94514746|NCT00673920|323682561|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
94514747|NCT00673920|323682562|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
94514748|NCT00673920|323682563|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
94655641|NCT01632579|324196113|FG003|Washout Period|Adverse Event|0|||
94655642|NCT01632579|324196114|FG004|Washout Period|Adverse Event|0|||
94655643|NCT01632579|324196115|FG005|Washout Period|Adverse Event|0|||
94514749|NCT00673920|323682564|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
94514750|NCT00673920|323682565|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
94514751|NCT00673920|323682566|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
94514752|NCT00673920|323682559|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
94514753|NCT00673920|323682560|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
94514754|NCT00673920|323682561|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
94514755|NCT00673920|323682562|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
94514756|NCT00673920|323682563|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
94514757|NCT00673920|323682564|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
94514758|NCT00673920|323682565|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
94514759|NCT00673920|323682566|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
94514760|NCT00673920|323682559|FG000|Week 24 to Week 48|Failure to return|0|||
94514761|NCT00673920|323682560|FG001|Week 24 to Week 48|Failure to return|0|||
94514762|NCT00673920|323682561|FG002|Week 24 to Week 48|Failure to return|0|||
94514763|NCT00673920|323682562|FG003|Week 24 to Week 48|Failure to return|0|||
94514764|NCT00673920|323682563|FG004|Week 24 to Week 48|Failure to return|0|||
94514765|NCT00673920|323682564|FG005|Week 24 to Week 48|Failure to return|1|||
94514766|NCT00673920|323682565|FG006|Week 24 to Week 48|Failure to return|0|||
94514767|NCT00673920|323682566|FG007|Week 24 to Week 48|Failure to return|0|||
94514768|NCT00673920|323682559|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
94514769|NCT00673920|323682560|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
94514770|NCT00673920|323682561|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
94514771|NCT00673920|323682562|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
94514772|NCT00673920|323682563|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
94514773|NCT00673920|323682564|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
94514774|NCT00673920|323682565|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
94514775|NCT00673920|323682566|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
94514776|NCT00673920|323682559|FG000|Week 24 to Week 48|Death|0|||
94514777|NCT00673920|323682560|FG001|Week 24 to Week 48|Death|0|||
94514778|NCT00673920|323682561|FG002|Week 24 to Week 48|Death|0|||
94514779|NCT00673920|323682562|FG003|Week 24 to Week 48|Death|0|||
94514780|NCT00673920|323682563|FG004|Week 24 to Week 48|Death|0|||
94514781|NCT00673920|323682564|FG005|Week 24 to Week 48|Death|1|||
94514782|NCT00673920|323682565|FG006|Week 24 to Week 48|Death|0|||
94514783|NCT00673920|323682566|FG007|Week 24 to Week 48|Death|0|||
94514784|NCT00673920|323682559|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
94514785|NCT00673920|323682560|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
94514786|NCT00673920|323682561|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
94514787|NCT00673920|323682562|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
94514788|NCT00673920|323682563|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
94514789|NCT00673920|323682564|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
94514790|NCT00673920|323682565|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
94514791|NCT00673920|323682566|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
94514792|NCT01917318|323682569|FG000|First Treatment|Withdrawal by Subject|0|||
94514793|NCT01917318|323682570|FG001|First Treatment|Withdrawal by Subject|1|||
94514794|NCT02493764|323682571|FG000|Overall Study|Adverse Event|2|||
94514795|NCT02493764|323682572|FG001|Overall Study|Adverse Event|2|||
94514796|NCT02493764|323682571|FG000|Overall Study|Death|44|||
94514797|NCT02493764|323682572|FG001|Overall Study|Death|58|||
94514798|NCT02493764|323682571|FG000|Overall Study|Lost to Follow-up|2|||
94514799|NCT02493764|323682572|FG001|Overall Study|Lost to Follow-up|1|||
94514800|NCT02493764|323682571|FG000|Overall Study|Protocol Violation|6|||
94514801|NCT02493764|323682572|FG001|Overall Study|Protocol Violation|7|||
94514802|NCT02493764|323682571|FG000|Overall Study|Physician Decision|1|||
94514803|NCT02493764|323682572|FG001|Overall Study|Physician Decision|1|||
94514804|NCT02493764|323682571|FG000|Overall Study|Participant moved|17|||
94514805|NCT02493764|323682572|FG001|Overall Study|Participant moved|5|||
94514806|NCT02493764|323682571|FG000|Overall Study|Withdrawal parent/guardian|0|||
94514807|NCT02493764|323682572|FG001|Overall Study|Withdrawal parent/guardian|1|||
94514808|NCT02493764|323682571|FG000|Overall Study|Withdrawal by Subject|11|||
94514809|NCT02493764|323682572|FG001|Overall Study|Withdrawal by Subject|7|||
94514810|NCT05136170|323682573|FG000|Overall Study|Withdrawal by Subject|2|||
94514811|NCT05136170|323682574|FG001|Overall Study|Withdrawal by Subject|2|||
94514812|NCT05136170|323682573|FG000|Overall Study|Can no longer make office visits|1|||
94514813|NCT05136170|323682574|FG001|Overall Study|Can no longer make office visits|0|||
94514814|NCT01531998|323682575|FG000|Overall Study|Withdrawal by Subject|3|||
94514815|NCT01156844|323682578|FG000|Overall Study|Adverse Event|0|||
94514816|NCT01156844|323682579|FG001|Overall Study|Adverse Event|0|||
94514817|NCT01156844|323682580|FG002|Overall Study|Adverse Event|1|||
94514818|NCT01156844|323682581|FG003|Overall Study|Adverse Event|1|||
94514819|NCT01156844|323682578|FG000|Overall Study|Abnormal test procedure result(s)|0|||
94514820|NCT01156844|323682579|FG001|Overall Study|Abnormal test procedure result(s)|1|||
94514821|NCT01156844|323682580|FG002|Overall Study|Abnormal test procedure result(s)|2|||
94514822|NCT01156844|323682581|FG003|Overall Study|Abnormal test procedure result(s)|2|||
94514823|NCT01156844|323682578|FG000|Overall Study|Withdrawal by Subject|0|||
94514824|NCT01156844|323682579|FG001|Overall Study|Withdrawal by Subject|0|||
94514825|NCT01156844|323682580|FG002|Overall Study|Withdrawal by Subject|2|||
94514826|NCT01156844|323682581|FG003|Overall Study|Withdrawal by Subject|2|||
94514827|NCT01156844|323682578|FG000|Overall Study|Lost to Follow-up|0|||
94514828|NCT01156844|323682579|FG001|Overall Study|Lost to Follow-up|0|||
94514829|NCT01156844|323682580|FG002|Overall Study|Lost to Follow-up|1|||
94514830|NCT01156844|323682581|FG003|Overall Study|Lost to Follow-up|0|||
94514831|NCT01156844|323682578|FG000|Overall Study|Administrative problems|0|||
94514832|NCT01156844|323682579|FG001|Overall Study|Administrative problems|1|||
94514833|NCT01156844|323682580|FG002|Overall Study|Administrative problems|0|||
94514834|NCT01156844|323682581|FG003|Overall Study|Administrative problems|1|||
94514835|NCT01156844|323682578|FG000|Overall Study|Protocol deviation|2|||
94514836|NCT01156844|323682579|FG001|Overall Study|Protocol deviation|0|||
94514837|NCT01156844|323682580|FG002|Overall Study|Protocol deviation|0|||
94514838|NCT01156844|323682581|FG003|Overall Study|Protocol deviation|0|||
94514839|NCT02921256|323682592|FG000|Arm 1a v. Arm II|Adverse Event|6|||
94514840|NCT02921256|323682593|FG001|Arm 1a v. Arm II|Adverse Event|15|||
94514841|NCT02921256|323682594|FG002|Arm 1a v. Arm II|Adverse Event|0|||
94514842|NCT02921256|323682592|FG000|Arm 1a v. Arm II|Death|0|||
94514843|NCT02921256|323682593|FG001|Arm 1a v. Arm II|Death|2|||
94514844|NCT02921256|323682594|FG002|Arm 1a v. Arm II|Death|0|||
94514845|NCT02921256|323682592|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
94514846|NCT02921256|323682593|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
94514847|NCT02921256|323682594|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
94514848|NCT02921256|323682592|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
94514849|NCT02921256|323682593|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
94514850|NCT02921256|323682594|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
94514851|NCT02921256|323682592|FG000|Arm 1a v. Arm II|Physician Decision|1|||
94514852|NCT02921256|323682593|FG001|Arm 1a v. Arm II|Physician Decision|1|||
94514853|NCT02921256|323682594|FG002|Arm 1a v. Arm II|Physician Decision|0|||
94514854|NCT02921256|323682592|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
94514855|NCT02921256|323682593|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
94514856|NCT02921256|323682594|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
94514857|NCT02921256|323682592|FG000|Arm Ib v Arm III|Adverse Event|9|||
94514858|NCT02921256|323682593|FG001|Arm Ib v Arm III|Adverse Event|0|||
94514859|NCT02921256|323682594|FG002|Arm Ib v Arm III|Adverse Event|4|||
94514860|NCT02921256|323682592|FG000|Arm Ib v Arm III|Death|1|||
94514861|NCT02921256|323682593|FG001|Arm Ib v Arm III|Death|0|||
94514862|NCT02921256|323682594|FG002|Arm Ib v Arm III|Death|1|||
94514863|NCT02921256|323682592|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
94514864|NCT02921256|323682593|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
94514865|NCT02921256|323682594|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
94514866|NCT02921256|323682592|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
94514867|NCT02921256|323682593|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
94514868|NCT02921256|323682594|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
94514869|NCT02921256|323682592|FG000|Arm Ib v Arm III|Physician Decision|4|||
94514870|NCT02921256|323682593|FG001|Arm Ib v Arm III|Physician Decision|0|||
94514871|NCT02921256|323682594|FG002|Arm Ib v Arm III|Physician Decision|1|||
94514872|NCT02921256|323682592|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
94514873|NCT02921256|323682593|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
94514874|NCT02921256|323682594|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
94514875|NCT01448616|323682595|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
94514876|NCT01448616|323682596|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
94514877|NCT01448616|323682597|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
94514878|NCT01448616|323682598|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
94514879|NCT01448616|323682595|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
94514880|NCT01448616|323682596|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
94514881|NCT01448616|323682597|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
94514882|NCT01448616|323682598|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
94514883|NCT01448616|323682595|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
94514884|NCT01448616|323682596|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
94514885|NCT01448616|323682597|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
94514886|NCT01448616|323682598|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
94514887|NCT01448616|323682595|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
94514888|NCT01448616|323682596|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
94514889|NCT01448616|323682597|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
94514890|NCT01448616|323682598|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
94514891|NCT01448616|323682595|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
94514892|NCT01448616|323682596|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
94514893|NCT01448616|323682597|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
94514894|NCT01448616|323682598|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
94514895|NCT02943473|323682606|FG000|Overall Study|enrolled but not dosed|1|||
94514896|NCT02943473|323682606|FG000|Overall Study|screen failure|1|||
94514897|NCT02943473|323682606|FG000|Overall Study|Physician Decision|4|||
94514898|NCT00049543|323682608|FG000|Overall Study|still on treatment|2|||
94514899|NCT00049543|323682609|FG001|Overall Study|still on treatment|9|||
94514900|NCT01736917|323682610|FG000|Overall Study|Adverse Event|1|||
94514901|NCT01736917|323682610|FG000|Overall Study|Protocol Violation|10|||
94514902|NCT01911260|323682611|FG000|Supplementation Period|transference or evasion of school|7|||
94514903|NCT01911260|323682612|FG001|Supplementation Period|transference or evasion of school|9|||
94514904|NCT01911260|323682613|FG002|Supplementation Period|transference or evasion of school|7|||
94514905|NCT01911260|323682614|FG003|Supplementation Period|transference or evasion of school|6|||
94514906|NCT01911260|323682611|FG000|Supplementation Period|Adverse Event|2|||
94514907|NCT01911260|323682612|FG001|Supplementation Period|Adverse Event|0|||
94514908|NCT01911260|323682613|FG002|Supplementation Period|Adverse Event|1|||
94514909|NCT01911260|323682614|FG003|Supplementation Period|Adverse Event|0|||
94514910|NCT01911260|323682611|FG000|Supplementation Period|refused to receive supplement|1|||
94514911|NCT01911260|323682612|FG001|Supplementation Period|refused to receive supplement|0|||
94514912|NCT01911260|323682613|FG002|Supplementation Period|refused to receive supplement|1|||
94514913|NCT01911260|323682614|FG003|Supplementation Period|refused to receive supplement|0|||
94514914|NCT01911260|323682611|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
94514915|NCT01911260|323682612|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
94514916|NCT01911260|323682613|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
94514917|NCT01911260|323682614|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
94514918|NCT01911260|323682611|FG000|Follow-up Period|transference or evasion of school|13|||
94514919|NCT01911260|323682612|FG001|Follow-up Period|transference or evasion of school|20|||
94514920|NCT01911260|323682613|FG002|Follow-up Period|transference or evasion of school|15|||
94514921|NCT01911260|323682614|FG003|Follow-up Period|transference or evasion of school|12|||
94514922|NCT00656370|323682635|FG000|Overall Study|Screen Failures|7|||
94514923|NCT00656370|323682635|FG000|Overall Study|Alternates|3|||
94514924|NCT05899829|323682636|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
94514925|NCT05899829|323682637|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
94514926|NCT05899829|323682636|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
94514927|NCT05899829|323682637|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
94514928|NCT01722669|323682642|FG000|Overall Study|Withdrawal by Subject|0|||
94514929|NCT01722669|323682643|FG001|Overall Study|Withdrawal by Subject|0|||
94514930|NCT01722669|323682644|FG002|Overall Study|Withdrawal by Subject|0|||
94514931|NCT01722669|323682645|FG003|Overall Study|Withdrawal by Subject|0|||
94514932|NCT01722669|323682646|FG004|Overall Study|Withdrawal by Subject|0|||
94514933|NCT01722669|323682647|FG005|Overall Study|Withdrawal by Subject|2|||
94514934|NCT00789555|323682648|FG000|Overall Study|Protocol Amendment|78|||
94514935|NCT00789555|323682649|FG001|Overall Study|Protocol Amendment|76|||
94514936|NCT00789555|323682650|FG002|Overall Study|Protocol Amendment|80|||
94514937|NCT00789555|323682648|FG000|Overall Study|Adverse Event|17|||
94514938|NCT00789555|323682649|FG001|Overall Study|Adverse Event|7|||
94514939|NCT00789555|323682650|FG002|Overall Study|Adverse Event|10|||
94514940|NCT00789555|323682648|FG000|Overall Study|Lost to Follow-up|9|||
94514941|NCT00789555|323682649|FG001|Overall Study|Lost to Follow-up|10|||
94514942|NCT00789555|323682650|FG002|Overall Study|Lost to Follow-up|18|||
94514943|NCT00789555|323682648|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
94514944|NCT00789555|323682649|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
94514945|NCT00789555|323682650|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
94514946|NCT00789555|323682648|FG000|Overall Study|Treatment failure|11|||
94514947|NCT00789555|323682649|FG001|Overall Study|Treatment failure|8|||
94514948|NCT00789555|323682650|FG002|Overall Study|Treatment failure|12|||
94514949|NCT00789555|323682648|FG000|Overall Study|Protocol Violation|6|||
94514950|NCT00789555|323682649|FG001|Overall Study|Protocol Violation|9|||
94514951|NCT00789555|323682650|FG002|Overall Study|Protocol Violation|13|||
94514952|NCT01152437|323682651|FG000|Overall Study|Other Adverse Event|8|||
94514953|NCT01152437|323682652|FG001|Overall Study|Other Adverse Event|1|||
94514954|NCT01152437|323682653|FG002|Overall Study|Other Adverse Event|7|||
94514955|NCT01152437|323682651|FG000|Overall Study|Not treated|0|||
94514956|NCT01152437|323682652|FG001|Overall Study|Not treated|1|||
94514957|NCT01152437|323682653|FG002|Overall Study|Not treated|2|||
94514958|NCT01152437|323682651|FG000|Overall Study|Progressive disease|27|||
94514959|NCT01152437|323682652|FG001|Overall Study|Progressive disease|13|||
94514960|NCT01152437|323682653|FG002|Overall Study|Progressive disease|32|||
94514961|NCT01152437|323682651|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
94514962|NCT01152437|323682652|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
94514963|NCT01152437|323682653|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
94514964|NCT00279214|323682657|FG000|Overall Study|Physician Decision|3|||
94514965|NCT00279214|323682658|FG001|Overall Study|Physician Decision|2|||
94514966|NCT04046939|323682659|FG000|Primary Assessment Period|Adverse Event|1|||
94514967|NCT04046939|323682660|FG001|Primary Assessment Period|Adverse Event|0|||
94514968|NCT04046939|323682661|FG002|Primary Assessment Period|Adverse Event|0|||
94514969|NCT04046939|323682662|FG003|Primary Assessment Period|Adverse Event|0|||
94514970|NCT04046939|323682659|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
94514971|NCT04046939|323682660|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
94514972|NCT04046939|323682661|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
94514973|NCT04046939|323682662|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
94514974|NCT04046939|323682659|FG000|Primary Assessment Period|Physician Decision|0|||
94514975|NCT04046939|323682660|FG001|Primary Assessment Period|Physician Decision|0|||
94514976|NCT04046939|323682661|FG002|Primary Assessment Period|Physician Decision|1|||
94514977|NCT04046939|323682662|FG003|Primary Assessment Period|Physician Decision|0|||
94514978|NCT04046939|323682659|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
94514979|NCT04046939|323682660|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
94514980|NCT04046939|323682661|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
94514981|NCT04046939|323682662|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
94514982|NCT00542178|323682664|FG000|Overall Study|did not complete year 4 follow-up|75|||
94514983|NCT00542178|323682665|FG001|Overall Study|did not complete year 4 follow-up|80|||
94514984|NCT00542178|323682666|FG002|Overall Study|did not complete year 4 follow-up|74|||
94514985|NCT00542178|323682667|FG003|Overall Study|did not complete year 4 follow-up|62|||
94514986|NCT00542178|323682668|FG004|Overall Study|did not complete year 4 follow-up|64|||
94514987|NCT00542178|323682669|FG005|Overall Study|did not complete year 4 follow-up|89|||
94514988|NCT00542178|323682670|FG006|Overall Study|did not complete year 4 follow-up|87|||
94514989|NCT00542178|323682671|FG007|Overall Study|did not complete year 4 follow-up|85|||
94514990|NCT01729039|323682672|FG000|Overall Study|disqualified|2|||
94514991|NCT01729039|323682673|FG001|Overall Study|disqualified|5|||
94514992|NCT01729039|323682672|FG000|Overall Study|Withdrawal by Subject|8|||
94514993|NCT01729039|323682673|FG001|Overall Study|Withdrawal by Subject|7|||
94514994|NCT00829998|323682674|FG000|Washout|Adverse Event|0|||
94514995|NCT00829998|323682675|FG001|Washout|Adverse Event|1|||
94514996|NCT05788991|323682676|FG000|Overall Study|Not treated with study medication|1|||
94514997|NCT05788991|323682677|FG001|Overall Study|Not treated with study medication|3|||
94514998|NCT05788991|323682676|FG000|Overall Study|Withdrawal by Subject|1|||
94514999|NCT05788991|323682677|FG001|Overall Study|Withdrawal by Subject|0|||
94515000|NCT05788991|323682676|FG000|Overall Study|Lack of Efficacy|0|||
94515001|NCT05788991|323682677|FG001|Overall Study|Lack of Efficacy|1|||
94515002|NCT05788991|323682676|FG000|Overall Study|Protocol Violation|1|||
94515003|NCT05788991|323682677|FG001|Overall Study|Protocol Violation|2|||
94515004|NCT05270863|323682678|FG000|Visit 2 First Intervention|Randomization error|0|||
94515005|NCT05270863|323682679|FG001|Visit 2 First Intervention|Randomization error|0|||
94515006|NCT05270863|323682680|FG002|Visit 2 First Intervention|Randomization error|0|||
94515007|NCT05270863|323682681|FG003|Visit 2 First Intervention|Randomization error|1|||
94515008|NCT05270863|323682682|FG004|Visit 2 First Intervention|Randomization error|0|||
94515009|NCT05270863|323682683|FG005|Visit 2 First Intervention|Randomization error|0|||
94515010|NCT05270863|323682678|FG000|First Washout|Withdrawal by Subject|0|||
94515011|NCT05270863|323682679|FG001|First Washout|Withdrawal by Subject|0|||
94515012|NCT05270863|323682680|FG002|First Washout|Withdrawal by Subject|0|||
94515013|NCT05270863|323682681|FG003|First Washout|Withdrawal by Subject|0|||
94515014|NCT05270863|323682682|FG004|First Washout|Withdrawal by Subject|1|||
94515015|NCT05270863|323682683|FG005|First Washout|Withdrawal by Subject|1|||
94515016|NCT05270863|323682678|FG000|First Washout|Lost to Follow-up|0|||
94515017|NCT05270863|323682679|FG001|First Washout|Lost to Follow-up|0|||
94515018|NCT05270863|323682680|FG002|First Washout|Lost to Follow-up|0|||
94515019|NCT05270863|323682681|FG003|First Washout|Lost to Follow-up|0|||
94515020|NCT05270863|323682682|FG004|First Washout|Lost to Follow-up|0|||
94515021|NCT05270863|323682683|FG005|First Washout|Lost to Follow-up|1|||
94515022|NCT05270863|323682678|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
94515023|NCT05270863|323682679|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
94515024|NCT05270863|323682680|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
94515025|NCT05270863|323682681|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
94515026|NCT05270863|323682682|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
94515027|NCT05270863|323682683|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
94515028|NCT05270863|323682678|FG000|Second Washout|Withdrawal by Subject|1|||
94515029|NCT05270863|323682679|FG001|Second Washout|Withdrawal by Subject|1|||
94515030|NCT05270863|323682680|FG002|Second Washout|Withdrawal by Subject|0|||
94515031|NCT05270863|323682681|FG003|Second Washout|Withdrawal by Subject|0|||
94515032|NCT05270863|323682682|FG004|Second Washout|Withdrawal by Subject|0|||
94515033|NCT05270863|323682683|FG005|Second Washout|Withdrawal by Subject|0|||
94515034|NCT05270863|323682678|FG000|Second Washout|Lost to Follow-up|0|||
94515035|NCT05270863|323682679|FG001|Second Washout|Lost to Follow-up|0|||
94515036|NCT05270863|323682680|FG002|Second Washout|Lost to Follow-up|0|||
94515037|NCT05270863|323682681|FG003|Second Washout|Lost to Follow-up|1|||
94515038|NCT05270863|323682682|FG004|Second Washout|Lost to Follow-up|0|||
94515039|NCT05270863|323682683|FG005|Second Washout|Lost to Follow-up|0|||
94515040|NCT02561962|323682687|FG000|Overall Study|Withdrawal by Subject|1|||
94515041|NCT02561962|323682688|FG001|Overall Study|Withdrawal by Subject|0|||
94515042|NCT02561962|323682689|FG002|Overall Study|Withdrawal by Subject|0|||
94515043|NCT02561962|323682690|FG003|Overall Study|Withdrawal by Subject|0|||
94515044|NCT02561962|323682691|FG004|Overall Study|Withdrawal by Subject|1|||
94515045|NCT02561962|323682692|FG005|Overall Study|Withdrawal by Subject|1|||
94515046|NCT02561962|323682693|FG006|Overall Study|Withdrawal by Subject|2|||
94515047|NCT02561962|323682694|FG007|Overall Study|Withdrawal by Subject|1|||
94515048|NCT02561962|323682695|FG008|Overall Study|Withdrawal by Subject|0|||
94515049|NCT02561962|323682687|FG000|Overall Study|Decision by sponsor|0|||
94515050|NCT02561962|323682688|FG001|Overall Study|Decision by sponsor|0|||
94515051|NCT02561962|323682689|FG002|Overall Study|Decision by sponsor|0|||
94515052|NCT02561962|323682690|FG003|Overall Study|Decision by sponsor|0|||
94515053|NCT02561962|323682691|FG004|Overall Study|Decision by sponsor|1|||
94515054|NCT02561962|323682692|FG005|Overall Study|Decision by sponsor|1|||
94515055|NCT02561962|323682693|FG006|Overall Study|Decision by sponsor|0|||
94515056|NCT02561962|323682694|FG007|Overall Study|Decision by sponsor|3|||
94515057|NCT02561962|323682695|FG008|Overall Study|Decision by sponsor|0|||
94515058|NCT02561962|323682687|FG000|Overall Study|Lost to Follow-up|0|||
94515059|NCT02561962|323682688|FG001|Overall Study|Lost to Follow-up|0|||
94515060|NCT02561962|323682689|FG002|Overall Study|Lost to Follow-up|0|||
94515061|NCT02561962|323682690|FG003|Overall Study|Lost to Follow-up|0|||
94515062|NCT02561962|323682691|FG004|Overall Study|Lost to Follow-up|0|||
94515063|NCT02561962|323682692|FG005|Overall Study|Lost to Follow-up|1|||
94515064|NCT02561962|323682693|FG006|Overall Study|Lost to Follow-up|0|||
94515065|NCT02561962|323682694|FG007|Overall Study|Lost to Follow-up|0|||
94515066|NCT02561962|323682695|FG008|Overall Study|Lost to Follow-up|0|||
94515067|NCT04237584|323682697|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
94515068|NCT04237584|323682698|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
94515069|NCT04237584|323682699|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
94515070|NCT04237584|323682700|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
94515071|NCT04237584|323682697|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
94515072|NCT04237584|323682698|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
94515073|NCT04237584|323682699|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
94515074|NCT04237584|323682700|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
94515075|NCT04237584|323682697|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
94515076|NCT04237584|323682698|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
94515077|NCT04237584|323682699|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
94515078|NCT04237584|323682700|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
94515079|NCT04237584|323682697|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
94515080|NCT04237584|323682698|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
94515081|NCT04237584|323682699|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
94515082|NCT04237584|323682700|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
94515083|NCT04237584|323682697|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
94515084|NCT04237584|323682698|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
94515085|NCT04237584|323682699|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
94515086|NCT04237584|323682700|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
94515087|NCT02471144|323684656|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
94515088|NCT02471144|323684657|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
94515089|NCT02471144|323684658|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
94515090|NCT02471144|323684659|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
94515091|NCT02471144|323684660|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
94515092|NCT02471144|323684661|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
94515093|NCT02471144|323684662|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
94515094|NCT02471144|323684663|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
94515095|NCT02471144|323684664|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
94515096|NCT02471144|323684665|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
94515097|NCT02471144|323684666|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
94515098|NCT02471144|323684656|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
94515099|NCT02471144|323684657|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
94515100|NCT02471144|323684658|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
94515101|NCT02471144|323684659|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
94515102|NCT02471144|323684660|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
94515103|NCT02471144|323684661|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
94515104|NCT02471144|323684662|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
94515105|NCT02471144|323684663|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
94515106|NCT02471144|323684664|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
94515107|NCT02471144|323684665|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
94515108|NCT02471144|323684666|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
94515109|NCT02471144|323684656|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
94515110|NCT02471144|323684657|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
94515111|NCT02471144|323684658|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
94515112|NCT02471144|323684659|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
94515113|NCT02471144|323684660|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
94515114|NCT02471144|323684661|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
94515115|NCT02471144|323684662|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
94515116|NCT02471144|323684663|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
94515117|NCT02471144|323684664|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
94515118|NCT02471144|323684665|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
94515119|NCT02471144|323684666|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
94515120|NCT02471144|323684656|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
94515121|NCT02471144|323684657|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
94515122|NCT02471144|323684658|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
94515123|NCT02471144|323684659|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
94515124|NCT02471144|323684660|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
94515125|NCT02471144|323684661|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
94515126|NCT02471144|323684662|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
94515127|NCT02471144|323684663|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
94515128|NCT02471144|323684664|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
94515129|NCT02471144|323684665|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
94515130|NCT02471144|323684666|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
94515131|NCT02471144|323684656|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
94515132|NCT02471144|323684657|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
94515133|NCT02471144|323684658|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
94515134|NCT02471144|323684659|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
94515135|NCT02471144|323684660|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
94515136|NCT02471144|323684661|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
94515137|NCT02471144|323684662|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
94515138|NCT02471144|323684663|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
94515139|NCT02471144|323684664|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
94515140|NCT02471144|323684665|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
94515141|NCT02471144|323684666|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
94515142|NCT02471144|323684656|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
94515143|NCT02471144|323684657|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
94515144|NCT02471144|323684658|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
94515145|NCT02471144|323684659|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
94515146|NCT02471144|323684660|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
94515147|NCT02471144|323684661|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
94515148|NCT02471144|323684662|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
94515149|NCT02471144|323684663|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
94515150|NCT02471144|323684664|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
94515151|NCT02471144|323684665|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
94515152|NCT02471144|323684666|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
94515153|NCT02471144|323684656|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
94515154|NCT02471144|323684657|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
94515155|NCT02471144|323684658|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
94515156|NCT02471144|323684659|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
94515157|NCT02471144|323684660|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
94515158|NCT02471144|323684661|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
94515159|NCT02471144|323684662|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
94515160|NCT02471144|323684663|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
94515161|NCT02471144|323684664|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
94515162|NCT02471144|323684665|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
94515163|NCT02471144|323684666|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
94515164|NCT02471144|323684656|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
94515165|NCT02471144|323684657|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
94515166|NCT02471144|323684658|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
94515167|NCT02471144|323684659|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
94515168|NCT02471144|323684660|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
94515169|NCT02471144|323684661|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
94515170|NCT02471144|323684662|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
94515171|NCT02471144|323684663|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
94515172|NCT02471144|323684664|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
94515173|NCT02471144|323684665|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
94515174|NCT02471144|323684666|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
94515175|NCT02471144|323684656|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
94515176|NCT02471144|323684657|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
94515177|NCT02471144|323684658|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
94515178|NCT02471144|323684659|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
94515179|NCT02471144|323684660|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
94515180|NCT02471144|323684661|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
94515181|NCT02471144|323684662|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
94515182|NCT02471144|323684663|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
94515183|NCT02471144|323684664|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
94515184|NCT02471144|323684665|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
94515185|NCT02471144|323684666|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
94515186|NCT02471144|323684656|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
94515187|NCT02471144|323684657|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
94515188|NCT02471144|323684658|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
94515189|NCT02471144|323684659|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
94515190|NCT02471144|323684660|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
94515191|NCT02471144|323684661|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
94515192|NCT02471144|323684662|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
94515193|NCT02471144|323684663|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
94515194|NCT02471144|323684664|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
94515195|NCT02471144|323684665|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
94515196|NCT02471144|323684666|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
94515197|NCT02471144|323684656|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
94515198|NCT02471144|323684657|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
94515199|NCT02471144|323684658|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
94515200|NCT02471144|323684659|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
94515201|NCT02471144|323684660|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
94515202|NCT02471144|323684661|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
94515203|NCT02471144|323684662|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
94515204|NCT02471144|323684663|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
94515205|NCT02471144|323684664|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
94515206|NCT02471144|323684665|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
94515207|NCT02471144|323684666|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
94515208|NCT02471144|323684656|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
94515209|NCT02471144|323684657|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
94515210|NCT02471144|323684658|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
94515211|NCT02471144|323684659|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
94515212|NCT02471144|323684660|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
94515213|NCT02471144|323684661|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
94515214|NCT02471144|323684662|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
94515215|NCT02471144|323684663|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
94515216|NCT02471144|323684664|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
94515217|NCT02471144|323684665|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
94515218|NCT02471144|323684666|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
94515219|NCT02471144|323684656|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
94515220|NCT02471144|323684657|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
94515221|NCT02471144|323684658|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
94515222|NCT02471144|323684659|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
94515223|NCT02471144|323684660|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
94515224|NCT02471144|323684661|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
94515225|NCT02471144|323684662|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
94515226|NCT02471144|323684663|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
94515227|NCT02471144|323684664|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
94515228|NCT02471144|323684665|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
94515229|NCT02471144|323684666|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
94515230|NCT02471144|323684656|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
94515231|NCT02471144|323684657|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
94515232|NCT02471144|323684658|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
94515233|NCT02471144|323684659|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
94515234|NCT02471144|323684660|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
94515235|NCT02471144|323684661|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
94515236|NCT02471144|323684662|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
94515237|NCT02471144|323684663|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
94515238|NCT02471144|323684664|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
94515239|NCT02471144|323684665|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
94515240|NCT02471144|323684666|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
94515241|NCT00791648|323684673|FG000|Overall Study|Physician Decision|0|||
94515242|NCT00791648|323684674|FG001|Overall Study|Physician Decision|1|||
94515243|NCT00791648|323684673|FG000|Overall Study|Withdrawal by Subject|0|||
94515244|NCT00791648|323684674|FG001|Overall Study|Withdrawal by Subject|1|||
94655644|NCT01632579|324196116|FG006|Washout Period|Adverse Event|0|||
94515245|NCT00462826|323684675|FG000|Overall Study|Ineligible - second primary|1|||
94515246|NCT00462826|323684675|FG000|Overall Study|Ineligible - wrong cell type|1|||
94515247|NCT00462826|323684675|FG000|Overall Study|Ineligible - wrong primary|2|||
94515248|NCT00462826|323684675|FG000|Overall Study|Never treated|1|||
94515249|NCT01657370|323684676|FG000|Overall Study|Withdrawal by Subject|0|||
94515250|NCT01657370|323684677|FG001|Overall Study|Withdrawal by Subject|0|||
94515251|NCT01657370|323684678|FG002|Overall Study|Withdrawal by Subject|1|||
94515252|NCT01657370|323684679|FG003|Overall Study|Withdrawal by Subject|0|||
94515253|NCT01657370|323684680|FG004|Overall Study|Withdrawal by Subject|0|||
94515254|NCT01657370|323684681|FG005|Overall Study|Withdrawal by Subject|1|||
94515255|NCT01657370|323684676|FG000|Overall Study|Physician Decision|2|||
94515256|NCT01657370|323684677|FG001|Overall Study|Physician Decision|3|||
94515257|NCT01657370|323684678|FG002|Overall Study|Physician Decision|1|||
94515258|NCT01657370|323684679|FG003|Overall Study|Physician Decision|2|||
94515259|NCT01657370|323684680|FG004|Overall Study|Physician Decision|5|||
94515260|NCT01657370|323684681|FG005|Overall Study|Physician Decision|0|||
94515261|NCT01657370|323684676|FG000|Overall Study|Lack of Qualifying Event|1|||
94515262|NCT01657370|323684677|FG001|Overall Study|Lack of Qualifying Event|0|||
94515263|NCT01657370|323684678|FG002|Overall Study|Lack of Qualifying Event|3|||
94515264|NCT01657370|323684679|FG003|Overall Study|Lack of Qualifying Event|2|||
94515265|NCT01657370|323684680|FG004|Overall Study|Lack of Qualifying Event|1|||
94515266|NCT01657370|323684681|FG005|Overall Study|Lack of Qualifying Event|2|||
94515267|NCT01657370|323684676|FG000|Overall Study|Adverse Event|0|||
94515268|NCT01657370|323684677|FG001|Overall Study|Adverse Event|0|||
94515269|NCT01657370|323684678|FG002|Overall Study|Adverse Event|0|||
94515270|NCT01657370|323684679|FG003|Overall Study|Adverse Event|0|||
94515271|NCT01657370|323684680|FG004|Overall Study|Adverse Event|1|||
94515272|NCT01657370|323684681|FG005|Overall Study|Adverse Event|0|||
94515273|NCT01657370|323684676|FG000|Overall Study|Protocol Violation|1|||
94515274|NCT01657370|323684677|FG001|Overall Study|Protocol Violation|1|||
94515275|NCT01657370|323684678|FG002|Overall Study|Protocol Violation|1|||
94515276|NCT01657370|323684679|FG003|Overall Study|Protocol Violation|1|||
94515277|NCT01657370|323684680|FG004|Overall Study|Protocol Violation|0|||
94515278|NCT01657370|323684681|FG005|Overall Study|Protocol Violation|0|||
94515279|NCT01657370|323684676|FG000|Overall Study|Lost to Follow-up|2|||
94515280|NCT01657370|323684677|FG001|Overall Study|Lost to Follow-up|0|||
94515281|NCT01657370|323684678|FG002|Overall Study|Lost to Follow-up|1|||
94515282|NCT01657370|323684679|FG003|Overall Study|Lost to Follow-up|0|||
94515283|NCT01657370|323684680|FG004|Overall Study|Lost to Follow-up|0|||
94515284|NCT01657370|323684681|FG005|Overall Study|Lost to Follow-up|1|||
94515285|NCT02278003|323684683|FG000|Overall Study|Withdrawal by Subject|11|||
94515286|NCT02278003|323684684|FG001|Overall Study|Withdrawal by Subject|0|||
94515287|NCT02278003|323684683|FG000|Overall Study|Not Treated|1|||
94515288|NCT02278003|323684684|FG001|Overall Study|Not Treated|0|||
94515289|NCT02278003|323684683|FG000|Overall Study|Recognition task improperly completed|7|||
94515290|NCT02278003|323684684|FG001|Overall Study|Recognition task improperly completed|0|||
94515291|NCT01585025|323684685|FG000|Overall Study|Withdrawal by Subject|0|||
94515292|NCT01585025|323684686|FG001|Overall Study|Withdrawal by Subject|3|||
94515293|NCT01585025|323684687|FG002|Overall Study|Withdrawal by Subject|4|||
94515294|NCT02552225|323684688|FG000|Overall Study|Withdrawal by Subject|1|||
94515295|NCT02552225|323684689|FG001|Overall Study|Withdrawal by Subject|0|||
94515296|NCT01276704|323684690|FG000|Overall Study|Lost to Follow-up|2|||
94515297|NCT01276704|323684691|FG001|Overall Study|Lost to Follow-up|3|||
94515298|NCT01276704|323684690|FG000|Overall Study|Non-compliant|2|||
94515299|NCT01276704|323684691|FG001|Overall Study|Non-compliant|2|||
94515300|NCT01276704|323684690|FG000|Overall Study|Withdrawal by Subject|7|||
94515301|NCT01276704|323684691|FG001|Overall Study|Withdrawal by Subject|1|||
94515302|NCT01276704|323684690|FG000|Overall Study|Physician Decision|3|||
94515303|NCT01276704|323684691|FG001|Overall Study|Physician Decision|5|||
94515304|NCT00876447|323684692|FG000|Overall Study|Other miscellaneous reasons|3|||
94515305|NCT00876447|323684693|FG001|Overall Study|Other miscellaneous reasons|8|||
94515306|NCT00876447|323684692|FG000|Overall Study|Site closure|19|||
94515307|NCT00876447|323684693|FG001|Overall Study|Site closure|14|||
94515308|NCT00876447|323684692|FG000|Overall Study|Protocol Violation|9|||
94515309|NCT00876447|323684693|FG001|Overall Study|Protocol Violation|3|||
94515310|NCT00876447|323684692|FG000|Overall Study|Personal reasons|30|||
94515311|NCT00876447|323684693|FG001|Overall Study|Personal reasons|28|||
94515312|NCT00876447|323684692|FG000|Overall Study|Lost to Follow-up|6|||
94515313|NCT00876447|323684693|FG001|Overall Study|Lost to Follow-up|15|||
94515314|NCT00876447|323684692|FG000|Overall Study|Pregnancy|4|||
94515315|NCT00876447|323684693|FG001|Overall Study|Pregnancy|2|||
94515316|NCT00876447|323684692|FG000|Overall Study|Lack of Efficacy|5|||
94515317|NCT00876447|323684693|FG001|Overall Study|Lack of Efficacy|3|||
94515318|NCT00876447|323684692|FG000|Overall Study|Adverse Event|4|||
94515319|NCT00876447|323684693|FG001|Overall Study|Adverse Event|8|||
94515320|NCT00710593|323684694|FG000|Overall Study|Incarceration|1|||
94515321|NCT00710593|323684695|FG001|Overall Study|Incarceration|0|||
94515322|NCT00710593|323684694|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
94655645|NCT01632579|324196117|FG007|Washout Period|Adverse Event|0|||
94515323|NCT00710593|323684695|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
94515324|NCT00710593|323684694|FG000|Overall Study|Lost to Follow-up|3|||
94515325|NCT00710593|323684695|FG001|Overall Study|Lost to Follow-up|1|||
94515326|NCT00710593|323684694|FG000|Overall Study|Moved out of area|1|||
94515327|NCT00710593|323684695|FG001|Overall Study|Moved out of area|0|||
94515328|NCT00710593|323684694|FG000|Overall Study|Failure to adhere or complete study eval|1|||
94515329|NCT00710593|323684695|FG001|Overall Study|Failure to adhere or complete study eval|1|||
94515330|NCT00710593|323684694|FG000|Overall Study|Protocol Violation|1|||
94515331|NCT00710593|323684695|FG001|Overall Study|Protocol Violation|1|||
94515332|NCT00710593|323684694|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
94515333|NCT00710593|323684695|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
94515334|NCT01784029|323684696|FG000|Overall Study|Lost to Follow-up|19|||
94515335|NCT01784029|323684697|FG001|Overall Study|Lost to Follow-up|20|||
94515336|NCT01784029|323684698|FG002|Overall Study|Lost to Follow-up|22|||
94515337|NCT02332928|323684699|FG000|Overall Study|Withdrawal by Subject|0|||
94515338|NCT02332928|323684700|FG001|Overall Study|Withdrawal by Subject|2|||
94515339|NCT02332928|323684699|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
94515340|NCT02332928|323684700|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
94515341|NCT01425814|323684703|FG000|Period 1|Stability criteria not fulfilled|0|||
94515342|NCT01425814|323684704|FG001|Period 1|Stability criteria not fulfilled|1|||
94515343|NCT01425814|323684705|FG002|Period 1|Stability criteria not fulfilled|0|||
94515344|NCT01425814|323684706|FG003|Period 1|Stability criteria not fulfilled|0|||
94515345|NCT01425814|323684707|FG004|Period 1|Stability criteria not fulfilled|0|||
94515346|NCT01425814|323684708|FG005|Period 1|Stability criteria not fulfilled|0|||
94515347|NCT01425814|323684703|FG000|Period 2|Stability criteria not fulfilled|0|||
94515348|NCT01425814|323684704|FG001|Period 2|Stability criteria not fulfilled|1|||
94515349|NCT01425814|323684705|FG002|Period 2|Stability criteria not fulfilled|0|||
94515350|NCT01425814|323684706|FG003|Period 2|Stability criteria not fulfilled|0|||
94515351|NCT01425814|323684707|FG004|Period 2|Stability criteria not fulfilled|0|||
94515352|NCT01425814|323684708|FG005|Period 2|Stability criteria not fulfilled|0|||
94515353|NCT01425814|323684703|FG000|Period 3|Adverse Event|0|||
94515354|NCT01425814|323684704|FG001|Period 3|Adverse Event|0|||
94515355|NCT01425814|323684705|FG002|Period 3|Adverse Event|0|||
94515356|NCT01425814|323684706|FG003|Period 3|Adverse Event|0|||
94515357|NCT01425814|323684707|FG004|Period 3|Adverse Event|0|||
94515358|NCT01425814|323684708|FG005|Period 3|Adverse Event|1|||
94515359|NCT01425814|323684703|FG000|Period 4|Adverse Event|1|||
94515360|NCT01425814|323684704|FG001|Period 4|Adverse Event|0|||
94515361|NCT01425814|323684705|FG002|Period 4|Adverse Event|1|||
94515362|NCT01425814|323684706|FG003|Period 4|Adverse Event|0|||
94515363|NCT01425814|323684707|FG004|Period 4|Adverse Event|0|||
94515364|NCT01425814|323684708|FG005|Period 4|Adverse Event|0|||
94515365|NCT01425814|323684703|FG000|Period 5|Stability criteria not fulfilled|0|||
94515366|NCT01425814|323684704|FG001|Period 5|Stability criteria not fulfilled|0|||
94515367|NCT01425814|323684705|FG002|Period 5|Stability criteria not fulfilled|1|||
94515368|NCT01425814|323684706|FG003|Period 5|Stability criteria not fulfilled|0|||
94515369|NCT01425814|323684707|FG004|Period 5|Stability criteria not fulfilled|0|||
94515370|NCT01425814|323684708|FG005|Period 5|Stability criteria not fulfilled|1|||
94515371|NCT03801525|323684709|FG000|Overall Study|Adverse Event|17|||
94515372|NCT03801525|323684710|FG001|Overall Study|Adverse Event|1|||
94515373|NCT03801525|323684711|FG002|Overall Study|Adverse Event|0|||
94515374|NCT03801525|323684709|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
94515375|NCT03801525|323684710|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
94515376|NCT03801525|323684711|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
94515377|NCT03801525|323684709|FG000|Overall Study|Death|29|||
94515378|NCT03801525|323684710|FG001|Overall Study|Death|1|||
94515379|NCT03801525|323684711|FG002|Overall Study|Death|4|||
94515380|NCT03801525|323684709|FG000|Overall Study|Disease Progression|6|||
94515381|NCT03801525|323684710|FG001|Overall Study|Disease Progression|0|||
94515382|NCT03801525|323684711|FG002|Overall Study|Disease Progression|1|||
94515383|NCT03801525|323684709|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
94515384|NCT03801525|323684710|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
94515385|NCT03801525|323684711|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
94515386|NCT03801525|323684709|FG000|Overall Study|Investigator Decision|18|||
94515387|NCT03801525|323684710|FG001|Overall Study|Investigator Decision|1|||
94515388|NCT03801525|323684711|FG002|Overall Study|Investigator Decision|0|||
94515389|NCT03801525|323684709|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
94515390|NCT03801525|323684710|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
94515391|NCT03801525|323684711|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
94515392|NCT03801525|323684709|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
94515393|NCT03801525|323684710|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
94515394|NCT03801525|323684711|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
94515395|NCT03801525|323684709|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
94515396|NCT03801525|323684710|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
94515397|NCT03801525|323684711|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
94515398|NCT03801525|323684709|FG000|Overall Study|Withdrawal of Subject Consent|38|||
94515399|NCT03801525|323684710|FG001|Overall Study|Withdrawal of Subject Consent|2|||
94515400|NCT03801525|323684711|FG002|Overall Study|Withdrawal of Subject Consent|1|||
94515401|NCT03801525|323684709|FG000|Overall Study|Reason not Specified|4|||
94515402|NCT03801525|323684710|FG001|Overall Study|Reason not Specified|0|||
94515403|NCT03801525|323684711|FG002|Overall Study|Reason not Specified|4|||
94515404|NCT01702298|323684712|FG000|Overall Study|Withdrawal by Subject|1|||
94515405|NCT00492557|323684713|FG000|Overall Study|Subject request|12|||
94515406|NCT00492557|323684714|FG001|Overall Study|Subject request|11|||
94515407|NCT00492557|323684713|FG000|Overall Study|Protocol Violation|7|||
94515408|NCT00492557|323684714|FG001|Overall Study|Protocol Violation|8|||
94515409|NCT00492557|323684713|FG000|Overall Study|Other|2|||
94515410|NCT00492557|323684714|FG001|Overall Study|Other|2|||
94515411|NCT00492557|323684713|FG000|Overall Study|Death|1|||
94515412|NCT00492557|323684714|FG001|Overall Study|Death|1|||
94515413|NCT00492557|323684713|FG000|Overall Study|Adverse Event|1|||
94515414|NCT00492557|323684714|FG001|Overall Study|Adverse Event|0|||
94515415|NCT00492557|323684713|FG000|Overall Study|Failed to return|1|||
94515416|NCT00492557|323684714|FG001|Overall Study|Failed to return|0|||
94515417|NCT00492557|323684713|FG000|Overall Study|Lost to Follow-up|0|||
94515418|NCT00492557|323684714|FG001|Overall Study|Lost to Follow-up|1|||
94515419|NCT04778592|323684715|FG000|Overall Study|Adverse Event|1|||
94515420|NCT04778592|323684716|FG001|Overall Study|Adverse Event|2|||
94515421|NCT04778592|323684715|FG000|Overall Study|Withdrawal by Subject|1|||
94515422|NCT04778592|323684716|FG001|Overall Study|Withdrawal by Subject|2|||
94515423|NCT03493958|323684717|FG000|Overall Study|Withdrawal by Subject|6|||
94515424|NCT03493958|323684717|FG000|Overall Study|Lost to Follow-up|7|||
94515425|NCT03493958|323684717|FG000|Overall Study|Did not complete all required study procedures|2|||
94515426|NCT01959529|323684718|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
94515427|NCT01959529|323684719|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
94515428|NCT01959529|323684718|FG000|Overall Study|Lost to Follow-up|4|||
94515429|NCT01959529|323684719|FG001|Overall Study|Lost to Follow-up|1|||
94515430|NCT01959529|323684718|FG000|Overall Study|Other|70|||
94515431|NCT01959529|323684719|FG001|Overall Study|Other|68|||
94515432|NCT01959529|323684718|FG000|Overall Study|Hypoglycaemia|1|||
94515433|NCT01959529|323684719|FG001|Overall Study|Hypoglycaemia|1|||
94515434|NCT01959529|323684718|FG000|Overall Study|Lack of glycaemic control|1|||
94515435|NCT01959529|323684719|FG001|Overall Study|Lack of glycaemic control|1|||
94515436|NCT00557193|323684720|FG000|Induction|Adverse Event|2|||
94515437|NCT00557193|323684721|FG001|Induction|Adverse Event|0|||
94515438|NCT00557193|323684722|FG002|Induction|Adverse Event|0|||
94515439|NCT00557193|323684723|FG003|Induction|Adverse Event|0|||
94515440|NCT00557193|323684724|FG004|Induction|Adverse Event|0|||
94515441|NCT00557193|323684725|FG005|Induction|Adverse Event|0|||
94515442|NCT00557193|323684720|FG000|Induction|Death|6|||
94515443|NCT00557193|323684721|FG001|Induction|Death|0|||
94515444|NCT00557193|323684722|FG002|Induction|Death|0|||
94515445|NCT00557193|323684723|FG003|Induction|Death|0|||
94515446|NCT00557193|323684724|FG004|Induction|Death|0|||
94515447|NCT00557193|323684725|FG005|Induction|Death|0|||
94515448|NCT00557193|323684720|FG000|Induction|Physician Decision|3|||
94515449|NCT00557193|323684721|FG001|Induction|Physician Decision|0|||
94515450|NCT00557193|323684722|FG002|Induction|Physician Decision|0|||
94515451|NCT00557193|323684723|FG003|Induction|Physician Decision|0|||
94515452|NCT00557193|323684724|FG004|Induction|Physician Decision|0|||
94515453|NCT00557193|323684725|FG005|Induction|Physician Decision|0|||
94515454|NCT00557193|323684720|FG000|Induction|Withdrawal by Subject|1|||
94515455|NCT00557193|323684721|FG001|Induction|Withdrawal by Subject|0|||
94515456|NCT00557193|323684722|FG002|Induction|Withdrawal by Subject|0|||
94515457|NCT00557193|323684723|FG003|Induction|Withdrawal by Subject|0|||
94515458|NCT00557193|323684724|FG004|Induction|Withdrawal by Subject|0|||
94515459|NCT00557193|323684725|FG005|Induction|Withdrawal by Subject|0|||
94515460|NCT00557193|323684720|FG000|Induction|Refusal of Further Protocol Therapy|2|||
94515461|NCT00557193|323684721|FG001|Induction|Refusal of Further Protocol Therapy|0|||
94515462|NCT00557193|323684722|FG002|Induction|Refusal of Further Protocol Therapy|0|||
94515463|NCT00557193|323684723|FG003|Induction|Refusal of Further Protocol Therapy|0|||
94515464|NCT00557193|323684724|FG004|Induction|Refusal of Further Protocol Therapy|0|||
94515465|NCT00557193|323684725|FG005|Induction|Refusal of Further Protocol Therapy|0|||
94515466|NCT00557193|323684720|FG000|Induction|Ineligible|8|||
94515467|NCT00557193|323684721|FG001|Induction|Ineligible|0|||
94515468|NCT00557193|323684722|FG002|Induction|Ineligible|0|||
94515469|NCT00557193|323684723|FG003|Induction|Ineligible|0|||
94515470|NCT00557193|323684724|FG004|Induction|Ineligible|0|||
94515471|NCT00557193|323684725|FG005|Induction|Ineligible|0|||
94515472|NCT00557193|323684720|FG000|Induction|Inevaluable for post Induction|2|||
94515473|NCT00557193|323684721|FG001|Induction|Inevaluable for post Induction|0|||
94515474|NCT00557193|323684722|FG002|Induction|Inevaluable for post Induction|0|||
94515475|NCT00557193|323684723|FG003|Induction|Inevaluable for post Induction|0|||
94515476|NCT00557193|323684724|FG004|Induction|Inevaluable for post Induction|0|||
94515477|NCT00557193|323684725|FG005|Induction|Inevaluable for post Induction|0|||
94515478|NCT00557193|323684720|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
94515479|NCT00557193|323684721|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
94515480|NCT00557193|323684722|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
94515481|NCT00557193|323684723|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
94515482|NCT00557193|323684724|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
94515483|NCT00557193|323684725|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
94515484|NCT00557193|323684720|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
94515485|NCT00557193|323684721|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
94515486|NCT00557193|323684722|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
94515487|NCT00557193|323684723|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
94515488|NCT00557193|323684724|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
94515489|NCT00557193|323684725|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
94515490|NCT00557193|323684720|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
94515491|NCT00557193|323684721|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
94515492|NCT00557193|323684722|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
94515493|NCT00557193|323684723|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
94515494|NCT00557193|323684724|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
94515495|NCT00557193|323684725|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
94515496|NCT00557193|323684720|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
94515497|NCT00557193|323684721|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
94515498|NCT00557193|323684722|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
94515499|NCT00557193|323684723|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
94515500|NCT00557193|323684724|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
94515501|NCT00557193|323684725|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
94515502|NCT00557193|323684720|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
94515503|NCT00557193|323684721|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
94515504|NCT00557193|323684722|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
94515505|NCT00557193|323684723|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
94515506|NCT00557193|323684724|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
94515507|NCT00557193|323684725|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
94515508|NCT00557193|323684720|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
94515509|NCT00557193|323684721|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
94515510|NCT00557193|323684722|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
94515511|NCT00557193|323684723|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
94515512|NCT00557193|323684724|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
94515513|NCT00557193|323684725|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
94515514|NCT00557193|323684720|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
94515515|NCT00557193|323684721|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
94515516|NCT00557193|323684722|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
94515517|NCT00557193|323684723|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
94515518|NCT00557193|323684724|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
94515519|NCT00557193|323684725|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
94515520|NCT00557193|323684720|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
94515521|NCT00557193|323684721|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
94515522|NCT00557193|323684722|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
94515523|NCT00557193|323684723|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
94515524|NCT00557193|323684724|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
94515525|NCT00557193|323684725|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
94515526|NCT00557193|323684720|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
94515527|NCT00557193|323684721|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
94515528|NCT00557193|323684722|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
94515529|NCT00557193|323684723|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
94515530|NCT00557193|323684724|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
94515531|NCT00557193|323684725|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
94515532|NCT03984825|323684726|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
94515533|NCT03984825|323684726|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
94515534|NCT03984825|323684726|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
94515535|NCT01948427|323684727|FG000|Overall Study|Serious Adverse Event|3|||
94515536|NCT01948427|323684728|FG001|Overall Study|Serious Adverse Event|0|||
94515537|NCT01948427|323684729|FG002|Overall Study|Serious Adverse Event|0|||
94515538|NCT01948427|323684730|FG003|Overall Study|Serious Adverse Event|0|||
94515539|NCT01948427|323684731|FG004|Overall Study|Serious Adverse Event|1|||
94515540|NCT01948427|323684727|FG000|Overall Study|Investigator Request|0|||
94515541|NCT01948427|323684728|FG001|Overall Study|Investigator Request|8|||
94515542|NCT01948427|323684729|FG002|Overall Study|Investigator Request|0|||
94515543|NCT01948427|323684730|FG003|Overall Study|Investigator Request|0|||
94515544|NCT01948427|323684731|FG004|Overall Study|Investigator Request|6|||
94515545|NCT01948427|323684727|FG000|Overall Study|Lost to Follow-up|1|||
94515546|NCT01948427|323684728|FG001|Overall Study|Lost to Follow-up|0|||
94515547|NCT01948427|323684729|FG002|Overall Study|Lost to Follow-up|0|||
94515548|NCT01948427|323684730|FG003|Overall Study|Lost to Follow-up|0|||
94515549|NCT01948427|323684731|FG004|Overall Study|Lost to Follow-up|4|||
94515550|NCT01948427|323684727|FG000|Overall Study|Withdrawal by Subject|2|||
94515551|NCT01948427|323684728|FG001|Overall Study|Withdrawal by Subject|0|||
94515552|NCT01948427|323684729|FG002|Overall Study|Withdrawal by Subject|0|||
94515553|NCT01948427|323684730|FG003|Overall Study|Withdrawal by Subject|0|||
94515554|NCT01948427|323684731|FG004|Overall Study|Withdrawal by Subject|1|||
94515555|NCT01948427|323684727|FG000|Overall Study|Other, Not Specified|1|||
94515556|NCT01948427|323684728|FG001|Overall Study|Other, Not Specified|9|||
94515557|NCT01948427|323684729|FG002|Overall Study|Other, Not Specified|0|||
94515558|NCT01948427|323684730|FG003|Overall Study|Other, Not Specified|0|||
94515559|NCT01948427|323684731|FG004|Overall Study|Other, Not Specified|2|||
94515560|NCT02448381|323684733|FG000|Overall Study|Adverse Event|2|||
94515561|NCT02448381|323684734|FG001|Overall Study|Adverse Event|0|||
94515562|NCT02448381|323684733|FG000|Overall Study|Lost to Follow-up|16|||
94515563|NCT02448381|323684734|FG001|Overall Study|Lost to Follow-up|9|||
94515564|NCT02448381|323684733|FG000|Overall Study|Physician Decision|1|||
94515565|NCT02448381|323684734|FG001|Overall Study|Physician Decision|1|||
94515566|NCT02448381|323684733|FG000|Overall Study|Pregnancy|1|||
94515567|NCT02448381|323684734|FG001|Overall Study|Pregnancy|0|||
94515568|NCT02448381|323684733|FG000|Overall Study|Withdrawal by Subject|13|||
94515569|NCT02448381|323684734|FG001|Overall Study|Withdrawal by Subject|9|||
94515570|NCT02448381|323684733|FG000|Overall Study|Noncompliance with Study Procedures|2|||
94515571|NCT02448381|323684734|FG001|Overall Study|Noncompliance with Study Procedures|0|||
94515572|NCT00854360|323684739|FG000|Overall Study|Adverse Event|0|||
94515573|NCT00854360|323684740|FG001|Overall Study|Adverse Event|1|||
94515574|NCT00854360|323684741|FG002|Overall Study|Adverse Event|2|||
94515575|NCT00854360|323684742|FG003|Overall Study|Adverse Event|6|||
94515576|NCT00854360|323684739|FG000|Overall Study|Withdrawal by Subject|0|||
94515577|NCT00854360|323684740|FG001|Overall Study|Withdrawal by Subject|0|||
94515578|NCT00854360|323684741|FG002|Overall Study|Withdrawal by Subject|0|||
94515579|NCT00854360|323684742|FG003|Overall Study|Withdrawal by Subject|1|||
94515580|NCT00854360|323684739|FG000|Overall Study|Pregnancy|0|||
94515581|NCT00854360|323684740|FG001|Overall Study|Pregnancy|1|||
94515582|NCT00854360|323684741|FG002|Overall Study|Pregnancy|0|||
94515583|NCT00854360|323684742|FG003|Overall Study|Pregnancy|0|||
94515584|NCT00854360|323684739|FG000|Overall Study|Lack of Efficacy|2|||
94515585|NCT00854360|323684740|FG001|Overall Study|Lack of Efficacy|1|||
94515586|NCT00854360|323684741|FG002|Overall Study|Lack of Efficacy|0|||
94515587|NCT00854360|323684742|FG003|Overall Study|Lack of Efficacy|0|||
94515588|NCT00854360|323684739|FG000|Overall Study|Other|0|||
94515589|NCT00854360|323684740|FG001|Overall Study|Other|0|||
94515590|NCT00854360|323684741|FG002|Overall Study|Other|0|||
94515591|NCT00854360|323684742|FG003|Overall Study|Other|3|||
94515592|NCT02949011|323684743|FG000|Overall Study|Adverse Event|6|||
94515593|NCT02949011|323684744|FG001|Overall Study|Adverse Event|7|||
94515594|NCT02949011|323684745|FG002|Overall Study|Adverse Event|3|||
94515595|NCT02949011|323684743|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
94515596|NCT02949011|323684744|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
94515597|NCT02949011|323684745|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
94515598|NCT02949011|323684743|FG000|Overall Study|Protocol Deviation|5|||
94515599|NCT02949011|323684744|FG001|Overall Study|Protocol Deviation|3|||
94515600|NCT02949011|323684745|FG002|Overall Study|Protocol Deviation|3|||
94515601|NCT02949011|323684743|FG000|Overall Study|Lack of Efficacy|0|||
94515602|NCT02949011|323684744|FG001|Overall Study|Lack of Efficacy|2|||
94515603|NCT02949011|323684745|FG002|Overall Study|Lack of Efficacy|0|||
94515604|NCT02949011|323684743|FG000|Overall Study|Withdrawal by Subject|13|||
94515605|NCT02949011|323684744|FG001|Overall Study|Withdrawal by Subject|13|||
94515606|NCT02949011|323684745|FG002|Overall Study|Withdrawal by Subject|21|||
94515607|NCT02949011|323684743|FG000|Overall Study|Lost to Follow-up|7|||
94515608|NCT02949011|323684744|FG001|Overall Study|Lost to Follow-up|5|||
94515609|NCT02949011|323684745|FG002|Overall Study|Lost to Follow-up|5|||
94515610|NCT02949011|323684743|FG000|Overall Study|Death|0|||
94515611|NCT02949011|323684744|FG001|Overall Study|Death|0|||
94515612|NCT02949011|323684745|FG002|Overall Study|Death|1|||
94515613|NCT02949011|323684743|FG000|Overall Study|Miscellaneous|2|||
94515614|NCT02949011|323684744|FG001|Overall Study|Miscellaneous|4|||
94515615|NCT02949011|323684745|FG002|Overall Study|Miscellaneous|6|||
94515616|NCT00718315|323684748|FG000|Overall Study|Adverse Event|1|||
94515617|NCT00718315|323684749|FG001|Overall Study|Adverse Event|2|||
94515618|NCT00718315|323684750|FG002|Overall Study|Adverse Event|3|||
94515619|NCT00718315|323684748|FG000|Overall Study|Death|6|||
94515620|NCT00718315|323684749|FG001|Overall Study|Death|6|||
94515621|NCT00718315|323684750|FG002|Overall Study|Death|5|||
94515622|NCT00718315|323684748|FG000|Overall Study|Lost to Follow-up|2|||
94515623|NCT00718315|323684749|FG001|Overall Study|Lost to Follow-up|3|||
94515624|NCT00718315|323684750|FG002|Overall Study|Lost to Follow-up|4|||
94515625|NCT00718315|323684748|FG000|Overall Study|Protocol Violation|5|||
94515626|NCT00718315|323684749|FG001|Overall Study|Protocol Violation|5|||
94515627|NCT00718315|323684750|FG002|Overall Study|Protocol Violation|3|||
94515628|NCT00718315|323684748|FG000|Overall Study|Erlotinib dose decreased|4|||
94515629|NCT00718315|323684749|FG001|Overall Study|Erlotinib dose decreased|3|||
94515630|NCT00718315|323684750|FG002|Overall Study|Erlotinib dose decreased|1|||
94515631|NCT00718315|323684748|FG000|Overall Study|Use of Minocyclin|1|||
94515632|NCT00718315|323684749|FG001|Overall Study|Use of Minocyclin|1|||
94515633|NCT00718315|323684750|FG002|Overall Study|Use of Minocyclin|1|||
94515634|NCT00718315|323684748|FG000|Overall Study|Disease progression|0|||
94515635|NCT00718315|323684749|FG001|Overall Study|Disease progression|1|||
94515636|NCT00718315|323684750|FG002|Overall Study|Disease progression|1|||
94515637|NCT00718315|323684748|FG000|Overall Study|Other|0|||
94515638|NCT00718315|323684749|FG001|Overall Study|Other|0|||
94515639|NCT00718315|323684750|FG002|Overall Study|Other|1|||
94515640|NCT00718315|323684748|FG000|Overall Study|Use of ATB and Corticoids|0|||
94515641|NCT00718315|323684749|FG001|Overall Study|Use of ATB and Corticoids|1|||
94515642|NCT00718315|323684750|FG002|Overall Study|Use of ATB and Corticoids|2|||
94515643|NCT00506142|323684753|FG000|Overall Study|Adverse Event|8|||
94515644|NCT00506142|323684754|FG001|Overall Study|Adverse Event|7|||
94515645|NCT00506142|323684753|FG000|Overall Study|Lack of Efficacy|21|||
94515646|NCT00506142|323684754|FG001|Overall Study|Lack of Efficacy|7|||
94515647|NCT00506142|323684753|FG000|Overall Study|Withdrawal by Subject|4|||
94515648|NCT00506142|323684754|FG001|Overall Study|Withdrawal by Subject|5|||
94515649|NCT00506142|323684753|FG000|Overall Study|Physician Decision|1|||
94515650|NCT00506142|323684754|FG001|Overall Study|Physician Decision|0|||
94515651|NCT00506142|323684753|FG000|Overall Study|New health condition|1|||
94515652|NCT00506142|323684754|FG001|Overall Study|New health condition|0|||
94515653|NCT03435380|323684755|FG000|Overall Study|Death|1|||
94515654|NCT03435380|323684756|FG001|Overall Study|Death|2|||
94515655|NCT03435380|323684757|FG002|Overall Study|Death|1|||
94515656|NCT03435380|323684755|FG000|Overall Study|Lost to Follow-up|12|||
94515657|NCT03435380|323684756|FG001|Overall Study|Lost to Follow-up|8|||
94515658|NCT03435380|323684757|FG002|Overall Study|Lost to Follow-up|6|||
94515659|NCT03435380|323684755|FG000|Overall Study|Physician Decision|1|||
94515660|NCT03435380|323684756|FG001|Overall Study|Physician Decision|0|||
94515661|NCT03435380|323684757|FG002|Overall Study|Physician Decision|0|||
94515662|NCT03435380|323684755|FG000|Overall Study|Withdrawal by Subject|0|||
94515663|NCT03435380|323684756|FG001|Overall Study|Withdrawal by Subject|1|||
94515664|NCT03435380|323684757|FG002|Overall Study|Withdrawal by Subject|1|||
94515665|NCT03435380|323684755|FG000|Overall Study|Ineligible|0|||
94515666|NCT03435380|323684756|FG001|Overall Study|Ineligible|1|||
94515667|NCT03435380|323684757|FG002|Overall Study|Ineligible|1|||
94515668|NCT01170663|323684763|FG000|Overall Study|Lost to Follow-up|3|||
94515669|NCT01170663|323684764|FG001|Overall Study|Lost to Follow-up|9|||
94515670|NCT01170663|323684763|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
94515671|NCT01170663|323684764|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
94515672|NCT00454116|323684768|FG000|Overall Study|Adverse Event|5|||
94515673|NCT00454116|323684769|FG001|Overall Study|Adverse Event|11|||
94515674|NCT00454116|323684770|FG002|Overall Study|Adverse Event|9|||
94515675|NCT00454116|323684768|FG000|Overall Study|Condition under investigation worsened|17|||
94515676|NCT00454116|323684769|FG001|Overall Study|Condition under investigation worsened|13|||
94515677|NCT00454116|323684770|FG002|Overall Study|Condition under investigation worsened|18|||
94515678|NCT00454116|323684768|FG000|Overall Study|Withdrawal by Subject|3|||
94515679|NCT00454116|323684769|FG001|Overall Study|Withdrawal by Subject|3|||
94515680|NCT00454116|323684770|FG002|Overall Study|Withdrawal by Subject|1|||
94515681|NCT00454116|323684768|FG000|Overall Study|Other|2|||
94515682|NCT00454116|323684769|FG001|Overall Study|Other|2|||
94515683|NCT00454116|323684770|FG002|Overall Study|Other|0|||
94515684|NCT01164007|323684779|FG000|Overall Study|Adverse Event|5|||
94515685|NCT01164007|323684779|FG000|Overall Study|Progression of Disease|30|||
94515686|NCT01164007|323684779|FG000|Overall Study|Protocol Violation|1|||
94515687|NCT01164007|323684779|FG000|Overall Study|Withdrawal by Subject|1|||
94515688|NCT01164007|323684779|FG000|Overall Study|Medical Decision|3|||
94515689|NCT02519842|323684780|FG000|Base Study: Cycle 1|Screening Failure|1|||
94515690|NCT02519842|323684781|FG001|Base Study: Cycle 1|Screening Failure|1|||
94515691|NCT02519842|323684782|FG002|Base Study: Cycle 1|Screening Failure|0|||
94515692|NCT02519842|323684780|FG000|Base Study: Cycle 1|Adverse Event|1|||
94515693|NCT02519842|323684781|FG001|Base Study: Cycle 1|Adverse Event|0|||
94515694|NCT02519842|323684782|FG002|Base Study: Cycle 1|Adverse Event|0|||
94515695|NCT02519842|323684780|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
94515696|NCT02519842|323684781|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
94515697|NCT02519842|323684782|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
94515698|NCT02519842|323684780|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
94655646|NCT01632579|324196118|FG008|Washout Period|Adverse Event|0|||
94515699|NCT02519842|323684781|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
94515700|NCT02519842|323684782|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
94515701|NCT02519842|323684780|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
94515702|NCT02519842|323684781|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
94515703|NCT02519842|323684782|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
94515704|NCT02519842|323684780|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
94515705|NCT02519842|323684781|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
94515706|NCT02519842|323684782|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
94515707|NCT02519842|323684780|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
94515708|NCT02519842|323684781|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
94515709|NCT02519842|323684782|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
94515710|NCT02519842|323684780|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
94515711|NCT02519842|323684781|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
94515712|NCT02519842|323684782|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
94515713|NCT02519842|323684780|FG000|Optional Extension: Cycles 2-6|Death|0|||
94515714|NCT02519842|323684781|FG001|Optional Extension: Cycles 2-6|Death|0|||
94515715|NCT02519842|323684782|FG002|Optional Extension: Cycles 2-6|Death|1|||
94515716|NCT02519842|323684780|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
94515717|NCT02519842|323684781|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
94515718|NCT02519842|323684782|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
94515719|NCT02519842|323684780|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
94515720|NCT02519842|323684781|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
94515721|NCT02519842|323684782|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
94515722|NCT02519842|323684780|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
94515723|NCT02519842|323684781|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
94515724|NCT02519842|323684782|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
94515725|NCT02519842|323684780|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
94515726|NCT02519842|323684781|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
94515727|NCT02519842|323684782|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
94515728|NCT03218917|323684784|FG000|Overall Study|Adverse Event|3|||
94515729|NCT03218917|323684785|FG001|Overall Study|Adverse Event|3|||
94515730|NCT03218917|323684786|FG002|Overall Study|Adverse Event|2|||
94515731|NCT03218917|323684784|FG000|Overall Study|Subject withdrew consent|2|||
94515732|NCT03218917|323684785|FG001|Overall Study|Subject withdrew consent|4|||
94515733|NCT03218917|323684786|FG002|Overall Study|Subject withdrew consent|10|||
94515734|NCT03218917|323684784|FG000|Overall Study|Physician Decision|0|||
94515735|NCT03218917|323684785|FG001|Overall Study|Physician Decision|1|||
94515736|NCT03218917|323684786|FG002|Overall Study|Physician Decision|1|||
94515737|NCT03218917|323684784|FG000|Overall Study|Lost to Follow-up|1|||
94515738|NCT03218917|323684785|FG001|Overall Study|Lost to Follow-up|0|||
94515739|NCT03218917|323684786|FG002|Overall Study|Lost to Follow-up|0|||
94515740|NCT03218917|323684784|FG000|Overall Study|Reason Missing|0|||
94515741|NCT03218917|323684785|FG001|Overall Study|Reason Missing|2|||
94515742|NCT03218917|323684786|FG002|Overall Study|Reason Missing|0|||
94515743|NCT03218917|323684784|FG000|Overall Study|Death|0|||
94515744|NCT03218917|323684785|FG001|Overall Study|Death|1|||
94515745|NCT03218917|323684786|FG002|Overall Study|Death|0|||
94515746|NCT03218917|323684784|FG000|Overall Study|Non-Compliance with Study Drug|0|||
94515747|NCT03218917|323684785|FG001|Overall Study|Non-Compliance with Study Drug|1|||
94515748|NCT03218917|323684786|FG002|Overall Study|Non-Compliance with Study Drug|0|||
94515749|NCT01463527|323684791|FG000|Overall Study|Protocol Violation|1|||
94515750|NCT01463527|323684792|FG001|Overall Study|Protocol Violation|1|||
94515751|NCT01463527|323684791|FG000|Overall Study|Crying >20% of sedation|5|||
94515752|NCT01463527|323684792|FG001|Overall Study|Crying >20% of sedation|6|||
94515753|NCT03605693|323684798|FG000|Overall Study|Lost to Follow-up|4|||
94515754|NCT03605693|323684799|FG001|Overall Study|Lost to Follow-up|0|||
94515755|NCT03605693|323684798|FG000|Overall Study|Physician Decision|1|||
94515756|NCT03605693|323684799|FG001|Overall Study|Physician Decision|0|||
94515757|NCT01570387|323684802|FG000|Overall Study|Adverse Event|1|||
94515758|NCT01570387|323684803|FG001|Overall Study|Adverse Event|0|||
94515759|NCT01570387|323684804|FG002|Overall Study|Adverse Event|0|||
94515760|NCT01570387|323684805|FG003|Overall Study|Adverse Event|0|||
94515761|NCT01570387|323684802|FG000|Overall Study|Death|0|||
94515762|NCT01570387|323684803|FG001|Overall Study|Death|0|||
94515763|NCT01570387|323684804|FG002|Overall Study|Death|0|||
94515764|NCT01570387|323684805|FG003|Overall Study|Death|1|||
94515765|NCT01570387|323684802|FG000|Overall Study|Withdrawal by Subject|0|||
94515766|NCT01570387|323684803|FG001|Overall Study|Withdrawal by Subject|0|||
94515767|NCT01570387|323684804|FG002|Overall Study|Withdrawal by Subject|0|||
94515768|NCT01570387|323684805|FG003|Overall Study|Withdrawal by Subject|1|||
94515769|NCT01832727|323684809|FG000|Overall Study|Adverse Event|4|||
94515770|NCT01832727|323684810|FG001|Overall Study|Adverse Event|6|||
94515771|NCT01832727|323684811|FG002|Overall Study|Adverse Event|1|||
94515772|NCT01832727|323684812|FG003|Overall Study|Adverse Event|0|||
94515773|NCT01832727|323684813|FG004|Overall Study|Adverse Event|1|||
94515774|NCT01832727|323684814|FG005|Overall Study|Adverse Event|1|||
94515775|NCT01832727|323684815|FG006|Overall Study|Adverse Event|2|||
94515776|NCT01832727|323684816|FG007|Overall Study|Adverse Event|1|||
94515777|NCT01832727|323684817|FG008|Overall Study|Adverse Event|9|||
94515778|NCT01832727|323684809|FG000|Overall Study|Disease progression|3|||
94515779|NCT01832727|323684810|FG001|Overall Study|Disease progression|0|||
94515780|NCT01832727|323684811|FG002|Overall Study|Disease progression|2|||
94515781|NCT01832727|323684812|FG003|Overall Study|Disease progression|1|||
94515782|NCT01832727|323684813|FG004|Overall Study|Disease progression|3|||
94515783|NCT01832727|323684814|FG005|Overall Study|Disease progression|3|||
94515784|NCT01832727|323684815|FG006|Overall Study|Disease progression|6|||
94515785|NCT01832727|323684816|FG007|Overall Study|Disease progression|2|||
94515786|NCT01832727|323684817|FG008|Overall Study|Disease progression|7|||
94515787|NCT01832727|323684809|FG000|Overall Study|Lost to Follow-up|0|||
94515788|NCT01832727|323684810|FG001|Overall Study|Lost to Follow-up|0|||
94515789|NCT01832727|323684811|FG002|Overall Study|Lost to Follow-up|0|||
94515790|NCT01832727|323684812|FG003|Overall Study|Lost to Follow-up|1|||
94515791|NCT01832727|323684813|FG004|Overall Study|Lost to Follow-up|0|||
94515792|NCT01832727|323684814|FG005|Overall Study|Lost to Follow-up|0|||
94515793|NCT01832727|323684815|FG006|Overall Study|Lost to Follow-up|0|||
94515794|NCT01832727|323684816|FG007|Overall Study|Lost to Follow-up|0|||
94515795|NCT01832727|323684817|FG008|Overall Study|Lost to Follow-up|0|||
94515796|NCT01832727|323684809|FG000|Overall Study|Physician Decision|1|||
94515797|NCT01832727|323684810|FG001|Overall Study|Physician Decision|0|||
94515798|NCT01832727|323684811|FG002|Overall Study|Physician Decision|0|||
94515799|NCT01832727|323684812|FG003|Overall Study|Physician Decision|1|||
94515800|NCT01832727|323684813|FG004|Overall Study|Physician Decision|0|||
94515801|NCT01832727|323684814|FG005|Overall Study|Physician Decision|1|||
94515802|NCT01832727|323684815|FG006|Overall Study|Physician Decision|0|||
94515803|NCT01832727|323684816|FG007|Overall Study|Physician Decision|0|||
94515804|NCT01832727|323684817|FG008|Overall Study|Physician Decision|0|||
94515805|NCT01832727|323684809|FG000|Overall Study|Withdrawal by Subject|1|||
94515806|NCT01832727|323684810|FG001|Overall Study|Withdrawal by Subject|1|||
94515807|NCT01832727|323684811|FG002|Overall Study|Withdrawal by Subject|0|||
94515808|NCT01832727|323684812|FG003|Overall Study|Withdrawal by Subject|1|||
94515809|NCT01832727|323684813|FG004|Overall Study|Withdrawal by Subject|0|||
94515810|NCT01832727|323684814|FG005|Overall Study|Withdrawal by Subject|1|||
94515811|NCT01832727|323684815|FG006|Overall Study|Withdrawal by Subject|0|||
94515812|NCT01832727|323684816|FG007|Overall Study|Withdrawal by Subject|2|||
94515813|NCT01832727|323684817|FG008|Overall Study|Withdrawal by Subject|1|||
94515814|NCT01832727|323684809|FG000|Overall Study|Study terminated by sponsor|0|||
94515815|NCT01832727|323684810|FG001|Overall Study|Study terminated by sponsor|0|||
94515816|NCT01832727|323684811|FG002|Overall Study|Study terminated by sponsor|0|||
94515817|NCT01832727|323684812|FG003|Overall Study|Study terminated by sponsor|0|||
94515818|NCT01832727|323684813|FG004|Overall Study|Study terminated by sponsor|0|||
94515819|NCT01832727|323684814|FG005|Overall Study|Study terminated by sponsor|0|||
94515820|NCT01832727|323684815|FG006|Overall Study|Study terminated by sponsor|0|||
94515821|NCT01832727|323684816|FG007|Overall Study|Study terminated by sponsor|1|||
94515822|NCT01832727|323684817|FG008|Overall Study|Study terminated by sponsor|1|||
94515823|NCT01542788|323684858|FG000|Overall Study|Randomized but Not Treated|2|||
94515824|NCT01542788|323684859|FG001|Overall Study|Randomized but Not Treated|0|||
94515825|NCT01542788|323684858|FG000|Overall Study|Lack of Efficacy|41|||
94515826|NCT01542788|323684859|FG001|Overall Study|Lack of Efficacy|71|||
94515827|NCT01542788|323684858|FG000|Overall Study|Lost to Follow-up|5|||
94515828|NCT01542788|323684859|FG001|Overall Study|Lost to Follow-up|0|||
94515829|NCT01542788|323684858|FG000|Overall Study|Death|3|||
94515830|NCT01542788|323684859|FG001|Overall Study|Death|0|||
94515831|NCT01542788|323684858|FG000|Overall Study|Protocol Violation|2|||
94515832|NCT01542788|323684859|FG001|Overall Study|Protocol Violation|0|||
94515833|NCT01542788|323684858|FG000|Overall Study|Physician Decision|1|||
94515834|NCT01542788|323684859|FG001|Overall Study|Physician Decision|0|||
94515835|NCT01542788|323684858|FG000|Overall Study|Withdrawal by Subject|1|||
94515836|NCT01542788|323684859|FG001|Overall Study|Withdrawal by Subject|0|||
94515837|NCT01214837|323684860|FG000|Overall Study|Death|0|||
94515838|NCT01214837|323684861|FG001|Overall Study|Death|0|||
94515839|NCT01214837|323684862|FG002|Overall Study|Death|1|||
94515840|NCT01214837|323684860|FG000|Overall Study|Adverse Event|1|||
94515841|NCT01214837|323684861|FG001|Overall Study|Adverse Event|2|||
94515842|NCT01214837|323684862|FG002|Overall Study|Adverse Event|1|||
94515843|NCT01214837|323684860|FG000|Overall Study|Withdrawal by Subject|27|||
94515844|NCT01214837|323684861|FG001|Overall Study|Withdrawal by Subject|36|||
94515845|NCT01214837|323684862|FG002|Overall Study|Withdrawal by Subject|28|||
94515846|NCT01214837|323684860|FG000|Overall Study|Lost to Follow-up|20|||
94515847|NCT01214837|323684861|FG001|Overall Study|Lost to Follow-up|15|||
94515848|NCT01214837|323684862|FG002|Overall Study|Lost to Follow-up|21|||
94515849|NCT01214837|323684860|FG000|Overall Study|Inappropriate Enrolment|0|||
94515850|NCT01214837|323684861|FG001|Overall Study|Inappropriate Enrolment|1|||
94515851|NCT01214837|323684862|FG002|Overall Study|Inappropriate Enrolment|2|||
94515852|NCT01214837|323684860|FG000|Overall Study|Administrative Reason|2|||
94515853|NCT01214837|323684861|FG001|Overall Study|Administrative Reason|6|||
94515854|NCT01214837|323684862|FG002|Overall Study|Administrative Reason|4|||
94515855|NCT01214837|323684860|FG000|Overall Study|Protocol Violation|3|||
94515856|NCT01214837|323684861|FG001|Overall Study|Protocol Violation|1|||
94515857|NCT01214837|323684862|FG002|Overall Study|Protocol Violation|5|||
94515858|NCT01214837|323684860|FG000|Overall Study|Unable to Classify|1|||
94515859|NCT01214837|323684861|FG001|Overall Study|Unable to Classify|3|||
94515860|NCT01214837|323684862|FG002|Overall Study|Unable to Classify|0|||
94515861|NCT01083602|323687156|FG000|Overall Study|Adverse Event|11|||
94515862|NCT01083602|323687156|FG000|Overall Study|New Cancer Therapy|2|||
94515863|NCT01083602|323687156|FG000|Overall Study|Death|1|||
94515864|NCT01083602|323687156|FG000|Overall Study|Withdrawal by Subject|5|||
94515865|NCT01083602|323687156|FG000|Overall Study|Lack of Efficacy|36|||
94515866|NCT01246960|323687157|FG000|Overall Study|Lost to Follow-up|3|||
94515867|NCT01246960|323687158|FG001|Overall Study|Lost to Follow-up|1|||
94515868|NCT01246960|323687157|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
94515869|NCT01246960|323687158|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
94515870|NCT03698279|323687163|FG000|Overall Study|Withdrawal by parent/guardian|1|||
94515871|NCT03698279|323687164|FG001|Overall Study|Withdrawal by parent/guardian|1|||
94515872|NCT03698279|323687165|FG002|Overall Study|Withdrawal by parent/guardian|1|||
94515873|NCT03698279|323687166|FG003|Overall Study|Withdrawal by parent/guardian|1|||
94515874|NCT03698279|323687167|FG004|Overall Study|Withdrawal by parent/guardian|0|||
94515875|NCT03698279|323687168|FG005|Overall Study|Withdrawal by parent/guardian|0|||
94515876|NCT03698279|323687163|FG000|Overall Study|Protocol deviation|1|||
94515877|NCT03698279|323687164|FG001|Overall Study|Protocol deviation|0|||
94515878|NCT03698279|323687165|FG002|Overall Study|Protocol deviation|1|||
94515879|NCT03698279|323687166|FG003|Overall Study|Protocol deviation|0|||
94515880|NCT03698279|323687167|FG004|Overall Study|Protocol deviation|0|||
94515881|NCT03698279|323687168|FG005|Overall Study|Protocol deviation|0|||
94515882|NCT03698279|323687163|FG000|Overall Study|Withdrawal by Subject|0|||
94515883|NCT03698279|323687164|FG001|Overall Study|Withdrawal by Subject|0|||
94515884|NCT03698279|323687165|FG002|Overall Study|Withdrawal by Subject|1|||
94515885|NCT03698279|323687166|FG003|Overall Study|Withdrawal by Subject|0|||
94515886|NCT03698279|323687167|FG004|Overall Study|Withdrawal by Subject|0|||
94515887|NCT03698279|323687168|FG005|Overall Study|Withdrawal by Subject|0|||
94515888|NCT03698279|323687163|FG000|Overall Study|Lost to Follow-up|3|||
94515889|NCT03698279|323687164|FG001|Overall Study|Lost to Follow-up|1|||
94515890|NCT03698279|323687165|FG002|Overall Study|Lost to Follow-up|4|||
94515891|NCT03698279|323687166|FG003|Overall Study|Lost to Follow-up|5|||
94515892|NCT03698279|323687167|FG004|Overall Study|Lost to Follow-up|0|||
94515893|NCT03698279|323687168|FG005|Overall Study|Lost to Follow-up|0|||
94515894|NCT00140140|323687175|FG000|Overall Study|Unacceptable toxicity|1|||
94515895|NCT00140140|323687176|FG001|Overall Study|Unacceptable toxicity|1|||
94515896|NCT00140140|323687177|FG002|Overall Study|Unacceptable toxicity|2|||
94515897|NCT00140140|323687175|FG000|Overall Study|Physician Decision|1|||
94515898|NCT00140140|323687176|FG001|Overall Study|Physician Decision|1|||
94515899|NCT00140140|323687177|FG002|Overall Study|Physician Decision|0|||
94515900|NCT03376516|323687178|FG000|Overall Study|Not treated|1|||
94515901|NCT03376516|323687178|FG000|Overall Study|Consent withdrawn|1|||
94515902|NCT02276040|323687179|FG000|Overall Study|Physician Decision|15|||
94515903|NCT02835690|323687180|FG000|Overall Study|Death|12|||
94515904|NCT02835690|323687181|FG001|Overall Study|Death|11|||
94515905|NCT02835690|323687182|FG002|Overall Study|Death|13|||
94515906|NCT02835690|323687180|FG000|Overall Study|Transferred to Extension Study|2|||
94515907|NCT02835690|323687181|FG001|Overall Study|Transferred to Extension Study|2|||
94515908|NCT02835690|323687182|FG002|Overall Study|Transferred to Extension Study|1|||
94515909|NCT02835690|323687180|FG000|Overall Study|Did Not Continue on Extension Study|0|||
94515910|NCT02835690|323687181|FG001|Overall Study|Did Not Continue on Extension Study|0|||
94515911|NCT02835690|323687182|FG002|Overall Study|Did Not Continue on Extension Study|1|||
94515912|NCT02835690|323687180|FG000|Overall Study|Not Treated|0|||
94515913|NCT02835690|323687181|FG001|Overall Study|Not Treated|2|||
94515914|NCT02835690|323687182|FG002|Overall Study|Not Treated|0|||
94515915|NCT04490278|323687183|FG000|Overall Study|Lost to Follow-up|6|||
94515916|NCT02684461|323687193|FG000|Overall Study|Adverse Event|1|||
94515917|NCT02684461|323687194|FG001|Overall Study|Adverse Event|0|||
94515918|NCT02684461|323687195|FG002|Overall Study|Adverse Event|0|||
94515919|NCT02684461|323687193|FG000|Overall Study|Lack of Efficacy|1|||
94515920|NCT02684461|323687194|FG001|Overall Study|Lack of Efficacy|2|||
94515921|NCT02684461|323687195|FG002|Overall Study|Lack of Efficacy|0|||
94515922|NCT01206517|323687200|FG000|Overall Study|Withdrawal by Subject|0|||
94515923|NCT01206517|323687201|FG001|Overall Study|Withdrawal by Subject|0|||
94515924|NCT01206517|323687202|FG002|Overall Study|Withdrawal by Subject|2|||
94515925|NCT01206517|323687203|FG003|Overall Study|Withdrawal by Subject|0|||
94515926|NCT01206517|323687204|FG004|Overall Study|Withdrawal by Subject|1|||
94515927|NCT01206517|323687205|FG005|Overall Study|Withdrawal by Subject|0|||
94515928|NCT01029535|323687210|FG000|Overall Study|Lost to Follow-up|24|||
94515929|NCT01029535|323687210|FG000|Overall Study|Protocol Violation|2|||
94515930|NCT01029535|323687210|FG000|Overall Study|Participant Withdrew Consent|2|||
94515931|NCT01029535|323687210|FG000|Overall Study|Adverse Event|1|||
94515932|NCT01029535|323687210|FG000|Overall Study|Use of Another Treatment|1|||
94515933|NCT01029535|323687210|FG000|Overall Study|Death|1|||
94515934|NCT04047446|323687211|FG000|Overall Study|Physician Decision|1|||
94515935|NCT04047446|323687212|FG001|Overall Study|Physician Decision|0|||
94515936|NCT00329420|323687213|FG000|Re-induction Phase|Lack of Efficacy|0|||
94515937|NCT00329420|323687214|FG001|Re-induction Phase|Lack of Efficacy|1|||
94515938|NCT00329420|323687215|FG002|Re-induction Phase|Lack of Efficacy|0|||
94515939|NCT00329420|323687213|FG000|Re-induction Phase|Withdrawal of Consent|0|||
94515940|NCT00329420|323687214|FG001|Re-induction Phase|Withdrawal of Consent|0|||
94515941|NCT00329420|323687215|FG002|Re-induction Phase|Withdrawal of Consent|1|||
94515942|NCT00329420|323687213|FG000|Re-induction Phase|Did not respond to re-induction|6|||
94515943|NCT00329420|323687214|FG001|Re-induction Phase|Did not respond to re-induction|5|||
94515944|NCT00329420|323687215|FG002|Re-induction Phase|Did not respond to re-induction|7|||
94515945|NCT00329420|323687213|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
94515946|NCT00329420|323687214|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
94515947|NCT00329420|323687215|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
94515948|NCT00329420|323687213|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
94515949|NCT00329420|323687214|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
94515950|NCT00329420|323687215|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
94515951|NCT00329420|323687213|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
94515952|NCT00329420|323687214|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
94515953|NCT00329420|323687215|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
94515954|NCT02862574|323687216|FG000|Double-Blind Treatment Period|Adverse Event|0|||
94515955|NCT02862574|323687217|FG001|Double-Blind Treatment Period|Adverse Event|1|||
94515956|NCT02862574|323687218|FG002|Double-Blind Treatment Period|Adverse Event|0|||
94515957|NCT02862574|323687216|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
94515958|NCT02862574|323687217|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
94515959|NCT02862574|323687218|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
94515960|NCT02862574|323687216|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
94515961|NCT02862574|323687217|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
94515962|NCT02862574|323687218|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
94515963|NCT02271880|323687219|FG000|Overall Study|Premature discontinuation of study|3|||
94515964|NCT02271880|323687220|FG001|Overall Study|Premature discontinuation of study|4|||
94515965|NCT00399529|323687221|FG000|Overall Study|Off Study Prior to Treatment|2|||
94515966|NCT03498716|323687232|FG000|Overall Study|Withdrawal by Subject|88|||
94515967|NCT03498716|323687233|FG001|Overall Study|Withdrawal by Subject|73|||
94515968|NCT03498716|323687232|FG000|Overall Study|Study Terminated By Sponsor|933|||
94515969|NCT03498716|323687233|FG001|Overall Study|Study Terminated By Sponsor|927|||
94515970|NCT03498716|323687232|FG000|Overall Study|Lost to Follow-up|15|||
94515971|NCT03498716|323687233|FG001|Overall Study|Lost to Follow-up|26|||
94515972|NCT03498716|323687232|FG000|Overall Study|Disease Relapse|0|||
94515973|NCT03498716|323687233|FG001|Overall Study|Disease Relapse|1|||
94515974|NCT03498716|323687232|FG000|Overall Study|Death|58|||
94515975|NCT03498716|323687233|FG001|Overall Study|Death|72|||
94515976|NCT03498716|323687232|FG000|Overall Study|Physician Decision|4|||
94515977|NCT03498716|323687233|FG001|Overall Study|Physician Decision|2|||
94515978|NCT04064905|323687234|FG000|Overall Study|Lost to Follow-up|0|||
94515979|NCT04064905|323687235|FG001|Overall Study|Lost to Follow-up|3|||
94515980|NCT04064905|323687236|FG002|Overall Study|Lost to Follow-up|1|||
94515981|NCT04064905|323687237|FG003|Overall Study|Lost to Follow-up|4|||
94515982|NCT04064905|323687238|FG004|Overall Study|Lost to Follow-up|2|||
94515983|NCT01143402|323687242|FG000|Overall Study|Rapid clinical decline|1|||
94515984|NCT01143402|323687243|FG001|Overall Study|Rapid clinical decline|1|||
94515985|NCT01143402|323687244|FG002|Overall Study|Rapid clinical decline|0|||
94515986|NCT01143402|323687242|FG000|Overall Study|Not Treated|0|||
94515987|NCT01143402|323687243|FG001|Overall Study|Not Treated|0|||
94515988|NCT01143402|323687244|FG002|Overall Study|Not Treated|1|||
94515989|NCT03323164|323687247|FG000|Overall Study|Poor quality imaging/scans|2|||
94515990|NCT03323164|323687248|FG001|Overall Study|Poor quality imaging/scans|2|||
94515991|NCT04211363|323687249|FG000|Overall Study|Adverse Event|5|||
94515992|NCT04211363|323687250|FG001|Overall Study|Adverse Event|2|||
94515993|NCT04211363|323687249|FG000|Overall Study|Physician Decision|0|||
94515994|NCT04211363|323687250|FG001|Overall Study|Physician Decision|1|||
94515995|NCT04211363|323687249|FG000|Overall Study|Protocol Violation|1|||
94515996|NCT04211363|323687250|FG001|Overall Study|Protocol Violation|0|||
94515997|NCT04211363|323687249|FG000|Overall Study|Pregnancy|1|||
94515998|NCT04211363|323687250|FG001|Overall Study|Pregnancy|0|||
94515999|NCT04211363|323687249|FG000|Overall Study|Lost to Follow-up|12|||
94516000|NCT04211363|323687250|FG001|Overall Study|Lost to Follow-up|4|||
94516001|NCT04211363|323687249|FG000|Overall Study|Withdrawal by Subject|11|||
94516002|NCT04211363|323687250|FG001|Overall Study|Withdrawal by Subject|11|||
94516003|NCT04211363|323687249|FG000|Overall Study|Other|1|||
94516004|NCT04211363|323687250|FG001|Overall Study|Other|2|||
94516005|NCT03961308|323687253|FG000|Overall Study|Withdrawal by Subject|1|||
94516006|NCT03961308|323687254|FG001|Overall Study|Withdrawal by Subject|0|||
94516007|NCT03961308|323687253|FG000|Overall Study|Other|1|||
94516008|NCT03961308|323687254|FG001|Overall Study|Other|0|||
94516009|NCT03961308|323687253|FG000|Overall Study|Lost to Follow-up|0|||
94516010|NCT03961308|323687254|FG001|Overall Study|Lost to Follow-up|1|||
94516011|NCT03961308|323687253|FG000|Overall Study|Adverse Event|0|||
94516012|NCT03961308|323687254|FG001|Overall Study|Adverse Event|1|||
94516013|NCT00485173|323687261|FG000|Overall Study|Death|4|||
94516014|NCT00485173|323687262|FG001|Overall Study|Death|3|||
94516015|NCT00485173|323687261|FG000|Overall Study|Lost to Follow-up|32|||
94516016|NCT00485173|323687262|FG001|Overall Study|Lost to Follow-up|61|||
94516017|NCT00746811|323687263|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
94516018|NCT00746811|323687264|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
94516019|NCT04881760|323687265|FG000|Overall Study|Adverse Event|0|||
94516020|NCT04881760|323687266|FG001|Overall Study|Adverse Event|1|||
94516021|NCT04881760|323687267|FG002|Overall Study|Adverse Event|1|||
94516022|NCT04881760|323687268|FG003|Overall Study|Adverse Event|0|||
94516023|NCT04881760|323687269|FG004|Overall Study|Adverse Event|1|||
94516024|NCT04881760|323687270|FG005|Overall Study|Adverse Event|1|||
94516025|NCT04881760|323687271|FG006|Overall Study|Adverse Event|2|||
94516026|NCT04881760|323687265|FG000|Overall Study|Death|0|||
94516027|NCT04881760|323687266|FG001|Overall Study|Death|0|||
94516028|NCT04881760|323687267|FG002|Overall Study|Death|0|||
94516029|NCT04881760|323687268|FG003|Overall Study|Death|1|||
94516030|NCT04881760|323687269|FG004|Overall Study|Death|0|||
94516031|NCT04881760|323687270|FG005|Overall Study|Death|0|||
94516032|NCT04881760|323687271|FG006|Overall Study|Death|0|||
94516033|NCT04881760|323687265|FG000|Overall Study|Lost to Follow-up|5|||
94516034|NCT04881760|323687266|FG001|Overall Study|Lost to Follow-up|7|||
94516035|NCT04881760|323687267|FG002|Overall Study|Lost to Follow-up|5|||
94516036|NCT04881760|323687268|FG003|Overall Study|Lost to Follow-up|1|||
94516037|NCT04881760|323687269|FG004|Overall Study|Lost to Follow-up|2|||
94516038|NCT04881760|323687270|FG005|Overall Study|Lost to Follow-up|4|||
94516039|NCT04881760|323687271|FG006|Overall Study|Lost to Follow-up|4|||
94516040|NCT04881760|323687265|FG000|Overall Study|Withdrawal by Subject|13|||
94516041|NCT04881760|323687266|FG001|Overall Study|Withdrawal by Subject|1|||
94516042|NCT04881760|323687267|FG002|Overall Study|Withdrawal by Subject|1|||
94516043|NCT04881760|323687268|FG003|Overall Study|Withdrawal by Subject|4|||
94516044|NCT04881760|323687269|FG004|Overall Study|Withdrawal by Subject|2|||
94516045|NCT04881760|323687270|FG005|Overall Study|Withdrawal by Subject|1|||
94516046|NCT04881760|323687271|FG006|Overall Study|Withdrawal by Subject|2|||
94516047|NCT04881760|323687265|FG000|Overall Study|Randomized but Never Treated|0|||
94516048|NCT04881760|323687266|FG001|Overall Study|Randomized but Never Treated|0|||
94516049|NCT04881760|323687267|FG002|Overall Study|Randomized but Never Treated|0|||
94516050|NCT04881760|323687268|FG003|Overall Study|Randomized but Never Treated|1|||
94516051|NCT04881760|323687269|FG004|Overall Study|Randomized but Never Treated|0|||
94516052|NCT04881760|323687270|FG005|Overall Study|Randomized but Never Treated|0|||
94516053|NCT04881760|323687271|FG006|Overall Study|Randomized but Never Treated|0|||
94516054|NCT04881760|323687265|FG000|Overall Study|Inadvertent Enrollment|2|||
94516055|NCT04881760|323687266|FG001|Overall Study|Inadvertent Enrollment|0|||
94516056|NCT04881760|323687267|FG002|Overall Study|Inadvertent Enrollment|0|||
94516057|NCT04881760|323687268|FG003|Overall Study|Inadvertent Enrollment|0|||
94516058|NCT04881760|323687269|FG004|Overall Study|Inadvertent Enrollment|0|||
94516059|NCT04881760|323687270|FG005|Overall Study|Inadvertent Enrollment|0|||
94516060|NCT04881760|323687271|FG006|Overall Study|Inadvertent Enrollment|0|||
94516061|NCT04881760|323687265|FG000|Overall Study|Site Closure|0|||
94516062|NCT04881760|323687266|FG001|Overall Study|Site Closure|0|||
94516063|NCT04881760|323687267|FG002|Overall Study|Site Closure|0|||
94516064|NCT04881760|323687268|FG003|Overall Study|Site Closure|1|||
94516065|NCT04881760|323687269|FG004|Overall Study|Site Closure|0|||
94516066|NCT04881760|323687270|FG005|Overall Study|Site Closure|0|||
94516067|NCT04881760|323687271|FG006|Overall Study|Site Closure|0|||
94516068|NCT01849276|323687272|FG000|Followed for Survival for 5 Years|Death|1|||
94516069|NCT01849276|323687272|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
94516070|NCT01538199|323687273|FG000|Overall Study|Lost to Follow-up|1|||
94516071|NCT01538199|323687274|FG001|Overall Study|Lost to Follow-up|2|||
94516072|NCT01538199|323687275|FG002|Overall Study|Lost to Follow-up|1|||
94516073|NCT01538199|323687276|FG003|Overall Study|Lost to Follow-up|0|||
94516074|NCT01538199|323687273|FG000|Overall Study|participant did not have time|1|||
94516075|NCT01538199|323687274|FG001|Overall Study|participant did not have time|0|||
94516076|NCT01538199|323687275|FG002|Overall Study|participant did not have time|0|||
94516077|NCT01538199|323687276|FG003|Overall Study|participant did not have time|2|||
94516078|NCT01538199|323687273|FG000|Overall Study|Lack of Efficacy|0|||
94516079|NCT01538199|323687274|FG001|Overall Study|Lack of Efficacy|1|||
94516080|NCT01538199|323687275|FG002|Overall Study|Lack of Efficacy|0|||
94516081|NCT01538199|323687276|FG003|Overall Study|Lack of Efficacy|0|||
94516082|NCT02081586|323687277|FG000|Overall Study|Lost to Follow-up|0|||
94516083|NCT02081586|323687278|FG001|Overall Study|Lost to Follow-up|1|||
94516084|NCT02081586|323687279|FG002|Overall Study|Lost to Follow-up|0|||
94516085|NCT02081586|323687280|FG003|Overall Study|Lost to Follow-up|1|||
94516086|NCT02081586|323687277|FG000|Overall Study|Head injury not related to study|0|||
94516087|NCT02081586|323687278|FG001|Overall Study|Head injury not related to study|0|||
94516088|NCT02081586|323687279|FG002|Overall Study|Head injury not related to study|1|||
94516089|NCT02081586|323687280|FG003|Overall Study|Head injury not related to study|0|||
94516090|NCT00659425|323687295|FG000|Overall Study|Disease progression|1|||
94516091|NCT00659425|323687296|FG001|Overall Study|Disease progression|0|||
94516092|NCT00659425|323687297|FG002|Overall Study|Disease progression|0|||
94516093|NCT00659425|323687298|FG003|Overall Study|Disease progression|1|||
94516094|NCT00659425|323687299|FG004|Overall Study|Disease progression|0|||
94516095|NCT00659425|323687300|FG005|Overall Study|Disease progression|2|||
94516096|NCT00659425|323687301|FG006|Overall Study|Disease progression|4|||
94516097|NCT00659425|323687302|FG007|Overall Study|Disease progression|3|||
94516098|NCT00659425|323687303|FG008|Overall Study|Disease progression|5|||
94516099|NCT00659425|323687304|FG009|Overall Study|Disease progression|3|||
94516100|NCT00659425|323687295|FG000|Overall Study|Death|0|||
94516101|NCT00659425|323687296|FG001|Overall Study|Death|0|||
94516102|NCT00659425|323687297|FG002|Overall Study|Death|0|||
94516103|NCT00659425|323687298|FG003|Overall Study|Death|1|||
94516104|NCT00659425|323687299|FG004|Overall Study|Death|0|||
94516105|NCT00659425|323687300|FG005|Overall Study|Death|0|||
94516106|NCT00659425|323687301|FG006|Overall Study|Death|1|||
94516107|NCT00659425|323687302|FG007|Overall Study|Death|0|||
94516108|NCT00659425|323687303|FG008|Overall Study|Death|0|||
94516109|NCT00659425|323687304|FG009|Overall Study|Death|0|||
94516110|NCT00659425|323687295|FG000|Overall Study|Adverse Event|0|||
94516111|NCT00659425|323687296|FG001|Overall Study|Adverse Event|0|||
94516112|NCT00659425|323687297|FG002|Overall Study|Adverse Event|0|||
94516113|NCT00659425|323687298|FG003|Overall Study|Adverse Event|0|||
94516114|NCT00659425|323687299|FG004|Overall Study|Adverse Event|0|||
94516115|NCT00659425|323687300|FG005|Overall Study|Adverse Event|1|||
94516116|NCT00659425|323687301|FG006|Overall Study|Adverse Event|0|||
94516117|NCT00659425|323687302|FG007|Overall Study|Adverse Event|3|||
94516118|NCT00659425|323687303|FG008|Overall Study|Adverse Event|1|||
94516119|NCT00659425|323687304|FG009|Overall Study|Adverse Event|4|||
94516120|NCT00659425|323687295|FG000|Overall Study|Investigator Discretion|0|||
94516121|NCT00659425|323687296|FG001|Overall Study|Investigator Discretion|0|||
94516122|NCT00659425|323687297|FG002|Overall Study|Investigator Discretion|0|||
94516123|NCT00659425|323687298|FG003|Overall Study|Investigator Discretion|0|||
94516124|NCT00659425|323687299|FG004|Overall Study|Investigator Discretion|0|||
94516125|NCT00659425|323687300|FG005|Overall Study|Investigator Discretion|1|||
94516126|NCT00659425|323687301|FG006|Overall Study|Investigator Discretion|0|||
94516127|NCT00659425|323687302|FG007|Overall Study|Investigator Discretion|3|||
94516128|NCT00659425|323687303|FG008|Overall Study|Investigator Discretion|0|||
94516129|NCT00659425|323687304|FG009|Overall Study|Investigator Discretion|0|||
94516130|NCT00659425|323687295|FG000|Overall Study|Other|0|||
94516131|NCT00659425|323687296|FG001|Overall Study|Other|1|||
94516132|NCT00659425|323687297|FG002|Overall Study|Other|1|||
94516133|NCT00659425|323687298|FG003|Overall Study|Other|2|||
94516134|NCT00659425|323687299|FG004|Overall Study|Other|4|||
94516135|NCT00659425|323687300|FG005|Overall Study|Other|0|||
94516136|NCT00659425|323687301|FG006|Overall Study|Other|3|||
94516137|NCT00659425|323687302|FG007|Overall Study|Other|2|||
94516138|NCT00659425|323687303|FG008|Overall Study|Other|0|||
94516139|NCT00659425|323687304|FG009|Overall Study|Other|6|||
94516140|NCT00271544|323687305|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
94516141|NCT00271544|323687305|FG000|Overall Study|Model 4196 lead not attempted|9|||
94516142|NCT00271544|323687305|FG000|Overall Study|Implant not attempted|4|||
94516143|NCT03358030|323687306|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
94516144|NCT03358030|323687307|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
94516145|NCT03358030|323687308|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
94516146|NCT03358030|323687309|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
94516147|NCT03358030|323687306|FG000|Overall Study|Ineligibility|0|||
94516148|NCT03358030|323687307|FG001|Overall Study|Ineligibility|0|||
94516149|NCT03358030|323687308|FG002|Overall Study|Ineligibility|0|||
94516150|NCT03358030|323687309|FG003|Overall Study|Ineligibility|2|||
94516151|NCT03358030|323687306|FG000|Overall Study|Voluntary Withdrawal|1|||
94516152|NCT03358030|323687307|FG001|Overall Study|Voluntary Withdrawal|1|||
94516153|NCT03358030|323687308|FG002|Overall Study|Voluntary Withdrawal|3|||
94516154|NCT03358030|323687309|FG003|Overall Study|Voluntary Withdrawal|1|||
94516155|NCT03358030|323687306|FG000|Overall Study|Other|0|||
94516156|NCT03358030|323687307|FG001|Overall Study|Other|0|||
94516157|NCT03358030|323687308|FG002|Overall Study|Other|1|||
94516158|NCT03358030|323687309|FG003|Overall Study|Other|0|||
94516159|NCT04290624|323687310|FG000|Overall Study|Adverse Event|1|||
94516160|NCT04290624|323687311|FG001|Overall Study|Adverse Event|0|||
94516161|NCT02297412|323687312|FG000|Overall Study|Canceled|1|||
94516162|NCT02297412|323687313|FG001|Overall Study|Canceled|1|||
94516163|NCT01150357|323687314|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
94516164|NCT01150357|323687315|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
94516165|NCT01150357|323687316|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
94516166|NCT01150357|323687314|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
94516167|NCT01150357|323687315|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
94516168|NCT01150357|323687316|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
94516169|NCT01150357|323687314|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
94516170|NCT01150357|323687315|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
94516171|NCT01150357|323687316|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
94516172|NCT01150357|323687314|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
94516173|NCT01150357|323687315|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
94516174|NCT01150357|323687316|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
94516175|NCT01150357|323687314|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
94516176|NCT01150357|323687315|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
94516177|NCT01150357|323687316|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
94516178|NCT01150357|323687314|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
94516179|NCT01150357|323687315|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
94516180|NCT01150357|323687316|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
94516181|NCT01150357|323687314|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
94516182|NCT01150357|323687315|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
94516183|NCT01150357|323687316|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
94516184|NCT04459416|323688993|FG000|Overall Study|Lost to Follow-up|2|||
94516185|NCT04459416|323688994|FG001|Overall Study|Lost to Follow-up|0|||
94516186|NCT04459416|323688993|FG000|Overall Study|Withdrawal by Subject|8|||
94516187|NCT04459416|323688994|FG001|Overall Study|Withdrawal by Subject|10|||
94516188|NCT04459416|323688993|FG000|Overall Study|Disease progression|0|||
94516189|NCT04459416|323688994|FG001|Overall Study|Disease progression|3|||
94516190|NCT00529633|323688999|FG000|Overall Study|Withdrawal by Subject|1|||
94516191|NCT00529633|323689000|FG001|Overall Study|Withdrawal by Subject|1|||
94516192|NCT00003645|323689004|FG000|Overall Study|Death|4|||
94516193|NCT00003645|323689005|FG001|Overall Study|Death|1|||
94516194|NCT00003645|323689004|FG000|Overall Study|Lost to Follow-up|7|||
94516195|NCT00003645|323689005|FG001|Overall Study|Lost to Follow-up|8|||
94516196|NCT00003645|323689004|FG000|Overall Study|Withdrawal by Subject|1|||
94516197|NCT00003645|323689005|FG001|Overall Study|Withdrawal by Subject|3|||
94516198|NCT05489328|323689006|FG000|Overall Study|Lost to Follow-up|0|||
94516199|NCT05489328|323689007|FG001|Overall Study|Lost to Follow-up|0|||
94516200|NCT05489328|323689008|FG002|Overall Study|Lost to Follow-up|1|||
94516201|NCT05489328|323689009|FG003|Overall Study|Lost to Follow-up|0|||
94516202|NCT05489328|323689010|FG004|Overall Study|Lost to Follow-up|2|||
94516203|NCT05489328|323689011|FG005|Overall Study|Lost to Follow-up|0|||
94516204|NCT05489328|323689012|FG006|Overall Study|Lost to Follow-up|0|||
94516205|NCT05489328|323689013|FG007|Overall Study|Lost to Follow-up|1|||
94516206|NCT05489328|323689014|FG008|Overall Study|Lost to Follow-up|0|||
94516207|NCT05489328|323689006|FG000|Overall Study|Withdrawal by Subject|0|||
94516208|NCT05489328|323689007|FG001|Overall Study|Withdrawal by Subject|0|||
94516209|NCT05489328|323689008|FG002|Overall Study|Withdrawal by Subject|0|||
94516210|NCT05489328|323689009|FG003|Overall Study|Withdrawal by Subject|0|||
94516211|NCT05489328|323689010|FG004|Overall Study|Withdrawal by Subject|0|||
94516212|NCT05489328|323689011|FG005|Overall Study|Withdrawal by Subject|0|||
94516213|NCT05489328|323689012|FG006|Overall Study|Withdrawal by Subject|1|||
94516214|NCT05489328|323689013|FG007|Overall Study|Withdrawal by Subject|1|||
94516215|NCT05489328|323689014|FG008|Overall Study|Withdrawal by Subject|0|||
94516216|NCT05489328|323689006|FG000|Overall Study|Other|0|||
94516217|NCT05489328|323689007|FG001|Overall Study|Other|0|||
94516218|NCT05489328|323689008|FG002|Overall Study|Other|0|||
94516219|NCT05489328|323689009|FG003|Overall Study|Other|0|||
94516220|NCT05489328|323689010|FG004|Overall Study|Other|0|||
94516221|NCT05489328|323689011|FG005|Overall Study|Other|0|||
94516222|NCT05489328|323689012|FG006|Overall Study|Other|0|||
94516223|NCT05489328|323689013|FG007|Overall Study|Other|1|||
94516224|NCT05489328|323689014|FG008|Overall Study|Other|1|||
94516225|NCT04976777|323689015|FG000|Overall Study|COVID-19 Infection|1|||
94516226|NCT04976777|323689016|FG001|Overall Study|COVID-19 Infection|0|||
94516227|NCT04795531|323689018|FG000|Overall Study|Withdrawal by Subject|4|||
94516228|NCT04795531|323689019|FG001|Overall Study|Withdrawal by Subject|4|||
94516229|NCT04795531|323689018|FG000|Overall Study|Lost to Follow-up|0|||
94516230|NCT04795531|323689019|FG001|Overall Study|Lost to Follow-up|1|||
94516231|NCT04795531|323689018|FG000|Overall Study|Physician Decision|0|||
94516232|NCT04795531|323689019|FG001|Overall Study|Physician Decision|2|||
94516233|NCT04795531|323689018|FG000|Overall Study|Death|2|||
94516234|NCT04795531|323689019|FG001|Overall Study|Death|1|||
94516235|NCT04043286|323689020|FG000|Overall Study|Withdrawal by Subject|2|||
94516236|NCT04043286|323689021|FG001|Overall Study|Withdrawal by Subject|2|||
94516237|NCT01323192|323689022|FG000|Overall Study|Adverse Event|6|||
94516238|NCT01323192|323689023|FG001|Overall Study|Adverse Event|1|||
94516239|NCT01323192|323689022|FG000|Overall Study|Withdrawal by Subject|3|||
94516240|NCT01323192|323689023|FG001|Overall Study|Withdrawal by Subject|1|||
94516241|NCT01323192|323689022|FG000|Overall Study|Noncompliance with study medication|0|||
94516242|NCT01323192|323689023|FG001|Overall Study|Noncompliance with study medication|3|||
94516243|NCT01323192|323689022|FG000|Overall Study|Nonmedical reasons|0|||
94516244|NCT01323192|323689023|FG001|Overall Study|Nonmedical reasons|1|||
94516245|NCT03186638|323689025|FG000|Overall Study|Withdrawal by Subject|4|||
94516246|NCT03186638|323689026|FG001|Overall Study|Withdrawal by Subject|4|||
94516247|NCT03186638|323689025|FG000|Overall Study|Withdrawn due to medical problem|3|||
94516248|NCT03186638|323689026|FG001|Overall Study|Withdrawn due to medical problem|2|||
94516249|NCT03186638|323689025|FG000|Overall Study|Lost to Follow-up|1|||
94516250|NCT03186638|323689026|FG001|Overall Study|Lost to Follow-up|0|||
94516251|NCT02239926|323689027|FG000|Overall Study|Withdrawal by Subject|0|||
94516252|NCT02239926|323689028|FG001|Overall Study|Withdrawal by Subject|1|||
94516253|NCT01263119|323689031|FG000|Period 1|Protocol Violation|2|||
94516254|NCT01263119|323689031|FG000|Period 2|Adverse Event|2|||
94516255|NCT04388826|323689032|FG000|Overall Study|Lost to Follow-up|3|||
94516256|NCT04388826|323689033|FG001|Overall Study|Lost to Follow-up|2|||
94516257|NCT04388826|323689032|FG000|Overall Study|Adverse Event|1|||
94516258|NCT04388826|323689033|FG001|Overall Study|Adverse Event|0|||
94516259|NCT03639610|323689034|FG000|Overall Study|Adverse Event|7|||
94516260|NCT03639610|323689035|FG001|Overall Study|Adverse Event|1|||
94516261|NCT03639610|323689036|FG002|Overall Study|Adverse Event|0|||
94516262|NCT03639610|323689034|FG000|Overall Study|Physician Decision|3|||
94516263|NCT03639610|323689035|FG001|Overall Study|Physician Decision|1|||
94516264|NCT03639610|323689036|FG002|Overall Study|Physician Decision|0|||
94516265|NCT03639610|323689034|FG000|Overall Study|Disease progression|8|||
94516266|NCT03639610|323689035|FG001|Overall Study|Disease progression|5|||
94516267|NCT03639610|323689036|FG002|Overall Study|Disease progression|3|||
94516268|NCT03639610|323689034|FG000|Overall Study|Study terminated by sponsor|2|||
94516269|NCT03639610|323689035|FG001|Overall Study|Study terminated by sponsor|1|||
94516270|NCT03639610|323689036|FG002|Overall Study|Study terminated by sponsor|1|||
94516271|NCT03639610|323689034|FG000|Overall Study|Patient request to stop treatment|1|||
94516272|NCT03639610|323689035|FG001|Overall Study|Patient request to stop treatment|2|||
94516273|NCT03639610|323689036|FG002|Overall Study|Patient request to stop treatment|0|||
94516274|NCT02660229|323689037|FG000|Overall Study|Adverse Event|2|||
94516275|NCT02660229|323689038|FG001|Overall Study|Adverse Event|0|||
94516276|NCT02660229|323689037|FG000|Overall Study|Withdrawal by Subject|0|||
94516277|NCT02660229|323689038|FG001|Overall Study|Withdrawal by Subject|1|||
94516278|NCT02410772|323689044|FG000|Overall Study|Death|3|||
94516279|NCT02410772|323689045|FG001|Overall Study|Death|4|||
94516280|NCT02410772|323689046|FG002|Overall Study|Death|8|||
94516281|NCT02410772|323689044|FG000|Overall Study|Lost to Follow-up|31|||
94516282|NCT02410772|323689045|FG001|Overall Study|Lost to Follow-up|23|||
94516283|NCT02410772|323689046|FG002|Overall Study|Lost to Follow-up|22|||
94516284|NCT02410772|323689044|FG000|Overall Study|Pregnancy|8|||
94516285|NCT02410772|323689045|FG001|Overall Study|Pregnancy|4|||
94516286|NCT02410772|323689046|FG002|Overall Study|Pregnancy|5|||
94516287|NCT02410772|323689044|FG000|Overall Study|Protocol Violation|8|||
94516288|NCT02410772|323689045|FG001|Overall Study|Protocol Violation|8|||
94516289|NCT02410772|323689046|FG002|Overall Study|Protocol Violation|4|||
94516290|NCT02410772|323689044|FG000|Overall Study|Baseline Drug Resistance|49|||
94516291|NCT02410772|323689045|FG001|Overall Study|Baseline Drug Resistance|40|||
94516292|NCT02410772|323689046|FG002|Overall Study|Baseline Drug Resistance|51|||
94516293|NCT02410772|323689044|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
94516294|NCT02410772|323689045|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
94516295|NCT02410772|323689046|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
94516296|NCT02410772|323689044|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
94516297|NCT02410772|323689045|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
94516298|NCT02410772|323689046|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
94516299|NCT01073293|323689049|FG000|Overall Study|Lost to Follow-up|0|||
94516300|NCT01073293|323689050|FG001|Overall Study|Lost to Follow-up|1|||
94516301|NCT01073293|323689049|FG000|Overall Study|Withdrawal by Subject|5|||
94516302|NCT01073293|323689050|FG001|Overall Study|Withdrawal by Subject|10|||
94516303|NCT00002766|323689053|FG000|Overall Study|Withdrawal by Subject|0|||
94516304|NCT00002766|323689054|FG001|Overall Study|Withdrawal by Subject|1|||
94516305|NCT00002766|323689053|FG000|Overall Study|Patient Not Treated|1|||
94516306|NCT00002766|323689054|FG001|Overall Study|Patient Not Treated|2|||
94516307|NCT00002766|323689053|FG000|Overall Study|Adverse Event|1|||
94516308|NCT00002766|323689054|FG001|Overall Study|Adverse Event|1|||
94516309|NCT00002766|323689053|FG000|Overall Study|Protocol Violation|1|||
94516310|NCT00002766|323689054|FG001|Overall Study|Protocol Violation|0|||
94516311|NCT00402987|323689055|FG000|Overall Study|Lack of Efficacy|0|||
94516312|NCT00402987|323689056|FG001|Overall Study|Lack of Efficacy|0|||
94516313|NCT00402987|323689057|FG002|Overall Study|Lack of Efficacy|1|||
94516314|NCT00402987|323689058|FG003|Overall Study|Lack of Efficacy|0|||
94516315|NCT01990742|323689063|FG000|Overall Study|Withdrawal by facility|407|||
94516316|NCT01990742|323689064|FG001|Overall Study|Withdrawal by facility|1083|||
94516317|NCT01990742|323689063|FG000|Overall Study|Facility closed|0|||
94516318|NCT01990742|323689064|FG001|Overall Study|Facility closed|270|||
94516319|NCT02037529|323689065|FG000|Overall Study|Withdrawal by Subject|1|||
94516320|NCT02037529|323689066|FG001|Overall Study|Withdrawal by Subject|3|||
94516321|NCT02037529|323689065|FG000|Overall Study|Adverse Event|0|||
94516322|NCT02037529|323689066|FG001|Overall Study|Adverse Event|1|||
94516323|NCT01541371|323689067|FG000|Overall Study|Withdrawal by Subject|14|||
94516324|NCT01541371|323689067|FG000|Overall Study|Lost to Follow-up|21|||
94516325|NCT01541371|323689067|FG000|Overall Study|Adverse Event|15|||
94516326|NCT01541371|323689067|FG000|Overall Study|Lack of Efficacy|12|||
94516327|NCT01541371|323689067|FG000|Overall Study|Protocol Violation|6|||
94516328|NCT01541371|323689067|FG000|Overall Study|Study medication non-compliance|3|||
94516329|NCT01541371|323689067|FG000|Overall Study|Other|6|||
94516330|NCT02441218|323689068|FG000|Overall Study|Death|503|||
94516331|NCT02441218|323689069|FG001|Overall Study|Death|553|||
94516332|NCT02441218|323689068|FG000|Overall Study|Withdrawal by Subject|73|||
94516333|NCT02441218|323689069|FG001|Overall Study|Withdrawal by Subject|58|||
94516334|NCT02441218|323689068|FG000|Overall Study|Lost to Follow-up|2|||
94516335|NCT02441218|323689069|FG001|Overall Study|Lost to Follow-up|1|||
94516336|NCT00806585|323689072|FG000|Overall Study|Study terminated by Sponsor|0|||
94516337|NCT00806585|323689073|FG001|Overall Study|Study terminated by Sponsor|0|||
94516338|NCT00806585|323689074|FG002|Overall Study|Study terminated by Sponsor|1|||
94516339|NCT00806585|323689075|FG003|Overall Study|Study terminated by Sponsor|2|||
94516340|NCT00806585|323689076|FG004|Overall Study|Study terminated by Sponsor|0|||
94516341|NCT00806585|323689072|FG000|Overall Study|Protocol Violation|3|||
94516342|NCT00806585|323689073|FG001|Overall Study|Protocol Violation|1|||
94516343|NCT00806585|323689074|FG002|Overall Study|Protocol Violation|2|||
94516344|NCT00806585|323689075|FG003|Overall Study|Protocol Violation|0|||
94516345|NCT00806585|323689076|FG004|Overall Study|Protocol Violation|0|||
94516346|NCT00806585|323689072|FG000|Overall Study|Physician Decision|0|||
94516347|NCT00806585|323689073|FG001|Overall Study|Physician Decision|2|||
94516348|NCT00806585|323689074|FG002|Overall Study|Physician Decision|3|||
94516349|NCT00806585|323689075|FG003|Overall Study|Physician Decision|0|||
94516350|NCT00806585|323689076|FG004|Overall Study|Physician Decision|1|||
94516351|NCT00806585|323689072|FG000|Overall Study|Lost to Follow-up|2|||
94516352|NCT00806585|323689073|FG001|Overall Study|Lost to Follow-up|1|||
94516353|NCT00806585|323689074|FG002|Overall Study|Lost to Follow-up|2|||
94516354|NCT00806585|323689075|FG003|Overall Study|Lost to Follow-up|2|||
94516355|NCT00806585|323689076|FG004|Overall Study|Lost to Follow-up|5|||
94516356|NCT00806585|323689072|FG000|Overall Study|Lack of Efficacy|1|||
94516357|NCT00806585|323689073|FG001|Overall Study|Lack of Efficacy|0|||
94516358|NCT00806585|323689074|FG002|Overall Study|Lack of Efficacy|0|||
94516359|NCT00806585|323689075|FG003|Overall Study|Lack of Efficacy|0|||
94516360|NCT00806585|323689076|FG004|Overall Study|Lack of Efficacy|0|||
94516361|NCT00806585|323689072|FG000|Overall Study|Adverse Event|1|||
94516362|NCT00806585|323689073|FG001|Overall Study|Adverse Event|5|||
94516363|NCT00806585|323689074|FG002|Overall Study|Adverse Event|3|||
94516364|NCT00806585|323689075|FG003|Overall Study|Adverse Event|4|||
94516365|NCT00806585|323689076|FG004|Overall Study|Adverse Event|2|||
94516366|NCT00806585|323689072|FG000|Overall Study|Withdrawal by Subject|10|||
94516367|NCT00806585|323689073|FG001|Overall Study|Withdrawal by Subject|8|||
94516368|NCT00806585|323689074|FG002|Overall Study|Withdrawal by Subject|9|||
94516369|NCT00806585|323689075|FG003|Overall Study|Withdrawal by Subject|3|||
94516370|NCT00806585|323689076|FG004|Overall Study|Withdrawal by Subject|11|||
94516371|NCT00806585|323689072|FG000|Overall Study|Completion status unknown|15|||
94516372|NCT00806585|323689073|FG001|Overall Study|Completion status unknown|14|||
94516373|NCT00806585|323689074|FG002|Overall Study|Completion status unknown|12|||
94516374|NCT00806585|323689075|FG003|Overall Study|Completion status unknown|4|||
94516375|NCT00806585|323689076|FG004|Overall Study|Completion status unknown|12|||
94516376|NCT01936831|323689077|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
94516377|NCT01936831|323689078|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
94516378|NCT01936831|323689079|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
94516379|NCT01936831|323689080|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
94516380|NCT01936831|323689081|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
94516381|NCT01936831|323689082|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
94516382|NCT01936831|323689083|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
94516383|NCT01936831|323689084|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
94516384|NCT01936831|323689085|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
94516385|NCT02133573|323689086|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
94516386|NCT02133573|323689087|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
94516387|NCT02133573|323689086|FG000|Overall Study|Child Deaths|3|||
94516388|NCT02133573|323689087|FG001|Overall Study|Child Deaths|5|||
94516389|NCT02133573|323689086|FG000|Overall Study|Child Declined Follow Ups|2|||
94516390|NCT02133573|323689087|FG001|Overall Study|Child Declined Follow Ups|1|||
94516391|NCT02133573|323689086|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
94516392|NCT02133573|323689087|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
94516393|NCT02746809|323689090|FG000|Enrollment|Inclusion Exclusion not met|9|||
94516394|NCT02746809|323689090|FG000|Enrollment|Withdrawal by Subject|1|||
94516395|NCT02746809|323689090|FG000|Enrollment|Expected Enrollment Met|2|||
94516396|NCT02746809|323689090|FG000|Procedure|Death|1|||
94516397|NCT02746809|323689090|FG000|1-Month|Death|5|||
94516398|NCT02746809|323689090|FG000|6-Month|Death|2|||
94516399|NCT02746809|323689090|FG000|6-Month|Withdrawal by Subject|1|||
94516400|NCT02746809|323689090|FG000|12-Month|Death|3|||
94516401|NCT02746809|323689090|FG000|12-Month|Withdrawal by Subject|2|||
94516402|NCT02746809|323689090|FG000|24-Month|Death|1|||
94516403|NCT02746809|323689090|FG000|24-Month|Withdrawal by Subject|1|||
94516404|NCT02746809|323689090|FG000|36-Month|Death|8|||
94516405|NCT02746809|323689090|FG000|36-Month|Withdrawal by Subject|1|||
94516406|NCT02746809|323689090|FG000|48-Month|Death|7|||
94516407|NCT02746809|323689090|FG000|48-Month|Withdrawal by Subject|1|||
94516408|NCT02746809|323689090|FG000|60-Month|Death|1|||
94516409|NCT02746809|323689090|FG000|60-Month|Lost to Follow-up|2|||
94516410|NCT02431325|323689091|FG000|Overall Study|Adverse Event|3|||
94516411|NCT02431325|323689092|FG001|Overall Study|Adverse Event|0|||
94516412|NCT02431325|323689091|FG000|Overall Study|Lost to Follow-up|0|||
94516413|NCT02431325|323689092|FG001|Overall Study|Lost to Follow-up|1|||
94516414|NCT02431325|323689091|FG000|Overall Study|Withdrawal by Subject|1|||
94516415|NCT02431325|323689092|FG001|Overall Study|Withdrawal by Subject|2|||
94516416|NCT02431325|323689091|FG000|Overall Study|Declined to take study medication|1|||
94516417|NCT02431325|323689092|FG001|Overall Study|Declined to take study medication|0|||
94516418|NCT02431325|323689091|FG000|Overall Study|Withdrew before starting study medication|1|||
94516419|NCT02431325|323689092|FG001|Overall Study|Withdrew before starting study medication|0|||
94516420|NCT02431325|323689091|FG000|Overall Study|Placebo shortage|2|||
94516421|NCT02431325|323689092|FG001|Overall Study|Placebo shortage|0|||
94516422|NCT00894387|323689093|FG000|Overall Study|Adverse Event|44|||
94516423|NCT00894387|323689094|FG001|Overall Study|Adverse Event|45|||
94516424|NCT00894387|323689093|FG000|Overall Study|Abnormal Laboratory values|2|||
94516425|NCT00894387|323689094|FG001|Overall Study|Abnormal Laboratory values|2|||
94516426|NCT00894387|323689093|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94516427|NCT00894387|323689094|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
94516428|NCT00894387|323689093|FG000|Overall Study|Lost to Follow-up|3|||
94516429|NCT00894387|323689094|FG001|Overall Study|Lost to Follow-up|5|||
94516430|NCT00894387|323689093|FG000|Overall Study|Administrative problems|2|||
94516431|NCT00894387|323689094|FG001|Overall Study|Administrative problems|2|||
94516432|NCT00894387|323689093|FG000|Overall Study|Death|77|||
94516433|NCT00894387|323689094|FG001|Overall Study|Death|76|||
94516434|NCT00894387|323689093|FG000|Overall Study|Protocol Deviation|4|||
94516435|NCT00894387|323689094|FG001|Overall Study|Protocol Deviation|0|||
94516436|NCT00894387|323689093|FG000|Overall Study|Patient's request|25|||
94516437|NCT00894387|323689094|FG001|Overall Study|Patient's request|30|||
94516438|NCT00894387|323689093|FG000|Overall Study|Other (Missing)|5|||
94516439|NCT00894387|323689094|FG001|Overall Study|Other (Missing)|3|||
94516440|NCT00894387|323689093|FG000|Overall Study|Mis-randomized|13|||
94516441|NCT00894387|323689094|FG001|Overall Study|Mis-randomized|9|||
94516442|NCT00894387|323689093|FG000|Overall Study|GCP non-compliance|0|||
94516443|NCT00894387|323689094|FG001|Overall Study|GCP non-compliance|2|||
94516444|NCT00760552|323689095|FG000|Overall Study|Death|2|||
94516445|NCT00760552|323689096|FG001|Overall Study|Death|0|||
94516446|NCT00760552|323689095|FG000|Overall Study|Lost to Follow-up|11|||
94516447|NCT00760552|323689096|FG001|Overall Study|Lost to Follow-up|10|||
94516448|NCT01657305|323689097|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
94516449|NCT01657305|323689097|FG000|Overall Study|Withdrawal by Subject|4|||
94516450|NCT01657305|323689097|FG000|Overall Study|Adverse Event|1|||
94516451|NCT01657305|323689097|FG000|Overall Study|Lost to Follow-up|1|||
94516452|NCT01657305|323689097|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
94516453|NCT04103450|323689098|FG000|Overall Study|Adverse Event|4|||
94516454|NCT04103450|323689099|FG001|Overall Study|Adverse Event|2|||
94516455|NCT04103450|323689098|FG000|Overall Study|Lack of Efficacy|3|||
94516456|NCT04103450|323689099|FG001|Overall Study|Lack of Efficacy|0|||
94516457|NCT04103450|323689098|FG000|Overall Study|Withdrawal by Subject|5|||
94516458|NCT04103450|323689099|FG001|Overall Study|Withdrawal by Subject|3|||
94516459|NCT04103450|323689098|FG000|Overall Study|Lost to Follow-up|1|||
94516460|NCT04103450|323689099|FG001|Overall Study|Lost to Follow-up|2|||
94516461|NCT04103450|323689098|FG000|Overall Study|Physician Decision|1|||
94516462|NCT04103450|323689099|FG001|Overall Study|Physician Decision|2|||
94516463|NCT04103450|323689098|FG000|Overall Study|Protocol Violation|1|||
94516464|NCT04103450|323689099|FG001|Overall Study|Protocol Violation|0|||
94516465|NCT04103450|323689098|FG000|Overall Study|Other|1|||
94516466|NCT04103450|323689099|FG001|Overall Study|Other|1|||
94516467|NCT04436744|323689105|FG000|Overall Study|Adverse Event|1|||
94516468|NCT04436744|323689106|FG001|Overall Study|Adverse Event|1|||
94516469|NCT04436744|323689105|FG000|Overall Study|Death|1|||
94516470|NCT04436744|323689106|FG001|Overall Study|Death|0|||
94516471|NCT04436744|323689105|FG000|Overall Study|Lost to Follow-up|0|||
94516472|NCT04436744|323689106|FG001|Overall Study|Lost to Follow-up|2|||
94516473|NCT04436744|323689105|FG000|Overall Study|Physician Decision|0|||
94516474|NCT04436744|323689106|FG001|Overall Study|Physician Decision|1|||
94516475|NCT04436744|323689105|FG000|Overall Study|Progressive Disease|0|||
94516476|NCT04436744|323689106|FG001|Overall Study|Progressive Disease|4|||
94516477|NCT04436744|323689105|FG000|Overall Study|Protocol Deviation|1|||
94516478|NCT04436744|323689106|FG001|Overall Study|Protocol Deviation|1|||
94516479|NCT04436744|323689105|FG000|Overall Study|Withdrawal by Subject|1|||
94516480|NCT04436744|323689106|FG001|Overall Study|Withdrawal by Subject|2|||
94516481|NCT00397540|323689107|FG000|Overall Study|short follow-up duration < 12 months|1|||
94516482|NCT00397540|323689108|FG001|Overall Study|short follow-up duration < 12 months|0|||
94516483|NCT01133847|323689109|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
94516484|NCT01133847|323689110|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
94516485|NCT01133847|323689111|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
94516486|NCT01133847|323689109|FG000|Follow-Up Phase|Lost to Follow-up|1|||
94516487|NCT01133847|323689110|FG001|Follow-Up Phase|Lost to Follow-up|3|||
94516488|NCT01133847|323689111|FG002|Follow-Up Phase|Lost to Follow-up|7|||
94516489|NCT01696643|323689115|FG000|Overall Study|Adverse Event|15|||
94516490|NCT01696643|323689116|FG001|Overall Study|Adverse Event|7|||
94516491|NCT01696643|323689115|FG000|Overall Study|Death|1|||
94516492|NCT01696643|323689116|FG001|Overall Study|Death|2|||
94516493|NCT01696643|323689115|FG000|Overall Study|Lack of Efficacy|3|||
94516494|NCT01696643|323689116|FG001|Overall Study|Lack of Efficacy|0|||
94516495|NCT01696643|323689115|FG000|Overall Study|Lost to Follow-up|67|||
94516496|NCT01696643|323689116|FG001|Overall Study|Lost to Follow-up|67|||
94516497|NCT01696643|323689115|FG000|Overall Study|Physician Decision|3|||
94516498|NCT01696643|323689116|FG001|Overall Study|Physician Decision|2|||
94516499|NCT01696643|323689115|FG000|Overall Study|Pregnancy|0|||
94516500|NCT01696643|323689116|FG001|Overall Study|Pregnancy|1|||
94516501|NCT01696643|323689115|FG000|Overall Study|Protocol Violation|7|||
94516502|NCT01696643|323689116|FG001|Overall Study|Protocol Violation|7|||
94516503|NCT01696643|323689115|FG000|Overall Study|Study Terminated by Sponsor|286|||
94516504|NCT01696643|323689116|FG001|Overall Study|Study Terminated by Sponsor|294|||
94516505|NCT01696643|323689115|FG000|Overall Study|Withdrawal by Subject|142|||
94516506|NCT01696643|323689116|FG001|Overall Study|Withdrawal by Subject|149|||
94516507|NCT01696643|323689115|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
94516508|NCT01696643|323689116|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
94516509|NCT01696643|323689115|FG000|Overall Study|Site Error|2|||
94516510|NCT01696643|323689116|FG001|Overall Study|Site Error|1|||
94516511|NCT01696643|323689115|FG000|Overall Study|Participant Incarcerated|0|||
94516512|NCT01696643|323689116|FG001|Overall Study|Participant Incarcerated|1|||
94516513|NCT01696643|323689115|FG000|Overall Study|Medical Monitor Decision|0|||
94516514|NCT01696643|323689116|FG001|Overall Study|Medical Monitor Decision|2|||
94516515|NCT01696643|323689115|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
94516516|NCT01696643|323689116|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
94516517|NCT00776230|323689117|FG000|Overall Study|Lost to Follow-up|2|||
94516518|NCT00776230|323689118|FG001|Overall Study|Lost to Follow-up|1|||
94516519|NCT00776230|323689119|FG002|Overall Study|Lost to Follow-up|5|||
94516520|NCT00776230|323689117|FG000|Overall Study|Not vaccinated at Day 0|1|||
94516521|NCT00776230|323689118|FG001|Overall Study|Not vaccinated at Day 0|0|||
94516522|NCT00776230|323689119|FG002|Overall Study|Not vaccinated at Day 0|0|||
94516523|NCT00776230|323689117|FG000|Overall Study|Withdrawal by Subject|0|||
94516524|NCT00776230|323689118|FG001|Overall Study|Withdrawal by Subject|1|||
94516525|NCT00776230|323689119|FG002|Overall Study|Withdrawal by Subject|0|||
94516526|NCT00776230|323689117|FG000|Overall Study|Subject missed Visit 4|0|||
94516527|NCT00776230|323689118|FG001|Overall Study|Subject missed Visit 4|1|||
94516528|NCT00776230|323689119|FG002|Overall Study|Subject missed Visit 4|0|||
94516529|NCT01215851|323689123|FG000|Treatment Period|Adverse Event|1|||
94516530|NCT01215851|323689124|FG001|Treatment Period|Adverse Event|1|||
94516531|NCT01215851|323689125|FG002|Treatment Period|Adverse Event|1|||
94516532|NCT01215851|323689126|FG003|Treatment Period|Adverse Event|3|||
94516533|NCT01215851|323689127|FG004|Treatment Period|Adverse Event|0|||
94516534|NCT01215851|323689128|FG005|Treatment Period|Adverse Event|1|||
94516535|NCT01215851|323689123|FG000|Follow up Period|Lost to Follow-up|0|||
94516536|NCT01215851|323689124|FG001|Follow up Period|Lost to Follow-up|0|||
94516537|NCT01215851|323689125|FG002|Follow up Period|Lost to Follow-up|0|||
94516538|NCT01215851|323689126|FG003|Follow up Period|Lost to Follow-up|0|||
94516539|NCT01215851|323689127|FG004|Follow up Period|Lost to Follow-up|0|||
94516540|NCT01215851|323689128|FG005|Follow up Period|Lost to Follow-up|1|||
94516541|NCT03383666|323689129|FG000|Overall Study|Withdrawal by Subject|2|||
94516542|NCT03383666|323689129|FG000|Overall Study|Lost to Follow-up|2|||
94516543|NCT03507127|323689130|FG000|Overall Study|Withdrawal by Subject|1|||
94516544|NCT03507127|323689131|FG001|Overall Study|Withdrawal by Subject|0|||
94516545|NCT03507127|323689130|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
94516546|NCT03507127|323689131|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
94516547|NCT03508050|323689132|FG000|Overall Study|Pleural adhesions|1|||
94516548|NCT03508050|323689133|FG001|Overall Study|Pleural adhesions|0|||
94516549|NCT03508050|323689132|FG000|Overall Study|Mucus plug|1|||
94516550|NCT03508050|323689133|FG001|Overall Study|Mucus plug|0|||
94516551|NCT03508050|323689132|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
94516552|NCT03508050|323689133|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
94516553|NCT03508050|323689132|FG000|Overall Study|Sustained desaturation|0|||
94516554|NCT03508050|323689133|FG001|Overall Study|Sustained desaturation|1|||
94516555|NCT01276106|323689134|FG000|Overall Study|Adverse Event|3|||
94516556|NCT01276106|323689135|FG001|Overall Study|Adverse Event|3|||
94516557|NCT01276106|323689136|FG002|Overall Study|Adverse Event|11|||
94516558|NCT01276106|323689137|FG003|Overall Study|Adverse Event|3|||
94516559|NCT01276106|323689134|FG000|Overall Study|Withdrawal by Subject|6|||
94516560|NCT01276106|323689135|FG001|Overall Study|Withdrawal by Subject|3|||
94516561|NCT01276106|323689136|FG002|Overall Study|Withdrawal by Subject|1|||
94516562|NCT01276106|323689137|FG003|Overall Study|Withdrawal by Subject|6|||
94516563|NCT01276106|323689134|FG000|Overall Study|Lack of Efficacy|0|||
94516564|NCT01276106|323689135|FG001|Overall Study|Lack of Efficacy|1|||
94516565|NCT01276106|323689136|FG002|Overall Study|Lack of Efficacy|0|||
94516566|NCT01276106|323689137|FG003|Overall Study|Lack of Efficacy|1|||
94516567|NCT01276106|323689134|FG000|Overall Study|Lost to Follow-up|2|||
94516568|NCT01276106|323689135|FG001|Overall Study|Lost to Follow-up|1|||
94516569|NCT01276106|323689136|FG002|Overall Study|Lost to Follow-up|1|||
94516570|NCT01276106|323689137|FG003|Overall Study|Lost to Follow-up|0|||
94516571|NCT01276106|323689134|FG000|Overall Study|Physician Decision|0|||
94516572|NCT01276106|323689135|FG001|Overall Study|Physician Decision|0|||
94516573|NCT01276106|323689136|FG002|Overall Study|Physician Decision|1|||
94516574|NCT01276106|323689137|FG003|Overall Study|Physician Decision|1|||
94516575|NCT01276106|323689134|FG000|Overall Study|Protocol Violation|1|||
94516576|NCT01276106|323689135|FG001|Overall Study|Protocol Violation|1|||
94516577|NCT01276106|323689136|FG002|Overall Study|Protocol Violation|0|||
94516578|NCT01276106|323689137|FG003|Overall Study|Protocol Violation|2|||
94516579|NCT01276106|323689134|FG000|Overall Study|Insufficient therapeutic effects|0|||
94516580|NCT01276106|323689135|FG001|Overall Study|Insufficient therapeutic effects|0|||
94516581|NCT01276106|323689136|FG002|Overall Study|Insufficient therapeutic effects|2|||
94516582|NCT01276106|323689137|FG003|Overall Study|Insufficient therapeutic effects|0|||
94516583|NCT01677988|323689138|FG000|Overall Study|Lack of Efficacy|2|||
94516584|NCT00907621|323689139|FG000|Overall Study|Lost to Follow-up|6|||
94516585|NCT00907621|323689140|FG001|Overall Study|Lost to Follow-up|3|||
94516586|NCT00907621|323689139|FG000|Overall Study|intercurrent febrile illness|1|||
94516587|NCT00907621|323689140|FG001|Overall Study|intercurrent febrile illness|1|||
94516588|NCT00902330|323689141|FG000|Overall Study|Too overwhelmed by treatment|2|||
94516589|NCT00902330|323689142|FG001|Overall Study|Too overwhelmed by treatment|5|||
94516590|NCT00902330|323689141|FG000|Overall Study|Adverse Event|1|||
94516591|NCT00902330|323689142|FG001|Overall Study|Adverse Event|0|||
94516592|NCT00902330|323689141|FG000|Overall Study|No post baseline data|1|||
94516593|NCT00902330|323689142|FG001|Overall Study|No post baseline data|0|||
94516594|NCT01847443|323689147|FG000|Study Period 1|Withdrawal by Subject|0|||
94516595|NCT01847443|323689148|FG001|Study Period 1|Withdrawal by Subject|1|||
94516596|NCT01847443|323689149|FG002|Study Period 1|Withdrawal by Subject|0|||
94516597|NCT01847443|323689150|FG003|Study Period 1|Withdrawal by Subject|0|||
94516598|NCT01847443|323689147|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
94516599|NCT01847443|323689148|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
94516600|NCT01847443|323689149|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
94516601|NCT01847443|323689150|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
94516602|NCT01847443|323689147|FG000|Washout Period Before Study Period 2|Other reason|1|||
94516603|NCT01847443|323689148|FG001|Washout Period Before Study Period 2|Other reason|0|||
94516604|NCT01847443|323689149|FG002|Washout Period Before Study Period 2|Other reason|0|||
94516605|NCT01847443|323689150|FG003|Washout Period Before Study Period 2|Other reason|0|||
94516606|NCT01847443|323689147|FG000|Washout Period Before Study Period 3|Other reason|1|||
94516607|NCT01847443|323689148|FG001|Washout Period Before Study Period 3|Other reason|0|||
94516608|NCT01847443|323689149|FG002|Washout Period Before Study Period 3|Other reason|0|||
94516609|NCT01847443|323689150|FG003|Washout Period Before Study Period 3|Other reason|0|||
94516610|NCT01847443|323689147|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
94516611|NCT01847443|323689148|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
94516612|NCT01847443|323689149|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
94516613|NCT01847443|323689150|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
94516614|NCT01847443|323689147|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
94516615|NCT01847443|323689148|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
94516616|NCT01847443|323689149|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
94516617|NCT01847443|323689150|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
94516618|NCT01085214|323689156|FG000|Overall Study|Alternate treatment required|1|||
94516619|NCT01634152|323689157|FG000|Overall Study|Adverse Event|2|||
94516620|NCT01634152|323689158|FG001|Overall Study|Adverse Event|0|||
94516621|NCT01634152|323689159|FG002|Overall Study|Adverse Event|2|||
94516622|NCT01634152|323689157|FG000|Overall Study|Consent withdrawn not due to AE|1|||
94516623|NCT01634152|323689158|FG001|Overall Study|Consent withdrawn not due to AE|0|||
94516624|NCT01634152|323689159|FG002|Overall Study|Consent withdrawn not due to AE|1|||
94516625|NCT01634152|323689157|FG000|Overall Study|Not treated|0|||
94516626|NCT01634152|323689158|FG001|Overall Study|Not treated|1|||
94516627|NCT01634152|323689159|FG002|Overall Study|Not treated|0|||
94516628|NCT01634152|323689157|FG000|Overall Study|Other reason not defined above|1|||
94516629|NCT01634152|323689158|FG001|Overall Study|Other reason not defined above|0|||
94516630|NCT01634152|323689159|FG002|Overall Study|Other reason not defined above|1|||
94516631|NCT01280968|323689161|FG000|Overall Study|Lost to Follow-up|8|||
94516632|NCT01280968|323689162|FG001|Overall Study|Lost to Follow-up|2|||
94516633|NCT01280968|323689161|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
94516634|NCT01280968|323689162|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
94516635|NCT01280968|323689161|FG000|Overall Study|Commuting Problems|2|||
94516636|NCT01280968|323689162|FG001|Overall Study|Commuting Problems|0|||
94516637|NCT01280968|323689161|FG000|Overall Study|Anxiety|2|||
94516638|NCT01280968|323689162|FG001|Overall Study|Anxiety|0|||
94516639|NCT01280968|323689161|FG000|Overall Study|Adverse Event|1|||
94516640|NCT01280968|323689162|FG001|Overall Study|Adverse Event|0|||
94516641|NCT01280968|323689161|FG000|Overall Study|Scheduling Conflicts|1|||
94516642|NCT01280968|323689162|FG001|Overall Study|Scheduling Conflicts|1|||
94516643|NCT01280968|323689161|FG000|Overall Study|Pre-existing Neurological Condition|1|||
94516644|NCT01280968|323689162|FG001|Overall Study|Pre-existing Neurological Condition|0|||
94516645|NCT01280968|323689161|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
94516646|NCT01280968|323689162|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
94516647|NCT01049373|323690717|FG000|Overall Study|Protocol Violation|9|||
94516648|NCT01049373|323690718|FG001|Overall Study|Protocol Violation|9|||
94516649|NCT01049373|323690717|FG000|Overall Study|Withdrawal by Subject|8|||
94516650|NCT01049373|323690718|FG001|Overall Study|Withdrawal by Subject|5|||
94516651|NCT01049373|323690717|FG000|Overall Study|Adverse Event|3|||
94516652|NCT01049373|323690718|FG001|Overall Study|Adverse Event|3|||
94516653|NCT01049373|323690717|FG000|Overall Study|Lost to Follow-up|9|||
94516654|NCT01049373|323690718|FG001|Overall Study|Lost to Follow-up|4|||
94516655|NCT01049373|323690717|FG000|Overall Study|no evaluable study values|9|||
94516656|NCT01049373|323690718|FG001|Overall Study|no evaluable study values|21|||
94516657|NCT01049373|323690717|FG000|Overall Study|Other|1|||
94516658|NCT01049373|323690718|FG001|Overall Study|Other|1|||
94516659|NCT01049373|323690717|FG000|Overall Study|Non-cooperation|0|||
94516660|NCT01049373|323690718|FG001|Overall Study|Non-cooperation|1|||
94516661|NCT01693367|323690723|FG000|Overall Study|Withdrawal by Subject|1|||
94516662|NCT01693367|323690724|FG001|Overall Study|Withdrawal by Subject|1|||
94516663|NCT01693367|323690723|FG000|Overall Study|Physician Decision|0|||
94516664|NCT01693367|323690724|FG001|Overall Study|Physician Decision|1|||
94516665|NCT02136914|323690725|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
94516666|NCT02136914|323690726|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
94516667|NCT02136914|323690725|FG000|Overall Study|Withdrawal by Subject|3|||
94516668|NCT02136914|323690726|FG001|Overall Study|Withdrawal by Subject|10|||
94516669|NCT02136914|323690725|FG000|Overall Study|Subject Unwilling to Proceed|7|||
94516670|NCT02136914|323690726|FG001|Overall Study|Subject Unwilling to Proceed|2|||
94516671|NCT02136914|323690725|FG000|Overall Study|Lost to Follow-up|1|||
94516672|NCT02136914|323690726|FG001|Overall Study|Lost to Follow-up|1|||
94516673|NCT02136914|323690725|FG000|Overall Study|Did Not Receive Study Drug|2|||
94516674|NCT02136914|323690726|FG001|Overall Study|Did Not Receive Study Drug|0|||
94516675|NCT02136914|323690725|FG000|Overall Study|Lack of Efficacy|1|||
94516676|NCT02136914|323690726|FG001|Overall Study|Lack of Efficacy|0|||
94516677|NCT02136914|323690725|FG000|Overall Study|Death|0|||
94516678|NCT02136914|323690726|FG001|Overall Study|Death|1|||
94516679|NCT00949533|323690727|FG000|Overall Study|Lost to Follow-up|0|||
94516680|NCT00949533|323690728|FG001|Overall Study|Lost to Follow-up|1|||
94516681|NCT01128569|323690736|FG000|Washout Period 1|Adverse Event|0|||
94516682|NCT01128569|323690737|FG001|Washout Period 1|Adverse Event|0|||
94516683|NCT01128569|323690738|FG002|Washout Period 1|Adverse Event|1|||
94516684|NCT01128569|323690739|FG003|Washout Period 1|Adverse Event|0|||
94516685|NCT01128569|323690740|FG004|Washout Period 1|Adverse Event|0|||
94516686|NCT01128569|323690741|FG005|Washout Period 1|Adverse Event|0|||
94516687|NCT01128569|323690736|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94516688|NCT01128569|323690737|FG001|Treatment Period 2|Withdrawal by Subject|1|||
94516689|NCT01128569|323690738|FG002|Treatment Period 2|Withdrawal by Subject|0|||
94516690|NCT01128569|323690739|FG003|Treatment Period 2|Withdrawal by Subject|0|||
94516691|NCT01128569|323690740|FG004|Treatment Period 2|Withdrawal by Subject|0|||
94516692|NCT01128569|323690741|FG005|Treatment Period 2|Withdrawal by Subject|0|||
94516693|NCT02300233|323690742|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
94516694|NCT02300233|323690743|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
94516695|NCT02300233|323690744|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
94516696|NCT02300233|323690742|FG000|Overall Study|Withdrawal by Subject|1|||
94516697|NCT02300233|323690743|FG001|Overall Study|Withdrawal by Subject|0|||
94516698|NCT02300233|323690744|FG002|Overall Study|Withdrawal by Subject|3|||
94516699|NCT02300233|323690742|FG000|Overall Study|Investigator Judgement|0|||
94516700|NCT02300233|323690743|FG001|Overall Study|Investigator Judgement|0|||
94516701|NCT02300233|323690744|FG002|Overall Study|Investigator Judgement|1|||
94516702|NCT02300233|323690742|FG000|Overall Study|Reason Not Specified|0|||
94516703|NCT02300233|323690743|FG001|Overall Study|Reason Not Specified|0|||
94516704|NCT02300233|323690744|FG002|Overall Study|Reason Not Specified|5|||
94516705|NCT01307449|323690745|FG000|Overall Study|Adverse Event|1|||
94516706|NCT01307449|323690746|FG001|Overall Study|Adverse Event|0|||
94516707|NCT01307449|323690747|FG002|Overall Study|Adverse Event|0|||
94516708|NCT01307449|323690748|FG003|Overall Study|Adverse Event|0|||
94516709|NCT01977222|323690749|FG000|Overall Study|Withdrawal by Subject|1|||
94516710|NCT01088503|323690750|FG000|Overall Study|Withdrawal by Subject|118|||
94516711|NCT01088503|323690751|FG001|Overall Study|Withdrawal by Subject|327|||
94516712|NCT01088503|323690752|FG002|Overall Study|Withdrawal by Subject|10|||
94516713|NCT01088503|323690750|FG000|Overall Study|Death|64|||
94516714|NCT01088503|323690751|FG001|Overall Study|Death|358|||
94516715|NCT01088503|323690752|FG002|Overall Study|Death|7|||
94516716|NCT00186628|323690753|FG000|Overall Study|Death|2|||
94516717|NCT00186628|323690753|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
94516718|NCT02927795|323690754|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
94516719|NCT02927795|323690754|FG000|Overall Study|Not Treated|4|||
94516720|NCT04403919|323690755|FG000|Overall Study|Lost to Follow-up|0|||
94516721|NCT04403919|323690756|FG001|Overall Study|Lost to Follow-up|0|||
94516722|NCT04403919|323690757|FG002|Overall Study|Lost to Follow-up|0|||
94516723|NCT04403919|323690758|FG003|Overall Study|Lost to Follow-up|1|||
94516724|NCT01612676|323690760|FG000|Overall Study|Adverse Event|2|||
94516725|NCT01612676|323690761|FG001|Overall Study|Adverse Event|3|||
94516726|NCT01612676|323690762|FG002|Overall Study|Adverse Event|1|||
94516727|NCT01612676|323690763|FG003|Overall Study|Adverse Event|3|||
94516728|NCT01612676|323690760|FG000|Overall Study|Protocol Violation|0|||
94516729|NCT01612676|323690761|FG001|Overall Study|Protocol Violation|1|||
94516730|NCT01612676|323690762|FG002|Overall Study|Protocol Violation|0|||
94516731|NCT01612676|323690763|FG003|Overall Study|Protocol Violation|0|||
94516732|NCT01534481|323690773|FG000|Overall Study|Lost to Follow-up|29|||
94516733|NCT01534481|323690774|FG001|Overall Study|Lost to Follow-up|24|||
94516734|NCT01534481|323690773|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
94516735|NCT01534481|323690774|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
94516736|NCT05525910|323690775|FG000|Period 4|Per sponsor due to study timelines|0|||
94516737|NCT05525910|323690776|FG001|Period 4|Per sponsor due to study timelines|0|||
94516738|NCT05525910|323690777|FG002|Period 4|Per sponsor due to study timelines|1|||
94516739|NCT05525910|323690778|FG003|Period 4|Per sponsor due to study timelines|1|||
94516740|NCT05525910|323690779|FG004|Period 4|Per sponsor due to study timelines|1|||
94516741|NCT02980107|323690784|FG000|Overall Study|Withdrawal by Subject|51|||
94516742|NCT02980107|323690785|FG001|Overall Study|Withdrawal by Subject|62|||
94516743|NCT00945659|323690786|FG000|Overall Study|Lost to Follow-up|7|||
94516744|NCT00945659|323690787|FG001|Overall Study|Lost to Follow-up|20|||
94516745|NCT00945659|323690788|FG002|Overall Study|Lost to Follow-up|17|||
94516746|NCT05134649|323690790|FG000|Overall Study|Lost to Follow-up|12|||
94516747|NCT05134649|323690790|FG000|Overall Study|Withdrawal by Subject|14|||
94516748|NCT05134649|323690790|FG000|Overall Study|Pregnancy|1|||
94516749|NCT05134649|323690790|FG000|Overall Study|Other, not specified|3|||
94516750|NCT02412670|323690795|FG000|Overall Study|Adverse Event|4|||
94516751|NCT02412670|323690796|FG001|Overall Study|Adverse Event|1|||
94516752|NCT02412670|323690795|FG000|Overall Study|Physician Decision|1|||
94516753|NCT02412670|323690796|FG001|Overall Study|Physician Decision|0|||
94516754|NCT02412670|323690795|FG000|Overall Study|Withdrawal by Subject|1|||
94516755|NCT02412670|323690796|FG001|Overall Study|Withdrawal by Subject|0|||
94516756|NCT02412670|323690795|FG000|Overall Study|Ineligible|1|||
94516757|NCT02412670|323690796|FG001|Overall Study|Ineligible|0|||
94516758|NCT02257684|323690799|FG000|Overall Study|Adverse Event|2|||
94516759|NCT02257684|323690799|FG000|Overall Study|Lack of Efficacy|1|||
94516760|NCT02257684|323690799|FG000|Overall Study|Sponsor's Decision|1|||
94516761|NCT01876381|323690803|FG000|Overall Study|Lack of Efficacy|5|||
94516762|NCT01876381|323690803|FG000|Overall Study|Physician Decision|1|||
94516763|NCT01876381|323690803|FG000|Overall Study|Withdrawal by Subject|1|||
94516764|NCT03139448|323690804|FG000|Overall Study|Lack of Efficacy|6|||
94516765|NCT03139448|323690805|FG001|Overall Study|Lack of Efficacy|7|||
94516766|NCT03139448|323690804|FG000|Overall Study|Location of procedure changed|2|||
94516767|NCT03139448|323690805|FG001|Overall Study|Location of procedure changed|8|||
94516768|NCT03139448|323690804|FG000|Overall Study|Withdrawal by Subject|3|||
94516769|NCT03139448|323690805|FG001|Overall Study|Withdrawal by Subject|6|||
94516770|NCT03139448|323690804|FG000|Overall Study|Screen fail|1|||
94516771|NCT03139448|323690805|FG001|Overall Study|Screen fail|3|||
94516772|NCT03139448|323690804|FG000|Overall Study|Physician Decision|0|||
94516773|NCT03139448|323690805|FG001|Overall Study|Physician Decision|2|||
94516774|NCT01987557|323690806|FG000|Overall Study|Protocol Violation|1|||
94516775|NCT01987557|323690807|FG001|Overall Study|Protocol Violation|0|||
94516776|NCT01987557|323690808|FG002|Overall Study|Protocol Violation|1|||
94516777|NCT01987557|323690806|FG000|Overall Study|Withdrawal by Subject|2|||
94516778|NCT01987557|323690807|FG001|Overall Study|Withdrawal by Subject|1|||
94516779|NCT01987557|323690808|FG002|Overall Study|Withdrawal by Subject|2|||
94516780|NCT01987557|323690806|FG000|Overall Study|Adverse Event|0|||
94516781|NCT01987557|323690807|FG001|Overall Study|Adverse Event|2|||
94516782|NCT01987557|323690808|FG002|Overall Study|Adverse Event|0|||
94516783|NCT01567722|323690817|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
94516784|NCT01567722|323690818|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
94516785|NCT01567722|323690819|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
94516786|NCT01567722|323690817|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
94516787|NCT01567722|323690818|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
94516788|NCT01567722|323690819|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
94516789|NCT01567722|323690817|FG000|Overall Study|Protocol closure by the OCG|2|||
94516790|NCT01567722|323690818|FG001|Overall Study|Protocol closure by the OCG|0|||
94516791|NCT01567722|323690819|FG002|Overall Study|Protocol closure by the OCG|0|||
94516792|NCT01567722|323690817|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
94516793|NCT01567722|323690818|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
94516794|NCT01567722|323690819|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
94516795|NCT00382174|323690821|FG000|Overall Study|Lost to Follow-up|1|||
94516796|NCT00382174|323690822|FG001|Overall Study|Lost to Follow-up|4|||
94516797|NCT00382174|323690823|FG002|Overall Study|Lost to Follow-up|5|||
94516798|NCT00382174|323690821|FG000|Overall Study|Adverse Event|1|||
94516799|NCT00382174|323690822|FG001|Overall Study|Adverse Event|4|||
94516800|NCT00382174|323690823|FG002|Overall Study|Adverse Event|5|||
94516801|NCT00382174|323690821|FG000|Overall Study|Withdrawal by Subject|1|||
94516802|NCT00382174|323690822|FG001|Overall Study|Withdrawal by Subject|4|||
94516803|NCT00382174|323690823|FG002|Overall Study|Withdrawal by Subject|5|||
94516804|NCT00382174|323690821|FG000|Overall Study|Non compliance|1|||
94516805|NCT00382174|323690822|FG001|Overall Study|Non compliance|0|||
94516806|NCT00382174|323690823|FG002|Overall Study|Non compliance|1|||
94516807|NCT00382174|323690821|FG000|Overall Study|Physician Decision|0|||
94516808|NCT00382174|323690822|FG001|Overall Study|Physician Decision|2|||
94516809|NCT00382174|323690823|FG002|Overall Study|Physician Decision|2|||
94516810|NCT00382174|323690821|FG000|Overall Study|Failed to meet criteria|0|||
94516811|NCT00382174|323690822|FG001|Overall Study|Failed to meet criteria|1|||
94516812|NCT00382174|323690823|FG002|Overall Study|Failed to meet criteria|1|||
94516813|NCT00382174|323690821|FG000|Overall Study|Wounds merged|0|||
94516814|NCT00382174|323690822|FG001|Overall Study|Wounds merged|2|||
94516815|NCT00382174|323690823|FG002|Overall Study|Wounds merged|2|||
94516816|NCT02216526|323690826|FG000|Overall Study|Adverse Event|1|||
94516817|NCT02216526|323690827|FG001|Overall Study|Adverse Event|1|||
94516818|NCT02216526|323690828|FG002|Overall Study|Adverse Event|0|||
94516819|NCT02216526|323690826|FG000|Overall Study|Death|0|||
94516820|NCT02216526|323690827|FG001|Overall Study|Death|1|||
94516821|NCT02216526|323690828|FG002|Overall Study|Death|3|||
94516822|NCT02216526|323690826|FG000|Overall Study|Protocol Violation|2|||
94516823|NCT02216526|323690827|FG001|Overall Study|Protocol Violation|0|||
94516824|NCT02216526|323690828|FG002|Overall Study|Protocol Violation|2|||
94516825|NCT02216526|323690826|FG000|Overall Study|Hospitalization|2|||
94516826|NCT02216526|323690827|FG001|Overall Study|Hospitalization|1|||
94516827|NCT02216526|323690828|FG002|Overall Study|Hospitalization|3|||
94516828|NCT03097289|323690829|FG000|Overall Study|Adverse Event|1|||
94516829|NCT03097289|323690829|FG000|Overall Study|Equipment failure|2|||
94516830|NCT03097289|323690829|FG000|Overall Study|Collected platelet product unusable|3|||
94516831|NCT02394561|323690830|FG000|CORE Phase|Adverse Event|7|||
94516832|NCT02394561|323690831|FG001|CORE Phase|Adverse Event|9|||
94516833|NCT02394561|323690830|FG000|CORE Phase|Death|0|||
94516834|NCT02394561|323690831|FG001|CORE Phase|Death|1|||
94516835|NCT02394561|323690830|FG000|CORE Phase|Pregnancy|1|||
94516836|NCT02394561|323690831|FG001|CORE Phase|Pregnancy|0|||
94516837|NCT02394561|323690830|FG000|CORE Phase|Lost to Follow-up|1|||
94516838|NCT02394561|323690831|FG001|CORE Phase|Lost to Follow-up|0|||
94516839|NCT02394561|323690830|FG000|CORE Phase|Physician Decision|1|||
94516840|NCT02394561|323690831|FG001|CORE Phase|Physician Decision|1|||
94516841|NCT02394561|323690830|FG000|CORE Phase|Withdrawal by Subject|2|||
94516842|NCT02394561|323690831|FG001|CORE Phase|Withdrawal by Subject|2|||
94516843|NCT02394561|323690830|FG000|CORE Phase|Lack of Efficacy|1|||
94516844|NCT02394561|323690831|FG001|CORE Phase|Lack of Efficacy|6|||
94516845|NCT02394561|323690830|FG000|Extension Phase|Adverse Event|6|||
94516846|NCT02394561|323690831|FG001|Extension Phase|Adverse Event|1|||
94516847|NCT02394561|323690830|FG000|Extension Phase|Death|0|||
94516848|NCT02394561|323690831|FG001|Extension Phase|Death|1|||
94516849|NCT02394561|323690830|FG000|Extension Phase|Protocol Violation|1|||
94516850|NCT02394561|323690831|FG001|Extension Phase|Protocol Violation|0|||
94516851|NCT02394561|323690830|FG000|Extension Phase|Lost to Follow-up|1|||
94516852|NCT02394561|323690831|FG001|Extension Phase|Lost to Follow-up|0|||
94516853|NCT02394561|323690830|FG000|Extension Phase|Physician Decision|0|||
94516854|NCT02394561|323690831|FG001|Extension Phase|Physician Decision|2|||
94516855|NCT02394561|323690830|FG000|Extension Phase|Withdrawal by Subject|0|||
94516856|NCT02394561|323690831|FG001|Extension Phase|Withdrawal by Subject|5|||
94516857|NCT02394561|323690830|FG000|Extension Phase|Lack of Efficacy|3|||
94516858|NCT02394561|323690831|FG001|Extension Phase|Lack of Efficacy|3|||
94516859|NCT02750514|323690832|FG000|Track 1|Disease progression|20|||
94516860|NCT02750514|323690833|FG001|Track 1|Disease progression|1|||
94516861|NCT02750514|323690834|FG002|Track 1|Disease progression|0|||
94516862|NCT02750514|323690835|FG003|Track 1|Disease progression|1|||
94516863|NCT02750514|323690836|FG004|Track 1|Disease progression|0|||
94516864|NCT02750514|323690832|FG000|Track 1|Adverse event unrelated to study drug|1|||
94516865|NCT02750514|323690833|FG001|Track 1|Adverse event unrelated to study drug|0|||
94516866|NCT02750514|323690834|FG002|Track 1|Adverse event unrelated to study drug|0|||
94516867|NCT02750514|323690835|FG003|Track 1|Adverse event unrelated to study drug|0|||
94516868|NCT02750514|323690836|FG004|Track 1|Adverse event unrelated to study drug|0|||
94516869|NCT02750514|323690832|FG000|Track 1|Study drug toxicity|4|||
94516870|NCT02750514|323690833|FG001|Track 1|Study drug toxicity|1|||
94516871|NCT02750514|323690834|FG002|Track 1|Study drug toxicity|0|||
94516872|NCT02750514|323690835|FG003|Track 1|Study drug toxicity|1|||
94516873|NCT02750514|323690836|FG004|Track 1|Study drug toxicity|0|||
94516874|NCT02750514|323690832|FG000|Track 1|Participant request to discontinue|1|||
94516875|NCT02750514|323690833|FG001|Track 1|Participant request to discontinue|0|||
94516876|NCT02750514|323690834|FG002|Track 1|Participant request to discontinue|0|||
94516877|NCT02750514|323690835|FG003|Track 1|Participant request to discontinue|0|||
94516878|NCT02750514|323690836|FG004|Track 1|Participant request to discontinue|0|||
94516879|NCT02750514|323690832|FG000|Track 1|Other reasons|1|||
94516880|NCT02750514|323690833|FG001|Track 1|Other reasons|0|||
94516881|NCT02750514|323690834|FG002|Track 1|Other reasons|0|||
94516882|NCT02750514|323690835|FG003|Track 1|Other reasons|0|||
94516883|NCT02750514|323690836|FG004|Track 1|Other reasons|0|||
94516884|NCT02750514|323690832|FG000|Track 2|Disease progression|4|||
94516885|NCT02750514|323690833|FG001|Track 2|Disease progression|5|||
94516886|NCT02750514|323690834|FG002|Track 2|Disease progression|2|||
94516887|NCT02750514|323690835|FG003|Track 2|Disease progression|5|||
94516888|NCT02750514|323690836|FG004|Track 2|Disease progression|0|||
94516889|NCT02750514|323690832|FG000|Track 2|Adverse event unrelated to study drug|1|||
94516890|NCT02750514|323690833|FG001|Track 2|Adverse event unrelated to study drug|0|||
94516891|NCT02750514|323690834|FG002|Track 2|Adverse event unrelated to study drug|0|||
94516892|NCT02750514|323690835|FG003|Track 2|Adverse event unrelated to study drug|0|||
94516893|NCT02750514|323690836|FG004|Track 2|Adverse event unrelated to study drug|0|||
94516894|NCT02750514|323690832|FG000|Track 2|Study drug toxicity|1|||
94516895|NCT02750514|323690833|FG001|Track 2|Study drug toxicity|2|||
94516896|NCT02750514|323690834|FG002|Track 2|Study drug toxicity|0|||
94516897|NCT02750514|323690835|FG003|Track 2|Study drug toxicity|2|||
94516898|NCT02750514|323690836|FG004|Track 2|Study drug toxicity|0|||
94516899|NCT02750514|323690832|FG000|Track 2|Participant withdrew consent|0|||
94516900|NCT02750514|323690833|FG001|Track 2|Participant withdrew consent|1|||
94516901|NCT02750514|323690834|FG002|Track 2|Participant withdrew consent|0|||
94516902|NCT02750514|323690835|FG003|Track 2|Participant withdrew consent|0|||
94516903|NCT02750514|323690836|FG004|Track 2|Participant withdrew consent|0|||
94516904|NCT02750514|323690832|FG000|Track 3|Disease progression|0|||
94516905|NCT02750514|323690833|FG001|Track 3|Disease progression|24|||
94516906|NCT02750514|323690834|FG002|Track 3|Disease progression|13|||
94516907|NCT02750514|323690835|FG003|Track 3|Disease progression|14|||
94516908|NCT02750514|323690836|FG004|Track 3|Disease progression|0|||
94516909|NCT02750514|323690832|FG000|Track 3|Adverse event unrelated to study drug|0|||
94516910|NCT02750514|323690833|FG001|Track 3|Adverse event unrelated to study drug|1|||
94516911|NCT02750514|323690834|FG002|Track 3|Adverse event unrelated to study drug|1|||
94516912|NCT02750514|323690835|FG003|Track 3|Adverse event unrelated to study drug|1|||
94516913|NCT02750514|323690836|FG004|Track 3|Adverse event unrelated to study drug|0|||
94516914|NCT02750514|323690832|FG000|Track 3|Study drug toxicity|0|||
94516915|NCT02750514|323690833|FG001|Track 3|Study drug toxicity|3|||
94516916|NCT02750514|323690834|FG002|Track 3|Study drug toxicity|0|||
94516917|NCT02750514|323690835|FG003|Track 3|Study drug toxicity|1|||
94516918|NCT02750514|323690836|FG004|Track 3|Study drug toxicity|0|||
94516919|NCT02750514|323690832|FG000|Track 3|Participant request to discontinue|0|||
94516920|NCT02750514|323690833|FG001|Track 3|Participant request to discontinue|2|||
94516921|NCT02750514|323690834|FG002|Track 3|Participant request to discontinue|0|||
94516922|NCT02750514|323690835|FG003|Track 3|Participant request to discontinue|0|||
94516923|NCT02750514|323690836|FG004|Track 3|Participant request to discontinue|0|||
94516924|NCT02750514|323690832|FG000|Track 3|Participant withdrew consent|0|||
94516925|NCT02750514|323690833|FG001|Track 3|Participant withdrew consent|3|||
94516926|NCT02750514|323690834|FG002|Track 3|Participant withdrew consent|1|||
94516927|NCT02750514|323690835|FG003|Track 3|Participant withdrew consent|0|||
94516928|NCT02750514|323690836|FG004|Track 3|Participant withdrew consent|0|||
94516929|NCT02750514|323690832|FG000|Track 3|Other reasons|0|||
94516930|NCT02750514|323690833|FG001|Track 3|Other reasons|3|||
94516931|NCT02750514|323690834|FG002|Track 3|Other reasons|0|||
94516932|NCT02750514|323690835|FG003|Track 3|Other reasons|0|||
94516933|NCT02750514|323690836|FG004|Track 3|Other reasons|0|||
94516934|NCT02750514|323690832|FG000|Track 4|Study drug toxicity|0|||
94516935|NCT02750514|323690833|FG001|Track 4|Study drug toxicity|6|||
94516936|NCT02750514|323690834|FG002|Track 4|Study drug toxicity|0|||
94516937|NCT02750514|323690835|FG003|Track 4|Study drug toxicity|5|||
94516938|NCT02750514|323690836|FG004|Track 4|Study drug toxicity|0|||
94516939|NCT02750514|323690832|FG000|Track 4|Participant request to discontinue|0|||
94516940|NCT02750514|323690833|FG001|Track 4|Participant request to discontinue|1|||
94516941|NCT02750514|323690834|FG002|Track 4|Participant request to discontinue|0|||
94516942|NCT02750514|323690835|FG003|Track 4|Participant request to discontinue|1|||
94516943|NCT02750514|323690836|FG004|Track 4|Participant request to discontinue|0|||
94516944|NCT02750514|323690832|FG000|Track 4|Participant withdrew consent|0|||
94516945|NCT02750514|323690833|FG001|Track 4|Participant withdrew consent|1|||
94516946|NCT02750514|323690834|FG002|Track 4|Participant withdrew consent|0|||
94516947|NCT02750514|323690835|FG003|Track 4|Participant withdrew consent|0|||
94516948|NCT02750514|323690836|FG004|Track 4|Participant withdrew consent|0|||
94516949|NCT02750514|323690832|FG000|Track 4|Other reasons|0|||
94516950|NCT02750514|323690833|FG001|Track 4|Other reasons|5|||
94516951|NCT02750514|323690834|FG002|Track 4|Other reasons|0|||
94516952|NCT02750514|323690835|FG003|Track 4|Other reasons|3|||
94516953|NCT02750514|323690836|FG004|Track 4|Other reasons|0|||
94516954|NCT02750514|323690832|FG000|Track 4|Disease progression|0|||
94516955|NCT02750514|323690833|FG001|Track 4|Disease progression|33|||
94516956|NCT02750514|323690834|FG002|Track 4|Disease progression|0|||
94516957|NCT02750514|323690835|FG003|Track 4|Disease progression|32|||
94516958|NCT02750514|323690836|FG004|Track 4|Disease progression|0|||
94516959|NCT02750514|323690832|FG000|Track 4|Adverse event unrelated to study drug|0|||
94516960|NCT02750514|323690833|FG001|Track 4|Adverse event unrelated to study drug|5|||
94516961|NCT02750514|323690834|FG002|Track 4|Adverse event unrelated to study drug|0|||
94516962|NCT02750514|323690835|FG003|Track 4|Adverse event unrelated to study drug|0|||
94516963|NCT02750514|323690836|FG004|Track 4|Adverse event unrelated to study drug|0|||
94516964|NCT02750514|323690832|FG000|Track 4|Death|0|||
94516965|NCT02750514|323690833|FG001|Track 4|Death|0|||
94516966|NCT02750514|323690834|FG002|Track 4|Death|0|||
94516967|NCT02750514|323690835|FG003|Track 4|Death|1|||
94516968|NCT02750514|323690836|FG004|Track 4|Death|0|||
94516969|NCT02750514|323690832|FG000|Track 5|Disease progression|0|||
94516970|NCT02750514|323690833|FG001|Track 5|Disease progression|0|||
94516971|NCT02750514|323690834|FG002|Track 5|Disease progression|0|||
94516972|NCT02750514|323690835|FG003|Track 5|Disease progression|0|||
94516973|NCT02750514|323690836|FG004|Track 5|Disease progression|34|||
94516974|NCT02750514|323690832|FG000|Track 5|Adverse event unrelated to study drug|0|||
94516975|NCT02750514|323690833|FG001|Track 5|Adverse event unrelated to study drug|0|||
94516976|NCT02750514|323690834|FG002|Track 5|Adverse event unrelated to study drug|0|||
94516977|NCT02750514|323690835|FG003|Track 5|Adverse event unrelated to study drug|0|||
94516978|NCT02750514|323690836|FG004|Track 5|Adverse event unrelated to study drug|2|||
94516979|NCT02750514|323690832|FG000|Track 5|Study drug toxicity|0|||
94516980|NCT02750514|323690833|FG001|Track 5|Study drug toxicity|0|||
94516981|NCT02750514|323690834|FG002|Track 5|Study drug toxicity|0|||
94516982|NCT02750514|323690835|FG003|Track 5|Study drug toxicity|0|||
94516983|NCT02750514|323690836|FG004|Track 5|Study drug toxicity|2|||
94516984|NCT02750514|323690832|FG000|Track 5|Participant request to discontinue|0|||
94516985|NCT02750514|323690833|FG001|Track 5|Participant request to discontinue|0|||
94516986|NCT02750514|323690834|FG002|Track 5|Participant request to discontinue|0|||
94516987|NCT02750514|323690835|FG003|Track 5|Participant request to discontinue|0|||
94516988|NCT02750514|323690836|FG004|Track 5|Participant request to discontinue|3|||
94516989|NCT02750514|323690832|FG000|Track 5|Other reasons|0|||
94516990|NCT02750514|323690833|FG001|Track 5|Other reasons|0|||
94516991|NCT02750514|323690834|FG002|Track 5|Other reasons|0|||
94516992|NCT02750514|323690835|FG003|Track 5|Other reasons|0|||
94516993|NCT02750514|323690836|FG004|Track 5|Other reasons|2|||
94516994|NCT01823289|323690841|FG000|Overall Study|Lost to Follow-up|5|||
94516995|NCT01823289|323690841|FG000|Overall Study|Adverse Event|5|||
94516996|NCT01823289|323690841|FG000|Overall Study|Lack of Efficacy|1|||
94516997|NCT01823289|323690841|FG000|Overall Study|Physician Decision|9|||
94655647|NCT01632579|324196110|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
94655648|NCT01632579|324196111|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
94516998|NCT01823289|323690841|FG000|Overall Study|Administered contraindicated medicine|1|||
94516999|NCT01823289|323690841|FG000|Overall Study|Transaminase increased more than 3 times|1|||
94517000|NCT01823289|323690841|FG000|Overall Study|Drug affected efficacy and safety|1|||
94517001|NCT01823289|323690841|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
94517002|NCT00940602|323690844|FG000|Overall Study|Administrative problems|1|||
94517003|NCT00940602|323690845|FG001|Overall Study|Administrative problems|1|||
94517004|NCT00940602|323690844|FG000|Overall Study|Patient/guardian decision|13|||
94517005|NCT00940602|323690845|FG001|Overall Study|Patient/guardian decision|28|||
94517006|NCT00940602|323690844|FG000|Overall Study|Physician Decision|8|||
94517007|NCT00940602|323690845|FG001|Overall Study|Physician Decision|5|||
94517008|NCT00940602|323690844|FG000|Overall Study|Pregnancy|1|||
94517009|NCT00940602|323690845|FG001|Overall Study|Pregnancy|0|||
94517010|NCT00940602|323690844|FG000|Overall Study|Protocol Deviation (untreated)|1|||
94517011|NCT00940602|323690845|FG001|Overall Study|Protocol Deviation (untreated)|0|||
94517012|NCT00940602|323690844|FG000|Overall Study|Disease progression|8|||
94517013|NCT00940602|323690845|FG001|Overall Study|Disease progression|2|||
94517014|NCT00940602|323690844|FG000|Overall Study|Death|38|||
94517015|NCT00940602|323690845|FG001|Overall Study|Death|19|||
94517016|NCT00940602|323690844|FG000|Overall Study|Lost to Follow-up|3|||
94517017|NCT00940602|323690845|FG001|Overall Study|Lost to Follow-up|1|||
94517018|NCT00940602|323690844|FG000|Overall Study|Patient withdrew consent|26|||
94517019|NCT00940602|323690845|FG001|Overall Study|Patient withdrew consent|13|||
94517020|NCT00940602|323690844|FG000|Overall Study|Adverse Event|7|||
94517021|NCT00940602|323690845|FG001|Overall Study|Adverse Event|2|||
94517022|NCT00940602|323690844|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
94517023|NCT00940602|323690845|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
94517024|NCT00060944|323690846|FG000|Overall Study|Adverse Event|12|||
94517025|NCT00060944|323690847|FG001|Overall Study|Adverse Event|10|||
94517026|NCT00060944|323690846|FG000|Overall Study|Death|2|||
94517027|NCT00060944|323690847|FG001|Overall Study|Death|3|||
94517028|NCT00060944|323690846|FG000|Overall Study|Withdrawal by Subject|18|||
94517029|NCT00060944|323690847|FG001|Overall Study|Withdrawal by Subject|5|||
94517030|NCT00060944|323690846|FG000|Overall Study|Disease Progression|93|||
94517031|NCT00060944|323690847|FG001|Overall Study|Disease Progression|94|||
94517032|NCT00060944|323690846|FG000|Overall Study|Lost to Follow-up|1|||
94517033|NCT00060944|323690847|FG001|Overall Study|Lost to Follow-up|0|||
94517034|NCT00060944|323690846|FG000|Overall Study|Subject Ineligible To Continue|2|||
94517035|NCT00060944|323690847|FG001|Overall Study|Subject Ineligible To Continue|1|||
94517036|NCT00060944|323690846|FG000|Overall Study|Treatment Switch|0|||
94517037|NCT00060944|323690847|FG001|Overall Study|Treatment Switch|13|||
94517038|NCT00060944|323690846|FG000|Overall Study|Other|2|||
94517039|NCT00060944|323690847|FG001|Overall Study|Other|4|||
94517040|NCT00060944|323690846|FG000|Overall Study|randomized but not treated|6|||
94517041|NCT00060944|323690847|FG001|Overall Study|randomized but not treated|4|||
94517042|NCT01656161|323690848|FG000|Overall Study|Death|3|||
94517043|NCT01656161|323690848|FG000|Overall Study|Adverse Event|2|||
94517044|NCT01656161|323690848|FG000|Overall Study|Protocol Violation|1|||
94517045|NCT01656161|323690848|FG000|Overall Study|Withdrawal by Subject|1|||
94517046|NCT03289533|323690850|FG000|Overall Study|Death|12|||
94517047|NCT03289533|323690850|FG000|Overall Study|Terminated from study by sponsor|10|||
94517048|NCT00829244|323690851|FG000|Overall Study|Adverse Event|1|||
94517049|NCT00829244|323690852|FG001|Overall Study|Adverse Event|3|||
94517050|NCT00829244|323690851|FG000|Overall Study|Protocol Violation|1|||
94517051|NCT00829244|323690852|FG001|Overall Study|Protocol Violation|0|||
94517052|NCT00829244|323690851|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
94517053|NCT00829244|323690852|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
94517054|NCT00829244|323690851|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
94517055|NCT00829244|323690852|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
94517056|NCT00829244|323690851|FG000|Overall Study|No fertilization|2|||
94517057|NCT00829244|323690852|FG001|Overall Study|No fertilization|2|||
94517058|NCT00829244|323690851|FG000|Overall Study|All embryos discarded|0|||
94517059|NCT00829244|323690852|FG001|Overall Study|All embryos discarded|3|||
94517060|NCT00829244|323690851|FG000|Overall Study|No embryo cleavage|0|||
94517061|NCT00829244|323690852|FG001|Overall Study|No embryo cleavage|2|||
94517062|NCT03958331|323690857|FG000|Overall Study|Withdrawal by Subject|3|||
94517063|NCT03958331|323690858|FG001|Overall Study|Withdrawal by Subject|1|||
94517064|NCT03958331|323690859|FG002|Overall Study|Withdrawal by Subject|5|||
94517065|NCT03958331|323690857|FG000|Overall Study|Weaned from medicine|2|||
94517066|NCT03958331|323690858|FG001|Overall Study|Weaned from medicine|0|||
94517067|NCT03958331|323690859|FG002|Overall Study|Weaned from medicine|0|||
94517068|NCT03958331|323690857|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
94517069|NCT03958331|323690858|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
94517070|NCT03958331|323690859|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
94517071|NCT03342560|323690860|FG000|Overall Study|Lost to Follow-up|2|||
94517072|NCT03213509|323690861|FG000|Overall Study|Did not consent for verbal autopsy|4|||
94517073|NCT03213509|323690862|FG001|Overall Study|Did not consent for verbal autopsy|5|||
94517074|NCT02604511|323690863|FG000|Overall Study|Adverse Event|3|||
94517075|NCT02604511|323690863|FG000|Overall Study|Disease Progression|4|||
94517076|NCT02604511|323690863|FG000|Overall Study|Withdrawal by Subject|3|||
94517077|NCT02604511|323690863|FG000|Overall Study|Participant ineligible|1|||
94517078|NCT02604511|323690863|FG000|Overall Study|Intercurrent illness|1|||
94517079|NCT03069716|323690866|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
94517080|NCT03069716|323690867|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
94517081|NCT03069716|323690868|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
94517082|NCT03069716|323690866|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
94517083|NCT03069716|323690867|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
94517084|NCT03069716|323690868|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
94517085|NCT03069716|323690866|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
94517086|NCT03069716|323690867|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
94517087|NCT03069716|323690868|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
94517088|NCT03069716|323690866|FG000|Randomized Treatment|Withdrawal by Subject|0|||
94517089|NCT03069716|323690867|FG001|Randomized Treatment|Withdrawal by Subject|2|||
94517090|NCT03069716|323690868|FG002|Randomized Treatment|Withdrawal by Subject|0|||
94517091|NCT05076045|323690869|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
94517092|NCT05076045|323690870|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
94517093|NCT03391882|323690871|FG000|Study Overall|Adverse Event|3|||
94517094|NCT03391882|323690872|FG001|Study Overall|Adverse Event|6|||
94517095|NCT03391882|323690873|FG002|Study Overall|Adverse Event|1|||
94517096|NCT03391882|323690874|FG003|Study Overall|Adverse Event|1|||
94517097|NCT03391882|323690875|FG004|Study Overall|Adverse Event|3|||
94517098|NCT03391882|323690876|FG005|Study Overall|Adverse Event|1|||
94517099|NCT03391882|323690871|FG000|Study Overall|Lack of Efficacy|13|||
94517100|NCT03391882|323690872|FG001|Study Overall|Lack of Efficacy|9|||
94517101|NCT03391882|323690873|FG002|Study Overall|Lack of Efficacy|0|||
94517102|NCT03391882|323690874|FG003|Study Overall|Lack of Efficacy|0|||
94517103|NCT03391882|323690875|FG004|Study Overall|Lack of Efficacy|0|||
94517104|NCT03391882|323690876|FG005|Study Overall|Lack of Efficacy|0|||
94517105|NCT03391882|323690871|FG000|Study Overall|Withdrawal by Subject|3|||
94517106|NCT03391882|323690872|FG001|Study Overall|Withdrawal by Subject|3|||
94517107|NCT03391882|323690873|FG002|Study Overall|Withdrawal by Subject|2|||
94517108|NCT03391882|323690874|FG003|Study Overall|Withdrawal by Subject|2|||
94517109|NCT03391882|323690875|FG004|Study Overall|Withdrawal by Subject|1|||
94517110|NCT03391882|323690876|FG005|Study Overall|Withdrawal by Subject|3|||
94517111|NCT03391882|323690871|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
94517112|NCT03391882|323690872|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
94517113|NCT03391882|323690873|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
94517114|NCT03391882|323690874|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
94517115|NCT03391882|323690875|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
94517116|NCT03391882|323690876|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
94517117|NCT03391882|323690871|FG000|Study Overall|Protocol Violation|1|||
94517118|NCT03391882|323690872|FG001|Study Overall|Protocol Violation|0|||
94517119|NCT03391882|323690873|FG002|Study Overall|Protocol Violation|0|||
94517120|NCT03391882|323690874|FG003|Study Overall|Protocol Violation|0|||
94517121|NCT03391882|323690875|FG004|Study Overall|Protocol Violation|0|||
94517122|NCT03391882|323690876|FG005|Study Overall|Protocol Violation|0|||
94517123|NCT03391882|323690871|FG000|Part A - Titration Phase|Adverse Event|3|||
94517124|NCT03391882|323690872|FG001|Part A - Titration Phase|Adverse Event|6|||
94517125|NCT03391882|323690873|FG002|Part A - Titration Phase|Adverse Event|0|||
94517126|NCT03391882|323690874|FG003|Part A - Titration Phase|Adverse Event|0|||
94517127|NCT03391882|323690875|FG004|Part A - Titration Phase|Adverse Event|0|||
94517128|NCT03391882|323690876|FG005|Part A - Titration Phase|Adverse Event|0|||
94517129|NCT03391882|323690871|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
94517130|NCT03391882|323690872|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
94517131|NCT03391882|323690873|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
94517132|NCT03391882|323690874|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
94517133|NCT03391882|323690875|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
94517134|NCT03391882|323690876|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
94517135|NCT03391882|323690871|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
94517136|NCT03391882|323690872|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
94517137|NCT03391882|323690873|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
94517138|NCT03391882|323690874|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
94517139|NCT03391882|323690875|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
94517140|NCT03391882|323690876|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
94517141|NCT03391882|323690871|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
94517142|NCT03391882|323690872|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
94517143|NCT03391882|323690873|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
94517144|NCT03391882|323690874|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
94517145|NCT03391882|323690875|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
94517146|NCT03391882|323690876|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
94517147|NCT03391882|323690871|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
94517148|NCT03391882|323690872|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
94517149|NCT03391882|323690873|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
94517150|NCT03391882|323690874|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
94517151|NCT03391882|323690875|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
94517152|NCT03391882|323690876|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
94517153|NCT03391882|323690871|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
94517154|NCT03391882|323690872|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
94517155|NCT03391882|323690873|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
94517156|NCT03391882|323690874|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
94517157|NCT03391882|323690875|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
94517158|NCT03391882|323690876|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
94517159|NCT03391882|323690871|FG000|Part B - Treatment Phase|Adverse Event|0|||
94517160|NCT03391882|323690872|FG001|Part B - Treatment Phase|Adverse Event|0|||
94517161|NCT03391882|323690873|FG002|Part B - Treatment Phase|Adverse Event|1|||
94517162|NCT03391882|323690874|FG003|Part B - Treatment Phase|Adverse Event|1|||
94517163|NCT03391882|323690875|FG004|Part B - Treatment Phase|Adverse Event|3|||
94517164|NCT03391882|323690876|FG005|Part B - Treatment Phase|Adverse Event|1|||
94517165|NCT03391882|323690871|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
94517166|NCT03391882|323690872|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
94517167|NCT03391882|323690873|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
94517168|NCT03391882|323690874|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
94517169|NCT03391882|323690875|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
94517170|NCT03391882|323690876|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
94517171|NCT03402841|323690882|FG000|Overall Study|Withdrawal by Subject|3|||
94517172|NCT03402841|323690882|FG000|Overall Study|Lost to Follow-up|2|||
94517173|NCT03402841|323690882|FG000|Overall Study|Death|146|||
94517174|NCT02317627|323690885|FG000|Overall Study|Withdrawal by Subject|0|||
94517175|NCT02317627|323690886|FG001|Overall Study|Withdrawal by Subject|1|||
94517176|NCT02317627|323690887|FG002|Overall Study|Withdrawal by Subject|1|||
94517177|NCT02317627|323690885|FG000|Overall Study|Lost to Follow-up|2|||
94517178|NCT02317627|323690886|FG001|Overall Study|Lost to Follow-up|0|||
94517179|NCT02317627|323690887|FG002|Overall Study|Lost to Follow-up|0|||
94517180|NCT02317627|323690885|FG000|Overall Study|Stopped by Investigator|0|||
94517181|NCT02317627|323690886|FG001|Overall Study|Stopped by Investigator|1|||
94517182|NCT02317627|323690887|FG002|Overall Study|Stopped by Investigator|0|||
94517183|NCT02317627|323690885|FG000|Overall Study|Adverse Event|0|||
94517184|NCT02317627|323690886|FG001|Overall Study|Adverse Event|2|||
94517185|NCT02317627|323690887|FG002|Overall Study|Adverse Event|3|||
94517186|NCT02317627|323690885|FG000|Overall Study|Non-compliance with study drug|0|||
94517187|NCT02317627|323690886|FG001|Overall Study|Non-compliance with study drug|1|||
94517188|NCT02317627|323690887|FG002|Overall Study|Non-compliance with study drug|0|||
94517189|NCT03132467|323690888|FG000|Overall Study|Adverse Event|2|||
94517190|NCT03132467|323690888|FG000|Overall Study|Withdrawal by Subject|2|||
94517191|NCT02112656|323690889|FG000|Overall Study|Death|78|||
94517192|NCT02112656|323690890|FG001|Overall Study|Death|82|||
94517193|NCT02112656|323690889|FG000|Overall Study|Withdrawal by Subject|9|||
94517194|NCT02112656|323690890|FG001|Overall Study|Withdrawal by Subject|11|||
94517195|NCT02112656|323690889|FG000|Overall Study|Lost to Follow-up|2|||
94517196|NCT02112656|323690890|FG001|Overall Study|Lost to Follow-up|4|||
94517197|NCT02112656|323690889|FG000|Overall Study|Noncompliance|1|||
94517198|NCT02112656|323690890|FG001|Overall Study|Noncompliance|2|||
94517199|NCT00027560|323690891|FG000|Overall Study|Withdrawal by Subject|1|||
94517200|NCT00457626|323690892|FG000|Overall Study|Adverse Event|3|||
94517201|NCT00457626|323690892|FG000|Overall Study|Administrative Problems|2|||
94517202|NCT00457626|323690892|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
94517203|NCT01365455|323690893|FG000|Induction Period|Adverse Event|5|||
94517204|NCT01365455|323690894|FG001|Induction Period|Adverse Event|3|||
94517205|NCT01365455|323690895|FG002|Induction Period|Adverse Event|4|||
94517206|NCT01365455|323690896|FG003|Induction Period|Adverse Event|0|||
94517207|NCT01365455|323690897|FG004|Induction Period|Adverse Event|0|||
94517208|NCT01365455|323690893|FG000|Induction Period|Lack of Efficacy|1|||
94517209|NCT01365455|323690894|FG001|Induction Period|Lack of Efficacy|1|||
94517210|NCT01365455|323690895|FG002|Induction Period|Lack of Efficacy|0|||
94517211|NCT01365455|323690896|FG003|Induction Period|Lack of Efficacy|0|||
94517212|NCT01365455|323690897|FG004|Induction Period|Lack of Efficacy|0|||
94517213|NCT01365455|323690893|FG000|Induction Period|Pregnancy|0|||
94517214|NCT01365455|323690894|FG001|Induction Period|Pregnancy|1|||
94517215|NCT01365455|323690895|FG002|Induction Period|Pregnancy|0|||
94517216|NCT01365455|323690896|FG003|Induction Period|Pregnancy|0|||
94517217|NCT01365455|323690897|FG004|Induction Period|Pregnancy|0|||
94517218|NCT01365455|323690893|FG000|Induction Period|Protocol deviation|0|||
94517219|NCT01365455|323690894|FG001|Induction Period|Protocol deviation|1|||
94517220|NCT01365455|323690895|FG002|Induction Period|Protocol deviation|1|||
94517221|NCT01365455|323690896|FG003|Induction Period|Protocol deviation|0|||
94517222|NCT01365455|323690897|FG004|Induction Period|Protocol deviation|0|||
94517223|NCT01365455|323690893|FG000|Induction Period|Subject/guardian decision|9|||
94517224|NCT01365455|323690894|FG001|Induction Period|Subject/guardian decision|1|||
94517225|NCT01365455|323690895|FG002|Induction Period|Subject/guardian decision|8|||
94517226|NCT01365455|323690896|FG003|Induction Period|Subject/guardian decision|0|||
94517227|NCT01365455|323690897|FG004|Induction Period|Subject/guardian decision|0|||
94517228|NCT01365455|323690893|FG000|Induction Period|Lost to Follow-up|0|||
94517229|NCT01365455|323690894|FG001|Induction Period|Lost to Follow-up|0|||
94655649|NCT01632579|324196112|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
94517230|NCT01365455|323690895|FG002|Induction Period|Lost to Follow-up|3|||
94517231|NCT01365455|323690896|FG003|Induction Period|Lost to Follow-up|0|||
94517232|NCT01365455|323690897|FG004|Induction Period|Lost to Follow-up|0|||
94517233|NCT01365455|323690893|FG000|Maintenance Period|Adverse Event|12|||
94517234|NCT01365455|323690894|FG001|Maintenance Period|Adverse Event|5|||
94517235|NCT01365455|323690895|FG002|Maintenance Period|Adverse Event|1|||
94517236|NCT01365455|323690896|FG003|Maintenance Period|Adverse Event|2|||
94517237|NCT01365455|323690897|FG004|Maintenance Period|Adverse Event|4|||
94517238|NCT01365455|323690893|FG000|Maintenance Period|Lack of Efficacy|10|||
94517239|NCT01365455|323690894|FG001|Maintenance Period|Lack of Efficacy|2|||
94517240|NCT01365455|323690895|FG002|Maintenance Period|Lack of Efficacy|0|||
94517241|NCT01365455|323690896|FG003|Maintenance Period|Lack of Efficacy|2|||
94517242|NCT01365455|323690897|FG004|Maintenance Period|Lack of Efficacy|2|||
94517243|NCT01365455|323690893|FG000|Maintenance Period|Lost to Follow-up|2|||
94517244|NCT01365455|323690894|FG001|Maintenance Period|Lost to Follow-up|4|||
94517245|NCT01365455|323690895|FG002|Maintenance Period|Lost to Follow-up|0|||
94517246|NCT01365455|323690896|FG003|Maintenance Period|Lost to Follow-up|0|||
94517247|NCT01365455|323690897|FG004|Maintenance Period|Lost to Follow-up|3|||
94517248|NCT01365455|323690893|FG000|Maintenance Period|Non-compliance with study treatment|0|||
94517249|NCT01365455|323690894|FG001|Maintenance Period|Non-compliance with study treatment|0|||
94517250|NCT01365455|323690895|FG002|Maintenance Period|Non-compliance with study treatment|0|||
94517251|NCT01365455|323690896|FG003|Maintenance Period|Non-compliance with study treatment|1|||
94517252|NCT01365455|323690897|FG004|Maintenance Period|Non-compliance with study treatment|0|||
94517253|NCT01365455|323690893|FG000|Maintenance Period|Physician Decision|0|||
94517254|NCT01365455|323690894|FG001|Maintenance Period|Physician Decision|1|||
94517255|NCT01365455|323690895|FG002|Maintenance Period|Physician Decision|0|||
94517256|NCT01365455|323690896|FG003|Maintenance Period|Physician Decision|0|||
94517257|NCT01365455|323690897|FG004|Maintenance Period|Physician Decision|1|||
94517258|NCT01365455|323690893|FG000|Maintenance Period|Pregnancy|0|||
94517259|NCT01365455|323690894|FG001|Maintenance Period|Pregnancy|4|||
94517260|NCT01365455|323690895|FG002|Maintenance Period|Pregnancy|0|||
94517261|NCT01365455|323690896|FG003|Maintenance Period|Pregnancy|0|||
94517262|NCT01365455|323690897|FG004|Maintenance Period|Pregnancy|2|||
94517263|NCT01365455|323690893|FG000|Maintenance Period|Protocol deviation|1|||
94517264|NCT01365455|323690894|FG001|Maintenance Period|Protocol deviation|1|||
94517265|NCT01365455|323690895|FG002|Maintenance Period|Protocol deviation|0|||
94517266|NCT01365455|323690896|FG003|Maintenance Period|Protocol deviation|0|||
94517267|NCT01365455|323690897|FG004|Maintenance Period|Protocol deviation|0|||
94517268|NCT01365455|323690893|FG000|Maintenance Period|Subject/guardian decision|4|||
94517269|NCT01365455|323690894|FG001|Maintenance Period|Subject/guardian decision|6|||
94517270|NCT01365455|323690895|FG002|Maintenance Period|Subject/guardian decision|2|||
94517271|NCT01365455|323690896|FG003|Maintenance Period|Subject/guardian decision|4|||
94517272|NCT01365455|323690897|FG004|Maintenance Period|Subject/guardian decision|1|||
94517273|NCT04696146|323693004|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
94517274|NCT04696146|323693005|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
94517275|NCT04696146|323693004|FG000|Overall Study|Off hours issue with product|1|||
94517276|NCT04696146|323693005|FG001|Overall Study|Off hours issue with product|0|||
94517277|NCT01173679|323693006|FG000|Overall Study|Death|1|||
94517278|NCT00328172|323693010|FG000|Overall Study|Adverse Event|3|||
94517279|NCT00328172|323693011|FG001|Overall Study|Adverse Event|2|||
94517280|NCT00328172|323693012|FG002|Overall Study|Adverse Event|1|||
94517281|NCT00328172|323693013|FG003|Overall Study|Adverse Event|2|||
94517282|NCT00328172|323693014|FG004|Overall Study|Adverse Event|1|||
94517283|NCT00328172|323693010|FG000|Overall Study|Protocol Violation|0|||
94517284|NCT00328172|323693011|FG001|Overall Study|Protocol Violation|1|||
94517285|NCT00328172|323693012|FG002|Overall Study|Protocol Violation|1|||
94517286|NCT00328172|323693013|FG003|Overall Study|Protocol Violation|0|||
94517287|NCT00328172|323693014|FG004|Overall Study|Protocol Violation|0|||
94517288|NCT00328172|323693010|FG000|Overall Study|Lost to Follow-up|1|||
94517289|NCT00328172|323693011|FG001|Overall Study|Lost to Follow-up|1|||
94517290|NCT00328172|323693012|FG002|Overall Study|Lost to Follow-up|2|||
94517291|NCT00328172|323693013|FG003|Overall Study|Lost to Follow-up|1|||
94517292|NCT00328172|323693014|FG004|Overall Study|Lost to Follow-up|1|||
94517293|NCT00328172|323693010|FG000|Overall Study|Withdrawal by Subject|1|||
94517294|NCT00328172|323693011|FG001|Overall Study|Withdrawal by Subject|1|||
94517295|NCT00328172|323693012|FG002|Overall Study|Withdrawal by Subject|1|||
94517296|NCT00328172|323693013|FG003|Overall Study|Withdrawal by Subject|6|||
94517297|NCT00328172|323693014|FG004|Overall Study|Withdrawal by Subject|0|||
94517298|NCT00328172|323693010|FG000|Overall Study|Lack of Efficacy|14|||
94517299|NCT00328172|323693011|FG001|Overall Study|Lack of Efficacy|9|||
94517300|NCT00328172|323693012|FG002|Overall Study|Lack of Efficacy|4|||
94517301|NCT00328172|323693013|FG003|Overall Study|Lack of Efficacy|4|||
94517302|NCT00328172|323693014|FG004|Overall Study|Lack of Efficacy|3|||
94517303|NCT00328172|323693010|FG000|Overall Study|Other reason (not specified)|3|||
94517304|NCT00328172|323693011|FG001|Overall Study|Other reason (not specified)|0|||
94517305|NCT00328172|323693012|FG002|Overall Study|Other reason (not specified)|1|||
94517306|NCT00328172|323693013|FG003|Overall Study|Other reason (not specified)|0|||
94517307|NCT00328172|323693014|FG004|Overall Study|Other reason (not specified)|0|||
94517308|NCT00399035|323693015|FG000|Overall Study|Death|289|||
94517309|NCT00399035|323693016|FG001|Overall Study|Death|141|||
94517310|NCT00399035|323693017|FG002|Overall Study|Death|234|||
94517311|NCT00399035|323693015|FG000|Overall Study|Lost to Follow-up|2|||
94517312|NCT00399035|323693016|FG001|Overall Study|Lost to Follow-up|1|||
94517313|NCT00399035|323693017|FG002|Overall Study|Lost to Follow-up|5|||
94517314|NCT00399035|323693015|FG000|Overall Study|Withdrawal by Subject|19|||
94517315|NCT00399035|323693016|FG001|Overall Study|Withdrawal by Subject|15|||
94517316|NCT00399035|323693017|FG002|Overall Study|Withdrawal by Subject|12|||
94517317|NCT00399035|323693015|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
94517318|NCT00399035|323693016|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
94517319|NCT00399035|323693017|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
94517320|NCT00399035|323693015|FG000|Overall Study|Severe non-compliance with protocol|2|||
94517321|NCT00399035|323693016|FG001|Overall Study|Severe non-compliance with protocol|1|||
94517322|NCT00399035|323693017|FG002|Overall Study|Severe non-compliance with protocol|0|||
94517323|NCT00487981|323693020|FG000|Overall Study|Hypothyroidism diagnosis|1|||
94517324|NCT02115321|323693021|FG000|Overall Study|Death|1|||
94517325|NCT02115321|323693022|FG001|Overall Study|Death|0|||
94517326|NCT00698828|323693025|FG000|Overall Study|Adverse Event|3|||
94517327|NCT00698828|323693026|FG001|Overall Study|Adverse Event|4|||
94517328|NCT00698828|323693027|FG002|Overall Study|Adverse Event|4|||
94517329|NCT00698828|323693025|FG000|Overall Study|Death|0|||
94517330|NCT00698828|323693026|FG001|Overall Study|Death|0|||
94517331|NCT00698828|323693027|FG002|Overall Study|Death|1|||
94517332|NCT00698828|323693025|FG000|Overall Study|Exacerbation of COPD|1|||
94517333|NCT00698828|323693026|FG001|Overall Study|Exacerbation of COPD|3|||
94517334|NCT00698828|323693027|FG002|Overall Study|Exacerbation of COPD|0|||
94517335|NCT00698828|323693025|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
94517336|NCT00698828|323693026|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
94517337|NCT00698828|323693027|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
94517338|NCT00698828|323693025|FG000|Overall Study|Investigator/Sponsor decision|1|||
94517339|NCT00698828|323693026|FG001|Overall Study|Investigator/Sponsor decision|0|||
94517340|NCT00698828|323693027|FG002|Overall Study|Investigator/Sponsor decision|2|||
94517341|NCT00698828|323693025|FG000|Overall Study|Lost to Follow-up|1|||
94517342|NCT00698828|323693026|FG001|Overall Study|Lost to Follow-up|1|||
94517343|NCT00698828|323693027|FG002|Overall Study|Lost to Follow-up|0|||
94517344|NCT00698828|323693025|FG000|Overall Study|Withdrew consent|0|||
94517345|NCT00698828|323693026|FG001|Overall Study|Withdrew consent|7|||
94517346|NCT00698828|323693027|FG002|Overall Study|Withdrew consent|4|||
94517347|NCT00698828|323693025|FG000|Overall Study|Withdrew consent (not treated)|2|||
94517348|NCT00698828|323693026|FG001|Overall Study|Withdrew consent (not treated)|0|||
94517349|NCT00698828|323693027|FG002|Overall Study|Withdrew consent (not treated)|0|||
94517350|NCT03273907|323693030|FG000|Overall Study|Death|1|||
94517351|NCT03273907|323693030|FG000|Overall Study|Lost to Follow-up|4|||
94517352|NCT03273907|323693030|FG000|Overall Study|Withdrawal by Subject|2|||
94517353|NCT03273907|323693030|FG000|Overall Study|COVID 19|2|||
94517354|NCT01130337|323693036|FG000|Overall Study|Withdrawal by Subject|3|||
94517355|NCT01130337|323693036|FG000|Overall Study|Principal investigator decision|1|||
94517356|NCT01130337|323693036|FG000|Overall Study|Death|1|||
94517357|NCT01130337|323693036|FG000|Overall Study|Disease progression|1|||
94517358|NCT01130337|323693036|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
94517359|NCT01130337|323693036|FG000|Overall Study|Surgical resection (R2)|1|||
94517360|NCT00181844|323693037|FG000|Signed Consent|Withdrawal by Subject|5|||
94517361|NCT00181844|323693037|FG000|Signed Consent|Did not meet entrance criteria|7|||
94517362|NCT00181844|323693037|FG000|Exposed to Study Medication|Adverse Event|10|||
94517363|NCT00181844|323693037|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
94517364|NCT00181844|323693037|FG000|Exposed to Study Medication|Non-compliance|2|||
94517365|NCT00181844|323693037|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
94517366|NCT00181844|323693037|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
94517367|NCT03179761|323693038|FG000|Overall Study|Death|2|||
94517368|NCT03179761|323693039|FG001|Overall Study|Death|5|||
94517369|NCT03179761|323693038|FG000|Overall Study|Lost to Follow-up|2|||
94517370|NCT03179761|323693039|FG001|Overall Study|Lost to Follow-up|2|||
94517371|NCT03179761|323693038|FG000|Overall Study|Protocol Violation|1|||
94517372|NCT03179761|323693039|FG001|Overall Study|Protocol Violation|0|||
94517373|NCT03179761|323693038|FG000|Overall Study|Withdrawal by Subject|1|||
94517374|NCT03179761|323693039|FG001|Overall Study|Withdrawal by Subject|4|||
94517375|NCT03179761|323693038|FG000|Overall Study|Investigator Request|0|||
94517376|NCT03179761|323693039|FG001|Overall Study|Investigator Request|2|||
94517377|NCT04661033|323693040|FG000|Overall Study|Adverse Event|0|||
94517378|NCT04661033|323693041|FG001|Overall Study|Adverse Event|0|||
94517379|NCT04661033|323693042|FG002|Overall Study|Adverse Event|1|||
94517380|NCT04661033|323693043|FG003|Overall Study|Adverse Event|0|||
94517381|NCT04661033|323693040|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
94517382|NCT04661033|323693041|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
94517383|NCT04661033|323693042|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
94517384|NCT04661033|323693043|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
94517385|NCT04661033|323693040|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
94517386|NCT04661033|323693041|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
94517387|NCT04661033|323693042|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
94517388|NCT04661033|323693043|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
94517389|NCT04661033|323693040|FG000|Overall Study|Early discontinuation as per PI|1|||
94517390|NCT04661033|323693041|FG001|Overall Study|Early discontinuation as per PI|0|||
94517391|NCT04661033|323693042|FG002|Overall Study|Early discontinuation as per PI|0|||
94517392|NCT04661033|323693043|FG003|Overall Study|Early discontinuation as per PI|0|||
94517393|NCT04562116|323693044|FG000|Overall Study|Lost to Follow-up|1|||
94517394|NCT04562116|323693044|FG000|Overall Study|Withdrawal by Subject|3|||
94517395|NCT00565409|323693045|FG000|Period 1 Open Label|Adverse Event|17|||
94517396|NCT00565409|323693046|FG001|Period 1 Open Label|Adverse Event|0|||
94517397|NCT00565409|323693047|FG002|Period 1 Open Label|Adverse Event|0|||
94517398|NCT00565409|323693048|FG003|Period 1 Open Label|Adverse Event|0|||
94517399|NCT00565409|323693045|FG000|Period 1 Open Label|Death|2|||
94517400|NCT00565409|323693046|FG001|Period 1 Open Label|Death|0|||
94517401|NCT00565409|323693047|FG002|Period 1 Open Label|Death|0|||
94517402|NCT00565409|323693048|FG003|Period 1 Open Label|Death|0|||
94517403|NCT00565409|323693045|FG000|Period 1 Open Label|Lost to Follow-up|1|||
94517404|NCT00565409|323693046|FG001|Period 1 Open Label|Lost to Follow-up|0|||
94517405|NCT00565409|323693047|FG002|Period 1 Open Label|Lost to Follow-up|0|||
94517406|NCT00565409|323693048|FG003|Period 1 Open Label|Lost to Follow-up|0|||
94517407|NCT00565409|323693045|FG000|Period 1 Open Label|Other|21|||
94517408|NCT00565409|323693046|FG001|Period 1 Open Label|Other|0|||
94517409|NCT00565409|323693047|FG002|Period 1 Open Label|Other|0|||
94517410|NCT00565409|323693048|FG003|Period 1 Open Label|Other|0|||
94517411|NCT00565409|323693045|FG000|Period 1 Open Label|Protocol Violation|14|||
94517412|NCT00565409|323693046|FG001|Period 1 Open Label|Protocol Violation|0|||
94517413|NCT00565409|323693047|FG002|Period 1 Open Label|Protocol Violation|0|||
94517414|NCT00565409|323693048|FG003|Period 1 Open Label|Protocol Violation|0|||
94517415|NCT00565409|323693045|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
94517416|NCT00565409|323693046|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
94517417|NCT00565409|323693047|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
94517418|NCT00565409|323693048|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
94517419|NCT00565409|323693045|FG000|Period 1 Open Label|no conclusion of participation record|1|||
94517420|NCT00565409|323693046|FG001|Period 1 Open Label|no conclusion of participation record|0|||
94517421|NCT00565409|323693047|FG002|Period 1 Open Label|no conclusion of participation record|0|||
94517422|NCT00565409|323693048|FG003|Period 1 Open Label|no conclusion of participation record|0|||
94517423|NCT00565409|323693045|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
94517424|NCT00565409|323693046|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
94517425|NCT00565409|323693047|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
94517426|NCT00565409|323693048|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
94517427|NCT00565409|323693045|FG000|Period 2 Double-Blind|Adverse Event|0|||
94517428|NCT00565409|323693046|FG001|Period 2 Double-Blind|Adverse Event|7|||
94517429|NCT00565409|323693047|FG002|Period 2 Double-Blind|Adverse Event|4|||
94517430|NCT00565409|323693048|FG003|Period 2 Double-Blind|Adverse Event|5|||
94517431|NCT00565409|323693045|FG000|Period 2 Double-Blind|Death|0|||
94517432|NCT00565409|323693046|FG001|Period 2 Double-Blind|Death|2|||
94517433|NCT00565409|323693047|FG002|Period 2 Double-Blind|Death|0|||
94517434|NCT00565409|323693048|FG003|Period 2 Double-Blind|Death|0|||
94517435|NCT00565409|323693045|FG000|Period 2 Double-Blind|Protocol Violation|0|||
94517436|NCT00565409|323693046|FG001|Period 2 Double-Blind|Protocol Violation|4|||
94517437|NCT00565409|323693047|FG002|Period 2 Double-Blind|Protocol Violation|6|||
94517438|NCT00565409|323693048|FG003|Period 2 Double-Blind|Protocol Violation|2|||
94517439|NCT00565409|323693045|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
94517440|NCT00565409|323693046|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
94517441|NCT00565409|323693047|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
94517442|NCT00565409|323693048|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
94517443|NCT00565409|323693045|FG000|Period 2 Double-Blind|Other|0|||
94517444|NCT00565409|323693046|FG001|Period 2 Double-Blind|Other|4|||
94517445|NCT00565409|323693047|FG002|Period 2 Double-Blind|Other|5|||
94517446|NCT00565409|323693048|FG003|Period 2 Double-Blind|Other|9|||
94517447|NCT00565409|323693045|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
94655650|NCT01632579|324196113|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
94517448|NCT00565409|323693046|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
94517449|NCT00565409|323693047|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
94517450|NCT00565409|323693048|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
94517451|NCT03440008|323693049|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
94517452|NCT03440008|323693050|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
94517453|NCT03440008|323693049|FG000|Overall Study|Withdrawal by Subject|1|||
94517454|NCT03440008|323693050|FG001|Overall Study|Withdrawal by Subject|0|||
94517455|NCT02284191|323693056|FG000|Overall Study|Withdrawal by Subject|1|||
94517456|NCT02284191|323693057|FG001|Overall Study|Withdrawal by Subject|3|||
94517457|NCT02284191|323693056|FG000|Overall Study|Lost to Follow-up|1|||
94517458|NCT02284191|323693057|FG001|Overall Study|Lost to Follow-up|0|||
94517459|NCT01188967|323693058|FG000|Overall Study|Withdrawal by Subject|1|||
94517460|NCT01188967|323693059|FG001|Overall Study|Withdrawal by Subject|1|||
94517461|NCT01188967|323693058|FG000|Overall Study|Physician Decision|1|||
94517462|NCT01188967|323693059|FG001|Overall Study|Physician Decision|1|||
94517463|NCT01188967|323693058|FG000|Overall Study|Lost to Follow-up|3|||
94517464|NCT01188967|323693059|FG001|Overall Study|Lost to Follow-up|2|||
94517465|NCT00332696|323693060|FG000|Overall Study|Death|24|||
94517466|NCT00332696|323693061|FG001|Overall Study|Death|14|||
94517467|NCT00332696|323693060|FG000|Overall Study|Insufficient therapeutic effect|4|||
94517468|NCT00332696|323693061|FG001|Overall Study|Insufficient therapeutic effect|11|||
94517469|NCT00332696|323693060|FG000|Overall Study|Adverse Event|1|||
94517470|NCT00332696|323693061|FG001|Overall Study|Adverse Event|2|||
94517471|NCT00332696|323693060|FG000|Overall Study|Condition does not justify treatment|0|||
94517472|NCT00332696|323693061|FG001|Overall Study|Condition does not justify treatment|2|||
94517473|NCT00332696|323693060|FG000|Overall Study|Lost to Follow-up|0|||
94517474|NCT00332696|323693061|FG001|Overall Study|Lost to Follow-up|1|||
94517475|NCT00332696|323693060|FG000|Overall Study|Withdrawal by Subject|1|||
94517476|NCT00332696|323693061|FG001|Overall Study|Withdrawal by Subject|0|||
94517477|NCT02170064|323693062|FG000|Overall Study|Withdrawal by Subject|5|||
94517478|NCT02170064|323693063|FG001|Overall Study|Withdrawal by Subject|1|||
94517479|NCT02170064|323693064|FG002|Overall Study|Withdrawal by Subject|1|||
94517480|NCT02170064|323693062|FG000|Overall Study|Physician Decision|1|||
94517481|NCT02170064|323693063|FG001|Overall Study|Physician Decision|1|||
94517482|NCT02170064|323693064|FG002|Overall Study|Physician Decision|0|||
94517483|NCT00461708|323693065|FG000|Overall Study|Adverse Event|17|||
94517484|NCT00461708|323693066|FG001|Overall Study|Adverse Event|7|||
94517485|NCT00461708|323693065|FG000|Overall Study|Lack of Efficacy|68|||
94517486|NCT00461708|323693066|FG001|Overall Study|Lack of Efficacy|20|||
94517487|NCT00461708|323693065|FG000|Overall Study|Physician Decision|10|||
94517488|NCT00461708|323693066|FG001|Overall Study|Physician Decision|4|||
94517489|NCT00461708|323693065|FG000|Overall Study|Withdrawal by Subject|8|||
94517490|NCT00461708|323693066|FG001|Overall Study|Withdrawal by Subject|2|||
94517491|NCT00461708|323693065|FG000|Overall Study|Other|4|||
94517492|NCT00461708|323693066|FG001|Overall Study|Other|4|||
94517493|NCT00461708|323693065|FG000|Overall Study|Death|8|||
94517494|NCT00461708|323693066|FG001|Overall Study|Death|1|||
94517495|NCT01464879|323693067|FG000|Overall Study|Physician Decision|1|||
94517496|NCT01464879|323693067|FG000|Overall Study|Non-compliance|1|||
94517497|NCT02259114|323693070|FG000|Overall Study|Progressive Disease|14|||
94517498|NCT02259114|323693071|FG001|Overall Study|Progressive Disease|2|||
94517499|NCT02259114|323693072|FG002|Overall Study|Progressive Disease|10|||
94517500|NCT02259114|323693073|FG003|Overall Study|Progressive Disease|2|||
94517501|NCT02259114|323693074|FG004|Overall Study|Progressive Disease|5|||
94517502|NCT02259114|323693070|FG000|Overall Study|Adverse Event|2|||
94517503|NCT02259114|323693071|FG001|Overall Study|Adverse Event|1|||
94517504|NCT02259114|323693072|FG002|Overall Study|Adverse Event|0|||
94517505|NCT02259114|323693073|FG003|Overall Study|Adverse Event|0|||
94517506|NCT02259114|323693074|FG004|Overall Study|Adverse Event|1|||
94517507|NCT02259114|323693070|FG000|Overall Study|Death|3|||
94517508|NCT02259114|323693071|FG001|Overall Study|Death|0|||
94517509|NCT02259114|323693072|FG002|Overall Study|Death|1|||
94517510|NCT02259114|323693073|FG003|Overall Study|Death|0|||
94517511|NCT02259114|323693074|FG004|Overall Study|Death|0|||
94517512|NCT02259114|323693070|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
94517513|NCT02259114|323693071|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
94517514|NCT02259114|323693072|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
94517515|NCT02259114|323693073|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
94517516|NCT02259114|323693074|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
94517517|NCT02259114|323693070|FG000|Overall Study|Withdrawal by Subject|0|||
94517518|NCT02259114|323693071|FG001|Overall Study|Withdrawal by Subject|0|||
94517519|NCT02259114|323693072|FG002|Overall Study|Withdrawal by Subject|1|||
94517520|NCT02259114|323693073|FG003|Overall Study|Withdrawal by Subject|1|||
94517521|NCT02259114|323693074|FG004|Overall Study|Withdrawal by Subject|0|||
94517522|NCT02259114|323693070|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
94517523|NCT02259114|323693071|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
94517524|NCT02259114|323693072|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
94517525|NCT02259114|323693073|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
94517526|NCT02259114|323693074|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
94517527|NCT02259114|323693070|FG000|Overall Study|Not Treated|1|||
94517528|NCT02259114|323693071|FG001|Overall Study|Not Treated|0|||
94517529|NCT02259114|323693072|FG002|Overall Study|Not Treated|0|||
94517530|NCT02259114|323693073|FG003|Overall Study|Not Treated|0|||
94517531|NCT02259114|323693074|FG004|Overall Study|Not Treated|0|||
94517532|NCT03937479|323693075|FG000|Overall Study|Adverse Event|2|||
94517533|NCT03937479|323693076|FG001|Overall Study|Adverse Event|3|||
94517534|NCT03937479|323693077|FG002|Overall Study|Adverse Event|0|||
94517535|NCT03937479|323693078|FG003|Overall Study|Adverse Event|0|||
94517536|NCT03937479|323693079|FG004|Overall Study|Adverse Event|1|||
94517537|NCT03937479|323693075|FG000|Overall Study|Withdrawal by Subject|3|||
94517538|NCT03937479|323693076|FG001|Overall Study|Withdrawal by Subject|5|||
94517539|NCT03937479|323693077|FG002|Overall Study|Withdrawal by Subject|2|||
94517540|NCT03937479|323693078|FG003|Overall Study|Withdrawal by Subject|2|||
94517541|NCT03937479|323693079|FG004|Overall Study|Withdrawal by Subject|1|||
94517542|NCT03937479|323693075|FG000|Overall Study|Protocol Violation|5|||
94517543|NCT03937479|323693076|FG001|Overall Study|Protocol Violation|6|||
94517544|NCT03937479|323693077|FG002|Overall Study|Protocol Violation|4|||
94517545|NCT03937479|323693078|FG003|Overall Study|Protocol Violation|3|||
94517546|NCT03937479|323693079|FG004|Overall Study|Protocol Violation|2|||
94517547|NCT03937479|323693075|FG000|Overall Study|Lost to Follow-up|0|||
94517548|NCT03937479|323693076|FG001|Overall Study|Lost to Follow-up|1|||
94517549|NCT03937479|323693077|FG002|Overall Study|Lost to Follow-up|0|||
94517550|NCT03937479|323693078|FG003|Overall Study|Lost to Follow-up|1|||
94517551|NCT03937479|323693079|FG004|Overall Study|Lost to Follow-up|0|||
94517552|NCT03937479|323693075|FG000|Overall Study|Physician Decision|0|||
94517553|NCT03937479|323693076|FG001|Overall Study|Physician Decision|0|||
94517554|NCT03937479|323693077|FG002|Overall Study|Physician Decision|1|||
94517555|NCT03937479|323693078|FG003|Overall Study|Physician Decision|0|||
94517556|NCT03937479|323693079|FG004|Overall Study|Physician Decision|1|||
94517557|NCT01854528|323693089|FG000|Overall Study|Adverse Event|0|||
94517558|NCT01854528|323693090|FG001|Overall Study|Adverse Event|4|||
94517559|NCT01854528|323693089|FG000|Overall Study|Withdrawal by Subject|0|||
94517560|NCT01854528|323693090|FG001|Overall Study|Withdrawal by Subject|2|||
94517561|NCT01854528|323693089|FG000|Overall Study|Virologic Failure|0|||
94517562|NCT01854528|323693090|FG001|Overall Study|Virologic Failure|9|||
94517563|NCT02230189|323693092|FG000|Overall Study|Withdrawal by Subject|3|||
94517564|NCT02230189|323693093|FG001|Overall Study|Withdrawal by Subject|0|||
94517565|NCT02230189|323693094|FG002|Overall Study|Withdrawal by Subject|1|||
94517566|NCT02230189|323693092|FG000|Overall Study|Lost to Follow-up|1|||
94517567|NCT02230189|323693093|FG001|Overall Study|Lost to Follow-up|0|||
94517568|NCT02230189|323693094|FG002|Overall Study|Lost to Follow-up|0|||
94517569|NCT02230189|323693092|FG000|Overall Study|Physician Decision|1|||
94517570|NCT02230189|323693093|FG001|Overall Study|Physician Decision|0|||
94517571|NCT02230189|323693094|FG002|Overall Study|Physician Decision|0|||
94517572|NCT01368614|323693095|FG000|Screening Period|Screen Failure|58|||
94517573|NCT01368614|323693096|FG001|Screening Period|Screen Failure|0|||
94517574|NCT01368614|323693097|FG002|Screening Period|Screen Failure|0|||
94517575|NCT01368614|323693098|FG003|Screening Period|Screen Failure|0|||
94517576|NCT01368614|323693095|FG000|Study Period|Withdrawal by Subject|0|||
94517577|NCT01368614|323693096|FG001|Study Period|Withdrawal by Subject|1|||
94517578|NCT01368614|323693097|FG002|Study Period|Withdrawal by Subject|1|||
94517579|NCT01368614|323693098|FG003|Study Period|Withdrawal by Subject|3|||
94517580|NCT01368614|323693095|FG000|Study Period|Lost to Follow-up|0|||
94517581|NCT01368614|323693096|FG001|Study Period|Lost to Follow-up|0|||
94517582|NCT01368614|323693097|FG002|Study Period|Lost to Follow-up|1|||
94517583|NCT01368614|323693098|FG003|Study Period|Lost to Follow-up|0|||
94517584|NCT02951780|323693099|FG000|Period 1|Adverse Event|0|||
94517585|NCT02951780|323693100|FG001|Period 1|Adverse Event|0|||
94517586|NCT02951780|323693101|FG002|Period 1|Adverse Event|0|||
94517587|NCT02951780|323693102|FG003|Period 1|Adverse Event|1|||
94517588|NCT02951780|323693103|FG004|Period 1|Adverse Event|0|||
94517589|NCT02951780|323693104|FG005|Period 1|Adverse Event|0|||
94517590|NCT02951780|323693105|FG006|Period 1|Adverse Event|0|||
94517591|NCT02951780|323693106|FG007|Period 1|Adverse Event|0|||
94517592|NCT02951780|323693107|FG008|Period 1|Adverse Event|0|||
94517593|NCT02951780|323693099|FG000|Period 1|Scheduling Conflicts|0|||
94517594|NCT02951780|323693100|FG001|Period 1|Scheduling Conflicts|0|||
94517595|NCT02951780|323693101|FG002|Period 1|Scheduling Conflicts|0|||
94517596|NCT02951780|323693102|FG003|Period 1|Scheduling Conflicts|0|||
94517597|NCT02951780|323693103|FG004|Period 1|Scheduling Conflicts|0|||
94517598|NCT02951780|323693104|FG005|Period 1|Scheduling Conflicts|0|||
94517599|NCT02951780|323693105|FG006|Period 1|Scheduling Conflicts|0|||
94517600|NCT02951780|323693106|FG007|Period 1|Scheduling Conflicts|1|||
94517601|NCT02951780|323693107|FG008|Period 1|Scheduling Conflicts|0|||
94517602|NCT02951780|323693099|FG000|Period 2|Scheduling Conflicts|0|||
94517603|NCT02951780|323693100|FG001|Period 2|Scheduling Conflicts|0|||
94517604|NCT02951780|323693101|FG002|Period 2|Scheduling Conflicts|0|||
94517605|NCT02951780|323693102|FG003|Period 2|Scheduling Conflicts|0|||
94517606|NCT02951780|323693103|FG004|Period 2|Scheduling Conflicts|0|||
94517607|NCT02951780|323693104|FG005|Period 2|Scheduling Conflicts|0|||
94517608|NCT02951780|323693105|FG006|Period 2|Scheduling Conflicts|0|||
94517609|NCT02951780|323693106|FG007|Period 2|Scheduling Conflicts|1|||
94517610|NCT02951780|323693107|FG008|Period 2|Scheduling Conflicts|0|||
94517611|NCT03510273|323693113|FG000|Overall Study|Withdrawal by Subject|2|||
94517612|NCT03510273|323693113|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
94517613|NCT03510273|323693113|FG000|Overall Study|Moved away from study area|4|||
94517614|NCT00956293|323693114|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
94517615|NCT00956293|323693115|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
94517616|NCT00956293|323693116|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
94517617|NCT00956293|323693114|FG000|Main Period (Pre-randomization)|Death|0|||
94517618|NCT00956293|323693115|FG001|Main Period (Pre-randomization)|Death|0|||
94517619|NCT00956293|323693116|FG002|Main Period (Pre-randomization)|Death|1|||
94517620|NCT00956293|323693114|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
94517621|NCT00956293|323693115|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
94517622|NCT00956293|323693116|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
94517623|NCT00956293|323693114|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
94517624|NCT00956293|323693115|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
94517625|NCT00956293|323693116|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
94517626|NCT00956293|323693114|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
94517627|NCT00956293|323693115|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
94517628|NCT00956293|323693116|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
94517629|NCT00956293|323693114|FG000|Main Period (Pre-randomization)|Graft loss|0|||
94517630|NCT00956293|323693115|FG001|Main Period (Pre-randomization)|Graft loss|0|||
94517631|NCT00956293|323693116|FG002|Main Period (Pre-randomization)|Graft loss|7|||
94517632|NCT00956293|323693114|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
94517633|NCT00956293|323693115|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
94517634|NCT00956293|323693116|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
94517635|NCT00956293|323693114|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
94517636|NCT00956293|323693115|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
94517637|NCT00956293|323693116|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
94517638|NCT00956293|323693114|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
94517639|NCT00956293|323693115|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
94517640|NCT00956293|323693116|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
94517641|NCT00956293|323693114|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
94517642|NCT00956293|323693115|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
94517643|NCT00956293|323693116|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
94517644|NCT00956293|323693114|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
94517645|NCT00956293|323693115|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
94517646|NCT00956293|323693116|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
94517647|NCT00956293|323693114|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
94517648|NCT00956293|323693115|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
94517649|NCT00956293|323693116|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
94517650|NCT00956293|323693114|FG000|Main Period (Randomization)|Adverse Event|0|||
94517651|NCT00956293|323693115|FG001|Main Period (Randomization)|Adverse Event|15|||
94517652|NCT00956293|323693116|FG002|Main Period (Randomization)|Adverse Event|0|||
94517653|NCT00956293|323693114|FG000|Follow-up Period|Follow-up period was terminated.|20|||
94517654|NCT00956293|323693115|FG001|Follow-up Period|Follow-up period was terminated.|32|||
94517655|NCT00956293|323693116|FG002|Follow-up Period|Follow-up period was terminated.|0|||
94517656|NCT02536664|323693117|FG000|Overall Study|Inadequate completion of documentation|2|||
94517657|NCT02536664|323693118|FG001|Overall Study|Inadequate completion of documentation|4|||
94517658|NCT02536664|323693117|FG000|Overall Study|Progression|13|||
94517659|NCT02536664|323693118|FG001|Overall Study|Progression|18|||
94517660|NCT02536664|323693117|FG000|Overall Study|Death due to lymphoma|2|||
94517661|NCT02536664|323693118|FG001|Overall Study|Death due to lymphoma|1|||
94517662|NCT02536664|323693117|FG000|Overall Study|Death due to other reason|3|||
94517663|NCT02536664|323693118|FG001|Overall Study|Death due to other reason|2|||
94517664|NCT02536664|323693117|FG000|Overall Study|Intolerability|8|||
94517665|NCT02536664|323693118|FG001|Overall Study|Intolerability|6|||
94517666|NCT02536664|323693117|FG000|Overall Study|Withdrawal by Subject|8|||
94517667|NCT02536664|323693118|FG001|Overall Study|Withdrawal by Subject|5|||
94517668|NCT02536664|323693117|FG000|Overall Study|Other|18|||
94517669|NCT02536664|323693118|FG001|Overall Study|Other|24|||
94517670|NCT02536664|323693117|FG000|Overall Study|Missing|53|||
94517671|NCT02536664|323693118|FG001|Overall Study|Missing|20|||
94517672|NCT02359903|323693119|FG000|Overall Study|Adverse Event|0|||
94517673|NCT02359903|323693120|FG001|Overall Study|Adverse Event|2|||
94517674|NCT00546481|323693121|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
94517675|NCT00546481|323693122|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
94517676|NCT00546481|323693123|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
94517677|NCT00546481|323693121|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
94517678|NCT00546481|323693122|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
94517679|NCT00546481|323693123|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
94517680|NCT00546481|323693121|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
94517681|NCT00546481|323693122|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
94517682|NCT00546481|323693123|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
94517683|NCT00546481|323693121|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
94517684|NCT00546481|323693122|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
94517685|NCT00546481|323693123|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
94517686|NCT00546481|323693121|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
94517687|NCT00546481|323693122|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
94517688|NCT00546481|323693123|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
94517689|NCT00546481|323693121|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
94517690|NCT00546481|323693122|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
94517691|NCT00546481|323693123|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
94517692|NCT00546481|323693121|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
94517693|NCT00546481|323693122|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
94517694|NCT00546481|323693123|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
94517695|NCT00546481|323693121|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
94517696|NCT00546481|323693122|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
94517697|NCT00546481|323693123|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
94517698|NCT00546481|323693121|FG000|Maintenance Phase (CERA)|Other Reason|0|||
94517699|NCT00546481|323693122|FG001|Maintenance Phase (CERA)|Other Reason|0|||
94517700|NCT00546481|323693123|FG002|Maintenance Phase (CERA)|Other Reason|1|||
94517701|NCT01193101|323693128|FG000|Overall Study|Adverse Event|0|||
94517702|NCT01193101|323693129|FG001|Overall Study|Adverse Event|1|||
94517703|NCT01193101|323693130|FG002|Overall Study|Adverse Event|1|||
94517704|NCT01193101|323693131|FG003|Overall Study|Adverse Event|3|||
94517705|NCT01193101|323693128|FG000|Overall Study|Lack of Efficacy|3|||
94517706|NCT01193101|323693129|FG001|Overall Study|Lack of Efficacy|1|||
94517707|NCT01193101|323693130|FG002|Overall Study|Lack of Efficacy|0|||
94517708|NCT01193101|323693131|FG003|Overall Study|Lack of Efficacy|8|||
94517709|NCT01193101|323693128|FG000|Overall Study|Withdrawal by Subject|2|||
94517710|NCT01193101|323693129|FG001|Overall Study|Withdrawal by Subject|4|||
94517711|NCT01193101|323693130|FG002|Overall Study|Withdrawal by Subject|1|||
94517712|NCT01193101|323693131|FG003|Overall Study|Withdrawal by Subject|1|||
94517713|NCT01193101|323693128|FG000|Overall Study|Administrative problems|0|||
94517714|NCT01193101|323693129|FG001|Overall Study|Administrative problems|0|||
94517715|NCT01193101|323693130|FG002|Overall Study|Administrative problems|1|||
94517716|NCT01193101|323693131|FG003|Overall Study|Administrative problems|0|||
94517717|NCT01193101|323693128|FG000|Overall Study|Abnormal test procedure results|0|||
94517718|NCT01193101|323693129|FG001|Overall Study|Abnormal test procedure results|1|||
94517719|NCT01193101|323693130|FG002|Overall Study|Abnormal test procedure results|0|||
94517720|NCT01193101|323693131|FG003|Overall Study|Abnormal test procedure results|0|||
94517721|NCT02271529|323693132|FG000|Overall Study|Withdrawal by Subject|1|||
94517722|NCT01240863|323693133|FG000|Open-label Titration Period|Adverse Event|47|||
94517723|NCT01240863|323693134|FG001|Open-label Titration Period|Adverse Event|0|||
94517724|NCT01240863|323693135|FG002|Open-label Titration Period|Adverse Event|0|||
94517725|NCT01240863|323693133|FG000|Open-label Titration Period|Lack of Efficacy|19|||
94517726|NCT01240863|323693134|FG001|Open-label Titration Period|Lack of Efficacy|0|||
94517727|NCT01240863|323693135|FG002|Open-label Titration Period|Lack of Efficacy|0|||
94517728|NCT01240863|323693133|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
94517729|NCT01240863|323693134|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
94517730|NCT01240863|323693135|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
94517731|NCT01240863|323693133|FG000|Open-label Titration Period|Protocol Violation|7|||
94517732|NCT01240863|323693134|FG001|Open-label Titration Period|Protocol Violation|0|||
94517733|NCT01240863|323693135|FG002|Open-label Titration Period|Protocol Violation|0|||
94517734|NCT01240863|323693133|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
94517735|NCT01240863|323693134|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
94517736|NCT01240863|323693135|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
94517737|NCT01240863|323693133|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
94517738|NCT01240863|323693134|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
94517739|NCT01240863|323693135|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
94517740|NCT01240863|323693133|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
94517741|NCT01240863|323693134|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
94517742|NCT01240863|323693135|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
94517743|NCT01240863|323693133|FG000|Open-label Titration Period|Other|7|||
94517744|NCT01240863|323693134|FG001|Open-label Titration Period|Other|0|||
94517745|NCT01240863|323693135|FG002|Open-label Titration Period|Other|0|||
94517746|NCT01240863|323693133|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
94517747|NCT01240863|323693134|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
94517748|NCT01240863|323693135|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
94517749|NCT01240863|323693133|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
94517750|NCT01240863|323693134|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
94517751|NCT01240863|323693135|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
94517752|NCT01240863|323693133|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
94517753|NCT01240863|323693134|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
94517754|NCT01240863|323693135|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
94517755|NCT01240863|323693133|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
94517756|NCT01240863|323693134|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
94517757|NCT01240863|323693135|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
94517758|NCT01240863|323693133|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
94517759|NCT01240863|323693134|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
94517760|NCT01240863|323693135|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
94517761|NCT01240863|323693133|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
94517762|NCT01240863|323693134|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
94517763|NCT01240863|323693135|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
94517764|NCT01240863|323693133|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
94517765|NCT01240863|323693134|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
94517766|NCT01240863|323693135|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
94517767|NCT01240863|323693133|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
94517768|NCT01240863|323693134|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
94517769|NCT01240863|323693135|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
94517770|NCT03894891|323693136|FG000|Overall Study|Withdrawal by Subject|1|||
94517771|NCT03894891|323693136|FG000|Overall Study|Completed protocol treatment per protocol|5|||
94517772|NCT01644643|323693140|FG000|Overall Study|Death|1|||
94517773|NCT01644643|323693141|FG001|Overall Study|Death|0|||
94517774|NCT01644643|323693142|FG002|Overall Study|Death|3|||
94517775|NCT01644643|323693143|FG003|Overall Study|Death|3|||
94517776|NCT01644643|323693140|FG000|Overall Study|Lost to Follow-up|0|||
94517777|NCT01644643|323693141|FG001|Overall Study|Lost to Follow-up|0|||
94517778|NCT01644643|323693142|FG002|Overall Study|Lost to Follow-up|0|||
94517779|NCT01644643|323693143|FG003|Overall Study|Lost to Follow-up|4|||
94517780|NCT01644643|323693140|FG000|Overall Study|Withdrawal by Subject|1|||
94517781|NCT01644643|323693141|FG001|Overall Study|Withdrawal by Subject|0|||
94517782|NCT01644643|323693142|FG002|Overall Study|Withdrawal by Subject|2|||
94517783|NCT01644643|323693143|FG003|Overall Study|Withdrawal by Subject|1|||
94517784|NCT01644643|323693140|FG000|Overall Study|Other Eligibility criteria|0|||
94517785|NCT01644643|323693141|FG001|Overall Study|Other Eligibility criteria|0|||
94517786|NCT01644643|323693142|FG002|Overall Study|Other Eligibility criteria|0|||
94517787|NCT01644643|323693143|FG003|Overall Study|Other Eligibility criteria|2|||
94517788|NCT02629861|323693146|FG000|Overall Study|Adverse Event|7|||
94517789|NCT02629861|323693147|FG001|Overall Study|Adverse Event|5|||
94517790|NCT02629861|323693148|FG002|Overall Study|Adverse Event|4|||
94517791|NCT02629861|323693146|FG000|Overall Study|Withdrawal by Subject|5|||
94517792|NCT02629861|323693147|FG001|Overall Study|Withdrawal by Subject|8|||
94517793|NCT02629861|323693148|FG002|Overall Study|Withdrawal by Subject|13|||
94517794|NCT02629861|323693146|FG000|Overall Study|Protocol Violation|2|||
94517795|NCT02629861|323693147|FG001|Overall Study|Protocol Violation|3|||
94517796|NCT02629861|323693148|FG002|Overall Study|Protocol Violation|7|||
94517797|NCT02629861|323693146|FG000|Overall Study|Lost to Follow-up|12|||
94517798|NCT02629861|323693147|FG001|Overall Study|Lost to Follow-up|9|||
94517799|NCT02629861|323693148|FG002|Overall Study|Lost to Follow-up|4|||
94517800|NCT02629861|323693146|FG000|Overall Study|Other|1|||
94517801|NCT02629861|323693147|FG001|Overall Study|Other|1|||
94517802|NCT02629861|323693148|FG002|Overall Study|Other|0|||
94517803|NCT02629861|323693146|FG000|Overall Study|Pregnancy|2|||
94517804|NCT02629861|323693147|FG001|Overall Study|Pregnancy|1|||
94517805|NCT02629861|323693148|FG002|Overall Study|Pregnancy|0|||
94517806|NCT00730886|323693150|FG000|Overall Study|Lost to Follow-up|1|||
94517807|NCT00730886|323693151|FG001|Overall Study|Lost to Follow-up|0|||
94517808|NCT00730886|323693150|FG000|Overall Study|Physician Decision|1|||
94517809|NCT00730886|323693151|FG001|Overall Study|Physician Decision|0|||
94517810|NCT02505425|323693152|FG000|Overall Study|Lost to Follow-up|41|||
94517811|NCT02505425|323693153|FG001|Overall Study|Lost to Follow-up|61|||
94517812|NCT02505425|323693154|FG002|Overall Study|Lost to Follow-up|31|||
94517813|NCT02505425|323693155|FG003|Overall Study|Lost to Follow-up|19|||
94517814|NCT02505425|323693152|FG000|Overall Study|Withdrawal by Subject|39|||
94517815|NCT02505425|323693153|FG001|Overall Study|Withdrawal by Subject|9|||
94517816|NCT02505425|323693154|FG002|Overall Study|Withdrawal by Subject|19|||
94517817|NCT02505425|323693155|FG003|Overall Study|Withdrawal by Subject|7|||
94517818|NCT02505425|323693152|FG000|Overall Study|Death|8|||
94517819|NCT02505425|323693153|FG001|Overall Study|Death|12|||
94517820|NCT02505425|323693154|FG002|Overall Study|Death|0|||
94517821|NCT02505425|323693155|FG003|Overall Study|Death|0|||
94517822|NCT01342094|323693157|FG000|Overall Study|Adverse Event|5|||
94517823|NCT01342094|323693158|FG001|Overall Study|Adverse Event|0|||
94517824|NCT01342094|323693157|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
94517825|NCT01342094|323693158|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
94517826|NCT01342094|323693157|FG000|Overall Study|Withdrawal by Subject|0|||
94517827|NCT01342094|323693158|FG001|Overall Study|Withdrawal by Subject|2|||
94517828|NCT04021290|323693163|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
94517829|NCT04021290|323693164|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
94517830|NCT04021290|323693165|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
94517831|NCT04021290|323693163|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
94517832|NCT04021290|323693164|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
94517833|NCT04021290|323693165|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
94517834|NCT04021290|323693163|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
94517835|NCT04021290|323693164|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
94517836|NCT04021290|323693165|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
94517837|NCT04021290|323693163|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
94517838|NCT04021290|323693164|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
94517839|NCT04021290|323693165|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
94517840|NCT04021290|323693163|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
94517841|NCT04021290|323693164|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
94517842|NCT04021290|323693165|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
94517843|NCT04021290|323693163|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
94517844|NCT04021290|323693164|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
94517845|NCT04021290|323693165|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
94517846|NCT04021290|323693163|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
94517847|NCT04021290|323693164|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
94517848|NCT04021290|323693165|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
94517849|NCT04021290|323693163|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
94517850|NCT04021290|323693164|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
94517851|NCT04021290|323693165|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
94517852|NCT04021290|323693163|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
94517853|NCT04021290|323693164|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
94517854|NCT04021290|323693165|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
94517855|NCT04021290|323693163|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
94517856|NCT04021290|323693164|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
94517857|NCT04021290|323693165|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
94517858|NCT04021290|323693163|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
94517859|NCT04021290|323693164|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
94517860|NCT04021290|323693165|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
94517861|NCT04021290|323693163|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
94517862|NCT04021290|323693164|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
94517863|NCT04021290|323693165|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
94517864|NCT00636181|323693166|FG000|Overall Study|Withdrawal by Subject|8|||
94517865|NCT00636181|323693167|FG001|Overall Study|Withdrawal by Subject|6|||
94517866|NCT00636181|323693168|FG002|Overall Study|Withdrawal by Subject|10|||
94517867|NCT01673126|323693174|FG000|Overall Study|change of diagnosis|4|||
94517868|NCT01673126|323693175|FG001|Overall Study|change of diagnosis|3|||
94517869|NCT00237042|323693176|FG000|Treatment|Became ineligible post-randomization|0|||
94517870|NCT00237042|323693177|FG001|Treatment|Became ineligible post-randomization|1|||
94517871|NCT00237042|323693178|FG002|Treatment|Became ineligible post-randomization|16|||
94517872|NCT00237042|323693176|FG000|Treatment|Moved out of state|1|||
94517873|NCT00237042|323693177|FG001|Treatment|Moved out of state|1|||
94517874|NCT00237042|323693178|FG002|Treatment|Moved out of state|1|||
94517875|NCT00237042|323693176|FG000|Treatment|Completed no treatment|5|||
94517876|NCT00237042|323693177|FG001|Treatment|Completed no treatment|5|||
94517877|NCT00237042|323693178|FG002|Treatment|Completed no treatment|21|||
94517878|NCT00237042|323693176|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
94517879|NCT00237042|323693177|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
94517880|NCT00237042|323693178|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
94517881|NCT00237042|323693176|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
94517882|NCT00237042|323693177|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
94517883|NCT00237042|323693178|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
94517884|NCT01074931|323693179|FG000|Overall Study|Economic reasons|1|||
94517885|NCT01074931|323693179|FG000|Overall Study|Death|5|||
94517886|NCT05223673|323693182|FG000|Overall Study|Protocol Violation|1|||
94517887|NCT05223673|323693182|FG000|Overall Study|Study termination|6|||
94517888|NCT02777086|323694795|FG000|Overall Study|Lost to Follow-up|96|||
94517889|NCT02777086|323694796|FG001|Overall Study|Lost to Follow-up|99|||
94517890|NCT00952705|323694799|FG000|Overall Study|Lost to Follow-up|24|||
94517891|NCT00952705|323694800|FG001|Overall Study|Lost to Follow-up|8|||
94517892|NCT00952705|323694801|FG002|Overall Study|Lost to Follow-up|9|||
94517893|NCT00952705|323694799|FG000|Overall Study|Withdrawal by Subject|2|||
94517894|NCT00952705|323694800|FG001|Overall Study|Withdrawal by Subject|1|||
94517895|NCT00952705|323694801|FG002|Overall Study|Withdrawal by Subject|1|||
94517896|NCT00952705|323694799|FG000|Overall Study|Death|2|||
94517897|NCT00952705|323694800|FG001|Overall Study|Death|0|||
94517898|NCT00952705|323694801|FG002|Overall Study|Death|0|||
94517899|NCT00952705|323694799|FG000|Overall Study|Incarcerated post dose|5|||
94517900|NCT00952705|323694800|FG001|Overall Study|Incarcerated post dose|0|||
94517901|NCT00952705|323694801|FG002|Overall Study|Incarcerated post dose|0|||
94517902|NCT00952705|323694799|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
94517903|NCT00952705|323694800|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
94517904|NCT00952705|323694801|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
94517905|NCT05246514|323694803|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
94517906|NCT05246514|323694803|FG000|Overall Study|Withdrawal by Subject|1|||
94517907|NCT05246514|323694803|FG000|Overall Study|Death|13|||
94517908|NCT00582907|323694811|FG000|1st Course|Withdrawal by Subject|1|||
94517909|NCT00582907|323694812|FG001|1st Course|Withdrawal by Subject|0|||
94517910|NCT00582907|323694813|FG002|1st Course|Withdrawal by Subject|0|||
94517911|NCT00582907|323694814|FG003|1st Course|Withdrawal by Subject|0|||
94517912|NCT00582907|323694811|FG000|1st Course|Lost to Follow-up|0|||
94517913|NCT00582907|323694812|FG001|1st Course|Lost to Follow-up|0|||
94517914|NCT00582907|323694813|FG002|1st Course|Lost to Follow-up|0|||
94517915|NCT00582907|323694814|FG003|1st Course|Lost to Follow-up|1|||
94517916|NCT00582907|323694811|FG000|2nd Course|Lack of Efficacy|1|||
94517917|NCT00582907|323694812|FG001|2nd Course|Lack of Efficacy|0|||
94517918|NCT00582907|323694813|FG002|2nd Course|Lack of Efficacy|0|||
94517919|NCT00582907|323694814|FG003|2nd Course|Lack of Efficacy|0|||
94517920|NCT02704208|323694815|FG000|Overall Study|Lost to Follow-up|42|||
94517921|NCT02704208|323694816|FG001|Overall Study|Lost to Follow-up|37|||
94517922|NCT04099277|323694820|FG000|Overall Study|Physician Decision|1|||
94517923|NCT04099277|323694820|FG000|Overall Study|Withdrawal by Subject|1|||
94517924|NCT02393859|323694821|FG000|Overall Study|Decision by Sponsor|2|||
94517925|NCT02393859|323694822|FG001|Overall Study|Decision by Sponsor|4|||
94517926|NCT02393859|323694821|FG000|Overall Study|Withdrawal by Subject|11|||
94517927|NCT02393859|323694822|FG001|Overall Study|Withdrawal by Subject|6|||
94517928|NCT02393859|323694821|FG000|Overall Study|Death|27|||
94517929|NCT02393859|323694822|FG001|Overall Study|Death|10|||
94517930|NCT02393859|323694821|FG000|Overall Study|Lost to Follow-up|1|||
94517931|NCT02393859|323694822|FG001|Overall Study|Lost to Follow-up|1|||
94517932|NCT02415556|323694823|FG000|Overall Study|Adverse Event|3|||
94517933|NCT02415556|323694824|FG001|Overall Study|Adverse Event|4|||
94517934|NCT02415556|323694825|FG002|Overall Study|Adverse Event|2|||
94517935|NCT02415556|323694826|FG003|Overall Study|Adverse Event|4|||
94517936|NCT02415556|323694823|FG000|Overall Study|Lost to Follow-up|4|||
94517937|NCT02415556|323694824|FG001|Overall Study|Lost to Follow-up|5|||
94517938|NCT02415556|323694825|FG002|Overall Study|Lost to Follow-up|4|||
94517939|NCT02415556|323694826|FG003|Overall Study|Lost to Follow-up|1|||
94517940|NCT02415556|323694823|FG000|Overall Study|Withdrawal by Subject|13|||
94517941|NCT02415556|323694824|FG001|Overall Study|Withdrawal by Subject|4|||
94517942|NCT02415556|323694825|FG002|Overall Study|Withdrawal by Subject|14|||
94517943|NCT02415556|323694826|FG003|Overall Study|Withdrawal by Subject|12|||
94517944|NCT02415556|323694823|FG000|Overall Study|Physician Decision|1|||
94517945|NCT02415556|323694824|FG001|Overall Study|Physician Decision|3|||
94517946|NCT02415556|323694825|FG002|Overall Study|Physician Decision|1|||
94517947|NCT02415556|323694826|FG003|Overall Study|Physician Decision|2|||
94517948|NCT02415556|323694823|FG000|Overall Study|Censored - study completion|4|||
94517949|NCT02415556|323694824|FG001|Overall Study|Censored - study completion|5|||
94517950|NCT02415556|323694825|FG002|Overall Study|Censored - study completion|1|||
94517951|NCT02415556|323694826|FG003|Overall Study|Censored - study completion|0|||
94517952|NCT02415556|323694823|FG000|Overall Study|Family-related issues|0|||
94517953|NCT02415556|323694824|FG001|Overall Study|Family-related issues|0|||
94517954|NCT02415556|323694825|FG002|Overall Study|Family-related issues|0|||
94517955|NCT02415556|323694826|FG003|Overall Study|Family-related issues|1|||
94517956|NCT03423602|323694827|FG000|Overall Study|Death|1|||
94517957|NCT03423602|323694827|FG000|Overall Study|Lost to Follow-up|6|||
94517958|NCT03423602|323694827|FG000|Overall Study|Protocol Violation|1|||
94517959|NCT03423602|323694827|FG000|Overall Study|Withdrawal by Subject|4|||
94517960|NCT03423121|323694828|FG000|Overall Study|Lost to Follow-up|2|||
94517961|NCT03423121|323694829|FG001|Overall Study|Lost to Follow-up|6|||
94517962|NCT03423121|323694828|FG000|Overall Study|Adverse Event|1|||
94517963|NCT03423121|323694829|FG001|Overall Study|Adverse Event|0|||
94517964|NCT00560508|323694830|FG000|12 Week Double-blind Period|Adverse Event|3|||
94517965|NCT00560508|323694831|FG001|12 Week Double-blind Period|Adverse Event|2|||
94517966|NCT00560508|323694830|FG000|12 Week Double-blind Period|Protocol Violation|1|||
94517967|NCT00560508|323694831|FG001|12 Week Double-blind Period|Protocol Violation|0|||
94517968|NCT00560508|323694830|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
94517969|NCT00560508|323694831|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
94517970|NCT00560508|323694830|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
94517971|NCT00560508|323694831|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
94517972|NCT00560508|323694830|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
94517973|NCT00560508|323694831|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
94517974|NCT00560508|323694830|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
94517975|NCT00560508|323694831|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
94517976|NCT00560508|323694830|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
94517977|NCT00560508|323694831|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
94517978|NCT01192126|323694832|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
94517979|NCT01192126|323694833|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
94517980|NCT01192126|323694832|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
94517981|NCT01192126|323694833|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
94517982|NCT04102007|323694834|FG000|Overall Study|Adverse Event|4|||
94517983|NCT04102007|323694834|FG000|Overall Study|Lost to Follow-up|3|||
94517984|NCT04102007|323694834|FG000|Overall Study|Withdrawal by Subject|12|||
94517985|NCT04102007|323694834|FG000|Overall Study|Eligibility Violation|5|||
94517986|NCT04102007|323694834|FG000|Overall Study|Lack of Efficacy|6|||
94517987|NCT04102007|323694834|FG000|Overall Study|Protocol Deviation|5|||
94517988|NCT04102007|323694834|FG000|Overall Study|Protocol Compliance|1|||
94517989|NCT04102007|323694834|FG000|Overall Study|Withdrew Treatment|2|||
94517990|NCT04102007|323694834|FG000|Overall Study|Pregnancy|1|||
94517991|NCT03257358|323694836|FG000|Overall Study|Adverse Event|25|||
94517992|NCT03257358|323694837|FG001|Overall Study|Adverse Event|12|||
94517993|NCT03257358|323694836|FG000|Overall Study|Lack of Efficacy|1|||
94517994|NCT03257358|323694837|FG001|Overall Study|Lack of Efficacy|1|||
94517995|NCT03257358|323694836|FG000|Overall Study|Lost to Follow-up|12|||
94517996|NCT03257358|323694837|FG001|Overall Study|Lost to Follow-up|4|||
94517997|NCT03257358|323694836|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
94517998|NCT03257358|323694837|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
94517999|NCT03257358|323694836|FG000|Overall Study|Physician Decision|2|||
94518000|NCT03257358|323694837|FG001|Overall Study|Physician Decision|2|||
94518001|NCT03257358|323694836|FG000|Overall Study|Protocol Violation|5|||
94518002|NCT03257358|323694837|FG001|Overall Study|Protocol Violation|3|||
94518003|NCT03257358|323694836|FG000|Overall Study|Technical problems|4|||
94518004|NCT03257358|323694837|FG001|Overall Study|Technical problems|1|||
94518005|NCT03257358|323694836|FG000|Overall Study|Withdrawal by Subject|8|||
94518006|NCT03257358|323694837|FG001|Overall Study|Withdrawal by Subject|3|||
94518007|NCT03257358|323694836|FG000|Overall Study|Withdrawal of informed consent|9|||
94518008|NCT03257358|323694837|FG001|Overall Study|Withdrawal of informed consent|5|||
94518009|NCT03257358|323694836|FG000|Overall Study|New therapy for study indication|1|||
94518010|NCT03257358|323694837|FG001|Overall Study|New therapy for study indication|0|||
94518011|NCT03257358|323694836|FG000|Overall Study|No longer requires treatment|0|||
94518012|NCT03257358|323694837|FG001|Overall Study|No longer requires treatment|1|||
94518013|NCT00305877|323694838|FG000|Overall Study|Lack of Efficacy|6|||
94518014|NCT00305877|323694839|FG001|Overall Study|Lack of Efficacy|9|||
94518015|NCT00305877|323694838|FG000|Overall Study|Adverse Event|9|||
94518016|NCT00305877|323694839|FG001|Overall Study|Adverse Event|14|||
94518017|NCT00305877|323694838|FG000|Overall Study|Death|0|||
94518018|NCT00305877|323694839|FG001|Overall Study|Death|1|||
94518019|NCT00305877|323694838|FG000|Overall Study|Withdrawal by Subject|4|||
94518020|NCT00305877|323694839|FG001|Overall Study|Withdrawal by Subject|2|||
94518021|NCT00305877|323694838|FG000|Overall Study|Physician Decision|1|||
94518022|NCT00305877|323694839|FG001|Overall Study|Physician Decision|1|||
94518023|NCT00305877|323694838|FG000|Overall Study|Never start treatment|2|||
94518024|NCT00305877|323694839|FG001|Overall Study|Never start treatment|5|||
94518025|NCT00305877|323694838|FG000|Overall Study|Ineligible|2|||
94518026|NCT00305877|323694839|FG001|Overall Study|Ineligible|1|||
94518027|NCT00305877|323694838|FG000|Overall Study|Transportation issue with daily RT|0|||
94518028|NCT00305877|323694839|FG001|Overall Study|Transportation issue with daily RT|1|||
94518029|NCT01475721|323694840|FG000|Overall Study|Death|3|||
94518030|NCT01475721|323694841|FG001|Overall Study|Death|6|||
94518031|NCT01475721|323694840|FG000|Overall Study|Withdrawal by Subject|8|||
94518032|NCT01475721|323694841|FG001|Overall Study|Withdrawal by Subject|8|||
94518033|NCT00812955|323694845|FG000|Overall Study|Adverse Event|7|||
94518034|NCT00812955|323694846|FG001|Overall Study|Adverse Event|6|||
94518035|NCT00812955|323694847|FG002|Overall Study|Adverse Event|3|||
94518036|NCT00812955|323694848|FG003|Overall Study|Adverse Event|4|||
94518037|NCT00812955|323694845|FG000|Overall Study|Lost to Follow-up|2|||
94518038|NCT00812955|323694846|FG001|Overall Study|Lost to Follow-up|1|||
94518039|NCT00812955|323694847|FG002|Overall Study|Lost to Follow-up|1|||
94518040|NCT00812955|323694848|FG003|Overall Study|Lost to Follow-up|2|||
94518041|NCT00812955|323694845|FG000|Overall Study|Withdrawal by Subject|1|||
94518042|NCT00812955|323694846|FG001|Overall Study|Withdrawal by Subject|0|||
94518043|NCT00812955|323694847|FG002|Overall Study|Withdrawal by Subject|1|||
94518044|NCT00812955|323694848|FG003|Overall Study|Withdrawal by Subject|2|||
94518045|NCT00812955|323694845|FG000|Overall Study|randomized in error|0|||
94518046|NCT00812955|323694846|FG001|Overall Study|randomized in error|0|||
94518047|NCT00812955|323694847|FG002|Overall Study|randomized in error|1|||
94518048|NCT00812955|323694848|FG003|Overall Study|randomized in error|0|||
94518049|NCT03046446|323694849|FG000|Overall Study|Lack of Efficacy|7|||
94518050|NCT03046446|323694849|FG000|Overall Study|Adverse Event|6|||
94518051|NCT03046446|323694849|FG000|Overall Study|Lost to Follow-up|3|||
94518052|NCT03046446|323694849|FG000|Overall Study|Withdrawal by Subject|14|||
94518053|NCT03046446|323694849|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
94518054|NCT03046446|323694849|FG000|Overall Study|Disease Progression (see caveats)|25|||
94518055|NCT03046446|323694849|FG000|Overall Study|Non OA related knee surgery|1|||
94518056|NCT00925002|323694850|FG000|Overall Study|Other|1|||
94518057|NCT00925002|323694851|FG001|Overall Study|Other|4|||
94518058|NCT00925002|323694852|FG002|Overall Study|Other|0|||
94518059|NCT00925002|323694850|FG000|Overall Study|Death|1|||
94518060|NCT00925002|323694851|FG001|Overall Study|Death|1|||
94518061|NCT00925002|323694852|FG002|Overall Study|Death|5|||
94518062|NCT00925002|323694850|FG000|Overall Study|Adverse Event|3|||
94518063|NCT00925002|323694851|FG001|Overall Study|Adverse Event|1|||
94518064|NCT00925002|323694852|FG002|Overall Study|Adverse Event|2|||
94518065|NCT00925002|323694850|FG000|Overall Study|Participant withdrew consent|1|||
94518066|NCT00925002|323694851|FG001|Overall Study|Participant withdrew consent|3|||
94518067|NCT00925002|323694852|FG002|Overall Study|Participant withdrew consent|3|||
94518068|NCT00329030|323694853|FG000|Overall Study|Withdrawal by Subject|1|||
94518069|NCT00329030|323694854|FG001|Overall Study|Withdrawal by Subject|3|||
94518070|NCT00329030|323694853|FG000|Overall Study|Progressive Disease|6|||
94518071|NCT00329030|323694854|FG001|Overall Study|Progressive Disease|2|||
94518072|NCT00329030|323694853|FG000|Overall Study|Ineligible Pathology|1|||
94518073|NCT00329030|323694854|FG001|Overall Study|Ineligible Pathology|1|||
94518074|NCT01500317|323694864|FG000|Overall Study|Withdrawal by Subject|3|||
94518075|NCT01500317|323694865|FG001|Overall Study|Withdrawal by Subject|2|||
94518076|NCT01500317|323694866|FG002|Overall Study|Withdrawal by Subject|0|||
94518077|NCT00976456|323694867|FG000|Overall Study|Adverse Event|17|||
94518078|NCT00976456|323694868|FG001|Overall Study|Adverse Event|22|||
94518079|NCT00976456|323694867|FG000|Overall Study|Death|7|||
94518080|NCT00976456|323694868|FG001|Overall Study|Death|9|||
94518081|NCT00976456|323694867|FG000|Overall Study|Lack of Efficacy|5|||
94518082|NCT00976456|323694868|FG001|Overall Study|Lack of Efficacy|2|||
94518083|NCT00976456|323694867|FG000|Overall Study|Withdrawal by Subject|3|||
94518084|NCT00976456|323694868|FG001|Overall Study|Withdrawal by Subject|1|||
94518085|NCT00976456|323694867|FG000|Overall Study|screening failure, unknown|11|||
94518086|NCT00976456|323694868|FG001|Overall Study|screening failure, unknown|4|||
94518087|NCT04108273|323694869|FG000|Overall Study|COVID Pandemic|1|||
94518088|NCT04108273|323694870|FG001|Overall Study|COVID Pandemic|0|||
94518089|NCT02131766|323694871|FG000|Overall Study|Withdrawal by Subject|4|||
94518090|NCT00163189|323694872|FG000|Overall Study|Other|6|||
94518091|NCT00163189|323694872|FG000|Overall Study|Lost to Follow-up|1|||
94518092|NCT00163189|323694872|FG000|Overall Study|Protocol Violation|2|||
94518093|NCT00163189|323694872|FG000|Overall Study|Death|3|||
94518094|NCT00163189|323694872|FG000|Overall Study|Adverse Event|6|||
94518095|NCT00163189|323694872|FG000|Overall Study|Lack of Efficacy|7|||
94518096|NCT00163189|323694872|FG000|Overall Study|Study terminated by sponsor|11|||
94518097|NCT00163189|323694872|FG000|Overall Study|Withdrawal by Subject|11|||
94518098|NCT00163189|323694872|FG000|Overall Study|Did not meet continuation criterion|16|||
94518099|NCT02154061|323694873|FG000|Overall Study|Pregnancy|1|||
94518100|NCT02154061|323694874|FG001|Overall Study|Pregnancy|0|||
94518101|NCT02154061|323694873|FG000|Overall Study|enrolled but not vaccinated|1|||
94518102|NCT02154061|323694874|FG001|Overall Study|enrolled but not vaccinated|0|||
94518103|NCT00523978|323694878|FG000|Overall Study|Withdrawal by Subject|3|||
94518104|NCT00523978|323694879|FG001|Overall Study|Withdrawal by Subject|7|||
94518105|NCT00523978|323694878|FG000|Overall Study|Screen Failures|5|||
94518106|NCT00523978|323694879|FG001|Overall Study|Screen Failures|1|||
94518107|NCT00523978|323694878|FG000|Overall Study|Death|1|||
94518108|NCT00523978|323694879|FG001|Overall Study|Death|0|||
94518109|NCT01880957|323694881|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
94518110|NCT01880957|323694882|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
94518111|NCT01880957|323694881|FG000|Overall Study|Lost to Follow-up|11|||
94518112|NCT01880957|323694882|FG001|Overall Study|Lost to Follow-up|0|||
94518113|NCT01880957|323694881|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
94518114|NCT01880957|323694882|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
94518115|NCT01378117|323694884|FG000|Overall Study|withdrawal|2|||
94518116|NCT01378117|323694885|FG001|Overall Study|withdrawal|1|||
94518117|NCT01378117|323694886|FG002|Overall Study|withdrawal|2|||
94518118|NCT01378117|323694884|FG000|Overall Study|discharged before med given|2|||
94518119|NCT01378117|323694885|FG001|Overall Study|discharged before med given|0|||
94518120|NCT01378117|323694886|FG002|Overall Study|discharged before med given|1|||
94518121|NCT01463033|323694887|FG000|Overall Study|Lost to Follow-up|4|||
94518122|NCT01463033|323694888|FG001|Overall Study|Lost to Follow-up|4|||
94518123|NCT01463033|323694887|FG000|Overall Study|Death|3|||
94518124|NCT01463033|323694888|FG001|Overall Study|Death|2|||
94518125|NCT02961244|323694891|FG000|Overall Study|Protocol Violation|0|||
94518126|NCT02961244|323694892|FG001|Overall Study|Protocol Violation|1|||
94518127|NCT02961244|323694891|FG000|Overall Study|Withdrawal by Subject|1|||
94518128|NCT02961244|323694892|FG001|Overall Study|Withdrawal by Subject|2|||
94518129|NCT02961244|323694891|FG000|Overall Study|Surgery plan change after study approval|0|||
94518130|NCT02961244|323694892|FG001|Overall Study|Surgery plan change after study approval|2|||
94518131|NCT02961244|323694891|FG000|Overall Study|Lost to Follow-up|0|||
94518132|NCT02961244|323694892|FG001|Overall Study|Lost to Follow-up|2|||
94518133|NCT02961244|323694891|FG000|Overall Study|İnadequate data|0|||
94518134|NCT02961244|323694892|FG001|Overall Study|İnadequate data|2|||
94518135|NCT02750930|323694893|FG000|Overall Study|Study closed/terminated|8|||
94518136|NCT02761642|323694898|FG000|Overall Study|Did not Receive Study Treatment|3|||
94518137|NCT02761642|323694898|FG000|Overall Study|Adverse Event|13|||
94518138|NCT02761642|323694898|FG000|Overall Study|Withdrawal by Subject|2|||
94518139|NCT02761642|323694898|FG000|Overall Study|Non-compliant|7|||
94518140|NCT02761642|323694898|FG000|Overall Study|Death|3|||
94518141|NCT02761642|323694898|FG000|Overall Study|Lack of Efficacy|20|||
94518142|NCT02761642|323694898|FG000|Overall Study|Physician Decision|1|||
94518143|NCT02761642|323694898|FG000|Overall Study|Reason Unspecified|21|||
94518144|NCT03783780|323694899|FG000|Overall Study|Withdrawn prior to completion|1|||
94518145|NCT03768427|323694900|FG000|Overall Study|Death|0|||
94518146|NCT03768427|323694901|FG001|Overall Study|Death|0|||
94518147|NCT03768427|323694902|FG002|Overall Study|Death|1|||
94518148|NCT03768427|323694903|FG003|Overall Study|Death|0|||
94518149|NCT03768427|323694900|FG000|Overall Study|Lost to Follow-up|2|||
94518150|NCT03768427|323694901|FG001|Overall Study|Lost to Follow-up|0|||
94518151|NCT03768427|323694902|FG002|Overall Study|Lost to Follow-up|0|||
94518152|NCT03768427|323694903|FG003|Overall Study|Lost to Follow-up|0|||
94518153|NCT03768427|323694900|FG000|Overall Study|Physician Decision|3|||
94518154|NCT03768427|323694901|FG001|Overall Study|Physician Decision|2|||
94518155|NCT03768427|323694902|FG002|Overall Study|Physician Decision|4|||
94518156|NCT03768427|323694903|FG003|Overall Study|Physician Decision|4|||
94518157|NCT03768427|323694900|FG000|Overall Study|Withdrawal by Subject|7|||
94518158|NCT03768427|323694901|FG001|Overall Study|Withdrawal by Subject|2|||
94518159|NCT03768427|323694902|FG002|Overall Study|Withdrawal by Subject|6|||
94518160|NCT03768427|323694903|FG003|Overall Study|Withdrawal by Subject|7|||
94518161|NCT03710889|323694904|FG000|Overall Study|Adverse Event|2|||
94518162|NCT03710889|323694904|FG000|Overall Study|Protocol Deviation|1|||
94518163|NCT02756403|323694905|FG000|Overall Study|Unable to swallow medication|0|||
94518164|NCT02756403|323694906|FG001|Overall Study|Unable to swallow medication|1|||
94518165|NCT02756403|323694907|FG002|Overall Study|Unable to swallow medication|1|||
94518166|NCT02756403|323694908|FG003|Overall Study|Unable to swallow medication|1|||
94518167|NCT02756403|323694905|FG000|Overall Study|Did not complete Procedure|0|||
94518168|NCT02756403|323694906|FG001|Overall Study|Did not complete Procedure|1|||
94518169|NCT02756403|323694907|FG002|Overall Study|Did not complete Procedure|0|||
94518170|NCT02756403|323694908|FG003|Overall Study|Did not complete Procedure|0|||
94518171|NCT02756403|323694905|FG000|Overall Study|Changed Mind About Procedure|0|||
94518172|NCT02756403|323694906|FG001|Overall Study|Changed Mind About Procedure|0|||
94518173|NCT02756403|323694907|FG002|Overall Study|Changed Mind About Procedure|1|||
94518174|NCT02756403|323694908|FG003|Overall Study|Changed Mind About Procedure|0|||
94518175|NCT02756403|323694905|FG000|Overall Study|Protocol Violation|0|||
94518176|NCT02756403|323694906|FG001|Overall Study|Protocol Violation|1|||
94518177|NCT02756403|323694907|FG002|Overall Study|Protocol Violation|0|||
94518178|NCT02756403|323694908|FG003|Overall Study|Protocol Violation|1|||
94518179|NCT00776789|323694911|FG000|Overall Study|Consent refusal|2|||
94518180|NCT00776789|323694912|FG001|Overall Study|Consent refusal|2|||
94518181|NCT00776789|323694911|FG000|Overall Study|Poor quality video|1|||
94518182|NCT00776789|323694912|FG001|Overall Study|Poor quality video|1|||
94518183|NCT00881894|323694917|FG000|Overall Study|Consent withdrawn|0|||
94518184|NCT00881894|323694918|FG001|Overall Study|Consent withdrawn|1|||
94518185|NCT00881894|323694917|FG000|Overall Study|Other reasons for premature termination|1|||
94518186|NCT00881894|323694918|FG001|Overall Study|Other reasons for premature termination|2|||
94518187|NCT00570713|323694919|FG000|Overall Study|Adverse Event|16|||
94518188|NCT00570713|323694920|FG001|Overall Study|Adverse Event|9|||
94518189|NCT00570713|323694919|FG000|Overall Study|Death|7|||
94518190|NCT00570713|323694920|FG001|Overall Study|Death|7|||
94518191|NCT00570713|323694919|FG000|Overall Study|Lack of Efficacy|40|||
94518192|NCT00570713|323694920|FG001|Overall Study|Lack of Efficacy|49|||
94518193|NCT00570713|323694919|FG000|Overall Study|Physician Decision|2|||
94518194|NCT00570713|323694920|FG001|Overall Study|Physician Decision|2|||
94518195|NCT00570713|323694919|FG000|Overall Study|Withdrawal by Subject|3|||
94518196|NCT00570713|323694920|FG001|Overall Study|Withdrawal by Subject|3|||
94518197|NCT00570713|323694919|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
94518198|NCT00570713|323694920|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
94518199|NCT00469833|323694921|FG000|Overall Study|No IV access|2|||
94518200|NCT01030822|323694922|FG000|Overall Study|Moved/migrated from study area|6|||
94518201|NCT01030822|323694923|FG001|Overall Study|Moved/migrated from study area|7|||
94518202|NCT01030822|323694924|FG002|Overall Study|Moved/migrated from study area|3|||
94518203|NCT01030822|323694922|FG000|Overall Study|Withdrawal by Subject|16|||
94518204|NCT01030822|323694923|FG001|Overall Study|Withdrawal by Subject|13|||
94518205|NCT01030822|323694924|FG002|Overall Study|Withdrawal by Subject|16|||
94518206|NCT01030822|323694922|FG000|Overall Study|Lost to Follow-up|9|||
94518207|NCT01030822|323694923|FG001|Overall Study|Lost to Follow-up|4|||
94518208|NCT01030822|323694924|FG002|Overall Study|Lost to Follow-up|7|||
94518209|NCT01508910|323694925|FG000|Treatment|Death|2|||
94518210|NCT01508910|323694926|FG001|Treatment|Death|3|||
94518211|NCT01508910|323694927|FG002|Treatment|Death|2|||
94518212|NCT01508910|323694928|FG003|Treatment|Death|0|||
94518213|NCT01508910|323694925|FG000|Treatment|Lost to Follow-up|0|||
94518214|NCT01508910|323694926|FG001|Treatment|Lost to Follow-up|0|||
94518215|NCT01508910|323694927|FG002|Treatment|Lost to Follow-up|2|||
94518216|NCT01508910|323694928|FG003|Treatment|Lost to Follow-up|1|||
94518217|NCT01508910|323694925|FG000|Treatment|Withdrawal by Subject|0|||
94518218|NCT01508910|323694926|FG001|Treatment|Withdrawal by Subject|1|||
94518219|NCT01508910|323694927|FG002|Treatment|Withdrawal by Subject|6|||
94518220|NCT01508910|323694928|FG003|Treatment|Withdrawal by Subject|1|||
94518221|NCT01508910|323694925|FG000|Treatment|Sponsor Decision|0|||
94518222|NCT01508910|323694926|FG001|Treatment|Sponsor Decision|0|||
94518223|NCT01508910|323694927|FG002|Treatment|Sponsor Decision|0|||
94518224|NCT01508910|323694928|FG003|Treatment|Sponsor Decision|1|||
94518225|NCT04016714|323694929|FG000|Overall Study|Death|1|||
94518226|NCT04016714|323694930|FG001|Overall Study|Death|0|||
94518227|NCT04016714|323694929|FG000|Overall Study|Lost to Follow-up|3|||
94518228|NCT04016714|323694930|FG001|Overall Study|Lost to Follow-up|1|||
94518229|NCT04016714|323694929|FG000|Overall Study|Physician Decision|3|||
94518230|NCT04016714|323694930|FG001|Overall Study|Physician Decision|3|||
94518231|NCT04016714|323694929|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
94518232|NCT04016714|323694930|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
94518233|NCT04540367|323694934|FG000|Overall Study|Withdrawal by Subject|0|||
94518234|NCT04540367|323694935|FG001|Overall Study|Withdrawal by Subject|0|||
94518235|NCT04540367|323694936|FG002|Overall Study|Withdrawal by Subject|0|||
94518236|NCT04540367|323694937|FG003|Overall Study|Withdrawal by Subject|2|||
94518237|NCT04540367|323694934|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
94518238|NCT04540367|323694935|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
94518239|NCT04540367|323694936|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
94518240|NCT04540367|323694937|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
94518241|NCT04540367|323694934|FG000|Overall Study|Adverse Event|0|||
94518242|NCT04540367|323694935|FG001|Overall Study|Adverse Event|0|||
94518243|NCT04540367|323694936|FG002|Overall Study|Adverse Event|1|||
94518244|NCT04540367|323694937|FG003|Overall Study|Adverse Event|1|||
94518245|NCT00165789|323694938|FG000|Overall Study|Adverse Event|0|||
94518246|NCT00165789|323694939|FG001|Overall Study|Adverse Event|3|||
94518247|NCT00165789|323694940|FG002|Overall Study|Adverse Event|0|||
94518248|NCT00165789|323694941|FG003|Overall Study|Adverse Event|12|||
94518249|NCT00165789|323694938|FG000|Overall Study|Withdrawal by Subject|0|||
94518250|NCT00165789|323694939|FG001|Overall Study|Withdrawal by Subject|1|||
94518251|NCT00165789|323694940|FG002|Overall Study|Withdrawal by Subject|1|||
94518252|NCT00165789|323694941|FG003|Overall Study|Withdrawal by Subject|2|||
94518253|NCT02121509|323694950|FG000|Washout Period (35 Days)|Adverse Event|1|||
94518254|NCT02121509|323694951|FG001|Washout Period (35 Days)|Adverse Event|1|||
94518255|NCT02121509|323694952|FG002|Washout Period (35 Days)|Adverse Event|0|||
94518256|NCT02121509|323694953|FG003|Washout Period (35 Days)|Adverse Event|0|||
94518257|NCT02121509|323694950|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
94518258|NCT02121509|323694951|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
94518259|NCT02121509|323694952|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
94518260|NCT02121509|323694953|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
94518261|NCT02121509|323694950|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
94518262|NCT02121509|323694951|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
94518263|NCT02121509|323694952|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
94518264|NCT02121509|323694953|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
94518265|NCT02268383|323694954|FG000|Overall Study|Death|12|||
94518266|NCT02268383|323694954|FG000|Overall Study|Lost to Follow-up|2|||
94518267|NCT02268383|323694954|FG000|Overall Study|Withdrawal by Subject|9|||
94518268|NCT02268383|323694954|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
94518269|NCT02268383|323694954|FG000|Overall Study|Protocol deviation|3|||
94518270|NCT02268383|323694954|FG000|Overall Study|Sponsor decision|22|||
94518271|NCT02268383|323694954|FG000|Overall Study|Not reported|12|||
94518272|NCT00714948|323694955|FG000|Overall Study|Adverse Event|2|||
94518273|NCT03092479|323694958|FG000|Overall Study|Lost to Follow-up|3|||
94518274|NCT03092479|323694959|FG001|Overall Study|Lost to Follow-up|2|||
94518275|NCT03092479|323694958|FG000|Overall Study|Withdrawal by Subject|4|||
94518276|NCT03092479|323694959|FG001|Overall Study|Withdrawal by Subject|0|||
94518277|NCT03382912|323694960|FG000|Overall Study|Physician Decision|0|||
94518278|NCT03382912|323694961|FG001|Overall Study|Physician Decision|1|||
94518279|NCT03382912|323694960|FG000|Overall Study|Sponsor Decision|6|||
94518280|NCT03382912|323694961|FG001|Overall Study|Sponsor Decision|6|||
94518281|NCT03382912|323694960|FG000|Overall Study|Withdrawal by Subject|0|||
94518282|NCT03382912|323694961|FG001|Overall Study|Withdrawal by Subject|5|||
94518283|NCT02114177|323696645|FG000|Overall Study|Lost to Follow-up|1|||
94518284|NCT02114177|323696646|FG001|Overall Study|Lost to Follow-up|2|||
94518285|NCT02114177|323696645|FG000|Overall Study|Withdrawal by Subject|6|||
94518286|NCT02114177|323696646|FG001|Overall Study|Withdrawal by Subject|1|||
94518287|NCT02114177|323696645|FG000|Overall Study|Other|2|||
94518288|NCT02114177|323696646|FG001|Overall Study|Other|1|||
94518289|NCT01819272|323696647|FG000|Overall Study|Adverse Event|1|||
94518290|NCT01819272|323696648|FG001|Overall Study|Adverse Event|0|||
94518291|NCT01819272|323696649|FG002|Overall Study|Adverse Event|0|||
94518292|NCT01819272|323696650|FG003|Overall Study|Adverse Event|2|||
94518293|NCT01819272|323696651|FG004|Overall Study|Adverse Event|0|||
94518294|NCT01819272|323696652|FG005|Overall Study|Adverse Event|0|||
94518295|NCT01819272|323696647|FG000|Overall Study|Lost to Follow-up|3|||
94518296|NCT01819272|323696648|FG001|Overall Study|Lost to Follow-up|0|||
94518297|NCT01819272|323696649|FG002|Overall Study|Lost to Follow-up|1|||
94518298|NCT01819272|323696650|FG003|Overall Study|Lost to Follow-up|0|||
94518299|NCT01819272|323696651|FG004|Overall Study|Lost to Follow-up|0|||
94518300|NCT01819272|323696652|FG005|Overall Study|Lost to Follow-up|3|||
94518301|NCT01819272|323696647|FG000|Overall Study|Protocol Violation|0|||
94518302|NCT01819272|323696648|FG001|Overall Study|Protocol Violation|0|||
94518303|NCT01819272|323696649|FG002|Overall Study|Protocol Violation|0|||
94518304|NCT01819272|323696650|FG003|Overall Study|Protocol Violation|1|||
94518305|NCT01819272|323696651|FG004|Overall Study|Protocol Violation|2|||
94518306|NCT01819272|323696652|FG005|Overall Study|Protocol Violation|3|||
94518307|NCT01819272|323696647|FG000|Overall Study|Physician Decision|0|||
94518308|NCT01819272|323696648|FG001|Overall Study|Physician Decision|1|||
94518309|NCT01819272|323696649|FG002|Overall Study|Physician Decision|0|||
94518310|NCT01819272|323696650|FG003|Overall Study|Physician Decision|0|||
94518311|NCT01819272|323696651|FG004|Overall Study|Physician Decision|0|||
94518312|NCT01819272|323696652|FG005|Overall Study|Physician Decision|0|||
94518313|NCT01819272|323696647|FG000|Overall Study|Withdrawal of Consent|0|||
94518314|NCT01819272|323696648|FG001|Overall Study|Withdrawal of Consent|1|||
94518315|NCT01819272|323696649|FG002|Overall Study|Withdrawal of Consent|2|||
94518316|NCT01819272|323696650|FG003|Overall Study|Withdrawal of Consent|1|||
94518317|NCT01819272|323696651|FG004|Overall Study|Withdrawal of Consent|0|||
94518318|NCT01819272|323696652|FG005|Overall Study|Withdrawal of Consent|1|||
94518319|NCT01819272|323696647|FG000|Overall Study|Loss of Glucose Control|2|||
94518320|NCT01819272|323696648|FG001|Overall Study|Loss of Glucose Control|1|||
94518321|NCT01819272|323696649|FG002|Overall Study|Loss of Glucose Control|0|||
94518322|NCT01819272|323696650|FG003|Overall Study|Loss of Glucose Control|1|||
94518323|NCT01819272|323696651|FG004|Overall Study|Loss of Glucose Control|2|||
94518324|NCT01819272|323696652|FG005|Overall Study|Loss of Glucose Control|0|||
94518325|NCT00503984|323696655|FG000|Overall Study|Protocol Violation|0|||
94518326|NCT00503984|323696656|FG001|Overall Study|Protocol Violation|1|||
94518327|NCT00503984|323696657|FG002|Overall Study|Protocol Violation|0|||
94518328|NCT00503984|323696658|FG003|Overall Study|Protocol Violation|0|||
94518329|NCT00503984|323696659|FG004|Overall Study|Protocol Violation|0|||
94518330|NCT00503984|323696660|FG005|Overall Study|Protocol Violation|0|||
94518331|NCT00503984|323696655|FG000|Overall Study|Adverse Event|0|||
94518332|NCT00503984|323696656|FG001|Overall Study|Adverse Event|1|||
94518333|NCT00503984|323696657|FG002|Overall Study|Adverse Event|0|||
94518334|NCT00503984|323696658|FG003|Overall Study|Adverse Event|0|||
94518335|NCT00503984|323696659|FG004|Overall Study|Adverse Event|0|||
94518336|NCT00503984|323696660|FG005|Overall Study|Adverse Event|0|||
94518337|NCT00503984|323696655|FG000|Overall Study|Death|0|||
94518338|NCT00503984|323696656|FG001|Overall Study|Death|0|||
94518339|NCT00503984|323696657|FG002|Overall Study|Death|0|||
94518340|NCT00503984|323696658|FG003|Overall Study|Death|0|||
94518341|NCT00503984|323696659|FG004|Overall Study|Death|1|||
94518342|NCT00503984|323696660|FG005|Overall Study|Death|0|||
94518343|NCT00805389|323696661|FG000|Overall Study|Adverse Event|0|||
94518344|NCT00805389|323696662|FG001|Overall Study|Adverse Event|0|||
94518345|NCT00805389|323696663|FG002|Overall Study|Adverse Event|1|||
94518346|NCT00805389|323696664|FG003|Overall Study|Adverse Event|2|||
94518347|NCT00805389|323696665|FG004|Overall Study|Adverse Event|0|||
94518348|NCT00805389|323696661|FG000|Overall Study|Lost to Follow-up|4|||
94518349|NCT00805389|323696662|FG001|Overall Study|Lost to Follow-up|3|||
94518350|NCT00805389|323696663|FG002|Overall Study|Lost to Follow-up|6|||
94518351|NCT00805389|323696664|FG003|Overall Study|Lost to Follow-up|10|||
94518352|NCT00805389|323696665|FG004|Overall Study|Lost to Follow-up|9|||
94518353|NCT00805389|323696661|FG000|Overall Study|Protocol Violation|0|||
94518354|NCT00805389|323696662|FG001|Overall Study|Protocol Violation|0|||
94518355|NCT00805389|323696663|FG002|Overall Study|Protocol Violation|1|||
94518356|NCT00805389|323696664|FG003|Overall Study|Protocol Violation|0|||
94518357|NCT00805389|323696665|FG004|Overall Study|Protocol Violation|0|||
94518358|NCT00805389|323696661|FG000|Overall Study|Withdrawal by Subject|3|||
94518359|NCT00805389|323696662|FG001|Overall Study|Withdrawal by Subject|2|||
94518360|NCT00805389|323696663|FG002|Overall Study|Withdrawal by Subject|4|||
94518361|NCT00805389|323696664|FG003|Overall Study|Withdrawal by Subject|5|||
94518362|NCT00805389|323696665|FG004|Overall Study|Withdrawal by Subject|4|||
94518363|NCT00272792|323696666|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
94518364|NCT00272792|323696667|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
94518365|NCT00272792|323696666|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
94518366|NCT00272792|323696667|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
94518367|NCT00272792|323696666|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
94518368|NCT00272792|323696667|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
94518369|NCT00272792|323696666|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
94518370|NCT00272792|323696667|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
94518371|NCT01359956|323696668|FG000|Overall Study|Death|58|||
94518372|NCT01359956|323696669|FG001|Overall Study|Death|60|||
94518373|NCT01359956|323696670|FG002|Overall Study|Death|66|||
94518374|NCT01359956|323696671|FG003|Overall Study|Death|57|||
94518375|NCT01359956|323696668|FG000|Overall Study|Lost to Follow-up|3|||
94518376|NCT01359956|323696669|FG001|Overall Study|Lost to Follow-up|4|||
94518377|NCT01359956|323696670|FG002|Overall Study|Lost to Follow-up|1|||
94518378|NCT01359956|323696671|FG003|Overall Study|Lost to Follow-up|1|||
94518379|NCT02829996|323696672|FG000|Overall Study|Withdrawal by Subject|1|||
94518380|NCT02829996|323696673|FG001|Overall Study|Withdrawal by Subject|0|||
94518381|NCT02829996|323696674|FG002|Overall Study|Withdrawal by Subject|0|||
94518382|NCT02829996|323696675|FG003|Overall Study|Withdrawal by Subject|0|||
94518383|NCT02829996|323696676|FG004|Overall Study|Withdrawal by Subject|0|||
94518384|NCT01441960|323696678|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
94518385|NCT01441960|323696679|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
94518386|NCT01441960|323696678|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
94518387|NCT01441960|323696679|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
94518388|NCT01441960|323696678|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
94518389|NCT01441960|323696679|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
94518390|NCT00639457|323696680|FG000|Overall Study|Withdrawal by Subject|2|||
94518391|NCT00639457|323696681|FG001|Overall Study|Withdrawal by Subject|3|||
94518392|NCT03235050|323696682|FG000|Overall Study|Adverse Event|0|||
94518393|NCT03235050|323696683|FG001|Overall Study|Adverse Event|0|||
94518394|NCT03235050|323696684|FG002|Overall Study|Adverse Event|1|||
94518395|NCT03235050|323696685|FG003|Overall Study|Adverse Event|4|||
94518396|NCT03235050|323696686|FG004|Overall Study|Adverse Event|1|||
94518397|NCT03235050|323696682|FG000|Overall Study|Death|0|||
94518398|NCT03235050|323696683|FG001|Overall Study|Death|0|||
94518399|NCT03235050|323696684|FG002|Overall Study|Death|0|||
94518400|NCT03235050|323696685|FG003|Overall Study|Death|2|||
94518401|NCT03235050|323696686|FG004|Overall Study|Death|1|||
94518402|NCT03235050|323696682|FG000|Overall Study|Lost to Follow-up|1|||
94518403|NCT03235050|323696683|FG001|Overall Study|Lost to Follow-up|2|||
94518404|NCT03235050|323696684|FG002|Overall Study|Lost to Follow-up|1|||
94518405|NCT03235050|323696685|FG003|Overall Study|Lost to Follow-up|2|||
94518406|NCT03235050|323696686|FG004|Overall Study|Lost to Follow-up|0|||
94518407|NCT03235050|323696682|FG000|Overall Study|Withdrawal by Subject|3|||
94518408|NCT03235050|323696683|FG001|Overall Study|Withdrawal by Subject|2|||
94518409|NCT03235050|323696684|FG002|Overall Study|Withdrawal by Subject|2|||
94518410|NCT03235050|323696685|FG003|Overall Study|Withdrawal by Subject|5|||
94518411|NCT03235050|323696686|FG004|Overall Study|Withdrawal by Subject|7|||
94518412|NCT03235050|323696682|FG000|Overall Study|Other reasons|0|||
94518413|NCT03235050|323696683|FG001|Overall Study|Other reasons|1|||
94518414|NCT03235050|323696684|FG002|Overall Study|Other reasons|0|||
94518415|NCT03235050|323696685|FG003|Overall Study|Other reasons|1|||
94518416|NCT03235050|323696686|FG004|Overall Study|Other reasons|2|||
94518417|NCT00370292|323696687|FG000|Overall Study|Disease Progression|4|||
94518418|NCT00370292|323696687|FG000|Overall Study|Adverse Event|7|||
94518419|NCT00370292|323696687|FG000|Overall Study|Physician Decision|2|||
94518420|NCT02986074|323696688|FG000|First Trial Period|Adverse Event|1|||
94518421|NCT02986074|323696689|FG001|First Trial Period|Adverse Event|0|||
94518422|NCT02986074|323696690|FG002|First Trial Period|Adverse Event|0|||
94518423|NCT02986074|323696691|FG003|First Trial Period|Adverse Event|0|||
94518424|NCT02986074|323696688|FG000|Follow up Period|system explant|0|||
94518425|NCT02986074|323696689|FG001|Follow up Period|system explant|0|||
94518426|NCT02986074|323696690|FG002|Follow up Period|system explant|1|||
94518427|NCT02986074|323696691|FG003|Follow up Period|system explant|2|||
94518428|NCT02986074|323696688|FG000|Follow up Period|Physician Decision|0|||
94518429|NCT02986074|323696689|FG001|Follow up Period|Physician Decision|0|||
94518430|NCT02986074|323696690|FG002|Follow up Period|Physician Decision|0|||
94518431|NCT02986074|323696691|FG003|Follow up Period|Physician Decision|1|||
94518432|NCT01497197|323696695|FG000|Overall Study|Lost to Follow-up|1|||
94518433|NCT01497197|323696696|FG001|Overall Study|Lost to Follow-up|0|||
94518434|NCT01497197|323696695|FG000|Overall Study|Protocol Violation|0|||
94518435|NCT01497197|323696696|FG001|Overall Study|Protocol Violation|2|||
94518436|NCT01497197|323696695|FG000|Overall Study|Withdrawal by Subject|2|||
94518437|NCT01497197|323696696|FG001|Overall Study|Withdrawal by Subject|1|||
94518438|NCT01497197|323696695|FG000|Overall Study|Excessive/lack of response to treatment|1|||
94518439|NCT01497197|323696696|FG001|Overall Study|Excessive/lack of response to treatment|0|||
94518440|NCT01497197|323696695|FG000|Overall Study|Risk of OHSS|1|||
94518441|NCT01497197|323696696|FG001|Overall Study|Risk of OHSS|0|||
94518442|NCT01497197|323696695|FG000|Overall Study|No oocytes retrieved|3|||
94518443|NCT01497197|323696696|FG001|Overall Study|No oocytes retrieved|2|||
94518444|NCT01497197|323696695|FG000|Overall Study|No fertilisation|6|||
94518445|NCT01497197|323696696|FG001|Overall Study|No fertilisation|5|||
94518446|NCT01497197|323696695|FG000|Overall Study|Intention to freeze all embryos|0|||
94518447|NCT01497197|323696696|FG001|Overall Study|Intention to freeze all embryos|1|||
94518448|NCT01497197|323696695|FG000|Overall Study|All embryos discarded|0|||
94518449|NCT01497197|323696696|FG001|Overall Study|All embryos discarded|3|||
94518450|NCT01497197|323696695|FG000|Overall Study|Other|3|||
94518451|NCT01497197|323696696|FG001|Overall Study|Other|1|||
94518452|NCT00276419|323696697|FG000|First Intervention|Adverse Event|1|||
94518453|NCT00276419|323696698|FG001|First Intervention|Adverse Event|0|||
94518454|NCT00276419|323696697|FG000|First Intervention|Withdrawal by Subject|0|||
94518455|NCT00276419|323696698|FG001|First Intervention|Withdrawal by Subject|2|||
94518456|NCT00069641|323696699|FG000|Overall Study|Death|1|||
94518457|NCT00069641|323696700|FG001|Overall Study|Death|0|||
94518458|NCT00069641|323696701|FG002|Overall Study|Death|1|||
94518459|NCT00688597|323696702|FG000|Overall Study|Adverse Event|2|||
94518460|NCT00688597|323696703|FG001|Overall Study|Adverse Event|0|||
94518461|NCT00688597|323696704|FG002|Overall Study|Adverse Event|0|||
94518462|NCT00688597|323696702|FG000|Overall Study|Physician Decision|1|||
94518463|NCT00688597|323696703|FG001|Overall Study|Physician Decision|0|||
94518464|NCT00688597|323696704|FG002|Overall Study|Physician Decision|0|||
94518465|NCT02921789|323696705|FG000|Overall Study|Adverse Event|0|||
94518466|NCT02921789|323696706|FG001|Overall Study|Adverse Event|1|||
94518467|NCT02921789|323696705|FG000|Overall Study|Lost to Follow-up|1|||
94518468|NCT02921789|323696706|FG001|Overall Study|Lost to Follow-up|0|||
94518469|NCT02921789|323696705|FG000|Overall Study|Protocol Deviation|2|||
94518470|NCT02921789|323696706|FG001|Overall Study|Protocol Deviation|0|||
94518471|NCT02921789|323696705|FG000|Overall Study|Withdrawal by Subject|2|||
94518472|NCT02921789|323696706|FG001|Overall Study|Withdrawal by Subject|1|||
94518473|NCT02921789|323696705|FG000|Overall Study|Miscellaneous|3|||
94518474|NCT02921789|323696706|FG001|Overall Study|Miscellaneous|2|||
94518475|NCT01334554|323696707|FG000|Overall Study|Adverse Event|4|||
94518476|NCT01334554|323696708|FG001|Overall Study|Adverse Event|2|||
94518477|NCT00954447|323696709|FG000|Overall Study|Adverse Event|33|||
94518478|NCT00954447|323696710|FG001|Overall Study|Adverse Event|25|||
94518479|NCT00954447|323696709|FG000|Overall Study|Lack of Efficacy|17|||
94518480|NCT00954447|323696710|FG001|Overall Study|Lack of Efficacy|3|||
94518481|NCT00954447|323696709|FG000|Overall Study|Protocol Violation|5|||
94518482|NCT00954447|323696710|FG001|Overall Study|Protocol Violation|7|||
94518483|NCT00954447|323696709|FG000|Overall Study|Lost to Follow-up|8|||
94518484|NCT00954447|323696710|FG001|Overall Study|Lost to Follow-up|14|||
94518485|NCT00954447|323696709|FG000|Overall Study|Withdrawal by Subject|26|||
94518486|NCT00954447|323696710|FG001|Overall Study|Withdrawal by Subject|21|||
94518487|NCT00954447|323696709|FG000|Overall Study|Other|21|||
94518488|NCT00954447|323696710|FG001|Overall Study|Other|18|||
94518489|NCT00598650|323696711|FG000|Overall Study|Withdrawal by Subject|3|||
94518490|NCT00598650|323696711|FG000|Overall Study|Adverse Event|18|||
94518491|NCT00598650|323696711|FG000|Overall Study|No treatment for 3 weeks|1|||
94518492|NCT00598650|323696711|FG000|Overall Study|Not eligible|1|||
94518493|NCT00598650|323696711|FG000|Overall Study|Prohibited Concomitant Medication|2|||
94518494|NCT00598650|323696711|FG000|Overall Study|Physician Decision|2|||
94518495|NCT03545672|323696712|FG000|Overall Study|Uncertain diagnosis|2|||
94518496|NCT03545672|323696713|FG001|Overall Study|Uncertain diagnosis|1|||
94518497|NCT03545672|323696712|FG000|Overall Study|Protocol Violation|2|||
94518498|NCT03545672|323696713|FG001|Overall Study|Protocol Violation|2|||
94518499|NCT01944020|323696716|FG000|Overall Study|Withdrawal by Subject|5|||
94518500|NCT01944020|323696717|FG001|Overall Study|Withdrawal by Subject|0|||
94518501|NCT00692003|323696725|FG000|Overall Study|Sponsor Decision|5|||
94518502|NCT00692003|323696726|FG001|Overall Study|Sponsor Decision|1|||
94518503|NCT04749745|323696727|FG000|Overall Study|Withdrawal by Subject|1|||
94518504|NCT04749745|323696728|FG001|Overall Study|Withdrawal by Subject|0|||
94518505|NCT00339040|323696729|FG000|Stage I|Not able to attend clinic|1|||
94518506|NCT00339040|323696730|FG001|Stage I|Not able to attend clinic|0|||
94518507|NCT00339040|323696729|FG000|Stage I|Protocol Violation|1|||
94518508|NCT00339040|323696730|FG001|Stage I|Protocol Violation|1|||
94518509|NCT00339040|323696729|FG000|Stage II|Lost to Follow-up|3|||
94518510|NCT00339040|323696730|FG001|Stage II|Lost to Follow-up|0|||
94518511|NCT00339040|323696729|FG000|Stage II|Withdrawal by Subject|1|||
94518512|NCT00339040|323696730|FG001|Stage II|Withdrawal by Subject|2|||
94518513|NCT00339040|323696729|FG000|Stage II|Protocol Violation|3|||
94518514|NCT00339040|323696730|FG001|Stage II|Protocol Violation|0|||
94518515|NCT00339040|323696729|FG000|Stage II|Not able to attend clinic|1|||
94518516|NCT00339040|323696730|FG001|Stage II|Not able to attend clinic|0|||
94518517|NCT00339040|323696729|FG000|Stage II|Site closing|2|||
94518518|NCT00339040|323696730|FG001|Stage II|Site closing|0|||
94518519|NCT01146613|323696737|FG000|Overall Study|Lost to Follow-up|3|||
94518520|NCT01146613|323696738|FG001|Overall Study|Lost to Follow-up|8|||
94518521|NCT01146613|323696737|FG000|Overall Study|Lack of Efficacy|0|||
94518522|NCT01146613|323696738|FG001|Overall Study|Lack of Efficacy|1|||
94518523|NCT01146613|323696737|FG000|Overall Study|Death|1|||
94518524|NCT01146613|323696738|FG001|Overall Study|Death|0|||
94518525|NCT01146613|323696737|FG000|Overall Study|Physician Decision|1|||
94518526|NCT01146613|323696738|FG001|Overall Study|Physician Decision|0|||
94518527|NCT01146613|323696737|FG000|Overall Study|Withdrawal by Subject|0|||
94518528|NCT01146613|323696738|FG001|Overall Study|Withdrawal by Subject|3|||
94518529|NCT01146613|323696737|FG000|Overall Study|schedule conflict|1|||
94518530|NCT01146613|323696738|FG001|Overall Study|schedule conflict|0|||
94518531|NCT01146613|323696737|FG000|Overall Study|Outpatient detox|1|||
94518532|NCT01146613|323696738|FG001|Overall Study|Outpatient detox|0|||
94518533|NCT01493089|323696739|FG000|Overall Study|Protocol Violation|2|||
94518534|NCT01493089|323696740|FG001|Overall Study|Protocol Violation|2|||
94518535|NCT01493089|323696739|FG000|Overall Study|Withdrawal by Subject|1|||
94518536|NCT01493089|323696740|FG001|Overall Study|Withdrawal by Subject|0|||
94518537|NCT01493089|323696739|FG000|Overall Study|Physician Decision|0|||
94518538|NCT01493089|323696740|FG001|Overall Study|Physician Decision|1|||
94518539|NCT01870869|323696741|FG000|Overall Study|Implanted with nonstudy device|1|||
94518540|NCT01870869|323696742|FG001|Overall Study|Implanted with nonstudy device|3|||
94518541|NCT01870869|323696743|FG002|Overall Study|Implanted with nonstudy device|14|||
94518542|NCT01870869|323696744|FG003|Overall Study|Implanted with nonstudy device|4|||
94518543|NCT01870869|323696741|FG000|Overall Study|Death|0|||
94518544|NCT01870869|323696742|FG001|Overall Study|Death|0|||
94518545|NCT01870869|323696743|FG002|Overall Study|Death|7|||
94518546|NCT01870869|323696744|FG003|Overall Study|Death|1|||
94518547|NCT01870869|323696741|FG000|Overall Study|Subject choice|6|||
94518548|NCT01870869|323696742|FG001|Overall Study|Subject choice|2|||
94518549|NCT01870869|323696743|FG002|Overall Study|Subject choice|22|||
94518550|NCT01870869|323696744|FG003|Overall Study|Subject choice|8|||
94518551|NCT01870869|323696741|FG000|Overall Study|Lost to Follow-up|10|||
94518552|NCT01870869|323696742|FG001|Overall Study|Lost to Follow-up|2|||
94518553|NCT01870869|323696743|FG002|Overall Study|Lost to Follow-up|25|||
94518554|NCT01870869|323696744|FG003|Overall Study|Lost to Follow-up|3|||
94518555|NCT01870869|323696741|FG000|Overall Study|Reason not Specified|1|||
94518556|NCT01870869|323696742|FG001|Overall Study|Reason not Specified|2|||
94518557|NCT01870869|323696743|FG002|Overall Study|Reason not Specified|20|||
94518558|NCT01870869|323696744|FG003|Overall Study|Reason not Specified|4|||
94518559|NCT01870869|323696741|FG000|Overall Study|Not evaluable|10|||
94518560|NCT01870869|323696742|FG001|Overall Study|Not evaluable|5|||
94518561|NCT01870869|323696743|FG002|Overall Study|Not evaluable|42|||
94518562|NCT01870869|323696744|FG003|Overall Study|Not evaluable|10|||
94518563|NCT02286895|323696745|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
94518564|NCT02286895|323696746|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
94518565|NCT02286895|323696745|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
94518566|NCT02286895|323696746|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
94518567|NCT02286895|323696745|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
94518568|NCT02286895|323696746|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
94518569|NCT00305448|323696749|FG000|Overall Study|Protocol Violation|0|||
94518570|NCT00305448|323696750|FG001|Overall Study|Protocol Violation|1|||
94518571|NCT00305448|323696751|FG002|Overall Study|Protocol Violation|0|||
94518572|NCT00305448|323696749|FG000|Overall Study|Withdrawal by Subject|2|||
94518573|NCT00305448|323696750|FG001|Overall Study|Withdrawal by Subject|0|||
94518574|NCT00305448|323696751|FG002|Overall Study|Withdrawal by Subject|1|||
94518575|NCT00305448|323696749|FG000|Overall Study|Adverse Event|1|||
94518576|NCT00305448|323696750|FG001|Overall Study|Adverse Event|0|||
94518577|NCT00305448|323696751|FG002|Overall Study|Adverse Event|1|||
94518578|NCT00305448|323696749|FG000|Overall Study|Disease Progression|27|||
94518579|NCT00305448|323696750|FG001|Overall Study|Disease Progression|31|||
94518580|NCT00305448|323696751|FG002|Overall Study|Disease Progression|28|||
94518581|NCT00305448|323696749|FG000|Overall Study|Subjective Disease Progression|1|||
94518582|NCT00305448|323696750|FG001|Overall Study|Subjective Disease Progression|2|||
94518583|NCT00305448|323696751|FG002|Overall Study|Subjective Disease Progression|2|||
94518584|NCT00305448|323696749|FG000|Overall Study|Tumor Marker Elevation|0|||
94518585|NCT00305448|323696750|FG001|Overall Study|Tumor Marker Elevation|0|||
94518586|NCT00305448|323696751|FG002|Overall Study|Tumor Marker Elevation|1|||
94518587|NCT00077974|323696752|FG000|Overall Study|Adverse Event|22|||
94518588|NCT00077974|323696752|FG000|Overall Study|Protocol Violation|1|||
94518589|NCT00077974|323696752|FG000|Overall Study|Withdrawal by Subject|3|||
94518590|NCT00077974|323696752|FG000|Overall Study|Lack of Efficacy|76|||
94518591|NCT00077974|323696752|FG000|Overall Study|Decision of Sponsor|2|||
94518592|NCT00256126|323696753|FG000|Overall Study|Adverse Event|1|||
94518593|NCT00256126|323696754|FG001|Overall Study|Adverse Event|0|||
94518594|NCT00256126|323696753|FG000|Overall Study|Other|1|||
94518595|NCT00256126|323696754|FG001|Overall Study|Other|2|||
94518596|NCT01788943|323696761|FG000|Overall Study|Withdrawal by Subject|1|||
94518597|NCT01788943|323696762|FG001|Overall Study|Withdrawal by Subject|0|||
94518598|NCT01331681|323696765|FG000|Overall Study|Adverse Event|10|||
94518599|NCT01331681|323696766|FG001|Overall Study|Adverse Event|13|||
94518600|NCT01331681|323696767|FG002|Overall Study|Adverse Event|10|||
94518601|NCT01331681|323696765|FG000|Overall Study|Death|6|||
94518602|NCT01331681|323696766|FG001|Overall Study|Death|6|||
94518603|NCT01331681|323696767|FG002|Overall Study|Death|2|||
94518604|NCT01331681|323696765|FG000|Overall Study|Lack of Efficacy|0|||
94518605|NCT01331681|323696766|FG001|Overall Study|Lack of Efficacy|1|||
94518606|NCT01331681|323696767|FG002|Overall Study|Lack of Efficacy|0|||
94518607|NCT01331681|323696765|FG000|Overall Study|Withdrawal by Subject|12|||
94518608|NCT01331681|323696766|FG001|Overall Study|Withdrawal by Subject|8|||
94518609|NCT01331681|323696767|FG002|Overall Study|Withdrawal by Subject|15|||
94518610|NCT01331681|323696765|FG000|Overall Study|Protocol Violation|1|||
94518611|NCT01331681|323696766|FG001|Overall Study|Protocol Violation|1|||
94518612|NCT01331681|323696767|FG002|Overall Study|Protocol Violation|0|||
94518613|NCT01331681|323696765|FG000|Overall Study|Lost to Follow-up|2|||
94518614|NCT01331681|323696766|FG001|Overall Study|Lost to Follow-up|4|||
94518615|NCT01331681|323696767|FG002|Overall Study|Lost to Follow-up|1|||
94518616|NCT01331681|323696765|FG000|Overall Study|Physician Decision|2|||
94518617|NCT01331681|323696766|FG001|Overall Study|Physician Decision|0|||
94518618|NCT01331681|323696767|FG002|Overall Study|Physician Decision|4|||
94518619|NCT01331681|323696765|FG000|Overall Study|Therapeutic procedure required|1|||
94518620|NCT01331681|323696766|FG001|Overall Study|Therapeutic procedure required|0|||
94518621|NCT01331681|323696767|FG002|Overall Study|Therapeutic procedure required|0|||
94518622|NCT01331681|323696765|FG000|Overall Study|Sponsor decision|1|||
94518623|NCT01331681|323696766|FG001|Overall Study|Sponsor decision|1|||
94518624|NCT01331681|323696767|FG002|Overall Study|Sponsor decision|0|||
94518625|NCT01331681|323696765|FG000|Overall Study|Switching to other therapy|0|||
94518626|NCT01331681|323696766|FG001|Overall Study|Switching to other therapy|0|||
94518627|NCT01331681|323696767|FG002|Overall Study|Switching to other therapy|1|||
94518628|NCT01331681|323696765|FG000|Overall Study|Not Received Study Treatment|0|||
94518629|NCT01331681|323696766|FG001|Overall Study|Not Received Study Treatment|0|||
94518630|NCT01331681|323696767|FG002|Overall Study|Not Received Study Treatment|2|||
94518631|NCT03886493|323696768|FG000|Overall Study|Adverse Event|1|||
94518632|NCT00696878|323696773|FG000|Overall Study|Adverse Event|8|||
94518633|NCT00696878|323696773|FG000|Overall Study|Withdrawal by Subject|87|||
94518634|NCT00696878|323696773|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
94518635|NCT00696878|323696773|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
94518636|NCT00696878|323696773|FG000|Overall Study|Trial stopped|32|||
94518637|NCT00696878|323696773|FG000|Overall Study|Other reason (not specified)|55|||
94518638|NCT02712788|323696776|FG000|Overall Study|Physician Decision|1|||
94518639|NCT02712788|323696777|FG001|Overall Study|Physician Decision|0|||
94518640|NCT02712788|323696776|FG000|Overall Study|Protocol Violation|1|||
94518641|NCT02712788|323696777|FG001|Overall Study|Protocol Violation|0|||
94518642|NCT03789292|323696778|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
94518643|NCT03789292|323696779|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
94518644|NCT03789292|323696780|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
94518645|NCT03789292|323696778|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
94518646|NCT03789292|323696779|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
94518647|NCT03789292|323696780|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
94518648|NCT03789292|323696778|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
94518649|NCT03789292|323696779|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
94518650|NCT03789292|323696780|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
94518651|NCT03789292|323696778|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
94518652|NCT03789292|323696779|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
94518653|NCT03789292|323696780|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
94518654|NCT03789292|323696778|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
94518655|NCT03789292|323696779|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
94518656|NCT03789292|323696780|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
94518657|NCT03789292|323696778|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
94518658|NCT03789292|323696779|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
94518659|NCT03789292|323696780|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
94518660|NCT03789292|323696778|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
94518661|NCT03789292|323696779|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
94518662|NCT03789292|323696780|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
94518663|NCT03789292|323696778|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
94518664|NCT03789292|323696779|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
94518665|NCT03789292|323696780|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
94518666|NCT03789292|323696778|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
94518667|NCT03789292|323696779|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
94518668|NCT03789292|323696780|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
94518669|NCT03789292|323696778|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
94518670|NCT03789292|323696779|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
94518671|NCT03789292|323696780|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
94518672|NCT03789292|323696778|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
94518673|NCT03789292|323696779|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
94518674|NCT03789292|323696780|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
94518675|NCT03789292|323696778|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
94518676|NCT03789292|323696779|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
94518677|NCT03789292|323696780|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
94518678|NCT03789292|323696778|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
94518679|NCT03789292|323696779|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
94518680|NCT03789292|323696780|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
94518681|NCT00967616|323696781|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
94518682|NCT00967616|323696782|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
94518683|NCT00967616|323696781|FG000|Overall Study|Death|0|||
94518684|NCT00967616|323696782|FG001|Overall Study|Death|3|||
94518685|NCT00967616|323696781|FG000|Overall Study|Withdrawal by Subject|8|||
94518686|NCT00967616|323696782|FG001|Overall Study|Withdrawal by Subject|4|||
94518687|NCT00967616|323696781|FG000|Overall Study|Progressive Disease|31|||
94518688|NCT00967616|323696782|FG001|Overall Study|Progressive Disease|18|||
94518689|NCT00967616|323696781|FG000|Overall Study|Other|8|||
94518690|NCT00967616|323696782|FG001|Overall Study|Other|8|||
94518691|NCT00967616|323696781|FG000|Overall Study|Protocol Violation|1|||
94518692|NCT00967616|323696782|FG001|Overall Study|Protocol Violation|0|||
94518693|NCT02343302|323696783|FG000|Overall Study|Physician Decision|1|||
94518694|NCT02343302|323696784|FG001|Overall Study|Physician Decision|1|||
94518695|NCT00575666|323696785|FG000|Overall Study|Withdrawal by Subject|3|||
94518696|NCT00575666|323696786|FG001|Overall Study|Withdrawal by Subject|2|||
94518697|NCT00575666|323696785|FG000|Overall Study|Physician Decision|1|||
94518698|NCT00575666|323696786|FG001|Overall Study|Physician Decision|1|||
94518699|NCT00508482|323696787|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
94518700|NCT00508482|323696788|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
94518701|NCT00508482|323696789|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
94518702|NCT00508482|323696787|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
94518703|NCT00508482|323696788|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
94518704|NCT00508482|323696789|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
94518705|NCT00508482|323696787|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
94518706|NCT00508482|323696788|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
94518707|NCT00508482|323696789|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
94518708|NCT01904721|323696792|FG000|Overall Study|Other Reasons|0|||
94518709|NCT01904721|323696793|FG001|Overall Study|Other Reasons|0|||
94518710|NCT01904721|323696794|FG002|Overall Study|Other Reasons|1|||
94518711|NCT01904721|323696795|FG003|Overall Study|Other Reasons|1|||
94518712|NCT01904721|323696796|FG004|Overall Study|Other Reasons|2|||
94518713|NCT01904721|323696797|FG005|Overall Study|Other Reasons|2|||
94518714|NCT01904721|323696798|FG006|Overall Study|Other Reasons|2|||
94518715|NCT01904721|323696792|FG000|Overall Study|Personal Reasons|0|||
94518716|NCT01904721|323696793|FG001|Overall Study|Personal Reasons|0|||
94518717|NCT01904721|323696794|FG002|Overall Study|Personal Reasons|0|||
94518718|NCT01904721|323696795|FG003|Overall Study|Personal Reasons|0|||
94518719|NCT01904721|323696796|FG004|Overall Study|Personal Reasons|2|||
94518720|NCT01904721|323696797|FG005|Overall Study|Personal Reasons|3|||
94518721|NCT01904721|323696798|FG006|Overall Study|Personal Reasons|3|||
94518722|NCT01904721|323696792|FG000|Overall Study|Lost to Follow-up|0|||
94518723|NCT01904721|323696793|FG001|Overall Study|Lost to Follow-up|0|||
94518724|NCT01904721|323696794|FG002|Overall Study|Lost to Follow-up|0|||
94518725|NCT01904721|323696795|FG003|Overall Study|Lost to Follow-up|0|||
94518726|NCT01904721|323696796|FG004|Overall Study|Lost to Follow-up|1|||
94518727|NCT01904721|323696797|FG005|Overall Study|Lost to Follow-up|3|||
94518728|NCT01904721|323696798|FG006|Overall Study|Lost to Follow-up|1|||
94518729|NCT01904721|323696792|FG000|Overall Study|Lack of Efficacy|0|||
94518730|NCT01904721|323696793|FG001|Overall Study|Lack of Efficacy|0|||
94518731|NCT01904721|323696794|FG002|Overall Study|Lack of Efficacy|0|||
94518732|NCT01904721|323696795|FG003|Overall Study|Lack of Efficacy|0|||
94518733|NCT01904721|323696796|FG004|Overall Study|Lack of Efficacy|0|||
94518734|NCT01904721|323696797|FG005|Overall Study|Lack of Efficacy|0|||
94518735|NCT01904721|323696798|FG006|Overall Study|Lack of Efficacy|1|||
94518736|NCT01904721|323696792|FG000|Overall Study|Adverse Event|0|||
94518737|NCT01904721|323696793|FG001|Overall Study|Adverse Event|0|||
94518738|NCT01904721|323696794|FG002|Overall Study|Adverse Event|0|||
94518739|NCT01904721|323696795|FG003|Overall Study|Adverse Event|0|||
94518740|NCT01904721|323696796|FG004|Overall Study|Adverse Event|3|||
94518741|NCT01904721|323696797|FG005|Overall Study|Adverse Event|1|||
94518742|NCT01904721|323696798|FG006|Overall Study|Adverse Event|0|||
94518743|NCT01957865|323696799|FG000|Overall Study|Found HIV negative|0|||
94518744|NCT01957865|323696800|FG001|Overall Study|Found HIV negative|0|||
94518745|NCT01957865|323696801|FG002|Overall Study|Found HIV negative|1|||
94518746|NCT01957865|323696799|FG000|Overall Study|Lost to Follow-up|0|||
94518747|NCT01957865|323696800|FG001|Overall Study|Lost to Follow-up|2|||
94518748|NCT01957865|323696801|FG002|Overall Study|Lost to Follow-up|2|||
94518749|NCT01082614|323696802|FG000|Overall Study|Adverse Event|1|||
94518750|NCT01082614|323696803|FG001|Overall Study|Adverse Event|4|||
94518751|NCT01082614|323696802|FG000|Overall Study|Equipment Malfunction|0|||
94518752|NCT01082614|323696803|FG001|Overall Study|Equipment Malfunction|1|||
94518753|NCT01082614|323696802|FG000|Overall Study|Physician Decision|2|||
94518754|NCT01082614|323696803|FG001|Overall Study|Physician Decision|0|||
94518755|NCT01077063|323696804|FG000|Overall Study|Adverse Event|3|||
94518756|NCT01077063|323696805|FG001|Overall Study|Adverse Event|0|||
94518757|NCT01077063|323696804|FG000|Overall Study|Death|1|||
94518758|NCT01077063|323696805|FG001|Overall Study|Death|1|||
94518759|NCT01077063|323696804|FG000|Overall Study|Withdrawal by Subject|0|||
94518760|NCT01077063|323696805|FG001|Overall Study|Withdrawal by Subject|2|||
94518761|NCT00553631|323696809|FG000|Overall Study|Withdrawal by Subject|0|||
94518762|NCT00553631|323696810|FG001|Overall Study|Withdrawal by Subject|1|||
94518763|NCT00553631|323696809|FG000|Overall Study|Lost to Follow-up|1|||
94518764|NCT00553631|323696810|FG001|Overall Study|Lost to Follow-up|0|||
94518765|NCT02765399|323696815|FG000|Overall Study|Nausea|1|||
94518766|NCT02765399|323696816|FG001|Overall Study|Nausea|0|||
94518767|NCT00363311|323696817|FG000|Overall Study|Adverse Event|6|||
94518768|NCT00363311|323696818|FG001|Overall Study|Adverse Event|4|||
94518769|NCT00363311|323696817|FG000|Overall Study|Lost to Follow-up|3|||
94518770|NCT00363311|323696818|FG001|Overall Study|Lost to Follow-up|0|||
94518771|NCT00363311|323696817|FG000|Overall Study|Protocol Violation|1|||
94518772|NCT00363311|323696818|FG001|Overall Study|Protocol Violation|2|||
94518773|NCT00363311|323696817|FG000|Overall Study|Withdrawal by Subject|12|||
94518774|NCT00363311|323696818|FG001|Overall Study|Withdrawal by Subject|6|||
94518775|NCT00363311|323696817|FG000|Overall Study|Physician Decision|1|||
94518776|NCT00363311|323696818|FG001|Overall Study|Physician Decision|1|||
94518777|NCT00363311|323696817|FG000|Overall Study|Sponsor Terminated Study|2|||
94518778|NCT00363311|323696818|FG001|Overall Study|Sponsor Terminated Study|2|||
94518779|NCT00363311|323696817|FG000|Overall Study|Disease Progression|46|||
94518780|NCT00363311|323696818|FG001|Overall Study|Disease Progression|26|||
94518781|NCT00363311|323696817|FG000|Overall Study|Non-Compliance|1|||
94518782|NCT00363311|323696818|FG001|Overall Study|Non-Compliance|1|||
94518783|NCT00363311|323696817|FG000|Overall Study|Participant Refused Biopsy|1|||
94518784|NCT00363311|323696818|FG001|Overall Study|Participant Refused Biopsy|0|||
94518785|NCT00363311|323696817|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
94518786|NCT00363311|323696818|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
94518787|NCT00363311|323696817|FG000|Overall Study|Participant Opted for Treatment|1|||
94518788|NCT00363311|323696818|FG001|Overall Study|Participant Opted for Treatment|0|||
94518789|NCT00363311|323696817|FG000|Overall Study|Participant Moved to Another Country|1|||
94518790|NCT00363311|323696818|FG001|Overall Study|Participant Moved to Another Country|0|||
94518791|NCT00363311|323696817|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
94518792|NCT00363311|323696818|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
94518793|NCT00363311|323696817|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
94518794|NCT00363311|323696818|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
94518795|NCT00363311|323696817|FG000|Overall Study|Participant Moved to Louisiana|0|||
94518796|NCT00363311|323696818|FG001|Overall Study|Participant Moved to Louisiana|1|||
94518797|NCT04068922|323696819|FG000|Overall Study|Lost to Follow-up|5|||
94518798|NCT04068922|323696819|FG000|Overall Study|Withdrawal by Subject|7|||
94518799|NCT04068922|323696819|FG000|Overall Study|Adverse Event|1|||
94518800|NCT01816048|323696823|FG000|Overall Study|Adverse Event|1|||
94518801|NCT01816048|323696823|FG000|Overall Study|Death|1|||
94518802|NCT01816048|323696823|FG000|Overall Study|Withdrawal by Subject|1|||
94518803|NCT01816048|323696823|FG000|Overall Study|Disease Progression|3|||
94518804|NCT00657267|323696824|FG000|Overall Study|Progressive disease|45|||
94518805|NCT00657267|323696824|FG000|Overall Study|Adverse Event|9|||
94518806|NCT01334918|323698402|FG000|Overall Study|Did not receive study drug|6|||
94518807|NCT01334918|323698403|FG001|Overall Study|Did not receive study drug|0|||
94518808|NCT01334918|323698402|FG000|Overall Study|Adverse Event|2|||
94518809|NCT01334918|323698403|FG001|Overall Study|Adverse Event|0|||
94518810|NCT01334918|323698402|FG000|Overall Study|Withdrawal by Subject|0|||
94518811|NCT01334918|323698403|FG001|Overall Study|Withdrawal by Subject|1|||
94518812|NCT01897493|323698405|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
94518813|NCT01250054|323698406|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
94518814|NCT01250054|323698407|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
94518815|NCT01770743|323698408|FG000|Overall Study|Adverse Event|1|||
94518816|NCT01770743|323698409|FG001|Overall Study|Adverse Event|0|||
94518817|NCT01770743|323698410|FG002|Overall Study|Adverse Event|0|||
94518818|NCT01770743|323698411|FG003|Overall Study|Adverse Event|0|||
94518819|NCT01770743|323698412|FG004|Overall Study|Adverse Event|0|||
94518820|NCT01770743|323698408|FG000|Overall Study|Withdrawal by Subject|0|||
94518821|NCT01770743|323698409|FG001|Overall Study|Withdrawal by Subject|0|||
94518822|NCT01770743|323698410|FG002|Overall Study|Withdrawal by Subject|1|||
94518823|NCT01770743|323698411|FG003|Overall Study|Withdrawal by Subject|1|||
94518824|NCT01770743|323698412|FG004|Overall Study|Withdrawal by Subject|1|||
94518825|NCT01770743|323698408|FG000|Overall Study|Lost to Follow-up|0|||
94518826|NCT01770743|323698409|FG001|Overall Study|Lost to Follow-up|2|||
94518827|NCT01770743|323698410|FG002|Overall Study|Lost to Follow-up|0|||
94518828|NCT01770743|323698411|FG003|Overall Study|Lost to Follow-up|0|||
94518829|NCT01770743|323698412|FG004|Overall Study|Lost to Follow-up|1|||
94518830|NCT01770743|323698408|FG000|Overall Study|Sponsor Terminated Subject|1|||
94518831|NCT01770743|323698409|FG001|Overall Study|Sponsor Terminated Subject|0|||
94518832|NCT01770743|323698410|FG002|Overall Study|Sponsor Terminated Subject|0|||
94518833|NCT01770743|323698411|FG003|Overall Study|Sponsor Terminated Subject|1|||
94518834|NCT01770743|323698412|FG004|Overall Study|Sponsor Terminated Subject|0|||
94518835|NCT01770743|323698408|FG000|Overall Study|Moving Out of State|0|||
94518836|NCT01770743|323698409|FG001|Overall Study|Moving Out of State|1|||
94518837|NCT01770743|323698410|FG002|Overall Study|Moving Out of State|0|||
94518838|NCT01770743|323698411|FG003|Overall Study|Moving Out of State|0|||
94518839|NCT01770743|323698412|FG004|Overall Study|Moving Out of State|0|||
94518840|NCT00755807|323698417|FG000|Acute Phase|Adverse Event|16|||
94518841|NCT00755807|323698418|FG001|Acute Phase|Adverse Event|5|||
94518842|NCT00755807|323698417|FG000|Acute Phase|Protocol Violation|1|||
94518843|NCT00755807|323698418|FG001|Acute Phase|Protocol Violation|3|||
94518844|NCT00755807|323698417|FG000|Acute Phase|Withdrawal by Subject|1|||
94518845|NCT00755807|323698418|FG001|Acute Phase|Withdrawal by Subject|2|||
94518846|NCT00755807|323698417|FG000|Acute Phase|Lack of Efficacy|0|||
94518847|NCT00755807|323698418|FG001|Acute Phase|Lack of Efficacy|1|||
94518848|NCT00755807|323698417|FG000|Acute Phase|Physician Decision|0|||
94518849|NCT00755807|323698418|FG001|Acute Phase|Physician Decision|1|||
94518850|NCT00755807|323698417|FG000|Open-label Extension Phase|Adverse Event|7|||
94518851|NCT00755807|323698418|FG001|Open-label Extension Phase|Adverse Event|7|||
94518852|NCT00755807|323698417|FG000|Open-label Extension Phase|Protocol Violation|5|||
94518853|NCT00755807|323698418|FG001|Open-label Extension Phase|Protocol Violation|2|||
94518854|NCT00755807|323698417|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
94518855|NCT00755807|323698418|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
94518856|NCT00755807|323698417|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
94518857|NCT00755807|323698418|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
94518858|NCT00755807|323698417|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
94518859|NCT00755807|323698418|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
94518860|NCT00755807|323698417|FG000|Open-label Extension Phase|Sponsor Decision|0|||
94518861|NCT00755807|323698418|FG001|Open-label Extension Phase|Sponsor Decision|1|||
94518862|NCT01732536|323698419|FG000|Overall Study|Withdrawal by Subject|1|||
94518863|NCT01732536|323698420|FG001|Overall Study|Withdrawal by Subject|1|||
94518864|NCT02296476|323698424|FG000|Overall Study|Disease Progression|6|||
94518865|NCT02296476|323698425|FG001|Overall Study|Disease Progression|4|||
94518866|NCT02296476|323698426|FG002|Overall Study|Disease Progression|2|||
94518867|NCT02122380|323698427|FG000|First Intervention (30 Days)|Adverse Event|1|||
94518868|NCT02122380|323698428|FG001|First Intervention (30 Days)|Adverse Event|0|||
94518869|NCT02122380|323698427|FG000|First Intervention (30 Days)|Physician Decision|0|||
94518870|NCT02122380|323698428|FG001|First Intervention (30 Days)|Physician Decision|1|||
94518871|NCT02122380|323698427|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
94518872|NCT02122380|323698428|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
94518873|NCT02122380|323698427|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
94518874|NCT02122380|323698428|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
94518875|NCT02122380|323698427|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
94518876|NCT02122380|323698428|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
94518877|NCT03247829|323698429|FG000|Overall Study|Death|3|||
94518878|NCT03247829|323698430|FG001|Overall Study|Death|4|||
94518879|NCT03247829|323698429|FG000|Overall Study|Enter Hospice Care|1|||
94518880|NCT03247829|323698430|FG001|Overall Study|Enter Hospice Care|0|||
94518881|NCT03247829|323698429|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
94518882|NCT03247829|323698430|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
94518883|NCT03247829|323698429|FG000|Overall Study|LVAD Explant|1|||
94518884|NCT03247829|323698430|FG001|Overall Study|LVAD Explant|1|||
94518885|NCT03247829|323698429|FG000|Overall Study|Transplant|1|||
94518886|NCT03247829|323698430|FG001|Overall Study|Transplant|1|||
94518887|NCT01783444|323698431|FG000|Treatment Phase|Adverse Event|9|||
94518888|NCT01783444|323698432|FG001|Treatment Phase|Adverse Event|20|||
94518889|NCT01783444|323698433|FG002|Treatment Phase|Adverse Event|19|||
94518890|NCT01783444|323698431|FG000|Treatment Phase|Disease Progression|76|||
94518891|NCT01783444|323698432|FG001|Treatment Phase|Disease Progression|66|||
94518892|NCT01783444|323698433|FG002|Treatment Phase|Disease Progression|64|||
94518893|NCT01783444|323698431|FG000|Treatment Phase|Death|2|||
94518894|NCT01783444|323698432|FG001|Treatment Phase|Death|2|||
94518895|NCT01783444|323698433|FG002|Treatment Phase|Death|2|||
94518896|NCT01783444|323698431|FG000|Treatment Phase|Protocol Violation|1|||
94518897|NCT01783444|323698432|FG001|Treatment Phase|Protocol Violation|1|||
94518898|NCT01783444|323698433|FG002|Treatment Phase|Protocol Violation|2|||
94518899|NCT01783444|323698431|FG000|Treatment Phase|Withdrawal by Subject|6|||
94518900|NCT01783444|323698432|FG001|Treatment Phase|Withdrawal by Subject|8|||
94518901|NCT01783444|323698433|FG002|Treatment Phase|Withdrawal by Subject|9|||
94518902|NCT01783444|323698431|FG000|Treatment Phase|Administrative problems|2|||
94518903|NCT01783444|323698432|FG001|Treatment Phase|Administrative problems|0|||
94518904|NCT01783444|323698433|FG002|Treatment Phase|Administrative problems|1|||
94518905|NCT01783444|323698431|FG000|Treatment Phase|Physician Decision|8|||
94518906|NCT01783444|323698432|FG001|Treatment Phase|Physician Decision|6|||
94518907|NCT01783444|323698433|FG002|Treatment Phase|Physician Decision|5|||
94518908|NCT01783444|323698431|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
94518909|NCT01783444|323698432|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
94518910|NCT01783444|323698433|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
94518911|NCT01783444|323698431|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
94518912|NCT01783444|323698432|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
94518913|NCT01783444|323698433|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
94518914|NCT01783444|323698431|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
94518915|NCT01783444|323698432|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
94518916|NCT01783444|323698433|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
94518917|NCT01783444|323698431|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
94518918|NCT01783444|323698432|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
94518919|NCT01783444|323698433|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
94518920|NCT01783444|323698431|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
94518921|NCT01783444|323698432|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
94518922|NCT01783444|323698433|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
94518923|NCT01783444|323698431|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
94518924|NCT01783444|323698432|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
94518925|NCT01783444|323698433|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
94518926|NCT00355030|323698436|FG000|Study Period 1 Treatment|Adverse Event|1|||
94518927|NCT00355030|323698437|FG001|Study Period 1 Treatment|Adverse Event|1|||
94518928|NCT00355030|323698436|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
94518929|NCT00355030|323698437|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
94518930|NCT00355030|323698436|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
94518931|NCT00355030|323698437|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
94518932|NCT00355030|323698436|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
94518933|NCT00355030|323698437|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
94518934|NCT00355030|323698436|FG000|Study Period 1 Treatment|Physician Decision|0|||
94518935|NCT00355030|323698437|FG001|Study Period 1 Treatment|Physician Decision|1|||
94518936|NCT00355030|323698436|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
94518937|NCT00355030|323698437|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
94518938|NCT00355030|323698436|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
94518939|NCT00355030|323698437|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
94518940|NCT00355030|323698436|FG000|Study Period 1 Treatment|Other|2|||
94518941|NCT00355030|323698437|FG001|Study Period 1 Treatment|Other|6|||
94518942|NCT00355030|323698436|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
94518943|NCT00355030|323698437|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
94518944|NCT00355030|323698436|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
94518945|NCT00355030|323698437|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
94518946|NCT02013609|323698438|FG000|Overall Study|Withdrawal by Subject|9|||
94518947|NCT02013609|323698438|FG000|Overall Study|Lost to Follow-up|3|||
94518948|NCT02013609|323698438|FG000|Overall Study|Adverse Event|3|||
94518949|NCT02013609|323698438|FG000|Overall Study|Met Withdrawal Criteria|3|||
94518950|NCT01119287|323698439|FG000|Overall Study|Patient Decision, not related to AE|0|||
94518951|NCT01119287|323698440|FG001|Overall Study|Patient Decision, not related to AE|0|||
94518952|NCT01119287|323698441|FG002|Overall Study|Patient Decision, not related to AE|2|||
94518953|NCT01119287|323698442|FG003|Overall Study|Patient Decision, not related to AE|2|||
94518954|NCT01119287|323698443|FG004|Overall Study|Patient Decision, not related to AE|1|||
94518955|NCT01119287|323698444|FG005|Overall Study|Patient Decision, not related to AE|0|||
94518956|NCT02581891|323698445|FG000|Overall Study|Adverse Event|4|||
94518957|NCT02581891|323698446|FG001|Overall Study|Adverse Event|6|||
94518958|NCT02581891|323698445|FG000|Overall Study|Death|3|||
94518959|NCT02581891|323698446|FG001|Overall Study|Death|4|||
94518960|NCT02581891|323698445|FG000|Overall Study|Lost to Follow-up|1|||
94518961|NCT02581891|323698446|FG001|Overall Study|Lost to Follow-up|2|||
94518962|NCT02581891|323698445|FG000|Overall Study|Physician Decision|0|||
94518963|NCT02581891|323698446|FG001|Overall Study|Physician Decision|1|||
94518964|NCT02581891|323698445|FG000|Overall Study|Withdrawal by Subject|4|||
94518965|NCT02581891|323698446|FG001|Overall Study|Withdrawal by Subject|5|||
94518966|NCT02581891|323698445|FG000|Overall Study|Other Reasons|3|||
94518967|NCT02581891|323698446|FG001|Overall Study|Other Reasons|1|||
94518968|NCT02581891|323698445|FG000|Overall Study|Discontinued during followup|1|||
94518969|NCT02581891|323698446|FG001|Overall Study|Discontinued during followup|0|||
94518970|NCT00616642|323698451|FG000|Overall Study|Withdrawal by Subject|0|||
94518971|NCT00616642|323698452|FG001|Overall Study|Withdrawal by Subject|1|||
94518972|NCT04846231|323698454|FG000|Overall Study|Lost to Follow-up|1|||
94518973|NCT04846231|323698455|FG001|Overall Study|Lost to Follow-up|0|||
94518974|NCT04846231|323698456|FG002|Overall Study|Lost to Follow-up|0|||
94518975|NCT04846231|323698457|FG003|Overall Study|Lost to Follow-up|0|||
94518976|NCT04846231|323698458|FG004|Overall Study|Lost to Follow-up|0|||
94518977|NCT04846231|323698459|FG005|Overall Study|Lost to Follow-up|0|||
94518978|NCT04846231|323698460|FG006|Overall Study|Lost to Follow-up|0|||
94518979|NCT04846231|323698461|FG007|Overall Study|Lost to Follow-up|1|||
94518980|NCT04846231|323698454|FG000|Overall Study|Withdrawal by Subject|0|||
94518981|NCT04846231|323698455|FG001|Overall Study|Withdrawal by Subject|1|||
94518982|NCT04846231|323698456|FG002|Overall Study|Withdrawal by Subject|2|||
94518983|NCT04846231|323698457|FG003|Overall Study|Withdrawal by Subject|1|||
94518984|NCT04846231|323698458|FG004|Overall Study|Withdrawal by Subject|0|||
94518985|NCT04846231|323698459|FG005|Overall Study|Withdrawal by Subject|0|||
94518986|NCT04846231|323698460|FG006|Overall Study|Withdrawal by Subject|0|||
94518987|NCT04846231|323698461|FG007|Overall Study|Withdrawal by Subject|0|||
94518988|NCT04846231|323698454|FG000|Overall Study|Protocol Violation|0|||
94518989|NCT04846231|323698455|FG001|Overall Study|Protocol Violation|1|||
94518990|NCT04846231|323698456|FG002|Overall Study|Protocol Violation|0|||
94518991|NCT04846231|323698457|FG003|Overall Study|Protocol Violation|0|||
94518992|NCT04846231|323698458|FG004|Overall Study|Protocol Violation|0|||
94518993|NCT04846231|323698459|FG005|Overall Study|Protocol Violation|0|||
94518994|NCT04846231|323698460|FG006|Overall Study|Protocol Violation|0|||
94518995|NCT04846231|323698461|FG007|Overall Study|Protocol Violation|0|||
94518996|NCT04846231|323698454|FG000|Overall Study|Adverse Event|0|||
94518997|NCT04846231|323698455|FG001|Overall Study|Adverse Event|0|||
94518998|NCT04846231|323698456|FG002|Overall Study|Adverse Event|0|||
94518999|NCT04846231|323698457|FG003|Overall Study|Adverse Event|0|||
94519000|NCT04846231|323698458|FG004|Overall Study|Adverse Event|0|||
94519001|NCT04846231|323698459|FG005|Overall Study|Adverse Event|0|||
94519002|NCT04846231|323698460|FG006|Overall Study|Adverse Event|1|||
94519003|NCT04846231|323698461|FG007|Overall Study|Adverse Event|1|||
94519004|NCT01023217|323698462|FG000|Overall Study|Withdrawal by Subject|1|||
94519005|NCT01023217|323698463|FG001|Overall Study|Withdrawal by Subject|0|||
94519006|NCT00658541|323698464|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
94519007|NCT00658541|323698465|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
94519008|NCT00658541|323698464|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
94519009|NCT00658541|323698465|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
94519010|NCT05518461|323698466|FG000|Overall Study|Lost to Follow-up|25|||
94519011|NCT00448448|323698467|FG000|Overall Study|Withdrawal by Subject|13|||
94519012|NCT00448448|323698468|FG001|Overall Study|Withdrawal by Subject|2|||
94519013|NCT00448448|323698467|FG000|Overall Study|On protocol when study ended|83|||
94519014|NCT00448448|323698468|FG001|Overall Study|On protocol when study ended|36|||
94519015|NCT00448448|323698467|FG000|Overall Study|Lost to Follow-up|2|||
94519016|NCT00448448|323698468|FG001|Overall Study|Lost to Follow-up|1|||
94519017|NCT00448448|323698467|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
94519018|NCT00448448|323698468|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
94519019|NCT00448448|323698467|FG000|Overall Study|Signed consent lost|0|||
94519020|NCT00448448|323698468|FG001|Overall Study|Signed consent lost|1|||
94519021|NCT04828707|323698473|FG000|Overall Study|Lost to Follow-up|3|||
94519022|NCT04828707|323698474|FG001|Overall Study|Lost to Follow-up|2|||
94519023|NCT04828707|323698473|FG000|Overall Study|Withdrawal by Subject|2|||
94519024|NCT04828707|323698474|FG001|Overall Study|Withdrawal by Subject|1|||
94519025|NCT00501644|323698475|FG000|Overall Study|Adverse Event|4|||
94519026|NCT00501644|323698475|FG000|Overall Study|Withdrawal by Subject|1|||
94519027|NCT02553629|323698476|FG000|Overall Study|Logistic reasons|3|||
94519028|NCT02553629|323698477|FG001|Overall Study|Logistic reasons|6|||
94519029|NCT02803203|323698478|FG000|Overall Study|Adverse Event|4|||
94519030|NCT02803203|323698478|FG000|Overall Study|Death|4|||
94519031|NCT02803203|323698478|FG000|Overall Study|Progressive disease|29|||
94519032|NCT02803203|323698478|FG000|Overall Study|Withdrawal by Subject|8|||
94519033|NCT02803203|323698478|FG000|Overall Study|Complete resection of target disease|2|||
94519034|NCT02803203|323698478|FG000|Overall Study|Switched to commercial Osi|1|||
94519035|NCT02803203|323698478|FG000|Overall Study|Participant moved away|1|||
94519036|NCT04577781|323698482|FG000|Overall Study|Adverse Event|2|||
94519037|NCT04577781|323698483|FG001|Overall Study|Adverse Event|2|||
94519038|NCT04577781|323698482|FG000|Overall Study|Physician Decision|1|||
94519039|NCT04577781|323698483|FG001|Overall Study|Physician Decision|0|||
94519040|NCT01812057|323698484|FG000|Overall Study|Protocol Violation|1|||
94519041|NCT01812057|323698485|FG001|Overall Study|Protocol Violation|0|||
94519042|NCT01812057|323698484|FG000|Overall Study|Physician Decision|1|||
94519043|NCT01812057|323698485|FG001|Overall Study|Physician Decision|0|||
94519044|NCT00127855|323698488|FG000|Primary Vaccination Course|Adverse Event|0|||
94519045|NCT00127855|323698489|FG001|Primary Vaccination Course|Adverse Event|0|||
94519046|NCT00127855|323698490|FG002|Primary Vaccination Course|Adverse Event|1|||
94519047|NCT00127855|323698491|FG003|Primary Vaccination Course|Adverse Event|0|||
94519048|NCT00127855|323698492|FG004|Primary Vaccination Course|Adverse Event|0|||
94519049|NCT00127855|323698488|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
94519050|NCT00127855|323698489|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
94519051|NCT00127855|323698490|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
94519052|NCT00127855|323698491|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
94519053|NCT00127855|323698492|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
94519054|NCT00127855|323698488|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
94519055|NCT00127855|323698489|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
94519056|NCT00127855|323698490|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
94519057|NCT00127855|323698491|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
94519058|NCT00127855|323698492|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
94519059|NCT00127855|323698488|FG000|Primary Vaccination Course|Other|0|||
94519060|NCT00127855|323698489|FG001|Primary Vaccination Course|Other|0|||
94519061|NCT00127855|323698490|FG002|Primary Vaccination Course|Other|0|||
94519062|NCT00127855|323698491|FG003|Primary Vaccination Course|Other|0|||
94519063|NCT00127855|323698492|FG004|Primary Vaccination Course|Other|1|||
94519064|NCT00950651|323698494|FG000|Overall Study|Adverse Event|17|||
94519065|NCT00950651|323698495|FG001|Overall Study|Adverse Event|20|||
94519066|NCT00950651|323698494|FG000|Overall Study|Death|1|||
94519067|NCT00950651|323698495|FG001|Overall Study|Death|0|||
94519068|NCT00950651|323698494|FG000|Overall Study|Lack of Efficacy|2|||
94519069|NCT00950651|323698495|FG001|Overall Study|Lack of Efficacy|2|||
94519070|NCT00950651|323698494|FG000|Overall Study|Protocol Violation|3|||
94519071|NCT00950651|323698495|FG001|Overall Study|Protocol Violation|4|||
94519072|NCT00950651|323698494|FG000|Overall Study|Withdrawal by Subject|8|||
94519073|NCT00950651|323698495|FG001|Overall Study|Withdrawal by Subject|9|||
94519074|NCT01261975|323698506|FG000|Overall Study|Surgical complication|1|||
94519075|NCT00716274|323698507|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
94519076|NCT00716274|323698508|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
94519077|NCT00716274|323698509|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
94519078|NCT00716274|323698510|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
94519079|NCT00716274|323698511|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
94519080|NCT00716274|323698512|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
94519081|NCT00716274|323698507|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
94519082|NCT00716274|323698508|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
94519083|NCT00716274|323698509|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
94519084|NCT00716274|323698510|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
94519085|NCT00716274|323698511|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
94519086|NCT00716274|323698512|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
94519087|NCT00716274|323698507|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
94519088|NCT00716274|323698508|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
94519089|NCT00716274|323698509|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
94519090|NCT00716274|323698510|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
94519091|NCT00716274|323698511|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
94519092|NCT00716274|323698512|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
94519093|NCT00716274|323698507|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
94519094|NCT00716274|323698508|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
94519095|NCT00716274|323698509|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
94519096|NCT00716274|323698510|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
94519097|NCT00716274|323698511|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
94519098|NCT00716274|323698512|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
94519099|NCT00716274|323698507|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
94519100|NCT00716274|323698508|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
94519101|NCT00716274|323698509|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
94519102|NCT00716274|323698510|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
94519103|NCT00716274|323698511|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
94519104|NCT00716274|323698512|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
94519105|NCT00716274|323698507|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
94519106|NCT00716274|323698508|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
94519107|NCT00716274|323698509|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
94519108|NCT00716274|323698510|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
94519109|NCT00716274|323698511|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
94519110|NCT00716274|323698512|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
94519111|NCT00716274|323698507|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
94519112|NCT00716274|323698508|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
94519113|NCT00716274|323698509|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
94519114|NCT00716274|323698510|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
94519115|NCT00716274|323698511|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
94519116|NCT00716274|323698512|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
94519117|NCT00716274|323698507|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
94519118|NCT00716274|323698508|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
94519119|NCT00716274|323698509|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
94519120|NCT00716274|323698510|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
94519121|NCT00716274|323698511|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
94519122|NCT00716274|323698512|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
94519123|NCT00716274|323698507|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
94519124|NCT00716274|323698508|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
94519125|NCT00716274|323698509|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
94519126|NCT00716274|323698510|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
94519127|NCT00716274|323698511|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
94519128|NCT00716274|323698512|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
94519129|NCT00716274|323698507|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
94519130|NCT00716274|323698508|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
94519131|NCT00716274|323698509|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
94519132|NCT00716274|323698510|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
94519133|NCT00716274|323698511|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
94519134|NCT00716274|323698512|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
94519135|NCT01932788|323698513|FG000|Overall Study|Protocol Violation|18|||
94519136|NCT01932788|323698514|FG001|Overall Study|Protocol Violation|0|||
94519137|NCT01932788|323698513|FG000|Overall Study|Lost to Follow-up|18|||
94519138|NCT01932788|323698514|FG001|Overall Study|Lost to Follow-up|46|||
94519139|NCT01932788|323698513|FG000|Overall Study|Lack of Efficacy|2|||
94519140|NCT01932788|323698514|FG001|Overall Study|Lack of Efficacy|0|||
94519141|NCT01932788|323698513|FG000|Overall Study|Withdrawal by Subject|0|||
94519142|NCT01932788|323698514|FG001|Overall Study|Withdrawal by Subject|5|||
94519143|NCT04819113|323698515|FG000|Overall Study|Withdrawal by parent/guardian|3|||
94519144|NCT04819113|323698515|FG000|Overall Study|Lost to Follow-up|1|||
94519145|NCT04819113|323698515|FG000|Overall Study|Withdrawn before vaccination|2|||
94519146|NCT04422431|323698518|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
94519147|NCT04422431|323698518|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
94519148|NCT04422431|323698518|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
94519149|NCT04422431|323698518|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
94519150|NCT04422431|323698518|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
94519151|NCT04422431|323698518|FG000|Extension Period (48 Weeks)|Other than specified|2|||
94519152|NCT04288089|323698519|FG000|Overall Study|Ongoing Treatment|2|||
94519153|NCT04288089|323698520|FG001|Overall Study|Ongoing Treatment|1|||
94519154|NCT04288089|323698521|FG002|Overall Study|Ongoing Treatment|1|||
94519155|NCT04288089|323698522|FG003|Overall Study|Ongoing Treatment|4|||
94519156|NCT02891226|323698523|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
94519157|NCT02891226|323698524|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
94519158|NCT02891226|323698525|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
94519159|NCT02891226|323698526|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
94519160|NCT02891226|323698527|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
94519161|NCT02891226|323698528|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
94519162|NCT02891226|323698529|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
94519163|NCT02891226|323698530|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
94519164|NCT02891226|323698531|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
94519165|NCT02891226|323698532|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
94519166|NCT02891226|323698533|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
94519167|NCT02891226|323698534|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
94519168|NCT02891226|323698535|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
94519169|NCT02891226|323698536|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
94519170|NCT02891226|323698537|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
94519171|NCT02891226|323698538|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
94519172|NCT02891226|323698523|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
94519173|NCT02891226|323698524|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
94519174|NCT02891226|323698525|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
94519175|NCT02891226|323698526|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
94519176|NCT02891226|323698527|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
94519177|NCT02891226|323698528|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
94519178|NCT02891226|323698529|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
94519179|NCT02891226|323698530|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
94519180|NCT02891226|323698531|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
94519181|NCT02891226|323698532|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
94519182|NCT02891226|323698533|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
94519183|NCT02891226|323698534|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
94519184|NCT02891226|323698535|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
94519185|NCT02891226|323698536|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
94519186|NCT02891226|323698537|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
94519187|NCT02891226|323698538|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
94519188|NCT02891226|323698523|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
94519189|NCT02891226|323698524|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
94519190|NCT02891226|323698525|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
94519191|NCT02891226|323698526|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
94519192|NCT02891226|323698527|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
94519193|NCT02891226|323698528|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
94519194|NCT02891226|323698529|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
94519195|NCT02891226|323698530|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
94519196|NCT02891226|323698531|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
94519197|NCT02891226|323698532|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
94519198|NCT02891226|323698533|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
94519199|NCT02891226|323698534|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
94519200|NCT02891226|323698535|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
94519201|NCT02891226|323698536|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
94519202|NCT02891226|323698537|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
94519203|NCT02891226|323698538|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
94519204|NCT02891226|323698523|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
94519205|NCT02891226|323698524|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
94519206|NCT02891226|323698525|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
94519207|NCT02891226|323698526|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
94519208|NCT02891226|323698527|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
94519209|NCT02891226|323698528|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
94519210|NCT02891226|323698529|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
94519211|NCT02891226|323698530|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
94519212|NCT02891226|323698531|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
94519213|NCT02891226|323698532|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
94519214|NCT02891226|323698533|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
94519215|NCT02891226|323698534|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
94519216|NCT02891226|323698535|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
94519217|NCT02891226|323698536|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
94519218|NCT02891226|323698537|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
94519219|NCT02891226|323698538|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
94519220|NCT02891226|323698523|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
94519221|NCT02891226|323698524|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
94519222|NCT02891226|323698525|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
94519223|NCT02891226|323698526|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
94519224|NCT02891226|323698527|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
94519225|NCT02891226|323698528|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
94519226|NCT02891226|323698529|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
94519227|NCT02891226|323698530|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
94519228|NCT02891226|323698531|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
94519229|NCT02891226|323698532|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
94519230|NCT02891226|323698533|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
94519231|NCT02891226|323698534|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
94519232|NCT02891226|323698535|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
94519233|NCT02891226|323698536|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
94519234|NCT02891226|323698537|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
94519235|NCT02891226|323698538|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
94519236|NCT02891226|323698523|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
94519237|NCT02891226|323698524|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
94519238|NCT02891226|323698525|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
94519239|NCT02891226|323698526|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
94519240|NCT02891226|323698527|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
94519241|NCT02891226|323698528|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
94519242|NCT02891226|323698529|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
94519243|NCT02891226|323698530|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
94519244|NCT02891226|323698531|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
94519245|NCT02891226|323698532|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
94519246|NCT02891226|323698533|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
94519247|NCT02891226|323698534|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
94519248|NCT02891226|323698535|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
94519249|NCT02891226|323698536|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
94519250|NCT02891226|323698537|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
94519251|NCT02891226|323698538|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
94519252|NCT02891226|323698523|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
94519253|NCT02891226|323698524|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
94519254|NCT02891226|323698525|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
94519255|NCT02891226|323698526|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
94519256|NCT02891226|323698527|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
94519257|NCT02891226|323698528|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
94519258|NCT02891226|323698529|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
94519259|NCT02891226|323698530|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
94519260|NCT02891226|323698531|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
94519261|NCT02891226|323698532|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
94519262|NCT02891226|323698533|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
94519263|NCT02891226|323698534|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
94519264|NCT02891226|323698535|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
94519265|NCT02891226|323698536|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
94519266|NCT02891226|323698537|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
94519267|NCT02891226|323698538|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
94519268|NCT02891226|323698523|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
94519269|NCT02891226|323698524|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
94519270|NCT02891226|323698525|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
94519271|NCT02891226|323698526|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
94519272|NCT02891226|323698527|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
94519273|NCT02891226|323698528|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
94519274|NCT02891226|323698529|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
94519275|NCT02891226|323698530|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
94519276|NCT02891226|323698531|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
94519277|NCT02891226|323698532|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
94519278|NCT02891226|323698533|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
94519279|NCT02891226|323698534|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
94519280|NCT02891226|323698535|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
94519281|NCT02891226|323698536|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
94519282|NCT02891226|323698537|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
94519283|NCT02891226|323698538|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
94519284|NCT02891226|323698523|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
94519285|NCT02891226|323698524|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
94519286|NCT02891226|323698525|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
94519287|NCT02891226|323698526|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
94519288|NCT02891226|323698527|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
94519289|NCT02891226|323698528|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
94519290|NCT02891226|323698529|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
94519291|NCT02891226|323698530|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
94519292|NCT02891226|323698531|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
94519293|NCT02891226|323698532|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
94519294|NCT02891226|323698533|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
94519295|NCT02891226|323698534|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
94519296|NCT02891226|323698535|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
94519297|NCT02891226|323698536|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
94519298|NCT02891226|323698537|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
94519299|NCT02891226|323698538|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
94519300|NCT02891226|323698523|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
94519301|NCT02891226|323698524|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
94519302|NCT02891226|323698525|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
94519303|NCT02891226|323698526|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
94519304|NCT02891226|323698527|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
94519305|NCT02891226|323698528|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
94519306|NCT02891226|323698529|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
94519307|NCT02891226|323698530|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
94519308|NCT02891226|323698531|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
94519309|NCT02891226|323698532|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
94519310|NCT02891226|323698533|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
94519311|NCT02891226|323698534|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
94519312|NCT02891226|323698535|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
94519313|NCT02891226|323698536|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
94519314|NCT02891226|323698537|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
94519315|NCT02891226|323698538|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
94519316|NCT02891226|323698523|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
94519317|NCT02891226|323698524|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
94519318|NCT02891226|323698525|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
94519319|NCT02891226|323698526|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
94519320|NCT02891226|323698527|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
94519321|NCT02891226|323698528|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
94519322|NCT02891226|323698529|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
94519323|NCT02891226|323698530|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
94519324|NCT02891226|323698531|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
94519325|NCT02891226|323698532|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
94519326|NCT02891226|323698533|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
94519327|NCT02891226|323698534|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
94519328|NCT02891226|323698535|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
94519329|NCT02891226|323698536|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
94519330|NCT02891226|323698537|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
94519331|NCT02891226|323698538|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
94519332|NCT02891226|323698523|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
94519333|NCT02891226|323698524|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
94519334|NCT02891226|323698525|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
94519335|NCT02891226|323698526|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
94519336|NCT02891226|323698527|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
94519337|NCT02891226|323698528|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
94519338|NCT02891226|323698529|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
94519339|NCT02891226|323698530|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
94519340|NCT02891226|323698531|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
94519341|NCT02891226|323698532|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
94519342|NCT02891226|323698533|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
94519343|NCT02891226|323698534|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
94519344|NCT02891226|323698535|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
94519345|NCT02891226|323698536|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
94519346|NCT02891226|323698537|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
94519347|NCT02891226|323698538|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
94519348|NCT02891226|323698523|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
94519349|NCT02891226|323698524|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
94519350|NCT02891226|323698525|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
94519351|NCT02891226|323698526|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
94519352|NCT02891226|323698527|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
94519353|NCT02891226|323698528|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
94519354|NCT02891226|323698529|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
94519355|NCT02891226|323698530|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
94519356|NCT02891226|323698531|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
94519357|NCT02891226|323698532|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
94519358|NCT02891226|323698533|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
94519359|NCT02891226|323698534|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
94519360|NCT02891226|323698535|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
94519361|NCT02891226|323698536|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
94519362|NCT02891226|323698537|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
94519363|NCT02891226|323698538|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
94519364|NCT02891226|323698523|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
94519365|NCT02891226|323698524|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
94519366|NCT02891226|323698525|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
94519367|NCT02891226|323698526|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
94519368|NCT02891226|323698527|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
94519369|NCT02891226|323698528|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
94519370|NCT02891226|323698529|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
94519371|NCT02891226|323698530|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
94519372|NCT02891226|323698531|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
94519373|NCT02891226|323698532|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
94519374|NCT02891226|323698533|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
94519375|NCT02891226|323698534|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
94519376|NCT02891226|323698535|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
94519377|NCT02891226|323698536|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
94519378|NCT02891226|323698537|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
94519379|NCT02891226|323698538|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
94519380|NCT02891226|323698523|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
94519381|NCT02891226|323698524|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
94519382|NCT02891226|323698525|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
94519383|NCT02891226|323698526|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
94519384|NCT02891226|323698527|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
94519385|NCT02891226|323698528|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
94519386|NCT02891226|323698529|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
94519387|NCT02891226|323698530|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
94519388|NCT02891226|323698531|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
94519389|NCT02891226|323698532|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
94519390|NCT02891226|323698533|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
94519391|NCT02891226|323698534|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
94519392|NCT02891226|323698535|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
94519393|NCT02891226|323698536|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
94519394|NCT02891226|323698537|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
94519395|NCT02891226|323698538|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
94519396|NCT02891226|323698523|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
94519397|NCT02891226|323698524|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
94519398|NCT02891226|323698525|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
94519399|NCT02891226|323698526|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
94519400|NCT02891226|323698527|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
94519401|NCT02891226|323698528|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
94519402|NCT02891226|323698529|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
94519403|NCT02891226|323698530|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
94519404|NCT02891226|323698531|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
94519405|NCT02891226|323698532|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
94519406|NCT02891226|323698533|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
94519407|NCT02891226|323698534|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
94519408|NCT02891226|323698535|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
94519409|NCT02891226|323698536|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
94519410|NCT02891226|323698537|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
94519411|NCT02891226|323698538|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
94519412|NCT02891226|323698523|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
94519413|NCT02891226|323698524|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
94519414|NCT02891226|323698525|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
94519415|NCT02891226|323698526|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
94519416|NCT02891226|323698527|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
94519417|NCT02891226|323698528|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
94519418|NCT02891226|323698529|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
94519419|NCT02891226|323698530|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
94519420|NCT02891226|323698531|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
94519421|NCT02891226|323698532|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
94519422|NCT02891226|323698533|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
94519423|NCT02891226|323698534|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
94519424|NCT02891226|323698535|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
94519425|NCT02891226|323698536|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
94519426|NCT02891226|323698537|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
94519427|NCT02891226|323698538|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
94519428|NCT02891226|323698523|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
94519429|NCT02891226|323698524|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
94519430|NCT02891226|323698525|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
94519431|NCT02891226|323698526|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
94519432|NCT02891226|323698527|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
94519433|NCT02891226|323698528|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
94519434|NCT02891226|323698529|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
94519435|NCT02891226|323698530|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
94519436|NCT02891226|323698531|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
94519437|NCT02891226|323698532|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
94519438|NCT02891226|323698533|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
94519439|NCT02891226|323698534|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
94519440|NCT02891226|323698535|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
94519441|NCT02891226|323698536|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
94519442|NCT02891226|323698537|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
94519443|NCT02891226|323698538|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
94519444|NCT02891226|323698523|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
94519445|NCT02891226|323698524|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
94519446|NCT02891226|323698525|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
94519447|NCT02891226|323698526|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
94519448|NCT02891226|323698527|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
94519449|NCT02891226|323698528|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
94519450|NCT02891226|323698529|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
94519451|NCT02891226|323698530|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
94519452|NCT02891226|323698531|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
94519453|NCT02891226|323698532|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
94519454|NCT02891226|323698533|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
94519455|NCT02891226|323698534|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
94655651|NCT01632579|324196114|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
94519456|NCT02891226|323698535|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
94519457|NCT02891226|323698536|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
94519458|NCT02891226|323698537|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
94519459|NCT02891226|323698538|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
94519460|NCT02891226|323698523|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
94519461|NCT02891226|323698524|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
94519462|NCT02891226|323698525|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
94519463|NCT02891226|323698526|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
94519464|NCT02891226|323698527|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
94519465|NCT02891226|323698528|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
94519466|NCT02891226|323698529|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
94519467|NCT02891226|323698530|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
94519468|NCT02891226|323698531|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
94519469|NCT02891226|323698532|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
94519470|NCT02891226|323698533|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
94519471|NCT02891226|323698534|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
94519472|NCT02891226|323698535|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
94519473|NCT02891226|323698536|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
94519474|NCT02891226|323698537|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
94519475|NCT02891226|323698538|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
94519476|NCT02891226|323698523|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
94519477|NCT02891226|323698524|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
94519478|NCT02891226|323698525|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
94519479|NCT02891226|323698526|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
94655652|NCT01632579|324196115|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
94655653|NCT01632579|324196116|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
94655654|NCT01632579|324196117|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
94655655|NCT01632579|324196118|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
94655656|NCT03930745|324196119|FG000|Overall Study|Lost to Follow-up|10|||
94655657|NCT03930745|324196120|FG001|Overall Study|Lost to Follow-up|5|||
94655658|NCT03930745|324196119|FG000|Overall Study|Withdrawal by Subject|1|||
94655659|NCT03930745|324196120|FG001|Overall Study|Withdrawal by Subject|2|||
94655660|NCT03930745|324196119|FG000|Overall Study|Protocol Violation|2|||
94655661|NCT03930745|324196120|FG001|Overall Study|Protocol Violation|2|||
94655662|NCT03930745|324196119|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
94655663|NCT03930745|324196120|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
94655664|NCT03930745|324196119|FG000|Overall Study|Adverse Event|0|||
94655665|NCT03930745|324196120|FG001|Overall Study|Adverse Event|1|||
94655666|NCT03930745|324196119|FG000|Overall Study|Pregnancy|0|||
94655667|NCT03930745|324196120|FG001|Overall Study|Pregnancy|1|||
94655668|NCT00818441|324196125|FG000|Overall Study|Death|69|||
94655669|NCT00818441|324196126|FG001|Overall Study|Death|26|||
94655670|NCT00818441|324196125|FG000|Overall Study|Other|5|||
94655671|NCT00818441|324196126|FG001|Overall Study|Other|0|||
94655672|NCT00818441|324196125|FG000|Overall Study|Lost to Follow-up|2|||
94655673|NCT00818441|324196126|FG001|Overall Study|Lost to Follow-up|1|||
94655674|NCT00818441|324196125|FG000|Overall Study|Withdrawal by Subject|2|||
94655675|NCT00818441|324196126|FG001|Overall Study|Withdrawal by Subject|0|||
94655676|NCT00818441|324196125|FG000|Overall Study|Adverse Event|0|||
94655677|NCT00818441|324196126|FG001|Overall Study|Adverse Event|1|||
94655678|NCT00818441|324196125|FG000|Overall Study|Study terminated by sponsor|11|||
94655679|NCT00818441|324196126|FG001|Overall Study|Study terminated by sponsor|2|||
94655680|NCT00560833|324196127|FG000|Overall Study|Adverse Event|16|||
94655681|NCT00560833|324196128|FG001|Overall Study|Adverse Event|10|||
94655682|NCT00560833|324196129|FG002|Overall Study|Adverse Event|25|||
94655683|NCT00560833|324196130|FG003|Overall Study|Adverse Event|23|||
94655684|NCT00560833|324196131|FG004|Overall Study|Adverse Event|35|||
94655685|NCT00560833|324196127|FG000|Overall Study|Lost to Follow-up|0|||
94655686|NCT00560833|324196128|FG001|Overall Study|Lost to Follow-up|0|||
94655687|NCT00560833|324196129|FG002|Overall Study|Lost to Follow-up|1|||
94655688|NCT00560833|324196130|FG003|Overall Study|Lost to Follow-up|0|||
94655689|NCT00560833|324196131|FG004|Overall Study|Lost to Follow-up|0|||
94655690|NCT00560833|324196127|FG000|Overall Study|Lack of Efficacy|22|||
94655691|NCT00560833|324196128|FG001|Overall Study|Lack of Efficacy|9|||
94655692|NCT00560833|324196129|FG002|Overall Study|Lack of Efficacy|6|||
94655693|NCT00560833|324196130|FG003|Overall Study|Lack of Efficacy|4|||
94655694|NCT00560833|324196131|FG004|Overall Study|Lack of Efficacy|4|||
94655695|NCT00560833|324196127|FG000|Overall Study|Participant uncooperative|5|||
94655696|NCT00560833|324196128|FG001|Overall Study|Participant uncooperative|5|||
94655697|NCT00560833|324196129|FG002|Overall Study|Participant uncooperative|4|||
94655698|NCT00560833|324196130|FG003|Overall Study|Participant uncooperative|4|||
94655699|NCT00560833|324196131|FG004|Overall Study|Participant uncooperative|2|||
94655700|NCT00560833|324196127|FG000|Overall Study|Other|1|||
94655701|NCT00560833|324196128|FG001|Overall Study|Other|1|||
94655702|NCT00560833|324196129|FG002|Overall Study|Other|3|||
94519480|NCT02891226|323698527|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
94519481|NCT02891226|323698528|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
94519482|NCT02891226|323698529|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
94519483|NCT02891226|323698530|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
94519484|NCT02891226|323698531|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
94519485|NCT02891226|323698532|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
94519486|NCT02891226|323698533|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
94519487|NCT02891226|323698534|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
94519488|NCT02891226|323698535|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
94519489|NCT02891226|323698536|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
94519490|NCT02891226|323698537|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
94519491|NCT02891226|323698538|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
94519492|NCT02891226|323698523|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
94519493|NCT02891226|323698524|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
94519494|NCT02891226|323698525|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
94519495|NCT02891226|323698526|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
94519496|NCT02891226|323698527|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
94519497|NCT02891226|323698528|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
94519498|NCT02891226|323698529|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
94519499|NCT02891226|323698530|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
94519500|NCT02891226|323698531|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
94519501|NCT02891226|323698532|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
94519502|NCT02891226|323698533|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
94519503|NCT02891226|323698534|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
94519504|NCT02891226|323698535|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
94519505|NCT02891226|323698536|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
94519506|NCT02891226|323698537|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
94519507|NCT02891226|323698538|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
94519508|NCT02891226|323698523|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
94519509|NCT02891226|323698524|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
94519510|NCT02891226|323698525|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
94519511|NCT02891226|323698526|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
94519512|NCT02891226|323698527|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
94519513|NCT02891226|323698528|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
94519514|NCT02891226|323698529|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
94519515|NCT02891226|323698530|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
94519516|NCT02891226|323698531|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
94519517|NCT02891226|323698532|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
94519518|NCT02891226|323698533|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
94519519|NCT02891226|323698534|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
94519520|NCT02891226|323698535|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
94519521|NCT02891226|323698536|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
94519522|NCT02891226|323698537|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
94519523|NCT02891226|323698538|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
94519524|NCT02891226|323698523|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
94519525|NCT02891226|323698524|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
94519526|NCT02891226|323698525|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
94519527|NCT02891226|323698526|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
94519528|NCT02891226|323698527|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
94519529|NCT02891226|323698528|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
94519530|NCT02891226|323698529|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
94519531|NCT02891226|323698530|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
94519532|NCT02891226|323698531|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
94519533|NCT02891226|323698532|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
94519534|NCT02891226|323698533|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
94519535|NCT02891226|323698534|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
94519536|NCT02891226|323698535|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
94519537|NCT02891226|323698536|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
94655703|NCT00560833|324196130|FG003|Overall Study|Other|0|||
94519538|NCT02891226|323698537|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
94519539|NCT02891226|323698538|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
94519540|NCT02891226|323698523|FG000|Follow-up Period|Withdrawal by Subject|0|||
94519541|NCT02891226|323698524|FG001|Follow-up Period|Withdrawal by Subject|0|||
94519542|NCT02891226|323698525|FG002|Follow-up Period|Withdrawal by Subject|0|||
94519543|NCT02891226|323698526|FG003|Follow-up Period|Withdrawal by Subject|0|||
94519544|NCT02891226|323698527|FG004|Follow-up Period|Withdrawal by Subject|0|||
94519545|NCT02891226|323698528|FG005|Follow-up Period|Withdrawal by Subject|0|||
94519546|NCT02891226|323698529|FG006|Follow-up Period|Withdrawal by Subject|0|||
94519547|NCT02891226|323698530|FG007|Follow-up Period|Withdrawal by Subject|0|||
94519548|NCT02891226|323698531|FG008|Follow-up Period|Withdrawal by Subject|0|||
94519549|NCT02891226|323698532|FG009|Follow-up Period|Withdrawal by Subject|0|||
94519550|NCT02891226|323698533|FG010|Follow-up Period|Withdrawal by Subject|0|||
94519551|NCT02891226|323698534|FG011|Follow-up Period|Withdrawal by Subject|1|||
94519552|NCT02891226|323698535|FG012|Follow-up Period|Withdrawal by Subject|0|||
94519553|NCT02891226|323698536|FG013|Follow-up Period|Withdrawal by Subject|0|||
94519554|NCT02891226|323698537|FG014|Follow-up Period|Withdrawal by Subject|1|||
94519555|NCT02891226|323698538|FG015|Follow-up Period|Withdrawal by Subject|1|||
94519556|NCT00543985|323698539|FG000|Overall Study|Withdrawal by Subject|4|||
94519557|NCT01897532|323698540|FG000|Discontinuation From Treatment|Not Treated|7|||
94519558|NCT01897532|323698541|FG001|Discontinuation From Treatment|Not Treated|5|||
94519559|NCT01897532|323698540|FG000|Discontinuation From Treatment|Other reason than specified|196|||
94519560|NCT01897532|323698541|FG001|Discontinuation From Treatment|Other reason than specified|176|||
94519561|NCT01897532|323698540|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
94519562|NCT01897532|323698541|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
94519563|NCT01897532|323698540|FG000|Discontinuation From Treatment|Non compliance|24|||
94519564|NCT01897532|323698541|FG001|Discontinuation From Treatment|Non compliance|15|||
94519565|NCT01897532|323698540|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
94519566|NCT01897532|323698541|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
94519567|NCT01897532|323698540|FG000|Discontinuation From Trial|Not Treated|7|||
94519568|NCT01897532|323698541|FG001|Discontinuation From Trial|Not Treated|5|||
94519569|NCT01897532|323698540|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
94519570|NCT01897532|323698541|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
94519571|NCT00953706|323698542|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
94519572|NCT00953706|323698543|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
94519573|NCT00953706|323698544|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
94519574|NCT00953706|323698545|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
94519575|NCT00953706|323698542|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
94519576|NCT00953706|323698543|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
94519577|NCT00953706|323698544|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
94519578|NCT00953706|323698545|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
94519579|NCT00953706|323698542|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
94519580|NCT00953706|323698543|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
94519581|NCT00953706|323698544|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
94519582|NCT00953706|323698545|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
94519583|NCT00953706|323698542|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
94519584|NCT00953706|323698543|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
94519585|NCT00953706|323698544|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
94519586|NCT00953706|323698545|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
94519587|NCT00953706|323698542|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
94519588|NCT00953706|323698543|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
94519589|NCT00953706|323698544|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
94519590|NCT00953706|323698545|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
94519591|NCT00953706|323698542|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
94519592|NCT00953706|323698543|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
94519593|NCT00953706|323698544|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
94519594|NCT00953706|323698545|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
94519595|NCT00953706|323698542|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
94519596|NCT00953706|323698543|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
94519597|NCT00953706|323698544|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
94519598|NCT00953706|323698545|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
94519599|NCT00953706|323698542|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
94519600|NCT00953706|323698543|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
94519601|NCT00953706|323698544|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
94519602|NCT00953706|323698545|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
94519603|NCT00953706|323698542|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
94519604|NCT00953706|323698543|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
94519605|NCT00953706|323698544|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
94519606|NCT00953706|323698545|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
94519607|NCT00953706|323698542|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
94519608|NCT00953706|323698543|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
94519609|NCT00953706|323698544|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
94519610|NCT00953706|323698545|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
94519611|NCT00953706|323698542|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
94519612|NCT00953706|323698543|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
94519613|NCT00953706|323698544|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
94519614|NCT00953706|323698545|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
94519615|NCT03816176|323698546|FG000|Overall Study|Miscellaneous|5|||
94519616|NCT03816176|323698546|FG000|Overall Study|Lack of Efficacy|4|||
94519617|NCT03816176|323698546|FG000|Overall Study|Adverse Event|3|||
94519618|NCT03384875|323698547|FG000|Overall Study|Death|1|||
94519619|NCT03384875|323698548|FG001|Overall Study|Death|1|||
94519620|NCT03384875|323698549|FG002|Overall Study|Death|0|||
94519621|NCT03384875|323698547|FG000|Overall Study|Reason not provided|1|||
94519622|NCT03384875|323698548|FG001|Overall Study|Reason not provided|0|||
94519623|NCT03384875|323698549|FG002|Overall Study|Reason not provided|0|||
94519624|NCT01576783|323699963|FG000|Overall Study|Change in Medical Care|1|||
94519625|NCT01576783|323699964|FG001|Overall Study|Change in Medical Care|0|||
94519626|NCT01576783|323699963|FG000|Overall Study|Lost to Follow-up|14|||
94519627|NCT01576783|323699964|FG001|Overall Study|Lost to Follow-up|16|||
94519628|NCT01576783|323699963|FG000|Overall Study|Withdrawal by Subject|5|||
94519629|NCT01576783|323699964|FG001|Overall Study|Withdrawal by Subject|1|||
94519630|NCT01581684|323699965|FG000|Overall Study|Other reason not defined|0|||
94519631|NCT01581684|323699966|FG001|Overall Study|Other reason not defined|0|||
94519632|NCT01581684|323699967|FG002|Overall Study|Other reason not defined|0|||
94519633|NCT01581684|323699968|FG003|Overall Study|Other reason not defined|0|||
94519634|NCT01581684|323699969|FG004|Overall Study|Other reason not defined|0|||
94519635|NCT01581684|323699970|FG005|Overall Study|Other reason not defined|0|||
94519636|NCT01581684|323699971|FG006|Overall Study|Other reason not defined|0|||
94519637|NCT01581684|323699972|FG007|Overall Study|Other reason not defined|0|||
94519638|NCT01581684|323699973|FG008|Overall Study|Other reason not defined|1|||
94519639|NCT01581684|323699974|FG009|Overall Study|Other reason not defined|0|||
94519640|NCT04592341|323699975|FG000|Overall Study|Physician Decision|5|||
94519641|NCT04592341|323699975|FG000|Overall Study|Study Terminated by Sponsor|5|||
94519642|NCT04592341|323699975|FG000|Overall Study|Withdrawal by Subject|53|||
94519643|NCT04592341|323699975|FG000|Overall Study|Lost to Follow-up|3|||
94519644|NCT04592341|323699975|FG000|Overall Study|Death|1|||
94519645|NCT04592341|323699975|FG000|Overall Study|Adverse Event|5|||
94519646|NCT04592341|323699975|FG000|Overall Study|other|4|||
94519647|NCT02935192|323699978|FG000|Overall Study|Withdrawal by Subject|8|||
94519648|NCT02935192|323699979|FG001|Overall Study|Withdrawal by Subject|4|||
94519649|NCT02896257|323699980|FG000|Providers|Without eligible patients|21|||
94519650|NCT02896257|323699981|FG001|Providers|Without eligible patients|28|||
94519651|NCT02896257|323699980|FG000|Patients|PFT entry criteria not met|43|||
94519652|NCT02896257|323699981|FG001|Patients|PFT entry criteria not met|50|||
94519653|NCT02896257|323699980|FG000|Patients|No capacity to review|8|||
94519654|NCT02896257|323699981|FG001|Patients|No capacity to review|11|||
94519655|NCT02896257|323699980|FG000|Patients|Appointment rescheduled/cancelled|5|||
94519656|NCT02896257|323699981|FG001|Patients|Appointment rescheduled/cancelled|7|||
94519657|NCT02896257|323699980|FG000|Patients|PCP not assigned a clinic|4|||
94519658|NCT02896257|323699981|FG001|Patients|PCP not assigned a clinic|0|||
94519659|NCT02896257|323699980|FG000|Patients|No history of COPD|0|||
94519660|NCT02896257|323699981|FG001|Patients|No history of COPD|1|||
94519661|NCT02896257|323699980|FG000|Patients|Deceased between review and index date|0|||
94519662|NCT02896257|323699981|FG001|Patients|Deceased between review and index date|1|||
94519663|NCT02896257|323699980|FG000|Patients|No ICS Rx upon review|1|||
94519664|NCT02896257|323699981|FG001|Patients|No ICS Rx upon review|1|||
94519665|NCT02896257|323699980|FG000|Patients|Protocol Violation|2|||
94519666|NCT02896257|323699981|FG001|Patients|Protocol Violation|1|||
94519667|NCT02896257|323699980|FG000|Patients|Hospice care|0|||
94519668|NCT02896257|323699981|FG001|Patients|Hospice care|1|||
94519669|NCT01354223|323699983|FG000|Overall Study|Withdrawal by Subject|3|||
94519670|NCT01354223|323699984|FG001|Overall Study|Withdrawal by Subject|1|||
94519671|NCT03289143|323699988|FG000|Overall Study|Caregiver Unavailability|1|||
94519672|NCT03289143|323699989|FG001|Overall Study|Caregiver Unavailability|1|||
94519673|NCT03289143|323699990|FG002|Overall Study|Caregiver Unavailability|0|||
94519674|NCT03289143|323699991|FG003|Overall Study|Caregiver Unavailability|0|||
94519675|NCT03289143|323699988|FG000|Overall Study|Research Department Closure|0|||
94519676|NCT03289143|323699989|FG001|Overall Study|Research Department Closure|0|||
94519677|NCT03289143|323699990|FG002|Overall Study|Research Department Closure|1|||
94519678|NCT03289143|323699991|FG003|Overall Study|Research Department Closure|0|||
94519679|NCT03289143|323699988|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
94519680|NCT03289143|323699989|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
94519681|NCT03289143|323699990|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
94519682|NCT03289143|323699991|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
94519683|NCT03289143|323699988|FG000|Overall Study|Medical Monitor Decision|1|||
94519684|NCT03289143|323699989|FG001|Overall Study|Medical Monitor Decision|0|||
94519685|NCT03289143|323699990|FG002|Overall Study|Medical Monitor Decision|0|||
94519686|NCT03289143|323699991|FG003|Overall Study|Medical Monitor Decision|0|||
94519687|NCT03289143|323699988|FG000|Overall Study|Participant Non-Compliance|0|||
94519688|NCT03289143|323699989|FG001|Overall Study|Participant Non-Compliance|0|||
94519689|NCT03289143|323699990|FG002|Overall Study|Participant Non-Compliance|1|||
94519690|NCT03289143|323699991|FG003|Overall Study|Participant Non-Compliance|0|||
94519691|NCT03289143|323699988|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
94519692|NCT03289143|323699989|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
94519693|NCT03289143|323699990|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
94519694|NCT03289143|323699991|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
94519695|NCT03289143|323699988|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
94519696|NCT03289143|323699989|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
94519697|NCT03289143|323699990|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
94519698|NCT03289143|323699991|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
94519699|NCT03289143|323699988|FG000|Overall Study|Caregiver Passed Away|1|||
94519700|NCT03289143|323699989|FG001|Overall Study|Caregiver Passed Away|0|||
94519701|NCT03289143|323699990|FG002|Overall Study|Caregiver Passed Away|0|||
94519702|NCT03289143|323699991|FG003|Overall Study|Caregiver Passed Away|0|||
94519703|NCT03289143|323699988|FG000|Overall Study|Physician Decision|0|||
94519704|NCT03289143|323699989|FG001|Overall Study|Physician Decision|2|||
94519705|NCT03289143|323699990|FG002|Overall Study|Physician Decision|2|||
94519706|NCT03289143|323699991|FG003|Overall Study|Physician Decision|2|||
94519707|NCT03289143|323699988|FG000|Overall Study|Protocol Deviation|2|||
94519708|NCT03289143|323699989|FG001|Overall Study|Protocol Deviation|1|||
94519709|NCT03289143|323699990|FG002|Overall Study|Protocol Deviation|3|||
94519710|NCT03289143|323699991|FG003|Overall Study|Protocol Deviation|1|||
94519711|NCT03289143|323699988|FG000|Overall Study|Study Terminated By Sponsor|101|||
94519712|NCT03289143|323699989|FG001|Overall Study|Study Terminated By Sponsor|75|||
94519713|NCT03289143|323699990|FG002|Overall Study|Study Terminated By Sponsor|100|||
94519714|NCT03289143|323699991|FG003|Overall Study|Study Terminated By Sponsor|69|||
94519715|NCT03289143|323699988|FG000|Overall Study|Withdrawal by Subject|14|||
94519716|NCT03289143|323699989|FG001|Overall Study|Withdrawal by Subject|6|||
94519717|NCT03289143|323699990|FG002|Overall Study|Withdrawal by Subject|14|||
94519718|NCT03289143|323699991|FG003|Overall Study|Withdrawal by Subject|12|||
94519719|NCT03289143|323699988|FG000|Overall Study|Adverse Event|10|||
94519720|NCT03289143|323699989|FG001|Overall Study|Adverse Event|7|||
94519721|NCT03289143|323699990|FG002|Overall Study|Adverse Event|6|||
94519722|NCT03289143|323699991|FG003|Overall Study|Adverse Event|5|||
94519723|NCT03289143|323699988|FG000|Overall Study|Death|2|||
94519724|NCT03289143|323699989|FG001|Overall Study|Death|0|||
94519725|NCT03289143|323699990|FG002|Overall Study|Death|2|||
94519726|NCT03289143|323699991|FG003|Overall Study|Death|1|||
94519727|NCT03289143|323699988|FG000|Overall Study|Lost to Follow-up|2|||
94519728|NCT03289143|323699989|FG001|Overall Study|Lost to Follow-up|1|||
94519729|NCT03289143|323699990|FG002|Overall Study|Lost to Follow-up|1|||
94519730|NCT03289143|323699991|FG003|Overall Study|Lost to Follow-up|0|||
94519731|NCT03289143|323699988|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
94519732|NCT03289143|323699989|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
94519733|NCT03289143|323699990|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
94519734|NCT03289143|323699991|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
94519735|NCT03289143|323699988|FG000|Overall Study|Withdrawal by Caregiver|0|||
94519736|NCT03289143|323699989|FG001|Overall Study|Withdrawal by Caregiver|1|||
94519737|NCT03289143|323699990|FG002|Overall Study|Withdrawal by Caregiver|0|||
94519738|NCT03289143|323699991|FG003|Overall Study|Withdrawal by Caregiver|0|||
94519739|NCT03289143|323699988|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
94519740|NCT03289143|323699989|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
94519741|NCT03289143|323699990|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
94519742|NCT03289143|323699991|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
94519743|NCT03289143|323699988|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
94519744|NCT03289143|323699989|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
94519745|NCT03289143|323699990|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
94519746|NCT03289143|323699991|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
94519747|NCT01669902|323699992|FG000|Overall Study|Adverse Event|11|||
94519748|NCT01669902|323699992|FG000|Overall Study|Lack of Efficacy|10|||
94519749|NCT01669902|323699992|FG000|Overall Study|Other|8|||
94519750|NCT00730756|323699993|FG000|Overall Study|Adverse Event|2|||
94519751|NCT00730756|323699994|FG001|Overall Study|Adverse Event|0|||
94519752|NCT00730756|323699993|FG000|Overall Study|Lack of Efficacy|1|||
94519753|NCT00730756|323699994|FG001|Overall Study|Lack of Efficacy|1|||
94519754|NCT00730756|323699993|FG000|Overall Study|Protocol Deviation|1|||
94519755|NCT00730756|323699994|FG001|Overall Study|Protocol Deviation|2|||
94519756|NCT00730756|323699993|FG000|Overall Study|Lost to Follow-up|0|||
94519757|NCT00730756|323699994|FG001|Overall Study|Lost to Follow-up|1|||
94519758|NCT00730756|323699993|FG000|Overall Study|Withdrew Consent|0|||
94519759|NCT00730756|323699994|FG001|Overall Study|Withdrew Consent|1|||
94519760|NCT01535287|323699998|FG000|Overall Study|drug not prepared in time|5|||
94519761|NCT01535287|323699999|FG001|Overall Study|drug not prepared in time|6|||
94519762|NCT00517699|323700000|FG000|Overall Study|Withdrawal by Subject|1|||
94519763|NCT00517699|323700000|FG000|Overall Study|Lack of Efficacy|1|||
94519764|NCT00517699|323700000|FG000|Overall Study|Administrative error|1|||
94519765|NCT00517699|323700000|FG000|Overall Study|Study terminated by Sponsor|2|||
94519766|NCT01126190|323700001|FG000|Double-Blind Phase|Death|0|||
94519767|NCT01126190|323700002|FG001|Double-Blind Phase|Death|1|||
94519768|NCT01126190|323700003|FG002|Double-Blind Phase|Death|0|||
94519769|NCT01126190|323700001|FG000|Double-Blind Phase|Adverse Event|1|||
94519770|NCT01126190|323700002|FG001|Double-Blind Phase|Adverse Event|2|||
94519771|NCT01126190|323700003|FG002|Double-Blind Phase|Adverse Event|0|||
94519772|NCT01126190|323700001|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
94519773|NCT01126190|323700002|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
94519774|NCT01126190|323700003|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
94519775|NCT01126190|323700001|FG000|Double-Blind Phase|Request of Investigator|1|||
94519776|NCT01126190|323700002|FG001|Double-Blind Phase|Request of Investigator|0|||
94519777|NCT01126190|323700003|FG002|Double-Blind Phase|Request of Investigator|0|||
94519778|NCT01126190|323700001|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
94519779|NCT01126190|323700002|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
94519780|NCT01126190|323700003|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
94519781|NCT01126190|323700001|FG000|Double-Blind Phase|Non-compliance|1|||
94519782|NCT01126190|323700002|FG001|Double-Blind Phase|Non-compliance|0|||
94519783|NCT01126190|323700003|FG002|Double-Blind Phase|Non-compliance|0|||
94519784|NCT01126190|323700001|FG000|Double-Blind Phase|Lost to Follow-up|1|||
94519785|NCT01126190|323700002|FG001|Double-Blind Phase|Lost to Follow-up|3|||
94519786|NCT01126190|323700003|FG002|Double-Blind Phase|Lost to Follow-up|0|||
94519787|NCT01126190|323700001|FG000|Open-Label Phase|Death|0|||
94519788|NCT01126190|323700002|FG001|Open-Label Phase|Death|0|||
94519789|NCT01126190|323700003|FG002|Open-Label Phase|Death|1|||
94519790|NCT01126190|323700001|FG000|Open-Label Phase|Adverse Event|0|||
94519791|NCT01126190|323700002|FG001|Open-Label Phase|Adverse Event|0|||
94519792|NCT01126190|323700003|FG002|Open-Label Phase|Adverse Event|4|||
94519793|NCT01126190|323700001|FG000|Open-Label Phase|Withdrawal by Subject|0|||
94519794|NCT01126190|323700002|FG001|Open-Label Phase|Withdrawal by Subject|0|||
94519795|NCT01126190|323700003|FG002|Open-Label Phase|Withdrawal by Subject|6|||
94519796|NCT00524121|323700004|FG000|Overall Study|Disease progression|6|||
94519797|NCT00524121|323700004|FG000|Overall Study|Adverse Event|4|||
94519798|NCT00524121|323700004|FG000|Overall Study|Patient refused|2|||
94519799|NCT00524121|323700004|FG000|Overall Study|Other|1|||
94519800|NCT00524121|323700004|FG000|Overall Study|Death|1|||
94519801|NCT00524121|323700004|FG000|Overall Study|Not treated (became ineligible)|4|||
94519802|NCT00524121|323700004|FG000|Overall Study|Not treated (changed mind)|1|||
94519803|NCT02332187|323700005|FG000|Overall Study|Withdrawal by Subject|2|||
94519804|NCT02332187|323700006|FG001|Overall Study|Withdrawal by Subject|2|||
94519805|NCT02332187|323700005|FG000|Overall Study|Adverse Event|0|||
94519806|NCT02332187|323700006|FG001|Overall Study|Adverse Event|1|||
94519807|NCT01114737|323700007|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
94519808|NCT01114737|323700008|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
94519809|NCT01114737|323700007|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
94519810|NCT01114737|323700008|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
94519811|NCT01114737|323700007|FG000|Randomized Treatment Period|Pregnancy|1|||
94519812|NCT01114737|323700008|FG001|Randomized Treatment Period|Pregnancy|0|||
94519813|NCT01114737|323700007|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
94519814|NCT01114737|323700008|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
94519815|NCT01114737|323700007|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
94519816|NCT01114737|323700008|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
94519817|NCT01114737|323700007|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
94519818|NCT01114737|323700008|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
94519819|NCT02973997|323700011|FG000|Overall Study|Withdrawal by Subject|4|||
94519820|NCT02973997|323700012|FG001|Overall Study|Withdrawal by Subject|0|||
94519821|NCT02973997|323700011|FG000|Overall Study|Adverse Event|4|||
94519822|NCT02973997|323700012|FG001|Overall Study|Adverse Event|1|||
94519823|NCT02973997|323700011|FG000|Overall Study|Disease Progression|11|||
94519824|NCT02973997|323700012|FG001|Overall Study|Disease Progression|20|||
94519825|NCT02973997|323700011|FG000|Overall Study|Alternative Therapy|3|||
94519826|NCT02973997|323700012|FG001|Overall Study|Alternative Therapy|0|||
94519827|NCT02973997|323700011|FG000|Overall Study|Other complicating disease|0|||
94519828|NCT02973997|323700012|FG001|Overall Study|Other complicating disease|1|||
94519829|NCT02973997|323700011|FG000|Overall Study|Death|0|||
94519830|NCT02973997|323700012|FG001|Overall Study|Death|1|||
94519831|NCT00783432|323700019|FG000|Overall Study|Adverse Event|22|||
94519832|NCT00783432|323700020|FG001|Overall Study|Adverse Event|17|||
94519833|NCT00783432|323700019|FG000|Overall Study|Lack of Efficacy|20|||
94519834|NCT00783432|323700020|FG001|Overall Study|Lack of Efficacy|21|||
94519835|NCT00783432|323700019|FG000|Overall Study|Lost to Follow-up|11|||
94519836|NCT00783432|323700020|FG001|Overall Study|Lost to Follow-up|6|||
94519837|NCT00783432|323700019|FG000|Overall Study|Withdrawal by Subject|23|||
94519838|NCT00783432|323700020|FG001|Overall Study|Withdrawal by Subject|20|||
94519839|NCT00783432|323700019|FG000|Overall Study|subject moved|3|||
94519840|NCT00783432|323700020|FG001|Overall Study|subject moved|5|||
94519841|NCT00783432|323700019|FG000|Overall Study|Protocol Violation|6|||
94519842|NCT00783432|323700020|FG001|Overall Study|Protocol Violation|9|||
94519843|NCT00107276|323700021|FG000|Overall Study|Progression|46|||
94519844|NCT00107276|323700021|FG000|Overall Study|Adverse Event|6|||
94519845|NCT00107276|323700021|FG000|Overall Study|M.D. decision|2|||
94519846|NCT00107276|323700021|FG000|Overall Study|Patient refusal|1|||
94519847|NCT00107276|323700021|FG000|Overall Study|Death|1|||
94519848|NCT00107276|323700021|FG000|Overall Study|Ineligible|16|||
94519849|NCT02504372|323700022|FG000|Overall Study|Death|136|||
94519850|NCT02504372|323700023|FG001|Overall Study|Death|154|||
94519851|NCT02504372|323700022|FG000|Overall Study|Lost to Follow-up|0|||
94519852|NCT02504372|323700023|FG001|Overall Study|Lost to Follow-up|2|||
94519853|NCT02504372|323700022|FG000|Overall Study|Withdrawal of consent|25|||
94519854|NCT02504372|323700023|FG001|Overall Study|Withdrawal of consent|16|||
94519855|NCT02504372|323700022|FG000|Overall Study|Participants ongoing|429|||
94519856|NCT02504372|323700023|FG001|Overall Study|Participants ongoing|415|||
94519857|NCT01882465|323700024|FG000|Period 1|Lens Discomfort|0|||
94519858|NCT01882465|323700025|FG001|Period 1|Lens Discomfort|0|||
94519859|NCT01882465|323700026|FG002|Period 1|Lens Discomfort|0|||
94519860|NCT01882465|323700027|FG003|Period 1|Lens Discomfort|1|||
94519861|NCT01882465|323700028|FG004|Period 1|Lens Discomfort|0|||
94519862|NCT01882465|323700029|FG005|Period 1|Lens Discomfort|0|||
94519863|NCT01882465|323700030|FG006|Period 1|Lens Discomfort|0|||
94519864|NCT01882465|323700024|FG000|Period 1|Withdrawal by Subject|0|||
94519865|NCT01882465|323700025|FG001|Period 1|Withdrawal by Subject|0|||
94519866|NCT01882465|323700026|FG002|Period 1|Withdrawal by Subject|0|||
94519867|NCT01882465|323700027|FG003|Period 1|Withdrawal by Subject|0|||
94519868|NCT01882465|323700028|FG004|Period 1|Withdrawal by Subject|0|||
94519869|NCT01882465|323700029|FG005|Period 1|Withdrawal by Subject|0|||
94519870|NCT01882465|323700030|FG006|Period 1|Withdrawal by Subject|1|||
94519871|NCT01882465|323700024|FG000|Period 2|Protocol Violation|0|||
94519872|NCT01882465|323700025|FG001|Period 2|Protocol Violation|0|||
94519873|NCT01882465|323700026|FG002|Period 2|Protocol Violation|0|||
94519874|NCT01882465|323700027|FG003|Period 2|Protocol Violation|0|||
94519875|NCT01882465|323700028|FG004|Period 2|Protocol Violation|1|||
94519876|NCT01882465|323700029|FG005|Period 2|Protocol Violation|0|||
94519877|NCT01882465|323700030|FG006|Period 2|Protocol Violation|0|||
94519878|NCT01887717|323700031|FG000|Overall Study|Withdrawal by Subject|1|||
94519879|NCT01887717|323700032|FG001|Overall Study|Withdrawal by Subject|7|||
94519880|NCT01887717|323700031|FG000|Overall Study|Physician Decision|0|||
94519881|NCT01887717|323700032|FG001|Overall Study|Physician Decision|2|||
94519882|NCT01887717|323700031|FG000|Overall Study|Administrative reasons|5|||
94519883|NCT01887717|323700032|FG001|Overall Study|Administrative reasons|2|||
94519884|NCT02289469|323700033|FG000|Overall Study|Unable to match a control|6|||
94519885|NCT02289469|323700034|FG001|Overall Study|Unable to match a control|0|||
94519886|NCT01847755|323700036|FG000|Overall Study|Adverse Event|2|||
94519887|NCT01847755|323700036|FG000|Overall Study|Withdrawal by Subject|2|||
94519888|NCT01847755|323700036|FG000|Overall Study|Physician Decision|1|||
94519889|NCT02347085|323700040|FG000|Overall Study|Adverse Event|2|||
94519890|NCT02347085|323700040|FG000|Overall Study|Lack of Efficacy|1|||
94519891|NCT02347085|323700040|FG000|Overall Study|Withdrawal by Subject|4|||
94519892|NCT02347085|323700040|FG000|Overall Study|Lost to Follow-up|1|||
94519893|NCT02347085|323700040|FG000|Overall Study|Protocol Criteria|2|||
94519894|NCT02834819|323700041|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
94519895|NCT02834819|323700042|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
94519896|NCT00421148|323700043|FG000|Overall Study|Lost to Follow-up|0|||
94519897|NCT00421148|323700044|FG001|Overall Study|Lost to Follow-up|0|||
94519898|NCT00421148|323700045|FG002|Overall Study|Lost to Follow-up|0|||
94519899|NCT00421148|323700046|FG003|Overall Study|Lost to Follow-up|0|||
94519900|NCT00421148|323700047|FG004|Overall Study|Lost to Follow-up|0|||
94519901|NCT00421148|323700048|FG005|Overall Study|Lost to Follow-up|0|||
94519902|NCT00421148|323700049|FG006|Overall Study|Lost to Follow-up|0|||
94519903|NCT00421148|323700050|FG007|Overall Study|Lost to Follow-up|0|||
94519904|NCT00421148|323700051|FG008|Overall Study|Lost to Follow-up|0|||
94519905|NCT00421148|323700052|FG009|Overall Study|Lost to Follow-up|0|||
94519906|NCT00421148|323700053|FG010|Overall Study|Lost to Follow-up|0|||
94519907|NCT00421148|323700054|FG011|Overall Study|Lost to Follow-up|0|||
94519908|NCT00421148|323700055|FG012|Overall Study|Lost to Follow-up|0|||
94519909|NCT00421148|323700056|FG013|Overall Study|Lost to Follow-up|0|||
94519910|NCT00421148|323700057|FG014|Overall Study|Lost to Follow-up|0|||
94519911|NCT00421148|323700058|FG015|Overall Study|Lost to Follow-up|0|||
94519912|NCT00421148|323700059|FG016|Overall Study|Lost to Follow-up|0|||
94519913|NCT00421148|323700060|FG017|Overall Study|Lost to Follow-up|1|||
94519914|NCT00421148|323700061|FG018|Overall Study|Lost to Follow-up|0|||
94519915|NCT00421148|323700062|FG019|Overall Study|Lost to Follow-up|0|||
94519916|NCT00421148|323700043|FG000|Overall Study|Withdrawal by Subject|0|||
94519917|NCT00421148|323700044|FG001|Overall Study|Withdrawal by Subject|0|||
94519918|NCT00421148|323700045|FG002|Overall Study|Withdrawal by Subject|0|||
94519919|NCT00421148|323700046|FG003|Overall Study|Withdrawal by Subject|0|||
94519920|NCT00421148|323700047|FG004|Overall Study|Withdrawal by Subject|0|||
94519921|NCT00421148|323700048|FG005|Overall Study|Withdrawal by Subject|0|||
94519922|NCT00421148|323700049|FG006|Overall Study|Withdrawal by Subject|0|||
94519923|NCT00421148|323700050|FG007|Overall Study|Withdrawal by Subject|0|||
94519924|NCT00421148|323700051|FG008|Overall Study|Withdrawal by Subject|0|||
94519925|NCT00421148|323700052|FG009|Overall Study|Withdrawal by Subject|0|||
94519926|NCT00421148|323700053|FG010|Overall Study|Withdrawal by Subject|0|||
94519927|NCT00421148|323700054|FG011|Overall Study|Withdrawal by Subject|0|||
94519928|NCT00421148|323700055|FG012|Overall Study|Withdrawal by Subject|0|||
94519929|NCT00421148|323700056|FG013|Overall Study|Withdrawal by Subject|0|||
94519930|NCT00421148|323700057|FG014|Overall Study|Withdrawal by Subject|0|||
94519931|NCT00421148|323700058|FG015|Overall Study|Withdrawal by Subject|0|||
94519932|NCT00421148|323700059|FG016|Overall Study|Withdrawal by Subject|0|||
94519933|NCT00421148|323700060|FG017|Overall Study|Withdrawal by Subject|1|||
94519934|NCT00421148|323700061|FG018|Overall Study|Withdrawal by Subject|0|||
94519935|NCT00421148|323700062|FG019|Overall Study|Withdrawal by Subject|0|||
94519936|NCT00421148|323700043|FG000|Overall Study|Protocol Violation|0|||
94519937|NCT00421148|323700044|FG001|Overall Study|Protocol Violation|0|||
94519938|NCT00421148|323700045|FG002|Overall Study|Protocol Violation|0|||
94519939|NCT00421148|323700046|FG003|Overall Study|Protocol Violation|0|||
94519940|NCT00421148|323700047|FG004|Overall Study|Protocol Violation|0|||
94519941|NCT00421148|323700048|FG005|Overall Study|Protocol Violation|1|||
94519942|NCT00421148|323700049|FG006|Overall Study|Protocol Violation|0|||
94519943|NCT00421148|323700050|FG007|Overall Study|Protocol Violation|0|||
94519944|NCT00421148|323700051|FG008|Overall Study|Protocol Violation|0|||
94519945|NCT00421148|323700052|FG009|Overall Study|Protocol Violation|0|||
94519946|NCT00421148|323700053|FG010|Overall Study|Protocol Violation|0|||
94519947|NCT00421148|323700054|FG011|Overall Study|Protocol Violation|0|||
94519948|NCT00421148|323700055|FG012|Overall Study|Protocol Violation|0|||
94519949|NCT00421148|323700056|FG013|Overall Study|Protocol Violation|0|||
94519950|NCT00421148|323700057|FG014|Overall Study|Protocol Violation|0|||
94519951|NCT00421148|323700058|FG015|Overall Study|Protocol Violation|0|||
94519952|NCT00421148|323700059|FG016|Overall Study|Protocol Violation|0|||
94519953|NCT00421148|323700060|FG017|Overall Study|Protocol Violation|0|||
94519954|NCT00421148|323700061|FG018|Overall Study|Protocol Violation|1|||
94519955|NCT00421148|323700062|FG019|Overall Study|Protocol Violation|0|||
94519956|NCT00087698|323700068|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
94519957|NCT00087698|323700068|FG000|Overall Study|Death from Other Causes|3|||
94519958|NCT00087698|323700068|FG000|Overall Study|Adverse Event|4|||
94519959|NCT00087698|323700068|FG000|Overall Study|Withdrawal by Subject|4|||
94519960|NCT00087698|323700068|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
94519961|NCT00087698|323700068|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
94519962|NCT00087698|323700068|FG000|Overall Study|Clinical Relapse|1|||
94519963|NCT00087698|323700068|FG000|Overall Study|Death from Study Disease|2|||
94519964|NCT00087698|323700068|FG000|Overall Study|Death from Study Drug Toxicity|2|||
94519965|NCT00087698|323700068|FG000|Overall Study|Protocol Violation|1|||
94519966|NCT02737501|323700072|FG000|Randomized Phase|Died|41|||
94519967|NCT02737501|323700073|FG001|Randomized Phase|Died|29|||
94519968|NCT02737501|323700074|FG002|Randomized Phase|Died|0|||
94519969|NCT02737501|323700072|FG000|Randomized Phase|Withdrawal by Subject|16|||
94519970|NCT02737501|323700073|FG001|Randomized Phase|Withdrawal by Subject|6|||
94519971|NCT02737501|323700074|FG002|Randomized Phase|Withdrawal by Subject|0|||
94519972|NCT02737501|323700072|FG000|Randomized Phase|Lost to Follow-up|0|||
94519973|NCT02737501|323700073|FG001|Randomized Phase|Lost to Follow-up|1|||
94519974|NCT02737501|323700074|FG002|Randomized Phase|Lost to Follow-up|0|||
94519975|NCT02737501|323700072|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
94519976|NCT02737501|323700073|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
94519977|NCT02737501|323700074|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
94519978|NCT02737501|323700072|FG000|Randomized Phase|Reason not Specified|1|||
94519979|NCT02737501|323700073|FG001|Randomized Phase|Reason not Specified|1|||
94519980|NCT02737501|323700074|FG002|Randomized Phase|Reason not Specified|0|||
94519981|NCT02737501|323700072|FG000|Randomized Phase|Never Treated|1|||
94519982|NCT02737501|323700073|FG001|Randomized Phase|Never Treated|1|||
94519983|NCT02737501|323700074|FG002|Randomized Phase|Never Treated|0|||
94519984|NCT02737501|323700072|FG000|Crossover Phase|Died|0|||
94519985|NCT02737501|323700073|FG001|Crossover Phase|Died|0|||
94519986|NCT02737501|323700074|FG002|Crossover Phase|Died|22|||
94519987|NCT02737501|323700072|FG000|Crossover Phase|Withdrew Consent|0|||
94519988|NCT02737501|323700073|FG001|Crossover Phase|Withdrew Consent|0|||
94519989|NCT02737501|323700074|FG002|Crossover Phase|Withdrew Consent|9|||
94519990|NCT02737501|323700072|FG000|Crossover Phase|Physician Decision|0|||
94519991|NCT02737501|323700073|FG001|Crossover Phase|Physician Decision|0|||
94519992|NCT02737501|323700074|FG002|Crossover Phase|Physician Decision|1|||
94519993|NCT02737501|323700072|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
94519994|NCT02737501|323700073|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
94519995|NCT02737501|323700074|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
94519996|NCT01171677|323700075|FG000|Overall Study|Withdrawal by Subject|0|||
94519997|NCT01171677|323700076|FG001|Overall Study|Withdrawal by Subject|3|||
94519998|NCT01171677|323700075|FG000|Overall Study|Adverse Event|1|||
94519999|NCT01171677|323700076|FG001|Overall Study|Adverse Event|0|||
94520000|NCT01171677|323700075|FG000|Overall Study|completed <70% IntenSati classes|5|||
94520001|NCT01171677|323700076|FG001|Overall Study|completed <70% IntenSati classes|0|||
94520002|NCT00833027|323700077|FG000|Overall Study|Adverse Event|33|||
94520003|NCT00833027|323700077|FG000|Overall Study|Death|1|||
94520004|NCT00833027|323700077|FG000|Overall Study|Lack of Efficacy|12|||
94520005|NCT00833027|323700077|FG000|Overall Study|Lost to Follow-up|24|||
94520006|NCT00833027|323700077|FG000|Overall Study|Protocol Violation|115|||
94520007|NCT00833027|323700077|FG000|Overall Study|Withdrawal by Subject|16|||
94520008|NCT00833027|323700077|FG000|Overall Study|Missing|10|||
94520009|NCT01816984|323700080|FG000|Overall Study|declining health status|1|||
94520010|NCT00943761|323700096|FG000|Overall Study|Lost to Follow-up|2|||
94520011|NCT00943761|323700097|FG001|Overall Study|Lost to Follow-up|0|||
94520012|NCT00943761|323700096|FG000|Overall Study|Withdrawal by Subject|2|||
94520013|NCT00943761|323700097|FG001|Overall Study|Withdrawal by Subject|1|||
94520014|NCT01928433|323700104|FG000|Overall Study|Adverse Event|5|||
94520015|NCT01928433|323700105|FG001|Overall Study|Adverse Event|2|||
94520016|NCT01928433|323700106|FG002|Overall Study|Adverse Event|5|||
94520017|NCT01928433|323700104|FG000|Overall Study|Protocol Violation|0|||
94520018|NCT01928433|323700105|FG001|Overall Study|Protocol Violation|0|||
94520019|NCT01928433|323700106|FG002|Overall Study|Protocol Violation|2|||
94520020|NCT01928433|323700104|FG000|Overall Study|Lack of Efficacy|5|||
94520021|NCT01928433|323700105|FG001|Overall Study|Lack of Efficacy|4|||
94520022|NCT01928433|323700106|FG002|Overall Study|Lack of Efficacy|4|||
94520023|NCT01928433|323700104|FG000|Overall Study|Withdrawal by Subject|0|||
94520024|NCT01928433|323700105|FG001|Overall Study|Withdrawal by Subject|4|||
94520025|NCT01928433|323700106|FG002|Overall Study|Withdrawal by Subject|0|||
94520026|NCT01928433|323700104|FG000|Overall Study|Negative screening urine culture|7|||
94520027|NCT01928433|323700105|FG001|Overall Study|Negative screening urine culture|6|||
94520028|NCT01928433|323700106|FG002|Overall Study|Negative screening urine culture|10|||
94520029|NCT01928433|323700104|FG000|Overall Study|Lost to Follow-up|0|||
94520030|NCT01928433|323700105|FG001|Overall Study|Lost to Follow-up|2|||
94520031|NCT01928433|323700106|FG002|Overall Study|Lost to Follow-up|3|||
94520032|NCT01928433|323700104|FG000|Overall Study|Other reasons|3|||
94520033|NCT01928433|323700105|FG001|Overall Study|Other reasons|3|||
94520034|NCT01928433|323700106|FG002|Overall Study|Other reasons|4|||
94520035|NCT01445847|323700109|FG000|Overall Study|Protocol Violation|13|||
94520036|NCT01445847|323700110|FG001|Overall Study|Protocol Violation|14|||
94520037|NCT01445847|323700109|FG000|Overall Study|Missed Data|1|||
94520038|NCT01445847|323700110|FG001|Overall Study|Missed Data|0|||
94520039|NCT01985022|323700113|FG000|Overall Study|Lost to Follow-up|0|||
94520040|NCT01985022|323700114|FG001|Overall Study|Lost to Follow-up|1|||
94520041|NCT01985022|323700113|FG000|Overall Study|Protocol Violation|0|||
94520042|NCT01985022|323700114|FG001|Overall Study|Protocol Violation|1|||
94520043|NCT01985022|323700113|FG000|Overall Study|Withdrawal by Subject|4|||
94520044|NCT01985022|323700114|FG001|Overall Study|Withdrawal by Subject|1|||
94520045|NCT02015039|323700115|FG000|Overall Study|Not eligible|0|||
94520046|NCT02015039|323700116|FG001|Overall Study|Not eligible|1|||
94520047|NCT04570384|323700117|FG000|Overall Study|Adverse Event|2|||
94520048|NCT04570384|323700118|FG001|Overall Study|Adverse Event|1|||
94520049|NCT04570384|323700117|FG000|Overall Study|Death|2|||
94520050|NCT04570384|323700118|FG001|Overall Study|Death|5|||
94520051|NCT04570384|323700117|FG000|Overall Study|Lost to Follow-up|1|||
94520052|NCT04570384|323700118|FG001|Overall Study|Lost to Follow-up|0|||
94520053|NCT04570384|323700117|FG000|Overall Study|Other|1|||
94520054|NCT04570384|323700118|FG001|Overall Study|Other|0|||
94520055|NCT04570384|323700117|FG000|Overall Study|Protocol Violation|0|||
94520056|NCT04570384|323700118|FG001|Overall Study|Protocol Violation|1|||
94520057|NCT04570384|323700117|FG000|Overall Study|Sponsor Decision|1|||
94520058|NCT04570384|323700118|FG001|Overall Study|Sponsor Decision|0|||
94520059|NCT04570384|323700117|FG000|Overall Study|Withdrawal by Subject|4|||
94520060|NCT04570384|323700118|FG001|Overall Study|Withdrawal by Subject|2|||
94520061|NCT02670473|323700120|FG000|Overall Study|Withdrawal by Subject|1|||
94520062|NCT01404234|323700124|FG000|Overall Study|Withdrawal by Subject|2|||
94520063|NCT04749914|323700125|FG000|Period 1|Adverse Event|1|||
94520064|NCT04749914|323700126|FG001|Period 1|Adverse Event|0|||
94520065|NCT04749914|323700127|FG002|Period 1|Adverse Event|0|||
94520066|NCT04749914|323700128|FG003|Period 1|Adverse Event|0|||
94520067|NCT04749914|323700125|FG000|Period 1|Withdrawal by Subject|1|||
94520068|NCT04749914|323700126|FG001|Period 1|Withdrawal by Subject|0|||
94520069|NCT04749914|323700127|FG002|Period 1|Withdrawal by Subject|1|||
94520070|NCT04749914|323700128|FG003|Period 1|Withdrawal by Subject|0|||
94520071|NCT00403130|323700131|FG000|2 Years From Start of Treatment|Not Eligible|3|||
94520072|NCT00403130|323700131|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
94520073|NCT00403130|323700131|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
94520074|NCT00403130|323700131|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
94520075|NCT00806260|323700132|FG000|Period 1 (1 Day)|Adverse Event|0|||
94520076|NCT00806260|323700133|FG001|Period 1 (1 Day)|Adverse Event|0|||
94520077|NCT00806260|323700134|FG002|Period 1 (1 Day)|Adverse Event|0|||
94520078|NCT00806260|323700135|FG003|Period 1 (1 Day)|Adverse Event|0|||
94520079|NCT00806260|323700136|FG004|Period 1 (1 Day)|Adverse Event|3|||
94520080|NCT00806260|323700137|FG005|Period 1 (1 Day)|Adverse Event|0|||
94520081|NCT00806260|323700132|FG000|Period 2|Adverse Event|0|||
94520082|NCT00806260|323700133|FG001|Period 2|Adverse Event|0|||
94520083|NCT00806260|323700134|FG002|Period 2|Adverse Event|0|||
94520084|NCT00806260|323700135|FG003|Period 2|Adverse Event|1|||
94520085|NCT00806260|323700136|FG004|Period 2|Adverse Event|0|||
94520086|NCT00806260|323700137|FG005|Period 2|Adverse Event|0|||
94520087|NCT00806260|323700132|FG000|Period 2|Protocol Violation|1|||
94520088|NCT00806260|323700133|FG001|Period 2|Protocol Violation|0|||
94520089|NCT00806260|323700134|FG002|Period 2|Protocol Violation|1|||
94520090|NCT00806260|323700135|FG003|Period 2|Protocol Violation|0|||
94520091|NCT00806260|323700136|FG004|Period 2|Protocol Violation|0|||
94520092|NCT00806260|323700137|FG005|Period 2|Protocol Violation|0|||
94520093|NCT00806260|323700132|FG000|Period 2|Need to take concomitant medication|1|||
94520094|NCT00806260|323700133|FG001|Period 2|Need to take concomitant medication|0|||
94520095|NCT00806260|323700134|FG002|Period 2|Need to take concomitant medication|0|||
94520096|NCT00806260|323700135|FG003|Period 2|Need to take concomitant medication|0|||
94520097|NCT00806260|323700136|FG004|Period 2|Need to take concomitant medication|0|||
94520098|NCT00806260|323700137|FG005|Period 2|Need to take concomitant medication|0|||
94520099|NCT00806260|323700132|FG000|Period 2|sponsor request|0|||
94520100|NCT00806260|323700133|FG001|Period 2|sponsor request|0|||
94520101|NCT00806260|323700134|FG002|Period 2|sponsor request|1|||
94520102|NCT00806260|323700135|FG003|Period 2|sponsor request|1|||
94520103|NCT00806260|323700136|FG004|Period 2|sponsor request|0|||
94520104|NCT00806260|323700137|FG005|Period 2|sponsor request|0|||
94520105|NCT00806260|323700132|FG000|Period 3|Protocol Violation|0|||
94520106|NCT00806260|323700133|FG001|Period 3|Protocol Violation|1|||
94520107|NCT00806260|323700134|FG002|Period 3|Protocol Violation|1|||
94520108|NCT00806260|323700135|FG003|Period 3|Protocol Violation|0|||
94520109|NCT00806260|323700136|FG004|Period 3|Protocol Violation|0|||
94520110|NCT00806260|323700137|FG005|Period 3|Protocol Violation|0|||
94520111|NCT00806260|323700132|FG000|Period 3|Pregnancy|1|||
94520112|NCT00806260|323700133|FG001|Period 3|Pregnancy|0|||
94520113|NCT00806260|323700134|FG002|Period 3|Pregnancy|0|||
94520114|NCT00806260|323700135|FG003|Period 3|Pregnancy|0|||
94520115|NCT00806260|323700136|FG004|Period 3|Pregnancy|0|||
94520116|NCT00806260|323700137|FG005|Period 3|Pregnancy|0|||
94520117|NCT01088906|323700143|FG000|Overall Study|Inclusion error|1|||
94520118|NCT01088906|323700143|FG000|Overall Study|Did not receive study treatment|3|||
94520119|NCT01088906|323700143|FG000|Overall Study|Missing data|1|||
94520120|NCT03559270|323700148|FG000|Overall Study|Adverse Event|6|||
94520121|NCT03559270|323700149|FG001|Overall Study|Adverse Event|5|||
94520122|NCT03559270|323700150|FG002|Overall Study|Adverse Event|3|||
94520123|NCT03559270|323700151|FG003|Overall Study|Adverse Event|0|||
94520124|NCT03559270|323700148|FG000|Overall Study|Lack of Efficacy|34|||
94520125|NCT03559270|323700149|FG001|Overall Study|Lack of Efficacy|52|||
94520126|NCT03559270|323700150|FG002|Overall Study|Lack of Efficacy|37|||
94520127|NCT03559270|323700151|FG003|Overall Study|Lack of Efficacy|2|||
94520128|NCT03559270|323700148|FG000|Overall Study|Death|0|||
94520129|NCT03559270|323700149|FG001|Overall Study|Death|2|||
94520130|NCT03559270|323700150|FG002|Overall Study|Death|0|||
94520131|NCT03559270|323700151|FG003|Overall Study|Death|0|||
94520132|NCT03559270|323700148|FG000|Overall Study|Lost to Follow-up|16|||
94520133|NCT03559270|323700149|FG001|Overall Study|Lost to Follow-up|4|||
94520134|NCT03559270|323700150|FG002|Overall Study|Lost to Follow-up|12|||
94520135|NCT03559270|323700151|FG003|Overall Study|Lost to Follow-up|3|||
94520136|NCT03559270|323700148|FG000|Overall Study|Sponsor Decision|38|||
94520137|NCT03559270|323700149|FG001|Overall Study|Sponsor Decision|31|||
94520138|NCT03559270|323700150|FG002|Overall Study|Sponsor Decision|35|||
94655704|NCT00560833|324196131|FG004|Overall Study|Other|0|||
94520139|NCT03559270|323700151|FG003|Overall Study|Sponsor Decision|18|||
94520140|NCT03559270|323700148|FG000|Overall Study|Withdrawal by Subject|19|||
94520141|NCT03559270|323700149|FG001|Overall Study|Withdrawal by Subject|21|||
94520142|NCT03559270|323700150|FG002|Overall Study|Withdrawal by Subject|18|||
94520143|NCT03559270|323700151|FG003|Overall Study|Withdrawal by Subject|7|||
94520144|NCT03559270|323700148|FG000|Overall Study|Physician Decision|3|||
94520145|NCT03559270|323700149|FG001|Overall Study|Physician Decision|2|||
94520146|NCT03559270|323700150|FG002|Overall Study|Physician Decision|1|||
94520147|NCT03559270|323700151|FG003|Overall Study|Physician Decision|0|||
94520148|NCT03559270|323700148|FG000|Overall Study|Pregnancy|0|||
94520149|NCT03559270|323700149|FG001|Overall Study|Pregnancy|1|||
94520150|NCT03559270|323700150|FG002|Overall Study|Pregnancy|0|||
94520151|NCT03559270|323700151|FG003|Overall Study|Pregnancy|0|||
94520152|NCT03559270|323700148|FG000|Overall Study|Protocol Violation|1|||
94520153|NCT03559270|323700149|FG001|Overall Study|Protocol Violation|0|||
94520154|NCT03559270|323700150|FG002|Overall Study|Protocol Violation|2|||
94520155|NCT03559270|323700151|FG003|Overall Study|Protocol Violation|0|||
94520156|NCT00322049|323701397|FG000|Overall Study|Moved out of area|0|||
94520157|NCT00322049|323701398|FG001|Overall Study|Moved out of area|0|||
94520158|NCT00322049|323701399|FG002|Overall Study|Moved out of area|0|||
94520159|NCT00322049|323701400|FG003|Overall Study|Moved out of area|1|||
94520160|NCT00322049|323701397|FG000|Overall Study|Infected with Dengue during study|0|||
94520161|NCT00322049|323701398|FG001|Overall Study|Infected with Dengue during study|1|||
94520162|NCT00322049|323701399|FG002|Overall Study|Infected with Dengue during study|0|||
94520163|NCT00322049|323701400|FG003|Overall Study|Infected with Dengue during study|0|||
94520164|NCT02026011|323701401|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
94520165|NCT02026011|323701402|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
94520166|NCT02026011|323701401|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
94520167|NCT02026011|323701402|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
94520168|NCT02026011|323701401|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
94520169|NCT02026011|323701402|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
94520170|NCT02026011|323701401|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
94520171|NCT02026011|323701402|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
94520172|NCT05111145|323701404|FG000|Overall Study|Commercial drug is available for participant|76|||
94520173|NCT05111145|323701404|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
94520174|NCT00441272|323701405|FG000|Overall Study|Study terminated prior to enrollment|25|||
94520175|NCT00441272|323701406|FG001|Overall Study|Study terminated prior to enrollment|25|||
94520176|NCT00427011|323701407|FG000|Overall Study|Adverse Event|10|||
94520177|NCT00427011|323701407|FG000|Overall Study|Withdrawal by Subject|1|||
94520178|NCT00427011|323701407|FG000|Overall Study|Lack of Efficacy|2|||
94520179|NCT00427011|323701407|FG000|Overall Study|Other|12|||
94520180|NCT03728933|323701408|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
94520181|NCT03728933|323701409|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94520182|NCT03728933|323701410|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
94520183|NCT03728933|323701408|FG000|Overall Study|Withdrawal by Subject|0|||
94520184|NCT03728933|323701409|FG001|Overall Study|Withdrawal by Subject|0|||
94520185|NCT03728933|323701410|FG002|Overall Study|Withdrawal by Subject|1|||
94520186|NCT03728933|323701408|FG000|Overall Study|Lost to Follow-up|0|||
94520187|NCT03728933|323701409|FG001|Overall Study|Lost to Follow-up|1|||
94520188|NCT03728933|323701410|FG002|Overall Study|Lost to Follow-up|0|||
94520189|NCT03728933|323701408|FG000|Overall Study|Adverse Event|1|||
94520190|NCT03728933|323701409|FG001|Overall Study|Adverse Event|0|||
94520191|NCT03728933|323701410|FG002|Overall Study|Adverse Event|0|||
94520192|NCT01628913|323701413|FG000|Overall Study|Adverse Event|12|||
94520193|NCT01628913|323701414|FG001|Overall Study|Adverse Event|5|||
94520194|NCT01628913|323701413|FG000|Overall Study|Disease Progression|11|||
94520195|NCT01628913|323701414|FG001|Overall Study|Disease Progression|14|||
94520196|NCT01628913|323701413|FG000|Overall Study|Protocol Violation|1|||
94520197|NCT01628913|323701414|FG001|Overall Study|Protocol Violation|0|||
94520198|NCT01628913|323701413|FG000|Overall Study|Death|1|||
94520199|NCT01628913|323701414|FG001|Overall Study|Death|0|||
94520200|NCT01628913|323701413|FG000|Overall Study|study terminated by Sponsor|4|||
94520201|NCT01628913|323701414|FG001|Overall Study|study terminated by Sponsor|9|||
94520202|NCT01628913|323701413|FG000|Overall Study|Withdrawal by Subject|1|||
94520203|NCT01628913|323701414|FG001|Overall Study|Withdrawal by Subject|0|||
94520204|NCT01628913|323701413|FG000|Overall Study|Physician Decision|1|||
94520205|NCT01628913|323701414|FG001|Overall Study|Physician Decision|3|||
94520206|NCT00105534|323701415|FG000|Overall Study|Adverse Event|2|||
94520207|NCT00105534|323701416|FG001|Overall Study|Adverse Event|5|||
94520208|NCT00105534|323701415|FG000|Overall Study|Protocol Violation|1|||
94520209|NCT00105534|323701416|FG001|Overall Study|Protocol Violation|4|||
94520210|NCT00105534|323701415|FG000|Overall Study|Withdrawal by Subject|6|||
94520211|NCT00105534|323701416|FG001|Overall Study|Withdrawal by Subject|6|||
94520212|NCT00105534|323701415|FG000|Overall Study|Lost to Follow-up|5|||
94520213|NCT00105534|323701416|FG001|Overall Study|Lost to Follow-up|1|||
94520214|NCT00105534|323701415|FG000|Overall Study|Lack of Efficacy|7|||
94520215|NCT00105534|323701416|FG001|Overall Study|Lack of Efficacy|15|||
94520216|NCT00105534|323701415|FG000|Overall Study|Treatment unmasked|1|||
94520217|NCT00105534|323701416|FG001|Overall Study|Treatment unmasked|0|||
94520218|NCT00105534|323701415|FG000|Overall Study|Other Reason|0|||
94520219|NCT00105534|323701416|FG001|Overall Study|Other Reason|2|||
94520220|NCT01621178|323701417|FG000|Overall Study|Adverse Event|5|||
94520221|NCT01621178|323701418|FG001|Overall Study|Adverse Event|2|||
94520222|NCT01621178|323701419|FG002|Overall Study|Adverse Event|8|||
94520223|NCT01621178|323701417|FG000|Overall Study|Death|6|||
94520224|NCT01621178|323701418|FG001|Overall Study|Death|7|||
94520225|NCT01621178|323701419|FG002|Overall Study|Death|2|||
94520226|NCT01621178|323701417|FG000|Overall Study|Lost to Follow-up|1|||
94520227|NCT01621178|323701418|FG001|Overall Study|Lost to Follow-up|2|||
94520228|NCT01621178|323701419|FG002|Overall Study|Lost to Follow-up|1|||
94520229|NCT01621178|323701417|FG000|Overall Study|Withdrawal by Subject|14|||
94520230|NCT01621178|323701418|FG001|Overall Study|Withdrawal by Subject|17|||
94520231|NCT01621178|323701419|FG002|Overall Study|Withdrawal by Subject|18|||
94520232|NCT01621178|323701417|FG000|Overall Study|Physician Decision|5|||
94520233|NCT01621178|323701418|FG001|Overall Study|Physician Decision|2|||
94520234|NCT01621178|323701419|FG002|Overall Study|Physician Decision|7|||
94520235|NCT02465931|323701420|FG000|Overall Study|Lost to Follow-up|9|||
94520236|NCT02465931|323701421|FG001|Overall Study|Lost to Follow-up|11|||
94520237|NCT02465931|323701420|FG000|Overall Study|Protocol Violation|1|||
94520238|NCT02465931|323701421|FG001|Overall Study|Protocol Violation|0|||
94520239|NCT02465931|323701420|FG000|Overall Study|Withdrawal by Subject|1|||
94520240|NCT02465931|323701421|FG001|Overall Study|Withdrawal by Subject|0|||
94520241|NCT05173974|323701422|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
94520242|NCT05173974|323701423|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
94520243|NCT05173974|323701424|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
94520244|NCT05173974|323701425|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
94520245|NCT05173974|323701422|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
94520246|NCT05173974|323701423|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
94520247|NCT05173974|323701424|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
94520248|NCT05173974|323701425|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
94520249|NCT01979614|323701426|FG000|Overall Study|Adverse Event|1|||
94520250|NCT01979614|323701427|FG001|Overall Study|Adverse Event|1|||
94520251|NCT00661830|323701428|FG000|Overall Study|Death|37|||
94520252|NCT00661830|323701429|FG001|Overall Study|Death|33|||
94520253|NCT00661830|323701428|FG000|Overall Study|Lost to Follow-up|1|||
94520254|NCT00661830|323701429|FG001|Overall Study|Lost to Follow-up|3|||
94520255|NCT00661830|323701428|FG000|Overall Study|Withdrawal by Subject|1|||
94520256|NCT00661830|323701429|FG001|Overall Study|Withdrawal by Subject|1|||
94520257|NCT00661830|323701428|FG000|Overall Study|Other reason|1|||
94520258|NCT00661830|323701429|FG001|Overall Study|Other reason|5|||
94520259|NCT00488514|323701430|FG000|Overall Study|Adverse Event|41|||
94520260|NCT00488514|323701430|FG000|Overall Study|Lost to Follow-up|44|||
94520261|NCT00488514|323701430|FG000|Overall Study|Protocol Violation|32|||
94520262|NCT00488514|323701430|FG000|Overall Study|Withdrawal by Subject|106|||
94520263|NCT00488514|323701430|FG000|Overall Study|Lack of Efficacy|28|||
94520264|NCT00488514|323701430|FG000|Overall Study|Did not meet criteria for treatment|30|||
94520265|NCT00488514|323701430|FG000|Overall Study|Postive drug screen|1|||
94520266|NCT00488514|323701430|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
94520267|NCT00488514|323701430|FG000|Overall Study|Investigator decision|1|||
94520268|NCT00488514|323701430|FG000|Overall Study|Participant had too few migraines|5|||
94520269|NCT00488514|323701430|FG000|Overall Study|Increase in number of migraines|2|||
94520270|NCT00488514|323701430|FG000|Overall Study|Increased use of concomitant medication|1|||
94520271|NCT01446874|323701431|FG000|Overall Study|Not eligible|1|||
94520272|NCT01446874|323701432|FG001|Overall Study|Not eligible|0|||
94520273|NCT01446874|323701433|FG002|Overall Study|Not eligible|0|||
94520274|NCT01446874|323701431|FG000|Overall Study|No surgery/No qualifying surgery|1|||
94520275|NCT01446874|323701432|FG001|Overall Study|No surgery/No qualifying surgery|0|||
94520276|NCT01446874|323701433|FG002|Overall Study|No surgery/No qualifying surgery|12|||
94520277|NCT01446874|323701431|FG000|Overall Study|Non-compliance|0|||
94520278|NCT01446874|323701432|FG001|Overall Study|Non-compliance|4|||
94520279|NCT01446874|323701433|FG002|Overall Study|Non-compliance|0|||
94520280|NCT01446874|323701431|FG000|Overall Study|Antibiotics for pre-op infection|0|||
94520281|NCT01446874|323701432|FG001|Overall Study|Antibiotics for pre-op infection|0|||
94520282|NCT01446874|323701433|FG002|Overall Study|Antibiotics for pre-op infection|2|||
94520283|NCT01446874|323701431|FG000|Overall Study|Withdrawal by Subject|0|||
94520284|NCT01446874|323701432|FG001|Overall Study|Withdrawal by Subject|0|||
94520285|NCT01446874|323701433|FG002|Overall Study|Withdrawal by Subject|4|||
94520286|NCT01977898|323701434|FG000|Overall Study|Non functioning catheter|1|||
94520287|NCT01977898|323701435|FG001|Overall Study|Non functioning catheter|1|||
94520288|NCT02580877|323701436|FG000|Overall Study|Withdrawal by Subject|1|||
94520289|NCT02580877|323701437|FG001|Overall Study|Withdrawal by Subject|3|||
94520290|NCT02580877|323701436|FG000|Overall Study|Adverse Event|0|||
94520291|NCT02580877|323701437|FG001|Overall Study|Adverse Event|1|||
94520292|NCT00892008|323701438|FG000|Overall Study|Death|5|||
94520293|NCT00892008|323701438|FG000|Overall Study|Lack of Efficacy|3|||
94520294|NCT00892008|323701438|FG000|Overall Study|Lost to Follow-up|142|||
94520295|NCT00892008|323701438|FG000|Overall Study|Other|378|||
94520296|NCT00892008|323701438|FG000|Overall Study|Adverse Event|37|||
94520297|NCT02727322|323701439|FG000|Overall Study|Withdrawal by Subject|1|||
94520298|NCT02727322|323701440|FG001|Overall Study|Withdrawal by Subject|1|||
94520299|NCT02727322|323701439|FG000|Overall Study|Protocol Violation|1|||
94520300|NCT02727322|323701440|FG001|Overall Study|Protocol Violation|0|||
94520301|NCT00325143|323701443|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
94520302|NCT00325143|323701443|FG000|Overall Study|Migrated/moved from study area|1|||
94520303|NCT00325143|323701443|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
94520304|NCT00325143|323701443|FG000|Overall Study|Withdrawal by Subject|8|||
94520305|NCT01343888|323701444|FG000|Overall Study|Adverse Event|12|||
94520306|NCT01343888|323701445|FG001|Overall Study|Adverse Event|22|||
94520307|NCT01343888|323701446|FG002|Overall Study|Adverse Event|5|||
94520308|NCT01343888|323701444|FG000|Overall Study|Lack of Efficacy|9|||
94520309|NCT01343888|323701445|FG001|Overall Study|Lack of Efficacy|9|||
94520310|NCT01343888|323701446|FG002|Overall Study|Lack of Efficacy|13|||
94520311|NCT01343888|323701444|FG000|Overall Study|Lost to Follow-up|0|||
94520312|NCT01343888|323701445|FG001|Overall Study|Lost to Follow-up|2|||
94520313|NCT01343888|323701446|FG002|Overall Study|Lost to Follow-up|1|||
94520314|NCT01343888|323701444|FG000|Overall Study|Protocol Violation|0|||
94520315|NCT01343888|323701445|FG001|Overall Study|Protocol Violation|2|||
94520316|NCT01343888|323701446|FG002|Overall Study|Protocol Violation|0|||
94520317|NCT01343888|323701444|FG000|Overall Study|Withdrawal by Subject|4|||
94520318|NCT01343888|323701445|FG001|Overall Study|Withdrawal by Subject|4|||
94520319|NCT01343888|323701446|FG002|Overall Study|Withdrawal by Subject|2|||
94520320|NCT01343888|323701444|FG000|Overall Study|other than stated above|0|||
94520321|NCT01343888|323701445|FG001|Overall Study|other than stated above|0|||
94520322|NCT01343888|323701446|FG002|Overall Study|other than stated above|1|||
94520323|NCT00558636|323701447|FG000|Treatment|Adverse Event|9|||
94520324|NCT00558636|323701448|FG001|Treatment|Adverse Event|2|||
94520325|NCT00558636|323701447|FG000|Treatment|Withdrawal by Subject|2|||
94520326|NCT00558636|323701448|FG001|Treatment|Withdrawal by Subject|0|||
94520327|NCT00558636|323701447|FG000|Treatment|Premature termination of the study|35|||
94520328|NCT00558636|323701448|FG001|Treatment|Premature termination of the study|37|||
94520329|NCT00558636|323701447|FG000|Treatment|Disease progression|1|||
94520330|NCT00558636|323701448|FG001|Treatment|Disease progression|5|||
94520331|NCT00558636|323701447|FG000|Follow-up|Premature termination of the study|12|||
94520332|NCT00558636|323701448|FG001|Follow-up|Premature termination of the study|7|||
94520333|NCT00387088|323701449|FG000|Overall Study|Adverse Event|143|||
94520334|NCT00387088|323701450|FG001|Overall Study|Adverse Event|156|||
94520335|NCT00387088|323701449|FG000|Overall Study|Protocol Violation|47|||
94520336|NCT00387088|323701450|FG001|Overall Study|Protocol Violation|35|||
94520337|NCT00387088|323701449|FG000|Overall Study|Withdrawal by Subject|20|||
94520338|NCT00387088|323701450|FG001|Overall Study|Withdrawal by Subject|35|||
94520339|NCT00387088|323701449|FG000|Overall Study|Lack of Efficacy|28|||
94520340|NCT00387088|323701450|FG001|Overall Study|Lack of Efficacy|67|||
94520341|NCT00387088|323701449|FG000|Overall Study|Lost to Follow-up|22|||
94520342|NCT00387088|323701450|FG001|Overall Study|Lost to Follow-up|28|||
94520343|NCT00387088|323701449|FG000|Overall Study|Other|58|||
94520344|NCT00387088|323701450|FG001|Overall Study|Other|52|||
94520345|NCT03443687|323701451|FG000|Overall Study|Lost to Follow-up|3|||
94520346|NCT03443687|323701452|FG001|Overall Study|Lost to Follow-up|5|||
94520347|NCT03443687|323701451|FG000|Overall Study|Withdrawal by Subject|1|||
94520348|NCT03443687|323701452|FG001|Overall Study|Withdrawal by Subject|0|||
94520349|NCT03443687|323701451|FG000|Overall Study|Discontinued intervention|1|||
94520350|NCT03443687|323701452|FG001|Overall Study|Discontinued intervention|1|||
94520351|NCT02805790|323701454|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
94520352|NCT02805790|323701455|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
94520353|NCT01627691|323701456|FG000|Overall Study|Death|11|||
94520354|NCT01627691|323701456|FG000|Overall Study|Lost to Follow-up|3|||
94520355|NCT01627691|323701456|FG000|Overall Study|Withdrawal by Subject|1|||
94520356|NCT01627691|323701456|FG000|Overall Study|Missed the visit|3|||
94520357|NCT00589797|323701458|FG000|Overall Study|Death|1|||
94520358|NCT00589797|323701459|FG001|Overall Study|Death|0|||
94520359|NCT00589797|323701458|FG000|Overall Study|Lost to Follow-up|12|||
94520360|NCT00589797|323701459|FG001|Overall Study|Lost to Follow-up|9|||
94520361|NCT00589797|323701458|FG000|Overall Study|Physician Decision|8|||
94520362|NCT00589797|323701459|FG001|Overall Study|Physician Decision|3|||
94520363|NCT00589797|323701458|FG000|Overall Study|Withdrawal by Subject|6|||
94520364|NCT00589797|323701459|FG001|Overall Study|Withdrawal by Subject|5|||
94520365|NCT00589797|323701458|FG000|Overall Study|Non-Randomized Training Subjects|46|||
94520366|NCT00589797|323701459|FG001|Overall Study|Non-Randomized Training Subjects|6|||
94520367|NCT02457247|323701460|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
94520368|NCT02457247|323701461|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
94520369|NCT02457247|323701462|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
94520370|NCT02457247|323701463|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
94520371|NCT02457247|323701460|FG000|Period 1|Significant Protocol Deviation|1|||
94520372|NCT02457247|323701461|FG001|Period 1|Significant Protocol Deviation|1|||
94520373|NCT02457247|323701462|FG002|Period 1|Significant Protocol Deviation|0|||
94520374|NCT02457247|323701463|FG003|Period 1|Significant Protocol Deviation|0|||
94520375|NCT02457247|323701460|FG000|Period 1|Voluntary Withdrawal|1|||
94520376|NCT02457247|323701461|FG001|Period 1|Voluntary Withdrawal|0|||
94520377|NCT02457247|323701462|FG002|Period 1|Voluntary Withdrawal|0|||
94520378|NCT02457247|323701463|FG003|Period 1|Voluntary Withdrawal|0|||
94520379|NCT02457247|323701460|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
94520380|NCT02457247|323701461|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
94520381|NCT02457247|323701462|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
94520382|NCT02457247|323701463|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
94520383|NCT02457247|323701460|FG000|Period 2|Significant Protocol Deviation|1|||
94520384|NCT02457247|323701461|FG001|Period 2|Significant Protocol Deviation|0|||
94520385|NCT02457247|323701462|FG002|Period 2|Significant Protocol Deviation|0|||
94520386|NCT02457247|323701463|FG003|Period 2|Significant Protocol Deviation|0|||
94520387|NCT02457247|323701460|FG000|Period 2|Lost to Follow-up|0|||
94520388|NCT02457247|323701461|FG001|Period 2|Lost to Follow-up|1|||
94520389|NCT02457247|323701462|FG002|Period 2|Lost to Follow-up|0|||
94520390|NCT02457247|323701463|FG003|Period 2|Lost to Follow-up|0|||
94520391|NCT02457247|323701460|FG000|Period 2|Voluntary Withdrawal|1|||
94520392|NCT02457247|323701461|FG001|Period 2|Voluntary Withdrawal|1|||
94520393|NCT02457247|323701462|FG002|Period 2|Voluntary Withdrawal|0|||
94520394|NCT02457247|323701463|FG003|Period 2|Voluntary Withdrawal|0|||
94520395|NCT03326063|323701464|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
94520396|NCT03326063|323701465|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
94520397|NCT03637491|323701466|FG000|Overall Study|Death|9|||
94520398|NCT03637491|323701467|FG001|Overall Study|Death|9|||
94520399|NCT03637491|323701468|FG002|Overall Study|Death|5|||
94520400|NCT03637491|323701469|FG003|Overall Study|Death|3|||
94520401|NCT03637491|323701466|FG000|Overall Study|Lost to Follow-up|0|||
94520402|NCT03637491|323701467|FG001|Overall Study|Lost to Follow-up|1|||
94520403|NCT03637491|323701468|FG002|Overall Study|Lost to Follow-up|0|||
94520404|NCT03637491|323701469|FG003|Overall Study|Lost to Follow-up|1|||
94520405|NCT03637491|323701466|FG000|Overall Study|Study Terminated By Sponsor|0|||
94520406|NCT03637491|323701467|FG001|Overall Study|Study Terminated By Sponsor|2|||
94520407|NCT03637491|323701468|FG002|Overall Study|Study Terminated By Sponsor|1|||
94520408|NCT03637491|323701469|FG003|Overall Study|Study Terminated By Sponsor|0|||
94520409|NCT03637491|323701466|FG000|Overall Study|Withdrawal by Subject|1|||
94520410|NCT03637491|323701467|FG001|Overall Study|Withdrawal by Subject|0|||
94520411|NCT03637491|323701468|FG002|Overall Study|Withdrawal by Subject|1|||
94520412|NCT03637491|323701469|FG003|Overall Study|Withdrawal by Subject|2|||
94520413|NCT01824290|323701470|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
94520414|NCT01824290|323701471|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
94520415|NCT01824290|323701472|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
94520416|NCT01824290|323701473|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
94520417|NCT01824290|323701470|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
94520418|NCT01824290|323701471|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
94520419|NCT01824290|323701472|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
94520420|NCT01824290|323701473|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
94520421|NCT01824290|323701470|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
94520422|NCT01824290|323701471|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
94520423|NCT01824290|323701472|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
94520424|NCT01824290|323701473|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
94520425|NCT01824290|323701470|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
94520426|NCT01824290|323701471|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
94520427|NCT01824290|323701472|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
94520428|NCT01824290|323701473|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
94520429|NCT01824290|323701470|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
94520430|NCT01824290|323701471|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
94520431|NCT01824290|323701472|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
94520432|NCT01824290|323701473|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
94520433|NCT01824290|323701470|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
94520434|NCT01824290|323701471|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
94520435|NCT01824290|323701472|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
94520436|NCT01824290|323701473|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
94520437|NCT00527618|323701474|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
94520438|NCT00527618|323701475|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
94520439|NCT00527618|323701474|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
94520440|NCT00527618|323701475|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
94520441|NCT00527618|323701474|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
94520442|NCT00527618|323701475|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
94520443|NCT00527618|323701474|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
94520444|NCT00527618|323701475|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
94655705|NCT00560833|324196127|FG000|Overall Study|Never received drug|0|||
94655706|NCT00560833|324196128|FG001|Overall Study|Never received drug|1|||
94520445|NCT00527618|323701474|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
94655707|NCT00560833|324196129|FG002|Overall Study|Never received drug|0|||
94520446|NCT00527618|323701475|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
94520447|NCT00527618|323701474|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
94520448|NCT00527618|323701475|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
94520449|NCT02850978|323701489|FG000|Overall Study|Uncollectable CRF|27|||
94520450|NCT02850978|323701489|FG000|Overall Study|No visit since the first visit|35|||
94520451|NCT02850978|323701489|FG000|Overall Study|Adverse Event|81|||
94520452|NCT02850978|323701489|FG000|Overall Study|Lack of Efficacy|40|||
94520453|NCT02850978|323701489|FG000|Overall Study|Improvement in condition|34|||
94520454|NCT02850978|323701489|FG000|Overall Study|Lost to Follow-up|121|||
94520455|NCT02850978|323701489|FG000|Overall Study|Reason not listed|88|||
94520456|NCT00114127|323701490|FG000|Overall Study|Adverse Event|2|||
94520457|NCT00114127|323701491|FG001|Overall Study|Adverse Event|1|||
94520458|NCT00114127|323701490|FG000|Overall Study|Lost to Follow-up|1|||
94520459|NCT00114127|323701491|FG001|Overall Study|Lost to Follow-up|0|||
94520460|NCT00114127|323701490|FG000|Overall Study|Withdrawal by Subject|1|||
94520461|NCT00114127|323701491|FG001|Overall Study|Withdrawal by Subject|3|||
94520462|NCT00699413|323701492|FG000|Overall Study|Withdrawal by Subject|0|||
94520463|NCT00699413|323701493|FG001|Overall Study|Withdrawal by Subject|2|||
94520464|NCT00699413|323701492|FG000|Overall Study|Study terminated by sponsor|4|||
94520465|NCT00699413|323701493|FG001|Overall Study|Study terminated by sponsor|2|||
94520466|NCT02779777|323701494|FG000|Overall Study|Disease Progression|1|||
94520467|NCT02779777|323701495|FG001|Overall Study|Disease Progression|0|||
94520468|NCT02779777|323701496|FG002|Overall Study|Disease Progression|0|||
94520469|NCT02779777|323701494|FG000|Overall Study|Adverse Event|3|||
94520470|NCT02779777|323701495|FG001|Overall Study|Adverse Event|1|||
94520471|NCT02779777|323701496|FG002|Overall Study|Adverse Event|0|||
94520472|NCT02779777|323701494|FG000|Overall Study|Physician Decision|9|||
94520473|NCT02779777|323701495|FG001|Overall Study|Physician Decision|0|||
94520474|NCT02779777|323701496|FG002|Overall Study|Physician Decision|1|||
94520475|NCT02779777|323701494|FG000|Overall Study|Withdrawal by Subject|1|||
94520476|NCT02779777|323701495|FG001|Overall Study|Withdrawal by Subject|0|||
94520477|NCT02779777|323701496|FG002|Overall Study|Withdrawal by Subject|0|||
94520478|NCT00442416|323701497|FG000|Overall Study|Adverse Event|4|||
94520479|NCT00442416|323701498|FG001|Overall Study|Adverse Event|1|||
94520480|NCT00442416|323701497|FG000|Overall Study|Death|1|||
94520481|NCT00442416|323701498|FG001|Overall Study|Death|0|||
94520482|NCT00442416|323701497|FG000|Overall Study|Lack of Efficacy|2|||
94520483|NCT00442416|323701498|FG001|Overall Study|Lack of Efficacy|0|||
94520484|NCT00442416|323701497|FG000|Overall Study|Protocol Violation|2|||
94520485|NCT00442416|323701498|FG001|Overall Study|Protocol Violation|3|||
94520486|NCT00442416|323701497|FG000|Overall Study|Withdrew consent|1|||
94520487|NCT00442416|323701498|FG001|Overall Study|Withdrew consent|2|||
94520488|NCT00442416|323701497|FG000|Overall Study|Administrative/Other|27|||
94520489|NCT00442416|323701498|FG001|Overall Study|Administrative/Other|33|||
94520490|NCT01055613|323701499|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
94520491|NCT01055613|323701500|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
94520492|NCT01055613|323701499|FG000|Overall Study|Unacceptable lens fit|1|||
94520493|NCT01055613|323701500|FG001|Overall Study|Unacceptable lens fit|0|||
94520494|NCT01055613|323701499|FG000|Overall Study|Discomfort|2|||
94520495|NCT01055613|323701500|FG001|Overall Study|Discomfort|1|||
94520496|NCT01055613|323701499|FG000|Overall Study|Lost to Follow-up|1|||
94520497|NCT01055613|323701500|FG001|Overall Study|Lost to Follow-up|1|||
94520498|NCT01055613|323701499|FG000|Overall Study|Protocol Violation|1|||
94520499|NCT01055613|323701500|FG001|Overall Study|Protocol Violation|1|||
94520500|NCT01055613|323701499|FG000|Overall Study|Subject Disinterest|1|||
94520501|NCT01055613|323701500|FG001|Overall Study|Subject Disinterest|1|||
94520502|NCT00444925|323701503|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
94520503|NCT00444925|323701504|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
94520504|NCT00444925|323701505|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
94520505|NCT00444925|323701503|FG000|Double-blind Treatment Period|Death|2|||
94520506|NCT00444925|323701504|FG001|Double-blind Treatment Period|Death|0|||
94520507|NCT00444925|323701505|FG002|Double-blind Treatment Period|Death|0|||
94520508|NCT00444925|323701503|FG000|Double-blind Treatment Period|Adverse Event|6|||
94520509|NCT00444925|323701504|FG001|Double-blind Treatment Period|Adverse Event|28|||
94520510|NCT00444925|323701505|FG002|Double-blind Treatment Period|Adverse Event|44|||
94520511|NCT00444925|323701503|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
94520512|NCT00444925|323701504|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
94520513|NCT00444925|323701505|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
94520514|NCT00444925|323701503|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
94520515|NCT00444925|323701504|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
94520516|NCT00444925|323701505|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
94520517|NCT00444925|323701503|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
94520518|NCT00444925|323701504|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
94520519|NCT00444925|323701505|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
94520520|NCT00444925|323701503|FG000|Double-blind Treatment Period|Other|7|||
94520521|NCT00444925|323701504|FG001|Double-blind Treatment Period|Other|7|||
94520522|NCT00444925|323701505|FG002|Double-blind Treatment Period|Other|12|||
94520523|NCT02806414|323701507|FG000|Overall Study|Lost to Follow-up|2|||
94520524|NCT01913327|323701512|FG000|Overall Study|Withdrawal by Subject|0|||
94520525|NCT01913327|323701513|FG001|Overall Study|Withdrawal by Subject|1|||
94520526|NCT03965403|323701518|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
94520527|NCT00939107|323703209|FG000|Overall Study|Lost to Follow-up|14|||
94520528|NCT00939107|323703210|FG001|Overall Study|Lost to Follow-up|12|||
94520529|NCT01133665|323703211|FG000|Overall Study|Physician Decision|2|||
94520530|NCT00529243|323703212|FG000|Overall Study|Adverse Event|1|||
94520531|NCT00529243|323703212|FG000|Overall Study|Death|1|||
94520532|NCT00529243|323703212|FG000|Overall Study|Relocated|1|||
94520533|NCT00937495|323703216|FG000|Overall Study|Protocol Violation|2|||
94520534|NCT00948688|323703220|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
94520535|NCT00948688|323703221|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
94520536|NCT00948688|323703220|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
94520537|NCT00948688|323703221|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
94520538|NCT00948688|323703220|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
94520539|NCT00948688|323703221|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
94520540|NCT01248793|323703222|FG000|Overall Study|Lost to Follow-up|0|||
94520541|NCT01248793|323703223|FG001|Overall Study|Lost to Follow-up|1|||
94520542|NCT01248793|323703222|FG000|Overall Study|Adverse Event|1|||
94520543|NCT01248793|323703223|FG001|Overall Study|Adverse Event|1|||
94520544|NCT01248793|323703222|FG000|Overall Study|Protocol Violation|0|||
94520545|NCT01248793|323703223|FG001|Overall Study|Protocol Violation|1|||
94520546|NCT01248793|323703222|FG000|Overall Study|Withdrawal by Subject|3|||
94520547|NCT01248793|323703223|FG001|Overall Study|Withdrawal by Subject|3|||
94520548|NCT01840943|323703228|FG000|Overall Study|Withdrawal by Subject|5|||
94520549|NCT01840943|323703229|FG001|Overall Study|Withdrawal by Subject|6|||
94520550|NCT01840943|323703228|FG000|Overall Study|Physician Decision|4|||
94520551|NCT01840943|323703229|FG001|Overall Study|Physician Decision|2|||
94520552|NCT01840943|323703228|FG000|Overall Study|Lost to Follow-up|4|||
94520553|NCT01840943|323703229|FG001|Overall Study|Lost to Follow-up|4|||
94520554|NCT00457392|323703230|FG000|Overall Study|Objective Progression or Relapse|229|||
94520555|NCT00457392|323703231|FG001|Overall Study|Objective Progression or Relapse|296|||
94520556|NCT00457392|323703230|FG000|Overall Study|Death|106|||
94520557|NCT00457392|323703231|FG001|Overall Study|Death|106|||
94520558|NCT00457392|323703230|FG000|Overall Study|Adverse Event|84|||
94520559|NCT00457392|323703231|FG001|Overall Study|Adverse Event|41|||
94520560|NCT00457392|323703230|FG000|Overall Study|Global Deterioration of Health Status|22|||
94520561|NCT00457392|323703231|FG001|Overall Study|Global Deterioration of Health Status|8|||
94520562|NCT00457392|323703230|FG000|Overall Study|Withdrawal by Subject|14|||
94520563|NCT00457392|323703231|FG001|Overall Study|Withdrawal by Subject|8|||
94520564|NCT00457392|323703230|FG000|Overall Study|Lost to Follow-up|6|||
94520565|NCT00457392|323703231|FG001|Overall Study|Lost to Follow-up|7|||
94520566|NCT00457392|323703230|FG000|Overall Study|Protocol Violation|4|||
94520567|NCT00457392|323703231|FG001|Overall Study|Protocol Violation|3|||
94520568|NCT00457392|323703230|FG000|Overall Study|Other|7|||
94520569|NCT00457392|323703231|FG001|Overall Study|Other|4|||
94520570|NCT00457392|323703230|FG000|Overall Study|Study Terminated by Sponsor|1|||
94520571|NCT00457392|323703231|FG001|Overall Study|Study Terminated by Sponsor|4|||
94520572|NCT00457392|323703230|FG000|Overall Study|Randomized, Not Treated|7|||
94520573|NCT00457392|323703231|FG001|Overall Study|Randomized, Not Treated|3|||
94520574|NCT01823107|323703234|FG000|Overall Study|Withdrawal by Subject|1|||
94520575|NCT03036852|323703235|FG000|Overall Study|Death|2|||
94520576|NCT03036852|323703235|FG000|Overall Study|Lack of Efficacy|2|||
94520577|NCT03036852|323703235|FG000|Overall Study|Adverse Event|1|||
94520578|NCT03036852|323703235|FG000|Overall Study|Lost to Follow-up|1|||
94520579|NCT01008618|323703243|FG000|Period 1 (Titration Period)|Physician Decision|2|||
94520580|NCT01008618|323703244|FG001|Period 1 (Titration Period)|Physician Decision|0|||
94520581|NCT01008618|323703245|FG002|Period 1 (Titration Period)|Physician Decision|0|||
94520582|NCT01008618|323703243|FG000|Period 1 (Titration Period)|Adverse Event|33|||
94520583|NCT01008618|323703244|FG001|Period 1 (Titration Period)|Adverse Event|0|||
94520584|NCT01008618|323703245|FG002|Period 1 (Titration Period)|Adverse Event|0|||
94520585|NCT01008618|323703243|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
94520586|NCT01008618|323703244|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
94520587|NCT01008618|323703245|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
94520588|NCT01008618|323703243|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
94520589|NCT01008618|323703244|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
94520590|NCT01008618|323703245|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
94520591|NCT01008618|323703243|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
94520592|NCT01008618|323703244|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
94520593|NCT01008618|323703245|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
94520594|NCT01008618|323703243|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
94520595|NCT01008618|323703244|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
94520596|NCT01008618|323703245|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
94520597|NCT01008618|323703243|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
94520598|NCT01008618|323703244|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
94520599|NCT01008618|323703245|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
94520600|NCT01008618|323703243|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
94520601|NCT01008618|323703244|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
94520602|NCT01008618|323703245|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
94520603|NCT01008618|323703243|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
94520604|NCT01008618|323703244|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
94520605|NCT01008618|323703245|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
94520606|NCT01008618|323703243|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
94520607|NCT01008618|323703244|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
94520608|NCT01008618|323703245|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
94520609|NCT01008618|323703243|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
94520610|NCT01008618|323703244|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
94520611|NCT01008618|323703245|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
94520612|NCT01008618|323703243|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
94520613|NCT01008618|323703244|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
94520614|NCT01008618|323703245|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
94520615|NCT02897115|323703246|FG000|Overall Study|Early termination of study by sponsor|11|||
94520616|NCT02897115|323703247|FG001|Overall Study|Early termination of study by sponsor|8|||
94520617|NCT01213082|323703248|FG000|Overall Study|Lost to Follow-up|6|||
94520618|NCT01213082|323703249|FG001|Overall Study|Lost to Follow-up|7|||
94520619|NCT01213082|323703250|FG002|Overall Study|Lost to Follow-up|4|||
94520620|NCT01213082|323703248|FG000|Overall Study|Physician Decision|0|||
94520621|NCT01213082|323703249|FG001|Overall Study|Physician Decision|0|||
94520622|NCT01213082|323703250|FG002|Overall Study|Physician Decision|1|||
94520623|NCT00856323|323703251|FG000|Overall Study|Withdrawal by Subject|2|||
94520624|NCT03848416|323703252|FG000|Overall Study|Withdrawal by Subject|1|||
94520625|NCT03848416|323703253|FG001|Overall Study|Withdrawal by Subject|0|||
94520626|NCT03848416|323703254|FG002|Overall Study|Withdrawal by Subject|0|||
94520627|NCT03848416|323703252|FG000|Overall Study|Death|0|||
94520628|NCT03848416|323703253|FG001|Overall Study|Death|0|||
94520629|NCT03848416|323703254|FG002|Overall Study|Death|1|||
94520630|NCT02808429|323703256|FG000|Overall Study|Lost to Follow-up|1|||
94520631|NCT02808429|323703257|FG001|Overall Study|Lost to Follow-up|0|||
94520632|NCT02808429|323703258|FG002|Overall Study|Lost to Follow-up|0|||
94520633|NCT02808429|323703256|FG000|Overall Study|Protocol Violation|0|||
94520634|NCT02808429|323703257|FG001|Overall Study|Protocol Violation|1|||
94520635|NCT02808429|323703258|FG002|Overall Study|Protocol Violation|0|||
94520636|NCT02808429|323703256|FG000|Overall Study|Premature study termination by sponsor|2|||
94520637|NCT02808429|323703257|FG001|Overall Study|Premature study termination by sponsor|0|||
94520638|NCT02808429|323703258|FG002|Overall Study|Premature study termination by sponsor|1|||
94520639|NCT02808429|323703256|FG000|Overall Study|Relocation|0|||
94520640|NCT02808429|323703257|FG001|Overall Study|Relocation|0|||
94520641|NCT02808429|323703258|FG002|Overall Study|Relocation|1|||
94520642|NCT01428219|323703267|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
94520643|NCT02479880|323703268|FG000|Overall Study|Study Terminated by Sponsor|13|||
94520644|NCT02479880|323703269|FG001|Overall Study|Study Terminated by Sponsor|12|||
94520645|NCT02479880|323703268|FG000|Overall Study|Pregnancy|0|||
94520646|NCT02479880|323703269|FG001|Overall Study|Pregnancy|1|||
94520647|NCT01696773|323703276|FG000|Days 15-27, Washout|Adverse Event|1|||
94520648|NCT01696773|323703277|FG001|Days 15-27, Washout|Adverse Event|0|||
94520649|NCT03745768|323703278|FG000|Overall Study|discontinued study|2|||
94520650|NCT03745768|323703279|FG001|Overall Study|discontinued study|0|||
94520651|NCT01791517|323703281|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
94520652|NCT01791517|323703282|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
94520653|NCT01791517|323703283|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
94520654|NCT01791517|323703284|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
94520655|NCT01791517|323703285|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
94520656|NCT01791517|323703286|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
94520657|NCT01791517|323703287|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
94520658|NCT01791517|323703288|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
94520659|NCT01791517|323703289|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
94520660|NCT01791517|323703290|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
94520661|NCT01791517|323703291|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
94520662|NCT01791517|323703292|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
94520663|NCT01791517|323703281|FG000|Phase I: Period 1|Adverse Event|0|||
94520664|NCT01791517|323703282|FG001|Phase I: Period 1|Adverse Event|0|||
94520665|NCT01791517|323703283|FG002|Phase I: Period 1|Adverse Event|1|||
94520666|NCT01791517|323703284|FG003|Phase I: Period 1|Adverse Event|1|||
94520667|NCT01791517|323703285|FG004|Phase I: Period 1|Adverse Event|0|||
94520668|NCT01791517|323703286|FG005|Phase I: Period 1|Adverse Event|0|||
94520669|NCT01791517|323703287|FG006|Phase I: Period 1|Adverse Event|0|||
94520670|NCT01791517|323703288|FG007|Phase I: Period 1|Adverse Event|0|||
94520671|NCT01791517|323703289|FG008|Phase I: Period 1|Adverse Event|0|||
94520672|NCT01791517|323703290|FG009|Phase I: Period 1|Adverse Event|0|||
94520673|NCT01791517|323703291|FG010|Phase I: Period 1|Adverse Event|0|||
94520674|NCT01791517|323703292|FG011|Phase I: Period 1|Adverse Event|0|||
94520675|NCT01791517|323703281|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
94520676|NCT01791517|323703282|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
94520677|NCT01791517|323703283|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
94520678|NCT01791517|323703284|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
94520679|NCT01791517|323703285|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
94520680|NCT01791517|323703286|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
94520681|NCT01791517|323703287|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
94655708|NCT00560833|324196130|FG003|Overall Study|Never received drug|0|||
94655709|NCT00560833|324196131|FG004|Overall Study|Never received drug|1|||
94655710|NCT00829621|324196132|FG000|Overall Study|Death|1|||
94655711|NCT00829621|324196133|FG001|Overall Study|Death|0|||
94655712|NCT00829621|324196132|FG000|Overall Study|Lost to Follow-up|3|||
94655713|NCT00829621|324196133|FG001|Overall Study|Lost to Follow-up|4|||
94655714|NCT02770391|324196134|FG000|Overall Study|Lost to Follow-up|2|||
94655715|NCT02770391|324196134|FG000|Overall Study|Withdrawal by Subject|1|||
94655716|NCT02770391|324196134|FG000|Overall Study|Surgery delayed unevaluable|2|||
94655717|NCT02770391|324196134|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
94655718|NCT03403634|324196135|FG000|Overall Study|Disease progression|3|||
94655719|NCT03403634|324196135|FG000|Overall Study|Did not meet eligibility criteria|4|||
94655720|NCT01850004|324196136|FG000|Overall Study|Poor/Non-compliance|1|||
94655721|NCT01850004|324196136|FG000|Overall Study|Participant Withdrew Consent|9|||
94655722|NCT01850004|324196136|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
94655723|NCT01850004|324196136|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
94655724|NCT01850004|324196136|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
94655725|NCT01850004|324196136|FG000|Overall Study|Other Reasons|2|||
94655726|NCT01850004|324196136|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
94655727|NCT01850004|324196136|FG000|Overall Study|Maximum Clinical Benefit|4|||
94520682|NCT01791517|323703288|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
94520683|NCT01791517|323703289|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
94520684|NCT01791517|323703290|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
94520685|NCT01791517|323703291|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
94520686|NCT01791517|323703292|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
94520687|NCT01791517|323703281|FG000|Phase I: Period 1|Protocol Violation|0|||
94520688|NCT01791517|323703282|FG001|Phase I: Period 1|Protocol Violation|1|||
94520689|NCT01791517|323703283|FG002|Phase I: Period 1|Protocol Violation|0|||
94520690|NCT01791517|323703284|FG003|Phase I: Period 1|Protocol Violation|0|||
94520691|NCT01791517|323703285|FG004|Phase I: Period 1|Protocol Violation|0|||
94520692|NCT01791517|323703286|FG005|Phase I: Period 1|Protocol Violation|0|||
94520693|NCT01791517|323703287|FG006|Phase I: Period 1|Protocol Violation|0|||
94520694|NCT01791517|323703288|FG007|Phase I: Period 1|Protocol Violation|0|||
94520695|NCT01791517|323703289|FG008|Phase I: Period 1|Protocol Violation|0|||
94520696|NCT01791517|323703290|FG009|Phase I: Period 1|Protocol Violation|0|||
94520697|NCT01791517|323703291|FG010|Phase I: Period 1|Protocol Violation|0|||
94520698|NCT01791517|323703292|FG011|Phase I: Period 1|Protocol Violation|0|||
94520699|NCT01791517|323703281|FG000|Phase I: Period 1|Lost to Follow-up|0|||
94520700|NCT01791517|323703282|FG001|Phase I: Period 1|Lost to Follow-up|0|||
94520701|NCT01791517|323703283|FG002|Phase I: Period 1|Lost to Follow-up|0|||
94520702|NCT01791517|323703284|FG003|Phase I: Period 1|Lost to Follow-up|1|||
94520703|NCT01791517|323703285|FG004|Phase I: Period 1|Lost to Follow-up|0|||
94520704|NCT01791517|323703286|FG005|Phase I: Period 1|Lost to Follow-up|0|||
94520705|NCT01791517|323703287|FG006|Phase I: Period 1|Lost to Follow-up|1|||
94520706|NCT01791517|323703288|FG007|Phase I: Period 1|Lost to Follow-up|0|||
94520707|NCT01791517|323703289|FG008|Phase I: Period 1|Lost to Follow-up|1|||
94520708|NCT01791517|323703290|FG009|Phase I: Period 1|Lost to Follow-up|1|||
94520709|NCT01791517|323703291|FG010|Phase I: Period 1|Lost to Follow-up|0|||
94520710|NCT01791517|323703292|FG011|Phase I: Period 1|Lost to Follow-up|0|||
94520711|NCT01791517|323703281|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
94520712|NCT01791517|323703282|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
94520713|NCT01791517|323703283|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
94520714|NCT01791517|323703284|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
94520715|NCT01791517|323703285|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
94520716|NCT01791517|323703286|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
94520717|NCT01791517|323703287|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
94520718|NCT01791517|323703288|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
94520719|NCT01791517|323703289|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
94520720|NCT01791517|323703290|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
94520721|NCT01791517|323703291|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
94520722|NCT01791517|323703292|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
94520723|NCT01791517|323703281|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
94520724|NCT01791517|323703282|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
94520725|NCT01791517|323703283|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
94520726|NCT01791517|323703284|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
94520727|NCT01791517|323703285|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
94520728|NCT01791517|323703286|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
94520729|NCT01791517|323703287|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
94520730|NCT01791517|323703288|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
94520731|NCT01791517|323703289|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
94520732|NCT01791517|323703290|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
94520733|NCT01791517|323703291|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
94520734|NCT01791517|323703292|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
94520735|NCT01791517|323703281|FG000|Phase I: Period 2|Protocol Violation|0|||
94520736|NCT01791517|323703282|FG001|Phase I: Period 2|Protocol Violation|0|||
94520737|NCT01791517|323703283|FG002|Phase I: Period 2|Protocol Violation|0|||
94520738|NCT01791517|323703284|FG003|Phase I: Period 2|Protocol Violation|1|||
94520739|NCT01791517|323703285|FG004|Phase I: Period 2|Protocol Violation|0|||
94520740|NCT01791517|323703286|FG005|Phase I: Period 2|Protocol Violation|0|||
94520741|NCT01791517|323703287|FG006|Phase I: Period 2|Protocol Violation|0|||
94520742|NCT01791517|323703288|FG007|Phase I: Period 2|Protocol Violation|0|||
94520743|NCT01791517|323703289|FG008|Phase I: Period 2|Protocol Violation|0|||
94520744|NCT01791517|323703290|FG009|Phase I: Period 2|Protocol Violation|0|||
94520745|NCT01791517|323703291|FG010|Phase I: Period 2|Protocol Violation|0|||
94520746|NCT01791517|323703292|FG011|Phase I: Period 2|Protocol Violation|0|||
94520747|NCT01791517|323703281|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
94520748|NCT01791517|323703282|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
94520749|NCT01791517|323703283|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
94520750|NCT01791517|323703284|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
94520751|NCT01791517|323703285|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
94520752|NCT01791517|323703286|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
94520753|NCT01791517|323703287|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
94520754|NCT01791517|323703288|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
94520755|NCT01791517|323703289|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
94520756|NCT01791517|323703290|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
94520757|NCT01791517|323703291|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
94520758|NCT01791517|323703292|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
94520759|NCT01791517|323703281|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
94520760|NCT01791517|323703282|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
94520761|NCT01791517|323703283|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
94520762|NCT01791517|323703284|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
94520763|NCT01791517|323703285|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
94520764|NCT01791517|323703286|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
94520765|NCT01791517|323703287|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
94520766|NCT01791517|323703288|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
94520767|NCT01791517|323703289|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
94520768|NCT01791517|323703290|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
94520769|NCT01791517|323703291|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
94520770|NCT01791517|323703292|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
94520771|NCT01791517|323703281|FG000|Phase I: Period 2|Lens Discomfort|0|||
94520772|NCT01791517|323703282|FG001|Phase I: Period 2|Lens Discomfort|0|||
94520773|NCT01791517|323703283|FG002|Phase I: Period 2|Lens Discomfort|0|||
94520774|NCT01791517|323703284|FG003|Phase I: Period 2|Lens Discomfort|0|||
94520775|NCT01791517|323703285|FG004|Phase I: Period 2|Lens Discomfort|0|||
94520776|NCT01791517|323703286|FG005|Phase I: Period 2|Lens Discomfort|1|||
94520777|NCT01791517|323703287|FG006|Phase I: Period 2|Lens Discomfort|0|||
94520778|NCT01791517|323703288|FG007|Phase I: Period 2|Lens Discomfort|0|||
94520779|NCT01791517|323703289|FG008|Phase I: Period 2|Lens Discomfort|0|||
94520780|NCT01791517|323703290|FG009|Phase I: Period 2|Lens Discomfort|0|||
94520781|NCT01791517|323703291|FG010|Phase I: Period 2|Lens Discomfort|0|||
94520782|NCT01791517|323703292|FG011|Phase I: Period 2|Lens Discomfort|0|||
94520783|NCT01791517|323703281|FG000|Phase I: Period 2|Lost to Follow-up|0|||
94520784|NCT01791517|323703282|FG001|Phase I: Period 2|Lost to Follow-up|3|||
94520785|NCT01791517|323703283|FG002|Phase I: Period 2|Lost to Follow-up|2|||
94520786|NCT01791517|323703284|FG003|Phase I: Period 2|Lost to Follow-up|0|||
94520787|NCT01791517|323703285|FG004|Phase I: Period 2|Lost to Follow-up|0|||
94520788|NCT01791517|323703286|FG005|Phase I: Period 2|Lost to Follow-up|0|||
94520789|NCT01791517|323703287|FG006|Phase I: Period 2|Lost to Follow-up|0|||
94520790|NCT01791517|323703288|FG007|Phase I: Period 2|Lost to Follow-up|0|||
94520791|NCT01791517|323703289|FG008|Phase I: Period 2|Lost to Follow-up|0|||
94520792|NCT01791517|323703290|FG009|Phase I: Period 2|Lost to Follow-up|0|||
94520793|NCT01791517|323703291|FG010|Phase I: Period 2|Lost to Follow-up|0|||
94520794|NCT01791517|323703292|FG011|Phase I: Period 2|Lost to Follow-up|0|||
94520795|NCT01791517|323703281|FG000|Phase I: Period 3|Lens Discomfort|0|||
94520796|NCT01791517|323703282|FG001|Phase I: Period 3|Lens Discomfort|0|||
94520797|NCT01791517|323703283|FG002|Phase I: Period 3|Lens Discomfort|0|||
94520798|NCT01791517|323703284|FG003|Phase I: Period 3|Lens Discomfort|0|||
94520799|NCT01791517|323703285|FG004|Phase I: Period 3|Lens Discomfort|0|||
94520800|NCT01791517|323703286|FG005|Phase I: Period 3|Lens Discomfort|0|||
94520801|NCT01791517|323703287|FG006|Phase I: Period 3|Lens Discomfort|0|||
94520802|NCT01791517|323703288|FG007|Phase I: Period 3|Lens Discomfort|0|||
94520803|NCT01791517|323703289|FG008|Phase I: Period 3|Lens Discomfort|0|||
94520804|NCT01791517|323703290|FG009|Phase I: Period 3|Lens Discomfort|0|||
94520805|NCT01791517|323703291|FG010|Phase I: Period 3|Lens Discomfort|0|||
94520806|NCT01791517|323703292|FG011|Phase I: Period 3|Lens Discomfort|1|||
94520807|NCT01791517|323703281|FG000|Phase I: Period 3|Lost to Follow-up|0|||
94520808|NCT01791517|323703282|FG001|Phase I: Period 3|Lost to Follow-up|1|||
94520809|NCT01791517|323703283|FG002|Phase I: Period 3|Lost to Follow-up|0|||
94520810|NCT01791517|323703284|FG003|Phase I: Period 3|Lost to Follow-up|0|||
94520811|NCT01791517|323703285|FG004|Phase I: Period 3|Lost to Follow-up|1|||
94520812|NCT01791517|323703286|FG005|Phase I: Period 3|Lost to Follow-up|0|||
94520813|NCT01791517|323703287|FG006|Phase I: Period 3|Lost to Follow-up|0|||
94520814|NCT01791517|323703288|FG007|Phase I: Period 3|Lost to Follow-up|0|||
94520815|NCT01791517|323703289|FG008|Phase I: Period 3|Lost to Follow-up|0|||
94520816|NCT01791517|323703290|FG009|Phase I: Period 3|Lost to Follow-up|0|||
94520817|NCT01791517|323703291|FG010|Phase I: Period 3|Lost to Follow-up|0|||
94520818|NCT01791517|323703292|FG011|Phase I: Period 3|Lost to Follow-up|0|||
94520819|NCT01791517|323703281|FG000|Phase I: Period 3|Adverse Event|0|||
94520820|NCT01791517|323703282|FG001|Phase I: Period 3|Adverse Event|0|||
94520821|NCT01791517|323703283|FG002|Phase I: Period 3|Adverse Event|0|||
94520822|NCT01791517|323703284|FG003|Phase I: Period 3|Adverse Event|1|||
94520823|NCT01791517|323703285|FG004|Phase I: Period 3|Adverse Event|0|||
94520824|NCT01791517|323703286|FG005|Phase I: Period 3|Adverse Event|0|||
94520825|NCT01791517|323703287|FG006|Phase I: Period 3|Adverse Event|0|||
94520826|NCT01791517|323703288|FG007|Phase I: Period 3|Adverse Event|0|||
94520827|NCT01791517|323703289|FG008|Phase I: Period 3|Adverse Event|0|||
94520828|NCT01791517|323703290|FG009|Phase I: Period 3|Adverse Event|0|||
94520829|NCT01791517|323703291|FG010|Phase I: Period 3|Adverse Event|0|||
94520830|NCT01791517|323703292|FG011|Phase I: Period 3|Adverse Event|0|||
94520831|NCT01791517|323703281|FG000|Phase II|Lost to Follow-up|1|||
94520832|NCT01791517|323703282|FG001|Phase II|Lost to Follow-up|0|||
94520833|NCT01791517|323703283|FG002|Phase II|Lost to Follow-up|1|||
94520834|NCT01791517|323703284|FG003|Phase II|Lost to Follow-up|0|||
94520835|NCT01791517|323703285|FG004|Phase II|Lost to Follow-up|1|||
94520836|NCT01791517|323703286|FG005|Phase II|Lost to Follow-up|2|||
94520837|NCT01791517|323703287|FG006|Phase II|Lost to Follow-up|0|||
94520838|NCT01791517|323703288|FG007|Phase II|Lost to Follow-up|1|||
94520839|NCT01791517|323703289|FG008|Phase II|Lost to Follow-up|1|||
94520840|NCT01791517|323703290|FG009|Phase II|Lost to Follow-up|1|||
94520841|NCT01791517|323703291|FG010|Phase II|Lost to Follow-up|0|||
94520842|NCT01791517|323703292|FG011|Phase II|Lost to Follow-up|0|||
94520843|NCT01791517|323703281|FG000|Phase II|Withdrawal by Subject|1|||
94520844|NCT01791517|323703282|FG001|Phase II|Withdrawal by Subject|0|||
94520845|NCT01791517|323703283|FG002|Phase II|Withdrawal by Subject|0|||
94520846|NCT01791517|323703284|FG003|Phase II|Withdrawal by Subject|0|||
94520847|NCT01791517|323703285|FG004|Phase II|Withdrawal by Subject|0|||
94520848|NCT01791517|323703286|FG005|Phase II|Withdrawal by Subject|2|||
94520849|NCT01791517|323703287|FG006|Phase II|Withdrawal by Subject|0|||
94520850|NCT01791517|323703288|FG007|Phase II|Withdrawal by Subject|1|||
94520851|NCT01791517|323703289|FG008|Phase II|Withdrawal by Subject|0|||
94520852|NCT01791517|323703290|FG009|Phase II|Withdrawal by Subject|0|||
94520853|NCT01791517|323703291|FG010|Phase II|Withdrawal by Subject|1|||
94520854|NCT01791517|323703292|FG011|Phase II|Withdrawal by Subject|0|||
94520855|NCT01791517|323703281|FG000|Phase II|Lack of Efficacy|0|||
94520856|NCT01791517|323703282|FG001|Phase II|Lack of Efficacy|0|||
94520857|NCT01791517|323703283|FG002|Phase II|Lack of Efficacy|0|||
94520858|NCT01791517|323703284|FG003|Phase II|Lack of Efficacy|0|||
94520859|NCT01791517|323703285|FG004|Phase II|Lack of Efficacy|1|||
94520860|NCT01791517|323703286|FG005|Phase II|Lack of Efficacy|0|||
94520861|NCT01791517|323703287|FG006|Phase II|Lack of Efficacy|0|||
94520862|NCT01791517|323703288|FG007|Phase II|Lack of Efficacy|0|||
94520863|NCT01791517|323703289|FG008|Phase II|Lack of Efficacy|0|||
94520864|NCT01791517|323703290|FG009|Phase II|Lack of Efficacy|0|||
94520865|NCT01791517|323703291|FG010|Phase II|Lack of Efficacy|0|||
94520866|NCT01791517|323703292|FG011|Phase II|Lack of Efficacy|0|||
94520867|NCT01791517|323703281|FG000|Phase II|Adverse Event|0|||
94520868|NCT01791517|323703282|FG001|Phase II|Adverse Event|0|||
94520869|NCT01791517|323703283|FG002|Phase II|Adverse Event|0|||
94520870|NCT01791517|323703284|FG003|Phase II|Adverse Event|0|||
94520871|NCT01791517|323703285|FG004|Phase II|Adverse Event|0|||
94520872|NCT01791517|323703286|FG005|Phase II|Adverse Event|0|||
94520873|NCT01791517|323703287|FG006|Phase II|Adverse Event|2|||
94520874|NCT01791517|323703288|FG007|Phase II|Adverse Event|1|||
94520875|NCT01791517|323703289|FG008|Phase II|Adverse Event|0|||
94520876|NCT01791517|323703290|FG009|Phase II|Adverse Event|1|||
94520877|NCT01791517|323703291|FG010|Phase II|Adverse Event|0|||
94520878|NCT01791517|323703292|FG011|Phase II|Adverse Event|0|||
94520879|NCT01791517|323703281|FG000|Phase II|Lens Handling Difficulties|0|||
94520880|NCT01791517|323703282|FG001|Phase II|Lens Handling Difficulties|0|||
94520881|NCT01791517|323703283|FG002|Phase II|Lens Handling Difficulties|0|||
94520882|NCT01791517|323703284|FG003|Phase II|Lens Handling Difficulties|0|||
94520883|NCT01791517|323703285|FG004|Phase II|Lens Handling Difficulties|0|||
94520884|NCT01791517|323703286|FG005|Phase II|Lens Handling Difficulties|0|||
94520885|NCT01791517|323703287|FG006|Phase II|Lens Handling Difficulties|0|||
94520886|NCT01791517|323703288|FG007|Phase II|Lens Handling Difficulties|0|||
94520887|NCT01791517|323703289|FG008|Phase II|Lens Handling Difficulties|1|||
94520888|NCT01791517|323703290|FG009|Phase II|Lens Handling Difficulties|0|||
94520889|NCT01791517|323703291|FG010|Phase II|Lens Handling Difficulties|0|||
94520890|NCT01791517|323703292|FG011|Phase II|Lens Handling Difficulties|0|||
94520891|NCT01791517|323703281|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
94520892|NCT01791517|323703282|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
94520893|NCT01791517|323703283|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
94520894|NCT01791517|323703284|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
94520895|NCT01791517|323703285|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
94520896|NCT01791517|323703286|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
94520897|NCT01791517|323703287|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
94520898|NCT01791517|323703288|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
94520899|NCT01791517|323703289|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
94520900|NCT01791517|323703290|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
94520901|NCT01791517|323703291|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
94520902|NCT01791517|323703292|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
94520903|NCT01791517|323703281|FG000|Phase II|Pre-Existing Ocular Issue|0|||
94520904|NCT01791517|323703282|FG001|Phase II|Pre-Existing Ocular Issue|0|||
94520905|NCT01791517|323703283|FG002|Phase II|Pre-Existing Ocular Issue|0|||
94520906|NCT01791517|323703284|FG003|Phase II|Pre-Existing Ocular Issue|0|||
94520907|NCT01791517|323703285|FG004|Phase II|Pre-Existing Ocular Issue|0|||
94520908|NCT01791517|323703286|FG005|Phase II|Pre-Existing Ocular Issue|0|||
94520909|NCT01791517|323703287|FG006|Phase II|Pre-Existing Ocular Issue|0|||
94520910|NCT01791517|323703288|FG007|Phase II|Pre-Existing Ocular Issue|0|||
94520911|NCT01791517|323703289|FG008|Phase II|Pre-Existing Ocular Issue|0|||
94520912|NCT01791517|323703290|FG009|Phase II|Pre-Existing Ocular Issue|0|||
94520913|NCT01791517|323703291|FG010|Phase II|Pre-Existing Ocular Issue|0|||
94520914|NCT01791517|323703292|FG011|Phase II|Pre-Existing Ocular Issue|1|||
94520915|NCT01194245|323703293|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
94520916|NCT01194245|323703294|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
94520917|NCT01194245|323703295|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
94520918|NCT01194245|323703296|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
94520919|NCT01194245|323703297|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
94520920|NCT01194245|323703293|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
94520921|NCT01194245|323703294|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
94520922|NCT01194245|323703295|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
94520923|NCT01194245|323703296|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
94520924|NCT01194245|323703297|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
94520925|NCT01194245|323703293|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
94520926|NCT01194245|323703294|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
94520927|NCT01194245|323703295|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
94520928|NCT01194245|323703296|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
94520929|NCT01194245|323703297|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
94520930|NCT01194245|323703293|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
94520931|NCT01194245|323703294|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
94520932|NCT01194245|323703295|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
94520933|NCT01194245|323703296|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
94520934|NCT01194245|323703297|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
94520935|NCT01194245|323703293|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
94520936|NCT01194245|323703294|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
94520937|NCT01194245|323703295|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
94520938|NCT01194245|323703296|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
94520939|NCT01194245|323703297|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
94520940|NCT01194245|323703293|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
94520941|NCT01194245|323703294|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
94520942|NCT01194245|323703295|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
94520943|NCT01194245|323703296|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
94520944|NCT01194245|323703297|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
94520945|NCT00532844|323703298|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
94520946|NCT00532844|323703299|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
94520947|NCT00532844|323703298|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
94520948|NCT00532844|323703299|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
94520949|NCT00532844|323703298|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
94520950|NCT00532844|323703299|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
94520951|NCT00532844|323703298|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
94520952|NCT00532844|323703299|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
94520953|NCT00532844|323703298|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
94520954|NCT00532844|323703299|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
94520955|NCT01284959|323703307|FG000|Overall Study|Withdrawal by Subject|1|||
94520956|NCT01284959|323703308|FG001|Overall Study|Withdrawal by Subject|0|||
94520957|NCT01284959|323703309|FG002|Overall Study|Withdrawal by Subject|0|||
94520958|NCT01284959|323703307|FG000|Overall Study|Adverse Event|0|||
94520959|NCT01284959|323703308|FG001|Overall Study|Adverse Event|0|||
94520960|NCT01284959|323703309|FG002|Overall Study|Adverse Event|1|||
94520961|NCT00326599|323703310|FG000|Overall Study|Withdrawal by Subject|1|||
94520962|NCT00326599|323703311|FG001|Overall Study|Withdrawal by Subject|0|||
94520963|NCT00326599|323703312|FG002|Overall Study|Withdrawal by Subject|5|||
94520964|NCT00326599|323703313|FG003|Overall Study|Withdrawal by Subject|2|||
94520965|NCT00326599|323703310|FG000|Overall Study|Adverse Event|1|||
94520966|NCT00326599|323703311|FG001|Overall Study|Adverse Event|0|||
94520967|NCT00326599|323703312|FG002|Overall Study|Adverse Event|32|||
94520968|NCT00326599|323703313|FG003|Overall Study|Adverse Event|3|||
94520969|NCT00326599|323703310|FG000|Overall Study|Disease Progression|3|||
94520970|NCT00326599|323703311|FG001|Overall Study|Disease Progression|1|||
94520971|NCT00326599|323703312|FG002|Overall Study|Disease Progression|13|||
94520972|NCT00326599|323703313|FG003|Overall Study|Disease Progression|11|||
94520973|NCT00326599|323703310|FG000|Overall Study|Alternate Treatment|1|||
94520974|NCT00326599|323703311|FG001|Overall Study|Alternate Treatment|0|||
94520975|NCT00326599|323703312|FG002|Overall Study|Alternate Treatment|0|||
94520976|NCT00326599|323703313|FG003|Overall Study|Alternate Treatment|0|||
94520977|NCT00326599|323703310|FG000|Overall Study|Death|0|||
94520978|NCT00326599|323703311|FG001|Overall Study|Death|0|||
94520979|NCT00326599|323703312|FG002|Overall Study|Death|1|||
94520980|NCT00326599|323703313|FG003|Overall Study|Death|2|||
94520981|NCT00326599|323703310|FG000|Overall Study|Other Unspecified Reason|0|||
94520982|NCT00326599|323703311|FG001|Overall Study|Other Unspecified Reason|0|||
94520983|NCT00326599|323703312|FG002|Overall Study|Other Unspecified Reason|2|||
94520984|NCT00326599|323703313|FG003|Overall Study|Other Unspecified Reason|1|||
94520985|NCT01595529|323703321|FG000|Overall Study|Adverse Event|2|||
94520986|NCT01595529|323703322|FG001|Overall Study|Adverse Event|0|||
94520987|NCT01595529|323703321|FG000|Overall Study|Subject Non-Compliant|2|||
94520988|NCT01595529|323703322|FG001|Overall Study|Subject Non-Compliant|0|||
94520989|NCT01595529|323703321|FG000|Overall Study|Lost to Follow-up|8|||
94520990|NCT01595529|323703322|FG001|Overall Study|Lost to Follow-up|14|||
94520991|NCT01595529|323703321|FG000|Overall Study|Protocol Violation|1|||
94520992|NCT01595529|323703322|FG001|Overall Study|Protocol Violation|2|||
94520993|NCT01595529|323703321|FG000|Overall Study|Physician Decision|1|||
94520994|NCT01595529|323703322|FG001|Overall Study|Physician Decision|0|||
94520995|NCT01595529|323703321|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
94520996|NCT01595529|323703322|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
94520997|NCT01595529|323703321|FG000|Overall Study|Administrative Decision|1|||
94520998|NCT01595529|323703322|FG001|Overall Study|Administrative Decision|0|||
94520999|NCT01595529|323703321|FG000|Overall Study|Entry Failure/Screening Failure|6|||
94521000|NCT01595529|323703322|FG001|Overall Study|Entry Failure/Screening Failure|1|||
94521001|NCT01822665|323703327|FG000|Overall Study|Adverse Event|3|||
94521002|NCT01822665|323703327|FG000|Overall Study|Other Reason|5|||
94521003|NCT04781816|323703328|FG000|Overall Study|Adverse Event|0|||
94521004|NCT04781816|323703329|FG001|Overall Study|Adverse Event|1|||
94521005|NCT04781816|323703328|FG000|Overall Study|Withdrawal by Subject|1|||
94521006|NCT04781816|323703329|FG001|Overall Study|Withdrawal by Subject|1|||
94521007|NCT04781816|323703328|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
94521008|NCT04781816|323703329|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
94521009|NCT01991483|323703330|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
94521010|NCT01991483|323703331|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
94521011|NCT01991483|323703332|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
94521012|NCT01991483|323703333|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
94521013|NCT01991483|323703330|FG000|Dose Level 600 mg|Physician Decision|0|||
94521014|NCT01991483|323703331|FG001|Dose Level 600 mg|Physician Decision|0|||
94521015|NCT01991483|323703332|FG002|Dose Level 600 mg|Physician Decision|1|||
94521016|NCT01991483|323703333|FG003|Dose Level 600 mg|Physician Decision|0|||
94521017|NCT01991483|323703330|FG000|Dose Level 1000 mg|Protocol Violation|0|||
94521018|NCT01991483|323703331|FG001|Dose Level 1000 mg|Protocol Violation|0|||
94521019|NCT01991483|323703332|FG002|Dose Level 1000 mg|Protocol Violation|0|||
94521020|NCT01991483|323703333|FG003|Dose Level 1000 mg|Protocol Violation|1|||
94521021|NCT03571971|323703336|FG000|Overall Study|Lost to Follow-up|2|||
94521022|NCT03571971|323703337|FG001|Overall Study|Lost to Follow-up|2|||
94521023|NCT03571971|323703336|FG000|Overall Study|Protocol Violation|2|||
94521024|NCT03571971|323703337|FG001|Overall Study|Protocol Violation|3|||
94521025|NCT03571971|323703336|FG000|Overall Study|Withdrawal by Subject|2|||
94521026|NCT03571971|323703337|FG001|Overall Study|Withdrawal by Subject|0|||
94521027|NCT03571971|323703336|FG000|Overall Study|Incomplete primary outcome data|2|||
94521028|NCT03571971|323703337|FG001|Overall Study|Incomplete primary outcome data|0|||
94521029|NCT04067492|323703338|FG000|Overall Study|Lost to Follow-up|0|||
94521030|NCT04067492|323703339|FG001|Overall Study|Lost to Follow-up|0|||
94521031|NCT04067492|323703340|FG002|Overall Study|Lost to Follow-up|0|||
94521032|NCT04067492|323703341|FG003|Overall Study|Lost to Follow-up|0|||
94521033|NCT04067492|323703342|FG004|Overall Study|Lost to Follow-up|0|||
94521034|NCT04067492|323703343|FG005|Overall Study|Lost to Follow-up|1|||
94521035|NCT04067492|323703338|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
94521036|NCT04067492|323703339|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
94521037|NCT04067492|323703340|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
94521038|NCT04067492|323703341|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
94521039|NCT04067492|323703342|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
94521040|NCT04067492|323703343|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
94521041|NCT04067492|323703338|FG000|Overall Study|COVID-19 epidemiological situation|0|||
94521042|NCT04067492|323703339|FG001|Overall Study|COVID-19 epidemiological situation|0|||
94521043|NCT04067492|323703340|FG002|Overall Study|COVID-19 epidemiological situation|0|||
94521044|NCT04067492|323703341|FG003|Overall Study|COVID-19 epidemiological situation|1|||
94521045|NCT04067492|323703342|FG004|Overall Study|COVID-19 epidemiological situation|0|||
94521046|NCT04067492|323703343|FG005|Overall Study|COVID-19 epidemiological situation|0|||
94521047|NCT01342926|323703344|FG000|Overall Study|Adverse Event|5|||
94521048|NCT01342926|323703345|FG001|Overall Study|Adverse Event|8|||
94521049|NCT01342926|323703346|FG002|Overall Study|Adverse Event|10|||
94521050|NCT01342926|323703347|FG003|Overall Study|Adverse Event|7|||
94521051|NCT01342926|323703344|FG000|Overall Study|Lost to Follow-up|0|||
94521052|NCT01342926|323703345|FG001|Overall Study|Lost to Follow-up|1|||
94521053|NCT01342926|323703346|FG002|Overall Study|Lost to Follow-up|1|||
94521054|NCT01342926|323703347|FG003|Overall Study|Lost to Follow-up|0|||
94521055|NCT01342926|323703344|FG000|Overall Study|Investigator Discretion|2|||
94521056|NCT01342926|323703345|FG001|Overall Study|Investigator Discretion|2|||
94521057|NCT01342926|323703346|FG002|Overall Study|Investigator Discretion|0|||
94521058|NCT01342926|323703347|FG003|Overall Study|Investigator Discretion|0|||
94521059|NCT01342926|323703344|FG000|Overall Study|Withdrawal by Subject|2|||
94521060|NCT01342926|323703345|FG001|Overall Study|Withdrawal by Subject|4|||
94521061|NCT01342926|323703346|FG002|Overall Study|Withdrawal by Subject|3|||
94521062|NCT01342926|323703347|FG003|Overall Study|Withdrawal by Subject|5|||
94521063|NCT05588440|323703348|FG000|Overall Study|Sponsor Decision|2|||
94521064|NCT05588440|323703349|FG001|Overall Study|Sponsor Decision|0|||
94521065|NCT05588440|323703350|FG002|Overall Study|Sponsor Decision|1|||
94521066|NCT05588440|323703348|FG000|Overall Study|Death|1|||
94521067|NCT05588440|323703349|FG001|Overall Study|Death|1|||
94521068|NCT05588440|323703350|FG002|Overall Study|Death|1|||
94521069|NCT05588440|323703348|FG000|Overall Study|Screen Fail|0|||
94521070|NCT05588440|323703349|FG001|Overall Study|Screen Fail|1|||
94521071|NCT05588440|323703350|FG002|Overall Study|Screen Fail|1|||
94521072|NCT05588440|323703348|FG000|Overall Study|Withdrawal by Subject|0|||
94521073|NCT05588440|323703349|FG001|Overall Study|Withdrawal by Subject|0|||
94521074|NCT05588440|323703350|FG002|Overall Study|Withdrawal by Subject|1|||
94521075|NCT03654274|323703353|FG000|Overall Study|Adverse Event|19|||
94521076|NCT03654274|323703354|FG001|Overall Study|Adverse Event|23|||
94521077|NCT03654274|323703355|FG002|Overall Study|Adverse Event|24|||
94521078|NCT03654274|323703353|FG000|Overall Study|Protocol Deviation|0|||
94521079|NCT03654274|323703354|FG001|Overall Study|Protocol Deviation|2|||
94521080|NCT03654274|323703355|FG002|Overall Study|Protocol Deviation|0|||
94521081|NCT03654274|323703353|FG000|Overall Study|Lost to Follow-up|8|||
94521082|NCT03654274|323703354|FG001|Overall Study|Lost to Follow-up|6|||
94521083|NCT03654274|323703355|FG002|Overall Study|Lost to Follow-up|5|||
94521084|NCT03654274|323703353|FG000|Overall Study|Withdrawal by Subject|46|||
94521085|NCT03654274|323703354|FG001|Overall Study|Withdrawal by Subject|25|||
94521086|NCT03654274|323703355|FG002|Overall Study|Withdrawal by Subject|33|||
94521087|NCT03654274|323703353|FG000|Overall Study|Lack of Efficacy|4|||
94521088|NCT03654274|323703354|FG001|Overall Study|Lack of Efficacy|5|||
94521089|NCT03654274|323703355|FG002|Overall Study|Lack of Efficacy|7|||
94521090|NCT03654274|323703353|FG000|Overall Study|Pregnancy|2|||
94521091|NCT03654274|323703354|FG001|Overall Study|Pregnancy|2|||
94521092|NCT03654274|323703355|FG002|Overall Study|Pregnancy|1|||
94521093|NCT03654274|323703353|FG000|Overall Study|Other|27|||
94521094|NCT03654274|323703354|FG001|Overall Study|Other|29|||
94521095|NCT03654274|323703355|FG002|Overall Study|Other|32|||
94521096|NCT03654274|323703353|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
94521097|NCT03654274|323703354|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
94521098|NCT03654274|323703355|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
94521099|NCT00038948|323703361|FG000|Overall Study|Adverse Event|131|||
94521100|NCT00038948|323703362|FG001|Overall Study|Adverse Event|43|||
94521101|NCT00038948|323703361|FG000|Overall Study|Lost to Follow-up|4|||
94521102|NCT00038948|323703362|FG001|Overall Study|Lost to Follow-up|4|||
94521103|NCT00038948|323703361|FG000|Overall Study|Nonmedical event|5|||
94521104|NCT00038948|323703362|FG001|Overall Study|Nonmedical event|7|||
94521105|NCT00038948|323703361|FG000|Overall Study|Withdrawal by Subject|23|||
94521106|NCT00038948|323703362|FG001|Overall Study|Withdrawal by Subject|10|||
94521107|NCT00038948|323703361|FG000|Overall Study|Protocol Violation|3|||
94521108|NCT00038948|323703362|FG001|Overall Study|Protocol Violation|7|||
94521109|NCT00038948|323703361|FG000|Overall Study|Lack of Efficacy|3|||
94521110|NCT00038948|323703362|FG001|Overall Study|Lack of Efficacy|6|||
94521111|NCT05414175|323703363|FG000|Overall Study|Withdrawal by Subject|1|||
94521112|NCT05414175|323703363|FG000|Overall Study|Other Reasons|1|||
94521113|NCT03960684|323703364|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
94521114|NCT03761056|323703365|FG000|Overall Study|Death|8|||
94521115|NCT03761056|323703365|FG000|Overall Study|Enrolled but never treated|2|||
94521116|NCT03761056|323703365|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
94521117|NCT03761056|323703365|FG000|Overall Study|Investigator decision|1|||
94521118|NCT02735421|323704650|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
94521119|NCT02735421|323704650|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
94521120|NCT02735421|323704650|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
94521121|NCT02735421|323704650|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
94521122|NCT02735421|323704650|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
94521123|NCT02735421|323704650|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
94521124|NCT02735421|323704650|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
94521125|NCT03549338|323704652|FG000|Overall Study|Progressive Disease|1|||
94521126|NCT03549338|323704653|FG001|Overall Study|Progressive Disease|0|||
94521127|NCT03549338|323704654|FG002|Overall Study|Progressive Disease|0|||
94521128|NCT03549338|323704652|FG000|Overall Study|Clinical Progression|0|||
94521129|NCT03549338|323704653|FG001|Overall Study|Clinical Progression|1|||
94521130|NCT03549338|323704654|FG002|Overall Study|Clinical Progression|0|||
94521131|NCT01492426|323704655|FG000|Treatment|Death|0|||
94521132|NCT01492426|323704656|FG001|Treatment|Death|1|||
94521133|NCT01492426|323704655|FG000|Treatment|Other|1|||
94521134|NCT01492426|323704656|FG001|Treatment|Other|0|||
94521135|NCT01492426|323704655|FG000|Treatment|Adverse Event|25|||
94521136|NCT01492426|323704656|FG001|Treatment|Adverse Event|25|||
94521137|NCT01492426|323704655|FG000|Treatment|Lack of Efficacy|38|||
94521138|NCT01492426|323704656|FG001|Treatment|Lack of Efficacy|5|||
94521139|NCT01492426|323704655|FG000|Treatment|Participant withdrew consent|1|||
94521140|NCT01492426|323704656|FG001|Treatment|Participant withdrew consent|2|||
94521141|NCT01492426|323704655|FG000|Treatment|Poor compliance/noncompliance|1|||
94521142|NCT01492426|323704656|FG001|Treatment|Poor compliance/noncompliance|0|||
94521143|NCT01492426|323704655|FG000|Treatment|Subject requested discontinue study drug|7|||
94521144|NCT01492426|323704656|FG001|Treatment|Subject requested discontinue study drug|3|||
94521145|NCT01492426|323704655|FG000|Treatment|Lost to Follow-up|9|||
94521146|NCT01492426|323704656|FG001|Treatment|Lost to Follow-up|4|||
94521147|NCT01492426|323704655|FG000|Treatment|Participant does not meet study criteria|1|||
94521148|NCT01492426|323704656|FG001|Treatment|Participant does not meet study criteria|0|||
94521149|NCT01492426|323704655|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
94521150|NCT01492426|323704656|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
94521151|NCT01492426|323704655|FG000|Follow-Up|Death|1|||
94521152|NCT01492426|323704656|FG001|Follow-Up|Death|0|||
94521153|NCT01492426|323704655|FG000|Follow-Up|Other|4|||
94521154|NCT01492426|323704656|FG001|Follow-Up|Other|2|||
94521155|NCT01492426|323704655|FG000|Follow-Up|Participant Withdrew Consent|6|||
94521156|NCT01492426|323704656|FG001|Follow-Up|Participant Withdrew Consent|1|||
94521157|NCT01492426|323704655|FG000|Follow-Up|Lost to Follow-up|12|||
94521158|NCT01492426|323704656|FG001|Follow-Up|Lost to Follow-up|6|||
94521159|NCT00652743|323704657|FG000|Months 12-18|Lost to Follow-up|1|||
94521160|NCT00652743|323704658|FG001|Months 12-18|Lost to Follow-up|2|||
94521161|NCT00652743|323704659|FG002|Months 12-18|Lost to Follow-up|7|||
94521162|NCT00652743|323704657|FG000|Months 24-30|Other|5|||
94521163|NCT00652743|323704658|FG001|Months 24-30|Other|1|||
94521164|NCT00652743|323704659|FG002|Months 24-30|Other|11|||
94521165|NCT00652743|323704657|FG000|Months 36-42|Serious Adverse Events|0|||
94521166|NCT00652743|323704658|FG001|Months 36-42|Serious Adverse Events|1|||
94521167|NCT00652743|323704659|FG002|Months 36-42|Serious Adverse Events|1|||
94521168|NCT00652743|323704657|FG000|Months 36-42|Withdrawal by Subject|1|||
94521169|NCT00652743|323704658|FG001|Months 36-42|Withdrawal by Subject|1|||
94521170|NCT00652743|323704659|FG002|Months 36-42|Withdrawal by Subject|0|||
94521171|NCT00652743|323704657|FG000|Months 36-42|Lost to Follow-up|0|||
94521172|NCT00652743|323704658|FG001|Months 36-42|Lost to Follow-up|1|||
94521173|NCT00652743|323704659|FG002|Months 36-42|Lost to Follow-up|0|||
94521174|NCT00652743|323704657|FG000|Months 36-42|Migrated/moved from study area|1|||
94521175|NCT00652743|323704658|FG001|Months 36-42|Migrated/moved from study area|0|||
94521176|NCT00652743|323704659|FG002|Months 36-42|Migrated/moved from study area|0|||
94521177|NCT00652743|323704657|FG000|Months 36-42|Other|4|||
94521178|NCT00652743|323704658|FG001|Months 36-42|Other|2|||
94521179|NCT00652743|323704659|FG002|Months 36-42|Other|8|||
94521180|NCT00269113|323704660|FG000|Overall Study|Adverse Event|14|||
94521181|NCT00269113|323704661|FG001|Overall Study|Adverse Event|7|||
94521182|NCT00269113|323704660|FG000|Overall Study|Lack of Efficacy|35|||
94521183|NCT00269113|323704661|FG001|Overall Study|Lack of Efficacy|18|||
94521184|NCT00269113|323704660|FG000|Overall Study|Early Improvement|2|||
94521185|NCT00269113|323704661|FG001|Overall Study|Early Improvement|0|||
94521186|NCT00269113|323704660|FG000|Overall Study|Withdrawal by Subject|0|||
94521187|NCT00269113|323704661|FG001|Overall Study|Withdrawal by Subject|2|||
94521188|NCT00269113|323704660|FG000|Overall Study|Death|6|||
94521189|NCT00269113|323704661|FG001|Overall Study|Death|2|||
94521190|NCT00269113|323704660|FG000|Overall Study|Lost to Follow-up|2|||
94521191|NCT00269113|323704661|FG001|Overall Study|Lost to Follow-up|1|||
94521192|NCT00269113|323704660|FG000|Overall Study|Protocol Violation|15|||
94521193|NCT00269113|323704661|FG001|Overall Study|Protocol Violation|5|||
94521194|NCT00269113|323704660|FG000|Overall Study|Other|0|||
94521195|NCT00269113|323704661|FG001|Overall Study|Other|2|||
94521196|NCT01978145|323704662|FG000|Treatment Period 1|Adverse Event|1|||
94521197|NCT01978145|323704663|FG001|Treatment Period 1|Adverse Event|9|||
94521198|NCT01978145|323704662|FG000|Treatment Period 1|Physician Decision|1|||
94521199|NCT01978145|323704663|FG001|Treatment Period 1|Physician Decision|0|||
94521200|NCT01978145|323704662|FG000|Treatment Period 1|Withdrawal by Subject|5|||
94521201|NCT01978145|323704663|FG001|Treatment Period 1|Withdrawal by Subject|4|||
94521202|NCT01978145|323704662|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
94521203|NCT01978145|323704663|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
94521204|NCT01978145|323704662|FG000|Washout Period 1|Adverse Event|0|||
94521205|NCT01978145|323704663|FG001|Washout Period 1|Adverse Event|1|||
94521206|NCT01978145|323704662|FG000|Washout Period 1|Withdrawal by Subject|1|||
94521207|NCT01978145|323704663|FG001|Washout Period 1|Withdrawal by Subject|1|||
94521208|NCT01978145|323704662|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
94521209|NCT01978145|323704663|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
94521210|NCT01978145|323704662|FG000|Treatment Period 2|Adverse Event|3|||
94521211|NCT01978145|323704663|FG001|Treatment Period 2|Adverse Event|3|||
94521212|NCT01978145|323704662|FG000|Treatment Period 2|Protocol Violation|0|||
94521213|NCT01978145|323704663|FG001|Treatment Period 2|Protocol Violation|1|||
94521214|NCT01978145|323704662|FG000|Treatment Period 2|Lost to Follow-up|1|||
94521215|NCT01978145|323704663|FG001|Treatment Period 2|Lost to Follow-up|1|||
94521216|NCT01978145|323704662|FG000|Treatment Period 2|Withdrawal by Subject|7|||
94521217|NCT01978145|323704663|FG001|Treatment Period 2|Withdrawal by Subject|4|||
94521218|NCT01978145|323704662|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
94521219|NCT01978145|323704663|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
94521220|NCT05010070|323704664|FG000|Overall Study|Lost to Follow-up|1|||
94521221|NCT05010070|323704664|FG000|Overall Study|Withdrawal by Subject|1|||
94521222|NCT01135992|323704672|FG000|Overall Study|Adverse Event|1|||
94521223|NCT01135992|323704672|FG000|Overall Study|Lack of Efficacy|1|||
94521224|NCT01135992|323704672|FG000|Overall Study|Protocol Violation|2|||
94521225|NCT01135992|323704672|FG000|Overall Study|Withdrawal criteria|10|||
94521226|NCT01135992|323704672|FG000|Overall Study|Unclassified|7|||
94521227|NCT00980148|323704673|FG000|Overall Study|Discharged from facility|89|||
94521228|NCT00980148|323704674|FG001|Overall Study|Discharged from facility|96|||
94521229|NCT00980148|323704673|FG000|Overall Study|Received other antichlamydia treatment|20|||
94521230|NCT00980148|323704674|FG001|Overall Study|Received other antichlamydia treatment|14|||
94521231|NCT00980148|323704673|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
94521232|NCT00980148|323704674|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
94521233|NCT00980148|323704673|FG000|Overall Study|Various other reasons|8|||
94521234|NCT00980148|323704674|FG001|Overall Study|Various other reasons|9|||
94521235|NCT01466491|323704675|FG000|Overall Study|Protocol Violation|0|||
94521236|NCT01466491|323704676|FG001|Overall Study|Protocol Violation|3|||
94521237|NCT01466491|323704677|FG002|Overall Study|Protocol Violation|2|||
94521238|NCT01466491|323704678|FG003|Overall Study|Protocol Violation|0|||
94521239|NCT01466491|323704675|FG000|Overall Study|Missing Data|0|||
94521240|NCT01466491|323704676|FG001|Overall Study|Missing Data|0|||
94521241|NCT01466491|323704677|FG002|Overall Study|Missing Data|1|||
94521242|NCT01466491|323704678|FG003|Overall Study|Missing Data|0|||
94521243|NCT02852967|323704679|FG000|Overall Study|Adverse Event|3|||
94521244|NCT02852967|323704680|FG001|Overall Study|Adverse Event|1|||
94521245|NCT02852967|323704681|FG002|Overall Study|Adverse Event|0|||
94521246|NCT02852967|323704682|FG003|Overall Study|Adverse Event|1|||
94521247|NCT02852967|323704683|FG004|Overall Study|Adverse Event|0|||
94521248|NCT02852967|323704679|FG000|Overall Study|Death|1|||
94521249|NCT02852967|323704680|FG001|Overall Study|Death|0|||
94521250|NCT02852967|323704681|FG002|Overall Study|Death|0|||
94521251|NCT02852967|323704682|FG003|Overall Study|Death|0|||
94521252|NCT02852967|323704683|FG004|Overall Study|Death|0|||
94521253|NCT02852967|323704679|FG000|Overall Study|Lost to Follow-up|1|||
94521254|NCT02852967|323704680|FG001|Overall Study|Lost to Follow-up|2|||
94521255|NCT02852967|323704681|FG002|Overall Study|Lost to Follow-up|3|||
94521256|NCT02852967|323704682|FG003|Overall Study|Lost to Follow-up|4|||
94521257|NCT02852967|323704683|FG004|Overall Study|Lost to Follow-up|4|||
94521258|NCT02852967|323704679|FG000|Overall Study|Withdrawal by Subject|6|||
94521259|NCT02852967|323704680|FG001|Overall Study|Withdrawal by Subject|12|||
94521260|NCT02852967|323704681|FG002|Overall Study|Withdrawal by Subject|7|||
94521261|NCT02852967|323704682|FG003|Overall Study|Withdrawal by Subject|10|||
94521262|NCT02852967|323704683|FG004|Overall Study|Withdrawal by Subject|10|||
94521263|NCT02852967|323704679|FG000|Overall Study|SAE|0|||
94521264|NCT02852967|323704680|FG001|Overall Study|SAE|0|||
94521265|NCT02852967|323704681|FG002|Overall Study|SAE|0|||
94521266|NCT02852967|323704682|FG003|Overall Study|SAE|3|||
94521267|NCT02852967|323704683|FG004|Overall Study|SAE|0|||
94521268|NCT02852967|323704679|FG000|Overall Study|Elevated Liver Enzymes|2|||
94521269|NCT02852967|323704680|FG001|Overall Study|Elevated Liver Enzymes|0|||
94521270|NCT02852967|323704681|FG002|Overall Study|Elevated Liver Enzymes|0|||
94521271|NCT02852967|323704682|FG003|Overall Study|Elevated Liver Enzymes|2|||
94521272|NCT02852967|323704683|FG004|Overall Study|Elevated Liver Enzymes|2|||
94521273|NCT02852967|323704679|FG000|Overall Study|Physician Decision|0|||
94521274|NCT02852967|323704680|FG001|Overall Study|Physician Decision|0|||
94521275|NCT02852967|323704681|FG002|Overall Study|Physician Decision|0|||
94521276|NCT02852967|323704682|FG003|Overall Study|Physician Decision|1|||
94521277|NCT02852967|323704683|FG004|Overall Study|Physician Decision|0|||
94521278|NCT02852967|323704679|FG000|Overall Study|Lack of Efficacy|0|||
94521279|NCT02852967|323704680|FG001|Overall Study|Lack of Efficacy|1|||
94521280|NCT02852967|323704681|FG002|Overall Study|Lack of Efficacy|0|||
94521281|NCT02852967|323704682|FG003|Overall Study|Lack of Efficacy|0|||
94521282|NCT02852967|323704683|FG004|Overall Study|Lack of Efficacy|0|||
94521283|NCT02852967|323704679|FG000|Overall Study|Non-compliance|0|||
94521284|NCT02852967|323704680|FG001|Overall Study|Non-compliance|0|||
94521285|NCT02852967|323704681|FG002|Overall Study|Non-compliance|1|||
94521286|NCT02852967|323704682|FG003|Overall Study|Non-compliance|1|||
94521287|NCT02852967|323704683|FG004|Overall Study|Non-compliance|0|||
94521288|NCT02852967|323704679|FG000|Overall Study|Dispensing Drug Violation|0|||
94521289|NCT02852967|323704680|FG001|Overall Study|Dispensing Drug Violation|0|||
94521290|NCT02852967|323704681|FG002|Overall Study|Dispensing Drug Violation|1|||
94521291|NCT02852967|323704682|FG003|Overall Study|Dispensing Drug Violation|0|||
94521292|NCT02852967|323704683|FG004|Overall Study|Dispensing Drug Violation|0|||
94521293|NCT02852967|323704679|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
94521294|NCT02852967|323704680|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
94521295|NCT02852967|323704681|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
94521296|NCT02852967|323704682|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
94521297|NCT02852967|323704683|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
94521298|NCT02903823|323704684|FG000|Overall Study|Physician Decision|5|||
94521299|NCT02903823|323704684|FG000|Overall Study|Could not advance catheter|1|||
94521300|NCT02903823|323704684|FG000|Overall Study|Catheter dislodgement|1|||
94521301|NCT01123148|323704685|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
94521302|NCT01123148|323704685|FG000|Overall Study|Didn't meet milestone criteria|1|||
94521303|NCT00938912|323704686|FG000|Overall Study|Withdrawal by Subject|28|||
94521304|NCT00938912|323704686|FG000|Overall Study|Lost to Follow-up|4|||
94521305|NCT00938912|323704686|FG000|Overall Study|Lack of Efficacy|43|||
94521306|NCT00938912|323704686|FG000|Overall Study|Adverse event, non-fatal|24|||
94521307|NCT00938912|323704686|FG000|Overall Study|Adverse event, fatal|1|||
94521308|NCT00938912|323704686|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
94521309|NCT00938912|323704686|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
94521310|NCT00938912|323704686|FG000|Overall Study|Participant needed prohibit medication|1|||
94521311|NCT00938912|323704686|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
94521312|NCT00938912|323704686|FG000|Overall Study|Did not meet Eligibility criteria|1|||
94521313|NCT00938912|323704686|FG000|Overall Study|Participant relocated not related to AE|1|||
94521314|NCT00938912|323704686|FG000|Overall Study|Participant moved to another city|1|||
94521315|NCT00938912|323704686|FG000|Overall Study|Participant experienced break through seizures|1|||
94521316|NCT00938912|323704686|FG000|Overall Study|No longer wished to participate in the study|1|||
94521317|NCT00938912|323704686|FG000|Overall Study|Protocol Deviation|2|||
94521318|NCT03341637|323704687|FG000|Overall Study|Lost to Follow-up|1|||
94521319|NCT03341637|323704688|FG001|Overall Study|Lost to Follow-up|0|||
94521320|NCT03341637|323704687|FG000|Overall Study|Withdrawal by Subject|3|||
94521321|NCT03341637|323704688|FG001|Overall Study|Withdrawal by Subject|3|||
94521322|NCT03341637|323704687|FG000|Overall Study|Reason not Specified|1|||
94521323|NCT03341637|323704688|FG001|Overall Study|Reason not Specified|1|||
94521324|NCT03183063|323704689|FG000|Overall Study|Withdrawal by Subject|2|||
94521325|NCT03183063|323704690|FG001|Overall Study|Withdrawal by Subject|0|||
94521326|NCT03183063|323704691|FG002|Overall Study|Withdrawal by Subject|0|||
94521327|NCT03183063|323704689|FG000|Overall Study|Physician Decision|3|||
94521328|NCT03183063|323704690|FG001|Overall Study|Physician Decision|4|||
94521329|NCT03183063|323704691|FG002|Overall Study|Physician Decision|4|||
94521330|NCT02808897|323704692|FG000|Overall Study|Lost to Follow-up|9|||
94521331|NCT02808897|323704693|FG001|Overall Study|Lost to Follow-up|11|||
94521332|NCT04460183|323704694|FG000|Overall Study|Lost to Follow-up|3|||
94521333|NCT04460183|323704695|FG001|Overall Study|Lost to Follow-up|1|||
94521334|NCT04460183|323704694|FG000|Overall Study|Withdrawal by Subject|1|||
94521335|NCT04460183|323704695|FG001|Overall Study|Withdrawal by Subject|0|||
94521336|NCT01865487|323704698|FG000|Overall Study|Lost to Follow-up|0|||
94521337|NCT01865487|323704699|FG001|Overall Study|Lost to Follow-up|0|||
94521338|NCT01865487|323704700|FG002|Overall Study|Lost to Follow-up|0|||
94521339|NCT01865487|323704701|FG003|Overall Study|Lost to Follow-up|1|||
94521340|NCT01865487|323704702|FG004|Overall Study|Lost to Follow-up|0|||
94521341|NCT01865487|323704703|FG005|Overall Study|Lost to Follow-up|0|||
94521342|NCT01865487|323704704|FG006|Overall Study|Lost to Follow-up|1|||
94521343|NCT01865487|323704705|FG007|Overall Study|Lost to Follow-up|0|||
94521344|NCT01865487|323704706|FG008|Overall Study|Lost to Follow-up|0|||
94521345|NCT01865487|323704707|FG009|Overall Study|Lost to Follow-up|0|||
94521346|NCT01865487|323704698|FG000|Overall Study|Withdrawal by Subject|0|||
94521347|NCT01865487|323704699|FG001|Overall Study|Withdrawal by Subject|0|||
94521348|NCT01865487|323704700|FG002|Overall Study|Withdrawal by Subject|0|||
94521349|NCT01865487|323704701|FG003|Overall Study|Withdrawal by Subject|0|||
94521350|NCT01865487|323704702|FG004|Overall Study|Withdrawal by Subject|1|||
94521351|NCT01865487|323704703|FG005|Overall Study|Withdrawal by Subject|0|||
94521352|NCT01865487|323704704|FG006|Overall Study|Withdrawal by Subject|0|||
94521353|NCT01865487|323704705|FG007|Overall Study|Withdrawal by Subject|0|||
94521354|NCT01865487|323704706|FG008|Overall Study|Withdrawal by Subject|0|||
94521355|NCT01865487|323704707|FG009|Overall Study|Withdrawal by Subject|0|||
94521356|NCT01119443|323704711|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
94521357|NCT01119443|323704712|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
94521358|NCT00110214|323704721|FG000|Overall Study|Never started treatment|21|||
94521359|NCT00110214|323704722|FG001|Overall Study|Never started treatment|20|||
94521360|NCT00110214|323704721|FG000|Overall Study|Disease progression or death|260|||
94521361|NCT00110214|323704722|FG001|Overall Study|Disease progression or death|151|||
94521362|NCT00110214|323704721|FG000|Overall Study|Adverse Event|115|||
94521363|NCT00110214|323704722|FG001|Overall Study|Adverse Event|192|||
94521364|NCT00110214|323704721|FG000|Overall Study|Refused further treatment|52|||
94521365|NCT00110214|323704722|FG001|Overall Study|Refused further treatment|65|||
94521366|NCT00110214|323704721|FG000|Overall Study|Other (not specified)|61|||
94521367|NCT00110214|323704722|FG001|Overall Study|Other (not specified)|75|||
94521368|NCT01847092|323704724|FG000|Overall Study|Adverse Event|12|||
94521369|NCT01847092|323704725|FG001|Overall Study|Adverse Event|3|||
94521370|NCT01847092|323704724|FG000|Overall Study|Withdrawal by Subject|5|||
94521371|NCT01847092|323704725|FG001|Overall Study|Withdrawal by Subject|5|||
94521372|NCT01847092|323704724|FG000|Overall Study|Protocol Specified|8|||
94521373|NCT01847092|323704725|FG001|Overall Study|Protocol Specified|0|||
94521374|NCT01847092|323704724|FG000|Overall Study|Physician Decision|1|||
94521375|NCT01847092|323704725|FG001|Overall Study|Physician Decision|1|||
94521376|NCT01847092|323704724|FG000|Overall Study|Protocol Violation|0|||
94521377|NCT01847092|323704725|FG001|Overall Study|Protocol Violation|2|||
94521378|NCT00775268|323704726|FG000|Baseline|Drug not synthesize dose|1|||
94521379|NCT00775268|323704727|FG001|Baseline|Drug not synthesize dose|0|||
94521380|NCT00775268|323704726|FG000|Baseline|Not treated-ineligible per CT|0|||
94521381|NCT00775268|323704727|FG001|Baseline|Not treated-ineligible per CT|1|||
94521382|NCT00775268|323704726|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
94521383|NCT00775268|323704727|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
94521384|NCT00775268|323704726|FG000|After Completion|Participant missed scan appointment|1|||
94521385|NCT00775268|323704727|FG001|After Completion|Participant missed scan appointment|0|||
94521386|NCT01106157|323704729|FG000|Overall Study|Withdrawal by Subject|1|||
94521387|NCT01106157|323704730|FG001|Overall Study|Withdrawal by Subject|0|||
94521388|NCT00800982|323704735|FG000|Overall Study|Lost to Follow-up|1|||
94521389|NCT00800982|323704736|FG001|Overall Study|Lost to Follow-up|2|||
94521390|NCT00800982|323704735|FG000|Overall Study|Withdrawal by Subject|0|||
94521391|NCT00800982|323704736|FG001|Overall Study|Withdrawal by Subject|1|||
94521392|NCT00800982|323704735|FG000|Overall Study|Patient moved out of state|1|||
94521393|NCT00800982|323704736|FG001|Overall Study|Patient moved out of state|0|||
94521394|NCT04940130|323704741|FG000|Overall Study|Travel|1|||
94521395|NCT04940130|323704742|FG001|Overall Study|Travel|0|||
94521396|NCT04940130|323704743|FG002|Overall Study|Travel|2|||
94521397|NCT04940130|323704741|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
94521398|NCT04940130|323704742|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
94521399|NCT04940130|323704743|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
94521400|NCT04940130|323704741|FG000|Overall Study|Adverse Event|0|||
94521401|NCT04940130|323704742|FG001|Overall Study|Adverse Event|0|||
94521402|NCT04940130|323704743|FG002|Overall Study|Adverse Event|2|||
94521403|NCT04940130|323704741|FG000|Overall Study|Disease progression/treatment failure|0|||
94521404|NCT04940130|323704742|FG001|Overall Study|Disease progression/treatment failure|0|||
94521405|NCT04940130|323704743|FG002|Overall Study|Disease progression/treatment failure|1|||
94521406|NCT04940130|323704741|FG000|Overall Study|Participant refusal|0|||
94521407|NCT04940130|323704742|FG001|Overall Study|Participant refusal|0|||
94521408|NCT04940130|323704743|FG002|Overall Study|Participant refusal|1|||
94521409|NCT00846846|323704744|FG000|Overall Study|Death|56|||
94521410|NCT00846846|323704744|FG000|Overall Study|Withdrawal by Subject|19|||
94521411|NCT00600067|323704746|FG000|Overall Study|Adverse Event|0|||
94521412|NCT00600067|323704747|FG001|Overall Study|Adverse Event|1|||
94521413|NCT00600067|323704746|FG000|Overall Study|Lost to Follow-up|2|||
94521414|NCT00600067|323704747|FG001|Overall Study|Lost to Follow-up|3|||
94521415|NCT00600067|323704746|FG000|Overall Study|protocol non-compliance|0|||
94521416|NCT00600067|323704747|FG001|Overall Study|protocol non-compliance|3|||
94521417|NCT00600067|323704746|FG000|Overall Study|Lack of Efficacy|1|||
94521418|NCT00600067|323704747|FG001|Overall Study|Lack of Efficacy|0|||
94521419|NCT03314935|323704748|FG000|Phase 1|Death|4|||
94521420|NCT03314935|323704749|FG001|Phase 1|Death|2|||
94521421|NCT03314935|323704750|FG002|Phase 1|Death|5|||
94521422|NCT03314935|323704751|FG003|Phase 1|Death|4|||
94521423|NCT03314935|323704752|FG004|Phase 1|Death|3|||
94521424|NCT03314935|323704753|FG005|Phase 1|Death|4|||
94521425|NCT03314935|323704754|FG006|Phase 1|Death|5|||
94521426|NCT03314935|323704755|FG007|Phase 1|Death|4|||
94521427|NCT03314935|323704756|FG008|Phase 1|Death|3|||
94521428|NCT03314935|323704757|FG009|Phase 1|Death|0|||
94521429|NCT03314935|323704758|FG010|Phase 1|Death|0|||
94521430|NCT03314935|323704759|FG011|Phase 1|Death|0|||
94521431|NCT03314935|323704760|FG012|Phase 1|Death|0|||
94521432|NCT03314935|323704761|FG013|Phase 1|Death|0|||
94521433|NCT03314935|323704762|FG014|Phase 1|Death|0|||
94521434|NCT03314935|323704748|FG000|Phase 1|Withdrawal by Subject|2|||
94521435|NCT03314935|323704749|FG001|Phase 1|Withdrawal by Subject|1|||
94521436|NCT03314935|323704750|FG002|Phase 1|Withdrawal by Subject|1|||
94521437|NCT03314935|323704751|FG003|Phase 1|Withdrawal by Subject|2|||
94521438|NCT03314935|323704752|FG004|Phase 1|Withdrawal by Subject|1|||
94521439|NCT03314935|323704753|FG005|Phase 1|Withdrawal by Subject|0|||
94521440|NCT03314935|323704754|FG006|Phase 1|Withdrawal by Subject|1|||
94521441|NCT03314935|323704755|FG007|Phase 1|Withdrawal by Subject|0|||
94521442|NCT03314935|323704756|FG008|Phase 1|Withdrawal by Subject|1|||
94521443|NCT03314935|323704757|FG009|Phase 1|Withdrawal by Subject|0|||
94521444|NCT03314935|323704758|FG010|Phase 1|Withdrawal by Subject|0|||
94521445|NCT03314935|323704759|FG011|Phase 1|Withdrawal by Subject|0|||
94521446|NCT03314935|323704760|FG012|Phase 1|Withdrawal by Subject|0|||
94521447|NCT03314935|323704761|FG013|Phase 1|Withdrawal by Subject|0|||
94521448|NCT03314935|323704762|FG014|Phase 1|Withdrawal by Subject|0|||
94521449|NCT03314935|323704748|FG000|Phase 1|Progressive Disease|2|||
94521450|NCT03314935|323704749|FG001|Phase 1|Progressive Disease|0|||
94521451|NCT03314935|323704750|FG002|Phase 1|Progressive Disease|0|||
94521452|NCT03314935|323704751|FG003|Phase 1|Progressive Disease|1|||
94521453|NCT03314935|323704752|FG004|Phase 1|Progressive Disease|0|||
94521454|NCT03314935|323704753|FG005|Phase 1|Progressive Disease|0|||
94521455|NCT03314935|323704754|FG006|Phase 1|Progressive Disease|0|||
94521456|NCT03314935|323704755|FG007|Phase 1|Progressive Disease|0|||
94521457|NCT03314935|323704756|FG008|Phase 1|Progressive Disease|0|||
94521458|NCT03314935|323704757|FG009|Phase 1|Progressive Disease|0|||
94521459|NCT03314935|323704758|FG010|Phase 1|Progressive Disease|0|||
94521460|NCT03314935|323704759|FG011|Phase 1|Progressive Disease|0|||
94521461|NCT03314935|323704760|FG012|Phase 1|Progressive Disease|0|||
94521462|NCT03314935|323704761|FG013|Phase 1|Progressive Disease|0|||
94521463|NCT03314935|323704762|FG014|Phase 1|Progressive Disease|0|||
94521464|NCT03314935|323704748|FG000|Phase 1|Study Terminated by Sponsor|0|||
94521465|NCT03314935|323704749|FG001|Phase 1|Study Terminated by Sponsor|1|||
94521466|NCT03314935|323704750|FG002|Phase 1|Study Terminated by Sponsor|0|||
94521467|NCT03314935|323704751|FG003|Phase 1|Study Terminated by Sponsor|0|||
94521468|NCT03314935|323704752|FG004|Phase 1|Study Terminated by Sponsor|0|||
94521469|NCT03314935|323704753|FG005|Phase 1|Study Terminated by Sponsor|0|||
94521470|NCT03314935|323704754|FG006|Phase 1|Study Terminated by Sponsor|0|||
94521471|NCT03314935|323704755|FG007|Phase 1|Study Terminated by Sponsor|0|||
94521472|NCT03314935|323704756|FG008|Phase 1|Study Terminated by Sponsor|1|||
94521473|NCT03314935|323704757|FG009|Phase 1|Study Terminated by Sponsor|0|||
94521474|NCT03314935|323704758|FG010|Phase 1|Study Terminated by Sponsor|0|||
94521475|NCT03314935|323704759|FG011|Phase 1|Study Terminated by Sponsor|0|||
94521476|NCT03314935|323704760|FG012|Phase 1|Study Terminated by Sponsor|0|||
94521477|NCT03314935|323704761|FG013|Phase 1|Study Terminated by Sponsor|0|||
94521478|NCT03314935|323704762|FG014|Phase 1|Study Terminated by Sponsor|0|||
94521479|NCT03314935|323704748|FG000|Phase 1|"Captured as Other in Database"|0|||
94521480|NCT03314935|323704749|FG001|Phase 1|"Captured as Other in Database"|2|||
94521481|NCT03314935|323704750|FG002|Phase 1|"Captured as Other in Database"|0|||
94521482|NCT03314935|323704751|FG003|Phase 1|"Captured as Other in Database"|0|||
94521483|NCT03314935|323704752|FG004|Phase 1|"Captured as Other in Database"|0|||
94521484|NCT03314935|323704753|FG005|Phase 1|"Captured as Other in Database"|0|||
94521485|NCT03314935|323704754|FG006|Phase 1|"Captured as Other in Database"|1|||
94521486|NCT03314935|323704755|FG007|Phase 1|"Captured as Other in Database"|1|||
94521487|NCT03314935|323704756|FG008|Phase 1|"Captured as Other in Database"|1|||
94521488|NCT03314935|323704757|FG009|Phase 1|"Captured as Other in Database"|0|||
94521489|NCT03314935|323704758|FG010|Phase 1|"Captured as Other in Database"|0|||
94521490|NCT03314935|323704759|FG011|Phase 1|"Captured as Other in Database"|0|||
94521491|NCT03314935|323704760|FG012|Phase 1|"Captured as Other in Database"|0|||
94521492|NCT03314935|323704761|FG013|Phase 1|"Captured as Other in Database"|0|||
94521493|NCT03314935|323704762|FG014|Phase 1|"Captured as Other in Database"|0|||
94521494|NCT03314935|323704748|FG000|Phase 1|Lost to Follow-up|0|||
94521495|NCT03314935|323704749|FG001|Phase 1|Lost to Follow-up|0|||
94521496|NCT03314935|323704750|FG002|Phase 1|Lost to Follow-up|0|||
94521497|NCT03314935|323704751|FG003|Phase 1|Lost to Follow-up|0|||
94521498|NCT03314935|323704752|FG004|Phase 1|Lost to Follow-up|0|||
94521499|NCT03314935|323704753|FG005|Phase 1|Lost to Follow-up|0|||
94521500|NCT03314935|323704754|FG006|Phase 1|Lost to Follow-up|0|||
94521501|NCT03314935|323704755|FG007|Phase 1|Lost to Follow-up|0|||
94521502|NCT03314935|323704756|FG008|Phase 1|Lost to Follow-up|1|||
94521503|NCT03314935|323704757|FG009|Phase 1|Lost to Follow-up|0|||
94521504|NCT03314935|323704758|FG010|Phase 1|Lost to Follow-up|0|||
94521505|NCT03314935|323704759|FG011|Phase 1|Lost to Follow-up|0|||
94521506|NCT03314935|323704760|FG012|Phase 1|Lost to Follow-up|0|||
94521507|NCT03314935|323704761|FG013|Phase 1|Lost to Follow-up|0|||
94521508|NCT03314935|323704762|FG014|Phase 1|Lost to Follow-up|0|||
94521509|NCT03314935|323704748|FG000|Phase 2|Death|0|||
94521510|NCT03314935|323704749|FG001|Phase 2|Death|0|||
94521511|NCT03314935|323704750|FG002|Phase 2|Death|0|||
94521512|NCT03314935|323704751|FG003|Phase 2|Death|0|||
94521513|NCT03314935|323704752|FG004|Phase 2|Death|0|||
94521514|NCT03314935|323704753|FG005|Phase 2|Death|0|||
94521515|NCT03314935|323704754|FG006|Phase 2|Death|0|||
94521516|NCT03314935|323704755|FG007|Phase 2|Death|0|||
94521517|NCT03314935|323704756|FG008|Phase 2|Death|0|||
94521518|NCT03314935|323704757|FG009|Phase 2|Death|5|||
94521519|NCT03314935|323704758|FG010|Phase 2|Death|20|||
94521520|NCT03314935|323704759|FG011|Phase 2|Death|6|||
94521521|NCT03314935|323704760|FG012|Phase 2|Death|7|||
94521522|NCT03314935|323704761|FG013|Phase 2|Death|6|||
94521523|NCT03314935|323704762|FG014|Phase 2|Death|17|||
94521524|NCT03314935|323704748|FG000|Phase 2|Withdrawal by Subject|0|||
94521525|NCT03314935|323704749|FG001|Phase 2|Withdrawal by Subject|0|||
94521526|NCT03314935|323704750|FG002|Phase 2|Withdrawal by Subject|0|||
94521527|NCT03314935|323704751|FG003|Phase 2|Withdrawal by Subject|0|||
94521528|NCT03314935|323704752|FG004|Phase 2|Withdrawal by Subject|0|||
94521529|NCT03314935|323704753|FG005|Phase 2|Withdrawal by Subject|0|||
94521530|NCT03314935|323704754|FG006|Phase 2|Withdrawal by Subject|0|||
94521531|NCT03314935|323704755|FG007|Phase 2|Withdrawal by Subject|0|||
94521532|NCT03314935|323704756|FG008|Phase 2|Withdrawal by Subject|0|||
94521533|NCT03314935|323704757|FG009|Phase 2|Withdrawal by Subject|1|||
94521534|NCT03314935|323704758|FG010|Phase 2|Withdrawal by Subject|4|||
94521535|NCT03314935|323704759|FG011|Phase 2|Withdrawal by Subject|0|||
94521536|NCT03314935|323704760|FG012|Phase 2|Withdrawal by Subject|1|||
94521537|NCT03314935|323704761|FG013|Phase 2|Withdrawal by Subject|0|||
94521538|NCT03314935|323704762|FG014|Phase 2|Withdrawal by Subject|1|||
94521539|NCT03314935|323704748|FG000|Phase 2|Progressive Disease|0|||
94521540|NCT03314935|323704749|FG001|Phase 2|Progressive Disease|0|||
94521541|NCT03314935|323704750|FG002|Phase 2|Progressive Disease|0|||
94521542|NCT03314935|323704751|FG003|Phase 2|Progressive Disease|0|||
94521543|NCT03314935|323704752|FG004|Phase 2|Progressive Disease|0|||
94521544|NCT03314935|323704753|FG005|Phase 2|Progressive Disease|0|||
94521545|NCT03314935|323704754|FG006|Phase 2|Progressive Disease|0|||
94521546|NCT03314935|323704755|FG007|Phase 2|Progressive Disease|0|||
94521547|NCT03314935|323704756|FG008|Phase 2|Progressive Disease|0|||
94521548|NCT03314935|323704757|FG009|Phase 2|Progressive Disease|1|||
94521549|NCT03314935|323704758|FG010|Phase 2|Progressive Disease|1|||
94521550|NCT03314935|323704759|FG011|Phase 2|Progressive Disease|1|||
94521551|NCT03314935|323704760|FG012|Phase 2|Progressive Disease|2|||
94521552|NCT03314935|323704761|FG013|Phase 2|Progressive Disease|0|||
94521553|NCT03314935|323704762|FG014|Phase 2|Progressive Disease|1|||
94521554|NCT03314935|323704748|FG000|Phase 2|Study Terminated by Sponsor|0|||
94521555|NCT03314935|323704749|FG001|Phase 2|Study Terminated by Sponsor|0|||
94521556|NCT03314935|323704750|FG002|Phase 2|Study Terminated by Sponsor|0|||
94521557|NCT03314935|323704751|FG003|Phase 2|Study Terminated by Sponsor|0|||
94521558|NCT03314935|323704752|FG004|Phase 2|Study Terminated by Sponsor|0|||
94521559|NCT03314935|323704753|FG005|Phase 2|Study Terminated by Sponsor|0|||
94521560|NCT03314935|323704754|FG006|Phase 2|Study Terminated by Sponsor|0|||
94521561|NCT03314935|323704755|FG007|Phase 2|Study Terminated by Sponsor|0|||
94521562|NCT03314935|323704756|FG008|Phase 2|Study Terminated by Sponsor|0|||
94521563|NCT03314935|323704757|FG009|Phase 2|Study Terminated by Sponsor|0|||
94521564|NCT03314935|323704758|FG010|Phase 2|Study Terminated by Sponsor|7|||
94521565|NCT03314935|323704759|FG011|Phase 2|Study Terminated by Sponsor|2|||
94521566|NCT03314935|323704760|FG012|Phase 2|Study Terminated by Sponsor|1|||
94521567|NCT03314935|323704761|FG013|Phase 2|Study Terminated by Sponsor|4|||
94521568|NCT03314935|323704762|FG014|Phase 2|Study Terminated by Sponsor|4|||
94521569|NCT03314935|323704748|FG000|Phase 2|Lost to Follow-up|0|||
94521570|NCT03314935|323704749|FG001|Phase 2|Lost to Follow-up|0|||
94521571|NCT03314935|323704750|FG002|Phase 2|Lost to Follow-up|0|||
94521572|NCT03314935|323704751|FG003|Phase 2|Lost to Follow-up|0|||
94521573|NCT03314935|323704752|FG004|Phase 2|Lost to Follow-up|0|||
94521574|NCT03314935|323704753|FG005|Phase 2|Lost to Follow-up|0|||
94521575|NCT03314935|323704754|FG006|Phase 2|Lost to Follow-up|0|||
94521576|NCT03314935|323704755|FG007|Phase 2|Lost to Follow-up|0|||
94521577|NCT03314935|323704756|FG008|Phase 2|Lost to Follow-up|0|||
94521578|NCT03314935|323704757|FG009|Phase 2|Lost to Follow-up|1|||
94521579|NCT03314935|323704758|FG010|Phase 2|Lost to Follow-up|0|||
94521580|NCT03314935|323704759|FG011|Phase 2|Lost to Follow-up|0|||
94521581|NCT03314935|323704760|FG012|Phase 2|Lost to Follow-up|0|||
94521582|NCT03314935|323704761|FG013|Phase 2|Lost to Follow-up|0|||
94521583|NCT03314935|323704762|FG014|Phase 2|Lost to Follow-up|1|||
94521584|NCT03314935|323704748|FG000|Phase 2|Physician Decision|0|||
94521585|NCT03314935|323704749|FG001|Phase 2|Physician Decision|0|||
94521586|NCT03314935|323704750|FG002|Phase 2|Physician Decision|0|||
94521587|NCT03314935|323704751|FG003|Phase 2|Physician Decision|0|||
94521588|NCT03314935|323704752|FG004|Phase 2|Physician Decision|0|||
94521589|NCT03314935|323704753|FG005|Phase 2|Physician Decision|0|||
94521590|NCT03314935|323704754|FG006|Phase 2|Physician Decision|0|||
94521591|NCT03314935|323704755|FG007|Phase 2|Physician Decision|0|||
94521592|NCT03314935|323704756|FG008|Phase 2|Physician Decision|0|||
94521593|NCT03314935|323704757|FG009|Phase 2|Physician Decision|0|||
94521594|NCT03314935|323704758|FG010|Phase 2|Physician Decision|1|||
94521595|NCT03314935|323704759|FG011|Phase 2|Physician Decision|0|||
94521596|NCT03314935|323704760|FG012|Phase 2|Physician Decision|0|||
94521597|NCT03314935|323704761|FG013|Phase 2|Physician Decision|0|||
94521598|NCT03314935|323704762|FG014|Phase 2|Physician Decision|0|||
94521599|NCT00251693|323704770|FG000|Overall Study|Adverse Event|17|||
94521600|NCT00251693|323704771|FG001|Overall Study|Adverse Event|9|||
94521601|NCT00251693|323704772|FG002|Overall Study|Adverse Event|9|||
94521602|NCT00251693|323704770|FG000|Overall Study|Protocol Violation|2|||
94521603|NCT00251693|323704771|FG001|Overall Study|Protocol Violation|0|||
94521604|NCT00251693|323704772|FG002|Overall Study|Protocol Violation|2|||
94521605|NCT00251693|323704770|FG000|Overall Study|Lost to Follow-up|12|||
94521606|NCT00251693|323704771|FG001|Overall Study|Lost to Follow-up|7|||
94521607|NCT00251693|323704772|FG002|Overall Study|Lost to Follow-up|8|||
94521608|NCT00251693|323704770|FG000|Overall Study|Withdrawal by Subject|11|||
94521609|NCT00251693|323704771|FG001|Overall Study|Withdrawal by Subject|17|||
94521610|NCT00251693|323704772|FG002|Overall Study|Withdrawal by Subject|14|||
94521611|NCT00251693|323704770|FG000|Overall Study|Lack of Efficacy|0|||
94521612|NCT00251693|323704771|FG001|Overall Study|Lack of Efficacy|1|||
94521613|NCT00251693|323704772|FG002|Overall Study|Lack of Efficacy|0|||
94521614|NCT00251693|323704770|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
94521615|NCT00251693|323704771|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
94521616|NCT00251693|323704772|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
94521617|NCT00251693|323704770|FG000|Overall Study|Noncompliant|0|||
94521618|NCT00251693|323704771|FG001|Overall Study|Noncompliant|0|||
94521619|NCT00251693|323704772|FG002|Overall Study|Noncompliant|2|||
94521620|NCT00251693|323704770|FG000|Overall Study|Possible Barrett's esophagus|3|||
94521621|NCT00251693|323704771|FG001|Overall Study|Possible Barrett's esophagus|5|||
94521622|NCT00251693|323704772|FG002|Overall Study|Possible Barrett's esophagus|2|||
94521623|NCT00251693|323704770|FG000|Overall Study|Subject request/subject unavailable|1|||
94521624|NCT00251693|323704771|FG001|Overall Study|Subject request/subject unavailable|2|||
94521625|NCT00251693|323704772|FG002|Overall Study|Subject request/subject unavailable|0|||
94521626|NCT00251693|323704770|FG000|Overall Study|Abnormal laboratory findings|0|||
94521627|NCT00251693|323704771|FG001|Overall Study|Abnormal laboratory findings|0|||
94521628|NCT00251693|323704772|FG002|Overall Study|Abnormal laboratory findings|1|||
94521629|NCT00539240|323704773|FG000|Overall Study|Withdrawal by Subject|0|||
94521630|NCT00539240|323704774|FG001|Overall Study|Withdrawal by Subject|2|||
94521631|NCT00539240|323704775|FG002|Overall Study|Withdrawal by Subject|0|||
94521632|NCT00539240|323704773|FG000|Overall Study|Protocol Violation|1|||
94521633|NCT00539240|323704774|FG001|Overall Study|Protocol Violation|1|||
94521634|NCT00539240|323704775|FG002|Overall Study|Protocol Violation|4|||
94521635|NCT00539240|323704773|FG000|Overall Study|Lost to Follow-up|2|||
94521636|NCT00539240|323704774|FG001|Overall Study|Lost to Follow-up|3|||
94521637|NCT00539240|323704775|FG002|Overall Study|Lost to Follow-up|1|||
94521638|NCT00539240|323704773|FG000|Overall Study|Adverse Event|3|||
94521639|NCT00539240|323704774|FG001|Overall Study|Adverse Event|1|||
94521640|NCT00539240|323704775|FG002|Overall Study|Adverse Event|10|||
94521641|NCT04179305|323704777|FG000|Overall Study|Death|1|||
94521642|NCT04179305|323704778|FG001|Overall Study|Death|1|||
94521643|NCT04179305|323704779|FG002|Overall Study|Death|0|||
94521644|NCT04179305|323704780|FG003|Overall Study|Death|0|||
94521645|NCT04179305|323704777|FG000|Overall Study|Lost to Follow-up|1|||
94521646|NCT04179305|323704778|FG001|Overall Study|Lost to Follow-up|1|||
94521647|NCT04179305|323704779|FG002|Overall Study|Lost to Follow-up|0|||
94521648|NCT04179305|323704780|FG003|Overall Study|Lost to Follow-up|0|||
94521649|NCT04179305|323704777|FG000|Overall Study|Withdrawal by Subject|0|||
94521650|NCT04179305|323704778|FG001|Overall Study|Withdrawal by Subject|1|||
94521651|NCT04179305|323704779|FG002|Overall Study|Withdrawal by Subject|0|||
94521652|NCT04179305|323704780|FG003|Overall Study|Withdrawal by Subject|0|||
94521653|NCT04179305|323704777|FG000|Overall Study|Did not have scan|1|||
94521654|NCT04179305|323704778|FG001|Overall Study|Did not have scan|0|||
94521655|NCT04179305|323704779|FG002|Overall Study|Did not have scan|0|||
94521656|NCT04179305|323704780|FG003|Overall Study|Did not have scan|0|||
94521657|NCT04179305|323704777|FG000|Overall Study|In hospice care|3|||
94521658|NCT04179305|323704778|FG001|Overall Study|In hospice care|0|||
94521659|NCT04179305|323704779|FG002|Overall Study|In hospice care|0|||
94521660|NCT04179305|323704780|FG003|Overall Study|In hospice care|0|||
94521661|NCT03381287|323704781|FG000|Overall Study|Withdrawal by Subject|0|||
94521662|NCT03381287|323704782|FG001|Overall Study|Withdrawal by Subject|1|||
94521663|NCT03381287|323704783|FG002|Overall Study|Withdrawal by Subject|0|||
94521664|NCT03381287|323704784|FG003|Overall Study|Withdrawal by Subject|0|||
94521665|NCT03381287|323704781|FG000|Overall Study|Adverse Event|0|||
94521666|NCT03381287|323704782|FG001|Overall Study|Adverse Event|0|||
94521667|NCT03381287|323704783|FG002|Overall Study|Adverse Event|0|||
94521668|NCT03381287|323704784|FG003|Overall Study|Adverse Event|1|||
94521669|NCT03381287|323704781|FG000|Overall Study|Physician Decision|0|||
94521670|NCT03381287|323704782|FG001|Overall Study|Physician Decision|0|||
94521671|NCT03381287|323704783|FG002|Overall Study|Physician Decision|0|||
94521672|NCT03381287|323704784|FG003|Overall Study|Physician Decision|1|||
94521673|NCT04409834|323704786|FG000|Overall Study|Death|55|||
94521674|NCT04409834|323704787|FG001|Overall Study|Death|62|||
94521675|NCT02336815|323706360|FG000|Overall Study|Disease Progression|45|||
94521676|NCT02336815|323706361|FG001|Overall Study|Disease Progression|70|||
94521677|NCT02336815|323706360|FG000|Overall Study|Adverse Event|18|||
94521678|NCT02336815|323706361|FG001|Overall Study|Adverse Event|39|||
94521679|NCT02336815|323706360|FG000|Overall Study|Physician Decision|11|||
94521680|NCT02336815|323706361|FG001|Overall Study|Physician Decision|4|||
94521681|NCT02336815|323706360|FG000|Overall Study|Withdrawal by Subject|3|||
94521682|NCT02336815|323706361|FG001|Overall Study|Withdrawal by Subject|2|||
94521683|NCT02336815|323706360|FG000|Overall Study|Lost to Follow-up|1|||
94521684|NCT02336815|323706361|FG001|Overall Study|Lost to Follow-up|3|||
94521685|NCT02336815|323706360|FG000|Overall Study|Other|1|||
94521686|NCT02336815|323706361|FG001|Overall Study|Other|5|||
94521687|NCT03759600|323706362|FG000|Overall Study|Adverse Event|2|||
94521688|NCT03759600|323706362|FG000|Overall Study|Progressive Disease|15|||
94521689|NCT03759600|323706362|FG000|Overall Study|Site Terminated by Sponsor|3|||
94521690|NCT01747915|323706363|FG000|Overall Study|Other|1|||
94521691|NCT01747915|323706364|FG001|Overall Study|Other|1|||
94521692|NCT01747915|323706365|FG002|Overall Study|Other|1|||
94521693|NCT01747915|323706363|FG000|Overall Study|Adverse Event|8|||
94521694|NCT01747915|323706364|FG001|Overall Study|Adverse Event|5|||
94521695|NCT01747915|323706365|FG002|Overall Study|Adverse Event|2|||
94521696|NCT01747915|323706363|FG000|Overall Study|Death|0|||
94521697|NCT01747915|323706364|FG001|Overall Study|Death|0|||
94521698|NCT01747915|323706365|FG002|Overall Study|Death|1|||
94521699|NCT01747915|323706363|FG000|Overall Study|Lack of Efficacy|0|||
94521700|NCT01747915|323706364|FG001|Overall Study|Lack of Efficacy|1|||
94521701|NCT01747915|323706365|FG002|Overall Study|Lack of Efficacy|0|||
94521702|NCT01747915|323706363|FG000|Overall Study|Lost to Follow-up|1|||
94521703|NCT01747915|323706364|FG001|Overall Study|Lost to Follow-up|0|||
94521704|NCT01747915|323706365|FG002|Overall Study|Lost to Follow-up|0|||
94521705|NCT01747915|323706363|FG000|Overall Study|Withdrawal by Subject|4|||
94521706|NCT01747915|323706364|FG001|Overall Study|Withdrawal by Subject|4|||
94521707|NCT01747915|323706365|FG002|Overall Study|Withdrawal by Subject|1|||
94521708|NCT01747915|323706363|FG000|Overall Study|Protocol Violation|1|||
94521709|NCT01747915|323706364|FG001|Overall Study|Protocol Violation|0|||
94521710|NCT01747915|323706365|FG002|Overall Study|Protocol Violation|0|||
94521711|NCT01747915|323706363|FG000|Overall Study|Pregnancy|0|||
94521712|NCT01747915|323706364|FG001|Overall Study|Pregnancy|0|||
94521713|NCT01747915|323706365|FG002|Overall Study|Pregnancy|1|||
94521714|NCT00803738|323706368|FG000|Overall Study|Adverse Event|3|||
94521715|NCT00803738|323706369|FG001|Overall Study|Adverse Event|5|||
94521716|NCT00803738|323706368|FG000|Overall Study|Lost to Follow-up|4|||
94521717|NCT00803738|323706369|FG001|Overall Study|Lost to Follow-up|4|||
94521718|NCT00803738|323706368|FG000|Overall Study|Protocol Violation|18|||
94521719|NCT00803738|323706369|FG001|Overall Study|Protocol Violation|10|||
94521720|NCT00803738|323706368|FG000|Overall Study|Withdrawal by Subject|1|||
94521721|NCT00803738|323706369|FG001|Overall Study|Withdrawal by Subject|4|||
94521722|NCT00803738|323706368|FG000|Overall Study|Lack of Efficacy|10|||
94521723|NCT00803738|323706369|FG001|Overall Study|Lack of Efficacy|16|||
94521724|NCT00803738|323706368|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
94521725|NCT00803738|323706369|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
94521726|NCT00803738|323706368|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
94521727|NCT00803738|323706369|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
94521728|NCT06164691|323706370|FG000|Overall Study|Withdrawal by Subject|2|||
94521729|NCT06164691|323706371|FG001|Overall Study|Withdrawal by Subject|0|||
94521730|NCT06164691|323706372|FG002|Overall Study|Withdrawal by Subject|0|||
94521731|NCT02391311|323706373|FG000|Overall Study|Lost to Follow-up|2|||
94521732|NCT02391311|323706374|FG001|Overall Study|Lost to Follow-up|1|||
94521733|NCT02391311|323706373|FG000|Overall Study|deemed ineligible after baseline|1|||
94521734|NCT02391311|323706374|FG001|Overall Study|deemed ineligible after baseline|1|||
94521735|NCT02364037|323706375|FG000|Overall Study|Withdrawal by Subject|7|||
94521736|NCT02364037|323706376|FG001|Overall Study|Withdrawal by Subject|4|||
94521737|NCT02364037|323706375|FG000|Overall Study|Lost to Follow-up|37|||
94521738|NCT02364037|323706376|FG001|Overall Study|Lost to Follow-up|49|||
94521739|NCT03374358|323706379|FG000|Overall Study|Withdrawal by Subject|0|||
94521740|NCT03374358|323706380|FG001|Overall Study|Withdrawal by Subject|2|||
94521741|NCT00688467|323706381|FG000|Treatment Period 1|Adverse Event|2|||
94521742|NCT00688467|323706382|FG001|Treatment Period 1|Adverse Event|1|||
94521743|NCT00688467|323706381|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
94521744|NCT00688467|323706382|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
94521745|NCT00688467|323706381|FG000|Treatment Period 2|Protocol Violation|0|||
94521746|NCT00688467|323706382|FG001|Treatment Period 2|Protocol Violation|1|||
94521747|NCT00688467|323706381|FG000|Treatment Period 2|Adverse Event|0|||
94521748|NCT00688467|323706382|FG001|Treatment Period 2|Adverse Event|1|||
94521749|NCT00690794|323706385|FG000|Overall Study|Adverse Event|12|||
94521750|NCT00690794|323706386|FG001|Overall Study|Adverse Event|10|||
94521751|NCT00690794|323706385|FG000|Overall Study|Lost to Follow-up|1|||
94521752|NCT00690794|323706386|FG001|Overall Study|Lost to Follow-up|4|||
94521753|NCT00690794|323706385|FG000|Overall Study|Withdrawal by Subject|0|||
94521754|NCT00690794|323706386|FG001|Overall Study|Withdrawal by Subject|9|||
94521755|NCT00690794|323706385|FG000|Overall Study|Protocol Violation|6|||
94521756|NCT00690794|323706386|FG001|Overall Study|Protocol Violation|7|||
94521757|NCT00690794|323706385|FG000|Overall Study|Noncompliance|1|||
94521758|NCT00690794|323706386|FG001|Overall Study|Noncompliance|2|||
94521759|NCT00690794|323706385|FG000|Overall Study|Other not specified|1|||
94521760|NCT00690794|323706386|FG001|Overall Study|Other not specified|3|||
94521761|NCT03012334|323706387|FG000|Period 1|Withdrawal by Subject|0|||
94521762|NCT03012334|323706388|FG001|Period 1|Withdrawal by Subject|0|||
94521763|NCT03012334|323706389|FG002|Period 1|Withdrawal by Subject|0|||
94521764|NCT03012334|323706390|FG003|Period 1|Withdrawal by Subject|0|||
94521765|NCT03012334|323706391|FG004|Period 1|Withdrawal by Subject|0|||
94521766|NCT03012334|323706392|FG005|Period 1|Withdrawal by Subject|0|||
94521767|NCT03012334|323706393|FG006|Period 1|Withdrawal by Subject|0|||
94521768|NCT03012334|323706394|FG007|Period 1|Withdrawal by Subject|0|||
94521769|NCT03012334|323706395|FG008|Period 1|Withdrawal by Subject|0|||
94521770|NCT03012334|323706396|FG009|Period 1|Withdrawal by Subject|1|||
94521771|NCT03012334|323706387|FG000|Period 2|Withdrawal by Subject|0|||
94521772|NCT03012334|323706388|FG001|Period 2|Withdrawal by Subject|1|||
94521773|NCT03012334|323706389|FG002|Period 2|Withdrawal by Subject|0|||
94521774|NCT03012334|323706390|FG003|Period 2|Withdrawal by Subject|0|||
94521775|NCT03012334|323706391|FG004|Period 2|Withdrawal by Subject|0|||
94521776|NCT03012334|323706392|FG005|Period 2|Withdrawal by Subject|0|||
94521777|NCT03012334|323706393|FG006|Period 2|Withdrawal by Subject|0|||
94521778|NCT03012334|323706394|FG007|Period 2|Withdrawal by Subject|0|||
94521779|NCT03012334|323706395|FG008|Period 2|Withdrawal by Subject|0|||
94521780|NCT03012334|323706396|FG009|Period 2|Withdrawal by Subject|0|||
94521781|NCT03012334|323706387|FG000|Period 2|Protocol Violation|0|||
94521782|NCT03012334|323706388|FG001|Period 2|Protocol Violation|0|||
94521783|NCT03012334|323706389|FG002|Period 2|Protocol Violation|1|||
94521784|NCT03012334|323706390|FG003|Period 2|Protocol Violation|0|||
94521785|NCT03012334|323706391|FG004|Period 2|Protocol Violation|0|||
94521786|NCT03012334|323706392|FG005|Period 2|Protocol Violation|0|||
94521787|NCT03012334|323706393|FG006|Period 2|Protocol Violation|0|||
94521788|NCT03012334|323706394|FG007|Period 2|Protocol Violation|1|||
94521789|NCT03012334|323706395|FG008|Period 2|Protocol Violation|0|||
94521790|NCT03012334|323706396|FG009|Period 2|Protocol Violation|0|||
94521791|NCT03012334|323706387|FG000|Period 4|Non-Compliance|0|||
94521792|NCT03012334|323706388|FG001|Period 4|Non-Compliance|0|||
94521793|NCT03012334|323706389|FG002|Period 4|Non-Compliance|0|||
94521794|NCT03012334|323706390|FG003|Period 4|Non-Compliance|0|||
94521795|NCT03012334|323706391|FG004|Period 4|Non-Compliance|0|||
94521796|NCT03012334|323706392|FG005|Period 4|Non-Compliance|0|||
94521797|NCT03012334|323706393|FG006|Period 4|Non-Compliance|1|||
94521798|NCT03012334|323706394|FG007|Period 4|Non-Compliance|0|||
94521799|NCT03012334|323706395|FG008|Period 4|Non-Compliance|0|||
94521800|NCT03012334|323706396|FG009|Period 4|Non-Compliance|0|||
94521801|NCT03012334|323706387|FG000|Period 4|Adverse Event|0|||
94521802|NCT03012334|323706388|FG001|Period 4|Adverse Event|0|||
94521803|NCT03012334|323706389|FG002|Period 4|Adverse Event|0|||
94521804|NCT03012334|323706390|FG003|Period 4|Adverse Event|0|||
94521805|NCT03012334|323706391|FG004|Period 4|Adverse Event|0|||
94521806|NCT03012334|323706392|FG005|Period 4|Adverse Event|0|||
94521807|NCT03012334|323706393|FG006|Period 4|Adverse Event|0|||
94521808|NCT03012334|323706394|FG007|Period 4|Adverse Event|0|||
94521809|NCT03012334|323706395|FG008|Period 4|Adverse Event|1|||
94521810|NCT03012334|323706396|FG009|Period 4|Adverse Event|0|||
94521811|NCT00742625|323706397|FG000|Remission Induction|Progression|6|||
94521812|NCT00742625|323706397|FG000|Remission Induction|Failed induction|8|||
94521813|NCT00742625|323706397|FG000|Remission Induction|Adverse Event|3|||
94521814|NCT00742625|323706397|FG000|Remission Induction|Death|10|||
94521815|NCT00742625|323706397|FG000|Remission Induction|Refusal|5|||
94521816|NCT00742625|323706397|FG000|Remission Induction|Non protocol treatment|17|||
94521817|NCT00742625|323706397|FG000|Remission Induction|Other, not specified|5|||
94521818|NCT00742625|323706397|FG000|Consolidation|Progression|5|||
94521819|NCT00742625|323706397|FG000|Consolidation|Adverse Event|1|||
94521820|NCT00742625|323706397|FG000|Consolidation|Death|1|||
94521821|NCT00742625|323706397|FG000|Consolidation|Refused|1|||
94521822|NCT00742625|323706397|FG000|Consolidation|Non protocol therapy|13|||
94521823|NCT02197572|323706398|FG000|Overall Study|Progressive Disease|28|||
94521824|NCT02197572|323706398|FG000|Overall Study|Withdrawal by Subject|9|||
94521825|NCT02197572|323706398|FG000|Overall Study|Adverse Event|3|||
94521826|NCT02197572|323706398|FG000|Overall Study|Reason Not Specified|4|||
94521827|NCT03338400|323706399|FG000|Overall Study|Lost to Follow-up|1|||
94521828|NCT03338400|323706400|FG001|Overall Study|Lost to Follow-up|2|||
94521829|NCT01306643|323706401|FG000|Overall Study|Adverse Event|5|||
94521830|NCT01306643|323706401|FG000|Overall Study|Disease Progression|7|||
94521831|NCT01306643|323706401|FG000|Overall Study|Other: Change in Eligibility Status|1|||
94521832|NCT02639390|323706410|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
94521833|NCT02639390|323706411|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
94521834|NCT01639469|323706416|FG000|Overall Study|Death|4|||
94521835|NCT01639469|323706417|FG001|Overall Study|Death|2|||
94521836|NCT01639469|323706416|FG000|Overall Study|Lost to Follow-up|1|||
94521837|NCT01639469|323706417|FG001|Overall Study|Lost to Follow-up|1|||
94521838|NCT02071771|323706424|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
94521839|NCT02071771|323706425|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
94521840|NCT02071771|323706424|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
94521841|NCT02071771|323706425|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
94521842|NCT02078752|323706426|FG000|Overall Study|Death|0|||
94521843|NCT02078752|323706427|FG001|Overall Study|Death|3|||
94521844|NCT02078752|323706428|FG002|Overall Study|Death|0|||
94521845|NCT02078752|323706429|FG003|Overall Study|Death|0|||
94521846|NCT02078752|323706430|FG004|Overall Study|Death|0|||
94521847|NCT02078752|323706431|FG005|Overall Study|Death|1|||
94521848|NCT02078752|323706432|FG006|Overall Study|Death|0|||
94521849|NCT02078752|323706433|FG007|Overall Study|Death|1|||
94521850|NCT02078752|323706434|FG008|Overall Study|Death|0|||
94521851|NCT02078752|323706435|FG009|Overall Study|Death|4|||
94521852|NCT02078752|323706426|FG000|Overall Study|Lost to Follow-up|1|||
94521853|NCT02078752|323706427|FG001|Overall Study|Lost to Follow-up|0|||
94521854|NCT02078752|323706428|FG002|Overall Study|Lost to Follow-up|0|||
94521855|NCT02078752|323706429|FG003|Overall Study|Lost to Follow-up|1|||
94521856|NCT02078752|323706430|FG004|Overall Study|Lost to Follow-up|0|||
94521857|NCT02078752|323706431|FG005|Overall Study|Lost to Follow-up|0|||
94521858|NCT02078752|323706432|FG006|Overall Study|Lost to Follow-up|0|||
94521859|NCT02078752|323706433|FG007|Overall Study|Lost to Follow-up|0|||
94521860|NCT02078752|323706434|FG008|Overall Study|Lost to Follow-up|0|||
94521861|NCT02078752|323706435|FG009|Overall Study|Lost to Follow-up|0|||
94521862|NCT02078752|323706426|FG000|Overall Study|Withdrawal by Subject|1|||
94521863|NCT02078752|323706427|FG001|Overall Study|Withdrawal by Subject|1|||
94521864|NCT02078752|323706428|FG002|Overall Study|Withdrawal by Subject|1|||
94521865|NCT02078752|323706429|FG003|Overall Study|Withdrawal by Subject|1|||
94521866|NCT02078752|323706430|FG004|Overall Study|Withdrawal by Subject|0|||
94521867|NCT02078752|323706431|FG005|Overall Study|Withdrawal by Subject|3|||
94521868|NCT02078752|323706432|FG006|Overall Study|Withdrawal by Subject|2|||
94521869|NCT02078752|323706433|FG007|Overall Study|Withdrawal by Subject|1|||
94521870|NCT02078752|323706434|FG008|Overall Study|Withdrawal by Subject|0|||
94521871|NCT02078752|323706435|FG009|Overall Study|Withdrawal by Subject|1|||
94521872|NCT02078752|323706426|FG000|Overall Study|Other|0|||
94521873|NCT02078752|323706427|FG001|Overall Study|Other|3|||
94521874|NCT02078752|323706428|FG002|Overall Study|Other|0|||
94521875|NCT02078752|323706429|FG003|Overall Study|Other|0|||
94521876|NCT02078752|323706430|FG004|Overall Study|Other|1|||
94521877|NCT02078752|323706431|FG005|Overall Study|Other|0|||
94521878|NCT02078752|323706432|FG006|Overall Study|Other|0|||
94521879|NCT02078752|323706433|FG007|Overall Study|Other|1|||
94521880|NCT02078752|323706434|FG008|Overall Study|Other|0|||
94521881|NCT02078752|323706435|FG009|Overall Study|Other|0|||
94521882|NCT02078752|323706426|FG000|Overall Study|Study terminated by sponsor|0|||
94521883|NCT02078752|323706427|FG001|Overall Study|Study terminated by sponsor|0|||
94521884|NCT02078752|323706428|FG002|Overall Study|Study terminated by sponsor|0|||
94521885|NCT02078752|323706429|FG003|Overall Study|Study terminated by sponsor|0|||
94521886|NCT02078752|323706430|FG004|Overall Study|Study terminated by sponsor|0|||
94521887|NCT02078752|323706431|FG005|Overall Study|Study terminated by sponsor|0|||
94521888|NCT02078752|323706432|FG006|Overall Study|Study terminated by sponsor|0|||
94521889|NCT02078752|323706433|FG007|Overall Study|Study terminated by sponsor|0|||
94521890|NCT02078752|323706434|FG008|Overall Study|Study terminated by sponsor|0|||
94521891|NCT02078752|323706435|FG009|Overall Study|Study terminated by sponsor|5|||
94521892|NCT00573391|323706444|FG000|Overall Study|study stopped|2|||
94521893|NCT00573391|323706445|FG001|Overall Study|study stopped|2|||
94521894|NCT00573391|323706444|FG000|Overall Study|Death|1|||
94521895|NCT00573391|323706445|FG001|Overall Study|Death|0|||
94521896|NCT04011735|323706446|FG000|Overall Study|Withdrawal by Subject|1|||
94521897|NCT04011735|323706447|FG001|Overall Study|Withdrawal by Subject|0|||
94521898|NCT04011735|323706448|FG002|Overall Study|Withdrawal by Subject|1|||
94521899|NCT04011735|323706446|FG000|Overall Study|Met exclusion criteria after study entry|0|||
94521900|NCT04011735|323706447|FG001|Overall Study|Met exclusion criteria after study entry|1|||
94521901|NCT04011735|323706448|FG002|Overall Study|Met exclusion criteria after study entry|0|||
94521902|NCT03064074|323706449|FG000|Overall Study|Physician Decision|0|||
94521903|NCT03064074|323706450|FG001|Overall Study|Physician Decision|0|||
94521904|NCT03064074|323706451|FG002|Overall Study|Physician Decision|0|||
94521905|NCT03064074|323706452|FG003|Overall Study|Physician Decision|1|||
94521906|NCT03962855|323706455|FG000|Overall Study|Death|0|||
94521907|NCT03962855|323706456|FG001|Overall Study|Death|1|||
94521908|NCT03962855|323706455|FG000|Overall Study|Lost to Follow-up|0|||
94521909|NCT03962855|323706456|FG001|Overall Study|Lost to Follow-up|1|||
94521910|NCT03962855|323706455|FG000|Overall Study|Adverse Event|0|||
94521911|NCT03962855|323706456|FG001|Overall Study|Adverse Event|1|||
94521912|NCT03962855|323706455|FG000|Overall Study|Physician Decision|0|||
94521913|NCT03962855|323706456|FG001|Overall Study|Physician Decision|2|||
94521914|NCT01071954|323706457|FG000|Overall Study|Noncompliance|4|||
94521915|NCT01071954|323706457|FG000|Overall Study|Adverse Event|1|||
94521916|NCT01071954|323706457|FG000|Overall Study|Withdrawal by Subject|11|||
94521917|NCT01071954|323706457|FG000|Overall Study|Requirement for Alternative Therapy|5|||
94521918|NCT01071954|323706457|FG000|Overall Study|Administrative Decision|5|||
94521919|NCT01071954|323706457|FG000|Overall Study|Protocol Specified Criteria|1|||
94521920|NCT01061385|323706458|FG000|Overall Study|Lost to Follow-up|1|||
94521921|NCT01061385|323706459|FG001|Overall Study|Lost to Follow-up|0|||
94521922|NCT01061385|323706458|FG000|Overall Study|subject decision not related to AE|0|||
94521923|NCT01061385|323706459|FG001|Overall Study|subject decision not related to AE|1|||
94521924|NCT00533429|323706460|FG000|Overall Study|Adverse Event|3|||
94521925|NCT00533429|323706461|FG001|Overall Study|Adverse Event|1|||
94521926|NCT00533429|323706460|FG000|Overall Study|Death|1|||
94521927|NCT00533429|323706461|FG001|Overall Study|Death|0|||
94521928|NCT00533429|323706460|FG000|Overall Study|Withdrawal by Subject|2|||
94521929|NCT00533429|323706461|FG001|Overall Study|Withdrawal by Subject|0|||
94521930|NCT00533429|323706460|FG000|Overall Study|Progressive Disease|12|||
94521931|NCT00533429|323706461|FG001|Overall Study|Progressive Disease|13|||
94521932|NCT00533429|323706460|FG000|Overall Study|Symptomatic deterioration|1|||
94521933|NCT00533429|323706461|FG001|Overall Study|Symptomatic deterioration|2|||
94521934|NCT00244621|323706463|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
94521935|NCT00244621|323706464|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
94521936|NCT00244621|323706465|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
94521937|NCT00244621|323706463|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
94521938|NCT00244621|323706464|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
94521939|NCT00244621|323706465|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
94521940|NCT00244621|323706463|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
94521941|NCT00244621|323706464|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
94521942|NCT00244621|323706465|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
94521943|NCT00244621|323706463|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
94521944|NCT00244621|323706464|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
94521945|NCT00244621|323706465|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
94521946|NCT00244621|323706463|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
94521947|NCT00244621|323706464|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
94521948|NCT00244621|323706465|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
94521949|NCT00244621|323706463|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
94521950|NCT00244621|323706464|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
94521951|NCT00244621|323706465|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
94521952|NCT00244621|323706463|FG000|Open-label Treatment Period|Adverse Event|0|||
94521953|NCT00244621|323706464|FG001|Open-label Treatment Period|Adverse Event|0|||
94521954|NCT00244621|323706465|FG002|Open-label Treatment Period|Adverse Event|1|||
94521955|NCT00244621|323706463|FG000|Open-label Treatment Period|Moved abroad|0|||
94521956|NCT00244621|323706464|FG001|Open-label Treatment Period|Moved abroad|0|||
94521957|NCT00244621|323706465|FG002|Open-label Treatment Period|Moved abroad|1|||
94521958|NCT00920556|323706466|FG000|Overall Study|Adverse Event|16|||
94521959|NCT00920556|323706466|FG000|Overall Study|Physician Decision|7|||
94521960|NCT00920556|323706466|FG000|Overall Study|Withdrawal by Subject|1|||
94521961|NCT01299389|323706467|FG000|Double-blind|Adverse Event|45|||
94521962|NCT01299389|323706468|FG001|Double-blind|Adverse Event|27|||
94521963|NCT01299389|323706469|FG002|Double-blind|Adverse Event|0|||
94521964|NCT01299389|323706470|FG003|Double-blind|Adverse Event|0|||
94521965|NCT01299389|323706467|FG000|Double-blind|Lack of Efficacy|45|||
94521966|NCT01299389|323706468|FG001|Double-blind|Lack of Efficacy|21|||
94521967|NCT01299389|323706469|FG002|Double-blind|Lack of Efficacy|0|||
94521968|NCT01299389|323706470|FG003|Double-blind|Lack of Efficacy|0|||
94521969|NCT01299389|323706467|FG000|Double-blind|Lost to Follow-up|2|||
94521970|NCT01299389|323706468|FG001|Double-blind|Lost to Follow-up|1|||
94521971|NCT01299389|323706469|FG002|Double-blind|Lost to Follow-up|0|||
94521972|NCT01299389|323706470|FG003|Double-blind|Lost to Follow-up|0|||
94521973|NCT01299389|323706467|FG000|Double-blind|Withdrawal by Subject|16|||
94521974|NCT01299389|323706468|FG001|Double-blind|Withdrawal by Subject|13|||
94521975|NCT01299389|323706469|FG002|Double-blind|Withdrawal by Subject|0|||
94521976|NCT01299389|323706470|FG003|Double-blind|Withdrawal by Subject|0|||
94521977|NCT01299389|323706467|FG000|Double-blind|Other|1|||
94521978|NCT01299389|323706468|FG001|Double-blind|Other|1|||
94521979|NCT01299389|323706469|FG002|Double-blind|Other|0|||
94521980|NCT01299389|323706470|FG003|Double-blind|Other|0|||
94521981|NCT01299389|323706467|FG000|Double-blind|"fail to meet study population criteria"|0|||
94521982|NCT01299389|323706468|FG001|Double-blind|"fail to meet study population criteria"|1|||
94521983|NCT01299389|323706469|FG002|Double-blind|"fail to meet study population criteria"|0|||
94521984|NCT01299389|323706470|FG003|Double-blind|"fail to meet study population criteria"|0|||
94521985|NCT01299389|323706467|FG000|Post-observational|Other|0|||
94521986|NCT01299389|323706468|FG001|Post-observational|Other|0|||
94521987|NCT01299389|323706469|FG002|Post-observational|Other|12|||
94521988|NCT01299389|323706470|FG003|Post-observational|Other|6|||
94521989|NCT02185534|323706475|FG000|First Period|Withdrawal by Subject|0|||
94521990|NCT02185534|323706476|FG001|First Period|Withdrawal by Subject|0|||
94521991|NCT02185534|323706477|FG002|First Period|Withdrawal by Subject|0|||
94521992|NCT02185534|323706478|FG003|First Period|Withdrawal by Subject|1|||
94521993|NCT02185534|323706479|FG004|First Period|Withdrawal by Subject|0|||
94521994|NCT02185534|323706480|FG005|First Period|Withdrawal by Subject|0|||
94521995|NCT02185534|323706475|FG000|First Washout Period|Withdrawal by Subject|1|||
94521996|NCT02185534|323706476|FG001|First Washout Period|Withdrawal by Subject|0|||
94521997|NCT02185534|323706477|FG002|First Washout Period|Withdrawal by Subject|0|||
94521998|NCT02185534|323706478|FG003|First Washout Period|Withdrawal by Subject|0|||
94521999|NCT02185534|323706479|FG004|First Washout Period|Withdrawal by Subject|1|||
94522000|NCT02185534|323706480|FG005|First Washout Period|Withdrawal by Subject|0|||
94522001|NCT02185534|323706475|FG000|First Washout Period|Protocol Violation|0|||
94522002|NCT02185534|323706476|FG001|First Washout Period|Protocol Violation|0|||
94522003|NCT02185534|323706477|FG002|First Washout Period|Protocol Violation|0|||
94522004|NCT02185534|323706478|FG003|First Washout Period|Protocol Violation|0|||
94522005|NCT02185534|323706479|FG004|First Washout Period|Protocol Violation|0|||
94522006|NCT02185534|323706480|FG005|First Washout Period|Protocol Violation|1|||
94522007|NCT00928187|323706481|FG000|Overall Study|Death|1|||
94522008|NCT00928187|323706482|FG001|Overall Study|Death|2|||
94522009|NCT00928187|323706483|FG002|Overall Study|Death|3|||
94522010|NCT00928187|323706481|FG000|Overall Study|Lost to Follow-up|1|||
94522011|NCT00928187|323706482|FG001|Overall Study|Lost to Follow-up|2|||
94522012|NCT00928187|323706483|FG002|Overall Study|Lost to Follow-up|1|||
94522013|NCT00928187|323706481|FG000|Overall Study|Withdrawal by Subject|0|||
94522014|NCT00928187|323706482|FG001|Overall Study|Withdrawal by Subject|1|||
94522015|NCT00928187|323706483|FG002|Overall Study|Withdrawal by Subject|1|||
94522016|NCT00928187|323706481|FG000|Overall Study|Protocol Violation|0|||
94522017|NCT00928187|323706482|FG001|Overall Study|Protocol Violation|1|||
94522018|NCT00928187|323706483|FG002|Overall Study|Protocol Violation|0|||
94522019|NCT00648037|323706484|FG000|Overall Study|Not Treated|1|||
94522020|NCT00648037|323706484|FG000|Overall Study|Withdrawal by Subject|1|||
94522021|NCT00648037|323706484|FG000|Overall Study|Adverse Event|11|||
94522022|NCT00648037|323706484|FG000|Overall Study|Relapse|2|||
94522023|NCT00648037|323706484|FG000|Overall Study|Other|1|||
94522024|NCT04419467|323706489|FG000|Overall Study|Not treated with IP|0|||
94522025|NCT04419467|323706490|FG001|Overall Study|Not treated with IP|0|||
94522026|NCT04419467|323706491|FG002|Overall Study|Not treated with IP|2|||
94522027|NCT04419467|323706489|FG000|Overall Study|Adverse Event|0|||
94522028|NCT04419467|323706490|FG001|Overall Study|Adverse Event|2|||
94522029|NCT04419467|323706491|FG002|Overall Study|Adverse Event|0|||
94522030|NCT04419467|323706489|FG000|Overall Study|Death|1|||
94522031|NCT04419467|323706490|FG001|Overall Study|Death|0|||
94522032|NCT04419467|323706491|FG002|Overall Study|Death|0|||
94522033|NCT04419467|323706489|FG000|Overall Study|Lost to Follow-up|0|||
94522034|NCT04419467|323706490|FG001|Overall Study|Lost to Follow-up|1|||
94522035|NCT04419467|323706491|FG002|Overall Study|Lost to Follow-up|2|||
94522036|NCT04419467|323706489|FG000|Overall Study|Withdrawal by Subject|0|||
94522037|NCT04419467|323706490|FG001|Overall Study|Withdrawal by Subject|0|||
94522038|NCT04419467|323706491|FG002|Overall Study|Withdrawal by Subject|4|||
94522039|NCT04419467|323706489|FG000|Overall Study|Pandemic related|0|||
94522040|NCT04419467|323706490|FG001|Overall Study|Pandemic related|0|||
94522041|NCT04419467|323706491|FG002|Overall Study|Pandemic related|1|||
94522042|NCT04419467|323706489|FG000|Overall Study|Reason not known|1|||
94522043|NCT04419467|323706490|FG001|Overall Study|Reason not known|0|||
94522044|NCT04419467|323706491|FG002|Overall Study|Reason not known|0|||
94522045|NCT00401843|323706496|FG000|Overall Study|Achieved Complete Response|1|||
94522046|NCT00401843|323706497|FG001|Overall Study|Achieved Complete Response|5|||
94522047|NCT00401843|323706498|FG002|Overall Study|Achieved Complete Response|11|||
94522048|NCT00401843|323706496|FG000|Overall Study|Adverse Event|7|||
94522049|NCT00401843|323706497|FG001|Overall Study|Adverse Event|26|||
94522050|NCT00401843|323706498|FG002|Overall Study|Adverse Event|27|||
94522051|NCT00401843|323706496|FG000|Overall Study|Death|0|||
94522052|NCT00401843|323706497|FG001|Overall Study|Death|8|||
94522053|NCT00401843|323706498|FG002|Overall Study|Death|10|||
94522054|NCT00401843|323706496|FG000|Overall Study|Disease progression|10|||
94522055|NCT00401843|323706497|FG001|Overall Study|Disease progression|60|||
94522056|NCT00401843|323706498|FG002|Overall Study|Disease progression|49|||
94522057|NCT00401843|323706496|FG000|Overall Study|End of Study|1|||
94522058|NCT00401843|323706497|FG001|Overall Study|End of Study|1|||
94522059|NCT00401843|323706498|FG002|Overall Study|End of Study|2|||
94522060|NCT00401843|323706496|FG000|Overall Study|Lost to Follow-up|0|||
94522061|NCT00401843|323706497|FG001|Overall Study|Lost to Follow-up|0|||
94522062|NCT00401843|323706498|FG002|Overall Study|Lost to Follow-up|2|||
94522063|NCT00401843|323706496|FG000|Overall Study|Other Unspecified|0|||
94522064|NCT00401843|323706497|FG001|Overall Study|Other Unspecified|3|||
94522065|NCT00401843|323706498|FG002|Overall Study|Other Unspecified|5|||
94522066|NCT00401843|323706496|FG000|Overall Study|Physician Decision|0|||
94522067|NCT00401843|323706497|FG001|Overall Study|Physician Decision|16|||
94522068|NCT00401843|323706498|FG002|Overall Study|Physician Decision|10|||
94522069|NCT00401843|323706496|FG000|Overall Study|Protocol Violation|0|||
94522070|NCT00401843|323706497|FG001|Overall Study|Protocol Violation|0|||
94522071|NCT00401843|323706498|FG002|Overall Study|Protocol Violation|1|||
94522072|NCT00401843|323706496|FG000|Overall Study|Withdrawal by Subject|1|||
94522073|NCT00401843|323706497|FG001|Overall Study|Withdrawal by Subject|5|||
94522074|NCT00401843|323706498|FG002|Overall Study|Withdrawal by Subject|5|||
94522075|NCT00401843|323706496|FG000|Overall Study|Withdrawal of consent to study agent|1|||
94522076|NCT00401843|323706497|FG001|Overall Study|Withdrawal of consent to study agent|15|||
94522077|NCT00401843|323706498|FG002|Overall Study|Withdrawal of consent to study agent|17|||
94522078|NCT00401843|323706496|FG000|Overall Study|Randomized but not Treated|0|||
94522079|NCT00401843|323706497|FG001|Overall Study|Randomized but not Treated|2|||
94522080|NCT00401843|323706498|FG002|Overall Study|Randomized but not Treated|3|||
94522081|NCT00401843|323706496|FG000|Overall Study|Received incorrect treatment|0|||
94522082|NCT00401843|323706497|FG001|Overall Study|Received incorrect treatment|3|||
94522083|NCT00401843|323706498|FG002|Overall Study|Received incorrect treatment|0|||
94522084|NCT01182298|323706501|FG000|Overall Study|Lack of Efficacy|4|||
94522085|NCT01182298|323706501|FG000|Overall Study|Withdrawal by Subject|2|||
94522086|NCT03328832|323706503|FG000|Overall Study|Lost to Follow-up|0|||
94522087|NCT03328832|323706504|FG001|Overall Study|Lost to Follow-up|1|||
94522088|NCT00414076|323706505|FG000|Overall Study|Progression|1|||
94522089|NCT00414076|323706506|FG001|Overall Study|Progression|2|||
94522090|NCT00414076|323706505|FG000|Overall Study|Withdrawal by Subject|1|||
94522091|NCT00414076|323706506|FG001|Overall Study|Withdrawal by Subject|3|||
94522092|NCT00414076|323706505|FG000|Overall Study|Adverse Event|1|||
94522093|NCT00414076|323706506|FG001|Overall Study|Adverse Event|0|||
94522094|NCT00959907|323706507|FG000|Overall Study|Protocol Violation|0|||
94522095|NCT00959907|323706508|FG001|Overall Study|Protocol Violation|1|||
94522096|NCT00959907|323706507|FG000|Overall Study|Adverse Event|1|||
94522097|NCT00959907|323706508|FG001|Overall Study|Adverse Event|0|||
94522098|NCT00959907|323706507|FG000|Overall Study|Withdrawal by Subject|2|||
94522099|NCT00959907|323706508|FG001|Overall Study|Withdrawal by Subject|0|||
94522100|NCT02030821|323706511|FG000|Overall Study|Physician Decision|2|||
94522101|NCT02030821|323706512|FG001|Overall Study|Physician Decision|2|||
94522102|NCT02030821|323706513|FG002|Overall Study|Physician Decision|5|||
94522103|NCT02030821|323706514|FG003|Overall Study|Physician Decision|2|||
94522104|NCT03192137|323706515|FG000|Overall Study|Adverse Event|10|||
94522105|NCT03192137|323706516|FG001|Overall Study|Adverse Event|11|||
94522106|NCT03192137|323706515|FG000|Overall Study|Physician Decision|1|||
94522107|NCT03192137|323706516|FG001|Overall Study|Physician Decision|0|||
94522108|NCT03192137|323706515|FG000|Overall Study|Lack of Efficacy|20|||
94522109|NCT03192137|323706516|FG001|Overall Study|Lack of Efficacy|37|||
94522110|NCT03192137|323706515|FG000|Overall Study|Withdrawal by Subject|3|||
94522111|NCT03192137|323706516|FG001|Overall Study|Withdrawal by Subject|3|||
94522112|NCT03192137|323706515|FG000|Overall Study|Protocol Violation|4|||
94522113|NCT03192137|323706516|FG001|Overall Study|Protocol Violation|3|||
94522114|NCT03192137|323706515|FG000|Overall Study|Surgery Cancelled|4|||
94522115|NCT03192137|323706516|FG001|Overall Study|Surgery Cancelled|1|||
94522116|NCT03192137|323706515|FG000|Overall Study|Other - Various Administrative Reasons|8|||
94522117|NCT03192137|323706516|FG001|Overall Study|Other - Various Administrative Reasons|3|||
94522118|NCT00437268|323706520|FG000|Overall Study|Adverse Event|1|||
94522119|NCT00437268|323706521|FG001|Overall Study|Adverse Event|1|||
94522120|NCT00437268|323706520|FG000|Overall Study|Withdrawal by Subject|2|||
94522121|NCT00437268|323706521|FG001|Overall Study|Withdrawal by Subject|2|||
94522122|NCT00437268|323706520|FG000|Overall Study|Progressive disease|9|||
94522123|NCT00437268|323706521|FG001|Overall Study|Progressive disease|9|||
94522124|NCT00437268|323706520|FG000|Overall Study|Physician Decision|1|||
94522125|NCT00437268|323706521|FG001|Overall Study|Physician Decision|0|||
94522126|NCT00437268|323706520|FG000|Overall Study|Death|0|||
94522127|NCT00437268|323706521|FG001|Overall Study|Death|1|||
94522128|NCT03666988|323706524|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
94522129|NCT03666988|323706525|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
94522130|NCT03666988|323706526|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
94522131|NCT03666988|323706527|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
94522132|NCT03666988|323706528|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
94522133|NCT03666988|323706529|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
94522134|NCT03666988|323706524|FG000|Part 1 (Up to 28 Months)|Other|0|||
94522135|NCT03666988|323706525|FG001|Part 1 (Up to 28 Months)|Other|1|||
94522136|NCT03666988|323706526|FG002|Part 1 (Up to 28 Months)|Other|1|||
94522137|NCT03666988|323706527|FG003|Part 1 (Up to 28 Months)|Other|0|||
94522138|NCT03666988|323706528|FG004|Part 1 (Up to 28 Months)|Other|0|||
94522139|NCT03666988|323706529|FG005|Part 1 (Up to 28 Months)|Other|0|||
94522140|NCT03666988|323706524|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
94522141|NCT03666988|323706525|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
94522142|NCT03666988|323706526|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
94522143|NCT03666988|323706527|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
94522144|NCT03666988|323706528|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
94522145|NCT03666988|323706529|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
94522146|NCT03666988|323706524|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
94522147|NCT03666988|323706525|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
94522148|NCT03666988|323706526|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
94522149|NCT03666988|323706527|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
94522150|NCT03666988|323706528|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
94522151|NCT03666988|323706529|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
94522152|NCT03666988|323706524|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
94522153|NCT03666988|323706525|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
94522154|NCT03666988|323706526|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
94522155|NCT03666988|323706527|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
94522156|NCT03666988|323706528|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
94522157|NCT03666988|323706529|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
94522158|NCT00444106|323706530|FG000|Overall Study|Lost to Follow-up|2|||
94522159|NCT00444106|323706531|FG001|Overall Study|Lost to Follow-up|1|||
94522160|NCT00444106|323706532|FG002|Overall Study|Lost to Follow-up|0|||
94522161|NCT00444106|323706530|FG000|Overall Study|Abnormal Test Procedure Results|0|||
94522162|NCT00444106|323706531|FG001|Overall Study|Abnormal Test Procedure Results|0|||
94522163|NCT00444106|323706532|FG002|Overall Study|Abnormal Test Procedure Results|1|||
94522164|NCT00145626|323706533|FG000|Overall Study|Did not have NK infusions|2|||
94522165|NCT00145626|323706533|FG000|Overall Study|Turned 2 years old before treatment|1|||
94522166|NCT00145626|323706533|FG000|Overall Study|Death|1|||
94522167|NCT00145626|323706533|FG000|Overall Study|Withdrawal by Subject|1|||
94522168|NCT02137070|323706538|FG000|Overall Study|Adverse Event|12|||
94522169|NCT02137070|323706539|FG001|Overall Study|Adverse Event|3|||
94522170|NCT02137070|323706538|FG000|Overall Study|Death|2|||
94522171|NCT02137070|323706539|FG001|Overall Study|Death|0|||
94522172|NCT02137070|323706538|FG000|Overall Study|Lost to Follow-up|24|||
94522173|NCT02137070|323706539|FG001|Overall Study|Lost to Follow-up|9|||
94522174|NCT02137070|323706538|FG000|Overall Study|Physician Decision|0|||
94522175|NCT02137070|323706539|FG001|Overall Study|Physician Decision|1|||
94522176|NCT02137070|323706538|FG000|Overall Study|Protocol Violation|18|||
94522177|NCT02137070|323706539|FG001|Overall Study|Protocol Violation|4|||
94522178|NCT02137070|323706538|FG000|Overall Study|Withdrawal by Subject|18|||
94522179|NCT02137070|323706539|FG001|Overall Study|Withdrawal by Subject|1|||
94522180|NCT01856322|323708603|FG000|Overall Study|off study due to lack of accrual|0|||
94522181|NCT01856322|323708604|FG001|Overall Study|off study due to lack of accrual|0|||
94522182|NCT01856322|323708605|FG002|Overall Study|off study due to lack of accrual|3|||
94522183|NCT00456755|323708606|FG000|Overall Study|Lost to Follow-up|2|||
94522184|NCT00456755|323708607|FG001|Overall Study|Lost to Follow-up|1|||
94522185|NCT01772550|323708613|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
94522186|NCT01772550|323708614|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
94522187|NCT01772550|323708615|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
94522188|NCT01772550|323708613|FG000|Overall Study|Adverse Event|0|||
94522189|NCT01772550|323708614|FG001|Overall Study|Adverse Event|0|||
94522190|NCT01772550|323708615|FG002|Overall Study|Adverse Event|1|||
94522191|NCT01815424|323708617|FG000|Week 0 to 16|Adverse Event|1|||
94522192|NCT01815424|323708618|FG001|Week 0 to 16|Adverse Event|3|||
94522193|NCT01815424|323708619|FG002|Week 0 to 16|Adverse Event|3|||
94522194|NCT01815424|323708620|FG003|Week 0 to 16|Adverse Event|0|||
94522195|NCT01815424|323708621|FG004|Week 0 to 16|Adverse Event|0|||
94522196|NCT01815424|323708617|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
94522197|NCT01815424|323708618|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
94522198|NCT01815424|323708619|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
94522199|NCT01815424|323708620|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
94522200|NCT01815424|323708621|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
94522201|NCT01815424|323708617|FG000|Week 0 to 16|Lost to Follow-up|0|||
94522202|NCT01815424|323708618|FG001|Week 0 to 16|Lost to Follow-up|1|||
94522203|NCT01815424|323708619|FG002|Week 0 to 16|Lost to Follow-up|0|||
94522204|NCT01815424|323708620|FG003|Week 0 to 16|Lost to Follow-up|0|||
94522205|NCT01815424|323708621|FG004|Week 0 to 16|Lost to Follow-up|0|||
94522206|NCT01815424|323708617|FG000|Week 0 to 16|Withdrawal by Subject|0|||
94522207|NCT01815424|323708618|FG001|Week 0 to 16|Withdrawal by Subject|0|||
94522208|NCT01815424|323708619|FG002|Week 0 to 16|Withdrawal by Subject|1|||
94522209|NCT01815424|323708620|FG003|Week 0 to 16|Withdrawal by Subject|0|||
94522210|NCT01815424|323708621|FG004|Week 0 to 16|Withdrawal by Subject|0|||
94522211|NCT01815424|323708617|FG000|Week 0 to 16|Other|1|||
94522212|NCT01815424|323708618|FG001|Week 0 to 16|Other|0|||
94522213|NCT01815424|323708619|FG002|Week 0 to 16|Other|3|||
94522214|NCT01815424|323708620|FG003|Week 0 to 16|Other|0|||
94522215|NCT01815424|323708621|FG004|Week 0 to 16|Other|0|||
94522216|NCT01815424|323708617|FG000|Week 0 to 16|Protocol Violation|1|||
94522217|NCT01815424|323708618|FG001|Week 0 to 16|Protocol Violation|0|||
94522218|NCT01815424|323708619|FG002|Week 0 to 16|Protocol Violation|0|||
94522219|NCT01815424|323708620|FG003|Week 0 to 16|Protocol Violation|0|||
94522220|NCT01815424|323708621|FG004|Week 0 to 16|Protocol Violation|0|||
94522221|NCT01815424|323708617|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
94522222|NCT01815424|323708618|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
94522223|NCT01815424|323708619|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
94522224|NCT01815424|323708620|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
94522225|NCT01815424|323708621|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
94522226|NCT01815424|323708617|FG000|Week 16 to 52|Other|0|||
94522227|NCT01815424|323708618|FG001|Week 16 to 52|Other|1|||
94522228|NCT01815424|323708619|FG002|Week 16 to 52|Other|0|||
94522229|NCT01815424|323708620|FG003|Week 16 to 52|Other|0|||
94522230|NCT01815424|323708621|FG004|Week 16 to 52|Other|0|||
94522231|NCT01815424|323708617|FG000|Week 16 to 52|Adverse Event|0|||
94522232|NCT01815424|323708618|FG001|Week 16 to 52|Adverse Event|0|||
94522233|NCT01815424|323708619|FG002|Week 16 to 52|Adverse Event|0|||
94522234|NCT01815424|323708620|FG003|Week 16 to 52|Adverse Event|0|||
94522235|NCT01815424|323708621|FG004|Week 16 to 52|Adverse Event|1|||
94522236|NCT01815424|323708617|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
94522237|NCT01815424|323708618|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
94522238|NCT01815424|323708619|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
94522239|NCT01815424|323708620|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
94522240|NCT01815424|323708621|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
94522241|NCT01815424|323708617|FG000|Week 16 to 52|Lost to Follow-up|0|||
94522242|NCT01815424|323708618|FG001|Week 16 to 52|Lost to Follow-up|2|||
94522243|NCT01815424|323708619|FG002|Week 16 to 52|Lost to Follow-up|0|||
94522244|NCT01815424|323708620|FG003|Week 16 to 52|Lost to Follow-up|2|||
94522245|NCT01815424|323708621|FG004|Week 16 to 52|Lost to Follow-up|1|||
94522246|NCT01815424|323708617|FG000|Week 16 to 52|Withdrawal by Subject|1|||
94522247|NCT01815424|323708618|FG001|Week 16 to 52|Withdrawal by Subject|2|||
94522248|NCT01815424|323708619|FG002|Week 16 to 52|Withdrawal by Subject|0|||
94522249|NCT01815424|323708620|FG003|Week 16 to 52|Withdrawal by Subject|0|||
94522250|NCT01815424|323708621|FG004|Week 16 to 52|Withdrawal by Subject|0|||
94522251|NCT01309204|323708622|FG000|Overall Study|Adverse Event|48|||
94522252|NCT01309204|323708623|FG001|Overall Study|Adverse Event|58|||
94522253|NCT01309204|323708622|FG000|Overall Study|Lost to Follow-up|2|||
94522254|NCT01309204|323708623|FG001|Overall Study|Lost to Follow-up|2|||
94522255|NCT01309204|323708622|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
94522256|NCT01309204|323708623|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
94522257|NCT01309204|323708622|FG000|Overall Study|Inadequate control of IOP|4|||
94522258|NCT01309204|323708623|FG001|Overall Study|Inadequate control of IOP|4|||
94522259|NCT01309204|323708622|FG000|Overall Study|Other|4|||
94522260|NCT01309204|323708623|FG001|Overall Study|Other|1|||
94522261|NCT01127633|323708624|FG000|Overall Study|Adverse Event|74|||
94522262|NCT01127633|323708625|FG001|Overall Study|Adverse Event|73|||
94522263|NCT01127633|323708624|FG000|Overall Study|Death|40|||
94522264|NCT01127633|323708625|FG001|Overall Study|Death|43|||
94522265|NCT01127633|323708624|FG000|Overall Study|Lost to Follow-up|4|||
94522266|NCT01127633|323708625|FG001|Overall Study|Lost to Follow-up|0|||
94522267|NCT01127633|323708624|FG000|Overall Study|Parent/Caregiver Decision|246|||
94522268|NCT01127633|323708625|FG001|Overall Study|Parent/Caregiver Decision|228|||
94522269|NCT01127633|323708624|FG000|Overall Study|Physician Decision|60|||
94522270|NCT01127633|323708625|FG001|Overall Study|Physician Decision|45|||
94522271|NCT01127633|323708624|FG000|Overall Study|Withdrawal by Subject|57|||
94522272|NCT01127633|323708625|FG001|Overall Study|Withdrawal by Subject|72|||
94522273|NCT01127633|323708624|FG000|Overall Study|Sponsor Decision|163|||
94522274|NCT01127633|323708625|FG001|Overall Study|Sponsor Decision|195|||
94522275|NCT01127633|323708624|FG000|Overall Study|Protocol Violation|8|||
94522276|NCT01127633|323708625|FG001|Overall Study|Protocol Violation|16|||
94522277|NCT01127633|323708624|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
94522278|NCT01127633|323708625|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
94522279|NCT01127633|323708624|FG000|Overall Study|Not treated|1|||
94522280|NCT01127633|323708625|FG001|Overall Study|Not treated|0|||
94522281|NCT01496287|323708628|FG000|Overall Study|Lost to Follow-up|1|||
94522282|NCT01496287|323708628|FG000|Overall Study|Incomplete anesthesia|5|||
94522283|NCT02477527|323708632|FG000|Overall Study|Lost to Follow-up|2|||
94522284|NCT02477527|323708632|FG000|Overall Study|Withdrawal by Subject|1|||
94522285|NCT02477527|323708632|FG000|Overall Study|Screen Failure|3|||
94522286|NCT01976299|323708633|FG000|Overall Study|Withdrawal by Subject|3|||
94522287|NCT01976299|323708634|FG001|Overall Study|Withdrawal by Subject|1|||
94522288|NCT01976299|323708633|FG000|Overall Study|Death|4|||
94522289|NCT01976299|323708634|FG001|Overall Study|Death|2|||
94522290|NCT01976299|323708633|FG000|Overall Study|Lost to Follow-up|7|||
94522291|NCT01976299|323708634|FG001|Overall Study|Lost to Follow-up|1|||
94522292|NCT01976299|323708633|FG000|Overall Study|See clarification above in comments|9|||
94522293|NCT01976299|323708634|FG001|Overall Study|See clarification above in comments|2|||
94522294|NCT00800735|323708635|FG000|Overall Study|Administrative/Other|2|||
94522295|NCT00800735|323708635|FG000|Overall Study|Insufficient Therapeutic Response|2|||
94522296|NCT00800735|323708635|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
94522297|NCT00800735|323708635|FG000|Overall Study|Withdrew Consent|3|||
94522298|NCT03692403|323708636|FG000|Overall Study|Withdrawal by Subject|1|||
94522299|NCT03692403|323708637|FG001|Overall Study|Withdrawal by Subject|0|||
94522300|NCT03692403|323708638|FG002|Overall Study|Withdrawal by Subject|1|||
94522301|NCT03692403|323708639|FG003|Overall Study|Withdrawal by Subject|0|||
94522302|NCT03692403|323708636|FG000|Overall Study|Adverse Event|0|||
94522303|NCT03692403|323708637|FG001|Overall Study|Adverse Event|0|||
94522304|NCT03692403|323708638|FG002|Overall Study|Adverse Event|0|||
94522305|NCT03692403|323708639|FG003|Overall Study|Adverse Event|1|||
94522306|NCT03692403|323708636|FG000|Overall Study|Pregnancy|0|||
94522307|NCT03692403|323708637|FG001|Overall Study|Pregnancy|1|||
94522308|NCT03692403|323708638|FG002|Overall Study|Pregnancy|0|||
94522309|NCT03692403|323708639|FG003|Overall Study|Pregnancy|0|||
94522310|NCT03692403|323708636|FG000|Overall Study|Other|0|||
94522311|NCT03692403|323708637|FG001|Overall Study|Other|0|||
94522312|NCT03692403|323708638|FG002|Overall Study|Other|1|||
94522313|NCT03692403|323708639|FG003|Overall Study|Other|0|||
94522314|NCT04567524|323708640|FG000|Overall Study|Adverse Event|1|||
94522315|NCT04567524|323708641|FG001|Overall Study|Adverse Event|1|||
94522316|NCT04567524|323708642|FG002|Overall Study|Adverse Event|0|||
94522317|NCT04567524|323708643|FG003|Overall Study|Adverse Event|0|||
94522318|NCT04567524|323708640|FG000|Overall Study|Withdrawal by Subject|2|||
94522319|NCT04567524|323708641|FG001|Overall Study|Withdrawal by Subject|0|||
94522320|NCT04567524|323708642|FG002|Overall Study|Withdrawal by Subject|0|||
94522321|NCT04567524|323708643|FG003|Overall Study|Withdrawal by Subject|1|||
94522322|NCT03500211|323708644|FG000|Overall Study|Withdrawal by Subject|1|||
94522323|NCT03500211|323708645|FG001|Overall Study|Withdrawal by Subject|1|||
94522324|NCT02848092|323708648|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
94522325|NCT02848092|323708649|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
94522326|NCT02848092|323708648|FG000|1-month Post-training Follow-up|Adverse Event|2|||
94522327|NCT02848092|323708649|FG001|1-month Post-training Follow-up|Adverse Event|1|||
94522328|NCT02848092|323708648|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
94522329|NCT02848092|323708649|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
94522330|NCT02848092|323708648|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
94522331|NCT02848092|323708649|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
94522332|NCT02848092|323708648|FG000|1-month Post-training Follow-up|fatigue|0|||
94522333|NCT02848092|323708649|FG001|1-month Post-training Follow-up|fatigue|1|||
94522334|NCT02848092|323708648|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
94522335|NCT02848092|323708649|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
94522336|NCT02848092|323708648|FG000|6-month Post-training Follow-up|Adverse Event|1|||
94522337|NCT02848092|323708649|FG001|6-month Post-training Follow-up|Adverse Event|1|||
94522338|NCT02848092|323708648|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
94522339|NCT02848092|323708649|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
94522340|NCT02848092|323708648|FG000|6-month Post-training Follow-up|frustrated with task|1|||
94522341|NCT02848092|323708649|FG001|6-month Post-training Follow-up|frustrated with task|0|||
94522342|NCT02848092|323708648|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
94522343|NCT02848092|323708649|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
94522344|NCT02848092|323708648|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
94522345|NCT02848092|323708649|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
94522346|NCT01908140|323708650|FG000|Overall Study|Other or Progressive Disease|5|||
94522347|NCT01908140|323708651|FG001|Overall Study|Other or Progressive Disease|12|||
94522348|NCT01908140|323708650|FG000|Overall Study|Lack of Efficacy|7|||
94522349|NCT01908140|323708651|FG001|Overall Study|Lack of Efficacy|5|||
94522350|NCT01908140|323708650|FG000|Overall Study|Withdrawal by Subject|23|||
94522351|NCT01908140|323708651|FG001|Overall Study|Withdrawal by Subject|24|||
94522352|NCT01908140|323708650|FG000|Overall Study|Lost to Follow-up|1|||
94522353|NCT01908140|323708651|FG001|Overall Study|Lost to Follow-up|6|||
94522354|NCT01908140|323708650|FG000|Overall Study|Protocol Violation|8|||
94522355|NCT01908140|323708651|FG001|Overall Study|Protocol Violation|9|||
94522356|NCT01908140|323708650|FG000|Overall Study|Adverse Event|22|||
94522357|NCT01908140|323708651|FG001|Overall Study|Adverse Event|23|||
94522358|NCT00420381|323708656|FG000|Overall Study|Protocol Violation|1|||
94522359|NCT02329743|323708657|FG000|Overall Study|Adverse Event|1|||
94522360|NCT02329743|323708658|FG001|Overall Study|Adverse Event|1|||
94522361|NCT02329743|323708659|FG002|Overall Study|Adverse Event|3|||
94522362|NCT02329743|323708657|FG000|Overall Study|Lost to Follow-up|1|||
94522363|NCT02329743|323708658|FG001|Overall Study|Lost to Follow-up|0|||
94522364|NCT02329743|323708659|FG002|Overall Study|Lost to Follow-up|1|||
94522365|NCT02329743|323708657|FG000|Overall Study|Withdrawal by Subject|4|||
94522366|NCT02329743|323708658|FG001|Overall Study|Withdrawal by Subject|4|||
94522367|NCT02329743|323708659|FG002|Overall Study|Withdrawal by Subject|1|||
94522368|NCT02329743|323708657|FG000|Overall Study|Other|0|||
94522369|NCT02329743|323708658|FG001|Overall Study|Other|2|||
94522370|NCT02329743|323708659|FG002|Overall Study|Other|3|||
94522371|NCT01147393|323708662|FG000|Dose Level 1|Dose limiting Toxicity|2|||
94522372|NCT01147393|323708662|FG000|Dose Level -1|Dose Limited Toxicity|1|||
94522373|NCT00856609|323708664|FG000|Overall Study|Adverse Event|1|||
94522374|NCT00856609|323708665|FG001|Overall Study|Adverse Event|0|||
94522375|NCT00355368|323708668|FG000|Overall Study|Protocol Violation|8|||
94522376|NCT00355368|323708669|FG001|Overall Study|Protocol Violation|7|||
94522377|NCT00355368|323708668|FG000|Overall Study|cardiac arrest prior to intubation|2|||
94522378|NCT00355368|323708669|FG001|Overall Study|cardiac arrest prior to intubation|2|||
94522379|NCT01436110|323708671|FG000|Overall Study|Lack of Efficacy|23|||
94522380|NCT01436110|323708672|FG001|Overall Study|Lack of Efficacy|14|||
94522381|NCT01436110|323708673|FG002|Overall Study|Lack of Efficacy|9|||
94522382|NCT01436110|323708671|FG000|Overall Study|Withdrawal by Subject|6|||
94522383|NCT01436110|323708672|FG001|Overall Study|Withdrawal by Subject|8|||
94522384|NCT01436110|323708673|FG002|Overall Study|Withdrawal by Subject|4|||
94522385|NCT01436110|323708671|FG000|Overall Study|Adverse Event|2|||
94522386|NCT01436110|323708672|FG001|Overall Study|Adverse Event|1|||
94522387|NCT01436110|323708673|FG002|Overall Study|Adverse Event|2|||
94522388|NCT01436110|323708671|FG000|Overall Study|Physician Decision|3|||
94522389|NCT01436110|323708672|FG001|Overall Study|Physician Decision|1|||
94522390|NCT01436110|323708673|FG002|Overall Study|Physician Decision|1|||
94522391|NCT01436110|323708671|FG000|Overall Study|Lost to Follow-up|1|||
94522392|NCT01436110|323708672|FG001|Overall Study|Lost to Follow-up|1|||
94522393|NCT01436110|323708673|FG002|Overall Study|Lost to Follow-up|3|||
94522394|NCT01436110|323708671|FG000|Overall Study|Protocol Violation|3|||
94522395|NCT01436110|323708672|FG001|Overall Study|Protocol Violation|1|||
94522396|NCT01436110|323708673|FG002|Overall Study|Protocol Violation|1|||
94522397|NCT01436110|323708671|FG000|Overall Study|Did Not Receive Trial Medication|1|||
94522398|NCT01436110|323708672|FG001|Overall Study|Did Not Receive Trial Medication|0|||
94522399|NCT01436110|323708673|FG002|Overall Study|Did Not Receive Trial Medication|3|||
94522400|NCT03389308|323708679|FG000|Overall Study|Withdrawal by Subject|5|||
94522401|NCT03389308|323708679|FG000|Overall Study|Lost to Follow-up|3|||
94522402|NCT03389308|323708679|FG000|Overall Study|Adverse Event|2|||
94522403|NCT03389308|323708679|FG000|Overall Study|Sponsor Request|2|||
94522404|NCT00506779|323708683|FG000|Overall Study|Withdrawal by Subject|1|||
94522405|NCT00506779|323708684|FG001|Overall Study|Withdrawal by Subject|0|||
94522406|NCT00506779|323708685|FG002|Overall Study|Withdrawal by Subject|1|||
94522407|NCT00506779|323708686|FG003|Overall Study|Withdrawal by Subject|0|||
94522408|NCT00506779|323708683|FG000|Overall Study|Adverse Event|0|||
94522409|NCT00506779|323708684|FG001|Overall Study|Adverse Event|1|||
94522410|NCT00506779|323708685|FG002|Overall Study|Adverse Event|1|||
94522411|NCT00506779|323708686|FG003|Overall Study|Adverse Event|1|||
94522412|NCT04703192|323708687|FG000|Overall Study|Withdrawal by Subject|2|||
94522413|NCT04703192|323708688|FG001|Overall Study|Withdrawal by Subject|0|||
94522414|NCT04703192|323708687|FG000|Overall Study|Death|3|||
94522415|NCT04703192|323708688|FG001|Overall Study|Death|1|||
94522416|NCT04703192|323708687|FG000|Overall Study|Adverse Event|13|||
94522417|NCT04703192|323708688|FG001|Overall Study|Adverse Event|2|||
94522418|NCT04703192|323708687|FG000|Overall Study|Progressive or Relapsed Disease|46|||
94522419|NCT04703192|323708688|FG001|Overall Study|Progressive or Relapsed Disease|7|||
94522420|NCT04703192|323708687|FG000|Overall Study|Clinical Progression|19|||
94522421|NCT04703192|323708688|FG001|Overall Study|Clinical Progression|8|||
94522422|NCT04703192|323708687|FG000|Overall Study|Lost to Follow-up|1|||
94522423|NCT04703192|323708688|FG001|Overall Study|Lost to Follow-up|0|||
94522424|NCT04703192|323708687|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
94522425|NCT04703192|323708688|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
94522426|NCT04703192|323708687|FG000|Overall Study|Other|5|||
94522427|NCT04703192|323708688|FG001|Overall Study|Other|1|||
94522428|NCT04232943|323708689|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
94522429|NCT04232943|323708690|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
94522430|NCT04232943|323708691|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
94522431|NCT04232943|323708689|FG000|Overall Study|Withdrawal by Subject|1|||
94522432|NCT04232943|323708690|FG001|Overall Study|Withdrawal by Subject|1|||
94522433|NCT04232943|323708691|FG002|Overall Study|Withdrawal by Subject|0|||
94522434|NCT02553928|323708692|FG000|Overall Study|Adverse Event|2|||
94522435|NCT02553928|323708693|FG001|Overall Study|Adverse Event|1|||
94522436|NCT02553928|323708692|FG000|Overall Study|Lost to Follow-up|0|||
94522437|NCT02553928|323708693|FG001|Overall Study|Lost to Follow-up|1|||
94522438|NCT02553928|323708692|FG000|Overall Study|Administrative reason(s)|0|||
94522439|NCT02553928|323708693|FG001|Overall Study|Administrative reason(s)|1|||
94522440|NCT01673646|323708695|FG000|Overall Study|Adverse Event|2|||
94522441|NCT01673646|323708696|FG001|Overall Study|Adverse Event|1|||
94522442|NCT01673646|323708697|FG002|Overall Study|Adverse Event|1|||
94522443|NCT01673646|323708695|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94522444|NCT01673646|323708696|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
94522445|NCT01673646|323708697|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
94522446|NCT01673646|323708695|FG000|Overall Study|Condition no longer requires study drug|0|||
94522447|NCT01673646|323708696|FG001|Overall Study|Condition no longer requires study drug|1|||
94522448|NCT01673646|323708697|FG002|Overall Study|Condition no longer requires study drug|0|||
94522449|NCT01673646|323708695|FG000|Overall Study|Withdrawal by Subject|0|||
94522450|NCT01673646|323708696|FG001|Overall Study|Withdrawal by Subject|2|||
94522451|NCT01673646|323708697|FG002|Overall Study|Withdrawal by Subject|2|||
94522452|NCT01673646|323708695|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
94522453|NCT01673646|323708696|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
94522454|NCT01673646|323708697|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
94522455|NCT02141672|323708698|FG000|Overall Study|Adverse Event|0|||
94522456|NCT02141672|323708699|FG001|Overall Study|Adverse Event|1|||
94522457|NCT02141672|323708700|FG002|Overall Study|Adverse Event|0|||
94522458|NCT02141672|323708698|FG000|Overall Study|Death|10|||
94522459|NCT02141672|323708699|FG001|Overall Study|Death|2|||
94522460|NCT02141672|323708700|FG002|Overall Study|Death|1|||
94522461|NCT02141672|323708698|FG000|Overall Study|Lack of Efficacy|0|||
94522462|NCT02141672|323708699|FG001|Overall Study|Lack of Efficacy|0|||
94522463|NCT02141672|323708700|FG002|Overall Study|Lack of Efficacy|2|||
94522464|NCT02141672|323708698|FG000|Overall Study|Lost to Follow-up|1|||
94522465|NCT02141672|323708699|FG001|Overall Study|Lost to Follow-up|1|||
94522466|NCT02141672|323708700|FG002|Overall Study|Lost to Follow-up|3|||
94522467|NCT02141672|323708698|FG000|Overall Study|Physician Decision|1|||
94522468|NCT02141672|323708699|FG001|Overall Study|Physician Decision|2|||
94522469|NCT02141672|323708700|FG002|Overall Study|Physician Decision|5|||
94522470|NCT02141672|323708698|FG000|Overall Study|Protocol Violation|0|||
94522471|NCT02141672|323708699|FG001|Overall Study|Protocol Violation|0|||
94522472|NCT02141672|323708700|FG002|Overall Study|Protocol Violation|1|||
94522473|NCT02141672|323708698|FG000|Overall Study|Withdrawal by Subject|3|||
94522474|NCT02141672|323708699|FG001|Overall Study|Withdrawal by Subject|2|||
94522475|NCT02141672|323708700|FG002|Overall Study|Withdrawal by Subject|5|||
94522476|NCT02141672|323708698|FG000|Overall Study|refused to follow-up|1|||
94522477|NCT02141672|323708699|FG001|Overall Study|refused to follow-up|0|||
94522478|NCT02141672|323708700|FG002|Overall Study|refused to follow-up|1|||
94522479|NCT02651116|323708704|FG000|Overall Study|Adverse Event|0|||
94522480|NCT02651116|323708705|FG001|Overall Study|Adverse Event|1|||
94522481|NCT02651116|323708704|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
94522482|NCT02651116|323708705|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
94522483|NCT01492088|323708715|FG000|Overall Study|Withdrawal by Patient|0|||
94522484|NCT01492088|323708716|FG001|Overall Study|Withdrawal by Patient|2|||
94522485|NCT01492088|323708717|FG002|Overall Study|Withdrawal by Patient|0|||
94522486|NCT01492088|323708715|FG000|Overall Study|Death|1|||
94522487|NCT01492088|323708716|FG001|Overall Study|Death|6|||
94522488|NCT01492088|323708717|FG002|Overall Study|Death|2|||
94522489|NCT01492088|323708715|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
94522490|NCT01492088|323708716|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
94522491|NCT01492088|323708717|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
94522492|NCT01492088|323708715|FG000|Overall Study|Alive at Last Follow-up|0|||
94522493|NCT01492088|323708716|FG001|Overall Study|Alive at Last Follow-up|6|||
94522494|NCT01492088|323708717|FG002|Overall Study|Alive at Last Follow-up|11|||
94522495|NCT00590967|323708718|FG000|Overall Study|Withdrawal by Subject|1|||
94522496|NCT00590967|323708719|FG001|Overall Study|Withdrawal by Subject|1|||
94522497|NCT00590967|323708718|FG000|Overall Study|Ineligible|1|||
94522498|NCT00590967|323708719|FG001|Overall Study|Ineligible|0|||
94522499|NCT00590967|323708718|FG000|Overall Study|Poor performance status|0|||
94522500|NCT00590967|323708719|FG001|Overall Study|Poor performance status|1|||
94522501|NCT00590967|323708718|FG000|Overall Study|Non-compliant|0|||
94522502|NCT00590967|323708719|FG001|Overall Study|Non-compliant|2|||
94522503|NCT00590967|323708718|FG000|Overall Study|Did not sign consent form|0|||
94522504|NCT00590967|323708719|FG001|Overall Study|Did not sign consent form|1|||
94522505|NCT00590967|323708718|FG000|Overall Study|Did not receive chemo per protocol|1|||
94522506|NCT00590967|323708719|FG001|Overall Study|Did not receive chemo per protocol|0|||
94522507|NCT01881789|323708720|FG000|Overall Study|Withdrawal by Subject|0|||
94522508|NCT01881789|323708721|FG001|Overall Study|Withdrawal by Subject|2|||
94522509|NCT01881789|323708722|FG002|Overall Study|Withdrawal by Subject|1|||
94522510|NCT01881789|323708723|FG003|Overall Study|Withdrawal by Subject|0|||
94522511|NCT01881789|323708724|FG004|Overall Study|Withdrawal by Subject|1|||
94522512|NCT01881789|323708725|FG005|Overall Study|Withdrawal by Subject|1|||
94522513|NCT01881789|323708720|FG000|Overall Study|Study Terminated by Sponsor|0|||
94522514|NCT01881789|323708721|FG001|Overall Study|Study Terminated by Sponsor|0|||
94522515|NCT01881789|323708722|FG002|Overall Study|Study Terminated by Sponsor|0|||
94522516|NCT01881789|323708723|FG003|Overall Study|Study Terminated by Sponsor|0|||
94522517|NCT01881789|323708724|FG004|Overall Study|Study Terminated by Sponsor|0|||
94522518|NCT01881789|323708725|FG005|Overall Study|Study Terminated by Sponsor|1|||
94522519|NCT01881789|323708720|FG000|Overall Study|Other|3|||
94522520|NCT01881789|323708721|FG001|Overall Study|Other|5|||
94522521|NCT01881789|323708722|FG002|Overall Study|Other|2|||
94522522|NCT01881789|323708723|FG003|Overall Study|Other|3|||
94522523|NCT01881789|323708724|FG004|Overall Study|Other|1|||
94522524|NCT01881789|323708725|FG005|Overall Study|Other|1|||
94522525|NCT02655887|323708726|FG000|Overall Study|Lost to Follow-up|3|||
94522526|NCT02655887|323708726|FG000|Overall Study|Death|4|||
94522527|NCT02655887|323708726|FG000|Overall Study|Withdrawal by Subject|3|||
94522528|NCT02655887|323708726|FG000|Overall Study|Missed 12-month follow-up visit|4|||
94522529|NCT00811720|323708730|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
94522530|NCT00811720|323708731|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
94522531|NCT00811720|323708730|FG000|All Treated Patients|Adverse Event|20|||
94522532|NCT00811720|323708731|FG001|All Treated Patients|Adverse Event|62|||
94522533|NCT00811720|323708730|FG000|All Treated Patients|Lack of Efficacy|22|||
94522534|NCT00811720|323708731|FG001|All Treated Patients|Lack of Efficacy|18|||
94522535|NCT00811720|323708730|FG000|All Treated Patients|Non-compliance|0|||
94522536|NCT00811720|323708731|FG001|All Treated Patients|Non-compliance|14|||
94522537|NCT00811720|323708730|FG000|All Treated Patients|Protocol Violation|9|||
94522538|NCT00811720|323708731|FG001|All Treated Patients|Protocol Violation|16|||
94522539|NCT00811720|323708730|FG000|All Treated Patients|Withdrawal by Subject|28|||
94522540|NCT00811720|323708731|FG001|All Treated Patients|Withdrawal by Subject|34|||
94522541|NCT00811720|323708730|FG000|All Treated Patients|Lost to Follow-up|10|||
94522542|NCT00811720|323708731|FG001|All Treated Patients|Lost to Follow-up|16|||
94522543|NCT00811720|323708730|FG000|All Treated Patients|Other Reason|7|||
94522544|NCT00811720|323708731|FG001|All Treated Patients|Other Reason|4|||
94522545|NCT04389866|323708733|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
94522546|NCT04389866|323708734|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
94522547|NCT00003869|323708739|FG000|Overall Study|Adverse Event|14|||
94522548|NCT00003869|323708740|FG001|Overall Study|Adverse Event|3|||
94522549|NCT00003869|323708739|FG000|Overall Study|Withdrawal by Subject|21|||
94522550|NCT00003869|323708740|FG001|Overall Study|Withdrawal by Subject|3|||
94522551|NCT00003869|323708739|FG000|Overall Study|Death|1|||
94522552|NCT00003869|323708740|FG001|Overall Study|Death|2|||
94522553|NCT00003869|323708739|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
94522554|NCT00003869|323708740|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
94522555|NCT03364231|323708741|FG000|Overall Study|Adverse Event|1|||
94522556|NCT03364231|323708742|FG001|Overall Study|Adverse Event|4|||
94522557|NCT03364231|323708741|FG000|Overall Study|Death|1|||
94522558|NCT03364231|323708742|FG001|Overall Study|Death|0|||
94522559|NCT03364231|323708741|FG000|Overall Study|Investigator Decision|2|||
94522560|NCT03364231|323708742|FG001|Overall Study|Investigator Decision|2|||
94522561|NCT03364231|323708741|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
94522562|NCT03364231|323708742|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
94522563|NCT03364231|323708741|FG000|Overall Study|Withdrawal of Subject Consent|1|||
94522564|NCT03364231|323708742|FG001|Overall Study|Withdrawal of Subject Consent|0|||
94522565|NCT03364231|323708741|FG000|Overall Study|Reason Not Specified|1|||
94522566|NCT03364231|323708742|FG001|Overall Study|Reason Not Specified|0|||
94522567|NCT03364231|323708741|FG000|Overall Study|Disease Progression|0|||
94522568|NCT03364231|323708742|FG001|Overall Study|Disease Progression|6|||
94522569|NCT01070979|323708745|FG000|Overall Study|Adverse Event|2|||
94522570|NCT01070979|323708746|FG001|Overall Study|Adverse Event|3|||
94522571|NCT01070979|323708747|FG002|Overall Study|Adverse Event|3|||
94522572|NCT01070979|323708745|FG000|Overall Study|Lost to Follow-up|2|||
94522573|NCT01070979|323708746|FG001|Overall Study|Lost to Follow-up|1|||
94522574|NCT01070979|323708747|FG002|Overall Study|Lost to Follow-up|1|||
94522575|NCT01070979|323708745|FG000|Overall Study|Protocol Violation|0|||
94522576|NCT01070979|323708746|FG001|Overall Study|Protocol Violation|2|||
94522577|NCT01070979|323708747|FG002|Overall Study|Protocol Violation|6|||
94522578|NCT01070979|323708745|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
94522579|NCT01070979|323708746|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
94522580|NCT01070979|323708747|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
94522581|NCT01070979|323708745|FG000|Overall Study|Withdrawal by Subject|3|||
94522582|NCT01070979|323708746|FG001|Overall Study|Withdrawal by Subject|1|||
94522583|NCT01070979|323708747|FG002|Overall Study|Withdrawal by Subject|1|||
94522584|NCT01070979|323708745|FG000|Overall Study|No study drug taken|0|||
94522585|NCT01070979|323708746|FG001|Overall Study|No study drug taken|1|||
94522586|NCT01070979|323708747|FG002|Overall Study|No study drug taken|0|||
94522587|NCT00142792|323708748|FG000|Overall Study|Death|0|||
94522588|NCT00142792|323708749|FG001|Overall Study|Death|0|||
94522589|NCT00142792|323708750|FG002|Overall Study|Death|1|||
94522590|NCT00142792|323708748|FG000|Overall Study|Withdrawal by Subject|3|||
94522591|NCT00142792|323708749|FG001|Overall Study|Withdrawal by Subject|2|||
94522592|NCT00142792|323708750|FG002|Overall Study|Withdrawal by Subject|3|||
94522593|NCT00142792|323708748|FG000|Overall Study|Lost to Follow-up|8|||
94522594|NCT00142792|323708749|FG001|Overall Study|Lost to Follow-up|11|||
94522595|NCT00142792|323708750|FG002|Overall Study|Lost to Follow-up|7|||
94522596|NCT00142792|323708748|FG000|Overall Study|No category|1|||
94522597|NCT00142792|323708749|FG001|Overall Study|No category|2|||
94522598|NCT00142792|323708750|FG002|Overall Study|No category|1|||
94522599|NCT00786422|323708753|FG000|Rivaroxaban Treatment|Death|2|||
94522600|NCT00786422|323708753|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
94522601|NCT00786422|323708753|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
94522602|NCT00786422|323708753|FG000|Rivaroxaban Treatment|Physician Decision|1|||
94522603|NCT00786422|323708753|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
94522604|NCT00786422|323708753|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
94522605|NCT00786422|323708753|FG000|Rivaroxaban Treatment|Adverse Event|2|||
94522606|NCT00786422|323708753|FG000|Follow-up Period|Death|1|||
94522607|NCT00786422|323708753|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
94522608|NCT03484429|323708754|FG000|Overall Study|Withdrawal by Subject|1|||
94522609|NCT03484429|323708755|FG001|Overall Study|Withdrawal by Subject|0|||
94522610|NCT03484429|323708754|FG000|Overall Study|Adverse Event|2|||
94522611|NCT03484429|323708755|FG001|Overall Study|Adverse Event|0|||
94522612|NCT02685826|323708758|FG000|Overall Study|Adverse Event|2|||
94522613|NCT02685826|323708759|FG001|Overall Study|Adverse Event|0|||
94522614|NCT02685826|323708760|FG002|Overall Study|Adverse Event|1|||
94522615|NCT02685826|323708758|FG000|Overall Study|Progressive Disease|2|||
94522616|NCT02685826|323708759|FG001|Overall Study|Progressive Disease|1|||
94522617|NCT02685826|323708760|FG002|Overall Study|Progressive Disease|0|||
94522618|NCT02685826|323708758|FG000|Overall Study|Withdrawal by Subject|2|||
94522619|NCT02685826|323708759|FG001|Overall Study|Withdrawal by Subject|0|||
94522620|NCT02685826|323708760|FG002|Overall Study|Withdrawal by Subject|0|||
94522621|NCT02685826|323708758|FG000|Overall Study|Full Clinical Hold by FDA|19|||
94522622|NCT02685826|323708759|FG001|Overall Study|Full Clinical Hold by FDA|9|||
94522623|NCT02685826|323708760|FG002|Overall Study|Full Clinical Hold by FDA|20|||
94522624|NCT01650831|323709797|FG000|Overall Study|Screen failure|1|||
94522625|NCT00887159|323709798|FG000|Overall Study|Disease progression|6|||
94522626|NCT00887159|323709799|FG001|Overall Study|Disease progression|39|||
94522627|NCT00887159|323709800|FG002|Overall Study|Disease progression|33|||
94522628|NCT00887159|323709798|FG000|Overall Study|Adverse Event|3|||
94522629|NCT00887159|323709799|FG001|Overall Study|Adverse Event|4|||
94522630|NCT00887159|323709800|FG002|Overall Study|Adverse Event|17|||
94522631|NCT00887159|323709798|FG000|Overall Study|Death|2|||
94522632|NCT00887159|323709799|FG001|Overall Study|Death|2|||
94522633|NCT00887159|323709800|FG002|Overall Study|Death|0|||
94522634|NCT00887159|323709798|FG000|Overall Study|Withdrawal by Subject|4|||
94522635|NCT00887159|323709799|FG001|Overall Study|Withdrawal by Subject|4|||
94522636|NCT00887159|323709800|FG002|Overall Study|Withdrawal by Subject|2|||
94522637|NCT00887159|323709798|FG000|Overall Study|Alternative therapy|2|||
94522638|NCT00887159|323709799|FG001|Overall Study|Alternative therapy|0|||
94522639|NCT00887159|323709800|FG002|Overall Study|Alternative therapy|0|||
94522640|NCT00887159|323709798|FG000|Overall Study|Physician Decision|1|||
94522641|NCT00887159|323709799|FG001|Overall Study|Physician Decision|1|||
94522642|NCT00887159|323709800|FG002|Overall Study|Physician Decision|0|||
94522643|NCT00887159|323709798|FG000|Overall Study|Sympomatic deterioration|1|||
94522644|NCT00887159|323709799|FG001|Overall Study|Sympomatic deterioration|0|||
94522645|NCT00887159|323709800|FG002|Overall Study|Sympomatic deterioration|0|||
94522646|NCT00887159|323709798|FG000|Overall Study|Treatment delayed|1|||
94522647|NCT00887159|323709799|FG001|Overall Study|Treatment delayed|1|||
94522648|NCT00887159|323709800|FG002|Overall Study|Treatment delayed|0|||
94522649|NCT00887159|323709798|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
94522650|NCT00887159|323709799|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
94522651|NCT00887159|323709800|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
94522652|NCT00887159|323709798|FG000|Overall Study|Received more tx instead of observation|1|||
94522653|NCT00887159|323709799|FG001|Overall Study|Received more tx instead of observation|0|||
94522654|NCT00887159|323709800|FG002|Overall Study|Received more tx instead of observation|0|||
94522655|NCT00887159|323709798|FG000|Overall Study|Ineligible|5|||
94522656|NCT00887159|323709799|FG001|Overall Study|Ineligible|1|||
94522657|NCT00887159|323709800|FG002|Overall Study|Ineligible|0|||
94522658|NCT00887159|323709798|FG000|Overall Study|Never started assigned therapy|3|||
94522659|NCT00887159|323709799|FG001|Overall Study|Never started assigned therapy|3|||
94522660|NCT00887159|323709800|FG002|Overall Study|Never started assigned therapy|4|||
94522661|NCT01273038|323709801|FG000|Second Intervention (14 Days)|Adverse Event|0|||
94522662|NCT01273038|323709802|FG001|Second Intervention (14 Days)|Adverse Event|1|||
94522663|NCT01273038|323709801|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
94522664|NCT01273038|323709802|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
94522665|NCT03604497|323709806|FG000|Overall Study|Protocol Violation|52|||
94522666|NCT00811954|323709807|FG000|Overall Study|Death|10|||
94522667|NCT00811954|323709808|FG001|Overall Study|Death|6|||
94522668|NCT00811954|323709809|FG002|Overall Study|Death|13|||
94522669|NCT00811954|323709807|FG000|Overall Study|Lost to Follow-up|29|||
94522670|NCT00811954|323709808|FG001|Overall Study|Lost to Follow-up|23|||
94522671|NCT00811954|323709809|FG002|Overall Study|Lost to Follow-up|34|||
94522672|NCT00811954|323709807|FG000|Overall Study|Not able to get to clinic|28|||
94522673|NCT00811954|323709808|FG001|Overall Study|Not able to get to clinic|35|||
94522674|NCT00811954|323709809|FG002|Overall Study|Not able to get to clinic|30|||
94522675|NCT00811954|323709807|FG000|Overall Study|Not willing to adhere to requirements|12|||
94522676|NCT00811954|323709808|FG001|Overall Study|Not willing to adhere to requirements|2|||
94522677|NCT00811954|323709809|FG002|Overall Study|Not willing to adhere to requirements|16|||
94522678|NCT00811954|323709807|FG000|Overall Study|Withdraw consent prior study completion|4|||
94522679|NCT00811954|323709808|FG001|Overall Study|Withdraw consent prior study completion|6|||
94522680|NCT00811954|323709809|FG002|Overall Study|Withdraw consent prior study completion|5|||
94522681|NCT00811954|323709807|FG000|Overall Study|Site Closure|4|||
94522682|NCT00811954|323709808|FG001|Overall Study|Site Closure|0|||
94522683|NCT00811954|323709809|FG002|Overall Study|Site Closure|1|||
94522684|NCT00811954|323709807|FG000|Overall Study|Severe Debilitation|2|||
94522685|NCT00811954|323709808|FG001|Overall Study|Severe Debilitation|0|||
94522686|NCT00811954|323709809|FG002|Overall Study|Severe Debilitation|1|||
94522687|NCT00811954|323709807|FG000|Overall Study|Complete Protocol: No follow-up|0|||
94522688|NCT00811954|323709808|FG001|Overall Study|Complete Protocol: No follow-up|0|||
94522689|NCT00811954|323709809|FG002|Overall Study|Complete Protocol: No follow-up|1|||
94522690|NCT00825994|323709810|FG000|Overall Study|Withdrawal by Subject|2|||
94522691|NCT00825994|323709810|FG000|Overall Study|Lost to Follow-up|1|||
94522692|NCT00825994|323709810|FG000|Overall Study|Protocol Violation|1|||
94522693|NCT00825994|323709810|FG000|Overall Study|Placebo Responder at V2|1|||
94522694|NCT01016067|323709811|FG000|Overall Study|Lost to Follow-up|1|||
94522695|NCT01016067|323709812|FG001|Overall Study|Lost to Follow-up|2|||
94522696|NCT01016067|323709811|FG000|Overall Study|Physician Decision|1|||
94522697|NCT01016067|323709812|FG001|Overall Study|Physician Decision|1|||
94522698|NCT01016067|323709811|FG000|Overall Study|Withdrew due to Relocation|0|||
94522699|NCT01016067|323709812|FG001|Overall Study|Withdrew due to Relocation|1|||
94522700|NCT04294459|323709814|FG000|Overall Study|Adverse Event|0|||
94522701|NCT04294459|323709815|FG001|Overall Study|Adverse Event|1|||
94522702|NCT01244035|323709816|FG000|Part 1: Period 1|Adverse Event|0|||
94522703|NCT01244035|323709817|FG001|Part 1: Period 1|Adverse Event|0|||
94522704|NCT01244035|323709818|FG002|Part 1: Period 1|Adverse Event|0|||
94522705|NCT01244035|323709819|FG003|Part 1: Period 1|Adverse Event|0|||
94522706|NCT01244035|323709820|FG004|Part 1: Period 1|Adverse Event|0|||
94522707|NCT01244035|323709821|FG005|Part 1: Period 1|Adverse Event|1|||
94522708|NCT01244035|323709816|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
94522709|NCT01244035|323709817|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
94522710|NCT01244035|323709818|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
94522711|NCT01244035|323709819|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
94522712|NCT01244035|323709820|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
94522713|NCT01244035|323709821|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
94522714|NCT01244035|323709816|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
94522715|NCT01244035|323709817|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
94522716|NCT01244035|323709818|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
94522717|NCT01244035|323709819|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
94522718|NCT01244035|323709820|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
94522719|NCT01244035|323709821|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
94522720|NCT01244035|323709816|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
94522721|NCT01244035|323709817|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
94522722|NCT01244035|323709818|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
94522723|NCT01244035|323709819|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
94522724|NCT01244035|323709820|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
94522725|NCT01244035|323709821|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
94522726|NCT01244035|323709816|FG000|Part 1: Period 3|Adverse Event|0|||
94522727|NCT01244035|323709817|FG001|Part 1: Period 3|Adverse Event|0|||
94522728|NCT01244035|323709818|FG002|Part 1: Period 3|Adverse Event|0|||
94522729|NCT01244035|323709819|FG003|Part 1: Period 3|Adverse Event|0|||
94522730|NCT01244035|323709820|FG004|Part 1: Period 3|Adverse Event|0|||
94522731|NCT01244035|323709821|FG005|Part 1: Period 3|Adverse Event|1|||
94522732|NCT01244035|323709816|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
94522733|NCT01244035|323709817|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
94522734|NCT01244035|323709818|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
94522735|NCT01244035|323709819|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
94522736|NCT01244035|323709820|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
94522737|NCT01244035|323709821|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
94522738|NCT01244035|323709816|FG000|Part 1: Period 3|Protocol Deviation|0|||
94522739|NCT01244035|323709817|FG001|Part 1: Period 3|Protocol Deviation|1|||
94522740|NCT01244035|323709818|FG002|Part 1: Period 3|Protocol Deviation|0|||
94522741|NCT01244035|323709819|FG003|Part 1: Period 3|Protocol Deviation|0|||
94522742|NCT01244035|323709820|FG004|Part 1: Period 3|Protocol Deviation|0|||
94522743|NCT01244035|323709821|FG005|Part 1: Period 3|Protocol Deviation|0|||
94522744|NCT02383862|323709822|FG000|3 Month Follow up|Lost to Follow-up|23|||
94522745|NCT02383862|323709823|FG001|3 Month Follow up|Lost to Follow-up|21|||
94522746|NCT00374595|323709828|FG000|Overall Study|Death|23|||
94522747|NCT00374595|323709828|FG000|Overall Study|Withdrawal by Subject|39|||
94522748|NCT00374595|323709828|FG000|Overall Study|Lost to Follow-up|3|||
94522749|NCT00374595|323709828|FG000|Overall Study|too much time commitment|1|||
94522750|NCT00374595|323709828|FG000|Overall Study|transfer care to other clinical site|1|||
94522751|NCT00374595|323709828|FG000|Overall Study|relocation|3|||
94522752|NCT02639247|323709835|FG000|Overall Study|Lost to Follow-up|2|||
94522753|NCT02639247|323709836|FG001|Overall Study|Lost to Follow-up|1|||
94522754|NCT02639247|323709835|FG000|Overall Study|Death|2|||
94522755|NCT02639247|323709836|FG001|Overall Study|Death|0|||
94522756|NCT02639247|323709835|FG000|Overall Study|Withdrew Consent|0|||
94522757|NCT02639247|323709836|FG001|Overall Study|Withdrew Consent|1|||
94522758|NCT02639247|323709835|FG000|Overall Study|Protocol Violation|1|||
94522759|NCT02639247|323709836|FG001|Overall Study|Protocol Violation|0|||
94522760|NCT01722994|323709841|FG000|Overall Study|Missing data|25|||
94522761|NCT01722994|323709842|FG001|Overall Study|Missing data|17|||
94522762|NCT02688192|323709843|FG000|Overall Study|Lost to Follow-up|11|||
94522763|NCT02688192|323709844|FG001|Overall Study|Lost to Follow-up|5|||
94522764|NCT02688192|323709843|FG000|Overall Study|Physician Decision|1|||
94522765|NCT02688192|323709844|FG001|Overall Study|Physician Decision|0|||
94522766|NCT01118780|323709845|FG000|Overall Study|Adverse Event|15|||
94522767|NCT01118780|323709846|FG001|Overall Study|Adverse Event|15|||
94522768|NCT01118780|323709845|FG000|Overall Study|Death|1|||
94522769|NCT01118780|323709846|FG001|Overall Study|Death|0|||
94522770|NCT01118780|323709845|FG000|Overall Study|Lack of Efficacy|2|||
94522771|NCT01118780|323709846|FG001|Overall Study|Lack of Efficacy|6|||
94522772|NCT01118780|323709845|FG000|Overall Study|Physician Decision|2|||
94522773|NCT01118780|323709846|FG001|Overall Study|Physician Decision|0|||
94522774|NCT01118780|323709845|FG000|Overall Study|Protocol Violation|3|||
94522775|NCT01118780|323709846|FG001|Overall Study|Protocol Violation|6|||
94522776|NCT01118780|323709845|FG000|Overall Study|Withdrawal by Subject|13|||
94522777|NCT01118780|323709846|FG001|Overall Study|Withdrawal by Subject|8|||
94522778|NCT03824392|323709856|FG000|Overall Study|Adverse Event|1|||
94522779|NCT03824392|323709857|FG001|Overall Study|Adverse Event|0|||
94522780|NCT03824392|323709858|FG002|Overall Study|Adverse Event|0|||
94522781|NCT03824392|323709859|FG003|Overall Study|Adverse Event|0|||
94522782|NCT03824392|323709856|FG000|Overall Study|Investigator Decision|0|||
94522783|NCT03824392|323709857|FG001|Overall Study|Investigator Decision|1|||
94522784|NCT03824392|323709858|FG002|Overall Study|Investigator Decision|0|||
94522785|NCT03824392|323709859|FG003|Overall Study|Investigator Decision|0|||
94522786|NCT03824392|323709856|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
94522787|NCT03824392|323709857|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
94522788|NCT03824392|323709858|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
94522789|NCT03824392|323709859|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
94522790|NCT01282866|323709860|FG000|Overall Study|Adverse Event|1|||
94522791|NCT03465722|323709861|FG000|Overall Study|Withdrawal by Subject|21|||
94522792|NCT03465722|323709862|FG001|Overall Study|Withdrawal by Subject|14|||
94522793|NCT03465722|323709861|FG000|Overall Study|Death|89|||
94522794|NCT03465722|323709862|FG001|Overall Study|Death|87|||
94522795|NCT03465722|323709861|FG000|Overall Study|Lost to Follow-up|5|||
94522796|NCT03465722|323709862|FG001|Overall Study|Lost to Follow-up|3|||
94522797|NCT03465722|323709861|FG000|Overall Study|Administrative/Other|33|||
94522798|NCT03465722|323709862|FG001|Overall Study|Administrative/Other|32|||
94522799|NCT03465722|323709861|FG000|Overall Study|Not treated|1|||
94522800|NCT03465722|323709862|FG001|Overall Study|Not treated|2|||
94522801|NCT03465722|323709861|FG000|Overall Study|Sponsor decision|91|||
94522802|NCT03465722|323709862|FG001|Overall Study|Sponsor decision|98|||
94522803|NCT01490918|323709865|FG000|Overall Study|Lost to Follow-up|2|||
94522804|NCT01490918|323709866|FG001|Overall Study|Lost to Follow-up|1|||
94522805|NCT01490918|323709867|FG002|Overall Study|Lost to Follow-up|0|||
94522806|NCT01490918|323709865|FG000|Overall Study|Withdrawal by Subject|7|||
94522807|NCT01490918|323709866|FG001|Overall Study|Withdrawal by Subject|8|||
94522808|NCT01490918|323709867|FG002|Overall Study|Withdrawal by Subject|3|||
94522809|NCT01490918|323709865|FG000|Overall Study|Adverse Event|0|||
94522810|NCT01490918|323709866|FG001|Overall Study|Adverse Event|0|||
94522811|NCT01490918|323709867|FG002|Overall Study|Adverse Event|1|||
94522812|NCT01490918|323709865|FG000|Overall Study|other cause|4|||
94522813|NCT01490918|323709866|FG001|Overall Study|other cause|5|||
94522814|NCT01490918|323709867|FG002|Overall Study|other cause|8|||
94522815|NCT02240121|323709871|FG000|Overall Study|Protocol Violation|1|||
94522816|NCT02240121|323709872|FG001|Overall Study|Protocol Violation|2|||
94522817|NCT02240121|323709871|FG000|Overall Study|Physician Decision|0|||
94522818|NCT02240121|323709872|FG001|Overall Study|Physician Decision|1|||
94522819|NCT02240121|323709871|FG000|Overall Study|Change in protocol interpretation|1|||
94522820|NCT02240121|323709872|FG001|Overall Study|Change in protocol interpretation|0|||
94522821|NCT02240121|323709871|FG000|Overall Study|Lack of Efficacy|2|||
94522822|NCT02240121|323709872|FG001|Overall Study|Lack of Efficacy|3|||
94522823|NCT02240121|323709871|FG000|Overall Study|Site closed|1|||
94522824|NCT02240121|323709872|FG001|Overall Study|Site closed|1|||
94522825|NCT02240121|323709871|FG000|Overall Study|Pregnancy|1|||
94522826|NCT02240121|323709872|FG001|Overall Study|Pregnancy|0|||
94522827|NCT02240121|323709871|FG000|Overall Study|Adverse Event|2|||
94522828|NCT02240121|323709872|FG001|Overall Study|Adverse Event|4|||
94522829|NCT02240121|323709871|FG000|Overall Study|Withdrawal by Subject|6|||
94522830|NCT02240121|323709872|FG001|Overall Study|Withdrawal by Subject|2|||
94522831|NCT02240121|323709871|FG000|Overall Study|Lost to Follow-up|3|||
94522832|NCT02240121|323709872|FG001|Overall Study|Lost to Follow-up|4|||
94522833|NCT02240121|323709871|FG000|Overall Study|Other than specified|1|||
94522834|NCT02240121|323709872|FG001|Overall Study|Other than specified|3|||
94522835|NCT04339413|323709875|FG000|Overall Study|Reason Not Specified|2|||
94522836|NCT04339413|323709876|FG001|Overall Study|Reason Not Specified|7|||
94522837|NCT04339413|323709875|FG000|Overall Study|Study Terminated by Sponsor|30|||
94522838|NCT04339413|323709876|FG001|Overall Study|Study Terminated by Sponsor|33|||
94522839|NCT04339413|323709875|FG000|Overall Study|Progressive Disease|9|||
94522840|NCT04339413|323709876|FG001|Overall Study|Progressive Disease|6|||
94522841|NCT04339413|323709875|FG000|Overall Study|Withdrawal by Subject|9|||
94522842|NCT04339413|323709876|FG001|Overall Study|Withdrawal by Subject|10|||
94522843|NCT04339413|323709875|FG000|Overall Study|Physician Decision|3|||
94522844|NCT04339413|323709876|FG001|Overall Study|Physician Decision|1|||
94522845|NCT04339413|323709875|FG000|Overall Study|Death|2|||
94522846|NCT04339413|323709876|FG001|Overall Study|Death|0|||
94522847|NCT04339413|323709875|FG000|Overall Study|Adverse Event|3|||
94522848|NCT04339413|323709876|FG001|Overall Study|Adverse Event|0|||
94522849|NCT03188263|323709877|FG000|Overall Study|Withdrawal by Subject|3|||
94522850|NCT03188263|323709878|FG001|Overall Study|Withdrawal by Subject|0|||
94522851|NCT03188263|323709877|FG000|Overall Study|Physician Decision|1|||
94522852|NCT03188263|323709878|FG001|Overall Study|Physician Decision|0|||
94522853|NCT04872569|323709879|FG000|Overall Study|Withdrawal by Subject|2|||
94522854|NCT02382991|323709880|FG000|Overall Study|Adverse Event|1|||
94522855|NCT02382991|323709881|FG001|Overall Study|Adverse Event|2|||
94522856|NCT02382991|323709880|FG000|Overall Study|Lost to Follow-up|1|||
94522857|NCT02382991|323709881|FG001|Overall Study|Lost to Follow-up|0|||
94522858|NCT02382991|323709880|FG000|Overall Study|Withdrawal by Subject|0|||
94522859|NCT02382991|323709881|FG001|Overall Study|Withdrawal by Subject|1|||
94522860|NCT01890265|323709882|FG000|Overall Study|Other (Unspecified reason)|0|||
94522861|NCT01890265|323709883|FG001|Overall Study|Other (Unspecified reason)|1|||
94522862|NCT01890265|323709884|FG002|Overall Study|Other (Unspecified reason)|0|||
94522863|NCT01890265|323709885|FG003|Overall Study|Other (Unspecified reason)|0|||
94522864|NCT01890265|323709886|FG004|Overall Study|Other (Unspecified reason)|0|||
94522865|NCT01890265|323709887|FG005|Overall Study|Other (Unspecified reason)|0|||
94522866|NCT01890265|323709882|FG000|Overall Study|Progressive disease|6|||
94522867|NCT01890265|323709883|FG001|Overall Study|Progressive disease|6|||
94522868|NCT01890265|323709884|FG002|Overall Study|Progressive disease|0|||
94522869|NCT01890265|323709885|FG003|Overall Study|Progressive disease|0|||
94522870|NCT01890265|323709886|FG004|Overall Study|Progressive disease|0|||
94522871|NCT01890265|323709887|FG005|Overall Study|Progressive disease|0|||
94522872|NCT01890265|323709882|FG000|Overall Study|Adverse Event|2|||
94522873|NCT01890265|323709883|FG001|Overall Study|Adverse Event|1|||
94522874|NCT01890265|323709884|FG002|Overall Study|Adverse Event|0|||
94522875|NCT01890265|323709885|FG003|Overall Study|Adverse Event|0|||
94522876|NCT01890265|323709886|FG004|Overall Study|Adverse Event|0|||
94522877|NCT01890265|323709887|FG005|Overall Study|Adverse Event|0|||
94522878|NCT01890265|323709882|FG000|Overall Study|Death|2|||
94522879|NCT01890265|323709883|FG001|Overall Study|Death|3|||
94522880|NCT01890265|323709884|FG002|Overall Study|Death|1|||
94522881|NCT01890265|323709885|FG003|Overall Study|Death|0|||
94522882|NCT01890265|323709886|FG004|Overall Study|Death|0|||
94522883|NCT01890265|323709887|FG005|Overall Study|Death|0|||
94522884|NCT01890265|323709882|FG000|Overall Study|Withdrawal by Subject|0|||
94522885|NCT01890265|323709883|FG001|Overall Study|Withdrawal by Subject|2|||
94522886|NCT01890265|323709884|FG002|Overall Study|Withdrawal by Subject|3|||
94522887|NCT01890265|323709885|FG003|Overall Study|Withdrawal by Subject|0|||
94522888|NCT01890265|323709886|FG004|Overall Study|Withdrawal by Subject|2|||
94522889|NCT01890265|323709887|FG005|Overall Study|Withdrawal by Subject|0|||
94522890|NCT02708680|323709888|FG000|Overall Study|Withdrawal by Subject|4|||
94522891|NCT02708680|323709889|FG001|Overall Study|Withdrawal by Subject|12|||
94522892|NCT02708680|323709890|FG002|Overall Study|Withdrawal by Subject|12|||
94522893|NCT02708680|323709888|FG000|Overall Study|Death|4|||
94522894|NCT02708680|323709889|FG001|Overall Study|Death|19|||
94522895|NCT02708680|323709890|FG002|Overall Study|Death|21|||
94522896|NCT02708680|323709888|FG000|Overall Study|Lost to Follow-up|0|||
94522897|NCT02708680|323709889|FG001|Overall Study|Lost to Follow-up|3|||
94522898|NCT02708680|323709890|FG002|Overall Study|Lost to Follow-up|3|||
94522899|NCT02708680|323709888|FG000|Overall Study|Study Terminated By Sponsor|0|||
94522900|NCT02708680|323709889|FG001|Overall Study|Study Terminated By Sponsor|5|||
94522901|NCT02708680|323709890|FG002|Overall Study|Study Terminated By Sponsor|4|||
94522902|NCT02708680|323709888|FG000|Overall Study|Other than Specified|0|||
94522903|NCT02708680|323709889|FG001|Overall Study|Other than Specified|0|||
94522904|NCT02708680|323709890|FG002|Overall Study|Other than Specified|1|||
94522905|NCT02708680|323709888|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
94522906|NCT02708680|323709889|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
94522907|NCT02708680|323709890|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
94522908|NCT03929913|323709891|FG000|Overall Study|Death|4|||
94522909|NCT03929913|323709891|FG000|Overall Study|Lost to Follow-up|1|||
94522910|NCT03929913|323709891|FG000|Overall Study|Failed Procedure|2|||
94522911|NCT01402869|323709894|FG000|Overall Study|Required Tooth Extraction|0|||
94522912|NCT01402869|323709895|FG001|Overall Study|Required Tooth Extraction|0|||
94522913|NCT01402869|323709896|FG002|Overall Study|Required Tooth Extraction|1|||
94522914|NCT01154452|323709897|FG000|Phase Ib|Not Treated|1|||
94522915|NCT01154452|323709898|FG001|Phase Ib|Not Treated|0|||
94522916|NCT01154452|323709899|FG002|Phase Ib|Not Treated|0|||
94522917|NCT01154452|323709900|FG003|Phase Ib|Not Treated|0|||
94522918|NCT01154452|323709897|FG000|Phase Ib|Adverse Event|2|||
94522919|NCT01154452|323709898|FG001|Phase Ib|Adverse Event|1|||
94522920|NCT01154452|323709899|FG002|Phase Ib|Adverse Event|0|||
94522921|NCT01154452|323709900|FG003|Phase Ib|Adverse Event|0|||
94522922|NCT01154452|323709897|FG000|Phase II|Withdrawal by Subject|0|||
94522923|NCT01154452|323709898|FG001|Phase II|Withdrawal by Subject|0|||
94522924|NCT01154452|323709899|FG002|Phase II|Withdrawal by Subject|1|||
94522925|NCT01154452|323709900|FG003|Phase II|Withdrawal by Subject|2|||
94522926|NCT01154452|323709897|FG000|Phase II|Adverse Event|0|||
94522927|NCT01154452|323709898|FG001|Phase II|Adverse Event|0|||
94522928|NCT01154452|323709899|FG002|Phase II|Adverse Event|4|||
94522929|NCT01154452|323709900|FG003|Phase II|Adverse Event|4|||
94522930|NCT01544348|323709905|FG000|Overall Study|Lost to Follow-up|1|||
94522931|NCT01544348|323709906|FG001|Overall Study|Lost to Follow-up|0|||
94522932|NCT01544348|323709907|FG002|Overall Study|Lost to Follow-up|0|||
94522933|NCT01544348|323709908|FG003|Overall Study|Lost to Follow-up|0|||
94522934|NCT01544348|323709909|FG004|Overall Study|Lost to Follow-up|0|||
94522935|NCT01544348|323709910|FG005|Overall Study|Lost to Follow-up|0|||
94522936|NCT01544348|323709911|FG006|Overall Study|Lost to Follow-up|1|||
94522937|NCT01544348|323709912|FG007|Overall Study|Lost to Follow-up|0|||
94522938|NCT01544348|323709905|FG000|Overall Study|Withdrawal by Subject|1|||
94522939|NCT01544348|323709906|FG001|Overall Study|Withdrawal by Subject|0|||
94522940|NCT01544348|323709907|FG002|Overall Study|Withdrawal by Subject|0|||
94522941|NCT01544348|323709908|FG003|Overall Study|Withdrawal by Subject|0|||
94522942|NCT01544348|323709909|FG004|Overall Study|Withdrawal by Subject|1|||
94522943|NCT01544348|323709910|FG005|Overall Study|Withdrawal by Subject|2|||
94522944|NCT01544348|323709911|FG006|Overall Study|Withdrawal by Subject|1|||
94522945|NCT01544348|323709912|FG007|Overall Study|Withdrawal by Subject|0|||
94522946|NCT01544348|323709905|FG000|Overall Study|Physician Decision|0|||
94522947|NCT01544348|323709906|FG001|Overall Study|Physician Decision|0|||
94522948|NCT01544348|323709907|FG002|Overall Study|Physician Decision|0|||
94522949|NCT01544348|323709908|FG003|Overall Study|Physician Decision|0|||
94522950|NCT01544348|323709909|FG004|Overall Study|Physician Decision|0|||
94522951|NCT01544348|323709910|FG005|Overall Study|Physician Decision|1|||
94522952|NCT01544348|323709911|FG006|Overall Study|Physician Decision|0|||
94522953|NCT01544348|323709912|FG007|Overall Study|Physician Decision|0|||
94522954|NCT05653700|323709913|FG000|Overall Study|Non Responders|9|||
94522955|NCT05653700|323709914|FG001|Overall Study|Non Responders|0|||
94522956|NCT01900665|323709915|FG000|Placebo Controlled Period|Death|9|||
94522957|NCT01900665|323709916|FG001|Placebo Controlled Period|Death|16|||
94522958|NCT01900665|323709915|FG000|Placebo Controlled Period|Adverse Event|48|||
94522959|NCT01900665|323709916|FG001|Placebo Controlled Period|Adverse Event|39|||
94522960|NCT01900665|323709915|FG000|Placebo Controlled Period|Protocol Violation|1|||
94522961|NCT01900665|323709916|FG001|Placebo Controlled Period|Protocol Violation|7|||
94522962|NCT01900665|323709915|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
94522963|NCT01900665|323709916|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
94522964|NCT01900665|323709915|FG000|Placebo Controlled Period|Physician Decision|11|||
94522965|NCT01900665|323709916|FG001|Placebo Controlled Period|Physician Decision|7|||
94522966|NCT01900665|323709915|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
94522967|NCT01900665|323709916|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
94522968|NCT01900665|323709915|FG000|Placebo Controlled Period|Caregiver Decision|33|||
94522969|NCT01900665|323709916|FG001|Placebo Controlled Period|Caregiver Decision|41|||
94522970|NCT01900665|323709915|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
94522971|NCT01900665|323709916|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
94522972|NCT01900665|323709915|FG000|Open Label Period|Adverse Event|16|||
94522973|NCT01900665|323709916|FG001|Open Label Period|Adverse Event|20|||
94522974|NCT01900665|323709915|FG000|Open Label Period|Death|5|||
94522975|NCT01900665|323709916|FG001|Open Label Period|Death|6|||
94522976|NCT01900665|323709915|FG000|Open Label Period|Lost to Follow-up|1|||
94522977|NCT01900665|323709916|FG001|Open Label Period|Lost to Follow-up|1|||
94522978|NCT01900665|323709915|FG000|Open Label Period|Parent/Caregiver Decision|33|||
94522979|NCT01900665|323709916|FG001|Open Label Period|Parent/Caregiver Decision|34|||
94522980|NCT01900665|323709915|FG000|Open Label Period|Physician Decision|4|||
94522981|NCT01900665|323709916|FG001|Open Label Period|Physician Decision|4|||
94522982|NCT01900665|323709915|FG000|Open Label Period|Protocol Violation|0|||
94522983|NCT01900665|323709916|FG001|Open Label Period|Protocol Violation|1|||
94522984|NCT01900665|323709915|FG000|Open Label Period|Sponsor Decision|802|||
94522985|NCT01900665|323709916|FG001|Open Label Period|Sponsor Decision|765|||
94522986|NCT01900665|323709915|FG000|Open Label Period|Withdrawal by Subject|20|||
94522987|NCT01900665|323709916|FG001|Open Label Period|Withdrawal by Subject|28|||
94522988|NCT02573948|323709917|FG000|Longitudinal Cohort|Death|9|||
94522989|NCT02573948|323709917|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
94522990|NCT02573948|323709917|FG000|Longitudinal Cohort|Incarcerated|25|||
94522991|NCT03154476|323709918|FG000|Overall Study|Lost to Follow-up|4|||
94522992|NCT03154476|323709919|FG001|Overall Study|Lost to Follow-up|4|||
94522993|NCT04472650|323711297|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
94522994|NCT04472650|323711298|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
94522995|NCT00628446|323711299|FG000|Overall Study|Lost to Follow-up|3|||
94522996|NCT00628446|323711299|FG000|Overall Study|Withdrawal by Subject|1|||
94522997|NCT00628446|323711299|FG000|Overall Study|Protocol Violation|3|||
94522998|NCT01898286|323711300|FG000|Overall Study|Withdrawal by Subject|1|||
94522999|NCT01898286|323711300|FG000|Overall Study|Protocol Violation|1|||
94523000|NCT01898286|323711300|FG000|Overall Study|Lost to Follow-up|1|||
94523001|NCT00682929|323711305|FG000|Overall Study|Adverse Event|4|||
94523002|NCT00682929|323711306|FG001|Overall Study|Adverse Event|1|||
94523003|NCT00682929|323711307|FG002|Overall Study|Adverse Event|1|||
94523004|NCT00682929|323711305|FG000|Overall Study|Withdrawal by Subject|1|||
94523005|NCT00682929|323711306|FG001|Overall Study|Withdrawal by Subject|2|||
94523006|NCT00682929|323711307|FG002|Overall Study|Withdrawal by Subject|1|||
94523007|NCT00682929|323711305|FG000|Overall Study|dosing compliance < 80%|0|||
94523008|NCT00682929|323711306|FG001|Overall Study|dosing compliance < 80%|2|||
94523009|NCT00682929|323711307|FG002|Overall Study|dosing compliance < 80%|0|||
94523010|NCT00682929|323711305|FG000|Overall Study|lag in DEA renewal|1|||
94523011|NCT00682929|323711306|FG001|Overall Study|lag in DEA renewal|0|||
94523012|NCT00682929|323711307|FG002|Overall Study|lag in DEA renewal|0|||
94523013|NCT01462929|323711308|FG000|Overall Study|Adverse Event|3|||
94523014|NCT01462929|323711309|FG001|Overall Study|Adverse Event|3|||
94523015|NCT01462929|323711310|FG002|Overall Study|Adverse Event|4|||
94523016|NCT01462929|323711308|FG000|Overall Study|Withdrawal by Subject|2|||
94523017|NCT01462929|323711309|FG001|Overall Study|Withdrawal by Subject|1|||
94523018|NCT01462929|323711310|FG002|Overall Study|Withdrawal by Subject|0|||
94523019|NCT01462929|323711308|FG000|Overall Study|Lack of Efficacy|0|||
94523020|NCT01462929|323711309|FG001|Overall Study|Lack of Efficacy|0|||
94523021|NCT01462929|323711310|FG002|Overall Study|Lack of Efficacy|1|||
94523022|NCT01694433|323711313|FG000|Overall Study|Adverse Event|7|||
94523023|NCT01694433|323711314|FG001|Overall Study|Adverse Event|0|||
94523024|NCT01694433|323711313|FG000|Overall Study|Physician Decision|1|||
94523025|NCT01694433|323711314|FG001|Overall Study|Physician Decision|0|||
94523026|NCT01694433|323711313|FG000|Overall Study|Withdrawal by Subject|3|||
94523027|NCT01694433|323711314|FG001|Overall Study|Withdrawal by Subject|4|||
94523028|NCT00443118|323711318|FG000|Overall Study|unknown primary outcome|3|||
94523029|NCT00443118|323711319|FG001|Overall Study|unknown primary outcome|1|||
94523030|NCT00443118|323711320|FG002|Overall Study|unknown primary outcome|0|||
94523031|NCT00443118|323711318|FG000|Overall Study|Withdrawal by Subject|1|||
94523032|NCT00443118|323711319|FG001|Overall Study|Withdrawal by Subject|0|||
94523033|NCT00443118|323711320|FG002|Overall Study|Withdrawal by Subject|0|||
94523034|NCT03688919|323711323|FG000|Overall Study|Lost to Follow-up|2|||
94523035|NCT03688919|323711324|FG001|Overall Study|Lost to Follow-up|1|||
94523036|NCT03688919|323711323|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
94523037|NCT03688919|323711324|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
94523038|NCT00347932|323711327|FG000|Overall Study|Adverse Event|4|||
94523039|NCT00347932|323711328|FG001|Overall Study|Adverse Event|5|||
94523040|NCT00347932|323711327|FG000|Overall Study|Lack of Efficacy|3|||
94523041|NCT00347932|323711328|FG001|Overall Study|Lack of Efficacy|14|||
94523042|NCT00347932|323711327|FG000|Overall Study|Lost to Follow-up|10|||
94523043|NCT00347932|323711328|FG001|Overall Study|Lost to Follow-up|9|||
94523044|NCT00347932|323711327|FG000|Overall Study|Withdrawal by Subject|10|||
94523045|NCT00347932|323711328|FG001|Overall Study|Withdrawal by Subject|16|||
94523046|NCT00347932|323711327|FG000|Overall Study|Did not meet inclusion criteria|4|||
94523047|NCT00347932|323711328|FG001|Overall Study|Did not meet inclusion criteria|8|||
94523048|NCT03462758|323711329|FG000|Overall Study|Chose no or other method of contraception|20|||
94523049|NCT03462758|323711330|FG001|Overall Study|Chose no or other method of contraception|23|||
94523050|NCT03462758|323711329|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
94523051|NCT03462758|323711330|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
94523052|NCT03462758|323711329|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
94523053|NCT03462758|323711330|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
94523054|NCT03462758|323711329|FG000|Overall Study|Medical contraindication|2|||
94523055|NCT03462758|323711330|FG001|Overall Study|Medical contraindication|2|||
94523056|NCT03462758|323711329|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
94523057|NCT03462758|323711330|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
94523058|NCT01000506|323711341|FG000|Overall Study|Adverse Event|6|||
94523059|NCT01000506|323711342|FG001|Overall Study|Adverse Event|5|||
94523060|NCT01000506|323711343|FG002|Overall Study|Adverse Event|8|||
94523061|NCT01000506|323711344|FG003|Overall Study|Adverse Event|9|||
94523062|NCT01000506|323711341|FG000|Overall Study|Lack of Efficacy|8|||
94523063|NCT01000506|323711342|FG001|Overall Study|Lack of Efficacy|6|||
94523064|NCT01000506|323711343|FG002|Overall Study|Lack of Efficacy|4|||
94523065|NCT01000506|323711344|FG003|Overall Study|Lack of Efficacy|4|||
94523066|NCT01000506|323711341|FG000|Overall Study|Protocol Violation|1|||
94523067|NCT01000506|323711342|FG001|Overall Study|Protocol Violation|1|||
94523068|NCT01000506|323711343|FG002|Overall Study|Protocol Violation|0|||
94523069|NCT01000506|323711344|FG003|Overall Study|Protocol Violation|0|||
94523070|NCT01000506|323711341|FG000|Overall Study|Lost to Follow-up|1|||
94523071|NCT01000506|323711342|FG001|Overall Study|Lost to Follow-up|1|||
94523072|NCT01000506|323711343|FG002|Overall Study|Lost to Follow-up|4|||
94523073|NCT01000506|323711344|FG003|Overall Study|Lost to Follow-up|0|||
94523074|NCT01000506|323711341|FG000|Overall Study|Physician Decision|1|||
94523075|NCT01000506|323711342|FG001|Overall Study|Physician Decision|3|||
94523076|NCT01000506|323711343|FG002|Overall Study|Physician Decision|3|||
94523077|NCT01000506|323711344|FG003|Overall Study|Physician Decision|3|||
94523078|NCT01000506|323711341|FG000|Overall Study|Withdrawal by Subject|11|||
94523079|NCT01000506|323711342|FG001|Overall Study|Withdrawal by Subject|8|||
94523080|NCT01000506|323711343|FG002|Overall Study|Withdrawal by Subject|2|||
94523081|NCT01000506|323711344|FG003|Overall Study|Withdrawal by Subject|7|||
94523082|NCT00003631|323711348|FG000|Overall Study|Patient not treated|1|||
94523083|NCT00003631|323711349|FG001|Overall Study|Patient not treated|0|||
94523084|NCT00003631|323711350|FG002|Overall Study|Patient not treated|1|||
94523085|NCT00003631|323711348|FG000|Overall Study|Protocol Violation|1|||
94523086|NCT00003631|323711349|FG001|Overall Study|Protocol Violation|0|||
94523087|NCT00003631|323711350|FG002|Overall Study|Protocol Violation|0|||
94523088|NCT00003631|323711348|FG000|Overall Study|Adverse Event|1|||
94523089|NCT00003631|323711349|FG001|Overall Study|Adverse Event|1|||
94523090|NCT00003631|323711350|FG002|Overall Study|Adverse Event|5|||
94523091|NCT00003631|323711348|FG000|Overall Study|Death|0|||
94523092|NCT00003631|323711349|FG001|Overall Study|Death|0|||
94523093|NCT00003631|323711350|FG002|Overall Study|Death|1|||
94523094|NCT00003631|323711348|FG000|Overall Study|Evaluable for toxicity only|0|||
94523095|NCT00003631|323711349|FG001|Overall Study|Evaluable for toxicity only|0|||
94523096|NCT00003631|323711350|FG002|Overall Study|Evaluable for toxicity only|2|||
94523097|NCT03072043|323711353|FG000|Overall Study|Death|0|||
94523098|NCT03072043|323711354|FG001|Overall Study|Death|0|||
94523099|NCT03072043|323711355|FG002|Overall Study|Death|3|||
94523100|NCT03072043|323711353|FG000|Overall Study|Adverse Event|0|||
94523101|NCT03072043|323711354|FG001|Overall Study|Adverse Event|0|||
94523102|NCT03072043|323711355|FG002|Overall Study|Adverse Event|2|||
94523103|NCT03072043|323711353|FG000|Overall Study|Withdrawal by Subject|0|||
94523104|NCT03072043|323711354|FG001|Overall Study|Withdrawal by Subject|0|||
94523105|NCT03072043|323711355|FG002|Overall Study|Withdrawal by Subject|4|||
94523106|NCT04571060|323711356|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
94523107|NCT04571060|323711357|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
94523108|NCT04571060|323711356|FG000|Overall Study|Never treated migraine|47|||
94523109|NCT04571060|323711357|FG001|Overall Study|Never treated migraine|36|||
94523110|NCT04571060|323711356|FG000|Overall Study|Protocol Violation|4|||
94523111|NCT04571060|323711357|FG001|Overall Study|Protocol Violation|2|||
94523112|NCT04571060|323711356|FG000|Overall Study|Withdrawal by Subject|6|||
94523113|NCT04571060|323711357|FG001|Overall Study|Withdrawal by Subject|2|||
94523114|NCT04571060|323711356|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
94523115|NCT04571060|323711357|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
94523116|NCT01853462|323711358|FG000|Overall Study|Withdrawal by Subject|1|||
94523117|NCT01853462|323711359|FG001|Overall Study|Withdrawal by Subject|1|||
94523118|NCT01926444|323711360|FG000|Overall Study|Colonoscopy not performed|0|||
94523119|NCT01926444|323711361|FG001|Overall Study|Colonoscopy not performed|0|||
94523120|NCT01926444|323711362|FG002|Overall Study|Colonoscopy not performed|4|||
94523121|NCT01926444|323711363|FG003|Overall Study|Colonoscopy not performed|2|||
94523122|NCT00295646|323711365|FG000|Overall Study|Protocol Violation|18|||
94523123|NCT00295646|323711366|FG001|Overall Study|Protocol Violation|20|||
94523124|NCT00295646|323711367|FG002|Overall Study|Protocol Violation|20|||
94523125|NCT00295646|323711368|FG003|Overall Study|Protocol Violation|18|||
94523126|NCT00295646|323711365|FG000|Overall Study|Withdrawal by Subject|8|||
94523127|NCT00295646|323711366|FG001|Overall Study|Withdrawal by Subject|9|||
94523128|NCT00295646|323711367|FG002|Overall Study|Withdrawal by Subject|11|||
94523129|NCT00295646|323711368|FG003|Overall Study|Withdrawal by Subject|14|||
94523130|NCT00295646|323711365|FG000|Overall Study|Lost to Follow-up|0|||
94523131|NCT00295646|323711366|FG001|Overall Study|Lost to Follow-up|5|||
94523132|NCT00295646|323711367|FG002|Overall Study|Lost to Follow-up|1|||
94523133|NCT00295646|323711368|FG003|Overall Study|Lost to Follow-up|5|||
94523134|NCT00295646|323711365|FG000|Overall Study|Death|9|||
94523135|NCT00295646|323711366|FG001|Overall Study|Death|7|||
94523136|NCT00295646|323711367|FG002|Overall Study|Death|18|||
94523137|NCT00295646|323711368|FG003|Overall Study|Death|8|||
94523138|NCT02441101|323711369|FG000|Overall Study|Withdrawal by Subject|1|||
94523139|NCT02441101|323711370|FG001|Overall Study|Withdrawal by Subject|0|||
94523140|NCT02441101|323711369|FG000|Overall Study|Lost to Follow-up|1|||
94523141|NCT02441101|323711370|FG001|Overall Study|Lost to Follow-up|0|||
94523142|NCT02441101|323711369|FG000|Overall Study|PI relocated and study terminated|1|||
94523143|NCT02441101|323711370|FG001|Overall Study|PI relocated and study terminated|0|||
94523144|NCT00503425|323711374|FG000|Overall Study|Participant files lost|6|||
94523145|NCT00503425|323711374|FG000|Overall Study|Adverse Event|5|||
94523146|NCT00503425|323711374|FG000|Overall Study|Lack of Efficacy|25|||
94523147|NCT00503425|323711374|FG000|Overall Study|Withdrawal by Subject|8|||
94523148|NCT00503425|323711374|FG000|Overall Study|Lost to Follow-up|3|||
94523149|NCT00503425|323711374|FG000|Overall Study|Death|3|||
94523150|NCT00503425|323711374|FG000|Overall Study|Missing Data/Unknown|4|||
94523151|NCT02148263|323711375|FG000|Overall Study|Withdrawal by Subject|3|||
94523152|NCT02148263|323711376|FG001|Overall Study|Withdrawal by Subject|2|||
94523153|NCT02103062|323711377|FG000|Overall Study|Adverse Event|1|||
94523154|NCT02103062|323711378|FG001|Overall Study|Adverse Event|2|||
94523155|NCT02103062|323711377|FG000|Overall Study|Progressive Disease|17|||
94523156|NCT02103062|323711378|FG001|Overall Study|Progressive Disease|20|||
94523157|NCT02103062|323711377|FG000|Overall Study|Death|0|||
94523158|NCT02103062|323711378|FG001|Overall Study|Death|1|||
94523159|NCT01964378|323711379|FG000|Overall Study|Disc. due to death before first dosing|0|||
94523160|NCT01964378|323711380|FG001|Overall Study|Disc. due to death before first dosing|1|||
94523161|NCT01964378|323711379|FG000|Overall Study|Disc. due to AE before first dosing|1|||
94523162|NCT01964378|323711380|FG001|Overall Study|Disc. due to AE before first dosing|0|||
94523163|NCT01964378|323711379|FG000|Overall Study|Death|3|||
94523164|NCT01964378|323711380|FG001|Overall Study|Death|2|||
94523165|NCT01964378|323711379|FG000|Overall Study|Adverse Event|12|||
94523166|NCT01964378|323711380|FG001|Overall Study|Adverse Event|5|||
94523167|NCT01964378|323711379|FG000|Overall Study|Lack of Efficacy|0|||
94523168|NCT01964378|323711380|FG001|Overall Study|Lack of Efficacy|1|||
94523169|NCT01964378|323711379|FG000|Overall Study|Protocol Violation|0|||
94523170|NCT01964378|323711380|FG001|Overall Study|Protocol Violation|1|||
94523171|NCT01964378|323711379|FG000|Overall Study|Lost to Follow-up|0|||
94523172|NCT01964378|323711380|FG001|Overall Study|Lost to Follow-up|1|||
94523173|NCT01964378|323711379|FG000|Overall Study|Withdrawal by Subject|7|||
94523174|NCT01964378|323711380|FG001|Overall Study|Withdrawal by Subject|5|||
94523175|NCT01964378|323711379|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
94523176|NCT01964378|323711380|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
94523177|NCT01964378|323711379|FG000|Overall Study|Other|1|||
94523178|NCT01964378|323711380|FG001|Overall Study|Other|2|||
94523179|NCT00120627|323711381|FG000|Overall Study|Withdrawal by Subject|5|||
94523180|NCT00120627|323711382|FG001|Overall Study|Withdrawal by Subject|5|||
94523181|NCT00049257|323711385|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
94523182|NCT00049257|323711385|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
94523183|NCT00049257|323711385|FG000|Carboplatin, Paclitaxel|Death|2|||
94523184|NCT00049257|323711385|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
94523185|NCT02131662|323711394|FG000|Overall Study|Protocol Violation|1|||
94523186|NCT02131662|323711395|FG001|Overall Study|Protocol Violation|0|||
94523187|NCT02131662|323711396|FG002|Overall Study|Protocol Violation|0|||
94523188|NCT02131662|323711397|FG003|Overall Study|Protocol Violation|0|||
94523189|NCT02131662|323711398|FG004|Overall Study|Protocol Violation|0|||
94523190|NCT02131662|323711394|FG000|Overall Study|Other|2|||
94523191|NCT02131662|323711395|FG001|Overall Study|Other|4|||
94523192|NCT02131662|323711396|FG002|Overall Study|Other|3|||
94523193|NCT02131662|323711397|FG003|Overall Study|Other|3|||
94523194|NCT02131662|323711398|FG004|Overall Study|Other|4|||
94523195|NCT02131662|323711394|FG000|Overall Study|Adverse Event|0|||
94523196|NCT02131662|323711395|FG001|Overall Study|Adverse Event|1|||
94523197|NCT02131662|323711396|FG002|Overall Study|Adverse Event|1|||
94523198|NCT02131662|323711397|FG003|Overall Study|Adverse Event|1|||
94523199|NCT02131662|323711398|FG004|Overall Study|Adverse Event|3|||
94523200|NCT02131662|323711394|FG000|Overall Study|Pregnancy|0|||
94523201|NCT02131662|323711395|FG001|Overall Study|Pregnancy|1|||
94523202|NCT02131662|323711396|FG002|Overall Study|Pregnancy|0|||
94523203|NCT02131662|323711397|FG003|Overall Study|Pregnancy|1|||
94523204|NCT02131662|323711398|FG004|Overall Study|Pregnancy|0|||
94523205|NCT02131662|323711394|FG000|Overall Study|Wish for pregnancy|0|||
94523206|NCT02131662|323711395|FG001|Overall Study|Wish for pregnancy|0|||
94523207|NCT02131662|323711396|FG002|Overall Study|Wish for pregnancy|0|||
94523208|NCT02131662|323711397|FG003|Overall Study|Wish for pregnancy|0|||
94523209|NCT02131662|323711398|FG004|Overall Study|Wish for pregnancy|1|||
94523210|NCT02131662|323711394|FG000|Overall Study|Lack of Efficacy|1|||
94523211|NCT02131662|323711395|FG001|Overall Study|Lack of Efficacy|0|||
94523212|NCT02131662|323711396|FG002|Overall Study|Lack of Efficacy|0|||
94523213|NCT02131662|323711397|FG003|Overall Study|Lack of Efficacy|0|||
94523214|NCT02131662|323711398|FG004|Overall Study|Lack of Efficacy|1|||
94523215|NCT02131662|323711394|FG000|Overall Study|Withdrawal by Subject|1|||
94523216|NCT02131662|323711395|FG001|Overall Study|Withdrawal by Subject|5|||
94523217|NCT02131662|323711396|FG002|Overall Study|Withdrawal by Subject|1|||
94523218|NCT02131662|323711397|FG003|Overall Study|Withdrawal by Subject|5|||
94523219|NCT02131662|323711398|FG004|Overall Study|Withdrawal by Subject|6|||
94523220|NCT02131662|323711394|FG000|Overall Study|Lost to Follow-up|1|||
94523221|NCT02131662|323711395|FG001|Overall Study|Lost to Follow-up|3|||
94523222|NCT02131662|323711396|FG002|Overall Study|Lost to Follow-up|0|||
94523223|NCT02131662|323711397|FG003|Overall Study|Lost to Follow-up|9|||
94523224|NCT02131662|323711398|FG004|Overall Study|Lost to Follow-up|0|||
94523225|NCT02131662|323711394|FG000|Overall Study|Not treated|2|||
94523226|NCT02131662|323711395|FG001|Overall Study|Not treated|0|||
94523227|NCT02131662|323711396|FG002|Overall Study|Not treated|2|||
94523228|NCT02131662|323711397|FG003|Overall Study|Not treated|2|||
94523229|NCT02131662|323711398|FG004|Overall Study|Not treated|3|||
94523230|NCT03554018|323711399|FG000|Overall Study|Lost to Follow-up|3|||
94523231|NCT03554018|323711400|FG001|Overall Study|Lost to Follow-up|7|||
94523232|NCT01740687|323711401|FG000|Overall Study|Lost to Follow-up|11|||
94523233|NCT01740687|323711401|FG000|Overall Study|Withdrawal by Subject|2|||
94523234|NCT01740687|323711401|FG000|Overall Study|other reason|22|||
94523235|NCT01740687|323711401|FG000|Overall Study|treatment not received|2|||
94523236|NCT01392573|323711405|FG000|Overall Study|Adverse Event|1|||
94523237|NCT01392573|323711406|FG001|Overall Study|Adverse Event|3|||
94523238|NCT01392573|323711405|FG000|Overall Study|Lack of Efficacy|1|||
94523239|NCT01392573|323711406|FG001|Overall Study|Lack of Efficacy|2|||
94523240|NCT01392573|323711405|FG000|Overall Study|Protocol Violation|0|||
94523241|NCT01392573|323711406|FG001|Overall Study|Protocol Violation|2|||
94523242|NCT01392573|323711405|FG000|Overall Study|Withdrawal Criteria|13|||
94523243|NCT01392573|323711406|FG001|Overall Study|Withdrawal Criteria|15|||
94523244|NCT01392573|323711405|FG000|Overall Study|Site closure|8|||
94523245|NCT01392573|323711406|FG001|Overall Study|Site closure|7|||
94523246|NCT01392573|323711405|FG000|Overall Study|Unclassified|9|||
94523247|NCT01392573|323711406|FG001|Overall Study|Unclassified|6|||
94523248|NCT00996658|323711412|FG000|Overall Study|Adverse Event|2|||
94523249|NCT00996658|323711413|FG001|Overall Study|Adverse Event|5|||
94523250|NCT00996658|323711412|FG000|Overall Study|Protocol Violation|0|||
94523251|NCT00996658|323711413|FG001|Overall Study|Protocol Violation|1|||
94523252|NCT00996658|323711412|FG000|Overall Study|Lost to Follow-up|2|||
94523253|NCT00996658|323711413|FG001|Overall Study|Lost to Follow-up|5|||
94523254|NCT00996658|323711412|FG000|Overall Study|Non-compliance issues|3|||
94523255|NCT00996658|323711413|FG001|Overall Study|Non-compliance issues|3|||
94523256|NCT00996658|323711412|FG000|Overall Study|Other|9|||
94523257|NCT00996658|323711413|FG001|Overall Study|Other|7|||
94523258|NCT00670930|323711414|FG000|Overall Study|Adminstrative Problem|0|||
94523259|NCT00670930|323711415|FG001|Overall Study|Adminstrative Problem|1|||
94523260|NCT00670930|323711414|FG000|Overall Study|Lost to Follow-up|1|||
94523261|NCT00670930|323711415|FG001|Overall Study|Lost to Follow-up|0|||
94523262|NCT00200967|323711416|FG000|First Treatment Period|Withdrawal by Subject|5|||
94523263|NCT00200967|323711417|FG001|First Treatment Period|Withdrawal by Subject|1|||
94523264|NCT00200967|323711416|FG000|First Treatment Period|Pregnancy|1|||
94523265|NCT00200967|323711417|FG001|First Treatment Period|Pregnancy|0|||
94523266|NCT00200967|323711416|FG000|Wash-out Period|Lost to Follow-up|0|||
94523267|NCT00200967|323711417|FG001|Wash-out Period|Lost to Follow-up|1|||
94523268|NCT00200967|323711416|FG000|Second Treatment Period|Withdrawal by Subject|1|||
94523269|NCT00200967|323711417|FG001|Second Treatment Period|Withdrawal by Subject|2|||
94523270|NCT00200967|323711416|FG000|Run-out Period|Lost to Follow-up|1|||
94523271|NCT00200967|323711417|FG001|Run-out Period|Lost to Follow-up|0|||
94523272|NCT01444430|323711419|FG000|Overall Study|Withdrawal by Subject|53|||
94523273|NCT01444430|323711420|FG001|Overall Study|Withdrawal by Subject|72|||
94523274|NCT01444430|323711419|FG000|Overall Study|Death|6|||
94523275|NCT01444430|323711420|FG001|Overall Study|Death|8|||
94523276|NCT01444430|323711419|FG000|Overall Study|Lost to Follow-up|2|||
94523277|NCT01444430|323711420|FG001|Overall Study|Lost to Follow-up|0|||
94523278|NCT01444430|323711419|FG000|Overall Study|CRF termination module not completed.|0|||
94523279|NCT01444430|323711420|FG001|Overall Study|CRF termination module not completed.|1|||
94523280|NCT00552071|323713338|FG000|Overall Study|Adverse Event|1|||
94523281|NCT00552071|323713339|FG001|Overall Study|Adverse Event|0|||
94523282|NCT00552071|323713338|FG000|Overall Study|Lack of Efficacy|1|||
94523283|NCT00552071|323713339|FG001|Overall Study|Lack of Efficacy|0|||
94523284|NCT00552071|323713338|FG000|Overall Study|Physician Decision|1|||
94523285|NCT00552071|323713339|FG001|Overall Study|Physician Decision|0|||
94523286|NCT00552071|323713338|FG000|Overall Study|Pregnancy|1|||
94523287|NCT00552071|323713339|FG001|Overall Study|Pregnancy|0|||
94523288|NCT00552071|323713338|FG000|Overall Study|Death|0|||
94523289|NCT00552071|323713339|FG001|Overall Study|Death|1|||
94523290|NCT00552071|323713338|FG000|Overall Study|Withdrawal by Subject|0|||
94523291|NCT00552071|323713339|FG001|Overall Study|Withdrawal by Subject|1|||
94523292|NCT02549989|323713340|FG000|Overall Study|Adverse Event|4|||
94523293|NCT02549989|323713340|FG000|Overall Study|Death|1|||
94523294|NCT02549989|323713340|FG000|Overall Study|Lack of Efficacy|19|||
94523295|NCT02549989|323713340|FG000|Overall Study|Withdrawal by Subject|3|||
94523296|NCT00288015|323713341|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
94523297|NCT00288015|323713341|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
94523298|NCT00288015|323713341|FG000|First Response Assessment|Withdrawal by Subject|1|||
94523299|NCT00288015|323713341|FG000|First Response Assessment|Death|1|||
94523300|NCT00288015|323713341|FG000|First Response Assessment|Physician Decision|2|||
94523301|NCT00288015|323713341|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
94523302|NCT00288015|323713341|FG000|Follow up for Survival x 2 Years|Death|13|||
94523303|NCT00288015|323713341|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
94523304|NCT00288015|323713341|FG000|Follow up for Survival x 2 Years|Other|9|||
94523305|NCT00532129|323713342|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
94523306|NCT00532129|323713342|FG000|Treatment Period|Physician Decision|15|||
94523307|NCT00532129|323713342|FG000|Treatment Period|Disease progression|3|||
94523308|NCT00532129|323713342|FG000|Treatment Period|Protocol Violation|1|||
94523309|NCT00532129|323713342|FG000|Treatment Period|Other|5|||
94523310|NCT00532129|323713342|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
94523311|NCT00532129|323713342|FG000|Follow-up Period|Disease progression|57|||
94523312|NCT00532129|323713342|FG000|Follow-up Period|Lost to Follow-up|1|||
94523313|NCT00532129|323713342|FG000|Follow-up Period|Other|6|||
94523314|NCT00443703|323713343|FG000|Overall Study|Never Treated|3|||
94523315|NCT00443703|323713344|FG001|Overall Study|Never Treated|1|||
94523316|NCT00443703|323713343|FG000|Overall Study|Adverse Event|7|||
94523317|NCT00443703|323713344|FG001|Overall Study|Adverse Event|3|||
94523318|NCT00443703|323713343|FG000|Overall Study|Lack of Efficacy|3|||
94523319|NCT00443703|323713344|FG001|Overall Study|Lack of Efficacy|1|||
94523320|NCT00443703|323713343|FG000|Overall Study|Lost to Follow-up|0|||
94523321|NCT00443703|323713344|FG001|Overall Study|Lost to Follow-up|4|||
94523322|NCT00443703|323713343|FG000|Overall Study|Physician Decision|4|||
94523323|NCT00443703|323713344|FG001|Overall Study|Physician Decision|2|||
94523324|NCT00443703|323713343|FG000|Overall Study|Protocol Violation|1|||
94523325|NCT00443703|323713344|FG001|Overall Study|Protocol Violation|1|||
94523326|NCT00443703|323713343|FG000|Overall Study|Withdrawal by Subject|9|||
94523327|NCT00443703|323713344|FG001|Overall Study|Withdrawal by Subject|6|||
94523328|NCT00443703|323713343|FG000|Overall Study|Progressive Disease|1|||
94523329|NCT00443703|323713344|FG001|Overall Study|Progressive Disease|0|||
94523330|NCT00784368|323713347|FG000|Overall Study|Physician Decision|0|||
94523331|NCT00784368|323713348|FG001|Overall Study|Physician Decision|0|||
94523332|NCT00784368|323713349|FG002|Overall Study|Physician Decision|6|||
94523333|NCT00784368|323713347|FG000|Overall Study|Lack of Efficacy|2|||
94523334|NCT00784368|323713348|FG001|Overall Study|Lack of Efficacy|0|||
94523335|NCT00784368|323713349|FG002|Overall Study|Lack of Efficacy|1|||
94523336|NCT00784368|323713347|FG000|Overall Study|Adverse Event|6|||
94523337|NCT00784368|323713348|FG001|Overall Study|Adverse Event|9|||
94523338|NCT00784368|323713349|FG002|Overall Study|Adverse Event|2|||
94523339|NCT00784368|323713347|FG000|Overall Study|Diagnosis of fever|0|||
94523340|NCT00784368|323713348|FG001|Overall Study|Diagnosis of fever|0|||
94523341|NCT00784368|323713349|FG002|Overall Study|Diagnosis of fever|1|||
94523342|NCT00784368|323713347|FG000|Overall Study|Worsening of complications|0|||
94523343|NCT00784368|323713348|FG001|Overall Study|Worsening of complications|0|||
94523344|NCT00784368|323713349|FG002|Overall Study|Worsening of complications|1|||
94523345|NCT00784368|323713347|FG000|Overall Study|Worsening of symptoms|0|||
94523346|NCT00784368|323713348|FG001|Overall Study|Worsening of symptoms|1|||
94523347|NCT00784368|323713349|FG002|Overall Study|Worsening of symptoms|0|||
94523348|NCT00784368|323713347|FG000|Overall Study|Withdrawal of informed consent|0|||
94523349|NCT00784368|323713348|FG001|Overall Study|Withdrawal of informed consent|1|||
94523350|NCT00784368|323713349|FG002|Overall Study|Withdrawal of informed consent|0|||
94523351|NCT04776161|323713350|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
94523352|NCT04776161|323713351|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
94523353|NCT04776161|323713352|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
94523354|NCT04776161|323713350|FG000|Overall Study|Withdrawal by Subject|1|||
94523355|NCT04776161|323713351|FG001|Overall Study|Withdrawal by Subject|0|||
94523356|NCT04776161|323713352|FG002|Overall Study|Withdrawal by Subject|1|||
94523357|NCT04776161|323713350|FG000|Overall Study|Adverse Event|0|||
94523358|NCT04776161|323713351|FG001|Overall Study|Adverse Event|1|||
94523359|NCT04776161|323713352|FG002|Overall Study|Adverse Event|1|||
94523360|NCT01396187|323713355|FG000|Overall Study|Adverse Event|0|||
94523361|NCT01396187|323713356|FG001|Overall Study|Adverse Event|1|||
94523362|NCT01396187|323713357|FG002|Overall Study|Adverse Event|0|||
94523363|NCT01396187|323713358|FG003|Overall Study|Adverse Event|0|||
94523364|NCT01396187|323713359|FG004|Overall Study|Adverse Event|0|||
94523365|NCT01396187|323713355|FG000|Overall Study|Withdrawal by Subject|0|||
94523366|NCT01396187|323713356|FG001|Overall Study|Withdrawal by Subject|1|||
94523367|NCT01396187|323713357|FG002|Overall Study|Withdrawal by Subject|1|||
94523368|NCT01396187|323713358|FG003|Overall Study|Withdrawal by Subject|0|||
94523369|NCT01396187|323713359|FG004|Overall Study|Withdrawal by Subject|0|||
94523370|NCT01396187|323713355|FG000|Overall Study|Other|1|||
94523371|NCT01396187|323713356|FG001|Overall Study|Other|1|||
94523372|NCT01396187|323713357|FG002|Overall Study|Other|0|||
94523373|NCT01396187|323713358|FG003|Overall Study|Other|0|||
94523374|NCT01396187|323713359|FG004|Overall Study|Other|1|||
94523375|NCT04971967|323713361|FG000|Overall Study|Lost to Follow-up|6|||
94523376|NCT04971967|323713362|FG001|Overall Study|Lost to Follow-up|7|||
94523377|NCT00399568|323713365|FG000|Overall Study|Adverse Event|1|||
94523378|NCT00399568|323713366|FG001|Overall Study|Adverse Event|2|||
94523379|NCT00399568|323713365|FG000|Overall Study|Withdrawal by Subject|7|||
94523380|NCT00399568|323713366|FG001|Overall Study|Withdrawal by Subject|3|||
94523381|NCT00399568|323713365|FG000|Overall Study|Protocol non-compliance|2|||
94523382|NCT00399568|323713366|FG001|Overall Study|Protocol non-compliance|2|||
94523383|NCT00399568|323713365|FG000|Overall Study|Lost to Follow-up|2|||
94523384|NCT00399568|323713366|FG001|Overall Study|Lost to Follow-up|2|||
94523385|NCT01897727|323713367|FG000|Overall Study|Exclusion: central sleep apnea|0|||
94523386|NCT01897727|323713368|FG001|Overall Study|Exclusion: central sleep apnea|1|||
94523387|NCT00856635|323713369|FG000|Overall Study|Lost to Follow-up|2|||
94523388|NCT00856635|323713370|FG001|Overall Study|Lost to Follow-up|5|||
94523389|NCT00856635|323713369|FG000|Overall Study|Pregnancy|1|||
94523390|NCT00856635|323713370|FG001|Overall Study|Pregnancy|0|||
94523391|NCT00856635|323713369|FG000|Overall Study|Withdrawal by Subject|3|||
94523392|NCT00856635|323713370|FG001|Overall Study|Withdrawal by Subject|1|||
94523393|NCT00856635|323713369|FG000|Overall Study|Serious Adverse Event|1|||
94523394|NCT00856635|323713370|FG001|Overall Study|Serious Adverse Event|0|||
94523395|NCT00856635|323713369|FG000|Overall Study|Other|1|||
94523396|NCT00856635|323713370|FG001|Overall Study|Other|0|||
94523397|NCT00856635|323713369|FG000|Overall Study|Discontinued at Randomization|2|||
94523398|NCT00856635|323713370|FG001|Overall Study|Discontinued at Randomization|2|||
94523399|NCT01833494|323713371|FG000|Overall Study|Adverse Event|24|||
94523400|NCT01833494|323713371|FG000|Overall Study|Physician Decision|6|||
94523401|NCT01833494|323713371|FG000|Overall Study|Withdrawal by Subject|6|||
94523402|NCT01833494|323713371|FG000|Overall Study|Decrease in serum phosphorus|4|||
94523403|NCT01833494|323713371|FG000|Overall Study|Decrease in serum calcium|4|||
94523404|NCT01833494|323713371|FG000|Overall Study|Increase in serum ferritin|1|||
94523405|NCT02820844|323713372|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
94523406|NCT02820844|323713373|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
94523407|NCT02820844|323713374|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
94523408|NCT02820844|323713375|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
94523409|NCT02820844|323713376|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
94523410|NCT02820844|323713377|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
94523411|NCT02820844|323713372|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
94523412|NCT02820844|323713373|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
94523413|NCT02820844|323713374|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
94523414|NCT02820844|323713375|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
94523415|NCT02820844|323713376|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
94523416|NCT02820844|323713377|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
94523417|NCT02820844|323713372|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
94523418|NCT02820844|323713373|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
94523419|NCT02820844|323713374|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
94523420|NCT02820844|323713375|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
94523421|NCT02820844|323713376|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
94523422|NCT02820844|323713377|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
94523423|NCT02820844|323713372|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
94523424|NCT02820844|323713373|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
94523425|NCT02820844|323713374|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
94523426|NCT02820844|323713375|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
94523427|NCT02820844|323713376|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
94523428|NCT02820844|323713377|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
94523429|NCT02820844|323713372|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
94523430|NCT02820844|323713373|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
94523431|NCT02820844|323713374|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
94523432|NCT02820844|323713375|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
94523433|NCT02820844|323713376|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
94523434|NCT02820844|323713377|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
94523435|NCT02820844|323713372|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
94523436|NCT02820844|323713373|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
94523437|NCT02820844|323713374|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
94523438|NCT02820844|323713375|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
94523439|NCT02820844|323713376|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
94523440|NCT02820844|323713377|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
94523441|NCT02820844|323713372|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
94523442|NCT02820844|323713373|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
94523443|NCT02820844|323713374|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
94523444|NCT02820844|323713375|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
94523445|NCT02820844|323713376|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
94523446|NCT02820844|323713377|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
94523447|NCT02820844|323713372|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
94523448|NCT02820844|323713373|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
94523449|NCT02820844|323713374|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
94523450|NCT02820844|323713375|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
94523451|NCT02820844|323713376|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
94523452|NCT02820844|323713377|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
94523453|NCT02820844|323713372|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
94523454|NCT02820844|323713373|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
94523455|NCT02820844|323713374|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
94523456|NCT02820844|323713375|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
94523457|NCT02820844|323713376|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
94523458|NCT02820844|323713377|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
94523459|NCT02820844|323713372|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
94523460|NCT02820844|323713373|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
94523461|NCT02820844|323713374|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
94523462|NCT02820844|323713375|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
94523463|NCT02820844|323713376|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
94523464|NCT02820844|323713377|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
94523465|NCT02266147|323713378|FG000|PART 1: Dose Escalation|Physician Decision|0|||
94523466|NCT02266147|323713379|FG001|PART 1: Dose Escalation|Physician Decision|0|||
94523467|NCT02266147|323713380|FG002|PART 1: Dose Escalation|Physician Decision|1|||
94523468|NCT02266147|323713381|FG003|PART 1: Dose Escalation|Physician Decision|0|||
94523469|NCT02266147|323713378|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
94523470|NCT02266147|323713379|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
94523471|NCT02266147|323713380|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
94523472|NCT02266147|323713381|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
94523473|NCT02266147|323713378|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
94523474|NCT02266147|323713379|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
94523475|NCT02266147|323713380|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
94523476|NCT02266147|323713381|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
94523477|NCT02266147|323713378|FG000|PART 1: Dose Escalation|Other|1|||
94523478|NCT02266147|323713379|FG001|PART 1: Dose Escalation|Other|1|||
94523479|NCT02266147|323713380|FG002|PART 1: Dose Escalation|Other|0|||
94523480|NCT02266147|323713381|FG003|PART 1: Dose Escalation|Other|0|||
94523481|NCT02266147|323713378|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
94523482|NCT02266147|323713379|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
94523483|NCT02266147|323713380|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
94523484|NCT02266147|323713381|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
94523485|NCT02266147|323713378|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
94523486|NCT02266147|323713379|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
94523487|NCT02266147|323713380|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
94523488|NCT02266147|323713381|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
94523489|NCT00413660|323713385|FG000|Up To Week 12|Adverse Event|1|||
94523490|NCT00413660|323713386|FG001|Up To Week 12|Adverse Event|3|||
94523491|NCT00413660|323713387|FG002|Up To Week 12|Adverse Event|1|||
94523492|NCT00413660|323713388|FG003|Up To Week 12|Adverse Event|4|||
94523493|NCT00413660|323713389|FG004|Up To Week 12|Adverse Event|6|||
94523494|NCT00413660|323713390|FG005|Up To Week 12|Adverse Event|4|||
94523495|NCT00413660|323713391|FG006|Up To Week 12|Adverse Event|1|||
94523496|NCT00413660|323713392|FG007|Up To Week 12|Adverse Event|0|||
94523497|NCT00413660|323713393|FG008|Up To Week 12|Adverse Event|0|||
94523498|NCT00413660|323713394|FG009|Up To Week 12|Adverse Event|0|||
94523499|NCT00413660|323713395|FG010|Up To Week 12|Adverse Event|0|||
94523500|NCT00413660|323713385|FG000|Up To Week 12|Lack of Efficacy|2|||
94523501|NCT00413660|323713386|FG001|Up To Week 12|Lack of Efficacy|0|||
94523502|NCT00413660|323713387|FG002|Up To Week 12|Lack of Efficacy|0|||
94523503|NCT00413660|323713388|FG003|Up To Week 12|Lack of Efficacy|0|||
94523504|NCT00413660|323713389|FG004|Up To Week 12|Lack of Efficacy|0|||
94523505|NCT00413660|323713390|FG005|Up To Week 12|Lack of Efficacy|0|||
94523506|NCT00413660|323713391|FG006|Up To Week 12|Lack of Efficacy|5|||
94523507|NCT00413660|323713392|FG007|Up To Week 12|Lack of Efficacy|0|||
94523508|NCT00413660|323713393|FG008|Up To Week 12|Lack of Efficacy|0|||
94523509|NCT00413660|323713394|FG009|Up To Week 12|Lack of Efficacy|0|||
94523510|NCT00413660|323713395|FG010|Up To Week 12|Lack of Efficacy|0|||
94523511|NCT00413660|323713385|FG000|Up To Week 12|Lost to Follow-up|0|||
94523512|NCT00413660|323713386|FG001|Up To Week 12|Lost to Follow-up|1|||
94523513|NCT00413660|323713387|FG002|Up To Week 12|Lost to Follow-up|0|||
94523514|NCT00413660|323713388|FG003|Up To Week 12|Lost to Follow-up|0|||
94523515|NCT00413660|323713389|FG004|Up To Week 12|Lost to Follow-up|1|||
94523516|NCT00413660|323713390|FG005|Up To Week 12|Lost to Follow-up|0|||
94523517|NCT00413660|323713391|FG006|Up To Week 12|Lost to Follow-up|0|||
94523518|NCT00413660|323713392|FG007|Up To Week 12|Lost to Follow-up|0|||
94523519|NCT00413660|323713393|FG008|Up To Week 12|Lost to Follow-up|0|||
94523520|NCT00413660|323713394|FG009|Up To Week 12|Lost to Follow-up|0|||
94523521|NCT00413660|323713395|FG010|Up To Week 12|Lost to Follow-up|0|||
94523522|NCT00413660|323713385|FG000|Up To Week 12|Withdrawal by Subject|0|||
94523523|NCT00413660|323713386|FG001|Up To Week 12|Withdrawal by Subject|2|||
94523524|NCT00413660|323713387|FG002|Up To Week 12|Withdrawal by Subject|0|||
94523525|NCT00413660|323713388|FG003|Up To Week 12|Withdrawal by Subject|2|||
94523526|NCT00413660|323713389|FG004|Up To Week 12|Withdrawal by Subject|0|||
94523527|NCT00413660|323713390|FG005|Up To Week 12|Withdrawal by Subject|2|||
94523528|NCT00413660|323713391|FG006|Up To Week 12|Withdrawal by Subject|2|||
94523529|NCT00413660|323713392|FG007|Up To Week 12|Withdrawal by Subject|0|||
94523530|NCT00413660|323713393|FG008|Up To Week 12|Withdrawal by Subject|0|||
94523531|NCT00413660|323713394|FG009|Up To Week 12|Withdrawal by Subject|0|||
94523532|NCT00413660|323713395|FG010|Up To Week 12|Withdrawal by Subject|0|||
94523533|NCT00413660|323713385|FG000|Up To Week 12|Randomized, Not Treated|1|||
94523534|NCT00413660|323713386|FG001|Up To Week 12|Randomized, Not Treated|0|||
94523535|NCT00413660|323713387|FG002|Up To Week 12|Randomized, Not Treated|0|||
94523536|NCT00413660|323713388|FG003|Up To Week 12|Randomized, Not Treated|1|||
94523537|NCT00413660|323713389|FG004|Up To Week 12|Randomized, Not Treated|0|||
94523538|NCT00413660|323713390|FG005|Up To Week 12|Randomized, Not Treated|0|||
94523539|NCT00413660|323713391|FG006|Up To Week 12|Randomized, Not Treated|0|||
94523540|NCT00413660|323713392|FG007|Up To Week 12|Randomized, Not Treated|0|||
94523541|NCT00413660|323713393|FG008|Up To Week 12|Randomized, Not Treated|0|||
94523542|NCT00413660|323713394|FG009|Up To Week 12|Randomized, Not Treated|0|||
94523543|NCT00413660|323713395|FG010|Up To Week 12|Randomized, Not Treated|0|||
94523544|NCT00413660|323713385|FG000|Up To Week 12|Other|3|||
94523545|NCT00413660|323713386|FG001|Up To Week 12|Other|1|||
94523546|NCT00413660|323713387|FG002|Up To Week 12|Other|6|||
94523547|NCT00413660|323713388|FG003|Up To Week 12|Other|1|||
94523548|NCT00413660|323713389|FG004|Up To Week 12|Other|2|||
94523549|NCT00413660|323713390|FG005|Up To Week 12|Other|4|||
94523550|NCT00413660|323713391|FG006|Up To Week 12|Other|3|||
94523551|NCT00413660|323713392|FG007|Up To Week 12|Other|0|||
94523552|NCT00413660|323713393|FG008|Up To Week 12|Other|0|||
94523553|NCT00413660|323713394|FG009|Up To Week 12|Other|0|||
94523554|NCT00413660|323713395|FG010|Up To Week 12|Other|0|||
94523555|NCT00413660|323713385|FG000|Post Week 12|Adverse Event|2|||
94523556|NCT00413660|323713386|FG001|Post Week 12|Adverse Event|0|||
94523557|NCT00413660|323713387|FG002|Post Week 12|Adverse Event|2|||
94523558|NCT00413660|323713388|FG003|Post Week 12|Adverse Event|1|||
94523559|NCT00413660|323713389|FG004|Post Week 12|Adverse Event|4|||
94523560|NCT00413660|323713390|FG005|Post Week 12|Adverse Event|2|||
94523561|NCT00413660|323713391|FG006|Post Week 12|Adverse Event|2|||
94523562|NCT00413660|323713392|FG007|Post Week 12|Adverse Event|0|||
94523563|NCT00413660|323713393|FG008|Post Week 12|Adverse Event|0|||
94523564|NCT00413660|323713394|FG009|Post Week 12|Adverse Event|0|||
94523565|NCT00413660|323713395|FG010|Post Week 12|Adverse Event|0|||
94523566|NCT00413660|323713385|FG000|Post Week 12|Lack of Efficacy|0|||
94523567|NCT00413660|323713386|FG001|Post Week 12|Lack of Efficacy|0|||
94523568|NCT00413660|323713387|FG002|Post Week 12|Lack of Efficacy|1|||
94523569|NCT00413660|323713388|FG003|Post Week 12|Lack of Efficacy|0|||
94523570|NCT00413660|323713389|FG004|Post Week 12|Lack of Efficacy|0|||
94523571|NCT00413660|323713390|FG005|Post Week 12|Lack of Efficacy|0|||
94523572|NCT00413660|323713391|FG006|Post Week 12|Lack of Efficacy|0|||
94523573|NCT00413660|323713392|FG007|Post Week 12|Lack of Efficacy|0|||
94523574|NCT00413660|323713393|FG008|Post Week 12|Lack of Efficacy|0|||
94523575|NCT00413660|323713394|FG009|Post Week 12|Lack of Efficacy|1|||
94523576|NCT00413660|323713395|FG010|Post Week 12|Lack of Efficacy|0|||
94523577|NCT00413660|323713385|FG000|Post Week 12|Lost to Follow-up|0|||
94523578|NCT00413660|323713386|FG001|Post Week 12|Lost to Follow-up|1|||
94523579|NCT00413660|323713387|FG002|Post Week 12|Lost to Follow-up|1|||
94523580|NCT00413660|323713388|FG003|Post Week 12|Lost to Follow-up|0|||
94523581|NCT00413660|323713389|FG004|Post Week 12|Lost to Follow-up|0|||
94523582|NCT00413660|323713390|FG005|Post Week 12|Lost to Follow-up|0|||
94523583|NCT00413660|323713391|FG006|Post Week 12|Lost to Follow-up|0|||
94523584|NCT00413660|323713392|FG007|Post Week 12|Lost to Follow-up|0|||
94523585|NCT00413660|323713393|FG008|Post Week 12|Lost to Follow-up|0|||
94523586|NCT00413660|323713394|FG009|Post Week 12|Lost to Follow-up|0|||
94523587|NCT00413660|323713395|FG010|Post Week 12|Lost to Follow-up|0|||
94523588|NCT00413660|323713385|FG000|Post Week 12|Withdrawal by Subject|0|||
94523589|NCT00413660|323713386|FG001|Post Week 12|Withdrawal by Subject|1|||
94523590|NCT00413660|323713387|FG002|Post Week 12|Withdrawal by Subject|1|||
94523591|NCT00413660|323713388|FG003|Post Week 12|Withdrawal by Subject|0|||
94523592|NCT00413660|323713389|FG004|Post Week 12|Withdrawal by Subject|1|||
94523593|NCT00413660|323713390|FG005|Post Week 12|Withdrawal by Subject|0|||
94523594|NCT00413660|323713391|FG006|Post Week 12|Withdrawal by Subject|0|||
94523595|NCT00413660|323713392|FG007|Post Week 12|Withdrawal by Subject|0|||
94523596|NCT00413660|323713393|FG008|Post Week 12|Withdrawal by Subject|0|||
94523597|NCT00413660|323713394|FG009|Post Week 12|Withdrawal by Subject|0|||
94523598|NCT00413660|323713395|FG010|Post Week 12|Withdrawal by Subject|1|||
94523599|NCT00413660|323713385|FG000|Post Week 12|Other|1|||
94523600|NCT00413660|323713386|FG001|Post Week 12|Other|2|||
94523601|NCT00413660|323713387|FG002|Post Week 12|Other|3|||
94523602|NCT00413660|323713388|FG003|Post Week 12|Other|0|||
94523603|NCT00413660|323713389|FG004|Post Week 12|Other|1|||
94523604|NCT00413660|323713390|FG005|Post Week 12|Other|1|||
94523605|NCT00413660|323713391|FG006|Post Week 12|Other|1|||
94523606|NCT00413660|323713392|FG007|Post Week 12|Other|0|||
94523607|NCT00413660|323713393|FG008|Post Week 12|Other|0|||
94523608|NCT00413660|323713394|FG009|Post Week 12|Other|0|||
94523609|NCT00413660|323713395|FG010|Post Week 12|Other|0|||
94523610|NCT03896477|323713396|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
94523611|NCT03896477|323713397|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
94523612|NCT03896477|323713398|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
94523613|NCT03896477|323713396|FG000|Overall Study|Parent Requested Withdrawal|8|||
94523614|NCT03896477|323713397|FG001|Overall Study|Parent Requested Withdrawal|12|||
94523615|NCT03896477|323713398|FG002|Overall Study|Parent Requested Withdrawal|9|||
94523616|NCT03896477|323713396|FG000|Overall Study|Adverse Event|0|||
94523617|NCT03896477|323713397|FG001|Overall Study|Adverse Event|0|||
94523618|NCT03896477|323713398|FG002|Overall Study|Adverse Event|1|||
94523619|NCT03896477|323713396|FG000|Overall Study|Death|1|||
94523620|NCT03896477|323713397|FG001|Overall Study|Death|0|||
94523621|NCT03896477|323713398|FG002|Overall Study|Death|0|||
94523622|NCT03896477|323713396|FG000|Overall Study|Other|5|||
94523623|NCT03896477|323713397|FG001|Overall Study|Other|6|||
94523624|NCT03896477|323713398|FG002|Overall Study|Other|7|||
94523625|NCT03896477|323713396|FG000|Overall Study|Lost to Follow-up|2|||
94523626|NCT03896477|323713397|FG001|Overall Study|Lost to Follow-up|1|||
94523627|NCT03896477|323713398|FG002|Overall Study|Lost to Follow-up|1|||
94523628|NCT03369665|323713399|FG000|Overall Study|Adverse Event|3|||
94523629|NCT03369665|323713399|FG000|Overall Study|Lost to Follow-up|7|||
94523630|NCT03369665|323713399|FG000|Overall Study|Withdrawal by Subject|15|||
94523631|NCT03369665|323713399|FG000|Overall Study|Progression Disease|2|||
94523632|NCT03369665|323713399|FG000|Overall Study|Not classified|3|||
94523633|NCT01881009|323713400|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
94523634|NCT01881009|323713401|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
94523635|NCT01063348|323713403|FG000|Overall Study|Lost to Follow-up|3|||
94523636|NCT01063348|323713404|FG001|Overall Study|Lost to Follow-up|10|||
94523637|NCT00269087|323713409|FG000|Overall Study|Adverse Event|20|||
94523638|NCT00269087|323713409|FG000|Overall Study|Withdrawal by Subject|1|||
94523639|NCT00269087|323713409|FG000|Overall Study|Exacerbation of COPD|13|||
94523640|NCT05384834|323713410|FG000|Overall Study|Lost to Follow-up|43|||
94523641|NCT05384834|323713410|FG000|Overall Study|Withdrawal by Subject|5|||
94523642|NCT00041470|323713411|FG000|Overall Study|Loss of Funding|38|||
94523643|NCT02954887|323713414|FG000|Overall Study|Withdrawal by Subject|3|||
94523644|NCT02954887|323713414|FG000|Overall Study|Lack of Efficacy|3|||
94523645|NCT02954887|323713414|FG000|Overall Study|Other|1|||
94523646|NCT01459666|323713416|FG000|Overall Study|PI left institution|5|||
94523647|NCT01459666|323713417|FG001|Overall Study|PI left institution|4|||
94523648|NCT01152788|323713419|FG000|Overall Study|Withdrawal by Subject|0|||
94523649|NCT01152788|323713420|FG001|Overall Study|Withdrawal by Subject|3|||
94523650|NCT01152788|323713419|FG000|Overall Study|No treatment|0|||
94523651|NCT01152788|323713420|FG001|Overall Study|No treatment|1|||
94523652|NCT02379052|323713422|FG000|Overall Study|Protocol Violation|0|||
94523653|NCT02379052|323713423|FG001|Overall Study|Protocol Violation|1|||
94523654|NCT02379052|323713422|FG000|Overall Study|Adverse Event|0|||
94523655|NCT02379052|323713423|FG001|Overall Study|Adverse Event|1|||
94523656|NCT02379052|323713422|FG000|Overall Study|Physician Decision|1|||
94523657|NCT02379052|323713423|FG001|Overall Study|Physician Decision|1|||
94523658|NCT02379052|323713422|FG000|Overall Study|Withdrawal by Subject|2|||
94523659|NCT02379052|323713423|FG001|Overall Study|Withdrawal by Subject|0|||
94523660|NCT02379052|323713422|FG000|Overall Study|Lost to Follow-up|2|||
94523661|NCT02379052|323713423|FG001|Overall Study|Lost to Follow-up|1|||
94523662|NCT02379052|323713422|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
94523663|NCT02379052|323713423|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
94523664|NCT02379052|323713422|FG000|Overall Study|Subject was Incarcerated|0|||
94523665|NCT02379052|323713423|FG001|Overall Study|Subject was Incarcerated|1|||
94523666|NCT04245709|323713424|FG000|Overall Study|Adverse Event|13|||
94523667|NCT04245709|323713424|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
94523668|NCT01434654|323713425|FG000|Overall Study|Withdrawal by Subject|1|||
94523669|NCT01434654|323713426|FG001|Overall Study|Withdrawal by Subject|0|||
94523670|NCT01434654|323713425|FG000|Overall Study|Lost to Follow-up|1|||
94523671|NCT01434654|323713426|FG001|Overall Study|Lost to Follow-up|0|||
94523672|NCT00889707|323713428|FG000|Overall Study|Adverse Event|1|||
94523673|NCT00889707|323713429|FG001|Overall Study|Adverse Event|0|||
94523674|NCT00889707|323713428|FG000|Overall Study|Withdrawal by Subject|4|||
94523675|NCT00889707|323713429|FG001|Overall Study|Withdrawal by Subject|3|||
94523676|NCT00889707|323713428|FG000|Overall Study|Lost to Follow-up|0|||
94523677|NCT00889707|323713429|FG001|Overall Study|Lost to Follow-up|2|||
94523678|NCT00889707|323713428|FG000|Overall Study|Lack of Efficacy|2|||
94523679|NCT00889707|323713429|FG001|Overall Study|Lack of Efficacy|5|||
94523680|NCT03810014|323713433|FG000|Overall Study|Pregnancy|2|||
94523681|NCT03810014|323713434|FG001|Overall Study|Pregnancy|2|||
94523682|NCT03810014|323713435|FG002|Overall Study|Pregnancy|0|||
94523683|NCT03810014|323713436|FG003|Overall Study|Pregnancy|2|||
94523684|NCT01151020|323713437|FG000|Overall Study|Death|25|||
94523685|NCT01151020|323713437|FG000|Overall Study|Conversion to open repair|1|||
94523686|NCT01151020|323713437|FG000|Overall Study|Lost to Follow-up|4|||
94523687|NCT01151020|323713437|FG000|Overall Study|Withdrawal by Subject|22|||
94523688|NCT01151020|323713437|FG000|Overall Study|Patients did not receive the device|2|||
94523689|NCT01925768|323713438|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
94523690|NCT01925768|323713439|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
94523691|NCT01925768|323713438|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
94523692|NCT01925768|323713439|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
94523693|NCT01925768|323713438|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
94523694|NCT01925768|323713439|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
94523695|NCT01925768|323713438|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
94523696|NCT01925768|323713439|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
94523697|NCT01925768|323713438|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
94523698|NCT01925768|323713439|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
94523699|NCT01925768|323713438|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
94523700|NCT01925768|323713439|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
94523701|NCT01925768|323713438|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
94523702|NCT01925768|323713439|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
94523703|NCT01925768|323713438|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
94523704|NCT01925768|323713439|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
94523705|NCT01925768|323713438|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
94523706|NCT01925768|323713439|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
94523707|NCT01925768|323713438|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
94523708|NCT01925768|323713439|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
94523709|NCT01925768|323713438|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
94523710|NCT01925768|323713439|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
94523711|NCT02967679|323713440|FG000|Overall Study|Adverse Event|1|||
94523712|NCT00707993|323713442|FG000|Overall Study|Adverse Event|16|||
94523713|NCT00707993|323713443|FG001|Overall Study|Adverse Event|20|||
94523714|NCT00707993|323713442|FG000|Overall Study|Protocol Violation|4|||
94523715|NCT00707993|323713443|FG001|Overall Study|Protocol Violation|7|||
94523716|NCT00707993|323713442|FG000|Overall Study|Lost to Follow-up|0|||
94523717|NCT00707993|323713443|FG001|Overall Study|Lost to Follow-up|4|||
94523718|NCT00707993|323713442|FG000|Overall Study|Withdrawal by Subject|12|||
94523719|NCT00707993|323713443|FG001|Overall Study|Withdrawal by Subject|16|||
94523720|NCT00707993|323713442|FG000|Overall Study|Hyperglycemic Rescue|55|||
94523721|NCT00707993|323713443|FG001|Overall Study|Hyperglycemic Rescue|47|||
94523722|NCT00707993|323713442|FG000|Overall Study|Other|2|||
94523723|NCT00707993|323713443|FG001|Overall Study|Other|0|||
94523724|NCT00100802|323713444|FG000|Overall Study|Adverse Event|9|||
94523725|NCT00100802|323713444|FG000|Overall Study|Death|1|||
94523726|NCT00100802|323713444|FG000|Overall Study|Lack of Efficacy|47|||
94523727|NCT00100802|323713444|FG000|Overall Study|Physician Decision|5|||
94523728|NCT00100802|323713444|FG000|Overall Study|Protocol Violation|1|||
94523729|NCT00100802|323713444|FG000|Overall Study|Withdrawal by Subject|5|||
94523730|NCT00100802|323713444|FG000|Overall Study|Ineligible|12|||
94523731|NCT02712996|323713445|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
94523732|NCT02712996|323713446|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
94523733|NCT00436436|323713447|FG000|Overall Study|Progression|4|||
94523734|NCT00436436|323713447|FG000|Overall Study|Adverse Event|2|||
94523735|NCT00436436|323713447|FG000|Overall Study|Death|6|||
94523736|NCT01451749|323713448|FG000|Overall Study|Protocol Violation|14|||
94523737|NCT01451749|323713449|FG001|Overall Study|Protocol Violation|7|||
94523738|NCT01451749|323713448|FG000|Overall Study|Lost to Follow-up|15|||
94523739|NCT01451749|323713449|FG001|Overall Study|Lost to Follow-up|5|||
94523740|NCT01451749|323713448|FG000|Overall Study|Meet the exclusion criteria,and|1|||
94523741|NCT01451749|323713449|FG001|Overall Study|Meet the exclusion criteria,and|1|||
94523742|NCT01451749|323713448|FG000|Overall Study|Adverse Event|2|||
94523743|NCT01451749|323713449|FG001|Overall Study|Adverse Event|0|||
94523744|NCT01451749|323713448|FG000|Overall Study|Withdrawal by Subject|0|||
94523745|NCT01451749|323713449|FG001|Overall Study|Withdrawal by Subject|1|||
94523746|NCT02709720|323713452|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
94523747|NCT02709720|323713452|FG000|Overall Study|Protocol Violation|1|||
94523748|NCT02709720|323713452|FG000|Overall Study|Not take study medication|1|||
94523749|NCT01265992|323713453|FG000|Overall Study|Lost to Follow-up|1|||
94523750|NCT01265992|323713453|FG000|Overall Study|Withdrawal by Subject|1|||
94523751|NCT01265992|323713453|FG000|Overall Study|Adverse Event|1|||
94523752|NCT01265992|323713453|FG000|Overall Study|Administrative reasons|2|||
94523753|NCT01265992|323713453|FG000|Overall Study|Stopped treatment|3|||
94523754|NCT01265992|323713453|FG000|Overall Study|Did not receive treatment|1|||
94523755|NCT01198574|323713482|FG000|Overall Study|Resigned from schools|4|||
94523756|NCT01198574|323713483|FG001|Overall Study|Resigned from schools|1|||
94523757|NCT01198574|323713484|FG002|Overall Study|Resigned from schools|1|||
94523758|NCT01198574|323713485|FG003|Overall Study|Resigned from schools|4|||
94523759|NCT01837680|323713486|FG000|Overall Study|Lost to Follow-up|2|||
94523760|NCT01837680|323713487|FG001|Overall Study|Lost to Follow-up|2|||
94523761|NCT01837680|323713486|FG000|Overall Study|lack of insurance|0|||
94523762|NCT01837680|323713487|FG001|Overall Study|lack of insurance|2|||
94523763|NCT01837680|323713486|FG000|Overall Study|allergic reaction|6|||
94523764|NCT01837680|323713487|FG001|Overall Study|allergic reaction|0|||
94523765|NCT01837680|323713486|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
94523766|NCT01837680|323713487|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
94523767|NCT03533660|323713488|FG000|Overall Study|Withdrawal by Subject|2|||
94523768|NCT03533660|323713489|FG001|Overall Study|Withdrawal by Subject|2|||
94523769|NCT03533660|323713488|FG000|Overall Study|Death|2|||
94523770|NCT03533660|323713489|FG001|Overall Study|Death|4|||
94523771|NCT03533660|323713488|FG000|Overall Study|Adverse Event|0|||
94523772|NCT03533660|323713489|FG001|Overall Study|Adverse Event|2|||
94523773|NCT05005273|323713490|FG000|Overall Study|Study Terminated|1|||
94523774|NCT05005273|323713491|FG001|Overall Study|Study Terminated|0|||
94523775|NCT02701764|323713492|FG000|Overall Study|Lost to Follow-up|0|||
94523776|NCT02701764|323713493|FG001|Overall Study|Lost to Follow-up|1|||
94523777|NCT00972023|323715091|FG000|Overall Study|Withdrawal by Subject|1|||
94523778|NCT02628444|323715092|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
94523779|NCT02628444|323715093|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
94523780|NCT02628444|323715094|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
94523781|NCT02628444|323715095|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
94523782|NCT02628444|323715096|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
94523783|NCT02628444|323715097|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
94523784|NCT02628444|323715098|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
94523785|NCT02628444|323715099|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
94523786|NCT02628444|323715100|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
94523787|NCT02628444|323715092|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
94523788|NCT02628444|323715093|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
94523789|NCT02628444|323715094|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
94523790|NCT02628444|323715095|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
94523791|NCT02628444|323715096|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
94523792|NCT02628444|323715097|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
94523793|NCT02628444|323715098|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
94523794|NCT02628444|323715099|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
94523795|NCT02628444|323715100|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
94523796|NCT02628444|323715092|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
94523797|NCT02628444|323715093|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
94523798|NCT02628444|323715094|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
94523799|NCT02628444|323715095|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
94523800|NCT02628444|323715096|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
94523801|NCT02628444|323715097|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
94523802|NCT02628444|323715098|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
94523803|NCT02628444|323715099|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
94523804|NCT02628444|323715100|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
94523805|NCT02628444|323715092|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
94523806|NCT02628444|323715093|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
94523807|NCT02628444|323715094|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
94523808|NCT02628444|323715095|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
94523809|NCT02628444|323715096|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
94523810|NCT02628444|323715097|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
94523811|NCT02628444|323715098|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
94523812|NCT02628444|323715099|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
94523813|NCT02628444|323715100|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
94523814|NCT02628444|323715092|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
94523815|NCT02628444|323715093|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
94523816|NCT02628444|323715094|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
94523817|NCT02628444|323715095|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
94523818|NCT02628444|323715096|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
94523819|NCT02628444|323715097|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
94523820|NCT02628444|323715098|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
94523821|NCT02628444|323715099|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
94523822|NCT02628444|323715100|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
94523823|NCT02628444|323715092|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
94523824|NCT02628444|323715093|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
94523825|NCT02628444|323715094|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
94523826|NCT02628444|323715095|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
94523827|NCT02628444|323715096|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
94523828|NCT02628444|323715097|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
94523829|NCT02628444|323715098|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
94523830|NCT02628444|323715099|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
94523831|NCT02628444|323715100|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
94523832|NCT02628444|323715092|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
94523833|NCT02628444|323715093|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
94523834|NCT02628444|323715094|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
94523835|NCT02628444|323715095|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
94523836|NCT02628444|323715096|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
94523837|NCT02628444|323715097|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
94523838|NCT02628444|323715098|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
94523839|NCT02628444|323715099|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
94523840|NCT02628444|323715100|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
94523841|NCT02628444|323715092|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
94523842|NCT02628444|323715093|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
94523843|NCT02628444|323715094|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
94523844|NCT02628444|323715095|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
94523845|NCT02628444|323715096|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
94523846|NCT02628444|323715097|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
94523847|NCT02628444|323715098|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
94523848|NCT02628444|323715099|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
94523849|NCT02628444|323715100|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
94523850|NCT02628444|323715092|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
94523851|NCT02628444|323715093|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
94523852|NCT02628444|323715094|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
94523853|NCT02628444|323715095|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
94523854|NCT02628444|323715096|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
94523855|NCT02628444|323715097|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
94523856|NCT02628444|323715098|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
94523857|NCT02628444|323715099|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
94523858|NCT02628444|323715100|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
94523859|NCT02628444|323715092|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
94523860|NCT02628444|323715093|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
94523861|NCT02628444|323715094|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
94523862|NCT02628444|323715095|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
94523863|NCT02628444|323715096|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
94523864|NCT02628444|323715097|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
94523865|NCT02628444|323715098|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
94523866|NCT02628444|323715099|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
94523867|NCT02628444|323715100|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
94523868|NCT01333722|323715101|FG000|Overall Study|Lack of Efficacy|0|||
94523869|NCT01333722|323715102|FG001|Overall Study|Lack of Efficacy|2|||
94523870|NCT01333722|323715101|FG000|Overall Study|Withdrawal by Subject|0|||
94523871|NCT01333722|323715102|FG001|Overall Study|Withdrawal by Subject|1|||
94523872|NCT02079909|323715103|FG000|Overall Study|Adverse Event|23|||
94523873|NCT02079909|323715104|FG001|Overall Study|Adverse Event|23|||
94523874|NCT02079909|323715105|FG002|Overall Study|Adverse Event|7|||
94523875|NCT02079909|323715103|FG000|Overall Study|Withdrawal by Subject|9|||
94523876|NCT02079909|323715104|FG001|Overall Study|Withdrawal by Subject|17|||
94523877|NCT02079909|323715105|FG002|Overall Study|Withdrawal by Subject|4|||
94523878|NCT02079909|323715103|FG000|Overall Study|Lost to Follow-up|2|||
94523879|NCT02079909|323715104|FG001|Overall Study|Lost to Follow-up|3|||
94523880|NCT02079909|323715105|FG002|Overall Study|Lost to Follow-up|1|||
94523881|NCT02079909|323715103|FG000|Overall Study|Death|2|||
94523882|NCT02079909|323715104|FG001|Overall Study|Death|2|||
94523883|NCT02079909|323715105|FG002|Overall Study|Death|0|||
94523884|NCT02079909|323715103|FG000|Overall Study|Lack of Efficacy|0|||
94523885|NCT02079909|323715104|FG001|Overall Study|Lack of Efficacy|0|||
94523886|NCT02079909|323715105|FG002|Overall Study|Lack of Efficacy|1|||
94523887|NCT02079909|323715103|FG000|Overall Study|Protocol Violation|0|||
94523888|NCT02079909|323715104|FG001|Overall Study|Protocol Violation|1|||
94523889|NCT02079909|323715105|FG002|Overall Study|Protocol Violation|1|||
94523890|NCT02079909|323715103|FG000|Overall Study|Physician Decision|0|||
94523891|NCT02079909|323715104|FG001|Overall Study|Physician Decision|1|||
94523892|NCT02079909|323715105|FG002|Overall Study|Physician Decision|1|||
94523893|NCT02079909|323715103|FG000|Overall Study|Relocation etc.|2|||
94523894|NCT02079909|323715104|FG001|Overall Study|Relocation etc.|2|||
94523895|NCT02079909|323715105|FG002|Overall Study|Relocation etc.|3|||
94523896|NCT00720356|323715108|FG000|Registration to Study|Determined to have methylated MGMT|67|||
94523897|NCT00720356|323715108|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
94523898|NCT00720356|323715108|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
94523899|NCT00720356|323715108|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
94523900|NCT00720356|323715108|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
94523901|NCT00720356|323715108|FG000|Follow up Until Death|Withdrawal by Subject|1|||
94523902|NCT00720356|323715108|FG000|Follow up Until Death|Alive at last data collection|4|||
94523903|NCT02237001|323715111|FG000|Overall Study|Lost to Follow-up|2|||
94523904|NCT02237001|323715111|FG000|Overall Study|Withdrawal by Subject|1|||
94523905|NCT02237001|323715111|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
94523906|NCT02237001|323715111|FG000|Overall Study|Re-operation|4|||
94523907|NCT02237001|323715111|FG000|Overall Study|Incarceration|1|||
94523908|NCT01047007|323715112|FG000|Overall Study|Adverse Event|0|||
94523909|NCT01047007|323715113|FG001|Overall Study|Adverse Event|2|||
94523910|NCT01047007|323715114|FG002|Overall Study|Adverse Event|1|||
94523911|NCT01047007|323715115|FG003|Overall Study|Adverse Event|0|||
94523912|NCT01047007|323715112|FG000|Overall Study|Progressive Disease|2|||
94523913|NCT01047007|323715113|FG001|Overall Study|Progressive Disease|4|||
94523914|NCT01047007|323715114|FG002|Overall Study|Progressive Disease|1|||
94523915|NCT01047007|323715115|FG003|Overall Study|Progressive Disease|0|||
94523916|NCT00342628|323715119|FG000|Overall Study|Withdrawal by Subject|19|||
94523917|NCT00342628|323715120|FG001|Overall Study|Withdrawal by Subject|19|||
94523918|NCT00342628|323715121|FG002|Overall Study|Withdrawal by Subject|18|||
94523919|NCT00342628|323715119|FG000|Overall Study|Death|1|||
94523920|NCT00342628|323715120|FG001|Overall Study|Death|1|||
94523921|NCT00342628|323715121|FG002|Overall Study|Death|0|||
94523922|NCT00342628|323715119|FG000|Overall Study|moved residence|0|||
94523923|NCT00342628|323715120|FG001|Overall Study|moved residence|1|||
94523924|NCT00342628|323715121|FG002|Overall Study|moved residence|1|||
94523925|NCT04551898|323715122|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
94523926|NCT04551898|323715123|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
94523927|NCT04551898|323715124|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
94523928|NCT04551898|323715125|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
94523929|NCT04551898|323715122|FG000|Overall Study|Withdrawal by Subject|5|||
94523930|NCT04551898|323715123|FG001|Overall Study|Withdrawal by Subject|1|||
94523931|NCT04551898|323715124|FG002|Overall Study|Withdrawal by Subject|2|||
94523932|NCT04551898|323715125|FG003|Overall Study|Withdrawal by Subject|2|||
94523933|NCT04551898|323715122|FG000|Overall Study|Lost to Follow-up|2|||
94523934|NCT04551898|323715123|FG001|Overall Study|Lost to Follow-up|1|||
94523935|NCT04551898|323715124|FG002|Overall Study|Lost to Follow-up|2|||
94523936|NCT04551898|323715125|FG003|Overall Study|Lost to Follow-up|2|||
94523937|NCT04551898|323715122|FG000|Overall Study|Death|1|||
94523938|NCT04551898|323715123|FG001|Overall Study|Death|0|||
94523939|NCT04551898|323715124|FG002|Overall Study|Death|0|||
94523940|NCT04551898|323715125|FG003|Overall Study|Death|0|||
94523941|NCT04551898|323715122|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
94523942|NCT04551898|323715123|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
94523943|NCT04551898|323715124|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
94523944|NCT04551898|323715125|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
94523945|NCT03427814|323715126|FG000|Overall Study|Withdrawal by Subject|4|||
94523946|NCT03427814|323715127|FG001|Overall Study|Withdrawal by Subject|4|||
94523947|NCT03427814|323715126|FG000|Overall Study|Lost to Follow-up|0|||
94523948|NCT03427814|323715127|FG001|Overall Study|Lost to Follow-up|2|||
94523949|NCT03427814|323715126|FG000|Overall Study|Death|42|||
94523950|NCT03427814|323715127|FG001|Overall Study|Death|31|||
94523951|NCT03427814|323715126|FG000|Overall Study|Sponsor's Decision|1|||
94523952|NCT03427814|323715127|FG001|Overall Study|Sponsor's Decision|0|||
94523953|NCT03427814|323715126|FG000|Overall Study|Investigator's Decision|1|||
94523954|NCT03427814|323715127|FG001|Overall Study|Investigator's Decision|2|||
94523955|NCT03427814|323715126|FG000|Overall Study|Disease progression|1|||
94523956|NCT03427814|323715127|FG001|Overall Study|Disease progression|0|||
94523957|NCT03427814|323715126|FG000|Overall Study|Treatment Completed|0|||
94523958|NCT03427814|323715127|FG001|Overall Study|Treatment Completed|1|||
94523959|NCT03427814|323715126|FG000|Overall Study|Sponsor's Decision to End study|21|||
94523960|NCT03427814|323715127|FG001|Overall Study|Sponsor's Decision to End study|25|||
94523961|NCT03427814|323715126|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
94523962|NCT03427814|323715127|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
94523963|NCT03846427|323715128|FG000|Overall Study|Death|13|||
94523964|NCT03846427|323715128|FG000|Overall Study|Withdrawal by Subject|3|||
94523965|NCT03846427|323715128|FG000|Overall Study|Physician Decision|1|||
94523966|NCT01693250|323715129|FG000|Overall Study|Lost to Follow-up|2|||
94523967|NCT01693250|323715130|FG001|Overall Study|Lost to Follow-up|2|||
94523968|NCT00756275|323715133|FG000|Overall Study|Lost to Follow-up|25|||
94523969|NCT00756275|323715134|FG001|Overall Study|Lost to Follow-up|21|||
94523970|NCT00756275|323715133|FG000|Overall Study|Withdrawal by Subject|4|||
94523971|NCT00756275|323715134|FG001|Overall Study|Withdrawal by Subject|7|||
94523972|NCT02257242|323715135|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
94523973|NCT02257242|323715136|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
94523974|NCT02257242|323715137|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
94523975|NCT02257242|323715138|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
94523976|NCT02257242|323715139|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
94523977|NCT02257242|323715140|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
94523978|NCT02257242|323715141|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
94523979|NCT02257242|323715142|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
94523980|NCT02257242|323715143|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
94523981|NCT00551031|323715147|FG000|Overall Study|Adverse Event|0|||
94523982|NCT00551031|323715148|FG001|Overall Study|Adverse Event|1|||
94523983|NCT00551031|323715149|FG002|Overall Study|Adverse Event|0|||
94523984|NCT00551031|323715150|FG003|Overall Study|Adverse Event|0|||
94523985|NCT00551031|323715151|FG004|Overall Study|Adverse Event|0|||
94523986|NCT00551031|323715147|FG000|Overall Study|Protocol Violation|1|||
94523987|NCT00551031|323715148|FG001|Overall Study|Protocol Violation|1|||
94523988|NCT00551031|323715149|FG002|Overall Study|Protocol Violation|0|||
94523989|NCT00551031|323715150|FG003|Overall Study|Protocol Violation|0|||
94523990|NCT00551031|323715151|FG004|Overall Study|Protocol Violation|0|||
94523991|NCT00551031|323715147|FG000|Overall Study|Lost to Follow-up|0|||
94523992|NCT00551031|323715148|FG001|Overall Study|Lost to Follow-up|1|||
94523993|NCT00551031|323715149|FG002|Overall Study|Lost to Follow-up|0|||
94523994|NCT00551031|323715150|FG003|Overall Study|Lost to Follow-up|1|||
94523995|NCT00551031|323715151|FG004|Overall Study|Lost to Follow-up|1|||
94523996|NCT00551031|323715147|FG000|Overall Study|Withdrawal by Subject|0|||
94523997|NCT00551031|323715148|FG001|Overall Study|Withdrawal by Subject|4|||
94523998|NCT00551031|323715149|FG002|Overall Study|Withdrawal by Subject|1|||
94523999|NCT00551031|323715150|FG003|Overall Study|Withdrawal by Subject|2|||
94524000|NCT00551031|323715151|FG004|Overall Study|Withdrawal by Subject|0|||
94524001|NCT00551031|323715147|FG000|Overall Study|Serious Adverse Event|0|||
94524002|NCT00551031|323715148|FG001|Overall Study|Serious Adverse Event|2|||
94524003|NCT00551031|323715149|FG002|Overall Study|Serious Adverse Event|1|||
94524004|NCT00551031|323715150|FG003|Overall Study|Serious Adverse Event|0|||
94524005|NCT00551031|323715151|FG004|Overall Study|Serious Adverse Event|0|||
94524006|NCT00551031|323715147|FG000|Overall Study|Did not receive vaccine|1|||
94524007|NCT00551031|323715148|FG001|Overall Study|Did not receive vaccine|2|||
94524008|NCT00551031|323715149|FG002|Overall Study|Did not receive vaccine|0|||
94524009|NCT00551031|323715150|FG003|Overall Study|Did not receive vaccine|0|||
94524010|NCT00551031|323715151|FG004|Overall Study|Did not receive vaccine|0|||
94524011|NCT04240886|323715156|FG000|Treatment Phase|Death|4|||
94524012|NCT04240886|323715156|FG000|Treatment Phase|Discontinuation by Subject|1|||
94524013|NCT04240886|323715156|FG000|Treatment Phase|Adverse Event|5|||
94524014|NCT04240886|323715156|FG000|Follow-up Phase|Withdrawal by Subject|1|||
94524015|NCT04240886|323715156|FG000|Follow-up Phase|Discontinuation by Subject|1|||
94524016|NCT04240886|323715156|FG000|Follow-up Phase|Death|2|||
94524017|NCT01048242|323715159|FG000|Overall Study|See study flow chart|4|||
94524018|NCT01048242|323715160|FG001|Overall Study|See study flow chart|2|||
94524019|NCT00592631|323715161|FG000|Overall Study|Lost to Follow-up|0|||
94524020|NCT00592631|323715162|FG001|Overall Study|Lost to Follow-up|2|||
94524021|NCT01349673|323715163|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
94524022|NCT01349673|323715163|FG000|Overall Study|No Longer Qualified For Study|1|||
94524023|NCT01349673|323715163|FG000|Overall Study|Site Closure|10|||
94524024|NCT01349673|323715163|FG000|Overall Study|Withdrawal by Subject|21|||
94524025|NCT01349673|323715163|FG000|Overall Study|Lost to Follow-up|6|||
94524026|NCT01349673|323715163|FG000|Overall Study|Adverse Event|17|||
94524027|NCT01349673|323715163|FG000|Overall Study|Study Terminated By Sponsor|50|||
94524028|NCT01349673|323715163|FG000|Overall Study|Lack of Efficacy|8|||
94524029|NCT00833469|323715164|FG000|Overall Study|Withdrawal by Subject|1|||
94524030|NCT00833469|323715164|FG000|Overall Study|Lost to Follow-up|1|||
94524031|NCT02370368|323715167|FG000|Overall Study|Adverse Event|1|||
94524032|NCT02370368|323715168|FG001|Overall Study|Adverse Event|2|||
94524033|NCT02370368|323715167|FG000|Overall Study|Withdrawal by Subject|5|||
94524034|NCT02370368|323715168|FG001|Overall Study|Withdrawal by Subject|4|||
94524035|NCT04512001|323715169|FG000|Week 0 to Week 24|Adverse Event|14|||
94524036|NCT04512001|323715170|FG001|Week 0 to Week 24|Adverse Event|10|||
94524037|NCT04512001|323715171|FG002|Week 0 to Week 24|Adverse Event|0|||
94524038|NCT04512001|323715172|FG003|Week 0 to Week 24|Adverse Event|0|||
94524039|NCT04512001|323715173|FG004|Week 0 to Week 24|Adverse Event|0|||
94524040|NCT04512001|323715169|FG000|Week 0 to Week 24|Death|0|||
94524041|NCT04512001|323715170|FG001|Week 0 to Week 24|Death|2|||
94524042|NCT04512001|323715171|FG002|Week 0 to Week 24|Death|0|||
94524043|NCT04512001|323715172|FG003|Week 0 to Week 24|Death|0|||
94524044|NCT04512001|323715173|FG004|Week 0 to Week 24|Death|0|||
94524045|NCT04512001|323715169|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
94524046|NCT04512001|323715170|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
94524047|NCT04512001|323715171|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
94524048|NCT04512001|323715172|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
94524049|NCT04512001|323715173|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
94524050|NCT04512001|323715169|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
94524051|NCT04512001|323715170|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
94524052|NCT04512001|323715171|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
94524053|NCT04512001|323715172|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
94524054|NCT04512001|323715173|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
94524055|NCT04512001|323715169|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
94524056|NCT04512001|323715170|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
94524057|NCT04512001|323715171|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
94524058|NCT04512001|323715172|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
94524059|NCT04512001|323715173|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
94524060|NCT04512001|323715169|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
94524061|NCT04512001|323715170|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
94524062|NCT04512001|323715171|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
94524063|NCT04512001|323715172|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
94524064|NCT04512001|323715173|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
94524065|NCT04512001|323715169|FG000|Week 24 to Week 63|Adverse Event|0|||
94524066|NCT04512001|323715170|FG001|Week 24 to Week 63|Adverse Event|0|||
94524067|NCT04512001|323715171|FG002|Week 24 to Week 63|Adverse Event|13|||
94524068|NCT04512001|323715172|FG003|Week 24 to Week 63|Adverse Event|8|||
94524069|NCT04512001|323715173|FG004|Week 24 to Week 63|Adverse Event|6|||
94524070|NCT04512001|323715169|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
94524071|NCT04512001|323715170|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
94524072|NCT04512001|323715171|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
94524073|NCT04512001|323715172|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
94524074|NCT04512001|323715173|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
94524075|NCT04512001|323715169|FG000|Week 24 to Week 63|Death|0|||
94524076|NCT04512001|323715170|FG001|Week 24 to Week 63|Death|0|||
94524077|NCT04512001|323715171|FG002|Week 24 to Week 63|Death|0|||
94524078|NCT04512001|323715172|FG003|Week 24 to Week 63|Death|1|||
94524079|NCT04512001|323715173|FG004|Week 24 to Week 63|Death|1|||
94524080|NCT04512001|323715169|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
94524081|NCT04512001|323715170|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
94524082|NCT04512001|323715171|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
94524083|NCT04512001|323715172|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
94524084|NCT04512001|323715173|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
94524085|NCT04512001|323715169|FG000|Week 24 to Week 63|Miscellaneous|0|||
94524086|NCT04512001|323715170|FG001|Week 24 to Week 63|Miscellaneous|0|||
94524087|NCT04512001|323715171|FG002|Week 24 to Week 63|Miscellaneous|3|||
94524088|NCT04512001|323715172|FG003|Week 24 to Week 63|Miscellaneous|2|||
94524089|NCT04512001|323715173|FG004|Week 24 to Week 63|Miscellaneous|1|||
94524090|NCT02776683|323715174|FG000|Pre-switch Period|Protocol Violation|1|||
94524091|NCT02776683|323715175|FG001|Pre-switch Period|Protocol Violation|0|||
94524092|NCT02776683|323715174|FG000|Pre-switch Period|Adverse Event|21|||
94524093|NCT02776683|323715175|FG001|Pre-switch Period|Adverse Event|0|||
94524094|NCT02776683|323715174|FG000|Pre-switch Period|Withdrawal by Subject|9|||
94524095|NCT02776683|323715175|FG001|Pre-switch Period|Withdrawal by Subject|0|||
94524096|NCT02776683|323715174|FG000|Pre-switch Period|Physician Decision|7|||
94524097|NCT02776683|323715175|FG001|Pre-switch Period|Physician Decision|0|||
94524098|NCT02776683|323715174|FG000|Pre-switch Period|Progressive disease|39|||
94524099|NCT02776683|323715175|FG001|Pre-switch Period|Progressive disease|0|||
94524100|NCT02776683|323715174|FG000|Pre-switch Period|Other than listed|3|||
94524101|NCT02776683|323715175|FG001|Pre-switch Period|Other than listed|0|||
94524102|NCT02776683|323715174|FG000|Post-switch Period|Adverse Event|0|||
94524103|NCT02776683|323715175|FG001|Post-switch Period|Adverse Event|3|||
94524104|NCT02776683|323715174|FG000|Post-switch Period|Withdrawal by Subject|0|||
94524105|NCT02776683|323715175|FG001|Post-switch Period|Withdrawal by Subject|2|||
94524106|NCT02776683|323715174|FG000|Post-switch Period|Physician Decision|0|||
94524107|NCT02776683|323715175|FG001|Post-switch Period|Physician Decision|3|||
94524108|NCT02776683|323715174|FG000|Post-switch Period|Progressive disease|0|||
94524109|NCT02776683|323715175|FG001|Post-switch Period|Progressive disease|20|||
94524110|NCT02776683|323715174|FG000|Post-switch Period|Other than listed|0|||
94524111|NCT02776683|323715175|FG001|Post-switch Period|Other than listed|15|||
94524112|NCT01724216|323715176|FG000|Overall Study|Scan was not completed|1|||
94524113|NCT03198767|323715177|FG000|Overall Study|Protocol Violation|0|||
94524114|NCT03198767|323715178|FG001|Overall Study|Protocol Violation|0|||
94524115|NCT03198767|323715179|FG002|Overall Study|Protocol Violation|0|||
94524116|NCT03198767|323715180|FG003|Overall Study|Protocol Violation|6|||
94524117|NCT03198767|323715181|FG004|Overall Study|Protocol Violation|0|||
94524118|NCT03198767|323715182|FG005|Overall Study|Protocol Violation|0|||
94524119|NCT03198767|323715183|FG006|Overall Study|Protocol Violation|0|||
94524120|NCT01891396|323715184|FG000|Overall Study|Withdrawal by Subject|4|||
94524121|NCT01891396|323715185|FG001|Overall Study|Withdrawal by Subject|4|||
94524122|NCT01891396|323715186|FG002|Overall Study|Withdrawal by Subject|3|||
94524123|NCT01891396|323715184|FG000|Overall Study|Lost to Follow-up|0|||
94524124|NCT01891396|323715185|FG001|Overall Study|Lost to Follow-up|1|||
94524125|NCT01891396|323715186|FG002|Overall Study|Lost to Follow-up|0|||
94524126|NCT00540592|323715187|FG000|Overall Study|Adverse Event|0|||
94524127|NCT00540592|323715188|FG001|Overall Study|Adverse Event|1|||
94524128|NCT00540592|323715189|FG002|Overall Study|Adverse Event|0|||
94524129|NCT00540592|323715190|FG003|Overall Study|Adverse Event|0|||
94524130|NCT00540592|323715191|FG004|Overall Study|Adverse Event|1|||
94524131|NCT00540592|323715192|FG005|Overall Study|Adverse Event|0|||
94524132|NCT00540592|323715193|FG006|Overall Study|Adverse Event|0|||
94524133|NCT00540592|323715194|FG007|Overall Study|Adverse Event|1|||
94524134|NCT00540592|323715195|FG008|Overall Study|Adverse Event|1|||
94524135|NCT00540592|323715196|FG009|Overall Study|Adverse Event|2|||
94524136|NCT00540592|323715187|FG000|Overall Study|Lost to Follow-up|2|||
94524137|NCT00540592|323715188|FG001|Overall Study|Lost to Follow-up|0|||
94524138|NCT00540592|323715189|FG002|Overall Study|Lost to Follow-up|0|||
94524139|NCT00540592|323715190|FG003|Overall Study|Lost to Follow-up|0|||
94524140|NCT00540592|323715191|FG004|Overall Study|Lost to Follow-up|0|||
94524141|NCT00540592|323715192|FG005|Overall Study|Lost to Follow-up|0|||
94524142|NCT00540592|323715193|FG006|Overall Study|Lost to Follow-up|0|||
94524143|NCT00540592|323715194|FG007|Overall Study|Lost to Follow-up|0|||
94524144|NCT00540592|323715195|FG008|Overall Study|Lost to Follow-up|0|||
94524145|NCT00540592|323715196|FG009|Overall Study|Lost to Follow-up|0|||
94524146|NCT00540592|323715187|FG000|Overall Study|Withdrawal by Subject|0|||
94524147|NCT00540592|323715188|FG001|Overall Study|Withdrawal by Subject|0|||
94524148|NCT00540592|323715189|FG002|Overall Study|Withdrawal by Subject|1|||
94524149|NCT00540592|323715190|FG003|Overall Study|Withdrawal by Subject|1|||
94524150|NCT00540592|323715191|FG004|Overall Study|Withdrawal by Subject|0|||
94524151|NCT00540592|323715192|FG005|Overall Study|Withdrawal by Subject|0|||
94524152|NCT00540592|323715193|FG006|Overall Study|Withdrawal by Subject|0|||
94524153|NCT00540592|323715194|FG007|Overall Study|Withdrawal by Subject|0|||
94524154|NCT00540592|323715195|FG008|Overall Study|Withdrawal by Subject|0|||
94524155|NCT00540592|323715196|FG009|Overall Study|Withdrawal by Subject|0|||
94524156|NCT03782064|323715197|FG000|Overall Study|Lack of Efficacy|2|||
94524157|NCT03782064|323715197|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
94524158|NCT02948582|323715198|FG000|Washout Period 1|Adverse Event|0|||
94524159|NCT02948582|323715199|FG001|Washout Period 1|Adverse Event|2|||
94524160|NCT02948582|323715200|FG002|Washout Period 1|Adverse Event|0|||
94524161|NCT02948582|323715201|FG003|Washout Period 1|Adverse Event|0|||
94524162|NCT02948582|323715202|FG004|Washout Period 1|Adverse Event|0|||
94524163|NCT02948582|323715203|FG005|Washout Period 1|Adverse Event|0|||
94524164|NCT02948582|323715198|FG000|Washout Period 1|Protocol Violation|0|||
94524165|NCT02948582|323715199|FG001|Washout Period 1|Protocol Violation|0|||
94524166|NCT02948582|323715200|FG002|Washout Period 1|Protocol Violation|0|||
94524167|NCT02948582|323715201|FG003|Washout Period 1|Protocol Violation|0|||
94524168|NCT02948582|323715202|FG004|Washout Period 1|Protocol Violation|0|||
94524169|NCT02948582|323715203|FG005|Washout Period 1|Protocol Violation|1|||
94524170|NCT02948582|323715198|FG000|Washout Period 2|Adverse Event|0|||
94524171|NCT02948582|323715199|FG001|Washout Period 2|Adverse Event|1|||
94524172|NCT02948582|323715200|FG002|Washout Period 2|Adverse Event|0|||
94524173|NCT02948582|323715201|FG003|Washout Period 2|Adverse Event|0|||
94524174|NCT02948582|323715202|FG004|Washout Period 2|Adverse Event|0|||
94524175|NCT02948582|323715203|FG005|Washout Period 2|Adverse Event|0|||
94524176|NCT02948582|323715198|FG000|Washout Period 2|personal reasons|0|||
94524177|NCT02948582|323715199|FG001|Washout Period 2|personal reasons|0|||
94524178|NCT02948582|323715200|FG002|Washout Period 2|personal reasons|0|||
94524179|NCT02948582|323715201|FG003|Washout Period 2|personal reasons|1|||
94524180|NCT02948582|323715202|FG004|Washout Period 2|personal reasons|0|||
94524181|NCT02948582|323715203|FG005|Washout Period 2|personal reasons|0|||
94524182|NCT02948582|323715198|FG000|Washout Period 4|Adverse Event|1|||
94524183|NCT02948582|323715199|FG001|Washout Period 4|Adverse Event|0|||
94524184|NCT02948582|323715200|FG002|Washout Period 4|Adverse Event|1|||
94524185|NCT02948582|323715201|FG003|Washout Period 4|Adverse Event|0|||
94524186|NCT02948582|323715202|FG004|Washout Period 4|Adverse Event|0|||
94524187|NCT02948582|323715203|FG005|Washout Period 4|Adverse Event|0|||
94524188|NCT02041299|323715204|FG000|Overall Study|Adverse Event|9|||
94524189|NCT02041299|323715205|FG001|Overall Study|Adverse Event|3|||
94524190|NCT02041299|323715204|FG000|Overall Study|Lost to Follow-up|4|||
94524191|NCT02041299|323715205|FG001|Overall Study|Lost to Follow-up|1|||
94524192|NCT02041299|323715204|FG000|Overall Study|Physician Decision|1|||
94524193|NCT02041299|323715205|FG001|Overall Study|Physician Decision|1|||
94524194|NCT02041299|323715204|FG000|Overall Study|Withdrawal by Subject|13|||
94524195|NCT02041299|323715205|FG001|Overall Study|Withdrawal by Subject|7|||
94524196|NCT02041299|323715204|FG000|Overall Study|Protocol Violation|11|||
94524197|NCT02041299|323715205|FG001|Overall Study|Protocol Violation|4|||
94524198|NCT02041299|323715204|FG000|Overall Study|Termination of the study|7|||
94524199|NCT02041299|323715205|FG001|Overall Study|Termination of the study|3|||
94524200|NCT02041299|323715204|FG000|Overall Study|Required bone marrow transplant|0|||
94524201|NCT02041299|323715205|FG001|Overall Study|Required bone marrow transplant|1|||
94524202|NCT02041299|323715204|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
94524203|NCT02041299|323715205|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
94524204|NCT02389465|323715206|FG000|Overall Study|Lost to Follow-up|1|||
94524205|NCT02389465|323715207|FG001|Overall Study|Lost to Follow-up|3|||
94524206|NCT02389465|323715208|FG002|Overall Study|Lost to Follow-up|3|||
94524207|NCT02389465|323715209|FG003|Overall Study|Lost to Follow-up|0|||
94524208|NCT02389465|323715206|FG000|Overall Study|Physician Decision|0|||
94524209|NCT02389465|323715207|FG001|Overall Study|Physician Decision|0|||
94524210|NCT02389465|323715208|FG002|Overall Study|Physician Decision|0|||
94524211|NCT02389465|323715209|FG003|Overall Study|Physician Decision|1|||
94524212|NCT02389465|323715206|FG000|Overall Study|Withdrawal by Subject|0|||
94524213|NCT02389465|323715207|FG001|Overall Study|Withdrawal by Subject|1|||
94524214|NCT02389465|323715208|FG002|Overall Study|Withdrawal by Subject|2|||
94524215|NCT02389465|323715209|FG003|Overall Study|Withdrawal by Subject|2|||
94524216|NCT00997984|323715213|FG000|Overall Study|Adverse Event|1|||
94524217|NCT00997984|323715214|FG001|Overall Study|Adverse Event|8|||
94524218|NCT00997984|323715215|FG002|Overall Study|Adverse Event|8|||
94524219|NCT00997984|323715213|FG000|Overall Study|Protocol Violation|1|||
94524220|NCT00997984|323715214|FG001|Overall Study|Protocol Violation|3|||
94524221|NCT00997984|323715215|FG002|Overall Study|Protocol Violation|0|||
94524222|NCT00997984|323715213|FG000|Overall Study|Withdrawal by Subject|6|||
94524223|NCT00997984|323715214|FG001|Overall Study|Withdrawal by Subject|9|||
94524224|NCT00997984|323715215|FG002|Overall Study|Withdrawal by Subject|5|||
94524225|NCT00997984|323715213|FG000|Overall Study|Lost to Follow-up|8|||
94524226|NCT00997984|323715214|FG001|Overall Study|Lost to Follow-up|5|||
94524227|NCT00997984|323715215|FG002|Overall Study|Lost to Follow-up|4|||
94524228|NCT00997984|323715213|FG000|Overall Study|Lack of Efficacy|20|||
94524229|NCT00997984|323715214|FG001|Overall Study|Lack of Efficacy|6|||
94524230|NCT00997984|323715215|FG002|Overall Study|Lack of Efficacy|3|||
94524231|NCT00997984|323715213|FG000|Overall Study|Met exclusion criteria|1|||
94524232|NCT00997984|323715214|FG001|Overall Study|Met exclusion criteria|0|||
94524233|NCT00997984|323715215|FG002|Overall Study|Met exclusion criteria|0|||
94524234|NCT00997984|323715213|FG000|Overall Study|non-compliance|0|||
94524235|NCT00997984|323715214|FG001|Overall Study|non-compliance|2|||
94524236|NCT00997984|323715215|FG002|Overall Study|non-compliance|3|||
94524237|NCT00997984|323715213|FG000|Overall Study|Wrong medication dispensed|0|||
94524238|NCT00997984|323715214|FG001|Overall Study|Wrong medication dispensed|1|||
94524239|NCT00997984|323715215|FG002|Overall Study|Wrong medication dispensed|0|||
94524240|NCT00997984|323715213|FG000|Overall Study|Suicidal ideation|0|||
94524241|NCT00997984|323715214|FG001|Overall Study|Suicidal ideation|0|||
94524242|NCT00997984|323715215|FG002|Overall Study|Suicidal ideation|1|||
94524243|NCT00997984|323715213|FG000|Overall Study|Work schedule|0|||
94524244|NCT00997984|323715214|FG001|Overall Study|Work schedule|0|||
94524245|NCT00997984|323715215|FG002|Overall Study|Work schedule|2|||
94524246|NCT02997865|323715216|FG000|Overall Study|Death|2|||
94524247|NCT02997865|323715217|FG001|Overall Study|Death|1|||
94524248|NCT02997865|323715216|FG000|Overall Study|Lost to Follow-up|6|||
94524249|NCT02997865|323715217|FG001|Overall Study|Lost to Follow-up|3|||
94524250|NCT02997865|323715216|FG000|Overall Study|Withdrawal by Subject|5|||
94524251|NCT02997865|323715217|FG001|Overall Study|Withdrawal by Subject|0|||
94524252|NCT02528942|323715220|FG000|Overall Study|Did not meet imaging criteria|9|||
94524253|NCT02528942|323715220|FG000|Overall Study|Lost to Follow-up|25|||
94524254|NCT03386435|323715221|FG000|Overall Study|Protocol Violation|5|||
94524255|NCT03386435|323715222|FG001|Overall Study|Protocol Violation|7|||
94524256|NCT03542266|323715223|FG000|Treatment Phase|Withdrawal by Subject|1|||
94524257|NCT03542266|323715223|FG000|Treatment Phase|Adverse Event|1|||
94524258|NCT03542266|323715223|FG000|Treatment Phase|PD|1|||
94524259|NCT01637584|323715224|FG000|Overall Study|Withdrawal by Subject|1|||
94524260|NCT01637584|323715225|FG001|Overall Study|Withdrawal by Subject|3|||
94524261|NCT01393899|323715229|FG000|Overall Study|Study terminated by sponsor|1|||
94524262|NCT01393899|323715230|FG001|Overall Study|Study terminated by sponsor|0|||
94524263|NCT01393899|323715231|FG002|Overall Study|Study terminated by sponsor|1|||
94524264|NCT01393899|323715229|FG000|Overall Study|Other|1|||
94524265|NCT01393899|323715230|FG001|Overall Study|Other|0|||
94524266|NCT01393899|323715231|FG002|Overall Study|Other|0|||
94524267|NCT01393899|323715229|FG000|Overall Study|Withdrawal by Subject|2|||
94524268|NCT01393899|323715230|FG001|Overall Study|Withdrawal by Subject|2|||
94524269|NCT01393899|323715231|FG002|Overall Study|Withdrawal by Subject|1|||
94524270|NCT01393899|323715229|FG000|Overall Study|Lost to Follow-up|0|||
94524271|NCT01393899|323715230|FG001|Overall Study|Lost to Follow-up|0|||
94524272|NCT01393899|323715231|FG002|Overall Study|Lost to Follow-up|1|||
94524273|NCT01393899|323715229|FG000|Overall Study|Does not meet entrance criteria|1|||
94524274|NCT01393899|323715230|FG001|Overall Study|Does not meet entrance criteria|0|||
94524275|NCT01393899|323715231|FG002|Overall Study|Does not meet entrance criteria|1|||
94524276|NCT01393899|323715229|FG000|Overall Study|Lack of Efficacy|26|||
94524277|NCT01393899|323715230|FG001|Overall Study|Lack of Efficacy|21|||
94524278|NCT01393899|323715231|FG002|Overall Study|Lack of Efficacy|16|||
94524279|NCT01393899|323715229|FG000|Overall Study|Adverse Event|1|||
94524280|NCT01393899|323715230|FG001|Overall Study|Adverse Event|5|||
94524281|NCT01393899|323715231|FG002|Overall Study|Adverse Event|3|||
94524282|NCT02534883|323715236|FG000|Overall Study|Early Termination|8|||
94524283|NCT02534883|323715237|FG001|Overall Study|Early Termination|3|||
94524284|NCT00886769|323715238|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
94524285|NCT00886769|323715239|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
94524286|NCT00132301|323715243|FG000|Overall Study|Death|7|||
94524287|NCT00132301|323715244|FG001|Overall Study|Death|6|||
94524288|NCT00132301|323715243|FG000|Overall Study|Withdrawal by Subject|5|||
94524289|NCT00132301|323715244|FG001|Overall Study|Withdrawal by Subject|2|||
94524290|NCT00132301|323715243|FG000|Overall Study|Physician Decision|1|||
94524291|NCT00132301|323715244|FG001|Overall Study|Physician Decision|1|||
94524292|NCT00132301|323715243|FG000|Overall Study|Lost to Follow-up|5|||
94524293|NCT00132301|323715244|FG001|Overall Study|Lost to Follow-up|3|||
94524294|NCT00132301|323715243|FG000|Overall Study|Other|1|||
94524295|NCT00132301|323715244|FG001|Overall Study|Other|1|||
94524296|NCT00132301|323715243|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
94524297|NCT00132301|323715244|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
94524298|NCT02012218|323715245|FG000|Overall Study|Withdrawal by Subject|1|||
94524299|NCT02012218|323715246|FG001|Overall Study|Withdrawal by Subject|0|||
94524300|NCT02012218|323715247|FG002|Overall Study|Withdrawal by Subject|1|||
94524301|NCT02012218|323715248|FG003|Overall Study|Withdrawal by Subject|1|||
94524302|NCT02012218|323715249|FG004|Overall Study|Withdrawal by Subject|1|||
94524303|NCT02012218|323715245|FG000|Overall Study|Adverse Event|1|||
94524304|NCT02012218|323715246|FG001|Overall Study|Adverse Event|0|||
94524305|NCT02012218|323715247|FG002|Overall Study|Adverse Event|0|||
94524306|NCT02012218|323715248|FG003|Overall Study|Adverse Event|1|||
94524307|NCT02012218|323715249|FG004|Overall Study|Adverse Event|0|||
94524308|NCT02012218|323715245|FG000|Overall Study|Lost to Follow-up|0|||
94524309|NCT02012218|323715246|FG001|Overall Study|Lost to Follow-up|1|||
94524310|NCT02012218|323715247|FG002|Overall Study|Lost to Follow-up|1|||
94524311|NCT02012218|323715248|FG003|Overall Study|Lost to Follow-up|0|||
94524312|NCT02012218|323715249|FG004|Overall Study|Lost to Follow-up|0|||
94524313|NCT02012218|323715245|FG000|Overall Study|Protocol Specified|1|||
94524314|NCT02012218|323715246|FG001|Overall Study|Protocol Specified|0|||
94524315|NCT02012218|323715247|FG002|Overall Study|Protocol Specified|0|||
94524316|NCT02012218|323715248|FG003|Overall Study|Protocol Specified|0|||
94524317|NCT02012218|323715249|FG004|Overall Study|Protocol Specified|0|||
94524318|NCT02012218|323715245|FG000|Overall Study|Protocol Deviation|1|||
94524319|NCT02012218|323715246|FG001|Overall Study|Protocol Deviation|0|||
94524320|NCT02012218|323715247|FG002|Overall Study|Protocol Deviation|0|||
94524321|NCT02012218|323715248|FG003|Overall Study|Protocol Deviation|0|||
94524322|NCT02012218|323715249|FG004|Overall Study|Protocol Deviation|0|||
94524323|NCT02375373|323715258|FG000|Overall Study|Withdrawal by Subject|11|||
94524324|NCT01445613|323715259|FG000|30-day Follow-up|Withdrawal by Subject|6|||
94524325|NCT01445613|323715259|FG000|30-day Follow-up|Physician Decision|3|||
94524326|NCT01445613|323715259|FG000|30-day Follow-up|Missed visit|23|||
94524327|NCT01445613|323715259|FG000|30-day Follow-up|Death|3|||
94524328|NCT01445613|323715259|FG000|1-year Follow-up|Withdrawal by Subject|12|||
94524329|NCT01445613|323715259|FG000|1-year Follow-up|Missed visit|29|||
94524330|NCT01445613|323715259|FG000|1-year Follow-up|Lost to Follow-up|2|||
94524331|NCT01445613|323715259|FG000|1-year Follow-up|Death|30|||
94524332|NCT01445613|323715259|FG000|1-year Follow-up|Physician Decision|2|||
94524333|NCT01445613|323715259|FG000|1-year Follow-up|Received a non-study stent|2|||
94524334|NCT01603043|323715260|FG000|Overall Study|Study Futility|7|||
94524335|NCT01603043|323715261|FG001|Overall Study|Study Futility|3|||
94524336|NCT04162470|323715264|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
94524337|NCT03941483|323715266|FG000|Overall Study|Miscellaneous|2|||
94524338|NCT03941483|323715267|FG001|Overall Study|Miscellaneous|3|||
94524339|NCT03941483|323715268|FG002|Overall Study|Miscellaneous|0|||
94524340|NCT03941483|323715266|FG000|Overall Study|Study Terminated by Sponsor|1|||
94524341|NCT03941483|323715267|FG001|Overall Study|Study Terminated by Sponsor|0|||
94524342|NCT03941483|323715268|FG002|Overall Study|Study Terminated by Sponsor|0|||
94524343|NCT03941483|323715266|FG000|Overall Study|Withdrawal by Subject|1|||
94524344|NCT03941483|323715267|FG001|Overall Study|Withdrawal by Subject|4|||
94524345|NCT03941483|323715268|FG002|Overall Study|Withdrawal by Subject|1|||
94524346|NCT03941483|323715266|FG000|Overall Study|Lost to Follow-up|2|||
94524347|NCT03941483|323715267|FG001|Overall Study|Lost to Follow-up|1|||
94524348|NCT03941483|323715268|FG002|Overall Study|Lost to Follow-up|8|||
94524349|NCT03941483|323715266|FG000|Overall Study|Death|3|||
94524350|NCT03941483|323715267|FG001|Overall Study|Death|2|||
94524351|NCT03941483|323715268|FG002|Overall Study|Death|6|||
94524352|NCT04790279|323716916|FG000|Overall Study|Did not meet medication start criteria|27|||
94524353|NCT04790279|323716917|FG001|Overall Study|Did not meet medication start criteria|15|||
94524354|NCT04790279|323716916|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
94524355|NCT04790279|323716917|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
94524356|NCT04790279|323716916|FG000|Overall Study|Protocol Violation|8|||
94524357|NCT04790279|323716917|FG001|Overall Study|Protocol Violation|3|||
94524358|NCT04790279|323716916|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
94524359|NCT04790279|323716917|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
94524360|NCT00810277|323716930|FG000|Overall Study|Adverse Event|1|||
94524361|NCT00678288|323716933|FG000|Overall Study|Adverse Event|0|||
94524362|NCT00678288|323716934|FG001|Overall Study|Adverse Event|2|||
94524363|NCT00678288|323716933|FG000|Overall Study|Withdrawal by Subject|1|||
94524364|NCT00678288|323716934|FG001|Overall Study|Withdrawal by Subject|1|||
94524365|NCT00678288|323716933|FG000|Overall Study|Study terminated by the sponsor|2|||
94524366|NCT00678288|323716934|FG001|Overall Study|Study terminated by the sponsor|0|||
94524367|NCT00678288|323716933|FG000|Overall Study|Not compliant with study medication|0|||
94524368|NCT00678288|323716934|FG001|Overall Study|Not compliant with study medication|1|||
94524369|NCT00678288|323716933|FG000|Overall Study|Switch to commercial drug|0|||
94524370|NCT00678288|323716934|FG001|Overall Study|Switch to commercial drug|1|||
94524371|NCT00678288|323716933|FG000|Overall Study|Reason not reported|1|||
94524372|NCT00678288|323716934|FG001|Overall Study|Reason not reported|0|||
94524373|NCT00678288|323716933|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
94524374|NCT00678288|323716934|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
94524375|NCT01336712|323716945|FG000|Overall Study|Death|2|||
94524376|NCT01336712|323716945|FG000|Overall Study|Lack of Efficacy|1|||
94524377|NCT01061723|323716946|FG000|Overall Study|Adverse Event|0|||
94524378|NCT01061723|323716947|FG001|Overall Study|Adverse Event|2|||
94524379|NCT01061723|323716948|FG002|Overall Study|Adverse Event|5|||
94524380|NCT01061723|323716949|FG003|Overall Study|Adverse Event|5|||
94524381|NCT01061723|323716950|FG004|Overall Study|Adverse Event|2|||
94524382|NCT01061723|323716951|FG005|Overall Study|Adverse Event|6|||
94524383|NCT01061723|323716946|FG000|Overall Study|Lack of Efficacy|2|||
94524384|NCT01061723|323716947|FG001|Overall Study|Lack of Efficacy|3|||
94524385|NCT01061723|323716948|FG002|Overall Study|Lack of Efficacy|4|||
94524386|NCT01061723|323716949|FG003|Overall Study|Lack of Efficacy|2|||
94524387|NCT01061723|323716950|FG004|Overall Study|Lack of Efficacy|1|||
94524388|NCT01061723|323716951|FG005|Overall Study|Lack of Efficacy|1|||
94524389|NCT01061723|323716946|FG000|Overall Study|Randomized but not treated|0|||
94524390|NCT01061723|323716947|FG001|Overall Study|Randomized but not treated|0|||
94524391|NCT01061723|323716948|FG002|Overall Study|Randomized but not treated|0|||
94524392|NCT01061723|323716949|FG003|Overall Study|Randomized but not treated|0|||
94524393|NCT01061723|323716950|FG004|Overall Study|Randomized but not treated|0|||
94524394|NCT01061723|323716951|FG005|Overall Study|Randomized but not treated|1|||
94524395|NCT01061723|323716946|FG000|Overall Study|Other than specified above|2|||
94524396|NCT01061723|323716947|FG001|Overall Study|Other than specified above|1|||
94524397|NCT01061723|323716948|FG002|Overall Study|Other than specified above|1|||
94524398|NCT01061723|323716949|FG003|Overall Study|Other than specified above|1|||
94524399|NCT01061723|323716950|FG004|Overall Study|Other than specified above|0|||
94524400|NCT01061723|323716951|FG005|Overall Study|Other than specified above|1|||
94524401|NCT00078806|323716956|FG000|Part 1A|Adverse Event|2|||
94524402|NCT00078806|323716957|FG001|Part 1A|Adverse Event|0|||
94524403|NCT00078806|323716958|FG002|Part 1A|Adverse Event|0|||
94524404|NCT00078806|323716959|FG003|Part 1A|Adverse Event|0|||
94524405|NCT00078806|323716956|FG000|Part 1A|Lack of Efficacy|7|||
94524406|NCT00078806|323716957|FG001|Part 1A|Lack of Efficacy|0|||
94524407|NCT00078806|323716958|FG002|Part 1A|Lack of Efficacy|0|||
94524408|NCT00078806|323716959|FG003|Part 1A|Lack of Efficacy|0|||
94524409|NCT00078806|323716956|FG000|Part 1A|Other|1|||
94524410|NCT00078806|323716957|FG001|Part 1A|Other|0|||
94524411|NCT00078806|323716958|FG002|Part 1A|Other|0|||
94524412|NCT00078806|323716959|FG003|Part 1A|Other|0|||
94524413|NCT00078806|323716956|FG000|Part 1B|Adverse Event|1|||
94524414|NCT00078806|323716957|FG001|Part 1B|Adverse Event|0|||
94524415|NCT00078806|323716958|FG002|Part 1B|Adverse Event|0|||
94524416|NCT00078806|323716959|FG003|Part 1B|Adverse Event|0|||
94524417|NCT00078806|323716956|FG000|Part 1B|Lack of Efficacy|7|||
94524418|NCT00078806|323716957|FG001|Part 1B|Lack of Efficacy|0|||
94524419|NCT00078806|323716958|FG002|Part 1B|Lack of Efficacy|0|||
94524420|NCT00078806|323716959|FG003|Part 1B|Lack of Efficacy|0|||
94524421|NCT00078806|323716956|FG000|Part 2|Adverse Event|0|||
94524422|NCT00078806|323716957|FG001|Part 2|Adverse Event|1|||
94524423|NCT00078806|323716958|FG002|Part 2|Adverse Event|0|||
94524424|NCT00078806|323716959|FG003|Part 2|Adverse Event|0|||
94524425|NCT00841776|323716960|FG000|Overall Study|Lack of Efficacy|0|||
94524426|NCT00841776|323716961|FG001|Overall Study|Lack of Efficacy|1|||
94524427|NCT00841776|323716960|FG000|Overall Study|Lost to Follow-up|2|||
94524428|NCT00841776|323716961|FG001|Overall Study|Lost to Follow-up|1|||
94524429|NCT00841776|323716960|FG000|Overall Study|Withdrawal by Subject|0|||
94524430|NCT00841776|323716961|FG001|Overall Study|Withdrawal by Subject|1|||
94524431|NCT04245449|323716962|FG000|Overall Study|COVID shutdown|7|||
94524432|NCT01408277|323716963|FG000|Overall Study|Adverse Event|3|||
94524433|NCT01408277|323716964|FG001|Overall Study|Adverse Event|4|||
94524434|NCT01408277|323716963|FG000|Overall Study|Lost to Follow-up|1|||
94524435|NCT01408277|323716964|FG001|Overall Study|Lost to Follow-up|0|||
94524436|NCT01408277|323716963|FG000|Overall Study|Withdrawal by Subject|2|||
94524437|NCT01408277|323716964|FG001|Overall Study|Withdrawal by Subject|0|||
94524438|NCT01408277|323716963|FG000|Overall Study|Protocol Violation|2|||
94524439|NCT01408277|323716964|FG001|Overall Study|Protocol Violation|0|||
94524440|NCT01456130|323716968|FG000|Overall Study|Adverse Event|4|||
94524441|NCT01456130|323716968|FG000|Overall Study|Voluntary Withdrawal|1|||
94524442|NCT01456130|323716968|FG000|Overall Study|Lack of Efficacy|4|||
94524443|NCT01456130|323716968|FG000|Overall Study|Other|1|||
94524444|NCT00400517|323716969|FG000|Overall Study|Withdrawal by Subject|1|||
94524445|NCT00400517|323716969|FG000|Overall Study|Physician Decision|1|||
94524446|NCT01194219|323716970|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
94524447|NCT01194219|323716971|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
94524448|NCT01194219|323716972|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
94524449|NCT01194219|323716973|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
94524450|NCT01194219|323716974|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
94524451|NCT01194219|323716975|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
94524452|NCT01194219|323716976|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
94524453|NCT01194219|323716977|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
94524454|NCT01194219|323716978|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
94524455|NCT01194219|323716979|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
94524456|NCT01194219|323716970|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
94524457|NCT01194219|323716971|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
94524458|NCT01194219|323716972|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
94524459|NCT01194219|323716973|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
94524460|NCT01194219|323716974|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
94524461|NCT01194219|323716975|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
94524462|NCT01194219|323716976|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
94524463|NCT01194219|323716977|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
94524464|NCT01194219|323716978|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
94524465|NCT01194219|323716979|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
94524466|NCT01194219|323716970|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
94524467|NCT01194219|323716971|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
94524468|NCT01194219|323716972|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
94524469|NCT01194219|323716973|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
94524470|NCT01194219|323716974|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
94524471|NCT01194219|323716975|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
94524472|NCT01194219|323716976|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
94524473|NCT01194219|323716977|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
94524474|NCT01194219|323716978|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
94524475|NCT01194219|323716979|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
94524476|NCT01194219|323716970|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
94524477|NCT01194219|323716971|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
94524478|NCT01194219|323716972|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
94524479|NCT01194219|323716973|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
94524480|NCT01194219|323716974|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
94524481|NCT01194219|323716975|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
94524482|NCT01194219|323716976|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
94524483|NCT01194219|323716977|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
94524484|NCT01194219|323716978|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
94524485|NCT01194219|323716979|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
94524486|NCT01194219|323716970|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
94524487|NCT01194219|323716971|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
94524488|NCT01194219|323716972|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
94524489|NCT01194219|323716973|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
94524490|NCT01194219|323716974|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
94524491|NCT01194219|323716975|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
94524492|NCT01194219|323716976|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
94524493|NCT01194219|323716977|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
94524494|NCT01194219|323716978|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
94524495|NCT01194219|323716979|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
94524496|NCT01194219|323716970|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
94524497|NCT01194219|323716971|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
94524498|NCT01194219|323716972|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
94524499|NCT01194219|323716973|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
94524500|NCT01194219|323716974|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
94524501|NCT01194219|323716975|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
94524502|NCT01194219|323716976|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
94524503|NCT01194219|323716977|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
94524504|NCT01194219|323716978|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
94524505|NCT01194219|323716979|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
94524506|NCT01194219|323716970|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
94524507|NCT01194219|323716971|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
94524508|NCT01194219|323716972|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
94524509|NCT01194219|323716973|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
94524510|NCT01194219|323716974|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
94524511|NCT01194219|323716975|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
94524512|NCT01194219|323716976|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
94524513|NCT01194219|323716977|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
94524514|NCT01194219|323716978|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
94524515|NCT01194219|323716979|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
94524516|NCT01194219|323716970|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
94524517|NCT01194219|323716971|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
94524518|NCT01194219|323716972|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
94524519|NCT01194219|323716973|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
94524520|NCT01194219|323716974|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
94524521|NCT01194219|323716975|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
94524522|NCT01194219|323716976|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
94524523|NCT01194219|323716977|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
94524524|NCT01194219|323716978|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
94524525|NCT01194219|323716979|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
94524526|NCT01194219|323716970|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
94524527|NCT01194219|323716971|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
94524528|NCT01194219|323716972|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
94524529|NCT01194219|323716973|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
94524530|NCT01194219|323716974|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
94524531|NCT01194219|323716975|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
94524532|NCT01194219|323716976|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
94524533|NCT01194219|323716977|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
94524534|NCT01194219|323716978|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
94524535|NCT01194219|323716979|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
94524536|NCT01194219|323716970|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
94524537|NCT01194219|323716971|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
94524538|NCT01194219|323716972|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
94524539|NCT01194219|323716973|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
94524540|NCT01194219|323716974|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
94524541|NCT01194219|323716975|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
94524542|NCT01194219|323716976|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
94524543|NCT01194219|323716977|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
94524544|NCT01194219|323716978|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
94524545|NCT01194219|323716979|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
94524546|NCT01194219|323716970|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
94524547|NCT01194219|323716971|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
94524548|NCT01194219|323716972|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
94524549|NCT01194219|323716973|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
94524550|NCT01194219|323716974|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
94524551|NCT01194219|323716975|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
94524552|NCT01194219|323716976|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
94524553|NCT01194219|323716977|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
94524554|NCT01194219|323716978|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
94524555|NCT01194219|323716979|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
94524556|NCT01194219|323716970|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
94524557|NCT01194219|323716971|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
94524558|NCT01194219|323716972|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
94524559|NCT01194219|323716973|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
94524560|NCT01194219|323716974|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
94524561|NCT01194219|323716975|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
94524562|NCT01194219|323716976|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
94524563|NCT01194219|323716977|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
94524564|NCT01194219|323716978|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
94524565|NCT01194219|323716979|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
94524566|NCT01194219|323716970|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
94524567|NCT01194219|323716971|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
94524568|NCT01194219|323716972|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
94524569|NCT01194219|323716973|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
94524570|NCT01194219|323716974|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
94524571|NCT01194219|323716975|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
94524572|NCT01194219|323716976|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
94524573|NCT01194219|323716977|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
94524574|NCT01194219|323716978|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
94524575|NCT01194219|323716979|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
94524576|NCT01194219|323716970|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
94524577|NCT01194219|323716971|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
94524578|NCT01194219|323716972|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
94524579|NCT01194219|323716973|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
94524580|NCT01194219|323716974|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
94524581|NCT01194219|323716975|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
94524582|NCT01194219|323716976|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
94524583|NCT01194219|323716977|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
94524584|NCT01194219|323716978|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
94524585|NCT01194219|323716979|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
94524586|NCT01194219|323716970|FG000|Maintenance Phase Weeks16-32|Other|0|||
94524587|NCT01194219|323716971|FG001|Maintenance Phase Weeks16-32|Other|0|||
94524588|NCT01194219|323716972|FG002|Maintenance Phase Weeks16-32|Other|2|||
94524589|NCT01194219|323716973|FG003|Maintenance Phase Weeks16-32|Other|1|||
94524590|NCT01194219|323716974|FG004|Maintenance Phase Weeks16-32|Other|0|||
94524591|NCT01194219|323716975|FG005|Maintenance Phase Weeks16-32|Other|0|||
94524592|NCT01194219|323716976|FG006|Maintenance Phase Weeks16-32|Other|0|||
94524593|NCT01194219|323716977|FG007|Maintenance Phase Weeks16-32|Other|0|||
94524594|NCT01194219|323716978|FG008|Maintenance Phase Weeks16-32|Other|0|||
94524595|NCT01194219|323716979|FG009|Maintenance Phase Weeks16-32|Other|0|||
94524596|NCT01194219|323716970|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
94524597|NCT01194219|323716971|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
94524598|NCT01194219|323716972|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
94524599|NCT01194219|323716973|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
94524600|NCT01194219|323716974|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
94524601|NCT01194219|323716975|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
94524602|NCT01194219|323716976|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
94524603|NCT01194219|323716977|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
94524604|NCT01194219|323716978|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
94524605|NCT01194219|323716979|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
94524606|NCT01194219|323716970|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
94524607|NCT01194219|323716971|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
94524608|NCT01194219|323716972|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
94524609|NCT01194219|323716973|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
94524610|NCT01194219|323716974|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
94524611|NCT01194219|323716975|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
94524612|NCT01194219|323716976|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
94524613|NCT01194219|323716977|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
94524614|NCT01194219|323716978|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
94524615|NCT01194219|323716979|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
94524616|NCT01194219|323716970|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
94524617|NCT01194219|323716971|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
94524618|NCT01194219|323716972|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
94524619|NCT01194219|323716973|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
94524620|NCT01194219|323716974|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
94524621|NCT01194219|323716975|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
94524622|NCT01194219|323716976|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
94524623|NCT01194219|323716977|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
94524624|NCT01194219|323716978|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
94524625|NCT01194219|323716979|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
94524626|NCT01194219|323716970|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
94524627|NCT01194219|323716971|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
94524628|NCT01194219|323716972|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
94524629|NCT01194219|323716973|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
94524630|NCT01194219|323716974|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
94524631|NCT01194219|323716975|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
94524632|NCT01194219|323716976|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
94524633|NCT01194219|323716977|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
94524634|NCT01194219|323716978|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
94524635|NCT01194219|323716979|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
94524636|NCT01194219|323716970|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
94524637|NCT01194219|323716971|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
94524638|NCT01194219|323716972|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
94524639|NCT01194219|323716973|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
94524640|NCT01194219|323716974|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
94524641|NCT01194219|323716975|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
94524642|NCT01194219|323716976|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
94524643|NCT01194219|323716977|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
94524644|NCT01194219|323716978|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
94524645|NCT01194219|323716979|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
94524646|NCT01194219|323716970|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
94524647|NCT01194219|323716971|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
94524648|NCT01194219|323716972|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
94524649|NCT01194219|323716973|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
94524650|NCT01194219|323716974|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
94524651|NCT01194219|323716975|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
94524652|NCT01194219|323716976|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
94524653|NCT01194219|323716977|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
94524654|NCT01194219|323716978|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
94524655|NCT01194219|323716979|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
94524656|NCT01194219|323716970|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
94524657|NCT01194219|323716971|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
94524658|NCT01194219|323716972|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
94524659|NCT01194219|323716973|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
94524660|NCT01194219|323716974|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
94524661|NCT01194219|323716975|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
94524662|NCT01194219|323716976|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
94524663|NCT01194219|323716977|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
94524664|NCT01194219|323716978|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
94524665|NCT01194219|323716979|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
94524666|NCT01194219|323716970|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
94524667|NCT01194219|323716971|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
94524668|NCT01194219|323716972|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
94524669|NCT01194219|323716973|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
94524670|NCT01194219|323716974|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
94524671|NCT01194219|323716975|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
94524672|NCT01194219|323716976|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
94524673|NCT01194219|323716977|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
94524674|NCT01194219|323716978|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
94524675|NCT01194219|323716979|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
94524676|NCT01194219|323716970|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
94524677|NCT01194219|323716971|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
94524678|NCT01194219|323716972|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
94524679|NCT01194219|323716973|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
94524680|NCT01194219|323716974|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
94524681|NCT01194219|323716975|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
94524682|NCT01194219|323716976|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
94524683|NCT01194219|323716977|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
94524684|NCT01194219|323716978|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
94524685|NCT01194219|323716979|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
94524686|NCT01194219|323716970|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
94524687|NCT01194219|323716971|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
94524688|NCT01194219|323716972|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
94524689|NCT01194219|323716973|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
94524690|NCT01194219|323716974|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
94524691|NCT01194219|323716975|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
94524692|NCT01194219|323716976|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
94524693|NCT01194219|323716977|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
94524694|NCT01194219|323716978|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
94524695|NCT01194219|323716979|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
94524696|NCT01194219|323716970|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
94524697|NCT01194219|323716971|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
94524698|NCT01194219|323716972|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
94524699|NCT01194219|323716973|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
94524700|NCT01194219|323716974|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
94524701|NCT01194219|323716975|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
94524702|NCT01194219|323716976|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
94524703|NCT01194219|323716977|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
94524704|NCT01194219|323716978|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
94524705|NCT01194219|323716979|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
94524706|NCT01194219|323716970|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
94524707|NCT01194219|323716971|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
94524708|NCT01194219|323716972|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
94524709|NCT01194219|323716973|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
94524710|NCT01194219|323716974|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
94524711|NCT01194219|323716975|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
94524712|NCT01194219|323716976|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
94524713|NCT01194219|323716977|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
94524714|NCT01194219|323716978|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
94524715|NCT01194219|323716979|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
94524716|NCT01194219|323716970|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
94524717|NCT01194219|323716971|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
94524718|NCT01194219|323716972|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
94524719|NCT01194219|323716973|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
94524720|NCT01194219|323716974|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
94524721|NCT01194219|323716975|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
94524722|NCT01194219|323716976|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
94524723|NCT01194219|323716977|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
94524724|NCT01194219|323716978|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
94524725|NCT01194219|323716979|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
94524726|NCT01194219|323716970|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
94524727|NCT01194219|323716971|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
94524728|NCT01194219|323716972|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
94524729|NCT01194219|323716973|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
94524730|NCT01194219|323716974|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
94524731|NCT01194219|323716975|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
94524732|NCT01194219|323716976|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
94524733|NCT01194219|323716977|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
94524734|NCT01194219|323716978|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
94524735|NCT01194219|323716979|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
94524736|NCT01194219|323716970|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
94524737|NCT01194219|323716971|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
94524738|NCT01194219|323716972|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
94524739|NCT01194219|323716973|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
94524740|NCT01194219|323716974|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
94524741|NCT01194219|323716975|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
94524742|NCT01194219|323716976|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
94524743|NCT01194219|323716977|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
94524744|NCT01194219|323716978|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
94524745|NCT01194219|323716979|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
94524746|NCT00292045|323716980|FG000|Core Study (Through Week 13)|Adverse Event|1|||
94524747|NCT00292045|323716980|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
94524748|NCT04474197|323716981|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
94524749|NCT04474197|323716982|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
94524750|NCT04474197|323716983|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
94524751|NCT04474197|323716984|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
94524752|NCT02236572|323716985|FG000|Overall Study|Withdrawal by Subject|1|||
94524753|NCT02236572|323716985|FG000|Overall Study|Protocol Violation|1|||
94524754|NCT02236572|323716985|FG000|Overall Study|Lost to Follow-up|1|||
94524755|NCT01057693|323716986|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
94524756|NCT01057693|323716987|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
94524757|NCT01057693|323716988|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
94524758|NCT01057693|323716986|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
94524759|NCT01057693|323716987|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
94524760|NCT01057693|323716988|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
94524761|NCT01057693|323716986|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
94524762|NCT01057693|323716987|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
94524763|NCT01057693|323716988|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
94524764|NCT01057693|323716986|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
94524765|NCT01057693|323716987|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
94524766|NCT01057693|323716988|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
94524767|NCT01057693|323716986|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
94524768|NCT01057693|323716987|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
94524769|NCT01057693|323716988|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
94524770|NCT01057693|323716986|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
94524771|NCT01057693|323716987|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
94524772|NCT01057693|323716988|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
94524773|NCT01057693|323716986|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
94524774|NCT01057693|323716987|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
94524775|NCT01057693|323716988|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
94524776|NCT01057693|323716986|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
94524777|NCT01057693|323716987|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
94524778|NCT01057693|323716988|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
94524779|NCT01057693|323716986|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
94524780|NCT01057693|323716987|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
94524781|NCT01057693|323716988|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
94524782|NCT01057693|323716986|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
94524783|NCT01057693|323716987|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
94524784|NCT01057693|323716988|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
94524785|NCT01057693|323716986|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
94524786|NCT01057693|323716987|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
94524787|NCT01057693|323716988|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
94524788|NCT01057693|323716986|FG000|Between Single-Blind and Double-Blind|Other|6|||
94524789|NCT01057693|323716987|FG001|Between Single-Blind and Double-Blind|Other|0|||
94524790|NCT01057693|323716988|FG002|Between Single-Blind and Double-Blind|Other|0|||
94524791|NCT01057693|323716986|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
94524792|NCT01057693|323716987|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
94524793|NCT01057693|323716988|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
94524794|NCT01057693|323716986|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
94524795|NCT01057693|323716987|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
94524796|NCT01057693|323716988|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
94524797|NCT01057693|323716986|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
94524798|NCT01057693|323716987|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
94524799|NCT01057693|323716988|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
94524800|NCT01057693|323716986|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
94524801|NCT01057693|323716987|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
94524802|NCT01057693|323716988|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
94524803|NCT01057693|323716986|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
94524804|NCT01057693|323716987|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
94524805|NCT01057693|323716988|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
94524806|NCT01057693|323716986|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
94524807|NCT01057693|323716987|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
94524808|NCT01057693|323716988|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
94524809|NCT01057693|323716986|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
94524810|NCT01057693|323716987|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
94524811|NCT01057693|323716988|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
94524812|NCT02413996|323716989|FG000|Overall Study|not comfortable with the intervention|9|||
94524813|NCT02413996|323716990|FG001|Overall Study|not comfortable with the intervention|2|||
94524814|NCT00579553|323716992|FG000|Overall Study|Lost to Follow-up|16|||
94524815|NCT00579553|323716993|FG001|Overall Study|Lost to Follow-up|13|||
94524816|NCT00635349|323716995|FG000|Overall Study|Other|8|||
94524817|NCT00635349|323716996|FG001|Overall Study|Other|6|||
94524818|NCT00635349|323716995|FG000|Overall Study|Protocol Violation|18|||
94524819|NCT00635349|323716996|FG001|Overall Study|Protocol Violation|22|||
94524820|NCT00635349|323716995|FG000|Overall Study|Withdrawal by Subject|3|||
94524821|NCT00635349|323716996|FG001|Overall Study|Withdrawal by Subject|8|||
94524822|NCT00635349|323716995|FG000|Overall Study|Lost to Follow-up|4|||
94524823|NCT00635349|323716996|FG001|Overall Study|Lost to Follow-up|3|||
94524824|NCT00635349|323716995|FG000|Overall Study|Adverse Event|11|||
94524825|NCT00635349|323716996|FG001|Overall Study|Adverse Event|9|||
94524826|NCT01318135|323716997|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
94524827|NCT01318135|323716998|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
94524828|NCT01318135|323716999|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
94524829|NCT01318135|323717000|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
94524830|NCT01318135|323717001|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
94524831|NCT01318135|323717002|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
94524832|NCT01318135|323717003|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
94524833|NCT01318135|323717004|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
94524834|NCT01318135|323716997|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
94524835|NCT01318135|323716998|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
94524836|NCT01318135|323716999|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
94524837|NCT01318135|323717000|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
94524838|NCT01318135|323717001|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
94524839|NCT01318135|323717002|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
94524840|NCT01318135|323717003|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
94524841|NCT01318135|323717004|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
94524842|NCT01318135|323716997|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
94524843|NCT01318135|323716998|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
94524844|NCT01318135|323716999|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
94524845|NCT01318135|323717000|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
94524846|NCT01318135|323717001|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
94524847|NCT01318135|323717002|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
94524848|NCT01318135|323717003|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
94524849|NCT01318135|323717004|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
94524850|NCT01318135|323716997|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
94524851|NCT01318135|323716998|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
94524852|NCT01318135|323716999|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
94524853|NCT01318135|323717000|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
94524854|NCT01318135|323717001|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
94524855|NCT01318135|323717002|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
94524856|NCT01318135|323717003|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
94524857|NCT01318135|323717004|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
94524858|NCT01318135|323716997|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
94524859|NCT01318135|323716998|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
94524860|NCT01318135|323716999|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
94524861|NCT01318135|323717000|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
94524862|NCT01318135|323717001|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
94524863|NCT01318135|323717002|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
94524864|NCT01318135|323717003|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
94524865|NCT01318135|323717004|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
94524866|NCT01318135|323716997|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
94524867|NCT01318135|323716998|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
94524868|NCT01318135|323716999|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
94524869|NCT01318135|323717000|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
94524870|NCT01318135|323717001|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
94524871|NCT01318135|323717002|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
94524872|NCT01318135|323717003|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
94524873|NCT01318135|323717004|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
94524874|NCT01318135|323716997|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
94524875|NCT01318135|323716998|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
94524876|NCT01318135|323716999|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
94524877|NCT01318135|323717000|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
94524878|NCT01318135|323717001|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
94524879|NCT01318135|323717002|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
94524880|NCT01318135|323717003|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
94524881|NCT01318135|323717004|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
94524882|NCT01672879|323717009|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
94524883|NCT01672879|323717010|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
94524884|NCT01672879|323717011|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
94524885|NCT01672879|323717009|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
94524886|NCT01672879|323717010|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
94524887|NCT01672879|323717011|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
94524888|NCT01672879|323717009|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
94524889|NCT01672879|323717010|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
94524890|NCT01672879|323717011|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
94524891|NCT01672879|323717009|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
94524892|NCT01672879|323717010|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
94524893|NCT01672879|323717011|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
94524894|NCT01672879|323717009|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
94524895|NCT01672879|323717010|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
94524896|NCT01672879|323717011|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
94524897|NCT01672879|323717009|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
94524898|NCT01672879|323717010|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
94524899|NCT01672879|323717011|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
94524900|NCT01672879|323717009|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
94524901|NCT01672879|323717010|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
94524902|NCT01672879|323717011|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
94524903|NCT01672879|323717009|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
94524904|NCT01672879|323717010|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
94524905|NCT01672879|323717011|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
94524906|NCT01672879|323717009|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
94524907|NCT01672879|323717010|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
94524908|NCT01672879|323717011|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
94524909|NCT01672879|323717009|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
94524910|NCT01672879|323717010|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
94524911|NCT01672879|323717011|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
94524912|NCT01672879|323717009|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
94524913|NCT01672879|323717010|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
94524914|NCT01672879|323717011|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
94524915|NCT01672879|323717009|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
94524916|NCT01672879|323717010|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
94524917|NCT01672879|323717011|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
94524918|NCT01672879|323717009|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
94524919|NCT01672879|323717010|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
94524920|NCT01672879|323717011|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
94524921|NCT03748706|323717013|FG000|Overall Study|Lost to Follow-up|1|||
94524922|NCT04860869|323717014|FG000|Overall Study|Withdrawal by Subject|1|||
94524923|NCT04860869|323717015|FG001|Overall Study|Withdrawal by Subject|0|||
94524924|NCT01775553|323717016|FG000|Overall Study|Adverse Event|1|||
94524925|NCT01775553|323717016|FG000|Overall Study|Disease Progression|12|||
94524926|NCT01871545|323717018|FG000|Overall Study|Death|2|||
94524927|NCT01871545|323717019|FG001|Overall Study|Death|0|||
94524928|NCT01871545|323717018|FG000|Overall Study|Lack of Efficacy|11|||
94524929|NCT01871545|323717019|FG001|Overall Study|Lack of Efficacy|2|||
94524930|NCT01871545|323717018|FG000|Overall Study|Physician Decision|4|||
94524931|NCT01871545|323717019|FG001|Overall Study|Physician Decision|0|||
94524932|NCT01871545|323717018|FG000|Overall Study|Withdrawal by Subject|0|||
94524933|NCT01871545|323717019|FG001|Overall Study|Withdrawal by Subject|1|||
94524934|NCT00739310|323717020|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
94524935|NCT00739310|323717020|FG000|Overall Study|Withdrawal by Subject|1|||
94524936|NCT00739310|323717020|FG000|Overall Study|Lost to Follow-up|2|||
94524937|NCT04834726|323717024|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
94524938|NCT04834726|323717025|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
94524939|NCT04834726|323717026|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
94524940|NCT04834726|323717027|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
94524941|NCT04834726|323717028|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
94524942|NCT04834726|323717029|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
94524943|NCT04834726|323717030|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
94524944|NCT04834726|323717031|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
94524945|NCT04834726|323717032|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
94524946|NCT00803361|323717033|FG000|Overall Study|Adverse Event|13|||
94524947|NCT00803361|323717034|FG001|Overall Study|Adverse Event|3|||
94524948|NCT00803361|323717033|FG000|Overall Study|Lack of Efficacy|4|||
94524949|NCT00803361|323717034|FG001|Overall Study|Lack of Efficacy|13|||
94524950|NCT00803361|323717033|FG000|Overall Study|Lost to Follow-up|1|||
94524951|NCT00803361|323717034|FG001|Overall Study|Lost to Follow-up|2|||
94524952|NCT00803361|323717033|FG000|Overall Study|Physician Decision|1|||
94524953|NCT00803361|323717034|FG001|Overall Study|Physician Decision|0|||
94524954|NCT00803361|323717033|FG000|Overall Study|Protocol Violation|2|||
94524955|NCT00803361|323717034|FG001|Overall Study|Protocol Violation|4|||
94524956|NCT00803361|323717033|FG000|Overall Study|Withdrawal by Subject|5|||
94524957|NCT00803361|323717034|FG001|Overall Study|Withdrawal by Subject|6|||
94524958|NCT00363142|323717038|FG000|Overall Study|Adverse Event|2|||
94524959|NCT00363142|323717039|FG001|Overall Study|Adverse Event|0|||
94524960|NCT00363142|323717038|FG000|Overall Study|Lack of Efficacy|0|||
94524961|NCT00363142|323717039|FG001|Overall Study|Lack of Efficacy|1|||
94524962|NCT00363142|323717038|FG000|Overall Study|Lost to Follow-up|1|||
94524963|NCT00363142|323717039|FG001|Overall Study|Lost to Follow-up|0|||
94524964|NCT00363142|323717038|FG000|Overall Study|Non-compliance|1|||
94524965|NCT00363142|323717039|FG001|Overall Study|Non-compliance|1|||
94524966|NCT00363142|323717038|FG000|Overall Study|Withdrawal by Subject|3|||
94524967|NCT00363142|323717039|FG001|Overall Study|Withdrawal by Subject|1|||
94524968|NCT01541865|323717040|FG000|Overall Study|Lost to Follow-up|11|||
94524969|NCT01541865|323717040|FG000|Overall Study|Withdrawal by Subject|9|||
94524970|NCT01541865|323717040|FG000|Overall Study|Adverse Event|1|||
94524971|NCT01541865|323717040|FG000|Overall Study|Protocol Violation|1|||
94524972|NCT01635998|323717044|FG000|Overall Study|Death|1|||
94524973|NCT01635998|323717045|FG001|Overall Study|Death|1|||
94524974|NCT01635998|323717044|FG000|Overall Study|Lost to Follow-up|2|||
94524975|NCT01635998|323717045|FG001|Overall Study|Lost to Follow-up|1|||
94524976|NCT01635998|323717044|FG000|Overall Study|Withdrawal by Subject|1|||
94524977|NCT01635998|323717045|FG001|Overall Study|Withdrawal by Subject|5|||
94524978|NCT03606486|323717049|FG000|Overall Study|Unable to collect sample|5|||
94524979|NCT02446769|323717050|FG000|Screening Period|Screen Failure|11|||
94524980|NCT02446769|323717051|FG001|Screening Period|Screen Failure|0|||
94524981|NCT02446769|323717052|FG002|Screening Period|Screen Failure|0|||
94524982|NCT02446769|323717050|FG000|Study Period|Randomized in Error|0|||
94524983|NCT02446769|323717051|FG001|Study Period|Randomized in Error|2|||
94524984|NCT02446769|323717052|FG002|Study Period|Randomized in Error|0|||
94524985|NCT00049322|323717057|FG000|Overall Study|disease burden|0|||
94524986|NCT00049322|323717058|FG001|Overall Study|disease burden|3|||
94524987|NCT00049322|323717057|FG000|Overall Study|Adverse Event|1|||
94524988|NCT00049322|323717058|FG001|Overall Study|Adverse Event|0|||
94524989|NCT00049322|323717057|FG000|Overall Study|refused angio|0|||
94524990|NCT00049322|323717058|FG001|Overall Study|refused angio|3|||
94524991|NCT00703963|323717059|FG000|Overall Study|Withdrawal by Subject|7|||
94524992|NCT00703963|323717060|FG001|Overall Study|Withdrawal by Subject|13|||
94524993|NCT00703963|323717059|FG000|Overall Study|Physician Decision|0|||
94524994|NCT00703963|323717060|FG001|Overall Study|Physician Decision|1|||
94524995|NCT00402324|323717061|FG000|Overall Study|Lost to Follow-up|11|||
94524996|NCT00402324|323717062|FG001|Overall Study|Lost to Follow-up|11|||
94524997|NCT00402324|323717061|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
94524998|NCT00402324|323717062|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
94524999|NCT00402324|323717061|FG000|Overall Study|Protocol Violation|8|||
94525000|NCT00402324|323717062|FG001|Overall Study|Protocol Violation|7|||
94525001|NCT00402324|323717061|FG000|Overall Study|Withdrawal by Subject|5|||
94525002|NCT00402324|323717062|FG001|Overall Study|Withdrawal by Subject|2|||
94525003|NCT00402324|323717061|FG000|Overall Study|Physician Decision|2|||
94525004|NCT00402324|323717062|FG001|Overall Study|Physician Decision|4|||
94525005|NCT00402324|323717061|FG000|Overall Study|Sponsor Decision|4|||
94525006|NCT00402324|323717062|FG001|Overall Study|Sponsor Decision|5|||
94525007|NCT00402324|323717061|FG000|Overall Study|Lack of Efficacy|1|||
94525008|NCT00402324|323717062|FG001|Overall Study|Lack of Efficacy|4|||
94525009|NCT00402324|323717061|FG000|Overall Study|Adverse Event|6|||
94525010|NCT00402324|323717062|FG001|Overall Study|Adverse Event|4|||
94525011|NCT00402324|323717061|FG000|Overall Study|Death|1|||
94525012|NCT00402324|323717062|FG001|Overall Study|Death|0|||
94525013|NCT02625220|323717063|FG000|Overall Study|Adverse Event|2|||
94525014|NCT02625220|323717063|FG000|Overall Study|Lost to Follow-up|2|||
94525015|NCT02625220|323717063|FG000|Overall Study|Protocol Violation|1|||
94525016|NCT02625220|323717063|FG000|Overall Study|Study discontinued at site|2|||
94525017|NCT01253369|323717064|FG000|Overall Study|Adverse Event|4|||
94525018|NCT01253369|323717064|FG000|Overall Study|Withdrawal by Subject|2|||
94525019|NCT01253369|323717064|FG000|Overall Study|Death|1|||
94525020|NCT01253369|323717064|FG000|Overall Study|Progressive disease|23|||
94525021|NCT01253369|323717064|FG000|Overall Study|Not Evaluable|3|||
94525022|NCT01823198|323717068|FG000|Overall Study|Physician Decision|0|||
94525023|NCT01823198|323717069|FG001|Overall Study|Physician Decision|1|||
94525024|NCT01823198|323717070|FG002|Overall Study|Physician Decision|0|||
94525025|NCT01823198|323717071|FG003|Overall Study|Physician Decision|0|||
94525026|NCT01823198|323717072|FG004|Overall Study|Physician Decision|0|||
94525027|NCT01823198|323717073|FG005|Overall Study|Physician Decision|3|||
94525028|NCT01823198|323717074|FG006|Overall Study|Physician Decision|3|||
94525029|NCT00783835|323717075|FG000|Overall Study|Adverse Event|3|||
94525030|NCT00783835|323717075|FG000|Overall Study|Medical Criteria|1|||
94525031|NCT00783835|323717075|FG000|Overall Study|Withdrawal by Subject|2|||
94525032|NCT00783835|323717075|FG000|Overall Study|Lost to Follow-up|1|||
94525033|NCT00783835|323717075|FG000|Overall Study|Participant not Adherent|3|||
94525034|NCT01945996|323717081|FG000|Overall Study|Lost to Follow-up|3|||
94525035|NCT01945996|323717082|FG001|Overall Study|Lost to Follow-up|5|||
94525036|NCT01509846|323717085|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
94525037|NCT01509846|323717086|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
94525038|NCT01509846|323717087|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
94525039|NCT01509846|323717088|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
94525040|NCT01509846|323717089|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
94525041|NCT01509846|323717085|FG000|Received Vaccination 2|Illness|0|||
94525042|NCT01509846|323717086|FG001|Received Vaccination 2|Illness|0|||
94525043|NCT01509846|323717087|FG002|Received Vaccination 2|Illness|0|||
94525044|NCT01509846|323717088|FG003|Received Vaccination 2|Illness|0|||
94525045|NCT01509846|323717089|FG004|Received Vaccination 2|Illness|1|||
94525046|NCT01509846|323717085|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
94525047|NCT01509846|323717086|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
94525048|NCT01509846|323717087|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
94525049|NCT01509846|323717088|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
94525050|NCT01509846|323717089|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
94525051|NCT01509846|323717085|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
94525052|NCT01509846|323717086|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
94525053|NCT01509846|323717087|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
94525054|NCT01509846|323717088|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
94525055|NCT01509846|323717089|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
94525056|NCT01509846|323717085|FG000|Received Vaccination 3|Pregnancy|0|||
94525057|NCT01509846|323717086|FG001|Received Vaccination 3|Pregnancy|0|||
94525058|NCT01509846|323717087|FG002|Received Vaccination 3|Pregnancy|0|||
94525059|NCT01509846|323717088|FG003|Received Vaccination 3|Pregnancy|1|||
94525060|NCT01509846|323717089|FG004|Received Vaccination 3|Pregnancy|0|||
94525061|NCT01509846|323717085|FG000|Received Vaccination 3|Lost to Follow-up|0|||
94525062|NCT01509846|323717086|FG001|Received Vaccination 3|Lost to Follow-up|0|||
94525063|NCT01509846|323717087|FG002|Received Vaccination 3|Lost to Follow-up|1|||
94525064|NCT01509846|323717088|FG003|Received Vaccination 3|Lost to Follow-up|0|||
94525065|NCT01509846|323717089|FG004|Received Vaccination 3|Lost to Follow-up|0|||
94525066|NCT04677543|323717090|FG000|Overall Study|Withdrawal by Subject|4|||
94525067|NCT04677543|323717091|FG001|Overall Study|Withdrawal by Subject|1|||
94525068|NCT04677543|323717090|FG000|Overall Study|Physician Decision|0|||
94525069|NCT04677543|323717091|FG001|Overall Study|Physician Decision|1|||
94525070|NCT04677543|323717090|FG000|Overall Study|Adverse Event|0|||
94525071|NCT04677543|323717091|FG001|Overall Study|Adverse Event|1|||
94525072|NCT02503085|323717092|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
94525073|NCT02503085|323717093|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
94525074|NCT02503085|323717094|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
94525075|NCT02503085|323717095|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
94525076|NCT02964273|323718372|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
94525077|NCT02964273|323718373|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
94525078|NCT02964273|323718374|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
94525079|NCT02964273|323718375|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
94525080|NCT02964273|323718372|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
94525081|NCT02964273|323718373|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
94525082|NCT02964273|323718374|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
94525083|NCT02964273|323718375|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
94525084|NCT02964273|323718372|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
94525085|NCT02964273|323718373|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
94525086|NCT02964273|323718374|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
94525087|NCT02964273|323718375|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
94525088|NCT02964273|323718372|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
94525089|NCT02964273|323718373|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
94525090|NCT02964273|323718374|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
94525091|NCT02964273|323718375|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
94525092|NCT02964273|323718372|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
94525093|NCT02964273|323718373|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
94525094|NCT02964273|323718374|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
94525095|NCT02964273|323718375|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
94525096|NCT02964273|323718372|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
94525097|NCT02964273|323718373|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
94525098|NCT02964273|323718374|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
94525099|NCT02964273|323718375|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
94525100|NCT01453036|323718376|FG000|Overall Study|Lost to Follow-up|26|||
94525101|NCT01453036|323718377|FG001|Overall Study|Lost to Follow-up|115|||
94525102|NCT01453036|323718378|FG002|Overall Study|Lost to Follow-up|31|||
94525103|NCT03073525|323718383|FG000|Overall Study|Withdrawal by Subject|0|||
94525104|NCT03073525|323718384|FG001|Overall Study|Withdrawal by Subject|0|||
94525105|NCT03073525|323718385|FG002|Overall Study|Withdrawal by Subject|3|||
94525106|NCT01465386|323718386|FG000|Overall Study|Lack of Efficacy|3|||
94525107|NCT01465386|323718386|FG000|Overall Study|Adverse Event|1|||
94525108|NCT01279044|323718389|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
94525109|NCT01279044|323718390|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
94525110|NCT01279044|323718391|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
94525111|NCT01279044|323718389|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
94525112|NCT01279044|323718390|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
94525113|NCT01279044|323718391|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
94525114|NCT01279044|323718389|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
94525115|NCT01279044|323718390|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
94525116|NCT01279044|323718391|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
94525117|NCT01582009|323718392|FG000|Overall Study|Withdrawal by Subject|1|||
94525118|NCT01582009|323718392|FG000|Overall Study|Physician Decision|1|||
94525119|NCT03432494|323718393|FG000|Overall Study|Death|1|||
94525120|NCT03432494|323718393|FG000|Overall Study|Noncompliance|1|||
94525121|NCT01947283|323718401|FG000|Overall Study|Death|1|||
94525122|NCT01947283|323718402|FG001|Overall Study|Death|1|||
94525123|NCT01947283|323718403|FG002|Overall Study|Death|1|||
94525124|NCT01947283|323718404|FG003|Overall Study|Death|0|||
94525125|NCT01947283|323718405|FG004|Overall Study|Death|0|||
94525126|NCT01947283|323718406|FG005|Overall Study|Death|0|||
94525127|NCT01947283|323718407|FG006|Overall Study|Death|0|||
94525128|NCT01947283|323718401|FG000|Overall Study|Lost to Follow-up|4|||
94525129|NCT01947283|323718402|FG001|Overall Study|Lost to Follow-up|6|||
94525130|NCT01947283|323718403|FG002|Overall Study|Lost to Follow-up|5|||
94525131|NCT01947283|323718404|FG003|Overall Study|Lost to Follow-up|5|||
94525132|NCT01947283|323718405|FG004|Overall Study|Lost to Follow-up|0|||
94525133|NCT01947283|323718406|FG005|Overall Study|Lost to Follow-up|2|||
94525134|NCT01947283|323718407|FG006|Overall Study|Lost to Follow-up|5|||
94525135|NCT01947283|323718401|FG000|Overall Study|Withdrawal by Subject|10|||
94525136|NCT01947283|323718402|FG001|Overall Study|Withdrawal by Subject|8|||
94525137|NCT01947283|323718403|FG002|Overall Study|Withdrawal by Subject|4|||
94525138|NCT01947283|323718404|FG003|Overall Study|Withdrawal by Subject|1|||
94525139|NCT01947283|323718405|FG004|Overall Study|Withdrawal by Subject|0|||
94525140|NCT01947283|323718406|FG005|Overall Study|Withdrawal by Subject|0|||
94525141|NCT01947283|323718407|FG006|Overall Study|Withdrawal by Subject|2|||
94525142|NCT01947283|323718401|FG000|Overall Study|No Clinical Recording|12|||
94525143|NCT01947283|323718402|FG001|Overall Study|No Clinical Recording|6|||
94525144|NCT01947283|323718403|FG002|Overall Study|No Clinical Recording|8|||
94525145|NCT01947283|323718404|FG003|Overall Study|No Clinical Recording|10|||
94525146|NCT01947283|323718405|FG004|Overall Study|No Clinical Recording|0|||
94525147|NCT01947283|323718406|FG005|Overall Study|No Clinical Recording|0|||
94525148|NCT01947283|323718407|FG006|Overall Study|No Clinical Recording|0|||
94525149|NCT01947283|323718401|FG000|Overall Study|Non-coding Clinical Recording language|0|||
94525150|NCT01947283|323718402|FG001|Overall Study|Non-coding Clinical Recording language|0|||
94525151|NCT01947283|323718403|FG002|Overall Study|Non-coding Clinical Recording language|0|||
94525152|NCT01947283|323718404|FG003|Overall Study|Non-coding Clinical Recording language|1|||
94525153|NCT01947283|323718405|FG004|Overall Study|Non-coding Clinical Recording language|0|||
94525154|NCT01947283|323718406|FG005|Overall Study|Non-coding Clinical Recording language|0|||
94525155|NCT01947283|323718407|FG006|Overall Study|Non-coding Clinical Recording language|0|||
94525156|NCT01947283|323718401|FG000|Overall Study|Missing Follow-up Assessment|2|||
94525157|NCT01947283|323718402|FG001|Overall Study|Missing Follow-up Assessment|2|||
94525158|NCT01947283|323718403|FG002|Overall Study|Missing Follow-up Assessment|3|||
94525159|NCT01947283|323718404|FG003|Overall Study|Missing Follow-up Assessment|0|||
94525160|NCT01947283|323718405|FG004|Overall Study|Missing Follow-up Assessment|0|||
94525161|NCT01947283|323718406|FG005|Overall Study|Missing Follow-up Assessment|2|||
94525162|NCT01947283|323718407|FG006|Overall Study|Missing Follow-up Assessment|0|||
94525163|NCT01947283|323718401|FG000|Overall Study|No patients were enrolled in study|0|||
94525164|NCT01947283|323718402|FG001|Overall Study|No patients were enrolled in study|0|||
94525165|NCT01947283|323718403|FG002|Overall Study|No patients were enrolled in study|0|||
94525166|NCT01947283|323718404|FG003|Overall Study|No patients were enrolled in study|0|||
94525167|NCT01947283|323718405|FG004|Overall Study|No patients were enrolled in study|0|||
94525168|NCT01947283|323718406|FG005|Overall Study|No patients were enrolled in study|3|||
94525169|NCT01947283|323718407|FG006|Overall Study|No patients were enrolled in study|1|||
94525170|NCT03592771|323718410|FG000|Overall Study|Adverse Event|2|||
94525171|NCT03592771|323718411|FG001|Overall Study|Adverse Event|0|||
94525172|NCT03592771|323718412|FG002|Overall Study|Adverse Event|1|||
94525173|NCT03592771|323718410|FG000|Overall Study|Death|0|||
94525174|NCT03592771|323718411|FG001|Overall Study|Death|1|||
94525175|NCT03592771|323718412|FG002|Overall Study|Death|1|||
94525176|NCT03592771|323718410|FG000|Overall Study|Lost to Follow-up|5|||
94525177|NCT03592771|323718411|FG001|Overall Study|Lost to Follow-up|11|||
94525178|NCT03592771|323718412|FG002|Overall Study|Lost to Follow-up|15|||
94525179|NCT03592771|323718410|FG000|Overall Study|Withdrawal by Subject|0|||
94525180|NCT03592771|323718411|FG001|Overall Study|Withdrawal by Subject|2|||
94525181|NCT03592771|323718412|FG002|Overall Study|Withdrawal by Subject|0|||
94525182|NCT03801928|323718413|FG000|Overall Study|Adverse Event|1|||
94525183|NCT03801928|323718414|FG001|Overall Study|Adverse Event|0|||
94525184|NCT03801928|323718415|FG002|Overall Study|Adverse Event|1|||
94525185|NCT03801928|323718416|FG003|Overall Study|Adverse Event|2|||
94525186|NCT03801928|323718417|FG004|Overall Study|Adverse Event|0|||
94525187|NCT03801928|323718418|FG005|Overall Study|Adverse Event|2|||
94525188|NCT03801928|323718413|FG000|Overall Study|Lack of Efficacy|0|||
94525189|NCT03801928|323718414|FG001|Overall Study|Lack of Efficacy|0|||
94525190|NCT03801928|323718415|FG002|Overall Study|Lack of Efficacy|1|||
94525191|NCT03801928|323718416|FG003|Overall Study|Lack of Efficacy|0|||
94525192|NCT03801928|323718417|FG004|Overall Study|Lack of Efficacy|0|||
94525193|NCT03801928|323718418|FG005|Overall Study|Lack of Efficacy|0|||
94525194|NCT03801928|323718413|FG000|Overall Study|Lost to Follow-up|5|||
94525195|NCT03801928|323718414|FG001|Overall Study|Lost to Follow-up|1|||
94525196|NCT03801928|323718415|FG002|Overall Study|Lost to Follow-up|1|||
94525197|NCT03801928|323718416|FG003|Overall Study|Lost to Follow-up|4|||
94525198|NCT03801928|323718417|FG004|Overall Study|Lost to Follow-up|4|||
94525199|NCT03801928|323718418|FG005|Overall Study|Lost to Follow-up|2|||
94525200|NCT03801928|323718413|FG000|Overall Study|Withdrawal by Subject|0|||
94525201|NCT03801928|323718414|FG001|Overall Study|Withdrawal by Subject|0|||
94525202|NCT03801928|323718415|FG002|Overall Study|Withdrawal by Subject|2|||
94525203|NCT03801928|323718416|FG003|Overall Study|Withdrawal by Subject|1|||
94525204|NCT03801928|323718417|FG004|Overall Study|Withdrawal by Subject|0|||
94525205|NCT03801928|323718418|FG005|Overall Study|Withdrawal by Subject|0|||
94525206|NCT03801928|323718413|FG000|Overall Study|Other|0|||
94525207|NCT03801928|323718414|FG001|Overall Study|Other|2|||
94525208|NCT03801928|323718415|FG002|Overall Study|Other|0|||
94525209|NCT03801928|323718416|FG003|Overall Study|Other|1|||
94525210|NCT03801928|323718417|FG004|Overall Study|Other|0|||
94525211|NCT03801928|323718418|FG005|Overall Study|Other|1|||
94525212|NCT00175916|323718419|FG000|Overall Study|Death|19|||
94525213|NCT00175916|323718419|FG000|Overall Study|Adverse Event|81|||
94525214|NCT00175916|323718419|FG000|Overall Study|Lack of Efficacy|354|||
94525215|NCT00175916|323718419|FG000|Overall Study|Lost to Follow-up|17|||
94525216|NCT00175916|323718419|FG000|Overall Study|Subject Choice|98|||
94525217|NCT00175916|323718419|FG000|Overall Study|Lack of compliance|8|||
94525218|NCT00175916|323718419|FG000|Overall Study|Patient cannot record seizures|1|||
94525219|NCT00175916|323718419|FG000|Overall Study|Sponsor decision|17|||
94525220|NCT00175916|323718419|FG000|Overall Study|Vigabatrin intake|1|||
94525221|NCT00175916|323718419|FG000|Overall Study|Suicidal behaviour|1|||
94525222|NCT00175916|323718419|FG000|Overall Study|Withdrawal by Subject|1|||
94525223|NCT00175916|323718419|FG000|Overall Study|Seizure - free|4|||
94525224|NCT00175916|323718419|FG000|Overall Study|Administrative reason|1|||
94525225|NCT00175916|323718419|FG000|Overall Study|Pregnancy|1|||
94525226|NCT00175916|323718419|FG000|Overall Study|Patient's request|2|||
94525227|NCT00175916|323718419|FG000|Overall Study|Treating physiciant's choice|1|||
94525228|NCT00175916|323718419|FG000|Overall Study|Moved overseas|1|||
94525229|NCT00175916|323718419|FG000|Overall Study|Loss of job and economic burden|1|||
94525230|NCT00175916|323718419|FG000|Overall Study|Site was closed|9|||
94525231|NCT00175916|323718419|FG000|Overall Study|Patient went to prison|1|||
94525232|NCT00310375|323718420|FG000|Primary Reporting Phase|Adverse Event|28|||
94525233|NCT00310375|323718421|FG001|Primary Reporting Phase|Adverse Event|22|||
94525234|NCT00310375|323718422|FG002|Primary Reporting Phase|Adverse Event|0|||
94525235|NCT00310375|323718420|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
94525236|NCT00310375|323718421|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
94525237|NCT00310375|323718422|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
94525238|NCT00310375|323718420|FG000|Primary Reporting Phase|Pregnancy|2|||
94525239|NCT00310375|323718421|FG001|Primary Reporting Phase|Pregnancy|2|||
94525240|NCT00310375|323718422|FG002|Primary Reporting Phase|Pregnancy|0|||
94525241|NCT00310375|323718420|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
94525242|NCT00310375|323718421|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
94525243|NCT00310375|323718422|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
94525244|NCT00310375|323718420|FG000|Primary Reporting Phase|Protocol Violation|8|||
94525245|NCT00310375|323718421|FG001|Primary Reporting Phase|Protocol Violation|5|||
94525246|NCT00310375|323718422|FG002|Primary Reporting Phase|Protocol Violation|0|||
94525247|NCT00310375|323718420|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
94525248|NCT00310375|323718421|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
94525249|NCT00310375|323718422|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
94525250|NCT00310375|323718420|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
94525251|NCT00310375|323718421|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
94525252|NCT00310375|323718422|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
94525253|NCT00310375|323718420|FG000|Primary Reporting Phase|Physician Decision|5|||
94525254|NCT00310375|323718421|FG001|Primary Reporting Phase|Physician Decision|3|||
94525255|NCT00310375|323718422|FG002|Primary Reporting Phase|Physician Decision|0|||
94525256|NCT00310375|323718420|FG000|Primary Reporting Phase|Request of the sponsor|2|||
94525257|NCT00310375|323718421|FG001|Primary Reporting Phase|Request of the sponsor|2|||
94525258|NCT00310375|323718422|FG002|Primary Reporting Phase|Request of the sponsor|0|||
94525259|NCT00310375|323718420|FG000|Primary Reporting Phase|Failed to return|1|||
94525260|NCT00310375|323718421|FG001|Primary Reporting Phase|Failed to return|3|||
94525261|NCT00310375|323718422|FG002|Primary Reporting Phase|Failed to return|0|||
94525262|NCT00310375|323718420|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
94525263|NCT00310375|323718421|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
94525264|NCT00310375|323718422|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
94525265|NCT00310375|323718420|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
94525266|NCT00310375|323718421|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
94525267|NCT00310375|323718422|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
94525268|NCT00310375|323718420|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
94525269|NCT00310375|323718421|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
94525270|NCT00310375|323718422|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
94525271|NCT00310375|323718420|FG000|Primary Reporting Phase|Site closure|3|||
94525272|NCT00310375|323718421|FG001|Primary Reporting Phase|Site closure|0|||
94525273|NCT00310375|323718422|FG002|Primary Reporting Phase|Site closure|0|||
94525274|NCT00310375|323718420|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
94525275|NCT00310375|323718421|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
94525276|NCT00310375|323718422|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
94525277|NCT00310375|323718420|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
94525278|NCT00310375|323718421|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
94525279|NCT00310375|323718422|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
94525280|NCT00310375|323718420|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
94525281|NCT00310375|323718421|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
94525282|NCT00310375|323718422|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
94525283|NCT00310375|323718420|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
94525284|NCT00310375|323718421|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
94525285|NCT00310375|323718422|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
94525286|NCT01664247|323718424|FG000|Overall Study|Adverse Event|5|||
94525287|NCT01664247|323718425|FG001|Overall Study|Adverse Event|3|||
94525288|NCT01664247|323718424|FG000|Overall Study|Protocol Violation|3|||
94525289|NCT01664247|323718425|FG001|Overall Study|Protocol Violation|5|||
94525290|NCT01664247|323718424|FG000|Overall Study|Withdrawal Criteria|1|||
94525291|NCT01664247|323718425|FG001|Overall Study|Withdrawal Criteria|4|||
94525292|NCT01664247|323718424|FG000|Overall Study|Unclassified|5|||
94525293|NCT01664247|323718425|FG001|Overall Study|Unclassified|29|||
94525294|NCT00131352|323718426|FG000|Initial Treatment Period|Adverse Event|1|||
94525295|NCT00131352|323718427|FG001|Initial Treatment Period|Adverse Event|3|||
94525296|NCT00131352|323718426|FG000|Initial Treatment Period|Non-compliant|1|||
94525297|NCT00131352|323718427|FG001|Initial Treatment Period|Non-compliant|2|||
94525298|NCT00131352|323718426|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
94525299|NCT00131352|323718427|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
94525300|NCT00131352|323718426|FG000|Initial Treatment Period|Lack of Efficacy|6|||
94525301|NCT00131352|323718427|FG001|Initial Treatment Period|Lack of Efficacy|4|||
94525302|NCT00131352|323718426|FG000|Initial Treatment Period|Other|0|||
94525303|NCT00131352|323718427|FG001|Initial Treatment Period|Other|2|||
94525304|NCT00131352|323718426|FG000|Repeat Treatment Period|Adverse Event|1|||
94525305|NCT00131352|323718427|FG001|Repeat Treatment Period|Adverse Event|0|||
94525306|NCT00131352|323718426|FG000|Repeat Treatment Period|Other|1|||
94525307|NCT00131352|323718427|FG001|Repeat Treatment Period|Other|0|||
94525308|NCT02168101|323718428|FG000|Overall Study|Death|2|||
94525309|NCT02168101|323718429|FG001|Overall Study|Death|2|||
94525310|NCT02168101|323718430|FG002|Overall Study|Death|1|||
94525311|NCT01973231|323718434|FG000|Overall Study|Protocol Violation|1|||
94525312|NCT01973231|323718435|FG001|Overall Study|Protocol Violation|1|||
94525313|NCT01973231|323718434|FG000|Overall Study|Lost to Follow-up|1|||
94525314|NCT01973231|323718435|FG001|Overall Study|Lost to Follow-up|1|||
94525315|NCT01973231|323718434|FG000|Overall Study|unclassified|2|||
94525316|NCT01973231|323718435|FG001|Overall Study|unclassified|1|||
94525317|NCT01973231|323718434|FG000|Overall Study|Withdrawal by Subject|7|||
94525318|NCT01973231|323718435|FG001|Overall Study|Withdrawal by Subject|9|||
94525319|NCT03230318|323718436|FG000|Overall Study|Radiographic disease progression|72|||
94525320|NCT03230318|323718437|FG001|Overall Study|Radiographic disease progression|19|||
94525321|NCT03230318|323718436|FG000|Overall Study|Clinical progression|17|||
94525322|NCT03230318|323718437|FG001|Overall Study|Clinical progression|7|||
94525323|NCT03230318|323718436|FG000|Overall Study|Adverse Event|5|||
94525324|NCT03230318|323718437|FG001|Overall Study|Adverse Event|3|||
94525325|NCT03230318|323718436|FG000|Overall Study|Physician Decision|2|||
94525326|NCT03230318|323718437|FG001|Overall Study|Physician Decision|3|||
94525327|NCT03230318|323718436|FG000|Overall Study|Death|3|||
94525328|NCT03230318|323718437|FG001|Overall Study|Death|2|||
94525329|NCT03230318|323718436|FG000|Overall Study|Lost to Follow-up|1|||
94525330|NCT03230318|323718437|FG001|Overall Study|Lost to Follow-up|0|||
94525331|NCT03230318|323718436|FG000|Overall Study|Withdrawal by Subject|1|||
94525332|NCT03230318|323718437|FG001|Overall Study|Withdrawal by Subject|3|||
94525333|NCT03230318|323718436|FG000|Overall Study|Other|3|||
94525334|NCT03230318|323718437|FG001|Overall Study|Other|7|||
94525335|NCT01485796|323718440|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
94525336|NCT01485796|323718440|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
94525337|NCT01485796|323718440|FG000|Period 2: Epoch 2|Adverse Event|3|||
94525338|NCT01485796|323718440|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
94525339|NCT01485796|323718440|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
94525340|NCT01485796|323718440|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
94525341|NCT01485796|323718440|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
94525342|NCT01485796|323718440|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
94525343|NCT04830215|323718441|FG000|Overall Study|Adverse Event|6|||
94525344|NCT04830215|323718441|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
94525345|NCT04830215|323718441|FG000|Overall Study|Withdrawal by Subject|3|||
94525346|NCT04830215|323718441|FG000|Overall Study|Protocol Deviation|1|||
94525347|NCT01206140|323718443|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
94525348|NCT01206140|323718444|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
94525349|NCT00075764|323718445|FG000|Overall Study|Adverse Event|5|||
94525350|NCT00075764|323718446|FG001|Overall Study|Adverse Event|12|||
94525351|NCT00075764|323718445|FG000|Overall Study|Death|4|||
94525352|NCT00075764|323718446|FG001|Overall Study|Death|8|||
94525353|NCT00075764|323718445|FG000|Overall Study|Withdrawal by Subject|28|||
94525354|NCT00075764|323718446|FG001|Overall Study|Withdrawal by Subject|18|||
94525355|NCT00075764|323718445|FG000|Overall Study|Progression|269|||
94525356|NCT00075764|323718446|FG001|Overall Study|Progression|274|||
94525357|NCT00075764|323718445|FG000|Overall Study|Still on treatment|8|||
94525358|NCT00075764|323718446|FG001|Overall Study|Still on treatment|15|||
94525359|NCT00075764|323718445|FG000|Overall Study|Delinquent|4|||
94525360|NCT00075764|323718446|FG001|Overall Study|Delinquent|2|||
94525361|NCT00075764|323718445|FG000|Overall Study|Not protocol specified|27|||
94525362|NCT00075764|323718446|FG001|Overall Study|Not protocol specified|19|||
94525363|NCT00075764|323718445|FG000|Overall Study|Under review|0|||
94525364|NCT00075764|323718446|FG001|Overall Study|Under review|1|||
94525365|NCT02010593|323718450|FG000|Overall Study|Lost to Follow-up|1|||
94525366|NCT02010593|323718451|FG001|Overall Study|Lost to Follow-up|0|||
94525367|NCT02010593|323718450|FG000|Overall Study|Physician Decision|1|||
94525368|NCT02010593|323718451|FG001|Overall Study|Physician Decision|0|||
94525369|NCT02010593|323718450|FG000|Overall Study|Unable to adhere to visit schedule|0|||
94525370|NCT02010593|323718451|FG001|Overall Study|Unable to adhere to visit schedule|2|||
94525371|NCT01773967|323718452|FG000|Overall Study|Lost to Follow-up|15|||
94525372|NCT01773967|323718453|FG001|Overall Study|Lost to Follow-up|13|||
94525373|NCT01135459|323718454|FG000|Overall Study|Adverse Event|8|||
94525374|NCT01135459|323718455|FG001|Overall Study|Adverse Event|10|||
94525375|NCT01135459|323718454|FG000|Overall Study|Lack of Efficacy|3|||
94525376|NCT01135459|323718455|FG001|Overall Study|Lack of Efficacy|1|||
94525377|NCT01135459|323718454|FG000|Overall Study|Withdrawal by Subject|2|||
94525378|NCT01135459|323718455|FG001|Overall Study|Withdrawal by Subject|3|||
94525379|NCT01135459|323718454|FG000|Overall Study|Protocol Violation|5|||
94525380|NCT01135459|323718455|FG001|Overall Study|Protocol Violation|3|||
94525381|NCT01135459|323718454|FG000|Overall Study|Lost to Follow-up|2|||
94525382|NCT01135459|323718455|FG001|Overall Study|Lost to Follow-up|1|||
94525383|NCT01135459|323718454|FG000|Overall Study|Non-compliance to study procedures|0|||
94525384|NCT01135459|323718455|FG001|Overall Study|Non-compliance to study procedures|1|||
94525385|NCT01135459|323718454|FG000|Overall Study|Other than specified|1|||
94525386|NCT01135459|323718455|FG001|Overall Study|Other than specified|1|||
94525387|NCT01803880|323718456|FG000|Overall Study|Adverse Event|1|||
94525388|NCT01803880|323718457|FG001|Overall Study|Adverse Event|0|||
94525389|NCT01803880|323718458|FG002|Overall Study|Adverse Event|0|||
94525390|NCT01803880|323718456|FG000|Overall Study|Withdrawal by Subject|1|||
94525391|NCT01803880|323718457|FG001|Overall Study|Withdrawal by Subject|1|||
94525392|NCT01803880|323718458|FG002|Overall Study|Withdrawal by Subject|4|||
94525393|NCT01803880|323718456|FG000|Overall Study|Physician Decision|0|||
94525394|NCT01803880|323718457|FG001|Overall Study|Physician Decision|0|||
94525395|NCT01803880|323718458|FG002|Overall Study|Physician Decision|1|||
94525396|NCT01803880|323718456|FG000|Overall Study|Unable to return for follow-up visits|0|||
94525397|NCT01803880|323718457|FG001|Overall Study|Unable to return for follow-up visits|1|||
94525398|NCT01803880|323718458|FG002|Overall Study|Unable to return for follow-up visits|2|||
94525399|NCT01803880|323718456|FG000|Overall Study|Lost to Follow-up|1|||
94525400|NCT01803880|323718457|FG001|Overall Study|Lost to Follow-up|2|||
94525401|NCT01803880|323718458|FG002|Overall Study|Lost to Follow-up|3|||
94525402|NCT01803880|323718456|FG000|Overall Study|Protocol Violation|1|||
94525403|NCT01803880|323718457|FG001|Overall Study|Protocol Violation|0|||
94525404|NCT01803880|323718458|FG002|Overall Study|Protocol Violation|0|||
94525405|NCT01803880|323718456|FG000|Overall Study|Early study termination|0|||
94525406|NCT01803880|323718457|FG001|Overall Study|Early study termination|6|||
94525407|NCT01803880|323718458|FG002|Overall Study|Early study termination|5|||
94525408|NCT01803880|323718456|FG000|Overall Study|Incomplete data entry by sites|2|||
94525409|NCT01803880|323718457|FG001|Overall Study|Incomplete data entry by sites|0|||
94525410|NCT01803880|323718458|FG002|Overall Study|Incomplete data entry by sites|0|||
94525411|NCT01766037|323718459|FG000|Overall Study|Adverse Event|1|||
94525412|NCT01766037|323718460|FG001|Overall Study|Adverse Event|0|||
94525413|NCT01766037|323718459|FG000|Overall Study|Lack of Efficacy|1|||
94525414|NCT01766037|323718460|FG001|Overall Study|Lack of Efficacy|0|||
94525415|NCT01766037|323718459|FG000|Overall Study|Lost to Follow-up|0|||
94525416|NCT01766037|323718460|FG001|Overall Study|Lost to Follow-up|10|||
94525417|NCT01766037|323718459|FG000|Overall Study|Physician Decision|0|||
94525418|NCT01766037|323718460|FG001|Overall Study|Physician Decision|1|||
94525419|NCT01766037|323718459|FG000|Overall Study|Withdrawal by Subject|18|||
94525420|NCT01766037|323718460|FG001|Overall Study|Withdrawal by Subject|16|||
94525421|NCT01766037|323718459|FG000|Overall Study|Moved from area|5|||
94525422|NCT01766037|323718460|FG001|Overall Study|Moved from area|0|||
94525423|NCT01766037|323718459|FG000|Overall Study|medical - unrelated|1|||
94525424|NCT01766037|323718460|FG001|Overall Study|medical - unrelated|2|||
94525425|NCT01766037|323718459|FG000|Overall Study|nausea / discomfort|3|||
94525426|NCT01766037|323718460|FG001|Overall Study|nausea / discomfort|0|||
94525427|NCT00770562|323718463|FG000|Overall Study|Did not take treatment|1|||
94525428|NCT00770562|323718464|FG001|Overall Study|Did not take treatment|1|||
94525429|NCT01643408|323718465|FG000|Overall Study|Adverse Event|12|||
94525430|NCT01643408|323718465|FG000|Overall Study|Other|2|||
94525431|NCT03951766|323718466|FG000|Treatment Phase|Lost to Follow-up|1|||
94525432|NCT03951766|323718466|FG000|Follow-up Phase|Lost to Follow-up|10|||
94525433|NCT00763256|323718469|FG000|Overall Study|Didn't return for appointments|7|||
94525434|NCT00763256|323718470|FG001|Overall Study|Didn't return for appointments|10|||
94525435|NCT02544750|323718472|FG000|Overall Study|Physician Decision|3|||
94525436|NCT02544750|323718473|FG001|Overall Study|Physician Decision|1|||
94525437|NCT02544750|323718472|FG000|Overall Study|Other reasons|69|||
94525438|NCT02544750|323718473|FG001|Overall Study|Other reasons|39|||
94525439|NCT02544750|323718472|FG000|Overall Study|Met withdrawal criteria|2|||
94525440|NCT02544750|323718473|FG001|Overall Study|Met withdrawal criteria|2|||
94525441|NCT02544750|323718472|FG000|Overall Study|Transition To Commercial Product|1|||
94525442|NCT02544750|323718473|FG001|Overall Study|Transition To Commercial Product|0|||
94525443|NCT02544750|323718472|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
94525444|NCT02544750|323718473|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
94525445|NCT02544750|323718472|FG000|Overall Study|Adverse Event|8|||
94525446|NCT02544750|323718473|FG001|Overall Study|Adverse Event|10|||
94525447|NCT02544750|323718472|FG000|Overall Study|Withdrawal by Subject|10|||
94525448|NCT02544750|323718473|FG001|Overall Study|Withdrawal by Subject|4|||
94525449|NCT02544750|323718472|FG000|Overall Study|Lost to Follow-up|1|||
94525450|NCT02544750|323718473|FG001|Overall Study|Lost to Follow-up|0|||
94525451|NCT04396795|323718476|FG000|Month 1|Lost to Follow-up|2|||
94525452|NCT04396795|323718477|FG001|Month 1|Lost to Follow-up|3|||
94525453|NCT04396795|323718476|FG000|Month 3|Lost to Follow-up|1|||
94525454|NCT04396795|323718477|FG001|Month 3|Lost to Follow-up|3|||
94525455|NCT04396795|323718476|FG000|Month 6|Lost to Follow-up|3|||
94525456|NCT04396795|323718477|FG001|Month 6|Lost to Follow-up|3|||
94525457|NCT01467466|323718478|FG000|Overall Study|Withdrawal by Subject|15|||
94525458|NCT01467466|323718479|FG001|Overall Study|Withdrawal by Subject|18|||
94525459|NCT01467466|323718480|FG002|Overall Study|Withdrawal by Subject|13|||
94525460|NCT01467466|323718481|FG003|Overall Study|Withdrawal by Subject|11|||
94525461|NCT01467466|323718478|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
94525462|NCT01467466|323718479|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
94525463|NCT01467466|323718480|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
94525464|NCT01467466|323718481|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
94525465|NCT01467466|323718478|FG000|Overall Study|Procedure Cancelled|46|||
94525466|NCT01467466|323718479|FG001|Overall Study|Procedure Cancelled|45|||
94525467|NCT01467466|323718480|FG002|Overall Study|Procedure Cancelled|25|||
94525468|NCT01467466|323718481|FG003|Overall Study|Procedure Cancelled|29|||
94525469|NCT01467466|323718478|FG000|Overall Study|No Endpoint Blood Draw|38|||
94525470|NCT01467466|323718479|FG001|Overall Study|No Endpoint Blood Draw|32|||
94525471|NCT01467466|323718480|FG002|Overall Study|No Endpoint Blood Draw|51|||
94525472|NCT01467466|323718481|FG003|Overall Study|No Endpoint Blood Draw|43|||
94525473|NCT01144416|323718482|FG000|Intervention Period|Adverse Event|5|||
94525474|NCT01144416|323718483|FG001|Intervention Period|Adverse Event|6|||
94525475|NCT01144416|323718482|FG000|Intervention Period|Insufficient ovarian response|11|||
94525476|NCT01144416|323718483|FG001|Intervention Period|Insufficient ovarian response|17|||
94525477|NCT01144416|323718482|FG000|Intervention Period|Risk of OHSS|0|||
94525478|NCT01144416|323718483|FG001|Intervention Period|Risk of OHSS|1|||
94525479|NCT01144416|323718482|FG000|Intervention Period|Too high ovarian response|4|||
94525480|NCT01144416|323718483|FG001|Intervention Period|Too high ovarian response|2|||
94525481|NCT01144416|323718482|FG000|Intervention Period|No/too few/bad oocytes|7|||
94525482|NCT01144416|323718483|FG001|Intervention Period|No/too few/bad oocytes|5|||
94525483|NCT01144416|323718482|FG000|Intervention Period|No or abnormal fertilization|25|||
94525484|NCT01144416|323718483|FG001|Intervention Period|No or abnormal fertilization|10|||
94525485|NCT01144416|323718482|FG000|Intervention Period|No/too few/bad quality embryos|3|||
94525486|NCT01144416|323718483|FG001|Intervention Period|No/too few/bad quality embryos|3|||
94525487|NCT01144416|323718482|FG000|Intervention Period|Other|7|||
94525488|NCT01144416|323718483|FG001|Intervention Period|Other|5|||
94525489|NCT02623205|323718488|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
94525490|NCT02623205|323718489|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
94525491|NCT00556439|323718495|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
94525492|NCT00556439|323718496|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
94525493|NCT00556439|323718497|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
94525494|NCT00556439|323718498|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
94525495|NCT00556439|323718495|FG000|Study Entry to Week 12|Physician Decision|1|||
94525496|NCT00556439|323718496|FG001|Study Entry to Week 12|Physician Decision|0|||
94525497|NCT00556439|323718497|FG002|Study Entry to Week 12|Physician Decision|0|||
94525498|NCT00556439|323718498|FG003|Study Entry to Week 12|Physician Decision|0|||
94525499|NCT00556439|323718495|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
94525500|NCT00556439|323718496|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
94525501|NCT00556439|323718497|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
94525502|NCT00556439|323718498|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
94525503|NCT00556439|323718495|FG000|Study Entry to Week 12|Recurrent infection|1|||
94525504|NCT00556439|323718496|FG001|Study Entry to Week 12|Recurrent infection|0|||
94525505|NCT00556439|323718497|FG002|Study Entry to Week 12|Recurrent infection|0|||
94525506|NCT00556439|323718498|FG003|Study Entry to Week 12|Recurrent infection|0|||
94525507|NCT00556439|323718495|FG000|Study Entry to Week 12|Malignancy|0|||
94525508|NCT00556439|323718496|FG001|Study Entry to Week 12|Malignancy|0|||
94525509|NCT00556439|323718497|FG002|Study Entry to Week 12|Malignancy|1|||
94525510|NCT00556439|323718498|FG003|Study Entry to Week 12|Malignancy|0|||
94525511|NCT00556439|323718495|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
94525512|NCT00556439|323718496|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
94525513|NCT00556439|323718497|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
94525514|NCT00556439|323718498|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
94525515|NCT00556439|323718495|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
94525516|NCT00556439|323718496|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
94525517|NCT00556439|323718497|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
94525518|NCT00556439|323718498|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
94525519|NCT00556439|323718495|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
94525520|NCT00556439|323718496|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
94525521|NCT00556439|323718497|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
94525522|NCT00556439|323718498|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
94525523|NCT00556439|323718495|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
94525524|NCT00556439|323718496|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
94525525|NCT00556439|323718497|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
94525526|NCT00556439|323718498|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
94525527|NCT02524145|323718502|FG000|Overall Study|Withdrawal by Subject|2|||
94525528|NCT02524145|323718503|FG001|Overall Study|Withdrawal by Subject|2|||
94525529|NCT02524145|323718504|FG002|Overall Study|Withdrawal by Subject|3|||
94525530|NCT03308968|323719713|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
94525531|NCT03308968|323719714|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
94525532|NCT03308968|323719715|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
94525533|NCT03308968|323719713|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
94525534|NCT03308968|323719714|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
94525535|NCT03308968|323719715|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
94525536|NCT03308968|323719713|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
94525537|NCT03308968|323719714|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
94525538|NCT03308968|323719715|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
94525539|NCT03308968|323719713|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
94525540|NCT03308968|323719714|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
94525541|NCT03308968|323719715|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
94525542|NCT03308968|323719713|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
94525543|NCT03308968|323719714|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
94525544|NCT03308968|323719715|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
94525545|NCT03308968|323719713|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
94525546|NCT03308968|323719714|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
94525547|NCT03308968|323719715|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
94525548|NCT03308968|323719713|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
94525549|NCT03308968|323719714|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
94525550|NCT03308968|323719715|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
94525551|NCT03308968|323719713|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
94525552|NCT03308968|323719714|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
94525553|NCT03308968|323719715|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
94525554|NCT03308968|323719713|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
94525555|NCT03308968|323719714|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
94525556|NCT03308968|323719715|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
94525557|NCT03308968|323719713|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
94525558|NCT03308968|323719714|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
94525559|NCT03308968|323719715|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
94525560|NCT03308968|323719713|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
94525561|NCT03308968|323719714|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
94525562|NCT03308968|323719715|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
94525563|NCT03308968|323719713|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
94525564|NCT03308968|323719714|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
94525565|NCT03308968|323719715|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
94525566|NCT03308968|323719713|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
94525567|NCT03308968|323719714|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
94525568|NCT03308968|323719715|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
94525569|NCT03308968|323719713|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
94525570|NCT03308968|323719714|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
94525571|NCT03308968|323719715|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
94525572|NCT00473889|323719717|FG000|Overall Study|Did not receive study medication|1|||
94525573|NCT00473889|323719718|FG001|Overall Study|Did not receive study medication|4|||
94525574|NCT00473889|323719717|FG000|Overall Study|Adverse Event|30|||
94525575|NCT00473889|323719718|FG001|Overall Study|Adverse Event|17|||
94525576|NCT00473889|323719717|FG000|Overall Study|Protocol Violation|4|||
94525577|NCT00473889|323719718|FG001|Overall Study|Protocol Violation|2|||
94525578|NCT00473889|323719717|FG000|Overall Study|Lack of Efficacy|28|||
94525579|NCT00473889|323719718|FG001|Overall Study|Lack of Efficacy|29|||
94525580|NCT00473889|323719717|FG000|Overall Study|Lost to Follow-up|2|||
94525581|NCT00473889|323719718|FG001|Overall Study|Lost to Follow-up|1|||
94525582|NCT00473889|323719717|FG000|Overall Study|Physician Decision|10|||
94525583|NCT00473889|323719718|FG001|Overall Study|Physician Decision|5|||
94525584|NCT00473889|323719717|FG000|Overall Study|Trial Terminated|3|||
94525585|NCT00473889|323719718|FG001|Overall Study|Trial Terminated|6|||
94525586|NCT00473889|323719717|FG000|Overall Study|Withdrawal by Subject|5|||
94525587|NCT00473889|323719718|FG001|Overall Study|Withdrawal by Subject|0|||
94525588|NCT02840253|323719719|FG000|Overall Study|Unsuccessful block|4|||
94525589|NCT01665911|323719720|FG000|Overall Study|Protocol Violation|4|||
94525590|NCT01665911|323719720|FG000|Overall Study|Withdrawal by Subject|1|||
94525591|NCT01665911|323719720|FG000|Overall Study|Adverse Event|1|||
94525592|NCT00735553|323719721|FG000|Overall Study|Study prematurely terminated|77|||
94525593|NCT00564733|323719722|FG000|Overall Study|Withdrawal by Subject|4|||
94525594|NCT00564733|323719722|FG000|Overall Study|Ineligible|5|||
94525595|NCT01014767|323719723|FG000|Overall Study|PI left institution, data unavailable|12|||
94525596|NCT01014767|323719724|FG001|Overall Study|PI left institution, data unavailable|1|||
94525597|NCT01014767|323719725|FG002|Overall Study|PI left institution, data unavailable|4|||
94525598|NCT01014767|323719726|FG003|Overall Study|PI left institution, data unavailable|1|||
94525599|NCT00570323|323719727|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
94525600|NCT00570323|323719728|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
94525601|NCT00570323|323719727|FG000|Started Treatment After Randomization|Protocol Violation|1|||
94525602|NCT00570323|323719728|FG001|Started Treatment After Randomization|Protocol Violation|0|||
94525603|NCT00570323|323719727|FG000|Started Treatment After Randomization|Physician Decision|1|||
94525604|NCT00570323|323719728|FG001|Started Treatment After Randomization|Physician Decision|0|||
94525605|NCT00570323|323719727|FG000|Complete Study After Start|Lost to Follow-up|0|||
94525606|NCT00570323|323719728|FG001|Complete Study After Start|Lost to Follow-up|1|||
94525607|NCT00570323|323719727|FG000|Complete Study After Start|Withdrawal by Subject|2|||
94525608|NCT00570323|323719728|FG001|Complete Study After Start|Withdrawal by Subject|0|||
94525609|NCT00570323|323719727|FG000|Complete Study After Start|Physician Decision|1|||
94525610|NCT00570323|323719728|FG001|Complete Study After Start|Physician Decision|0|||
94525611|NCT04263766|323719729|FG000|Overall Study|Withdrawal by Subject|6|||
94525612|NCT04263766|323719730|FG001|Overall Study|Withdrawal by Subject|4|||
94525613|NCT04263766|323719729|FG000|Overall Study|Lack of Efficacy|1|||
94525614|NCT04263766|323719730|FG001|Overall Study|Lack of Efficacy|3|||
94525615|NCT02443337|323719733|FG000|Overall Study|Adverse Event|0|||
94525616|NCT02443337|323719734|FG001|Overall Study|Adverse Event|1|||
94525617|NCT02443337|323719733|FG000|Overall Study|Clinical Progressive Disease|3|||
94525618|NCT02443337|323719734|FG001|Overall Study|Clinical Progressive Disease|0|||
94525619|NCT02443337|323719733|FG000|Overall Study|Withdrawal by Subject|2|||
94525620|NCT02443337|323719734|FG001|Overall Study|Withdrawal by Subject|1|||
94525621|NCT00709319|323719735|FG000|Overall Study|Death|4|||
94525622|NCT00709319|323719735|FG000|Overall Study|Withdrawal by Subject|2|||
94525623|NCT00988052|323719736|FG000|Overall Study|Missing|1|||
94525624|NCT00988052|323719737|FG001|Overall Study|Missing|0|||
94525625|NCT00988052|323719736|FG000|Overall Study|Teva requested subject withdrawal|3|||
94525626|NCT00988052|323719737|FG001|Overall Study|Teva requested subject withdrawal|1|||
94525627|NCT00988052|323719736|FG000|Overall Study|Death|1|||
94525628|NCT00988052|323719737|FG001|Overall Study|Death|3|||
94525629|NCT00988052|323719736|FG000|Overall Study|Protocol Violation|6|||
94525630|NCT00988052|323719737|FG001|Overall Study|Protocol Violation|5|||
94525631|NCT00988052|323719736|FG000|Overall Study|Pregnancy|6|||
94525632|NCT00988052|323719737|FG001|Overall Study|Pregnancy|6|||
94525633|NCT00988052|323719736|FG000|Overall Study|Lack of Efficacy|8|||
94525634|NCT00988052|323719737|FG001|Overall Study|Lack of Efficacy|7|||
94525635|NCT00988052|323719736|FG000|Overall Study|Lost to Follow-up|6|||
94525636|NCT00988052|323719737|FG001|Overall Study|Lost to Follow-up|11|||
94525637|NCT00988052|323719736|FG000|Overall Study|Physician Decision|27|||
94525638|NCT00988052|323719737|FG001|Overall Study|Physician Decision|28|||
94525639|NCT00988052|323719736|FG000|Overall Study|Adverse Event|35|||
94525640|NCT00988052|323719737|FG001|Overall Study|Adverse Event|28|||
94525641|NCT00988052|323719736|FG000|Overall Study|Withdrawal by Subject|90|||
94525642|NCT00988052|323719737|FG001|Overall Study|Withdrawal by Subject|91|||
94525643|NCT00988052|323719736|FG000|Overall Study|Study terminated by sponsor|240|||
94525644|NCT00988052|323719737|FG001|Overall Study|Study terminated by sponsor|236|||
94525645|NCT00645840|323719746|FG000|Overall Study|Protocol Violation|3|||
94525646|NCT01340664|323719750|FG000|Overall Study|Adverse Event|0|||
94525647|NCT01340664|323719751|FG001|Overall Study|Adverse Event|1|||
94525648|NCT01340664|323719752|FG002|Overall Study|Adverse Event|7|||
94525649|NCT01340664|323719750|FG000|Overall Study|Lost to Follow-up|2|||
94525650|NCT01340664|323719751|FG001|Overall Study|Lost to Follow-up|0|||
94525651|NCT01340664|323719752|FG002|Overall Study|Lost to Follow-up|2|||
94525652|NCT01340664|323719750|FG000|Overall Study|Withdrawal by Subject|2|||
94525653|NCT01340664|323719751|FG001|Overall Study|Withdrawal by Subject|4|||
94525654|NCT01340664|323719752|FG002|Overall Study|Withdrawal by Subject|0|||
94525655|NCT01340664|323719750|FG000|Overall Study|Glycemic withdrawal criteria|2|||
94525656|NCT01340664|323719751|FG001|Overall Study|Glycemic withdrawal criteria|0|||
94525657|NCT01340664|323719752|FG002|Overall Study|Glycemic withdrawal criteria|0|||
94525658|NCT01340664|323719750|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
94525659|NCT01340664|323719751|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
94525660|NCT01340664|323719752|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
94525661|NCT01340664|323719750|FG000|Overall Study|Other|1|||
94525662|NCT01340664|323719751|FG001|Overall Study|Other|2|||
94525663|NCT01340664|323719752|FG002|Overall Study|Other|2|||
94525664|NCT01277822|323719755|FG000|Overall Study|Adverse Event|2|||
94525665|NCT01277822|323719756|FG001|Overall Study|Adverse Event|1|||
94525666|NCT01277822|323719755|FG000|Overall Study|Withdrawal by Subject|6|||
94525667|NCT01277822|323719756|FG001|Overall Study|Withdrawal by Subject|7|||
94525668|NCT01277822|323719755|FG000|Overall Study|Physician Decision|1|||
94525669|NCT01277822|323719756|FG001|Overall Study|Physician Decision|1|||
94525670|NCT01277822|323719755|FG000|Overall Study|Protocol Violation|1|||
94525671|NCT01277822|323719756|FG001|Overall Study|Protocol Violation|0|||
94525672|NCT01277822|323719755|FG000|Overall Study|Lost to Follow-up|2|||
94525673|NCT01277822|323719756|FG001|Overall Study|Lost to Follow-up|1|||
94525674|NCT01277822|323719755|FG000|Overall Study|Contraindicated medication used|2|||
94525675|NCT01277822|323719756|FG001|Overall Study|Contraindicated medication used|1|||
94525676|NCT01277822|323719755|FG000|Overall Study|Participant moved|1|||
94525677|NCT01277822|323719756|FG001|Overall Study|Participant moved|0|||
94525678|NCT01220401|323719759|FG000|Overall Study|Withdrawal by Subject|2|||
94525679|NCT01220401|323719759|FG000|Overall Study|Protocol Violation|1|||
94525680|NCT01119066|323719760|FG000|Overall Study|Withdrawal by Subject|4|||
94525681|NCT01119066|323719761|FG001|Overall Study|Withdrawal by Subject|6|||
94525682|NCT01119066|323719762|FG002|Overall Study|Withdrawal by Subject|0|||
94525683|NCT01119066|323719763|FG003|Overall Study|Withdrawal by Subject|0|||
94525684|NCT01119066|323719760|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
94525685|NCT01119066|323719761|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
94525686|NCT01119066|323719762|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
94525687|NCT01119066|323719763|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
94525688|NCT01119066|323719760|FG000|Overall Study|Relapse identified before transplant|1|||
94525689|NCT01119066|323719761|FG001|Overall Study|Relapse identified before transplant|0|||
94525690|NCT01119066|323719762|FG002|Overall Study|Relapse identified before transplant|0|||
94525691|NCT01119066|323719763|FG003|Overall Study|Relapse identified before transplant|0|||
94525692|NCT01119066|323719760|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
94525693|NCT01119066|323719761|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
94525694|NCT01119066|323719762|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
94525695|NCT01119066|323719763|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
94525696|NCT01119066|323719760|FG000|Overall Study|Relapse identified before transplant|0|||
94525697|NCT01119066|323719761|FG001|Overall Study|Relapse identified before transplant|4|||
94525698|NCT01119066|323719762|FG002|Overall Study|Relapse identified before transplant|0|||
94525699|NCT01119066|323719763|FG003|Overall Study|Relapse identified before transplant|0|||
94525700|NCT03943290|323719765|FG000|Overall Study|Sponsor Terminated Study|6|||
94525701|NCT03943290|323719766|FG001|Overall Study|Sponsor Terminated Study|1|||
94525702|NCT03943290|323719767|FG002|Overall Study|Sponsor Terminated Study|11|||
94525703|NCT03943290|323719768|FG003|Overall Study|Sponsor Terminated Study|6|||
94525704|NCT03943290|323719769|FG004|Overall Study|Sponsor Terminated Study|7|||
94525705|NCT03943290|323719770|FG005|Overall Study|Sponsor Terminated Study|6|||
94525706|NCT03943290|323719771|FG006|Overall Study|Sponsor Terminated Study|6|||
94525707|NCT03943290|323719772|FG007|Overall Study|Sponsor Terminated Study|7|||
94525708|NCT03943290|323719773|FG008|Overall Study|Sponsor Terminated Study|8|||
94525709|NCT03943290|323719765|FG000|Overall Study|Lost to Follow-up|1|||
94525710|NCT03943290|323719766|FG001|Overall Study|Lost to Follow-up|0|||
94525711|NCT03943290|323719767|FG002|Overall Study|Lost to Follow-up|1|||
94525712|NCT03943290|323719768|FG003|Overall Study|Lost to Follow-up|0|||
94525713|NCT03943290|323719769|FG004|Overall Study|Lost to Follow-up|0|||
94525714|NCT03943290|323719770|FG005|Overall Study|Lost to Follow-up|0|||
94525715|NCT03943290|323719771|FG006|Overall Study|Lost to Follow-up|0|||
94525716|NCT03943290|323719772|FG007|Overall Study|Lost to Follow-up|1|||
94525717|NCT03943290|323719773|FG008|Overall Study|Lost to Follow-up|0|||
94525718|NCT03943290|323719765|FG000|Overall Study|Withdrawal by Subject|0|||
94525719|NCT03943290|323719766|FG001|Overall Study|Withdrawal by Subject|0|||
94525720|NCT03943290|323719767|FG002|Overall Study|Withdrawal by Subject|1|||
94525721|NCT03943290|323719768|FG003|Overall Study|Withdrawal by Subject|0|||
94525722|NCT03943290|323719769|FG004|Overall Study|Withdrawal by Subject|0|||
94525723|NCT03943290|323719770|FG005|Overall Study|Withdrawal by Subject|0|||
94525724|NCT03943290|323719771|FG006|Overall Study|Withdrawal by Subject|0|||
94525725|NCT03943290|323719772|FG007|Overall Study|Withdrawal by Subject|0|||
94525726|NCT03943290|323719773|FG008|Overall Study|Withdrawal by Subject|0|||
94525727|NCT00955474|323719780|FG000|Overall Study|Physician Decision|7|||
94525728|NCT00955474|323719781|FG001|Overall Study|Physician Decision|5|||
94525729|NCT03012828|323719783|FG000|Overall Study|Lost to Follow-up|1|||
94525730|NCT03012828|323719784|FG001|Overall Study|Lost to Follow-up|0|||
94525731|NCT03012828|323719785|FG002|Overall Study|Lost to Follow-up|1|||
94525732|NCT03012828|323719786|FG003|Overall Study|Lost to Follow-up|0|||
94525733|NCT03012828|323719787|FG004|Overall Study|Lost to Follow-up|1|||
94525734|NCT03012828|323719788|FG005|Overall Study|Lost to Follow-up|0|||
94525735|NCT03012828|323719783|FG000|Overall Study|Withdrawal by Subject|0|||
94525736|NCT03012828|323719784|FG001|Overall Study|Withdrawal by Subject|0|||
94525737|NCT03012828|323719785|FG002|Overall Study|Withdrawal by Subject|1|||
94525738|NCT03012828|323719786|FG003|Overall Study|Withdrawal by Subject|0|||
94525739|NCT03012828|323719787|FG004|Overall Study|Withdrawal by Subject|0|||
94525740|NCT03012828|323719788|FG005|Overall Study|Withdrawal by Subject|1|||
94525741|NCT03012828|323719783|FG000|Overall Study|Non-compliance with protocol|0|||
94525742|NCT03012828|323719784|FG001|Overall Study|Non-compliance with protocol|0|||
94525743|NCT03012828|323719785|FG002|Overall Study|Non-compliance with protocol|0|||
94525744|NCT03012828|323719786|FG003|Overall Study|Non-compliance with protocol|0|||
94525745|NCT03012828|323719787|FG004|Overall Study|Non-compliance with protocol|1|||
94525746|NCT03012828|323719788|FG005|Overall Study|Non-compliance with protocol|0|||
94525747|NCT03012828|323719783|FG000|Overall Study|Delay to last visit would delay DBL|0|||
94525748|NCT03012828|323719784|FG001|Overall Study|Delay to last visit would delay DBL|0|||
94525749|NCT03012828|323719785|FG002|Overall Study|Delay to last visit would delay DBL|0|||
94525750|NCT03012828|323719786|FG003|Overall Study|Delay to last visit would delay DBL|0|||
94525751|NCT03012828|323719787|FG004|Overall Study|Delay to last visit would delay DBL|0|||
94525752|NCT03012828|323719788|FG005|Overall Study|Delay to last visit would delay DBL|1|||
94525753|NCT00690430|323719789|FG000|Core Phase|Abnormal Laboratory value|0|||
94525754|NCT00690430|323719790|FG001|Core Phase|Abnormal Laboratory value|1|||
94525755|NCT00690430|323719791|FG002|Core Phase|Abnormal Laboratory value|0|||
94525756|NCT00690430|323719789|FG000|Core Phase|Adverse Event|5|||
94525757|NCT00690430|323719790|FG001|Core Phase|Adverse Event|1|||
94525758|NCT00690430|323719791|FG002|Core Phase|Adverse Event|0|||
94525759|NCT00690430|323719789|FG000|Core Phase|Death|0|||
94525760|NCT00690430|323719790|FG001|Core Phase|Death|2|||
94525761|NCT00690430|323719791|FG002|Core Phase|Death|0|||
94525762|NCT00690430|323719789|FG000|Core Phase|Protocol Violation|1|||
94525763|NCT00690430|323719790|FG001|Core Phase|Protocol Violation|0|||
94525764|NCT00690430|323719791|FG002|Core Phase|Protocol Violation|0|||
94525765|NCT00690430|323719789|FG000|Core Phase|Withdrawal by Subject|3|||
94525766|NCT00690430|323719790|FG001|Core Phase|Withdrawal by Subject|3|||
94525767|NCT00690430|323719791|FG002|Core Phase|Withdrawal by Subject|0|||
94525768|NCT00690430|323719789|FG000|Core Phase|Subject no longer requires study drug|1|||
94525769|NCT00690430|323719790|FG001|Core Phase|Subject no longer requires study drug|0|||
94525770|NCT00690430|323719791|FG002|Core Phase|Subject no longer requires study drug|0|||
94525771|NCT00690430|323719789|FG000|Core Phase|Lack of Efficacy|8|||
94525772|NCT00690430|323719790|FG001|Core Phase|Lack of Efficacy|10|||
94525773|NCT00690430|323719791|FG002|Core Phase|Lack of Efficacy|0|||
94525774|NCT00690430|323719789|FG000|Core Phase|Administrative Problems|0|||
94525775|NCT00690430|323719790|FG001|Core Phase|Administrative Problems|1|||
94525776|NCT00690430|323719791|FG002|Core Phase|Administrative Problems|0|||
94525777|NCT00690430|323719789|FG000|Core Phase|Early Termination|0|||
94525778|NCT00690430|323719790|FG001|Core Phase|Early Termination|5|||
94525779|NCT00690430|323719791|FG002|Core Phase|Early Termination|0|||
94525780|NCT00690430|323719789|FG000|Extension Phase|Lack of Efficacy|3|||
94525781|NCT00690430|323719790|FG001|Extension Phase|Lack of Efficacy|1|||
94525782|NCT00690430|323719791|FG002|Extension Phase|Lack of Efficacy|4|||
94525783|NCT00690430|323719789|FG000|Extension Phase|Abnormal Lab Values|1|||
94525784|NCT00690430|323719790|FG001|Extension Phase|Abnormal Lab Values|0|||
94525785|NCT00690430|323719791|FG002|Extension Phase|Abnormal Lab Values|0|||
94525786|NCT00690430|323719789|FG000|Extension Phase|Abnormal test procedure results|1|||
94525787|NCT00690430|323719790|FG001|Extension Phase|Abnormal test procedure results|0|||
94525788|NCT00690430|323719791|FG002|Extension Phase|Abnormal test procedure results|0|||
94525789|NCT00690430|323719789|FG000|Extension Phase|Administrative Problems|0|||
94525790|NCT00690430|323719790|FG001|Extension Phase|Administrative Problems|1|||
94525791|NCT00690430|323719791|FG002|Extension Phase|Administrative Problems|1|||
94525792|NCT00690430|323719789|FG000|Extension Phase|Adverse Event|2|||
94525793|NCT00690430|323719790|FG001|Extension Phase|Adverse Event|1|||
94525794|NCT00690430|323719791|FG002|Extension Phase|Adverse Event|2|||
94525795|NCT00690430|323719789|FG000|Extension Phase|Death|1|||
94525796|NCT00690430|323719790|FG001|Extension Phase|Death|1|||
94525797|NCT00690430|323719791|FG002|Extension Phase|Death|1|||
94525798|NCT00690430|323719789|FG000|Extension Phase|Withdrawal by Subject|0|||
94525799|NCT00690430|323719790|FG001|Extension Phase|Withdrawal by Subject|0|||
94525800|NCT00690430|323719791|FG002|Extension Phase|Withdrawal by Subject|2|||
94525801|NCT00690430|323719789|FG000|Extension Phase|Early Termination|10|||
94525802|NCT00690430|323719790|FG001|Extension Phase|Early Termination|1|||
94525803|NCT00690430|323719791|FG002|Extension Phase|Early Termination|3|||
94525804|NCT00625586|323719793|FG000|Overall Study|Adverse Event|1|||
94525805|NCT00625586|323719793|FG000|Overall Study|Progressive disease|1|||
94525806|NCT02366923|323719794|FG000|Overall Study|Withdrawal by Subject|1|||
94525807|NCT02366923|323719794|FG000|Overall Study|Positive Slit Lamp Findings|2|||
94525808|NCT02366923|323719794|FG000|Overall Study|High Astigmatism|3|||
94525809|NCT03083665|323719796|FG000|Double-Blind Period|Adverse Event|5|||
94525810|NCT03083665|323719797|FG001|Double-Blind Period|Adverse Event|4|||
94525811|NCT03083665|323719798|FG002|Double-Blind Period|Adverse Event|5|||
94525812|NCT03083665|323719799|FG003|Double-Blind Period|Adverse Event|0|||
94525813|NCT03083665|323719800|FG004|Double-Blind Period|Adverse Event|0|||
94525814|NCT03083665|323719801|FG005|Double-Blind Period|Adverse Event|0|||
94525815|NCT03083665|323719796|FG000|Double-Blind Period|Lack of Efficacy|0|||
94525816|NCT03083665|323719797|FG001|Double-Blind Period|Lack of Efficacy|0|||
94525817|NCT03083665|323719798|FG002|Double-Blind Period|Lack of Efficacy|1|||
94525818|NCT03083665|323719799|FG003|Double-Blind Period|Lack of Efficacy|0|||
94525819|NCT03083665|323719800|FG004|Double-Blind Period|Lack of Efficacy|0|||
94525820|NCT03083665|323719801|FG005|Double-Blind Period|Lack of Efficacy|0|||
94525821|NCT03083665|323719796|FG000|Double-Blind Period|Protocol Violation|1|||
94525822|NCT03083665|323719797|FG001|Double-Blind Period|Protocol Violation|0|||
94525823|NCT03083665|323719798|FG002|Double-Blind Period|Protocol Violation|1|||
94525824|NCT03083665|323719799|FG003|Double-Blind Period|Protocol Violation|0|||
94525825|NCT03083665|323719800|FG004|Double-Blind Period|Protocol Violation|0|||
94525826|NCT03083665|323719801|FG005|Double-Blind Period|Protocol Violation|0|||
94525827|NCT03083665|323719796|FG000|Double-Blind Period|Lost to Follow-up|1|||
94525828|NCT03083665|323719797|FG001|Double-Blind Period|Lost to Follow-up|0|||
94525829|NCT03083665|323719798|FG002|Double-Blind Period|Lost to Follow-up|1|||
94525830|NCT03083665|323719799|FG003|Double-Blind Period|Lost to Follow-up|0|||
94525831|NCT03083665|323719800|FG004|Double-Blind Period|Lost to Follow-up|0|||
94525832|NCT03083665|323719801|FG005|Double-Blind Period|Lost to Follow-up|0|||
94525833|NCT03083665|323719796|FG000|Double-Blind Period|Withdrawal by Subject|3|||
94525834|NCT03083665|323719797|FG001|Double-Blind Period|Withdrawal by Subject|0|||
94525835|NCT03083665|323719798|FG002|Double-Blind Period|Withdrawal by Subject|0|||
94525836|NCT03083665|323719799|FG003|Double-Blind Period|Withdrawal by Subject|0|||
94525837|NCT03083665|323719800|FG004|Double-Blind Period|Withdrawal by Subject|0|||
94525838|NCT03083665|323719801|FG005|Double-Blind Period|Withdrawal by Subject|0|||
94525839|NCT03083665|323719796|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
94525840|NCT03083665|323719797|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
94525841|NCT03083665|323719798|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
94525842|NCT03083665|323719799|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
94525843|NCT03083665|323719800|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
94525844|NCT03083665|323719801|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
94525845|NCT03083665|323719796|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
94525846|NCT03083665|323719797|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
94525847|NCT03083665|323719798|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
94525848|NCT03083665|323719799|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
94525849|NCT03083665|323719800|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
94525850|NCT03083665|323719801|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
94525851|NCT03083665|323719796|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
94525852|NCT03083665|323719797|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
94525853|NCT03083665|323719798|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
94525854|NCT03083665|323719799|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
94525855|NCT03083665|323719800|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
94525856|NCT03083665|323719801|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
94525857|NCT03083665|323719796|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
94525858|NCT03083665|323719797|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
94525859|NCT03083665|323719798|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
94525860|NCT03083665|323719799|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
94525861|NCT03083665|323719800|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
94525862|NCT03083665|323719801|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
94525863|NCT03083665|323719796|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
94525864|NCT03083665|323719797|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
94525865|NCT03083665|323719798|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
94525866|NCT03083665|323719799|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
94525867|NCT03083665|323719800|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
94525868|NCT03083665|323719801|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
94525869|NCT03083665|323719796|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
94525870|NCT03083665|323719797|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
94525871|NCT03083665|323719798|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
94525872|NCT03083665|323719799|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
94525873|NCT03083665|323719800|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
94525874|NCT03083665|323719801|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
94525875|NCT03083665|323719796|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
94525876|NCT03083665|323719797|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
94525877|NCT03083665|323719798|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
94525878|NCT03083665|323719799|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
94525879|NCT03083665|323719800|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
94525880|NCT03083665|323719801|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
94525881|NCT03083665|323719796|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
94525882|NCT03083665|323719797|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
94525883|NCT03083665|323719798|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
94525884|NCT03083665|323719799|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
94525885|NCT03083665|323719800|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
94525886|NCT03083665|323719801|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
94525887|NCT03083665|323719796|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
94525888|NCT03083665|323719797|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
94525889|NCT03083665|323719798|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
94525890|NCT03083665|323719799|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
94525891|NCT03083665|323719800|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
94525892|NCT03083665|323719801|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
94525893|NCT02484443|323719804|FG000|Overall Study|Lack of Efficacy|28|||
94525894|NCT02484443|323719804|FG000|Overall Study|Physician Decision|2|||
94525895|NCT02484443|323719804|FG000|Overall Study|Ineligible|2|||
94525896|NCT03902392|323719805|FG000|Overall Study|Lost to Follow-up|7|||
94525897|NCT03902392|323719806|FG001|Overall Study|Lost to Follow-up|7|||
94525898|NCT00809926|323719813|FG000|Overall Study|Adverse Event|18|||
94525899|NCT00809926|323719814|FG001|Overall Study|Adverse Event|10|||
94525900|NCT00809926|323719813|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
94525901|NCT00809926|323719814|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
94525902|NCT00809926|323719813|FG000|Overall Study|Patient withdrew consent|8|||
94525903|NCT00809926|323719814|FG001|Overall Study|Patient withdrew consent|6|||
94525904|NCT00809926|323719813|FG000|Overall Study|Lost to Follow-up|2|||
94525905|NCT00809926|323719814|FG001|Overall Study|Lost to Follow-up|1|||
94525906|NCT00809926|323719813|FG000|Overall Study|Administrative Problems|0|||
94525907|NCT00809926|323719814|FG001|Overall Study|Administrative Problems|1|||
94525908|NCT00809926|323719813|FG000|Overall Study|Protocol deviation|0|||
94525909|NCT00809926|323719814|FG001|Overall Study|Protocol deviation|2|||
94525910|NCT00130039|323719819|FG000|Overall Study|Withdrawal by Subject|15|||
94525911|NCT00130039|323719820|FG001|Overall Study|Withdrawal by Subject|11|||
94525912|NCT00130039|323719819|FG000|Overall Study|Lost to Follow-up|3|||
94525913|NCT00130039|323719820|FG001|Overall Study|Lost to Follow-up|1|||
94525914|NCT00130039|323719819|FG000|Overall Study|Adverse Event|4|||
94525915|NCT00130039|323719820|FG001|Overall Study|Adverse Event|2|||
94525916|NCT00130039|323719819|FG000|Overall Study|Physician Decision|3|||
94525917|NCT00130039|323719820|FG001|Overall Study|Physician Decision|0|||
94525918|NCT00130039|323719819|FG000|Overall Study|clinical events without follow up MRI|5|||
94525919|NCT00130039|323719820|FG001|Overall Study|clinical events without follow up MRI|4|||
94525920|NCT00642707|323719823|FG000|Overall Study|Adverse Event|0|||
94525921|NCT00642707|323719824|FG001|Overall Study|Adverse Event|0|||
94525922|NCT00642707|323719825|FG002|Overall Study|Adverse Event|0|||
94525923|NCT00642707|323719826|FG003|Overall Study|Adverse Event|2|||
94525924|NCT00642707|323719823|FG000|Overall Study|Withdrawal by Subject|1|||
94525925|NCT00642707|323719824|FG001|Overall Study|Withdrawal by Subject|0|||
94525926|NCT00642707|323719825|FG002|Overall Study|Withdrawal by Subject|0|||
94525927|NCT00642707|323719826|FG003|Overall Study|Withdrawal by Subject|0|||
94525928|NCT01016132|323719842|FG000|Overall Study|Discomfort|1|||
94525929|NCT02311881|323719843|FG000|Overall Study|Did not meet the study criteria|2|||
94525930|NCT02311881|323719844|FG001|Overall Study|Did not meet the study criteria|2|||
94525931|NCT02311881|323719845|FG002|Overall Study|Did not meet the study criteria|0|||
94525932|NCT02311881|323719843|FG000|Overall Study|Adverse Event|7|||
94525933|NCT02311881|323719844|FG001|Overall Study|Adverse Event|15|||
94525934|NCT02311881|323719845|FG002|Overall Study|Adverse Event|8|||
94525935|NCT02311881|323719843|FG000|Overall Study|Lost to Follow-up|3|||
94525936|NCT02311881|323719844|FG001|Overall Study|Lost to Follow-up|3|||
94525937|NCT02311881|323719845|FG002|Overall Study|Lost to Follow-up|2|||
94525938|NCT02311881|323719843|FG000|Overall Study|Protocol Violation|1|||
94525939|NCT02311881|323719844|FG001|Overall Study|Protocol Violation|2|||
94525940|NCT02311881|323719845|FG002|Overall Study|Protocol Violation|3|||
94525941|NCT02311881|323719843|FG000|Overall Study|Withdrawal of consent|14|||
94525942|NCT02311881|323719844|FG001|Overall Study|Withdrawal of consent|16|||
94525943|NCT02311881|323719845|FG002|Overall Study|Withdrawal of consent|17|||
94525944|NCT02311881|323719843|FG000|Overall Study|Other|0|||
94525945|NCT02311881|323719844|FG001|Overall Study|Other|0|||
94525946|NCT02311881|323719845|FG002|Overall Study|Other|1|||
94525947|NCT02311881|323719843|FG000|Overall Study|Lack of Efficacy|1|||
94525948|NCT02311881|323719844|FG001|Overall Study|Lack of Efficacy|2|||
94525949|NCT02311881|323719845|FG002|Overall Study|Lack of Efficacy|0|||
94525950|NCT02311881|323719843|FG000|Overall Study|Subject has border line pregnancy test|1|||
94525951|NCT02311881|323719844|FG001|Overall Study|Subject has border line pregnancy test|0|||
94525952|NCT02311881|323719845|FG002|Overall Study|Subject has border line pregnancy test|0|||
94525953|NCT02311881|323719843|FG000|Overall Study|Withdrawal by Subject|3|||
94525954|NCT02311881|323719844|FG001|Overall Study|Withdrawal by Subject|1|||
94525955|NCT02311881|323719845|FG002|Overall Study|Withdrawal by Subject|4|||
94525956|NCT02311881|323719843|FG000|Overall Study|Sponsor Decision|1|||
94525957|NCT02311881|323719844|FG001|Overall Study|Sponsor Decision|1|||
94525958|NCT02311881|323719845|FG002|Overall Study|Sponsor Decision|1|||
94525959|NCT02311881|323719843|FG000|Overall Study|Protocol Deviation|1|||
94525960|NCT02311881|323719844|FG001|Overall Study|Protocol Deviation|0|||
94525961|NCT02311881|323719845|FG002|Overall Study|Protocol Deviation|0|||
94525962|NCT02311881|323719843|FG000|Overall Study|Non-Compliance|1|||
94525963|NCT02311881|323719844|FG001|Overall Study|Non-Compliance|0|||
94525964|NCT02311881|323719845|FG002|Overall Study|Non-Compliance|2|||
94525965|NCT02311881|323719843|FG000|Overall Study|Physician Decision|0|||
94525966|NCT02311881|323719844|FG001|Overall Study|Physician Decision|0|||
94525967|NCT02311881|323719845|FG002|Overall Study|Physician Decision|1|||
94525968|NCT02311881|323719843|FG000|Overall Study|Medical Monitor Discretion|0|||
94525969|NCT02311881|323719844|FG001|Overall Study|Medical Monitor Discretion|0|||
94525970|NCT02311881|323719845|FG002|Overall Study|Medical Monitor Discretion|1|||
94525971|NCT02311881|323719843|FG000|Overall Study|Participant taking another medication|0|||
94525972|NCT02311881|323719844|FG001|Overall Study|Participant taking another medication|0|||
94525973|NCT02311881|323719845|FG002|Overall Study|Participant taking another medication|1|||
94525974|NCT02311881|323719843|FG000|Overall Study|Serious Adverse Event|0|||
94525975|NCT02311881|323719844|FG001|Overall Study|Serious Adverse Event|1|||
94525976|NCT02311881|323719845|FG002|Overall Study|Serious Adverse Event|0|||
94525977|NCT00803595|323719846|FG000|Overall Study|Adverse Event|3|||
94525978|NCT00803595|323719847|FG001|Overall Study|Adverse Event|4|||
94525979|NCT00803595|323719848|FG002|Overall Study|Adverse Event|1|||
94525980|NCT00803595|323719846|FG000|Overall Study|Protocol Violation|7|||
94525981|NCT00803595|323719847|FG001|Overall Study|Protocol Violation|2|||
94525982|NCT00803595|323719848|FG002|Overall Study|Protocol Violation|12|||
94525983|NCT00803595|323719846|FG000|Overall Study|Withdrawal by Subject|5|||
94525984|NCT00803595|323719847|FG001|Overall Study|Withdrawal by Subject|2|||
94525985|NCT00803595|323719848|FG002|Overall Study|Withdrawal by Subject|3|||
94525986|NCT00837161|323719849|FG000|Overall Study|refused hysterectomy|2|||
94525987|NCT01963767|323719850|FG000|Overall Study|Withdrawal by Subject|4|||
94525988|NCT01963767|323719851|FG001|Overall Study|Withdrawal by Subject|2|||
94525989|NCT01963767|323719850|FG000|Overall Study|Adverse Event|2|||
94525990|NCT01963767|323719851|FG001|Overall Study|Adverse Event|0|||
94525991|NCT02151786|323719852|FG000|Overall Study|Unavailability of Case Report Form|26|||
94525992|NCT02151786|323719852|FG000|Overall Study|Outside the Contract Period|1|||
94525993|NCT02151786|323719852|FG000|Overall Study|Randomized, not Treated|1|||
94525994|NCT02151786|323719852|FG000|Overall Study|Unavailability of Information|8|||
94525995|NCT02949024|323719853|FG000|Overall Study|Withdrawal by Subject|0|||
94525996|NCT02949024|323719854|FG001|Overall Study|Withdrawal by Subject|1|||
94525997|NCT03640325|323721127|FG000|Overall Study|Withdrawal by Subject|4|||
94525998|NCT03640325|323721128|FG001|Overall Study|Withdrawal by Subject|1|||
94525999|NCT03640325|323721129|FG002|Overall Study|Withdrawal by Subject|0|||
94526000|NCT03640325|323721127|FG000|Overall Study|Lost to Follow-up|4|||
94526001|NCT03640325|323721128|FG001|Overall Study|Lost to Follow-up|5|||
94526002|NCT03640325|323721129|FG002|Overall Study|Lost to Follow-up|21|||
94526003|NCT03640325|323721127|FG000|Overall Study|Death|5|||
94526004|NCT03640325|323721128|FG001|Overall Study|Death|5|||
94526005|NCT03640325|323721129|FG002|Overall Study|Death|0|||
94526006|NCT01566149|323721130|FG000|Overall Study|Adverse Event|0|||
94526007|NCT01566149|323721131|FG001|Overall Study|Adverse Event|1|||
94526008|NCT01566149|323721130|FG000|Overall Study|Non-compliance with study medication|2|||
94526009|NCT01566149|323721131|FG001|Overall Study|Non-compliance with study medication|0|||
94526010|NCT01566149|323721130|FG000|Overall Study|Protocol Violation|0|||
94526011|NCT01566149|323721131|FG001|Overall Study|Protocol Violation|1|||
94526012|NCT01566149|323721130|FG000|Overall Study|Withdrawal by Subject|1|||
94526013|NCT01566149|323721131|FG001|Overall Study|Withdrawal by Subject|0|||
94526014|NCT03276728|323721132|FG000|Overall Study|Lost to Follow-up|0|||
94526015|NCT03276728|323721133|FG001|Overall Study|Lost to Follow-up|0|||
94526016|NCT03276728|323721134|FG002|Overall Study|Lost to Follow-up|2|||
94526017|NCT03276728|323721135|FG003|Overall Study|Lost to Follow-up|2|||
94526018|NCT03276728|323721136|FG004|Overall Study|Lost to Follow-up|0|||
94526019|NCT03276728|323721137|FG005|Overall Study|Lost to Follow-up|0|||
94526020|NCT03276728|323721138|FG006|Overall Study|Lost to Follow-up|0|||
94526021|NCT03276728|323721139|FG007|Overall Study|Lost to Follow-up|0|||
94526022|NCT03276728|323721132|FG000|Overall Study|Withdrawal by Subject|0|||
94526023|NCT03276728|323721133|FG001|Overall Study|Withdrawal by Subject|0|||
94526024|NCT03276728|323721134|FG002|Overall Study|Withdrawal by Subject|0|||
94526025|NCT03276728|323721135|FG003|Overall Study|Withdrawal by Subject|3|||
94526026|NCT03276728|323721136|FG004|Overall Study|Withdrawal by Subject|0|||
94526027|NCT03276728|323721137|FG005|Overall Study|Withdrawal by Subject|0|||
94526028|NCT03276728|323721138|FG006|Overall Study|Withdrawal by Subject|0|||
94526029|NCT03276728|323721139|FG007|Overall Study|Withdrawal by Subject|0|||
94526030|NCT03276728|323721132|FG000|Overall Study|Decision by sponsor|0|||
94526031|NCT03276728|323721133|FG001|Overall Study|Decision by sponsor|0|||
94526032|NCT03276728|323721134|FG002|Overall Study|Decision by sponsor|0|||
94526033|NCT03276728|323721135|FG003|Overall Study|Decision by sponsor|0|||
94526034|NCT03276728|323721136|FG004|Overall Study|Decision by sponsor|1|||
94526035|NCT03276728|323721137|FG005|Overall Study|Decision by sponsor|0|||
94526036|NCT03276728|323721138|FG006|Overall Study|Decision by sponsor|2|||
94526037|NCT03276728|323721139|FG007|Overall Study|Decision by sponsor|1|||
94526038|NCT02982772|323721140|FG000|Intervention|Lost to Follow-up|19|||
94526039|NCT02982772|323721141|FG001|Intervention|Lost to Follow-up|13|||
94526040|NCT02982772|323721140|FG000|1M Follow-Up|Lost to Follow-up|21|||
94526041|NCT02982772|323721141|FG001|1M Follow-Up|Lost to Follow-up|18|||
94526042|NCT02982772|323721140|FG000|3M Follow-Up|Lost to Follow-up|17|||
94526043|NCT02982772|323721141|FG001|3M Follow-Up|Lost to Follow-up|11|||
94526044|NCT02982772|323721140|FG000|6M Follow-Up|Lost to Follow-up|11|||
94526045|NCT02982772|323721141|FG001|6M Follow-Up|Lost to Follow-up|9|||
94526046|NCT02982772|323721140|FG000|12M Follow-Up|Lost to Follow-up|11|||
94526047|NCT02982772|323721141|FG001|12M Follow-Up|Lost to Follow-up|5|||
94526048|NCT01713582|323721144|FG000|Overall Study|Disease progression|3|||
94526049|NCT01713582|323721145|FG001|Overall Study|Disease progression|3|||
94526050|NCT01713582|323721146|FG002|Overall Study|Disease progression|3|||
94526051|NCT01713582|323721147|FG003|Overall Study|Disease progression|2|||
94526052|NCT01713582|323721148|FG004|Overall Study|Disease progression|3|||
94526053|NCT01713582|323721149|FG005|Overall Study|Disease progression|3|||
94526054|NCT01713582|323721150|FG006|Overall Study|Disease progression|3|||
94526055|NCT01713582|323721151|FG007|Overall Study|Disease progression|3|||
94526056|NCT01713582|323721152|FG008|Overall Study|Disease progression|3|||
94526057|NCT01713582|323721153|FG009|Overall Study|Disease progression|11|||
94526058|NCT01713582|323721154|FG010|Overall Study|Disease progression|10|||
94526059|NCT01713582|323721155|FG011|Overall Study|Disease progression|5|||
94526060|NCT01713582|323721156|FG012|Overall Study|Disease progression|3|||
94526061|NCT01713582|323721157|FG013|Overall Study|Disease progression|3|||
94526062|NCT01713582|323721158|FG014|Overall Study|Disease progression|6|||
94526063|NCT01713582|323721159|FG015|Overall Study|Disease progression|6|||
94526064|NCT01713582|323721160|FG016|Overall Study|Disease progression|5|||
94526065|NCT01713582|323721161|FG017|Overall Study|Disease progression|2|||
94526066|NCT01713582|323721162|FG018|Overall Study|Disease progression|3|||
94526067|NCT01713582|323721163|FG019|Overall Study|Disease progression|5|||
94526068|NCT01713582|323721164|FG020|Overall Study|Disease progression|15|||
94526069|NCT01713582|323721144|FG000|Overall Study|Death|0|||
94526070|NCT01713582|323721145|FG001|Overall Study|Death|0|||
94526071|NCT01713582|323721146|FG002|Overall Study|Death|0|||
94526072|NCT01713582|323721147|FG003|Overall Study|Death|1|||
94526073|NCT01713582|323721148|FG004|Overall Study|Death|1|||
94526074|NCT01713582|323721149|FG005|Overall Study|Death|3|||
94526075|NCT01713582|323721150|FG006|Overall Study|Death|3|||
94526076|NCT01713582|323721151|FG007|Overall Study|Death|2|||
94526077|NCT01713582|323721152|FG008|Overall Study|Death|3|||
94526078|NCT01713582|323721153|FG009|Overall Study|Death|4|||
94526079|NCT01713582|323721154|FG010|Overall Study|Death|3|||
94526080|NCT01713582|323721155|FG011|Overall Study|Death|0|||
94526081|NCT01713582|323721156|FG012|Overall Study|Death|0|||
94526082|NCT01713582|323721157|FG013|Overall Study|Death|0|||
94526083|NCT01713582|323721158|FG014|Overall Study|Death|0|||
94526084|NCT01713582|323721159|FG015|Overall Study|Death|0|||
94526085|NCT01713582|323721160|FG016|Overall Study|Death|0|||
94526086|NCT01713582|323721161|FG017|Overall Study|Death|0|||
94526087|NCT01713582|323721162|FG018|Overall Study|Death|0|||
94526088|NCT01713582|323721163|FG019|Overall Study|Death|0|||
94526089|NCT01713582|323721164|FG020|Overall Study|Death|0|||
94526090|NCT01713582|323721144|FG000|Overall Study|Adverse event-related|0|||
94526091|NCT01713582|323721145|FG001|Overall Study|Adverse event-related|0|||
94526092|NCT01713582|323721146|FG002|Overall Study|Adverse event-related|0|||
94526093|NCT01713582|323721147|FG003|Overall Study|Adverse event-related|0|||
94526094|NCT01713582|323721148|FG004|Overall Study|Adverse event-related|0|||
94526095|NCT01713582|323721149|FG005|Overall Study|Adverse event-related|0|||
94526096|NCT01713582|323721150|FG006|Overall Study|Adverse event-related|0|||
94526097|NCT01713582|323721151|FG007|Overall Study|Adverse event-related|0|||
94526098|NCT01713582|323721152|FG008|Overall Study|Adverse event-related|0|||
94526099|NCT01713582|323721153|FG009|Overall Study|Adverse event-related|1|||
94526100|NCT01713582|323721154|FG010|Overall Study|Adverse event-related|1|||
94526101|NCT01713582|323721155|FG011|Overall Study|Adverse event-related|0|||
94526102|NCT01713582|323721156|FG012|Overall Study|Adverse event-related|0|||
94526103|NCT01713582|323721157|FG013|Overall Study|Adverse event-related|0|||
94526104|NCT01713582|323721158|FG014|Overall Study|Adverse event-related|0|||
94526105|NCT01713582|323721159|FG015|Overall Study|Adverse event-related|0|||
94526106|NCT01713582|323721160|FG016|Overall Study|Adverse event-related|0|||
94526107|NCT01713582|323721161|FG017|Overall Study|Adverse event-related|0|||
94526108|NCT01713582|323721162|FG018|Overall Study|Adverse event-related|1|||
94526109|NCT01713582|323721163|FG019|Overall Study|Adverse event-related|0|||
94526110|NCT01713582|323721164|FG020|Overall Study|Adverse event-related|0|||
94526111|NCT01713582|323721144|FG000|Overall Study|Adverse event-unrelated|0|||
94526112|NCT01713582|323721145|FG001|Overall Study|Adverse event-unrelated|0|||
94526113|NCT01713582|323721146|FG002|Overall Study|Adverse event-unrelated|0|||
94526114|NCT01713582|323721147|FG003|Overall Study|Adverse event-unrelated|0|||
94526115|NCT01713582|323721148|FG004|Overall Study|Adverse event-unrelated|0|||
94526116|NCT01713582|323721149|FG005|Overall Study|Adverse event-unrelated|1|||
94526117|NCT01713582|323721150|FG006|Overall Study|Adverse event-unrelated|1|||
94526118|NCT01713582|323721151|FG007|Overall Study|Adverse event-unrelated|1|||
94526119|NCT01713582|323721152|FG008|Overall Study|Adverse event-unrelated|0|||
94526120|NCT01713582|323721153|FG009|Overall Study|Adverse event-unrelated|0|||
94526121|NCT01713582|323721154|FG010|Overall Study|Adverse event-unrelated|0|||
94526122|NCT01713582|323721155|FG011|Overall Study|Adverse event-unrelated|0|||
94526123|NCT01713582|323721156|FG012|Overall Study|Adverse event-unrelated|0|||
94526124|NCT01713582|323721157|FG013|Overall Study|Adverse event-unrelated|1|||
94526125|NCT01713582|323721158|FG014|Overall Study|Adverse event-unrelated|1|||
94526126|NCT01713582|323721159|FG015|Overall Study|Adverse event-unrelated|0|||
94526127|NCT01713582|323721160|FG016|Overall Study|Adverse event-unrelated|0|||
94526128|NCT01713582|323721161|FG017|Overall Study|Adverse event-unrelated|0|||
94526129|NCT01713582|323721162|FG018|Overall Study|Adverse event-unrelated|0|||
94526130|NCT01713582|323721163|FG019|Overall Study|Adverse event-unrelated|0|||
94526131|NCT01713582|323721164|FG020|Overall Study|Adverse event-unrelated|0|||
94526132|NCT01713582|323721144|FG000|Overall Study|Withdrawal of consent|0|||
94526133|NCT01713582|323721145|FG001|Overall Study|Withdrawal of consent|0|||
94526134|NCT01713582|323721146|FG002|Overall Study|Withdrawal of consent|1|||
94526135|NCT01713582|323721147|FG003|Overall Study|Withdrawal of consent|0|||
94526136|NCT01713582|323721148|FG004|Overall Study|Withdrawal of consent|0|||
94526137|NCT01713582|323721149|FG005|Overall Study|Withdrawal of consent|1|||
94526138|NCT01713582|323721150|FG006|Overall Study|Withdrawal of consent|0|||
94526139|NCT01713582|323721151|FG007|Overall Study|Withdrawal of consent|0|||
94526140|NCT01713582|323721152|FG008|Overall Study|Withdrawal of consent|0|||
94526141|NCT01713582|323721153|FG009|Overall Study|Withdrawal of consent|1|||
94526142|NCT01713582|323721154|FG010|Overall Study|Withdrawal of consent|0|||
94526143|NCT01713582|323721155|FG011|Overall Study|Withdrawal of consent|0|||
94526144|NCT01713582|323721156|FG012|Overall Study|Withdrawal of consent|0|||
94526145|NCT01713582|323721157|FG013|Overall Study|Withdrawal of consent|0|||
94526146|NCT01713582|323721158|FG014|Overall Study|Withdrawal of consent|0|||
94526147|NCT01713582|323721159|FG015|Overall Study|Withdrawal of consent|0|||
94526148|NCT01713582|323721160|FG016|Overall Study|Withdrawal of consent|0|||
94526149|NCT01713582|323721161|FG017|Overall Study|Withdrawal of consent|0|||
94526150|NCT01713582|323721162|FG018|Overall Study|Withdrawal of consent|1|||
94526151|NCT01713582|323721163|FG019|Overall Study|Withdrawal of consent|0|||
94526152|NCT01713582|323721164|FG020|Overall Study|Withdrawal of consent|0|||
94526153|NCT01713582|323721144|FG000|Overall Study|Lack of Efficacy|0|||
94526154|NCT01713582|323721145|FG001|Overall Study|Lack of Efficacy|0|||
94526155|NCT01713582|323721146|FG002|Overall Study|Lack of Efficacy|0|||
94526156|NCT01713582|323721147|FG003|Overall Study|Lack of Efficacy|0|||
94526157|NCT01713582|323721148|FG004|Overall Study|Lack of Efficacy|0|||
94526158|NCT01713582|323721149|FG005|Overall Study|Lack of Efficacy|0|||
94526159|NCT01713582|323721150|FG006|Overall Study|Lack of Efficacy|0|||
94526160|NCT01713582|323721151|FG007|Overall Study|Lack of Efficacy|0|||
94526161|NCT01713582|323721152|FG008|Overall Study|Lack of Efficacy|0|||
94526162|NCT01713582|323721153|FG009|Overall Study|Lack of Efficacy|1|||
94526163|NCT01713582|323721154|FG010|Overall Study|Lack of Efficacy|2|||
94526164|NCT01713582|323721155|FG011|Overall Study|Lack of Efficacy|0|||
94526165|NCT01713582|323721156|FG012|Overall Study|Lack of Efficacy|0|||
94526166|NCT01713582|323721157|FG013|Overall Study|Lack of Efficacy|0|||
94526167|NCT01713582|323721158|FG014|Overall Study|Lack of Efficacy|0|||
94526168|NCT01713582|323721159|FG015|Overall Study|Lack of Efficacy|0|||
94526169|NCT01713582|323721160|FG016|Overall Study|Lack of Efficacy|0|||
94526170|NCT01713582|323721161|FG017|Overall Study|Lack of Efficacy|0|||
94526171|NCT01713582|323721162|FG018|Overall Study|Lack of Efficacy|0|||
94526172|NCT01713582|323721163|FG019|Overall Study|Lack of Efficacy|0|||
94526173|NCT01713582|323721164|FG020|Overall Study|Lack of Efficacy|0|||
94526174|NCT01713582|323721144|FG000|Overall Study|Withdrawal by Subject|0|||
94526175|NCT01713582|323721145|FG001|Overall Study|Withdrawal by Subject|0|||
94526176|NCT01713582|323721146|FG002|Overall Study|Withdrawal by Subject|0|||
94526177|NCT01713582|323721147|FG003|Overall Study|Withdrawal by Subject|0|||
94526178|NCT01713582|323721148|FG004|Overall Study|Withdrawal by Subject|0|||
94526179|NCT01713582|323721149|FG005|Overall Study|Withdrawal by Subject|0|||
94526180|NCT01713582|323721150|FG006|Overall Study|Withdrawal by Subject|0|||
94526181|NCT01713582|323721151|FG007|Overall Study|Withdrawal by Subject|0|||
94526182|NCT01713582|323721152|FG008|Overall Study|Withdrawal by Subject|0|||
94526183|NCT01713582|323721153|FG009|Overall Study|Withdrawal by Subject|0|||
94526184|NCT01713582|323721154|FG010|Overall Study|Withdrawal by Subject|0|||
94526185|NCT01713582|323721155|FG011|Overall Study|Withdrawal by Subject|0|||
94526186|NCT01713582|323721156|FG012|Overall Study|Withdrawal by Subject|0|||
94526187|NCT01713582|323721157|FG013|Overall Study|Withdrawal by Subject|0|||
94526188|NCT01713582|323721158|FG014|Overall Study|Withdrawal by Subject|0|||
94526189|NCT01713582|323721159|FG015|Overall Study|Withdrawal by Subject|0|||
94526190|NCT01713582|323721160|FG016|Overall Study|Withdrawal by Subject|0|||
94526191|NCT01713582|323721161|FG017|Overall Study|Withdrawal by Subject|1|||
94526192|NCT01713582|323721162|FG018|Overall Study|Withdrawal by Subject|0|||
94526193|NCT01713582|323721163|FG019|Overall Study|Withdrawal by Subject|0|||
94526194|NCT01713582|323721164|FG020|Overall Study|Withdrawal by Subject|0|||
94526195|NCT01713582|323721144|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
94526196|NCT01713582|323721145|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
94526197|NCT01713582|323721146|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
94526198|NCT01713582|323721147|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
94526199|NCT01713582|323721148|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
94526200|NCT01713582|323721149|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
94526201|NCT01713582|323721150|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
94526202|NCT01713582|323721151|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
94526203|NCT01713582|323721152|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
94526204|NCT01713582|323721153|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
94526205|NCT01713582|323721154|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
94526206|NCT01713582|323721155|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
94526207|NCT01713582|323721156|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
94526208|NCT01713582|323721157|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
94526209|NCT01713582|323721158|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
94526210|NCT01713582|323721159|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
94526211|NCT01713582|323721160|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
94526212|NCT01713582|323721161|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
94526213|NCT01713582|323721162|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
94526214|NCT01713582|323721163|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
94526215|NCT01713582|323721164|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
94526216|NCT01713582|323721144|FG000|Overall Study|Disease progression and adverse event|0|||
94526217|NCT01713582|323721145|FG001|Overall Study|Disease progression and adverse event|0|||
94526218|NCT01713582|323721146|FG002|Overall Study|Disease progression and adverse event|0|||
94526219|NCT01713582|323721147|FG003|Overall Study|Disease progression and adverse event|0|||
94526220|NCT01713582|323721148|FG004|Overall Study|Disease progression and adverse event|0|||
94526221|NCT01713582|323721149|FG005|Overall Study|Disease progression and adverse event|0|||
94526222|NCT01713582|323721150|FG006|Overall Study|Disease progression and adverse event|0|||
94526223|NCT01713582|323721151|FG007|Overall Study|Disease progression and adverse event|0|||
94526224|NCT01713582|323721152|FG008|Overall Study|Disease progression and adverse event|0|||
94526225|NCT01713582|323721153|FG009|Overall Study|Disease progression and adverse event|0|||
94526226|NCT01713582|323721154|FG010|Overall Study|Disease progression and adverse event|0|||
94526227|NCT01713582|323721155|FG011|Overall Study|Disease progression and adverse event|0|||
94526228|NCT01713582|323721156|FG012|Overall Study|Disease progression and adverse event|0|||
94526229|NCT01713582|323721157|FG013|Overall Study|Disease progression and adverse event|0|||
94526230|NCT01713582|323721158|FG014|Overall Study|Disease progression and adverse event|0|||
94526231|NCT01713582|323721159|FG015|Overall Study|Disease progression and adverse event|0|||
94526232|NCT01713582|323721160|FG016|Overall Study|Disease progression and adverse event|1|||
94526233|NCT01713582|323721161|FG017|Overall Study|Disease progression and adverse event|0|||
94526234|NCT01713582|323721162|FG018|Overall Study|Disease progression and adverse event|0|||
94526235|NCT01713582|323721163|FG019|Overall Study|Disease progression and adverse event|0|||
94526236|NCT01713582|323721164|FG020|Overall Study|Disease progression and adverse event|0|||
94526237|NCT03783962|323721165|FG000|Overall Study|Lost to Follow-up|3|||
94526238|NCT03783962|323721166|FG001|Overall Study|Lost to Follow-up|6|||
94526239|NCT03783962|323721165|FG000|Overall Study|Protocol Violation|0|||
94526240|NCT03783962|323721166|FG001|Overall Study|Protocol Violation|1|||
94526241|NCT03458325|323721167|FG000|Overall Study|Withdrawal by Subject|1|||
94526242|NCT01484496|323721171|FG000|Period 1|Protocol Violation|3|||
94526243|NCT01484496|323721172|FG001|Period 1|Protocol Violation|4|||
94526244|NCT01484496|323721173|FG002|Period 1|Protocol Violation|0|||
94526245|NCT01484496|323721174|FG003|Period 1|Protocol Violation|0|||
94526246|NCT01484496|323721171|FG000|Period 1|Physician Decision|5|||
94526247|NCT01484496|323721172|FG001|Period 1|Physician Decision|1|||
94526248|NCT01484496|323721173|FG002|Period 1|Physician Decision|0|||
94526249|NCT01484496|323721174|FG003|Period 1|Physician Decision|0|||
94526250|NCT01484496|323721171|FG000|Period 1|Lack of Efficacy|10|||
94526251|NCT01484496|323721172|FG001|Period 1|Lack of Efficacy|15|||
94526252|NCT01484496|323721173|FG002|Period 1|Lack of Efficacy|0|||
94526253|NCT01484496|323721174|FG003|Period 1|Lack of Efficacy|0|||
94526254|NCT01484496|323721171|FG000|Period 1|Adverse Event|25|||
94526255|NCT01484496|323721172|FG001|Period 1|Adverse Event|40|||
94526256|NCT01484496|323721173|FG002|Period 1|Adverse Event|0|||
94526257|NCT01484496|323721174|FG003|Period 1|Adverse Event|0|||
94526258|NCT01484496|323721171|FG000|Period 1|Withdrawal by Subject|15|||
94526259|NCT01484496|323721172|FG001|Period 1|Withdrawal by Subject|12|||
94526260|NCT01484496|323721173|FG002|Period 1|Withdrawal by Subject|0|||
94526261|NCT01484496|323721174|FG003|Period 1|Withdrawal by Subject|0|||
94526262|NCT01484496|323721171|FG000|Period 1|Lost to Follow-up|2|||
94526263|NCT01484496|323721172|FG001|Period 1|Lost to Follow-up|6|||
94526264|NCT01484496|323721173|FG002|Period 1|Lost to Follow-up|0|||
94526265|NCT01484496|323721174|FG003|Period 1|Lost to Follow-up|0|||
94526266|NCT01484496|323721171|FG000|Period 1|Positive Pregnancy|1|||
94526267|NCT01484496|323721172|FG001|Period 1|Positive Pregnancy|6|||
94526268|NCT01484496|323721173|FG002|Period 1|Positive Pregnancy|0|||
94526269|NCT01484496|323721174|FG003|Period 1|Positive Pregnancy|0|||
94526270|NCT01484496|323721171|FG000|Period 1|Treatment Failure|3|||
94526271|NCT01484496|323721172|FG001|Period 1|Treatment Failure|6|||
94526272|NCT01484496|323721173|FG002|Period 1|Treatment Failure|0|||
94526273|NCT01484496|323721174|FG003|Period 1|Treatment Failure|0|||
94526274|NCT01484496|323721171|FG000|Period 1|Lack of Compliance|2|||
94526275|NCT01484496|323721172|FG001|Period 1|Lack of Compliance|1|||
94526276|NCT01484496|323721173|FG002|Period 1|Lack of Compliance|0|||
94526277|NCT01484496|323721174|FG003|Period 1|Lack of Compliance|0|||
94526278|NCT01484496|323721171|FG000|Period 1|Unable to Visit Site|0|||
94526279|NCT01484496|323721172|FG001|Period 1|Unable to Visit Site|2|||
94526280|NCT01484496|323721173|FG002|Period 1|Unable to Visit Site|0|||
94526281|NCT01484496|323721174|FG003|Period 1|Unable to Visit Site|0|||
94526282|NCT01484496|323721171|FG000|Period 2|Lack of Efficacy|0|||
94526283|NCT01484496|323721172|FG001|Period 2|Lack of Efficacy|0|||
94526284|NCT01484496|323721173|FG002|Period 2|Lack of Efficacy|1|||
94526285|NCT01484496|323721174|FG003|Period 2|Lack of Efficacy|3|||
94526286|NCT01484496|323721171|FG000|Period 2|Adverse Event|0|||
94526287|NCT01484496|323721172|FG001|Period 2|Adverse Event|0|||
94526288|NCT01484496|323721173|FG002|Period 2|Adverse Event|5|||
94526289|NCT01484496|323721174|FG003|Period 2|Adverse Event|13|||
94526290|NCT01484496|323721171|FG000|Period 2|Other|0|||
94526291|NCT01484496|323721172|FG001|Period 2|Other|0|||
94526292|NCT01484496|323721173|FG002|Period 2|Other|9|||
94526293|NCT01484496|323721174|FG003|Period 2|Other|6|||
94526294|NCT00700622|323721175|FG000|Overall Study|Adverse Event|4|||
94526295|NCT00700622|323721176|FG001|Overall Study|Adverse Event|0|||
94526296|NCT00700622|323721175|FG000|Overall Study|Lost to Follow-up|0|||
94526297|NCT00700622|323721176|FG001|Overall Study|Lost to Follow-up|1|||
94526298|NCT00700622|323721175|FG000|Overall Study|Physician Decision|2|||
94526299|NCT00700622|323721176|FG001|Overall Study|Physician Decision|1|||
94526300|NCT00700622|323721175|FG000|Overall Study|Protocol Violation|0|||
94526301|NCT00700622|323721176|FG001|Overall Study|Protocol Violation|1|||
94526302|NCT00700622|323721175|FG000|Overall Study|Withdrawal by Subject|4|||
94526303|NCT00700622|323721176|FG001|Overall Study|Withdrawal by Subject|1|||
94526304|NCT00700622|323721175|FG000|Overall Study|Other|3|||
94526305|NCT00700622|323721176|FG001|Overall Study|Other|1|||
94526306|NCT00383331|323721177|FG000|Overall Study|Protocol Violation|0|||
94526307|NCT00383331|323721178|FG001|Overall Study|Protocol Violation|1|||
94526308|NCT00375427|323721179|FG000|Overall Study|Adverse Event|21|||
94526309|NCT00375427|323721180|FG001|Overall Study|Adverse Event|27|||
94526310|NCT00375427|323721179|FG000|Overall Study|Abnormal test procedure result(s)|0|||
94526311|NCT00375427|323721180|FG001|Overall Study|Abnormal test procedure result(s)|1|||
94526312|NCT00375427|323721179|FG000|Overall Study|Abnormal laboratory value(s)|1|||
94526313|NCT00375427|323721180|FG001|Overall Study|Abnormal laboratory value(s)|2|||
94526314|NCT00375427|323721179|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
94526315|NCT00375427|323721180|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
94526316|NCT00375427|323721179|FG000|Overall Study|Patient no longer requires study drug|3|||
94526317|NCT00375427|323721180|FG001|Overall Study|Patient no longer requires study drug|7|||
94526318|NCT00375427|323721179|FG000|Overall Study|Protocol Violation|10|||
94526319|NCT00375427|323721180|FG001|Overall Study|Protocol Violation|8|||
94526320|NCT00375427|323721179|FG000|Overall Study|Withdrawal by Subject|9|||
94526321|NCT00375427|323721180|FG001|Overall Study|Withdrawal by Subject|13|||
94526322|NCT00375427|323721179|FG000|Overall Study|Lost to Follow-up|1|||
94526323|NCT00375427|323721180|FG001|Overall Study|Lost to Follow-up|1|||
94526324|NCT00375427|323721179|FG000|Overall Study|Administrative reasons|0|||
94526325|NCT00375427|323721180|FG001|Overall Study|Administrative reasons|1|||
94526326|NCT00375427|323721179|FG000|Overall Study|Death|11|||
94526327|NCT00375427|323721180|FG001|Overall Study|Death|10|||
94526328|NCT02831855|323721183|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
94526329|NCT02831855|323721184|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
94526330|NCT02831855|323721185|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
94526331|NCT02831855|323721183|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
94526332|NCT02831855|323721184|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
94526333|NCT02831855|323721185|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
94526334|NCT02831855|323721183|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
94526335|NCT02831855|323721184|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
94526336|NCT02831855|323721185|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
94526337|NCT02831855|323721183|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
94526338|NCT02831855|323721184|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
94526339|NCT02831855|323721185|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
94526340|NCT02831855|323721183|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
94526341|NCT02831855|323721184|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
94526342|NCT02831855|323721185|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
94526343|NCT02831855|323721183|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
94526344|NCT02831855|323721184|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
94526345|NCT02831855|323721185|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
94526346|NCT02831855|323721183|FG000|Open Label Phase (24 Weeks)|Other|4|||
94526347|NCT02831855|323721184|FG001|Open Label Phase (24 Weeks)|Other|0|||
94526348|NCT02831855|323721185|FG002|Open Label Phase (24 Weeks)|Other|0|||
94526349|NCT02831855|323721183|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
94526350|NCT02831855|323721184|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
94526351|NCT02831855|323721185|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
94526352|NCT02831855|323721183|FG000|Double Blind Phase (24 Weeks)|Death|0|||
94526353|NCT02831855|323721184|FG001|Double Blind Phase (24 Weeks)|Death|0|||
94526354|NCT02831855|323721185|FG002|Double Blind Phase (24 Weeks)|Death|2|||
94526355|NCT02831855|323721183|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
94526356|NCT02831855|323721184|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
94526357|NCT02831855|323721185|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
94526358|NCT02831855|323721183|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
94526359|NCT02831855|323721184|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
94526360|NCT02831855|323721185|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
94526361|NCT02831855|323721183|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
94526362|NCT02831855|323721184|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
94526363|NCT02831855|323721185|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
94526364|NCT02831855|323721183|FG000|Double Blind Phase (24 Weeks)|Other|0|||
94526365|NCT02831855|323721184|FG001|Double Blind Phase (24 Weeks)|Other|2|||
94526366|NCT02831855|323721185|FG002|Double Blind Phase (24 Weeks)|Other|5|||
94526367|NCT02831855|323721183|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
94526368|NCT02831855|323721184|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
94526369|NCT02831855|323721185|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
94526370|NCT02831855|323721183|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
94526371|NCT02831855|323721184|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
94526372|NCT02831855|323721185|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
94526373|NCT02831855|323721183|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
94526374|NCT02831855|323721184|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
94526375|NCT02831855|323721185|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
94526376|NCT02298868|323721186|FG000|Overall Study|Adverse Event|1|||
94526377|NCT02298868|323721186|FG000|Overall Study|Death|1|||
94526378|NCT02298868|323721186|FG000|Overall Study|Patient underwent transplant|1|||
94526379|NCT00606411|323721194|FG000|Overall Study|Adverse Event|1|||
94526380|NCT00606411|323721195|FG001|Overall Study|Adverse Event|2|||
94526381|NCT00606411|323721194|FG000|Overall Study|Lack of Adherence|1|||
94526382|NCT00606411|323721195|FG001|Overall Study|Lack of Adherence|1|||
94526383|NCT00606411|323721194|FG000|Overall Study|Lack of Efficacy|1|||
94526384|NCT00606411|323721195|FG001|Overall Study|Lack of Efficacy|1|||
94526385|NCT00606411|323721194|FG000|Overall Study|Withdrawal by Subject|2|||
94526386|NCT00606411|323721195|FG001|Overall Study|Withdrawal by Subject|0|||
94526387|NCT00606411|323721194|FG000|Overall Study|Lost to Follow-up|1|||
94526388|NCT00606411|323721195|FG001|Overall Study|Lost to Follow-up|2|||
94526389|NCT00606411|323721194|FG000|Overall Study|Move out of state|0|||
94526390|NCT00606411|323721195|FG001|Overall Study|Move out of state|1|||
94526391|NCT01369199|323721204|FG000|Overall Study|Withdrawal by Subject|1|||
94526392|NCT01369199|323721204|FG000|Overall Study|Lost to Follow-up|2|||
94526393|NCT03900728|323721205|FG000|Overall Study|No text responses|0|||
94526394|NCT03900728|323721206|FG001|Overall Study|No text responses|0|||
94526395|NCT03900728|323721207|FG002|Overall Study|No text responses|4|||
94526396|NCT02125838|323721208|FG000|Overall Study|Lost to Follow-up|4|||
94526397|NCT02125838|323721209|FG001|Overall Study|Lost to Follow-up|4|||
94526398|NCT02565147|323721210|FG000|Overall Study|Withdrawal by Subject|5|||
94526399|NCT02565147|323721211|FG001|Overall Study|Withdrawal by Subject|1|||
94526400|NCT02565147|323721210|FG000|Overall Study|Lost to Follow-up|0|||
94526401|NCT02565147|323721211|FG001|Overall Study|Lost to Follow-up|1|||
94526402|NCT02565147|323721210|FG000|Overall Study|Death|1|||
94526403|NCT02565147|323721211|FG001|Overall Study|Death|1|||
94526404|NCT02969915|323721212|FG000|Overall Study|Death|104|||
94526405|NCT02969915|323721213|FG001|Overall Study|Death|125|||
94526406|NCT02969915|323721212|FG000|Overall Study|Lost to Follow-up|108|||
94526407|NCT02969915|323721213|FG001|Overall Study|Lost to Follow-up|112|||
94526408|NCT02969915|323721212|FG000|Overall Study|Censored due to COVID-19|481|||
94526409|NCT02969915|323721213|FG001|Overall Study|Censored due to COVID-19|471|||
94526410|NCT03799952|323721214|FG000|Overall Study|Program was too easy, discontinued|1|||
94526411|NCT03799952|323721215|FG001|Overall Study|Program was too easy, discontinued|0|||
94526412|NCT03799952|323721214|FG000|Overall Study|Lost to Follow-up|0|||
94526413|NCT03799952|323721215|FG001|Overall Study|Lost to Follow-up|2|||
94526414|NCT03472495|323721216|FG000|Overall Study|Treatment no longer indicated|1|||
94526415|NCT03472495|323721217|FG001|Overall Study|Treatment no longer indicated|2|||
94526416|NCT03472495|323721216|FG000|Overall Study|Physician Decision|0|||
94526417|NCT03472495|323721217|FG001|Overall Study|Physician Decision|2|||
94526418|NCT01162473|323721219|FG000|Overall Study|Adverse Event|2|||
94526419|NCT01162473|323721220|FG001|Overall Study|Adverse Event|1|||
94526420|NCT01162473|323721219|FG000|Overall Study|Withdrawal by Subject|0|||
94526421|NCT01162473|323721220|FG001|Overall Study|Withdrawal by Subject|4|||
94526422|NCT01001767|323721221|FG000|Overall Study|no baseline study performed|1|||
94526423|NCT01001767|323721222|FG001|Overall Study|no baseline study performed|0|||
94526424|NCT01001767|323721221|FG000|Overall Study|Protocol Violation|1|||
94526425|NCT01001767|323721222|FG001|Overall Study|Protocol Violation|0|||
94526426|NCT01001767|323721221|FG000|Overall Study|Lost to Follow-up|1|||
94526427|NCT01001767|323721222|FG001|Overall Study|Lost to Follow-up|0|||
94526428|NCT01001767|323721221|FG000|Overall Study|Physician Decision|1|||
94526429|NCT01001767|323721222|FG001|Overall Study|Physician Decision|0|||
94526430|NCT00407602|323721224|FG000|Overall Study|Death - unrelated to device|1|||
94526431|NCT00407602|323721224|FG000|Overall Study|Device explanted|5|||
94526432|NCT00407602|323721224|FG000|Overall Study|Withdrawal by Subject|1|||
94526433|NCT02063984|323721225|FG000|Overall Study|Lost to Follow-up|6|||
94526434|NCT02063984|323721226|FG001|Overall Study|Lost to Follow-up|5|||
94526435|NCT04466384|323721227|FG000|First Phase|Protocol Violation|1|||
94526436|NCT04466384|323721228|FG001|First Phase|Protocol Violation|0|||
94526437|NCT04466384|323721227|FG000|First Phase|Missing data|1|||
94526438|NCT04466384|323721228|FG001|First Phase|Missing data|0|||
94526439|NCT04466384|323721227|FG000|Cross Over Phase|Physician Decision|1|||
94526440|NCT04466384|323721228|FG001|Cross Over Phase|Physician Decision|0|||
94526441|NCT04466384|323721227|FG000|Cross Over Phase|Withdrawal by Subject|0|||
94526442|NCT04466384|323721228|FG001|Cross Over Phase|Withdrawal by Subject|1|||
94526443|NCT03089047|323721231|FG000|Overall Study|Lost to Follow-up|1|||
94526444|NCT03089047|323721232|FG001|Overall Study|Lost to Follow-up|0|||
94526445|NCT00790582|323721243|FG000|Overall Study|Death|14|||
94526446|NCT00790582|323721244|FG001|Overall Study|Death|32|||
94526447|NCT00790582|323721243|FG000|Overall Study|Physician Decision|7|||
94526448|NCT00790582|323721244|FG001|Overall Study|Physician Decision|1|||
94526449|NCT00790582|323721243|FG000|Overall Study|Lost to Follow-up|3|||
94526450|NCT00790582|323721244|FG001|Overall Study|Lost to Follow-up|3|||
94526451|NCT00790582|323721243|FG000|Overall Study|Withdrawal by Subject|7|||
94526452|NCT00790582|323721244|FG001|Overall Study|Withdrawal by Subject|51|||
94526453|NCT03135431|323721246|FG000|Overall Study|Study Surgeon not available|2|||
94526454|NCT03135431|323721247|FG001|Overall Study|Study Surgeon not available|0|||
94526455|NCT03008070|323721248|FG000|Overall Study|Adverse Event|3|||
94526456|NCT03008070|323721249|FG001|Overall Study|Adverse Event|3|||
94526457|NCT03008070|323721250|FG002|Overall Study|Adverse Event|3|||
94526458|NCT03008070|323721248|FG000|Overall Study|Lost to Follow-up|1|||
94526459|NCT03008070|323721249|FG001|Overall Study|Lost to Follow-up|1|||
94526460|NCT03008070|323721250|FG002|Overall Study|Lost to Follow-up|0|||
94526461|NCT03008070|323721248|FG000|Overall Study|Non compliance|0|||
94526462|NCT03008070|323721249|FG001|Overall Study|Non compliance|1|||
94526463|NCT03008070|323721250|FG002|Overall Study|Non compliance|1|||
94526464|NCT03008070|323721248|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
94526465|NCT03008070|323721249|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
94526466|NCT03008070|323721250|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
94526467|NCT03008070|323721248|FG000|Overall Study|Withdrawal by Subject|2|||
94526468|NCT03008070|323721249|FG001|Overall Study|Withdrawal by Subject|0|||
94526469|NCT03008070|323721250|FG002|Overall Study|Withdrawal by Subject|1|||
94526470|NCT03008070|323721248|FG000|Overall Study|Use of prohibited drug|0|||
94526471|NCT03008070|323721249|FG001|Overall Study|Use of prohibited drug|0|||
94526472|NCT03008070|323721250|FG002|Overall Study|Use of prohibited drug|2|||
94526473|NCT00325130|323721253|FG000|Overall Study|Lost to Follow-up|6|||
94526474|NCT00325130|323721254|FG001|Overall Study|Lost to Follow-up|14|||
94526475|NCT00325130|323721253|FG000|Overall Study|Withdrawal by Subject|12|||
94526476|NCT00325130|323721254|FG001|Overall Study|Withdrawal by Subject|14|||
94526477|NCT00325130|323721253|FG000|Overall Study|Protocol Deviation|0|||
94526478|NCT00325130|323721254|FG001|Overall Study|Protocol Deviation|1|||
94526479|NCT00325130|323721253|FG000|Overall Study|Moved|0|||
94526480|NCT00325130|323721254|FG001|Overall Study|Moved|1|||
94526481|NCT00325130|323721253|FG000|Overall Study|Patient Discontinued for Other|1|||
94526482|NCT00325130|323721254|FG001|Overall Study|Patient Discontinued for Other|0|||
94526483|NCT00326001|323721255|FG000|Overall Study|Adverse Event|4|||
94526484|NCT00326001|323721256|FG001|Overall Study|Adverse Event|5|||
94526485|NCT00326001|323721255|FG000|Overall Study|Physician Decision|3|||
94526486|NCT00326001|323721256|FG001|Overall Study|Physician Decision|3|||
94526487|NCT03110029|323721258|FG000|Overall Study|Withdrawal by Subject|1|||
94526488|NCT03110029|323721259|FG001|Overall Study|Withdrawal by Subject|1|||
94526489|NCT01082081|323721262|FG000|Overall Study|Lost to Follow-up|0|||
94526490|NCT01082081|323721263|FG001|Overall Study|Lost to Follow-up|0|||
94526491|NCT01082081|323721264|FG002|Overall Study|Lost to Follow-up|1|||
94526492|NCT01082081|323721262|FG000|Overall Study|Withdrawal by Subject|0|||
94526493|NCT01082081|323721263|FG001|Overall Study|Withdrawal by Subject|0|||
94526494|NCT01082081|323721264|FG002|Overall Study|Withdrawal by Subject|1|||
94526495|NCT01082081|323721262|FG000|Overall Study|Other Reason|0|||
94526496|NCT01082081|323721263|FG001|Overall Study|Other Reason|1|||
94526497|NCT01082081|323721264|FG002|Overall Study|Other Reason|0|||
94526498|NCT02175277|323721265|FG000|Overall Study|Protocol-specified Criteria|1|||
94526499|NCT00375674|323721273|FG000|Overall Study|Other|26|||
94526500|NCT00375674|323721274|FG001|Overall Study|Other|18|||
94526501|NCT00375674|323721273|FG000|Overall Study|Death|67|||
94526502|NCT00375674|323721274|FG001|Overall Study|Death|76|||
94526503|NCT00375674|323721273|FG000|Overall Study|Participants refused further follow-up|31|||
94526504|NCT00375674|323721274|FG001|Overall Study|Participants refused further follow-up|30|||
94526505|NCT00375674|323721273|FG000|Overall Study|Lost to Follow-up|17|||
94526506|NCT00375674|323721274|FG001|Overall Study|Lost to Follow-up|15|||
94526507|NCT00375674|323721273|FG000|Overall Study|Enrolled but not treated|3|||
94526508|NCT00375674|323721274|FG001|Overall Study|Enrolled but not treated|2|||
94526509|NCT00912782|323721275|FG000|Overall Study|Death|2|||
94526510|NCT00912782|323721276|FG001|Overall Study|Death|1|||
94526511|NCT00912782|323721275|FG000|Overall Study|Lost to Follow-up|0|||
94526512|NCT00912782|323721276|FG001|Overall Study|Lost to Follow-up|1|||
94526513|NCT00912782|323721275|FG000|Overall Study|Did not receive vascular access type|1|||
94526514|NCT00912782|323721276|FG001|Overall Study|Did not receive vascular access type|2|||
94526515|NCT00912782|323721275|FG000|Overall Study|Relocated before study completion|0|||
94526516|NCT00912782|323721276|FG001|Overall Study|Relocated before study completion|1|||
94526517|NCT03333928|323722852|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
94526518|NCT03333928|323722853|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
94526519|NCT03333928|323722854|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
94526520|NCT03333928|323722852|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
94526521|NCT03333928|323722853|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
94526522|NCT03333928|323722854|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
94526523|NCT03333928|323722852|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
94526524|NCT03333928|323722853|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
94526525|NCT03333928|323722854|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
94526526|NCT03333928|323722852|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
94526527|NCT03333928|323722853|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
94526528|NCT03333928|323722854|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
94526529|NCT03333928|323722852|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
94526530|NCT03333928|323722853|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
94526531|NCT03333928|323722854|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
94526532|NCT03333928|323722852|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
94526533|NCT03333928|323722853|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
94526534|NCT03333928|323722854|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
94526535|NCT03333928|323722852|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
94526536|NCT03333928|323722853|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
94526537|NCT03333928|323722854|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
94526538|NCT03333928|323722852|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
94526539|NCT03333928|323722853|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
94526540|NCT03333928|323722854|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
94526541|NCT00559104|323722855|FG000|Overall Study|Lack of Efficacy|9|||
94526542|NCT00559104|323722856|FG001|Overall Study|Lack of Efficacy|0|||
94526543|NCT04723355|323722859|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
94526544|NCT04723355|323722859|FG000|Overall Study|Errors in the informed consent form|2|||
94526545|NCT04072835|323722860|FG000|Overall Study|Overall trial ended|603|||
94526546|NCT04072835|323722860|FG000|Overall Study|Ablation|97|||
94526547|NCT04072835|323722860|FG000|Overall Study|Withdrawal of consent|66|||
94526548|NCT04072835|323722860|FG000|Overall Study|Physician Decision|50|||
94526549|NCT04072835|323722860|FG000|Overall Study|Lost to Follow-up|39|||
94526550|NCT04072835|323722860|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
94526551|NCT04072835|323722860|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
94526552|NCT04072835|323722860|FG000|Overall Study|Adverse Event|25|||
94526553|NCT04072835|323722860|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
94526554|NCT04072835|323722860|FG000|Overall Study|Death|11|||
94526555|NCT04072835|323722860|FG000|Overall Study|Participant felt the drug did not work|8|||
94526556|NCT04072835|323722860|FG000|Overall Study|Participant tolerability|5|||
94526557|NCT04072835|323722860|FG000|Overall Study|Missing|5|||
94526558|NCT04072835|323722860|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
94526559|NCT04072835|323722860|FG000|Overall Study|Pregnancy|3|||
94526560|NCT00620373|323722863|FG000|Overall Study|Unverified cancer status|33|||
94526561|NCT00566982|323722865|FG000|Overall Study|Adverse Event|6|||
94526562|NCT00566982|323722866|FG001|Overall Study|Adverse Event|48|||
94526563|NCT00566982|323722865|FG000|Overall Study|Withdrawal by Subject|1|||
94526564|NCT00566982|323722866|FG001|Overall Study|Withdrawal by Subject|14|||
94526565|NCT00566982|323722865|FG000|Overall Study|Protocol Violation|1|||
94526566|NCT00566982|323722866|FG001|Overall Study|Protocol Violation|4|||
94526567|NCT00566982|323722865|FG000|Overall Study|Lost to Follow-up|0|||
94526568|NCT00566982|323722866|FG001|Overall Study|Lost to Follow-up|1|||
94526569|NCT00566982|323722865|FG000|Overall Study|Other-family problems & doctor's request|0|||
94526570|NCT00566982|323722866|FG001|Overall Study|Other-family problems & doctor's request|2|||
94526571|NCT00293813|323722870|FG000|Overall Study|Physician Decision|0|||
94526572|NCT00293813|323722871|FG001|Overall Study|Physician Decision|1|||
94526573|NCT00293813|323722872|FG002|Overall Study|Physician Decision|0|||
94526574|NCT00293813|323722870|FG000|Overall Study|Adverse Event|3|||
94526575|NCT00293813|323722871|FG001|Overall Study|Adverse Event|1|||
94526576|NCT00293813|323722872|FG002|Overall Study|Adverse Event|1|||
94526577|NCT00293813|323722870|FG000|Overall Study|Withdrawal by Subject|7|||
94526578|NCT00293813|323722871|FG001|Overall Study|Withdrawal by Subject|4|||
94526579|NCT00293813|323722872|FG002|Overall Study|Withdrawal by Subject|4|||
94526580|NCT00293813|323722870|FG000|Overall Study|Lost to Follow-up|3|||
94526581|NCT00293813|323722871|FG001|Overall Study|Lost to Follow-up|2|||
94526582|NCT00293813|323722872|FG002|Overall Study|Lost to Follow-up|3|||
94526583|NCT00293813|323722870|FG000|Overall Study|Noncompliance|0|||
94526584|NCT00293813|323722871|FG001|Overall Study|Noncompliance|1|||
94526585|NCT00293813|323722872|FG002|Overall Study|Noncompliance|0|||
94526586|NCT02140970|323722873|FG000|Overall Study|Lost to Follow-up|1|||
94526587|NCT02140970|323722874|FG001|Overall Study|Lost to Follow-up|2|||
94526588|NCT02140970|323722873|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
94526589|NCT02140970|323722874|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
94526590|NCT02140970|323722873|FG000|Overall Study|Did not meet inclusion criteria|0|||
94526591|NCT02140970|323722874|FG001|Overall Study|Did not meet inclusion criteria|1|||
94526592|NCT00460655|323722875|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
94526593|NCT00460655|323722876|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
94526594|NCT00460655|323722877|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
94526595|NCT00460655|323722878|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
94526596|NCT00460655|323722875|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
94526597|NCT00460655|323722876|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
94526598|NCT00460655|323722877|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
94526599|NCT00460655|323722878|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
94526600|NCT00460655|323722875|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
94526601|NCT00460655|323722876|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
94526602|NCT00460655|323722877|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
94526603|NCT00460655|323722878|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
94526604|NCT00460655|323722875|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
94526605|NCT00460655|323722876|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
94526606|NCT00460655|323722877|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
94526607|NCT00460655|323722878|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
94526608|NCT00460655|323722875|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
94526609|NCT00460655|323722876|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
94526610|NCT00460655|323722877|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
94526611|NCT00460655|323722878|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
94526612|NCT00460655|323722875|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
94526613|NCT00460655|323722876|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
94526614|NCT00460655|323722877|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
94526615|NCT00460655|323722878|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
94526616|NCT01709110|323722879|FG000|Overall Study|Adverse Event|56|||
94526617|NCT01709110|323722880|FG001|Overall Study|Adverse Event|48|||
94526618|NCT01709110|323722879|FG000|Overall Study|Death|14|||
94526619|NCT01709110|323722880|FG001|Overall Study|Death|6|||
94526620|NCT01709110|323722879|FG000|Overall Study|Lost to Follow-up|7|||
94526621|NCT01709110|323722880|FG001|Overall Study|Lost to Follow-up|5|||
94526622|NCT01709110|323722879|FG000|Overall Study|Protocol Violation|4|||
94526623|NCT01709110|323722880|FG001|Overall Study|Protocol Violation|6|||
94526624|NCT01709110|323722879|FG000|Overall Study|Withdrawal by Subject|96|||
94526625|NCT01709110|323722880|FG001|Overall Study|Withdrawal by Subject|89|||
94526626|NCT01709110|323722879|FG000|Overall Study|Physician Decision|4|||
94526627|NCT01709110|323722880|FG001|Overall Study|Physician Decision|10|||
94526628|NCT01709110|323722879|FG000|Overall Study|Sponsor Decision|2|||
94526629|NCT01709110|323722880|FG001|Overall Study|Sponsor Decision|2|||
94526630|NCT01709110|323722879|FG000|Overall Study|Lack of Efficacy|1|||
94526631|NCT01709110|323722880|FG001|Overall Study|Lack of Efficacy|1|||
94526632|NCT01709110|323722879|FG000|Overall Study|Caregiver Decision|1|||
94526633|NCT01709110|323722880|FG001|Overall Study|Caregiver Decision|1|||
94526634|NCT01645735|323722883|FG000|Overall Study|Physician Decision|2|||
94526635|NCT01645735|323722884|FG001|Overall Study|Physician Decision|0|||
94526636|NCT01645735|323722883|FG000|Overall Study|Withdrawal by Subject|1|||
94526637|NCT01645735|323722884|FG001|Overall Study|Withdrawal by Subject|0|||
94526638|NCT01645735|323722883|FG000|Overall Study|Protocol Violation|1|||
94526639|NCT01645735|323722884|FG001|Overall Study|Protocol Violation|0|||
94526640|NCT01645735|323722883|FG000|Overall Study|Adverse Event|0|||
94526641|NCT01645735|323722884|FG001|Overall Study|Adverse Event|1|||
94526642|NCT00211172|323722887|FG000|Overall Study|Died or lost health plan eligibility|39|||
94526643|NCT00211172|323722888|FG001|Overall Study|Died or lost health plan eligibility|32|||
94526644|NCT05059301|323722894|FG000|Overall Study|Adverse Event|0|||
94526645|NCT05059301|323722895|FG001|Overall Study|Adverse Event|2|||
94526646|NCT05059301|323722896|FG002|Overall Study|Adverse Event|2|||
94526647|NCT05059301|323722894|FG000|Overall Study|Lost to Follow-up|2|||
94526648|NCT05059301|323722895|FG001|Overall Study|Lost to Follow-up|3|||
94526649|NCT05059301|323722896|FG002|Overall Study|Lost to Follow-up|3|||
94526650|NCT03726658|323722897|FG000|Overall Study|Lost to Follow-up|0|||
94526651|NCT03726658|323722898|FG001|Overall Study|Lost to Follow-up|0|||
94526652|NCT03726658|323722899|FG002|Overall Study|Lost to Follow-up|2|||
94526653|NCT03726658|323722900|FG003|Overall Study|Lost to Follow-up|0|||
94526654|NCT03726658|323722901|FG004|Overall Study|Lost to Follow-up|0|||
94526655|NCT03726658|323722902|FG005|Overall Study|Lost to Follow-up|1|||
94526656|NCT03726658|323722903|FG006|Overall Study|Lost to Follow-up|1|||
94526657|NCT03726658|323722897|FG000|Overall Study|Withdrawal by Subject|1|||
94526658|NCT03726658|323722898|FG001|Overall Study|Withdrawal by Subject|0|||
94526659|NCT03726658|323722899|FG002|Overall Study|Withdrawal by Subject|0|||
94526660|NCT03726658|323722900|FG003|Overall Study|Withdrawal by Subject|0|||
94526661|NCT03726658|323722901|FG004|Overall Study|Withdrawal by Subject|6|||
94526662|NCT03726658|323722902|FG005|Overall Study|Withdrawal by Subject|4|||
94526663|NCT03726658|323722903|FG006|Overall Study|Withdrawal by Subject|2|||
94526664|NCT03726658|323722897|FG000|Overall Study|Pregnancy|0|||
94526665|NCT03726658|323722898|FG001|Overall Study|Pregnancy|0|||
94526666|NCT03726658|323722899|FG002|Overall Study|Pregnancy|0|||
94526667|NCT03726658|323722900|FG003|Overall Study|Pregnancy|0|||
94526668|NCT03726658|323722901|FG004|Overall Study|Pregnancy|0|||
94526669|NCT03726658|323722902|FG005|Overall Study|Pregnancy|0|||
94526670|NCT03726658|323722903|FG006|Overall Study|Pregnancy|1|||
94526671|NCT03726658|323722897|FG000|Overall Study|Not Reported|0|||
94526672|NCT03726658|323722898|FG001|Overall Study|Not Reported|0|||
94526673|NCT03726658|323722899|FG002|Overall Study|Not Reported|0|||
94526674|NCT03726658|323722900|FG003|Overall Study|Not Reported|0|||
94526675|NCT03726658|323722901|FG004|Overall Study|Not Reported|0|||
94526676|NCT03726658|323722902|FG005|Overall Study|Not Reported|0|||
94526677|NCT03726658|323722903|FG006|Overall Study|Not Reported|1|||
94526678|NCT00412958|323722904|FG000|Overall Study|Withdrawal by Subject|3|||
94526679|NCT00412958|323722905|FG001|Overall Study|Withdrawal by Subject|0|||
94526680|NCT00412958|323722906|FG002|Overall Study|Withdrawal by Subject|0|||
94526681|NCT00412958|323722907|FG003|Overall Study|Withdrawal by Subject|1|||
94526682|NCT00412958|323722904|FG000|Overall Study|Adverse Event|0|||
94526683|NCT00412958|323722905|FG001|Overall Study|Adverse Event|1|||
94526684|NCT00412958|323722906|FG002|Overall Study|Adverse Event|0|||
94526685|NCT00412958|323722907|FG003|Overall Study|Adverse Event|0|||
94526686|NCT00412958|323722904|FG000|Overall Study|Lost to Follow-up|0|||
94526687|NCT00412958|323722905|FG001|Overall Study|Lost to Follow-up|1|||
94526688|NCT00412958|323722906|FG002|Overall Study|Lost to Follow-up|0|||
94526689|NCT00412958|323722907|FG003|Overall Study|Lost to Follow-up|0|||
94526690|NCT00412958|323722904|FG000|Overall Study|Death|0|||
94526691|NCT00412958|323722905|FG001|Overall Study|Death|1|||
94526692|NCT00412958|323722906|FG002|Overall Study|Death|0|||
94526693|NCT00412958|323722907|FG003|Overall Study|Death|0|||
94526694|NCT00412958|323722904|FG000|Overall Study|Transport issue|0|||
94526695|NCT00412958|323722905|FG001|Overall Study|Transport issue|1|||
94526696|NCT00412958|323722906|FG002|Overall Study|Transport issue|0|||
94526697|NCT00412958|323722907|FG003|Overall Study|Transport issue|0|||
94526698|NCT01524224|323722916|FG000|Overall Study|Progressive Disease|1|||
94526699|NCT01524224|323722917|FG001|Overall Study|Progressive Disease|0|||
94526700|NCT01524224|323722918|FG002|Overall Study|Progressive Disease|2|||
94526701|NCT01524224|323722919|FG003|Overall Study|Progressive Disease|1|||
94526702|NCT01524224|323722920|FG004|Overall Study|Progressive Disease|2|||
94526703|NCT01524224|323722921|FG005|Overall Study|Progressive Disease|1|||
94526704|NCT01524224|323722922|FG006|Overall Study|Progressive Disease|1|||
94526705|NCT01524224|323722923|FG007|Overall Study|Progressive Disease|5|||
94526706|NCT01524224|323722916|FG000|Overall Study|Withdrawal by Subject|2|||
94526707|NCT01524224|323722917|FG001|Overall Study|Withdrawal by Subject|0|||
94526708|NCT01524224|323722918|FG002|Overall Study|Withdrawal by Subject|0|||
94526709|NCT01524224|323722919|FG003|Overall Study|Withdrawal by Subject|0|||
94526710|NCT01524224|323722920|FG004|Overall Study|Withdrawal by Subject|0|||
94526711|NCT01524224|323722921|FG005|Overall Study|Withdrawal by Subject|0|||
94526712|NCT01524224|323722922|FG006|Overall Study|Withdrawal by Subject|2|||
94526713|NCT01524224|323722923|FG007|Overall Study|Withdrawal by Subject|0|||
94526714|NCT01524224|323722916|FG000|Overall Study|Adverse Event|0|||
94526715|NCT01524224|323722917|FG001|Overall Study|Adverse Event|1|||
94526716|NCT01524224|323722918|FG002|Overall Study|Adverse Event|0|||
94526717|NCT01524224|323722919|FG003|Overall Study|Adverse Event|0|||
94526718|NCT01524224|323722920|FG004|Overall Study|Adverse Event|0|||
94526719|NCT01524224|323722921|FG005|Overall Study|Adverse Event|1|||
94526720|NCT01524224|323722922|FG006|Overall Study|Adverse Event|0|||
94526721|NCT01524224|323722923|FG007|Overall Study|Adverse Event|0|||
94526722|NCT01524224|323722916|FG000|Overall Study|Physician Decision|0|||
94526723|NCT01524224|323722917|FG001|Overall Study|Physician Decision|0|||
94526724|NCT01524224|323722918|FG002|Overall Study|Physician Decision|0|||
94526725|NCT01524224|323722919|FG003|Overall Study|Physician Decision|1|||
94526726|NCT01524224|323722920|FG004|Overall Study|Physician Decision|1|||
94526727|NCT01524224|323722921|FG005|Overall Study|Physician Decision|0|||
94526728|NCT01524224|323722922|FG006|Overall Study|Physician Decision|0|||
94526729|NCT01524224|323722923|FG007|Overall Study|Physician Decision|1|||
94526730|NCT01524224|323722916|FG000|Overall Study|Sponsor Decision|0|||
94526731|NCT01524224|323722917|FG001|Overall Study|Sponsor Decision|0|||
94526732|NCT01524224|323722918|FG002|Overall Study|Sponsor Decision|0|||
94526733|NCT01524224|323722919|FG003|Overall Study|Sponsor Decision|0|||
94526734|NCT01524224|323722920|FG004|Overall Study|Sponsor Decision|1|||
94526735|NCT01524224|323722921|FG005|Overall Study|Sponsor Decision|0|||
94526736|NCT01524224|323722922|FG006|Overall Study|Sponsor Decision|0|||
94526737|NCT01524224|323722923|FG007|Overall Study|Sponsor Decision|0|||
94526738|NCT04550832|323722924|FG000|Overall Study|Adverse Event|0|||
94526739|NCT04550832|323722925|FG001|Overall Study|Adverse Event|0|||
94526740|NCT04550832|323722926|FG002|Overall Study|Adverse Event|2|||
94526741|NCT04550832|323722927|FG003|Overall Study|Adverse Event|0|||
94526742|NCT04550832|323722928|FG004|Overall Study|Adverse Event|1|||
94526743|NCT02923531|323722929|FG000|Overall Study|Adverse Event|4|||
94526744|NCT02923531|323722929|FG000|Overall Study|Clinical Deterioration|1|||
94526745|NCT02923531|323722929|FG000|Overall Study|Disease Progression|3|||
94526746|NCT02923531|323722929|FG000|Overall Study|Study Termination|1|||
94526747|NCT01140867|323722930|FG000|Overall Study|Adverse Event|22|||
94526748|NCT01140867|323722930|FG000|Overall Study|Lack of Efficacy|3|||
94526749|NCT01140867|323722930|FG000|Overall Study|Lost to Follow-up|2|||
94526750|NCT01140867|323722930|FG000|Overall Study|Withdrawal by Subject|1|||
94526751|NCT01140867|323722930|FG000|Overall Study|Protocol Violation|1|||
94526752|NCT01140867|323722930|FG000|Overall Study|Uncooperative patient|2|||
94526753|NCT01140867|323722930|FG000|Overall Study|Medication Noncompliance|2|||
94526754|NCT01558596|323722934|FG000|Overall Study|Withdrawal by Subject|1|||
94526755|NCT01558596|323722935|FG001|Overall Study|Withdrawal by Subject|0|||
94526756|NCT01558596|323722934|FG000|Overall Study|surgery elsewhere or cancelled|1|||
94526757|NCT01558596|323722935|FG001|Overall Study|surgery elsewhere or cancelled|1|||
94526758|NCT01558596|323722934|FG000|Overall Study|Protocol Violation|1|||
94526759|NCT01558596|323722935|FG001|Overall Study|Protocol Violation|0|||
94526760|NCT01437111|323722936|FG000|Overall Study|Adverse Event|2|||
94526761|NCT01437111|323722936|FG000|Overall Study|Withdrawal by Subject|4|||
94526762|NCT01437111|323722936|FG000|Overall Study|Not reported|5|||
94526763|NCT01437111|323722936|FG000|Overall Study|Physician Decision|1|||
94526764|NCT01437111|323722936|FG000|Overall Study|Lost to Follow-up|5|||
94526765|NCT01437111|323722936|FG000|Overall Study|Protocol Violation|1|||
94526766|NCT02131311|323722937|FG000|Overall Study|Adverse Event|2|||
94526767|NCT02131311|323722937|FG000|Overall Study|Protocol Violation|1|||
94526768|NCT02131311|323722937|FG000|Overall Study|Lost to Follow-up|1|||
94526769|NCT01232127|323722938|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
94526770|NCT01232127|323722939|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
94526771|NCT01232127|323722940|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
94526772|NCT03035864|323722945|FG000|Treatment Period|Adverse Event|1|||
94526773|NCT03035864|323722946|FG001|Treatment Period|Adverse Event|0|||
94526774|NCT03035864|323722945|FG000|Treatment Period|Other|3|||
94526775|NCT03035864|323722946|FG001|Treatment Period|Other|1|||
94526776|NCT03035864|323722945|FG000|Follow-up Period|Adverse Event|1|||
94526777|NCT03035864|323722946|FG001|Follow-up Period|Adverse Event|0|||
94526778|NCT03035864|323722945|FG000|Follow-up Period|Lost to Follow-up|6|||
94526779|NCT03035864|323722946|FG001|Follow-up Period|Lost to Follow-up|2|||
94526780|NCT03035864|323722945|FG000|Follow-up Period|Physician Decision|1|||
94526781|NCT03035864|323722946|FG001|Follow-up Period|Physician Decision|0|||
94526782|NCT03035864|323722945|FG000|Follow-up Period|Other|3|||
94526783|NCT03035864|323722946|FG001|Follow-up Period|Other|2|||
94526784|NCT02342288|323722947|FG000|Overall Study|no protocol anesthesiologist available|3|||
94526785|NCT02342288|323722948|FG001|Overall Study|no protocol anesthesiologist available|2|||
94526786|NCT02342288|323722947|FG000|Overall Study|anesthesia leak in system|1|||
94526787|NCT02342288|323722948|FG001|Overall Study|anesthesia leak in system|0|||
94526788|NCT02342288|323722947|FG000|Overall Study|Withdrawal by Subject|1|||
94526789|NCT02342288|323722948|FG001|Overall Study|Withdrawal by Subject|0|||
94526790|NCT02342288|323722947|FG000|Overall Study|coordinator contaminated with blood|0|||
94526791|NCT02342288|323722948|FG001|Overall Study|coordinator contaminated with blood|1|||
94526792|NCT02342288|323722947|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
94526793|NCT02342288|323722948|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
94526794|NCT02342288|323722947|FG000|Overall Study|coordinator not available|0|||
94526795|NCT02342288|323722948|FG001|Overall Study|coordinator not available|2|||
94526796|NCT00771927|323722953|FG000|Overall Study|Adverse Event|100|||
94526797|NCT00771927|323722954|FG001|Overall Study|Adverse Event|105|||
94526798|NCT00771927|323722953|FG000|Overall Study|Lack of Efficacy|70|||
94526799|NCT00771927|323722954|FG001|Overall Study|Lack of Efficacy|42|||
94526800|NCT00771927|323722953|FG000|Overall Study|Lost to Follow-up|46|||
94526801|NCT00771927|323722954|FG001|Overall Study|Lost to Follow-up|46|||
94526802|NCT00771927|323722953|FG000|Overall Study|Withdrawal by Subject|16|||
94526803|NCT00771927|323722954|FG001|Overall Study|Withdrawal by Subject|17|||
94526804|NCT00771927|323722953|FG000|Overall Study|Other reason|23|||
94526805|NCT00771927|323722954|FG001|Overall Study|Other reason|27|||
94526806|NCT00255723|323722955|FG000|Overall Study|Adverse Event|1|||
94526807|NCT00255723|323722956|FG001|Overall Study|Adverse Event|1|||
94526808|NCT00255723|323722955|FG000|Overall Study|Death|0|||
94526809|NCT00255723|323722956|FG001|Overall Study|Death|1|||
94526810|NCT00255723|323722955|FG000|Overall Study|Response Data Not Available|1|||
94526811|NCT00255723|323722956|FG001|Overall Study|Response Data Not Available|0|||
94526812|NCT03711370|323722957|FG000|Overall Study|Lost to Follow-up|16|||
94526813|NCT03711370|323722958|FG001|Overall Study|Lost to Follow-up|10|||
94526814|NCT03711370|323722957|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
94526815|NCT03711370|323722958|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
94526816|NCT01270880|323722959|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
94526817|NCT00976716|323722960|FG000|Overall Study|Adverse Event|1|||
94526818|NCT01169701|323722966|FG000|Overall Study|Lost to Follow-up|1|||
94526819|NCT01169701|323722967|FG001|Overall Study|Lost to Follow-up|1|||
94526820|NCT01169701|323722966|FG000|Overall Study|Withdrawal by Subject|1|||
94526821|NCT01169701|323722967|FG001|Overall Study|Withdrawal by Subject|3|||
94526822|NCT01169701|323722966|FG000|Overall Study|Adverse Event|1|||
94526823|NCT01169701|323722967|FG001|Overall Study|Adverse Event|2|||
94526824|NCT01169701|323722966|FG000|Overall Study|Exclusion criteria|2|||
94526825|NCT01169701|323722967|FG001|Overall Study|Exclusion criteria|0|||
94526826|NCT01169701|323722966|FG000|Overall Study|Death|0|||
94526827|NCT01169701|323722967|FG001|Overall Study|Death|1|||
94526828|NCT01169701|323722966|FG000|Overall Study|Administrative problems|0|||
94526829|NCT01169701|323722967|FG001|Overall Study|Administrative problems|1|||
94526830|NCT01169701|323722966|FG000|Overall Study|Serious adverse event|0|||
94526831|NCT01169701|323722967|FG001|Overall Study|Serious adverse event|1|||
94526832|NCT01169701|323722966|FG000|Overall Study|Sponsor decision|0|||
94526833|NCT01169701|323722967|FG001|Overall Study|Sponsor decision|1|||
94526834|NCT01832493|323722968|FG000|Overall Study|Physician Decision|2|||
94526835|NCT01832493|323722968|FG000|Overall Study|Protocol Violation|4|||
94526836|NCT01832493|323722968|FG000|Overall Study|Unable to place LV lead|2|||
94526837|NCT00553436|323722969|FG000|Overall Study|Conversion to another procedure|1|||
94526838|NCT04188834|323722970|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
94526839|NCT00577707|323722971|FG000|Overall Study|Withdrawal by Subject|3|||
94526840|NCT03299244|323722972|FG000|Overall Study|Withdrawal by Subject|34|||
94526841|NCT03299244|323722973|FG001|Overall Study|Withdrawal by Subject|29|||
94526842|NCT03299244|323722972|FG000|Overall Study|Decision by Sponsor|4|||
94526843|NCT03299244|323722973|FG001|Overall Study|Decision by Sponsor|5|||
94526844|NCT03299244|323722972|FG000|Overall Study|Death|9|||
94526845|NCT03299244|323722973|FG001|Overall Study|Death|4|||
94526846|NCT03599518|323722988|FG000|Overall Study|Clinical progression|0|||
94526847|NCT03599518|323722989|FG001|Overall Study|Clinical progression|0|||
94526848|NCT03599518|323722990|FG002|Overall Study|Clinical progression|0|||
94526849|NCT03599518|323722991|FG003|Overall Study|Clinical progression|0|||
94526850|NCT03599518|323722992|FG004|Overall Study|Clinical progression|1|||
94526851|NCT03599518|323722988|FG000|Overall Study|Adverse Event|0|||
94526852|NCT03599518|323722989|FG001|Overall Study|Adverse Event|0|||
94526853|NCT03599518|323722990|FG002|Overall Study|Adverse Event|0|||
94526854|NCT03599518|323722991|FG003|Overall Study|Adverse Event|0|||
94526855|NCT03599518|323722992|FG004|Overall Study|Adverse Event|1|||
94526856|NCT03599518|323722988|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
94526857|NCT03599518|323722989|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
94526858|NCT03599518|323722990|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
94526859|NCT03599518|323722991|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
94526860|NCT03599518|323722992|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
94526861|NCT03599518|323722988|FG000|Overall Study|Participant withdrawal from study treatment|0|||
94526862|NCT03599518|323722989|FG001|Overall Study|Participant withdrawal from study treatment|0|||
94526863|NCT03599518|323722990|FG002|Overall Study|Participant withdrawal from study treatment|1|||
94526864|NCT03599518|323722991|FG003|Overall Study|Participant withdrawal from study treatment|0|||
94526865|NCT03599518|323722992|FG004|Overall Study|Participant withdrawal from study treatment|0|||
94526866|NCT02517398|323722993|FG000|Overall Study|Death|2|||
94526867|NCT02517398|323722994|FG001|Overall Study|Death|3|||
94526868|NCT02517398|323722995|FG002|Overall Study|Death|4|||
94526869|NCT02517398|323722996|FG003|Overall Study|Death|2|||
94526870|NCT02517398|323722997|FG004|Overall Study|Death|3|||
94526871|NCT02517398|323722998|FG005|Overall Study|Death|8|||
94526872|NCT02517398|323722999|FG006|Overall Study|Death|3|||
94526873|NCT02517398|323723000|FG007|Overall Study|Death|2|||
94526874|NCT02517398|323723001|FG008|Overall Study|Death|6|||
94526875|NCT02517398|323723002|FG009|Overall Study|Death|24|||
94526876|NCT02517398|323723003|FG010|Overall Study|Death|53|||
94526877|NCT02517398|323723004|FG011|Overall Study|Death|25|||
94526878|NCT02517398|323723005|FG012|Overall Study|Death|73|||
94526879|NCT02517398|323723006|FG013|Overall Study|Death|29|||
94526880|NCT02517398|323723007|FG014|Overall Study|Death|26|||
94526881|NCT02517398|323723008|FG015|Overall Study|Death|23|||
94526882|NCT02517398|323723009|FG016|Overall Study|Death|26|||
94526883|NCT02517398|323723010|FG017|Overall Study|Death|25|||
94526884|NCT02517398|323723011|FG018|Overall Study|Death|22|||
94526885|NCT02517398|323723012|FG019|Overall Study|Death|7|||
94526886|NCT02517398|323723013|FG020|Overall Study|Death|26|||
94526887|NCT02517398|323723014|FG021|Overall Study|Death|30|||
94526888|NCT02517398|323723015|FG022|Overall Study|Death|20|||
94526889|NCT02517398|323722993|FG000|Overall Study|Other|0|||
94526890|NCT02517398|323722994|FG001|Overall Study|Other|0|||
94526891|NCT02517398|323722995|FG002|Overall Study|Other|0|||
94526892|NCT02517398|323722996|FG003|Overall Study|Other|1|||
94526893|NCT02517398|323722997|FG004|Overall Study|Other|0|||
94526894|NCT02517398|323722998|FG005|Overall Study|Other|0|||
94526895|NCT02517398|323722999|FG006|Overall Study|Other|0|||
94526896|NCT02517398|323723000|FG007|Overall Study|Other|0|||
94526897|NCT02517398|323723001|FG008|Overall Study|Other|0|||
94526898|NCT02517398|323723002|FG009|Overall Study|Other|1|||
94526899|NCT02517398|323723003|FG010|Overall Study|Other|0|||
94526900|NCT02517398|323723004|FG011|Overall Study|Other|0|||
94526901|NCT02517398|323723005|FG012|Overall Study|Other|0|||
94526902|NCT02517398|323723006|FG013|Overall Study|Other|1|||
94526903|NCT02517398|323723007|FG014|Overall Study|Other|0|||
94526904|NCT02517398|323723008|FG015|Overall Study|Other|1|||
94526905|NCT02517398|323723009|FG016|Overall Study|Other|1|||
94526906|NCT02517398|323723010|FG017|Overall Study|Other|0|||
94526907|NCT02517398|323723011|FG018|Overall Study|Other|0|||
94526908|NCT02517398|323723012|FG019|Overall Study|Other|1|||
94526909|NCT02517398|323723013|FG020|Overall Study|Other|0|||
94526910|NCT02517398|323723014|FG021|Overall Study|Other|0|||
94526911|NCT02517398|323723015|FG022|Overall Study|Other|0|||
94526912|NCT02517398|323722993|FG000|Overall Study|Lost to Follow-up|0|||
94526913|NCT02517398|323722994|FG001|Overall Study|Lost to Follow-up|0|||
94526914|NCT02517398|323722995|FG002|Overall Study|Lost to Follow-up|0|||
94526915|NCT02517398|323722996|FG003|Overall Study|Lost to Follow-up|0|||
94526916|NCT02517398|323722997|FG004|Overall Study|Lost to Follow-up|0|||
94526917|NCT02517398|323722998|FG005|Overall Study|Lost to Follow-up|0|||
94526918|NCT02517398|323722999|FG006|Overall Study|Lost to Follow-up|0|||
94526919|NCT02517398|323723000|FG007|Overall Study|Lost to Follow-up|0|||
94526920|NCT02517398|323723001|FG008|Overall Study|Lost to Follow-up|0|||
94526921|NCT02517398|323723002|FG009|Overall Study|Lost to Follow-up|1|||
94526922|NCT02517398|323723003|FG010|Overall Study|Lost to Follow-up|0|||
94526923|NCT02517398|323723004|FG011|Overall Study|Lost to Follow-up|2|||
94526924|NCT02517398|323723005|FG012|Overall Study|Lost to Follow-up|2|||
94526925|NCT02517398|323723006|FG013|Overall Study|Lost to Follow-up|0|||
94526926|NCT02517398|323723007|FG014|Overall Study|Lost to Follow-up|1|||
94526927|NCT02517398|323723008|FG015|Overall Study|Lost to Follow-up|1|||
94526928|NCT02517398|323723009|FG016|Overall Study|Lost to Follow-up|0|||
94526929|NCT02517398|323723010|FG017|Overall Study|Lost to Follow-up|3|||
94526930|NCT02517398|323723011|FG018|Overall Study|Lost to Follow-up|1|||
94526931|NCT02517398|323723012|FG019|Overall Study|Lost to Follow-up|0|||
94526932|NCT02517398|323723013|FG020|Overall Study|Lost to Follow-up|1|||
94526933|NCT02517398|323723014|FG021|Overall Study|Lost to Follow-up|0|||
94526934|NCT02517398|323723015|FG022|Overall Study|Lost to Follow-up|2|||
94526935|NCT02517398|323722993|FG000|Overall Study|Withdrew Consent|0|||
94526936|NCT02517398|323722994|FG001|Overall Study|Withdrew Consent|0|||
94526937|NCT02517398|323722995|FG002|Overall Study|Withdrew Consent|0|||
94526938|NCT02517398|323722996|FG003|Overall Study|Withdrew Consent|0|||
94526939|NCT02517398|323722997|FG004|Overall Study|Withdrew Consent|0|||
94526940|NCT02517398|323722998|FG005|Overall Study|Withdrew Consent|0|||
94526941|NCT02517398|323722999|FG006|Overall Study|Withdrew Consent|1|||
94526942|NCT02517398|323723000|FG007|Overall Study|Withdrew Consent|0|||
94526943|NCT02517398|323723001|FG008|Overall Study|Withdrew Consent|0|||
94526944|NCT02517398|323723002|FG009|Overall Study|Withdrew Consent|2|||
94526945|NCT02517398|323723003|FG010|Overall Study|Withdrew Consent|7|||
94526946|NCT02517398|323723004|FG011|Overall Study|Withdrew Consent|1|||
94526947|NCT02517398|323723005|FG012|Overall Study|Withdrew Consent|5|||
94526948|NCT02517398|323723006|FG013|Overall Study|Withdrew Consent|4|||
94526949|NCT02517398|323723007|FG014|Overall Study|Withdrew Consent|2|||
94526950|NCT02517398|323723008|FG015|Overall Study|Withdrew Consent|5|||
94526951|NCT02517398|323723009|FG016|Overall Study|Withdrew Consent|4|||
94526952|NCT02517398|323723010|FG017|Overall Study|Withdrew Consent|2|||
94526953|NCT02517398|323723011|FG018|Overall Study|Withdrew Consent|3|||
94526954|NCT02517398|323723012|FG019|Overall Study|Withdrew Consent|2|||
94526955|NCT02517398|323723013|FG020|Overall Study|Withdrew Consent|9|||
94526956|NCT02517398|323723014|FG021|Overall Study|Withdrew Consent|3|||
94526957|NCT02517398|323723015|FG022|Overall Study|Withdrew Consent|1|||
94526958|NCT00375505|323723020|FG000|Overall Study|Adverse Event|1|||
94526959|NCT00375505|323723021|FG001|Overall Study|Adverse Event|2|||
94526960|NCT00429182|323723022|FG000|Overall Study|Not evaluable, Disease Progression|2|||
94526961|NCT00429182|323723022|FG000|Overall Study|Not eligible|5|||
94526962|NCT03497039|323723026|FG000|Overall Study|Withdrawal by Subject|1|||
94526963|NCT03497039|323723027|FG001|Overall Study|Withdrawal by Subject|0|||
94526964|NCT03497039|323723026|FG000|Overall Study|Protocol Violation|0|||
94526965|NCT03497039|323723027|FG001|Overall Study|Protocol Violation|1|||
94526966|NCT00465972|323723030|FG000|Overall Study|Withdrawal by Subject|2|||
94526967|NCT00465972|323723031|FG001|Overall Study|Withdrawal by Subject|1|||
94526968|NCT01102491|323723034|FG000|Overall Study|Protocol Violation|11|||
94526969|NCT01102491|323723035|FG001|Overall Study|Protocol Violation|12|||
94526970|NCT03306433|323723036|FG000|Overall Study|Lost to Follow-up|3|||
94526971|NCT03306433|323723036|FG000|Overall Study|Patient did not have teeth extracted|1|||
94526972|NCT03306433|323723036|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
94526973|NCT00851890|323723040|FG000|Overall Study|Lost to Follow-up|0|||
94526974|NCT00851890|323723041|FG001|Overall Study|Lost to Follow-up|1|||
94526975|NCT00851890|323723042|FG002|Overall Study|Lost to Follow-up|0|||
94526976|NCT00851890|323723043|FG003|Overall Study|Lost to Follow-up|1|||
94526977|NCT00617084|323724740|FG000|Overall Study|Withdrawal by Subject|5|||
94526978|NCT00617084|323724741|FG001|Overall Study|Withdrawal by Subject|7|||
94526979|NCT00617084|323724740|FG000|Overall Study|Missed 12 Months visit|16|||
94526980|NCT00617084|323724741|FG001|Overall Study|Missed 12 Months visit|19|||
94526981|NCT02574078|323724745|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94526982|NCT02574078|323724746|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94526983|NCT02574078|323724747|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94526984|NCT02574078|323724748|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94526985|NCT02574078|323724749|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94526986|NCT02574078|323724750|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
94526987|NCT02574078|323724751|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
94526988|NCT02574078|323724752|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94526989|NCT02574078|323724753|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
94526990|NCT02574078|323724754|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94526991|NCT02574078|323724755|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94526992|NCT02574078|323724756|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94526993|NCT02574078|323724757|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
94526994|NCT02574078|323724745|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
94526995|NCT02574078|323724746|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
94526996|NCT02574078|323724747|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
94526997|NCT02574078|323724748|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
94526998|NCT02574078|323724749|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
94526999|NCT02574078|323724750|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
94527000|NCT02574078|323724751|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
94527001|NCT02574078|323724752|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
94527002|NCT02574078|323724753|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
94527003|NCT02574078|323724754|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
94527004|NCT02574078|323724755|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
94527005|NCT02574078|323724756|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
94527006|NCT02574078|323724757|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
94527007|NCT02574078|323724745|FG000|Pre-Treatment Period|Other reasons|0|||
94527008|NCT02574078|323724746|FG001|Pre-Treatment Period|Other reasons|0|||
94527009|NCT02574078|323724747|FG002|Pre-Treatment Period|Other reasons|0|||
94527010|NCT02574078|323724748|FG003|Pre-Treatment Period|Other reasons|0|||
94527011|NCT02574078|323724749|FG004|Pre-Treatment Period|Other reasons|0|||
94527012|NCT02574078|323724750|FG005|Pre-Treatment Period|Other reasons|0|||
94527013|NCT02574078|323724751|FG006|Pre-Treatment Period|Other reasons|2|||
94527014|NCT02574078|323724752|FG007|Pre-Treatment Period|Other reasons|0|||
94527015|NCT02574078|323724753|FG008|Pre-Treatment Period|Other reasons|0|||
94527016|NCT02574078|323724754|FG009|Pre-Treatment Period|Other reasons|0|||
94527017|NCT02574078|323724755|FG010|Pre-Treatment Period|Other reasons|2|||
94527018|NCT02574078|323724756|FG011|Pre-Treatment Period|Other reasons|0|||
94527019|NCT02574078|323724757|FG012|Pre-Treatment Period|Other reasons|0|||
94527020|NCT02574078|323724745|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
94527021|NCT02574078|323724746|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
94527022|NCT02574078|323724747|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
94527023|NCT02574078|323724748|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
94527024|NCT02574078|323724749|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
94527025|NCT02574078|323724750|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
94527026|NCT02574078|323724751|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
94527027|NCT02574078|323724752|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
94527028|NCT02574078|323724753|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
94527029|NCT02574078|323724754|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
94527030|NCT02574078|323724755|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
94527031|NCT02574078|323724756|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
94527032|NCT02574078|323724757|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
94527033|NCT02574078|323724745|FG000|Treatment Period|Disease progression|6|||
94527034|NCT02574078|323724746|FG001|Treatment Period|Disease progression|4|||
94527035|NCT02574078|323724747|FG002|Treatment Period|Disease progression|7|||
94527036|NCT02574078|323724748|FG003|Treatment Period|Disease progression|18|||
94527037|NCT02574078|323724749|FG004|Treatment Period|Disease progression|16|||
94527038|NCT02574078|323724750|FG005|Treatment Period|Disease progression|26|||
94527039|NCT02574078|323724751|FG006|Treatment Period|Disease progression|5|||
94527040|NCT02574078|323724752|FG007|Treatment Period|Disease progression|9|||
94527041|NCT02574078|323724753|FG008|Treatment Period|Disease progression|8|||
94527042|NCT02574078|323724754|FG009|Treatment Period|Disease progression|5|||
94527043|NCT02574078|323724755|FG010|Treatment Period|Disease progression|20|||
94527044|NCT02574078|323724756|FG011|Treatment Period|Disease progression|29|||
94527045|NCT02574078|323724757|FG012|Treatment Period|Disease progression|2|||
94527046|NCT02574078|323724745|FG000|Treatment Period|Study drug toxicity|1|||
94527047|NCT02574078|323724746|FG001|Treatment Period|Study drug toxicity|1|||
94527048|NCT02574078|323724747|FG002|Treatment Period|Study drug toxicity|0|||
94527049|NCT02574078|323724748|FG003|Treatment Period|Study drug toxicity|5|||
94527050|NCT02574078|323724749|FG004|Treatment Period|Study drug toxicity|3|||
94527051|NCT02574078|323724750|FG005|Treatment Period|Study drug toxicity|1|||
94527052|NCT02574078|323724751|FG006|Treatment Period|Study drug toxicity|2|||
94527053|NCT02574078|323724752|FG007|Treatment Period|Study drug toxicity|0|||
94527054|NCT02574078|323724753|FG008|Treatment Period|Study drug toxicity|2|||
94527055|NCT02574078|323724754|FG009|Treatment Period|Study drug toxicity|1|||
94527056|NCT02574078|323724755|FG010|Treatment Period|Study drug toxicity|16|||
94527057|NCT02574078|323724756|FG011|Treatment Period|Study drug toxicity|2|||
94527058|NCT02574078|323724757|FG012|Treatment Period|Study drug toxicity|4|||
94527059|NCT02574078|323724745|FG000|Treatment Period|Death|2|||
94527060|NCT02574078|323724746|FG001|Treatment Period|Death|0|||
94527061|NCT02574078|323724747|FG002|Treatment Period|Death|0|||
94527062|NCT02574078|323724748|FG003|Treatment Period|Death|0|||
94527063|NCT02574078|323724749|FG004|Treatment Period|Death|1|||
94527064|NCT02574078|323724750|FG005|Treatment Period|Death|1|||
94527065|NCT02574078|323724751|FG006|Treatment Period|Death|1|||
94527066|NCT02574078|323724752|FG007|Treatment Period|Death|1|||
94527067|NCT02574078|323724753|FG008|Treatment Period|Death|7|||
94527068|NCT02574078|323724754|FG009|Treatment Period|Death|1|||
94527069|NCT02574078|323724755|FG010|Treatment Period|Death|0|||
94527070|NCT02574078|323724756|FG011|Treatment Period|Death|2|||
94527071|NCT02574078|323724757|FG012|Treatment Period|Death|1|||
94527072|NCT02574078|323724745|FG000|Treatment Period|Adverse event unrelated to drug|0|||
94527073|NCT02574078|323724746|FG001|Treatment Period|Adverse event unrelated to drug|0|||
94527074|NCT02574078|323724747|FG002|Treatment Period|Adverse event unrelated to drug|1|||
94527075|NCT02574078|323724748|FG003|Treatment Period|Adverse event unrelated to drug|0|||
94527076|NCT02574078|323724749|FG004|Treatment Period|Adverse event unrelated to drug|2|||
94527077|NCT02574078|323724750|FG005|Treatment Period|Adverse event unrelated to drug|3|||
94527078|NCT02574078|323724751|FG006|Treatment Period|Adverse event unrelated to drug|0|||
94527079|NCT02574078|323724752|FG007|Treatment Period|Adverse event unrelated to drug|0|||
94527080|NCT02574078|323724753|FG008|Treatment Period|Adverse event unrelated to drug|1|||
94527081|NCT02574078|323724754|FG009|Treatment Period|Adverse event unrelated to drug|2|||
94527082|NCT02574078|323724755|FG010|Treatment Period|Adverse event unrelated to drug|4|||
94527083|NCT02574078|323724756|FG011|Treatment Period|Adverse event unrelated to drug|1|||
94527084|NCT02574078|323724757|FG012|Treatment Period|Adverse event unrelated to drug|0|||
94527085|NCT02574078|323724745|FG000|Treatment Period|Administrative reason by Sponsor|0|||
94527086|NCT02574078|323724746|FG001|Treatment Period|Administrative reason by Sponsor|1|||
94527087|NCT02574078|323724747|FG002|Treatment Period|Administrative reason by Sponsor|0|||
94527088|NCT02574078|323724748|FG003|Treatment Period|Administrative reason by Sponsor|0|||
94527089|NCT02574078|323724749|FG004|Treatment Period|Administrative reason by Sponsor|0|||
94527090|NCT02574078|323724750|FG005|Treatment Period|Administrative reason by Sponsor|0|||
94527091|NCT02574078|323724751|FG006|Treatment Period|Administrative reason by Sponsor|1|||
94527092|NCT02574078|323724752|FG007|Treatment Period|Administrative reason by Sponsor|0|||
94527093|NCT02574078|323724753|FG008|Treatment Period|Administrative reason by Sponsor|0|||
94527094|NCT02574078|323724754|FG009|Treatment Period|Administrative reason by Sponsor|0|||
94527095|NCT02574078|323724755|FG010|Treatment Period|Administrative reason by Sponsor|0|||
94527096|NCT02574078|323724756|FG011|Treatment Period|Administrative reason by Sponsor|0|||
94527097|NCT02574078|323724757|FG012|Treatment Period|Administrative reason by Sponsor|3|||
94527098|NCT02574078|323724745|FG000|Treatment Period|Other reasons|1|||
94527099|NCT02574078|323724746|FG001|Treatment Period|Other reasons|0|||
94527100|NCT02574078|323724747|FG002|Treatment Period|Other reasons|1|||
94527101|NCT02574078|323724748|FG003|Treatment Period|Other reasons|3|||
94527102|NCT02574078|323724749|FG004|Treatment Period|Other reasons|3|||
94527103|NCT02574078|323724750|FG005|Treatment Period|Other reasons|1|||
94527104|NCT02574078|323724751|FG006|Treatment Period|Other reasons|2|||
94527105|NCT02574078|323724752|FG007|Treatment Period|Other reasons|1|||
94527106|NCT02574078|323724753|FG008|Treatment Period|Other reasons|3|||
94527107|NCT02574078|323724754|FG009|Treatment Period|Other reasons|1|||
94527108|NCT02574078|323724755|FG010|Treatment Period|Other reasons|1|||
94527109|NCT02574078|323724756|FG011|Treatment Period|Other reasons|3|||
94527110|NCT02574078|323724757|FG012|Treatment Period|Other reasons|1|||
94527111|NCT02574078|323724745|FG000|Treatment Period|Participant request to stop drug|0|||
94527112|NCT02574078|323724746|FG001|Treatment Period|Participant request to stop drug|0|||
94527113|NCT02574078|323724747|FG002|Treatment Period|Participant request to stop drug|0|||
94527114|NCT02574078|323724748|FG003|Treatment Period|Participant request to stop drug|2|||
94527115|NCT02574078|323724749|FG004|Treatment Period|Participant request to stop drug|4|||
94527116|NCT02574078|323724750|FG005|Treatment Period|Participant request to stop drug|0|||
94527117|NCT02574078|323724751|FG006|Treatment Period|Participant request to stop drug|1|||
94527118|NCT02574078|323724752|FG007|Treatment Period|Participant request to stop drug|0|||
94527119|NCT02574078|323724753|FG008|Treatment Period|Participant request to stop drug|3|||
94527120|NCT02574078|323724754|FG009|Treatment Period|Participant request to stop drug|2|||
94527121|NCT02574078|323724755|FG010|Treatment Period|Participant request to stop drug|2|||
94527122|NCT02574078|323724756|FG011|Treatment Period|Participant request to stop drug|4|||
94527123|NCT02574078|323724757|FG012|Treatment Period|Participant request to stop drug|1|||
94527124|NCT02574078|323724745|FG000|Treatment Period|Participant withdrew consent|0|||
94527125|NCT02574078|323724746|FG001|Treatment Period|Participant withdrew consent|0|||
94527126|NCT02574078|323724747|FG002|Treatment Period|Participant withdrew consent|0|||
94527127|NCT02574078|323724748|FG003|Treatment Period|Participant withdrew consent|0|||
94527128|NCT02574078|323724749|FG004|Treatment Period|Participant withdrew consent|1|||
94527129|NCT02574078|323724750|FG005|Treatment Period|Participant withdrew consent|1|||
94527130|NCT02574078|323724751|FG006|Treatment Period|Participant withdrew consent|0|||
94527131|NCT02574078|323724752|FG007|Treatment Period|Participant withdrew consent|1|||
94527132|NCT02574078|323724753|FG008|Treatment Period|Participant withdrew consent|0|||
94527133|NCT02574078|323724754|FG009|Treatment Period|Participant withdrew consent|2|||
94527134|NCT02574078|323724755|FG010|Treatment Period|Participant withdrew consent|1|||
94527135|NCT02574078|323724756|FG011|Treatment Period|Participant withdrew consent|4|||
94527136|NCT02574078|323724757|FG012|Treatment Period|Participant withdrew consent|1|||
94527137|NCT02574078|323724745|FG000|Treatment Period|Participant no longer meets criteria|0|||
94527138|NCT02574078|323724746|FG001|Treatment Period|Participant no longer meets criteria|0|||
94527139|NCT02574078|323724747|FG002|Treatment Period|Participant no longer meets criteria|0|||
94527140|NCT02574078|323724748|FG003|Treatment Period|Participant no longer meets criteria|0|||
94527141|NCT02574078|323724749|FG004|Treatment Period|Participant no longer meets criteria|1|||
94527142|NCT02574078|323724750|FG005|Treatment Period|Participant no longer meets criteria|0|||
94527143|NCT02574078|323724751|FG006|Treatment Period|Participant no longer meets criteria|0|||
94527144|NCT02574078|323724752|FG007|Treatment Period|Participant no longer meets criteria|0|||
94527145|NCT02574078|323724753|FG008|Treatment Period|Participant no longer meets criteria|0|||
94527146|NCT02574078|323724754|FG009|Treatment Period|Participant no longer meets criteria|1|||
94527147|NCT02574078|323724755|FG010|Treatment Period|Participant no longer meets criteria|1|||
94527148|NCT02574078|323724756|FG011|Treatment Period|Participant no longer meets criteria|1|||
94527149|NCT02574078|323724757|FG012|Treatment Period|Participant no longer meets criteria|0|||
94527150|NCT02574078|323724745|FG000|Treatment Period|Lost to Follow-up|0|||
94527151|NCT02574078|323724746|FG001|Treatment Period|Lost to Follow-up|0|||
94527152|NCT02574078|323724747|FG002|Treatment Period|Lost to Follow-up|0|||
94527153|NCT02574078|323724748|FG003|Treatment Period|Lost to Follow-up|0|||
94527154|NCT02574078|323724749|FG004|Treatment Period|Lost to Follow-up|0|||
94527155|NCT02574078|323724750|FG005|Treatment Period|Lost to Follow-up|0|||
94527156|NCT02574078|323724751|FG006|Treatment Period|Lost to Follow-up|0|||
94527157|NCT02574078|323724752|FG007|Treatment Period|Lost to Follow-up|0|||
94527158|NCT02574078|323724753|FG008|Treatment Period|Lost to Follow-up|0|||
94527159|NCT02574078|323724754|FG009|Treatment Period|Lost to Follow-up|1|||
94527160|NCT02574078|323724755|FG010|Treatment Period|Lost to Follow-up|0|||
94527161|NCT02574078|323724756|FG011|Treatment Period|Lost to Follow-up|1|||
94527162|NCT02574078|323724757|FG012|Treatment Period|Lost to Follow-up|0|||
94527163|NCT02574078|323724745|FG000|Treatment Period|Maximum clinical benefit|0|||
94527164|NCT02574078|323724746|FG001|Treatment Period|Maximum clinical benefit|0|||
94527165|NCT02574078|323724747|FG002|Treatment Period|Maximum clinical benefit|0|||
94527166|NCT02574078|323724748|FG003|Treatment Period|Maximum clinical benefit|0|||
94527167|NCT02574078|323724749|FG004|Treatment Period|Maximum clinical benefit|0|||
94527168|NCT02574078|323724750|FG005|Treatment Period|Maximum clinical benefit|0|||
94527169|NCT02574078|323724751|FG006|Treatment Period|Maximum clinical benefit|0|||
94527170|NCT02574078|323724752|FG007|Treatment Period|Maximum clinical benefit|0|||
94527171|NCT02574078|323724753|FG008|Treatment Period|Maximum clinical benefit|0|||
94527172|NCT02574078|323724754|FG009|Treatment Period|Maximum clinical benefit|1|||
94527173|NCT02574078|323724755|FG010|Treatment Period|Maximum clinical benefit|0|||
94527174|NCT02574078|323724756|FG011|Treatment Period|Maximum clinical benefit|0|||
94527175|NCT02574078|323724757|FG012|Treatment Period|Maximum clinical benefit|0|||
94527176|NCT03145064|323724764|FG000|Overall Study|Death|24|||
94527177|NCT03145064|323724764|FG000|Overall Study|Lost to Follow-up|3|||
94527178|NCT03145064|323724764|FG000|Overall Study|Withdrawal by Subject|6|||
94527179|NCT03145064|323724764|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
94527180|NCT03145064|323724764|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
94527181|NCT02297815|323724774|FG000|Overall Study|Lost to Follow-up|236|||
94527182|NCT02297815|323724775|FG001|Overall Study|Lost to Follow-up|140|||
94527183|NCT00662831|323724779|FG000|Overall Study|Death|4|||
94527184|NCT00662831|323724780|FG001|Overall Study|Death|1|||
94527185|NCT00662831|323724779|FG000|Overall Study|Lack of Efficacy|6|||
94527186|NCT00662831|323724780|FG001|Overall Study|Lack of Efficacy|6|||
94527187|NCT00662831|323724779|FG000|Overall Study|Lost to Follow-up|1|||
94527188|NCT00662831|323724780|FG001|Overall Study|Lost to Follow-up|0|||
94527189|NCT00662831|323724779|FG000|Overall Study|Withdrawal by Subject|2|||
94527190|NCT00662831|323724780|FG001|Overall Study|Withdrawal by Subject|1|||
94527191|NCT00662831|323724779|FG000|Overall Study|Other|62|||
94527192|NCT00662831|323724780|FG001|Overall Study|Other|31|||
94527193|NCT00662831|323724779|FG000|Overall Study|Protocol Violation|8|||
94527194|NCT00662831|323724780|FG001|Overall Study|Protocol Violation|4|||
94527195|NCT00662831|323724779|FG000|Overall Study|Adverse Event|23|||
94527196|NCT00662831|323724780|FG001|Overall Study|Adverse Event|16|||
94527197|NCT02522429|323724781|FG000|Overall Study|Lost to Follow-up|8|||
94527198|NCT02522429|323724781|FG000|Overall Study|Adverse Event|2|||
94527199|NCT02522429|323724781|FG000|Overall Study|Death|1|||
94527200|NCT02522429|323724781|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
94527201|NCT00294671|323724782|FG000|Overall Study|Lack of Efficacy|11|||
94527202|NCT00294671|323724783|FG001|Overall Study|Lack of Efficacy|23|||
94527203|NCT00294671|323724782|FG000|Overall Study|Liver transplant|7|||
94527204|NCT00294671|323724783|FG001|Overall Study|Liver transplant|9|||
94527205|NCT00294671|323724782|FG000|Overall Study|Drug related adverse event (AE)|4|||
94527206|NCT00294671|323724783|FG001|Overall Study|Drug related adverse event (AE)|2|||
94527207|NCT00294671|323724782|FG000|Overall Study|Non-drug related AE|3|||
94527208|NCT00294671|323724783|FG001|Overall Study|Non-drug related AE|2|||
94527209|NCT00294671|323724782|FG000|Overall Study|Lost to Follow-up|1|||
94527210|NCT00294671|323724783|FG001|Overall Study|Lost to Follow-up|3|||
94527211|NCT00294671|323724782|FG000|Overall Study|Non-compliance|1|||
94527212|NCT00294671|323724783|FG001|Overall Study|Non-compliance|0|||
94527213|NCT00294671|323724782|FG000|Overall Study|Death|0|||
94527214|NCT00294671|323724783|FG001|Overall Study|Death|1|||
94527215|NCT00600106|323724787|FG000|Overall Study|Withdrawal by Subject|1|||
94527216|NCT00600106|323724788|FG001|Overall Study|Withdrawal by Subject|1|||
94527217|NCT00958360|323724797|FG000|Overall Study|Withdrawal by Subject|3|||
94527218|NCT00958360|323724798|FG001|Overall Study|Withdrawal by Subject|1|||
94527219|NCT00958360|323724797|FG000|Overall Study|Death|6|||
94527220|NCT00958360|323724798|FG001|Overall Study|Death|7|||
94527221|NCT00958360|323724797|FG000|Overall Study|Physician Decision|2|||
94527222|NCT00958360|323724798|FG001|Overall Study|Physician Decision|1|||
94527223|NCT00958360|323724797|FG000|Overall Study|Lost to Follow-up|0|||
94527224|NCT00958360|323724798|FG001|Overall Study|Lost to Follow-up|1|||
94527225|NCT03015363|323724799|FG000|Overall Study|Physician Decision|14|||
94527226|NCT03015363|323724799|FG000|Overall Study|Withdrawal by Subject|3|||
94527227|NCT03107052|323724800|FG000|Overall Study|Adverse Event|6|||
94527228|NCT03107052|323724801|FG001|Overall Study|Adverse Event|1|||
94527229|NCT03107052|323724802|FG002|Overall Study|Adverse Event|2|||
94527230|NCT03107052|323724800|FG000|Overall Study|Withdrawal by Subject|9|||
94527231|NCT03107052|323724801|FG001|Overall Study|Withdrawal by Subject|5|||
94527232|NCT03107052|323724802|FG002|Overall Study|Withdrawal by Subject|8|||
94527233|NCT03107052|323724800|FG000|Overall Study|Protocol Violation|6|||
94527234|NCT03107052|323724801|FG001|Overall Study|Protocol Violation|0|||
94527235|NCT03107052|323724802|FG002|Overall Study|Protocol Violation|3|||
94527236|NCT03107052|323724800|FG000|Overall Study|Lost to Follow-up|4|||
94527237|NCT03107052|323724801|FG001|Overall Study|Lost to Follow-up|0|||
94527238|NCT03107052|323724802|FG002|Overall Study|Lost to Follow-up|1|||
94527239|NCT03107052|323724800|FG000|Overall Study|Lack of Efficacy|23|||
94527240|NCT03107052|323724801|FG001|Overall Study|Lack of Efficacy|7|||
94527241|NCT03107052|323724802|FG002|Overall Study|Lack of Efficacy|4|||
94527242|NCT03107052|323724800|FG000|Overall Study|Other than specified|4|||
94527243|NCT03107052|323724801|FG001|Overall Study|Other than specified|2|||
94527244|NCT03107052|323724802|FG002|Overall Study|Other than specified|0|||
94527245|NCT03107052|323724800|FG000|Overall Study|Study terminated due to futility|67|||
94527246|NCT03107052|323724801|FG001|Overall Study|Study terminated due to futility|31|||
94527247|NCT03107052|323724802|FG002|Overall Study|Study terminated due to futility|23|||
94527248|NCT01734785|323724803|FG000|Open-Label Period|Adverse Event|0|||
94527249|NCT01734785|323724804|FG001|Open-Label Period|Adverse Event|0|||
94527250|NCT01734785|323724805|FG002|Open-Label Period|Adverse Event|0|||
94527251|NCT01734785|323724806|FG003|Open-Label Period|Adverse Event|9|||
94527252|NCT01734785|323724803|FG000|Open-Label Period|Lack of Efficacy|0|||
94527253|NCT01734785|323724804|FG001|Open-Label Period|Lack of Efficacy|0|||
94527254|NCT01734785|323724805|FG002|Open-Label Period|Lack of Efficacy|0|||
94527255|NCT01734785|323724806|FG003|Open-Label Period|Lack of Efficacy|1|||
94527256|NCT01734785|323724803|FG000|Open-Label Period|Protocol Violation|0|||
94527257|NCT01734785|323724804|FG001|Open-Label Period|Protocol Violation|0|||
94527258|NCT01734785|323724805|FG002|Open-Label Period|Protocol Violation|0|||
94527259|NCT01734785|323724806|FG003|Open-Label Period|Protocol Violation|13|||
94527260|NCT01734785|323724803|FG000|Open-Label Period|Lost to Follow-up|0|||
94527261|NCT01734785|323724804|FG001|Open-Label Period|Lost to Follow-up|0|||
94527262|NCT01734785|323724805|FG002|Open-Label Period|Lost to Follow-up|0|||
94527263|NCT01734785|323724806|FG003|Open-Label Period|Lost to Follow-up|14|||
94527264|NCT01734785|323724803|FG000|Open-Label Period|Withdrawal by Subject|0|||
94527265|NCT01734785|323724804|FG001|Open-Label Period|Withdrawal by Subject|0|||
94527266|NCT01734785|323724805|FG002|Open-Label Period|Withdrawal by Subject|0|||
94527267|NCT01734785|323724806|FG003|Open-Label Period|Withdrawal by Subject|12|||
94527268|NCT01734785|323724803|FG000|Open-Label Period|Other Reasons|0|||
94527269|NCT01734785|323724804|FG001|Open-Label Period|Other Reasons|0|||
94527270|NCT01734785|323724805|FG002|Open-Label Period|Other Reasons|0|||
94527271|NCT01734785|323724806|FG003|Open-Label Period|Other Reasons|224|||
94527272|NCT01734785|323724803|FG000|Double-Blind Period|Adverse Event|0|||
94527273|NCT01734785|323724804|FG001|Double-Blind Period|Adverse Event|3|||
94527274|NCT01734785|323724805|FG002|Double-Blind Period|Adverse Event|2|||
94527275|NCT01734785|323724806|FG003|Double-Blind Period|Adverse Event|0|||
94527276|NCT01734785|323724803|FG000|Double-Blind Period|Lack of Efficacy|0|||
94527277|NCT01734785|323724804|FG001|Double-Blind Period|Lack of Efficacy|1|||
94527278|NCT01734785|323724805|FG002|Double-Blind Period|Lack of Efficacy|0|||
94527279|NCT01734785|323724806|FG003|Double-Blind Period|Lack of Efficacy|0|||
94527280|NCT01734785|323724803|FG000|Double-Blind Period|Protocol Violation|0|||
94527281|NCT01734785|323724804|FG001|Double-Blind Period|Protocol Violation|1|||
94527282|NCT01734785|323724805|FG002|Double-Blind Period|Protocol Violation|1|||
94527283|NCT01734785|323724806|FG003|Double-Blind Period|Protocol Violation|0|||
94527284|NCT01734785|323724803|FG000|Double-Blind Period|Lost to Follow-up|2|||
94527285|NCT01734785|323724804|FG001|Double-Blind Period|Lost to Follow-up|4|||
94527286|NCT01734785|323724805|FG002|Double-Blind Period|Lost to Follow-up|2|||
94527287|NCT01734785|323724806|FG003|Double-Blind Period|Lost to Follow-up|0|||
94527288|NCT01734785|323724803|FG000|Double-Blind Period|Withdrawal by Subject|2|||
94527289|NCT01734785|323724804|FG001|Double-Blind Period|Withdrawal by Subject|0|||
94527290|NCT01734785|323724805|FG002|Double-Blind Period|Withdrawal by Subject|0|||
94527291|NCT01734785|323724806|FG003|Double-Blind Period|Withdrawal by Subject|0|||
94527292|NCT01734785|323724803|FG000|Double-Blind Period|Not treated|1|||
94527293|NCT01734785|323724804|FG001|Double-Blind Period|Not treated|0|||
94527294|NCT01734785|323724805|FG002|Double-Blind Period|Not treated|0|||
94527295|NCT01734785|323724806|FG003|Double-Blind Period|Not treated|0|||
94527296|NCT02397915|323724807|FG000|Period 1|Protocol Violation|0|||
94527297|NCT02397915|323724808|FG001|Period 1|Protocol Violation|1|||
94527298|NCT02397915|323724809|FG002|Period 1|Protocol Violation|0|||
94527299|NCT02397915|323724810|FG003|Period 1|Protocol Violation|0|||
94527300|NCT02397915|323724807|FG000|Period 1|Physician Decision|1|||
94527301|NCT02397915|323724808|FG001|Period 1|Physician Decision|0|||
94527302|NCT02397915|323724809|FG002|Period 1|Physician Decision|0|||
94527303|NCT02397915|323724810|FG003|Period 1|Physician Decision|0|||
94527304|NCT00040742|323724814|FG000|Overall Study|Death|0|||
94527305|NCT00040742|323724815|FG001|Overall Study|Death|0|||
94527306|NCT00040742|323724816|FG002|Overall Study|Death|1|||
94527307|NCT00040742|323724817|FG003|Overall Study|Death|0|||
94527308|NCT00040742|323724814|FG000|Overall Study|Adverse Event|15|||
94527309|NCT00040742|323724815|FG001|Overall Study|Adverse Event|16|||
94527310|NCT00040742|323724816|FG002|Overall Study|Adverse Event|21|||
94527311|NCT00040742|323724817|FG003|Overall Study|Adverse Event|9|||
94527312|NCT00040742|323724814|FG000|Overall Study|Withdrawal by Subject|7|||
94527313|NCT00040742|323724815|FG001|Overall Study|Withdrawal by Subject|15|||
94527314|NCT00040742|323724816|FG002|Overall Study|Withdrawal by Subject|10|||
94527315|NCT00040742|323724817|FG003|Overall Study|Withdrawal by Subject|13|||
94527316|NCT00040742|323724814|FG000|Overall Study|Chemotoxicity|4|||
94527317|NCT00040742|323724815|FG001|Overall Study|Chemotoxicity|3|||
94527318|NCT00040742|323724816|FG002|Overall Study|Chemotoxicity|5|||
94527319|NCT00040742|323724817|FG003|Overall Study|Chemotoxicity|2|||
94527320|NCT00040742|323724814|FG000|Overall Study|Incomplete Forms|6|||
94527321|NCT00040742|323724815|FG001|Overall Study|Incomplete Forms|10|||
94527322|NCT00040742|323724816|FG002|Overall Study|Incomplete Forms|4|||
94527323|NCT00040742|323724817|FG003|Overall Study|Incomplete Forms|5|||
94527324|NCT00040742|323724814|FG000|Overall Study|Other medical|7|||
94527325|NCT00040742|323724815|FG001|Overall Study|Other medical|5|||
94527326|NCT00040742|323724816|FG002|Overall Study|Other medical|5|||
94527327|NCT00040742|323724817|FG003|Overall Study|Other medical|5|||
94527328|NCT00615719|323724819|FG000|Overall Study|Physician Decision|5|||
94527329|NCT01523743|323724822|FG000|Period 1|Adverse Event|1|||
94527330|NCT01523743|323724823|FG001|Period 1|Adverse Event|0|||
94527331|NCT01523743|323724822|FG000|Period 1|Withdrawal by Subject|6|||
94527332|NCT01523743|323724823|FG001|Period 1|Withdrawal by Subject|2|||
94527333|NCT01523743|323724822|FG000|Period 1|Lost to Follow-up|1|||
94527334|NCT01523743|323724823|FG001|Period 1|Lost to Follow-up|0|||
94527335|NCT01523743|323724822|FG000|Period 1|Lack of Efficacy|1|||
94527336|NCT01523743|323724823|FG001|Period 1|Lack of Efficacy|0|||
94527337|NCT01523743|323724822|FG000|Period 1|Felt unable to empty bladder|1|||
94527338|NCT01523743|323724823|FG001|Period 1|Felt unable to empty bladder|0|||
94527339|NCT01523743|323724822|FG000|Period 2|Withdrawal by Subject|0|||
94527340|NCT01523743|323724823|FG001|Period 2|Withdrawal by Subject|2|||
94527341|NCT01523743|323724822|FG000|Period 2|Adverse Event|1|||
94527342|NCT01523743|323724823|FG001|Period 2|Adverse Event|0|||
94527343|NCT02569476|323724824|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
94527344|NCT02569476|323724824|FG000|Overall Study|Death|33|||
94527345|NCT02569476|323724824|FG000|Overall Study|Withdrawal by Subject|9|||
94527346|NCT02569476|323724824|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
94527347|NCT02569476|323724824|FG000|Overall Study|Palliative care|1|||
94527348|NCT02569476|323724824|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
94527349|NCT02569476|323724824|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
94527350|NCT04482439|323724825|FG000|Overall Study|Lost to Follow-up|1|||
94527351|NCT04482439|323724825|FG000|Overall Study|Unrelated illness|1|||
94527352|NCT01534351|323724826|FG000|Overall Study|Study Terminated Early|1|||
94527353|NCT01534351|323724827|FG001|Overall Study|Study Terminated Early|0|||
94527354|NCT01534351|323724828|FG002|Overall Study|Study Terminated Early|0|||
94527355|NCT01066104|323724829|FG000|Overall Study|Adverse Event|1|||
94527356|NCT01066104|323724830|FG001|Overall Study|Adverse Event|1|||
94527357|NCT01066104|323724829|FG000|Overall Study|Protocol Violation|1|||
94527358|NCT01066104|323724830|FG001|Overall Study|Protocol Violation|0|||
94527359|NCT01737762|323724831|FG000|Overall Study|Adverse Event|2|||
94527360|NCT01737762|323724832|FG001|Overall Study|Adverse Event|2|||
94527361|NCT01737762|323724831|FG000|Overall Study|Lost to Follow-up|1|||
94527362|NCT01737762|323724832|FG001|Overall Study|Lost to Follow-up|0|||
94527363|NCT01737762|323724831|FG000|Overall Study|Withdrawal by Subject|2|||
94527364|NCT01737762|323724832|FG001|Overall Study|Withdrawal by Subject|2|||
94527365|NCT01737762|323724831|FG000|Overall Study|Progressive disease|1|||
94527366|NCT01737762|323724832|FG001|Overall Study|Progressive disease|2|||
94527367|NCT01737762|323724831|FG000|Overall Study|Physician Decision|1|||
94527368|NCT01737762|323724832|FG001|Overall Study|Physician Decision|1|||
94527369|NCT01737762|323724831|FG000|Overall Study|Moved from area|2|||
94527370|NCT01737762|323724832|FG001|Overall Study|Moved from area|1|||
94527371|NCT01737762|323724831|FG000|Overall Study|Trial termination|11|||
94527372|NCT01737762|323724832|FG001|Overall Study|Trial termination|9|||
94527373|NCT00881530|323724833|FG000|Overall Study|Adverse Event|5|||
94527374|NCT00881530|323724834|FG001|Overall Study|Adverse Event|1|||
94527375|NCT00881530|323724835|FG002|Overall Study|Adverse Event|1|||
94527376|NCT00881530|323724836|FG003|Overall Study|Adverse Event|4|||
94527377|NCT00881530|323724837|FG004|Overall Study|Adverse Event|10|||
94527378|NCT00881530|323724838|FG005|Overall Study|Adverse Event|2|||
94527379|NCT00881530|323724833|FG000|Overall Study|Lack of Efficacy|1|||
94527380|NCT00881530|323724834|FG001|Overall Study|Lack of Efficacy|0|||
94527381|NCT00881530|323724835|FG002|Overall Study|Lack of Efficacy|0|||
94527382|NCT00881530|323724836|FG003|Overall Study|Lack of Efficacy|0|||
94527383|NCT00881530|323724837|FG004|Overall Study|Lack of Efficacy|1|||
94527384|NCT00881530|323724838|FG005|Overall Study|Lack of Efficacy|1|||
94527385|NCT00881530|323724833|FG000|Overall Study|Not compliant with the protocol|0|||
94527386|NCT00881530|323724834|FG001|Overall Study|Not compliant with the protocol|0|||
94527387|NCT00881530|323724835|FG002|Overall Study|Not compliant with the protocol|0|||
94527388|NCT00881530|323724836|FG003|Overall Study|Not compliant with the protocol|0|||
94527389|NCT00881530|323724837|FG004|Overall Study|Not compliant with the protocol|2|||
94527390|NCT00881530|323724838|FG005|Overall Study|Not compliant with the protocol|0|||
94527391|NCT00881530|323724833|FG000|Overall Study|Lost to Follow-up|0|||
94527392|NCT00881530|323724834|FG001|Overall Study|Lost to Follow-up|1|||
94527393|NCT00881530|323724835|FG002|Overall Study|Lost to Follow-up|1|||
94527394|NCT00881530|323724836|FG003|Overall Study|Lost to Follow-up|3|||
94527395|NCT00881530|323724837|FG004|Overall Study|Lost to Follow-up|1|||
94527396|NCT00881530|323724838|FG005|Overall Study|Lost to Follow-up|0|||
94527397|NCT00881530|323724833|FG000|Overall Study|Refused to continue medication|7|||
94527398|NCT00881530|323724834|FG001|Overall Study|Refused to continue medication|2|||
94527399|NCT00881530|323724835|FG002|Overall Study|Refused to continue medication|1|||
94527400|NCT00881530|323724836|FG003|Overall Study|Refused to continue medication|2|||
94527401|NCT00881530|323724837|FG004|Overall Study|Refused to continue medication|0|||
94527402|NCT00881530|323724838|FG005|Overall Study|Refused to continue medication|0|||
94527403|NCT00881530|323724833|FG000|Overall Study|Other reason not defined above|1|||
94527404|NCT00881530|323724834|FG001|Overall Study|Other reason not defined above|1|||
94527405|NCT00881530|323724835|FG002|Overall Study|Other reason not defined above|2|||
94527406|NCT00881530|323724836|FG003|Overall Study|Other reason not defined above|0|||
94527407|NCT00881530|323724837|FG004|Overall Study|Other reason not defined above|0|||
94527408|NCT00881530|323724838|FG005|Overall Study|Other reason not defined above|2|||
94527409|NCT00244725|323724844|FG000|Overall Study|Lost to Follow-up|3|||
94527410|NCT00244725|323724845|FG001|Overall Study|Lost to Follow-up|4|||
94527411|NCT00244725|323724846|FG002|Overall Study|Lost to Follow-up|9|||
94527412|NCT00244725|323724847|FG003|Overall Study|Lost to Follow-up|2|||
94527413|NCT00244725|323724844|FG000|Overall Study|Withdrawal by Subject|9|||
94527414|NCT00244725|323724845|FG001|Overall Study|Withdrawal by Subject|7|||
94527415|NCT00244725|323724846|FG002|Overall Study|Withdrawal by Subject|7|||
94527416|NCT00244725|323724847|FG003|Overall Study|Withdrawal by Subject|8|||
94527417|NCT00244725|323724844|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
94527418|NCT00244725|323724845|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
94527419|NCT00244725|323724846|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
94527420|NCT00244725|323724847|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
94527421|NCT00244725|323724844|FG000|Overall Study|Physician Decision|3|||
94527422|NCT00244725|323724845|FG001|Overall Study|Physician Decision|0|||
94527423|NCT00244725|323724846|FG002|Overall Study|Physician Decision|1|||
94527424|NCT00244725|323724847|FG003|Overall Study|Physician Decision|2|||
94527425|NCT00244725|323724844|FG000|Overall Study|Adverse Events|3|||
94527426|NCT00244725|323724845|FG001|Overall Study|Adverse Events|1|||
94527427|NCT00244725|323724846|FG002|Overall Study|Adverse Events|4|||
94527428|NCT00244725|323724847|FG003|Overall Study|Adverse Events|4|||
94527429|NCT00244725|323724844|FG000|Overall Study|Withdrwal by participant|1|||
94527430|NCT00244725|323724845|FG001|Overall Study|Withdrwal by participant|0|||
94527431|NCT00244725|323724846|FG002|Overall Study|Withdrwal by participant|0|||
94527432|NCT00244725|323724847|FG003|Overall Study|Withdrwal by participant|1|||
94527433|NCT00244725|323724844|FG000|Overall Study|Liver function test abnormality|2|||
94527434|NCT00244725|323724845|FG001|Overall Study|Liver function test abnormality|0|||
94527435|NCT00244725|323724846|FG002|Overall Study|Liver function test abnormality|0|||
94527436|NCT00244725|323724847|FG003|Overall Study|Liver function test abnormality|1|||
94527437|NCT00244725|323724844|FG000|Overall Study|Sponsor withdrew the participant|1|||
94527438|NCT00244725|323724845|FG001|Overall Study|Sponsor withdrew the participant|0|||
94527439|NCT00244725|323724846|FG002|Overall Study|Sponsor withdrew the participant|0|||
94527440|NCT00244725|323724847|FG003|Overall Study|Sponsor withdrew the participant|1|||
94527441|NCT00244725|323724844|FG000|Overall Study|Mediciation Error|0|||
94527442|NCT00244725|323724845|FG001|Overall Study|Mediciation Error|1|||
94527443|NCT00244725|323724846|FG002|Overall Study|Mediciation Error|0|||
94527444|NCT00244725|323724847|FG003|Overall Study|Mediciation Error|0|||
94527445|NCT00244725|323724844|FG000|Overall Study|Rehab Refused to allow participantion|0|||
94527446|NCT00244725|323724845|FG001|Overall Study|Rehab Refused to allow participantion|1|||
94527447|NCT00244725|323724846|FG002|Overall Study|Rehab Refused to allow participantion|0|||
94527448|NCT00244725|323724847|FG003|Overall Study|Rehab Refused to allow participantion|0|||
94527449|NCT00244725|323724844|FG000|Overall Study|Headache|0|||
94527450|NCT00244725|323724845|FG001|Overall Study|Headache|1|||
94527451|NCT00244725|323724846|FG002|Overall Study|Headache|0|||
94527452|NCT00244725|323724847|FG003|Overall Study|Headache|0|||
94527453|NCT00244725|323724844|FG000|Overall Study|Received prohibited medication|0|||
94527454|NCT00244725|323724845|FG001|Overall Study|Received prohibited medication|1|||
94527455|NCT00244725|323724846|FG002|Overall Study|Received prohibited medication|0|||
94527456|NCT00244725|323724847|FG003|Overall Study|Received prohibited medication|1|||
94527457|NCT00244725|323724844|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
94527458|NCT00244725|323724845|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
94527459|NCT00244725|323724846|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
94527460|NCT00244725|323724847|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
94527461|NCT00244725|323724844|FG000|Overall Study|Administrative reason|0|||
94527462|NCT00244725|323724845|FG001|Overall Study|Administrative reason|0|||
94527463|NCT00244725|323724846|FG002|Overall Study|Administrative reason|1|||
94527464|NCT00244725|323724847|FG003|Overall Study|Administrative reason|0|||
94527465|NCT00244725|323724844|FG000|Overall Study|Vomit|0|||
94527466|NCT00244725|323724845|FG001|Overall Study|Vomit|0|||
94527467|NCT00244725|323724846|FG002|Overall Study|Vomit|1|||
94527468|NCT00244725|323724847|FG003|Overall Study|Vomit|0|||
94527469|NCT00244725|323724844|FG000|Overall Study|Failed to follow-up|0|||
94527470|NCT00244725|323724845|FG001|Overall Study|Failed to follow-up|0|||
94527471|NCT00244725|323724846|FG002|Overall Study|Failed to follow-up|1|||
94527472|NCT00244725|323724847|FG003|Overall Study|Failed to follow-up|1|||
94527473|NCT00506454|323724848|FG000|Overall Study|Withdrawal by Subject|1|||
94527474|NCT00506454|323724849|FG001|Overall Study|Withdrawal by Subject|1|||
94527475|NCT00124072|323724850|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
94527476|NCT00124072|323724851|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
94527477|NCT00124072|323724852|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
94527478|NCT00124072|323724853|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
94527479|NCT00124072|323724850|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
94527480|NCT00124072|323724851|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
94527481|NCT00124072|323724852|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
94527482|NCT00124072|323724853|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
94527483|NCT00124072|323724850|FG000|Overall Study|Death|499|||
94527484|NCT00124072|323724851|FG001|Overall Study|Death|484|||
94527485|NCT00124072|323724852|FG002|Overall Study|Death|471|||
94527486|NCT00124072|323724853|FG003|Overall Study|Death|480|||
94527487|NCT00995436|323724854|FG000|Overall Study|Withdrawal by Subject|2|||
94527488|NCT00995436|323724855|FG001|Overall Study|Withdrawal by Subject|5|||
94527489|NCT00995436|323724856|FG002|Overall Study|Withdrawal by Subject|0|||
94527490|NCT01107392|323724857|FG000|Overall Study|Adverse Event|2|||
94527491|NCT01107392|323724858|FG001|Overall Study|Adverse Event|0|||
94527492|NCT01107392|323724857|FG000|Overall Study|Personal Reasons|2|||
94527493|NCT01107392|323724858|FG001|Overall Study|Personal Reasons|3|||
94527494|NCT01107392|323724857|FG000|Overall Study|Administrative decision|1|||
94527495|NCT01107392|323724858|FG001|Overall Study|Administrative decision|0|||
94527496|NCT00778336|323724859|FG000|Index Procedure-Discharge|Death|6|||
94527497|NCT00778336|323724860|FG001|Index Procedure-Discharge|Death|3|||
94527498|NCT00778336|323724861|FG002|Index Procedure-Discharge|Death|2|||
94527499|NCT00778336|323724862|FG003|Index Procedure-Discharge|Death|0|||
94527500|NCT00778336|323724859|FG000|3 Month Follow Up|Lost to Follow-up|15|||
94527501|NCT00778336|323724860|FG001|3 Month Follow Up|Lost to Follow-up|20|||
94527502|NCT00778336|323724861|FG002|3 Month Follow Up|Lost to Follow-up|3|||
94527503|NCT00778336|323724862|FG003|3 Month Follow Up|Lost to Follow-up|0|||
94527504|NCT00778336|323724859|FG000|3 Month Follow Up|Death|8|||
94527505|NCT00778336|323724860|FG001|3 Month Follow Up|Death|3|||
94527506|NCT00778336|323724861|FG002|3 Month Follow Up|Death|2|||
94527507|NCT00778336|323724862|FG003|3 Month Follow Up|Death|0|||
94527508|NCT02520388|323724863|FG000|Overall Study|Physician Decision|1|||
94527509|NCT02520388|323724864|FG001|Overall Study|Physician Decision|0|||
94527510|NCT02520388|323724863|FG000|Overall Study|Subject or parent/guardian request|0|||
94527511|NCT02520388|323724864|FG001|Overall Study|Subject or parent/guardian request|6|||
94527512|NCT02520388|323724863|FG000|Overall Study|Adverse Event|1|||
94527513|NCT02520388|323724864|FG001|Overall Study|Adverse Event|4|||
94527514|NCT02520388|323724863|FG000|Overall Study|Lost to Follow-up|3|||
94527515|NCT02520388|323724864|FG001|Overall Study|Lost to Follow-up|2|||
94527516|NCT02520388|323724863|FG000|Overall Study|Other (reason not defined)|4|||
94527517|NCT02520388|323724864|FG001|Overall Study|Other (reason not defined)|4|||
94527518|NCT02038946|323724865|FG000|Overall Study|Death|5|||
94527519|NCT02038946|323724865|FG000|Overall Study|Withdrawal by Subject|3|||
94527520|NCT02038946|323724865|FG000|Overall Study|Lost to Follow-up|2|||
94527521|NCT02038946|323724865|FG000|Overall Study|Other reasons|2|||
94527522|NCT03519997|323724867|FG000|Overall Study|Adverse Event|4|||
94527523|NCT03519997|323724867|FG000|Overall Study|Withdrawal by Subject|2|||
94527524|NCT03519997|323724867|FG000|Overall Study|Protocol Violation|1|||
94527525|NCT03162796|323724869|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
94527526|NCT03162796|323724870|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
94527527|NCT03162796|323724871|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
94527528|NCT03162796|323724869|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
94527529|NCT03162796|323724870|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
94527530|NCT03162796|323724871|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
94527531|NCT03162796|323724869|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
94527532|NCT03162796|323724870|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
94527533|NCT03162796|323724871|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
94527534|NCT03162796|323724869|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
94527535|NCT03162796|323724870|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
94527536|NCT03162796|323724871|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
94527537|NCT03162796|323724869|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
94527538|NCT03162796|323724870|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
94527539|NCT03162796|323724871|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
94527540|NCT03162796|323724869|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
94527541|NCT03162796|323724870|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
94527542|NCT03162796|323724871|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
94527543|NCT03162796|323724869|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
94527544|NCT03162796|323724870|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
94527545|NCT03162796|323724871|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
94527546|NCT03162796|323724869|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
94527547|NCT03162796|323724870|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
94527548|NCT03162796|323724871|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
94527549|NCT03162796|323724869|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
94527550|NCT03162796|323724870|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
94527551|NCT03162796|323724871|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
94527552|NCT03162796|323724869|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
94527553|NCT03162796|323724870|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
94527554|NCT03162796|323724871|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
94527555|NCT03162796|323724869|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
94527556|NCT03162796|323724870|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
94527557|NCT03162796|323724871|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
94527558|NCT02473471|323724872|FG000|Overall Study|poor oral hygiene|2|||
94527559|NCT02473471|323724872|FG000|Overall Study|Lost to Follow-up|1|||
94527560|NCT02720523|323724873|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
94527561|NCT02720523|323724874|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
94527562|NCT02720523|323724875|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
94527563|NCT02720523|323724876|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
94527564|NCT02720523|323724877|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
94527565|NCT02720523|323724878|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
94527566|NCT02720523|323724879|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
94527567|NCT02720523|323724873|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
94527568|NCT02720523|323724874|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
94527569|NCT02720523|323724875|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
94527570|NCT02720523|323724876|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
94527571|NCT02720523|323724877|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
94527572|NCT02720523|323724878|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
94527573|NCT02720523|323724879|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
94527574|NCT02720523|323724873|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
94527575|NCT02720523|323724874|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
94527576|NCT02720523|323724875|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
94527577|NCT02720523|323724876|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
94527578|NCT02720523|323724877|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
94527579|NCT02720523|323724878|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
94527580|NCT02720523|323724879|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
94527581|NCT02720523|323724873|FG000|Period 1: Placebo-controlled Period|Other|0|||
94527582|NCT02720523|323724874|FG001|Period 1: Placebo-controlled Period|Other|0|||
94527583|NCT02720523|323724875|FG002|Period 1: Placebo-controlled Period|Other|1|||
94527584|NCT02720523|323724876|FG003|Period 1: Placebo-controlled Period|Other|1|||
94527585|NCT02720523|323724877|FG004|Period 1: Placebo-controlled Period|Other|0|||
94527586|NCT02720523|323724878|FG005|Period 1: Placebo-controlled Period|Other|0|||
94527587|NCT02720523|323724879|FG006|Period 1: Placebo-controlled Period|Other|0|||
94527588|NCT02720523|323724873|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
94527589|NCT02720523|323724874|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
94527590|NCT02720523|323724875|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
94527591|NCT02720523|323724876|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
94527592|NCT02720523|323724877|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
94527593|NCT02720523|323724878|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
94527594|NCT02720523|323724879|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
94527595|NCT02720523|323724873|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
94527596|NCT02720523|323724874|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
94527597|NCT02720523|323724875|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
94527598|NCT02720523|323724876|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
94527599|NCT02720523|323724877|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
94527600|NCT02720523|323724878|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
94527601|NCT02720523|323724879|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
94527602|NCT02720523|323724873|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
94527603|NCT02720523|323724874|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
94527604|NCT02720523|323724875|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
94527605|NCT02720523|323724876|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
94527606|NCT02720523|323724877|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
94527607|NCT02720523|323724878|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
94527608|NCT02720523|323724879|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
94527609|NCT02720523|323724873|FG000|Period 2: Long-term Extension Period|Other|0|||
94527610|NCT02720523|323724874|FG001|Period 2: Long-term Extension Period|Other|0|||
94527611|NCT02720523|323724875|FG002|Period 2: Long-term Extension Period|Other|0|||
94527612|NCT02720523|323724876|FG003|Period 2: Long-term Extension Period|Other|0|||
94527613|NCT02720523|323724877|FG004|Period 2: Long-term Extension Period|Other|2|||
94527614|NCT02720523|323724878|FG005|Period 2: Long-term Extension Period|Other|0|||
94527615|NCT02720523|323724879|FG006|Period 2: Long-term Extension Period|Other|3|||
94527616|NCT02931838|323724880|FG000|Overall Study|Reason not provided by investigator|1|||
94527617|NCT02931838|323724881|FG001|Overall Study|Reason not provided by investigator|0|||
94527618|NCT02931838|323724882|FG002|Overall Study|Reason not provided by investigator|1|||
94527619|NCT02931838|323724883|FG003|Overall Study|Reason not provided by investigator|0|||
94527620|NCT02931838|323724884|FG004|Overall Study|Reason not provided by investigator|0|||
94527621|NCT02931838|323724885|FG005|Overall Study|Reason not provided by investigator|0|||
94527622|NCT02931838|323724880|FG000|Overall Study|Poor/non-compliance|0|||
94527623|NCT02931838|323724881|FG001|Overall Study|Poor/non-compliance|0|||
94527624|NCT02931838|323724882|FG002|Overall Study|Poor/non-compliance|1|||
94527625|NCT02931838|323724883|FG003|Overall Study|Poor/non-compliance|0|||
94527626|NCT02931838|323724884|FG004|Overall Study|Poor/non-compliance|0|||
94527627|NCT02931838|323724885|FG005|Overall Study|Poor/non-compliance|0|||
94527628|NCT02931838|323724880|FG000|Overall Study|Lack of Efficacy|5|||
94527629|NCT02931838|323724881|FG001|Overall Study|Lack of Efficacy|4|||
94527630|NCT02931838|323724882|FG002|Overall Study|Lack of Efficacy|0|||
94527631|NCT02931838|323724883|FG003|Overall Study|Lack of Efficacy|0|||
94527632|NCT02931838|323724884|FG004|Overall Study|Lack of Efficacy|0|||
94527633|NCT02931838|323724885|FG005|Overall Study|Lack of Efficacy|1|||
94527634|NCT02931838|323724880|FG000|Overall Study|Lost to Follow-up|1|||
94527635|NCT02931838|323724881|FG001|Overall Study|Lost to Follow-up|0|||
94527636|NCT02931838|323724882|FG002|Overall Study|Lost to Follow-up|1|||
94527637|NCT02931838|323724883|FG003|Overall Study|Lost to Follow-up|1|||
94527638|NCT02931838|323724884|FG004|Overall Study|Lost to Follow-up|2|||
94527639|NCT02931838|323724885|FG005|Overall Study|Lost to Follow-up|0|||
94527640|NCT02931838|323724880|FG000|Overall Study|Subject request to discontinue treatment|4|||
94527641|NCT02931838|323724881|FG001|Overall Study|Subject request to discontinue treatment|3|||
94527642|NCT02931838|323724882|FG002|Overall Study|Subject request to discontinue treatment|3|||
94527643|NCT02931838|323724883|FG003|Overall Study|Subject request to discontinue treatment|0|||
94527644|NCT02931838|323724884|FG004|Overall Study|Subject request to discontinue treatment|1|||
94527645|NCT02931838|323724885|FG005|Overall Study|Subject request to discontinue treatment|0|||
94527646|NCT02931838|323724880|FG000|Overall Study|Withdrawal by Subject|1|||
94527647|NCT02931838|323724881|FG001|Overall Study|Withdrawal by Subject|2|||
94527648|NCT02931838|323724882|FG002|Overall Study|Withdrawal by Subject|0|||
94527649|NCT02931838|323724883|FG003|Overall Study|Withdrawal by Subject|1|||
94527650|NCT02931838|323724884|FG004|Overall Study|Withdrawal by Subject|0|||
94527651|NCT02931838|323724885|FG005|Overall Study|Withdrawal by Subject|0|||
94527652|NCT02931838|323724880|FG000|Overall Study|Adverse Event|2|||
94527653|NCT02931838|323724881|FG001|Overall Study|Adverse Event|1|||
94527654|NCT02931838|323724882|FG002|Overall Study|Adverse Event|2|||
94527655|NCT02931838|323724883|FG003|Overall Study|Adverse Event|1|||
94527656|NCT02931838|323724884|FG004|Overall Study|Adverse Event|3|||
94527657|NCT02931838|323724885|FG005|Overall Study|Adverse Event|1|||
94527658|NCT00104728|323724886|FG000|Overall Study|screen failures|19|||
94527659|NCT01027650|323724887|FG000|Overall Study|Personal Reasons|0|||
94527660|NCT01027650|323724888|FG001|Overall Study|Personal Reasons|0|||
94527661|NCT01027650|323724889|FG002|Overall Study|Personal Reasons|0|||
94527662|NCT01027650|323724890|FG003|Overall Study|Personal Reasons|0|||
94527663|NCT01027650|323724891|FG004|Overall Study|Personal Reasons|2|||
94527664|NCT01027650|323724892|FG005|Overall Study|Personal Reasons|1|||
94527665|NCT01027650|323724893|FG006|Overall Study|Personal Reasons|0|||
94527666|NCT01027650|323724894|FG007|Overall Study|Personal Reasons|0|||
94527667|NCT01027650|323724887|FG000|Overall Study|Lost to Follow-up|0|||
94527668|NCT01027650|323724888|FG001|Overall Study|Lost to Follow-up|0|||
94527669|NCT01027650|323724889|FG002|Overall Study|Lost to Follow-up|0|||
94527670|NCT01027650|323724890|FG003|Overall Study|Lost to Follow-up|0|||
94527671|NCT01027650|323724891|FG004|Overall Study|Lost to Follow-up|0|||
94527672|NCT01027650|323724892|FG005|Overall Study|Lost to Follow-up|0|||
94527673|NCT01027650|323724893|FG006|Overall Study|Lost to Follow-up|1|||
94527674|NCT01027650|323724894|FG007|Overall Study|Lost to Follow-up|0|||
94527675|NCT01027650|323724887|FG000|Overall Study|Lack of Efficacy|0|||
94527676|NCT01027650|323724888|FG001|Overall Study|Lack of Efficacy|0|||
94527677|NCT01027650|323724889|FG002|Overall Study|Lack of Efficacy|0|||
94527678|NCT01027650|323724890|FG003|Overall Study|Lack of Efficacy|0|||
94527679|NCT01027650|323724891|FG004|Overall Study|Lack of Efficacy|0|||
94527680|NCT01027650|323724892|FG005|Overall Study|Lack of Efficacy|1|||
94527681|NCT01027650|323724893|FG006|Overall Study|Lack of Efficacy|0|||
94527682|NCT01027650|323724894|FG007|Overall Study|Lack of Efficacy|0|||
94527683|NCT01042158|323724897|FG000|Overall Study|Physician Decision|1|||
94527684|NCT01575808|323724899|FG000|Overall Study|Death|2|||
94527685|NCT01575808|323724900|FG001|Overall Study|Death|0|||
94527686|NCT01575808|323724899|FG000|Overall Study|Withdrawal by Subject|1|||
94527687|NCT01575808|323724900|FG001|Overall Study|Withdrawal by Subject|0|||
94527688|NCT03159468|323724901|FG000|Overall Study|Withdrawal by Subject|0|||
94527689|NCT03159468|323724902|FG001|Overall Study|Withdrawal by Subject|0|||
94527690|NCT03159468|323724903|FG002|Overall Study|Withdrawal by Subject|3|||
94527691|NCT03159468|323724904|FG003|Overall Study|Withdrawal by Subject|0|||
94527692|NCT03159468|323724905|FG004|Overall Study|Withdrawal by Subject|0|||
94527693|NCT03159468|323724906|FG005|Overall Study|Withdrawal by Subject|0|||
94527694|NCT00316706|323726298|FG000|Overall Study|Lost to Follow-up|38|||
94527695|NCT00316706|323726299|FG001|Overall Study|Lost to Follow-up|48|||
94527696|NCT03493451|323726302|FG000|Overall Study|Death|11|||
94527697|NCT03493451|323726303|FG001|Overall Study|Death|26|||
94527698|NCT03493451|323726304|FG002|Overall Study|Death|3|||
94527699|NCT03493451|323726302|FG000|Overall Study|Lost to Follow-up|1|||
94527700|NCT03493451|323726303|FG001|Overall Study|Lost to Follow-up|4|||
94527701|NCT03493451|323726304|FG002|Overall Study|Lost to Follow-up|1|||
94527702|NCT03493451|323726302|FG000|Overall Study|Withdrawal by Subject|1|||
94527703|NCT03493451|323726303|FG001|Overall Study|Withdrawal by Subject|1|||
94527704|NCT03493451|323726304|FG002|Overall Study|Withdrawal by Subject|2|||
94527705|NCT03493451|323726302|FG000|Overall Study|Progressive Disease|1|||
94527706|NCT03493451|323726303|FG001|Overall Study|Progressive Disease|0|||
94527707|NCT03493451|323726304|FG002|Overall Study|Progressive Disease|0|||
94527708|NCT03493451|323726302|FG000|Overall Study|Transferred to long term extension study|8|||
94527709|NCT03493451|323726303|FG001|Overall Study|Transferred to long term extension study|13|||
94527710|NCT03493451|323726304|FG002|Overall Study|Transferred to long term extension study|5|||
94527711|NCT01133756|323726306|FG000|Overall Study|Adverse Event|1|||
94527712|NCT01133756|323726307|FG001|Overall Study|Adverse Event|2|||
94527713|NCT01133756|323726308|FG002|Overall Study|Adverse Event|1|||
94527714|NCT01133756|323726306|FG000|Overall Study|Investigator Decision|1|||
94527715|NCT01133756|323726307|FG001|Overall Study|Investigator Decision|0|||
94527716|NCT01133756|323726308|FG002|Overall Study|Investigator Decision|0|||
94527717|NCT01133756|323726306|FG000|Overall Study|Withdrawal by Subject|0|||
94527718|NCT01133756|323726307|FG001|Overall Study|Withdrawal by Subject|1|||
94527719|NCT01133756|323726308|FG002|Overall Study|Withdrawal by Subject|0|||
94527720|NCT01133756|323726306|FG000|Overall Study|Progression of Disease|0|||
94527721|NCT01133756|323726307|FG001|Overall Study|Progression of Disease|0|||
94527722|NCT01133756|323726308|FG002|Overall Study|Progression of Disease|1|||
94527723|NCT03941873|323726317|FG000|Overall Study|Death|0|||
94527724|NCT03941873|323726318|FG001|Overall Study|Death|12|||
94527725|NCT03941873|323726319|FG002|Overall Study|Death|2|||
94527726|NCT03941873|323726320|FG003|Overall Study|Death|53|||
94527727|NCT03941873|323726317|FG000|Overall Study|Withdrawal by Subject|1|||
94527728|NCT03941873|323726318|FG001|Overall Study|Withdrawal by Subject|1|||
94527729|NCT03941873|323726319|FG002|Overall Study|Withdrawal by Subject|0|||
94527730|NCT03941873|323726320|FG003|Overall Study|Withdrawal by Subject|5|||
94527731|NCT03941873|323726317|FG000|Overall Study|Lost to Follow-up|1|||
94527732|NCT03941873|323726318|FG001|Overall Study|Lost to Follow-up|2|||
94527733|NCT03941873|323726319|FG002|Overall Study|Lost to Follow-up|0|||
94527734|NCT03941873|323726320|FG003|Overall Study|Lost to Follow-up|0|||
94527735|NCT03941873|323726317|FG000|Overall Study|Sponsor Decision|0|||
94527736|NCT03941873|323726318|FG001|Overall Study|Sponsor Decision|6|||
94527737|NCT03941873|323726319|FG002|Overall Study|Sponsor Decision|0|||
94527738|NCT03941873|323726320|FG003|Overall Study|Sponsor Decision|15|||
94527739|NCT00391053|323726326|FG000|Overall Study|Serious Adverse Events|1|||
94527740|NCT00391053|323726327|FG001|Overall Study|Serious Adverse Events|0|||
94527741|NCT00391053|323726328|FG002|Overall Study|Serious Adverse Events|1|||
94527742|NCT00391053|323726329|FG003|Overall Study|Serious Adverse Events|4|||
94527743|NCT00391053|323726326|FG000|Overall Study|Protocol Violation|2|||
94527744|NCT00391053|323726327|FG001|Overall Study|Protocol Violation|0|||
94527745|NCT00391053|323726328|FG002|Overall Study|Protocol Violation|0|||
94527746|NCT00391053|323726329|FG003|Overall Study|Protocol Violation|0|||
94527747|NCT00391053|323726326|FG000|Overall Study|Lost to Follow-up|1|||
94527748|NCT00391053|323726327|FG001|Overall Study|Lost to Follow-up|0|||
94527749|NCT00391053|323726328|FG002|Overall Study|Lost to Follow-up|0|||
94527750|NCT00391053|323726329|FG003|Overall Study|Lost to Follow-up|5|||
94527751|NCT00391053|323726326|FG000|Overall Study|Withdrawal by Subject|5|||
94527752|NCT00391053|323726327|FG001|Overall Study|Withdrawal by Subject|1|||
94527753|NCT00391053|323726328|FG002|Overall Study|Withdrawal by Subject|1|||
94527754|NCT00391053|323726329|FG003|Overall Study|Withdrawal by Subject|1|||
94527755|NCT04556591|323726337|FG000|Overall Study|Lost to Follow-up|1|||
94527756|NCT04556591|323726338|FG001|Overall Study|Lost to Follow-up|0|||
94527757|NCT04556591|323726337|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
94527758|NCT04556591|323726338|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
94527759|NCT04551963|323726339|FG000|Overall Study|Physician Decision|1|||
94527760|NCT04551963|323726340|FG001|Overall Study|Physician Decision|1|||
94527761|NCT04551963|323726339|FG000|Overall Study|Death|1|||
94527762|NCT04551963|323726340|FG001|Overall Study|Death|0|||
94527763|NCT03332173|323726341|FG000|Overall Study|Death|7|||
94527764|NCT03332173|323726341|FG000|Overall Study|Withdrawal by Subject|6|||
94527765|NCT03332173|323726341|FG000|Overall Study|Lost to Follow-up|2|||
94527766|NCT03332173|323726341|FG000|Overall Study|Transferred to long-term extension study|29|||
94527767|NCT03226249|323726343|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
94527768|NCT03226249|323726343|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
94527769|NCT03226249|323726343|FG000|Survival Follow-up|Patients still in follow-up.|30|||
94527770|NCT01390298|323726344|FG000|Overall Study|Death|1|||
94527771|NCT01390298|323726344|FG000|Overall Study|long term ICU admission|1|||
94527772|NCT01390298|323726344|FG000|Overall Study|Withdrawal by Subject|14|||
94527773|NCT01390298|323726344|FG000|Overall Study|Lost to Follow-up|7|||
94527774|NCT01390298|323726344|FG000|Overall Study|Surgery cancelled|1|||
94527775|NCT02684617|323726348|FG000|Overall Study|Adverse Event|1|||
94527776|NCT02684617|323726349|FG001|Overall Study|Adverse Event|0|||
94527777|NCT02684617|323726350|FG002|Overall Study|Adverse Event|1|||
94527778|NCT02684617|323726348|FG000|Overall Study|Death|8|||
94527779|NCT02684617|323726349|FG001|Overall Study|Death|16|||
94527780|NCT02684617|323726350|FG002|Overall Study|Death|28|||
94527781|NCT02684617|323726348|FG000|Overall Study|Withdrawal by Subject|2|||
94527782|NCT02684617|323726349|FG001|Overall Study|Withdrawal by Subject|0|||
94527783|NCT02684617|323726350|FG002|Overall Study|Withdrawal by Subject|4|||
94527784|NCT02684617|323726348|FG000|Overall Study|Screen Failure|1|||
94527785|NCT02684617|323726349|FG001|Overall Study|Screen Failure|0|||
94527786|NCT02684617|323726350|FG002|Overall Study|Screen Failure|2|||
94527787|NCT02684617|323726348|FG000|Overall Study|Study Terminated by Sponsor|6|||
94527788|NCT02684617|323726349|FG001|Overall Study|Study Terminated by Sponsor|1|||
94527789|NCT02684617|323726350|FG002|Overall Study|Study Terminated by Sponsor|5|||
94527790|NCT00090779|323726351|FG000|Step 1|Withdrawal by Subject|4|||
94527791|NCT00090779|323726352|FG001|Step 1|Withdrawal by Subject|2|||
94527792|NCT00090779|323726351|FG000|Step 1|Lost to Follow-up|3|||
94527793|NCT00090779|323726352|FG001|Step 1|Lost to Follow-up|2|||
94527794|NCT00090779|323726351|FG000|Step 1|Death|0|||
94527795|NCT00090779|323726352|FG001|Step 1|Death|2|||
94527796|NCT00090779|323726351|FG000|Step 1|Physician Decision|1|||
94527797|NCT00090779|323726352|FG001|Step 1|Physician Decision|0|||
94527798|NCT00090779|323726351|FG000|Step 1|Pregnancy|1|||
94527799|NCT00090779|323726352|FG001|Step 1|Pregnancy|0|||
94527800|NCT00090779|323726351|FG000|Step 1|Non-compliance to study requirements|0|||
94527801|NCT00090779|323726352|FG001|Step 1|Non-compliance to study requirements|1|||
94527802|NCT00090779|323726351|FG000|Step 1|Subject relocated|2|||
94527803|NCT00090779|323726352|FG001|Step 1|Subject relocated|8|||
94527804|NCT00090779|323726351|FG000|Step 2|Off study per study closure|6|||
94527805|NCT00090779|323726352|FG001|Step 2|Off study per study closure|16|||
94527806|NCT00090779|323726351|FG000|Step 2|Subject relocated|0|||
94527807|NCT00090779|323726352|FG001|Step 2|Subject relocated|1|||
94527808|NCT00090779|323726351|FG000|Step 2|Non-compliance to study requirements|0|||
94527809|NCT00090779|323726352|FG001|Step 2|Non-compliance to study requirements|1|||
94527810|NCT00090779|323726351|FG000|Step 3|Initiation of ART and off extended study|3|||
94527811|NCT00090779|323726352|FG001|Step 3|Initiation of ART and off extended study|2|||
94527812|NCT00090779|323726351|FG000|Step 3|Off extended study due to study closure|4|||
94527813|NCT00090779|323726352|FG001|Step 3|Off extended study due to study closure|3|||
94527814|NCT02819297|323726361|FG000|Overall Study|Withdrawal by Subject|25|||
94527815|NCT02819297|323726362|FG001|Overall Study|Withdrawal by Subject|13|||
94527816|NCT02819297|323726361|FG000|Overall Study|Lost to Follow-up|12|||
94527817|NCT02819297|323726362|FG001|Overall Study|Lost to Follow-up|14|||
94527818|NCT02819297|323726361|FG000|Overall Study|Adverse Event|12|||
94527819|NCT02819297|323726362|FG001|Overall Study|Adverse Event|10|||
94527820|NCT02819297|323726361|FG000|Overall Study|Physician Decision|5|||
94527821|NCT02819297|323726362|FG001|Overall Study|Physician Decision|5|||
94527822|NCT02819297|323726361|FG000|Overall Study|Lack of Efficacy|5|||
94527823|NCT02819297|323726362|FG001|Overall Study|Lack of Efficacy|8|||
94527824|NCT02819297|323726361|FG000|Overall Study|Protocol Violation|1|||
94527825|NCT02819297|323726362|FG001|Overall Study|Protocol Violation|2|||
94527826|NCT02151903|323726363|FG000|Overall Study|Withdrawal by Subject|1|||
94527827|NCT02151903|323726364|FG001|Overall Study|Withdrawal by Subject|0|||
94527828|NCT02151903|323726363|FG000|Overall Study|Progressive disease|2|||
94527829|NCT02151903|323726364|FG001|Overall Study|Progressive disease|1|||
94527830|NCT02201329|323726365|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
94527831|NCT02201329|323726365|FG000|Overall Study|Withdrawal by Subject|2|||
94527832|NCT02702609|323726366|FG000|Overall Study|Lost to Follow-up|8|||
94527833|NCT02702609|323726367|FG001|Overall Study|Lost to Follow-up|4|||
94527834|NCT02702609|323726366|FG000|Overall Study|Physician Decision|1|||
94527835|NCT02702609|323726367|FG001|Overall Study|Physician Decision|0|||
94527836|NCT00935493|323726368|FG000|Overall Study|Lost to Follow-up|1|||
94527837|NCT00935493|323726369|FG001|Overall Study|Lost to Follow-up|1|||
94527838|NCT00935493|323726370|FG002|Overall Study|Lost to Follow-up|1|||
94527839|NCT00935493|323726368|FG000|Overall Study|Treatment Discontinued|0|||
94527840|NCT00935493|323726369|FG001|Overall Study|Treatment Discontinued|1|||
94527841|NCT00935493|323726370|FG002|Overall Study|Treatment Discontinued|0|||
94527842|NCT02674464|323726371|FG000|Overall Study|Death|10|||
94527843|NCT02674464|323726372|FG001|Overall Study|Death|21|||
94527844|NCT02674464|323726371|FG000|Overall Study|Withdrawal by Subject|24|||
94527845|NCT02674464|323726372|FG001|Overall Study|Withdrawal by Subject|44|||
94527846|NCT02674464|323726371|FG000|Overall Study|Lost to Follow-up|97|||
94527847|NCT02674464|323726372|FG001|Overall Study|Lost to Follow-up|92|||
94527848|NCT02674464|323726371|FG000|Overall Study|Outside survey window|6|||
94527849|NCT02674464|323726372|FG001|Overall Study|Outside survey window|3|||
94527850|NCT02243371|323726375|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
94527851|NCT02243371|323726376|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
94527852|NCT02243371|323726375|FG000|Overall Study|Death (unrelated)|2|||
94527853|NCT02243371|323726376|FG001|Overall Study|Death (unrelated)|4|||
94527854|NCT02243371|323726375|FG000|Overall Study|Adverse Event (unrelated)|0|||
94527855|NCT02243371|323726376|FG001|Overall Study|Adverse Event (unrelated)|1|||
94527856|NCT02243371|323726375|FG000|Overall Study|Lack of Clinical Benefit|0|||
94527857|NCT02243371|323726376|FG001|Overall Study|Lack of Clinical Benefit|1|||
94527858|NCT02243371|323726375|FG000|Overall Study|Withdrawal by Subject|0|||
94527859|NCT02243371|323726376|FG001|Overall Study|Withdrawal by Subject|2|||
94527860|NCT00787839|323726377|FG000|Overall Study|Failure to have the OGTT was most common|404|||
94527861|NCT00335738|323726380|FG000|Overall Study|Physician Decision|6|||
94527862|NCT00335738|323726381|FG001|Overall Study|Physician Decision|0|||
94527863|NCT00335738|323726380|FG000|Overall Study|Withdrawal by Subject|2|||
94527864|NCT00335738|323726381|FG001|Overall Study|Withdrawal by Subject|0|||
94527865|NCT00335738|323726380|FG000|Overall Study|Ineligible|3|||
94527866|NCT00335738|323726381|FG001|Overall Study|Ineligible|4|||
94527867|NCT03248167|323726382|FG000|Overall Study|Withdrawal by Subject|2|||
94527868|NCT03248167|323726383|FG001|Overall Study|Withdrawal by Subject|2|||
94527869|NCT03248167|323726382|FG000|Overall Study|Physician Decision|0|||
94527870|NCT03248167|323726383|FG001|Overall Study|Physician Decision|1|||
94527871|NCT03248167|323726382|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
94527872|NCT03248167|323726383|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
94527873|NCT03248167|323726382|FG000|Overall Study|Lost to Follow-up|1|||
94527874|NCT03248167|323726383|FG001|Overall Study|Lost to Follow-up|0|||
94527875|NCT02036580|323726387|FG000|Overall Study|Withdrawal by Subject|0|||
94527876|NCT02036580|323726388|FG001|Overall Study|Withdrawal by Subject|1|||
94527877|NCT02036580|323726389|FG002|Overall Study|Withdrawal by Subject|0|||
94527878|NCT02036580|323726387|FG000|Overall Study|Adverse Event|1|||
94527879|NCT02036580|323726388|FG001|Overall Study|Adverse Event|0|||
94527880|NCT02036580|323726389|FG002|Overall Study|Adverse Event|0|||
94527881|NCT03082677|323726393|FG000|Overall Study|Not Treated|2|||
94527882|NCT01916824|323726394|FG000|Overall Study|Lost to Follow-up|3|||
94527883|NCT01916824|323726395|FG001|Overall Study|Lost to Follow-up|6|||
94527884|NCT01916824|323726394|FG000|Overall Study|Physician Decision|2|||
94527885|NCT01916824|323726395|FG001|Overall Study|Physician Decision|0|||
94527886|NCT01916824|323726394|FG000|Overall Study|Withdrawal by Subject|2|||
94527887|NCT01916824|323726395|FG001|Overall Study|Withdrawal by Subject|3|||
94527888|NCT03835481|323726396|FG000|Double-blind Period|Other not stated below|0|||
94527889|NCT03835481|323726397|FG001|Double-blind Period|Other not stated below|0|||
94527890|NCT03835481|323726398|FG002|Double-blind Period|Other not stated below|0|||
94527891|NCT03835481|323726399|FG003|Double-blind Period|Other not stated below|1|||
94527892|NCT03835481|323726400|FG004|Double-blind Period|Other not stated below|1|||
94527893|NCT03835481|323726396|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
94527894|NCT03835481|323726397|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
94527895|NCT03835481|323726398|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
94527896|NCT03835481|323726399|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
94527897|NCT03835481|323726400|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
94527898|NCT03835481|323726396|FG000|Double-blind Period|Withdrawal by Subject|0|||
94527899|NCT03835481|323726397|FG001|Double-blind Period|Withdrawal by Subject|0|||
94527900|NCT03835481|323726398|FG002|Double-blind Period|Withdrawal by Subject|1|||
94527901|NCT03835481|323726399|FG003|Double-blind Period|Withdrawal by Subject|0|||
94527902|NCT03835481|323726400|FG004|Double-blind Period|Withdrawal by Subject|5|||
94527903|NCT03835481|323726396|FG000|Double-blind Period|Lost to Follow-up|0|||
94527904|NCT03835481|323726397|FG001|Double-blind Period|Lost to Follow-up|0|||
94527905|NCT03835481|323726398|FG002|Double-blind Period|Lost to Follow-up|0|||
94527906|NCT03835481|323726399|FG003|Double-blind Period|Lost to Follow-up|1|||
94527907|NCT03835481|323726400|FG004|Double-blind Period|Lost to Follow-up|0|||
94527908|NCT03835481|323726396|FG000|Double-blind Period|Protocol Violation|0|||
94527909|NCT03835481|323726397|FG001|Double-blind Period|Protocol Violation|2|||
94527910|NCT03835481|323726398|FG002|Double-blind Period|Protocol Violation|0|||
94527911|NCT03835481|323726399|FG003|Double-blind Period|Protocol Violation|1|||
94527912|NCT03835481|323726400|FG004|Double-blind Period|Protocol Violation|0|||
94527913|NCT03835481|323726396|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
94527914|NCT03835481|323726397|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
94527915|NCT03835481|323726398|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
94527916|NCT03835481|323726399|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
94527917|NCT03835481|323726400|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
94527918|NCT03835481|323726396|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
94527919|NCT03835481|323726397|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
94527920|NCT03835481|323726398|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
94527921|NCT03835481|323726399|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
94527922|NCT03835481|323726400|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
94527923|NCT03835481|323726396|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
94527924|NCT03835481|323726397|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
94527925|NCT03835481|323726398|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
94527926|NCT03835481|323726399|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
94527927|NCT03835481|323726400|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
94527928|NCT03835481|323726396|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
94527929|NCT03835481|323726397|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
94527930|NCT03835481|323726398|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
94527931|NCT03835481|323726399|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
94527932|NCT03835481|323726400|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
94527933|NCT03835481|323726396|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
94527934|NCT03835481|323726397|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
94527935|NCT03835481|323726398|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
94527936|NCT03835481|323726399|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
94527937|NCT03835481|323726400|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
94527938|NCT03835481|323726396|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
94527939|NCT03835481|323726397|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
94527940|NCT03835481|323726398|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
94527941|NCT03835481|323726399|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
94527942|NCT03835481|323726400|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
94527943|NCT03028129|323726401|FG000|Overall Study|Adverse Event|13|||
94527944|NCT03028129|323726402|FG001|Overall Study|Adverse Event|2|||
94527945|NCT03028129|323726401|FG000|Overall Study|Lost to Follow-up|50|||
94527946|NCT03028129|323726402|FG001|Overall Study|Lost to Follow-up|38|||
94527947|NCT03028129|323726401|FG000|Overall Study|Physician Decision|0|||
94527948|NCT03028129|323726402|FG001|Overall Study|Physician Decision|1|||
94527949|NCT03028129|323726401|FG000|Overall Study|Protocol Violation|1|||
94527950|NCT03028129|323726402|FG001|Overall Study|Protocol Violation|1|||
94527951|NCT03028129|323726401|FG000|Overall Study|Withdrawal by Subject|62|||
94527952|NCT03028129|323726402|FG001|Overall Study|Withdrawal by Subject|45|||
94527953|NCT00923351|323726403|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
94527954|NCT00923351|323726404|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
94527955|NCT00923351|323726405|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
94527956|NCT01814397|323726410|FG000|Overall Study|Adverse Event|7|||
94527957|NCT01814397|323726410|FG000|Overall Study|Withdrawal by Subject|7|||
94527958|NCT01221753|323726411|FG000|Overall Study|Adverse Event|1|||
94527959|NCT02467192|323726412|FG000|Overall Study|Death|1|||
94527960|NCT02467192|323726412|FG000|Overall Study|revealed to have pneumonia before|2|||
94527961|NCT03583359|323726413|FG000|Overall Study|Withdrawal by Subject|15|||
94527962|NCT03583359|323726414|FG001|Overall Study|Withdrawal by Subject|6|||
94527963|NCT03583359|323726413|FG000|Overall Study|Lost to Follow-up|12|||
94527964|NCT03583359|323726414|FG001|Overall Study|Lost to Follow-up|3|||
94527965|NCT03583359|323726413|FG000|Overall Study|Adverse Event|0|||
94527966|NCT03583359|323726414|FG001|Overall Study|Adverse Event|1|||
94527967|NCT03583359|323726413|FG000|Overall Study|Protocol Violation|0|||
94527968|NCT03583359|323726414|FG001|Overall Study|Protocol Violation|1|||
94527969|NCT03583359|323726413|FG000|Overall Study|Other|2|||
94527970|NCT03583359|323726414|FG001|Overall Study|Other|1|||
94527971|NCT02952313|323726418|FG000|Primary Endpoint|Lost to Follow-up|4|||
94527972|NCT02952313|323726418|FG000|Primary Endpoint|Withdrawal by Subject|1|||
94527973|NCT02952313|323726418|FG000|Primary Endpoint|Lack of Efficacy|1|||
94527974|NCT02952313|323726418|FG000|Primary Endpoint|Missed visit|1|||
94527975|NCT02952313|323726418|FG000|Long-term Follow-up|Lost to Follow-up|12|||
94527976|NCT02952313|323726418|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
94527977|NCT02952313|323726418|FG000|Long-term Follow-up|Lack of Efficacy|6|||
94527978|NCT02952313|323726418|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
94527979|NCT02952313|323726418|FG000|Long-term Follow-up|Physician Decision|1|||
94527980|NCT02952313|323726418|FG000|Long-term Follow-up|Death|1|||
94527981|NCT02798315|323726419|FG000|Overall Study|Failure to return|1|||
94527982|NCT02146131|323726420|FG000|Overall Study|Physician Decision|61|||
94527983|NCT02146131|323726421|FG001|Overall Study|Physician Decision|56|||
94527984|NCT02567799|323726422|FG000|Concurrent Chemoradiotherapy|Death|1|||
94527985|NCT02567799|323726423|FG001|Concurrent Chemoradiotherapy|Death|0|||
94527986|NCT02567799|323726424|FG002|Concurrent Chemoradiotherapy|Death|0|||
94527987|NCT02567799|323726422|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
94527988|NCT02567799|323726423|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
94527989|NCT02567799|323726424|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
94527990|NCT02567799|323726422|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
94527991|NCT02567799|323726423|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
94527992|NCT02567799|323726424|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
94527993|NCT02567799|323726422|FG000|Follow-up|Death|1|||
94527994|NCT02567799|323726423|FG001|Follow-up|Death|0|||
94527995|NCT02567799|323726424|FG002|Follow-up|Death|1|||
94527996|NCT02567799|323726422|FG000|Follow-up|Progressive Disease|1|||
94527997|NCT02567799|323726423|FG001|Follow-up|Progressive Disease|1|||
94527998|NCT02567799|323726424|FG002|Follow-up|Progressive Disease|3|||
94527999|NCT03292640|323726425|FG000|Overall Study|Withdrawal by Subject|17|||
94528000|NCT03292640|323726426|FG001|Overall Study|Withdrawal by Subject|16|||
94528001|NCT03292640|323726425|FG000|Overall Study|Adverse Event|20|||
94528002|NCT03292640|323726426|FG001|Overall Study|Adverse Event|2|||
94528003|NCT03292640|323726425|FG000|Overall Study|Lost to Follow-up|24|||
94528004|NCT03292640|323726426|FG001|Overall Study|Lost to Follow-up|24|||
94528005|NCT00972517|323726427|FG000|Overall Study|Adverse Event|0|||
94528006|NCT00972517|323726428|FG001|Overall Study|Adverse Event|0|||
94528007|NCT00972517|323726429|FG002|Overall Study|Adverse Event|0|||
94528008|NCT00972517|323726430|FG003|Overall Study|Adverse Event|1|||
94528009|NCT00972517|323726431|FG004|Overall Study|Adverse Event|0|||
94528010|NCT00972517|323726432|FG005|Overall Study|Adverse Event|0|||
94528011|NCT00972517|323726427|FG000|Overall Study|Withdrawal by Subject|0|||
94528012|NCT00972517|323726428|FG001|Overall Study|Withdrawal by Subject|1|||
94528013|NCT00972517|323726429|FG002|Overall Study|Withdrawal by Subject|0|||
94528014|NCT00972517|323726430|FG003|Overall Study|Withdrawal by Subject|2|||
94528015|NCT00972517|323726431|FG004|Overall Study|Withdrawal by Subject|1|||
94528016|NCT00972517|323726432|FG005|Overall Study|Withdrawal by Subject|0|||
94528017|NCT00819156|323726433|FG000|Overall Study|Adverse Event|1|||
94528018|NCT00819156|323726434|FG001|Overall Study|Adverse Event|4|||
94528019|NCT00819156|323726435|FG002|Overall Study|Adverse Event|2|||
94528020|NCT00819156|323726436|FG003|Overall Study|Adverse Event|1|||
94528021|NCT00819156|323726437|FG004|Overall Study|Adverse Event|2|||
94528022|NCT00819156|323726438|FG005|Overall Study|Adverse Event|3|||
94528023|NCT00819156|323726433|FG000|Overall Study|Withdrawal by Subject|0|||
94528024|NCT00819156|323726434|FG001|Overall Study|Withdrawal by Subject|3|||
94528025|NCT00819156|323726435|FG002|Overall Study|Withdrawal by Subject|2|||
94528026|NCT00819156|323726436|FG003|Overall Study|Withdrawal by Subject|0|||
94528027|NCT00819156|323726437|FG004|Overall Study|Withdrawal by Subject|1|||
94528028|NCT00819156|323726438|FG005|Overall Study|Withdrawal by Subject|0|||
94528029|NCT00819156|323726433|FG000|Overall Study|Protocol Violation|1|||
94528030|NCT00819156|323726434|FG001|Overall Study|Protocol Violation|0|||
94528031|NCT00819156|323726435|FG002|Overall Study|Protocol Violation|1|||
94528032|NCT00819156|323726436|FG003|Overall Study|Protocol Violation|0|||
94528033|NCT00819156|323726437|FG004|Overall Study|Protocol Violation|0|||
94528034|NCT00819156|323726438|FG005|Overall Study|Protocol Violation|1|||
94528035|NCT00819156|323726433|FG000|Overall Study|Lost to Follow-up|0|||
94528036|NCT00819156|323726434|FG001|Overall Study|Lost to Follow-up|1|||
94528037|NCT00819156|323726435|FG002|Overall Study|Lost to Follow-up|0|||
94528038|NCT00819156|323726436|FG003|Overall Study|Lost to Follow-up|0|||
94528039|NCT00819156|323726437|FG004|Overall Study|Lost to Follow-up|0|||
94528040|NCT00819156|323726438|FG005|Overall Study|Lost to Follow-up|2|||
94528041|NCT00819156|323726433|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
94528042|NCT00819156|323726434|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
94528043|NCT00819156|323726435|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
94528044|NCT00819156|323726436|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
94528045|NCT00819156|323726437|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
94528046|NCT00819156|323726438|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
94528047|NCT00819156|323726433|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
94528048|NCT00819156|323726434|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
94528049|NCT00819156|323726435|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
94528050|NCT00819156|323726436|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
94528051|NCT00819156|323726437|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
94528052|NCT00819156|323726438|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
94528053|NCT00819156|323726433|FG000|Overall Study|Prostate-specific antigen progression|0|||
94528054|NCT00819156|323726434|FG001|Overall Study|Prostate-specific antigen progression|0|||
94528055|NCT00819156|323726435|FG002|Overall Study|Prostate-specific antigen progression|0|||
94528056|NCT00819156|323726436|FG003|Overall Study|Prostate-specific antigen progression|0|||
94528057|NCT00819156|323726437|FG004|Overall Study|Prostate-specific antigen progression|1|||
94528058|NCT00819156|323726438|FG005|Overall Study|Prostate-specific antigen progression|0|||
94528059|NCT00984594|323726441|FG000|Overall Study|Lost to Follow-up|1|||
94528060|NCT00984594|323726442|FG001|Overall Study|Lost to Follow-up|0|||
94528061|NCT00984594|323726441|FG000|Overall Study|Withdrawal by Subject|0|||
94528062|NCT00984594|323726442|FG001|Overall Study|Withdrawal by Subject|1|||
94528063|NCT02100423|323726443|FG000|Overall Study|Death|1|||
94528064|NCT02100423|323726443|FG000|Overall Study|Withdrawal by Subject|3|||
94528065|NCT02100423|323726443|FG000|Overall Study|Adverse Event|1|||
94528066|NCT02100423|323726443|FG000|Overall Study|Physician Decision|1|||
94528067|NCT02454530|323726444|FG000|Overall Study|Other|8|||
94528068|NCT02454530|323726445|FG001|Overall Study|Other|13|||
94528069|NCT02454530|323726444|FG000|Overall Study|Missing information|56|||
94528070|NCT02454530|323726445|FG001|Overall Study|Missing information|69|||
94528071|NCT02454530|323726444|FG000|Overall Study|Death|2|||
94528072|NCT02454530|323726445|FG001|Overall Study|Death|41|||
94528073|NCT02454530|323726444|FG000|Overall Study|Lost to Follow-up|4|||
94528074|NCT02454530|323726445|FG001|Overall Study|Lost to Follow-up|4|||
94528075|NCT02195700|323726446|FG000|Overall Study|Protocol Violation|0|||
94528076|NCT02195700|323726447|FG001|Overall Study|Protocol Violation|2|||
94528077|NCT02195700|323726446|FG000|Overall Study|Noncompliance|1|||
94528078|NCT02195700|323726447|FG001|Overall Study|Noncompliance|0|||
94528079|NCT02195700|323726446|FG000|Overall Study|Adverse Event|1|||
94528080|NCT02195700|323726447|FG001|Overall Study|Adverse Event|2|||
94528081|NCT02195700|323726446|FG000|Overall Study|Withdrawal by Subject|3|||
94528082|NCT02195700|323726447|FG001|Overall Study|Withdrawal by Subject|2|||
94528083|NCT02195700|323726446|FG000|Overall Study|Lost to Follow-up|1|||
94528084|NCT02195700|323726447|FG001|Overall Study|Lost to Follow-up|1|||
94528085|NCT02015481|323726448|FG000|Overall Study|Death|1|||
94528086|NCT03122145|323726449|FG000|Overall Study|Concurrent respiratory disease|3|||
94528087|NCT03122145|323726450|FG001|Overall Study|Concurrent respiratory disease|0|||
94528088|NCT01234480|323728380|FG000|Overall Study|Pregnancy|88|||
94528089|NCT01234480|323728380|FG000|Overall Study|>36/Normal History|50|||
94528090|NCT01234480|323728380|FG000|Overall Study|Age|3|||
94528091|NCT01234480|323728380|FG000|Overall Study|HPV Vaccine History|28|||
94528092|NCT01234480|323728380|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
94528093|NCT01234480|323728380|FG000|Overall Study|Hysterectomy|2|||
94528094|NCT01234480|323728380|FG000|Overall Study|Hysterectomy post enrollment|1|||
94528095|NCT01234480|323728380|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
94528096|NCT01234480|323728380|FG000|Overall Study|Informed Consent Form Violation|30|||
94528097|NCT01234480|323728380|FG000|Overall Study|Incorrect Visit|3|||
94528098|NCT01234480|323728380|FG000|Overall Study|No Florida Lab License|20|||
94528099|NCT01234480|323728380|FG000|Overall Study|Out of Window|42|||
94528100|NCT01234480|323728380|FG000|Overall Study|Sample Processing/Storage|92|||
94528101|NCT01234480|323728380|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
94528102|NCT01234480|323728380|FG000|Overall Study|Site/Subject non-compliance|44|||
94528103|NCT01234480|323728380|FG000|Overall Study|Missing Sample|9|||
94528104|NCT00500357|323728381|FG000|Overall Study|Death|1|||
94528105|NCT02263326|323728382|FG000|Overall Study|Lost to Follow-up|1|||
94528106|NCT02263326|323728383|FG001|Overall Study|Lost to Follow-up|1|||
94528107|NCT01893411|323728384|FG000|Overall Study|Protocol Violation|1|||
94528108|NCT01893411|323728385|FG001|Overall Study|Protocol Violation|0|||
94528109|NCT01893411|323728386|FG002|Overall Study|Protocol Violation|0|||
94528110|NCT01893411|323728384|FG000|Overall Study|Physician Decision|1|||
94528111|NCT01893411|323728385|FG001|Overall Study|Physician Decision|1|||
94528112|NCT01893411|323728386|FG002|Overall Study|Physician Decision|2|||
94528113|NCT01893411|323728384|FG000|Overall Study|Lack of Efficacy|2|||
94528114|NCT01893411|323728385|FG001|Overall Study|Lack of Efficacy|1|||
94528115|NCT01893411|323728386|FG002|Overall Study|Lack of Efficacy|0|||
94528116|NCT01893411|323728384|FG000|Overall Study|Other|3|||
94528117|NCT01893411|323728385|FG001|Overall Study|Other|1|||
94528118|NCT01893411|323728386|FG002|Overall Study|Other|3|||
94528119|NCT01893411|323728384|FG000|Overall Study|Adverse Event|1|||
94528120|NCT01893411|323728385|FG001|Overall Study|Adverse Event|0|||
94528121|NCT01893411|323728386|FG002|Overall Study|Adverse Event|0|||
94528122|NCT01893411|323728384|FG000|Overall Study|Withdrawal by Subject|7|||
94528123|NCT01893411|323728385|FG001|Overall Study|Withdrawal by Subject|4|||
94528124|NCT01893411|323728386|FG002|Overall Study|Withdrawal by Subject|3|||
94528125|NCT01893411|323728384|FG000|Overall Study|Lost to Follow-up|2|||
94528126|NCT01893411|323728385|FG001|Overall Study|Lost to Follow-up|0|||
94528127|NCT01893411|323728386|FG002|Overall Study|Lost to Follow-up|1|||
94528128|NCT03292874|323728387|FG000|Overall Study|Due to pandemic|5|||
94528129|NCT00161616|323728388|FG000|Overall Study|Withdrawal by Subject|6|||
94528130|NCT00161616|323728389|FG001|Overall Study|Withdrawal by Subject|5|||
94528131|NCT00161616|323728388|FG000|Overall Study|Physician Decision|1|||
94528132|NCT00161616|323728389|FG001|Overall Study|Physician Decision|0|||
94528133|NCT00161616|323728388|FG000|Overall Study|Death|1|||
94528134|NCT00161616|323728389|FG001|Overall Study|Death|1|||
94528135|NCT00161616|323728388|FG000|Overall Study|Lost to Follow-up|17|||
94528136|NCT00161616|323728389|FG001|Overall Study|Lost to Follow-up|13|||
94528137|NCT00161616|323728388|FG000|Overall Study|Protocol deviation|1|||
94528138|NCT00161616|323728389|FG001|Overall Study|Protocol deviation|0|||
94528139|NCT00933608|323728390|FG000|Overall Study|Adverse Event|4|||
94528140|NCT00933608|323728391|FG001|Overall Study|Adverse Event|2|||
94528141|NCT00933608|323728390|FG000|Overall Study|Physician Decision|1|||
94528142|NCT00933608|323728391|FG001|Overall Study|Physician Decision|0|||
94528143|NCT02719691|323728392|FG000|Overall Study|Physician Decision|0|||
94528144|NCT02719691|323728393|FG001|Overall Study|Physician Decision|0|||
94528145|NCT02719691|323728394|FG002|Overall Study|Physician Decision|1|||
94528146|NCT02719691|323728395|FG003|Overall Study|Physician Decision|0|||
94528147|NCT02719691|323728396|FG004|Overall Study|Physician Decision|0|||
94528148|NCT02719691|323728397|FG005|Overall Study|Physician Decision|0|||
94528149|NCT02719691|323728398|FG006|Overall Study|Physician Decision|0|||
94528150|NCT02719691|323728392|FG000|Overall Study|Withdrawal by Subject|0|||
94528151|NCT02719691|323728393|FG001|Overall Study|Withdrawal by Subject|0|||
94528152|NCT02719691|323728394|FG002|Overall Study|Withdrawal by Subject|0|||
94528153|NCT02719691|323728395|FG003|Overall Study|Withdrawal by Subject|0|||
94528154|NCT02719691|323728396|FG004|Overall Study|Withdrawal by Subject|0|||
94528155|NCT02719691|323728397|FG005|Overall Study|Withdrawal by Subject|1|||
94528156|NCT02719691|323728398|FG006|Overall Study|Withdrawal by Subject|0|||
94528157|NCT00336284|323728401|FG000|Overall Study|Death|52|||
94528158|NCT00336284|323728402|FG001|Overall Study|Death|26|||
94528159|NCT00336284|323728401|FG000|Overall Study|Lost to Follow-up|82|||
94528160|NCT00336284|323728402|FG001|Overall Study|Lost to Follow-up|61|||
94528161|NCT00336284|323728401|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
94528162|NCT00336284|323728402|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
94528163|NCT00861757|323728403|FG000|Overall Study|Adverse Event|1|||
94528164|NCT00861757|323728404|FG001|Overall Study|Adverse Event|5|||
94528165|NCT00861757|323728405|FG002|Overall Study|Adverse Event|7|||
94528166|NCT00861757|323728406|FG003|Overall Study|Adverse Event|2|||
94528167|NCT00861757|323728403|FG000|Overall Study|Entry Criteria Not Met|1|||
94528168|NCT00861757|323728404|FG001|Overall Study|Entry Criteria Not Met|2|||
94528169|NCT00861757|323728405|FG002|Overall Study|Entry Criteria Not Met|1|||
94528170|NCT00861757|323728406|FG003|Overall Study|Entry Criteria Not Met|1|||
94528171|NCT00861757|323728403|FG000|Overall Study|Lack of Efficacy|3|||
94528172|NCT00861757|323728404|FG001|Overall Study|Lack of Efficacy|1|||
94528173|NCT00861757|323728405|FG002|Overall Study|Lack of Efficacy|0|||
94528174|NCT00861757|323728406|FG003|Overall Study|Lack of Efficacy|1|||
94528175|NCT00861757|323728403|FG000|Overall Study|Lost to Follow-up|1|||
94528176|NCT00861757|323728404|FG001|Overall Study|Lost to Follow-up|0|||
94528177|NCT00861757|323728405|FG002|Overall Study|Lost to Follow-up|1|||
94528178|NCT00861757|323728406|FG003|Overall Study|Lost to Follow-up|1|||
94528179|NCT00861757|323728403|FG000|Overall Study|Physician Decision|0|||
94528180|NCT00861757|323728404|FG001|Overall Study|Physician Decision|0|||
94528181|NCT00861757|323728405|FG002|Overall Study|Physician Decision|0|||
94528182|NCT00861757|323728406|FG003|Overall Study|Physician Decision|1|||
94528183|NCT00861757|323728403|FG000|Overall Study|Protocol Violation|2|||
94528184|NCT00861757|323728404|FG001|Overall Study|Protocol Violation|2|||
94528185|NCT00861757|323728405|FG002|Overall Study|Protocol Violation|4|||
94528186|NCT00861757|323728406|FG003|Overall Study|Protocol Violation|1|||
94528187|NCT00861757|323728403|FG000|Overall Study|Withdrawal by Subject|1|||
94528188|NCT00861757|323728404|FG001|Overall Study|Withdrawal by Subject|5|||
94528189|NCT00861757|323728405|FG002|Overall Study|Withdrawal by Subject|5|||
94528190|NCT00861757|323728406|FG003|Overall Study|Withdrawal by Subject|2|||
94528191|NCT01521923|323728409|FG000|Overall Study|AE, serious fatal|1|||
94528192|NCT01521923|323728410|FG001|Overall Study|AE, serious fatal|0|||
94528193|NCT01521923|323728411|FG002|Overall Study|AE, serious fatal|0|||
94528194|NCT01521923|323728412|FG003|Overall Study|AE, serious fatal|0|||
94528195|NCT01521923|323728409|FG000|Overall Study|SAE, non-fatal|0|||
94528196|NCT01521923|323728410|FG001|Overall Study|SAE, non-fatal|2|||
94528197|NCT01521923|323728411|FG002|Overall Study|SAE, non-fatal|2|||
94528198|NCT01521923|323728412|FG003|Overall Study|SAE, non-fatal|0|||
94528199|NCT01521923|323728409|FG000|Overall Study|AE, non-serious, non-fatal|1|||
94528200|NCT01521923|323728410|FG001|Overall Study|AE, non-serious, non-fatal|3|||
94528201|NCT01521923|323728411|FG002|Overall Study|AE, non-serious, non-fatal|6|||
94528202|NCT01521923|323728412|FG003|Overall Study|AE, non-serious, non-fatal|2|||
94528203|NCT01521923|323728409|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
94528204|NCT01521923|323728410|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
94528205|NCT01521923|323728411|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
94528206|NCT01521923|323728412|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
94528207|NCT01521923|323728409|FG000|Overall Study|Lack of Efficacy|1|||
94528208|NCT01521923|323728410|FG001|Overall Study|Lack of Efficacy|1|||
94528209|NCT01521923|323728411|FG002|Overall Study|Lack of Efficacy|0|||
94528210|NCT01521923|323728412|FG003|Overall Study|Lack of Efficacy|0|||
94528211|NCT01521923|323728409|FG000|Overall Study|Protocol Violation|0|||
94528212|NCT01521923|323728410|FG001|Overall Study|Protocol Violation|0|||
94528213|NCT01521923|323728411|FG002|Overall Study|Protocol Violation|1|||
94528214|NCT01521923|323728412|FG003|Overall Study|Protocol Violation|0|||
94528215|NCT01521923|323728409|FG000|Overall Study|Lost to Follow-up|1|||
94528216|NCT01521923|323728410|FG001|Overall Study|Lost to Follow-up|0|||
94528217|NCT01521923|323728411|FG002|Overall Study|Lost to Follow-up|2|||
94528218|NCT01521923|323728412|FG003|Overall Study|Lost to Follow-up|1|||
94528219|NCT01521923|323728409|FG000|Overall Study|Withdrawal by Subject|1|||
94528220|NCT01521923|323728410|FG001|Overall Study|Withdrawal by Subject|1|||
94528221|NCT01521923|323728411|FG002|Overall Study|Withdrawal by Subject|1|||
94528222|NCT01521923|323728412|FG003|Overall Study|Withdrawal by Subject|2|||
94528223|NCT01521923|323728409|FG000|Overall Study|Other|2|||
94528224|NCT01521923|323728410|FG001|Overall Study|Other|1|||
94528225|NCT01521923|323728411|FG002|Overall Study|Other|3|||
94528226|NCT01521923|323728412|FG003|Overall Study|Other|6|||
94528227|NCT01521923|323728409|FG000|Overall Study|AE, captured in Period 1|0|||
94528228|NCT01521923|323728410|FG001|Overall Study|AE, captured in Period 1|1|||
94528229|NCT01521923|323728411|FG002|Overall Study|AE, captured in Period 1|0|||
94528230|NCT01521923|323728412|FG003|Overall Study|AE, captured in Period 1|1|||
94528231|NCT04908384|323728413|FG000|Overall Study|Lost to Follow-up|4|||
94528232|NCT04908384|323728414|FG001|Overall Study|Lost to Follow-up|4|||
94528233|NCT04908384|323728415|FG002|Overall Study|Lost to Follow-up|0|||
94528234|NCT04908384|323728416|FG003|Overall Study|Lost to Follow-up|0|||
94528235|NCT00603941|323728420|FG000|Overall Study|Disease progression|6|||
94528236|NCT00603941|323728421|FG001|Overall Study|Disease progression|7|||
94528237|NCT00603941|323728422|FG002|Overall Study|Disease progression|1|||
94528238|NCT00603941|323728420|FG000|Overall Study|Adverse Event|1|||
94528239|NCT00603941|323728421|FG001|Overall Study|Adverse Event|0|||
94528240|NCT00603941|323728422|FG002|Overall Study|Adverse Event|1|||
94528241|NCT00603941|323728420|FG000|Overall Study|Physician Decision|0|||
94528242|NCT00603941|323728421|FG001|Overall Study|Physician Decision|1|||
94528243|NCT00603941|323728422|FG002|Overall Study|Physician Decision|0|||
94528244|NCT00603941|323728420|FG000|Overall Study|Withdrawal by Subject|0|||
94528245|NCT00603941|323728421|FG001|Overall Study|Withdrawal by Subject|2|||
94528246|NCT00603941|323728422|FG002|Overall Study|Withdrawal by Subject|0|||
94528247|NCT02705105|323728423|FG000|Treatment|Objective Disease Progression|1|||
94528248|NCT02705105|323728424|FG001|Treatment|Objective Disease Progression|50|||
94528249|NCT02705105|323728423|FG000|Treatment|Withdrawal by Subject|3|||
94528250|NCT02705105|323728424|FG001|Treatment|Withdrawal by Subject|5|||
94528251|NCT02705105|323728423|FG000|Treatment|Adverse Event|0|||
94528252|NCT02705105|323728424|FG001|Treatment|Adverse Event|17|||
94528253|NCT02705105|323728423|FG000|Treatment|Clinical Disease Progression|0|||
94528254|NCT02705105|323728424|FG001|Treatment|Clinical Disease Progression|32|||
94528255|NCT02705105|323728423|FG000|Treatment|Physician Decision|0|||
94528256|NCT02705105|323728424|FG001|Treatment|Physician Decision|3|||
94528257|NCT02705105|323728423|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
94528258|NCT02705105|323728424|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
94528259|NCT02705105|323728423|FG000|Follow-Up|Death|3|||
94528260|NCT02705105|323728424|FG001|Follow-Up|Death|68|||
94528261|NCT02705105|323728423|FG000|Follow-Up|Withdrawal by Subject|1|||
94528262|NCT02705105|323728424|FG001|Follow-Up|Withdrawal by Subject|14|||
94528263|NCT02705105|323728423|FG000|Follow-Up|Study Terminated|0|||
94528264|NCT02705105|323728424|FG001|Follow-Up|Study Terminated|26|||
94528265|NCT02705105|323728423|FG000|Follow-Up|Discontinued per Amendment 3|0|||
94528266|NCT02705105|323728424|FG001|Follow-Up|Discontinued per Amendment 3|2|||
94528267|NCT03650413|323728425|FG000|Overall Study|Adverse Event|1|||
94528268|NCT03650413|323728425|FG000|Overall Study|Lack of Efficacy|17|||
94528269|NCT03650413|323728425|FG000|Overall Study|Other|9|||
94528270|NCT03650413|323728425|FG000|Overall Study|Physician Decision|2|||
94528271|NCT03650413|323728425|FG000|Overall Study|Study Terminated By Sponsor|16|||
94528272|NCT03650413|323728425|FG000|Overall Study|Withdrawal by Subject|16|||
94528273|NCT05559905|323728426|FG000|Overall Study|Withdrawal by Subject|1|||
94528274|NCT05559905|323728427|FG001|Overall Study|Withdrawal by Subject|0|||
94528275|NCT05559905|323728428|FG002|Overall Study|Withdrawal by Subject|0|||
94528276|NCT05559905|323728426|FG000|Overall Study|Not Reported|1|||
94528277|NCT05559905|323728427|FG001|Overall Study|Not Reported|0|||
94528278|NCT05559905|323728428|FG002|Overall Study|Not Reported|0|||
94528279|NCT03654040|323728429|FG000|Overall Study|Death|1|||
94528280|NCT03654040|323728430|FG001|Overall Study|Death|0|||
94528281|NCT03654040|323728429|FG000|Overall Study|Withdrawal by Subject|1|||
94528282|NCT03654040|323728430|FG001|Overall Study|Withdrawal by Subject|0|||
94528283|NCT03654040|323728429|FG000|Overall Study|Study terminated by sponsor|8|||
94528284|NCT03654040|323728430|FG001|Overall Study|Study terminated by sponsor|2|||
94528285|NCT03654040|323728429|FG000|Overall Study|Failure to initiate study therapy|2|||
94528286|NCT03654040|323728430|FG001|Overall Study|Failure to initiate study therapy|0|||
94528287|NCT03654040|323728429|FG000|Overall Study|Transplanted at another center|2|||
94528288|NCT03654040|323728430|FG001|Overall Study|Transplanted at another center|0|||
94528289|NCT03654040|323728429|FG000|Overall Study|Failure to meet eligibility criteria|14|||
94528290|NCT03654040|323728430|FG001|Overall Study|Failure to meet eligibility criteria|2|||
94528291|NCT03654040|323728429|FG000|Overall Study|No longer transplant candidate|1|||
94528292|NCT03654040|323728430|FG001|Overall Study|No longer transplant candidate|0|||
94528293|NCT03654040|323728429|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
94528294|NCT03654040|323728430|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
94528295|NCT03654040|323728429|FG000|Overall Study|Recipient ineligible|0|||
94528296|NCT03654040|323728430|FG001|Overall Study|Recipient ineligible|2|||
94528297|NCT03654040|323728429|FG000|Overall Study|Received deceased liver|0|||
94528298|NCT03654040|323728430|FG001|Overall Study|Received deceased liver|1|||
94528299|NCT02120781|323728431|FG000|Overall Study|Physician Decision|2|||
94528300|NCT02120781|323728432|FG001|Overall Study|Physician Decision|0|||
94528301|NCT02120781|323728431|FG000|Overall Study|Completion not documented|2|||
94528302|NCT02120781|323728432|FG001|Overall Study|Completion not documented|1|||
94528303|NCT01995526|323728433|FG000|Overall Study|Physician Decision|1|||
94528304|NCT00910910|323728434|FG000|Overall Study|Adverse Event|63|||
94528305|NCT00910910|323728435|FG001|Overall Study|Adverse Event|35|||
94528306|NCT00910910|323728434|FG000|Overall Study|PD without histologic change|27|||
94528307|NCT00910910|323728435|FG001|Overall Study|PD without histologic change|23|||
94528308|NCT00910910|323728434|FG000|Overall Study|PD with histologic change|0|||
94528309|NCT00910910|323728435|FG001|Overall Study|PD with histologic change|2|||
94528310|NCT00910910|323728434|FG000|Overall Study|Withdrawal by Subject|7|||
94528311|NCT00910910|323728435|FG001|Overall Study|Withdrawal by Subject|5|||
94528312|NCT00910910|323728434|FG000|Overall Study|Lost to Follow-up|2|||
94528313|NCT00910910|323728435|FG001|Overall Study|Lost to Follow-up|2|||
94528314|NCT00910910|323728434|FG000|Overall Study|Death|9|||
94528315|NCT00910910|323728435|FG001|Overall Study|Death|3|||
94528316|NCT00910910|323728434|FG000|Overall Study|Protocol Violation|2|||
94528317|NCT00910910|323728435|FG001|Overall Study|Protocol Violation|2|||
94528318|NCT00910910|323728434|FG000|Overall Study|Completed 13 cycles of treatment|0|||
94528319|NCT00910910|323728435|FG001|Overall Study|Completed 13 cycles of treatment|118|||
94528320|NCT00910910|323728434|FG000|Overall Study|Other|114|||
94528321|NCT00910910|323728435|FG001|Overall Study|Other|32|||
94528322|NCT00910910|323728434|FG000|Overall Study|Untreated before cycle 1|1|||
94528323|NCT00910910|323728435|FG001|Overall Study|Untreated before cycle 1|2|||
94528324|NCT02817594|323728441|FG000|Overall Study|Withdrawal by Subject|1|||
94528325|NCT02817594|323728441|FG000|Overall Study|Other|1|||
94528326|NCT02817594|323728441|FG000|Overall Study|Did Not Receive Treatment|1|||
94528327|NCT03367403|323728442|FG000|Overall Study|Adverse Event|20|||
94528328|NCT03367403|323728443|FG001|Overall Study|Adverse Event|6|||
94528329|NCT03367403|323728444|FG002|Overall Study|Adverse Event|2|||
94528330|NCT03367403|323728442|FG000|Overall Study|Withdrawal by Subject|12|||
94528331|NCT03367403|323728443|FG001|Overall Study|Withdrawal by Subject|13|||
94528332|NCT03367403|323728444|FG002|Overall Study|Withdrawal by Subject|1|||
94528333|NCT03367403|323728442|FG000|Overall Study|Death|1|||
94528334|NCT03367403|323728443|FG001|Overall Study|Death|2|||
94528335|NCT03367403|323728444|FG002|Overall Study|Death|0|||
94528336|NCT03367403|323728442|FG000|Overall Study|Physician Decision|0|||
94528337|NCT03367403|323728443|FG001|Overall Study|Physician Decision|1|||
94528338|NCT03367403|323728444|FG002|Overall Study|Physician Decision|0|||
94528339|NCT03367403|323728442|FG000|Overall Study|Protocol Violation|1|||
94528340|NCT03367403|323728443|FG001|Overall Study|Protocol Violation|1|||
94528341|NCT03367403|323728444|FG002|Overall Study|Protocol Violation|0|||
94528342|NCT03367403|323728442|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
94528343|NCT03367403|323728443|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
94528344|NCT03367403|323728444|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
94528345|NCT03367403|323728442|FG000|Overall Study|COVID-19|3|||
94528346|NCT03367403|323728443|FG001|Overall Study|COVID-19|6|||
94528347|NCT03367403|323728444|FG002|Overall Study|COVID-19|0|||
94528348|NCT03367403|323728442|FG000|Overall Study|Abuse of Alcohol Intake|0|||
94528349|NCT03367403|323728443|FG001|Overall Study|Abuse of Alcohol Intake|1|||
94528350|NCT03367403|323728444|FG002|Overall Study|Abuse of Alcohol Intake|0|||
94528351|NCT03367403|323728442|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
94528352|NCT03367403|323728443|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
94528353|NCT03367403|323728444|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
94528354|NCT01977729|323728445|FG000|Overall Study|Study terminated|1|||
94528355|NCT02229825|323728446|FG000|Overall Study|Personal Reasons|0|||
94528356|NCT02229825|323728447|FG001|Overall Study|Personal Reasons|1|||
94528357|NCT02229825|323728446|FG000|Overall Study|Refused continuing medication|7|||
94528358|NCT02229825|323728447|FG001|Overall Study|Refused continuing medication|6|||
94528359|NCT02229825|323728446|FG000|Overall Study|Lost to Follow-up|1|||
94528360|NCT02229825|323728447|FG001|Overall Study|Lost to Follow-up|2|||
94528361|NCT02229825|323728446|FG000|Overall Study|Protocol Violation|1|||
94528362|NCT02229825|323728447|FG001|Overall Study|Protocol Violation|1|||
94528363|NCT02229825|323728446|FG000|Overall Study|Lack of Efficacy|4|||
94528364|NCT02229825|323728447|FG001|Overall Study|Lack of Efficacy|10|||
94528365|NCT02229825|323728446|FG000|Overall Study|Adverse Event|11|||
94528366|NCT02229825|323728447|FG001|Overall Study|Adverse Event|9|||
94528367|NCT02229825|323728446|FG000|Overall Study|Not treated|0|||
94528368|NCT02229825|323728447|FG001|Overall Study|Not treated|1|||
94528369|NCT01670279|323728454|FG000|Overall Study|Adverse Event|0|||
94528370|NCT01670279|323728455|FG001|Overall Study|Adverse Event|1|||
94528371|NCT01670279|323728456|FG002|Overall Study|Adverse Event|0|||
94528372|NCT01670279|323728457|FG003|Overall Study|Adverse Event|0|||
94528373|NCT01670279|323728454|FG000|Overall Study|Physician Decision|0|||
94528374|NCT01670279|323728455|FG001|Overall Study|Physician Decision|1|||
94528375|NCT01670279|323728456|FG002|Overall Study|Physician Decision|0|||
94528376|NCT01670279|323728457|FG003|Overall Study|Physician Decision|0|||
94528377|NCT01670279|323728454|FG000|Overall Study|Participant met withdrawal criteria|0|||
94528378|NCT01670279|323728455|FG001|Overall Study|Participant met withdrawal criteria|0|||
94528379|NCT01670279|323728456|FG002|Overall Study|Participant met withdrawal criteria|0|||
94528380|NCT01670279|323728457|FG003|Overall Study|Participant met withdrawal criteria|1|||
94528381|NCT03994211|323728458|FG000|Core Phase|Adverse Event|0|||
94528382|NCT03994211|323728459|FG001|Core Phase|Adverse Event|1|||
94528383|NCT03994211|323728460|FG002|Core Phase|Adverse Event|0|||
94528384|NCT03994211|323728458|FG000|Extension Phase|Adverse Event|0|||
94528385|NCT03994211|323728459|FG001|Extension Phase|Adverse Event|0|||
94528386|NCT03994211|323728460|FG002|Extension Phase|Adverse Event|1|||
94528387|NCT03994211|323728458|FG000|Extension Phase|Physician Decision|0|||
94528388|NCT03994211|323728459|FG001|Extension Phase|Physician Decision|0|||
94528389|NCT03994211|323728460|FG002|Extension Phase|Physician Decision|1|||
94528390|NCT03994211|323728458|FG000|Extension Phase|Progressive Disease|0|||
94528391|NCT03994211|323728459|FG001|Extension Phase|Progressive Disease|0|||
94528392|NCT03994211|323728460|FG002|Extension Phase|Progressive Disease|20|||
94528393|NCT03994211|323728458|FG000|Extension Phase|Withdrawal by Subject|0|||
94528394|NCT03994211|323728459|FG001|Extension Phase|Withdrawal by Subject|0|||
94528395|NCT03994211|323728460|FG002|Extension Phase|Withdrawal by Subject|2|||
94528396|NCT01901614|323728461|FG000|Overall Study|Adverse Event|0|||
94528397|NCT01901614|323728462|FG001|Overall Study|Adverse Event|1|||
94528398|NCT01901614|323728461|FG000|Overall Study|Lost to Follow-up|1|||
94528399|NCT01901614|323728462|FG001|Overall Study|Lost to Follow-up|0|||
94528400|NCT01901614|323728461|FG000|Overall Study|Screen Fail|1|||
94528401|NCT01901614|323728462|FG001|Overall Study|Screen Fail|0|||
94528402|NCT03928418|323728465|FG000|Overall Study|Lost to Follow-up|5|||
94528403|NCT03928418|323728466|FG001|Overall Study|Lost to Follow-up|3|||
94528404|NCT03928418|323728467|FG002|Overall Study|Lost to Follow-up|5|||
94528405|NCT03928418|323728465|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
94528406|NCT03928418|323728466|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
94528407|NCT03928418|323728467|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
94528408|NCT00286091|323728470|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
94528409|NCT00286091|323728471|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
94528410|NCT00286091|323728470|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
94528411|NCT00286091|323728471|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
94528412|NCT00286091|323728470|FG000|Double-blind Treatment Phase|Death|58|||
94528413|NCT00286091|323728471|FG001|Double-blind Treatment Phase|Death|65|||
94528414|NCT00286091|323728470|FG000|Double-blind Treatment Phase|Adverse Event|28|||
94528415|NCT00286091|323728471|FG001|Double-blind Treatment Phase|Adverse Event|40|||
94528416|NCT00286091|323728470|FG000|Double-blind Treatment Phase|Disease Progression|22|||
94528417|NCT00286091|323728471|FG001|Double-blind Treatment Phase|Disease Progression|35|||
94528418|NCT00286091|323728470|FG000|Double-blind Treatment Phase|Other|25|||
94528419|NCT00286091|323728471|FG001|Double-blind Treatment Phase|Other|33|||
94528420|NCT00286091|323728470|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
94528421|NCT00286091|323728471|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
94528422|NCT00286091|323728470|FG000|Double-blind Treatment Phase|Noncompliance|8|||
94528423|NCT00286091|323728471|FG001|Double-blind Treatment Phase|Noncompliance|8|||
94528424|NCT00286091|323728470|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
94528425|NCT00286091|323728471|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
94528426|NCT00286091|323728470|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
94528427|NCT00286091|323728471|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
94528428|NCT00286091|323728470|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
94528429|NCT00286091|323728471|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
94528430|NCT00286091|323728470|FG000|Open-label Treatment Phase|Physician Decision|24|||
94528431|NCT00286091|323728471|FG001|Open-label Treatment Phase|Physician Decision|21|||
94528432|NCT00286091|323728470|FG000|Open-label Treatment Phase|Adverse Event|5|||
94528433|NCT00286091|323728471|FG001|Open-label Treatment Phase|Adverse Event|16|||
94528434|NCT00286091|323728470|FG000|Open-label Treatment Phase|Other|11|||
94528435|NCT00286091|323728471|FG001|Open-label Treatment Phase|Other|11|||
94528436|NCT00286091|323728470|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
94528437|NCT00286091|323728471|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
94528438|NCT00286091|323728470|FG000|Open-label Treatment Phase|Death|10|||
94528439|NCT00286091|323728471|FG001|Open-label Treatment Phase|Death|7|||
94528440|NCT00286091|323728470|FG000|Open-label Treatment Phase|Disease Progression|9|||
94528441|NCT00286091|323728471|FG001|Open-label Treatment Phase|Disease Progression|3|||
94528442|NCT00286091|323728470|FG000|Open-label Treatment Phase|Noncompliance|3|||
94528443|NCT00286091|323728471|FG001|Open-label Treatment Phase|Noncompliance|1|||
94528444|NCT00286091|323728470|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
94528445|NCT00286091|323728471|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
94528446|NCT00286091|323728470|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
94528447|NCT00286091|323728471|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
94528448|NCT00286091|323728470|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
94528449|NCT00286091|323728471|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
94528450|NCT02122146|323728480|FG000|Part 1: Dose Escalation|Death|0|||
94528451|NCT02122146|323728481|FG001|Part 1: Dose Escalation|Death|1|||
94528452|NCT02122146|323728482|FG002|Part 1: Dose Escalation|Death|1|||
94528453|NCT02122146|323728483|FG003|Part 1: Dose Escalation|Death|0|||
94528454|NCT02122146|323728484|FG004|Part 1: Dose Escalation|Death|0|||
94528455|NCT02122146|323728485|FG005|Part 1: Dose Escalation|Death|0|||
94528456|NCT02122146|323728486|FG006|Part 1: Dose Escalation|Death|0|||
94528457|NCT02122146|323728487|FG007|Part 1: Dose Escalation|Death|0|||
94528458|NCT02122146|323728480|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
94528459|NCT02122146|323728481|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
94528460|NCT02122146|323728482|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
94528461|NCT02122146|323728483|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
94528462|NCT02122146|323728484|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
94528463|NCT02122146|323728485|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
94528464|NCT02122146|323728486|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
94528465|NCT02122146|323728487|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
94528466|NCT02122146|323728480|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94528467|NCT02122146|323728481|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94528468|NCT02122146|323728482|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94528469|NCT02122146|323728483|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
94528470|NCT02122146|323728484|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94528471|NCT02122146|323728485|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94528472|NCT02122146|323728486|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94528473|NCT02122146|323728487|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
94528474|NCT02122146|323728480|FG000|Part 1: Dose Escalation|Other|1|||
94528475|NCT02122146|323728481|FG001|Part 1: Dose Escalation|Other|0|||
94528476|NCT02122146|323728482|FG002|Part 1: Dose Escalation|Other|0|||
94528477|NCT02122146|323728483|FG003|Part 1: Dose Escalation|Other|0|||
94528478|NCT02122146|323728484|FG004|Part 1: Dose Escalation|Other|0|||
94528479|NCT02122146|323728485|FG005|Part 1: Dose Escalation|Other|1|||
94528480|NCT02122146|323728486|FG006|Part 1: Dose Escalation|Other|1|||
94528481|NCT02122146|323728487|FG007|Part 1: Dose Escalation|Other|2|||
94528482|NCT02595866|323728488|FG000|Overall Study|Adverse Event|2|||
94528483|NCT02595866|323728489|FG001|Overall Study|Adverse Event|5|||
94528484|NCT02595866|323728488|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
94528485|NCT02595866|323728489|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
94528486|NCT02595866|323728488|FG000|Overall Study|Death|0|||
94528487|NCT02595866|323728489|FG001|Overall Study|Death|1|||
94528488|NCT02595866|323728488|FG000|Overall Study|Incarceration|1|||
94528489|NCT02595866|323728489|FG001|Overall Study|Incarceration|0|||
94528490|NCT02595866|323728488|FG000|Overall Study|Lack of Efficacy|17|||
94528491|NCT02595866|323728489|FG001|Overall Study|Lack of Efficacy|7|||
94528492|NCT02595866|323728488|FG000|Overall Study|Physician Decision|4|||
94528493|NCT02595866|323728489|FG001|Overall Study|Physician Decision|3|||
94528494|NCT02595866|323728488|FG000|Overall Study|Switched to Alternative Treatment|1|||
94528495|NCT02595866|323728489|FG001|Overall Study|Switched to Alternative Treatment|0|||
94528496|NCT02595866|323728488|FG000|Overall Study|Study Terminated|0|||
94528497|NCT02595866|323728489|FG001|Overall Study|Study Terminated|4|||
94528498|NCT02595866|323728488|FG000|Overall Study|Withdrawal by Subject|6|||
94528499|NCT02595866|323728489|FG001|Overall Study|Withdrawal by Subject|1|||
94528500|NCT02689206|323728490|FG000|Overall Study|Adverse Event|0|||
94528501|NCT02689206|323728491|FG001|Overall Study|Adverse Event|0|||
94528502|NCT02689206|323728492|FG002|Overall Study|Adverse Event|1|||
94528503|NCT02689206|323728493|FG003|Overall Study|Adverse Event|0|||
94528504|NCT02689206|323728494|FG004|Overall Study|Adverse Event|2|||
94528505|NCT02689206|323728490|FG000|Overall Study|Protocol Violation|1|||
94528506|NCT02689206|323728491|FG001|Overall Study|Protocol Violation|0|||
94528507|NCT02689206|323728492|FG002|Overall Study|Protocol Violation|0|||
94528508|NCT02689206|323728493|FG003|Overall Study|Protocol Violation|1|||
94528509|NCT02689206|323728494|FG004|Overall Study|Protocol Violation|2|||
94528510|NCT02689206|323728490|FG000|Overall Study|Other: Reached stopping criteria|0|||
94528511|NCT02689206|323728491|FG001|Overall Study|Other: Reached stopping criteria|1|||
94528512|NCT02689206|323728492|FG002|Overall Study|Other: Reached stopping criteria|2|||
94528513|NCT02689206|323728493|FG003|Overall Study|Other: Reached stopping criteria|3|||
94528514|NCT02689206|323728494|FG004|Overall Study|Other: Reached stopping criteria|4|||
94528515|NCT02689206|323728490|FG000|Overall Study|Physician Decision|1|||
94528516|NCT02689206|323728491|FG001|Overall Study|Physician Decision|0|||
94528517|NCT02689206|323728492|FG002|Overall Study|Physician Decision|0|||
94528518|NCT02689206|323728493|FG003|Overall Study|Physician Decision|0|||
94528519|NCT02689206|323728494|FG004|Overall Study|Physician Decision|0|||
94528520|NCT02689206|323728490|FG000|Overall Study|Withdrawal by Subject|1|||
94528521|NCT02689206|323728491|FG001|Overall Study|Withdrawal by Subject|0|||
94528522|NCT02689206|323728492|FG002|Overall Study|Withdrawal by Subject|1|||
94528523|NCT02689206|323728493|FG003|Overall Study|Withdrawal by Subject|0|||
94528524|NCT02689206|323728494|FG004|Overall Study|Withdrawal by Subject|0|||
94528525|NCT04721158|323728495|FG000|Overall Study|Lost to Follow-up|4|||
94528526|NCT04721158|323728495|FG000|Overall Study|Device did not connect|1|||
94528527|NCT02998671|323728496|FG000|Period 1|Study Terminated By Sponsor|2|||
94528528|NCT02998671|323728497|FG001|Period 1|Study Terminated By Sponsor|1|||
94528529|NCT02998671|323728498|FG002|Period 1|Study Terminated By Sponsor|0|||
94528530|NCT02998671|323728499|FG003|Period 1|Study Terminated By Sponsor|0|||
94528531|NCT02998671|323728500|FG004|Period 1|Study Terminated By Sponsor|1|||
94528532|NCT02998671|323728496|FG000|Period 1|Withdrawal by Subject|1|||
94528533|NCT02998671|323728497|FG001|Period 1|Withdrawal by Subject|2|||
94528534|NCT02998671|323728498|FG002|Period 1|Withdrawal by Subject|0|||
94528535|NCT02998671|323728499|FG003|Period 1|Withdrawal by Subject|0|||
94528536|NCT02998671|323728500|FG004|Period 1|Withdrawal by Subject|2|||
94528537|NCT02998671|323728496|FG000|Period 1|Pregnancy|1|||
94528538|NCT02998671|323728497|FG001|Period 1|Pregnancy|0|||
94528539|NCT02998671|323728498|FG002|Period 1|Pregnancy|0|||
94528540|NCT02998671|323728499|FG003|Period 1|Pregnancy|0|||
94528541|NCT02998671|323728500|FG004|Period 1|Pregnancy|0|||
94528542|NCT02998671|323728496|FG000|Period 1|Adverse Event|0|||
94528543|NCT02998671|323728497|FG001|Period 1|Adverse Event|0|||
94528544|NCT02998671|323728498|FG002|Period 1|Adverse Event|0|||
94528545|NCT02998671|323728499|FG003|Period 1|Adverse Event|0|||
94528546|NCT02998671|323728500|FG004|Period 1|Adverse Event|1|||
94528547|NCT02998671|323728496|FG000|Period 2|Adverse Event|0|||
94528548|NCT02998671|323728497|FG001|Period 2|Adverse Event|1|||
94528549|NCT02998671|323728498|FG002|Period 2|Adverse Event|0|||
94528550|NCT02998671|323728499|FG003|Period 2|Adverse Event|0|||
94528551|NCT02998671|323728500|FG004|Period 2|Adverse Event|0|||
94528552|NCT02998671|323728496|FG000|Period 2|Study Terminated By Sponsor|3|||
94528553|NCT02998671|323728497|FG001|Period 2|Study Terminated By Sponsor|5|||
94528554|NCT02998671|323728498|FG002|Period 2|Study Terminated By Sponsor|1|||
94528555|NCT02998671|323728499|FG003|Period 2|Study Terminated By Sponsor|3|||
94528556|NCT02998671|323728500|FG004|Period 2|Study Terminated By Sponsor|0|||
94528557|NCT02998671|323728496|FG000|Period 2|Withdrawal by Subject|0|||
94528558|NCT02998671|323728497|FG001|Period 2|Withdrawal by Subject|1|||
94528559|NCT02998671|323728498|FG002|Period 2|Withdrawal by Subject|0|||
94528560|NCT02998671|323728499|FG003|Period 2|Withdrawal by Subject|0|||
94528561|NCT02998671|323728500|FG004|Period 2|Withdrawal by Subject|0|||
94528562|NCT02998671|323728496|FG000|Period 2|Lost to Follow-up|0|||
94528563|NCT02998671|323728497|FG001|Period 2|Lost to Follow-up|0|||
94528564|NCT02998671|323728498|FG002|Period 2|Lost to Follow-up|0|||
94528565|NCT02998671|323728499|FG003|Period 2|Lost to Follow-up|1|||
94528566|NCT02998671|323728500|FG004|Period 2|Lost to Follow-up|0|||
94528567|NCT03640507|323728504|FG000|Overall Study|Withdrawal by Subject|0|||
94528568|NCT03640507|323728505|FG001|Overall Study|Withdrawal by Subject|0|||
94528569|NCT03640507|323728506|FG002|Overall Study|Withdrawal by Subject|1|||
94528570|NCT00191945|323728508|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
94528571|NCT00191945|323728509|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
94528572|NCT00191945|323728508|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
94528573|NCT00191945|323728509|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
94528574|NCT00191945|323728508|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
94528575|NCT00191945|323728509|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
94528576|NCT00191945|323728508|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
94528577|NCT00191945|323728509|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
94528578|NCT03604172|323728512|FG000|Overall Study|Lost to Follow-up|1|||
94528579|NCT03604172|323728513|FG001|Overall Study|Lost to Follow-up|2|||
94528580|NCT03146663|323728516|FG000|Overall Study|Did not receive study treatment|1|||
94528581|NCT03146663|323728517|FG001|Overall Study|Did not receive study treatment|1|||
94528582|NCT00005947|323728521|FG000|Overall Study|Death|54|||
94528583|NCT00005947|323728522|FG001|Overall Study|Death|40|||
94528584|NCT00005947|323728521|FG000|Overall Study|Patient Refused to Continue|2|||
94528585|NCT00005947|323728522|FG001|Overall Study|Patient Refused to Continue|1|||
94528586|NCT00005947|323728521|FG000|Overall Study|Site Closure|1|||
94528587|NCT00005947|323728522|FG001|Overall Study|Site Closure|0|||
94528588|NCT02470585|323728523|FG000|Overall Study|Death|224|||
94528589|NCT02470585|323728524|FG001|Overall Study|Death|227|||
94528590|NCT02470585|323728525|FG002|Overall Study|Death|199|||
94528591|NCT02470585|323728523|FG000|Overall Study|Withdrew consent|21|||
94528592|NCT02470585|323728524|FG001|Overall Study|Withdrew consent|22|||
94528593|NCT02470585|323728525|FG002|Overall Study|Withdrew consent|31|||
94528594|NCT02470585|323728523|FG000|Overall Study|Lost to Follow-up|8|||
94528595|NCT02470585|323728524|FG001|Overall Study|Lost to Follow-up|15|||
94528596|NCT02470585|323728525|FG002|Overall Study|Lost to Follow-up|13|||
94528597|NCT02470585|323728523|FG000|Overall Study|Sponsor discontinued study|117|||
94528598|NCT02470585|323728524|FG001|Overall Study|Sponsor discontinued study|110|||
94528599|NCT02470585|323728525|FG002|Overall Study|Sponsor discontinued study|122|||
94528600|NCT02470585|323728523|FG000|Overall Study|Other, not specified|5|||
94528601|NCT02470585|323728524|FG001|Overall Study|Other, not specified|7|||
94528602|NCT02470585|323728525|FG002|Overall Study|Other, not specified|14|||
94528603|NCT02470585|323728523|FG000|Overall Study|Missing due to site non-compliance|0|||
94528604|NCT02470585|323728524|FG001|Overall Study|Missing due to site non-compliance|2|||
94528605|NCT02470585|323728525|FG002|Overall Study|Missing due to site non-compliance|3|||
94528606|NCT01248728|323728528|FG000|Overall Study|Adverse Event|1|||
94528607|NCT01248728|323728529|FG001|Overall Study|Adverse Event|1|||
94528608|NCT01248728|323728528|FG000|Overall Study|Withdrawal by Subject|2|||
94528609|NCT01248728|323728529|FG001|Overall Study|Withdrawal by Subject|1|||
94528610|NCT01248728|323728528|FG000|Overall Study|Lack of Efficacy|1|||
94528611|NCT01248728|323728529|FG001|Overall Study|Lack of Efficacy|0|||
94528612|NCT02974140|323730318|FG000|Overall Study|Adverse Event|2|||
94528613|NCT02974140|323730318|FG000|Overall Study|Lost to Follow-up|1|||
94528614|NCT02974140|323730318|FG000|Overall Study|Study Terminated by Sponsor|36|||
94528615|NCT01238991|323730319|FG000|Overall Study|Adverse Event|1|||
94528616|NCT01238991|323730320|FG001|Overall Study|Adverse Event|0|||
94528617|NCT01238991|323730321|FG002|Overall Study|Adverse Event|3|||
94528618|NCT01238991|323730322|FG003|Overall Study|Adverse Event|1|||
94528619|NCT01238991|323730323|FG004|Overall Study|Adverse Event|1|||
94528620|NCT01238991|323730324|FG005|Overall Study|Adverse Event|0|||
94528621|NCT01238991|323730325|FG006|Overall Study|Adverse Event|1|||
94528622|NCT01238991|323730326|FG007|Overall Study|Adverse Event|1|||
94528623|NCT01238991|323730327|FG008|Overall Study|Adverse Event|0|||
94528624|NCT01238991|323730328|FG009|Overall Study|Adverse Event|0|||
94528625|NCT01238991|323730319|FG000|Overall Study|Death|0|||
94528626|NCT01238991|323730320|FG001|Overall Study|Death|0|||
94528627|NCT01238991|323730321|FG002|Overall Study|Death|0|||
94528628|NCT01238991|323730322|FG003|Overall Study|Death|1|||
94528629|NCT01238991|323730323|FG004|Overall Study|Death|0|||
94528630|NCT01238991|323730324|FG005|Overall Study|Death|0|||
94528631|NCT01238991|323730325|FG006|Overall Study|Death|0|||
94528632|NCT01238991|323730326|FG007|Overall Study|Death|0|||
94528633|NCT01238991|323730327|FG008|Overall Study|Death|0|||
94528634|NCT01238991|323730328|FG009|Overall Study|Death|0|||
94528635|NCT01238991|323730319|FG000|Overall Study|Lack of Efficacy|0|||
94528636|NCT01238991|323730320|FG001|Overall Study|Lack of Efficacy|0|||
94528637|NCT01238991|323730321|FG002|Overall Study|Lack of Efficacy|1|||
94528638|NCT01238991|323730322|FG003|Overall Study|Lack of Efficacy|0|||
94528639|NCT01238991|323730323|FG004|Overall Study|Lack of Efficacy|0|||
94528640|NCT01238991|323730324|FG005|Overall Study|Lack of Efficacy|0|||
94528641|NCT01238991|323730325|FG006|Overall Study|Lack of Efficacy|0|||
94528642|NCT01238991|323730326|FG007|Overall Study|Lack of Efficacy|0|||
94528643|NCT01238991|323730327|FG008|Overall Study|Lack of Efficacy|1|||
94528644|NCT01238991|323730328|FG009|Overall Study|Lack of Efficacy|0|||
94528645|NCT01238991|323730319|FG000|Overall Study|Withdrawal by Subject|0|||
94528646|NCT01238991|323730320|FG001|Overall Study|Withdrawal by Subject|0|||
94528647|NCT01238991|323730321|FG002|Overall Study|Withdrawal by Subject|1|||
94528648|NCT01238991|323730322|FG003|Overall Study|Withdrawal by Subject|0|||
94528649|NCT01238991|323730323|FG004|Overall Study|Withdrawal by Subject|0|||
94528650|NCT01238991|323730324|FG005|Overall Study|Withdrawal by Subject|0|||
94528651|NCT01238991|323730325|FG006|Overall Study|Withdrawal by Subject|0|||
94528652|NCT01238991|323730326|FG007|Overall Study|Withdrawal by Subject|0|||
94528653|NCT01238991|323730327|FG008|Overall Study|Withdrawal by Subject|0|||
94528654|NCT01238991|323730328|FG009|Overall Study|Withdrawal by Subject|0|||
94528655|NCT01238991|323730319|FG000|Overall Study|Study Terminated by Sponsor|0|||
94528656|NCT01238991|323730320|FG001|Overall Study|Study Terminated by Sponsor|0|||
94528657|NCT01238991|323730321|FG002|Overall Study|Study Terminated by Sponsor|0|||
94528658|NCT01238991|323730322|FG003|Overall Study|Study Terminated by Sponsor|0|||
94528659|NCT01238991|323730323|FG004|Overall Study|Study Terminated by Sponsor|1|||
94528660|NCT01238991|323730324|FG005|Overall Study|Study Terminated by Sponsor|0|||
94528661|NCT01238991|323730325|FG006|Overall Study|Study Terminated by Sponsor|7|||
94528662|NCT01238991|323730326|FG007|Overall Study|Study Terminated by Sponsor|4|||
94528663|NCT01238991|323730327|FG008|Overall Study|Study Terminated by Sponsor|2|||
94528664|NCT01238991|323730328|FG009|Overall Study|Study Terminated by Sponsor|2|||
94528665|NCT01238991|323730319|FG000|Overall Study|Caregiver's request|0|||
94528666|NCT01238991|323730320|FG001|Overall Study|Caregiver's request|0|||
94528667|NCT01238991|323730321|FG002|Overall Study|Caregiver's request|0|||
94528668|NCT01238991|323730322|FG003|Overall Study|Caregiver's request|0|||
94528669|NCT01238991|323730323|FG004|Overall Study|Caregiver's request|0|||
94528670|NCT01238991|323730324|FG005|Overall Study|Caregiver's request|0|||
94528671|NCT01238991|323730325|FG006|Overall Study|Caregiver's request|0|||
94528672|NCT01238991|323730326|FG007|Overall Study|Caregiver's request|0|||
94528673|NCT01238991|323730327|FG008|Overall Study|Caregiver's request|1|||
94528674|NCT01238991|323730328|FG009|Overall Study|Caregiver's request|0|||
94528675|NCT01238991|323730319|FG000|Overall Study|Admission to a nursing home|1|||
94528676|NCT01238991|323730320|FG001|Overall Study|Admission to a nursing home|0|||
94528677|NCT01238991|323730321|FG002|Overall Study|Admission to a nursing home|1|||
94528678|NCT01238991|323730322|FG003|Overall Study|Admission to a nursing home|0|||
94528679|NCT01238991|323730323|FG004|Overall Study|Admission to a nursing home|0|||
94528680|NCT01238991|323730324|FG005|Overall Study|Admission to a nursing home|0|||
94528681|NCT01238991|323730325|FG006|Overall Study|Admission to a nursing home|0|||
94528682|NCT01238991|323730326|FG007|Overall Study|Admission to a nursing home|0|||
94528683|NCT01238991|323730327|FG008|Overall Study|Admission to a nursing home|0|||
94528684|NCT01238991|323730328|FG009|Overall Study|Admission to a nursing home|0|||
94528685|NCT00485758|323730337|FG000|Overall Study|Adverse Event|102|||
94528686|NCT00485758|323730338|FG001|Overall Study|Adverse Event|31|||
94528687|NCT00485758|323730337|FG000|Overall Study|Death|0|||
94528688|NCT00485758|323730338|FG001|Overall Study|Death|1|||
94528689|NCT00485758|323730337|FG000|Overall Study|Lost to Follow-up|5|||
94528690|NCT00485758|323730338|FG001|Overall Study|Lost to Follow-up|1|||
94528691|NCT00485758|323730337|FG000|Overall Study|Physician Decision|3|||
94528692|NCT00485758|323730338|FG001|Overall Study|Physician Decision|3|||
94528693|NCT00485758|323730337|FG000|Overall Study|Protocol Violation|11|||
94528694|NCT00485758|323730338|FG001|Overall Study|Protocol Violation|2|||
94528695|NCT00485758|323730337|FG000|Overall Study|Withdrawal by Subject|32|||
94528696|NCT00485758|323730338|FG001|Overall Study|Withdrawal by Subject|27|||
94528697|NCT00485758|323730337|FG000|Overall Study|Study Terminated by Sponsor|3|||
94528698|NCT00485758|323730338|FG001|Overall Study|Study Terminated by Sponsor|0|||
94528699|NCT00984165|323730339|FG000|Overall Study|Death on study|2|||
94528700|NCT00984165|323730340|FG001|Overall Study|Death on study|0|||
94528701|NCT00984165|323730341|FG002|Overall Study|Death on study|0|||
94528702|NCT00984165|323730342|FG003|Overall Study|Death on study|0|||
94528703|NCT00984165|323730339|FG000|Overall Study|Disease progression on study|5|||
94528704|NCT00984165|323730340|FG001|Overall Study|Disease progression on study|1|||
94528705|NCT00984165|323730341|FG002|Overall Study|Disease progression on study|0|||
94528706|NCT00984165|323730342|FG003|Overall Study|Disease progression on study|0|||
94528707|NCT00984165|323730339|FG000|Overall Study|Death of recipient|0|||
94528708|NCT00984165|323730340|FG001|Overall Study|Death of recipient|0|||
94528709|NCT00984165|323730341|FG002|Overall Study|Death of recipient|0|||
94528710|NCT00984165|323730342|FG003|Overall Study|Death of recipient|1|||
94528711|NCT00984165|323730339|FG000|Overall Study|New protocol|0|||
94528712|NCT00984165|323730340|FG001|Overall Study|New protocol|0|||
94528713|NCT00984165|323730341|FG002|Overall Study|New protocol|0|||
94528714|NCT00984165|323730342|FG003|Overall Study|New protocol|1|||
94528715|NCT00984165|323730339|FG000|Overall Study|P+/donor pair removed from protocol|0|||
94528716|NCT00984165|323730340|FG001|Overall Study|P+/donor pair removed from protocol|0|||
94528717|NCT00984165|323730341|FG002|Overall Study|P+/donor pair removed from protocol|0|||
94528718|NCT00984165|323730342|FG003|Overall Study|P+/donor pair removed from protocol|1|||
94528719|NCT00984165|323730339|FG000|Overall Study|removed with a pair recipient|0|||
94528720|NCT00984165|323730340|FG001|Overall Study|removed with a pair recipient|0|||
94528721|NCT00984165|323730341|FG002|Overall Study|removed with a pair recipient|0|||
94528722|NCT00984165|323730342|FG003|Overall Study|removed with a pair recipient|1|||
94528723|NCT00748618|323730343|FG000|Overall Study|Adverse Event|1|||
94528724|NCT00748618|323730344|FG001|Overall Study|Adverse Event|0|||
94528725|NCT00372619|323730350|FG000|Overall Study|Ineligible|0|||
94528726|NCT00372619|323730351|FG001|Overall Study|Ineligible|0|||
94528727|NCT00372619|323730352|FG002|Overall Study|Ineligible|0|||
94528728|NCT00372619|323730353|FG003|Overall Study|Ineligible|0|||
94528729|NCT00372619|323730354|FG004|Overall Study|Ineligible|0|||
94528730|NCT00372619|323730355|FG005|Overall Study|Ineligible|2|||
94528731|NCT00372619|323730356|FG006|Overall Study|Ineligible|0|||
94528732|NCT00372619|323730350|FG000|Overall Study|Inevaluable|0|||
94528733|NCT00372619|323730351|FG001|Overall Study|Inevaluable|0|||
94528734|NCT00372619|323730352|FG002|Overall Study|Inevaluable|0|||
94528735|NCT00372619|323730353|FG003|Overall Study|Inevaluable|0|||
94528736|NCT00372619|323730354|FG004|Overall Study|Inevaluable|0|||
94528737|NCT00372619|323730355|FG005|Overall Study|Inevaluable|1|||
94528738|NCT00372619|323730356|FG006|Overall Study|Inevaluable|0|||
94528739|NCT00405392|323730357|FG000|Overall Study|Adverse Event|15|||
94528740|NCT00405392|323730358|FG001|Overall Study|Adverse Event|14|||
94528741|NCT00405392|323730357|FG000|Overall Study|Did not meet Eligibility criteria|7|||
94528742|NCT00405392|323730358|FG001|Overall Study|Did not meet Eligibility criteria|2|||
94528743|NCT00405392|323730357|FG000|Overall Study|Withdrawal by Subject|4|||
94528744|NCT00405392|323730358|FG001|Overall Study|Withdrawal by Subject|3|||
94528745|NCT00405392|323730357|FG000|Overall Study|Lost to Follow-up|1|||
94528746|NCT00405392|323730358|FG001|Overall Study|Lost to Follow-up|2|||
94528747|NCT00405392|323730357|FG000|Overall Study|Data missing|2|||
94528748|NCT00405392|323730358|FG001|Overall Study|Data missing|0|||
94528749|NCT00405392|323730357|FG000|Overall Study|Non-compliance|0|||
94528750|NCT00405392|323730358|FG001|Overall Study|Non-compliance|1|||
94528751|NCT00405392|323730357|FG000|Overall Study|Other|1|||
94528752|NCT00405392|323730358|FG001|Overall Study|Other|5|||
94528753|NCT00022763|323730363|FG000|Overall Study|Adverse Event|1|||
94528754|NCT00022763|323730364|FG001|Overall Study|Adverse Event|2|||
94528755|NCT00022763|323730363|FG000|Overall Study|Injection Site Reactions|0|||
94528756|NCT00022763|323730364|FG001|Overall Study|Injection Site Reactions|2|||
94528757|NCT00022763|323730363|FG000|Overall Study|Death|0|||
94528758|NCT00022763|323730364|FG001|Overall Study|Death|1|||
94528759|NCT00022763|323730363|FG000|Overall Study|Lost to Follow-up|0|||
94528760|NCT00022763|323730364|FG001|Overall Study|Lost to Follow-up|3|||
94528761|NCT00022763|323730363|FG000|Overall Study|Withdrawal by Subject|4|||
94528762|NCT00022763|323730364|FG001|Overall Study|Withdrawal by Subject|7|||
94528763|NCT00022763|323730363|FG000|Overall Study|Insufficient Therapy|1|||
94528764|NCT00022763|323730364|FG001|Overall Study|Insufficient Therapy|0|||
94528765|NCT00022763|323730363|FG000|Overall Study|Admin|3|||
94528766|NCT00022763|323730364|FG001|Overall Study|Admin|2|||
94528767|NCT01092780|323730369|FG000|Washout Period 1|Adverse Event|0|||
94528768|NCT01092780|323730370|FG001|Washout Period 1|Adverse Event|1|||
94528769|NCT01092780|323730371|FG002|Washout Period 1|Adverse Event|0|||
94528770|NCT01092780|323730372|FG003|Washout Period 1|Adverse Event|0|||
94528771|NCT01092780|323730369|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
94528772|NCT01092780|323730370|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
94528773|NCT01092780|323730371|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
94528774|NCT01092780|323730372|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
94528775|NCT01092780|323730369|FG000|Washout Period 2|Adverse Event|0|||
94528776|NCT01092780|323730370|FG001|Washout Period 2|Adverse Event|1|||
94528777|NCT01092780|323730371|FG002|Washout Period 2|Adverse Event|1|||
94528778|NCT01092780|323730372|FG003|Washout Period 2|Adverse Event|0|||
94528779|NCT02318368|323730375|FG000|Overall Study|Withdrawal by Subject|2|||
94528780|NCT02318368|323730376|FG001|Overall Study|Withdrawal by Subject|0|||
94528781|NCT02318368|323730375|FG000|Overall Study|Study terminated by the sponsor|5|||
94528782|NCT02318368|323730376|FG001|Overall Study|Study terminated by the sponsor|2|||
94528783|NCT02318368|323730375|FG000|Overall Study|Death|0|||
94528784|NCT02318368|323730376|FG001|Overall Study|Death|1|||
94528785|NCT02027311|323730377|FG000|Overall Study|Protocol Violation|3|||
94528786|NCT02027311|323730378|FG001|Overall Study|Protocol Violation|2|||
94528787|NCT03768089|323730381|FG000|Part A|Lost to Follow-up|0|||
94528788|NCT03768089|323730382|FG001|Part A|Lost to Follow-up|0|||
94528789|NCT03768089|323730383|FG002|Part A|Lost to Follow-up|0|||
94528790|NCT03768089|323730384|FG003|Part A|Lost to Follow-up|0|||
94528791|NCT03768089|323730385|FG004|Part A|Lost to Follow-up|1|||
94528792|NCT03768089|323730386|FG005|Part A|Lost to Follow-up|0|||
94528793|NCT03768089|323730387|FG006|Part A|Lost to Follow-up|0|||
94528794|NCT03768089|323730388|FG007|Part A|Lost to Follow-up|0|||
94528795|NCT03768089|323730389|FG008|Part A|Lost to Follow-up|0|||
94528796|NCT03768089|323730390|FG009|Part A|Lost to Follow-up|0|||
94528797|NCT03768089|323730391|FG010|Part A|Lost to Follow-up|0|||
94528798|NCT03768089|323730392|FG011|Part A|Lost to Follow-up|0|||
94528799|NCT03768089|323730393|FG012|Part A|Lost to Follow-up|0|||
94528800|NCT03768089|323730394|FG013|Part A|Lost to Follow-up|0|||
94528801|NCT03768089|323730395|FG014|Part A|Lost to Follow-up|0|||
94528802|NCT03768089|323730396|FG015|Part A|Lost to Follow-up|0|||
94528803|NCT03768089|323730397|FG016|Part A|Lost to Follow-up|0|||
94528804|NCT03768089|323730398|FG017|Part A|Lost to Follow-up|0|||
94528805|NCT03768089|323730381|FG000|Part C|Randomized, Never Dosed|0|||
94528806|NCT03768089|323730382|FG001|Part C|Randomized, Never Dosed|0|||
94528807|NCT03768089|323730383|FG002|Part C|Randomized, Never Dosed|0|||
94528808|NCT03768089|323730384|FG003|Part C|Randomized, Never Dosed|0|||
94528809|NCT03768089|323730385|FG004|Part C|Randomized, Never Dosed|0|||
94528810|NCT03768089|323730386|FG005|Part C|Randomized, Never Dosed|0|||
94528811|NCT03768089|323730387|FG006|Part C|Randomized, Never Dosed|0|||
94528812|NCT03768089|323730388|FG007|Part C|Randomized, Never Dosed|0|||
94528813|NCT03768089|323730389|FG008|Part C|Randomized, Never Dosed|0|||
94528814|NCT03768089|323730390|FG009|Part C|Randomized, Never Dosed|0|||
94528815|NCT03768089|323730391|FG010|Part C|Randomized, Never Dosed|0|||
94528816|NCT03768089|323730392|FG011|Part C|Randomized, Never Dosed|0|||
94528817|NCT03768089|323730393|FG012|Part C|Randomized, Never Dosed|0|||
94528818|NCT03768089|323730394|FG013|Part C|Randomized, Never Dosed|0|||
94528819|NCT03768089|323730395|FG014|Part C|Randomized, Never Dosed|1|||
94528820|NCT03768089|323730396|FG015|Part C|Randomized, Never Dosed|0|||
94528821|NCT03768089|323730397|FG016|Part C|Randomized, Never Dosed|0|||
94528822|NCT03768089|323730398|FG017|Part C|Randomized, Never Dosed|0|||
94528823|NCT00470262|323730399|FG000|Overall Study|Withdrawal by Subject|2|||
94528824|NCT00470262|323730400|FG001|Overall Study|Withdrawal by Subject|0|||
94528825|NCT00992056|323730405|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
94528826|NCT00992056|323730406|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
94528827|NCT00992056|323730405|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
94528828|NCT00992056|323730406|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
94528829|NCT01479764|323730408|FG000|Randomized|Adverse Event|1|||
94528830|NCT01479764|323730409|FG001|Randomized|Adverse Event|1|||
94528831|NCT01479764|323730408|FG000|Randomized|Withdrawal by Subject|1|||
94528832|NCT01479764|323730409|FG001|Randomized|Withdrawal by Subject|0|||
94528833|NCT01479764|323730408|FG000|Treated|Lost to Follow-up|0|||
94528834|NCT01479764|323730409|FG001|Treated|Lost to Follow-up|2|||
94528835|NCT00289289|323730412|FG000|Overall Study|Withdrawal by Subject|5|||
94528836|NCT00289289|323730413|FG001|Overall Study|Withdrawal by Subject|3|||
94528837|NCT00289289|323730414|FG002|Overall Study|Withdrawal by Subject|15|||
94528838|NCT00289289|323730412|FG000|Overall Study|Lost to Follow-up|1|||
94528839|NCT00289289|323730413|FG001|Overall Study|Lost to Follow-up|0|||
94528840|NCT00289289|323730414|FG002|Overall Study|Lost to Follow-up|1|||
94528841|NCT00289289|323730412|FG000|Overall Study|Death|4|||
94528842|NCT00289289|323730413|FG001|Overall Study|Death|2|||
94528843|NCT00289289|323730414|FG002|Overall Study|Death|5|||
94528844|NCT00289289|323730412|FG000|Overall Study|No implant attempted|0|||
94528845|NCT00289289|323730413|FG001|Overall Study|No implant attempted|0|||
94528846|NCT00289289|323730414|FG002|Overall Study|No implant attempted|1|||
94528847|NCT00289289|323730412|FG000|Overall Study|Physician Decision|1|||
94528848|NCT00289289|323730413|FG001|Overall Study|Physician Decision|0|||
94528849|NCT00289289|323730414|FG002|Overall Study|Physician Decision|6|||
94528850|NCT00289289|323730412|FG000|Overall Study|Non-study device implanted|2|||
94528851|NCT00289289|323730413|FG001|Overall Study|Non-study device implanted|1|||
94528852|NCT00289289|323730414|FG002|Overall Study|Non-study device implanted|3|||
94528853|NCT00289289|323730412|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
94528854|NCT00289289|323730413|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
94528855|NCT00289289|323730414|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
94528856|NCT00289289|323730412|FG000|Overall Study|Other Exit Reason|6|||
94528857|NCT00289289|323730413|FG001|Overall Study|Other Exit Reason|4|||
94528858|NCT00289289|323730414|FG002|Overall Study|Other Exit Reason|12|||
94528859|NCT04222699|323730428|FG000|Overall Study|Lost to Follow-up|2|||
94528860|NCT00182078|323730429|FG000|Overall Study|Withdrawal by Subject|1|||
94528861|NCT00182078|323730430|FG001|Overall Study|Withdrawal by Subject|0|||
94528862|NCT00431444|323730432|FG000|Overall Study|Protocol Violation|1|||
94528863|NCT00431444|323730433|FG001|Overall Study|Protocol Violation|4|||
94528864|NCT00431444|323730432|FG000|Overall Study|Adverse Event|2|||
94528865|NCT00431444|323730433|FG001|Overall Study|Adverse Event|1|||
94528866|NCT00431444|323730432|FG000|Overall Study|Withdrawal by Subject|1|||
94528867|NCT00431444|323730433|FG001|Overall Study|Withdrawal by Subject|1|||
94528868|NCT00431444|323730432|FG000|Overall Study|Lost to Follow-up|1|||
94528869|NCT00431444|323730433|FG001|Overall Study|Lost to Follow-up|0|||
94528870|NCT00431444|323730432|FG000|Overall Study|Administrative Problems|0|||
94528871|NCT00431444|323730433|FG001|Overall Study|Administrative Problems|1|||
94528872|NCT00861692|323730436|FG000|Overall Study|Death|6|||
94528873|NCT05111002|323730440|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
94528874|NCT05111002|323730441|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
94528875|NCT05111002|323730440|FG000|Secondary Outcome|Lost to Follow-up|1|||
94528876|NCT05111002|323730441|FG001|Secondary Outcome|Lost to Follow-up|0|||
94528877|NCT03802630|323730442|FG000|Overall Study|Study terminated by sponsor|130|||
94528878|NCT03802630|323730443|FG001|Overall Study|Study terminated by sponsor|134|||
94528879|NCT03802630|323730442|FG000|Overall Study|Subject decision|16|||
94528880|NCT03802630|323730443|FG001|Overall Study|Subject decision|9|||
94528881|NCT03802630|323730442|FG000|Overall Study|Adverse Event|3|||
94528882|NCT03802630|323730443|FG001|Overall Study|Adverse Event|1|||
94528883|NCT03802630|323730442|FG000|Overall Study|Lost to Follow-up|2|||
94528884|NCT03802630|323730443|FG001|Overall Study|Lost to Follow-up|2|||
94528885|NCT03802630|323730442|FG000|Overall Study|Physician Decision|2|||
94528886|NCT03802630|323730443|FG001|Overall Study|Physician Decision|0|||
94528887|NCT03802630|323730442|FG000|Overall Study|Death|0|||
94528888|NCT03802630|323730443|FG001|Overall Study|Death|2|||
94528889|NCT00792740|323730444|FG000|Overall Study|Disease Worsening|3|||
94528890|NCT00792740|323730445|FG001|Overall Study|Disease Worsening|2|||
94528891|NCT00792740|323730444|FG000|Overall Study|Personal Reason|1|||
94528892|NCT00792740|323730445|FG001|Overall Study|Personal Reason|0|||
94528893|NCT00792740|323730444|FG000|Overall Study|Adverse Event|1|||
94528894|NCT00792740|323730445|FG001|Overall Study|Adverse Event|3|||
94528895|NCT00792740|323730444|FG000|Overall Study|Patient's withdrawal of consent|0|||
94528896|NCT00792740|323730445|FG001|Overall Study|Patient's withdrawal of consent|1|||
94528897|NCT00792740|323730444|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
94528898|NCT00792740|323730445|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
94528899|NCT00792740|323730444|FG000|Overall Study|Other reasons|0|||
94528900|NCT00792740|323730445|FG001|Overall Study|Other reasons|1|||
94528901|NCT03265145|323730450|FG000|Overall Study|Protocol Violation|2|||
94528902|NCT03265145|323730451|FG001|Overall Study|Protocol Violation|0|||
94528903|NCT03265145|323730450|FG000|Overall Study|Adverse Event|1|||
94528904|NCT03265145|323730451|FG001|Overall Study|Adverse Event|0|||
94528905|NCT03265145|323730450|FG000|Overall Study|Withdrawal by Subject|23|||
94528906|NCT03265145|323730451|FG001|Overall Study|Withdrawal by Subject|19|||
94528907|NCT03265145|323730450|FG000|Overall Study|Death|12|||
94528908|NCT03265145|323730451|FG001|Overall Study|Death|12|||
94528909|NCT03265145|323730450|FG000|Overall Study|Lost to Follow-up|13|||
94528910|NCT03265145|323730451|FG001|Overall Study|Lost to Follow-up|9|||
94528911|NCT03265145|323730450|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
94528912|NCT03265145|323730451|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
94528913|NCT03265145|323730450|FG000|Overall Study|Switched back to previous medication|1|||
94528914|NCT03265145|323730451|FG001|Overall Study|Switched back to previous medication|0|||
94528915|NCT03265145|323730450|FG000|Overall Study|Did not want to take medication|1|||
94528916|NCT03265145|323730451|FG001|Overall Study|Did not want to take medication|0|||
94528917|NCT03265145|323730450|FG000|Overall Study|Subject could not afford medication|0|||
94528918|NCT03265145|323730451|FG001|Overall Study|Subject could not afford medication|1|||
94528919|NCT03265145|323730450|FG000|Overall Study|Site closed|2|||
94528920|NCT03265145|323730451|FG001|Overall Study|Site closed|3|||
94528921|NCT03265145|323730450|FG000|Overall Study|Incorrectly randomized|16|||
94528922|NCT03265145|323730451|FG001|Overall Study|Incorrectly randomized|6|||
94528923|NCT03265145|323730450|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
94528924|NCT03265145|323730451|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
94528925|NCT03265145|323730450|FG000|Overall Study|Physician Decision|0|||
94528926|NCT03265145|323730451|FG001|Overall Study|Physician Decision|3|||
94528927|NCT03265145|323730450|FG000|Overall Study|Subject transferred to another facility|0|||
94528928|NCT03265145|323730451|FG001|Overall Study|Subject transferred to another facility|1|||
94528929|NCT04621240|323730452|FG000|Overall Study|Withdrawal by Subject|36|||
94528930|NCT01659996|323730453|FG000|Overall Study|Protocol Violation|3|||
94528931|NCT01659996|323730454|FG001|Overall Study|Protocol Violation|3|||
94528932|NCT01659996|323730455|FG002|Overall Study|Protocol Violation|3|||
94528933|NCT01659996|323730453|FG000|Overall Study|Lost to Follow-up|1|||
94528934|NCT01659996|323730454|FG001|Overall Study|Lost to Follow-up|3|||
94528935|NCT01659996|323730455|FG002|Overall Study|Lost to Follow-up|2|||
94528936|NCT01659996|323730453|FG000|Overall Study|Adverse Event|0|||
94528937|NCT01659996|323730454|FG001|Overall Study|Adverse Event|0|||
94528938|NCT01659996|323730455|FG002|Overall Study|Adverse Event|1|||
94528939|NCT01659996|323730453|FG000|Overall Study|Withdrawal by Subject|4|||
94528940|NCT01659996|323730454|FG001|Overall Study|Withdrawal by Subject|1|||
94528941|NCT01659996|323730455|FG002|Overall Study|Withdrawal by Subject|5|||
94528942|NCT02709577|323730456|FG000|Overall Study|non-accommodating anatomy|0|||
94528943|NCT02709577|323730457|FG001|Overall Study|non-accommodating anatomy|1|||
94528944|NCT02709577|323730458|FG002|Overall Study|non-accommodating anatomy|0|||
94528945|NCT02709577|323730459|FG003|Overall Study|non-accommodating anatomy|0|||
94528946|NCT02709577|323730456|FG000|Overall Study|procedural complication|0|||
94528947|NCT02709577|323730457|FG001|Overall Study|procedural complication|1|||
94528948|NCT02709577|323730458|FG002|Overall Study|procedural complication|0|||
94528949|NCT02709577|323730459|FG003|Overall Study|procedural complication|0|||
94528950|NCT02709577|323730456|FG000|Overall Study|Withdrawal by Subject|2|||
94528951|NCT02709577|323730457|FG001|Overall Study|Withdrawal by Subject|3|||
94528952|NCT02709577|323730458|FG002|Overall Study|Withdrawal by Subject|2|||
94528953|NCT02709577|323730459|FG003|Overall Study|Withdrawal by Subject|0|||
94528954|NCT01059864|323730466|FG000|Open-Label Run-In Phase|Adverse Event|7|||
94528955|NCT01059864|323730467|FG001|Open-Label Run-In Phase|Adverse Event|0|||
94528956|NCT01059864|323730468|FG002|Open-Label Run-In Phase|Adverse Event|0|||
94528957|NCT01059864|323730466|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
94528958|NCT01059864|323730467|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
94528959|NCT01059864|323730468|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
94528960|NCT01059864|323730466|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
94528961|NCT01059864|323730467|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
94528962|NCT01059864|323730468|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
94528963|NCT01059864|323730466|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
94528964|NCT01059864|323730467|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
94528965|NCT01059864|323730468|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
94528966|NCT01059864|323730466|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
94528967|NCT01059864|323730467|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
94528968|NCT01059864|323730468|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
94528969|NCT01059864|323730466|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
94528970|NCT01059864|323730467|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
94528971|NCT01059864|323730468|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
94528972|NCT00451958|323730469|FG000|CS21A (NCT00451958)|Adverse Event|21|||
94528973|NCT00451958|323730470|FG001|CS21A (NCT00451958)|Adverse Event|34|||
94528974|NCT00451958|323730471|FG002|CS21A (NCT00451958)|Adverse Event|14|||
94528975|NCT00451958|323730472|FG003|CS21A (NCT00451958)|Adverse Event|17|||
94528976|NCT00451958|323730473|FG004|CS21A (NCT00451958)|Adverse Event|0|||
94528977|NCT00451958|323730469|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
94528978|NCT00451958|323730470|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
94528979|NCT00451958|323730471|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
94528980|NCT00451958|323730472|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
94528981|NCT00451958|323730473|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
94528982|NCT00451958|323730469|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
94528983|NCT00451958|323730470|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
94528984|NCT00451958|323730471|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
94528985|NCT00451958|323730472|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
94528986|NCT00451958|323730473|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
94528987|NCT00451958|323730469|FG000|CS21A (NCT00451958)|Physician Decision|2|||
94528988|NCT00451958|323730470|FG001|CS21A (NCT00451958)|Physician Decision|4|||
94528989|NCT00451958|323730471|FG002|CS21A (NCT00451958)|Physician Decision|4|||
94528990|NCT00451958|323730472|FG003|CS21A (NCT00451958)|Physician Decision|4|||
94528991|NCT00451958|323730473|FG004|CS21A (NCT00451958)|Physician Decision|0|||
94528992|NCT00451958|323730469|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
94528993|NCT00451958|323730470|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
94528994|NCT00451958|323730471|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
94528995|NCT00451958|323730472|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
94528996|NCT00451958|323730473|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
94528997|NCT00451958|323730469|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
94528998|NCT00451958|323730470|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
94528999|NCT00451958|323730471|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
94529000|NCT00451958|323730472|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
94529001|NCT00451958|323730473|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
94529002|NCT03281629|323730475|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
94529003|NCT03281629|323730476|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
94529004|NCT03281629|323730475|FG000|Overall Study|Death|0|||
94529005|NCT03281629|323730476|FG001|Overall Study|Death|1|||
94529006|NCT03281629|323730475|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
94529007|NCT03281629|323730476|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
94529008|NCT01170273|323730481|FG000|Overall Study|Lost to Follow-up|6|||
94529009|NCT01170273|323730482|FG001|Overall Study|Lost to Follow-up|8|||
94529010|NCT01170273|323730481|FG000|Overall Study|Protocol Violation|1|||
94529011|NCT01170273|323730482|FG001|Overall Study|Protocol Violation|0|||
94529012|NCT01170273|323730481|FG000|Overall Study|Death|1|||
94529013|NCT01170273|323730482|FG001|Overall Study|Death|0|||
94529014|NCT01170273|323730481|FG000|Overall Study|Adverse Event|0|||
94529015|NCT01170273|323730482|FG001|Overall Study|Adverse Event|1|||
94529016|NCT00334737|323730483|FG000|Hospital Phase|Death|1|||
94529017|NCT00334737|323730484|FG001|Hospital Phase|Death|2|||
94529018|NCT00334737|323730485|FG002|Hospital Phase|Death|3|||
94529019|NCT00334737|323730483|FG000|Hospital Phase|Withdrawal by Subject|0|||
94529020|NCT00334737|323730484|FG001|Hospital Phase|Withdrawal by Subject|0|||
94529021|NCT00334737|323730485|FG002|Hospital Phase|Withdrawal by Subject|1|||
94529022|NCT00334737|323730483|FG000|Hospital Phase|Did not receive study drug|1|||
94529023|NCT00334737|323730484|FG001|Hospital Phase|Did not receive study drug|0|||
94529024|NCT00334737|323730485|FG002|Hospital Phase|Did not receive study drug|0|||
94529025|NCT00334737|323730483|FG000|Follow up Phase|Lost to Follow-up|5|||
94529026|NCT00334737|323730484|FG001|Follow up Phase|Lost to Follow-up|3|||
94529027|NCT00334737|323730485|FG002|Follow up Phase|Lost to Follow-up|6|||
94529028|NCT00830375|323730491|FG000|Overall Study|Lost to Follow-up|1|||
94529029|NCT03419897|323732269|FG000|Overall Study|Death|180|||
94529030|NCT03419897|323732269|FG000|Overall Study|Lost to Follow-up|1|||
94529031|NCT03419897|323732269|FG000|Overall Study|Withdrawal by Subject|6|||
94529032|NCT03419897|323732269|FG000|Overall Study|Sponsor Decision|61|||
94529033|NCT03419897|323732269|FG000|Overall Study|Physician Decision|1|||
94529035|NCT00368745|323732271|FG000|Double-blind Treatment Period|Adverse Event|6|||
94529036|NCT00368745|323732272|FG001|Double-blind Treatment Period|Adverse Event|6|||
94529037|NCT00368745|323732271|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
94529038|NCT00368745|323732272|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
94529039|NCT00368745|323732271|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
94529040|NCT00368745|323732272|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
94529041|NCT00368745|323732271|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
94529042|NCT00368745|323732272|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
94529043|NCT00368745|323732271|FG000|Double-blind Treatment Period|Other|7|||
94529044|NCT00368745|323732272|FG001|Double-blind Treatment Period|Other|6|||
94529045|NCT02013778|323732275|FG000|Overall Study|Death|4|||
94529046|NCT02013778|323732275|FG000|Overall Study|Withdrawal by Subject|1|||
94529047|NCT02013778|323732275|FG000|Overall Study|Physician Decision|1|||
94529048|NCT02013778|323732275|FG000|Overall Study|Adverse Event|1|||
94529049|NCT01961297|323732278|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
94529050|NCT01961297|323732279|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
94529051|NCT00430989|323732280|FG000|Overall Study|Lost to Follow-up|2|||
94529052|NCT00430989|323732281|FG001|Overall Study|Lost to Follow-up|3|||
94529053|NCT00430989|323732280|FG000|Overall Study|Withdrawal by Subject|15|||
94529054|NCT00430989|323732281|FG001|Overall Study|Withdrawal by Subject|14|||
94529055|NCT00430989|323732280|FG000|Overall Study|Protocol Violation|30|||
94529056|NCT00430989|323732281|FG001|Overall Study|Protocol Violation|37|||
94529057|NCT00430989|323732280|FG000|Overall Study|Not eligible|13|||
94529058|NCT00430989|323732281|FG001|Overall Study|Not eligible|6|||
94529059|NCT03782259|323732282|FG000|Overall Study|Lost to Follow-up|1|||
94529060|NCT03782259|323732283|FG001|Overall Study|Lost to Follow-up|1|||
94529061|NCT03782259|323732282|FG000|Overall Study|Moved out of state|0|||
94529062|NCT03782259|323732283|FG001|Overall Study|Moved out of state|2|||
94529063|NCT03782259|323732282|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
94529064|NCT03782259|323732283|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
94529065|NCT03782259|323732282|FG000|Overall Study|Subject discontinued intervention|1|||
94529066|NCT03782259|323732283|FG001|Overall Study|Subject discontinued intervention|0|||
94529067|NCT00590122|323732284|FG000|Overall Study|swallowed oral dissolving dose|1|||
94529068|NCT00590122|323732285|FG001|Overall Study|swallowed oral dissolving dose|0|||
94529069|NCT01642901|323732286|FG000|12-month Follow-up|Withdrawal by Subject|1|||
94529070|NCT01642901|323732287|FG001|12-month Follow-up|Withdrawal by Subject|0|||
94529071|NCT01208324|323732288|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
94529072|NCT01208324|323732289|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
94529073|NCT01208324|323732290|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
94529074|NCT01208324|323732291|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
94529075|NCT05069597|323732292|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
94529076|NCT05069597|323732293|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
94529077|NCT02943070|323732295|FG000|Overall Study|Physician Decision|1|||
94529078|NCT02943070|323732295|FG000|Overall Study|Adverse Event|2|||
94529079|NCT02943070|323732295|FG000|Overall Study|Death|2|||
94529080|NCT02943070|323732295|FG000|Overall Study|Withdrawal by Subject|3|||
94529081|NCT02943070|323732295|FG000|Overall Study|Lost to Follow-up|4|||
94529082|NCT02943070|323732295|FG000|Overall Study|Retreatment or TURP|13|||
94529083|NCT02943070|323732295|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
94529084|NCT01701362|323732296|FG000|Overall Study|Adverse events not related to study drug|1|||
94529085|NCT01701362|323732297|FG001|Overall Study|Adverse events not related to study drug|6|||
94529086|NCT01701362|323732296|FG000|Overall Study|Adverse events related to study drug|12|||
94529087|NCT01701362|323732297|FG001|Overall Study|Adverse events related to study drug|10|||
94529088|NCT01701362|323732296|FG000|Overall Study|Protocol Violation|5|||
94529089|NCT01701362|323732297|FG001|Overall Study|Protocol Violation|3|||
94529090|NCT01701362|323732296|FG000|Overall Study|No longer willing to participate|8|||
94529091|NCT01701362|323732297|FG001|Overall Study|No longer willing to participate|14|||
94529092|NCT01701362|323732296|FG000|Overall Study|Lost to Follow-up|6|||
94529093|NCT01701362|323732297|FG001|Overall Study|Lost to Follow-up|9|||
94529094|NCT01701362|323732296|FG000|Overall Study|Insufficient clinical response|6|||
94529095|NCT01701362|323732297|FG001|Overall Study|Insufficient clinical response|6|||
94529096|NCT01701362|323732296|FG000|Overall Study|Death|0|||
94529097|NCT01701362|323732297|FG001|Overall Study|Death|1|||
94529098|NCT01701362|323732296|FG000|Overall Study|Randomized but not treated|1|||
94529099|NCT01701362|323732297|FG001|Overall Study|Randomized but not treated|2|||
94529100|NCT01701362|323732296|FG000|Overall Study|Reasons other than those mentioned above|3|||
94529101|NCT01701362|323732297|FG001|Overall Study|Reasons other than those mentioned above|5|||
94529102|NCT00570778|323732298|FG000|Overall Study|Protocol deviation|2|||
94529103|NCT00570778|323732299|FG001|Overall Study|Protocol deviation|1|||
94529104|NCT00570778|323732300|FG002|Overall Study|Protocol deviation|2|||
94529105|NCT00570778|323732301|FG003|Overall Study|Protocol deviation|2|||
94529106|NCT00570778|323732298|FG000|Overall Study|Adverse Event|0|||
94529107|NCT00570778|323732299|FG001|Overall Study|Adverse Event|1|||
94529108|NCT00570778|323732300|FG002|Overall Study|Adverse Event|4|||
94529109|NCT00570778|323732301|FG003|Overall Study|Adverse Event|1|||
94529110|NCT00570778|323732298|FG000|Overall Study|Subject withdrew consent|0|||
94529111|NCT00570778|323732299|FG001|Overall Study|Subject withdrew consent|1|||
94529112|NCT00570778|323732300|FG002|Overall Study|Subject withdrew consent|0|||
94529113|NCT00570778|323732301|FG003|Overall Study|Subject withdrew consent|1|||
94529114|NCT00570778|323732298|FG000|Overall Study|Abnormal test procedure|1|||
94529115|NCT00570778|323732299|FG001|Overall Study|Abnormal test procedure|0|||
94529116|NCT00570778|323732300|FG002|Overall Study|Abnormal test procedure|0|||
94529117|NCT00570778|323732301|FG003|Overall Study|Abnormal test procedure|0|||
94529118|NCT00570778|323732298|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
94529119|NCT00570778|323732299|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94529120|NCT00570778|323732300|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
94529121|NCT00570778|323732301|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
94529122|NCT00570778|323732298|FG000|Overall Study|Lost to Follow-up|0|||
94529123|NCT00570778|323732299|FG001|Overall Study|Lost to Follow-up|0|||
94529124|NCT00570778|323732300|FG002|Overall Study|Lost to Follow-up|1|||
94529125|NCT00570778|323732301|FG003|Overall Study|Lost to Follow-up|0|||
94529126|NCT00570778|323732298|FG000|Overall Study|Subject no longer requires study drug|0|||
94529127|NCT00570778|323732299|FG001|Overall Study|Subject no longer requires study drug|1|||
94529128|NCT00570778|323732300|FG002|Overall Study|Subject no longer requires study drug|0|||
94529129|NCT00570778|323732301|FG003|Overall Study|Subject no longer requires study drug|0|||
94529130|NCT00711594|323732302|FG000|Overall Study|Progressive disease|2|||
94529131|NCT00711594|323732303|FG001|Overall Study|Progressive disease|2|||
94529132|NCT00711594|323732304|FG002|Overall Study|Progressive disease|6|||
94529133|NCT00711594|323732305|FG003|Overall Study|Progressive disease|44|||
94529134|NCT00711594|323732302|FG000|Overall Study|Other Adverse Event|1|||
94529135|NCT00711594|323732303|FG001|Overall Study|Other Adverse Event|0|||
94529136|NCT00711594|323732304|FG002|Overall Study|Other Adverse Event|0|||
94529137|NCT00711594|323732305|FG003|Overall Study|Other Adverse Event|16|||
94529138|NCT00711594|323732302|FG000|Overall Study|Withdrawal by Subject|0|||
94529139|NCT00711594|323732303|FG001|Overall Study|Withdrawal by Subject|1|||
94529140|NCT00711594|323732304|FG002|Overall Study|Withdrawal by Subject|0|||
94529141|NCT00711594|323732305|FG003|Overall Study|Withdrawal by Subject|2|||
94529142|NCT05507567|323732306|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
94529143|NCT05507567|323732307|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
94529144|NCT05507567|323732308|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
94529145|NCT05507567|323732306|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
94529146|NCT05507567|323732307|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
94529147|NCT05507567|323732308|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
94529148|NCT05507567|323732306|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
94529149|NCT05507567|323732307|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
94529150|NCT05507567|323732308|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
94529151|NCT05507567|323732306|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
94529152|NCT05507567|323732307|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
94529153|NCT05507567|323732308|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
94529154|NCT00135330|323732309|FG000|Overall Study|Adverse Event|2|||
94529155|NCT00135330|323732310|FG001|Overall Study|Adverse Event|5|||
94529156|NCT00135330|323732311|FG002|Overall Study|Adverse Event|1|||
94529157|NCT00135330|323732309|FG000|Overall Study|Lost to Follow-up|0|||
94529158|NCT00135330|323732310|FG001|Overall Study|Lost to Follow-up|2|||
94529159|NCT00135330|323732311|FG002|Overall Study|Lost to Follow-up|3|||
94529160|NCT00135330|323732309|FG000|Overall Study|Physician Decision|1|||
94529161|NCT00135330|323732310|FG001|Overall Study|Physician Decision|1|||
94529162|NCT00135330|323732311|FG002|Overall Study|Physician Decision|0|||
94529163|NCT00135330|323732309|FG000|Overall Study|Protocol Violation|4|||
94529164|NCT00135330|323732310|FG001|Overall Study|Protocol Violation|3|||
94529165|NCT00135330|323732311|FG002|Overall Study|Protocol Violation|3|||
94529166|NCT00135330|323732309|FG000|Overall Study|Patient Decision|5|||
94529167|NCT00135330|323732310|FG001|Overall Study|Patient Decision|1|||
94529168|NCT00135330|323732311|FG002|Overall Study|Patient Decision|4|||
94529169|NCT00135330|323732309|FG000|Overall Study|Sponsor Decision|0|||
94529170|NCT00135330|323732310|FG001|Overall Study|Sponsor Decision|1|||
94529171|NCT00135330|323732311|FG002|Overall Study|Sponsor Decision|0|||
94529172|NCT01822899|323732315|FG000|Overall Study|Adverse Event|6|||
94529173|NCT01822899|323732316|FG001|Overall Study|Adverse Event|5|||
94529174|NCT01822899|323732315|FG000|Overall Study|Lack of Efficacy|6|||
94529175|NCT01822899|323732316|FG001|Overall Study|Lack of Efficacy|3|||
94529176|NCT01822899|323732315|FG000|Overall Study|Protocol Violation|6|||
94529177|NCT01822899|323732316|FG001|Overall Study|Protocol Violation|3|||
94529178|NCT01822899|323732315|FG000|Overall Study|Lost to Follow-up|1|||
94529179|NCT01822899|323732316|FG001|Overall Study|Lost to Follow-up|0|||
94529180|NCT01822899|323732315|FG000|Overall Study|Withdrawal by Subject|5|||
94529181|NCT01822899|323732316|FG001|Overall Study|Withdrawal by Subject|7|||
94529182|NCT03850093|323732323|FG000|Overall Study|Withdrawal by Subject|1|||
94529183|NCT03850093|323732324|FG001|Overall Study|Withdrawal by Subject|0|||
94529184|NCT03850093|323732325|FG002|Overall Study|Withdrawal by Subject|2|||
94529185|NCT00759876|323732328|FG000|Overall Study|Sponsor terminated study early|36|||
94529186|NCT02836717|323732332|FG000|Test Phase|Lack of Efficacy|14|||
94529187|NCT02836717|323732333|FG001|Test Phase|Lack of Efficacy|8|||
94529188|NCT02836717|323732334|FG002|Test Phase|Lack of Efficacy|0|||
94529189|NCT02836717|323732332|FG000|Study Phase|Adverse Event|2|||
94529190|NCT02836717|323732333|FG001|Study Phase|Adverse Event|0|||
94529191|NCT02836717|323732334|FG002|Study Phase|Adverse Event|0|||
94529192|NCT02836717|323732332|FG000|Study Phase|Lack of Efficacy|8|||
94529193|NCT02836717|323732333|FG001|Study Phase|Lack of Efficacy|6|||
94529194|NCT02836717|323732334|FG002|Study Phase|Lack of Efficacy|1|||
94529195|NCT02836717|323732332|FG000|Study Phase|Withdrawal by Subject|1|||
94529196|NCT02836717|323732333|FG001|Study Phase|Withdrawal by Subject|0|||
94529197|NCT02836717|323732334|FG002|Study Phase|Withdrawal by Subject|0|||
94529198|NCT02836717|323732332|FG000|Study Phase|Death|1|||
94529199|NCT02836717|323732333|FG001|Study Phase|Death|0|||
94529200|NCT02836717|323732334|FG002|Study Phase|Death|0|||
94529201|NCT02836717|323732332|FG000|Study Phase|abdominal surgeries|2|||
94529202|NCT02836717|323732333|FG001|Study Phase|abdominal surgeries|1|||
94529203|NCT02836717|323732334|FG002|Study Phase|abdominal surgeries|0|||
94529204|NCT02314156|323732336|FG000|Overall Study|Adverse Event|1|||
94529205|NCT02314156|323732337|FG001|Overall Study|Adverse Event|0|||
94529206|NCT02314156|323732336|FG000|Overall Study|Withdrawal by Subject|1|||
94529207|NCT02314156|323732337|FG001|Overall Study|Withdrawal by Subject|0|||
94529208|NCT00224120|323732338|FG000|Overall Study|Adverse Event|10|||
94529209|NCT00224120|323732339|FG001|Overall Study|Adverse Event|4|||
94529210|NCT00224120|323732338|FG000|Overall Study|Protocol Violation|1|||
94529211|NCT00224120|323732339|FG001|Overall Study|Protocol Violation|0|||
94529212|NCT00224120|323732338|FG000|Overall Study|Withdrawal by Subject|5|||
94529213|NCT00224120|323732339|FG001|Overall Study|Withdrawal by Subject|10|||
94529214|NCT00224120|323732338|FG000|Overall Study|Lack of Efficacy|0|||
94529215|NCT00224120|323732339|FG001|Overall Study|Lack of Efficacy|2|||
94529216|NCT00224120|323732338|FG000|Overall Study|Lost to Follow-up|2|||
94529217|NCT00224120|323732339|FG001|Overall Study|Lost to Follow-up|3|||
94529218|NCT00224120|323732338|FG000|Overall Study|Other|4|||
94529219|NCT00224120|323732339|FG001|Overall Study|Other|5|||
94529220|NCT00104416|323732340|FG000|Double-Blind Phase|Adverse Event|2|||
94529221|NCT00104416|323732341|FG001|Double-Blind Phase|Adverse Event|1|||
94529222|NCT00104416|323732342|FG002|Double-Blind Phase|Adverse Event|0|||
94529223|NCT00104416|323732343|FG003|Double-Blind Phase|Adverse Event|0|||
94529224|NCT00104416|323732344|FG004|Double-Blind Phase|Adverse Event|0|||
94529225|NCT00104416|323732340|FG000|Double-Blind Phase|Lost to Follow-up|0|||
94529226|NCT00104416|323732341|FG001|Double-Blind Phase|Lost to Follow-up|1|||
94529227|NCT00104416|323732342|FG002|Double-Blind Phase|Lost to Follow-up|0|||
94529228|NCT00104416|323732343|FG003|Double-Blind Phase|Lost to Follow-up|0|||
94529229|NCT00104416|323732344|FG004|Double-Blind Phase|Lost to Follow-up|0|||
94529230|NCT00104416|323732340|FG000|Double-Blind Phase|Protocol Violation|0|||
94529231|NCT00104416|323732341|FG001|Double-Blind Phase|Protocol Violation|1|||
94529232|NCT00104416|323732342|FG002|Double-Blind Phase|Protocol Violation|0|||
94529233|NCT00104416|323732343|FG003|Double-Blind Phase|Protocol Violation|0|||
94529234|NCT00104416|323732344|FG004|Double-Blind Phase|Protocol Violation|0|||
94529235|NCT00104416|323732340|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
94529236|NCT00104416|323732341|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
94529237|NCT00104416|323732342|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
94529238|NCT00104416|323732343|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
94529239|NCT00104416|323732344|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
94529240|NCT00104416|323732340|FG000|Double-Blind Phase|Pregnancy|1|||
94529241|NCT00104416|323732341|FG001|Double-Blind Phase|Pregnancy|0|||
94529242|NCT00104416|323732342|FG002|Double-Blind Phase|Pregnancy|0|||
94529243|NCT00104416|323732343|FG003|Double-Blind Phase|Pregnancy|0|||
94529244|NCT00104416|323732344|FG004|Double-Blind Phase|Pregnancy|0|||
94529245|NCT00104416|323732340|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
94529246|NCT00104416|323732341|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
94529247|NCT00104416|323732342|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
94529248|NCT00104416|323732343|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
94529249|NCT00104416|323732344|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
94529250|NCT00104416|323732340|FG000|Continuation Phase|Adverse Event|0|||
94529251|NCT00104416|323732341|FG001|Continuation Phase|Adverse Event|0|||
94529252|NCT00104416|323732342|FG002|Continuation Phase|Adverse Event|2|||
94529253|NCT00104416|323732343|FG003|Continuation Phase|Adverse Event|0|||
94529254|NCT00104416|323732344|FG004|Continuation Phase|Adverse Event|2|||
94529255|NCT00104416|323732340|FG000|Continuation Phase|Lost to Follow-up|0|||
94529256|NCT00104416|323732341|FG001|Continuation Phase|Lost to Follow-up|0|||
94529257|NCT00104416|323732342|FG002|Continuation Phase|Lost to Follow-up|1|||
94529258|NCT00104416|323732343|FG003|Continuation Phase|Lost to Follow-up|0|||
94529259|NCT00104416|323732344|FG004|Continuation Phase|Lost to Follow-up|1|||
94529260|NCT00104416|323732340|FG000|Continuation Phase|Withdrawal by Subject|0|||
94529261|NCT00104416|323732341|FG001|Continuation Phase|Withdrawal by Subject|0|||
94529262|NCT00104416|323732342|FG002|Continuation Phase|Withdrawal by Subject|2|||
94529263|NCT00104416|323732343|FG003|Continuation Phase|Withdrawal by Subject|1|||
94529264|NCT00104416|323732344|FG004|Continuation Phase|Withdrawal by Subject|1|||
94529265|NCT00104416|323732340|FG000|Continuation Phase|Pregnancy|0|||
94529266|NCT00104416|323732341|FG001|Continuation Phase|Pregnancy|0|||
94529267|NCT00104416|323732342|FG002|Continuation Phase|Pregnancy|1|||
94529268|NCT00104416|323732343|FG003|Continuation Phase|Pregnancy|1|||
94529269|NCT00104416|323732344|FG004|Continuation Phase|Pregnancy|0|||
94529270|NCT00104416|323732340|FG000|Continuation Phase|Non-compliance|0|||
94529271|NCT00104416|323732341|FG001|Continuation Phase|Non-compliance|0|||
94529272|NCT00104416|323732342|FG002|Continuation Phase|Non-compliance|0|||
94529273|NCT00104416|323732343|FG003|Continuation Phase|Non-compliance|0|||
94529274|NCT00104416|323732344|FG004|Continuation Phase|Non-compliance|1|||
94529275|NCT01532921|323732350|FG000|Overall Study|Death|3|||
94529276|NCT01532921|323732350|FG000|Overall Study|Withdrawal by Subject|2|||
94529277|NCT01532921|323732350|FG000|Overall Study|Lost to Follow-up|3|||
94529278|NCT01532921|323732350|FG000|Overall Study|Physician Decision|7|||
94529279|NCT01532921|323732350|FG000|Overall Study|Device was explanted during procedure|1|||
94529280|NCT03462641|323732351|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
94529281|NCT03462641|323732352|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
94529282|NCT03462641|323732351|FG000|Visit 2|Withdrawal by Subject|0|||
94529283|NCT03462641|323732352|FG001|Visit 2|Withdrawal by Subject|1|||
94529284|NCT01804049|323732353|FG000|Overall Study|Adverse Event|2|||
94529285|NCT01804049|323732354|FG001|Overall Study|Adverse Event|10|||
94529286|NCT01804049|323732353|FG000|Overall Study|Lost to Follow-up|2|||
94529287|NCT01804049|323732354|FG001|Overall Study|Lost to Follow-up|1|||
94529288|NCT01804049|323732353|FG000|Overall Study|Decreased interest/personal|4|||
94529289|NCT01804049|323732354|FG001|Overall Study|Decreased interest/personal|5|||
94529290|NCT01804049|323732353|FG000|Overall Study|Other health concerns|2|||
94529291|NCT01804049|323732354|FG001|Overall Study|Other health concerns|7|||
94529292|NCT01804049|323732353|FG000|Overall Study|Moved out of area|0|||
94529293|NCT01804049|323732354|FG001|Overall Study|Moved out of area|7|||
94529294|NCT01804049|323732353|FG000|Overall Study|other MD recommended|1|||
94529295|NCT01804049|323732354|FG001|Overall Study|other MD recommended|1|||
94529296|NCT01804049|323732353|FG000|Overall Study|Enrollment in dual studies|0|||
94529297|NCT01804049|323732354|FG001|Overall Study|Enrollment in dual studies|1|||
94529298|NCT02526212|323732355|FG000|Overall Study|Incarceration|1|||
94529299|NCT02526212|323732356|FG001|Overall Study|Incarceration|0|||
94529300|NCT02526212|323732355|FG000|Overall Study|Lost to Follow-up|1|||
94529301|NCT02526212|323732356|FG001|Overall Study|Lost to Follow-up|0|||
94529302|NCT02526212|323732355|FG000|Overall Study|Death|0|||
94529303|NCT02526212|323732356|FG001|Overall Study|Death|1|||
94529304|NCT00070109|323732357|FG000|Overall Study|Death|1|||
94529305|NCT00070109|323732358|FG001|Overall Study|Death|1|||
94529306|NCT00070109|323732359|FG002|Overall Study|Death|0|||
94529307|NCT00070109|323732360|FG003|Overall Study|Death|0|||
94529308|NCT00070109|323732361|FG004|Overall Study|Death|1|||
94529309|NCT00070109|323732357|FG000|Overall Study|Lack of Efficacy|6|||
94529310|NCT00070109|323732358|FG001|Overall Study|Lack of Efficacy|4|||
94529311|NCT00070109|323732359|FG002|Overall Study|Lack of Efficacy|5|||
94529312|NCT00070109|323732360|FG003|Overall Study|Lack of Efficacy|15|||
94529313|NCT00070109|323732361|FG004|Overall Study|Lack of Efficacy|5|||
94529314|NCT00070109|323732357|FG000|Overall Study|Physician Decision|1|||
94529315|NCT00070109|323732358|FG001|Overall Study|Physician Decision|0|||
94529316|NCT00070109|323732359|FG002|Overall Study|Physician Decision|0|||
94529317|NCT00070109|323732360|FG003|Overall Study|Physician Decision|0|||
94529318|NCT00070109|323732361|FG004|Overall Study|Physician Decision|0|||
94529319|NCT00070109|323732357|FG000|Overall Study|Withdrawal by Subject|0|||
94529320|NCT00070109|323732358|FG001|Overall Study|Withdrawal by Subject|1|||
94529321|NCT00070109|323732359|FG002|Overall Study|Withdrawal by Subject|1|||
94529322|NCT00070109|323732360|FG003|Overall Study|Withdrawal by Subject|0|||
94529323|NCT00070109|323732361|FG004|Overall Study|Withdrawal by Subject|0|||
94529324|NCT00070109|323732357|FG000|Overall Study|Adverse Event|0|||
94529325|NCT00070109|323732358|FG001|Overall Study|Adverse Event|0|||
94529326|NCT00070109|323732359|FG002|Overall Study|Adverse Event|2|||
94529327|NCT00070109|323732360|FG003|Overall Study|Adverse Event|4|||
94529328|NCT00070109|323732361|FG004|Overall Study|Adverse Event|2|||
94529329|NCT00070109|323732357|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
94529330|NCT00070109|323732358|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
94529331|NCT00070109|323732359|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
94529332|NCT00070109|323732360|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
94529333|NCT00070109|323732361|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
94529334|NCT01147250|323732367|FG000|Overall Study|Lost to Follow-up|14|||
94529335|NCT01147250|323732368|FG001|Overall Study|Lost to Follow-up|11|||
94529336|NCT01147250|323732367|FG000|Overall Study|Withdrawal by Subject|83|||
94529337|NCT01147250|323732368|FG001|Overall Study|Withdrawal by Subject|88|||
94529338|NCT01147250|323732367|FG000|Overall Study|Site termination by sponsor|13|||
94529339|NCT01147250|323732368|FG001|Overall Study|Site termination by sponsor|5|||
94529340|NCT01147250|323732367|FG000|Overall Study|Other than specified|0|||
94529341|NCT01147250|323732368|FG001|Overall Study|Other than specified|1|||
94529342|NCT02096952|323732375|FG000|Overall Study|Adverse Event|1|||
94529343|NCT00624468|323732377|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
94529344|NCT00624468|323732378|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
94529345|NCT00624468|323732379|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
94529346|NCT00624468|323732380|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
94529347|NCT00624468|323732377|FG000|Double-blind Period|Withdrew Prematurely|1|||
94529348|NCT00624468|323732378|FG001|Double-blind Period|Withdrew Prematurely|1|||
94529349|NCT00624468|323732379|FG002|Double-blind Period|Withdrew Prematurely|0|||
94529350|NCT00624468|323732380|FG003|Double-blind Period|Withdrew Prematurely|0|||
94529351|NCT00624468|323732377|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
94529352|NCT00624468|323732378|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
94529353|NCT00624468|323732379|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
94529354|NCT00624468|323732380|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
94529355|NCT00624468|323732377|FG000|Safety Follow-up (SFU) Period|Other|0|||
94529356|NCT00624468|323732378|FG001|Safety Follow-up (SFU) Period|Other|0|||
94529357|NCT00624468|323732379|FG002|Safety Follow-up (SFU) Period|Other|1|||
94529358|NCT00624468|323732380|FG003|Safety Follow-up (SFU) Period|Other|1|||
94529359|NCT00066222|323732381|FG000|Overall Study|No protocol treatment received|1|||
94529360|NCT01500252|323732382|FG000|Overall Study|Death|4|||
94529361|NCT01500252|323732383|FG001|Overall Study|Death|2|||
94529362|NCT01500252|323732382|FG000|Overall Study|Lost to Follow-up|5|||
94529363|NCT01500252|323732383|FG001|Overall Study|Lost to Follow-up|4|||
94529364|NCT01071252|323732384|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
94529365|NCT01071252|323732385|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
94529366|NCT01071252|323732386|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
94529367|NCT01071252|323732387|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
94529368|NCT01071252|323732388|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
94529369|NCT01071252|323732384|FG000|Overall Study|Withdrawal by Subject|8|||
94529370|NCT01071252|323732385|FG001|Overall Study|Withdrawal by Subject|2|||
94529371|NCT01071252|323732386|FG002|Overall Study|Withdrawal by Subject|1|||
94529372|NCT01071252|323732387|FG003|Overall Study|Withdrawal by Subject|2|||
94529373|NCT01071252|323732388|FG004|Overall Study|Withdrawal by Subject|3|||
94529374|NCT01071252|323732384|FG000|Overall Study|administrative problems|1|||
94529375|NCT01071252|323732385|FG001|Overall Study|administrative problems|1|||
94529376|NCT01071252|323732386|FG002|Overall Study|administrative problems|0|||
94529377|NCT01071252|323732387|FG003|Overall Study|administrative problems|2|||
94529378|NCT01071252|323732388|FG004|Overall Study|administrative problems|1|||
94529379|NCT01071252|323732384|FG000|Overall Study|Lost to Follow-up|1|||
94529380|NCT01071252|323732385|FG001|Overall Study|Lost to Follow-up|0|||
94529381|NCT01071252|323732386|FG002|Overall Study|Lost to Follow-up|1|||
94529382|NCT01071252|323732387|FG003|Overall Study|Lost to Follow-up|2|||
94529383|NCT01071252|323732388|FG004|Overall Study|Lost to Follow-up|0|||
94529384|NCT01071252|323732384|FG000|Overall Study|Adverse Event|1|||
94529385|NCT01071252|323732385|FG001|Overall Study|Adverse Event|1|||
94529386|NCT01071252|323732386|FG002|Overall Study|Adverse Event|0|||
94529387|NCT01071252|323732387|FG003|Overall Study|Adverse Event|1|||
94529388|NCT01071252|323732388|FG004|Overall Study|Adverse Event|0|||
94529389|NCT01071252|323732384|FG000|Overall Study|Death|0|||
94529390|NCT01071252|323732385|FG001|Overall Study|Death|0|||
94529391|NCT01071252|323732386|FG002|Overall Study|Death|0|||
94529392|NCT01071252|323732387|FG003|Overall Study|Death|0|||
94529393|NCT01071252|323732388|FG004|Overall Study|Death|1|||
94529394|NCT04599803|323732394|FG000|Overall Study|Withdrawal by Subject|5|||
94529395|NCT04599803|323732394|FG000|Overall Study|Lost to Follow-up|26|||
94529396|NCT02466425|323732395|FG000|Overall Study|Adverse Event|3|||
94529397|NCT02466425|323732396|FG001|Overall Study|Adverse Event|11|||
94529398|NCT02466425|323732395|FG000|Overall Study|Lack of Efficacy|4|||
94529399|NCT02466425|323732396|FG001|Overall Study|Lack of Efficacy|1|||
94529400|NCT02466425|323732395|FG000|Overall Study|Lost to Follow-up|3|||
94529401|NCT02466425|323732396|FG001|Overall Study|Lost to Follow-up|0|||
94529402|NCT02466425|323732395|FG000|Overall Study|Protocol Violation|1|||
94529403|NCT02466425|323732396|FG001|Overall Study|Protocol Violation|0|||
94529404|NCT02466425|323732395|FG000|Overall Study|Withdrawal by Subject|0|||
94529405|NCT02466425|323732396|FG001|Overall Study|Withdrawal by Subject|1|||
94529406|NCT02466425|323732395|FG000|Overall Study|Other|1|||
94529407|NCT02466425|323732396|FG001|Overall Study|Other|3|||
94529408|NCT02466425|323732395|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
94529409|NCT02466425|323732396|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
94529410|NCT02584452|323732397|FG000|Overall Study|Physician Decision|1|||
94529411|NCT02584452|323732398|FG001|Overall Study|Physician Decision|1|||
94529412|NCT02584452|323732397|FG000|Overall Study|Lost to Follow-up|1|||
94529413|NCT02584452|323732398|FG001|Overall Study|Lost to Follow-up|1|||
94529414|NCT00902850|323732400|FG000|Overall Study|Physician Decision|2|||
94529415|NCT00902850|323732401|FG001|Overall Study|Physician Decision|2|||
94529416|NCT00260832|323732402|FG000|Overall Study|Adverse Event|26|||
94529417|NCT00260832|323732403|FG001|Overall Study|Adverse Event|19|||
94529418|NCT00260832|323732402|FG000|Overall Study|Progression|116|||
94529419|NCT00260832|323732403|FG001|Overall Study|Progression|96|||
94529420|NCT00260832|323732402|FG000|Overall Study|Withdrawal by Subject|15|||
94529421|NCT00260832|323732403|FG001|Overall Study|Withdrawal by Subject|17|||
94529422|NCT00260832|323732402|FG000|Overall Study|Physician Decision|15|||
94529423|NCT00260832|323732403|FG001|Overall Study|Physician Decision|9|||
94529424|NCT00260832|323732402|FG000|Overall Study|Death|43|||
94529425|NCT00260832|323732403|FG001|Overall Study|Death|62|||
94529426|NCT00260832|323732402|FG000|Overall Study|Other|10|||
94529427|NCT00260832|323732403|FG001|Overall Study|Other|7|||
94529428|NCT00260832|323732402|FG000|Overall Study|Protocol Violation|3|||
94529429|NCT00260832|323732403|FG001|Overall Study|Protocol Violation|1|||
94529430|NCT03098433|323732404|FG000|Overall Study|Withdrawal by Subject|10|||
94529431|NCT01667133|323732405|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
94529432|NCT01667133|323732406|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
94529433|NCT01667133|323732407|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
94529434|NCT01667133|323732408|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
94529435|NCT01667133|323732409|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
94529436|NCT01667133|323732410|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
94529437|NCT01667133|323732411|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
94529438|NCT01667133|323732412|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
94529439|NCT01667133|323732413|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
94529440|NCT01667133|323732414|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
94529441|NCT01667133|323732415|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
94529442|NCT01667133|323732416|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
94529443|NCT01667133|323732405|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
94529444|NCT01667133|323732406|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
94529445|NCT01667133|323732407|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
94529446|NCT01667133|323732408|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
94529447|NCT01667133|323732409|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
94529448|NCT01667133|323732410|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
94529449|NCT01667133|323732411|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
94529450|NCT01667133|323732412|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
94529451|NCT01667133|323732413|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
94529452|NCT01667133|323732414|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
94529453|NCT01667133|323732415|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
94529454|NCT01667133|323732416|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
94529455|NCT01667133|323732405|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
94529456|NCT01667133|323732406|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
94529457|NCT01667133|323732407|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
94529458|NCT01667133|323732408|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
94529459|NCT01667133|323732409|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
94529460|NCT01667133|323732410|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
94529461|NCT01667133|323732411|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
94529462|NCT01667133|323732412|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
94529463|NCT01667133|323732413|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
94529464|NCT01667133|323732414|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
94529465|NCT01667133|323732415|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
94529466|NCT01667133|323732416|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
94529467|NCT01667133|323732405|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
94529468|NCT01667133|323732406|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
94529469|NCT01667133|323732407|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
94529470|NCT01667133|323732408|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
94529471|NCT01667133|323732409|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
94529472|NCT01667133|323732410|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
94529473|NCT01667133|323732411|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
94529474|NCT01667133|323732412|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
94529475|NCT01667133|323732413|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
94529476|NCT01667133|323732414|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
94529477|NCT01667133|323732415|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
94529478|NCT01667133|323732416|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
94529479|NCT01667133|323732405|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
94529480|NCT01667133|323732406|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
94529481|NCT01667133|323732407|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
94529482|NCT01667133|323732408|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
94529483|NCT01667133|323732409|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
94529484|NCT01667133|323732410|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
94529485|NCT01667133|323732411|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
94529486|NCT01667133|323732412|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
94529487|NCT01667133|323732413|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
94529488|NCT01667133|323732414|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
94529489|NCT01667133|323732415|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
94529490|NCT01667133|323732416|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
94529491|NCT01667133|323732405|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
94529492|NCT01667133|323732406|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
94529493|NCT01667133|323732407|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
94529494|NCT01667133|323732408|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
94529495|NCT01667133|323732409|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
94529496|NCT01667133|323732410|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
94529497|NCT01667133|323732411|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
94529498|NCT01667133|323732412|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
94529499|NCT01667133|323732413|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
94529500|NCT01667133|323732414|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
94529501|NCT01667133|323732415|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
94529502|NCT01667133|323732416|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
94529503|NCT01667133|323732405|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
94529504|NCT01667133|323732406|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
94529505|NCT01667133|323732407|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
94529506|NCT01667133|323732408|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
94529507|NCT01667133|323732409|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
94529508|NCT01667133|323732410|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
94529509|NCT01667133|323732411|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
94529510|NCT01667133|323732412|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
94529511|NCT01667133|323732413|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
94529512|NCT01667133|323732414|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
94529513|NCT01667133|323732415|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
94529514|NCT01667133|323732416|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
94529515|NCT01667133|323732405|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
94529516|NCT01667133|323732406|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
94529517|NCT01667133|323732407|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
94529518|NCT01667133|323732408|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
94529519|NCT01667133|323732409|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
94529520|NCT01667133|323732410|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
94529521|NCT01667133|323732411|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
94529522|NCT01667133|323732412|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
94529523|NCT01667133|323732413|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
94529524|NCT01667133|323732414|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
94529525|NCT01667133|323732415|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
94529526|NCT01667133|323732416|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
94529527|NCT01667133|323732405|FG000|Phase 2: Dose-expansion|Death|0|||
94529528|NCT01667133|323732406|FG001|Phase 2: Dose-expansion|Death|0|||
94529529|NCT01667133|323732407|FG002|Phase 2: Dose-expansion|Death|0|||
94529530|NCT01667133|323732408|FG003|Phase 2: Dose-expansion|Death|0|||
94529531|NCT01667133|323732409|FG004|Phase 2: Dose-expansion|Death|0|||
94529532|NCT01667133|323732410|FG005|Phase 2: Dose-expansion|Death|0|||
94529533|NCT01667133|323732411|FG006|Phase 2: Dose-expansion|Death|0|||
94529534|NCT01667133|323732412|FG007|Phase 2: Dose-expansion|Death|0|||
94529535|NCT01667133|323732413|FG008|Phase 2: Dose-expansion|Death|0|||
94529536|NCT01667133|323732414|FG009|Phase 2: Dose-expansion|Death|1|||
94529537|NCT01667133|323732415|FG010|Phase 2: Dose-expansion|Death|0|||
94529538|NCT01667133|323732416|FG011|Phase 2: Dose-expansion|Death|0|||
94529539|NCT01667133|323732405|FG000|Phase 2: Dose-expansion|Other|0|||
94529540|NCT01667133|323732406|FG001|Phase 2: Dose-expansion|Other|0|||
94529541|NCT01667133|323732407|FG002|Phase 2: Dose-expansion|Other|0|||
94529542|NCT01667133|323732408|FG003|Phase 2: Dose-expansion|Other|0|||
94529543|NCT01667133|323732409|FG004|Phase 2: Dose-expansion|Other|0|||
94529544|NCT01667133|323732410|FG005|Phase 2: Dose-expansion|Other|0|||
94529545|NCT01667133|323732411|FG006|Phase 2: Dose-expansion|Other|0|||
94529546|NCT01667133|323732412|FG007|Phase 2: Dose-expansion|Other|0|||
94529547|NCT01667133|323732413|FG008|Phase 2: Dose-expansion|Other|0|||
94529548|NCT01667133|323732414|FG009|Phase 2: Dose-expansion|Other|0|||
94529549|NCT01667133|323732415|FG010|Phase 2: Dose-expansion|Other|0|||
94529550|NCT01667133|323732416|FG011|Phase 2: Dose-expansion|Other|1|||
94529551|NCT02725476|323732419|FG000|Overall Study|Physician Decision|2|||
94529552|NCT02725476|323732420|FG001|Overall Study|Physician Decision|0|||
94529553|NCT02725476|323732419|FG000|Overall Study|Adverse Event|1|||
94529554|NCT02725476|323732420|FG001|Overall Study|Adverse Event|1|||
94529555|NCT02676895|323732424|FG000|Overall Study|Administrative reason|1|||
94529556|NCT02676895|323732425|FG001|Overall Study|Administrative reason|0|||
94529557|NCT02676895|323732426|FG002|Overall Study|Administrative reason|0|||
94529558|NCT02676895|323732424|FG000|Overall Study|Protocol Violation|1|||
94529559|NCT02676895|323732425|FG001|Overall Study|Protocol Violation|0|||
94529560|NCT02676895|323732426|FG002|Overall Study|Protocol Violation|0|||
94529561|NCT02676895|323732424|FG000|Overall Study|Adverse Event|0|||
94529562|NCT02676895|323732425|FG001|Overall Study|Adverse Event|3|||
94529563|NCT02676895|323732426|FG002|Overall Study|Adverse Event|1|||
94529564|NCT02676895|323732424|FG000|Overall Study|Lost to Follow-up|0|||
94529565|NCT02676895|323732425|FG001|Overall Study|Lost to Follow-up|0|||
94529566|NCT02676895|323732426|FG002|Overall Study|Lost to Follow-up|1|||
94529567|NCT02676895|323732424|FG000|Overall Study|Withdrawal by Subject|0|||
94529568|NCT02676895|323732425|FG001|Overall Study|Withdrawal by Subject|0|||
94529569|NCT02676895|323732426|FG002|Overall Study|Withdrawal by Subject|1|||
94529570|NCT00391430|323732427|FG000|Overall Study|Withdrawal by Subject|3|||
94529571|NCT00391430|323732428|FG001|Overall Study|Withdrawal by Subject|0|||
94529572|NCT00391430|323732429|FG002|Overall Study|Withdrawal by Subject|12|||
94529573|NCT01939977|323732435|FG000|Overall Study|Adverse Event|4|||
94529574|NCT01939977|323732436|FG001|Overall Study|Adverse Event|3|||
94529575|NCT01939977|323732435|FG000|Overall Study|Lack of Efficacy|3|||
94529576|NCT01939977|323732436|FG001|Overall Study|Lack of Efficacy|0|||
94529577|NCT01939977|323732435|FG000|Overall Study|Physician Decision|1|||
94529578|NCT01939977|323732436|FG001|Overall Study|Physician Decision|1|||
94529579|NCT01939977|323732435|FG000|Overall Study|Withdrawal by Subject|0|||
94529580|NCT01939977|323732436|FG001|Overall Study|Withdrawal by Subject|2|||
94529581|NCT01939977|323732435|FG000|Overall Study|Did not meet inclusion criteria|1|||
94529582|NCT01939977|323732436|FG001|Overall Study|Did not meet inclusion criteria|0|||
94529583|NCT01939977|323732435|FG000|Overall Study|Did not receive study medication|0|||
94529584|NCT01939977|323732436|FG001|Overall Study|Did not receive study medication|1|||
94529585|NCT00564902|323732442|FG000|Overall Study|Withdrawal by Subject|0|||
94529586|NCT00564902|323732443|FG001|Overall Study|Withdrawal by Subject|3|||
94529587|NCT00564902|323732444|FG002|Overall Study|Withdrawal by Subject|4|||
94529588|NCT00564902|323732442|FG000|Overall Study|Death|1|||
94529589|NCT00564902|323732443|FG001|Overall Study|Death|1|||
94529590|NCT00564902|323732444|FG002|Overall Study|Death|0|||
94529591|NCT01831466|323732445|FG000|Overall Study|Protocol Violation|1|||
94529592|NCT01831466|323732446|FG001|Overall Study|Protocol Violation|1|||
94529593|NCT01831466|323732447|FG002|Overall Study|Protocol Violation|2|||
94529594|NCT01831466|323732448|FG003|Overall Study|Protocol Violation|0|||
94529595|NCT01831466|323732449|FG004|Overall Study|Protocol Violation|0|||
94529596|NCT01831466|323732450|FG005|Overall Study|Protocol Violation|1|||
94529597|NCT01831466|323732451|FG006|Overall Study|Protocol Violation|0|||
94529598|NCT01831466|323732452|FG007|Overall Study|Protocol Violation|0|||
94529599|NCT01831466|323732453|FG008|Overall Study|Protocol Violation|0|||
94529600|NCT01831466|323732454|FG009|Overall Study|Protocol Violation|0|||
94529601|NCT01831466|323732455|FG010|Overall Study|Protocol Violation|0|||
94529602|NCT01831466|323732456|FG011|Overall Study|Protocol Violation|0|||
94529603|NCT01831466|323732445|FG000|Overall Study|Other|2|||
94529604|NCT01831466|323732446|FG001|Overall Study|Other|3|||
94529605|NCT01831466|323732447|FG002|Overall Study|Other|2|||
94529606|NCT01831466|323732448|FG003|Overall Study|Other|2|||
94529607|NCT01831466|323732449|FG004|Overall Study|Other|2|||
94529608|NCT01831466|323732450|FG005|Overall Study|Other|1|||
94529609|NCT01831466|323732451|FG006|Overall Study|Other|0|||
94529610|NCT01831466|323732452|FG007|Overall Study|Other|0|||
94529611|NCT01831466|323732453|FG008|Overall Study|Other|0|||
94529612|NCT01831466|323732454|FG009|Overall Study|Other|0|||
94529613|NCT01831466|323732455|FG010|Overall Study|Other|0|||
94529614|NCT01831466|323732456|FG011|Overall Study|Other|0|||
94529615|NCT01831466|323732445|FG000|Overall Study|Non-compliance with study treatment|2|||
94529616|NCT01831466|323732446|FG001|Overall Study|Non-compliance with study treatment|1|||
94529617|NCT01831466|323732447|FG002|Overall Study|Non-compliance with study treatment|1|||
94529618|NCT01831466|323732448|FG003|Overall Study|Non-compliance with study treatment|0|||
94529619|NCT01831466|323732449|FG004|Overall Study|Non-compliance with study treatment|0|||
94529620|NCT01831466|323732450|FG005|Overall Study|Non-compliance with study treatment|1|||
94529621|NCT01831466|323732451|FG006|Overall Study|Non-compliance with study treatment|0|||
94529622|NCT01831466|323732452|FG007|Overall Study|Non-compliance with study treatment|0|||
94529623|NCT01831466|323732453|FG008|Overall Study|Non-compliance with study treatment|0|||
94529624|NCT01831466|323732454|FG009|Overall Study|Non-compliance with study treatment|0|||
94529625|NCT01831466|323732455|FG010|Overall Study|Non-compliance with study treatment|0|||
94529626|NCT01831466|323732456|FG011|Overall Study|Non-compliance with study treatment|0|||
94529627|NCT01831466|323732445|FG000|Overall Study|Death|0|||
94529628|NCT01831466|323732446|FG001|Overall Study|Death|1|||
94529629|NCT01831466|323732447|FG002|Overall Study|Death|0|||
94529630|NCT01831466|323732448|FG003|Overall Study|Death|0|||
94529631|NCT01831466|323732449|FG004|Overall Study|Death|0|||
94529632|NCT01831466|323732450|FG005|Overall Study|Death|0|||
94529633|NCT01831466|323732451|FG006|Overall Study|Death|0|||
94529634|NCT01831466|323732452|FG007|Overall Study|Death|0|||
94529635|NCT01831466|323732453|FG008|Overall Study|Death|0|||
94529636|NCT01831466|323732454|FG009|Overall Study|Death|0|||
94529637|NCT01831466|323732455|FG010|Overall Study|Death|0|||
94529638|NCT01831466|323732456|FG011|Overall Study|Death|0|||
94529639|NCT01831466|323732445|FG000|Overall Study|Withdrawal by Subject|6|||
94529640|NCT01831466|323732446|FG001|Overall Study|Withdrawal by Subject|3|||
94529641|NCT01831466|323732447|FG002|Overall Study|Withdrawal by Subject|3|||
94529642|NCT01831466|323732448|FG003|Overall Study|Withdrawal by Subject|3|||
94529643|NCT01831466|323732449|FG004|Overall Study|Withdrawal by Subject|3|||
94529644|NCT01831466|323732450|FG005|Overall Study|Withdrawal by Subject|5|||
94529645|NCT01831466|323732451|FG006|Overall Study|Withdrawal by Subject|0|||
94529646|NCT01831466|323732452|FG007|Overall Study|Withdrawal by Subject|0|||
94529647|NCT01831466|323732453|FG008|Overall Study|Withdrawal by Subject|0|||
94529648|NCT01831466|323732454|FG009|Overall Study|Withdrawal by Subject|1|||
94529649|NCT01831466|323732455|FG010|Overall Study|Withdrawal by Subject|0|||
94529650|NCT01831466|323732456|FG011|Overall Study|Withdrawal by Subject|1|||
94529651|NCT01831466|323732445|FG000|Overall Study|Lost to Follow-up|0|||
94529652|NCT01831466|323732446|FG001|Overall Study|Lost to Follow-up|1|||
94529653|NCT01831466|323732447|FG002|Overall Study|Lost to Follow-up|4|||
94529654|NCT01831466|323732448|FG003|Overall Study|Lost to Follow-up|2|||
94529655|NCT01831466|323732449|FG004|Overall Study|Lost to Follow-up|0|||
94529656|NCT01831466|323732450|FG005|Overall Study|Lost to Follow-up|3|||
94529657|NCT01831466|323732451|FG006|Overall Study|Lost to Follow-up|0|||
94529658|NCT01831466|323732452|FG007|Overall Study|Lost to Follow-up|0|||
94529659|NCT01831466|323732453|FG008|Overall Study|Lost to Follow-up|0|||
94529660|NCT01831466|323732454|FG009|Overall Study|Lost to Follow-up|1|||
94529661|NCT01831466|323732455|FG010|Overall Study|Lost to Follow-up|0|||
94529662|NCT01831466|323732456|FG011|Overall Study|Lost to Follow-up|1|||
94529663|NCT01831466|323732445|FG000|Overall Study|Lack of Efficacy|5|||
94529664|NCT01831466|323732446|FG001|Overall Study|Lack of Efficacy|8|||
94529665|NCT01831466|323732447|FG002|Overall Study|Lack of Efficacy|7|||
94529666|NCT01831466|323732448|FG003|Overall Study|Lack of Efficacy|6|||
94529667|NCT01831466|323732449|FG004|Overall Study|Lack of Efficacy|9|||
94529668|NCT01831466|323732450|FG005|Overall Study|Lack of Efficacy|8|||
94529669|NCT01831466|323732451|FG006|Overall Study|Lack of Efficacy|1|||
94529670|NCT01831466|323732452|FG007|Overall Study|Lack of Efficacy|1|||
94529671|NCT01831466|323732453|FG008|Overall Study|Lack of Efficacy|2|||
94529672|NCT01831466|323732454|FG009|Overall Study|Lack of Efficacy|2|||
94529673|NCT01831466|323732455|FG010|Overall Study|Lack of Efficacy|2|||
94529674|NCT01831466|323732456|FG011|Overall Study|Lack of Efficacy|0|||
94529675|NCT01831466|323732445|FG000|Overall Study|Adverse Event|0|||
94529676|NCT01831466|323732446|FG001|Overall Study|Adverse Event|0|||
94529677|NCT01831466|323732447|FG002|Overall Study|Adverse Event|4|||
94529678|NCT01831466|323732448|FG003|Overall Study|Adverse Event|6|||
94529679|NCT01831466|323732449|FG004|Overall Study|Adverse Event|3|||
94529680|NCT01831466|323732450|FG005|Overall Study|Adverse Event|7|||
94529681|NCT01831466|323732451|FG006|Overall Study|Adverse Event|0|||
94529682|NCT01831466|323732452|FG007|Overall Study|Adverse Event|1|||
94529683|NCT01831466|323732453|FG008|Overall Study|Adverse Event|1|||
94529684|NCT01831466|323732454|FG009|Overall Study|Adverse Event|1|||
94529685|NCT01831466|323732455|FG010|Overall Study|Adverse Event|0|||
94529686|NCT01831466|323732456|FG011|Overall Study|Adverse Event|2|||
94529687|NCT02248649|323732457|FG000|Overall Study|Death|7|||
94529688|NCT02248649|323732458|FG001|Overall Study|Death|11|||
94529689|NCT02248649|323732457|FG000|Overall Study|Lost to Follow-up|14|||
94529690|NCT02248649|323732458|FG001|Overall Study|Lost to Follow-up|10|||
94529691|NCT02628600|323732459|FG000|Overall Study|Death|2|||
94529692|NCT02628600|323732460|FG001|Overall Study|Death|1|||
94529693|NCT02628600|323732459|FG000|Overall Study|Adverse Event|3|||
94529694|NCT02628600|323732460|FG001|Overall Study|Adverse Event|20|||
94529695|NCT02628600|323732459|FG000|Overall Study|Protocol Violation|0|||
94529696|NCT02628600|323732460|FG001|Overall Study|Protocol Violation|1|||
94529697|NCT02628600|323732459|FG000|Overall Study|Lack of Efficacy|2|||
94529698|NCT02628600|323732460|FG001|Overall Study|Lack of Efficacy|0|||
94529699|NCT02628600|323732459|FG000|Overall Study|Withdrawal by Subject|13|||
94529700|NCT02628600|323732460|FG001|Overall Study|Withdrawal by Subject|8|||
94529701|NCT02628600|323732459|FG000|Overall Study|Lost to Follow-up|1|||
94529702|NCT02628600|323732460|FG001|Overall Study|Lost to Follow-up|0|||
94529703|NCT02628600|323732459|FG000|Overall Study|Physician Decision|2|||
94529704|NCT02628600|323732460|FG001|Overall Study|Physician Decision|2|||
94529705|NCT02628600|323732459|FG000|Overall Study|Other not specified|1|||
94529706|NCT02628600|323732460|FG001|Overall Study|Other not specified|0|||
94529707|NCT00301262|323734228|FG000|Double Blind Phase (DB)|Adverse Event|1|||
94529708|NCT00301262|323734229|FG001|Double Blind Phase (DB)|Adverse Event|0|||
94529709|NCT00301262|323734228|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
94529710|NCT00301262|323734229|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
94529711|NCT00301262|323734228|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
94529712|NCT00301262|323734229|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
94529713|NCT00301262|323734228|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
94529714|NCT00301262|323734229|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
94529715|NCT00301262|323734228|FG000|Double Blind Phase (DB)|Other|1|||
94529716|NCT00301262|323734229|FG001|Double Blind Phase (DB)|Other|4|||
94529717|NCT00301262|323734228|FG000|Open Label Phase (OL)|Adverse Event|1|||
94529718|NCT00301262|323734229|FG001|Open Label Phase (OL)|Adverse Event|0|||
94529719|NCT00301262|323734228|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
94529720|NCT00301262|323734229|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
94529721|NCT00301262|323734228|FG000|Open Label Phase (OL)|Other|2|||
94529722|NCT00301262|323734229|FG001|Open Label Phase (OL)|Other|0|||
94529723|NCT00854724|323734230|FG000|First Intervention|Withdrawal by Subject|1|||
94529724|NCT00854724|323734231|FG001|First Intervention|Withdrawal by Subject|1|||
94529725|NCT00854724|323734230|FG000|Washout|Protocol Violation|1|||
94529726|NCT00854724|323734231|FG001|Washout|Protocol Violation|0|||
94529727|NCT00854724|323734230|FG000|Washout|Withdrawal by Subject|0|||
94529728|NCT00854724|323734231|FG001|Washout|Withdrawal by Subject|1|||
94529729|NCT00854724|323734230|FG000|Second Intervention|Protocol Violation|1|||
94529730|NCT00854724|323734231|FG001|Second Intervention|Protocol Violation|0|||
94529731|NCT00854724|323734230|FG000|Second Intervention|Physician Decision|0|||
94529732|NCT00854724|323734231|FG001|Second Intervention|Physician Decision|1|||
94529733|NCT02582814|323734232|FG000|Overall Study|Study-specific withdrawal criteria|1|||
94529734|NCT02582814|323734233|FG001|Overall Study|Study-specific withdrawal criteria|0|||
94529735|NCT02582814|323734232|FG000|Overall Study|Withdrawal by Subject|4|||
94529736|NCT02582814|323734233|FG001|Overall Study|Withdrawal by Subject|3|||
94529737|NCT02582814|323734232|FG000|Overall Study|Adverse Event|4|||
94529738|NCT02582814|323734233|FG001|Overall Study|Adverse Event|4|||
94529739|NCT02141633|323734242|FG000|Overall Study|Physician Decision|1|||
94529740|NCT02141633|323734243|FG001|Overall Study|Physician Decision|0|||
94529741|NCT02482298|323734244|FG000|Overall Study|Withdrawal by Subject|2|||
94529742|NCT02482298|323734245|FG001|Overall Study|Withdrawal by Subject|1|||
94529743|NCT02482298|323734246|FG002|Overall Study|Withdrawal by Subject|2|||
94529744|NCT02482298|323734244|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
94529745|NCT02482298|323734245|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
94529746|NCT02482298|323734246|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
94529747|NCT02482298|323734244|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
94529748|NCT02482298|323734245|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
94529749|NCT02482298|323734246|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
94529750|NCT02482298|323734244|FG000|Overall Study|Lost to Follow-up|0|||
94529751|NCT02482298|323734245|FG001|Overall Study|Lost to Follow-up|1|||
94529752|NCT02482298|323734246|FG002|Overall Study|Lost to Follow-up|0|||
94529753|NCT01188551|323734249|FG000|Overall Study|Pharmacy issues|1|||
94529754|NCT01188551|323734250|FG001|Overall Study|Pharmacy issues|0|||
94529755|NCT01188551|323734251|FG002|Overall Study|Pharmacy issues|0|||
94529756|NCT01188551|323734252|FG003|Overall Study|Pharmacy issues|0|||
94529757|NCT05002985|323734253|FG000|Overall Study|Withdrawal by Subject|1|||
94529758|NCT04123093|323734257|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
94529759|NCT04123093|323734258|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
94529760|NCT04123093|323734257|FG000|Phase 2|Physician Decision|0|||
94529761|NCT04123093|323734258|FG001|Phase 2|Physician Decision|1|||
94529762|NCT04123093|323734257|FG000|Phase 2|Withdrawal by Subject|0|||
94529763|NCT04123093|323734258|FG001|Phase 2|Withdrawal by Subject|1|||
94529764|NCT00466947|323734261|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
94529765|NCT00466947|323734262|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
94529766|NCT00466947|323734261|FG000|Study End Analysis Period|Adverse Event|35|||
94529767|NCT00466947|323734262|FG001|Study End Analysis Period|Adverse Event|43|||
94529768|NCT00466947|323734261|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
94529769|NCT00466947|323734262|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
94529770|NCT00466947|323734261|FG000|Study End Analysis Period|Physician Decision|29|||
94529771|NCT00466947|323734262|FG001|Study End Analysis Period|Physician Decision|29|||
94529772|NCT00466947|323734261|FG000|Study End Analysis Period|Protocol Violation|9|||
94529773|NCT00466947|323734262|FG001|Study End Analysis Period|Protocol Violation|17|||
94529774|NCT00466947|323734261|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
94529775|NCT00466947|323734262|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
94529776|NCT00466947|323734261|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
94529777|NCT00466947|323734262|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
94529778|NCT00466947|323734261|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
94529779|NCT00466947|323734262|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
94529780|NCT00466947|323734261|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
94529781|NCT00466947|323734262|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
94529782|NCT03818607|323734271|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
94529783|NCT03818607|323734272|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
94529784|NCT03818607|323734271|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
94529785|NCT03818607|323734272|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
94529786|NCT03818607|323734271|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
94529787|NCT03818607|323734272|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
94529788|NCT00588237|323734273|FG000|Overall Study|Evaluable for toxicity only|3|||
94529789|NCT00588237|323734273|FG000|Overall Study|Patien not treated|1|||
94529790|NCT03520920|323734274|FG000|Overall Study|Death|13|||
94529791|NCT03520920|323734275|FG001|Overall Study|Death|1|||
94529792|NCT03520920|323734276|FG002|Overall Study|Death|0|||
94529793|NCT03520920|323734274|FG000|Overall Study|Withdrawal by Subject|2|||
94529794|NCT03520920|323734275|FG001|Overall Study|Withdrawal by Subject|1|||
94529795|NCT03520920|323734276|FG002|Overall Study|Withdrawal by Subject|0|||
94529796|NCT03520920|323734274|FG000|Overall Study|Study Terminated by the Sponsor|5|||
94529797|NCT03520920|323734275|FG001|Overall Study|Study Terminated by the Sponsor|14|||
94529798|NCT03520920|323734276|FG002|Overall Study|Study Terminated by the Sponsor|5|||
94529799|NCT01703091|323734277|FG000|Overall Study|Adverse Event|5|||
94529800|NCT01703091|323734278|FG001|Overall Study|Adverse Event|3|||
94529801|NCT01703091|323734277|FG000|Overall Study|Physician Decision|2|||
94529802|NCT01703091|323734278|FG001|Overall Study|Physician Decision|1|||
94529803|NCT01703091|323734277|FG000|Overall Study|Withdrawal by Subject|1|||
94529804|NCT01703091|323734278|FG001|Overall Study|Withdrawal by Subject|0|||
94529805|NCT01703091|323734277|FG000|Overall Study|Sponsor Decision|1|||
94529806|NCT01703091|323734278|FG001|Overall Study|Sponsor Decision|0|||
94529807|NCT03248531|323734282|FG000|Overall Study|Adverse Event|0|||
94529808|NCT03248531|323734283|FG001|Overall Study|Adverse Event|0|||
94529809|NCT03248531|323734284|FG002|Overall Study|Adverse Event|1|||
94529810|NCT03248531|323734282|FG000|Overall Study|Lost to Follow-up|1|||
94529811|NCT03248531|323734283|FG001|Overall Study|Lost to Follow-up|0|||
94529812|NCT03248531|323734284|FG002|Overall Study|Lost to Follow-up|5|||
94529813|NCT03248531|323734282|FG000|Overall Study|Withdrawal by Subject|3|||
94529814|NCT03248531|323734283|FG001|Overall Study|Withdrawal by Subject|3|||
94529815|NCT03248531|323734284|FG002|Overall Study|Withdrawal by Subject|2|||
94529816|NCT03248531|323734282|FG000|Overall Study|Sponsor Request|0|||
94529817|NCT03248531|323734283|FG001|Overall Study|Sponsor Request|2|||
94529818|NCT03248531|323734284|FG002|Overall Study|Sponsor Request|0|||
94529819|NCT04075513|323734285|FG000|Overall Study|Withdrawal by Subject|2|||
94529820|NCT04075513|323734286|FG001|Overall Study|Withdrawal by Subject|2|||
94529821|NCT04075513|323734285|FG000|Overall Study|Lack of Efficacy|1|||
94529822|NCT04075513|323734286|FG001|Overall Study|Lack of Efficacy|0|||
94529823|NCT04075513|323734285|FG000|Overall Study|Lost to Follow-up|4|||
94529824|NCT04075513|323734286|FG001|Overall Study|Lost to Follow-up|2|||
94529825|NCT04075513|323734285|FG000|Overall Study|Switch to insulin pump|1|||
94529826|NCT04075513|323734286|FG001|Overall Study|Switch to insulin pump|0|||
94529827|NCT00904670|323734287|FG000|Open Label Phase|Withdrawal by Subject|2|||
94529828|NCT00904670|323734288|FG001|Open Label Phase|Withdrawal by Subject|0|||
94529829|NCT00904670|323734287|FG000|Open Label Phase|Adverse Event|2|||
94529830|NCT00904670|323734288|FG001|Open Label Phase|Adverse Event|0|||
94529831|NCT00904670|323734287|FG000|Open Label Phase|Lack of Efficacy|1|||
94529832|NCT00904670|323734288|FG001|Open Label Phase|Lack of Efficacy|0|||
94529833|NCT00904670|323734287|FG000|Open Label Phase|Lost to Follow-up|1|||
94529834|NCT00904670|323734288|FG001|Open Label Phase|Lost to Follow-up|0|||
94529835|NCT00271856|323734289|FG000|Overall Study|Withdrawal by Subject|1|||
94529836|NCT00271856|323734290|FG001|Overall Study|Withdrawal by Subject|7|||
94529837|NCT00271856|323734289|FG000|Overall Study|Lost to Follow-up|10|||
94529838|NCT00271856|323734290|FG001|Overall Study|Lost to Follow-up|11|||
94529839|NCT02091362|323734298|FG000|Period 1|Protocol Violation|1|||
94529840|NCT02091362|323734299|FG001|Period 1|Protocol Violation|0|||
94529841|NCT02091362|323734298|FG000|Period 1|Withdrawal by Subject|2|||
94529842|NCT02091362|323734299|FG001|Period 1|Withdrawal by Subject|3|||
94529843|NCT02091362|323734298|FG000|Period 1|Lost to Follow-up|0|||
94529844|NCT02091362|323734299|FG001|Period 1|Lost to Follow-up|1|||
94529845|NCT02091362|323734298|FG000|Period 1|Adverse Event|2|||
94529846|NCT02091362|323734299|FG001|Period 1|Adverse Event|0|||
94529847|NCT02091362|323734298|FG000|Wash-out|Lost to Follow-up|1|||
94529848|NCT02091362|323734299|FG001|Wash-out|Lost to Follow-up|1|||
94529849|NCT02091362|323734298|FG000|Wash-out|Withdrawal by Subject|0|||
94529850|NCT02091362|323734299|FG001|Wash-out|Withdrawal by Subject|2|||
94529851|NCT02091362|323734298|FG000|Period 2|Adverse Event|1|||
94529852|NCT02091362|323734299|FG001|Period 2|Adverse Event|0|||
94529853|NCT02091362|323734298|FG000|Period 2|Lost to Follow-up|0|||
94529854|NCT02091362|323734299|FG001|Period 2|Lost to Follow-up|1|||
94529855|NCT02091362|323734298|FG000|Period 2|Withdrawal by Subject|1|||
94529856|NCT02091362|323734299|FG001|Period 2|Withdrawal by Subject|1|||
94529857|NCT01721486|323734310|FG000|Overall Study|Protocol Violation|1|||
94529858|NCT01721486|323734311|FG001|Overall Study|Protocol Violation|0|||
94529859|NCT01721486|323734310|FG000|Overall Study|Physician Decision|0|||
94529860|NCT01721486|323734311|FG001|Overall Study|Physician Decision|1|||
94529861|NCT03423238|323734314|FG000|Overall Study|Lost to Follow-up|1|||
94529862|NCT03423238|323734315|FG001|Overall Study|Lost to Follow-up|0|||
94529863|NCT03423238|323734314|FG000|Overall Study|Withdrawal by Subject|1|||
94529864|NCT03423238|323734315|FG001|Overall Study|Withdrawal by Subject|0|||
94529865|NCT00851552|323734316|FG000|Overall Study|Death|2|||
94529866|NCT00851552|323734316|FG000|Overall Study|Adverse Event|1|||
94529867|NCT00851552|323734316|FG000|Overall Study|Disease Progression|4|||
94529868|NCT00395486|323734320|FG000|Overall Study|Adverse Event|1|||
94529869|NCT00395486|323734321|FG001|Overall Study|Adverse Event|2|||
94529870|NCT00395486|323734320|FG000|Overall Study|Withdrawal by Subject|5|||
94529871|NCT00395486|323734321|FG001|Overall Study|Withdrawal by Subject|2|||
94529872|NCT00395486|323734320|FG000|Overall Study|Lost to Follow-up|0|||
94529873|NCT00395486|323734321|FG001|Overall Study|Lost to Follow-up|1|||
94529874|NCT04731298|323734325|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
94529875|NCT04731298|323734326|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
94529876|NCT02455336|323734327|FG000|Overall Study|Withdrawal by Subject|0|||
94529877|NCT02455336|323734328|FG001|Overall Study|Withdrawal by Subject|2|||
94529878|NCT02455336|323734327|FG000|Overall Study|Adverse Event|3|||
94529879|NCT02455336|323734328|FG001|Overall Study|Adverse Event|0|||
94529880|NCT02455336|323734327|FG000|Overall Study|Non-responder to treatment|2|||
94529881|NCT02455336|323734328|FG001|Overall Study|Non-responder to treatment|0|||
94529882|NCT01262560|323734338|FG000|Overall Study|Protocol Violation|0|||
94529883|NCT01262560|323734339|FG001|Overall Study|Protocol Violation|1|||
94529884|NCT01262560|323734340|FG002|Overall Study|Protocol Violation|2|||
94529885|NCT03213938|323734341|FG000|Overall Study|Lost to Follow-up|4|||
94529886|NCT03213938|323734342|FG001|Overall Study|Lost to Follow-up|3|||
94529887|NCT03213938|323734341|FG000|Overall Study|Lack of Efficacy|1|||
94529888|NCT03213938|323734342|FG001|Overall Study|Lack of Efficacy|0|||
94529889|NCT03213938|323734341|FG000|Overall Study|Decline to participate|5|||
94529890|NCT03213938|323734342|FG001|Overall Study|Decline to participate|4|||
94529891|NCT03213938|323734341|FG000|Overall Study|Without reason|4|||
94529892|NCT03213938|323734342|FG001|Overall Study|Without reason|5|||
94529893|NCT04238481|323734344|FG000|Overall Study|Miscellaneous|0|||
94529894|NCT04238481|323734345|FG001|Overall Study|Miscellaneous|1|||
94529895|NCT04238481|323734346|FG002|Overall Study|Miscellaneous|0|||
94529896|NCT04238481|323734347|FG003|Overall Study|Miscellaneous|0|||
94529897|NCT01932372|323734348|FG000|Overall Study|Not meeting eligibility criteria|33|||
94529898|NCT01932372|323734349|FG001|Overall Study|Not meeting eligibility criteria|179|||
94529899|NCT03594747|323734352|FG000|Overall Study|Death|78|||
94529900|NCT03594747|323734353|FG001|Overall Study|Death|86|||
94529901|NCT03594747|323734354|FG002|Overall Study|Death|87|||
94529902|NCT03594747|323734352|FG000|Overall Study|Withdrawal by Subject|5|||
94529903|NCT03594747|323734353|FG001|Overall Study|Withdrawal by Subject|2|||
94529904|NCT03594747|323734354|FG002|Overall Study|Withdrawal by Subject|11|||
94529905|NCT03594747|323734352|FG000|Overall Study|Lost to Follow-up|4|||
94529906|NCT03594747|323734353|FG001|Overall Study|Lost to Follow-up|1|||
94529907|NCT03594747|323734354|FG002|Overall Study|Lost to Follow-up|1|||
94529908|NCT03594747|323734352|FG000|Overall Study|Physician Decision|0|||
94529909|NCT03594747|323734353|FG001|Overall Study|Physician Decision|1|||
94529910|NCT03594747|323734354|FG002|Overall Study|Physician Decision|0|||
94529911|NCT03594747|323734352|FG000|Overall Study|Sponsor decision|23|||
94529912|NCT03594747|323734353|FG001|Overall Study|Sponsor decision|17|||
94529913|NCT03594747|323734354|FG002|Overall Study|Sponsor decision|16|||
94529914|NCT03594747|323734352|FG000|Overall Study|Did not meet inclusion criteria|0|||
94529915|NCT03594747|323734353|FG001|Overall Study|Did not meet inclusion criteria|0|||
94529916|NCT03594747|323734354|FG002|Overall Study|Did not meet inclusion criteria|1|||
94529917|NCT03594747|323734352|FG000|Overall Study|Transfer to long term extension study|10|||
94529918|NCT03594747|323734353|FG001|Overall Study|Transfer to long term extension study|12|||
94529919|NCT03594747|323734354|FG002|Overall Study|Transfer to long term extension study|5|||
94529920|NCT03028415|323734355|FG000|Overall Study|Lost to Follow-up|6|||
94529921|NCT03028415|323734356|FG001|Overall Study|Lost to Follow-up|3|||
94529922|NCT03028415|323734355|FG000|Overall Study|Withdrawal by Subject|1|||
94529923|NCT03028415|323734356|FG001|Overall Study|Withdrawal by Subject|0|||
94529924|NCT03028415|323734355|FG000|Overall Study|Discontinued due to COVID-19|1|||
94529925|NCT03028415|323734356|FG001|Overall Study|Discontinued due to COVID-19|0|||
94529926|NCT02907216|323734357|FG000|Overall Study|No benefit to be obtained by continuing|0|||
94529927|NCT02907216|323734358|FG001|Overall Study|No benefit to be obtained by continuing|1|||
94529928|NCT02907216|323734357|FG000|Overall Study|Withdrawal by Subject|1|||
94529929|NCT02907216|323734358|FG001|Overall Study|Withdrawal by Subject|0|||
94529930|NCT02597452|323734359|FG000|Overall Study|testing incomplete|30|||
94529931|NCT01905943|323736434|FG000|Overall Study|Withdrawal of consent|90|||
94529932|NCT01905943|323736434|FG000|Overall Study|Lost to Follow-up|16|||
94529933|NCT01905943|323736434|FG000|Overall Study|Investigator discretion|7|||
94529934|NCT01905943|323736434|FG000|Overall Study|Death|186|||
94529935|NCT01905943|323736434|FG000|Overall Study|Adverse Event|3|||
94529936|NCT01905943|323736434|FG000|Overall Study|Other|12|||
94529937|NCT03370419|323736435|FG000|Overall Study|Lost to Follow-up|16|||
94529938|NCT02222688|323736436|FG000|Overall Study|Withdrawal by Subject|0|||
94529939|NCT02222688|323736437|FG001|Overall Study|Withdrawal by Subject|0|||
94529940|NCT02222688|323736438|FG002|Overall Study|Withdrawal by Subject|0|||
94529941|NCT02222688|323736439|FG003|Overall Study|Withdrawal by Subject|2|||
94529942|NCT02222688|323736440|FG004|Overall Study|Withdrawal by Subject|1|||
94529943|NCT02222688|323736441|FG005|Overall Study|Withdrawal by Subject|0|||
94529944|NCT02222688|323736442|FG006|Overall Study|Withdrawal by Subject|1|||
94529945|NCT02222688|323736436|FG000|Overall Study|Disease progression|1|||
94529946|NCT02222688|323736437|FG001|Overall Study|Disease progression|0|||
94529947|NCT02222688|323736438|FG002|Overall Study|Disease progression|0|||
94529948|NCT02222688|323736439|FG003|Overall Study|Disease progression|0|||
94529949|NCT02222688|323736440|FG004|Overall Study|Disease progression|0|||
94529950|NCT02222688|323736441|FG005|Overall Study|Disease progression|0|||
94529951|NCT02222688|323736442|FG006|Overall Study|Disease progression|0|||
94529952|NCT01558115|323736451|FG000|Overall Study|Withdrawal by Subject|3|||
94529953|NCT01558115|323736451|FG000|Overall Study|Study closed due to poor enrollment|4|||
94529954|NCT01436656|323736452|FG000|Dose Escalation|Death|1|||
94529955|NCT01436656|323736453|FG001|Dose Escalation|Death|3|||
94529956|NCT01436656|323736454|FG002|Dose Escalation|Death|1|||
94529957|NCT01436656|323736455|FG003|Dose Escalation|Death|0|||
94529958|NCT01436656|323736456|FG004|Dose Escalation|Death|2|||
94529959|NCT01436656|323736457|FG005|Dose Escalation|Death|1|||
94529960|NCT01436656|323736458|FG006|Dose Escalation|Death|1|||
94529961|NCT01436656|323736459|FG007|Dose Escalation|Death|1|||
94529962|NCT01436656|323736460|FG008|Dose Escalation|Death|1|||
94529963|NCT01436656|323736461|FG009|Dose Escalation|Death|0|||
94529964|NCT01436656|323736462|FG010|Dose Escalation|Death|0|||
94529965|NCT01436656|323736463|FG011|Dose Escalation|Death|0|||
94529966|NCT01436656|323736464|FG012|Dose Escalation|Death|0|||
94529967|NCT01436656|323736465|FG013|Dose Escalation|Death|0|||
94529968|NCT01436656|323736466|FG014|Dose Escalation|Death|0|||
94529969|NCT01436656|323736467|FG015|Dose Escalation|Death|0|||
94529970|NCT01436656|323736468|FG016|Dose Escalation|Death|0|||
94529971|NCT01436656|323736469|FG017|Dose Escalation|Death|0|||
94529972|NCT01436656|323736452|FG000|Dose Escalation|Protocol Violation|0|||
94529973|NCT01436656|323736453|FG001|Dose Escalation|Protocol Violation|0|||
94529974|NCT01436656|323736454|FG002|Dose Escalation|Protocol Violation|0|||
94529975|NCT01436656|323736455|FG003|Dose Escalation|Protocol Violation|0|||
94529976|NCT01436656|323736456|FG004|Dose Escalation|Protocol Violation|0|||
94529977|NCT01436656|323736457|FG005|Dose Escalation|Protocol Violation|1|||
94529978|NCT01436656|323736458|FG006|Dose Escalation|Protocol Violation|0|||
94529979|NCT01436656|323736459|FG007|Dose Escalation|Protocol Violation|0|||
94529980|NCT01436656|323736460|FG008|Dose Escalation|Protocol Violation|0|||
94529981|NCT01436656|323736461|FG009|Dose Escalation|Protocol Violation|0|||
94529982|NCT01436656|323736462|FG010|Dose Escalation|Protocol Violation|0|||
94529983|NCT01436656|323736463|FG011|Dose Escalation|Protocol Violation|0|||
94529984|NCT01436656|323736464|FG012|Dose Escalation|Protocol Violation|0|||
94529985|NCT01436656|323736465|FG013|Dose Escalation|Protocol Violation|0|||
94529986|NCT01436656|323736466|FG014|Dose Escalation|Protocol Violation|0|||
94529987|NCT01436656|323736467|FG015|Dose Escalation|Protocol Violation|0|||
94529988|NCT01436656|323736468|FG016|Dose Escalation|Protocol Violation|0|||
94529989|NCT01436656|323736469|FG017|Dose Escalation|Protocol Violation|0|||
94529990|NCT01436656|323736452|FG000|Dose Escalation|Withdrawal by Subject|0|||
94529991|NCT01436656|323736453|FG001|Dose Escalation|Withdrawal by Subject|0|||
94529992|NCT01436656|323736454|FG002|Dose Escalation|Withdrawal by Subject|0|||
94529993|NCT01436656|323736455|FG003|Dose Escalation|Withdrawal by Subject|0|||
94529994|NCT01436656|323736456|FG004|Dose Escalation|Withdrawal by Subject|1|||
94529995|NCT01436656|323736457|FG005|Dose Escalation|Withdrawal by Subject|0|||
94529996|NCT01436656|323736458|FG006|Dose Escalation|Withdrawal by Subject|0|||
94529997|NCT01436656|323736459|FG007|Dose Escalation|Withdrawal by Subject|2|||
94529998|NCT01436656|323736460|FG008|Dose Escalation|Withdrawal by Subject|0|||
94529999|NCT01436656|323736461|FG009|Dose Escalation|Withdrawal by Subject|1|||
94530000|NCT01436656|323736462|FG010|Dose Escalation|Withdrawal by Subject|1|||
94530001|NCT01436656|323736463|FG011|Dose Escalation|Withdrawal by Subject|0|||
94530002|NCT01436656|323736464|FG012|Dose Escalation|Withdrawal by Subject|0|||
94530003|NCT01436656|323736465|FG013|Dose Escalation|Withdrawal by Subject|0|||
94530004|NCT01436656|323736466|FG014|Dose Escalation|Withdrawal by Subject|0|||
94530005|NCT01436656|323736467|FG015|Dose Escalation|Withdrawal by Subject|0|||
94530006|NCT01436656|323736468|FG016|Dose Escalation|Withdrawal by Subject|0|||
94530007|NCT01436656|323736469|FG017|Dose Escalation|Withdrawal by Subject|0|||
94530008|NCT01436656|323736452|FG000|Dose Escalation|Administrative problems|0|||
94530009|NCT01436656|323736453|FG001|Dose Escalation|Administrative problems|1|||
94530010|NCT01436656|323736454|FG002|Dose Escalation|Administrative problems|0|||
94530011|NCT01436656|323736455|FG003|Dose Escalation|Administrative problems|0|||
94530012|NCT01436656|323736456|FG004|Dose Escalation|Administrative problems|0|||
94530013|NCT01436656|323736457|FG005|Dose Escalation|Administrative problems|0|||
94530014|NCT01436656|323736458|FG006|Dose Escalation|Administrative problems|0|||
94530015|NCT01436656|323736459|FG007|Dose Escalation|Administrative problems|0|||
94530016|NCT01436656|323736460|FG008|Dose Escalation|Administrative problems|0|||
94530017|NCT01436656|323736461|FG009|Dose Escalation|Administrative problems|0|||
94530018|NCT01436656|323736462|FG010|Dose Escalation|Administrative problems|0|||
94530019|NCT01436656|323736463|FG011|Dose Escalation|Administrative problems|0|||
94530020|NCT01436656|323736464|FG012|Dose Escalation|Administrative problems|0|||
94530021|NCT01436656|323736465|FG013|Dose Escalation|Administrative problems|0|||
94530022|NCT01436656|323736466|FG014|Dose Escalation|Administrative problems|0|||
94530023|NCT01436656|323736467|FG015|Dose Escalation|Administrative problems|0|||
94530024|NCT01436656|323736468|FG016|Dose Escalation|Administrative problems|0|||
94530025|NCT01436656|323736469|FG017|Dose Escalation|Administrative problems|0|||
94530026|NCT01436656|323736452|FG000|Dose Escalation|Lost to Follow-up|1|||
94530027|NCT01436656|323736453|FG001|Dose Escalation|Lost to Follow-up|0|||
94530028|NCT01436656|323736454|FG002|Dose Escalation|Lost to Follow-up|0|||
94530029|NCT01436656|323736455|FG003|Dose Escalation|Lost to Follow-up|0|||
94530030|NCT01436656|323736456|FG004|Dose Escalation|Lost to Follow-up|1|||
94530031|NCT01436656|323736457|FG005|Dose Escalation|Lost to Follow-up|0|||
94530032|NCT01436656|323736458|FG006|Dose Escalation|Lost to Follow-up|0|||
94530033|NCT01436656|323736459|FG007|Dose Escalation|Lost to Follow-up|0|||
94530034|NCT01436656|323736460|FG008|Dose Escalation|Lost to Follow-up|0|||
94530035|NCT01436656|323736461|FG009|Dose Escalation|Lost to Follow-up|0|||
94530036|NCT01436656|323736462|FG010|Dose Escalation|Lost to Follow-up|0|||
94530037|NCT01436656|323736463|FG011|Dose Escalation|Lost to Follow-up|0|||
94530038|NCT01436656|323736464|FG012|Dose Escalation|Lost to Follow-up|0|||
94530039|NCT01436656|323736465|FG013|Dose Escalation|Lost to Follow-up|0|||
94530040|NCT01436656|323736466|FG014|Dose Escalation|Lost to Follow-up|0|||
94530041|NCT01436656|323736467|FG015|Dose Escalation|Lost to Follow-up|0|||
94530042|NCT01436656|323736468|FG016|Dose Escalation|Lost to Follow-up|0|||
94530043|NCT01436656|323736469|FG017|Dose Escalation|Lost to Follow-up|0|||
94530044|NCT01436656|323736452|FG000|Dose Escalation|New anti-cancer therapy|1|||
94530045|NCT01436656|323736453|FG001|Dose Escalation|New anti-cancer therapy|0|||
94530046|NCT01436656|323736454|FG002|Dose Escalation|New anti-cancer therapy|0|||
94530047|NCT01436656|323736455|FG003|Dose Escalation|New anti-cancer therapy|0|||
94530048|NCT01436656|323736456|FG004|Dose Escalation|New anti-cancer therapy|0|||
94530049|NCT01436656|323736457|FG005|Dose Escalation|New anti-cancer therapy|0|||
94530050|NCT01436656|323736458|FG006|Dose Escalation|New anti-cancer therapy|0|||
94530051|NCT01436656|323736459|FG007|Dose Escalation|New anti-cancer therapy|0|||
94530052|NCT01436656|323736460|FG008|Dose Escalation|New anti-cancer therapy|1|||
94530053|NCT01436656|323736461|FG009|Dose Escalation|New anti-cancer therapy|1|||
94530054|NCT01436656|323736462|FG010|Dose Escalation|New anti-cancer therapy|0|||
94530055|NCT01436656|323736463|FG011|Dose Escalation|New anti-cancer therapy|0|||
94530056|NCT01436656|323736464|FG012|Dose Escalation|New anti-cancer therapy|0|||
94530057|NCT01436656|323736465|FG013|Dose Escalation|New anti-cancer therapy|0|||
94530058|NCT01436656|323736466|FG014|Dose Escalation|New anti-cancer therapy|0|||
94530059|NCT01436656|323736467|FG015|Dose Escalation|New anti-cancer therapy|0|||
94530060|NCT01436656|323736468|FG016|Dose Escalation|New anti-cancer therapy|0|||
94530061|NCT01436656|323736469|FG017|Dose Escalation|New anti-cancer therapy|0|||
94530062|NCT01436656|323736452|FG000|Dose Expansion|Adverse Event|0|||
94530063|NCT01436656|323736453|FG001|Dose Expansion|Adverse Event|0|||
94530064|NCT01436656|323736454|FG002|Dose Expansion|Adverse Event|0|||
94530065|NCT01436656|323736455|FG003|Dose Expansion|Adverse Event|0|||
94530066|NCT01436656|323736456|FG004|Dose Expansion|Adverse Event|0|||
94530067|NCT01436656|323736457|FG005|Dose Expansion|Adverse Event|0|||
94530068|NCT01436656|323736458|FG006|Dose Expansion|Adverse Event|0|||
94530069|NCT01436656|323736459|FG007|Dose Expansion|Adverse Event|0|||
94530070|NCT01436656|323736460|FG008|Dose Expansion|Adverse Event|0|||
94530071|NCT01436656|323736461|FG009|Dose Expansion|Adverse Event|0|||
94530072|NCT01436656|323736462|FG010|Dose Expansion|Adverse Event|0|||
94530073|NCT01436656|323736463|FG011|Dose Expansion|Adverse Event|1|||
94530074|NCT01436656|323736464|FG012|Dose Expansion|Adverse Event|0|||
94530075|NCT01436656|323736465|FG013|Dose Expansion|Adverse Event|0|||
94530076|NCT01436656|323736466|FG014|Dose Expansion|Adverse Event|0|||
94530077|NCT01436656|323736467|FG015|Dose Expansion|Adverse Event|0|||
94530078|NCT01436656|323736468|FG016|Dose Expansion|Adverse Event|0|||
94530079|NCT01436656|323736469|FG017|Dose Expansion|Adverse Event|0|||
94530080|NCT01436656|323736452|FG000|Dose Expansion|Withdrawal by Subject|0|||
94530081|NCT01436656|323736453|FG001|Dose Expansion|Withdrawal by Subject|0|||
94530082|NCT01436656|323736454|FG002|Dose Expansion|Withdrawal by Subject|0|||
94530083|NCT01436656|323736455|FG003|Dose Expansion|Withdrawal by Subject|0|||
94530084|NCT01436656|323736456|FG004|Dose Expansion|Withdrawal by Subject|0|||
94530085|NCT01436656|323736457|FG005|Dose Expansion|Withdrawal by Subject|0|||
94530086|NCT01436656|323736458|FG006|Dose Expansion|Withdrawal by Subject|0|||
94530087|NCT01436656|323736459|FG007|Dose Expansion|Withdrawal by Subject|0|||
94530088|NCT01436656|323736460|FG008|Dose Expansion|Withdrawal by Subject|0|||
94530089|NCT01436656|323736461|FG009|Dose Expansion|Withdrawal by Subject|0|||
94530090|NCT01436656|323736462|FG010|Dose Expansion|Withdrawal by Subject|0|||
94530091|NCT01436656|323736463|FG011|Dose Expansion|Withdrawal by Subject|1|||
94530092|NCT01436656|323736464|FG012|Dose Expansion|Withdrawal by Subject|3|||
94530093|NCT01436656|323736465|FG013|Dose Expansion|Withdrawal by Subject|1|||
94530094|NCT01436656|323736466|FG014|Dose Expansion|Withdrawal by Subject|2|||
94530095|NCT01436656|323736467|FG015|Dose Expansion|Withdrawal by Subject|0|||
94530096|NCT01436656|323736468|FG016|Dose Expansion|Withdrawal by Subject|1|||
94530097|NCT01436656|323736469|FG017|Dose Expansion|Withdrawal by Subject|1|||
94530098|NCT01436656|323736452|FG000|Dose Expansion|Death|0|||
94530099|NCT01436656|323736453|FG001|Dose Expansion|Death|0|||
94530100|NCT01436656|323736454|FG002|Dose Expansion|Death|0|||
94530101|NCT01436656|323736455|FG003|Dose Expansion|Death|0|||
94530102|NCT01436656|323736456|FG004|Dose Expansion|Death|0|||
94530103|NCT01436656|323736457|FG005|Dose Expansion|Death|0|||
94530104|NCT01436656|323736458|FG006|Dose Expansion|Death|0|||
94530105|NCT01436656|323736459|FG007|Dose Expansion|Death|0|||
94530106|NCT01436656|323736460|FG008|Dose Expansion|Death|0|||
94530107|NCT01436656|323736461|FG009|Dose Expansion|Death|0|||
94530108|NCT01436656|323736462|FG010|Dose Expansion|Death|0|||
94530109|NCT01436656|323736463|FG011|Dose Expansion|Death|0|||
94530110|NCT01436656|323736464|FG012|Dose Expansion|Death|1|||
94530111|NCT01436656|323736465|FG013|Dose Expansion|Death|0|||
94530112|NCT01436656|323736466|FG014|Dose Expansion|Death|3|||
94530113|NCT01436656|323736467|FG015|Dose Expansion|Death|0|||
94530114|NCT01436656|323736468|FG016|Dose Expansion|Death|3|||
94530115|NCT01436656|323736469|FG017|Dose Expansion|Death|3|||
94530116|NCT01436656|323736452|FG000|Dose Expansion|Lost to Follow-up|0|||
94530117|NCT01436656|323736453|FG001|Dose Expansion|Lost to Follow-up|0|||
94530118|NCT01436656|323736454|FG002|Dose Expansion|Lost to Follow-up|0|||
94530119|NCT01436656|323736455|FG003|Dose Expansion|Lost to Follow-up|0|||
94530120|NCT01436656|323736456|FG004|Dose Expansion|Lost to Follow-up|0|||
94530121|NCT01436656|323736457|FG005|Dose Expansion|Lost to Follow-up|0|||
94530122|NCT01436656|323736458|FG006|Dose Expansion|Lost to Follow-up|0|||
94530123|NCT01436656|323736459|FG007|Dose Expansion|Lost to Follow-up|0|||
94530124|NCT01436656|323736460|FG008|Dose Expansion|Lost to Follow-up|0|||
94530125|NCT01436656|323736461|FG009|Dose Expansion|Lost to Follow-up|0|||
94530126|NCT01436656|323736462|FG010|Dose Expansion|Lost to Follow-up|0|||
94530127|NCT01436656|323736463|FG011|Dose Expansion|Lost to Follow-up|0|||
94530128|NCT01436656|323736464|FG012|Dose Expansion|Lost to Follow-up|0|||
94530129|NCT01436656|323736465|FG013|Dose Expansion|Lost to Follow-up|0|||
94530130|NCT01436656|323736466|FG014|Dose Expansion|Lost to Follow-up|0|||
94530131|NCT01436656|323736467|FG015|Dose Expansion|Lost to Follow-up|0|||
94530132|NCT01436656|323736468|FG016|Dose Expansion|Lost to Follow-up|0|||
94530133|NCT01436656|323736469|FG017|Dose Expansion|Lost to Follow-up|3|||
94530134|NCT01436656|323736452|FG000|Dose Expansion|Disease progression|0|||
94530135|NCT01436656|323736453|FG001|Dose Expansion|Disease progression|0|||
94530136|NCT01436656|323736454|FG002|Dose Expansion|Disease progression|0|||
94530137|NCT01436656|323736455|FG003|Dose Expansion|Disease progression|0|||
94530138|NCT01436656|323736456|FG004|Dose Expansion|Disease progression|0|||
94530139|NCT01436656|323736457|FG005|Dose Expansion|Disease progression|0|||
94530140|NCT01436656|323736458|FG006|Dose Expansion|Disease progression|0|||
94530141|NCT01436656|323736459|FG007|Dose Expansion|Disease progression|0|||
94530142|NCT01436656|323736460|FG008|Dose Expansion|Disease progression|0|||
94530143|NCT01436656|323736461|FG009|Dose Expansion|Disease progression|0|||
94530144|NCT01436656|323736462|FG010|Dose Expansion|Disease progression|0|||
94530145|NCT01436656|323736463|FG011|Dose Expansion|Disease progression|3|||
94530146|NCT01436656|323736464|FG012|Dose Expansion|Disease progression|1|||
94530147|NCT01436656|323736465|FG013|Dose Expansion|Disease progression|0|||
94530148|NCT01436656|323736466|FG014|Dose Expansion|Disease progression|1|||
94530149|NCT01436656|323736467|FG015|Dose Expansion|Disease progression|0|||
94530150|NCT01436656|323736468|FG016|Dose Expansion|Disease progression|0|||
94530151|NCT01436656|323736469|FG017|Dose Expansion|Disease progression|1|||
94530152|NCT01436656|323736452|FG000|Dose Expansion|New cancer therapy|0|||
94530153|NCT01436656|323736453|FG001|Dose Expansion|New cancer therapy|0|||
94530154|NCT01436656|323736454|FG002|Dose Expansion|New cancer therapy|0|||
94530155|NCT01436656|323736455|FG003|Dose Expansion|New cancer therapy|0|||
94530156|NCT01436656|323736456|FG004|Dose Expansion|New cancer therapy|0|||
94530157|NCT01436656|323736457|FG005|Dose Expansion|New cancer therapy|0|||
94530158|NCT01436656|323736458|FG006|Dose Expansion|New cancer therapy|0|||
94530159|NCT01436656|323736459|FG007|Dose Expansion|New cancer therapy|0|||
94530160|NCT01436656|323736460|FG008|Dose Expansion|New cancer therapy|0|||
94530161|NCT01436656|323736461|FG009|Dose Expansion|New cancer therapy|0|||
94530162|NCT01436656|323736462|FG010|Dose Expansion|New cancer therapy|0|||
94530163|NCT01436656|323736463|FG011|Dose Expansion|New cancer therapy|1|||
94530164|NCT01436656|323736464|FG012|Dose Expansion|New cancer therapy|1|||
94530165|NCT01436656|323736465|FG013|Dose Expansion|New cancer therapy|0|||
94530166|NCT01436656|323736466|FG014|Dose Expansion|New cancer therapy|2|||
94530167|NCT01436656|323736467|FG015|Dose Expansion|New cancer therapy|0|||
94530168|NCT01436656|323736468|FG016|Dose Expansion|New cancer therapy|0|||
94530169|NCT01436656|323736469|FG017|Dose Expansion|New cancer therapy|0|||
94530170|NCT04644276|323736471|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
94530171|NCT04644276|323736472|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
94530172|NCT04644276|323736473|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
94530173|NCT01498692|323736474|FG000|Overall Study|Death|4|||
94530174|NCT01498692|323736474|FG000|Overall Study|Withdrawal by Subject|1|||
94530175|NCT01498692|323736474|FG000|Overall Study|Missed 12-month visit|3|||
94530176|NCT00473668|323736475|FG000|Overall Study|Withdrawal by Subject|0|||
94530177|NCT00473668|323736476|FG001|Overall Study|Withdrawal by Subject|2|||
94530178|NCT00473668|323736477|FG002|Overall Study|Withdrawal by Subject|0|||
94530179|NCT00473668|323736475|FG000|Overall Study|Migrated/moved from study area|3|||
94530180|NCT00473668|323736476|FG001|Overall Study|Migrated/moved from study area|2|||
94530181|NCT00473668|323736477|FG002|Overall Study|Migrated/moved from study area|0|||
94530182|NCT00473668|323736475|FG000|Overall Study|Lost to Follow-up|0|||
94530183|NCT00473668|323736476|FG001|Overall Study|Lost to Follow-up|4|||
94530184|NCT00473668|323736477|FG002|Overall Study|Lost to Follow-up|6|||
94530185|NCT00473668|323736475|FG000|Overall Study|Other|2|||
94530186|NCT00473668|323736476|FG001|Overall Study|Other|3|||
94530187|NCT00473668|323736477|FG002|Overall Study|Other|4|||
94530188|NCT00194077|323736479|FG000|Overall Study|Lack of Efficacy|22|||
94530189|NCT00194077|323736480|FG001|Overall Study|Lack of Efficacy|29|||
94530190|NCT00194077|323736479|FG000|Overall Study|Study nonadherence|1|||
94530191|NCT00194077|323736480|FG001|Overall Study|Study nonadherence|0|||
94530192|NCT00194077|323736479|FG000|Overall Study|Withdrawal by Subject|1|||
94530193|NCT00194077|323736480|FG001|Overall Study|Withdrawal by Subject|1|||
94530194|NCT03286543|323736481|FG000|Consented|Screen failure before randomization|2|||
94530195|NCT03286543|323736482|FG001|Consented|Screen failure before randomization|0|||
94530196|NCT03286543|323736483|FG002|Consented|Screen failure before randomization|0|||
94530197|NCT03286543|323736481|FG000|Consented|Screen failure before enrollment|4|||
94530198|NCT03286543|323736482|FG001|Consented|Screen failure before enrollment|0|||
94530199|NCT03286543|323736483|FG002|Consented|Screen failure before enrollment|0|||
94530200|NCT03286543|323736481|FG000|Consented|TKA cancelled after enrollment|1|||
94530201|NCT03286543|323736482|FG001|Consented|TKA cancelled after enrollment|0|||
94530202|NCT03286543|323736483|FG002|Consented|TKA cancelled after enrollment|0|||
94530203|NCT03286543|323736481|FG000|Consented|Withdrawn from study|12|||
94530204|NCT03286543|323736482|FG001|Consented|Withdrawn from study|0|||
94530205|NCT03286543|323736483|FG002|Consented|Withdrawn from study|0|||
94530206|NCT03286543|323736481|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
94530207|NCT03286543|323736482|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
94530208|NCT03286543|323736483|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
94530209|NCT03286543|323736481|FG000|Study Enrollment|Withdrawn from study|0|||
94530210|NCT03286543|323736482|FG001|Study Enrollment|Withdrawn from study|6|||
94530211|NCT03286543|323736483|FG002|Study Enrollment|Withdrawn from study|6|||
94530212|NCT05332392|323736484|FG000|Overall Study|Did not meet inclusion criteria|25|||
94530213|NCT05332392|323736484|FG000|Overall Study|Principal Investigator's decision|17|||
94530214|NCT05332392|323736484|FG000|Overall Study|Adverse Event|1|||
94530215|NCT05332392|323736484|FG000|Overall Study|Subject's decision|1|||
94530216|NCT01268046|323736485|FG000|Overall Study|Withdrawal by Subject|1|||
94530217|NCT01268046|323736486|FG001|Overall Study|Withdrawal by Subject|0|||
94530218|NCT01268046|323736487|FG002|Overall Study|Withdrawal by Subject|0|||
94530219|NCT01268046|323736488|FG003|Overall Study|Withdrawal by Subject|1|||
94530220|NCT01268046|323736485|FG000|Overall Study|Lost to Follow-up|0|||
94530221|NCT01268046|323736486|FG001|Overall Study|Lost to Follow-up|0|||
94530222|NCT01268046|323736487|FG002|Overall Study|Lost to Follow-up|1|||
94530223|NCT01268046|323736488|FG003|Overall Study|Lost to Follow-up|0|||
94530224|NCT02253433|323736490|FG000|Overall Study|Unable to Contact|9|||
94530225|NCT02253433|323736491|FG001|Overall Study|Unable to Contact|16|||
94530226|NCT02253433|323736490|FG000|Overall Study|Death|1|||
94530227|NCT02253433|323736491|FG001|Overall Study|Death|1|||
94530228|NCT02253433|323736490|FG000|Overall Study|No Longer Interested|3|||
94530229|NCT02253433|323736491|FG001|Overall Study|No Longer Interested|15|||
94530230|NCT02253433|323736490|FG000|Overall Study|Out of Study Area|2|||
94530231|NCT02253433|323736491|FG001|Overall Study|Out of Study Area|7|||
94530232|NCT02253433|323736490|FG000|Overall Study|Uncomfortable with home visitors|0|||
94530233|NCT02253433|323736491|FG001|Overall Study|Uncomfortable with home visitors|3|||
94530234|NCT02253433|323736490|FG000|Overall Study|Unstable Housing/Homeless|0|||
94530235|NCT02253433|323736491|FG001|Overall Study|Unstable Housing/Homeless|7|||
94530236|NCT02253433|323736490|FG000|Overall Study|Too Busy|0|||
94530237|NCT02253433|323736491|FG001|Overall Study|Too Busy|4|||
94530238|NCT02253433|323736490|FG000|Overall Study|Medical or Other Concerns|1|||
94530239|NCT02253433|323736491|FG001|Overall Study|Medical or Other Concerns|2|||
94530240|NCT00438360|323736492|FG000|Overall Study|Adverse Event|6|||
94530241|NCT00438360|323736493|FG001|Overall Study|Adverse Event|1|||
94530242|NCT00438360|323736492|FG000|Overall Study|Lack of Efficacy|42|||
94530243|NCT00438360|323736493|FG001|Overall Study|Lack of Efficacy|27|||
94530244|NCT00438360|323736492|FG000|Overall Study|Other|24|||
94530245|NCT00438360|323736493|FG001|Overall Study|Other|15|||
94530246|NCT01309997|323736494|FG000|Overall Study|Adverse Event|1|||
94530247|NCT01309997|323736495|FG001|Overall Study|Adverse Event|0|||
94530248|NCT01309997|323736494|FG000|Overall Study|Death|1|||
94530249|NCT01309997|323736495|FG001|Overall Study|Death|3|||
94530250|NCT01309997|323736494|FG000|Overall Study|Lack of Efficacy|2|||
94530251|NCT01309997|323736495|FG001|Overall Study|Lack of Efficacy|2|||
94530252|NCT01309997|323736494|FG000|Overall Study|Withdrawal by Subject|1|||
94530253|NCT01309997|323736495|FG001|Overall Study|Withdrawal by Subject|1|||
94530254|NCT00282087|323736496|FG000|Overall Study|Death|1|||
94530255|NCT00758069|323736497|FG000|Overall Study|Lack of Efficacy|0|||
94530256|NCT00758069|323736498|FG001|Overall Study|Lack of Efficacy|0|||
94530257|NCT00758069|323736499|FG002|Overall Study|Lack of Efficacy|1|||
94530258|NCT00758069|323736497|FG000|Overall Study|Incorrect Study Drug|1|||
94530259|NCT00758069|323736498|FG001|Overall Study|Incorrect Study Drug|0|||
94530260|NCT00758069|323736499|FG002|Overall Study|Incorrect Study Drug|0|||
94530261|NCT02752633|323736500|FG000|Overall Study|Withdrawal by Subject|1|||
94530262|NCT04560816|323736501|FG000|Overall Study|Withdrawal by Subject|1|||
94530263|NCT04560816|323736502|FG001|Overall Study|Withdrawal by Subject|1|||
94530264|NCT04560816|323736503|FG002|Overall Study|Withdrawal by Subject|1|||
94530265|NCT04560816|323736504|FG003|Overall Study|Withdrawal by Subject|0|||
94530266|NCT04560816|323736505|FG004|Overall Study|Withdrawal by Subject|3|||
94530267|NCT04560816|323736506|FG005|Overall Study|Withdrawal by Subject|0|||
94530268|NCT04560816|323736501|FG000|Overall Study|Lost to Follow-up|1|||
94530269|NCT04560816|323736502|FG001|Overall Study|Lost to Follow-up|0|||
94530270|NCT04560816|323736503|FG002|Overall Study|Lost to Follow-up|0|||
94530271|NCT04560816|323736504|FG003|Overall Study|Lost to Follow-up|0|||
94530272|NCT04560816|323736505|FG004|Overall Study|Lost to Follow-up|0|||
94530273|NCT04560816|323736506|FG005|Overall Study|Lost to Follow-up|0|||
94530274|NCT04560816|323736501|FG000|Overall Study|Protocol Violation|1|||
94530275|NCT04560816|323736502|FG001|Overall Study|Protocol Violation|0|||
94530276|NCT04560816|323736503|FG002|Overall Study|Protocol Violation|0|||
94530277|NCT04560816|323736504|FG003|Overall Study|Protocol Violation|0|||
94530278|NCT04560816|323736505|FG004|Overall Study|Protocol Violation|0|||
94530279|NCT04560816|323736506|FG005|Overall Study|Protocol Violation|0|||
94530280|NCT02277691|323736509|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
94530281|NCT02277691|323736509|FG000|Overall Study|Voluntary Withdrawal|7|||
94530282|NCT02277691|323736509|FG000|Overall Study|Lack of Efficacy|5|||
94530283|NCT02277691|323736509|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
94530284|NCT01450696|323736512|FG000|Overall Study|Never Treated|1|||
94530285|NCT01450696|323736513|FG001|Overall Study|Never Treated|1|||
94530286|NCT01450696|323736512|FG000|Overall Study|Death|77|||
94530287|NCT01450696|323736513|FG001|Overall Study|Death|84|||
94530288|NCT01450696|323736512|FG000|Overall Study|Lost to Follow-up|3|||
94530289|NCT01450696|323736513|FG001|Overall Study|Lost to Follow-up|3|||
94530290|NCT01450696|323736512|FG000|Overall Study|Non-Compliance|1|||
94530291|NCT01450696|323736513|FG001|Overall Study|Non-Compliance|0|||
94530292|NCT01450696|323736512|FG000|Overall Study|Withdrawal by Subject|13|||
94530293|NCT01450696|323736513|FG001|Overall Study|Withdrawal by Subject|2|||
94530294|NCT01450696|323736512|FG000|Overall Study|Study Terminated by Sponsor|53|||
94530295|NCT01450696|323736513|FG001|Overall Study|Study Terminated by Sponsor|58|||
94530296|NCT00610857|323736527|FG000|Overall Study|Not evaluable for response|2|||
94530297|NCT00842153|323736530|FG000|Overall Study|Adverse Event|0|||
94530298|NCT00842153|323736531|FG001|Overall Study|Adverse Event|1|||
94530299|NCT00842153|323736530|FG000|Overall Study|Lost to Follow-up|1|||
94530300|NCT00842153|323736531|FG001|Overall Study|Lost to Follow-up|2|||
94530301|NCT05420961|323736532|FG000|Overall Study|Withdrawal by Subject|2|||
94530302|NCT05420961|323736533|FG001|Overall Study|Withdrawal by Subject|1|||
94530303|NCT05420961|323736534|FG002|Overall Study|Withdrawal by Subject|1|||
94530304|NCT05420961|323736535|FG003|Overall Study|Withdrawal by Subject|0|||
94530305|NCT05420961|323736536|FG004|Overall Study|Withdrawal by Subject|0|||
94530306|NCT05420961|323736532|FG000|Overall Study|Lost to Follow-up|0|||
94530307|NCT05420961|323736533|FG001|Overall Study|Lost to Follow-up|0|||
94530308|NCT05420961|323736534|FG002|Overall Study|Lost to Follow-up|1|||
94530309|NCT05420961|323736535|FG003|Overall Study|Lost to Follow-up|0|||
94530310|NCT05420961|323736536|FG004|Overall Study|Lost to Follow-up|0|||
94530311|NCT05420961|323736532|FG000|Overall Study|Randomized by mistake without study treatment|0|||
94530312|NCT05420961|323736533|FG001|Overall Study|Randomized by mistake without study treatment|0|||
94530313|NCT05420961|323736534|FG002|Overall Study|Randomized by mistake without study treatment|1|||
94530314|NCT05420961|323736535|FG003|Overall Study|Randomized by mistake without study treatment|0|||
94530315|NCT05420961|323736536|FG004|Overall Study|Randomized by mistake without study treatment|1|||
94530316|NCT04283656|323736537|FG000|Overall Study|Adverse Event|1|||
94530317|NCT04283656|323736538|FG001|Overall Study|Adverse Event|0|||
94530318|NCT04283656|323736537|FG000|Overall Study|Lost to Follow-up|0|||
94530319|NCT04283656|323736538|FG001|Overall Study|Lost to Follow-up|1|||
94530320|NCT03629223|323736541|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
94530321|NCT03629223|323736542|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
94530322|NCT03629223|323736543|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
94530323|NCT03629223|323736544|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
94530324|NCT03629223|323736545|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
94530325|NCT03629223|323736546|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
94530326|NCT03629223|323736541|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
94530327|NCT03629223|323736542|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
94530328|NCT03629223|323736543|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
94530329|NCT03629223|323736544|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
94530330|NCT03629223|323736545|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
94530331|NCT03629223|323736546|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
94530332|NCT03629223|323736541|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
94530333|NCT03629223|323736542|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
94530334|NCT03629223|323736543|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
94530335|NCT03629223|323736544|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
94530336|NCT03629223|323736545|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
94530337|NCT03629223|323736546|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
94530338|NCT03629223|323736541|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
94530339|NCT03629223|323736542|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
94530340|NCT03629223|323736543|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
94530341|NCT03629223|323736544|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
94530342|NCT03629223|323736545|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
94530343|NCT03629223|323736546|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
94530344|NCT03629223|323736541|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
94530345|NCT03629223|323736542|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
94530346|NCT03629223|323736543|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
94530347|NCT03629223|323736544|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
94530348|NCT03629223|323736545|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
94530349|NCT03629223|323736546|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
94530350|NCT01864148|323736547|FG000|Overall Study|Other|2|||
94530351|NCT01864148|323736548|FG001|Overall Study|Other|1|||
94530352|NCT01864148|323736549|FG002|Overall Study|Other|1|||
94530353|NCT01864148|323736550|FG003|Overall Study|Other|3|||
94530354|NCT01864148|323736551|FG004|Overall Study|Other|1|||
94530355|NCT01864148|323736547|FG000|Overall Study|Death|0|||
94530356|NCT01864148|323736548|FG001|Overall Study|Death|0|||
94530357|NCT01864148|323736549|FG002|Overall Study|Death|0|||
94530358|NCT01864148|323736550|FG003|Overall Study|Death|1|||
94530359|NCT01864148|323736551|FG004|Overall Study|Death|0|||
94530360|NCT01864148|323736547|FG000|Overall Study|Investigator Decision|5|||
94530361|NCT01864148|323736548|FG001|Overall Study|Investigator Decision|0|||
94530362|NCT01864148|323736549|FG002|Overall Study|Investigator Decision|0|||
94530363|NCT01864148|323736550|FG003|Overall Study|Investigator Decision|4|||
94530364|NCT01864148|323736551|FG004|Overall Study|Investigator Decision|6|||
94530365|NCT01864148|323736547|FG000|Overall Study|Withdrawal by Subject|9|||
94530366|NCT01864148|323736548|FG001|Overall Study|Withdrawal by Subject|2|||
94530367|NCT01864148|323736549|FG002|Overall Study|Withdrawal by Subject|6|||
94530368|NCT01864148|323736550|FG003|Overall Study|Withdrawal by Subject|8|||
94530369|NCT01864148|323736551|FG004|Overall Study|Withdrawal by Subject|8|||
94530370|NCT01864148|323736547|FG000|Overall Study|Lost to Follow-up|0|||
94530371|NCT01864148|323736548|FG001|Overall Study|Lost to Follow-up|0|||
94530372|NCT01864148|323736549|FG002|Overall Study|Lost to Follow-up|0|||
94530373|NCT01864148|323736550|FG003|Overall Study|Lost to Follow-up|2|||
94530374|NCT01864148|323736551|FG004|Overall Study|Lost to Follow-up|1|||
94530375|NCT01864148|323736547|FG000|Overall Study|Adverse Event|4|||
94530376|NCT01864148|323736548|FG001|Overall Study|Adverse Event|2|||
94530377|NCT01864148|323736549|FG002|Overall Study|Adverse Event|4|||
94530378|NCT01864148|323736550|FG003|Overall Study|Adverse Event|7|||
94530379|NCT01864148|323736551|FG004|Overall Study|Adverse Event|7|||
94530380|NCT01864148|323736547|FG000|Overall Study|Not Dosed|0|||
94530381|NCT01864148|323736548|FG001|Overall Study|Not Dosed|0|||
94530382|NCT01864148|323736549|FG002|Overall Study|Not Dosed|0|||
94530383|NCT01864148|323736550|FG003|Overall Study|Not Dosed|1|||
94530384|NCT01864148|323736551|FG004|Overall Study|Not Dosed|0|||
94530385|NCT04153981|323736552|FG000|Overall Study|Death|1|||
94530386|NCT04153981|323736552|FG000|Overall Study|Withdrawal by Subject|24|||
94530387|NCT04153981|323736552|FG000|Overall Study|Lost to Follow-up|1|||
94530388|NCT04153981|323736552|FG000|Overall Study|Physician Decision|1|||
94530389|NCT04153981|323736552|FG000|Overall Study|Due to Unavailable Glucometer|1|||
94530390|NCT04153981|323736552|FG000|Overall Study|Covid 19|52|||
94530391|NCT04153981|323736552|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
94530392|NCT04153981|323736552|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
94530393|NCT01555073|323736553|FG000|Overall Study|Lost to Follow-up|1|||
94530394|NCT01555073|323736554|FG001|Overall Study|Lost to Follow-up|2|||
94530395|NCT01555073|323736555|FG002|Overall Study|Lost to Follow-up|0|||
94530396|NCT01555073|323736556|FG003|Overall Study|Lost to Follow-up|5|||
94530397|NCT01262638|323736557|FG000|Overall Study|Adverse Event|3|||
94530398|NCT01262638|323736558|FG001|Overall Study|Adverse Event|4|||
94530399|NCT01262638|323736559|FG002|Overall Study|Adverse Event|3|||
94530400|NCT01262638|323736560|FG003|Overall Study|Adverse Event|4|||
94530401|NCT01262638|323736557|FG000|Overall Study|Protocol Violation|1|||
94530402|NCT01262638|323736558|FG001|Overall Study|Protocol Violation|0|||
94530403|NCT01262638|323736559|FG002|Overall Study|Protocol Violation|0|||
94530404|NCT01262638|323736560|FG003|Overall Study|Protocol Violation|1|||
94530405|NCT01262638|323736557|FG000|Overall Study|Withdrawal by Subject|2|||
94530406|NCT01262638|323736558|FG001|Overall Study|Withdrawal by Subject|1|||
94530407|NCT01262638|323736559|FG002|Overall Study|Withdrawal by Subject|0|||
94530408|NCT01262638|323736560|FG003|Overall Study|Withdrawal by Subject|1|||
94530409|NCT01262638|323736557|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
94530410|NCT01262638|323736558|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
94530411|NCT01262638|323736559|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
94530412|NCT01262638|323736560|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
94530413|NCT01262638|323736557|FG000|Overall Study|Lost to Follow-up|1|||
94530414|NCT01262638|323736558|FG001|Overall Study|Lost to Follow-up|1|||
94530415|NCT01262638|323736559|FG002|Overall Study|Lost to Follow-up|1|||
94530416|NCT01262638|323736560|FG003|Overall Study|Lost to Follow-up|1|||
94530417|NCT01262638|323736557|FG000|Overall Study|Participant Went Out of Town|0|||
94530418|NCT01262638|323736558|FG001|Overall Study|Participant Went Out of Town|0|||
94530419|NCT01262638|323736559|FG002|Overall Study|Participant Went Out of Town|1|||
94530420|NCT01262638|323736560|FG003|Overall Study|Participant Went Out of Town|0|||
94530421|NCT01355679|323736562|FG000|Overall Study|benign tumor types found at biopsy|2|||
94530422|NCT03490292|323736563|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
94530423|NCT03490292|323736564|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
94530424|NCT03490292|323736563|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
94530425|NCT03490292|323736564|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
94530426|NCT03490292|323736563|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
94530427|NCT03490292|323736564|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
94530428|NCT03490292|323736563|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
94530429|NCT03490292|323736564|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
94530430|NCT03490292|323736563|FG000|1 Year Follow Up Post Last Dose|Death|1|||
94530431|NCT03490292|323736564|FG001|1 Year Follow Up Post Last Dose|Death|1|||
94530432|NCT00582712|323736565|FG000|Overall Study|Adverse Event|1|||
94530433|NCT00582712|323736565|FG000|Overall Study|Lack of Efficacy|1|||
94530434|NCT00582712|323736565|FG000|Overall Study|Withdrawal by Subject|1|||
94530435|NCT00582712|323736565|FG000|Overall Study|Complicating disease requiring treatment|1|||
94530436|NCT04004221|323736566|FG000|Overall Study|Death|89|||
94530437|NCT04004221|323736566|FG000|Overall Study|Withdrawal by Subject|5|||
94530438|NCT04004221|323736566|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
94530439|NCT04004221|323736566|FG000|Overall Study|Sponsor Decision|9|||
94530440|NCT04004221|323736566|FG000|Overall Study|Participant refused to enter LTE|1|||
94530441|NCT01606176|323736567|FG000|Overall Study|Adverse Event|2|||
94530442|NCT01606176|323736568|FG001|Overall Study|Adverse Event|3|||
94530443|NCT01606176|323736567|FG000|Overall Study|Disease progression|1|||
94530444|NCT01606176|323736568|FG001|Overall Study|Disease progression|0|||
94530445|NCT01606176|323736567|FG000|Overall Study|Withdrawal by Subject|1|||
94530446|NCT01606176|323736568|FG001|Overall Study|Withdrawal by Subject|0|||
94530447|NCT01076205|323736570|FG000|Overall Study|Adverse Drug Reaction|299|||
94530448|NCT01076205|323736570|FG000|Overall Study|Lack of Effectiveness|1423|||
94530449|NCT01076205|323736570|FG000|Overall Study|Other Reason|1075|||
94530450|NCT01076205|323736570|FG000|Overall Study|Unknown Reason|71|||
94530451|NCT01076205|323736570|FG000|Overall Study|Lost to Follow-up|3151|||
94530452|NCT00361231|323736571|FG000|Overall Study|Physician Decision|3|||
94530453|NCT00361231|323736571|FG000|Overall Study|Symptomatic deterioration|5|||
94530454|NCT00361231|323736571|FG000|Overall Study|Radiographic disease progression|16|||
94530455|NCT00361231|323736571|FG000|Overall Study|Withdrawal by Subject|4|||
94530456|NCT00361231|323736571|FG000|Overall Study|Adverse Event|6|||
94530457|NCT01030952|323736573|FG000|Overall Study|Protocol Violation|0|||
94530458|NCT01030952|323736574|FG001|Overall Study|Protocol Violation|1|||
94530459|NCT01030952|323736573|FG000|Overall Study|Informed consent withdrawal|1|||
94530460|NCT01030952|323736574|FG001|Overall Study|Informed consent withdrawal|0|||
94530461|NCT01030952|323736573|FG000|Overall Study|Lost to Follow-up|0|||
94530462|NCT01030952|323736574|FG001|Overall Study|Lost to Follow-up|1|||
94530463|NCT01030952|323736573|FG000|Overall Study|Unexplained|1|||
94530464|NCT01030952|323736574|FG001|Overall Study|Unexplained|1|||
94530465|NCT01814046|323736575|FG000|Drug Administration|Death due to complications of RSV|1|||
94530466|NCT01814046|323736576|FG001|Drug Administration|Death due to complications of RSV|0|||
94530467|NCT01814046|323736577|FG002|Drug Administration|Death due to complications of RSV|0|||
94530468|NCT00958347|323736578|FG000|Overall Study|Death|43|||
94530469|NCT00958347|323736578|FG000|Overall Study|Withdrawal by Subject|23|||
94530470|NCT00958347|323736578|FG000|Overall Study|Lost to Follow-up|15|||
94530471|NCT00958347|323736578|FG000|Overall Study|revision/removal|10|||
94530472|NCT00958347|323736578|FG000|Overall Study|study termination|135|||
94530473|NCT04532294|323736579|FG000|Overall Study|Withdrawal by Subject|0|||
94530474|NCT04532294|323736580|FG001|Overall Study|Withdrawal by Subject|0|||
94530475|NCT04532294|323736581|FG002|Overall Study|Withdrawal by Subject|1|||
94530476|NCT04532294|323736579|FG000|Overall Study|Participants Not Dosed|0|||
94530477|NCT04532294|323736580|FG001|Overall Study|Participants Not Dosed|0|||
94530478|NCT04532294|323736581|FG002|Overall Study|Participants Not Dosed|2|||
94530479|NCT00673231|323736582|FG000|Overall Study|Withdrawal by Subject|14|||
94530480|NCT00673231|323736583|FG001|Overall Study|Withdrawal by Subject|10|||
94530481|NCT00673231|323736584|FG002|Overall Study|Withdrawal by Subject|8|||
94530482|NCT00673231|323736585|FG003|Overall Study|Withdrawal by Subject|6|||
94530483|NCT00673231|323736582|FG000|Overall Study|Adverse Event|6|||
94530484|NCT00673231|323736583|FG001|Overall Study|Adverse Event|5|||
94530485|NCT00673231|323736584|FG002|Overall Study|Adverse Event|9|||
94530486|NCT00673231|323736585|FG003|Overall Study|Adverse Event|6|||
94530487|NCT00673231|323736582|FG000|Overall Study|Lost to Follow-up|1|||
94530488|NCT00673231|323736583|FG001|Overall Study|Lost to Follow-up|2|||
94530489|NCT00673231|323736584|FG002|Overall Study|Lost to Follow-up|1|||
94530490|NCT00673231|323736585|FG003|Overall Study|Lost to Follow-up|2|||
94530491|NCT00673231|323736582|FG000|Overall Study|Death|0|||
94530492|NCT00673231|323736583|FG001|Overall Study|Death|0|||
94530493|NCT00673231|323736584|FG002|Overall Study|Death|1|||
94530494|NCT00673231|323736585|FG003|Overall Study|Death|0|||
94530495|NCT00673231|323736582|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
94530496|NCT00673231|323736583|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
94530497|NCT00673231|323736584|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
94530498|NCT00673231|323736585|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
94530499|NCT00703846|323736591|FG000|Overall Study|Adverse Event|8|||
94530500|NCT00703846|323736591|FG000|Overall Study|Lost to Follow-up|55|||
94530501|NCT00703846|323736591|FG000|Overall Study|Lack of Efficacy|15|||
94530502|NCT00703846|323736591|FG000|Overall Study|Noncompliance with Study Treatment|2|||
94530503|NCT00703846|323736591|FG000|Overall Study|Withdrawal by Subject|40|||
94530504|NCT00703846|323736591|FG000|Overall Study|Death|1|||
94530505|NCT00703846|323736591|FG000|Overall Study|Other|14|||
94530506|NCT00703846|323736591|FG000|Overall Study|Did Not Receive Study Drug|2|||
94530507|NCT02485639|323736594|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
94530508|NCT02485639|323736594|FG000|Overall Study|Early termination|4|||
94530509|NCT02485639|323736594|FG000|Overall Study|Withdrawal by Subject|4|||
94530510|NCT03989349|323736595|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
94530511|NCT03989349|323736596|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
94530512|NCT03989349|323736597|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
94530513|NCT03989349|323736598|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
94530514|NCT03989349|323736599|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
94530515|NCT03989349|323736600|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
94530516|NCT03989349|323736595|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
94530517|NCT03989349|323736596|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
94530518|NCT03989349|323736597|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
94530519|NCT03989349|323736598|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
94530520|NCT03989349|323736599|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
94530521|NCT03989349|323736600|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
94530522|NCT03989349|323736595|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
94530523|NCT03989349|323736596|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
94530524|NCT03989349|323736597|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
94530525|NCT03989349|323736598|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
94530526|NCT03989349|323736599|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
94530527|NCT03989349|323736600|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
94530528|NCT03989349|323736595|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
94530529|NCT03989349|323736596|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
94530530|NCT03989349|323736597|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
94530531|NCT03989349|323736598|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
94530532|NCT03989349|323736599|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
94530533|NCT03989349|323736600|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
94530534|NCT03989349|323736595|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
94530535|NCT03989349|323736596|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
94530536|NCT03989349|323736597|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
94530537|NCT03989349|323736598|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
94530538|NCT03989349|323736599|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
94530539|NCT03989349|323736600|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
94530540|NCT03989349|323736595|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
94530541|NCT03989349|323736596|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
94530542|NCT03989349|323736597|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
94530543|NCT03989349|323736598|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
94530544|NCT03989349|323736599|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
94530545|NCT03989349|323736600|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
94530546|NCT03989349|323736595|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
94530547|NCT03989349|323736596|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
94530548|NCT03989349|323736597|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
94530549|NCT03989349|323736598|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
94530550|NCT03989349|323736599|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
94530551|NCT03989349|323736600|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
94530552|NCT03989349|323736595|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
94530553|NCT03989349|323736596|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
94530554|NCT03989349|323736597|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
94530555|NCT03989349|323736598|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
94530556|NCT03989349|323736599|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
94530557|NCT03989349|323736600|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
94530558|NCT03989349|323736595|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
94530559|NCT03989349|323736596|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
94530560|NCT03989349|323736597|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
94530561|NCT03989349|323736598|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
94530562|NCT03989349|323736599|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
94530563|NCT03989349|323736600|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
94530564|NCT03989349|323736595|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
94530565|NCT03989349|323736596|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
94530566|NCT03989349|323736597|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
94530567|NCT03989349|323736598|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
94530568|NCT03989349|323736599|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
94530569|NCT03989349|323736600|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
94530570|NCT03989349|323736595|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
94530571|NCT03989349|323736596|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
94530572|NCT03989349|323736597|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
94530573|NCT03989349|323736598|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
94530574|NCT03989349|323736599|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
94530575|NCT03989349|323736600|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
94530576|NCT03989349|323736595|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
94530577|NCT03989349|323736596|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
94530578|NCT03989349|323736597|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
94530579|NCT03989349|323736598|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
94530580|NCT03989349|323736599|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
94530581|NCT03989349|323736600|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
94530582|NCT03989349|323736595|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
94530583|NCT03989349|323736596|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
94530584|NCT03989349|323736597|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
94530585|NCT03989349|323736598|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
94530586|NCT03989349|323736599|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
94530587|NCT03989349|323736600|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
94530588|NCT03989349|323736595|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
94530589|NCT03989349|323736596|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
94530590|NCT03989349|323736597|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
94530591|NCT03989349|323736598|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
94530592|NCT03989349|323736599|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
94530593|NCT03989349|323736600|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
94530594|NCT02016716|323736605|FG000|Overall Study|Withdrawal by Subject|5|||
94530595|NCT02016716|323736606|FG001|Overall Study|Withdrawal by Subject|5|||
94530596|NCT02016716|323736607|FG002|Overall Study|Withdrawal by Subject|5|||
94530597|NCT02016716|323736605|FG000|Overall Study|Protocol-specified Criteria|0|||
94530598|NCT02016716|323736606|FG001|Overall Study|Protocol-specified Criteria|1|||
94530599|NCT02016716|323736607|FG002|Overall Study|Protocol-specified Criteria|0|||
94530600|NCT02016716|323736605|FG000|Overall Study|Lost to Follow-up|1|||
94530601|NCT02016716|323736606|FG001|Overall Study|Lost to Follow-up|2|||
94530602|NCT02016716|323736607|FG002|Overall Study|Lost to Follow-up|1|||
94530603|NCT00079391|323736608|FG000|Overall Study|Withdrawal by Subject|1|||
94530604|NCT00281099|323736611|FG000|Overall Study|Death|46|||
94530605|NCT00281099|323736612|FG001|Overall Study|Death|57|||
94530606|NCT00281099|323736611|FG000|Overall Study|Lost to Follow-up|10|||
94530607|NCT00281099|323736612|FG001|Overall Study|Lost to Follow-up|19|||
94530608|NCT00281099|323736611|FG000|Overall Study|Withdrawal by Subject|65|||
94530609|NCT00281099|323736612|FG001|Overall Study|Withdrawal by Subject|70|||
94530610|NCT00281099|323736611|FG000|Overall Study|Physician Decision|79|||
94530611|NCT00281099|323736612|FG001|Overall Study|Physician Decision|72|||
94530612|NCT00281099|323736611|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
94530613|NCT00281099|323736612|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
94530614|NCT01221623|323736618|FG000|Overall Study|Withdrawal by Subject|19|||
94530615|NCT01221623|323736619|FG001|Overall Study|Withdrawal by Subject|8|||
94530616|NCT01221623|323736618|FG000|Overall Study|Lost to Follow-up|7|||
94530617|NCT01221623|323736619|FG001|Overall Study|Lost to Follow-up|1|||
94530618|NCT01221623|323736618|FG000|Overall Study|Adverse Event|6|||
94530619|NCT01221623|323736619|FG001|Overall Study|Adverse Event|3|||
94530620|NCT01221623|323736618|FG000|Overall Study|Death|1|||
94530621|NCT01221623|323736619|FG001|Overall Study|Death|0|||
94530622|NCT01221623|323736618|FG000|Overall Study|Other|5|||
94530623|NCT01221623|323736619|FG001|Overall Study|Other|2|||
94530624|NCT03108521|323736620|FG000|Overall Study|Lost to Follow-up|3|||
94530625|NCT03108521|323736621|FG001|Overall Study|Lost to Follow-up|0|||
94530626|NCT03108521|323736620|FG000|Overall Study|Lack of Efficacy|2|||
94530627|NCT03108521|323736621|FG001|Overall Study|Lack of Efficacy|0|||
94530628|NCT03108521|323736620|FG000|Overall Study|Physician Decision|4|||
94530629|NCT03108521|323736621|FG001|Overall Study|Physician Decision|0|||
94530630|NCT03108521|323736620|FG000|Overall Study|Adverse Event|3|||
94530631|NCT03108521|323736621|FG001|Overall Study|Adverse Event|0|||
94530632|NCT01673854|323736622|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
94530633|NCT01673854|323736622|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
94530634|NCT01673854|323736622|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
94530635|NCT01673854|323736622|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
94530636|NCT01673854|323736622|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
94530637|NCT01673854|323736622|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
94530638|NCT01673854|323736622|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
94530639|NCT01673854|323736622|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
94530640|NCT01673854|323736622|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
94530641|NCT01673854|323736622|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
94530642|NCT01673854|323736622|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
94530643|NCT01673854|323736622|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
94530644|NCT00583752|323736623|FG000|Overall Study|Lost to Follow-up|5|||
94530645|NCT00583752|323736624|FG001|Overall Study|Lost to Follow-up|5|||
94530646|NCT02316353|323736625|FG000|Overall Study|Pregnancy|1|||
94530647|NCT02316353|323736626|FG001|Overall Study|Pregnancy|3|||
94530648|NCT02316353|323736625|FG000|Overall Study|Adverse Event|1|||
94530649|NCT02316353|323736626|FG001|Overall Study|Adverse Event|3|||
94530650|NCT02316353|323736625|FG000|Overall Study|Withdrawal by Subject|6|||
94530651|NCT02316353|323736626|FG001|Overall Study|Withdrawal by Subject|2|||
94530652|NCT03559517|323736630|FG000|Overall Study|Withdrawal by Subject|1|||
94530653|NCT03559517|323736631|FG001|Overall Study|Withdrawal by Subject|0|||
94530654|NCT03559517|323736632|FG002|Overall Study|Withdrawal by Subject|0|||
94530655|NCT02644096|323736633|FG000|Overall Study|Withdrawal by Subject|28|||
94530656|NCT02644096|323736634|FG001|Overall Study|Withdrawal by Subject|25|||
94530657|NCT02147197|323736635|FG000|Overall Study|Adverse Event|1|||
94530658|NCT02147197|323736636|FG001|Overall Study|Adverse Event|0|||
94530659|NCT02147197|323736637|FG002|Overall Study|Adverse Event|0|||
94530660|NCT02147197|323736635|FG000|Overall Study|Withdrawal of Consent|4|||
94530661|NCT02147197|323736636|FG001|Overall Study|Withdrawal of Consent|3|||
94530662|NCT02147197|323736637|FG002|Overall Study|Withdrawal of Consent|2|||
94530663|NCT02147197|323736635|FG000|Overall Study|Lost to Follow-up|2|||
94530664|NCT02147197|323736636|FG001|Overall Study|Lost to Follow-up|3|||
94530665|NCT02147197|323736637|FG002|Overall Study|Lost to Follow-up|1|||
94530666|NCT02147197|323736635|FG000|Overall Study|Protocol Violation|1|||
94530667|NCT02147197|323736636|FG001|Overall Study|Protocol Violation|0|||
94530668|NCT02147197|323736637|FG002|Overall Study|Protocol Violation|3|||
94530669|NCT02147197|323736635|FG000|Overall Study|Other Miscellaneous Reasons|1|||
94530670|NCT02147197|323736636|FG001|Overall Study|Other Miscellaneous Reasons|0|||
94530671|NCT02147197|323736637|FG002|Overall Study|Other Miscellaneous Reasons|3|||
94530672|NCT01700959|323736638|FG000|Overall Study|Adverse Event|0|||
94530673|NCT01700959|323736639|FG001|Overall Study|Adverse Event|1|||
94530674|NCT01700959|323736640|FG002|Overall Study|Adverse Event|1|||
94530675|NCT01700959|323736641|FG003|Overall Study|Adverse Event|2|||
94530676|NCT01700959|323736642|FG004|Overall Study|Adverse Event|0|||
94530677|NCT01700959|323736643|FG005|Overall Study|Adverse Event|2|||
94530678|NCT01700959|323736638|FG000|Overall Study|Withdrawal by Subject|15|||
94530679|NCT01700959|323736639|FG001|Overall Study|Withdrawal by Subject|9|||
94530680|NCT01700959|323736640|FG002|Overall Study|Withdrawal by Subject|12|||
94530681|NCT01700959|323736641|FG003|Overall Study|Withdrawal by Subject|11|||
94530682|NCT01700959|323736642|FG004|Overall Study|Withdrawal by Subject|8|||
94530683|NCT01700959|323736643|FG005|Overall Study|Withdrawal by Subject|12|||
94530684|NCT01700959|323736638|FG000|Overall Study|Ineligible|2|||
94530685|NCT01700959|323736639|FG001|Overall Study|Ineligible|1|||
94530686|NCT01700959|323736640|FG002|Overall Study|Ineligible|2|||
94530687|NCT01700959|323736641|FG003|Overall Study|Ineligible|0|||
94530688|NCT01700959|323736642|FG004|Overall Study|Ineligible|0|||
94530689|NCT01700959|323736643|FG005|Overall Study|Ineligible|1|||
94530690|NCT01700959|323736638|FG000|Overall Study|Noncompliant|9|||
94530691|NCT01700959|323736639|FG001|Overall Study|Noncompliant|9|||
94530692|NCT01700959|323736640|FG002|Overall Study|Noncompliant|17|||
94530693|NCT01700959|323736641|FG003|Overall Study|Noncompliant|18|||
94530694|NCT01700959|323736642|FG004|Overall Study|Noncompliant|15|||
94530695|NCT01700959|323736643|FG005|Overall Study|Noncompliant|9|||
94530696|NCT01700959|323736638|FG000|Overall Study|Side effects|1|||
94530697|NCT01700959|323736639|FG001|Overall Study|Side effects|4|||
94530698|NCT01700959|323736640|FG002|Overall Study|Side effects|8|||
94530699|NCT01700959|323736641|FG003|Overall Study|Side effects|4|||
94530700|NCT01700959|323736642|FG004|Overall Study|Side effects|4|||
94530701|NCT01700959|323736643|FG005|Overall Study|Side effects|1|||
94530702|NCT02712983|323738951|FG000|Treatment Phase|Adverse Event|3|||
94530703|NCT02712983|323738952|FG001|Treatment Phase|Adverse Event|1|||
94530704|NCT02712983|323738953|FG002|Treatment Phase|Adverse Event|1|||
94530705|NCT02712983|323738954|FG003|Treatment Phase|Adverse Event|4|||
94530706|NCT02712983|323738955|FG004|Treatment Phase|Adverse Event|3|||
94530707|NCT02712983|323738956|FG005|Treatment Phase|Adverse Event|0|||
94530708|NCT02712983|323738957|FG006|Treatment Phase|Adverse Event|6|||
94530709|NCT02712983|323738958|FG007|Treatment Phase|Adverse Event|6|||
94530710|NCT02712983|323738959|FG008|Treatment Phase|Adverse Event|1|||
94530711|NCT02712983|323738951|FG000|Treatment Phase|Protocol Deviation|0|||
94530712|NCT02712983|323738952|FG001|Treatment Phase|Protocol Deviation|0|||
94530713|NCT02712983|323738953|FG002|Treatment Phase|Protocol Deviation|0|||
94530714|NCT02712983|323738954|FG003|Treatment Phase|Protocol Deviation|2|||
94530715|NCT02712983|323738955|FG004|Treatment Phase|Protocol Deviation|0|||
94530716|NCT02712983|323738956|FG005|Treatment Phase|Protocol Deviation|0|||
94530717|NCT02712983|323738957|FG006|Treatment Phase|Protocol Deviation|1|||
94530718|NCT02712983|323738958|FG007|Treatment Phase|Protocol Deviation|0|||
94530719|NCT02712983|323738959|FG008|Treatment Phase|Protocol Deviation|0|||
94530720|NCT02712983|323738951|FG000|Treatment Phase|Technical Problems|0|||
94530721|NCT02712983|323738952|FG001|Treatment Phase|Technical Problems|0|||
94530722|NCT02712983|323738953|FG002|Treatment Phase|Technical Problems|0|||
94530723|NCT02712983|323738954|FG003|Treatment Phase|Technical Problems|0|||
94530724|NCT02712983|323738955|FG004|Treatment Phase|Technical Problems|0|||
94530725|NCT02712983|323738956|FG005|Treatment Phase|Technical Problems|0|||
94530726|NCT02712983|323738957|FG006|Treatment Phase|Technical Problems|1|||
94530727|NCT02712983|323738958|FG007|Treatment Phase|Technical Problems|0|||
94530728|NCT02712983|323738959|FG008|Treatment Phase|Technical Problems|0|||
94530729|NCT02712983|323738951|FG000|Treatment Phase|Physician Decision|0|||
94530730|NCT02712983|323738952|FG001|Treatment Phase|Physician Decision|0|||
94530731|NCT02712983|323738953|FG002|Treatment Phase|Physician Decision|0|||
94530732|NCT02712983|323738954|FG003|Treatment Phase|Physician Decision|0|||
94530733|NCT02712983|323738955|FG004|Treatment Phase|Physician Decision|0|||
94530734|NCT02712983|323738956|FG005|Treatment Phase|Physician Decision|0|||
94530735|NCT02712983|323738957|FG006|Treatment Phase|Physician Decision|0|||
94530736|NCT02712983|323738958|FG007|Treatment Phase|Physician Decision|1|||
94530737|NCT02712983|323738959|FG008|Treatment Phase|Physician Decision|1|||
94530738|NCT02712983|323738951|FG000|Treatment Phase|Subject Decision|2|||
94530739|NCT02712983|323738952|FG001|Treatment Phase|Subject Decision|0|||
94530740|NCT02712983|323738953|FG002|Treatment Phase|Subject Decision|0|||
94530741|NCT02712983|323738954|FG003|Treatment Phase|Subject Decision|2|||
94530742|NCT02712983|323738955|FG004|Treatment Phase|Subject Decision|1|||
94530743|NCT02712983|323738956|FG005|Treatment Phase|Subject Decision|0|||
94530744|NCT02712983|323738957|FG006|Treatment Phase|Subject Decision|1|||
94530745|NCT02712983|323738958|FG007|Treatment Phase|Subject Decision|2|||
94530746|NCT02712983|323738959|FG008|Treatment Phase|Subject Decision|0|||
94530747|NCT02712983|323738951|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
94530748|NCT02712983|323738952|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
94530749|NCT02712983|323738953|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
94530750|NCT02712983|323738954|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
94530751|NCT02712983|323738955|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
94530752|NCT02712983|323738956|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
94530753|NCT02712983|323738957|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
94530754|NCT02712983|323738958|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
94530755|NCT02712983|323738959|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
94530756|NCT02712983|323738951|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
94530757|NCT02712983|323738952|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
94530758|NCT02712983|323738953|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
94530759|NCT02712983|323738954|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
94530760|NCT02712983|323738955|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
94530761|NCT02712983|323738956|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
94530762|NCT02712983|323738957|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
94530763|NCT02712983|323738958|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
94530764|NCT02712983|323738959|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
94530765|NCT02712983|323738951|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
94530766|NCT02712983|323738952|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
94530767|NCT02712983|323738953|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
94530768|NCT02712983|323738954|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
94530769|NCT02712983|323738955|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
94530770|NCT02712983|323738956|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
94530771|NCT02712983|323738957|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
94530772|NCT02712983|323738958|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
94530773|NCT02712983|323738959|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
94530774|NCT00283803|323738960|FG000|Overall Study|Physician Decision|9|||
94530775|NCT00283803|323738960|FG000|Overall Study|Withdrawal by Subject|4|||
94530776|NCT01127607|323738961|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
94530777|NCT01127607|323738962|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
94530778|NCT01127607|323738961|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
94530779|NCT01127607|323738962|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
94530780|NCT02220855|323738963|FG000|Overall Study|Adverse Event|8|||
94530781|NCT02220855|323738963|FG000|Overall Study|Disease Progression|5|||
94530782|NCT02220855|323738963|FG000|Overall Study|Withdrawal by Subject|1|||
94530783|NCT03280303|323738964|FG000|Overall Study|Death|505|||
94530784|NCT03280303|323738964|FG000|Overall Study|Study terminated by sponsor|383|||
94530785|NCT03280303|323738964|FG000|Overall Study|Other|148|||
94530786|NCT03280303|323738964|FG000|Overall Study|No longer willing to participate in study|101|||
94530787|NCT03280303|323738964|FG000|Overall Study|Lost to follow up|39|||
94530788|NCT03280303|323738964|FG000|Overall Study|Adverse Event|20|||
94530789|NCT00064259|323738965|FG000|Overall Study|Adverse Event|1|||
94530790|NCT00064259|323738966|FG001|Overall Study|Adverse Event|0|||
94530791|NCT00064259|323738967|FG002|Overall Study|Adverse Event|0|||
94530792|NCT00064259|323738968|FG003|Overall Study|Adverse Event|1|||
94530793|NCT01132651|323738969|FG000|Overall Study|Lost to Follow-up|1|||
94530794|NCT01132651|323738970|FG001|Overall Study|Lost to Follow-up|1|||
94530795|NCT00948857|323738971|FG000|Overall Study|Lost to Follow-up|1|||
94530796|NCT00948857|323738972|FG001|Overall Study|Lost to Follow-up|0|||
94530797|NCT03430843|323738973|FG000|Overall Study|Death|233|||
94530798|NCT03430843|323738974|FG001|Overall Study|Death|233|||
94530799|NCT03430843|323738973|FG000|Overall Study|Sponsor Decision|17|||
94530800|NCT03430843|323738974|FG001|Overall Study|Sponsor Decision|6|||
94530801|NCT03430843|323738973|FG000|Overall Study|Withdrawal by Subject|5|||
94530802|NCT03430843|323738974|FG001|Overall Study|Withdrawal by Subject|14|||
94530803|NCT03430843|323738973|FG000|Overall Study|Lost to Follow-up|1|||
94530804|NCT03430843|323738974|FG001|Overall Study|Lost to Follow-up|3|||
94530805|NCT00956007|323738977|FG000|Overall Study|Protocol Violation|27|||
94530806|NCT00956007|323738978|FG001|Overall Study|Protocol Violation|23|||
94530807|NCT02547038|323738980|FG000|Overall Study|Lost to Follow-up|3|||
94530808|NCT02547038|323738981|FG001|Overall Study|Lost to Follow-up|2|||
94530809|NCT05935878|323738982|FG000|Overall Study|Death|1|||
94530810|NCT05935878|323738983|FG001|Overall Study|Death|2|||
94530811|NCT05935878|323738982|FG000|Overall Study|Withdrawal by Subject|5|||
94530812|NCT05935878|323738983|FG001|Overall Study|Withdrawal by Subject|5|||
94530813|NCT05935878|323738982|FG000|Overall Study|Revision of implant|1|||
94530814|NCT05935878|323738983|FG001|Overall Study|Revision of implant|1|||
94530815|NCT05935878|323738982|FG000|Overall Study|Mobile bearing dislocation|0|||
94530816|NCT05935878|323738983|FG001|Overall Study|Mobile bearing dislocation|1|||
94530817|NCT05924165|323738984|FG000|Overall Study|Physician Decision|2|||
94530818|NCT05924165|323738985|FG001|Overall Study|Physician Decision|3|||
94530819|NCT04308239|323738986|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
94530820|NCT04308239|323738987|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
94530821|NCT04308239|323738986|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
94530822|NCT04308239|323738987|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
94530823|NCT04308239|323738986|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
94530824|NCT04308239|323738987|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
94530825|NCT04308239|323738986|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
94530826|NCT04308239|323738987|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
94530827|NCT00880269|323738991|FG000|Overall Study|Protocol Violation|1|||
94530828|NCT00880269|323738992|FG001|Overall Study|Protocol Violation|0|||
94530829|NCT00880269|323738991|FG000|Overall Study|Disease Progression|13|||
94530830|NCT00880269|323738992|FG001|Overall Study|Disease Progression|11|||
94530831|NCT00880269|323738991|FG000|Overall Study|New Cancer Therapy|1|||
94530832|NCT00880269|323738992|FG001|Overall Study|New Cancer Therapy|0|||
94530833|NCT00880269|323738991|FG000|Overall Study|Death|4|||
94530834|NCT00880269|323738992|FG001|Overall Study|Death|2|||
94530835|NCT00880269|323738991|FG000|Overall Study|Lost to Follow-up|0|||
94530836|NCT00880269|323738992|FG001|Overall Study|Lost to Follow-up|1|||
94530837|NCT00880269|323738991|FG000|Overall Study|Withdrawal by Subject|3|||
94530838|NCT00880269|323738992|FG001|Overall Study|Withdrawal by Subject|4|||
94530839|NCT00880269|323738991|FG000|Overall Study|Adverse Event|10|||
94530840|NCT00880269|323738992|FG001|Overall Study|Adverse Event|9|||
94530841|NCT00576628|323738993|FG000|Overall Study|Adverse Event|11|||
94530842|NCT00576628|323738993|FG000|Overall Study|Death|2|||
94530843|NCT00576628|323738993|FG000|Overall Study|Failure to return|1|||
94530844|NCT00576628|323738993|FG000|Overall Study|Refused Treatment|8|||
94530845|NCT00576628|323738993|FG000|Overall Study|Pregnancy|1|||
94530846|NCT00576628|323738993|FG000|Overall Study|RBC transfusion|1|||
94530847|NCT00576628|323738993|FG000|Overall Study|Progression of Kidney Disease|1|||
94530848|NCT00576628|323738993|FG000|Overall Study|Progression of Renal Failure|1|||
94530849|NCT00576628|323738993|FG000|Overall Study|The patient move into other town|1|||
94530850|NCT00576628|323738993|FG000|Overall Study|Transplantation|1|||
94530851|NCT00576628|323738993|FG000|Overall Study|Dialysis|15|||
94530852|NCT00654745|323739003|FG000|Overall Study|Adverse Event|12|||
94530853|NCT00654745|323739003|FG000|Overall Study|Lost to Follow-up|7|||
94530854|NCT00654745|323739003|FG000|Overall Study|Protocol Violation|11|||
94530855|NCT00654745|323739003|FG000|Overall Study|Withdrawal by Subject|10|||
94530856|NCT00654745|323739003|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
94530857|NCT02321319|323739004|FG000|Overall Study|Product discontinued|5|||
94530858|NCT01296711|323739005|FG000|Overall Study|Adverse Event|3|||
94530859|NCT01296711|323739006|FG001|Overall Study|Adverse Event|1|||
94530860|NCT01296711|323739007|FG002|Overall Study|Adverse Event|4|||
94530861|NCT01296711|323739008|FG003|Overall Study|Adverse Event|3|||
94530862|NCT01296711|323739009|FG004|Overall Study|Adverse Event|1|||
94530863|NCT01296711|323739010|FG005|Overall Study|Adverse Event|6|||
94530864|NCT01296711|323739011|FG006|Overall Study|Adverse Event|11|||
94530865|NCT01296711|323739012|FG007|Overall Study|Adverse Event|3|||
94530866|NCT01296711|323739005|FG000|Overall Study|Lack of Efficacy|1|||
94530867|NCT01296711|323739006|FG001|Overall Study|Lack of Efficacy|4|||
94530868|NCT01296711|323739007|FG002|Overall Study|Lack of Efficacy|1|||
94530869|NCT01296711|323739008|FG003|Overall Study|Lack of Efficacy|1|||
94530870|NCT01296711|323739009|FG004|Overall Study|Lack of Efficacy|1|||
94530871|NCT01296711|323739010|FG005|Overall Study|Lack of Efficacy|0|||
94530872|NCT01296711|323739011|FG006|Overall Study|Lack of Efficacy|2|||
94530873|NCT01296711|323739012|FG007|Overall Study|Lack of Efficacy|3|||
94530874|NCT01296711|323739005|FG000|Overall Study|Lost to Follow-up|0|||
94530875|NCT01296711|323739006|FG001|Overall Study|Lost to Follow-up|0|||
94530876|NCT01296711|323739007|FG002|Overall Study|Lost to Follow-up|1|||
94530877|NCT01296711|323739008|FG003|Overall Study|Lost to Follow-up|1|||
94530878|NCT01296711|323739009|FG004|Overall Study|Lost to Follow-up|2|||
94530879|NCT01296711|323739010|FG005|Overall Study|Lost to Follow-up|0|||
94530880|NCT01296711|323739011|FG006|Overall Study|Lost to Follow-up|4|||
94530881|NCT01296711|323739012|FG007|Overall Study|Lost to Follow-up|2|||
94530882|NCT01296711|323739005|FG000|Overall Study|Protocol Violation|0|||
94530883|NCT01296711|323739006|FG001|Overall Study|Protocol Violation|0|||
94530884|NCT01296711|323739007|FG002|Overall Study|Protocol Violation|0|||
94530885|NCT01296711|323739008|FG003|Overall Study|Protocol Violation|1|||
94530886|NCT01296711|323739009|FG004|Overall Study|Protocol Violation|1|||
94530887|NCT01296711|323739010|FG005|Overall Study|Protocol Violation|0|||
94530888|NCT01296711|323739011|FG006|Overall Study|Protocol Violation|0|||
94530889|NCT01296711|323739012|FG007|Overall Study|Protocol Violation|0|||
94530890|NCT01296711|323739005|FG000|Overall Study|Withdrawal by Subject|4|||
94530891|NCT01296711|323739006|FG001|Overall Study|Withdrawal by Subject|2|||
94530892|NCT01296711|323739007|FG002|Overall Study|Withdrawal by Subject|2|||
94530893|NCT01296711|323739008|FG003|Overall Study|Withdrawal by Subject|1|||
94530894|NCT01296711|323739009|FG004|Overall Study|Withdrawal by Subject|1|||
94530895|NCT01296711|323739010|FG005|Overall Study|Withdrawal by Subject|1|||
94530896|NCT01296711|323739011|FG006|Overall Study|Withdrawal by Subject|2|||
94530897|NCT01296711|323739012|FG007|Overall Study|Withdrawal by Subject|1|||
94530898|NCT01296711|323739005|FG000|Overall Study|Study termination|8|||
94530899|NCT01296711|323739006|FG001|Overall Study|Study termination|1|||
94530900|NCT01296711|323739007|FG002|Overall Study|Study termination|5|||
94530901|NCT01296711|323739008|FG003|Overall Study|Study termination|4|||
94530902|NCT01296711|323739009|FG004|Overall Study|Study termination|4|||
94530903|NCT01296711|323739010|FG005|Overall Study|Study termination|4|||
94530904|NCT01296711|323739011|FG006|Overall Study|Study termination|8|||
94530905|NCT01296711|323739012|FG007|Overall Study|Study termination|10|||
94530906|NCT01296711|323739005|FG000|Overall Study|Continued elevated liver enzymes|0|||
94530907|NCT01296711|323739006|FG001|Overall Study|Continued elevated liver enzymes|0|||
94530908|NCT01296711|323739007|FG002|Overall Study|Continued elevated liver enzymes|0|||
94530909|NCT01296711|323739008|FG003|Overall Study|Continued elevated liver enzymes|1|||
94530910|NCT01296711|323739009|FG004|Overall Study|Continued elevated liver enzymes|0|||
94530911|NCT01296711|323739010|FG005|Overall Study|Continued elevated liver enzymes|0|||
94530912|NCT01296711|323739011|FG006|Overall Study|Continued elevated liver enzymes|0|||
94530913|NCT01296711|323739012|FG007|Overall Study|Continued elevated liver enzymes|0|||
94530914|NCT01296711|323739005|FG000|Overall Study|Methotrexate discontinued|0|||
94530915|NCT01296711|323739006|FG001|Overall Study|Methotrexate discontinued|0|||
94530916|NCT01296711|323739007|FG002|Overall Study|Methotrexate discontinued|0|||
94530917|NCT01296711|323739008|FG003|Overall Study|Methotrexate discontinued|1|||
94530918|NCT01296711|323739009|FG004|Overall Study|Methotrexate discontinued|0|||
94530919|NCT01296711|323739010|FG005|Overall Study|Methotrexate discontinued|0|||
94530920|NCT01296711|323739011|FG006|Overall Study|Methotrexate discontinued|0|||
94530921|NCT01296711|323739012|FG007|Overall Study|Methotrexate discontinued|0|||
94530922|NCT01296711|323739005|FG000|Overall Study|Investigator discretion|0|||
94530923|NCT01296711|323739006|FG001|Overall Study|Investigator discretion|0|||
94530924|NCT01296711|323739007|FG002|Overall Study|Investigator discretion|0|||
94530925|NCT01296711|323739008|FG003|Overall Study|Investigator discretion|0|||
94530926|NCT01296711|323739009|FG004|Overall Study|Investigator discretion|0|||
94530927|NCT01296711|323739010|FG005|Overall Study|Investigator discretion|0|||
94530928|NCT01296711|323739011|FG006|Overall Study|Investigator discretion|1|||
94530929|NCT01296711|323739012|FG007|Overall Study|Investigator discretion|0|||
94530930|NCT01296711|323739005|FG000|Overall Study|Other|0|||
94530931|NCT01296711|323739006|FG001|Overall Study|Other|0|||
94530932|NCT01296711|323739007|FG002|Overall Study|Other|0|||
94530933|NCT01296711|323739008|FG003|Overall Study|Other|0|||
94530934|NCT01296711|323739009|FG004|Overall Study|Other|0|||
94530935|NCT01296711|323739010|FG005|Overall Study|Other|0|||
94530936|NCT01296711|323739011|FG006|Overall Study|Other|1|||
94530937|NCT01296711|323739012|FG007|Overall Study|Other|0|||
94530938|NCT01296711|323739005|FG000|Overall Study|Required restricted steroid injections|0|||
94530939|NCT01296711|323739006|FG001|Overall Study|Required restricted steroid injections|0|||
94530940|NCT01296711|323739007|FG002|Overall Study|Required restricted steroid injections|0|||
94530941|NCT01296711|323739008|FG003|Overall Study|Required restricted steroid injections|0|||
94530942|NCT01296711|323739009|FG004|Overall Study|Required restricted steroid injections|0|||
94530943|NCT01296711|323739010|FG005|Overall Study|Required restricted steroid injections|0|||
94530944|NCT01296711|323739011|FG006|Overall Study|Required restricted steroid injections|1|||
94530945|NCT01296711|323739012|FG007|Overall Study|Required restricted steroid injections|0|||
94530946|NCT01296711|323739005|FG000|Overall Study|Ongoing missed appointments|0|||
94530947|NCT01296711|323739006|FG001|Overall Study|Ongoing missed appointments|0|||
94530948|NCT01296711|323739007|FG002|Overall Study|Ongoing missed appointments|0|||
94530949|NCT01296711|323739008|FG003|Overall Study|Ongoing missed appointments|0|||
94530950|NCT01296711|323739009|FG004|Overall Study|Ongoing missed appointments|0|||
94530951|NCT01296711|323739010|FG005|Overall Study|Ongoing missed appointments|0|||
94530952|NCT01296711|323739011|FG006|Overall Study|Ongoing missed appointments|1|||
94530953|NCT01296711|323739012|FG007|Overall Study|Ongoing missed appointments|0|||
94530954|NCT01296711|323739005|FG000|Overall Study|Failure to comply with visits|0|||
94530955|NCT01296711|323739006|FG001|Overall Study|Failure to comply with visits|0|||
94530956|NCT01296711|323739007|FG002|Overall Study|Failure to comply with visits|0|||
94530957|NCT01296711|323739008|FG003|Overall Study|Failure to comply with visits|0|||
94530958|NCT01296711|323739009|FG004|Overall Study|Failure to comply with visits|0|||
94530959|NCT01296711|323739010|FG005|Overall Study|Failure to comply with visits|0|||
94530960|NCT01296711|323739011|FG006|Overall Study|Failure to comply with visits|0|||
94530961|NCT01296711|323739012|FG007|Overall Study|Failure to comply with visits|1|||
94530962|NCT01296711|323739005|FG000|Overall Study|Patient decision due to transport|0|||
94530963|NCT01296711|323739006|FG001|Overall Study|Patient decision due to transport|0|||
94530964|NCT01296711|323739007|FG002|Overall Study|Patient decision due to transport|0|||
94530965|NCT01296711|323739008|FG003|Overall Study|Patient decision due to transport|0|||
94530966|NCT01296711|323739009|FG004|Overall Study|Patient decision due to transport|0|||
94530967|NCT01296711|323739010|FG005|Overall Study|Patient decision due to transport|0|||
94530968|NCT01296711|323739011|FG006|Overall Study|Patient decision due to transport|0|||
94530969|NCT01296711|323739012|FG007|Overall Study|Patient decision due to transport|1|||
94530970|NCT03249909|323739019|FG000|Overall Study|Withdrawal by Subject|3|||
94530971|NCT03249909|323739020|FG001|Overall Study|Withdrawal by Subject|0|||
94530972|NCT03249909|323739021|FG002|Overall Study|Withdrawal by Subject|0|||
94530973|NCT03249909|323739019|FG000|Overall Study|Adverse Event|3|||
94530974|NCT03249909|323739020|FG001|Overall Study|Adverse Event|0|||
94530975|NCT03249909|323739021|FG002|Overall Study|Adverse Event|0|||
94530976|NCT03249909|323739019|FG000|Overall Study|Lost to Follow-up|0|||
94530977|NCT03249909|323739020|FG001|Overall Study|Lost to Follow-up|1|||
94530978|NCT03249909|323739021|FG002|Overall Study|Lost to Follow-up|0|||
94530979|NCT05286658|323739023|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
94530980|NCT05286658|323739023|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
94530981|NCT01035463|323739024|FG000|Overall Study|Adverse Event|0|||
94530982|NCT01035463|323739025|FG001|Overall Study|Adverse Event|0|||
94530983|NCT01035463|323739026|FG002|Overall Study|Adverse Event|4|||
94530984|NCT01035463|323739027|FG003|Overall Study|Adverse Event|1|||
94530985|NCT01035463|323739028|FG004|Overall Study|Adverse Event|5|||
94530986|NCT01035463|323739029|FG005|Overall Study|Adverse Event|7|||
94530987|NCT01035463|323739024|FG000|Overall Study|Withdrawal by Subject|0|||
94530988|NCT01035463|323739025|FG001|Overall Study|Withdrawal by Subject|2|||
94530989|NCT01035463|323739026|FG002|Overall Study|Withdrawal by Subject|1|||
94530990|NCT01035463|323739027|FG003|Overall Study|Withdrawal by Subject|0|||
94530991|NCT01035463|323739028|FG004|Overall Study|Withdrawal by Subject|1|||
94530992|NCT01035463|323739029|FG005|Overall Study|Withdrawal by Subject|4|||
94530993|NCT01035463|323739024|FG000|Overall Study|Disease progression|0|||
94530994|NCT01035463|323739025|FG001|Overall Study|Disease progression|0|||
94530995|NCT01035463|323739026|FG002|Overall Study|Disease progression|0|||
94530996|NCT01035463|323739027|FG003|Overall Study|Disease progression|0|||
94530997|NCT01035463|323739028|FG004|Overall Study|Disease progression|0|||
94530998|NCT01035463|323739029|FG005|Overall Study|Disease progression|3|||
94530999|NCT01035463|323739024|FG000|Overall Study|Other Malignancy|0|||
94531000|NCT01035463|323739025|FG001|Overall Study|Other Malignancy|0|||
94531001|NCT01035463|323739026|FG002|Overall Study|Other Malignancy|0|||
94531002|NCT01035463|323739027|FG003|Overall Study|Other Malignancy|0|||
94531003|NCT01035463|323739028|FG004|Overall Study|Other Malignancy|0|||
94531004|NCT01035463|323739029|FG005|Overall Study|Other Malignancy|2|||
94531005|NCT01035463|323739024|FG000|Overall Study|Other|0|||
94531006|NCT01035463|323739025|FG001|Overall Study|Other|0|||
94531007|NCT01035463|323739026|FG002|Overall Study|Other|0|||
94531008|NCT01035463|323739027|FG003|Overall Study|Other|1|||
94531009|NCT01035463|323739028|FG004|Overall Study|Other|0|||
94531010|NCT01035463|323739029|FG005|Overall Study|Other|2|||
94531011|NCT02936869|323739036|FG000|Overall Study|Lost to Follow-up|1|||
94531012|NCT02936869|323739037|FG001|Overall Study|Lost to Follow-up|3|||
94531013|NCT02936869|323739036|FG000|Overall Study|Death|0|||
94531014|NCT02936869|323739037|FG001|Overall Study|Death|1|||
94531015|NCT02936869|323739036|FG000|Overall Study|Legal Case|0|||
94531016|NCT02936869|323739037|FG001|Overall Study|Legal Case|1|||
94531017|NCT02936869|323739036|FG000|Overall Study|Protocol Violation|1|||
94531018|NCT02936869|323739037|FG001|Overall Study|Protocol Violation|0|||
94531019|NCT01970241|323739038|FG000|Overall Study|Withdrawal by Subject|2|||
94531020|NCT01970241|323739039|FG001|Overall Study|Withdrawal by Subject|0|||
94531021|NCT01970241|323739038|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
94531022|NCT01970241|323739039|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
94531023|NCT05141175|323739040|FG000|Overall Study|Withdrawal by Subject|1|||
94531024|NCT00177294|323739042|FG000|Overall Study|Withdrawal by Subject|7|||
94531025|NCT00177294|323739043|FG001|Overall Study|Withdrawal by Subject|5|||
94531026|NCT03745638|323739045|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
94531027|NCT03745638|323739046|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
94531028|NCT03745638|323739047|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
94531029|NCT03745638|323739048|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
94531030|NCT03745638|323739049|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
94531031|NCT03745638|323739050|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
94531032|NCT03745638|323739051|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
94531033|NCT03745638|323739045|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
94531034|NCT03745638|323739046|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94531035|NCT03745638|323739047|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94531036|NCT03745638|323739048|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94531037|NCT03745638|323739049|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94531038|NCT03745638|323739050|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94531039|NCT03745638|323739051|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
94531040|NCT03745638|323739045|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
94531041|NCT03745638|323739046|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
94531042|NCT03745638|323739047|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
94531043|NCT03745638|323739048|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94531044|NCT03745638|323739049|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94531045|NCT03745638|323739050|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94531046|NCT03745638|323739051|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
94531047|NCT03745638|323739045|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
94531048|NCT03745638|323739046|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
94531049|NCT03745638|323739047|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
94531050|NCT03745638|323739048|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
94531051|NCT03745638|323739049|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
94531052|NCT03745638|323739050|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
94531053|NCT03745638|323739051|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
94531054|NCT03745638|323739045|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
94531055|NCT03745638|323739046|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
94531056|NCT03745638|323739047|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
94531057|NCT03745638|323739048|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
94531058|NCT03745638|323739049|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
94531059|NCT03745638|323739050|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
94531060|NCT03745638|323739051|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
94531061|NCT03745638|323739045|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
94531062|NCT03745638|323739046|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
94531063|NCT03745638|323739047|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
94531064|NCT03745638|323739048|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
94531065|NCT03745638|323739049|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
94531066|NCT03745638|323739050|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
94531067|NCT03745638|323739051|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
94531068|NCT03745638|323739045|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
94531069|NCT03745638|323739046|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
94531070|NCT03745638|323739047|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
94531071|NCT03745638|323739048|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94531072|NCT03745638|323739049|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94531073|NCT03745638|323739050|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94531074|NCT03745638|323739051|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
94531075|NCT03745638|323739045|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
94531076|NCT03745638|323739046|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
94531077|NCT03745638|323739047|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
94531078|NCT03745638|323739048|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
94531079|NCT03745638|323739049|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
94531080|NCT03745638|323739050|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
94531081|NCT03745638|323739051|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
94531082|NCT03745638|323739045|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
94531083|NCT03745638|323739046|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
94531084|NCT03745638|323739047|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
94531085|NCT03745638|323739048|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
94531086|NCT03745638|323739049|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
94531087|NCT03745638|323739050|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
94531088|NCT03745638|323739051|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
94531089|NCT03745638|323739045|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
94531090|NCT03745638|323739046|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
94531091|NCT03745638|323739047|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
94531092|NCT03745638|323739048|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
94531093|NCT03745638|323739049|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
94531094|NCT03745638|323739050|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
94531095|NCT03745638|323739051|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
94531096|NCT03745638|323739045|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
94531097|NCT03745638|323739046|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
94531098|NCT03745638|323739047|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
94531099|NCT03745638|323739048|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
94531100|NCT03745638|323739049|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
94531101|NCT03745638|323739050|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
94531102|NCT03745638|323739051|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
94531103|NCT03745638|323739045|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
94531104|NCT03745638|323739046|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
94531105|NCT03745638|323739047|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
94531106|NCT03745638|323739048|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
94531107|NCT03745638|323739049|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
94531108|NCT03745638|323739050|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
94531109|NCT03745638|323739051|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
94531110|NCT03745638|323739045|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
94531111|NCT03745638|323739046|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
94531112|NCT03745638|323739047|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
94531113|NCT03745638|323739048|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
94531114|NCT03745638|323739049|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
94531115|NCT03745638|323739050|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
94531116|NCT03745638|323739051|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
94531117|NCT03745638|323739045|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
94531118|NCT03745638|323739046|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
94531119|NCT03745638|323739047|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
94531120|NCT03745638|323739048|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
94531121|NCT03745638|323739049|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
94531122|NCT03745638|323739050|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
94531123|NCT03745638|323739051|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
94531124|NCT03745638|323739045|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
94531125|NCT03745638|323739046|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
94531126|NCT03745638|323739047|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
94531127|NCT03745638|323739048|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
94531128|NCT03745638|323739049|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
94531129|NCT03745638|323739050|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
94531130|NCT03745638|323739051|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
94531131|NCT04470050|323739054|FG000|Double-blind Treatment Phase|Adverse Event|0|||
94531132|NCT04470050|323739055|FG001|Double-blind Treatment Phase|Adverse Event|0|||
94531133|NCT04470050|323739056|FG002|Double-blind Treatment Phase|Adverse Event|0|||
94531134|NCT04470050|323739057|FG003|Double-blind Treatment Phase|Adverse Event|1|||
94531135|NCT04470050|323739058|FG004|Double-blind Treatment Phase|Adverse Event|0|||
94531136|NCT04470050|323739059|FG005|Double-blind Treatment Phase|Adverse Event|0|||
94531137|NCT04470050|323739060|FG006|Double-blind Treatment Phase|Adverse Event|0|||
94531138|NCT04470050|323739054|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
94531139|NCT04470050|323739055|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
94531140|NCT04470050|323739056|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
94531141|NCT04470050|323739057|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
94531142|NCT04470050|323739058|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
94531143|NCT04470050|323739059|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
94531144|NCT04470050|323739060|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
94531145|NCT04470050|323739054|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
94531146|NCT04470050|323739055|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
94531147|NCT04470050|323739056|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
94531148|NCT04470050|323739057|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
94531149|NCT04470050|323739058|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
94531150|NCT04470050|323739059|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
94531151|NCT04470050|323739060|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
94531152|NCT03585764|323739064|FG000|Overall Study|Death|3|||
94531153|NCT03585764|323739065|FG001|Overall Study|Death|2|||
94531154|NCT03585764|323739066|FG002|Overall Study|Death|3|||
94531155|NCT03585764|323739067|FG003|Overall Study|Death|0|||
94531156|NCT03585764|323739064|FG000|Overall Study|Lost to Follow-up|0|||
94531157|NCT03585764|323739065|FG001|Overall Study|Lost to Follow-up|1|||
94531158|NCT03585764|323739066|FG002|Overall Study|Lost to Follow-up|0|||
94531159|NCT03585764|323739067|FG003|Overall Study|Lost to Follow-up|0|||
94531160|NCT03585764|323739064|FG000|Overall Study|Physician Decision|0|||
94531161|NCT03585764|323739065|FG001|Overall Study|Physician Decision|0|||
94531162|NCT03585764|323739066|FG002|Overall Study|Physician Decision|2|||
94531163|NCT03585764|323739067|FG003|Overall Study|Physician Decision|0|||
94531164|NCT01581021|323739068|FG000|Overall Study|Lost to Follow-up|4|||
94531165|NCT01581021|323739069|FG001|Overall Study|Lost to Follow-up|6|||
94531166|NCT01581021|323739068|FG000|Overall Study|More than 2 hooks in thoracic|3|||
94531167|NCT01581021|323739069|FG001|Overall Study|More than 2 hooks in thoracic|0|||
94531168|NCT01581021|323739068|FG000|Overall Study|Neuromuscular|2|||
94531169|NCT01581021|323739069|FG001|Overall Study|Neuromuscular|1|||
94531170|NCT01581021|323739068|FG000|Overall Study|Not Randomized|1|||
94531171|NCT01581021|323739069|FG001|Overall Study|Not Randomized|2|||
94531172|NCT01581021|323739068|FG000|Overall Study|Lenke 6 Classification|0|||
94531173|NCT01581021|323739069|FG001|Overall Study|Lenke 6 Classification|1|||
94531174|NCT01581021|323739068|FG000|Overall Study|Lack of Efficacy|0|||
94531175|NCT01581021|323739069|FG001|Overall Study|Lack of Efficacy|1|||
94531176|NCT00700882|323739074|FG000|Overall Study|Never received treatment|6|||
94531177|NCT00700882|323739074|FG000|Overall Study|Ineligible|2|||
94531178|NCT00700882|323739074|FG000|Overall Study|No KIT mutation|51|||
94531179|NCT01536561|323739080|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
94531180|NCT01536561|323739080|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
94531181|NCT01536561|323739080|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
94531182|NCT01536561|323739080|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
94531183|NCT01536561|323739080|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
94531184|NCT01536561|323739080|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
94531185|NCT02993822|323739092|FG000|Overall Study|Lack of Efficacy|1|||
94531186|NCT02993822|323739093|FG001|Overall Study|Lack of Efficacy|1|||
94531187|NCT02993822|323739094|FG002|Overall Study|Lack of Efficacy|0|||
94531188|NCT02993822|323739095|FG003|Overall Study|Lack of Efficacy|0|||
94531189|NCT02993822|323739092|FG000|Overall Study|Protocol Violation|1|||
94531190|NCT02993822|323739093|FG001|Overall Study|Protocol Violation|0|||
94531191|NCT02993822|323739094|FG002|Overall Study|Protocol Violation|0|||
94531192|NCT02993822|323739095|FG003|Overall Study|Protocol Violation|0|||
94531193|NCT02993822|323739092|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
94531194|NCT02993822|323739093|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
94531195|NCT02993822|323739094|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
94531196|NCT02993822|323739095|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
94531197|NCT02993822|323739092|FG000|Overall Study|Adverse Event|3|||
94531198|NCT02993822|323739093|FG001|Overall Study|Adverse Event|1|||
94531199|NCT02993822|323739094|FG002|Overall Study|Adverse Event|7|||
94531200|NCT02993822|323739095|FG003|Overall Study|Adverse Event|0|||
94531201|NCT02993822|323739092|FG000|Overall Study|Withdrawal by Subject|4|||
94531202|NCT02993822|323739093|FG001|Overall Study|Withdrawal by Subject|2|||
94531203|NCT02993822|323739094|FG002|Overall Study|Withdrawal by Subject|2|||
94531204|NCT02993822|323739095|FG003|Overall Study|Withdrawal by Subject|3|||
94531205|NCT02993822|323739092|FG000|Overall Study|Lost to Follow-up|1|||
94531206|NCT02993822|323739093|FG001|Overall Study|Lost to Follow-up|0|||
94531207|NCT02993822|323739094|FG002|Overall Study|Lost to Follow-up|1|||
94531208|NCT02993822|323739095|FG003|Overall Study|Lost to Follow-up|0|||
94531209|NCT01732510|323739100|FG000|Overall Study|Adverse Event|0|||
94531210|NCT01732510|323739101|FG001|Overall Study|Adverse Event|1|||
94531211|NCT01732510|323739102|FG002|Overall Study|Adverse Event|1|||
94531212|NCT01732510|323739103|FG003|Overall Study|Adverse Event|0|||
94531213|NCT01732510|323739104|FG004|Overall Study|Adverse Event|0|||
94531214|NCT01732510|323739105|FG005|Overall Study|Adverse Event|0|||
94531215|NCT01732510|323739106|FG006|Overall Study|Adverse Event|1|||
94531216|NCT01732510|323739100|FG000|Overall Study|Protocol Violation|0|||
94531217|NCT01732510|323739101|FG001|Overall Study|Protocol Violation|0|||
94531218|NCT01732510|323739102|FG002|Overall Study|Protocol Violation|0|||
94531219|NCT01732510|323739103|FG003|Overall Study|Protocol Violation|1|||
94531220|NCT01732510|323739104|FG004|Overall Study|Protocol Violation|0|||
94531221|NCT01732510|323739105|FG005|Overall Study|Protocol Violation|0|||
94531222|NCT01732510|323739106|FG006|Overall Study|Protocol Violation|0|||
94531223|NCT01732510|323739100|FG000|Overall Study|Withdrawal by Subject|1|||
94531224|NCT01732510|323739101|FG001|Overall Study|Withdrawal by Subject|3|||
94531225|NCT01732510|323739102|FG002|Overall Study|Withdrawal by Subject|2|||
94531226|NCT01732510|323739103|FG003|Overall Study|Withdrawal by Subject|1|||
94531227|NCT01732510|323739104|FG004|Overall Study|Withdrawal by Subject|5|||
94531228|NCT01732510|323739105|FG005|Overall Study|Withdrawal by Subject|0|||
94531229|NCT01732510|323739106|FG006|Overall Study|Withdrawal by Subject|1|||
94531230|NCT01732510|323739100|FG000|Overall Study|Lost to Follow-up|0|||
94531231|NCT01732510|323739101|FG001|Overall Study|Lost to Follow-up|0|||
94531232|NCT01732510|323739102|FG002|Overall Study|Lost to Follow-up|1|||
94531233|NCT01732510|323739103|FG003|Overall Study|Lost to Follow-up|1|||
94531234|NCT01732510|323739104|FG004|Overall Study|Lost to Follow-up|0|||
94531235|NCT01732510|323739105|FG005|Overall Study|Lost to Follow-up|1|||
94531236|NCT01732510|323739106|FG006|Overall Study|Lost to Follow-up|0|||
94531237|NCT01732510|323739100|FG000|Overall Study|Physician Decision|0|||
94531238|NCT01732510|323739101|FG001|Overall Study|Physician Decision|1|||
94531239|NCT01732510|323739102|FG002|Overall Study|Physician Decision|0|||
94531240|NCT01732510|323739103|FG003|Overall Study|Physician Decision|0|||
94531241|NCT01732510|323739104|FG004|Overall Study|Physician Decision|0|||
94531242|NCT01732510|323739105|FG005|Overall Study|Physician Decision|0|||
94531243|NCT01732510|323739106|FG006|Overall Study|Physician Decision|0|||
94531244|NCT01732510|323739100|FG000|Overall Study|Pregnancy|0|||
94531245|NCT01732510|323739101|FG001|Overall Study|Pregnancy|0|||
94531246|NCT01732510|323739102|FG002|Overall Study|Pregnancy|0|||
94531247|NCT01732510|323739103|FG003|Overall Study|Pregnancy|1|||
94531248|NCT01732510|323739104|FG004|Overall Study|Pregnancy|0|||
94531249|NCT01732510|323739105|FG005|Overall Study|Pregnancy|0|||
94531250|NCT01732510|323739106|FG006|Overall Study|Pregnancy|0|||
94531251|NCT01732510|323739100|FG000|Overall Study|Study Terminated By Sponsor|0|||
94531252|NCT01732510|323739101|FG001|Overall Study|Study Terminated By Sponsor|0|||
94531253|NCT01732510|323739102|FG002|Overall Study|Study Terminated By Sponsor|0|||
94531254|NCT01732510|323739103|FG003|Overall Study|Study Terminated By Sponsor|1|||
94531255|NCT01732510|323739104|FG004|Overall Study|Study Terminated By Sponsor|0|||
94531256|NCT01732510|323739105|FG005|Overall Study|Study Terminated By Sponsor|12|||
94531257|NCT01732510|323739106|FG006|Overall Study|Study Terminated By Sponsor|6|||
94531258|NCT00313144|323739107|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
94531259|NCT00313144|323739107|FG000|Overall Study|Death|7|||
94531260|NCT00313144|323739107|FG000|Overall Study|Lost to Follow-up|5|||
94531261|NCT00313144|323739107|FG000|Overall Study|Withdrawal by Subject|4|||
94531262|NCT00313144|323739107|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
94531263|NCT00313144|323739107|FG000|Overall Study|Physician Decision|4|||
94531264|NCT00313144|323739107|FG000|Overall Study|Adverse event - transient|5|||
94531265|NCT00313144|323739107|FG000|Overall Study|Liver transplant|1|||
94531266|NCT00313144|323739107|FG000|Overall Study|Insurance (homecare provider) change|1|||
94531267|NCT00313144|323739107|FG000|Overall Study|Change to different product|1|||
94531268|NCT00313144|323739107|FG000|Overall Study|Due to termination of the study|66|||
94531269|NCT04154293|323739108|FG000|Overall Study|Withdrawal by Subject|2|||
94531270|NCT04154293|323739109|FG001|Overall Study|Withdrawal by Subject|3|||
94531271|NCT04154293|323739110|FG002|Overall Study|Withdrawal by Subject|1|||
94531272|NCT04154293|323739108|FG000|Overall Study|Physician Decision|0|||
94531273|NCT04154293|323739109|FG001|Overall Study|Physician Decision|0|||
94531274|NCT04154293|323739110|FG002|Overall Study|Physician Decision|1|||
94531275|NCT03335150|323739112|FG000|Overall Study|Withdrawal by Subject|10|||
94531276|NCT03335150|323739113|FG001|Overall Study|Withdrawal by Subject|4|||
94531277|NCT03335150|323739112|FG000|Overall Study|Adverse Event|0|||
94531278|NCT03335150|323739113|FG001|Overall Study|Adverse Event|1|||
94531279|NCT02218697|323739116|FG000|Overall Study|Adverse Event|0|||
94531280|NCT02218697|323739117|FG001|Overall Study|Adverse Event|2|||
94531281|NCT02218697|323739116|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
94531282|NCT02218697|323739117|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
94531283|NCT02218697|323739116|FG000|Overall Study|Withdrawal by Subject|2|||
94531284|NCT02218697|323739117|FG001|Overall Study|Withdrawal by Subject|3|||
94531285|NCT02744612|323741878|FG000|Overall Study|Withdrawal by Subject|0|||
94531286|NCT02744612|323741879|FG001|Overall Study|Withdrawal by Subject|2|||
94531287|NCT00875485|323741881|FG000|Challenge Dose Epoch|Pregnancy|1|||
94531288|NCT00875485|323741882|FG001|Challenge Dose Epoch|Pregnancy|0|||
94531289|NCT02954406|323741883|FG000|Overall Study|Adverse Event|0|||
94531290|NCT02954406|323741884|FG001|Overall Study|Adverse Event|1|||
94531291|NCT02954406|323741885|FG002|Overall Study|Adverse Event|0|||
94531292|NCT02954406|323741886|FG003|Overall Study|Adverse Event|0|||
94531293|NCT02954406|323741887|FG004|Overall Study|Adverse Event|1|||
94531294|NCT02954406|323741888|FG005|Overall Study|Adverse Event|0|||
94531295|NCT02954406|323741889|FG006|Overall Study|Adverse Event|0|||
94531296|NCT02954406|323741890|FG007|Overall Study|Adverse Event|0|||
94531297|NCT02954406|323741891|FG008|Overall Study|Adverse Event|1|||
94531298|NCT02954406|323741892|FG009|Overall Study|Adverse Event|1|||
94531299|NCT02954406|323741893|FG010|Overall Study|Adverse Event|0|||
94531300|NCT02954406|323741883|FG000|Overall Study|Progressive Disease|3|||
94531301|NCT02954406|323741884|FG001|Overall Study|Progressive Disease|4|||
94531302|NCT02954406|323741885|FG002|Overall Study|Progressive Disease|3|||
94531303|NCT02954406|323741886|FG003|Overall Study|Progressive Disease|4|||
94531304|NCT02954406|323741887|FG004|Overall Study|Progressive Disease|3|||
94531305|NCT02954406|323741888|FG005|Overall Study|Progressive Disease|3|||
94531306|NCT02954406|323741889|FG006|Overall Study|Progressive Disease|2|||
94531307|NCT02954406|323741890|FG007|Overall Study|Progressive Disease|2|||
94531308|NCT02954406|323741891|FG008|Overall Study|Progressive Disease|1|||
94531309|NCT02954406|323741892|FG009|Overall Study|Progressive Disease|1|||
94531310|NCT02954406|323741893|FG010|Overall Study|Progressive Disease|0|||
94531311|NCT02954406|323741883|FG000|Overall Study|Symptomatic Deterioration|0|||
94531312|NCT02954406|323741884|FG001|Overall Study|Symptomatic Deterioration|1|||
94531313|NCT02954406|323741885|FG002|Overall Study|Symptomatic Deterioration|0|||
94531314|NCT02954406|323741886|FG003|Overall Study|Symptomatic Deterioration|0|||
94531315|NCT02954406|323741887|FG004|Overall Study|Symptomatic Deterioration|0|||
94531316|NCT02954406|323741888|FG005|Overall Study|Symptomatic Deterioration|0|||
94531317|NCT02954406|323741889|FG006|Overall Study|Symptomatic Deterioration|0|||
94531318|NCT02954406|323741890|FG007|Overall Study|Symptomatic Deterioration|0|||
94531319|NCT02954406|323741891|FG008|Overall Study|Symptomatic Deterioration|0|||
94531320|NCT02954406|323741892|FG009|Overall Study|Symptomatic Deterioration|0|||
94531321|NCT02954406|323741893|FG010|Overall Study|Symptomatic Deterioration|0|||
94531322|NCT02954406|323741883|FG000|Overall Study|Death|0|||
94531323|NCT02954406|323741884|FG001|Overall Study|Death|0|||
94531324|NCT02954406|323741885|FG002|Overall Study|Death|0|||
94531325|NCT02954406|323741886|FG003|Overall Study|Death|0|||
94531326|NCT02954406|323741887|FG004|Overall Study|Death|1|||
94531327|NCT02954406|323741888|FG005|Overall Study|Death|0|||
94531328|NCT02954406|323741889|FG006|Overall Study|Death|0|||
94531329|NCT02954406|323741890|FG007|Overall Study|Death|0|||
94531330|NCT02954406|323741891|FG008|Overall Study|Death|1|||
94531331|NCT02954406|323741892|FG009|Overall Study|Death|1|||
94531332|NCT02954406|323741893|FG010|Overall Study|Death|0|||
94531333|NCT02954406|323741883|FG000|Overall Study|Reason Not Specified|0|||
94531334|NCT02954406|323741884|FG001|Overall Study|Reason Not Specified|0|||
94531335|NCT02954406|323741885|FG002|Overall Study|Reason Not Specified|3|||
94531336|NCT02954406|323741886|FG003|Overall Study|Reason Not Specified|2|||
94531337|NCT02954406|323741887|FG004|Overall Study|Reason Not Specified|2|||
94531338|NCT02954406|323741888|FG005|Overall Study|Reason Not Specified|0|||
94531339|NCT02954406|323741889|FG006|Overall Study|Reason Not Specified|1|||
94531340|NCT02954406|323741890|FG007|Overall Study|Reason Not Specified|0|||
94531341|NCT02954406|323741891|FG008|Overall Study|Reason Not Specified|1|||
94531342|NCT02954406|323741892|FG009|Overall Study|Reason Not Specified|0|||
94531343|NCT02954406|323741893|FG010|Overall Study|Reason Not Specified|0|||
94531344|NCT03062280|323741896|FG000|Overall Study|Adverse Event|1|||
94531345|NCT03062280|323741896|FG000|Overall Study|Death|1|||
94531346|NCT03062280|323741896|FG000|Overall Study|Fertility Treatment|2|||
94531347|NCT03062280|323741896|FG000|Overall Study|Physician Decision|2|||
94531348|NCT03062280|323741896|FG000|Overall Study|Pregnancy|5|||
94531349|NCT03062280|323741896|FG000|Overall Study|Withdrawal by Subject|11|||
94531350|NCT04493424|323741897|FG000|Overall Study|Termination of the trial by the sponsor|89|||
94531351|NCT04493424|323741897|FG000|Overall Study|Withdrawal by Subject|9|||
94531352|NCT04493424|323741897|FG000|Overall Study|Lost to Follow-up|2|||
94531353|NCT04493424|323741897|FG000|Overall Study|Lack of Efficacy|3|||
94531354|NCT04493424|323741897|FG000|Overall Study|Adverse Event|5|||
94531355|NCT02920528|323741898|FG000|Overall Study|Incomplete Data|1|||
94531356|NCT02920528|323741899|FG001|Overall Study|Incomplete Data|1|||
94531357|NCT02920528|323741900|FG002|Overall Study|Incomplete Data|1|||
94531358|NCT02920528|323741898|FG000|Overall Study|Adverse Event|0|||
94531359|NCT02920528|323741899|FG001|Overall Study|Adverse Event|0|||
94531360|NCT02920528|323741900|FG002|Overall Study|Adverse Event|3|||
94531361|NCT02920528|323741898|FG000|Overall Study|Did not meet inclusion criteria|2|||
94531362|NCT02920528|323741899|FG001|Overall Study|Did not meet inclusion criteria|0|||
94531363|NCT02920528|323741900|FG002|Overall Study|Did not meet inclusion criteria|1|||
94531364|NCT00809835|323741901|FG000|Overall Study|Lost to Follow-up|7|||
94531365|NCT00809835|323741902|FG001|Overall Study|Lost to Follow-up|6|||
94531366|NCT00809835|323741903|FG002|Overall Study|Lost to Follow-up|10|||
94531367|NCT00809835|323741904|FG003|Overall Study|Lost to Follow-up|2|||
94531368|NCT00809835|323741901|FG000|Overall Study|Withdrawal by Subject|1|||
94531369|NCT00809835|323741902|FG001|Overall Study|Withdrawal by Subject|1|||
94531370|NCT00809835|323741903|FG002|Overall Study|Withdrawal by Subject|1|||
94531371|NCT00809835|323741904|FG003|Overall Study|Withdrawal by Subject|0|||
94531372|NCT05959447|323741905|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
94531373|NCT05959447|323741906|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
94531374|NCT05959447|323741905|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
94531375|NCT05959447|323741906|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
94531376|NCT05959447|323741905|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
94531377|NCT05959447|323741906|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
94531378|NCT05959447|323741905|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
94531379|NCT05959447|323741906|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
94531380|NCT00734604|323741907|FG000|Overall Study|Adverse Event|0|||
94531381|NCT00734604|323741908|FG001|Overall Study|Adverse Event|2|||
94531382|NCT00734604|323741909|FG002|Overall Study|Adverse Event|0|||
94531383|NCT00734604|323741910|FG003|Overall Study|Adverse Event|2|||
94531384|NCT00734604|323741911|FG004|Overall Study|Adverse Event|1|||
94531385|NCT00734604|323741912|FG005|Overall Study|Adverse Event|1|||
94531386|NCT00734604|323741907|FG000|Overall Study|Serious Adverse Event|1|||
94531387|NCT00734604|323741908|FG001|Overall Study|Serious Adverse Event|0|||
94531388|NCT00734604|323741909|FG002|Overall Study|Serious Adverse Event|1|||
94531389|NCT00734604|323741910|FG003|Overall Study|Serious Adverse Event|2|||
94531390|NCT00734604|323741911|FG004|Overall Study|Serious Adverse Event|0|||
94531391|NCT00734604|323741912|FG005|Overall Study|Serious Adverse Event|1|||
94531392|NCT00734604|323741907|FG000|Overall Study|Lost to Follow-up|1|||
94531393|NCT00734604|323741908|FG001|Overall Study|Lost to Follow-up|2|||
94531394|NCT00734604|323741909|FG002|Overall Study|Lost to Follow-up|2|||
94531395|NCT00734604|323741910|FG003|Overall Study|Lost to Follow-up|4|||
94531396|NCT00734604|323741911|FG004|Overall Study|Lost to Follow-up|2|||
94531397|NCT00734604|323741912|FG005|Overall Study|Lost to Follow-up|3|||
94531398|NCT00734604|323741907|FG000|Overall Study|Physician Decision|0|||
94531399|NCT00734604|323741908|FG001|Overall Study|Physician Decision|1|||
94531400|NCT00734604|323741909|FG002|Overall Study|Physician Decision|1|||
94531401|NCT00734604|323741910|FG003|Overall Study|Physician Decision|0|||
94531402|NCT00734604|323741911|FG004|Overall Study|Physician Decision|0|||
94531403|NCT00734604|323741912|FG005|Overall Study|Physician Decision|0|||
94531404|NCT00734604|323741907|FG000|Overall Study|Protocol Violation|0|||
94531405|NCT00734604|323741908|FG001|Overall Study|Protocol Violation|2|||
94531406|NCT00734604|323741909|FG002|Overall Study|Protocol Violation|0|||
94531407|NCT00734604|323741910|FG003|Overall Study|Protocol Violation|0|||
94531408|NCT00734604|323741911|FG004|Overall Study|Protocol Violation|1|||
94531409|NCT00734604|323741912|FG005|Overall Study|Protocol Violation|0|||
94531410|NCT00734604|323741907|FG000|Overall Study|Sponsor Decision|1|||
94531411|NCT00734604|323741908|FG001|Overall Study|Sponsor Decision|2|||
94531412|NCT00734604|323741909|FG002|Overall Study|Sponsor Decision|1|||
94531413|NCT00734604|323741910|FG003|Overall Study|Sponsor Decision|0|||
94531414|NCT00734604|323741911|FG004|Overall Study|Sponsor Decision|2|||
94531415|NCT00734604|323741912|FG005|Overall Study|Sponsor Decision|0|||
94531416|NCT00734604|323741907|FG000|Overall Study|Withdrawal by Subject|0|||
94531417|NCT00734604|323741908|FG001|Overall Study|Withdrawal by Subject|2|||
94531418|NCT00734604|323741909|FG002|Overall Study|Withdrawal by Subject|0|||
94531419|NCT00734604|323741910|FG003|Overall Study|Withdrawal by Subject|1|||
94531420|NCT00734604|323741911|FG004|Overall Study|Withdrawal by Subject|2|||
94531421|NCT00734604|323741912|FG005|Overall Study|Withdrawal by Subject|1|||
94531422|NCT00734604|323741907|FG000|Overall Study|Lack of Efficacy|0|||
94531423|NCT00734604|323741908|FG001|Overall Study|Lack of Efficacy|1|||
94531424|NCT00734604|323741909|FG002|Overall Study|Lack of Efficacy|1|||
94531425|NCT00734604|323741910|FG003|Overall Study|Lack of Efficacy|0|||
94531426|NCT00734604|323741911|FG004|Overall Study|Lack of Efficacy|0|||
94531427|NCT00734604|323741912|FG005|Overall Study|Lack of Efficacy|0|||
94531428|NCT05243745|323741913|FG000|Overall Study|Withdrawal by Subject|0|||
94531429|NCT05243745|323741914|FG001|Overall Study|Withdrawal by Subject|0|||
94531430|NCT05243745|323741915|FG002|Overall Study|Withdrawal by Subject|0|||
94531431|NCT05243745|323741916|FG003|Overall Study|Withdrawal by Subject|1|||
94531432|NCT05243745|323741913|FG000|Overall Study|Unable to Attend Visit 6|0|||
94531433|NCT05243745|323741914|FG001|Overall Study|Unable to Attend Visit 6|0|||
94531434|NCT05243745|323741915|FG002|Overall Study|Unable to Attend Visit 6|1|||
94531435|NCT05243745|323741916|FG003|Overall Study|Unable to Attend Visit 6|0|||
94531436|NCT03037476|323741917|FG000|Overall Study|Lost to Follow-up|63|||
94531437|NCT03037476|323741918|FG001|Overall Study|Lost to Follow-up|46|||
94531438|NCT00176488|323741919|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
94531439|NCT01986231|323741920|FG000|Overall Study|Adverse Event|1|||
94531440|NCT00623233|323741921|FG000|Overall Study|Adverse Event|10|||
94531441|NCT00623233|323741921|FG000|Overall Study|Physician Decision|10|||
94531442|NCT00623233|323741921|FG000|Overall Study|Lost to Follow-up|1|||
94531443|NCT00623233|323741921|FG000|Overall Study|Withdrawal by Subject|3|||
94531444|NCT01751906|323741922|FG000|Overall Study|Lost to Follow-up|151|||
94531445|NCT01751906|323741923|FG001|Overall Study|Lost to Follow-up|68|||
94531446|NCT01751906|323741922|FG000|Overall Study|Withdrawal by Subject|22|||
94531447|NCT01751906|323741923|FG001|Overall Study|Withdrawal by Subject|18|||
94531448|NCT01751906|323741922|FG000|Overall Study|Physician Decision|5|||
94531449|NCT01751906|323741923|FG001|Overall Study|Physician Decision|2|||
94531450|NCT01751906|323741922|FG000|Overall Study|Death|84|||
94531451|NCT01751906|323741923|FG001|Overall Study|Death|43|||
94531452|NCT01751906|323741922|FG000|Overall Study|Denied on premises for follow-up by law|1|||
94531453|NCT01751906|323741923|FG001|Overall Study|Denied on premises for follow-up by law|0|||
94531454|NCT03053440|323741924|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
94531455|NCT03053440|323741925|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
94531456|NCT03053440|323741924|FG000|Overall Study|Death|18|||
94531457|NCT03053440|323741925|FG001|Overall Study|Death|14|||
94531458|NCT03053440|323741924|FG000|Overall Study|Withdrawal by Subject|9|||
94531459|NCT03053440|323741925|FG001|Overall Study|Withdrawal by Subject|8|||
94531460|NCT03053440|323741924|FG000|Overall Study|Lost to Follow-up|1|||
94531461|NCT03053440|323741925|FG001|Overall Study|Lost to Follow-up|0|||
94531462|NCT03053440|323741924|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
94531463|NCT03053440|323741925|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
94531464|NCT03053440|323741924|FG000|Overall Study|Physician Decision|2|||
94531465|NCT03053440|323741925|FG001|Overall Study|Physician Decision|1|||
94531466|NCT03053440|323741924|FG000|Overall Study|Participant Randomized but died before dosing|1|||
94531467|NCT03053440|323741925|FG001|Overall Study|Participant Randomized but died before dosing|0|||
94531468|NCT02707965|323741926|FG000|Overall Study|Withdrawal by Subject|0|||
94531469|NCT02707965|323741927|FG001|Overall Study|Withdrawal by Subject|0|||
94531470|NCT02707965|323741928|FG002|Overall Study|Withdrawal by Subject|1|||
94531471|NCT02707965|323741929|FG003|Overall Study|Withdrawal by Subject|0|||
94531472|NCT02707965|323741930|FG004|Overall Study|Withdrawal by Subject|0|||
94531473|NCT02707965|323741931|FG005|Overall Study|Withdrawal by Subject|0|||
94531474|NCT02707965|323741932|FG006|Overall Study|Withdrawal by Subject|0|||
94531475|NCT02707965|323741933|FG007|Overall Study|Withdrawal by Subject|2|||
94531476|NCT02707965|323741934|FG008|Overall Study|Withdrawal by Subject|0|||
94531477|NCT02707965|323741935|FG009|Overall Study|Withdrawal by Subject|0|||
94531478|NCT02707965|323741936|FG010|Overall Study|Withdrawal by Subject|0|||
94531479|NCT02707965|323741937|FG011|Overall Study|Withdrawal by Subject|0|||
94531480|NCT02707965|323741938|FG012|Overall Study|Withdrawal by Subject|0|||
94531481|NCT02707965|323741939|FG013|Overall Study|Withdrawal by Subject|0|||
94531482|NCT02707965|323741940|FG014|Overall Study|Withdrawal by Subject|0|||
94531483|NCT02707965|323741941|FG015|Overall Study|Withdrawal by Subject|0|||
94531484|NCT02707965|323741926|FG000|Overall Study|PI decisions|0|||
94531485|NCT02707965|323741927|FG001|Overall Study|PI decisions|0|||
94531486|NCT02707965|323741928|FG002|Overall Study|PI decisions|0|||
94531487|NCT02707965|323741929|FG003|Overall Study|PI decisions|0|||
94531488|NCT02707965|323741930|FG004|Overall Study|PI decisions|0|||
94531489|NCT02707965|323741931|FG005|Overall Study|PI decisions|0|||
94531490|NCT02707965|323741932|FG006|Overall Study|PI decisions|0|||
94531491|NCT02707965|323741933|FG007|Overall Study|PI decisions|0|||
94531492|NCT02707965|323741934|FG008|Overall Study|PI decisions|0|||
94531493|NCT02707965|323741935|FG009|Overall Study|PI decisions|0|||
94531494|NCT02707965|323741936|FG010|Overall Study|PI decisions|0|||
94531495|NCT02707965|323741937|FG011|Overall Study|PI decisions|0|||
94531496|NCT02707965|323741938|FG012|Overall Study|PI decisions|0|||
94531497|NCT02707965|323741939|FG013|Overall Study|PI decisions|0|||
94531498|NCT02707965|323741940|FG014|Overall Study|PI decisions|2|||
94531499|NCT02707965|323741941|FG015|Overall Study|PI decisions|0|||
94531500|NCT02707965|323741926|FG000|Overall Study|Protocol deviation|1|||
94531501|NCT02707965|323741927|FG001|Overall Study|Protocol deviation|1|||
94531502|NCT02707965|323741928|FG002|Overall Study|Protocol deviation|0|||
94531503|NCT02707965|323741929|FG003|Overall Study|Protocol deviation|0|||
94531504|NCT02707965|323741930|FG004|Overall Study|Protocol deviation|0|||
94531505|NCT02707965|323741931|FG005|Overall Study|Protocol deviation|0|||
94531506|NCT02707965|323741932|FG006|Overall Study|Protocol deviation|0|||
94531507|NCT02707965|323741933|FG007|Overall Study|Protocol deviation|1|||
94531508|NCT02707965|323741934|FG008|Overall Study|Protocol deviation|0|||
94531509|NCT02707965|323741935|FG009|Overall Study|Protocol deviation|0|||
94531510|NCT02707965|323741936|FG010|Overall Study|Protocol deviation|0|||
94531511|NCT02707965|323741937|FG011|Overall Study|Protocol deviation|0|||
94531512|NCT02707965|323741938|FG012|Overall Study|Protocol deviation|0|||
94531513|NCT02707965|323741939|FG013|Overall Study|Protocol deviation|0|||
94531514|NCT02707965|323741940|FG014|Overall Study|Protocol deviation|0|||
94531515|NCT02707965|323741941|FG015|Overall Study|Protocol deviation|0|||
94531516|NCT00249808|323741942|FG000|Overall Study|Other|27|||
94531517|NCT00249808|323741942|FG000|Overall Study|Protocol Violation|3|||
94531518|NCT00249808|323741942|FG000|Overall Study|Lost to Follow-up|8|||
94531519|NCT00249808|323741942|FG000|Overall Study|Adverse Event|81|||
94531520|NCT00249808|323741942|FG000|Overall Study|Lack of Efficacy|52|||
94531521|NCT00249808|323741942|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
94531522|NCT02516982|323741943|FG000|Overall Study|Called in to antenatal appointment|32|||
94531523|NCT02516982|323741944|FG001|Overall Study|Called in to antenatal appointment|35|||
94531524|NCT02516982|323741945|FG002|Overall Study|Called in to antenatal appointment|0|||
94531525|NCT02516982|323741946|FG003|Overall Study|Called in to antenatal appointment|0|||
94531526|NCT02516982|323741943|FG000|Overall Study|Withdrawal by Subject|0|||
94531527|NCT02516982|323741944|FG001|Overall Study|Withdrawal by Subject|0|||
94531528|NCT02516982|323741945|FG002|Overall Study|Withdrawal by Subject|1|||
94531529|NCT02516982|323741946|FG003|Overall Study|Withdrawal by Subject|2|||
94531530|NCT02516982|323741943|FG000|Overall Study|Protocol Violation|0|||
94531531|NCT02516982|323741944|FG001|Overall Study|Protocol Violation|0|||
94531532|NCT02516982|323741945|FG002|Overall Study|Protocol Violation|1|||
94531533|NCT02516982|323741946|FG003|Overall Study|Protocol Violation|1|||
94531534|NCT02516982|323741943|FG000|Overall Study|Did not install the app|0|||
94531535|NCT02516982|323741944|FG001|Overall Study|Did not install the app|0|||
94531536|NCT02516982|323741945|FG002|Overall Study|Did not install the app|46|||
94531537|NCT02516982|323741946|FG003|Overall Study|Did not install the app|47|||
94531538|NCT00316225|323741947|FG000|Overall Study|Adverse Event|2|||
94531539|NCT00316225|323741947|FG000|Overall Study|Physician Decision|3|||
94531540|NCT00316225|323741947|FG000|Overall Study|Progressive Disease|15|||
94531541|NCT00316225|323741947|FG000|Overall Study|Withdrawal by Subject|3|||
94531542|NCT00316225|323741947|FG000|Overall Study|Death|2|||
94531543|NCT01811485|323741948|FG000|Overall Study|Adverse Event|1|||
94531544|NCT01811485|323741949|FG001|Overall Study|Adverse Event|3|||
94531545|NCT01811485|323741950|FG002|Overall Study|Adverse Event|2|||
94531546|NCT01811485|323741948|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94531547|NCT01811485|323741949|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
94531548|NCT01811485|323741950|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
94531549|NCT01811485|323741948|FG000|Overall Study|Administrative problems|1|||
94531550|NCT01811485|323741949|FG001|Overall Study|Administrative problems|0|||
94531551|NCT01811485|323741950|FG002|Overall Study|Administrative problems|0|||
94531552|NCT01811485|323741948|FG000|Overall Study|Protocol Deviation|0|||
94531553|NCT01811485|323741949|FG001|Overall Study|Protocol Deviation|1|||
94531554|NCT01811485|323741950|FG002|Overall Study|Protocol Deviation|0|||
94531555|NCT03379259|323741956|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
94531556|NCT03379259|323741957|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
94531557|NCT03379259|323741958|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
94531558|NCT03379259|323741959|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
94531559|NCT03379259|323741960|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
94531560|NCT03379259|323741961|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
94531561|NCT03379259|323741956|FG000|Overall Study|Death|0|||
94531562|NCT03379259|323741957|FG001|Overall Study|Death|1|||
94531563|NCT03379259|323741958|FG002|Overall Study|Death|2|||
94531564|NCT03379259|323741959|FG003|Overall Study|Death|1|||
94531565|NCT03379259|323741960|FG004|Overall Study|Death|4|||
94531566|NCT03379259|323741961|FG005|Overall Study|Death|2|||
94531567|NCT03379259|323741956|FG000|Overall Study|Withdrawal by Subject|0|||
94531568|NCT03379259|323741957|FG001|Overall Study|Withdrawal by Subject|0|||
94531569|NCT03379259|323741958|FG002|Overall Study|Withdrawal by Subject|1|||
94531570|NCT03379259|323741959|FG003|Overall Study|Withdrawal by Subject|0|||
94531571|NCT03379259|323741960|FG004|Overall Study|Withdrawal by Subject|2|||
94531572|NCT03379259|323741961|FG005|Overall Study|Withdrawal by Subject|0|||
94531573|NCT03379259|323741956|FG000|Overall Study|Study terminated by sponsor|0|||
94531574|NCT03379259|323741957|FG001|Overall Study|Study terminated by sponsor|0|||
94531575|NCT03379259|323741958|FG002|Overall Study|Study terminated by sponsor|0|||
94531576|NCT03379259|323741959|FG003|Overall Study|Study terminated by sponsor|1|||
94531577|NCT03379259|323741960|FG004|Overall Study|Study terminated by sponsor|1|||
94531578|NCT03379259|323741961|FG005|Overall Study|Study terminated by sponsor|4|||
94531579|NCT03379259|323741956|FG000|Overall Study|Disease progression|0|||
94531580|NCT03379259|323741957|FG001|Overall Study|Disease progression|0|||
94531581|NCT03379259|323741958|FG002|Overall Study|Disease progression|0|||
94531582|NCT03379259|323741959|FG003|Overall Study|Disease progression|1|||
94531583|NCT03379259|323741960|FG004|Overall Study|Disease progression|0|||
94531584|NCT03379259|323741961|FG005|Overall Study|Disease progression|1|||
94531585|NCT03379259|323741956|FG000|Overall Study|Lost to Follow-up|0|||
94531586|NCT03379259|323741957|FG001|Overall Study|Lost to Follow-up|0|||
94531587|NCT03379259|323741958|FG002|Overall Study|Lost to Follow-up|0|||
94531588|NCT03379259|323741959|FG003|Overall Study|Lost to Follow-up|0|||
94531589|NCT03379259|323741960|FG004|Overall Study|Lost to Follow-up|1|||
94531590|NCT03379259|323741961|FG005|Overall Study|Lost to Follow-up|0|||
94531591|NCT03379259|323741956|FG000|Overall Study|Deteriorating condition|0|||
94531592|NCT03379259|323741957|FG001|Overall Study|Deteriorating condition|0|||
94531593|NCT03379259|323741958|FG002|Overall Study|Deteriorating condition|0|||
94531594|NCT03379259|323741959|FG003|Overall Study|Deteriorating condition|0|||
94531595|NCT03379259|323741960|FG004|Overall Study|Deteriorating condition|1|||
94531596|NCT03379259|323741961|FG005|Overall Study|Deteriorating condition|0|||
94531597|NCT03470194|323741962|FG000|Overall Study|Lost to Follow-up|11|||
94531598|NCT03470194|323741963|FG001|Overall Study|Lost to Follow-up|17|||
94531599|NCT01901289|323741967|FG000|Overall Study|Death|32|||
94531600|NCT01901289|323741967|FG000|Overall Study|Lost to Follow-up|16|||
94531601|NCT01901289|323741967|FG000|Overall Study|Withdrawal by Subject|35|||
94531602|NCT01901289|323741967|FG000|Overall Study|Other type of endpoint met|2|||
94531603|NCT01104545|323741968|FG000|Overall Study|Adverse Event|0|||
94531604|NCT01104545|323741969|FG001|Overall Study|Adverse Event|1|||
94531605|NCT01104545|323741970|FG002|Overall Study|Adverse Event|2|||
94531606|NCT04382586|323741971|FG000|Overall Study|Death|3|||
94531607|NCT04382586|323741972|FG001|Overall Study|Death|4|||
94531608|NCT04382586|323741971|FG000|Overall Study|Lost to Follow-up|11|||
94531609|NCT04382586|323741972|FG001|Overall Study|Lost to Follow-up|8|||
94531610|NCT04382586|323741971|FG000|Overall Study|Withdrawal by Subject|3|||
94531611|NCT04382586|323741972|FG001|Overall Study|Withdrawal by Subject|1|||
94531612|NCT04382586|323741971|FG000|Overall Study|Physician Decision|0|||
94531613|NCT04382586|323741972|FG001|Overall Study|Physician Decision|3|||
94531614|NCT00349349|323741973|FG000|Overall Study|Adverse Event|5|||
94531615|NCT00349349|323741974|FG001|Overall Study|Adverse Event|6|||
94531616|NCT00349349|323741975|FG002|Overall Study|Adverse Event|2|||
94531617|NCT00349349|323741973|FG000|Overall Study|Withdrawal by Subject|5|||
94531618|NCT00349349|323741974|FG001|Overall Study|Withdrawal by Subject|2|||
94531619|NCT00349349|323741975|FG002|Overall Study|Withdrawal by Subject|1|||
94531620|NCT00349349|323741973|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
94531621|NCT00349349|323741974|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
94531622|NCT00349349|323741975|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
94531623|NCT00349349|323741973|FG000|Overall Study|Death|13|||
94531624|NCT00349349|323741974|FG001|Overall Study|Death|10|||
94531625|NCT00349349|323741975|FG002|Overall Study|Death|1|||
94531626|NCT00349349|323741973|FG000|Overall Study|Other Treatment Selected|2|||
94531627|NCT00349349|323741974|FG001|Overall Study|Other Treatment Selected|0|||
94531628|NCT00349349|323741975|FG002|Overall Study|Other Treatment Selected|0|||
94531629|NCT00349349|323741973|FG000|Overall Study|Participant Reduced General Condition|0|||
94531630|NCT00349349|323741974|FG001|Overall Study|Participant Reduced General Condition|1|||
94531631|NCT00349349|323741975|FG002|Overall Study|Participant Reduced General Condition|0|||
94531632|NCT00349349|323741973|FG000|Overall Study|Physician Decision|1|||
94531633|NCT00349349|323741974|FG001|Overall Study|Physician Decision|2|||
94531634|NCT00349349|323741975|FG002|Overall Study|Physician Decision|1|||
94531635|NCT00349349|323741973|FG000|Overall Study|No Response|0|||
94531636|NCT00349349|323741974|FG001|Overall Study|No Response|3|||
94531637|NCT00349349|323741975|FG002|Overall Study|No Response|0|||
94531638|NCT00349349|323741973|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
94531639|NCT00349349|323741974|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
94531640|NCT00349349|323741975|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
94531641|NCT02097719|323741977|FG000|Overall Study|Subject Withdrew Consent|1|||
94531642|NCT02097719|323741978|FG001|Overall Study|Subject Withdrew Consent|0|||
94531643|NCT02097719|323741977|FG000|Overall Study|Lost to Follow-up|0|||
94531644|NCT02097719|323741978|FG001|Overall Study|Lost to Follow-up|1|||
94531645|NCT02097719|323741977|FG000|Overall Study|Adverse Event|2|||
94531646|NCT02097719|323741978|FG001|Overall Study|Adverse Event|0|||
94531647|NCT02241733|323741979|FG000|Overall Study|Lost to Follow-up|9|||
94531648|NCT02241733|323741980|FG001|Overall Study|Lost to Follow-up|4|||
94531649|NCT02241733|323741979|FG000|Overall Study|Physician Decision|6|||
94531650|NCT02241733|323741980|FG001|Overall Study|Physician Decision|2|||
94531651|NCT02241733|323741979|FG000|Overall Study|Withdrawal by Subject|0|||
94531652|NCT02241733|323741980|FG001|Overall Study|Withdrawal by Subject|2|||
94531653|NCT02241733|323741979|FG000|Overall Study|Death|0|||
94531654|NCT02241733|323741980|FG001|Overall Study|Death|2|||
94531655|NCT03268954|323741984|FG000|Overall Study|Ongoing|23|||
94531656|NCT03268954|323741985|FG001|Overall Study|Ongoing|31|||
94531657|NCT03268954|323741984|FG000|Overall Study|Adverse Event|53|||
94531658|NCT03268954|323741985|FG001|Overall Study|Adverse Event|62|||
94531659|NCT03268954|323741984|FG000|Overall Study|Withdrawal by Subject|25|||
94531660|NCT03268954|323741985|FG001|Overall Study|Withdrawal by Subject|16|||
94531661|NCT03268954|323741984|FG000|Overall Study|Progressive Disease|61|||
94531662|NCT03268954|323741985|FG001|Overall Study|Progressive Disease|48|||
94531663|NCT03268954|323741984|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
94531664|NCT03268954|323741985|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
94531665|NCT03268954|323741984|FG000|Overall Study|Reason not Specified|40|||
94531666|NCT03268954|323741985|FG001|Overall Study|Reason not Specified|40|||
94531667|NCT01974206|323741986|FG000|Overall Study|Did Not Take Study Drug|0|||
94531668|NCT01974206|323741987|FG001|Overall Study|Did Not Take Study Drug|1|||
94531669|NCT01974206|323741986|FG000|Overall Study|Physician Decision|1|||
94531670|NCT01974206|323741987|FG001|Overall Study|Physician Decision|0|||
94531671|NCT01974206|323741986|FG000|Overall Study|Withdrawal by Subject|3|||
94531672|NCT01974206|323741987|FG001|Overall Study|Withdrawal by Subject|0|||
94531673|NCT01974206|323741986|FG000|Overall Study|Lost to Follow-up|1|||
94531674|NCT01974206|323741987|FG001|Overall Study|Lost to Follow-up|0|||
94531675|NCT01974206|323741986|FG000|Overall Study|Death|1|||
94531676|NCT01974206|323741987|FG001|Overall Study|Death|0|||
94531677|NCT01946529|323741988|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
94531678|NCT01946529|323741989|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
94531679|NCT01946529|323741990|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
94531680|NCT01946529|323741988|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
94531681|NCT01946529|323741989|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
94531682|NCT01946529|323741990|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
94531683|NCT01108731|323741999|FG000|Overall Study|Withdrawal by Subject|1|||
94531684|NCT01108731|323742000|FG001|Overall Study|Withdrawal by Subject|1|||
94531685|NCT01108731|323741999|FG000|Overall Study|Adverse Event|3|||
94531686|NCT01108731|323742000|FG001|Overall Study|Adverse Event|3|||
94531687|NCT02095873|323742001|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
94531688|NCT02095873|323742002|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
94531689|NCT02095873|323742001|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
94531690|NCT02095873|323742002|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
94531691|NCT02095873|323742001|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
94531692|NCT02095873|323742002|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
94531693|NCT04776720|323742003|FG000|Overall Study|COVID Related|4|||
94531694|NCT04776720|323742004|FG001|Overall Study|COVID Related|2|||
94531695|NCT04776720|323742003|FG000|Overall Study|Adverse Event|2|||
94531696|NCT04776720|323742004|FG001|Overall Study|Adverse Event|0|||
94531697|NCT04776720|323742003|FG000|Overall Study|Serious Adverse Event|0|||
94531698|NCT04776720|323742004|FG001|Overall Study|Serious Adverse Event|1|||
94531699|NCT04776720|323742003|FG000|Overall Study|Too Busy|3|||
94531700|NCT04776720|323742004|FG001|Overall Study|Too Busy|1|||
94531701|NCT04776720|323742003|FG000|Overall Study|Lost to Follow-up|1|||
94531702|NCT04776720|323742004|FG001|Overall Study|Lost to Follow-up|2|||
94531703|NCT04776720|323742003|FG000|Overall Study|Family|2|||
94531704|NCT04776720|323742004|FG001|Overall Study|Family|2|||
94531705|NCT04776720|323742003|FG000|Overall Study|No remote technology access|0|||
94531706|NCT04776720|323742004|FG001|Overall Study|No remote technology access|1|||
94531707|NCT04776720|323742003|FG000|Overall Study|Withdrawal by Subject|1|||
94531708|NCT04776720|323742004|FG001|Overall Study|Withdrawal by Subject|0|||
94531709|NCT04776720|323742003|FG000|Overall Study|Cannot tolerate intervention|1|||
94531710|NCT04776720|323742004|FG001|Overall Study|Cannot tolerate intervention|0|||
94531711|NCT04776720|323742003|FG000|Overall Study|Incomplete outcome data|6|||
94531712|NCT04776720|323742004|FG001|Overall Study|Incomplete outcome data|1|||
94531713|NCT01063062|323742007|FG000|Overall Study|Patient withdrew consent|0|||
94531714|NCT01063062|323742008|FG001|Overall Study|Patient withdrew consent|1|||
94531715|NCT01063062|323742007|FG000|Overall Study|Adverse Event|2|||
94531716|NCT01063062|323742008|FG001|Overall Study|Adverse Event|4|||
94531717|NCT01063062|323742007|FG000|Overall Study|Protocol Violation|5|||
94531718|NCT01063062|323742008|FG001|Overall Study|Protocol Violation|4|||
94531719|NCT01063062|323742007|FG000|Overall Study|Investigator's request|1|||
94531720|NCT01063062|323742008|FG001|Overall Study|Investigator's request|0|||
94531721|NCT01063062|323742007|FG000|Overall Study|Lost to Follow-up|0|||
94531722|NCT01063062|323742008|FG001|Overall Study|Lost to Follow-up|2|||
94531723|NCT01063062|323742007|FG000|Overall Study|Miscellaneous reason|0|||
94531724|NCT01063062|323742008|FG001|Overall Study|Miscellaneous reason|1|||
94531725|NCT04601532|323742009|FG000|Overall Study|Lost to Follow-up|1|||
94531726|NCT04601532|323742010|FG001|Overall Study|Lost to Follow-up|2|||
94531727|NCT04601532|323742009|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
94531728|NCT04601532|323742010|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
94531729|NCT01352221|323742011|FG000|Double-blind Phase|Adverse Event|6|||
94531730|NCT01352221|323742012|FG001|Double-blind Phase|Adverse Event|4|||
94531731|NCT01352221|323742013|FG002|Double-blind Phase|Adverse Event|0|||
94531732|NCT01352221|323742014|FG003|Double-blind Phase|Adverse Event|0|||
94531733|NCT01352221|323742011|FG000|Double-blind Phase|Withdrawal by Subject|3|||
94531734|NCT01352221|323742012|FG001|Double-blind Phase|Withdrawal by Subject|5|||
94531735|NCT01352221|323742013|FG002|Double-blind Phase|Withdrawal by Subject|0|||
94531736|NCT01352221|323742014|FG003|Double-blind Phase|Withdrawal by Subject|0|||
94531737|NCT01352221|323742011|FG000|Double-blind Phase|Lost to Follow-up|0|||
94531738|NCT01352221|323742012|FG001|Double-blind Phase|Lost to Follow-up|1|||
94531739|NCT01352221|323742013|FG002|Double-blind Phase|Lost to Follow-up|0|||
94531740|NCT01352221|323742014|FG003|Double-blind Phase|Lost to Follow-up|0|||
94531741|NCT01352221|323742011|FG000|Double-blind Phase|Protocol Violation|0|||
94531742|NCT01352221|323742012|FG001|Double-blind Phase|Protocol Violation|1|||
94531743|NCT01352221|323742013|FG002|Double-blind Phase|Protocol Violation|0|||
94531744|NCT01352221|323742014|FG003|Double-blind Phase|Protocol Violation|0|||
94531745|NCT01352221|323742011|FG000|Open-label Phase|Physician Decision|0|||
94531746|NCT01352221|323742012|FG001|Open-label Phase|Physician Decision|0|||
94531747|NCT01352221|323742013|FG002|Open-label Phase|Physician Decision|2|||
94531748|NCT01352221|323742014|FG003|Open-label Phase|Physician Decision|1|||
94531749|NCT01352221|323742011|FG000|Open-label Phase|Pregnancy|0|||
94531750|NCT01352221|323742012|FG001|Open-label Phase|Pregnancy|0|||
94531751|NCT01352221|323742013|FG002|Open-label Phase|Pregnancy|1|||
94531752|NCT01352221|323742014|FG003|Open-label Phase|Pregnancy|0|||
94531753|NCT01352221|323742011|FG000|Open-label Phase|Adverse Event|0|||
94531754|NCT01352221|323742012|FG001|Open-label Phase|Adverse Event|0|||
94531755|NCT01352221|323742013|FG002|Open-label Phase|Adverse Event|8|||
94531756|NCT01352221|323742014|FG003|Open-label Phase|Adverse Event|4|||
94531757|NCT01352221|323742011|FG000|Open-label Phase|Withdrawal by Subject|0|||
94531758|NCT01352221|323742012|FG001|Open-label Phase|Withdrawal by Subject|0|||
94531759|NCT01352221|323742013|FG002|Open-label Phase|Withdrawal by Subject|1|||
94531760|NCT01352221|323742014|FG003|Open-label Phase|Withdrawal by Subject|6|||
94531761|NCT01352221|323742011|FG000|Open-label Phase|Worsening of IBD|0|||
94531762|NCT01352221|323742012|FG001|Open-label Phase|Worsening of IBD|0|||
94531763|NCT01352221|323742013|FG002|Open-label Phase|Worsening of IBD|1|||
94531764|NCT01352221|323742014|FG003|Open-label Phase|Worsening of IBD|0|||
94531765|NCT00082368|323742020|FG000|Overall Study|Not treated-pt had poor IV access|1|||
94531766|NCT00107900|323742021|FG000|Overall Study|Adverse Event|3|||
94531767|NCT00107900|323742022|FG001|Overall Study|Adverse Event|2|||
94531768|NCT00107900|323742023|FG002|Overall Study|Adverse Event|10|||
94531769|NCT00107900|323742024|FG003|Overall Study|Adverse Event|3|||
94531770|NCT00107900|323742025|FG004|Overall Study|Adverse Event|5|||
94531771|NCT00107900|323742026|FG005|Overall Study|Adverse Event|3|||
94531772|NCT00107900|323742021|FG000|Overall Study|Death|0|||
94531773|NCT00107900|323742022|FG001|Overall Study|Death|0|||
94531774|NCT00107900|323742023|FG002|Overall Study|Death|0|||
94531775|NCT00107900|323742024|FG003|Overall Study|Death|0|||
94531776|NCT00107900|323742025|FG004|Overall Study|Death|1|||
94531777|NCT00107900|323742026|FG005|Overall Study|Death|0|||
94531778|NCT00107900|323742021|FG000|Overall Study|Lost to Follow-up|4|||
94531779|NCT00107900|323742022|FG001|Overall Study|Lost to Follow-up|1|||
94531780|NCT00107900|323742023|FG002|Overall Study|Lost to Follow-up|3|||
94531781|NCT00107900|323742024|FG003|Overall Study|Lost to Follow-up|2|||
94531782|NCT00107900|323742025|FG004|Overall Study|Lost to Follow-up|5|||
94531783|NCT00107900|323742026|FG005|Overall Study|Lost to Follow-up|5|||
94531784|NCT00107900|323742021|FG000|Overall Study|Protocol Violation|1|||
94531785|NCT00107900|323742022|FG001|Overall Study|Protocol Violation|0|||
94531786|NCT00107900|323742023|FG002|Overall Study|Protocol Violation|5|||
94531787|NCT00107900|323742024|FG003|Overall Study|Protocol Violation|5|||
94531788|NCT00107900|323742025|FG004|Overall Study|Protocol Violation|7|||
94531789|NCT00107900|323742026|FG005|Overall Study|Protocol Violation|0|||
94531790|NCT00107900|323742021|FG000|Overall Study|Withdrawal by Subject|1|||
94531791|NCT00107900|323742022|FG001|Overall Study|Withdrawal by Subject|0|||
94531792|NCT00107900|323742023|FG002|Overall Study|Withdrawal by Subject|5|||
94531793|NCT00107900|323742024|FG003|Overall Study|Withdrawal by Subject|0|||
94531794|NCT00107900|323742025|FG004|Overall Study|Withdrawal by Subject|1|||
94531795|NCT00107900|323742026|FG005|Overall Study|Withdrawal by Subject|1|||
94531796|NCT00107900|323742021|FG000|Overall Study|Administrative Reasons|1|||
94531797|NCT00107900|323742022|FG001|Overall Study|Administrative Reasons|0|||
94531798|NCT00107900|323742023|FG002|Overall Study|Administrative Reasons|2|||
94531799|NCT00107900|323742024|FG003|Overall Study|Administrative Reasons|2|||
94531800|NCT00107900|323742025|FG004|Overall Study|Administrative Reasons|2|||
94531801|NCT00107900|323742026|FG005|Overall Study|Administrative Reasons|0|||
94531802|NCT02461290|323742027|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
94531803|NCT02461290|323742027|FG000|Overall Study|Lost to Follow-up|3|||
94531804|NCT04091581|323742028|FG000|Overall Study|Lost to Follow-up|0|||
94531805|NCT04091581|323742029|FG001|Overall Study|Lost to Follow-up|1|||
94531806|NCT03315793|323742031|FG000|Overall Study|Adverse Event|4|||
94531807|NCT03315793|323742032|FG001|Overall Study|Adverse Event|2|||
94531808|NCT03315793|323742031|FG000|Overall Study|Protocol Deviation|1|||
94531809|NCT03315793|323742032|FG001|Overall Study|Protocol Deviation|0|||
94531810|NCT03315793|323742031|FG000|Overall Study|Difficult for regular visit|0|||
94531811|NCT03315793|323742032|FG001|Overall Study|Difficult for regular visit|1|||
94531812|NCT01331837|323742033|FG000|Overall Study|Death|30|||
94531813|NCT01331837|323742034|FG001|Overall Study|Death|34|||
94531814|NCT01331837|323742033|FG000|Overall Study|Lost to Follow-up|3|||
94531815|NCT01331837|323742034|FG001|Overall Study|Lost to Follow-up|1|||
94531816|NCT01331837|323742033|FG000|Overall Study|Info not recorded|10|||
94531817|NCT01331837|323742034|FG001|Overall Study|Info not recorded|16|||
94531818|NCT01331837|323742033|FG000|Overall Study|Withdrawal by Subject|13|||
94531819|NCT01331837|323742034|FG001|Overall Study|Withdrawal by Subject|16|||
94531820|NCT01271010|323743447|FG000|Overall Study|Reason not specified|11|||
94531821|NCT01271010|323743447|FG000|Overall Study|Start of new CLL therapy|1|||
94531822|NCT01271010|323743447|FG000|Overall Study|Protocol Violation|1|||
94531823|NCT01271010|323743447|FG000|Overall Study|Death|2|||
94531824|NCT01271010|323743447|FG000|Overall Study|Progression and relapse of disease|1|||
94531825|NCT01271010|323743447|FG000|Overall Study|Withdrawal by Subject|18|||
94531826|NCT01271010|323743447|FG000|Overall Study|Disease progression|27|||
94531827|NCT05258890|323743449|FG000|Overall Study|Patient withdrawal|6|||
94531828|NCT05258890|323743450|FG001|Overall Study|Patient withdrawal|7|||
94531829|NCT05258890|323743449|FG000|Overall Study|Patient lost to follow-up|10|||
94531830|NCT05258890|323743450|FG001|Overall Study|Patient lost to follow-up|3|||
94531831|NCT05258890|323743449|FG000|Overall Study|Social network member withdrawal|1|||
94531832|NCT05258890|323743450|FG001|Overall Study|Social network member withdrawal|0|||
94531833|NCT05258890|323743449|FG000|Overall Study|Social network member lost to follow-up|5|||
94531834|NCT05258890|323743450|FG001|Overall Study|Social network member lost to follow-up|0|||
94531835|NCT00814580|323743451|FG000|Overall Study|Adverse Event|6|||
94531836|NCT00814580|323743452|FG001|Overall Study|Adverse Event|15|||
94531837|NCT00814580|323743451|FG000|Overall Study|Lack of Efficacy|18|||
94531838|NCT00814580|323743452|FG001|Overall Study|Lack of Efficacy|25|||
94531839|NCT00814580|323743451|FG000|Overall Study|Protocol Violation|2|||
94531840|NCT00814580|323743452|FG001|Overall Study|Protocol Violation|0|||
94531841|NCT00814580|323743451|FG000|Overall Study|Withdrawal by Subject|2|||
94531842|NCT00814580|323743452|FG001|Overall Study|Withdrawal by Subject|2|||
94531843|NCT00814580|323743451|FG000|Overall Study|Other|1|||
94531844|NCT00814580|323743452|FG001|Overall Study|Other|3|||
94531845|NCT00814580|323743451|FG000|Overall Study|Did Not Take Drug|2|||
94531846|NCT00814580|323743452|FG001|Overall Study|Did Not Take Drug|2|||
94531847|NCT02482428|323743453|FG000|Overall Study|Lost to Follow-up|4|||
94531848|NCT02482428|323743454|FG001|Overall Study|Lost to Follow-up|9|||
94531849|NCT02482428|323743455|FG002|Overall Study|Lost to Follow-up|1|||
94531850|NCT02482428|323743456|FG003|Overall Study|Lost to Follow-up|2|||
94531851|NCT02482428|323743457|FG004|Overall Study|Lost to Follow-up|4|||
94531852|NCT02482428|323743453|FG000|Overall Study|Physician Decision|0|||
94531853|NCT02482428|323743454|FG001|Overall Study|Physician Decision|0|||
94531854|NCT02482428|323743455|FG002|Overall Study|Physician Decision|0|||
94531855|NCT02482428|323743456|FG003|Overall Study|Physician Decision|0|||
94531856|NCT02482428|323743457|FG004|Overall Study|Physician Decision|1|||
94531857|NCT02482428|323743453|FG000|Overall Study|protocol deviation|1|||
94531858|NCT02482428|323743454|FG001|Overall Study|protocol deviation|1|||
94531859|NCT02482428|323743455|FG002|Overall Study|protocol deviation|0|||
94531860|NCT02482428|323743456|FG003|Overall Study|protocol deviation|0|||
94531861|NCT02482428|323743457|FG004|Overall Study|protocol deviation|0|||
94531862|NCT02482428|323743453|FG000|Overall Study|subject/guardian decision|4|||
94531863|NCT02482428|323743454|FG001|Overall Study|subject/guardian decision|2|||
94531864|NCT02482428|323743455|FG002|Overall Study|subject/guardian decision|0|||
94531865|NCT02482428|323743456|FG003|Overall Study|subject/guardian decision|0|||
94531866|NCT02482428|323743457|FG004|Overall Study|subject/guardian decision|2|||
94531867|NCT00516893|323743460|FG000|Overall Study|Lost to Follow-up|4|||
94531868|NCT00516893|323743460|FG000|Overall Study|Adverse Event|3|||
94531869|NCT00516893|323743460|FG000|Overall Study|Withdrawal by Subject|2|||
94531870|NCT00516893|323743460|FG000|Overall Study|Noncompliance|2|||
94531871|NCT00516893|323743460|FG000|Overall Study|Death|1|||
94531872|NCT00516893|323743460|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
94531873|NCT00516893|323743460|FG000|Overall Study|Relocated|1|||
94531874|NCT00516893|323743460|FG000|Overall Study|Pregnancy|1|||
94531875|NCT00516893|323743460|FG000|Overall Study|Received Medication From Another Study|1|||
94531876|NCT01340625|323743461|FG000|First Intervention|Adverse Event|1|||
94531877|NCT01340625|323743462|FG001|First Intervention|Adverse Event|0|||
94531878|NCT01340625|323743461|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
94531879|NCT01340625|323743462|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
94531880|NCT05659719|323743466|FG000|Overall Study|At sponsor's request|0|||
94531881|NCT05659719|323743467|FG001|Overall Study|At sponsor's request|0|||
94531882|NCT05659719|323743468|FG002|Overall Study|At sponsor's request|0|||
94531883|NCT05659719|323743469|FG003|Overall Study|At sponsor's request|95|||
94531884|NCT05659719|323743466|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
94531885|NCT05659719|323743467|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
94531886|NCT05659719|323743468|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
94531887|NCT05659719|323743469|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
94531888|NCT05659719|323743466|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
94531889|NCT05659719|323743467|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
94531890|NCT05659719|323743468|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
94531891|NCT05659719|323743469|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
94531892|NCT05659719|323743466|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
94531893|NCT05659719|323743467|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
94531894|NCT05659719|323743468|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
94531895|NCT05659719|323743469|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
94531896|NCT05659719|323743466|FG000|Overall Study|Lost to Follow-up|0|||
94531897|NCT05659719|323743467|FG001|Overall Study|Lost to Follow-up|0|||
94531898|NCT05659719|323743468|FG002|Overall Study|Lost to Follow-up|0|||
94531899|NCT05659719|323743469|FG003|Overall Study|Lost to Follow-up|2|||
94531900|NCT05659719|323743466|FG000|Overall Study|Moved to another observational study|0|||
94531901|NCT05659719|323743467|FG001|Overall Study|Moved to another observational study|0|||
94531902|NCT05659719|323743468|FG002|Overall Study|Moved to another observational study|0|||
94531903|NCT05659719|323743469|FG003|Overall Study|Moved to another observational study|1|||
94531904|NCT05659719|323743466|FG000|Overall Study|The child was enrolled in an interventional study|0|||
94531905|NCT05659719|323743467|FG001|Overall Study|The child was enrolled in an interventional study|0|||
94531906|NCT05659719|323743468|FG002|Overall Study|The child was enrolled in an interventional study|0|||
94531907|NCT05659719|323743469|FG003|Overall Study|The child was enrolled in an interventional study|55|||
94531908|NCT05659719|323743466|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
94531909|NCT05659719|323743467|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
94531910|NCT05659719|323743468|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
94531911|NCT05659719|323743469|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
94531912|NCT05659719|323743466|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
94531913|NCT05659719|323743467|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
94531914|NCT05659719|323743468|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
94531915|NCT05659719|323743469|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
94531916|NCT00967694|323743480|FG000|Overall Study|Withdrawal by Subject|6|||
94531917|NCT02249091|323743481|FG000|Overall Study|Lack of Efficacy|8|||
94531918|NCT02249091|323743482|FG001|Overall Study|Lack of Efficacy|3|||
94531919|NCT02249091|323743481|FG000|Overall Study|Physician Decision|4|||
94531920|NCT02249091|323743482|FG001|Overall Study|Physician Decision|1|||
94531921|NCT02249091|323743481|FG000|Overall Study|Withdrawal by Subject|2|||
94531922|NCT02249091|323743482|FG001|Overall Study|Withdrawal by Subject|2|||
94531923|NCT02249091|323743481|FG000|Overall Study|Death|3|||
94531924|NCT02249091|323743482|FG001|Overall Study|Death|4|||
94531925|NCT02249091|323743481|FG000|Overall Study|Adverse Event|1|||
94531926|NCT02249091|323743482|FG001|Overall Study|Adverse Event|0|||
94531927|NCT02249091|323743481|FG000|Overall Study|Stable disease with following SCT|0|||
94531928|NCT02249091|323743482|FG001|Overall Study|Stable disease with following SCT|1|||
94531929|NCT02249091|323743481|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
94531930|NCT02249091|323743482|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
94531931|NCT02249091|323743481|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
94531932|NCT02249091|323743482|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
94531933|NCT02249091|323743481|FG000|Overall Study|Refractory AML|1|||
94531934|NCT02249091|323743482|FG001|Overall Study|Refractory AML|1|||
94531935|NCT00853242|323743483|FG000|Overall Study|Adverse Event|0|||
94531936|NCT00853242|323743484|FG001|Overall Study|Adverse Event|1|||
94531937|NCT00853242|323743485|FG002|Overall Study|Adverse Event|1|||
94531938|NCT00853242|323743486|FG003|Overall Study|Adverse Event|0|||
94531939|NCT00853242|323743487|FG004|Overall Study|Adverse Event|3|||
94531940|NCT00853242|323743488|FG005|Overall Study|Adverse Event|1|||
94531941|NCT00853242|323743489|FG006|Overall Study|Adverse Event|1|||
94531942|NCT00853242|323743483|FG000|Overall Study|Noncompliant|0|||
94531943|NCT00853242|323743484|FG001|Overall Study|Noncompliant|0|||
94531944|NCT00853242|323743485|FG002|Overall Study|Noncompliant|0|||
94531945|NCT00853242|323743486|FG003|Overall Study|Noncompliant|0|||
94531946|NCT00853242|323743487|FG004|Overall Study|Noncompliant|1|||
94531947|NCT00853242|323743488|FG005|Overall Study|Noncompliant|0|||
94531948|NCT00853242|323743489|FG006|Overall Study|Noncompliant|0|||
94531949|NCT00853242|323743483|FG000|Overall Study|Withdrawal by Subject|1|||
94531950|NCT00853242|323743484|FG001|Overall Study|Withdrawal by Subject|2|||
94531951|NCT00853242|323743485|FG002|Overall Study|Withdrawal by Subject|0|||
94531952|NCT00853242|323743486|FG003|Overall Study|Withdrawal by Subject|4|||
94531953|NCT00853242|323743487|FG004|Overall Study|Withdrawal by Subject|0|||
94531954|NCT00853242|323743488|FG005|Overall Study|Withdrawal by Subject|0|||
94531955|NCT00853242|323743489|FG006|Overall Study|Withdrawal by Subject|2|||
94531956|NCT00853242|323743483|FG000|Overall Study|Other|2|||
94531957|NCT00853242|323743484|FG001|Overall Study|Other|0|||
94531958|NCT00853242|323743485|FG002|Overall Study|Other|2|||
94531959|NCT00853242|323743486|FG003|Overall Study|Other|0|||
94531960|NCT00853242|323743487|FG004|Overall Study|Other|0|||
94531961|NCT00853242|323743488|FG005|Overall Study|Other|1|||
94531962|NCT00853242|323743489|FG006|Overall Study|Other|2|||
94531963|NCT02957747|323743490|FG000|Overall Study|Withdrawal by Subject|0|||
94531964|NCT02957747|323743491|FG001|Overall Study|Withdrawal by Subject|3|||
94531965|NCT02957747|323743490|FG000|Overall Study|Lost to Follow-up|10|||
94531966|NCT02957747|323743491|FG001|Overall Study|Lost to Follow-up|5|||
94531967|NCT01164891|323743493|FG000|Overall Study|Disease Progression|5|||
94531968|NCT01164891|323743493|FG000|Overall Study|Adverse Event|1|||
94531969|NCT03985943|323743494|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
94531970|NCT03985943|323743495|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
94531971|NCT03985943|323743496|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
94531972|NCT03985943|323743497|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
94531973|NCT03985943|323743498|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
94531974|NCT03985943|323743499|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
94531975|NCT03985943|323743494|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
94531976|NCT03985943|323743495|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
94531977|NCT03985943|323743496|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
94531978|NCT03985943|323743497|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
94531979|NCT03985943|323743498|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
94531980|NCT03985943|323743499|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
94531981|NCT03985943|323743494|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
94531982|NCT03985943|323743495|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
94531983|NCT03985943|323743496|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
94531984|NCT03985943|323743497|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
94531985|NCT03985943|323743498|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
94531986|NCT03985943|323743499|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
94531987|NCT03985943|323743494|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
94531988|NCT03985943|323743495|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
94531989|NCT03985943|323743496|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
94531990|NCT03985943|323743497|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
94531991|NCT03985943|323743498|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
94531992|NCT03985943|323743499|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
94531993|NCT03985943|323743494|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
94531994|NCT03985943|323743495|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
94531995|NCT03985943|323743496|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
94531996|NCT03985943|323743497|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
94531997|NCT03985943|323743498|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
94531998|NCT03985943|323743499|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
94531999|NCT03985943|323743494|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
94532000|NCT03985943|323743495|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
94532001|NCT03985943|323743496|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
94532002|NCT03985943|323743497|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
94532003|NCT03985943|323743498|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
94532004|NCT03985943|323743499|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
94532005|NCT03985943|323743494|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
94532006|NCT03985943|323743495|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
94532007|NCT03985943|323743496|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
94532008|NCT03985943|323743497|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
94532009|NCT03985943|323743498|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
94532010|NCT03985943|323743499|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
94532011|NCT03985943|323743494|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
94532012|NCT03985943|323743495|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
94532013|NCT03985943|323743496|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
94532014|NCT03985943|323743497|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
94532015|NCT03985943|323743498|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
94532016|NCT03985943|323743499|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
94532017|NCT03985943|323743494|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
94532018|NCT03985943|323743495|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
94532019|NCT03985943|323743496|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
94532020|NCT03985943|323743497|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
94532021|NCT03985943|323743498|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
94532022|NCT03985943|323743499|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
94532023|NCT03985943|323743494|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
94532024|NCT03985943|323743495|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
94532025|NCT03985943|323743496|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
94532026|NCT03985943|323743497|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
94532027|NCT03985943|323743498|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
94532028|NCT03985943|323743499|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
94532029|NCT03985943|323743494|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
94532030|NCT03985943|323743495|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
94532031|NCT03985943|323743496|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
94532032|NCT03985943|323743497|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
94532033|NCT03985943|323743498|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
94532034|NCT03985943|323743499|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
94532035|NCT03985943|323743494|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
94532036|NCT03985943|323743495|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
94532037|NCT03985943|323743496|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
94532038|NCT03985943|323743497|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
94532039|NCT03985943|323743498|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
94532040|NCT03985943|323743499|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
94532041|NCT03985943|323743494|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
94532042|NCT03985943|323743495|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
94532043|NCT03985943|323743496|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
94532044|NCT03985943|323743497|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
94532045|NCT03985943|323743498|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
94532046|NCT03985943|323743499|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
94532047|NCT03985943|323743494|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
94532048|NCT03985943|323743495|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
94532049|NCT03985943|323743496|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
94532050|NCT03985943|323743497|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
94532051|NCT03985943|323743498|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
94532052|NCT03985943|323743499|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
94532053|NCT03985943|323743494|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
94532054|NCT03985943|323743495|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
94532055|NCT03985943|323743496|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
94532056|NCT03985943|323743497|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
94532057|NCT03985943|323743498|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
94532058|NCT03985943|323743499|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
94532059|NCT00441142|323743500|FG000|Overall Study|Adverse Event|2|||
94532060|NCT00441142|323743501|FG001|Overall Study|Adverse Event|3|||
94532061|NCT00441142|323743502|FG002|Overall Study|Adverse Event|3|||
94532062|NCT00441142|323743503|FG003|Overall Study|Adverse Event|22|||
94532063|NCT00441142|323743500|FG000|Overall Study|Lack of Efficacy|3|||
94532064|NCT00441142|323743501|FG001|Overall Study|Lack of Efficacy|3|||
94532065|NCT00441142|323743502|FG002|Overall Study|Lack of Efficacy|17|||
94532066|NCT00441142|323743503|FG003|Overall Study|Lack of Efficacy|32|||
94532067|NCT00441142|323743500|FG000|Overall Study|Withdrawal by Subject|0|||
94532068|NCT00441142|323743501|FG001|Overall Study|Withdrawal by Subject|0|||
94532069|NCT00441142|323743502|FG002|Overall Study|Withdrawal by Subject|2|||
94532070|NCT00441142|323743503|FG003|Overall Study|Withdrawal by Subject|10|||
94532071|NCT00441142|323743500|FG000|Overall Study|Patient still receiving active study tx|1|||
94532072|NCT00441142|323743501|FG001|Overall Study|Patient still receiving active study tx|0|||
94532073|NCT00441142|323743502|FG002|Overall Study|Patient still receiving active study tx|0|||
94532074|NCT00441142|323743503|FG003|Overall Study|Patient still receiving active study tx|2|||
94532075|NCT00441142|323743500|FG000|Overall Study|Physician Decision|0|||
94532076|NCT00441142|323743501|FG001|Overall Study|Physician Decision|1|||
94532077|NCT00441142|323743502|FG002|Overall Study|Physician Decision|0|||
94532078|NCT00441142|323743503|FG003|Overall Study|Physician Decision|1|||
94532079|NCT00441142|323743500|FG000|Overall Study|Death|0|||
94532080|NCT00441142|323743501|FG001|Overall Study|Death|0|||
94532081|NCT00441142|323743502|FG002|Overall Study|Death|0|||
94532082|NCT00441142|323743503|FG003|Overall Study|Death|1|||
94532083|NCT00338286|323743504|FG000|Overall Study|Withdrawal by Subject|50|||
94532084|NCT00338286|323743505|FG001|Overall Study|Withdrawal by Subject|54|||
94532085|NCT00338286|323743504|FG000|Overall Study|Lost to Follow-up|80|||
94532086|NCT00338286|323743505|FG001|Overall Study|Lost to Follow-up|66|||
94532087|NCT00338286|323743504|FG000|Overall Study|Other|103|||
94532088|NCT00338286|323743505|FG001|Overall Study|Other|93|||
94532089|NCT02141399|323743509|FG000|Overall Study|Adverse Event|158|||
94532090|NCT02141399|323743509|FG000|Overall Study|Lack of Efficacy|62|||
94532091|NCT02141399|323743509|FG000|Overall Study|Lost to Follow-up|151|||
94532092|NCT02141399|323743509|FG000|Overall Study|Non-compliance with study drug|18|||
94532093|NCT02141399|323743509|FG000|Overall Study|Other|45|||
94532094|NCT02141399|323743509|FG000|Overall Study|Physician Decision|17|||
94532095|NCT02141399|323743509|FG000|Overall Study|Pregnancy|3|||
94532096|NCT02141399|323743509|FG000|Overall Study|Protocol Violation|38|||
94532097|NCT02141399|323743509|FG000|Overall Study|Withdrawal by Subject|238|||
94532098|NCT02141399|323743509|FG000|Overall Study|Failure to meet eligibility criteria|14|||
94532099|NCT02550288|323743512|FG000|Overall Study|Adverse Event|0|||
94532100|NCT02550288|323743513|FG001|Overall Study|Adverse Event|1|||
94532101|NCT02550288|323743514|FG002|Overall Study|Adverse Event|0|||
94532102|NCT02550288|323743515|FG003|Overall Study|Adverse Event|0|||
94532103|NCT02550288|323743516|FG004|Overall Study|Adverse Event|0|||
94532104|NCT02550288|323743512|FG000|Overall Study|Physician Decision|0|||
94532105|NCT02550288|323743513|FG001|Overall Study|Physician Decision|0|||
94532106|NCT02550288|323743514|FG002|Overall Study|Physician Decision|0|||
94532107|NCT02550288|323743515|FG003|Overall Study|Physician Decision|1|||
94532108|NCT02550288|323743516|FG004|Overall Study|Physician Decision|0|||
94532109|NCT02550288|323743512|FG000|Overall Study|Protocol Violation|2|||
94532110|NCT02550288|323743513|FG001|Overall Study|Protocol Violation|2|||
94532111|NCT02550288|323743514|FG002|Overall Study|Protocol Violation|1|||
94532112|NCT02550288|323743515|FG003|Overall Study|Protocol Violation|0|||
94532113|NCT02550288|323743516|FG004|Overall Study|Protocol Violation|3|||
94532114|NCT02550288|323743512|FG000|Overall Study|Participant moved|0|||
94532115|NCT02550288|323743513|FG001|Overall Study|Participant moved|0|||
94532116|NCT02550288|323743514|FG002|Overall Study|Participant moved|0|||
94532117|NCT02550288|323743515|FG003|Overall Study|Participant moved|1|||
94532118|NCT02550288|323743516|FG004|Overall Study|Participant moved|0|||
94532119|NCT02550288|323743512|FG000|Overall Study|Withdrawal by Subject|0|||
94532120|NCT02550288|323743513|FG001|Overall Study|Withdrawal by Subject|0|||
94532121|NCT02550288|323743514|FG002|Overall Study|Withdrawal by Subject|0|||
94532122|NCT02550288|323743515|FG003|Overall Study|Withdrawal by Subject|1|||
94532123|NCT02550288|323743516|FG004|Overall Study|Withdrawal by Subject|0|||
94532124|NCT03517371|323743518|FG000|Overall Study|Adverse Event|8|||
94532125|NCT03517371|323743519|FG001|Overall Study|Adverse Event|9|||
94532126|NCT03517371|323743518|FG000|Overall Study|Lost to Follow-up|1|||
94532127|NCT03517371|323743519|FG001|Overall Study|Lost to Follow-up|2|||
94532128|NCT03517371|323743518|FG000|Overall Study|Withdrawal by Subject|4|||
94532129|NCT03517371|323743519|FG001|Overall Study|Withdrawal by Subject|4|||
94532130|NCT03517371|323743518|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
94532131|NCT03517371|323743519|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
94532132|NCT03517371|323743518|FG000|Overall Study|COVID restrictions|2|||
94532133|NCT03517371|323743519|FG001|Overall Study|COVID restrictions|0|||
94532134|NCT03517371|323743518|FG000|Overall Study|Receiving DBS Surgery|0|||
94532135|NCT03517371|323743519|FG001|Overall Study|Receiving DBS Surgery|1|||
94532136|NCT01345929|323743520|FG000|Overall Study|Withdrawal by Subject|9|||
94532137|NCT01345929|323743521|FG001|Overall Study|Withdrawal by Subject|8|||
94532138|NCT01345929|323743520|FG000|Overall Study|Lost to Follow-up|9|||
94532139|NCT01345929|323743521|FG001|Overall Study|Lost to Follow-up|9|||
94532140|NCT01345929|323743520|FG000|Overall Study|Adverse Event|0|||
94532141|NCT01345929|323743521|FG001|Overall Study|Adverse Event|1|||
94532142|NCT01345929|323743520|FG000|Overall Study|Didn't meet eligibility criteria|2|||
94532143|NCT01345929|323743521|FG001|Overall Study|Didn't meet eligibility criteria|0|||
94532144|NCT01345929|323743520|FG000|Overall Study|40,000 CFU/ML|1|||
94532145|NCT01345929|323743521|FG001|Overall Study|40,000 CFU/ML|0|||
94532146|NCT01345929|323743520|FG000|Overall Study|Patient withdrawal|0|||
94532147|NCT01345929|323743521|FG001|Overall Study|Patient withdrawal|1|||
94532148|NCT02858440|323743522|FG000|Overall Study|Lost to Follow-up|3|||
94532149|NCT02858440|323743522|FG000|Overall Study|Protocol Violation|2|||
94532150|NCT02858440|323743522|FG000|Overall Study|Consent withdrawal|3|||
94532151|NCT02858440|323743522|FG000|Overall Study|Migrated/moved from study area|4|||
94532152|NCT04660552|323743526|FG000|Overall Study|Withdrawal by Subject|3|||
94532153|NCT04660552|323743527|FG001|Overall Study|Withdrawal by Subject|1|||
94532154|NCT00939029|323743530|FG000|Overall Study|Withdrawal by Subject|3|||
94532155|NCT00939029|323743531|FG001|Overall Study|Withdrawal by Subject|7|||
94532156|NCT00939029|323743530|FG000|Overall Study|Lost to Follow-up|3|||
94532157|NCT00939029|323743531|FG001|Overall Study|Lost to Follow-up|4|||
94532158|NCT00939029|323743530|FG000|Overall Study|Adverse Event|0|||
94532159|NCT00939029|323743531|FG001|Overall Study|Adverse Event|1|||
94532160|NCT00964002|323743532|FG000|Overall Study|Protocol Violation|8|||
94532161|NCT00613327|323743543|FG000|Overall Study|Adverse Event|38|||
94532162|NCT00613327|323743543|FG000|Overall Study|Lost to Follow-up|8|||
94532163|NCT00613327|323743543|FG000|Overall Study|Withdrawal by Subject|6|||
94532164|NCT00613327|323743543|FG000|Overall Study|Protocol Violation|2|||
94532165|NCT00613327|323743543|FG000|Overall Study|Other|47|||
94532166|NCT01208961|323743546|FG000|High-Fat Period III|Protocol Violation|1|||
94532167|NCT01208961|323743547|FG001|High-Fat Period III|Protocol Violation|0|||
94532168|NCT02487654|323743552|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
94532169|NCT02487654|323743553|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
94532170|NCT02487654|323743552|FG000|Overall Study|Withdrawal by Subject|3|||
94532171|NCT02487654|323743553|FG001|Overall Study|Withdrawal by Subject|7|||
94532172|NCT05129449|323743554|FG000|Overall Study|Protocol Violation|1|||
94532173|NCT00656058|323743555|FG000|Overall Study|Withdrawal by Subject|2|||
94532174|NCT00656058|323743555|FG000|Overall Study|Withdrawal by Subject|4|||
94532175|NCT00616018|323743556|FG000|Overall Study|Protocol Violation|3|||
94532176|NCT05248997|323743557|FG000|Overall Study|Lost to Follow-up|1|||
94532177|NCT05248997|323743558|FG001|Overall Study|Lost to Follow-up|1|||
94532178|NCT05248997|323743557|FG000|Overall Study|Randomized but not treated|32|||
94532179|NCT05248997|323743558|FG001|Overall Study|Randomized but not treated|25|||
94532180|NCT04730635|323743559|FG000|Overall Study|Lost to Follow-up|1|||
94532181|NCT04730635|323743560|FG001|Overall Study|Lost to Follow-up|0|||
94532182|NCT04730635|323743559|FG000|Overall Study|Withdrawal by Subject|0|||
94532183|NCT04730635|323743560|FG001|Overall Study|Withdrawal by Subject|1|||
94532184|NCT02684058|323743566|FG000|Treatment Period|Progressive disease|4|||
94532185|NCT02684058|323743567|FG001|Treatment Period|Progressive disease|10|||
94532186|NCT02684058|323743568|FG002|Treatment Period|Progressive disease|19|||
94532187|NCT02684058|323743566|FG000|Treatment Period|Adverse Event|3|||
94532188|NCT02684058|323743567|FG001|Treatment Period|Adverse Event|8|||
94532189|NCT02684058|323743568|FG002|Treatment Period|Adverse Event|1|||
94532190|NCT02684058|323743566|FG000|Treatment Period|Physician Decision|5|||
94532191|NCT02684058|323743567|FG001|Treatment Period|Physician Decision|1|||
94532192|NCT02684058|323743568|FG002|Treatment Period|Physician Decision|2|||
94532193|NCT02684058|323743566|FG000|Treatment Period|New therapy for study indication|1|||
94532194|NCT02684058|323743567|FG001|Treatment Period|New therapy for study indication|0|||
94532195|NCT02684058|323743568|FG002|Treatment Period|New therapy for study indication|0|||
94532196|NCT02684058|323743566|FG000|Treatment Period|Protocol deviation|0|||
94532197|NCT02684058|323743567|FG001|Treatment Period|Protocol deviation|1|||
94532198|NCT02684058|323743568|FG002|Treatment Period|Protocol deviation|0|||
94532199|NCT02684058|323743566|FG000|Treatment Period|Subject/guardian decision|4|||
94532200|NCT02684058|323743567|FG001|Treatment Period|Subject/guardian decision|3|||
94532201|NCT02684058|323743568|FG002|Treatment Period|Subject/guardian decision|0|||
94532202|NCT02684058|323743566|FG000|Treatment Period|Death|0|||
94532203|NCT02684058|323743567|FG001|Treatment Period|Death|0|||
94532204|NCT02684058|323743568|FG002|Treatment Period|Death|2|||
94532205|NCT02684058|323743566|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
94532206|NCT02684058|323743567|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
94532207|NCT02684058|323743568|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
94532208|NCT02684058|323743566|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
94532209|NCT02684058|323743567|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
94532210|NCT02684058|323743568|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
94532211|NCT02684058|323743566|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
94532212|NCT02684058|323743567|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
94532213|NCT02684058|323743568|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
94532214|NCT02684058|323743566|FG000|Post-treatment Efficacy Follow-up|Death|0|||
94532215|NCT02684058|323743567|FG001|Post-treatment Efficacy Follow-up|Death|0|||
94532216|NCT02684058|323743568|FG002|Post-treatment Efficacy Follow-up|Death|3|||
94532217|NCT02684058|323743566|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
94532218|NCT02684058|323743567|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
94532219|NCT02684058|323743568|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
94532220|NCT02684058|323743566|FG000|Post-treatment Survival Follow-up|Death|0|||
94532221|NCT02684058|323743567|FG001|Post-treatment Survival Follow-up|Death|0|||
94532222|NCT02684058|323743568|FG002|Post-treatment Survival Follow-up|Death|7|||
94532223|NCT02684058|323743566|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
94532224|NCT02684058|323743567|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
94532225|NCT02684058|323743568|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
94532226|NCT02684058|323743566|FG000|Crossover Treatment Period|Progressive disease|0|||
94532227|NCT02684058|323743567|FG001|Crossover Treatment Period|Progressive disease|1|||
94532228|NCT02684058|323743568|FG002|Crossover Treatment Period|Progressive disease|0|||
94532229|NCT02566785|323743569|FG000|Overall Study|Lost to Follow-up|0|||
94532230|NCT02566785|323743570|FG001|Overall Study|Lost to Follow-up|2|||
94532231|NCT02566785|323743569|FG000|Overall Study|Worsening condition|1|||
94532232|NCT02566785|323743570|FG001|Overall Study|Worsening condition|1|||
94532233|NCT01802580|323743572|FG000|Overall Study|Physician Decision|1|||
94532234|NCT01802580|323743573|FG001|Overall Study|Physician Decision|0|||
94532235|NCT01802580|323743572|FG000|Overall Study|Protocol Violation|2|||
94532236|NCT01802580|323743573|FG001|Overall Study|Protocol Violation|0|||
94532237|NCT01802580|323743572|FG000|Overall Study|Withdrawal by Subject|5|||
94532238|NCT01802580|323743573|FG001|Overall Study|Withdrawal by Subject|6|||
94532239|NCT01802580|323743572|FG000|Overall Study|Other|1|||
94532240|NCT01802580|323743573|FG001|Overall Study|Other|3|||
94532241|NCT01802580|323743572|FG000|Overall Study|Lack of Efficacy|0|||
94532242|NCT01802580|323743573|FG001|Overall Study|Lack of Efficacy|2|||
94532243|NCT01597908|323743574|FG000|Randomized Phase|Death|217|||
94532244|NCT01597908|323743575|FG001|Randomized Phase|Death|238|||
94532245|NCT01597908|323743576|FG002|Randomized Phase|Death|0|||
94532246|NCT01597908|323743574|FG000|Randomized Phase|Sponsor Decision|93|||
94532247|NCT01597908|323743575|FG001|Randomized Phase|Sponsor Decision|39|||
94532248|NCT01597908|323743576|FG002|Randomized Phase|Sponsor Decision|0|||
94532249|NCT01597908|323743574|FG000|Randomized Phase|Lost to Follow-up|9|||
94532250|NCT01597908|323743575|FG001|Randomized Phase|Lost to Follow-up|16|||
94532251|NCT01597908|323743576|FG002|Randomized Phase|Lost to Follow-up|0|||
94532252|NCT01597908|323743574|FG000|Randomized Phase|Physician Decision|6|||
94532253|NCT01597908|323743575|FG001|Randomized Phase|Physician Decision|3|||
94532254|NCT01597908|323743576|FG002|Randomized Phase|Physician Decision|0|||
94532255|NCT01597908|323743574|FG000|Randomized Phase|Withdrawal by Subject|26|||
94532256|NCT01597908|323743575|FG001|Randomized Phase|Withdrawal by Subject|22|||
94532257|NCT01597908|323743576|FG002|Randomized Phase|Withdrawal by Subject|0|||
94532258|NCT01597908|323743574|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
94532259|NCT01597908|323743575|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
94532260|NCT01597908|323743576|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
94532261|NCT01597908|323743574|FG000|Crossover Phase|Death|0|||
94532262|NCT01597908|323743575|FG001|Crossover Phase|Death|0|||
94532263|NCT01597908|323743576|FG002|Crossover Phase|Death|11|||
94532264|NCT01597908|323743574|FG000|Crossover Phase|Withdrawal by Subject|0|||
94532265|NCT01597908|323743575|FG001|Crossover Phase|Withdrawal by Subject|0|||
94532266|NCT01597908|323743576|FG002|Crossover Phase|Withdrawal by Subject|3|||
94532267|NCT01597908|323743574|FG000|Crossover Phase|Sponsor Decision|0|||
94532268|NCT01597908|323743575|FG001|Crossover Phase|Sponsor Decision|0|||
94532269|NCT01597908|323743576|FG002|Crossover Phase|Sponsor Decision|20|||
94532270|NCT02524275|323743579|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
94532271|NCT03206918|323743584|FG000|Overall Study|Death|11|||
94532272|NCT03206918|323743584|FG000|Overall Study|Withdrawal by Subject|5|||
94532273|NCT03206918|323743584|FG000|Overall Study|Study terminated by sponsor|12|||
94532274|NCT03206918|323743584|FG000|Overall Study|Lost to Follow-up|3|||
94532275|NCT03206918|323743584|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
94532276|NCT00661726|323743585|FG000|Overall Study|Adverse Event|1|||
94532277|NCT00780143|323743586|FG000|Overall Study|Progressive disease|1|||
94532278|NCT00780143|323743586|FG000|Overall Study|Toxicity|1|||
94532279|NCT00780143|323743586|FG000|Overall Study|Adverse Event|1|||
94532280|NCT01846299|323743587|FG000|Overall Study|Physician Decision|4|||
94532281|NCT01846299|323743588|FG001|Overall Study|Physician Decision|2|||
94532282|NCT01846299|323743587|FG000|Overall Study|Protocol deviation|1|||
94532283|NCT01846299|323743588|FG001|Overall Study|Protocol deviation|0|||
94532284|NCT01846299|323743587|FG000|Overall Study|Death|1|||
94532285|NCT01846299|323743588|FG001|Overall Study|Death|2|||
94532286|NCT01846299|323743587|FG000|Overall Study|Lost to Follow-up|3|||
94532287|NCT01846299|323743588|FG001|Overall Study|Lost to Follow-up|0|||
94532288|NCT01846299|323743587|FG000|Overall Study|Withdrawal by Subject|1|||
94532289|NCT01846299|323743588|FG001|Overall Study|Withdrawal by Subject|6|||
94532290|NCT01846299|323743587|FG000|Overall Study|Adverse Event|2|||
94532291|NCT01846299|323743588|FG001|Overall Study|Adverse Event|0|||
94532292|NCT00526656|323743589|FG000|Overall Study|Death|1|||
94532293|NCT00526656|323743589|FG000|Overall Study|Refused surgery|1|||
94532294|NCT01681186|323745358|FG000|Washout Period From Second Intervention|Adverse Event|0|||
94532295|NCT01681186|323745359|FG001|Washout Period From Second Intervention|Adverse Event|0|||
94532296|NCT01681186|323745360|FG002|Washout Period From Second Intervention|Adverse Event|0|||
94532297|NCT01681186|323745361|FG003|Washout Period From Second Intervention|Adverse Event|0|||
94532298|NCT01681186|323745362|FG004|Washout Period From Second Intervention|Adverse Event|0|||
94532299|NCT01681186|323745363|FG005|Washout Period From Second Intervention|Adverse Event|0|||
94532300|NCT01681186|323745364|FG006|Washout Period From Second Intervention|Adverse Event|1|||
94532301|NCT01681186|323745365|FG007|Washout Period From Second Intervention|Adverse Event|0|||
94532302|NCT01681186|323745358|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
94532303|NCT01681186|323745359|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
94532304|NCT01681186|323745360|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
94532305|NCT01681186|323745361|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
94532306|NCT01681186|323745362|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
94532307|NCT01681186|323745363|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
94532308|NCT01681186|323745364|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
94532309|NCT01681186|323745365|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
94532310|NCT01681186|323745358|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
94532311|NCT01681186|323745359|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
94532312|NCT01681186|323745360|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
94532313|NCT01681186|323745361|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
94532314|NCT01681186|323745362|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
94532315|NCT01681186|323745363|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
94532316|NCT01681186|323745364|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
94532317|NCT01681186|323745365|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
94532318|NCT01681186|323745358|FG000|Fourth Intervention|Protocol Violation|0|||
94532319|NCT01681186|323745359|FG001|Fourth Intervention|Protocol Violation|0|||
94532320|NCT01681186|323745360|FG002|Fourth Intervention|Protocol Violation|0|||
94532321|NCT01681186|323745361|FG003|Fourth Intervention|Protocol Violation|0|||
94532322|NCT01681186|323745362|FG004|Fourth Intervention|Protocol Violation|0|||
94532323|NCT01681186|323745363|FG005|Fourth Intervention|Protocol Violation|0|||
94532324|NCT01681186|323745364|FG006|Fourth Intervention|Protocol Violation|0|||
94532325|NCT01681186|323745365|FG007|Fourth Intervention|Protocol Violation|1|||
94532326|NCT02290691|323745366|FG000|Overall Study|Noncompliance|0|||
94532327|NCT02290691|323745367|FG001|Overall Study|Noncompliance|1|||
94532328|NCT02290691|323745366|FG000|Overall Study|Withdrawal by Subject|1|||
94532329|NCT02290691|323745367|FG001|Overall Study|Withdrawal by Subject|1|||
94532330|NCT02290691|323745366|FG000|Overall Study|Lost to Follow-up|7|||
94532331|NCT02290691|323745367|FG001|Overall Study|Lost to Follow-up|7|||
94532332|NCT03530995|323745369|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
94532333|NCT03530995|323745370|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
94532334|NCT03530995|323745369|FG000|Part 1 Period 3|Protocol Violation|1|||
94532335|NCT03530995|323745370|FG001|Part 1 Period 3|Protocol Violation|0|||
94532336|NCT03530995|323745369|FG000|Part 1 Period 4|Physician Decision|1|||
94532337|NCT03530995|323745370|FG001|Part 1 Period 4|Physician Decision|0|||
94532338|NCT03530995|323745369|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
94532339|NCT03530995|323745370|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
94532340|NCT00218634|323745376|FG000|Overall Study|Lost to Follow-up|8|||
94532341|NCT00218634|323745377|FG001|Overall Study|Lost to Follow-up|15|||
94532342|NCT00327015|323745378|FG000|Overall Study|Lack of Efficacy|18|||
94532343|NCT00327015|323745379|FG001|Overall Study|Lack of Efficacy|18|||
94532344|NCT00327015|323745380|FG002|Overall Study|Lack of Efficacy|35|||
94532345|NCT00327015|323745381|FG003|Overall Study|Lack of Efficacy|29|||
94532346|NCT00327015|323745378|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
94532347|NCT00327015|323745379|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
94532348|NCT00327015|323745380|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
94532349|NCT00327015|323745381|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
94532350|NCT00327015|323745378|FG000|Overall Study|Lost to Follow-up|22|||
94532351|NCT00327015|323745379|FG001|Overall Study|Lost to Follow-up|23|||
94532352|NCT00327015|323745380|FG002|Overall Study|Lost to Follow-up|29|||
94532353|NCT00327015|323745381|FG003|Overall Study|Lost to Follow-up|22|||
94532354|NCT00327015|323745378|FG000|Overall Study|Adverse Event|14|||
94532355|NCT00327015|323745379|FG001|Overall Study|Adverse Event|10|||
94532356|NCT00327015|323745380|FG002|Overall Study|Adverse Event|14|||
94532357|NCT00327015|323745381|FG003|Overall Study|Adverse Event|14|||
94532358|NCT00327015|323745378|FG000|Overall Study|Subject no longer meets study criteria|4|||
94532359|NCT00327015|323745379|FG001|Overall Study|Subject no longer meets study criteria|2|||
94532360|NCT00327015|323745380|FG002|Overall Study|Subject no longer meets study criteria|8|||
94532361|NCT00327015|323745381|FG003|Overall Study|Subject no longer meets study criteria|7|||
94532362|NCT00327015|323745378|FG000|Overall Study|Poor/Noncompliance|11|||
94532363|NCT00327015|323745379|FG001|Overall Study|Poor/Noncompliance|8|||
94532364|NCT00327015|323745380|FG002|Overall Study|Poor/Noncompliance|4|||
94532365|NCT00327015|323745381|FG003|Overall Study|Poor/Noncompliance|5|||
94532366|NCT00327015|323745378|FG000|Overall Study|Physician Decision|0|||
94532367|NCT00327015|323745379|FG001|Overall Study|Physician Decision|1|||
94532368|NCT00327015|323745380|FG002|Overall Study|Physician Decision|3|||
94532369|NCT00327015|323745381|FG003|Overall Study|Physician Decision|2|||
94532370|NCT00327015|323745378|FG000|Overall Study|Death|1|||
94532371|NCT00327015|323745379|FG001|Overall Study|Death|2|||
94532372|NCT00327015|323745380|FG002|Overall Study|Death|2|||
94532373|NCT00327015|323745381|FG003|Overall Study|Death|3|||
94532374|NCT00327015|323745378|FG000|Overall Study|Pregnancy|0|||
94532375|NCT00327015|323745379|FG001|Overall Study|Pregnancy|2|||
94532376|NCT00327015|323745380|FG002|Overall Study|Pregnancy|1|||
94532377|NCT00327015|323745381|FG003|Overall Study|Pregnancy|1|||
94532378|NCT00327015|323745378|FG000|Overall Study|Administrative Reason by Sponsor|1|||
94532379|NCT00327015|323745379|FG001|Overall Study|Administrative Reason by Sponsor|2|||
94532380|NCT00327015|323745380|FG002|Overall Study|Administrative Reason by Sponsor|2|||
94532381|NCT00327015|323745381|FG003|Overall Study|Administrative Reason by Sponsor|1|||
94532382|NCT04848220|323745386|FG000|Overall Study|Unable to proceed to study procedure|0|||
94532383|NCT04848220|323745387|FG001|Overall Study|Unable to proceed to study procedure|1|||
94532384|NCT04848220|323745388|FG002|Overall Study|Unable to proceed to study procedure|0|||
94532385|NCT04848220|323745386|FG000|Overall Study|Fractional flow not significant|0|||
94532386|NCT04848220|323745387|FG001|Overall Study|Fractional flow not significant|1|||
94532387|NCT04848220|323745388|FG002|Overall Study|Fractional flow not significant|0|||
94532388|NCT02923830|323745389|FG000|Overall Study|Physician Decision|13|||
94532389|NCT02923830|323745390|FG001|Overall Study|Physician Decision|15|||
94532390|NCT00837265|323745393|FG000|Pilot Phase|Withdrawal by Subject|0|||
94532391|NCT00837265|323745394|FG001|Pilot Phase|Withdrawal by Subject|2|||
94532392|NCT00837265|323745395|FG002|Pilot Phase|Withdrawal by Subject|3|||
94532393|NCT00837265|323745396|FG003|Pilot Phase|Withdrawal by Subject|2|||
94532394|NCT00837265|323745397|FG004|Pilot Phase|Withdrawal by Subject|0|||
94532395|NCT00837265|323745398|FG005|Pilot Phase|Withdrawal by Subject|0|||
94532396|NCT00837265|323745399|FG006|Pilot Phase|Withdrawal by Subject|0|||
94532397|NCT00837265|323745393|FG000|Pilot Phase|Decision of the investigator|2|||
94532398|NCT00837265|323745394|FG001|Pilot Phase|Decision of the investigator|1|||
94532399|NCT00837265|323745395|FG002|Pilot Phase|Decision of the investigator|0|||
94532400|NCT00837265|323745396|FG003|Pilot Phase|Decision of the investigator|0|||
94532401|NCT00837265|323745397|FG004|Pilot Phase|Decision of the investigator|0|||
94532402|NCT00837265|323745398|FG005|Pilot Phase|Decision of the investigator|0|||
94532403|NCT00837265|323745399|FG006|Pilot Phase|Decision of the investigator|0|||
94532404|NCT00837265|323745393|FG000|Pilot Phase|Adverse Event|1|||
94532405|NCT00837265|323745394|FG001|Pilot Phase|Adverse Event|0|||
94532406|NCT00837265|323745395|FG002|Pilot Phase|Adverse Event|0|||
94532407|NCT00837265|323745396|FG003|Pilot Phase|Adverse Event|0|||
94532408|NCT00837265|323745397|FG004|Pilot Phase|Adverse Event|0|||
94532409|NCT00837265|323745398|FG005|Pilot Phase|Adverse Event|0|||
94532410|NCT00837265|323745399|FG006|Pilot Phase|Adverse Event|0|||
94532411|NCT00837265|323745393|FG000|Pilot Phase|Disease progression|0|||
94532412|NCT00837265|323745394|FG001|Pilot Phase|Disease progression|0|||
94532413|NCT00837265|323745395|FG002|Pilot Phase|Disease progression|0|||
94532414|NCT00837265|323745396|FG003|Pilot Phase|Disease progression|1|||
94532415|NCT00837265|323745397|FG004|Pilot Phase|Disease progression|0|||
94532416|NCT00837265|323745398|FG005|Pilot Phase|Disease progression|0|||
94532417|NCT00837265|323745399|FG006|Pilot Phase|Disease progression|0|||
94532418|NCT00837265|323745393|FG000|Pilot Phase|Participant left the city|0|||
94532419|NCT00837265|323745394|FG001|Pilot Phase|Participant left the city|0|||
94532420|NCT00837265|323745395|FG002|Pilot Phase|Participant left the city|0|||
94532421|NCT00837265|323745396|FG003|Pilot Phase|Participant left the city|1|||
94532422|NCT00837265|323745397|FG004|Pilot Phase|Participant left the city|0|||
94532423|NCT00837265|323745398|FG005|Pilot Phase|Participant left the city|0|||
94532424|NCT00837265|323745399|FG006|Pilot Phase|Participant left the city|0|||
94532425|NCT00837265|323745393|FG000|Main Phase|Withdrawal by Subject|0|||
94532426|NCT00837265|323745394|FG001|Main Phase|Withdrawal by Subject|0|||
94532427|NCT00837265|323745395|FG002|Main Phase|Withdrawal by Subject|0|||
94532428|NCT00837265|323745396|FG003|Main Phase|Withdrawal by Subject|0|||
94532429|NCT00837265|323745397|FG004|Main Phase|Withdrawal by Subject|4|||
94532430|NCT00837265|323745398|FG005|Main Phase|Withdrawal by Subject|2|||
94532431|NCT00837265|323745399|FG006|Main Phase|Withdrawal by Subject|1|||
94532432|NCT00837265|323745393|FG000|Main Phase|Decision of the investigator|0|||
94532433|NCT00837265|323745394|FG001|Main Phase|Decision of the investigator|0|||
94532434|NCT00837265|323745395|FG002|Main Phase|Decision of the investigator|0|||
94532435|NCT00837265|323745396|FG003|Main Phase|Decision of the investigator|0|||
94532436|NCT00837265|323745397|FG004|Main Phase|Decision of the investigator|0|||
94532437|NCT00837265|323745398|FG005|Main Phase|Decision of the investigator|2|||
94532438|NCT00837265|323745399|FG006|Main Phase|Decision of the investigator|1|||
94532439|NCT00837265|323745393|FG000|Main Phase|Adverse Event|0|||
94532440|NCT00837265|323745394|FG001|Main Phase|Adverse Event|0|||
94532441|NCT00837265|323745395|FG002|Main Phase|Adverse Event|0|||
94532442|NCT00837265|323745396|FG003|Main Phase|Adverse Event|0|||
94532443|NCT00837265|323745397|FG004|Main Phase|Adverse Event|0|||
94532444|NCT00837265|323745398|FG005|Main Phase|Adverse Event|1|||
94532445|NCT00837265|323745399|FG006|Main Phase|Adverse Event|0|||
94532446|NCT00837265|323745393|FG000|Main Phase|Death|0|||
94532447|NCT00837265|323745394|FG001|Main Phase|Death|0|||
94532448|NCT00837265|323745395|FG002|Main Phase|Death|0|||
94532449|NCT00837265|323745396|FG003|Main Phase|Death|0|||
94532450|NCT00837265|323745397|FG004|Main Phase|Death|2|||
94532451|NCT00837265|323745398|FG005|Main Phase|Death|0|||
94532452|NCT00837265|323745399|FG006|Main Phase|Death|1|||
94532453|NCT00837265|323745393|FG000|Main Phase|Lost to Follow-up|0|||
94532454|NCT00837265|323745394|FG001|Main Phase|Lost to Follow-up|0|||
94532455|NCT00837265|323745395|FG002|Main Phase|Lost to Follow-up|0|||
94532456|NCT00837265|323745396|FG003|Main Phase|Lost to Follow-up|0|||
94532457|NCT00837265|323745397|FG004|Main Phase|Lost to Follow-up|1|||
94532458|NCT00837265|323745398|FG005|Main Phase|Lost to Follow-up|0|||
94532459|NCT00837265|323745399|FG006|Main Phase|Lost to Follow-up|0|||
94532460|NCT00837265|323745393|FG000|Main Phase|Principal investigator resignation|0|||
94532461|NCT00837265|323745394|FG001|Main Phase|Principal investigator resignation|0|||
94532462|NCT00837265|323745395|FG002|Main Phase|Principal investigator resignation|0|||
94532463|NCT00837265|323745396|FG003|Main Phase|Principal investigator resignation|0|||
94532464|NCT00837265|323745397|FG004|Main Phase|Principal investigator resignation|2|||
94532465|NCT00837265|323745398|FG005|Main Phase|Principal investigator resignation|0|||
94532466|NCT00837265|323745399|FG006|Main Phase|Principal investigator resignation|0|||
94532467|NCT00837265|323745393|FG000|Main Phase|Participant's personal reason|0|||
94532468|NCT00837265|323745394|FG001|Main Phase|Participant's personal reason|0|||
94532469|NCT00837265|323745395|FG002|Main Phase|Participant's personal reason|0|||
94532470|NCT00837265|323745396|FG003|Main Phase|Participant's personal reason|0|||
94532471|NCT00837265|323745397|FG004|Main Phase|Participant's personal reason|1|||
94532472|NCT00837265|323745398|FG005|Main Phase|Participant's personal reason|0|||
94532473|NCT00837265|323745399|FG006|Main Phase|Participant's personal reason|0|||
94532474|NCT02403817|323745400|FG000|Overall Study|Withdrawal by Subject|5|||
94532475|NCT02403817|323745401|FG001|Overall Study|Withdrawal by Subject|0|||
94532476|NCT01110330|323745408|FG000|Overall Study|Adverse Event|0|||
94532477|NCT01110330|323745409|FG001|Overall Study|Adverse Event|4|||
94532478|NCT01110330|323745410|FG002|Overall Study|Adverse Event|3|||
94532479|NCT01110330|323745408|FG000|Overall Study|Lack of Efficacy|3|||
94532480|NCT01110330|323745409|FG001|Overall Study|Lack of Efficacy|1|||
94532481|NCT01110330|323745410|FG002|Overall Study|Lack of Efficacy|1|||
94532482|NCT01110330|323745408|FG000|Overall Study|Lost to Follow-up|9|||
94532483|NCT01110330|323745409|FG001|Overall Study|Lost to Follow-up|10|||
94532484|NCT01110330|323745410|FG002|Overall Study|Lost to Follow-up|15|||
94532485|NCT01110330|323745408|FG000|Overall Study|Physician Decision|0|||
94532486|NCT01110330|323745409|FG001|Overall Study|Physician Decision|1|||
94532487|NCT01110330|323745410|FG002|Overall Study|Physician Decision|0|||
94532488|NCT01110330|323745408|FG000|Overall Study|Protocol Violation|2|||
94532489|NCT01110330|323745409|FG001|Overall Study|Protocol Violation|0|||
94532490|NCT01110330|323745410|FG002|Overall Study|Protocol Violation|4|||
94532491|NCT01110330|323745408|FG000|Overall Study|Withdrawal by Subject|0|||
94532492|NCT01110330|323745409|FG001|Overall Study|Withdrawal by Subject|6|||
94532493|NCT01110330|323745410|FG002|Overall Study|Withdrawal by Subject|2|||
94532494|NCT01110330|323745408|FG000|Overall Study|Other|1|||
94532495|NCT01110330|323745409|FG001|Overall Study|Other|1|||
94532496|NCT01110330|323745410|FG002|Overall Study|Other|1|||
94532497|NCT00459875|323745411|FG000|Overall Study|Ineligible participant|1|||
94532498|NCT00459875|323745411|FG000|Overall Study|Adverse Event|2|||
94532499|NCT02557100|323745420|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
94532500|NCT02557100|323745421|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
94532501|NCT02557100|323745422|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
94532502|NCT02557100|323745420|FG000|Single Blind Treatment Period|Death|0|||
94532503|NCT02557100|323745421|FG001|Single Blind Treatment Period|Death|1|||
94532504|NCT02557100|323745422|FG002|Single Blind Treatment Period|Death|0|||
94532505|NCT02557100|323745420|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
94532506|NCT02557100|323745421|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
94532507|NCT02557100|323745422|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
94532508|NCT02557100|323745420|FG000|Single Blind Treatment Period|Adverse Event|0|||
94532509|NCT02557100|323745421|FG001|Single Blind Treatment Period|Adverse Event|1|||
94532510|NCT02557100|323745422|FG002|Single Blind Treatment Period|Adverse Event|0|||
94532511|NCT02557100|323745420|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
94532512|NCT02557100|323745421|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
94532513|NCT02557100|323745422|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
94532514|NCT02557100|323745420|FG000|Cumulative Abatacept Period|Other Reasons|0|||
94532515|NCT02557100|323745421|FG001|Cumulative Abatacept Period|Other Reasons|0|||
94532516|NCT02557100|323745422|FG002|Cumulative Abatacept Period|Other Reasons|1|||
94532517|NCT02557100|323745420|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
94532518|NCT02557100|323745421|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
94532519|NCT02557100|323745422|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
94532520|NCT02557100|323745420|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
94532521|NCT02557100|323745421|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
94532522|NCT02557100|323745422|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
94532523|NCT02150057|323745432|FG000|Overall Study|Lost to Follow-up|6|||
94532524|NCT02150057|323745433|FG001|Overall Study|Lost to Follow-up|4|||
94532525|NCT05791565|323745434|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
94532526|NCT05791565|323745435|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
94532527|NCT04729972|323745436|FG000|Overall Study|Adverse Event|1|||
94532528|NCT02388165|323745437|FG000|Overall Study|Study terminated by sponsor|5|||
94532529|NCT02388165|323745438|FG001|Overall Study|Study terminated by sponsor|5|||
94532530|NCT02388165|323745437|FG000|Overall Study|Other|11|||
94532531|NCT02388165|323745438|FG001|Overall Study|Other|13|||
94532532|NCT02388165|323745437|FG000|Overall Study|No longer meet eligibility criteria|40|||
94532533|NCT02388165|323745438|FG001|Overall Study|No longer meet eligibility criteria|43|||
94532534|NCT02388165|323745437|FG000|Overall Study|Withdrawal of consent|31|||
94532535|NCT02388165|323745438|FG001|Overall Study|Withdrawal of consent|32|||
94532536|NCT02388165|323745437|FG000|Overall Study|Lost to Follow-up|19|||
94532537|NCT02388165|323745438|FG001|Overall Study|Lost to Follow-up|20|||
94532538|NCT02388165|323745437|FG000|Overall Study|Death|13|||
94532539|NCT02388165|323745438|FG001|Overall Study|Death|10|||
94532540|NCT02388165|323745437|FG000|Overall Study|Adverse Event|3|||
94532541|NCT02388165|323745438|FG001|Overall Study|Adverse Event|5|||
94532542|NCT02388165|323745437|FG000|Overall Study|Did not meet entrance criteria|5|||
94532543|NCT02388165|323745438|FG001|Overall Study|Did not meet entrance criteria|2|||
94532544|NCT03050450|323745439|FG000|Overall Study|Physician Decision|1|||
94532545|NCT03050450|323745440|FG001|Overall Study|Physician Decision|0|||
94532546|NCT03050450|323745441|FG002|Overall Study|Physician Decision|0|||
94532547|NCT03050450|323745442|FG003|Overall Study|Physician Decision|0|||
94532548|NCT03050450|323745443|FG004|Overall Study|Physician Decision|0|||
94532549|NCT00443872|323745447|FG000|Overall Study|Protocol Violation|7|||
94532550|NCT00443872|323745447|FG000|Overall Study|Lost to Follow-up|2|||
94532551|NCT00443872|323745447|FG000|Overall Study|Adverse Event|8|||
94532552|NCT01951586|323745450|FG000|Overall Study|Death|61|||
94532553|NCT01951586|323745451|FG001|Overall Study|Death|120|||
94532554|NCT01951586|323745450|FG000|Overall Study|Withdrawal by Subject|8|||
94532555|NCT01951586|323745451|FG001|Overall Study|Withdrawal by Subject|17|||
94532556|NCT01951586|323745450|FG000|Overall Study|Lost to Follow-up|0|||
94532557|NCT01951586|323745451|FG001|Overall Study|Lost to Follow-up|1|||
94532558|NCT01951586|323745450|FG000|Overall Study|Sponsor Decision|9|||
94532559|NCT01951586|323745451|FG001|Overall Study|Sponsor Decision|10|||
94532560|NCT02789345|323745452|FG000|Overall Study|Adverse Event|0|||
94532561|NCT02789345|323745453|FG001|Overall Study|Adverse Event|0|||
94532562|NCT02789345|323745454|FG002|Overall Study|Adverse Event|1|||
94532563|NCT02789345|323745452|FG000|Overall Study|Death|0|||
94532564|NCT02789345|323745453|FG001|Overall Study|Death|0|||
94532565|NCT02789345|323745454|FG002|Overall Study|Death|1|||
94532566|NCT02789345|323745452|FG000|Overall Study|Physician Decision|2|||
94532567|NCT02789345|323745453|FG001|Overall Study|Physician Decision|0|||
94532568|NCT02789345|323745454|FG002|Overall Study|Physician Decision|1|||
94532569|NCT02789345|323745452|FG000|Overall Study|Progressive Disease|1|||
94532570|NCT02789345|323745453|FG001|Overall Study|Progressive Disease|3|||
94532571|NCT02789345|323745454|FG002|Overall Study|Progressive Disease|14|||
94532572|NCT01667224|323745455|FG000|Overall Study|Withdrawal by Subject|3|||
94532573|NCT01667224|323745456|FG001|Overall Study|Withdrawal by Subject|1|||
94532574|NCT01667224|323745455|FG000|Overall Study|Protocol Violation|1|||
94532575|NCT01667224|323745456|FG001|Overall Study|Protocol Violation|1|||
94532576|NCT03645421|323745462|FG000|Overall Study|Adverse Event|0|||
94532577|NCT03645421|323745463|FG001|Overall Study|Adverse Event|0|||
94532578|NCT03645421|323745464|FG002|Overall Study|Adverse Event|4|||
94532579|NCT03645421|323745465|FG003|Overall Study|Adverse Event|1|||
94532580|NCT03645421|323745462|FG000|Overall Study|Withdrawal by patient|0|||
94532581|NCT03645421|323745463|FG001|Overall Study|Withdrawal by patient|0|||
94532582|NCT03645421|323745464|FG002|Overall Study|Withdrawal by patient|0|||
94532583|NCT03645421|323745465|FG003|Overall Study|Withdrawal by patient|3|||
94532584|NCT03645421|323745462|FG000|Overall Study|Study specific withdrawal criteria|0|||
94532585|NCT03645421|323745463|FG001|Overall Study|Study specific withdrawal criteria|0|||
94532586|NCT03645421|323745464|FG002|Overall Study|Study specific withdrawal criteria|1|||
94532587|NCT03645421|323745465|FG003|Overall Study|Study specific withdrawal criteria|0|||
94532588|NCT03654404|323745466|FG000|Overall Study|Death|1|||
94532589|NCT03654404|323745466|FG000|Overall Study|Lost to Follow-up|2|||
94532590|NCT03654404|323745466|FG000|Overall Study|Withdrawal by Subject|5|||
94532591|NCT02003638|323745471|FG000|Overall Study|Withdrawal by Subject|1|||
94532592|NCT02003638|323745472|FG001|Overall Study|Withdrawal by Subject|0|||
94532593|NCT03215758|323745473|FG000|Overall Study|Technical Problems|1|||
94532594|NCT03215758|323745474|FG001|Overall Study|Technical Problems|0|||
94532595|NCT03215758|323745473|FG000|Overall Study|Protocol deviation|0|||
94532596|NCT03215758|323745474|FG001|Overall Study|Protocol deviation|1|||
94532597|NCT03215758|323745473|FG000|Overall Study|Physician Decision|0|||
94532598|NCT03215758|323745474|FG001|Overall Study|Physician Decision|1|||
94532599|NCT03215758|323745473|FG000|Overall Study|Death|0|||
94532600|NCT03215758|323745474|FG001|Overall Study|Death|1|||
94532601|NCT03215758|323745473|FG000|Overall Study|Adverse Event|1|||
94532602|NCT03215758|323745474|FG001|Overall Study|Adverse Event|2|||
94532603|NCT03215758|323745473|FG000|Overall Study|Subject/Guardian Decision|3|||
94532604|NCT03215758|323745474|FG001|Overall Study|Subject/Guardian Decision|3|||
94532605|NCT04115748|323745475|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
94532606|NCT04115748|323745476|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
94532607|NCT04115748|323745477|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
94532608|NCT04115748|323745478|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
94532609|NCT04115748|323745479|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
94532610|NCT04115748|323745480|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
94532611|NCT04115748|323745481|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
94532612|NCT04115748|323745482|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
94532613|NCT04115748|323745483|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
94532614|NCT04115748|323745484|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
94532615|NCT04115748|323745475|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
94532616|NCT04115748|323745476|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
94532617|NCT04115748|323745477|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
94532618|NCT04115748|323745478|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
94532619|NCT04115748|323745479|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
94532620|NCT04115748|323745480|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
94532621|NCT04115748|323745481|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
94532622|NCT04115748|323745482|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
94532623|NCT04115748|323745483|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
94532624|NCT04115748|323745484|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
94532625|NCT04115748|323745475|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
94532626|NCT04115748|323745476|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
94532627|NCT04115748|323745477|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
94532628|NCT04115748|323745478|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
94532629|NCT04115748|323745479|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
94532630|NCT04115748|323745480|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
94532631|NCT04115748|323745481|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
94532632|NCT04115748|323745482|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
94532633|NCT04115748|323745483|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
94532634|NCT04115748|323745484|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
94532635|NCT04115748|323745475|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
94532636|NCT04115748|323745476|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
94532637|NCT04115748|323745477|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
94532638|NCT04115748|323745478|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
94532639|NCT04115748|323745479|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
94532640|NCT04115748|323745480|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
94532641|NCT04115748|323745481|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
94532642|NCT04115748|323745482|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
94532643|NCT04115748|323745483|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
94532644|NCT04115748|323745484|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
94532645|NCT01200407|323745485|FG000|Overall Study|Lost to Follow-up|56|||
94532646|NCT01200407|323745485|FG000|Overall Study|Adverse Event|3|||
94532647|NCT01200407|323745485|FG000|Overall Study|Withdrawal by Subject|4|||
94532648|NCT01200407|323745485|FG000|Overall Study|Other|19|||
94532649|NCT03299881|323745486|FG000|Overall Study|Study Termination|17|||
94532650|NCT03299881|323745487|FG001|Overall Study|Study Termination|13|||
94532651|NCT01289353|323745488|FG000|Overall Study|Lost to Follow-up|2|||
94532652|NCT01549886|323745489|FG000|Overall Study|Sponsor's decision|2|||
94532653|NCT01549886|323745490|FG001|Overall Study|Sponsor's decision|3|||
94532654|NCT00006164|323745492|FG000|Overall Study|Withdrew or lost to follow-up|70|||
94532655|NCT00006164|323745493|FG001|Overall Study|Withdrew or lost to follow-up|81|||
94532656|NCT01474772|323745494|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
94532657|NCT01474772|323745495|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
94532658|NCT01474772|323745494|FG000|Period 1|AE not Related to Study Drug|1|||
94532659|NCT01474772|323745495|FG001|Period 1|AE not Related to Study Drug|0|||
94532660|NCT01474772|323745494|FG000|Period 1|Withdrawal by Subject|3|||
94532661|NCT01474772|323745495|FG001|Period 1|Withdrawal by Subject|1|||
94532662|NCT01474772|323745494|FG000|Period 1|Lost to Follow-up|1|||
94532663|NCT01474772|323745495|FG001|Period 1|Lost to Follow-up|0|||
94532664|NCT01474772|323745494|FG000|Period 1|Reason not Specified|1|||
94532665|NCT01474772|323745495|FG001|Period 1|Reason not Specified|1|||
94532666|NCT01474772|323745494|FG000|Washout|AE not Related to Study Drug|2|||
94532667|NCT01474772|323745495|FG001|Washout|AE not Related to Study Drug|0|||
94532668|NCT01474772|323745494|FG000|Washout|Withdrawal by Subject|1|||
94532669|NCT01474772|323745495|FG001|Washout|Withdrawal by Subject|0|||
94532670|NCT01474772|323745494|FG000|Washout|Lost to Follow-up|0|||
94532671|NCT01474772|323745495|FG001|Washout|Lost to Follow-up|1|||
94532672|NCT01474772|323745494|FG000|Washout|Reason not Specified|0|||
94532673|NCT01474772|323745495|FG001|Washout|Reason not Specified|1|||
94532674|NCT01474772|323745494|FG000|Period 2|Death|0|||
94532675|NCT01474772|323745495|FG001|Period 2|Death|1|||
94532676|NCT01474772|323745494|FG000|Period 2|AE Related to Study Drug|0|||
94532677|NCT01474772|323745495|FG001|Period 2|AE Related to Study Drug|1|||
94532678|NCT01474772|323745494|FG000|Period 2|AE not Related to Study Drug|4|||
94532679|NCT01474772|323745495|FG001|Period 2|AE not Related to Study Drug|1|||
94532680|NCT01474772|323745494|FG000|Period 2|Lack of Efficacy|1|||
94532681|NCT01474772|323745495|FG001|Period 2|Lack of Efficacy|0|||
94532682|NCT01474772|323745494|FG000|Period 2|Withdrawal by Subject|3|||
94532683|NCT01474772|323745495|FG001|Period 2|Withdrawal by Subject|4|||
94532684|NCT01474772|323745494|FG000|Period 2|Lost to Follow-up|1|||
94532685|NCT01474772|323745495|FG001|Period 2|Lost to Follow-up|1|||
94532686|NCT01474772|323745494|FG000|Period 2|Reason not Specified|0|||
94532687|NCT01474772|323745495|FG001|Period 2|Reason not Specified|2|||
94532688|NCT01474772|323745494|FG000|Follow-up|AE not Related to Study Drug|0|||
94532689|NCT01474772|323745495|FG001|Follow-up|AE not Related to Study Drug|1|||
94532690|NCT00633074|323745496|FG000|Overall Study|Adverse Event|1|||
94532691|NCT00633074|323745497|FG001|Overall Study|Adverse Event|0|||
94532692|NCT00223808|323745498|FG000|Overall Study|<5 hrs therapy before discharge|3|||
94532693|NCT00223808|323745499|FG001|Overall Study|<5 hrs therapy before discharge|5|||
94532694|NCT00223808|323745500|FG002|Overall Study|<5 hrs therapy before discharge|5|||
94532695|NCT04484649|323745501|FG000|Overall Study|Lost to Follow-up|2|||
94532696|NCT04484649|323745502|FG001|Overall Study|Lost to Follow-up|1|||
94532697|NCT04484649|323745501|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
94532698|NCT04484649|323745502|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
94532699|NCT01463696|323745503|FG000|Overall Study|Adverse Event|0|||
94532700|NCT01463696|323745504|FG001|Overall Study|Adverse Event|1|||
94532701|NCT01463696|323745505|FG002|Overall Study|Adverse Event|0|||
94532702|NCT01463696|323745506|FG003|Overall Study|Adverse Event|2|||
94532703|NCT01463696|323745507|FG004|Overall Study|Adverse Event|0|||
94532704|NCT01463696|323745508|FG005|Overall Study|Adverse Event|1|||
94532705|NCT01463696|323745509|FG006|Overall Study|Adverse Event|3|||
94532706|NCT01463696|323745510|FG007|Overall Study|Adverse Event|2|||
94532707|NCT01463696|323745503|FG000|Overall Study|Lost to Follow-up|0|||
94532708|NCT01463696|323745504|FG001|Overall Study|Lost to Follow-up|0|||
94532709|NCT01463696|323745505|FG002|Overall Study|Lost to Follow-up|1|||
94532710|NCT01463696|323745506|FG003|Overall Study|Lost to Follow-up|0|||
94532711|NCT01463696|323745507|FG004|Overall Study|Lost to Follow-up|0|||
94532712|NCT01463696|323745508|FG005|Overall Study|Lost to Follow-up|0|||
94532713|NCT01463696|323745509|FG006|Overall Study|Lost to Follow-up|0|||
94532714|NCT01463696|323745510|FG007|Overall Study|Lost to Follow-up|0|||
94532715|NCT01463696|323745503|FG000|Overall Study|Progressive Disease|0|||
94532716|NCT01463696|323745504|FG001|Overall Study|Progressive Disease|1|||
94532717|NCT01463696|323745505|FG002|Overall Study|Progressive Disease|0|||
94532718|NCT01463696|323745506|FG003|Overall Study|Progressive Disease|1|||
94532719|NCT01463696|323745507|FG004|Overall Study|Progressive Disease|0|||
94532720|NCT01463696|323745508|FG005|Overall Study|Progressive Disease|1|||
94532721|NCT01463696|323745509|FG006|Overall Study|Progressive Disease|4|||
94532722|NCT01463696|323745510|FG007|Overall Study|Progressive Disease|2|||
94532723|NCT01463696|323745503|FG000|Overall Study|Withdrawal by Subject|0|||
94532724|NCT01463696|323745504|FG001|Overall Study|Withdrawal by Subject|0|||
94532725|NCT01463696|323745505|FG002|Overall Study|Withdrawal by Subject|0|||
94532726|NCT01463696|323745506|FG003|Overall Study|Withdrawal by Subject|1|||
94532727|NCT01463696|323745507|FG004|Overall Study|Withdrawal by Subject|1|||
94532728|NCT01463696|323745508|FG005|Overall Study|Withdrawal by Subject|1|||
94532729|NCT01463696|323745509|FG006|Overall Study|Withdrawal by Subject|2|||
94532730|NCT01463696|323745510|FG007|Overall Study|Withdrawal by Subject|0|||
94532731|NCT01463696|323745503|FG000|Overall Study|Not Treated|0|||
94532732|NCT01463696|323745504|FG001|Overall Study|Not Treated|0|||
94532733|NCT01463696|323745505|FG002|Overall Study|Not Treated|0|||
94532734|NCT01463696|323745506|FG003|Overall Study|Not Treated|0|||
94532735|NCT01463696|323745507|FG004|Overall Study|Not Treated|0|||
94532736|NCT01463696|323745508|FG005|Overall Study|Not Treated|0|||
94532737|NCT01463696|323745509|FG006|Overall Study|Not Treated|1|||
94532738|NCT01463696|323745510|FG007|Overall Study|Not Treated|0|||
94532739|NCT01843673|323745511|FG000|Overall Study|Lack of Efficacy|2|||
94532740|NCT01843673|323745511|FG000|Overall Study|Withdrawal by Subject|4|||
94532741|NCT00425698|323745512|FG000|Overall Study|Adverse Event|3|||
94532742|NCT00425698|323745513|FG001|Overall Study|Adverse Event|1|||
94532743|NCT00425698|323745512|FG000|Overall Study|Withdrawal by Subject|0|||
94532744|NCT00425698|323745513|FG001|Overall Study|Withdrawal by Subject|1|||
94532745|NCT01265563|323745517|FG000|Overall Study|Withdrawal by Subject|0|||
94532746|NCT01265563|323745518|FG001|Overall Study|Withdrawal by Subject|1|||
94532747|NCT01265563|323745519|FG002|Overall Study|Withdrawal by Subject|1|||
94532748|NCT01265563|323745520|FG003|Overall Study|Withdrawal by Subject|0|||
94532749|NCT01265563|323745521|FG004|Overall Study|Withdrawal by Subject|2|||
94532750|NCT00716482|323745522|FG000|Overall Study|Lost to Follow-up|6|||
94532751|NCT00716482|323745522|FG000|Overall Study|Inadequate acquisition or analysis|50|||
94532752|NCT00716482|323745522|FG000|Overall Study|no pathology obtained|10|||
94532753|NCT00716482|323745522|FG000|Overall Study|technical/machine error|28|||
94532754|NCT00716482|323745522|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
94532755|NCT00313313|323745525|FG000|Overall Study|Lack of Efficacy|14|||
94532756|NCT00313313|323745526|FG001|Overall Study|Lack of Efficacy|9|||
94532757|NCT00313313|323745527|FG002|Overall Study|Lack of Efficacy|20|||
94532758|NCT00313313|323745525|FG000|Overall Study|Withdrawal of consent by subject|18|||
94532759|NCT00313313|323745526|FG001|Overall Study|Withdrawal of consent by subject|17|||
94532760|NCT00313313|323745527|FG002|Overall Study|Withdrawal of consent by subject|31|||
94532761|NCT00313313|323745525|FG000|Overall Study|Lost to Follow-up|10|||
94532762|NCT00313313|323745526|FG001|Overall Study|Lost to Follow-up|7|||
94532763|NCT00313313|323745527|FG002|Overall Study|Lost to Follow-up|9|||
94532764|NCT00313313|323745525|FG000|Overall Study|Adverse Event|15|||
94532765|NCT00313313|323745526|FG001|Overall Study|Adverse Event|16|||
94532766|NCT00313313|323745527|FG002|Overall Study|Adverse Event|12|||
94532767|NCT00313313|323745525|FG000|Overall Study|Physician Decision|2|||
94532768|NCT00313313|323745526|FG001|Overall Study|Physician Decision|6|||
94532769|NCT00313313|323745527|FG002|Overall Study|Physician Decision|4|||
94532770|NCT00313313|323745525|FG000|Overall Study|Poor/Noncompliance|3|||
94532771|NCT00313313|323745526|FG001|Overall Study|Poor/Noncompliance|6|||
94532772|NCT00313313|323745527|FG002|Overall Study|Poor/Noncompliance|2|||
94532773|NCT00313313|323745525|FG000|Overall Study|Pregnancy|1|||
94532774|NCT00313313|323745526|FG001|Overall Study|Pregnancy|2|||
94532775|NCT00313313|323745527|FG002|Overall Study|Pregnancy|0|||
94532776|NCT00313313|323745525|FG000|Overall Study|Death|0|||
94532777|NCT00313313|323745526|FG001|Overall Study|Death|0|||
94532778|NCT00313313|323745527|FG002|Overall Study|Death|2|||
94532779|NCT00313313|323745525|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
94532780|NCT00313313|323745526|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
94532781|NCT00313313|323745527|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
94532782|NCT01813058|323745528|FG000|Overall Study|Withdrawal by Subject|5|||
94532783|NCT01813058|323745529|FG001|Overall Study|Withdrawal by Subject|4|||
94532784|NCT00675441|323745530|FG000|Overall Study|Withdrawal by Subject|2|||
94532785|NCT00675441|323745530|FG000|Overall Study|Death|1|||
94532786|NCT03525600|323745531|FG000|Overall Study|Adverse Event|9|||
94532787|NCT03525600|323745532|FG001|Overall Study|Adverse Event|6|||
94532788|NCT03525600|323745533|FG002|Overall Study|Adverse Event|5|||
94532789|NCT03525600|323745534|FG003|Overall Study|Adverse Event|3|||
94532790|NCT03525600|323745531|FG000|Overall Study|Lost to Follow-up|2|||
94532791|NCT03525600|323745532|FG001|Overall Study|Lost to Follow-up|4|||
94532792|NCT03525600|323745533|FG002|Overall Study|Lost to Follow-up|4|||
94532793|NCT03525600|323745534|FG003|Overall Study|Lost to Follow-up|0|||
94532794|NCT03525600|323745531|FG000|Overall Study|Physician Decision|1|||
94532795|NCT03525600|323745532|FG001|Overall Study|Physician Decision|0|||
94532796|NCT03525600|323745533|FG002|Overall Study|Physician Decision|2|||
94532797|NCT03525600|323745534|FG003|Overall Study|Physician Decision|0|||
94532798|NCT03525600|323745531|FG000|Overall Study|Consent withdrawal|36|||
94532799|NCT03525600|323745532|FG001|Overall Study|Consent withdrawal|20|||
94532800|NCT03525600|323745533|FG002|Overall Study|Consent withdrawal|6|||
94532801|NCT03525600|323745534|FG003|Overall Study|Consent withdrawal|13|||
94532802|NCT03525600|323745531|FG000|Overall Study|Death|7|||
94532803|NCT03525600|323745532|FG001|Overall Study|Death|6|||
94532804|NCT03525600|323745533|FG002|Overall Study|Death|4|||
94532805|NCT03525600|323745534|FG003|Overall Study|Death|3|||
94532806|NCT03525600|323745531|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
94532807|NCT03525600|323745532|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
94532808|NCT03525600|323745533|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
94532809|NCT03525600|323745534|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
94532810|NCT03525600|323745531|FG000|Overall Study|Other|0|||
94532811|NCT03525600|323745532|FG001|Overall Study|Other|1|||
94532812|NCT03525600|323745533|FG002|Overall Study|Other|0|||
94532813|NCT03525600|323745534|FG003|Overall Study|Other|0|||
94532814|NCT00054327|323745535|FG000|Overall Study|Engraftment failure|1|||
94532815|NCT00054327|323745536|FG001|Overall Study|Engraftment failure|0|||
94532816|NCT00054327|323745537|FG002|Overall Study|Engraftment failure|0|||
94532817|NCT00054327|323745538|FG003|Overall Study|Engraftment failure|0|||
94532818|NCT00054327|323745539|FG004|Overall Study|Engraftment failure|0|||
94532819|NCT00054327|323745540|FG005|Overall Study|Engraftment failure|0|||
94532820|NCT01694121|323745541|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
94532821|NCT01694121|323745542|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
94532822|NCT03718884|323745544|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
94532823|NCT03718884|323745545|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
94532824|NCT03718884|323745544|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
94532825|NCT03718884|323745545|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
94532826|NCT00350870|323745546|FG000|Overall Study|Withdrawal by Subject|21|||
94532827|NCT00350870|323745547|FG001|Overall Study|Withdrawal by Subject|17|||
94532828|NCT00350870|323745548|FG002|Overall Study|Withdrawal by Subject|15|||
94532829|NCT00350870|323745549|FG003|Overall Study|Withdrawal by Subject|14|||
94532830|NCT00350870|323745546|FG000|Overall Study|Physician Decision|1|||
94532831|NCT00350870|323745547|FG001|Overall Study|Physician Decision|0|||
94532832|NCT00350870|323745548|FG002|Overall Study|Physician Decision|1|||
94532833|NCT00350870|323745549|FG003|Overall Study|Physician Decision|1|||
94532834|NCT03783442|323745550|FG000|Overall Study|Remained on study (ongoing at time of DCO)|114|||
94532835|NCT03783442|323745551|FG001|Overall Study|Remained on study (ongoing at time of DCO)|77|||
94532836|NCT03783442|323745550|FG000|Overall Study|Death|196|||
94532837|NCT03783442|323745551|FG001|Overall Study|Death|226|||
94532838|NCT03783442|323745550|FG000|Overall Study|Withdrawal by Subject|14|||
94532839|NCT03783442|323745551|FG001|Overall Study|Withdrawal by Subject|17|||
94532840|NCT03783442|323745550|FG000|Overall Study|Lost to Follow-up|2|||
94532841|NCT03783442|323745551|FG001|Overall Study|Lost to Follow-up|3|||
94532842|NCT04700540|323745552|FG000|Overall Study|Withdrawal by Subject|12|||
94532843|NCT04700540|323745553|FG001|Overall Study|Withdrawal by Subject|8|||
94532844|NCT04700540|323745552|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
94532845|NCT04700540|323745553|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
94532846|NCT00920387|323745557|FG000|Stage 1|Adverse Event|1|||
94532847|NCT00920387|323745558|FG001|Stage 1|Adverse Event|0|||
94532848|NCT00920387|323745559|FG002|Stage 1|Adverse Event|0|||
94532849|NCT02265536|323745560|FG000|Overall Study|Adverse Event|1|||
94532850|NCT02265536|323745561|FG001|Overall Study|Adverse Event|0|||
94532851|NCT02265536|323745562|FG002|Overall Study|Adverse Event|0|||
94532852|NCT02265536|323745563|FG003|Overall Study|Adverse Event|0|||
94532853|NCT02265536|323745564|FG004|Overall Study|Adverse Event|1|||
94532854|NCT02265536|323745565|FG005|Overall Study|Adverse Event|0|||
94532855|NCT02265536|323745560|FG000|Overall Study|Physician Decision|0|||
94532856|NCT02265536|323745561|FG001|Overall Study|Physician Decision|0|||
94532857|NCT02265536|323745562|FG002|Overall Study|Physician Decision|0|||
94532858|NCT02265536|323745563|FG003|Overall Study|Physician Decision|0|||
94532859|NCT02265536|323745564|FG004|Overall Study|Physician Decision|2|||
94532860|NCT02265536|323745565|FG005|Overall Study|Physician Decision|0|||
94532861|NCT02265536|323745560|FG000|Overall Study|Withdrawal by Subject|0|||
94532862|NCT02265536|323745561|FG001|Overall Study|Withdrawal by Subject|3|||
94532863|NCT02265536|323745562|FG002|Overall Study|Withdrawal by Subject|0|||
94532864|NCT02265536|323745563|FG003|Overall Study|Withdrawal by Subject|0|||
94532865|NCT02265536|323745564|FG004|Overall Study|Withdrawal by Subject|0|||
94532866|NCT02265536|323745565|FG005|Overall Study|Withdrawal by Subject|0|||
94532867|NCT02378298|323745566|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
94532868|NCT02378298|323745567|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
94532869|NCT02378298|323745568|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
94532870|NCT02378298|323745566|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
94532871|NCT02378298|323745567|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
94532872|NCT02378298|323745568|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
94532873|NCT02378298|323745566|FG000|Surveillance (19-68 Weeks)|Death|1|||
94532874|NCT02378298|323745567|FG001|Surveillance (19-68 Weeks)|Death|0|||
94532875|NCT02378298|323745568|FG002|Surveillance (19-68 Weeks)|Death|0|||
94532876|NCT03763656|323745569|FG000|Overall Study|Physician Decision|1|||
94532877|NCT03763656|323745569|FG000|Overall Study|Protocol Violation|1|||
94532878|NCT03763656|323745569|FG000|Overall Study|Withdrawal by Subject|7|||
94532879|NCT00770809|323747089|FG000|Overall Study|Adverse Event|9|||
94532880|NCT00770809|323747090|FG001|Overall Study|Adverse Event|1|||
94532881|NCT00770809|323747091|FG002|Overall Study|Adverse Event|12|||
94532882|NCT00770809|323747089|FG000|Overall Study|Death|1|||
94532883|NCT00770809|323747090|FG001|Overall Study|Death|0|||
94532884|NCT00770809|323747091|FG002|Overall Study|Death|0|||
94532885|NCT00770809|323747089|FG000|Overall Study|Withdrawal by Subject|3|||
94532886|NCT00770809|323747090|FG001|Overall Study|Withdrawal by Subject|3|||
94532887|NCT00770809|323747091|FG002|Overall Study|Withdrawal by Subject|7|||
94532888|NCT00770809|323747089|FG000|Overall Study|Progression|2|||
94532889|NCT00770809|323747090|FG001|Overall Study|Progression|2|||
94532890|NCT00770809|323747091|FG002|Overall Study|Progression|0|||
94532891|NCT00770809|323747089|FG000|Overall Study|Complicating illness|0|||
94532892|NCT00770809|323747090|FG001|Overall Study|Complicating illness|0|||
94532893|NCT00770809|323747091|FG002|Overall Study|Complicating illness|1|||
94532894|NCT00770809|323747089|FG000|Overall Study|Other Medical Reasons|2|||
94532895|NCT00770809|323747090|FG001|Overall Study|Other Medical Reasons|4|||
94532896|NCT00770809|323747091|FG002|Overall Study|Other Medical Reasons|3|||
94532897|NCT05897242|323747103|FG000|Overall Study|Lost to Follow-up|6|||
94532898|NCT05897242|323747104|FG001|Overall Study|Lost to Follow-up|1|||
94532899|NCT05897242|323747103|FG000|Overall Study|Incomplete|1|||
94532900|NCT05897242|323747104|FG001|Overall Study|Incomplete|0|||
94532901|NCT05897242|323747103|FG000|Overall Study|Withdrawal by Subject|1|||
94532902|NCT05897242|323747104|FG001|Overall Study|Withdrawal by Subject|0|||
94532903|NCT03522246|323747105|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
94532904|NCT03522246|323747106|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
94532905|NCT03522246|323747107|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
94532906|NCT03522246|323747108|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
94532907|NCT03522246|323747109|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
94532908|NCT04439539|323747110|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
94532909|NCT04439539|323747111|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
94532910|NCT04439539|323747112|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
94532911|NCT04439539|323747110|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
94532912|NCT04439539|323747111|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
94532913|NCT04439539|323747112|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
94532914|NCT04439539|323747110|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
94532915|NCT04439539|323747111|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
94532916|NCT04439539|323747112|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
94532917|NCT01995669|323747116|FG000|Overall Study|Progression|2|||
94532918|NCT01995669|323747117|FG001|Overall Study|Progression|1|||
94532919|NCT01995669|323747118|FG002|Overall Study|Progression|1|||
94532920|NCT01995669|323747119|FG003|Overall Study|Progression|13|||
94532921|NCT01995669|323747116|FG000|Overall Study|Adverse Event|0|||
94532922|NCT01995669|323747117|FG001|Overall Study|Adverse Event|0|||
94532923|NCT01995669|323747118|FG002|Overall Study|Adverse Event|0|||
94532924|NCT01995669|323747119|FG003|Overall Study|Adverse Event|3|||
94532925|NCT01995669|323747116|FG000|Overall Study|Death|0|||
94532926|NCT01995669|323747117|FG001|Overall Study|Death|0|||
94532927|NCT01995669|323747118|FG002|Overall Study|Death|0|||
94532928|NCT01995669|323747119|FG003|Overall Study|Death|6|||
94532929|NCT01995669|323747116|FG000|Overall Study|Withdrawal by Subject|0|||
94532930|NCT01995669|323747117|FG001|Overall Study|Withdrawal by Subject|0|||
94532931|NCT01995669|323747118|FG002|Overall Study|Withdrawal by Subject|0|||
94532932|NCT01995669|323747119|FG003|Overall Study|Withdrawal by Subject|6|||
94532933|NCT01995669|323747116|FG000|Overall Study|Insurance Expired|0|||
94532934|NCT01995669|323747117|FG001|Overall Study|Insurance Expired|0|||
94532935|NCT01995669|323747118|FG002|Overall Study|Insurance Expired|0|||
94532936|NCT01995669|323747119|FG003|Overall Study|Insurance Expired|1|||
94532937|NCT01171898|323747120|FG000|Overall Study|Death|0|||
94532938|NCT01171898|323747121|FG001|Overall Study|Death|0|||
94532939|NCT01171898|323747122|FG002|Overall Study|Death|2|||
94532940|NCT01171898|323747123|FG003|Overall Study|Death|0|||
94532941|NCT01171898|323747120|FG000|Overall Study|Lost to Follow-up|0|||
94532942|NCT01171898|323747121|FG001|Overall Study|Lost to Follow-up|1|||
94532943|NCT01171898|323747122|FG002|Overall Study|Lost to Follow-up|1|||
94532944|NCT01171898|323747123|FG003|Overall Study|Lost to Follow-up|1|||
94532945|NCT01171898|323747120|FG000|Overall Study|Withdrawal by Subject|1|||
94532946|NCT01171898|323747121|FG001|Overall Study|Withdrawal by Subject|4|||
94532947|NCT01171898|323747122|FG002|Overall Study|Withdrawal by Subject|6|||
94532948|NCT01171898|323747123|FG003|Overall Study|Withdrawal by Subject|3|||
94532949|NCT01171898|323747120|FG000|Overall Study|Terminated by Sponsor|1|||
94532950|NCT01171898|323747121|FG001|Overall Study|Terminated by Sponsor|0|||
94532951|NCT01171898|323747122|FG002|Overall Study|Terminated by Sponsor|0|||
94532952|NCT01171898|323747123|FG003|Overall Study|Terminated by Sponsor|0|||
94532953|NCT01171898|323747120|FG000|Overall Study|Ongoing|1|||
94532954|NCT01171898|323747121|FG001|Overall Study|Ongoing|9|||
94532955|NCT01171898|323747122|FG002|Overall Study|Ongoing|3|||
94532956|NCT01171898|323747123|FG003|Overall Study|Ongoing|0|||
94532957|NCT01171898|323747120|FG000|Overall Study|Other|1|||
94532958|NCT01171898|323747121|FG001|Overall Study|Other|5|||
94532959|NCT01171898|323747122|FG002|Overall Study|Other|0|||
94532960|NCT01171898|323747123|FG003|Overall Study|Other|2|||
94532961|NCT00433511|323747124|FG000|Step 1|Adverse Event|50|||
94532962|NCT00433511|323747125|FG001|Step 1|Adverse Event|157|||
94532963|NCT00433511|323747126|FG002|Step 1|Adverse Event|153|||
94532964|NCT00433511|323747124|FG000|Step 1|Withdrawal by Subject|45|||
94532965|NCT00433511|323747125|FG001|Step 1|Withdrawal by Subject|143|||
94532966|NCT00433511|323747126|FG002|Step 1|Withdrawal by Subject|154|||
94532967|NCT00433511|323747124|FG000|Step 1|Death|3|||
94532968|NCT00433511|323747125|FG001|Step 1|Death|1|||
94532969|NCT00433511|323747126|FG002|Step 1|Death|1|||
94532970|NCT00433511|323747124|FG000|Step 1|Physician Decision|1|||
94532971|NCT00433511|323747125|FG001|Step 1|Physician Decision|4|||
94532972|NCT00433511|323747126|FG002|Step 1|Physician Decision|3|||
94532973|NCT00433511|323747124|FG000|Step 1|Never started protocol therapy|28|||
94532974|NCT00433511|323747125|FG001|Step 1|Never started protocol therapy|64|||
94532975|NCT00433511|323747126|FG002|Step 1|Never started protocol therapy|66|||
94532976|NCT00433511|323747124|FG000|Step 1|Alternative therapy|2|||
94532977|NCT00433511|323747125|FG001|Step 1|Alternative therapy|1|||
94532978|NCT00433511|323747126|FG002|Step 1|Alternative therapy|3|||
94532979|NCT00433511|323747124|FG000|Step 1|Disease progression, relapse|5|||
94532980|NCT00433511|323747125|FG001|Step 1|Disease progression, relapse|3|||
94532981|NCT00433511|323747126|FG002|Step 1|Disease progression, relapse|3|||
94532982|NCT00433511|323747124|FG000|Step 1|Other complicating disease|2|||
94532983|NCT00433511|323747125|FG001|Step 1|Other complicating disease|6|||
94532984|NCT00433511|323747126|FG002|Step 1|Other complicating disease|3|||
94532985|NCT00433511|323747124|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
94532986|NCT00433511|323747125|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
94532987|NCT00433511|323747126|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
94532988|NCT00433511|323747124|FG000|Step 1|Suspected recurrence|0|||
94532989|NCT00433511|323747125|FG001|Step 1|Suspected recurrence|1|||
94532990|NCT00433511|323747126|FG002|Step 1|Suspected recurrence|0|||
94532991|NCT00433511|323747124|FG000|Step 1|Insurance/drug distribution issues|0|||
94532992|NCT00433511|323747125|FG001|Step 1|Insurance/drug distribution issues|1|||
94532993|NCT00433511|323747126|FG002|Step 1|Insurance/drug distribution issues|2|||
94532994|NCT00433511|323747124|FG000|Step 1|Patient moved|0|||
94532995|NCT00433511|323747125|FG001|Step 1|Patient moved|0|||
94532996|NCT00433511|323747126|FG002|Step 1|Patient moved|1|||
94532997|NCT00433511|323747124|FG000|Step 2 (Arm D)|Adverse Event|0|||
94532998|NCT00433511|323747125|FG001|Step 2 (Arm D)|Adverse Event|0|||
94532999|NCT00433511|323747126|FG002|Step 2 (Arm D)|Adverse Event|135|||
94533000|NCT00433511|323747124|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
94533001|NCT00433511|323747125|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
94533002|NCT00433511|323747126|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
94533003|NCT00433511|323747124|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
94533004|NCT00433511|323747125|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
94533005|NCT00433511|323747126|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
94533006|NCT00433511|323747124|FG000|Step 2 (Arm D)|Physician Decision|0|||
94533007|NCT00433511|323747125|FG001|Step 2 (Arm D)|Physician Decision|0|||
94533008|NCT00433511|323747126|FG002|Step 2 (Arm D)|Physician Decision|9|||
94533009|NCT00433511|323747124|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
94533010|NCT00433511|323747125|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
94533011|NCT00433511|323747126|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
94533012|NCT00433511|323747124|FG000|Step 2 (Arm D)|Other complicating disease|0|||
94533013|NCT00433511|323747125|FG001|Step 2 (Arm D)|Other complicating disease|0|||
94533014|NCT00433511|323747126|FG002|Step 2 (Arm D)|Other complicating disease|3|||
94533015|NCT00433511|323747124|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
94533016|NCT00433511|323747125|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
94533017|NCT00433511|323747126|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
94533018|NCT00433511|323747124|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
94533019|NCT00433511|323747125|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
94533020|NCT00433511|323747126|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
94533021|NCT00433511|323747124|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
94533022|NCT00433511|323747125|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
94533023|NCT00433511|323747126|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
94533024|NCT00433511|323747124|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
94533025|NCT00433511|323747125|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
94533026|NCT00433511|323747126|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
94533027|NCT05160415|323747127|FG000|Overall Study|Withdrawal by Subject|3|||
94533028|NCT00334815|323747130|FG000|Overall Study|Adverse Event|3|||
94533029|NCT00334815|323747131|FG001|Overall Study|Adverse Event|2|||
94533030|NCT00334815|323747130|FG000|Overall Study|Death|0|||
94533031|NCT00334815|323747131|FG001|Overall Study|Death|2|||
94533032|NCT00334815|323747130|FG000|Overall Study|Progression|1|||
94533033|NCT00334815|323747131|FG001|Overall Study|Progression|0|||
94533034|NCT00334815|323747130|FG000|Overall Study|ineligible|1|||
94533035|NCT00334815|323747131|FG001|Overall Study|ineligible|1|||
94533036|NCT00334815|323747130|FG000|Overall Study|patient refused treatment|0|||
94533037|NCT00334815|323747131|FG001|Overall Study|patient refused treatment|1|||
94533038|NCT00334815|323747130|FG000|Overall Study|Physician Decision|2|||
94533039|NCT00334815|323747131|FG001|Overall Study|Physician Decision|4|||
94533040|NCT06422364|323747132|FG000|Overall Study|Withdrawn due to study closure|0|||
94533041|NCT06422364|323747133|FG001|Overall Study|Withdrawn due to study closure|2|||
94533042|NCT01169337|323747135|FG000|Overall Study|Lack of Efficacy|5|||
94533043|NCT01169337|323747136|FG001|Overall Study|Lack of Efficacy|7|||
94533044|NCT01169337|323747137|FG002|Overall Study|Lack of Efficacy|0|||
94533045|NCT01169337|323747135|FG000|Overall Study|Adverse Event|12|||
94533046|NCT01169337|323747136|FG001|Overall Study|Adverse Event|18|||
94533047|NCT01169337|323747137|FG002|Overall Study|Adverse Event|0|||
94533048|NCT01169337|323747135|FG000|Overall Study|Death|2|||
94533049|NCT01169337|323747136|FG001|Overall Study|Death|0|||
94533050|NCT01169337|323747137|FG002|Overall Study|Death|0|||
94533051|NCT01169337|323747135|FG000|Overall Study|Withdrawal by Subject|11|||
94533052|NCT01169337|323747136|FG001|Overall Study|Withdrawal by Subject|11|||
94533053|NCT01169337|323747137|FG002|Overall Study|Withdrawal by Subject|6|||
94533054|NCT01169337|323747135|FG000|Overall Study|Noncompliance|2|||
94533055|NCT01169337|323747136|FG001|Overall Study|Noncompliance|0|||
94533056|NCT01169337|323747137|FG002|Overall Study|Noncompliance|0|||
94533057|NCT01169337|323747135|FG000|Overall Study|Other complicating disease|1|||
94533058|NCT01169337|323747136|FG001|Overall Study|Other complicating disease|1|||
94533059|NCT01169337|323747137|FG002|Overall Study|Other complicating disease|0|||
94533060|NCT01169337|323747135|FG000|Overall Study|Physician Decision|1|||
94533061|NCT01169337|323747136|FG001|Overall Study|Physician Decision|5|||
94533062|NCT01169337|323747137|FG002|Overall Study|Physician Decision|0|||
94533063|NCT01169337|323747135|FG000|Overall Study|Alternative therapy|0|||
94533064|NCT01169337|323747136|FG001|Overall Study|Alternative therapy|2|||
94533065|NCT01169337|323747137|FG002|Overall Study|Alternative therapy|0|||
94533066|NCT01169337|323747135|FG000|Overall Study|Changed hospital|0|||
94533067|NCT01169337|323747136|FG001|Overall Study|Changed hospital|1|||
94533068|NCT01169337|323747137|FG002|Overall Study|Changed hospital|0|||
94533069|NCT01169337|323747135|FG000|Overall Study|Never started treatment|0|||
94533070|NCT01169337|323747136|FG001|Overall Study|Never started treatment|2|||
94533071|NCT01169337|323747137|FG002|Overall Study|Never started treatment|0|||
94533072|NCT01169337|323747135|FG000|Overall Study|Reason not reported|1|||
94533073|NCT01169337|323747136|FG001|Overall Study|Reason not reported|0|||
94533074|NCT01169337|323747137|FG002|Overall Study|Reason not reported|0|||
94533075|NCT01169337|323747135|FG000|Overall Study|Continuing lenalidomide|9|||
94533076|NCT01169337|323747136|FG001|Overall Study|Continuing lenalidomide|43|||
94533077|NCT01169337|323747137|FG002|Overall Study|Continuing lenalidomide|0|||
94533078|NCT03883165|323747139|FG000|Overall Study|Withdrawal by Subject|4|||
94533079|NCT03883165|323747140|FG001|Overall Study|Withdrawal by Subject|3|||
94533080|NCT03497975|323747141|FG000|Overall Study|Withdrew Consent|34|||
94533081|NCT03497975|323747142|FG001|Overall Study|Withdrew Consent|35|||
94533082|NCT03497975|323747141|FG000|Overall Study|Lost to Follow-up|7|||
94533083|NCT03497975|323747142|FG001|Overall Study|Lost to Follow-up|7|||
94533084|NCT03497975|323747141|FG000|Overall Study|Physician Decision|4|||
94533085|NCT03497975|323747142|FG001|Overall Study|Physician Decision|5|||
94533086|NCT03497975|323747141|FG000|Overall Study|Discontinued|42|||
94533087|NCT03497975|323747142|FG001|Overall Study|Discontinued|39|||
94533088|NCT03497975|323747141|FG000|Overall Study|Reason Not Specified|15|||
94533089|NCT03497975|323747142|FG001|Overall Study|Reason Not Specified|14|||
94533090|NCT05730335|323747147|FG000|Overall Study|Lost to Follow-up|8|||
94533091|NCT05730335|323747147|FG000|Overall Study|Withdrawal by Subject|6|||
94533092|NCT01522976|323747148|FG000|Overall Study|Ineligible|4|||
94533093|NCT01522976|323747149|FG001|Overall Study|Ineligible|0|||
94533094|NCT01522976|323747150|FG002|Overall Study|Ineligible|1|||
94533095|NCT01522976|323747148|FG000|Overall Study|Death|7|||
94533096|NCT01522976|323747149|FG001|Overall Study|Death|6|||
94533097|NCT01522976|323747150|FG002|Overall Study|Death|2|||
94533098|NCT01522976|323747148|FG000|Overall Study|Still on treatment|9|||
94533099|NCT01522976|323747149|FG001|Overall Study|Still on treatment|9|||
94533100|NCT01522976|323747150|FG002|Overall Study|Still on treatment|6|||
94533101|NCT01522976|323747148|FG000|Overall Study|Disease progression|28|||
94533102|NCT01522976|323747149|FG001|Overall Study|Disease progression|30|||
94533103|NCT01522976|323747150|FG002|Overall Study|Disease progression|25|||
94533104|NCT01522976|323747148|FG000|Overall Study|Adverse Event|17|||
94533105|NCT01522976|323747149|FG001|Overall Study|Adverse Event|7|||
94533106|NCT01522976|323747150|FG002|Overall Study|Adverse Event|18|||
94533107|NCT01522976|323747148|FG000|Overall Study|Refusal unrelated to adverse event|10|||
94533108|NCT01522976|323747149|FG001|Overall Study|Refusal unrelated to adverse event|13|||
94533109|NCT01522976|323747150|FG002|Overall Study|Refusal unrelated to adverse event|14|||
94533110|NCT01522976|323747148|FG000|Overall Study|Not protocol specified|22|||
94533111|NCT01522976|323747149|FG001|Overall Study|Not protocol specified|27|||
94533112|NCT01522976|323747150|FG002|Overall Study|Not protocol specified|27|||
94533113|NCT05411822|323747151|FG000|Overall Study|Withdrawal by Subject|2|||
94533114|NCT05411822|323747152|FG001|Overall Study|Withdrawal by Subject|1|||
94533115|NCT02166463|323747153|FG000|Overall Study|Lost to Follow-up|0|||
94533116|NCT02166463|323747154|FG001|Overall Study|Lost to Follow-up|1|||
94533117|NCT02166463|323747153|FG000|Overall Study|Physician Decision|10|||
94533118|NCT02166463|323747154|FG001|Overall Study|Physician Decision|10|||
94533119|NCT02166463|323747153|FG000|Overall Study|Ineligible|11|||
94533120|NCT02166463|323747154|FG001|Overall Study|Ineligible|2|||
94533121|NCT02166463|323747153|FG000|Overall Study|Progressive Disease|9|||
94533122|NCT02166463|323747154|FG001|Overall Study|Progressive Disease|6|||
94533123|NCT02166463|323747153|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
94533124|NCT02166463|323747154|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
94533125|NCT02166463|323747153|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
94533126|NCT02166463|323747154|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
94533127|NCT02166463|323747153|FG000|Overall Study|Refusal of further protocol therapy|5|||
94533128|NCT02166463|323747154|FG001|Overall Study|Refusal of further protocol therapy|6|||
94533129|NCT04154345|323747159|FG000|Overall Study|Covid-19 pandemic|4|||
94533130|NCT04445519|323747160|FG000|Overall Study|Due to adaptive design|3|||
94533131|NCT04445519|323747161|FG001|Overall Study|Due to adaptive design|0|||
94533132|NCT04445519|323747162|FG002|Overall Study|Due to adaptive design|0|||
94533133|NCT04445519|323747160|FG000|Overall Study|Lost to Follow-up|0|||
94533134|NCT04445519|323747161|FG001|Overall Study|Lost to Follow-up|1|||
94533135|NCT04445519|323747162|FG002|Overall Study|Lost to Follow-up|4|||
94533136|NCT04445519|323747160|FG000|Overall Study|Sponsor or IRB Decision|0|||
94533137|NCT04445519|323747161|FG001|Overall Study|Sponsor or IRB Decision|1|||
94533138|NCT04445519|323747162|FG002|Overall Study|Sponsor or IRB Decision|2|||
94533139|NCT04445519|323747160|FG000|Overall Study|Withdrawal by Subject|0|||
94533140|NCT04445519|323747161|FG001|Overall Study|Withdrawal by Subject|3|||
94533141|NCT04445519|323747162|FG002|Overall Study|Withdrawal by Subject|3|||
94533142|NCT04445519|323747160|FG000|Overall Study|Adverse Event|0|||
94533143|NCT04445519|323747161|FG001|Overall Study|Adverse Event|8|||
94533144|NCT04445519|323747162|FG002|Overall Study|Adverse Event|6|||
94533145|NCT04445519|323747160|FG000|Overall Study|Other Reason|0|||
94533146|NCT04445519|323747161|FG001|Overall Study|Other Reason|1|||
94533147|NCT04445519|323747162|FG002|Overall Study|Other Reason|1|||
94533148|NCT04445519|323747160|FG000|Overall Study|Protocol Violation|0|||
94533149|NCT04445519|323747161|FG001|Overall Study|Protocol Violation|0|||
94533150|NCT04445519|323747162|FG002|Overall Study|Protocol Violation|1|||
94533151|NCT06003777|323747163|FG000|Period 1|Adverse Event|0|||
94533152|NCT06003777|323747164|FG001|Period 1|Adverse Event|0|||
94533153|NCT06003777|323747165|FG002|Period 1|Adverse Event|1|||
94533154|NCT06003777|323747166|FG003|Period 1|Adverse Event|0|||
94533155|NCT06003777|323747167|FG004|Period 1|Adverse Event|0|||
94533156|NCT06003777|323747168|FG005|Period 1|Adverse Event|0|||
94533157|NCT06003777|323747169|FG006|Period 1|Adverse Event|0|||
94533158|NCT06003777|323747170|FG007|Period 1|Adverse Event|0|||
94533159|NCT06003777|323747171|FG008|Period 1|Adverse Event|0|||
94533160|NCT06003777|323747172|FG009|Period 1|Adverse Event|0|||
94533161|NCT06003777|323747173|FG010|Period 1|Adverse Event|0|||
94533162|NCT06003777|323747174|FG011|Period 1|Adverse Event|0|||
94533163|NCT06003777|323747163|FG000|Period 1|Withdrawal by Subject|0|||
94533164|NCT06003777|323747164|FG001|Period 1|Withdrawal by Subject|0|||
94533165|NCT06003777|323747165|FG002|Period 1|Withdrawal by Subject|0|||
94533166|NCT06003777|323747166|FG003|Period 1|Withdrawal by Subject|0|||
94533167|NCT06003777|323747167|FG004|Period 1|Withdrawal by Subject|1|||
94533168|NCT06003777|323747168|FG005|Period 1|Withdrawal by Subject|0|||
94533169|NCT06003777|323747169|FG006|Period 1|Withdrawal by Subject|0|||
94533170|NCT06003777|323747170|FG007|Period 1|Withdrawal by Subject|0|||
94533171|NCT06003777|323747171|FG008|Period 1|Withdrawal by Subject|0|||
94533172|NCT06003777|323747172|FG009|Period 1|Withdrawal by Subject|0|||
94533173|NCT06003777|323747173|FG010|Period 1|Withdrawal by Subject|0|||
94533174|NCT06003777|323747174|FG011|Period 1|Withdrawal by Subject|0|||
94533175|NCT06003777|323747163|FG000|Period 2|Withdrawal by Subject|0|||
94533176|NCT06003777|323747164|FG001|Period 2|Withdrawal by Subject|0|||
94533177|NCT06003777|323747165|FG002|Period 2|Withdrawal by Subject|0|||
94533178|NCT06003777|323747166|FG003|Period 2|Withdrawal by Subject|0|||
94533179|NCT06003777|323747167|FG004|Period 2|Withdrawal by Subject|0|||
94533180|NCT06003777|323747168|FG005|Period 2|Withdrawal by Subject|0|||
94533181|NCT06003777|323747169|FG006|Period 2|Withdrawal by Subject|0|||
94533182|NCT06003777|323747170|FG007|Period 2|Withdrawal by Subject|0|||
94533183|NCT06003777|323747171|FG008|Period 2|Withdrawal by Subject|1|||
94533184|NCT06003777|323747172|FG009|Period 2|Withdrawal by Subject|0|||
94533185|NCT06003777|323747173|FG010|Period 2|Withdrawal by Subject|0|||
94533186|NCT06003777|323747174|FG011|Period 2|Withdrawal by Subject|0|||
94533187|NCT06003777|323747163|FG000|Period 3|Adverse Event|0|||
94533188|NCT06003777|323747164|FG001|Period 3|Adverse Event|0|||
94533189|NCT06003777|323747165|FG002|Period 3|Adverse Event|0|||
94533190|NCT06003777|323747166|FG003|Period 3|Adverse Event|0|||
94533191|NCT06003777|323747167|FG004|Period 3|Adverse Event|0|||
94533192|NCT06003777|323747168|FG005|Period 3|Adverse Event|0|||
94533193|NCT06003777|323747169|FG006|Period 3|Adverse Event|1|||
94533194|NCT06003777|323747170|FG007|Period 3|Adverse Event|0|||
94533195|NCT06003777|323747171|FG008|Period 3|Adverse Event|0|||
94533196|NCT06003777|323747172|FG009|Period 3|Adverse Event|0|||
94533197|NCT06003777|323747173|FG010|Period 3|Adverse Event|0|||
94533198|NCT06003777|323747174|FG011|Period 3|Adverse Event|0|||
94533199|NCT06003777|323747163|FG000|Period 4|No longer met eligibility criteria|0|||
94533200|NCT06003777|323747164|FG001|Period 4|No longer met eligibility criteria|0|||
94533201|NCT06003777|323747165|FG002|Period 4|No longer met eligibility criteria|1|||
94533202|NCT06003777|323747166|FG003|Period 4|No longer met eligibility criteria|0|||
94533203|NCT06003777|323747167|FG004|Period 4|No longer met eligibility criteria|0|||
94533204|NCT06003777|323747168|FG005|Period 4|No longer met eligibility criteria|0|||
94533205|NCT06003777|323747169|FG006|Period 4|No longer met eligibility criteria|0|||
94533206|NCT06003777|323747170|FG007|Period 4|No longer met eligibility criteria|0|||
94533207|NCT06003777|323747171|FG008|Period 4|No longer met eligibility criteria|0|||
94533208|NCT06003777|323747172|FG009|Period 4|No longer met eligibility criteria|0|||
94533209|NCT06003777|323747173|FG010|Period 4|No longer met eligibility criteria|0|||
94533210|NCT06003777|323747174|FG011|Period 4|No longer met eligibility criteria|0|||
94533211|NCT06003777|323747163|FG000|Period 4|Withdrawal by Subject|0|||
94533212|NCT06003777|323747164|FG001|Period 4|Withdrawal by Subject|1|||
94533213|NCT06003777|323747165|FG002|Period 4|Withdrawal by Subject|0|||
94533214|NCT06003777|323747166|FG003|Period 4|Withdrawal by Subject|0|||
94533215|NCT06003777|323747167|FG004|Period 4|Withdrawal by Subject|0|||
94533216|NCT06003777|323747168|FG005|Period 4|Withdrawal by Subject|0|||
94533217|NCT06003777|323747169|FG006|Period 4|Withdrawal by Subject|0|||
94533218|NCT06003777|323747170|FG007|Period 4|Withdrawal by Subject|0|||
94533219|NCT06003777|323747171|FG008|Period 4|Withdrawal by Subject|0|||
94533220|NCT06003777|323747172|FG009|Period 4|Withdrawal by Subject|0|||
94533221|NCT06003777|323747173|FG010|Period 4|Withdrawal by Subject|0|||
94533222|NCT06003777|323747174|FG011|Period 4|Withdrawal by Subject|0|||
94533223|NCT01272037|323747175|FG000|Overall Study|Death|25|||
94533224|NCT01272037|323747176|FG001|Overall Study|Death|28|||
94533225|NCT01272037|323747175|FG000|Overall Study|Adverse Event|12|||
94533226|NCT01272037|323747176|FG001|Overall Study|Adverse Event|7|||
94533227|NCT01272037|323747175|FG000|Overall Study|Withdrawal by Subject|175|||
94533228|NCT01272037|323747176|FG001|Overall Study|Withdrawal by Subject|93|||
94533229|NCT01272037|323747175|FG000|Overall Study|Disease progression|70|||
94533230|NCT01272037|323747176|FG001|Overall Study|Disease progression|111|||
94533231|NCT01272037|323747175|FG000|Overall Study|Other reason|42|||
94533232|NCT01272037|323747176|FG001|Overall Study|Other reason|41|||
94533233|NCT01272037|323747175|FG000|Overall Study|Delinquent data|24|||
94533234|NCT01272037|323747176|FG001|Overall Study|Delinquent data|19|||
94533235|NCT01272037|323747175|FG000|Overall Study|Reason under review|33|||
94533236|NCT01272037|323747176|FG001|Overall Study|Reason under review|29|||
94533237|NCT01272037|323747175|FG000|Overall Study|On treatment|626|||
94533238|NCT01272037|323747176|FG001|Overall Study|On treatment|632|||
94533239|NCT04590404|323747177|FG000|Overall Study|Death|16|||
94533240|NCT04590404|323747178|FG001|Overall Study|Death|17|||
94533241|NCT04590404|323747177|FG000|Overall Study|Withdrawal by Subject|7|||
94533242|NCT04590404|323747178|FG001|Overall Study|Withdrawal by Subject|2|||
94533243|NCT04948333|323747181|FG000|Overall Study|Adverse Event|6|||
94533244|NCT04948333|323747182|FG001|Overall Study|Adverse Event|4|||
94533245|NCT04948333|323747183|FG002|Overall Study|Adverse Event|0|||
94533246|NCT04948333|323747184|FG003|Overall Study|Adverse Event|2|||
94533247|NCT04948333|323747181|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
94533248|NCT04948333|323747182|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
94533249|NCT04948333|323747183|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
94533250|NCT04948333|323747184|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
94533251|NCT04948333|323747181|FG000|Overall Study|Progressive Disease|1|||
94533252|NCT04948333|323747182|FG001|Overall Study|Progressive Disease|5|||
94533253|NCT04948333|323747183|FG002|Overall Study|Progressive Disease|0|||
94533254|NCT04948333|323747184|FG003|Overall Study|Progressive Disease|0|||
94533255|NCT04948333|323747181|FG000|Overall Study|Physician Decision|2|||
94533256|NCT04948333|323747182|FG001|Overall Study|Physician Decision|2|||
94533257|NCT04948333|323747183|FG002|Overall Study|Physician Decision|0|||
94533258|NCT04948333|323747184|FG003|Overall Study|Physician Decision|0|||
94533259|NCT04948333|323747181|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
94533260|NCT04948333|323747182|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
94533261|NCT04948333|323747183|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
94533262|NCT04948333|323747184|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
94533263|NCT04948333|323747181|FG000|Overall Study|Withdrawal by Subject|2|||
94533264|NCT04948333|323747182|FG001|Overall Study|Withdrawal by Subject|0|||
94533265|NCT04948333|323747183|FG002|Overall Study|Withdrawal by Subject|0|||
94533266|NCT04948333|323747184|FG003|Overall Study|Withdrawal by Subject|1|||
94533267|NCT04948333|323747181|FG000|Overall Study|Protocol Violation|0|||
94533268|NCT04948333|323747182|FG001|Overall Study|Protocol Violation|1|||
94533269|NCT04948333|323747183|FG002|Overall Study|Protocol Violation|0|||
94533270|NCT04948333|323747184|FG003|Overall Study|Protocol Violation|0|||
94533271|NCT04948333|323747181|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
94533272|NCT04948333|323747182|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
94533273|NCT04948333|323747183|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
94533274|NCT04948333|323747184|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
94533275|NCT06359028|323747189|FG000|Overall Study|Adverse Event|1|||
94533276|NCT06359028|323747190|FG001|Overall Study|Adverse Event|0|||
94533277|NCT06359028|323747189|FG000|Overall Study|Withdrawal by Subject|1|||
94533278|NCT06359028|323747190|FG001|Overall Study|Withdrawal by Subject|0|||
94533279|NCT00843882|323747191|FG000|Step 1|Lack of Efficacy|14|||
94533280|NCT00843882|323747192|FG001|Step 1|Lack of Efficacy|10|||
94533281|NCT00843882|323747193|FG002|Step 1|Lack of Efficacy|21|||
94533282|NCT00843882|323747191|FG000|Step 1|Adverse Event|8|||
94533283|NCT00843882|323747192|FG001|Step 1|Adverse Event|17|||
94533284|NCT00843882|323747193|FG002|Step 1|Adverse Event|20|||
94533285|NCT00843882|323747191|FG000|Step 1|Death|1|||
94533286|NCT00843882|323747192|FG001|Step 1|Death|2|||
94533287|NCT00843882|323747193|FG002|Step 1|Death|4|||
94533288|NCT00843882|323747191|FG000|Step 1|Withdrawal by Subject|6|||
94533289|NCT00843882|323747192|FG001|Step 1|Withdrawal by Subject|12|||
94533290|NCT00843882|323747193|FG002|Step 1|Withdrawal by Subject|9|||
94533291|NCT00843882|323747191|FG000|Step 1|Physician Decision|0|||
94533292|NCT00843882|323747192|FG001|Step 1|Physician Decision|5|||
94533293|NCT00843882|323747193|FG002|Step 1|Physician Decision|1|||
94533294|NCT00843882|323747191|FG000|Step 1|Patient and physician's decision|0|||
94533295|NCT00843882|323747192|FG001|Step 1|Patient and physician's decision|0|||
94533296|NCT00843882|323747193|FG002|Step 1|Patient and physician's decision|1|||
94533297|NCT00843882|323747191|FG000|Step 1|Other complicating disease|1|||
94533298|NCT00843882|323747192|FG001|Step 1|Other complicating disease|3|||
94533299|NCT00843882|323747193|FG002|Step 1|Other complicating disease|4|||
94533300|NCT00843882|323747191|FG000|Step 1|Alternative therapy|0|||
94533301|NCT00843882|323747192|FG001|Step 1|Alternative therapy|1|||
94533302|NCT00843882|323747193|FG002|Step 1|Alternative therapy|1|||
94533303|NCT00843882|323747191|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
94533304|NCT00843882|323747192|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
94533305|NCT00843882|323747193|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
94533306|NCT00843882|323747191|FG000|Step 1|Off treatment reason unknown|0|||
94533307|NCT00843882|323747192|FG001|Step 1|Off treatment reason unknown|1|||
94533308|NCT00843882|323747193|FG002|Step 1|Off treatment reason unknown|4|||
94533309|NCT00843882|323747191|FG000|Step 1|Never started treatment|2|||
94533310|NCT00843882|323747192|FG001|Step 1|Never started treatment|0|||
94533311|NCT00843882|323747193|FG002|Step 1|Never started treatment|0|||
94533312|NCT00843882|323747191|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
94533313|NCT00843882|323747192|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
94533314|NCT00843882|323747193|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
94533315|NCT00843882|323747191|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
94533316|NCT00843882|323747192|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
94533317|NCT00843882|323747193|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
94533318|NCT00843882|323747191|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
94533319|NCT00843882|323747192|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
94533320|NCT00843882|323747193|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
94533321|NCT00843882|323747191|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
94533322|NCT00843882|323747192|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
94533323|NCT00843882|323747193|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
94533324|NCT00843882|323747191|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
94533325|NCT00843882|323747192|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
94533326|NCT00843882|323747193|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
94533327|NCT00843882|323747191|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
94533328|NCT00843882|323747192|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
94533329|NCT00843882|323747193|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
94533330|NCT00843882|323747191|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
94533331|NCT00843882|323747192|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
94533332|NCT00843882|323747193|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
94533333|NCT02602275|323747199|FG000|Day 1|Physician Decision|0|||
94533334|NCT02602275|323747200|FG001|Day 1|Physician Decision|1|||
94533335|NCT06107803|323747201|FG000|Overall Study|Adverse Event|1|||
94533336|NCT06107803|323747201|FG000|Overall Study|Withdrawal by Subject|2|||
94533337|NCT06107803|323747201|FG000|Overall Study|Protocol Violation|1|||
94533338|NCT01866111|323747202|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
94533339|NCT01866111|323747203|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
94533340|NCT01866111|323747204|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
94533341|NCT01866111|323747205|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
94533342|NCT01866111|323747202|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
94533343|NCT01866111|323747203|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
94533344|NCT01866111|323747204|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
94533345|NCT01866111|323747205|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
94533346|NCT01866111|323747202|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
94533347|NCT01866111|323747203|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
94533348|NCT01866111|323747204|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
94533349|NCT01866111|323747205|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
94533350|NCT01866111|323747202|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
94533351|NCT01866111|323747203|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
94533352|NCT01866111|323747204|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
94533353|NCT01866111|323747205|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
94533354|NCT01866111|323747202|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
94533355|NCT01866111|323747203|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
94533356|NCT01866111|323747204|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
94533357|NCT01866111|323747205|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
94533358|NCT01866111|323747202|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
94533359|NCT01866111|323747203|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
94533360|NCT01866111|323747204|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
94533361|NCT01866111|323747205|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
94533362|NCT01866111|323747202|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
94533363|NCT01866111|323747203|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
94533364|NCT01866111|323747204|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
94533365|NCT01866111|323747205|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
94533366|NCT01866111|323747202|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
94533367|NCT01866111|323747203|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
94533368|NCT01866111|323747204|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
94533369|NCT01866111|323747205|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
94533370|NCT01866111|323747202|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
94533371|NCT01866111|323747203|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
94533372|NCT01866111|323747204|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
94533373|NCT01866111|323747205|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
94533374|NCT01866111|323747202|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
94533375|NCT01866111|323747203|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
94533376|NCT01866111|323747204|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
94533377|NCT01866111|323747205|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
94533378|NCT01866111|323747202|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
94533379|NCT01866111|323747203|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
94533380|NCT01866111|323747204|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
94533381|NCT01866111|323747205|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
94533382|NCT01866111|323747202|FG000|Open-label Extension Study YKP3089C017|Death|1|||
94533383|NCT01866111|323747203|FG001|Open-label Extension Study YKP3089C017|Death|1|||
94533384|NCT01866111|323747204|FG002|Open-label Extension Study YKP3089C017|Death|3|||
94533385|NCT01866111|323747205|FG003|Open-label Extension Study YKP3089C017|Death|2|||
94533386|NCT01866111|323747202|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
94533387|NCT01866111|323747203|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
94533388|NCT01866111|323747204|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
94533389|NCT01866111|323747205|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
94533390|NCT01866111|323747202|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
94533391|NCT01866111|323747203|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
94533392|NCT01866111|323747204|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
94533393|NCT01866111|323747205|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
94533394|NCT01866111|323747202|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
94533395|NCT01866111|323747203|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
94533396|NCT01866111|323747204|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
94533397|NCT01866111|323747205|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
94533398|NCT03099174|323747207|FG000|Overall Study|Withdrawal by Subject|0|||
94533399|NCT03099174|323747208|FG001|Overall Study|Withdrawal by Subject|0|||
94533400|NCT03099174|323747209|FG002|Overall Study|Withdrawal by Subject|1|||
94533401|NCT03099174|323747210|FG003|Overall Study|Withdrawal by Subject|0|||
94533402|NCT03099174|323747211|FG004|Overall Study|Withdrawal by Subject|2|||
94533403|NCT03099174|323747212|FG005|Overall Study|Withdrawal by Subject|2|||
94533404|NCT03099174|323747213|FG006|Overall Study|Withdrawal by Subject|1|||
94533405|NCT03099174|323747214|FG007|Overall Study|Withdrawal by Subject|4|||
94533406|NCT03099174|323747207|FG000|Overall Study|Adverse Event|0|||
94533407|NCT03099174|323747208|FG001|Overall Study|Adverse Event|1|||
94533408|NCT03099174|323747209|FG002|Overall Study|Adverse Event|1|||
94533409|NCT03099174|323747210|FG003|Overall Study|Adverse Event|2|||
94533410|NCT03099174|323747211|FG004|Overall Study|Adverse Event|5|||
94533411|NCT03099174|323747212|FG005|Overall Study|Adverse Event|3|||
94533412|NCT03099174|323747213|FG006|Overall Study|Adverse Event|6|||
94533413|NCT03099174|323747214|FG007|Overall Study|Adverse Event|4|||
94533414|NCT03099174|323747207|FG000|Overall Study|Other than listed|6|||
94533415|NCT03099174|323747208|FG001|Overall Study|Other than listed|6|||
94533416|NCT03099174|323747209|FG002|Overall Study|Other than listed|5|||
94533417|NCT03099174|323747210|FG003|Overall Study|Other than listed|6|||
94533418|NCT03099174|323747211|FG004|Overall Study|Other than listed|19|||
94533419|NCT03099174|323747212|FG005|Overall Study|Other than listed|10|||
94533420|NCT03099174|323747213|FG006|Overall Study|Other than listed|26|||
94533421|NCT03099174|323747214|FG007|Overall Study|Other than listed|23|||
94533422|NCT04934800|323747215|FG000|Overall Study|Other|1|||
94533423|NCT04934800|323747215|FG000|Overall Study|Withdrawal by Subject|5|||
94533424|NCT04934800|323747215|FG000|Overall Study|Lack of Efficacy|1|||
94533425|NCT04934800|323747215|FG000|Overall Study|Adverse Event|9|||
94533426|NCT04934800|323747215|FG000|Overall Study|Lost to Follow-up|5|||
94533427|NCT04934800|323747215|FG000|Overall Study|Enrolled but not treated|1|||
94533428|NCT00980538|323747220|FG000|Overall Study|Lost to Follow-up|20|||
94533429|NCT00980538|323747220|FG000|Overall Study|Sponsor's Decision|4|||
94533430|NCT00980538|323747220|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
94533431|NCT00980538|323747220|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
94533432|NCT00980538|323747220|FG000|Overall Study|Switch to Commercially Available Medication|25|||
94533433|NCT00980538|323747220|FG000|Overall Study|Participant Non-Compliant|9|||
94533434|NCT00980538|323747220|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
94533435|NCT00980538|323747220|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
94533436|NCT00980538|323747220|FG000|Overall Study|Other|60|||
94533437|NCT00980538|323747220|FG000|Overall Study|Other|1|||
94533438|NCT00157196|323747221|FG000|Overall Study|Ongoing at data cut-off|9|||
94533439|NCT05005013|323747222|FG000|Overall Study|Withdrawal by Subject|5|||
94533440|NCT05005013|323747223|FG001|Overall Study|Withdrawal by Subject|1|||
94533441|NCT05005013|323747222|FG000|Overall Study|Lost to Follow-up|3|||
94533442|NCT05005013|323747223|FG001|Overall Study|Lost to Follow-up|1|||
94533443|NCT05005013|323747222|FG000|Overall Study|Ineligibility|1|||
94533444|NCT05005013|323747223|FG001|Overall Study|Ineligibility|1|||
94533445|NCT06099223|323747225|FG000|Overall Study|Preoperative surveys missed|0|||
94533446|NCT06099223|323747226|FG001|Overall Study|Preoperative surveys missed|1|||
94533447|NCT02791516|323747227|FG000|Overall Study|Withdrawal by Subject|1|||
94533448|NCT02791516|323747228|FG001|Overall Study|Withdrawal by Subject|1|||
94533449|NCT00211757|323747232|FG000|Overall Study|Withdrawal by Subject|1|||
94533450|NCT00211757|323747233|FG001|Overall Study|Withdrawal by Subject|1|||
94533451|NCT00211757|323747232|FG000|Overall Study|Lack of Efficacy|0|||
94533452|NCT00211757|323747233|FG001|Overall Study|Lack of Efficacy|1|||
94533453|NCT00705250|323748211|FG000|Overall Study|Withdrawal by Subject|1|||
94533454|NCT00705250|323748211|FG000|Overall Study|Patient died in car accident|1|||
94533455|NCT01576146|323748212|FG000|Extension Period 1|Adverse Event|2|||
94533456|NCT01576146|323748212|FG000|Extension Period 1|Death|2|||
94533457|NCT01576146|323748212|FG000|Extension Period 1|Physician Decision|2|||
94533458|NCT01576146|323748212|FG000|Extension Period 1|Withdrawal by Subject|1|||
94533459|NCT01576146|323748212|FG000|Extension Period 1|Lost to Follow-up|1|||
94533460|NCT01576146|323748212|FG000|Extension Period 1|Parathyroidectomy|1|||
94533461|NCT01576146|323748212|FG000|Extension Period 1|Renal Transplant|1|||
94533462|NCT01576146|323748212|FG000|Extension Period 2|Sponsor Decision|13|||
94533463|NCT01576146|323748212|FG000|Extension Period 2|Death|1|||
94533464|NCT01576146|323748212|FG000|Extension Period 2|Adverse Event|1|||
94533465|NCT01576146|323748212|FG000|Extension Period 2|Renal Transplant|1|||
94533466|NCT01576146|323748212|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
94533467|NCT01814878|323748213|FG000|Overall Study|Adverse Event|16|||
94533468|NCT01814878|323748214|FG001|Overall Study|Adverse Event|5|||
94533469|NCT01814878|323748213|FG000|Overall Study|Withdrawal by Subject|20|||
94533470|NCT01814878|323748214|FG001|Overall Study|Withdrawal by Subject|16|||
94533471|NCT01814878|323748213|FG000|Overall Study|Protocol Violation|5|||
94533472|NCT01814878|323748214|FG001|Overall Study|Protocol Violation|5|||
94533473|NCT01814878|323748213|FG000|Overall Study|Physician Decision|3|||
94533474|NCT01814878|323748214|FG001|Overall Study|Physician Decision|1|||
94533475|NCT01814878|323748213|FG000|Overall Study|Screening failure (drop-out)|0|||
94533476|NCT01814878|323748214|FG001|Overall Study|Screening failure (drop-out)|3|||
94533477|NCT01814878|323748213|FG000|Overall Study|Other|2|||
94533478|NCT01814878|323748214|FG001|Overall Study|Other|0|||
94533479|NCT01545934|323748215|FG000|Overall Study|Withdrawal by Subject|4|||
94533480|NCT01545934|323748216|FG001|Overall Study|Withdrawal by Subject|3|||
94533481|NCT01545934|323748215|FG000|Overall Study|Lost to Follow-up|1|||
94533482|NCT01545934|323748216|FG001|Overall Study|Lost to Follow-up|0|||
94533483|NCT00365105|323748217|FG000|Overall Study|Protocol Violation|5|||
94533484|NCT00365105|323748218|FG001|Overall Study|Protocol Violation|8|||
94533485|NCT04026009|323748219|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
94533486|NCT04026009|323748220|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
94533487|NCT04026009|323748221|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
94533488|NCT04026009|323748222|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
94533489|NCT04026009|323748223|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
94533490|NCT04026009|323748219|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
94533491|NCT04026009|323748220|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
94533492|NCT04026009|323748221|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
94533493|NCT04026009|323748222|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
94533494|NCT04026009|323748223|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
94533495|NCT01177553|323748224|FG000|Overall Study|babies not yet 6 months of age|1|||
94533496|NCT01177553|323748225|FG001|Overall Study|babies not yet 6 months of age|0|||
94533497|NCT03888235|323748233|FG000|Overall Study|Lost to Follow-up|1|||
94533498|NCT03888235|323748234|FG001|Overall Study|Lost to Follow-up|1|||
94533499|NCT03888235|323748235|FG002|Overall Study|Lost to Follow-up|0|||
94533500|NCT04826094|323748236|FG000|Overall Study|Lost to Follow-up|2|||
94533501|NCT04826094|323748237|FG001|Overall Study|Lost to Follow-up|1|||
94533502|NCT04826094|323748238|FG002|Overall Study|Lost to Follow-up|0|||
94533503|NCT04826094|323748239|FG003|Overall Study|Lost to Follow-up|0|||
94533504|NCT04826094|323748240|FG004|Overall Study|Lost to Follow-up|1|||
94533505|NCT04826094|323748241|FG005|Overall Study|Lost to Follow-up|3|||
94533506|NCT04826094|323748242|FG006|Overall Study|Lost to Follow-up|1|||
94533507|NCT04826094|323748243|FG007|Overall Study|Lost to Follow-up|1|||
94533508|NCT04826094|323748236|FG000|Overall Study|Participant withdrew consent|1|||
94533509|NCT04826094|323748237|FG001|Overall Study|Participant withdrew consent|0|||
94533510|NCT04826094|323748238|FG002|Overall Study|Participant withdrew consent|0|||
94533511|NCT04826094|323748239|FG003|Overall Study|Participant withdrew consent|1|||
94533512|NCT04826094|323748240|FG004|Overall Study|Participant withdrew consent|1|||
94533513|NCT04826094|323748241|FG005|Overall Study|Participant withdrew consent|1|||
94533514|NCT04826094|323748242|FG006|Overall Study|Participant withdrew consent|0|||
94533515|NCT04826094|323748243|FG007|Overall Study|Participant withdrew consent|1|||
94533516|NCT04826094|323748236|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
94533517|NCT04826094|323748237|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
94533518|NCT04826094|323748238|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
94533519|NCT04826094|323748239|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
94533520|NCT04826094|323748240|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
94533521|NCT04826094|323748241|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
94533522|NCT04826094|323748242|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
94533523|NCT04826094|323748243|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
94533524|NCT04826094|323748236|FG000|Overall Study|Withdrawn by Investigator|0|||
94533525|NCT04826094|323748237|FG001|Overall Study|Withdrawn by Investigator|0|||
94533526|NCT04826094|323748238|FG002|Overall Study|Withdrawn by Investigator|0|||
94533527|NCT04826094|323748239|FG003|Overall Study|Withdrawn by Investigator|0|||
94533528|NCT04826094|323748240|FG004|Overall Study|Withdrawn by Investigator|0|||
94533529|NCT04826094|323748241|FG005|Overall Study|Withdrawn by Investigator|1|||
94533530|NCT04826094|323748242|FG006|Overall Study|Withdrawn by Investigator|0|||
94533531|NCT04826094|323748243|FG007|Overall Study|Withdrawn by Investigator|1|||
94533532|NCT04826094|323748236|FG000|Overall Study|Other: Moved from area|1|||
94533533|NCT04826094|323748237|FG001|Overall Study|Other: Moved from area|1|||
94533534|NCT04826094|323748238|FG002|Overall Study|Other: Moved from area|1|||
94533535|NCT04826094|323748239|FG003|Overall Study|Other: Moved from area|0|||
94533536|NCT04826094|323748240|FG004|Overall Study|Other: Moved from area|0|||
94533537|NCT04826094|323748241|FG005|Overall Study|Other: Moved from area|0|||
94533538|NCT04826094|323748242|FG006|Overall Study|Other: Moved from area|0|||
94533539|NCT04826094|323748243|FG007|Overall Study|Other: Moved from area|0|||
94533540|NCT04826094|323748236|FG000|Overall Study|Other: Declined|0|||
94533541|NCT04826094|323748237|FG001|Overall Study|Other: Declined|0|||
94533542|NCT04826094|323748238|FG002|Overall Study|Other: Declined|0|||
94533543|NCT04826094|323748239|FG003|Overall Study|Other: Declined|0|||
94533544|NCT04826094|323748240|FG004|Overall Study|Other: Declined|1|||
94533545|NCT04826094|323748241|FG005|Overall Study|Other: Declined|0|||
94533546|NCT04826094|323748242|FG006|Overall Study|Other: Declined|0|||
94533547|NCT04826094|323748243|FG007|Overall Study|Other: Declined|0|||
94533548|NCT04826094|323748236|FG000|Overall Study|Other: Vaccine not administered|0|||
94533549|NCT04826094|323748237|FG001|Overall Study|Other: Vaccine not administered|0|||
94533550|NCT04826094|323748238|FG002|Overall Study|Other: Vaccine not administered|1|||
94533551|NCT04826094|323748239|FG003|Overall Study|Other: Vaccine not administered|0|||
94533552|NCT04826094|323748240|FG004|Overall Study|Other: Vaccine not administered|0|||
94533553|NCT04826094|323748241|FG005|Overall Study|Other: Vaccine not administered|1|||
94533554|NCT04826094|323748242|FG006|Overall Study|Other: Vaccine not administered|1|||
94533555|NCT04826094|323748243|FG007|Overall Study|Other: Vaccine not administered|3|||
94533556|NCT04295681|323748245|FG000|Overall Study|Eligibility error|1|||
94533557|NCT04295681|323748246|FG001|Overall Study|Eligibility error|3|||
94533558|NCT03931382|323748247|FG000|Overall Study|Equipment malfunction|2|||
94533559|NCT03931382|323748248|FG001|Overall Study|Equipment malfunction|0|||
94533560|NCT03931382|323748249|FG002|Overall Study|Equipment malfunction|2|||
94533561|NCT03931382|323748247|FG000|Overall Study|Withdrawal by Subject|0|||
94533562|NCT03931382|323748248|FG001|Overall Study|Withdrawal by Subject|1|||
94533563|NCT03931382|323748249|FG002|Overall Study|Withdrawal by Subject|0|||
94533564|NCT05101993|323748258|FG000|Overall Study|Withdrawal by Subject|1|||
94533565|NCT04283994|323748265|FG000|Overall Study|Death|11|||
94533566|NCT04283994|323748266|FG001|Overall Study|Death|20|||
94533567|NCT04283994|323748267|FG002|Overall Study|Death|11|||
94533568|NCT04283994|323748268|FG003|Overall Study|Death|0|||
94533569|NCT04283994|323748269|FG004|Overall Study|Death|0|||
94533570|NCT04283994|323748270|FG005|Overall Study|Death|0|||
94533571|NCT04283994|323748271|FG006|Overall Study|Death|0|||
94533572|NCT04283994|323748265|FG000|Overall Study|Withdrawal by Subject|16|||
94533573|NCT04283994|323748266|FG001|Overall Study|Withdrawal by Subject|4|||
94533574|NCT04283994|323748267|FG002|Overall Study|Withdrawal by Subject|6|||
94533575|NCT04283994|323748268|FG003|Overall Study|Withdrawal by Subject|1|||
94533576|NCT04283994|323748269|FG004|Overall Study|Withdrawal by Subject|0|||
94533577|NCT04283994|323748270|FG005|Overall Study|Withdrawal by Subject|1|||
94533578|NCT04283994|323748271|FG006|Overall Study|Withdrawal by Subject|0|||
94533579|NCT03479541|323748275|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
94533580|NCT03479541|323748276|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
94533581|NCT03479541|323748277|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
94533582|NCT03479541|323748278|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
94533583|NCT03479541|323748275|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
94533584|NCT03479541|323748276|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
94533585|NCT03479541|323748277|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
94533586|NCT03479541|323748278|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
94533587|NCT03479541|323748275|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
94533588|NCT03479541|323748276|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
94533589|NCT03479541|323748277|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
94533590|NCT03479541|323748278|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
94533591|NCT03479541|323748275|FG000|Home Monitoring|Lost to Follow-up|0|||
94533592|NCT03479541|323748276|FG001|Home Monitoring|Lost to Follow-up|0|||
94533593|NCT03479541|323748277|FG002|Home Monitoring|Lost to Follow-up|8|||
94533594|NCT03479541|323748278|FG003|Home Monitoring|Lost to Follow-up|12|||
94533595|NCT03479541|323748275|FG000|Home Monitoring|Withdrawal by Subject|0|||
94533596|NCT03479541|323748276|FG001|Home Monitoring|Withdrawal by Subject|0|||
94533597|NCT03479541|323748277|FG002|Home Monitoring|Withdrawal by Subject|17|||
94533598|NCT03479541|323748278|FG003|Home Monitoring|Withdrawal by Subject|30|||
94533599|NCT03479541|323748275|FG000|Home Monitoring|Early Termination - PI Decision|0|||
94533600|NCT03479541|323748276|FG001|Home Monitoring|Early Termination - PI Decision|0|||
94533601|NCT03479541|323748277|FG002|Home Monitoring|Early Termination - PI Decision|4|||
94533602|NCT03479541|323748278|FG003|Home Monitoring|Early Termination - PI Decision|6|||
94533603|NCT05463744|323748280|FG000|Treatment Period|Withdrawal by Subject|19|||
94533604|NCT05463744|323748281|FG001|Treatment Period|Withdrawal by Subject|16|||
94533605|NCT05463744|323748280|FG000|Treatment Period|Adverse Event|4|||
94533606|NCT05463744|323748281|FG001|Treatment Period|Adverse Event|4|||
94533607|NCT05463744|323748280|FG000|Treatment Period|Pregnancy|0|||
94533608|NCT05463744|323748281|FG001|Treatment Period|Pregnancy|3|||
94533609|NCT05463744|323748280|FG000|Treatment Period|Lost to Follow-up|1|||
94533610|NCT05463744|323748281|FG001|Treatment Period|Lost to Follow-up|3|||
94533611|NCT05463744|323748280|FG000|Treatment Period|Inadvertent enrollment|2|||
94533612|NCT05463744|323748281|FG001|Treatment Period|Inadvertent enrollment|1|||
94533613|NCT05463744|323748280|FG000|Treatment Period|Death|0|||
94533614|NCT05463744|323748281|FG001|Treatment Period|Death|1|||
94533615|NCT05463744|323748280|FG000|Treatment Period|Non-compliance with Study Drug|1|||
94533616|NCT05463744|323748281|FG001|Treatment Period|Non-compliance with Study Drug|0|||
94533617|NCT05463744|323748280|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
94533618|NCT05463744|323748281|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
94533619|NCT05463744|323748280|FG000|Treatment Period|Physician Decision|0|||
94533620|NCT05463744|323748281|FG001|Treatment Period|Physician Decision|1|||
94533621|NCT05463744|323748280|FG000|Follow-Up Period|Withdrawal by Subject|3|||
94533622|NCT05463744|323748281|FG001|Follow-Up Period|Withdrawal by Subject|1|||
94533623|NCT05463744|323748280|FG000|Follow-Up Period|Lost to Follow-up|1|||
94533624|NCT05463744|323748281|FG001|Follow-Up Period|Lost to Follow-up|1|||
94533625|NCT03551665|323748288|FG000|Overall Study|Lost to Follow-up|11|||
94533626|NCT03551665|323748289|FG001|Overall Study|Lost to Follow-up|2|||
94533627|NCT01631747|323749790|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
94533628|NCT01631747|323749791|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
94533629|NCT01631747|323749790|FG000|Live Birth|Pregnancy Termination|1|||
94533630|NCT01631747|323749791|FG001|Live Birth|Pregnancy Termination|0|||
94533631|NCT01631747|323749790|FG000|Live Birth|MIscarriage|2|||
94533632|NCT01631747|323749791|FG001|Live Birth|MIscarriage|0|||
94533633|NCT01631747|323749790|FG000|Live Birth|Stillbirth|1|||
94533634|NCT01631747|323749791|FG001|Live Birth|Stillbirth|1|||
94533635|NCT01631747|323749790|FG000|One Year Infant Outcomes|Patient Refused|13|||
94533636|NCT01631747|323749791|FG001|One Year Infant Outcomes|Patient Refused|9|||
94533637|NCT02013206|323749792|FG000|Overall Study|Progressive disease (PD)|14|||
94533638|NCT02013206|323749793|FG001|Overall Study|Progressive disease (PD)|17|||
94533639|NCT02013206|323749792|FG000|Overall Study|Symptomatic deterioration|3|||
94533640|NCT02013206|323749793|FG001|Overall Study|Symptomatic deterioration|1|||
94533641|NCT02013206|323749792|FG000|Overall Study|Adverse Event|1|||
94533642|NCT02013206|323749793|FG001|Overall Study|Adverse Event|0|||
94533643|NCT02013206|323749792|FG000|Overall Study|Patient refusal|2|||
94533644|NCT02013206|323749793|FG001|Overall Study|Patient refusal|0|||
94533645|NCT02013206|323749792|FG000|Overall Study|Patient non-compliance|1|||
94533646|NCT02013206|323749793|FG001|Overall Study|Patient non-compliance|0|||
94533647|NCT02013206|323749792|FG000|Overall Study|Death|1|||
94533648|NCT02013206|323749793|FG001|Overall Study|Death|2|||
94533649|NCT02013206|323749792|FG000|Overall Study|Other reasons off treatment|5|||
94533650|NCT02013206|323749793|FG001|Overall Study|Other reasons off treatment|2|||
94533651|NCT00782171|323749799|FG000|Overall Study|Lost to Follow-up|2|||
94533652|NCT00782171|323749800|FG001|Overall Study|Lost to Follow-up|2|||
94533653|NCT00782171|323749799|FG000|Overall Study|Withdrawal by Subject|2|||
94533654|NCT00782171|323749800|FG001|Overall Study|Withdrawal by Subject|1|||
94533655|NCT00782171|323749799|FG000|Overall Study|complications|3|||
94533656|NCT00782171|323749800|FG001|Overall Study|complications|1|||
94533657|NCT00782171|323749799|FG000|Overall Study|others|7|||
94533658|NCT00782171|323749800|FG001|Overall Study|others|9|||
94533659|NCT00782171|323749799|FG000|Overall Study|not eligible|8|||
94533660|NCT00782171|323749800|FG001|Overall Study|not eligible|6|||
94533661|NCT00185380|323749801|FG000|Overall Study|Adverse Event|41|||
94533662|NCT00185380|323749802|FG001|Overall Study|Adverse Event|43|||
94533663|NCT00185380|323749803|FG002|Overall Study|Adverse Event|48|||
94533664|NCT00185380|323749801|FG000|Overall Study|Lost to Follow-up|0|||
94533665|NCT00185380|323749802|FG001|Overall Study|Lost to Follow-up|4|||
94533666|NCT00185380|323749803|FG002|Overall Study|Lost to Follow-up|3|||
94533667|NCT00185380|323749801|FG000|Overall Study|Pregnancy|1|||
94533668|NCT00185380|323749802|FG001|Overall Study|Pregnancy|4|||
94533669|NCT00185380|323749803|FG002|Overall Study|Pregnancy|0|||
94533670|NCT00185380|323749801|FG000|Overall Study|Protocol Violation|2|||
94533671|NCT00185380|323749802|FG001|Overall Study|Protocol Violation|2|||
94533672|NCT00185380|323749803|FG002|Overall Study|Protocol Violation|1|||
94533673|NCT00185380|323749801|FG000|Overall Study|Withdrawal by Subject|1|||
94533674|NCT00185380|323749802|FG001|Overall Study|Withdrawal by Subject|2|||
94533675|NCT00185380|323749803|FG002|Overall Study|Withdrawal by Subject|0|||
94533676|NCT00185380|323749801|FG000|Overall Study|Failed insertion|1|||
94533677|NCT00185380|323749802|FG001|Overall Study|Failed insertion|1|||
94533678|NCT00185380|323749803|FG002|Overall Study|Failed insertion|2|||
94533679|NCT00185380|323749801|FG000|Overall Study|Planned pregnancy|9|||
94533680|NCT00185380|323749802|FG001|Overall Study|Planned pregnancy|12|||
94533681|NCT00185380|323749803|FG002|Overall Study|Planned pregnancy|12|||
94533682|NCT00185380|323749801|FG000|Overall Study|No need for contraception|3|||
94533683|NCT00185380|323749802|FG001|Overall Study|No need for contraception|3|||
94533684|NCT00185380|323749803|FG002|Overall Study|No need for contraception|3|||
94533685|NCT00185380|323749801|FG000|Overall Study|Could not attend visits|2|||
94533686|NCT00185380|323749802|FG001|Overall Study|Could not attend visits|0|||
94533687|NCT00185380|323749803|FG002|Overall Study|Could not attend visits|4|||
94533688|NCT00185380|323749801|FG000|Overall Study|personal reason|6|||
94533689|NCT00185380|323749802|FG001|Overall Study|personal reason|1|||
94533690|NCT00185380|323749803|FG002|Overall Study|personal reason|1|||
94533691|NCT01443364|323749804|FG000|Overall Study|Lack of Efficacy|14|||
94533692|NCT01443364|323749804|FG000|Overall Study|Lost to Follow-up|3|||
94533693|NCT01443364|323749804|FG000|Overall Study|Withdrawal by Subject|5|||
94533694|NCT01443364|323749804|FG000|Overall Study|Other Reason|4|||
94533695|NCT01443364|323749804|FG000|Overall Study|SAE, non-fatal|6|||
94533696|NCT01443364|323749804|FG000|Overall Study|AE, non-serious non-fatal|8|||
94533697|NCT01443364|323749804|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
94533698|NCT02650804|323749805|FG000|Overall Study|Adverse Event|3|||
94533699|NCT02650804|323749806|FG001|Overall Study|Adverse Event|2|||
94533700|NCT02650804|323749805|FG000|Overall Study|Death|1|||
94533701|NCT02650804|323749806|FG001|Overall Study|Death|2|||
94533702|NCT02650804|323749805|FG000|Overall Study|Progressive Disease|7|||
94533703|NCT02650804|323749806|FG001|Overall Study|Progressive Disease|10|||
94533704|NCT02650804|323749805|FG000|Overall Study|Physician Decision|0|||
94533705|NCT02650804|323749806|FG001|Overall Study|Physician Decision|2|||
94533706|NCT02650804|323749805|FG000|Overall Study|Withdrawal by Subject|1|||
94533707|NCT02650804|323749806|FG001|Overall Study|Withdrawal by Subject|4|||
94533708|NCT02650804|323749805|FG000|Overall Study|Symptomatic deterioration|5|||
94533709|NCT02650804|323749806|FG001|Overall Study|Symptomatic deterioration|7|||
94533710|NCT02650804|323749805|FG000|Overall Study|Protocol Violation|0|||
94533711|NCT02650804|323749806|FG001|Overall Study|Protocol Violation|1|||
94533712|NCT01519791|323749808|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
94533713|NCT01519791|323749809|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
94533714|NCT01519791|323749808|FG000|Overall Study|Protocol Violation|6|||
94533715|NCT01519791|323749809|FG001|Overall Study|Protocol Violation|19|||
94533716|NCT01519791|323749808|FG000|Overall Study|Other Reason|87|||
94533717|NCT01519791|323749809|FG001|Overall Study|Other Reason|222|||
94533718|NCT01519791|323749808|FG000|Overall Study|subjects randomized in error|2|||
94533719|NCT01519791|323749809|FG001|Overall Study|subjects randomized in error|0|||
94533720|NCT01519791|323749808|FG000|Overall Study|Lack of Efficacy|16|||
94533721|NCT01519791|323749809|FG001|Overall Study|Lack of Efficacy|20|||
94533722|NCT01519791|323749808|FG000|Overall Study|SAE, non-fatal|6|||
94533723|NCT01519791|323749809|FG001|Overall Study|SAE, non-fatal|22|||
94533724|NCT01519791|323749808|FG000|Overall Study|AE, serious fatal|0|||
94533725|NCT01519791|323749809|FG001|Overall Study|AE, serious fatal|1|||
94533726|NCT01519791|323749808|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
94533727|NCT01519791|323749809|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
94533728|NCT01519791|323749808|FG000|Overall Study|AE, non-serious non-fatal|12|||
94533729|NCT01519791|323749809|FG001|Overall Study|AE, non-serious non-fatal|31|||
94533730|NCT01519791|323749808|FG000|Overall Study|Withdrawal by Subject|15|||
94533731|NCT01519791|323749809|FG001|Overall Study|Withdrawal by Subject|37|||
94533732|NCT01519791|323749808|FG000|Overall Study|Lost to Follow-up|6|||
94533733|NCT01519791|323749809|FG001|Overall Study|Lost to Follow-up|14|||
94533734|NCT00733291|323749810|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
94533735|NCT00733291|323749811|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
94533736|NCT00733291|323749812|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
94533737|NCT00733291|323749813|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
94533738|NCT01406938|323749819|FG000|Induction Period|Subject/guardian decision|6|||
94533739|NCT01406938|323749820|FG001|Induction Period|Subject/guardian decision|8|||
94533740|NCT01406938|323749821|FG002|Induction Period|Subject/guardian decision|0|||
94533741|NCT01406938|323749822|FG003|Induction Period|Subject/guardian decision|0|||
94533742|NCT01406938|323749823|FG004|Induction Period|Subject/guardian decision|0|||
94533743|NCT01406938|323749824|FG005|Induction Period|Subject/guardian decision|0|||
94533744|NCT01406938|323749819|FG000|Induction Period|Protocol deviation|1|||
94533745|NCT01406938|323749820|FG001|Induction Period|Protocol deviation|0|||
94533746|NCT01406938|323749821|FG002|Induction Period|Protocol deviation|0|||
94533747|NCT01406938|323749822|FG003|Induction Period|Protocol deviation|0|||
94533748|NCT01406938|323749823|FG004|Induction Period|Protocol deviation|0|||
94533749|NCT01406938|323749824|FG005|Induction Period|Protocol deviation|0|||
94533750|NCT01406938|323749819|FG000|Induction Period|Adverse Event|8|||
94533751|NCT01406938|323749820|FG001|Induction Period|Adverse Event|9|||
94533752|NCT01406938|323749821|FG002|Induction Period|Adverse Event|0|||
94533753|NCT01406938|323749822|FG003|Induction Period|Adverse Event|0|||
94533754|NCT01406938|323749823|FG004|Induction Period|Adverse Event|0|||
94533755|NCT01406938|323749824|FG005|Induction Period|Adverse Event|0|||
94533756|NCT01406938|323749819|FG000|Induction Period|Lack of Efficacy|1|||
94533757|NCT01406938|323749820|FG001|Induction Period|Lack of Efficacy|0|||
94533758|NCT01406938|323749821|FG002|Induction Period|Lack of Efficacy|0|||
94533759|NCT01406938|323749822|FG003|Induction Period|Lack of Efficacy|0|||
94533760|NCT01406938|323749823|FG004|Induction Period|Lack of Efficacy|0|||
94533761|NCT01406938|323749824|FG005|Induction Period|Lack of Efficacy|0|||
94533762|NCT01406938|323749819|FG000|Induction Period|Lost to Follow-up|2|||
94533763|NCT01406938|323749820|FG001|Induction Period|Lost to Follow-up|3|||
94533764|NCT01406938|323749821|FG002|Induction Period|Lost to Follow-up|0|||
94533765|NCT01406938|323749822|FG003|Induction Period|Lost to Follow-up|0|||
94533766|NCT01406938|323749823|FG004|Induction Period|Lost to Follow-up|0|||
94533767|NCT01406938|323749824|FG005|Induction Period|Lost to Follow-up|0|||
94533768|NCT01406938|323749819|FG000|Maintenance Period|Adverse Event|0|||
94533769|NCT01406938|323749820|FG001|Maintenance Period|Adverse Event|0|||
94533770|NCT01406938|323749821|FG002|Maintenance Period|Adverse Event|2|||
94533771|NCT01406938|323749822|FG003|Maintenance Period|Adverse Event|8|||
94533772|NCT01406938|323749823|FG004|Maintenance Period|Adverse Event|4|||
94533773|NCT01406938|323749824|FG005|Maintenance Period|Adverse Event|2|||
94533774|NCT01406938|323749819|FG000|Maintenance Period|Death|0|||
94533775|NCT01406938|323749820|FG001|Maintenance Period|Death|0|||
94533776|NCT01406938|323749821|FG002|Maintenance Period|Death|0|||
94533777|NCT01406938|323749822|FG003|Maintenance Period|Death|0|||
94533778|NCT01406938|323749823|FG004|Maintenance Period|Death|1|||
94533779|NCT01406938|323749824|FG005|Maintenance Period|Death|0|||
94533780|NCT01406938|323749819|FG000|Maintenance Period|Subject/guardian decision|0|||
94533781|NCT01406938|323749820|FG001|Maintenance Period|Subject/guardian decision|0|||
94533782|NCT01406938|323749821|FG002|Maintenance Period|Subject/guardian decision|11|||
94533783|NCT01406938|323749822|FG003|Maintenance Period|Subject/guardian decision|7|||
94533784|NCT01406938|323749823|FG004|Maintenance Period|Subject/guardian decision|10|||
94533785|NCT01406938|323749824|FG005|Maintenance Period|Subject/guardian decision|7|||
94533786|NCT01406938|323749819|FG000|Maintenance Period|Protocol Violation|0|||
94533787|NCT01406938|323749820|FG001|Maintenance Period|Protocol Violation|0|||
94533788|NCT01406938|323749821|FG002|Maintenance Period|Protocol Violation|2|||
94533789|NCT01406938|323749822|FG003|Maintenance Period|Protocol Violation|2|||
94533790|NCT01406938|323749823|FG004|Maintenance Period|Protocol Violation|2|||
94533791|NCT01406938|323749824|FG005|Maintenance Period|Protocol Violation|2|||
94533792|NCT01406938|323749819|FG000|Maintenance Period|Pregnancy|0|||
94533793|NCT01406938|323749820|FG001|Maintenance Period|Pregnancy|0|||
94533794|NCT01406938|323749821|FG002|Maintenance Period|Pregnancy|0|||
94533795|NCT01406938|323749822|FG003|Maintenance Period|Pregnancy|0|||
94533796|NCT01406938|323749823|FG004|Maintenance Period|Pregnancy|1|||
94533797|NCT01406938|323749824|FG005|Maintenance Period|Pregnancy|0|||
94533798|NCT01406938|323749819|FG000|Maintenance Period|Lost to Follow-up|0|||
94533799|NCT01406938|323749820|FG001|Maintenance Period|Lost to Follow-up|0|||
94533800|NCT01406938|323749821|FG002|Maintenance Period|Lost to Follow-up|0|||
94533801|NCT01406938|323749822|FG003|Maintenance Period|Lost to Follow-up|0|||
94533802|NCT01406938|323749823|FG004|Maintenance Period|Lost to Follow-up|4|||
94533803|NCT01406938|323749824|FG005|Maintenance Period|Lost to Follow-up|0|||
94533804|NCT01406938|323749819|FG000|Maintenance Period|Lack of Efficacy|0|||
94533805|NCT01406938|323749820|FG001|Maintenance Period|Lack of Efficacy|0|||
94533806|NCT01406938|323749821|FG002|Maintenance Period|Lack of Efficacy|2|||
94533807|NCT01406938|323749822|FG003|Maintenance Period|Lack of Efficacy|1|||
94533808|NCT01406938|323749823|FG004|Maintenance Period|Lack of Efficacy|3|||
94533809|NCT01406938|323749824|FG005|Maintenance Period|Lack of Efficacy|5|||
94533810|NCT01406938|323749819|FG000|Follow up|Lack of Efficacy|3|||
94533811|NCT01406938|323749820|FG001|Follow up|Lack of Efficacy|2|||
94533812|NCT01406938|323749821|FG002|Follow up|Lack of Efficacy|1|||
94533813|NCT01406938|323749822|FG003|Follow up|Lack of Efficacy|0|||
94533814|NCT01406938|323749823|FG004|Follow up|Lack of Efficacy|0|||
94533815|NCT01406938|323749824|FG005|Follow up|Lack of Efficacy|0|||
94533816|NCT01406938|323749819|FG000|Follow up|Patient/guardian decision|4|||
94533817|NCT01406938|323749820|FG001|Follow up|Patient/guardian decision|2|||
94533818|NCT01406938|323749821|FG002|Follow up|Patient/guardian decision|4|||
94533819|NCT01406938|323749822|FG003|Follow up|Patient/guardian decision|2|||
94533820|NCT01406938|323749823|FG004|Follow up|Patient/guardian decision|4|||
94533821|NCT01406938|323749824|FG005|Follow up|Patient/guardian decision|1|||
94533822|NCT01406938|323749819|FG000|Follow up|Protocol Violation|0|||
94533823|NCT01406938|323749820|FG001|Follow up|Protocol Violation|0|||
94533824|NCT01406938|323749821|FG002|Follow up|Protocol Violation|1|||
94533825|NCT01406938|323749822|FG003|Follow up|Protocol Violation|0|||
94533826|NCT01406938|323749823|FG004|Follow up|Protocol Violation|0|||
94533827|NCT01406938|323749824|FG005|Follow up|Protocol Violation|0|||
94533828|NCT01406938|323749819|FG000|Follow up|Physician Decision|0|||
94533829|NCT01406938|323749820|FG001|Follow up|Physician Decision|0|||
94533830|NCT01406938|323749821|FG002|Follow up|Physician Decision|2|||
94533831|NCT01406938|323749822|FG003|Follow up|Physician Decision|0|||
94533832|NCT01406938|323749823|FG004|Follow up|Physician Decision|3|||
94533833|NCT01406938|323749824|FG005|Follow up|Physician Decision|1|||
94533834|NCT01406938|323749819|FG000|Follow up|Lost to Follow-up|1|||
94533835|NCT01406938|323749820|FG001|Follow up|Lost to Follow-up|1|||
94533836|NCT01406938|323749821|FG002|Follow up|Lost to Follow-up|0|||
94533837|NCT01406938|323749822|FG003|Follow up|Lost to Follow-up|1|||
94533838|NCT01406938|323749823|FG004|Follow up|Lost to Follow-up|2|||
94533839|NCT01406938|323749824|FG005|Follow up|Lost to Follow-up|1|||
94533840|NCT03206970|323749825|FG000|Overall Study|Death|21|||
94533841|NCT03206970|323749825|FG000|Overall Study|Withdrawal by Subject|13|||
94533842|NCT03206970|323749825|FG000|Overall Study|Lost to Follow-up|3|||
94533843|NCT03206970|323749825|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
94533844|NCT00962741|323749836|FG000|Overall Study|Failed to return|3|||
94533845|NCT00962741|323749836|FG000|Overall Study|Lost to Follow-up|2|||
94533846|NCT00962741|323749836|FG000|Overall Study|Withdrawal by Subject|1|||
94533847|NCT00962741|323749836|FG000|Overall Study|Lack of Efficacy|1|||
94533848|NCT00962741|323749836|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
94533849|NCT03350035|323749837|FG000|Overall Study|Lack of Efficacy|2|||
94533850|NCT03350035|323749838|FG001|Overall Study|Lack of Efficacy|0|||
94533851|NCT03350035|323749839|FG002|Overall Study|Lack of Efficacy|0|||
94533852|NCT03350035|323749837|FG000|Overall Study|Subject discharged to hospice|0|||
94533853|NCT03350035|323749838|FG001|Overall Study|Subject discharged to hospice|0|||
94533854|NCT03350035|323749839|FG002|Overall Study|Subject discharged to hospice|1|||
94533855|NCT03195660|323749840|FG000|Overall Study|The study was terminated|2|||
94533856|NCT00433966|323749842|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
94533857|NCT00433966|323749843|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
94533858|NCT00433966|323749844|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
94533859|NCT00433966|323749845|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
94533860|NCT00433966|323749842|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
94533861|NCT00433966|323749843|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
94533862|NCT00433966|323749844|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
94533863|NCT00433966|323749845|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
94533864|NCT00433966|323749842|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
94533865|NCT00433966|323749843|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
94533866|NCT00433966|323749844|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
94533867|NCT00433966|323749845|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
94533868|NCT00433966|323749842|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
94533869|NCT00433966|323749843|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
94533870|NCT00433966|323749844|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
94533871|NCT00433966|323749845|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
94533872|NCT00433966|323749842|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
94533873|NCT00433966|323749843|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
94533874|NCT00433966|323749844|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
94533875|NCT00433966|323749845|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
94533876|NCT04952597|323749846|FG000|Overall Study|Death|12|||
94533877|NCT04952597|323749847|FG001|Overall Study|Death|13|||
94533878|NCT04952597|323749848|FG002|Overall Study|Death|14|||
94533879|NCT04952597|323749846|FG000|Overall Study|Withdrawal by Subject|1|||
94533880|NCT04952597|323749847|FG001|Overall Study|Withdrawal by Subject|0|||
94533881|NCT04952597|323749848|FG002|Overall Study|Withdrawal by Subject|3|||
94533882|NCT04952597|323749846|FG000|Overall Study|Lost to Follow-up|0|||
94533883|NCT04952597|323749847|FG001|Overall Study|Lost to Follow-up|1|||
94533884|NCT04952597|323749848|FG002|Overall Study|Lost to Follow-up|1|||
94533885|NCT00606034|323749849|FG000|Overall Study|incarceration|1|||
94533886|NCT00632827|323749850|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
94533887|NCT00632827|323749850|FG000|Overall Study|Death|2|||
94533888|NCT00632827|323749850|FG000|Overall Study|Adverse Event|5|||
94533889|NCT00632827|323749850|FG000|Overall Study|Lost to Follow-up|1|||
94533890|NCT01126268|323749851|FG000|Overall Study|Adverse Event|1|||
94533891|NCT01205061|323749852|FG000|Overall Study|Adverse Event|4|||
94533892|NCT01205061|323749852|FG000|Overall Study|Withdrawal by Subject|11|||
94533893|NCT01205061|323749852|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
94533894|NCT01205061|323749852|FG000|Overall Study|Lost to Follow-up|9|||
94533895|NCT01205061|323749852|FG000|Overall Study|Other|1|||
94533896|NCT00765037|323749853|FG000|Overall Study|Lost to Follow-up|5|||
94533897|NCT00765037|323749853|FG000|Overall Study|Adverse Event|1|||
94533898|NCT03070171|323749862|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
94533899|NCT03070171|323749863|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
94533900|NCT03070171|323749862|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
94533901|NCT03070171|323749863|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
94533902|NCT01471028|323749864|FG000|VTI-208|Adverse Event|39|||
94533903|NCT01471028|323749865|FG001|VTI-208|Adverse Event|41|||
94533904|NCT01471028|323749864|FG000|VTI-208|Withdrawal by Subject|0|||
94533905|NCT01471028|323749865|FG001|VTI-208|Withdrawal by Subject|2|||
94533906|NCT01471028|323749864|FG000|VTI-208|Lost to Follow-up|1|||
94533907|NCT01471028|323749865|FG001|VTI-208|Lost to Follow-up|1|||
94533908|NCT01471028|323749864|FG000|VTI-208E|Death|7|||
94533909|NCT01471028|323749865|FG001|VTI-208E|Death|10|||
94533910|NCT01471028|323749864|FG000|VTI-208E|Withdrawal by Subject|1|||
94533911|NCT01471028|323749865|FG001|VTI-208E|Withdrawal by Subject|0|||
94533912|NCT01471028|323749864|FG000|VTI-208E|Lost to Follow-up|0|||
94533913|NCT01471028|323749865|FG001|VTI-208E|Lost to Follow-up|2|||
94533914|NCT01972308|323749866|FG000|Overall Study|Withdrawal by Subject|0|||
94533915|NCT01972308|323749867|FG001|Overall Study|Withdrawal by Subject|1|||
94533916|NCT01972308|323749866|FG000|Overall Study|Lost to Follow-up|4|||
94533917|NCT01972308|323749867|FG001|Overall Study|Lost to Follow-up|6|||
94533918|NCT01972308|323749866|FG000|Overall Study|Death|4|||
94533919|NCT01972308|323749867|FG001|Overall Study|Death|1|||
94533920|NCT02851797|323749870|FG000|Overall Study|Withdrawal by Subject|4|||
94533921|NCT02851797|323749871|FG001|Overall Study|Withdrawal by Subject|2|||
94533922|NCT02851797|323749870|FG000|Overall Study|Adverse Event|3|||
94533923|NCT02851797|323749871|FG001|Overall Study|Adverse Event|0|||
94533924|NCT02256384|323749873|FG000|Overall Study|Withdrawal by Subject|12|||
94533925|NCT02256384|323749873|FG000|Overall Study|Equipment not capturing data|2|||
94533926|NCT01054560|323749876|FG000|Overall Study|Death|10|||
94533927|NCT01054560|323749877|FG001|Overall Study|Death|21|||
94533928|NCT01054560|323749876|FG000|Overall Study|Lost to Follow-up|2|||
94533929|NCT01054560|323749877|FG001|Overall Study|Lost to Follow-up|5|||
94533930|NCT01054560|323749876|FG000|Overall Study|Withdrawal by Subject|0|||
94533931|NCT01054560|323749877|FG001|Overall Study|Withdrawal by Subject|2|||
94533932|NCT01054560|323749876|FG000|Overall Study|Physician Decision|1|||
94533933|NCT01054560|323749877|FG001|Overall Study|Physician Decision|0|||
94533934|NCT05319600|323749882|FG000|Overall Study|Withdrawal by Subject|1|||
94533935|NCT05319600|323749883|FG001|Overall Study|Withdrawal by Subject|0|||
94533936|NCT05319600|323749882|FG000|Overall Study|Lost to Follow-up|0|||
94533937|NCT05319600|323749883|FG001|Overall Study|Lost to Follow-up|4|||
94533938|NCT03466099|323749885|FG000|Overall Study|Adverse Event|1|||
94533939|NCT03466099|323749886|FG001|Overall Study|Adverse Event|1|||
94533940|NCT03466099|323749887|FG002|Overall Study|Adverse Event|1|||
94533941|NCT03466099|323749885|FG000|Overall Study|Withdrawal by Subject|2|||
94533942|NCT03466099|323749886|FG001|Overall Study|Withdrawal by Subject|3|||
94533943|NCT03466099|323749887|FG002|Overall Study|Withdrawal by Subject|1|||
94533944|NCT03466099|323749885|FG000|Overall Study|Use of rescue medication|8|||
94533945|NCT03466099|323749886|FG001|Overall Study|Use of rescue medication|9|||
94533946|NCT03466099|323749887|FG002|Overall Study|Use of rescue medication|13|||
94533947|NCT03466099|323749885|FG000|Overall Study|Rescued without meeting criteria|4|||
94533948|NCT03466099|323749886|FG001|Overall Study|Rescued without meeting criteria|1|||
94533949|NCT03466099|323749887|FG002|Overall Study|Rescued without meeting criteria|1|||
94533950|NCT03466099|323749885|FG000|Overall Study|Subject compliance|2|||
94533951|NCT03466099|323749886|FG001|Overall Study|Subject compliance|0|||
94533952|NCT03466099|323749887|FG002|Overall Study|Subject compliance|0|||
94533953|NCT03466099|323749885|FG000|Overall Study|Worsening disease|0|||
94533954|NCT03466099|323749886|FG001|Overall Study|Worsening disease|0|||
94533955|NCT03466099|323749887|FG002|Overall Study|Worsening disease|1|||
94533956|NCT03650803|323749888|FG000|Overall Study|Lost to Follow-up|6|||
94533957|NCT01453205|323749895|FG000|Overall Study|Lost to Follow-up|3|||
94533958|NCT01453205|323749896|FG001|Overall Study|Lost to Follow-up|0|||
94533959|NCT01453205|323749897|FG002|Overall Study|Lost to Follow-up|1|||
94533960|NCT01453205|323749895|FG000|Overall Study|Withdrawal by Subject|8|||
94533961|NCT01453205|323749896|FG001|Overall Study|Withdrawal by Subject|3|||
94533962|NCT01453205|323749897|FG002|Overall Study|Withdrawal by Subject|0|||
94533963|NCT01453205|323749895|FG000|Overall Study|Death|24|||
94533964|NCT01453205|323749896|FG001|Overall Study|Death|22|||
94533965|NCT01453205|323749897|FG002|Overall Study|Death|18|||
94533966|NCT01453205|323749895|FG000|Overall Study|Other|45|||
94533967|NCT01453205|323749896|FG001|Overall Study|Other|27|||
94533968|NCT01453205|323749897|FG002|Overall Study|Other|35|||
94533969|NCT00503581|323749900|FG000|Overall Study|Study closed|3|||
94533970|NCT00503581|323749901|FG001|Overall Study|Study closed|4|||
94533971|NCT00503581|323749902|FG002|Overall Study|Study closed|2|||
94533972|NCT04376684|323749903|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
94533973|NCT04376684|323749904|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
94533974|NCT04376684|323749905|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
94533975|NCT04376684|323749906|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
94533976|NCT04376684|323749903|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
94533977|NCT04376684|323749904|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
94533978|NCT04376684|323749905|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
94533979|NCT04376684|323749906|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
94533980|NCT04376684|323749903|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
94533981|NCT04376684|323749904|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
94533982|NCT04376684|323749905|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
94533983|NCT04376684|323749906|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
94533984|NCT04376684|323749903|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
94533985|NCT04376684|323749904|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
94533986|NCT04376684|323749905|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
94533987|NCT04376684|323749906|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
94533988|NCT04376684|323749903|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
94533989|NCT04376684|323749904|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
94533990|NCT04376684|323749905|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
94533991|NCT04376684|323749906|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
94533992|NCT04376684|323749903|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
94533993|NCT04376684|323749904|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
94533994|NCT04376684|323749905|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
94533995|NCT04376684|323749906|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
94533996|NCT04376684|323749903|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
94533997|NCT04376684|323749904|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
94533998|NCT04376684|323749905|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
94533999|NCT04376684|323749906|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
94534000|NCT04262882|323749907|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
94534001|NCT04262882|323749908|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
94534002|NCT04262882|323749907|FG000|Overall Study|Lost to Follow-up|1|||
94534003|NCT04262882|323749908|FG001|Overall Study|Lost to Follow-up|0|||
94534004|NCT03070223|323749913|FG000|Overall Study|Lost to Follow-up|34|||
94534005|NCT03070223|323749914|FG001|Overall Study|Lost to Follow-up|27|||
94534006|NCT03070223|323749913|FG000|Overall Study|Withdrawal by Subject|12|||
94534007|NCT03070223|323749914|FG001|Overall Study|Withdrawal by Subject|22|||
94534008|NCT03070223|323749913|FG000|Overall Study|Protocol Violation|0|||
94534009|NCT03070223|323749914|FG001|Overall Study|Protocol Violation|1|||
94534010|NCT04210245|323749915|FG000|Overall Study|Adverse Event|0|||
94534011|NCT04210245|323749916|FG001|Overall Study|Adverse Event|3|||
94534012|NCT04210245|323749917|FG002|Overall Study|Adverse Event|6|||
94534013|NCT04210245|323749918|FG003|Overall Study|Adverse Event|0|||
94534014|NCT04210245|323749915|FG000|Overall Study|Withdrawal by Subject|0|||
94534015|NCT04210245|323749916|FG001|Overall Study|Withdrawal by Subject|1|||
94534016|NCT04210245|323749917|FG002|Overall Study|Withdrawal by Subject|4|||
94534017|NCT04210245|323749918|FG003|Overall Study|Withdrawal by Subject|4|||
94534018|NCT04210245|323749915|FG000|Overall Study|Lost to Follow-up|0|||
94534019|NCT04210245|323749916|FG001|Overall Study|Lost to Follow-up|1|||
94534020|NCT04210245|323749917|FG002|Overall Study|Lost to Follow-up|1|||
94534021|NCT04210245|323749918|FG003|Overall Study|Lost to Follow-up|1|||
94534022|NCT04210245|323749915|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
94534023|NCT04210245|323749916|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
94534024|NCT04210245|323749917|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
94534025|NCT04210245|323749918|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
94534026|NCT01691105|323749921|FG000|1 Month Follow-up|Lost to Follow-up|41|||
94534027|NCT01691105|323749922|FG001|1 Month Follow-up|Lost to Follow-up|38|||
94534028|NCT01691105|323749921|FG000|1 Month Follow-up|Death|2|||
94534029|NCT01691105|323749922|FG001|1 Month Follow-up|Death|3|||
94534030|NCT01691105|323749921|FG000|6 Month Follow-up|Lost to Follow-up|39|||
94534031|NCT01691105|323749922|FG001|6 Month Follow-up|Lost to Follow-up|58|||
94534032|NCT01691105|323749921|FG000|6 Month Follow-up|Death|13|||
94534033|NCT01691105|323749922|FG001|6 Month Follow-up|Death|13|||
94534034|NCT01691105|323749921|FG000|12 Month Follow-up|Lost to Follow-up|50|||
94534035|NCT01691105|323749922|FG001|12 Month Follow-up|Lost to Follow-up|71|||
94534036|NCT01691105|323749921|FG000|12 Month Follow-up|Death|22|||
94534037|NCT01691105|323749922|FG001|12 Month Follow-up|Death|30|||
94534038|NCT01691105|323749921|FG000|12 Month Biochemical Verification|Death|22|||
94534039|NCT01691105|323749922|FG001|12 Month Biochemical Verification|Death|30|||
94534040|NCT01691105|323749921|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
94534041|NCT01691105|323749922|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
94534042|NCT01691105|323749921|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
94534043|NCT01691105|323749922|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
94534044|NCT03255967|323749925|FG000|Overall Study|Adverse Event|26|||
94534045|NCT03255967|323749926|FG001|Overall Study|Adverse Event|30|||
94534046|NCT03255967|323749925|FG000|Overall Study|Withdrawal by Subject|6|||
94534047|NCT03255967|323749926|FG001|Overall Study|Withdrawal by Subject|6|||
94534048|NCT03255967|323749925|FG000|Overall Study|Schedule conflict|6|||
94534049|NCT03255967|323749926|FG001|Overall Study|Schedule conflict|4|||
94534050|NCT03255967|323749925|FG000|Overall Study|POA did not sign consent form|2|||
94534051|NCT03255967|323749926|FG001|Overall Study|POA did not sign consent form|0|||
94534052|NCT00443053|323749927|FG000|Overall Study|Adverse Event|2|||
94534053|NCT00443053|323749928|FG001|Overall Study|Adverse Event|1|||
94534054|NCT00443053|323749927|FG000|Overall Study|Withdrawal by Subject|9|||
94534055|NCT00443053|323749928|FG001|Overall Study|Withdrawal by Subject|18|||
94534056|NCT00443053|323749927|FG000|Overall Study|Lost to Follow-up|4|||
94534057|NCT00443053|323749928|FG001|Overall Study|Lost to Follow-up|5|||
94534058|NCT00443053|323749927|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
94534059|NCT00443053|323749928|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
94534060|NCT00443053|323749927|FG000|Overall Study|Noncompliance|2|||
94534061|NCT00443053|323749928|FG001|Overall Study|Noncompliance|1|||
94534062|NCT00443053|323749927|FG000|Overall Study|Other|3|||
94534063|NCT00443053|323749928|FG001|Overall Study|Other|4|||
94534064|NCT00443053|323749927|FG000|Overall Study|Physician Decision|0|||
94534065|NCT00443053|323749928|FG001|Overall Study|Physician Decision|4|||
94534066|NCT04187144|323751860|FG000|Overall Study|Lost to Follow-up|12|||
94534067|NCT04187144|323751861|FG001|Overall Study|Lost to Follow-up|11|||
94534068|NCT04187144|323751860|FG000|Overall Study|Withdrawal by Subject|20|||
94534069|NCT04187144|323751861|FG001|Overall Study|Withdrawal by Subject|18|||
94534070|NCT04187144|323751860|FG000|Overall Study|Adverse Event|19|||
94534071|NCT04187144|323751861|FG001|Overall Study|Adverse Event|4|||
94534072|NCT04187144|323751860|FG000|Overall Study|Physician Decision|5|||
94534073|NCT04187144|323751861|FG001|Overall Study|Physician Decision|3|||
94534074|NCT04187144|323751860|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
94534075|NCT04187144|323751861|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
94534076|NCT04187144|323751860|FG000|Overall Study|Protocol Deviation|1|||
94534077|NCT04187144|323751861|FG001|Overall Study|Protocol Deviation|4|||
94534078|NCT03842969|323751862|FG000|Overall Study|Participant declined follow-up visit|0|||
94534079|NCT03842969|323751863|FG001|Overall Study|Participant declined follow-up visit|1|||
94534080|NCT03842969|323751864|FG002|Overall Study|Participant declined follow-up visit|0|||
94534081|NCT03842969|323751862|FG000|Overall Study|Sponsor's decision|12|||
94534082|NCT03842969|323751863|FG001|Overall Study|Sponsor's decision|99|||
94534083|NCT03842969|323751864|FG002|Overall Study|Sponsor's decision|61|||
94534084|NCT03842969|323751862|FG000|Overall Study|Pregnancy|0|||
94534085|NCT03842969|323751863|FG001|Overall Study|Pregnancy|0|||
94534086|NCT03842969|323751864|FG002|Overall Study|Pregnancy|1|||
94534087|NCT03842969|323751862|FG000|Overall Study|Death|1|||
94534088|NCT03842969|323751863|FG001|Overall Study|Death|0|||
94534089|NCT03842969|323751864|FG002|Overall Study|Death|1|||
94534090|NCT03842969|323751862|FG000|Overall Study|Withdrawal by Subject|3|||
94534091|NCT03842969|323751863|FG001|Overall Study|Withdrawal by Subject|30|||
94534092|NCT03842969|323751864|FG002|Overall Study|Withdrawal by Subject|18|||
94534093|NCT03842969|323751862|FG000|Overall Study|Protocol Violation|1|||
94534094|NCT03842969|323751863|FG001|Overall Study|Protocol Violation|1|||
94534095|NCT03842969|323751864|FG002|Overall Study|Protocol Violation|0|||
94534096|NCT03842969|323751862|FG000|Overall Study|Physician Decision|0|||
94534097|NCT03842969|323751863|FG001|Overall Study|Physician Decision|3|||
94534098|NCT03842969|323751864|FG002|Overall Study|Physician Decision|0|||
94534099|NCT03842969|323751862|FG000|Overall Study|Lost to Follow-up|0|||
94534100|NCT03842969|323751863|FG001|Overall Study|Lost to Follow-up|2|||
94534101|NCT03842969|323751864|FG002|Overall Study|Lost to Follow-up|0|||
94534102|NCT03842969|323751862|FG000|Overall Study|Adverse Event|0|||
94534103|NCT03842969|323751863|FG001|Overall Study|Adverse Event|2|||
94534104|NCT03842969|323751864|FG002|Overall Study|Adverse Event|0|||
94534105|NCT01610557|323751865|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
94534106|NCT01610557|323751866|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
94534107|NCT01610557|323751867|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
94534108|NCT01610557|323751868|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
94534109|NCT01610557|323751869|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
94534110|NCT01610557|323751865|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
94534111|NCT01610557|323751866|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
94534112|NCT01610557|323751867|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
94534113|NCT01610557|323751868|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
94534114|NCT01610557|323751869|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
94534115|NCT03764631|323751870|FG000|Overall Study|Personal Reasons|3|||
94534116|NCT03764631|323751871|FG001|Overall Study|Personal Reasons|2|||
94534117|NCT03764631|323751870|FG000|Overall Study|Switching Therapy|3|||
94534118|NCT03764631|323751871|FG001|Overall Study|Switching Therapy|3|||
94534119|NCT03764631|323751870|FG000|Overall Study|Adverse Event|0|||
94534120|NCT03764631|323751871|FG001|Overall Study|Adverse Event|1|||
94534121|NCT03764631|323751870|FG000|Overall Study|Lost to Follow-up|33|||
94534122|NCT03764631|323751871|FG001|Overall Study|Lost to Follow-up|41|||
94534123|NCT03764631|323751870|FG000|Overall Study|No data as study site was closed|2|||
94534124|NCT03764631|323751871|FG001|Overall Study|No data as study site was closed|6|||
94534125|NCT02226562|323751872|FG000|Overall Study|Lost to Follow-up|0|||
94534126|NCT02226562|323751873|FG001|Overall Study|Lost to Follow-up|1|||
94534127|NCT00245050|323751881|FG000|Overall Study|Adverse Event|3|||
94534128|NCT00245050|323751882|FG001|Overall Study|Adverse Event|2|||
94534129|NCT02570152|323751883|FG000|Overall Study|Protocol Violation|2|||
94534130|NCT02570152|323751883|FG000|Overall Study|Migrated/moved from study area|13|||
94534131|NCT05526781|323751884|FG000|Overall Study|Lost to Follow-up|1|||
94534132|NCT03905265|323751885|FG000|Overall Study|Withdrawal by Subject|1|||
94534133|NCT03905265|323751886|FG001|Overall Study|Withdrawal by Subject|1|||
94534134|NCT03905265|323751887|FG002|Overall Study|Withdrawal by Subject|0|||
94534135|NCT03905265|323751888|FG003|Overall Study|Withdrawal by Subject|0|||
94534136|NCT00960011|323751889|FG000|Overall Study|Death|5|||
94534137|NCT00960011|323751890|FG001|Overall Study|Death|0|||
94534138|NCT00960011|323751889|FG000|Overall Study|Lost to Follow-up|6|||
94534139|NCT00960011|323751890|FG001|Overall Study|Lost to Follow-up|2|||
94534140|NCT00873041|323751891|FG000|Core Study|Adverse Event|2|||
94534141|NCT00873041|323751892|FG001|Core Study|Adverse Event|3|||
94534142|NCT00873041|323751893|FG002|Core Study|Adverse Event|1|||
94534143|NCT00873041|323751891|FG000|Core Study|Withdrawal by Subject|1|||
94534144|NCT00873041|323751892|FG001|Core Study|Withdrawal by Subject|2|||
94534145|NCT00873041|323751893|FG002|Core Study|Withdrawal by Subject|2|||
94534146|NCT00873041|323751891|FG000|Core Study|Lost to Follow-up|3|||
94534147|NCT00873041|323751892|FG001|Core Study|Lost to Follow-up|1|||
94534148|NCT00873041|323751893|FG002|Core Study|Lost to Follow-up|0|||
94534149|NCT00873041|323751891|FG000|Core Study|Abnormal laboratory value|0|||
94534150|NCT00873041|323751892|FG001|Core Study|Abnormal laboratory value|0|||
94534151|NCT00873041|323751893|FG002|Core Study|Abnormal laboratory value|1|||
94534152|NCT00873041|323751891|FG000|Core Study|Protocol deviation|1|||
94534153|NCT00873041|323751892|FG001|Core Study|Protocol deviation|0|||
94534154|NCT00873041|323751893|FG002|Core Study|Protocol deviation|1|||
94534155|NCT00873041|323751891|FG000|Extension Study|Adverse Event|1|||
94534156|NCT00873041|323751892|FG001|Extension Study|Adverse Event|0|||
94534157|NCT00873041|323751893|FG002|Extension Study|Adverse Event|1|||
94534158|NCT00873041|323751891|FG000|Extension Study|Administrative reasons|0|||
94534159|NCT00873041|323751892|FG001|Extension Study|Administrative reasons|0|||
94534160|NCT00873041|323751893|FG002|Extension Study|Administrative reasons|1|||
94534161|NCT04752566|323751895|FG000|Overall Study|Protocol Violation|0|||
94534162|NCT04752566|323751896|FG001|Overall Study|Protocol Violation|1|||
94534163|NCT04752566|323751895|FG000|Overall Study|Death|1|||
94534164|NCT04752566|323751896|FG001|Overall Study|Death|0|||
94534165|NCT04752566|323751895|FG000|Overall Study|Adverse Event|1|||
94534166|NCT04752566|323751896|FG001|Overall Study|Adverse Event|0|||
94534167|NCT04752566|323751895|FG000|Overall Study|Withdrawal by Subject|2|||
94534168|NCT04752566|323751896|FG001|Overall Study|Withdrawal by Subject|0|||
94534169|NCT04752566|323751895|FG000|Overall Study|Physician Decision|1|||
94534170|NCT04752566|323751896|FG001|Overall Study|Physician Decision|1|||
94534171|NCT03831191|323751897|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
94534172|NCT03831191|323751898|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
94534173|NCT03831191|323751899|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
94534174|NCT03831191|323751900|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
94534175|NCT03831191|323751901|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
94534176|NCT03831191|323751902|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
94534177|NCT03831191|323751903|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
94534178|NCT03831191|323751904|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
94534179|NCT03831191|323751905|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
94534180|NCT03831191|323751906|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
94534181|NCT03831191|323751907|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
94534182|NCT03831191|323751908|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
94534183|NCT03831191|323751909|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
94534184|NCT03831191|323751910|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
94534185|NCT03831191|323751911|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
94534186|NCT03831191|323751897|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
94534187|NCT03831191|323751898|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
94534188|NCT03831191|323751899|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94534189|NCT03831191|323751900|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94534190|NCT03831191|323751901|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94534191|NCT03831191|323751902|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94534192|NCT03831191|323751903|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94534193|NCT03831191|323751904|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94534194|NCT03831191|323751905|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94534195|NCT03831191|323751906|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94534196|NCT03831191|323751907|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94534197|NCT03831191|323751908|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94534198|NCT03831191|323751909|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94534199|NCT03831191|323751910|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94534200|NCT03831191|323751911|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
94534201|NCT03831191|323751897|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
94534202|NCT03831191|323751898|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
94534203|NCT03831191|323751899|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
94534204|NCT03831191|323751900|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
94534205|NCT03831191|323751901|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
94534206|NCT03831191|323751902|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
94534207|NCT03831191|323751903|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
94534208|NCT03831191|323751904|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
94534209|NCT03831191|323751905|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
94534210|NCT03831191|323751906|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
94534211|NCT03831191|323751907|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
94534212|NCT03831191|323751908|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
94534213|NCT03831191|323751909|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
94534214|NCT03831191|323751910|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
94534215|NCT03831191|323751911|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
94534216|NCT03831191|323751897|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
94534217|NCT03831191|323751898|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
94534218|NCT03831191|323751899|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
94534219|NCT03831191|323751900|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
94534220|NCT03831191|323751901|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
94534221|NCT03831191|323751902|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
94534222|NCT03831191|323751903|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
94534223|NCT03831191|323751904|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
94534224|NCT03831191|323751905|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
94534225|NCT03831191|323751906|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
94534226|NCT03831191|323751907|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
94534227|NCT03831191|323751908|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
94534228|NCT03831191|323751909|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
94534229|NCT03831191|323751910|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
94534230|NCT03831191|323751911|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
94534231|NCT03831191|323751897|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
94534232|NCT03831191|323751898|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
94534233|NCT03831191|323751899|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
94534234|NCT03831191|323751900|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
94534235|NCT03831191|323751901|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94534236|NCT03831191|323751902|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94534237|NCT03831191|323751903|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94534238|NCT03831191|323751904|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94534239|NCT03831191|323751905|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94534240|NCT03831191|323751906|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94534241|NCT03831191|323751907|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94534242|NCT03831191|323751908|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94534243|NCT03831191|323751909|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94534244|NCT03831191|323751910|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94534245|NCT03831191|323751911|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
94534246|NCT03831191|323751897|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
94534247|NCT03831191|323751898|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
94534248|NCT03831191|323751899|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
94534249|NCT03831191|323751900|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
94534250|NCT03831191|323751901|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
94534251|NCT03831191|323751902|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
94534252|NCT03831191|323751903|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
94534253|NCT03831191|323751904|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
94534254|NCT03831191|323751905|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
94534255|NCT03831191|323751906|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
94534256|NCT03831191|323751907|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
94534257|NCT03831191|323751908|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
94534258|NCT03831191|323751909|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
94534259|NCT03831191|323751910|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
94534260|NCT03831191|323751911|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
94534261|NCT03831191|323751897|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
94534262|NCT03831191|323751898|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
94534263|NCT03831191|323751899|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
94534264|NCT03831191|323751900|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
94534265|NCT03831191|323751901|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
94534266|NCT03831191|323751902|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
94534267|NCT03831191|323751903|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
94534268|NCT03831191|323751904|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
94534269|NCT03831191|323751905|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
94534270|NCT03831191|323751906|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
94534271|NCT03831191|323751907|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
94534272|NCT03831191|323751908|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
94534273|NCT03831191|323751909|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
94534274|NCT03831191|323751910|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
94534275|NCT03831191|323751911|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
94534276|NCT03831191|323751897|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
94534277|NCT03831191|323751898|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
94534278|NCT03831191|323751899|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
94534279|NCT03831191|323751900|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
94534280|NCT03831191|323751901|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
94534281|NCT03831191|323751902|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
94534282|NCT03831191|323751903|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
94534283|NCT03831191|323751904|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
94534284|NCT03831191|323751905|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
94534285|NCT03831191|323751906|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
94534286|NCT03831191|323751907|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
94534287|NCT03831191|323751908|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
94534288|NCT03831191|323751909|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
94534289|NCT03831191|323751910|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
94534290|NCT03831191|323751911|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
94534291|NCT03831191|323751897|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94534292|NCT03831191|323751898|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94534293|NCT03831191|323751899|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94534294|NCT03831191|323751900|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94534295|NCT03831191|323751901|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94534296|NCT03831191|323751902|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94534297|NCT03831191|323751903|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94534298|NCT03831191|323751904|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94534299|NCT03831191|323751905|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94534300|NCT03831191|323751906|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94534301|NCT03831191|323751907|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94534302|NCT03831191|323751908|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94534303|NCT03831191|323751909|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94534304|NCT03831191|323751910|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
94534305|NCT03831191|323751911|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
94534306|NCT03831191|323751897|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94534307|NCT03831191|323751898|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94534308|NCT03831191|323751899|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94534309|NCT03831191|323751900|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94534310|NCT03831191|323751901|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94534311|NCT03831191|323751902|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94534312|NCT03831191|323751903|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94534313|NCT03831191|323751904|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94534314|NCT03831191|323751905|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94534315|NCT03831191|323751906|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94534316|NCT03831191|323751907|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94534317|NCT03831191|323751908|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94534318|NCT03831191|323751909|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94534319|NCT03831191|323751910|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
94534320|NCT03831191|323751911|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
94534321|NCT01126437|323751915|FG000|Overall Study|Not treated|11|||
94534322|NCT01126437|323751916|FG001|Overall Study|Not treated|18|||
94534323|NCT01126437|323751917|FG002|Overall Study|Not treated|19|||
94534324|NCT01126437|323751915|FG000|Overall Study|Sites with data irregularities/fraud|6|||
94534325|NCT01126437|323751916|FG001|Overall Study|Sites with data irregularities/fraud|6|||
94534326|NCT01126437|323751917|FG002|Overall Study|Sites with data irregularities/fraud|7|||
94534327|NCT01126437|323751915|FG000|Overall Study|Adverse Event|602|||
94534328|NCT01126437|323751916|FG001|Overall Study|Adverse Event|606|||
94534329|NCT01126437|323751917|FG002|Overall Study|Adverse Event|635|||
94534330|NCT01126437|323751915|FG000|Overall Study|Lack of Efficacy|65|||
94534331|NCT01126437|323751916|FG001|Overall Study|Lack of Efficacy|60|||
94534332|NCT01126437|323751917|FG002|Overall Study|Lack of Efficacy|59|||
94534333|NCT01126437|323751915|FG000|Overall Study|Protocol Violation|64|||
94534334|NCT01126437|323751916|FG001|Overall Study|Protocol Violation|66|||
94534335|NCT01126437|323751917|FG002|Overall Study|Protocol Violation|41|||
94534336|NCT01126437|323751915|FG000|Overall Study|Lost to Follow-up|52|||
94534337|NCT01126437|323751916|FG001|Overall Study|Lost to Follow-up|63|||
94534338|NCT01126437|323751917|FG002|Overall Study|Lost to Follow-up|55|||
94534339|NCT01126437|323751915|FG000|Overall Study|Withdrawal by Subject|331|||
94534340|NCT01126437|323751916|FG001|Overall Study|Withdrawal by Subject|335|||
94534341|NCT01126437|323751917|FG002|Overall Study|Withdrawal by Subject|319|||
94534342|NCT01126437|323751915|FG000|Overall Study|Other reason not specified|210|||
94534343|NCT01126437|323751916|FG001|Overall Study|Other reason not specified|176|||
94534344|NCT01126437|323751917|FG002|Overall Study|Other reason not specified|178|||
94534345|NCT00695955|323751919|FG000|Cohort 1|Adverse Event|26|||
94534346|NCT00695955|323751919|FG000|Cohort 1|Protocol Violation|2|||
94534347|NCT00695955|323751919|FG000|Cohort 1|Lost to Follow-up|30|||
94534348|NCT00695955|323751919|FG000|Cohort 1|Withdrawal by Subject|25|||
94534349|NCT00695955|323751919|FG000|Cohort 1|Lack of Efficacy|3|||
94534350|NCT00695955|323751919|FG000|Cohort 1|Other|16|||
94534351|NCT00695955|323751919|FG000|Cohort 2|Adverse Event|24|||
94534352|NCT00695955|323751919|FG000|Cohort 2|Protocol Violation|5|||
94534353|NCT00695955|323751919|FG000|Cohort 2|Lost to Follow-up|38|||
94534354|NCT00695955|323751919|FG000|Cohort 2|Withdrawal by Subject|28|||
94534355|NCT00695955|323751919|FG000|Cohort 2|Lack of Efficacy|4|||
94534356|NCT00695955|323751919|FG000|Cohort 2|Other|5|||
94534357|NCT03655054|323751920|FG000|Overall Study|Lost to Follow-up|1|||
94534358|NCT04537208|323751921|FG000|Overall Study|Adverse Event|0|||
94534359|NCT04537208|323751922|FG001|Overall Study|Adverse Event|0|||
94534360|NCT04537208|323751923|FG002|Overall Study|Adverse Event|0|||
94534361|NCT04537208|323751924|FG003|Overall Study|Adverse Event|0|||
94534362|NCT04537208|323751925|FG004|Overall Study|Adverse Event|0|||
94534363|NCT04537208|323751926|FG005|Overall Study|Adverse Event|0|||
94534364|NCT04537208|323751927|FG006|Overall Study|Adverse Event|0|||
94534365|NCT04537208|323751928|FG007|Overall Study|Adverse Event|0|||
94534366|NCT04537208|323751929|FG008|Overall Study|Adverse Event|1|||
94534367|NCT04537208|323751930|FG009|Overall Study|Adverse Event|0|||
94534368|NCT04537208|323751931|FG010|Overall Study|Adverse Event|0|||
94534369|NCT04537208|323751921|FG000|Overall Study|Protocol deviation|0|||
94534370|NCT04537208|323751922|FG001|Overall Study|Protocol deviation|0|||
94534371|NCT04537208|323751923|FG002|Overall Study|Protocol deviation|2|||
94534372|NCT04537208|323751924|FG003|Overall Study|Protocol deviation|0|||
94534373|NCT04537208|323751925|FG004|Overall Study|Protocol deviation|0|||
94534374|NCT04537208|323751926|FG005|Overall Study|Protocol deviation|2|||
94534375|NCT04537208|323751927|FG006|Overall Study|Protocol deviation|4|||
94534376|NCT04537208|323751928|FG007|Overall Study|Protocol deviation|0|||
94534377|NCT04537208|323751929|FG008|Overall Study|Protocol deviation|1|||
94534378|NCT04537208|323751930|FG009|Overall Study|Protocol deviation|0|||
94534379|NCT04537208|323751931|FG010|Overall Study|Protocol deviation|2|||
94534380|NCT04537208|323751921|FG000|Overall Study|Withdrawal by Subject|4|||
94534381|NCT04537208|323751922|FG001|Overall Study|Withdrawal by Subject|2|||
94534382|NCT04537208|323751923|FG002|Overall Study|Withdrawal by Subject|1|||
94534383|NCT04537208|323751924|FG003|Overall Study|Withdrawal by Subject|3|||
94534384|NCT04537208|323751925|FG004|Overall Study|Withdrawal by Subject|5|||
94534385|NCT04537208|323751926|FG005|Overall Study|Withdrawal by Subject|1|||
94534386|NCT04537208|323751927|FG006|Overall Study|Withdrawal by Subject|6|||
94534387|NCT04537208|323751928|FG007|Overall Study|Withdrawal by Subject|1|||
94534388|NCT04537208|323751929|FG008|Overall Study|Withdrawal by Subject|7|||
94534389|NCT04537208|323751930|FG009|Overall Study|Withdrawal by Subject|2|||
94534390|NCT04537208|323751931|FG010|Overall Study|Withdrawal by Subject|4|||
94534391|NCT04537208|323751921|FG000|Overall Study|Lost to Follow-up|4|||
94534392|NCT04537208|323751922|FG001|Overall Study|Lost to Follow-up|1|||
94534393|NCT04537208|323751923|FG002|Overall Study|Lost to Follow-up|3|||
94534394|NCT04537208|323751924|FG003|Overall Study|Lost to Follow-up|4|||
94534395|NCT04537208|323751925|FG004|Overall Study|Lost to Follow-up|3|||
94534396|NCT04537208|323751926|FG005|Overall Study|Lost to Follow-up|2|||
94534397|NCT04537208|323751927|FG006|Overall Study|Lost to Follow-up|3|||
94534398|NCT04537208|323751928|FG007|Overall Study|Lost to Follow-up|2|||
94534399|NCT04537208|323751929|FG008|Overall Study|Lost to Follow-up|7|||
94534400|NCT04537208|323751930|FG009|Overall Study|Lost to Follow-up|2|||
94534401|NCT04537208|323751931|FG010|Overall Study|Lost to Follow-up|2|||
94534402|NCT04154605|323751949|FG000|Overall Study|Procedure Canceled|1|||
94534403|NCT04154605|323751950|FG001|Overall Study|Procedure Canceled|1|||
94534404|NCT04154605|323751949|FG000|Overall Study|Missed follow up|1|||
94534405|NCT04154605|323751950|FG001|Overall Study|Missed follow up|1|||
94534406|NCT04154605|323751949|FG000|Overall Study|Withdrawal by Subject|1|||
94534407|NCT04154605|323751950|FG001|Overall Study|Withdrawal by Subject|0|||
94534408|NCT00344318|323751951|FG000|Overall Study|Adverse Event|0|||
94534409|NCT00344318|323751952|FG001|Overall Study|Adverse Event|3|||
94534410|NCT00344318|323751953|FG002|Overall Study|Adverse Event|0|||
94534411|NCT00344318|323751954|FG003|Overall Study|Adverse Event|1|||
94534412|NCT00344318|323751951|FG000|Overall Study|Withdrawal by Subject|2|||
94534413|NCT00344318|323751952|FG001|Overall Study|Withdrawal by Subject|2|||
94534414|NCT00344318|323751953|FG002|Overall Study|Withdrawal by Subject|0|||
94534415|NCT00344318|323751954|FG003|Overall Study|Withdrawal by Subject|2|||
94534416|NCT00344318|323751951|FG000|Overall Study|Lost to Follow-up|2|||
94534417|NCT00344318|323751952|FG001|Overall Study|Lost to Follow-up|0|||
94534418|NCT00344318|323751953|FG002|Overall Study|Lost to Follow-up|1|||
94534419|NCT00344318|323751954|FG003|Overall Study|Lost to Follow-up|0|||
94534420|NCT03832322|323751955|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
94534421|NCT03832322|323751956|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
94534422|NCT02680041|323751958|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
94534423|NCT02680041|323751958|FG000|Overall Study|Lost to Follow-up|2|||
94534424|NCT02379988|323751959|FG000|Overall Study|Not eligible|1|||
94534425|NCT03403361|323751960|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
94534426|NCT03136497|323751963|FG000|Overall Study|Screen Failure|1|||
94534427|NCT03136497|323751964|FG001|Overall Study|Screen Failure|0|||
94534428|NCT03136497|323751965|FG002|Overall Study|Screen Failure|0|||
94534429|NCT00349921|323751973|FG000|First Spinal Injection|Physician Decision|1|||
94534430|NCT00349921|323751974|FG001|First Spinal Injection|Physician Decision|0|||
94534431|NCT00349921|323751975|FG002|First Spinal Injection|Physician Decision|0|||
94534432|NCT00349921|323751976|FG003|First Spinal Injection|Physician Decision|0|||
94534433|NCT00349921|323751973|FG000|First Spinal Injection|Adverse Event|0|||
94534434|NCT00349921|323751974|FG001|First Spinal Injection|Adverse Event|0|||
94534435|NCT00349921|323751975|FG002|First Spinal Injection|Adverse Event|1|||
94534436|NCT00349921|323751976|FG003|First Spinal Injection|Adverse Event|0|||
94534437|NCT03194568|323751977|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
94534438|NCT01451931|323751982|FG000|Overall Study|Lost to Follow-up|17|||
94534439|NCT01451931|323751983|FG001|Overall Study|Lost to Follow-up|36|||
94534440|NCT01451931|323751984|FG002|Overall Study|Lost to Follow-up|21|||
94534441|NCT01451931|323751982|FG000|Overall Study|Withdrawal by Subject|16|||
94534442|NCT01451931|323751983|FG001|Overall Study|Withdrawal by Subject|22|||
94534443|NCT01451931|323751984|FG002|Overall Study|Withdrawal by Subject|22|||
94534444|NCT02308163|323751988|FG000|Overall Study|Not fulfill eligible criteria|1|||
94534445|NCT02308163|323751989|FG001|Overall Study|Not fulfill eligible criteria|2|||
94534446|NCT02308163|323751990|FG002|Overall Study|Not fulfill eligible criteria|0|||
94534447|NCT02308163|323751991|FG003|Overall Study|Not fulfill eligible criteria|1|||
94534448|NCT02308163|323751992|FG004|Overall Study|Not fulfill eligible criteria|1|||
94534449|NCT02308163|323751988|FG000|Overall Study|Adverse Event|9|||
94534450|NCT02308163|323751989|FG001|Overall Study|Adverse Event|5|||
94534451|NCT02308163|323751990|FG002|Overall Study|Adverse Event|2|||
94534452|NCT02308163|323751991|FG003|Overall Study|Adverse Event|2|||
94534453|NCT02308163|323751992|FG004|Overall Study|Adverse Event|11|||
94534454|NCT02308163|323751988|FG000|Overall Study|Lack of Efficacy|11|||
94534455|NCT02308163|323751989|FG001|Overall Study|Lack of Efficacy|3|||
94534456|NCT02308163|323751990|FG002|Overall Study|Lack of Efficacy|8|||
94534457|NCT02308163|323751991|FG003|Overall Study|Lack of Efficacy|4|||
94534458|NCT02308163|323751992|FG004|Overall Study|Lack of Efficacy|6|||
94534459|NCT02308163|323751988|FG000|Overall Study|Withdrawal of consent|2|||
94534460|NCT02308163|323751989|FG001|Overall Study|Withdrawal of consent|3|||
94534461|NCT02308163|323751990|FG002|Overall Study|Withdrawal of consent|0|||
94534462|NCT02308163|323751991|FG003|Overall Study|Withdrawal of consent|2|||
94534463|NCT02308163|323751992|FG004|Overall Study|Withdrawal of consent|6|||
94534464|NCT02308163|323751988|FG000|Overall Study|Protocol Violation|3|||
94534465|NCT02308163|323751989|FG001|Overall Study|Protocol Violation|3|||
94534466|NCT02308163|323751990|FG002|Overall Study|Protocol Violation|3|||
94534467|NCT02308163|323751991|FG003|Overall Study|Protocol Violation|2|||
94534468|NCT02308163|323751992|FG004|Overall Study|Protocol Violation|5|||
94534469|NCT02308163|323751988|FG000|Overall Study|Lab data met discontinuation criteria|3|||
94534470|NCT02308163|323751989|FG001|Overall Study|Lab data met discontinuation criteria|0|||
94534471|NCT02308163|323751990|FG002|Overall Study|Lab data met discontinuation criteria|0|||
94534472|NCT02308163|323751991|FG003|Overall Study|Lab data met discontinuation criteria|2|||
94534473|NCT02308163|323751992|FG004|Overall Study|Lab data met discontinuation criteria|0|||
94534474|NCT02308163|323751988|FG000|Overall Study|Miscellaneous|2|||
94534475|NCT02308163|323751989|FG001|Overall Study|Miscellaneous|2|||
94534476|NCT02308163|323751990|FG002|Overall Study|Miscellaneous|1|||
94534477|NCT02308163|323751991|FG003|Overall Study|Miscellaneous|0|||
94534478|NCT02308163|323751992|FG004|Overall Study|Miscellaneous|5|||
94534479|NCT00516906|323751993|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
94534480|NCT00516906|323751994|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
94534481|NCT01439971|323752004|FG000|Overall Study|Required number in cohort dosed|0|||
94534482|NCT01439971|323752005|FG001|Overall Study|Required number in cohort dosed|1|||
94534483|NCT01439971|323752006|FG002|Overall Study|Required number in cohort dosed|2|||
94534484|NCT01439971|323752007|FG003|Overall Study|Required number in cohort dosed|0|||
94534485|NCT01439971|323752008|FG004|Overall Study|Required number in cohort dosed|1|||
94534486|NCT00790868|323754265|FG000|Overall Study|Withdrawal by Subject|4|||
94534487|NCT00790868|323754266|FG001|Overall Study|Withdrawal by Subject|5|||
94534488|NCT00790868|323754265|FG000|Overall Study|Lost to Follow-up|2|||
94534489|NCT00790868|323754266|FG001|Overall Study|Lost to Follow-up|12|||
94534490|NCT02867813|323754267|FG000|Overall Study|Withdrawal by Subject|57|||
94534491|NCT02867813|323754268|FG001|Overall Study|Withdrawal by Subject|56|||
94534492|NCT02867813|323754267|FG000|Overall Study|Decision by Sponsor|7|||
94534493|NCT02867813|323754268|FG001|Overall Study|Decision by Sponsor|7|||
94534494|NCT02867813|323754267|FG000|Overall Study|Lost to Follow-up|91|||
94534495|NCT02867813|323754268|FG001|Overall Study|Lost to Follow-up|78|||
94534496|NCT02867813|323754267|FG000|Overall Study|Missing|2|||
94534497|NCT02867813|323754268|FG001|Overall Study|Missing|1|||
94534498|NCT02867813|323754267|FG000|Overall Study|Death|294|||
94534499|NCT02867813|323754268|FG001|Overall Study|Death|268|||
94534500|NCT01461928|323754273|FG000|Induction (up to 8 Months)|Adverse Event|76|||
94534501|NCT01461928|323754274|FG001|Induction (up to 8 Months)|Adverse Event|0|||
94534502|NCT01461928|323754275|FG002|Induction (up to 8 Months)|Adverse Event|0|||
94534503|NCT01461928|323754273|FG000|Induction (up to 8 Months)|Death|3|||
94534504|NCT01461928|323754274|FG001|Induction (up to 8 Months)|Death|0|||
94534505|NCT01461928|323754275|FG002|Induction (up to 8 Months)|Death|0|||
94534506|NCT01461928|323754273|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
94534507|NCT01461928|323754274|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
94534508|NCT01461928|323754275|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
94534509|NCT01461928|323754273|FG000|Induction (up to 8 Months)|Physician Decision|9|||
94534510|NCT01461928|323754274|FG001|Induction (up to 8 Months)|Physician Decision|0|||
94534511|NCT01461928|323754275|FG002|Induction (up to 8 Months)|Physician Decision|0|||
94534512|NCT01461928|323754273|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
94534513|NCT01461928|323754274|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
94534514|NCT01461928|323754275|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
94534515|NCT01461928|323754273|FG000|Induction (up to 8 Months)|Disease progression|45|||
94534516|NCT01461928|323754274|FG001|Induction (up to 8 Months)|Disease progression|0|||
94534517|NCT01461928|323754275|FG002|Induction (up to 8 Months)|Disease progression|0|||
94534518|NCT01461928|323754273|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
94534519|NCT01461928|323754274|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
94534520|NCT01461928|323754275|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
94534521|NCT01461928|323754273|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
94534522|NCT01461928|323754274|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
94534523|NCT01461928|323754275|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
94534524|NCT01461928|323754273|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
94534525|NCT01461928|323754274|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
94534526|NCT01461928|323754275|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
94534527|NCT01461928|323754273|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
94534528|NCT01461928|323754274|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
94534529|NCT01461928|323754275|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
94534530|NCT01461928|323754273|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
94534531|NCT01461928|323754274|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
94534532|NCT01461928|323754275|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
94534533|NCT01461928|323754273|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
94534534|NCT01461928|323754274|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
94534535|NCT01461928|323754275|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
94534536|NCT01461928|323754273|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
94534537|NCT01461928|323754274|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
94534538|NCT01461928|323754275|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
94534539|NCT01461928|323754273|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
94534540|NCT01461928|323754274|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
94534541|NCT01461928|323754275|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
94534542|NCT01461928|323754273|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
94534543|NCT01461928|323754274|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
94534544|NCT01461928|323754275|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
94534545|NCT01461928|323754273|FG000|Induction (up to 8 Months)|Promotor request|1|||
94534546|NCT01461928|323754274|FG001|Induction (up to 8 Months)|Promotor request|0|||
94534547|NCT01461928|323754275|FG002|Induction (up to 8 Months)|Promotor request|0|||
94534548|NCT01461928|323754273|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
94534549|NCT01461928|323754274|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
94534550|NCT01461928|323754275|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
94534551|NCT01461928|323754273|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
94534552|NCT01461928|323754274|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
94534553|NCT01461928|323754275|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
94534554|NCT01461928|323754273|FG000|Maintenance I (24 Months)|Death|3|||
94534555|NCT01461928|323754274|FG001|Maintenance I (24 Months)|Death|0|||
94534556|NCT01461928|323754275|FG002|Maintenance I (24 Months)|Death|0|||
94534557|NCT01461928|323754273|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
94534558|NCT01461928|323754274|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
94534559|NCT01461928|323754275|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
94534560|NCT01461928|323754273|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
94534561|NCT01461928|323754274|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
94534562|NCT01461928|323754275|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
94534563|NCT01461928|323754273|FG000|Maintenance I (24 Months)|Diseases progression|91|||
94534564|NCT01461928|323754274|FG001|Maintenance I (24 Months)|Diseases progression|0|||
94534565|NCT01461928|323754275|FG002|Maintenance I (24 Months)|Diseases progression|0|||
94534566|NCT01461928|323754273|FG000|Maintenance I (24 Months)|Adverse Event|70|||
94534567|NCT01461928|323754274|FG001|Maintenance I (24 Months)|Adverse Event|0|||
94534568|NCT01461928|323754275|FG002|Maintenance I (24 Months)|Adverse Event|0|||
94534569|NCT01461928|323754273|FG000|Maintenance I (24 Months)|Physician Decision|9|||
94534570|NCT01461928|323754274|FG001|Maintenance I (24 Months)|Physician Decision|0|||
94534571|NCT01461928|323754275|FG002|Maintenance I (24 Months)|Physician Decision|0|||
94534572|NCT01461928|323754273|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
94534573|NCT01461928|323754274|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
94534574|NCT01461928|323754275|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
94534575|NCT01461928|323754273|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
94534576|NCT01461928|323754274|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
94534577|NCT01461928|323754275|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
94534578|NCT01461928|323754273|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
94534579|NCT01461928|323754274|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
94534580|NCT01461928|323754275|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
94534581|NCT01461928|323754273|FG000|Maintenance I (24 Months)|Not compliant|1|||
94534582|NCT01461928|323754274|FG001|Maintenance I (24 Months)|Not compliant|0|||
94534583|NCT01461928|323754275|FG002|Maintenance I (24 Months)|Not compliant|0|||
94534584|NCT01461928|323754273|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
94534585|NCT01461928|323754274|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
94534586|NCT01461928|323754275|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
94534587|NCT01461928|323754273|FG000|Maintenance II (15 Months)|Adverse Event|0|||
94534588|NCT01461928|323754274|FG001|Maintenance II (15 Months)|Adverse Event|2|||
94534589|NCT01461928|323754275|FG002|Maintenance II (15 Months)|Adverse Event|0|||
94534590|NCT01461928|323754273|FG000|Maintenance II (15 Months)|Death|0|||
94534591|NCT01461928|323754274|FG001|Maintenance II (15 Months)|Death|10|||
94534592|NCT01461928|323754275|FG002|Maintenance II (15 Months)|Death|8|||
94534593|NCT01461928|323754273|FG000|Maintenance II (15 Months)|Physician Decision|0|||
94534594|NCT01461928|323754274|FG001|Maintenance II (15 Months)|Physician Decision|0|||
94534595|NCT01461928|323754275|FG002|Maintenance II (15 Months)|Physician Decision|4|||
94534596|NCT01461928|323754273|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
94534597|NCT01461928|323754274|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
94534598|NCT01461928|323754275|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
94534599|NCT01461928|323754273|FG000|Maintenance II (15 Months)|Moved to another town|0|||
94534600|NCT01461928|323754274|FG001|Maintenance II (15 Months)|Moved to another town|1|||
94534601|NCT01461928|323754275|FG002|Maintenance II (15 Months)|Moved to another town|0|||
94534602|NCT01461928|323754273|FG000|Maintenance II (15 Months)|Disease progression|0|||
94534603|NCT01461928|323754274|FG001|Maintenance II (15 Months)|Disease progression|0|||
94534604|NCT01461928|323754275|FG002|Maintenance II (15 Months)|Disease progression|3|||
94534605|NCT01461928|323754273|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
94534606|NCT01461928|323754274|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
94534607|NCT01461928|323754275|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
94534608|NCT01461928|323754273|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
94534609|NCT01461928|323754274|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
94534610|NCT01461928|323754275|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
94534611|NCT01461928|323754273|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
94534612|NCT01461928|323754274|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
94534613|NCT01461928|323754275|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
94534614|NCT01461928|323754273|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
94534615|NCT01461928|323754274|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
94534616|NCT01461928|323754275|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
94534617|NCT01461928|323754273|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
94534618|NCT01461928|323754274|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
94534619|NCT01461928|323754275|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
94534620|NCT00559845|323754277|FG000|Overall Study|Withdrew Consent|1|||
94534621|NCT00559845|323754277|FG000|Overall Study|Disease Progression|1|||
94534622|NCT00559845|323754277|FG000|Overall Study|Adverse Event|3|||
94534623|NCT00559845|323754277|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
94534624|NCT00559845|323754277|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
94534625|NCT02242435|323754280|FG000|Overall Study|Lost to Follow-up|3|||
94534626|NCT02242435|323754281|FG001|Overall Study|Lost to Follow-up|4|||
94534627|NCT02242435|323754280|FG000|Overall Study|Adverse Event|3|||
94534628|NCT02242435|323754281|FG001|Overall Study|Adverse Event|2|||
94534629|NCT02242435|323754280|FG000|Overall Study|Withdrawal by Subject|13|||
94534630|NCT02242435|323754281|FG001|Overall Study|Withdrawal by Subject|8|||
94534631|NCT02242435|323754280|FG000|Overall Study|Death|0|||
94534632|NCT02242435|323754281|FG001|Overall Study|Death|1|||
94534633|NCT02242435|323754280|FG000|Overall Study|Protocol Violation|1|||
94534634|NCT02242435|323754281|FG001|Overall Study|Protocol Violation|0|||
94534635|NCT02242435|323754280|FG000|Overall Study|Physician Decision|0|||
94534636|NCT02242435|323754281|FG001|Overall Study|Physician Decision|1|||
94534637|NCT00510718|323754286|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
94534638|NCT00510718|323754287|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
94534639|NCT00510718|323754286|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
94534640|NCT00510718|323754287|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
94534641|NCT00510718|323754286|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
94534642|NCT00510718|323754287|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
94534643|NCT00510718|323754286|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
94534644|NCT00510718|323754287|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
94534645|NCT00510718|323754286|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
94534646|NCT00510718|323754287|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
94534647|NCT00510718|323754286|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
94534648|NCT00510718|323754287|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
94534649|NCT00394251|323754294|FG000|Overall Study|Adverse Event|7|||
94534650|NCT00394251|323754295|FG001|Overall Study|Adverse Event|5|||
94534651|NCT00394251|323754294|FG000|Overall Study|Unacceptable Toxicity|20|||
94534652|NCT00394251|323754295|FG001|Overall Study|Unacceptable Toxicity|18|||
94534653|NCT00394251|323754294|FG000|Overall Study|Physician Decision|1|||
94534654|NCT00394251|323754295|FG001|Overall Study|Physician Decision|1|||
94534655|NCT00394251|323754294|FG000|Overall Study|Protocol Violation|0|||
94534656|NCT00394251|323754295|FG001|Overall Study|Protocol Violation|1|||
94534657|NCT00394251|323754294|FG000|Overall Study|Withdrawal by Subject|7|||
94534658|NCT00394251|323754295|FG001|Overall Study|Withdrawal by Subject|11|||
94534659|NCT00394251|323754294|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
94534660|NCT00394251|323754295|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
94534661|NCT00713349|323754296|FG000|Overall Study|Protocol Violation|1|||
94534662|NCT02974855|323754301|FG000|Overall Study|Adverse Event|0|||
94534663|NCT02974855|323754302|FG001|Overall Study|Adverse Event|1|||
94534664|NCT02974855|323754303|FG002|Overall Study|Adverse Event|0|||
94534665|NCT02974855|323754304|FG003|Overall Study|Adverse Event|1|||
94534666|NCT00129701|323754305|FG000|Overall Study|Withdrawal by Subject|33|||
94534667|NCT02750345|323754306|FG000|Intervention 1|Adverse Event|0|||
94534668|NCT02750345|323754307|FG001|Intervention 1|Adverse Event|0|||
94534669|NCT02750345|323754308|FG002|Intervention 1|Adverse Event|0|||
94534670|NCT02750345|323754309|FG003|Intervention 1|Adverse Event|0|||
94534671|NCT02750345|323754310|FG004|Intervention 1|Adverse Event|1|||
94534672|NCT02750345|323754311|FG005|Intervention 1|Adverse Event|0|||
94534673|NCT01681069|323754312|FG000|Overall Study|Withdrawal by Subject|4|||
94534674|NCT01681069|323754313|FG001|Overall Study|Withdrawal by Subject|5|||
94534675|NCT01681069|323754312|FG000|Overall Study|Protocol Violation|1|||
94534676|NCT01681069|323754313|FG001|Overall Study|Protocol Violation|1|||
94534677|NCT01681069|323754312|FG000|Overall Study|Adverse Event|0|||
94534678|NCT01681069|323754313|FG001|Overall Study|Adverse Event|1|||
94534679|NCT00152477|323754319|FG000|Chemotherapy Period|Adverse Event|9|||
94534680|NCT00152477|323754320|FG001|Chemotherapy Period|Adverse Event|4|||
94534681|NCT00152477|323754321|FG002|Chemotherapy Period|Adverse Event|5|||
94534682|NCT00152477|323754319|FG000|Chemotherapy Period|Death|1|||
94534683|NCT00152477|323754320|FG001|Chemotherapy Period|Death|3|||
94534684|NCT00152477|323754321|FG002|Chemotherapy Period|Death|3|||
94534685|NCT00152477|323754319|FG000|Chemotherapy Period|Lack of Efficacy|4|||
94534686|NCT00152477|323754320|FG001|Chemotherapy Period|Lack of Efficacy|5|||
94534687|NCT00152477|323754321|FG002|Chemotherapy Period|Lack of Efficacy|6|||
94534688|NCT00152477|323754319|FG000|Chemotherapy Period|Lost to Follow-up|1|||
94534689|NCT00152477|323754320|FG001|Chemotherapy Period|Lost to Follow-up|0|||
94534690|NCT00152477|323754321|FG002|Chemotherapy Period|Lost to Follow-up|1|||
94534691|NCT00152477|323754319|FG000|Chemotherapy Period|Protocol Violation|1|||
94534692|NCT00152477|323754320|FG001|Chemotherapy Period|Protocol Violation|1|||
94534693|NCT00152477|323754321|FG002|Chemotherapy Period|Protocol Violation|0|||
94534694|NCT00152477|323754319|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
94534695|NCT00152477|323754320|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
94534696|NCT00152477|323754321|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
94534697|NCT00152477|323754319|FG000|Chemotherapy Period|Progression of Disease|6|||
94534698|NCT00152477|323754320|FG001|Chemotherapy Period|Progression of Disease|8|||
94534699|NCT00152477|323754321|FG002|Chemotherapy Period|Progression of Disease|4|||
94534700|NCT00152477|323754319|FG000|Chemotherapy Period|Investigator decision|0|||
94534701|NCT00152477|323754320|FG001|Chemotherapy Period|Investigator decision|0|||
94534702|NCT00152477|323754321|FG002|Chemotherapy Period|Investigator decision|1|||
94534703|NCT00152477|323754319|FG000|Chemotherapy Period|Patient condition worsened|1|||
94534704|NCT00152477|323754320|FG001|Chemotherapy Period|Patient condition worsened|0|||
94534705|NCT00152477|323754321|FG002|Chemotherapy Period|Patient condition worsened|0|||
94534706|NCT00152477|323754319|FG000|Monotherapy Period|Adverse Event|1|||
94534707|NCT00152477|323754320|FG001|Monotherapy Period|Adverse Event|0|||
94534708|NCT00152477|323754321|FG002|Monotherapy Period|Adverse Event|5|||
94534709|NCT00152477|323754319|FG000|Monotherapy Period|Death|2|||
94534710|NCT00152477|323754320|FG001|Monotherapy Period|Death|0|||
94534711|NCT00152477|323754321|FG002|Monotherapy Period|Death|1|||
94534712|NCT00152477|323754319|FG000|Monotherapy Period|Lack of Efficacy|7|||
94534713|NCT00152477|323754320|FG001|Monotherapy Period|Lack of Efficacy|16|||
94534714|NCT00152477|323754321|FG002|Monotherapy Period|Lack of Efficacy|10|||
94534715|NCT00152477|323754319|FG000|Monotherapy Period|Protocol Violation|0|||
94534716|NCT00152477|323754320|FG001|Monotherapy Period|Protocol Violation|1|||
94534717|NCT00152477|323754321|FG002|Monotherapy Period|Protocol Violation|0|||
94534718|NCT00152477|323754319|FG000|Monotherapy Period|Withdrawal by Subject|0|||
94534719|NCT00152477|323754320|FG001|Monotherapy Period|Withdrawal by Subject|0|||
94534720|NCT00152477|323754321|FG002|Monotherapy Period|Withdrawal by Subject|4|||
94534721|NCT00152477|323754319|FG000|Monotherapy Period|Progression of Disease|5|||
94534722|NCT00152477|323754320|FG001|Monotherapy Period|Progression of Disease|11|||
94534723|NCT00152477|323754321|FG002|Monotherapy Period|Progression of Disease|12|||
94534724|NCT00152477|323754319|FG000|Monotherapy Period|Patient decision|0|||
94534725|NCT00152477|323754320|FG001|Monotherapy Period|Patient decision|1|||
94534726|NCT00152477|323754321|FG002|Monotherapy Period|Patient decision|1|||
94534727|NCT00152477|323754319|FG000|Monotherapy Period|Study personel decision|0|||
94534728|NCT00152477|323754320|FG001|Monotherapy Period|Study personel decision|0|||
94534729|NCT00152477|323754321|FG002|Monotherapy Period|Study personel decision|1|||
94534730|NCT03275246|323754322|FG000|Overall Study|Protocol Violation|5|||
94534731|NCT03275246|323754322|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
94534732|NCT03632993|323754325|FG000|Overall Study|Withdrawal by Subject|1|||
94534733|NCT03632993|323754326|FG001|Overall Study|Withdrawal by Subject|0|||
94534734|NCT03632993|323754327|FG002|Overall Study|Withdrawal by Subject|0|||
94534735|NCT03632993|323754328|FG003|Overall Study|Withdrawal by Subject|0|||
94534736|NCT03632993|323754329|FG004|Overall Study|Withdrawal by Subject|0|||
94534737|NCT03632993|323754330|FG005|Overall Study|Withdrawal by Subject|0|||
94534738|NCT03632993|323754331|FG006|Overall Study|Withdrawal by Subject|0|||
94534739|NCT03632993|323754332|FG007|Overall Study|Withdrawal by Subject|0|||
94534740|NCT03632993|323754333|FG008|Overall Study|Withdrawal by Subject|0|||
94534741|NCT03632993|323754334|FG009|Overall Study|Withdrawal by Subject|1|||
94534742|NCT03632993|323754325|FG000|Overall Study|Protocol Non-compliance|0|||
94534743|NCT03632993|323754326|FG001|Overall Study|Protocol Non-compliance|1|||
94534744|NCT03632993|323754327|FG002|Overall Study|Protocol Non-compliance|0|||
94534745|NCT03632993|323754328|FG003|Overall Study|Protocol Non-compliance|0|||
94534746|NCT03632993|323754329|FG004|Overall Study|Protocol Non-compliance|0|||
94534747|NCT03632993|323754330|FG005|Overall Study|Protocol Non-compliance|0|||
94534748|NCT03632993|323754331|FG006|Overall Study|Protocol Non-compliance|0|||
94534749|NCT03632993|323754332|FG007|Overall Study|Protocol Non-compliance|0|||
94534750|NCT03632993|323754333|FG008|Overall Study|Protocol Non-compliance|0|||
94534751|NCT03632993|323754334|FG009|Overall Study|Protocol Non-compliance|0|||
94534752|NCT03632993|323754325|FG000|Overall Study|Lost to Follow-up|0|||
94534753|NCT03632993|323754326|FG001|Overall Study|Lost to Follow-up|0|||
94534754|NCT03632993|323754327|FG002|Overall Study|Lost to Follow-up|0|||
94534755|NCT03632993|323754328|FG003|Overall Study|Lost to Follow-up|0|||
94534756|NCT03632993|323754329|FG004|Overall Study|Lost to Follow-up|0|||
94534757|NCT03632993|323754330|FG005|Overall Study|Lost to Follow-up|1|||
94534758|NCT03632993|323754331|FG006|Overall Study|Lost to Follow-up|0|||
94534759|NCT03632993|323754332|FG007|Overall Study|Lost to Follow-up|1|||
94534760|NCT03632993|323754333|FG008|Overall Study|Lost to Follow-up|0|||
94534761|NCT03632993|323754334|FG009|Overall Study|Lost to Follow-up|0|||
94534762|NCT03632993|323754325|FG000|Overall Study|Adverse Event|0|||
94534763|NCT03632993|323754326|FG001|Overall Study|Adverse Event|0|||
94534764|NCT03632993|323754327|FG002|Overall Study|Adverse Event|0|||
94534765|NCT03632993|323754328|FG003|Overall Study|Adverse Event|0|||
94534766|NCT03632993|323754329|FG004|Overall Study|Adverse Event|0|||
94534767|NCT03632993|323754330|FG005|Overall Study|Adverse Event|1|||
94534768|NCT03632993|323754331|FG006|Overall Study|Adverse Event|0|||
94534769|NCT03632993|323754332|FG007|Overall Study|Adverse Event|1|||
94534770|NCT03632993|323754333|FG008|Overall Study|Adverse Event|0|||
94534771|NCT03632993|323754334|FG009|Overall Study|Adverse Event|0|||
94534772|NCT01885208|323754339|FG000|Overall Study|Unclassified|32|||
94534773|NCT01885208|323754340|FG001|Overall Study|Unclassified|38|||
94534774|NCT00920218|323754341|FG000|Overall Study|Serious Adverse Event|2|||
94534775|NCT00920218|323754342|FG001|Overall Study|Serious Adverse Event|0|||
94534776|NCT00920218|323754343|FG002|Overall Study|Serious Adverse Event|2|||
94534777|NCT00920218|323754344|FG003|Overall Study|Serious Adverse Event|1|||
94534778|NCT00920218|323754341|FG000|Overall Study|Withdrawal by Subject|0|||
94534779|NCT00920218|323754342|FG001|Overall Study|Withdrawal by Subject|3|||
94534780|NCT00920218|323754343|FG002|Overall Study|Withdrawal by Subject|2|||
94534781|NCT00920218|323754344|FG003|Overall Study|Withdrawal by Subject|0|||
94534782|NCT00920218|323754341|FG000|Overall Study|Migrated/moved from study area|0|||
94534783|NCT00920218|323754342|FG001|Overall Study|Migrated/moved from study area|0|||
94534784|NCT00920218|323754343|FG002|Overall Study|Migrated/moved from study area|1|||
94534785|NCT00920218|323754344|FG003|Overall Study|Migrated/moved from study area|0|||
94534786|NCT00920218|323754341|FG000|Overall Study|Lost to Follow-up|0|||
94534787|NCT00920218|323754342|FG001|Overall Study|Lost to Follow-up|1|||
94534788|NCT00920218|323754343|FG002|Overall Study|Lost to Follow-up|0|||
94534789|NCT00920218|323754344|FG003|Overall Study|Lost to Follow-up|3|||
94534790|NCT00920218|323754341|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
94534791|NCT00920218|323754342|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
94534792|NCT00920218|323754343|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
94534793|NCT00920218|323754344|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
94534794|NCT00920218|323754341|FG000|Overall Study|Other|0|||
94534795|NCT00920218|323754342|FG001|Overall Study|Other|0|||
94534796|NCT00920218|323754343|FG002|Overall Study|Other|1|||
94534797|NCT00920218|323754344|FG003|Overall Study|Other|0|||
94534798|NCT00923975|323754346|FG000|Overall Study|Did not meet inclusion criteria|1|||
94534799|NCT02300558|323754351|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
94534800|NCT02300558|323754351|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
94534801|NCT02300558|323754351|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
94534802|NCT02300558|323754351|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
94534803|NCT03359785|323754357|FG000|Overall Study|Protocol Violation|0|||
94534804|NCT03359785|323754358|FG001|Overall Study|Protocol Violation|1|||
94534805|NCT03359785|323754359|FG002|Overall Study|Protocol Violation|0|||
94534806|NCT03359785|323754360|FG003|Overall Study|Protocol Violation|0|||
94534807|NCT03359785|323754357|FG000|Overall Study|Early study termination due to study pause|0|||
94534808|NCT03359785|323754358|FG001|Overall Study|Early study termination due to study pause|0|||
94534809|NCT03359785|323754359|FG002|Overall Study|Early study termination due to study pause|2|||
94534810|NCT03359785|323754360|FG003|Overall Study|Early study termination due to study pause|0|||
94534811|NCT03359785|323754357|FG000|Overall Study|Withdrawal by Subject|2|||
94534812|NCT03359785|323754358|FG001|Overall Study|Withdrawal by Subject|2|||
94534813|NCT03359785|323754359|FG002|Overall Study|Withdrawal by Subject|0|||
94534814|NCT03359785|323754360|FG003|Overall Study|Withdrawal by Subject|0|||
94534815|NCT02247011|323754365|FG000|Overall Study|Poor quality of radiological results|125|||
94534816|NCT02152371|323754366|FG000|Overall Study|Adverse Event|6|||
94534817|NCT02152371|323754367|FG001|Overall Study|Adverse Event|2|||
94534818|NCT02152371|323754366|FG000|Overall Study|Withdrawal by Subject|3|||
94534819|NCT02152371|323754367|FG001|Overall Study|Withdrawal by Subject|7|||
94534820|NCT02152371|323754366|FG000|Overall Study|Protocol Violation|2|||
94534821|NCT02152371|323754367|FG001|Overall Study|Protocol Violation|3|||
94534822|NCT02152371|323754366|FG000|Overall Study|Lost to Follow-up|1|||
94534823|NCT02152371|323754367|FG001|Overall Study|Lost to Follow-up|0|||
94534824|NCT02152371|323754366|FG000|Overall Study|Lack of Efficacy|0|||
94534825|NCT02152371|323754367|FG001|Overall Study|Lack of Efficacy|1|||
94534826|NCT02152371|323754366|FG000|Overall Study|Physician Decision|0|||
94534827|NCT02152371|323754367|FG001|Overall Study|Physician Decision|2|||
94534828|NCT02152371|323754366|FG000|Overall Study|Reason Not Given|0|||
94534829|NCT02152371|323754367|FG001|Overall Study|Reason Not Given|1|||
94534830|NCT03022097|323754369|FG000|Overall Study|Adverse Event|3|||
94534831|NCT03022097|323754370|FG001|Overall Study|Adverse Event|4|||
94534832|NCT03022097|323754371|FG002|Overall Study|Adverse Event|1|||
94534833|NCT03022097|323754372|FG003|Overall Study|Adverse Event|3|||
94534834|NCT03022097|323754369|FG000|Overall Study|Progressive Disease|2|||
94534835|NCT03022097|323754370|FG001|Overall Study|Progressive Disease|0|||
94534836|NCT03022097|323754371|FG002|Overall Study|Progressive Disease|5|||
94534837|NCT03022097|323754372|FG003|Overall Study|Progressive Disease|2|||
94534838|NCT03022097|323754369|FG000|Overall Study|Lack of Efficacy|0|||
94534839|NCT03022097|323754370|FG001|Overall Study|Lack of Efficacy|0|||
94534840|NCT03022097|323754371|FG002|Overall Study|Lack of Efficacy|3|||
94534841|NCT03022097|323754372|FG003|Overall Study|Lack of Efficacy|3|||
94534842|NCT03022097|323754369|FG000|Overall Study|Protocol Violation|1|||
94534843|NCT03022097|323754370|FG001|Overall Study|Protocol Violation|0|||
94534844|NCT03022097|323754371|FG002|Overall Study|Protocol Violation|1|||
94534845|NCT03022097|323754372|FG003|Overall Study|Protocol Violation|0|||
94534846|NCT03022097|323754369|FG000|Overall Study|Withdrawal by Subject|11|||
94534847|NCT03022097|323754370|FG001|Overall Study|Withdrawal by Subject|13|||
94534848|NCT03022097|323754371|FG002|Overall Study|Withdrawal by Subject|15|||
94534849|NCT03022097|323754372|FG003|Overall Study|Withdrawal by Subject|21|||
94534850|NCT03022097|323754369|FG000|Overall Study|Lost to Follow-up|0|||
94534851|NCT03022097|323754370|FG001|Overall Study|Lost to Follow-up|0|||
94534852|NCT03022097|323754371|FG002|Overall Study|Lost to Follow-up|1|||
94534853|NCT03022097|323754372|FG003|Overall Study|Lost to Follow-up|1|||
94534854|NCT03022097|323754369|FG000|Overall Study|Other|4|||
94534855|NCT03022097|323754370|FG001|Overall Study|Other|1|||
94534856|NCT03022097|323754371|FG002|Overall Study|Other|6|||
94534857|NCT03022097|323754372|FG003|Overall Study|Other|4|||
94534858|NCT03022097|323754369|FG000|Overall Study|Due to COVID-19 pandemic|0|||
94534859|NCT03022097|323754370|FG001|Overall Study|Due to COVID-19 pandemic|1|||
94534860|NCT03022097|323754371|FG002|Overall Study|Due to COVID-19 pandemic|0|||
94534861|NCT03022097|323754372|FG003|Overall Study|Due to COVID-19 pandemic|0|||
94534862|NCT03515551|323754373|FG000|Overall Study|Death|4|||
94534863|NCT03515551|323754374|FG001|Overall Study|Death|1|||
94534864|NCT03515551|323754375|FG002|Overall Study|Death|2|||
94534865|NCT03515551|323754376|FG003|Overall Study|Death|2|||
94534866|NCT03515551|323754377|FG004|Overall Study|Death|2|||
94534867|NCT03515551|323754378|FG005|Overall Study|Death|4|||
94534868|NCT03515551|323754379|FG006|Overall Study|Death|1|||
94534869|NCT03515551|323754373|FG000|Overall Study|Lost to Follow-up|0|||
94534870|NCT03515551|323754374|FG001|Overall Study|Lost to Follow-up|0|||
94534871|NCT03515551|323754375|FG002|Overall Study|Lost to Follow-up|1|||
94534872|NCT03515551|323754376|FG003|Overall Study|Lost to Follow-up|0|||
94534873|NCT03515551|323754377|FG004|Overall Study|Lost to Follow-up|0|||
94534874|NCT03515551|323754378|FG005|Overall Study|Lost to Follow-up|0|||
94534875|NCT03515551|323754379|FG006|Overall Study|Lost to Follow-up|0|||
94534876|NCT03515551|323754373|FG000|Overall Study|Withdrawal by Subject|0|||
94534877|NCT03515551|323754374|FG001|Overall Study|Withdrawal by Subject|1|||
94534878|NCT03515551|323754375|FG002|Overall Study|Withdrawal by Subject|0|||
94534879|NCT03515551|323754376|FG003|Overall Study|Withdrawal by Subject|0|||
94534880|NCT03515551|323754377|FG004|Overall Study|Withdrawal by Subject|0|||
94534881|NCT03515551|323754378|FG005|Overall Study|Withdrawal by Subject|0|||
94534882|NCT03515551|323754379|FG006|Overall Study|Withdrawal by Subject|1|||
94534883|NCT03515551|323754373|FG000|Overall Study|Study ended by sponsor|0|||
94534884|NCT03515551|323754374|FG001|Overall Study|Study ended by sponsor|0|||
94534885|NCT03515551|323754375|FG002|Overall Study|Study ended by sponsor|2|||
94534886|NCT03515551|323754376|FG003|Overall Study|Study ended by sponsor|1|||
94534887|NCT03515551|323754377|FG004|Overall Study|Study ended by sponsor|3|||
94534888|NCT03515551|323754378|FG005|Overall Study|Study ended by sponsor|0|||
94534889|NCT03515551|323754379|FG006|Overall Study|Study ended by sponsor|3|||
94534890|NCT03515551|323754373|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
94534891|NCT03515551|323754374|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
94534892|NCT03515551|323754375|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
94534893|NCT03515551|323754376|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
94534894|NCT03515551|323754377|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
94534895|NCT03515551|323754378|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
94534896|NCT03515551|323754379|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
94534897|NCT01301066|323754390|FG000|Overall Study|Lost to Follow-up|5|||
94534898|NCT01301066|323754391|FG001|Overall Study|Lost to Follow-up|11|||
94534899|NCT01301066|323754390|FG000|Overall Study|Protocol Violation|8|||
94534900|NCT01301066|323754391|FG001|Overall Study|Protocol Violation|7|||
94534901|NCT01301066|323754390|FG000|Overall Study|Withdrawal by Subject|4|||
94534902|NCT01301066|323754391|FG001|Overall Study|Withdrawal by Subject|9|||
94534903|NCT01301066|323754390|FG000|Overall Study|Adverse Event|6|||
94534904|NCT01301066|323754391|FG001|Overall Study|Adverse Event|6|||
94534905|NCT01301066|323754390|FG000|Overall Study|Sponsor Decision|2|||
94534906|NCT01301066|323754391|FG001|Overall Study|Sponsor Decision|1|||
94534907|NCT01301066|323754390|FG000|Overall Study|Physician Decision|0|||
94534908|NCT01301066|323754391|FG001|Overall Study|Physician Decision|1|||
94534909|NCT01301066|323754390|FG000|Overall Study|Other|2|||
94534910|NCT01301066|323754391|FG001|Overall Study|Other|0|||
94534911|NCT03941964|323754394|FG000|Overall Study|Adverse Event|1|||
94534912|NCT03941964|323754395|FG001|Overall Study|Adverse Event|8|||
94534913|NCT03941964|323754394|FG000|Overall Study|Progressive disease|7|||
94534914|NCT03941964|323754395|FG001|Overall Study|Progressive disease|3|||
94534915|NCT03941964|323754394|FG000|Overall Study|Lack of Efficacy|0|||
94534916|NCT03941964|323754395|FG001|Overall Study|Lack of Efficacy|1|||
94534917|NCT03941964|323754394|FG000|Overall Study|Death|3|||
94534918|NCT03941964|323754395|FG001|Overall Study|Death|1|||
94534919|NCT03941964|323754394|FG000|Overall Study|Withdrew consent|1|||
94534920|NCT03941964|323754395|FG001|Overall Study|Withdrew consent|3|||
94534921|NCT03941964|323754394|FG000|Overall Study|Physician Decision|9|||
94534922|NCT03941964|323754395|FG001|Overall Study|Physician Decision|2|||
94534923|NCT03941964|323754394|FG000|Overall Study|Other, not specified|2|||
94534924|NCT03941964|323754395|FG001|Overall Study|Other, not specified|1|||
94534925|NCT03219034|323754396|FG000|Overall Study|Lost to Follow-up|9|||
94534926|NCT03219034|323754397|FG001|Overall Study|Lost to Follow-up|13|||
94534927|NCT03219034|323754396|FG000|Overall Study|Additional dental work needed|1|||
94534928|NCT03219034|323754397|FG001|Overall Study|Additional dental work needed|0|||
94534929|NCT03219034|323754396|FG000|Overall Study|UPPP Surgery|1|||
94534930|NCT03219034|323754397|FG001|Overall Study|UPPP Surgery|0|||
94534931|NCT03219034|323754396|FG000|Overall Study|Dental sensitivity|0|||
94534932|NCT03219034|323754397|FG001|Overall Study|Dental sensitivity|1|||
94534933|NCT03219034|323754396|FG000|Overall Study|Death in family|0|||
94534934|NCT03219034|323754397|FG001|Overall Study|Death in family|1|||
94534935|NCT00721578|323754398|FG000|Overall Study|Death|1|||
94534936|NCT00721578|323754399|FG001|Overall Study|Death|1|||
94534937|NCT00721578|323754398|FG000|Overall Study|Withdrawal by Subject|1|||
94534938|NCT00721578|323754399|FG001|Overall Study|Withdrawal by Subject|1|||
94534939|NCT01202188|323754402|FG000|Overall Study|Protocol deviation|14|||
94534940|NCT01202188|323754403|FG001|Overall Study|Protocol deviation|8|||
94534941|NCT01202188|323754404|FG002|Overall Study|Protocol deviation|12|||
94534942|NCT01202188|323754405|FG003|Overall Study|Protocol deviation|10|||
94534943|NCT01202188|323754406|FG004|Overall Study|Protocol deviation|11|||
94534944|NCT01202188|323754402|FG000|Overall Study|Subject withdrew consent|12|||
94534945|NCT01202188|323754403|FG001|Overall Study|Subject withdrew consent|13|||
94534946|NCT01202188|323754404|FG002|Overall Study|Subject withdrew consent|22|||
94534947|NCT01202188|323754405|FG003|Overall Study|Subject withdrew consent|11|||
94534948|NCT01202188|323754406|FG004|Overall Study|Subject withdrew consent|13|||
94534949|NCT01202188|323754402|FG000|Overall Study|Adverse Event|5|||
94534950|NCT01202188|323754403|FG001|Overall Study|Adverse Event|23|||
94534951|NCT01202188|323754404|FG002|Overall Study|Adverse Event|13|||
94534952|NCT01202188|323754405|FG003|Overall Study|Adverse Event|10|||
94534953|NCT01202188|323754406|FG004|Overall Study|Adverse Event|10|||
94534954|NCT01202188|323754402|FG000|Overall Study|Administrative problems|3|||
94534955|NCT01202188|323754403|FG001|Overall Study|Administrative problems|2|||
94534956|NCT01202188|323754404|FG002|Overall Study|Administrative problems|1|||
94534957|NCT01202188|323754405|FG003|Overall Study|Administrative problems|1|||
94534958|NCT01202188|323754406|FG004|Overall Study|Administrative problems|2|||
94534959|NCT01202188|323754402|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
94534960|NCT01202188|323754403|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
94534961|NCT01202188|323754404|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
94534962|NCT01202188|323754405|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
94534963|NCT01202188|323754406|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
94534964|NCT01202188|323754402|FG000|Overall Study|Lost to Follow-up|1|||
94534965|NCT01202188|323754403|FG001|Overall Study|Lost to Follow-up|1|||
94534966|NCT01202188|323754404|FG002|Overall Study|Lost to Follow-up|0|||
94534967|NCT01202188|323754405|FG003|Overall Study|Lost to Follow-up|4|||
94534968|NCT01202188|323754406|FG004|Overall Study|Lost to Follow-up|1|||
94534969|NCT01202188|323754402|FG000|Overall Study|Death|1|||
94534970|NCT01202188|323754403|FG001|Overall Study|Death|1|||
94534971|NCT01202188|323754404|FG002|Overall Study|Death|1|||
94534972|NCT01202188|323754405|FG003|Overall Study|Death|1|||
94534973|NCT01202188|323754406|FG004|Overall Study|Death|0|||
94534974|NCT01202188|323754402|FG000|Overall Study|Abnormal test procedure result (s)|0|||
94534975|NCT01202188|323754403|FG001|Overall Study|Abnormal test procedure result (s)|0|||
94534976|NCT01202188|323754404|FG002|Overall Study|Abnormal test procedure result (s)|2|||
94534977|NCT01202188|323754405|FG003|Overall Study|Abnormal test procedure result (s)|0|||
94534978|NCT01202188|323754406|FG004|Overall Study|Abnormal test procedure result (s)|0|||
94534979|NCT00487942|323754408|FG000|Overall Study|Adverse Event|1|||
94534980|NCT00487942|323754409|FG001|Overall Study|Adverse Event|1|||
94534981|NCT00487942|323754410|FG002|Overall Study|Adverse Event|1|||
94534982|NCT00487942|323754411|FG003|Overall Study|Adverse Event|1|||
94534983|NCT00487942|323754408|FG000|Overall Study|Lost to Follow-up|1|||
94534984|NCT00487942|323754409|FG001|Overall Study|Lost to Follow-up|0|||
94534985|NCT00487942|323754410|FG002|Overall Study|Lost to Follow-up|0|||
94534986|NCT00487942|323754411|FG003|Overall Study|Lost to Follow-up|1|||
94534987|NCT00487942|323754408|FG000|Overall Study|Protocol Violation|1|||
94534988|NCT00487942|323754409|FG001|Overall Study|Protocol Violation|1|||
94534989|NCT00487942|323754410|FG002|Overall Study|Protocol Violation|0|||
94534990|NCT00487942|323754411|FG003|Overall Study|Protocol Violation|0|||
94534991|NCT00487942|323754408|FG000|Overall Study|Withdrawal by Subject|0|||
94534992|NCT00487942|323754409|FG001|Overall Study|Withdrawal by Subject|1|||
94534993|NCT00487942|323754410|FG002|Overall Study|Withdrawal by Subject|2|||
94534994|NCT00487942|323754411|FG003|Overall Study|Withdrawal by Subject|0|||
94534995|NCT01638013|323754412|FG000|Overall Study|Adverse Event|36|||
94534996|NCT01638013|323754413|FG001|Overall Study|Adverse Event|29|||
94534997|NCT01638013|323754414|FG002|Overall Study|Adverse Event|48|||
94534998|NCT01638013|323754412|FG000|Overall Study|Lack of Efficacy|39|||
94534999|NCT01638013|323754413|FG001|Overall Study|Lack of Efficacy|11|||
94535000|NCT01638013|323754414|FG002|Overall Study|Lack of Efficacy|14|||
94535001|NCT01638013|323754412|FG000|Overall Study|Protocol Violation|10|||
94535002|NCT01638013|323754413|FG001|Overall Study|Protocol Violation|7|||
94535003|NCT01638013|323754414|FG002|Overall Study|Protocol Violation|11|||
94535004|NCT01638013|323754412|FG000|Overall Study|Met discontinuation criteria|4|||
94535005|NCT01638013|323754413|FG001|Overall Study|Met discontinuation criteria|0|||
94535006|NCT01638013|323754414|FG002|Overall Study|Met discontinuation criteria|7|||
94535007|NCT01638013|323754412|FG000|Overall Study|Subject Lost to Follow up|1|||
94535008|NCT01638013|323754413|FG001|Overall Study|Subject Lost to Follow up|0|||
94535009|NCT01638013|323754414|FG002|Overall Study|Subject Lost to Follow up|1|||
94535010|NCT01638013|323754412|FG000|Overall Study|Miscellaneous|25|||
94535011|NCT01638013|323754413|FG001|Overall Study|Miscellaneous|19|||
94535012|NCT01638013|323754414|FG002|Overall Study|Miscellaneous|23|||
94535013|NCT01638013|323754412|FG000|Overall Study|Withdrawal of Consent|16|||
94535014|NCT01638013|323754413|FG001|Overall Study|Withdrawal of Consent|12|||
94535015|NCT01638013|323754414|FG002|Overall Study|Withdrawal of Consent|16|||
94535016|NCT01638013|323754412|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
94535017|NCT01638013|323754413|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
94535018|NCT01638013|323754414|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
94535019|NCT00322452|323754418|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
94535020|NCT00322452|323754419|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
94535021|NCT00322452|323754418|FG000|Overall Study|Lost to Follow-up|5|||
94535022|NCT00322452|323754419|FG001|Overall Study|Lost to Follow-up|2|||
94535023|NCT00322452|323754418|FG000|Overall Study|Withdrawal by Subject|19|||
94535024|NCT00322452|323754419|FG001|Overall Study|Withdrawal by Subject|46|||
94535025|NCT00322452|323754418|FG000|Overall Study|Death|223|||
94535026|NCT00322452|323754419|FG001|Overall Study|Death|227|||
94535027|NCT01330628|323754421|FG000|Overall Study|Death|2|||
94535028|NCT01330628|323754422|FG001|Overall Study|Death|3|||
94535029|NCT01330628|323754421|FG000|Overall Study|Lost to Follow-up|5|||
94535030|NCT01330628|323754422|FG001|Overall Study|Lost to Follow-up|6|||
94535031|NCT01330628|323754421|FG000|Overall Study|Adverse Event|44|||
94535032|NCT01330628|323754422|FG001|Overall Study|Adverse Event|25|||
94535033|NCT01330628|323754421|FG000|Overall Study|Withdrawn|18|||
94535034|NCT01330628|323754422|FG001|Overall Study|Withdrawn|6|||
94535035|NCT01330628|323754421|FG000|Overall Study|Didn't receive study treatment|1|||
94535036|NCT01330628|323754422|FG001|Overall Study|Didn't receive study treatment|0|||
94535037|NCT02910401|323754423|FG000|Overall Study|Study closure Study closure|0|||
94535038|NCT02910401|323754424|FG001|Overall Study|Study closure Study closure|0|||
94535039|NCT02910401|323754425|FG002|Overall Study|Study closure Study closure|2|||
94535040|NCT02910401|323754423|FG000|Overall Study|Physician Decision|1|||
94535041|NCT02910401|323754424|FG001|Overall Study|Physician Decision|0|||
94535042|NCT02910401|323754425|FG002|Overall Study|Physician Decision|0|||
94535043|NCT03300024|323754426|FG000|Overall Study|Physician Decision|4|||
94535044|NCT03300024|323754427|FG001|Overall Study|Physician Decision|6|||
94535045|NCT03724981|323756147|FG000|First Device|Protocol Violation|1|||
94535046|NCT03724981|323756148|FG001|First Device|Protocol Violation|1|||
94535047|NCT01456195|323756149|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
94535048|NCT01456195|323756150|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
94535049|NCT01456195|323756151|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
94535050|NCT01456195|323756149|FG000|Overall Study|Lost to Follow-up|3|||
94535051|NCT01456195|323756150|FG001|Overall Study|Lost to Follow-up|1|||
94535052|NCT01456195|323756151|FG002|Overall Study|Lost to Follow-up|3|||
94535053|NCT01456195|323756149|FG000|Overall Study|Voluntary Withdrawal|5|||
94535054|NCT01456195|323756150|FG001|Overall Study|Voluntary Withdrawal|3|||
94535055|NCT01456195|323756151|FG002|Overall Study|Voluntary Withdrawal|7|||
94535056|NCT01456195|323756149|FG000|Overall Study|Lack of Efficacy|0|||
94535057|NCT01456195|323756150|FG001|Overall Study|Lack of Efficacy|1|||
94535058|NCT01456195|323756151|FG002|Overall Study|Lack of Efficacy|0|||
94535059|NCT01456195|323756149|FG000|Overall Study|Other Reasons|2|||
94535060|NCT01456195|323756150|FG001|Overall Study|Other Reasons|1|||
94535061|NCT01456195|323756151|FG002|Overall Study|Other Reasons|3|||
94535062|NCT02109432|323756152|FG000|Overall Study|Withdrawal by Subject|1|||
94535063|NCT02358031|323756154|FG000|Overall Study|Death|253|||
94535064|NCT02358031|323756155|FG001|Overall Study|Death|237|||
94535065|NCT02358031|323756156|FG002|Overall Study|Death|266|||
94535066|NCT02358031|323756154|FG000|Overall Study|Lost to Follow-up|1|||
94535067|NCT02358031|323756155|FG001|Overall Study|Lost to Follow-up|1|||
94535068|NCT02358031|323756156|FG002|Overall Study|Lost to Follow-up|0|||
94535069|NCT02358031|323756154|FG000|Overall Study|Withdrawal by Subject|19|||
94535070|NCT02358031|323756155|FG001|Overall Study|Withdrawal by Subject|14|||
94535071|NCT02358031|323756156|FG002|Overall Study|Withdrawal by Subject|18|||
94535072|NCT02358031|323756154|FG000|Overall Study|Sponsor Decision|26|||
94535073|NCT02358031|323756155|FG001|Overall Study|Sponsor Decision|28|||
94535074|NCT02358031|323756156|FG002|Overall Study|Sponsor Decision|16|||
94535075|NCT01579565|323756163|FG000|Randomized|Adverse Event|1|||
94535076|NCT01579565|323756164|FG001|Randomized|Adverse Event|3|||
94535077|NCT01579565|323756163|FG000|Randomized|Withdrawal by Subject|3|||
94535078|NCT01579565|323756164|FG001|Randomized|Withdrawal by Subject|0|||
94535079|NCT01579565|323756163|FG000|Randomized|inadequate preoperative pupil dilation|0|||
94535080|NCT01579565|323756164|FG001|Randomized|inadequate preoperative pupil dilation|1|||
94535081|NCT01579565|323756163|FG000|Randomized|prohibited preoperative eating|1|||
94535082|NCT01579565|323756164|FG001|Randomized|prohibited preoperative eating|0|||
94535083|NCT01579565|323756163|FG000|Randomized|prohibited preoperative medication|0|||
94535084|NCT01579565|323756164|FG001|Randomized|prohibited preoperative medication|1|||
94535085|NCT01579565|323756163|FG000|Treated|Physician Decision|0|||
94535086|NCT01579565|323756164|FG001|Treated|Physician Decision|1|||
94535087|NCT01579565|323756163|FG000|Treated|Lost to Follow-up|2|||
94535088|NCT01579565|323756164|FG001|Treated|Lost to Follow-up|1|||
94535089|NCT01579565|323756163|FG000|Treated|declined to return for final visit|0|||
94535090|NCT01579565|323756164|FG001|Treated|declined to return for final visit|1|||
94535091|NCT01380535|323756165|FG000|Overall Study|Adverse Event|3|||
94535092|NCT01380535|323756166|FG001|Overall Study|Adverse Event|3|||
94535093|NCT01380535|323756165|FG000|Overall Study|Death|3|||
94535094|NCT01380535|323756166|FG001|Overall Study|Death|0|||
94535095|NCT01380535|323756165|FG000|Overall Study|Study site closed|0|||
94535096|NCT01380535|323756166|FG001|Overall Study|Study site closed|5|||
94535097|NCT01380535|323756165|FG000|Overall Study|Withdrawal by Subject|1|||
94535098|NCT01380535|323756166|FG001|Overall Study|Withdrawal by Subject|2|||
94535099|NCT01380535|323756165|FG000|Overall Study|Protocol Violation|0|||
94535100|NCT01380535|323756166|FG001|Overall Study|Protocol Violation|2|||
94535101|NCT01380535|323756165|FG000|Overall Study|Lack of Efficacy|0|||
94535102|NCT01380535|323756166|FG001|Overall Study|Lack of Efficacy|3|||
94535103|NCT02791191|323756170|FG000|Overall Study|Adverse Event|2|||
94535104|NCT02791191|323756171|FG001|Overall Study|Adverse Event|4|||
94535105|NCT02791191|323756172|FG002|Overall Study|Adverse Event|5|||
94535106|NCT02791191|323756170|FG000|Overall Study|Lack of Efficacy|0|||
94535107|NCT02791191|323756171|FG001|Overall Study|Lack of Efficacy|1|||
94535108|NCT02791191|323756172|FG002|Overall Study|Lack of Efficacy|0|||
94535109|NCT02791191|323756170|FG000|Overall Study|Study Drug Non-Compliance|0|||
94535110|NCT02791191|323756171|FG001|Overall Study|Study Drug Non-Compliance|2|||
94535111|NCT02791191|323756172|FG002|Overall Study|Study Drug Non-Compliance|0|||
94535112|NCT02791191|323756170|FG000|Overall Study|Site Closed by Sponsor|1|||
94535113|NCT02791191|323756171|FG001|Overall Study|Site Closed by Sponsor|1|||
94535114|NCT02791191|323756172|FG002|Overall Study|Site Closed by Sponsor|3|||
94535115|NCT02791191|323756170|FG000|Overall Study|Progressive Disease|1|||
94535116|NCT02791191|323756171|FG001|Overall Study|Progressive Disease|0|||
94535117|NCT02791191|323756172|FG002|Overall Study|Progressive Disease|0|||
94535118|NCT02791191|323756170|FG000|Overall Study|Study Terminated by Sponsor|29|||
94535119|NCT02791191|323756171|FG001|Overall Study|Study Terminated by Sponsor|101|||
94535120|NCT02791191|323756172|FG002|Overall Study|Study Terminated by Sponsor|109|||
94535121|NCT02791191|323756170|FG000|Overall Study|Withdrawal by Subject|3|||
94535122|NCT02791191|323756171|FG001|Overall Study|Withdrawal by Subject|1|||
94535123|NCT02791191|323756172|FG002|Overall Study|Withdrawal by Subject|3|||
94535124|NCT02791191|323756170|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
94535125|NCT02791191|323756171|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
94535126|NCT02791191|323756172|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
94535127|NCT01945216|323756173|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
94535128|NCT01945216|323756173|FG000|Overall Study|Protocol Violation|42|||
94535129|NCT01945216|323756173|FG000|Overall Study|CRF not assured by investigators|5|||
94535130|NCT02578680|323756183|FG000|Overall Study|Death|329|||
94535131|NCT02578680|323756184|FG001|Overall Study|Death|181|||
94535132|NCT02578680|323756183|FG000|Overall Study|Lost to Follow-up|3|||
94535133|NCT02578680|323756184|FG001|Overall Study|Lost to Follow-up|1|||
94535134|NCT02578680|323756183|FG000|Overall Study|Physician Decision|0|||
94535135|NCT02578680|323756184|FG001|Overall Study|Physician Decision|1|||
94535136|NCT02578680|323756183|FG000|Overall Study|Protocol Violation|1|||
94535137|NCT02578680|323756184|FG001|Overall Study|Protocol Violation|1|||
94535138|NCT02578680|323756183|FG000|Overall Study|Sponsor Decision|64|||
94535139|NCT02578680|323756184|FG001|Overall Study|Sponsor Decision|13|||
94535140|NCT02578680|323756183|FG000|Overall Study|Withdrawal by Subject|13|||
94535141|NCT02578680|323756184|FG001|Overall Study|Withdrawal by Subject|9|||
94535142|NCT03116828|323756185|FG000|Overall Study|Adverse Event|1|||
94535143|NCT03116828|323756186|FG001|Overall Study|Adverse Event|10|||
94535144|NCT03116828|323756185|FG000|Overall Study|Withdrawal by Subject|4|||
94535145|NCT03116828|323756186|FG001|Overall Study|Withdrawal by Subject|8|||
94535146|NCT03116828|323756185|FG000|Overall Study|OTHER|3|||
94535147|NCT03116828|323756186|FG001|Overall Study|OTHER|3|||
94535148|NCT00882583|323756187|FG000|Overall Study|Physician Decision|1|||
94535149|NCT00882583|323756188|FG001|Overall Study|Physician Decision|0|||
94535150|NCT00882583|323756187|FG000|Overall Study|Adverse Event|0|||
94535151|NCT00882583|323756188|FG001|Overall Study|Adverse Event|1|||
94535152|NCT02596958|323756194|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
94535153|NCT02596958|323756194|FG000|Overall Study|Cancer Progression|441|||
94535154|NCT02596958|323756194|FG000|Overall Study|Death From Cancer|112|||
94535155|NCT02596958|323756194|FG000|Overall Study|Death From Other Cause|33|||
94535156|NCT02596958|323756194|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
94535157|NCT02596958|323756194|FG000|Overall Study|Administrative Reasons/Other|231|||
94535158|NCT02596958|323756194|FG000|Overall Study|Lost to Follow-up|33|||
94535159|NCT02596958|323756194|FG000|Overall Study|Missing|32|||
94535160|NCT02596958|323756194|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
94535161|NCT03596047|323756195|FG000|Overall Study|Withdrawal by Subject|7|||
94535162|NCT03596047|323756196|FG001|Overall Study|Withdrawal by Subject|4|||
94535163|NCT03596047|323756195|FG000|Overall Study|Lost to Follow-up|0|||
94535164|NCT03596047|323756196|FG001|Overall Study|Lost to Follow-up|2|||
94535165|NCT00066703|323756197|FG000|Overall Study|Adverse Event|80|||
94535166|NCT00066703|323756198|FG001|Overall Study|Adverse Event|111|||
94535167|NCT00066703|323756197|FG000|Overall Study|Death|3|||
94535168|NCT00066703|323756198|FG001|Overall Study|Death|0|||
94535169|NCT00066703|323756197|FG000|Overall Study|Lack of Efficacy|114|||
94535170|NCT00066703|323756198|FG001|Overall Study|Lack of Efficacy|69|||
94535171|NCT00066703|323756197|FG000|Overall Study|Lost to Follow-up|31|||
94535172|NCT00066703|323756198|FG001|Overall Study|Lost to Follow-up|28|||
94535173|NCT00066703|323756197|FG000|Overall Study|Withdrawal by Subject|38|||
94535174|NCT00066703|323756198|FG001|Overall Study|Withdrawal by Subject|63|||
94535175|NCT00066703|323756197|FG000|Overall Study|Treatment ongoing|346|||
94535176|NCT00066703|323756198|FG001|Overall Study|Treatment ongoing|311|||
94535177|NCT05425732|323756199|FG000|Overall Study|Death|4|||
94535178|NCT05425732|323756200|FG001|Overall Study|Death|2|||
94535179|NCT05425732|323756201|FG002|Overall Study|Death|0|||
94535180|NCT05425732|323756202|FG003|Overall Study|Death|0|||
94535181|NCT05425732|323756199|FG000|Overall Study|Lost to Follow-up|10|||
94535182|NCT05425732|323756200|FG001|Overall Study|Lost to Follow-up|15|||
94535183|NCT05425732|323756201|FG002|Overall Study|Lost to Follow-up|5|||
94535184|NCT05425732|323756202|FG003|Overall Study|Lost to Follow-up|3|||
94535185|NCT05425732|323756199|FG000|Overall Study|Physician Decision|0|||
94535186|NCT05425732|323756200|FG001|Overall Study|Physician Decision|2|||
94535187|NCT05425732|323756201|FG002|Overall Study|Physician Decision|0|||
94535188|NCT05425732|323756202|FG003|Overall Study|Physician Decision|0|||
94535189|NCT05425732|323756199|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
94535190|NCT05425732|323756200|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
94535191|NCT05425732|323756201|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94535192|NCT05425732|323756202|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
94535193|NCT05425732|323756199|FG000|Overall Study|Withdrawal by Subject|4|||
94535194|NCT05425732|323756200|FG001|Overall Study|Withdrawal by Subject|8|||
94535195|NCT05425732|323756201|FG002|Overall Study|Withdrawal by Subject|1|||
94535196|NCT05425732|323756202|FG003|Overall Study|Withdrawal by Subject|1|||
94535197|NCT05425732|323756199|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
94535198|NCT05425732|323756200|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
94535199|NCT05425732|323756201|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
94535200|NCT05425732|323756202|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
94535201|NCT03727646|323756203|FG000|Overall Study|Adverse Event|1|||
94535202|NCT03727646|323756204|FG001|Overall Study|Adverse Event|0|||
94535203|NCT04753658|323756205|FG000|Overall Study|Progressive disease|7|||
94535204|NCT04753658|323756205|FG000|Overall Study|Other|7|||
94535205|NCT04753658|323756205|FG000|Overall Study|Adverse Event|1|||
94535206|NCT02998203|323756208|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
94535207|NCT02998203|323756209|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
94535208|NCT02998203|323756208|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
94535209|NCT02998203|323756209|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
94535210|NCT02589665|323756210|FG000|Induction Period|Did not receive drug|0|||
94535211|NCT02589665|323756211|FG001|Induction Period|Did not receive drug|0|||
94535212|NCT02589665|323756212|FG002|Induction Period|Did not receive drug|0|||
94535213|NCT02589665|323756213|FG003|Induction Period|Did not receive drug|1|||
94535214|NCT02589665|323756214|FG004|Induction Period|Did not receive drug|0|||
94535215|NCT02589665|323756215|FG005|Induction Period|Did not receive drug|0|||
94535216|NCT02589665|323756216|FG006|Induction Period|Did not receive drug|0|||
94535217|NCT02589665|323756217|FG007|Induction Period|Did not receive drug|0|||
94535218|NCT02589665|323756218|FG008|Induction Period|Did not receive drug|0|||
94535219|NCT02589665|323756219|FG009|Induction Period|Did not receive drug|0|||
94535220|NCT02589665|323756210|FG000|Induction Period|Adverse Event|3|||
94535221|NCT02589665|323756211|FG001|Induction Period|Adverse Event|0|||
94535222|NCT02589665|323756212|FG002|Induction Period|Adverse Event|2|||
94535223|NCT02589665|323756213|FG003|Induction Period|Adverse Event|2|||
94535224|NCT02589665|323756214|FG004|Induction Period|Adverse Event|0|||
94535225|NCT02589665|323756215|FG005|Induction Period|Adverse Event|0|||
94535226|NCT02589665|323756216|FG006|Induction Period|Adverse Event|0|||
94535227|NCT02589665|323756217|FG007|Induction Period|Adverse Event|0|||
94535228|NCT02589665|323756218|FG008|Induction Period|Adverse Event|0|||
94535229|NCT02589665|323756219|FG009|Induction Period|Adverse Event|0|||
94535230|NCT02589665|323756210|FG000|Induction Period|Withdrawal by Subject|0|||
94535231|NCT02589665|323756211|FG001|Induction Period|Withdrawal by Subject|1|||
94535232|NCT02589665|323756212|FG002|Induction Period|Withdrawal by Subject|0|||
94535233|NCT02589665|323756213|FG003|Induction Period|Withdrawal by Subject|1|||
94535234|NCT02589665|323756214|FG004|Induction Period|Withdrawal by Subject|0|||
94535235|NCT02589665|323756215|FG005|Induction Period|Withdrawal by Subject|0|||
94535236|NCT02589665|323756216|FG006|Induction Period|Withdrawal by Subject|0|||
94535237|NCT02589665|323756217|FG007|Induction Period|Withdrawal by Subject|0|||
94535238|NCT02589665|323756218|FG008|Induction Period|Withdrawal by Subject|0|||
94535239|NCT02589665|323756219|FG009|Induction Period|Withdrawal by Subject|0|||
94535240|NCT02589665|323756210|FG000|Induction Period|Protocol Violation|0|||
94535241|NCT02589665|323756211|FG001|Induction Period|Protocol Violation|1|||
94535242|NCT02589665|323756212|FG002|Induction Period|Protocol Violation|0|||
94535243|NCT02589665|323756213|FG003|Induction Period|Protocol Violation|0|||
94535244|NCT02589665|323756214|FG004|Induction Period|Protocol Violation|0|||
94535245|NCT02589665|323756215|FG005|Induction Period|Protocol Violation|0|||
94535246|NCT02589665|323756216|FG006|Induction Period|Protocol Violation|0|||
94535247|NCT02589665|323756217|FG007|Induction Period|Protocol Violation|0|||
94535248|NCT02589665|323756218|FG008|Induction Period|Protocol Violation|0|||
94535249|NCT02589665|323756219|FG009|Induction Period|Protocol Violation|0|||
94535250|NCT02589665|323756210|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
94535251|NCT02589665|323756211|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
94535252|NCT02589665|323756212|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
94535253|NCT02589665|323756213|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
94535254|NCT02589665|323756214|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
94535255|NCT02589665|323756215|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
94535256|NCT02589665|323756216|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
94535257|NCT02589665|323756217|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
94535258|NCT02589665|323756218|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
94535259|NCT02589665|323756219|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
94535260|NCT02589665|323756210|FG000|Maintenance Period|Withdrawal by Subject|0|||
94535261|NCT02589665|323756211|FG001|Maintenance Period|Withdrawal by Subject|0|||
94535262|NCT02589665|323756212|FG002|Maintenance Period|Withdrawal by Subject|0|||
94535263|NCT02589665|323756213|FG003|Maintenance Period|Withdrawal by Subject|0|||
94535264|NCT02589665|323756214|FG004|Maintenance Period|Withdrawal by Subject|4|||
94535265|NCT02589665|323756215|FG005|Maintenance Period|Withdrawal by Subject|2|||
94535266|NCT02589665|323756216|FG006|Maintenance Period|Withdrawal by Subject|4|||
94535267|NCT02589665|323756217|FG007|Maintenance Period|Withdrawal by Subject|0|||
94535268|NCT02589665|323756218|FG008|Maintenance Period|Withdrawal by Subject|0|||
94535269|NCT02589665|323756219|FG009|Maintenance Period|Withdrawal by Subject|0|||
94535270|NCT02589665|323756210|FG000|Maintenance Period|Lack of Efficacy|0|||
94535271|NCT02589665|323756211|FG001|Maintenance Period|Lack of Efficacy|0|||
94535272|NCT02589665|323756212|FG002|Maintenance Period|Lack of Efficacy|0|||
94535273|NCT02589665|323756213|FG003|Maintenance Period|Lack of Efficacy|0|||
94535274|NCT02589665|323756214|FG004|Maintenance Period|Lack of Efficacy|2|||
94535275|NCT02589665|323756215|FG005|Maintenance Period|Lack of Efficacy|1|||
94535276|NCT02589665|323756216|FG006|Maintenance Period|Lack of Efficacy|0|||
94535277|NCT02589665|323756217|FG007|Maintenance Period|Lack of Efficacy|0|||
94535278|NCT02589665|323756218|FG008|Maintenance Period|Lack of Efficacy|0|||
94535279|NCT02589665|323756219|FG009|Maintenance Period|Lack of Efficacy|0|||
94535280|NCT02589665|323756210|FG000|Maintenance Period|Adverse Event|0|||
94535281|NCT02589665|323756211|FG001|Maintenance Period|Adverse Event|0|||
94535282|NCT02589665|323756212|FG002|Maintenance Period|Adverse Event|0|||
94535283|NCT02589665|323756213|FG003|Maintenance Period|Adverse Event|0|||
94535284|NCT02589665|323756214|FG004|Maintenance Period|Adverse Event|0|||
94535285|NCT02589665|323756215|FG005|Maintenance Period|Adverse Event|0|||
94535286|NCT02589665|323756216|FG006|Maintenance Period|Adverse Event|2|||
94535287|NCT02589665|323756217|FG007|Maintenance Period|Adverse Event|0|||
94535288|NCT02589665|323756218|FG008|Maintenance Period|Adverse Event|0|||
94535289|NCT02589665|323756219|FG009|Maintenance Period|Adverse Event|0|||
94535290|NCT02589665|323756210|FG000|Maintenance Period|Lost to Follow-up|0|||
94535291|NCT02589665|323756211|FG001|Maintenance Period|Lost to Follow-up|0|||
94535292|NCT02589665|323756212|FG002|Maintenance Period|Lost to Follow-up|0|||
94535293|NCT02589665|323756213|FG003|Maintenance Period|Lost to Follow-up|0|||
94535294|NCT02589665|323756214|FG004|Maintenance Period|Lost to Follow-up|0|||
94535295|NCT02589665|323756215|FG005|Maintenance Period|Lost to Follow-up|1|||
94535296|NCT02589665|323756216|FG006|Maintenance Period|Lost to Follow-up|0|||
94535297|NCT02589665|323756217|FG007|Maintenance Period|Lost to Follow-up|0|||
94535298|NCT02589665|323756218|FG008|Maintenance Period|Lost to Follow-up|0|||
94535299|NCT02589665|323756219|FG009|Maintenance Period|Lost to Follow-up|0|||
94535300|NCT02589665|323756210|FG000|Maintenance Period|Physician Decision|0|||
94535301|NCT02589665|323756211|FG001|Maintenance Period|Physician Decision|0|||
94535302|NCT02589665|323756212|FG002|Maintenance Period|Physician Decision|0|||
94535303|NCT02589665|323756213|FG003|Maintenance Period|Physician Decision|0|||
94535304|NCT02589665|323756214|FG004|Maintenance Period|Physician Decision|0|||
94535305|NCT02589665|323756215|FG005|Maintenance Period|Physician Decision|1|||
94535306|NCT02589665|323756216|FG006|Maintenance Period|Physician Decision|0|||
94535307|NCT02589665|323756217|FG007|Maintenance Period|Physician Decision|0|||
94535308|NCT02589665|323756218|FG008|Maintenance Period|Physician Decision|0|||
94535309|NCT02589665|323756219|FG009|Maintenance Period|Physician Decision|0|||
94535310|NCT02589665|323756210|FG000|Maintenance Period|Reason Not Collected|0|||
94535311|NCT02589665|323756211|FG001|Maintenance Period|Reason Not Collected|0|||
94535312|NCT02589665|323756212|FG002|Maintenance Period|Reason Not Collected|0|||
94535313|NCT02589665|323756213|FG003|Maintenance Period|Reason Not Collected|0|||
94535314|NCT02589665|323756214|FG004|Maintenance Period|Reason Not Collected|0|||
94535315|NCT02589665|323756215|FG005|Maintenance Period|Reason Not Collected|1|||
94535316|NCT02589665|323756216|FG006|Maintenance Period|Reason Not Collected|1|||
94535317|NCT02589665|323756217|FG007|Maintenance Period|Reason Not Collected|0|||
94535318|NCT02589665|323756218|FG008|Maintenance Period|Reason Not Collected|0|||
94535319|NCT02589665|323756219|FG009|Maintenance Period|Reason Not Collected|0|||
94535320|NCT02589665|323756210|FG000|Induction Extension Period|Adverse Event|0|||
94535321|NCT02589665|323756211|FG001|Induction Extension Period|Adverse Event|0|||
94535322|NCT02589665|323756212|FG002|Induction Extension Period|Adverse Event|0|||
94535323|NCT02589665|323756213|FG003|Induction Extension Period|Adverse Event|0|||
94535324|NCT02589665|323756214|FG004|Induction Extension Period|Adverse Event|0|||
94535325|NCT02589665|323756215|FG005|Induction Extension Period|Adverse Event|0|||
94535326|NCT02589665|323756216|FG006|Induction Extension Period|Adverse Event|0|||
94535327|NCT02589665|323756217|FG007|Induction Extension Period|Adverse Event|0|||
94535328|NCT02589665|323756218|FG008|Induction Extension Period|Adverse Event|4|||
94535329|NCT02589665|323756219|FG009|Induction Extension Period|Adverse Event|0|||
94535330|NCT02589665|323756210|FG000|Induction Extension Period|Lack of Efficacy|0|||
94535331|NCT02589665|323756211|FG001|Induction Extension Period|Lack of Efficacy|0|||
94535332|NCT02589665|323756212|FG002|Induction Extension Period|Lack of Efficacy|0|||
94535333|NCT02589665|323756213|FG003|Induction Extension Period|Lack of Efficacy|0|||
94535334|NCT02589665|323756214|FG004|Induction Extension Period|Lack of Efficacy|0|||
94535335|NCT02589665|323756215|FG005|Induction Extension Period|Lack of Efficacy|0|||
94535336|NCT02589665|323756216|FG006|Induction Extension Period|Lack of Efficacy|0|||
94535337|NCT02589665|323756217|FG007|Induction Extension Period|Lack of Efficacy|0|||
94535338|NCT02589665|323756218|FG008|Induction Extension Period|Lack of Efficacy|3|||
94535339|NCT02589665|323756219|FG009|Induction Extension Period|Lack of Efficacy|0|||
94535340|NCT02589665|323756210|FG000|Induction Extension Period|Withdrawal by Subject|0|||
94535341|NCT02589665|323756211|FG001|Induction Extension Period|Withdrawal by Subject|0|||
94535342|NCT02589665|323756212|FG002|Induction Extension Period|Withdrawal by Subject|0|||
94535343|NCT02589665|323756213|FG003|Induction Extension Period|Withdrawal by Subject|0|||
94535344|NCT02589665|323756214|FG004|Induction Extension Period|Withdrawal by Subject|0|||
94535345|NCT02589665|323756215|FG005|Induction Extension Period|Withdrawal by Subject|0|||
94535346|NCT02589665|323756216|FG006|Induction Extension Period|Withdrawal by Subject|0|||
94535347|NCT02589665|323756217|FG007|Induction Extension Period|Withdrawal by Subject|2|||
94535348|NCT02589665|323756218|FG008|Induction Extension Period|Withdrawal by Subject|3|||
94535349|NCT02589665|323756219|FG009|Induction Extension Period|Withdrawal by Subject|0|||
94535350|NCT02589665|323756210|FG000|Induction Extension Period|Physician Decision|0|||
94535351|NCT02589665|323756211|FG001|Induction Extension Period|Physician Decision|0|||
94535352|NCT02589665|323756212|FG002|Induction Extension Period|Physician Decision|0|||
94535353|NCT02589665|323756213|FG003|Induction Extension Period|Physician Decision|0|||
94535354|NCT02589665|323756214|FG004|Induction Extension Period|Physician Decision|0|||
94535355|NCT02589665|323756215|FG005|Induction Extension Period|Physician Decision|0|||
94535356|NCT02589665|323756216|FG006|Induction Extension Period|Physician Decision|0|||
94535357|NCT02589665|323756217|FG007|Induction Extension Period|Physician Decision|0|||
94535358|NCT02589665|323756218|FG008|Induction Extension Period|Physician Decision|1|||
94535359|NCT02589665|323756219|FG009|Induction Extension Period|Physician Decision|0|||
94535360|NCT02589665|323756210|FG000|Induction Extension Period|Reason Not Collected|0|||
94535361|NCT02589665|323756211|FG001|Induction Extension Period|Reason Not Collected|0|||
94535362|NCT02589665|323756212|FG002|Induction Extension Period|Reason Not Collected|0|||
94535363|NCT02589665|323756213|FG003|Induction Extension Period|Reason Not Collected|0|||
94535364|NCT02589665|323756214|FG004|Induction Extension Period|Reason Not Collected|0|||
94535365|NCT02589665|323756215|FG005|Induction Extension Period|Reason Not Collected|0|||
94535366|NCT02589665|323756216|FG006|Induction Extension Period|Reason Not Collected|0|||
94535367|NCT02589665|323756217|FG007|Induction Extension Period|Reason Not Collected|0|||
94535368|NCT02589665|323756218|FG008|Induction Extension Period|Reason Not Collected|1|||
94535369|NCT02589665|323756219|FG009|Induction Extension Period|Reason Not Collected|0|||
94535370|NCT02589665|323756210|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
94535371|NCT02589665|323756211|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
94535372|NCT02589665|323756212|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
94535373|NCT02589665|323756213|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
94535374|NCT02589665|323756214|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
94535375|NCT02589665|323756215|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
94535376|NCT02589665|323756216|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
94535377|NCT02589665|323756217|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
94535378|NCT02589665|323756218|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
94535379|NCT02589665|323756219|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
94535380|NCT02589665|323756210|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
94535381|NCT02589665|323756211|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
94535382|NCT02589665|323756212|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
94535383|NCT02589665|323756213|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
94535384|NCT02589665|323756214|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
94535385|NCT02589665|323756215|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
94535386|NCT02589665|323756216|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
94535387|NCT02589665|323756217|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
94535388|NCT02589665|323756218|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
94535389|NCT02589665|323756219|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
94535390|NCT02589665|323756210|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
94535391|NCT02589665|323756211|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
94535392|NCT02589665|323756212|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
94535393|NCT02589665|323756213|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
94535394|NCT02589665|323756214|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
94535395|NCT02589665|323756215|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
94535396|NCT02589665|323756216|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
94535397|NCT02589665|323756217|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
94535398|NCT02589665|323756218|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
94535399|NCT02589665|323756219|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
94535400|NCT02589665|323756210|FG000|Maintenance Extension Period|Adverse Event|0|||
94535401|NCT02589665|323756211|FG001|Maintenance Extension Period|Adverse Event|0|||
94535402|NCT02589665|323756212|FG002|Maintenance Extension Period|Adverse Event|0|||
94535403|NCT02589665|323756213|FG003|Maintenance Extension Period|Adverse Event|0|||
94535404|NCT02589665|323756214|FG004|Maintenance Extension Period|Adverse Event|0|||
94535405|NCT02589665|323756215|FG005|Maintenance Extension Period|Adverse Event|0|||
94535406|NCT02589665|323756216|FG006|Maintenance Extension Period|Adverse Event|0|||
94535407|NCT02589665|323756217|FG007|Maintenance Extension Period|Adverse Event|0|||
94535408|NCT02589665|323756218|FG008|Maintenance Extension Period|Adverse Event|0|||
94535409|NCT02589665|323756219|FG009|Maintenance Extension Period|Adverse Event|2|||
94535410|NCT02589665|323756210|FG000|Maintenance Extension Period|Non-responder|0|||
94535411|NCT02589665|323756211|FG001|Maintenance Extension Period|Non-responder|0|||
94535412|NCT02589665|323756212|FG002|Maintenance Extension Period|Non-responder|0|||
94535413|NCT02589665|323756213|FG003|Maintenance Extension Period|Non-responder|0|||
94535414|NCT02589665|323756214|FG004|Maintenance Extension Period|Non-responder|0|||
94535415|NCT02589665|323756215|FG005|Maintenance Extension Period|Non-responder|0|||
94535416|NCT02589665|323756216|FG006|Maintenance Extension Period|Non-responder|0|||
94535417|NCT02589665|323756217|FG007|Maintenance Extension Period|Non-responder|0|||
94535418|NCT02589665|323756218|FG008|Maintenance Extension Period|Non-responder|0|||
94535419|NCT02589665|323756219|FG009|Maintenance Extension Period|Non-responder|1|||
94535420|NCT00978380|323756220|FG000|Overall Study|Protocol Violation|2|||
94535421|NCT00978380|323756220|FG000|Overall Study|Withdrawal criteria|9|||
94535422|NCT00978380|323756220|FG000|Overall Study|Unclassified|8|||
94535423|NCT02199314|323756223|FG000|Overall Study|Withdrawal by Subject|6|||
94535424|NCT02199314|323756223|FG000|Overall Study|Physician Decision|10|||
94535425|NCT01044745|323756224|FG000|Overall Study|Ineiligible|2|||
94535426|NCT01892436|323756225|FG000|Overall Study|Withdrawal by Subject|8|||
94535427|NCT01892436|323756226|FG001|Overall Study|Withdrawal by Subject|15|||
94535428|NCT01892436|323756227|FG002|Overall Study|Withdrawal by Subject|4|||
94535429|NCT01892436|323756228|FG003|Overall Study|Withdrawal by Subject|4|||
94535430|NCT01892436|323756225|FG000|Overall Study|Death|1|||
94535431|NCT01892436|323756226|FG001|Overall Study|Death|1|||
94535432|NCT01892436|323756227|FG002|Overall Study|Death|0|||
94535433|NCT01892436|323756228|FG003|Overall Study|Death|0|||
94535434|NCT01892436|323756225|FG000|Overall Study|Physician Decision|2|||
94535435|NCT01892436|323756226|FG001|Overall Study|Physician Decision|1|||
94535436|NCT01892436|323756227|FG002|Overall Study|Physician Decision|0|||
94535437|NCT01892436|323756228|FG003|Overall Study|Physician Decision|1|||
94535438|NCT01892436|323756225|FG000|Overall Study|Pregnancy|0|||
94535439|NCT01892436|323756226|FG001|Overall Study|Pregnancy|2|||
94535440|NCT01892436|323756227|FG002|Overall Study|Pregnancy|1|||
94535441|NCT01892436|323756228|FG003|Overall Study|Pregnancy|0|||
94535442|NCT01892436|323756225|FG000|Overall Study|Technical problems|2|||
94535443|NCT01892436|323756226|FG001|Overall Study|Technical problems|1|||
94535444|NCT01892436|323756227|FG002|Overall Study|Technical problems|1|||
94535445|NCT01892436|323756228|FG003|Overall Study|Technical problems|1|||
94535446|NCT01892436|323756225|FG000|Overall Study|Lack of Efficacy|1|||
94535447|NCT01892436|323756226|FG001|Overall Study|Lack of Efficacy|2|||
94535448|NCT01892436|323756227|FG002|Overall Study|Lack of Efficacy|2|||
94535449|NCT01892436|323756228|FG003|Overall Study|Lack of Efficacy|2|||
94535450|NCT01892436|323756225|FG000|Overall Study|Lost to Follow-up|1|||
94535451|NCT01892436|323756226|FG001|Overall Study|Lost to Follow-up|1|||
94535452|NCT01892436|323756227|FG002|Overall Study|Lost to Follow-up|1|||
94535453|NCT01892436|323756228|FG003|Overall Study|Lost to Follow-up|3|||
94535454|NCT01892436|323756225|FG000|Overall Study|non-compliance with treatment|1|||
94535455|NCT01892436|323756226|FG001|Overall Study|non-compliance with treatment|0|||
94535456|NCT01892436|323756227|FG002|Overall Study|non-compliance with treatment|0|||
94535457|NCT01892436|323756228|FG003|Overall Study|non-compliance with treatment|0|||
94535458|NCT01892436|323756225|FG000|Overall Study|Adverse Event|7|||
94535459|NCT01892436|323756226|FG001|Overall Study|Adverse Event|6|||
94535460|NCT01892436|323756227|FG002|Overall Study|Adverse Event|2|||
94535461|NCT01892436|323756228|FG003|Overall Study|Adverse Event|3|||
94535462|NCT01089413|323756232|FG000|Overall Study|Lost to Follow-up|1|||
94535463|NCT01089413|323756232|FG000|Overall Study|Progressive Disease|93|||
94535464|NCT01089413|323756232|FG000|Overall Study|Participant Withdrew Consent|1|||
94535465|NCT01089413|323756232|FG000|Overall Study|Unacceptable Toxicity|12|||
94535466|NCT01089413|323756232|FG000|Overall Study|Death|10|||
94535467|NCT01089413|323756232|FG000|Overall Study|Metastasectomy|13|||
94535468|NCT01089413|323756232|FG000|Overall Study|Other|71|||
94535469|NCT02513485|323756233|FG000|Overall Study|Adverse Event|1|||
94535470|NCT02513485|323756234|FG001|Overall Study|Adverse Event|0|||
94535471|NCT00470093|323756235|FG000|Overall Study|Adverse Event|2|||
94535472|NCT00664560|323756236|FG000|Overall Study|Adverse Event|19|||
94535473|NCT00664560|323756237|FG001|Overall Study|Adverse Event|16|||
94535474|NCT00664560|323756238|FG002|Overall Study|Adverse Event|7|||
94535475|NCT00664560|323756236|FG000|Overall Study|Withdrawal by Subject|9|||
94535476|NCT00664560|323756237|FG001|Overall Study|Withdrawal by Subject|13|||
94535477|NCT00664560|323756238|FG002|Overall Study|Withdrawal by Subject|7|||
94535478|NCT00664560|323756236|FG000|Overall Study|Lost to Follow-up|0|||
94535479|NCT00664560|323756237|FG001|Overall Study|Lost to Follow-up|2|||
94535480|NCT00664560|323756238|FG002|Overall Study|Lost to Follow-up|0|||
94535481|NCT00664560|323756236|FG000|Overall Study|Other|11|||
94535482|NCT00664560|323756237|FG001|Overall Study|Other|4|||
94535483|NCT00664560|323756238|FG002|Overall Study|Other|5|||
94535484|NCT00519376|323756241|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
94535485|NCT00519376|323756242|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
94535486|NCT00519376|323756243|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
94535487|NCT00519376|323756244|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
94535488|NCT00519376|323756245|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
94535489|NCT00519376|323756246|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
94535490|NCT00519376|323756247|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
94535491|NCT00519376|323756248|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
94535492|NCT00519376|323756249|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
94535493|NCT00519376|323756250|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
94535494|NCT00519376|323756251|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
94535495|NCT00519376|323756252|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
94535496|NCT00519376|323756253|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
94535497|NCT00519376|323756254|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
94535498|NCT00519376|323756255|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
94535499|NCT00519376|323756256|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
94535500|NCT00519376|323756241|FG000|Treatment Period 4|Lost to Follow-up|0|||
94535501|NCT00519376|323756242|FG001|Treatment Period 4|Lost to Follow-up|0|||
94535502|NCT00519376|323756243|FG002|Treatment Period 4|Lost to Follow-up|1|||
94535503|NCT00519376|323756244|FG003|Treatment Period 4|Lost to Follow-up|0|||
94535504|NCT00519376|323756245|FG004|Treatment Period 4|Lost to Follow-up|0|||
94535505|NCT00519376|323756246|FG005|Treatment Period 4|Lost to Follow-up|0|||
94535506|NCT00519376|323756247|FG006|Treatment Period 4|Lost to Follow-up|0|||
94535507|NCT00519376|323756248|FG007|Treatment Period 4|Lost to Follow-up|0|||
94535508|NCT00519376|323756249|FG008|Treatment Period 4|Lost to Follow-up|0|||
94535509|NCT00519376|323756250|FG009|Treatment Period 4|Lost to Follow-up|0|||
94535510|NCT00519376|323756251|FG010|Treatment Period 4|Lost to Follow-up|0|||
94535511|NCT00519376|323756252|FG011|Treatment Period 4|Lost to Follow-up|0|||
94535512|NCT00519376|323756253|FG012|Treatment Period 4|Lost to Follow-up|0|||
94535513|NCT00519376|323756254|FG013|Treatment Period 4|Lost to Follow-up|0|||
94535514|NCT00519376|323756255|FG014|Treatment Period 4|Lost to Follow-up|0|||
94535515|NCT00519376|323756256|FG015|Treatment Period 4|Lost to Follow-up|0|||
94535516|NCT02039219|323756257|FG000|Treatment|Withdrawal by Subject|1|||
94535517|NCT02039219|323756258|FG001|Treatment|Withdrawal by Subject|0|||
94535518|NCT02039219|323756257|FG000|Treatment|Adverse Event|0|||
94535519|NCT02039219|323756258|FG001|Treatment|Adverse Event|1|||
94535520|NCT02039219|323756257|FG000|Treatment|Physician Decision|1|||
94535521|NCT02039219|323756258|FG001|Treatment|Physician Decision|0|||
94535522|NCT02039219|323756257|FG000|Treatment|Lost to Follow-up|0|||
94535523|NCT02039219|323756258|FG001|Treatment|Lost to Follow-up|1|||
94535524|NCT02039219|323756257|FG000|Treatment|Protocol Violation|1|||
94535525|NCT02039219|323756258|FG001|Treatment|Protocol Violation|0|||
94535526|NCT02039219|323756257|FG000|Treatment|Death|1|||
94535527|NCT02039219|323756258|FG001|Treatment|Death|0|||
94535528|NCT02039219|323756257|FG000|Follow up|Adverse Event|0|||
94535529|NCT02039219|323756258|FG001|Follow up|Adverse Event|1|||
94535530|NCT00730041|323756259|FG000|Overall Study|Lost to Follow-up|0|||
94535531|NCT00730041|323756260|FG001|Overall Study|Lost to Follow-up|2|||
94535532|NCT01988662|323756261|FG000|Overall Study|Subject/guardian decision|1|||
94535533|NCT01988662|323756262|FG001|Overall Study|Subject/guardian decision|1|||
94535534|NCT01988662|323756261|FG000|Overall Study|Adverse Event|3|||
94535535|NCT01988662|323756262|FG001|Overall Study|Adverse Event|1|||
94535536|NCT01498575|323756263|FG000|Overall Sample|Withdrawal by Subject|60|||
94535537|NCT01498575|323756264|FG001|Overall Sample|Withdrawal by Subject|14|||
94535538|NCT01498575|323756263|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
94535539|NCT01498575|323756264|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
94535540|NCT01498575|323756263|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
94535541|NCT01498575|323756264|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
94535542|NCT03575065|323756268|FG000|Overall Study|Death|31|||
94535543|NCT03575065|323756269|FG001|Overall Study|Death|12|||
94535544|NCT03575065|323756268|FG000|Overall Study|Sponsor's Decision|28|||
94535545|NCT03575065|323756269|FG001|Overall Study|Sponsor's Decision|13|||
94535546|NCT03575065|323756268|FG000|Overall Study|Withdrawal by Subject|2|||
94535547|NCT03575065|323756269|FG001|Overall Study|Withdrawal by Subject|1|||
94535548|NCT03575065|323756268|FG000|Overall Study|Lost to Follow-up|1|||
94535549|NCT03575065|323756269|FG001|Overall Study|Lost to Follow-up|0|||
94535550|NCT01685801|323756274|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
94535551|NCT01685801|323756275|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
94535552|NCT01685801|323756276|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
94535553|NCT01685801|323756277|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
94535554|NCT01685801|323756274|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
94535555|NCT01685801|323756275|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
94535556|NCT01685801|323756276|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
94535557|NCT01685801|323756277|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
94535558|NCT01165320|323756280|FG000|Overall Study|Clinical adverse experience|2|||
94535559|NCT01165320|323756281|FG001|Overall Study|Clinical adverse experience|1|||
94535560|NCT01165320|323756282|FG002|Overall Study|Clinical adverse experience|0|||
94535561|NCT01165320|323756280|FG000|Overall Study|Laboratory adverse experience|1|||
94535562|NCT01165320|323756281|FG001|Overall Study|Laboratory adverse experience|0|||
94535563|NCT01165320|323756282|FG002|Overall Study|Laboratory adverse experience|0|||
94535564|NCT01165320|323756280|FG000|Overall Study|Lack of Efficacy|0|||
94535565|NCT01165320|323756281|FG001|Overall Study|Lack of Efficacy|2|||
94535566|NCT01165320|323756282|FG002|Overall Study|Lack of Efficacy|0|||
94535567|NCT01165320|323756280|FG000|Overall Study|Reason unknown|0|||
94535568|NCT01165320|323756281|FG001|Overall Study|Reason unknown|1|||
94535569|NCT01165320|323756282|FG002|Overall Study|Reason unknown|0|||
94535570|NCT01229254|323756287|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
94535571|NCT01229254|323756288|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
94535572|NCT01229254|323756289|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
94535573|NCT01229254|323756287|FG000|Overall Study|Adverse Event|4|||
94535574|NCT01229254|323756288|FG001|Overall Study|Adverse Event|5|||
94535575|NCT01229254|323756289|FG002|Overall Study|Adverse Event|3|||
94535576|NCT01229254|323756287|FG000|Overall Study|Lost to Follow-up|3|||
94535577|NCT01229254|323756288|FG001|Overall Study|Lost to Follow-up|0|||
94535578|NCT01229254|323756289|FG002|Overall Study|Lost to Follow-up|1|||
94535579|NCT01229254|323756287|FG000|Overall Study|Physician Decision|0|||
94535580|NCT01229254|323756288|FG001|Overall Study|Physician Decision|3|||
94535581|NCT01229254|323756289|FG002|Overall Study|Physician Decision|0|||
94535582|NCT01229254|323756287|FG000|Overall Study|Protocol Violation|4|||
94535583|NCT01229254|323756288|FG001|Overall Study|Protocol Violation|6|||
94535584|NCT01229254|323756289|FG002|Overall Study|Protocol Violation|5|||
94535585|NCT01229254|323756287|FG000|Overall Study|Withdrawal by Subject|1|||
94535586|NCT01229254|323756288|FG001|Overall Study|Withdrawal by Subject|0|||
94535587|NCT01229254|323756289|FG002|Overall Study|Withdrawal by Subject|1|||
94535588|NCT01229254|323756287|FG000|Overall Study|Non-compliance with Study Drug|0|||
94535589|NCT01229254|323756288|FG001|Overall Study|Non-compliance with Study Drug|1|||
94535590|NCT01229254|323756289|FG002|Overall Study|Non-compliance with Study Drug|1|||
94535591|NCT02231892|323756290|FG000|Overall Study|Lost to Follow-up|1|||
94535592|NCT02231892|323756291|FG001|Overall Study|Lost to Follow-up|0|||
94535593|NCT02231892|323756292|FG002|Overall Study|Lost to Follow-up|3|||
94535594|NCT02231892|323756290|FG000|Overall Study|Withdrawal by Subject|4|||
94535595|NCT02231892|323756291|FG001|Overall Study|Withdrawal by Subject|3|||
94535596|NCT02231892|323756292|FG002|Overall Study|Withdrawal by Subject|15|||
94535597|NCT02231892|323756290|FG000|Overall Study|Physician Decision|0|||
94535598|NCT02231892|323756291|FG001|Overall Study|Physician Decision|2|||
94535599|NCT02231892|323756292|FG002|Overall Study|Physician Decision|4|||
94535600|NCT02231892|323756290|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
94535601|NCT02231892|323756291|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
94535602|NCT02231892|323756292|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
94535603|NCT02231892|323756290|FG000|Overall Study|Participant motor threshold was >83%|0|||
94535604|NCT02231892|323756291|FG001|Overall Study|Participant motor threshold was >83%|0|||
94535605|NCT02231892|323756292|FG002|Overall Study|Participant motor threshold was >83%|9|||
94535606|NCT02231892|323756290|FG000|Overall Study|Could not find motor threshold|2|||
94535607|NCT02231892|323756291|FG001|Overall Study|Could not find motor threshold|0|||
94535608|NCT02231892|323756292|FG002|Overall Study|Could not find motor threshold|1|||
94535609|NCT02231892|323756290|FG000|Overall Study|Could not find reliable motor hotspot|0|||
94535610|NCT02231892|323756291|FG001|Overall Study|Could not find reliable motor hotspot|0|||
94535611|NCT02231892|323756292|FG002|Overall Study|Could not find reliable motor hotspot|1|||
94535612|NCT01923363|323756293|FG000|Overall Study|Protocol Violation|1|||
94535613|NCT00521599|323756294|FG000|Overall Study|Adverse Event|5|||
94535614|NCT00521599|323756295|FG001|Overall Study|Adverse Event|7|||
94535615|NCT00521599|323756296|FG002|Overall Study|Adverse Event|6|||
94535616|NCT00521599|323756294|FG000|Overall Study|Treatment Failure|8|||
94535617|NCT00521599|323756295|FG001|Overall Study|Treatment Failure|9|||
94535618|NCT00521599|323756296|FG002|Overall Study|Treatment Failure|22|||
94535619|NCT00521599|323756294|FG000|Overall Study|Lost to Follow-up|2|||
94535620|NCT00521599|323756295|FG001|Overall Study|Lost to Follow-up|1|||
94535621|NCT00521599|323756296|FG002|Overall Study|Lost to Follow-up|2|||
94535622|NCT00521599|323756294|FG000|Overall Study|Withdrawal by Subject|3|||
94535623|NCT00521599|323756295|FG001|Overall Study|Withdrawal by Subject|5|||
94535624|NCT00521599|323756296|FG002|Overall Study|Withdrawal by Subject|1|||
94535625|NCT00521599|323756294|FG000|Overall Study|Withdrawal by subject treatment related|3|||
94535626|NCT00521599|323756295|FG001|Overall Study|Withdrawal by subject treatment related|1|||
94535627|NCT00521599|323756296|FG002|Overall Study|Withdrawal by subject treatment related|2|||
94535628|NCT00521599|323756294|FG000|Overall Study|Protocol Violation|2|||
94535629|NCT00521599|323756295|FG001|Overall Study|Protocol Violation|4|||
94535630|NCT00521599|323756296|FG002|Overall Study|Protocol Violation|2|||
94535631|NCT00521599|323756294|FG000|Overall Study|Did not meet protocol eligibility|2|||
94535632|NCT00521599|323756295|FG001|Overall Study|Did not meet protocol eligibility|2|||
94535633|NCT00521599|323756296|FG002|Overall Study|Did not meet protocol eligibility|1|||
94535634|NCT00578877|323756302|FG000|Overall Study|Lost to Follow-up|8|||
94535635|NCT00578877|323756303|FG001|Overall Study|Lost to Follow-up|10|||
94535636|NCT00578877|323756302|FG000|Overall Study|early discontinue|61|||
94535637|NCT00578877|323756303|FG001|Overall Study|early discontinue|101|||
94535638|NCT00578877|323756302|FG000|Overall Study|did not provide follow-up data|12|||
94535639|NCT00578877|323756303|FG001|Overall Study|did not provide follow-up data|17|||
94535640|NCT05032690|323756312|FG000|Period 1|Adverse Event|0|||
94535641|NCT05032690|323756313|FG001|Period 1|Adverse Event|1|||
94535642|NCT05032690|323756314|FG002|Period 1|Adverse Event|0|||
94535643|NCT05032690|323756315|FG003|Period 1|Adverse Event|0|||
94535644|NCT05032690|323756312|FG000|Period 1|Withdrawal by Subject|1|||
94535645|NCT05032690|323756313|FG001|Period 1|Withdrawal by Subject|0|||
94535646|NCT05032690|323756314|FG002|Period 1|Withdrawal by Subject|0|||
94535647|NCT05032690|323756315|FG003|Period 1|Withdrawal by Subject|0|||
94535648|NCT05032690|323756312|FG000|Period 1|No longer meets eligibility criteria|0|||
94535649|NCT05032690|323756313|FG001|Period 1|No longer meets eligibility criteria|1|||
94535650|NCT05032690|323756314|FG002|Period 1|No longer meets eligibility criteria|0|||
94535651|NCT05032690|323756315|FG003|Period 1|No longer meets eligibility criteria|0|||
94535652|NCT05032690|323756312|FG000|Period 2|Adverse Event|1|||
94535653|NCT05032690|323756313|FG001|Period 2|Adverse Event|0|||
94535654|NCT05032690|323756314|FG002|Period 2|Adverse Event|0|||
94535655|NCT05032690|323756315|FG003|Period 2|Adverse Event|0|||
94535656|NCT05032690|323756312|FG000|Period 2|Withdrawal by Subject|0|||
94535657|NCT05032690|323756313|FG001|Period 2|Withdrawal by Subject|1|||
94535658|NCT05032690|323756314|FG002|Period 2|Withdrawal by Subject|0|||
94535659|NCT05032690|323756315|FG003|Period 2|Withdrawal by Subject|0|||
94535660|NCT05032690|323756312|FG000|Period 2|No longer meets eligibility criteria|0|||
94535661|NCT05032690|323756313|FG001|Period 2|No longer meets eligibility criteria|1|||
94535662|NCT05032690|323756314|FG002|Period 2|No longer meets eligibility criteria|0|||
94535663|NCT05032690|323756315|FG003|Period 2|No longer meets eligibility criteria|0|||
94535664|NCT05032690|323756312|FG000|Period 3|Adverse Event|0|||
94535665|NCT05032690|323756313|FG001|Period 3|Adverse Event|1|||
94535666|NCT05032690|323756314|FG002|Period 3|Adverse Event|0|||
94535667|NCT05032690|323756315|FG003|Period 3|Adverse Event|0|||
94535668|NCT01357161|323756316|FG000|Part 1 (Open Label Run-in)|Death|5|||
94535669|NCT01357161|323756317|FG001|Part 1 (Open Label Run-in)|Death|0|||
94535670|NCT01357161|323756318|FG002|Part 1 (Open Label Run-in)|Death|0|||
94535671|NCT01357161|323756316|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
94535672|NCT01357161|323756317|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
94535673|NCT01357161|323756318|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
94535674|NCT01357161|323756316|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
94535675|NCT01357161|323756317|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
94535676|NCT01357161|323756318|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
94535677|NCT01357161|323756316|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
94535678|NCT01357161|323756317|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
94535679|NCT01357161|323756318|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
94535680|NCT01357161|323756316|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
94535681|NCT01357161|323756317|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
94535682|NCT01357161|323756318|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
94535683|NCT01357161|323756316|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
94535684|NCT01357161|323756317|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
94535685|NCT01357161|323756318|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
94535686|NCT01357161|323756316|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
94535687|NCT01357161|323756317|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
94535688|NCT01357161|323756318|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
94535689|NCT01357161|323756316|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
94535690|NCT01357161|323756317|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
94535691|NCT01357161|323756318|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
94535692|NCT01357161|323756316|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
94535693|NCT01357161|323756317|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
94535694|NCT01357161|323756318|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
94535695|NCT01357161|323756316|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
94535696|NCT01357161|323756317|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
94535697|NCT01357161|323756318|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
94535698|NCT01357161|323756316|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
94535699|NCT01357161|323756317|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
94535700|NCT01357161|323756318|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
94535701|NCT03319953|323756319|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
94535702|NCT03319953|323756320|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
94535703|NCT03319953|323756321|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
94535704|NCT03319953|323756322|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
94535705|NCT03319953|323756319|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
94535706|NCT03319953|323756320|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
94535707|NCT03319953|323756321|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
94535708|NCT03319953|323756322|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
94535709|NCT02438384|323756323|FG000|Overall Study|Lost to Follow-up|8|||
94535710|NCT02438384|323756324|FG001|Overall Study|Lost to Follow-up|6|||
94535711|NCT02438384|323756325|FG002|Overall Study|Lost to Follow-up|4|||
94535712|NCT00098748|323756326|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
94535713|NCT00098748|323756327|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
94535714|NCT00098748|323756328|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
94535715|NCT00098748|323756326|FG000|Received Study Treatment|Death|2|||
94535716|NCT00098748|323756327|FG001|Received Study Treatment|Death|1|||
94535717|NCT00098748|323756328|FG002|Received Study Treatment|Death|2|||
94535718|NCT00098748|323756326|FG000|Received Study Treatment|Adverse Event|1|||
94535719|NCT00098748|323756327|FG001|Received Study Treatment|Adverse Event|2|||
94535720|NCT00098748|323756328|FG002|Received Study Treatment|Adverse Event|5|||
94535721|NCT00098748|323756326|FG000|Received Study Treatment|Lack of Efficacy|40|||
94535722|NCT00098748|323756327|FG001|Received Study Treatment|Lack of Efficacy|27|||
94535723|NCT00098748|323756328|FG002|Received Study Treatment|Lack of Efficacy|27|||
94535724|NCT00098748|323756326|FG000|Received Study Treatment|Other|2|||
94535725|NCT00098748|323756327|FG001|Received Study Treatment|Other|2|||
94535726|NCT00098748|323756328|FG002|Received Study Treatment|Other|6|||
94535727|NCT00098748|323756326|FG000|Received Study Treatment|Subject defaulted|3|||
94535728|NCT00098748|323756327|FG001|Received Study Treatment|Subject defaulted|4|||
94535729|NCT00098748|323756328|FG002|Received Study Treatment|Subject defaulted|4|||
94535730|NCT00098748|323756326|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
94535731|NCT00098748|323756327|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
94535732|NCT00098748|323756328|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
94535733|NCT00098748|323756326|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
94535734|NCT00098748|323756327|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
94535735|NCT00098748|323756328|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
94535736|NCT00098748|323756326|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
94535737|NCT00098748|323756327|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
94535738|NCT00098748|323756328|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
94535739|NCT00098748|323756326|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
94535740|NCT00098748|323756327|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
94535741|NCT00098748|323756328|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
94535742|NCT00098748|323756326|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
94535743|NCT00098748|323756327|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
94535744|NCT00098748|323756328|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
94535745|NCT02264665|323758188|FG000|Overall Study|Other|0|||
94535746|NCT02264665|323758189|FG001|Overall Study|Other|0|||
94535747|NCT02264665|323758190|FG002|Overall Study|Other|3|||
94535748|NCT02264665|323758191|FG003|Overall Study|Other|0|||
94535749|NCT02264665|323758192|FG004|Overall Study|Other|0|||
94535750|NCT02264665|323758193|FG005|Overall Study|Other|0|||
94535751|NCT02264665|323758194|FG006|Overall Study|Other|0|||
94535752|NCT02264665|323758188|FG000|Overall Study|Death|9|||
94535753|NCT02264665|323758189|FG001|Overall Study|Death|8|||
94535754|NCT02264665|323758190|FG002|Overall Study|Death|13|||
94535755|NCT02264665|323758191|FG003|Overall Study|Death|5|||
94535756|NCT02264665|323758192|FG004|Overall Study|Death|0|||
94535757|NCT02264665|323758193|FG005|Overall Study|Death|0|||
94535758|NCT02264665|323758194|FG006|Overall Study|Death|1|||
94535759|NCT02264665|323758188|FG000|Overall Study|Lost to Follow-up|1|||
94535760|NCT02264665|323758189|FG001|Overall Study|Lost to Follow-up|0|||
94535761|NCT02264665|323758190|FG002|Overall Study|Lost to Follow-up|2|||
94535762|NCT02264665|323758191|FG003|Overall Study|Lost to Follow-up|1|||
94535763|NCT02264665|323758192|FG004|Overall Study|Lost to Follow-up|0|||
94535764|NCT02264665|323758193|FG005|Overall Study|Lost to Follow-up|0|||
94535765|NCT02264665|323758194|FG006|Overall Study|Lost to Follow-up|0|||
94535766|NCT02264665|323758188|FG000|Overall Study|Participant decision|0|||
94535767|NCT02264665|323758189|FG001|Overall Study|Participant decision|0|||
94535768|NCT02264665|323758190|FG002|Overall Study|Participant decision|0|||
94535769|NCT02264665|323758191|FG003|Overall Study|Participant decision|1|||
94535770|NCT02264665|323758192|FG004|Overall Study|Participant decision|0|||
94535771|NCT02264665|323758193|FG005|Overall Study|Participant decision|0|||
94535772|NCT02264665|323758194|FG006|Overall Study|Participant decision|0|||
94535773|NCT02264665|323758188|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
94535774|NCT02264665|323758189|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
94535775|NCT02264665|323758190|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
94535776|NCT02264665|323758191|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
94535777|NCT02264665|323758192|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
94535778|NCT02264665|323758193|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
94535779|NCT02264665|323758194|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
94535780|NCT02264665|323758188|FG000|Overall Study|Data Missing|0|||
94535781|NCT02264665|323758189|FG001|Overall Study|Data Missing|0|||
94535782|NCT02264665|323758190|FG002|Overall Study|Data Missing|1|||
94535783|NCT02264665|323758191|FG003|Overall Study|Data Missing|0|||
94535784|NCT02264665|323758192|FG004|Overall Study|Data Missing|0|||
94535785|NCT02264665|323758193|FG005|Overall Study|Data Missing|0|||
94535786|NCT02264665|323758194|FG006|Overall Study|Data Missing|0|||
94535787|NCT00489424|323758197|FG000|Overall Study|Adverse Event|3|||
94535788|NCT00489424|323758198|FG001|Overall Study|Adverse Event|3|||
94535789|NCT00489424|323758199|FG002|Overall Study|Adverse Event|4|||
94535790|NCT00489424|323758197|FG000|Overall Study|Lack of Efficacy|1|||
94535791|NCT00489424|323758198|FG001|Overall Study|Lack of Efficacy|0|||
94535792|NCT00489424|323758199|FG002|Overall Study|Lack of Efficacy|0|||
94535793|NCT00489424|323758197|FG000|Overall Study|Administrative problems|0|||
94535794|NCT00489424|323758198|FG001|Overall Study|Administrative problems|2|||
94535795|NCT00489424|323758199|FG002|Overall Study|Administrative problems|1|||
94535796|NCT01466660|323758209|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
94535797|NCT01466660|323758210|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
94535798|NCT01466660|323758209|FG000|Overall Study|Worsening of underlying cancer disease|5|||
94535799|NCT01466660|323758210|FG001|Overall Study|Worsening of underlying cancer disease|2|||
94535800|NCT01466660|323758209|FG000|Overall Study|Other adverse event|19|||
94535801|NCT01466660|323758210|FG001|Overall Study|Other adverse event|18|||
94535802|NCT01466660|323758209|FG000|Overall Study|Protocol Violation|2|||
94535803|NCT01466660|323758210|FG001|Overall Study|Protocol Violation|1|||
94535804|NCT01466660|323758209|FG000|Overall Study|Refused continuation of trial medication|4|||
94535805|NCT01466660|323758210|FG001|Overall Study|Refused continuation of trial medication|3|||
94535806|NCT01466660|323758209|FG000|Overall Study|Other reason not defined above|10|||
94535807|NCT01466660|323758210|FG001|Overall Study|Other reason not defined above|8|||
94535808|NCT03576066|323758211|FG000|Overall Study|Noncompliance with study drug|0|||
94535809|NCT03576066|323758212|FG001|Overall Study|Noncompliance with study drug|1|||
94535810|NCT00191724|323758213|FG000|Overall Study|Adverse Event|0|||
94535811|NCT00191724|323758214|FG001|Overall Study|Adverse Event|0|||
94535812|NCT00191724|323758215|FG002|Overall Study|Adverse Event|1|||
94535813|NCT00191724|323758216|FG003|Overall Study|Adverse Event|0|||
94535814|NCT00191724|323758217|FG004|Overall Study|Adverse Event|0|||
94535815|NCT00191724|323758213|FG000|Overall Study|Lost to Follow-up|1|||
94535816|NCT00191724|323758214|FG001|Overall Study|Lost to Follow-up|1|||
94535817|NCT00191724|323758215|FG002|Overall Study|Lost to Follow-up|0|||
94535818|NCT00191724|323758216|FG003|Overall Study|Lost to Follow-up|2|||
94535819|NCT00191724|323758217|FG004|Overall Study|Lost to Follow-up|3|||
94535820|NCT00191724|323758213|FG000|Overall Study|Withdrawal by Subject|0|||
94535821|NCT00191724|323758214|FG001|Overall Study|Withdrawal by Subject|0|||
94535822|NCT00191724|323758215|FG002|Overall Study|Withdrawal by Subject|0|||
94535823|NCT00191724|323758216|FG003|Overall Study|Withdrawal by Subject|1|||
94535824|NCT00191724|323758217|FG004|Overall Study|Withdrawal by Subject|0|||
94535825|NCT05260073|323758218|FG000|Overall Study|Physician Decision|1|||
94535826|NCT05260073|323758218|FG000|Overall Study|Withdrawal by Subject|6|||
94535827|NCT05260073|323758218|FG000|Overall Study|Lost to Follow-up|14|||
94535828|NCT02447250|323758222|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
94535829|NCT02447250|323758222|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
94535830|NCT02447250|323758222|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
94535831|NCT01328535|323758223|FG000|Overall Study|Ineligible|1|||
94535832|NCT01032291|323758229|FG000|Safety Lead-in|Adverse Event|1|||
94535833|NCT01032291|323758230|FG001|Safety Lead-in|Adverse Event|0|||
94535834|NCT01032291|323758231|FG002|Safety Lead-in|Adverse Event|0|||
94535835|NCT01032291|323758229|FG000|Safety Lead-in|Death|1|||
94535836|NCT01032291|323758230|FG001|Safety Lead-in|Death|0|||
94535837|NCT01032291|323758231|FG002|Safety Lead-in|Death|0|||
94535838|NCT01032291|323758229|FG000|Proof of Concept|Adverse Event|0|||
94535839|NCT01032291|323758230|FG001|Proof of Concept|Adverse Event|5|||
94535840|NCT01032291|323758231|FG002|Proof of Concept|Adverse Event|1|||
94535841|NCT01032291|323758229|FG000|Proof of Concept|Death|0|||
94535842|NCT01032291|323758230|FG001|Proof of Concept|Death|1|||
94535843|NCT01032291|323758231|FG002|Proof of Concept|Death|2|||
94535844|NCT01032291|323758229|FG000|Proof of Concept|Lack of Efficacy|0|||
94535845|NCT01032291|323758230|FG001|Proof of Concept|Lack of Efficacy|1|||
94535846|NCT01032291|323758231|FG002|Proof of Concept|Lack of Efficacy|0|||
94535847|NCT01032291|323758229|FG000|Proof of Concept|Never Received Study Drug|0|||
94535848|NCT01032291|323758230|FG001|Proof of Concept|Never Received Study Drug|1|||
94535849|NCT01032291|323758231|FG002|Proof of Concept|Never Received Study Drug|0|||
94535850|NCT02449889|323758232|FG000|Overall Study|Adverse Event|1|||
94535851|NCT02449889|323758233|FG001|Overall Study|Adverse Event|2|||
94535852|NCT02449889|323758234|FG002|Overall Study|Adverse Event|0|||
94535853|NCT02449889|323758232|FG000|Overall Study|Protocol Violation|0|||
94535854|NCT02449889|323758233|FG001|Overall Study|Protocol Violation|4|||
94535855|NCT02449889|323758234|FG002|Overall Study|Protocol Violation|1|||
94535856|NCT01257230|323758235|FG000|Overall Study|Not Treated|0|||
94535857|NCT01257230|323758236|FG001|Overall Study|Not Treated|0|||
94535858|NCT01257230|323758237|FG002|Overall Study|Not Treated|1|||
94535859|NCT01257230|323758235|FG000|Overall Study|Adverse Event|2|||
94535860|NCT01257230|323758236|FG001|Overall Study|Adverse Event|0|||
94535861|NCT01257230|323758237|FG002|Overall Study|Adverse Event|0|||
94535862|NCT01257230|323758235|FG000|Overall Study|Lack of Efficacy|0|||
94535863|NCT01257230|323758236|FG001|Overall Study|Lack of Efficacy|1|||
94535864|NCT01257230|323758237|FG002|Overall Study|Lack of Efficacy|0|||
94535865|NCT01257230|323758235|FG000|Overall Study|Protocol Violation|3|||
94535866|NCT01257230|323758236|FG001|Overall Study|Protocol Violation|0|||
94535867|NCT01257230|323758237|FG002|Overall Study|Protocol Violation|1|||
94535868|NCT01257230|323758235|FG000|Overall Study|Withdrawal by Subject|0|||
94535869|NCT01257230|323758236|FG001|Overall Study|Withdrawal by Subject|4|||
94535870|NCT01257230|323758237|FG002|Overall Study|Withdrawal by Subject|1|||
94535871|NCT01257230|323758235|FG000|Overall Study|Other reason not defined above|1|||
94535872|NCT01257230|323758236|FG001|Overall Study|Other reason not defined above|5|||
94535873|NCT01257230|323758237|FG002|Overall Study|Other reason not defined above|3|||
94535874|NCT01973387|323758238|FG000|Overall Study|Adverse Event|14|||
94535875|NCT01973387|323758239|FG001|Overall Study|Adverse Event|4|||
94535876|NCT01973387|323758238|FG000|Overall Study|Withdrawal by Subject|7|||
94535877|NCT01973387|323758239|FG001|Overall Study|Withdrawal by Subject|4|||
94535878|NCT01973387|323758238|FG000|Overall Study|Study terminated by sponsor|63|||
94535879|NCT01973387|323758239|FG001|Overall Study|Study terminated by sponsor|0|||
94535880|NCT01973387|323758238|FG000|Overall Study|Progressive disease or relapse|16|||
94535881|NCT01973387|323758239|FG001|Overall Study|Progressive disease or relapse|5|||
94535882|NCT01973387|323758238|FG000|Overall Study|Death|4|||
94535883|NCT01973387|323758239|FG001|Overall Study|Death|3|||
94535884|NCT01973387|323758238|FG000|Overall Study|Randomized, not treated|2|||
94535885|NCT01973387|323758239|FG001|Overall Study|Randomized, not treated|2|||
94535886|NCT00322023|323758240|FG000|Overall Study|various|0|||
94535887|NCT00322023|323758241|FG001|Overall Study|various|2|||
94535888|NCT00322023|323758242|FG002|Overall Study|various|6|||
94535889|NCT00758264|323758243|FG000|Active Phase|Withdrawal by Subject|0|||
94535890|NCT00758264|323758244|FG001|Active Phase|Withdrawal by Subject|0|||
94535891|NCT00758264|323758245|FG002|Active Phase|Withdrawal by Subject|1|||
94535892|NCT00758264|323758243|FG000|Active Phase|Lost to Follow-up|1|||
94535893|NCT00758264|323758244|FG001|Active Phase|Lost to Follow-up|0|||
94535894|NCT00758264|323758245|FG002|Active Phase|Lost to Follow-up|0|||
94535895|NCT00758264|323758243|FG000|Active Phase|Other|0|||
94535896|NCT00758264|323758244|FG001|Active Phase|Other|0|||
94535897|NCT00758264|323758245|FG002|Active Phase|Other|4|||
94535898|NCT03425006|323758248|FG000|Overall Study|Withdrawal by Subject|1|||
94535899|NCT03425006|323758248|FG000|Overall Study|Physician Decision|1|||
94535900|NCT03425006|323758248|FG000|Overall Study|Death|1|||
94535901|NCT01239381|323758249|FG000|Overall Study|Protocol Violation|1|||
94535902|NCT01239381|323758249|FG000|Overall Study|Withdrawal by Subject|1|||
94535903|NCT01846663|323758257|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
94535904|NCT01846663|323758258|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
94535905|NCT01846663|323758257|FG000|Overall Study|Withdrawal by Subject|1|||
94535906|NCT01846663|323758258|FG001|Overall Study|Withdrawal by Subject|0|||
94535907|NCT01846663|323758257|FG000|Overall Study|Adverse Event|1|||
94535908|NCT01846663|323758258|FG001|Overall Study|Adverse Event|2|||
94535909|NCT03077438|323758261|FG000|Overall Study|Protocol Violation|3|||
94535910|NCT03077438|323758262|FG001|Overall Study|Protocol Violation|5|||
94535911|NCT03077438|323758261|FG000|Overall Study|Withdrawal by Subject|3|||
94535912|NCT03077438|323758262|FG001|Overall Study|Withdrawal by Subject|6|||
94535913|NCT03077438|323758261|FG000|Overall Study|Lost to Follow-up|6|||
94535914|NCT03077438|323758262|FG001|Overall Study|Lost to Follow-up|3|||
94535915|NCT00543803|323758267|FG000|Overall Study|Adverse Event|14|||
94535916|NCT00543803|323758267|FG000|Overall Study|Lack of Efficacy|22|||
94535917|NCT00543803|323758267|FG000|Overall Study|Lost to Follow-up|20|||
94535918|NCT00543803|323758267|FG000|Overall Study|Other|86|||
94535919|NCT03333252|323758271|FG000|Overall Study|Adverse Event|10|||
94535920|NCT03333252|323758272|FG001|Overall Study|Adverse Event|6|||
94535921|NCT03333252|323758273|FG002|Overall Study|Adverse Event|5|||
94535922|NCT03333252|323758274|FG003|Overall Study|Adverse Event|2|||
94535923|NCT03333252|323758271|FG000|Overall Study|Death|1|||
94535924|NCT03333252|323758272|FG001|Overall Study|Death|3|||
94535925|NCT03333252|323758273|FG002|Overall Study|Death|0|||
94535926|NCT03333252|323758274|FG003|Overall Study|Death|0|||
94535927|NCT03333252|323758271|FG000|Overall Study|Lack of Efficacy|8|||
94535928|NCT03333252|323758272|FG001|Overall Study|Lack of Efficacy|4|||
94535929|NCT03333252|323758273|FG002|Overall Study|Lack of Efficacy|0|||
94535930|NCT03333252|323758274|FG003|Overall Study|Lack of Efficacy|7|||
94535931|NCT03333252|323758271|FG000|Overall Study|Lost to Follow-up|0|||
94535932|NCT03333252|323758272|FG001|Overall Study|Lost to Follow-up|5|||
94535933|NCT03333252|323758273|FG002|Overall Study|Lost to Follow-up|9|||
94535934|NCT03333252|323758274|FG003|Overall Study|Lost to Follow-up|3|||
94535935|NCT03333252|323758271|FG000|Overall Study|Withdrawal by Subject|14|||
94535936|NCT03333252|323758272|FG001|Overall Study|Withdrawal by Subject|24|||
94535937|NCT03333252|323758273|FG002|Overall Study|Withdrawal by Subject|11|||
94535938|NCT03333252|323758274|FG003|Overall Study|Withdrawal by Subject|17|||
94535939|NCT00778375|323758275|FG000|Overall Study|Ineligible|3|||
94535940|NCT01779856|323758276|FG000|Overall Study|Withdrawal by Subject|15|||
94535941|NCT01779856|323758276|FG000|Overall Study|Death|3|||
94535942|NCT01779856|323758276|FG000|Overall Study|Physician Decision|1|||
94535943|NCT01779856|323758276|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
94535944|NCT01779856|323758276|FG000|Overall Study|Delays in scheduling implant|1|||
94535945|NCT01779856|323758276|FG000|Overall Study|Subject ineligible for Implant|2|||
94535946|NCT02135029|323758279|FG000|Overall Study|Adverse Event|2|||
94535947|NCT02135029|323758280|FG001|Overall Study|Adverse Event|2|||
94535948|NCT02135029|323758281|FG002|Overall Study|Adverse Event|2|||
94535949|NCT02135029|323758279|FG000|Overall Study|Lost to Follow-up|0|||
94535950|NCT02135029|323758280|FG001|Overall Study|Lost to Follow-up|1|||
94535951|NCT02135029|323758281|FG002|Overall Study|Lost to Follow-up|0|||
94535952|NCT02135029|323758279|FG000|Overall Study|Withdrawal by Subject|2|||
94535953|NCT02135029|323758280|FG001|Overall Study|Withdrawal by Subject|0|||
94535954|NCT02135029|323758281|FG002|Overall Study|Withdrawal by Subject|1|||
94535955|NCT02135029|323758279|FG000|Overall Study|Other|0|||
94535956|NCT02135029|323758280|FG001|Overall Study|Other|1|||
94535957|NCT02135029|323758281|FG002|Overall Study|Other|0|||
94535958|NCT02135029|323758279|FG000|Overall Study|Death|0|||
94535959|NCT02135029|323758280|FG001|Overall Study|Death|1|||
94535960|NCT02135029|323758281|FG002|Overall Study|Death|0|||
94535961|NCT00712725|323758282|FG000|Overall Study|Adverse Event|1|||
94535962|NCT00712725|323758283|FG001|Overall Study|Adverse Event|0|||
94535963|NCT00712725|323758284|FG002|Overall Study|Adverse Event|0|||
94535964|NCT00712725|323758285|FG003|Overall Study|Adverse Event|1|||
94535965|NCT00712725|323758286|FG004|Overall Study|Adverse Event|0|||
94535966|NCT00712725|323758287|FG005|Overall Study|Adverse Event|0|||
94535967|NCT00712725|323758288|FG006|Overall Study|Adverse Event|0|||
94535968|NCT00712725|323758289|FG007|Overall Study|Adverse Event|0|||
94535969|NCT00712725|323758282|FG000|Overall Study|Lost to Follow-up|3|||
94535970|NCT00712725|323758283|FG001|Overall Study|Lost to Follow-up|2|||
94535971|NCT00712725|323758284|FG002|Overall Study|Lost to Follow-up|1|||
94535972|NCT00712725|323758285|FG003|Overall Study|Lost to Follow-up|1|||
94535973|NCT00712725|323758286|FG004|Overall Study|Lost to Follow-up|2|||
94535974|NCT00712725|323758287|FG005|Overall Study|Lost to Follow-up|2|||
94535975|NCT00712725|323758288|FG006|Overall Study|Lost to Follow-up|3|||
94535976|NCT00712725|323758289|FG007|Overall Study|Lost to Follow-up|1|||
94535977|NCT00712725|323758282|FG000|Overall Study|Physician Decision|2|||
94535978|NCT00712725|323758283|FG001|Overall Study|Physician Decision|0|||
94535979|NCT00712725|323758284|FG002|Overall Study|Physician Decision|0|||
94535980|NCT00712725|323758285|FG003|Overall Study|Physician Decision|0|||
94535981|NCT00712725|323758286|FG004|Overall Study|Physician Decision|1|||
94535982|NCT00712725|323758287|FG005|Overall Study|Physician Decision|0|||
94535983|NCT00712725|323758288|FG006|Overall Study|Physician Decision|2|||
94535984|NCT00712725|323758289|FG007|Overall Study|Physician Decision|0|||
94535985|NCT00712725|323758282|FG000|Overall Study|Pregnancy|0|||
94535986|NCT00712725|323758283|FG001|Overall Study|Pregnancy|1|||
94535987|NCT00712725|323758284|FG002|Overall Study|Pregnancy|0|||
94535988|NCT00712725|323758285|FG003|Overall Study|Pregnancy|0|||
94535989|NCT00712725|323758286|FG004|Overall Study|Pregnancy|1|||
94535990|NCT00712725|323758287|FG005|Overall Study|Pregnancy|0|||
94535991|NCT00712725|323758288|FG006|Overall Study|Pregnancy|2|||
94535992|NCT00712725|323758289|FG007|Overall Study|Pregnancy|0|||
94535993|NCT00712725|323758282|FG000|Overall Study|Protocol Violation|2|||
94535994|NCT00712725|323758283|FG001|Overall Study|Protocol Violation|0|||
94535995|NCT00712725|323758284|FG002|Overall Study|Protocol Violation|1|||
94535996|NCT00712725|323758285|FG003|Overall Study|Protocol Violation|3|||
94535997|NCT00712725|323758286|FG004|Overall Study|Protocol Violation|2|||
94535998|NCT00712725|323758287|FG005|Overall Study|Protocol Violation|0|||
94535999|NCT00712725|323758288|FG006|Overall Study|Protocol Violation|1|||
94536000|NCT00712725|323758289|FG007|Overall Study|Protocol Violation|1|||
94536001|NCT00712725|323758282|FG000|Overall Study|Withdrawal by Subject|2|||
94536002|NCT00712725|323758283|FG001|Overall Study|Withdrawal by Subject|1|||
94536003|NCT00712725|323758284|FG002|Overall Study|Withdrawal by Subject|1|||
94536004|NCT00712725|323758285|FG003|Overall Study|Withdrawal by Subject|2|||
94536005|NCT00712725|323758286|FG004|Overall Study|Withdrawal by Subject|1|||
94536006|NCT00712725|323758287|FG005|Overall Study|Withdrawal by Subject|1|||
94536007|NCT00712725|323758288|FG006|Overall Study|Withdrawal by Subject|1|||
94536008|NCT00712725|323758289|FG007|Overall Study|Withdrawal by Subject|2|||
94536009|NCT00712725|323758282|FG000|Overall Study|Lack of Qualifying Event|16|||
94536010|NCT00712725|323758283|FG001|Overall Study|Lack of Qualifying Event|2|||
94536011|NCT00712725|323758284|FG002|Overall Study|Lack of Qualifying Event|6|||
94536012|NCT00712725|323758285|FG003|Overall Study|Lack of Qualifying Event|8|||
94536013|NCT00712725|323758286|FG004|Overall Study|Lack of Qualifying Event|11|||
94536014|NCT00712725|323758287|FG005|Overall Study|Lack of Qualifying Event|13|||
94536015|NCT00712725|323758288|FG006|Overall Study|Lack of Qualifying Event|11|||
94536016|NCT00712725|323758289|FG007|Overall Study|Lack of Qualifying Event|6|||
94536017|NCT00712725|323758282|FG000|Overall Study|Protocol Specified Criteria|3|||
94536018|NCT00712725|323758283|FG001|Overall Study|Protocol Specified Criteria|0|||
94536019|NCT00712725|323758284|FG002|Overall Study|Protocol Specified Criteria|1|||
94536020|NCT00712725|323758285|FG003|Overall Study|Protocol Specified Criteria|2|||
94536021|NCT00712725|323758286|FG004|Overall Study|Protocol Specified Criteria|1|||
94536022|NCT00712725|323758287|FG005|Overall Study|Protocol Specified Criteria|0|||
94536023|NCT00712725|323758288|FG006|Overall Study|Protocol Specified Criteria|2|||
94536024|NCT00712725|323758289|FG007|Overall Study|Protocol Specified Criteria|1|||
94536025|NCT02120300|323758290|FG000|Overall Study|Enrolled but Never Treated|2|||
94536026|NCT02120300|323758291|FG001|Overall Study|Enrolled but Never Treated|0|||
94536027|NCT02120300|323758292|FG002|Overall Study|Enrolled but Never Treated|0|||
94536028|NCT02120300|323758293|FG003|Overall Study|Enrolled but Never Treated|0|||
94536029|NCT02120300|323758290|FG000|Overall Study|Lack of Efficacy|0|||
94536030|NCT02120300|323758291|FG001|Overall Study|Lack of Efficacy|0|||
94536031|NCT02120300|323758292|FG002|Overall Study|Lack of Efficacy|0|||
94536032|NCT02120300|323758293|FG003|Overall Study|Lack of Efficacy|1|||
94536033|NCT02120300|323758290|FG000|Overall Study|Lost to Follow-up|1|||
94536034|NCT02120300|323758291|FG001|Overall Study|Lost to Follow-up|0|||
94536035|NCT02120300|323758292|FG002|Overall Study|Lost to Follow-up|0|||
94536036|NCT02120300|323758293|FG003|Overall Study|Lost to Follow-up|0|||
94536037|NCT00385944|323758294|FG000|1st Maintenance Dose Period|Physician Decision|1|||
94536038|NCT00385944|323758295|FG001|1st Maintenance Dose Period|Physician Decision|0|||
94536039|NCT00385944|323758296|FG002|1st Maintenance Dose Period|Physician Decision|0|||
94536040|NCT00385944|323758294|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
94536041|NCT00385944|323758295|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
94536042|NCT00385944|323758296|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
94536043|NCT00385944|323758294|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
94536044|NCT00385944|323758295|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
94536045|NCT00385944|323758296|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
94536046|NCT00385944|323758294|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
94536047|NCT00385944|323758295|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
94536048|NCT00385944|323758296|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
94536049|NCT00075946|323758297|FG000|Overall Study|Path ineligible: undetermined histology|0|||
94536050|NCT00075946|323758298|FG001|Overall Study|Path ineligible: undetermined histology|0|||
94536051|NCT00075946|323758299|FG002|Overall Study|Path ineligible: undetermined histology|0|||
94536052|NCT00075946|323758300|FG003|Overall Study|Path ineligible: undetermined histology|0|||
94536053|NCT00075946|323758301|FG004|Overall Study|Path ineligible: undetermined histology|6|||
94536054|NCT00075946|323758297|FG000|Overall Study|Did not achieve response after induction|0|||
94536055|NCT00075946|323758298|FG001|Overall Study|Did not achieve response after induction|0|||
94536056|NCT00075946|323758299|FG002|Overall Study|Did not achieve response after induction|0|||
94536057|NCT00075946|323758300|FG003|Overall Study|Did not achieve response after induction|0|||
94536058|NCT00075946|323758301|FG004|Overall Study|Did not achieve response after induction|182|||
94536059|NCT00075946|323758297|FG000|Overall Study|Incorrectly randomized (no response)|5|||
94536060|NCT00075946|323758298|FG001|Overall Study|Incorrectly randomized (no response)|5|||
94536061|NCT00075946|323758299|FG002|Overall Study|Incorrectly randomized (no response)|5|||
94536062|NCT00075946|323758300|FG003|Overall Study|Incorrectly randomized (no response)|1|||
94536063|NCT00075946|323758301|FG004|Overall Study|Incorrectly randomized (no response)|0|||
94536064|NCT00075946|323758297|FG000|Overall Study|Adverse Event|2|||
94536065|NCT00075946|323758298|FG001|Overall Study|Adverse Event|10|||
94536066|NCT00075946|323758299|FG002|Overall Study|Adverse Event|0|||
94536067|NCT00075946|323758300|FG003|Overall Study|Adverse Event|2|||
94536068|NCT00075946|323758301|FG004|Overall Study|Adverse Event|0|||
94536069|NCT00075946|323758297|FG000|Overall Study|Death|0|||
94536070|NCT00075946|323758298|FG001|Overall Study|Death|1|||
94536071|NCT00075946|323758299|FG002|Overall Study|Death|0|||
94536072|NCT00075946|323758300|FG003|Overall Study|Death|0|||
94536073|NCT00075946|323758301|FG004|Overall Study|Death|0|||
94536074|NCT00075946|323758297|FG000|Overall Study|Withdrawal by Subject|23|||
94536075|NCT00075946|323758298|FG001|Overall Study|Withdrawal by Subject|58|||
94536076|NCT00075946|323758299|FG002|Overall Study|Withdrawal by Subject|4|||
94536077|NCT00075946|323758300|FG003|Overall Study|Withdrawal by Subject|9|||
94536078|NCT00075946|323758301|FG004|Overall Study|Withdrawal by Subject|0|||
94536079|NCT00075946|323758297|FG000|Overall Study|Alternative therapy|16|||
94536080|NCT00075946|323758298|FG001|Overall Study|Alternative therapy|2|||
94536081|NCT00075946|323758299|FG002|Overall Study|Alternative therapy|5|||
94536082|NCT00075946|323758300|FG003|Overall Study|Alternative therapy|0|||
94536083|NCT00075946|323758301|FG004|Overall Study|Alternative therapy|0|||
94536084|NCT00075946|323758297|FG000|Overall Study|Other complicating disease|7|||
94536085|NCT00075946|323758298|FG001|Overall Study|Other complicating disease|13|||
94536086|NCT00075946|323758299|FG002|Overall Study|Other complicating disease|1|||
94536087|NCT00075946|323758300|FG003|Overall Study|Other complicating disease|4|||
94536088|NCT00075946|323758301|FG004|Overall Study|Other complicating disease|0|||
94536089|NCT00075946|323758297|FG000|Overall Study|No response to retreatment|23|||
94536090|NCT00075946|323758298|FG001|Overall Study|No response to retreatment|0|||
94536091|NCT00075946|323758299|FG002|Overall Study|No response to retreatment|2|||
94536092|NCT00075946|323758300|FG003|Overall Study|No response to retreatment|0|||
94536093|NCT00075946|323758301|FG004|Overall Study|No response to retreatment|0|||
94536094|NCT00075946|323758297|FG000|Overall Study|Time to progression less than 6 months|15|||
94536095|NCT00075946|323758298|FG001|Overall Study|Time to progression less than 6 months|30|||
94536096|NCT00075946|323758299|FG002|Overall Study|Time to progression less than 6 months|8|||
94536097|NCT00075946|323758300|FG003|Overall Study|Time to progression less than 6 months|3|||
94536098|NCT00075946|323758301|FG004|Overall Study|Time to progression less than 6 months|0|||
94536099|NCT00075946|323758297|FG000|Overall Study|Other|57|||
94536100|NCT00075946|323758298|FG001|Overall Study|Other|32|||
94536101|NCT00075946|323758299|FG002|Overall Study|Other|3|||
94536102|NCT00075946|323758300|FG003|Overall Study|Other|11|||
94536103|NCT00075946|323758301|FG004|Overall Study|Other|0|||
94536104|NCT00791479|323758302|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
94536105|NCT00791479|323758303|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
94536106|NCT00791479|323758304|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
94536107|NCT00791479|323758305|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
94536108|NCT00791479|323758306|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
94536109|NCT00791479|323758307|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
94536110|NCT00791479|323758302|FG000|Overall Study|Adverse Event|0|||
94536111|NCT00791479|323758303|FG001|Overall Study|Adverse Event|1|||
94536112|NCT00791479|323758304|FG002|Overall Study|Adverse Event|0|||
94536113|NCT00791479|323758305|FG003|Overall Study|Adverse Event|2|||
94536114|NCT00791479|323758306|FG004|Overall Study|Adverse Event|0|||
94536115|NCT00791479|323758307|FG005|Overall Study|Adverse Event|1|||
94536116|NCT00791479|323758302|FG000|Overall Study|Lost to Follow-up|0|||
94536117|NCT00791479|323758303|FG001|Overall Study|Lost to Follow-up|1|||
94536118|NCT00791479|323758304|FG002|Overall Study|Lost to Follow-up|0|||
94536119|NCT00791479|323758305|FG003|Overall Study|Lost to Follow-up|0|||
94536120|NCT00791479|323758306|FG004|Overall Study|Lost to Follow-up|0|||
94536121|NCT00791479|323758307|FG005|Overall Study|Lost to Follow-up|1|||
94536122|NCT00791479|323758302|FG000|Overall Study|Protocol Violation|2|||
94536123|NCT00791479|323758303|FG001|Overall Study|Protocol Violation|1|||
94536124|NCT00791479|323758304|FG002|Overall Study|Protocol Violation|0|||
94536125|NCT00791479|323758305|FG003|Overall Study|Protocol Violation|1|||
94536126|NCT00791479|323758306|FG004|Overall Study|Protocol Violation|0|||
94536127|NCT00791479|323758307|FG005|Overall Study|Protocol Violation|0|||
94536128|NCT00791479|323758302|FG000|Overall Study|Withdrawal by Subject|0|||
94536129|NCT00791479|323758303|FG001|Overall Study|Withdrawal by Subject|0|||
94536130|NCT00791479|323758304|FG002|Overall Study|Withdrawal by Subject|0|||
94536131|NCT00791479|323758305|FG003|Overall Study|Withdrawal by Subject|1|||
94536132|NCT00791479|323758306|FG004|Overall Study|Withdrawal by Subject|0|||
94536133|NCT00791479|323758307|FG005|Overall Study|Withdrawal by Subject|1|||
94536134|NCT00290771|323758308|FG000|Overall Study|Disease progression|95|||
94536135|NCT00290771|323758309|FG001|Overall Study|Disease progression|73|||
94536136|NCT00290771|323758308|FG000|Overall Study|Death|11|||
94536137|NCT00290771|323758309|FG001|Overall Study|Death|10|||
94536138|NCT00290771|323758308|FG000|Overall Study|Adverse Event|12|||
94536139|NCT00290771|323758309|FG001|Overall Study|Adverse Event|6|||
94536140|NCT00290771|323758308|FG000|Overall Study|Withdrawal by Subject|5|||
94536141|NCT00290771|323758309|FG001|Overall Study|Withdrawal by Subject|6|||
94536142|NCT00290771|323758308|FG000|Overall Study|Administrative problems|2|||
94536143|NCT00290771|323758309|FG001|Overall Study|Administrative problems|1|||
94536144|NCT00290771|323758308|FG000|Overall Study|Protocol Violation|2|||
94536145|NCT00290771|323758309|FG001|Overall Study|Protocol Violation|0|||
94536146|NCT00290771|323758308|FG000|Overall Study|Lost to Follow-up|0|||
94536147|NCT00290771|323758309|FG001|Overall Study|Lost to Follow-up|1|||
94536148|NCT01534260|323758316|FG000|Overall Study|Adverse Event|1|||
94536149|NCT01534260|323758317|FG001|Overall Study|Adverse Event|8|||
94536150|NCT01534260|323758316|FG000|Overall Study|Death|2|||
94536151|NCT01534260|323758317|FG001|Overall Study|Death|0|||
94536152|NCT01534260|323758316|FG000|Overall Study|Lack of Efficacy|1|||
94536153|NCT01534260|323758317|FG001|Overall Study|Lack of Efficacy|1|||
94536154|NCT01534260|323758316|FG000|Overall Study|Withdrawal by Subject|1|||
94536155|NCT01534260|323758317|FG001|Overall Study|Withdrawal by Subject|3|||
94536156|NCT01534260|323758316|FG000|Overall Study|Disease Progression|8|||
94536157|NCT01534260|323758317|FG001|Overall Study|Disease Progression|6|||
94536158|NCT01534260|323758316|FG000|Overall Study|Physician Decision|3|||
94536159|NCT01534260|323758317|FG001|Overall Study|Physician Decision|1|||
94536160|NCT01534260|323758316|FG000|Overall Study|No treatment, per protocol|0|||
94536161|NCT01534260|323758317|FG001|Overall Study|No treatment, per protocol|1|||
94536162|NCT02359045|323758318|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
94536163|NCT02359045|323758319|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
94536164|NCT02359045|323758318|FG000|Overall Study|Lost to Follow-up|1|||
94536165|NCT02359045|323758319|FG001|Overall Study|Lost to Follow-up|1|||
94536166|NCT02359045|323758318|FG000|Overall Study|Adverse Event|0|||
94536167|NCT02359045|323758319|FG001|Overall Study|Adverse Event|1|||
94536168|NCT00404755|323758323|FG000|Phase I (Bupropion)|Adverse Event|3|||
94536169|NCT00404755|323758323|FG000|Phase I (Bupropion)|Other|1|||
94536170|NCT00404755|323758323|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
94536171|NCT01639339|323758324|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
94536172|NCT01639339|323758325|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
94536173|NCT01639339|323758324|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
94536174|NCT01639339|323758325|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
94536175|NCT01639339|323758324|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
94536176|NCT01639339|323758325|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
94536177|NCT01639339|323758324|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
94536178|NCT01639339|323758325|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
94536179|NCT01639339|323758324|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
94536180|NCT01639339|323758325|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
94536181|NCT01639339|323758324|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
94536182|NCT01639339|323758325|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
94536183|NCT01639339|323758324|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
94536184|NCT01639339|323758325|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
94536185|NCT01639339|323758324|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
94536186|NCT01639339|323758325|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
94536187|NCT01639339|323758324|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
94536188|NCT01639339|323758325|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
94536189|NCT01639339|323758324|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
94536190|NCT01639339|323758325|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
94536191|NCT05145322|323758328|FG000|Overall Study|Lost to Follow-up|4|||
94536192|NCT05145322|323758329|FG001|Overall Study|Lost to Follow-up|5|||
94536193|NCT00118846|323758330|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
94536194|NCT00118846|323758331|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
94536195|NCT00118846|323758330|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
94536196|NCT00118846|323758331|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
94536197|NCT00118846|323758330|FG000|Overall Study|Physician Decision|1|||
94536198|NCT00118846|323758331|FG001|Overall Study|Physician Decision|0|||
94536199|NCT00118846|323758330|FG000|Overall Study|Medical condition|2|||
94536200|NCT00118846|323758331|FG001|Overall Study|Medical condition|2|||
94536201|NCT00118846|323758330|FG000|Overall Study|Lost to Follow-up|0|||
94536202|NCT00118846|323758331|FG001|Overall Study|Lost to Follow-up|2|||
94536203|NCT00118846|323758330|FG000|Overall Study|Personal reason|4|||
94536204|NCT00118846|323758331|FG001|Overall Study|Personal reason|5|||
94536205|NCT00457821|323758332|FG000|Part 2|Withdrawal by Subject|0|||
94536206|NCT00457821|323758333|FG001|Part 2|Withdrawal by Subject|0|||
94536207|NCT00457821|323758334|FG002|Part 2|Withdrawal by Subject|0|||
94536208|NCT00457821|323758335|FG003|Part 2|Withdrawal by Subject|0|||
94536209|NCT00457821|323758336|FG004|Part 2|Withdrawal by Subject|0|||
94536210|NCT00457821|323758337|FG005|Part 2|Withdrawal by Subject|0|||
94536211|NCT00457821|323758338|FG006|Part 2|Withdrawal by Subject|0|||
94536212|NCT00457821|323758339|FG007|Part 2|Withdrawal by Subject|1|||
94536213|NCT02438683|323758340|FG000|Overall Study|Adverse Event|1|||
94536214|NCT02438683|323758341|FG001|Overall Study|Adverse Event|0|||
94536215|NCT02438683|323758342|FG002|Overall Study|Adverse Event|0|||
94536216|NCT02438683|323758343|FG003|Overall Study|Adverse Event|0|||
94536217|NCT02438683|323758344|FG004|Overall Study|Adverse Event|0|||
94536218|NCT02438683|323758345|FG005|Overall Study|Adverse Event|0|||
94536219|NCT01944098|323758346|FG000|Overall Study|Physician Decision|1|||
94536220|NCT01944098|323758347|FG001|Overall Study|Physician Decision|0|||
94536221|NCT00027378|323758348|FG000|Overall Study|Physician Decision|0|||
94536222|NCT00027378|323758349|FG001|Overall Study|Physician Decision|3|||
94536223|NCT05151445|323758351|FG000|Overall Study|Withdrawal by Subject|3|||
94536224|NCT00350272|323758352|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
94536225|NCT00350272|323758353|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
94536226|NCT00350272|323758352|FG000|Blinded 12-Week Treatment|Death|1|||
94536227|NCT00350272|323758353|FG001|Blinded 12-Week Treatment|Death|0|||
94536228|NCT00350272|323758352|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
94536229|NCT00350272|323758353|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
94536230|NCT00350272|323758352|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
94536231|NCT00350272|323758353|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
94536232|NCT00350272|323758352|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
94536233|NCT00350272|323758353|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
94536234|NCT00350272|323758352|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
94536235|NCT00350272|323758353|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
94536236|NCT00350272|323758352|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
94536237|NCT00350272|323758353|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
94536238|NCT00350272|323758352|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
94536239|NCT00350272|323758353|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
94536240|NCT00350272|323758352|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
94536241|NCT00350272|323758353|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
94536242|NCT00350272|323758352|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
94536243|NCT00350272|323758353|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
94536244|NCT00350272|323758352|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
94536245|NCT00350272|323758353|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
94536246|NCT01795495|323758355|FG000|Overall Study|Protocol Violation|1|||
94536247|NCT01795495|323758356|FG001|Overall Study|Protocol Violation|0|||
94536248|NCT01795495|323758357|FG002|Overall Study|Protocol Violation|1|||
94536249|NCT01795495|323758355|FG000|Overall Study|Physician Decision|0|||
94536250|NCT01795495|323758356|FG001|Overall Study|Physician Decision|0|||
94536251|NCT01795495|323758357|FG002|Overall Study|Physician Decision|1|||
94536252|NCT00413894|323759981|FG000|Overall Study|Withdrawal by Subject|10|||
94536253|NCT00413894|323759981|FG000|Overall Study|Administrative Reasons|1|||
94536254|NCT00413894|323759981|FG000|Overall Study|Hb <10 grams/deciliter|12|||
94536255|NCT00413894|323759981|FG000|Overall Study|Adverse Event|28|||
94536256|NCT00413894|323759981|FG000|Overall Study|Protocol Violation|11|||
94536257|NCT00413894|323759981|FG000|Overall Study|Other|18|||
94536258|NCT02019108|323759982|FG000|Overall Study|Lost to Follow-up|5|||
94536259|NCT02019108|323759983|FG001|Overall Study|Lost to Follow-up|7|||
94536260|NCT00608023|323759984|FG000|Overall Study|Withdrawal by Subject|8|||
94536261|NCT00608023|323759985|FG001|Overall Study|Withdrawal by Subject|10|||
94536262|NCT00608023|323759986|FG002|Overall Study|Withdrawal by Subject|7|||
94536263|NCT00608023|323759984|FG000|Overall Study|Adverse Event|1|||
94536264|NCT00608023|323759985|FG001|Overall Study|Adverse Event|4|||
94536265|NCT00608023|323759986|FG002|Overall Study|Adverse Event|5|||
94536266|NCT00608023|323759984|FG000|Overall Study|Lost to Follow-up|2|||
94536267|NCT00608023|323759985|FG001|Overall Study|Lost to Follow-up|2|||
94536268|NCT00608023|323759986|FG002|Overall Study|Lost to Follow-up|1|||
94536269|NCT00608023|323759984|FG000|Overall Study|Protocol Violation|1|||
94536270|NCT00608023|323759985|FG001|Overall Study|Protocol Violation|3|||
94536271|NCT00608023|323759986|FG002|Overall Study|Protocol Violation|1|||
94536272|NCT00608023|323759984|FG000|Overall Study|Unknown reason|0|||
94536273|NCT00608023|323759985|FG001|Overall Study|Unknown reason|3|||
94536274|NCT00608023|323759986|FG002|Overall Study|Unknown reason|0|||
94536275|NCT02301546|323759989|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
94536276|NCT02301546|323759990|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
94536277|NCT02301546|323759989|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
94536278|NCT02301546|323759990|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
94536279|NCT02301546|323759989|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
94536280|NCT02301546|323759990|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
94536281|NCT02301546|323759989|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
94536282|NCT02301546|323759990|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
94536283|NCT02301546|323759989|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
94536284|NCT02301546|323759990|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
94536285|NCT02301546|323759989|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
94536286|NCT02301546|323759990|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
94536287|NCT02301546|323759989|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
94536288|NCT02301546|323759990|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
94536289|NCT01801436|323759991|FG000|Overall Study|Withdrawal by Subject|3|||
94536290|NCT01801436|323759991|FG000|Overall Study|Adverse Event|2|||
94536291|NCT01801436|323759991|FG000|Overall Study|Progressive disease|4|||
94536292|NCT04085458|323759992|FG000|Overall Study|Other|1|||
94536293|NCT04085458|323759992|FG000|Overall Study|Withdrawal by Subject|2|||
94536294|NCT04085458|323759992|FG000|Overall Study|Adverse Event|2|||
94536295|NCT02743949|323759995|FG000|Overall Study|Adverse Event|0|||
94536296|NCT02743949|323759996|FG001|Overall Study|Adverse Event|0|||
94536297|NCT02743949|323759997|FG002|Overall Study|Adverse Event|2|||
94536298|NCT02743949|323759995|FG000|Overall Study|Significant Protocol Deviation|2|||
94536299|NCT02743949|323759996|FG001|Overall Study|Significant Protocol Deviation|0|||
94536300|NCT02743949|323759997|FG002|Overall Study|Significant Protocol Deviation|1|||
94536301|NCT02743949|323759995|FG000|Overall Study|Voluntary Withdrawal|2|||
94536302|NCT02743949|323759996|FG001|Overall Study|Voluntary Withdrawal|1|||
94536303|NCT02743949|323759997|FG002|Overall Study|Voluntary Withdrawal|0|||
94536304|NCT01005316|323759998|FG000|Overall Study|Adverse Event|0|||
94536305|NCT01005316|323759999|FG001|Overall Study|Adverse Event|0|||
94536306|NCT01005316|323760000|FG002|Overall Study|Adverse Event|0|||
94536307|NCT01005316|323760001|FG003|Overall Study|Adverse Event|1|||
94536308|NCT01005316|323759998|FG000|Overall Study|Death|20|||
94536309|NCT01005316|323759999|FG001|Overall Study|Death|5|||
94536310|NCT01005316|323760000|FG002|Overall Study|Death|1|||
94536311|NCT01005316|323760001|FG003|Overall Study|Death|15|||
94536312|NCT01005316|323759998|FG000|Overall Study|Study Termination|5|||
94536313|NCT01005316|323759999|FG001|Overall Study|Study Termination|63|||
94536314|NCT01005316|323760000|FG002|Overall Study|Study Termination|9|||
94536315|NCT01005316|323760001|FG003|Overall Study|Study Termination|85|||
94536316|NCT01005316|323759998|FG000|Overall Study|Lost to Follow-up|1|||
94536317|NCT01005316|323759999|FG001|Overall Study|Lost to Follow-up|3|||
94536318|NCT01005316|323760000|FG002|Overall Study|Lost to Follow-up|0|||
94536319|NCT01005316|323760001|FG003|Overall Study|Lost to Follow-up|2|||
94536320|NCT01005316|323759998|FG000|Overall Study|Physician Decision|6|||
94536321|NCT01005316|323759999|FG001|Overall Study|Physician Decision|0|||
94536322|NCT01005316|323760000|FG002|Overall Study|Physician Decision|0|||
94536323|NCT01005316|323760001|FG003|Overall Study|Physician Decision|0|||
94536324|NCT01005316|323759998|FG000|Overall Study|Sponsor Decision|6|||
94536325|NCT01005316|323759999|FG001|Overall Study|Sponsor Decision|3|||
94536326|NCT01005316|323760000|FG002|Overall Study|Sponsor Decision|0|||
94536327|NCT01005316|323760001|FG003|Overall Study|Sponsor Decision|0|||
94536328|NCT01005316|323759998|FG000|Overall Study|Withdrawal by Subject|1|||
94536329|NCT01005316|323759999|FG001|Overall Study|Withdrawal by Subject|1|||
94536330|NCT01005316|323760000|FG002|Overall Study|Withdrawal by Subject|0|||
94536331|NCT01005316|323760001|FG003|Overall Study|Withdrawal by Subject|2|||
94536332|NCT01005316|323759998|FG000|Overall Study|Consented to Another Study|2|||
94536333|NCT01005316|323759999|FG001|Overall Study|Consented to Another Study|0|||
94536334|NCT01005316|323760000|FG002|Overall Study|Consented to Another Study|0|||
94536335|NCT01005316|323760001|FG003|Overall Study|Consented to Another Study|0|||
94536336|NCT01005316|323759998|FG000|Overall Study|Delisted|8|||
94536337|NCT01005316|323759999|FG001|Overall Study|Delisted|0|||
94536338|NCT01005316|323760000|FG002|Overall Study|Delisted|0|||
94536339|NCT01005316|323760001|FG003|Overall Study|Delisted|0|||
94536340|NCT01005316|323759998|FG000|Overall Study|Transferred Care|1|||
94536341|NCT01005316|323759999|FG001|Overall Study|Transferred Care|0|||
94536342|NCT01005316|323760000|FG002|Overall Study|Transferred Care|1|||
94536343|NCT01005316|323760001|FG003|Overall Study|Transferred Care|3|||
94536344|NCT01005316|323759998|FG000|Overall Study|Retransplanted|0|||
94536345|NCT01005316|323759999|FG001|Overall Study|Retransplanted|1|||
94536346|NCT01005316|323760000|FG002|Overall Study|Retransplanted|0|||
94536347|NCT01005316|323760001|FG003|Overall Study|Retransplanted|0|||
94536348|NCT04417218|323760002|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
94536349|NCT04417218|323760003|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
94536350|NCT01007435|323760006|FG000|Overall Study|Adverse Event|16|||
94536351|NCT01007435|323760007|FG001|Overall Study|Adverse Event|25|||
94536352|NCT01007435|323760008|FG002|Overall Study|Adverse Event|47|||
94536353|NCT01007435|323760009|FG003|Overall Study|Adverse Event|31|||
94536354|NCT01007435|323760006|FG000|Overall Study|Death|2|||
94536355|NCT01007435|323760007|FG001|Overall Study|Death|4|||
94536356|NCT01007435|323760008|FG002|Overall Study|Death|2|||
94536357|NCT01007435|323760009|FG003|Overall Study|Death|1|||
94536358|NCT01007435|323760006|FG000|Overall Study|Insufficient Therapeutic Response|21|||
94536359|NCT01007435|323760007|FG001|Overall Study|Insufficient Therapeutic Response|7|||
94536360|NCT01007435|323760008|FG002|Overall Study|Insufficient Therapeutic Response|2|||
94536361|NCT01007435|323760009|FG003|Overall Study|Insufficient Therapeutic Response|9|||
94536362|NCT01007435|323760006|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
94536363|NCT01007435|323760007|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
94536364|NCT01007435|323760008|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
94536365|NCT01007435|323760009|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
94536366|NCT01007435|323760006|FG000|Overall Study|Other Protocol Violation|2|||
94536367|NCT01007435|323760007|FG001|Overall Study|Other Protocol Violation|0|||
94536368|NCT01007435|323760008|FG002|Overall Study|Other Protocol Violation|1|||
94536369|NCT01007435|323760009|FG003|Overall Study|Other Protocol Violation|0|||
94536370|NCT01007435|323760006|FG000|Overall Study|Refused Treatment|13|||
94536371|NCT01007435|323760007|FG001|Overall Study|Refused Treatment|13|||
94536372|NCT01007435|323760008|FG002|Overall Study|Refused Treatment|5|||
94536373|NCT01007435|323760009|FG003|Overall Study|Refused Treatment|8|||
94536374|NCT01007435|323760006|FG000|Overall Study|Failure to Return|5|||
94536375|NCT01007435|323760007|FG001|Overall Study|Failure to Return|4|||
94536376|NCT01007435|323760008|FG002|Overall Study|Failure to Return|3|||
94536377|NCT01007435|323760009|FG003|Overall Study|Failure to Return|6|||
94536378|NCT01007435|323760006|FG000|Overall Study|Reason not Specified|1|||
94536379|NCT01007435|323760007|FG001|Overall Study|Reason not Specified|1|||
94536380|NCT01007435|323760008|FG002|Overall Study|Reason not Specified|2|||
94536381|NCT01007435|323760009|FG003|Overall Study|Reason not Specified|1|||
94536382|NCT00368836|323760010|FG000|Phase II|Screen Failure|1|||
94536383|NCT00368836|323760010|FG000|Phase II|Withdrawal by Subject|1|||
94536384|NCT00368836|323760010|FG000|Phase II|unable to collect blood and/or breath|17|||
94536385|NCT00368836|323760010|FG000|Phase II|Protocol Violation|2|||
94536386|NCT00596154|323760011|FG000|Overall Study|Not Evaluable|2|||
94536387|NCT00813865|323760012|FG000|Overall Study|Failure to Respond|3|||
94536388|NCT00813865|323760012|FG000|Overall Study|Lost to Follow-up|3|||
94536389|NCT00813865|323760012|FG000|Overall Study|Withdrawal by Subject|1|||
94536390|NCT00624585|323760013|FG000|Overall Study|Death|3|||
94536391|NCT00624585|323760013|FG000|Overall Study|Disease Progression|6|||
94536392|NCT00624585|323760013|FG000|Overall Study|Adverse Event|3|||
94536393|NCT02323126|323760016|FG000|Overall Study|Patient / guardian decision|0|||
94536394|NCT02323126|323760017|FG001|Overall Study|Patient / guardian decision|1|||
94536395|NCT02323126|323760018|FG002|Overall Study|Patient / guardian decision|2|||
94536396|NCT02323126|323760016|FG000|Overall Study|Progressive disease|14|||
94536397|NCT02323126|323760017|FG001|Overall Study|Progressive disease|8|||
94536398|NCT02323126|323760018|FG002|Overall Study|Progressive disease|14|||
94536399|NCT02323126|323760016|FG000|Overall Study|Physician Decision|0|||
94536400|NCT02323126|323760017|FG001|Overall Study|Physician Decision|1|||
94536401|NCT02323126|323760018|FG002|Overall Study|Physician Decision|3|||
94536402|NCT02323126|323760016|FG000|Overall Study|Death|1|||
94536403|NCT02323126|323760017|FG001|Overall Study|Death|1|||
94536404|NCT02323126|323760018|FG002|Overall Study|Death|4|||
94536405|NCT02323126|323760016|FG000|Overall Study|Adverse Event|3|||
94536406|NCT02323126|323760017|FG001|Overall Study|Adverse Event|5|||
94536407|NCT02323126|323760018|FG002|Overall Study|Adverse Event|7|||
94536408|NCT01421303|323760021|FG000|Overall Study|Lost to Follow-up|13|||
94536409|NCT01421303|323760021|FG000|Overall Study|Non compliance with study procedure|1|||
94536410|NCT01421303|323760021|FG000|Overall Study|Other|7|||
94536411|NCT01421303|323760021|FG000|Overall Study|Withdrawal by Subject|1|||
94536412|NCT00396136|323760026|FG000|Overall Study|Death|43|||
94536413|NCT00396136|323760026|FG000|Overall Study|Withdrawal by Subject|59|||
94536414|NCT00396136|323760026|FG000|Overall Study|Lost to Follow-up|15|||
94536415|NCT00396136|323760026|FG000|Overall Study|Study device explanted|8|||
94536416|NCT03172325|323760027|FG000|Overall Study|Adverse Event|2|||
94536417|NCT03172325|323760028|FG001|Overall Study|Adverse Event|3|||
94536418|NCT03172325|323760027|FG000|Overall Study|Positive PPD|1|||
94536419|NCT03172325|323760028|FG001|Overall Study|Positive PPD|0|||
94536420|NCT03172325|323760027|FG000|Overall Study|Poor Compliance|1|||
94536421|NCT03172325|323760028|FG001|Overall Study|Poor Compliance|1|||
94536422|NCT03622112|323760031|FG000|Overall Study|Withdrawal by Subject|6|||
94536423|NCT03622112|323760032|FG001|Overall Study|Withdrawal by Subject|2|||
94536424|NCT03622112|323760033|FG002|Overall Study|Withdrawal by Subject|4|||
94536425|NCT03622112|323760034|FG003|Overall Study|Withdrawal by Subject|2|||
94536426|NCT03622112|323760035|FG004|Overall Study|Withdrawal by Subject|1|||
94536427|NCT03622112|323760036|FG005|Overall Study|Withdrawal by Subject|2|||
94536428|NCT03622112|323760037|FG006|Overall Study|Withdrawal by Subject|2|||
94536429|NCT03622112|323760031|FG000|Overall Study|Death|0|||
94536430|NCT03622112|323760032|FG001|Overall Study|Death|0|||
94536431|NCT03622112|323760033|FG002|Overall Study|Death|0|||
94536432|NCT03622112|323760034|FG003|Overall Study|Death|1|||
94536433|NCT03622112|323760035|FG004|Overall Study|Death|0|||
94536434|NCT03622112|323760036|FG005|Overall Study|Death|0|||
94536435|NCT03622112|323760037|FG006|Overall Study|Death|0|||
94536436|NCT03622112|323760031|FG000|Overall Study|Lost to Follow-up|1|||
94536437|NCT03622112|323760032|FG001|Overall Study|Lost to Follow-up|1|||
94536438|NCT03622112|323760033|FG002|Overall Study|Lost to Follow-up|0|||
94536439|NCT03622112|323760034|FG003|Overall Study|Lost to Follow-up|0|||
94536440|NCT03622112|323760035|FG004|Overall Study|Lost to Follow-up|0|||
94536441|NCT03622112|323760036|FG005|Overall Study|Lost to Follow-up|0|||
94536442|NCT03622112|323760037|FG006|Overall Study|Lost to Follow-up|0|||
94536443|NCT03622112|323760031|FG000|Overall Study|Study-specific withdrawal criteria|10|||
94536444|NCT03622112|323760032|FG001|Overall Study|Study-specific withdrawal criteria|8|||
94536445|NCT03622112|323760033|FG002|Overall Study|Study-specific withdrawal criteria|7|||
94536446|NCT03622112|323760034|FG003|Overall Study|Study-specific withdrawal criteria|6|||
94536447|NCT03622112|323760035|FG004|Overall Study|Study-specific withdrawal criteria|4|||
94536448|NCT03622112|323760036|FG005|Overall Study|Study-specific withdrawal criteria|18|||
94536449|NCT03622112|323760037|FG006|Overall Study|Study-specific withdrawal criteria|4|||
94536450|NCT03622112|323760031|FG000|Overall Study|Protocol Violation|2|||
94536451|NCT03622112|323760032|FG001|Overall Study|Protocol Violation|0|||
94536452|NCT03622112|323760033|FG002|Overall Study|Protocol Violation|1|||
94536453|NCT03622112|323760034|FG003|Overall Study|Protocol Violation|1|||
94536454|NCT03622112|323760035|FG004|Overall Study|Protocol Violation|0|||
94536455|NCT03622112|323760036|FG005|Overall Study|Protocol Violation|0|||
94536456|NCT03622112|323760037|FG006|Overall Study|Protocol Violation|0|||
94536457|NCT03622112|323760031|FG000|Overall Study|Adverse Event|6|||
94536458|NCT03622112|323760032|FG001|Overall Study|Adverse Event|8|||
94536459|NCT03622112|323760033|FG002|Overall Study|Adverse Event|4|||
94536460|NCT03622112|323760034|FG003|Overall Study|Adverse Event|11|||
94536461|NCT03622112|323760035|FG004|Overall Study|Adverse Event|4|||
94536462|NCT03622112|323760036|FG005|Overall Study|Adverse Event|20|||
94536463|NCT03622112|323760037|FG006|Overall Study|Adverse Event|2|||
94536464|NCT03622112|323760031|FG000|Overall Study|Reason not specified|0|||
94536465|NCT03622112|323760032|FG001|Overall Study|Reason not specified|1|||
94536466|NCT03622112|323760033|FG002|Overall Study|Reason not specified|0|||
94536467|NCT03622112|323760034|FG003|Overall Study|Reason not specified|1|||
94536468|NCT03622112|323760035|FG004|Overall Study|Reason not specified|1|||
94536469|NCT03622112|323760036|FG005|Overall Study|Reason not specified|2|||
94536470|NCT03622112|323760037|FG006|Overall Study|Reason not specified|1|||
94536471|NCT00889603|323760038|FG000|Overall Study|Adverse Event|7|||
94536472|NCT00889603|323760038|FG000|Overall Study|Death|3|||
94536473|NCT00889603|323760038|FG000|Overall Study|Lost to Follow-up|19|||
94536474|NCT00889603|323760038|FG000|Overall Study|No longer willing to participant in stud|4|||
94536475|NCT00889603|323760038|FG000|Overall Study|Other|4|||
94536476|NCT00244933|323760050|FG000|Overall Study|Not response evaluable|2|||
94536477|NCT00866047|323760051|FG000|Treatment Period|Progressive disease|13|||
94536478|NCT00866047|323760051|FG000|Treatment Period|Adverse Event|16|||
94536479|NCT00866047|323760051|FG000|Treatment Period|Physician Decision|14|||
94536480|NCT00866047|323760051|FG000|Treatment Period|Withdrawal by Subject|5|||
94536481|NCT00866047|323760051|FG000|Follow-up Period|Lost to Follow-up|5|||
94536482|NCT00515294|323760052|FG000|Overall Study|Lost to Follow-up|3|||
94536483|NCT00515294|323760053|FG001|Overall Study|Lost to Follow-up|2|||
94536484|NCT00515294|323760054|FG002|Overall Study|Lost to Follow-up|3|||
94536485|NCT00515294|323760055|FG003|Overall Study|Lost to Follow-up|1|||
94536486|NCT00515294|323760052|FG000|Overall Study|Driver simulator problems|1|||
94536487|NCT00515294|323760053|FG001|Overall Study|Driver simulator problems|1|||
94536488|NCT00515294|323760054|FG002|Overall Study|Driver simulator problems|1|||
94536489|NCT00515294|323760055|FG003|Overall Study|Driver simulator problems|3|||
94536490|NCT00515294|323760052|FG000|Overall Study|Caffeine amount inaccurate|5|||
94536491|NCT00515294|323760053|FG001|Overall Study|Caffeine amount inaccurate|0|||
94536492|NCT00515294|323760054|FG002|Overall Study|Caffeine amount inaccurate|7|||
94536493|NCT00515294|323760055|FG003|Overall Study|Caffeine amount inaccurate|0|||
94536494|NCT00503776|323760063|FG000|Overall Study|Withdrawal by Subject|1|||
94536495|NCT00503776|323760064|FG001|Overall Study|Withdrawal by Subject|0|||
94536496|NCT00503776|323760065|FG002|Overall Study|Withdrawal by Subject|1|||
94536497|NCT00503776|323760066|FG003|Overall Study|Withdrawal by Subject|1|||
94536498|NCT00503776|323760063|FG000|Overall Study|Physician Decision|0|||
94536499|NCT00503776|323760064|FG001|Overall Study|Physician Decision|0|||
94536500|NCT00503776|323760065|FG002|Overall Study|Physician Decision|1|||
94536501|NCT00503776|323760066|FG003|Overall Study|Physician Decision|1|||
94536502|NCT03703817|323760067|FG000|Overall Study|Not meeting eligibility criteria|7|||
94536503|NCT03703817|323760068|FG001|Overall Study|Not meeting eligibility criteria|4|||
94536504|NCT02778555|323760069|FG000|Overall Study|Withdrawal by Subject|55|||
94536505|NCT02778555|323760070|FG001|Overall Study|Withdrawal by Subject|32|||
94536506|NCT02778555|323760071|FG002|Overall Study|Withdrawal by Subject|107|||
94536507|NCT00107315|323760072|FG000|Overall Study|Disease Progression|9|||
94536508|NCT00107315|323760072|FG000|Overall Study|Adverse Event|4|||
94536509|NCT00107315|323760072|FG000|Overall Study|Withdrawal by Subject|2|||
94536510|NCT02509039|323760073|FG000|Overall Study|Adverse Event|0|||
94536511|NCT02509039|323760074|FG001|Overall Study|Adverse Event|1|||
94536512|NCT02509039|323760075|FG002|Overall Study|Adverse Event|1|||
94536513|NCT02509039|323760076|FG003|Overall Study|Adverse Event|1|||
94536514|NCT02509039|323760073|FG000|Overall Study|Withdrawal by Subject|0|||
94536515|NCT02509039|323760074|FG001|Overall Study|Withdrawal by Subject|0|||
94536516|NCT02509039|323760075|FG002|Overall Study|Withdrawal by Subject|1|||
94536517|NCT02509039|323760076|FG003|Overall Study|Withdrawal by Subject|0|||
94536518|NCT02509039|323760073|FG000|Overall Study|Progressive disease|2|||
94536519|NCT02509039|323760074|FG001|Overall Study|Progressive disease|2|||
94536520|NCT02509039|323760075|FG002|Overall Study|Progressive disease|1|||
94536521|NCT02509039|323760076|FG003|Overall Study|Progressive disease|5|||
94536522|NCT02509039|323760073|FG000|Overall Study|Study terminated by Sponsor|1|||
94536523|NCT02509039|323760074|FG001|Overall Study|Study terminated by Sponsor|0|||
94536524|NCT02509039|323760075|FG002|Overall Study|Study terminated by Sponsor|0|||
94536525|NCT02509039|323760076|FG003|Overall Study|Study terminated by Sponsor|0|||
94536526|NCT04049266|323760079|FG000|Overall Study|Adverse Event|16|||
94536527|NCT04049266|323760080|FG001|Overall Study|Adverse Event|9|||
94536528|NCT04049266|323760079|FG000|Overall Study|Non-compliance with study drug|0|||
94536529|NCT04049266|323760080|FG001|Overall Study|Non-compliance with study drug|3|||
94536530|NCT04049266|323760079|FG000|Overall Study|Withdrawal by Subject|6|||
94536531|NCT04049266|323760080|FG001|Overall Study|Withdrawal by Subject|10|||
94536532|NCT04049266|323760079|FG000|Overall Study|Lost to Follow-up|2|||
94536533|NCT04049266|323760080|FG001|Overall Study|Lost to Follow-up|2|||
94536534|NCT04049266|323760079|FG000|Overall Study|Progressive disease|11|||
94536535|NCT04049266|323760080|FG001|Overall Study|Progressive disease|2|||
94536536|NCT04049266|323760079|FG000|Overall Study|Physician Decision|1|||
94536537|NCT04049266|323760080|FG001|Overall Study|Physician Decision|0|||
94536538|NCT04049266|323760079|FG000|Overall Study|Patient moved out of state|1|||
94536539|NCT04049266|323760080|FG001|Overall Study|Patient moved out of state|0|||
94536540|NCT01703208|323760082|FG000|Overall Study|Death|61|||
94536541|NCT01703208|323760083|FG001|Overall Study|Death|48|||
94536542|NCT01703208|323760082|FG000|Overall Study|Lack of Efficacy|1|||
94536543|NCT01703208|323760083|FG001|Overall Study|Lack of Efficacy|2|||
94536544|NCT01703208|323760082|FG000|Overall Study|Lost to Follow-up|68|||
94536545|NCT01703208|323760083|FG001|Overall Study|Lost to Follow-up|62|||
94536546|NCT01703208|323760082|FG000|Overall Study|Non-Compliance with Study Drug|1|||
94536547|NCT01703208|323760083|FG001|Overall Study|Non-Compliance with Study Drug|0|||
94536548|NCT01703208|323760082|FG000|Overall Study|Excluded Medication|1|||
94536549|NCT01703208|323760083|FG001|Overall Study|Excluded Medication|2|||
94536550|NCT01703208|323760082|FG000|Overall Study|Site Discontinued Study Participation|23|||
94536551|NCT01703208|323760083|FG001|Overall Study|Site Discontinued Study Participation|27|||
94536552|NCT01703208|323760082|FG000|Overall Study|Physician Decision|11|||
94536553|NCT01703208|323760083|FG001|Overall Study|Physician Decision|13|||
94536554|NCT01703208|323760082|FG000|Overall Study|Progressive disease|2|||
94536555|NCT01703208|323760083|FG001|Overall Study|Progressive disease|2|||
94536556|NCT01703208|323760082|FG000|Overall Study|Protocol Violation|1|||
94536557|NCT01703208|323760083|FG001|Overall Study|Protocol Violation|1|||
94536558|NCT01703208|323760082|FG000|Overall Study|Study Terminated by Sponsor|1710|||
94536559|NCT01703208|323760083|FG001|Overall Study|Study Terminated by Sponsor|1716|||
94536560|NCT01703208|323760082|FG000|Overall Study|Withdrawal by Subject|205|||
94536561|NCT01703208|323760083|FG001|Overall Study|Withdrawal by Subject|209|||
94536562|NCT01703208|323760082|FG000|Overall Study|Adverse Event|14|||
94536563|NCT01703208|323760083|FG001|Overall Study|Adverse Event|19|||
94536564|NCT01703208|323760082|FG000|Overall Study|Technical Problems|0|||
94536565|NCT01703208|323760083|FG001|Overall Study|Technical Problems|1|||
94536566|NCT01703208|323760082|FG000|Overall Study|Protocol Deviation|2|||
94536567|NCT01703208|323760083|FG001|Overall Study|Protocol Deviation|0|||
94536568|NCT02099344|323760084|FG000|Overall Study|Physician Decision|1|||
94536569|NCT02099344|323760085|FG001|Overall Study|Physician Decision|0|||
94536570|NCT04470908|323760089|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
94536571|NCT00096226|323760090|FG000|Overall Study|Ineligible|2|||
94536572|NCT00096226|323760090|FG000|Overall Study|Protocol treatment not started|1|||
94536573|NCT01096368|323760098|FG000|Overall Study|Death|0|||
94536574|NCT01096368|323760099|FG001|Overall Study|Death|1|||
94536575|NCT01096368|323760100|FG002|Overall Study|Death|0|||
94536576|NCT01096368|323760101|FG003|Overall Study|Death|0|||
94536577|NCT01096368|323760102|FG004|Overall Study|Death|0|||
94536578|NCT01096368|323760098|FG000|Overall Study|Physician Decision|0|||
94536579|NCT01096368|323760099|FG001|Overall Study|Physician Decision|13|||
94536580|NCT01096368|323760100|FG002|Overall Study|Physician Decision|2|||
94536581|NCT01096368|323760101|FG003|Overall Study|Physician Decision|4|||
94536582|NCT01096368|323760102|FG004|Overall Study|Physician Decision|6|||
94536583|NCT01096368|323760098|FG000|Overall Study|Withdrawal by Subject|0|||
94536584|NCT01096368|323760099|FG001|Overall Study|Withdrawal by Subject|52|||
94536585|NCT01096368|323760100|FG002|Overall Study|Withdrawal by Subject|0|||
94536586|NCT01096368|323760101|FG003|Overall Study|Withdrawal by Subject|10|||
94536587|NCT01096368|323760102|FG004|Overall Study|Withdrawal by Subject|14|||
94536588|NCT01096368|323760098|FG000|Overall Study|Ineligible|0|||
94536589|NCT01096368|323760099|FG001|Overall Study|Ineligible|3|||
94536590|NCT01096368|323760100|FG002|Overall Study|Ineligible|2|||
94536591|NCT01096368|323760101|FG003|Overall Study|Ineligible|0|||
94536592|NCT01096368|323760102|FG004|Overall Study|Ineligible|25|||
94536593|NCT01096368|323760098|FG000|Overall Study|Did not start treatment|0|||
94536594|NCT01096368|323760099|FG001|Overall Study|Did not start treatment|4|||
94536595|NCT01096368|323760100|FG002|Overall Study|Did not start treatment|4|||
94536596|NCT01096368|323760101|FG003|Overall Study|Did not start treatment|0|||
94536597|NCT01096368|323760102|FG004|Overall Study|Did not start treatment|0|||
94536598|NCT01096368|323760098|FG000|Overall Study|Progressive disease|0|||
94536599|NCT01096368|323760099|FG001|Overall Study|Progressive disease|6|||
94536600|NCT01096368|323760100|FG002|Overall Study|Progressive disease|0|||
94536601|NCT01096368|323760101|FG003|Overall Study|Progressive disease|10|||
94536602|NCT01096368|323760102|FG004|Overall Study|Progressive disease|3|||
94536603|NCT01096368|323760098|FG000|Overall Study|Other|0|||
94536604|NCT01096368|323760099|FG001|Overall Study|Other|0|||
94536605|NCT01096368|323760100|FG002|Overall Study|Other|1|||
94536606|NCT01096368|323760101|FG003|Overall Study|Other|0|||
94536607|NCT01096368|323760102|FG004|Overall Study|Other|0|||
94536608|NCT01096368|323760098|FG000|Overall Study|Treated with institutional review|0|||
94536609|NCT01096368|323760099|FG001|Overall Study|Treated with institutional review|0|||
94536610|NCT01096368|323760100|FG002|Overall Study|Treated with institutional review|0|||
94536611|NCT01096368|323760101|FG003|Overall Study|Treated with institutional review|0|||
94536612|NCT01096368|323760102|FG004|Overall Study|Treated with institutional review|1|||
94536613|NCT01252186|323760104|FG000|Overall Study|Adverse Event|9|||
94536614|NCT01252186|323760105|FG001|Overall Study|Adverse Event|6|||
94536615|NCT01252186|323760106|FG002|Overall Study|Adverse Event|8|||
94536616|NCT01252186|323760104|FG000|Overall Study|Withdrawal by Subject|2|||
94536617|NCT01252186|323760105|FG001|Overall Study|Withdrawal by Subject|5|||
94536618|NCT01252186|323760106|FG002|Overall Study|Withdrawal by Subject|2|||
94536619|NCT01252186|323760104|FG000|Overall Study|Physician Decision|0|||
94536620|NCT01252186|323760105|FG001|Overall Study|Physician Decision|0|||
94536621|NCT01252186|323760106|FG002|Overall Study|Physician Decision|1|||
94536622|NCT01252186|323760104|FG000|Overall Study|Non-compliance|0|||
94536623|NCT01252186|323760105|FG001|Overall Study|Non-compliance|3|||
94536624|NCT01252186|323760106|FG002|Overall Study|Non-compliance|4|||
94536625|NCT01252186|323760104|FG000|Overall Study|Protocol Violation|0|||
94536626|NCT01252186|323760105|FG001|Overall Study|Protocol Violation|0|||
94536627|NCT01252186|323760106|FG002|Overall Study|Protocol Violation|1|||
94536628|NCT01252186|323760104|FG000|Overall Study|Pregnancy|2|||
94536629|NCT01252186|323760105|FG001|Overall Study|Pregnancy|2|||
94536630|NCT01252186|323760106|FG002|Overall Study|Pregnancy|0|||
94536631|NCT01252186|323760104|FG000|Overall Study|Sponsor Request|2|||
94536632|NCT01252186|323760105|FG001|Overall Study|Sponsor Request|1|||
94536633|NCT01252186|323760106|FG002|Overall Study|Sponsor Request|0|||
94536634|NCT01252186|323760104|FG000|Overall Study|Lost to Follow-up|10|||
94536635|NCT01252186|323760105|FG001|Overall Study|Lost to Follow-up|10|||
94536636|NCT01252186|323760106|FG002|Overall Study|Lost to Follow-up|11|||
94536637|NCT01252186|323760104|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
94536638|NCT01252186|323760105|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
94536639|NCT01252186|323760106|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
94536640|NCT01468233|323760111|FG000|Treatment Period 1|Adverse Event|5|||
94536641|NCT01468233|323760112|FG001|Treatment Period 1|Adverse Event|3|||
94536642|NCT01468233|323760113|FG002|Treatment Period 1|Adverse Event|0|||
94536643|NCT01468233|323760114|FG003|Treatment Period 1|Adverse Event|0|||
94536644|NCT01468233|323760115|FG004|Treatment Period 1|Adverse Event|0|||
94536645|NCT01468233|323760116|FG005|Treatment Period 1|Adverse Event|0|||
94536646|NCT01468233|323760111|FG000|Treatment Period 1|Withdrawal by Subject|3|||
94536647|NCT01468233|323760112|FG001|Treatment Period 1|Withdrawal by Subject|4|||
94536648|NCT01468233|323760113|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94536649|NCT01468233|323760114|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94536650|NCT01468233|323760115|FG004|Treatment Period 1|Withdrawal by Subject|0|||
94536651|NCT01468233|323760116|FG005|Treatment Period 1|Withdrawal by Subject|0|||
94536652|NCT01468233|323760111|FG000|Treatment Period 1|Lost to Follow-up|3|||
94536653|NCT01468233|323760112|FG001|Treatment Period 1|Lost to Follow-up|0|||
94536654|NCT01468233|323760113|FG002|Treatment Period 1|Lost to Follow-up|0|||
94536655|NCT01468233|323760114|FG003|Treatment Period 1|Lost to Follow-up|0|||
94536656|NCT01468233|323760115|FG004|Treatment Period 1|Lost to Follow-up|0|||
94536657|NCT01468233|323760116|FG005|Treatment Period 1|Lost to Follow-up|0|||
94536658|NCT01468233|323760111|FG000|Treatment Period 1|Other|1|||
94536659|NCT01468233|323760112|FG001|Treatment Period 1|Other|1|||
94536660|NCT01468233|323760113|FG002|Treatment Period 1|Other|0|||
94536661|NCT01468233|323760114|FG003|Treatment Period 1|Other|0|||
94536662|NCT01468233|323760115|FG004|Treatment Period 1|Other|0|||
94536663|NCT01468233|323760116|FG005|Treatment Period 1|Other|0|||
94536664|NCT01468233|323760111|FG000|Treatment Period 2|Adverse Event|0|||
94536665|NCT01468233|323760112|FG001|Treatment Period 2|Adverse Event|0|||
94536666|NCT01468233|323760113|FG002|Treatment Period 2|Adverse Event|3|||
94536667|NCT01468233|323760114|FG003|Treatment Period 2|Adverse Event|0|||
94536668|NCT01468233|323760115|FG004|Treatment Period 2|Adverse Event|2|||
94536669|NCT01468233|323760116|FG005|Treatment Period 2|Adverse Event|1|||
94536670|NCT01468233|323760111|FG000|Treatment Period 2|Lack of Efficacy|0|||
94536671|NCT01468233|323760112|FG001|Treatment Period 2|Lack of Efficacy|0|||
94536672|NCT01468233|323760113|FG002|Treatment Period 2|Lack of Efficacy|9|||
94536673|NCT01468233|323760114|FG003|Treatment Period 2|Lack of Efficacy|2|||
94536674|NCT01468233|323760115|FG004|Treatment Period 2|Lack of Efficacy|0|||
94536675|NCT01468233|323760116|FG005|Treatment Period 2|Lack of Efficacy|1|||
94536676|NCT01468233|323760111|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94536677|NCT01468233|323760112|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94536678|NCT01468233|323760113|FG002|Treatment Period 2|Withdrawal by Subject|9|||
94536679|NCT01468233|323760114|FG003|Treatment Period 2|Withdrawal by Subject|1|||
94536680|NCT01468233|323760115|FG004|Treatment Period 2|Withdrawal by Subject|1|||
94536681|NCT01468233|323760116|FG005|Treatment Period 2|Withdrawal by Subject|1|||
94536682|NCT01468233|323760111|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
94536683|NCT01468233|323760112|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
94536684|NCT01468233|323760113|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
94536685|NCT01468233|323760114|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
94536686|NCT01468233|323760115|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
94536687|NCT01468233|323760116|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
94536688|NCT01468233|323760111|FG000|Treatment Period 2|Lost to Follow-up|0|||
94536689|NCT01468233|323760112|FG001|Treatment Period 2|Lost to Follow-up|0|||
94536690|NCT01468233|323760113|FG002|Treatment Period 2|Lost to Follow-up|3|||
94536691|NCT01468233|323760114|FG003|Treatment Period 2|Lost to Follow-up|0|||
94536692|NCT01468233|323760115|FG004|Treatment Period 2|Lost to Follow-up|2|||
94536693|NCT01468233|323760116|FG005|Treatment Period 2|Lost to Follow-up|0|||
94536694|NCT01468233|323760111|FG000|Treatment Period 2|Other|0|||
94536695|NCT01468233|323760112|FG001|Treatment Period 2|Other|0|||
94536696|NCT01468233|323760113|FG002|Treatment Period 2|Other|3|||
94536697|NCT01468233|323760114|FG003|Treatment Period 2|Other|0|||
94536698|NCT01468233|323760115|FG004|Treatment Period 2|Other|1|||
94536699|NCT01468233|323760116|FG005|Treatment Period 2|Other|0|||
94536700|NCT00778258|323760117|FG000|Overall Study|Adverse Event|1|||
94536701|NCT00778258|323760118|FG001|Overall Study|Adverse Event|0|||
94536702|NCT00778258|323760119|FG002|Overall Study|Adverse Event|0|||
94536703|NCT00778258|323760120|FG003|Overall Study|Adverse Event|0|||
94536704|NCT00778258|323760121|FG004|Overall Study|Adverse Event|0|||
94536705|NCT00778258|323760122|FG005|Overall Study|Adverse Event|1|||
94536706|NCT00778258|323760123|FG006|Overall Study|Adverse Event|0|||
94536707|NCT00778258|323760124|FG007|Overall Study|Adverse Event|0|||
94536708|NCT00778258|323760125|FG008|Overall Study|Adverse Event|0|||
94536709|NCT00778258|323760117|FG000|Overall Study|Lost to Follow-up|0|||
94536710|NCT00778258|323760118|FG001|Overall Study|Lost to Follow-up|0|||
94536711|NCT00778258|323760119|FG002|Overall Study|Lost to Follow-up|2|||
94536712|NCT00778258|323760120|FG003|Overall Study|Lost to Follow-up|0|||
94536713|NCT00778258|323760121|FG004|Overall Study|Lost to Follow-up|0|||
94536714|NCT00778258|323760122|FG005|Overall Study|Lost to Follow-up|3|||
94536715|NCT00778258|323760123|FG006|Overall Study|Lost to Follow-up|2|||
94536716|NCT00778258|323760124|FG007|Overall Study|Lost to Follow-up|2|||
94536717|NCT00778258|323760125|FG008|Overall Study|Lost to Follow-up|0|||
94536718|NCT00778258|323760117|FG000|Overall Study|Withdrawal by Subject|6|||
94536719|NCT00778258|323760118|FG001|Overall Study|Withdrawal by Subject|2|||
94536720|NCT00778258|323760119|FG002|Overall Study|Withdrawal by Subject|8|||
94536721|NCT00778258|323760120|FG003|Overall Study|Withdrawal by Subject|2|||
94536722|NCT00778258|323760121|FG004|Overall Study|Withdrawal by Subject|0|||
94536723|NCT00778258|323760122|FG005|Overall Study|Withdrawal by Subject|6|||
94536724|NCT00778258|323760123|FG006|Overall Study|Withdrawal by Subject|12|||
94536725|NCT00778258|323760124|FG007|Overall Study|Withdrawal by Subject|12|||
94536726|NCT00778258|323760125|FG008|Overall Study|Withdrawal by Subject|4|||
94536727|NCT00778258|323760117|FG000|Overall Study|New Contraindication|0|||
94536728|NCT00778258|323760118|FG001|Overall Study|New Contraindication|0|||
94536729|NCT00778258|323760119|FG002|Overall Study|New Contraindication|0|||
94536730|NCT00778258|323760120|FG003|Overall Study|New Contraindication|0|||
94536731|NCT00778258|323760121|FG004|Overall Study|New Contraindication|0|||
94536732|NCT00778258|323760122|FG005|Overall Study|New Contraindication|0|||
94536733|NCT00778258|323760123|FG006|Overall Study|New Contraindication|0|||
94536734|NCT00778258|323760124|FG007|Overall Study|New Contraindication|1|||
94536735|NCT00778258|323760125|FG008|Overall Study|New Contraindication|0|||
94536736|NCT00778258|323760117|FG000|Overall Study|Non-compliance|0|||
94536737|NCT00778258|323760118|FG001|Overall Study|Non-compliance|0|||
94536738|NCT00778258|323760119|FG002|Overall Study|Non-compliance|0|||
94536739|NCT00778258|323760120|FG003|Overall Study|Non-compliance|1|||
94536740|NCT00778258|323760121|FG004|Overall Study|Non-compliance|0|||
94536741|NCT00778258|323760122|FG005|Overall Study|Non-compliance|0|||
94536742|NCT00778258|323760123|FG006|Overall Study|Non-compliance|0|||
94536743|NCT00778258|323760124|FG007|Overall Study|Non-compliance|0|||
94536744|NCT00778258|323760125|FG008|Overall Study|Non-compliance|0|||
94536745|NCT00778258|323760117|FG000|Overall Study|Other|0|||
94536746|NCT00778258|323760118|FG001|Overall Study|Other|0|||
94536747|NCT00778258|323760119|FG002|Overall Study|Other|0|||
94536748|NCT00778258|323760120|FG003|Overall Study|Other|0|||
94536749|NCT00778258|323760121|FG004|Overall Study|Other|0|||
94536750|NCT00778258|323760122|FG005|Overall Study|Other|0|||
94536751|NCT00778258|323760123|FG006|Overall Study|Other|1|||
94536752|NCT00778258|323760124|FG007|Overall Study|Other|0|||
94536753|NCT00778258|323760125|FG008|Overall Study|Other|0|||
94536754|NCT05605691|323760129|FG000|Overall Study|Lost to Follow-up|1|||
94536755|NCT04926831|323760130|FG000|Overall Study|Withdrawal by Subject|2|||
94536756|NCT04926831|323760130|FG000|Overall Study|Adverse Event|2|||
94536757|NCT04669262|323760131|FG000|Overall Study|Withdrawal by Subject|0|||
94536758|NCT04669262|323760132|FG001|Overall Study|Withdrawal by Subject|0|||
94536759|NCT04669262|323760133|FG002|Overall Study|Withdrawal by Subject|0|||
94536760|NCT04669262|323760134|FG003|Overall Study|Withdrawal by Subject|1|||
94536761|NCT04669262|323760131|FG000|Overall Study|Randomized but Not Treated|0|||
94536762|NCT04669262|323760132|FG001|Overall Study|Randomized but Not Treated|1|||
94536763|NCT04669262|323760133|FG002|Overall Study|Randomized but Not Treated|0|||
94536764|NCT04669262|323760134|FG003|Overall Study|Randomized but Not Treated|0|||
94536765|NCT01457014|323760135|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
94536766|NCT01457014|323760136|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
94536767|NCT01457014|323760137|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
94536768|NCT01457014|323760138|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
94536769|NCT01457014|323760135|FG000|First Night|Withdrawal by Subject|3|||
94536770|NCT01457014|323760136|FG001|First Night|Withdrawal by Subject|0|||
94536771|NCT01457014|323760137|FG002|First Night|Withdrawal by Subject|0|||
94536772|NCT01457014|323760138|FG003|First Night|Withdrawal by Subject|0|||
94536773|NCT01166373|323760143|FG000|Overall Study|Lost to Follow-up|3|||
94536774|NCT01166373|323760144|FG001|Overall Study|Lost to Follow-up|2|||
94536775|NCT01166373|323760145|FG002|Overall Study|Lost to Follow-up|2|||
94536776|NCT01166373|323760146|FG003|Overall Study|Lost to Follow-up|2|||
94536777|NCT01166373|323760143|FG000|Overall Study|Withdrawal by Subject|1|||
94536778|NCT01166373|323760144|FG001|Overall Study|Withdrawal by Subject|2|||
94536779|NCT01166373|323760145|FG002|Overall Study|Withdrawal by Subject|2|||
94536780|NCT01166373|323760146|FG003|Overall Study|Withdrawal by Subject|3|||
94536781|NCT01166373|323760143|FG000|Overall Study|Physician Decision|1|||
94536782|NCT01166373|323760144|FG001|Overall Study|Physician Decision|0|||
94536783|NCT01166373|323760145|FG002|Overall Study|Physician Decision|0|||
94536784|NCT01166373|323760146|FG003|Overall Study|Physician Decision|0|||
94536785|NCT02752958|323760147|FG000|Overall Study|Adverse Event|3|||
94536786|NCT02752958|323760147|FG000|Overall Study|Lost to Follow-up|1|||
94536787|NCT02752958|323760147|FG000|Overall Study|Protocol Violation|1|||
94536788|NCT02752958|323760147|FG000|Overall Study|Withdrawal by Subject|2|||
94536789|NCT02752958|323760147|FG000|Overall Study|Other (Reason not specified)|2|||
94536790|NCT02640625|323762189|FG000|Overall Study|Adverse Event|1|||
94536791|NCT00511433|323762190|FG000|Overall Study|Adverse Event|5|||
94536792|NCT00511433|323762191|FG001|Overall Study|Adverse Event|0|||
94536793|NCT00511433|323762190|FG000|Overall Study|Other Reason|1|||
94536794|NCT00511433|323762191|FG001|Overall Study|Other Reason|1|||
94536795|NCT02908685|323762192|FG000|Part 1 OLE|Withdrawal by Subject|0|||
94536796|NCT02908685|323762193|FG001|Part 1 OLE|Withdrawal by Subject|0|||
94536797|NCT02908685|323762194|FG002|Part 1 OLE|Withdrawal by Subject|0|||
94536798|NCT02908685|323762195|FG003|Part 1 OLE|Withdrawal by Subject|0|||
94536799|NCT02908685|323762196|FG004|Part 1 OLE|Withdrawal by Subject|0|||
94536800|NCT02908685|323762197|FG005|Part 1 OLE|Withdrawal by Subject|0|||
94536801|NCT02908685|323762198|FG006|Part 1 OLE|Withdrawal by Subject|0|||
94536802|NCT02908685|323762199|FG007|Part 1 OLE|Withdrawal by Subject|0|||
94536803|NCT02908685|323762200|FG008|Part 1 OLE|Withdrawal by Subject|0|||
94536804|NCT02908685|323762201|FG009|Part 1 OLE|Withdrawal by Subject|0|||
94536805|NCT02908685|323762202|FG010|Part 1 OLE|Withdrawal by Subject|2|||
94536806|NCT02908685|323762203|FG011|Part 1 OLE|Withdrawal by Subject|1|||
94536807|NCT02908685|323762204|FG012|Part 1 OLE|Withdrawal by Subject|0|||
94536808|NCT02908685|323762205|FG013|Part 1 OLE|Withdrawal by Subject|0|||
94536809|NCT02908685|323762192|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
94536810|NCT02908685|323762193|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
94536811|NCT02908685|323762194|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
94536812|NCT02908685|323762195|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
94536813|NCT02908685|323762196|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
94536814|NCT02908685|323762197|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
94536815|NCT02908685|323762198|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
94536816|NCT02908685|323762199|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
94536817|NCT02908685|323762200|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
94536818|NCT02908685|323762201|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
94536819|NCT02908685|323762202|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
94536820|NCT02908685|323762203|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
94536821|NCT02908685|323762204|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
94536822|NCT02908685|323762205|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
94536823|NCT02908685|323762192|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
94536824|NCT02908685|323762193|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
94536825|NCT02908685|323762194|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
94536826|NCT02908685|323762195|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
94536827|NCT02908685|323762196|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
94536828|NCT02908685|323762197|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
94536829|NCT02908685|323762198|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
94536830|NCT02908685|323762199|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
94536831|NCT02908685|323762200|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
94536832|NCT02908685|323762201|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
94536833|NCT02908685|323762202|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
94536834|NCT02908685|323762203|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
94536835|NCT02908685|323762204|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
94536836|NCT02908685|323762205|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
94536837|NCT02908685|323762192|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
94536838|NCT02908685|323762193|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
94536839|NCT02908685|323762194|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
94536840|NCT02908685|323762195|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
94536841|NCT02908685|323762196|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
94536842|NCT02908685|323762197|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
94536843|NCT02908685|323762198|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
94536844|NCT02908685|323762199|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
94536845|NCT02908685|323762200|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
94536846|NCT02908685|323762201|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
94536847|NCT02908685|323762202|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
94536848|NCT02908685|323762203|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
94536849|NCT02908685|323762204|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
94536850|NCT02908685|323762205|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
94536851|NCT02908685|323762192|FG000|Part 2 OLE: > Month 24|Death|0|||
94536852|NCT02908685|323762193|FG001|Part 2 OLE: > Month 24|Death|0|||
94536853|NCT02908685|323762194|FG002|Part 2 OLE: > Month 24|Death|0|||
94536854|NCT02908685|323762195|FG003|Part 2 OLE: > Month 24|Death|0|||
94536855|NCT02908685|323762196|FG004|Part 2 OLE: > Month 24|Death|0|||
94536856|NCT02908685|323762197|FG005|Part 2 OLE: > Month 24|Death|0|||
94536857|NCT02908685|323762198|FG006|Part 2 OLE: > Month 24|Death|0|||
94536858|NCT02908685|323762199|FG007|Part 2 OLE: > Month 24|Death|0|||
94536859|NCT02908685|323762200|FG008|Part 2 OLE: > Month 24|Death|0|||
94536860|NCT02908685|323762201|FG009|Part 2 OLE: > Month 24|Death|0|||
94536861|NCT02908685|323762202|FG010|Part 2 OLE: > Month 24|Death|0|||
94536862|NCT02908685|323762203|FG011|Part 2 OLE: > Month 24|Death|0|||
94536863|NCT02908685|323762204|FG012|Part 2 OLE: > Month 24|Death|1|||
94536864|NCT02908685|323762205|FG013|Part 2 OLE: > Month 24|Death|0|||
94536865|NCT02908685|323762192|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
94536866|NCT02908685|323762193|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
94536867|NCT02908685|323762194|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
94536868|NCT02908685|323762195|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
94536869|NCT02908685|323762196|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
94536870|NCT02908685|323762197|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
94536871|NCT02908685|323762198|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
94536872|NCT02908685|323762199|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
94536873|NCT02908685|323762200|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
94536874|NCT02908685|323762201|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
94536875|NCT02908685|323762202|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
94536876|NCT02908685|323762203|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
94536877|NCT02908685|323762204|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
94536878|NCT02908685|323762205|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
94536879|NCT02908685|323762192|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
94536880|NCT02908685|323762193|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
94536881|NCT02908685|323762194|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
94536882|NCT02908685|323762195|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
94536883|NCT02908685|323762196|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
94536884|NCT02908685|323762197|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
94536885|NCT02908685|323762198|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
94536886|NCT02908685|323762199|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
94536887|NCT02908685|323762200|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
94536888|NCT02908685|323762201|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
94536889|NCT02908685|323762202|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
94536890|NCT02908685|323762203|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
94536891|NCT02908685|323762204|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
94536892|NCT02908685|323762205|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
94536893|NCT01740089|323762206|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
94536894|NCT01740089|323762207|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
94536895|NCT01740089|323762208|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
94536896|NCT01740089|323762206|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
94536897|NCT01740089|323762207|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
94536898|NCT01740089|323762208|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
94536899|NCT01740089|323762206|FG000|After 12 Weeks|Lack of Efficacy|3|||
94536900|NCT01740089|323762207|FG001|After 12 Weeks|Lack of Efficacy|1|||
94536901|NCT01740089|323762208|FG002|After 12 Weeks|Lack of Efficacy|4|||
94536902|NCT01740089|323762206|FG000|After 12 Weeks|Adverse Event|2|||
94536903|NCT01740089|323762207|FG001|After 12 Weeks|Adverse Event|0|||
94536904|NCT01740089|323762208|FG002|After 12 Weeks|Adverse Event|5|||
94536905|NCT01740089|323762206|FG000|After 12 Weeks|Protocol Violation|1|||
94536906|NCT01740089|323762207|FG001|After 12 Weeks|Protocol Violation|1|||
94536907|NCT01740089|323762208|FG002|After 12 Weeks|Protocol Violation|1|||
94536908|NCT01740089|323762206|FG000|After 12 Weeks|Withdrawal by Subject|1|||
94536909|NCT01740089|323762207|FG001|After 12 Weeks|Withdrawal by Subject|1|||
94536910|NCT01740089|323762208|FG002|After 12 Weeks|Withdrawal by Subject|1|||
94536911|NCT01691014|323762213|FG000|Overall Study|Premature Termination|1|||
94536912|NCT01691014|323762214|FG001|Overall Study|Premature Termination|6|||
94536913|NCT01691014|323762215|FG002|Overall Study|Premature Termination|0|||
94536914|NCT01691014|323762216|FG003|Overall Study|Premature Termination|3|||
94536915|NCT01691014|323762213|FG000|Overall Study|Other|0|||
94536916|NCT01691014|323762214|FG001|Overall Study|Other|0|||
94536917|NCT01691014|323762215|FG002|Overall Study|Other|2|||
94536918|NCT01691014|323762216|FG003|Overall Study|Other|0|||
94536919|NCT01691014|323762213|FG000|Overall Study|Withdrawal by Subject|0|||
94536920|NCT01691014|323762214|FG001|Overall Study|Withdrawal by Subject|1|||
94536921|NCT01691014|323762215|FG002|Overall Study|Withdrawal by Subject|1|||
94536922|NCT01691014|323762216|FG003|Overall Study|Withdrawal by Subject|1|||
94536923|NCT01691014|323762213|FG000|Overall Study|Adverse Event|0|||
94536924|NCT01691014|323762214|FG001|Overall Study|Adverse Event|5|||
94536925|NCT01691014|323762215|FG002|Overall Study|Adverse Event|1|||
94536926|NCT01691014|323762216|FG003|Overall Study|Adverse Event|1|||
94536927|NCT01691014|323762213|FG000|Overall Study|Lack of Efficacy|2|||
94536928|NCT01691014|323762214|FG001|Overall Study|Lack of Efficacy|3|||
94536929|NCT01691014|323762215|FG002|Overall Study|Lack of Efficacy|7|||
94536930|NCT01691014|323762216|FG003|Overall Study|Lack of Efficacy|0|||
94536931|NCT02370537|323762217|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
94536932|NCT02370537|323762218|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
94536933|NCT02370537|323762219|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
94536934|NCT02370537|323762217|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
94536935|NCT02370537|323762218|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
94536936|NCT02370537|323762219|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
94536937|NCT02370537|323762217|FG000|Part B|Not randomised to receive treatment|1|||
94536938|NCT02370537|323762218|FG001|Part B|Not randomised to receive treatment|2|||
94536939|NCT02370537|323762219|FG002|Part B|Not randomised to receive treatment|259|||
94536940|NCT02370537|323762217|FG000|Part B|Withdrawal by Subject|0|||
94536941|NCT02370537|323762218|FG001|Part B|Withdrawal by Subject|1|||
94536942|NCT02370537|323762219|FG002|Part B|Withdrawal by Subject|0|||
94536943|NCT03372551|323762220|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
94536944|NCT03372551|323762221|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
94536945|NCT01952665|323762222|FG000|Overall Study|Physician Decision|3|||
94536946|NCT01952665|323762223|FG001|Overall Study|Physician Decision|2|||
94536947|NCT01952665|323762222|FG000|Overall Study|Lost to Follow-up|1|||
94536948|NCT01952665|323762223|FG001|Overall Study|Lost to Follow-up|2|||
94536949|NCT01952665|323762222|FG000|Overall Study|Adverse Event|2|||
94536950|NCT01952665|323762223|FG001|Overall Study|Adverse Event|1|||
94536951|NCT01952665|323762222|FG000|Overall Study|Protocol Violation|0|||
94536952|NCT01952665|323762223|FG001|Overall Study|Protocol Violation|1|||
94536953|NCT01537081|323762224|FG000|Overall Study|Adverse Event|5|||
94536954|NCT01537081|323762225|FG001|Overall Study|Adverse Event|2|||
94536955|NCT01537081|323762226|FG002|Overall Study|Adverse Event|2|||
94536956|NCT01537081|323762224|FG000|Overall Study|Lack of Efficacy|2|||
94536957|NCT01537081|323762225|FG001|Overall Study|Lack of Efficacy|1|||
94536958|NCT01537081|323762226|FG002|Overall Study|Lack of Efficacy|0|||
94536959|NCT01537081|323762224|FG000|Overall Study|Lost to Follow-up|17|||
94536960|NCT01537081|323762225|FG001|Overall Study|Lost to Follow-up|15|||
94536961|NCT01537081|323762226|FG002|Overall Study|Lost to Follow-up|9|||
94536962|NCT01537081|323762224|FG000|Overall Study|Protocol Violation|3|||
94536963|NCT01537081|323762225|FG001|Overall Study|Protocol Violation|2|||
94536964|NCT01537081|323762226|FG002|Overall Study|Protocol Violation|2|||
94536965|NCT01537081|323762224|FG000|Overall Study|Withdrawal by Subject|6|||
94536966|NCT01537081|323762225|FG001|Overall Study|Withdrawal by Subject|11|||
94536967|NCT01537081|323762226|FG002|Overall Study|Withdrawal by Subject|3|||
94536968|NCT01537081|323762224|FG000|Overall Study|Physician Decision|5|||
94536969|NCT01537081|323762225|FG001|Overall Study|Physician Decision|6|||
94536970|NCT01537081|323762226|FG002|Overall Study|Physician Decision|0|||
94536971|NCT01537081|323762224|FG000|Overall Study|Sponsor decision|0|||
94536972|NCT01537081|323762225|FG001|Overall Study|Sponsor decision|1|||
94536973|NCT01537081|323762226|FG002|Overall Study|Sponsor decision|0|||
94536974|NCT01537081|323762224|FG000|Overall Study|Assigned but never dosed|1|||
94536975|NCT01537081|323762225|FG001|Overall Study|Assigned but never dosed|0|||
94536976|NCT01537081|323762226|FG002|Overall Study|Assigned but never dosed|0|||
94536977|NCT03285958|323762231|FG000|Overall Study|Lost to Follow-up|1|||
94536978|NCT03285958|323762232|FG001|Overall Study|Lost to Follow-up|1|||
94536979|NCT03285958|323762231|FG000|Overall Study|Withdrawal by Subject|1|||
94536980|NCT03285958|323762232|FG001|Overall Study|Withdrawal by Subject|0|||
94536981|NCT03285958|323762231|FG000|Overall Study|Not able to attend required orientation|3|||
94536982|NCT03285958|323762232|FG001|Overall Study|Not able to attend required orientation|0|||
94536983|NCT01559259|323762240|FG000|Overall Study|Withdrawal by Subject|0|||
94536984|NCT01559259|323762241|FG001|Overall Study|Withdrawal by Subject|0|||
94536985|NCT01559259|323762242|FG002|Overall Study|Withdrawal by Subject|0|||
94536986|NCT01559259|323762243|FG003|Overall Study|Withdrawal by Subject|1|||
94536987|NCT01559259|323762244|FG004|Overall Study|Withdrawal by Subject|0|||
94536988|NCT01559259|323762240|FG000|Overall Study|Adverse Event|0|||
94536989|NCT01559259|323762241|FG001|Overall Study|Adverse Event|1|||
94536990|NCT01559259|323762242|FG002|Overall Study|Adverse Event|1|||
94536991|NCT01559259|323762243|FG003|Overall Study|Adverse Event|0|||
94536992|NCT01559259|323762244|FG004|Overall Study|Adverse Event|0|||
94536993|NCT00306293|323762245|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
94536994|NCT00306293|323762246|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
94536995|NCT00306293|323762245|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
94536996|NCT00306293|323762246|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
94536997|NCT00306293|323762245|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
94536998|NCT00306293|323762246|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
94536999|NCT00306293|323762245|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
94537000|NCT00306293|323762246|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
94537001|NCT00306293|323762245|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
94537002|NCT00306293|323762246|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
94537003|NCT00306293|323762245|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
94537004|NCT00306293|323762246|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
94537005|NCT00306293|323762245|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
94537006|NCT00306293|323762246|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
94537007|NCT00306293|323762245|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
94537008|NCT00306293|323762246|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
94537009|NCT01159171|323762249|FG000|Overall Study|Adverse Event|11|||
94537010|NCT01159171|323762249|FG000|Overall Study|Progression of Disease|28|||
94537011|NCT01159171|323762249|FG000|Overall Study|Protocol Violation|1|||
94537012|NCT01159171|323762249|FG000|Overall Study|Need for Surgery|5|||
94537013|NCT01159171|323762249|FG000|Overall Study|Medical Decision|4|||
94537014|NCT01159171|323762249|FG000|Overall Study|Death|1|||
94537015|NCT01145352|323762251|FG000|Overall Study|Found to have been registered twice|6|||
94537016|NCT01145352|323762251|FG000|Overall Study|Treated before marketing approval|4|||
94537017|NCT01145352|323762251|FG000|Overall Study|Syringe formulation was used|1|||
94537018|NCT03095027|323762252|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
94537019|NCT03095027|323762253|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
94537020|NCT00420004|323762254|FG000|Overall Study|Adverse Event|4|||
94537021|NCT00420004|323762255|FG001|Overall Study|Adverse Event|1|||
94537022|NCT00420004|323762256|FG002|Overall Study|Adverse Event|1|||
94537023|NCT00420004|323762254|FG000|Overall Study|Lack of Efficacy|5|||
94537024|NCT00420004|323762255|FG001|Overall Study|Lack of Efficacy|4|||
94537025|NCT00420004|323762256|FG002|Overall Study|Lack of Efficacy|1|||
94537026|NCT00420004|323762254|FG000|Overall Study|Lost to Follow-up|31|||
94537027|NCT00420004|323762255|FG001|Overall Study|Lost to Follow-up|12|||
94537028|NCT00420004|323762256|FG002|Overall Study|Lost to Follow-up|10|||
94537029|NCT00420004|323762254|FG000|Overall Study|Entry Criteria Not Met|0|||
94537030|NCT00420004|323762255|FG001|Overall Study|Entry Criteria Not Met|1|||
94537031|NCT00420004|323762256|FG002|Overall Study|Entry Criteria Not Met|0|||
94537032|NCT00420004|323762254|FG000|Overall Study|Physician Decision|14|||
94537033|NCT00420004|323762255|FG001|Overall Study|Physician Decision|4|||
94537034|NCT00420004|323762256|FG002|Overall Study|Physician Decision|2|||
94537035|NCT00420004|323762254|FG000|Overall Study|Protocol Violation|5|||
94537036|NCT00420004|323762255|FG001|Overall Study|Protocol Violation|4|||
94537037|NCT00420004|323762256|FG002|Overall Study|Protocol Violation|3|||
94537038|NCT00420004|323762254|FG000|Overall Study|Withdrawal by Subject|67|||
94537039|NCT00420004|323762255|FG001|Overall Study|Withdrawal by Subject|42|||
94537040|NCT00420004|323762256|FG002|Overall Study|Withdrawal by Subject|14|||
94537041|NCT00420004|323762254|FG000|Overall Study|Sponsor Decision|3|||
94537042|NCT00420004|323762255|FG001|Overall Study|Sponsor Decision|3|||
94537043|NCT00420004|323762256|FG002|Overall Study|Sponsor Decision|1|||
94537044|NCT02379221|323762260|FG000|Overall Study|Lost to Follow-up|1|||
94537045|NCT04569136|323762261|FG000|Overall Study|Lost to Follow-up|2|||
94537046|NCT04569136|323762262|FG001|Overall Study|Lost to Follow-up|0|||
94537047|NCT04569136|323762263|FG002|Overall Study|Lost to Follow-up|1|||
94537048|NCT02650128|323762264|FG000|Overall Study|Death|2|||
94537049|NCT02516098|323762275|FG000|Period 1|Protocol Violation|1|||
94537050|NCT02516098|323762276|FG001|Period 1|Protocol Violation|0|||
94537051|NCT02516098|323762275|FG000|Washout After Period 1|Adverse Event|0|||
94537052|NCT02516098|323762276|FG001|Washout After Period 1|Adverse Event|1|||
94537053|NCT02516098|323762275|FG000|Period 2|Withdrawal by Subject|0|||
94537054|NCT02516098|323762276|FG001|Period 2|Withdrawal by Subject|1|||
94537055|NCT02442310|323762277|FG000|Overall Study|Adverse Event|2|||
94537056|NCT02442310|323762277|FG000|Overall Study|Withdrawal by Subject|1|||
94537057|NCT03176472|323762278|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
94537058|NCT03176472|323762279|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
94537059|NCT03176472|323762278|FG000|Double Blind Treatment Period|Adverse Event|0|||
94537060|NCT03176472|323762279|FG001|Double Blind Treatment Period|Adverse Event|5|||
94537061|NCT03176472|323762278|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
94537062|NCT03176472|323762279|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
94537063|NCT03176472|323762278|FG000|Double Blind Treatment Period|Physician Decision|0|||
94537064|NCT03176472|323762279|FG001|Double Blind Treatment Period|Physician Decision|1|||
94537065|NCT03176472|323762278|FG000|Double Blind Treatment Period|Protocol Violation|1|||
94537066|NCT03176472|323762279|FG001|Double Blind Treatment Period|Protocol Violation|0|||
94537067|NCT03176472|323762278|FG000|Double Blind Treatment Period|Not Provided|1|||
94537068|NCT03176472|323762279|FG001|Double Blind Treatment Period|Not Provided|0|||
94537069|NCT03176472|323762278|FG000|Open Label Extension|Withdrawal by Subject|3|||
94537070|NCT03176472|323762279|FG001|Open Label Extension|Withdrawal by Subject|4|||
94537071|NCT03176472|323762278|FG000|Open Label Extension|Adverse Event|2|||
94537072|NCT03176472|323762279|FG001|Open Label Extension|Adverse Event|4|||
94537073|NCT03176472|323762278|FG000|Open Label Extension|Lost to Follow-up|1|||
94537074|NCT03176472|323762279|FG001|Open Label Extension|Lost to Follow-up|2|||
94537075|NCT03176472|323762278|FG000|Open Label Extension|Protocol Violation|0|||
94537076|NCT03176472|323762279|FG001|Open Label Extension|Protocol Violation|1|||
94537077|NCT03176472|323762278|FG000|Open Label Extension|Not Provided|2|||
94537078|NCT03176472|323762279|FG001|Open Label Extension|Not Provided|1|||
94537079|NCT01562314|323762292|FG000|Overall Study|Adverse Event|10|||
94537080|NCT01562314|323762293|FG001|Overall Study|Adverse Event|5|||
94537081|NCT01562314|323762292|FG000|Overall Study|Met Withdrawal Criteria|3|||
94537082|NCT01562314|323762293|FG001|Overall Study|Met Withdrawal Criteria|2|||
94537083|NCT01562314|323762292|FG000|Overall Study|Withdrawal by Subject|0|||
94537084|NCT01562314|323762293|FG001|Overall Study|Withdrawal by Subject|1|||
94537085|NCT00888329|323762294|FG000|Overall Study|Physician Decision|6|||
94537086|NCT00888329|323762295|FG001|Overall Study|Physician Decision|9|||
94537087|NCT03344549|323762296|FG000|Overall Study|Withdrawal by Subject|3|||
94537088|NCT03344549|323762297|FG001|Overall Study|Withdrawal by Subject|2|||
94537089|NCT03344549|323762296|FG000|Overall Study|Dialysis|2|||
94537090|NCT03344549|323762297|FG001|Overall Study|Dialysis|0|||
94537091|NCT03344549|323762296|FG000|Overall Study|Cancer|1|||
94537092|NCT03344549|323762297|FG001|Overall Study|Cancer|0|||
94537093|NCT03344549|323762296|FG000|Overall Study|Lack of electronic device|1|||
94537094|NCT03344549|323762297|FG001|Overall Study|Lack of electronic device|0|||
94537095|NCT03344549|323762296|FG000|Overall Study|Transportation difficulty|0|||
94537096|NCT03344549|323762297|FG001|Overall Study|Transportation difficulty|13|||
94537097|NCT01106651|323762298|FG000|Overall Study|Adverse Event|17|||
94537098|NCT01106651|323762299|FG001|Overall Study|Adverse Event|9|||
94537099|NCT01106651|323762300|FG002|Overall Study|Adverse Event|23|||
94537100|NCT01106651|323762298|FG000|Overall Study|Lost to Follow-up|8|||
94537101|NCT01106651|323762299|FG001|Overall Study|Lost to Follow-up|2|||
94537102|NCT01106651|323762300|FG002|Overall Study|Lost to Follow-up|6|||
94537103|NCT01106651|323762298|FG000|Overall Study|Physician Decision|4|||
94537104|NCT01106651|323762299|FG001|Overall Study|Physician Decision|3|||
94537105|NCT01106651|323762300|FG002|Overall Study|Physician Decision|1|||
94537106|NCT01106651|323762298|FG000|Overall Study|Protocol Violation|1|||
94537107|NCT01106651|323762299|FG001|Overall Study|Protocol Violation|2|||
94537108|NCT01106651|323762300|FG002|Overall Study|Protocol Violation|1|||
94537109|NCT01106651|323762298|FG000|Overall Study|Withdrawal by Subject|14|||
94537110|NCT01106651|323762299|FG001|Overall Study|Withdrawal by Subject|7|||
94537111|NCT01106651|323762300|FG002|Overall Study|Withdrawal by Subject|4|||
94537112|NCT01106651|323762298|FG000|Overall Study|Noncompliance with study drug|1|||
94537113|NCT01106651|323762299|FG001|Overall Study|Noncompliance with study drug|0|||
94537114|NCT01106651|323762300|FG002|Overall Study|Noncompliance with study drug|2|||
94537115|NCT01106651|323762298|FG000|Overall Study|Other|34|||
94537116|NCT01106651|323762299|FG001|Overall Study|Other|31|||
94537117|NCT01106651|323762300|FG002|Overall Study|Other|21|||
94537118|NCT01106651|323762298|FG000|Overall Study|Death|0|||
94537119|NCT01106651|323762299|FG001|Overall Study|Death|3|||
94537120|NCT01106651|323762300|FG002|Overall Study|Death|0|||
94537121|NCT04686084|323762302|FG000|Overall Study|Lost to Follow-up|1|||
94537122|NCT01535599|323762304|FG000|Overall Study|Adverse Event|6|||
94537123|NCT01535599|323762305|FG001|Overall Study|Adverse Event|15|||
94537124|NCT01535599|323762304|FG000|Overall Study|Lost to Follow-up|3|||
94537125|NCT01535599|323762305|FG001|Overall Study|Lost to Follow-up|4|||
94537126|NCT01535599|323762304|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
94537127|NCT01535599|323762305|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
94537128|NCT01535599|323762304|FG000|Overall Study|Treatment Failure|33|||
94537129|NCT01535599|323762305|FG001|Overall Study|Treatment Failure|66|||
94537130|NCT01535599|323762304|FG000|Overall Study|BL Culture + for Group A Strep|0|||
94537131|NCT01535599|323762305|FG001|Overall Study|BL Culture + for Group A Strep|1|||
94537132|NCT01535599|323762304|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
94537133|NCT01535599|323762305|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
94537134|NCT01535599|323762304|FG000|Overall Study|Randomized in Error|2|||
94537135|NCT01535599|323762305|FG001|Overall Study|Randomized in Error|4|||
94537136|NCT01535599|323762304|FG000|Overall Study|Did not use product|1|||
94537137|NCT01535599|323762305|FG001|Overall Study|Did not use product|0|||
94537138|NCT01535599|323762304|FG000|Overall Study|Other|1|||
94537139|NCT01535599|323762305|FG001|Overall Study|Other|0|||
94537140|NCT01535599|323762304|FG000|Overall Study|Stopped medication|0|||
94537141|NCT01535599|323762305|FG001|Overall Study|Stopped medication|1|||
94537142|NCT01535599|323762304|FG000|Overall Study|Noncompliance|0|||
94537143|NCT01535599|323762305|FG001|Overall Study|Noncompliance|1|||
94537144|NCT03350256|323762306|FG000|Overall Study|Inclusion/exclusion violation|4|||
94537145|NCT03350256|323762306|FG000|Overall Study|Recommended for other therapies|2|||
94537146|NCT03350256|323762306|FG000|Overall Study|Protocol Violation|3|||
94537147|NCT03350256|323762306|FG000|Overall Study|Non compliance|2|||
94537148|NCT03350256|323762306|FG000|Overall Study|Denial by insurance|1|||
94537149|NCT03350256|323762306|FG000|Overall Study|Adverse Event|2|||
94537150|NCT03350256|323762306|FG000|Overall Study|Trial failure|12|||
94537151|NCT03350256|323762306|FG000|Overall Study|Did not proceed to permanent implant|3|||
94537152|NCT03350256|323762306|FG000|Overall Study|Withdrawal by Subject|3|||
94537153|NCT03350256|323762306|FG000|Overall Study|Subject moving out of state|1|||
94537154|NCT03350256|323762306|FG000|Overall Study|Lost to Follow-up|1|||
94537155|NCT03350256|323762306|FG000|Overall Study|Lack of Efficacy|2|||
94537156|NCT00676520|323762310|FG000|Overall Study|Withdrawal by Subject|163|||
94537157|NCT00676520|323762310|FG000|Overall Study|Lost to Follow-up|162|||
94537158|NCT00676520|323762310|FG000|Overall Study|Death|159|||
94537159|NCT00676520|323762310|FG000|Overall Study|Physician Decision|20|||
94537160|NCT00676520|323762310|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
94537161|NCT00676520|323762310|FG000|Overall Study|Other Reason|18|||
94537162|NCT03960580|323762311|FG000|Overall Study|Adverse Event|2|||
94537163|NCT03960580|323762312|FG001|Overall Study|Adverse Event|1|||
94537164|NCT03960580|323762313|FG002|Overall Study|Adverse Event|1|||
94537165|NCT03960580|323762311|FG000|Overall Study|Lost to Follow-up|1|||
94537166|NCT03960580|323762312|FG001|Overall Study|Lost to Follow-up|0|||
94537167|NCT03960580|323762313|FG002|Overall Study|Lost to Follow-up|0|||
94537168|NCT03960580|323762311|FG000|Overall Study|Lack of Efficacy|2|||
94537169|NCT03960580|323762312|FG001|Overall Study|Lack of Efficacy|1|||
94537170|NCT03960580|323762313|FG002|Overall Study|Lack of Efficacy|0|||
94537171|NCT03960580|323762311|FG000|Overall Study|Protocol Violation|0|||
94537172|NCT03960580|323762312|FG001|Overall Study|Protocol Violation|0|||
94537173|NCT03960580|323762313|FG002|Overall Study|Protocol Violation|1|||
94537174|NCT03960580|323762311|FG000|Overall Study|Withdrawal by Subject|1|||
94537175|NCT03960580|323762312|FG001|Overall Study|Withdrawal by Subject|1|||
94537176|NCT03960580|323762313|FG002|Overall Study|Withdrawal by Subject|1|||
94537177|NCT03960580|323762311|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
94537178|NCT03960580|323762312|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
94537179|NCT03960580|323762313|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
94537180|NCT01425359|323762314|FG000|Overall Study|Randomized but Not Treated|2|||
94537181|NCT01425359|323762315|FG001|Overall Study|Randomized but Not Treated|3|||
94537182|NCT01425359|323762314|FG000|Overall Study|Adverse Event|9|||
94537183|NCT01425359|323762315|FG001|Overall Study|Adverse Event|8|||
94537184|NCT01425359|323762314|FG000|Overall Study|Revascularization|0|||
94537185|NCT01425359|323762315|FG001|Overall Study|Revascularization|1|||
94537186|NCT01425359|323762314|FG000|Overall Study|Death|0|||
94537187|NCT01425359|323762315|FG001|Overall Study|Death|1|||
94537188|NCT01425359|323762314|FG000|Overall Study|Unsatisfactory Response|1|||
94537189|NCT01425359|323762315|FG001|Overall Study|Unsatisfactory Response|0|||
94537190|NCT01425359|323762314|FG000|Overall Study|Protocol Violation|1|||
94537191|NCT01425359|323762315|FG001|Overall Study|Protocol Violation|2|||
94537192|NCT01425359|323762314|FG000|Overall Study|Subject Withdrew Consent|1|||
94537193|NCT01425359|323762315|FG001|Overall Study|Subject Withdrew Consent|2|||
94537194|NCT01425359|323762314|FG000|Overall Study|Investigator's Discretion|2|||
94537195|NCT01425359|323762315|FG001|Overall Study|Investigator's Discretion|0|||
94537196|NCT01425359|323762314|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
94537197|NCT01425359|323762315|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
94537198|NCT03305419|323762318|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
94537199|NCT03305419|323762319|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
94537200|NCT03305419|323762320|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
94537201|NCT03305419|323762321|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
94537202|NCT03305419|323762322|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
94537203|NCT03305419|323762323|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
94537204|NCT03305419|323762324|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
94537205|NCT03305419|323762325|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
94537206|NCT03305419|323762318|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
94537207|NCT03305419|323762319|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
94537208|NCT03305419|323762320|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
94537209|NCT03305419|323762321|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
94537210|NCT03305419|323762322|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
94537211|NCT03305419|323762323|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
94537212|NCT03305419|323762324|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
94537213|NCT03305419|323762325|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
94537214|NCT03305419|323762318|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
94537215|NCT03305419|323762319|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
94537216|NCT03305419|323762320|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
94537217|NCT03305419|323762321|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
94537218|NCT03305419|323762322|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
94537219|NCT03305419|323762323|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
94537220|NCT03305419|323762324|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
94537221|NCT03305419|323762325|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
94537222|NCT03305419|323762318|FG000|Part B (14 Days)|Adverse Event|0|||
94537223|NCT03305419|323762319|FG001|Part B (14 Days)|Adverse Event|0|||
94537224|NCT03305419|323762320|FG002|Part B (14 Days)|Adverse Event|0|||
94537225|NCT03305419|323762321|FG003|Part B (14 Days)|Adverse Event|0|||
94537226|NCT03305419|323762322|FG004|Part B (14 Days)|Adverse Event|1|||
94537227|NCT03305419|323762323|FG005|Part B (14 Days)|Adverse Event|2|||
94537228|NCT03305419|323762324|FG006|Part B (14 Days)|Adverse Event|4|||
94537229|NCT03305419|323762325|FG007|Part B (14 Days)|Adverse Event|0|||
94537230|NCT03305419|323762318|FG000|Part B (14 Days)|Physician Decision|0|||
94537231|NCT03305419|323762319|FG001|Part B (14 Days)|Physician Decision|0|||
94537232|NCT03305419|323762320|FG002|Part B (14 Days)|Physician Decision|0|||
94537233|NCT03305419|323762321|FG003|Part B (14 Days)|Physician Decision|0|||
94537234|NCT03305419|323762322|FG004|Part B (14 Days)|Physician Decision|2|||
94537235|NCT03305419|323762323|FG005|Part B (14 Days)|Physician Decision|8|||
94537236|NCT03305419|323762324|FG006|Part B (14 Days)|Physician Decision|1|||
94537237|NCT03305419|323762325|FG007|Part B (14 Days)|Physician Decision|0|||
94537238|NCT01895543|323762332|FG000|Overall Study|Withdrawal by Subject|43|||
94537239|NCT01895543|323762332|FG000|Overall Study|Lost to Follow-up|25|||
94537240|NCT01895543|323762332|FG000|Overall Study|Adverse Event|28|||
94537241|NCT01895543|323762332|FG000|Overall Study|Subject's substantial non-compliance|6|||
94537242|NCT01895543|323762332|FG000|Overall Study|Protocol Violation|1|||
94537243|NCT01895543|323762332|FG000|Overall Study|Physician Decision|2|||
94537244|NCT01895543|323762332|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
94537245|NCT00557310|323762335|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
94537246|NCT00557310|323762335|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
94537247|NCT00557310|323762335|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
94537248|NCT00557310|323762335|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
94537249|NCT00557310|323762335|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
94537250|NCT00557310|323762335|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
94537251|NCT04659174|323762336|FG000|Overall Study|Sponsor decision to discontinue study|0|||
94537252|NCT04659174|323762337|FG001|Overall Study|Sponsor decision to discontinue study|2|||
94537253|NCT04659174|323762336|FG000|Overall Study|Lost to Follow-up|9|||
94537254|NCT04659174|323762337|FG001|Overall Study|Lost to Follow-up|11|||
94537255|NCT04659174|323762336|FG000|Overall Study|Adverse Event|8|||
94537256|NCT04659174|323762337|FG001|Overall Study|Adverse Event|5|||
94537257|NCT04659174|323762336|FG000|Overall Study|Withdrawal by Subject|17|||
94537258|NCT04659174|323762337|FG001|Overall Study|Withdrawal by Subject|33|||
94537259|NCT04659174|323762336|FG000|Overall Study|Progressive disease|0|||
94537260|NCT04659174|323762337|FG001|Overall Study|Progressive disease|2|||
94537261|NCT04659174|323762336|FG000|Overall Study|Other reasons|0|||
94537262|NCT04659174|323762337|FG001|Overall Study|Other reasons|2|||
94537263|NCT04659174|323762336|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
94537264|NCT04659174|323762337|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
94537265|NCT04659174|323762336|FG000|Overall Study|Alcohol or illegal drug use|0|||
94537266|NCT04659174|323762337|FG001|Overall Study|Alcohol or illegal drug use|3|||
94537267|NCT04659174|323762336|FG000|Overall Study|Violation of entry criteria|1|||
94537268|NCT04659174|323762337|FG001|Overall Study|Violation of entry criteria|0|||
94537269|NCT04659174|323762336|FG000|Overall Study|Death|0|||
94537270|NCT04659174|323762337|FG001|Overall Study|Death|1|||
94537271|NCT03276026|323762338|FG000|Overall Study|Protocol Violation|1|||
94537272|NCT03276026|323762339|FG001|Overall Study|Protocol Violation|0|||
94537273|NCT02901054|323762343|FG000|Overall Study|Physician Decision|1|||
94537274|NCT02901054|323762343|FG000|Overall Study|Withdrawal by Subject|3|||
94537275|NCT02839720|323762344|FG000|Overall Study|Adverse Event|2|||
94537276|NCT02839720|323762344|FG000|Overall Study|Non-compliance|2|||
94537277|NCT02839720|323762344|FG000|Overall Study|Intercurrent Illness|1|||
94537278|NCT02839720|323762344|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
94537279|NCT01271712|323762345|FG000|Double Blind Treatment|Death|2|||
94537280|NCT01271712|323762346|FG001|Double Blind Treatment|Death|0|||
94537281|NCT01271712|323762345|FG000|Double Blind Treatment|Lack of Efficacy|1|||
94537282|NCT01271712|323762346|FG001|Double Blind Treatment|Lack of Efficacy|0|||
94537283|NCT01271712|323762345|FG000|Double Blind Treatment|Adverse Event|9|||
94537284|NCT01271712|323762346|FG001|Double Blind Treatment|Adverse Event|4|||
94537285|NCT01271712|323762345|FG000|Double Blind Treatment|Progressive disease|23|||
94537286|NCT01271712|323762346|FG001|Double Blind Treatment|Progressive disease|3|||
94537287|NCT01271712|323762345|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
94537288|NCT01271712|323762346|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
94537289|NCT01271712|323762345|FG000|Double Blind Treatment|Non compliance with study drug|2|||
94537290|NCT01271712|323762346|FG001|Double Blind Treatment|Non compliance with study drug|0|||
94537291|NCT01271712|323762345|FG000|Double Blind Treatment|receive no study drug|1|||
94537292|NCT01271712|323762346|FG001|Double Blind Treatment|receive no study drug|0|||
94537293|NCT01271712|323762345|FG000|Open Label Treatment|Death|6|||
94537294|NCT01271712|323762346|FG001|Open Label Treatment|Death|5|||
94537295|NCT01271712|323762345|FG000|Open Label Treatment|Withdrawal by Subject|6|||
94537296|NCT01271712|323762346|FG001|Open Label Treatment|Withdrawal by Subject|11|||
94537297|NCT01271712|323762345|FG000|Open Label Treatment|Physician Decision|2|||
94537298|NCT01271712|323762346|FG001|Open Label Treatment|Physician Decision|0|||
94537299|NCT01271712|323762345|FG000|Open Label Treatment|Adverse Event|14|||
94537300|NCT01271712|323762346|FG001|Open Label Treatment|Adverse Event|8|||
94537301|NCT01271712|323762345|FG000|Open Label Treatment|Progressive disease|59|||
94537302|NCT01271712|323762346|FG001|Open Label Treatment|Progressive disease|32|||
94537303|NCT01271712|323762345|FG000|Open Label Treatment|transferred to rollover study|1|||
94537304|NCT01271712|323762346|FG001|Open Label Treatment|transferred to rollover study|0|||
94537305|NCT01271712|323762345|FG000|Open Label Treatment|Non-compliance with study drug|1|||
94537306|NCT01271712|323762346|FG001|Open Label Treatment|Non-compliance with study drug|0|||
94537307|NCT01271712|323762345|FG000|Open Label Treatment|Protocol Violation|0|||
94537308|NCT01271712|323762346|FG001|Open Label Treatment|Protocol Violation|1|||
94537309|NCT01271712|323762345|FG000|Open Label Treatment|Switching to other therapy|2|||
94537310|NCT01271712|323762346|FG001|Open Label Treatment|Switching to other therapy|1|||
94537311|NCT01271712|323762345|FG000|Safety Follow-up|Death|11|||
94537312|NCT01271712|323762346|FG001|Safety Follow-up|Death|7|||
94537313|NCT01271712|323762345|FG000|Safety Follow-up|Withdrawal by Subject|4|||
94537314|NCT01271712|323762346|FG001|Safety Follow-up|Withdrawal by Subject|2|||
94537315|NCT01271712|323762345|FG000|Safety Follow-up|Protocol Violation|1|||
94537316|NCT01271712|323762346|FG001|Safety Follow-up|Protocol Violation|1|||
94537317|NCT01271712|323762345|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
94537318|NCT01271712|323762346|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
94537319|NCT01271712|323762345|FG000|Safety Follow-up|No follow-up|1|||
94537320|NCT01271712|323762346|FG001|Safety Follow-up|No follow-up|1|||
94537321|NCT01271712|323762345|FG000|Safety Follow-up|Progressive disease|1|||
94537322|NCT01271712|323762346|FG001|Safety Follow-up|Progressive disease|0|||
94537323|NCT01271712|323762345|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
94537324|NCT01271712|323762346|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
94537325|NCT00724854|323762349|FG000|Overall Study|Lack of Efficacy|187|||
94537326|NCT00724854|323762350|FG001|Overall Study|Lack of Efficacy|13|||
94537327|NCT00724854|323762349|FG000|Overall Study|Lost to Follow-up|87|||
94537328|NCT00724854|323762350|FG001|Overall Study|Lost to Follow-up|10|||
94537329|NCT00724854|323762349|FG000|Overall Study|Adverse Event|62|||
94537330|NCT00724854|323762350|FG001|Overall Study|Adverse Event|4|||
94537331|NCT00724854|323762349|FG000|Overall Study|Other|42|||
94537332|NCT00724854|323762350|FG001|Overall Study|Other|3|||
94537333|NCT00724854|323762349|FG000|Overall Study|Death|11|||
94537334|NCT00724854|323762350|FG001|Overall Study|Death|0|||
94537335|NCT00724854|323762349|FG000|Overall Study|Change of treatment|7|||
94537336|NCT00724854|323762350|FG001|Overall Study|Change of treatment|0|||
94537337|NCT00724854|323762349|FG000|Overall Study|Withdrawal by Subject|5|||
94537338|NCT00724854|323762350|FG001|Overall Study|Withdrawal by Subject|0|||
94537339|NCT00724854|323762349|FG000|Overall Study|Adverse event + lack of efficacy|2|||
94537340|NCT00724854|323762350|FG001|Overall Study|Adverse event + lack of efficacy|1|||
94537341|NCT04003207|323762351|FG000|Overall Study|Protocol Violation|1|||
94537342|NCT02979093|323762353|FG000|First Scan Session|Scanning data problems|1|||
94537343|NCT02979093|323762354|FG001|First Scan Session|Scanning data problems|2|||
94537344|NCT02979093|323762355|FG002|First Scan Session|Scanning data problems|2|||
94537345|NCT02979093|323762356|FG003|First Scan Session|Scanning data problems|0|||
94537346|NCT02979093|323762353|FG000|Second Scan Session|Scanning data problems|3|||
94537347|NCT02979093|323762354|FG001|Second Scan Session|Scanning data problems|0|||
94537348|NCT02979093|323762355|FG002|Second Scan Session|Scanning data problems|1|||
94537349|NCT02979093|323762356|FG003|Second Scan Session|Scanning data problems|3|||
94537350|NCT04173260|323762357|FG000|Overall Study|Early termination|4|||
94537351|NCT03834506|323762360|FG000|Overall Study|Death|336|||
94537352|NCT03834506|323762361|FG001|Overall Study|Death|326|||
94537353|NCT03834506|323762360|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
94537354|NCT03834506|323762361|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
94537355|NCT03834506|323762360|FG000|Overall Study|Withdrawal by Subject|10|||
94537356|NCT03834506|323762361|FG001|Overall Study|Withdrawal by Subject|8|||
94537357|NCT03834506|323762360|FG000|Overall Study|Sponsor decision|165|||
94537358|NCT03834506|323762361|FG001|Overall Study|Sponsor decision|178|||
94537359|NCT03834506|323762360|FG000|Overall Study|Physician Decision|3|||
94537360|NCT03834506|323762361|FG001|Overall Study|Physician Decision|1|||
94537361|NCT03834506|323762360|FG000|Overall Study|Lost to Follow-up|0|||
94537362|NCT03834506|323762361|FG001|Overall Study|Lost to Follow-up|1|||
94537363|NCT02499900|323762365|FG000|Core Study Period|Other|1|||
94537364|NCT02499900|323762366|FG001|Core Study Period|Other|4|||
94537365|NCT02499900|323762365|FG000|Core Study Period|Lost to Follow-up|1|||
94537366|NCT02499900|323762366|FG001|Core Study Period|Lost to Follow-up|2|||
94537367|NCT02499900|323762365|FG000|Core Study Period|Per sponsor request|0|||
94537368|NCT02499900|323762366|FG001|Core Study Period|Per sponsor request|1|||
94537369|NCT02499900|323762365|FG000|Core Study Period|Pregnancy|1|||
94537370|NCT02499900|323762366|FG001|Core Study Period|Pregnancy|0|||
94537371|NCT02499900|323762365|FG000|Core Study Period|Protocol Violation|3|||
94537372|NCT02499900|323762366|FG001|Core Study Period|Protocol Violation|0|||
94537373|NCT02499900|323762365|FG000|Core Study Period|Withdrawal by Subject|11|||
94537374|NCT02499900|323762366|FG001|Core Study Period|Withdrawal by Subject|10|||
94537375|NCT02499900|323762365|FG000|Core Study Period|Adverse Event|18|||
94537376|NCT02499900|323762366|FG001|Core Study Period|Adverse Event|14|||
94537377|NCT02499900|323762365|FG000|Core Study Period|Death|0|||
94537378|NCT02499900|323762366|FG001|Core Study Period|Death|1|||
94537379|NCT02499900|323762365|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
94537380|NCT02499900|323762366|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
94537381|NCT02499900|323762365|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
94537382|NCT02499900|323762366|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
94537383|NCT02499900|323762365|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
94537384|NCT02499900|323762366|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
94537385|NCT02499900|323762365|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
94537386|NCT02499900|323762366|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
94537387|NCT02499900|323762365|FG000|Extension Study Period|Adverse Event|2|||
94537388|NCT02499900|323762366|FG001|Extension Study Period|Adverse Event|4|||
94537389|NCT02499900|323762365|FG000|Extension Study Period|Withdrawal by Subject|5|||
94537390|NCT02499900|323762366|FG001|Extension Study Period|Withdrawal by Subject|2|||
94537391|NCT02499900|323762365|FG000|Extension Study Period|Physician Decision|2|||
94537392|NCT02499900|323762366|FG001|Extension Study Period|Physician Decision|5|||
94537393|NCT02499900|323762365|FG000|Extension Study Period|Pregnancy|1|||
94537394|NCT02499900|323762366|FG001|Extension Study Period|Pregnancy|2|||
94537395|NCT02499900|323762365|FG000|Extension Study Period|Lost to Follow-up|2|||
94537396|NCT02499900|323762366|FG001|Extension Study Period|Lost to Follow-up|5|||
94537397|NCT02499900|323762365|FG000|Extension Study Period|Other|0|||
94537398|NCT02499900|323762366|FG001|Extension Study Period|Other|2|||
94537399|NCT00496483|323764319|FG000|Overall Study|Not dosed|9|||
94537400|NCT00496483|323764319|FG000|Overall Study|Adverse Event|2|||
94537401|NCT00496483|323764319|FG000|Overall Study|Lack of Efficacy|1|||
94537402|NCT00197145|323764320|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
94537403|NCT00197145|323764321|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
94537404|NCT00197145|323764320|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
94537405|NCT00197145|323764321|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
94537406|NCT00197145|323764320|FG000|Period 1: Randomized Treatment Phase|Other|2|||
94537407|NCT00197145|323764321|FG001|Period 1: Randomized Treatment Phase|Other|2|||
94537408|NCT00197145|323764320|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
94537409|NCT00197145|323764321|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
94537410|NCT00197145|323764320|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
94537411|NCT00197145|323764321|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
94537412|NCT00197145|323764320|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
94537413|NCT00197145|323764321|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
94537414|NCT00197145|323764320|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
94537415|NCT00197145|323764321|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
94537416|NCT00197145|323764320|FG000|Period 2 : Open Label Phase|Other|1|||
94537417|NCT00197145|323764321|FG001|Period 2 : Open Label Phase|Other|0|||
94537418|NCT01448824|323764322|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
94537419|NCT01448824|323764323|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
94537420|NCT01448824|323764324|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
94537421|NCT01448824|323764325|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
94537422|NCT01448824|323764326|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
94537423|NCT01448824|323764327|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
94537424|NCT01448824|323764328|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
94537425|NCT01448824|323764329|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
94537426|NCT01448824|323764322|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
94537427|NCT01448824|323764323|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
94537428|NCT01448824|323764324|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
94537429|NCT01448824|323764325|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
94537430|NCT01448824|323764326|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
94537431|NCT01448824|323764327|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
94537432|NCT01448824|323764328|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
94537433|NCT01448824|323764329|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
94537434|NCT01448824|323764322|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
94537435|NCT01448824|323764323|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
94537436|NCT01448824|323764324|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
94537437|NCT01448824|323764325|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
94537438|NCT01448824|323764326|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
94537439|NCT01448824|323764327|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
94537440|NCT01448824|323764328|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
94537441|NCT01448824|323764329|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
94537442|NCT01448824|323764322|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
94537443|NCT01448824|323764323|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
94537444|NCT01448824|323764324|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
94537445|NCT01448824|323764325|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
94537446|NCT01448824|323764326|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
94537447|NCT01448824|323764327|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
94537448|NCT01448824|323764328|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
94537449|NCT01448824|323764329|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
94537450|NCT01448824|323764322|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
94537451|NCT01448824|323764323|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
94537452|NCT01448824|323764324|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
94537453|NCT01448824|323764325|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
94537454|NCT01448824|323764326|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
94537455|NCT01448824|323764327|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
94537456|NCT01448824|323764328|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
94537457|NCT01448824|323764329|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
94537458|NCT01448824|323764322|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
94537459|NCT01448824|323764323|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
94537460|NCT01448824|323764324|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
94537461|NCT01448824|323764325|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
94537462|NCT01448824|323764326|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
94537463|NCT01448824|323764327|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
94537464|NCT01448824|323764328|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
94537465|NCT01448824|323764329|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
94537466|NCT01448824|323764322|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
94537467|NCT01448824|323764323|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
94537468|NCT01448824|323764324|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
94537469|NCT01448824|323764325|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
94537470|NCT01448824|323764326|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
94537471|NCT01448824|323764327|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
94537472|NCT01448824|323764328|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
94537473|NCT01448824|323764329|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
94537474|NCT01448824|323764322|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
94537475|NCT01448824|323764323|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
94537476|NCT01448824|323764324|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
94537477|NCT01448824|323764325|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
94537478|NCT01448824|323764326|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
94537479|NCT01448824|323764327|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
94537480|NCT01448824|323764328|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
94537481|NCT01448824|323764329|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
94537482|NCT03100539|323764336|FG000|Overall Study|Lost to Follow-up|60|||
94537483|NCT03100539|323764337|FG001|Overall Study|Lost to Follow-up|54|||
94537484|NCT03100539|323764338|FG002|Overall Study|Lost to Follow-up|17|||
94537485|NCT03100539|323764336|FG000|Overall Study|Uncollected|8|||
94537486|NCT03100539|323764337|FG001|Overall Study|Uncollected|8|||
94537487|NCT03100539|323764338|FG002|Overall Study|Uncollected|0|||
94537488|NCT03100539|323764336|FG000|Overall Study|Ally Health|0|||
94537489|NCT03100539|323764337|FG001|Overall Study|Ally Health|0|||
94537490|NCT03100539|323764338|FG002|Overall Study|Ally Health|3|||
94537491|NCT03100539|323764336|FG000|Overall Study|Disinterest|0|||
94537492|NCT03100539|323764337|FG001|Overall Study|Disinterest|0|||
94537493|NCT03100539|323764338|FG002|Overall Study|Disinterest|22|||
94537494|NCT03100539|323764336|FG000|Overall Study|Veteran Health|0|||
94537495|NCT03100539|323764337|FG001|Overall Study|Veteran Health|0|||
94537496|NCT03100539|323764338|FG002|Overall Study|Veteran Health|8|||
94537497|NCT03100539|323764336|FG000|Overall Study|Moved|0|||
94537498|NCT03100539|323764337|FG001|Overall Study|Moved|0|||
94537499|NCT03100539|323764338|FG002|Overall Study|Moved|1|||
94537500|NCT03100539|323764336|FG000|Overall Study|Scheduling Conflicts|0|||
94537501|NCT03100539|323764337|FG001|Overall Study|Scheduling Conflicts|0|||
94537502|NCT03100539|323764338|FG002|Overall Study|Scheduling Conflicts|12|||
94537503|NCT03895086|323764339|FG000|Overall Study|Early termination study|1|||
94537504|NCT03895086|323764340|FG001|Overall Study|Early termination study|0|||
94537505|NCT02759107|323764341|FG000|Overall Study|Adverse Event|0|||
94537506|NCT02759107|323764342|FG001|Overall Study|Adverse Event|0|||
94537507|NCT02759107|323764343|FG002|Overall Study|Adverse Event|0|||
94537508|NCT02759107|323764344|FG003|Overall Study|Adverse Event|0|||
94537509|NCT02759107|323764345|FG004|Overall Study|Adverse Event|0|||
94537510|NCT02759107|323764346|FG005|Overall Study|Adverse Event|0|||
94537511|NCT02759107|323764347|FG006|Overall Study|Adverse Event|0|||
94537512|NCT02759107|323764348|FG007|Overall Study|Adverse Event|0|||
94537513|NCT02759107|323764349|FG008|Overall Study|Adverse Event|0|||
94537514|NCT02759107|323764350|FG009|Overall Study|Adverse Event|0|||
94537515|NCT02759107|323764351|FG010|Overall Study|Adverse Event|0|||
94537516|NCT02759107|323764352|FG011|Overall Study|Adverse Event|0|||
94537517|NCT02759107|323764353|FG012|Overall Study|Adverse Event|2|||
94537518|NCT02759107|323764354|FG013|Overall Study|Adverse Event|0|||
94537519|NCT02759107|323764355|FG014|Overall Study|Adverse Event|0|||
94537520|NCT02759107|323764356|FG015|Overall Study|Adverse Event|1|||
94537521|NCT02759107|323764357|FG016|Overall Study|Adverse Event|0|||
94537522|NCT02759107|323764358|FG017|Overall Study|Adverse Event|2|||
94537523|NCT02759107|323764341|FG000|Overall Study|Scheduling Conflict|0|||
94537524|NCT02759107|323764342|FG001|Overall Study|Scheduling Conflict|0|||
94537525|NCT02759107|323764343|FG002|Overall Study|Scheduling Conflict|0|||
94537526|NCT02759107|323764344|FG003|Overall Study|Scheduling Conflict|0|||
94537527|NCT02759107|323764345|FG004|Overall Study|Scheduling Conflict|0|||
94537528|NCT02759107|323764346|FG005|Overall Study|Scheduling Conflict|0|||
94537529|NCT02759107|323764347|FG006|Overall Study|Scheduling Conflict|0|||
94537530|NCT02759107|323764348|FG007|Overall Study|Scheduling Conflict|0|||
94537531|NCT02759107|323764349|FG008|Overall Study|Scheduling Conflict|0|||
94537532|NCT02759107|323764350|FG009|Overall Study|Scheduling Conflict|1|||
94537533|NCT02759107|323764351|FG010|Overall Study|Scheduling Conflict|0|||
94537534|NCT02759107|323764352|FG011|Overall Study|Scheduling Conflict|0|||
94537535|NCT02759107|323764353|FG012|Overall Study|Scheduling Conflict|0|||
94537536|NCT02759107|323764354|FG013|Overall Study|Scheduling Conflict|0|||
94537537|NCT02759107|323764355|FG014|Overall Study|Scheduling Conflict|0|||
94537538|NCT02759107|323764356|FG015|Overall Study|Scheduling Conflict|0|||
94537539|NCT02759107|323764357|FG016|Overall Study|Scheduling Conflict|0|||
94537540|NCT02759107|323764358|FG017|Overall Study|Scheduling Conflict|0|||
94537541|NCT02526524|323764373|FG000|Overall Study|Withdrawal by Subject|3|||
94537542|NCT02526524|323764374|FG001|Overall Study|Withdrawal by Subject|3|||
94537543|NCT02526524|323764375|FG002|Overall Study|Withdrawal by Subject|6|||
94537544|NCT02526524|323764376|FG003|Overall Study|Withdrawal by Subject|1|||
94537545|NCT02526524|323764377|FG004|Overall Study|Withdrawal by Subject|9|||
94537546|NCT02526524|323764378|FG005|Overall Study|Withdrawal by Subject|5|||
94537547|NCT02526524|323764373|FG000|Overall Study|Adverse Event|3|||
94537548|NCT02526524|323764374|FG001|Overall Study|Adverse Event|2|||
94537549|NCT02526524|323764375|FG002|Overall Study|Adverse Event|4|||
94537550|NCT02526524|323764376|FG003|Overall Study|Adverse Event|2|||
94537551|NCT02526524|323764377|FG004|Overall Study|Adverse Event|6|||
94537552|NCT02526524|323764378|FG005|Overall Study|Adverse Event|8|||
94537553|NCT02526524|323764373|FG000|Overall Study|Lost to Follow-up|2|||
94537554|NCT02526524|323764374|FG001|Overall Study|Lost to Follow-up|3|||
94537555|NCT02526524|323764375|FG002|Overall Study|Lost to Follow-up|8|||
94537556|NCT02526524|323764376|FG003|Overall Study|Lost to Follow-up|1|||
94537557|NCT02526524|323764377|FG004|Overall Study|Lost to Follow-up|2|||
94537558|NCT02526524|323764378|FG005|Overall Study|Lost to Follow-up|5|||
94537559|NCT02526524|323764373|FG000|Overall Study|Protocol Violation|3|||
94537560|NCT02526524|323764374|FG001|Overall Study|Protocol Violation|1|||
94537561|NCT02526524|323764375|FG002|Overall Study|Protocol Violation|5|||
94537562|NCT02526524|323764376|FG003|Overall Study|Protocol Violation|3|||
94537563|NCT02526524|323764377|FG004|Overall Study|Protocol Violation|4|||
94537564|NCT02526524|323764378|FG005|Overall Study|Protocol Violation|3|||
94537565|NCT02526524|323764373|FG000|Overall Study|Loss of Glucose Control|0|||
94537566|NCT02526524|323764374|FG001|Overall Study|Loss of Glucose Control|0|||
94537567|NCT02526524|323764375|FG002|Overall Study|Loss of Glucose Control|3|||
94537568|NCT02526524|323764376|FG003|Overall Study|Loss of Glucose Control|0|||
94537569|NCT02526524|323764377|FG004|Overall Study|Loss of Glucose Control|2|||
94537570|NCT02526524|323764378|FG005|Overall Study|Loss of Glucose Control|0|||
94537571|NCT02526524|323764373|FG000|Overall Study|Physician Decision|0|||
94537572|NCT02526524|323764374|FG001|Overall Study|Physician Decision|0|||
94537573|NCT02526524|323764375|FG002|Overall Study|Physician Decision|0|||
94537574|NCT02526524|323764376|FG003|Overall Study|Physician Decision|0|||
94537575|NCT02526524|323764377|FG004|Overall Study|Physician Decision|1|||
94537576|NCT02526524|323764378|FG005|Overall Study|Physician Decision|0|||
94537577|NCT02526524|323764373|FG000|Overall Study|Sponsor Decision|1|||
94537578|NCT02526524|323764374|FG001|Overall Study|Sponsor Decision|0|||
94537579|NCT02526524|323764375|FG002|Overall Study|Sponsor Decision|0|||
94537580|NCT02526524|323764376|FG003|Overall Study|Sponsor Decision|0|||
94537581|NCT02526524|323764377|FG004|Overall Study|Sponsor Decision|0|||
94537582|NCT02526524|323764378|FG005|Overall Study|Sponsor Decision|0|||
94537583|NCT01468207|323764379|FG000|Treatment Period 1|Adverse Event|1|||
94537584|NCT01468207|323764380|FG001|Treatment Period 1|Adverse Event|0|||
94537585|NCT01468207|323764381|FG002|Treatment Period 1|Adverse Event|0|||
94537586|NCT01468207|323764382|FG003|Treatment Period 1|Adverse Event|0|||
94537587|NCT01468207|323764383|FG004|Treatment Period 1|Adverse Event|0|||
94537588|NCT01468207|323764384|FG005|Treatment Period 1|Adverse Event|0|||
94537589|NCT01468207|323764379|FG000|Treatment Period 1|Protocol Violation|1|||
94537590|NCT01468207|323764380|FG001|Treatment Period 1|Protocol Violation|1|||
94537591|NCT01468207|323764381|FG002|Treatment Period 1|Protocol Violation|0|||
94537592|NCT01468207|323764382|FG003|Treatment Period 1|Protocol Violation|0|||
94537593|NCT01468207|323764383|FG004|Treatment Period 1|Protocol Violation|0|||
94537594|NCT01468207|323764384|FG005|Treatment Period 1|Protocol Violation|0|||
94537595|NCT01468207|323764379|FG000|Treatment Period 1|Withdrawal by Subject|5|||
94537596|NCT01468207|323764380|FG001|Treatment Period 1|Withdrawal by Subject|4|||
94537597|NCT01468207|323764381|FG002|Treatment Period 1|Withdrawal by Subject|0|||
94537598|NCT01468207|323764382|FG003|Treatment Period 1|Withdrawal by Subject|0|||
94537599|NCT01468207|323764383|FG004|Treatment Period 1|Withdrawal by Subject|0|||
94537600|NCT01468207|323764384|FG005|Treatment Period 1|Withdrawal by Subject|0|||
94537601|NCT01468207|323764379|FG000|Treatment Period 1|Lost to Follow-up|2|||
94537602|NCT01468207|323764380|FG001|Treatment Period 1|Lost to Follow-up|1|||
94537603|NCT01468207|323764381|FG002|Treatment Period 1|Lost to Follow-up|0|||
94537604|NCT01468207|323764382|FG003|Treatment Period 1|Lost to Follow-up|0|||
94537605|NCT01468207|323764383|FG004|Treatment Period 1|Lost to Follow-up|0|||
94537606|NCT01468207|323764384|FG005|Treatment Period 1|Lost to Follow-up|0|||
94537607|NCT01468207|323764379|FG000|Treatment Period 1|Other|0|||
94537608|NCT01468207|323764380|FG001|Treatment Period 1|Other|2|||
94537609|NCT01468207|323764381|FG002|Treatment Period 1|Other|0|||
94537610|NCT01468207|323764382|FG003|Treatment Period 1|Other|0|||
94537611|NCT01468207|323764383|FG004|Treatment Period 1|Other|0|||
94537612|NCT01468207|323764384|FG005|Treatment Period 1|Other|0|||
94537613|NCT01468207|323764379|FG000|Treatment Period 2|Adverse Event|0|||
94537614|NCT01468207|323764380|FG001|Treatment Period 2|Adverse Event|0|||
94537615|NCT01468207|323764381|FG002|Treatment Period 2|Adverse Event|6|||
94537616|NCT01468207|323764382|FG003|Treatment Period 2|Adverse Event|1|||
94537617|NCT01468207|323764383|FG004|Treatment Period 2|Adverse Event|2|||
94537618|NCT01468207|323764384|FG005|Treatment Period 2|Adverse Event|1|||
94537619|NCT01468207|323764379|FG000|Treatment Period 2|Lack of Efficacy|0|||
94537620|NCT01468207|323764380|FG001|Treatment Period 2|Lack of Efficacy|0|||
94537621|NCT01468207|323764381|FG002|Treatment Period 2|Lack of Efficacy|1|||
94537622|NCT01468207|323764382|FG003|Treatment Period 2|Lack of Efficacy|1|||
94537623|NCT01468207|323764383|FG004|Treatment Period 2|Lack of Efficacy|0|||
94537624|NCT01468207|323764384|FG005|Treatment Period 2|Lack of Efficacy|2|||
94537625|NCT01468207|323764379|FG000|Treatment Period 2|Withdrawal by Subject|0|||
94537626|NCT01468207|323764380|FG001|Treatment Period 2|Withdrawal by Subject|0|||
94537627|NCT01468207|323764381|FG002|Treatment Period 2|Withdrawal by Subject|5|||
94537628|NCT01468207|323764382|FG003|Treatment Period 2|Withdrawal by Subject|0|||
94537629|NCT01468207|323764383|FG004|Treatment Period 2|Withdrawal by Subject|0|||
94537630|NCT01468207|323764384|FG005|Treatment Period 2|Withdrawal by Subject|2|||
94537631|NCT01468207|323764379|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
94537632|NCT01468207|323764380|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
94537633|NCT01468207|323764381|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
94537634|NCT01468207|323764382|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
94537635|NCT01468207|323764383|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
94537636|NCT01468207|323764384|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
94537637|NCT01468207|323764379|FG000|Treatment Period 2|Lost to Follow-up|0|||
94537638|NCT01468207|323764380|FG001|Treatment Period 2|Lost to Follow-up|0|||
94537639|NCT01468207|323764381|FG002|Treatment Period 2|Lost to Follow-up|5|||
94537640|NCT01468207|323764382|FG003|Treatment Period 2|Lost to Follow-up|1|||
94537641|NCT01468207|323764383|FG004|Treatment Period 2|Lost to Follow-up|0|||
94537642|NCT01468207|323764384|FG005|Treatment Period 2|Lost to Follow-up|0|||
94537643|NCT01468207|323764379|FG000|Treatment Period 2|Other|0|||
94537644|NCT01468207|323764380|FG001|Treatment Period 2|Other|0|||
94537645|NCT01468207|323764381|FG002|Treatment Period 2|Other|5|||
94537646|NCT01468207|323764382|FG003|Treatment Period 2|Other|1|||
94537647|NCT01468207|323764383|FG004|Treatment Period 2|Other|1|||
94537648|NCT01468207|323764384|FG005|Treatment Period 2|Other|2|||
94537649|NCT00591149|323764385|FG000|Overall Study|Adverse Event|4|||
94537650|NCT00591149|323764385|FG000|Overall Study|Withdrawal by Subject|1|||
94537651|NCT04225676|323764386|FG000|Overall Study|Physician Decision|1|||
94537652|NCT04225676|323764386|FG000|Overall Study|Lack of Efficacy|1|||
94537653|NCT04225676|323764386|FG000|Overall Study|Study terminated by sponsor|3|||
94537654|NCT03245736|323764387|FG000|Overall Study|Adverse Event|1|||
94537655|NCT03245736|323764387|FG000|Overall Study|Progressive Disease|4|||
94537656|NCT05312632|323764390|FG000|Overall Study|Adverse Event|12|||
94537657|NCT05312632|323764390|FG000|Overall Study|Withdrawal by Subject|10|||
94537658|NCT05312632|323764390|FG000|Overall Study|Lack of Efficacy|4|||
94537659|NCT05312632|323764390|FG000|Overall Study|Non-compliance with study procedures|9|||
94537660|NCT05312632|323764390|FG000|Overall Study|Other|4|||
94537661|NCT05289271|323764392|FG000|Overall Study|Mistakenly allocated, untreated|1|||
94537662|NCT05289271|323764393|FG001|Overall Study|Mistakenly allocated, untreated|0|||
94537663|NCT02928029|323764396|FG000|Overall Study|Withdrawal by Subject|0|||
94537664|NCT02928029|323764397|FG001|Overall Study|Withdrawal by Subject|1|||
94537665|NCT02928029|323764396|FG000|Overall Study|Radiological progression|1|||
94537666|NCT02928029|323764397|FG001|Overall Study|Radiological progression|0|||
94537667|NCT02928029|323764396|FG000|Overall Study|Clinical progression|1|||
94537668|NCT02928029|323764397|FG001|Overall Study|Clinical progression|2|||
94537669|NCT02928029|323764396|FG000|Overall Study|AE not related to clinical progression|1|||
94537670|NCT02928029|323764397|FG001|Overall Study|AE not related to clinical progression|1|||
94537671|NCT01610713|323764398|FG000|Overall Study|Adverse Event|3|||
94537672|NCT01610713|323764399|FG001|Overall Study|Adverse Event|0|||
94537673|NCT01610713|323764398|FG000|Overall Study|Lack of Efficacy|1|||
94537674|NCT01610713|323764399|FG001|Overall Study|Lack of Efficacy|0|||
94537675|NCT01610713|323764398|FG000|Overall Study|low mood and poor motivation|1|||
94537676|NCT01610713|323764399|FG001|Overall Study|low mood and poor motivation|0|||
94537677|NCT01610713|323764398|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
94537678|NCT01610713|323764399|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
94537679|NCT01610713|323764398|FG000|Overall Study|Lost to Follow-up|0|||
94537680|NCT01610713|323764399|FG001|Overall Study|Lost to Follow-up|1|||
94537681|NCT05427539|323764400|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
94537682|NCT05427539|323764401|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
94537683|NCT05427539|323764400|FG000|Period 1|Withdrawal by Subject|1|||
94537684|NCT05427539|323764401|FG001|Period 1|Withdrawal by Subject|0|||
94537685|NCT03943550|323764402|FG000|Overall Study|Adverse Event|0|||
94537686|NCT03943550|323764403|FG001|Overall Study|Adverse Event|0|||
94537687|NCT03943550|323764404|FG002|Overall Study|Adverse Event|1|||
94537688|NCT03943550|323764402|FG000|Overall Study|Lost to Follow-up|0|||
94537689|NCT03943550|323764403|FG001|Overall Study|Lost to Follow-up|0|||
94537690|NCT03943550|323764404|FG002|Overall Study|Lost to Follow-up|1|||
94537691|NCT03943550|323764402|FG000|Overall Study|Progressive Disease|0|||
94537692|NCT03943550|323764403|FG001|Overall Study|Progressive Disease|0|||
94537693|NCT03943550|323764404|FG002|Overall Study|Progressive Disease|2|||
94537694|NCT03943550|323764402|FG000|Overall Study|Participant Moved Out of the Country|0|||
94537695|NCT03943550|323764403|FG001|Overall Study|Participant Moved Out of the Country|1|||
94537696|NCT03943550|323764404|FG002|Overall Study|Participant Moved Out of the Country|0|||
94537697|NCT01774097|323764405|FG000|Overall Study|Withdrawal by Subject|1|||
94537698|NCT01774097|323764406|FG001|Overall Study|Withdrawal by Subject|1|||
94537699|NCT01774097|323764405|FG000|Overall Study|Adverse Event|1|||
94537700|NCT01774097|323764406|FG001|Overall Study|Adverse Event|1|||
94537701|NCT00613925|323764409|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
94537702|NCT00613925|323764410|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
94537703|NCT03447314|323764411|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
94537704|NCT03447314|323764412|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
94537705|NCT03447314|323764413|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
94537706|NCT03447314|323764414|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
94537707|NCT03447314|323764415|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
94537708|NCT03447314|323764416|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
94537709|NCT03447314|323764417|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
94537710|NCT03447314|323764418|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
94537711|NCT03447314|323764419|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
94537712|NCT03447314|323764420|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
94537713|NCT03447314|323764421|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
94537714|NCT03447314|323764422|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
94537715|NCT03447314|323764423|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
94537716|NCT03447314|323764424|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
94537717|NCT03447314|323764425|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
94537718|NCT03447314|323764426|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
94537719|NCT03447314|323764427|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
94537720|NCT03447314|323764428|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
94537721|NCT03447314|323764411|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
94537722|NCT03447314|323764412|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
94537723|NCT03447314|323764413|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
94537724|NCT03447314|323764414|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
94537725|NCT03447314|323764415|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
94537726|NCT03447314|323764416|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
94537727|NCT03447314|323764417|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
94537728|NCT03447314|323764418|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
94537729|NCT03447314|323764419|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
94537730|NCT03447314|323764420|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
94537731|NCT03447314|323764421|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
94537732|NCT03447314|323764422|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
94537733|NCT03447314|323764423|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
94537734|NCT03447314|323764424|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
94537735|NCT03447314|323764425|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
94537736|NCT03447314|323764426|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
94537737|NCT03447314|323764427|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
94537738|NCT03447314|323764428|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
94537739|NCT03447314|323764411|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
94537740|NCT03447314|323764412|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
94537741|NCT03447314|323764413|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
94537742|NCT03447314|323764414|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
94537743|NCT03447314|323764415|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
94537744|NCT03447314|323764416|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
94537745|NCT03447314|323764417|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
94537746|NCT03447314|323764418|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
94537747|NCT03447314|323764419|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
94537748|NCT03447314|323764420|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
94537749|NCT03447314|323764421|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
94537750|NCT03447314|323764422|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
94537751|NCT03447314|323764423|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
94537752|NCT03447314|323764424|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
94537753|NCT03447314|323764425|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
94537754|NCT03447314|323764426|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
94537755|NCT03447314|323764427|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
94537756|NCT03447314|323764428|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
94537757|NCT03447314|323764411|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
94537758|NCT03447314|323764412|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
94537759|NCT03447314|323764413|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
94537760|NCT03447314|323764414|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
94537761|NCT03447314|323764415|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
94537762|NCT03447314|323764416|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
94537763|NCT03447314|323764417|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
94537764|NCT03447314|323764418|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
94537765|NCT03447314|323764419|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
94537766|NCT03447314|323764420|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
94537767|NCT03447314|323764421|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
94537768|NCT03447314|323764422|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
94537769|NCT03447314|323764423|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
94537770|NCT03447314|323764424|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
94537771|NCT03447314|323764425|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
94537772|NCT03447314|323764426|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
94537773|NCT03447314|323764427|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
94537774|NCT03447314|323764428|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
94537775|NCT03447314|323764411|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
94537776|NCT03447314|323764412|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
94537777|NCT03447314|323764413|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
94537778|NCT03447314|323764414|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
94537779|NCT03447314|323764415|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
94537780|NCT03447314|323764416|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
94537781|NCT03447314|323764417|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
94537782|NCT03447314|323764418|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
94537783|NCT03447314|323764419|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
94537784|NCT03447314|323764420|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
94537785|NCT03447314|323764421|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
94537786|NCT03447314|323764422|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
94537787|NCT03447314|323764423|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
94537788|NCT03447314|323764424|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
94537789|NCT03447314|323764425|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
94537790|NCT03447314|323764426|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
94537791|NCT03447314|323764427|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
94537792|NCT03447314|323764428|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
94537793|NCT03447314|323764411|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
94537794|NCT03447314|323764412|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
94537795|NCT03447314|323764413|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
94537796|NCT03447314|323764414|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
94537797|NCT03447314|323764415|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
94537798|NCT03447314|323764416|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
94537799|NCT03447314|323764417|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
94537800|NCT03447314|323764418|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
94537801|NCT03447314|323764419|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
94537802|NCT03447314|323764420|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
94537803|NCT03447314|323764421|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
94537804|NCT03447314|323764422|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
94537805|NCT03447314|323764423|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
94537806|NCT03447314|323764424|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
94537807|NCT03447314|323764425|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
94537808|NCT03447314|323764426|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
94537809|NCT03447314|323764427|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
94537810|NCT03447314|323764428|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
94537811|NCT02649218|323764430|FG000|Overall Study|Adverse Event|8|||
94537812|NCT02649218|323764430|FG000|Overall Study|Lack of Efficacy|8|||
94537813|NCT02649218|323764430|FG000|Overall Study|Pregnancy|3|||
94537814|NCT02649218|323764430|FG000|Overall Study|Protocol Violation|3|||
94537815|NCT02649218|323764430|FG000|Overall Study|Physician Decision|1|||
94537816|NCT02649218|323764430|FG000|Overall Study|Withdrawal by Subject|2|||
94537817|NCT05479097|323764436|FG000|Overall Study|Withdrawal by Subject|2|||
94537818|NCT04644237|323764437|FG000|Overall Study|Death|3|||
94537819|NCT04644237|323764438|FG001|Overall Study|Death|2|||
94537820|NCT04644237|323764437|FG000|Overall Study|Adverse Event|15|||
94537821|NCT04644237|323764438|FG001|Overall Study|Adverse Event|12|||
94537822|NCT04644237|323764437|FG000|Overall Study|Progressive Disease|47|||
94537823|NCT04644237|323764438|FG001|Overall Study|Progressive Disease|19|||
94537824|NCT04644237|323764437|FG000|Overall Study|Clinical Progression|4|||
94537825|NCT04644237|323764438|FG001|Overall Study|Clinical Progression|1|||
94537826|NCT04644237|323764437|FG000|Overall Study|Withdrawal by Subject|1|||
94537827|NCT04644237|323764438|FG001|Overall Study|Withdrawal by Subject|2|||
94537828|NCT04644237|323764437|FG000|Overall Study|Physician Decision|3|||
94537829|NCT04644237|323764438|FG001|Overall Study|Physician Decision|0|||
94537830|NCT04644237|323764437|FG000|Overall Study|Other|1|||
94537831|NCT04644237|323764438|FG001|Overall Study|Other|0|||
94537832|NCT04644237|323764437|FG000|Overall Study|Randomized but not Treated|1|||
94537833|NCT04644237|323764438|FG001|Overall Study|Randomized but not Treated|0|||
94537834|NCT02118766|323764439|FG000|Overall Study|Adverse Event|7|||
94537835|NCT02118766|323764440|FG001|Overall Study|Adverse Event|2|||
94537836|NCT02118766|323764439|FG000|Overall Study|Withdrawal by Subject|3|||
94537837|NCT02118766|323764440|FG001|Overall Study|Withdrawal by Subject|6|||
94537838|NCT02118766|323764439|FG000|Overall Study|Lost to Follow-up|5|||
94537839|NCT02118766|323764440|FG001|Overall Study|Lost to Follow-up|4|||
94537840|NCT02118766|323764439|FG000|Overall Study|Withdrawal by parent/guardian|12|||
94537841|NCT02118766|323764440|FG001|Overall Study|Withdrawal by parent/guardian|18|||
94537842|NCT02118766|323764439|FG000|Overall Study|Other|3|||
94537843|NCT02118766|323764440|FG001|Overall Study|Other|1|||
94537844|NCT00090233|323764441|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
94537845|NCT00090233|323764442|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
94537846|NCT00090233|323764441|FG000|Overall Study|Adverse Event|214|||
94537847|NCT00090233|323764442|FG001|Overall Study|Adverse Event|198|||
94537848|NCT00090233|323764441|FG000|Overall Study|Lost to Follow-up|68|||
94537849|NCT00090233|323764442|FG001|Overall Study|Lost to Follow-up|95|||
94537850|NCT00090233|323764441|FG000|Overall Study|Protocol Violation|960|||
94537851|NCT00090233|323764442|FG001|Overall Study|Protocol Violation|1022|||
94537852|NCT00090233|323764441|FG000|Overall Study|Withdrawal by Subject|182|||
94537853|NCT00090233|323764442|FG001|Overall Study|Withdrawal by Subject|211|||
94537854|NCT00090233|323764441|FG000|Overall Study|Moved|203|||
94537855|NCT00090233|323764442|FG001|Overall Study|Moved|189|||
94537856|NCT00090233|323764441|FG000|Overall Study|Other|1211|||
94537857|NCT00090233|323764442|FG001|Overall Study|Other|1160|||
94537858|NCT00090233|323764441|FG000|Overall Study|Data not available at data cut-off point|1552|||
94537859|NCT00090233|323764442|FG001|Overall Study|Data not available at data cut-off point|1563|||
94537860|NCT04863248|323764443|FG000|Overall Study|Sponsor Terminated|4|||
94537861|NCT04863248|323764444|FG001|Overall Study|Sponsor Terminated|1|||
94537862|NCT04863248|323764443|FG000|Overall Study|Death|0|||
94537863|NCT04863248|323764444|FG001|Overall Study|Death|1|||
94537864|NCT04863248|323764443|FG000|Overall Study|Withdrawal by Subject|0|||
94537865|NCT04863248|323764444|FG001|Overall Study|Withdrawal by Subject|1|||
94537866|NCT00957944|323764445|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
94537867|NCT00957944|323764446|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
94537868|NCT04706273|323764447|FG000|Overall Study|Withdrawal by Subject|27|||
94537869|NCT04706273|323764447|FG000|Overall Study|Physician Decision|1|||
94537870|NCT04706273|323764447|FG000|Overall Study|Lost to Follow-up|42|||
94537871|NCT04706273|323764447|FG000|Overall Study|Death|85|||
94537872|NCT04706273|323764447|FG000|Overall Study|Amputation that removes study device|2|||
94537873|NCT04706273|323764447|FG000|Overall Study|Surgical bypass|3|||
94537874|NCT04706273|323764447|FG000|Overall Study|Changing hospital|23|||
94537875|NCT04706273|323764447|FG000|Overall Study|Unable to attend hospital|2|||
94537876|NCT00737568|323764450|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
94537877|NCT00737568|323764451|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
94537878|NCT00737568|323764450|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
94537879|NCT00737568|323764451|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
94537880|NCT00737568|323764450|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
94537881|NCT00737568|323764451|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
94537882|NCT00737568|323764450|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
94537883|NCT00737568|323764451|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
94537884|NCT00737568|323764450|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
94537885|NCT00737568|323764451|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
94537886|NCT00737568|323764450|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
94537887|NCT00737568|323764451|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
94537888|NCT00737568|323764450|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
94537889|NCT00737568|323764451|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
94537890|NCT00737568|323764450|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
94537891|NCT00737568|323764451|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
94537892|NCT00737568|323764450|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
94537893|NCT00737568|323764451|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
94537894|NCT03298984|323764454|FG000|Overall Study|Physician Decision|1|||
94537895|NCT03298984|323764455|FG001|Overall Study|Physician Decision|0|||
94537896|NCT03298984|323764456|FG002|Overall Study|Physician Decision|0|||
94537897|NCT03298984|323764457|FG003|Overall Study|Physician Decision|6|||
94537898|NCT03298984|323764454|FG000|Overall Study|Lack of Efficacy|0|||
94537899|NCT03298984|323764455|FG001|Overall Study|Lack of Efficacy|1|||
94537900|NCT03298984|323764456|FG002|Overall Study|Lack of Efficacy|1|||
94537901|NCT03298984|323764457|FG003|Overall Study|Lack of Efficacy|4|||
94537902|NCT03298984|323764454|FG000|Overall Study|Relapsed disease (following remission)|0|||
94537903|NCT03298984|323764455|FG001|Overall Study|Relapsed disease (following remission)|0|||
94537904|NCT03298984|323764456|FG002|Overall Study|Relapsed disease (following remission)|1|||
94537905|NCT03298984|323764457|FG003|Overall Study|Relapsed disease (following remission)|1|||
94537906|NCT03298984|323764454|FG000|Overall Study|Adverse Event|0|||
94537907|NCT03298984|323764455|FG001|Overall Study|Adverse Event|0|||
94537908|NCT03298984|323764456|FG002|Overall Study|Adverse Event|0|||
94537909|NCT03298984|323764457|FG003|Overall Study|Adverse Event|1|||
94537910|NCT03298984|323764454|FG000|Overall Study|Death|0|||
94537911|NCT03298984|323764455|FG001|Overall Study|Death|0|||
94537912|NCT03298984|323764456|FG002|Overall Study|Death|0|||
94537913|NCT03298984|323764457|FG003|Overall Study|Death|2|||
94537914|NCT03298984|323764454|FG000|Overall Study|Insurance Company Decision|0|||
94537915|NCT03298984|323764455|FG001|Overall Study|Insurance Company Decision|0|||
94537916|NCT03298984|323764456|FG002|Overall Study|Insurance Company Decision|0|||
94537917|NCT03298984|323764457|FG003|Overall Study|Insurance Company Decision|1|||
94537918|NCT00294645|323764458|FG000|Overall Study|Death|10|||
94537919|NCT00294645|323764459|FG001|Overall Study|Death|18|||
94537920|NCT00294645|323764458|FG000|Overall Study|Lost to Follow-up|1|||
94537921|NCT00294645|323764459|FG001|Overall Study|Lost to Follow-up|10|||
94537922|NCT00294645|323764458|FG000|Overall Study|Withdrawal by Subject|18|||
94537923|NCT00294645|323764459|FG001|Overall Study|Withdrawal by Subject|34|||
94537924|NCT00294645|323764458|FG000|Overall Study|Physician Decision|15|||
94537925|NCT00294645|323764459|FG001|Overall Study|Physician Decision|20|||
94537926|NCT00294645|323764458|FG000|Overall Study|Other|4|||
94537927|NCT00294645|323764459|FG001|Overall Study|Other|10|||
94537928|NCT01713283|323764460|FG000|Overall Study|Lack of Efficacy|10|||
94537929|NCT01713283|323764461|FG001|Overall Study|Lack of Efficacy|2|||
94537930|NCT01713283|323764460|FG000|Overall Study|Lost to Follow-up|1|||
94537931|NCT01713283|323764461|FG001|Overall Study|Lost to Follow-up|1|||
94537932|NCT03263923|323764464|FG000|Overall Study|Withdrawal by Subject|10|||
94537933|NCT03263923|323764465|FG001|Overall Study|Withdrawal by Subject|8|||
94537934|NCT03263923|323764464|FG000|Overall Study|Lost to Follow-up|15|||
94537935|NCT03263923|323764465|FG001|Overall Study|Lost to Follow-up|13|||
94537936|NCT00580034|323764469|FG000|Overall Study|Toxicity|10|||
94537937|NCT00580034|323764470|FG001|Overall Study|Toxicity|0|||
94537938|NCT01939002|323764471|FG000|Overall Study|Adverse Event|13|||
94537939|NCT01939002|323764472|FG001|Overall Study|Adverse Event|13|||
94537940|NCT01939002|323764471|FG000|Overall Study|Withdrawal by Subject|5|||
94537941|NCT01939002|323764472|FG001|Overall Study|Withdrawal by Subject|3|||
94537942|NCT01939002|323764471|FG000|Overall Study|Other|1|||
94537943|NCT01939002|323764472|FG001|Overall Study|Other|2|||
94537944|NCT01133405|323764475|FG000|Period 1|Withdrawal by Subject|0|||
94537945|NCT01133405|323764476|FG001|Period 1|Withdrawal by Subject|1|||
94537946|NCT01133405|323764477|FG002|Period 1|Withdrawal by Subject|0|||
94537947|NCT01133405|323764478|FG003|Period 1|Withdrawal by Subject|1|||
94537948|NCT01133405|323764479|FG004|Period 1|Withdrawal by Subject|0|||
94537949|NCT01133405|323764480|FG005|Period 1|Withdrawal by Subject|1|||
94537950|NCT01133405|323764481|FG006|Period 1|Withdrawal by Subject|0|||
94537951|NCT01133405|323764482|FG007|Period 1|Withdrawal by Subject|0|||
94537952|NCT01133405|323764483|FG008|Period 1|Withdrawal by Subject|0|||
94537953|NCT01133405|323764484|FG009|Period 1|Withdrawal by Subject|0|||
94537954|NCT01133405|323764475|FG000|Period 1|Physician Decision|0|||
94537955|NCT01133405|323764476|FG001|Period 1|Physician Decision|0|||
94537956|NCT01133405|323764477|FG002|Period 1|Physician Decision|0|||
94537957|NCT01133405|323764478|FG003|Period 1|Physician Decision|1|||
94537958|NCT01133405|323764479|FG004|Period 1|Physician Decision|0|||
94537959|NCT01133405|323764480|FG005|Period 1|Physician Decision|0|||
94537960|NCT01133405|323764481|FG006|Period 1|Physician Decision|0|||
94537961|NCT01133405|323764482|FG007|Period 1|Physician Decision|0|||
94537962|NCT01133405|323764483|FG008|Period 1|Physician Decision|0|||
94537963|NCT01133405|323764484|FG009|Period 1|Physician Decision|0|||
94537964|NCT01133405|323764475|FG000|Period 1|Discontinued after randomization|1|||
94537965|NCT01133405|323764476|FG001|Period 1|Discontinued after randomization|0|||
94537966|NCT01133405|323764477|FG002|Period 1|Discontinued after randomization|0|||
94537967|NCT01133405|323764478|FG003|Period 1|Discontinued after randomization|0|||
94537968|NCT01133405|323764479|FG004|Period 1|Discontinued after randomization|0|||
94537969|NCT01133405|323764480|FG005|Period 1|Discontinued after randomization|0|||
94537970|NCT01133405|323764481|FG006|Period 1|Discontinued after randomization|1|||
94537971|NCT01133405|323764482|FG007|Period 1|Discontinued after randomization|0|||
94537972|NCT01133405|323764483|FG008|Period 1|Discontinued after randomization|0|||
94537973|NCT01133405|323764484|FG009|Period 1|Discontinued after randomization|0|||
94537974|NCT01133405|323764475|FG000|Period 1|Received drug only in period 2|0|||
94537975|NCT01133405|323764476|FG001|Period 1|Received drug only in period 2|1|||
94537976|NCT01133405|323764477|FG002|Period 1|Received drug only in period 2|0|||
94537977|NCT01133405|323764478|FG003|Period 1|Received drug only in period 2|2|||
94537978|NCT01133405|323764479|FG004|Period 1|Received drug only in period 2|0|||
94537979|NCT01133405|323764480|FG005|Period 1|Received drug only in period 2|1|||
94537980|NCT01133405|323764481|FG006|Period 1|Received drug only in period 2|0|||
94537981|NCT01133405|323764482|FG007|Period 1|Received drug only in period 2|0|||
94537982|NCT01133405|323764483|FG008|Period 1|Received drug only in period 2|0|||
94537983|NCT01133405|323764484|FG009|Period 1|Received drug only in period 2|0|||
94537984|NCT01133405|323764475|FG000|Period 1|Received drug only in period 3|0|||
94537985|NCT01133405|323764476|FG001|Period 1|Received drug only in period 3|1|||
94537986|NCT01133405|323764477|FG002|Period 1|Received drug only in period 3|1|||
94537987|NCT01133405|323764478|FG003|Period 1|Received drug only in period 3|0|||
94537988|NCT01133405|323764479|FG004|Period 1|Received drug only in period 3|0|||
94537989|NCT01133405|323764480|FG005|Period 1|Received drug only in period 3|0|||
94537990|NCT01133405|323764481|FG006|Period 1|Received drug only in period 3|0|||
94537991|NCT01133405|323764482|FG007|Period 1|Received drug only in period 3|0|||
94537992|NCT01133405|323764483|FG008|Period 1|Received drug only in period 3|0|||
94537993|NCT01133405|323764484|FG009|Period 1|Received drug only in period 3|0|||
94537994|NCT01133405|323764475|FG000|Period 2|Adverse Event|0|||
94537995|NCT01133405|323764476|FG001|Period 2|Adverse Event|0|||
94537996|NCT01133405|323764477|FG002|Period 2|Adverse Event|1|||
94537997|NCT01133405|323764478|FG003|Period 2|Adverse Event|0|||
94537998|NCT01133405|323764479|FG004|Period 2|Adverse Event|0|||
94537999|NCT01133405|323764480|FG005|Period 2|Adverse Event|0|||
94538000|NCT01133405|323764481|FG006|Period 2|Adverse Event|0|||
94538001|NCT01133405|323764482|FG007|Period 2|Adverse Event|0|||
94538002|NCT01133405|323764483|FG008|Period 2|Adverse Event|0|||
94538003|NCT01133405|323764484|FG009|Period 2|Adverse Event|0|||
94538004|NCT01133405|323764475|FG000|Period 2|Withdrawal by Subject|0|||
94538005|NCT01133405|323764476|FG001|Period 2|Withdrawal by Subject|0|||
94538006|NCT01133405|323764477|FG002|Period 2|Withdrawal by Subject|0|||
94538007|NCT01133405|323764478|FG003|Period 2|Withdrawal by Subject|1|||
94538008|NCT01133405|323764479|FG004|Period 2|Withdrawal by Subject|0|||
94538009|NCT01133405|323764480|FG005|Period 2|Withdrawal by Subject|1|||
94538010|NCT01133405|323764481|FG006|Period 2|Withdrawal by Subject|0|||
94538011|NCT01133405|323764482|FG007|Period 2|Withdrawal by Subject|0|||
94538012|NCT01133405|323764483|FG008|Period 2|Withdrawal by Subject|0|||
94538013|NCT01133405|323764484|FG009|Period 2|Withdrawal by Subject|0|||
94538014|NCT01133405|323764475|FG000|Period 2|Entry Criteria Not Met|0|||
94538015|NCT01133405|323764476|FG001|Period 2|Entry Criteria Not Met|1|||
94538016|NCT01133405|323764477|FG002|Period 2|Entry Criteria Not Met|0|||
94538017|NCT01133405|323764478|FG003|Period 2|Entry Criteria Not Met|0|||
94538018|NCT01133405|323764479|FG004|Period 2|Entry Criteria Not Met|0|||
94538019|NCT01133405|323764480|FG005|Period 2|Entry Criteria Not Met|0|||
94538020|NCT01133405|323764481|FG006|Period 2|Entry Criteria Not Met|0|||
94538021|NCT01133405|323764482|FG007|Period 2|Entry Criteria Not Met|0|||
94538022|NCT01133405|323764483|FG008|Period 2|Entry Criteria Not Met|0|||
94538023|NCT01133405|323764484|FG009|Period 2|Entry Criteria Not Met|0|||
94538024|NCT01133405|323764475|FG000|Period 2|Physician Decision|0|||
94538025|NCT01133405|323764476|FG001|Period 2|Physician Decision|0|||
94538026|NCT01133405|323764477|FG002|Period 2|Physician Decision|0|||
94538027|NCT01133405|323764478|FG003|Period 2|Physician Decision|0|||
94538028|NCT01133405|323764479|FG004|Period 2|Physician Decision|0|||
94538029|NCT01133405|323764480|FG005|Period 2|Physician Decision|1|||
94538030|NCT01133405|323764481|FG006|Period 2|Physician Decision|0|||
94538031|NCT01133405|323764482|FG007|Period 2|Physician Decision|0|||
94538032|NCT01133405|323764483|FG008|Period 2|Physician Decision|0|||
94538033|NCT01133405|323764484|FG009|Period 2|Physician Decision|0|||
94538034|NCT03305081|323764486|FG000|Overall Study|Lost to Follow-up|10|||
94538035|NCT03305081|323764487|FG001|Overall Study|Lost to Follow-up|15|||
94538036|NCT03372460|323764489|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
94538037|NCT03372460|323764490|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
94538038|NCT04065074|323764493|FG000|Overall Study|Adverse Event|1|||
94538039|NCT04065074|323764493|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
94538040|NCT03222973|323764494|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
94538041|NCT03222973|323764495|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
94538042|NCT03222973|323764496|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
94538043|NCT03222973|323764497|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
94538044|NCT03222973|323764494|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
94538045|NCT03222973|323764495|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
94538046|NCT03222973|323764496|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
94538047|NCT03222973|323764497|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
94538048|NCT03222973|323764494|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
94538049|NCT03222973|323764495|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
94538050|NCT03222973|323764496|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
94538051|NCT03222973|323764497|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
94538052|NCT03222973|323764494|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
94538053|NCT03222973|323764495|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
94538054|NCT03222973|323764496|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
94538055|NCT03222973|323764497|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
94538056|NCT03222973|323764494|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
94538057|NCT03222973|323764495|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
94538058|NCT03222973|323764496|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
94538059|NCT03222973|323764497|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
94538060|NCT03222973|323764494|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
94538061|NCT03222973|323764495|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
94538062|NCT03222973|323764496|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
94538063|NCT03222973|323764497|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
94538064|NCT03222973|323764494|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
94538065|NCT03222973|323764495|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
94538066|NCT03222973|323764496|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
94538067|NCT03222973|323764497|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
94538068|NCT03222973|323764494|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
94538069|NCT03222973|323764495|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
94538070|NCT03222973|323764496|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
94538071|NCT03222973|323764497|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
94538072|NCT03222973|323764494|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
94538073|NCT03222973|323764495|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
94538074|NCT03222973|323764496|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
94538075|NCT03222973|323764497|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
94538076|NCT03222973|323764494|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
94538077|NCT03222973|323764495|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
94538078|NCT03222973|323764496|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
94538079|NCT03222973|323764497|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
94538080|NCT03222973|323764494|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
94538081|NCT03222973|323764495|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
94538082|NCT03222973|323764496|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
94538083|NCT03222973|323764497|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
94538084|NCT03222973|323764494|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
94538085|NCT03222973|323764495|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
94538086|NCT03222973|323764496|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
94538087|NCT03222973|323764497|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
94538088|NCT02825420|323764498|FG000|Overall Study|Death|30|||
94538089|NCT02825420|323764499|FG001|Overall Study|Death|12|||
94538090|NCT02825420|323764498|FG000|Overall Study|Progressive disease|6|||
94538091|NCT02825420|323764499|FG001|Overall Study|Progressive disease|1|||
94538092|NCT02825420|323764498|FG000|Overall Study|Lost to Follow-up|2|||
94538093|NCT02825420|323764499|FG001|Overall Study|Lost to Follow-up|2|||
94538094|NCT02825420|323764498|FG000|Overall Study|Withdrawal by Subject|1|||
94538095|NCT02825420|323764499|FG001|Overall Study|Withdrawal by Subject|1|||
94538096|NCT02825420|323764498|FG000|Overall Study|Protocol amendment not signed|1|||
94538097|NCT02825420|323764499|FG001|Overall Study|Protocol amendment not signed|1|||
94538098|NCT02825420|323764498|FG000|Overall Study|Physician Decision|1|||
94538099|NCT02825420|323764499|FG001|Overall Study|Physician Decision|0|||
94538100|NCT02825420|323764498|FG000|Overall Study|Did not receive PLD|2|||
94538101|NCT02825420|323764499|FG001|Overall Study|Did not receive PLD|0|||
94538102|NCT02080481|323764500|FG000|Overall Study|Never received a block.|1|||
94538103|NCT02080481|323764501|FG001|Overall Study|Never received a block.|0|||
94538104|NCT02439450|323764503|FG000|Overall Study|Adverse Event|4|||
94538105|NCT02439450|323764504|FG001|Overall Study|Adverse Event|1|||
94538106|NCT02439450|323764505|FG002|Overall Study|Adverse Event|0|||
94538107|NCT02439450|323764506|FG003|Overall Study|Adverse Event|0|||
94538108|NCT02439450|323764503|FG000|Overall Study|Withdrawal by Subject|1|||
94538109|NCT02439450|323764504|FG001|Overall Study|Withdrawal by Subject|2|||
94538110|NCT02439450|323764505|FG002|Overall Study|Withdrawal by Subject|0|||
94538111|NCT02439450|323764506|FG003|Overall Study|Withdrawal by Subject|0|||
94538112|NCT02439450|323764503|FG000|Overall Study|Death|3|||
94538113|NCT02439450|323764504|FG001|Overall Study|Death|0|||
94538114|NCT02439450|323764505|FG002|Overall Study|Death|0|||
94538115|NCT02439450|323764506|FG003|Overall Study|Death|1|||
94538116|NCT02439450|323764503|FG000|Overall Study|Progressive Disease|18|||
94538117|NCT02439450|323764504|FG001|Overall Study|Progressive Disease|41|||
94538118|NCT02439450|323764505|FG002|Overall Study|Progressive Disease|2|||
94538119|NCT02439450|323764506|FG003|Overall Study|Progressive Disease|3|||
94538120|NCT01560637|323764509|FG000|Overall Study|Adverse Event|63|||
94538121|NCT01560637|323764509|FG000|Overall Study|Death|69|||
94538122|NCT01560637|323764509|FG000|Overall Study|Lost to Follow-up|8|||
94538123|NCT01560637|323764509|FG000|Overall Study|Protocol Violation|8|||
94538124|NCT01560637|323764509|FG000|Overall Study|Withdrawal by Subject|24|||
94538125|NCT01560637|323764509|FG000|Overall Study|Progressive Disease|20|||
94538126|NCT01560637|323764509|FG000|Overall Study|Other Reason Not Specified|6|||
94538127|NCT01170065|323764510|FG000|Overall Study|Adverse Event|17|||
94538128|NCT01170065|323764511|FG001|Overall Study|Adverse Event|50|||
94538129|NCT01170065|323764512|FG002|Overall Study|Adverse Event|10|||
94538130|NCT01170065|323764510|FG000|Overall Study|Lost to Follow-up|1|||
94538131|NCT01170065|323764511|FG001|Overall Study|Lost to Follow-up|4|||
94538132|NCT01170065|323764512|FG002|Overall Study|Lost to Follow-up|1|||
94538133|NCT01170065|323764510|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
94538134|NCT01170065|323764511|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
94538135|NCT01170065|323764512|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
94538136|NCT01170065|323764510|FG000|Overall Study|Reason other than specified|3|||
94538137|NCT01170065|323764511|FG001|Overall Study|Reason other than specified|8|||
94538138|NCT01170065|323764512|FG002|Overall Study|Reason other than specified|3|||
94538139|NCT01170065|323764510|FG000|Overall Study|Ongoing after planned observation time|5|||
94538140|NCT01170065|323764511|FG001|Overall Study|Ongoing after planned observation time|26|||
94538141|NCT01170065|323764512|FG002|Overall Study|Ongoing after planned observation time|10|||
94538142|NCT01463111|323766147|FG000|Overall Study|Withdrawal by Subject|2|||
94538143|NCT01463111|323766147|FG000|Overall Study|Lost to Follow-up|5|||
94538144|NCT01463111|323766147|FG000|Overall Study|Physician Decision|2|||
94538145|NCT01962987|323766148|FG000|Overall Study|Adverse Event|4|||
94538146|NCT01962987|323766149|FG001|Overall Study|Adverse Event|4|||
94538147|NCT01962987|323766150|FG002|Overall Study|Adverse Event|0|||
94538148|NCT01962987|323766148|FG000|Overall Study|Lost to Follow-up|0|||
94538149|NCT01962987|323766149|FG001|Overall Study|Lost to Follow-up|0|||
94538150|NCT01962987|323766150|FG002|Overall Study|Lost to Follow-up|1|||
94538151|NCT01962987|323766148|FG000|Overall Study|Non compliance with dosing requirements|4|||
94538152|NCT01962987|323766149|FG001|Overall Study|Non compliance with dosing requirements|2|||
94538153|NCT01962987|323766150|FG002|Overall Study|Non compliance with dosing requirements|0|||
94538154|NCT01962987|323766148|FG000|Overall Study|Miscellaneous|1|||
94538155|NCT01962987|323766149|FG001|Overall Study|Miscellaneous|9|||
94538156|NCT01962987|323766150|FG002|Overall Study|Miscellaneous|2|||
94538157|NCT01962987|323766148|FG000|Overall Study|Restricted medication|5|||
94538158|NCT01962987|323766149|FG001|Overall Study|Restricted medication|1|||
94538159|NCT01962987|323766150|FG002|Overall Study|Restricted medication|1|||
94538160|NCT01962987|323766148|FG000|Overall Study|Serious Adverse Event|1|||
94538161|NCT01962987|323766149|FG001|Overall Study|Serious Adverse Event|0|||
94538162|NCT01962987|323766150|FG002|Overall Study|Serious Adverse Event|0|||
94538163|NCT01962987|323766148|FG000|Overall Study|Withdrawal by Subject|11|||
94538164|NCT01962987|323766149|FG001|Overall Study|Withdrawal by Subject|10|||
94538165|NCT01962987|323766150|FG002|Overall Study|Withdrawal by Subject|6|||
94538166|NCT01962987|323766148|FG000|Overall Study|Randomized in Error|4|||
94538167|NCT01962987|323766149|FG001|Overall Study|Randomized in Error|2|||
94538168|NCT01962987|323766150|FG002|Overall Study|Randomized in Error|2|||
94538169|NCT01967823|323766151|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
94538170|NCT01942161|323766152|FG000|Overall Study|Adverse Event|1|||
94538171|NCT01942161|323766153|FG001|Overall Study|Adverse Event|2|||
94538172|NCT01942161|323766154|FG002|Overall Study|Adverse Event|5|||
94538173|NCT01942161|323766152|FG000|Overall Study|Physician Decision|3|||
94538174|NCT01942161|323766153|FG001|Overall Study|Physician Decision|1|||
94538175|NCT01942161|323766154|FG002|Overall Study|Physician Decision|0|||
94538176|NCT01942161|323766152|FG000|Overall Study|Protocol Violation|1|||
94538177|NCT01942161|323766153|FG001|Overall Study|Protocol Violation|0|||
94538178|NCT01942161|323766154|FG002|Overall Study|Protocol Violation|0|||
94538179|NCT01942161|323766152|FG000|Overall Study|Withdrawal by Subject|3|||
94538180|NCT01942161|323766153|FG001|Overall Study|Withdrawal by Subject|3|||
94538181|NCT01942161|323766154|FG002|Overall Study|Withdrawal by Subject|1|||
94538182|NCT03733028|323766156|FG000|Overall Study|Study was stopped by PI|1|||
94538183|NCT03733028|323766157|FG001|Overall Study|Study was stopped by PI|2|||
94538184|NCT01739933|323766161|FG000|Overall Study|Death|89|||
94538185|NCT01739933|323766162|FG001|Overall Study|Death|86|||
94538186|NCT01739933|323766161|FG000|Overall Study|Withdrawal by Subject|10|||
94538187|NCT01739933|323766162|FG001|Overall Study|Withdrawal by Subject|8|||
94538188|NCT01739933|323766161|FG000|Overall Study|Lost to Follow-up|3|||
94538189|NCT01739933|323766162|FG001|Overall Study|Lost to Follow-up|10|||
94538190|NCT01739933|323766161|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
94538191|NCT01739933|323766162|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
94538192|NCT03224507|323766167|FG000|Overall Study|Death|3|||
94538193|NCT03224507|323766168|FG001|Overall Study|Death|0|||
94538194|NCT03224507|323766167|FG000|Overall Study|Lack of Efficacy|6|||
94538195|NCT03224507|323766168|FG001|Overall Study|Lack of Efficacy|0|||
94538196|NCT03224507|323766167|FG000|Overall Study|Withdrawal by Subject|6|||
94538197|NCT03224507|323766168|FG001|Overall Study|Withdrawal by Subject|0|||
94538198|NCT01734395|323766169|FG000|Overall Study|Other|65|||
94538199|NCT01734395|323766169|FG000|Overall Study|Lost to Follow-up|287|||
94538200|NCT01734395|323766169|FG000|Overall Study|Lack of Efficacy|5|||
94538201|NCT01734395|323766169|FG000|Overall Study|Adverse Event|40|||
94538202|NCT01734395|323766169|FG000|Overall Study|Withdrawal by Subject|10|||
94538203|NCT01734395|323766169|FG000|Overall Study|Missing the reasons for not completed|3|||
94538204|NCT00688324|323766176|FG000|Overall Study|Withdrawal by Subject|2|||
94538205|NCT00688324|323766176|FG000|Overall Study|Physician Decision|5|||
94538206|NCT00688324|323766176|FG000|Overall Study|Lost to Follow-up|1|||
94538207|NCT00847665|323766183|FG000|Overall Study|Withdrawal by Subject|1|||
94538208|NCT00847665|323766184|FG001|Overall Study|Withdrawal by Subject|0|||
94538209|NCT00585546|323766185|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
94538210|NCT00585546|323766185|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
94538211|NCT01190475|323766186|FG000|Overall Study|Withdrawal by Subject|0|||
94538212|NCT01190475|323766187|FG001|Overall Study|Withdrawal by Subject|0|||
94538213|NCT01190475|323766188|FG002|Overall Study|Withdrawal by Subject|1|||
94538214|NCT01626118|323766191|FG000|Overall Study|Lack of Efficacy|1|||
94538215|NCT01626118|323766192|FG001|Overall Study|Lack of Efficacy|0|||
94538216|NCT01626118|323766193|FG002|Overall Study|Lack of Efficacy|1|||
94538217|NCT01626118|323766194|FG003|Overall Study|Lack of Efficacy|3|||
94538218|NCT01626118|323766191|FG000|Overall Study|Lost to Follow-up|1|||
94538219|NCT01626118|323766192|FG001|Overall Study|Lost to Follow-up|0|||
94538220|NCT01626118|323766193|FG002|Overall Study|Lost to Follow-up|0|||
94538221|NCT01626118|323766194|FG003|Overall Study|Lost to Follow-up|0|||
94538222|NCT01626118|323766191|FG000|Overall Study|Adverse Event|0|||
94538223|NCT01626118|323766192|FG001|Overall Study|Adverse Event|1|||
94538224|NCT01626118|323766193|FG002|Overall Study|Adverse Event|1|||
94538225|NCT01626118|323766194|FG003|Overall Study|Adverse Event|0|||
94538226|NCT01626118|323766191|FG000|Overall Study|Investigator Decision|0|||
94538227|NCT01626118|323766192|FG001|Overall Study|Investigator Decision|1|||
94538228|NCT01626118|323766193|FG002|Overall Study|Investigator Decision|0|||
94538229|NCT01626118|323766194|FG003|Overall Study|Investigator Decision|0|||
94538230|NCT02754141|323766197|FG000|Overall Study|Disease progression|11|||
94538231|NCT02754141|323766198|FG001|Overall Study|Disease progression|7|||
94538232|NCT02754141|323766199|FG002|Overall Study|Disease progression|8|||
94538233|NCT02754141|323766200|FG003|Overall Study|Disease progression|5|||
94538234|NCT02754141|323766201|FG004|Overall Study|Disease progression|7|||
94538235|NCT02754141|323766202|FG005|Overall Study|Disease progression|7|||
94538236|NCT02754141|323766203|FG006|Overall Study|Disease progression|7|||
94538237|NCT02754141|323766204|FG007|Overall Study|Disease progression|6|||
94538238|NCT02754141|323766205|FG008|Overall Study|Disease progression|11|||
94538239|NCT02754141|323766206|FG009|Overall Study|Disease progression|16|||
94538240|NCT02754141|323766207|FG010|Overall Study|Disease progression|18|||
94538241|NCT02754141|323766208|FG011|Overall Study|Disease progression|13|||
94538242|NCT02754141|323766209|FG012|Overall Study|Disease progression|10|||
94538243|NCT02754141|323766210|FG013|Overall Study|Disease progression|12|||
94538244|NCT02754141|323766211|FG014|Overall Study|Disease progression|12|||
94538245|NCT02754141|323766212|FG015|Overall Study|Disease progression|14|||
94538246|NCT02754141|323766213|FG016|Overall Study|Disease progression|0|||
94538247|NCT02754141|323766214|FG017|Overall Study|Disease progression|1|||
94538248|NCT02754141|323766197|FG000|Overall Study|Study drug toxicity|1|||
94538249|NCT02754141|323766198|FG001|Overall Study|Study drug toxicity|1|||
94538250|NCT02754141|323766199|FG002|Overall Study|Study drug toxicity|0|||
94538251|NCT02754141|323766200|FG003|Overall Study|Study drug toxicity|0|||
94538252|NCT02754141|323766201|FG004|Overall Study|Study drug toxicity|0|||
94538253|NCT02754141|323766202|FG005|Overall Study|Study drug toxicity|0|||
94538254|NCT02754141|323766203|FG006|Overall Study|Study drug toxicity|0|||
94538255|NCT02754141|323766204|FG007|Overall Study|Study drug toxicity|0|||
94538256|NCT02754141|323766205|FG008|Overall Study|Study drug toxicity|0|||
94538257|NCT02754141|323766206|FG009|Overall Study|Study drug toxicity|0|||
94538258|NCT02754141|323766207|FG010|Overall Study|Study drug toxicity|2|||
94538259|NCT02754141|323766208|FG011|Overall Study|Study drug toxicity|1|||
94538260|NCT02754141|323766209|FG012|Overall Study|Study drug toxicity|1|||
94538261|NCT02754141|323766210|FG013|Overall Study|Study drug toxicity|0|||
94538262|NCT02754141|323766211|FG014|Overall Study|Study drug toxicity|0|||
94538263|NCT02754141|323766212|FG015|Overall Study|Study drug toxicity|0|||
94538264|NCT02754141|323766213|FG016|Overall Study|Study drug toxicity|0|||
94538265|NCT02754141|323766214|FG017|Overall Study|Study drug toxicity|0|||
94538266|NCT02754141|323766197|FG000|Overall Study|AE unrelated to study drug|1|||
94538267|NCT02754141|323766198|FG001|Overall Study|AE unrelated to study drug|1|||
94538268|NCT02754141|323766199|FG002|Overall Study|AE unrelated to study drug|0|||
94538269|NCT02754141|323766200|FG003|Overall Study|AE unrelated to study drug|1|||
94538270|NCT02754141|323766201|FG004|Overall Study|AE unrelated to study drug|3|||
94538271|NCT02754141|323766202|FG005|Overall Study|AE unrelated to study drug|2|||
94538272|NCT02754141|323766203|FG006|Overall Study|AE unrelated to study drug|1|||
94538273|NCT02754141|323766204|FG007|Overall Study|AE unrelated to study drug|0|||
94538274|NCT02754141|323766205|FG008|Overall Study|AE unrelated to study drug|0|||
94538275|NCT02754141|323766206|FG009|Overall Study|AE unrelated to study drug|0|||
94538276|NCT02754141|323766207|FG010|Overall Study|AE unrelated to study drug|0|||
94538277|NCT02754141|323766208|FG011|Overall Study|AE unrelated to study drug|0|||
94538278|NCT02754141|323766209|FG012|Overall Study|AE unrelated to study drug|0|||
94538279|NCT02754141|323766210|FG013|Overall Study|AE unrelated to study drug|0|||
94538280|NCT02754141|323766211|FG014|Overall Study|AE unrelated to study drug|0|||
94538281|NCT02754141|323766212|FG015|Overall Study|AE unrelated to study drug|0|||
94538282|NCT02754141|323766213|FG016|Overall Study|AE unrelated to study drug|0|||
94538283|NCT02754141|323766214|FG017|Overall Study|AE unrelated to study drug|0|||
94538284|NCT02754141|323766197|FG000|Overall Study|Request to discontinue|0|||
94538285|NCT02754141|323766198|FG001|Overall Study|Request to discontinue|0|||
94538286|NCT02754141|323766199|FG002|Overall Study|Request to discontinue|0|||
94538287|NCT02754141|323766200|FG003|Overall Study|Request to discontinue|0|||
94538288|NCT02754141|323766201|FG004|Overall Study|Request to discontinue|0|||
94538289|NCT02754141|323766202|FG005|Overall Study|Request to discontinue|0|||
94538290|NCT02754141|323766203|FG006|Overall Study|Request to discontinue|0|||
94538291|NCT02754141|323766204|FG007|Overall Study|Request to discontinue|0|||
94538292|NCT02754141|323766205|FG008|Overall Study|Request to discontinue|1|||
94538293|NCT02754141|323766206|FG009|Overall Study|Request to discontinue|0|||
94538294|NCT02754141|323766207|FG010|Overall Study|Request to discontinue|0|||
94538295|NCT02754141|323766208|FG011|Overall Study|Request to discontinue|0|||
94538296|NCT02754141|323766209|FG012|Overall Study|Request to discontinue|0|||
94538297|NCT02754141|323766210|FG013|Overall Study|Request to discontinue|1|||
94538298|NCT02754141|323766211|FG014|Overall Study|Request to discontinue|1|||
94538299|NCT02754141|323766212|FG015|Overall Study|Request to discontinue|0|||
94538300|NCT02754141|323766213|FG016|Overall Study|Request to discontinue|0|||
94538301|NCT02754141|323766214|FG017|Overall Study|Request to discontinue|0|||
94538302|NCT02754141|323766197|FG000|Overall Study|Withdrew consent|0|||
94538303|NCT02754141|323766198|FG001|Overall Study|Withdrew consent|0|||
94538304|NCT02754141|323766199|FG002|Overall Study|Withdrew consent|0|||
94538305|NCT02754141|323766200|FG003|Overall Study|Withdrew consent|0|||
94538306|NCT02754141|323766201|FG004|Overall Study|Withdrew consent|0|||
94538307|NCT02754141|323766202|FG005|Overall Study|Withdrew consent|0|||
94538308|NCT02754141|323766203|FG006|Overall Study|Withdrew consent|0|||
94538309|NCT02754141|323766204|FG007|Overall Study|Withdrew consent|0|||
94538310|NCT02754141|323766205|FG008|Overall Study|Withdrew consent|0|||
94538311|NCT02754141|323766206|FG009|Overall Study|Withdrew consent|1|||
94538312|NCT02754141|323766207|FG010|Overall Study|Withdrew consent|0|||
94538313|NCT02754141|323766208|FG011|Overall Study|Withdrew consent|0|||
94538314|NCT02754141|323766209|FG012|Overall Study|Withdrew consent|0|||
94538315|NCT02754141|323766210|FG013|Overall Study|Withdrew consent|0|||
94538316|NCT02754141|323766211|FG014|Overall Study|Withdrew consent|0|||
94538317|NCT02754141|323766212|FG015|Overall Study|Withdrew consent|0|||
94538318|NCT02754141|323766213|FG016|Overall Study|Withdrew consent|0|||
94538319|NCT02754141|323766214|FG017|Overall Study|Withdrew consent|0|||
94538320|NCT02754141|323766197|FG000|Overall Study|Maximum clinical benefit|0|||
94538321|NCT02754141|323766198|FG001|Overall Study|Maximum clinical benefit|0|||
94538322|NCT02754141|323766199|FG002|Overall Study|Maximum clinical benefit|0|||
94538323|NCT02754141|323766200|FG003|Overall Study|Maximum clinical benefit|1|||
94538324|NCT02754141|323766201|FG004|Overall Study|Maximum clinical benefit|0|||
94538325|NCT02754141|323766202|FG005|Overall Study|Maximum clinical benefit|0|||
94538326|NCT02754141|323766203|FG006|Overall Study|Maximum clinical benefit|0|||
94538327|NCT02754141|323766204|FG007|Overall Study|Maximum clinical benefit|0|||
94538328|NCT02754141|323766205|FG008|Overall Study|Maximum clinical benefit|0|||
94538329|NCT02754141|323766206|FG009|Overall Study|Maximum clinical benefit|0|||
94538330|NCT02754141|323766207|FG010|Overall Study|Maximum clinical benefit|0|||
94538331|NCT02754141|323766208|FG011|Overall Study|Maximum clinical benefit|0|||
94538332|NCT02754141|323766209|FG012|Overall Study|Maximum clinical benefit|0|||
94538333|NCT02754141|323766210|FG013|Overall Study|Maximum clinical benefit|0|||
94538334|NCT02754141|323766211|FG014|Overall Study|Maximum clinical benefit|0|||
94538335|NCT02754141|323766212|FG015|Overall Study|Maximum clinical benefit|0|||
94538336|NCT02754141|323766213|FG016|Overall Study|Maximum clinical benefit|0|||
94538337|NCT02754141|323766214|FG017|Overall Study|Maximum clinical benefit|0|||
94538338|NCT02754141|323766197|FG000|Overall Study|No longer meets study criteria|0|||
94538339|NCT02754141|323766198|FG001|Overall Study|No longer meets study criteria|0|||
94538340|NCT02754141|323766199|FG002|Overall Study|No longer meets study criteria|0|||
94538341|NCT02754141|323766200|FG003|Overall Study|No longer meets study criteria|1|||
94538342|NCT02754141|323766201|FG004|Overall Study|No longer meets study criteria|0|||
94538343|NCT02754141|323766202|FG005|Overall Study|No longer meets study criteria|0|||
94538344|NCT02754141|323766203|FG006|Overall Study|No longer meets study criteria|0|||
94538345|NCT02754141|323766204|FG007|Overall Study|No longer meets study criteria|0|||
94538346|NCT02754141|323766205|FG008|Overall Study|No longer meets study criteria|0|||
94538347|NCT02754141|323766206|FG009|Overall Study|No longer meets study criteria|0|||
94538348|NCT02754141|323766207|FG010|Overall Study|No longer meets study criteria|0|||
94538349|NCT02754141|323766208|FG011|Overall Study|No longer meets study criteria|0|||
94538350|NCT02754141|323766209|FG012|Overall Study|No longer meets study criteria|0|||
94538351|NCT02754141|323766210|FG013|Overall Study|No longer meets study criteria|0|||
94538352|NCT02754141|323766211|FG014|Overall Study|No longer meets study criteria|0|||
94538353|NCT02754141|323766212|FG015|Overall Study|No longer meets study criteria|0|||
94538354|NCT02754141|323766213|FG016|Overall Study|No longer meets study criteria|0|||
94538355|NCT02754141|323766214|FG017|Overall Study|No longer meets study criteria|0|||
94538356|NCT02754141|323766197|FG000|Overall Study|Other reasons|0|||
94538357|NCT02754141|323766198|FG001|Overall Study|Other reasons|0|||
94538358|NCT02754141|323766199|FG002|Overall Study|Other reasons|0|||
94538359|NCT02754141|323766200|FG003|Overall Study|Other reasons|0|||
94538360|NCT02754141|323766201|FG004|Overall Study|Other reasons|0|||
94538361|NCT02754141|323766202|FG005|Overall Study|Other reasons|0|||
94538362|NCT02754141|323766203|FG006|Overall Study|Other reasons|0|||
94538363|NCT02754141|323766204|FG007|Overall Study|Other reasons|1|||
94538364|NCT02754141|323766205|FG008|Overall Study|Other reasons|0|||
94538365|NCT02754141|323766206|FG009|Overall Study|Other reasons|0|||
94538366|NCT02754141|323766207|FG010|Overall Study|Other reasons|0|||
94538367|NCT02754141|323766208|FG011|Overall Study|Other reasons|0|||
94538368|NCT02754141|323766209|FG012|Overall Study|Other reasons|2|||
94538369|NCT02754141|323766210|FG013|Overall Study|Other reasons|0|||
94538370|NCT02754141|323766211|FG014|Overall Study|Other reasons|0|||
94538371|NCT02754141|323766212|FG015|Overall Study|Other reasons|0|||
94538372|NCT02754141|323766213|FG016|Overall Study|Other reasons|0|||
94538373|NCT02754141|323766214|FG017|Overall Study|Other reasons|0|||
94538374|NCT02754141|323766197|FG000|Overall Study|Completed treatment as per protocol|0|||
94538375|NCT02754141|323766198|FG001|Overall Study|Completed treatment as per protocol|1|||
94538376|NCT02754141|323766199|FG002|Overall Study|Completed treatment as per protocol|0|||
94538377|NCT02754141|323766200|FG003|Overall Study|Completed treatment as per protocol|0|||
94538378|NCT02754141|323766201|FG004|Overall Study|Completed treatment as per protocol|0|||
94538379|NCT02754141|323766202|FG005|Overall Study|Completed treatment as per protocol|0|||
94538380|NCT02754141|323766203|FG006|Overall Study|Completed treatment as per protocol|0|||
94538381|NCT02754141|323766204|FG007|Overall Study|Completed treatment as per protocol|0|||
94538382|NCT02754141|323766205|FG008|Overall Study|Completed treatment as per protocol|0|||
94538383|NCT02754141|323766206|FG009|Overall Study|Completed treatment as per protocol|0|||
94538384|NCT02754141|323766207|FG010|Overall Study|Completed treatment as per protocol|0|||
94538385|NCT02754141|323766208|FG011|Overall Study|Completed treatment as per protocol|0|||
94538386|NCT02754141|323766209|FG012|Overall Study|Completed treatment as per protocol|1|||
94538387|NCT02754141|323766210|FG013|Overall Study|Completed treatment as per protocol|0|||
94538388|NCT02754141|323766211|FG014|Overall Study|Completed treatment as per protocol|0|||
94538389|NCT02754141|323766212|FG015|Overall Study|Completed treatment as per protocol|0|||
94538390|NCT02754141|323766213|FG016|Overall Study|Completed treatment as per protocol|0|||
94538391|NCT02754141|323766214|FG017|Overall Study|Completed treatment as per protocol|0|||
94538392|NCT02754141|323766197|FG000|Overall Study|Not completing monotherapy|0|||
94538393|NCT02754141|323766198|FG001|Overall Study|Not completing monotherapy|0|||
94538394|NCT02754141|323766199|FG002|Overall Study|Not completing monotherapy|0|||
94538395|NCT02754141|323766200|FG003|Overall Study|Not completing monotherapy|0|||
94538396|NCT02754141|323766201|FG004|Overall Study|Not completing monotherapy|0|||
94538397|NCT02754141|323766202|FG005|Overall Study|Not completing monotherapy|0|||
94538398|NCT02754141|323766203|FG006|Overall Study|Not completing monotherapy|0|||
94538399|NCT02754141|323766204|FG007|Overall Study|Not completing monotherapy|0|||
94538400|NCT02754141|323766205|FG008|Overall Study|Not completing monotherapy|0|||
94538401|NCT02754141|323766206|FG009|Overall Study|Not completing monotherapy|0|||
94538402|NCT02754141|323766207|FG010|Overall Study|Not completing monotherapy|0|||
94538403|NCT02754141|323766208|FG011|Overall Study|Not completing monotherapy|0|||
94538404|NCT02754141|323766209|FG012|Overall Study|Not completing monotherapy|0|||
94538405|NCT02754141|323766210|FG013|Overall Study|Not completing monotherapy|1|||
94538406|NCT02754141|323766211|FG014|Overall Study|Not completing monotherapy|0|||
94538407|NCT02754141|323766212|FG015|Overall Study|Not completing monotherapy|0|||
94538408|NCT02754141|323766213|FG016|Overall Study|Not completing monotherapy|0|||
94538409|NCT02754141|323766214|FG017|Overall Study|Not completing monotherapy|0|||
94538410|NCT00113399|323766215|FG000|Overall Study|Death|1|||
94538411|NCT00113399|323766216|FG001|Overall Study|Death|1|||
94538412|NCT00113399|323766215|FG000|Overall Study|Withdrawal by Subject|1|||
94538413|NCT00113399|323766216|FG001|Overall Study|Withdrawal by Subject|2|||
94538414|NCT00113399|323766215|FG000|Overall Study|Complete Response|0|||
94538415|NCT00113399|323766216|FG001|Overall Study|Complete Response|1|||
94538416|NCT00113399|323766215|FG000|Overall Study|Other|0|||
94538417|NCT00113399|323766216|FG001|Overall Study|Other|1|||
94538418|NCT00666588|323766217|FG000|Overall Study|ineligible|2|||
94538419|NCT00666588|323766218|FG001|Overall Study|ineligible|0|||
94538420|NCT00666588|323766219|FG002|Overall Study|ineligible|0|||
94538421|NCT00666588|323766220|FG003|Overall Study|ineligible|2|||
94538422|NCT00666588|323766217|FG000|Overall Study|inevaluable|2|||
94538423|NCT00666588|323766218|FG001|Overall Study|inevaluable|0|||
94538424|NCT00666588|323766219|FG002|Overall Study|inevaluable|0|||
94538425|NCT00666588|323766220|FG003|Overall Study|inevaluable|0|||
94538426|NCT04043234|323766221|FG000|Overall Study|Lost to Follow-up|1|||
94538427|NCT04043234|323766221|FG000|Overall Study|Withdrawal by Subject|1|||
94538428|NCT02186652|323766228|FG000|Overall Study|Lost to Follow-up|2|||
94538429|NCT02186652|323766229|FG001|Overall Study|Lost to Follow-up|0|||
94538430|NCT00744978|323766230|FG000|Period 1|Lost to Follow-up|1|||
94538431|NCT00744978|323766231|FG001|Period 1|Lost to Follow-up|0|||
94538432|NCT00744978|323766230|FG000|Period 1|Withdrawal by Subject|0|||
94538433|NCT00744978|323766231|FG001|Period 1|Withdrawal by Subject|2|||
94538434|NCT00744978|323766230|FG000|Period 1|Other|0|||
94538435|NCT00744978|323766231|FG001|Period 1|Other|2|||
94538436|NCT00744978|323766230|FG000|Period 1|Adverse Event|4|||
94538437|NCT00744978|323766231|FG001|Period 1|Adverse Event|0|||
94538438|NCT00744978|323766230|FG000|Period 1|Randomized but not Treated|1|||
94538439|NCT00744978|323766231|FG001|Period 1|Randomized but not Treated|1|||
94538440|NCT00744978|323766230|FG000|Period 2|Adverse Event|0|||
94538441|NCT00744978|323766231|FG001|Period 2|Adverse Event|1|||
94538442|NCT00496197|323766232|FG000|Overall Study|Discontinued study due to death|43|||
94538443|NCT00496197|323766232|FG000|Overall Study|Adverse Event|13|||
94538444|NCT00496197|323766232|FG000|Overall Study|Does not meet entrance criteria|5|||
94538445|NCT00496197|323766232|FG000|Overall Study|Insufficient clinical response|3|||
94538446|NCT00496197|323766232|FG000|Overall Study|Insufficient bacteriological response|10|||
94538447|NCT00496197|323766232|FG000|Overall Study|Lost to Follow-up|11|||
94538448|NCT00496197|323766232|FG000|Overall Study|Withdrawal by Subject|11|||
94538449|NCT00496197|323766232|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
94538450|NCT00496197|323766232|FG000|Overall Study|Other|14|||
94538451|NCT00496197|323766232|FG000|Overall Study|Protocol Violation|8|||
94538452|NCT03773133|323766233|FG000|Overall Study|Screen Failure|8|||
94538453|NCT05593913|323766240|FG000|Overall Study|Insufficient image quality|39|||
94538454|NCT00541866|323766241|FG000|Overall Study|Adverse Event|3|||
94538455|NCT00541866|323766242|FG001|Overall Study|Adverse Event|0|||
94538456|NCT00541866|323766243|FG002|Overall Study|Adverse Event|0|||
94538457|NCT00541866|323766244|FG003|Overall Study|Adverse Event|0|||
94538458|NCT00541866|323766245|FG004|Overall Study|Adverse Event|0|||
94538459|NCT00541866|323766241|FG000|Overall Study|Death|1|||
94538460|NCT00541866|323766242|FG001|Overall Study|Death|0|||
94538461|NCT00541866|323766243|FG002|Overall Study|Death|0|||
94538462|NCT00541866|323766244|FG003|Overall Study|Death|0|||
94538463|NCT00541866|323766245|FG004|Overall Study|Death|0|||
94538464|NCT00541866|323766241|FG000|Overall Study|Lack of Efficacy|19|||
94538465|NCT00541866|323766242|FG001|Overall Study|Lack of Efficacy|15|||
94538466|NCT00541866|323766243|FG002|Overall Study|Lack of Efficacy|10|||
94538467|NCT00541866|323766244|FG003|Overall Study|Lack of Efficacy|12|||
94538468|NCT00541866|323766245|FG004|Overall Study|Lack of Efficacy|14|||
94538469|NCT00541866|323766241|FG000|Overall Study|Not Reported or Other|11|||
94538470|NCT00541866|323766242|FG001|Overall Study|Not Reported or Other|3|||
94538471|NCT00541866|323766243|FG002|Overall Study|Not Reported or Other|3|||
94538472|NCT00541866|323766244|FG003|Overall Study|Not Reported or Other|3|||
94538473|NCT00541866|323766245|FG004|Overall Study|Not Reported or Other|1|||
94538474|NCT00541866|323766241|FG000|Overall Study|Physician Decision|0|||
94538475|NCT00541866|323766242|FG001|Overall Study|Physician Decision|0|||
94538476|NCT00541866|323766243|FG002|Overall Study|Physician Decision|2|||
94538477|NCT00541866|323766244|FG003|Overall Study|Physician Decision|1|||
94538478|NCT00541866|323766245|FG004|Overall Study|Physician Decision|0|||
94538479|NCT00522418|323766246|FG000|Overall Study|Local IRB Consent Violation|5|||
94538480|NCT00522418|323766247|FG001|Overall Study|Local IRB Consent Violation|5|||
94538481|NCT00522418|323766246|FG000|Overall Study|Early Study Termination|46|||
94538482|NCT00522418|323766247|FG001|Overall Study|Early Study Termination|47|||
94538483|NCT00522418|323766246|FG000|Overall Study|Noncompliance|2|||
94538484|NCT00522418|323766247|FG001|Overall Study|Noncompliance|2|||
94538485|NCT00522418|323766246|FG000|Overall Study|Reason Not Specified|3|||
94538486|NCT00522418|323766247|FG001|Overall Study|Reason Not Specified|1|||
94538487|NCT00522418|323766246|FG000|Overall Study|Consent Withdraw|1|||
94538488|NCT00522418|323766247|FG001|Overall Study|Consent Withdraw|2|||
94538489|NCT00522418|323766246|FG000|Overall Study|Lack of Efficacy|0|||
94538490|NCT00522418|323766247|FG001|Overall Study|Lack of Efficacy|1|||
94538491|NCT02437409|323766250|FG000|Overall Study|Withdrawal by Subject|3|||
94538492|NCT02437409|323766250|FG000|Overall Study|Screening failure|12|||
94538493|NCT02136680|323766251|FG000|Overall Study|No Longer Interested|1|||
94538494|NCT02136680|323766252|FG001|Overall Study|No Longer Interested|1|||
94538495|NCT02136680|323766251|FG000|Overall Study|No longer receiving care at clinic|3|||
94538496|NCT02136680|323766252|FG001|Overall Study|No longer receiving care at clinic|5|||
94538497|NCT02136680|323766251|FG000|Overall Study|Moved away|5|||
94538498|NCT02136680|323766252|FG001|Overall Study|Moved away|4|||
94538499|NCT02136680|323766251|FG000|Overall Study|Unable to schedule|17|||
94538500|NCT02136680|323766252|FG001|Overall Study|Unable to schedule|16|||
94538501|NCT02136680|323766251|FG000|Overall Study|Study ended before interview due|6|||
94538502|NCT02136680|323766252|FG001|Overall Study|Study ended before interview due|3|||
94538503|NCT00951080|323766253|FG000|Overall Study|Adverse Event|3|||
94538504|NCT00951080|323766254|FG001|Overall Study|Adverse Event|3|||
94538505|NCT00951080|323766253|FG000|Overall Study|Lost to Follow-up|0|||
94538506|NCT00951080|323766254|FG001|Overall Study|Lost to Follow-up|1|||
94538507|NCT00951080|323766253|FG000|Overall Study|Physician Decision|4|||
94538508|NCT00951080|323766254|FG001|Overall Study|Physician Decision|1|||
94538509|NCT00951080|323766253|FG000|Overall Study|Other|19|||
94538510|NCT00951080|323766254|FG001|Overall Study|Other|22|||
94538511|NCT01824823|323766255|FG000|Overall Study|Lack of Efficacy|1|||
94538512|NCT01824823|323766256|FG001|Overall Study|Lack of Efficacy|1|||
94538513|NCT01824823|323766255|FG000|Overall Study|Off-treatment reason not submitted|1|||
94538514|NCT01824823|323766256|FG001|Overall Study|Off-treatment reason not submitted|0|||
94538515|NCT01323270|323766257|FG000|Overall Study|Withdrawal by Subject|19|||
94538516|NCT01323270|323766258|FG001|Overall Study|Withdrawal by Subject|10|||
94538517|NCT01323270|323766257|FG000|Overall Study|Protocol Violation|9|||
94538518|NCT01323270|323766258|FG001|Overall Study|Protocol Violation|7|||
94538519|NCT01323270|323766257|FG000|Overall Study|Lost to Follow-up|4|||
94538520|NCT01323270|323766258|FG001|Overall Study|Lost to Follow-up|6|||
94538521|NCT01323270|323766257|FG000|Overall Study|Adverse Event|8|||
94538522|NCT01323270|323766258|FG001|Overall Study|Adverse Event|0|||
94538523|NCT01323270|323766257|FG000|Overall Study|Other|0|||
94538524|NCT01323270|323766258|FG001|Overall Study|Other|3|||
94538525|NCT01323270|323766257|FG000|Overall Study|Physician Decision|0|||
94538526|NCT01323270|323766258|FG001|Overall Study|Physician Decision|2|||
94538527|NCT01323270|323766257|FG000|Overall Study|Not eligible|1|||
94538528|NCT01323270|323766258|FG001|Overall Study|Not eligible|1|||
94538529|NCT01323270|323766257|FG000|Overall Study|Death|1|||
94538530|NCT01323270|323766258|FG001|Overall Study|Death|0|||
94538531|NCT01323270|323766257|FG000|Overall Study|Randomized, but not vaccinated|1|||
94538532|NCT01323270|323766258|FG001|Overall Study|Randomized, but not vaccinated|0|||
94538533|NCT03576755|323766264|FG000|Overall Study|Withdrawal by Subject|1|||
94538534|NCT03576755|323766265|FG001|Overall Study|Withdrawal by Subject|0|||
94538535|NCT03576755|323766266|FG002|Overall Study|Withdrawal by Subject|0|||
94538536|NCT03576755|323766267|FG003|Overall Study|Withdrawal by Subject|0|||
94538537|NCT02374814|323766270|FG000|Overall Study|Lost to Follow-up|1|||
94538538|NCT02374814|323766271|FG001|Overall Study|Lost to Follow-up|1|||
94538539|NCT02374814|323766272|FG002|Overall Study|Lost to Follow-up|0|||
94538540|NCT02374814|323766273|FG003|Overall Study|Lost to Follow-up|1|||
94538541|NCT02374814|323766274|FG004|Overall Study|Lost to Follow-up|0|||
94538542|NCT02374814|323766275|FG005|Overall Study|Lost to Follow-up|0|||
94538543|NCT02374814|323766270|FG000|Overall Study|Withdrawal by Subject|0|||
94538544|NCT02374814|323766271|FG001|Overall Study|Withdrawal by Subject|0|||
94538545|NCT02374814|323766272|FG002|Overall Study|Withdrawal by Subject|1|||
94538546|NCT02374814|323766273|FG003|Overall Study|Withdrawal by Subject|1|||
94538547|NCT02374814|323766274|FG004|Overall Study|Withdrawal by Subject|0|||
94538548|NCT02374814|323766275|FG005|Overall Study|Withdrawal by Subject|0|||
94538549|NCT00884039|323766276|FG000|Overall Study|Withdrawal by Subject|0|||
94538550|NCT00884039|323766277|FG001|Overall Study|Withdrawal by Subject|1|||
94538551|NCT00884039|323766276|FG000|Overall Study|Lack of Efficacy|2|||
94538552|NCT00884039|323766277|FG001|Overall Study|Lack of Efficacy|0|||
94538553|NCT00624819|323766278|FG000|Follow-up Period: Year 4|Parents decision|0|||
94538554|NCT00624819|323766279|FG001|Follow-up Period: Year 4|Parents decision|0|||
94538555|NCT00624819|323766280|FG002|Follow-up Period: Year 4|Parents decision|1|||
94538556|NCT00624819|323766281|FG003|Follow-up Period: Year 4|Parents decision|0|||
94538557|NCT00624819|323766278|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
94538558|NCT00624819|323766279|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
94538559|NCT00624819|323766280|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
94538560|NCT00624819|323766281|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
94538561|NCT01360398|323766288|FG000|Overall Study|Withdrawal by Subject|14|||
94538562|NCT01360398|323766288|FG000|Overall Study|Other|7|||
94538563|NCT01360398|323766288|FG000|Overall Study|Migrated/moved from study area|1|||
94538564|NCT00737711|323766289|FG000|Overall Study|Adverse Event|2|||
94538565|NCT00737711|323766289|FG000|Overall Study|Death|8|||
94538566|NCT00737711|323766289|FG000|Overall Study|Failure to return|4|||
94538567|NCT00737711|323766289|FG000|Overall Study|Protocol Violation|1|||
94538568|NCT00737711|323766289|FG000|Overall Study|Withdrawal by Subject|5|||
94538569|NCT00737711|323766289|FG000|Overall Study|Blood transfusion|6|||
94538570|NCT00737711|323766289|FG000|Overall Study|Other|5|||
94538571|NCT02456636|323767966|FG000|Overall Study|Death|0|||
94538572|NCT02456636|323767967|FG001|Overall Study|Death|3|||
94538573|NCT02456636|323767968|FG002|Overall Study|Death|0|||
94538574|NCT02456636|323767966|FG000|Overall Study|Pregnancy|1|||
94538575|NCT02456636|323767967|FG001|Overall Study|Pregnancy|3|||
94538576|NCT02456636|323767968|FG002|Overall Study|Pregnancy|5|||
94538577|NCT02456636|323767966|FG000|Overall Study|Physician Decision|4|||
94538578|NCT02456636|323767967|FG001|Overall Study|Physician Decision|5|||
94538579|NCT02456636|323767968|FG002|Overall Study|Physician Decision|4|||
94538580|NCT02456636|323767966|FG000|Overall Study|Withdrawal by Subject|13|||
94538581|NCT02456636|323767967|FG001|Overall Study|Withdrawal by Subject|14|||
94538582|NCT02456636|323767968|FG002|Overall Study|Withdrawal by Subject|16|||
94538583|NCT02456636|323767966|FG000|Overall Study|Lost to Follow-up|50|||
94538584|NCT02456636|323767967|FG001|Overall Study|Lost to Follow-up|44|||
94538585|NCT02456636|323767968|FG002|Overall Study|Lost to Follow-up|50|||
94538586|NCT02688088|323767970|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
94538587|NCT02688088|323767971|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
94538588|NCT02688088|323767972|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
94538589|NCT02688088|323767973|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
94538590|NCT02688088|323767974|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
94538591|NCT02688088|323767970|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
94538592|NCT02688088|323767971|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
94538593|NCT02688088|323767972|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
94538594|NCT02688088|323767973|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
94538595|NCT02688088|323767974|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
94538596|NCT02688088|323767970|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
94538597|NCT02688088|323767971|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
94538598|NCT02688088|323767972|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
94538599|NCT02688088|323767973|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
94538600|NCT02688088|323767974|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
94538601|NCT02688088|323767970|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
94538602|NCT02688088|323767971|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
94538603|NCT02688088|323767972|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
94538604|NCT02688088|323767973|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
94538605|NCT02688088|323767974|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
94538606|NCT02688088|323767970|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
94538607|NCT02688088|323767971|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
94538608|NCT02688088|323767972|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
94538609|NCT02688088|323767973|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
94538610|NCT02688088|323767974|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
94538611|NCT02688088|323767970|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
94538612|NCT02688088|323767971|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
94538613|NCT02688088|323767972|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
94538614|NCT02688088|323767973|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
94538615|NCT02688088|323767974|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
94538616|NCT02688088|323767970|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
94538617|NCT02688088|323767971|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
94538618|NCT02688088|323767972|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
94538619|NCT02688088|323767973|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
94538620|NCT02688088|323767974|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
94538621|NCT02688088|323767970|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
94538622|NCT02688088|323767971|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
94538623|NCT02688088|323767972|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
94538624|NCT02688088|323767973|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
94538625|NCT02688088|323767974|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
94538626|NCT02688088|323767970|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
94538627|NCT02688088|323767971|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
94538628|NCT02688088|323767972|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
94538629|NCT02688088|323767973|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
94538630|NCT02688088|323767974|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
94538631|NCT00378599|323767977|FG000|Overall Study|Adverse Event|38|||
94538632|NCT00378599|323767977|FG000|Overall Study|Protocol Violation|2|||
94538633|NCT00378599|323767977|FG000|Overall Study|Treatment failure|7|||
94538634|NCT00378599|323767977|FG000|Overall Study|Withdrawal by Subject|5|||
94538635|NCT05275010|323767978|FG000|Overall Study|Reason Not Specified|4|||
94538636|NCT05275010|323767979|FG001|Overall Study|Reason Not Specified|1|||
94538637|NCT05275010|323767978|FG000|Overall Study|Withdrawal by Subject|1|||
94538638|NCT05275010|323767979|FG001|Overall Study|Withdrawal by Subject|0|||
94538639|NCT05275010|323767978|FG000|Overall Study|Lost to Follow-up|0|||
94538640|NCT05275010|323767979|FG001|Overall Study|Lost to Follow-up|1|||
94538641|NCT03389555|323767981|FG000|Overall Study|Protocol Violation|1|||
94538642|NCT03389555|323767982|FG001|Overall Study|Protocol Violation|3|||
94538643|NCT03389555|323767981|FG000|Overall Study|Death|1|||
94538644|NCT03389555|323767982|FG001|Overall Study|Death|0|||
94538645|NCT00347438|323767985|FG000|Overall Study|Withdrawal by Subject|1|||
94538646|NCT00347438|323767985|FG000|Overall Study|Physician Decision|1|||
94538647|NCT02545517|323767986|FG000|Overall Study|Death|2|||
94538648|NCT02545517|323767987|FG001|Overall Study|Death|2|||
94538649|NCT02545517|323767988|FG002|Overall Study|Death|1|||
94538650|NCT02545517|323767986|FG000|Overall Study|Lost to Follow-up|14|||
94538651|NCT02545517|323767987|FG001|Overall Study|Lost to Follow-up|13|||
94538652|NCT02545517|323767988|FG002|Overall Study|Lost to Follow-up|17|||
94538653|NCT02545517|323767986|FG000|Overall Study|Protocol Violation|0|||
94538654|NCT02545517|323767987|FG001|Overall Study|Protocol Violation|1|||
94538655|NCT02545517|323767988|FG002|Overall Study|Protocol Violation|1|||
94538656|NCT02545517|323767986|FG000|Overall Study|Withdrawal by Subject|5|||
94538657|NCT02545517|323767987|FG001|Overall Study|Withdrawal by Subject|8|||
94538658|NCT02545517|323767988|FG002|Overall Study|Withdrawal by Subject|9|||
94538659|NCT02545517|323767986|FG000|Overall Study|Administrative reason|5|||
94538660|NCT02545517|323767987|FG001|Overall Study|Administrative reason|6|||
94538661|NCT02545517|323767988|FG002|Overall Study|Administrative reason|10|||
94538662|NCT02545517|323767986|FG000|Overall Study|Other|2|||
94538663|NCT02545517|323767987|FG001|Overall Study|Other|4|||
94538664|NCT02545517|323767988|FG002|Overall Study|Other|3|||
94538665|NCT03327220|323767989|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
94538666|NCT03327220|323767990|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
94538667|NCT03327220|323767989|FG000|Overall Study|Investigator Decision|2|||
94538668|NCT03327220|323767990|FG001|Overall Study|Investigator Decision|0|||
94538669|NCT03327220|323767989|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
94538670|NCT03327220|323767990|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
94538671|NCT03327220|323767989|FG000|Overall Study|Fungal infection|1|||
94538672|NCT03327220|323767990|FG001|Overall Study|Fungal infection|0|||
94538673|NCT03327220|323767989|FG000|Overall Study|Discharged to Rehabilitation|0|||
94538674|NCT03327220|323767990|FG001|Overall Study|Discharged to Rehabilitation|1|||
94538675|NCT03327220|323767989|FG000|Overall Study|Missing|1|||
94538676|NCT03327220|323767990|FG001|Overall Study|Missing|0|||
94538677|NCT03920293|323767991|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
94538678|NCT03920293|323767992|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
94538679|NCT03920293|323767991|FG000|Randomized-Controlled Period|Physician Decision|1|||
94538680|NCT03920293|323767992|FG001|Randomized-Controlled Period|Physician Decision|2|||
94538681|NCT03920293|323767991|FG000|Randomized-Controlled Period|Adverse Event|0|||
94538682|NCT03920293|323767992|FG001|Randomized-Controlled Period|Adverse Event|2|||
94538683|NCT03920293|323767991|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
94538684|NCT03920293|323767992|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
94538685|NCT03920293|323767991|FG000|Randomized-Controlled Period|Death|2|||
94538686|NCT03920293|323767992|FG001|Randomized-Controlled Period|Death|0|||
94538687|NCT03920293|323767991|FG000|Randomized-Controlled Period|Protocol Violation|1|||
94538688|NCT03920293|323767992|FG001|Randomized-Controlled Period|Protocol Violation|0|||
94538689|NCT03920293|323767991|FG000|Randomized-Controlled Period|Noncompliance|1|||
94538690|NCT03920293|323767992|FG001|Randomized-Controlled Period|Noncompliance|0|||
94538691|NCT03920293|323767991|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
94538692|NCT03920293|323767992|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
94538693|NCT03920293|323767991|FG000|Open- Label Extension Period|Death|3|||
94538694|NCT03920293|323767992|FG001|Open- Label Extension Period|Death|3|||
94538695|NCT03920293|323767991|FG000|Open- Label Extension Period|Physician Decision|5|||
94538696|NCT03920293|323767992|FG001|Open- Label Extension Period|Physician Decision|3|||
94538697|NCT03920293|323767991|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
94538698|NCT03920293|323767992|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
94538699|NCT00523705|323767993|FG000|Overall Study|No time for study.|0|||
94538700|NCT00523705|323767994|FG001|Overall Study|No time for study.|1|||
94538701|NCT01691885|323767995|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
94538702|NCT01691885|323767996|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
94538703|NCT01691885|323767995|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
94538704|NCT01691885|323767996|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
94538705|NCT01345591|323767997|FG000|Overall Study|Lost to Follow-up|1|||
94538706|NCT01155466|323767999|FG000|Overall Study|Adverse Event|13|||
94538707|NCT01155466|323768000|FG001|Overall Study|Adverse Event|15|||
94538708|NCT01155466|323768001|FG002|Overall Study|Adverse Event|6|||
94538709|NCT01155466|323768002|FG003|Overall Study|Adverse Event|17|||
94538710|NCT01155466|323768003|FG004|Overall Study|Adverse Event|18|||
94538711|NCT01155466|323767999|FG000|Overall Study|Lost to Follow-up|0|||
94538712|NCT01155466|323768000|FG001|Overall Study|Lost to Follow-up|0|||
94538713|NCT01155466|323768001|FG002|Overall Study|Lost to Follow-up|0|||
94538714|NCT01155466|323768002|FG003|Overall Study|Lost to Follow-up|0|||
94538715|NCT01155466|323768003|FG004|Overall Study|Lost to Follow-up|2|||
94538716|NCT01155466|323767999|FG000|Overall Study|Withdrawal by Subject|7|||
94538717|NCT01155466|323768000|FG001|Overall Study|Withdrawal by Subject|5|||
94538718|NCT01155466|323768001|FG002|Overall Study|Withdrawal by Subject|9|||
94538719|NCT01155466|323768002|FG003|Overall Study|Withdrawal by Subject|4|||
94538720|NCT01155466|323768003|FG004|Overall Study|Withdrawal by Subject|4|||
94538721|NCT01155466|323767999|FG000|Overall Study|Protocol Violation|0|||
94538722|NCT01155466|323768000|FG001|Overall Study|Protocol Violation|0|||
94538723|NCT01155466|323768001|FG002|Overall Study|Protocol Violation|2|||
94538724|NCT01155466|323768002|FG003|Overall Study|Protocol Violation|0|||
94538725|NCT01155466|323768003|FG004|Overall Study|Protocol Violation|1|||
94538726|NCT01155466|323767999|FG000|Overall Study|Administrative|0|||
94538727|NCT01155466|323768000|FG001|Overall Study|Administrative|3|||
94538728|NCT01155466|323768001|FG002|Overall Study|Administrative|0|||
94538729|NCT01155466|323768002|FG003|Overall Study|Administrative|0|||
94538730|NCT01155466|323768003|FG004|Overall Study|Administrative|0|||
94538731|NCT01155466|323767999|FG000|Overall Study|Randomized not treated|2|||
94538732|NCT01155466|323768000|FG001|Overall Study|Randomized not treated|2|||
94538733|NCT01155466|323768001|FG002|Overall Study|Randomized not treated|3|||
94538734|NCT01155466|323768002|FG003|Overall Study|Randomized not treated|0|||
94538735|NCT01155466|323768003|FG004|Overall Study|Randomized not treated|2|||
94538736|NCT00590824|323768004|FG000|Overall Study|Disease could not be resected|0|||
94538737|NCT00590824|323768005|FG001|Overall Study|Disease could not be resected|2|||
94538738|NCT00590824|323768006|FG002|Overall Study|Disease could not be resected|1|||
94538739|NCT00590824|323768007|FG003|Overall Study|Disease could not be resected|0|||
94538740|NCT00590824|323768004|FG000|Overall Study|Adverse Event|0|||
94538741|NCT00590824|323768005|FG001|Overall Study|Adverse Event|0|||
94538742|NCT00590824|323768006|FG002|Overall Study|Adverse Event|0|||
94538743|NCT00590824|323768007|FG003|Overall Study|Adverse Event|1|||
94538744|NCT02210689|323768008|FG000|Overall Study|Withdrawal by Subject|7|||
94538745|NCT02210689|323768009|FG001|Overall Study|Withdrawal by Subject|4|||
94538746|NCT02210689|323768010|FG002|Overall Study|Withdrawal by Subject|2|||
94538747|NCT02210689|323768008|FG000|Overall Study|Adverse Event|0|||
94538748|NCT02210689|323768009|FG001|Overall Study|Adverse Event|1|||
94538749|NCT02210689|323768010|FG002|Overall Study|Adverse Event|0|||
94538750|NCT02210689|323768008|FG000|Overall Study|Protocol Violation|1|||
94538751|NCT02210689|323768009|FG001|Overall Study|Protocol Violation|0|||
94538752|NCT02210689|323768010|FG002|Overall Study|Protocol Violation|0|||
94538753|NCT02210689|323768008|FG000|Overall Study|Lost to Follow-up|11|||
94538754|NCT02210689|323768009|FG001|Overall Study|Lost to Follow-up|9|||
94538755|NCT02210689|323768010|FG002|Overall Study|Lost to Follow-up|5|||
94538756|NCT02210689|323768008|FG000|Overall Study|Pregnancy|0|||
94538757|NCT02210689|323768009|FG001|Overall Study|Pregnancy|1|||
94538758|NCT02210689|323768010|FG002|Overall Study|Pregnancy|0|||
94538759|NCT02210689|323768008|FG000|Overall Study|Lack of Efficacy|0|||
94538760|NCT02210689|323768009|FG001|Overall Study|Lack of Efficacy|1|||
94538761|NCT02210689|323768010|FG002|Overall Study|Lack of Efficacy|5|||
94538762|NCT02210689|323768008|FG000|Overall Study|Prohibited medication|2|||
94538763|NCT02210689|323768009|FG001|Overall Study|Prohibited medication|8|||
94538764|NCT02210689|323768010|FG002|Overall Study|Prohibited medication|1|||
94538765|NCT02210689|323768008|FG000|Overall Study|Negative Nugent score at baseline|6|||
94538766|NCT02210689|323768009|FG001|Overall Study|Negative Nugent score at baseline|2|||
94538767|NCT02210689|323768010|FG002|Overall Study|Negative Nugent score at baseline|2|||
94538768|NCT02210689|323768008|FG000|Overall Study|Other|25|||
94538769|NCT02210689|323768009|FG001|Overall Study|Other|21|||
94538770|NCT02210689|323768010|FG002|Overall Study|Other|8|||
94538771|NCT04195438|323768015|FG000|Overall Study|Withdrawal by Subject|1|||
94538772|NCT00223977|323768016|FG000|Overall Study|Adverse Event|7|||
94538773|NCT00223977|323768017|FG001|Overall Study|Adverse Event|10|||
94538774|NCT00223977|323768018|FG002|Overall Study|Adverse Event|0|||
94538775|NCT00223977|323768016|FG000|Overall Study|Protocol Violation|0|||
94538776|NCT00223977|323768017|FG001|Overall Study|Protocol Violation|0|||
94538777|NCT00223977|323768018|FG002|Overall Study|Protocol Violation|1|||
94538778|NCT00223977|323768016|FG000|Overall Study|Withdrawal by Subject|1|||
94538779|NCT00223977|323768017|FG001|Overall Study|Withdrawal by Subject|1|||
94538780|NCT00223977|323768018|FG002|Overall Study|Withdrawal by Subject|2|||
94538781|NCT00223977|323768016|FG000|Overall Study|Other|1|||
94538782|NCT00223977|323768017|FG001|Overall Study|Other|0|||
94538783|NCT00223977|323768018|FG002|Overall Study|Other|0|||
94538784|NCT04239222|323768023|FG000|Baseline|Withdrawal by Subject|0|||
94538785|NCT04239222|323768024|FG001|Baseline|Withdrawal by Subject|0|||
94538786|NCT04239222|323768025|FG002|Baseline|Withdrawal by Subject|1|||
94538787|NCT04239222|323768026|FG003|Baseline|Withdrawal by Subject|1|||
94538788|NCT04239222|323768023|FG000|First Foot Assignment|Withdrawal by Subject|0|||
94538789|NCT04239222|323768024|FG001|First Foot Assignment|Withdrawal by Subject|0|||
94538790|NCT04239222|323768025|FG002|First Foot Assignment|Withdrawal by Subject|1|||
94538791|NCT04239222|323768026|FG003|First Foot Assignment|Withdrawal by Subject|0|||
94538792|NCT04239222|323768023|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
94538793|NCT04239222|323768024|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
94538794|NCT04239222|323768025|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
94538795|NCT04239222|323768026|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
94538796|NCT00230282|323768029|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
94538797|NCT00230282|323768029|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
94538798|NCT00230282|323768029|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
94538799|NCT00230282|323768029|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
94538800|NCT01327053|323768034|FG000|Overall Study|Adverse Event|23|||
94538801|NCT01327053|323768035|FG001|Overall Study|Adverse Event|57|||
94538802|NCT01327053|323768034|FG000|Overall Study|Patient/guardian decision|11|||
94538803|NCT01327053|323768035|FG001|Overall Study|Patient/guardian decision|35|||
94538804|NCT01327053|323768034|FG000|Overall Study|Physician Decision|10|||
94538805|NCT01327053|323768035|FG001|Overall Study|Physician Decision|14|||
94538806|NCT01327053|323768034|FG000|Overall Study|Death|1|||
94538807|NCT01327053|323768035|FG001|Overall Study|Death|5|||
94538808|NCT01327053|323768034|FG000|Overall Study|Lost to Follow-up|2|||
94538809|NCT01327053|323768035|FG001|Overall Study|Lost to Follow-up|4|||
94538810|NCT01327053|323768034|FG000|Overall Study|Non-compliance with study treatment|0|||
94538811|NCT01327053|323768035|FG001|Overall Study|Non-compliance with study treatment|5|||
94538812|NCT01327053|323768034|FG000|Overall Study|Study terminated by Sponsor|1|||
94538813|NCT01327053|323768035|FG001|Overall Study|Study terminated by Sponsor|3|||
94538814|NCT01327053|323768034|FG000|Overall Study|Progressive disease|31|||
94538815|NCT01327053|323768035|FG001|Overall Study|Progressive disease|26|||
94538816|NCT01327053|323768034|FG000|Overall Study|Protocol Violation|0|||
94538817|NCT01327053|323768035|FG001|Overall Study|Protocol Violation|1|||
94538818|NCT01327053|323768034|FG000|Overall Study|Untreated|0|||
94538819|NCT01327053|323768035|FG001|Overall Study|Untreated|1|||
94538820|NCT01482169|323768037|FG000|Overall Study|Physician Decision|2|||
94538821|NCT01574157|323768041|FG000|Overall Study|Withdrawal by Subject|4|||
94538822|NCT01574157|323768042|FG001|Overall Study|Withdrawal by Subject|5|||
94538823|NCT01574157|323768041|FG000|Overall Study|Lost to Follow-up|0|||
94538824|NCT01574157|323768042|FG001|Overall Study|Lost to Follow-up|3|||
94538825|NCT00790647|323768047|FG000|Overall Study|Adverse Event|1|||
94538826|NCT01632241|323768048|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
94538827|NCT01632241|323768049|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
94538828|NCT01632241|323768048|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
94538829|NCT01632241|323768049|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
94538830|NCT01632241|323768048|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
94538831|NCT01632241|323768049|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
94538832|NCT01632241|323768048|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
94538833|NCT01632241|323768049|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
94538834|NCT01632241|323768048|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
94538835|NCT01632241|323768049|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
94538836|NCT01632241|323768048|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
94538837|NCT01632241|323768049|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
94538838|NCT01632241|323768048|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
94538839|NCT01632241|323768049|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
94538840|NCT01632241|323768048|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
94538841|NCT01632241|323768049|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
94538842|NCT01632241|323768048|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
94538843|NCT01632241|323768049|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
94538844|NCT01632241|323768048|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
94538845|NCT01632241|323768049|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
94538846|NCT01632241|323768048|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
94538847|NCT01632241|323768049|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
94538848|NCT01632241|323768048|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
94538849|NCT01632241|323768049|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
94538850|NCT01632241|323768048|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
94538851|NCT01632241|323768049|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
94538852|NCT01632241|323768048|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
94538853|NCT01632241|323768049|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
94538854|NCT02298179|323768050|FG000|Overall Study|Lost to Follow-up|0|||
94538855|NCT02298179|323768051|FG001|Overall Study|Lost to Follow-up|0|||
94538856|NCT02298179|323768052|FG002|Overall Study|Lost to Follow-up|1|||
94538857|NCT02298179|323768053|FG003|Overall Study|Lost to Follow-up|0|||
94538858|NCT02298179|323768054|FG004|Overall Study|Lost to Follow-up|0|||
94538859|NCT02298179|323768055|FG005|Overall Study|Lost to Follow-up|0|||
94538860|NCT02298179|323768056|FG006|Overall Study|Lost to Follow-up|0|||
94538861|NCT02298179|323768057|FG007|Overall Study|Lost to Follow-up|1|||
94538862|NCT02298179|323768058|FG008|Overall Study|Lost to Follow-up|0|||
94538863|NCT02298179|323768059|FG009|Overall Study|Lost to Follow-up|0|||
94538864|NCT02298179|323768060|FG010|Overall Study|Lost to Follow-up|0|||
94538865|NCT02298179|323768061|FG011|Overall Study|Lost to Follow-up|0|||
94538866|NCT02701777|323768062|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
94538867|NCT02701777|323768063|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
94538868|NCT02701777|323768064|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
94538869|NCT02701777|323768065|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
94538870|NCT02701777|323768062|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
94538871|NCT02701777|323768063|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
94538872|NCT02701777|323768064|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
94538873|NCT02701777|323768065|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
94538874|NCT00855933|323768066|FG000|Overall Study|Withdrawal by Subject|0|||
94538875|NCT00855933|323768067|FG001|Overall Study|Withdrawal by Subject|1|||
94538876|NCT01960998|323768068|FG000|Overall Study|Lost to Follow-up|3|||
94538877|NCT01960998|323768069|FG001|Overall Study|Lost to Follow-up|7|||
94538878|NCT01960998|323768068|FG000|Overall Study|Death|0|||
94538879|NCT01960998|323768069|FG001|Overall Study|Death|1|||
94538880|NCT01960998|323768068|FG000|Overall Study|Withdrawal by Subject|8|||
94538881|NCT01960998|323768069|FG001|Overall Study|Withdrawal by Subject|2|||
94538882|NCT01960998|323768068|FG000|Overall Study|lost computer access|0|||
94538883|NCT01960998|323768069|FG001|Overall Study|lost computer access|1|||
94538884|NCT00835640|323768080|FG000|Second Intervention|Protocol Violation|1|||
94538885|NCT00835640|323768081|FG001|Second Intervention|Protocol Violation|0|||
94538886|NCT00812006|323768082|FG000|Overall Study|Lost to Follow-up|0|||
94538887|NCT00812006|323768083|FG001|Overall Study|Lost to Follow-up|0|||
94538888|NCT00812006|323768084|FG002|Overall Study|Lost to Follow-up|2|||
94538889|NCT00812006|323768082|FG000|Overall Study|Physician Decision|0|||
94538890|NCT00812006|323768083|FG001|Overall Study|Physician Decision|0|||
94538891|NCT00812006|323768084|FG002|Overall Study|Physician Decision|1|||
94538892|NCT00812006|323768082|FG000|Overall Study|Withdrawal by Subject|2|||
94538893|NCT00812006|323768083|FG001|Overall Study|Withdrawal by Subject|1|||
94538894|NCT00812006|323768084|FG002|Overall Study|Withdrawal by Subject|1|||
94538895|NCT00812006|323768082|FG000|Overall Study|Lack of Qualifying Event|4|||
94538896|NCT00812006|323768083|FG001|Overall Study|Lack of Qualifying Event|2|||
94538897|NCT00812006|323768084|FG002|Overall Study|Lack of Qualifying Event|2|||
94538898|NCT00433160|323768100|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
94538899|NCT00433160|323768101|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
94538900|NCT00433160|323768100|FG000|52-Week Double-Blind (DB) Period|Death|0|||
94538901|NCT00433160|323768101|FG001|52-Week Double-Blind (DB) Period|Death|0|||
94538902|NCT00433160|323768100|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
94538903|NCT00433160|323768101|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
94538904|NCT00433160|323768100|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
94538905|NCT00433160|323768101|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
94538906|NCT00433160|323768100|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
94538907|NCT00433160|323768101|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
94538908|NCT00433160|323768100|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
94538909|NCT00433160|323768101|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
94538910|NCT00433160|323768100|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
94538911|NCT00433160|323768101|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
94538912|NCT00433160|323768100|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
94538913|NCT00433160|323768101|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
94538914|NCT00433160|323768100|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
94538915|NCT00433160|323768101|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
94538916|NCT00433160|323768100|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
94538917|NCT00433160|323768101|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
94538918|NCT00433160|323768100|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
94538919|NCT00433160|323768101|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
94538920|NCT00433160|323768100|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
94538921|NCT00433160|323768101|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
94538922|NCT00433160|323768100|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
94538923|NCT00433160|323768101|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
94538924|NCT00433160|323768100|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
94538925|NCT00433160|323768101|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
94538926|NCT00433160|323768100|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
94538927|NCT00433160|323768101|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
94538928|NCT00433160|323768100|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
94538929|NCT00433160|323768101|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
94538930|NCT00570037|323768102|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
94538931|NCT00570037|323768103|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
94538932|NCT00075725|323768104|FG000|Overall Study|Adverse Event|6|||
94538933|NCT00075725|323768105|FG001|Overall Study|Adverse Event|6|||
94538934|NCT00075725|323768106|FG002|Overall Study|Adverse Event|20|||
94538935|NCT00075725|323768107|FG003|Overall Study|Adverse Event|8|||
94538936|NCT00075725|323768108|FG004|Overall Study|Adverse Event|4|||
94538937|NCT00075725|323768109|FG005|Overall Study|Adverse Event|38|||
94538938|NCT00075725|323768110|FG006|Overall Study|Adverse Event|3|||
94538939|NCT00075725|323768111|FG007|Overall Study|Adverse Event|51|||
94538940|NCT00075725|323768112|FG008|Overall Study|Adverse Event|15|||
94538941|NCT00075725|323768113|FG009|Overall Study|Adverse Event|4|||
94538942|NCT00075725|323768114|FG010|Overall Study|Adverse Event|2|||
94538943|NCT00075725|323768115|FG011|Overall Study|Adverse Event|2|||
94538944|NCT00075725|323768104|FG000|Overall Study|Death|3|||
94538945|NCT00075725|323768105|FG001|Overall Study|Death|5|||
94538946|NCT00075725|323768106|FG002|Overall Study|Death|10|||
94538947|NCT00075725|323768107|FG003|Overall Study|Death|2|||
94538948|NCT00075725|323768108|FG004|Overall Study|Death|3|||
94538949|NCT00075725|323768109|FG005|Overall Study|Death|25|||
94538950|NCT00075725|323768110|FG006|Overall Study|Death|4|||
94538951|NCT00075725|323768111|FG007|Overall Study|Death|22|||
94538952|NCT00075725|323768112|FG008|Overall Study|Death|14|||
94538953|NCT00075725|323768113|FG009|Overall Study|Death|4|||
94538954|NCT00075725|323768114|FG010|Overall Study|Death|3|||
94538955|NCT00075725|323768115|FG011|Overall Study|Death|0|||
94538956|NCT00075725|323768104|FG000|Overall Study|Lost to Follow-up|1|||
94538957|NCT00075725|323768105|FG001|Overall Study|Lost to Follow-up|1|||
94538958|NCT00075725|323768106|FG002|Overall Study|Lost to Follow-up|4|||
94538959|NCT00075725|323768107|FG003|Overall Study|Lost to Follow-up|1|||
94538960|NCT00075725|323768108|FG004|Overall Study|Lost to Follow-up|0|||
94538961|NCT00075725|323768109|FG005|Overall Study|Lost to Follow-up|13|||
94538962|NCT00075725|323768110|FG006|Overall Study|Lost to Follow-up|2|||
94538963|NCT00075725|323768111|FG007|Overall Study|Lost to Follow-up|4|||
94538964|NCT00075725|323768112|FG008|Overall Study|Lost to Follow-up|1|||
94538965|NCT00075725|323768113|FG009|Overall Study|Lost to Follow-up|0|||
94538966|NCT00075725|323768114|FG010|Overall Study|Lost to Follow-up|0|||
94538967|NCT00075725|323768115|FG011|Overall Study|Lost to Follow-up|0|||
94538968|NCT00075725|323768104|FG000|Overall Study|Physician Decision|2|||
94538969|NCT00075725|323768105|FG001|Overall Study|Physician Decision|6|||
94538970|NCT00075725|323768106|FG002|Overall Study|Physician Decision|5|||
94538971|NCT00075725|323768107|FG003|Overall Study|Physician Decision|8|||
94538972|NCT00075725|323768108|FG004|Overall Study|Physician Decision|4|||
94538973|NCT00075725|323768109|FG005|Overall Study|Physician Decision|19|||
94538974|NCT00075725|323768110|FG006|Overall Study|Physician Decision|3|||
94538975|NCT00075725|323768111|FG007|Overall Study|Physician Decision|17|||
94538976|NCT00075725|323768112|FG008|Overall Study|Physician Decision|5|||
94538977|NCT00075725|323768113|FG009|Overall Study|Physician Decision|0|||
94538978|NCT00075725|323768114|FG010|Overall Study|Physician Decision|1|||
94538979|NCT00075725|323768115|FG011|Overall Study|Physician Decision|0|||
94538980|NCT00075725|323768104|FG000|Overall Study|Pregnancy|0|||
94538981|NCT00075725|323768105|FG001|Overall Study|Pregnancy|0|||
94538982|NCT00075725|323768106|FG002|Overall Study|Pregnancy|0|||
94538983|NCT00075725|323768107|FG003|Overall Study|Pregnancy|0|||
94538984|NCT00075725|323768108|FG004|Overall Study|Pregnancy|0|||
94538985|NCT00075725|323768109|FG005|Overall Study|Pregnancy|1|||
94538986|NCT00075725|323768110|FG006|Overall Study|Pregnancy|0|||
94538987|NCT00075725|323768111|FG007|Overall Study|Pregnancy|1|||
94538988|NCT00075725|323768112|FG008|Overall Study|Pregnancy|0|||
94538989|NCT00075725|323768113|FG009|Overall Study|Pregnancy|0|||
94538990|NCT00075725|323768114|FG010|Overall Study|Pregnancy|0|||
94538991|NCT00075725|323768115|FG011|Overall Study|Pregnancy|0|||
94538992|NCT00075725|323768104|FG000|Overall Study|Protocol Violation|1|||
94538993|NCT00075725|323768105|FG001|Overall Study|Protocol Violation|1|||
94538994|NCT00075725|323768106|FG002|Overall Study|Protocol Violation|0|||
94538995|NCT00075725|323768107|FG003|Overall Study|Protocol Violation|3|||
94538996|NCT00075725|323768108|FG004|Overall Study|Protocol Violation|3|||
94538997|NCT00075725|323768109|FG005|Overall Study|Protocol Violation|2|||
94538998|NCT00075725|323768110|FG006|Overall Study|Protocol Violation|1|||
94538999|NCT00075725|323768111|FG007|Overall Study|Protocol Violation|2|||
94539000|NCT00075725|323768112|FG008|Overall Study|Protocol Violation|3|||
94539001|NCT00075725|323768113|FG009|Overall Study|Protocol Violation|0|||
94539002|NCT00075725|323768114|FG010|Overall Study|Protocol Violation|0|||
94539003|NCT00075725|323768115|FG011|Overall Study|Protocol Violation|1|||
94539004|NCT00075725|323768104|FG000|Overall Study|Withdrawal by Subject|12|||
94539005|NCT00075725|323768105|FG001|Overall Study|Withdrawal by Subject|3|||
94539006|NCT00075725|323768106|FG002|Overall Study|Withdrawal by Subject|6|||
94539007|NCT00075725|323768107|FG003|Overall Study|Withdrawal by Subject|10|||
94539008|NCT00075725|323768108|FG004|Overall Study|Withdrawal by Subject|6|||
94539009|NCT00075725|323768109|FG005|Overall Study|Withdrawal by Subject|27|||
94539010|NCT00075725|323768110|FG006|Overall Study|Withdrawal by Subject|7|||
94539011|NCT00075725|323768111|FG007|Overall Study|Withdrawal by Subject|31|||
94539012|NCT00075725|323768112|FG008|Overall Study|Withdrawal by Subject|10|||
94539013|NCT00075725|323768113|FG009|Overall Study|Withdrawal by Subject|2|||
94539014|NCT00075725|323768114|FG010|Overall Study|Withdrawal by Subject|0|||
94539015|NCT00075725|323768115|FG011|Overall Study|Withdrawal by Subject|0|||
94539016|NCT00075725|323768104|FG000|Overall Study|Disease Progression, all other reasons|17|||
94539017|NCT00075725|323768105|FG001|Overall Study|Disease Progression, all other reasons|5|||
94539018|NCT00075725|323768106|FG002|Overall Study|Disease Progression, all other reasons|33|||
94539019|NCT00075725|323768107|FG003|Overall Study|Disease Progression, all other reasons|6|||
94539020|NCT00075725|323768108|FG004|Overall Study|Disease Progression, all other reasons|21|||
94539021|NCT00075725|323768109|FG005|Overall Study|Disease Progression, all other reasons|59|||
94539022|NCT00075725|323768110|FG006|Overall Study|Disease Progression, all other reasons|20|||
94539023|NCT00075725|323768111|FG007|Overall Study|Disease Progression, all other reasons|46|||
94539024|NCT00075725|323768112|FG008|Overall Study|Disease Progression, all other reasons|21|||
94539025|NCT00075725|323768113|FG009|Overall Study|Disease Progression, all other reasons|4|||
94539026|NCT00075725|323768114|FG010|Overall Study|Disease Progression, all other reasons|0|||
94539027|NCT00075725|323768115|FG011|Overall Study|Disease Progression, all other reasons|5|||
94539028|NCT00075725|323768104|FG000|Overall Study|Patient off treatment|0|||
94539029|NCT00075725|323768105|FG001|Overall Study|Patient off treatment|0|||
94539030|NCT00075725|323768106|FG002|Overall Study|Patient off treatment|1|||
94539031|NCT00075725|323768107|FG003|Overall Study|Patient off treatment|2|||
94539032|NCT00075725|323768108|FG004|Overall Study|Patient off treatment|1|||
94539033|NCT00075725|323768109|FG005|Overall Study|Patient off treatment|0|||
94539034|NCT00075725|323768110|FG006|Overall Study|Patient off treatment|0|||
94539035|NCT00075725|323768111|FG007|Overall Study|Patient off treatment|2|||
94539036|NCT00075725|323768112|FG008|Overall Study|Patient off treatment|1|||
94539037|NCT00075725|323768113|FG009|Overall Study|Patient off treatment|0|||
94539038|NCT00075725|323768114|FG010|Overall Study|Patient off treatment|0|||
94539039|NCT00075725|323768115|FG011|Overall Study|Patient off treatment|0|||
94539040|NCT00075725|323768104|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
94539041|NCT00075725|323768105|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
94539042|NCT00075725|323768106|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
94539043|NCT00075725|323768107|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
94539044|NCT00075725|323768108|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
94539045|NCT00075725|323768109|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
94539046|NCT00075725|323768110|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
94539047|NCT00075725|323768111|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
94539048|NCT00075725|323768112|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
94539049|NCT00075725|323768113|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
94539050|NCT00075725|323768114|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
94539051|NCT00075725|323768115|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
94539052|NCT00075725|323768104|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
94539053|NCT00075725|323768105|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
94539054|NCT00075725|323768106|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
94539055|NCT00075725|323768107|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
94539056|NCT00075725|323768108|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
94539057|NCT00075725|323768109|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
94539058|NCT00075725|323768110|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
94539059|NCT00075725|323768111|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
94539060|NCT00075725|323768112|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
94539061|NCT00075725|323768113|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
94539062|NCT00075725|323768114|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
94539063|NCT00075725|323768115|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
94539064|NCT00075725|323768104|FG000|Overall Study|Pt non compliant with therapy|2|||
94539065|NCT00075725|323768105|FG001|Overall Study|Pt non compliant with therapy|1|||
94539066|NCT00075725|323768106|FG002|Overall Study|Pt non compliant with therapy|1|||
94539067|NCT00075725|323768107|FG003|Overall Study|Pt non compliant with therapy|0|||
94539068|NCT00075725|323768108|FG004|Overall Study|Pt non compliant with therapy|2|||
94539069|NCT00075725|323768109|FG005|Overall Study|Pt non compliant with therapy|14|||
94539070|NCT00075725|323768110|FG006|Overall Study|Pt non compliant with therapy|2|||
94539071|NCT00075725|323768111|FG007|Overall Study|Pt non compliant with therapy|5|||
94539072|NCT00075725|323768112|FG008|Overall Study|Pt non compliant with therapy|3|||
94539073|NCT00075725|323768113|FG009|Overall Study|Pt non compliant with therapy|0|||
94539074|NCT00075725|323768114|FG010|Overall Study|Pt non compliant with therapy|0|||
94539075|NCT00075725|323768115|FG011|Overall Study|Pt non compliant with therapy|0|||
94539076|NCT00075725|323768104|FG000|Overall Study|Pt age out of range for treatment|0|||
94539077|NCT00075725|323768105|FG001|Overall Study|Pt age out of range for treatment|1|||
94539078|NCT00075725|323768106|FG002|Overall Study|Pt age out of range for treatment|0|||
94539079|NCT00075725|323768107|FG003|Overall Study|Pt age out of range for treatment|0|||
94539080|NCT00075725|323768108|FG004|Overall Study|Pt age out of range for treatment|0|||
94539081|NCT00075725|323768109|FG005|Overall Study|Pt age out of range for treatment|1|||
94539082|NCT00075725|323768110|FG006|Overall Study|Pt age out of range for treatment|0|||
94539083|NCT00075725|323768111|FG007|Overall Study|Pt age out of range for treatment|1|||
94539084|NCT00075725|323768112|FG008|Overall Study|Pt age out of range for treatment|0|||
94539085|NCT00075725|323768113|FG009|Overall Study|Pt age out of range for treatment|0|||
94539086|NCT00075725|323768114|FG010|Overall Study|Pt age out of range for treatment|0|||
94539087|NCT00075725|323768115|FG011|Overall Study|Pt age out of range for treatment|0|||
94539088|NCT00075725|323768104|FG000|Overall Study|Insurance issues|0|||
94539089|NCT00075725|323768105|FG001|Overall Study|Insurance issues|1|||
94539090|NCT00075725|323768106|FG002|Overall Study|Insurance issues|0|||
94539091|NCT00075725|323768107|FG003|Overall Study|Insurance issues|1|||
94539092|NCT00075725|323768108|FG004|Overall Study|Insurance issues|1|||
94539093|NCT00075725|323768109|FG005|Overall Study|Insurance issues|1|||
94539094|NCT00075725|323768110|FG006|Overall Study|Insurance issues|0|||
94539095|NCT00075725|323768111|FG007|Overall Study|Insurance issues|1|||
94539096|NCT00075725|323768112|FG008|Overall Study|Insurance issues|0|||
94539097|NCT00075725|323768113|FG009|Overall Study|Insurance issues|0|||
94539098|NCT00075725|323768114|FG010|Overall Study|Insurance issues|0|||
94539099|NCT00075725|323768115|FG011|Overall Study|Insurance issues|0|||
94539100|NCT00075725|323768104|FG000|Overall Study|MRD positive after extended ind|0|||
94539101|NCT00075725|323768105|FG001|Overall Study|MRD positive after extended ind|1|||
94539102|NCT00075725|323768106|FG002|Overall Study|MRD positive after extended ind|1|||
94539103|NCT00075725|323768107|FG003|Overall Study|MRD positive after extended ind|0|||
94539104|NCT00075725|323768108|FG004|Overall Study|MRD positive after extended ind|1|||
94539105|NCT00075725|323768109|FG005|Overall Study|MRD positive after extended ind|2|||
94539106|NCT00075725|323768110|FG006|Overall Study|MRD positive after extended ind|0|||
94539107|NCT00075725|323768111|FG007|Overall Study|MRD positive after extended ind|1|||
94539108|NCT00075725|323768112|FG008|Overall Study|MRD positive after extended ind|0|||
94539109|NCT00075725|323768113|FG009|Overall Study|MRD positive after extended ind|0|||
94539110|NCT00075725|323768114|FG010|Overall Study|MRD positive after extended ind|0|||
94539111|NCT00075725|323768115|FG011|Overall Study|MRD positive after extended ind|0|||
94539112|NCT00075725|323768104|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
94539113|NCT00075725|323768105|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
94539114|NCT00075725|323768106|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
94539115|NCT00075725|323768107|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
94539116|NCT00075725|323768108|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
94539117|NCT00075725|323768109|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
94539118|NCT00075725|323768110|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
94539119|NCT00075725|323768111|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
94539120|NCT00075725|323768112|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
94539121|NCT00075725|323768113|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
94539122|NCT00075725|323768114|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
94539123|NCT00075725|323768115|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
94539124|NCT00075725|323768104|FG000|Overall Study|Inevaluable|1|||
94539125|NCT00075725|323768105|FG001|Overall Study|Inevaluable|1|||
94539126|NCT00075725|323768106|FG002|Overall Study|Inevaluable|4|||
94539127|NCT00075725|323768107|FG003|Overall Study|Inevaluable|2|||
94539128|NCT00075725|323768108|FG004|Overall Study|Inevaluable|2|||
94539129|NCT00075725|323768109|FG005|Overall Study|Inevaluable|9|||
94539130|NCT00075725|323768110|FG006|Overall Study|Inevaluable|1|||
94539131|NCT00075725|323768111|FG007|Overall Study|Inevaluable|11|||
94539132|NCT00075725|323768112|FG008|Overall Study|Inevaluable|2|||
94539133|NCT00075725|323768113|FG009|Overall Study|Inevaluable|0|||
94539134|NCT00075725|323768114|FG010|Overall Study|Inevaluable|1|||
94539135|NCT00075725|323768115|FG011|Overall Study|Inevaluable|0|||
94539136|NCT00075725|323768104|FG000|Overall Study|Other|4|||
94539137|NCT00075725|323768105|FG001|Overall Study|Other|2|||
94539138|NCT00075725|323768106|FG002|Overall Study|Other|1|||
94539139|NCT00075725|323768107|FG003|Overall Study|Other|1|||
94539140|NCT00075725|323768108|FG004|Overall Study|Other|1|||
94539141|NCT00075725|323768109|FG005|Overall Study|Other|4|||
94539142|NCT00075725|323768110|FG006|Overall Study|Other|2|||
94539143|NCT00075725|323768111|FG007|Overall Study|Other|9|||
94539144|NCT00075725|323768112|FG008|Overall Study|Other|2|||
94539145|NCT00075725|323768113|FG009|Overall Study|Other|1|||
94539146|NCT00075725|323768114|FG010|Overall Study|Other|0|||
94539147|NCT00075725|323768115|FG011|Overall Study|Other|3|||
94539148|NCT00075725|323768104|FG000|Overall Study|Pt trying to find a BM donor|0|||
94539149|NCT00075725|323768105|FG001|Overall Study|Pt trying to find a BM donor|1|||
94539150|NCT00075725|323768106|FG002|Overall Study|Pt trying to find a BM donor|0|||
94539151|NCT00075725|323768107|FG003|Overall Study|Pt trying to find a BM donor|0|||
94539152|NCT00075725|323768108|FG004|Overall Study|Pt trying to find a BM donor|0|||
94539153|NCT00075725|323768109|FG005|Overall Study|Pt trying to find a BM donor|0|||
94539154|NCT00075725|323768110|FG006|Overall Study|Pt trying to find a BM donor|0|||
94539155|NCT00075725|323768111|FG007|Overall Study|Pt trying to find a BM donor|0|||
94539156|NCT00075725|323768112|FG008|Overall Study|Pt trying to find a BM donor|0|||
94539157|NCT00075725|323768113|FG009|Overall Study|Pt trying to find a BM donor|0|||
94539158|NCT00075725|323768114|FG010|Overall Study|Pt trying to find a BM donor|0|||
94539159|NCT00075725|323768115|FG011|Overall Study|Pt trying to find a BM donor|0|||
94539160|NCT00075725|323768104|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
94539161|NCT00075725|323768105|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
94539162|NCT00075725|323768106|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
94539163|NCT00075725|323768107|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
94539164|NCT00075725|323768108|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
94539165|NCT00075725|323768109|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
94539166|NCT00075725|323768110|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
94539167|NCT00075725|323768111|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
94539168|NCT00075725|323768112|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
94539169|NCT00075725|323768113|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
94539170|NCT00075725|323768114|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
94539171|NCT00075725|323768115|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
94539172|NCT00075725|323768104|FG000|Overall Study|Unsuccessful institutional transfer|0|||
94539173|NCT00075725|323768105|FG001|Overall Study|Unsuccessful institutional transfer|0|||
94539174|NCT00075725|323768106|FG002|Overall Study|Unsuccessful institutional transfer|2|||
94539175|NCT00075725|323768107|FG003|Overall Study|Unsuccessful institutional transfer|0|||
94539176|NCT00075725|323768108|FG004|Overall Study|Unsuccessful institutional transfer|0|||
94539177|NCT00075725|323768109|FG005|Overall Study|Unsuccessful institutional transfer|0|||
94539178|NCT00075725|323768110|FG006|Overall Study|Unsuccessful institutional transfer|0|||
94539179|NCT00075725|323768111|FG007|Overall Study|Unsuccessful institutional transfer|0|||
94539180|NCT00075725|323768112|FG008|Overall Study|Unsuccessful institutional transfer|0|||
94539181|NCT00075725|323768113|FG009|Overall Study|Unsuccessful institutional transfer|1|||
94539182|NCT00075725|323768114|FG010|Overall Study|Unsuccessful institutional transfer|0|||
94539183|NCT00075725|323768115|FG011|Overall Study|Unsuccessful institutional transfer|0|||
94539184|NCT00075725|323768104|FG000|Overall Study|specimen(s) not submitted|0|||
94539185|NCT00075725|323768105|FG001|Overall Study|specimen(s) not submitted|0|||
94539186|NCT00075725|323768106|FG002|Overall Study|specimen(s) not submitted|2|||
94539187|NCT00075725|323768107|FG003|Overall Study|specimen(s) not submitted|0|||
94539188|NCT00075725|323768108|FG004|Overall Study|specimen(s) not submitted|0|||
94539189|NCT00075725|323768109|FG005|Overall Study|specimen(s) not submitted|0|||
94539190|NCT00075725|323768110|FG006|Overall Study|specimen(s) not submitted|0|||
94539191|NCT00075725|323768111|FG007|Overall Study|specimen(s) not submitted|0|||
94539192|NCT00075725|323768112|FG008|Overall Study|specimen(s) not submitted|0|||
94539193|NCT00075725|323768113|FG009|Overall Study|specimen(s) not submitted|0|||
94539194|NCT00075725|323768114|FG010|Overall Study|specimen(s) not submitted|0|||
94539195|NCT00075725|323768115|FG011|Overall Study|specimen(s) not submitted|0|||
94539196|NCT00075725|323768104|FG000|Overall Study|Pt went to transplant|0|||
94539197|NCT00075725|323768105|FG001|Overall Study|Pt went to transplant|0|||
94539198|NCT00075725|323768106|FG002|Overall Study|Pt went to transplant|0|||
94539199|NCT00075725|323768107|FG003|Overall Study|Pt went to transplant|1|||
94539200|NCT00075725|323768108|FG004|Overall Study|Pt went to transplant|0|||
94539201|NCT00075725|323768109|FG005|Overall Study|Pt went to transplant|1|||
94539202|NCT00075725|323768110|FG006|Overall Study|Pt went to transplant|0|||
94539203|NCT00075725|323768111|FG007|Overall Study|Pt went to transplant|0|||
94539204|NCT00075725|323768112|FG008|Overall Study|Pt went to transplant|0|||
94539205|NCT00075725|323768113|FG009|Overall Study|Pt went to transplant|0|||
94539206|NCT00075725|323768114|FG010|Overall Study|Pt went to transplant|0|||
94539207|NCT00075725|323768115|FG011|Overall Study|Pt went to transplant|0|||
94539208|NCT00075725|323768104|FG000|Overall Study|Pt received additional steroids|0|||
94539209|NCT00075725|323768105|FG001|Overall Study|Pt received additional steroids|0|||
94539210|NCT00075725|323768106|FG002|Overall Study|Pt received additional steroids|0|||
94539211|NCT00075725|323768107|FG003|Overall Study|Pt received additional steroids|1|||
94539212|NCT00075725|323768108|FG004|Overall Study|Pt received additional steroids|0|||
94539213|NCT00075725|323768109|FG005|Overall Study|Pt received additional steroids|0|||
94539214|NCT00075725|323768110|FG006|Overall Study|Pt received additional steroids|0|||
94539215|NCT00075725|323768111|FG007|Overall Study|Pt received additional steroids|0|||
94539216|NCT00075725|323768112|FG008|Overall Study|Pt received additional steroids|0|||
94539217|NCT00075725|323768113|FG009|Overall Study|Pt received additional steroids|0|||
94539218|NCT00075725|323768114|FG010|Overall Study|Pt received additional steroids|0|||
94539219|NCT00075725|323768115|FG011|Overall Study|Pt received additional steroids|0|||
94539220|NCT00075725|323768104|FG000|Overall Study|Pt relocated|0|||
94539221|NCT00075725|323768105|FG001|Overall Study|Pt relocated|0|||
94539222|NCT00075725|323768106|FG002|Overall Study|Pt relocated|0|||
94539223|NCT00075725|323768107|FG003|Overall Study|Pt relocated|2|||
94539224|NCT00075725|323768108|FG004|Overall Study|Pt relocated|0|||
94539225|NCT00075725|323768109|FG005|Overall Study|Pt relocated|1|||
94539226|NCT00075725|323768110|FG006|Overall Study|Pt relocated|1|||
94539227|NCT00075725|323768111|FG007|Overall Study|Pt relocated|2|||
94539228|NCT00075725|323768112|FG008|Overall Study|Pt relocated|1|||
94539229|NCT00075725|323768113|FG009|Overall Study|Pt relocated|0|||
94539230|NCT00075725|323768114|FG010|Overall Study|Pt relocated|0|||
94539231|NCT00075725|323768115|FG011|Overall Study|Pt relocated|0|||
94539232|NCT00075725|323768104|FG000|Overall Study|Institution Terminated|0|||
94539233|NCT00075725|323768105|FG001|Overall Study|Institution Terminated|0|||
94539234|NCT00075725|323768106|FG002|Overall Study|Institution Terminated|0|||
94539235|NCT00075725|323768107|FG003|Overall Study|Institution Terminated|0|||
94539236|NCT00075725|323768108|FG004|Overall Study|Institution Terminated|1|||
94539237|NCT00075725|323768109|FG005|Overall Study|Institution Terminated|0|||
94539238|NCT00075725|323768110|FG006|Overall Study|Institution Terminated|0|||
94539239|NCT00075725|323768111|FG007|Overall Study|Institution Terminated|3|||
94539240|NCT00075725|323768112|FG008|Overall Study|Institution Terminated|0|||
94539241|NCT00075725|323768113|FG009|Overall Study|Institution Terminated|0|||
94539242|NCT00075725|323768114|FG010|Overall Study|Institution Terminated|0|||
94539243|NCT00075725|323768115|FG011|Overall Study|Institution Terminated|0|||
94539244|NCT00075725|323768104|FG000|Overall Study|Study Closure|1|||
94539245|NCT00075725|323768105|FG001|Overall Study|Study Closure|0|||
94539246|NCT00075725|323768106|FG002|Overall Study|Study Closure|0|||
94539247|NCT00075725|323768107|FG003|Overall Study|Study Closure|0|||
94539248|NCT00075725|323768108|FG004|Overall Study|Study Closure|1|||
94539249|NCT00075725|323768109|FG005|Overall Study|Study Closure|3|||
94539250|NCT00075725|323768110|FG006|Overall Study|Study Closure|0|||
94539251|NCT00075725|323768111|FG007|Overall Study|Study Closure|1|||
94539252|NCT00075725|323768112|FG008|Overall Study|Study Closure|0|||
94539253|NCT00075725|323768113|FG009|Overall Study|Study Closure|0|||
94539254|NCT00075725|323768114|FG010|Overall Study|Study Closure|0|||
94539255|NCT00075725|323768115|FG011|Overall Study|Study Closure|0|||
94539256|NCT00075725|323768104|FG000|Overall Study|Other complications|0|||
94539257|NCT00075725|323768105|FG001|Overall Study|Other complications|0|||
94539258|NCT00075725|323768106|FG002|Overall Study|Other complications|0|||
94539259|NCT00075725|323768107|FG003|Overall Study|Other complications|0|||
94539260|NCT00075725|323768108|FG004|Overall Study|Other complications|0|||
94539261|NCT00075725|323768109|FG005|Overall Study|Other complications|1|||
94539262|NCT00075725|323768110|FG006|Overall Study|Other complications|0|||
94539263|NCT00075725|323768111|FG007|Overall Study|Other complications|0|||
94539264|NCT00075725|323768112|FG008|Overall Study|Other complications|0|||
94539265|NCT00075725|323768113|FG009|Overall Study|Other complications|0|||
94539266|NCT00075725|323768114|FG010|Overall Study|Other complications|0|||
94539267|NCT00075725|323768115|FG011|Overall Study|Other complications|0|||
94539268|NCT00075725|323768104|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
94539269|NCT00075725|323768105|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
94539270|NCT00075725|323768106|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
94539271|NCT00075725|323768107|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
94539272|NCT00075725|323768108|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
94539273|NCT00075725|323768109|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
94539274|NCT00075725|323768110|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
94539275|NCT00075725|323768111|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
94539276|NCT00075725|323768112|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
94539277|NCT00075725|323768113|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
94539278|NCT00075725|323768114|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
94539279|NCT00075725|323768115|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
94539280|NCT00075725|323768104|FG000|Overall Study|Pt incarcerated|0|||
94539281|NCT00075725|323768105|FG001|Overall Study|Pt incarcerated|0|||
94539282|NCT00075725|323768106|FG002|Overall Study|Pt incarcerated|0|||
94539283|NCT00075725|323768107|FG003|Overall Study|Pt incarcerated|0|||
94539284|NCT00075725|323768108|FG004|Overall Study|Pt incarcerated|0|||
94539285|NCT00075725|323768109|FG005|Overall Study|Pt incarcerated|0|||
94539286|NCT00075725|323768110|FG006|Overall Study|Pt incarcerated|0|||
94539287|NCT00075725|323768111|FG007|Overall Study|Pt incarcerated|1|||
94539288|NCT00075725|323768112|FG008|Overall Study|Pt incarcerated|0|||
94539289|NCT00075725|323768113|FG009|Overall Study|Pt incarcerated|0|||
94539290|NCT00075725|323768114|FG010|Overall Study|Pt incarcerated|0|||
94539291|NCT00075725|323768115|FG011|Overall Study|Pt incarcerated|0|||
94539292|NCT04027049|323768116|FG000|Overall Study|Withdrawn by family|1|||
94539293|NCT04027049|323768117|FG001|Overall Study|Withdrawn by family|0|||
94539294|NCT04027049|323768116|FG000|Overall Study|Participant safety|1|||
94539295|NCT04027049|323768117|FG001|Overall Study|Participant safety|0|||
94539296|NCT02446418|323768118|FG000|Overall Study|Adverse Event|4|||
94539297|NCT02446418|323768119|FG001|Overall Study|Adverse Event|8|||
94539298|NCT02446418|323768118|FG000|Overall Study|Physician Decision|5|||
94539299|NCT02446418|323768119|FG001|Overall Study|Physician Decision|1|||
94539300|NCT02446418|323768118|FG000|Overall Study|Withdrawal by Subject|3|||
94539301|NCT02446418|323768119|FG001|Overall Study|Withdrawal by Subject|3|||
94539302|NCT02446418|323768118|FG000|Overall Study|Lost to Follow-up|2|||
94539303|NCT02446418|323768119|FG001|Overall Study|Lost to Follow-up|2|||
94539304|NCT02446418|323768118|FG000|Overall Study|Protocol Violation|1|||
94539305|NCT02446418|323768119|FG001|Overall Study|Protocol Violation|2|||
94539306|NCT02446418|323768118|FG000|Overall Study|Lack of Efficacy|2|||
94539307|NCT02446418|323768119|FG001|Overall Study|Lack of Efficacy|0|||
94539308|NCT02446418|323768118|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
94539309|NCT02446418|323768119|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
94539310|NCT01095653|323768120|FG000|Overall Study|Lack of Efficacy|3|||
94539311|NCT01095653|323768121|FG001|Overall Study|Lack of Efficacy|0|||
94539312|NCT01095653|323768122|FG002|Overall Study|Lack of Efficacy|0|||
94539313|NCT01095653|323768120|FG000|Overall Study|Adverse Event|1|||
94539314|NCT01095653|323768121|FG001|Overall Study|Adverse Event|4|||
94539315|NCT01095653|323768122|FG002|Overall Study|Adverse Event|4|||
94539316|NCT01095653|323768120|FG000|Overall Study|Lost to Follow-up|1|||
94539317|NCT01095653|323768121|FG001|Overall Study|Lost to Follow-up|0|||
94539318|NCT01095653|323768122|FG002|Overall Study|Lost to Follow-up|4|||
94539319|NCT01095653|323768120|FG000|Overall Study|Withdrawal by Subject|4|||
94539320|NCT01095653|323768121|FG001|Overall Study|Withdrawal by Subject|5|||
94539321|NCT01095653|323768122|FG002|Overall Study|Withdrawal by Subject|3|||
94539322|NCT01095653|323768120|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
94539323|NCT01095653|323768121|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
94539324|NCT01095653|323768122|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
94539325|NCT03746600|323768123|FG000|Overall Study|Withdrawal by Subject|3|||
94539326|NCT03746600|323768124|FG001|Overall Study|Withdrawal by Subject|3|||
94539327|NCT03746600|323768123|FG000|Overall Study|dismissed from study|1|||
94539328|NCT03746600|323768124|FG001|Overall Study|dismissed from study|0|||
94539329|NCT03746600|323768123|FG000|Overall Study|Lost to Follow-up|1|||
94539330|NCT03746600|323768124|FG001|Overall Study|Lost to Follow-up|0|||
94539331|NCT04209114|323768125|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
94539332|NCT04209114|323768126|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
94539333|NCT04209114|323768127|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
94539334|NCT04209114|323768125|FG000|Pre-Treatment Phase|Other reasons|0|||
94539335|NCT04209114|323768126|FG001|Pre-Treatment Phase|Other reasons|0|||
94539336|NCT04209114|323768127|FG002|Pre-Treatment Phase|Other reasons|1|||
94539337|NCT04209114|323768125|FG000|Pre-Treatment Phase|Death|0|||
94539338|NCT04209114|323768126|FG001|Pre-Treatment Phase|Death|0|||
94539339|NCT04209114|323768127|FG002|Pre-Treatment Phase|Death|1|||
94539340|NCT04209114|323768125|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
94539341|NCT04209114|323768126|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
94539342|NCT04209114|323768127|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
94539343|NCT04209114|323768125|FG000|Treatment Phase|Other reasons|5|||
94539344|NCT04209114|323768126|FG001|Treatment Phase|Other reasons|3|||
94539345|NCT04209114|323768127|FG002|Treatment Phase|Other reasons|0|||
94539346|NCT04209114|323768125|FG000|Treatment Phase|Lost to Follow-up|1|||
94539347|NCT04209114|323768126|FG001|Treatment Phase|Lost to Follow-up|0|||
94539348|NCT04209114|323768127|FG002|Treatment Phase|Lost to Follow-up|0|||
94539349|NCT04209114|323768125|FG000|Treatment Phase|Participant withdrew consent|1|||
94539350|NCT04209114|323768126|FG001|Treatment Phase|Participant withdrew consent|0|||
94539351|NCT04209114|323768127|FG002|Treatment Phase|Participant withdrew consent|0|||
94539352|NCT04209114|323768125|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
94539353|NCT04209114|323768126|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
94539354|NCT04209114|323768127|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
94539355|NCT04209114|323768125|FG000|Treatment Phase|Death|4|||
94539356|NCT04209114|323768126|FG001|Treatment Phase|Death|1|||
94539357|NCT04209114|323768127|FG002|Treatment Phase|Death|0|||
94539358|NCT04209114|323768125|FG000|Treatment Phase|Study drug toxicity|4|||
94539359|NCT04209114|323768126|FG001|Treatment Phase|Study drug toxicity|6|||
94539360|NCT04209114|323768127|FG002|Treatment Phase|Study drug toxicity|0|||
94539361|NCT04209114|323768125|FG000|Treatment Phase|Disease progression|6|||
94539362|NCT04209114|323768126|FG001|Treatment Phase|Disease progression|9|||
94539363|NCT04209114|323768127|FG002|Treatment Phase|Disease progression|0|||
94539364|NCT02141490|323768128|FG000|Overall Study|Screening failures|4|||
94539365|NCT02141490|323768129|FG001|Overall Study|Screening failures|0|||
94539366|NCT02141490|323768130|FG002|Overall Study|Screening failures|0|||
94539367|NCT00066469|323768131|FG000|Overall Study|Death|3|||
94539368|NCT00066469|323768131|FG000|Overall Study|Lack of Efficacy|9|||
94539369|NCT00066469|323768131|FG000|Overall Study|Lost to Follow-up|1|||
94539370|NCT00066469|323768131|FG000|Overall Study|Physician Decision|1|||
94539371|NCT00066469|323768131|FG000|Overall Study|Withdrawal by Subject|1|||
94539372|NCT00066469|323768131|FG000|Overall Study|ineligible|1|||
94539373|NCT02981407|323768132|FG000|Overall Study|Withdrawal by Subject|2|||
94539374|NCT02981407|323768133|FG001|Overall Study|Withdrawal by Subject|0|||
94539375|NCT01440517|323770020|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
94539376|NCT01288612|323770022|FG000|Overall Study|Unable to contact|11|||
94539377|NCT01288612|323770023|FG001|Overall Study|Unable to contact|16|||
94539378|NCT01288612|323770024|FG002|Overall Study|Unable to contact|20|||
94539379|NCT01288612|323770022|FG000|Overall Study|Declined|78|||
94539380|NCT01288612|323770023|FG001|Overall Study|Declined|63|||
94539381|NCT01288612|323770024|FG002|Overall Study|Declined|62|||
94539382|NCT01288612|323770022|FG000|Overall Study|Unable to intubate|0|||
94539383|NCT01288612|323770023|FG001|Overall Study|Unable to intubate|3|||
94539384|NCT01288612|323770024|FG002|Overall Study|Unable to intubate|0|||
94539385|NCT00871923|323770025|FG000|Overall Study|Death|1|||
94539386|NCT00871923|323770025|FG000|Overall Study|Withdrawal by Subject|1|||
94539387|NCT02723006|323770026|FG000|Overall Study|Withdrawal by Subject|0|||
94539388|NCT02723006|323770027|FG001|Overall Study|Withdrawal by Subject|1|||
94539389|NCT02723006|323770028|FG002|Overall Study|Withdrawal by Subject|1|||
94539390|NCT02723006|323770026|FG000|Overall Study|Study Terminated by Sponsor|1|||
94539391|NCT02723006|323770027|FG001|Overall Study|Study Terminated by Sponsor|6|||
94539392|NCT02723006|323770028|FG002|Overall Study|Study Terminated by Sponsor|6|||
94539393|NCT04258995|323770029|FG000|Overall Study|Lost to Follow-up|1|||
94539394|NCT04258995|323770030|FG001|Overall Study|Lost to Follow-up|1|||
94539395|NCT00428220|323770033|FG000|Overall Study|Participant died|8|||
94539396|NCT00428220|323770033|FG000|Overall Study|Global deterioration of health status|7|||
94539397|NCT00428220|323770033|FG000|Overall Study|Lost to Follow-up|4|||
94539398|NCT00428220|323770033|FG000|Overall Study|Objective progression or relapse|123|||
94539399|NCT00428220|323770033|FG000|Overall Study|Participant refused continued treatment|7|||
94539400|NCT00428220|323770033|FG000|Overall Study|Adverse Event|51|||
94539401|NCT00428220|323770033|FG000|Overall Study|Other|23|||
94539402|NCT00642174|323770034|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
94539403|NCT00642174|323770035|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
94539404|NCT00549900|323770036|FG000|Overall Study|Adverse Event|1|||
94539405|NCT01730339|323770037|FG000|Overall Study|Withdrawal by Subject|3|||
94539406|NCT01730339|323770038|FG001|Overall Study|Withdrawal by Subject|2|||
94539407|NCT01730339|323770037|FG000|Overall Study|Lost to Follow-up|1|||
94539408|NCT01730339|323770038|FG001|Overall Study|Lost to Follow-up|1|||
94539409|NCT01730339|323770037|FG000|Overall Study|Un-specified|1|||
94539410|NCT01730339|323770038|FG001|Overall Study|Un-specified|0|||
94539411|NCT00896363|323770039|FG000|Overall Study|Adverse Event|3|||
94539412|NCT00896363|323770040|FG001|Overall Study|Adverse Event|4|||
94539413|NCT00896363|323770041|FG002|Overall Study|Adverse Event|2|||
94539414|NCT00896363|323770039|FG000|Overall Study|Lack of Efficacy|0|||
94539415|NCT00896363|323770040|FG001|Overall Study|Lack of Efficacy|2|||
94539416|NCT00896363|323770041|FG002|Overall Study|Lack of Efficacy|1|||
94539417|NCT00896363|323770039|FG000|Overall Study|Withdrawal by Subject|3|||
94539418|NCT00896363|323770040|FG001|Overall Study|Withdrawal by Subject|5|||
94539419|NCT00896363|323770041|FG002|Overall Study|Withdrawal by Subject|5|||
94539420|NCT04143217|323770046|FG000|Overall Study|Withdrawal by Subject|42|||
94539421|NCT04143217|323770046|FG000|Overall Study|Adverse Event|29|||
94539422|NCT04143217|323770046|FG000|Overall Study|Lost to Follow-up|29|||
94539423|NCT04143217|323770046|FG000|Overall Study|Lack of Efficacy|15|||
94539424|NCT04143217|323770046|FG000|Overall Study|Physician Decision|1|||
94539425|NCT04143217|323770046|FG000|Overall Study|Non-Compliance With Study Drug|6|||
94539426|NCT04143217|323770046|FG000|Overall Study|Other, Multiple Categories|11|||
94539427|NCT00789581|323770047|FG000|AC Therapy|Adverse Event|2|||
94539428|NCT00789581|323770048|FG001|AC Therapy|Adverse Event|3|||
94539429|NCT00789581|323770047|FG000|AC Therapy|Withdrawal by Subject|4|||
94539430|NCT00789581|323770048|FG001|AC Therapy|Withdrawal by Subject|7|||
94539431|NCT00789581|323770047|FG000|AC Therapy|Disease recurrence|3|||
94539432|NCT00789581|323770048|FG001|AC Therapy|Disease recurrence|1|||
94539433|NCT00789581|323770047|FG000|AC Therapy|Intercurrent Illness|1|||
94539434|NCT00789581|323770048|FG001|AC Therapy|Intercurrent Illness|0|||
94539435|NCT00789581|323770047|FG000|AC Therapy|Never Treated|1|||
94539436|NCT00789581|323770048|FG001|AC Therapy|Never Treated|4|||
94539437|NCT00789581|323770047|FG000|AC Therapy|Other|0|||
94539438|NCT00789581|323770048|FG001|AC Therapy|Other|2|||
94539439|NCT00789581|323770047|FG000|Adjuvant Therapy|Never treated|2|||
94539440|NCT00789581|323770048|FG001|Adjuvant Therapy|Never treated|2|||
94539441|NCT00789581|323770047|FG000|Adjuvant Therapy|Adverse Event|20|||
94539442|NCT00789581|323770048|FG001|Adjuvant Therapy|Adverse Event|44|||
94539443|NCT00789581|323770047|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
94539444|NCT00789581|323770048|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
94539445|NCT00789581|323770047|FG000|Adjuvant Therapy|Disease recurrence|2|||
94539446|NCT00789581|323770048|FG001|Adjuvant Therapy|Disease recurrence|1|||
94539447|NCT00789581|323770047|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
94539448|NCT00789581|323770048|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
94539449|NCT00789581|323770047|FG000|Adjuvant Therapy|Protocol Violation|1|||
94539450|NCT00789581|323770048|FG001|Adjuvant Therapy|Protocol Violation|1|||
94539451|NCT00789581|323770047|FG000|Adjuvant Therapy|Other|0|||
94539452|NCT00789581|323770048|FG001|Adjuvant Therapy|Other|1|||
94539453|NCT03002818|323770052|FG000|Overall Study|Decision of the investigator|1|||
94539454|NCT01728077|323770053|FG000|Overall Study|Lack of Efficacy|3|||
94539455|NCT01728077|323770054|FG001|Overall Study|Lack of Efficacy|1|||
94539456|NCT01728077|323770053|FG000|Overall Study|Lost to Follow-up|1|||
94539457|NCT01728077|323770054|FG001|Overall Study|Lost to Follow-up|0|||
94539458|NCT01728077|323770053|FG000|Overall Study|Subject choice|2|||
94539459|NCT01728077|323770054|FG001|Overall Study|Subject choice|3|||
94539460|NCT01728077|323770053|FG000|Overall Study|Death|0|||
94539461|NCT01728077|323770054|FG001|Overall Study|Death|1|||
94539462|NCT01728077|323770053|FG000|Overall Study|Patient moving|1|||
94539463|NCT01728077|323770054|FG001|Overall Study|Patient moving|0|||
94539464|NCT01728077|323770053|FG000|Overall Study|Non compliance|1|||
94539465|NCT01728077|323770054|FG001|Overall Study|Non compliance|0|||
94539466|NCT03505788|323770059|FG000|Overall Study|Lost to Follow-up|2|||
94539467|NCT03505788|323770060|FG001|Overall Study|Lost to Follow-up|1|||
94539468|NCT03505788|323770059|FG000|Overall Study|Withdrawal by Subject|1|||
94539469|NCT03505788|323770060|FG001|Overall Study|Withdrawal by Subject|3|||
94539470|NCT03505788|323770059|FG000|Overall Study|Physician Decision|0|||
94539471|NCT03505788|323770060|FG001|Overall Study|Physician Decision|1|||
94539472|NCT03770728|323770065|FG000|Overall Study|Adverse Event|1|||
94539473|NCT03770728|323770066|FG001|Overall Study|Adverse Event|0|||
94539474|NCT03770728|323770067|FG002|Overall Study|Adverse Event|1|||
94539475|NCT03770728|323770068|FG003|Overall Study|Adverse Event|0|||
94539476|NCT03770728|323770065|FG000|Overall Study|Poor compliance to protocol|0|||
94539477|NCT03770728|323770066|FG001|Overall Study|Poor compliance to protocol|0|||
94539478|NCT03770728|323770067|FG002|Overall Study|Poor compliance to protocol|1|||
94539479|NCT03770728|323770068|FG003|Overall Study|Poor compliance to protocol|0|||
94539480|NCT03770728|323770065|FG000|Overall Study|Withdrawal by Subject|13|||
94539481|NCT03770728|323770066|FG001|Overall Study|Withdrawal by Subject|8|||
94539482|NCT03770728|323770067|FG002|Overall Study|Withdrawal by Subject|9|||
94539483|NCT03770728|323770068|FG003|Overall Study|Withdrawal by Subject|13|||
94539484|NCT03770728|323770065|FG000|Overall Study|Other than specified|24|||
94539485|NCT03770728|323770066|FG001|Overall Study|Other than specified|23|||
94539486|NCT03770728|323770067|FG002|Overall Study|Other than specified|21|||
94539487|NCT03770728|323770068|FG003|Overall Study|Other than specified|22|||
94539488|NCT02324205|323770071|FG000|Overall Study|Withdrawal by Subject|37|||
94539489|NCT00320255|323770072|FG000|Overall Study|Lack of Efficacy|1|||
94539490|NCT00320255|323770073|FG001|Overall Study|Lack of Efficacy|0|||
94539491|NCT00320255|323770074|FG002|Overall Study|Lack of Efficacy|0|||
94539492|NCT00320255|323770075|FG003|Overall Study|Lack of Efficacy|0|||
94539493|NCT00320255|323770076|FG004|Overall Study|Lack of Efficacy|0|||
94539494|NCT00320255|323770077|FG005|Overall Study|Lack of Efficacy|0|||
94539495|NCT00320255|323770072|FG000|Overall Study|Adverse Event|5|||
94539496|NCT00320255|323770073|FG001|Overall Study|Adverse Event|2|||
94539497|NCT00320255|323770074|FG002|Overall Study|Adverse Event|3|||
94539498|NCT00320255|323770075|FG003|Overall Study|Adverse Event|2|||
94539499|NCT00320255|323770076|FG004|Overall Study|Adverse Event|0|||
94539500|NCT00320255|323770077|FG005|Overall Study|Adverse Event|0|||
94539501|NCT00320255|323770072|FG000|Overall Study|Withdrawal by Subject|1|||
94539502|NCT00320255|323770073|FG001|Overall Study|Withdrawal by Subject|2|||
94539503|NCT00320255|323770074|FG002|Overall Study|Withdrawal by Subject|2|||
94539504|NCT00320255|323770075|FG003|Overall Study|Withdrawal by Subject|4|||
94539505|NCT00320255|323770076|FG004|Overall Study|Withdrawal by Subject|0|||
94539506|NCT00320255|323770077|FG005|Overall Study|Withdrawal by Subject|0|||
94539507|NCT00320255|323770072|FG000|Overall Study|Poor compliance/noncompliance|1|||
94539508|NCT00320255|323770073|FG001|Overall Study|Poor compliance/noncompliance|1|||
94539509|NCT00320255|323770074|FG002|Overall Study|Poor compliance/noncompliance|0|||
94539510|NCT00320255|323770075|FG003|Overall Study|Poor compliance/noncompliance|1|||
94539511|NCT00320255|323770076|FG004|Overall Study|Poor compliance/noncompliance|0|||
94539512|NCT00320255|323770077|FG005|Overall Study|Poor compliance/noncompliance|0|||
94539513|NCT00320255|323770072|FG000|Overall Study|No longer meets study criteria|0|||
94539514|NCT00320255|323770073|FG001|Overall Study|No longer meets study criteria|0|||
94539515|NCT00320255|323770074|FG002|Overall Study|No longer meets study criteria|0|||
94539516|NCT00320255|323770075|FG003|Overall Study|No longer meets study criteria|1|||
94539517|NCT00320255|323770076|FG004|Overall Study|No longer meets study criteria|0|||
94539518|NCT00320255|323770077|FG005|Overall Study|No longer meets study criteria|0|||
94539519|NCT00320255|323770072|FG000|Overall Study|Other|3|||
94539520|NCT00320255|323770073|FG001|Overall Study|Other|2|||
94539521|NCT00320255|323770074|FG002|Overall Study|Other|1|||
94539522|NCT00320255|323770075|FG003|Overall Study|Other|0|||
94539523|NCT00320255|323770076|FG004|Overall Study|Other|0|||
94539524|NCT00320255|323770077|FG005|Overall Study|Other|0|||
94539525|NCT01920568|323770088|FG000|Overall Study|Adverse Event|27|||
94539526|NCT01920568|323770089|FG001|Overall Study|Adverse Event|8|||
94539527|NCT01920568|323770088|FG000|Overall Study|Protocol Violation|5|||
94539528|NCT01920568|323770089|FG001|Overall Study|Protocol Violation|3|||
94539529|NCT01920568|323770088|FG000|Overall Study|Lost to Follow-up|2|||
94539530|NCT01920568|323770089|FG001|Overall Study|Lost to Follow-up|2|||
94539531|NCT01920568|323770088|FG000|Overall Study|Physician Decision|13|||
94539532|NCT01920568|323770089|FG001|Overall Study|Physician Decision|4|||
94539533|NCT01920568|323770088|FG000|Overall Study|Withdrawal by Subject|79|||
94539534|NCT01920568|323770089|FG001|Overall Study|Withdrawal by Subject|55|||
94539535|NCT01920568|323770088|FG000|Overall Study|Death due to disease progression|25|||
94539536|NCT01920568|323770089|FG001|Overall Study|Death due to disease progression|12|||
94539537|NCT00252694|323770096|FG000|Overall Study|Withdrawal by Subject|83|||
94539538|NCT00252694|323770097|FG001|Overall Study|Withdrawal by Subject|91|||
94539539|NCT00252694|323770096|FG000|Overall Study|Death|36|||
94539540|NCT00252694|323770097|FG001|Overall Study|Death|34|||
94539541|NCT00252694|323770096|FG000|Overall Study|Mostly Lost to Follow Up|8|||
94539542|NCT00252694|323770097|FG001|Overall Study|Mostly Lost to Follow Up|13|||
94539543|NCT00252694|323770096|FG000|Overall Study|Patient Moving|17|||
94539544|NCT00252694|323770097|FG001|Overall Study|Patient Moving|16|||
94539545|NCT02891681|323770099|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
94539546|NCT02891681|323770100|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
94539547|NCT02891681|323770101|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
94539548|NCT02891681|323770099|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
94539549|NCT02891681|323770100|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
94539550|NCT02891681|323770101|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
94539551|NCT02891681|323770099|FG000|Overall Study|Taken off study after first imaging appointment|1|||
94539552|NCT02891681|323770100|FG001|Overall Study|Taken off study after first imaging appointment|0|||
94539553|NCT02891681|323770101|FG002|Overall Study|Taken off study after first imaging appointment|0|||
94539554|NCT02174523|323770104|FG000|Overall Study|Withdrawal by Subject|1|||
94539555|NCT02174523|323770105|FG001|Overall Study|Withdrawal by Subject|0|||
94539556|NCT00856206|323770108|FG000|Overall Study|Protocol Violation|6|||
94539557|NCT00856206|323770109|FG001|Overall Study|Protocol Violation|18|||
94539558|NCT00856206|323770108|FG000|Overall Study|Adverse Event|10|||
94539559|NCT00856206|323770109|FG001|Overall Study|Adverse Event|46|||
94539560|NCT00856206|323770108|FG000|Overall Study|Lack of Efficacy|1|||
94539561|NCT00856206|323770109|FG001|Overall Study|Lack of Efficacy|2|||
94539562|NCT00856206|323770108|FG000|Overall Study|Withdrawal by Subject|15|||
94539563|NCT00856206|323770109|FG001|Overall Study|Withdrawal by Subject|36|||
94539564|NCT00856206|323770108|FG000|Overall Study|Lost to Follow-up|13|||
94539565|NCT00856206|323770109|FG001|Overall Study|Lost to Follow-up|39|||
94539566|NCT00856206|323770108|FG000|Overall Study|Death|2|||
94539567|NCT00856206|323770109|FG001|Overall Study|Death|2|||
94539568|NCT00856206|323770108|FG000|Overall Study|Decision by the Sponsor|4|||
94539569|NCT00856206|323770109|FG001|Overall Study|Decision by the Sponsor|8|||
94539570|NCT00856206|323770108|FG000|Overall Study|Other than specified above|3|||
94539571|NCT00856206|323770109|FG001|Overall Study|Other than specified above|10|||
94539572|NCT04584346|323770116|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
94539573|NCT04584346|323770117|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
94539574|NCT03500172|323770123|FG000|Period 1: Baseline Randomization|Death|0|||
94539575|NCT03500172|323770124|FG001|Period 1: Baseline Randomization|Death|0|||
94539576|NCT03500172|323770125|FG002|Period 1: Baseline Randomization|Death|0|||
94539577|NCT03500172|323770126|FG003|Period 1: Baseline Randomization|Death|0|||
94539578|NCT03500172|323770127|FG004|Period 1: Baseline Randomization|Death|0|||
94539579|NCT03500172|323770128|FG005|Period 1: Baseline Randomization|Death|0|||
94539580|NCT03500172|323770129|FG006|Period 1: Baseline Randomization|Death|0|||
94539581|NCT03500172|323770130|FG007|Period 1: Baseline Randomization|Death|0|||
94539582|NCT03500172|323770131|FG008|Period 1: Baseline Randomization|Death|0|||
94539583|NCT03500172|323770132|FG009|Period 1: Baseline Randomization|Death|2|||
94539584|NCT03500172|323770133|FG010|Period 1: Baseline Randomization|Death|0|||
94539585|NCT03500172|323770123|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
94539586|NCT03500172|323770124|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
94539587|NCT03500172|323770125|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
94539588|NCT03500172|323770126|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
94539589|NCT03500172|323770127|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
94539590|NCT03500172|323770128|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
94539591|NCT03500172|323770129|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
94539592|NCT03500172|323770130|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
94539593|NCT03500172|323770131|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
94539594|NCT03500172|323770132|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
94539595|NCT03500172|323770133|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
94539596|NCT03500172|323770123|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
94539597|NCT03500172|323770124|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
94539598|NCT03500172|323770125|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
94539599|NCT03500172|323770126|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
94539600|NCT03500172|323770127|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
94539601|NCT03500172|323770128|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
94539602|NCT03500172|323770129|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
94539603|NCT03500172|323770130|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
94539604|NCT03500172|323770131|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
94539605|NCT03500172|323770132|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
94539606|NCT03500172|323770133|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
94539607|NCT03500172|323770123|FG000|Period 2: Re-Randomization|Death|0|||
94539608|NCT03500172|323770124|FG001|Period 2: Re-Randomization|Death|0|||
94539609|NCT03500172|323770125|FG002|Period 2: Re-Randomization|Death|0|||
94539610|NCT03500172|323770126|FG003|Period 2: Re-Randomization|Death|4|||
94539611|NCT03500172|323770127|FG004|Period 2: Re-Randomization|Death|2|||
94539612|NCT03500172|323770128|FG005|Period 2: Re-Randomization|Death|0|||
94539613|NCT03500172|323770129|FG006|Period 2: Re-Randomization|Death|5|||
94539614|NCT03500172|323770130|FG007|Period 2: Re-Randomization|Death|2|||
94539615|NCT03500172|323770131|FG008|Period 2: Re-Randomization|Death|0|||
94539616|NCT03500172|323770132|FG009|Period 2: Re-Randomization|Death|0|||
94539617|NCT03500172|323770133|FG010|Period 2: Re-Randomization|Death|0|||
94539618|NCT00468676|323770134|FG000|Overall Study|Lost to Follow-up|14|||
94539619|NCT00468676|323770135|FG001|Overall Study|Lost to Follow-up|11|||
94539620|NCT00468676|323770134|FG000|Overall Study|Death|2|||
94539621|NCT00468676|323770135|FG001|Overall Study|Death|1|||
94539622|NCT01779869|323770136|FG000|Overall Study|Physician Decision|2|||
94539623|NCT03006458|323770137|FG000|First Intervention|Unsatisfied Vision|0|||
94539624|NCT03006458|323770138|FG001|First Intervention|Unsatisfied Vision|3|||
94539625|NCT02233738|323770140|FG000|Overall Study|Lost to Follow-up|5|||
94539626|NCT02233738|323770141|FG001|Overall Study|Lost to Follow-up|12|||
94539627|NCT02233738|323770140|FG000|Overall Study|Death|0|||
94539628|NCT02233738|323770141|FG001|Overall Study|Death|1|||
94539629|NCT02233738|323770140|FG000|Overall Study|Withdrawal by Subject|0|||
94539630|NCT02233738|323770141|FG001|Overall Study|Withdrawal by Subject|1|||
94539631|NCT02233738|323770140|FG000|Overall Study|Did not return after Baseline|3|||
94539632|NCT02233738|323770141|FG001|Overall Study|Did not return after Baseline|2|||
94539633|NCT00096174|323770142|FG000|Overall Study|Lack of Efficacy|9|||
94539634|NCT00096174|323770142|FG000|Overall Study|Adverse Event|15|||
94539635|NCT00096174|323770142|FG000|Overall Study|Death|6|||
94539636|NCT00096174|323770142|FG000|Overall Study|Withdrawal by Subject|15|||
94539637|NCT00096174|323770142|FG000|Overall Study|Not started protocol therapy|3|||
94539638|NCT00096174|323770142|FG000|Overall Study|Ineligible|6|||
94539639|NCT00096174|323770142|FG000|Overall Study|other reason|8|||
94539640|NCT01571284|323770148|FG000|Overall Study|Participant's decision|84|||
94539641|NCT01571284|323770148|FG000|Overall Study|Lost to Follow-up|3|||
94539642|NCT01571284|323770148|FG000|Overall Study|Enrolled but not treated|2|||
94539643|NCT01571284|323770148|FG000|Overall Study|Other than specified above|80|||
94539644|NCT03762616|323770150|FG000|Overall Study|Protocol Violation|2|||
94539645|NCT02323204|323770151|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
94539646|NCT02323204|323770152|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
94539647|NCT02323204|323770153|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
94539648|NCT02323204|323770154|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
94539649|NCT02323204|323770151|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
94539650|NCT02323204|323770152|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
94539651|NCT02323204|323770153|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
94539652|NCT02323204|323770154|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
94539653|NCT02323204|323770151|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
94539654|NCT02323204|323770152|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
94539655|NCT02323204|323770153|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
94539656|NCT02323204|323770154|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
94539657|NCT02323204|323770151|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
94539658|NCT02323204|323770152|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
94539659|NCT02323204|323770153|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
94539660|NCT02323204|323770154|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
94539661|NCT02323204|323770151|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
94539662|NCT02323204|323770152|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
94539663|NCT02323204|323770153|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
94539664|NCT02323204|323770154|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
94539665|NCT02323204|323770151|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
94539666|NCT02323204|323770152|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
94539667|NCT02323204|323770153|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
94539668|NCT02323204|323770154|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
94539669|NCT02323204|323770151|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
94539670|NCT02323204|323770152|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
94539671|NCT02323204|323770153|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
94539672|NCT02323204|323770154|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
94539673|NCT02323204|323770151|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
94539674|NCT02323204|323770152|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
94539675|NCT02323204|323770153|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
94539676|NCT02323204|323770154|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
94539677|NCT02323204|323770151|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
94539678|NCT02323204|323770152|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
94539679|NCT02323204|323770153|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
94539680|NCT02323204|323770154|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
94539681|NCT03958656|323770155|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
94539682|NCT03958656|323770156|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
94539683|NCT03958656|323770157|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
94539684|NCT03958656|323770158|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
94539685|NCT03958656|323770155|FG000|Overall Study|No longer meets eligibility criteria|0|||
94539686|NCT03958656|323770156|FG001|Overall Study|No longer meets eligibility criteria|0|||
94539687|NCT03958656|323770157|FG002|Overall Study|No longer meets eligibility criteria|1|||
94539688|NCT03958656|323770158|FG003|Overall Study|No longer meets eligibility criteria|0|||
94539689|NCT03958656|323770155|FG000|Overall Study|Started anti-cancer treatment|0|||
94539690|NCT03958656|323770156|FG001|Overall Study|Started anti-cancer treatment|0|||
94539691|NCT03958656|323770157|FG002|Overall Study|Started anti-cancer treatment|1|||
94539692|NCT03958656|323770158|FG003|Overall Study|Started anti-cancer treatment|0|||
94539693|NCT01081301|323770159|FG000|Overall Study|Bereaved|3|||
94539694|NCT01081301|323770159|FG000|Overall Study|Too busy|5|||
94539695|NCT01081301|323770159|FG000|Overall Study|Patient too ill|2|||
94539696|NCT01081301|323770159|FG000|Overall Study|Lost to Follow-up|4|||
94539697|NCT02182440|323770166|FG000|Overall Study|Adverse Event|0|||
94539698|NCT02182440|323770167|FG001|Overall Study|Adverse Event|1|||
94539699|NCT02182440|323770168|FG002|Overall Study|Adverse Event|0|||
94539700|NCT02182440|323770169|FG003|Overall Study|Adverse Event|0|||
94539701|NCT02182440|323770166|FG000|Overall Study|Death|31|||
94539702|NCT02182440|323770167|FG001|Overall Study|Death|8|||
94539703|NCT02182440|323770168|FG002|Overall Study|Death|5|||
94539704|NCT02182440|323770169|FG003|Overall Study|Death|16|||
94539705|NCT02182440|323770166|FG000|Overall Study|Protocol Violation|0|||
94539706|NCT02182440|323770167|FG001|Overall Study|Protocol Violation|1|||
94539707|NCT02182440|323770168|FG002|Overall Study|Protocol Violation|0|||
94539708|NCT02182440|323770169|FG003|Overall Study|Protocol Violation|0|||
94539709|NCT02182440|323770166|FG000|Overall Study|Physician Decision|1|||
94539710|NCT02182440|323770167|FG001|Overall Study|Physician Decision|0|||
94539711|NCT02182440|323770168|FG002|Overall Study|Physician Decision|0|||
94539712|NCT02182440|323770169|FG003|Overall Study|Physician Decision|0|||
94539713|NCT02182440|323770166|FG000|Overall Study|Withdrawal by Subject|1|||
94539714|NCT02182440|323770167|FG001|Overall Study|Withdrawal by Subject|1|||
94539715|NCT02182440|323770168|FG002|Overall Study|Withdrawal by Subject|3|||
94539716|NCT02182440|323770169|FG003|Overall Study|Withdrawal by Subject|4|||
94539717|NCT02182440|323770166|FG000|Overall Study|different, e.g adm other hospital|12|||
94539718|NCT02182440|323770167|FG001|Overall Study|different, e.g adm other hospital|3|||
94539719|NCT02182440|323770168|FG002|Overall Study|different, e.g adm other hospital|3|||
94539720|NCT02182440|323770169|FG003|Overall Study|different, e.g adm other hospital|10|||
94539721|NCT00072293|323770170|FG000|Overall Study|Lost to Follow-up|1|||
94539722|NCT00072293|323770171|FG001|Overall Study|Lost to Follow-up|1|||
94539723|NCT00072293|323770170|FG000|Overall Study|Withdrawal by Subject|0|||
94539724|NCT00072293|323770171|FG001|Overall Study|Withdrawal by Subject|1|||
94539725|NCT01510145|323770178|FG000|Overall Study|Adverse Event|6|||
94539726|NCT01510145|323770178|FG000|Overall Study|Lost to Follow-up|5|||
94539727|NCT01510145|323770178|FG000|Overall Study|Withdrawal by Subject|6|||
94539728|NCT01510145|323770178|FG000|Overall Study|Relative reported subject withdrew|1|||
94539729|NCT04068519|323770179|FG000|Dose Verification|Death|15|||
94539730|NCT04068519|323770179|FG000|Dose Verification|Withdrawal by Subject|1|||
94539731|NCT04068519|323770179|FG000|Pharmacokinetic Sub-study|Death|35|||
94539732|NCT04068519|323770179|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
94539733|NCT04068519|323770179|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
94539734|NCT04068519|323770179|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
94539735|NCT04068519|323770179|FG000|Indication Expansion|Death|152|||
94539736|NCT04068519|323770179|FG000|Indication Expansion|Withdrawal by Subject|10|||
94539737|NCT04068519|323770179|FG000|Indication Expansion|Lost to Follow-up|7|||
94539738|NCT02226198|323771935|FG000|Lead-in Phase|Protocol Violation|1|||
94539739|NCT02226198|323771936|FG001|Lead-in Phase|Protocol Violation|0|||
94539740|NCT02226198|323771937|FG002|Lead-in Phase|Protocol Violation|0|||
94539741|NCT02226198|323771935|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
94539742|NCT02226198|323771936|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
94539743|NCT02226198|323771937|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
94539744|NCT01514240|323771938|FG000|Overall Study|Adverse Event|4|||
94539745|NCT01514240|323771939|FG001|Overall Study|Adverse Event|4|||
94539746|NCT01514240|323771938|FG000|Overall Study|Subject Decision|2|||
94539747|NCT01514240|323771939|FG001|Overall Study|Subject Decision|7|||
94539748|NCT00983515|323771940|FG000|Ritonavir Alone|liver panel out of range|6|||
94539749|NCT00983515|323771940|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
94539750|NCT00539513|323771949|FG000|Overall Study|Withdrawal by Subject|2|||
94539751|NCT00539513|323771950|FG001|Overall Study|Withdrawal by Subject|1|||
94539752|NCT00539513|323771949|FG000|Overall Study|Lost to Follow-up|0|||
94539753|NCT00539513|323771950|FG001|Overall Study|Lost to Follow-up|1|||
94539754|NCT00316693|323771951|FG000|Overall Study|Adverse Event|6|||
94539755|NCT00316693|323771952|FG001|Overall Study|Adverse Event|1|||
94539756|NCT00316693|323771951|FG000|Overall Study|Protocol Violation|1|||
94539757|NCT00316693|323771952|FG001|Overall Study|Protocol Violation|0|||
94539758|NCT00316693|323771951|FG000|Overall Study|Withdrawal by Subject|6|||
94539759|NCT00316693|323771952|FG001|Overall Study|Withdrawal by Subject|6|||
94539760|NCT00316693|323771951|FG000|Overall Study|Lost to Follow-up|26|||
94539761|NCT00316693|323771952|FG001|Overall Study|Lost to Follow-up|34|||
94539762|NCT00316693|323771951|FG000|Overall Study|Other|38|||
94539763|NCT00316693|323771952|FG001|Overall Study|Other|44|||
94539764|NCT02982018|323771953|FG000|Overall Study|Incorrect Lens Dispensed|1|||
94539765|NCT02982018|323771954|FG001|Overall Study|Incorrect Lens Dispensed|0|||
94539766|NCT02982018|323771953|FG000|Overall Study|Protocol Violation|1|||
94539767|NCT02982018|323771954|FG001|Overall Study|Protocol Violation|1|||
94539768|NCT02982018|323771953|FG000|Overall Study|Adverse Event|1|||
94539769|NCT02982018|323771954|FG001|Overall Study|Adverse Event|1|||
94539770|NCT02982018|323771953|FG000|Overall Study|Lens Discomfort|2|||
94539771|NCT02982018|323771954|FG001|Overall Study|Lens Discomfort|0|||
94539772|NCT02982018|323771953|FG000|Overall Study|Withdrawal by Subject|0|||
94539773|NCT02982018|323771954|FG001|Overall Study|Withdrawal by Subject|1|||
94539774|NCT01328041|323771955|FG000|Overall Study|Adverse Event|7|||
94539775|NCT01328041|323771955|FG000|Overall Study|Lack of Efficacy|27|||
94539776|NCT01328041|323771955|FG000|Overall Study|Protocol Violation|7|||
94539777|NCT01328041|323771955|FG000|Overall Study|Lost to Follow-up|7|||
94539778|NCT01328041|323771955|FG000|Overall Study|Physician Decision|2|||
94539779|NCT01328041|323771955|FG000|Overall Study|Withdrawal by Subject|7|||
94539780|NCT03283098|323771956|FG000|Overall Study|Withdrawal by Subject|0|||
94539781|NCT03283098|323771957|FG001|Overall Study|Withdrawal by Subject|1|||
94539782|NCT01606787|323771964|FG000|Overall Study|Withdrawal by Subject|4|||
94539783|NCT01606787|323771965|FG001|Overall Study|Withdrawal by Subject|5|||
94539784|NCT01606787|323771964|FG000|Overall Study|Surgery canceled|0|||
94539785|NCT01606787|323771965|FG001|Overall Study|Surgery canceled|2|||
94539786|NCT01257568|323771968|FG000|Overall Study|Lost to Follow-up|2|||
94539787|NCT01257568|323771968|FG000|Overall Study|Withdrawal by Subject|6|||
94539788|NCT01257568|323771968|FG000|Overall Study|Terminated|1|||
94539789|NCT01257568|323771968|FG000|Overall Study|Component Revision|24|||
94539790|NCT03392883|323771972|FG000|Overall Study|Lost to Follow-up|122|||
94539791|NCT03392883|323771973|FG001|Overall Study|Lost to Follow-up|13|||
94539792|NCT03392883|323771974|FG002|Overall Study|Lost to Follow-up|9|||
94539793|NCT03392883|323771972|FG000|Overall Study|Death|4|||
94539794|NCT03392883|323771973|FG001|Overall Study|Death|0|||
94539795|NCT03392883|323771974|FG002|Overall Study|Death|0|||
94539796|NCT03392883|323771972|FG000|Overall Study|Lack of Efficacy|29|||
94539797|NCT03392883|323771973|FG001|Overall Study|Lack of Efficacy|0|||
94539798|NCT03392883|323771974|FG002|Overall Study|Lack of Efficacy|0|||
94539799|NCT03392883|323771972|FG000|Overall Study|Withdrawal by Subject|180|||
94539800|NCT03392883|323771973|FG001|Overall Study|Withdrawal by Subject|0|||
94539801|NCT03392883|323771974|FG002|Overall Study|Withdrawal by Subject|0|||
94539802|NCT03392883|323771972|FG000|Overall Study|Adverse Event|1|||
94539803|NCT03392883|323771973|FG001|Overall Study|Adverse Event|0|||
94539804|NCT03392883|323771974|FG002|Overall Study|Adverse Event|0|||
94539805|NCT00132691|323771975|FG000|Overall Study|Lost to Follow-up|5|||
94539806|NCT00132691|323771976|FG001|Overall Study|Lost to Follow-up|8|||
94539807|NCT00132691|323771975|FG000|Overall Study|Missed 2-year visit|4|||
94539808|NCT00132691|323771976|FG001|Overall Study|Missed 2-year visit|4|||
94539809|NCT00132691|323771975|FG000|Overall Study|Death|2|||
94539810|NCT00132691|323771976|FG001|Overall Study|Death|0|||
94539811|NCT04098367|323771983|FG000|Overall Study|Adverse Event|0|||
94539812|NCT04098367|323771984|FG001|Overall Study|Adverse Event|0|||
94539813|NCT04098367|323771985|FG002|Overall Study|Adverse Event|1|||
94539814|NCT04098367|323771983|FG000|Overall Study|Lost to Follow-up|1|||
94539815|NCT04098367|323771984|FG001|Overall Study|Lost to Follow-up|5|||
94539816|NCT04098367|323771985|FG002|Overall Study|Lost to Follow-up|2|||
94539817|NCT04098367|323771983|FG000|Overall Study|Withdrawal by Subject|0|||
94539818|NCT04098367|323771984|FG001|Overall Study|Withdrawal by Subject|0|||
94539819|NCT04098367|323771985|FG002|Overall Study|Withdrawal by Subject|1|||
94539820|NCT04098367|323771983|FG000|Overall Study|Sick . Could not attend visit|1|||
94539821|NCT04098367|323771984|FG001|Overall Study|Sick . Could not attend visit|0|||
94539822|NCT04098367|323771985|FG002|Overall Study|Sick . Could not attend visit|0|||
94539823|NCT02251717|323771986|FG000|Overall Study|Adverse Event|0|||
94539824|NCT02251717|323771987|FG001|Overall Study|Adverse Event|1|||
94539825|NCT02251717|323771986|FG000|Overall Study|Withdrew Consent|1|||
94539826|NCT02251717|323771987|FG001|Overall Study|Withdrew Consent|0|||
94539827|NCT05438602|323771997|FG000|Treatment (15 Days)|Adverse Event|2|||
94539828|NCT05438602|323771998|FG001|Treatment (15 Days)|Adverse Event|1|||
94539829|NCT05438602|323771999|FG002|Treatment (15 Days)|Adverse Event|3|||
94539830|NCT05438602|323771997|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
94539831|NCT05438602|323771998|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
94539832|NCT05438602|323771999|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
94539833|NCT05438602|323771997|FG000|Treatment (15 Days)|Other|0|||
94539834|NCT05438602|323771998|FG001|Treatment (15 Days)|Other|0|||
94539835|NCT05438602|323771999|FG002|Treatment (15 Days)|Other|1|||
94539836|NCT05438602|323771997|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
94539837|NCT05438602|323771998|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
94539838|NCT05438602|323771999|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
94539839|NCT05438602|323771997|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
94539840|NCT05438602|323771998|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
94539841|NCT05438602|323771999|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
94539842|NCT05438602|323771997|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
94539843|NCT05438602|323771998|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
94539844|NCT05438602|323771999|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
94539845|NCT05438602|323771997|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
94539846|NCT05438602|323771998|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
94539847|NCT05438602|323771999|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
94539848|NCT05438602|323771997|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
94539849|NCT05438602|323771998|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
94539850|NCT05438602|323771999|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
94539851|NCT05438602|323771997|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
94539852|NCT05438602|323771998|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
94539853|NCT05438602|323771999|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
94539854|NCT05438602|323771997|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
94539855|NCT05438602|323771998|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
94539856|NCT05438602|323771999|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
94539857|NCT01231321|323772002|FG000|Overall Study|Adverse Event|3|||
94539858|NCT01231321|323772002|FG000|Overall Study|Lack of Efficacy|2|||
94539859|NCT00908115|323772004|FG000|Overall Study|Other|14|||
94539860|NCT00445939|323772005|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
94539861|NCT00445939|323772006|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
94539862|NCT00445939|323772007|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
94539863|NCT00445939|323772008|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
94539864|NCT00445939|323772005|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
94539865|NCT00445939|323772006|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
94539866|NCT00445939|323772007|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
94539867|NCT00445939|323772008|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
94539868|NCT00416715|323772009|FG000|Overall Study|Not evaluable for joint aches|7|||
94539869|NCT00416715|323772009|FG000|Overall Study|Vitamin D levels not evaluable|8|||
94539870|NCT00489736|323772010|FG000|Overall Study|Lack of Efficacy|53|||
94539871|NCT00489736|323772011|FG001|Overall Study|Lack of Efficacy|14|||
94539872|NCT00489736|323772010|FG000|Overall Study|Adverse Event|32|||
94539873|NCT00489736|323772011|FG001|Overall Study|Adverse Event|45|||
94539874|NCT00489736|323772010|FG000|Overall Study|Poor compliance|6|||
94539875|NCT00489736|323772011|FG001|Overall Study|Poor compliance|2|||
94539876|NCT00489736|323772010|FG000|Overall Study|Not coded/ Not pre-specified|5|||
94539877|NCT00489736|323772011|FG001|Overall Study|Not coded/ Not pre-specified|8|||
94539878|NCT04021524|323772012|FG000|Overall Study|Change in surgical intervention|0|||
94539879|NCT04021524|323772013|FG001|Overall Study|Change in surgical intervention|1|||
94539880|NCT00693017|323772017|FG000|Overall Study|Sponsor Decision|2|||
94539881|NCT00693017|323772018|FG001|Overall Study|Sponsor Decision|1|||
94539882|NCT00693017|323772017|FG000|Overall Study|Death|0|||
94539883|NCT00693017|323772018|FG001|Overall Study|Death|1|||
94539884|NCT01082874|323772019|FG000|Overall Study|Lost to Follow-up|10|||
94539885|NCT01082874|323772020|FG001|Overall Study|Lost to Follow-up|10|||
94539886|NCT01082874|323772021|FG002|Overall Study|Lost to Follow-up|6|||
94539887|NCT01082874|323772022|FG003|Overall Study|Lost to Follow-up|10|||
94539888|NCT01082874|323772019|FG000|Overall Study|Withdrawal by Subject|1|||
94539889|NCT01082874|323772020|FG001|Overall Study|Withdrawal by Subject|2|||
94539890|NCT01082874|323772021|FG002|Overall Study|Withdrawal by Subject|5|||
94539891|NCT01082874|323772022|FG003|Overall Study|Withdrawal by Subject|3|||
94539892|NCT01069861|323772023|FG000|Overall Study|Death|1|||
94539893|NCT01069861|323772023|FG000|Overall Study|Adverse Event|1|||
94539894|NCT01069861|323772023|FG000|Overall Study|Did not meet entrance criteria|1|||
94539895|NCT00090142|323772027|FG000|Treatment Period I|Lost to Follow-up|1|||
94539896|NCT00090142|323772028|FG001|Treatment Period I|Lost to Follow-up|2|||
94539897|NCT00090142|323772027|FG000|Treatment Period I|Protocol Violation|2|||
94539898|NCT00090142|323772028|FG001|Treatment Period I|Protocol Violation|0|||
94539899|NCT00090142|323772027|FG000|Treatment Period I|Withdrawal by Subject|2|||
94539900|NCT00090142|323772028|FG001|Treatment Period I|Withdrawal by Subject|0|||
94539901|NCT00090142|323772027|FG000|Treatment Period I|Other|0|||
94539902|NCT00090142|323772028|FG001|Treatment Period I|Other|1|||
94539903|NCT00090142|323772027|FG000|Treatment Period II|Other|1|||
94539904|NCT00090142|323772028|FG001|Treatment Period II|Other|0|||
94539905|NCT03555981|323772029|FG000|Overall Study|Lost to Follow-up|0|||
94539906|NCT03555981|323772030|FG001|Overall Study|Lost to Follow-up|2|||
94539907|NCT00006046|323772031|FG000|Overall Study|Adverse Event|3|||
94539908|NCT00006046|323772032|FG001|Overall Study|Adverse Event|0|||
94539909|NCT00006046|323772033|FG002|Overall Study|Adverse Event|0|||
94539910|NCT00006046|323772034|FG003|Overall Study|Adverse Event|0|||
94539911|NCT00006046|323772035|FG004|Overall Study|Adverse Event|0|||
94539912|NCT00006046|323772031|FG000|Overall Study|Disease Progression|2|||
94539913|NCT00006046|323772032|FG001|Overall Study|Disease Progression|0|||
94539914|NCT00006046|323772033|FG002|Overall Study|Disease Progression|0|||
94539915|NCT00006046|323772034|FG003|Overall Study|Disease Progression|0|||
94539916|NCT00006046|323772035|FG004|Overall Study|Disease Progression|0|||
94539917|NCT04600076|323772040|FG000|Overall Study|Lost to Follow-up|3|||
94539918|NCT00367744|323772041|FG000|Overall Study|Lost to Follow-up|4|||
94539919|NCT00367744|323772042|FG001|Overall Study|Lost to Follow-up|5|||
94539920|NCT03664674|323772044|FG000|Overall Study|Adverse Event|1|||
94539921|NCT03664674|323772045|FG001|Overall Study|Adverse Event|1|||
94539922|NCT03664674|323772044|FG000|Overall Study|Physician Decision|0|||
94539923|NCT03664674|323772045|FG001|Overall Study|Physician Decision|1|||
94539924|NCT03664674|323772044|FG000|Overall Study|Withdrawal by Subject|2|||
94539925|NCT03664674|323772045|FG001|Overall Study|Withdrawal by Subject|0|||
94539926|NCT00683917|323772046|FG000|Overall Study|Study prematurely terminated|10|||
94539927|NCT01349322|323772063|FG000|Overall Study|Protocol Violation|45|||
94539928|NCT01349322|323772064|FG001|Overall Study|Protocol Violation|47|||
94539929|NCT01133626|323772070|FG000|Overall Study|Adverse Event|0|||
94539930|NCT01133626|323772071|FG001|Overall Study|Adverse Event|1|||
94539931|NCT01133626|323772072|FG002|Overall Study|Adverse Event|0|||
94539932|NCT01133626|323772070|FG000|Overall Study|Withdrawal by Subject|1|||
94539933|NCT01133626|323772071|FG001|Overall Study|Withdrawal by Subject|2|||
94539934|NCT01133626|323772072|FG002|Overall Study|Withdrawal by Subject|2|||
94539935|NCT01133626|323772070|FG000|Overall Study|Other|0|||
94539936|NCT01133626|323772071|FG001|Overall Study|Other|2|||
94539937|NCT01133626|323772072|FG002|Overall Study|Other|0|||
94539938|NCT02851407|323772073|FG000|Overall Study|Withdrawal by parent/guardian|2|||
94539939|NCT02851407|323772074|FG001|Overall Study|Withdrawal by parent/guardian|7|||
94539940|NCT02851407|323772073|FG000|Overall Study|Protocol deviation|0|||
94539941|NCT02851407|323772074|FG001|Overall Study|Protocol deviation|1|||
94539942|NCT02851407|323772073|FG000|Overall Study|Transferred to another hospital to continue|1|||
94539943|NCT02851407|323772074|FG001|Overall Study|Transferred to another hospital to continue|0|||
94539944|NCT02851407|323772073|FG000|Overall Study|Other Death|30|||
94539945|NCT02851407|323772074|FG001|Overall Study|Other Death|20|||
94539946|NCT02851407|323772073|FG000|Overall Study|Adverse event, serious fatal|6|||
94539947|NCT02851407|323772074|FG001|Overall Study|Adverse event, serious fatal|8|||
94539948|NCT02851407|323772073|FG000|Overall Study|Consent withdrawn by participant|5|||
94539949|NCT02851407|323772074|FG001|Overall Study|Consent withdrawn by participant|3|||
94539950|NCT02851407|323772073|FG000|Overall Study|Screen failure|2|||
94539951|NCT02851407|323772074|FG001|Overall Study|Screen failure|1|||
94539952|NCT02851407|323772073|FG000|Overall Study|Disease relapse|9|||
94539953|NCT02851407|323772074|FG001|Overall Study|Disease relapse|6|||
94539954|NCT02851407|323772073|FG000|Overall Study|Physician Decision|7|||
94539955|NCT02851407|323772074|FG001|Overall Study|Physician Decision|6|||
94539956|NCT02851407|323772073|FG000|Overall Study|Transferred to hospital closer to home|0|||
94539957|NCT02851407|323772074|FG001|Overall Study|Transferred to hospital closer to home|1|||
94539958|NCT02851407|323772073|FG000|Overall Study|Enrolled in an investigational study|0|||
94539959|NCT02851407|323772074|FG001|Overall Study|Enrolled in an investigational study|1|||
94539960|NCT02851407|323772073|FG000|Overall Study|Early recovery|1|||
94539961|NCT02851407|323772074|FG001|Overall Study|Early recovery|0|||
94539962|NCT02851407|323772073|FG000|Overall Study|Adverse event, non-fatal|7|||
94539963|NCT02851407|323772074|FG001|Overall Study|Adverse event, non-fatal|5|||
94539964|NCT02851407|323772073|FG000|Overall Study|Lost to Follow-up|0|||
94539965|NCT02851407|323772074|FG001|Overall Study|Lost to Follow-up|2|||
94539966|NCT02509052|323772075|FG000|Overall Study|Non compliance|0|||
94539967|NCT02509052|323772076|FG001|Overall Study|Non compliance|0|||
94539968|NCT02509052|323772077|FG002|Overall Study|Non compliance|1|||
94539969|NCT02927925|323772078|FG000|Overall Study|Death|16|||
94539970|NCT02927925|323772078|FG000|Overall Study|Physician Decision|1|||
94539971|NCT02927925|323772078|FG000|Overall Study|Withdrawal by Subject|11|||
94539972|NCT02927925|323772078|FG000|Overall Study|Other|3|||
94539973|NCT02927925|323772078|FG000|Overall Study|Disease progression at clinical cutoff|1|||
94539974|NCT01166958|323772084|FG000|Overall Study|Withdrawal by Subject|1|||
94539975|NCT01166958|323772085|FG001|Overall Study|Withdrawal by Subject|0|||
94539976|NCT05599451|323773975|FG000|Overall Study|Not randomized|11|||
94539977|NCT05599451|323773976|FG001|Overall Study|Not randomized|0|||
94539978|NCT05599451|323773977|FG002|Overall Study|Not randomized|0|||
94539979|NCT05599451|323773978|FG003|Overall Study|Not randomized|0|||
94539980|NCT05599451|323773979|FG004|Overall Study|Not randomized|0|||
94539981|NCT05599451|323773975|FG000|Overall Study|Physician Decision|0|||
94539982|NCT05599451|323773976|FG001|Overall Study|Physician Decision|0|||
94539983|NCT05599451|323773977|FG002|Overall Study|Physician Decision|0|||
94539984|NCT05599451|323773978|FG003|Overall Study|Physician Decision|1|||
94539985|NCT05599451|323773979|FG004|Overall Study|Physician Decision|0|||
94539986|NCT00303446|323773980|FG000|Overall Study|Withdrawal by Subject|2|||
94539987|NCT00303446|323773981|FG001|Overall Study|Withdrawal by Subject|2|||
94539988|NCT00303446|323773980|FG000|Overall Study|Death|0|||
94539989|NCT00303446|323773981|FG001|Overall Study|Death|1|||
94539990|NCT00303446|323773980|FG000|Overall Study|Physician Decision|0|||
94539991|NCT00303446|323773981|FG001|Overall Study|Physician Decision|1|||
94539992|NCT00711113|323773982|FG000|Overall Study|Lost to Follow-up|9|||
94539993|NCT00711113|323773982|FG000|Overall Study|Implant lost|2|||
94539994|NCT00798317|323773987|FG000|Overall Study|Physician Decision|0|||
94539995|NCT00798317|323773988|FG001|Overall Study|Physician Decision|1|||
94539996|NCT00798317|323773987|FG000|Overall Study|Withdrawal by Subject|5|||
94539997|NCT00798317|323773988|FG001|Overall Study|Withdrawal by Subject|4|||
94539998|NCT00798317|323773987|FG000|Overall Study|Lost to Follow-up|2|||
94539999|NCT00798317|323773988|FG001|Overall Study|Lost to Follow-up|2|||
94540000|NCT00798317|323773987|FG000|Overall Study|Adverse Event|2|||
94540001|NCT00798317|323773988|FG001|Overall Study|Adverse Event|0|||
94540002|NCT00798317|323773987|FG000|Overall Study|Death|1|||
94540003|NCT00798317|323773988|FG001|Overall Study|Death|0|||
94540004|NCT02576535|323774000|FG000|Overall Study|Withdrawal by Subject|2|||
94540005|NCT02534935|323774004|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
94540006|NCT02534935|323774005|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
94540007|NCT02534935|323774006|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
94540008|NCT02534935|323774004|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
94540009|NCT02534935|323774005|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
94540010|NCT02534935|323774006|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
94540011|NCT02534935|323774004|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
94540012|NCT02534935|323774005|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
94540013|NCT02534935|323774006|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
94540014|NCT02534935|323774004|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
94540015|NCT02534935|323774005|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
94540016|NCT02534935|323774006|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
94540017|NCT02534935|323774004|FG000|Stage 1: 24 Months|Adverse Event|0|||
94540018|NCT02534935|323774005|FG001|Stage 1: 24 Months|Adverse Event|2|||
94540019|NCT02534935|323774006|FG002|Stage 1: 24 Months|Adverse Event|0|||
94540020|NCT02534935|323774004|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
94540021|NCT02534935|323774005|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
94540022|NCT02534935|323774006|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
94540023|NCT02534935|323774004|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
94540024|NCT02534935|323774005|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
94540025|NCT02534935|323774006|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
94540026|NCT00996281|323774009|FG000|Overall Study|Adverse Event|75|||
94540027|NCT00996281|323774010|FG001|Overall Study|Adverse Event|37|||
94540028|NCT00996281|323774009|FG000|Overall Study|Major Protocol Deviation|6|||
94540029|NCT00996281|323774010|FG001|Overall Study|Major Protocol Deviation|7|||
94540030|NCT00996281|323774009|FG000|Overall Study|Lost to Follow-up|14|||
94540031|NCT00996281|323774010|FG001|Overall Study|Lost to Follow-up|16|||
94540032|NCT00996281|323774009|FG000|Overall Study|Withdrawal by Subject|31|||
94540033|NCT00996281|323774010|FG001|Overall Study|Withdrawal by Subject|20|||
94540034|NCT00996281|323774009|FG000|Overall Study|Lack of Efficacy|0|||
94540035|NCT00996281|323774010|FG001|Overall Study|Lack of Efficacy|2|||
94540036|NCT00996281|323774009|FG000|Overall Study|Other|5|||
94540037|NCT00996281|323774010|FG001|Overall Study|Other|7|||
94540038|NCT03361189|323774011|FG000|Overall Study|Received heart transplant|1|||
94540039|NCT03361189|323774012|FG001|Overall Study|Received heart transplant|0|||
94540040|NCT03361189|323774011|FG000|Overall Study|Pacemake replacement|0|||
94540041|NCT03361189|323774012|FG001|Overall Study|Pacemake replacement|1|||
94540042|NCT00543296|323774023|FG000|Overall Study|Physician Decision|7|||
94540043|NCT03028480|323774024|FG000|Overall Study|No revisit after the first prescription date|2|||
94540044|NCT03028480|323774024|FG000|Overall Study|Did not use the drug|1|||
94540045|NCT03028480|323774024|FG000|Overall Study|Violation of the enrollment deadline|10|||
94540046|NCT03028480|323774024|FG000|Overall Study|Case report forms were not collected|21|||
94540047|NCT01777542|323774025|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
94540048|NCT01777542|323774026|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
94540049|NCT00759356|323774027|FG000|Overall Study|Adverse Event|0|||
94540050|NCT00759356|323774028|FG001|Overall Study|Adverse Event|1|||
94540051|NCT00759356|323774027|FG000|Overall Study|Withdrawal by Subject|0|||
94540052|NCT00759356|323774028|FG001|Overall Study|Withdrawal by Subject|2|||
94540053|NCT00759356|323774027|FG000|Overall Study|Subject was unable to return|1|||
94540054|NCT00759356|323774028|FG001|Overall Study|Subject was unable to return|0|||
94540055|NCT03199053|323774029|FG000|ST Period|Withdrawal by Subject|2|||
94540056|NCT03199053|323774030|FG001|ST Period|Withdrawal by Subject|4|||
94540057|NCT03199053|323774031|FG002|ST Period|Withdrawal by Subject|6|||
94540058|NCT03199053|323774029|FG000|ST Period|Withdrawal by parent/guardian|1|||
94540059|NCT03199053|323774030|FG001|ST Period|Withdrawal by parent/guardian|1|||
94540060|NCT03199053|323774031|FG002|ST Period|Withdrawal by parent/guardian|1|||
94540061|NCT03199053|323774029|FG000|ST Period|Lost to Follow-up|2|||
94540062|NCT03199053|323774030|FG001|ST Period|Lost to Follow-up|0|||
94540063|NCT03199053|323774031|FG002|ST Period|Lost to Follow-up|1|||
94540064|NCT03199053|323774029|FG000|LT Period|Withdrawal by Subject|1|||
94540065|NCT03199053|323774030|FG001|LT Period|Withdrawal by Subject|3|||
94540066|NCT03199053|323774031|FG002|LT Period|Withdrawal by Subject|3|||
94540067|NCT03199053|323774029|FG000|LT Period|Withdrawal by parent/guardian|0|||
94540068|NCT03199053|323774030|FG001|LT Period|Withdrawal by parent/guardian|0|||
94540069|NCT03199053|323774031|FG002|LT Period|Withdrawal by parent/guardian|1|||
94540070|NCT03199053|323774029|FG000|LT Period|Lost to Follow-up|0|||
94540071|NCT03199053|323774030|FG001|LT Period|Lost to Follow-up|1|||
94540072|NCT03199053|323774031|FG002|LT Period|Lost to Follow-up|1|||
94540073|NCT03199053|323774029|FG000|LT Period|Miscellaneous|0|||
94540074|NCT03199053|323774030|FG001|LT Period|Miscellaneous|0|||
94540075|NCT03199053|323774031|FG002|LT Period|Miscellaneous|2|||
94540076|NCT03199053|323774029|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
94540077|NCT03199053|323774030|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
94540078|NCT03199053|323774031|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
94540079|NCT03199053|323774029|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
94540080|NCT03199053|323774030|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
94540081|NCT03199053|323774031|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
94540082|NCT03199053|323774029|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
94540083|NCT03199053|323774030|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
94540084|NCT03199053|323774031|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
94540085|NCT03199053|323774029|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
94540086|NCT03199053|323774030|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
94540087|NCT03199053|323774031|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
94540088|NCT02403635|323774032|FG000|Overall Study|Not eligible|9|||
94540089|NCT00585221|323774033|FG000|Overall Study|Protocol Violation|8|||
94540090|NCT02585830|323774034|FG000|Overall Study|Withdrawal by Subject|3|||
94540091|NCT01904149|323774035|FG000|Overall Study|Adverse Event|3|||
94540092|NCT01904149|323774036|FG001|Overall Study|Adverse Event|4|||
94540093|NCT01904149|323774037|FG002|Overall Study|Adverse Event|0|||
94540094|NCT01904149|323774038|FG003|Overall Study|Adverse Event|1|||
94540095|NCT01904149|323774039|FG004|Overall Study|Adverse Event|1|||
94540096|NCT01904149|323774040|FG005|Overall Study|Adverse Event|2|||
94540097|NCT01904149|323774035|FG000|Overall Study|Lack of Efficacy|0|||
94540098|NCT01904149|323774036|FG001|Overall Study|Lack of Efficacy|3|||
94540099|NCT01904149|323774037|FG002|Overall Study|Lack of Efficacy|1|||
94540100|NCT01904149|323774038|FG003|Overall Study|Lack of Efficacy|3|||
94540101|NCT01904149|323774039|FG004|Overall Study|Lack of Efficacy|3|||
94540102|NCT01904149|323774040|FG005|Overall Study|Lack of Efficacy|1|||
94540103|NCT01904149|323774035|FG000|Overall Study|Withdrawal by Subject|1|||
94540104|NCT01904149|323774036|FG001|Overall Study|Withdrawal by Subject|3|||
94540105|NCT01904149|323774037|FG002|Overall Study|Withdrawal by Subject|1|||
94540106|NCT01904149|323774038|FG003|Overall Study|Withdrawal by Subject|0|||
94540107|NCT01904149|323774039|FG004|Overall Study|Withdrawal by Subject|1|||
94540108|NCT01904149|323774040|FG005|Overall Study|Withdrawal by Subject|0|||
94540109|NCT01904149|323774035|FG000|Overall Study|Protocol Violation|0|||
94540110|NCT01904149|323774036|FG001|Overall Study|Protocol Violation|1|||
94540111|NCT01904149|323774037|FG002|Overall Study|Protocol Violation|0|||
94540112|NCT01904149|323774038|FG003|Overall Study|Protocol Violation|0|||
94540113|NCT01904149|323774039|FG004|Overall Study|Protocol Violation|0|||
94540114|NCT01904149|323774040|FG005|Overall Study|Protocol Violation|0|||
94540115|NCT01904149|323774035|FG000|Overall Study|non compliance with study drug|1|||
94540116|NCT01904149|323774036|FG001|Overall Study|non compliance with study drug|0|||
94540117|NCT01904149|323774037|FG002|Overall Study|non compliance with study drug|0|||
94540118|NCT01904149|323774038|FG003|Overall Study|non compliance with study drug|0|||
94540119|NCT01904149|323774039|FG004|Overall Study|non compliance with study drug|0|||
94540120|NCT01904149|323774040|FG005|Overall Study|non compliance with study drug|0|||
94540121|NCT00068250|323774041|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
94540122|NCT00068250|323774042|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
94540123|NCT00068250|323774043|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
94540124|NCT00068250|323774044|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
94540125|NCT00235391|323774046|FG000|Overall Study|Adverse Event|4|||
94540126|NCT00235391|323774047|FG001|Overall Study|Adverse Event|5|||
94540127|NCT00235391|323774048|FG002|Overall Study|Adverse Event|10|||
94540128|NCT00235391|323774049|FG003|Overall Study|Adverse Event|72|||
94540129|NCT00235391|323774050|FG004|Overall Study|Adverse Event|5|||
94540130|NCT00235391|323774051|FG005|Overall Study|Adverse Event|2|||
94540131|NCT00235391|323774046|FG000|Overall Study|Abnormal laboratory value(s)|3|||
94540132|NCT00235391|323774047|FG001|Overall Study|Abnormal laboratory value(s)|5|||
94540133|NCT00235391|323774048|FG002|Overall Study|Abnormal laboratory value(s)|4|||
94540134|NCT00235391|323774049|FG003|Overall Study|Abnormal laboratory value(s)|27|||
94540135|NCT00235391|323774050|FG004|Overall Study|Abnormal laboratory value(s)|1|||
94540136|NCT00235391|323774051|FG005|Overall Study|Abnormal laboratory value(s)|2|||
94540137|NCT00235391|323774046|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
94540138|NCT00235391|323774047|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
94540139|NCT00235391|323774048|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
94540140|NCT00235391|323774049|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
94540141|NCT00235391|323774050|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
94540142|NCT00235391|323774051|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
94540143|NCT00235391|323774046|FG000|Overall Study|Condition no longer requires treatment|3|||
94540144|NCT00235391|323774047|FG001|Overall Study|Condition no longer requires treatment|0|||
94540145|NCT00235391|323774048|FG002|Overall Study|Condition no longer requires treatment|0|||
94540146|NCT00235391|323774049|FG003|Overall Study|Condition no longer requires treatment|11|||
94540147|NCT00235391|323774050|FG004|Overall Study|Condition no longer requires treatment|1|||
94540148|NCT00235391|323774051|FG005|Overall Study|Condition no longer requires treatment|0|||
94540149|NCT00235391|323774046|FG000|Overall Study|Protocol deviation|0|||
94540150|NCT00235391|323774047|FG001|Overall Study|Protocol deviation|0|||
94540151|NCT00235391|323774048|FG002|Overall Study|Protocol deviation|1|||
94540152|NCT00235391|323774049|FG003|Overall Study|Protocol deviation|11|||
94540153|NCT00235391|323774050|FG004|Overall Study|Protocol deviation|0|||
94540154|NCT00235391|323774051|FG005|Overall Study|Protocol deviation|0|||
94540155|NCT00235391|323774046|FG000|Overall Study|Withdrawal by Subject|2|||
94540156|NCT00235391|323774047|FG001|Overall Study|Withdrawal by Subject|3|||
94540157|NCT00235391|323774048|FG002|Overall Study|Withdrawal by Subject|3|||
94540158|NCT00235391|323774049|FG003|Overall Study|Withdrawal by Subject|61|||
94540159|NCT00235391|323774050|FG004|Overall Study|Withdrawal by Subject|5|||
94540160|NCT00235391|323774051|FG005|Overall Study|Withdrawal by Subject|0|||
94540161|NCT00235391|323774046|FG000|Overall Study|Lost to Follow-up|0|||
94540162|NCT00235391|323774047|FG001|Overall Study|Lost to Follow-up|3|||
94540163|NCT00235391|323774048|FG002|Overall Study|Lost to Follow-up|3|||
94540164|NCT00235391|323774049|FG003|Overall Study|Lost to Follow-up|16|||
94540165|NCT00235391|323774050|FG004|Overall Study|Lost to Follow-up|0|||
94540166|NCT00235391|323774051|FG005|Overall Study|Lost to Follow-up|0|||
94540167|NCT00235391|323774046|FG000|Overall Study|Administrative problems|0|||
94540168|NCT00235391|323774047|FG001|Overall Study|Administrative problems|0|||
94540169|NCT00235391|323774048|FG002|Overall Study|Administrative problems|0|||
94540170|NCT00235391|323774049|FG003|Overall Study|Administrative problems|1|||
94540171|NCT00235391|323774050|FG004|Overall Study|Administrative problems|0|||
94540172|NCT00235391|323774051|FG005|Overall Study|Administrative problems|0|||
94540173|NCT00235391|323774046|FG000|Overall Study|Death|0|||
94540174|NCT00235391|323774047|FG001|Overall Study|Death|0|||
94540175|NCT00235391|323774048|FG002|Overall Study|Death|1|||
94540176|NCT00235391|323774049|FG003|Overall Study|Death|4|||
94540177|NCT00235391|323774050|FG004|Overall Study|Death|0|||
94540178|NCT00235391|323774051|FG005|Overall Study|Death|0|||
94540179|NCT02098369|323774052|FG000|Overall Study|Withdrawal by Subject|1|||
94540180|NCT02098369|323774053|FG001|Overall Study|Withdrawal by Subject|5|||
94540181|NCT02098369|323774054|FG002|Overall Study|Withdrawal by Subject|0|||
94540182|NCT02098369|323774052|FG000|Overall Study|Lost to Follow-up|5|||
94540183|NCT02098369|323774053|FG001|Overall Study|Lost to Follow-up|1|||
94540184|NCT02098369|323774054|FG002|Overall Study|Lost to Follow-up|3|||
94540185|NCT02098369|323774052|FG000|Overall Study|Death|1|||
94540186|NCT02098369|323774053|FG001|Overall Study|Death|1|||
94540187|NCT02098369|323774054|FG002|Overall Study|Death|1|||
94540188|NCT02098369|323774052|FG000|Overall Study|Other|0|||
94540189|NCT02098369|323774053|FG001|Overall Study|Other|2|||
94540190|NCT02098369|323774054|FG002|Overall Study|Other|1|||
94540191|NCT03349645|323774056|FG000|Overall Study|Sponsor Terminated Study|75|||
94540192|NCT03349645|323774056|FG000|Overall Study|Withdrawal by Subject|4|||
94540193|NCT03349645|323774056|FG000|Overall Study|Protocol Violation|1|||
94540194|NCT03349645|323774056|FG000|Overall Study|Other|2|||
94540195|NCT01080768|323774068|FG000|Overall Study|Protocol Deviation|2|||
94540196|NCT01080768|323774069|FG001|Overall Study|Protocol Deviation|1|||
94540197|NCT00246025|323774070|FG000|Overall Study|Adverse Event|7|||
94540198|NCT00246025|323774071|FG001|Overall Study|Adverse Event|9|||
94540199|NCT00246025|323774072|FG002|Overall Study|Adverse Event|9|||
94540200|NCT00246025|323774073|FG003|Overall Study|Adverse Event|10|||
94540201|NCT00246025|323774070|FG000|Overall Study|Withdrawal by Subject|3|||
94540202|NCT00246025|323774071|FG001|Overall Study|Withdrawal by Subject|0|||
94540203|NCT00246025|323774072|FG002|Overall Study|Withdrawal by Subject|1|||
94540204|NCT00246025|323774073|FG003|Overall Study|Withdrawal by Subject|2|||
94540205|NCT00246025|323774070|FG000|Overall Study|unsuitable medical history was found|0|||
94540206|NCT00246025|323774071|FG001|Overall Study|unsuitable medical history was found|0|||
94540207|NCT00246025|323774072|FG002|Overall Study|unsuitable medical history was found|0|||
94540208|NCT00246025|323774073|FG003|Overall Study|unsuitable medical history was found|1|||
94540209|NCT00931723|323774074|FG000|Overall Study|Withdrawal by Subject|11|||
94540210|NCT00931723|323774075|FG001|Overall Study|Withdrawal by Subject|13|||
94540211|NCT00931723|323774074|FG000|Overall Study|Adverse Event|6|||
94540212|NCT00931723|323774075|FG001|Overall Study|Adverse Event|13|||
94540213|NCT00931723|323774074|FG000|Overall Study|Lithium found in blood|0|||
94540214|NCT00931723|323774075|FG001|Overall Study|Lithium found in blood|1|||
94540215|NCT00931723|323774074|FG000|Overall Study|Condition under investigation worsened|1|||
94540216|NCT00931723|323774075|FG001|Overall Study|Condition under investigation worsened|2|||
94540217|NCT00931723|323774074|FG000|Overall Study|Lost to Follow-up|1|||
94540218|NCT00931723|323774075|FG001|Overall Study|Lost to Follow-up|2|||
94540219|NCT00931723|323774074|FG000|Overall Study|Study-specific discontinuation criteria|1|||
94540220|NCT00931723|323774075|FG001|Overall Study|Study-specific discontinuation criteria|1|||
94540221|NCT00931723|323774074|FG000|Overall Study|Severe non-compliance to protocol|2|||
94540222|NCT00931723|323774075|FG001|Overall Study|Severe non-compliance to protocol|0|||
94540223|NCT00931723|323774074|FG000|Overall Study|Safety reasons|0|||
94540224|NCT00931723|323774075|FG001|Overall Study|Safety reasons|1|||
94540225|NCT00931723|323774074|FG000|Overall Study|Took prohibited concomitant medication|0|||
94540226|NCT00931723|323774075|FG001|Overall Study|Took prohibited concomitant medication|1|||
94540227|NCT00931723|323774074|FG000|Overall Study|Lack or insufficient theraputic response|2|||
94540228|NCT00931723|323774075|FG001|Overall Study|Lack or insufficient theraputic response|5|||
94540229|NCT00931723|323774074|FG000|Overall Study|Sponsor decision|1|||
94540230|NCT00931723|323774075|FG001|Overall Study|Sponsor decision|0|||
94540231|NCT00931723|323774074|FG000|Overall Study|Late hospital discharge|1|||
94540232|NCT00931723|323774075|FG001|Overall Study|Late hospital discharge|0|||
94540233|NCT01238835|323774076|FG000|Overall Study|Death|124|||
94540234|NCT01238835|323774076|FG000|Overall Study|Withdrawal by Subject|9|||
94540235|NCT01238835|323774076|FG000|Overall Study|Lost to Follow-up|1|||
94540236|NCT01238835|323774076|FG000|Overall Study|Site early discontinuation|2|||
94540237|NCT00772369|323774077|FG000|Overall Study|Did not return record release form|1|||
94540238|NCT00554619|323774078|FG000|Overall Study|Adverse Event|1|||
94540239|NCT00554619|323774078|FG000|Overall Study|Physician Decision|1|||
94540240|NCT00554619|323774078|FG000|Overall Study|Liver Function Test Abnormality|1|||
94540241|NCT03242772|323774080|FG000|Overall Study|Lost to Follow-up|2|||
94540242|NCT03242772|323774081|FG001|Overall Study|Lost to Follow-up|0|||
94540243|NCT03242772|323774080|FG000|Overall Study|Physician Decision|0|||
94540244|NCT03242772|323774081|FG001|Overall Study|Physician Decision|1|||
94540245|NCT03242772|323774080|FG000|Overall Study|Withdrawal by Subject|1|||
94540246|NCT03242772|323774081|FG001|Overall Study|Withdrawal by Subject|0|||
94540247|NCT00916058|323774088|FG000|Phase 1|Screen Failure|0|||
94540248|NCT00916058|323774089|FG001|Phase 1|Screen Failure|0|||
94540249|NCT00916058|323774090|FG002|Phase 1|Screen Failure|0|||
94540250|NCT00916058|323774091|FG003|Phase 1|Screen Failure|0|||
94540251|NCT00916058|323774092|FG004|Phase 1|Screen Failure|0|||
94540252|NCT00916058|323774093|FG005|Phase 1|Screen Failure|1|||
94540253|NCT00916058|323774094|FG006|Phase 1|Screen Failure|0|||
94540254|NCT00916058|323774088|FG000|Phase 2|Screen Failure|0|||
94540255|NCT00916058|323774089|FG001|Phase 2|Screen Failure|0|||
94540256|NCT00916058|323774090|FG002|Phase 2|Screen Failure|0|||
94540257|NCT00916058|323774091|FG003|Phase 2|Screen Failure|0|||
94540258|NCT00916058|323774092|FG004|Phase 2|Screen Failure|0|||
94540259|NCT00916058|323774093|FG005|Phase 2|Screen Failure|0|||
94540260|NCT00916058|323774094|FG006|Phase 2|Screen Failure|3|||
94540261|NCT00871117|323774095|FG000|Overall Study|Lost to Follow-up|5|||
94540262|NCT00871117|323774096|FG001|Overall Study|Lost to Follow-up|6|||
94540263|NCT00871117|323774095|FG000|Overall Study|Other|0|||
94540264|NCT00871117|323774096|FG001|Overall Study|Other|4|||
94540265|NCT00241631|323774097|FG000|Run in (2 Weeks)|Physician Decision|3|||
94540266|NCT00241631|323774098|FG001|Run in (2 Weeks)|Physician Decision|3|||
94540267|NCT00241631|323774097|FG000|Phase 1 (4 Weeks)|sore throat|1|||
94540268|NCT00241631|323774098|FG001|Phase 1 (4 Weeks)|sore throat|0|||
94540269|NCT00241631|323774097|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
94540270|NCT00241631|323774098|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
94540271|NCT00241631|323774097|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
94540272|NCT00241631|323774098|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
94540273|NCT00241631|323774097|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
94540274|NCT00241631|323774098|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
94540275|NCT03385265|323774099|FG000|Overall Study|Withdrawal by Subject|5|||
94540276|NCT03385265|323774100|FG001|Overall Study|Withdrawal by Subject|2|||
94540277|NCT03385265|323774101|FG002|Overall Study|Withdrawal by Subject|5|||
94540278|NCT03385265|323774102|FG003|Overall Study|Withdrawal by Subject|2|||
94540279|NCT02437305|323774103|FG000|Overall Study|Lost to Follow-up|18|||
94540280|NCT02437305|323774104|FG001|Overall Study|Lost to Follow-up|12|||
94540281|NCT01396265|323774115|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
94540282|NCT03158012|323774116|FG000|Overall Study|Withdrawal by Subject|0|||
94540283|NCT03158012|323774117|FG001|Overall Study|Withdrawal by Subject|1|||
94540284|NCT01598753|323774118|FG000|Overall Study|Adverse Event|1|||
94540285|NCT01598753|323774119|FG001|Overall Study|Adverse Event|9|||
94540286|NCT01598753|323774120|FG002|Overall Study|Adverse Event|1|||
94540287|NCT01598753|323774121|FG003|Overall Study|Adverse Event|7|||
94540288|NCT01598753|323774118|FG000|Overall Study|Lost to Follow-up|4|||
94540289|NCT01598753|323774119|FG001|Overall Study|Lost to Follow-up|3|||
94540290|NCT01598753|323774120|FG002|Overall Study|Lost to Follow-up|7|||
94540291|NCT01598753|323774121|FG003|Overall Study|Lost to Follow-up|5|||
94540292|NCT01598753|323774118|FG000|Overall Study|Physician Decision|0|||
94540293|NCT01598753|323774119|FG001|Overall Study|Physician Decision|1|||
94540294|NCT01598753|323774120|FG002|Overall Study|Physician Decision|0|||
94540295|NCT01598753|323774121|FG003|Overall Study|Physician Decision|2|||
94540296|NCT01598753|323774118|FG000|Overall Study|Withdrawal by Subject|7|||
94540297|NCT01598753|323774119|FG001|Overall Study|Withdrawal by Subject|2|||
94540298|NCT01598753|323774120|FG002|Overall Study|Withdrawal by Subject|0|||
94540299|NCT01598753|323774121|FG003|Overall Study|Withdrawal by Subject|1|||
94540300|NCT01852825|323774122|FG000|Overall Study|Withdrawal by Subject|2|||
94540301|NCT01852825|323774123|FG001|Overall Study|Withdrawal by Subject|0|||
94540302|NCT01852825|323774124|FG002|Overall Study|Withdrawal by Subject|0|||
94540303|NCT00405964|323774131|FG000|Overall Study|Treatment Failure|17|||
94540304|NCT00405964|323774132|FG001|Overall Study|Treatment Failure|45|||
94540305|NCT00405964|323774131|FG000|Overall Study|Adverse Event|7|||
94540306|NCT00405964|323774132|FG001|Overall Study|Adverse Event|16|||
94540307|NCT00405964|323774131|FG000|Overall Study|Lost to Follow-up|5|||
94540308|NCT00405964|323774132|FG001|Overall Study|Lost to Follow-up|5|||
94540309|NCT00405964|323774131|FG000|Overall Study|Withdrawal by Subject|19|||
94540310|NCT00405964|323774132|FG001|Overall Study|Withdrawal by Subject|23|||
94540311|NCT00405964|323774131|FG000|Overall Study|Protocol Violation|11|||
94540312|NCT00405964|323774132|FG001|Overall Study|Protocol Violation|6|||
94540313|NCT02305849|323774135|FG000|Overall Study|Adverse Event|10|||
94540314|NCT02305849|323774136|FG001|Overall Study|Adverse Event|12|||
94540315|NCT02305849|323774137|FG002|Overall Study|Adverse Event|7|||
94540316|NCT02305849|323774138|FG003|Overall Study|Adverse Event|3|||
94540317|NCT02305849|323774135|FG000|Overall Study|Lack of Efficacy|10|||
94540318|NCT02305849|323774136|FG001|Overall Study|Lack of Efficacy|6|||
94540319|NCT02305849|323774137|FG002|Overall Study|Lack of Efficacy|3|||
94540320|NCT02305849|323774138|FG003|Overall Study|Lack of Efficacy|9|||
94540321|NCT02305849|323774135|FG000|Overall Study|Withdrawal by Subject|2|||
94540322|NCT02305849|323774136|FG001|Overall Study|Withdrawal by Subject|2|||
94540323|NCT02305849|323774137|FG002|Overall Study|Withdrawal by Subject|1|||
94540324|NCT02305849|323774138|FG003|Overall Study|Withdrawal by Subject|4|||
94540325|NCT02305849|323774135|FG000|Overall Study|Lost to Follow-up|0|||
94540326|NCT02305849|323774136|FG001|Overall Study|Lost to Follow-up|2|||
94540327|NCT02305849|323774137|FG002|Overall Study|Lost to Follow-up|0|||
94540328|NCT02305849|323774138|FG003|Overall Study|Lost to Follow-up|0|||
94540329|NCT02305849|323774135|FG000|Overall Study|Protocol Violation|3|||
94540330|NCT02305849|323774136|FG001|Overall Study|Protocol Violation|2|||
94540331|NCT02305849|323774137|FG002|Overall Study|Protocol Violation|1|||
94540332|NCT02305849|323774138|FG003|Overall Study|Protocol Violation|1|||
94540333|NCT02305849|323774135|FG000|Overall Study|Lab data met discontinuation criteria|0|||
94540334|NCT02305849|323774136|FG001|Overall Study|Lab data met discontinuation criteria|1|||
94540335|NCT02305849|323774137|FG002|Overall Study|Lab data met discontinuation criteria|2|||
94540336|NCT02305849|323774138|FG003|Overall Study|Lab data met discontinuation criteria|1|||
94540337|NCT02305849|323774135|FG000|Overall Study|Miscellaneous|1|||
94540338|NCT02305849|323774136|FG001|Overall Study|Miscellaneous|2|||
94540339|NCT02305849|323774137|FG002|Overall Study|Miscellaneous|4|||
94540340|NCT02305849|323774138|FG003|Overall Study|Miscellaneous|1|||
94540341|NCT02305849|323774135|FG000|Overall Study|Not fulfill eligibility criteria|1|||
94540342|NCT02305849|323774136|FG001|Overall Study|Not fulfill eligibility criteria|1|||
94540343|NCT02305849|323774137|FG002|Overall Study|Not fulfill eligibility criteria|0|||
94540344|NCT02305849|323774138|FG003|Overall Study|Not fulfill eligibility criteria|0|||
94540345|NCT02649855|323774139|FG000|Overall Study|Refused further treatment|2|||
94540346|NCT02649855|323774140|FG001|Overall Study|Refused further treatment|1|||
94540347|NCT02649855|323774141|FG002|Overall Study|Refused further treatment|1|||
94540348|NCT02649855|323774139|FG000|Overall Study|Withdrew consent|0|||
94540349|NCT02649855|323774140|FG001|Overall Study|Withdrew consent|1|||
94540350|NCT02649855|323774141|FG002|Overall Study|Withdrew consent|0|||
94540351|NCT02649855|323774139|FG000|Overall Study|Switched to alternative treatment|0|||
94540352|NCT02649855|323774140|FG001|Overall Study|Switched to alternative treatment|1|||
94540353|NCT02649855|323774141|FG002|Overall Study|Switched to alternative treatment|1|||
94540354|NCT02649855|323774139|FG000|Overall Study|Principal investigator discretion|0|||
94540355|NCT02649855|323774140|FG001|Overall Study|Principal investigator discretion|1|||
94540356|NCT02649855|323774141|FG002|Overall Study|Principal investigator discretion|1|||
94540357|NCT02649855|323774139|FG000|Overall Study|No treatment, per protocol|1|||
94540358|NCT02649855|323774140|FG001|Overall Study|No treatment, per protocol|0|||
94540359|NCT02649855|323774141|FG002|Overall Study|No treatment, per protocol|0|||
94540360|NCT02649855|323774139|FG000|Overall Study|Initiate new treatment|1|||
94540361|NCT02649855|323774140|FG001|Overall Study|Initiate new treatment|0|||
94540362|NCT02649855|323774141|FG002|Overall Study|Initiate new treatment|0|||
94540363|NCT01154283|323774142|FG000|0-6 Weeks|Withdrawal by Subject|7|||
94540364|NCT01154283|323774143|FG001|0-6 Weeks|Withdrawal by Subject|2|||
94540365|NCT01154283|323774142|FG000|0-6 Weeks|Death|0|||
94540366|NCT01154283|323774143|FG001|0-6 Weeks|Death|1|||
94540367|NCT01154283|323774142|FG000|7-12 Weeks|Death|1|||
94540368|NCT01154283|323774143|FG001|7-12 Weeks|Death|0|||
94540369|NCT01154283|323774142|FG000|7-12 Weeks|Withdrawal by Subject|0|||
94540370|NCT01154283|323774143|FG001|7-12 Weeks|Withdrawal by Subject|1|||
94540371|NCT04070326|323774146|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
94540372|NCT04070326|323774147|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
94540373|NCT04096820|323774148|FG000|Overall Study|Did not return for intervention|2|||
94540374|NCT04096820|323774148|FG000|Overall Study|Death|1|||
94540375|NCT02279719|323774149|FG000|Overall Study|Patients randomized but never treated|0|||
94540376|NCT02279719|323774150|FG001|Overall Study|Patients randomized but never treated|0|||
94540377|NCT02279719|323774151|FG002|Overall Study|Patients randomized but never treated|0|||
94540378|NCT02279719|323774152|FG003|Overall Study|Patients randomized but never treated|0|||
94540379|NCT02279719|323774153|FG004|Overall Study|Patients randomized but never treated|3|||
94540380|NCT02279719|323774154|FG005|Overall Study|Patients randomized but never treated|0|||
94540381|NCT02279719|323774155|FG006|Overall Study|Patients randomized but never treated|3|||
94540382|NCT00846040|323774156|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
94540383|NCT00846040|323774157|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
94540384|NCT00846040|323774158|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
94540385|NCT00846040|323774156|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
94540386|NCT00846040|323774157|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
94540387|NCT00846040|323774158|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
94540388|NCT00546260|323774159|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
94540389|NCT00546260|323774160|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
94540390|NCT02725593|323774163|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
94540391|NCT02725593|323774164|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
94540392|NCT02725593|323774163|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
94540393|NCT02725593|323774164|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
94540394|NCT02725593|323774163|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
94540395|NCT02725593|323774164|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
94540396|NCT02725593|323774163|FG000|Long Term Extension|Withdrawal by Subject|1|||
94540397|NCT02725593|323774164|FG001|Long Term Extension|Withdrawal by Subject|3|||
94540398|NCT03356977|323776114|FG000|Overall Study|Lost to Follow-up|3|||
94540399|NCT03356977|323776114|FG000|Overall Study|Withdrawal by parent/guardian|2|||
94540400|NCT03812185|323776117|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
94540401|NCT01921218|323776120|FG000|Overall Study|Death|2|||
94540402|NCT01921218|323776121|FG001|Overall Study|Death|1|||
94540403|NCT01921218|323776120|FG000|Overall Study|Withdrawal by Subject|0|||
94540404|NCT01921218|323776121|FG001|Overall Study|Withdrawal by Subject|2|||
94540405|NCT01921218|323776120|FG000|Overall Study|Kidney transplant|1|||
94540406|NCT01921218|323776121|FG001|Overall Study|Kidney transplant|1|||
94540407|NCT01529515|323776122|FG000|TRANSITION PHASE|Adverse Event|16|||
94540408|NCT01529515|323776123|FG001|TRANSITION PHASE|Adverse Event|0|||
94540409|NCT01529515|323776124|FG002|TRANSITION PHASE|Adverse Event|0|||
94540410|NCT01529515|323776125|FG003|TRANSITION PHASE|Adverse Event|0|||
94540411|NCT01529515|323776122|FG000|TRANSITION PHASE|Death|1|||
94540412|NCT01529515|323776123|FG001|TRANSITION PHASE|Death|0|||
94540413|NCT01529515|323776124|FG002|TRANSITION PHASE|Death|0|||
94540414|NCT01529515|323776125|FG003|TRANSITION PHASE|Death|0|||
94540415|NCT01529515|323776122|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
94540416|NCT01529515|323776123|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
94540417|NCT01529515|323776124|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
94540418|NCT01529515|323776125|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
94540419|NCT01529515|323776122|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
94540420|NCT01529515|323776123|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
94540421|NCT01529515|323776124|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
94540422|NCT01529515|323776125|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
94540423|NCT01529515|323776122|FG000|TRANSITION PHASE|Protocol Violation|4|||
94540424|NCT01529515|323776123|FG001|TRANSITION PHASE|Protocol Violation|0|||
94540425|NCT01529515|323776124|FG002|TRANSITION PHASE|Protocol Violation|0|||
94540426|NCT01529515|323776125|FG003|TRANSITION PHASE|Protocol Violation|0|||
94540427|NCT01529515|323776122|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
94540428|NCT01529515|323776123|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
94540429|NCT01529515|323776124|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
94540430|NCT01529515|323776125|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
94540431|NCT01529515|323776122|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
94540432|NCT01529515|323776123|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
94540433|NCT01529515|323776124|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
94540434|NCT01529515|323776125|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
94540435|NCT01529515|323776122|FG000|TRANSITION PHASE|Other|9|||
94540436|NCT01529515|323776123|FG001|TRANSITION PHASE|Other|0|||
94540437|NCT01529515|323776124|FG002|TRANSITION PHASE|Other|0|||
94540438|NCT01529515|323776125|FG003|TRANSITION PHASE|Other|0|||
94540439|NCT01529515|323776122|FG000|MAINTENANCE PHASE|Adverse Event|0|||
94540440|NCT01529515|323776123|FG001|MAINTENANCE PHASE|Adverse Event|10|||
94540441|NCT01529515|323776124|FG002|MAINTENANCE PHASE|Adverse Event|0|||
94540442|NCT01529515|323776125|FG003|MAINTENANCE PHASE|Adverse Event|0|||
94540443|NCT01529515|323776122|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
94540444|NCT01529515|323776123|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
94540445|NCT01529515|323776124|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
94540446|NCT01529515|323776125|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
94540447|NCT01529515|323776122|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
94540448|NCT01529515|323776123|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
94540449|NCT01529515|323776124|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
94540450|NCT01529515|323776125|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
94540451|NCT01529515|323776122|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
94540452|NCT01529515|323776123|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
94540453|NCT01529515|323776124|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
94540454|NCT01529515|323776125|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
94540455|NCT01529515|323776122|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
94540456|NCT01529515|323776123|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
94540457|NCT01529515|323776124|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
94540458|NCT01529515|323776125|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
94540459|NCT01529515|323776122|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
94540460|NCT01529515|323776123|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
94540461|NCT01529515|323776124|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
94540462|NCT01529515|323776125|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
94540463|NCT01529515|323776122|FG000|MAINTENANCE PHASE|Other|0|||
94540464|NCT01529515|323776123|FG001|MAINTENANCE PHASE|Other|10|||
94540465|NCT01529515|323776124|FG002|MAINTENANCE PHASE|Other|0|||
94540466|NCT01529515|323776125|FG003|MAINTENANCE PHASE|Other|0|||
94540467|NCT01529515|323776122|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
94540468|NCT01529515|323776123|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
94540469|NCT01529515|323776124|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
94540470|NCT01529515|323776125|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
94540471|NCT01529515|323776122|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
94540472|NCT01529515|323776123|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
94540473|NCT01529515|323776124|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
94540474|NCT01529515|323776125|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
94540475|NCT01529515|323776122|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
94540476|NCT01529515|323776123|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
94540477|NCT01529515|323776124|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
94540478|NCT01529515|323776125|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
94540479|NCT01529515|323776122|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
94540480|NCT01529515|323776123|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
94540481|NCT01529515|323776124|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
94540482|NCT01529515|323776125|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
94540483|NCT01529515|323776122|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
94540484|NCT01529515|323776123|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
94540485|NCT01529515|323776124|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
94540486|NCT01529515|323776125|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
94540487|NCT01529515|323776122|FG000|DOUBLE BLIND PHASE|Other|0|||
94540488|NCT01529515|323776123|FG001|DOUBLE BLIND PHASE|Other|0|||
94540489|NCT01529515|323776124|FG002|DOUBLE BLIND PHASE|Other|9|||
94540490|NCT01529515|323776125|FG003|DOUBLE BLIND PHASE|Other|2|||
94540491|NCT03334851|323776126|FG000|Overall Study|Other|0|||
94540492|NCT03334851|323776127|FG001|Overall Study|Other|0|||
94540493|NCT03334851|323776128|FG002|Overall Study|Other|0|||
94540494|NCT03334851|323776129|FG003|Overall Study|Other|0|||
94540495|NCT03334851|323776130|FG004|Overall Study|Other|0|||
94540496|NCT03334851|323776131|FG005|Overall Study|Other|0|||
94540497|NCT03334851|323776132|FG006|Overall Study|Other|0|||
94540498|NCT03334851|323776133|FG007|Overall Study|Other|1|||
94540499|NCT03334851|323776134|FG008|Overall Study|Other|0|||
94540500|NCT03334851|323776135|FG009|Overall Study|Other|0|||
94540501|NCT03334851|323776136|FG010|Overall Study|Other|0|||
94540502|NCT03334851|323776137|FG011|Overall Study|Other|0|||
94540503|NCT03334851|323776138|FG012|Overall Study|Other|0|||
94540504|NCT03334851|323776126|FG000|Overall Study|Adverse Event|0|||
94540505|NCT03334851|323776127|FG001|Overall Study|Adverse Event|0|||
94540506|NCT03334851|323776128|FG002|Overall Study|Adverse Event|0|||
94540507|NCT03334851|323776129|FG003|Overall Study|Adverse Event|0|||
94540508|NCT03334851|323776130|FG004|Overall Study|Adverse Event|0|||
94540509|NCT03334851|323776131|FG005|Overall Study|Adverse Event|0|||
94540510|NCT03334851|323776132|FG006|Overall Study|Adverse Event|0|||
94540511|NCT03334851|323776133|FG007|Overall Study|Adverse Event|1|||
94540512|NCT03334851|323776134|FG008|Overall Study|Adverse Event|0|||
94540513|NCT03334851|323776135|FG009|Overall Study|Adverse Event|0|||
94540514|NCT03334851|323776136|FG010|Overall Study|Adverse Event|0|||
94540515|NCT03334851|323776137|FG011|Overall Study|Adverse Event|0|||
94540516|NCT03334851|323776138|FG012|Overall Study|Adverse Event|0|||
94540517|NCT03334851|323776126|FG000|Overall Study|Withdrawal by Subject|0|||
94540518|NCT03334851|323776127|FG001|Overall Study|Withdrawal by Subject|0|||
94540519|NCT03334851|323776128|FG002|Overall Study|Withdrawal by Subject|0|||
94540520|NCT03334851|323776129|FG003|Overall Study|Withdrawal by Subject|0|||
94540521|NCT03334851|323776130|FG004|Overall Study|Withdrawal by Subject|0|||
94540522|NCT03334851|323776131|FG005|Overall Study|Withdrawal by Subject|0|||
94540523|NCT03334851|323776132|FG006|Overall Study|Withdrawal by Subject|0|||
94540524|NCT03334851|323776133|FG007|Overall Study|Withdrawal by Subject|0|||
94540525|NCT03334851|323776134|FG008|Overall Study|Withdrawal by Subject|0|||
94540526|NCT03334851|323776135|FG009|Overall Study|Withdrawal by Subject|0|||
94540527|NCT03334851|323776136|FG010|Overall Study|Withdrawal by Subject|1|||
94540528|NCT03334851|323776137|FG011|Overall Study|Withdrawal by Subject|0|||
94540529|NCT03334851|323776138|FG012|Overall Study|Withdrawal by Subject|1|||
94540530|NCT03334851|323776126|FG000|Overall Study|Lost to Follow-up|0|||
94540531|NCT03334851|323776127|FG001|Overall Study|Lost to Follow-up|0|||
94540532|NCT03334851|323776128|FG002|Overall Study|Lost to Follow-up|0|||
94540533|NCT03334851|323776129|FG003|Overall Study|Lost to Follow-up|0|||
94540534|NCT03334851|323776130|FG004|Overall Study|Lost to Follow-up|0|||
94540535|NCT03334851|323776131|FG005|Overall Study|Lost to Follow-up|0|||
94540536|NCT03334851|323776132|FG006|Overall Study|Lost to Follow-up|0|||
94540537|NCT03334851|323776133|FG007|Overall Study|Lost to Follow-up|0|||
94540538|NCT03334851|323776134|FG008|Overall Study|Lost to Follow-up|0|||
94540539|NCT03334851|323776135|FG009|Overall Study|Lost to Follow-up|0|||
94540540|NCT03334851|323776136|FG010|Overall Study|Lost to Follow-up|2|||
94540541|NCT03334851|323776137|FG011|Overall Study|Lost to Follow-up|1|||
94540542|NCT03334851|323776138|FG012|Overall Study|Lost to Follow-up|0|||
94540543|NCT03272828|323776139|FG000|Overall Study|Lost to Follow-up|7|||
94540544|NCT03272828|323776140|FG001|Overall Study|Lost to Follow-up|7|||
94540545|NCT03272828|323776139|FG000|Overall Study|Withdrawal by Subject|2|||
94540546|NCT03272828|323776140|FG001|Overall Study|Withdrawal by Subject|0|||
94540547|NCT03272828|323776139|FG000|Overall Study|Deceased|1|||
94540548|NCT03272828|323776140|FG001|Overall Study|Deceased|1|||
94540549|NCT03272828|323776139|FG000|Overall Study|Failed implant|1|||
94540550|NCT03272828|323776140|FG001|Overall Study|Failed implant|2|||
94540551|NCT00642369|323776141|FG000|Overall Study|Adverse Event|2|||
94540552|NCT00642369|323776142|FG001|Overall Study|Adverse Event|3|||
94540553|NCT00642369|323776141|FG000|Overall Study|Withdrawal by Subject|1|||
94540554|NCT00642369|323776142|FG001|Overall Study|Withdrawal by Subject|0|||
94540555|NCT00642369|323776141|FG000|Overall Study|misdiagnosis|0|||
94540556|NCT00642369|323776142|FG001|Overall Study|misdiagnosis|1|||
94540557|NCT00642369|323776141|FG000|Overall Study|Lack of Efficacy|2|||
94540558|NCT00642369|323776142|FG001|Overall Study|Lack of Efficacy|2|||
94540559|NCT00354107|323776143|FG000|Overall Study|Adverse Event|2|||
94540560|NCT00354107|323776143|FG000|Overall Study|Physician Decision|2|||
94540561|NCT00354107|323776143|FG000|Overall Study|Withdrawal by Subject|1|||
94540562|NCT02075047|323776145|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
94540563|NCT02075047|323776146|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
94540564|NCT02075047|323776145|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
94540565|NCT02075047|323776146|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
94540566|NCT02075047|323776145|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
94540567|NCT02075047|323776146|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
94540568|NCT02075047|323776145|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
94540569|NCT02075047|323776146|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
94540570|NCT02075047|323776145|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
94540571|NCT02075047|323776146|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
94540572|NCT02075047|323776145|FG000|Treatment Phase (4 Weeks)|Other|1|||
94540573|NCT02075047|323776146|FG001|Treatment Phase (4 Weeks)|Other|1|||
94540574|NCT02075047|323776145|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
94540575|NCT02075047|323776146|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
94540576|NCT02075047|323776145|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
94540577|NCT02075047|323776146|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
94540578|NCT02075047|323776145|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
94540579|NCT02075047|323776146|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
94540580|NCT02075047|323776145|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
94540581|NCT02075047|323776146|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
94540582|NCT02075047|323776145|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
94540583|NCT02075047|323776146|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
94540584|NCT02075047|323776145|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
94540585|NCT02075047|323776146|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
94540586|NCT02075047|323776145|FG000|Follow up Phase (5 Weeks)|Other|1|||
94540587|NCT02075047|323776146|FG001|Follow up Phase (5 Weeks)|Other|2|||
94540588|NCT02075047|323776145|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
94540589|NCT02075047|323776146|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
94540590|NCT01344538|323776147|FG000|Overall Study|Adverse Event|1|||
94540591|NCT01344538|323776148|FG001|Overall Study|Adverse Event|1|||
94540592|NCT01344538|323776147|FG000|Overall Study|Lost to Follow-up|1|||
94540593|NCT01344538|323776148|FG001|Overall Study|Lost to Follow-up|0|||
94540594|NCT04979897|323776149|FG000|Overall Study|Death|1|||
94540595|NCT04979897|323776150|FG001|Overall Study|Death|8|||
94540596|NCT04979897|323776149|FG000|Overall Study|Lost to Follow-up|111|||
94540597|NCT04979897|323776150|FG001|Overall Study|Lost to Follow-up|56|||
94540598|NCT04979897|323776149|FG000|Overall Study|Withdrawal by Subject|7|||
94540599|NCT04979897|323776150|FG001|Overall Study|Withdrawal by Subject|2|||
94540600|NCT01818258|323776151|FG000|Overall Study|Death|3|||
94540601|NCT01818258|323776152|FG001|Overall Study|Death|0|||
94540602|NCT01818258|323776151|FG000|Overall Study|Withdrawal by Subject|0|||
94540603|NCT01818258|323776152|FG001|Overall Study|Withdrawal by Subject|1|||
94540604|NCT01818258|323776151|FG000|Overall Study|Lost to Follow-up|0|||
94540605|NCT01818258|323776152|FG001|Overall Study|Lost to Follow-up|1|||
94540606|NCT01818258|323776151|FG000|Overall Study|Unable to Travel to Clinic|0|||
94540607|NCT01818258|323776152|FG001|Overall Study|Unable to Travel to Clinic|1|||
94540608|NCT02780856|323776154|FG000|Overall Study|Lost to Follow-up|1|||
94540609|NCT03640052|323776158|FG000|Overall Study|Lost to Follow-up|0|||
94540610|NCT03640052|323776159|FG001|Overall Study|Lost to Follow-up|1|||
94540611|NCT03640052|323776160|FG002|Overall Study|Lost to Follow-up|0|||
94540612|NCT03640052|323776161|FG003|Overall Study|Lost to Follow-up|0|||
94540613|NCT03640052|323776162|FG004|Overall Study|Lost to Follow-up|0|||
94540614|NCT02536300|323776163|FG000|Overall Study|Investigator's Discretion|17|||
94540615|NCT02536300|323776164|FG001|Overall Study|Investigator's Discretion|11|||
94540616|NCT02536300|323776165|FG002|Overall Study|Investigator's Discretion|2|||
94540617|NCT02536300|323776163|FG000|Overall Study|Progressive Disease|11|||
94540618|NCT02536300|323776164|FG001|Overall Study|Progressive Disease|7|||
94540619|NCT02536300|323776165|FG002|Overall Study|Progressive Disease|6|||
94540620|NCT02536300|323776163|FG000|Overall Study|Study Terminated by Sponsor|6|||
94540621|NCT02536300|323776164|FG001|Overall Study|Study Terminated by Sponsor|4|||
94540622|NCT02536300|323776165|FG002|Overall Study|Study Terminated by Sponsor|7|||
94540623|NCT02536300|323776163|FG000|Overall Study|Death|7|||
94540624|NCT02536300|323776164|FG001|Overall Study|Death|0|||
94540625|NCT02536300|323776165|FG002|Overall Study|Death|5|||
94540626|NCT02536300|323776163|FG000|Overall Study|Withdrew Consent|4|||
94540627|NCT02536300|323776164|FG001|Overall Study|Withdrew Consent|2|||
94540628|NCT02536300|323776165|FG002|Overall Study|Withdrew Consent|0|||
94540629|NCT02536300|323776163|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
94540630|NCT02536300|323776164|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
94540631|NCT02536300|323776165|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
94540632|NCT02536300|323776163|FG000|Overall Study|Enrolled but Never Treated|0|||
94540633|NCT02536300|323776164|FG001|Overall Study|Enrolled but Never Treated|0|||
94540634|NCT02536300|323776165|FG002|Overall Study|Enrolled but Never Treated|1|||
94540635|NCT02536300|323776163|FG000|Overall Study|Non-compliance With Study Drug|1|||
94540636|NCT02536300|323776164|FG001|Overall Study|Non-compliance With Study Drug|0|||
94540637|NCT02536300|323776165|FG002|Overall Study|Non-compliance With Study Drug|0|||
94540638|NCT02536300|323776163|FG000|Overall Study|Protocol Violation|0|||
94540639|NCT02536300|323776164|FG001|Overall Study|Protocol Violation|1|||
94540640|NCT02536300|323776165|FG002|Overall Study|Protocol Violation|0|||
94540641|NCT02240368|323776173|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
94540642|NCT02240368|323776174|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
94540643|NCT02240368|323776175|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
94540644|NCT02240368|323776173|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
94540645|NCT02240368|323776174|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
94540646|NCT02240368|323776175|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
94540647|NCT04612842|323776176|FG000|Overall Study|Lost to Follow-up|20|||
94540648|NCT04612842|323776177|FG001|Overall Study|Lost to Follow-up|11|||
94540649|NCT04612842|323776176|FG000|Overall Study|Withdrawal by Subject|26|||
94540650|NCT04612842|323776177|FG001|Overall Study|Withdrawal by Subject|15|||
94540651|NCT04612842|323776176|FG000|Overall Study|Death|2|||
94540652|NCT04612842|323776177|FG001|Overall Study|Death|2|||
94540653|NCT04677660|323776178|FG000|Overall Study|Lost to Follow-up|0|||
94540654|NCT04677660|323776179|FG001|Overall Study|Lost to Follow-up|2|||
94540655|NCT04677660|323776178|FG000|Overall Study|Withdrawal by Subject|0|||
94540656|NCT04677660|323776179|FG001|Overall Study|Withdrawal by Subject|1|||
94540657|NCT04677660|323776178|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
94540658|NCT04677660|323776179|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
94540659|NCT03060512|323776180|FG000|Overall Study|Adverse Event|4|||
94540660|NCT03060512|323776181|FG001|Overall Study|Adverse Event|6|||
94540661|NCT03060512|323776180|FG000|Overall Study|Lost to Follow-up|1|||
94540662|NCT03060512|323776181|FG001|Overall Study|Lost to Follow-up|1|||
94540663|NCT03060512|323776180|FG000|Overall Study|Withdrawal by Subject|1|||
94540664|NCT03060512|323776181|FG001|Overall Study|Withdrawal by Subject|0|||
94540665|NCT03060512|323776180|FG000|Overall Study|Non-compliance with study medication|1|||
94540666|NCT03060512|323776181|FG001|Overall Study|Non-compliance with study medication|2|||
94540667|NCT01218100|323776183|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
94540668|NCT01218100|323776184|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
94540669|NCT01218100|323776185|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
94540670|NCT01218100|323776186|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
94540671|NCT01218100|323776183|FG000|Overall Study|Adverse Event|4|||
94540672|NCT01218100|323776184|FG001|Overall Study|Adverse Event|6|||
94540673|NCT01218100|323776185|FG002|Overall Study|Adverse Event|6|||
94540674|NCT01218100|323776186|FG003|Overall Study|Adverse Event|7|||
94540675|NCT01218100|323776183|FG000|Overall Study|Lack of Efficacy|9|||
94540676|NCT01218100|323776184|FG001|Overall Study|Lack of Efficacy|6|||
94540677|NCT01218100|323776185|FG002|Overall Study|Lack of Efficacy|5|||
94540678|NCT01218100|323776186|FG003|Overall Study|Lack of Efficacy|12|||
94540679|NCT01218100|323776183|FG000|Overall Study|Protocol Violation|0|||
94540680|NCT01218100|323776184|FG001|Overall Study|Protocol Violation|0|||
94540681|NCT01218100|323776185|FG002|Overall Study|Protocol Violation|1|||
94540682|NCT01218100|323776186|FG003|Overall Study|Protocol Violation|1|||
94540683|NCT01218100|323776183|FG000|Overall Study|Withdrawal by Subject|5|||
94540684|NCT01218100|323776184|FG001|Overall Study|Withdrawal by Subject|2|||
94540685|NCT01218100|323776185|FG002|Overall Study|Withdrawal by Subject|6|||
94540686|NCT01218100|323776186|FG003|Overall Study|Withdrawal by Subject|7|||
94540687|NCT01218100|323776183|FG000|Overall Study|Lost to Follow-up|3|||
94540688|NCT01218100|323776184|FG001|Overall Study|Lost to Follow-up|8|||
94540689|NCT01218100|323776185|FG002|Overall Study|Lost to Follow-up|2|||
94540690|NCT01218100|323776186|FG003|Overall Study|Lost to Follow-up|1|||
94540691|NCT01218100|323776183|FG000|Overall Study|Other Reason|2|||
94540692|NCT01218100|323776184|FG001|Overall Study|Other Reason|2|||
94540693|NCT01218100|323776185|FG002|Overall Study|Other Reason|6|||
94540694|NCT01218100|323776186|FG003|Overall Study|Other Reason|4|||
94540695|NCT01118520|323776187|FG000|Overall Study|AAA repair|9|||
94540696|NCT01118520|323776188|FG001|Overall Study|AAA repair|7|||
94540697|NCT01118520|323776189|FG002|Overall Study|AAA repair|9|||
94540698|NCT01118520|323776187|FG000|Overall Study|Adverse Event|3|||
94540699|NCT01118520|323776188|FG001|Overall Study|Adverse Event|3|||
94540700|NCT01118520|323776189|FG002|Overall Study|Adverse Event|3|||
94540701|NCT01118520|323776187|FG000|Overall Study|Withdrawal by Subject|8|||
94540702|NCT01118520|323776188|FG001|Overall Study|Withdrawal by Subject|13|||
94540703|NCT01118520|323776189|FG002|Overall Study|Withdrawal by Subject|8|||
94540704|NCT01089023|323776206|FG000|Overall Study|Lost to Follow-up|3|||
94540705|NCT01089023|323776206|FG000|Overall Study|Adverse Event|1|||
94540706|NCT01089023|323776206|FG000|Overall Study|Withdrawal by Subject|1|||
94540707|NCT01089023|323776206|FG000|Overall Study|Protocol Violation|1|||
94540708|NCT01089023|323776206|FG000|Overall Study|Lack of Efficacy|1|||
94540709|NCT01146652|323776209|FG000|Overall Study|Adverse Event|506|||
94540710|NCT01146652|323776210|FG001|Overall Study|Adverse Event|15|||
94540711|NCT01146652|323776209|FG000|Overall Study|Lack of Efficacy|91|||
94540712|NCT01146652|323776210|FG001|Overall Study|Lack of Efficacy|7|||
94540713|NCT01146652|323776209|FG000|Overall Study|Poor compliance to protocol|38|||
94540714|NCT01146652|323776210|FG001|Overall Study|Poor compliance to protocol|1|||
94540715|NCT01146652|323776209|FG000|Overall Study|Other unspecified reasons|314|||
94540716|NCT01146652|323776210|FG001|Overall Study|Other unspecified reasons|22|||
94540717|NCT01146652|323776209|FG000|Overall Study|Enrolled but not treated|2|||
94540718|NCT01146652|323776210|FG001|Overall Study|Enrolled but not treated|0|||
94540719|NCT04465877|323776211|FG000|Overall Study|Noncompliant with study requirements|0|||
94540720|NCT04465877|323776212|FG001|Overall Study|Noncompliant with study requirements|0|||
94540721|NCT04465877|323776213|FG002|Overall Study|Noncompliant with study requirements|1|||
94540722|NCT04465877|323776214|FG003|Overall Study|Noncompliant with study requirements|0|||
94540723|NCT03831880|323776216|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
94540724|NCT03831880|323776217|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
94540725|NCT03831880|323776216|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
94540726|NCT03831880|323776217|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
94540727|NCT03444766|323776222|FG000|Overall Study|Other Reasons|2|||
94540728|NCT03444766|323776222|FG000|Overall Study|Participant Withdrew Consent|5|||
94540729|NCT03444766|323776222|FG000|Overall Study|Lost to Follow-up|2|||
94540730|NCT03444766|323776222|FG000|Overall Study|Death|2|||
94540731|NCT03444766|323776222|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
94540732|NCT03444766|323776222|FG000|Overall Study|Disease Progression|49|||
94540733|NCT04346108|323776223|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
94540734|NCT04346108|323776224|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
94540735|NCT04346108|323776225|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
94540736|NCT04346108|323776223|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
94540737|NCT04346108|323776224|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
94540738|NCT04346108|323776225|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
94540739|NCT02788201|323776226|FG000|Overall Study|Death|1|||
94540740|NCT02788201|323776227|FG001|Overall Study|Death|1|||
94540741|NCT02788201|323776228|FG002|Overall Study|Death|1|||
94540742|NCT02788201|323776229|FG003|Overall Study|Death|1|||
94540743|NCT02788201|323776230|FG004|Overall Study|Death|0|||
94540744|NCT02788201|323776231|FG005|Overall Study|Death|1|||
94540745|NCT02788201|323776226|FG000|Overall Study|Ineligible|0|||
94540746|NCT02788201|323776227|FG001|Overall Study|Ineligible|0|||
94540747|NCT02788201|323776228|FG002|Overall Study|Ineligible|0|||
94540748|NCT02788201|323776229|FG003|Overall Study|Ineligible|0|||
94540749|NCT02788201|323776230|FG004|Overall Study|Ineligible|0|||
94540750|NCT02788201|323776231|FG005|Overall Study|Ineligible|1|||
94540751|NCT02788201|323776226|FG000|Overall Study|Withdrawal by Subject|0|||
94540752|NCT02788201|323776227|FG001|Overall Study|Withdrawal by Subject|0|||
94540753|NCT02788201|323776228|FG002|Overall Study|Withdrawal by Subject|0|||
94540754|NCT02788201|323776229|FG003|Overall Study|Withdrawal by Subject|0|||
94540755|NCT02788201|323776230|FG004|Overall Study|Withdrawal by Subject|0|||
94540756|NCT02788201|323776231|FG005|Overall Study|Withdrawal by Subject|1|||
94540757|NCT04508751|323776235|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
94540758|NCT04508751|323776236|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
94540759|NCT04508751|323776237|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
94540760|NCT01338610|323776238|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
94540761|NCT01338610|323776239|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
94540762|NCT01338610|323776240|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
94540763|NCT01338610|323776238|FG000|Overall Study|Protocol Violation|1|||
94540764|NCT01338610|323776239|FG001|Overall Study|Protocol Violation|0|||
94540765|NCT01338610|323776240|FG002|Overall Study|Protocol Violation|1|||
94540766|NCT01338610|323776238|FG000|Overall Study|Adverse Event|3|||
94540767|NCT01338610|323776239|FG001|Overall Study|Adverse Event|0|||
94540768|NCT01338610|323776240|FG002|Overall Study|Adverse Event|0|||
94540769|NCT01414205|323776241|FG000|Overall Study|Death|5|||
94540770|NCT01414205|323776242|FG001|Overall Study|Death|1|||
94540771|NCT01414205|323776241|FG000|Overall Study|Lost to Follow-up|1|||
94540772|NCT01414205|323776242|FG001|Overall Study|Lost to Follow-up|4|||
94540773|NCT01414205|323776241|FG000|Overall Study|Physician Decision|0|||
94540774|NCT01414205|323776242|FG001|Overall Study|Physician Decision|1|||
94540775|NCT01414205|323776241|FG000|Overall Study|Randomized but not Treated|1|||
94540776|NCT01414205|323776242|FG001|Overall Study|Randomized but not Treated|1|||
94540777|NCT01457950|323776243|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
94540778|NCT01457950|323776244|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
94540779|NCT01457950|323776245|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
94540780|NCT01457950|323776246|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
94540781|NCT01457950|323776243|FG000|Double-Blind Phase|Protocol Violation|2|||
94540782|NCT01457950|323776244|FG001|Double-Blind Phase|Protocol Violation|1|||
94540783|NCT01457950|323776245|FG002|Double-Blind Phase|Protocol Violation|0|||
94540784|NCT01457950|323776246|FG003|Double-Blind Phase|Protocol Violation|0|||
94540785|NCT01457950|323776243|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
94540786|NCT01457950|323776244|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
94540787|NCT01457950|323776245|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
94540788|NCT01457950|323776246|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
94540789|NCT01457950|323776243|FG000|Open-Label Phase|Adverse Event|0|||
94540790|NCT01457950|323776244|FG001|Open-Label Phase|Adverse Event|0|||
94540791|NCT01457950|323776245|FG002|Open-Label Phase|Adverse Event|0|||
94540792|NCT01457950|323776246|FG003|Open-Label Phase|Adverse Event|1|||
94540793|NCT01457950|323776243|FG000|Open-Label Phase|Protocol Violation|0|||
94540794|NCT01457950|323776244|FG001|Open-Label Phase|Protocol Violation|0|||
94540795|NCT01457950|323776245|FG002|Open-Label Phase|Protocol Violation|0|||
94540796|NCT01457950|323776246|FG003|Open-Label Phase|Protocol Violation|1|||
94540797|NCT01457950|323776243|FG000|Open-Label Phase|Withdrawal by Subject|0|||
94540798|NCT01457950|323776244|FG001|Open-Label Phase|Withdrawal by Subject|0|||
94540799|NCT01457950|323776245|FG002|Open-Label Phase|Withdrawal by Subject|2|||
94540800|NCT01457950|323776246|FG003|Open-Label Phase|Withdrawal by Subject|0|||
94540801|NCT00977938|323776249|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
94540802|NCT00977938|323776250|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
94540803|NCT00977938|323776251|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
94540804|NCT00977938|323776252|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
94540805|NCT00977938|323776249|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
94540806|NCT00977938|323776250|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
94540807|NCT00977938|323776251|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
94540808|NCT00977938|323776252|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
94540809|NCT00977938|323776249|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
94540810|NCT00977938|323776250|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
94540811|NCT00977938|323776251|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
94540812|NCT00977938|323776252|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
94540813|NCT00977938|323776249|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
94540814|NCT00977938|323776250|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
94540815|NCT00977938|323776251|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
94540816|NCT00977938|323776252|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
94540817|NCT00977938|323776249|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
94540818|NCT00977938|323776250|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
94540819|NCT00977938|323776251|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
94540820|NCT00977938|323776252|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
94540821|NCT00977938|323776249|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
94540822|NCT00977938|323776250|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
94540823|NCT00977938|323776251|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
94540824|NCT00977938|323776252|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
94540825|NCT02498067|323776253|FG000|Overall Study|Lost to Follow-up|22|||
94540826|NCT02498067|323776253|FG000|Overall Study|Did not meet inclusion criteria|11|||
94540827|NCT02142283|323776256|FG000|Overall Study|Death|20|||
94540828|NCT02142283|323776257|FG001|Overall Study|Death|18|||
94540829|NCT02142283|323776256|FG000|Overall Study|Withdrawal by Subject|1|||
94540830|NCT02142283|323776257|FG001|Overall Study|Withdrawal by Subject|3|||
94540831|NCT00747344|323776258|FG000|Controlled Period|Adverse Event|3|||
94540832|NCT00747344|323776259|FG001|Controlled Period|Adverse Event|0|||
94540833|NCT00747344|323776260|FG002|Controlled Period|Adverse Event|0|||
94540834|NCT00747344|323776261|FG003|Controlled Period|Adverse Event|0|||
94540835|NCT00747344|323776258|FG000|Controlled Period|Lack of Efficacy|2|||
94540836|NCT00747344|323776259|FG001|Controlled Period|Lack of Efficacy|1|||
94540837|NCT00747344|323776260|FG002|Controlled Period|Lack of Efficacy|0|||
94540838|NCT00747344|323776261|FG003|Controlled Period|Lack of Efficacy|0|||
94540839|NCT00747344|323776258|FG000|Controlled Period|Other|0|||
94540840|NCT00747344|323776259|FG001|Controlled Period|Other|3|||
94540841|NCT00747344|323776260|FG002|Controlled Period|Other|0|||
94540842|NCT00747344|323776261|FG003|Controlled Period|Other|0|||
94540843|NCT00747344|323776258|FG000|After Controlled Period|Adverse Event|0|||
94540844|NCT00747344|323776259|FG001|After Controlled Period|Adverse Event|0|||
94540845|NCT00747344|323776260|FG002|After Controlled Period|Adverse Event|0|||
94540846|NCT00747344|323776261|FG003|After Controlled Period|Adverse Event|1|||
94540847|NCT01646645|323776262|FG000|Overall Study|No Treated|1|||
94540848|NCT01646645|323776262|FG000|Overall Study|Inevaluable Donor|29|||
94540849|NCT02231762|323776263|FG000|Combination Phase|Adverse Event|10|||
94540850|NCT02231762|323776264|FG001|Combination Phase|Adverse Event|0|||
94540851|NCT02231762|323776265|FG002|Combination Phase|Adverse Event|0|||
94540852|NCT02231762|323776266|FG003|Combination Phase|Adverse Event|0|||
94540853|NCT02231762|323776263|FG000|Combination Phase|Withdrawal by Subject|2|||
94540854|NCT02231762|323776264|FG001|Combination Phase|Withdrawal by Subject|0|||
94540855|NCT02231762|323776265|FG002|Combination Phase|Withdrawal by Subject|0|||
94540856|NCT02231762|323776266|FG003|Combination Phase|Withdrawal by Subject|0|||
94540857|NCT02231762|323776263|FG000|Combination Phase|Disease Progression|6|||
94540858|NCT02231762|323776264|FG001|Combination Phase|Disease Progression|0|||
94540859|NCT02231762|323776265|FG002|Combination Phase|Disease Progression|0|||
94540860|NCT02231762|323776266|FG003|Combination Phase|Disease Progression|0|||
94540861|NCT02231762|323776263|FG000|Combination Phase|Did not meet inclusion criteria|1|||
94540862|NCT02231762|323776264|FG001|Combination Phase|Did not meet inclusion criteria|0|||
94540863|NCT02231762|323776265|FG002|Combination Phase|Did not meet inclusion criteria|0|||
94540864|NCT02231762|323776266|FG003|Combination Phase|Did not meet inclusion criteria|0|||
94540865|NCT02231762|323776263|FG000|Combination Phase|Protocol Violation|1|||
94540866|NCT02231762|323776264|FG001|Combination Phase|Protocol Violation|0|||
94540867|NCT02231762|323776265|FG002|Combination Phase|Protocol Violation|0|||
94540868|NCT02231762|323776266|FG003|Combination Phase|Protocol Violation|0|||
94540869|NCT02231762|323776263|FG000|Maintenance Phase|Disease progression|0|||
94540870|NCT02231762|323776264|FG001|Maintenance Phase|Disease progression|3|||
94540871|NCT02231762|323776265|FG002|Maintenance Phase|Disease progression|4|||
94540872|NCT02231762|323776266|FG003|Maintenance Phase|Disease progression|3|||
94540873|NCT02231762|323776263|FG000|Maintenance Phase|Adverse Event|0|||
94540874|NCT02231762|323776264|FG001|Maintenance Phase|Adverse Event|0|||
94540875|NCT02231762|323776265|FG002|Maintenance Phase|Adverse Event|1|||
94540876|NCT02231762|323776266|FG003|Maintenance Phase|Adverse Event|2|||
94540877|NCT02310230|323776267|FG000|Overall Study|Physician Decision|1|||
94540878|NCT02310230|323776268|FG001|Overall Study|Physician Decision|3|||
94540879|NCT02310230|323776267|FG000|Overall Study|monitor baseline taken after induction|2|||
94540880|NCT02310230|323776268|FG001|Overall Study|monitor baseline taken after induction|7|||
94540881|NCT02310230|323776267|FG000|Overall Study|Poor signal quality|5|||
94540882|NCT02310230|323776268|FG001|Overall Study|Poor signal quality|8|||
94540883|NCT02310230|323776267|FG000|Overall Study|Case cancelled|1|||
94540884|NCT02310230|323776268|FG001|Overall Study|Case cancelled|0|||
94540885|NCT01371643|323776269|FG000|Overall Study|Withdrawal by Subject|3|||
94540886|NCT01371643|323776270|FG001|Overall Study|Withdrawal by Subject|0|||
94540887|NCT00168103|323776271|FG000|Overall Study|Withdrawal by Subject|1|||
94540888|NCT00168103|323776272|FG001|Overall Study|Withdrawal by Subject|2|||
94540889|NCT00168103|323776273|FG002|Overall Study|Withdrawal by Subject|1|||
94540890|NCT00168103|323776274|FG003|Overall Study|Withdrawal by Subject|0|||
94540891|NCT00168103|323776271|FG000|Overall Study|Lost to Follow-up|1|||
94540892|NCT00168103|323776272|FG001|Overall Study|Lost to Follow-up|3|||
94540893|NCT00168103|323776273|FG002|Overall Study|Lost to Follow-up|0|||
94540894|NCT00168103|323776274|FG003|Overall Study|Lost to Follow-up|0|||
94540895|NCT02743780|323776278|FG000|Part 3 (7 Days)|Adverse Event|0|||
94540896|NCT02743780|323776279|FG001|Part 3 (7 Days)|Adverse Event|0|||
94540897|NCT02743780|323776280|FG002|Part 3 (7 Days)|Adverse Event|1|||
94540898|NCT02743780|323776281|FG003|Part 3 (7 Days)|Adverse Event|0|||
94540899|NCT02743780|323776282|FG004|Part 3 (7 Days)|Adverse Event|0|||
94540900|NCT00394901|323776283|FG000|Baseline Phase|Protocol Violation|0|||
94540901|NCT00394901|323776284|FG001|Baseline Phase|Protocol Violation|0|||
94540902|NCT00394901|323776285|FG002|Baseline Phase|Protocol Violation|1|||
94540903|NCT00394901|323776286|FG003|Baseline Phase|Protocol Violation|0|||
94540904|NCT00394901|323776283|FG000|Double-blind Phase|Adverse Event|5|||
94540905|NCT00394901|323776284|FG001|Double-blind Phase|Adverse Event|7|||
94540906|NCT00394901|323776285|FG002|Double-blind Phase|Adverse Event|16|||
94540907|NCT00394901|323776286|FG003|Double-blind Phase|Adverse Event|20|||
94540908|NCT00394901|323776283|FG000|Double-blind Phase|Lack of Efficacy|6|||
94540909|NCT00394901|323776284|FG001|Double-blind Phase|Lack of Efficacy|4|||
94540910|NCT00394901|323776285|FG002|Double-blind Phase|Lack of Efficacy|1|||
94540911|NCT00394901|323776286|FG003|Double-blind Phase|Lack of Efficacy|3|||
94540912|NCT00394901|323776283|FG000|Double-blind Phase|Withdrawal by Subject|2|||
94540913|NCT00394901|323776284|FG001|Double-blind Phase|Withdrawal by Subject|0|||
94540914|NCT00394901|323776285|FG002|Double-blind Phase|Withdrawal by Subject|0|||
94540915|NCT00394901|323776286|FG003|Double-blind Phase|Withdrawal by Subject|0|||
94540916|NCT00394901|323776283|FG000|Double-blind Phase|Lost to Follow-up|0|||
94540917|NCT00394901|323776284|FG001|Double-blind Phase|Lost to Follow-up|0|||
94540918|NCT00394901|323776285|FG002|Double-blind Phase|Lost to Follow-up|0|||
94540919|NCT00394901|323776286|FG003|Double-blind Phase|Lost to Follow-up|1|||
94540920|NCT00394901|323776283|FG000|Double-blind Phase|Protocol Violation|0|||
94540921|NCT00394901|323776284|FG001|Double-blind Phase|Protocol Violation|0|||
94540922|NCT00394901|323776285|FG002|Double-blind Phase|Protocol Violation|0|||
94540923|NCT00394901|323776286|FG003|Double-blind Phase|Protocol Violation|1|||
94540924|NCT00394901|323776283|FG000|Double-blind Phase|Death|1|||
94540925|NCT00394901|323776284|FG001|Double-blind Phase|Death|0|||
94540926|NCT00394901|323776285|FG002|Double-blind Phase|Death|0|||
94540927|NCT00394901|323776286|FG003|Double-blind Phase|Death|0|||
94540928|NCT00394901|323776283|FG000|Double-blind Phase|Subject's Personal Reason|1|||
94540929|NCT00394901|323776284|FG001|Double-blind Phase|Subject's Personal Reason|0|||
94540930|NCT00394901|323776285|FG002|Double-blind Phase|Subject's Personal Reason|0|||
94540931|NCT00394901|323776286|FG003|Double-blind Phase|Subject's Personal Reason|1|||
94540932|NCT00394901|323776283|FG000|Double-blind Phase|Lack of Compliance|0|||
94540933|NCT00394901|323776284|FG001|Double-blind Phase|Lack of Compliance|3|||
94540934|NCT00394901|323776285|FG002|Double-blind Phase|Lack of Compliance|0|||
94540935|NCT00394901|323776286|FG003|Double-blind Phase|Lack of Compliance|0|||
94540936|NCT00394901|323776283|FG000|Double-blind Phase|Entry into another study was found|0|||
94540937|NCT00394901|323776284|FG001|Double-blind Phase|Entry into another study was found|0|||
94540938|NCT00394901|323776285|FG002|Double-blind Phase|Entry into another study was found|1|||
94540939|NCT00394901|323776286|FG003|Double-blind Phase|Entry into another study was found|0|||
94540940|NCT00394901|323776283|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
94540941|NCT00394901|323776284|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
94540942|NCT00394901|323776285|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
94540943|NCT00394901|323776286|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
94540944|NCT01007123|323778771|FG000|Overall Study|Adverse Event|3|||
94540945|NCT01007123|323778772|FG001|Overall Study|Adverse Event|4|||
94540946|NCT01007123|323778773|FG002|Overall Study|Adverse Event|7|||
94540947|NCT01007123|323778774|FG003|Overall Study|Adverse Event|1|||
94540948|NCT01007123|323778771|FG000|Overall Study|Lack of Efficacy|1|||
94540949|NCT01007123|323778772|FG001|Overall Study|Lack of Efficacy|0|||
94540950|NCT01007123|323778773|FG002|Overall Study|Lack of Efficacy|1|||
94540951|NCT01007123|323778774|FG003|Overall Study|Lack of Efficacy|4|||
94540952|NCT01007123|323778771|FG000|Overall Study|Protocol Violation|1|||
94540953|NCT01007123|323778772|FG001|Overall Study|Protocol Violation|1|||
94540954|NCT01007123|323778773|FG002|Overall Study|Protocol Violation|2|||
94540955|NCT01007123|323778774|FG003|Overall Study|Protocol Violation|1|||
94540956|NCT01007123|323778771|FG000|Overall Study|Withdrawal by Subject|1|||
94540957|NCT01007123|323778772|FG001|Overall Study|Withdrawal by Subject|0|||
94540958|NCT01007123|323778773|FG002|Overall Study|Withdrawal by Subject|1|||
94540959|NCT01007123|323778774|FG003|Overall Study|Withdrawal by Subject|0|||
94540960|NCT01007123|323778771|FG000|Overall Study|Lost to Follow-up|0|||
94540961|NCT01007123|323778772|FG001|Overall Study|Lost to Follow-up|1|||
94540962|NCT01007123|323778773|FG002|Overall Study|Lost to Follow-up|0|||
94540963|NCT01007123|323778774|FG003|Overall Study|Lost to Follow-up|0|||
94540964|NCT00823212|323778778|FG000|Overall Study|Death|8|||
94540965|NCT00823212|323778779|FG001|Overall Study|Death|10|||
94540966|NCT00823212|323778778|FG000|Overall Study|Withdrawal by Subject|6|||
94540967|NCT00823212|323778779|FG001|Overall Study|Withdrawal by Subject|1|||
94540968|NCT00823212|323778778|FG000|Overall Study|Incarcerated|0|||
94540969|NCT00823212|323778779|FG001|Overall Study|Incarcerated|1|||
94540970|NCT00823212|323778778|FG000|Overall Study|Missed 12-month visit|21|||
94540971|NCT00823212|323778779|FG001|Overall Study|Missed 12-month visit|21|||
94540972|NCT01778049|323778780|FG000|Open Label Treatment Period|Adverse Event|5|||
94540973|NCT01778049|323778781|FG001|Open Label Treatment Period|Adverse Event|15|||
94540974|NCT01778049|323778782|FG002|Open Label Treatment Period|Adverse Event|0|||
94540975|NCT01778049|323778783|FG003|Open Label Treatment Period|Adverse Event|0|||
94540976|NCT01778049|323778784|FG004|Open Label Treatment Period|Adverse Event|0|||
94540977|NCT01778049|323778785|FG005|Open Label Treatment Period|Adverse Event|0|||
94540978|NCT01778049|323778780|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
94540979|NCT01778049|323778781|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
94540980|NCT01778049|323778782|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
94540981|NCT01778049|323778783|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
94540982|NCT01778049|323778784|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
94540983|NCT01778049|323778785|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
94540984|NCT01778049|323778780|FG000|Open Label Treatment Period|Protocol Violation|5|||
94540985|NCT01778049|323778781|FG001|Open Label Treatment Period|Protocol Violation|5|||
94540986|NCT01778049|323778782|FG002|Open Label Treatment Period|Protocol Violation|0|||
94540987|NCT01778049|323778783|FG003|Open Label Treatment Period|Protocol Violation|0|||
94540988|NCT01778049|323778784|FG004|Open Label Treatment Period|Protocol Violation|0|||
94540989|NCT01778049|323778785|FG005|Open Label Treatment Period|Protocol Violation|0|||
94540990|NCT01778049|323778780|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
94540991|NCT01778049|323778781|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
94540992|NCT01778049|323778782|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
94540993|NCT01778049|323778783|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
94540994|NCT01778049|323778784|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
94540995|NCT01778049|323778785|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
94540996|NCT01778049|323778780|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
94540997|NCT01778049|323778781|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
94540998|NCT01778049|323778782|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
94540999|NCT01778049|323778783|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
94541000|NCT01778049|323778784|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
94541001|NCT01778049|323778785|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
94541002|NCT01778049|323778780|FG000|Open Label Treatment Period|Not treated|2|||
94541003|NCT01778049|323778781|FG001|Open Label Treatment Period|Not treated|1|||
94541004|NCT01778049|323778782|FG002|Open Label Treatment Period|Not treated|0|||
94541005|NCT01778049|323778783|FG003|Open Label Treatment Period|Not treated|0|||
94541006|NCT01778049|323778784|FG004|Open Label Treatment Period|Not treated|0|||
94541007|NCT01778049|323778785|FG005|Open Label Treatment Period|Not treated|0|||
94541008|NCT01778049|323778780|FG000|Open Label Treatment Period|Other reason not defined above|77|||
94541009|NCT01778049|323778781|FG001|Open Label Treatment Period|Other reason not defined above|94|||
94541010|NCT01778049|323778782|FG002|Open Label Treatment Period|Other reason not defined above|0|||
94541011|NCT01778049|323778783|FG003|Open Label Treatment Period|Other reason not defined above|0|||
94541012|NCT01778049|323778784|FG004|Open Label Treatment Period|Other reason not defined above|0|||
94541013|NCT01778049|323778785|FG005|Open Label Treatment Period|Other reason not defined above|0|||
94541014|NCT01778049|323778780|FG000|Double Blind Treatment Period|Adverse Event|0|||
94541015|NCT01778049|323778781|FG001|Double Blind Treatment Period|Adverse Event|0|||
94541016|NCT01778049|323778782|FG002|Double Blind Treatment Period|Adverse Event|4|||
94541017|NCT01778049|323778783|FG003|Double Blind Treatment Period|Adverse Event|5|||
94541018|NCT01778049|323778784|FG004|Double Blind Treatment Period|Adverse Event|3|||
94541019|NCT01778049|323778785|FG005|Double Blind Treatment Period|Adverse Event|2|||
94541020|NCT01778049|323778780|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
94541021|NCT01778049|323778781|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
94541022|NCT01778049|323778782|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
94541023|NCT01778049|323778783|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
94541024|NCT01778049|323778784|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
94541025|NCT01778049|323778785|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
94541026|NCT01778049|323778780|FG000|Double Blind Treatment Period|Protocol Violation|0|||
94541027|NCT01778049|323778781|FG001|Double Blind Treatment Period|Protocol Violation|0|||
94541028|NCT01778049|323778782|FG002|Double Blind Treatment Period|Protocol Violation|2|||
94541029|NCT01778049|323778783|FG003|Double Blind Treatment Period|Protocol Violation|0|||
94541030|NCT01778049|323778784|FG004|Double Blind Treatment Period|Protocol Violation|0|||
94541031|NCT01778049|323778785|FG005|Double Blind Treatment Period|Protocol Violation|0|||
94541032|NCT01778049|323778780|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
94541033|NCT01778049|323778781|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
94541034|NCT01778049|323778782|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
94541035|NCT01778049|323778783|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
94541036|NCT01778049|323778784|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
94541037|NCT01778049|323778785|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
94541038|NCT01778049|323778780|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
94541039|NCT01778049|323778781|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
94541040|NCT01778049|323778782|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
94541041|NCT01778049|323778783|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
94541042|NCT01778049|323778784|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
94541043|NCT01778049|323778785|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
94541044|NCT01778049|323778780|FG000|Double Blind Treatment Period|Not treated|0|||
94541045|NCT01778049|323778781|FG001|Double Blind Treatment Period|Not treated|0|||
94541046|NCT01778049|323778782|FG002|Double Blind Treatment Period|Not treated|0|||
94541047|NCT01778049|323778783|FG003|Double Blind Treatment Period|Not treated|2|||
94541048|NCT01778049|323778784|FG004|Double Blind Treatment Period|Not treated|2|||
94541049|NCT01778049|323778785|FG005|Double Blind Treatment Period|Not treated|0|||
94541050|NCT01778049|323778780|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
94541051|NCT01778049|323778781|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
94541052|NCT01778049|323778782|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
94541053|NCT01778049|323778783|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
94541054|NCT01778049|323778784|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
94541055|NCT01778049|323778785|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
94541056|NCT00934947|323778787|FG000|Overall Study|Adverse Event|0|||
94541057|NCT00934947|323778788|FG001|Overall Study|Adverse Event|2|||
94541058|NCT00794365|323778789|FG000|Overall Study|Lost to Follow-up|38|||
94541059|NCT00794365|323778789|FG000|Overall Study|Other|17|||
94541060|NCT00794365|323778789|FG000|Overall Study|Poor Compliance|11|||
94541061|NCT00794365|323778789|FG000|Overall Study|Adverse Event|10|||
94541062|NCT00794365|323778789|FG000|Overall Study|Lack of Efficacy|3|||
94541063|NCT04422561|323778794|FG000|Overall Study|Lost to Follow-up|25|||
94541064|NCT04422561|323778795|FG001|Overall Study|Lost to Follow-up|11|||
94541065|NCT01666119|323778796|FG000|Overall Study|Adverse Event|6|||
94541066|NCT01666119|323778796|FG000|Overall Study|Withdrawal by Subject|16|||
94541067|NCT01666119|323778796|FG000|Overall Study|Lost to Follow-up|7|||
94541068|NCT01666119|323778796|FG000|Overall Study|non compliance with study medication, pa|18|||
94541069|NCT01666119|323778796|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
94541070|NCT02685748|323778799|FG000|Overall Study|Withdrawal by Subject|3|||
94541071|NCT02685748|323778800|FG001|Overall Study|Withdrawal by Subject|2|||
94541072|NCT04126564|323778801|FG000|Overall Study|Withdrawal by Subject|0|||
94541073|NCT04126564|323778802|FG001|Overall Study|Withdrawal by Subject|2|||
94541074|NCT04126564|323778801|FG000|Overall Study|Lost to Follow-up|0|||
94541075|NCT04126564|323778802|FG001|Overall Study|Lost to Follow-up|1|||
94541076|NCT00937404|323778803|FG000|Overall Study|Protocol Violation|1|||
94541077|NCT00937404|323778803|FG000|Overall Study|Withdrawal by Subject|1|||
94541078|NCT03549871|323778804|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
94541079|NCT03549871|323778805|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
94541080|NCT03549871|323778804|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
94541081|NCT03549871|323778805|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
94541082|NCT03549871|323778804|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
94541083|NCT03549871|323778805|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
94541084|NCT03549871|323778804|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
94541085|NCT03549871|323778805|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
94541086|NCT03549871|323778804|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
94541087|NCT03549871|323778805|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
94541088|NCT03549871|323778804|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
94541089|NCT03549871|323778805|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
94541090|NCT03549871|323778804|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
94541091|NCT03549871|323778805|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
94541092|NCT03549871|323778804|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
94541093|NCT03549871|323778805|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
94541094|NCT03549871|323778804|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
94541095|NCT03549871|323778805|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
94541096|NCT03549871|323778804|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
94541097|NCT03549871|323778805|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
94541098|NCT03549871|323778804|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
94541099|NCT03549871|323778805|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
94541100|NCT03894969|323778812|FG000|Overall Study|Adverse Event|0|||
94541101|NCT03894969|323778813|FG001|Overall Study|Adverse Event|2|||
94541102|NCT03894969|323778814|FG002|Overall Study|Adverse Event|0|||
94541103|NCT03894969|323778815|FG003|Overall Study|Adverse Event|1|||
94541104|NCT03894969|323778816|FG004|Overall Study|Adverse Event|2|||
94541105|NCT03894969|323778812|FG000|Overall Study|Lost to Follow-up|3|||
94541106|NCT03894969|323778813|FG001|Overall Study|Lost to Follow-up|1|||
94541107|NCT03894969|323778814|FG002|Overall Study|Lost to Follow-up|1|||
94541108|NCT03894969|323778815|FG003|Overall Study|Lost to Follow-up|0|||
94541109|NCT03894969|323778816|FG004|Overall Study|Lost to Follow-up|0|||
94541110|NCT03894969|323778812|FG000|Overall Study|Withdrawal by Subject|2|||
94541111|NCT03894969|323778813|FG001|Overall Study|Withdrawal by Subject|1|||
94541112|NCT03894969|323778814|FG002|Overall Study|Withdrawal by Subject|3|||
94541113|NCT03894969|323778815|FG003|Overall Study|Withdrawal by Subject|4|||
94541114|NCT03894969|323778816|FG004|Overall Study|Withdrawal by Subject|8|||
94541115|NCT03894969|323778812|FG000|Overall Study|Other|0|||
94541116|NCT03894969|323778813|FG001|Overall Study|Other|0|||
94541117|NCT03894969|323778814|FG002|Overall Study|Other|0|||
94541118|NCT03894969|323778815|FG003|Overall Study|Other|0|||
94541119|NCT03894969|323778816|FG004|Overall Study|Other|3|||
94541120|NCT03894969|323778812|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
94541121|NCT03894969|323778813|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
94541122|NCT03894969|323778814|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
94541123|NCT03894969|323778815|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
94541124|NCT03894969|323778816|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
94541125|NCT03894969|323778812|FG000|Overall Study|Solicited Adverse Event|0|||
94541126|NCT03894969|323778813|FG001|Overall Study|Solicited Adverse Event|1|||
94541127|NCT03894969|323778814|FG002|Overall Study|Solicited Adverse Event|0|||
94541128|NCT03894969|323778815|FG003|Overall Study|Solicited Adverse Event|0|||
94541129|NCT03894969|323778816|FG004|Overall Study|Solicited Adverse Event|0|||
94541130|NCT02435680|323778821|FG000|Overall Study|Physician Decision|3|||
94541131|NCT02435680|323778822|FG001|Overall Study|Physician Decision|0|||
94541132|NCT02435680|323778823|FG002|Overall Study|Physician Decision|0|||
94541133|NCT02435680|323778821|FG000|Overall Study|subject / guardian decision|0|||
94541134|NCT02435680|323778822|FG001|Overall Study|subject / guardian decision|3|||
94541135|NCT02435680|323778823|FG002|Overall Study|subject / guardian decision|2|||
94541136|NCT02435680|323778821|FG000|Overall Study|Adverse Event|8|||
94541137|NCT02435680|323778822|FG001|Overall Study|Adverse Event|3|||
94541138|NCT02435680|323778823|FG002|Overall Study|Adverse Event|2|||
94541139|NCT02435680|323778821|FG000|Overall Study|progressive disease|10|||
94541140|NCT02435680|323778822|FG001|Overall Study|progressive disease|7|||
94541141|NCT02435680|323778823|FG002|Overall Study|progressive disease|11|||
94541142|NCT02435680|323778821|FG000|Overall Study|not treated|0|||
94541143|NCT02435680|323778822|FG001|Overall Study|not treated|0|||
94541144|NCT02435680|323778823|FG002|Overall Study|not treated|1|||
94541145|NCT00445848|323778824|FG000|Overall Study|Adverse Event|14|||
94541146|NCT00445848|323778824|FG000|Overall Study|Withdrawal by Subject|4|||
94541147|NCT00445848|323778824|FG000|Overall Study|Progression|62|||
94541148|NCT00445848|323778824|FG000|Overall Study|Other-Not protocol specified|5|||
94541149|NCT02229214|323778842|FG000|Overall Study|Adverse Event|2|||
94541150|NCT02229214|323778843|FG001|Overall Study|Adverse Event|0|||
94541151|NCT02229214|323778842|FG000|Overall Study|Withdrawal by Subject|4|||
94541152|NCT02229214|323778843|FG001|Overall Study|Withdrawal by Subject|0|||
94541153|NCT00969761|323778844|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
94541154|NCT00969761|323778845|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
94541155|NCT00969761|323778846|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
94541156|NCT00969761|323778847|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
94541157|NCT00969761|323778848|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
94541158|NCT00969761|323778849|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
94541159|NCT00969761|323778850|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
94541160|NCT00969761|323778851|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
94541161|NCT00969761|323778852|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
94541162|NCT00969761|323778853|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
94541163|NCT00969761|323778854|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
94541164|NCT00969761|323778855|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
94541165|NCT00969761|323778844|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
94541166|NCT00969761|323778845|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
94541167|NCT00969761|323778846|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
94541168|NCT00969761|323778847|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
94541169|NCT00969761|323778848|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
94541170|NCT00969761|323778849|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
94541171|NCT00969761|323778850|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
94541172|NCT00969761|323778851|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
94541173|NCT00969761|323778852|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
94541174|NCT00969761|323778853|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
94541175|NCT00969761|323778854|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
94541176|NCT00969761|323778855|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
94541177|NCT00969761|323778844|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
94541178|NCT00969761|323778845|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
94541179|NCT00969761|323778846|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
94541180|NCT00969761|323778847|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
94541181|NCT00969761|323778848|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
94541182|NCT00969761|323778849|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
94541183|NCT00969761|323778850|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
94541184|NCT00969761|323778851|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
94541185|NCT00969761|323778852|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
94541186|NCT00969761|323778853|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
94541187|NCT00969761|323778854|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
94541188|NCT00969761|323778855|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
94541189|NCT00969761|323778844|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
94541190|NCT00969761|323778845|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
94541191|NCT00969761|323778846|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
94541192|NCT00969761|323778847|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
94541193|NCT00969761|323778848|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
94541194|NCT00969761|323778849|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
94541195|NCT00969761|323778850|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
94541196|NCT00969761|323778851|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
94541197|NCT00969761|323778852|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
94541198|NCT00969761|323778853|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
94541199|NCT00969761|323778854|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
94541200|NCT00969761|323778855|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
94541201|NCT00969761|323778844|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
94541202|NCT00969761|323778845|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
94541203|NCT00969761|323778846|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
94541204|NCT00969761|323778847|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
94541205|NCT00969761|323778848|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
94541206|NCT00969761|323778849|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
94541207|NCT00969761|323778850|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
94541208|NCT00969761|323778851|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
94541209|NCT00969761|323778852|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
94541210|NCT00969761|323778853|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
94541211|NCT00969761|323778854|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
94541212|NCT00969761|323778855|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
94541213|NCT00969761|323778844|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
94541214|NCT00969761|323778845|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
94541215|NCT00969761|323778846|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
94541216|NCT00969761|323778847|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
94541217|NCT00969761|323778848|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
94541218|NCT00969761|323778849|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
94541219|NCT00969761|323778850|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
94541220|NCT00969761|323778851|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
94541221|NCT00969761|323778852|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
94541222|NCT00969761|323778853|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
94541223|NCT00969761|323778854|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
94541224|NCT00969761|323778855|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
94541225|NCT01774253|323778863|FG000|Overall Study|Lack of Efficacy|4|||
94541226|NCT01774253|323778863|FG000|Overall Study|Physician Decision|2|||
94541227|NCT01774253|323778863|FG000|Overall Study|Withdrawal by Subject|2|||
94541228|NCT01774253|323778863|FG000|Overall Study|Death|1|||
94541229|NCT00907803|323778864|FG000|Overall Study|Withdrawal of consent - long commute|1|||
94541230|NCT00907803|323778865|FG001|Overall Study|Withdrawal of consent - long commute|0|||
94541231|NCT00907803|323778866|FG002|Overall Study|Withdrawal of consent - long commute|0|||
94541232|NCT00907803|323778864|FG000|Overall Study|Adverse Event|2|||
94541233|NCT00907803|323778865|FG001|Overall Study|Adverse Event|0|||
94541234|NCT00907803|323778866|FG002|Overall Study|Adverse Event|0|||
94541235|NCT00907803|323778864|FG000|Overall Study|Withdrawal by Subject|0|||
94541236|NCT00907803|323778865|FG001|Overall Study|Withdrawal by Subject|1|||
94541237|NCT00907803|323778866|FG002|Overall Study|Withdrawal by Subject|0|||
94541238|NCT00907803|323778864|FG000|Overall Study|Lost to Follow-up|0|||
94541239|NCT00907803|323778865|FG001|Overall Study|Lost to Follow-up|1|||
94541240|NCT00907803|323778866|FG002|Overall Study|Lost to Follow-up|0|||
94541241|NCT00907803|323778864|FG000|Overall Study|Protocol Violation|0|||
94541242|NCT00907803|323778865|FG001|Overall Study|Protocol Violation|1|||
94541243|NCT00907803|323778866|FG002|Overall Study|Protocol Violation|0|||
94541244|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|Death|1|||
94541245|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|Death|1|||
94541246|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|Death|0|||
94541247|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|Death|0|||
94541248|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|Death|1|||
94541249|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|Death|0|||
94541250|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|Death|0|||
94541251|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|Death|0|||
94541252|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|Death|0|||
94541253|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|Death|0|||
94541254|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
94541255|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
94541256|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
94541257|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
94541258|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
94541259|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
94541260|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
94541261|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
94541262|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
94541263|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
94541264|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
94541265|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
94541266|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
94541267|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
94541268|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
94541269|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
94541270|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
94541271|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
94541272|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
94541273|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
94541274|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
94541275|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
94541276|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
94541277|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
94541278|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
94541279|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
94541280|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
94541281|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
94541282|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
94541283|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
94541284|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
94541285|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
94541286|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
94541287|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
94541288|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
94541289|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
94541290|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
94541291|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
94541292|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
94541293|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
94541294|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
94541295|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
94541296|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
94541297|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
94541298|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
94541299|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
94541300|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
94541301|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
94541302|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
94541303|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
94541304|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
94541305|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
94541306|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
94541307|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
94541308|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
94541309|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
94541310|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
94541311|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
94541312|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
94541313|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
94541314|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
94541315|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
94541316|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
94541317|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
94541318|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
94541319|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
94541320|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
94541321|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
94541322|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
94541323|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
94541324|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
94541325|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
94541326|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
94541327|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
94541328|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
94541329|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
94541330|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
94541331|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
94541332|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
94541333|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
94541334|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
94541335|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
94541336|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
94541337|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
94541338|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
94541339|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
94541340|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
94541341|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
94541342|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
94541343|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
94541344|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
94541345|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
94541346|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
94541347|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
94541348|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
94541349|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
94541350|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
94541351|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
94541352|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
94541353|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
94541354|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
94541355|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
94541356|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
94541357|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
94541358|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
94541359|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
94541360|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
94541361|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
94541362|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
94541363|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
94541364|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
94541365|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
94541366|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
94541367|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
94541368|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
94541369|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
94541370|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
94541371|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
94541372|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
94541373|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
94541374|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
94541375|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
94541376|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
94541377|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
94541378|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
94541379|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
94541380|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
94541381|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
94541382|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
94541383|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
94541384|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
94541385|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
94541386|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
94541387|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
94541388|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
94541389|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
94541390|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
94541391|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
94541392|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
94541393|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
94541394|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
94541395|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
94541396|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
94541397|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
94541398|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
94541399|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
94541400|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
94541401|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
94541402|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
94541403|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
94541404|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
94541405|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
94541406|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
94541407|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
94541408|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
94541409|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
94541410|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
94541411|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
94541412|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
94541413|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
94541414|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
94541415|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
94541416|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
94541417|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
94541418|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
94541419|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
94541420|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
94541421|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
94541422|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
94541423|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
94541424|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
94541425|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
94541426|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
94541427|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
94541428|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
94541429|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
94541430|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
94541431|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
94541432|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
94541433|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
94541434|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|Other|5|||
94541435|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|Other|1|||
94541436|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|Other|0|||
94541437|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|Other|3|||
94541438|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|Other|0|||
94541439|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|Other|0|||
94541440|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|Other|0|||
94541441|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|Other|0|||
94541442|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|Other|0|||
94541443|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|Other|0|||
94541444|NCT03352557|323778867|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
94541445|NCT03352557|323778868|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
94541446|NCT03352557|323778869|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
94541447|NCT03352557|323778870|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
94541448|NCT03352557|323778871|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
94541449|NCT03352557|323778872|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
94541450|NCT03352557|323778873|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
94541451|NCT03352557|323778874|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
94541452|NCT03352557|323778875|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
94541453|NCT03352557|323778876|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
94541454|NCT03352557|323778867|FG000|LTE Period: Week 80 to Week 173|Death|0|||
94541455|NCT03352557|323778868|FG001|LTE Period: Week 80 to Week 173|Death|0|||
94541456|NCT03352557|323778869|FG002|LTE Period: Week 80 to Week 173|Death|0|||
94541457|NCT03352557|323778870|FG003|LTE Period: Week 80 to Week 173|Death|0|||
94541458|NCT03352557|323778871|FG004|LTE Period: Week 80 to Week 173|Death|0|||
94541459|NCT03352557|323778872|FG005|LTE Period: Week 80 to Week 173|Death|1|||
94541460|NCT03352557|323778873|FG006|LTE Period: Week 80 to Week 173|Death|0|||
94541461|NCT03352557|323778874|FG007|LTE Period: Week 80 to Week 173|Death|1|||
94541462|NCT03352557|323778875|FG008|LTE Period: Week 80 to Week 173|Death|1|||
94541463|NCT03352557|323778876|FG009|LTE Period: Week 80 to Week 173|Death|1|||
94541464|NCT03352557|323778867|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
94541465|NCT03352557|323778868|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
94541466|NCT03352557|323778869|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
94541467|NCT03352557|323778870|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
94541468|NCT03352557|323778871|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
94541469|NCT03352557|323778872|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
94541470|NCT03352557|323778873|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
94541471|NCT03352557|323778874|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
94541472|NCT03352557|323778875|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
94541473|NCT03352557|323778876|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
94541474|NCT03352557|323778867|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
94541475|NCT03352557|323778868|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
94541476|NCT03352557|323778869|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
94541477|NCT03352557|323778870|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
94541478|NCT03352557|323778871|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
94541479|NCT03352557|323778872|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
94541480|NCT03352557|323778873|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
94541481|NCT03352557|323778874|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
94541482|NCT03352557|323778875|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
94541483|NCT03352557|323778876|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
94541484|NCT03352557|323778867|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
94541485|NCT03352557|323778868|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
94541486|NCT03352557|323778869|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
94541487|NCT03352557|323778870|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
94541488|NCT03352557|323778871|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
94541489|NCT03352557|323778872|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
94541490|NCT03352557|323778873|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
94541491|NCT03352557|323778874|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
94541492|NCT03352557|323778875|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
94541493|NCT03352557|323778876|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
94541494|NCT03352557|323778867|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
94541495|NCT03352557|323778868|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
94541496|NCT03352557|323778869|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
94541497|NCT03352557|323778870|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
94541498|NCT03352557|323778871|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
94541499|NCT03352557|323778872|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
94541500|NCT03352557|323778873|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
94541501|NCT03352557|323778874|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
94541502|NCT03352557|323778875|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
94541503|NCT03352557|323778876|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
94541504|NCT03352557|323778867|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
94541505|NCT03352557|323778868|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
94541506|NCT03352557|323778869|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
94541507|NCT03352557|323778870|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
94541508|NCT03352557|323778871|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
94541509|NCT03352557|323778872|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
94541510|NCT03352557|323778873|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
94541511|NCT03352557|323778874|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
94541512|NCT03352557|323778875|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
94541513|NCT03352557|323778876|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
94541514|NCT03352557|323778867|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
94541515|NCT03352557|323778868|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
94541516|NCT03352557|323778869|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
94541517|NCT03352557|323778870|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
94541518|NCT03352557|323778871|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
94541519|NCT03352557|323778872|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
94541520|NCT03352557|323778873|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
94541521|NCT03352557|323778874|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
94541522|NCT03352557|323778875|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
94541523|NCT03352557|323778876|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
94541524|NCT03352557|323778867|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
94541525|NCT03352557|323778868|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
94541526|NCT03352557|323778869|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
94541527|NCT03352557|323778870|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
94541528|NCT03352557|323778871|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
94541529|NCT03352557|323778872|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
94541530|NCT03352557|323778873|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
94541531|NCT03352557|323778874|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
94541532|NCT03352557|323778875|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
94541533|NCT03352557|323778876|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
94541534|NCT03352557|323778867|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
94541535|NCT03352557|323778868|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
94541536|NCT03352557|323778869|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
94541537|NCT03352557|323778870|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
94541538|NCT03352557|323778871|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
94541539|NCT03352557|323778872|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
94541540|NCT03352557|323778873|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
94541541|NCT03352557|323778874|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
94541542|NCT03352557|323778875|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
94541543|NCT03352557|323778876|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
94541544|NCT03352557|323778867|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
94541545|NCT03352557|323778868|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
94541546|NCT03352557|323778869|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
94541547|NCT03352557|323778870|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
94541548|NCT03352557|323778871|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
94541549|NCT03352557|323778872|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
94541550|NCT03352557|323778873|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
94541551|NCT03352557|323778874|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
94541552|NCT03352557|323778875|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
94541553|NCT03352557|323778876|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
94541554|NCT03352557|323778867|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
94541555|NCT03352557|323778868|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
94541556|NCT03352557|323778869|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
94541557|NCT03352557|323778870|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
94541558|NCT03352557|323778871|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
94541559|NCT03352557|323778872|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
94541560|NCT03352557|323778873|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
94541561|NCT03352557|323778874|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
94541562|NCT03352557|323778875|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
94541563|NCT03352557|323778876|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
94541564|NCT03352557|323778867|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
94541565|NCT03352557|323778868|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
94541566|NCT03352557|323778869|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
94541567|NCT03352557|323778870|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
94541568|NCT03352557|323778871|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
94541569|NCT03352557|323778872|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
94541570|NCT03352557|323778873|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
94541571|NCT03352557|323778874|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
94541572|NCT03352557|323778875|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
94541573|NCT03352557|323778876|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
94541574|NCT03352557|323778867|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
94541575|NCT03352557|323778868|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
94541576|NCT03352557|323778869|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
94541577|NCT03352557|323778870|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
94541578|NCT03352557|323778871|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
94541579|NCT03352557|323778872|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
94541580|NCT03352557|323778873|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
94541581|NCT03352557|323778874|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
94541582|NCT03352557|323778875|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
94541583|NCT03352557|323778876|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
94541584|NCT03352557|323778867|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
94541585|NCT03352557|323778868|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
94541586|NCT03352557|323778869|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
94541587|NCT03352557|323778870|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
94541588|NCT03352557|323778871|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
94541589|NCT03352557|323778872|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
94541590|NCT03352557|323778873|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
94541591|NCT03352557|323778874|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
94541592|NCT03352557|323778875|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
94541593|NCT03352557|323778876|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
94541594|NCT03352557|323778867|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
94541595|NCT03352557|323778868|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
94541596|NCT03352557|323778869|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
94541597|NCT03352557|323778870|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
94541598|NCT03352557|323778871|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
94541599|NCT03352557|323778872|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
94541600|NCT03352557|323778873|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
94541601|NCT03352557|323778874|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
94541602|NCT03352557|323778875|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
94541603|NCT03352557|323778876|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
94541604|NCT03352557|323778867|FG000|LTE Period: Week 80 to Week 173|Other|0|||
94541605|NCT03352557|323778868|FG001|LTE Period: Week 80 to Week 173|Other|0|||
94541606|NCT03352557|323778869|FG002|LTE Period: Week 80 to Week 173|Other|0|||
94541607|NCT03352557|323778870|FG003|LTE Period: Week 80 to Week 173|Other|0|||
94541608|NCT03352557|323778871|FG004|LTE Period: Week 80 to Week 173|Other|0|||
94541609|NCT03352557|323778872|FG005|LTE Period: Week 80 to Week 173|Other|0|||
94541610|NCT03352557|323778873|FG006|LTE Period: Week 80 to Week 173|Other|0|||
94541611|NCT03352557|323778874|FG007|LTE Period: Week 80 to Week 173|Other|1|||
94541612|NCT03352557|323778875|FG008|LTE Period: Week 80 to Week 173|Other|0|||
94541613|NCT03352557|323778876|FG009|LTE Period: Week 80 to Week 173|Other|0|||
94541614|NCT03510468|323778877|FG000|Overall Study|Lost to Follow-up|1|||
94541615|NCT03510468|323778877|FG000|Overall Study|Adverse Event|5|||
94541616|NCT03510468|323778877|FG000|Overall Study|Physician Decision|1|||
94541617|NCT03510468|323778877|FG000|Overall Study|non-compliant with treatment|2|||
94541618|NCT03510468|323778877|FG000|Overall Study|Missed visit|1|||
94541619|NCT02419131|323778882|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
94541620|NCT02419131|323778883|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
94541621|NCT02419131|323778884|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
94541622|NCT02419131|323778882|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
94541623|NCT02419131|323778883|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
94541624|NCT02419131|323778884|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
94541625|NCT05426031|323778885|FG000|Overall Study|Circulatory Arrest|3|||
94541626|NCT05426031|323778886|FG001|Overall Study|Circulatory Arrest|2|||
94541627|NCT00089986|323778889|FG000|Overall Study|Adverse Event|6|||
94541628|NCT00089986|323778890|FG001|Overall Study|Adverse Event|9|||
94541629|NCT00089986|323778891|FG002|Overall Study|Adverse Event|6|||
94541630|NCT00089986|323778889|FG000|Overall Study|Lost to Follow-up|3|||
94541631|NCT00089986|323778890|FG001|Overall Study|Lost to Follow-up|1|||
94541632|NCT00089986|323778891|FG002|Overall Study|Lost to Follow-up|1|||
94541633|NCT00089986|323778889|FG000|Overall Study|Protocol Violation|0|||
94541634|NCT00089986|323778890|FG001|Overall Study|Protocol Violation|1|||
94541635|NCT00089986|323778891|FG002|Overall Study|Protocol Violation|0|||
94541636|NCT00089986|323778889|FG000|Overall Study|Patient transferred to another hospital|2|||
94541637|NCT00089986|323778890|FG001|Overall Study|Patient transferred to another hospital|1|||
94541638|NCT00089986|323778891|FG002|Overall Study|Patient transferred to another hospital|0|||
94541639|NCT00089986|323778889|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
94541640|NCT00089986|323778890|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
94541641|NCT00089986|323778891|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
94541642|NCT00089986|323778889|FG000|Overall Study|Hemohlobin stopping rule|0|||
94541643|NCT00089986|323778890|FG001|Overall Study|Hemohlobin stopping rule|1|||
94541644|NCT00089986|323778891|FG002|Overall Study|Hemohlobin stopping rule|0|||
94541645|NCT00089986|323778889|FG000|Overall Study|Investigator decision to withdrew|0|||
94541646|NCT00089986|323778890|FG001|Overall Study|Investigator decision to withdrew|1|||
94541647|NCT00089986|323778891|FG002|Overall Study|Investigator decision to withdrew|0|||
94541648|NCT00089986|323778889|FG000|Overall Study|Enrollment in another study|0|||
94541649|NCT00089986|323778890|FG001|Overall Study|Enrollment in another study|1|||
94541650|NCT00089986|323778891|FG002|Overall Study|Enrollment in another study|0|||
94541651|NCT00089986|323778889|FG000|Overall Study|Family decision|0|||
94541652|NCT00089986|323778890|FG001|Overall Study|Family decision|1|||
94541653|NCT00089986|323778891|FG002|Overall Study|Family decision|0|||
94541654|NCT00089986|323778889|FG000|Overall Study|Do not resuscitate (DNR)|0|||
94541655|NCT00089986|323778890|FG001|Overall Study|Do not resuscitate (DNR)|0|||
94541656|NCT00089986|323778891|FG002|Overall Study|Do not resuscitate (DNR)|1|||
94541657|NCT00089986|323778889|FG000|Overall Study|Withdrawal by Subject|3|||
94541658|NCT00089986|323778890|FG001|Overall Study|Withdrawal by Subject|6|||
94541659|NCT00089986|323778891|FG002|Overall Study|Withdrawal by Subject|2|||
94541660|NCT03220581|323778901|FG000|Overall Study|Withdrawal by Subject|0|||
94541661|NCT03220581|323778902|FG001|Overall Study|Withdrawal by Subject|1|||
94541662|NCT03220581|323778901|FG000|Overall Study|Lost to Follow-up|3|||
94541663|NCT03220581|323778902|FG001|Overall Study|Lost to Follow-up|6|||
94541664|NCT00413920|323778903|FG000|Overall Study|Adverse Event|9|||
94541665|NCT00413920|323778904|FG001|Overall Study|Adverse Event|11|||
94541666|NCT00413920|323778903|FG000|Overall Study|Lack of Efficacy|11|||
94541667|NCT00413920|323778904|FG001|Overall Study|Lack of Efficacy|9|||
94541668|NCT00413920|323778903|FG000|Overall Study|Death|3|||
94541669|NCT00413920|323778904|FG001|Overall Study|Death|5|||
94541670|NCT00413920|323778903|FG000|Overall Study|Graft Loss|5|||
94541671|NCT00413920|323778904|FG001|Overall Study|Graft Loss|3|||
94541672|NCT01071200|323778905|FG000|Overall Study|Lack of ovarian response|1|||
94541673|NCT01071200|323778906|FG001|Overall Study|Lack of ovarian response|1|||
94541674|NCT01071200|323778905|FG000|Overall Study|No fertilization|4|||
94541675|NCT01071200|323778906|FG001|Overall Study|No fertilization|0|||
94541676|NCT01071200|323778905|FG000|Overall Study|No oocytes retrieved|1|||
94541677|NCT01071200|323778906|FG001|Overall Study|No oocytes retrieved|1|||
94541678|NCT01071200|323778905|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
94541679|NCT01071200|323778906|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
94541680|NCT01071200|323778905|FG000|Overall Study|No viable embryos|0|||
94541681|NCT01071200|323778906|FG001|Overall Study|No viable embryos|1|||
94541682|NCT02434354|323778907|FG000|Overall Study|screen fail|3|||
94541683|NCT03730961|323778908|FG000|Overall Study|Adverse Event|0|||
94541684|NCT03730961|323778909|FG001|Overall Study|Adverse Event|1|||
94541685|NCT03440918|323778913|FG000|Overall Study|Protocol Violation|0|||
94541686|NCT03440918|323778914|FG001|Overall Study|Protocol Violation|16|||
94541687|NCT01767493|323778915|FG000|Overall Study|screen failures|3|||
94541688|NCT02014480|323778919|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
94541689|NCT02014480|323778920|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
94541690|NCT02014480|323778921|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
94541691|NCT02014480|323778922|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
94541692|NCT02014480|323778923|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
94541693|NCT02014480|323778924|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
94541694|NCT02014480|323778919|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
94541695|NCT02014480|323778920|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
94541696|NCT02014480|323778921|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
94541697|NCT02014480|323778922|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
94541698|NCT02014480|323778923|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
94541699|NCT02014480|323778924|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
94541700|NCT02014480|323778919|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
94541701|NCT02014480|323778920|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
94541702|NCT02014480|323778921|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
94541703|NCT02014480|323778922|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
94541704|NCT02014480|323778923|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
94541705|NCT02014480|323778924|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
94541706|NCT02014480|323778919|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
94541707|NCT02014480|323778920|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
94541708|NCT02014480|323778921|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
94541709|NCT02014480|323778922|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
94541710|NCT02014480|323778923|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
94541711|NCT02014480|323778924|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
94541712|NCT02014480|323778919|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
94541713|NCT02014480|323778920|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
94541714|NCT02014480|323778921|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
94541715|NCT02014480|323778922|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
94541716|NCT02014480|323778923|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
94541717|NCT02014480|323778924|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
94541718|NCT02014480|323778919|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
94541719|NCT02014480|323778920|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
94541720|NCT02014480|323778921|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
94541721|NCT02014480|323778922|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
94541722|NCT02014480|323778923|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
94541723|NCT02014480|323778924|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
94541724|NCT02014480|323778919|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
94541725|NCT02014480|323778920|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
94541726|NCT02014480|323778921|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
94541727|NCT02014480|323778922|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
94541728|NCT02014480|323778923|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
94541729|NCT02014480|323778924|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
94541730|NCT01865812|323778927|FG000|Primary Treatment Phase|Adverse Event|2|||
94541731|NCT01865812|323778928|FG001|Primary Treatment Phase|Adverse Event|0|||
94541732|NCT01865812|323778927|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
94541733|NCT01865812|323778928|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
94541734|NCT01865812|323778927|FG000|Long-term Safety Extension Phase|Pruritus|0|||
94541735|NCT01865812|323778928|FG001|Long-term Safety Extension Phase|Pruritus|3|||
94541736|NCT01865812|323778927|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
94541737|NCT01865812|323778928|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
94541738|NCT01865812|323778927|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
94541739|NCT01865812|323778928|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
94541740|NCT03294135|323778929|FG000|Overall Study|Serious Adverse Event|1|||
94541741|NCT03294135|323778930|FG001|Overall Study|Serious Adverse Event|0|||
94541742|NCT03294135|323778931|FG002|Overall Study|Serious Adverse Event|0|||
94541743|NCT03294135|323778929|FG000|Overall Study|Lost to Follow-up|1|||
94541744|NCT03294135|323778930|FG001|Overall Study|Lost to Follow-up|0|||
94541745|NCT03294135|323778931|FG002|Overall Study|Lost to Follow-up|1|||
94541746|NCT03294135|323778929|FG000|Overall Study|Withdrawal by Subject|0|||
94541747|NCT03294135|323778930|FG001|Overall Study|Withdrawal by Subject|0|||
94541748|NCT03294135|323778931|FG002|Overall Study|Withdrawal by Subject|1|||
94541749|NCT03294135|323778929|FG000|Overall Study|Other|2|||
94541750|NCT03294135|323778930|FG001|Overall Study|Other|0|||
94541751|NCT03294135|323778931|FG002|Overall Study|Other|0|||
94541752|NCT02046226|323778932|FG000|Overall Study|Lost to Follow-up|7|||
94541753|NCT02692040|323778933|FG000|Overall Study|Protocol Violation|0|||
94541754|NCT02692040|323778934|FG001|Overall Study|Protocol Violation|0|||
94541755|NCT02692040|323778935|FG002|Overall Study|Protocol Violation|0|||
94541756|NCT02692040|323778936|FG003|Overall Study|Protocol Violation|0|||
94541757|NCT02692040|323778937|FG004|Overall Study|Protocol Violation|0|||
94541758|NCT02692040|323778938|FG005|Overall Study|Protocol Violation|0|||
94541759|NCT02692040|323778939|FG006|Overall Study|Protocol Violation|0|||
94541760|NCT02692040|323778940|FG007|Overall Study|Protocol Violation|0|||
94541761|NCT02692040|323778941|FG008|Overall Study|Protocol Violation|0|||
94541762|NCT02692040|323778942|FG009|Overall Study|Protocol Violation|0|||
94541763|NCT02692040|323778943|FG010|Overall Study|Protocol Violation|0|||
94541764|NCT02692040|323778944|FG011|Overall Study|Protocol Violation|0|||
94541765|NCT02692040|323778945|FG012|Overall Study|Protocol Violation|1|||
94541766|NCT02692040|323778946|FG013|Overall Study|Protocol Violation|0|||
94541767|NCT02692040|323778947|FG014|Overall Study|Protocol Violation|0|||
94541768|NCT02692040|323778948|FG015|Overall Study|Protocol Violation|0|||
94541769|NCT02692040|323778949|FG016|Overall Study|Protocol Violation|0|||
94541770|NCT02692040|323778933|FG000|Overall Study|Adverse Event|0|||
94541771|NCT02692040|323778934|FG001|Overall Study|Adverse Event|0|||
94541772|NCT02692040|323778935|FG002|Overall Study|Adverse Event|0|||
94541773|NCT02692040|323778936|FG003|Overall Study|Adverse Event|0|||
94541774|NCT02692040|323778937|FG004|Overall Study|Adverse Event|0|||
94541775|NCT02692040|323778938|FG005|Overall Study|Adverse Event|0|||
94541776|NCT02692040|323778939|FG006|Overall Study|Adverse Event|0|||
94541777|NCT02692040|323778940|FG007|Overall Study|Adverse Event|0|||
94541778|NCT02692040|323778941|FG008|Overall Study|Adverse Event|0|||
94541779|NCT02692040|323778942|FG009|Overall Study|Adverse Event|0|||
94541780|NCT02692040|323778943|FG010|Overall Study|Adverse Event|0|||
94541781|NCT02692040|323778944|FG011|Overall Study|Adverse Event|0|||
94541782|NCT02692040|323778945|FG012|Overall Study|Adverse Event|0|||
94541783|NCT02692040|323778946|FG013|Overall Study|Adverse Event|3|||
94541784|NCT02692040|323778947|FG014|Overall Study|Adverse Event|1|||
94541785|NCT02692040|323778948|FG015|Overall Study|Adverse Event|1|||
94541786|NCT02692040|323778949|FG016|Overall Study|Adverse Event|0|||
94541787|NCT00171925|323778953|FG000|Overall Study|Adverse Event|10|||
94541788|NCT00171925|323778954|FG001|Overall Study|Adverse Event|6|||
94541789|NCT00171925|323778953|FG000|Overall Study|Protocol Violation|1|||
94541790|NCT00171925|323778954|FG001|Overall Study|Protocol Violation|1|||
94541791|NCT00171925|323778953|FG000|Overall Study|Withdrawal by Subject|6|||
94541792|NCT00171925|323778954|FG001|Overall Study|Withdrawal by Subject|9|||
94541793|NCT00171925|323778953|FG000|Overall Study|Lost to Follow-up|2|||
94541794|NCT00171925|323778954|FG001|Overall Study|Lost to Follow-up|2|||
94541795|NCT00171925|323778953|FG000|Overall Study|Administrative problems|10|||
94541796|NCT00171925|323778954|FG001|Overall Study|Administrative problems|11|||
94541797|NCT00171925|323778953|FG000|Overall Study|Death|1|||
94541798|NCT00171925|323778954|FG001|Overall Study|Death|2|||
94541799|NCT02590562|323778957|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
94541800|NCT03249935|323778958|FG000|Overall Study|Discharged from facility early|36|||
94541801|NCT03249935|323778958|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
94541802|NCT03249935|323778958|FG000|Overall Study|Protocol Violation|5|||
94541803|NCT02214225|323778959|FG000|Overall Study|Lost to Follow-up|46|||
94541804|NCT02214225|323778960|FG001|Overall Study|Lost to Follow-up|18|||
94541805|NCT02214225|323778961|FG002|Overall Study|Lost to Follow-up|18|||
94541806|NCT02214225|323778959|FG000|Overall Study|Withdrawal by Subject|2|||
94541807|NCT02214225|323778960|FG001|Overall Study|Withdrawal by Subject|0|||
94541808|NCT02214225|323778961|FG002|Overall Study|Withdrawal by Subject|2|||
94541809|NCT02214225|323778959|FG000|Overall Study|Death|5|||
94541810|NCT02214225|323778960|FG001|Overall Study|Death|0|||
94541811|NCT02214225|323778961|FG002|Overall Study|Death|1|||
94541812|NCT02214225|323778959|FG000|Overall Study|randomized in error, not vaccinated|2|||
94541813|NCT02214225|323778960|FG001|Overall Study|randomized in error, not vaccinated|1|||
94541814|NCT02214225|323778961|FG002|Overall Study|randomized in error, not vaccinated|1|||
94541815|NCT03754582|323778967|FG000|Treatment Phase|Adverse Event|0|||
94541816|NCT03754582|323778968|FG001|Treatment Phase|Adverse Event|1|||
94541817|NCT03754582|323778969|FG002|Treatment Phase|Adverse Event|0|||
94541818|NCT03754582|323778967|FG000|Follow-up Phase|Other|0|||
94541819|NCT03754582|323778968|FG001|Follow-up Phase|Other|0|||
94541820|NCT03754582|323778969|FG002|Follow-up Phase|Other|1|||
94541821|NCT01561755|323778970|FG000|Overall Study|Lost to Follow-up|0|||
94541822|NCT01561755|323778971|FG001|Overall Study|Lost to Follow-up|1|||
94541823|NCT02680574|323778972|FG000|Overall Study|Death|137|||
94541824|NCT02680574|323778973|FG001|Overall Study|Death|137|||
94541825|NCT02680574|323778972|FG000|Overall Study|Withdrawal by Subject|17|||
94541826|NCT02680574|323778973|FG001|Overall Study|Withdrawal by Subject|9|||
94541827|NCT02680574|323778972|FG000|Overall Study|Lost to Follow-up|4|||
94541828|NCT02680574|323778973|FG001|Overall Study|Lost to Follow-up|6|||
94541829|NCT02847858|323778976|FG000|Overall Study|Lost to Follow-up|401|||
94541830|NCT02847858|323778977|FG001|Overall Study|Lost to Follow-up|269|||
94541831|NCT00681564|323778978|FG000|Overall Study|Lost to Follow-up|6|||
94541832|NCT00681564|323778979|FG001|Overall Study|Lost to Follow-up|6|||
94541833|NCT00681564|323778978|FG000|Overall Study|Withdrawal by Subject|0|||
94541834|NCT00681564|323778979|FG001|Overall Study|Withdrawal by Subject|1|||
94541835|NCT00681564|323778978|FG000|Overall Study|Death|0|||
94541836|NCT00681564|323778979|FG001|Overall Study|Death|1|||
94541837|NCT02826421|323778980|FG000|Overall Study|Adverse Event|1|||
94541838|NCT02826421|323778981|FG001|Overall Study|Adverse Event|0|||
94541839|NCT02826421|323778982|FG002|Overall Study|Adverse Event|0|||
94541840|NCT02826421|323778983|FG003|Overall Study|Adverse Event|1|||
94541841|NCT02826421|323778980|FG000|Overall Study|Withdrawal by Subject|1|||
94541842|NCT02826421|323778981|FG001|Overall Study|Withdrawal by Subject|3|||
94541843|NCT02826421|323778982|FG002|Overall Study|Withdrawal by Subject|1|||
94541844|NCT02826421|323778983|FG003|Overall Study|Withdrawal by Subject|1|||
94541845|NCT02826421|323778980|FG000|Overall Study|Reason not given|1|||
94541846|NCT02826421|323778981|FG001|Overall Study|Reason not given|0|||
94541847|NCT02826421|323778982|FG002|Overall Study|Reason not given|1|||
94541848|NCT02826421|323778983|FG003|Overall Study|Reason not given|0|||
94541849|NCT02961790|323778984|FG000|Overall Study|Canceled|4|||
94541850|NCT02961790|323778985|FG001|Overall Study|Canceled|5|||
94541851|NCT02961790|323778986|FG002|Overall Study|Canceled|1|||
94541852|NCT02961790|323778987|FG003|Overall Study|Canceled|4|||
94541853|NCT02961790|323778984|FG000|Overall Study|without baseline data|4|||
94541854|NCT02961790|323778985|FG001|Overall Study|without baseline data|0|||
94541855|NCT02961790|323778986|FG002|Overall Study|without baseline data|1|||
94541856|NCT02961790|323778987|FG003|Overall Study|without baseline data|0|||
94541857|NCT02961790|323778984|FG000|Overall Study|without post baseline data|7|||
94541858|NCT02961790|323778985|FG001|Overall Study|without post baseline data|6|||
94541859|NCT02961790|323778986|FG002|Overall Study|without post baseline data|4|||
94541860|NCT02961790|323778987|FG003|Overall Study|without post baseline data|1|||
94541861|NCT02210221|323778988|FG000|Overall Study|Lack of Efficacy|7|||
94541862|NCT02210221|323778988|FG000|Overall Study|Withdrawal by Subject|43|||
94541863|NCT00355342|323778994|FG000|Overall Study|Adverse Event|13|||
94541864|NCT00355342|323778995|FG001|Overall Study|Adverse Event|15|||
94541865|NCT00355342|323778994|FG000|Overall Study|Lost to Follow-up|4|||
94541866|NCT00355342|323778995|FG001|Overall Study|Lost to Follow-up|2|||
94541867|NCT00355342|323778994|FG000|Overall Study|Withdrawal by Subject|14|||
94541868|NCT00355342|323778995|FG001|Overall Study|Withdrawal by Subject|11|||
94541869|NCT00355342|323778994|FG000|Overall Study|Sponsor terminated study|2|||
94541870|NCT00355342|323778995|FG001|Overall Study|Sponsor terminated study|2|||
94541871|NCT00355342|323778994|FG000|Overall Study|Overcompliant-PI discretion|1|||
94541872|NCT00355342|323778995|FG001|Overall Study|Overcompliant-PI discretion|0|||
94541873|NCT00355342|323778994|FG000|Overall Study|Use of prohibited medication|1|||
94541874|NCT00355342|323778995|FG001|Overall Study|Use of prohibited medication|0|||
94541875|NCT00355342|323778994|FG000|Overall Study|COPD exacerbation|1|||
94541876|NCT00355342|323778995|FG001|Overall Study|COPD exacerbation|1|||
94541877|NCT00355342|323778994|FG000|Overall Study|Dispensed wrong study drug kit|1|||
94541878|NCT00355342|323778995|FG001|Overall Study|Dispensed wrong study drug kit|0|||
94541879|NCT00355342|323778994|FG000|Overall Study|Non-compliance with Dexa scans|1|||
94541880|NCT00355342|323778995|FG001|Overall Study|Non-compliance with Dexa scans|0|||
94541881|NCT00355342|323778994|FG000|Overall Study|Withdrawal by participant and physician|1|||
94541882|NCT00355342|323778995|FG001|Overall Study|Withdrawal by participant and physician|0|||
94541883|NCT00355342|323778994|FG000|Overall Study|Participant relocated|0|||
94541884|NCT00355342|323778995|FG001|Overall Study|Participant relocated|1|||
94541885|NCT00355342|323778994|FG000|Overall Study|Participant discontinued study drug|0|||
94541886|NCT00355342|323778995|FG001|Overall Study|Participant discontinued study drug|1|||
94541887|NCT00355342|323778994|FG000|Overall Study|Study management|0|||
94541888|NCT00355342|323778995|FG001|Overall Study|Study management|1|||
94541889|NCT00355342|323778994|FG000|Overall Study|Protocol Violation|0|||
94541890|NCT00355342|323778995|FG001|Overall Study|Protocol Violation|1|||
94541891|NCT00355342|323778994|FG000|Overall Study|Use of protocol excluded medication|0|||
94541892|NCT00355342|323778995|FG001|Overall Study|Use of protocol excluded medication|1|||
94541893|NCT00787930|323779008|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
94541894|NCT02763254|323780758|FG000|Overall Study|Adverse Event|1|||
94541895|NCT00435162|323780759|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
94541896|NCT00435162|323780760|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
94541897|NCT00435162|323780761|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
94541898|NCT00435162|323780762|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
94541899|NCT00435162|323780763|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
94541900|NCT00435162|323780764|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
94541901|NCT01765426|323780767|FG000|Overall Study|Lost to Follow-up|0|||
94541902|NCT01765426|323780768|FG001|Overall Study|Lost to Follow-up|1|||
94541903|NCT01765426|323780769|FG002|Overall Study|Lost to Follow-up|0|||
94541904|NCT01765426|323780770|FG003|Overall Study|Lost to Follow-up|0|||
94541905|NCT01819129|323780771|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
94541906|NCT01819129|323780772|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
94541907|NCT01819129|323780771|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
94541908|NCT01819129|323780772|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
94541909|NCT01819129|323780771|FG000|Overall Study|Other, Subject moved out of the country|0|||
94541910|NCT01819129|323780772|FG001|Overall Study|Other, Subject moved out of the country|1|||
94541911|NCT01819129|323780771|FG000|Overall Study|Withdrawal by Subject|15|||
94541912|NCT01819129|323780772|FG001|Overall Study|Withdrawal by Subject|15|||
94541913|NCT01819129|323780771|FG000|Overall Study|Lost to Follow-up|5|||
94541914|NCT01819129|323780772|FG001|Overall Study|Lost to Follow-up|2|||
94541915|NCT01819129|323780771|FG000|Overall Study|Lack of Efficacy|0|||
94541916|NCT01819129|323780772|FG001|Overall Study|Lack of Efficacy|1|||
94541917|NCT01819129|323780771|FG000|Overall Study|Adverse Event|1|||
94541918|NCT01819129|323780772|FG001|Overall Study|Adverse Event|4|||
94541919|NCT01819129|323780771|FG000|Overall Study|Death|1|||
94541920|NCT01819129|323780772|FG001|Overall Study|Death|1|||
94541921|NCT01819129|323780771|FG000|Overall Study|Withdrawal Criteria|20|||
94541922|NCT01819129|323780772|FG001|Overall Study|Withdrawal Criteria|15|||
94541923|NCT02836873|323780773|FG000|Overall Study|Protocol Violation|0|||
94541924|NCT02836873|323780774|FG001|Overall Study|Protocol Violation|1|||
94541925|NCT02836873|323780773|FG000|Overall Study|Adverse Event|1|||
94541926|NCT02836873|323780774|FG001|Overall Study|Adverse Event|4|||
94541927|NCT02836873|323780773|FG000|Overall Study|Withdrawal by Subject|2|||
94541928|NCT02836873|323780774|FG001|Overall Study|Withdrawal by Subject|2|||
94541929|NCT02836873|323780773|FG000|Overall Study|Lost to Follow-up|1|||
94541930|NCT02836873|323780774|FG001|Overall Study|Lost to Follow-up|3|||
94541931|NCT02836873|323780773|FG000|Overall Study|Physician Decision|0|||
94541932|NCT02836873|323780774|FG001|Overall Study|Physician Decision|1|||
94541933|NCT02836873|323780773|FG000|Overall Study|Other|1|||
94541934|NCT02836873|323780774|FG001|Overall Study|Other|0|||
94541935|NCT00694096|323780775|FG000|Overall Study|Withdrawal by Subject|5|||
94541936|NCT00853125|323780776|FG000|Overall Study|Study participant's donor was CMV +|1|||
94541937|NCT02914548|323780778|FG000|Overall Study|Adverse Event|15|||
94541938|NCT02914548|323780779|FG001|Overall Study|Adverse Event|7|||
94541939|NCT02914548|323780780|FG002|Overall Study|Adverse Event|15|||
94541940|NCT02914548|323780778|FG000|Overall Study|Physician Decision|2|||
94541941|NCT02914548|323780779|FG001|Overall Study|Physician Decision|2|||
94541942|NCT02914548|323780780|FG002|Overall Study|Physician Decision|0|||
94541943|NCT02914548|323780778|FG000|Overall Study|Protocol Violation|1|||
94541944|NCT02914548|323780779|FG001|Overall Study|Protocol Violation|0|||
94541945|NCT02914548|323780780|FG002|Overall Study|Protocol Violation|0|||
94541946|NCT02914548|323780778|FG000|Overall Study|Withdrawal by Subject|3|||
94541947|NCT02914548|323780779|FG001|Overall Study|Withdrawal by Subject|4|||
94541948|NCT02914548|323780780|FG002|Overall Study|Withdrawal by Subject|4|||
94541949|NCT02914548|323780778|FG000|Overall Study|>40% of body surface area|0|||
94541950|NCT02914548|323780779|FG001|Overall Study|>40% of body surface area|1|||
94541951|NCT02914548|323780780|FG002|Overall Study|>40% of body surface area|1|||
94541952|NCT03023826|323780785|FG000|Period 1|Withdrawal by Subject|0|||
94541953|NCT03023826|323780786|FG001|Period 1|Withdrawal by Subject|0|||
94541954|NCT03023826|323780787|FG002|Period 1|Withdrawal by Subject|0|||
94541955|NCT03023826|323780788|FG003|Period 1|Withdrawal by Subject|0|||
94541956|NCT03023826|323780789|FG004|Period 1|Withdrawal by Subject|1|||
94541957|NCT03023826|323780790|FG005|Period 1|Withdrawal by Subject|0|||
94541958|NCT02460783|323780791|FG000|Overall Study|Withdrawal by Subject|1|||
94541959|NCT02460783|323780792|FG001|Overall Study|Withdrawal by Subject|3|||
94541960|NCT02460783|323780791|FG000|Overall Study|Lost to Follow-up|1|||
94541961|NCT02460783|323780792|FG001|Overall Study|Lost to Follow-up|1|||
94541962|NCT00765882|323780793|FG000|Overall Study|Adverse Event|10|||
94541963|NCT00765882|323780794|FG001|Overall Study|Adverse Event|21|||
94541964|NCT00765882|323780795|FG002|Overall Study|Adverse Event|20|||
94541965|NCT00765882|323780793|FG000|Overall Study|Lack of Efficacy|4|||
94541966|NCT00765882|323780794|FG001|Overall Study|Lack of Efficacy|0|||
94541967|NCT00765882|323780795|FG002|Overall Study|Lack of Efficacy|1|||
94541968|NCT00765882|323780793|FG000|Overall Study|Protocol Violation|4|||
94541969|NCT00765882|323780794|FG001|Overall Study|Protocol Violation|3|||
94541970|NCT00765882|323780795|FG002|Overall Study|Protocol Violation|1|||
94541971|NCT00765882|323780793|FG000|Overall Study|Withdrawal by Subject|2|||
94541972|NCT00765882|323780794|FG001|Overall Study|Withdrawal by Subject|6|||
94541973|NCT00765882|323780795|FG002|Overall Study|Withdrawal by Subject|6|||
94541974|NCT00765882|323780793|FG000|Overall Study|Lost to Follow-up|1|||
94541975|NCT00765882|323780794|FG001|Overall Study|Lost to Follow-up|9|||
94541976|NCT00765882|323780795|FG002|Overall Study|Lost to Follow-up|6|||
94541977|NCT00765882|323780793|FG000|Overall Study|Other Reason|3|||
94541978|NCT00765882|323780794|FG001|Overall Study|Other Reason|1|||
94541979|NCT00765882|323780795|FG002|Overall Study|Other Reason|2|||
94541980|NCT01697462|323780796|FG000|Overall Study|Disease Progression|1|||
94541981|NCT01697462|323780796|FG000|Overall Study|Adverse Event|6|||
94541982|NCT01697462|323780796|FG000|Overall Study|Lost to Follow-up|21|||
94541983|NCT01697462|323780796|FG000|Overall Study|Withdrawal by Subject|12|||
94541984|NCT01697462|323780796|FG000|Overall Study|Investigator Decision|21|||
94541985|NCT01697462|323780796|FG000|Overall Study|Death|1|||
94541986|NCT01697462|323780796|FG000|Overall Study|Other|10|||
94541987|NCT01697462|323780796|FG000|Overall Study|Missing|5|||
94541988|NCT03593681|323780801|FG000|Overall Study|Inadequate sample collected|12|||
94541989|NCT03593681|323780801|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
94541990|NCT03593681|323780801|FG000|Overall Study|Protocol Violation|3|||
94541991|NCT03593681|323780801|FG000|Overall Study|Withdrawal by Subject|3|||
94541992|NCT03593681|323780801|FG000|Overall Study|Procedure not attempted|3|||
94541993|NCT03593681|323780801|FG000|Overall Study|Adverse Event|2|||
94541994|NCT03593681|323780801|FG000|Overall Study|Physician Decision|1|||
94541995|NCT00717522|323780804|FG000|Overall Study|Disease Progression|5|||
94541996|NCT00717522|323780804|FG000|Overall Study|Adverse Event|1|||
94541997|NCT00717522|323780804|FG000|Overall Study|Death|1|||
94541998|NCT03987932|323780805|FG000|Overall Study|Lost to Follow-up|2|||
94541999|NCT03987932|323780806|FG001|Overall Study|Lost to Follow-up|1|||
94542000|NCT03987932|323780807|FG002|Overall Study|Lost to Follow-up|1|||
94542001|NCT03987932|323780805|FG000|Overall Study|Non-study related elective surgery|0|||
94542002|NCT03987932|323780806|FG001|Overall Study|Non-study related elective surgery|0|||
94542003|NCT03987932|323780807|FG002|Overall Study|Non-study related elective surgery|1|||
94542004|NCT01799239|323780811|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
94542005|NCT01799239|323780812|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
94542006|NCT01799239|323780811|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
94542007|NCT01799239|323780812|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
94542008|NCT01799239|323780811|FG000|Period 1 (7 Days)|Protocol Violation|0|||
94542009|NCT01799239|323780812|FG001|Period 1 (7 Days)|Protocol Violation|1|||
94542010|NCT01799239|323780811|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
94542011|NCT01799239|323780812|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
94542012|NCT01799239|323780811|FG000|Period 2 (7 Days)|Protocol Violation|1|||
94542013|NCT01799239|323780812|FG001|Period 2 (7 Days)|Protocol Violation|0|||
94542014|NCT01605227|323780815|FG000|Overall Study|Did not receive study treatment|2|||
94542015|NCT01605227|323780816|FG001|Overall Study|Did not receive study treatment|3|||
94542016|NCT01605227|323780815|FG000|Overall Study|Adverse Event|228|||
94542017|NCT01605227|323780816|FG001|Overall Study|Adverse Event|42|||
94542018|NCT01605227|323780815|FG000|Overall Study|Progressive Disease|132|||
94542019|NCT01605227|323780816|FG001|Overall Study|Progressive Disease|128|||
94542020|NCT01605227|323780815|FG000|Overall Study|Clinical Deterioration|227|||
94542021|NCT01605227|323780816|FG001|Overall Study|Clinical Deterioration|133|||
94542022|NCT01605227|323780815|FG000|Overall Study|Lost to Follow-up|1|||
94542023|NCT01605227|323780816|FG001|Overall Study|Lost to Follow-up|0|||
94542024|NCT01605227|323780815|FG000|Overall Study|Protocol Violation|1|||
94542025|NCT01605227|323780816|FG001|Overall Study|Protocol Violation|0|||
94542026|NCT01605227|323780815|FG000|Overall Study|Physician Decision|9|||
94542027|NCT01605227|323780816|FG001|Overall Study|Physician Decision|7|||
94542028|NCT01605227|323780815|FG000|Overall Study|Withdrawal by Subject|18|||
94542029|NCT01605227|323780816|FG001|Overall Study|Withdrawal by Subject|14|||
94542030|NCT01605227|323780815|FG000|Overall Study|Sponsor Decision|2|||
94542031|NCT01605227|323780816|FG001|Overall Study|Sponsor Decision|0|||
94542032|NCT01605227|323780815|FG000|Overall Study|Started New Therapy|1|||
94542033|NCT01605227|323780816|FG001|Overall Study|Started New Therapy|0|||
94542034|NCT01605227|323780815|FG000|Overall Study|Subject Decision|0|||
94542035|NCT01605227|323780816|FG001|Overall Study|Subject Decision|1|||
94542036|NCT01605227|323780815|FG000|Overall Study|Dose Held >6 weeks|0|||
94542037|NCT01605227|323780816|FG001|Overall Study|Dose Held >6 weeks|1|||
94542038|NCT02594098|323780819|FG000|Overall Study|Lack of Efficacy|17|||
94542039|NCT02594098|323780820|FG001|Overall Study|Lack of Efficacy|6|||
94542040|NCT02594098|323780819|FG000|Overall Study|Withdrawal by Subject|1|||
94542041|NCT02594098|323780820|FG001|Overall Study|Withdrawal by Subject|3|||
94542042|NCT02594098|323780819|FG000|Overall Study|Terminated participation|6|||
94542043|NCT02594098|323780820|FG001|Overall Study|Terminated participation|2|||
94542044|NCT02594098|323780819|FG000|Overall Study|Seek alternative treatment|2|||
94542045|NCT02594098|323780820|FG001|Overall Study|Seek alternative treatment|1|||
94542046|NCT02594098|323780819|FG000|Overall Study|Other|0|||
94542047|NCT02594098|323780820|FG001|Overall Study|Other|1|||
94542048|NCT02078102|323780823|FG000|Overall Study|Adverse Event|1|||
94542049|NCT02078102|323780824|FG001|Overall Study|Adverse Event|0|||
94542050|NCT02078102|323780823|FG000|Overall Study|Withdrawal by Subject|1|||
94542051|NCT02078102|323780824|FG001|Overall Study|Withdrawal by Subject|0|||
94542052|NCT02078102|323780823|FG000|Overall Study|Physician Decision|0|||
94542053|NCT02078102|323780824|FG001|Overall Study|Physician Decision|1|||
94542054|NCT00598078|323780825|FG000|Period 2 (Day 2)|Adverse Event|1|||
94542055|NCT00598078|323780826|FG001|Period 2 (Day 2)|Adverse Event|0|||
94542056|NCT02185014|323780827|FG000|Overall Study|Adverse Event|18|||
94542057|NCT02185014|323780827|FG000|Overall Study|Withdrew Consent|8|||
94542058|NCT02185014|323780827|FG000|Overall Study|Lost to Follow-up|4|||
94542059|NCT02185014|323780827|FG000|Overall Study|Lack of Efficacy|14|||
94542060|NCT02185014|323780827|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
94542061|NCT02185014|323780827|FG000|Overall Study|Subject Noncompliance|1|||
94542062|NCT02185014|323780827|FG000|Overall Study|Other|4|||
94542063|NCT02370641|323780830|FG000|Overall Study|dropped study|4|||
94542064|NCT02370641|323780831|FG001|Overall Study|dropped study|2|||
94542065|NCT02699450|323780832|FG000|Overall Study|Death|2|||
94542066|NCT02699450|323780833|FG001|Overall Study|Death|1|||
94542067|NCT02699450|323780834|FG002|Overall Study|Death|2|||
94542068|NCT02699450|323780832|FG000|Overall Study|Met Criteria for Study Exit|0|||
94542069|NCT02699450|323780833|FG001|Overall Study|Met Criteria for Study Exit|0|||
94542070|NCT02699450|323780834|FG002|Overall Study|Met Criteria for Study Exit|1|||
94542071|NCT02699450|323780832|FG000|Overall Study|Protocol Violation|4|||
94542072|NCT02699450|323780833|FG001|Overall Study|Protocol Violation|3|||
94542073|NCT02699450|323780834|FG002|Overall Study|Protocol Violation|5|||
94542074|NCT02699450|323780832|FG000|Overall Study|Lost to Follow-up|3|||
94542075|NCT02699450|323780833|FG001|Overall Study|Lost to Follow-up|0|||
94542076|NCT02699450|323780834|FG002|Overall Study|Lost to Follow-up|5|||
94542077|NCT02699450|323780832|FG000|Overall Study|Physician Decision|2|||
94542078|NCT02699450|323780833|FG001|Overall Study|Physician Decision|0|||
94542079|NCT02699450|323780834|FG002|Overall Study|Physician Decision|0|||
94542080|NCT02699450|323780832|FG000|Overall Study|Withdrawal by Subject|3|||
94542081|NCT02699450|323780833|FG001|Overall Study|Withdrawal by Subject|1|||
94542082|NCT02699450|323780834|FG002|Overall Study|Withdrawal by Subject|2|||
94542083|NCT02699450|323780832|FG000|Overall Study|Adverse Event|1|||
94542084|NCT02699450|323780833|FG001|Overall Study|Adverse Event|0|||
94542085|NCT02699450|323780834|FG002|Overall Study|Adverse Event|0|||
94542086|NCT01009346|323780837|FG000|Overall Study|Adverse Event|4|||
94542087|NCT00033540|323780838|FG000|Overall Study|Adverse Event|14|||
94542088|NCT00033540|323780838|FG000|Overall Study|Death|1|||
94542089|NCT00033540|323780838|FG000|Overall Study|Progression|26|||
94542090|NCT00033540|323780838|FG000|Overall Study|Withdrawal by Subject|6|||
94542091|NCT00033540|323780838|FG000|Overall Study|Other|5|||
94542092|NCT00033540|323780838|FG000|Overall Study|Ineligible|3|||
94542093|NCT00033540|323780838|FG000|Overall Study|Never received treatment|2|||
94542094|NCT03366103|323780839|FG000|Overall Study|Disease Progression|3|||
94542095|NCT03366103|323780840|FG001|Overall Study|Disease Progression|1|||
94542096|NCT03366103|323780841|FG002|Overall Study|Disease Progression|0|||
94542097|NCT03366103|323780839|FG000|Overall Study|Adverse Event|0|||
94542098|NCT03366103|323780840|FG001|Overall Study|Adverse Event|1|||
94542099|NCT03366103|323780841|FG002|Overall Study|Adverse Event|0|||
94542100|NCT01036529|323780842|FG000|Overall Study|Adverse Event|0|||
94542101|NCT01036529|323780843|FG001|Overall Study|Adverse Event|1|||
94542102|NCT01036529|323780842|FG000|Overall Study|Lost to Follow-up|0|||
94542103|NCT01036529|323780843|FG001|Overall Study|Lost to Follow-up|1|||
94542104|NCT01036529|323780842|FG000|Overall Study|Physician Decision|1|||
94542105|NCT01036529|323780843|FG001|Overall Study|Physician Decision|0|||
94542106|NCT01036529|323780842|FG000|Overall Study|Withdrawal by Subject|1|||
94542107|NCT01036529|323780843|FG001|Overall Study|Withdrawal by Subject|1|||
94542108|NCT01036529|323780842|FG000|Overall Study|Sponsor study termination|11|||
94542109|NCT01036529|323780843|FG001|Overall Study|Sponsor study termination|12|||
94542110|NCT01253265|323780846|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
94542111|NCT01253265|323780847|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
94542112|NCT01253265|323780848|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
94542113|NCT01253265|323780849|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
94542114|NCT01253265|323780850|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
94542115|NCT01253265|323780846|FG000|Overall Study|Withdrawal by Subject|0|||
94542116|NCT01253265|323780847|FG001|Overall Study|Withdrawal by Subject|0|||
94542117|NCT01253265|323780848|FG002|Overall Study|Withdrawal by Subject|0|||
94542118|NCT01253265|323780849|FG003|Overall Study|Withdrawal by Subject|0|||
94542119|NCT01253265|323780850|FG004|Overall Study|Withdrawal by Subject|1|||
94542120|NCT00541099|323780852|FG000|Overall Study|Ineligible|3|||
94542121|NCT03271047|323780853|FG000|Phase 1b: Dose Finding Period|Death|8|||
94542122|NCT03271047|323780854|FG001|Phase 1b: Dose Finding Period|Death|8|||
94542123|NCT03271047|323780855|FG002|Phase 1b: Dose Finding Period|Death|0|||
94542124|NCT03271047|323780856|FG003|Phase 1b: Dose Finding Period|Death|0|||
94542125|NCT03271047|323780853|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
94542126|NCT03271047|323780854|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
94542127|NCT03271047|323780855|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
94542128|NCT03271047|323780856|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
94542129|NCT03271047|323780853|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
94542130|NCT03271047|323780854|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
94542131|NCT03271047|323780855|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
94542132|NCT03271047|323780856|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
94542133|NCT03271047|323780853|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
94542134|NCT03271047|323780854|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
94542135|NCT03271047|323780855|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
94542136|NCT03271047|323780856|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
94542137|NCT03271047|323780853|FG000|Randomized Phase 2 Period|Other|0|||
94542138|NCT03271047|323780854|FG001|Randomized Phase 2 Period|Other|0|||
94542139|NCT03271047|323780855|FG002|Randomized Phase 2 Period|Other|0|||
94542140|NCT03271047|323780856|FG003|Randomized Phase 2 Period|Other|1|||
94542141|NCT03271047|323780853|FG000|Randomized Phase 2 Period|Death|0|||
94542142|NCT03271047|323780854|FG001|Randomized Phase 2 Period|Death|0|||
94542143|NCT03271047|323780855|FG002|Randomized Phase 2 Period|Death|20|||
94542144|NCT03271047|323780856|FG003|Randomized Phase 2 Period|Death|21|||
94542145|NCT03271047|323780853|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
94542146|NCT03271047|323780854|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
94542147|NCT03271047|323780855|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
94542148|NCT03271047|323780856|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
94542149|NCT03271047|323780853|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
94542150|NCT03271047|323780854|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
94542151|NCT03271047|323780855|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
94542152|NCT03271047|323780856|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
94542153|NCT03271047|323780853|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
94542154|NCT03271047|323780854|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
94542155|NCT03271047|323780855|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
94542156|NCT03271047|323780856|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
94542157|NCT00711802|323780857|FG000|Overall Study|Not treated (no further detail)|2|||
94542158|NCT00711802|323780858|FG001|Overall Study|Not treated (no further detail)|1|||
94542159|NCT00711802|323780859|FG002|Overall Study|Not treated (no further detail)|2|||
94542160|NCT00711802|323780860|FG003|Overall Study|Not treated (no further detail)|0|||
94542161|NCT00711802|323780861|FG004|Overall Study|Not treated (no further detail)|2|||
94542162|NCT00711802|323780862|FG005|Overall Study|Not treated (no further detail)|0|||
94542163|NCT00711802|323780863|FG006|Overall Study|Not treated (no further detail)|0|||
94542164|NCT00711802|323780864|FG007|Overall Study|Not treated (no further detail)|0|||
94542165|NCT00711802|323780857|FG000|Overall Study|Adverse Event|0|||
94542166|NCT00711802|323780858|FG001|Overall Study|Adverse Event|0|||
94542167|NCT00711802|323780859|FG002|Overall Study|Adverse Event|0|||
94542168|NCT00711802|323780860|FG003|Overall Study|Adverse Event|0|||
94542169|NCT00711802|323780861|FG004|Overall Study|Adverse Event|1|||
94542170|NCT00711802|323780862|FG005|Overall Study|Adverse Event|1|||
94542171|NCT00711802|323780863|FG006|Overall Study|Adverse Event|0|||
94542172|NCT00711802|323780864|FG007|Overall Study|Adverse Event|0|||
94542173|NCT00711802|323780857|FG000|Overall Study|Microbiological failure|0|||
94542174|NCT00711802|323780858|FG001|Overall Study|Microbiological failure|1|||
94542175|NCT00711802|323780859|FG002|Overall Study|Microbiological failure|0|||
94542176|NCT00711802|323780860|FG003|Overall Study|Microbiological failure|0|||
94542177|NCT00711802|323780861|FG004|Overall Study|Microbiological failure|0|||
94542178|NCT00711802|323780862|FG005|Overall Study|Microbiological failure|1|||
94542179|NCT00711802|323780863|FG006|Overall Study|Microbiological failure|0|||
94542180|NCT00711802|323780864|FG007|Overall Study|Microbiological failure|0|||
94542181|NCT00711802|323780857|FG000|Overall Study|Protocol Violation|0|||
94542182|NCT00711802|323780858|FG001|Overall Study|Protocol Violation|0|||
94542183|NCT00711802|323780859|FG002|Overall Study|Protocol Violation|0|||
94542184|NCT00711802|323780860|FG003|Overall Study|Protocol Violation|1|||
94542185|NCT00711802|323780861|FG004|Overall Study|Protocol Violation|0|||
94542186|NCT00711802|323780862|FG005|Overall Study|Protocol Violation|0|||
94542187|NCT00711802|323780863|FG006|Overall Study|Protocol Violation|0|||
94542188|NCT00711802|323780864|FG007|Overall Study|Protocol Violation|0|||
94542189|NCT00711802|323780857|FG000|Overall Study|Physician Decision|0|||
94542190|NCT00711802|323780858|FG001|Overall Study|Physician Decision|2|||
94542191|NCT00711802|323780859|FG002|Overall Study|Physician Decision|0|||
94542192|NCT00711802|323780860|FG003|Overall Study|Physician Decision|0|||
94542193|NCT00711802|323780861|FG004|Overall Study|Physician Decision|0|||
94542194|NCT00711802|323780862|FG005|Overall Study|Physician Decision|0|||
94542195|NCT00711802|323780863|FG006|Overall Study|Physician Decision|0|||
94542196|NCT00711802|323780864|FG007|Overall Study|Physician Decision|0|||
94542197|NCT00711802|323780857|FG000|Overall Study|Withdrawal by Subject|0|||
94542198|NCT00711802|323780858|FG001|Overall Study|Withdrawal by Subject|1|||
94542199|NCT00711802|323780859|FG002|Overall Study|Withdrawal by Subject|0|||
94542200|NCT00711802|323780860|FG003|Overall Study|Withdrawal by Subject|1|||
94542201|NCT00711802|323780861|FG004|Overall Study|Withdrawal by Subject|0|||
94542202|NCT00711802|323780862|FG005|Overall Study|Withdrawal by Subject|0|||
94542203|NCT00711802|323780863|FG006|Overall Study|Withdrawal by Subject|0|||
94542204|NCT00711802|323780864|FG007|Overall Study|Withdrawal by Subject|0|||
94542205|NCT00711802|323780857|FG000|Overall Study|Lost to Follow-up|0|||
94542206|NCT00711802|323780858|FG001|Overall Study|Lost to Follow-up|0|||
94542207|NCT00711802|323780859|FG002|Overall Study|Lost to Follow-up|3|||
94542208|NCT00711802|323780860|FG003|Overall Study|Lost to Follow-up|1|||
94542209|NCT00711802|323780861|FG004|Overall Study|Lost to Follow-up|10|||
94542210|NCT00711802|323780862|FG005|Overall Study|Lost to Follow-up|6|||
94542211|NCT00711802|323780863|FG006|Overall Study|Lost to Follow-up|4|||
94542212|NCT00711802|323780864|FG007|Overall Study|Lost to Follow-up|2|||
94542213|NCT00711802|323780857|FG000|Overall Study|Reason not reported|0|||
94542214|NCT00711802|323780858|FG001|Overall Study|Reason not reported|1|||
94542215|NCT00711802|323780859|FG002|Overall Study|Reason not reported|1|||
94542216|NCT00711802|323780860|FG003|Overall Study|Reason not reported|0|||
94542217|NCT00711802|323780861|FG004|Overall Study|Reason not reported|1|||
94542218|NCT00711802|323780862|FG005|Overall Study|Reason not reported|0|||
94542219|NCT00711802|323780863|FG006|Overall Study|Reason not reported|1|||
94542220|NCT00711802|323780864|FG007|Overall Study|Reason not reported|0|||
94542221|NCT00882908|323780865|FG000|Overall Study|Adverse Event|0|||
94542222|NCT00882908|323780866|FG001|Overall Study|Adverse Event|0|||
94542223|NCT00882908|323780867|FG002|Overall Study|Adverse Event|1|||
94542224|NCT00882908|323780868|FG003|Overall Study|Adverse Event|0|||
94542225|NCT00882908|323780869|FG004|Overall Study|Adverse Event|1|||
94542226|NCT00882908|323780865|FG000|Overall Study|Lost to Follow-up|3|||
94542227|NCT00882908|323780866|FG001|Overall Study|Lost to Follow-up|5|||
94542228|NCT00882908|323780867|FG002|Overall Study|Lost to Follow-up|3|||
94542229|NCT00882908|323780868|FG003|Overall Study|Lost to Follow-up|1|||
94542230|NCT00882908|323780869|FG004|Overall Study|Lost to Follow-up|2|||
94542231|NCT00882908|323780865|FG000|Overall Study|Protocol Violation|0|||
94542232|NCT00882908|323780866|FG001|Overall Study|Protocol Violation|1|||
94542233|NCT00882908|323780867|FG002|Overall Study|Protocol Violation|0|||
94542234|NCT00882908|323780868|FG003|Overall Study|Protocol Violation|0|||
94542235|NCT00882908|323780869|FG004|Overall Study|Protocol Violation|0|||
94542236|NCT00882908|323780865|FG000|Overall Study|Withdrawal by Subject|0|||
94542237|NCT00882908|323780866|FG001|Overall Study|Withdrawal by Subject|0|||
94542238|NCT00882908|323780867|FG002|Overall Study|Withdrawal by Subject|3|||
94542239|NCT00882908|323780868|FG003|Overall Study|Withdrawal by Subject|5|||
94542240|NCT00882908|323780869|FG004|Overall Study|Withdrawal by Subject|2|||
94542241|NCT00882908|323780865|FG000|Overall Study|Subject reached a virologic endpoint|0|||
94542242|NCT00882908|323780866|FG001|Overall Study|Subject reached a virologic endpoint|0|||
94542243|NCT00882908|323780867|FG002|Overall Study|Subject reached a virologic endpoint|0|||
94542244|NCT00882908|323780868|FG003|Overall Study|Subject reached a virologic endpoint|0|||
94542245|NCT00882908|323780869|FG004|Overall Study|Subject reached a virologic endpoint|1|||
94542246|NCT00882908|323780865|FG000|Overall Study|Study terminated in error|0|||
94542247|NCT00882908|323780866|FG001|Overall Study|Study terminated in error|0|||
94542248|NCT00882908|323780867|FG002|Overall Study|Study terminated in error|0|||
94542249|NCT00882908|323780868|FG003|Overall Study|Study terminated in error|1|||
94542250|NCT00882908|323780869|FG004|Overall Study|Study terminated in error|0|||
94542251|NCT01133275|323780871|FG000|Overall Study|Withdrawal by Subject|1|||
94542252|NCT01133275|323780871|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
94542253|NCT00700102|323780872|FG000|Overall Study|Died|394|||
94542254|NCT00700102|323780873|FG001|Overall Study|Died|385|||
94542255|NCT00700102|323780872|FG000|Overall Study|Lost to Follow-up|8|||
94542256|NCT00700102|323780873|FG001|Overall Study|Lost to Follow-up|10|||
94542257|NCT01667562|323780874|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
94542258|NCT01667562|323780875|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
94542259|NCT01667562|323780874|FG000|Erlotinib Phase|Lost to Follow-up|0|||
94542260|NCT01667562|323780875|FG001|Erlotinib Phase|Lost to Follow-up|1|||
94542261|NCT01667562|323780874|FG000|Erlotinib Phase|Adverse Event|0|||
94542262|NCT01667562|323780875|FG001|Erlotinib Phase|Adverse Event|1|||
94542263|NCT01667562|323780874|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
94542264|NCT01667562|323780875|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
94542265|NCT01129882|323780879|FG000|Overall Study|Adverse Event|39|||
94542266|NCT01129882|323780879|FG000|Overall Study|Death|6|||
94542267|NCT01129882|323780879|FG000|Overall Study|Lack of Efficacy|5|||
94542268|NCT01129882|323780879|FG000|Overall Study|Lost to Follow-up|13|||
94542269|NCT01129882|323780879|FG000|Overall Study|Physician Decision|27|||
94542270|NCT01129882|323780879|FG000|Overall Study|Protocol Deviation|3|||
94542271|NCT01129882|323780879|FG000|Overall Study|Withdrawal Criteria Met|19|||
94542272|NCT01129882|323780879|FG000|Overall Study|Trial Termination by Sponsor|6|||
94542273|NCT01129882|323780879|FG000|Overall Study|Withdrawal by Subject|160|||
94542274|NCT01028716|323780880|FG000|Overall Study|Physician Decision|1|||
94542275|NCT05590000|323780881|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
94542276|NCT00536874|323780882|FG000|Overall Study|Adverse Event|1|||
94542277|NCT00536874|323780882|FG000|Overall Study|Death|2|||
94542278|NCT00536874|323780882|FG000|Overall Study|Withdrawal by Subject|1|||
94542279|NCT00495521|323780886|FG000|Overall Study|Physician Decision|0|||
94542280|NCT00495521|323780887|FG001|Overall Study|Physician Decision|1|||
94542281|NCT02436408|323780888|FG000|Overall Study|Death|1|||
94542282|NCT01300819|323780889|FG000|Overall Study|Adverse Event|9|||
94542283|NCT01300819|323780890|FG001|Overall Study|Adverse Event|27|||
94542284|NCT01300819|323780889|FG000|Overall Study|Lack of Efficacy|2|||
94542285|NCT01300819|323780890|FG001|Overall Study|Lack of Efficacy|1|||
94542286|NCT01300819|323780889|FG000|Overall Study|Withdrawal by Subject|10|||
94542287|NCT01300819|323780890|FG001|Overall Study|Withdrawal by Subject|12|||
94542288|NCT01300819|323780889|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
94542289|NCT01300819|323780890|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
94542290|NCT01300819|323780889|FG000|Overall Study|Refusal to down titrate study drug|0|||
94542291|NCT01300819|323780890|FG001|Overall Study|Refusal to down titrate study drug|1|||
94542292|NCT01300819|323780889|FG000|Overall Study|Administrative reason|0|||
94542293|NCT01300819|323780890|FG001|Overall Study|Administrative reason|1|||
94542294|NCT01300819|323780889|FG000|Overall Study|Safety follow up not done by mistake|0|||
94542295|NCT01300819|323780890|FG001|Overall Study|Safety follow up not done by mistake|1|||
94542296|NCT01300819|323780889|FG000|Overall Study|Follow up call was not done|1|||
94542297|NCT01300819|323780890|FG001|Overall Study|Follow up call was not done|0|||
94542298|NCT02782325|323780891|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
94542299|NCT02782325|323780892|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
94542300|NCT02782325|323780893|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
94542301|NCT02782325|323780891|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
94542302|NCT02782325|323780892|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
94542303|NCT02782325|323780893|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
94542304|NCT02818036|323780896|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
94542305|NCT02818036|323780897|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
94542306|NCT02818036|323780896|FG000|Overall Study|Withdrawal by Subject|1|||
94542307|NCT02818036|323780897|FG001|Overall Study|Withdrawal by Subject|0|||
94542308|NCT01038713|323780898|FG000|Overall Study|Patient to hospice|1|||
94542309|NCT01038713|323780899|FG001|Overall Study|Patient to hospice|1|||
94542310|NCT01038713|323780900|FG002|Overall Study|Patient to hospice|1|||
94542311|NCT01038713|323780898|FG000|Overall Study|Lost to Follow-up|3|||
94542312|NCT01038713|323780899|FG001|Overall Study|Lost to Follow-up|0|||
94542313|NCT01038713|323780900|FG002|Overall Study|Lost to Follow-up|0|||
94542314|NCT01038713|323780898|FG000|Overall Study|Neuroendocrine Tumor|0|||
94542315|NCT01038713|323780899|FG001|Overall Study|Neuroendocrine Tumor|1|||
94542316|NCT01038713|323780900|FG002|Overall Study|Neuroendocrine Tumor|0|||
94542317|NCT01038713|323780898|FG000|Overall Study|died from PEP|0|||
94542318|NCT01038713|323780899|FG001|Overall Study|died from PEP|1|||
94542319|NCT01038713|323780900|FG002|Overall Study|died from PEP|0|||
94542320|NCT01038713|323780898|FG000|Overall Study|Autoimmune Pancreatitis|1|||
94542321|NCT01038713|323780899|FG001|Overall Study|Autoimmune Pancreatitis|0|||
94542322|NCT01038713|323780900|FG002|Overall Study|Autoimmune Pancreatitis|0|||
94542323|NCT03777917|323780904|FG000|Overall Study|Withdrawal by Subject|1|||
94542324|NCT03777917|323780905|FG001|Overall Study|Withdrawal by Subject|0|||
94542325|NCT03777917|323780904|FG000|Overall Study|Physician Decision|1|||
94542326|NCT03777917|323780905|FG001|Overall Study|Physician Decision|0|||
94542327|NCT03777917|323780904|FG000|Overall Study|Lost to Follow-up|6|||
94542328|NCT03777917|323780905|FG001|Overall Study|Lost to Follow-up|2|||
94542329|NCT03777917|323780904|FG000|Overall Study|Other|1|||
94542330|NCT03777917|323780905|FG001|Overall Study|Other|0|||
94542331|NCT00042432|323780906|FG000|Overall Study|Adverse Event|4|||
94542332|NCT00042432|323780907|FG001|Overall Study|Adverse Event|1|||
94542333|NCT00042432|323780906|FG000|Overall Study|Withdrawal by Subject|1|||
94542334|NCT00042432|323780907|FG001|Overall Study|Withdrawal by Subject|3|||
94542335|NCT00042432|323780906|FG000|Overall Study|Death|0|||
94542336|NCT00042432|323780907|FG001|Overall Study|Death|2|||
94542337|NCT00042432|323780906|FG000|Overall Study|Ineligibility determined|1|||
94542338|NCT00042432|323780907|FG001|Overall Study|Ineligibility determined|0|||
94542339|NCT00042432|323780906|FG000|Overall Study|Initiation of maintenance dialysis|1|||
94542340|NCT00042432|323780907|FG001|Overall Study|Initiation of maintenance dialysis|1|||
94542341|NCT00042432|323780906|FG000|Overall Study|Other|2|||
94542342|NCT00042432|323780907|FG001|Overall Study|Other|0|||
94542343|NCT01853072|323780910|FG000|Overall Study|Adverse event prior to treatment|0|||
94542344|NCT01853072|323780911|FG001|Overall Study|Adverse event prior to treatment|1|||
94542345|NCT01853072|323780910|FG000|Overall Study|Adverse Event|0|||
94542346|NCT01853072|323780911|FG001|Overall Study|Adverse Event|3|||
94542347|NCT01853072|323780910|FG000|Overall Study|Death|1|||
94542348|NCT01853072|323780911|FG001|Overall Study|Death|4|||
94542349|NCT01853072|323780910|FG000|Overall Study|Lost to Follow-up|0|||
94542350|NCT01853072|323780911|FG001|Overall Study|Lost to Follow-up|3|||
94542351|NCT01853072|323780910|FG000|Overall Study|Non-compliance with study drug|0|||
94542352|NCT01853072|323780911|FG001|Overall Study|Non-compliance with study drug|1|||
94542353|NCT01853072|323780910|FG000|Overall Study|Physician Decision|1|||
94542354|NCT01853072|323780911|FG001|Overall Study|Physician Decision|1|||
94542355|NCT01853072|323780910|FG000|Overall Study|Withdrawal by Subject|1|||
94542356|NCT01853072|323780911|FG001|Overall Study|Withdrawal by Subject|2|||
94542357|NCT01853072|323780910|FG000|Overall Study|Reason not specified|9|||
94542358|NCT01853072|323780911|FG001|Overall Study|Reason not specified|6|||
94542359|NCT01816906|323780912|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
94542360|NCT01816906|323780913|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
94542361|NCT01816906|323780912|FG000|Six Months|Lost to Follow-up|14|||
94542362|NCT01816906|323780913|FG001|Six Months|Lost to Follow-up|16|||
94542363|NCT01816906|323780912|FG000|12 Months|Adverse Event|2|||
94542364|NCT01816906|323780913|FG001|12 Months|Adverse Event|2|||
94542365|NCT01816906|323780912|FG000|12 Months|Death|0|||
94542366|NCT01816906|323780913|FG001|12 Months|Death|2|||
94542367|NCT01816906|323780912|FG000|12 Months|Lost to Follow-up|2|||
94542368|NCT01816906|323780913|FG001|12 Months|Lost to Follow-up|1|||
94542369|NCT01527383|323780914|FG000|Overall Study|Adverse Event|5|||
94542370|NCT01527383|323780915|FG001|Overall Study|Adverse Event|0|||
94542371|NCT01527383|323780914|FG000|Overall Study|Lost to Follow-up|3|||
94542372|NCT01527383|323780915|FG001|Overall Study|Lost to Follow-up|0|||
94542373|NCT01527383|323780914|FG000|Overall Study|Physician Decision|2|||
94542374|NCT01527383|323780915|FG001|Overall Study|Physician Decision|0|||
94542375|NCT01527383|323780914|FG000|Overall Study|Pregnancy|1|||
94542376|NCT01527383|323780915|FG001|Overall Study|Pregnancy|0|||
94542377|NCT01527383|323780914|FG000|Overall Study|Protocol Violation|1|||
94542378|NCT01527383|323780915|FG001|Overall Study|Protocol Violation|0|||
94542379|NCT01527383|323780914|FG000|Overall Study|Screen failure|1|||
94542380|NCT01527383|323780915|FG001|Overall Study|Screen failure|0|||
94542381|NCT01527383|323780914|FG000|Overall Study|Participant moved|0|||
94542382|NCT01527383|323780915|FG001|Overall Study|Participant moved|1|||
94542383|NCT01527383|323780914|FG000|Overall Study|Withdrawal by Subject|2|||
94542384|NCT01527383|323780915|FG001|Overall Study|Withdrawal by Subject|3|||
94542385|NCT00746733|323780916|FG000|Second Intervention|Adverse Event|1|||
94542386|NCT00746733|323780917|FG001|Second Intervention|Adverse Event|0|||
94542387|NCT00746733|323780916|FG000|Third Intervention|Withdrawal by Subject|1|||
94542388|NCT00746733|323780917|FG001|Third Intervention|Withdrawal by Subject|1|||
94542389|NCT01287221|323780918|FG000|Overall Study|Lack of Perceived Benefit|1|||
94542390|NCT01287221|323780919|FG001|Overall Study|Lack of Perceived Benefit|1|||
94542391|NCT01287221|323780918|FG000|Overall Study|Adverse Event|3|||
94542392|NCT01287221|323780919|FG001|Overall Study|Adverse Event|3|||
94542393|NCT01287221|323780918|FG000|Overall Study|Withdrawal by Subject|0|||
94542394|NCT01287221|323780919|FG001|Overall Study|Withdrawal by Subject|1|||
94542395|NCT02966795|323780921|FG000|Overall Study|Patient Left the Country|0|||
94542396|NCT02966795|323780922|FG001|Overall Study|Patient Left the Country|1|||
94542397|NCT00432744|323780923|FG000|Months 0-6|Withdrawal by Subject|4|||
94542398|NCT00432744|323780924|FG001|Months 0-6|Withdrawal by Subject|4|||
94542399|NCT00432744|323780923|FG000|Months 0-6|Too disabled to score|1|||
94542400|NCT00432744|323780924|FG001|Months 0-6|Too disabled to score|0|||
94542401|NCT00432744|323780923|FG000|Months 7 - 12|Withdrawal by Subject|1|||
94542402|NCT00432744|323780924|FG001|Months 7 - 12|Withdrawal by Subject|0|||
94542403|NCT00432744|323780923|FG000|Months 7 - 12|Too disabled to score|0|||
94542404|NCT00432744|323780924|FG001|Months 7 - 12|Too disabled to score|1|||
94542405|NCT01416441|323780925|FG000|Overall Study|Lost to Follow-up|5|||
94542406|NCT01416441|323780925|FG000|Overall Study|Adverse Event|6|||
94542407|NCT01416441|323780925|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
94542408|NCT01416441|323780925|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
94542409|NCT01416441|323780925|FG000|Overall Study|Investigator Withdrew Subject|2|||
94542410|NCT01416441|323780925|FG000|Overall Study|Subject Withdrew Consent|12|||
94542411|NCT01416441|323780925|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
94542412|NCT00076336|323782517|FG000|Overall Study|Death|13|||
94542413|NCT00076336|323782518|FG001|Overall Study|Death|17|||
94542414|NCT00076336|323782517|FG000|Overall Study|Adverse Event|4|||
94542415|NCT00076336|323782518|FG001|Overall Study|Adverse Event|4|||
94542416|NCT00076336|323782517|FG000|Overall Study|Lost to Follow-up|4|||
94542417|NCT00076336|323782518|FG001|Overall Study|Lost to Follow-up|4|||
94542418|NCT00076336|323782517|FG000|Overall Study|Non-Compliance|2|||
94542419|NCT00076336|323782518|FG001|Overall Study|Non-Compliance|0|||
94542420|NCT00076336|323782517|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
94542421|NCT00076336|323782518|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
94542422|NCT00076336|323782517|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
94542423|NCT00076336|323782518|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
94542424|NCT00076336|323782517|FG000|Overall Study|Liver Transplantation|3|||
94542425|NCT00076336|323782518|FG001|Overall Study|Liver Transplantation|3|||
94542426|NCT00076336|323782517|FG000|Overall Study|Virologic Breakthrough|14|||
94542427|NCT00076336|323782518|FG001|Overall Study|Virologic Breakthrough|16|||
94542428|NCT00076336|323782517|FG000|Overall Study|Treatment failure|4|||
94542429|NCT00076336|323782518|FG001|Overall Study|Treatment failure|5|||
94542430|NCT00524589|323782519|FG000|Overall Study|Withdrawal by Subject|2|||
94542431|NCT00524589|323782519|FG000|Overall Study|Disease Progression|16|||
94542432|NCT01224821|323782520|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
94542433|NCT01224821|323782520|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
94542434|NCT01224821|323782520|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
94542435|NCT01224821|323782520|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
94542436|NCT01224821|323782520|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
94542437|NCT01224821|323782520|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
94542438|NCT01224821|323782520|FG000|Long-Term Follow-Up|Death|2|||
94542439|NCT01224821|323782520|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
94542440|NCT01342965|323782521|FG000|Overall Study|Death|58|||
94542441|NCT01342965|323782522|FG001|Overall Study|Death|57|||
94542442|NCT01342965|323782521|FG000|Overall Study|Lost to Follow-up|5|||
94542443|NCT01342965|323782522|FG001|Overall Study|Lost to Follow-up|3|||
94542444|NCT01342965|323782521|FG000|Overall Study|Other Reasons- Unspecified|44|||
94542445|NCT01342965|323782522|FG001|Overall Study|Other Reasons- Unspecified|38|||
94542446|NCT01342965|323782521|FG000|Overall Study|Withdrawal by Subject|2|||
94542447|NCT01342965|323782522|FG001|Overall Study|Withdrawal by Subject|9|||
94542448|NCT01170598|323782523|FG000|Overall Study|Withdrawal by Subject|1|||
94542449|NCT01170598|323782523|FG000|Overall Study|Death|3|||
94542450|NCT01170598|323782523|FG000|Overall Study|Lost to Follow-up|1|||
94542451|NCT01170598|323782523|FG000|Overall Study|Refused|1|||
94542452|NCT00350623|323782524|FG000|Overall Study|Lost to Follow-up|8|||
94542453|NCT00350623|323782525|FG001|Overall Study|Lost to Follow-up|3|||
94542454|NCT00350623|323782526|FG002|Overall Study|Lost to Follow-up|4|||
94542455|NCT00350623|323782524|FG000|Overall Study|Withdrawal by Subject|0|||
94542456|NCT00350623|323782525|FG001|Overall Study|Withdrawal by Subject|1|||
94542457|NCT00350623|323782526|FG002|Overall Study|Withdrawal by Subject|1|||
94542458|NCT00350623|323782524|FG000|Overall Study|patient traveling outside the country|0|||
94542459|NCT00350623|323782525|FG001|Overall Study|patient traveling outside the country|0|||
94542460|NCT00350623|323782526|FG002|Overall Study|patient traveling outside the country|1|||
94542461|NCT00953524|323782530|FG000|Overall Study|Adverse Event|2|||
94542462|NCT00953524|323782531|FG001|Overall Study|Adverse Event|0|||
94542463|NCT00953524|323782532|FG002|Overall Study|Adverse Event|1|||
94542464|NCT00953524|323782533|FG003|Overall Study|Adverse Event|2|||
94542465|NCT00953524|323782530|FG000|Overall Study|Protocol Violation|18|||
94542466|NCT00953524|323782531|FG001|Overall Study|Protocol Violation|10|||
94542467|NCT00953524|323782532|FG002|Overall Study|Protocol Violation|11|||
94542468|NCT00953524|323782533|FG003|Overall Study|Protocol Violation|6|||
94542469|NCT00953524|323782530|FG000|Overall Study|Lost to Follow-up|0|||
94542470|NCT00953524|323782531|FG001|Overall Study|Lost to Follow-up|1|||
94542471|NCT00953524|323782532|FG002|Overall Study|Lost to Follow-up|1|||
94542472|NCT00953524|323782533|FG003|Overall Study|Lost to Follow-up|0|||
94542473|NCT00953524|323782530|FG000|Overall Study|Withdrawal by Subject|2|||
94542474|NCT00953524|323782531|FG001|Overall Study|Withdrawal by Subject|4|||
94542475|NCT00953524|323782532|FG002|Overall Study|Withdrawal by Subject|1|||
94542476|NCT00953524|323782533|FG003|Overall Study|Withdrawal by Subject|0|||
94542477|NCT03784846|323782539|FG000|Pre-COVID Study|Lost to Follow-up|3|||
94542478|NCT03784846|323782540|FG001|Pre-COVID Study|Lost to Follow-up|3|||
94542479|NCT03784846|323782541|FG002|Pre-COVID Study|Lost to Follow-up|2|||
94542480|NCT03784846|323782539|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
94542481|NCT03784846|323782540|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
94542482|NCT03784846|323782541|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
94542483|NCT03784846|323782539|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
94542484|NCT03784846|323782540|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
94542485|NCT03784846|323782541|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
94542486|NCT03784846|323782539|FG000|Post-COVID Study|Lost to Follow-up|3|||
94542487|NCT03784846|323782540|FG001|Post-COVID Study|Lost to Follow-up|5|||
94542488|NCT03784846|323782541|FG002|Post-COVID Study|Lost to Follow-up|1|||
94542489|NCT03784846|323782539|FG000|Post-COVID Study|Withdrawal by Subject|1|||
94542490|NCT03784846|323782540|FG001|Post-COVID Study|Withdrawal by Subject|2|||
94542491|NCT03784846|323782541|FG002|Post-COVID Study|Withdrawal by Subject|0|||
94542492|NCT03946124|323782542|FG000|Overall Study|Withdrawal by Subject|19|||
94542493|NCT01510184|323782543|FG000|Overall Study|Sponsor discretion|28|||
94542494|NCT01510184|323782544|FG001|Overall Study|Sponsor discretion|28|||
94542495|NCT01510184|323782543|FG000|Overall Study|Death|1|||
94542496|NCT01510184|323782544|FG001|Overall Study|Death|2|||
94542497|NCT01510184|323782543|FG000|Overall Study|Withdrawal by Subject|1|||
94542498|NCT01510184|323782544|FG001|Overall Study|Withdrawal by Subject|4|||
94542499|NCT01510184|323782543|FG000|Overall Study|Other|0|||
94542500|NCT01510184|323782544|FG001|Overall Study|Other|1|||
94542501|NCT00260065|323782549|FG000|Overall Study|Progressive Disease|22|||
94542502|NCT00260065|323782549|FG000|Overall Study|Adverse Event|17|||
94542503|NCT00260065|323782549|FG000|Overall Study|Death|13|||
94542504|NCT00260065|323782549|FG000|Overall Study|Withdrawal by Subject|13|||
94542505|NCT00260065|323782549|FG000|Overall Study|Physician Decision|19|||
94542506|NCT00260065|323782549|FG000|Overall Study|Not otherwise specified|8|||
94542507|NCT00260065|323782549|FG000|Overall Study|Medication Noncompliance|1|||
94542508|NCT00989235|323782550|FG000|Overall Study|Death|0|||
94542509|NCT00989235|323782551|FG001|Overall Study|Death|1|||
94542510|NCT00989235|323782550|FG000|Overall Study|Adverse Event|0|||
94542511|NCT00989235|323782551|FG001|Overall Study|Adverse Event|1|||
94542512|NCT00989235|323782550|FG000|Overall Study|Lack of Efficacy|1|||
94542513|NCT00989235|323782551|FG001|Overall Study|Lack of Efficacy|0|||
94542514|NCT00989235|323782550|FG000|Overall Study|Withdrawal of Consent|1|||
94542515|NCT00989235|323782551|FG001|Overall Study|Withdrawal of Consent|1|||
94542516|NCT00989235|323782550|FG000|Overall Study|Desire to Become Pregnant|1|||
94542517|NCT00989235|323782551|FG001|Overall Study|Desire to Become Pregnant|0|||
94542518|NCT00989235|323782550|FG000|Overall Study|Randomized by Mistake|0|||
94542519|NCT00989235|323782551|FG001|Overall Study|Randomized by Mistake|2|||
94542520|NCT00989235|323782550|FG000|Overall Study|Lost to Follow-up|0|||
94542521|NCT00989235|323782551|FG001|Overall Study|Lost to Follow-up|1|||
94542522|NCT01669421|323782552|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
94542523|NCT01669421|323782552|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
94542524|NCT03093974|323782561|FG000|Overall Study|Withdrawal by Subject|32|||
94542525|NCT03093974|323782562|FG001|Overall Study|Withdrawal by Subject|27|||
94542526|NCT03093974|323782561|FG000|Overall Study|Adverse Event|17|||
94542527|NCT03093974|323782562|FG001|Overall Study|Adverse Event|24|||
94542528|NCT03093974|323782561|FG000|Overall Study|Death|0|||
94542529|NCT03093974|323782562|FG001|Overall Study|Death|1|||
94542530|NCT03093974|323782561|FG000|Overall Study|Non-Compliance with Study Drug|1|||
94542531|NCT03093974|323782562|FG001|Overall Study|Non-Compliance with Study Drug|0|||
94542532|NCT03093974|323782561|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
94542533|NCT03093974|323782562|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
94542534|NCT03093974|323782561|FG000|Overall Study|Lost to Follow-up|0|||
94542535|NCT03093974|323782562|FG001|Overall Study|Lost to Follow-up|1|||
94542536|NCT03093974|323782561|FG000|Overall Study|Other|1|||
94542537|NCT03093974|323782562|FG001|Overall Study|Other|2|||
94542538|NCT01813721|323782563|FG000|Overall Study|Ineligibility determined|63|||
94542539|NCT01813721|323782563|FG000|Overall Study|Withdrawal by Subject|1|||
94542540|NCT01866423|323782564|FG000|Overall Study|Lack of Efficacy|3|||
94542541|NCT01866423|323782564|FG000|Overall Study|Sponsor Decision|1|||
94542542|NCT00810901|323782570|FG000|Overall Study|Lost to Follow-up|88|||
94542543|NCT00810901|323782571|FG001|Overall Study|Lost to Follow-up|58|||
94542544|NCT00581828|323782579|FG000|Overall Study|Protocol Violation|1|||
94542545|NCT01174004|323782584|FG000|Overall Study|Adverse Event|2|||
94542546|NCT01174004|323782585|FG001|Overall Study|Adverse Event|10|||
94542547|NCT01174004|323782584|FG000|Overall Study|Withdrawal by Subject|2|||
94542548|NCT01174004|323782585|FG001|Overall Study|Withdrawal by Subject|3|||
94542549|NCT01174004|323782584|FG000|Overall Study|At Discretion of Sponsor|2|||
94542550|NCT01174004|323782585|FG001|Overall Study|At Discretion of Sponsor|2|||
94542551|NCT01174004|323782584|FG000|Overall Study|Protocol Violation|0|||
94542552|NCT01174004|323782585|FG001|Overall Study|Protocol Violation|1|||
94542553|NCT01174004|323782584|FG000|Overall Study|Physician Decision|1|||
94542554|NCT01174004|323782585|FG001|Overall Study|Physician Decision|0|||
94542555|NCT00434759|323782589|FG000|Overall Study|Lack of Efficacy|5|||
94542556|NCT00434759|323782590|FG001|Overall Study|Lack of Efficacy|4|||
94542557|NCT00434759|323782589|FG000|Overall Study|Withdrawal by Subject|17|||
94542558|NCT00434759|323782590|FG001|Overall Study|Withdrawal by Subject|1|||
94542559|NCT00434759|323782589|FG000|Overall Study|family affairs|2|||
94542560|NCT00434759|323782590|FG001|Overall Study|family affairs|0|||
94542561|NCT00869050|323782592|FG000|Overall Study|Screen Failure|3|||
94542562|NCT01444027|323782596|FG000|Overall Study|Withdrawal by Subject|4|||
94542563|NCT01444027|323782597|FG001|Overall Study|Withdrawal by Subject|10|||
94542564|NCT01444027|323782598|FG002|Overall Study|Withdrawal by Subject|24|||
94542565|NCT01444027|323782596|FG000|Overall Study|Lost to Follow-up|26|||
94542566|NCT01444027|323782597|FG001|Overall Study|Lost to Follow-up|20|||
94542567|NCT01444027|323782598|FG002|Overall Study|Lost to Follow-up|14|||
94542568|NCT01319721|323782602|FG000|Overall Study|Lost to Follow-up|1|||
94542569|NCT01319721|323782603|FG001|Overall Study|Lost to Follow-up|6|||
94542570|NCT02653495|323782606|FG000|Overall Study|Lost to Follow-up|2|||
94542571|NCT02653495|323782607|FG001|Overall Study|Lost to Follow-up|0|||
94542572|NCT02653495|323782606|FG000|Overall Study|Screening Failure|10|||
94542573|NCT02653495|323782607|FG001|Overall Study|Screening Failure|0|||
94542574|NCT00624780|323782608|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
94542575|NCT00624780|323782609|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
94542576|NCT00624780|323782610|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
94542577|NCT00624780|323782611|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
94542578|NCT00624780|323782612|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
94542579|NCT00624780|323782613|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
94542580|NCT00624780|323782608|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
94542581|NCT00624780|323782609|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
94542582|NCT00624780|323782610|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
94542583|NCT00624780|323782611|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
94542584|NCT00624780|323782612|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
94542585|NCT00624780|323782613|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
94542586|NCT00624780|323782608|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
94542587|NCT00624780|323782609|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
94542588|NCT00624780|323782610|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
94542589|NCT00624780|323782611|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
94542590|NCT00624780|323782612|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
94542591|NCT00624780|323782613|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
94542592|NCT00624780|323782608|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
94542593|NCT00624780|323782609|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
94542594|NCT00624780|323782610|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
94542595|NCT00624780|323782611|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
94542596|NCT00624780|323782612|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
94542597|NCT00624780|323782613|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
94542598|NCT00624780|323782608|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
94542599|NCT00624780|323782609|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
94542600|NCT00624780|323782610|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
94542601|NCT00624780|323782611|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
94542602|NCT00624780|323782612|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
94542603|NCT00624780|323782613|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
94542604|NCT00624780|323782608|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
94542605|NCT00624780|323782609|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
94542606|NCT00624780|323782610|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
94542607|NCT00624780|323782611|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
94542608|NCT00624780|323782612|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
94542609|NCT00624780|323782613|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
94542610|NCT00624780|323782608|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
94542611|NCT00624780|323782609|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
94542612|NCT00624780|323782610|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
94542613|NCT00624780|323782611|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
94542614|NCT00624780|323782612|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
94542615|NCT00624780|323782613|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
94542616|NCT00624780|323782608|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
94542617|NCT00624780|323782609|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
94542618|NCT00624780|323782610|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
94542619|NCT00624780|323782611|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
94542620|NCT00624780|323782612|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
94542621|NCT00624780|323782613|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
94542622|NCT00624780|323782608|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
94542623|NCT00624780|323782609|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
94542624|NCT00624780|323782610|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
94542625|NCT00624780|323782611|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
94542626|NCT00624780|323782612|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
94542627|NCT00624780|323782613|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
94542628|NCT00624780|323782608|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
94542629|NCT00624780|323782609|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
94542630|NCT00624780|323782610|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
94542631|NCT00624780|323782611|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
94542632|NCT00624780|323782612|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
94542633|NCT00624780|323782613|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
94542634|NCT00624780|323782608|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
94542635|NCT00624780|323782609|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
94542636|NCT00624780|323782610|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
94542637|NCT00624780|323782611|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
94542638|NCT00624780|323782612|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
94542639|NCT00624780|323782613|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
94542640|NCT00624780|323782608|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
94542641|NCT00624780|323782609|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
94542642|NCT00624780|323782610|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
94542643|NCT00624780|323782611|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
94542644|NCT00624780|323782612|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
94542645|NCT00624780|323782613|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
94542646|NCT00624780|323782608|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
94542647|NCT00624780|323782609|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
94542648|NCT00624780|323782610|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
94542649|NCT00624780|323782611|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
94542650|NCT00624780|323782612|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
94542651|NCT00624780|323782613|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
94542652|NCT00624780|323782608|FG000|Follow-up (Week 26)|Death|0|||
94542653|NCT00624780|323782609|FG001|Follow-up (Week 26)|Death|0|||
94542654|NCT00624780|323782610|FG002|Follow-up (Week 26)|Death|1|||
94542655|NCT00624780|323782611|FG003|Follow-up (Week 26)|Death|0|||
94542656|NCT00624780|323782612|FG004|Follow-up (Week 26)|Death|0|||
94542657|NCT00624780|323782613|FG005|Follow-up (Week 26)|Death|0|||
94542658|NCT00624780|323782608|FG000|Follow-up (Week 26)|Adverse Event|0|||
94542659|NCT00624780|323782609|FG001|Follow-up (Week 26)|Adverse Event|0|||
94542660|NCT00624780|323782610|FG002|Follow-up (Week 26)|Adverse Event|0|||
94542661|NCT00624780|323782611|FG003|Follow-up (Week 26)|Adverse Event|0|||
94542662|NCT00624780|323782612|FG004|Follow-up (Week 26)|Adverse Event|1|||
94542663|NCT00624780|323782613|FG005|Follow-up (Week 26)|Adverse Event|0|||
94542664|NCT00624780|323782608|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
94542665|NCT00624780|323782609|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
94542666|NCT00624780|323782610|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
94542667|NCT00624780|323782611|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
94542668|NCT00624780|323782612|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
94542669|NCT00624780|323782613|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
94542670|NCT00624780|323782608|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
94542671|NCT00624780|323782609|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
94542672|NCT00624780|323782610|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
94542673|NCT00624780|323782611|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
94542674|NCT00624780|323782612|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
94542675|NCT00624780|323782613|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
94542676|NCT00624780|323782608|FG000|Follow-up (Week 26)|Other|1|||
94542677|NCT00624780|323782609|FG001|Follow-up (Week 26)|Other|1|||
94542678|NCT00624780|323782610|FG002|Follow-up (Week 26)|Other|0|||
94542679|NCT00624780|323782611|FG003|Follow-up (Week 26)|Other|0|||
94542680|NCT00624780|323782612|FG004|Follow-up (Week 26)|Other|0|||
94542681|NCT00624780|323782613|FG005|Follow-up (Week 26)|Other|0|||
94542682|NCT01515475|323782614|FG000|Overall Study|Lost to Follow-up|20|||
94542683|NCT01515475|323782615|FG001|Overall Study|Lost to Follow-up|15|||
94542684|NCT01515475|323782616|FG002|Overall Study|Lost to Follow-up|12|||
94542685|NCT01515475|323782617|FG003|Overall Study|Lost to Follow-up|12|||
94542686|NCT05028517|323782618|FG000|Overall Study|Lost to Follow-up|13|||
94542687|NCT05028517|323782619|FG001|Overall Study|Lost to Follow-up|20|||
94542688|NCT05028517|323782620|FG002|Overall Study|Lost to Follow-up|12|||
94542689|NCT05028517|323782618|FG000|Overall Study|Withdrawal by Subject|0|||
94542690|NCT05028517|323782619|FG001|Overall Study|Withdrawal by Subject|0|||
94542691|NCT05028517|323782620|FG002|Overall Study|Withdrawal by Subject|1|||
94542692|NCT01460407|323782623|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
94542693|NCT01460407|323782624|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
94542694|NCT01367704|323782626|FG000|Overall Study|Lost to Follow-up|47|||
94542695|NCT01367704|323782627|FG001|Overall Study|Lost to Follow-up|161|||
94542696|NCT00645528|323782628|FG000|Overall Study|Did not show up for Visit 2|7|||
94542697|NCT01886690|323782629|FG000|Overall Study|Protocol Violation|0|||
94542698|NCT01886690|323782630|FG001|Overall Study|Protocol Violation|1|||
94542699|NCT01886690|323782629|FG000|Overall Study|Personal Reasons|0|||
94542700|NCT01886690|323782630|FG001|Overall Study|Personal Reasons|1|||
94542701|NCT01011933|323782631|FG000|Overall Study|Wrong cell type|1|||
94542702|NCT01011933|323782631|FG000|Overall Study|Improper pre-protocol Rx|1|||
94542703|NCT01011933|323782631|FG000|Overall Study|Inadequate pathology|1|||
94542704|NCT01011933|323782631|FG000|Overall Study|Never treated|1|||
94542705|NCT01140568|323782633|FG000|Overall Study|disease progression|31|||
94542706|NCT01140568|323782633|FG000|Overall Study|Withdrawal by Subject|1|||
94542707|NCT01140568|323782633|FG000|Overall Study|Screen Fail|4|||
94542708|NCT03618628|323782635|FG000|Overall Study|Death|1|||
94542709|NCT03618628|323782635|FG000|Overall Study|Lost to Follow-up|1|||
94542710|NCT00953680|323782636|FG000|Period 1|Withdrawal by Subject|0|||
94542711|NCT00953680|323782637|FG001|Period 1|Withdrawal by Subject|1|||
94542712|NCT02193087|323782638|FG000|Overall Study|Adverse Event|2|||
94542713|NCT02193087|323782639|FG001|Overall Study|Adverse Event|0|||
94542714|NCT02193087|323782640|FG002|Overall Study|Adverse Event|0|||
94542715|NCT02193087|323782641|FG003|Overall Study|Adverse Event|11|||
94542716|NCT02193087|323782638|FG000|Overall Study|Lost to Follow-up|14|||
94542717|NCT02193087|323782639|FG001|Overall Study|Lost to Follow-up|6|||
94542718|NCT02193087|323782640|FG002|Overall Study|Lost to Follow-up|4|||
94542719|NCT02193087|323782641|FG003|Overall Study|Lost to Follow-up|37|||
94542720|NCT02193087|323782638|FG000|Overall Study|Protocol Violation|2|||
94542721|NCT02193087|323782639|FG001|Overall Study|Protocol Violation|0|||
94542722|NCT02193087|323782640|FG002|Overall Study|Protocol Violation|1|||
94542723|NCT02193087|323782641|FG003|Overall Study|Protocol Violation|2|||
94542724|NCT02193087|323782638|FG000|Overall Study|Withdrawal by Subject|10|||
94542725|NCT02193087|323782639|FG001|Overall Study|Withdrawal by Subject|3|||
94542726|NCT02193087|323782640|FG002|Overall Study|Withdrawal by Subject|1|||
94542727|NCT02193087|323782641|FG003|Overall Study|Withdrawal by Subject|19|||
94542728|NCT02193087|323782638|FG000|Overall Study|Other Reason Not Specified|7|||
94542729|NCT02193087|323782639|FG001|Overall Study|Other Reason Not Specified|2|||
94542730|NCT02193087|323782640|FG002|Overall Study|Other Reason Not Specified|1|||
94542731|NCT02193087|323782641|FG003|Overall Study|Other Reason Not Specified|9|||
94542732|NCT02193087|323782638|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
94542733|NCT02193087|323782639|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
94542734|NCT02193087|323782640|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
94542735|NCT02193087|323782641|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
94542736|NCT03757130|323782642|FG000|Overall Study|Lost to Follow-up|0|||
94542737|NCT03757130|323782643|FG001|Overall Study|Lost to Follow-up|0|||
94542738|NCT03757130|323782644|FG002|Overall Study|Lost to Follow-up|0|||
94542739|NCT03757130|323782645|FG003|Overall Study|Lost to Follow-up|1|||
94542740|NCT03757130|323782646|FG004|Overall Study|Lost to Follow-up|0|||
94542741|NCT03757130|323782647|FG005|Overall Study|Lost to Follow-up|0|||
94542742|NCT03757130|323782648|FG006|Overall Study|Lost to Follow-up|0|||
94542743|NCT03757130|323782649|FG007|Overall Study|Lost to Follow-up|1|||
94542744|NCT03757130|323782642|FG000|Overall Study|Withdrawal by Subject|0|||
94542745|NCT03757130|323782643|FG001|Overall Study|Withdrawal by Subject|0|||
94542746|NCT03757130|323782644|FG002|Overall Study|Withdrawal by Subject|0|||
94542747|NCT03757130|323782645|FG003|Overall Study|Withdrawal by Subject|0|||
94542748|NCT03757130|323782646|FG004|Overall Study|Withdrawal by Subject|0|||
94542749|NCT03757130|323782647|FG005|Overall Study|Withdrawal by Subject|0|||
94542750|NCT03757130|323782648|FG006|Overall Study|Withdrawal by Subject|1|||
94542751|NCT03757130|323782649|FG007|Overall Study|Withdrawal by Subject|0|||
94542752|NCT04941807|323782651|FG000|Overall Study|Lost to Follow-up|1|||
94542753|NCT04941807|323782652|FG001|Overall Study|Lost to Follow-up|1|||
94542754|NCT01453946|323782653|FG000|Overall Study|Did not receive drug for the taper phase|1|||
94542755|NCT01453946|323782653|FG000|Overall Study|Protocol Violation|2|||
94542756|NCT01453946|323782653|FG000|Overall Study|Lack of Efficacy|3|||
94542757|NCT01453946|323782653|FG000|Overall Study|Adverse Event|3|||
94542758|NCT02153346|323782654|FG000|Overall Study|Lost to Follow-up|11|||
94542759|NCT01710527|323782655|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
94542760|NCT01710527|323782656|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
94542761|NCT02635347|323782658|FG000|Overall Study|Failed screening|20|||
94542762|NCT02635347|323782659|FG001|Overall Study|Failed screening|7|||
94542763|NCT03158272|323782662|FG000|Overall Study|Disease progression|3|||
94542764|NCT03158272|323782663|FG001|Overall Study|Disease progression|3|||
94542765|NCT03158272|323782664|FG002|Overall Study|Disease progression|4|||
94542766|NCT03158272|323782665|FG003|Overall Study|Disease progression|6|||
94542767|NCT03158272|323782662|FG000|Overall Study|Death|0|||
94542768|NCT03158272|323782663|FG001|Overall Study|Death|0|||
94542769|NCT03158272|323782664|FG002|Overall Study|Death|1|||
94542770|NCT03158272|323782665|FG003|Overall Study|Death|0|||
94542771|NCT03158272|323782662|FG000|Overall Study|Other reasons|0|||
94542772|NCT03158272|323782663|FG001|Overall Study|Other reasons|0|||
94542773|NCT03158272|323782664|FG002|Overall Study|Other reasons|1|||
94542774|NCT03158272|323782665|FG003|Overall Study|Other reasons|0|||
94542775|NCT03158272|323782662|FG000|Overall Study|Adverse event unrelated to the drug|0|||
94542776|NCT03158272|323782663|FG001|Overall Study|Adverse event unrelated to the drug|1|||
94542777|NCT03158272|323782664|FG002|Overall Study|Adverse event unrelated to the drug|0|||
94542778|NCT03158272|323782665|FG003|Overall Study|Adverse event unrelated to the drug|0|||
94542779|NCT00149994|323784588|FG000|Overall Study|Administrative problems:|1|||
94542780|NCT00149994|323784589|FG001|Overall Study|Administrative problems:|0|||
94542781|NCT00149994|323784588|FG000|Overall Study|Protocol Violation|0|||
94542782|NCT00149994|323784589|FG001|Overall Study|Protocol Violation|1|||
94542783|NCT01655381|323784590|FG000|Overall Study|Investigator Decision|1|||
94542784|NCT01655381|323784590|FG000|Overall Study|Moved to Another City|1|||
94542785|NCT01655381|323784590|FG000|Overall Study|Insufficient Treatment Response|1|||
94542786|NCT03405935|323784591|FG000|Overall Study|Adverse Event|3|||
94542787|NCT03405935|323784591|FG000|Overall Study|Death|2|||
94542788|NCT03405935|323784591|FG000|Overall Study|Withdrawal by Subject|1|||
94542789|NCT03405935|323784591|FG000|Overall Study|Lost to Follow-up|2|||
94542790|NCT03383783|323784593|FG000|Overall Study|Withdrawal by Subject|2|||
94542791|NCT03538444|323784594|FG000|Overall Study|opioid withdrawal|1|||
94542792|NCT03538444|323784595|FG001|Overall Study|opioid withdrawal|0|||
94542793|NCT03362931|323784597|FG000|Overall Study|Adverse Event|1|||
94542794|NCT03362931|323784597|FG000|Overall Study|Death|2|||
94542795|NCT01643850|323784598|FG000|Overall Study|Withdrawal by Subject|0|||
94542796|NCT01643850|323784599|FG001|Overall Study|Withdrawal by Subject|0|||
94542797|NCT01643850|323784600|FG002|Overall Study|Withdrawal by Subject|0|||
94542798|NCT01643850|323784601|FG003|Overall Study|Withdrawal by Subject|0|||
94542799|NCT01643850|323784602|FG004|Overall Study|Withdrawal by Subject|1|||
94542800|NCT01643850|323784603|FG005|Overall Study|Withdrawal by Subject|0|||
94542801|NCT01643850|323784604|FG006|Overall Study|Withdrawal by Subject|0|||
94542802|NCT01643850|323784605|FG007|Overall Study|Withdrawal by Subject|0|||
94542803|NCT01643850|323784606|FG008|Overall Study|Withdrawal by Subject|0|||
94542804|NCT01643850|323784598|FG000|Overall Study|Lost to Follow-up|0|||
94542805|NCT01643850|323784599|FG001|Overall Study|Lost to Follow-up|0|||
94542806|NCT01643850|323784600|FG002|Overall Study|Lost to Follow-up|0|||
94542807|NCT01643850|323784601|FG003|Overall Study|Lost to Follow-up|0|||
94542808|NCT01643850|323784602|FG004|Overall Study|Lost to Follow-up|0|||
94542809|NCT01643850|323784603|FG005|Overall Study|Lost to Follow-up|0|||
94542810|NCT01643850|323784604|FG006|Overall Study|Lost to Follow-up|1|||
94542811|NCT01643850|323784605|FG007|Overall Study|Lost to Follow-up|0|||
94542812|NCT01643850|323784606|FG008|Overall Study|Lost to Follow-up|1|||
94542813|NCT01643850|323784598|FG000|Overall Study|Adverse Event|0|||
94542814|NCT01643850|323784599|FG001|Overall Study|Adverse Event|0|||
94542815|NCT01643850|323784600|FG002|Overall Study|Adverse Event|0|||
94542816|NCT01643850|323784601|FG003|Overall Study|Adverse Event|0|||
94542817|NCT01643850|323784602|FG004|Overall Study|Adverse Event|1|||
94542818|NCT01643850|323784603|FG005|Overall Study|Adverse Event|0|||
94542819|NCT01643850|323784604|FG006|Overall Study|Adverse Event|0|||
94542820|NCT01643850|323784605|FG007|Overall Study|Adverse Event|0|||
94542821|NCT01643850|323784606|FG008|Overall Study|Adverse Event|0|||
94542822|NCT01643850|323784598|FG000|Overall Study|Administrative Problems|0|||
94542823|NCT01643850|323784599|FG001|Overall Study|Administrative Problems|0|||
94542824|NCT01643850|323784600|FG002|Overall Study|Administrative Problems|1|||
94542825|NCT01643850|323784601|FG003|Overall Study|Administrative Problems|0|||
94542826|NCT01643850|323784602|FG004|Overall Study|Administrative Problems|1|||
94542827|NCT01643850|323784603|FG005|Overall Study|Administrative Problems|0|||
94542828|NCT01643850|323784604|FG006|Overall Study|Administrative Problems|0|||
94542829|NCT01643850|323784605|FG007|Overall Study|Administrative Problems|0|||
94542830|NCT01643850|323784606|FG008|Overall Study|Administrative Problems|0|||
94542831|NCT02334683|323784608|FG000|First 12 Week Period|Lost to Follow-up|1|||
94542832|NCT02334683|323784609|FG001|First 12 Week Period|Lost to Follow-up|0|||
94542833|NCT02334683|323784608|FG000|Second 12 Week Period|Adverse Event|0|||
94542834|NCT02334683|323784609|FG001|Second 12 Week Period|Adverse Event|1|||
94542835|NCT01062841|323784610|FG000|Overall Study|Indwelling Device Removed|41|||
94542836|NCT01062841|323784611|FG001|Overall Study|Indwelling Device Removed|48|||
94542837|NCT01062841|323784610|FG000|Overall Study|Death|3|||
94542838|NCT01062841|323784611|FG001|Overall Study|Death|5|||
94542839|NCT01062841|323784610|FG000|Overall Study|Withdrawal by Subject|2|||
94542840|NCT01062841|323784611|FG001|Overall Study|Withdrawal by Subject|0|||
94542841|NCT01062841|323784610|FG000|Overall Study|Withdrawal by Study|3|||
94542842|NCT01062841|323784611|FG001|Overall Study|Withdrawal by Study|0|||
94542843|NCT02046174|323784612|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
94542844|NCT02046174|323784613|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
94542845|NCT00919867|323784614|FG000|First Intervention|Withdrawal by Subject|0|||
94542846|NCT00919867|323784615|FG001|First Intervention|Withdrawal by Subject|0|||
94542847|NCT00919867|323784616|FG002|First Intervention|Withdrawal by Subject|1|||
94542848|NCT00919867|323784617|FG003|First Intervention|Withdrawal by Subject|0|||
94542849|NCT00919867|323784618|FG004|First Intervention|Withdrawal by Subject|0|||
94542850|NCT00919867|323784619|FG005|First Intervention|Withdrawal by Subject|0|||
94542851|NCT00919867|323784614|FG000|First Intervention|Physician Decision|0|||
94542852|NCT00919867|323784615|FG001|First Intervention|Physician Decision|0|||
94542853|NCT00919867|323784616|FG002|First Intervention|Physician Decision|0|||
94542854|NCT00919867|323784617|FG003|First Intervention|Physician Decision|0|||
94542855|NCT00919867|323784618|FG004|First Intervention|Physician Decision|0|||
94542856|NCT00919867|323784619|FG005|First Intervention|Physician Decision|1|||
94542857|NCT01185964|323784620|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
94542858|NCT01185964|323784621|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
94542859|NCT01185964|323784622|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
94542860|NCT01185964|323784623|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
94542861|NCT01185964|323784620|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
94542862|NCT01185964|323784621|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
94542863|NCT01185964|323784622|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
94542864|NCT01185964|323784623|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
94542865|NCT01185964|323784620|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
94542866|NCT01185964|323784621|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
94542867|NCT01185964|323784622|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
94542868|NCT01185964|323784623|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
94542869|NCT01185964|323784620|FG000|Phase 1b and Phase 2|Adverse Event|1|||
94542870|NCT01185964|323784621|FG001|Phase 1b and Phase 2|Adverse Event|0|||
94542871|NCT01185964|323784622|FG002|Phase 1b and Phase 2|Adverse Event|2|||
94542872|NCT01185964|323784623|FG003|Phase 1b and Phase 2|Adverse Event|0|||
94542873|NCT01185964|323784620|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
94542874|NCT01185964|323784621|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
94542875|NCT01185964|323784622|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
94542876|NCT01185964|323784623|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
94542877|NCT01185964|323784620|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
94542878|NCT01185964|323784621|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
94542879|NCT01185964|323784622|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
94542880|NCT01185964|323784623|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
94542881|NCT01185964|323784620|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
94542882|NCT01185964|323784621|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
94542883|NCT01185964|323784622|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
94542884|NCT01185964|323784623|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
94542885|NCT01185964|323784620|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
94542886|NCT01185964|323784621|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
94542887|NCT01185964|323784622|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
94542888|NCT01185964|323784623|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
94542889|NCT01920893|323784624|FG000|Overall Study|Adverse Event|5|||
94542890|NCT01920893|323784625|FG001|Overall Study|Adverse Event|2|||
94542891|NCT01920893|323784624|FG000|Overall Study|Lack of Efficacy|2|||
94542892|NCT01920893|323784625|FG001|Overall Study|Lack of Efficacy|0|||
94542893|NCT04962230|323784637|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
94542894|NCT04962230|323784637|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
94542895|NCT02118597|323784638|FG000|Overall Study|Sponsor terminated the study|14|||
94542896|NCT02118597|323784638|FG000|Overall Study|Serious Adverse Event|1|||
94542897|NCT02118597|323784638|FG000|Overall Study|Investigator's decision|1|||
94542898|NCT02275117|323784641|FG000|Overall Study|Adverse Event|0|||
94542899|NCT02275117|323784642|FG001|Overall Study|Adverse Event|0|||
94542900|NCT02275117|323784643|FG002|Overall Study|Adverse Event|0|||
94542901|NCT02275117|323784644|FG003|Overall Study|Adverse Event|0|||
94542902|NCT02275117|323784645|FG004|Overall Study|Adverse Event|1|||
94542903|NCT02275117|323784641|FG000|Overall Study|Lack of Efficacy|6|||
94542904|NCT02275117|323784642|FG001|Overall Study|Lack of Efficacy|7|||
94542905|NCT02275117|323784643|FG002|Overall Study|Lack of Efficacy|5|||
94542906|NCT02275117|323784644|FG003|Overall Study|Lack of Efficacy|2|||
94542907|NCT02275117|323784645|FG004|Overall Study|Lack of Efficacy|10|||
94542908|NCT02275117|323784641|FG000|Overall Study|Lost to Follow-up|11|||
94542909|NCT02275117|323784642|FG001|Overall Study|Lost to Follow-up|16|||
94542910|NCT02275117|323784643|FG002|Overall Study|Lost to Follow-up|15|||
94542911|NCT02275117|323784644|FG003|Overall Study|Lost to Follow-up|16|||
94542912|NCT02275117|323784645|FG004|Overall Study|Lost to Follow-up|8|||
94542913|NCT02275117|323784641|FG000|Overall Study|Physician Decision|0|||
94542914|NCT02275117|323784642|FG001|Overall Study|Physician Decision|1|||
94542915|NCT02275117|323784643|FG002|Overall Study|Physician Decision|1|||
94542916|NCT02275117|323784644|FG003|Overall Study|Physician Decision|0|||
94542917|NCT02275117|323784645|FG004|Overall Study|Physician Decision|1|||
94542918|NCT02275117|323784641|FG000|Overall Study|Protocol Violation|1|||
94542919|NCT02275117|323784642|FG001|Overall Study|Protocol Violation|0|||
94542920|NCT02275117|323784643|FG002|Overall Study|Protocol Violation|1|||
94542921|NCT02275117|323784644|FG003|Overall Study|Protocol Violation|1|||
94542922|NCT02275117|323784645|FG004|Overall Study|Protocol Violation|0|||
94542923|NCT02275117|323784641|FG000|Overall Study|Withdrawal by Subject|6|||
94542924|NCT02275117|323784642|FG001|Overall Study|Withdrawal by Subject|4|||
94542925|NCT02275117|323784643|FG002|Overall Study|Withdrawal by Subject|7|||
94542926|NCT02275117|323784644|FG003|Overall Study|Withdrawal by Subject|3|||
94542927|NCT02275117|323784645|FG004|Overall Study|Withdrawal by Subject|3|||
94542928|NCT02275117|323784641|FG000|Overall Study|Terminated by Sponsor|4|||
94542929|NCT02275117|323784642|FG001|Overall Study|Terminated by Sponsor|4|||
94542930|NCT02275117|323784643|FG002|Overall Study|Terminated by Sponsor|4|||
94542931|NCT02275117|323784644|FG003|Overall Study|Terminated by Sponsor|6|||
94542932|NCT02275117|323784645|FG004|Overall Study|Terminated by Sponsor|4|||
94542933|NCT02275117|323784641|FG000|Overall Study|Worsening of Study Indication|0|||
94542934|NCT02275117|323784642|FG001|Overall Study|Worsening of Study Indication|1|||
94542935|NCT02275117|323784643|FG002|Overall Study|Worsening of Study Indication|2|||
94542936|NCT02275117|323784644|FG003|Overall Study|Worsening of Study Indication|0|||
94542937|NCT02275117|323784645|FG004|Overall Study|Worsening of Study Indication|0|||
94542938|NCT02275117|323784641|FG000|Overall Study|Study Burden|5|||
94542939|NCT02275117|323784642|FG001|Overall Study|Study Burden|4|||
94542940|NCT02275117|323784643|FG002|Overall Study|Study Burden|7|||
94542941|NCT02275117|323784644|FG003|Overall Study|Study Burden|5|||
94542942|NCT02275117|323784645|FG004|Overall Study|Study Burden|7|||
94542943|NCT02275117|323784641|FG000|Overall Study|Other|1|||
94542944|NCT02275117|323784642|FG001|Overall Study|Other|0|||
94542945|NCT02275117|323784643|FG002|Overall Study|Other|0|||
94542946|NCT02275117|323784644|FG003|Overall Study|Other|0|||
94542947|NCT02275117|323784645|FG004|Overall Study|Other|2|||
94542948|NCT00054691|323784646|FG000|Overall Study|Unmeasurable Disease|2|||
94542949|NCT00054691|323784646|FG000|Overall Study|Noncompliant|1|||
94542950|NCT03351114|323784654|FG000|Overall Study|Withdrawal by Subject|1|||
94542951|NCT01665430|323784658|FG000|Overall Study|Adverse Event|1|||
94542952|NCT01665430|323784658|FG000|Overall Study|Withdrawal by Subject|6|||
94542953|NCT01665430|323784658|FG000|Overall Study|Other Unspecified|2|||
94542954|NCT00545532|323784661|FG000|Overall Study|Withdrawal by Subject|1|||
94542955|NCT00545532|323784662|FG001|Overall Study|Withdrawal by Subject|3|||
94542956|NCT00545532|323784661|FG000|Overall Study|Lost to Follow-up|5|||
94542957|NCT00545532|323784662|FG001|Overall Study|Lost to Follow-up|6|||
94542958|NCT00545532|323784661|FG000|Overall Study|Death|0|||
94542959|NCT00545532|323784662|FG001|Overall Study|Death|1|||
94542960|NCT01149486|323784663|FG000|First Intervention|Adverse Event|0|||
94542961|NCT01149486|323784664|FG001|First Intervention|Adverse Event|1|||
94542962|NCT03630302|323784665|FG000|Surgery|hardware issue prevented LFP recordings|1|||
94542963|NCT03630302|323784665|FG000|3 Month Visit|Adverse Event|2|||
94542964|NCT03630302|323784665|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
94542965|NCT02813668|323784667|FG000|Overall Study|Death|4|||
94542966|NCT02813668|323784667|FG000|Overall Study|Lost to Follow-up|509|||
94542967|NCT02813668|323784667|FG000|Overall Study|Withdrawal by Subject|148|||
94542968|NCT02813668|323784667|FG000|Overall Study|No longer at worksite|85|||
94542969|NCT02813668|323784667|FG000|Overall Study|Medical reasons not related to the study|4|||
94542970|NCT01286987|323784668|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
94542971|NCT01286987|323784669|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
94542972|NCT01286987|323784670|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
94542973|NCT01286987|323784671|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
94542974|NCT01286987|323784672|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
94542975|NCT01286987|323784673|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
94542976|NCT01286987|323784674|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
94542977|NCT01286987|323784675|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
94542978|NCT01286987|323784676|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
94542979|NCT01286987|323784677|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
94542980|NCT01286987|323784678|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
94542981|NCT01286987|323784679|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
94542982|NCT01286987|323784680|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
94542983|NCT01286987|323784681|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
94542984|NCT01286987|323784682|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
94542985|NCT01286987|323784668|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
94542986|NCT01286987|323784669|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
94542987|NCT01286987|323784670|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
94542988|NCT01286987|323784671|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
94542989|NCT01286987|323784672|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
94542990|NCT01286987|323784673|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
94542991|NCT01286987|323784674|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
94542992|NCT01286987|323784675|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
94542993|NCT01286987|323784676|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
94542994|NCT01286987|323784677|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
94542995|NCT01286987|323784678|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
94542996|NCT01286987|323784679|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
94542997|NCT01286987|323784680|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
94542998|NCT01286987|323784681|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
94542999|NCT01286987|323784682|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
94543000|NCT01286987|323784668|FG000|Part 1: Dose Escalation|Physician Decision|0|||
94543001|NCT01286987|323784669|FG001|Part 1: Dose Escalation|Physician Decision|0|||
94543002|NCT01286987|323784670|FG002|Part 1: Dose Escalation|Physician Decision|0|||
94543003|NCT01286987|323784671|FG003|Part 1: Dose Escalation|Physician Decision|0|||
94543004|NCT01286987|323784672|FG004|Part 1: Dose Escalation|Physician Decision|1|||
94543005|NCT01286987|323784673|FG005|Part 1: Dose Escalation|Physician Decision|0|||
94543006|NCT01286987|323784674|FG006|Part 1: Dose Escalation|Physician Decision|0|||
94543007|NCT01286987|323784675|FG007|Part 1: Dose Escalation|Physician Decision|0|||
94543008|NCT01286987|323784676|FG008|Part 1: Dose Escalation|Physician Decision|0|||
94543009|NCT01286987|323784677|FG009|Part 1: Dose Escalation|Physician Decision|0|||
94543010|NCT01286987|323784678|FG010|Part 1: Dose Escalation|Physician Decision|0|||
94543011|NCT01286987|323784679|FG011|Part 1: Dose Escalation|Physician Decision|0|||
94543012|NCT01286987|323784680|FG012|Part 1: Dose Escalation|Physician Decision|0|||
94543013|NCT01286987|323784681|FG013|Part 1: Dose Escalation|Physician Decision|0|||
94543014|NCT01286987|323784682|FG014|Part 1: Dose Escalation|Physician Decision|0|||
94543015|NCT01286987|323784668|FG000|Part 2: Dose Expansion|Death|0|||
94543016|NCT01286987|323784669|FG001|Part 2: Dose Expansion|Death|0|||
94543017|NCT01286987|323784670|FG002|Part 2: Dose Expansion|Death|0|||
94543018|NCT01286987|323784671|FG003|Part 2: Dose Expansion|Death|0|||
94543019|NCT01286987|323784672|FG004|Part 2: Dose Expansion|Death|0|||
94543020|NCT01286987|323784673|FG005|Part 2: Dose Expansion|Death|0|||
94543021|NCT01286987|323784674|FG006|Part 2: Dose Expansion|Death|0|||
94543022|NCT01286987|323784675|FG007|Part 2: Dose Expansion|Death|0|||
94543023|NCT01286987|323784676|FG008|Part 2: Dose Expansion|Death|0|||
94543024|NCT01286987|323784677|FG009|Part 2: Dose Expansion|Death|0|||
94543025|NCT01286987|323784678|FG010|Part 2: Dose Expansion|Death|0|||
94543026|NCT01286987|323784679|FG011|Part 2: Dose Expansion|Death|0|||
94543027|NCT01286987|323784680|FG012|Part 2: Dose Expansion|Death|1|||
94543028|NCT01286987|323784681|FG013|Part 2: Dose Expansion|Death|1|||
94543029|NCT01286987|323784682|FG014|Part 2: Dose Expansion|Death|0|||
94543030|NCT01286987|323784668|FG000|Part 2: Dose Expansion|Physician Decision|0|||
94543031|NCT01286987|323784669|FG001|Part 2: Dose Expansion|Physician Decision|0|||
94543032|NCT01286987|323784670|FG002|Part 2: Dose Expansion|Physician Decision|0|||
94543033|NCT01286987|323784671|FG003|Part 2: Dose Expansion|Physician Decision|0|||
94543034|NCT01286987|323784672|FG004|Part 2: Dose Expansion|Physician Decision|0|||
94543035|NCT01286987|323784673|FG005|Part 2: Dose Expansion|Physician Decision|0|||
94543036|NCT01286987|323784674|FG006|Part 2: Dose Expansion|Physician Decision|0|||
94543037|NCT01286987|323784675|FG007|Part 2: Dose Expansion|Physician Decision|0|||
94543038|NCT01286987|323784676|FG008|Part 2: Dose Expansion|Physician Decision|0|||
94543039|NCT01286987|323784677|FG009|Part 2: Dose Expansion|Physician Decision|0|||
94543040|NCT01286987|323784678|FG010|Part 2: Dose Expansion|Physician Decision|1|||
94543041|NCT01286987|323784679|FG011|Part 2: Dose Expansion|Physician Decision|1|||
94543042|NCT01286987|323784680|FG012|Part 2: Dose Expansion|Physician Decision|0|||
94543043|NCT01286987|323784681|FG013|Part 2: Dose Expansion|Physician Decision|1|||
94543044|NCT01286987|323784682|FG014|Part 2: Dose Expansion|Physician Decision|0|||
94543045|NCT01286987|323784668|FG000|Part 2: Dose Expansion|Other|0|||
94543046|NCT01286987|323784669|FG001|Part 2: Dose Expansion|Other|0|||
94543047|NCT01286987|323784670|FG002|Part 2: Dose Expansion|Other|0|||
94543048|NCT01286987|323784671|FG003|Part 2: Dose Expansion|Other|0|||
94543049|NCT01286987|323784672|FG004|Part 2: Dose Expansion|Other|0|||
94543050|NCT01286987|323784673|FG005|Part 2: Dose Expansion|Other|0|||
94543051|NCT01286987|323784674|FG006|Part 2: Dose Expansion|Other|0|||
94543052|NCT01286987|323784675|FG007|Part 2: Dose Expansion|Other|0|||
94543053|NCT01286987|323784676|FG008|Part 2: Dose Expansion|Other|0|||
94543054|NCT01286987|323784677|FG009|Part 2: Dose Expansion|Other|0|||
94543055|NCT01286987|323784678|FG010|Part 2: Dose Expansion|Other|0|||
94543056|NCT01286987|323784679|FG011|Part 2: Dose Expansion|Other|0|||
94543057|NCT01286987|323784680|FG012|Part 2: Dose Expansion|Other|0|||
94543058|NCT01286987|323784681|FG013|Part 2: Dose Expansion|Other|1|||
94543059|NCT01286987|323784682|FG014|Part 2: Dose Expansion|Other|0|||
94543060|NCT01286987|323784668|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
94543061|NCT01286987|323784669|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
94543062|NCT01286987|323784670|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
94543063|NCT01286987|323784671|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
94543064|NCT01286987|323784672|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
94543065|NCT01286987|323784673|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
94543066|NCT01286987|323784674|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
94543067|NCT01286987|323784675|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
94543068|NCT01286987|323784676|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
94543069|NCT01286987|323784677|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
94543070|NCT01286987|323784678|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
94543071|NCT01286987|323784679|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
94543072|NCT01286987|323784680|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
94543073|NCT01286987|323784681|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
94543074|NCT01286987|323784682|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
94543075|NCT01286987|323784668|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
94543076|NCT01286987|323784669|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
94543077|NCT01286987|323784670|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
94543078|NCT01286987|323784671|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
94543079|NCT01286987|323784672|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
94543080|NCT01286987|323784673|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
94543081|NCT01286987|323784674|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
94543082|NCT01286987|323784675|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
94543083|NCT01286987|323784676|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
94543084|NCT01286987|323784677|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
94543085|NCT01286987|323784678|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
94543086|NCT01286987|323784679|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
94543087|NCT01286987|323784680|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
94543088|NCT01286987|323784681|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
94543089|NCT01286987|323784682|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
94543090|NCT01286987|323784668|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
94543091|NCT01286987|323784669|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
94543092|NCT01286987|323784670|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
94543093|NCT01286987|323784671|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
94543094|NCT01286987|323784672|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
94543095|NCT01286987|323784673|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
94543096|NCT01286987|323784674|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
94543097|NCT01286987|323784675|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
94543098|NCT01286987|323784676|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
94543099|NCT01286987|323784677|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
94543100|NCT01286987|323784678|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
94543101|NCT01286987|323784679|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
94543102|NCT01286987|323784680|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
94543103|NCT01286987|323784681|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
94543104|NCT01286987|323784682|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
94543105|NCT01135914|323784683|FG000|Overall Study|Withdrawal by Subject|1|||
94543106|NCT01135914|323784684|FG001|Overall Study|Withdrawal by Subject|3|||
94543107|NCT01135914|323784685|FG002|Overall Study|Withdrawal by Subject|6|||
94543108|NCT01135914|323784683|FG000|Overall Study|Lost to Follow-up|1|||
94543109|NCT01135914|323784684|FG001|Overall Study|Lost to Follow-up|0|||
94543110|NCT01135914|323784685|FG002|Overall Study|Lost to Follow-up|1|||
94543111|NCT01135914|323784683|FG000|Overall Study|Protocol Violation|0|||
94543112|NCT01135914|323784684|FG001|Overall Study|Protocol Violation|0|||
94543113|NCT01135914|323784685|FG002|Overall Study|Protocol Violation|3|||
94543114|NCT01135914|323784683|FG000|Overall Study|Lack of Efficacy|2|||
94543115|NCT01135914|323784684|FG001|Overall Study|Lack of Efficacy|1|||
94543116|NCT01135914|323784685|FG002|Overall Study|Lack of Efficacy|10|||
94543117|NCT01135914|323784683|FG000|Overall Study|Adverse Event|0|||
94543118|NCT01135914|323784684|FG001|Overall Study|Adverse Event|1|||
94543119|NCT01135914|323784685|FG002|Overall Study|Adverse Event|2|||
94543120|NCT01996592|323784692|FG000|Overall Study|no response to text/no diary entry|32|||
94543121|NCT01996592|323784692|FG000|Overall Study|change in surgical date|4|||
94543122|NCT01996592|323784692|FG000|Overall Study|Withdrawal by Subject|5|||
94543123|NCT01996592|323784692|FG000|Overall Study|change in mode of delivery|4|||
94543124|NCT02387164|323784693|FG000|Overall Study|Lost to Follow-up|2|||
94543125|NCT02387164|323784694|FG001|Overall Study|Lost to Follow-up|0|||
94543126|NCT02387164|323784693|FG000|Overall Study|Diagnosed|1|||
94543127|NCT02387164|323784694|FG001|Overall Study|Diagnosed|2|||
94543128|NCT01479595|323784697|FG000|Overall Study|Protocol deviation|0|||
94543129|NCT01479595|323784698|FG001|Overall Study|Protocol deviation|1|||
94543130|NCT01479595|323784697|FG000|Overall Study|Adverse Event|2|||
94543131|NCT01479595|323784698|FG001|Overall Study|Adverse Event|1|||
94543132|NCT02255565|323784699|FG000|Overall Study|Withdrawal by Subject|0|||
94543133|NCT02255565|323784700|FG001|Overall Study|Withdrawal by Subject|1|||
94543134|NCT02255565|323784701|FG002|Overall Study|Withdrawal by Subject|0|||
94543135|NCT02133664|323784702|FG000|Overall Study|Lost to Follow-up|2|||
94543136|NCT02133664|323784703|FG001|Overall Study|Lost to Follow-up|1|||
94543137|NCT02133664|323784702|FG000|Overall Study|Adverse Event|3|||
94543138|NCT02133664|323784703|FG001|Overall Study|Adverse Event|6|||
94543139|NCT03906656|323784704|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
94543140|NCT03906656|323784705|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
94543141|NCT03906656|323784704|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
94543142|NCT03906656|323784705|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
94543143|NCT03906656|323784704|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
94543144|NCT03906656|323784705|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
94543145|NCT03906656|323784704|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
94543146|NCT03906656|323784705|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
94543147|NCT03906656|323784704|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
94543148|NCT03906656|323784705|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
94543149|NCT03906656|323784704|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
94543150|NCT03906656|323784705|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
94543151|NCT03906656|323784704|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
94543152|NCT03906656|323784705|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
94543153|NCT03906656|323784704|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
94543154|NCT03906656|323784705|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
94543155|NCT03906656|323784704|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
94543156|NCT03906656|323784705|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
94543157|NCT03906656|323784704|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
94543158|NCT03906656|323784705|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
94543159|NCT03906656|323784704|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
94543160|NCT03906656|323784705|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
94543161|NCT03906656|323784704|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
94543162|NCT03906656|323784705|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
94543163|NCT03906656|323784704|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
94543164|NCT03906656|323784705|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
94543165|NCT03906656|323784704|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
94543166|NCT03906656|323784705|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
94543167|NCT03906656|323784704|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
94543168|NCT03906656|323784705|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
94543169|NCT03906656|323784704|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
94543170|NCT03906656|323784705|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
94543171|NCT03906656|323784704|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
94543172|NCT03906656|323784705|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
94543173|NCT03906656|323784704|FG000|Home Use 2 (3 Months)|Death|2|||
94543174|NCT03906656|323784705|FG001|Home Use 2 (3 Months)|Death|0|||
94543175|NCT03906656|323784704|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
94543176|NCT03906656|323784705|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
94543177|NCT03906656|323784704|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
94543178|NCT03906656|323784705|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
94543179|NCT02120365|323784712|FG000|Overall Study|Withdrawal by Subject|0|||
94543180|NCT02120365|323784713|FG001|Overall Study|Withdrawal by Subject|0|||
94543181|NCT02120365|323784714|FG002|Overall Study|Withdrawal by Subject|2|||
94543182|NCT02120365|323784715|FG003|Overall Study|Withdrawal by Subject|4|||
94543183|NCT02120365|323784716|FG004|Overall Study|Withdrawal by Subject|0|||
94543184|NCT02120365|323784717|FG005|Overall Study|Withdrawal by Subject|2|||
94543185|NCT00343915|323784719|FG000|Primary Study|Withdrawal by Subject|1|||
94543186|NCT00343915|323784720|FG001|Primary Study|Withdrawal by Subject|0|||
94543187|NCT00343915|323784719|FG000|Primary Study|Lost to Follow-up|2|||
94543188|NCT00343915|323784720|FG001|Primary Study|Lost to Follow-up|3|||
94543189|NCT00343915|323784719|FG000|Primary Study|Other|1|||
94543190|NCT00343915|323784720|FG001|Primary Study|Other|0|||
94543191|NCT01344629|323784723|FG000|Crossover Period 2|Withdrawal by Subject|0|||
94543192|NCT01344629|323784724|FG001|Crossover Period 2|Withdrawal by Subject|1|||
94543193|NCT02370095|323784725|FG000|Overall Study|Withdrawal by Subject|0|||
94543194|NCT02370095|323784726|FG001|Overall Study|Withdrawal by Subject|1|||
94543195|NCT02956850|323784728|FG000|Overall Study|Withdrawal by Subject|0|||
94543196|NCT02956850|323784729|FG001|Overall Study|Withdrawal by Subject|0|||
94543197|NCT02956850|323784730|FG002|Overall Study|Withdrawal by Subject|0|||
94543198|NCT02956850|323784731|FG003|Overall Study|Withdrawal by Subject|0|||
94543199|NCT02956850|323784732|FG004|Overall Study|Withdrawal by Subject|0|||
94543200|NCT02956850|323784733|FG005|Overall Study|Withdrawal by Subject|0|||
94543201|NCT02956850|323784734|FG006|Overall Study|Withdrawal by Subject|0|||
94543202|NCT02956850|323784735|FG007|Overall Study|Withdrawal by Subject|0|||
94543203|NCT02956850|323784736|FG008|Overall Study|Withdrawal by Subject|0|||
94543204|NCT02956850|323784737|FG009|Overall Study|Withdrawal by Subject|0|||
94543205|NCT02956850|323784738|FG010|Overall Study|Withdrawal by Subject|0|||
94543206|NCT02956850|323784739|FG011|Overall Study|Withdrawal by Subject|0|||
94543207|NCT02956850|323784740|FG012|Overall Study|Withdrawal by Subject|0|||
94543208|NCT02956850|323784741|FG013|Overall Study|Withdrawal by Subject|0|||
94543209|NCT02956850|323784742|FG014|Overall Study|Withdrawal by Subject|0|||
94543210|NCT02956850|323784743|FG015|Overall Study|Withdrawal by Subject|0|||
94543211|NCT02956850|323784744|FG016|Overall Study|Withdrawal by Subject|0|||
94543212|NCT02956850|323784745|FG017|Overall Study|Withdrawal by Subject|1|||
94543213|NCT02410824|323784748|FG000|First Intervention (One Week)|Headache|0|||
94543214|NCT02410824|323784749|FG001|First Intervention (One Week)|Headache|1|||
94543215|NCT00392808|323784750|FG000|Overall Study|Lost to Follow-up|3|||
94543216|NCT00392808|323784751|FG001|Overall Study|Lost to Follow-up|2|||
94543217|NCT00392808|323784752|FG002|Overall Study|Lost to Follow-up|1|||
94543218|NCT00392808|323784753|FG003|Overall Study|Lost to Follow-up|2|||
94543219|NCT00392808|323784750|FG000|Overall Study|Unable to withdraw blood|3|||
94543220|NCT00392808|323784751|FG001|Overall Study|Unable to withdraw blood|1|||
94543221|NCT00392808|323784752|FG002|Overall Study|Unable to withdraw blood|1|||
94543222|NCT00392808|323784753|FG003|Overall Study|Unable to withdraw blood|2|||
94543223|NCT00657150|323784761|FG000|Overall Study|Adverse Event|19|||
94543224|NCT00657150|323784762|FG001|Overall Study|Adverse Event|10|||
94543225|NCT00657150|323784761|FG000|Overall Study|Non-compliant with protocol|5|||
94543226|NCT00657150|323784762|FG001|Overall Study|Non-compliant with protocol|9|||
94543227|NCT00657150|323784761|FG000|Overall Study|Lost to Follow-up|2|||
94543228|NCT00657150|323784762|FG001|Overall Study|Lost to Follow-up|0|||
94543229|NCT00657150|323784761|FG000|Overall Study|Withdrawal by Subject|51|||
94543230|NCT00657150|323784762|FG001|Overall Study|Withdrawal by Subject|36|||
94543231|NCT00657150|323784761|FG000|Overall Study|Other|38|||
94543232|NCT00657150|323784762|FG001|Overall Study|Other|38|||
94543233|NCT00657150|323784761|FG000|Treatment|Adverse Event|60|||
94543234|NCT00657150|323784762|FG001|Treatment|Adverse Event|53|||
94543235|NCT00657150|323784761|FG000|Treatment|Non-compliant with protocol|10|||
94543236|NCT00657150|323784762|FG001|Treatment|Non-compliant with protocol|9|||
94543237|NCT00657150|323784761|FG000|Treatment|Lost to Follow-up|1|||
94543238|NCT00657150|323784762|FG001|Treatment|Lost to Follow-up|0|||
94543239|NCT00657150|323784761|FG000|Treatment|Withdrawal by Subject|23|||
94543240|NCT00657150|323784762|FG001|Treatment|Withdrawal by Subject|20|||
94543241|NCT00657150|323784761|FG000|Treatment|Other|13|||
94543242|NCT00657150|323784762|FG001|Treatment|Other|15|||
94543243|NCT04030247|323786623|FG000|Overall Study|Withdrawal by Subject|4|||
94543244|NCT04030247|323786623|FG000|Overall Study|Lost to Follow-up|13|||
94543245|NCT00840060|323786624|FG000|Overall Study|Withdrawal by Subject|1|||
94543246|NCT00840060|323786625|FG001|Overall Study|Withdrawal by Subject|0|||
94543247|NCT00840060|323786624|FG000|Overall Study|Change in emotional/behavioral status|0|||
94543248|NCT00840060|323786625|FG001|Overall Study|Change in emotional/behavioral status|1|||
94543249|NCT01263015|323786626|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
94543250|NCT01263015|323786627|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
94543251|NCT01263015|323786626|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
94543252|NCT01263015|323786627|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
94543253|NCT01263015|323786626|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
94543254|NCT01263015|323786627|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
94543255|NCT01263015|323786626|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
94543256|NCT01263015|323786627|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
94543257|NCT01263015|323786626|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
94543258|NCT01263015|323786627|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
94543259|NCT01263015|323786626|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
94543260|NCT01263015|323786627|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
94543261|NCT01263015|323786626|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
94543262|NCT01263015|323786627|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
94543263|NCT01263015|323786626|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
94543264|NCT01263015|323786627|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
94543265|NCT01263015|323786626|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
94543266|NCT01263015|323786627|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
94543267|NCT01263015|323786626|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
94543268|NCT01263015|323786627|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
94543269|NCT01263015|323786626|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
94543270|NCT01263015|323786627|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
94543271|NCT01263015|323786626|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
94543272|NCT01263015|323786627|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
94543273|NCT03187834|323786629|FG000|Overall Study|Lost to Follow-up|0|||
94543274|NCT03187834|323786630|FG001|Overall Study|Lost to Follow-up|1|||
94543275|NCT03187834|323786631|FG002|Overall Study|Lost to Follow-up|2|||
94543276|NCT03187834|323786632|FG003|Overall Study|Lost to Follow-up|2|||
94543277|NCT03187834|323786629|FG000|Overall Study|Had invalid anthropometric measurements|5|||
94543278|NCT03187834|323786630|FG001|Overall Study|Had invalid anthropometric measurements|3|||
94543279|NCT03187834|323786631|FG002|Overall Study|Had invalid anthropometric measurements|4|||
94543280|NCT03187834|323786632|FG003|Overall Study|Had invalid anthropometric measurements|2|||
94543281|NCT00583791|323786633|FG000|Overall Study|Other|67|||
94543282|NCT00583791|323786633|FG000|Overall Study|Death|6|||
94543283|NCT03899064|323786634|FG000|Overall Study|Lost to Follow-up|1|||
94543284|NCT03899064|323786634|FG000|Overall Study|Protocol Violation|2|||
94543285|NCT03899064|323786634|FG000|Overall Study|Withdrawal by Subject|2|||
94543286|NCT03899064|323786634|FG000|Overall Study|Other|2|||
94543287|NCT01930890|323786637|FG000|Overall Study|Study Termination|14|||
94543288|NCT01930890|323786638|FG001|Overall Study|Study Termination|28|||
94543289|NCT01930890|323786639|FG002|Overall Study|Study Termination|13|||
94543290|NCT01930890|323786640|FG003|Overall Study|Study Termination|25|||
94543291|NCT01930890|323786637|FG000|Overall Study|Death|0|||
94543292|NCT01930890|323786638|FG001|Overall Study|Death|0|||
94543293|NCT01930890|323786639|FG002|Overall Study|Death|0|||
94543294|NCT01930890|323786640|FG003|Overall Study|Death|1|||
94543295|NCT01930890|323786637|FG000|Overall Study|Investigator Decision|0|||
94543296|NCT01930890|323786638|FG001|Overall Study|Investigator Decision|1|||
94543297|NCT01930890|323786639|FG002|Overall Study|Investigator Decision|0|||
94543298|NCT01930890|323786640|FG003|Overall Study|Investigator Decision|0|||
94543299|NCT01930890|323786637|FG000|Overall Study|Consent Withdrawn|0|||
94543300|NCT01930890|323786638|FG001|Overall Study|Consent Withdrawn|3|||
94543301|NCT01930890|323786639|FG002|Overall Study|Consent Withdrawn|0|||
94543302|NCT01930890|323786640|FG003|Overall Study|Consent Withdrawn|1|||
94543303|NCT01930890|323786637|FG000|Overall Study|Adverse Event|0|||
94543304|NCT01930890|323786638|FG001|Overall Study|Adverse Event|1|||
94543305|NCT01930890|323786639|FG002|Overall Study|Adverse Event|0|||
94543306|NCT01930890|323786640|FG003|Overall Study|Adverse Event|0|||
94543307|NCT01278407|323786641|FG000|Confirmatory Phase|Adverse Event|5|||
94543308|NCT01278407|323786642|FG001|Confirmatory Phase|Adverse Event|10|||
94543309|NCT01278407|323786643|FG002|Confirmatory Phase|Adverse Event|1|||
94543310|NCT01278407|323786644|FG003|Confirmatory Phase|Adverse Event|0|||
94543311|NCT01278407|323786645|FG004|Confirmatory Phase|Adverse Event|0|||
94543312|NCT01278407|323786641|FG000|Confirmatory Phase|Participant's Choice|3|||
94543313|NCT01278407|323786642|FG001|Confirmatory Phase|Participant's Choice|5|||
94543314|NCT01278407|323786643|FG002|Confirmatory Phase|Participant's Choice|3|||
94543315|NCT01278407|323786644|FG003|Confirmatory Phase|Participant's Choice|0|||
94543316|NCT01278407|323786645|FG004|Confirmatory Phase|Participant's Choice|0|||
94543317|NCT01278407|323786641|FG000|Confirmatory Phase|Other|1|||
94543318|NCT01278407|323786642|FG001|Confirmatory Phase|Other|1|||
94543319|NCT01278407|323786643|FG002|Confirmatory Phase|Other|2|||
94543320|NCT01278407|323786644|FG003|Confirmatory Phase|Other|0|||
94543321|NCT01278407|323786645|FG004|Confirmatory Phase|Other|0|||
94543322|NCT01278407|323786641|FG000|Extension Phase|Adverse Event|0|||
94543323|NCT01278407|323786642|FG001|Extension Phase|Adverse Event|0|||
94543324|NCT01278407|323786643|FG002|Extension Phase|Adverse Event|0|||
94543325|NCT01278407|323786644|FG003|Extension Phase|Adverse Event|7|||
94543326|NCT01278407|323786645|FG004|Extension Phase|Adverse Event|16|||
94543327|NCT01278407|323786641|FG000|Extension Phase|Participant's Choice|0|||
94543328|NCT01278407|323786642|FG001|Extension Phase|Participant's Choice|0|||
94543329|NCT01278407|323786643|FG002|Extension Phase|Participant's Choice|0|||
94543330|NCT01278407|323786644|FG003|Extension Phase|Participant's Choice|4|||
94543331|NCT01278407|323786645|FG004|Extension Phase|Participant's Choice|11|||
94543332|NCT01278407|323786641|FG000|Extension Phase|Other|0|||
94543333|NCT01278407|323786642|FG001|Extension Phase|Other|0|||
94543334|NCT01278407|323786643|FG002|Extension Phase|Other|0|||
94543335|NCT01278407|323786644|FG003|Extension Phase|Other|1|||
94543336|NCT01278407|323786645|FG004|Extension Phase|Other|3|||
94543337|NCT03627065|323786650|FG000|Overall Study|Study Terminated by sponsor|1|||
94543338|NCT03627065|323786650|FG000|Overall Study|Withdrawal by Subject|2|||
94543339|NCT04035564|323786651|FG000|Overall Study|Protocol Violation|1|||
94543340|NCT04035564|323786652|FG001|Overall Study|Protocol Violation|2|||
94543341|NCT04035564|323786651|FG000|Overall Study|No laboratory available|2|||
94543342|NCT04035564|323786652|FG001|Overall Study|No laboratory available|2|||
94543343|NCT04035564|323786651|FG000|Overall Study|Guardian declined consent|1|||
94543344|NCT04035564|323786652|FG001|Overall Study|Guardian declined consent|2|||
94543345|NCT02838901|323786653|FG000|Overall Study|Withdrawal by Subject|1|||
94543346|NCT02838901|323786654|FG001|Overall Study|Withdrawal by Subject|1|||
94543347|NCT02838901|323786653|FG000|Overall Study|Lost to Follow-up|1|||
94543348|NCT02838901|323786654|FG001|Overall Study|Lost to Follow-up|1|||
94543349|NCT01156389|323786660|FG000|Overall Study|Elevated liver enzymes|4|||
94543350|NCT01156389|323786661|FG001|Overall Study|Elevated liver enzymes|0|||
94543351|NCT01156389|323786660|FG000|Overall Study|Vomiting|0|||
94543352|NCT01156389|323786661|FG001|Overall Study|Vomiting|1|||
94543353|NCT00046930|323786662|FG000|Overall Study|Ineligible|12|||
94543354|NCT00046930|323786663|FG001|Overall Study|Ineligible|4|||
94543355|NCT01030874|323786667|FG000|Overall Study|Withdrawal by Subject|1|||
94543356|NCT01030874|323786668|FG001|Overall Study|Withdrawal by Subject|0|||
94543357|NCT01030874|323786667|FG000|Overall Study|Discharged in first 2 weeks|17|||
94543358|NCT01030874|323786668|FG001|Overall Study|Discharged in first 2 weeks|16|||
94543359|NCT03541187|323786669|FG000|Overall Study|Lost to Follow-up|2|||
94543360|NCT03541187|323786670|FG001|Overall Study|Lost to Follow-up|6|||
94543361|NCT03541187|323786669|FG000|Overall Study|Pregnancy|0|||
94543362|NCT03541187|323786670|FG001|Overall Study|Pregnancy|1|||
94543363|NCT03541187|323786669|FG000|Overall Study|Withdrawal by Subject|6|||
94543364|NCT03541187|323786670|FG001|Overall Study|Withdrawal by Subject|2|||
94543365|NCT03541187|323786669|FG000|Overall Study|Moved out of town|1|||
94543366|NCT03541187|323786670|FG001|Overall Study|Moved out of town|0|||
94543367|NCT03541187|323786669|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
94543368|NCT03541187|323786670|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
94543369|NCT03541187|323786669|FG000|Overall Study|Did not meet randomization criteria|1|||
94543370|NCT03541187|323786670|FG001|Overall Study|Did not meet randomization criteria|1|||
94543371|NCT03541187|323786669|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
94543372|NCT03541187|323786670|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
94543373|NCT03541187|323786669|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
94543374|NCT03541187|323786670|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
94543375|NCT01994863|323786672|FG000|Period 1|Adverse Event|4|||
94543376|NCT01994863|323786673|FG001|Period 1|Adverse Event|0|||
94543377|NCT01994863|323786672|FG000|Period 1|Withdrawal by Subject|1|||
94543378|NCT01994863|323786673|FG001|Period 1|Withdrawal by Subject|0|||
94543379|NCT01994863|323786672|FG000|Period 1|Trial stopped by sponsor|1|||
94543380|NCT01994863|323786673|FG001|Period 1|Trial stopped by sponsor|3|||
94543381|NCT01994863|323786672|FG000|Period 1|Lack of Efficacy|1|||
94543382|NCT01994863|323786673|FG001|Period 1|Lack of Efficacy|0|||
94543383|NCT01994863|323786672|FG000|Period 2|Adverse Event|0|||
94543384|NCT01994863|323786673|FG001|Period 2|Adverse Event|1|||
94543385|NCT01994863|323786672|FG000|Period 2|Lack of Efficacy|0|||
94543386|NCT01994863|323786673|FG001|Period 2|Lack of Efficacy|2|||
94543387|NCT01994863|323786672|FG000|Period 2|Withdrawal by Subject|1|||
94543388|NCT01994863|323786673|FG001|Period 2|Withdrawal by Subject|1|||
94543389|NCT03054350|323786674|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
94543390|NCT03054350|323786675|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
94543391|NCT03054350|323786676|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
94543392|NCT03054350|323786677|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
94543393|NCT03054350|323786678|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
94543394|NCT03054350|323786679|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
94543395|NCT03054350|323786674|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
94543396|NCT03054350|323786675|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
94543397|NCT03054350|323786676|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
94543398|NCT03054350|323786677|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
94543399|NCT03054350|323786678|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
94543400|NCT03054350|323786679|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
94543401|NCT03054350|323786674|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
94543402|NCT03054350|323786675|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
94543403|NCT03054350|323786676|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
94543404|NCT03054350|323786677|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
94543405|NCT03054350|323786678|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
94543406|NCT03054350|323786679|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
94543407|NCT03054350|323786674|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
94543408|NCT03054350|323786675|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
94543409|NCT03054350|323786676|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
94543410|NCT03054350|323786677|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
94543411|NCT03054350|323786678|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
94543412|NCT03054350|323786679|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
94543413|NCT00293709|323786685|FG000|Overall Study|Other|47|||
94543414|NCT02088073|323786686|FG000|Acute Phase|Withdrawal by Subject|5|||
94543415|NCT02088073|323786687|FG001|Acute Phase|Withdrawal by Subject|0|||
94543416|NCT02088073|323786688|FG002|Acute Phase|Withdrawal by Subject|0|||
94543417|NCT02088073|323786689|FG003|Acute Phase|Withdrawal by Subject|0|||
94543418|NCT02088073|323786690|FG004|Acute Phase|Withdrawal by Subject|0|||
94543419|NCT02088073|323786686|FG000|Acute Phase|Hyperkalemia|2|||
94543420|NCT02088073|323786687|FG001|Acute Phase|Hyperkalemia|0|||
94543421|NCT02088073|323786688|FG002|Acute Phase|Hyperkalemia|0|||
94543422|NCT02088073|323786689|FG003|Acute Phase|Hyperkalemia|0|||
94543423|NCT02088073|323786690|FG004|Acute Phase|Hyperkalemia|0|||
94543424|NCT02088073|323786686|FG000|Maintanance Phase|Withdrawal by Subject|0|||
94543425|NCT02088073|323786687|FG001|Maintanance Phase|Withdrawal by Subject|2|||
94543426|NCT02088073|323786688|FG002|Maintanance Phase|Withdrawal by Subject|0|||
94543427|NCT02088073|323786689|FG003|Maintanance Phase|Withdrawal by Subject|0|||
94543428|NCT02088073|323786690|FG004|Maintanance Phase|Withdrawal by Subject|0|||
94543429|NCT02088073|323786686|FG000|Maintanance Phase|Adverse Event|0|||
94543430|NCT02088073|323786687|FG001|Maintanance Phase|Adverse Event|0|||
94543431|NCT02088073|323786688|FG002|Maintanance Phase|Adverse Event|3|||
94543432|NCT02088073|323786689|FG003|Maintanance Phase|Adverse Event|0|||
94543433|NCT02088073|323786690|FG004|Maintanance Phase|Adverse Event|1|||
94543434|NCT02088073|323786686|FG000|Maintanance Phase|Physician Decision|0|||
94543435|NCT02088073|323786687|FG001|Maintanance Phase|Physician Decision|0|||
94543436|NCT02088073|323786688|FG002|Maintanance Phase|Physician Decision|0|||
94543437|NCT02088073|323786689|FG003|Maintanance Phase|Physician Decision|0|||
94543438|NCT02088073|323786690|FG004|Maintanance Phase|Physician Decision|1|||
94543439|NCT02088073|323786686|FG000|Maintanance Phase|Sponsor's decision|0|||
94543440|NCT02088073|323786687|FG001|Maintanance Phase|Sponsor's decision|2|||
94543441|NCT02088073|323786688|FG002|Maintanance Phase|Sponsor's decision|0|||
94543442|NCT02088073|323786689|FG003|Maintanance Phase|Sponsor's decision|2|||
94543443|NCT02088073|323786690|FG004|Maintanance Phase|Sponsor's decision|1|||
94543444|NCT02088073|323786686|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
94543445|NCT02088073|323786687|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
94543446|NCT02088073|323786688|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
94543447|NCT02088073|323786689|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
94543448|NCT02088073|323786690|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
94543449|NCT02088073|323786686|FG000|Maintanance Phase|Miscellaneous|0|||
94543450|NCT02088073|323786687|FG001|Maintanance Phase|Miscellaneous|2|||
94543451|NCT02088073|323786688|FG002|Maintanance Phase|Miscellaneous|1|||
94543452|NCT02088073|323786689|FG003|Maintanance Phase|Miscellaneous|2|||
94543453|NCT02088073|323786690|FG004|Maintanance Phase|Miscellaneous|1|||
94543454|NCT02088073|323786686|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
94543455|NCT02088073|323786687|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
94543456|NCT02088073|323786688|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
94543457|NCT02088073|323786689|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
94543458|NCT02088073|323786690|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
94543459|NCT02088073|323786686|FG000|Maintanance Phase|Subject compliance|0|||
94543460|NCT02088073|323786687|FG001|Maintanance Phase|Subject compliance|1|||
94543461|NCT02088073|323786688|FG002|Maintanance Phase|Subject compliance|0|||
94543462|NCT02088073|323786689|FG003|Maintanance Phase|Subject compliance|0|||
94543463|NCT02088073|323786690|FG004|Maintanance Phase|Subject compliance|0|||
94543464|NCT03421743|323786695|FG000|Overall Study|Lack of Efficacy|1|||
94543465|NCT03421743|323786696|FG001|Overall Study|Lack of Efficacy|0|||
94543466|NCT03421743|323786695|FG000|Overall Study|Adverse Event|2|||
94543467|NCT03421743|323786696|FG001|Overall Study|Adverse Event|1|||
94543468|NCT03421743|323786695|FG000|Overall Study|Withdrawal by Subject|0|||
94543469|NCT03421743|323786696|FG001|Overall Study|Withdrawal by Subject|1|||
94543470|NCT02230683|323786699|FG000|Overall Study|Adverse Event|1|||
94543471|NCT01390779|323786700|FG000|Overall Study|Physician Decision|1|||
94543472|NCT01874275|323786701|FG000|Overall Study|Lost to Follow-up|1|||
94543473|NCT01874275|323786702|FG001|Overall Study|Lost to Follow-up|0|||
94543474|NCT04662073|323786712|FG000|Overall Study|Withdrawal by Subject|1|||
94543475|NCT04662073|323786713|FG001|Overall Study|Withdrawal by Subject|0|||
94543476|NCT00283868|323786721|FG000|Overall Study|Lost to Follow-up|7|||
94543477|NCT00283868|323786722|FG001|Overall Study|Lost to Follow-up|8|||
94543478|NCT00837876|323786723|FG000|Overall Study|Death|2|||
94543479|NCT00837876|323786723|FG000|Overall Study|Adverse Event|7|||
94543480|NCT00837876|323786723|FG000|Overall Study|Physician Decision|1|||
94543481|NCT00837876|323786723|FG000|Overall Study|Withdrawal by Subject|3|||
94543482|NCT00837876|323786723|FG000|Overall Study|disease progression|24|||
94543483|NCT03464422|323786725|FG000|Overall Study|Lost to Follow-up|2|||
94543484|NCT03464422|323786725|FG000|Overall Study|Withdrawal by Subject|2|||
94543485|NCT01628367|323786728|FG000|Overall Study|Adverse Event|1|||
94543486|NCT01628367|323786729|FG001|Overall Study|Adverse Event|0|||
94543487|NCT00740714|323786730|FG000|Overall Study|Withdrawal by Subject|17|||
94543488|NCT00740714|323786731|FG001|Overall Study|Withdrawal by Subject|19|||
94543489|NCT00740714|323786732|FG002|Overall Study|Withdrawal by Subject|29|||
94543490|NCT00886119|323786733|FG000|Period 1|Did not meet inclusion criteria|1|||
94543491|NCT00886119|323786734|FG001|Period 1|Did not meet inclusion criteria|0|||
94543492|NCT01294462|323786735|FG000|Overall Study|Lost to Follow-up|1|||
94543493|NCT01294462|323786736|FG001|Overall Study|Lost to Follow-up|0|||
94543494|NCT01294462|323786735|FG000|Overall Study|Withdrawal by Subject|65|||
94543495|NCT01294462|323786736|FG001|Overall Study|Withdrawal by Subject|63|||
94543496|NCT02256267|323786740|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
94543497|NCT02256267|323786740|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
94543498|NCT01352741|323786741|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
94543499|NCT01352741|323786742|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
94543500|NCT01352741|323786741|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
94543501|NCT01352741|323786742|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
94543502|NCT01352741|323786741|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
94543503|NCT01352741|323786742|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
94543504|NCT01352741|323786741|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
94543505|NCT01352741|323786742|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
94543506|NCT01352741|323786741|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
94543507|NCT01352741|323786742|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
94543508|NCT01352741|323786741|FG000|Open-label Tapentadol Titration Period|Other|4|||
94543509|NCT01352741|323786742|FG001|Open-label Tapentadol Titration Period|Other|0|||
94543510|NCT01352741|323786741|FG000|Double-blind Comparative Period|Protocol Violation|2|||
94543511|NCT01352741|323786742|FG001|Double-blind Comparative Period|Protocol Violation|0|||
94543512|NCT01352741|323786741|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
94543513|NCT01352741|323786742|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
94543514|NCT01352741|323786741|FG000|Double-blind Comparative Period|Adverse Event|16|||
94543515|NCT01352741|323786742|FG001|Double-blind Comparative Period|Adverse Event|17|||
94543516|NCT01352741|323786741|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
94543517|NCT01352741|323786742|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
94543518|NCT01352741|323786741|FG000|Double-blind Comparative Period|Death|0|||
94543519|NCT01352741|323786742|FG001|Double-blind Comparative Period|Death|1|||
94543520|NCT01352741|323786741|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
94543521|NCT01352741|323786742|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
94543522|NCT01352741|323786741|FG000|Double-blind Comparative Period|Other|1|||
94543523|NCT01352741|323786742|FG001|Double-blind Comparative Period|Other|2|||
94543524|NCT01352741|323786741|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
94543525|NCT01352741|323786742|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
94543526|NCT01352741|323786741|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
94543527|NCT01352741|323786742|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
94543528|NCT01352741|323786741|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
94543529|NCT01352741|323786742|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
94543530|NCT01352741|323786741|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
94543531|NCT01352741|323786742|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
94543532|NCT01400243|323786746|FG000|Overall Study|Protocol Violation|8|||
94543533|NCT01400243|323786747|FG001|Overall Study|Protocol Violation|11|||
94543534|NCT00493636|323786749|FG000|Overall Study|Withdrawal by Subject|1|||
94543535|NCT00493636|323786750|FG001|Overall Study|Withdrawal by Subject|0|||
94543536|NCT00493636|323786749|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
94543537|NCT00493636|323786750|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
94543538|NCT00493636|323786749|FG000|Overall Study|Mis-randomization|1|||
94543539|NCT00493636|323786750|FG001|Overall Study|Mis-randomization|1|||
94543540|NCT02463032|323786751|FG000|Overall Study|Lack of Efficacy|61|||
94543541|NCT02463032|323786752|FG001|Overall Study|Lack of Efficacy|50|||
94543542|NCT02463032|323786751|FG000|Overall Study|Death|8|||
94543543|NCT02463032|323786752|FG001|Overall Study|Death|8|||
94543544|NCT02463032|323786751|FG000|Overall Study|Adverse Event|2|||
94543545|NCT02463032|323786752|FG001|Overall Study|Adverse Event|6|||
94543546|NCT01741532|323786753|FG000|Overall Study|Adverse Event|4|||
94543547|NCT01741532|323786754|FG001|Overall Study|Adverse Event|0|||
94543548|NCT01741532|323786753|FG000|Overall Study|Withdrawal by Subject|1|||
94543549|NCT01741532|323786754|FG001|Overall Study|Withdrawal by Subject|1|||
94543550|NCT01741532|323786753|FG000|Overall Study|Protocol Violation|0|||
94543551|NCT01741532|323786754|FG001|Overall Study|Protocol Violation|1|||
94543552|NCT01741532|323786753|FG000|Overall Study|Worsening of the disease|3|||
94543553|NCT01741532|323786754|FG001|Overall Study|Worsening of the disease|1|||
94543554|NCT01741532|323786753|FG000|Overall Study|Sponsor decision|1|||
94543555|NCT01741532|323786754|FG001|Overall Study|Sponsor decision|0|||
94543556|NCT01741532|323786753|FG000|Overall Study|Medical event|1|||
94543557|NCT01741532|323786754|FG001|Overall Study|Medical event|0|||
94543558|NCT00613080|323786755|FG000|Overall Study|Ineligible / no protocol treatment|11|||
94543559|NCT02360293|323786756|FG000|Overall Study|Lost to Follow-up|73|||
94543560|NCT02360293|323786757|FG001|Overall Study|Lost to Follow-up|95|||
94543561|NCT02360293|323786756|FG000|Overall Study|Withdrawal by Subject|2|||
94543562|NCT02360293|323786757|FG001|Overall Study|Withdrawal by Subject|1|||
94543563|NCT02360293|323786756|FG000|Overall Study|Excluded|1|||
94543564|NCT02360293|323786757|FG001|Overall Study|Excluded|0|||
94543565|NCT00787202|323786758|FG000|Overall Study|Adverse Event|3|||
94543566|NCT00787202|323786759|FG001|Overall Study|Adverse Event|2|||
94543567|NCT00787202|323786760|FG002|Overall Study|Adverse Event|0|||
94543568|NCT00787202|323786761|FG003|Overall Study|Adverse Event|0|||
94543569|NCT00787202|323786762|FG004|Overall Study|Adverse Event|2|||
94543570|NCT00787202|323786758|FG000|Overall Study|Lack of Efficacy|5|||
94543571|NCT00787202|323786759|FG001|Overall Study|Lack of Efficacy|6|||
94543572|NCT00787202|323786760|FG002|Overall Study|Lack of Efficacy|5|||
94543573|NCT00787202|323786761|FG003|Overall Study|Lack of Efficacy|2|||
94543574|NCT00787202|323786762|FG004|Overall Study|Lack of Efficacy|1|||
94543575|NCT00787202|323786758|FG000|Overall Study|Lost to Follow-up|1|||
94543576|NCT00787202|323786759|FG001|Overall Study|Lost to Follow-up|0|||
94543577|NCT00787202|323786760|FG002|Overall Study|Lost to Follow-up|0|||
94543578|NCT00787202|323786761|FG003|Overall Study|Lost to Follow-up|0|||
94543579|NCT00787202|323786762|FG004|Overall Study|Lost to Follow-up|0|||
94543580|NCT00787202|323786758|FG000|Overall Study|Withdrawal by Subject|2|||
94543581|NCT00787202|323786759|FG001|Overall Study|Withdrawal by Subject|2|||
94543582|NCT00787202|323786760|FG002|Overall Study|Withdrawal by Subject|2|||
94543583|NCT00787202|323786761|FG003|Overall Study|Withdrawal by Subject|0|||
94543584|NCT00787202|323786762|FG004|Overall Study|Withdrawal by Subject|0|||
94543585|NCT00787202|323786758|FG000|Overall Study|Protocol Violation|2|||
94543586|NCT00787202|323786759|FG001|Overall Study|Protocol Violation|1|||
94543587|NCT00787202|323786760|FG002|Overall Study|Protocol Violation|0|||
94543588|NCT00787202|323786761|FG003|Overall Study|Protocol Violation|0|||
94543589|NCT00787202|323786762|FG004|Overall Study|Protocol Violation|1|||
94543590|NCT00787202|323786758|FG000|Overall Study|Randomized, not treated|1|||
94543591|NCT00787202|323786759|FG001|Overall Study|Randomized, not treated|0|||
94543592|NCT00787202|323786760|FG002|Overall Study|Randomized, not treated|0|||
94543593|NCT00787202|323786761|FG003|Overall Study|Randomized, not treated|0|||
94543594|NCT00787202|323786762|FG004|Overall Study|Randomized, not treated|0|||
94543595|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
94543596|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
94543597|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
94543598|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
94543599|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
94543600|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
94543601|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
94543602|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
94543603|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
94543604|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
94543605|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
94543606|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
94543607|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
94543608|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
94543609|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
94543610|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
94543611|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
94543612|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
94543613|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
94543614|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
94543615|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
94543616|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
94543617|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
94543618|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
94543619|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
94543620|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
94543621|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
94543622|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
94543623|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
94543624|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
94543625|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
94543626|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
94543627|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
94543628|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
94543629|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
94543630|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
94543631|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
94543632|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
94543633|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
94543634|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
94543635|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
94543636|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
94543637|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
94543638|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
94543639|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
94543640|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
94543641|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
94543642|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
94543643|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
94543644|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
94543645|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
94543646|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
94543647|NCT02008357|323786763|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
94543648|NCT02008357|323786764|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
94543649|NCT02008357|323786763|FG000|Open-label Extension Period|Adverse Event|8|||
94543650|NCT02008357|323786764|FG001|Open-label Extension Period|Adverse Event|7|||
94543651|NCT02008357|323786763|FG000|Open-label Extension Period|Death|7|||
94543652|NCT02008357|323786764|FG001|Open-label Extension Period|Death|4|||
94543653|NCT02008357|323786763|FG000|Open-label Extension Period|Lack of Efficacy|9|||
94543654|NCT02008357|323786764|FG001|Open-label Extension Period|Lack of Efficacy|5|||
94543655|NCT02008357|323786763|FG000|Open-label Extension Period|Lost to Follow-up|2|||
94543656|NCT02008357|323786764|FG001|Open-label Extension Period|Lost to Follow-up|2|||
94543657|NCT02008357|323786763|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
94543658|NCT02008357|323786764|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
94543659|NCT02008357|323786763|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
94543660|NCT02008357|323786764|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
94543661|NCT02008357|323786763|FG000|Open-label Extension Period|Safety Risk|2|||
94543662|NCT02008357|323786764|FG001|Open-label Extension Period|Safety Risk|1|||
94543663|NCT02008357|323786763|FG000|Open-label Extension Period|Non-Compliance|0|||
94543664|NCT02008357|323786764|FG001|Open-label Extension Period|Non-Compliance|1|||
94543665|NCT02008357|323786763|FG000|Open-label Extension Period|Investigator Recommendation|0|||
94543666|NCT02008357|323786764|FG001|Open-label Extension Period|Investigator Recommendation|1|||
94543667|NCT02008357|323786763|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
94543668|NCT02008357|323786764|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
94543669|NCT02008357|323786763|FG000|Open-label Extension Period|Coordinating Center Request|2|||
94543670|NCT02008357|323786764|FG001|Open-label Extension Period|Coordinating Center Request|4|||
94543671|NCT02008357|323786763|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
94543672|NCT02008357|323786764|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
94543673|NCT02008357|323786763|FG000|Open-label Extension Period|Study Ended|20|||
94543674|NCT02008357|323786764|FG001|Open-label Extension Period|Study Ended|25|||
94543675|NCT02008357|323786763|FG000|Open-label Extension Period|Personal Reasons|0|||
94543676|NCT02008357|323786764|FG001|Open-label Extension Period|Personal Reasons|1|||
94543677|NCT02008357|323786763|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
94543678|NCT02008357|323786764|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
94543679|NCT02008357|323786763|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
94543680|NCT02008357|323786764|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
94543681|NCT02008357|323786763|FG000|Open-label Extension Period|Other|2|||
94543682|NCT02008357|323786764|FG001|Open-label Extension Period|Other|0|||
94543683|NCT01269385|323786765|FG000|Overall Study|Adverse Event|1|||
94543684|NCT01269385|323786766|FG001|Overall Study|Adverse Event|1|||
94543685|NCT01269385|323786767|FG002|Overall Study|Adverse Event|0|||
94543686|NCT01269385|323786768|FG003|Overall Study|Adverse Event|0|||
94543687|NCT00966719|323786769|FG000|Overall Study|Lost to Follow-up|6|||
94543688|NCT00966719|323786770|FG001|Overall Study|Lost to Follow-up|11|||
94543689|NCT02741570|323786773|FG000|Pre-Treatment Period|Other reasons|0|||
94543690|NCT02741570|323786774|FG001|Pre-Treatment Period|Other reasons|3|||
94543691|NCT02741570|323786773|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
94543692|NCT02741570|323786774|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
94543693|NCT02741570|323786773|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
94543694|NCT02741570|323786774|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
94543695|NCT02741570|323786773|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
94543696|NCT02741570|323786774|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
94543697|NCT02741570|323786773|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
94543698|NCT02741570|323786774|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
94543699|NCT02741570|323786773|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
94543700|NCT02741570|323786774|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
94543701|NCT02741570|323786773|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
94543702|NCT02741570|323786774|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
94543703|NCT02741570|323786773|FG000|Pre-Treatment Period|Death|0|||
94543704|NCT02741570|323786774|FG001|Pre-Treatment Period|Death|1|||
94543705|NCT02741570|323786773|FG000|Pre-Treatment Period|Disease progression|0|||
94543706|NCT02741570|323786774|FG001|Pre-Treatment Period|Disease progression|1|||
94543707|NCT02741570|323786773|FG000|Treatment Period|Other reasons|47|||
94543708|NCT02741570|323786774|FG001|Treatment Period|Other reasons|12|||
94543709|NCT02741570|323786773|FG000|Treatment Period|Poor/non-compliance|0|||
94543710|NCT02741570|323786774|FG001|Treatment Period|Poor/non-compliance|2|||
94543711|NCT02741570|323786773|FG000|Treatment Period|Maximum clinical benefit|4|||
94543712|NCT02741570|323786774|FG001|Treatment Period|Maximum clinical benefit|6|||
94543713|NCT02741570|323786773|FG000|Treatment Period|Lost to Follow-up|1|||
94543714|NCT02741570|323786774|FG001|Treatment Period|Lost to Follow-up|3|||
94543715|NCT02741570|323786773|FG000|Treatment Period|Participant withdrew consent|9|||
94543716|NCT02741570|323786774|FG001|Treatment Period|Participant withdrew consent|13|||
94543717|NCT02741570|323786773|FG000|Treatment Period|Participant request to discontinue treatment|8|||
94543718|NCT02741570|323786774|FG001|Treatment Period|Participant request to discontinue treatment|23|||
94543719|NCT02741570|323786773|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
94543720|NCT02741570|323786774|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
94543721|NCT02741570|323786773|FG000|Treatment Period|Death|9|||
94543722|NCT02741570|323786774|FG001|Treatment Period|Death|7|||
94543723|NCT02741570|323786773|FG000|Treatment Period|Study drug toxicity|55|||
94543724|NCT02741570|323786774|FG001|Treatment Period|Study drug toxicity|47|||
94543725|NCT02741570|323786773|FG000|Treatment Period|Disease progression|294|||
94543726|NCT02741570|323786774|FG001|Treatment Period|Disease progression|301|||
94543727|NCT02741570|323786773|FG000|Treatment Period|Administrative reason by sponsor|0|||
94543728|NCT02741570|323786774|FG001|Treatment Period|Administrative reason by sponsor|1|||
94543729|NCT00831701|323786779|FG000|Overall Study|Withdrawal by Subject|2|||
94543730|NCT00831701|323786780|FG001|Overall Study|Withdrawal by Subject|0|||
94543731|NCT00831701|323786779|FG000|Overall Study|Stone expulsion before first medication|2|||
94543732|NCT00831701|323786780|FG001|Overall Study|Stone expulsion before first medication|2|||
94543733|NCT00831701|323786779|FG000|Overall Study|Lost to Follow-up|1|||
94543734|NCT00831701|323786780|FG001|Overall Study|Lost to Follow-up|3|||
94543735|NCT02242981|323786781|FG000|Overall Study|Withdrawal by Subject|1|||
94543736|NCT02739321|323786786|FG000|Overall Study|Lack of Efficacy|1|||
94543737|NCT02739321|323786787|FG001|Overall Study|Lack of Efficacy|1|||
94543738|NCT02739321|323786786|FG000|Overall Study|Lost to Follow-up|1|||
94543739|NCT02739321|323786787|FG001|Overall Study|Lost to Follow-up|1|||
94543740|NCT02739321|323786786|FG000|Overall Study|Withdrawal by Subject|1|||
94543741|NCT02739321|323786787|FG001|Overall Study|Withdrawal by Subject|2|||
94543742|NCT00459537|323786788|FG000|Overall Study|Adverse Event|1|||
94543743|NCT00459537|323786789|FG001|Overall Study|Adverse Event|6|||
94543744|NCT00459537|323786788|FG000|Overall Study|Lack of Efficacy|10|||
94543745|NCT00459537|323786789|FG001|Overall Study|Lack of Efficacy|11|||
94543746|NCT00459537|323786788|FG000|Overall Study|Withdrawal by Subject|20|||
94543747|NCT00459537|323786789|FG001|Overall Study|Withdrawal by Subject|26|||
94543748|NCT00459537|323786788|FG000|Overall Study|Lost to Follow-up|27|||
94543749|NCT00459537|323786789|FG001|Overall Study|Lost to Follow-up|30|||
94543750|NCT00459537|323786788|FG000|Overall Study|Administrative problems|3|||
94543751|NCT00459537|323786789|FG001|Overall Study|Administrative problems|0|||
94543752|NCT00459537|323786788|FG000|Overall Study|Protocol Violation|4|||
94543753|NCT00459537|323786789|FG001|Overall Study|Protocol Violation|3|||
94543754|NCT00459537|323786788|FG000|Overall Study|Missing|1|||
94543755|NCT00459537|323786789|FG001|Overall Study|Missing|0|||
94543756|NCT00456599|323786790|FG000|Overall Study|Non-compliance|1|||
94543757|NCT00456599|323786790|FG000|Overall Study|Withdrawal by Subject|2|||
94543758|NCT01999218|323786791|FG000|Overall Study|Hyperglycemia|18|||
94543759|NCT01999218|323786792|FG001|Overall Study|Hyperglycemia|17|||
94543760|NCT01999218|323786793|FG002|Overall Study|Hyperglycemia|17|||
94543761|NCT01999218|323786791|FG000|Overall Study|Lack of Efficacy|1|||
94543762|NCT01999218|323786792|FG001|Overall Study|Lack of Efficacy|0|||
94543763|NCT01999218|323786793|FG002|Overall Study|Lack of Efficacy|1|||
94543764|NCT01999218|323786791|FG000|Overall Study|Lost to Follow-up|22|||
94543765|NCT01999218|323786792|FG001|Overall Study|Lost to Follow-up|17|||
94543766|NCT01999218|323786793|FG002|Overall Study|Lost to Follow-up|18|||
94543767|NCT01999218|323786791|FG000|Overall Study|Non-Compliance With Study Drug|6|||
94543768|NCT01999218|323786792|FG001|Overall Study|Non-Compliance With Study Drug|4|||
94543769|NCT01999218|323786793|FG002|Overall Study|Non-Compliance With Study Drug|1|||
94543770|NCT01999218|323786791|FG000|Overall Study|Physician Decision|1|||
94543771|NCT01999218|323786792|FG001|Overall Study|Physician Decision|4|||
94543772|NCT01999218|323786793|FG002|Overall Study|Physician Decision|6|||
94543773|NCT01999218|323786791|FG000|Overall Study|Protocol Violation|4|||
94543774|NCT01999218|323786792|FG001|Overall Study|Protocol Violation|5|||
94543775|NCT01999218|323786793|FG002|Overall Study|Protocol Violation|4|||
94543776|NCT01999218|323786791|FG000|Overall Study|Screen failure|0|||
94543777|NCT01999218|323786792|FG001|Overall Study|Screen failure|1|||
94543778|NCT01999218|323786793|FG002|Overall Study|Screen failure|0|||
94543779|NCT01999218|323786791|FG000|Overall Study|Study Terminated By Sponsor|7|||
94543780|NCT01999218|323786792|FG001|Overall Study|Study Terminated By Sponsor|5|||
94543781|NCT01999218|323786793|FG002|Overall Study|Study Terminated By Sponsor|12|||
94543782|NCT01999218|323786791|FG000|Overall Study|Participant moves|2|||
94543783|NCT01999218|323786792|FG001|Overall Study|Participant moves|5|||
94543784|NCT01999218|323786793|FG002|Overall Study|Participant moves|3|||
94543785|NCT01999218|323786791|FG000|Overall Study|Withdrawal by Subject|28|||
94543786|NCT01999218|323786792|FG001|Overall Study|Withdrawal by Subject|29|||
94543787|NCT01999218|323786793|FG002|Overall Study|Withdrawal by Subject|34|||
94543788|NCT01999218|323786791|FG000|Overall Study|Creatinine/eGFR|0|||
94543789|NCT01999218|323786792|FG001|Overall Study|Creatinine/eGFR|0|||
94543790|NCT01999218|323786793|FG002|Overall Study|Creatinine/eGFR|1|||
94543791|NCT01999218|323786791|FG000|Overall Study|Death|7|||
94543792|NCT01999218|323786792|FG001|Overall Study|Death|1|||
94543793|NCT01999218|323786793|FG002|Overall Study|Death|2|||
94543794|NCT01999218|323786791|FG000|Overall Study|Excluded Medication|1|||
94543795|NCT01999218|323786792|FG001|Overall Study|Excluded Medication|1|||
94543796|NCT01999218|323786793|FG002|Overall Study|Excluded Medication|2|||
94543797|NCT01999218|323786791|FG000|Overall Study|Adverse Event|9|||
94543798|NCT01999218|323786792|FG001|Overall Study|Adverse Event|7|||
94543799|NCT01999218|323786793|FG002|Overall Study|Adverse Event|7|||
94543800|NCT01999218|323786791|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
94543801|NCT01999218|323786792|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
94543802|NCT01999218|323786793|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
94543803|NCT01350115|323788867|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
94543804|NCT01350115|323788868|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
94543805|NCT01350115|323788867|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
94543806|NCT01350115|323788868|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
94543807|NCT01350115|323788867|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
94543808|NCT01350115|323788868|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
94543809|NCT00509093|323788869|FG000|Overall Study|Adverse Event|10|||
94543810|NCT00509093|323788869|FG000|Overall Study|Disease Progression|9|||
94543811|NCT00509093|323788869|FG000|Overall Study|Transformed into MDS|1|||
94543812|NCT00509093|323788869|FG000|Overall Study|Withdrawal by Subject|3|||
94543813|NCT00509093|323788869|FG000|Overall Study|Physician Decision|1|||
94543814|NCT05320393|323788870|FG000|Overall Study|Withdrawal by Subject|1|||
94543815|NCT05320393|323788871|FG001|Overall Study|Withdrawal by Subject|0|||
94543816|NCT05320393|323788872|FG002|Overall Study|Withdrawal by Subject|2|||
94543817|NCT05320393|323788870|FG000|Overall Study|Lost to Follow-up|1|||
94543818|NCT05320393|323788871|FG001|Overall Study|Lost to Follow-up|2|||
94543819|NCT05320393|323788872|FG002|Overall Study|Lost to Follow-up|1|||
94543820|NCT05320393|323788870|FG000|Overall Study|Moved; too much driving|0|||
94543821|NCT05320393|323788871|FG001|Overall Study|Moved; too much driving|0|||
94543822|NCT05320393|323788872|FG002|Overall Study|Moved; too much driving|2|||
94543823|NCT05320393|323788870|FG000|Overall Study|Did not receive treatment|0|||
94543824|NCT05320393|323788871|FG001|Overall Study|Did not receive treatment|0|||
94543825|NCT05320393|323788872|FG002|Overall Study|Did not receive treatment|1|||
94543826|NCT00240110|323788874|FG000|Overall Study|Lost to Follow-up|6|||
94543827|NCT00240110|323788875|FG001|Overall Study|Lost to Follow-up|7|||
94543828|NCT03559699|323788876|FG000|Overall Study|Withdrawal by Subject|6|||
94543829|NCT03559699|323788876|FG000|Overall Study|Lost to Follow-up|1|||
94543830|NCT02654236|323788879|FG000|Overall Study|Withdrawal by Subject|0|||
94543831|NCT02654236|323788880|FG001|Overall Study|Withdrawal by Subject|0|||
94543832|NCT02654236|323788881|FG002|Overall Study|Withdrawal by Subject|2|||
94543833|NCT01460719|323788885|FG000|Overall Study|Adverse Event|1|||
94543834|NCT01460719|323788885|FG000|Overall Study|Withdrawal by Subject|1|||
94543835|NCT02119156|323788900|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
94543836|NCT02119156|323788901|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
94543837|NCT02119156|323788902|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
94543838|NCT02119156|323788900|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
94543839|NCT02119156|323788901|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
94543840|NCT02119156|323788902|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
94543841|NCT02119156|323788900|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
94543842|NCT02119156|323788901|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
94543843|NCT02119156|323788902|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
94543844|NCT02119156|323788900|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
94543845|NCT02119156|323788901|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
94543846|NCT02119156|323788902|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
94543847|NCT02119156|323788900|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
94543848|NCT02119156|323788901|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
94543849|NCT02119156|323788902|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
94543850|NCT01998893|323788906|FG000|Overall Study|Adverse Event|2|||
94543851|NCT01998893|323788906|FG000|Overall Study|Death|1|||
94543852|NCT01998893|323788906|FG000|Overall Study|Lost to Follow-up|8|||
94543853|NCT01998893|323788906|FG000|Overall Study|Physician Decision|2|||
94543854|NCT01998893|323788906|FG000|Overall Study|Protocol Violation|2|||
94543855|NCT01998893|323788906|FG000|Overall Study|Withdrawal by Subject|1|||
94543856|NCT01998893|323788906|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
94543857|NCT03276052|323788907|FG000|Overall Study|Withdrawal by Subject|5|||
94543858|NCT03276052|323788907|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
94543859|NCT01920152|323788918|FG000|Overall Study|Withdrawal by Subject|1|||
94543860|NCT01920152|323788919|FG001|Overall Study|Withdrawal by Subject|2|||
94543861|NCT00320372|323788920|FG000|Overall Study|Physician Decision|4|||
94543862|NCT00320372|323788921|FG001|Overall Study|Physician Decision|7|||
94543863|NCT00320372|323788920|FG000|Overall Study|Death|7|||
94543864|NCT00320372|323788921|FG001|Overall Study|Death|8|||
94543865|NCT00320372|323788920|FG000|Overall Study|Withdrawal by Subject|55|||
94543866|NCT00320372|323788921|FG001|Overall Study|Withdrawal by Subject|37|||
94543867|NCT00320372|323788920|FG000|Overall Study|Non-Compliance|40|||
94543868|NCT00320372|323788921|FG001|Overall Study|Non-Compliance|39|||
94543869|NCT00320372|323788920|FG000|Overall Study|Did not Meet (I/E)|3|||
94543870|NCT00320372|323788921|FG001|Overall Study|Did not Meet (I/E)|1|||
94543871|NCT00320372|323788920|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
94543872|NCT00320372|323788921|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
94543873|NCT00849875|323788923|FG000|Overall Study|Death|28|||
94543874|NCT00849875|323788923|FG000|Overall Study|Ongoing (unknown completion status)|11|||
94543875|NCT00849875|323788923|FG000|Overall Study|Others|6|||
94543876|NCT00849875|323788923|FG000|Overall Study|Lost to Follow-up|2|||
94543881|NCT00787137|323788926|FG000|Overall Study|Study Termination|0|||
94543882|NCT00787137|323788927|FG001|Overall Study|Study Termination|0|||
94543883|NCT00787137|323788928|FG002|Overall Study|Study Termination|1|||
94543884|NCT02761694|323788930|FG000|Overall Study|Lack of Efficacy|0|||
94543885|NCT02761694|323788931|FG001|Overall Study|Lack of Efficacy|0|||
94543886|NCT02761694|323788932|FG002|Overall Study|Lack of Efficacy|0|||
94543887|NCT02761694|323788933|FG003|Overall Study|Lack of Efficacy|0|||
94543888|NCT02761694|323788934|FG004|Overall Study|Lack of Efficacy|0|||
94543889|NCT02761694|323788935|FG005|Overall Study|Lack of Efficacy|0|||
94543890|NCT02761694|323788936|FG006|Overall Study|Lack of Efficacy|6|||
94543891|NCT02761694|323788937|FG007|Overall Study|Lack of Efficacy|0|||
94543892|NCT02761694|323788938|FG008|Overall Study|Lack of Efficacy|0|||
94543893|NCT02761694|323788939|FG009|Overall Study|Lack of Efficacy|1|||
94543894|NCT02761694|323788940|FG010|Overall Study|Lack of Efficacy|1|||
94543895|NCT02761694|323788941|FG011|Overall Study|Lack of Efficacy|4|||
94543896|NCT02761694|323788930|FG000|Overall Study|Death|0|||
94543897|NCT02761694|323788931|FG001|Overall Study|Death|0|||
94543898|NCT02761694|323788932|FG002|Overall Study|Death|0|||
94543899|NCT02761694|323788933|FG003|Overall Study|Death|0|||
94543900|NCT02761694|323788934|FG004|Overall Study|Death|0|||
94543901|NCT02761694|323788935|FG005|Overall Study|Death|0|||
94543902|NCT02761694|323788936|FG006|Overall Study|Death|2|||
94543903|NCT02761694|323788937|FG007|Overall Study|Death|0|||
94543904|NCT02761694|323788938|FG008|Overall Study|Death|2|||
94543905|NCT02761694|323788939|FG009|Overall Study|Death|2|||
94543906|NCT02761694|323788940|FG010|Overall Study|Death|1|||
94543907|NCT02761694|323788941|FG011|Overall Study|Death|0|||
94543908|NCT02761694|323788930|FG000|Overall Study|Physician Decision|0|||
94543909|NCT02761694|323788931|FG001|Overall Study|Physician Decision|0|||
94543910|NCT02761694|323788932|FG002|Overall Study|Physician Decision|0|||
94543911|NCT02761694|323788933|FG003|Overall Study|Physician Decision|0|||
94543912|NCT02761694|323788934|FG004|Overall Study|Physician Decision|0|||
94543913|NCT02761694|323788935|FG005|Overall Study|Physician Decision|0|||
94543914|NCT02761694|323788936|FG006|Overall Study|Physician Decision|1|||
94543915|NCT02761694|323788937|FG007|Overall Study|Physician Decision|0|||
94543916|NCT02761694|323788938|FG008|Overall Study|Physician Decision|0|||
94543917|NCT02761694|323788939|FG009|Overall Study|Physician Decision|0|||
94543918|NCT02761694|323788940|FG010|Overall Study|Physician Decision|0|||
94543919|NCT02761694|323788941|FG011|Overall Study|Physician Decision|0|||
94543920|NCT02761694|323788930|FG000|Overall Study|Withdrawal by Subject|0|||
94543921|NCT02761694|323788931|FG001|Overall Study|Withdrawal by Subject|0|||
94543922|NCT02761694|323788932|FG002|Overall Study|Withdrawal by Subject|0|||
94543923|NCT02761694|323788933|FG003|Overall Study|Withdrawal by Subject|1|||
94543924|NCT02761694|323788934|FG004|Overall Study|Withdrawal by Subject|0|||
94543925|NCT02761694|323788935|FG005|Overall Study|Withdrawal by Subject|0|||
94543926|NCT02761694|323788936|FG006|Overall Study|Withdrawal by Subject|4|||
94543927|NCT02761694|323788937|FG007|Overall Study|Withdrawal by Subject|0|||
94543928|NCT02761694|323788938|FG008|Overall Study|Withdrawal by Subject|2|||
94543929|NCT02761694|323788939|FG009|Overall Study|Withdrawal by Subject|1|||
94543930|NCT02761694|323788940|FG010|Overall Study|Withdrawal by Subject|0|||
94543931|NCT02761694|323788941|FG011|Overall Study|Withdrawal by Subject|0|||
94543932|NCT02761694|323788930|FG000|Overall Study|Lost to Follow-up|0|||
94543933|NCT02761694|323788931|FG001|Overall Study|Lost to Follow-up|0|||
94543934|NCT02761694|323788932|FG002|Overall Study|Lost to Follow-up|0|||
94543935|NCT02761694|323788933|FG003|Overall Study|Lost to Follow-up|0|||
94543936|NCT02761694|323788934|FG004|Overall Study|Lost to Follow-up|0|||
94543937|NCT02761694|323788935|FG005|Overall Study|Lost to Follow-up|0|||
94543938|NCT02761694|323788936|FG006|Overall Study|Lost to Follow-up|1|||
94543939|NCT02761694|323788937|FG007|Overall Study|Lost to Follow-up|0|||
94543940|NCT02761694|323788938|FG008|Overall Study|Lost to Follow-up|0|||
94543941|NCT02761694|323788939|FG009|Overall Study|Lost to Follow-up|0|||
94543942|NCT02761694|323788940|FG010|Overall Study|Lost to Follow-up|0|||
94543943|NCT02761694|323788941|FG011|Overall Study|Lost to Follow-up|1|||
94543944|NCT02761694|323788930|FG000|Overall Study|Adverse Event|0|||
94543945|NCT02761694|323788931|FG001|Overall Study|Adverse Event|0|||
94543946|NCT02761694|323788932|FG002|Overall Study|Adverse Event|0|||
94543947|NCT02761694|323788933|FG003|Overall Study|Adverse Event|0|||
94543948|NCT02761694|323788934|FG004|Overall Study|Adverse Event|0|||
94543949|NCT02761694|323788935|FG005|Overall Study|Adverse Event|0|||
94543950|NCT02761694|323788936|FG006|Overall Study|Adverse Event|1|||
94543951|NCT02761694|323788937|FG007|Overall Study|Adverse Event|0|||
94543952|NCT02761694|323788938|FG008|Overall Study|Adverse Event|1|||
94543953|NCT02761694|323788939|FG009|Overall Study|Adverse Event|0|||
94543954|NCT02761694|323788940|FG010|Overall Study|Adverse Event|0|||
94543955|NCT02761694|323788941|FG011|Overall Study|Adverse Event|1|||
94543956|NCT02761694|323788930|FG000|Overall Study|Other|4|||
94543957|NCT02761694|323788931|FG001|Overall Study|Other|4|||
94543958|NCT02761694|323788932|FG002|Overall Study|Other|1|||
94543959|NCT02761694|323788933|FG003|Overall Study|Other|2|||
94543960|NCT02761694|323788934|FG004|Overall Study|Other|3|||
94543961|NCT02761694|323788935|FG005|Overall Study|Other|3|||
94543962|NCT02761694|323788936|FG006|Overall Study|Other|18|||
94543963|NCT02761694|323788937|FG007|Overall Study|Other|8|||
94543964|NCT02761694|323788938|FG008|Overall Study|Other|0|||
94543965|NCT02761694|323788939|FG009|Overall Study|Other|1|||
94543966|NCT02761694|323788940|FG010|Overall Study|Other|1|||
94543967|NCT02761694|323788941|FG011|Overall Study|Other|0|||
94543968|NCT04342689|323788942|FG000|Overall Study|Withdrawal by Subject|32|||
94543969|NCT04342689|323788943|FG001|Overall Study|Withdrawal by Subject|33|||
94543970|NCT04342689|323788942|FG000|Overall Study|Lost to Follow-up|10|||
94543971|NCT04342689|323788943|FG001|Overall Study|Lost to Follow-up|12|||
94543972|NCT00526110|323788962|FG000|Overall Study|Adverse Event|2|||
94543973|NCT00526110|323788963|FG001|Overall Study|Adverse Event|9|||
94543974|NCT00526110|323788962|FG000|Overall Study|Disease Progression|0|||
94543975|NCT00526110|323788963|FG001|Overall Study|Disease Progression|19|||
94543976|NCT00526110|323788962|FG000|Overall Study|Maximal Response|0|||
94543977|NCT00526110|323788963|FG001|Overall Study|Maximal Response|6|||
94543978|NCT00526110|323788962|FG000|Overall Study|Withdrawal by Subject|0|||
94543979|NCT00526110|323788963|FG001|Overall Study|Withdrawal by Subject|2|||
94543980|NCT00526110|323788962|FG000|Overall Study|Poor Tolerance|0|||
94543981|NCT00526110|323788963|FG001|Overall Study|Poor Tolerance|5|||
94543982|NCT01873729|323788966|FG000|Overall Study|Withdrawal by Subject|1|||
94543983|NCT01066780|323788967|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
94543984|NCT01066780|323788968|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
94543985|NCT00475865|323788969|FG000|Overall Study|Adverse Event|0|||
94543986|NCT00475865|323788970|FG001|Overall Study|Adverse Event|3|||
94543987|NCT00475865|323788971|FG002|Overall Study|Adverse Event|4|||
94543988|NCT00475865|323788969|FG000|Overall Study|Lack of Efficacy|1|||
94543989|NCT00475865|323788970|FG001|Overall Study|Lack of Efficacy|0|||
94543990|NCT00475865|323788971|FG002|Overall Study|Lack of Efficacy|0|||
94543991|NCT00475865|323788969|FG000|Overall Study|Progressive disease|0|||
94543992|NCT00475865|323788970|FG001|Overall Study|Progressive disease|1|||
94543993|NCT00475865|323788971|FG002|Overall Study|Progressive disease|2|||
94543994|NCT00475865|323788969|FG000|Overall Study|Participant did not wish to continue|1|||
94543995|NCT00475865|323788970|FG001|Overall Study|Participant did not wish to continue|0|||
94543996|NCT00475865|323788971|FG002|Overall Study|Participant did not wish to continue|0|||
94543997|NCT00475865|323788969|FG000|Overall Study|Other than above|0|||
94543998|NCT00475865|323788970|FG001|Overall Study|Other than above|1|||
94543999|NCT00475865|323788971|FG002|Overall Study|Other than above|0|||
94544000|NCT02226549|323788972|FG000|Overall Study|Randomized but Never Treated|1|||
94544001|NCT02226549|323788973|FG001|Overall Study|Randomized but Never Treated|0|||
94544002|NCT02226549|323788972|FG000|Overall Study|Lost to Follow-up|0|||
94544003|NCT02226549|323788973|FG001|Overall Study|Lost to Follow-up|1|||
94544004|NCT02726880|323788975|FG000|Overall Study|Withdrawal by Subject|2|||
94544005|NCT02726880|323788976|FG001|Overall Study|Withdrawal by Subject|0|||
94544006|NCT02726880|323788975|FG000|Overall Study|Lost to Follow-up|1|||
94544007|NCT02726880|323788976|FG001|Overall Study|Lost to Follow-up|3|||
94544008|NCT04316741|323788977|FG000|Baseline Enrollment|Lost to Follow-up|1|||
94544009|NCT04316741|323788978|FG001|Baseline Enrollment|Lost to Follow-up|1|||
94544010|NCT04316741|323788977|FG000|Immediate Post-Test|Lost to Follow-up|5|||
94544011|NCT04316741|323788978|FG001|Immediate Post-Test|Lost to Follow-up|1|||
94544012|NCT04316741|323788977|FG000|1-month Post-test|Lost to Follow-up|7|||
94544013|NCT04316741|323788978|FG001|1-month Post-test|Lost to Follow-up|2|||
94544014|NCT04316741|323788977|FG000|3-month Follow-up|Lost to Follow-up|10|||
94544015|NCT04316741|323788978|FG001|3-month Follow-up|Lost to Follow-up|2|||
94544016|NCT00612508|323788979|FG000|Overall Study|Withdrawal by Subject|3|||
94544017|NCT00612508|323788980|FG001|Overall Study|Withdrawal by Subject|4|||
94544018|NCT02312219|323788981|FG000|Overall Study|Withdrawal by Subject|1|||
94544019|NCT02312219|323788982|FG001|Overall Study|Withdrawal by Subject|2|||
94544020|NCT02312219|323788981|FG000|Overall Study|could not schedule imaging in time|0|||
94544021|NCT02312219|323788982|FG001|Overall Study|could not schedule imaging in time|2|||
94544022|NCT02312219|323788981|FG000|Overall Study|Other|0|||
94544023|NCT02312219|323788982|FG001|Overall Study|Other|1|||
94544024|NCT02312219|323788981|FG000|Overall Study|Not randomized. Ineligible|0|||
94544025|NCT02312219|323788982|FG001|Overall Study|Not randomized. Ineligible|1|||
94544026|NCT01100567|323788983|FG000|Overall Study|Withdrawal by Subject|5|||
94544027|NCT01100567|323788984|FG001|Overall Study|Withdrawal by Subject|8|||
94544028|NCT01100567|323788983|FG000|Overall Study|Early Hospital Discharge|6|||
94544029|NCT01100567|323788984|FG001|Overall Study|Early Hospital Discharge|4|||
94544030|NCT01100567|323788983|FG000|Overall Study|Lost to Follow-up|1|||
94544031|NCT01100567|323788984|FG001|Overall Study|Lost to Follow-up|2|||
94544032|NCT01100567|323788983|FG000|Overall Study|Physician Decision|0|||
94544033|NCT01100567|323788984|FG001|Overall Study|Physician Decision|1|||
94544034|NCT01100567|323788983|FG000|Overall Study|Deemed ineligible after consent|0|||
94544035|NCT01100567|323788984|FG001|Overall Study|Deemed ineligible after consent|1|||
94544036|NCT01498185|323788988|FG000|Overall Study|Adverse Event|0|||
94544037|NCT01498185|323788989|FG001|Overall Study|Adverse Event|0|||
94544038|NCT01498185|323788990|FG002|Overall Study|Adverse Event|0|||
94544039|NCT01498185|323788991|FG003|Overall Study|Adverse Event|1|||
94544040|NCT01498185|323788992|FG004|Overall Study|Adverse Event|0|||
94544041|NCT01498185|323788988|FG000|Overall Study|Withdrawal by Subject|1|||
94544042|NCT01498185|323788989|FG001|Overall Study|Withdrawal by Subject|1|||
94544043|NCT01498185|323788990|FG002|Overall Study|Withdrawal by Subject|0|||
94544044|NCT01498185|323788991|FG003|Overall Study|Withdrawal by Subject|2|||
94544045|NCT01498185|323788992|FG004|Overall Study|Withdrawal by Subject|1|||
94544046|NCT01498185|323788988|FG000|Overall Study|No longer met criteria, etc|0|||
94544047|NCT01498185|323788989|FG001|Overall Study|No longer met criteria, etc|0|||
94544048|NCT01498185|323788990|FG002|Overall Study|No longer met criteria, etc|0|||
94544049|NCT01498185|323788991|FG003|Overall Study|No longer met criteria, etc|0|||
94544050|NCT01498185|323788992|FG004|Overall Study|No longer met criteria, etc|2|||
94544051|NCT00946322|323788993|FG000|Pre-treatment|participant failure to follow up|1|||
94544052|NCT00946322|323788993|FG000|Post-treatment|participant failure to follow up|2|||
94544053|NCT00160199|323788994|FG000|Overall Study|Adverse Event|5|||
94544054|NCT00160199|323788995|FG001|Overall Study|Adverse Event|14|||
94544055|NCT00160199|323788994|FG000|Overall Study|Lack of Efficacy|0|||
94544056|NCT00160199|323788995|FG001|Overall Study|Lack of Efficacy|1|||
94544057|NCT00160199|323788994|FG000|Overall Study|Lost to Follow-up|7|||
94544058|NCT00160199|323788995|FG001|Overall Study|Lost to Follow-up|7|||
94544059|NCT00160199|323788994|FG000|Overall Study|Withdrawal by Subject|4|||
94544060|NCT00160199|323788995|FG001|Overall Study|Withdrawal by Subject|6|||
94544061|NCT00160199|323788994|FG000|Overall Study|Administrative|0|||
94544062|NCT00160199|323788995|FG001|Overall Study|Administrative|1|||
94544063|NCT00160199|323788994|FG000|Overall Study|Protocol Violation|8|||
94544064|NCT00160199|323788995|FG001|Overall Study|Protocol Violation|8|||
94544065|NCT01827332|323788996|FG000|Overall Study|Lost to Follow-up|2|||
94544066|NCT01827332|323788997|FG001|Overall Study|Lost to Follow-up|1|||
94544067|NCT03352453|323788998|FG000|Overall Study|Miscellaneous Reasons|1|||
94544068|NCT03352453|323788999|FG001|Overall Study|Miscellaneous Reasons|2|||
94544069|NCT03352453|323788998|FG000|Overall Study|Lack of Efficacy|1|||
94544070|NCT03352453|323788999|FG001|Overall Study|Lack of Efficacy|0|||
94544071|NCT03352453|323788998|FG000|Overall Study|Withdrawal by Subject|8|||
94544072|NCT03352453|323788999|FG001|Overall Study|Withdrawal by Subject|14|||
94544073|NCT03352453|323788998|FG000|Overall Study|Study Terminated by Sponsor|2|||
94544074|NCT03352453|323788999|FG001|Overall Study|Study Terminated by Sponsor|1|||
94544075|NCT03352453|323788998|FG000|Overall Study|Protocol Deviation|1|||
94544076|NCT03352453|323788999|FG001|Overall Study|Protocol Deviation|0|||
94544077|NCT03352453|323788998|FG000|Overall Study|Lost to Follow-up|7|||
94544078|NCT03352453|323788999|FG001|Overall Study|Lost to Follow-up|6|||
94544079|NCT03352453|323788998|FG000|Overall Study|Adverse Event|2|||
94544080|NCT03352453|323788999|FG001|Overall Study|Adverse Event|9|||
94544081|NCT01241760|323789002|FG000|Overall Study|Adverse Event|1|||
94544082|NCT01241760|323789003|FG001|Overall Study|Adverse Event|0|||
94544083|NCT01241760|323789002|FG000|Overall Study|Lost to Follow-up|18|||
94544084|NCT01241760|323789003|FG001|Overall Study|Lost to Follow-up|22|||
94544085|NCT01241760|323789002|FG000|Overall Study|Withdrawal by Subject|13|||
94544086|NCT01241760|323789003|FG001|Overall Study|Withdrawal by Subject|13|||
94544087|NCT01241760|323789002|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
94544088|NCT01241760|323789003|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
94544089|NCT01241760|323789002|FG000|Overall Study|Other|1|||
94544090|NCT01241760|323789003|FG001|Overall Study|Other|1|||
94544091|NCT03089944|323789004|FG000|Overall Study|Lost to Follow-up|8|||
94544092|NCT03089944|323789004|FG000|Overall Study|Withdrew Consent|2|||
94544093|NCT03089944|323789004|FG000|Overall Study|Adverse Event|1|||
94544094|NCT03089944|323789004|FG000|Overall Study|Other|1|||
94544095|NCT02358044|323789005|FG000|Overall Study|Adverse Event|0|||
94544096|NCT02358044|323789006|FG001|Overall Study|Adverse Event|1|||
94544097|NCT02358044|323789005|FG000|Overall Study|Lost to Follow-up|2|||
94544098|NCT02358044|323789006|FG001|Overall Study|Lost to Follow-up|1|||
94544099|NCT02358044|323789005|FG000|Overall Study|Physician Decision|0|||
94544100|NCT02358044|323789006|FG001|Overall Study|Physician Decision|1|||
94544101|NCT02358044|323789005|FG000|Overall Study|Withdrawal by Subject|0|||
94544102|NCT02358044|323789006|FG001|Overall Study|Withdrawal by Subject|4|||
94544103|NCT04493684|323789007|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
94544104|NCT04493684|323789008|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
94544105|NCT04493684|323789009|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
94544106|NCT04493684|323789010|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
94544107|NCT04493684|323789011|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
94544108|NCT04493684|323789012|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
94544109|NCT04493684|323789013|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
94544110|NCT04493684|323789014|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
94544111|NCT04493684|323789015|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
94544112|NCT04493684|323789016|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
94544113|NCT04493684|323789017|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
94544114|NCT04493684|323789018|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
94544115|NCT04493684|323789019|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
94544116|NCT04493684|323789020|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
94544117|NCT04493684|323789021|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
94544118|NCT04493684|323789022|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
94544119|NCT04493684|323789023|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
94544120|NCT04493684|323789007|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
94544121|NCT04493684|323789008|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
94544122|NCT04493684|323789009|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
94544123|NCT04493684|323789010|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
94544124|NCT04493684|323789011|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
94544125|NCT04493684|323789012|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
94544126|NCT04493684|323789013|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
94544127|NCT04493684|323789014|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
94544128|NCT04493684|323789015|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
94544129|NCT04493684|323789016|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
94544130|NCT04493684|323789017|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
94544131|NCT04493684|323789018|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
94544132|NCT04493684|323789019|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
94544133|NCT04493684|323789020|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
94544134|NCT04493684|323789021|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
94544135|NCT04493684|323789022|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
94544136|NCT04493684|323789023|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
94544137|NCT04493684|323789007|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
94544138|NCT04493684|323789008|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
94544139|NCT04493684|323789009|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
94544140|NCT04493684|323789010|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
94544141|NCT04493684|323789011|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
94544142|NCT04493684|323789012|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
94544143|NCT04493684|323789013|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
94544144|NCT04493684|323789014|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
94544145|NCT04493684|323789015|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
94544146|NCT04493684|323789016|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
94544147|NCT04493684|323789017|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
94544148|NCT04493684|323789018|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
94544149|NCT04493684|323789019|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
94544150|NCT04493684|323789020|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
94544151|NCT04493684|323789021|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
94544152|NCT04493684|323789022|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
94544153|NCT04493684|323789023|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
94544154|NCT04493684|323789007|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
94544155|NCT04493684|323789008|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
94544156|NCT04493684|323789009|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
94544157|NCT04493684|323789010|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
94544158|NCT04493684|323789011|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
94544159|NCT04493684|323789012|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
94544160|NCT04493684|323789013|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
94544161|NCT04493684|323789014|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
94544162|NCT04493684|323789015|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
94544163|NCT04493684|323789016|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
94544164|NCT04493684|323789017|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
94544165|NCT04493684|323789018|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
94544166|NCT04493684|323789019|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
94544167|NCT04493684|323789020|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
94544168|NCT04493684|323789021|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
94544169|NCT04493684|323789022|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
94544170|NCT04493684|323789023|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
94544171|NCT04493684|323789007|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
94544172|NCT04493684|323789008|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
94544173|NCT04493684|323789009|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
94544174|NCT04493684|323789010|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
94544175|NCT04493684|323789011|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
94544176|NCT04493684|323789012|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
94544177|NCT04493684|323789013|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
94544178|NCT04493684|323789014|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
94544179|NCT04493684|323789015|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
94544180|NCT04493684|323789016|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
94544181|NCT04493684|323789017|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
94544182|NCT04493684|323789018|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
94544183|NCT04493684|323789019|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
94544184|NCT04493684|323789020|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
94544185|NCT04493684|323789021|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
94544186|NCT04493684|323789022|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
94544187|NCT04493684|323789023|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
94544188|NCT04493684|323789007|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
94544189|NCT04493684|323789008|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
94544190|NCT04493684|323789009|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
94544191|NCT04493684|323789010|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
94544192|NCT04493684|323789011|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
94544193|NCT04493684|323789012|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
94544194|NCT04493684|323789013|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
94544195|NCT04493684|323789014|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
94544196|NCT04493684|323789015|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
94544197|NCT04493684|323789016|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
94544198|NCT04493684|323789017|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
94544199|NCT04493684|323789018|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
94544200|NCT04493684|323789019|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
94544201|NCT04493684|323789020|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
94544202|NCT04493684|323789021|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
94544203|NCT04493684|323789022|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
94544204|NCT04493684|323789023|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
94544205|NCT04493684|323789007|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
94544206|NCT04493684|323789008|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
94544207|NCT04493684|323789009|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
94544208|NCT04493684|323789010|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
94544209|NCT04493684|323789011|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
94544210|NCT04493684|323789012|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
94544211|NCT04493684|323789013|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
94544212|NCT04493684|323789014|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
94544213|NCT04493684|323789015|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
94544214|NCT04493684|323789016|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
94544215|NCT04493684|323789017|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
94544216|NCT04493684|323789018|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
94544217|NCT04493684|323789019|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
94544218|NCT04493684|323789020|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
94544219|NCT04493684|323789021|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
94544220|NCT04493684|323789022|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
94544221|NCT04493684|323789023|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
94544222|NCT04493684|323789007|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
94544223|NCT04493684|323789008|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
94544224|NCT04493684|323789009|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
94544225|NCT04493684|323789010|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
94544226|NCT04493684|323789011|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
94544227|NCT04493684|323789012|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
94544228|NCT04493684|323789013|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
94544229|NCT04493684|323789014|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
94544230|NCT04493684|323789015|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
94544231|NCT04493684|323789016|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
94544232|NCT04493684|323789017|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
94544233|NCT04493684|323789018|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
94544234|NCT04493684|323789019|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
94544235|NCT04493684|323789020|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
94544236|NCT04493684|323789021|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
94544237|NCT04493684|323789022|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
94544238|NCT04493684|323789023|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
94544239|NCT03689244|323789024|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
94544240|NCT03689244|323789025|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
94544241|NCT03689244|323789026|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
94544242|NCT03689244|323789027|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
94544243|NCT03689244|323789024|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
94544244|NCT03689244|323789025|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
94544245|NCT03689244|323789026|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
94544246|NCT03689244|323789027|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
94544247|NCT03689244|323789024|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
94544248|NCT03689244|323789025|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
94544249|NCT03689244|323789026|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
94544250|NCT03689244|323789027|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
94544251|NCT03689244|323789024|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
94544252|NCT03689244|323789025|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
94544253|NCT03689244|323789026|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
94544254|NCT03689244|323789027|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
94544255|NCT03689244|323789024|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
94544256|NCT03689244|323789025|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
94544257|NCT03689244|323789026|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
94544258|NCT03689244|323789027|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
94544259|NCT03689244|323789024|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
94544260|NCT03689244|323789025|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
94544261|NCT03689244|323789026|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
94544262|NCT03689244|323789027|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
94544263|NCT03689244|323789024|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
94544264|NCT03689244|323789025|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
94544265|NCT03689244|323789026|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
94544266|NCT03689244|323789027|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
94544267|NCT03689244|323789024|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
94544268|NCT03689244|323789025|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
94544269|NCT03689244|323789026|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
94544270|NCT03689244|323789027|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
94544271|NCT01822535|323789028|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
94544272|NCT01822535|323789029|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
94544273|NCT01822535|323789028|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
94544274|NCT01822535|323789029|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
94544275|NCT01822535|323789028|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
94544276|NCT01822535|323789029|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
94544277|NCT03697993|323789039|FG000|Overall Study|Became Ineligible after Enrollment|1|||
94544278|NCT03697993|323789040|FG001|Overall Study|Became Ineligible after Enrollment|3|||
94544279|NCT03697993|323789039|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
94544280|NCT03697993|323789040|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
94544281|NCT03697993|323789039|FG000|Overall Study|Lost to Follow-up|3|||
94544282|NCT03697993|323789040|FG001|Overall Study|Lost to Follow-up|0|||
94544283|NCT03697993|323789039|FG000|Overall Study|Physician Decision|4|||
94544284|NCT03697993|323789040|FG001|Overall Study|Physician Decision|0|||
94544285|NCT03697993|323789039|FG000|Overall Study|Initial Urine Culture Negative|0|||
94544286|NCT03697993|323789040|FG001|Overall Study|Initial Urine Culture Negative|1|||
94544287|NCT03759041|323789041|FG000|Overall Study|Withdrawal by Subject|4|||
94544288|NCT03759041|323789042|FG001|Overall Study|Withdrawal by Subject|10|||
94544289|NCT03759041|323789043|FG002|Overall Study|Withdrawal by Subject|10|||
94544290|NCT03759041|323789041|FG000|Overall Study|Adverse Event|1|||
94544291|NCT03759041|323789042|FG001|Overall Study|Adverse Event|3|||
94544292|NCT03759041|323789043|FG002|Overall Study|Adverse Event|4|||
94544293|NCT03759041|323789041|FG000|Overall Study|Lack of Efficacy|0|||
94544294|NCT03759041|323789042|FG001|Overall Study|Lack of Efficacy|0|||
94544295|NCT03759041|323789043|FG002|Overall Study|Lack of Efficacy|1|||
94544296|NCT03759041|323789041|FG000|Overall Study|Study Terminated by Sponsor|15|||
94544297|NCT03759041|323789042|FG001|Overall Study|Study Terminated by Sponsor|16|||
94544298|NCT03759041|323789043|FG002|Overall Study|Study Terminated by Sponsor|10|||
94544299|NCT03759041|323789041|FG000|Overall Study|Other reason for discontinuation|0|||
94544300|NCT03759041|323789042|FG001|Overall Study|Other reason for discontinuation|2|||
94544301|NCT03759041|323789043|FG002|Overall Study|Other reason for discontinuation|1|||
94544302|NCT03759041|323789041|FG000|Overall Study|Lost to Follow-up|7|||
94544303|NCT03759041|323789042|FG001|Overall Study|Lost to Follow-up|2|||
94544304|NCT03759041|323789043|FG002|Overall Study|Lost to Follow-up|2|||
94544305|NCT03759041|323789041|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
94544306|NCT03759041|323789042|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
94544307|NCT03759041|323789043|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
94544308|NCT02279498|323789044|FG000|Overall Study|Adverse Event|3|||
94544309|NCT02279498|323789045|FG001|Overall Study|Adverse Event|0|||
94544310|NCT02279498|323789044|FG000|Overall Study|Lack of Efficacy|4|||
94544311|NCT02279498|323789045|FG001|Overall Study|Lack of Efficacy|0|||
94544312|NCT02279498|323789044|FG000|Overall Study|Lost to Follow-up|0|||
94544313|NCT02279498|323789045|FG001|Overall Study|Lost to Follow-up|1|||
94544314|NCT02279498|323789044|FG000|Overall Study|Withdrawal by Subject|9|||
94544315|NCT02279498|323789045|FG001|Overall Study|Withdrawal by Subject|2|||
94544316|NCT02279498|323789044|FG000|Overall Study|Undefined|2|||
94544317|NCT02279498|323789045|FG001|Overall Study|Undefined|1|||
94544318|NCT01048866|323789046|FG000|Overall Study|Adverse Event|1|||
94544319|NCT01048866|323789047|FG001|Overall Study|Adverse Event|0|||
94544320|NCT01048866|323789046|FG000|Overall Study|Protocol Violation|1|||
94544321|NCT01048866|323789047|FG001|Overall Study|Protocol Violation|0|||
94544322|NCT01048866|323789046|FG000|Overall Study|Physician Decision|1|||
94544323|NCT01048866|323789047|FG001|Overall Study|Physician Decision|0|||
94544324|NCT01048866|323789046|FG000|Overall Study|Withdrawal by Subject|0|||
94544325|NCT01048866|323789047|FG001|Overall Study|Withdrawal by Subject|2|||
94544326|NCT01048866|323789046|FG000|Overall Study|Lost to Follow-up|0|||
94544327|NCT01048866|323789047|FG001|Overall Study|Lost to Follow-up|2|||
94544328|NCT01048866|323789046|FG000|Overall Study|Other|1|||
94544329|NCT01048866|323789047|FG001|Overall Study|Other|1|||
94544330|NCT03582813|323789048|FG000|Overall Study|Lost to Follow-up|18|||
94544331|NCT03582813|323789049|FG001|Overall Study|Lost to Follow-up|21|||
94544332|NCT03582813|323789048|FG000|Overall Study|Withdrawal by Subject|1|||
94544333|NCT03582813|323789049|FG001|Overall Study|Withdrawal by Subject|0|||
94544334|NCT02525094|323789050|FG000|Overall Study|Lost to Follow-up|2|||
94544335|NCT02525094|323789051|FG001|Overall Study|Lost to Follow-up|1|||
94544336|NCT02525094|323789050|FG000|Overall Study|Withdrawal by Subject|5|||
94544337|NCT02525094|323789051|FG001|Overall Study|Withdrawal by Subject|6|||
94544338|NCT02525094|323789050|FG000|Overall Study|Not Treated|1|||
94544339|NCT02525094|323789051|FG001|Overall Study|Not Treated|1|||
94544340|NCT01591863|323789052|FG000|Overall Study|Adverse Event|3|||
94544341|NCT01591863|323789052|FG000|Overall Study|Withdrawal by Subject|1|||
94544342|NCT01591863|323789052|FG000|Overall Study|recurrence|9|||
94544343|NCT01591863|323789052|FG000|Overall Study|Lack of Efficacy|1|||
94544344|NCT00969436|323789054|FG000|Overall Study|Protocol Violation|1|||
94544345|NCT00969436|323789055|FG001|Overall Study|Protocol Violation|3|||
94544346|NCT00969436|323789056|FG002|Overall Study|Protocol Violation|0|||
94544347|NCT00969436|323789054|FG000|Overall Study|Migrated/moved from study area|12|||
94544348|NCT00969436|323789055|FG001|Overall Study|Migrated/moved from study area|10|||
94544349|NCT00969436|323789056|FG002|Overall Study|Migrated/moved from study area|2|||
94544350|NCT00969436|323789054|FG000|Overall Study|Father - serious health problem|0|||
94544351|NCT00969436|323789055|FG001|Overall Study|Father - serious health problem|0|||
94544352|NCT00969436|323789056|FG002|Overall Study|Father - serious health problem|1|||
94544353|NCT00969436|323789054|FG000|Overall Study|Parents personal problem|0|||
94544354|NCT00969436|323789055|FG001|Overall Study|Parents personal problem|0|||
94544355|NCT00969436|323789056|FG002|Overall Study|Parents personal problem|1|||
94544356|NCT00969436|323789054|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
94544357|NCT00969436|323789055|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
94544358|NCT00969436|323789056|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
94544359|NCT00969436|323789054|FG000|Overall Study|Withdrawal by Subject|3|||
94544360|NCT00969436|323789055|FG001|Overall Study|Withdrawal by Subject|0|||
94544361|NCT00969436|323789056|FG002|Overall Study|Withdrawal by Subject|2|||
94544362|NCT00969436|323789054|FG000|Overall Study|Lost to Follow-up|8|||
94544363|NCT00969436|323789055|FG001|Overall Study|Lost to Follow-up|8|||
94544364|NCT00969436|323789056|FG002|Overall Study|Lost to Follow-up|5|||
94544365|NCT02366767|323789068|FG000|Overall Study|left for home after 1 day at camp|1|||
94544366|NCT02366767|323789069|FG001|Overall Study|left for home after 1 day at camp|0|||
94544367|NCT02535416|323789074|FG000|Overall Study|Family bereavement overseas|1|||
94544368|NCT02535416|323789075|FG001|Overall Study|Family bereavement overseas|0|||
94544369|NCT02535416|323789076|FG002|Overall Study|Family bereavement overseas|0|||
94544370|NCT02535416|323789077|FG003|Overall Study|Family bereavement overseas|0|||
94544371|NCT02535416|323789078|FG004|Overall Study|Family bereavement overseas|0|||
94544372|NCT02535416|323789079|FG005|Overall Study|Family bereavement overseas|0|||
94544373|NCT02535416|323789080|FG006|Overall Study|Family bereavement overseas|0|||
94544374|NCT02535416|323789081|FG007|Overall Study|Family bereavement overseas|0|||
94544375|NCT02535416|323789082|FG008|Overall Study|Family bereavement overseas|0|||
94544376|NCT00758589|323791140|FG000|Overall Study|Adverse Event|3|||
94544377|NCT00758589|323791141|FG001|Overall Study|Adverse Event|2|||
94544378|NCT00758589|323791142|FG002|Overall Study|Adverse Event|5|||
94544379|NCT00758589|323791143|FG003|Overall Study|Adverse Event|4|||
94544380|NCT00758589|323791140|FG000|Overall Study|Withdrawal by Subject|0|||
94544381|NCT00758589|323791141|FG001|Overall Study|Withdrawal by Subject|1|||
94544382|NCT00758589|323791142|FG002|Overall Study|Withdrawal by Subject|1|||
94544383|NCT00758589|323791143|FG003|Overall Study|Withdrawal by Subject|1|||
94544384|NCT00758589|323791140|FG000|Overall Study|Palm stopped to work|0|||
94544385|NCT00758589|323791141|FG001|Overall Study|Palm stopped to work|0|||
94544386|NCT00758589|323791142|FG002|Overall Study|Palm stopped to work|0|||
94544387|NCT00758589|323791143|FG003|Overall Study|Palm stopped to work|1|||
94544388|NCT00734071|323791149|FG000|Overall Study|Adverse Event|4|||
94544389|NCT00734071|323791150|FG001|Overall Study|Adverse Event|3|||
94544390|NCT00734071|323791149|FG000|Overall Study|Lack of Efficacy|3|||
94544391|NCT00734071|323791150|FG001|Overall Study|Lack of Efficacy|1|||
94544392|NCT00734071|323791149|FG000|Overall Study|Noncompliance|2|||
94544393|NCT00734071|323791150|FG001|Overall Study|Noncompliance|2|||
94544394|NCT00734071|323791149|FG000|Overall Study|Protocol Deviations|3|||
94544395|NCT00734071|323791150|FG001|Overall Study|Protocol Deviations|4|||
94544396|NCT00734071|323791149|FG000|Overall Study|Voluntary Withdrawal|9|||
94544397|NCT00734071|323791150|FG001|Overall Study|Voluntary Withdrawal|7|||
94544398|NCT00734071|323791149|FG000|Overall Study|Lost to Follow-up|16|||
94544399|NCT00734071|323791150|FG001|Overall Study|Lost to Follow-up|8|||
94544400|NCT00734071|323791149|FG000|Overall Study|Other|1|||
94544401|NCT00734071|323791150|FG001|Overall Study|Other|2|||
94544402|NCT01176565|323791151|FG000|Overall Study|Lost to Follow-up|12|||
94544403|NCT01176565|323791152|FG001|Overall Study|Lost to Follow-up|16|||
94544404|NCT01176565|323791151|FG000|Overall Study|Withdrawal by Subject|7|||
94544405|NCT01176565|323791152|FG001|Overall Study|Withdrawal by Subject|1|||
94544406|NCT01176565|323791151|FG000|Overall Study|Not Analyzed (any other reason)|1|||
94544407|NCT01176565|323791152|FG001|Overall Study|Not Analyzed (any other reason)|2|||
94544408|NCT01187446|323791154|FG000|Overall Study|Patient started non-protocol therapy|0|||
94544409|NCT01187446|323791155|FG001|Overall Study|Patient started non-protocol therapy|1|||
94544410|NCT00098722|323791158|FG000|Double Blind Phase|Adverse Event|7|||
94544411|NCT00098722|323791159|FG001|Double Blind Phase|Adverse Event|7|||
94544412|NCT00098722|323791160|FG002|Double Blind Phase|Adverse Event|3|||
94544413|NCT00098722|323791161|FG003|Double Blind Phase|Adverse Event|0|||
94544414|NCT00098722|323791162|FG004|Double Blind Phase|Adverse Event|0|||
94544415|NCT00098722|323791163|FG005|Double Blind Phase|Adverse Event|0|||
94544416|NCT00098722|323791164|FG006|Double Blind Phase|Adverse Event|0|||
94544417|NCT00098722|323791158|FG000|Double Blind Phase|Death|2|||
94544418|NCT00098722|323791159|FG001|Double Blind Phase|Death|5|||
94544419|NCT00098722|323791160|FG002|Double Blind Phase|Death|0|||
94544420|NCT00098722|323791161|FG003|Double Blind Phase|Death|0|||
94544421|NCT00098722|323791162|FG004|Double Blind Phase|Death|0|||
94544422|NCT00098722|323791163|FG005|Double Blind Phase|Death|0|||
94544423|NCT00098722|323791164|FG006|Double Blind Phase|Death|0|||
94544424|NCT00098722|323791158|FG000|Double Blind Phase|Lack of Efficacy|21|||
94544425|NCT00098722|323791159|FG001|Double Blind Phase|Lack of Efficacy|23|||
94544426|NCT00098722|323791160|FG002|Double Blind Phase|Lack of Efficacy|15|||
94544427|NCT00098722|323791161|FG003|Double Blind Phase|Lack of Efficacy|0|||
94544428|NCT00098722|323791162|FG004|Double Blind Phase|Lack of Efficacy|0|||
94544429|NCT00098722|323791163|FG005|Double Blind Phase|Lack of Efficacy|0|||
94544430|NCT00098722|323791164|FG006|Double Blind Phase|Lack of Efficacy|0|||
94544431|NCT00098722|323791158|FG000|Double Blind Phase|Participant defaulted|16|||
94544432|NCT00098722|323791159|FG001|Double Blind Phase|Participant defaulted|11|||
94544433|NCT00098722|323791160|FG002|Double Blind Phase|Participant defaulted|9|||
94544434|NCT00098722|323791161|FG003|Double Blind Phase|Participant defaulted|0|||
94544435|NCT00098722|323791162|FG004|Double Blind Phase|Participant defaulted|0|||
94544436|NCT00098722|323791163|FG005|Double Blind Phase|Participant defaulted|0|||
94544437|NCT00098722|323791164|FG006|Double Blind Phase|Participant defaulted|0|||
94544438|NCT00098722|323791158|FG000|Double Blind Phase|Pregnancy|1|||
94544439|NCT00098722|323791159|FG001|Double Blind Phase|Pregnancy|0|||
94544440|NCT00098722|323791160|FG002|Double Blind Phase|Pregnancy|0|||
94544441|NCT00098722|323791161|FG003|Double Blind Phase|Pregnancy|0|||
94544442|NCT00098722|323791162|FG004|Double Blind Phase|Pregnancy|0|||
94544443|NCT00098722|323791163|FG005|Double Blind Phase|Pregnancy|0|||
94544444|NCT00098722|323791164|FG006|Double Blind Phase|Pregnancy|0|||
94544445|NCT00098722|323791158|FG000|Double Blind Phase|Randomized, not treated|4|||
94544446|NCT00098722|323791159|FG001|Double Blind Phase|Randomized, not treated|3|||
94544447|NCT00098722|323791160|FG002|Double Blind Phase|Randomized, not treated|3|||
94544448|NCT00098722|323791161|FG003|Double Blind Phase|Randomized, not treated|0|||
94544449|NCT00098722|323791162|FG004|Double Blind Phase|Randomized, not treated|0|||
94544450|NCT00098722|323791163|FG005|Double Blind Phase|Randomized, not treated|0|||
94544451|NCT00098722|323791164|FG006|Double Blind Phase|Randomized, not treated|0|||
94544452|NCT00098722|323791158|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
94544453|NCT00098722|323791159|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
94544454|NCT00098722|323791160|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
94544455|NCT00098722|323791161|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
94544456|NCT00098722|323791162|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
94544457|NCT00098722|323791163|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
94544458|NCT00098722|323791164|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
94544459|NCT00098722|323791158|FG000|Double Blind Phase|Other|7|||
94544460|NCT00098722|323791159|FG001|Double Blind Phase|Other|8|||
94544461|NCT00098722|323791160|FG002|Double Blind Phase|Other|7|||
94544462|NCT00098722|323791161|FG003|Double Blind Phase|Other|0|||
94544463|NCT00098722|323791162|FG004|Double Blind Phase|Other|0|||
94544464|NCT00098722|323791163|FG005|Double Blind Phase|Other|0|||
94544465|NCT00098722|323791164|FG006|Double Blind Phase|Other|0|||
94544466|NCT00098722|323791158|FG000|Open Label Phase|Adverse Event|0|||
94544467|NCT00098722|323791159|FG001|Open Label Phase|Adverse Event|0|||
94544468|NCT00098722|323791160|FG002|Open Label Phase|Adverse Event|0|||
94544469|NCT00098722|323791161|FG003|Open Label Phase|Adverse Event|5|||
94544470|NCT00098722|323791162|FG004|Open Label Phase|Adverse Event|0|||
94544471|NCT00098722|323791163|FG005|Open Label Phase|Adverse Event|0|||
94544472|NCT00098722|323791164|FG006|Open Label Phase|Adverse Event|0|||
94544473|NCT00098722|323791158|FG000|Open Label Phase|Death|0|||
94544474|NCT00098722|323791159|FG001|Open Label Phase|Death|0|||
94544475|NCT00098722|323791160|FG002|Open Label Phase|Death|0|||
94544476|NCT00098722|323791161|FG003|Open Label Phase|Death|2|||
94544477|NCT00098722|323791162|FG004|Open Label Phase|Death|0|||
94544478|NCT00098722|323791163|FG005|Open Label Phase|Death|0|||
94544479|NCT00098722|323791164|FG006|Open Label Phase|Death|0|||
94544480|NCT00098722|323791158|FG000|Open Label Phase|Lack of Efficacy|0|||
94544481|NCT00098722|323791159|FG001|Open Label Phase|Lack of Efficacy|0|||
94544482|NCT00098722|323791160|FG002|Open Label Phase|Lack of Efficacy|0|||
94544483|NCT00098722|323791161|FG003|Open Label Phase|Lack of Efficacy|8|||
94544484|NCT00098722|323791162|FG004|Open Label Phase|Lack of Efficacy|0|||
94544485|NCT00098722|323791163|FG005|Open Label Phase|Lack of Efficacy|0|||
94544486|NCT00098722|323791164|FG006|Open Label Phase|Lack of Efficacy|0|||
94544487|NCT00098722|323791158|FG000|Open Label Phase|Pregnancy|0|||
94544488|NCT00098722|323791159|FG001|Open Label Phase|Pregnancy|0|||
94544489|NCT00098722|323791160|FG002|Open Label Phase|Pregnancy|0|||
94544490|NCT00098722|323791161|FG003|Open Label Phase|Pregnancy|1|||
94544491|NCT00098722|323791162|FG004|Open Label Phase|Pregnancy|0|||
94544492|NCT00098722|323791163|FG005|Open Label Phase|Pregnancy|0|||
94544493|NCT00098722|323791164|FG006|Open Label Phase|Pregnancy|0|||
94544494|NCT00098722|323791158|FG000|Open Label Phase|Participant defaulted|0|||
94544495|NCT00098722|323791159|FG001|Open Label Phase|Participant defaulted|0|||
94544496|NCT00098722|323791160|FG002|Open Label Phase|Participant defaulted|0|||
94544497|NCT00098722|323791161|FG003|Open Label Phase|Participant defaulted|18|||
94544498|NCT00098722|323791162|FG004|Open Label Phase|Participant defaulted|0|||
94544499|NCT00098722|323791163|FG005|Open Label Phase|Participant defaulted|0|||
94544500|NCT00098722|323791164|FG006|Open Label Phase|Participant defaulted|0|||
94544501|NCT00098722|323791158|FG000|Open Label Phase|Ongoing at cut-off date|0|||
94544502|NCT00098722|323791159|FG001|Open Label Phase|Ongoing at cut-off date|0|||
94544503|NCT00098722|323791160|FG002|Open Label Phase|Ongoing at cut-off date|0|||
94544504|NCT00098722|323791161|FG003|Open Label Phase|Ongoing at cut-off date|220|||
94544505|NCT00098722|323791162|FG004|Open Label Phase|Ongoing at cut-off date|50|||
94544506|NCT00098722|323791163|FG005|Open Label Phase|Ongoing at cut-off date|0|||
94544507|NCT00098722|323791164|FG006|Open Label Phase|Ongoing at cut-off date|0|||
94544508|NCT00098722|323791158|FG000|Open Label Phase|Other|0|||
94544509|NCT00098722|323791159|FG001|Open Label Phase|Other|0|||
94544510|NCT00098722|323791160|FG002|Open Label Phase|Other|0|||
94544511|NCT00098722|323791161|FG003|Open Label Phase|Other|18|||
94544512|NCT00098722|323791162|FG004|Open Label Phase|Other|0|||
94544513|NCT00098722|323791163|FG005|Open Label Phase|Other|0|||
94544514|NCT00098722|323791164|FG006|Open Label Phase|Other|0|||
94544515|NCT00098722|323791158|FG000|Observation Phase|Death|0|||
94544516|NCT00098722|323791159|FG001|Observation Phase|Death|0|||
94544517|NCT00098722|323791160|FG002|Observation Phase|Death|0|||
94544518|NCT00098722|323791161|FG003|Observation Phase|Death|0|||
94544519|NCT00098722|323791162|FG004|Observation Phase|Death|0|||
94544520|NCT00098722|323791163|FG005|Observation Phase|Death|5|||
94544521|NCT00098722|323791164|FG006|Observation Phase|Death|3|||
94544522|NCT00098722|323791158|FG000|Observation Phase|Lack of Efficacy|0|||
94544523|NCT00098722|323791159|FG001|Observation Phase|Lack of Efficacy|0|||
94544524|NCT00098722|323791160|FG002|Observation Phase|Lack of Efficacy|0|||
94544525|NCT00098722|323791161|FG003|Observation Phase|Lack of Efficacy|0|||
94544526|NCT00098722|323791162|FG004|Observation Phase|Lack of Efficacy|0|||
94544527|NCT00098722|323791163|FG005|Observation Phase|Lack of Efficacy|2|||
94544528|NCT00098722|323791164|FG006|Observation Phase|Lack of Efficacy|0|||
94544529|NCT00098722|323791158|FG000|Observation Phase|Participant defaulted|0|||
94544530|NCT00098722|323791159|FG001|Observation Phase|Participant defaulted|0|||
94544531|NCT00098722|323791160|FG002|Observation Phase|Participant defaulted|0|||
94544532|NCT00098722|323791161|FG003|Observation Phase|Participant defaulted|0|||
94544533|NCT00098722|323791162|FG004|Observation Phase|Participant defaulted|0|||
94544534|NCT00098722|323791163|FG005|Observation Phase|Participant defaulted|17|||
94544535|NCT00098722|323791164|FG006|Observation Phase|Participant defaulted|4|||
94544536|NCT00098722|323791158|FG000|Observation Phase|Other|0|||
94544537|NCT00098722|323791159|FG001|Observation Phase|Other|0|||
94544538|NCT00098722|323791160|FG002|Observation Phase|Other|0|||
94544539|NCT00098722|323791161|FG003|Observation Phase|Other|0|||
94544540|NCT00098722|323791162|FG004|Observation Phase|Other|0|||
94544541|NCT00098722|323791163|FG005|Observation Phase|Other|21|||
94544542|NCT00098722|323791164|FG006|Observation Phase|Other|10|||
94544543|NCT01703117|323791168|FG000|Overall Study|Adverse Event|4|||
94544544|NCT01703117|323791169|FG001|Overall Study|Adverse Event|3|||
94544545|NCT01703117|323791168|FG000|Overall Study|Withdrawal by Subject|0|||
94544546|NCT01703117|323791169|FG001|Overall Study|Withdrawal by Subject|1|||
94544547|NCT01340937|323791170|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
94544548|NCT01340937|323791171|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
94544549|NCT01340937|323791172|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
94544550|NCT01340937|323791173|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
94544551|NCT01340937|323791170|FG000|Period 1: Infant Series|Adverse Event|0|||
94544552|NCT01340937|323791171|FG001|Period 1: Infant Series|Adverse Event|1|||
94544553|NCT01340937|323791172|FG002|Period 1: Infant Series|Adverse Event|4|||
94544554|NCT01340937|323791173|FG003|Period 1: Infant Series|Adverse Event|0|||
94544555|NCT01340937|323791170|FG000|Period 1: Infant Series|Death|2|||
94544556|NCT01340937|323791171|FG001|Period 1: Infant Series|Death|0|||
94544557|NCT01340937|323791172|FG002|Period 1: Infant Series|Death|2|||
94544558|NCT01340937|323791173|FG003|Period 1: Infant Series|Death|0|||
94544559|NCT01340937|323791170|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
94544560|NCT01340937|323791171|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
94544561|NCT01340937|323791172|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
94544562|NCT01340937|323791173|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
94544563|NCT01340937|323791170|FG000|Period 1: Infant Series|Physician Decision|2|||
94544564|NCT01340937|323791171|FG001|Period 1: Infant Series|Physician Decision|3|||
94544565|NCT01340937|323791172|FG002|Period 1: Infant Series|Physician Decision|1|||
94544566|NCT01340937|323791173|FG003|Period 1: Infant Series|Physician Decision|0|||
94544567|NCT01340937|323791170|FG000|Period 1: Infant Series|Protocol Violation|1|||
94544568|NCT01340937|323791171|FG001|Period 1: Infant Series|Protocol Violation|4|||
94544569|NCT01340937|323791172|FG002|Period 1: Infant Series|Protocol Violation|4|||
94544570|NCT01340937|323791173|FG003|Period 1: Infant Series|Protocol Violation|3|||
94544571|NCT01340937|323791170|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
94544572|NCT01340937|323791171|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
94544573|NCT01340937|323791172|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
94544574|NCT01340937|323791173|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
94544575|NCT01340937|323791170|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
94544576|NCT01340937|323791171|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
94544577|NCT01340937|323791172|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
94544578|NCT01340937|323791173|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
94544579|NCT01340937|323791170|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
94544580|NCT01340937|323791171|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
94544581|NCT01340937|323791172|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
94544582|NCT01340937|323791173|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
94544583|NCT01340937|323791170|FG000|Period 2: Interim Period|Adverse Event|1|||
94544584|NCT01340937|323791171|FG001|Period 2: Interim Period|Adverse Event|0|||
94544585|NCT01340937|323791172|FG002|Period 2: Interim Period|Adverse Event|1|||
94544586|NCT01340937|323791173|FG003|Period 2: Interim Period|Adverse Event|0|||
94544587|NCT01340937|323791170|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
94544588|NCT01340937|323791171|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
94544589|NCT01340937|323791172|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
94544590|NCT01340937|323791173|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
94544591|NCT01340937|323791170|FG000|Period 2: Interim Period|Physician Decision|0|||
94544592|NCT01340937|323791171|FG001|Period 2: Interim Period|Physician Decision|1|||
94544593|NCT01340937|323791172|FG002|Period 2: Interim Period|Physician Decision|1|||
94544594|NCT01340937|323791173|FG003|Period 2: Interim Period|Physician Decision|0|||
94544595|NCT01340937|323791170|FG000|Period 2: Interim Period|Protocol Violation|5|||
94544596|NCT01340937|323791171|FG001|Period 2: Interim Period|Protocol Violation|3|||
94544597|NCT01340937|323791172|FG002|Period 2: Interim Period|Protocol Violation|6|||
94544598|NCT01340937|323791173|FG003|Period 2: Interim Period|Protocol Violation|3|||
94544599|NCT01340937|323791170|FG000|Period 2: Interim Period|Technical problems|4|||
94544600|NCT01340937|323791171|FG001|Period 2: Interim Period|Technical problems|4|||
94544601|NCT01340937|323791172|FG002|Period 2: Interim Period|Technical problems|6|||
94544602|NCT01340937|323791173|FG003|Period 2: Interim Period|Technical problems|3|||
94544603|NCT01340937|323791170|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
94544604|NCT01340937|323791171|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
94544605|NCT01340937|323791172|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
94544606|NCT01340937|323791173|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
94544607|NCT01340937|323791170|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
94544608|NCT01340937|323791171|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
94544609|NCT01340937|323791172|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
94544610|NCT01340937|323791173|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
94544611|NCT01340937|323791170|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
94544612|NCT01340937|323791171|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
94544613|NCT01340937|323791172|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
94544614|NCT01340937|323791173|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
94544615|NCT01340937|323791170|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
94544616|NCT01340937|323791171|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
94544617|NCT01340937|323791172|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
94544618|NCT01340937|323791173|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
94544619|NCT00623545|323791174|FG000|Overall Study|Adverse Event|6|||
94544620|NCT00623545|323791174|FG000|Overall Study|Withdrawal by Subject|4|||
94544621|NCT01145053|323791176|FG000|Overall Study|Adverse Event|22|||
94544622|NCT01145053|323791176|FG000|Overall Study|Lost to Follow-up|28|||
94544623|NCT01145053|323791176|FG000|Overall Study|Withdrawal by Subject|25|||
94544624|NCT01145053|323791176|FG000|Overall Study|Other|18|||
94544625|NCT02969590|323791177|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
94544626|NCT02969590|323791178|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
94544627|NCT02969590|323791179|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
94544628|NCT00824005|323791180|FG000|Overall Study|Death|0|||
94544629|NCT00824005|323791181|FG001|Overall Study|Death|1|||
94544630|NCT00824005|323791180|FG000|Overall Study|Lost to Follow-up|0|||
94544631|NCT00824005|323791181|FG001|Overall Study|Lost to Follow-up|1|||
94544632|NCT00431951|323791182|FG000|Overall Study|Inability to follow study procedures|1|||
94544633|NCT00431951|323791183|FG001|Overall Study|Inability to follow study procedures|0|||
94544634|NCT00431951|323791184|FG002|Overall Study|Inability to follow study procedures|1|||
94544635|NCT00431951|323791185|FG003|Overall Study|Inability to follow study procedures|2|||
94544636|NCT00431951|323791182|FG000|Overall Study|Lost to Follow-up|0|||
94544637|NCT00431951|323791183|FG001|Overall Study|Lost to Follow-up|1|||
94544638|NCT00431951|323791184|FG002|Overall Study|Lost to Follow-up|0|||
94544639|NCT00431951|323791185|FG003|Overall Study|Lost to Follow-up|0|||
94544640|NCT00431951|323791182|FG000|Overall Study|Withdrawal by Subject|0|||
94544641|NCT00431951|323791183|FG001|Overall Study|Withdrawal by Subject|1|||
94544642|NCT00431951|323791184|FG002|Overall Study|Withdrawal by Subject|0|||
94544643|NCT00431951|323791185|FG003|Overall Study|Withdrawal by Subject|0|||
94544644|NCT00431951|323791182|FG000|Overall Study|Adverse Event|0|||
94544645|NCT00431951|323791183|FG001|Overall Study|Adverse Event|0|||
94544646|NCT00431951|323791184|FG002|Overall Study|Adverse Event|1|||
94544647|NCT00431951|323791185|FG003|Overall Study|Adverse Event|0|||
94544648|NCT01143051|323791186|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
94544649|NCT01143051|323791187|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
94544650|NCT01143051|323791188|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
94544651|NCT01143051|323791189|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
94544652|NCT01143051|323791190|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
94544653|NCT01143051|323791191|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
94544654|NCT01143051|323791186|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
94544655|NCT01143051|323791187|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
94544656|NCT01143051|323791188|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
94544657|NCT01143051|323791189|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
94544658|NCT01143051|323791190|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
94544659|NCT01143051|323791191|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
94544660|NCT00086502|323791194|FG000|Overall Study|Adverse Event|11|||
94544661|NCT00086502|323791195|FG001|Overall Study|Adverse Event|2|||
94544662|NCT00086502|323791194|FG000|Overall Study|Lack of Efficacy|0|||
94544663|NCT00086502|323791195|FG001|Overall Study|Lack of Efficacy|2|||
94544664|NCT00086502|323791194|FG000|Overall Study|Lost to Follow-up|3|||
94544665|NCT00086502|323791195|FG001|Overall Study|Lost to Follow-up|1|||
94544666|NCT00086502|323791194|FG000|Overall Study|Physician Decision|1|||
94544667|NCT00086502|323791195|FG001|Overall Study|Physician Decision|1|||
94544668|NCT00086502|323791194|FG000|Overall Study|Pregnancy|0|||
94544669|NCT00086502|323791195|FG001|Overall Study|Pregnancy|1|||
94544670|NCT00086502|323791194|FG000|Overall Study|Protocol Violation|3|||
94544671|NCT00086502|323791195|FG001|Overall Study|Protocol Violation|3|||
94544672|NCT00086502|323791194|FG000|Overall Study|Withdrawal by Subject|5|||
94544673|NCT00086502|323791195|FG001|Overall Study|Withdrawal by Subject|6|||
94544674|NCT00086502|323791194|FG000|Overall Study|Patient Moved|1|||
94544675|NCT00086502|323791195|FG001|Overall Study|Patient Moved|1|||
94544676|NCT00086502|323791194|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
94544677|NCT00086502|323791195|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
94544678|NCT00086502|323791194|FG000|Overall Study|Patient Accidentally Unblinded|1|||
94544679|NCT00086502|323791195|FG001|Overall Study|Patient Accidentally Unblinded|0|||
94544680|NCT01304329|323791196|FG000|Third Intervention (3 Days)|Adverse Event|0|||
94544681|NCT01304329|323791197|FG001|Third Intervention (3 Days)|Adverse Event|1|||
94544682|NCT01304329|323791198|FG002|Third Intervention (3 Days)|Adverse Event|0|||
94544683|NCT01304329|323791199|FG003|Third Intervention (3 Days)|Adverse Event|0|||
94544684|NCT01304329|323791200|FG004|Third Intervention (3 Days)|Adverse Event|0|||
94544685|NCT01304329|323791201|FG005|Third Intervention (3 Days)|Adverse Event|0|||
94544686|NCT00610441|323791202|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
94544687|NCT00610441|323791203|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
94544688|NCT00610441|323791204|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
94544689|NCT00610441|323791205|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
94544690|NCT00610441|323791202|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
94544691|NCT00610441|323791203|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
94544692|NCT00610441|323791204|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
94544693|NCT00610441|323791205|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
94544694|NCT00610441|323791202|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
94544695|NCT00610441|323791203|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
94544696|NCT00610441|323791204|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
94544697|NCT00610441|323791205|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
94544698|NCT00610441|323791202|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
94544699|NCT00610441|323791203|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
94544700|NCT00610441|323791204|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
94544701|NCT00610441|323791205|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
94544702|NCT00610441|323791202|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
94544703|NCT00610441|323791203|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
94544704|NCT00610441|323791204|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
94544705|NCT00610441|323791205|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
94544706|NCT00610441|323791202|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
94544707|NCT00610441|323791203|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
94544708|NCT00610441|323791204|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
94544709|NCT00610441|323791205|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
94544710|NCT00610441|323791202|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
94544711|NCT00610441|323791203|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
94544712|NCT00610441|323791204|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
94544713|NCT00610441|323791205|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
94544714|NCT00610441|323791202|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
94544715|NCT00610441|323791203|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
94544716|NCT00610441|323791204|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
94544717|NCT00610441|323791205|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
94544718|NCT00610441|323791202|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
94544719|NCT00610441|323791203|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
94544720|NCT00610441|323791204|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
94544721|NCT00610441|323791205|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
94544722|NCT00930969|323791206|FG000|Overall Study|Death|5|||
94544723|NCT00930969|323791206|FG000|Overall Study|Lost to Follow-up|1|||
94544724|NCT00930969|323791206|FG000|Overall Study|Physician Decision|13|||
94544725|NCT00930969|323791206|FG000|Overall Study|Withdrawal by Subject|19|||
94544726|NCT00993499|323791207|FG000|Run-in Period (8 Days)|Adverse Event|0|||
94544727|NCT00993499|323791208|FG001|Run-in Period (8 Days)|Adverse Event|1|||
94544728|NCT00993499|323791209|FG002|Run-in Period (8 Days)|Adverse Event|0|||
94544729|NCT00993499|323791210|FG003|Run-in Period (8 Days)|Adverse Event|0|||
94544730|NCT00993499|323791211|FG004|Run-in Period (8 Days)|Adverse Event|0|||
94544731|NCT00993499|323791212|FG005|Run-in Period (8 Days)|Adverse Event|0|||
94544732|NCT00993499|323791207|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
94544733|NCT00993499|323791208|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
94544734|NCT00993499|323791209|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
94544735|NCT00993499|323791210|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
94544736|NCT00993499|323791211|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
94544737|NCT00993499|323791212|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
94544738|NCT00993499|323791207|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
94544739|NCT00993499|323791208|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
94544740|NCT00993499|323791209|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
94544741|NCT00993499|323791210|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
94544742|NCT00993499|323791211|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
94544743|NCT00993499|323791212|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
94544744|NCT00993499|323791207|FG000|Run-in Period (8 Days)|Progressive disease|0|||
94544745|NCT00993499|323791208|FG001|Run-in Period (8 Days)|Progressive disease|1|||
94544746|NCT00993499|323791209|FG002|Run-in Period (8 Days)|Progressive disease|1|||
94544747|NCT00993499|323791210|FG003|Run-in Period (8 Days)|Progressive disease|0|||
94544748|NCT00993499|323791211|FG004|Run-in Period (8 Days)|Progressive disease|0|||
94544749|NCT00993499|323791212|FG005|Run-in Period (8 Days)|Progressive disease|0|||
94544750|NCT00993499|323791207|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
94544751|NCT00993499|323791208|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
94544752|NCT00993499|323791209|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
94544753|NCT00993499|323791210|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
94544754|NCT00993499|323791211|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
94544755|NCT00993499|323791212|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
94544756|NCT00993499|323791207|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
94544757|NCT00993499|323791208|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
94544758|NCT00993499|323791209|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
94544759|NCT00993499|323791210|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
94544760|NCT00993499|323791211|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
94544761|NCT00993499|323791212|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
94544762|NCT00993499|323791207|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
94544763|NCT00993499|323791208|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
94544764|NCT00993499|323791209|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
94544765|NCT00993499|323791210|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
94544766|NCT00993499|323791211|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
94544767|NCT00993499|323791212|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
94544768|NCT00993499|323791207|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
94544769|NCT00993499|323791208|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
94544770|NCT00993499|323791209|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
94544771|NCT00993499|323791210|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
94544772|NCT00993499|323791211|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
94544773|NCT00993499|323791212|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
94544774|NCT00993499|323791207|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
94544775|NCT00993499|323791208|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
94544776|NCT00993499|323791209|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
94544777|NCT00993499|323791210|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
94544778|NCT00993499|323791211|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
94544779|NCT00993499|323791212|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
94544780|NCT00993499|323791207|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
94544781|NCT00993499|323791208|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
94544782|NCT00993499|323791209|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
94544783|NCT00993499|323791210|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
94544784|NCT00993499|323791211|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
94544785|NCT00993499|323791212|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
94544786|NCT00993499|323791207|FG000|Discontinued After Starting Course 3|DLT|1|||
94544787|NCT00993499|323791208|FG001|Discontinued After Starting Course 3|DLT|0|||
94544788|NCT00993499|323791209|FG002|Discontinued After Starting Course 3|DLT|2|||
94544789|NCT00993499|323791210|FG003|Discontinued After Starting Course 3|DLT|1|||
94544790|NCT00993499|323791211|FG004|Discontinued After Starting Course 3|DLT|0|||
94544791|NCT00993499|323791212|FG005|Discontinued After Starting Course 3|DLT|0|||
94544792|NCT00993499|323791207|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
94544793|NCT00993499|323791208|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
94544794|NCT00993499|323791209|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
94544795|NCT00993499|323791210|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
94544796|NCT00993499|323791211|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
94544797|NCT00993499|323791212|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
94544798|NCT01945775|323791213|FG000|Overall Study|Death|214|||
94544799|NCT01945775|323791214|FG001|Overall Study|Death|98|||
94544800|NCT01945775|323791213|FG000|Overall Study|Lost to Follow-up|12|||
94544801|NCT01945775|323791214|FG001|Overall Study|Lost to Follow-up|7|||
94544802|NCT01945775|323791213|FG000|Overall Study|Withdrawal by Subject|11|||
94544803|NCT01945775|323791214|FG001|Overall Study|Withdrawal by Subject|21|||
94544804|NCT01945775|323791213|FG000|Overall Study|Other|50|||
94544805|NCT01945775|323791214|FG001|Overall Study|Other|18|||
94544806|NCT02876328|323791215|FG000|Overall Study|Death|2|||
94544807|NCT02876328|323791216|FG001|Overall Study|Death|1|||
94544808|NCT02876328|323791217|FG002|Overall Study|Death|3|||
94544809|NCT02876328|323791218|FG003|Overall Study|Death|0|||
94544810|NCT02876328|323791219|FG004|Overall Study|Death|0|||
94544811|NCT02876328|323791220|FG005|Overall Study|Death|0|||
94544812|NCT02876328|323791221|FG006|Overall Study|Death|1|||
94544813|NCT02876328|323791222|FG007|Overall Study|Death|3|||
94544814|NCT02876328|323791223|FG008|Overall Study|Death|0|||
94544815|NCT02876328|323791224|FG009|Overall Study|Death|1|||
94544816|NCT02876328|323791225|FG010|Overall Study|Death|1|||
94544817|NCT02876328|323791226|FG011|Overall Study|Death|0|||
94544818|NCT02876328|323791227|FG012|Overall Study|Death|0|||
94544819|NCT02876328|323791228|FG013|Overall Study|Death|0|||
94544820|NCT02876328|323791229|FG014|Overall Study|Death|0|||
94544821|NCT02876328|323791230|FG015|Overall Study|Death|0|||
94544822|NCT02876328|323791231|FG016|Overall Study|Death|1|||
94544823|NCT02876328|323791232|FG017|Overall Study|Death|1|||
94544824|NCT02876328|323791233|FG018|Overall Study|Death|0|||
94544825|NCT02876328|323791234|FG019|Overall Study|Death|0|||
94544826|NCT02876328|323791235|FG020|Overall Study|Death|0|||
94544827|NCT02876328|323791236|FG021|Overall Study|Death|1|||
94544828|NCT02876328|323791237|FG022|Overall Study|Death|0|||
94544829|NCT02876328|323791238|FG023|Overall Study|Death|0|||
94544830|NCT02876328|323791215|FG000|Overall Study|Withdrawal by Subject|0|||
94544831|NCT02876328|323791216|FG001|Overall Study|Withdrawal by Subject|2|||
94544832|NCT02876328|323791217|FG002|Overall Study|Withdrawal by Subject|3|||
94544833|NCT02876328|323791218|FG003|Overall Study|Withdrawal by Subject|3|||
94544834|NCT02876328|323791219|FG004|Overall Study|Withdrawal by Subject|0|||
94544835|NCT02876328|323791220|FG005|Overall Study|Withdrawal by Subject|1|||
94544836|NCT02876328|323791221|FG006|Overall Study|Withdrawal by Subject|0|||
94544837|NCT02876328|323791222|FG007|Overall Study|Withdrawal by Subject|1|||
94544838|NCT02876328|323791223|FG008|Overall Study|Withdrawal by Subject|1|||
94544839|NCT02876328|323791224|FG009|Overall Study|Withdrawal by Subject|2|||
94544840|NCT02876328|323791225|FG010|Overall Study|Withdrawal by Subject|0|||
94544841|NCT02876328|323791226|FG011|Overall Study|Withdrawal by Subject|0|||
94544842|NCT02876328|323791227|FG012|Overall Study|Withdrawal by Subject|0|||
94544843|NCT02876328|323791228|FG013|Overall Study|Withdrawal by Subject|0|||
94544844|NCT02876328|323791229|FG014|Overall Study|Withdrawal by Subject|0|||
94544845|NCT02876328|323791230|FG015|Overall Study|Withdrawal by Subject|0|||
94544846|NCT02876328|323791231|FG016|Overall Study|Withdrawal by Subject|1|||
94544847|NCT02876328|323791232|FG017|Overall Study|Withdrawal by Subject|3|||
94544848|NCT02876328|323791233|FG018|Overall Study|Withdrawal by Subject|0|||
94544849|NCT02876328|323791234|FG019|Overall Study|Withdrawal by Subject|0|||
94544850|NCT02876328|323791235|FG020|Overall Study|Withdrawal by Subject|1|||
94544851|NCT02876328|323791236|FG021|Overall Study|Withdrawal by Subject|0|||
94544852|NCT02876328|323791237|FG022|Overall Study|Withdrawal by Subject|0|||
94544853|NCT02876328|323791238|FG023|Overall Study|Withdrawal by Subject|0|||
94544854|NCT02876328|323791215|FG000|Overall Study|Missed 12 Month Visit|15|||
94544855|NCT02876328|323791216|FG001|Overall Study|Missed 12 Month Visit|10|||
94544856|NCT02876328|323791217|FG002|Overall Study|Missed 12 Month Visit|11|||
94544857|NCT02876328|323791218|FG003|Overall Study|Missed 12 Month Visit|6|||
94544858|NCT02876328|323791219|FG004|Overall Study|Missed 12 Month Visit|10|||
94544859|NCT02876328|323791220|FG005|Overall Study|Missed 12 Month Visit|14|||
94544860|NCT02876328|323791221|FG006|Overall Study|Missed 12 Month Visit|3|||
94544861|NCT02876328|323791222|FG007|Overall Study|Missed 12 Month Visit|8|||
94544862|NCT02876328|323791223|FG008|Overall Study|Missed 12 Month Visit|9|||
94544863|NCT02876328|323791224|FG009|Overall Study|Missed 12 Month Visit|5|||
94544864|NCT02876328|323791225|FG010|Overall Study|Missed 12 Month Visit|4|||
94544865|NCT02876328|323791226|FG011|Overall Study|Missed 12 Month Visit|1|||
94544866|NCT02876328|323791227|FG012|Overall Study|Missed 12 Month Visit|5|||
94544867|NCT02876328|323791228|FG013|Overall Study|Missed 12 Month Visit|4|||
94544868|NCT02876328|323791229|FG014|Overall Study|Missed 12 Month Visit|4|||
94544869|NCT02876328|323791230|FG015|Overall Study|Missed 12 Month Visit|4|||
94544870|NCT02876328|323791231|FG016|Overall Study|Missed 12 Month Visit|3|||
94544871|NCT02876328|323791232|FG017|Overall Study|Missed 12 Month Visit|6|||
94544872|NCT02876328|323791233|FG018|Overall Study|Missed 12 Month Visit|2|||
94544873|NCT02876328|323791234|FG019|Overall Study|Missed 12 Month Visit|2|||
94544874|NCT02876328|323791235|FG020|Overall Study|Missed 12 Month Visit|11|||
94544875|NCT02876328|323791236|FG021|Overall Study|Missed 12 Month Visit|7|||
94544876|NCT02876328|323791237|FG022|Overall Study|Missed 12 Month Visit|1|||
94544877|NCT02876328|323791238|FG023|Overall Study|Missed 12 Month Visit|0|||
94544878|NCT01995552|323791239|FG000|Overall Study|Protocol Violation|1|||
94544879|NCT01995552|323791239|FG000|Overall Study|Lack of Efficacy|15|||
94544880|NCT01995552|323791239|FG000|Overall Study|Death|1|||
94544881|NCT00334282|323791244|FG000|Overall Study|Lost to Follow-up|11|||
94544882|NCT00334282|323791245|FG001|Overall Study|Lost to Follow-up|5|||
94544883|NCT00334282|323791244|FG000|Overall Study|Withdrawal by Subject|17|||
94544884|NCT00334282|323791245|FG001|Overall Study|Withdrawal by Subject|3|||
94544885|NCT00334282|323791244|FG000|Overall Study|Death|194|||
94544886|NCT00334282|323791245|FG001|Overall Study|Death|100|||
94544887|NCT00468845|323791246|FG000|Overall Study|Adverse Event|9|||
94544888|NCT00468845|323791247|FG001|Overall Study|Adverse Event|14|||
94544889|NCT00468845|323791248|FG002|Overall Study|Adverse Event|11|||
94544890|NCT00468845|323791246|FG000|Overall Study|Lost to Follow-up|2|||
94544891|NCT00468845|323791247|FG001|Overall Study|Lost to Follow-up|1|||
94544892|NCT00468845|323791248|FG002|Overall Study|Lost to Follow-up|2|||
94544893|NCT00468845|323791246|FG000|Overall Study|Other|4|||
94544894|NCT00468845|323791247|FG001|Overall Study|Other|9|||
94544895|NCT00468845|323791248|FG002|Overall Study|Other|5|||
94544896|NCT00468845|323791246|FG000|Overall Study|No longer willing to participate|5|||
94544897|NCT00468845|323791247|FG001|Overall Study|No longer willing to participate|6|||
94544898|NCT00468845|323791248|FG002|Overall Study|No longer willing to participate|10|||
94544899|NCT00468845|323791246|FG000|Overall Study|Randomized, not treated|1|||
94544900|NCT00468845|323791247|FG001|Overall Study|Randomized, not treated|4|||
94544901|NCT00468845|323791248|FG002|Overall Study|Randomized, not treated|2|||
94544902|NCT01420627|323791249|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
94544903|NCT00276094|323791250|FG000|Overall Study|Adverse Event|15|||
94544904|NCT00276094|323791251|FG001|Overall Study|Adverse Event|13|||
94544905|NCT00276094|323791252|FG002|Overall Study|Adverse Event|11|||
94544906|NCT00276094|323791250|FG000|Overall Study|Withdrawal by Subject|14|||
94544907|NCT00276094|323791251|FG001|Overall Study|Withdrawal by Subject|14|||
94544908|NCT00276094|323791252|FG002|Overall Study|Withdrawal by Subject|12|||
94544909|NCT00276094|323791250|FG000|Overall Study|Protocol Violation|16|||
94544910|NCT00276094|323791251|FG001|Overall Study|Protocol Violation|7|||
94544911|NCT00276094|323791252|FG002|Overall Study|Protocol Violation|10|||
94544912|NCT00276094|323791250|FG000|Overall Study|Lost to Follow-up|8|||
94544913|NCT00276094|323791251|FG001|Overall Study|Lost to Follow-up|6|||
94544914|NCT00276094|323791252|FG002|Overall Study|Lost to Follow-up|4|||
94544915|NCT00276094|323791250|FG000|Overall Study|Other-Subject moved out of country|1|||
94544916|NCT00276094|323791251|FG001|Overall Study|Other-Subject moved out of country|0|||
94544917|NCT00276094|323791252|FG002|Overall Study|Other-Subject moved out of country|0|||
94544918|NCT00276094|323791250|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
94544919|NCT00276094|323791251|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
94544920|NCT00276094|323791252|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
94544921|NCT00276094|323791250|FG000|Overall Study|Other-Lack of efficacy|1|||
94544922|NCT00276094|323791251|FG001|Overall Study|Other-Lack of efficacy|0|||
94544923|NCT00276094|323791252|FG002|Overall Study|Other-Lack of efficacy|0|||
94544924|NCT00276094|323791250|FG000|Overall Study|Other-Refused follow-up visit|1|||
94544925|NCT00276094|323791251|FG001|Overall Study|Other-Refused follow-up visit|0|||
94544926|NCT00276094|323791252|FG002|Overall Study|Other-Refused follow-up visit|0|||
94544927|NCT00276094|323791250|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
94544928|NCT00276094|323791251|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
94544929|NCT00276094|323791252|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
94544930|NCT00276094|323791250|FG000|Overall Study|Other-Relocation|0|||
94544931|NCT00276094|323791251|FG001|Overall Study|Other-Relocation|1|||
94544932|NCT00276094|323791252|FG002|Overall Study|Other-Relocation|0|||
94544933|NCT00276094|323791250|FG000|Overall Study|Other-Study medication lost|0|||
94544934|NCT00276094|323791251|FG001|Overall Study|Other-Study medication lost|0|||
94544935|NCT00276094|323791252|FG002|Overall Study|Other-Study medication lost|1|||
94544936|NCT02759315|323791257|FG000|Overall Study|Adverse Event|0|||
94544937|NCT02759315|323791258|FG001|Overall Study|Adverse Event|0|||
94544938|NCT02759315|323791259|FG002|Overall Study|Adverse Event|0|||
94544939|NCT02759315|323791260|FG003|Overall Study|Adverse Event|1|||
94544940|NCT02759315|323791261|FG004|Overall Study|Adverse Event|0|||
94544941|NCT02759315|323791257|FG000|Overall Study|Death|0|||
94544942|NCT02759315|323791258|FG001|Overall Study|Death|0|||
94544943|NCT02759315|323791259|FG002|Overall Study|Death|1|||
94544944|NCT02759315|323791260|FG003|Overall Study|Death|0|||
94544945|NCT02759315|323791261|FG004|Overall Study|Death|0|||
94544946|NCT02759315|323791257|FG000|Overall Study|Lost to Follow-up|2|||
94544947|NCT02759315|323791258|FG001|Overall Study|Lost to Follow-up|0|||
94544948|NCT02759315|323791259|FG002|Overall Study|Lost to Follow-up|4|||
94544949|NCT02759315|323791260|FG003|Overall Study|Lost to Follow-up|0|||
94544950|NCT02759315|323791261|FG004|Overall Study|Lost to Follow-up|0|||
94544951|NCT02759315|323791257|FG000|Overall Study|Protocol Violation|0|||
94544952|NCT02759315|323791258|FG001|Overall Study|Protocol Violation|1|||
94544953|NCT02759315|323791259|FG002|Overall Study|Protocol Violation|0|||
94544954|NCT02759315|323791260|FG003|Overall Study|Protocol Violation|0|||
94544955|NCT02759315|323791261|FG004|Overall Study|Protocol Violation|0|||
94544956|NCT02759315|323791257|FG000|Overall Study|Study terminated prior to completion|2|||
94544957|NCT02759315|323791258|FG001|Overall Study|Study terminated prior to completion|0|||
94544958|NCT02759315|323791259|FG002|Overall Study|Study terminated prior to completion|5|||
94544959|NCT02759315|323791260|FG003|Overall Study|Study terminated prior to completion|0|||
94544960|NCT02759315|323791261|FG004|Overall Study|Study terminated prior to completion|1|||
94544961|NCT00461305|323791266|FG000|Treatment|Adverse Event|26|||
94544962|NCT00461305|323791267|FG001|Treatment|Adverse Event|3|||
94544963|NCT00461305|323791266|FG000|Treatment|Lost to Follow-up|4|||
94544964|NCT00461305|323791267|FG001|Treatment|Lost to Follow-up|2|||
94544965|NCT00461305|323791266|FG000|Treatment|Protocol Violation|13|||
94544966|NCT00461305|323791267|FG001|Treatment|Protocol Violation|2|||
94544967|NCT00461305|323791266|FG000|Treatment|Withdrawal by Subject|48|||
94544968|NCT00461305|323791267|FG001|Treatment|Withdrawal by Subject|2|||
94544969|NCT00461305|323791266|FG000|Treatment|Never dispensed|5|||
94544970|NCT00461305|323791267|FG001|Treatment|Never dispensed|0|||
94544971|NCT00461305|323791266|FG000|Treatment|Study drug not taken|1|||
94544972|NCT00461305|323791267|FG001|Treatment|Study drug not taken|0|||
94544973|NCT00461305|323791266|FG000|Treatment|Partially missing diary|2|||
94544974|NCT00461305|323791267|FG001|Treatment|Partially missing diary|0|||
94544975|NCT00461305|323791266|FG000|Treatment|Other (missing drug etc)|2|||
94544976|NCT00461305|323791267|FG001|Treatment|Other (missing drug etc)|0|||
94544977|NCT00461305|323791266|FG000|Continued Treatment|Adverse Event|26|||
94544978|NCT00461305|323791267|FG001|Continued Treatment|Adverse Event|0|||
94544979|NCT00461305|323791266|FG000|Continued Treatment|Lost to Follow-up|4|||
94544980|NCT00461305|323791267|FG001|Continued Treatment|Lost to Follow-up|0|||
94544981|NCT00461305|323791266|FG000|Continued Treatment|Protocol Violation|13|||
94544982|NCT00461305|323791267|FG001|Continued Treatment|Protocol Violation|0|||
94544983|NCT00461305|323791266|FG000|Continued Treatment|Withdrawal by Subject|48|||
94544984|NCT00461305|323791267|FG001|Continued Treatment|Withdrawal by Subject|0|||
94544985|NCT00461305|323791266|FG000|Continued Treatment|Partially missing diary|2|||
94544986|NCT00461305|323791267|FG001|Continued Treatment|Partially missing diary|0|||
94544987|NCT00461305|323791266|FG000|Continued Treatment|Other (missing drug etc)|2|||
94544988|NCT00461305|323791267|FG001|Continued Treatment|Other (missing drug etc)|0|||
94544989|NCT02395055|323791274|FG000|Overall Study|Withdrawal by Subject|7|||
94544990|NCT02395055|323791275|FG001|Overall Study|Withdrawal by Subject|3|||
94544991|NCT02513823|323791276|FG000|Overall Study|Lost to Follow-up|4|||
94544992|NCT02513823|323791276|FG000|Overall Study|Physician Decision|1|||
94544993|NCT03353922|323791277|FG000|Overall Study|Withdrawal by Subject|1|||
94544994|NCT03353922|323791278|FG001|Overall Study|Withdrawal by Subject|0|||
94544995|NCT03353922|323791279|FG002|Overall Study|Withdrawal by Subject|1|||
94544996|NCT03353922|323791280|FG003|Overall Study|Withdrawal by Subject|1|||
94544997|NCT03353922|323791281|FG004|Overall Study|Withdrawal by Subject|0|||
94544998|NCT03353922|323791282|FG005|Overall Study|Withdrawal by Subject|0|||
94544999|NCT03353922|323791277|FG000|Overall Study|Adverse Event|0|||
94545000|NCT03353922|323791278|FG001|Overall Study|Adverse Event|1|||
94545001|NCT03353922|323791279|FG002|Overall Study|Adverse Event|0|||
94545002|NCT03353922|323791280|FG003|Overall Study|Adverse Event|0|||
94545003|NCT03353922|323791281|FG004|Overall Study|Adverse Event|0|||
94545004|NCT03353922|323791282|FG005|Overall Study|Adverse Event|0|||
94545005|NCT03688555|323791283|FG000|Treatment Period|Adverse Event|0|||
94545006|NCT03688555|323791284|FG001|Treatment Period|Adverse Event|0|||
94545007|NCT03688555|323791285|FG002|Treatment Period|Adverse Event|1|||
94545008|NCT01896271|323791286|FG000|Overall Study|Physician Decision|10|||
94545009|NCT03002623|323791292|FG000|Overall Study|Lost to Follow-up|1|||
94545010|NCT03002623|323791293|FG001|Overall Study|Lost to Follow-up|0|||
94545011|NCT03002623|323791292|FG000|Overall Study|Physician Decision|1|||
94545012|NCT03002623|323791293|FG001|Overall Study|Physician Decision|1|||
94545013|NCT00844805|323791294|FG000|Treatment Phase|Adverse Event|5|||
94545014|NCT00844805|323791295|FG001|Treatment Phase|Adverse Event|1|||
94545015|NCT00844805|323791296|FG002|Treatment Phase|Adverse Event|0|||
94545016|NCT00844805|323791297|FG003|Treatment Phase|Adverse Event|0|||
94545017|NCT00844805|323791294|FG000|Treatment Phase|Withdrawal by Subject|3|||
94545018|NCT00844805|323791295|FG001|Treatment Phase|Withdrawal by Subject|4|||
94545019|NCT00844805|323791296|FG002|Treatment Phase|Withdrawal by Subject|0|||
94545020|NCT00844805|323791297|FG003|Treatment Phase|Withdrawal by Subject|0|||
94545021|NCT00844805|323791294|FG000|Treatment Phase|Noncompliance With Protocol|1|||
94545022|NCT00844805|323791295|FG001|Treatment Phase|Noncompliance With Protocol|0|||
94545023|NCT00844805|323791296|FG002|Treatment Phase|Noncompliance With Protocol|0|||
94545024|NCT00844805|323791297|FG003|Treatment Phase|Noncompliance With Protocol|0|||
94545025|NCT00844805|323791294|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
94545026|NCT00844805|323791295|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
94545027|NCT00844805|323791296|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
94545028|NCT00844805|323791297|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
94545029|NCT00844805|323791294|FG000|Follow-Up Phase|Adverse Event|0|||
94545030|NCT00844805|323791295|FG001|Follow-Up Phase|Adverse Event|0|||
94545031|NCT00844805|323791296|FG002|Follow-Up Phase|Adverse Event|1|||
94545032|NCT00844805|323791297|FG003|Follow-Up Phase|Adverse Event|0|||
94545033|NCT00844805|323791294|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
94545034|NCT00844805|323791295|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
94545035|NCT00844805|323791296|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
94545036|NCT00844805|323791297|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
94545037|NCT00844805|323791294|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
94545038|NCT00844805|323791295|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
94545039|NCT00844805|323791296|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
94545040|NCT00844805|323791297|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
94545041|NCT00844805|323791294|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
94545042|NCT00844805|323791295|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
94545043|NCT00844805|323791296|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
94545044|NCT00844805|323791297|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
94545045|NCT00844805|323791294|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
94545046|NCT00844805|323791295|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
94545047|NCT00844805|323791296|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
94545048|NCT00844805|323791297|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
94545049|NCT04384107|323791306|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
94545050|NCT04384107|323791307|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
94545051|NCT04384107|323791306|FG000|Overall Study|Lost to Follow-up|1|||
94545052|NCT04384107|323791307|FG001|Overall Study|Lost to Follow-up|0|||
94545053|NCT00276614|323791308|FG000|Overall Study|Progression of disease under study|3|||
94545054|NCT00525824|323791309|FG000|Overall Study|Adverse Event|7|||
94545055|NCT00525824|323791310|FG001|Overall Study|Adverse Event|11|||
94545056|NCT00525824|323791311|FG002|Overall Study|Adverse Event|6|||
94545057|NCT00525824|323791312|FG003|Overall Study|Adverse Event|7|||
94545058|NCT00525824|323791309|FG000|Overall Study|Withdrawal by Subject|5|||
94331002|NCT00555906|322991788|FG000|Phase 1|Objective Progression or Relapse|3|||
94331003|NCT00555906|322991789|FG001|Phase 1|Objective Progression or Relapse|5|||
94331004|NCT00555906|322991790|FG002|Phase 1|Objective Progression or Relapse|3|||
94331005|NCT00555906|322991791|FG003|Phase 1|Objective Progression or Relapse|1|||
94331006|NCT00555906|322991792|FG004|Phase 1|Objective Progression or Relapse|0|||
94331007|NCT00555906|322991788|FG000|Phase 1|Global Deterioration of Health Status|0|||
94331008|NCT00555906|322991789|FG001|Phase 1|Global Deterioration of Health Status|1|||
94331009|NCT00555906|322991790|FG002|Phase 1|Global Deterioration of Health Status|1|||
94331010|NCT00555906|322991791|FG003|Phase 1|Global Deterioration of Health Status|1|||
94331011|NCT00555906|322991792|FG004|Phase 1|Global Deterioration of Health Status|0|||
94331012|NCT00555906|322991788|FG000|Phase 1|Adverse Event|0|||
94331013|NCT00555906|322991789|FG001|Phase 1|Adverse Event|0|||
94331014|NCT00555906|322991790|FG002|Phase 1|Adverse Event|3|||
94331015|NCT00555906|322991791|FG003|Phase 1|Adverse Event|2|||
94331016|NCT00555906|322991792|FG004|Phase 1|Adverse Event|0|||
94331017|NCT00555906|322991788|FG000|Phase 1|Withdrawal by Subject|0|||
94331018|NCT00555906|322991789|FG001|Phase 1|Withdrawal by Subject|0|||
94331019|NCT00555906|322991790|FG002|Phase 1|Withdrawal by Subject|0|||
94331020|NCT00555906|322991791|FG003|Phase 1|Withdrawal by Subject|1|||
94331021|NCT00555906|322991792|FG004|Phase 1|Withdrawal by Subject|0|||
94331022|NCT00555906|322991788|FG000|Phase 2|Adverse Event|0|||
94331023|NCT00555906|322991789|FG001|Phase 2|Adverse Event|0|||
94331024|NCT00555906|322991790|FG002|Phase 2|Adverse Event|0|||
94331025|NCT00555906|322991791|FG003|Phase 2|Adverse Event|0|||
94331026|NCT00555906|322991792|FG004|Phase 2|Adverse Event|4|||
94331027|NCT00555906|322991788|FG000|Phase 2|Global Deterioration of Health Status|0|||
94331028|NCT00555906|322991789|FG001|Phase 2|Global Deterioration of Health Status|0|||
94331029|NCT00555906|322991790|FG002|Phase 2|Global Deterioration of Health Status|0|||
94331030|NCT00555906|322991791|FG003|Phase 2|Global Deterioration of Health Status|0|||
94331031|NCT00555906|322991792|FG004|Phase 2|Global Deterioration of Health Status|2|||
94331032|NCT00555906|322991788|FG000|Phase 2|Objective Progression or Relapse|0|||
94331033|NCT00555906|322991789|FG001|Phase 2|Objective Progression or Relapse|0|||
94331034|NCT00555906|322991790|FG002|Phase 2|Objective Progression or Relapse|0|||
94331035|NCT00555906|322991791|FG003|Phase 2|Objective Progression or Relapse|0|||
94331036|NCT00555906|322991792|FG004|Phase 2|Objective Progression or Relapse|16|||
94331037|NCT00555906|322991788|FG000|Phase 2|Withdrawal by Subject|0|||
94331038|NCT00555906|322991789|FG001|Phase 2|Withdrawal by Subject|0|||
94331039|NCT00555906|322991790|FG002|Phase 2|Withdrawal by Subject|0|||
94331040|NCT00555906|322991791|FG003|Phase 2|Withdrawal by Subject|0|||
94331041|NCT00555906|322991792|FG004|Phase 2|Withdrawal by Subject|2|||
94331042|NCT00555906|322991788|FG000|Phase 2|Other|0|||
94331043|NCT00555906|322991789|FG001|Phase 2|Other|0|||
94331044|NCT00555906|322991790|FG002|Phase 2|Other|0|||
94331045|NCT00555906|322991791|FG003|Phase 2|Other|0|||
94331046|NCT00555906|322991792|FG004|Phase 2|Other|6|||
94331047|NCT00555906|322991788|FG000|Phase 2|Randomized but not Treated|0|||
94331048|NCT00555906|322991789|FG001|Phase 2|Randomized but not Treated|0|||
94331049|NCT00555906|322991790|FG002|Phase 2|Randomized but not Treated|0|||
94331050|NCT00555906|322991791|FG003|Phase 2|Randomized but not Treated|0|||
94331051|NCT00555906|322991792|FG004|Phase 2|Randomized but not Treated|2|||
94331052|NCT01586806|322991793|FG000|Overall Study|Protocol Violation|0|||
94331053|NCT01586806|322991794|FG001|Overall Study|Protocol Violation|1|||
94331054|NCT01586806|322991795|FG002|Overall Study|Protocol Violation|0|||
94331055|NCT01586806|322991793|FG000|Overall Study|Withdrawal by Subject|1|||
94331056|NCT01586806|322991794|FG001|Overall Study|Withdrawal by Subject|0|||
94331057|NCT01586806|322991795|FG002|Overall Study|Withdrawal by Subject|0|||
94331058|NCT01586806|322991793|FG000|Overall Study|Lost to Follow-up|2|||
94331059|NCT01586806|322991794|FG001|Overall Study|Lost to Follow-up|3|||
94331060|NCT01586806|322991795|FG002|Overall Study|Lost to Follow-up|2|||
94331061|NCT02939599|322991798|FG000|Overall Study|Adverse Event|1|||
94331062|NCT02939599|322991799|FG001|Overall Study|Adverse Event|0|||
94331063|NCT02939599|322991798|FG000|Overall Study|Study Terminated By Sponsor|2|||
94331064|NCT02939599|322991799|FG001|Overall Study|Study Terminated By Sponsor|2|||
94331065|NCT01686958|322991803|FG000|Overall Study|Withdrawal by Subject|1|||
94331066|NCT00405652|322991807|FG000|Overall Study|Adverse Event|4|||
94331067|NCT03700736|322991810|FG000|Overall Study|Pregnancy|1|||
94331068|NCT03700736|322991811|FG001|Overall Study|Pregnancy|1|||
94331069|NCT03700736|322991810|FG000|Overall Study|Withdrawal by Subject|2|||
94331070|NCT03700736|322991811|FG001|Overall Study|Withdrawal by Subject|6|||
94545059|NCT00525824|323791310|FG001|Overall Study|Withdrawal by Subject|9|||
94545060|NCT00525824|323791311|FG002|Overall Study|Withdrawal by Subject|3|||
94545061|NCT00525824|323791312|FG003|Overall Study|Withdrawal by Subject|4|||
94545062|NCT00525824|323791309|FG000|Overall Study|Lost to Follow-up|4|||
94545063|NCT00525824|323791310|FG001|Overall Study|Lost to Follow-up|2|||
94545064|NCT00525824|323791311|FG002|Overall Study|Lost to Follow-up|4|||
94545065|NCT00525824|323791312|FG003|Overall Study|Lost to Follow-up|0|||
94545066|NCT00525824|323791309|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
94545067|NCT00525824|323791310|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
94545068|NCT00525824|323791311|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
94545069|NCT00525824|323791312|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
94545070|NCT00525824|323791309|FG000|Overall Study|Severe non-compliance|0|||
94545071|NCT00525824|323791310|FG001|Overall Study|Severe non-compliance|1|||
94545072|NCT00525824|323791311|FG002|Overall Study|Severe non-compliance|1|||
94545073|NCT00525824|323791312|FG003|Overall Study|Severe non-compliance|1|||
94545074|NCT00525824|323791309|FG000|Overall Study|Safety reasons|1|||
94545075|NCT00525824|323791310|FG001|Overall Study|Safety reasons|0|||
94545076|NCT00525824|323791311|FG002|Overall Study|Safety reasons|1|||
94545077|NCT00525824|323791312|FG003|Overall Study|Safety reasons|0|||
94545078|NCT00525824|323791309|FG000|Overall Study|Other|1|||
94545079|NCT00525824|323791310|FG001|Overall Study|Other|3|||
94545080|NCT00525824|323791311|FG002|Overall Study|Other|3|||
94545081|NCT00525824|323791312|FG003|Overall Study|Other|1|||
94545082|NCT01522404|323791313|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
94545083|NCT01522404|323791314|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
94545084|NCT01522404|323791313|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
94545085|NCT01522404|323791314|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
94545086|NCT01522404|323791313|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
94545087|NCT01522404|323791314|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
94545088|NCT02698371|323791317|FG000|All Participants Flow|Lost to Follow-up|3|||
94545089|NCT02698371|323791317|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
94545090|NCT02698371|323791317|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
94545091|NCT02698371|323791317|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
94545092|NCT02698371|323791317|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
94545093|NCT02698371|323791317|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
94545094|NCT02698371|323791317|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
94545095|NCT03734029|323791318|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
94545096|NCT03734029|323791319|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
94545097|NCT03734029|323791318|FG000|Overall Study|Adverse Event|60|||
94545098|NCT03734029|323791319|FG001|Overall Study|Adverse Event|14|||
94545099|NCT03734029|323791318|FG000|Overall Study|Withdrawal by Subject|12|||
94545100|NCT03734029|323791319|FG001|Overall Study|Withdrawal by Subject|11|||
94545101|NCT03734029|323791318|FG000|Overall Study|Clinical progression by investigator|10|||
94545102|NCT03734029|323791319|FG001|Overall Study|Clinical progression by investigator|8|||
94545103|NCT03734029|323791318|FG000|Overall Study|Death|5|||
94545104|NCT03734029|323791319|FG001|Overall Study|Death|2|||
94545105|NCT03734029|323791318|FG000|Overall Study|Physician Decision|4|||
94545106|NCT03734029|323791319|FG001|Overall Study|Physician Decision|3|||
94545107|NCT03734029|323791318|FG000|Overall Study|Other|2|||
94545108|NCT03734029|323791319|FG001|Overall Study|Other|0|||
94545109|NCT03734029|323791318|FG000|Overall Study|Lost to Follow-up|0|||
94545110|NCT03734029|323791319|FG001|Overall Study|Lost to Follow-up|1|||
94545111|NCT03734029|323791318|FG000|Overall Study|Randomized, but not treated|2|||
94545112|NCT03734029|323791319|FG001|Overall Study|Randomized, but not treated|12|||
94545113|NCT02558400|323791328|FG000|Overall Study|Adverse Event|47|||
94545114|NCT02558400|323791329|FG001|Overall Study|Adverse Event|53|||
94545115|NCT02558400|323791330|FG002|Overall Study|Adverse Event|4|||
94545116|NCT02558400|323791328|FG000|Overall Study|Withdrawal by Subject|13|||
94545117|NCT02558400|323791329|FG001|Overall Study|Withdrawal by Subject|9|||
94545118|NCT02558400|323791330|FG002|Overall Study|Withdrawal by Subject|8|||
94545119|NCT02558400|323791328|FG000|Overall Study|Non-Compliant|0|||
94545120|NCT02558400|323791329|FG001|Overall Study|Non-Compliant|1|||
94545121|NCT02558400|323791330|FG002|Overall Study|Non-Compliant|3|||
94545122|NCT02558400|323791328|FG000|Overall Study|Lost to Follow-up|5|||
94545123|NCT02558400|323791329|FG001|Overall Study|Lost to Follow-up|5|||
94545124|NCT02558400|323791330|FG002|Overall Study|Lost to Follow-up|4|||
94545125|NCT02558400|323791328|FG000|Overall Study|Lack of Efficacy|0|||
94545126|NCT02558400|323791329|FG001|Overall Study|Lack of Efficacy|13|||
94545127|NCT02558400|323791330|FG002|Overall Study|Lack of Efficacy|1|||
94545128|NCT02558400|323791328|FG000|Overall Study|Disallowed Concurrent Medication|6|||
94545129|NCT02558400|323791329|FG001|Overall Study|Disallowed Concurrent Medication|7|||
94545130|NCT02558400|323791330|FG002|Overall Study|Disallowed Concurrent Medication|5|||
94545131|NCT02558400|323791328|FG000|Overall Study|Physician Decision|2|||
94545132|NCT02558400|323791329|FG001|Overall Study|Physician Decision|2|||
94545133|NCT02558400|323791330|FG002|Overall Study|Physician Decision|0|||
94545134|NCT02558400|323791328|FG000|Overall Study|Protocol Violation|6|||
94545135|NCT02558400|323791329|FG001|Overall Study|Protocol Violation|3|||
94545136|NCT02558400|323791330|FG002|Overall Study|Protocol Violation|8|||
94545137|NCT02558400|323791328|FG000|Overall Study|Death|0|||
94545138|NCT02558400|323791329|FG001|Overall Study|Death|1|||
94545139|NCT02558400|323791330|FG002|Overall Study|Death|0|||
94545140|NCT02558400|323791328|FG000|Overall Study|Ineligible for the study|0|||
94545141|NCT02558400|323791329|FG001|Overall Study|Ineligible for the study|2|||
94545142|NCT02558400|323791330|FG002|Overall Study|Ineligible for the study|0|||
94545143|NCT03159104|323791331|FG000|Overall Study|Violation of inclusion criteria|1|||
94545144|NCT03159104|323791332|FG001|Overall Study|Violation of inclusion criteria|2|||
94545145|NCT03529110|323792787|FG000|Overall Study|Progressive Disease|66|||
94545146|NCT03529110|323792788|FG001|Overall Study|Progressive Disease|158|||
94545147|NCT03529110|323792787|FG000|Overall Study|Clinical Progression|4|||
94545148|NCT03529110|323792788|FG001|Overall Study|Clinical Progression|12|||
94545149|NCT03529110|323792787|FG000|Overall Study|Adverse Event|35|||
94545150|NCT03529110|323792788|FG001|Overall Study|Adverse Event|17|||
94545151|NCT03529110|323792787|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
94545152|NCT03529110|323792788|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
94545153|NCT03529110|323792787|FG000|Overall Study|Lack of Efficacy|3|||
94545154|NCT03529110|323792788|FG001|Overall Study|Lack of Efficacy|3|||
94545155|NCT03529110|323792787|FG000|Overall Study|Physician Decision|2|||
94545156|NCT03529110|323792788|FG001|Overall Study|Physician Decision|8|||
94545157|NCT03529110|323792787|FG000|Overall Study|Miscellaneous|2|||
94545158|NCT03529110|323792788|FG001|Overall Study|Miscellaneous|5|||
94545159|NCT03959982|323792789|FG000|Overall Study|Withdrawal by Subject|1|||
94545160|NCT03959982|323792790|FG001|Overall Study|Withdrawal by Subject|0|||
94545161|NCT03959982|323792789|FG000|Overall Study|Physician Decision|2|||
94545162|NCT03959982|323792790|FG001|Overall Study|Physician Decision|0|||
94545163|NCT03959982|323792789|FG000|Overall Study|Lost to Follow-up|1|||
94545164|NCT03959982|323792790|FG001|Overall Study|Lost to Follow-up|0|||
94545165|NCT02080260|323792796|FG000|Overall Study|Death|18|||
94545166|NCT02080260|323792796|FG000|Overall Study|Withdrawal by Subject|1|||
94545167|NCT02469415|323792799|FG000|Overall Study|Withdrawal by Subject|1|||
94545168|NCT02469415|323792799|FG000|Overall Study|Investigational agent placed on hold|2|||
94545169|NCT01974752|323792802|FG000|Overall Study|Death|33|||
94545170|NCT01974752|323792803|FG001|Overall Study|Death|11|||
94545171|NCT01974752|323792802|FG000|Overall Study|Lost to Follow-up|2|||
94545172|NCT01974752|323792803|FG001|Overall Study|Lost to Follow-up|0|||
94545173|NCT01974752|323792802|FG000|Overall Study|Withdrawal by Subject|2|||
94545174|NCT01974752|323792803|FG001|Overall Study|Withdrawal by Subject|3|||
94545175|NCT01974752|323792802|FG000|Overall Study|Other Eligibility Criteria|0|||
94545176|NCT01974752|323792803|FG001|Overall Study|Other Eligibility Criteria|1|||
94545177|NCT00330928|323792806|FG000|Overall Study|Lost to Follow-up|6|||
94545178|NCT00330928|323792806|FG000|Overall Study|Physician Decision|9|||
94545179|NCT00330928|323792806|FG000|Overall Study|Death|1|||
94545180|NCT00330928|323792806|FG000|Overall Study|IVUS could not be performed.|1|||
94545181|NCT03554772|323792807|FG000|Overall Study|Lost to Follow-up|0|||
94545182|NCT03554772|323792808|FG001|Overall Study|Lost to Follow-up|0|||
94545183|NCT03554772|323792809|FG002|Overall Study|Lost to Follow-up|0|||
94545184|NCT03554772|323792810|FG003|Overall Study|Lost to Follow-up|2|||
94545185|NCT03761394|323792811|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
94545186|NCT03761394|323792812|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
94545187|NCT03761394|323792813|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
94545188|NCT03761394|323792814|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
94545189|NCT03761394|323792811|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
94545190|NCT03761394|323792812|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
94545191|NCT03761394|323792813|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
94545192|NCT03761394|323792814|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
94545193|NCT03761394|323792811|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
94545194|NCT03761394|323792812|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
94545195|NCT03761394|323792813|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
94545196|NCT03761394|323792814|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
94545197|NCT03761394|323792811|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
94545198|NCT03761394|323792812|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
94545199|NCT03761394|323792813|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
94545200|NCT03761394|323792814|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
94545201|NCT05136898|323792815|FG000|Overall Study|Adverse Event|2|||
94545202|NCT00867087|323792816|FG000|Overall Study|Other|1|||
94545203|NCT00867087|323792816|FG000|Overall Study|Withdrawal by Subject|4|||
94545204|NCT00867087|323792816|FG000|Overall Study|Death|37|||
94545205|NCT03532932|323792819|FG000|Overall Study|Protocol Deviation|33|||
94545206|NCT03532932|323792820|FG001|Overall Study|Protocol Deviation|31|||
94545207|NCT03532932|323792819|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
94545208|NCT03532932|323792820|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
94545209|NCT03532932|323792819|FG000|Overall Study|Withdrawal by Subject|2|||
94545210|NCT03532932|323792820|FG001|Overall Study|Withdrawal by Subject|0|||
94545211|NCT03532932|323792819|FG000|Overall Study|Lost to Follow-up|15|||
94545212|NCT03532932|323792820|FG001|Overall Study|Lost to Follow-up|9|||
94545213|NCT03532932|323792819|FG000|Overall Study|Adverse Event|4|||
94545214|NCT03532932|323792820|FG001|Overall Study|Adverse Event|3|||
94545215|NCT03532932|323792819|FG000|Overall Study|Death|0|||
94545216|NCT03532932|323792820|FG001|Overall Study|Death|2|||
94545217|NCT03532932|323792819|FG000|Overall Study|Other|11|||
94545218|NCT03532932|323792820|FG001|Overall Study|Other|16|||
94545219|NCT01299571|323792821|FG000|Overall Study|Protocol Violation|107|||
94545220|NCT02525939|323792822|FG000|Overall Study|Lost to Follow-up|27|||
94545221|NCT02525939|323792823|FG001|Overall Study|Lost to Follow-up|24|||
94545222|NCT02525939|323792822|FG000|Overall Study|Physician Decision|0|||
94545223|NCT02525939|323792823|FG001|Overall Study|Physician Decision|1|||
94545224|NCT02525939|323792822|FG000|Overall Study|Withdrawal by Subject|24|||
94545225|NCT02525939|323792823|FG001|Overall Study|Withdrawal by Subject|39|||
94545226|NCT02525939|323792822|FG000|Overall Study|Death|180|||
94545227|NCT02525939|323792823|FG001|Overall Study|Death|179|||
94545228|NCT02130986|323792824|FG000|Overall Study|Withdrawal by Subject|4|||
94545229|NCT02130986|323792825|FG001|Overall Study|Withdrawal by Subject|4|||
94545230|NCT02130986|323792824|FG000|Overall Study|Lost to Follow-up|151|||
94545231|NCT02130986|323792825|FG001|Overall Study|Lost to Follow-up|160|||
94545232|NCT00762996|323792826|FG000|Period One|Protocol Violation|0|||
94545233|NCT00762996|323792827|FG001|Period One|Protocol Violation|0|||
94545234|NCT00762996|323792828|FG002|Period One|Protocol Violation|1|||
94545235|NCT00762996|323792829|FG003|Period One|Protocol Violation|0|||
94545236|NCT00762996|323792826|FG000|Period One|ineligible|0|||
94545237|NCT00762996|323792827|FG001|Period One|ineligible|0|||
94545238|NCT00762996|323792828|FG002|Period One|ineligible|1|||
94545239|NCT00762996|323792829|FG003|Period One|ineligible|1|||
94545240|NCT00762996|323792826|FG000|Period One|Adverse Event|0|||
94545241|NCT00762996|323792827|FG001|Period One|Adverse Event|0|||
94545242|NCT00762996|323792828|FG002|Period One|Adverse Event|1|||
94545243|NCT00762996|323792829|FG003|Period One|Adverse Event|0|||
94545244|NCT00762996|323792826|FG000|Period One|Withdrawal by Subject|0|||
94545245|NCT00762996|323792827|FG001|Period One|Withdrawal by Subject|0|||
94545246|NCT00762996|323792828|FG002|Period One|Withdrawal by Subject|1|||
94545247|NCT00762996|323792829|FG003|Period One|Withdrawal by Subject|0|||
94545248|NCT04063787|323792830|FG000|Overall Study|Inadequate Doppler data|4|||
94545249|NCT04063787|323792830|FG000|Overall Study|Lost to Follow-up|2|||
94545250|NCT04063787|323792830|FG000|Overall Study|Death|3|||
94545251|NCT00933244|323792831|FG000|Overall Study|Withdrawal by Subject|5|||
94545252|NCT00933244|323792832|FG001|Overall Study|Withdrawal by Subject|1|||
94545253|NCT00933244|323792833|FG002|Overall Study|Withdrawal by Subject|3|||
94545254|NCT02689076|323792834|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
94545255|NCT02689076|323792835|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
94545256|NCT02689076|323792836|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
94545257|NCT02689076|323792834|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
94545258|NCT02689076|323792835|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
94545259|NCT02689076|323792836|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
94545260|NCT02689076|323792834|FG000|Overall Study|Did not have an HIE match|2|||
94545261|NCT02689076|323792835|FG001|Overall Study|Did not have an HIE match|0|||
94545262|NCT02689076|323792836|FG002|Overall Study|Did not have an HIE match|0|||
94545263|NCT02689076|323792834|FG000|Overall Study|Death during non-VA encounter|2|||
94545264|NCT02689076|323792835|FG001|Overall Study|Death during non-VA encounter|5|||
94545265|NCT02689076|323792836|FG002|Overall Study|Death during non-VA encounter|0|||
94545266|NCT02689076|323792834|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
94545267|NCT02689076|323792835|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
94545268|NCT02689076|323792836|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
94545269|NCT02689076|323792834|FG000|Overall Study|Participant no longer active in VA system|1|||
94545270|NCT02689076|323792835|FG001|Overall Study|Participant no longer active in VA system|0|||
94545271|NCT02689076|323792836|FG002|Overall Study|Participant no longer active in VA system|0|||
94545272|NCT02689076|323792834|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
94545273|NCT02689076|323792835|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
94545274|NCT02689076|323792836|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
94545275|NCT01143896|323792838|FG000|Overall Study|Did not complete Baseline Interview|5|||
94545276|NCT01143896|323792839|FG001|Overall Study|Did not complete Baseline Interview|4|||
94545277|NCT01143896|323792838|FG000|Overall Study|Lost to Follow-up|18|||
94545278|NCT01143896|323792839|FG001|Overall Study|Lost to Follow-up|13|||
94545279|NCT01143896|323792838|FG000|Overall Study|Withdrawal by Subject|13|||
94545280|NCT01143896|323792839|FG001|Overall Study|Withdrawal by Subject|5|||
94545281|NCT01143896|323792838|FG000|Overall Study|Death|6|||
94545282|NCT01143896|323792839|FG001|Overall Study|Death|3|||
94545283|NCT00875056|323792840|FG000|Overall Study|Adverse Event|6|||
94545284|NCT00875056|323792841|FG001|Overall Study|Adverse Event|1|||
94545285|NCT00875056|323792842|FG002|Overall Study|Adverse Event|2|||
94545286|NCT00875056|323792840|FG000|Overall Study|Progressive Disease|14|||
94545287|NCT00875056|323792841|FG001|Overall Study|Progressive Disease|8|||
94545288|NCT00875056|323792842|FG002|Overall Study|Progressive Disease|3|||
94545289|NCT00875056|323792840|FG000|Overall Study|Withdrawal by Subject|3|||
94545290|NCT00875056|323792841|FG001|Overall Study|Withdrawal by Subject|0|||
94545291|NCT00875056|323792842|FG002|Overall Study|Withdrawal by Subject|1|||
94545292|NCT00391391|323792843|FG000|Overall Study|Adverse Event|0|||
94545293|NCT00391391|323792844|FG001|Overall Study|Adverse Event|0|||
94545294|NCT00391391|323792845|FG002|Overall Study|Adverse Event|0|||
94545295|NCT00391391|323792846|FG003|Overall Study|Adverse Event|1|||
94545296|NCT00391391|323792843|FG000|Overall Study|Lost to Follow-up|1|||
94545297|NCT00391391|323792844|FG001|Overall Study|Lost to Follow-up|3|||
94545298|NCT00391391|323792845|FG002|Overall Study|Lost to Follow-up|7|||
94545299|NCT00391391|323792846|FG003|Overall Study|Lost to Follow-up|4|||
94545300|NCT00391391|323792843|FG000|Overall Study|Protocol Violation|2|||
94545301|NCT00391391|323792844|FG001|Overall Study|Protocol Violation|3|||
94545302|NCT00391391|323792845|FG002|Overall Study|Protocol Violation|6|||
94545303|NCT00391391|323792846|FG003|Overall Study|Protocol Violation|7|||
94545304|NCT00391391|323792843|FG000|Overall Study|Withdrawal by Subject|6|||
94545305|NCT00391391|323792844|FG001|Overall Study|Withdrawal by Subject|4|||
94545306|NCT00391391|323792845|FG002|Overall Study|Withdrawal by Subject|10|||
94545307|NCT00391391|323792846|FG003|Overall Study|Withdrawal by Subject|7|||
94545308|NCT02084238|323792847|FG000|Overall Study|Lost to Follow-up|2|||
94545309|NCT00693472|323792848|FG000|Part 1|Adverse Event|1|||
94545310|NCT00693472|323792849|FG001|Part 1|Adverse Event|1|||
94545311|NCT00693472|323792850|FG002|Part 1|Adverse Event|0|||
94545312|NCT00693472|323792851|FG003|Part 1|Adverse Event|0|||
94545313|NCT00693472|323792848|FG000|Part 1|Lost to Follow-up|0|||
94545314|NCT00693472|323792849|FG001|Part 1|Lost to Follow-up|1|||
94545315|NCT00693472|323792850|FG002|Part 1|Lost to Follow-up|0|||
94545316|NCT00693472|323792851|FG003|Part 1|Lost to Follow-up|0|||
94545317|NCT00693472|323792848|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
94545318|NCT00693472|323792849|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
94545319|NCT00693472|323792850|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
94545320|NCT00693472|323792851|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
94545321|NCT00693472|323792848|FG000|Part 2|Adverse Event|0|||
94545322|NCT00693472|323792849|FG001|Part 2|Adverse Event|0|||
94545323|NCT00693472|323792850|FG002|Part 2|Adverse Event|1|||
94545324|NCT00693472|323792851|FG003|Part 2|Adverse Event|0|||
94545325|NCT00693472|323792848|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
94545326|NCT00693472|323792849|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
94545327|NCT00693472|323792850|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
94545328|NCT00693472|323792851|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
94545329|NCT04375397|323792852|FG000|Overall Study|Death|1|||
94545330|NCT04375397|323792853|FG001|Overall Study|Death|1|||
94545331|NCT04375397|323792852|FG000|Overall Study|Withdrew consent|2|||
94545332|NCT04375397|323792853|FG001|Overall Study|Withdrew consent|0|||
94545333|NCT04375397|323792852|FG000|Overall Study|Lost to Follow-up|6|||
94545334|NCT04375397|323792853|FG001|Overall Study|Lost to Follow-up|4|||
94545335|NCT04375397|323792852|FG000|Overall Study|Other, not specified|0|||
94545336|NCT04375397|323792853|FG001|Overall Study|Other, not specified|1|||
94545337|NCT01443130|323792857|FG000|Overall Study|Lost to Follow-up|44|||
94545338|NCT01443130|323792858|FG001|Overall Study|Lost to Follow-up|42|||
94545339|NCT01443130|323792859|FG002|Overall Study|Lost to Follow-up|50|||
94545340|NCT01443130|323792860|FG003|Overall Study|Lost to Follow-up|23|||
94545341|NCT01443130|323792861|FG004|Overall Study|Lost to Follow-up|25|||
94545342|NCT01443130|323792862|FG005|Overall Study|Lost to Follow-up|21|||
94545343|NCT01443130|323792857|FG000|Overall Study|Death|0|||
94545344|NCT01443130|323792858|FG001|Overall Study|Death|1|||
94545345|NCT01443130|323792859|FG002|Overall Study|Death|0|||
94545346|NCT01443130|323792860|FG003|Overall Study|Death|7|||
94545347|NCT01443130|323792861|FG004|Overall Study|Death|10|||
94545348|NCT01443130|323792862|FG005|Overall Study|Death|8|||
94545349|NCT01443130|323792857|FG000|Overall Study|Adverse Event|2|||
94545350|NCT01443130|323792858|FG001|Overall Study|Adverse Event|1|||
94545351|NCT01443130|323792859|FG002|Overall Study|Adverse Event|1|||
94545352|NCT01443130|323792860|FG003|Overall Study|Adverse Event|0|||
94545353|NCT01443130|323792861|FG004|Overall Study|Adverse Event|0|||
94545354|NCT01443130|323792862|FG005|Overall Study|Adverse Event|0|||
94545355|NCT01443130|323792857|FG000|Overall Study|Protocol Violation|2|||
94545356|NCT01443130|323792858|FG001|Overall Study|Protocol Violation|1|||
94545357|NCT01443130|323792859|FG002|Overall Study|Protocol Violation|3|||
94545358|NCT01443130|323792860|FG003|Overall Study|Protocol Violation|2|||
94545359|NCT01443130|323792861|FG004|Overall Study|Protocol Violation|2|||
94545360|NCT01443130|323792862|FG005|Overall Study|Protocol Violation|3|||
94545361|NCT01443130|323792857|FG000|Overall Study|Withdrawal by Subject|15|||
94545362|NCT01443130|323792858|FG001|Overall Study|Withdrawal by Subject|14|||
94545363|NCT01443130|323792859|FG002|Overall Study|Withdrawal by Subject|12|||
94545364|NCT01443130|323792860|FG003|Overall Study|Withdrawal by Subject|7|||
94545365|NCT01443130|323792861|FG004|Overall Study|Withdrawal by Subject|7|||
94545366|NCT01443130|323792862|FG005|Overall Study|Withdrawal by Subject|2|||
94545367|NCT01443130|323792857|FG000|Overall Study|Death of Subject's Infant|5|||
94545368|NCT01443130|323792858|FG001|Overall Study|Death of Subject's Infant|10|||
94545369|NCT01443130|323792859|FG002|Overall Study|Death of Subject's Infant|11|||
94545370|NCT01443130|323792860|FG003|Overall Study|Death of Subject's Infant|0|||
94545371|NCT01443130|323792861|FG004|Overall Study|Death of Subject's Infant|0|||
94545372|NCT01443130|323792862|FG005|Overall Study|Death of Subject's Infant|0|||
94545373|NCT00857948|323792863|FG000|Overall Study|Withdrawal by Subject|2|||
94545374|NCT00857948|323792864|FG001|Overall Study|Withdrawal by Subject|0|||
94545375|NCT00857948|323792865|FG002|Overall Study|Withdrawal by Subject|0|||
94545376|NCT00857948|323792866|FG003|Overall Study|Withdrawal by Subject|0|||
94545377|NCT00857948|323792863|FG000|Overall Study|Protocol Violation|1|||
94545378|NCT00857948|323792864|FG001|Overall Study|Protocol Violation|0|||
94545379|NCT00857948|323792865|FG002|Overall Study|Protocol Violation|1|||
94545380|NCT00857948|323792866|FG003|Overall Study|Protocol Violation|0|||
94545381|NCT00259298|323792869|FG000|Overall Study|Withdrawal by Subject|1|||
94545382|NCT00259298|323792869|FG000|Overall Study|Physician Decision|2|||
94545383|NCT01439074|323792870|FG000|Overall Study|Lost to Follow-up|3|||
94545384|NCT01439074|323792871|FG001|Overall Study|Lost to Follow-up|4|||
94545385|NCT01439074|323792870|FG000|Overall Study|Subject shedding|1|||
94545386|NCT01439074|323792871|FG001|Overall Study|Subject shedding|0|||
94545387|NCT01439074|323792870|FG000|Overall Study|Withdrawal by Subject|1|||
94545388|NCT01439074|323792871|FG001|Overall Study|Withdrawal by Subject|5|||
94545389|NCT01439074|323792870|FG000|Overall Study|Other|4|||
94545390|NCT01439074|323792871|FG001|Overall Study|Other|4|||
94545391|NCT04135859|323792873|FG000|Overall Study|Withdrawal by Subject|1|||
94545392|NCT04135859|323792874|FG001|Overall Study|Withdrawal by Subject|0|||
94545393|NCT04135859|323792873|FG000|Overall Study|Withdrawal due to screening failure|1|||
94545394|NCT04135859|323792874|FG001|Overall Study|Withdrawal due to screening failure|2|||
94545395|NCT04135859|323792873|FG000|Overall Study|Did not complete stress test|3|||
94545396|NCT04135859|323792874|FG001|Overall Study|Did not complete stress test|3|||
94545397|NCT04135859|323792873|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
94545398|NCT04135859|323792874|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
94545399|NCT01969500|323792875|FG000|Overall Study|Death|0|||
94545400|NCT01969500|323792876|FG001|Overall Study|Death|1|||
94545401|NCT01969500|323792875|FG000|Overall Study|extended hospitalization|1|||
94545402|NCT01969500|323792876|FG001|Overall Study|extended hospitalization|1|||
94545403|NCT00815191|323792877|FG000|Overall Study|Protocol Violation|1|||
94545404|NCT00815191|323792878|FG001|Overall Study|Protocol Violation|1|||
94545405|NCT02639338|323792879|FG000|Overall Study|Lost to Follow-up|2|||
94545406|NCT02639338|323792880|FG001|Overall Study|Lost to Follow-up|2|||
94545407|NCT02639338|323792879|FG000|Overall Study|Withdrew Consent|1|||
94545408|NCT02639338|323792880|FG001|Overall Study|Withdrew Consent|2|||
94545409|NCT02639338|323792879|FG000|Overall Study|Death|1|||
94545410|NCT02639338|323792880|FG001|Overall Study|Death|0|||
94545411|NCT02639338|323792879|FG000|Overall Study|Randomized but Not Treated|0|||
94545412|NCT02639338|323792880|FG001|Overall Study|Randomized but Not Treated|1|||
94545413|NCT00973102|323792883|FG000|Overall Study|Protocol Violation|1|||
94545414|NCT00973102|323792884|FG001|Overall Study|Protocol Violation|0|||
94545415|NCT00973102|323792883|FG000|Overall Study|Prisoner|0|||
94545416|NCT00973102|323792884|FG001|Overall Study|Prisoner|1|||
94545417|NCT03553498|323792886|FG000|Overall Study|Missing primary outcome|1|||
94545418|NCT03553498|323792887|FG001|Overall Study|Missing primary outcome|2|||
94545419|NCT02365285|323792889|FG000|Overall Study|Physician Decision|0|||
94545420|NCT02365285|323792890|FG001|Overall Study|Physician Decision|1|||
94545421|NCT02365285|323792891|FG002|Overall Study|Physician Decision|1|||
94545422|NCT02365285|323792892|FG003|Overall Study|Physician Decision|0|||
94545423|NCT02365285|323792889|FG000|Overall Study|Adverse Event|0|||
94545424|NCT02365285|323792890|FG001|Overall Study|Adverse Event|0|||
94545425|NCT02365285|323792891|FG002|Overall Study|Adverse Event|0|||
94545426|NCT02365285|323792892|FG003|Overall Study|Adverse Event|2|||
94545427|NCT02608450|323792897|FG000|Overall Study|Lost to Follow-up|39|||
94545428|NCT02608450|323792898|FG001|Overall Study|Lost to Follow-up|32|||
94545429|NCT02608450|323792897|FG000|Overall Study|Withdrawal by Subject|21|||
94545430|NCT02608450|323792898|FG001|Overall Study|Withdrawal by Subject|15|||
94545431|NCT02608450|323792897|FG000|Overall Study|Adverse Event|3|||
94545432|NCT02608450|323792898|FG001|Overall Study|Adverse Event|6|||
94545433|NCT02608450|323792897|FG000|Overall Study|Withdrawal by parent|2|||
94545434|NCT02608450|323792898|FG001|Overall Study|Withdrawal by parent|3|||
94545435|NCT02608450|323792897|FG000|Overall Study|Lack of Efficacy|0|||
94545436|NCT02608450|323792898|FG001|Overall Study|Lack of Efficacy|3|||
94545437|NCT02608450|323792897|FG000|Overall Study|Noncompliance with study drug|0|||
94545438|NCT02608450|323792898|FG001|Overall Study|Noncompliance with study drug|2|||
94545439|NCT02608450|323792897|FG000|Overall Study|Physician Decision|0|||
94545440|NCT02608450|323792898|FG001|Overall Study|Physician Decision|1|||
94545441|NCT02608450|323792897|FG000|Overall Study|Pregnancy|0|||
94545442|NCT02608450|323792898|FG001|Overall Study|Pregnancy|1|||
94545443|NCT02608450|323792897|FG000|Overall Study|Progressive disease|1|||
94545444|NCT02608450|323792898|FG001|Overall Study|Progressive disease|0|||
94545445|NCT02608450|323792897|FG000|Overall Study|Multiple reasons|0|||
94545446|NCT02608450|323792898|FG001|Overall Study|Multiple reasons|2|||
94545447|NCT02124772|323792901|FG000|Overall Study|Lack of Efficacy|2|||
94545448|NCT02124772|323792902|FG001|Overall Study|Lack of Efficacy|0|||
94545449|NCT02124772|323792903|FG002|Overall Study|Lack of Efficacy|0|||
94545450|NCT02124772|323792904|FG003|Overall Study|Lack of Efficacy|1|||
94545451|NCT02124772|323792905|FG004|Overall Study|Lack of Efficacy|2|||
94545452|NCT02124772|323792906|FG005|Overall Study|Lack of Efficacy|3|||
94545453|NCT02124772|323792907|FG006|Overall Study|Lack of Efficacy|0|||
94545454|NCT02124772|323792908|FG007|Overall Study|Lack of Efficacy|2|||
94545455|NCT02124772|323792909|FG008|Overall Study|Lack of Efficacy|0|||
94545456|NCT02124772|323792910|FG009|Overall Study|Lack of Efficacy|1|||
94545457|NCT02124772|323792911|FG010|Overall Study|Lack of Efficacy|0|||
94545458|NCT02124772|323792912|FG011|Overall Study|Lack of Efficacy|0|||
94545459|NCT02124772|323792913|FG012|Overall Study|Lack of Efficacy|1|||
94545460|NCT02124772|323792901|FG000|Overall Study|Adverse Event|1|||
94545461|NCT02124772|323792902|FG001|Overall Study|Adverse Event|4|||
94545462|NCT02124772|323792903|FG002|Overall Study|Adverse Event|1|||
94545463|NCT02124772|323792904|FG003|Overall Study|Adverse Event|5|||
94545464|NCT02124772|323792905|FG004|Overall Study|Adverse Event|2|||
94545465|NCT02124772|323792906|FG005|Overall Study|Adverse Event|1|||
94545466|NCT02124772|323792907|FG006|Overall Study|Adverse Event|1|||
94545467|NCT02124772|323792908|FG007|Overall Study|Adverse Event|5|||
94545468|NCT02124772|323792909|FG008|Overall Study|Adverse Event|0|||
94545469|NCT02124772|323792910|FG009|Overall Study|Adverse Event|3|||
94545470|NCT02124772|323792911|FG010|Overall Study|Adverse Event|1|||
94545471|NCT02124772|323792912|FG011|Overall Study|Adverse Event|3|||
94545472|NCT02124772|323792913|FG012|Overall Study|Adverse Event|1|||
94545473|NCT02124772|323792901|FG000|Overall Study|Withdrawal consent|0|||
94545474|NCT02124772|323792902|FG001|Overall Study|Withdrawal consent|1|||
94545475|NCT02124772|323792903|FG002|Overall Study|Withdrawal consent|1|||
94545476|NCT02124772|323792904|FG003|Overall Study|Withdrawal consent|1|||
94545477|NCT02124772|323792905|FG004|Overall Study|Withdrawal consent|0|||
94545478|NCT02124772|323792906|FG005|Overall Study|Withdrawal consent|1|||
94545479|NCT02124772|323792907|FG006|Overall Study|Withdrawal consent|1|||
94545480|NCT02124772|323792908|FG007|Overall Study|Withdrawal consent|0|||
94545481|NCT02124772|323792909|FG008|Overall Study|Withdrawal consent|0|||
94545482|NCT02124772|323792910|FG009|Overall Study|Withdrawal consent|1|||
94545483|NCT02124772|323792911|FG010|Overall Study|Withdrawal consent|0|||
94545484|NCT02124772|323792912|FG011|Overall Study|Withdrawal consent|1|||
94545485|NCT02124772|323792913|FG012|Overall Study|Withdrawal consent|0|||
94545486|NCT02124772|323792901|FG000|Overall Study|Investigator discretion|0|||
94545487|NCT02124772|323792902|FG001|Overall Study|Investigator discretion|2|||
94545488|NCT02124772|323792903|FG002|Overall Study|Investigator discretion|2|||
94545489|NCT02124772|323792904|FG003|Overall Study|Investigator discretion|1|||
94545490|NCT02124772|323792905|FG004|Overall Study|Investigator discretion|1|||
94545491|NCT02124772|323792906|FG005|Overall Study|Investigator discretion|0|||
94545492|NCT02124772|323792907|FG006|Overall Study|Investigator discretion|1|||
94545493|NCT02124772|323792908|FG007|Overall Study|Investigator discretion|0|||
94545494|NCT02124772|323792909|FG008|Overall Study|Investigator discretion|0|||
94545495|NCT02124772|323792910|FG009|Overall Study|Investigator discretion|1|||
94545496|NCT02124772|323792911|FG010|Overall Study|Investigator discretion|0|||
94545497|NCT02124772|323792912|FG011|Overall Study|Investigator discretion|1|||
94545498|NCT02124772|323792913|FG012|Overall Study|Investigator discretion|0|||
94545499|NCT02124772|323792901|FG000|Overall Study|Progressive disease|0|||
94545500|NCT02124772|323792902|FG001|Overall Study|Progressive disease|0|||
94545501|NCT02124772|323792903|FG002|Overall Study|Progressive disease|0|||
94545502|NCT02124772|323792904|FG003|Overall Study|Progressive disease|0|||
94545503|NCT02124772|323792905|FG004|Overall Study|Progressive disease|0|||
94545504|NCT02124772|323792906|FG005|Overall Study|Progressive disease|0|||
94545505|NCT02124772|323792907|FG006|Overall Study|Progressive disease|1|||
94545506|NCT02124772|323792908|FG007|Overall Study|Progressive disease|1|||
94545507|NCT02124772|323792909|FG008|Overall Study|Progressive disease|0|||
94545508|NCT02124772|323792910|FG009|Overall Study|Progressive disease|0|||
94545509|NCT02124772|323792911|FG010|Overall Study|Progressive disease|0|||
94545510|NCT02124772|323792912|FG011|Overall Study|Progressive disease|0|||
94545511|NCT02124772|323792913|FG012|Overall Study|Progressive disease|0|||
94545512|NCT02124772|323792901|FG000|Overall Study|Other|0|||
94545513|NCT02124772|323792902|FG001|Overall Study|Other|7|||
94545514|NCT02124772|323792903|FG002|Overall Study|Other|2|||
94545515|NCT02124772|323792904|FG003|Overall Study|Other|5|||
94545516|NCT02124772|323792905|FG004|Overall Study|Other|4|||
94545517|NCT02124772|323792906|FG005|Overall Study|Other|3|||
94545518|NCT02124772|323792907|FG006|Overall Study|Other|4|||
94545519|NCT02124772|323792908|FG007|Overall Study|Other|1|||
94545520|NCT02124772|323792909|FG008|Overall Study|Other|1|||
94545521|NCT02124772|323792910|FG009|Overall Study|Other|1|||
94545522|NCT02124772|323792911|FG010|Overall Study|Other|1|||
94545523|NCT02124772|323792912|FG011|Overall Study|Other|1|||
94545524|NCT02124772|323792913|FG012|Overall Study|Other|0|||
94545525|NCT01369680|323792914|FG000|Overall Study|Lost to Follow-up|0|||
94545526|NCT01369680|323792915|FG001|Overall Study|Lost to Follow-up|0|||
94545527|NCT01369680|323792916|FG002|Overall Study|Lost to Follow-up|1|||
94545528|NCT01369680|323792917|FG003|Overall Study|Lost to Follow-up|2|||
94545529|NCT02827500|323792918|FG000|Overall Study|Death|7|||
94545530|NCT02827500|323792919|FG001|Overall Study|Death|3|||
94545531|NCT02827500|323792918|FG000|Overall Study|Lost to Follow-up|1|||
94545532|NCT02827500|323792919|FG001|Overall Study|Lost to Follow-up|1|||
94545533|NCT02827500|323792918|FG000|Overall Study|Withdrawal by Subject|3|||
94545534|NCT02827500|323792919|FG001|Overall Study|Withdrawal by Subject|1|||
94545535|NCT02827500|323792918|FG000|Overall Study|Missing primary endpoint data|3|||
94545536|NCT02827500|323792919|FG001|Overall Study|Missing primary endpoint data|1|||
94545537|NCT02827500|323792918|FG000|Overall Study|Other|5|||
94545538|NCT02827500|323792919|FG001|Overall Study|Other|1|||
94545539|NCT01688921|323792920|FG000|Overall Study|Lost to Follow-up|7|||
94545540|NCT01688921|323792921|FG001|Overall Study|Lost to Follow-up|13|||
94545541|NCT01688921|323792920|FG000|Overall Study|Physician Decision|6|||
94545542|NCT01688921|323792921|FG001|Overall Study|Physician Decision|1|||
94545543|NCT01688921|323792920|FG000|Overall Study|Protocol Violation|0|||
94545544|NCT01688921|323792921|FG001|Overall Study|Protocol Violation|1|||
94545545|NCT01688921|323792920|FG000|Overall Study|informed consent|3|||
94545546|NCT01688921|323792921|FG001|Overall Study|informed consent|0|||
94545547|NCT01636713|323792926|FG000|Overall Study|Adverse Event|16|||
94545548|NCT01636713|323792927|FG001|Overall Study|Adverse Event|16|||
94545549|NCT01636713|323792928|FG002|Overall Study|Adverse Event|7|||
94545550|NCT01636713|323792926|FG000|Overall Study|Lack of Efficacy|6|||
94545551|NCT01636713|323792927|FG001|Overall Study|Lack of Efficacy|6|||
94545552|NCT01636713|323792928|FG002|Overall Study|Lack of Efficacy|2|||
94545553|NCT01636713|323792926|FG000|Overall Study|Protocol Violation|3|||
94545554|NCT01636713|323792927|FG001|Overall Study|Protocol Violation|0|||
94545555|NCT01636713|323792928|FG002|Overall Study|Protocol Violation|1|||
94545556|NCT01636713|323792926|FG000|Overall Study|Lost to Follow-up|0|||
94545557|NCT01636713|323792927|FG001|Overall Study|Lost to Follow-up|0|||
94545558|NCT01636713|323792928|FG002|Overall Study|Lost to Follow-up|1|||
94545559|NCT01636713|323792926|FG000|Overall Study|Withdrawal by Subject|5|||
94545560|NCT01636713|323792927|FG001|Overall Study|Withdrawal by Subject|4|||
94545561|NCT01636713|323792928|FG002|Overall Study|Withdrawal by Subject|8|||
94545562|NCT01636713|323792926|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
94545563|NCT01636713|323792927|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
94545564|NCT01636713|323792928|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
94545565|NCT03780959|323792929|FG000|Part 1|Adverse Event|1|||
94545566|NCT03780959|323792930|FG001|Part 1|Adverse Event|0|||
94545567|NCT03780959|323792931|FG002|Part 1|Adverse Event|0|||
94545568|NCT03780959|323792929|FG000|Part 1|Withdrawal by Subject|1|||
94545569|NCT03780959|323792930|FG001|Part 1|Withdrawal by Subject|0|||
94545570|NCT03780959|323792931|FG002|Part 1|Withdrawal by Subject|0|||
94545571|NCT03780959|323792929|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
94545572|NCT03780959|323792930|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
94545573|NCT03780959|323792931|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
94545574|NCT03780959|323792929|FG000|Part 1|Response Status|2|||
94545575|NCT03780959|323792930|FG001|Part 1|Response Status|0|||
94545576|NCT03780959|323792931|FG002|Part 1|Response Status|0|||
94545577|NCT03780959|323792929|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
94545578|NCT03780959|323792930|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
94545579|NCT03780959|323792931|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
94545580|NCT03780959|323792929|FG000|Part 2|Response Status|0|||
94545581|NCT03780959|323792930|FG001|Part 2|Response Status|18|||
94545582|NCT03780959|323792931|FG002|Part 2|Response Status|6|||
94545583|NCT02308488|323792936|FG000|Overall Study|Withdrawal by Subject|2|||
94545584|NCT01739803|323792937|FG000|Overall Study|Lost to Follow-up|9|||
94545585|NCT01739803|323792938|FG001|Overall Study|Lost to Follow-up|6|||
94545586|NCT02278614|323792939|FG000|Overall Study|Withdrawal by Subject|3|||
94545587|NCT02278614|323792940|FG001|Overall Study|Withdrawal by Subject|5|||
94545588|NCT02278614|323792939|FG000|Overall Study|Adverse Event|1|||
94545589|NCT02278614|323792940|FG001|Overall Study|Adverse Event|0|||
94545590|NCT02278614|323792939|FG000|Overall Study|left eye was not eligible|1|||
94545591|NCT02278614|323792940|FG001|Overall Study|left eye was not eligible|0|||
94545592|NCT01565564|323792945|FG000|Overall Study|Lost to Follow-up|5|||
94545593|NCT01565564|323792946|FG001|Overall Study|Lost to Follow-up|1|||
94545594|NCT02210091|323792960|FG000|Overall Study|Physician Decision|0|||
94545595|NCT02210091|323792961|FG001|Overall Study|Physician Decision|1|||
94545596|NCT02210091|323792960|FG000|Overall Study|Withdrawal by Sponsor|0|||
94545597|NCT02210091|323792961|FG001|Overall Study|Withdrawal by Sponsor|1|||
94545598|NCT00897390|323792962|FG000|Overall Study|Adverse Event|2|||
94545599|NCT00897390|323792962|FG000|Overall Study|No Longer Met Study Criteria|1|||
94545600|NCT00897390|323792962|FG000|Overall Study|Personal Reasons|1|||
94545601|NCT00897390|323792962|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
94545602|NCT03966885|323794752|FG000|Overall Study|Death|1|||
94545603|NCT03966885|323794753|FG001|Overall Study|Death|0|||
94545604|NCT03966885|323794752|FG000|Overall Study|Lost to Follow-up|1|||
94545605|NCT03966885|323794753|FG001|Overall Study|Lost to Follow-up|2|||
94545606|NCT03966885|323794752|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
94545607|NCT03966885|323794753|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
94545608|NCT03966885|323794752|FG000|Overall Study|Moved from study area.|0|||
94545609|NCT03966885|323794753|FG001|Overall Study|Moved from study area.|2|||
94545610|NCT02032407|323794754|FG000|Overall Study|Lost to Follow-up|2|||
94545611|NCT02032407|323794754|FG000|Overall Study|Pregnancy|1|||
94545612|NCT02032407|323794754|FG000|Overall Study|Other Miscellaneous Reasons|2|||
94545613|NCT01309269|323794755|FG000|Overall Study|Adverse Event|56|||
94545614|NCT01309269|323794755|FG000|Overall Study|Withdrawal by Subject|25|||
94545615|NCT01309269|323794755|FG000|Overall Study|Lack of Acceptance|15|||
94545616|NCT01309269|323794755|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
94545617|NCT01309269|323794755|FG000|Overall Study|Kidney Transplant|25|||
94545618|NCT01309269|323794755|FG000|Overall Study|Administrative Problems|141|||
94545619|NCT01309269|323794755|FG000|Overall Study|Other|256|||
94545620|NCT01309269|323794755|FG000|Overall Study|Other|1|||
94545621|NCT01309269|323794755|FG000|Overall Study|Study Completion Data Not Recorded|95|||
94545622|NCT01309269|323794755|FG000|Overall Study|Enrolled but not Treated|107|||
94545623|NCT05079477|323794771|FG000|Overall Study|Lost to Follow-up|2|||
94545624|NCT05079477|323794772|FG001|Overall Study|Lost to Follow-up|0|||
94545625|NCT05079477|323794771|FG000|Overall Study|Withdrawal by Subject|1|||
94545626|NCT05079477|323794772|FG001|Overall Study|Withdrawal by Subject|0|||
94545627|NCT05079477|323794771|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
94545628|NCT05079477|323794772|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
94545629|NCT05079477|323794771|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
94545630|NCT05079477|323794772|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
94545631|NCT03131596|323794773|FG000|Overall Study|Protocol Violation|3|||
94545632|NCT03131596|323794774|FG001|Overall Study|Protocol Violation|3|||
94545633|NCT03131596|323794773|FG000|Overall Study|Lost to Follow-up|3|||
94545634|NCT03131596|323794774|FG001|Overall Study|Lost to Follow-up|0|||
94545635|NCT03654885|323794775|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
94545636|NCT03654885|323794776|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
94545637|NCT03654885|323794775|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
94545638|NCT03654885|323794776|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
94545639|NCT03654885|323794775|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
94545640|NCT03654885|323794776|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
94545641|NCT03654885|323794775|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
94545642|NCT03654885|323794776|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
94545643|NCT03654885|323794775|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
94545644|NCT03654885|323794776|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
94545645|NCT03654885|323794775|FG000|Overall Study|Adverse Event in Study Eye|3|||
94545646|NCT03654885|323794776|FG001|Overall Study|Adverse Event in Study Eye|0|||
94545647|NCT03654885|323794775|FG000|Overall Study|Consent Withdrawn|1|||
94545648|NCT03654885|323794776|FG001|Overall Study|Consent Withdrawn|0|||
94545649|NCT03654885|323794775|FG000|Overall Study|Death|3|||
94545650|NCT03654885|323794776|FG001|Overall Study|Death|1|||
94545651|NCT03654885|323794775|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
94545652|NCT03654885|323794776|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
94545653|NCT03654885|323794775|FG000|Overall Study|Lost to Follow-up|3|||
94545654|NCT03654885|323794776|FG001|Overall Study|Lost to Follow-up|3|||
94545655|NCT01103063|323794777|FG000|Overall Study|Adverse Event|3|||
94545656|NCT01103063|323794778|FG001|Overall Study|Adverse Event|1|||
94545657|NCT01103063|323794777|FG000|Overall Study|Lost to Follow-up|68|||
94545658|NCT01103063|323794778|FG001|Overall Study|Lost to Follow-up|51|||
94545659|NCT01103063|323794777|FG000|Overall Study|Withdrawal by Subject|60|||
94545660|NCT01103063|323794778|FG001|Overall Study|Withdrawal by Subject|15|||
94545661|NCT01103063|323794777|FG000|Overall Study|Other|16|||
94545662|NCT01103063|323794778|FG001|Overall Study|Other|11|||
94545663|NCT01103063|323794777|FG000|Overall Study|Protocol Violation|1|||
94545664|NCT01103063|323794778|FG001|Overall Study|Protocol Violation|0|||
94545665|NCT01103063|323794777|FG000|Overall Study|Study terminated by Sponsor|326|||
94545666|NCT01103063|323794778|FG001|Overall Study|Study terminated by Sponsor|342|||
94545667|NCT01103063|323794777|FG000|Overall Study|Death|3|||
94545668|NCT01103063|323794778|FG001|Overall Study|Death|1|||
94545669|NCT02091284|323794779|FG000|Overall Study|Withdrawal by Subject|2|||
94545670|NCT02091284|323794780|FG001|Overall Study|Withdrawal by Subject|1|||
94545671|NCT02091284|323794779|FG000|Overall Study|unreliable data|1|||
94545672|NCT02091284|323794780|FG001|Overall Study|unreliable data|0|||
94545673|NCT00289198|323794782|FG000|Overall Study|Adverse Event|0|||
94545674|NCT00289198|323794783|FG001|Overall Study|Adverse Event|2|||
94545675|NCT00289198|323794782|FG000|Overall Study|Protocol Violation|2|||
94545676|NCT00289198|323794783|FG001|Overall Study|Protocol Violation|1|||
94545677|NCT00289198|323794782|FG000|Overall Study|Withdrawal by Subject|4|||
94545678|NCT00289198|323794783|FG001|Overall Study|Withdrawal by Subject|1|||
94545679|NCT00289198|323794782|FG000|Overall Study|Lack of Efficacy|2|||
94545680|NCT00289198|323794783|FG001|Overall Study|Lack of Efficacy|0|||
94545681|NCT00289198|323794782|FG000|Overall Study|Other: Low compliance|0|||
94545682|NCT00289198|323794783|FG001|Overall Study|Other: Low compliance|1|||
94545683|NCT00289198|323794782|FG000|Overall Study|Other: Physician's decision|0|||
94545684|NCT00289198|323794783|FG001|Overall Study|Other: Physician's decision|1|||
94545685|NCT00289198|323794782|FG000|Overall Study|Other: Unable to attend on schedule|2|||
94545686|NCT00289198|323794783|FG001|Overall Study|Other: Unable to attend on schedule|1|||
94545687|NCT00289198|323794782|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
94545688|NCT00289198|323794783|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
94545689|NCT00289198|323794782|FG000|Overall Study|Other: Impossible to come on visit|0|||
94545690|NCT00289198|323794783|FG001|Overall Study|Other: Impossible to come on visit|1|||
94545691|NCT00440310|323794784|FG000|Overall Study|Lost to Follow-up|4|||
94545692|NCT00440310|323794785|FG001|Overall Study|Lost to Follow-up|5|||
94545693|NCT00440310|323794784|FG000|Overall Study|Protocol Violation|0|||
94545694|NCT00440310|323794785|FG001|Overall Study|Protocol Violation|1|||
94545695|NCT00440310|323794784|FG000|Overall Study|Withdrawal by Subject|15|||
94545696|NCT00440310|323794785|FG001|Overall Study|Withdrawal by Subject|14|||
94545697|NCT00440310|323794784|FG000|Overall Study|No Reply at EOS|7|||
94545698|NCT00440310|323794785|FG001|Overall Study|No Reply at EOS|7|||
94545699|NCT00440310|323794784|FG000|Overall Study|Other|1|||
94545700|NCT00440310|323794785|FG001|Overall Study|Other|0|||
94545701|NCT00440310|323794784|FG000|Overall Study|Status Unknown|1|||
94545702|NCT00440310|323794785|FG001|Overall Study|Status Unknown|3|||
94545703|NCT04599166|323794789|FG000|Overall Study|Technological failure connecting to study app|80|||
94545704|NCT02317809|323794790|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
94545705|NCT02317809|323794791|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
94545706|NCT02317809|323794790|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
94545707|NCT02317809|323794791|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
94545708|NCT02059499|323794794|FG000|Upto Week 20|Lost to Follow-up|2|||
94545709|NCT02059499|323794795|FG001|Upto Week 20|Lost to Follow-up|6|||
94545710|NCT02059499|323794796|FG002|Upto Week 20|Lost to Follow-up|0|||
94545711|NCT02059499|323794794|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
94545712|NCT02059499|323794795|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
94545713|NCT02059499|323794796|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
94545714|NCT02059499|323794794|FG000|Upto Week 20|Withdrawal by Subject|1|||
94545715|NCT02059499|323794795|FG001|Upto Week 20|Withdrawal by Subject|1|||
94545716|NCT02059499|323794796|FG002|Upto Week 20|Withdrawal by Subject|0|||
94545717|NCT02059499|323794794|FG000|Upto Week 20|No treatment per protocol criteria|0|||
94545718|NCT02059499|323794795|FG001|Upto Week 20|No treatment per protocol criteria|0|||
94545719|NCT02059499|323794796|FG002|Upto Week 20|No treatment per protocol criteria|5|||
94545720|NCT02059499|323794794|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
94545721|NCT02059499|323794795|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
94545722|NCT02059499|323794796|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
94545723|NCT02059499|323794794|FG000|Post-week 20|Lost to Follow-up|0|||
94545724|NCT02059499|323794795|FG001|Post-week 20|Lost to Follow-up|2|||
94545725|NCT02059499|323794796|FG002|Post-week 20|Lost to Follow-up|0|||
94545726|NCT02059499|323794794|FG000|Post-week 20|Withdrawal by Subject|0|||
94545727|NCT02059499|323794795|FG001|Post-week 20|Withdrawal by Subject|1|||
94545728|NCT02059499|323794796|FG002|Post-week 20|Withdrawal by Subject|0|||
94545729|NCT02059499|323794794|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
94545730|NCT02059499|323794795|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
94545731|NCT02059499|323794796|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
94545732|NCT04912895|323794801|FG000|Overall Study|Unable to provide specimen|2|||
94545733|NCT04912895|323794802|FG001|Overall Study|Unable to provide specimen|0|||
94545734|NCT04912895|323794803|FG002|Overall Study|Unable to provide specimen|0|||
94545735|NCT02785458|323794806|FG000|1 Month|Withdrawal by Subject|2|||
94545736|NCT02785458|323794807|FG001|1 Month|Withdrawal by Subject|1|||
94545737|NCT02785458|323794806|FG000|1 Month|Lost to Follow-up|38|||
94545738|NCT02785458|323794807|FG001|1 Month|Lost to Follow-up|31|||
94545739|NCT02785458|323794806|FG000|1 Month|Deemed Ineligible|1|||
94545740|NCT02785458|323794807|FG001|1 Month|Deemed Ineligible|0|||
94545741|NCT02785458|323794806|FG000|1 Month|Completed Evaluation by Baseline|42|||
94545742|NCT02785458|323794807|FG001|1 Month|Completed Evaluation by Baseline|39|||
94545743|NCT02785458|323794806|FG000|1 Month|Partial Interview|0|||
94545744|NCT02785458|323794807|FG001|1 Month|Partial Interview|4|||
94545745|NCT02785458|323794806|FG000|3 Months|Withdrawal by Subject|3|||
94545746|NCT02785458|323794807|FG001|3 Months|Withdrawal by Subject|1|||
94545747|NCT02785458|323794806|FG000|3 Months|Lost to Follow-up|25|||
94545748|NCT02785458|323794807|FG001|3 Months|Lost to Follow-up|21|||
94545749|NCT02785458|323794806|FG000|3 Months|Completed Evaluation at 1 Month|100|||
94545750|NCT02785458|323794807|FG001|3 Months|Completed Evaluation at 1 Month|89|||
94545751|NCT01804582|323794808|FG000|Overall Study|Lost to Follow-up|47|||
94545752|NCT01804582|323794809|FG001|Overall Study|Lost to Follow-up|56|||
94545753|NCT01804582|323794808|FG000|Overall Study|Physician Decision|2|||
94545754|NCT01804582|323794809|FG001|Overall Study|Physician Decision|0|||
94545755|NCT03883113|323794811|FG000|Overall Study|Physician Decision|4|||
94545756|NCT03883113|323794812|FG001|Overall Study|Physician Decision|2|||
94545757|NCT03883113|323794811|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
94545758|NCT03883113|323794812|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
94545759|NCT03883113|323794811|FG000|Overall Study|Pregnancy|1|||
94545760|NCT03883113|323794812|FG001|Overall Study|Pregnancy|0|||
94545761|NCT03883113|323794811|FG000|Overall Study|Adverse Event|0|||
94545762|NCT03883113|323794812|FG001|Overall Study|Adverse Event|1|||
94545763|NCT03883113|323794811|FG000|Overall Study|Withdrawal by Subject|1|||
94545764|NCT03883113|323794812|FG001|Overall Study|Withdrawal by Subject|2|||
94545765|NCT03883113|323794811|FG000|Overall Study|Lost to Follow-up|1|||
94545766|NCT03883113|323794812|FG001|Overall Study|Lost to Follow-up|0|||
94545767|NCT00520013|323794813|FG000|Overall Study|Withdrawal by Subject|0|||
94545768|NCT00520013|323794814|FG001|Overall Study|Withdrawal by Subject|0|||
94545769|NCT00520013|323794815|FG002|Overall Study|Withdrawal by Subject|1|||
94545770|NCT00520013|323794813|FG000|Overall Study|Adverse Event|2|||
94545771|NCT00520013|323794814|FG001|Overall Study|Adverse Event|10|||
94545772|NCT00520013|323794815|FG002|Overall Study|Adverse Event|7|||
94545773|NCT00520013|323794813|FG000|Overall Study|Progressive Disease|7|||
94545774|NCT00520013|323794814|FG001|Overall Study|Progressive Disease|3|||
94545775|NCT00520013|323794815|FG002|Overall Study|Progressive Disease|0|||
94545776|NCT00520013|323794813|FG000|Overall Study|Clinical Progression|3|||
94545777|NCT00520013|323794814|FG001|Overall Study|Clinical Progression|1|||
94545778|NCT00520013|323794815|FG002|Overall Study|Clinical Progression|0|||
94545779|NCT00520013|323794813|FG000|Overall Study|Death|0|||
94545780|NCT00520013|323794814|FG001|Overall Study|Death|1|||
94545781|NCT00520013|323794815|FG002|Overall Study|Death|0|||
94545782|NCT00520013|323794813|FG000|Overall Study|Physician Decision|0|||
94545783|NCT00520013|323794814|FG001|Overall Study|Physician Decision|0|||
94545784|NCT00520013|323794815|FG002|Overall Study|Physician Decision|3|||
94545785|NCT01891344|323794816|FG000|Overall Study|Ongoing|6|||
94545786|NCT01891344|323794817|FG001|Overall Study|Ongoing|2|||
94545787|NCT01891344|323794818|FG002|Overall Study|Ongoing|0|||
94545788|NCT01891344|323794819|FG003|Overall Study|Ongoing|1|||
94545789|NCT01891344|323794820|FG004|Overall Study|Ongoing|4|||
94545790|NCT01891344|323794821|FG005|Overall Study|Ongoing|1|||
94545791|NCT01891344|323794822|FG006|Overall Study|Ongoing|0|||
94545792|NCT01891344|323794823|FG007|Overall Study|Ongoing|0|||
94545793|NCT00159913|323794824|FG000|Overall Study|Adverse Event|1|||
94545794|NCT00159913|323794825|FG001|Overall Study|Adverse Event|0|||
94545795|NCT00159913|323794826|FG002|Overall Study|Adverse Event|1|||
94545796|NCT00159913|323794827|FG003|Overall Study|Adverse Event|0|||
94545797|NCT00159913|323794824|FG000|Overall Study|Withdrawal by Subject|0|||
94545798|NCT00159913|323794825|FG001|Overall Study|Withdrawal by Subject|0|||
94545799|NCT00159913|323794826|FG002|Overall Study|Withdrawal by Subject|0|||
94545800|NCT00159913|323794827|FG003|Overall Study|Withdrawal by Subject|1|||
94545801|NCT00159913|323794824|FG000|Overall Study|Lost to Follow-up|0|||
94545802|NCT00159913|323794825|FG001|Overall Study|Lost to Follow-up|0|||
94545803|NCT00159913|323794826|FG002|Overall Study|Lost to Follow-up|0|||
94545804|NCT00159913|323794827|FG003|Overall Study|Lost to Follow-up|1|||
94545805|NCT00159913|323794824|FG000|Overall Study|Protocol Violation|1|||
94545806|NCT00159913|323794825|FG001|Overall Study|Protocol Violation|0|||
94545807|NCT00159913|323794826|FG002|Overall Study|Protocol Violation|1|||
94545808|NCT00159913|323794827|FG003|Overall Study|Protocol Violation|0|||
94545809|NCT00186537|323794828|FG000|Overall Study|Withdrawal by Subject|4|||
94545810|NCT00186537|323794829|FG001|Overall Study|Withdrawal by Subject|0|||
94545811|NCT00186537|323794830|FG002|Overall Study|Withdrawal by Subject|3|||
94545812|NCT00186537|323794828|FG000|Overall Study|ALT > 1.5 x ULN|3|||
94545813|NCT00186537|323794829|FG001|Overall Study|ALT > 1.5 x ULN|0|||
94545814|NCT00186537|323794830|FG002|Overall Study|ALT > 1.5 x ULN|0|||
94545815|NCT03458702|323794831|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
94545816|NCT03458702|323794832|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
94545817|NCT03458702|323794831|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
94545818|NCT03458702|323794832|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
94545819|NCT01484834|323794833|FG000|Overall Study|Lost to Follow-up|5|||
94545820|NCT01484834|323794834|FG001|Overall Study|Lost to Follow-up|8|||
94545821|NCT01484834|323794835|FG002|Overall Study|Lost to Follow-up|1|||
94545822|NCT01484834|323794836|FG003|Overall Study|Lost to Follow-up|4|||
94545823|NCT01719003|323794840|FG000|Overall Study|Non compliant with protocol|1|||
94545824|NCT01719003|323794841|FG001|Overall Study|Non compliant with protocol|1|||
94545825|NCT01719003|323794842|FG002|Overall Study|Non compliant with protocol|0|||
94545826|NCT01719003|323794843|FG003|Overall Study|Non compliant with protocol|1|||
94545827|NCT01719003|323794844|FG004|Overall Study|Non compliant with protocol|2|||
94545828|NCT01719003|323794845|FG005|Overall Study|Non compliant with protocol|1|||
94545829|NCT01719003|323794846|FG006|Overall Study|Non compliant with protocol|2|||
94545830|NCT01719003|323794847|FG007|Overall Study|Non compliant with protocol|3|||
94545831|NCT01719003|323794848|FG008|Overall Study|Non compliant with protocol|0|||
94545832|NCT01719003|323794840|FG000|Overall Study|Adverse Event|6|||
94545833|NCT01719003|323794841|FG001|Overall Study|Adverse Event|5|||
94545834|NCT01719003|323794842|FG002|Overall Study|Adverse Event|4|||
94545835|NCT01719003|323794843|FG003|Overall Study|Adverse Event|3|||
94545836|NCT01719003|323794844|FG004|Overall Study|Adverse Event|4|||
94545837|NCT01719003|323794845|FG005|Overall Study|Adverse Event|3|||
94545838|NCT01719003|323794846|FG006|Overall Study|Adverse Event|6|||
94545839|NCT01719003|323794847|FG007|Overall Study|Adverse Event|5|||
94545840|NCT01719003|323794848|FG008|Overall Study|Adverse Event|0|||
94545841|NCT01719003|323794840|FG000|Overall Study|Lost to Follow-up|0|||
94545842|NCT01719003|323794841|FG001|Overall Study|Lost to Follow-up|6|||
94545843|NCT01719003|323794842|FG002|Overall Study|Lost to Follow-up|7|||
94545844|NCT01719003|323794843|FG003|Overall Study|Lost to Follow-up|2|||
94545845|NCT01719003|323794844|FG004|Overall Study|Lost to Follow-up|3|||
94545846|NCT01719003|323794845|FG005|Overall Study|Lost to Follow-up|4|||
94545847|NCT01719003|323794846|FG006|Overall Study|Lost to Follow-up|3|||
94545848|NCT01719003|323794847|FG007|Overall Study|Lost to Follow-up|2|||
94545849|NCT01719003|323794848|FG008|Overall Study|Lost to Follow-up|2|||
94545850|NCT01719003|323794840|FG000|Overall Study|Refusal to continue, not due to AE|2|||
94545851|NCT01719003|323794841|FG001|Overall Study|Refusal to continue, not due to AE|5|||
94545852|NCT01719003|323794842|FG002|Overall Study|Refusal to continue, not due to AE|4|||
94545853|NCT01719003|323794843|FG003|Overall Study|Refusal to continue, not due to AE|4|||
94545854|NCT01719003|323794844|FG004|Overall Study|Refusal to continue, not due to AE|4|||
94545855|NCT01719003|323794845|FG005|Overall Study|Refusal to continue, not due to AE|3|||
94545856|NCT01719003|323794846|FG006|Overall Study|Refusal to continue, not due to AE|8|||
94545857|NCT01719003|323794847|FG007|Overall Study|Refusal to continue, not due to AE|7|||
94545858|NCT01719003|323794848|FG008|Overall Study|Refusal to continue, not due to AE|1|||
94545859|NCT01719003|323794840|FG000|Overall Study|Reason other than those specified|0|||
94545860|NCT01719003|323794841|FG001|Overall Study|Reason other than those specified|0|||
94545861|NCT01719003|323794842|FG002|Overall Study|Reason other than those specified|2|||
94545862|NCT01719003|323794843|FG003|Overall Study|Reason other than those specified|3|||
94545863|NCT01719003|323794844|FG004|Overall Study|Reason other than those specified|4|||
94545864|NCT01719003|323794845|FG005|Overall Study|Reason other than those specified|1|||
94545865|NCT01719003|323794846|FG006|Overall Study|Reason other than those specified|0|||
94545866|NCT01719003|323794847|FG007|Overall Study|Reason other than those specified|3|||
94545867|NCT01719003|323794848|FG008|Overall Study|Reason other than those specified|1|||
94545868|NCT01719003|323794840|FG000|Overall Study|Lack of Efficacy|0|||
94545869|NCT01719003|323794841|FG001|Overall Study|Lack of Efficacy|0|||
94545870|NCT01719003|323794842|FG002|Overall Study|Lack of Efficacy|0|||
94545871|NCT01719003|323794843|FG003|Overall Study|Lack of Efficacy|0|||
94545872|NCT01719003|323794844|FG004|Overall Study|Lack of Efficacy|0|||
94545873|NCT01719003|323794845|FG005|Overall Study|Lack of Efficacy|0|||
94545874|NCT01719003|323794846|FG006|Overall Study|Lack of Efficacy|1|||
94545875|NCT01719003|323794847|FG007|Overall Study|Lack of Efficacy|0|||
94545876|NCT01719003|323794848|FG008|Overall Study|Lack of Efficacy|0|||
94545877|NCT00689793|323794849|FG000|Overall Study|Lost to Follow-up|4|||
94545878|NCT00689793|323794850|FG001|Overall Study|Lost to Follow-up|5|||
94545879|NCT01100528|323794851|FG000|Overall Study|Death|1|||
94545880|NCT01100528|323794851|FG000|Overall Study|Withdrawal by Subject|2|||
94545881|NCT03968159|323794852|FG000|Overall Study|Adverse Event|4|||
94545882|NCT03968159|323794853|FG001|Overall Study|Adverse Event|4|||
94545883|NCT03968159|323794852|FG000|Overall Study|Lost to Follow-up|1|||
94545884|NCT03968159|323794853|FG001|Overall Study|Lost to Follow-up|1|||
94545885|NCT03968159|323794852|FG000|Overall Study|Use of prohibited medication|0|||
94545886|NCT03968159|323794853|FG001|Overall Study|Use of prohibited medication|1|||
94545887|NCT03968159|323794852|FG000|Overall Study|Protocol Violation|2|||
94545888|NCT03968159|323794853|FG001|Overall Study|Protocol Violation|2|||
94545889|NCT03968159|323794852|FG000|Overall Study|Withdrawal by Subject|4|||
94545890|NCT03968159|323794853|FG001|Overall Study|Withdrawal by Subject|6|||
94545891|NCT03968159|323794852|FG000|Overall Study|Lack of Efficacy|0|||
94545892|NCT03968159|323794853|FG001|Overall Study|Lack of Efficacy|1|||
94545893|NCT03968159|323794852|FG000|Overall Study|Not further specified|2|||
94545894|NCT03968159|323794853|FG001|Overall Study|Not further specified|0|||
94545895|NCT03283150|323794855|FG000|Overall Study|Withdrawal by Subject|6|||
94545896|NCT03283150|323794856|FG001|Overall Study|Withdrawal by Subject|0|||
94545897|NCT03283150|323794857|FG002|Overall Study|Withdrawal by Subject|0|||
94545898|NCT05291936|323794858|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
94545899|NCT05291936|323794859|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
94545900|NCT05291936|323794858|FG000|Period 1|Withdrew Consent during study|1|||
94545901|NCT05291936|323794859|FG001|Period 1|Withdrew Consent during study|0|||
94545902|NCT05291936|323794858|FG000|Period 2|Adverse Event|0|||
94545903|NCT05291936|323794859|FG001|Period 2|Adverse Event|1|||
94545904|NCT05291936|323794858|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
94545905|NCT05291936|323794859|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
94545906|NCT00900146|323794860|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
94545907|NCT00900146|323794861|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
94545908|NCT00900146|323794862|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
94545909|NCT00900146|323794863|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
94545910|NCT00900146|323794864|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
94545911|NCT00900146|323794860|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
94545912|NCT00900146|323794861|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
94545913|NCT00900146|323794862|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
94545914|NCT00900146|323794863|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
94545915|NCT00900146|323794864|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
94545916|NCT00900146|323794860|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
94545917|NCT00900146|323794861|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
94545918|NCT00900146|323794862|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
94545919|NCT00900146|323794863|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
94545920|NCT00900146|323794864|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
94545921|NCT00900146|323794860|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
94545922|NCT00900146|323794861|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
94545923|NCT00900146|323794862|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
94545924|NCT00900146|323794863|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
94545925|NCT00900146|323794864|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
94545926|NCT00900146|323794860|FG000|Intermediate: Period III|Lost to Follow-up|2|||
94545927|NCT00900146|323794861|FG001|Intermediate: Period III|Lost to Follow-up|0|||
94545928|NCT00900146|323794862|FG002|Intermediate: Period III|Lost to Follow-up|0|||
94545929|NCT00900146|323794863|FG003|Intermediate: Period III|Lost to Follow-up|0|||
94545930|NCT00900146|323794864|FG004|Intermediate: Period III|Lost to Follow-up|1|||
94545931|NCT00900146|323794860|FG000|Intermediate: Period III|Administrative problems|85|||
94545932|NCT00900146|323794861|FG001|Intermediate: Period III|Administrative problems|92|||
94545933|NCT00900146|323794862|FG002|Intermediate: Period III|Administrative problems|84|||
94545934|NCT00900146|323794863|FG003|Intermediate: Period III|Administrative problems|90|||
94545935|NCT00900146|323794864|FG004|Intermediate: Period III|Administrative problems|163|||
94545936|NCT01635764|323794867|FG000|Overall Study|Adverse Event|46|||
94545937|NCT01635764|323794867|FG000|Overall Study|Lack of Efficacy|76|||
94545938|NCT01635764|323794867|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
94545939|NCT01635764|323794867|FG000|Overall Study|Protocol Deviation|1|||
94545940|NCT01635764|323794867|FG000|Overall Study|Withdrew Consent|67|||
94545941|NCT01635764|323794867|FG000|Overall Study|Lost to Follow-up|53|||
94545942|NCT01635764|323794867|FG000|Overall Study|Other|28|||
94545943|NCT02266875|323794868|FG000|Overall Study|Withdrawal by Subject|9|||
94545944|NCT02266875|323794869|FG001|Overall Study|Withdrawal by Subject|0|||
94545945|NCT02266875|323794868|FG000|Overall Study|Lost to Follow-up|2|||
94545946|NCT02266875|323794869|FG001|Overall Study|Lost to Follow-up|0|||
94545947|NCT03515941|323794870|FG000|Overall Study|Adverse Event|1|||
94545948|NCT03515941|323794871|FG001|Overall Study|Adverse Event|0|||
94545949|NCT00453973|323794873|FG000|Overall Study|Adverse Event|4|||
94545950|NCT00453973|323794874|FG001|Overall Study|Adverse Event|9|||
94545951|NCT00453973|323794873|FG000|Overall Study|Withdrawal by Subject|7|||
94545952|NCT00453973|323794874|FG001|Overall Study|Withdrawal by Subject|6|||
94545953|NCT00453973|323794873|FG000|Overall Study|PI Decision|0|||
94545954|NCT00453973|323794874|FG001|Overall Study|PI Decision|2|||
94545955|NCT00453973|323794873|FG000|Overall Study|Relocation|1|||
94545956|NCT00453973|323794874|FG001|Overall Study|Relocation|0|||
94545957|NCT00453973|323794873|FG000|Overall Study|Renal transplant|1|||
94545958|NCT00453973|323794874|FG001|Overall Study|Renal transplant|1|||
94545959|NCT00453973|323794873|FG000|Overall Study|Site closed by sponsor|3|||
94545960|NCT00453973|323794874|FG001|Overall Study|Site closed by sponsor|0|||
94545961|NCT00453973|323794873|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
94545962|NCT00453973|323794874|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
94545963|NCT01406015|323794875|FG000|Overall Study|Withdrawal by Subject|3|||
94545964|NCT01406015|323794876|FG001|Overall Study|Withdrawal by Subject|3|||
94545965|NCT00707746|323794880|FG000|Treatment Period|Adverse Event|2|||
94545966|NCT00707746|323794881|FG001|Treatment Period|Adverse Event|4|||
94545967|NCT00707746|323794880|FG000|Treatment Period|Ineligibility|0|||
94545968|NCT00707746|323794881|FG001|Treatment Period|Ineligibility|1|||
94545969|NCT02573246|323794885|FG000|Overall Study|Lost to Follow-up|2|||
94545970|NCT02573246|323794886|FG001|Overall Study|Lost to Follow-up|0|||
94545971|NCT02573246|323794887|FG002|Overall Study|Lost to Follow-up|0|||
94545972|NCT02573246|323794888|FG003|Overall Study|Lost to Follow-up|0|||
94545973|NCT02573246|323794889|FG004|Overall Study|Lost to Follow-up|1|||
94545974|NCT02573246|323794885|FG000|Overall Study|Withdrawal by Subject|0|||
94545975|NCT02573246|323794886|FG001|Overall Study|Withdrawal by Subject|0|||
94545976|NCT02573246|323794887|FG002|Overall Study|Withdrawal by Subject|0|||
94545977|NCT02573246|323794888|FG003|Overall Study|Withdrawal by Subject|0|||
94545978|NCT02573246|323794889|FG004|Overall Study|Withdrawal by Subject|1|||
94545979|NCT02573246|323794885|FG000|Overall Study|Physician Decision|1|||
94545980|NCT02573246|323794886|FG001|Overall Study|Physician Decision|1|||
94545981|NCT02573246|323794887|FG002|Overall Study|Physician Decision|3|||
94545982|NCT02573246|323794888|FG003|Overall Study|Physician Decision|2|||
94545983|NCT02573246|323794889|FG004|Overall Study|Physician Decision|2|||
94545984|NCT00316888|323794890|FG000|Overall Study|Adverse Event|4|||
94545985|NCT00316888|323794891|FG001|Overall Study|Adverse Event|5|||
94545986|NCT00316888|323794890|FG000|Overall Study|Withdrawal by Subject|2|||
94545987|NCT00316888|323794891|FG001|Overall Study|Withdrawal by Subject|2|||
94545988|NCT00316888|323794890|FG000|Overall Study|Not start protocol therapy|0|||
94545989|NCT00316888|323794891|FG001|Overall Study|Not start protocol therapy|1|||
94545990|NCT01685983|323794892|FG000|Overall Study|Adverse Event|7|||
94545991|NCT01685983|323794892|FG000|Overall Study|Death|1|||
94545992|NCT01685983|323794892|FG000|Overall Study|Withdrawal by Subject|19|||
94545993|NCT01685983|323794892|FG000|Overall Study|Protocol Violation|2|||
94545994|NCT01685983|323794892|FG000|Overall Study|Physician Decision|13|||
94545995|NCT01685983|323794892|FG000|Overall Study|Other|7|||
94545996|NCT01685983|323794892|FG000|Overall Study|Progressive Disease|32|||
94545997|NCT01685983|323794892|FG000|Overall Study|Noncompliance with Study Drug|1|||
94545998|NCT01167907|323794895|FG000|Overall Study|Protocol Violation|1|||
94545999|NCT01167907|323794896|FG001|Overall Study|Protocol Violation|0|||
94546000|NCT01167907|323794895|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
94546001|NCT01167907|323794896|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
94546002|NCT03461406|323794897|FG000|Overall Study|Death|1|||
94546003|NCT03461406|323794898|FG001|Overall Study|Death|2|||
94546004|NCT03461406|323794897|FG000|Overall Study|Consent Withdrawn by Participant|0|||
94546005|NCT03461406|323794898|FG001|Overall Study|Consent Withdrawn by Participant|1|||
94546006|NCT03461406|323794897|FG000|Overall Study|Screen Failure|3|||
94546007|NCT03461406|323794898|FG001|Overall Study|Screen Failure|1|||
94546008|NCT03461406|323794897|FG000|Overall Study|Reason not Specified|1|||
94546009|NCT03461406|323794898|FG001|Overall Study|Reason not Specified|3|||
94546010|NCT03461406|323794897|FG000|Overall Study|Lost to Follow-up|3|||
94546011|NCT03461406|323794898|FG001|Overall Study|Lost to Follow-up|0|||
94546012|NCT03077698|323794899|FG000|Progestin Monotherapy|Stable Disease|8|||
94546013|NCT03077698|323794900|FG001|Progestin Monotherapy|Stable Disease|0|||
94546014|NCT03077698|323794899|FG000|Progestin Monotherapy|Adverse Event|1|||
94546015|NCT03077698|323794900|FG001|Progestin Monotherapy|Adverse Event|0|||
94546016|NCT03077698|323794899|FG000|Progestin Monotherapy|Death|1|||
94546017|NCT03077698|323794900|FG001|Progestin Monotherapy|Death|0|||
94546018|NCT03077698|323794899|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
94546019|NCT03077698|323794900|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
94546020|NCT03077698|323794899|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
94546021|NCT03077698|323794900|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
94546022|NCT03077698|323794899|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
94546023|NCT03077698|323794900|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
94546024|NCT03077698|323794899|FG000|Safety Follow Up|Withdrawal by Subject|2|||
94546025|NCT03077698|323794900|FG001|Safety Follow Up|Withdrawal by Subject|1|||
94546026|NCT03077698|323794899|FG000|Safety Follow Up|Transfer of care to hospice|1|||
94546027|NCT03077698|323794900|FG001|Safety Follow Up|Transfer of care to hospice|0|||
94546028|NCT01075984|323794903|FG000|Treatment Phase|Adverse Event|0|||
94546029|NCT01075984|323794904|FG001|Treatment Phase|Adverse Event|1|||
94546030|NCT01075984|323794905|FG002|Treatment Phase|Adverse Event|3|||
94546031|NCT01075984|323794906|FG003|Treatment Phase|Adverse Event|7|||
94546032|NCT01075984|323794907|FG004|Treatment Phase|Adverse Event|35|||
94546033|NCT01075984|323794903|FG000|Treatment Phase|Protocol Violation|0|||
94546034|NCT01075984|323794904|FG001|Treatment Phase|Protocol Violation|0|||
94546035|NCT01075984|323794905|FG002|Treatment Phase|Protocol Violation|1|||
94546036|NCT01075984|323794906|FG003|Treatment Phase|Protocol Violation|0|||
94546037|NCT01075984|323794907|FG004|Treatment Phase|Protocol Violation|3|||
94546038|NCT01075984|323794903|FG000|Treatment Phase|Withdrawal by Subject|0|||
94546039|NCT01075984|323794904|FG001|Treatment Phase|Withdrawal by Subject|0|||
94546040|NCT01075984|323794905|FG002|Treatment Phase|Withdrawal by Subject|2|||
94546041|NCT01075984|323794906|FG003|Treatment Phase|Withdrawal by Subject|0|||
94546042|NCT01075984|323794907|FG004|Treatment Phase|Withdrawal by Subject|15|||
94546043|NCT01075984|323794903|FG000|Treatment Phase|Treatment Failure|0|||
94546044|NCT01075984|323794904|FG001|Treatment Phase|Treatment Failure|0|||
94546045|NCT01075984|323794905|FG002|Treatment Phase|Treatment Failure|1|||
94546046|NCT01075984|323794906|FG003|Treatment Phase|Treatment Failure|0|||
94546047|NCT01075984|323794907|FG004|Treatment Phase|Treatment Failure|5|||
94546048|NCT01075984|323794903|FG000|Treatment Phase|Progression of disease|0|||
94546049|NCT01075984|323794904|FG001|Treatment Phase|Progression of disease|0|||
94546050|NCT01075984|323794905|FG002|Treatment Phase|Progression of disease|0|||
94546051|NCT01075984|323794906|FG003|Treatment Phase|Progression of disease|0|||
94546052|NCT01075984|323794907|FG004|Treatment Phase|Progression of disease|2|||
94546053|NCT01075984|323794903|FG000|Follow-up Phase|Protocol Violation|0|||
94546054|NCT01075984|323794904|FG001|Follow-up Phase|Protocol Violation|0|||
94546055|NCT01075984|323794905|FG002|Follow-up Phase|Protocol Violation|1|||
94546056|NCT01075984|323794906|FG003|Follow-up Phase|Protocol Violation|0|||
94546057|NCT01075984|323794907|FG004|Follow-up Phase|Protocol Violation|3|||
94546058|NCT01075984|323794903|FG000|Follow-up Phase|Adverse Event|0|||
94546059|NCT01075984|323794904|FG001|Follow-up Phase|Adverse Event|0|||
94546060|NCT01075984|323794905|FG002|Follow-up Phase|Adverse Event|0|||
94546061|NCT01075984|323794906|FG003|Follow-up Phase|Adverse Event|2|||
94546062|NCT01075984|323794907|FG004|Follow-up Phase|Adverse Event|27|||
94546063|NCT01075984|323794903|FG000|Follow-up Phase|Administrative|0|||
94546064|NCT01075984|323794904|FG001|Follow-up Phase|Administrative|0|||
94546065|NCT01075984|323794905|FG002|Follow-up Phase|Administrative|0|||
94546066|NCT01075984|323794906|FG003|Follow-up Phase|Administrative|0|||
94546067|NCT01075984|323794907|FG004|Follow-up Phase|Administrative|1|||
94546068|NCT01075984|323794903|FG000|Follow-up Phase|Withdrawal by Subject|0|||
94546069|NCT01075984|323794904|FG001|Follow-up Phase|Withdrawal by Subject|0|||
94546070|NCT01075984|323794905|FG002|Follow-up Phase|Withdrawal by Subject|0|||
94546071|NCT01075984|323794906|FG003|Follow-up Phase|Withdrawal by Subject|0|||
94546072|NCT01075984|323794907|FG004|Follow-up Phase|Withdrawal by Subject|10|||
94546073|NCT01075984|323794903|FG000|Follow-up Phase|Progression of disease|0|||
94546074|NCT01075984|323794904|FG001|Follow-up Phase|Progression of disease|0|||
94546075|NCT01075984|323794905|FG002|Follow-up Phase|Progression of disease|0|||
94546076|NCT01075984|323794906|FG003|Follow-up Phase|Progression of disease|0|||
94546077|NCT01075984|323794907|FG004|Follow-up Phase|Progression of disease|2|||
94546078|NCT01075984|323794903|FG000|Follow-up Phase|Treatment failure|0|||
94546079|NCT01075984|323794904|FG001|Follow-up Phase|Treatment failure|0|||
94546080|NCT01075984|323794905|FG002|Follow-up Phase|Treatment failure|0|||
94546081|NCT01075984|323794906|FG003|Follow-up Phase|Treatment failure|0|||
94546082|NCT01075984|323794907|FG004|Follow-up Phase|Treatment failure|4|||
94546083|NCT02198235|323794909|FG000|Overall Study|Lost to Follow-up|3|||
94546084|NCT02198235|323794910|FG001|Overall Study|Lost to Follow-up|2|||
94546085|NCT02198235|323794911|FG002|Overall Study|Lost to Follow-up|2|||
94546086|NCT03684694|323794917|FG000|Phase 1|Withdrawal by Subject|1|||
94546087|NCT03684694|323794918|FG001|Phase 1|Withdrawal by Subject|0|||
94546088|NCT03684694|323794919|FG002|Phase 1|Withdrawal by Subject|0|||
94546089|NCT03684694|323794920|FG003|Phase 1|Withdrawal by Subject|0|||
94546090|NCT03684694|323794921|FG004|Phase 1|Withdrawal by Subject|0|||
94546091|NCT03684694|323794922|FG005|Phase 1|Withdrawal by Subject|0|||
94546092|NCT03684694|323794917|FG000|Phase 1|Investigator/Sponsor Decision|12|||
94546093|NCT03684694|323794918|FG001|Phase 1|Investigator/Sponsor Decision|2|||
94546094|NCT03684694|323794919|FG002|Phase 1|Investigator/Sponsor Decision|1|||
94546095|NCT03684694|323794920|FG003|Phase 1|Investigator/Sponsor Decision|0|||
94546096|NCT03684694|323794921|FG004|Phase 1|Investigator/Sponsor Decision|0|||
94546097|NCT03684694|323794922|FG005|Phase 1|Investigator/Sponsor Decision|0|||
94546098|NCT03684694|323794917|FG000|Phase 1|Death|24|||
94546099|NCT03684694|323794918|FG001|Phase 1|Death|0|||
94546100|NCT03684694|323794919|FG002|Phase 1|Death|3|||
94546101|NCT03684694|323794920|FG003|Phase 1|Death|0|||
94546102|NCT03684694|323794921|FG004|Phase 1|Death|0|||
94546103|NCT03684694|323794922|FG005|Phase 1|Death|0|||
94546104|NCT03684694|323794917|FG000|Phase 1|Lost to Follow-up|0|||
94546105|NCT03684694|323794918|FG001|Phase 1|Lost to Follow-up|0|||
94546106|NCT03684694|323794919|FG002|Phase 1|Lost to Follow-up|1|||
94546107|NCT03684694|323794920|FG003|Phase 1|Lost to Follow-up|0|||
94546108|NCT03684694|323794921|FG004|Phase 1|Lost to Follow-up|0|||
94546109|NCT03684694|323794922|FG005|Phase 1|Lost to Follow-up|0|||
94546110|NCT03684694|323794917|FG000|Phase 1|Miscellaneous|0|||
94546111|NCT03684694|323794918|FG001|Phase 1|Miscellaneous|1|||
94546112|NCT03684694|323794919|FG002|Phase 1|Miscellaneous|0|||
94546113|NCT03684694|323794920|FG003|Phase 1|Miscellaneous|0|||
94546114|NCT03684694|323794921|FG004|Phase 1|Miscellaneous|0|||
94546115|NCT03684694|323794922|FG005|Phase 1|Miscellaneous|0|||
94546116|NCT03684694|323794917|FG000|Phase 2|Withdrawal by Subject|0|||
94546117|NCT03684694|323794918|FG001|Phase 2|Withdrawal by Subject|0|||
94546118|NCT03684694|323794919|FG002|Phase 2|Withdrawal by Subject|0|||
94546119|NCT03684694|323794920|FG003|Phase 2|Withdrawal by Subject|0|||
94546120|NCT03684694|323794921|FG004|Phase 2|Withdrawal by Subject|0|||
94546121|NCT03684694|323794922|FG005|Phase 2|Withdrawal by Subject|1|||
94546122|NCT03684694|323794917|FG000|Phase 2|Investigator/Sponsor Decision|0|||
94546123|NCT03684694|323794918|FG001|Phase 2|Investigator/Sponsor Decision|0|||
94546124|NCT03684694|323794919|FG002|Phase 2|Investigator/Sponsor Decision|0|||
94546125|NCT03684694|323794920|FG003|Phase 2|Investigator/Sponsor Decision|17|||
94546126|NCT03684694|323794921|FG004|Phase 2|Investigator/Sponsor Decision|16|||
94546127|NCT03684694|323794922|FG005|Phase 2|Investigator/Sponsor Decision|6|||
94546128|NCT03684694|323794917|FG000|Phase 2|Death|0|||
94546129|NCT03684694|323794918|FG001|Phase 2|Death|0|||
94546130|NCT03684694|323794919|FG002|Phase 2|Death|0|||
94546131|NCT03684694|323794920|FG003|Phase 2|Death|28|||
94546132|NCT03684694|323794921|FG004|Phase 2|Death|14|||
94546133|NCT03684694|323794922|FG005|Phase 2|Death|3|||
94546134|NCT03684694|323794917|FG000|Phase 2|Lost to Follow-up|0|||
94546135|NCT03684694|323794918|FG001|Phase 2|Lost to Follow-up|0|||
94546136|NCT03684694|323794919|FG002|Phase 2|Lost to Follow-up|0|||
94546137|NCT03684694|323794920|FG003|Phase 2|Lost to Follow-up|1|||
94546138|NCT03684694|323794921|FG004|Phase 2|Lost to Follow-up|0|||
94546139|NCT03684694|323794922|FG005|Phase 2|Lost to Follow-up|0|||
94546140|NCT03684694|323794917|FG000|Phase 2|Miscellaneous|0|||
94546141|NCT03684694|323794918|FG001|Phase 2|Miscellaneous|0|||
94546142|NCT03684694|323794919|FG002|Phase 2|Miscellaneous|0|||
94546143|NCT03684694|323794920|FG003|Phase 2|Miscellaneous|3|||
94546144|NCT03684694|323794921|FG004|Phase 2|Miscellaneous|0|||
94546145|NCT03684694|323794922|FG005|Phase 2|Miscellaneous|0|||
94546146|NCT00664326|323796324|FG000|Overall Study|Adverse Event|14|||
94546147|NCT00664326|323796324|FG000|Overall Study|Noncompliance with study medication|3|||
94546148|NCT00664326|323796324|FG000|Overall Study|Withdrawal by Subject|1|||
94546149|NCT00664326|323796324|FG000|Overall Study|Physician Decision|1|||
94546150|NCT00664326|323796324|FG000|Overall Study|Other Reasons|3|||
94546151|NCT00664326|323796324|FG000|Overall Study|Death|2|||
94546152|NCT00664326|323796324|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
94546153|NCT00262847|323796325|FG000|Overall Study|Disease Progression|309|||
94546154|NCT00262847|323796326|FG001|Overall Study|Disease Progression|274|||
94546155|NCT00262847|323796327|FG002|Overall Study|Disease Progression|195|||
94546156|NCT00262847|323796325|FG000|Overall Study|Patient Refusal|41|||
94546157|NCT00262847|323796326|FG001|Overall Study|Patient Refusal|52|||
94546158|NCT00262847|323796327|FG002|Overall Study|Patient Refusal|47|||
94546159|NCT00262847|323796325|FG000|Overall Study|Adverse Event|74|||
94546160|NCT00262847|323796326|FG001|Overall Study|Adverse Event|88|||
94546161|NCT00262847|323796327|FG002|Overall Study|Adverse Event|108|||
94546162|NCT00262847|323796325|FG000|Overall Study|Death|8|||
94546163|NCT00262847|323796326|FG001|Overall Study|Death|8|||
94546164|NCT00262847|323796327|FG002|Overall Study|Death|11|||
94546165|NCT00262847|323796325|FG000|Overall Study|Concomitant disease|3|||
94546166|NCT00262847|323796326|FG001|Overall Study|Concomitant disease|2|||
94546167|NCT00262847|323796327|FG002|Overall Study|Concomitant disease|4|||
94546168|NCT00262847|323796325|FG000|Overall Study|Other Reasons|79|||
94546169|NCT00262847|323796326|FG001|Overall Study|Other Reasons|88|||
94546170|NCT00262847|323796327|FG002|Overall Study|Other Reasons|27|||
94546171|NCT00262847|323796325|FG000|Overall Study|Did not receive study treatment|4|||
94546172|NCT00262847|323796326|FG001|Overall Study|Did not receive study treatment|1|||
94546173|NCT00262847|323796327|FG002|Overall Study|Did not receive study treatment|4|||
94546174|NCT00387647|323796328|FG000|Overall Study|Death|18|||
94546175|NCT02191605|323796329|FG000|Overall Study|Lost to Follow-up|9|||
94546176|NCT02191605|323796330|FG001|Overall Study|Lost to Follow-up|4|||
94546177|NCT02191605|323796331|FG002|Overall Study|Lost to Follow-up|7|||
94546178|NCT02191605|323796332|FG003|Overall Study|Lost to Follow-up|3|||
94546179|NCT02191605|323796333|FG004|Overall Study|Lost to Follow-up|4|||
94546180|NCT00541346|323796338|FG000|Follow-up|Adverse Event|1|||
94546181|NCT04732949|323796339|FG000|Overall Study|Withdrawal by Subject|23|||
94546182|NCT04732949|323796340|FG001|Overall Study|Withdrawal by Subject|27|||
94546183|NCT04732949|323796339|FG000|Overall Study|Protocol Violation|0|||
94546184|NCT04732949|323796340|FG001|Overall Study|Protocol Violation|1|||
94546185|NCT04732949|323796339|FG000|Overall Study|Non-compliance|0|||
94546186|NCT04732949|323796340|FG001|Overall Study|Non-compliance|2|||
94546187|NCT04732949|323796339|FG000|Overall Study|Physician Decision|2|||
94546188|NCT04732949|323796340|FG001|Overall Study|Physician Decision|1|||
94546189|NCT04732949|323796339|FG000|Overall Study|Serious adverse event (Fatal)|16|||
94546190|NCT04732949|323796340|FG001|Overall Study|Serious adverse event (Fatal)|18|||
94546191|NCT04732949|323796339|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
94546192|NCT04732949|323796340|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
94546193|NCT04732949|323796339|FG000|Overall Study|Non-serious adverse event|1|||
94546194|NCT04732949|323796340|FG001|Overall Study|Non-serious adverse event|3|||
94546195|NCT04732949|323796339|FG000|Overall Study|Lost to Follow-up|26|||
94546196|NCT04732949|323796340|FG001|Overall Study|Lost to Follow-up|27|||
94546197|NCT04732949|323796339|FG000|Overall Study|Other|6|||
94546198|NCT04732949|323796340|FG001|Overall Study|Other|3|||
94546199|NCT02258529|323796344|FG000|Overall Study|Study Terminated by Sponsor|9|||
94546200|NCT02258529|323796344|FG000|Overall Study|Adverse Event|1|||
94546201|NCT01318070|323796347|FG000|Overall Study|Adverse Event|1|||
94546202|NCT01318070|323796348|FG001|Overall Study|Adverse Event|1|||
94546203|NCT01318070|323796349|FG002|Overall Study|Adverse Event|5|||
94546204|NCT01318070|323796347|FG000|Overall Study|Withdrawal by Subject|0|||
94546205|NCT01318070|323796348|FG001|Overall Study|Withdrawal by Subject|1|||
94546206|NCT01318070|323796349|FG002|Overall Study|Withdrawal by Subject|1|||
94546207|NCT01318070|323796347|FG000|Overall Study|Lack of Efficacy|0|||
94546208|NCT01318070|323796348|FG001|Overall Study|Lack of Efficacy|0|||
94546209|NCT01318070|323796349|FG002|Overall Study|Lack of Efficacy|1|||
94546210|NCT01318070|323796347|FG000|Overall Study|Principal Investigator Discretion|1|||
94546211|NCT01318070|323796348|FG001|Overall Study|Principal Investigator Discretion|0|||
94546212|NCT01318070|323796349|FG002|Overall Study|Principal Investigator Discretion|0|||
94546213|NCT03412604|323796353|FG000|Overall Study|Withdrawal by Subject|1|||
94546214|NCT05545644|323796354|FG000|Overall Study|Lost to Follow-up|4|||
94546215|NCT05545644|323796355|FG001|Overall Study|Lost to Follow-up|3|||
94546216|NCT02068118|323796358|FG000|18-month Comparative Study Period|Death|90|||
94546217|NCT02068118|323796359|FG001|18-month Comparative Study Period|Death|97|||
94546218|NCT02068118|323796358|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
94546219|NCT02068118|323796359|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
94546220|NCT02068118|323796358|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
94546221|NCT02068118|323796359|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
94546222|NCT02068118|323796358|FG000|18-month Comparative Study Period|Heart transplant|9|||
94546223|NCT02068118|323796359|FG001|18-month Comparative Study Period|Heart transplant|15|||
94546224|NCT02068118|323796358|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
94546225|NCT02068118|323796359|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
94546226|NCT02068118|323796358|FG000|18-month Comparative Study Period|Hemiplegia|0|||
94546227|NCT02068118|323796359|FG001|18-month Comparative Study Period|Hemiplegia|1|||
94546228|NCT02068118|323796358|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
94546229|NCT02068118|323796359|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
94546230|NCT02068118|323796358|FG000|18-month Comparative Study Period|Move|0|||
94546231|NCT02068118|323796359|FG001|18-month Comparative Study Period|Move|1|||
94546232|NCT02068118|323796358|FG000|18-month Comparative Study Period|Hearing loss|0|||
94546233|NCT02068118|323796359|FG001|18-month Comparative Study Period|Hearing loss|1|||
94546234|NCT02068118|323796358|FG000|Extension Period|Death|0|||
94546235|NCT02068118|323796359|FG001|Extension Period|Death|2|||
94546236|NCT02068118|323796358|FG000|Extension Period|Withdrawal by Subject|1|||
94546237|NCT02068118|323796359|FG001|Extension Period|Withdrawal by Subject|0|||
94546238|NCT02068118|323796358|FG000|Extension Period|Heart transplant|1|||
94546239|NCT02068118|323796359|FG001|Extension Period|Heart transplant|0|||
94546240|NCT02068118|323796358|FG000|Extension Period|Wrong device use|0|||
94546241|NCT02068118|323796359|FG001|Extension Period|Wrong device use|1|||
94546242|NCT00353873|323796360|FG000|Overall Study|Protocol Violation|1|||
94546243|NCT00353873|323796361|FG001|Overall Study|Protocol Violation|2|||
94546244|NCT00353873|323796360|FG000|Overall Study|Exacerbation|1|||
94546245|NCT00353873|323796361|FG001|Overall Study|Exacerbation|0|||
94546246|NCT00353873|323796360|FG000|Overall Study|Adverse Event|1|||
94546247|NCT00353873|323796361|FG001|Overall Study|Adverse Event|0|||
94546248|NCT00353873|323796360|FG000|Overall Study|Physician Decision|2|||
94546249|NCT00353873|323796361|FG001|Overall Study|Physician Decision|0|||
94546250|NCT00353873|323796360|FG000|Overall Study|Withdrawal by Subject|1|||
94546251|NCT00353873|323796361|FG001|Overall Study|Withdrawal by Subject|1|||
94546252|NCT00870194|323796364|FG000|Overall Study|Adverse Event|10|||
94546253|NCT00870194|323796365|FG001|Overall Study|Adverse Event|5|||
94546254|NCT00870194|323796364|FG000|Overall Study|Lack of Efficacy|0|||
94546255|NCT00870194|323796365|FG001|Overall Study|Lack of Efficacy|1|||
94546256|NCT00870194|323796364|FG000|Overall Study|Lost to Follow-up|2|||
94546257|NCT00870194|323796365|FG001|Overall Study|Lost to Follow-up|0|||
94546258|NCT00870194|323796364|FG000|Overall Study|Physician Decision|3|||
94546259|NCT00870194|323796365|FG001|Overall Study|Physician Decision|1|||
94546260|NCT00870194|323796364|FG000|Overall Study|Protocol Violation|3|||
94546261|NCT00870194|323796365|FG001|Overall Study|Protocol Violation|3|||
94546262|NCT00870194|323796364|FG000|Overall Study|Entry Criteria Not Met|1|||
94546263|NCT00870194|323796365|FG001|Overall Study|Entry Criteria Not Met|2|||
94546264|NCT00870194|323796364|FG000|Overall Study|Subject Decision|7|||
94546265|NCT00870194|323796365|FG001|Overall Study|Subject Decision|2|||
94546266|NCT04094584|323796366|FG000|Overall Study|No interest in study|88|||
94546267|NCT04094584|323796366|FG000|Overall Study|Unwilling to undergo screening tests|36|||
94546268|NCT04094584|323796366|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
94546269|NCT04094584|323796366|FG000|Overall Study|Opioid use|7|||
94546270|NCT04094584|323796366|FG000|Overall Study|Need for major surgery in study period|4|||
94546271|NCT04094584|323796366|FG000|Overall Study|eligible but declined enrollment|4|||
94546272|NCT04094584|323796366|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
94546273|NCT04094584|323796366|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
94546274|NCT04094584|323796366|FG000|Overall Study|Lost to Follow-up|3|||
94546275|NCT04094584|323796366|FG000|Overall Study|Withdrawal by Subject|2|||
94546276|NCT02717130|323796367|FG000|Overall Study|Withdrawal by Subject|1|||
94546277|NCT02717130|323796367|FG000|Overall Study|Adverse Event|1|||
94546278|NCT02717130|323796367|FG000|Overall Study|Physician Decision|1|||
94546279|NCT02717130|323796367|FG000|Overall Study|Study Closure|4|||
94546280|NCT00554099|323796368|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
94546281|NCT00554099|323796369|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
94546282|NCT00554099|323796370|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
94546283|NCT00554099|323796368|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
94546284|NCT00554099|323796369|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
94546285|NCT00554099|323796370|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
94546286|NCT00554099|323796368|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
94546287|NCT00554099|323796369|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
94546288|NCT00554099|323796370|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
94546289|NCT00554099|323796368|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
94546290|NCT00554099|323796369|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
94546291|NCT00554099|323796370|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
94546292|NCT00554099|323796368|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
94546293|NCT00554099|323796369|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
94546294|NCT00554099|323796370|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
94546295|NCT00554099|323796368|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
94546296|NCT00554099|323796369|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
94546297|NCT00554099|323796370|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
94546298|NCT00554099|323796368|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
94546299|NCT00554099|323796369|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
94546300|NCT00554099|323796370|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
94546301|NCT00554099|323796368|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
94546302|NCT00554099|323796369|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
94546303|NCT00554099|323796370|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
94546304|NCT00554099|323796368|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
94546305|NCT00554099|323796369|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
94546306|NCT00554099|323796370|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
94546307|NCT00106691|323796371|FG000|Overall Study|Adverse Event|60|||
94546308|NCT00106691|323796372|FG001|Overall Study|Adverse Event|64|||
94546309|NCT00106691|323796371|FG000|Overall Study|Lost to Follow-up|23|||
94546310|NCT00106691|323796372|FG001|Overall Study|Lost to Follow-up|18|||
94546311|NCT00106691|323796371|FG000|Overall Study|Physician Decision|18|||
94546312|NCT00106691|323796372|FG001|Overall Study|Physician Decision|21|||
94546313|NCT00106691|323796371|FG000|Overall Study|Protocol Violation|13|||
94546314|NCT00106691|323796372|FG001|Overall Study|Protocol Violation|18|||
94546315|NCT00106691|323796371|FG000|Overall Study|Withdrawal by Subject|75|||
94546316|NCT00106691|323796372|FG001|Overall Study|Withdrawal by Subject|70|||
94546317|NCT00106691|323796371|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
94546318|NCT00106691|323796372|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
94546319|NCT00106691|323796371|FG000|Overall Study|QTc>480|3|||
94546320|NCT00106691|323796372|FG001|Overall Study|QTc>480|1|||
94546321|NCT00106691|323796371|FG000|Overall Study|mililtary deployment|2|||
94546322|NCT00106691|323796372|FG001|Overall Study|mililtary deployment|0|||
94546323|NCT00106691|323796371|FG000|Overall Study|Study Site Closing/PI Moved|1|||
94546324|NCT00106691|323796372|FG001|Overall Study|Study Site Closing/PI Moved|2|||
94546325|NCT00106691|323796371|FG000|Overall Study|Cardiologist recommendation|1|||
94546326|NCT00106691|323796372|FG001|Overall Study|Cardiologist recommendation|0|||
94546327|NCT00106691|323796371|FG000|Overall Study|Pt. moved to another state|1|||
94546328|NCT00106691|323796372|FG001|Overall Study|Pt. moved to another state|0|||
94546329|NCT00106691|323796371|FG000|Overall Study|Taking exclusionary avodart|1|||
94546330|NCT00106691|323796372|FG001|Overall Study|Taking exclusionary avodart|0|||
94546331|NCT00106691|323796371|FG000|Overall Study|Not able to discontinue plavix|0|||
94546332|NCT00106691|323796372|FG001|Overall Study|Not able to discontinue plavix|1|||
94546333|NCT02075632|323796376|FG000|Overall Study|Adverse Event|1|||
94546334|NCT02075632|323796377|FG001|Overall Study|Adverse Event|1|||
94546335|NCT02075632|323796376|FG000|Overall Study|Lost to Follow-up|0|||
94546336|NCT02075632|323796377|FG001|Overall Study|Lost to Follow-up|3|||
94546337|NCT02075632|323796376|FG000|Overall Study|Withdrawal by Subject|0|||
94546338|NCT02075632|323796377|FG001|Overall Study|Withdrawal by Subject|1|||
94546339|NCT01754194|323796378|FG000|Overall Study|Lost to Follow-up|39|||
94546340|NCT01754194|323796379|FG001|Overall Study|Lost to Follow-up|14|||
94546341|NCT01754194|323796378|FG000|Overall Study|Withdrawal by Subject|4|||
94546342|NCT01754194|323796379|FG001|Overall Study|Withdrawal by Subject|5|||
94546343|NCT01754194|323796378|FG000|Overall Study|Other|9|||
94546344|NCT01754194|323796379|FG001|Overall Study|Other|8|||
94546345|NCT00530920|323796380|FG000|Overall Study|Randomized but not treated|0|||
94546346|NCT00530920|323796381|FG001|Overall Study|Randomized but not treated|2|||
94546347|NCT00530920|323796382|FG002|Overall Study|Randomized but not treated|0|||
94546348|NCT00530920|323796380|FG000|Overall Study|Adverse Event|0|||
94546349|NCT00530920|323796381|FG001|Overall Study|Adverse Event|0|||
94546350|NCT00530920|323796382|FG002|Overall Study|Adverse Event|3|||
94546351|NCT00530920|323796380|FG000|Overall Study|Withdrawal by Subject|0|||
94546352|NCT00530920|323796381|FG001|Overall Study|Withdrawal by Subject|0|||
94546353|NCT00530920|323796382|FG002|Overall Study|Withdrawal by Subject|1|||
94546354|NCT00791557|323796383|FG000|Overall Study|Adverse Event|1|||
94546355|NCT04957758|323796385|FG000|Overall Study|Adverse Event|1|||
94546356|NCT04957758|323796386|FG001|Overall Study|Adverse Event|0|||
94546357|NCT04957758|323796385|FG000|Overall Study|Lost to Follow-up|0|||
94546358|NCT04957758|323796386|FG001|Overall Study|Lost to Follow-up|2|||
94546359|NCT04957758|323796385|FG000|Overall Study|Withdrawal by Subject|4|||
94546360|NCT04957758|323796386|FG001|Overall Study|Withdrawal by Subject|2|||
94546361|NCT04957758|323796385|FG000|Overall Study|Protocol Violation|0|||
94546362|NCT04957758|323796386|FG001|Overall Study|Protocol Violation|1|||
94546363|NCT03344640|323796387|FG000|Overall Study|Adverse Event|1|||
94546364|NCT03344640|323796388|FG001|Overall Study|Adverse Event|0|||
94546365|NCT03344640|323796387|FG000|Overall Study|Physician Decision|1|||
94546366|NCT03344640|323796388|FG001|Overall Study|Physician Decision|1|||
94546367|NCT03344640|323796387|FG000|Overall Study|Withdrawal by Subject|1|||
94546368|NCT03344640|323796388|FG001|Overall Study|Withdrawal by Subject|2|||
94546369|NCT03344640|323796387|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
94546370|NCT03344640|323796388|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
94546371|NCT00685373|323796392|FG000|Overall Study|Adverse Event|3|||
94546372|NCT00685373|323796392|FG000|Overall Study|Withdrawal by Subject|5|||
94546373|NCT00685373|323796392|FG000|Overall Study|Lack of Efficacy|3|||
94546374|NCT00685373|323796392|FG000|Overall Study|Condition no longer requires study drug|1|||
94546375|NCT00685373|323796392|FG000|Overall Study|Lost to Follow-up|2|||
94546376|NCT00685373|323796392|FG000|Overall Study|Protocol Violation|1|||
94546377|NCT05239221|323796393|FG000|Overall Study|Adverse Event|0|||
94546378|NCT05239221|323796394|FG001|Overall Study|Adverse Event|0|||
94546379|NCT05239221|323796395|FG002|Overall Study|Adverse Event|0|||
94546380|NCT05239221|323796396|FG003|Overall Study|Adverse Event|0|||
94546381|NCT05239221|323796397|FG004|Overall Study|Adverse Event|0|||
94546382|NCT05239221|323796398|FG005|Overall Study|Adverse Event|0|||
94546383|NCT05239221|323796399|FG006|Overall Study|Adverse Event|1|||
94546384|NCT05239221|323796400|FG007|Overall Study|Adverse Event|0|||
94546385|NCT05239221|323796401|FG008|Overall Study|Adverse Event|0|||
94546386|NCT05239221|323796402|FG009|Overall Study|Adverse Event|0|||
94546387|NCT05239221|323796403|FG010|Overall Study|Adverse Event|1|||
94546388|NCT05239221|323796404|FG011|Overall Study|Adverse Event|1|||
94546389|NCT05239221|323796405|FG012|Overall Study|Adverse Event|0|||
94546390|NCT05239221|323796406|FG013|Overall Study|Adverse Event|0|||
94546391|NCT05239221|323796407|FG014|Overall Study|Adverse Event|0|||
94546392|NCT05239221|323796408|FG015|Overall Study|Adverse Event|0|||
94546393|NCT05239221|323796393|FG000|Overall Study|Withdrawal by Subject|0|||
94546394|NCT05239221|323796394|FG001|Overall Study|Withdrawal by Subject|0|||
94546395|NCT05239221|323796395|FG002|Overall Study|Withdrawal by Subject|0|||
94546396|NCT05239221|323796396|FG003|Overall Study|Withdrawal by Subject|0|||
94546397|NCT05239221|323796397|FG004|Overall Study|Withdrawal by Subject|0|||
94546398|NCT05239221|323796398|FG005|Overall Study|Withdrawal by Subject|0|||
94546399|NCT05239221|323796399|FG006|Overall Study|Withdrawal by Subject|0|||
94546400|NCT05239221|323796400|FG007|Overall Study|Withdrawal by Subject|0|||
94546401|NCT05239221|323796401|FG008|Overall Study|Withdrawal by Subject|0|||
94546402|NCT05239221|323796402|FG009|Overall Study|Withdrawal by Subject|0|||
94546403|NCT05239221|323796403|FG010|Overall Study|Withdrawal by Subject|1|||
94546404|NCT05239221|323796404|FG011|Overall Study|Withdrawal by Subject|0|||
94546405|NCT05239221|323796405|FG012|Overall Study|Withdrawal by Subject|0|||
94546406|NCT05239221|323796406|FG013|Overall Study|Withdrawal by Subject|0|||
94546407|NCT05239221|323796407|FG014|Overall Study|Withdrawal by Subject|0|||
94546408|NCT05239221|323796408|FG015|Overall Study|Withdrawal by Subject|1|||
94546409|NCT02642965|323796410|FG000|Overall Study|Lack of Efficacy|4|||
94546410|NCT02642965|323796410|FG000|Overall Study|Physician Decision|9|||
94546411|NCT00652899|323796411|FG000|Overall Study|Death|1|||
94546412|NCT00652899|323796411|FG000|Overall Study|Treating physician decision|1|||
94546413|NCT02012686|323796417|FG000|Overall Study|muscle contraction|0|||
94546414|NCT02012686|323796418|FG001|Overall Study|muscle contraction|1|||
94546415|NCT02012686|323796417|FG000|Overall Study|electrocardiography monitoring noise|0|||
94546416|NCT02012686|323796418|FG001|Overall Study|electrocardiography monitoring noise|1|||
94546417|NCT01442064|323796419|FG000|Overall Study|Adverse Event|2|||
94546418|NCT01442064|323796420|FG001|Overall Study|Adverse Event|2|||
94546419|NCT01442064|323796421|FG002|Overall Study|Adverse Event|2|||
94546420|NCT01442064|323796422|FG003|Overall Study|Adverse Event|1|||
94546421|NCT01442064|323796423|FG004|Overall Study|Adverse Event|2|||
94546422|NCT01442064|323796424|FG005|Overall Study|Adverse Event|0|||
94546423|NCT01442064|323796419|FG000|Overall Study|Death|0|||
94546424|NCT01442064|323796420|FG001|Overall Study|Death|1|||
94546425|NCT01442064|323796421|FG002|Overall Study|Death|3|||
94546426|NCT01442064|323796422|FG003|Overall Study|Death|3|||
94546427|NCT01442064|323796423|FG004|Overall Study|Death|1|||
94546428|NCT01442064|323796424|FG005|Overall Study|Death|3|||
94546429|NCT01442064|323796419|FG000|Overall Study|Lost to Follow-up|5|||
94546430|NCT01442064|323796420|FG001|Overall Study|Lost to Follow-up|5|||
94546431|NCT01442064|323796421|FG002|Overall Study|Lost to Follow-up|1|||
94546432|NCT01442064|323796422|FG003|Overall Study|Lost to Follow-up|1|||
94546433|NCT01442064|323796423|FG004|Overall Study|Lost to Follow-up|3|||
94546434|NCT01442064|323796424|FG005|Overall Study|Lost to Follow-up|3|||
94546435|NCT01442064|323796419|FG000|Overall Study|Physician Decision|1|||
94546436|NCT01442064|323796420|FG001|Overall Study|Physician Decision|1|||
94546437|NCT01442064|323796421|FG002|Overall Study|Physician Decision|2|||
94546438|NCT01442064|323796422|FG003|Overall Study|Physician Decision|3|||
94546439|NCT01442064|323796423|FG004|Overall Study|Physician Decision|3|||
94546440|NCT01442064|323796424|FG005|Overall Study|Physician Decision|1|||
94546441|NCT01442064|323796419|FG000|Overall Study|Withdrawal by Subject|6|||
94546442|NCT01442064|323796420|FG001|Overall Study|Withdrawal by Subject|3|||
94546443|NCT01442064|323796421|FG002|Overall Study|Withdrawal by Subject|2|||
94546444|NCT01442064|323796422|FG003|Overall Study|Withdrawal by Subject|2|||
94546445|NCT01442064|323796423|FG004|Overall Study|Withdrawal by Subject|2|||
94546446|NCT01442064|323796424|FG005|Overall Study|Withdrawal by Subject|1|||
94546447|NCT01442064|323796419|FG000|Overall Study|Sponsor decision|82|||
94546448|NCT01442064|323796420|FG001|Overall Study|Sponsor decision|88|||
94546449|NCT01442064|323796421|FG002|Overall Study|Sponsor decision|92|||
94546450|NCT01442064|323796422|FG003|Overall Study|Sponsor decision|88|||
94546451|NCT01442064|323796423|FG004|Overall Study|Sponsor decision|95|||
94546452|NCT01442064|323796424|FG005|Overall Study|Sponsor decision|87|||
94546453|NCT01442064|323796419|FG000|Overall Study|Subject non-compliance|0|||
94546454|NCT01442064|323796420|FG001|Overall Study|Subject non-compliance|0|||
94546455|NCT01442064|323796421|FG002|Overall Study|Subject non-compliance|0|||
94546456|NCT01442064|323796422|FG003|Overall Study|Subject non-compliance|0|||
94546457|NCT01442064|323796423|FG004|Overall Study|Subject non-compliance|0|||
94546458|NCT01442064|323796424|FG005|Overall Study|Subject non-compliance|2|||
94546459|NCT01442064|323796419|FG000|Overall Study|Condition mandated other intervention|1|||
94546460|NCT01442064|323796420|FG001|Overall Study|Condition mandated other intervention|1|||
94546461|NCT01442064|323796421|FG002|Overall Study|Condition mandated other intervention|2|||
94546462|NCT01442064|323796422|FG003|Overall Study|Condition mandated other intervention|0|||
94546463|NCT01442064|323796423|FG004|Overall Study|Condition mandated other intervention|0|||
94546464|NCT01442064|323796424|FG005|Overall Study|Condition mandated other intervention|2|||
94546465|NCT03099148|323796425|FG000|Wash-out|scheduling conflict|0|||
94546466|NCT03099148|323796426|FG001|Wash-out|scheduling conflict|1|||
94546467|NCT03099148|323796427|FG002|Wash-out|scheduling conflict|0|||
94546468|NCT03099148|323796428|FG003|Wash-out|scheduling conflict|0|||
94546469|NCT03099148|323796425|FG000|Wash-out|Adverse Event|0|||
94546470|NCT03099148|323796426|FG001|Wash-out|Adverse Event|1|||
94546471|NCT03099148|323796427|FG002|Wash-out|Adverse Event|0|||
94546472|NCT03099148|323796428|FG003|Wash-out|Adverse Event|0|||
94546473|NCT01703065|323796429|FG000|Overall Study|Lack of Efficacy|1|||
94546474|NCT01703065|323796430|FG001|Overall Study|Lack of Efficacy|0|||
94546475|NCT03242018|323796431|FG000|Overall Study|Adverse Event|7|||
94546476|NCT03242018|323796432|FG001|Overall Study|Adverse Event|7|||
94546477|NCT03242018|323796433|FG002|Overall Study|Adverse Event|6|||
94546478|NCT03242018|323796431|FG000|Overall Study|Lost to Follow-up|2|||
94546479|NCT03242018|323796432|FG001|Overall Study|Lost to Follow-up|2|||
94546480|NCT03242018|323796433|FG002|Overall Study|Lost to Follow-up|2|||
94546481|NCT03242018|323796431|FG000|Overall Study|At the Participant's Own Request|5|||
94546482|NCT03242018|323796432|FG001|Overall Study|At the Participant's Own Request|1|||
94546483|NCT03242018|323796433|FG002|Overall Study|At the Participant's Own Request|4|||
94546484|NCT03242018|323796431|FG000|Overall Study|Reason Not Specified|3|||
94546485|NCT03242018|323796432|FG001|Overall Study|Reason Not Specified|4|||
94546486|NCT03242018|323796433|FG002|Overall Study|Reason Not Specified|1|||
94546487|NCT03242018|323796431|FG000|Overall Study|Study Terminated by Sponsor|1|||
94546488|NCT03242018|323796432|FG001|Overall Study|Study Terminated by Sponsor|0|||
94546489|NCT03242018|323796433|FG002|Overall Study|Study Terminated by Sponsor|1|||
94546490|NCT01617447|323796434|FG000|Overall Study|Adverse Event|0|||
94546491|NCT01617447|323796435|FG001|Overall Study|Adverse Event|1|||
94546492|NCT01617447|323796434|FG000|Overall Study|Physician Decision|0|||
94546493|NCT01617447|323796435|FG001|Overall Study|Physician Decision|2|||
94546494|NCT02713529|323796437|FG000|Overall Study|Withdrawal by Subject|3|||
94546495|NCT02713529|323796438|FG001|Overall Study|Withdrawal by Subject|1|||
94546496|NCT02713529|323796439|FG002|Overall Study|Withdrawal by Subject|4|||
94546497|NCT02713529|323796440|FG003|Overall Study|Withdrawal by Subject|2|||
94546498|NCT02713529|323796441|FG004|Overall Study|Withdrawal by Subject|0|||
94546499|NCT02713529|323796442|FG005|Overall Study|Withdrawal by Subject|1|||
94546500|NCT02713529|323796443|FG006|Overall Study|Withdrawal by Subject|1|||
94546501|NCT02713529|323796437|FG000|Overall Study|Lost to Follow-up|1|||
94546502|NCT02713529|323796438|FG001|Overall Study|Lost to Follow-up|0|||
94546503|NCT02713529|323796439|FG002|Overall Study|Lost to Follow-up|1|||
94546504|NCT02713529|323796440|FG003|Overall Study|Lost to Follow-up|0|||
94546505|NCT02713529|323796441|FG004|Overall Study|Lost to Follow-up|0|||
94546506|NCT02713529|323796442|FG005|Overall Study|Lost to Follow-up|0|||
94546507|NCT02713529|323796443|FG006|Overall Study|Lost to Follow-up|0|||
94546508|NCT02713529|323796437|FG000|Overall Study|Death|3|||
94546509|NCT02713529|323796438|FG001|Overall Study|Death|3|||
94546510|NCT02713529|323796439|FG002|Overall Study|Death|26|||
94546511|NCT02713529|323796440|FG003|Overall Study|Death|27|||
94546512|NCT02713529|323796441|FG004|Overall Study|Death|3|||
94546513|NCT02713529|323796442|FG005|Overall Study|Death|13|||
94546514|NCT02713529|323796443|FG006|Overall Study|Death|3|||
94546515|NCT00780273|323796444|FG000|Overall Study|Death|1|||
94546516|NCT00780273|323796444|FG000|Overall Study|Lost to Follow-up|1|||
94546517|NCT02576860|323796445|FG000|Overall Study|Adverse Event|6|||
94546518|NCT02576860|323796446|FG001|Overall Study|Adverse Event|6|||
94546519|NCT02576860|323796445|FG000|Overall Study|Lost to Follow-up|5|||
94546520|NCT02576860|323796446|FG001|Overall Study|Lost to Follow-up|7|||
94546521|NCT02576860|323796445|FG000|Overall Study|Physician Decision|0|||
94546522|NCT02576860|323796446|FG001|Overall Study|Physician Decision|1|||
94546523|NCT02576860|323796445|FG000|Overall Study|Protocol Violation|0|||
94546524|NCT02576860|323796446|FG001|Overall Study|Protocol Violation|2|||
94546525|NCT02576860|323796445|FG000|Overall Study|Withdrawal by Subject|13|||
94546526|NCT02576860|323796446|FG001|Overall Study|Withdrawal by Subject|8|||
94546527|NCT02576860|323796445|FG000|Overall Study|Disallowed medication|1|||
94546528|NCT02576860|323796446|FG001|Overall Study|Disallowed medication|0|||
94546529|NCT00477269|323796447|FG000|Core Study|Adverse Event|6|||
94546530|NCT00477269|323796448|FG001|Core Study|Adverse Event|4|||
94546531|NCT00477269|323796449|FG002|Core Study|Adverse Event|0|||
94546532|NCT00477269|323796447|FG000|Core Study|Death|3|||
94546533|NCT00477269|323796448|FG001|Core Study|Death|3|||
94546534|NCT00477269|323796449|FG002|Core Study|Death|0|||
94546535|NCT00477269|323796447|FG000|Core Study|Withdrawn Consent|0|||
94546536|NCT00477269|323796448|FG001|Core Study|Withdrawn Consent|1|||
94546537|NCT00477269|323796449|FG002|Core Study|Withdrawn Consent|0|||
94546538|NCT00477269|323796447|FG000|Open Label Extension|Adverse Event|0|||
94546539|NCT00477269|323796448|FG001|Open Label Extension|Adverse Event|0|||
94546540|NCT00477269|323796449|FG002|Open Label Extension|Adverse Event|4|||
94546541|NCT00477269|323796447|FG000|Open Label Extension|Abnormal laboratory values|0|||
94546542|NCT00477269|323796448|FG001|Open Label Extension|Abnormal laboratory values|0|||
94546543|NCT00477269|323796449|FG002|Open Label Extension|Abnormal laboratory values|1|||
94546544|NCT00477269|323796447|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
94546545|NCT00477269|323796448|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
94546546|NCT00477269|323796449|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
94546547|NCT00477269|323796447|FG000|Open Label Extension|Adminiatrative problems|0|||
94546548|NCT00477269|323796448|FG001|Open Label Extension|Adminiatrative problems|0|||
94546549|NCT00477269|323796449|FG002|Open Label Extension|Adminiatrative problems|2|||
94546550|NCT00477269|323796447|FG000|Open Label Extension|Death|0|||
94546551|NCT00477269|323796448|FG001|Open Label Extension|Death|0|||
94546552|NCT00477269|323796449|FG002|Open Label Extension|Death|4|||
94546553|NCT00514020|323796450|FG000|Overall Study|Adverse Event|6|||
94546554|NCT00514020|323796450|FG000|Overall Study|Withdrawal by Subject|3|||
94546555|NCT00514020|323796450|FG000|Overall Study|Physician Decision|1|||
94546556|NCT00514020|323796450|FG000|Overall Study|disease progression|9|||
94546557|NCT00514020|323796450|FG000|Overall Study|other complicating disease|2|||
94546558|NCT00514020|323796450|FG000|Overall Study|patient went to radiation treatment|1|||
94546559|NCT00514020|323796450|FG000|Overall Study|"patients moved to the no tx group"|6|||
94546560|NCT01541917|323796453|FG000|Overall Study|Lost to Follow-up|2|||
94546561|NCT01541917|323796454|FG001|Overall Study|Lost to Follow-up|2|||
94546562|NCT01541917|323796453|FG000|Overall Study|Withdrawal by Subject|13|||
94546563|NCT01541917|323796454|FG001|Overall Study|Withdrawal by Subject|7|||
94546564|NCT03263780|323796455|FG000|Overall Study|Withdrawal by Subject|3|||
94546565|NCT03263780|323796455|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
94546566|NCT02449018|323796463|FG000|Overall Study|Abnormal laboratory value|0|||
94546567|NCT02449018|323796464|FG001|Overall Study|Abnormal laboratory value|1|||
94546568|NCT02449018|323796463|FG000|Overall Study|Administrative problems|1|||
94546569|NCT02449018|323796464|FG001|Overall Study|Administrative problems|0|||
94546570|NCT02449018|323796463|FG000|Overall Study|Adverse Event|5|||
94546571|NCT02449018|323796464|FG001|Overall Study|Adverse Event|1|||
94546572|NCT02449018|323796463|FG000|Overall Study|Protocol deviation|4|||
94546573|NCT02449018|323796464|FG001|Overall Study|Protocol deviation|0|||
94546574|NCT02449018|323796463|FG000|Overall Study|Patient decision|2|||
94546575|NCT02449018|323796464|FG001|Overall Study|Patient decision|0|||
94546576|NCT02383433|323796496|FG000|Overall Study|Disease progression|2|||
94546577|NCT02920957|323796497|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
94546578|NCT02920957|323796498|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
94546579|NCT02920957|323796497|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
94546580|NCT02920957|323796498|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
94546581|NCT02920957|323796497|FG000|First Intervention : 1 Month|Adverse Event|1|||
94546582|NCT02920957|323796498|FG001|First Intervention : 1 Month|Adverse Event|0|||
94546583|NCT02920957|323796497|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
94546584|NCT02920957|323796498|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
94546585|NCT00031460|323797974|FG000|Overall Study|Lost to Follow-up|0|||
94546586|NCT00031460|323797975|FG001|Overall Study|Lost to Follow-up|1|||
94546587|NCT00031460|323797974|FG000|Overall Study|Withdrawal by Subject|1|||
94546588|NCT00031460|323797975|FG001|Overall Study|Withdrawal by Subject|1|||
94546589|NCT00031460|323797974|FG000|Overall Study|Non-Compliant|1|||
94546590|NCT00031460|323797975|FG001|Overall Study|Non-Compliant|1|||
94546591|NCT00031460|323797974|FG000|Overall Study|Death|0|||
94546592|NCT00031460|323797975|FG001|Overall Study|Death|1|||
94546593|NCT00031460|323797974|FG000|Overall Study|Reactivation of Disease|5|||
94546594|NCT00031460|323797975|FG001|Overall Study|Reactivation of Disease|9|||
94546595|NCT00031460|323797974|FG000|Overall Study|Disruption of blinded drug supply|2|||
94546596|NCT00031460|323797975|FG001|Overall Study|Disruption of blinded drug supply|0|||
94546597|NCT00031460|323797974|FG000|Overall Study|Confirmed unevaluable|0|||
94546598|NCT00031460|323797975|FG001|Overall Study|Confirmed unevaluable|1|||
94546599|NCT03204890|323797980|FG000|Overall Study|Withdrawal by Subject|1|||
94546600|NCT03710876|323797981|FG000|Overall Study|Death|0|||
94546601|NCT03710876|323797982|FG001|Overall Study|Death|2|||
94546602|NCT03710876|323797981|FG000|Overall Study|Withdrawal by Subject|0|||
94546603|NCT03710876|323797982|FG001|Overall Study|Withdrawal by Subject|2|||
94546604|NCT01596335|323797983|FG000|Overall Study|exacerbation of primary disease|5|||
94546605|NCT01596335|323797984|FG001|Overall Study|exacerbation of primary disease|9|||
94546606|NCT01688739|323797985|FG000|Overall Study|Administrative Decision|1|||
94546607|NCT01688739|323797986|FG001|Overall Study|Administrative Decision|0|||
94546608|NCT01688739|323797987|FG002|Overall Study|Administrative Decision|0|||
94546609|NCT01688739|323797988|FG003|Overall Study|Administrative Decision|0|||
94546610|NCT01688739|323797989|FG004|Overall Study|Administrative Decision|0|||
94546611|NCT01688739|323797990|FG005|Overall Study|Administrative Decision|0|||
94546612|NCT01688739|323797991|FG006|Overall Study|Administrative Decision|0|||
94546613|NCT01688739|323797992|FG007|Overall Study|Administrative Decision|0|||
94546614|NCT01688739|323797993|FG008|Overall Study|Administrative Decision|0|||
94546615|NCT01688739|323797994|FG009|Overall Study|Administrative Decision|0|||
94546616|NCT02804750|323798001|FG000|Period 1|Adverse Event|0|||
94546617|NCT02804750|323798002|FG001|Period 1|Adverse Event|2|||
94546618|NCT02804750|323798001|FG000|Period 1|Withdrawal by Subject|0|||
94546619|NCT02804750|323798002|FG001|Period 1|Withdrawal by Subject|1|||
94546620|NCT02804750|323798001|FG000|Period 2|Adverse Event|1|||
94546621|NCT02804750|323798002|FG001|Period 2|Adverse Event|0|||
94546622|NCT02804750|323798001|FG000|Period 3|Adverse Event|0|||
94546623|NCT02804750|323798002|FG001|Period 3|Adverse Event|2|||
94546624|NCT02804750|323798001|FG000|Period 4|Adverse Event|0|||
94546625|NCT02804750|323798002|FG001|Period 4|Adverse Event|5|||
94546626|NCT02559414|323798003|FG000|Overall Study|Lost to Follow-up|0|||
94546627|NCT02559414|323798004|FG001|Overall Study|Lost to Follow-up|1|||
94546628|NCT02559414|323798005|FG002|Overall Study|Lost to Follow-up|0|||
94546629|NCT02559414|323798003|FG000|Overall Study|Withdrawal by Subject|1|||
94546630|NCT02559414|323798004|FG001|Overall Study|Withdrawal by Subject|0|||
94546631|NCT02559414|323798005|FG002|Overall Study|Withdrawal by Subject|1|||
94546632|NCT02559414|323798003|FG000|Overall Study|Other|0|||
94546633|NCT02559414|323798004|FG001|Overall Study|Other|1|||
94546634|NCT02559414|323798005|FG002|Overall Study|Other|1|||
94546635|NCT03369431|323798008|FG000|Overall Study|Lost to Follow-up|1|||
94546636|NCT03369431|323798009|FG001|Overall Study|Lost to Follow-up|3|||
94546637|NCT03369431|323798008|FG000|Overall Study|Withdrawal by Subject|2|||
94546638|NCT03369431|323798009|FG001|Overall Study|Withdrawal by Subject|3|||
94546639|NCT03369431|323798008|FG000|Overall Study|Protocol Violation|1|||
94546640|NCT03369431|323798009|FG001|Overall Study|Protocol Violation|1|||
94546641|NCT01062061|323798014|FG000|Overall Study|Enrolled more than once|2|||
94546642|NCT01062061|323798014|FG000|Overall Study|Investigated before study start|13|||
94546643|NCT01062061|323798014|FG000|Overall Study|Outside chief indications|10|||
94546644|NCT01062061|323798014|FG000|Overall Study|Failed to meet inclusion criteria|2|||
94546645|NCT02351349|323798022|FG000|Overall Study|Withdrawal by Subject|2|||
94546646|NCT02351349|323798023|FG001|Overall Study|Withdrawal by Subject|3|||
94546647|NCT02936284|323798024|FG000|Overall Study|Withdrawal by Subject|3|||
94546648|NCT02936284|323798025|FG001|Overall Study|Withdrawal by Subject|1|||
94546649|NCT02936284|323798024|FG000|Overall Study|Lost to Follow-up|7|||
94546650|NCT02936284|323798025|FG001|Overall Study|Lost to Follow-up|8|||
94546651|NCT02046070|323798032|FG000|Overall Study|Progressive Disease|18|||
94546652|NCT02046070|323798033|FG001|Overall Study|Progressive Disease|11|||
94546653|NCT02046070|323798034|FG002|Overall Study|Progressive Disease|40|||
94546654|NCT02046070|323798032|FG000|Overall Study|Adverse Event|8|||
94546655|NCT02046070|323798033|FG001|Overall Study|Adverse Event|10|||
94546656|NCT02046070|323798034|FG002|Overall Study|Adverse Event|17|||
94546657|NCT02046070|323798032|FG000|Overall Study|Withdrawal by Subject|1|||
94546658|NCT02046070|323798033|FG001|Overall Study|Withdrawal by Subject|2|||
94546659|NCT02046070|323798034|FG002|Overall Study|Withdrawal by Subject|6|||
94546660|NCT02046070|323798032|FG000|Overall Study|Study Terminated by Sponsor|1|||
94546661|NCT02046070|323798033|FG001|Overall Study|Study Terminated by Sponsor|1|||
94546662|NCT02046070|323798034|FG002|Overall Study|Study Terminated by Sponsor|1|||
94546663|NCT02046070|323798032|FG000|Overall Study|Reason not Specified|4|||
94546664|NCT02046070|323798033|FG001|Overall Study|Reason not Specified|4|||
94546665|NCT02046070|323798034|FG002|Overall Study|Reason not Specified|6|||
94546666|NCT00799591|323798035|FG000|Overall Study|De-escalation of doses|20|||
94546667|NCT00799591|323798035|FG000|Overall Study|Death|14|||
94546668|NCT00799591|323798035|FG000|Overall Study|Technical failure|12|||
94546669|NCT00799591|323798035|FG000|Overall Study|Resistant germ|11|||
94546670|NCT00799591|323798035|FG000|Overall Study|New infection|4|||
94546671|NCT00799591|323798035|FG000|Overall Study|Resistance germ and technical failure|2|||
94546672|NCT00799591|323798035|FG000|Overall Study|Persistance of fever undetermined origin|1|||
94546673|NCT00799591|323798035|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
94546674|NCT00799591|323798035|FG000|Overall Study|Infectious origin not probable|1|||
94546675|NCT04284813|323798037|FG000|Overall Study|Withdrawal by Subject|1|||
94546676|NCT01300351|323798038|FG000|Overall Study|Did not receive treatment|2|||
94546677|NCT01300351|323798039|FG001|Overall Study|Did not receive treatment|0|||
94546678|NCT01300351|323798038|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
94546679|NCT01300351|323798039|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
94546680|NCT01300351|323798038|FG000|Overall Study|Lost to Follow-up|0|||
94546681|NCT01300351|323798039|FG001|Overall Study|Lost to Follow-up|1|||
94546682|NCT01300351|323798038|FG000|Overall Study|Adverse Event|0|||
94546683|NCT01300351|323798039|FG001|Overall Study|Adverse Event|4|||
94546684|NCT01300351|323798038|FG000|Overall Study|Withdrawal by Subject|7|||
94546685|NCT01300351|323798039|FG001|Overall Study|Withdrawal by Subject|10|||
94546686|NCT02677844|323798041|FG000|Period 3|Withdrawal by Subject|0|||
94546687|NCT02677844|323798042|FG001|Period 3|Withdrawal by Subject|0|||
94546688|NCT02677844|323798043|FG002|Period 3|Withdrawal by Subject|0|||
94546689|NCT02677844|323798044|FG003|Period 3|Withdrawal by Subject|1|||
94546690|NCT02677844|323798045|FG004|Period 3|Withdrawal by Subject|0|||
94546691|NCT02677844|323798046|FG005|Period 3|Withdrawal by Subject|0|||
94546692|NCT02677844|323798047|FG006|Period 3|Withdrawal by Subject|0|||
94546693|NCT00096018|323798048|FG000|Overall Study|Became Ineligible (not treated)|0|||
94546694|NCT00096018|323798049|FG001|Overall Study|Became Ineligible (not treated)|3|||
94546695|NCT00096018|323798048|FG000|Overall Study|Miscellaneous (not treated)|0|||
94546696|NCT00096018|323798049|FG001|Overall Study|Miscellaneous (not treated)|2|||
94546697|NCT00096018|323798048|FG000|Overall Study|Adverse Event|0|||
94546698|NCT00096018|323798049|FG001|Overall Study|Adverse Event|5|||
94546699|NCT00096018|323798048|FG000|Overall Study|Death|0|||
94546700|NCT00096018|323798049|FG001|Overall Study|Death|1|||
94546701|NCT00096018|323798048|FG000|Overall Study|Withdrawal by Subject|0|||
94546702|NCT00096018|323798049|FG001|Overall Study|Withdrawal by Subject|2|||
94546703|NCT00096018|323798048|FG000|Overall Study|Miscellaneous|2|||
94546704|NCT00096018|323798049|FG001|Overall Study|Miscellaneous|1|||
94546705|NCT02989805|323798050|FG000|Overall Study|invalid consent|6|||
94546706|NCT02989805|323798051|FG001|Overall Study|invalid consent|4|||
94546707|NCT00907296|323798052|FG000|Overall Study|Ineligibility Determined|1|||
94546708|NCT00907296|323798053|FG001|Overall Study|Ineligibility Determined|0|||
94546709|NCT00907296|323798054|FG002|Overall Study|Ineligibility Determined|0|||
94546710|NCT00907296|323798055|FG003|Overall Study|Ineligibility Determined|1|||
94546711|NCT00907296|323798056|FG004|Overall Study|Ineligibility Determined|0|||
94546712|NCT00907296|323798057|FG005|Overall Study|Ineligibility Determined|0|||
94546713|NCT00907296|323798058|FG006|Overall Study|Ineligibility Determined|0|||
94546714|NCT00907296|323798059|FG007|Overall Study|Ineligibility Determined|1|||
94546715|NCT00907296|323798060|FG008|Overall Study|Ineligibility Determined|0|||
94546716|NCT00907296|323798061|FG009|Overall Study|Ineligibility Determined|0|||
94546717|NCT00907296|323798052|FG000|Overall Study|Protocol Deviation|0|||
94546718|NCT00907296|323798053|FG001|Overall Study|Protocol Deviation|1|||
94546719|NCT00907296|323798054|FG002|Overall Study|Protocol Deviation|0|||
94546720|NCT00907296|323798055|FG003|Overall Study|Protocol Deviation|0|||
94546721|NCT00907296|323798056|FG004|Overall Study|Protocol Deviation|0|||
94546722|NCT00907296|323798057|FG005|Overall Study|Protocol Deviation|0|||
94546723|NCT00907296|323798058|FG006|Overall Study|Protocol Deviation|0|||
94546724|NCT00907296|323798059|FG007|Overall Study|Protocol Deviation|0|||
94546725|NCT00907296|323798060|FG008|Overall Study|Protocol Deviation|0|||
94546726|NCT00907296|323798061|FG009|Overall Study|Protocol Deviation|0|||
94546727|NCT00907296|323798052|FG000|Overall Study|Noncompliance|1|||
94546728|NCT00907296|323798053|FG001|Overall Study|Noncompliance|1|||
94546729|NCT00907296|323798054|FG002|Overall Study|Noncompliance|1|||
94546730|NCT00907296|323798055|FG003|Overall Study|Noncompliance|0|||
94546731|NCT00907296|323798056|FG004|Overall Study|Noncompliance|0|||
94546732|NCT00907296|323798057|FG005|Overall Study|Noncompliance|1|||
94546733|NCT00907296|323798058|FG006|Overall Study|Noncompliance|0|||
94546734|NCT00907296|323798059|FG007|Overall Study|Noncompliance|2|||
94546735|NCT00907296|323798060|FG008|Overall Study|Noncompliance|0|||
94546736|NCT00907296|323798061|FG009|Overall Study|Noncompliance|0|||
94546737|NCT00907296|323798052|FG000|Overall Study|Adverse Event|2|||
94546738|NCT00907296|323798053|FG001|Overall Study|Adverse Event|0|||
94546739|NCT00907296|323798054|FG002|Overall Study|Adverse Event|0|||
94546740|NCT00907296|323798055|FG003|Overall Study|Adverse Event|0|||
94546741|NCT00907296|323798056|FG004|Overall Study|Adverse Event|0|||
94546742|NCT00907296|323798057|FG005|Overall Study|Adverse Event|0|||
94546743|NCT00907296|323798058|FG006|Overall Study|Adverse Event|1|||
94546744|NCT00907296|323798059|FG007|Overall Study|Adverse Event|0|||
94546745|NCT00907296|323798060|FG008|Overall Study|Adverse Event|0|||
94546746|NCT00907296|323798061|FG009|Overall Study|Adverse Event|1|||
94546747|NCT00907296|323798052|FG000|Overall Study|Withdrawal by Subject|7|||
94546748|NCT00907296|323798053|FG001|Overall Study|Withdrawal by Subject|2|||
94546749|NCT00907296|323798054|FG002|Overall Study|Withdrawal by Subject|1|||
94546750|NCT00907296|323798055|FG003|Overall Study|Withdrawal by Subject|1|||
94546751|NCT00907296|323798056|FG004|Overall Study|Withdrawal by Subject|1|||
94546752|NCT00907296|323798057|FG005|Overall Study|Withdrawal by Subject|5|||
94546753|NCT00907296|323798058|FG006|Overall Study|Withdrawal by Subject|3|||
94546754|NCT00907296|323798059|FG007|Overall Study|Withdrawal by Subject|2|||
94546755|NCT00907296|323798060|FG008|Overall Study|Withdrawal by Subject|4|||
94546756|NCT00907296|323798061|FG009|Overall Study|Withdrawal by Subject|2|||
94546757|NCT00907296|323798052|FG000|Overall Study|Lost to Follow-up|9|||
94546758|NCT00907296|323798053|FG001|Overall Study|Lost to Follow-up|1|||
94546759|NCT00907296|323798054|FG002|Overall Study|Lost to Follow-up|0|||
94546760|NCT00907296|323798055|FG003|Overall Study|Lost to Follow-up|2|||
94546761|NCT00907296|323798056|FG004|Overall Study|Lost to Follow-up|0|||
94546762|NCT00907296|323798057|FG005|Overall Study|Lost to Follow-up|3|||
94546763|NCT00907296|323798058|FG006|Overall Study|Lost to Follow-up|2|||
94546764|NCT00907296|323798059|FG007|Overall Study|Lost to Follow-up|2|||
94546765|NCT00907296|323798060|FG008|Overall Study|Lost to Follow-up|0|||
94546766|NCT00907296|323798061|FG009|Overall Study|Lost to Follow-up|4|||
94546767|NCT00357656|323798062|FG000|Overall Study|Other, No surgery performed|0|||
94546768|NCT00357656|323798063|FG001|Overall Study|Other, No surgery performed|3|||
94546769|NCT01814670|323798065|FG000|Overall Study|Protocol Violation|12|||
94546770|NCT01565941|323798066|FG000|Overall Study|Withdrawn by parent/guardian|3|||
94546771|NCT01565941|323798067|FG001|Overall Study|Withdrawn by parent/guardian|2|||
94546772|NCT01565941|323798066|FG000|Overall Study|Randomized; did not receive intevention|8|||
94546773|NCT01565941|323798067|FG001|Overall Study|Randomized; did not receive intevention|2|||
94546774|NCT04047420|323798068|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
94546775|NCT04047420|323798068|FG000|Washout Period|Refused Participation|2|||
94546776|NCT01439126|323798071|FG000|Overall Study|Adverse Event|2|||
94546777|NCT01439126|323798072|FG001|Overall Study|Adverse Event|0|||
94546778|NCT01439126|323798071|FG000|Overall Study|Withdrawal by Subject|5|||
94546779|NCT01439126|323798072|FG001|Overall Study|Withdrawal by Subject|21|||
94546780|NCT01439126|323798071|FG000|Overall Study|Protocol Violation|6|||
94546781|NCT01439126|323798072|FG001|Overall Study|Protocol Violation|4|||
94546782|NCT01439126|323798071|FG000|Overall Study|Lost to Follow-up|6|||
94546783|NCT01439126|323798072|FG001|Overall Study|Lost to Follow-up|3|||
94546784|NCT01439126|323798071|FG000|Overall Study|Other-Use of prohibited treatment|0|||
94546785|NCT01439126|323798072|FG001|Overall Study|Other-Use of prohibited treatment|2|||
94546786|NCT01439126|323798071|FG000|Overall Study|Other-Miscellaneous|12|||
94546787|NCT01439126|323798072|FG001|Overall Study|Other-Miscellaneous|12|||
94546788|NCT03262116|323798074|FG000|Overall Study|Physician Decision|0|||
94546789|NCT03262116|323798075|FG001|Overall Study|Physician Decision|2|||
94546790|NCT03262116|323798076|FG002|Overall Study|Physician Decision|1|||
94546791|NCT03262116|323798077|FG003|Overall Study|Physician Decision|1|||
94546792|NCT03262116|323798078|FG004|Overall Study|Physician Decision|1|||
94546793|NCT03262116|323798079|FG005|Overall Study|Physician Decision|2|||
94546794|NCT00490022|323798080|FG000|Overall Study|Adverse Event|0|||
94546795|NCT00490022|323798081|FG001|Overall Study|Adverse Event|2|||
94546796|NCT00490022|323798080|FG000|Overall Study|Withdrawal by Subject|1|||
94546797|NCT00490022|323798081|FG001|Overall Study|Withdrawal by Subject|0|||
94546798|NCT00490022|323798080|FG000|Overall Study|Subject failed to disclose concommitant|0|||
94546799|NCT00490022|323798081|FG001|Overall Study|Subject failed to disclose concommitant|1|||
94546800|NCT03426631|323798082|FG000|Overall Study|Lost to Follow-up|0|||
94546801|NCT03426631|323798083|FG001|Overall Study|Lost to Follow-up|1|||
94546802|NCT03831945|323798084|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
94546803|NCT03831945|323798085|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
94546804|NCT03831945|323798084|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
94546805|NCT03831945|323798085|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
94546806|NCT03831945|323798084|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
94546807|NCT03831945|323798085|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
94546808|NCT00806442|323798087|FG000|Overall Study|Lost to Follow-up|3|||
94546809|NCT00806442|323798088|FG001|Overall Study|Lost to Follow-up|2|||
94546810|NCT00806442|323798087|FG000|Overall Study|Withdrawal by Subject|1|||
94546811|NCT00806442|323798088|FG001|Overall Study|Withdrawal by Subject|5|||
94546812|NCT00654004|323798095|FG000|Overall Study|Lost to Follow-up|1|||
94546813|NCT00654004|323798096|FG001|Overall Study|Lost to Follow-up|0|||
94546814|NCT01264770|323798100|FG000|Overall Study|Not reported|0|||
94546815|NCT01264770|323798101|FG001|Overall Study|Not reported|0|||
94546816|NCT01264770|323798102|FG002|Overall Study|Not reported|1|||
94546817|NCT01264770|323798103|FG003|Overall Study|Not reported|0|||
94546818|NCT01264770|323798104|FG004|Overall Study|Not reported|0|||
94546819|NCT01264770|323798105|FG005|Overall Study|Not reported|0|||
94546820|NCT01264770|323798100|FG000|Overall Study|e.g., change in circumstances|8|||
94546821|NCT01264770|323798101|FG001|Overall Study|e.g., change in circumstances|3|||
94546822|NCT01264770|323798102|FG002|Overall Study|e.g., change in circumstances|3|||
94546823|NCT01264770|323798103|FG003|Overall Study|e.g., change in circumstances|3|||
94546824|NCT01264770|323798104|FG004|Overall Study|e.g., change in circumstances|4|||
94546825|NCT01264770|323798105|FG005|Overall Study|e.g., change in circumstances|4|||
94546826|NCT01264770|323798100|FG000|Overall Study|Severe non-compliance to protocol|0|||
94546827|NCT01264770|323798101|FG001|Overall Study|Severe non-compliance to protocol|0|||
94546828|NCT01264770|323798102|FG002|Overall Study|Severe non-compliance to protocol|1|||
94546829|NCT01264770|323798103|FG003|Overall Study|Severe non-compliance to protocol|1|||
94546830|NCT01264770|323798104|FG004|Overall Study|Severe non-compliance to protocol|0|||
94546831|NCT01264770|323798105|FG005|Overall Study|Severe non-compliance to protocol|0|||
94546832|NCT01264770|323798100|FG000|Overall Study|Lack of therapeutic response|1|||
94546833|NCT01264770|323798101|FG001|Overall Study|Lack of therapeutic response|0|||
94546834|NCT01264770|323798102|FG002|Overall Study|Lack of therapeutic response|2|||
94546835|NCT01264770|323798103|FG003|Overall Study|Lack of therapeutic response|1|||
94546836|NCT01264770|323798104|FG004|Overall Study|Lack of therapeutic response|1|||
94546837|NCT01264770|323798105|FG005|Overall Study|Lack of therapeutic response|0|||
94546838|NCT01264770|323798100|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
94546839|NCT01264770|323798101|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
94546840|NCT01264770|323798102|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
94546841|NCT01264770|323798103|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
94546842|NCT01264770|323798104|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
94546843|NCT01264770|323798105|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
94546844|NCT01264770|323798100|FG000|Overall Study|Lost to Follow-up|0|||
94546845|NCT01264770|323798101|FG001|Overall Study|Lost to Follow-up|0|||
94546846|NCT01264770|323798102|FG002|Overall Study|Lost to Follow-up|1|||
94546847|NCT01264770|323798103|FG003|Overall Study|Lost to Follow-up|1|||
94546848|NCT01264770|323798104|FG004|Overall Study|Lost to Follow-up|0|||
94546849|NCT01264770|323798105|FG005|Overall Study|Lost to Follow-up|0|||
94546850|NCT01264770|323798100|FG000|Overall Study|Adverse Event|7|||
94546851|NCT01264770|323798101|FG001|Overall Study|Adverse Event|7|||
94546852|NCT01264770|323798102|FG002|Overall Study|Adverse Event|8|||
94546853|NCT01264770|323798103|FG003|Overall Study|Adverse Event|0|||
94546854|NCT01264770|323798104|FG004|Overall Study|Adverse Event|2|||
94546855|NCT01264770|323798105|FG005|Overall Study|Adverse Event|1|||
94546856|NCT03332160|323798114|FG000|Overall Study|Withdrawal by Subject|1|||
94546857|NCT03332160|323798115|FG001|Overall Study|Withdrawal by Subject|1|||
94546858|NCT03332160|323798114|FG000|Overall Study|Adverse Event|0|||
94546859|NCT03332160|323798115|FG001|Overall Study|Adverse Event|1|||
94546860|NCT03332160|323798114|FG000|Overall Study|Developed Exclusion Criteria|0|||
94546861|NCT03332160|323798115|FG001|Overall Study|Developed Exclusion Criteria|1|||
94546862|NCT03332160|323798114|FG000|Overall Study|Non-adherence to treatment|0|||
94546863|NCT03332160|323798115|FG001|Overall Study|Non-adherence to treatment|2|||
94546864|NCT02598128|323798116|FG000|Period A: Days -7 to -1|Adverse Event|1|||
94546865|NCT02598128|323798117|FG001|Period A: Days -7 to -1|Adverse Event|0|||
94546866|NCT02598128|323798118|FG002|Period A: Days -7 to -1|Adverse Event|0|||
94546867|NCT02598128|323798119|FG003|Period A: Days -7 to -1|Adverse Event|0|||
94546868|NCT05219669|323798120|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
94546869|NCT05219669|323798121|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
94546870|NCT05219669|323798122|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
94546871|NCT05219669|323798123|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
94546872|NCT05219669|323798124|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
94546873|NCT05219669|323798125|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
94546874|NCT01839656|323798126|FG000|Overall Study|Withdrawal by Subject|1|||
94546875|NCT01839656|323798127|FG001|Overall Study|Withdrawal by Subject|1|||
94546876|NCT01839656|323798126|FG000|Overall Study|Adverse event, serious fatal|1|||
94546877|NCT01839656|323798127|FG001|Overall Study|Adverse event, serious fatal|4|||
94546878|NCT01839656|323798126|FG000|Overall Study|Early study closure|0|||
94546879|NCT01839656|323798127|FG001|Overall Study|Early study closure|11|||
94546880|NCT01839656|323798126|FG000|Overall Study|Adverse Event|1|||
94546881|NCT01839656|323798127|FG001|Overall Study|Adverse Event|0|||
94546882|NCT01595581|323798128|FG000|Overall Study|Withdrawal by Subject|1|||
94546883|NCT01595581|323798129|FG001|Overall Study|Withdrawal by Subject|0|||
94546884|NCT02621073|323798130|FG000|Overall Study|Lost to Follow-up|0|||
94546885|NCT02621073|323798131|FG001|Overall Study|Lost to Follow-up|1|||
94546886|NCT02621073|323798130|FG000|Overall Study|Physician Decision|3|||
94546887|NCT02621073|323798131|FG001|Overall Study|Physician Decision|2|||
94546888|NCT01711866|323798134|FG000|Overall Study|Noncompliant|3|||
94546889|NCT01711866|323798134|FG000|Overall Study|Withdrawal by Subject|3|||
94546890|NCT01711866|323798134|FG000|Overall Study|Adverse Event|2|||
94546891|NCT01291277|323798135|FG000|Overall Study|Death|2|||
94546892|NCT01291277|323798136|FG001|Overall Study|Death|2|||
94546893|NCT01291277|323798135|FG000|Overall Study|Lost to Follow-up|3|||
94546894|NCT01291277|323798136|FG001|Overall Study|Lost to Follow-up|1|||
94546895|NCT01831817|323798137|FG000|Overall Study|Lost to Follow-up|1|||
94546896|NCT01831817|323798138|FG001|Overall Study|Lost to Follow-up|0|||
94546897|NCT01831817|323798139|FG002|Overall Study|Lost to Follow-up|0|||
94546898|NCT01831817|323798140|FG003|Overall Study|Lost to Follow-up|0|||
94546899|NCT01831817|323798137|FG000|Overall Study|Withdrawl of Consent|3|||
94546900|NCT01831817|323798138|FG001|Overall Study|Withdrawl of Consent|0|||
94546901|NCT01831817|323798139|FG002|Overall Study|Withdrawl of Consent|0|||
94546902|NCT01831817|323798140|FG003|Overall Study|Withdrawl of Consent|0|||
94546903|NCT00447122|323798145|FG000|Overall Study|worsening medical condition -came off|0|||
94546904|NCT00447122|323798146|FG001|Overall Study|worsening medical condition -came off|1|||
94546905|NCT00447122|323798147|FG002|Overall Study|worsening medical condition -came off|0|||
94546906|NCT00447122|323798148|FG003|Overall Study|worsening medical condition -came off|0|||
94546907|NCT05275582|323799447|FG000|Overall Study|Lost to Follow-up|1|||
94546908|NCT05275582|323799448|FG001|Overall Study|Lost to Follow-up|0|||
94546909|NCT05275582|323799447|FG000|Overall Study|Withdrawal by Subject|0|||
94546910|NCT05275582|323799448|FG001|Overall Study|Withdrawal by Subject|2|||
94546911|NCT05275582|323799447|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
94546912|NCT05275582|323799448|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
94546913|NCT05275582|323799447|FG000|Overall Study|Death|1|||
94546914|NCT05275582|323799448|FG001|Overall Study|Death|0|||
94546915|NCT05275582|323799447|FG000|Overall Study|Protocol Violation|1|||
94546916|NCT05275582|323799448|FG001|Overall Study|Protocol Violation|0|||
94546917|NCT04938037|323799450|FG000|Overall Study|Lost to Follow-up|4|||
94546918|NCT04938037|323799451|FG001|Overall Study|Lost to Follow-up|3|||
94546919|NCT03323736|323799454|FG000|Overall Study|Screen Failure|14|||
94546920|NCT03323736|323799455|FG001|Overall Study|Screen Failure|9|||
94546921|NCT03323736|323799456|FG002|Overall Study|Screen Failure|1|||
94546922|NCT03323736|323799454|FG000|Overall Study|Withdrawal Before Treatment|3|||
94546923|NCT03323736|323799455|FG001|Overall Study|Withdrawal Before Treatment|1|||
94546924|NCT03323736|323799456|FG002|Overall Study|Withdrawal Before Treatment|1|||
94546925|NCT03323736|323799454|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
94546926|NCT03323736|323799455|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
94546927|NCT03323736|323799456|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
94546928|NCT01806064|323799457|FG000|Overall Study|Randomized Not Enrolled|0|||
94546929|NCT01806064|323799458|FG001|Overall Study|Randomized Not Enrolled|0|||
94546930|NCT01806064|323799459|FG002|Overall Study|Randomized Not Enrolled|0|||
94546931|NCT01806064|323799460|FG003|Overall Study|Randomized Not Enrolled|1|||
94546932|NCT01806064|323799461|FG004|Overall Study|Randomized Not Enrolled|2|||
94546933|NCT02210832|323799462|FG000|Overall Study|Pregnancy termination .|3|||
94546934|NCT02210832|323799463|FG001|Overall Study|Pregnancy termination .|4|||
94546935|NCT02210832|323799464|FG002|Overall Study|Pregnancy termination .|1|||
94546936|NCT02210832|323799462|FG000|Overall Study|Lost to Follow-up|26|||
94546937|NCT02210832|323799463|FG001|Overall Study|Lost to Follow-up|32|||
94546938|NCT02210832|323799464|FG002|Overall Study|Lost to Follow-up|17|||
94546939|NCT04524455|323799468|FG000|Overall Study|Death|3|||
94546940|NCT04524455|323799469|FG001|Overall Study|Death|3|||
94546941|NCT04524455|323799468|FG000|Overall Study|Decision by Sponsor|0|||
94546942|NCT04524455|323799469|FG001|Overall Study|Decision by Sponsor|2|||
94546943|NCT04524455|323799468|FG000|Overall Study|Withdrawal of Consent From Study|1|||
94546944|NCT04524455|323799469|FG001|Overall Study|Withdrawal of Consent From Study|0|||
94546945|NCT04524455|323799468|FG000|Overall Study|Lost to Follow-up|0|||
94546946|NCT04524455|323799469|FG001|Overall Study|Lost to Follow-up|1|||
94546947|NCT00996801|323799470|FG000|Overall Study|Adverse Event|6|||
94546948|NCT00996801|323799471|FG001|Overall Study|Adverse Event|4|||
94546949|NCT00996801|323799472|FG002|Overall Study|Adverse Event|12|||
94546950|NCT00996801|323799473|FG003|Overall Study|Adverse Event|17|||
94546951|NCT00996801|323799474|FG004|Overall Study|Adverse Event|31|||
94546952|NCT00996801|323799475|FG005|Overall Study|Adverse Event|3|||
94546953|NCT00996801|323799470|FG000|Overall Study|Lack of Efficacy|3|||
94546954|NCT00996801|323799471|FG001|Overall Study|Lack of Efficacy|0|||
94546955|NCT00996801|323799472|FG002|Overall Study|Lack of Efficacy|1|||
94546956|NCT00996801|323799473|FG003|Overall Study|Lack of Efficacy|3|||
94546957|NCT00996801|323799474|FG004|Overall Study|Lack of Efficacy|0|||
94546958|NCT00996801|323799475|FG005|Overall Study|Lack of Efficacy|1|||
94546959|NCT00996801|323799470|FG000|Overall Study|Lost to Follow-up|0|||
94546960|NCT00996801|323799471|FG001|Overall Study|Lost to Follow-up|0|||
94546961|NCT00996801|323799472|FG002|Overall Study|Lost to Follow-up|0|||
94546962|NCT00996801|323799473|FG003|Overall Study|Lost to Follow-up|3|||
94546963|NCT00996801|323799474|FG004|Overall Study|Lost to Follow-up|3|||
94546964|NCT00996801|323799475|FG005|Overall Study|Lost to Follow-up|2|||
94546965|NCT00996801|323799470|FG000|Overall Study|Physician Decision|0|||
94546966|NCT00996801|323799471|FG001|Overall Study|Physician Decision|0|||
94546967|NCT00996801|323799472|FG002|Overall Study|Physician Decision|0|||
94546968|NCT00996801|323799473|FG003|Overall Study|Physician Decision|1|||
94546969|NCT00996801|323799474|FG004|Overall Study|Physician Decision|0|||
94546970|NCT00996801|323799475|FG005|Overall Study|Physician Decision|0|||
94546971|NCT00996801|323799470|FG000|Overall Study|Progressive Disease|0|||
94546972|NCT00996801|323799471|FG001|Overall Study|Progressive Disease|1|||
94546973|NCT00996801|323799472|FG002|Overall Study|Progressive Disease|0|||
94546974|NCT00996801|323799473|FG003|Overall Study|Progressive Disease|0|||
94546975|NCT00996801|323799474|FG004|Overall Study|Progressive Disease|0|||
94546976|NCT00996801|323799475|FG005|Overall Study|Progressive Disease|0|||
94546977|NCT00996801|323799470|FG000|Overall Study|Protocol Violation|3|||
94546978|NCT00996801|323799471|FG001|Overall Study|Protocol Violation|4|||
94546979|NCT00996801|323799472|FG002|Overall Study|Protocol Violation|1|||
94546980|NCT00996801|323799473|FG003|Overall Study|Protocol Violation|2|||
94546981|NCT00996801|323799474|FG004|Overall Study|Protocol Violation|3|||
94546982|NCT00996801|323799475|FG005|Overall Study|Protocol Violation|4|||
94546983|NCT00996801|323799470|FG000|Overall Study|Study Terminated by Sponsor|0|||
94546984|NCT00996801|323799471|FG001|Overall Study|Study Terminated by Sponsor|1|||
94546985|NCT00996801|323799472|FG002|Overall Study|Study Terminated by Sponsor|0|||
94546986|NCT00996801|323799473|FG003|Overall Study|Study Terminated by Sponsor|0|||
94546987|NCT00996801|323799474|FG004|Overall Study|Study Terminated by Sponsor|46|||
94546988|NCT00996801|323799475|FG005|Overall Study|Study Terminated by Sponsor|0|||
94546989|NCT00996801|323799470|FG000|Overall Study|Withdrawal by Subject|8|||
94546990|NCT00996801|323799471|FG001|Overall Study|Withdrawal by Subject|6|||
94546991|NCT00996801|323799472|FG002|Overall Study|Withdrawal by Subject|9|||
94546992|NCT00996801|323799473|FG003|Overall Study|Withdrawal by Subject|5|||
94546993|NCT00996801|323799474|FG004|Overall Study|Withdrawal by Subject|5|||
94546994|NCT00996801|323799475|FG005|Overall Study|Withdrawal by Subject|9|||
94546995|NCT03602885|323799476|FG000|Overall Study|Lost to Follow-up|3|||
94546996|NCT03602885|323799477|FG001|Overall Study|Lost to Follow-up|0|||
94546997|NCT04397263|323799478|FG000|Overall Study|Withdrawal by Subject|2|||
94546998|NCT00004445|323799479|FG000|Overall Study|Physician Decision|2|||
94546999|NCT00004445|323799479|FG000|Overall Study|Withdrawal by Subject|1|||
94547000|NCT02753127|323799480|FG000|Overall Study|Lost to Follow-up|13|||
94547001|NCT02753127|323799481|FG001|Overall Study|Lost to Follow-up|11|||
94547002|NCT02753127|323799480|FG000|Overall Study|Withdrawal by Subject|37|||
94547003|NCT02753127|323799481|FG001|Overall Study|Withdrawal by Subject|47|||
94547004|NCT02753127|323799480|FG000|Overall Study|Other|3|||
94547005|NCT02753127|323799481|FG001|Overall Study|Other|8|||
94547006|NCT02753127|323799480|FG000|Overall Study|Hospice|0|||
94547007|NCT02753127|323799481|FG001|Overall Study|Hospice|2|||
94547008|NCT02212678|323799482|FG000|Overall Study|Adverse Event|1|||
94547009|NCT01519674|323799483|FG000|Overall Study|Adverse Event|3|||
94547010|NCT01519674|323799484|FG001|Overall Study|Adverse Event|3|||
94547011|NCT01519674|323799485|FG002|Overall Study|Adverse Event|0|||
94547012|NCT01519674|323799483|FG000|Overall Study|Lack of Efficacy|1|||
94547013|NCT01519674|323799484|FG001|Overall Study|Lack of Efficacy|1|||
94547014|NCT01519674|323799485|FG002|Overall Study|Lack of Efficacy|1|||
94547015|NCT01519674|323799483|FG000|Overall Study|Protocol Violation|0|||
94547016|NCT01519674|323799484|FG001|Overall Study|Protocol Violation|3|||
94547017|NCT01519674|323799485|FG002|Overall Study|Protocol Violation|1|||
94547018|NCT01519674|323799483|FG000|Overall Study|Withdrawal Criteria|7|||
94547019|NCT01519674|323799484|FG001|Overall Study|Withdrawal Criteria|2|||
94547020|NCT01519674|323799485|FG002|Overall Study|Withdrawal Criteria|7|||
94547021|NCT01519674|323799483|FG000|Overall Study|Unsclassified|10|||
94547022|NCT01519674|323799484|FG001|Overall Study|Unsclassified|4|||
94547023|NCT01519674|323799485|FG002|Overall Study|Unsclassified|3|||
94547024|NCT01610596|323799488|FG000|Overall Study|Lost to Follow-up|0|||
94547025|NCT01610596|323799489|FG001|Overall Study|Lost to Follow-up|1|||
94547026|NCT01114360|323799490|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
94547027|NCT01114360|323799491|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
94547028|NCT03921554|323799494|FG000|Overall Study|Adverse Event|2|||
94547029|NCT03921554|323799494|FG000|Overall Study|Withdrawal by Subject|1|||
94547030|NCT03921554|323799494|FG000|Overall Study|Death|3|||
94547031|NCT01646203|323799499|FG000|Overall Study|Adverse Event|2|||
94547032|NCT01646203|323799500|FG001|Overall Study|Adverse Event|0|||
94547033|NCT01646203|323799501|FG002|Overall Study|Adverse Event|1|||
94547034|NCT01646203|323799499|FG000|Overall Study|Withdrawal by Subject|0|||
94547035|NCT01646203|323799500|FG001|Overall Study|Withdrawal by Subject|1|||
94547036|NCT01646203|323799501|FG002|Overall Study|Withdrawal by Subject|0|||
94547037|NCT01646203|323799499|FG000|Overall Study|Physician's Decision|0|||
94547038|NCT01646203|323799500|FG001|Overall Study|Physician's Decision|1|||
94547039|NCT01646203|323799501|FG002|Overall Study|Physician's Decision|0|||
94547040|NCT00673881|323799507|FG000|Overall Study|Withdrawal by Subject|1|||
94547041|NCT01554514|323799511|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
94547042|NCT01554514|323799511|FG000|Overall Study|Physician Decision|1|||
94547043|NCT02322190|323799512|FG000|Overall Study|Death on study|1|||
94547044|NCT02322190|323799513|FG001|Overall Study|Death on study|0|||
94547050|NCT02758301|323799519|FG000|Overall Study|Death|12|||
94547051|NCT02758301|323799520|FG001|Overall Study|Death|0|||
94547052|NCT02758301|323799519|FG000|Overall Study|Physician Decision|10|||
94547053|NCT02758301|323799520|FG001|Overall Study|Physician Decision|1|||
94547054|NCT02758301|323799519|FG000|Overall Study|Withdrawal by Subject|5|||
94547055|NCT02758301|323799520|FG001|Overall Study|Withdrawal by Subject|6|||
94547056|NCT02758301|323799519|FG000|Overall Study|Lost to Follow-up|7|||
94547057|NCT02758301|323799520|FG001|Overall Study|Lost to Follow-up|0|||
94547058|NCT02758301|323799519|FG000|Overall Study|Protocol Violation|0|||
94547059|NCT02758301|323799520|FG001|Overall Study|Protocol Violation|1|||
94547060|NCT03157583|323799521|FG000|Overall Study|Other (did not meet study criteria)|1|||
94547061|NCT02900170|323799522|FG000|Overall Study|Lost to Follow-up|8|||
94547062|NCT01943552|323799523|FG000|Overall Study|Adverse Event|3|||
94547063|NCT01943552|323799524|FG001|Overall Study|Adverse Event|2|||
94547064|NCT01943552|323799523|FG000|Overall Study|Withdrawal by Subject|6|||
94547065|NCT01943552|323799524|FG001|Overall Study|Withdrawal by Subject|6|||
94547066|NCT01943552|323799523|FG000|Overall Study|Other Reasons|16|||
94547067|NCT01943552|323799524|FG001|Overall Study|Other Reasons|17|||
94547068|NCT02241187|323799533|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
94547069|NCT02356887|323799534|FG000|Overall Study|poor compliance|2|||
94547070|NCT01490294|323799535|FG000|Overall Study|Prematurely discontinuation|4|||
94547071|NCT01490294|323799536|FG001|Overall Study|Prematurely discontinuation|0|||
94547072|NCT01490294|323799537|FG002|Overall Study|Prematurely discontinuation|1|||
94547073|NCT01490294|323799538|FG003|Overall Study|Prematurely discontinuation|1|||
94547074|NCT01490294|323799535|FG000|Overall Study|Adverse Event|1|||
94547075|NCT01490294|323799536|FG001|Overall Study|Adverse Event|0|||
94547076|NCT01490294|323799537|FG002|Overall Study|Adverse Event|0|||
94547077|NCT01490294|323799538|FG003|Overall Study|Adverse Event|0|||
94547078|NCT00199888|323799541|FG000|Overall Study|Lost to Follow-up|1|||
94547079|NCT02544373|323799546|FG000|Overall Study|Lost to Follow-up|5|||
94547080|NCT02544373|323799547|FG001|Overall Study|Lost to Follow-up|3|||
94547081|NCT02544373|323799546|FG000|Overall Study|Withdrawal by Subject|8|||
94547082|NCT02544373|323799547|FG001|Overall Study|Withdrawal by Subject|2|||
94547083|NCT02404649|323799548|FG000|Overall Study|Adverse Event|1|||
94547084|NCT02404649|323799549|FG001|Overall Study|Adverse Event|2|||
94547085|NCT02299076|323799550|FG000|Overall Study|Fraudulent Entries|20|||
94547086|NCT02299076|323799551|FG001|Overall Study|Fraudulent Entries|14|||
94547087|NCT00330668|323799552|FG000|BID Dosing Period|Adverse Event|1|||
94547088|NCT00330668|323799552|FG000|BID Dosing Period|Lost to Follow-up|7|||
94547089|NCT00330668|323799552|FG000|BID Dosing Period|Non-Compliance|5|||
94547090|NCT00330668|323799552|FG000|BID Dosing Period|Withdrawal by Subject|19|||
94547091|NCT00330668|323799552|FG000|BID Dosing Period|Sponsor's decision|1|||
94547092|NCT00330668|323799552|FG000|BID Dosing Period|Other|3|||
94547093|NCT00330668|323799552|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
94547094|NCT00330668|323799552|FG000|QD Dosing Period|Other|1|||
94547095|NCT00330668|323799552|FG000|QD Dosing Period|Withdrawal by Subject|1|||
94547096|NCT00330668|323799552|FG000|QD Dosing Period|Lost to Follow-up|2|||
94547097|NCT03474081|323799555|FG000|Overall Study|Adverse Event|6|||
94547098|NCT03474081|323799556|FG001|Overall Study|Adverse Event|3|||
94547099|NCT03474081|323799555|FG000|Overall Study|Lost to Follow-up|2|||
94547100|NCT03474081|323799556|FG001|Overall Study|Lost to Follow-up|1|||
94547101|NCT03474081|323799555|FG000|Overall Study|Physician Decision|3|||
94547102|NCT03474081|323799556|FG001|Overall Study|Physician Decision|2|||
94547103|NCT03474081|323799555|FG000|Overall Study|Withdrawal by Subject|5|||
94547104|NCT03474081|323799556|FG001|Overall Study|Withdrawal by Subject|7|||
94547105|NCT03474081|323799555|FG000|Overall Study|Investigator site closed|1|||
94547106|NCT03474081|323799556|FG001|Overall Study|Investigator site closed|0|||
94547107|NCT04023682|323799557|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
94547108|NCT02290938|323799558|FG000|Overall Study|Lost to Follow-up|14|||
94547109|NCT02290938|323799559|FG001|Overall Study|Lost to Follow-up|43|||
94547110|NCT00958217|323799560|FG000|Overall Study|Death|2|||
94547111|NCT00958217|323799561|FG001|Overall Study|Death|1|||
94547112|NCT00958217|323799560|FG000|Overall Study|Withdrawal by Subject|4|||
94547113|NCT00958217|323799561|FG001|Overall Study|Withdrawal by Subject|3|||
94547114|NCT00958217|323799560|FG000|Overall Study|Lost to Follow-up|17|||
94547115|NCT00958217|323799561|FG001|Overall Study|Lost to Follow-up|19|||
94547116|NCT00958217|323799560|FG000|Overall Study|Moved out of area|1|||
94547117|NCT00958217|323799561|FG001|Overall Study|Moved out of area|1|||
94547118|NCT00958217|323799560|FG000|Overall Study|Inpatient hospitalization|0|||
94547119|NCT00958217|323799561|FG001|Overall Study|Inpatient hospitalization|1|||
94547120|NCT01638559|323799563|FG000|Overall Study|Lost to Follow-up|1|||
94547121|NCT01638559|323799563|FG000|Overall Study|Withdrawal by Subject|1|||
94547122|NCT01638559|323799563|FG000|Overall Study|Subject declined to travel for biopsy|1|||
94547123|NCT04232215|323799566|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
94547124|NCT04232215|323799567|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
